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Preface
The 21st International Pig Veterinary Society Congress is held in Vancouver, Canada, marking the first time Can-
adians have had the opportunity of hosting this meeting.  As a tribute to one of the founders of the IPVS and one 
of its most influential members, the 21st Congress will begin with the Tom Alexander Memorial Lecture delivered 
by Dr Hank Harris. In a slight departure from the format of previous meetings there will be only two keynote 
speakers, both on the opening morning. To introduce major topics there will be eight lead speakers who will 
each present a talk at the beginning of the specific concurrent session matching their area of expertise. For the 
first time at an IPVS congress posters will be presented electronically. The number of abstracts for this conference 
exceeds that of any previous IPVS congresses and this provided the scientific chairs with a challenge in terms of 
organizing the submissions for oral and poster presentations.  
We wish to thank the following reviewers for reading and scoring the abstracts and assisting with the organiza-
tion of the program: 
Glen Almond  Janet Alsop  Oystein Angen  Marie Archambault  Poul Baekbo
David Benfield  Pat Blackall  Tim Blackwell  Thomas Blaha  Patrick Boerlin
Corrie Brown  Mary Buhr  William Caine  Susy Carman  Glen Cassar
Chan Hee Chae  Jan Dahl  Peter Davies   Martin de Jong  Kees deLange
Anne Deckert  Cate Dewey  Scott Dee  John Deen  Jérôme del Castillo
Dennis DiPietre  Mariano Domingo  Trish Dowling  Richard Drolet  Gerald Duhamel
Kay Faaberg  John Fairbrother  Ying Fang  George Foxcroft  Julie Funk
Carl Gagnon  Connie Gebhart  Harold Gonyou  Marcelo Gottschalk  Marie Gramer
Roberto Guedes  Carlton Gyles  Fred Haesebrouk  Pat Halbur  Derek Haley
David Hampson  Patricia Holyoake  Scott Hurd  Dan Hurnik  André Jestin
Han Soo Joo Sven Jorsal  Roy Kirkwood  Robert Knox  Paul Langford
Lars Larsen  Martine Laitat  Arlette Laval  Ann Letellier  Paul Luimes
Joan Lunney  Janet MacInnes  François Madec  Dominiek Maes  Guy-Pierre Martineau
Eric Mateu  Scott McEwen  Steven McOrist  B.M. Meehan  Suzanne Millman
Cora Miry  Soenke Moehn  Antonio Morilla  Bob Morrisson  Herve Morvan
Michael Murtaugh  Hans Nauwynck  Eric Nelson  Jens Peter Nielsen  John Patience
Cinta Prieto  Zvonimir Poljak  John Prescott  Sylvain Quessy  Simone Oliviera
Tanja Opriessnig  Andrijana Rajic  Jim Riviere  Nicolas Rose  J. M. Sanchez-Vizcaino
Joaquim Segales   Mariela Segura  Glenn Songer  Vibeke Sørensen  Jim Squires
 Tomasz Stadejek  Katharina Stärk  Eileen Thacker  Flemming Thorup  Montserrat Torremorell
J.-P. Vaillancourt  Alain Villeneuve  Amy Vincent  Per Wallgren  Scott Weese
 Michael Wendt  Kyoung-Jin Yoon  Ruurd Zijlstra  Jeff Zimmerman. 
The final program consists of 266 oral presentations in addition to the 2 keynote and 8 lead presentations. There 
are roughly 890 posters. For the convenience of delegates the proceedings are divided into two parts repre-
senting oral presentations in part 1 arranged according to session and the posters in part 2 with papers grouped 
based on subject. For quick overview, a table of contents for both orals and posters is included at the beginning 
of the proceedings as well as an overall author index at the end
We sincerely hope all delegates will enjoy this time of coming together and sharing ideas and information and 
that the scientific and social programs will stimulate and encourage the advancement of knowledge and friend-
ship.
Sylvie D’Allaire and Robert Friendship
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Pig health assurance - underlying principles and future direction
DL Hank Harris
Department of Animal Science, College of Life Sciences and Agriculture and Veterinary Diagnostic 
and Production Animal Medicine, College of Veterinary Medicine, Iowa State University , Ames, IA, USA
Abstract 
The work of Tom Alexander centered on controlling swine dis-
eases to benefi t the breeding stock and commercial pig produ-
cer; and his discoveries and keen insight led to the principles 
of health assurance used world-wide in the industry today. 
An overview of his contributions to pig disease research and 
production, beginning with his involvement as an organizer of 
the fi rst IPVS Congress in 1969, and exemplifi ed by his paper de-
livered at that meeting concerning the development of disease-
free pigs, will be followed by a look to the future. 
Introduction 
“Important principles may, and must be infl exible“ 
—- Abraham Lincoln 
“The principles of disease control must not be set in stone. They are 
really guidelines which should be under constant re-evaluation 
and modifi cation. But modifi cation of a principle or action contrary 
to a principle should not be taken by any department or country 
without good reason and only after consultation and agreement 
among the appropriate parties. 
—— Tom Alexander, PIC Veterinary Liaison Meeting, Schlesvig, 
Germany 1991 “
The contradiction between these two quotations, one by a great 
politician and one by a great contributor to swine medicine 
exemplify Tom’s career as both an academician and as an early 
proponent of what we now refer to as evidenced-based medi-
cine (1,6,52). 
Let me explain by presenting an example - Tom was a student 
and early adopter of the Specifi c Pathogen-Free (SPF) program 
originated by George Young in the U.S. (61). In fact, Tom’s paper 
presented at the fi rst IPVS meeting in 1969 and co-authored 
by Ken Woolley (founder of Pig Improvement Company, now 
known as PIC) was entitled, SPF Swine Repopulation (15). By that 
time, Tom had designed and operated the fi rst experimental 
primary SPF procurement unit in Ontario, Canada and his paper 
was the fi rst introduction to the concept in Europe. It was Tom’s 
association with Ken and PIC which caused him to realize that 
strict adherence to the SPF principles would not be practical for 
either a breeder or a commercial operation. And although SPF 
organizations are still in existence today in some countries such 
as Switzerland, Denmark and at a minor level in North Amer-
ica, they have had to adopt Tom’s approach to fl exibility in the 
principles of health assurance. One could further expand this 
example by stating that the SPF association is a political organ-
ization while practical health assurance programs are carried 
out under the context of a profi table business. To paraphrase 
Tom’s philosophy, which has now been adopted by virtually all 
breeders and commercial operations of any size world-wide, 
health assurance principles must be adhered to as long a they don’t 
bankrupt the business. 
It seems only fi tting that at the fi rst IPVS meeting to be held in 
Canada that we honor Tom Alexander and give him credit for 
establishing the fi rst SPF units in Canada and bringing these pro-
cedures to Europe via the fi rst IPVS meeting held in Cambridge, 
England. 
Tom’s Major Achievements and Contributions 
I’ll return to more about Tom’s approach to swine evidenced-
based medicine but fi rst let us look at his educational back-
ground and his many contributions to swine medicine as an 
academician. 
After receiving his veterinary degree at London, Tom became 
house surgeon at the Large Animal Clinic in Ontario Veterinary 
College, fi nished a Master of Veterinary Science degree (Toronto) 
and served in various academic posts in Ontario through 1966. 
He completed his PhD degree at Cambridge during the years of 
1962-65, returning for a short time to Ontario prior to accepting 
a lecturer position at Cambridge in 1966 where he remained 
until retirement in 2004. It was while in Canada that Tom met 
and married his wife Lenore. 
Tom’s work at Ontario regarding SPF and gnotobiotic pigs 
(10,12,57) led to investigations into vomiting and wasting 
disease of pigs (3,5,11,56). He was the fi rst to describe its viral 
etiology, and picornaviruses became the subject of his PhD dis-
sertation at Cambridge (8) under the mentorship of A.O. Betts. 
David Taylor and Tom were the fi rst to describe the etiologic 
agent of swine dysentery (SD) in 1971(58). Their work was simul-
taneously and independently confi rmed by Bob Glock and my 
team at Iowa State University (ISU) (33,41). The fi rst IPVS meeting 
I attended was in 1972 in Hanover, Germany where Tom’s group 
and mine presented papers on the etiology and pathology of 
SD. These discoveries by our two teams led to a lasting friend-
ship, my consultative involvement with PIC, and scientifi c collab-
oration between Tom and me (40,62). Tom subsequently made 
many other contributions to our knowledge of swine dysentery 
(4,14,44). 
Tom’s pioneering work in primary SFP pigs, gnotobiotes and dis-
covery of anaerobic spirochetes in the intestine of pigs led him 
to more sophisticated studies on the anaerobic microbiota of 
pigs, sheep and rabbits [9538;9556;9559]. Eventually, his group 
at Cambridge and mine at ISU combined eff orts to discern the 
role of ‘normal’ fl ora such as Bacteroides and Fusobacteria in the 
pathogenesis of SD (40,62). Tom and Dick Lysons were the fi rst 
to develop gnotobiotic lambs with a defi ned functional rumen 
fl ora (46). 
While Tom was completing his PhD work on picornaviruses, he 
conducted some collaborative investigations and experiments 
with S.D. Elliott and J.H. Thomas on streptococcal meningitis 
and arthritis (28). Eventually, when streptococcal meningitis re-
emerged in the British pig industry and became a threat to both 
pigs and humans around 1975, Tom led the eff ort to understand 
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and control the disease. This work by Tom and his student and 
colleague, Feliciti Clifton-Hadley was his largest contribution to 
the scientifi c literature. These clinical investigations and experi-
ments led to discoveries pertaining to pathogenesis, control 
measures including vaccine development, and epidemiology of 
the disease (19,21-26,42,43,64). 
The development of Medicated Early Weaning (MEW) was one 
of Tom’s best known contributions to the pig industry (13). 
Until 1978, there were 3 methods of starting and maintaining 
high health status herds with new genetic material: 1) direct 
population from another high health status herd; 2) grafting 
desired genes by artifi cial insemination or embryo transfer or 
cross-fostering young piglets; and 3) population by primary SPF 
methods (1). In 1977, the main PIC nucleus herd (Fyfi eld Wicke) 
became infected with Mycoplasma hyopneumoniae. The herd 
had been established by surgical-derivation in 1962 and this was 
its fi rst encounter with the organism. Ken Woolley asked Tom to 
try a diff erent method other than surgical-derivation to set up 
a new nucleus herd free of M. hyopneumoniae. Tom proposed 
the hypothesis that medication of both the sow and piglets 
combined with early weaning would result in pigs free of the in-
fection. He enlisted Dick Lysons (then at Compton) and some PIC 
folks (mainly Graham Boon and Keith Thornton) to help with the 
design and implementation of his hypothesis. The MEW project 
was a huge success and resulted in not only the elimination of 
M. hyopneumoniae but also Bordetella bronchiseptica and some 
non-pathogenic colonic treponemes (now called Brachyspira). 
The MEW technique was soon adopted in PIC herds in France, 
Brazil and the U.S. with similar results. In an attempt to decrease 
the cost of repopulating herds even further, PIC modifed the 
procedures which became known by several synonyms; modi-
fi ed MEW (MMEW), Isowean, and Segregated Early Weaning 
(SEW) (27,32,36-39,45,53). MEW or MMEW are now used to 
eliminate a variety of infectious agents including: pseudorabies 
virus, Porcine Reproductive Respiratory Syndrome Virus (PRRSV), 
Transmissible Gastroenteritis (TGE) Virus, Leptospira, Pasteurella 
multocida, Actinobacillus pleuropneumoniae, Streptococcus 
suis type II, and Haemophilus parasuis. The modifi cations applied 
to MEW were the basis for the l development of three site and 
multiple site production rearing systems (37,39). Other breeding 
stock companies have used the techniques to eliminate various 
infectious agents. 
In the late 90s, Tom became interested in zoonoses involved in 
pig to human xenotransplantation (54). One of his last presenta-
tions, at the 1998 IPVS, bore the title ‘Zoonoses’, in which he de-
scribed all the pathogens of pigs of possible concern to human 
health. He concluded that the only pathogen of signifi cance was 
Salmonella (2). His concern at the time was the possibility that 
transgenic pig hearts and kidneys would soon be transplanted 
into humans. This has not been forthcoming, unfortunately, for a 
variety of reasons unrelated to the risk of pig to human transmis-
sion of disease. 
During the early days of his tenure as Lecturer at Cambridge 
University, Tom fi rst met Ken Woolley, President of PIC. Becom-
ing an advisor to PIC was crucial to Tom’s development as both 
an academician, applied scientist and leader of evidenced-based 
swine medicine. The most important swine diseases at the 
time were atrophic rhinitis and enzootic pneumonia. Professor 
Betts in London was an early investigator in etiologic studies on 
enzootic pneumonia of pigs and pig producers in England were 
wanting pigs free of the disease. While Peter Whittlestone and 
Reg Goodwin at Cambridge and Bill Switzer and John Mare in 
Ames were discovering the causative agent (called Mycoplasma 
hyopneumoniae (48) in Ames and M. suipneumoniae (34,35) in 
Cambridge), Tom was busy establishing enzootic pneumonia 
free herds for PIC. Goodwin was a proponent of the SPF ap-
proach which he later named ‘Minimal Disease (MD) Program’. 
Through his experience in dealing with the practical aspects of 
advising a breeding stock company, Tom departed from the SPF 
and MD programs strict adherence to rigid rules concerning the 
presence/absence of specifi c pathogens. It was his departure 
from testing for the presence of specifi c pathogens to considera-
tion of the practical diff erence between infection versus disease 
which set the stage for Tom’s remarkable contributions to pig 
production world-wide (1). 
Tom relied heavily on the discoveries being made by Betts, 
Goodwin, Whittlestone and Switzer in his advisory capacity 
to PIC, as it was during this period of time when respiratory 
diseases such as Mycoplasma pneumonia and atrophic rhinitis 
were key economic factors in commercial production Tom for-
mulatedthe Veterinary Liaison Scheme for PIC and the imple-
mented disease control strategies in that document have now 
become dogma in the swine industry world-wide. 
This was how they worked: 
Tom was one of the fi rst veterinarians to recognize that pig 
density and farm location were important for disease control 
for both commercial operaters and breeding stock producers 
(reviewed by Tom in his Howard Dunne Memorial lecture at the 
American Association of Swine Practitioners in 1988 (16)and also 
published by the Pig Veterinary Society (7). 
Tom found that the SPF and MD programs were too infl exible for 
the development of a breeding stock organization such as PIC. 
His insight led to concepts which are common terms/principles 
in the industry today: single sourcing of breeding stock and 
replacements, vet to vet interactions for matching the infectious 
disease status between source farm and the recipient farm, lab-
oratory tests can be useful but never do a test if you aren’t sure 
of how to interpret the results, a breeder cannot guarantee free-
dom from disease (the main downfall of the SPF/MD programs), 
when problems arise in a breeder herd, shipments must be 
put on ‘hold’ until an investigation can occur to protect down-
stream recipient herds, pig movement should only be one way, 
down a pyramid but never reversed or across a pyramid and the 
implementation of biosecurity measures including shower-in; 
shower-out. Without doubt, many breeders went out of busi-
ness for failure to follow these rules. Today, most breeders follow 
these rules and many commercial operations who have become 
breeders in their own organizations should follow them more 
closely. There is no doubt that PIC would not enjoy its dominant 
position today in the breeding stock business if it had not been 
for Tom’s insight and creativity in these early days of PIC (person-
al communication, Bill Christianson, CEO, Genus Americas). 
In 1989, Tom organized a meeting of all the PIC associated 
veterinarians from around the world in Schlesvig, Germany. It 
was a 3 day meeting in which he led the 30 plus attendees in a 
discussion leading to the creation of a document entitled the 
Principles of Disease Control (later called The Principles which 
underlie the PIC Health Assurance Programme). The current 
version is reprinted here with the permission of PIC. One of the 
most entertaining aspects of the meeting was the ‘role playing’ 
performed by veterinarians from various countries which led to 
a better understanding of practical disease control approaches. 
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The Principles Which Underlie The PIC Health Assurance 
Programme 
1 Genetic improvement is a long term business and therefore 
the over-riding approach to disease control in PIC must be 
long term. 
2 Every PIC herd should be set up with the healthiest pigs 
available that are appropriate for the purpose. 
3 For insurance purposes there should be a contingency plan 
for the supply of suitable genetics to sustain the business. 
4 It is both impossible and unnecessary to try to standardise 
the health status of all the herds throughout a breeding 
organisation. 
5- PIC aims to protect customer health but cannot guarantee 
freedom from specifi c infectious agents. 
6 PIC should adopt a continuous policy of maintaining high 
health status overall by such measures as closure of herds 
when they become unsatisfactory, the application of total 
or partial repopulation and the establishment of new high 
health status herds. 
7 PIC must monitor for evidence of virulent pathogens over a 
wide spectrum of diseases and anticipate that new diseases 
will arise. 
8 When a problem is suspected in a herd, sales must be put on 
hold while it is investigated. 
9 Location is the most important factor in preventing contam-
ination and herd breakdowns. 
10 If a herd is situated in an excellent location the most import-
ant biosecurity factor is then the introduction and removal 
systems. 
11 All pig transport and pig movement must meet PIC specifi ca-
tions 
12 Pigs should move in one direction only, that is down the 
pyramids and not across it or up it. 
13 Appropriate biosecurity measures must be taken on every 
farm to prevent contamination and should be proportional 
to the impact of a breakdown in that unit. 
14 The movement of people between herds or other sources of 
contamination must be controlled and appropriate down-
time must be laid down for each herd. 
15 To prevent dissemination of disease and because PIC cannot 
standardise health, PIC should aim at single sourcing and 
minimize source changes, keeping necessary changes within 
pyramids. 
16 Laboratory tests can be very useful, but never do a test if you 
cannot be sure of interpreting the results. 
17 The implementation of the health assurance programme 
should be predominantly regional and local rather than 
central, and where appropriate PIC should use independent 
veterinarians. 
18 Every new nucleus and multiplier herd should be totally 
populated with PIC stock and must be pre-approved by 
Health Assurance. 
19 Because clinical signs of disease are a major component of 
monitoring and diagnosis, antibiotics or vaccines that mask 
clinical signs must not be used routinely in PIC herds. 
20 Every herd that receives live animals should isolate and mon-
itor them before introduction. 
21 Boar studs should be considered equal to nucleus herds with 
respect to set-up, monitoring and biosecurity. 
22 PIC should be open about the operation of the health assur-
ance programme and should communicate with individual 
customers particularly when problems arise. 
23 Welfare is a component of the health assurance programme 
and should be monitored regularly. 
The principles must not be set in stone. They are really guide-
lines which should be under constant re-evaluation and 
modifi cation. But modifi cation of a principle or action contrary 
to a principle should not be taken by any department or country 
without good reason and after consultation and agreement with 
Health Assurance. 
No matter where in the world a new infectious agent emerged 
or re-emerged, Tom would often play a role in discerning the 
economic importance of the agent in a particular region or 
country and then either direct or assist in developing disease 
control strategies. Many of these opportunities came about 
because of his senior advisory role to PIC but often veterinarians 
and geneticists from other breeding stock companies or SPF 
organizations would call on him for advice. There are numerous 
unpublished documents penned by Tom in the fi les of veterinar-
ians world-wide. These deal with a variety of infectious agents 
from Pasteurella multocida to PRRSV and PCV-2. Many of these 
contributions were not necessarily credited to Tom. For example, 
he had a major role in the early development of procedures to 
control PRRSV in boar studs UK and US and in the elimination of 
Foot and Mouth Disease virus in a herds in China (55). 
Future Direction 
Advancing Pig Health 
I commend the organizing and scientifi c committees of this 
meeting for choosing this theme. Since the fi rst IPVS meeting 
in 1969 which Tom helped organize, this group has emphasized 
the importance of infectious and non-infectious diseases and 
their impact on pig health. As new agents emerge and old ones 
re-emerge, pig veterinarians and scientists must continually util-
ize fi eld data, evidence-based analysis/conclusions and scientifi c 
discoveries to improve the health status of swine. Furthermore, 
economic constraints combined with management and struc-
tural changes such as vertical integration are continual threats 
to the health and well-being of swine. The scientifi c program 
committee has done an excellent job in fulfi lling the theme of 
the congress. 
Vaccines will become increasingly important for the control of 
infectious diseases especially when fewer and fewer pharma-
ceuticals are available for either growth promotion or preven-
tion/therapy. Within the next 10 years, immunogenetics will 
become increasingly important not necessarily for the creation 
of disease resistant pigs but rather for the development of 
vaccine-ready pigs (47,63). Evidence already exists in both 
swine and cattle that multi-disciplinary approaches combin-
ing immunobiology, quantitative and molecular genetics with 
reverse genetics related to infectious agents will lead to more 
powerful and cost eff ective prevention of infectious diseases. If 
regulatory agencies do not streamline approval processes and 
recognize molecular based technologic advances, the consoli-
dation of the swine industry will result in integrators preparing 
their own sophisticated vaccines. Both virulent and avirulent 
(modifi ed live) viruses have been used extensively in swine in an 
attempt to control PRRSV (49-51,65). It has been clearly shown 
that the re-introduction of live PRRSV into swine induces new 
strains of the virus containing both virulent and vaccine genes 
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(29,66). These newly created viruses not easily contolled with 
currently available vaccines. Recently, it was reported that the 
use of attenuated Newcastle Vaccines has created and main-
tained a large population ofvaccine-related genotype viruses. 
The presence of these viruses has allowed for co-infection and 
recombination of vaccine and wild type strains (20). 
I predict that by 2020, Porcine Reproductive Respiratory Syn-
drome (PRRS) virus will be eradicated from major swine rearing 
areas of the world. This will be due to industry recognition that 
live viruses (modifi ed live or virulent) must not be used in con-
trol programs for the disease. Breeders have long since recog-
nized the necessity of maintaining nucleus and multiplier herds 
free of PRRSV. In addition, it is well known and accepted that 
closed herds with high biosecurity measures often eliminate the 
virus if live viruses are not used in the herd (60) . 
Swine infl uenza virus (SIV) will continue to infect and form 
reassortants in the adult breeding herds. The concern that these 
viruses pose a threat to human health will drive the industry to 
wean and rear pigs free of SIV. Isowean pigs can be procurred 
free of SIV(38) and a multi-site system has sucessfully elminated 
SIV without vaccination (59). Vaccines will be developed which 
override the interference of the SIV immune response due to 
maternal antibody. 
Recombinant-based vaccines will become more commonly 
available for the prevention of swine diseases. At the present 
time, they are more costly to produce than traditional vaccines 
from live or inactivated viruses. It is important for the creation 
of stockpiles of vaccines for Foreign Animal Diseases (FAD) that 
recombinant based vaccines be created and approved for use in 
the U.S. For example, Foot and Mouth Disease vaccines are cur-
rently not produced in the U.S. due to diffi  culty in production of 
vaccines requiring growth of the virus. As the recombinant vac-
cines are improved and shown to provide a signifi cant economic 
benefi t, these vaccines will replace traditional vaccines. Some 
vaccines for Porcine Circovirus (PCV) are recombinant pro-
teins (derived from baculovirus) and others are prepared from 
chimeric viruses (30,31). There are no recombinant vector based 
vaccines for swine available in the U.S. Chimeric and vector 
based recombinant vaccines have a distinct advantage in that 
they induce both humoral and cell mediated responses (17,18). 
Recombinant vaccines will be especially useful in the develop-
ment of vaccines which diff erentiate infected from vaccinated 
animals (DIVA). 
Pig Health Assurance World-Wide 
Pigs world-wide will be reared in systems in which the newly 
weaned pig is placed in isolation away from the breeding and 
farrowing operations. This simple concept originated with Tom’s 
concept of medicated early weaning (MEW) in 1978 (13). The 
modifi cations made to MEW eventually led to the development 
of three site and multi-site production systems which are util-
ized in every main pig rearing country in the world (37,39). Even 
natural and organic pig rearing systems rely on this concept of 
isolated weaning for disease control. 
The major disadvantage of multi-site rearing systems is the 
evolution of lowered herd immunity due to separation of the 
young growing and fi nisher pigs (37). This will be overcome by 
improved vaccines. However, as consolidation continues in the 
swine industry, a major restructuring of wean to fi nish build-
ings will occur. This will result in more strict adherence to all-in; 
all-out and single sourcing principles as advocated by Tom many 
years ago. Furthermore, commercial operations will follow the 
lead of breeders and pay closer attention to the value of well 
isolated sites in order to minimize disease during the grower-
fi nisher stages. 
Welfare and environmental issues will continually challenge the 
industry but the solutions to these problems will actual improve 
the health and productivity of pigs. Less crowding with better 
housing will lead to improved pig health andfi nancial success. 
Furthermore, the environment will improve as the concentration 
of pigs per square mile decreases. The isolation/location of pig 
units will benefi t from a biosecurity standpoint. 
In the 1960/70s, the United Kingdom led the world in innova-
tion and effi  cient swine production. This was soon followed by 
North American producers in the adoption of new technology, 
expansion, improvement in pigs per sow per year and feed ef-
fi ciency and vertical integration especially in the 1980/90s. For 
2010 and beyond, we’ll witness huge technological advance and 
contribution to the pig industry in China. As Tom suggested, the 
Principles of Health Assurance will need to be fl exible to meet 
these changing times and situations by country. 
I would like to end on a personal note. 
Tom was friend, mentor, and colleague to me but most of all I 
was the pupil. He came into my life at a most opportune time. I 
am forever grateful. 
When the pupil is ready to learn, a teacher will appear. 
-Zen Proverb 
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KS2
Animal welfare and the veterinary profession: 50 years of change
David Fraser
Animal Welfare Program, Faculty of Land and Food Systems, University of British Columbia, Vancouver, BC, Canada
Introduction 
About 10 years ago I received an unexpected telephone call. It 
was from the Burger King Corporation to say that the company 
wanted to create a program to assure their customers about the 
welfare of the animals in their supply chain, and would I serve on 
the advisory committee. I admit to having been a trifl e skeptical. 
Fast food restaurants as agents of social change? – it did not 
quite fi t the popular stereotype. But I joined the committee and 
was pleasantly surprised to fi nd myself in discussions about 
maintaining public trust and ‘doing the right thing’ for animals. 
To cut a long story short, Burger King’s engagement in animal 
welfare led to some tangible changes. In fact Temple Grandin 
(2000), after years of inspecting slaughter plants with mediocre 
animal welfare standards, reported a dramatic improvement im-
mediately after chain restaurants became involved.
This, of course, is just one example of the remarkable growth 
in attention being paid to animal welfare, in some cases by 
unexpected players:
• In 2005 the 170 member nations of the World Organization 
for Animal Health unanimously adopted 80 pages of animal 
welfare standards which now appear in the highly infl uential 
Terrestrial Animal Health Code. 
• Around the same time the International Finance Corporation, 
the investment arm of the World Bank, called for animal wel-
fare to be part of the business plan of the livestock compan-
ies in which they invest.
• In 2008 the FAO, the United Nations agency involved in 
agriculture and hunger reduction, held an international 
consultation on how to help countries, especially developing 
countries, to implement good animal welfare practices.
• And it is expected that a ‘Universal Declaration on Animal 
Welfare’ will soon be presented to the United Nations with 
the expressed support of many of the world’s countries.
Nearly 40 years ago, when I began doing research on the welfare 
of pigs, animal welfare was on the very fringe of science. To most 
people the words ‘research’ and ‘animal welfare’ did not belong 
in the same sentence except perhaps to criticize animal welfare 
standards in laboratories. So how did it happen that animal wel-
fare moved from being a fringe issue to something that attracts 
the attention of Burger King, the World Bank and the United 
Nations? 
In this presentation I would like to trace this change by looking 
at four topics:
• some of the reasons behind the growing focus on animal 
welfare
• the debate about exactly what ‘animal welfare’ means
• some of the science that has been applied to animal welfare 
issues
• and the role of veterinarians in this rapidly changing world.
The growing focus on animal welfare
Every culture has an ‘animal mythology’ – a set of fundamen-
tal beliefs and values regarding animals – which we can often 
perceive through the art and stories of the culture (material 
in this section is from Fraser, 2008). In the creation story of the 
Ojibway culture of central Canada, people had fallen from the 
sky onto an earth that was covered in water, and they were able 
to survive only because the animals took pity on them, start-
ing with the turtle who allowed its shell to form the base of the 
dry land. And throughout Ojibway legends and conduct, we 
see this fundamental assumption – perhaps not surprising for a 
hunting culture living in a harsh northern climate – that people 
are vulnerable beings whose survival is made possible by the 
cooperation of animals. 
The fi rst chapter of the Bible tells the very diff erent creation 
story of a pastoralist culture where the ownership and care of 
animals was fundamental to the economy. In that story we read 
that life began when God created the natural world and fi lled 
it with plants and animals, and then, as a fi nal act of creation, 
produced human beings and set them to rule over the natural 
world in god’s place. And later in the story, when God fl ooded 
the world, it was the capable humans who saved the helpless 
animals from drowning, which is roughly the opposite of how 
the Ojibway saw the relationship.
In these two examples of animal mythology we see both empir-
ical beliefs – about what animals are like and the history of our 
involvement with them – and evaluative or ethical beliefs about 
how important animals are and how they should be treated. 
The biblical creation story implied that people and animals are 
separated by a large gulf which included at least three com-
ponents. One was appearance: people had been created in the 
‘image’ of God, and therefore looked nothing like birds, fi sh or 
quadrupeds. Second, people had a diff erent origin: they were 
created separately from the animals and for a diff erent purpose. 
And third (although disagreement arose on this point) people 
were seen as having a unique inner, spiritual nature that animals 
did not share. Here, then, were three empirical beliefs – about 
diff erent appearance, diff erent origin, and diff erent inner life – 
that reinforced the idea of humans as fundamentally diff erent 
from animals and helped to justify the use of animals for human 
purposes.
But in modern culture, empirical beliefs are not fi xed by the 
constant retelling of traditional stories, but rather are subject to 
change in light of scientifi c discoveries and other developments. 
And indeed over the centuries we have seen these three empir-
ical beliefs gradually chipped away, at least partly by science.
The fi rst scientifi c development came from anatomy. Beginning 
in Italy during medieval times, the study of anatomy became 
one of the frontiers of scientifi c research for many centuries. 
Moreover, this research was communicated to the public in the 
many ‘dissecting theatres’ that sprouted up in the major centres 
of learning. These theatres allowed people to witness the dis-
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section of animals or even humans cut down from the gallows. 
And through this anatomical research and the remarkably direct 
form of public education, it came to be recognized that humans 
– organ for organ and bone for bone – are actually built on the 
same anatomical template as the other vertebrate animals.
This realization became common knowledge around the year 
1700, and it touched off  two centuries when scientists and phil-
osophers alike struggled to understand the implications of this 
new knowledge. The process culminated with the evolutionary 
biology of the 1800s and the startling proposal that the reason 
why we and other species have the same anatomical structure 
is that we share a common evolutionary origin. Thus, by about a 
century ago people had lost both their unique appearance and 
their unique origin. 
Late in the 1900s, I think the study of animal behaviour led to a 
further revision in our view of animals, this one centred on their 
mental and emotional lives. A classic example is the work of 
primatologist Jane Goodall who studied animals in such detail 
that she could describe their personalities and unique life histor-
ies. From Jane Goodall we learn about the young chimpanzee 
she called ‘Flint’ who, at the mature age of eight, remained so 
attached to his aging mother that when she died, he stayed near 
the place of her death until he himself died of starvation. Draw-
ing together this and many other observations, primatologist 
Roger Fouts (1997) described the chimpanzee as a: 
‘highly intelligent, co-operative, and violent primate 
who nurtures family bonds, adopts orphans, mourns 
the death of mothers, practises self-medication, 
struggles for power, and wages war.’ 
Thus, with some species at least, even in our mental lives the 
gap between humans and animals has come to seem remark-
ably narrow. 
To sum up, the large gap between people and animals that 
we saw in the Biblican creation story has narrowed through 
scientifi c research, so that many people today believe that 
humans and animals share a common anatomical form, a com-
mon evolutionary ancestry and, with some species, a complex 
mental and emotional life. This altered set of empirical beliefs, 
about what animals are like, has stimulated a massive rethink-
ing of our ethical beliefs, about how animals should be treated. 
And because science has expanded from being an element of 
Western culture, and has become more an element of global 
culture, perhaps it is not surprising that animal welfare is rapidly 
becoming a global issue.
What is animal welfare?
As the current wave of concern about animal welfare began, 
roughly in the 1960s, a debate emerged over what animal wel-
fare really involves.
The fi rst major criticism of confi nement production systems 
came in the book Animal Machines, by the English animal advo-
cate Ruth Harrison (1964). She described cages for laying hens 
and crates for veal calves, and she claimed that these systems 
are so unnatural that they cause animals to lead miserable and 
unhealthy lives. She went on to ask: 
How far have we the right to take our domination of 
the animal world? Have we the right to rob them of all 
pleasure in life simply to make more money more quickly 
out of their carcasses?
Later, in Animal Liberation, Australian philosopher Peter Singer 
(1990) adopted the principle that actions should be judged right 
or wrong on the basis of the pain or pleasure that they cause, 
and he claimed:
There can be no moral justifi cation for regarding the 
pain (or pleasure) that animals feel as less important than 
the same amount of pain (or pleasure) felt by humans.
In these and many other quotations, a key concern centres on 
words like “pleasure”, “pain”, “suff ering”, and “happiness”. There is 
no simple English word to capture this class of concepts. They 
are sometimes called “feelings but that term seems too insub-
stantial for states like pain and suff ering. They are sometimes 
called “emotions but emotions do not include states like hunger 
and thirst. Perhaps the most accurate, if rather technical, term is 
“aff ective states”, a term that refers to emotions and other feel-
ings that are experienced as either pleasant or unpleasant rather 
than hedonically neutral.
In discussing animal welfare, however, some people put the 
emphasis elsewhere. A British committee that was formed to 
evaluate the welfare of farm animals concluded:
In principle we disapprove of a degree of confi nement 
of an animal which necessarily frustrates most of the 
major activities which make up its natural behaviour. 
(Brambell 1965)
Astrid Lindgren, the famous author of the Pippi Longstock-
ing stories and a driving force behind animal welfare reform in 
Sweden, proposed:
Let [farm animals] see the sun just once, get away from the 
murderous roar of the fans. Let them get to breathe fresh air for 
once, instead of manure gas. (Anonymous 1989)
And American philosopher Bernard Rollin (1993) insisted that 
we need:
 … a much increased concept of welfare. Not only will 
welfare mean control of pain and suff ering, it will also 
entail nurturing and fulfi lment of the animals’ natures 
In these quotations, although aff ective states were often 
involved implicitly or explicitly, the central concern was for a de-
gree of “naturalness” in the lives of animals: that animals should 
be able to perform their natural behaviour, that there should 
be natural elements in their environment, and that we should 
respect the “nature” of the animals themselves.
All of the above quotations refl ected the views of social critics 
and philosophers, but when farmers and veterinarians engaged 
in the debate, they brought a diff erent focus. For example, one 
veterinarian defended confi nement systems this way:
My experience has been that ... by-and-large the stan-
dard of welfare among animals kept in the so called 
“intensive” systems is higher. On balance I feel that 
the animal is better cared for; it is certainly much freer 
from disease and attack by its mates; it receives much 
better attention from the attendants, is sure of shelter 
and bedding and a reasonable amount of good food 
and water. (Taylor 1972)
Or as the veterinary educator David Sainsbury (1986) put it:
Good health is the birthright of every animal that we 
rear, whether intensively or otherwise. 
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Here the primary emphasis is on the fairly traditional concerns 
of veterinarians and animal producers that animals should have 
freedom from disease and injury, plus food, water, shelter and 
other necessities of life – concerns that we might sum up as the 
basic health and functioning of the animals. 
In these various quotations, then, we see a variety of concerns 
that can be grouped roughly under three broad headings: one 
centres on the aff ective states of animals, one on the ability of 
animals to lead reasonably natural lives, and one emphasizes 
basic health and functioning. These are not, of course, complete-
ly separate or mutually exclusive; in fact, they often go hand in 
hand. Letting a pig wallow in mud on a hot day is good for its 
welfare because the pig will presumably feel more comfortable 
(an aff ective state), because it can perform its natural cooling be-
haviour (natural living), and because it will have less disruption 
of its body processes caused by heat stress (basic health).
But the diff erent criteria do not always go together. The gesta-
tion stall, where sows cannot walk or turn around for most of 
pregnancy, is a way of promoting healthy weight gain and 
avoiding injuries from aggression, but it is very unnatural and 
may create a life that is not very pleasurable. Feeding sows as 
much as they want may avoid unpleasant feelings of hunger, but 
can lead to unhealthy weight gain. Some outdoor systems look 
very natural, but involve parasitism and low piglet survival. Thus, 
genuine disagreements can arise when people try to create 
standards or practices to promote animal welfare based on any 
one of the three areas of concern.
Animal welfare science
As this debate unfolded in the 1960s and 1970s, people began 
doing scientifi c research on animal welfare. Partly the research 
was done for the practical goal of making production systems 
more effi  cient by making them better suited to the animals. And 
partly the research was done because people expected science 
to resolve the disagreements over the interpretation of animal 
welfare. Surely, if animal welfare standards were ‘science-based’, 
there could be no disagreements based on diff ering interpreta-
tions of animal welfare. The outcome, however, proved more 
interesting as the following simple examples show.
Some of the research used the basic health and functioning 
of animals as an indicator of animal welfare. In one elegantly 
simple example Ragnar Tauson and co-workers (1998) improved 
the design of cages for laying hens just by studying the health 
of birds in cages of diff erent types. They found that the birds 
developed foot lesions if the slope of the fl oor was too steep, 
and neck lesions if the feed trough was too deep and installed 
too high for comfortable access. There was often feather dam-
age that could be reduced by using solid side partitions, and 
overgrown claws that could be prevented by installing abra-
sive strips. By modifying cage designs accordingly, Tauson was 
able to make large improvements in animal welfare as well as 
production effi  ciency, and this research then formed the basis 
of animal welfare standards for cage design, fi rst in Sweden and 
then in the European Union.
Other scientists tried to improve animal welfare by making living 
conditions more ‘natural’ for animals. On many commercial dairy 
farms, calves are separated from their mothers within the fi rst 
day after birth, and are then fed milk from a bucket, usually in 
two fairly large meals per day. This, of course, is very unnatural. 
Under natural conditions, the calf would stay close to the cow 
for the fi rst two weeks, and would feed many times per day in 
smaller meals. Leaving cows and calves together is not feasible 
on dairy farms, but calves can still be fed in a more natural way. 
First, if the calves suck from a teat rather than drink from a pail, 
the sucking action seems to stimulate certain digestive process-
es more eff ectively. Second, if the teat feeding system allows the 
calves to have many small meals per day (as they would if feed-
ing from the cow), then they can consume a larger daily intake 
without developing digestive problems. As a result, such calves 
gain much more weight than calves fed twice a day by bucket 
(Appleby et al. 2001).
In other cases, research has tried to reduce unpleasant aff ective 
states in animals. Hot-iron disbudding of calves involves heating 
a ring-shaped iron to about 600 degrees Celcius and pressing it 
against the calf’s head so that it burns through the nerves and 
blood vessels that would allow the horn to develop. Research 
in New Zealand by Staff ord and Mellor (2005) used changes 
in plasma levels of the stress-related hormone cortisol as an 
indirect indicator of the resulting pain. Hot-iron disbudding was 
followed immediately by an increase in cortisol, but that reac-
tion was blocked if lidocaine was used to freeze the area. Even 
with lidocaine, however, cortisol levels showed a clear increase 
several hours after the disbudding, probably because the area 
remained infl amed and painful after the freezing had worn off . 
However, if an analgesic such as ketoprofen is added to the calf’s 
milk on the morning and evening of the dehorning, the second 
peak of cortisol is also eliminated. The results indicate that 
eff ective pain management requires both local freezing and a 
longer-acting analgesic.
In the early stages of the debate about animal welfare, some 
people expected that the science would eliminate any disagree-
ment over the diff erent elements of animal welfare by fi nding 
the one ‘scientifi c’ view. Instead, each of the diff erent views 
of animal welfare led to research that provided diff erent and 
complementary ways of improving animal welfare, and all three 
have led to practical improvements and science-based animal 
welfare standards. Thus, instead of the science resolving the dif-
ferent interpretations of animal welfare, the diff erent interpreta-
tions actually came to underlie and enrich the science.
The take-home message for the animal-based industries is that 
all three views of animal welfare have a scientifi c basis, and 
that the single-minded pursuit of any one criterion of animal 
welfare may fail to promote animal welfare as judged by the 
other criteria. For standards and practices to be widely accepted 
as improving animal welfare, they need to make a reasonable 
accommodation to all three.
The role of veterinarians
What is the role of veterinarians in this world of changing values 
and emerging science? 
First, we need to recognize that animal welfare research is not 
a mature fi eld of science. Much of the research is still more 
conceptual than strategic. Much of it is done at a research-
farm scale, not a commercial scale. And much of it does not yet 
involve the multi-disciplinary teams that are needed to look at 
all the implications of new ideas. There is a great opportunity for 
veterinarians to work with animal welfare scientists to refi ne and 
broaden the science, and to apply it in practical ways. Here, then, 
is a scientifi c and technical role.
Second, the increased public concern about the welfare of ani-
mals has created an expectation that veterinarians will provide 
leadership in promoting animal welfare, not just as technical 
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specialists working to prevent and treat disease (important as 
that is), but also as champions of animal welfare in a broader 
sense that includes the diff erent areas of concern. Here is a social 
leadership role.
I believe there is some urgency about fulfi lling these roles. 
Some highly intensive pig production emphasizes basic health 
but ignores other animal welfare concerns; these systems 
sometimes off end against the public’s view of what constitutes 
decent treatment of animals. Unless scientists and veterinar-
ians can deal with the problems, then legislators and referenda 
may do so instead, and the outcomes may be less than ideal for 
the animals and for producers. At the other extreme there is a 
growth in outdoor systems that tend to be seen by the public as 
high-welfare, more or less by defi nition, but may involve serious 
problems of basic health and functioning. There is a need for 
technical innovation and good standards to ensure that this 
well-intentioned development does lead to good welfare for the 
animals. 
But why, in 2010, are such basic problems as these still waiting 
to be solved? A century ago, agricultural and veterinary students 
studied a subject called ‘animal husbandry’ which included 
the feeding, breeding, handling, management and housing of 
animals. Then certain branches of science became established 
– nutrition, physiology, genetics – and before long, animal 
husbandry was replaced by a handful of scientifi c specialties. 
But when that happened, some of the original components of 
animal husbandry – the handling and management and hous-
ing – seemed to be forgotten as areas for scientifi c research and 
training. I think animal welfare science is fi nally restoring these 
missing elements of animal husbandry, but with a scientifi c basis 
that was not available a century ago. Here we see an educational 
role for veterinarians: to use animal welfare science as a way of 
restoring animal husbandry in veterinary education.
Conclusions
What can we conclude from a presentation that has ranged from 
creation stories to studies of animal pain? Perhaps fi ve things:
• First, the social concern about animal welfare that we see 
today has grown out of a long history of change in atti-
tudes, driven to a large degree by scientifi c discoveries that 
narrowed the gap that we perceive between people and 
animals.
• Second, social concern about animal welfare includes three 
main elements: (1) the basic health and functioning of ani-
mals, (2) the aff ective states of animals, especially freedom 
from negative states such as pain and distress, and (3) the 
ability to live in a way that suits the animals’ natural behav-
iour and other adaptations.
• Third, each of these elements of animal welfare has a scien-
tifi c basis, and all three have given rise to practical improve-
ments and science-based standards. The science did not 
arbitrate among the diff erent views of animal welfare; rather 
the diff erent views of animal welfare infl uenced the science 
and contributed to the richness of its ideas and approaches. 
• Fourth, the single-minded pursuit of any one element of ani-
mal welfare does not guarantee a high level of animal welfare 
as judged by the others. For practices and standards to be 
widely accepted as improving animal welfare, they need to 
strike a balance among all three.
• Fifth, the increased focus on animal welfare, and the emer-
ging science of animal welfare, have created expanded 
opportunities for veterinarians to take on new scientifi c and 
technical roles, new social leadership roles, and new educa-
tional roles in improving the lives of animals.
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LS.1
Role of nutrition and intestinal adaptation in weanling pig health
Douglas Burrin
USDA-ARS, Children’s Nutrition Research Center, Houston, TX, USA
Summary
The growth rate of the pig is most rapid during the neonatal and 
weaning periods. Nutrition and gastrointestinal function play a 
critical role in the survival, health and growth of the young pig 
during this transition from suckling to weaning. The high meta-
bolic rate and cellular turnover of gut tissues result in substantial 
fi rst-pass utilization of dietary nutrients, especially amino acids, 
to maintain gut function. The changes in the diet composition 
and gut microbiota after weaning are associated with increased 
gut growth and metabolism, which may limit the systemic avail-
ability of dietary nutrients. Strategies aimed at optimizing gut 
metabolism and supplementing key gut-nutrients in support of 
gut function may improve growth. 
Early gut development and nutrition
The neonatal and weaning phases occupy critical periods of 
postnatal growth and development in commercially reared 
pigs. The relative rates of growth are higher during the neonatal 
period than at any time during postnatal life. More importantly 
however, is that during the neonatal and weaning phases, the 
survival, health and subsequent growth rate of young pigs 
depends on their ability to adapt physiologically to signifi cant 
changes in nutrition and the environment. Critically to this 
adaptation process is the development of the gastrointestinal 
tract, particularly digestive, absorptive and immune function. 
Nutrition is a key determinant in the functional development 
and growth of the gastrointestinal tract.
The gastrointestinal tract of the piglet increases nearly three-
fold between birth and two weeks after weaning, increasing 
from 2% to 6% body weight. A major stimulus for gut growth at 
birth is the initiation of suckling or enteral nutrition. Enterally 
nutrients have a major anabolic eff ect on the neonatal gut, but 
growth factors present in sow’s colostrum and milk may also 
have trophic eff ects. Weaning is the second major milestone in 
gastrointestinal growth in the developing piglet. Nutrition plays 
a central role during weaning, fi rst by limiting gut growth due 
to reduced feed intake and then providing a major stimulus due 
to increased dry matter intake and changes in diet composition. 
The weaning transition is marked by reduced villus height, 
increased crypt cell hyperplasia and expansion of the lamina 
propria cell population. The weight of the colon is increased ap-
proximately threefold within seven days after weaning, mainly 
due to increased fermentation of undigested dietary carbohy-
drates and fi ber. The hyperplasia in the crypt epithelium and 
lamina propria is thought to be linked to gut hypersensitivity 
reactions associated with plant proteins in the weaning diet, 
such as soy glycinins and lectins. 
The weanling pig is especially vulnerable to pathogenic infec-
tion because of the withdrawal of sow’s milk and the increased 
colonization of commensal gut microorganisms. Pathogenic 
infection results in an activation of the mucosal immune system 
and release of proinfl ammatory cytokines (e.g. tumor necrosis 
factor “ and interleukins) that have been shown to increase crypt 
cell proliferation, villus enterocyte apoptosis, and intestinal 
acute phase protein synthesis. 
The concept of gut nutrient requirements
Most swine nutritionists have an extensive knowledge of the 
nutrition requirements for the pig growth. However, in recent 
years, the concept of nutrient requirements has evolved to in-
clude the needs specifi cally for the gut. Technical advances have 
enabled direct estimates of gut nutrient utilization and their 
impact on whole animal nutrient metabolism in vivo studies in 
pigs using isotopic tracers and measurements of trans-organ 
balance of substrates. These and other studies with cultured 
porcine intestinal epithelial cells have revealed important quali-
tative characteristics of the metabolic fate of key substrates and 
the underlying cellular basis for intestinal nutrient utilization. 
A major concept that has emerged from studies with young pigs 
is that non-essential amino acids are major gut fuels, especially 
glutamate, glutamine and aspartate. In vivo studies in pigs show 
that roughly 70-80% of the dietary glutamate, glutamine and 
aspartate is taken up by the gut in fi rst pass and metabolized to 
CO2. Glucose is also quantitatively an important oxidative fuel 
for the pig intestine, in absolute amounts; the intestinal utiliza-
tion of glucose is similar to the combined total from glutamate, 
glutamine and aspartate. However, the proportional use is lower, 
such that only ~20-30% of the dietary glucose is metabolized by 
the gut. 
Studies with pigs have shown that the neonatal intestine plays 
a key role in the metabolism of amino acids involved in the 
urea cycle, particularly arginine, proline, and ornithine. There is 
extensive interconversion between these amino acids and the 
intestine represents an important site of net arginine synthesis 
in neonatal pigs. Studies in pigs have also demonstrated the 
extensive metabolism of other essential amino acids, including 
threonine, lysine, phenylalanine, branched-chain amino acids, 
and methionine. It is generally considered that the primary 
metabolic fate of essential amino acids taken up by the gut is 
incorporation into tissue proteins. However, studies show that 
extensive irreversible catabolism and oxidation of amino acids 
occurs in the gut. Moreover, many of these essential amino acids 
are metabolized to other intermediates involved in intestinal 
function. For example, threonine is believed to be channeled 
into mucin synthesis and secreted by goblet cells, because mu-
cin peptides are rich in threonine. Methionine may be converted 
to cysteine or s-adenosyl-methionine used in polyamine syn-
thesis. Cysteine is used as a precursor for glutathione synthesis 
and maintenance of mucosal anti-oxidant status. The oxidation 
of some essential amino acids, such as the branched-chains and 
lysine, in the gut maybe nutritionally signifi cant. The high essen-
tial amino acid utilization rate by gut tissues can have a signifi -
cant impact on the systemic availability for lean tissue growth. 
Historically, weanling pig diets have been formulated largely to 
overcome the limitations or immaturity in digestive function in 
Lead Speaker, Nutrition/growth
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order to maximize growth of the whole animal. However, with a 
new understanding of intestinal nutrient utilization, it is possible 
to now formulate weanling pig diets with the specifi c goal of 
optimizing the growth, function and health of the gut. From the 
foregoing discussion of intestinal nutrient utilization some of 
the most promising candidates are glutamine, glutamate and 
threonine. 
Nutrition and enteric health and function 
A critical factor infl uencing the growth of weanling pigs is the 
degree of colonization with commensal and pathogenic mi-
crobes. Exposure to these microbes and their toxins can adverse-
ly aff ect intestinal structure and function. The pro-infl ammatory 
stimulus induced by bacteria, endotoxin and cytokines signifi -
cantly increases the intestinal protein synthesis rate. Studies in 
sheep show that parasitic infection increases the rate of leucine 
utilization and oxidation by PDV tissues, thereby reducing the 
systemic availability of dietary amino acids by 20-30%. Thus, it is 
likely that the degree of commensal and pathogenic microbial 
load directly aff ects the intestinal nutrient requirements, which 
in turn may consume dietary nutrients and limit growth of 
weanling pig. 
Antimicrobial compounds are fed to weanling pigs in order to 
suppress the activity of the gut microfl ora and enhance growth. 
Antimicrobials are thought to act via four possible mechanisms, 
a) prevention of infection, b) reduced microbial nutrient use, c) 
enhanced nutrient absorption, and d) reduced growth-depress-
ing microbial metabolite load. It is generally held that one or a 
combination of these mechanisms act to diminish the thickness 
and mass of the intestinal mucosa and associated lymphoid tis-
sue. A critical mechanistic question regarding the site of dietary 
amino acid utilization in the gastrointestinal tract is whether 
this activity is associated with the luminal microbes or the cell 
populations of the mucosa. 
Alternative nutritional strategies are being used to manipulate 
the gut microfl ora including probiotics, prebiotics, organic acids, 
spray-dried plasma, and high concentrations of copper and 
zinc. These approaches have become an increasingly import-
ant consideration in swine nutrition, given the evidence of their 
benefi ts in animals and humans coupled with the growing 
concern of antimicrobial resistance. Probiotics and prebiotics 
are used to induce the colonization of bacteria (e.g. lactobacillus 
and bifi dobacteria) considered to be benefi cial for the host. The 
consequences of these alternative nutritional strategies on gut 
metabolism and nutrient utilization are poorly understood and 
warrant further study.
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LS.2
Progress in Porcine Reproductive and Respiratory Syndrome Virus (PRRSV): What we 
know about PRRSV, from basic to applied science – A historical perspective
Jane Christopher-Hennings
South Dakota State University, Veterinary and Biomedical Sciences, Brookings, SD, USA
It is an absolute honor to be asked to give the opening talk 
at the PRRSV session at the 21st International Pig Veterinary 
Society Congress in Vancouver. After looking through the list 
of subsequent speakers, I recognize the great expertise and 
innovative thinking that is present and want to recognize those 
that have contributed to our knowledge about PRRSV. Hopefully 
this will be an encouraging presentation by demonstrating how 
we have collaborated and innovated in the past and how we can 
continue the momentum in trying to prevent this disease. 
This talk will show a historical and comparative viewpoint in the 
discovery of PRRSV and subsequent development of reagents 
and diagnostic applications. I think we should take some en-
couragement in knowing that PRRSV is still a relatively “young” 
pathogen in the swine population compared to others such as 
transmissible gastroenteritis virus (TGEV) which was described 
in the US in 1946; pseudorabies virus (PRV), fi rst found to be 
fi lterable in 1813 in cattle, but recovered from swine in 1909; and 
foot and mouth disease virus (FMDV) which was identifi ed as a 
fi lterable agent in 1897 [1]. In addition, PRRSV is not “latent” like 
PRV where there is a constant risk of previously infected animals 
transmitting the virus; PRRSV is very susceptible to disinfect-
ants, heat and drying (compared to porcine circovirus 2 (PCV2) 
and some other viruses which are not as readily inactivated); it 
is not transmissible to or from people like swine infl uenza virus 
(SIV) and we also have new technologies to rapidly identify 
the virus which were not previously available for other disease 
eradication programs. In addition, we currently have a voluntary, 
coordinated, funded and focused eff ort in the United States 
http://www.prrs.org http://www.prrssymposium.org), Canada 
and other countries, to understand, control and eliminate PRRSV 
transmission. 
PRRSV was fi rst identifi ed as the cause of “Mystery Swine Dis-
ease”, “Blue-eared” Pig Disease or “Swine Infertility and Respira-
tory Syndrome” (SIRS), now known as “PRRSV” in 1991 in Europe 
and subsequently in the US. Even though PRRSV is not eradi-
cated, it should be noted that the causative agent of PRRSV was 
fi rst identifi ed only about 20 years ago. By comparison, PRV was 
discovered in swine in 1909 with much of the eradication com-
pleted in 2005; classical swine fever virus (CSF/Hog cholera) was 
fi rst reported in 1810 with much of the eradication completed in 
the US between 1962 and 1976 and Brucellosis was identifi ed in 
1887 and nearly eradicated at this time. In these cases, between 
100-200 years passed before eradication or near eradication was 
completed after identifi cation of these swine pathogens. 
Persistence of PRRSV was initially described, but PRRSV is not 
“latent” whereby viral replication can be re-activated and shed-
ding of the virus can recur. With PRRSV, transmission of virus 
from pigs infected in utero can be documented up to 112 days 
of age [2]. However, duration of shedding may be somewhat 
age dependent with 4 month old gilts not demonstrating viral 
shedding between 90-180 days post inoculation [3], whereas 
90-100% of PRRSV infected 3 week old pigs were still infected at 
63-100 days [4]. Therefore, recommendations have been made 
to close herds for 200 days post clinical signs to prevent shed-
ding to newly introduced pigs. These fi ndings demonstrate that 
there is a fi nite time period of viral shedding, unless a new viral 
strain or PRRSV naïve pigs are introduced.
Since PRRSV is an enveloped virus (unlike PCV2), it is susceptible 
to heat, drying and disinfectants which allows for more effi  cient 
removal of the virus from the environment. In 1992, the charac-
teristics of this virus were described in cell culture whereby virus 
infectivity was completely inactivated after 45 minutes at 56 C, 
but more stable after 1 month incubation at 4 C or 4 months at 
-70 C [5]. This susceptibility to higher temperatures and stabil-
ity at lower temperatures was further confi rmed for a range of 
PRRSV strains [6]. This information is also useful for eff ective 
biosecurity protocols [7].
Transmission of PRRSV through other animal vectors or people 
has not been confi rmed, although mechanical transmission 
could occur through insects and fomites [8, 9]. This diff ers from 
SIV whereby pigs are susceptible to infl uenza that could be 
transmitted through people [10], making biosecurity more dif-
fi cult.
Newer diagnostics such as rapid molecular tests (real-time, 
quantitative or isothermal PCR) were discovered and utilized 
after 1983 [11] for “same day” results. These tests were not previ-
ously available for other swine pathogen elimination programs, 
but should be an advantage for PRRSV elimination protocols. 
More convenient surveillance methods are also available to ob-
tain and test samples economically and with the welfare of the 
animal in mind. These include pooling of samples, obtaining oral 
fl uids [12] or blood swabs [13] and using newer technologies to 
multiplex for identifi cation of various swine disease antigens, 
antibodies or immune parameters simultaneously [14].
Coordinated eff orts to control or eliminate PRRSV are becoming 
more prevalent worldwide. In the US, the PRRSV Coordinated 
Agriculture Program (CAP1 and CAP2) started by the USDA in 
2004 are designed to enable ”the collective talents of the stake-
holder community of scientists, veterinarians, pork producers, 
and allied industry researchers to develop innovative strategies 
to lessen the impact of PRRS and lead to the eventual elimination 
of the virus.”  Research on vaccines that are eff ective against a 
wide-variety of PRRSV strains and that can be diff erentiated from 
fi eld strains should continue. With these resources and fi ndings, 
we should be further along on PRRSV elimination than historic-
ally has been the case with other swine pathogen elimination 
programs.
Lead Speaker, PRRS Diagnostic/Immunology
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Pork safety: past achievements and future challenges
Peter Davies
University of Minnesota, St Paul, MN, USA
Introduction
Ever since the dawn of phagocytosis, eating has been a risky 
endeavor. Because internalizing portions of our external en-
vironment can never be entirely risk free, food safety is a relative 
concept. However, eating entails less risk than not eating, and 
the availability and cost of food infl uence the levels of protec-
tion or assurance that consumers demand for their food supply. 
Hunger and undernutrition are responsible for about 35% of 
child deaths and 11% of the total global disease burden. 1 At 
the other extreme, the World Health Organization projects that 
by 2015 more than 700 million adults will be obese, and 2.3 bil-
lion overweight. Overnutrition is imposing increasing burdens 
on health costs in many countries, with a recent estimate of 
$147 billion annually for the USA. 2 Paradoxically, obesity is also 
positively associated with poverty as energy dense foods of low 
nutritional value tend to be cheap. 3 Like malnutrition and obes-
ity, food safety presents another manifestation of global inequity 
linked to poverty and food security. 
Pork has long been the most consumed meat globally, and 
projections of future global pork demand remain robust, largely 
driven by anticipated growth in developing economies. The fact 
that per capita meat consumption increases as wealth increases 
refl ects that animal proteins are preferred protein sources across 
the majority of cultures. However, contemporary discussions of 
projected world population growth, its implications for land use, 
and the environmental impact of food production raise complex 
questions about the future of meat consumption. 4,5 McMichael 
et al (2007) calculated that global average meat consumption 
was 100 grams per person per day, but varied ten-fold between 
high-consuming and low-consuming populations.4 They pro-
posed 90 g per day as a “working global target” but advocated 
more even distribution and that not more than 50 g per day 
should be from ruminants.5 Although some grass roots groups 
and celebrities have promoted campaigns to reduce meat 
consumption (e.g. meat-free Monday), it is unrealistic to expect 
material change will arise from ‘enlightened’ consumer behavior. 
Policy options that could infl uence meat consumption patterns 
are yet to be clearly articulated. Similar to the situation with 
greenhouse gas emissions, increasing tensions are likely as the 
force of growing demand for animal protein in the developing 
world strains against calls for restraint from the relatively well 
fed western world. Priority issues in food safety also vary geo-
graphically, and some foodborne hazards that remain major 
public health issues in developing countries have been reduced 
to insignifi cance in developed countries. However, in most coun-
tries biological hazards greatly outweigh physical and chemical 
hazards in terms of public health impact and consumer concern, 
and therefore will be the focus of this paper.
How safe is pork today?
It depends - whose pork and compared to what? Unlike crossing 
a road, where the hazards can be directly perceived, foodborne 
hazards are mostly invisible to consumers. Food safety is termed 
a ‘credence attribute’. 8 Opinions are forged from both personal 
experience and external information, and perceptions of safety 
are infl uenced by social processes, including the media and gov-
ernment agencies. Food is such an intimate element of the hu-
man experience that there are all manner of passionate opinions 
about what we should eat, and how it should be produced, pro-
cured and prepared. Engaging authors such as Michael Pollan 
and Eric Schlosser, and fi lms like Food Inc., have inspired a mass 
of neoromantic ‘locavores’ who disparage almost every facet of 
the mainstream commercial food industry. Critics of ‘industrial-
ized production’ and ‘factory farming’ habitually confl ate diverse 
issues (social justice, environmentalism, animal welfare…), and 
food safety is usually prominent in the mix. 5 Mostly, however, 
they tend to be vague about which hazards are of particular 
concern, and why those specifi c hazards present greater risk in 
modern systems of animal production. Ironically, the consumer 
pressures that propelled revision of Federal regulations of meat 
inspection in the USA in the 1990s, 6 may have also contributed 
to integration in the pork industry. Market demands for as-
surance of safety and quality (including traceability) motivate 
stronger packer-producer alliances, vertical integration, and 
marketing of branded products. 7 
In the USA, the ritually cited estimate of the annual burden of 
foodborne illness is 76 million cases per year, 325,000 hospital-
izations, and 5000 deaths (based on the 1997 population).9 Cer-
tainly disturbing numbers, but denominators matter and those 
numbers translate to approximately one foodborne illness per 
4,200 meals; one hospitalization for every 1 million meals; and 
one death for every 65 million meals. Food is consumed without 
any harm more than 3,999 times out of 4,000 meals, demonstrat-
ing that the US food supply is relatively safe. However, the con-
siderable burden of foodborne disease refl ects the huge impact 
of low risk events that are spread across entire populations, and 
guarantees that food safety will remain a pivotal issue across all 
sectors of the food industry and in international trade. Export 
markets will remain exquisitely sensitive to real or perceived 
concerns with pork safety.
Pork safety - contemporary vs. historic risks
Swine production in developed countries has evolved rapidly, 
and shifts towards larger farms and more ‘industrial’ pork pro-
duction practices are also evident in some developing countries. 
I will avoid the perilous turf of contemporary international 
comparisons, but pork safety in the USA today is demonstrably 
safer that at any time in the past. The aspirations driving most 
innovation in pork production [e.g., all-in/all-out (AIAO) man-
agement; multiple site production] have been improved animal 
health, productivity and profi tability. Factors likely to infl uence 
pathogen transmission include herd size, population structure 
and dynamics; sources and health status of incoming stock; area 
density of pigs and other species; biosecurity practices; group 
sizes and animal density; replacement practices in breeding 
herds; pig fl ow (e.g., AIAO vs. continuous fl ow); housing systems; 
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ventilation systems and air quality; sources, quality and delivery 
systems of feed and water; hygiene and effl  uent management; 
nutritional programs; weaning age; and specifi c health interven-
tions (e.g., vaccines). Although designed to control pathogens of 
swine, the collective modifi cations implemented in modern pig 
production logically will have had collateral impact on the risks 
of introduction and transmission foodborne pathogens. Avail-
able evidence indicates that foodborne risks to US pork consum-
ers have declined markedly in recent decades. 
Parasitic hazards – achievements to celebrate 
A telling feature at last year’s 8th International Symposium on 
Epidemiology and Control of Foodborne Pathogens in Pork 
(Safepork), in Quebec City, was the paucity of current research 
on parasitic hazards in pork. Primarily a gathering of scientists 
from developed countries, there was not one paper on Taenia 
solium, the most injurious porkborne pathogen in the world. 
Estimated to infect 50 million people worldwide and cause up to 
50,000 deaths per year, 10,11 it is also largely responsible for the 
fourfold higher rates of epilepsy in developing versus developed 
countries. 12 This parasite thrives where sanitation is poor and 
traditional, free-range/scavenging pig production is practiced, 13 
and has a tragic impact on the poorer populations of many de-
veloping countries. It has been excluded from commercial pork 
production in developed countries. At Safepork, only two papers 
addressed pork’s most infamous hazard, Trichinella spiralis, with 
one of these papers documenting the extremely low seropreva-
lence of T. spiralis in commercial pigs in the USA. 14 The virtual 
elimination of T. spiralis from modern commercial swine produc-
tion has relegated the once perennial ‘poster child’ of porkborne 
disease to little more than an historical footnote in the annals of 
US public health and the commercial swine industry. 15 
Toxoplasma gondii is one of three pathogens responsible for 
three-quarters of fatal foodborne infections in the United 
States.9 Congenital T. gondii infection occurs in 500 to 5000 of 
the 4.2 million US newborns annually and about 1.2 million 
Americans are aff ected by ocular toxoplasmosis. 16 The societal 
cost of congenital toxoplasmosis alone was estimated in 1990 
to be up to $8.8 billion annually, 17 and it has been inferred that 
about 50% of cases in the USA are foodborne.8 Less than 30 
years ago T. gondii infection occurred in 40% of US sows and 
20% of market hogs,18 and undercooked pork was considered 
an important risk for human infection. Subsequent studies of 
national scope indicate that T. gondii seroprevalence has been 
reduced by some 90% (Figure 1). 18-22 Because Toxoplasma sero-
prevalence in the past was much higher in pigs than in other 
food animals in the USA, pork was conventionally viewed to be 
the highest risk meat. Whether true or not in the past, recent 
case-control studies in the USA and Serbia suggest that this is 
not the case. 23, 24 
The parasitic triad of Taenia, Trichinella and Toxoplasma has 
arguably been responsible for the lion’s share of the burden of 
porkborne illness throughout the history of mankind, and they 
remain obdurate problems in many developing countries. The 
reduction of these agents to a state of relative inconsequence in 
modern pork production in developed countries is a substantial, 
yet largely unheralded, public health accomplishment. Even 
for the more epidemiologically complex T. gondii, the virtual 
elimination of Toxoplasma risk from pork is a feasible goal in 
modern confi nement systems. The inherent trade off  between 
parasite risk and the desired attributes of non-confi nement 
livestock systems is captured in the following quotation about 
the potential for producing Toxoplasma-free meat: “Modern 
production technologies have shown that this is feasible and 
have led to a marked decrease of T. gondii infections in meat 
producing animals such as pigs. Conversely, demand for animal 
friendly production systems may however lead to a re-emer-
gence of T. gondii in pork and poultry”. 25 The fi rst step towards 
eff ective management of T. gondii in less intensive pork produc-
tion systems will be recognition of the inherently greater risk of 
exposure. 
Enteric foodborne pathogens – a challenge for the 21st 
century?
In contrast to the heady progress in preharvest control of para-
sitic agents, experiences with bacterial foodborne pathogens 
have been humbling. The bacterial pathogens of most concern 
to pork safety (Salmonella, Campylobacter, Listeria, and Yersinia 
enterocolitica) 26 have their primary ecological niche in the in-
testinal tracts of healthy birds and mammals. Their presence on 
meat stems from contamination events that can occur anytime 
during harvest and processing until meat is served to the end 
consumer. Contamination risk during harvest and processing 
is clearly a function of both on-farm exposure and slaughter 
hygiene, therefore both preharvest and postharvest arenas 
are logical targets for interventions. 27 Salmonella, remains the 
preeminent bacterial hazard in most pork industries and was the 
subject of some 40% of papers at Safepork in 2009. Apart from 
the northern Nordic countries (Sweden, Finland and Norway), 
where uncommonly low Salmonella prevalence supports the 
possibility of excluding Salmonella from pig populations, most 
countries identify reduction rather than elimination of Salmon-
ella to be a more attainable goal in pork production. 28-30 
The body of epidemiologic knowledge and experience with 
preharvest control of Salmonella dwarfs those of other enteric 
bacterial pathogens. Even so, there remains a dearth of valid-
ated, evidence-based interventions for preharvest Salmonella 
control. Despite the appealing logic for preharvest control of 
foodborne pathogens, the task has proven daunting and opin-
ions remain divided on the feasibility and cost-eff ectiveness of 
preharvest control programs for Salmonella in pigs. Investment 
in preharvest surveillance and control has been widespread in 
western Europe, but much less in North America where sub-
stantial reduction of Salmonella contamination of hog carcasses 
has been achieved by improvements in the post harvest sector 
(Figure 2). 31 Over some 15 years, the wealth of data generated 
by the Danish National Salmonella control program has provided 
much insight into the challenge of preharvest control. 32-34 The 
most recent analysis from this program indicated that benefi ts 
from preharvest control were most likely to accrue in low preva-
lence regions and small processing plants. It was concluded that 
in medium to high prevalence scenarios, even drastic reduc-
tions at herd level may yield only limited benefi ts in reducing 
the prevalence of positive carcasses. 35 These fi ndings reinforce 
the importance of ‘downstream’ exposure to Salmonella during 
transport and lairage which has been extensively documented 
but remains diffi  cult to resolve. 36 While advances in process 
control and new interventions during slaughter and process-
ing have yielded measurable improvements in meat hygiene, 
considerable investments in preharvest control of Salmonella 
appear to have yielded only modest benefi ts. Epidemiologic 
knowledge about Campylobacter, Listeria, and Yersinia in swine 
production remains insuffi  cient to adequately inform specifi c 
preharvest control measures for these pathogens. 
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The most vocal proponents of preharvest control of foodborne 
enteric bacteria have combined a degree of epidemiological 
naïveté with a belief (regardless of the vacuum of supporting 
data) that ‘the problem’ was attributable to modern farming 
methods, and specifi cally confi nement production. In my opin-
ion, the least equivocal outcome from fi fteen of so years of pre-
harvest research is that elimination of organisms that are normal 
fl ora (Campylobacter coli), or common commensals (Salmonella, 
Listeria, Yersinia) of the swine intestinal tract will not be achieved 
by facile interventions in farm management. The complexity of 
the epidemiology of Salmonella and other enteric organisms 
is diffi  cult to overstate, but dominated by the fact that these 
organisms are commonly carried by, and shed in the feces of, 
healthy animals. In a review of preharvest food safety, Oliver 
et al (2009) conveyed the likely magnitude of the challenge 
of control of foodborne bacteria by forecasting ‘there is little 
doubt that solutions to these and many other complex issues 
will be delineated through science-based research that will be 
conducted during the next century.’ 37 Development of valid and 
reliable preharvest interventions to control bacterial foodborne 
pathogens remains the preeminent challenge for researchers in 
pork safety, and one that may indeed endure for several decades 
even for the most researched pathogens. In contrast post har-
vest interventions, and most notably food irradiation, present 
proven, safe and relatively low cost options for risk reduction 
for multiple hazards which should be pursued for higher risk 
items such as ready-to-eat and comminuted meat products. 
38,39 However, implementation of food irradiation in the meat 
industry remains enmeshed in ideological opposition. Those 
who might oppose irradiation of higher risk meat products of 
on the grounds that producers must take more responsibility for 
food safety must be more motivated to constrain industry than 
to protect consumers from foodborne illness.
Into the future and the wild card of emerging pathogens 
Just a few decades back, several of today’s headlining foodborne 
pathogens were either unknown (E. coli O157:H7) or not known 
to be transmitted in food (e.g. Listeria, Campylobacter). We can 
anticipate that both true emergence and apparent emergence 
(discovery of pre-existing agents through new diagnostic ap-
proaches) of pathogens will present new challenges to pork 
safety and risk communication for the swine industry. Currently 
topical examples are methicillin resistant Staphylococcus aureus 
and Clostridium diffi  cile. 40-42 These are major emerging patho-
gens in human medicine, and the presence of strains of these 
organisms in animal reservoirs, including pigs, is a valid cause 
for consternation. There is a need for much better understand-
ing of the ecology and epidemiology of these organisms 
both in swine production and post harvest. Similarly ongoing 
discoveries of multihost viral agents in pigs (e.g., Hepatitis E 
and B viruses, caliciviruses and noroviruses) prompt questions 
about their zoonotic and foodborne disease potential. For all 
multihost microbial species, both emerging and familiar, more 
profound understanding of host adaptation and host specifi city 
is necessary and requires greater research investment. For newly 
recognized organisms, understanding the biological and epi-
demiological determinants of possible risk to human or animal 
health is not a trivial task. The likely complexity is exemplifi ed by 
Hepatitis E viruses which are widespread in swine throughout 
the world, but vary in genotype geographically, by host species, 
and in zoonotic risk. 43 In some countries swine reservoirs have 
been shown to make negligible contributions to the human 
disease,44,45 demonstrating the principle that prevalence of an 
agent alone is a highly inadequate measure of zoonotic or food-
borne risk. Advances in sequencing, subtyping, and other tools 
for ‘molecular epidemiology’ are bringing new opportunities to 
explore host adaptation of potential porkborne pathogens, with 
the power to greatly enhance both our biological insight and 
the acuity of risk analysis and communication eff orts. Unfortu-
nately, the increasingly adversarial climate in the USA promises 
rapid (and therefore not necessarily well founded) accusations of 
industry culpability whenever any potential zoonotic or food-
borne issue comes to light. 
Looking forward, the international marketplace for pork will re-
quire incrementally more demanding standards for pork safety. 
In order to remain competitive in premium markets, exporters 
must achieve and assure very low risks for chemical, physical 
and microbial hazards, and any failures have the potential to 
incite crippling consequences for market access. Quality as-
surance programs implemented on farms should be adequate 
to manage the majority of physical and chemical hazards, as 
well as parasitic foodborne hazards. Unless major research 
breakthroughs occur in preharvest control of enteric bacteria, 
improved meat hygiene and slaughter processing will continue 
to be the mainstay for microbiological safety. As always, the 
emergence of new or previously unrecognized foodborne haz-
ards (both real and perceived) remains the most unpredictable 
and potentially devastating food safety issue.
Figure 1: Toxoplasma gondii seroprevalence reported in large studies 
of market hogs in the USA.18-22
Figure 2: Salmonella prevalence on market hog carcasses in large, 
small and very small plants in the USA (1998-2009).30
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Porcine circovirus type 2: success and failure
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Introduction
Vaccination against porcine circovirus type 2 (PCV2) reduces 
the incidence and severity of porcine circoviral disease (PCVD), 
in particular the postweaning multisystemic wasting syndrome 
(PMWS). This confi rms that PCV2 is the essential infectious agent 
in this disease syndrome, but attempts to elucidate why PMWS 
became an emerging disease have failed. Much still remain to 
be clarifi ed regarding the epidemiology of PCV2, its interaction 
with the host and the role of other infections in the develop-
ment of PCVD. The current views on these issues are summar-
ized below. 
Porcine circovirus
Porcine circovirus (PCV) are small (approximately 1760 nt), 
single-stranded (ss) DNA virus that belong to the family Circo-
viridae. Two genotypes of PCV (PCV type 1 and PCV type 2) with 
similar genomic organisation and an approximate 80% homol-
ogy at their nucleotide sequences are described (Meehan et al., 
1998). PCV1 is regarded apathogenic whereas PCV2 has been 
associated with a number of disease syndromes of which PMWS 
is the best characterized. In 1999, an experimental model that 
evoked PMWS in colostrum-deprived piglets at co-inoculation of 
porcine parvovirus (PPV) and PCV2 was established (Allan et al., 
1999). 
The circular genome of PCV encodes a structural protein, the 
capsid (cap) protein, and a replicase protein with two splice 
variants (Rep and Rep´). Both Rep and Rep´ are necessary for 
initiating the rolling-circle amplifi cation used by PCV. In addi-
tion, a third open reading frame (ORF3) exists in PCV that is 
transcribed counter clockwise to ORF1 (rep, rep´) and ORF2 (cap). 
The proposed apoptotic role of the gene product from ORF3 
(Liu et al., 2005) or its importance for viral pathogenesis is not 
fully clarifi ed but it is noteworthy that the greatest genomic 
diff erences between PCV1 and PCV2 are found within ORF3. Our 
current knowledge about the genomic organisation of PCV, their 
replication and interaction with host proteins are detailed in a 
recent review by Finsterbusch and Mankertz (2009). 
Porcine circovirus type 2 (PCV2) and diseases 
related to PCV2 
Despite many similarities between PCV1 and PCV2, only PCV2 
has been associated with disease. Today, PCV2 is confi rmed to 
be a necessary infectious agent for development of PMWS and 
demonstration of moderate to massive quantities of PCV2 within 
histopathological lesions in lymphoid tissues (lymphocyte 
depletion together with histiocytic infi ltration and/or inclu-
sion bodies and/or giant cells) is a major diagnostic criterium. 
Clinical signs of PMWS include progressive weight loss (wasting), 
enlarged inguinal lymph nodes, and in some cases jaundice, 
dyspnoea and/or diarrhoea. As reviewed (Ramamoorthy and 
Meng, 2009; Gillespie et al., 2009; Grau-Roma et al., 2010), PCV2 
is also involved in a number of other syndromes including “res-
piratory”, “reproductive” and “enteric” disorders as well as porcine 
dermatitis and nephropathy syndrome (PDNS). 
PCV2 isolated from pigs with various clinical conditions showed 
diff erent replication kinetics when studied in vitro (Meerts et 
al., 2005), perhaps suggesting a variation in their virulence. 
Due to a high similarity between sequences from various PCV2 
isolates (approximately 95% at the amino acid level) such a link 
is not very likely, but cannot be ruled out. Phylogenetic analysis 
performed in several countries however revealed a clustering of 
PCV2 into “genotypes / genogroups” with clade formations that 
could be related to “year of isolate” (Olvera et al., 2007). Analyses 
of these clades showes a relation between patterns in the PCV2 
ORF2 sequence and cases of PMWS. Such a connection is further 
supported during an outbreak of PCVD in Canada in late 2004 
- 2006 with more severe lesions and increased mortalities and 
the emergence of a new PCV2 variant, referred to as “RFLP type 
321” (Gagnon et al., 2007; Carman et al., 2008). Indeed, reports 
from several countries describing a shift in genotype/genogroup 
of PCV2 accompanied by increased incidences of PMWS are ac-
cumulating as summarized in a recent review (Grau-Roma et al., 
2010). To ease further comparative analyses a common nom-
enclature has been proposed with two main genotypes (PCV2a 
and PCV2b) and a very rare genotype, recovered from pigs in 
Denmark, designated PCV2c (Segalés et al., 2008). In general, it 
appears from the epidemiological evidence that PCV2b is the 
genotype associated with outbreaks of severe PMWS post 2003.
The importance of PCV2 genotype for the pathogenicity of the 
virus is however still puzzling and results from experimental 
infections are not conclusive (Lager et al., 2007; Opriessnig et 
al., 2008; Saha et al., 2010). It appears that PCV2a and PCV2b on 
their own do not diff er in virulence but a recent study highlights 
the importance of order of infection (Harding et al., 2010). In that 
experimental model, infection of gnotobiotic pigs with PCV2b 
seven days after a PCV2a infection, but not vice versa, caused 
PMWS. A similar approach but using eleven week old SPF-pigs 
that were repeatedly infected with infectious clones of heterolo-
gous PCV2a or with PCV2a followed by PCV2b did not induce 
any signs of clinical disease (Opriessnig et al., 2010a). Neither 
were any macroscopic lesions observed in the pigs although 
all seroconverted to PCV2 and PCV2 could be demonstrated at 
microscopic lesions in some samples. Both PCV2a and PCV2b 
DNA sequences were present in samples obtained from some of 
these dually infected pigs. 
The simultaneous presence of PCV2a and PCV2b has been 
reported in fi eld samples and also chimeric virus composed of 
an ORF1 region from PCV2a and an ORF2 region from PCV2b is 
described (Hesse et al., 2008). Even more interesting is the dem-
onstration of naturally occurring chimeric PCV2 genomes that 
are recombined within the ORF2 region (Cheung, 2009). Modifi -
cations within this region that encodes the cap gene can aff ect 
the structural capsid protein and thereby modify B-cell epitopes 
of the virus. Antigenic diff erences between PCV2 isolates have 
been demonstrated using monoclonal antibodies to the capsid 
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protein (Lefebre et al., 2008) and to the N-terminal part of the 
Rep protein (Meng et al., 2010). Indeed, a new genomic variant 
of PCV, apparently composed of ORF 1 from PCV1 and ORF 2 
from PCV2a, has been detected in Canada (Gagnon et al., 2010). 
The prevalence of this virus, designated PCV1/2a, is low and its 
origin not clear, although it is now recognised that this isolate 
may be linked to a partially inactivated chimeric PCV2 vaccine.
Taken together, some epidemiological evidence favours the 
hypotheses that various isolates of PCV2 diff er in their patho-
genicity as a shift in genotype of PCV2 has repeatedly been 
reported when PMWS occurs in a region. This appears also to be 
the case in Norway that has succeeded to stay free from PMWS 
until recently. Thereafter, sequence analyses of PCV2 in samples 
obtained from pigs on 27 healthy farms all grouped into PCV2a 
whereas PCV2b was detected in samples from 12 farms aff ected 
by PMWS (Sonja Ylving, National Veterinary Institute, Oslo, Nor-
way, personal communication). However it should be noted that 
severe outbreaks of PMWS, associated with PCV2a, did occur 
from 1996 onwards in N America and Europe, with no recovery 
of PCV2b from these outbreaks. 
Porcine circovirus type 2 (PCV2) and other viral 
infections in PMWS 
It is generally accepted that herd management has a predomin-
ant impact on the incidence of PMWS. In particular animal 
hygiene and other general disease-preventing measures are 
important factors to reduce porcine circoviral disease (Madec et 
al., 2008). In a fi eld study conducted in one Norwegian and two 
Swedish fi nishing farms the role of management became evi-
dent (Brunborg et al., 2010). One of the Swedish farms changed 
their recruitment routines and fi nishing pigs were during a 
period obtained from the open market and the time between 
batches was reduced to less than 24 hours. This shift coincided 
in time with an increased frequency of runts, wasting pigs and 
a subsequent diagnose with PMWS whereas pigs in the other 
Swedish farm and in the Norwegian farm performed normal. 
Serological analyses revealed prominent diff erences in the 
levels of antibodies to PCV2 and number of PCV2 DNA copies in 
samples collected sequentially during the fi rst fi ve weeks of the 
fi nishing period in the three farms. The amount of PCV2 DNA 
copies was similar in samples obtained from pigs at arrival to 
the two Swedish fi nishing farms but was hardly detectable in 
samples collected in the Norwegian farm. The initial level of anti-
bodies to PCV2 was comparatively low and increased with time 
in the PMWS aff ected farm but remained at a steady high level 
in samples collected from pigs in the healthy Swedish farm. The 
majority of the Norwegian pigs remained seronegative to PCV2 
during the fi rs fi ve weeks but an extended sampling revealed 
that these pigs had seroconverted after 9 weeks in the fi nishing 
herd and that the pigs then displayed a low number of PCV2 
DNA copies in blood. This study was conducted when Norway 
was still free from PMWS and it is notable that the genotype of 
PCV2 determined for the Norwegian samples was PCV2a where-
as pigs in the Swedish farms harboured PCV2b, irrespectively 
they originated from the healthy farm or from that aff ected by 
PMWS. Indeed, a high similarity within PCV2b genotype was 
determined in samples obtained form the two Swedish farms 
(full genome sequence 99.7% at the nucleotide level) regardless 
they were aff ected by PMWS or not. 
Longitudinal case-control studies, analysing time for serocon-
version and PCV2 DNA load, performed in Danish and Spanish 
herds showed that the PCV2 load increased with decreasing 
maternal immunity (Grau-Roma et al., 2009). PMWS developed 
when the PCV2 DNA load was at its highest which in Spain oc-
curred at the beginning of the fattening period but in Den-
mark took place in the nursery phase. In another Danish study 
weaned pigs, aged 8-14 weeks, from PMWS aff ected herds were 
mingled with 4 – 6 weeks old PCV2 positive pigs from PMWS 
unaff ected herds (Kristensen et al., 2009). Three to four weeks 
later PMWS developed in pigs from the unaff ected herds both in 
those that were mingled in the same pen and in those housed 
in pens adjacent to pigs from the PMWS-aff ected herds. Thus, 
PMWS can be induced in pigs from PMWS free herd following 
contact to pigs from farms with clinical PMWS. 
In both studies referred to above other pathogens than PCV2 
were present on the farms. In the Spanish/Danish study the 
presence of Mycoplasma hyopneumoniae, Actinobacillus pleuro-
pneumoniae, Pasteurella multocida, Lawsonia intracellularis, 
Salmonella spp. PPV, porcine reproductive and respiratory virus 
(PRRSV), swine infl uenza virus and Aujeszky´s disease virus (AD) 
was confi rmed and in the latter Danish study the PMWS-aff ected 
herds were seropositive for M. hyopneumoniae and PRRSV. 
Therefore an attempt was made to isolate virus from organ ma-
terial collected from the PMWS-aff ected pigs using a large panel 
of diff erent cell-types (Lohse et al., 2008). However, no viral co-
factor could be linked to the development of PMWS. Instead, a 
diff erence in nucleotide sequence was found for PCV2 obtained 
from PMWS-aff ected and from non-aff ected herds. It is thus 
demonstrated that PMWS can be transmitted from aff ected to 
non-aff ected animals but we have failed to identify the “agent” 
that spreads the disease and to understand the disease process.
An earlier fi eld study in Spain has indicated that another 
circular single-stranded DNA virus, the Torque teno virus (TTV) 
belonging to the genus Anellovirus, family Circoviridae, and in 
particular genogroup 2 (g2) of porcine TTV is more frequent in 
PMWS-aff ected pigs (Kekarinen et al., 2006). An experimental 
co-infection with g1-TTV and PCV2 in gnotobiotic pigs supports 
the theory that TTV can act as a co-factor in the development of 
PMWS (Ellis et al., 2008). A metagenomic analyse was therefore 
performed on viral DNA (Blomström et al., 2009) recovered from 
lymph nodes collected from two of the pigs that succumbed 
from PMWS in the Norwegian/Swedish study referred to above. 
Random amplifi cation and large-scale sequencing generated 
approximately 9000 unique sequences. The majority of these 
(99.6%) were from PCV2 and only 12 sequences were of other 
viral origin; 7 representing TTV and 5 representing a parvo-like 
virus. Further analyses confi rmed that both g1-TTV and g2-TTV 
were present and interestingly the parvovirus sequence showed 
a relationship to human bocavirus (HBoV) and phylogenetic 
studies approved that the sequence emanated from a porcine 
boca-like virus (pBo-likeV). 
Human Boca-virus was discovered in 2005 and was given its 
name due to sequence homologies with bovine parvovirus and 
canine minute virus. This parvovirus is widespread in the hu-
man population and has been associated with respiratory tract 
diseases and gastrointestinal infection (Allander, 2008). Thus the 
fi nding of a porcine boca-like virus together with TTV and PCV2 
in lymph nodes from clinical cases of PMWS was exiting. For a 
further study of the distribution of these viruses an archived 
material was used. The archived material consisted of lymph 
nodes collected during a phylogentic study of PCV2 carried out 
in Sweden before and after the enzootic outbreak of PMWS in 
2004 (Timmusk et al., 2008) and was supplemented with more 
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recently collected samples, including some from piglets with 
congenital tremor. In total, samples from 58 pigs, 34 with PMWS 
and 24 without PMWS, were analysed by PCR or qPCR for the 
presence of PCV2a, PCV2b, g1-TTV, g2-TTV and the porcine 
boca-like virus. 
A discriminative qPCR confi rmed earlier sequencing data (Tim-
musk et al., 2008) showing that PCV2b was present at high DNA 
copy numbers (≥108 per 100 ng DNA) in samples obtained 
from PMWS-aff ected pigs. In two of these pigs PCV2a was also 
detected but at a lower DNA copy number. PCV2b was also de-
tected in samples from pigs not aff ected by PMWS but then al-
ways at DNA copy numbers below 106 per 100 ng DNA. Regard-
less of health status TTV-1, TTV-2 and pBo-likeV were present 
in 70-90% of the samples, and PCV2 was demonstrated in the 
majority of samples although at higher levels in samples col-
lected from pigs aff ected with PMWS than from the others. The 
most pronounced diff erence was that pBo-likeV was detected in 
more samples from PMWS aff ected pigs and the simultaneous 
detection of TTV-1, TTV-2 and pBo-likeV was more frequent in 
samples form PMWS aff ected pigs (Table 1). 
Table 1. Percentage of samples positive for PCV2a, PCV2b, g1-TTV, g2-
TTV-2 or pBo-likeV as determined by qPCR or PCR among pigs aff ected 
by PMWS (PMWS+) or not (PMWS-). Also the percentage of samples 
simultaneously positive for g1-TTV, g2-TTV-2 and pBo-likeV is given
PCV2a 
(%)
PCV2b 
(%)
g1-TTV
 (%)
g2-TTV 
(%)
pBo-likeV 
(%)
g1-TTV/g1-TTV/ 
pBo-likeV (%)
PMWS + 6 100 77 94 88 71
PMWS - 12 50 79 83 46 33
A similar distribution of g1-TTV, g2-TTV-2 and pBo-likeV in pigs 
with and without PMWS has been described for samples col-
lected in UK (Gordon Allan and Michael McMenamy, Dept of 
Veterinary Science, Queen´s University Belfast, Belfast, Northern 
Ireland, personal communication). Thus, it is not possible from 
these studies to determine the role of TTV and the porcine Boca-
like virus in the aetiology of PMWS. However, in a Chinese study 
PCV2, PRRS, CSFV and TTV2 were more frequent in samples 
collected from pigs that also were postive for pBo-likeV than 
among those negative for the boac-like virus (Zhai et al., 2010) 
suggesting that pBo-likeV could act in synergy with other virus 
or predispose for other viral infections. 
Interestingly, in vitro studies using DNA from human TTV geno-
group 4 demonstrated that DNA of this TTV can induce murine 
immune cells to produce and secrete cytokines such as inter-
feron- γ (IFN- γ), interleuin-6 (IL-6), and IL-12 (Rocchi et al., 2009). 
Indeed, linearized DNA from porcine g1-TTV and g-2TTV could 
in vitro interfere with IFN- α production by porcine plasmacytoid 
dendritic cells (Martinez-Guinó et al., 2009).
PCV2 and the immune response
The possibility that small circular DNA virus could harbour 
immunomodulatory sequences, i.e., CpG-motifs, was fi rst sug-
gested for PCV2 (Hasslung et al., 2003). It was shown that the 
DNA genome of PCV2 contains sequences that in synthetic form 
(oligodeoxyribonucleotides; ODNs) could act immunomodula-
tory on porcine peripheral blood mononuclear cells (poPBMC) in 
vitro and e.g. inhibit the IFN- α response to other DNA- but not 
RNA-virus (Wikstöm et al., 2007). Further analyses of the PCV2 
genome for presence of CpG motifs identifi ed additional 18 
motifs that could induce IFN- α production and three inhibitory 
motifs (Kekarainen et al., 2008a). Indeed, PCV2 propagated in PK-
15 cells, but not PCV1, could act immunomodulatory and reduce 
the IFN- γ and IFN- α responses to recall antigen stimulation 
(Kekarainen et al., 2008b). In addition, PCV2 and UV-inactivated 
PCV2 induce IL-10 and thereby down-regulates the production 
of IFN- γ and IL-12. Thus, a reduced production of IFN- α in com-
bination with IL-10 production is likely to suppress a Th-1 type of 
immune response and thereby promote virus persistence.
One of the most important factors in the defence against 
viral infections is IFN- α. This cytokine can be produced in low 
amounts by monocytes / macrophages and myeloid dendritic 
cells and in particular by plasmacytoid dendritic cells (PDC) 
that respond with high production of IFN- α to certain stimuli. 
Inerferon- α is important during the early defence against viral 
infections because it can induce an antiviral state in neighbour-
ing non-infected cells and it activates the killing activity by 
Natural killer (NK) cells. Furthermore, IFN- α together with IL-12 
promotes the development of a T helper cell (Th) type 1 immune 
response that is important in the defence against viral infections. 
The IFN- α response is thus a strategic point for a virus to modify 
and demonstration of non-replicating PCV2 in cells of the my-
eloid lineage (monocytes, macrophages and dendritic cells) in 
infected pigs is therefore remarkable. Series of elegant studies 
performed at the Institute of Virology and Immunoprophyl-
axis, Mittelhäusern, Switzerland have outlined the interaction 
of PCV2 and /or the viral DNA with porcine dendritic cells and 
eff ects on their function that are summarized in a recent review 
(Kekarainen et al., 2010). 
Against this background it is plausible that the replication of 
PCV2 in vitro is enhanced by addition of IFN- α or IFN- γ (Meerts 
et al., 2005). Indeed an interferon-stimulated response element 
(ISRE) is present in the PCV2 genome within the promoter region 
of the rep gene that seems to play a role in the response of PCV2 
to IFNs (Ramamoothy et al, 2009) but the underlying mechan-
isms are far from outlined.
Using the PCV2/PPV co-infection experimental model a weak T 
lymphocyte response, measured as PCV2-specifi c IFN- γ secre-
ting cells at in vitro re-stimulation was evidenced (Steiner et 
al., 2009). This response coincided with viremia, approximately 
8 days post infection whereas the specifi c antibody response 
was delayed until four weeks post infection. Indeed, a transient 
correlation exists between viremia and IL-10 expression in pigs 
subclinically infected with PCV2 (Darwich et al., 2008). Studies 
that further support these fi ndings include the increased expres-
sion of IL-10 mRNA levels observed in PBMC obtained form pigs 
experimentally co-infected with PRRSV and PCV2 (Shi et al., 
2010) and examination of IL-10 producing splenocytes obtained 
from naturally cases of PMWS (Crisci et al., 2010).
An important role of IL-10 is the regulation of B cell isotype 
switch. A number of fi eld studies have documented the import-
ance of neutralizing antibodies against PCV2 for protection 
against PMWS (for review see Kekarainen et al., 2010). As initially 
demonstrated by Meerts et al. (2006) protection is correlated 
to isotype switching and animals that remain IgM positive are 
those that are most likely to develop PMWS. 
Taken together, the studies of PCV2 and its interaction with 
the porcine immune system has been a partial success and the 
knowledge that pigs can mount an immune response to the cap 
protein of PCV2 that protects against PCVD has been utilized in 
the vaccine development.
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Vaccination against PCV2
Vaccine development has so far focused on induction of im-
munity against the structural cap protein of PCV2. For instance, 
a chimeric viral particle composed of ORF1 from PCV1 and ORF2 
from PCV2 is the source of antigen in the inactivated vaccine 
Suvaxyn® PCV2 from Fort Dodge. Also Ingelvac® CircoFLEX 
(Boehringer Ingelheim) and Porcilis® PCV (Intervet/Schering-
Plough) contain at killed baculovirs vector carrying ORF2 where-
as killed PCV2 is included in Circovac® (Merial). The latter vaccine 
is intended for vaccination of sows two week before farrowing. 
The immune sow will transfer a passive immunity to the piglet 
that is expected be protective during the subsequently develop-
ment of an active immunity at exposure to PCV2 in the environ-
ment. The other three commercial vaccines are used for vaccina-
tion of pigs, approximately 3 weeks old. Despite diff erences in 
the source of antigen, adjuvant formulation and administration 
regime all these commercial vaccines have proven to protect 
effi  ciently against PMWS during fi eld conditions. In addition, the 
sow vaccine improves farrowing rates and infertility problems 
(reviewed in Kekarainen et al., 2010). 
A concern has been that PCV2a is the antigen source in the com-
mercial vaccines listed above. Theoretically, amino acid changes 
in the cap protein of PCV2b could reduce the protective eff ect 
of an immune response elicited by PCV2a. Results obtained at 
experimental challenge of PCV2a-vaccinated pigs with PCV2b 
however imply a good “cross-protection” (Fort et al., 2009; 
Opriessnig et al., 2010b). Thus, development of vaccine against 
PCVD has been an outstanding success. Also immunologists 
are likely to benefi t from these achievements. By scrutinizing 
the protective immune response elicited at vaccination against 
PCV2 insight will be gained about immune mechanisms neces-
sary for induction of protection against porcine circovirus. 
PCV as a contaminant in vaccines 
Lately attention has been drawn to PCV as contaminants in vac-
cines for human use. Two licensed rotavirus vaccines, aimed to 
protect against enteric disease in infants, were found contamin-
ated with PCV1 alone or in combination with PCV2, (http://www.
fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/
ucm211101.htm). In particular the PCV2 contamination urges for 
continual studies that increase our understanding of this virus, 
including its potential to replicate in human cells and the even-
tual immune modulating capacity of PCV2 DNA on human cells. 
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Application of advanced AI technologies to improve the competitiveness of the pork industry
George R. Foxcroft; Jenny Patterson; Audrey Cameron; Michael K. Dyck
Swine Reproduction-Development Program, Swine Research & Technology Centre, University of Alberta, Edmonton, AB, Canada
Introduction
The use of artifi cial insemination (AI) in the pig has had a major 
impact on genetic improvement in the swine industry over the 
last 40 years. However, the overall production effi  ciency of the 
breeding herd is highly dependent on the reproductive capacity 
(fertility) of the boars used for breeding and the genetic merit of 
the boars for the performance of terminal line off spring. Given 
the polygamous structure of swine production, poor quality 
boars will aff ect the reproductive outcome of numerous females. 
In the case of AI this could be thousands of females. Although 
ejaculates collected for use in AI are subjected to standard 
semen analysis in commercial boar studs, the eff ectiveness of 
these evaluations is low compared to other food-animal species. 
The following discussion of the need to use more advanced AI 
technologies to improve the impact of genetically elite boars is 
based on three assumptions: 
1.  Employing the use sub-fertile boars and low quality ejacu-
lates reduces production effi  ciency.
2.  The use of pooled semen from poorly defi ned males breaks 
the link between known genetic value of individual boars 
and the paternity of progeny produced.
3.  The excessive number of sperm used per litter born (prob-
ably over 9 billion sperm using current practices), and hence 
the high numbers of boars needed for semen production, 
reduces the genetic impact of the best boars. 
Collectively, these ineffi  ciencies in AI use in the pork industry 
represent a major disadvantage to pork producers in a global 
food-animal marketplace. Given the recent advances in genom-
ics technologies, our ability to identify boars with even greater 
potential EBVs will increase and the potential to optimize the 
use of these boars in effi  cient pork production systems will 
increase. Available estimates suggests that advanced AI tech-
nologies can increase the genetic value of every pig produced by 
as much as $1.00. 
Strategic advantages resulting from improved evaluation of 
boar fertility.
The ultimate measures of boar reproductive performance are 
pregnancy rate and litter size born. However, these are retro-
spective measures of boar fertility and can be highly infl uenced 
by breeding management and the quality of the gilts and sows 
bred (Colenbrander et al., 2003). A combination of a thorough 
physical examinations of the boar and conventional semen 
evaluation (concentration, morphology, motility) can provide 
an alternative to actual fertility data (Gibson, 1989). While these 
evaluations can establish that an animal is either sub-fertile or 
infertile, they fail to identify the relative fertility of boars that 
meet accepted industry standards for sperm and ejaculate 
quality (Ruiz-Sanchez, 2006). In general, the predictors of fertil-
ity currently applied in most commercial AI centers provide a 
very conservative estimate of the relative fertility of individual 
boars. Furthermore, the relatively high sperm numbers used in 
commercial AI practice (usually more than 3 billion total sperm 
per dose of extended semen), and the pooling of semen from 
multiple ejaculates, masks the limited fertility of some of these 
boars. Diff erences in fertility are more evident when lower numbers 
of sperm are used for AI and boars are evaluated on an individual 
basis.
As discussed by other reviewers, if the full economic impact of 
the highest genetically indexed boars is to be realized at com-
mercial production level, the number of gilts and sows bred 
per boar must be maximized (Gerrits et al., 2005). A number of 
innovations in insemination technology, including post-cervical 
(Watson and Behan, 2002) and deep-uterine (Vazquez et al., 
2005) insemination are conducive to the use of lower sperm 
numbers per insemination. The further possibility of using 
controlled ovulation techniques to achieve single fi xed-time 
insemination protocols (Baer and Bilkei, 2004; Cassar et al., 2005) 
would also substantially increase the utilization of genetically 
superior boars. The combined application of post-cervical and 
fi xed-time insemination (Pelland et al. 2008) could further pro-
mote dissemination of the most superior genetics. 
Eff ective prediction of relative boar fertility is essential and will 
allow for the removal of less productive boars from commercial 
studs. This in turn will optimize the use of proven, high fertility, 
and genetically high indexed boars at lower sperm numbers per 
AI dose. At the nucleus level this will allow for increased selec-
tion pressure by increasing the number of off spring bred per 
collection from high ranking boars. At the level of terminal line 
production, this would allow for considerable improvements 
in production effi  ciency to be realized, by capitalizing on boars 
with a high index for traits such as growth rate, feed conversion 
effi  ciency and the carcass characteristics of their progeny. Even 
if the same costs were paid in genetic royalties, by purchasing 
fewer total doses of semen from genetically superior boars, the 
cost benefi ts realized by producers in grow-fi nish performance 
of the progeny and the value of the carcass sold appear to be 
substantial.
If these changes in production strategy are to be realized, it is 
critical to identify boars of relatively low fertility that will not 
perform well when used in the more challenging situations 
of reduced sperm numbers per AI dose or single fi xed-time 
insemination. The very defi nition of “useable semen” changes in 
this more demanding context. Existing information, and recent 
research directed to achieving these more demanding criteria 
of useable semen, is presented below. This review will consider 
preliminary data that reinforces the need to identify substantial 
diff erences in boar fertility, and the “averaging eff ect” that results 
from the use of pooled semen doses from several boars. Finally, 
recent data supporting the case for a move towards single fi xed-
time AI and possibly post-cervical insemination as the critical 
“next steps” in applying our best pig genetics to more competi-
tive pork production systems will be presented. 
Lead Speaker, Reproduction - Sow management
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Approaches to boar semen evaluation
There is a long history behind the search to fi nd a single or 
combination of tests that can accurately predict male fertil-
ity from a semen sample (Amann, 1989). Unfortunately, there 
appears to be no simple answer to this very complex question 
(Rodriguez-Martinez, 2003). Laboratory assays often examine 
all of the sperm present in a sample for fertility, yet only one to 
30 or so sperm are necessary to fertilize all available oocytes. 
Braundmeier and Miller (2001) suggested that the sperm that 
fertilize the oocytes in vivo may be a small (even a single), 
highly selected, sub-population that is not representative of 
the average sperm evaluated in the sample. They also suggest 
that, because sperm must meet many requirements for success-
ful fertilization, testing a single attribute is unlikely to be a true 
measure of ultimate fertility. Using similar reasoning, Rodriguez-
Martinez (2003) suggested that to accurately predict semen 
quality it is necessary to test all key sperm attributes within large 
and heterogeneous sperm populations that potentially aff ect 
fertilization and embryonic development. Nevertheless, the 
markers of relative fertility fi nally selected must ultimately pre-
dict the relative fertility of boars when using low sperm doses of 
extended semen for AI (Rodriguez-Martinez et al., 2009).
Braundmeier and Miller (2001) reviewed a number of functional 
and molecular tests used to assess male fertility. In this review 
they described two diff erent sperm traits that aff ect fertility. 
•  Compensable traits are those that can be overcome by 
introducing large numbers of sperm during insemination. 
Problems with motility and morphology will reduce the 
number of sperm that are able to reach the oocyte, but by 
introducing large numbers of sperm the reduction in fertility 
can be minimized. 
•  Uncompensable traits are those that cannot be overcome by 
introducing larger numbers of sperm. These defects aff ect 
fertilization and embryo development and include nuclear 
vacuoles, sperm chromatin structure issues and morphologic-
al problems that do not inhibit fertilization. 
To eff ectively predict fertility, it is essential to discriminate 
between compensable and uncompensable traits in an ejacu-
late. Evaluation of relative boar fertility in vivo using high sperm 
numbers per dose (e.g. 3 billion sperm) will mask diff erences in 
compensable traits and will not allow the industry to identify 
boars that will perform well in more demanding applications of 
AI. 
Conventional semen evaluation generally includes a measure 
of seminal volume, sperm concentration, and the percentage 
progressively motile and morphologically normal sperm (Amann 
et al., 1995). Although some of these parameters are correlated 
with fertility in the boar (Flowers, 1997; Xu et al., 1998), several 
authors suggest that this information, while important, does 
not accurately predict whether a male is truly fertile (Brahmk-
shtri et al., 1999; Correa et al., 1997; Rawls et al., 1998). As shown 
in Table 1, existing analyses are also usually inadequate for 
predicting relative fertility in healthy boars with ejaculate qual-
ity that meets normal industry standards (>70 % motility and 
<30% abnormal sperm) (Flowers, 1997; Alm et al., 2006), even 
though the reproductive effi  ciency of these boars may still be 
substantially diff erent (Flowers, 1997; Tardif et al., 1999; Popwell 
and Flowers, 2004; Ruiz-Sanchez, 2006). As illustrated in Table 2, 
diff erences in relative fertility become increasingly evident when 
low sperm doses (<2.0 billion sperm) are used for AI (Tardif et al., 
1999; Watson and Behan, 2002; Ardon et al., 2003; Ruiz-Sanchez, 
2006). This approach likely averts the compensatory eff ect of 
using excessive sperm numbers per AI dose (Saacke et al., 2000 ; 
Alm et al., 2006), thereby revealing important fertility diff erences 
among boars. 
Table 1. Relationships between boar sperm motility, sperm penetra-
tion rates, farrowing rates and number of piglets born alive (from 
Flowers, 1997).
Motility
(%) a
Sperm penetration 
rate(%) b
Farrowing rate
(%) c 
Number born 
alive
94.7 89.5v                 (58) 86.9 v                 (460) 10.6 v
82.3 81.7 v w             (55) 87.1 v                 (330) 10.5 v
76.1 84.3 v w              (50) 84.5 v                 (300) 10.5 v
66.2 74.7 w                  (44) 86.1 v                 (264) 10.1 
v
52.4 55.5 x                   (40) 72.4 w                (201) 9.2 w
44.2 34.7 y                   (28) 72.3 w                (168) 9.2 w
32.6 21.3 z                    (17) 51.7 
x                 (  85) 7.8 x
SEM 4.8 5.8 0.3
*Motility is expressed as the average number of motile spermatozoa within the following 
classes: >90; 80-89; 70-79; 60-69; 50-59; 40-49; and 30-39.
b: Sperm penetration rate is defi ned as the percentage of eggs that were fertilized. The numbers 
in parentheses represent the number of ejaculates within a motility category.
c: Number in parentheses represent the number of sows inseminated within a motility category.
SEM: Standard error of the mean.
v,w,x,y,z: Means within the same column with diff erent superscripts are signifi cantly diff erent 
(P<0.05).
Table 2. In vivo fertility results from nine boars with acceptable semen 
characteristics (> 80% sperm motility and < 15% abnormal sperm). 
Gilts inseminated with 1.5 x 109 morphologically normal, motile sperm 
per 50-mL dose. (from Ruiz-Sanchez, 2006).
Boar
Number of Gilts Fertility in vivo
Bred
Preg-
nant
Far-
rowed
Preg-
nancy 
rate (%)
Farrow-
ing rate 
(%)
Total born 
(mean±SE)
Fertility 
Index 
(mean±SE)
R-2 51 50 50 98 x 98  x 11.7±0.4 ab 11.4±0.6a
Y-2 53 48 47 91 xy 89 xy 12.0±0.5 a 10.9±0.6ab
Pu-3 57 54 52 95 xy 91 xy 11.2±0.5 abc 10.2±0.6ab
B-1 55 54 52 98 x 94 xy 10.7±0.5 abcd 10.2±0.6ab
R-3 55 52 52 94 xy 95 xy 10.9±0.4 abcd 10.1±0.6ab
G-2 45 42 41 93 xy 91 xy 10.1±0.5 abcd 9.5±0.6ab
B-3 55 51 51 93 xy 93 xy 9.6±0.5 cd 8.8±0.6abc
R-1 56 48 47 86 yz 84 yz 10.0±0.4 bcd 8.4±0.6bc
G-1 51 37 36 72 z 71z 8.4±0.6 d 6.0±0.6c
P =0.0003 P =0.0003 P < 0.001 P <0.0001
x-z: Means with diff erent superscripts within each column were diff erent by χ2 analysis (P <0.05).
a-b: LSM with diff erent superscripts within each column were diff erent (P <0.05). Values in the 
table are least means (LSM) ± standard errors (SE) of LSM. P: probability of main eff ect of boar.
Although numerous other potential markers of semen quality 
and boar fertility have been investigated (see reviews of Fox-
croft et al., 2008), and might eventually simplify the evaluation 
process, suffi  cient information already exists on which to base 
dramatic improvements in AI technology in the pork industry. 
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Evidence for diﬀ erences in relative boar fertility in commer-
cial studs
The almost universal use of pooled semen doses in commercial 
boar studs severely limits the collection of data on relative boar 
fertility at production level. However, the limited data avail-
able continues to suggest a substantial range of fertility exists 
in contemporary populations of boars. Indeed, in the absence 
of routine procedures for identifying relative boar fertility, and 
hence an ability to eff ectively select stud boars for relative fertil-
ity at genetic nucleus level, a normal distribution of fertility traits 
should be expected. In recent discussions of overall breeding 
herd performance (Billy Flowers – personal communication) 
the point has also been made that limitations in AI technology 
may lead the industry to continually underestimate the existing 
productivity of contemporary commercial dam-lines. All these 
points are evident in recent data obtained from single-sire mat-
ings at the multiplication level (Figure 1).
Figure 1. Data on litter size born in sows bred to commercial Landrace 
boars using single-sire matings with 3 billion sperm per AI dose. (Tony 
Chandaruk - Personal communication)
These results indicate that the productivity of the top two thirds 
of these boars is very high, and at an average of over 13 pigs total 
born, would allow ambitious targets for breeding herd perform-
ance to be achieved. However, when the productivity of the lower 
one third of these boars is included, overall productivity falls by 
over one pig born. This relatively inferior performance of 20 to 
30% of boars evaluated is consistent with the more extensive 
data presented in Tables 1 and 2. With current AI practices, these 
substantial diff erences in boar productivity, and the link to known 
progeny produced by individual boars, are confounded by 1) the 
use of pooled semen and 2) high sperm numbers per AI dose. 
The problem of pooling semen when trying to optimize 
production eﬃ  ciency.
In one recent preliminary study, we evaluated the performance 
of two boars which routinely met normal criteria for acceptable 
semen quality (better than 80% motility and <15% abnormal 
sperm) and had a history of good fertility when used in experi-
ments requiring adequate numbers of pooled semen doses to 
normalize any confounding “boar eff ect” on the fertility of gilts 
and sows allocated to diff erent experimental treatments. Before 
using these boars for homospermic (single sire) inseminations in 
gilts and sows in an experiment, we evaluated the performance 
of the two boars (Blue and Red) using both pooled (hetero-
spermic) and single-sire (homospermic) AI protocols. In all 
cases, a total of 2 billion sperm per AI dose were used. As shown 
in Table 3, both boars were very productive with single-sire 
inseminations and still performed acceptably in AI with pooled 
semen. There was, nevertheless, a diff erence of 2.5 total embryos 
at day 30 of gestation between these boars, due to a 15% dif-
ference in either the fertilization rate and/or embryonic survival 
to this stage of pregnancy. Notably, the outstanding perform-
ance of the most fertile (Blue) boar was masked by using pooled 
semen and adoption of a single sire (homospermic) AI strategy 
would improve the total numbers of pigs born, by allowing the 
Blue boar to express his true reproductive potential. It seems 
reasonable to assume that a similar “averaging eff ect” results 
from the pooling of semen from the best boars shown in Figure 
1 with less productive boars in this population. 
Table 3 Results from two fertile boars when used in homospermic or 
heterospermic AI protocols with 2 billion sperm per AI dose. (SRTC – 
unpublished data, 2009)
Variable Pooled AI Doses Blue Boar Single Sire AI Red Boar
Single Sire AI
# sows bred 32 11 14
Ovulation Rate of sows bred† 20.3 20.7 20.3
Live Embryos at d30† 15.2 17.7 15.0
Embryo Survival (%)† 75 85 75
†: mean values
Data from another recent study, comparing seminal plasma 
protein profi les from two boars with dramatically diff erent fertil-
ity (Novak et al., 2008), highlights the problem of linking the 
progeny born to boars used for AI when using pooled semen 
doses for commercial production. The fertilizing capacity the 
two boars studied (Boar A and B, Table 4), which had similar 
and traditionally acceptable semen parameters at collection, 
was initially tested with homospermic matings (i.e. single-sire 
AI). Based on approximately 30 mating records per boar, major 
diff erences between these boars in recorded farrowing rate and 
litter size born were evident. The semen from these boars was 
then pooled with 3 other boars with similar semen parameters 
and used for insemination (i.e. heterospermic semen from 5 
boars in total, with equal numbers of sperm from each boar 
within the pooled AI dose). These pooled inseminations resulted 
in a 90% farrowing rate (9 pregnancies from 10 inseminations 
made) and 104 piglets were born these 9 litters. Paternity testing 
of the resulting piglets, using a panel of up to 84 single nu-
cleotide polymorphism markers, identifi ed Boar B as the sire of 
29.8% (31/104) of the piglets, while Boar A was identifi ed as the 
sire for only a single piglet. 
Table 4. Comparisons of homospermic vs. heterospermic insemina-
tions with boars exhibiting diff erent relative fertility (SRTC/Alberta 
Swine Genetics Corporation – unpublished data, Alberta, 2008)
Homospermic AI
Variable Boar A (n=31 breedings) Boar B (n=27 breedings)
Farrowing Rate (%) 45 100
Av. Total Born 9.22 12.04
Heterospermic AI
(Pool of 5 boars, including A and B, at equal sperm #) 
( n = 10 breedings)
Farrowing Rate (%) 9
Av. Total Born (n=9) 11.56
Progeny sired  (of 104 total) 1 31
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(Simply from the perspective of optimizing breeding herd 
productivity, a move to single-sire AI programs seems to be 
justifi ed. The very best boars will express their real potential, and 
overall herd productivity appears to increase. Furthermore, the 
small percentage of very inferior boars will quickly be identifi ed 
and can be removed from commercial production. In time, it is 
realistic to suggest that both phenotypic and genomic mark-
ers will be developed that can be used prospectively to remove 
inferior boars before they are extensively used for commercial AI. 
However, the data presented above suggest that progress can 
be made by adopting single-sire mating strategies and evaluat-
ing boars on the basis of routine production criteria. Economic-
ally, there appears to be little down-side risk in adopting this 
strategy and considerable possibilities of positive benefi ts.
Even these preliminary data demonstrate the critical problems 
related to using heterospermic matings (pooled semen) in com-
mercial practice:
1.  As is evident from the results shown in Table 2 and Figure 1 
above, even when semen appears to meet standard criteria 
for motility and morphology at collection, homospermic 
matings still identify some important diff erences among 
particular boars. 
2.  If inferior boars like Boar A in Table 4 are included in pooled 
semen doses, they produce very few of the terminal line 
progeny. Therefore, in practice, very high EBV boars may not 
pass on genetic potential in terms of pigs entering grow-
fi nish production if they are used in a “competitive” pooled 
semen AI protocol. 
3.  The disproportionate contribution of each boar to the litter 
progeny essentially means that the boars that do sire pro-
geny are actually being required to do so at much lower than 
the total number of sperm originally included in the AI dose 
(say 1 to 2 billion, rather than 3 billion sperm). 
Application of advance AI technologies to optimize genetic 
transfer.
Taking all of the above information into consideration, the logic-
al conclusion regarding future developments in AI technology 
would be a move to single-sire inseminations with the lowest 
possible doses of semen using ejaculates from boars with high 
genetic value and proven fertility in a “low semen dose” environ-
ment. As in other domestic species, the logical way to achieve 
this outcome is with the introduction of single fi xed-time AI pro-
grams and possibly linking this to post-cervical AI techniques. 
The substantial body of data describing the development of 
hormone treatment protocols for induced ovulation in the pig 
was extensively reviewed by Brüssow et al. (2009). Linked to this 
discussion is the interesting conclusion that contemporary com-
mercial sows in well managed breeding herds show increasingly 
less variation in the weaning-to-estrus interval and may not 
even show a clear response to equine Chorionic Gonadotropin 
(eCG) treatment at weaning (Patterson et al., 2009). As a result, 
there are already reports of acceptable outcomes when exogen-
ous hormones are used to induce ovulation in sows at a fi xed 
time after weaning. 
A recent study by Johnston et al. (2009), using a Gonadotropin 
Releasing Hormone (GnRH) agonist which was applied to sows 
4 days post-weaning and followed by a single insemination 24 
hours later, resulted in farrowing rates and litter sizes compar-
able to sows receiving multiple inseminations during estrus 
(Table 5). It also resulted in a major improvement in the number 
of pigs born per insemination dose used and demonstrates the 
potential to maximize the use of a smaller number of high index 
boars.
Table 5. Fertility of sows bred by 10 days post-weaning (21-d lactation 
and average 10.7 pigs weaned) as Controls (no treatment) or after 
synchronization of ovulation with a GnRH agonist per vaginum in a 
gel-based vehicle (Ovugel). (From Johnson et al., 2009) † = mean ± S.E.
Control OvuGel Signif.
Initial No. Sows 150 150 *
No. Sows Bred 123 150 *
In Estrus at AI (%) 100 83.3 < 0.001
No. of Services/Sow 2.3 1.0 < 0.001
Wean to Estrus (days) † 4.7 ± 0.11 4.4 ± 0.11 0.05
Sows Farrowed/Weaned (%) 72.7 76.7 0.43
Total Born Alive/Litter † 10.9 ± 0.29 11.3 ± 0.29 0.37
Total Born/Semen Dose 5.3 9.6 < 0.001
Furthermore, Zak et al. (2009) have demonstrated that admin-
istration of porcine Luteinizing Hormone (pLH) at the onset of 
behavioural estrus to control ovulation not only facilitated fi xed-
time insemination, but also resulted in reduced semen usage, 
less labour devoted to estrus detection, as well as improved sow 
productivity (see Table 6). These data demonstrate that adminis-
tration of pLH at the time of estrus detection would allow for the 
application of a single fi xed-timed administration 24-30 hours 
after pLH treatment.
Table 6. Fertility of sows bred as Controls (no treatment) or after 
synchronization of ovulation with a pLH at onset of estrus. (From Zak et 
al., 2009)
C Control pLH Signif.
No. Sows 156 163 *
No. Inseminations 2.2 2.0 P < 0.001
Farrowing Rate  (%) 82.3 87.4 P = 0.01
Total Born/litter † 11.7 ± 0.3 12.9 ± 0.3 P < 0.01
Total Born Alive/Litter † 10.8 ± 0.3 11.8 ± 0.3 P < 0.01
† = mean ± S.E.
In situations in which the synchrony of estrus after weaning 
may not allow the eff ective application of either pLH or GnRH 
at a fi xed time after weaning, the alternative strategy of using 
ovulation-induction after an initial treatment at weaning with 
eCG continues to be explored with acceptable results (Cassar et 
al., 2005). The eCG/pLH protocol has been successfully applied in 
combination with post-cervical AI with reduced sperm numbers 
per AI dose, without adversely aff ecting sow fertility (Table 7). 
Table 7. Reproductive performance of sows inseminated either cervic-
ally or post-cervically and with either 1 or 3 billion sperm per dose after 
synchronization of ovulation with eCG at weaning and pLH 80 hours 
later (from Pelland et al. 2008).
Cervical AI Post-Cervical AI 
No. Sperm/dose 3 billion 3 billion 1 billion
No. Sows bred 104 102 101
Conception rate (%) 74.04 78.43 73.27
Farrowing rate (%) 67.31 68.63 68.32
Total litter size † 10.93 ± 3.08 10.27 ± 3.27 10.79 ± 2.83
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The results of these studies has prompted work to evaluate the 
application of pLH at the onset of estrus followed by a single, 
low semen dose, 24-30 hours later using post-cervical AI (studies 
on-going). These and other results suggest that the implementa-
tion of single fi xed-time AI programs in well managed sow herd 
can be a reality. Linked to the use of proven superior sires, post-
cervical insemination catheters and lower doses of semen, this 
fi xed-time insemination will allow the pork production industry 
to apply the genetic value of elite boars to breeding programs 
that are competitive with other livestock species. 
Conclusions
The evaluation of relative fertility amongst commercial AI boars 
and a move to single-boar AI programs holds the potential for 
signifi cant economic benefi t to the swine industry. Informa-
tion provided by this approach would also be rapidly available 
so that elimination of less fertile boars could be achieved at an 
early stage. The characterization of AI boars that maintain high 
productivity at lower numbers of sperm per AI dose will also 
allow the industry to capitalize on established and emerging AI 
technologies like post-cervical insemination and single, fi xed-
time insemination. Moreover, all these changes can be made 
without any loss in productivity as measured in terms of pigs 
born per sow per year. The higher genetic merit of boars that 
could be used across an greater number of gilts and sows bred 
would provide substantial benefi ts to the producer in terms of 
the performance of terminal line progeny. These changes can be 
made without aff ecting, or perhaps even increasing, the total 
genetic royalties paid to breeding companies and commercial 
boar studs that are willing to facilitate these improvements in 
the effi  ciency and fi nancial performance of the pork industry. 
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Mycoplasma hyopneumoniae infections in pigs: update on epidemiology and control
Dominiek Maes
Faculty of Veterinary Medicine, Ghent University, Belgium, Merelbeke, Belgium
Introduction
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary 
pathogen of enzootic pneumonia (EP), a chronic respiratory 
disease in pigs resulting from combined infections with M. 
hyopneumoniae and one or more secondary bacterial pathogens 
(Thacker, 2006). M. hyopneumoniae is also one of the primary 
agents involved in the porcine respiratory disease complex 
(PRDC). This respiratory complex includes both bacterial (Actino-
bacillus pleuropneumoniae, Pasteurella multocida, streptococci) 
and viral (porcine reproductive and respiratory syndrome virus 
(PRRSV), porcine circovirus type 2 (PCV2), Aujeszky’s disease 
virus, swine infl uenza viruses (SIV) and porcine respiratory 
coronavirus) agents (Sibila et al., 2009). Both disease conditions 
cause major economic losses to the swine industry mainly due 
to reduced growth rate, poor feed conversion ratio, increased 
medication costs and increased mortality (Maes et al., 1996). 
Since elimination of M. hyopneumoniae from infected herds is 
diffi  cult to achieve and also to maintain, most eff orts are current-
ly directed towards control of the disease. In the present paper, 
fi rst some aspects of the epidemiology of M. hyopneumoniae 
infections will be reviewed, next interactions with other respira-
tory pathogens will be discussed, and fi nally an update will be 
given on control strategies.
Transmission of M. hyopneumoniae
Within a herd, M. hyopneumoniae is normally transmitted to 
susceptible pigs by direct contact with infected pigs or by shar-
ing the same air-space with infected pigs. Piglets can become 
infected already in the farrowing unit by the sow either by direct 
nose-to-nose contact or by aerosols (vertical transmission). 
The chance of transmission from sow to off spring is higher in 
gilts and low parity sows (Fano et al., 2006), but also older sows 
up to the 7th parity may transmit the pathogen to the piglets 
(Calsamiglia and Pijoan, 2000). This is not surprising as infected 
animals are not able to effi  ciently and quickly clear the M. hyo-
pneumoniae organisms from the respiratory tract. A recent study 
(Pieters et al., 2009) showed that pigs can remain infectious for 
at least 200 days post infection. The percentage of sows testing 
positive by nPCR varies depending on the study. Calsamiglia and 
Pijoan (2000) reported that between 24 and 56% of the sows 
were positive for M. hyopneumoniae in a multiple site system. 
Sibila et al. (2007) found lower prevalences namely between 0 
and 11%. The latter authors did not fi nd any prevalence diff er-
ences between sows from multiple site (MS) or farrow-to-fi nish 
(FTF) pig herds. Beilage et al. (2009) found that 65% of the sows 
were seropositive in 67 German pig herds, and that diff erent 
management practices such as all-in all-out production in the 
farrowing units and acclimatization for replacement boars were 
associated with lower seroprevalences.
Also the percentage of infected pigs at weaning varies between 
studies. In most reports, approximately 5-20% of the piglets are 
positive at or shortly after weaning using nested PCR on nasal 
swabs (Sibila et al., 2008; Villarreal et al., 2010b), both in farrow-
to-fi nish and multi-site systems. 
Dff erent infection and disease patterns have been reported in 
farrow-to-fi nish and multi-site systems (Sibila et al., 2004). In 
farrow-to-fi nish operations, infection of piglets at the nursery 
stage tends to be higher and the percentage of infected pigs in-
creases progressively with advancing age. In multi-site systems, 
infections in nursery and growing pigs are less important than in 
single-site herds, and then may increase abruptly in the fatten-
ing unit (Sibila et al., 2004). In case of PRDC, clinical symptoms 
typically occur at 14 to 20 weeks of age (Dee, 1996).
Transmission does not only depend on the infectivity of infec-
tious animals, but also on the susceptibility of not yet infected 
animals. In an experimental study aiming to quantify the spread 
of M. hyopneumoniae using reproduction ratios (Meyns et al., 
2004), it was shown that during the nursery period, one infected 
pig will infect at least one penmate (Table 1). In the same study, 
it was also shown that the transmission rate tended to be higher 
with a highly virulent M. hyopneumoniae isolate than with a 
low virulent isolate (Vicca et al., 2003), but the diff erence was 
not statistically diff erent. Villarreal et al. (2010a) found slightly 
lower transmission rates in pigs during the same period under 
fi eld conditions. Morris et al. (1995) showed that pigs being in 
direct contact with other infected pigs are 7 times more likely to 
seroconvert than those having indirect contact.
Table 1. Results of transmission experiments of M. hyopneumoniae in 
nursery pigs (4-10 weeks old). Two out of 8 piglets were experimentally 
infected at the start of the experiment and the number of infected pigs 
was investigated 6 weeks later. Transmission rates are expressed using 
adjusted reproduction ratios (Rn) values (Meyns et al., 2004)
Highly virulent 
M. hyopneumoniae  isolate
Low virulent M. hyopneu 
M. hyopneumoniae moniae isolate
# of infected animals / # of susceptible animals
Pen 1 Pen 2 Pen 3 Pen 4 Pen 5 Pen 6
2/6 3/6 5/6 2/6 2/6 2/6
Rn=1.47 (0.68-5.38) Rn=0.85 (0.33-3.39)
The transmission of M. hyopneumoniae between herds can 
take place either by trade of (subclinically) infected pigs or by 
airborne transmission. The importance of airborne transmission 
has been illustrated in many fi eld studies. Goodwin (1985) con-
cluded that EP-free herds could be reinfected by airborne trans-
mission of M. hyopneumoniae over a distance of 3.2 km. Dee 
et al. (2009) have recently shown that airborne transport of M. 
hyopneumoniae organisms occurred out to a distance of 4.7 km. 
Apart from direct contact and airborne transmission, indirect 
transmission of infection through fomites is not considered to 
be important.
Interactions of M. hyopneumoniae with other pathogens
The interaction of M. hyopneumoniae with other pathogens has 
received much attention. In the past, studies mainly focussed on 
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the interaction with parasitic and bacterial infections, whereas 
recently, the emphasis has been shifted towards the interactions 
with viral infections.
Parasitic pathogens
Lesions typical for EP are more severe in M. hyopneumoniae 
infected pigs that are concurrently infected with parasites such 
as Metastrongylus elongatus or Ascaris suum. Flesja and Ulvesaeter 
(1980) reported that the extent of pneumonia was associated with 
the presence of liver lesions due to migrating A. suum larvae. Other 
studies reported that the prevalence of pneumonia in a herd 
was positively associated with the prevalence of liver lesions 
in the herd. Steenhard et al. (2009) showed that experimental 
infections with A. suum may signifi cantly compromise the immune 
response following M. hyopneumoniae vaccination.
Bacterial pathogens
M. hyopneumoniae predisposes pigs to infections with second-
ary bacteria. Diff erent mechanisms may be involved in this 
phenomenon: damage of the epithelium, induction of cuffi  ng 
lesions (massive infi ltration of lymphohistiocytic cells), induction 
of thick, viscous mucus, and modulation of the immune system. 
Combined experimental infections with M. hyopneumoniae and 
either Pasteurella multocida (Sörensen et al., 1997) or Actinobacil-
lus pleuropneumoniae (Marois et al., 2009) result in more severe 
lesions compared to the single infections. Co- or subsequent 
infections with P. multocida and A. pleuropneumoniae, and with 
other bacteria such as Bordetella bronchiseptica, Haemophilus 
parasuis, Arcanobacterium pyogenes, streptococci or staphylo-
cocci are commonly found in fi eld outbreaks of EP. Diff erent 
studies are inconsistent as to whether there is an association 
between turbinate atrophy and pneumonia.
Viral pathogens
Initial studies focussing on the interaction between M. hyo-
pneumoniae and PRRSV could not demonstrate a potentiating 
eff ect of both pathogens (Van Alstine et al., 1996). Some years 
later however, it was shown under experimental conditions that 
M. hyopneumoniae signifi cantly prolonged and increased the 
severity of PRRSV-induced pneumonia (Thacker et al., 1999). 
Dual infection studies with M. hyopneumoniae and SIV could not 
show the potentiating eff ects of both pathogens as observed 
with PRRSV. The eff ect was less pronounced and only transi-
tory. Opriessnig et al. (2004) indicated using an experimental 
study that M. hyopneumoniae infection potentiates the sever-
ity of PCV2-associated lung and lymphoid lesions, increases 
the amount and prolongs the presence of PCV2-antigen, and 
increases the incidence of PMWS in pigs. On the contrary, the 
diff erent experiments using dual infections with M. hyopneu-
moniae plus either PRRSV, SIV or PCV2 could not demonstrate 
a virus-dependent enhancement of mycoplasmal pneumonia. 
Combined infections under standardised experimental condi-
tions may provide very useful information on the interactions 
of pathogens, but they only partially refl ect the complexity of 
PRDC as occurring under fi eld conditions. Many diff erent patho-
gens may be involved under fi eld circumstances, and environ-
mental conditions such as management, breed and immunity 
of the animals, housing and air quality may largely infl uence the 
infection and disease course.
Control of M. hyopneumoniae infections
Optimization of management practices and housing conditions
Optimizing management and housing conditions is primordial 
in the control of M. hyopneumoniae infections and should be the 
fi rst to be accomplished. Instituting management changes that 
reduce the possibilities of spreading M. hyopneumoniae or result 
in decreased lung damage by other pathogens may signifi cantly 
improve the control of enzootic pneumonia. Additional fac-
tors diff erent from housing and management conditions, such 
as strain diff erences, may determine the infection pattern and 
clinical course of the disease (Vicca et al., 2002). An overview of 
control measures for M. hyopneumoniae infections related to 
environmental and management factors has been published by 
Maes et al. (2008).
Antimicrobial medication
To control and treat respiratory disease including M. hyo-
pneumoniae infections in pigs, tetracyclines and macrolides 
are most frequently used. Also, other potentially active anti-
microbials against M. hyopneumoniae include lincosamides, 
pleuromutilins, fl uoroquinolones, fl orfenicol, aminoglycosides 
and aminocyclitols. Fluoroquinolones and aminoglycosides have 
mycoplasmacidal eff ects. Since the organism lacks a cell wall, 
it is insensitive to β-lactamic antibiotics such as penicillins and 
cephalosporins. Although acquired antimicrobial resistance of 
M. hyopneumoniae has been reported to tetracyclines (Inamoto 
et al., 1994), and recently also to macrolides, lincosamides and 
fl uoroquinoles (Vicca et al., 2004), it does not seem to constitute 
a major problem for treatment of M. hyopneumoniae infections 
to date.
An overview of peer reviewed studies assessing the effi  cacy of 
various antimicrobials used against M. hyopneumoniae infections 
under experimental as well as under fi eld conditions is given by 
Vicca (2005). It can be concluded that for most antimicrobials 
tested, performance parameters were improved and lung le-
sions as well as clinical signs were decreased in treated animals. 
Treatment and control of enzootic pneumonia outbreaks may 
be disappointing because the symptoms may reappear after 
cessation of the therapy. Pulse medication in which medication 
is provided intermittently during critical production stages of 
the pigs, can also be used (Le Grand and Kobish, 1996). Pulse 
medication during extended periods of time as well as continu-
ous medication during one or more production stages should 
be discouraged because of both the increased risk of spread of 
antimicrobial resistance and the possible risk for antimicrobial 
residues in the pig carcasses at slaughter.
In endemically infected farms, strategic medication of the repro-
ductive herd is sometimes practiced as an attempt to decrease 
the bacterial shedding from sows to the newly introduced gilts. 
Antimicrobial medication of recently weaned pigs has been 
shown to reduce the number of MM. hyopneumoniae organisms 
in the respiratory tract (Vicca et al., 2005; Thacker et al., 2006), 
but further research is necessary to quantify the shedding of 
M. hyopneumoniae organisms in sows receiving antimicrobial 
medication.
Vaccination
Commercial vaccines
Commercial vaccines, consisting of inactivated, adjuvanted 
whole-cell preparations, are widely applied worldwide. The 
major advantages of vaccination include improvement of daily 
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weight gain (2-8%), feed conversion ratio (2-5%) and sometimes 
mortality rate. Additionally, shorter time to reach slaughter 
weight, reduced clinical signs, lung lesions and lower treatment 
costs are observed (Maes et al., 1998, 1999). Although protection 
against clinical pneumonia is often incomplete and vaccines 
do not prevent colonization, some studies indicate that the 
currently used vaccines may reduce the number of organisms in 
the respiratory tract (Meyns et al., 2006) and may decrease the 
infection level in a herd (Sibila et al., 2007). Transmission studies 
under experimental (Meyns et al., 2006) and fi eld (Villarreal et al., 
2010a) conditions showed that vaccination against M. hyopneu-
moniae with commercial vaccines induced only a limited and 
non-signifi cant reduction in the spread of M. hyopneumoniae. 
Consequently, vaccination alone with the current vaccines will 
not be suffi  cient to eliminate M. hyopneumoniae from infected 
pig herds.
Vaccination strategies
Diff erent vaccination strategies have been adopted, depending 
on the type of herd, the production system and management 
practices, the infection pattern and the preferences of the pig 
producer. Moreover, under fi eld conditions, optimal vaccination 
strategies must balance the advantage of delayed vaccination 
with the need to induce immunity before exposure to patho-
gens. Since infections with M. hyopneumoniae may already 
occur during the fi rst weeks of life, vaccination of piglets is most 
commonly used. Its effi  cacy has been demonstrated by means 
of numerous studies under experimental as well as fi eld condi-
tions (Jensen et al., 2002). Vaccination of suckling piglets (early 
vaccination; < 4 weeks of age) is more common in single-site 
herds, whereas vaccination of nursery/early fattening pigs (late 
vaccination; between 4 and 10 weeks) is more often practiced in 
three-site systems where late infections are more common.
Traditionally, double vaccination was the most frequent practice. 
During the last years, one-shot vaccines have been shown 
to confer similar benefi ts as two-shot vaccines and are more 
often used now (Baccaro et al., 2006). One-shot vaccination is 
especially popular because it requires less labor and it can be 
implemented more easily in routine management practices on 
the farm.
Vaccination of suckling piglets has the advantage that immun-
ity can be induced before pigs become infected, and that less 
pathogens are present that can interfere with immune response. 
Possible disadvantages of vaccinating piglets before weaning 
include the presence of maternal antibodies and an increased 
risk for more severe PCV2 infections after weaning. 
Vaccination of nursery pigs has no or less interference with pos-
sible maternally derived antibodies. However, nursery pigs may 
already be infected with M. hyopneumoniae. In addition, the age 
of infection or the age-window in which the piglets become in-
fected may vary between successive groups within a herd (Sibila 
et al., 2004). Finally, many infections such as PRRSV or PCV2 
mainly take place after weaning and may aff ect the general 
health status of the pigs, and consequently also interfere with 
proper immune responses after vaccination.
Only a few studies have assessed the eff ects of sow vaccina-
tion. Vaccination of sows at the end of gestation aims to both 
reduce the shedding of M. hyopneumoniae from the sow to 
the off spring and to protect the piglets against infection via 
maternally-derived immunity. It has been shown that vaccinat-
ing sows 5 and 3 weeks before farrowing was associated with a 
lower number of positive piglets at weaning using nested PCR 
on nasal swabs, both in farrow-to-fi nish operations and multi-
site production systems (Sibila et al., 2008). However, maternally 
derived antibodies only provide partial protection against lesion 
development and provide limited to no eff ect on colonization 
of M. hyopneumoniae (Thacker et al., 2000). The role of antigen-
specifi c maternally derived immune cells in protection against 
M. hyopneumoniae is not known. Bandrick et al. (2006) showed 
in vivo response by delayed-type hypersensitivity and in vitro 
proliferation of maternally derived cells when newborn piglets 
were stimulated with M. hyopneumoniae antigen. Since piglets 
from vaccinated sows can still be infected, additional measures 
to control M. hyopneumoniae during the nursery and fi nishing 
phases may be warranted.
Vaccination of gilts is recommended in endemically infected 
herds to avoid destabilization of breeding stock immunity 
(Bargen et al., 2004). This is particularly the case when gilts are 
purchased from herds that are free from M. hyopneumoniae or 
from herds with a low infection level of M. hyopneumoniae. 
Although vaccination confers benefi cial eff ects in most infected 
herds, the eff ects are variable between herds. The variable 
results may be due to diff erent factors such as improper vaccine 
storage conditions and injection technique, antigenic diff eren-
ces between fi eld strains and vaccine strains, presence of disease 
at the time of vaccination, and interference of vaccine induced 
immune responses by maternally derived (colostral) antibodies.
Experimental vaccines
Investigation of new vaccines is actively occurring, including the 
use of aerosol and feed-based vaccines as well as subunit and 
DNA vaccines (Fagan et al., 2001; Lin et al., 2003; Murphy et al., 
1993). Intradermal vaccination with a commercial bacterin has 
been shown to be effi  cacious (Jones et al., 2004). If M. hyopneu-
moniae vaccines could be delivered to the animals via aerosols 
or via the feed, this would provide an easy means for mass 
vaccination since it would substantially reduce labor costs and 
it would also be better for the welfare of the pigs as well as for 
stimulating a mucosal immune response at the respiratory tract. 
However, aerosol vaccination given 3 times with 2 weeks interval 
provided insuffi  cient protection, in contrast with the intra-
muscular application of the same commercial vaccine which was 
effi  cacious (Murphy et al., 1993). On the other hand, Lin et al. 
(2003) showed that an oral micro-spheres experimental vaccine 
based on the PRIT-5 M. hyopneumoniae strain and prepared by 
a co-spray drying method signifi cantly reduced pneumonia 
lesions following challenge infection with M. hyopneumoniae in 
pigs.
King et al. (1996) found only minimal and non-signifi cant protec-
tion in a pig challenge infection model using a recombinant 
subunit vaccine based on the P97 adhesin of M. hyopneumoniae. 
Intranasal immunization of pigs with the attenuated Erysip-
elothrix rhusiopathiae YS-19 strain expressing a recombinant 
protein of M. hyopneumoniae P97 adhesin signifi cantly reduced 
the severity of pneumonic lung lesions following challenge 
infection (Shimoji et al., 2003). However, apparently signifi cant 
immune responses were not observed in the immunized pigs. 
Oral administration of the same recombinant protein in another 
live strain of E. rhusiopathiae (Ogawa et al., 2009) signifi cantly 
reduced the severity of pneumonic lung lesions. Okamba et al. 
(2007) showed that a replication-defective adenovirus express-
ing the C-terminal portion of M. hyopneumoniae-P97 adhesin 
applied intranasally and intramuscularly in BALB/c mice, induced 
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signifi cant immune responses. Also several experimental 
DNA-vaccines have been developed and tested for immune 
responses in mice or pigs. Signifi cant immune responses with 
DNA-vaccines were elicited in mice, based on the expression of 
a heat shock protein gene P42 (Chen et al., 2003), a ribonucleo-
tide reductase R2 subunit gene fragment of M. hyopneumoniae 
(Chen et al., 2006), or the expression of diff erent genes coding 
for several potential protective antigens (P36, P46, NrdF, P97, 
P97R1) (Chen et al., 2008). The studies suggest that these vac-
cines may represent new strategies for controlling M. hyopneu-
moniae infections in pigs, but they need to be validated in pigs 
under experimental and practical circumstances. Villarreal et al. 
(2009) showed that pigs inoculated with low virulent isolates 
of M. hyopneumoniae are not protected against a subsequent 
infection with a highly virulent M. hyopneumoniae isolate 4 
weeks later and may even develop more severe disease signs. 
This may indicate that subsequent infections with diff erent M. 
hyopneumoniae isolates may lead to more severe clinical disease 
in a pig herd.
Further studies are necessary for improving vaccines and 
vaccination strategies. From an immunological point of view, 
challenges include induction of immunity at the mucosal level. 
For rational design of vaccines, a comprehensive understand-
ing of the pathobiology of M. hyopneumoniae infections and 
the molecular basis of pathogenicity of this micro-organism is 
required. Bacterial genes and antigens involved in survival of the 
bacterium in the host or that render the bacterium harmful to 
the host need to be identifi ed. This may be facilitated by the fact 
that the genome of 3 diff erent M. hyopneumoniae isolates has 
been sequenced (Minion et al., 2004; Vasconcelos et al., 2005).
Preventive medication versus vaccination
The use and effi  cacy of either vaccination or preventive (stra-
tegic) medication has been frequently discussed and the 
question arises whether medication and/or vaccination should 
be used. Advantages and disadvantages of both strategies are 
given in Table 2. Antimicrobials can be used in a fl exible way, 
they are often eff ective against several (respiratory) pathogens 
and their administration is less labor-intensive since in-feed or 
in-water medication is mostly used. Vaccination, on the other 
hand, does not select for antimicrobial resistance in pathogenic 
bacteria and in bacteria belonging to the microbiota of the ani-
mal. It also avoids risks for antimicrobial residues in the pig car-
casses at slaughter. While an immediate eff ect can be expected 
for antimicrobial treatment, the eff ect of vaccination of young 
piglets will only be evident at herd level if it is practiced for at 
least several months. Although vaccines are directed towards 
control of M. hyopneumoniae infections, also other second-
ary bacterial infections (Pasteurella multocida, Actinobacillus 
pleuropneumoniae) or lung lesions caused by these pathogens 
less frequently occur after vaccination (Maes et al., 1998; 1999; 
Meyns et al., 2006). In addition, it is very likely that combined 
vaccines will be used more frequently in the future. In this way, 
vaccination against diff erent respiratory pathogens will be pos-
sible using one single application.
Neither vaccination nor preventive medication can prevent in-
fection and adherence of M. hyopneumoniaeto the ciliated cells 
of the respiratory tract (Le Grand and Kobisch 1996). Finally, in 
case of high infection levels and/or in herds with poor manage-
ment and housing conditions, the use of antimicrobials may 
remain necessary or may confer additional clinical and perform-
ance benefi ts in vaccinated herds (Mateusen et al., 2002).
Table 2. Comparison between vaccination and antimicrobial medica-
tion for the control of M. hyopneumoniae infections
Parameter Vaccination Antimicrobial medication
Strategy for use on farm Long term More fl exible
Labor More laborious Less laborious
Effi  cacy Against one pathogen
Against diff erent pathogens 
(e.g. multiple disease chal-
lenges)
Risk for residues No Yes (inappropriate use)
Risk for antimicrobial resistance No Yes (inappropriate use)
Prevention of colonization No No
Conclusions
M. hyopneumoniae infections occur worldwide and may aff ect 
pigs in various types of pig herds. The infection pattern, clinical 
course, the lung lesions and ultimately the fi nancial losses vary 
largely depending on the herd, the management practices, the 
housing conditions, and also on the interactions between diff er-
ent respiratory pathogens. Control measures include optimiz-
ing management practices and housing conditions, the use of 
medication and vaccination. These measures can decrease the 
infection level in a herd and the number of organisms in the 
lungs, and improve health conditions of the animals but they do 
not guarantee the absence of M. hyopneumoniae. Further eff orts 
are needed for development of more eff ective vaccines and vac-
cination strategies.
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LS.7
Social behavior in swine and its impact on welfare
Jeremy N. Marchant-Forde
USDA-ARS, Livestock Behavior Research Unit, Purdue University, West Lafayette, IN, USA
Introduction
Pigs are social animals. From an evolutionary perspective, being 
social conveys a number of benefi ts, but potentially some dis-
advantages, especially for certain individuals within the group. 
Living in a social group can reduce predation, improve success-
ful foraging, improve rearing of off spring, increase chances of 
mating and help thermoregulation. On the fl ip side, a group 
can be more conspicuous to a predator, competition within the 
group can reduce access to resources for some individuals, and 
may increase the risk of disease (1).
By defi nition, “social behavior is comprised of those patterns of 
behavior that involve two or more members of a species” (2). 
Thus, social behavior includes sexual behavior and parental 
behavior. However, the emphasis of this manuscript will be on 
those behaviors that relate to formation and maintenance of so-
cial organization in swine, namely those centered on aggression 
and social dominance, as these are the aspects of social behavior 
in swine that have garnered most attention in relation to the ani-
mal’s welfare. The animal’s welfare can be defi ned as its state as 
regards its attempts to cope with its environment (3). 
Natural social organization
In order to better understand the consequences of the systems 
in which we place pigs during commercial production, it is 
crucial to acknowledge the pig’s origins and social behavior 
in a natural setting. The domestic pig is descended from the 
wild boar, but although they have changed greatly in terms of 
phenotype, their behavior, when given the opportunity, is ex-
tremely similar to their wild ancestors. The data from which we 
can conclude this comes from three main sources: 1) studies of 
wild boar in their natural habitat, 2) studies of feral populations 
of domestic pigs, and 3) studies of domestic pigs released into 
naturalistic enclosures. 
The natural social organization of pigs centers on a core group 
or ‘sounder’ of 2-4 related sows plus their associated off spring 
of diff erent sizes and ages (4,5,6). Sows in the group are likely to 
be sisters or mother and daughters. Group size will be infl u-
enced by habitat and resource availability (especially food), 
as will the size of the home range, but can be as large as 6000 
hectares (7). Home ranges may overlap with other sounders, but 
even when sharing home ranges, sounders will tend to actively 
avoid open confrontation with each other (6). As the off spring 
mature, the females split off  to form their own sounders and the 
males split off  to form adolescent bachelor groups, becoming 
solitary as mature boars. During the breeding season, mature 
boars may associate with sounders, becoming dominant to all 
sounder members. Within sounders, aggression is very rare. 
The group usually maintains a simple, linear social hierarchy, 
which is relatively stable over time. Position within the hier-
archy is mostly determined by size and age, with large, mature, 
physically-strong sows being dominant over smaller sub-adults 
and juveniles (4). Aggression does occur during competition for 
resources, especially food, but most often, subordinate animals 
actively avoid confl ict with dominant animals (8). Food will be 
scattered but available ad libitum in their complex environment, 
as long as the pigs forage. This social organization is such that 
pigs are not exposed to unrelated, unfamiliar pigs. New litters 
are integrated into the group early in life (7-14 days of age) 
when the sow returns to the group with her litter after isolation 
at farrowing, but no aggression has been observed during these 
interactions (9, 10). 
In contrast, pigs housed in commercial systems may be housed 
individually (but in close proximity to others) or in groups 
ranging from small (4-5) to large (200+). Regardless of group 
size, there will be relatively limited space and a relatively simple 
environment and they may encounter frequent remixing. Access 
to food may be ad libitum or restricted. Unsurprisingly, aggres-
sion will be much more prevalent under commercial conditions 
than under natural conditions. How prevalent will be largely 
infl uenced by: 1) the degree of mixing/remixing, 2) the method 
of feeding, and 3) the amount and quality of space.
Aggression and mixing
When unacquainted pigs are mixed together, they often fi ght. 
The fi ght does not often break out immediately but can be a 
complex and gradual event as the pigs investigate each other 
using a series of specifi c and often reciprocal behaviors, char-
acterized by nosing, sniffi  ng and gentle nudging (11). This may 
then escalate into more vigorous pushing and pressing, bites, 
head-knocks and mounting, which continues until one pig with-
draws, with or without being pursued. Most fi ghting takes place 
within 2 h of mixing and by 24-48 h post-mixing, the level of 
aggressive interactions should be basal, and a hierarchy estab-
lished. The hierarchy is then maintained by threats, avoidance 
and withdrawal, or short-lived aggressive interactions.
A fi ght can result in injury to one or both parties and thus the 
potential cost of fi ghting can be high, particularly for the loser, 
both in terms of welfare of the pig but also economically for 
the producer. For the individual pig, the choice to engage in 
fi ght or not in the fi rst place, or to know when to stop calls 
for the pig to be able to assess its fi ghting ability relative to 
the fi ghting ability of its opponent (12). If pigs were unable to 
carry out assessment of relative fi ghting ability, then we may 
expect that every pig would have to fi ght with every pig with 
which it is mixed in order for social order to be established. We 
know, however, that this is not the case in some instances. For 
example, a study examined mixing 4 pigs from one litter with 4 
pigs from another litter, meaning that there were a total of 16 
possible unacquainted pairs in each of 11 pens (12). The actual 
number of pairs which fought ranged from only 2 to 10 (median 
6). The most supported explanation as to why this happens is 
that within each litter, the pigs had a clear idea of their own pos-
ition within the hierarchy. Seeing the outcome of an interaction 
between a pen-mate and an unacquainted pig thus yields useful 
information about your own likelihood of success in a fi ght. In 
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fact the study demonstrated a litter eff ect, with in each case, a 
‘dominant’ litter moving freely around the pen, with a ‘subordin-
ate’ litter huddling in one corner (12). In production, this is the 
most usual scenario – i.e. when pigs are mixed into a pen, there 
will already be existing pair-wise relationships between some 
members, which can help individual pigs gather information. 
We have examined close one-on-one encounters and looked at 
the sequences of behaviors that occur before a fi ght breaks out. 
We have found that escalation is more often preceded by the 
receiving pig ignoring the attention of the investigating pig. If 
the receiving pig turns to maintain nose-to-nose contact, then 
the chance of subsequent escalation is reduced (13). 
Not surprisingly, there has been a great deal of research carried 
out into methods to reduce aggression at mixing (14). Many 
have little or no eff ect but there are some which clearly have an 
eff ect over the short or long term. Elements of pen design, such 
as a solid barrier in the center of the pen (15, 16) or the division 
of the lying area into distinct sub-areas can reduce aggression 
over the long term (17). Mixing at sunset (18, 19) and the use 
of drugs such as amperozide (19) and azaperone (20) can have 
short-term eff ects, but only so long as it remains dark or the 
drugs wear off . Mixing in the presence of a super-dominant 
animal – i.e. a boar – can reduce number of aggressive inter-
actions, skin damage and fl ight distance (21). Other longer-term 
solutions include early social experience, repeated mixing, pre-
mixing and use of pre-exposure pens. Allowing piglets to mix 
before weaning can benefi t their social development and enable 
them to form stable social hierarchies quicker (22, 23). Repeated 
mixing during growth may help replacement gilts acquire 
social skills that serve them better later in life (24). Pre-mixing 
of sows into groups at weaning can help them when they are 
subsequently mixed into a larger group post-service (25). Finally, 
placing pigs into adjacent pens or a small pen within a pen, so 
that they can have contact without the ability to fi ght, prior to 
mixing together can greatly reduce aggression (26). 
What is clear is that any method that might facilitate communi-
cation, be it olfactory, vocal or, to a degree, physical will help the 
pig’s ability to assess its chances better and thereby avoid fi ght-
ing or at least avoid prolonged contests. 
Aggression and feeding
Naturally, pigs tend to synchronize feeding and actively for-
age for relatively low quality food for many hours during the 
day, with peaks in activity around dawn and dusk. Again, this 
is potentially very diff erent from the commercial situation. In 
production, pigs will have access to high quality feed, which 
can meet their nutritional requirements quickly and it may only 
be available for an extremely limited period of time each day. 
Whereas the grow/fi nish herd may have ad libitum access, but 
with restricted number of feeding spaces, the breeding herd 
usually has access to a single food drop a day, with food present 
for about 15-20 minutes every 24 h. In many ‘intensive’ produc-
tion systems, pigs do not have access to any alternative foraging 
substrate, such as straw, and thus, access to food becomes 
an important resource and one that may play a major role in 
determining the amount of aggression being displayed within 
a system. For sows, feeding systems that promote competition 
for access, such as fl oor feeding, can have relatively high levels 
of aggression. Feeding systems that reduce competition by 
enclosing sows in stalls or being available ad libitum, can have 
relatively low aggression. 
Floor feeding may be cheap and ‘low tech’ in terms of equip-
ment, but it is highly competitive (27) with dominant sows able 
to monopolize the feed if it is not widely distributed (28). The 
aggression elicited by fl oor feeding, and its production conse-
quences, can be manipulated by ensuring that the feeding area 
is as widespread as possible and that group size is kept small 
and stable, with animals of similar body condition and nutri-
tional needs (29). Trough feeding is another method of feeding 
a group simultaneously, but without any partitions, dominant 
animals can again monopolize large lengths of trough space, 
displacing subordinate sows, especially if food distribution along 
the trough is uneven. Aggression can be reduced by using wet 
feed (30), which fl ows better along the trough, and by using div-
iders to separate the trough into individual feeding spaces. Use 
of trickle feeders for delivery can also help to keep sows ‘tied’ to 
a single feeding space and reduce displacements (29).
Other feeding options for sows include individual feeding stalls 
into which the sows can be shut either manually or under their 
own control (free-access stalls) and thereby eat at their own rate 
without threat of displacement. Electronic Sow Feeder (ESF) 
systems have the big advantage of allowing each sow to eat an 
individual, stockperson-controlled allowance without fear of 
displacement, but sows have to feed sequentially. With a single 
feeder per 40-60 sows, the feeder station may be occupied for 
much of the day with sows queuing outside. Usually a fairly 
stable feeding order develops, with dominant sows accessing 
the feeder soon after the daily cycle begins and the more sub-
ordinate sows waiting to feeding towards the end of the cycle. 
However, the entrance to the feeder can become a focal point 
of activity for large parts of the day and hence, a focal point for 
aggression (31).
For the growing/fi nishing pig, feed is usually available ad 
libitum. Although feeding behavior and actual feed intake is 
stimulated by allowing pigs to feed simultaneously, there is still 
the need to have allocated individual feeding spaces incorpor-
ated into the feeder design to keep aggression as low as pos-
sible (32). There is also the question of how many feeding spaces 
are made available for the number of pigs in the pen, whether 
these should be in the form of one ‘multi-space’ feeder or several 
‘single-space’ feeders and where the feeder or feeders should be 
placed in the pen (33, 34). The term ‘social workload’ has been 
used to describe the eff ort required and aggression encountered 
in negotiating a route through pen-mates to a feeder and displa-
cing pigs which are either feeding or obstructing the feeder (35). 
Ad libitum feeding has also been investigated for sows using 
high fi ber diets which have increased bulk and low energy. In 
general, increasing fi ber doubles the amount of time that sows 
spend eating and reduces stereotypic behavior, restlessness and 
aggression (36). 
Aggression and space
The amount of space that pigs have, and the quality of that 
space, can have a large impact on their behavioral repertoire, 
including agonistic social behavior. With sows, the minimum 
amount of space given to sows in current commercial systems is 
that encompassed by a gestation crate, which at about 1.25m2 
encloses the sow’s static space requirement (37). The sow 
enclosed within this space has no pen-mates and thus, it is com-
monly assumed that she is free from the aggression attributed 
to group housing systems. In reality, this is not true. She may be 
free from the physical eff ects of aggression – i.e. the skin lesions 
and other injuries that group-housed sows may show – but 
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several studies have shown that aggression between neighbors 
in crates can be high. Initial attack is more often followed by 
retaliation in crates, resulting in escalation in the intensity of ag-
gression rather than the withdrawal and cessation of interaction 
most often seen in group housing systems (38, 39, 40).
In pen systems, the amount of space given per animal will 
impact aggression. In general, as space allowance decreases, the 
total number of aggressive interactions increases (41). However, 
few studies have investigated the eff ects of space allowance as a 
single factor. In many comparative studies, when space allow-
ance has varied, so have other aspects of the pen design or the 
group size, making drawing conclusion about space per se dif-
fi cult. In some instances, space allowance may not show a linear 
relationship with aggression. For example, a study examining 
the eff ects of communal area space behind free-access sow 
stalls shows that decreasing communal space allowance may 
show in inverted U-shape relationship with aggression. At high 
space allowance, sows using the communal area can avoid each 
other and at low space allowance, they utilize the free-access 
stalls more, also reducing aggression. When the space allowance 
is intermediate, the sows are motivated to use the space, but 
are unable to avoid agonistic interactions so easily and thus, this 
treatment shows most aggression.
The other important aspect of space is its quality. Much of the 
current research in to group housing in North America involves 
the changing of stall systems to pen systems within similar types 
of building – i.e. into fully-slatted or part-slatted, non-bedded 
group housing. Usually, space is still fairly restricted and the en-
vironment off ers no real ‘enrichment’ apart from pen-mates with 
which to interact. In these systems, there may be increases in 
skin lesions and aggression-associated lameness compared with 
sows in crates. However, if other enrichment is included, such 
as a foraging substrate and bedding, then aggression is often 
reduced compared with sows in non-enriched pens (42). 
Welfare impact of aggression
The most obvious physical impact of aggression can be injury. 
This can take the form of lameness, skin lesions - which are often 
seen on the shoulders, fl anks, hindquarters and ears - or vulva 
biting, seen in sows in particular. If occurring near slaughter, 
severe physical damage may lead to condemnation of parts of 
the carcass, thereby fi nancially impacting the producer. Another 
economic impact can be decreased growth. If individuals are 
unable to access enough food to meet their requirements, then 
growth can be reduced. This can increase the weight variability 
within the pen and can become self-reinforcing, with the smaller 
pigs getting smaller and smaller relative to their pen-mates. 
Within the breeding herd, the timing of group formation and 
any post-service mixing can be critical. It is widely acknow-
ledged that mixing around the time of implantation should be 
avoided and thus mixing at weaning and/or 5-6 weeks post-
service are recommended to maximize farrowing rate (43). 
In terms of internal physiology, we also know that aggression 
activates both the sympathetic-adrenal-medullary axis and the 
hypothalamic-pituitary-adrenal axis, resulting in increased heart 
rate (31), increased plasma cortisol concentrations, increased 
plasma epinephrine and norepinephrine levels. For the breed-
ing sow, this can explain the potential impact of stress due to 
aggression on fertility. For the slaughter pig, this can also help 
explain the eff ects of aggression on growth. With activation of 
the stress axes also comes a negative impact on immunity and 
thus disease incidence and rate of healing of any injury may be 
impacted. Finally, there is recent evidence that for the breeding 
sow, the stress due to aggression that she encounters during 
gestation can impact both the behavior and stress-reactivity of 
her off spring (44). 
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Dysentery and ileitis – High time to tackle the diﬃ  cult science behind these diseases
Steven McOrist
University of Nottingham, Sutton Bonington, UK
Swine dysentery
Clinical features of swine dysentery (SD) have been well de-
scribed in the pig industry since the 1920’s. There is a severe in-
fl ammation of the large intestine with bloody mucous diarrhoea. 
On aff ected farms, disease is usually common in fattening pigs 
from 12 to 75 kg, but cases also occur regularly in gilts and sows. 
Spread of the disease through the herd is slow, building up in 
numbers as the dose rate of the agent builds up in the environ-
ment. The incubation period in fi eld cases is normally 7 to 14 
days. Pigs that recover only develop a mild immunity, but rarely 
suff er from the full disease again. The high economic cost of 
disease is associated with pig mortality, high morbidity, marked 
depression of growth and feed conversion effi  ciency, and the 
costs of continual in-feed medication. It is an oppressive disease 
for pig farmers, who rarely feel able to maintain a functional pig 
farm while a clinical presence continues.
Swine dysentery remains a major pig health issue in Europe and 
Asia-Pacifi c regions and is increasing in the USA, as carbadox 
usage declines. No useful vaccine or blood test is available and 
on-going medication is problematic for endemic SD – a major 
issue in central European pig farming is the high prevalence of 
tiamulin-resistant and pathogenic B hyodysenteriae strains. The 
actions of regulatory authorities have removed many useful and 
eff ective anti-SD drugs (quinoxalines, metronidazoles, iono-
phores) across the pig raising world. 
This major enteric disease is caused by the snake-like spiro-
chaete bacterium, now called Brachyspira hyodysenteriae. This 
organism was fi rst cultured and used to verify Koch’s postulates 
by the groups of David J. Taylor in Cambridge and Hank Harris 
in Iowa in 1970. They published a wide set of studies exploring 
the spirochaetal invasion of colonic epithelial cells and other 
key pathogenesis features of the early lesions (see Taylor and 
Blakemore 1971). 
Microbiological diagnosis is critical because of the serious nature 
of SD, for example, a key issue surrounding the purchase of new 
breeding stock is whether any SD-free reassurance provided by 
a breeding company supplier is accurate. Diagnosis is therefore 
based on the history, the clinical picture, post-mortem examina-
tions and laboratory tests involving both anaerobic isolation and 
PCR identifi cation of haemolytic B hyodysenteriae.
The key scientifi c questions regarding Brachyspira hyodysenteriae 
and SD are i/ those surrounding the pathogenesis of SD – how 
does this organism cause the lesions ? and ii/ those of immunity 
– why is the immune and blood reaction so weak ? The failure of 
the veterinary science community to answer these critical ques-
tions since 1970 has been regularly noted (see ter Huurne and 
Gaastra 1995) and I wish to note it again here. The genome has 
fi nally been elucidated (see Bellgard et al 2009) and it points to 
the existence of 6 likely haemolysins and 15 proteases. However, 
the few mechanistic studies on pathogenesis factors of motility, 
LPS outer coats and putative haemolysins do not amount to a 
real challenge-exposure based explanation about how this bac-
terium produces such an impressive yet immunologically silent 
lesion and illness. The desired outcomes of vaccines and blood 
tests and new drugs for SD, which all became viable targets in 
1971, will presumably wait many further years until these basic 
microbiology challenge-exposure studies come about.
Part of this failure must lie with the lack of funding for basic 
studies of pig enteric diseases. Much of the previous funding in 
livestock microbiology research has ended up with the chicken 
and cattle sectors and focused largely on zoonotic/food industry 
issues such as Salmonella. Any left-over for pig studies have 
previously ended up in these food industry issues or studies in 
respiratory diseases such as PRRS. 
Ileitis – proliferative enteropathy
Clinical features of proliferative enteropathy (PE, ileitis) have 
been well described in the pig industry since the 1930’s. In grow-
ing pigs with uncomplicated proliferation of the mucosa, the 
condition is a chronic proliferative enteropathy, also known as 
porcine intestinal adenomatosis (PIA). Case lesions and clinical 
signs can vary from mild and sub-clinical, through to clinical 
diarrhoea and weight loss; or in more severe cases additional 
changes can be superimposed on this basic lesion, includ-
ing necrotic enteritis, or an acute proliferative haemorrhagic 
enteropathy. All these forms of PE remain common and import-
ant enteric diseases. Estimates across the global swine industry 
show that around 96 percent of farm sites are infected, wherein 
around 30 percent of weaner-to-fi nisher pigs often have detect-
able lesions at some point, causing clear economic losses (see 
McOrist et al 2003).
The nature of PE was not clear until 1973, when lesions were 
examined ultrastructurally and small, curved intracellular 
vibrioid bacteria were consistently present only within the ab-
normal proliferating cells of the aff ected mucosa (see Rowland 
and Lawson 1974). The identity of these PE bacteria and their 
true aetiologic role were fi nally resolved in 1993 with successful 
co-culture of the intracellular organism and the reproduction 
of the disease in pigs using a pure culture of this agent (see 
Lawson et al. 1993 and McOrist et al. 1993). The name Lawsonia 
intracellularis was chosen to refl ect the key role and persistence 
of the Scottish veterinarian, Gordon Lawson in its discovery. The 
unique feature of PE pathogenesis is therefore the clear causa-
tion of a monotypic epithelial cell proliferation by an infectious 
bacterium. To my knowledge, only two other bacteria (unrelated 
species of Bartonella and Citrobacter) have some parallels in 
this proliferative pathogenesis and the exact mechanism also 
remains unknown for them.
Lawsonia research has largely focused on issues important to 
the pig farming industry, such as the susceptibility of Lawsonia 
to various antibiotics, its epidemiology within and between pig 
farms and methods of diagnosis in live pigs and related topics 
(see Stege et al 2004). Lawsonia has a small, single circular gen-
ome and 3 mega-plasmids which are features commonly seen in 
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41
Invited Speakers
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010
other obligate and symbiont intracellular bacteria (see Gebhart 
and Kapur 2007 and Schmitz-Esser et al 2008). A vaccine for 
ileitis was fi rst registered in 2001 (Enterisol Ileitis, Boehringer 
Ingelheim) and is now widely registered and used around the 
world (see Guedes and Gebhart 2003 and Kroll et al 2004). Pre-
sumably, the choice of vaccine format (live attenuated oral deliv-
ery) is well-suited to this type of intracellular gut mucosal agent. 
This rapid ileitis vaccine development is in contrast to the slow 
pace of development for vaccines for other key enteric diseases 
of pigs, such as swine dysentery and post-weaning colibacillosis. 
However, despite the interesting and unique nature of the pro-
liferative nature of PE, with perhaps insights to be gained into 
human colon cancer and the gut fl ora, no real progress has been 
made on the key scientifi c question regarding Lawsonia – how 
does this bacterial organism cause the monotypic proliferative 
lesions in the gut epithelium ? The intriguing mechanism where-
by the bacteria cause infected epithelial cells to fail to mature, 
but continue to undergo mitosis, and form the hyperplastic to 
adenomatous crypts is not yet understood fully. This adenoma-
tous eff ect probably refl ects a Lawsonia-specifi c inhibition of 
the normal crypt cell diff erentiation process, as regulated locally 
at the crypt neck (see McOrist et al 2006 and Oh et al 2010). L 
intracellularis-infected intestinal crypts can become enormously 
elongated and often branched. Loss of body protein and amino 
acids into the intestinal lumen and the reduced nutrient absorp-
tion by the intestinal mucosa lacking mature enterocytes are the 
likely causes of the reduction in weight gain and feed conver-
sion effi  ciency seen in pigs aff ected with chronic uncomplicated 
PE lesions (see Rowan and Lawrence 1982 and Gogolewski et al 
1991). So far, further examination of the Lawsonia genome has 
proved of limited insight into exactly which genes cause this cell 
cycle/diff erentiation eff ect, with many unknown genes evident. 
We therefore note again the failure of the veterinary science 
community to answer this critical question with basic studies 
in pig enteric disease. Presumably the reasons for this failure 
lie again in the lack of funding for basic studies of pig enteric 
diseases as part of the pots allocated for livestock microbiology 
research.
So what will all be saying at IPVS 2020 ...... So, Grandpa Ernie, 
what did all the old pig scientists fi nd out about SD and PE ??? 
Lack of curiosity will kill the pig .....????
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Exudative epidermitis is diﬃ  cult to treat because of widespread 
antimicrobial resistant Staphylococcus hyicus
Jeonghwa Park; Robert Friendship; Cate Dewey; Scott Weese; Zvonimir Poljak
University of Guelph, Guelph, ON, Canada
Introduction
Exudative epidermitis (EE) or greasy pig disease is caused by 
Staphylococcus hyicus. Certain strains of S. hyicus produce heat-
labile exfoliative toxins that are important in the pathogenesis of 
the disease. Infection of skin wounds during the early suckling 
period is the typical presentation. Recently many herds have 
moved away from clipping needle teeth at birth. There may 
be a resultant, an increase in prevalence of EE. Traditionally, an 
injection of penicillin has been the treatment of choice but anti-
microbial resistance to penicillin has been noted (1). 
There are several studies determining the occurrence of diff er-
ent genes encoding antimicrobial resistance in S. hyicus (2) but 
there is limited information about the distribution of the mecA 
gene which encodes the low affi  nity penicillin-binding protein 
PBP 2A. The objectives of this study were to evaluate the extent 
of antimicrobial resistance of S.hyicus and to determine whether 
the mecA gene is present in S. hyicus in Ontario, Canada.
Materials and Methods
In a survey, farmers (n=49) were asked how they treated EE and 
whether the treatment worked. In addition herds (n=17) with 
EE problems were visited and skin swabs and scrapings were 
obtained from pigs with clinical signs of EE (generally 6 pigs per 
farm). Bacterial culture was performed on the samples with S. 
hyicus and S. aureus recovered from 77.3 % (85/110) and 45.9% 
(50/109) of the samples respectively. Susceptibility to penicillin 
(pen), ampicillin (amp), ceftiofur (cef ), spectinomycin (spec), sul-
phonamides (sul), tetracycline (tet), tiamulin (tia) and trimetho-
prim/sulfa (tri/sul) was determined by the agar diff usion method 
defi ned by the Clinical and Laboratory Standards Institute (CLSI). 
In addition, molecular studies were conducted on isolates to 
determine the presence of the mecA gene using PCR and Pulsed-
fi eld gel electrophoresis (PFGE) analysis (3).
Results
Based on the survey, 69.4% (34/49) of farmers used topical 
treatments routinely to treat EE, including mixtures of topical 
antibiotics, antiseptics and mineral oil. In addition, 57% of 
respondents said that they used injectable antibiotics and 82% 
indicated injectable penicillin as the treatment of choice. Many 
of the respondents expressed concern that treatment was of 
little value and that response was poor. 
Antimicrobial resistance testing revealed that all isolates of 
S .hyicus and almost all isolates of S. aureus were resistant to 
penicillin and ampicillin and the majority were also resistant to 
ceftiofur (Figure 1).
Figure1. Percent of isolates resistant to antimicrobials
The percentage of isolates of S. hyicus and S. aureus from which 
the mecA gene was demonstrated was 2.73% (3/110), and 5.45% 
(6/110), respectively. The mecA gene was present in 12.96% 
(14/108) of the S. aureus isolated from nasal swabs from these 
same pigs.
Discussion
Penicillin was identifi ed as the most common treatment choice 
by pig farmers and yet all isolates from cases of EE were shown 
to be resistant to not only penicillin but in most cases resistant 
to the entire family of beta-lactam antibiotics. These results ex-
plain why farmers reported a poor response to treatment of EE. 
Previous researchers have noted that penicillin-resistant isolates 
of S. hyicus containing the blaZ gene were relatively common in 
the pig population, aff ecting 50 to 75% of isolates (2). Methicil-
lin-resistant S. aureus has been shown to be widespread in On-
tario pig farms (4) and therefore it is not surprising that the mecA 
gene was isolated from S. aureus in these pigs. The relationship 
between S. aureus and S. hyicus and the possibility of gene trans-
fer between these bacteria needs to be investigated further.
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Etiology of the ear necrosis syndrome – investigation of infectious agents
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Mathias Ritzmann1
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Introduction
During the summer months lesions of the so-called ear necrosis 
syndrome can be observed frequently in weaners during the 
raising period. The stages range from mild epidermal changes 
to severe ulcers and necrosis (1). In the past, various pathogens 
have been discussed to be responsible for the development of 
ear necrosis, but the exact etiology of this disease could not be 
determined. Aim of this study was the evaluation of diff erent 
infectious agents in pigs with ear necrosis syndrome.
Materials and Methods
A total of 96 piglets (age 6 to 10 weeks) were included in the 
study. Piglets in 9 of the 15 farms were sampled twice in the 
interval of a year; in the other 6 farms piglets were only sampled 
once. All piglets showed clinical signs of the ear necrosis syn-
drome in an initial stage. The total of piglets with ear necrosis 
on the respective farms ranged from 10 to 100 %. Collected 
samples and methods are summarized in table 1.
Table 1: Types of samples and methods
Sample type n Method
Ear tissue 96 Pathohistology
Ear tissue 96 In situ hybridization PCV2
Swab of lesion 91 Bacteriology
Serum 88 PRRSV-PCR
Serum 96 PCV2-PCR
Serum 96 Mycoplasma suis-PCR
Serum 96 Sarcoptes suis-Ab-ELISA
Serum 15 Endotoxin
Serum 96 Calcium, phosphorous 
Results
The pathohistological fi ndings included epidermal necrosis, 
epidermal hyperplasia, bacterial growth in superfi cial cell debris 
and intimal proliferation with consecutive vascular occlusion. In 
situ hybridization for PCV-2 was negative in all cases.
In 61 of the swabs streptococci could be found, in 48 of the 
swabs staphylococci were determined. 8 piglets were PRRSV 
positive, none of them was positive for PCV2. Only one piglet 
showed a positive result for Mycoplasma suis. 3 piglets showed 
antibodies against Sarcoptes suis. The measured endotoxin 
concentration ranged between 0.10 and 1.13 U/ml. Calcium 
levels were increased in 20, decreased in 6 piglets, phosphorous 
concentrations were increased in 57 and decreased in 1 of the 
piglets.
Discussion
The pathohistological fi ndings proved that ear necrosis did 
not only develop because of external infl icted injuries and ear 
biting. A multifactorial disease seemed more likely. The various 
infectious agents seemed to play a minor role, PCV2 could be 
completely excluded. Strepococci and staphylococci could be 
determined frequently in the swabs as well as pathohistological-
ly, but it was unclear if they act in a sense of a primary or second-
ary infection. The endotoxin concentrations were in a non-
critical range, but participation earlier in the course of infection 
can not be ruled out. Finally, the development of ear necrosis is 
caused by an interaction of several factors and infectious agents 
are defi nitely able to contribute to this disease pattern.
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The association between tail lesions and abscesses recorded at slaughter
Marie Erika Busch; Niels Peter Baadsgaard
Pig Research Centre, Danish Agriculture & Food Council, Copenhagen, Denmark
Introduction
The presence of tail lesions in slaughter pigs has been shown to 
be correlated to the risk of abscesses, including osteomyelitis (1, 
2, 3). However, the location of abscesses associated with tail le-
sions has been described in only one published paper (4), which 
describes signifi cant correlations between tail lesions and ab-
scesses in the spine, peritoneum, pelvis, legs, ribs and lungs. Ab-
scesses are costly to the pig producer because of partial or total 
condemnations at slaughter. In addition, it is most likely that the 
disease process leading to abscesses causes reduced pig welfare 
and productivity, increased mortality and higher expenses for 
medical treatment (5, 6). The aim of the present study was to 
investigate the degree to which abscesses, including embolic 
pneumonia and osteomyelitis, could be attributed to tail lesions 
and to investigate the location of the abscesses associated with 
tail lesions. This would help the pig producer assess whether 
diff erent kinds of abscesses recorded at slaughter are likely to be 
caused by tail lesions or whether other causes are more likely. 
Materials and Methods
Data from the meat inspection was used for the analysis. The 
data set comprised records from 732,282 slaughter pigs (cas-
trates and females) from 2,027 herds slaughtered at the largest 
Danish abattoir in Jan-Feb 2008. The meat inspection records 
the presence/absence of tail lesion for each individual pig as 
standard procedure. Similarly, the presence/absence of abscess-
es at diff erent locations on the pig is recorded (see locations in 
Table 1). In the case of osteomyelitis, the location is not record-
ed. Each pig can have abscesses at several locations.
Statistical analysis: For each type of abscess, we calculated the 
relative risk (RR) of having an abscess when having a tail lesion 
compared to not having a tail lesion. The statistical signifi cance 
of the interrelationships was tested by chi-square tests. In addi-
tion, the following were calculated:
• AF (attributable fraction): the proportion of abscesses in pigs 
with tail lesion attributable to tail lesions
• PAF (population attributable fraction): the proportion of 
abscesses in the population attributable to tail lesions
Results
The overall prevalence of tail lesions was 0.85 %. Table 1 shows 
an overview of the results. 
Table 1. The association between tail lesions and abscesses recorded 
at slaughter
Prevalence 
of
+ tail lesion 
lesions (%)
- tail le-
sion 
RR AF PAF
Abscesses
    Head 0.96 0.99 0.97 -3.0 -0.03
    Abdomen 3.5 0.8 4.7* 78.5 3.0
    Neck/breast 4.9 1.3 3.9* 74.2 2.4
    Limbs/toes 4.2 1.0 4.1* 75.7 2.6
    Hind part 9.0 0.5 17.2* 94.2 12.1
Embolic pneum. 1.2 0.05 25.9* 96.1 17.5
Osteomyelitis 12.4 0.2 57.2* 98.3 32.3
*=P<<<0.05
Discussion
The associations between tail lesion and all types of abscesses, 
except abscess in the head, were statistically signifi cant. The 
highest RR, AF and PAF were found for osteomyelitis and em-
bolic pneumonia. Osteomyelitis was found 57 times more often 
in pigs with tail lesion than in pigs without tail lesion, and 32 
% of the osteomyelitis cases could be attributed to tail lesions. 
However, these numbers are probably underestimated, since 
many cases of healed tail lesions are probably not recorded by 
the meat inspection. The risks of abscesses in the abdomen, 
neck/breast and limbs/toes were also correlated with the pres-
ence of tail lesion (RR 3.9-4.7). However, as seen by the low PAFs 
(2.4-3.0), in most cases the causes of these abscesses should be 
found elsewhere. For example, they could be caused by un-
hygienic injection practice, hernias, foot injuries or other injuries 
serving as an entrance for bacteria. The potential associations 
among diseases recorded at slaughter may direct attention to 
preventive measures and hence help reduce costs of partial or 
total condemnation of the carcass for the producer.
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The development and consequences of ear necrosis in a weaner herd and two growing-ﬁ nishing herds
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Introduction
In Danish herds, ear necrosis (EN) in weaners and older pigs is 
mainly located along the ventral edge of the ear. Biting by other 
pigs and infections (possibly as a sequel to trauma) have been 
suggested as causes of EN (1, 2). The aim of this investigation 
was to explore 1) the development and healing of EN, 2) factors 
within the herd associated with EN and 3) the eff ect of EN on the 
health and growth of the pigs.
Materials and Methods
Three herds with high prevalences of EN were chosen for two 
studies. All study pigs were females or castrates. Study 1: Study 
1 was carried out in a sow/weaner herd. A total of 136 randomly 
selected pigs from two batches were examined 2-3 times a week 
for 7 weeks beginning two days before weaning (day -2). EN was 
scored on a scale of 0-4 representing increasing severity (0: no 
EN; 4: loss of ear tissue and/or EN on > 20 % of the ear). The aver-
age daily gain (ADG) of each pig during the observation period 
was measured. The study pigs were housed in 11 weaner pens 
with slatted fl oors and tube feeders (25 pigs/pen). The eff ects 
of weight at weaning, ear scratches on day 4, gender and sow 
parity on the binary ‘EN score 2-4 on day 46’ were analyzed in a 
logistic regression model. Study 2: Study 2 was carried out in two 
growing-fi nishing herds receiving pigs from the same sow herd 
(not the herd in study 1). The study comprised 218 pigs from one 
batch: 109 pigs without EN (controls) and 109 with EN (matched 
on pen, gender and weight). Pigs were examined once a week 
for 12 weeks from a weight of approx. 45 kg. EN was scored on 
a scale of 0-4 (0: no EN; 4: bloody lesion with loss of ear tissue). 
ADG of each pig during the observation period was measured. 
Pens housed 11-22 pigs and had varying fl ooring and feeding 
systems. Meat inspection data for all pigs were collected. The 
eff ects of EN, herd, gender, weight at entrance and at slaughter 
on ADG were analyzed in a linear mixed model.
Results
Study 1: The prevalence of severe EN was highest at the end 
of the observation period (Figure 1). Weight at weaning, ear 
scratches on day 4, gender and sow parity were not found to 
have any eff ect on the risk of having EN on day 46. Pigs with and 
without EN had the same ADG (250 g/day). EN was not found 
to have any eff ect on signs of disease. Study 2: No eff ect of EN 
on ADG, lean mean percentage or mortality was found (overall 
mortality 2.8 %). Five pigs in the EN group and one control pig 
became unthrifty or lame, but the diff erence was not statistically 
signifi cant (P=0.1). At slaughter, abscesses were found in only 
two pigs, both from the EN group (corresponding to 1.8 % of the 
EN pigs).
Figure 1. EN prevalence in the weaner herd (study 1) and in the EN 
group in the growing-fi nishing herds (study 2).
Discussion 
There were no signs that small or weak pigs were predisposed 
to EN. EN was not found to have any eff ect on growth. Despite 
severe lesions, EN did not result in the amount of abscesses that 
are common in pigs with tail lesions (3). In growing-fi nishing 
pigs, more disease was found in pigs with EN, but a larger 
investigation would be necessary to determine whether the 
diff erence is statistically signifi cant. The healing of EN seen in the 
growing-fi nishing pigs could be caused by immunological or 
behavioral changes in the pigs.
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Idiopathic Vesicular Disease (IVD): a case report in the centre of Italy
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Introduction
Several Swine Vesicular Disease (SVD) outbreacks were regis-
tered in central Italy (Umbria and Marche regions) during Octo-
ber 2008. In the same time vesicular lesions were observed in 
an high percentage of animals of a fattening unit (approx. 2000 
fattening pigs), located the surveillance area. 
The aim of this work is to describe the episode and explain the 
diff erential diagnostic pathway to rule out SVD and suspect 
Idiopathic Vesicular Disease (IVD)
Materials and Methods
A state veterinarian noted vesicular lesions on snout of several 
hogs during an inspective visit in a fattening farm, before their 
transport to slaughter house. The farm was immediately quaran-
tined. 
A trace back and trace forward investigation was performed by 
our Institute (Istituto Zooprofi lattico Sperimentale dell’Umbria e 
delle Marche). Blood and fecal samples were collected from pigs 
with lesions and not and checked for exotic diseases (SVD and 
Foot and Mouth Disease – FMD) and for parvovirus. 
Blood samples were investigated for blood count parameters. 
Feed samples were collected from the hoppers and from the silo 
bean and tested for mycotoxines (Afl atoxines, Deoxynivalenol, 
Zearalenone, T2 toxin, Fumonisine) . 
Results and discussion
Snout erosions were observed on 20 % of the pig farm popula-
tion. Few animals showed gingival and oral lesions, too. Coron-
ary band was not interested.
Lesions were of 3-4 mm of diameter and circular or “V” shaped. 
(Fig. 1 and 2).
Rectal temperatures ranged from 38,5 to 39,3 °C ruling out an 
infectious aetiology . 
Feed was commercially purchased and the epidemiological 
trace back showed all the biosecurity measures were respected. 
The last pig replacement happened six months before and no 
pigs were sold in the same time.
Lab test results were negative for SVD, FMD and parvovirosis. 
Blood parameters didn’t reveal signifi cative alterations and 
mycotoxins levels in the feed resulted within the normal ranges. 
Lesions resolved in nearly three weeks time.
In the last two years we observed, always in fattening farms and 
in the same season, two other episodes characterized by similar 
lesions. 
The fi rst case was referred to high levels of Deoxynilvalenol and 
the second one to a mistake in the organic acids inclusion in the 
feed.
In this case, looking the lab results and the symptomatology we 
reasonably suspect Idiopathic Vesicular Disease (IVD) even if a 
defi nitive diagnosis was impossible to achieve.
Idiopathic Vesicular Disease (IVD) is a sporadic condition aff ect-
ing swine already reported in Australia, New Zealand, Canada 
and USA. It is characterized by a seasonal pattern (spring – au-
tumn). Although, it isn’t a severe disease for pigs and economic-
ally heavy for breeders, IVD represents an important diff erential 
diagnostic condition must be considered for SVD and FMD 
diagnosis. 
We have to bear in mind predisposing factors can play an im-
portant role to exacerbate the clinical symptoms. In this case the 
particular shape of the nipple-drinkers could be contributed to 
complicate the symptoms. 
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Prevalence and risk factors of lameness and claw lesions in two types of group housing for pregnant sows
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Introduction
Claw lesions and lameness in sows are an important welfare 
concern as well as a cause of considerable economic loss for pig 
producers. These problems are more common in group housing 
than in individual housing systems1. Given that group housing 
for pregnant sows will become mandatory in the EU from 2013 
onwards, the aim of the present study was fi rstly to determine 
the prevalence of lameness and claw lesions, and secondly to 
analyze type of group housing and sow related risk factors as-
sociated with lameness and claw lesions.
Materials and methods
Eight Belgian pig herds with loose housing of pregnant sows 
were selected. In four of them, sows were housed in pens with 
electronic sow feeders, the other four herds used free access 
stalls (table 1). At the end of gestation, sows were investigated 
for lameness by visual judgement of their gait (lame or not 
lame). Within 3 days after farrowing, possible lesions of the claws 
of their hind limbs were scored using a standardized scoring 
system2. Information about feed, housing conditions and cull-
ing (strategy) was collected as well as information about parity 
and breed of each sow. Logistic regression analysis was used to 
evaluate risk factors (type of group housing, breed, parity and 
lesion score) for lameness. The dataset of claw lesion scores was 
analyzed by using linear mixed model analyses. All analyses 
were performed using SPSS version 16.00. A P value <0.05 was 
considered signifi cant. 
Table 1: General characteristics of the 8 investigated herds (B1-B8)
B1 B2 B3 B4 B5 B6 B7 B8
Herd size 200 750 230 200 140 160 700 280
No. of sows as-
sessed 55 69 85 47 13 53 58 41
Breed T T D H RS J D J
Mean parity as-
sessed sows 1.8 2.8 4.5 4.0 2.8 3.6 3.2 3.2
# week batch pro-
duction system 3 2 4 3 1 5 4 3
Type of group 
housing FA FA FA FA ESF ESF ESF ESF
Culling % due to 
locom. disorders 6 0.6 3 4 9 15 12 7
Use of bedding - - - - - - - +
ESF: electronic sow feeder, FA: free access stalls
T: Topigs, H: Hypor, D: Danbred, J: JSR, RS: Rattlerow-Seghers
Results
Of the total of 421 sows that were investigated, 9.7% was lame 
(min. 2.4% max. 23.1%). No signifi cant diff erence for lameness 
was found between the two types of group housing (mean 
prevalence: 7.4% in free access stalls, 13% in pens with elec-
tronic sow feeders). The prevalence of lameness signifi cantly 
increased with increasing parity of sows. Claw lesions were seen 
most frequently on the wall and heel area of the claw - almost 
every sow had heel lesions - and there were signifi cantly more 
lesions found on lateral claws than on medial claws. Only lesions 
on the heel area diff ered signifi cantly between both types of 
group housing with higher scores in free access stalls (mean 
total score 8.3 versus 7.7). The prevalence of side wall lesions and 
overgrown (dew-)claws was increased with increasing parity. 
Breed was not signifi cantly associated with lameness or claw 
lesions. 
Conclusions
Lameness and claw lesions in sows housed in group during ges-
tation are commonly found in Belgian pig herds, and their preva-
lence was higher in older sows. This indicates that a balanced 
parity distribution of sows is not only important for productivity 
reasons but also from a health and welfare point of view. Further 
research will focus on ways to control or prevent claw lesions in 
group housed sows.
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Kyphosis and lordosis: possible link to nutrition
Jesus Borobia Belsué
MOSSVET, Portadown, UK
Introduction
In September 2008 two 600 sow birth to bacon units reported 
an increase of ”humpy-backs” from 6 – 8 weeks of age and lame-
ness from 6 weeks of age during the previous 5 months. There 
was no response to antibiotic treatment.
Farm B re-stocked from Farm A. Both units are closed to outside 
pig introductions other than semen.
Both units are negative to major pathogens other than Porcine 
Circovirosis and Mulberry Heart Disease.
Materials and Methods
Clinical investigation consisted of a farm visit in September 2008 
and every 3 months thereafter. Three live 10 week old and one 
16 week old pig were submitted to the laboratory (AFBI, Omagh, 
Northern Ireland). A blood sample was taken from the three 10 
week old pigs for biochemistry (Ca, Mg, P, CPK, GPX, vitamin E). 
The vertebrae and ribs of all 4 pigs were analysed for Ca, Mg, P & 
Ash.
Ca, P & Mg were analysed in dry sow, lactating and grower diet 
in an independent laboratory (Anser Laboratories, Moy, North-
ern Ireland).
Vitamins A, E & D3 were examined in all pig diets.
Results
Post-mortem examination of the pigs revealed lordosis from 
T9 to T10; T8 to T10; T5 to T12; T7 to T11 and kyphosis from T12 
to T13; T12 to L1; T13 to L2; T12 to L2. Midshaft bony exostoses 
were found half way between the costrochondral junctions and 
the vertebral bodies in 3 pigs and thickened costrochondral 
junctions in one animal.
No signifi cant fi ndings detected at histological examination. 
Immunofl uorescence negative to PCV-2. No signifi cant bacteria 
isolated.
Biochemistry of the blood was within normal range parameters 
apart of one pig with 3.72 mM P (upper limit: 3.4) and 7956 U/l 
CPK (upper limit: 5000).
Biochemistry of the bones detected values ranging from 18.6 
to 27.0% Ash (Normal Values: >50%) and slightly high P values 
ranging from 19.6 to 20.6% (Normal Values: 17 -19%).
Ca, P & Mg in dry sow, lactating and grower diet were analysed 
(Ca Dry Sow: 1.35%, Ca Lactating Sow: 1.12%, Ca Grower: 1.01%; 
P Dry Sow: 0.56%, P Lactating Sow: 0.51%, P Grower: 0.50%; Mg 
Dry Sow: 0.21%, Mg Lactating Sow: 0.14%, Mg Grower: 0.14%).
Vitamin A in Dry Sow diet was 15,000 mg/kg.
Vitamin E in 1st & 2nd stage diets were 124 mg/kg & 125 mg/kg, 
respectively. 
Discussion
Kyphosis in pigs is similar to Scheuermann´s Disease in humans 
(Lowe, 1990). This lesion could be a factor in carcass downgrad-
ing and limit the number of replacement gilts. ”Humpy-back” 
is described as an idiopathic lumbar kyphosis with thoracic 
lordosis which has no hereditable basis and is associated with 
management and environmental factors (Penny et al., 1984). 
According to Lahrmann et al., 1993, it is secondary to a num-
ber of diff erent primary lesions located in the vertebrae, e.g. 
osteomyelitis, fractures, neoplasm and metabolic diseases. Other 
possible causes are painful conditions of the legs and back 
(Lahrmann, 1990), musculo-mechanical stress on the lumbar 
spine (Corradi et al., 2004), early onset of puberty in male pigs 
(Done et al., 1988) and intrauterine viral infections (Done et al., 
1999). Furthermore, there are suggestions of genetic involve-
ment (Foster, 1986; Pearson et al., 2004; Laitat et al., 2006).
Infections, genetic, managerial and structural factors were 
removed as causes in this case. However, metabolic diseases 
could not be ruled out. This statement agrees with Lahrmann et 
al. (1993).
The thickening of costrochondral junctions is a failure of bone 
mineralisation and growth plate cartilage. Ca, P and Vit. D defi -
ciencies are the common cause (Muirhead et al., 1997; Jackson 
et al., 2007). 
Ca:P ratio in bone ash analysed was normal. However, bone ash 
percentage was low. This decreased mineralisation could have 
been the cause of bony exostoses and Lordosis/Kyphosis. These 
diets had phytase incorporated in order to reduce addition of 
inorganic P in the diet and reducing contamination. 500 UF 
(Phytase Units) = 0.8 – 1g/kg of P (0.08 – 0.1%). Heat treatments 
of the feed, such as pelleting, could destroy phytase in feed 
(Pérez, 2009). All these diets were pelleted. As a consequence of 
this, Ca & P in the diets was re-formulated (Ca Dry Sow: 1.1%, Ca 
Lactating Sow: 1.12%, Ca Grower: 1.01%; P Dry Sow: 0.6 – 0.8%, P 
Lactating Sow: 0.7 -0.9%, P Grower: 0.6 – 0.8%).
High levels of vitamin A lead to lameness, decreased bone 
weight and narrow metaphyseal growth plates in the vertebrae 
(Taylor, 1995). Furthermore, it interferes with normal growth of 
epiphyseal plates leading to osteochondrosis (OCD) (Muirhead 
et al., 1997). OCD of vertebrae, with or without spondylosis, 
results in kyphosis (Hill, 1990).
European Food Safety Authority (EFSA) recommended the re-
vision of maximum vitamin A level in feed for main food produ-
cing animals as a consequence of link to bone health problems 
(osteoporosis and bone fracture). The Panel proposed setting a 
level for fattening pigs at 1⁄2 the current amount allowed by EU 
Regulation (EC) No 1831/2003.
Vitamin A in sow’s diet was reduced to 8,500 mg/kg.
Vitamin E in 1st and 2nd stage was increased to 250 & 200 mg/
kg, respectively.
Genetics were not changed.
Control program was successful in this case. No further cases 
were seen since May 2009..
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Porcine Postweaning Wasting/Catabolic Syndrome (PWCS): pathological features
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Introduction
Porcine Postweaning Wasting/Catabolic Syndrome (PWCS) is 
an emerging condition causing elevated nursery mortality1. Af-
fected pigs, weaned in robust body condition, develop anorexia 
and most become severely emaciated and die within 3 weeks of 
weaning. Mortality rates wax and wane and reach 10% in peak 
months. The cause of PWCS is unknown, but an infectious etiol-
ogy suspected. Pathogens including PRRSV, porcine circovirus 
2, rotavirus, transmissible gastroenteritis virus, infl uenza virus, 
Lawsonia intracellularis, Mycoplasma hyopneumoniae, Helicobac-
ter spp., Campylobacter spp., calicivirus and coccidia were not 
causally related to PWCS2 (and unpublished data). The objective 
of the current study was to characterize the pathologic changes 
in PWCS-aff ected pigs.
Materials and Methods
Five emaciated pigs (PWCS-E) and 3 age-matched healthy pigs 
(PWCS-H) from a PWCS-aff ected farm, and 4 healthy age-
matched pigs from each of two PWCS unaff ected farms (CTR1, 
CTR2; 8 pigs in total) were selected 2 to 3 weeks postweaning. 
Necropsy examinations were performed immediately after 
humane euthanasia. Gross and histologic lesions were as-
sessed and multiple fresh and fi xed tissues processed routinely. 
Morphometrics of villi lengths of duodenum, jejunum and ileum 
(at least 10 villi from each section) were conducted on all PWCS-
E and PWCS-H pigs, 2 CTR1 and 4 CTR2 pigs. The average villi 
length was calculated for each tissue and pig. Potential group 
diff erences were examined using a Kruskal-Wallis H followed 
by a post-hoc Mann-Whitney U test with P < .05 considered 
signifi cant. 
Results
No gross lesions were observed in any PWCS-H, CTR1 or CTR2 
pig. Of PWCS-E pigs, 4/5 had severe thymic atrophy and 3/5 had 
mild to moderate bronchopneumonia. Histologically, the thymic 
atrophy was mainly due to the reduced thickness of the cortex. 
Small intestinal villous atrophy was readily observed histologic-
ally in PWCS-E pigs. Mean villi lengths in duodenum, jejunum 
and ileum were signifi cantly shorter in PWCS-E than CTR pigs 
(control considered normal) (Table 1). Mean villi lengths in je-
junum, but not the duodenum or ileum (P = 0.05 for ileum), were 
signifi cantly shorter in PWCS-E than PWCS-H. Colitis, character-
ized by multifocal to diff use necrosis of the epithelium and/
or increase mononuclear infi ltration in the lamina propria, was 
found in all PWCS-E and PWCS-H pigs, but not in any CTR pig. 
Subjective assessment concluded the colitis was more severe in 
PWCS-E than PWCS-H. No microscopic changes were found in 
any CTR pig. 
Table 1. Mean intestinal villous lengths (μm ± SD) of emaciated 
(PWCS-E) and age-matched healthy (PWCS-H) pigs from a PWCS-af-
fected farm, and from age-matched pigs (CTR) from 2 unaff ected farms
Groups n Duodenum Jejunum Ileum
PWCS-E 5 188.1 (38.5)a 166.4 (31.3)a 182.8 (69.8)a
PWCS-H 3 251.1 (81.1)a 287.4 (26.2)b 299.6 (40.3)a
CTR (1 & 2) 6 516.0 (64.6)b 409.7 (37.8)c 401.2 (50.8)b
Values within columns with diff erent superscripted letters are statistically diff erent at P < 0.05.
Discussion 
The results of this study indicate the principle lesions associ-
ated with PWCS are thymic and intestinal villous atrophy, and 
colitis. Villous atrophy was highly prevalent but less severe 
in the PWCS-H compared to the PWCS-E pigs suggesting the 
former were either subclinically aff ected, in the early stages of 
the disease before notable loss of condition, or villous atrophy 
is a predisposing risk factor for PWCS. The presence of thymic 
atrophy in PWCS-E pigs may be the direct consequence of the 
condition, or an indirect result of prolonged anorexia. The latter 
is supported by the absence of thymic atrophy in PWCS-H pigs 
and in one PWCS-E pig that was only moderately aff ected. Colitis 
may be a direct result of the disease or indirectly associated with 
small intestinal pathology including villous atrophy. Broncho-
pneumonia was not observed previously in PWCS1. Its import-
ance cannot be ruled out but it is less likely because clinical res-
piratory signs (coughing, dyspnea) were not observed. Further 
eff orts to identify the cause of PWCS are underway. 
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Introduction
Since 2008, veterinarians have reported persistent and some-
times extensive nursery mortality associated with anorexia 
and weight loss in PCV2-vaccinated pigs1. We have performed 
a diagnostic investigation in an aff ected farm and have tem-
porarily named the condition Postweaning Wasting/Catabolic 
Syndrome (PWCS). Evidence suggests PWCS is likely infectious. 
The etiology is unknown, but common porcine pathogens have 
been ruled out. The objective of this report is to summarize the 
diagnostic investigation in the PWCS-aff ected farm.
Clinical Presentation and Interventions
A well-managed, high health (PRRSV, Mycoplasma hyopneu-
moniae negative, PCV2 positive) 100-sow farrow-fi nish farm 
experienced elevated nursery mortality since 2007 (Table 1) 
almost exclusively due to PWCS. Aff ected pigs in good body 
condition at weaning develop anorexia, lethargy and emaciation 
shortly thereafter. Most PWCS-aff ected pigs die within 3 weeks. 
Survivors grow slower than their pen-mates. Management inter-
ventions targeting ventilation, piglet comfort, diet and water 
quality have not reduced PWCS-losses. PCV2 piglet vaccination 
and all antimicrobial strategies attempted have been unsuccess-
ful. Losses have been partially mitigated following aggressive 
sanitation of farrowing and nursery rooms using either strong 
sodium hypochlorite solution or hydrated lime. 
Table 1. Nursery mortality in the PWCS-aff ected farm. 
Year Mortality (%) Year Mortality (%)
2005 1.7 2007 6.6
2005 1.3 2008 6.3
2006 2.6 2009 8.3
 
Diagnostic Investigation
In response to the elevated mortality, live pigs or tissues from 4 
pigs in poor body condition were submitted for routine diagnos-
tics. Lesions were non-specifi c, the etiology was undetermined, 
and adjunct testing for PRRS (IHC), PCV2 (IHC), Leptospira spp. 
(silver staining) was negative. There was no evidence of coccidi-
osis. A specialized disease investigation team was recruited and 
more extensive diagnostics on 7 cases were undertaken. Histo-
logical examination revealed severe thymic atrophy (5/7 pigs), 
mild lymphocytic gastritis (7/7), severe small villous intestinal 
atrophy (7/7), moderate to severe colitis (6/7), mild interstitial 
thickening of lung (7/7), moderate to severe lymphoplasmacytic 
rhinitis (4/5) and mild lymphoid depletion (4/7). Bacteria culture 
of various organs did not yield signifi cant fi ndings in 7/7 pigs. 
Complete blood counts in 3/3 pigs were unremarkable. Serum 
chemistry in 3/3 pigs was consistent with cholestasis, gastric 
stasis, anorexia and dehydration. Adjunct testing of appropriate 
tissues from selected pigs failed to conclusively identify com-
mon swine pathogens (Table 2). Feces subsequently submit-
ted from 5 healthy suckling (1-18 day old), 5 thin and diarrheic 
nursery (25-35 day old), and 2 grow-fi nisher pigs was examined 
by electron microscopy (EM) to detect possible gastrointes-
tinal pathogens. Six of 12 samples were negative. Calicivirus 
was observed in 4/12 (1 suckling, 3 nursery, 1 grower) samples. 
Rotavirus, coronavirus, and either parvovirus or enterovirus were 
observed in 1 nursery sample each.
Table 2. Microbiologic results of PWCS-aff ected pigs
Pathogens Assay Tissue # pos / # tested
PRRSV PCR lung 0/7
PCV2 IHC tonsil 4/7
Infl uenza PCR lung 0/7
TGEV IHC intestine 0/1
Rotavirus IHC intestine 0/3
Helicobacter spp PCR stomach 0/3
Campylobacter spp PCR stomach 0/3
Enteric calicivirus PCR intestine 3/7
Discussion and Conclusions
Major porcine pathogens have been ruled out as the cause of 
PWCS. Scant PCV2-positive staining with/without mild lymphoid 
depletion is not uncommon in commercial pigs. Failure of PCV2 
vaccination to control PWCS in this farm makes PCVD unlikely. 
Calicivirus is highly prevalent but not reported to cause disease 
in commercial pigs2. Moreover, porcine enteric Calicivirus DNA2 
was demonstrated in 2/3 healthy and 2/5 sick pigs subsequently 
submitted from the farm. Further eff orts to identify the cause of 
PWCS are underway. 
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Emergence of a new type of porcine circovirus (PCV1/2a) in swine in Canada
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Introduction
Between September 2008 and January 2009, three cases 
(FMV08-1114252, FMV08-1133505 and FMV09-1134568) were 
submitted to the Veterinary diagnostic service of the University 
of Montreal. None of the three submitted cases were related to 
“Porcine circovirus associated diseases” (PCVAD). Several diag-
nostic assays were performed including a multiplex real-time 
quantitative PCR assay (mrtqPCR) for the detection and diff eren-
tiation of porcine circovirus (PCV) type 2a and 2b genotypes in 
the lung and lymph nodes(1). Odds results were obtained with 
the mrtqPCR assay, suggesting genomic mutations in the viral 
genome.
Materials and methods
To confi rm the genomic nature of the three PCV positive cases, 
specifi c PCR assays were performed to detect the ORF1 of PCV1 
and the ORF2 of PCV2 genes. A third PCR assay was selected 
to amplify both ORF1 of PCV1 and ORF2 of PCV2 genes simul-
taneously. The entire PCV genome was amplifi ed by PCR that 
produced 2 overlapping PCR products. Both strands of the puri-
fi ed DNA PCR products were sequenced(2). Virus isolation was 
conducted using the PK15A cell line as previously described(2) 
and an immunofl uorescence assay (IFA) was performed to 
confi rm the presence of PCV using an anti-PCV2 pig serum as 
described previously(3).
Results
All the obtained results converge to demonstrate the emer-
gence of a new PCV. In addition, infectious viruses were isolated 
from 2 out of the 3 submitted cases and expression of the viral 
Cap protein encoded by the ORF2 gene was confi rmed by IFA 
in PCV infected cells. The results indicate the presence of both 
PCV1 ORF1 and PCV2 ORF2 genes in the PCR products. To 
confi rm the genomic nature of the new PCV, its viral genome 
was sequenced. The ORF1 was more genomically related to the 
ORF1 of PCV1 with a nucleotide (nt) identity of 99.7% compared 
to ORF1 of PCV2a and 2b with nt identities of 82.5% and 82.8%, 
respectively. On the other hand, the ORF2 was more genomic-
ally related to the ORF2 of PCV2a with a nt identity of 98 5% 
compared to ORF2 of PCV1 and PCV2b with nt identities of 
66.7% and 92.5%, respectively. The nt identity of the entire viral 
genome of the new PCV was 86.4%, 88.7% and 86.5% compared 
to PCV1, PCV2a and PCV2b, respectively. 
Discussion
It is proposed to name this new PCV by taking into account pre-
viously described nomenclature(4) and by indicating the origin 
of the ORF1 at fi rst and the origin of the ORF2 in second. Con-
sequently, the name proposed for this new PCV is PCV1/2a. The 
prevalence of PCV1/2a seems to be very low in Quebec, Canada 
(2.5% of PCV positive cases), and its origin is now in debate. 
Two hypotheses could explain the emergence of the PCV1/2a in 
swine: (a) the natural genetic recombination between PCV1 and 
PCV2a in infected animals; or (b) a human made virus originat-
ing from a chimeric killed vaccine strain. Still, even if PCV1 and 
PCV2a are found in low amount in Quebec swine, the genetic 
recombination between PCV1 and PCV2a is a possible explana-
tion. In early 2008, a new vaccine was commercially available in 
Canada (Suvaxyn® PCV2). This vaccine uses a chimeric killed or 
inactivated PCV(5, 6). This chimeric PCV genome is composed of 
the ORF1 of PCV1 and the ORF2 of PCV2a. The nt sequences of 
the PCV1/2a strains were found to possess 5 to 6 nt diff erences 
compared to the chimeric PCV vaccine strain with a nt identity 
of 99.6–99.7% and all nt diff erences were located in ORF1.
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Mutations of the PCV-2 capsid motif, speciﬁ c of each PCV-2 genogroup, attenuate virulence in vivo
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Introduction
The porcine circovirus of type 2 (PCV-2) is a non-enveloped, 
small single-stranded DNA virus. It is the causal agent of post-
weaning multisystemic wasting syndrome (PMWS) and is in-
volved in “porcine circovirus diseases”. After the re-emergence of 
PMWS in North America in 2005, the presence of new circulating 
PCV-2 isolates belonging to PCV-2b genogroup raises the as-
sumption that this genogroup is more virulent than the PCV-2a 
one. Viruses of each genogroup contain a distinct motif of amino 
acid in the capsid protein (amino acids 86 to 91), the unique 
component of the virus outer structure1. In this study, we inves-
tigate if PCV-2 genetic variation is responsible of virulence and 
check if the capsid motif contributes to this diff erence.
Materials and Methods
Two infectious clones representative of both PCV-2 genogroups 
were constructed (PCV-2a and PCV-2b clones). Two mutants 
were generated by directed mutagenesis. The PCV-2a (PCV-2b 
motif ) mutant has the capsid motif of PCV2b genogroup into 
the backbone of PCV-2a and the PCV-2b (PCV-2a motif ) mutant, 
the capsid motif of PCV-2a genogroup in the backbone of PCV-
2b. The infectious clones and the mutants were characterized 
in vitro. Then their virulence was assessed by an experimental 
trial on PCV-2 free SPF (Specifi c pathogen free) piglets. Forty 
6-weeks-old SPF piglets were divided into six groups as shown 
on Table 1. The experiment ended between 35 and 40 dpi. 
Table1: Experimental protocol
Group 
number 1 2 3 4 5 6
Inoculum PBS PBS PCV-2a DNA PCV-2b DNA
PCV-2a (PCV-
2b motif) 
DNA
PCV-2b (PCV-
2a motif) 
DNA
Day 0: 400μg DNA/pig
400μg 
DNA/pig
400μg DNA/
pig
400μg DNA/
pig
Days 2, 7: KLH/ICFA by IM
KLH/ICFA 
by IM
KLH/ICFA 
by IM
KLH/ICFA 
by IM
KLH/ICFA 
by IM
Number of 
pigs 4 4 8 8 8 8
Tissue samples were collected at necropsy. The PCV-2 serocon-
version was monitored using ELISA test. Quantifi cation of viral 
genomes and infectious particles were respectively assessed by 
quantitative PCR and by IPMA2.
Results
Both parental clones and both mutants were infectious in vitro. 
The results of the experimental trial are summarized in Table 2.
All the controls were negative for the presence of PCV-2.
Table 2: Results of the in vivo characterization of both parental strains 
and both capsid motif mutants.
Parental 
clone
Parental 
clone
Mutant 
clone
Mutant 
clone
PCV-2a PCV-2b PCV-2a (PCV-2b motif)
PCV-2b (PCV-
2a motif)
Score mean (hypertrophy of TB 
lymph nodes) 1.37a 1.5a 0.62b 0.87ab
Seroconversion of all pigs 28 to 35dpi 21 to 28 dpi absence 21 to 28dpi
Genomic load in serum (mean 
in log10/ml) 4.8a 6.8b 0c 4.1a
a, b, c indicates signifi cant diff erences (p<0.06) 
Moreover, infectious particles were detected in tissue of the four 
groups inoculated with the clones and mutants.
Discussion and Conclusion
In vitro, both PCV-2 parental clones and both capsid motif 
mutants were infectious. In vivo: (i) The PCV-2b strain induced an 
earlier seroconversion and a higher genomic load in serum than 
the PCV-2a strain. The PCV-2b strain was more virulent than the 
PCV-2a one. (ii) The PCV-2b (PCV-a motif ) mutant showed similar 
features to the PCV-2a parental strain with a moderate virulence 
attenuation. (iii) The PCV-2a (PCV-2b motif ) mutant was highly 
attenuated. 
In conclusion, these results showed that the PCV-2 capsid motif 
specifi c of genogroup is a molecular marker of virulence of PCV-
2.
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Cell-dependent susceptibility to Porcine circovirus ORF3-induced apoptosis
Mark Chaiyakul1 Karolynn Hsu1 Avril Hatherell1 Rkia Dardari1 Frank Marshall1, 2 Markus Czub1
1. University of Calgary, Calgary, AB, Canada; 2. Swine Health Services, Calgary, AB, Canada
Introduction
Porcine circovirus associated disease (PCVAD) has caused con-
siderable economic impact worldwide since its fi rst description 
on a Canadian pig farm in the 1990s. PCVAD, a wasting and 
immunosuppressive disease in post-weaned pigs, is caused 
by Porcine circovirus type 2 (PCV2). Despite the availability of 
eff ective vaccines, little is known about the molecular patho-
genesis of the disease. Belonging to the Circoviridae family, PCV2 
and PCV1 are closely-related viruses with a 1.7kb, ambisensed 
and circular ssDNA genome 1. While PCV2 is pathogenic, PCV1 is 
not. Investigating the diff erences in the genomic composition of 
these viruses will provide clues to the molecular pathogenesis 
of PCVAD. ORF3 is a good candidate as a determinant of PCV 
pathogenicity because PCV1 and PCV2 ORF3 share only 60.6% 
amino acid (aa) sequence identity in the translated region. In 
addition, a consistent single nucleotide (nt) substitution in the 
PCV2ORF3 coding region resulted in a stop codon, leading to 
PCV2ORF3 that is half the length of PCV1ORF3 (104aa versus 
206aa). PCV2ORF3 was shown to induce apoptosis and a mutant 
virus devoid of ORF3 expression did not induce apoptosis in Cos-
7 and PK-15 cell lines 2. Abrogation of ORF3 expression appeared 
to reduce PCV2 virulence in a specifi c-pathogen-free (SPF) piglet 
model 3. Due to the diff erences between PCV1 and PCV2 ORF3 
and what is known about PCV2ORF3, it is hypothesized that 
ORF3 determines the pathogenicity of PCV. Thus, the object-
ive of this study is to compare and contrast the pro-apoptotic 
capability of PCV1 and PCV2 ORF3.
Materials and Methods
PCV1 and PCV2 ORF3 genes were cloned into mammalian ex-
pression peGFP-C1 vector to create fusion proteins with eGFP at 
the N’terminus. Flow cytometry was used to assess cell viability 
and apoptosis. Immunoblot was used to detect protein expres-
sion and PARP cleavage associated with apoptosis. Z-Asp-CH2-
DCB was used as a caspase inhibitor. Three cell lines were used 
in this study: human epithelial 293T, porcine kidney epithelial 
PK-15 and porcine primary kidney (PPK) cells. Statistical analysis 
was performed, using ANOVA and Tukey’s multiple comparison 
tests with p<0.05 considered as statistically signifi cant. 
Results and Discussion
In all three cell lines, eGFPPCV1ORF3 signifi cantly induced 
higher cell death. Meanwhile, eGFPPCV2ORF3 signifi cantly 
induced higher cell death only in PK-15 cells. It was also consist-
ently observed that eGFPPCV1ORF3 was a more potent inducer 
of cell death than eGFPPCV2ORF3. 
During apoptosis, a programmed cell death process, phos-
phatidylserine molecules become externalized to the outer 
surface of the cell membrane. This externalization is important 
for macrophage recognition, phagocytosis and clearance of 
apoptotic cells without causing an infl ammatory response 4. In 
addition, caspases become activated and cleave PARP mol-
ecules, DNA repair enzymes, leading to apoptosis 5. In this study, 
signifi cantly higher percentage of phosphatidylserine external-
ization as well as the presence of a cleaved PARP fragment was 
observed in cells transfected with eGFPPCV1ORF3. Moreover, 
addition of increasing concentration of a caspase inhibitor 
reduced the level of cell death induced by eGFPPCV1ORF3. 
Hence, cell death induced by PCV1ORF3 occurs via a caspase-
dependent apoptotic pathway, similar to what was reported for 
PCV2ORF3 2. 
While PCV1 does not cause disease, PCV2 causes PCVAD. Their 
distinctly diff erent ORF3 protein was hypothesized to be the 
factor for their diff erent pathogenicity. Although both PCV1 and 
PCV2 ORF3 can induce cell death via apoptosis, it is not com-
pletely surprising because they share 60.6% aa sequence iden-
tity. However, PCV1ORF3 appears more potent than PCV2ORF3 
in inducing cell death despite the lack of cytopathic eff ects in 
cells infected with PCV1 6. It is speculated then that PCV1ORF3 
expression is absent or is tightly regulated by other viral 
protein(s), incapacitating PCV1 from causing PCVAD in pigs. Dif-
ferent cell death profi les seen with diff erent cell lines and even 
within the same cell population suggest a cellular-dependent 
response to ORF3-induced apoptosis. 
References
(1)  Opriessnig et al. 2007. J Vet Diagn Invest 19:591-615. 
(2)  Liu et al. 2005. J Virol 79: 8262-74. 
(3)  Karuppanan et al. 2009. Virol 383:338-47. 
(4)  Duvall et al. 1985. Immunol 56:351-8. 
(5)  Tewari et al. 1995. Cell 81:801-9. (6) Tischer et al. 1982. Nature 
295:64-6..
Porcine Circovirus Associated Diseases - Molecular biology
54
Oral Presentations
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010
O.014
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infections in mid-gestational porcine foetuses
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Introduction
PCV2 may cause reproductive failure in the fi eld (1), and there-
fore the eff ects of experimental PCV2 infections, mainly PCV2a, 
on reproduction have been studied extensively (2). Recent 
fi eld observations on the occurrence of PMWS suggest that 
PCV2b may be more pathogenic than PCV2a (3). The aims of the 
present study were to investigate if there are diff erences in viral 
replication and clinical outcome between PCV2a and PCV2b 
infections in porcine foetuses.
Materials and Methods
Four conventional sows were submitted to laparotomy at 55 
days of gestation. In each of four sows, three foetuses were 
inoculated with PCV2 and one foetus was mock inoculated. 
Inoculations were performed by transuterine injection with 
104.3TCID50 of PCV2 into the peritoneal and amniotic cavities of 
the foetuses (4). In the fi rst sow, two foetuses were inoculated 
with PCV2a strain Stoon-1010 and one with PCV2a strain 1121. 
In the second sow, two foetuses were inoculated with PCV2b 
strain 48285 and one with PCV2b strain 1147. In the third sow, 
one foetus was inoculated with PCV2a strain Stoon-1010, one 
with PCV2a strain 1121 and one with PCV2b strain 1147. In the 
fourth sow, one foetus was inoculated with PCV2a strain 1121, 
one with PCV2b strain 48285 and one with PCV2b strain 1147. 
Twenty-one days post inoculation (dpi), the sows were eutha-
nized and all foetuses were collected. All foetuses were exam-
ined for gross lesions and tissue samples from various organs 
were taken for titration on PK-15 cells and for localization of viral 
antigens. In order to verify that the foetuses had been inoculat-
ed with the specifi c PCV2 strain, the capsid gene was amplifi ed 
using heart and/or lung tissue from infected foetuses followed 
by sequencing. Abdominal fl uids were tested for the presence of 
PCV2-specifi c antibodies by IPMA.
Results
All PCV2-inoculated foetuses, except one PCV2 (1147)-inocu-
lated foetus, were oedematous and had distended abdomens 
(Fig.1.a). Haemorrhages and congestion in internal organs and 
liver enlargement were observed (Fig.1.b). One PCV2 (1147)-in-
oculated foetus had a normal external appearance, but liver 
enlargement and generalized lymph node enlargement were 
observed. Gross pathological lesions were not observed in 
mock-inoculated and non-inoculated foetuses. High PCV2 titres 
(> 104.3TCID50 / g tissue) were found in all PCV2-inoculated 
foetuses, especially in the heart, spleen and liver. High numbers 
of PCV2-infected cells (> 1,000 infected cells / 10 mm2 tissue) 
were observed in the heart (Fig.1.c). PCR and DNA sequencing of 
the capsid gene recovered pure PCV2a and pure PCV2b sequen-
ces from PCV2a- and PCV2b-inoculated foetuses, respectively. 
No evidence for mixed samples (e.g. containing more than one 
PCV2 strain) was seen. All adjacent foetuses of PCV2-inoculated 
foetuses were negative in PCR assays with the exception of one 
adjacent foetus of Stoon-1010- inoculated foetus, which was 
positive in PCR assays and a pure Stoon-1010 sequence was ob-
tained. All mock-inoculated foetuses and their adjacent foetuses 
were negative in PCR assays. Three PCV2-inoculated foetuses 
had a low anti-PCV2 Ab titre of 10 to 40.
Conclusions
From this model, it can be concluded that diff erent PCV2 strains 
of both genotypes induced similar gross pathological lesions 
and replicated to similar high titres in diff erent foetal organs.
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Fig. 1. Diff erent aspects of PCV2 replication after inoculation of a 55-
day old foetus. a) Subcutaneous oedema and abdominal distension. b) 
Haemorrhages and congestieon in internal organs and liver enlarge-
ment. c) Immunofl uorescent staining for the PCV2 capsid protein in the 
heart. Bar = 50 μm.
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Singular PCV2a or PCV2b infection results in apoptosis of hepatocytes in clinically aﬀ ected gnotobiotic pigs
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Introduction
Systemic infection with porcine circovirus type 2 (PCV2) is often 
clinically associated with respiratory signs, failure to thrive and 
diarrhea (1) Currently, PCV2 can be further subdivided into two 
main genotypes, PCV2a and PCV2b which under experimental 
conditions result in very similar macroscopic and microscopic 
lesions in conventional pigs (2). Viruses are often associated with 
apoptosis of host cells but there are confl icting results of the role 
of PCV2 in this pathway (3,4). The objective of the present study 
was to assess the association of PCV2 antigen with apoptosis 
in liver tissues from gnotobiotic pigs experimentally inoculated 
with PCV2.
Materials and Methods
Forty-eight gnotobiotic pigs were separated into fi ve groups 
based on inoculation status and development of clinical disease: 
(1) Non-inoculated, healthy (n=4), (2) PCV2a, healthy (n=10), 
(3) PCV2a, clinically aff ected (n=6), (4) PCV2b, healthy, (n=13) 
and (5) PCV2b, clinically aff ected (n=15). Formalin-fi xed and 
paraffi  n-embedded sections of liver from all pigs were subjected 
to a CCaspase-3 (CCasp-3) immunohistochemistry (IHC) assay, a 
TUNEL assay, and a PCV2 IHC (5). For each slide, 10 random 40x 
fi elds were scored for presence of characteristic staining. The 
scoring scheme used ranged from 0 (no signal) to 3 (high degree 
of staining in the majority of the cells and fi elds examined). All 
sections of liver tissue were also scored for the presence of the 
following microscopic lesions: Presence of neutrophils and pres-
ence and degree of necrosis, degeneration and infl ammation. 
The sum scores were used for analysis. The following nine com-
parisons were made using the Fisher’s Exact Test for dependency 
between the categorical variables in paired situations: (1) TUNEL 
score versus disease status, (2) CCaspase-3 score versus disease 
status, (3) PCV2 IHC score versus disease status, (4) PCV2 IHC 
versus TUNEL score, (5) PCV2 IHC versus CCaspase-3 score, (6) Le-
sion sum versus CCaspase-3 score, (7) Lesion sum versus TUNEL 
score, (8) Lesion sum versus PCV IHC and (9) Lesion sum versus 
disease status. A statistically signifi cant diff erence was defi ned as 
a P-value of less than 0.05.
Results
Sixteen of 21 (76 2%) clinically aff ected PCV2-inoculated pigs 
and 11/27 (40.7%) clinically unaff ected PCV2 inoculated pigs 
had moderate-to-severe hepatic lesions characterized by severe 
diff use lymphohistiocytic hepatitis associated with degeneration 
and loss of hepatocytes. Specifi c CCasp-3 staining and TUNEL 
labeling was detected in the nuclei of hepatocytes in PCV2a and 
PCV2b infected pigs with signifi cantly (P < 0.05) higher levels of 
apoptotic cells in clinically aff ected pigs. Clinically aff ected pigs 
also had signifi cantly (P < 0.05) higher levels of PCV2 IHC stain 
compared to non-aff ected pigs. The lesion sum score was also 
signifi cant in the clinically aff ected pigs (P < 0.05). 
Discussion
This experiment was conducted in order to delineate the role 
of PCV2a and PCV2b genotypes in apoptosis of hepatic cells 
in gnotobiotic pigs. According to the results obtained, the 
gnotobiotic pigs when experimentally inoculated with PCV2a 
or PCV2b developed clinical disease which was associated 
with severe hepatitis, abundant amount of PCV2 antigen in 
infl ammatory cells and hepatocytes, and apoptosis occurred in 
hepatocyte-like cells detectable by CCasp3 stains and the TUNEL 
assay. The pig experiments were of limited duration and it is not 
known if the 11/27 infected, but healthy pigs that had hepatic 
lesions and minimal apoptosis, would manifest clinical disease 
with a signifi cant increase in CCasp4 and TUNEL stained cells. 
In conclusion, PCV2 infection regardless of genotype resulted 
in apoptosis of hepatocytes in clinically aff ected gnotobiotic 
pigs and apoptosis appears to be one pathway by which PCV2 
induces disease.
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High prevalence of porcine circovirus viremia in newborn piglets in ﬁ ve 
clinically normal swine breeding herds in North America
Huigang Shen; Darin Madson; Tanja Opriessnig
Iowa State University, Ames, IA, USA
Introduction
Porcine circovirus type 2 (PCV2) has been associated with a 
number of disease manifestations in pigs including reproductive 
failure (1). It has been demonstrated that PCV2 can be transmit-
ted horizontally and vertically; however, it is unclear to what 
extent vertical PCV2 transmission occurs under fi eld conditions 
especially in farms subclinically infected with PCV2. The object-
ive of the current study was to evaluate the rate of intrauterine 
PCV2 infection in healthy piglets born on commercial farms in 
North America and to further characterize dam viremia, dam 
antibody levels, and piglet antibody levels.
Materials and Methods
Five commercial breeding herds were selected to participate 
in this study, with one farm located in Mexico (Farm A) and the 
remaining four farms located in the U.S. (Farms B-E). A total of 
128 clinically healthy sows and 504 live-born normal appearing 
piglets born to the dams were randomly selected at a rate of 
three to four piglets per litter. Serum and colostrum samples 
of the dams were collected immediately after parturition and 
before suckling. Piglet serum samples were collected after birth 
and prior to colostrum uptake. All samples were tested for the 
presence of anti-PCV2 IgG antibodies using a PCV2 ORF2-based 
ELISA (2) and for the presence and amount of PCV2a and PCV2b 
DNA by a multiplex diff erential real-time PCR (3).
Results
All (128/128) dams and 21.2% (107/504) of the piglets were 
positive for anti-PCV2 IgG antibody. The overall PCV2 DNA 
prevalence was 66.4% (85/128) in dams and 43.1% (217/504) 
in piglets. In general, more dams and piglets were positive 
for PCV2b (71.8 and 75.1%, respectively) compared to PCV2a 
(12.9 and 15.1%, respectively). Concurrent PCV2a/b infection 
was detected in 13/128 dams and in 21/504 piglets on all fi ve 
farms. Piglets born to dams with higher PCV2 DNA loads had 
increased frequency of PCV2 viremia and elevated PCV2 DNA 
copy numbers in serum. Higher amounts of PCV2 DNA were 
detected in PCV2 seronegative piglets compared to seropositive 
piglets indicating that some level of protective humoral immun-
ity developed in utero.
Discussion
Vertical transmission is an important means of PCV2 transmis-
sion in clinically normal herds. In the selected farms, PCV2b was 
more prevalent than PCV2a in piglets, and virus transmission 
through breeding herds may result in continuous PCV2b expos-
ure to grow-fi nish herds. Dam viremia was associated with the 
frequency and level of PCV2 infection in the piglets. The piglet 
anti-PCV2 antibody could alleviate PCV2 infection, indicating 
humoral immune responses occurring in the fetuses may play a 
protective role. Dam PCV2 antibodies did not necessarily allevi-
ate PCV2 infection in fetuses. 
Acknowledgements
We thank Boehringer Ingelheim Vetmedica Inc. for funding of 
this study. 
References
1.  Opriessnig, T. et al. (2007) J. Vet. Diagn. Invest. 19, 591-615.
2.  Nawagitgul, P. et al. (2002) Clin. Diagn. Lab. Immun. 1, 33-40.
3.  Opriessnig, T. et al. (2010) Vet. Res. 41:31.
.
Porcine Circovirus Associated Diseases - Clinical aspects
57
Oral Presentations
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010
O.017
Assessment and quantiﬁ cation of Post-weaning Multi-systemic 
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Introduction
Post-weaning Multi-systemic Wasting Syndrome (PMWS) causes 
major economic losses in the English pig industry (1). Severity of 
clinical signs and economic impact vary considerably between 
aff ected farms. Appropriate diagnosis and determination of 
PMWS severity on the farm are crucial for informing decision 
about control measures. The present study aimed to defi ne and 
quantify severity levels of PMWS observed on farms using a 
novel approach based on morbidity, mortality and presence of 
porcine circovirus type 2 (PCV2).
Materials and Methods
In 2008-2009, 147 pig farms across England and not vaccinating 
against PCV2 were enrolled in a cross-sectional study, and retro-
spective data on PMWS morbidity and production indicators 
were collected. Classical data collection methods were com-
bined with tools used in participatory epidemiology. In addition, 
on each farm serum samples from 20 pigs of four diff erent age 
groups were collected and tested for PCV2 antigen and anti-
bodies against other important pathogens (2). After correcting 
for misclassifi cation, factor analysis was used to generate a small 
number of factor variables representing biological meaningful 
aspects of variation among morbidity variables and these were 
then together with relevant risk factors variables subjected to 
principal component analysis to derive an algorithm for PMWS 
severity.
Results
Evidence of PCV2 presence was found on all farms enrolled in 
the study. Factor analysis performed on morbidity data resulted 
in two factors: Morbidity Factor 1 (MF1) representing mainly 
weaner and grower morbidity, and Morbidity Factor 2 (MF2) 
which mainly refl ect variation in fi nisher morbidity. Principal 
component analysis was performed on the identifi ed morbid-
ity factors, all production variables and laboratory results. This 
resulted in the extraction of one component representing varia-
tion in MF1, post-weaning mortality and percentage of PCV2 
PCR positive animals. The extracted component accounted for 
60% of the total variance of these three variables. The distribu-
tion of the resulting values for each variable is shown in Figure 
1.The scores from the resulting component were normalised 
within a value range from 0 to 10. Cut-off s values were identi-
fi ed and farms were classifi ed into: non or slightly aff ected farms 
(24%) with a score <4, highly aff ected farms (23%) with a score 
>6.5 and, the majority of the farms (53%), considered to be mod-
erately aff ected farms with middle scores (4 – 6.5). 
Figure 1: Contribution of morbidity, post-weaning mortality and PCV2 
PCR results to the PMWS severity score. In blue ‘non or slightly aff ected’ 
farms, orange ‘moderately aff ected’ and in red ‘highly aff ected’ farms.
Discussion
The factor analysis indicated a clustered pattern of PMWS 
morbidity, with farms either having high morbidity in weaners/
growers or mainly in fi nishers. The principal component meas-
ures PMWS severity on the farms and establishes weaners and 
growers as the main age groups aff ected by the disease. The 
distribution in the three severity categories is believed to refl ect 
the situation of PMWS in the English pig population before the 
onset of PCV2 vaccination and will be used in further research to 
investigate risk factors associated with diff erent PMWS severity 
levels and to measure PCV2 vaccination effi  cacy at each of these. 
The outcomes will then inform economic models for the de-
velopment of cost-eff ective disease control measures for PMWS.
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Introduction
Dietary supplementation of omega-3 polyunsaturated fatty 
acids (n-3 PUFAs) during gestation and/or lactation is reported 
to increase litter size in pigs (Spencer et al., 2004; Webel et al., 
2003) and is believed to be benefi cial for reproductive perform-
ance in sows (Webel et al., 2004). However, results are incon-
sistent. This study re-assessed the eff ects of n-3 PUFA supple-
mentation to gilts during late gestation and lactation on the 
subsequent reproductive performance and the growth perform-
ance of their litters. 
Material and Methods
At day 60 (d60) of gestation 117 pregnant gilts were pair-
matched by weight and litter of origin, and allocated to one of 
two treatments:
•  Control gilts (CON, N=56) fed standard gestation and lacta-
tion diets, or 
• Treated gilts (FP10, N=61) fed the standard diets supple-
mented with 84 g/d of Sow Fat Pack 10 (JBS United, Sheridan, 
IN), a fi sh-oil based supplement rich in omega-3 fatty acids. 
Gilts were fed CON or FP10 diets from d60 of fi rst gestation, 
through a 21-d lactation, and until euthanasia at d30 of their 
second gestation. All sows were feed restricted during the last 
week of lactation (fed 60% of expected feed intake).
Sow body weight, and backfat and loin depth, were measured 
at d60 of gestation, d1 of lactation, 7 days before weaning, at 
weaning, after last breeding and at d30 of second gestation. 
Net energy balance was calculated as reported by Vinsky et al. 
(2006). Individual piglet weights were measured on d1 of lacta-
tion, 7 days before weaning and at weaning in all litters, and at 
the end of the nursery phase in a subset of litters. 
After weaning, sows were heat checked twice daily and bred 
by AI using semen from the same boars for both treatments. 
Sows were euthanized on-site at d30 of gestation, reproductive 
tracts were recovered, and the number, crown-rump length and 
weight of embryos, placental fl uid volume, ovulation rate (CL 
number) and CL weight were recorded, and embryonic survival 
was calculated. 
Results
Net energy balance during lactation and sow body composition 
were not diff erent between CON and FP10 sows. The total num-
ber of piglets born (13.0 ± 0.4 vs. 12.9 ± 0.3) and average piglet 
birth weight per litter (1.32 ± 0.03 vs. 1.34 ± 0.03 kg) were also 
not diff erent between treatments. Repeated measures analysis 
for average piglet weight per litter showed that litters from FP10 
sows compared to litters from CON sows were heavier at wean-
ing (5.57 ± 0.10 vs. 5.88 ± 0.10 kg, respectively; P<0.05) and had 
improved overall growth performance to the end of the nursery 
stage (P<0.05). Weaning-to-estrus interval, ovulation rate, and 
embryo weight/crown-rump length and survival to d30, did not 
diff er between treatments. However, average weight of the CL’s 
at d30 was higher in FP10 compared to CON sows (378.1 ± 6.9 
vs. 341.0 ± 7.1 mg, respectively; P<0.001). 
Discussion
Supplementing gilt diets with omega-3 fatty acids during late 
gestation and lactation positively impacted litter weight after 
birth, but did not aff ect the most common reproductive charac-
teristics in sows after rebreeding.
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Evaluation of an aluminosilicate to decrease the toxic eﬀ ects of Aﬂ atoxin B1 in swine
Juan C. Medina1 Jose A. Fierro1 Ruben Perez-Franco1 Elizabeth Rodriguez2 Leticia Duran1 Mariana Altamirano1 Veronica Moreno2
1. NUTEK S.A de C.V., Tehuacan, PUE, Mexico; 2. Investigación Aplicada S.A. de C.V., Tehuacan, PUE, Mexico
Background
Afl atoxin B1 (AFB1) is a mycotoxin with carcinogenic, terato-
genic, mutagenic and immunosuppressant properties; it is 
produced by several species of the Aspergillus genus (fl avus, 
parasiticus, nomiusy pseudotamarii). Its target organ is the liver 
(hepatotoxic). The eff ects of afl atoxins (AFs) in swine depend on 
the age, concentration in feed, and exposure periods. Problems 
related to contamination with these toxins have been reported 
in all stages of swine lifespan. Several aluminosilicates have 
been reported to reduce the eff ects of afl atoxins in swine diets 
(Ramos and Hernandez, 1997). 
Aim
To evaluate the effi  ciency of a mycotoxin binder to decrease 
the toxic eff ects of a diet contaminated with 680 μg/kg (ppb) of 
AFB1 in swine balanced feeds.
Materials and Methods
18 swine were used, weaned at 21 days of age divided into 3 
groups with 6 repetitions. They were housed in individual corrals 
with swine use fl oor. A week of contiditioning was considered. 
Commercial feeds were used, they were proven to be free of 
contamination with other mycotoxins (AFs, fumonisin B1, Ochra-
toxin A, DON and T.2). The treatments were: 1. Negative control 
diet, 2. Positive control diet with 680 ppb of AFB1, 3. Challenge 
diet with adsorbent: 5 kg/t + 680 ppb of AFB1. The experiment 
took 21 days. Swine were weighed at the beginning of the 
experiment and individual weights were recorded weekly. Feed 
conversion was calculated weekly. At the end of the experiment 
all swine were sacrifi ced; during the necropsy, samples of tonsils, 
lungs, livers, gallbladders, kidneys, spleens and mesenteric 
lymph nodes. All organs were previously weighed. Samples were 
submitted to histopathology studies. Fat, iron, vitamin A and 
AFM1 were quantifi ed in livers. Biochemical parameters were 
analyzed in sera (aspartate aminotransferase, alanine amino-
transferase, alkaline phosphatase, gamma-glutamyltransferase 
(GGT), glucose, local proteins, albumen, creatinine, triglycerides, 
cholesterol, urea, uric acid) and vitamin A. The information 
obtained was analyzed with the Tukey test using the SYSTAT 
statistical software; the signifi cance value was based on a prob-
ability of 0.05.
Results and Discussion
Ssignifi cative statistical diff erences were observed in animal 
weight gain, total weight, feed consumption, alkaline phos-
phatase, GGT and total proteins. In animals in which damages 
produced by afl atoxins were observed, a recovery was obtained 
from the challenge diet that included the adsorbent. The de-
crease in weight gain of the positive control group was of 31.2% 
compared to the negative control group. 52.3% of the weight 
gain diff erence was recovered in the challenge group. The rest 
of the evaluated parameters only showed numeric diff erences. 
The histopathological analysis showed the eff ects of consuming 
afl atoxins in livers and kidneys. 
Conclusion
AFB1 at the concentrations used in the experiment aff ected 
animals. The increase of the concentration of alkaline phos-
phatase and GGT enzymes indicate the eff ects of AFB1 in swine. 
The decrease of these enzymes in the group given a diet with 
adsorbent is another proof of the protection aff orded by the 
adsorbent Adding mycotoxin adsorbents in the diets of animals 
exposed to contamination with afl atoxins diminished economic 
losses attributable to these toxins, especially in large productive 
facilities.
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O.021
Eﬀ ect of energy intake during gestation on performance and blood parameters of primiparous sows
Octávio H. Eckhardt1 Felipe C. Horta1 Larissa J. Parazzi1 Esther R. Afonso1 Simone M. Martins1 Carolina I. Silva1 José E. Junior2 
Francisco P. Rennó2 Aníbal S. Moretti1
1. Laboratory of Swine Research, University of Sao Paulo, Depto. Nutrição e Produção Animal (VNP), Pirassununga, SP, Brazil; 2. Laboratory of 
Biochemistry and Animal Physiology, University of Sao Paulo, Depto. Nutrição e Produção Animal (VNP), Pirassununga, SP, Brazil
Introduction
The relationship between productivity and metabolic status, es-
pecially in gilts, is of great interest. Greater energy intakes during 
late gestation have been linked to lower lactational feed intake, 
resulting in catabolism and a poorer reproductive outcome in 
the next parity1,2,3. The aim of the study was to investigate the 
eff ects of energy intake in primiparous sows’ performance and 
metabolic state.
Materials and Methods
Twenty three hybrid gilts, with 75 days of gestation, were fed 
according to 2 treatments until farrowing: (P, n=12) 2,9kg of a 
pre-lactation diet (3203 kcalME/kg, 17,25%CP),and (G) 2,5kg 
gestation diet (2930 kcalEM/kg, 16,43%CP). Gilts were weighted 
at 75 days of gestation, 3 days before farrowing, at farrowing, 
and weekly during lactation until weaning. Animals were fed to 
appetite during lactation. Blood collections were made during 
gestation (days 82, 89, 96 and 103), at farrowing, lactation (days 
7 and 14) and weaning, to evaluate HDL, LDL and VLDL chol-
esterol, triglyceride (TGL), and non-esterifi ed fatty acids (NEFA) 
(Laborlab®/Randox® kits, SBA200 Celm® analyzer/Asys Expert 
Plus microplate reader). In a random design the performance 
variables and blood parameters were analysed with the PROC 
GLM and MIXED of SAS4, respectively.
Results
Daily weight gain from d75 until farrowing was higher for treat-
ment P (Table 1). Energy intake during late gestation did not 
infl uence lactational feed intake or weights. Although there 
was not signifi cant diff erence regarding the animal’s weights 
during lactation, the P treatment refl ected in a weight loss while 
G treatment in gain. Blood parameters showed some signifi cant 
diff erences among the treatments related to time variable, and 
some interactions eff ect as show table 2. 
Discussion
Unlike other reports1, higher gestational energy intake did not 
infl uence fed intake and weight during lactation. HDL and LDL 
levels remained higher for P during gestation, as a result of a 
higher energy intake and thus a numerically higher TGL liver 
production, requiring transport through lipoproteins. Higher 
TGL concentrations for G during lactation, as a result of high 
consumption, led to higher VLDL levels for transport from 
liver and HDL for reverse transport to that organ. Higher NEFA 
concentration for P is due to a peak during parturition, sugges-
tion a higher response to lipolytic stimuli in heavier animals. In 
conclusion, blood parameters refl ected the higher energy intake 
during gestation for treatment P, and despite this treatment 
lost more weight during lactation, this fact did not aff ected the 
metabolic state of the females. 
Table 1- Weight (Wt), Avarage Daily gain (ADG) and feed intake during 
late gestation and lactation (Lact)
G P p
Wt d75 Gestation (kg) 186.4±9.6 183,8±7.1 ns
Farrowing Wt (kg) 220.1±13.7 229.1±10.2 **
ADG 75-112d (kg/d) 0.92±0.16 1.23±0.16 *
Postpartum Wt (kg) 194.1±10.4 199.7±8.8 ns
Weaning Wt (kg) 197.0±15.2 195.3±12.2 ns
Feed intake Lact (kg/d) 5.4±0.8 5.2±0.9 ns
* p<0.05; ** p<0.010
Table 2 - Blood parameters during gestation and farrowing (Gest) and 
lactation (Lact)
G P VC p Treat p Time p TXT
TGL 1 Gest 34.61 40.23 22.3% 0.113 * 0.14
Lact 34.10 29.74 20.1% 0.124 * 0.26
HDL 1 Gest 23.26 26.83 10.4% * * *
Lact 29.14 26.76 12.1% 0.143 * *
LDL 1 Gest 48.22 56.09 12.0% * * 0.29
Lact 72.32 72.54 16.4% 0.843 * 0.46
VLDL 1 Gest 6.92 8.05 22.3% 0.113 * 0.14
Lact 6.82 5.95 20.1% 0.124 * 0.26
NEFA 2 Gest 0.189 0.274 48.7% * * *
Lact 0.204 0.244 43.6% 0.181 * 0.53
1mg/dl; 2mmol/l; * p<0.05; Treatment X Time interaction
References
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Eﬀ ects of feeding oregano essential oil to sows on performance 
of her oﬀ spring from weaning through market 
Claudia Ariza-Nieto2, 3 Roger D. Walker2 Martha A. Mellencamp1 Samuel K. Baidoo2
1. Ralco Nutrition, Inc., Marshall, MN, USA; 2. Southern Research and Outreach Center, University of Minnesota, Waseca, MN, USA; 
3. CORPOICA, Bogata, Colombia
Introduction
It has long been acknowledged that some plant essential oils 
exhibit diverse functional activities. Oregano essential oil (OEO) 
has been shown to possess anti-bacterial, anti-fungal, and 
anti-oxidant activities (1). Analysis of the chemical compon-
ents of OEO has shown that it contains high levels of carvacrol 
and thymol. The phenolic nature of these two compounds is 
responsible for the potent activities associated with OEO. Results 
from several studies have shown that OEO supplementation 
positively infl uences sow reproduction and litter health (2, 3). In 
this study, we investigated the eff ects of feeding OEO to sows on 
performance and carcass characteristics of her off spring. 
Materials and Methods
This experiment was carried out at the University of Minnesota 
Southern Research and Outreach Center. A total of 384 early 
weaned piglets (d19) from sows fed control (corn-soy) or OEO 
(control+250 ppm OEO, Ralco Nutrition, Inc., Marshall, MN) diets 
during lactation and gestation were randomly assigned to 48 
pens. Each pen was randomly assigned to one of four dietary 
treatments: control, antibiotic (Mecadox® 10kg/ton phase 1 and 
2), OEO (1000 ppm phase 1 and 2, 500 ppm phase 3, 250 ppm 
phase 4 and 5) and antibiotic+OEO. Pigs were weighed at wean-
ing (19d), phase 1 (33d), phase 2 (54d), phase 3 (89d), phase 4 
(131d) and phase 5 (152 d). Twenty-seven pigs per treatment 
were randomly selected for collection of carcass data. Pigs were 
shipped to a commercial abattoir for slaughter at the end of 
phase 5. Standard carcass measurements were collected, includ-
ing carcass weight, carcass yield, fat depth, loin depth, lean 
percentage, carcass premium score and carcass value. 
Results 
Analysis of variance showed that sow treatment signifi cantly af-
fected ADG. At the end of phase 1, pigs from OEO-fed sows grew 
faster than controls (175 v. 153 g/d). When measured over the 
entire wean-to-fi nish period, pigs from OEO-sows grew faster 
than pigs from control sows (817 v. 789 g/d) and ate more feed 
(1.92 v. 1.86 kg/d). Pig treatment eff ect was signifi cant for OEO. 
Supplementation of OEO in pig diets showed an increase in ADG 
(20g/d) compared to pigs without supplementation. 
Dietary supplementation with OEO to sows signifi cantly 
increased body weight of off spring at slaughter (116 v. 112.6 
kg) (Table 1). Sow treatment eff ects were observed for several 
carcass traits. There was no pig treatment eff ect observed for 
body weight or carcass traits, except for a sow treatment by pig 
treatment interaction for carcass premium (grade index). Carcass 
value showed that off spring from OEO-sows earned an addition-
al $4.90 when compared with pigs from control sows. 
Discussion 
In this study, administration of OEO to sows signifi cantly 
improved her off spring’s post-weaning growth and overall 
carcass quality and value. The eff ect of OEO in sow diets was fi rst 
apparent in the higher litter weaning weights compared with 
control off spring. OEO-sows had better quality colostrum (more 
IgG and lymphocytes) than control sows, and this may have 
contributed to improved weaning weights (2). Study of post-
weaning performance showed that the off spring of OEO-sows 
gained more weight during the fi rst two weeks post-weaning 
than controls. Pig performance following weaning is a known 
predictor of subsequent performance. The underlying mechan-
ism responsible for improved post-weaning performance seems 
likely related to gut structure. OEO supplementation was shown 
to reduce the negative morphological changes that occur in the 
small intestine during the post-weaning period (4). Feeding OEO 
in sow gestation and lactation diets supports nutritional pro-
grams designed to increase post-weaning pig performance and 
subsequent growth through slaughter. Pigs from OEO-fed sows 
showed clear benefi ts to the producer in higher carcass weight, 
greater loin depth, improved premium score and additional 
value. 
References
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2.  Ariza-Nieto, C., et al. 2005. Proc. A. D. Leman Conf. 32:abstract 33.
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Table 1.   Eff ects of OEO in sow diet on off spring carcass characteristics and value.
Sow diet Number of pigs Carcass characteristics
Body weight 
(kg)
Carcass 
weight 
(kg)
Yield (%) Fat depth (mm)
Loin depth 
(mm)
Lean 
(%)
Grade 
index Carcass value ($)
OEO 108 116.0 88.2 76 0.77 2.85 55.5 6.6 136.80
Control 108 112.6 85.6 76 0.77 2.75 55.1 6.1 131.70
P value not applic-able P<0.05 P<0.05
not signifi -
cant not signifi cant P<0.05 P<0.05 P<0.05 P<0.05
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Eﬀ ects of multi-enzyme preparations in the growth performance 
and jejunum morphology in weaned pig diets
Guillermo Cano2 Alain Kanora3 Daniel Villalba1 Alberto Morillo2
1. University of Lleida, Lleida, Spain; 2. Tests and Trials, Lleida, Spain; 3. Huvepharma N.V., Antwerp, Belgium
Introduction and Objectives
The exogenous enzyme use is an alternative to increase ingredi-
ents digestibility and interest is growing in the use of enzymes 
to improve animal performance. One of the responses to diet-
ary changes at weaning is the modifi cation of the epithelium 
structure1. Absorption in the small intestine depends on the 
villus-crypt relation. The objective of the present study was 
to investigate the eff ect of multi-enzyme preparations in the 
growth performance and jejunum morphology in weaned pigs 
fed a wheat-barley diet.
Material and Methods
269 pigs (Landrace x Large White x Pietrain) were assigned at 
weaning (28 days old) to one of three treatment diets (16 pen 
per treatment) during 14 days: Control without enzymes; 0.25 
g per kg of Hostazym® suis 2000; and 0.50 g per kg of a com-
mercial Multi-Enzyme Preparation (MEP). Individual Bodyweight 
(BW) was measured on days 0, 7 and 14 and Average Daily Gain 
(ADG), Average Daily Feed Intake (ADFI) and Gain to Feed (G:F) 
were calculated during fi rst week and overall study. Two pigs per 
treatment were slaughtered on days 7 and 14 to collect intes-
tinal jejunum samples, from the proximal (PJ) and distal portion 
(DJ), to measure Villus Height (VH) and Depth of Crypt (CD).
Data were analyzed with an ANOVA test. Pen was the experi-
mental unit to productive variables and pig to morphological 
ones, the pig error term was used to perform statistical tests.
Results and Discussion
In pigs fed diets containing Hostazym®, ADG was 45 g/day 
higher (p<0.01) during fi rst week and 49 g/day higher (p<0.05) 
on overall compared with pigs fed the Control diet. These higher 
ADG changes conduces Hostazym® pigs to had signifi cantly 
higher BW at days 7 (p<0.01) and 14 (p<0.05). There were no 
diff erences in productive performance between MEP and 
CONTROL diets. Compared with MEP treatment, diet containing 
Hostazym® tended to had higher ADG during fi rst week (+26 g/
day, p=0.09) and BW on day 7 (184 g, p=0.09) but these sta-
tistical tendency disappeared in the overall. There were no diff er-
ences (p>0.05) in ADFI and G:F between groups.
 
Hostazym® tended to have higher VH compared with Control 
on day 7 in proximal jejunum (p=0.082). On day 14, Hostazym® 
diet had longer villus than Control diet and MEP diet in proximal 
jejunum and in distal jejunum (p<0.05). Depth of Crypt was not 
aff ected (p>0.05). Villus Height and Depth of Crypt are import-
ant indicators of the digestive health and directly related to the 
absorption capacity of the mucus membrane2. Eff ects on VH 
may be due to enzyme supplementation reduces erosion of the 
villus3 due to improved digestibility of nutrients4, thus could 
improve ADG.
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O.024
The use of bone metabolites excreted in urine as markers for evaluation of 
the phosphorus retention and status in grower-ﬁ nisher pigs
Kristina U. Sørensen; Hanne D. Poulsen
Dept. of Animal Health and Bioscience, Faculty of Agricultural Sciences, Aarhus University, Tjele, Denmark
Introduction
Phosphorus (P) has several physiological functions and is vital 
for the maintenance of the skeletal tissue. Due to environmental 
concern, P supply in feed is lowered in order to reduce P excre-
tion. However, pigs may develop hypophosphatemia if P is not 
supplied in suffi  cient amounts resulting in reduced performance 
and bone strength. This project addresses the eff ect of lowering 
the dietary P content. The overall aim was to combine results on 
P retention and excretion with physiological responses in urine 
and bones in order to evaluate if the urinary compounds are cor-
related to P intake and thus may serve as markers for suffi  cient P 
intake.
Material and Methods
Grower-fi nisher female pigs were fed LP (4.1), MP (6.2), or HP 
(8.8 g P/kg dry matter) from 40 to 105 kg body weight (BW). No 
microbial phytase was added. Determinations of P, calcium (Ca) 
and nitrogen (N) balances were performed at 40, 70, and 105 kg 
BW. Furthermore, urine was analyzed for metabolites released 
during bone turnover refl ecting the degradation of the bone 
collagen matrix. Bones were collected at slaughter (105 kg), de-
fatted, dried, and analyzed for mineral content and bone mineral 
density.
Results and Discussions
The preliminary results show that P retention was lowered by 
50% and up to 60% in pigs fed LP compared with MP and HP 
(Table 1).
Table 1. Phosphorus (P), calcium (Ca), and nitrogen (N) retention, g 
day-1. Mean values for three periods.
LP MP HP
P retention, g day-1 2.87 5.96 7.12
Ca retention, g day-1 4.79 8.30 9.66
N retention, g day-1 23.0 27.7 27.2
At 40 kg BW, P retention was identical for pigs fed MP and HP 
whereas P retention was higher in pigs fed HP at 70 and 105 
kg BW. These results indicate that the P retention capacity was 
met at MP at 40 kg BW but not in the heavier pigs. Comparable 
results were obtained on Ca whereas the N retention was identi-
cal for pigs fed MP and HP but almost 20% lower in pigs fed LP. 
Seven diff erent bone turnover metabolites were measured in 
urine; among these were pyridinoline, deoxypyridinoline, and 
hydroxylysine (HYL). The results showed that some metabolites 
were aff ected by the dietary P content and the excretion was 
generally increased by 35-75 % in pigs fed LP compared to HP. 
However, other traits were more aff ected by ageing showing an 
increase in urinary excretion by 15-75% from 40 to 105 kg BW. 
Figure 1 summarizes results on dry weight of humerus, HYL, and 
daily P retention as aff ected by P intake.
Figure 1. Humerus dry weight, g, hydroxylysine (HYL), μmol day-1, and 
P retention, g day-1.
Conclusions
Lowering the dietary P supply greatly aff ect nutrient balances 
and bone turnover. There seems to be correlations between 
urinary metabolites and bone characteristics. Thus, these metab-
olites found in urine seem to be useful as non-invasive markers 
for the evaluation of suffi  cient P supply to grower-fi nisher pigs. 
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Variation of nutrient content in a batch of growing pig meal due to segregation 
in the feeding silo and to transport with diﬀ erent feed conveyors
An Cools; Dominiek Maes; Geert Janssens
Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
Introduction
Pig meal is a heterogeneous mixture of diff erent particles. Each 
particle has a specifi c size but also a specifi c nutritional value. 
The particle size profi le as well as average nutrient content of 
fattening meal is mostly quite similar between diff erent batches. 
However, diff erent manipulations of a batch such as emptying 
the feed silo or distribution of the meal throughout the stable 
by a feed conveyor can aff ect the particle profi le of the feed. The 
particle size of pig feed is related to feed digestibility (Al-Rabadi 
et al, 2009) and voluntary feed intake (Anguita et al, 2007), but 
it also aff ects the incidence of gastric ulceration (Dirkzwager et 
al, 1998) and the occurrence of tail biting (Brumm et al, 2008). 
This study aimed to investigate possible variations in nutrient 
content of fattening pig meal between the point a new batch of 
meal is delivered in the silo and the point when the silo is almost 
empty. Secondly the eff ect of transport of meal by diff erent 
types of conveyors on the nutrient content of feed was investi-
gated.
Materials and Methods
The study was performed in four diff erent farms. In each farm, 
feed samples were taken one day after the feed silo was fi lled 
with a new batch of growing pig meal (BEGIN) and again when 
the feed silo was almost empty (END). Every time, samples were 
taken in the feeding troughs in the pens on four diff erent places 
along the feed conveyor: in the fi rst pen of the fi rst compart-
ment (DISTANCE 1, 2, 3, 4). Two of the sampled farms used screw 
conveyors (SCREW) to transport the pig meal from the feed silo 
to the feed troughs in the pens, the two other farms used round-
bottom drag conveyors (DRAG). Secondly, two of the farms of-
fered their pigs standard meal (STANDARD), the other two farms 
added corn cob mix (CCM) on a daily basis to the standard meal 
before it was delivered to the diff erent feeding troughs. The 
nutrient content of all feed samples was analysed for the follow-
ing parameters by using near infrared spectroscopy: dry matter 
(DM), crude fi bre (CF), crude fat (CFAT), crude protein (CP), crude 
ash (CA), sugar (SU) and starch (ST). All data were statistically 
analysed by using SPSS 17.0 statistical software.
Results
The amount of CP and ST was signifi cantly higher when samples 
were taken shortly after fi lling the silo than samples taken when 
the silo was almost empty (P < 0.001). For CFAT, CF and CA the 
opposite was true, these nutrients were lower in the beginning 
of the silo than at the end (P < 0.001 for CFAT and CF and P < 
0.05 for CA). The SU content of the feed samples was lower at 
the end of the silo than at the beginning, although this was not 
signifi cantly (0.1 > P > 0.05). The diff erences between BEGIN 
and END for CFAT, CF and CA were signifi cantly larger for stables 
using DRAG than those using SCREW (P < 0.05). Also the diff er-
ence is SU content was numerically larger for DRAG (0.1 > P > 
0.05). The diff erences in RE and ST were not aff ected by the con-
veyor type. Feed type did not signifi cantly aff ect the diff erences 
in nutrient content between BEGIN and END but numerically, 
CCM had a more stable nutrient content than STANDARD. Dis-
tance, neither at BEGIN nor at END, signifi cantly infl uenced the 
nutrient content of the feed. However, some numerical trends 
could be observed which are similar to those seen between 
BEGIN and END of the silo.
Discussion
The results indicate that manipulation of feed by emptying of 
the silo and distribution throughout the stable by automated 
feed conveyors can aff ect the nutrient content of the feed. 
Although diff erences are small from a fi rst point of view, they 
can have an eff ect on the performance and health of the pigs in 
the diff erent pens of a stable. There for the link of these diff er-
ences in nutrient content will be further linked with diff erences 
in particle size and profi le. In a following study the link between 
the variation in nutrient content throughout the stable will be 
studied in relation to feed intake and growth performance of 
pigs.
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Eﬀ ects of reduced stimulation of sows during insemination – a ﬁ eld trial
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Pig Research Centre, Agriculture & Food Council, Copenhagen, Denmark
Introduction
Effi  cient heat detection is crucial for correct timing of insemina-
tion. Before insemination, correct stimulation consists of the fi ve 
point plan: 1. elevating the inguinal fold, 2. pushing the fl anks, 3. 
applying pressure below the vulvae, 4. applying pressure on the 
pelvis and 5. riding test, where the inseminator sits on the back 
of the sow. During this manual stimulation, a boar should be 
present in front of the sow. Stimulation increases contractions 
in the uterus [1], which is expected to support sperm transport. 
After inserting the catheter, the technician should sit on the 
back of the sow during the insemination. Some technicians 
exclude this during insemination. It has never been investigated 
if this reduced stimulation eff ects farrowing rate or litter size. 
The aim of this study was to investigate the eff ect of reduced 
stimulation during insemination of sows.
Materials and Methods
The experiment included 2912 multiparous Danbred L x Y sows 
in 4 commercial herds. The herds all displayed a farrowing rate 
above 86 per cent at start of the trial, to avoid management 
failures or infections to aff ect the study. Heat detection was per-
formed once a day from day 4 after weaning. A boar was present 
in front of the sow during heat detection. Duration of heat de-
tection using the fi ve point plan was approximately 1 minute per 
sow If the sow was in standing heat, the fi ve point plan was also 
the stimulation before introducing the insemination catheter..
Sows were assigned randomly into two groups. 
Group 1: Traditional stimulation, where the technician sat on the 
back of the sow during insemination.
Group 2: Restricted stimulation. No stimulation of the sow dur-
ing insemination. Semen entered the servix passively in both 
groups.
Group 2A: If semen did not enter within twenty minutes, sows 
in group 2 were stimulated by back pressure to achieve semen 
uptake. These sows were transferred to group 2A.
Date of farrowing and total born piglets were recorded for all 
sows in the experiment.
Signifi cant diff erence between groups were analyzed using 
Mixed model for total number born and logistic regression was 
used to analyze for diff erences in farrowing rate.
Results
There was no statistically signifi cant diff erence between groups 
when results from the four farms where pooled. Table 1 shows, 
that none of the farms experienced signifi cant diff erences in 
farrowing rate nor total born piglets between the groups. There 
was a large diff erence between farms in percent sows trans-
ferred from group 2 to group 2A.
Table 1. Farrowing rate and total born  for the three groups in the four 
farms.
Group 1 Group 2 Group 2a
Farm 1
No. of sows 247 291 21
Farrowing rate 87.6 89.5 95.5
Total born 16.7 16.6 17.1
Farm 2
No. of sows 724 562 103
Farrowing rate 88.4 90.9 92.0
Total born 17.8 18.1 18.2
Farm 3
No. of sows 357 338 10
Farrowing rate 93.9 94.2 100
Total born 17.5 17.4 18
Farm 4
No. of sows 133 102 24
Farrowing rate 90.5 82.3 88.9
Total born 18.2 17.5 17.5
Discussion
The results indicate that one minute of stimulation prior to 
insemination including use of the boar is enough stimulation 
to assure sperm transport. The number of sows in farm 4 was 
low, but a numerically lower farrowing percentage and number 
of total born in group 2 in this farm may indicate a problem in 
some farms, when sows are not stimulated during insemination. 
Farm 4 had diagnosed leptospirosis io the sow population dur-
ing the experiment, which may have infl uenced the experiment, 
although this remains unknown.
References
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Productivity in sows nursing large litters
Flemming Thorup
Center for Pig Production, Agriculture and Food Council, Copenhagen, Denmark
Introduction
Litter size in Danish production herds increased from 11 to 14 
live born piglets from 1996 to 2009. The average sow has 14.3 
productive milk glands. Can they assert high piglet survival and 
growth, and still achieve high fertility in the following litter?
Materials and Methods
In two production herds three sows with at least 15 productive 
milk glands were selected at least 12 hours after farrowing. From 
these three sows 39 piglets were selected. The rest (the smallest 
piglets) were transferred to nurse sows (1). The 39 piglets were 
randomized back to the sows with 11, 13 and 15 piglets per lit-
ter. This was repeated 44 and 43 times in the two herds, includ-
ing 261 sows in the study. The next 22 days, the litters were 
managed following standard management in the two herds. In 
case a piglet fell behind, it was transferred to a runt nurse. No 
new piglets were added to the litters. Piglets were weighed at 
weaning, and the sows were followed through the next cycle.
Results
Data for piglet mortality and piglet removal is given in table one. 
Mortality includes mortality among piglets transferred to runt 
nurses. Herd 2 saw only minor diff erences in mortality between 
the three groups. The high piglet survival in this trial may be 
caused by the removal of the smallest piglets to nurse sows to 
achieve the low litter sizes. Also only healthy sows were included 
in the study. Figure 1 and 2 indicates how many piglets were still 
with the mother at 22 days, when the sow was given 11, 13 and 
15 piglets. Table 2 gives the eff ect of litter size nursed on days to 
mating, farrowing rate and total born piglets in the next litter. 
Discussion 
Mortality and number of transferred piglets increased, when 
litter size was increased. The number of piglets weaned per 
sow and per pen did also increase. Most sows weaned 12 to 
14 piglets. Only 10 per cent of the 87 sows nursing 15 piglets 
weaned all 15 piglets (Fig. 1 and 2). More knowledge to evaluate 
the capacity of the specifi c milk glands will give the manager a 
better chance to predict the optimal capacity of a specifi c sow. 
Glands not used in the previous lactation, were less product-
ive in the succeeding lactation (2). Thus when increasing litter 
size at the sows, it is important fi rst to challenge the youngest 
sows in the herd. Neither farrowing percentage nor litter size in 
the following litter was signifi cantly aff ected by the number of 
piglets nursed. 
Table 1. Piglet mortality and runt piglets in two herds
Herd 1 Herd 2
Piglets per litter 11 13 15 11 13 15
Piglet mortality 5 6 10 4 3 5
Runt Piglets 4 5 8 4 9 12
Table 2. Eff ect on fertility in the following cycle
Herd 1 Herd 2
Piglets/ litter 11 13 15 11 13 1⁄25
Days to mating 4 5 4 5 5 6
Farr. rate % 86 80 86 84 79 83
Tot. born pigs 17.3 17.6 17.1 17.1 17.2 17.2
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Eﬀ ect of early parturition on the reproductive performance in sows
Caroline Vanderhaeghe1 Jeroen Dewulf1 Jan Jourquin2 Dominiek Maes1
1. Facutly of Veterinary Medicine, Department of Reproduction, Obstetrics and Herd Health, Merelbeke, Belgium; 
2. Janssen Animal Health, Beerse, Belgium
Objectives
The purpose of this study was to determine the incidence of 
early parturition (< 114 days of gestation) and to investigate the 
eff ect of early parturition on the reproductive performance in 
sows.
Material and Methods
This study was based on reproductive data records (Cercosoft 
NV, Oudenaarde, Belgium) of 37 pig herds that were willing to 
collaborate with the study. Two of these herds were excluded 
because the insemination date was not recorded for each 
individual sow and/or altrenogest was administered at the end 
of gestation. The database of the remaining 35 herds contained 
87,978 farrowing records of which 26,988 records were excluded 
because induction of parturition was performed or due to 
missing information on farrowing data. Hence, 60,990 farrow-
ing records of 17,401 sows were used for further analyses. The 
association of the outcome variables (total litter size, live born 
piglets, stillborn piglets) with the gestation length (GL) (cat-
egorized in 4 groups: 109-111d, 112-113d, 114-117d, 117-121d) 
was assessed using a multilevel linear mixed eff ect model, with 
herd included as random factor, and parity and breed as fi xed 
factors. The infl uence of the duration of the previous gestation 
on the next was also determined. All statistical analyses were 
performed in MLwiN 2.0. 
Results
The mean gestation length was 115.4 ±1.62 days. Early partur-
ition occurred in 10% of all farrowing events (Fig 1). 
Table 1 shows that sows with GL <112d have more stillborn 
piglets (Odds ratio/OR: 5.8) and less piglets born alive (OR: 0.2) 
compared to those with GL 114-117d. A GL of 112-113d was 
associated with more total born piglets (OR: 1.7), more piglets 
born alive (OR: 1.1) and more stillborn piglets (OR: 1.5). Sows 
with GL ≥ 118d were more likely to have less total born piglets 
(OR: 0.3) and less piglets born alive (OR: 0.3) compared to those 
with GL 114-117d. Sows with a gestation length of < 114d were 
more likely to have a gestation length of < 114d at the subse-
quent parity (OR: 1.2) as those with a gestation length of ≥ 114d 
(P<0.05). 
Tabel 1: Mean (s.d.) of total litter size, live born and stillborn piglets by 
gestation length (GL) 
GL (d) n Total litter size Live born piglets stillborn piglets
109-111 576 13.1 (3.7) 10.5 (4.4) * 2.6 (3.4)*
112-113 5544 13.8 (3.3)* 12.5 (3.2)* 1.3 (1.8)*
114-117 = refer-
ence 48929 13.3 (3.5) 12.4 (3.3) 0.9 (1.6)
118-121 5941 11.9 (3.9)* 10.9 (3.8)* 1.0 (1.7)
* Within a column, values diff erent from the reference (P<0.05)
Fig 1: Frequency distribution (%) of gestation length in 60,990 farrow-
ing records.
Discussion and conclusion
The present study showed that early parturition (< 114d) oc-
curred in 10% of the farrowing events. Early parturition signifi -
cantly increased the risk for stillborn piglets, especially in sows 
with a GL < 112d. This is likely due to the relative immaturity of 
the piglets at parturition (1). Large litters and more piglets born 
alive were associated with a GL < 114d, while small litter size and 
low numbers of live born piglets were related to a GL ≥ 118d. 
This is in agreement with Sasaki and Koketsu (2007). Sows with a 
short gestation length were more likely to have an early partur-
ition at the subsequent parity. This information may be import-
ant for producers to identify potential sows-at-risk. It may enable 
them to improve the reproductive performance by assisting 
farrowing or by preventing an early parturition. 
References
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Relationship between pre- and post freezing semen quality characteristics and ﬁ eld fertility
Eveline Willems1 Hanneke Feitsma2 Jascha Leenhouwers2
1. TOPIGS S&D, Vught, Netherlands; 2. Institute for Pig Genetics, Beuningen, Netherlands
Introduction
In pig breeding, frozen semen is used for global linkage of 
nucleus herds. The objective of this study was to investigate the 
relationship between fresh and post thaw semen quality charac-
teristics and fertility in sows. 
Materials and Methods
A database (Cryobase) was set up with semen variables of 
ejaculates used for freezing. All ejaculates have been analyzed 
for several semen quality characteristics; Fresh ejaculates were 
evaluated for motility, progressive motility (0, 24 & 72 hours after 
collection) and morphology. Frozen-thawed ejaculates were 
evaluated for motility, progressive motility (0, 24 & 48 hours after 
thawing), morphology and for % membrane intact cells (0 and 
24 hours after thawing) using Nucleocounter SP100. Fertility re-
sults of TOPIGS nucleus herds are recorded and exchanged with 
a breeding database (PigBase) at the Institute for Pig Genetics. In 
order to analyze the fertility results of frozen semen PigBase and 
Cryobase were merged, corrected for outliers and standardized 
for farm, parity and boar line. This resulted in a dataset of 742 
frozen ejaculates from 400 boars. The analysis was performed 
using SAS statistical package.
Results
Variables with a signifi cant eff ect on farrowing rate (FR) and total 
number born (TNB) are found in this analysis. In table 1 the dif-
ferent P-values for the variables tested are mentioned.
Table 1: P-values for the variables tested
variable FR TNB
fresh motility 0,0001 ns
fresh progressive motility 0,04 ns
fresh motility 24h 0,001 0,004
fresh progressive motility 24h 0,002 0,06
fresh motility 72h 0,002 0,01
fresh progressive motility 72h 0,03 ns
fresh morphology total 0,001 0,01
post thaw motility 0,009 0,01
post thaw progressive motility ns 0,07
post thaw motility 24h ns 0,08
post thaw progressive motility 24h ns ns
post thaw motility 48h ns ns
post thaw progressive motility 48h ns ns
post thaw morphology total ns 0,01
post thaw % intact cells ns 0,06
post thaw % intact cells 24h ns 0,04
In general more fresh semen quality characteristics have a 
signifi cant eff ect on fertility than post-thawing semen quality 
characteristics.
Correlations between certain semen quality characteristics and 
fi eld fertility came forward during the analysis and some esti-
mates of eff ect of variables are exposed in table 2.
Table 2: Regression coeffi  cients of relationships between fertility 
and semen quality. Eff ects expressed as change in FR(%) or TNB(#) per 
percent increased morphologic abnormalities or percent membrane 
intact cells 
variable analyzed FR TNB
fresh morphology total -2,41 -0,26
post thaw morphology total ns -0,04
post thaw membrane intact cells (0h) ns 0,06
post thaw membrane intact cells (24h) ns 0,04
Some motility variables of the evaluated ejaculates shown to 
have a signifi cant eff ect on fi eld fertility. Mainly fresh motility 
variables have a signifi cant eff ect on FR and TNB. For example 
the FR was 21,7% less when fresh semen had a progressive mo-
tility 24h of <70% compared to fresh semen progressive motility 
of ≥70%. 
Discussion 
Signifi cant relationships between fertility and fresh semen qual-
ity could lower the production costs of frozen semen, due to 
more adequate approval guidelines for evaluating suitability of 
ejaculates for freezing. 
When the dataset increases, there may be more variables signifi -
cantly important for fi eld fertility. 
UltiMateTM Computer Assisted Semen Analysis (CASA) systems 
are implemented since 2006 to check the motility and progres-
sive motility of the ejaculates objectively, but not enough data 
were available for analysis yet. 
References
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Quality parameters assessment of boars seminal doses which were delivered 
to farms by artiﬁ cial insemination centres in Spain during 2009
Yahya Dahmani; René Mozo-Martín; Carmen Larraz; Juan Luís Úbeda
R&D Department, Magapor SL, Ejea de los Caballeros. Zaragoza, Spain
Introduction 
The methodology of analyses and process of swine ejaculated 
change among Artifi cial insemination centres in Spain. This 
change can aff ect the quality of semen doses delivered to farms 
for the insemination process . The analysis and control of the 
quality of seminal doses has a great importance as the product-
ive improvement of the farms will depend on it. These param-
eters should comply minimum values required of semen quality 
standards for the swine artifi cial insemination (1). Therefore, the 
aim of this study is to assess quality parameters of boar seminal 
doses delivered to farms, by artifi cial insemination centres in 
Spain during 2009. 
Materials and methods 
For this study, we assessed 1678 boars seminal doses from 20 
swine artifi cial insemination centres in Spain. The analyzed 
parameters of seminal doses were: concentration, pH, osmolar-
ity, agglutination, sperm motility, whole acrosomes, abnormal 
morphology and the hypo-osmotic (Host) test. All analyses were 
carried out by the same person and by microscopic standard 
examination. Data were processed by StatView 5.0 software(2). 
Normal distribution was checked by Kolmogorov Smirnov 
test. Variance of quality parameters of seminal doses between 
centres was analysed by ANOVA 2x2 way, and Fisher’s PLSD test. 
Values are presented as means ± standard deviation, and signifi -
cant diff erences are considered when p<0.05. 
Results
ANOVA analysis of the diff erent seminal parameters has showed 
a signifi cant diff erence among AI centres (P<0.0001). In the table 
1, we illustrated only the most important parameters: motility, 
concentration, abnormal morphology and Host test. Despite 
these diff erences among centres, almost all values of the par-
ameters fulfi l the recommended standards limits for the seminal 
doses analysis in swine, except for the motility parameter and 
abnormal morphology of sperm. Only in the centres C05 the 
seminal doses presented an average lower than the standard 
limit (64.6%) for motility, meaning the possible rejection of 
12.9% of all 1678 doses. However, diff erences in the parameter 
in an abnormal forms, have been very pronounced statistically. 
Values of abnormal forms sperm were higher than standard limit 
(>30%) in the majority of centres. This result mean that 67.3% 
of total samples can be discarded. Concerning the concentra-
tion of doses 21.6% of samples showed values not conform 
with standard limit, however, the doses should not be rejected 
for this motif as we don’t know if the samples were destined to 
post-cervical AI. The remaining parameters showed acceptable 
values and were within standard limits
Discussion 
Values were within standard limits in most of the cases, but for 
the parameter of sperm abnormal forms. This result is coherent 
with the diversity in the methodology of work and process of 
swine semen doses. Besides, other factors interfere in this vari-
ability, such as the reception and transportation, temperature of 
doses, type of semen extender...etc. Nevertheless, it is surprising 
that the sperm abnormal forms parameter is out of the stan-
dard limits, since it depends on semen extender, temperature 
of transportation, boar and process of spermatogenesis. In 
addition to it , determination of this parameter was objective, 
contrary to others. Therefore, this anomaly would also be due to 
the high extraction rhythm of ejaculated, which can aff ect the 
sperm morphology. 
Summing up, due to the fact that all seminal quality parameters 
should fulfi l standard limits, without exception, it is necessary 
to maximize the precaution and to guarantee the quality of the 
seminal dose delivered to farms.
Table1. Means distribution of sperm motility, concentration, abnormal 
morphology and Host test, in 20 centres (CRI) from Spain. Values are 
presented as means ± standard deviation. AF: Abnormal forms. Conc: 
concentration. LS: limits standard (1).
CRI Motility Conc. x108/ml AF Host
C01 81.2±18.5 31.2±7.4 27.7±12.6 55.7±13.2
C02 85.2±8.3 36.7±10.3 21.7±9.9 55.6±11.1
C03 83.9±12.4 25.9±6.5 26.7±15.5 57.2±12.7
C04 79.3±15.3 52.3±27.6 33.5±19.3 53.2±13.5
C05 64.4±26.8 23.4±7.1 23.8±13.1 58.6±12.5
C06 77.8±19.5 39.03±11.2 30.4±12.9 56.8±14.4
C07 74.5±21.8 40.5±8.9 39.9±15.2 59.1±10.7
C08 81.4±16.7 27.6±10.5 30.7±14.8 54.8±12.2
C09 76.4±17.8 50.1±22.4 31.8±19.2 58.3±13.2
C10 76.3±19.7 45.6±18.3 32.9±114.9 51.9±13.8
C11 81.8±12.9 37.7±12.1 37±18.2 53.7±9.7
C12 78±18.7 34.14±7.1 27±13.8 65.1±10.3
C13 85±15.5 47.98±10.2 26.2±11.8 54.3±14.9
C14 90±0.0 38.5±12.6 26.8±8.9 61.5±2.4
C15 82.1±11.9 43±9.6 37.5±16.6 66.1±11.1
C16 77.6±22.6 43.5±20.6 45.8±25.1 58.7±12.3
C17 75.5±22.8 34.2±9.9 37.8±15.1 55.6±13.9
C18 70.2±27.4 42.6±13.1 51.7±19.5 54.1±12.8
C19 80.9±15.1 28.7±6.7 22.8±9.4 50.9±11.4
C20 87.2±5.45 31.8±8.8 29.5±13.2 58.9±14.6
P <0.0001 <0.0001 <0.0001 <0.0001
LS ≥65% 3x109 ≤25% ≥50%
References
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Inﬂ uence of organic selenium supplementation on lipid peroxidation of boar sperm membranes
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1. Laboratory of Swine Research, University of Sao Paulo, Depto. Nutrição e Produção Animal (VNP), Pirassununga, SP, Brazil; 
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Introduction
Boar spermatozoa are characterized by a high level of poly-
unsaturated fatty acids. Lipid peroxidation (LP) may be one of 
the mechanisms responsible for the negative biochemical and 
physiological changes during sperm storage. However, data on 
the changes in sperm lipid composition and their susceptibility 
to peroxidation during storage are limited1. Previous results 
demonstrated that boar spermatozoa contains glutathione 
peroxidase and α-tocopherol, suggesting that both selenium 
and vitamin E have a role in preventing peroxide damage to the 
sperm cell2. Therefore, the aim of this study was to evaluate the 
eff ect of dietary organic selenium on the membrane lipid peroxi-
dation in the boar semen diluted with BTS and stored for 3 days. 
Materials and Methods
Fifteen boars were kept on the same conditions and were fed 
the same standard diet during training. The animals were fed 
with three experimental diets: 0.3ppm sodium selenite (Control); 
0.5ppm sodium selenite (Inorganic) and 0.5ppm selenium yeast 
(Organic). Ejaculates were collected from each boar once per 
week using the gloved-hand technique. Semen was diluted with 
standard extender to 3x109 cells/dose and stored for 3 days at 
18ºC. The peroxidation of the membranes was measured with 
the use of the fl uorescent probe C11-BODIPY581/591. Semen 
aliquots were collected during the analysis steps to obtain 
samples. These were then stained with 0.5μL of probe C11-
BODIPY581/591(1mg/mL, Molecular Probes) for 30 minutes at 
37°C. Then, 3μL of propidium iodide (PI) (0.5mg/mL, Sigma) was 
added to the sample to mark the cells with damaged plasma 
membranes, when they were analysed by fl ow cytometry. The 
viable sperm cells (PI negative) were stained with probe C11-
BODIPY581/591 and analysed as the mean intensity of fl uores-
cence emission (arbitrary units-a.u.) captured in the photomulti-
plier with a long pass of 502 and a band pass of 530±15nm3. 
The experimental design was a randomised block. Data were 
analyzed using the PROC repeated from SAS4 and outcomes 
were compared among the three treatments by the orthogonal 
contrast method with P<.05 level of signifi cance.
Results
No interaction was found between the independent 
variables time and treatment during the analysis of the depend-
ent variable fl uorescence intensity emitted by the sperm with 
plasma membrane that was intact and stained with the fl uor-
escent probe C11-BODIPY581/591. Therefore, it was possible to 
carry out the analysis of the main eff ects separately. There were 
no changes in the fl uorescence intensity emitted by viable cells 
independently of the treatment added. When analysing the time 
eff ect, it was verifi ed that the fl uorescence intensity emitted 
increased within 24 hours and decreased after that (Graphic 1).
Graphic 1 – Means ± SEM of the fl uorescence intensity of the sperm 
with intact plasma membrane and stained with a fl uorescent probe 
C11-BODIPY581/591
Values with a diff erent letters diff er (P<.05)
Discussion
Higher lipid peroxidation was found within 24 hours, this was 
probably due to a high cell metabolism in the beginning of the 
cooling process5. The cooling led to a reduction in metabolism, 
which in turn, decreased lipid peroxidation after 48 hours, prob-
ably by the action of antioxidant systems of their own sperm.5 
In conclusion, the selenium yeast showed no better results in 
comparison to others treatments regarding lipid peroxidation.
References
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Practical review on reproductive testis pathology in boar
Juan Luís Úbeda1 María Victoria Falceto2 Yahya Dahmani1 René Mozo-Martín1 José Antonio Bascuas2
1. R&DDepartment, Magapor SL, Ejea de los Caballeros. Zaragoza, Spain; 
2. Departamento de Patologia Animal. University of Zaragoza, Zaragoza, Spain
Introduction
The boar low fertility depends on many factors like nutrition, 
stress, season, libido problems, anatomical problems of the 
reproductive organ, infections, as well as genetic transcendence 
causes.
Artifi cial insemination centres (AIC) discard boars when they 
start to present fertility problems or low seminal quality due to 
unknown causes, since animals maintenance supposes a con-
siderable cost. In several cases, the reason for rejection is some 
reproductive pathology of testis misdiagnosed which is mani-
fested as low seminal quality or bad fertility. 
The aim of this study is to determine possible reproductive path-
ologies of testicle in culled boars from AI centres, which were 
sent to the slaughterhouse because of low fertility, low seminal 
quality or unknown causes. Seeking also a possible treatment, 
through morphological and histological studies of testicles. 
Material and methods
More than 500 testis of slaughtered boars were collected. All 
animals were coming from AIC because of their low fertility or 
low semen quality or other unknown causes. 
Biological material was conducted to the laboratory for pro-
cessing and analyses. First morphologic exam of testis was 
performed. followed by processing of fi xation and histological 
preparation (head, tail, epididymis body and the pampiniform 
plexus). Samples obtained were analyzed by microscopy illus-
trating every case by pictures. 
Results
Several pathological reproductive incidences of the testicle 
were detected and registered (varicocele, fi brosis, infl ammation, 
haemorrhages...etc). Figure 1 and 2 illustrate cases of varicocele 
and injuries with infl ammation, respectively. The most frequent 
pathology was varicocele and lesions.
Discussion
Is very remarkable the frequency of the cases found of testicular 
pathology in the culled boars. This fi nding concord with some 
reported studies (1). In the majority of the cases in which boars 
were eliminated without specifi c cause, we found diff erent 
degrees of fi brosis, as well as infl ammatory focus.
Figure 1. Exam of testis with varicocele. From right to left, morpho-
logical, anatomical and histological assessment of the same testis 
respectively.
 Figure 2. Exam of testis with lesion and infl ammation. From right to 
left, anatomical and histological checking respectively.
Theses symptoms are diffi  cult to diagnose in farm without anat-
omy assessment and they are related to the low semen quality 
or low seminal production. This fact explains the lost of males 
productivity, the diffi  culty of covering seminal doses purchase 
orders from farms, as well as the dissatisfaction of the customers 
because of the seminal dose bad quality.
Similarly, testicular injuries take time to recover and many of 
them are chronic which involves a substantial increase in the 
fi nal cost for the boar-stud. Finally, even though discarding 
animals seems to be the best solution in this case, we should 
increase inspection in slaughterhouse to examine the testicular 
pathologies in sacrifi ced boars, and try to give treatment to cor-
rect this fault and avoid animal sacrifi ce. 
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Considerations in assessing the serological cross-reactivity of pig and novel H1N1 inﬂ uenza viruses
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Introduction
The novel human H1N1 (nH1N1) virus can infect pigs and its 
occurrence in swine farms has been reported recently in several 
countries. Besides, it has been shown that nH1N1 cross-react 
with porcine viruses in the hemagglutination inhibition assay 
(HI)2. This work reports on the observed antigenic and genetic 
relatedness between nH1N1 and swine H1N1 viruses.
Materials and Methods
Two groups of H1N1 viruses isolated from swine (SIVs) in the 80s 
(early = 8) and 2000s (recent = 7) in Spain, together with the Sw/
California/07/2009 virus of human origin were analyzed. Cross-HI 
was performed using antisera against each virus group. Partial 
nucleotide (nt) sequences (450nt) of the hemagglutinin seg-
ment (HA) were obtained and analyzed by multiple alignments 
(MEGA 4, ClustalW and BLAST).
Results and Discussion
HI antibodies against early SIVs, recent SIVs and nH1N1 showed 
cross-reaction to viruses in each group to a variable extent 
(Table 1). Geometric Mean Titters (GMT) for early sera against 
early and recent SIVs were 269 and 98, respectively. GMTs for 
recent sera were 538 and 476. HI titers for early and recent sera 
against nH1N1 were 160 and 80 respectively. nH1N1 antiserum 
also showed cross-reactivity against early and recent SIVs with 
GMTs of 59 and 21, respectively. These fi ndings indicate that 
cross-reactivity among nH1N1 and SIVs occurs, regardless of 
the virus isolation period or the nature of antiserum tested in 
the HI assay (hyperimmune or convalescent in Table 1). Thus, 
the broad cross-reactivity of SwCA09H1N1 antiserum and SIVs 
isolated more than 20 years apart may suggest the existence of 
cross-reactive epitopes conserved between the hemagglutinins 
of infl uenza A H1N1 viruses. However these fi ndings deserve 
further studies. 
Nucleotide sequence analysis of the HA segment allowed clear 
diff erentiation among early, recent and the nH1N1 viruses. How-
ever, early SIVs showed slightly higher similarity to nH1N1 (73%) 
than recent SIVs (range 69%-71%). Furthermore, BLAST search 
against all GenBank HA nucleotide entries returned signifi cant 
(>90% similaruty) matches to several avian species for early (10-
12 out of 100 hits) compared to recent (1 out of 100 hits) SIVs, 
suggesting adaptation to the swine host in recent SIVs1. To what 
extent the observed cross-reactivity is infl uenced by such diff er-
ences is something that should be investigated further. Taken 
together, the additional data presented here support previous 
observations that demonstrate serologic cross-reactivity with 
nH1N1 virus in pigs in Europe. The repercussions that could have 
this in diagnosis and vaccination are yet to be assessed.
Table 1. Hemaglutination Inhibition titres of convalescent and hyper-
immune antisera against swine and human infl uenza viruses 
Swine and human viruses
Early 
H1N1 
SwSp80a
Swine and human antisera
Recent 
H1N1 
SwSp04b
nH1N1 
CA09c,* 
H1N2 
SwSp04b
H3N2 
SwSp04b
Early 
H1N1 A/sw/spain/1248/1988 320 640 80 <20 <20
A/sw/spain/1873-1/1987 160 320 80 20 <20
A/sw/spain/2688c/1989 320 640 80 <20 <20
A/sw/spain/1877-4/1987 320 320 80 <20 <20
A/sw/spain/Girona/1989 320 640 NT <20 <20
A/sw/spain/M87/1987 160 640 40 <20 <20
A/sw/
spain/785Tarrag/1987 320 640 40 <20 <20
A/sw/spain/
pp86BCN/1986 320 640 40 <20 <20
Recent 
H1N1 A/sw/spain/45304/2003 80 320 20 <20 <20
A/sw/spain/58788/2004 80 320 80 <20 <20
A/sw/spain/59169/2004 160 640 40 <20 <20
A/sw/spain/83649/2007 80 640 80 <20 <20
A/sw/spain/50047/2003 160 640 20 <20 <20
A/sw/spain/51915/2003 80 320 <20 <20 <20
A/sw/spain/53207/2004 80 640 20 <20 <20
nH1N1 A/california/07/2009* 160 80 320 <20 <20
H1N2 A/sw/spain/40564/2004 <20 <20 <20 1280 <20
H3N2 A/sw/spain/54008/2004 <20 <20 <20 <20 320
a = Convalescent pig serum; b = Hyperimmune pig serum; c = Convalescent human serum; NT 
= Non-tested; * = Human source
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Introduction: 
Since pandemic H1N1 infection in humans began its global 
spread, countries around the world have reported spread of in-
fection to pigs. This paper describes the clinical, epidemiological 
and virological fi ndings in the fi rst three pig farms found to be 
infected with pandemic (H1N1) 2009 infl uenza virus in England. 
These showed interesting diff erences in disease presentation, 
spread and likely sources of infection and the fi ndings have 
implications for the control of swine infl uenza infection in com-
mercial breeding and growing pig units.
Materials and Methods: 
Tonsil, trachea and lung samples were collected from pigs sub-
mitted for diagnostic postmortem examination with a history of 
respiratory disease or with respiratory pathology. Nasal swabs 
and sera were collected from pigs on farms where pandemic 
H1N1 was detected in submitted pigs. Nasal swabs and tissues 
were tested by infl uenza M gene PCR, positive samples were 
then tested by PCR for pandemic H1. Sera were tested for anti-
bodies using the haemagglutination inhibition assay (HAIT). 
Results:
The fi rst three pandemic H1N1 infected units identifi ed in 
England were an outdoor breeding unit (farm A) and two indoor 
nursery-fi nishers (farms B and C). Morbidity ranged from 0 to 
75% within groups and mortality was negligible or low. Clinical 
signs varied from inapparent infection to non-specifi c without 
respiratory signs in breeding pigs on farm A, to typical acute 
respiratory disease with rapidly spreading coughing highly 
suggestive of infl uenza infection in growing pigs (farms B and 
C). The breeding unit from which growing pigs derived (which 
was not farm A) was suspected to be the source of infection for 
farms B and C which were weaned from the unit three weeks 
apart, however the origin of infection for this supply unit was 
not established and breeding sows on the unit showed no signs 
suspicious of infl uenza. Infection was detected on farm B for 
an 8-week period, as infection spread from one pig source to 
another; within any one shed of pigs the maximum duration of 
active infection detected was 4 weeks although pigs showed 
clinical recovery within 2 weeks. Circumstantial evidence sug-
gests that a pig lorry driver was the possible origin of infection 
for the outdoor breeding unit (farm A). Active infection was 
present on this unit over at least a seven-week period at the 
end of which four week-old weaners moved to an indoor unit 
on which active infection was detectable three weeks later. On 
several occasions, PCR positive nasal swabs were obtained from 
pigs in which signifi cant antibody titres could be detected. There 
was no or insignifi cant cross reactivity of HAIT antibody to pan-
demic virus with other UK endemic infl uenza strains (avian-like 
H1N1, H1N2, H3N2) in recovered pigs. The H1N1 virus isolated 
from all three farms was 99.7% identical to pandemic H1N1 
(2009) circulating in the human population.
Discussion:
The main implications of these fi ndings for the control of infec-
tion of pigs with pandemic (H1N1) 2009 are:
a)  vigilance for clinical signs as a means of surveillance for 
suspect pandemic H1N1 infection in adult breeding pigs is 
unlikely to be eff ective as many undergo inapparent infec-
tion, or mild non-specifi c signs which could go unnoticed, 
particularly in an extensive outdoor setting.
b)  in extensive outdoor situations where pigs are in the open 
air and stocking density is low, spread around the unit may 
occur more slowly and less predictably than on indoor units. 
Without the use of serology, it would be diffi  cult to deter-
mine whether susceptible groups remain. In such situations, 
it may be appropriate to deliberately seed infection into 
potentially susceptible groups (for example unserved gilts) 
to avoid possible reproductive or respiratory problems dur-
ing acute infection later.
c)  infl uenza infection may persist within some types of unit for 
a more extended period than expected and movement of 
pigs on or off  the unit should be undertaken in the know-
ledge that clinical recovery alone may not be suffi  cient 
evidence that the unit is no longer infected.
d)  seropositive pigs can still shed virus during recovery and 
detection of seropositive groups does not necessarily mean 
that infection has fully resolved; infection can persist in 
batches of pigs weaned off  site from sows following an out-
break. Further evaluation of these fi ndings is in progress.
e)  the serology results show that HAIT can be a useful means 
of surveillance for pandemic H1N1 infl uenza in pigs in some 
settings, but HAIT with endemic strains should be included 
to exclude cross reactions.
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Experimental challenge with two isolates of 2009 A/H1N1 in weaned pigs
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Introduction 
The gene constellation of the 2009 pandemic H1N1 virus is a 
unique combination from swine infl uenza A viruses (SIV) of 
North American and Eurasian lineages, but prior to April 2009 
had never before been identifi ed in swine or other species (1). 
Although the hemagglutinin gene is related to North American 
H1 SIV, the infection potential in pigs was unknown immediately 
following the emergence of the virus in the human population. 
The objective of this study was to evaluate two isolates of 2009 
pandemic H1N1 in a pathogenesis and transmission study in 
weaned pigs. 
Materials and methods
Pathogenic and transmission characteristics between A/
CA/04/2009 (CA/09) and A/Mexico/4108/2009 (MX/09) were 
compared in pigs. A total of 30 4-week old pigs were inoculated 
with A/CA/04/2009 H1N1 (n=15 pigs) or A/Mexico/4108/2009 
H1N1 (n=15 pigs) with approximately 2 x 105 TCID50/ml of each 
respective virus. Pigs were sampled at 0, 2, 3, 5, 7, and 9 days 
post infection (dpi) by nasal swab. Direct (n=5) and indirect 
(n=5) contact pigs were placed with each of the primary in-
fected pig groups on 2 days post infection (dpi) and nasal swab 
samples were collected at 0, 3, 5, 7, and 9 days post contact 
(dpc). Five primary challenged pigs were necropsied on days 
3, 5, 7, and 21 pi. Contact pigs were necropsied on day 20 pc. 
Hemagglutination inhibition (HI) assays were done with 21 dpi 
and 20 dpc to evaluate sero-conversion using challenge virus as 
well as a panel of North American H1 SIV isolates representing 
each phylogenetic cluster (2). 
Results
Pigs experimentally infected with pandemic H1N1 2009 
infl uenza A viruses developed similar respiratory disease and 
demonstrated equivalent macroscopic lung lesions on each 
given necropsy day. Virus titers in the lung were not diff erent 
between CA/09 and MX/09 infected pigs, with mean titers of 
104.8 and 104.5 respectively on 3 dpi, 104.8 and 104.8 respect-
ively on 5 dpi, and undetectable on 7 dpi. However, diff erences 
in viral replication in nasal secretions and transmission to 
contact pigs were detected between CA/09 and MX/09 (Figure 
1). CA/09 inoculated pigs shed virus from the nose in a higher 
percentage of pigs as well as at higher viral titers. Additionally, 
direct and indirect contact pigs shed CA/09 virus at levels similar 
to primary inoculated pigs and for an extended time course. In 
contrast, MX/09 inoculated pigs shed virus in a lower percentage 
of pigs and at lower virus titers. A limited number of nasal swabs 
were positive from pigs in direct contact with MX/09 inoculated 
pigs and no samples from indirect contact pigs were found 
to be positive for MX/09 virus. Serologic cross-reactivity was 
demonstrated between the 2 pandemic isolates and with North 
American H1 isolates, although signifi cant reductions in HI titers 
were detected.
Figure 1. Virus titers in nasal swab samples.
CA/09 and MX/09=intratracheally inoculated pigs with each 
respective virus; Dir=sentinel pigs placed in direct contact with 
inoculated pigs; Indir=sentinel pigs placed in the same room, 
but without physical contact.
Discussion
Understanding the shedding and transmission patterns of dif-
ferent genotypes of H1N1 2009 in swine is important as several 
countries are now reporting outbreaks in commercial pig herds. 
The diff erence in the patterns of shedding and transmission may 
partially explain why some swine outbreaks have been relatively 
self-limiting. Virus variants that replicate to higher titers in the 
nose of pigs and easily transmit from pig to pig could present a 
greater threat to animal and human health. Based on sequence 
analysis, the HA genes from CA/09 and Mexico/09 diff er by 4 or 5 
amino acids depending on the reference sequences compared. 
Further work must be done to correlate the changes in the HA 
gene to the reduced shedding and transmission of the MX/09 
virus. 
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Introduction
The Center for Veterinary Biologics (USDA/APHIS/ CVB) provided 
Master Seed Viruses (MSV) to veterinary biologics manufacturers 
for developing a conditionally-licensed pandemic H1N1 (pH1N1) 
swine infl uenza virus (SIV) vaccine for use in the US swine herd.1 
The objective of these studies was to demonstrate a reasonable 
expectation of effi  cacy to support USDA requirements for con-
ditional licensure and to evaluate the vaccine in a vaccination-
challenge model in pigs.2
Materials and Methods
Three studies were conducted in SIV negative pigs.3 In all stud-
ies, pigs were vaccinated on Days 0 and 14 and an adjuvanted 
placebo (T01) was included. In Study 1, pigs were vaccinated 
with adjuvanted, killed pH1N1 vaccines prepared from A/Califor-
nia/04/2009 (T02) or A/Mexico/ 4108/2009 (T03). In Study 2, pigs 
were vaccinated with low (T02), mid (T03) or high (T04) doses 
of A/CA/04/ 2009 pH1N1 vaccine. Sera from both studies were 
tested for hemagglutination inhibition (HI) antibodies to pH1N1. 
In Study 3, pigs were vaccinated with the A/CA/04/2009 pH1N1 
vaccine formulated at a high (T02) or low (T03) dose. Lung le-
sions were scored at necropsy, 5 or 10 days after challenge with 
A/Mexico/ 4108/2009 pH1N1 virus. The studies were conducted 
in accordance with the Institutional Animal Care and Use Com-
mittees at the PAH, MVS or BBL sites.
Results 
Cross-reactivity between the two pH1N1 viruses was apparent in 
Study 1 (Figure 1). In Study 2, the GMT, and individual HI titers of 
all vaccinated pigs, were ≥ 40 in sera collected 7 or 14 days post-
revaccination (data not shown). In Study 3, the mean percent 
lung lesion scores for both vaccine groups were signifi cantly 
lower (P≤0.0001) than that of the placebo group (Figure 2).
Discussion
Pigs vaccinated with the A/CA/04/2009 pH1N1 vaccine de-
veloped HI titers of ≥ 40, generally considered as a protective 
level.4,5 The vaccine also signifi cantly reduced lung lesions in 
pigs challenged with a heterologous pH1N1 virus. 
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Introduction
The recent pandemic human infl uenza virus A(H1N1) 2009 
contains gene segments from ancestors in North American 
and Eurasian swine lineages as well as from avian and human 
lineages. The emergence of this A(H1N1) 2009 virus poses a 
potential global threat for human health. Importantly, the 
fact that it can infect other species, like pigs, favors a possible 
encounter with other infl uenza virus circulating in swine herds. 
In Europe, H1N1, H1N2 and H3N2 subtypes of swine infl uenza 
virus (SIV) currently have a high prevalence in commercial farms. 
To achieve a better assessment of the risk posed by the A(H1N1) 
2009 virus in the actual situation of swine farms, it was analyzed 
whether a previous infection with a circulating European avian-
like swine infl uenza virus generated cross-protective immunity 
against a subsequent infection with the new human infl uenza 
virus A(H1N1) 2009. 
Material and methods
Two Infl uenza A virus isolates were used in this study: a cir-
culating European avian-like swine infl uenza virus strain (A/
Swine/Spain/53207/2004 (H1N1)) (GenBank accession num-
ber CY010587 and hereafter referred to as V1) and the new 
human infl uenza virus A(H1N1) 2009 (A/Catalonia/63/2009 
(H1N1)) (GenBank accession numbers GQ464405-GQ464411 
and GQ168897, hereafter referred to as V2). Twenty-two snatch-
farrowed, colostrum-deprived Large White x Landrace piglets 
were obtained from a herd with a standard health status. At the 
age of 40 days, pigs were randomly distributed into four groups, 
namely C/C (n = 6), V1/C (n = 4), C/V2 (n = 8) and V1/V2 (n = 4) 
balanced by sex and weight. Group V1/C animals were intran-
asally inoculated with 3.5 ml of 107.04 tissue culture infectious 
doses 50% (TCID50) per ml of V1 on day 0. Pigs from group C/V2 
received 3.5 ml of 106.15 TCID50 per ml of V2 on day 21. Finally, 
pigs in group V1/V2 were inoculated with both viruses, V1 on 
day 0 and V2 on day 21, whereas C/C pigs served as control 
animals. 
Pigs were clinically monitored daily until the necropsy day 
(28 days post-inoculation). Blood and nasal swabs were taken 
regularly during the experimental period. Anti-infl uenza A virus 
nucleoprotein (NP) antibodies (IgG in serum and IgA in nasal 
swabs) levels were also measured. Samples were analyzed by 
ID Screen® Infl uenza A Antibody Competition ELISA (ID-Vet, 
France). Primers and probes were modifi ed to improve the Euro-
pean avian-like swine and new human infl uenza virus A(H1N1) 
2009 detection based on sequences database and previous 
reports (1). V1 and V2 viral loads in nasal swabs and lung tissue 
were assessed by a TaqMan quantitative RT-PCR. Inhibition of 
hemagglutination on serum was performed following standard 
procedures (2). The test was standardized at four hemagglutinin 
units and the starting dilution was 1:20. 
Results
Pigs only infected with V2 had mild to moderate gross lesions 
(broncho-interstitial pneumonia). However, pigs inoculated with 
V1 virus and subsequently infected with V2 had very mild lung 
lesions, apparently attributed to the residual lesions caused 
by V1 infection. These later pigs also exhibited boosting levels 
of specifi c IgA antibodies in nasal swabs and IgG in sera. This 
boosting eff ect was also apparent for inhibition of V1 and V2 
hemagglutination levels. Finally, in all animals from group V1/V2, 
neither virus shedding nor viral load in lungs or in nasal swabs 
were detected after challenge with V2, indicating a cross-pro-
tective eff ect in which specifi c anti-infl uenza antibodies seem to 
play a crucial role.
Discussion
A previous infection with one of the circulating European avian-
like SIV H1N1 in the fi eld was able to confer protective immunity 
to pigs against a challenge with the new variant infl uenza virus 
A(H1N1) 2009 virus. These data pave the way for understanding 
the intimate immune responses generated between diff erent 
infl uenza viral infections, within the same subtype. Further char-
acterizations are required to understand the whole picture and 
all the mechanisms involved in protection. 
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Introduction
Pigs can be infected with avian, swine and human infl uenza A 
viruses and, historically, swine was proposed to be the mixing 
vessel where reassortant infl uenza strains arise; however the 
H5N1 incidents showed that avian infl uenza viruses could be 
transmited directly to humans. The recent emergence of a hu-
man pandemic infl uenza A virus harbouring genes thought to 
be originally of swine infl uenza viruses (SIV) fuelled again the 
interest in the epidemiology of infl uenza in pigs. Swine infl uenza 
is a common respiratory pathogen of pigs causing a disease 
clinically similar to human infl uenza although, as suggested by 
others (1), subclinical infections might be common, particularly 
when considering the high seroprevalences (2) and the relatively 
low incidence of confi rmed infl uenza outbreaks. It is worth to 
note, that the precise dynamic of SIV infection within a farm is 
scarcely known beyond the situation of an epidemic clinical out-
break. The present study was aimed to determine the infection 
dynamics of SIV in a farrow-to-fi nish farm.
Material and methods 
A farrow-to-fi nish farm previously known to be positive for SIV 
antibodies was selected for the present study. The farm had 
300 sows in stock and the annual replacement percentage in 
average was a 55%. Farrowing batches were scheduled every 3 
weeks. A whole weaning batch (n=121) of 3-week-old piglets 
was selected for the study. Nasal swabs and sera were taken 
weekly between the 3rd and the 13th week of age and after-
wards, pigs were sampled again at 15, 17, 20 and 24 weeks of 
age. In each visit to the farm a clinical inspection of pigs was 
performed. Serum samples were tested for antibodies against 
swine infl uenza nucleoprotein using a commercial indirect ELISA 
(CIVTEST infl uenza, HIPRA, Spain). Samples were considered to 
be positive when the sample-to-positive control (S/P) ratio ≥ 
0.2. SIV shedding was determined in nasal swabs by means of a 
TaqMan one-step qRT-PCR using a Fast7500 equipment (Applied 
Biosystems, Foster City, CA). Primers and probe were adapted 
from a previous report (3) and the design was based on sequen-
ces of European SIV strains retrieved from Genbank to improve 
the SIV matrix (M) gene detection.
Results
No clinical signs of infl uenza were observed for the duration 
of the study. However, seropositive animals were detected by 
ELISA at all sampling times (Figure 1). Initially, (3 weeks of age) 
seroprevalence was of 56.2% (68/121) declining until a low of 
10.4% (12/115) at 6-weeks of age. Afterwards and until 13 weeks 
of age, seroprevalence showed ups and downs. From 15 weeks 
of age, all remaining seronegative animals seroconverted. Based 
on RT-PCR results, shedder pigs were observed at 3, 4, 7, 13, 15, 
17, 20 and 24 weeks of age with point prevalences ranging from 
1 to 25%. As shown in Figure 1, four waves of viral circulation 
were observed: weaning (3-4 weeks of age), 7 weeks of age, 13 
weeks of age and 20 weeks of age. Interestingly the same animal 
could be shedding SIV in diff erent infection waves.
Figure.1: Percentage of positive animals by ELISA and RT-PCR per 
week
Discussion
Results of the present study showed that SIV may circulate 
subclinically in an endemic farm. Maternal-derived antibodies 
(MDA) probably persisted for at least 6 weeks and, most prob-
ably, very early infections became softened because of those 
MDA. The results also show diff erent consecutive viral waves 
that were not translated to an explosive spread in the farm (gen-
eral seroconversion) except for the last two waves, suggesting 
the introduction and circulation of a strain previously absent in 
the population in late stage fatteners and fi nishers. In summary, 
the present data suggests an endemic and subclinical circulation 
of SIV in consecutive viral waves.
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Introduction
The use of an appropriate challenge model is of considerable 
importance for any demonstration of the effi  cacy of a vaccine. 
Experimental induction of swine infl uenza is a diffi  cult process. 
Pigs very often show no clinical signs of disease, or only a few 
such signs, upon experimental infection with infl uenza A viruses. 
Intratracheal infection is the method recommended by the 
European Pharmacopoeia (1), but this method is not entirely 
satisfactory in terms of disease induction. Therefore a new aero-
sol challenge model for swine infl uenza was developed using a 
nebulizer.
Materials and Methods 
The nebulizer (SAG-1) generates very fi ne droplets in a stable 
aerosol. Nebulization was performed in isolation rooms, with the 
generators suspended from the ceiling above the pigs, and all 
swine were in one room. The containers were fi lled with medium 
from tissue-cultivated virus (around 6 l of medium with 10 6.0-8.0 
TCID50/ml on average), the doors to the isolation rooms were 
closed and an air pressure of 3-4 bar set on the generator. Princi-
pally the generator produces droplets in the range 0.5 to 20 mi-
crometers. Droplets in the range 5 to 20 μm are deposited in the 
trachea, bronchi and alveoli. Smaller droplets of 2 – 5 μm reach 
the alveoli and very small droplets of 0.2 – 0.5 μm are exhaled 
again. Once nebulization was started the ventilation system was 
switched off  so that the aerosol was constant for at least 1 hour. 
Intratracheal challenge tests were also performed for compari-
son purposes by two diff erent methods i) injection through a 
needle positioned close to the larynx in the cartilage without 
narcosis, ii) injection through a tube after intubation under 
narcosis. 
In total, 60 infection trials with 2346 pigs using 46 strains of 
swine infl uenza A viruses of subtypes H1N1, H1N2 and H3N2 
including the new pandemic H1N1 2009 virus were carried out. 
Vaccinated and un vaccinated pigs were investigated in trials for 
proof of onset of immunity and duration of immunity as well as 
in dose titration trials comprising > 100 pigs in one trial. 
Results
Within 24 hours of aerosol nebulization the unvaccinated pigs 
developed elevated body temperatures of around 41 °C, tachy-
pnea and dyspnea characterized by frequent labored abdom-
inal breathing. The animals had a remarkable loss of appetite. 
Infected pigs generally recovered very soon. Body temperature 
and breathing normalized within 3-4 days of infection. Coughing 
was observed during that period and disappeared a few days 
later. Virus was shed over seven days. First antibodies occurred 
after 5-7 days. Vaccinated animals did not have elevated body 
temperature or only a low temperature rise. They were free of 
clinical signs of disease or had only very minor signs compared 
to unvaccinated pigs. Whereas unvaccinated pigs reached a 
plateau in body weight development, vaccinated pigs were not 
infl uenced by the infection. Strains of the subtypes diff ered in 
their virulence. Strains of subtype H3N2 were always virulent 
inducing severe respiratory disease and isolated cases of death. 
H1N2 strains were also virulent whereas H1N1 strains refl ected 
a great variation in virulence but being in the majority of the 
experiments very mild (weak respiratory symptoms, no, or a very 
short period of fever induction). Aerosol infection did not harm 
the animals whereas after intratracheal infection single pigs 
suff ered from the procedure due to either narcosis or injection 
which infl uenced the clinical outcome. Moreover, after intratra-
cheal injection lungs had strong atypical lesions whereas lungs 
after aerosol injection refl ected lesions in the apical parts of the 
lungs comparable to those after natural infection.
Discussion 
The newly developed aerosol infection model is superior to 
intratracheal infection. It allows infecting a large number of pigs 
(up to 200) in one single trial within a very short period of time 
and without harm to the animals. Disease is induced within 
24 hours and is either more severe after aerosol challenge in 
comparison to intratracheal challenge or comparable to it. In 
contrast to intratracheal infection there are no artifi cial lung le-
sions. The newly developed model is a valuable tool for vaccine 
development and research.
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Introduction
The emergence of the 2009 pandemic H1N1 infl uenza virus from 
swine origin viruses1 reinforced the concern about transmission 
of animal infl uenza viruses to man. This follows the transmission 
of highly pathogenic H5N1 viruses from birds to people identi-
fi ed in the late 1990s and continuing today.2 These two events 
demonstrate the transmission of novel infl uenza viruses to man. 
In addition, the discovery of a unique H2N3 reassortant virus in 
swine3 provided insight into the introduction and adaptation of 
low pathogenic avian infl uenza virus (AIV) genes into a mam-
malian host. To explore the likelihood of swine serving as an 
indirect host for AIV, we tested the susceptibility of swine to low 
pathogenic H5 and H7 viruses isolated from North America. 
Materials and Methods
Four-week-old infl uenza-free pigs were randomly allotted to one 
of 12 groups (Table 1). All pigs in each group (n=12) were inocu-
lated with a sham (Group 1) or virus inoculum (Groups 2-12). 
Virus challenge dose was about 1 x 106 EID50 in a two ml volume 
that was dripped behind each lower eyelid and into each naris. 
Group 6 was given a swine virus to serve as a positive control; 
the remaining groups received either an H5 or H7 AIV.
At 3, 5, 7, and 28 days-post-inoculation (dpi), three pigs were 
euthanized in each group for virus detection and lesion evalua-
tion. At 2 dpi, fi ve contact pigs were comingled with each group 
and maintained as a group until 28 dpi when all pigs were 
euthanized. Nasal swabs were collected on days 2, 4, and 6 pi 
from all live pigs in each group. Bronchioalveolar lavage fl uid 
(BALF) was collected at necropsy. Nasal swabs and BALF were 
tested for viral nucleic acid with real-time RT-PCR.4 Day 28 pi 
sera was tested for infl uenza virus antibody with a commercially 
available ELISA.5
Results
No virus, antibody, or lesions were found in the negative control 
group, Group 1 pigs (Table 1). Challenge virus was only detected 
in NS from group 6 pigs challenged with the swine H1N1 at 2, 4, 
and 6 dpi (data not shown). Group 6 contact pigs were the only 
contact pigs that seroconverted by 28 dpi. AIV challenge virus 
was detected in the BALF from one or more pigs in each chal-
lenge group. Except for group 7, one or more inoculated pigs 
developed antibody by 28 dpi: however no contact pigs in the 
AIV groups seroconverted. Mild lung lesions were observed in 
each group of pigs. 
Table 1: Challenge group/subtype, virus detection in BALF, and sero-
conversion by ELISA.
Group  3 dpi 5 dpi 7 dpi IN DC
1 Control 0/0 0/0 0/0 0 0
2 H7N9 WF 2/0.8 0/2.9 0/0.4 2 0
3 H5N3 CK 3/1.2 1/0.7 2/0.3 1 0
4 H7N2 TY 1/1.0 0/0.3 0/0.3 1 0
5 H5N9 TY 2/3.7 1/0.3 0/0.0 3 0
6 H1N1 SW 3/11 3/17 3/13 3 5
7 H5N9 EM 2/3.7 3/3.2 2/4.3 0 0
8 H5N3 MA 1/3.9 1/4.7 0/2.1 3 0
9 H7N8 MA 3/2.4 2/5.1 1/2.0 3 0
10 H7N2 CK 2/1.4 2/2.2 0/0.7 3 0
11 H5N2 PH 2/1.6 3/1.5 1/3.0 3 0
12 H7N2 QU 2/0.8 3/0.2 0/0.4 2 0
WF-waterfowl, CK-chicken, TY-turkey, SW-swine, EM-emu, MA-mallard, PH-pheasant, QU-quail. 
*Number of PCR positive BALF samples out of 3 pigs/Mean lung lesion score for the 3 pigs.**IN= 
inoculated (positive out of 3) DC=direct contact pigs (positive out of 5)
Discussion 
Challenge virus was detected in the BALF from one or more pigs 
in each of the AIV-challenged groups indicating that swine were 
susceptible to infection via a mucosal exposure. Although pigs 
were susceptible to infection, lung lesions were mild and vari-
able. There was no virus detected from or serologic evidence of 
virus transmission from AIV-inoculated pigs to their respective 
contacts. In contrast, the contact pigs for group 6 were infected 
with the swine challenge virus and each pig seroconverted. 
Moreover, this was the only contact group from which viral nu-
cleic acid was detected in nasal swabs. Some pigs were negative 
following mucosal challenge with AIV suggesting innate resist-
ance or a challenge dose at the minimal threshold of infection. 
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Introduction
Swine infl uenza virus (SIV) is a common pathogen in pigs. In 
Denmark 90% of the sow herds are infl uenza A positive. The 
most common serotypes are H1N1, H3N2 and H1N2. Clinical 
signs are often manifested as acute respiratory disease with 
fever, anorexia, weight loss, lethargy, coughing, dyspnea, nasal, 
and ocular discharge. Reproductive failure and abortions can be 
seen in sows (1). Secondary infections and increased use of anti-
biotics are common sequelae (2). The economic importance, the 
within-herd infection dynamics and the clinical impact of the 
disease on piglets are, however, not fully elucidated. The aim of 
this study was to examine the clinical impact and the infection 
dynamics of SIV in a Danish sow herd. Furthermore, the eff ect of 
the age of the sows on SIV infection in the piglets was studied.
Materials and Methods
A total of 44 sows of Danish landrace and Yorkshire crossbreds 
and 199 piglets were included. From each sow, fi ve randomly 
selected piglets were earmarked. Blood samples (serum) were 
collected from each sow prior to the transfer to the farrowing 
unit and 4 weeks after transfer. Nasal swabs were collected 5 
days after transfer. Rectal temperature were taken at each sam-
pling and the sows were monitored clinically daily during the 
fi rst week after farrowing.
The piglets were observed clinically daily until weaning and a 
detailed clinical examination were performed 10-14 days after 
birth. The piglets were weighed 0-5 days after birth, 10-14 days 
after birth and at weaning (approx. day 28). From each piglet, 
nasal swabs were collected from both nostrils and pooled by lit-
ter (10 swabs per pool/litter). The nasal swabs were collected in 1 
ml saline, send to the laboratory at the day of sampling and kept 
at -80oC until test. Serum was separated from the blood samples 
by centrifugation and stored at -20 oC. The nasal swabs were 
tested for SIV by real-time SYBR RT-PCR using primers previously 
described (3) and the serum samples were tested for antibodies 
by the standard haemagglutination inhibition test against the 
common SIV subtypes present in Denmark.
Results
SI virus was detected by RT-PCR in 12 out of the 43 tested litters 
(28.6%). In contrast, SI virus was not detected in any of the 43 
tested sows. Of the 43 sows, however, 12 (27.9%) showed a 
signifi cant (minimum 2-fold) increase in HI titer against at least 
one of the tested SIV subtypes. There was no signifi cant relation-
ship between SIV positive litter and increased antibody titer of 
the mother sow. The 1.st and 2.nd. parity sows had signifi cantly 
more SIV positive litters compared to the older sows. Accord-
ingly, the younger sows had a statistically signifi cant higher risk 
of having a minimum 2-fold increase in antibodies against SIV 
in relation to farrowing. Apart from coughing, there were no 
signifi cant diff erences in the incidences of individual clinical 
symptoms of SIV positive and negative litters, however, when 
the clinical signs were scored and summed up for each litter 
there was a signifi cant higher score in litters with SIV positive 
piglets. The average daily weight gain was not diff erent between 
SIV positive and negative litters.
Discussion and conclusion 
The present study showed that a relatively high proportion of 
young piglets in a farrowing unit of a herd with circulating swine 
infl uenza virus were positive for SIV during the fi rst weeks after 
birth. This was surprising since we expected that the piglets 
were protected by maternal antibodies. Interestingly, piglets 
from young sows had a higher risk of being infected by SIV 
compared to piglets from older sows. Since all the sows were 
negative for virus in nasal swabs and there was no correlation 
between seroconversion of a particular sow and the risk of her 
litter being positive, the piglets are probably not infected by 
their mother-sow. Thus, the increased risk of piglets from young 
sows being infected by SIV may be due to sub optimal qual-
ity of the passively acquired immunity. Thus, in relation to the 
handling of SIV in breeding units, the focus should be on the 
off spring of gilts and young sows.
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Introduction
The use of medications dosed in water is a common occurrence 
in swine medicine. However, no published pharmacokinetic (PK) 
studies are available on tetracycline dosed in water in swine 
or the factors that determine the plasma concentration levels 
achieved in medicated swine.
Materials and Methods
Study. Twenty-four castrated male swine, 9 weeks of age (early 
grower), divided into 4 groups (n=6), were exposed to tetracy-
cline powder administered exclusively in water at 0, 125, 250 
and 500 ppm via a randomized block design (1). Blood samples 
were collected before and at 4, 8, 12, 24, 32, 48, 56, 72, 80, 96 
and 104 h post-exposure. All plasma samples were assayed 
using HPLC-UV with a LOD of 0.05 μg/mL within 7 days of collec-
tion (1). Statistical analysis across groups and covariates using a 
one-way ANOVA (SAS 9.1, Cary NC) revealed no bias. All animals 
were healthy and the protocol met IACUC standards at NC State 
University College of Veterinary Medicine.
Pharmacokinetic analysis. Non-compartmental analysis was 
performed on plasma concentrations. Population PK analysis 
using a one-compartmental model was performed in Phoe-
nix WinNonMix NLME 1.0 (Pharsight, Mountain View, CA). The 
developed model was improved and validated by two additional 
data sets from Dorr et al (2). Potential covariates considered 
were body weight, ambient temperature, water consumption, 
water concentration of tetracycline and health status of the 
animal.
Results
Non-compartmental PK analysis and statistical analysis showed 
that all plasma levels were above control (no exposure). Average 
plasma concentration levels for the 125- and 250-ppm groups 
were not signifi cantly diff erent from one another, but were 
signifi cantly less than the 500-ppm group (Table 1). Population 
PK analysis showed that for tetracycline, health status did not 
improve the ability of the model to predict plasma concentra-
tions. The population model included body weight, medication 
and water use. The population model was able to predict plasma 
concentrations of tetracycline and PK values (Vd, Cl) similar to 
previously published values. Bio-availability for the population 
model was similar to oral bioavailability (F) from the in vivo 
study. 
Table 1: Pharmacokinetic parameters of tetracycline
Parameter/Groupa 125 ppm 250 ppm 500 ppm
Cmax, μg/ml 0.80 1.26 1.29 
Css, μg/ml 0.33 0.47 0.77 
Half-life, h 4.60 4.58 4.46 
Cl, L/(kg*h) 0.083 0.107 0.106  
Vdss, L/kg 0.554 0.646 0.769
F, apparent 0.059 0.061 0.057
aCmax, maximum plasma concentration; Css, steady state concentration; Cl, clearance; 
Vd, volume of distribution at steady state, F, bioavailability.
Discussion
Tetracycline water medication PK parameters were consistent 
with values from the literature. Plasma levels were lower than 
those from observational studies in which animals were fasted. 
Low plasma concentrations may be due to low oral bioavailabil-
ity and cation chelation of tetracycline by food. 
Body weight, water consumption and water concentrations of 
the medication are the most important covariates for population 
PK analysis. Temperature was important in the initial study; how-
ever, ambient temperatures were not recorded for validation 
data. Temperatures appear important when large fl uctuations 
are present, because this changes the baseline water consump-
tion.
Population analysis on other medications is necessary for further 
validation of the above factors and to elucidate other potential 
covariates. In conclusion, tetracycline exemplifi es how drugs 
with poor absorption have decreased ability to achieve ad-
equate blood levels when dosed via water.
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Introduction
The fl uoroquinolones (FQ) are synthetic, broad spectrum bac-
tericidal antibiotics which use in Canada is restricted to compan-
ion animals and beef cattle. Since their introduction in veterinary 
medicine, FQ-resistant bacteria are emerging in domestic ani-
mals, but the relationship between drug use and drug resistance 
awaits elucidation. Recently, the “mutant selection window” 
(MSW) concept has been proposed to explain the enrichment 
of resistant bacteria during FQ exposure [1]. Because drug effl  ux 
transporters excrete FQ into the intestinal lumen, where drug-
resistant zoonotic pathogens may be selected, we hypothesized 
that the level of selection pressure will vary depending on the 
FQ dosing route. The study objective was to compare the chan-
ges in fecal E. coli population size and antimicrobial sensitivity of 
pigs treated with enrofl oxacin (EFX) orally, intramuscularly, or by 
way of local delivery implants.
Materials and Methods
Parts of the study have been published elsewhere [2]. Briefl y, 21 
healthy pigs (13.6 ± 5.9 kg) with no previous exposure to anti-
biotics, and instrumented with a jugular catheter were random-
ized across EFX-dosing groups: oral (O), intramuscular (I), or local 
(L: peri-femoral implants with 65 mg EFX). Pigs in groups I and 
O were dosed daily for 15 days with ; 5.0 mg•kg-1•d-1 EFX. Feces 
were sampled rectally for 7 days prior to and during exposure to 
FQ. Jugular blood was sampled during treatment, and plasma 
EFX and ciprofl oxacin (CFX) concentrations were measured with 
tandem mass spectrometry. Individual daily fecal E. coli counts, 
and disk diff usion testing of 12 antibiotics (3 colonies/pig) were 
performed daily. The eff ects of dosing route and time (as divided 
in fi rst-exposure, bactericidal eff ect, and bacterial regrowth 
phases) on E. coli inhibition diameters were estimated with a 
repeated-measures linear mixed model. The eff ect of dosing 
route on the duration of FQ bactericidal phase was analysed 
with survival analysis. The α-level was set to 0.05 for all statistical 
tests.
Results
Average plasma EFX concentrations in pigs of group L were 4.5% 
of those in the other two groups, and plasma CFX concentra-
tions were 8.5% of those of EFX. Fecal E. coli were undetectable 
during the bactericidal phase in all 3 groups. The sensitivity of 
fecal E. coli to EFX (Fig. 1), CFX, nalidixic acid, ampicillin, and 
trimethoprim-sulfamethoxazole was signifi cantly aff ected by 
dosing route (P<0.05) and time (P<0.05). In contrast, these 
factors had negligible eff ect on E. coli sensitivity to amoxicillin, 
ceftiofur, streptomycin, apramicin, gentamicin, fl orfenicol, and 
tetracycline.
Figure 1. Enrofl oxacin inhibition diameters (least-square means± 
standard error) of Escherichia coli as a function of dosing route and 
exposure phase
Discussion
Our hypothesis was verifi ed: the local EFX delivery minimized 
both the intestinal effl  ux and selection of drug-resistant E. coli. 
Moreover, oral EFX maximized the bactericidal eff ect on E. coli, 
which retarded the resistance selection process. Exposure to EFX 
co-selected resistance to other antibiotic classes. The i.m. dosing 
of EFX causes signifi cant resistance selection pressure on poten-
tially zoonotic intestinal bacteria such as fecal E. coli. Because the 
intestinal FQ effl  ux exists in other mammals, these drugs should 
be used with caution.
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Introduction
Clostridium perfringens type A is a causative agent of diarrhoea 
in neonatal piglets with widespread occurrence in many pig 
producing areas; indeed the consensus β2 toxin (cpb2con) was 
recently considered the key virulence factor characterising the 
strains involved in neonatal enteritis of pigs (1, 2). The role of 
Clostridium diffi  cile in neonatal diarrhea is increasing and becom-
ing of greater clinical importance (3, 4) in many countries. Aim 
of the study was to assess the MIC values of toxigenic C. perfrin-
gens and C. diffi  cile isolates from neonatal healthy piglets (less 
than 7 days old) or aff ected by enteritis, collected in Italian and 
Danish farms, against the pleuromutilin antibiotics, tiamulin and 
valnemulin (Denagard® & Econor® respectively - Novartis Animal 
Health Inc.) 
Materials and methods
Strains: Sixty-eight C. perfringens isolates (30 strains from Italy, 38 
strains from Denmark) were used for the study. The Italian strains 
were recovered from 30 diff erent farms in 2007-2008 and the 
Danish strains from 20 diff erent farms in 2006. Fifteen C. diffi  cile 
strains (10 from Italy and 5 from Denmark) were recovered in 
2007 -2008 and originated from diff erent farms. 
Genetic characterization of isolates: Clostridium perfringens strains 
were toxin-typed by a multiplex PCR for the detection of major 
toxin encoding genes (cpa, cpi, cpetx and cpb) (5) and β2 gene 
presence was evaluated according to Baums et al. (6). Cpb2 posi-
tive strains were further characterized according to Jost et al. (2) 
by PCR detection of consensus or atypical cpb2 alleles. Clostrid-
ium diffi  cile strains were tested for the presence of toxin A and 
B (tcdA e tcdB) encoding gene and the presence of binary toxin 
genes (cdtA and cdtB) was also evaluated (7, 8). MIC testing: The 
MICs of tiamulin hydrogen fumarate and valnemulin hydrochlor-
ide were evaluated using the agar dilution method and concen-
trations ranged 0.016-256 μg/ml. MIC testing was performed 
according to the CLSI guidelines (CLSI document M11-A7). 
Results
The MIC values of the tested antimicrobial agents for C. perfrin-
gens and C. diffi  cile isolates are shown in Tables 1 & 2.
Table1: Tiamulin MIC values.
Italian C. perfrin-
gens type A (n=30)
Danish C. perfrin-
gens type A (n=38) C. diffi  cile (n=15)
MIC50 4 2 8
MIC90 64 4 16
Geometric mean 4.6 2 8.4
MIC range 0.125-128 0.25-8 0.125-16
Table2: Valnemulin MIC values.
Italian C. perfrin-
gens type A (n=30)
Danish C. perfrin-
gens type A (n=38) C. diffi  cile (n=15)
MIC50 0.125 0.063 0.5
MIC90 8 0.125 1
Geometric mean 0.3 0.06 0.5
MIC range 0.063-32 0.016-0.25 0.063-1
Discussion
The Danish isolates of C. perfringens were more susceptible 
to pleuromutilins compared to the Italian isolates. Results for 
the tested C. perfringens and C. diffi  cile strains show a higher 
susceptibility to valnemulin compared to tiamulin. Tiamulin 
pharmacokinetic data at doses of 15-20 mg/kg bodyweight/
day showed that after oral or parenteral application concentra-
tions in colon contents between 13-18 μg/ml can be achieved 
(9,10). Based on these data all Danish C. perfringens isolates 
could be considered susceptible to tiamulin. Twenty percent of 
the Italian C. perfringens isolates with MIC values between 32 & 
128 μg/ml were considered resistant to tiamulin. All Danish and 
90% of the Italian strains of C. perfringens could be considered 
susceptible to valnemulin due to colon concentrations (1.7-5.2 
μg/ml) achieved after oral application of valnemulin at doses of 
3.8 & 11.6 mg/kg bodyweight/day (11). All 15 C. diffi  cile isolates 
showed susceptibility to valnemulin and tiamulin. 
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Introduction
Iron is an essential mineral for composition of blood cells, 
muscle and various enzymes and it is directly related to the 
cellular respiration of the body, as well as enzymatic reactions 
and immune cells in the animal organism (1). The current system 
of intensive pig farming deprives the animal’s access to soil, the 
main natural source of iron supplementation for this species. 
In order to prevent iron defi ciency anemia cases, it is recom-
mended the application of dextran iron injection at the 3rd day 
of life of piglets. However, this management practice can bring 
a lot of inconveniences to the development of these animals. 
In the practice of human medicine for over 3 decades is made 
of iron supplementation with oral presentations (capsules and 
tablets) in order to prevent various types of anemia. One of 
the molecules of iron commonly used for this purpose is the 
carbonyl iron, due to its high content if organic iron available 
and high intestinal absorption (2). The purpose of this study was 
to evaluate the eff ectiveness of iron carbonyl orally in the iron 
supplementation in piglets.
Material and Methods
The experiment was conducted in a farm producing piglets in 
the state of Santa Catarina – Brazil. A total of 60 piglets (initially 
1.95 ± 0.45 Kg) from 12 sows with same age and number of 
births and receiving the same management were used in this 
study. The experiment design was randomized blocks with 5 
treatments and 12 repetitions, with each sow representing one 
experimental block. The treatments were: T1 – non iron supple-
mentation, T2 – 2000mg dextran iron injectable the 3rd day, 
T3 – 150mg carbonyl iron orally the 3rd day, T4 – 200mg dextran 
iron injetable the 5th day; T5 – 150mg carbonyl iron orally the 
5th day. No source of iron supplementation was used in addi-
tion to the treatments. The data were compared by Tukey test at 
a signifi cance level of 5% for analysis of variance (ANOVA). The 
parameters evaluated were weight gain (at 21 and 57 days old) 
and blood parameters (hemoglobin, packed cell volume (at 21 
days old).
Results
The evaluation of weight gain of piglets at 21 days of age 
showed a non-signifi cant diff erence (P> 0.05) among animals 
not supplemented and supplemented (dextran iron and car-
bonyl iron). However, analysis of blood parameters in the same 
period showed that piglets which did not receive iron supple-
ments had lower (P<0.05) levels of hemoglobin (less 19.34%) 
and packed cell volume (less 18.37%) than those who received 
supplementation (dextran iron and carbonyl iron). Furthermore, 
piglets supplemented with dextran iron the 3rd day had higher 
(P<0.05) levels of hemoglobin (over 11.99%) and packed cell vol-
ume (over 9.25%) than those who received carbonyl iron on the 
same day, but they were similar (P>0.05) to piglets who received 
iron supplementation the 5th day (dextran and carbonyl). Even 
at 57 days of age, data analysis showed that the piglets non iron 
supplemented had lower (P <0.05) weight gain (less 10.31%) 
than those who received dextran iron supplementation the 3rd 
day. There was not diff erence (P>0.05) in weight gain of piglets 
according to the source of iron supplementation (dextran or car-
bonyl) and the timing of supplementation (the 3rd or 5th day).
Discussion
The data are consistent with (3), showing that piglets kept in 
intensive system of production and did not receive iron supple-
mentation develop early iron defi ciency anemia, evidenced by 
lower levels of hemoglobin and packed cell volume at 21 days 
old. However, the negative eff ect of livestock of iron defi ciency 
in piglets may have a delayed response in relation to blood 
parameters, since the diff erence in weight gain among supple-
mented and non supplemented animals only became evident 
at 57 days old. The supplementation of carbonyl iron orally was 
shown to have a positive eff ect in preventing iron defi ciency 
anemia in sucking piglets, and the administration the 5th day 
most appropriate. Even so, piglets supplemented with dextran 
iron the 3rd day had superior results for the blood parameters 
than piglets non supplemented and the supplemented with 
carbonyl iron.
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Eﬀ ectiveness of tulathromycin injection for the control of porcine 
pleuropneumonia on a grower-ﬁ nisher farm in an outbreak situation
Kristen Reynolds; Zvonimir Poljak; Robert Friendship; Cate Dewey
Department of Population medicine, OVC, University of Guelph, Guelph, ON, Canada
Introduction
Outbreaks of diseases that result in acute death such as pleuro-
pneumonia caused by Actinobacillus pleuropneumoniae are a 
great concern in some swine facilities. Porcine pleuopneumonia 
is partly controllable through good management practices (1,2), 
though sudden outbreaks can periodically occur. Tulathromycin 
(DraxxinTM,Pfi zer Animal Health) has been proven eff ective for 
the treatment of multifactorial swine respiratory disease (3,4), 
as well as the treatment of porcine pleuropneumonia caused by 
A. pleuropneumoniae (5) if given up to 9 days prior to known 
exposure (6). The objective of this study was to evaluate the ef-
fi cacy of tulathromycin in preventing losses in swine herds due 
to Actinobacillus pleuropneumoniae under fi eld conditions.
Materials and Methods
Three fi eld trials were carried out in a farrow-to-fi nish herd 
located in Ontario. The fi nisher barn had a continuous pig fl ow, 
and pigs of diff erent ages were frequently housed in the neigh-
bouring pens. The swine herd was endemically infected with a 
number of swine pathogens including Mycoplasma hyopneu-
moniae, Actinobacillus pleuropneumoniae, and PRRS virus. In 
late September 2007, the herd started to experience a sudden 
increase in mortality during the fi nisher phase, with both clinical 
signs and gross pathological lesions indicative of porcine plero-
pneumonia (PP). Presence of A. pleuropneumoniae (susceptible 
to penicillin and ceftiofur) was confi rmed in typical lung lesions 
using bacteriological culturing. 
Three trials performed in the fi nisher barn compared treatment 
with tulathromycin to treatment with long-acting penicillin, cef-
tiofur hydrochloride, or a combination of the two. Three diff erent 
types of mortality (overall, reported and mortality due to A. 
pleuropneumoniae) were analyzed using logistic regression and 
Cox’s proportional hazard models. Linear regression was used to 
analyze average daily gain (ADG).
Results
Serotypes 5A and 5B were detected in samples of pigs that died 
with typical PP lesions. The hazard of dying (Hazard Ratio = HR) 
was higher in treatments other than tulathromycin in trials 1 
(HR=2.36 , P=0.05) and 2 (HR=3.66 P=0.02) for reported mortal-
ity. Similar results were attained for mortality due to A. pleuro-
pneumoniae (Figure 1). Tulathromycin was found to increase 
average daily gain of pigs in trials 2 (ADG, Beta=120 g/day, 
P<0.001) and 3 (ADG, Beta=52.6 g/day, P<0.01). 
Figure 1. Expected survival curves based on mortality due to A. 
pleuropneumoniae for pigs of average weight exposed to two interven-
tions strategies in three consecutive fi eld trials in a farm experiencing 
outbreak of porcine pleuropneumonia.
Discussion
It was concluded that under the conditions of this study and 
suffi  cient exposure to A. pleuropneumoniae, tulathromycin 
would signifi cantly reduce pig mortality and improve growth 
performance relative to similar treatment with either penicillin 
or ceftiofur.
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Marboﬂ oxacin achieves high concentration in pig tonsils according to a dose dependent fashion
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1. CReSA, Bellaterra , Spain; 2. Vetoquinol R&D Department, Lure, France; 3. Vetoquinol E.V.S.A, San Fernando de Henares, Spain; 
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Introduction
Actinobacillus pleuropneumonaie (APP) is the causative agent of 
porcine pleuropneumonia. Pigs can become asymptomatic car-
riers of the organism in their tonsils for long periods. Attempts 
to eradicate APP from pig herds have been made with antibiot-
ics but there is a paucity of information about the penetration 
of antibiotics in tonsils. Marbofl oxacin (MB) is a fl uoroquinolone 
widely used in veterinary medicine to control APP under fi eld 
conditions. The goal of this study was to quantify the MB pene-
tration in tonsils after applying several MB regimen dosages.
Material and methods
Pigs were randomly divided in three groups (control, P1 and 
P2) of ten animals each one. The control group received 2 mL of 
serum saline. On the other hand, P1 group received a dose of 2 
mg of MB/Kg every day for three consecutive days and P2 group 
received a dose of 4 mg of MB/Kg every 48 hours two times. The 
animals were sacrifi ced 24 hours after fi nishing the treatment to 
obtain tonsils and serum samples. The concentration of marbo-
fl oxacin in sera and tonsils was quantifi ed by an HPLC analytical 
method. Finally, It was also calculated the ratio MB tonsil con-
centration versus APP MIC90 value (0.03 mg/mL,) determined 
following the CLSI recommendations (4, 7). This ratio is one of 
the PK/PD effi  cacy parameters described for fl uoroquinolones 
(5).
Results
Average marbofl oxacin serum concentration (AMSC) was 0.16 
and 0.24 mg/mL for the P1 and P2 group, respectively. Aver-
age marbofl oxacin tonsil concentration (AMTC) was 0.50 and 
0.70 mg/gr for the P1 and P2 group, respectively (see fi gure). 
Thus, AMSC and AMTC increased in a dose-dependent fashion. 
However, the tonsil MB versus serum MB concentration ratio was 
close to 3 independently of the dose administered to animals. 
Moreover, the MB tonsil concentration: APP MIC90 ratio was 16.6 
and 23.3 for P1 and P2 groups, respectively.
Discussion
Marbofl oxacin achieves a good penetration in tonsillar tissue, 
which compares favourably with 
tonsil/plasma mean concentration ratios reported for other 
fl uoroquinolones (2,3). However, tonsil/plasma ratio observed 
for MB was very similar to the described by Esposito et al. (2006) 
for moxifl oxacin in humans. 
A great deal of information is now available on the PK/PD rela-
tionships for fl uoroquinolones. Ratios of 125 for AUC0—24:MIC 
and 10 for Cmax:MIC have been recommended to achieve high 
clinical effi  cacy for concentration-dependent antimicrobial 
drugs like MB. The MB tonsil:MIC ratio described is above the 
threshold value (10) that is associated with clinical effi  cacy for 
all the doses studied (6). Thus, all the posology regimens tested 
might be effi  cacious to eliminate APP from tonsils. Obviously, 
the information provided here paves the way to carry out stud-
ies whose main goal could be to detect APP in tonsils of animals 
receiving several posology regimens of marbofl oxacin.
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Assessment of decisions pertaining to antimicrobials used in nursery pigs 
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Introduction
Judicious use of antimicrobials is a public health and civic re-
sponsibility and one of the most controversial of all therapeutics 
currently in use. Surveys of United States and Canadian pig pro-
ducers indicate that the greatest proportions of antimicrobials 
are administered to nursery pigs1,2. Guidance on antimicrobial 
use has been developed but no single treatment standard 
established. Thus, we conducted the fi rst of a series of studies to 
determine patterns in antimicrobial treatment based on current 
practices in commercial nurseries. 
Materials and Methods
The use of antimicrobials via injection or water was observed for 
123 conventional health nursery barns. Barns housed pigs from 
weaning until 9-10 weeks of age and were isolated from farrow-
ing or fi nishing barns. During the six month study period, 368 
barns were observed. The unit of analysis was the barn (ecologic 
design). Antimicrobials delivered through the feed did not vary 
during the study and were not described. Reason for adminis-
tration, clinical diagnosis, severity of disease, and antimicrobial 
regimen were recorded. Descriptive statistics were conducted in 
SAS (v. 9.1, Cary, NC, USA). 
Results
There were 136 reports of barns that used an antimicrobial via 
water or injection representing 37% of nursery barns observed. 
Of the 136 medicated barns, 28 (20.6%) were received anti-
microbials more than once. Pigs ≤7 weeks old received anti-
microbials with the greatest frequency (63%). Water was the 
favored route of administration at 61%. We observed 65% of 
antimicrobials were for treating disease as opposed to meta-
phylaxis and 87% of disease was considered mild or moderate 
rather than severe. The majority (75%) of clinical diagnoses had 
signs of respiratory disease; other diagnoses were systemic 
(18%) or enteric (7%) conditions. The antimicrobial regimens 
favored the use of chlortetracycline plus tiamulin (31%) in water 
and enrofl oxacin (29%) by injection. The remaining 40% was 
spread over 8 other regimens. We also observed that the route 
of antimicrobial administration was infl uenced by disease sever-
ity (p=0.002), purpose of administration (p=0.019), and clinical 
diagnosis (p<0.001). The relationships were further expressed 
in odds ratios (OR) with 95% confi dence limits (CL) and p-value 
reported in Table 1. 
Odds ratio if injection OR 95% CL p-value
Severity of disease
Mild - - -
Moderate 1.5 0.8, 2.8 0.26
Severe 5.7 2.1, 15.7 0.00
Reason for administration
Treatment - - -
Metaphylaxis 2.1 1.1, 3.8 0.02
Clinical diagnosis
Enteric - - -
Systemic * * *
Respiratory * * *
- reference category; * non-rational outcome
Discussion
A previous report found that treatment frequency could ap-
proximate disease prevalence3. If this observation is valid, then 
we expect at least 1/3 of nurseries to be diseased in a 6 month 
period. We would expect most disease to be respiratory in na-
ture. The frequency of antimicrobial regimens applied also sup-
ports this expectation. Although we observed a preference for 
administration through water, the route was infl uenced by other 
factors. There is a strong preference for injectable antimicrobials 
when nurseries are severely diseased. Therefore, we believe that 
disease severity and route of administration are proxies of one 
another. Unfortunately, we could not obtain OR for clinical diag-
nosis due to sparse data. No enteric cases received antimicrob-
ials by injection and this is likely due the exclusive use of single 
injection products having regulatory prohibitions in the U.S. as 
well as the pharmacodynamics of oral medications. In summary, 
decisions regarding antimicrobial use in pig populations are 
complex and are related to factors other than the antimicrobial 
or route of its administration. 
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Compatibility of vaccines against atrophic rhinitis and neonatal E. coli diarrhea
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Introduction
In modern swine production sows are vaccinated against 
several diseases, either to protect the sows or to protect the 
sows’ progeny (or both). This leads to the fact that sow vaccina-
tion schemes can become very extended and very complex. 
To be able to work more practical and to reduce the number of 
injections for the sows, farmers are eager to look for options to 
combine vaccines without compromising on the effi  cacy.
Porcilis AR-T DF (1) and Porcilis Porcoli DF (2) are two vaccines 
that are given to pregnant sows to pass on passive immunity 
through MDA to their off spring to protect them against atrophic 
rhinitis and neonatal E. coli diarrhea, respectively. Porcilis AR-T 
DF contains a subunit of the P. multocida toxin (PMT) in com-
bination with B. bronchiseptica (Bb) cells and Porcilis Porcoli 
DF contains purifi ed fi mbrial adhesins (F4ab, F4ac, F5 and F6) 
and the E. coli heat labile toxin (LT). Since both vaccines require 
the same vaccination schedule (basic vaccination 8-6 weeks 
and booster / re-vaccination 4-2 weeks before farrowing) and 
both vaccine use Diluvac Forte (d,l- α-tocopheryl acetate) as the 
adjuvant, it was tested in the present study if injection of the 
vaccines after mixing would infl uence the antibody responses 
against the individual vaccine antigens. 
Materials and Methods
Three groups of 10 pigs of 8 months of age with no or low 
antibody titers against the vaccine antigens were injected twice 
intramuscularly with a 4-week interval with Porcilis AR-T DF (2 
ml), Porcilis Porcoli DF (2 ml) or both products after mixing (4 
ml). Two weeks after the second vaccination, serum samples 
were taken. Antibody titers were determined in a toxin-neutral-
ization assay (PMT), a micro-agglutination test (Bb) or by ELISA 
(E. coli antigens). 
Results
The serological responses after vaccination with the two vac-
cines given individually or mixed are presented in Table 1. 
Table 1. Antibody titers (log2) against both vaccine antigens at 2 
weeks after the second vaccination.
Vaccine antigen Groups
Porcilis AR-T DF Porcilis Porcoli DF Mixed
PMT 8.1 a ± 1.9 <1 b 8.0 a ± 1.2
Bb 11.0 a ± 2.5 4.1 b ± 0.3 11.5 a ± 0.8
F4ab (K88ab) 5.8 a ± 0.5 12.1 b ± 1.2 12.2 b ± 0.9
F4ac (K88ac) 6.2 a ± 0.9 11.6 b ± 1.2 11.0 b ± 0.9
F5 (K99) 7.5 a ± 1.0 12.0 b ± 0.9 11.0 c ± 0.9
F6 (987P) 8.1 a ± 0.8 13.0 b ± 0.8 12.6 b ± 0.6
LT 7.5 a ± 1.3 11.9 b ± 0.9 10.7 c ± 1.0
For each antigen, groups with diff erent superscripts are signifi cantly diff erent (p<0.05, two-
sample t-test). 
Discussion and Conclusion
For nearly all antigens, there was no signifi cant diff erence 
between the antibody titer induced by the single vaccines or by 
the mixed products.
However, for the F5 and LT antigens, the antibody levels induced 
after mixing of the two vaccines were signifi cantly lower than 
those induced by Porcilis Porcoli DF alone. In both the single 
and the combined group uniform titer values were reached after 
vaccination, which allowed for detecting signifi cant diff erence 
between for the F5 and the LT titer values, however the serum 
antibody levels against these two antigens after mixed vaccina-
tion were still above the level that can be considered to provide 
protection via the colostrum (2).
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Possibilities of overcoming the inhibitory eﬀ ect of colostrum-derived antibodies 
using intradermal immunization and immunization via mucosae
Katerina Nechvatalova; Martin Faldyna; Eduard Gopfert; Pavlina Knotigova; Hana Kudlackova; Lenka Leva
Veterinary Research Institute Brno, Brno, Czech Republic
Introduction and objectives
The colostrum-derived antibodies protect piglets in early life. 
Levels of these antibodies gradually decrease in sera of growing 
piglets and according to the prevailing opinion they decline so 
much at a certain time point that they cannot protect the organ-
ism against infection and even block the onset of active immun-
ity. This period has been generally designated as the “immun-
ity window” (1). On the other hand, our previous studies and 
studies of other authors (1-3) indicated that colostrum-derived 
antibodies do not completely prevent the immune response 
after immunization and that this period could be overcome or 
shortened by properly timed vaccination, local administration of 
antigens and/or by the use of proper type of adjuvant.
The aims of this study were to verify the possibility of over-
coming the inhibitory eff ect of colostrum-derived antibodies in 
piglets using immunization via the skin or mucosae and to test 
the eff ect of higher proportions of adjuvant and/or higher con-
centrations of model antigen on quality and quantity of induced 
local and systemic immune responses.
Materials and methods
Piglets (5 animals in each group) with colostrum-derived anti-
gen-specifi c antibodies were intranasally (i.n.), intratracheally 
(i.tr.) or intradermally (i.d.) immunized with increasing concen-
trations (3 mg, 5 mg or 10 mg/piglet) of a model antigen – Key-
hole Limpet Hemocyanin (KLH; Pierce, France) and increasing 
proportions of adjuvant Montanide IMS 1312 (Seppic, France) 
per immunization dose (50-75%), i.e. at ratios of adjuvant to KLH 
from 1:1 to 3:1; the volume of each immunization dose was 1 
ml. Immunization of respective groups started at diff erent age 
(2, 4 or 6 weeks of life) i.e. at periods of high and subsequently 
decreasing levels of total and local antigen-specifi c antibodies. 
All piglets were reimmunized 3 weeks after the fi rst administra-
tion of KLH. 
Blood samples, nasal and bronchoalveolar lavage samples from 
all pigs were taken regularly for immunologic examination 
(isotype–specifi c indirect enzyme linked immunosorbent assays 
with purifi ed KLH antigen and for the KLH-driven lymphocyte 
transformation test). 
Results
The piglets were able to give a quantifi able (cell-mediated and 
antibody) primary immune response to i.n., i.tr., and i.d. im-
munization with KLH already at the age of 2 weeks of life in the 
presence of high levels of colostrum-derived antibodies, but 
only after use of higher concentrations of KLH and/or addition 
of higher amounts of adjuvant. Immunization led to produc-
tion of local IgA and IgG and systemic IgM antibodies in these 
piglets. The levels of systemic IgG antibodies increased only in 
older piglets (aged 4 and 6 weeks) after i.d. and i.tr. immuniza-
tion with KLH, using the highest proportion of the adjuvant 
(75%). Generally, the use of higher concentrations of KLH and 
higher proportions of adjuvant per immunization dose resulted 
in a faster and more intense immune response. On the other 
hand, the immunization dose containing 10 mg of KLH elicited 
excessive but transient local infl ammation of the respiratory 
tract. The immune response intensity after i.n. immunization 
was generally lower than after i.tr. immunization; moreover, the 
former provided weaker systemic immune response than i.d. im-
munization. After revaccination, no signifi cant diff erences were 
observed in the immune responses of piglets with higher and 
lower levels of colostrum-derived antigen-specifi c antibodies at 
the time of primary vaccination.
Discussion and conclusions
The present study confi rmed in accordance with other authors 
(4) that vaccination might be successful even in piglets with 
high levels of colostrum-derived antibodies at the time of im-
munization. Inhibitory eff ect of colostrum-derived antibodies 
was overcome in this study using local administration of antigen 
and proper balancing between the antigen concentration and 
adjuvant proportion in the immunization dose which were of 
crucial importance. 
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Time point for vaccination sows with E. coli vaccines may inﬂ uence the protection of the oﬀ spring
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Introduction
Neonatal diarrhoeas induced by E. coli are commonly prevented 
by vaccination of sows that are booster vaccinated 2-3 weeks 
before farrowing (1). However, the transfer of immunoglobulin 
from serum to colostrum is initiated at least four weeks prior 
to farrowing. (2). Therefore, vaccinating sows at an earlier time 
point appears tempting in herds that are aff ected by neonatal 
diarrhoeas caused by E. coli despite vaccinating sows.
Materials and Methods
The study was conducted in a multiplying herd with 160 land-
race sows producing Landrace-Yorkshire hybrids. Forty sows far-
rowed every fourth week in an age segregated system, and the 
piglets were weaned at an age of 4 weeks. Despite vaccinating 
sows with E. coli vaccines (Porcovac, Plus vet/PorcilisPorcoli Dilu-
vac Forte) during late pregnancy the herd had a high incidence 
of neonatal diarrhoeas. E. coli serotype O149 had repeatedly 
been diagnosed as the cause of these diarrhoeas by laboratory 
analyses.
The productivity of sows and piglets was documented in which 
the birth weight was standardised to 1.5 kg. Piglets attended 
with diarrhoea were medically treated and recorded at an 
individual and litter level. 43 batches boostering sows with E coli 
vaccine two weeks before farrowing, were compared with 28 
batches following altering the booster vaccination to six weeks 
before farrowing No other measures were carried out with the 
aim to control E. coli associated neonatal diarrhoeas. The statis-
tical calculations were carried out using t-tests. 
Figure 1. Productivity before and after switch of boostering sows with 
E. coli vaccine from two to six weeks ante partus
Results
Piglets were weaned at a somewhat higher (p<0.001) weight 
before altering the time point of vaccinating sows. However, 
this was achieved by a higher (p<0.001) weaning age as also 
deomnstrated by an equal daily weight gain of the two groups 
(Figure 1). Also the productivity of the sows was equal in the two 
goups.
The incidence of diarrhoeas during the sucklin period was de-
creased, both at individual (p<0.001) and at litter (p<0.05) level 
following the change of time for vaccinations (Figure 2). 
Figure 2. The incidense of diarrhoea during the suckling period in the 
off spring to sows booster vaccinated with E coli vaccine at two or six 
weeks prior to farrowing.
Discussion and Conclusions
The incidence of diarrhoea during the suckling period decreased 
following vaccinating sows at an earlier time point which was a 
positive welfare issue, both for the piglets and the staff . Thereby 
the use of antimicrobials also decreased, which ought to be 
favourable from an antimicrobial resistance point of view. Yet, 
the productivity in itself was not aff ected by the altered vaccina-
tion strategy, which probabaly could be explained by an alert 
staff  treating piglets with neonatal diarrhoeas at an early stage 
- thereby preventing increased piglet mortality.
This work concludes that vaccinating sows at an earlier point 
of time than generally recomended could be worth testing in 
herds with E. coli associated neonatal diarrhioeas despite vac-
cinting sows.
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Agreement between culture of intestinal and fecal samples for Escherichia coli and Brachyspira spp.
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1. University of Copenhagen, Frederiksberg, Denmark; 2. National Veterinary Institute, Technical University of Denmark , Frederiksberg, Denmark
Introduction
Culture of fecal samples is often applied for examination of 
intestinal pathogens. Culture of feces may not refl ect the intes-
tinal microbiology and result in biased estimates of pathogen 
prevalence or incorrect diagnosis. The objective of the current 
study was to evaluate agreement between culture of intestinal 
and fecal samples for E. coli and Brachyspira spp.
Materials and Methods
Fecal samples and intestines were collected in a case control 
study conducted in 20 Danish herds. All herds were visited the 
day following notifi cation from the farmer/veterinarian of an 
acute treatment requiring outbreak of diarrhea in pigs between 
10 and 70 days post weaning. The farmer was not allowed to 
medicate before the pigs were examined. A sample of 80 pigs 
in each herd was selected by systematic random sampling 
among all pigs in the nursery room where the outbreak of acute 
diarrhea occurred. The pigs were subjected to a clinical exam-
ination and a fecal sample was collected. Among the examined 
pigs a simple random sample of 8 pigs with diarrhea and 8 pigs 
without diarrhea was selected and euthanized. Fecal samples 
from all euthanized pigs were examined for Escherichia coli and 
Brachyspira spp. by standard culturing methods. Small intestinal 
content was examined for E. coli and large intestinal content 
was examined for Brachyspira spp. Dry matter (DM%) was 
determined for the fecal samples. DM% ≤ 18.8 was considered 
as diarrhea and was used (if necessary) to reclassify the pigs as 
diarrheic or non-diarrheic in the statistical analysis. For each 
Brachyspira spp., hemolytic E. coli, non-hemolytic E. coli (if found 
in pure culture or as the dominant bacterial fl ora) diagnostic 
sensitivity and specifi city of the fecal culture were evaluated 
using the culture of the intestinal samples as reference standard. 
Further, diff erences between diagnostic sensitivity and speci-
fi city in pigs with or without diarrhea were evaluated using a 
Chi-sq test.
Results 
Diagnostic sensitivity and specifi city for fecal culture are dis-
played in table 1. In pigs with diarrhea and pigs without diarrhea 
the diagnostic sensitivity was signifi cant diff erent for hemo-
lytic E. coli and borderline signifi cant for non-hemolytic E. coli 
(p=0.068) and B. innocens/B. murdochii (p=0.066).
Discussion 
A clear correlation between fecal and intestinal cultivation 
was only found for hemolytic E. coli. A diff erence in diagnostic 
sensitivity between pigs with and without diarrhea was also only 
observed for hemolytic E. coli. However, culture from intestinal 
content may not always be considered a true gold standard 
and the obtained estimates of sensitivity and specifi city should 
therefore be interpreted with caution. The results imply that 
culture of fecal samples can either under or over estimate 
prevalence of these pathogens compared to culture of intestinal 
content. The study also demonstrates that diagnostic test have 
diff erent performance in various subpopulations. The relatively 
low sensitivity for Brachyspira spp. may have implications for 
surveillance of swine dysentery.
Table 1. Diagnostic sensitivity and specifi city of culture of fecal sam-
ples for E. coli and Brachyspira spp. using culture of intestinal content as 
reference test.
Hemolytic 
E. coli
Non-
hemolytic 
E. coli
B. inter-
media
B. inno-
cens or B. 
murdochii
B. pilosi-
coli
Pigs with diarrhea 
(DM%≤18.8) (n=166) n = 31 n = 65 n = 13 n = 48 n = 14
Diagnostic sensitivity* 83.9# (66.3 - 94.5)
49.2 (36.6 - 
61.9)
30.8 (9.1 - 
61.4)
47.9 (33.3 - 
62.8)
28.6 (8.4 - 
58.1)
Diagnostic specifi city* 91.1 (85.0 - 95.3)
85.1 (76.7 - 
91.4)
98.7 (95.4 - 
99.8)
85.6 (77.9 - 
91.4)
99.3 (96.4 - 
100)
Pigs without diarrhea 
(DM%>18.8) (n=146) n = 15 n = 63 n = 9 n = 32 n = 6
Diagnostic sensitivity* 40.0# (16.3 - 67.7)
33.3 (22.0 - 
46.3)
33.3 (7.5 - 
70.1)
68.8 (50.0 - 
83.9)
16.7 (0.4 - 
64.1)
Diagnostic specifi city* 96.2 (91.4 - 98.8)
82.1 (72.3 - 
89.6)
97.8 (93.7 - 
99.5)
89.5 (82.3 - 
94.4)
100 (97.4 - 
100)
All numbers in %, 95% confi dence interval in brackets.
# P<0.01 in chi-sq test for diff erent sensitivity or specifi city in diarrheic and non-diarrheic pigs
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Factors associated with the occurrence and the level of Isospora suis infection in Greek pig herds
Vasilis Skampardonis1, 2 Smaragda Sotiraki2 Polychronis Kostoulas 1 Leonidas Leontides1
1. University of Thessaly, Karditsa, Greece; 2. Veterinary Research Institute, National Agricultural Research Foundation, Thessaloniki, Greece
Introduction
Neonatal coccidiosis, which is due to Isospora suis parasitism, 
occurs in all types of farrowing facilities and under all types of 
management systems (Lindsay and Blagburn, 1994; Meyer et al., 
1999; Mundt et al., 2005). In this study, we identifi ed herd- and 
litter-level factors associated with the odds and the level of I. suis 
oocyst excretion in Greek pig herds. 
Materials and Methods
Data were collected from 55 farrow-to-fi nish herds with continu-
ous farrowing. From each herd, depending on the herd size, at 
least fi ve and up to ten litters, in their second week of life, were 
coprologically sampled. Each litter-sample comprised a pool 
of individually collected faeces from half of the piglets. Oocyst 
excretion, expressed as oocysts per gram of faeces (OPG), was 
determined, by a modifi ed McMaster technique, for all samples. 
A standarized risk-factor questionnaire was used to collect 
information on the use of toltrazuril (BAYCOX® 5%) and other 
herd- and litter-level factors that could be associated with I. suis 
infection. To simultaneously identify factors associated with the 
odds of and/or the amount of litter-level oocyst excretion we 
employed a two-part model (Liu et al., 2008). Presence or ab-
sence of oocyst excretion was the response variable in the logis-
tic part of the model, while the natural logarithm of the non-
zero OPG values was the response in the linear part (parts I and 
II, respectively). Initially, all factors were screened one by one in 
univariable models. Those with P<0.25 in any part of the model, 
were off ered to the full model, which was further reduced by 
backwards elimination until only signifi cant (P<0.05) variables 
were left. In all models, the herd was incorporated in both parts 
as random-eff ects term and the likely cross-equation correlation 
( ρCEC) of the herd-level random-eff ects between parts I and II 
was accounted for. A weighting method, which adjusted for the 
unequal selection probabilities of litters in herds was applied in 
all models. Models were built in the aML software. 
Results and Discussion 
The odds of I. suis litter-level excretion were reduced when 
piglets were treated with toltrazuril, when the farrowing rooms 
were completely emptied and cleaned after weaning, when pig-
lets were not cross-fostered between litters after the 1st day of 
life and when the fl ooring of the pens was plastic. Further, larger 
farrowing rooms and more caretakers in the farrowing rooms 
reduced the odds of excretion. The level of OPG was decreased 
with toltrazuril-treatment, larger farrowing rooms and caretakers 
avoiding walking into farrowing pens. Thus, additionally to 
toltrazuril treatment, control of neonatal coccidiosis can be bet-
tered by other factors. 
Logistic part (I) OR (95%C.I.) P
Toltrazuril Yes 0.2 (0.1 ; 0.5) 0.001
No 1
Clean entire Yes 0.3 (0.1 ; 0.9) 0.039
farrowing room No 1
Fostering after Yes 4 (1.0 ; 16) 0.045
1st day No 1
Metallic pen fl oor* Yes 2.5 (1.1 ; 5.7) 0.034
No 1
Pens per room* 0.93 (0.9 ; 0.97) 0.001
Number of 0.6 (0.5 ; 0.97) 0.042
caretakers
Linear part (II) Coef. (95% C.I.) P
Toltrazuril Yes -1.8 (-0.6 ; -2.9) 0.004
No ref.
Caretakers Yes 2.1 (0.6 ; 3.6) 0.009
entering in pens No ref.
Pens per room* -0.04 (-0.01;-0.08) 0.023
 ρCEC 0.99 0.005
*  litter-level factors
 
References
Lindsay, D.S., Blagburn, B.L., 1994. Parasitol. Today 10, 214-219.
Meyer et al., 1999. Vet. Parasitol. 82, 277-284.
Mundt et al., 2005. J. Vet. Med. B 52, 93-97. 
Liu et al., 2008. Stat. Med. 27, 3528-3539.
aML Multilevel Multiprocess Statistical Software: Version 2.0 (www.
applied-ml.com).
Practitioner Line - Enteric diseases
93
Oral Presentations
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010
O.055
Likely carriage of Brachyspira hyodysenteriae in cockroaches and ﬂ ies on pig farms
Ruth Blunt; Laura Hancox; Ken Mellits; Steven McOrist
University of Nottingham, Sutton Bonington, UK
Introduction
Insects on pig farms can cause loss in various ways, including 
an ability to spread disease within and between farms. This may 
conceivably include re-infection of eradication project farms by 
insects travelling from adjacent farms when infected with the 
agent in question. Some 1980’s research documented the occur-
rence of enteric pathogens, such as Brachyspira hyodysenteriae 
among possible vectors on pig farms. However, no information 
exists on a truly wide range of vectors or on the movement of 
exact strains or isolates around farms. Vector types may also 
have altered in pigs now facing PRRS, PMWS etc. Other studies 
have indicated that some fl oor-dwelling insects, such as cock-
roaches and beetles, may be capable of carrying other enteric 
agents such as Salmonella and E coli for signifi cant periods on 
commercial pig and chicken farms. Increases in farm bedding 
usage will presumably also increase populations of potential 
infected vectors. This study aimed to investigate carriage of 
Brachyspira among farm insects.
Materials and Methods
We constructed a set of 15 case study farms in England and 
Ireland to include the following:- mixed-age farms, breeder only 
farms, recently depopulated farms, empty farms and various 
other scenarios. Most farms were Lawsonia and PCV-2 positive, 
as determined by clinical signs and faecal PCR results. Farms that 
are positive and negative for Brachyspira hyodysenteriae (swine 
dysentery = SD) were targeted, as determined by clinical signs 
and faecal PCR and cultures.
At each farm, numerous longitudinal and age-group specifi c 
vector samples and population-stratifi ed faecal samples were 
collected. Insects were collected via aerial sticky traps, motor-
ised vacuum devices, fl oor and pitfall traps and sweep nets and 
identifi ed by trained entomologists. DNA was extracted from 
the GI tract of larger insects and from whole body samples of 
smaller insects. PCR was performed on pig and insect origin 
DNA by published duplex species-specifi c methods for Brachy-
spira – both B hyodysenteriae and B pilosicoli. At present, 
strain or isolate typing methods are not readily available for B 
hyodysenteriae.
We also conducted separate experimental challenge exposure 
studies of housed cockroaches and Musca domestica fl ies, dosed 
orally with 107 live B hyodysenteriae derived from a confi rmed 
SD case. We cultured and PCR tested both the intestinal tracts 
and faeces of dosed and control insects.
Results
A wide range of insects were found at varying levels in the 15 
study farms. Prominent groups of fl ies were found – Diptera, 
including Musca domestica (house fl y), Muscina stabulans (false 
stable fl y), Ophyra spp (garbage fl y), Stomoxys calcitrans (stable 
fl y) and Syrphidae, including Eristalis sp (hover fl ies), as well as 
numerous fl oor-dwelling beetles associated with feed storage. 
The oriental cockroach, Blatta orientalis was detected in 
considerable numbers on 2 farms. One of these farms was also 
positive for SD signs and B hyodysenteriae (by faecal PCR) in its 
pigs. B hyodysenteriae PCR products were also detected in the 
faeces of several pigs on 3 other swine dysentery-positive farms 
(with no cockroaches). No clear Brachyspira positive fl y or other 
vectors were noted on these 3 farms. However, PCR products in-
dicative of Brachyspira hyodysenteriae were also detected in 30 
% of cockroaches, caught in association with the SD pig-positive 
farm. This agent was not detected in cockroaches on the other 
cockroach-positive but SD-negative farm. 
Separate challenge exposure studies of Musca fl ies and cock-
roaches indicated that these potential vectors may hold B 
hyodysenteriae in their gastrointestinal tracts for periods of 1 to 
3 days. We determined that these insects could not only retain 
these bacteria in their GI tracts, but also excrete viable culturable 
B hyodysenteriae for these periods, via their faeces.
Brachyspira pilosicoli was only noted in pig faeces collected on 
one farm, no clear positive B pilosicoli infection was noted in any 
potential vector.
Discussion
We found a wide range of fl ies, beetles, midges and cockroach 
activity on British and Irish pig farms – some of these appear 
to have the potential to carry and transmit pathogens, such as 
PCV2. In particular we found that cockroaches had the potential 
to carry Brachyspira hyodysenteriae for a potentially import-
ant period of 3 days. Cockroaches form large indestructible 
communities on pig farms when they are introduced – usu-
ally via food waste or other waste products. They may assist 
transmission of the SD agent within and between farms. This 
suggests that a program aimed at reducing infection levels or 
post-eradication re-infection with this agent should include 
not only appropriate biosecurity and pig medication, such as 
pleuromutilins, but also anti-insect population control measures, 
targeted at cockroaches and fl ies in association with pigs.
.
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Sub-clinical ileitis: Technical and economic impact of nutrition and therapeutic measures implemented
Annick Saives1 Jeanne Dupuis2 Alban Chauvin3
1. Elanco Europe, Brussels, Belgium; 2. Selas Veterinaire de la Hunaudaye, Lamballe, France; 3. Cooperl Arc’atlantique, Montfort Sur Meu, France
Introduction
Lawsonia intracellularis is responsible for an infection known 
as ileitis, of which the sub-clinical disease leads to decrease 
zootechnical performance (1). The symptoms are therefore non-
specifi c and diff erential diagnosis is essential for determining 
the prevention and treatment measures to be implemented. The 
purpose of this study is to describe the use of diagnostic tools 
in farms aff ected by sub-clinical ileitis, enabling therapeutic and 
zootechnical measures to be applied, and to evaluate their eff ect 
on zootechnical performances. 
Materials and methods
A site 3 fi nishing barn with 320 pigs per batch, of a single animal 
origin and showing lack of uniformity at the entry of the animals 
(84th day of life) and also in the last part of the fi nishing stage, 
was selected (period 1, tab 1).
An anti-Lawsonia Ab serum profi le was carried out in April 2008 
using the IFAT (indirect fl uorescence antibody technique (Ileit-
est®)) method, by collecting samples at 95, 125 and 167 days of 
age.
At 95 days of age, 10 out of 10 samples were negative; at 125 
days of age, 10 out of 10 samples were positive; at 167 days of 
age, 5 samples out of 5 were positive.
Seroconversion occurs around 100 days of age, and according 
to experimental infection studies (2), spread probably primarily 
takes place at the entry.
An initial dose of Tylan was introduced into feed (100 ppm for 10 
days) upon entry of the animals, followed by a second dose in 
the drinking water mid-fi nishing stage (10 days at 5 mg/kg), due 
to the 2nd period of heterogeneity.
After the treatment, an improvement in the ADG was seen (per-
iod 2, tab 1) but performances are still unsatisfactory at the end 
of the complete period. In October 2008, Lawsonia excretion 
FIRSTtest® was carried out to know if the problem persists. The 
FIRSTtest® is a single-use test for the colorimetric detection of 
Lawsonia using the ELISA technique, which identifi es the bacter-
ial surface antigen.10 samples were collected per age.
At 110 days of age, 9 out of 10 samples were negative and at 150 
days, 10 out of 10 samples were negative.
As the herd was not excreting Lawsonia on this period, a change 
in feed rationing plan was decided in November 2008 (changes 
in formulation and schedule plan at the beginning of fattening 
period) and the 2nd soluble Tylan treatment was reduced from 
10 to 7 days ( period 3, tab 1).
78 animals per batch were weighed upon their arrival, 21 days 
later, and again, a further 21 days later, allowing to calculate 3 
ADG periods. The slaughtering results per batch were also avail-
able and a comparison of results of the cold carcass weight per 
period was possible (period 1 before treatment, period 2 with 
the 2 Tylan treatments, period 3 with Tylan treatments changed 
and formulation adjustment).
Results
Tab 1: Progression of results per period
Discussion and conclusion
The 2 diagnostic tools described here are complementary. 
Serum testing made it possible to understand how Lawsonia 
circulates in the herd and to target the ideal treatment time. The 
FIRSTtest® made it possible to understand that the diarrhoea at 
the end of the fi nishing stage and heterogeneity were not re-
lated to Lawsonia and could therefore be improved by zootech-
nical measures (rationing and formulation). 
Administration of Tylan treatments led to an improvement of 1.6 
kg in average cold carcass weight and formulation adjustment 
led to a 1.1 kg gain.
References
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Evaluation of eﬃ  cacy of oral toltrazuril (Baycox 5 %®) for the 
improvement of post-weaning gut health in pigs in Spain
Alberto M. Alujas2 Ruth Blunt1 Steven McOrist1
1. University of Nottingham, Sutton Bonington, UK; 2. Tests and Trials Ltd, Lleida, Spain
Introduction
Isospora suis disease often occurs around the second week of 
life, through to the normal pig weaning age of 3-weeks-old. It 
is characterized by yellowish pasty diarrhoea for one to several 
days; with dehydration evident even though nursing from the 
mother often continues. Oocysts can survive outside the pig, in 
the farrowing area, for many months and are resistant to most 
disinfectants. The time for intervention in piglets with a control 
strategy is critical; use of a preventive drug usually take place 
at 3 to 4 days of age so that it can kill appropriate stages of the 
parasite within newly infected piglets. Various anti-coccidial 
drugs have been developed and tested against porcine neonatal 
isosporosis, such as sulphadimidine. However, in the European 
Union, the symmetrical triazintrione toltrazuril is the only cocci-
diocidal registered (since 2002) specifi cally for the control of por-
cine neonatal coccidiosis in a single oral dose format of 20mg 
per kg bodyweight. Clinical studies of toltrazuril after weaning 
have not been comprehensive and have not usually included in-
formation on the possible benefi cial eff ects on gut health in the 
dosed pigs in the later post-weaner, grower or fi nisher stages. 
This is an important issue in pigs, which are considered to show 
limited compensatory growth in animals recovering from a 
previous illness or weight check around weaning age. The exact 
reasons for this are not clear, but could include better intestinal 
maturity and enzymatic activity and a lower susceptibility to 
further post-weaning infectious agents, in those heavier pigs at 
weaning. The aim of this on-farm study was to evaluate the effi  -
cacy of toltrazuril (Baycox® 5% oral suspension) for the improve-
ment of gut health in a European grower-fi nisher pig herd. 
Methods
Four-day-old matched piglets either received toltrazuril (Group 
A, n=218) or placebo (Group B, n=216) via blinded colour-coded 
medications. The subsequent diarrhoea scores, growth perform-
ance, gut health and entero-pathogen load in each group was 
monitored by blinded observations, feed and pig weighing, 
faecal PCR tests for Brachyspira and Lawsonia and PCV2, culture 
for coliforms and Clostridia, as well as Lawsonia immunofl uor-
escence assay serology. Observations were made daily and 
measurements collected weekly from day 21 up to day 105 in 
the grower-fi nisher stage of farming. 
Results
There was a markedly improved feed conversion in grower-fi n-
isher pigs in Group A, particularly in the fi nisher period, but simi-
lar weight gains throughout. Lawsonia serology results indicated 
an early (before day 56) and moderate on-farm exposure. Titres 
in Group B pigs were higher, with fewer negatives throughout 
(p< 0.01), suggesting that the intestines of these pigs were more 
receptive to pathogenic Lawsonia infections, just after weaning. 
Four Group B pigs, 77 to 105-days-old, but no Group A pigs, had 
putative positive faecal PCR results for Brachyspira hyodysenter-
iae (swine dysentery). Salmonella, PCV2, Brachyspira pilosicoli, E 
coli and Clostridia results were not noteworthy. There was more 
diarrhoea noted (p<0.05) in the piglets up to weaning age in 
group B (untreated), by blinded investigators. 
Discussion
These results confi rm the protective eff ect of toltrazuril 
(Baycox™) for coccidiosis prior to weaning and demonstrate 
specifi c benefi cial eff ects on gut health and feed conversion 
after weaning. We also found that post-weaning enteric diseases 
including both ileitis and swine dysentery due to Brachyspira 
hyodysenteriae were more severe in pigs untreated for coccidi-
osis. 
We therefore suggest there are two main reasons why the 
lifetime eff ects of small weaning weight and peri-weaning 
infections of rotavirus and coccidia are so important and detri-
mental. First, there is an innate anatomical issue in that smaller, 
gut-damaged piglets being weaned with a limited supply of 
mature villi units, will grow more slowly and second, there is the 
likelihood that pre-weaning infections can carry forward into 
an increased number of post-weaning infections such as ETEC, 
Lawsonia and Brachyspira. 
In the past 5 years, novel and eff ective preventive programs for 
Lawsonia and Isospora been introduced, related to an oral live 
attenuated vaccine (Enterisol ileitis™) and the oral anti-coccidial 
medication toltrazuril (Baycox™), respectively. Unlike coccidiosis 
in chickens, no major vaccines have been identifi ed for coccidi-
osis in pigs. 
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Early farrowing, possibly induced by intoxication via feed, reduced piglet survival with 70%
Per Wallgren
Dept of Animal Health and Antimicrobial Strategies, Uppsala, Sweden
Introduction
Survival of piglets is depending of a full length gestation, and 
events leading to farrowing earlier than expected may seriously 
aff ect piglet survival. This report describes two groups of sows 
mated at the same time and standing in adjacent units, but with 
dissimilar results at farrowing.
Materials and Methods
Three weeks prior to farrowing, 69 sows belonging to the same 
group of sows at the central unit of a multisite production sys-
tem (sow pool) were transported to a satellite herd and divided 
into two groups. Group A with 36 sows was placed in unit A, and 
Group B with 33 sows was placed in unit B. All sows were off ered 
a wet feed from the same batch and prepared at the farm. Pig-
lets born were registered as live born, and still alive at three, 35 
(weaning) and 70 (allocation) days of life.
Figure 1. Number of live piglets per sow in group A (○) and group B 
(◆), and the survival rate (%) of piglets in group B at three days of life in 
relation to day of farrowing in relation to expected day.
Results
Sows in group B started to farrow six days prior to expected 
farrowing with a mean of -3.0 ± 1.9 days. Piglets born were 
premature and the mortality was signifi cant. In mean these 
sows gave birth to 10.0 ± 3.0 live born piglets of which 3.4 ± 3.5 
still were alive at three days of age. The mortality was 100% in 
litters born 5 or 6 days earlier than expected. The liquid feed was 
replaced with dry feed to the sows at the third day after the fi rst 
farrowing, but only 4 out of 33 sows in group B farrowed at the 
expected day or later. The survival rate at 3 days of age in these 4 
litters was 88% (Fig 1). 
In contrast, sows in unit A farrowed at the expected time (at day 
-0.1 ± 1.1), with expected number of piglets born (13.3 ± 3.8) 
and still alive at three days (10.8 ± 2.2). From the third day of life, 
mortality was near to zero in both groups (Fig 1).
Necropsy of 6 stillborn piglets including placenta in group B 
excluded infections as a cause of the incidence. Instead they 
supported, but did not prove, intoxication (of the sows). 
Discussion and Conclusions
The incident in Group B clearly demonstrated the importance of 
the last days of the gestation for the survival rate of the piglets 
born.
It is also interesting that the sows in group A farrowed at the 
same time in the adjacent unit with perfectly normal results. 
Due to the necropsy results and the lack of clinical signs in any 
other unit, infections were concluded less likely to have caused 
the incident in group B. Instead the feed was focused.
Liquid feed systems hold 3 kg feed per meter and the systems 
are generally neither emptied nor cleaned. Instead, unwanted 
microbial growth is assumed to be controlled with a low pH.
However, aggregations of food may arise, eg following curva-
tures, creating other conditions where growth of bacteria or 
fungi may take place. Considering the high water activity in 
the liquid feeding systems, bacterial growth probably appear 
fi rst, with risk for bacterial toxins/endotoxins. With time, mould 
growth could also occur with subsequent mycotoxin formation.
If such an aggregate let go from the tube, pigs fed from the 
valves downstream will be exposed to its content, including 
endotoxins/mycotoxins which both have been proven able to 
induce abortion in sows (1, 2). However, as any toxin provocation 
will precede the abortions in time, a true relationship may be 
impossible to certify - even when strongly suspected as in this 
case. The feed loop to Unit B was opened by saw, cleaned and 
re-sealed. Subsequent farrowing batches have been normal.
References 
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Acute selenium toxicity in ﬁ nishing pigs due to a contaminated feed supplement
Catriona M. Ritchie
SAC Veterinary Services, Aberdeen, UK
Introduction 
Selenium toxicity in pigs is often due to accidental contamina-
tion of the diet (1-5). The acute form may present as sudden 
onset paralysis due to poliomyelomalacia of the spinal cord and 
it can be fatal. If fi nishing pigs ingest high levels of selenium the 
elevated tissue selenium levels present a potential risk to food 
safety. The mean blood selenium elimination half-life in pigs has 
been estimated to be 12 days (4). Selenium levels in liver and 
kidneys can still be elevated two months after a toxicity incident, 
with the kidney having the highest level (1). Livestock owners 
have a responsibility to produce food that is safe for human con-
sumption. In the UK the Food Standards Agency (FSA) provides 
advice if there is a potential risk to the food chain, such as from 
a contamination incident. The fi nancial losses due to selenium 
toxicity in fi nishing pigs are mainly due to culling of paralysed 
pigs, deaths and reduced marketability of exposed pigs. The 
consequences of the exposure are described and the loss due to 
acute selenium toxicosis in fi nishing pigs has been calculated. 
Materials and methods
Fifty out of 316 twelve to fi fteen-week-old pigs developed acute 
onset paralysis following the ingestion of a commercial, selen-
ium contaminated, feed supplement. Two groups of pigs had 
clinical cases and a third group of 100 pigs, which had ingested 
the high selenium ration but for a shorter period, showed no 
clinical signs. Quadriplegia of alert pigs was the main fi nding. 
Aff ected pigs were usually willing to eat when presented with 
food. Alopecia developed in exposed pigs.
Results
Serum selenium levels in six pigs from the clinically aff ected 
groups ranged from 740 to 1880ng/ml, with a mean of 1310ng/
ml (reference range 140-190ng/ml). Histopathological examina-
tion of the spinal cords from two pigs showed severe, bilaterally 
symmetrical lesions of poliomyelomalacia aff ecting the cervical 
and lumbar enlargements. The two, necropsied, quadriplegic 
pigs had pre-mortem serum selenium levels of 1370 and 
1620ng/ml. Three other quadriplegic pigs had liver selenium 
levels of 9.49-13.2mg/kg DM (reference range 0.7-1.8mg.kg DM). 
Analysis of the commercial feed supplement detected a selen-
ium content of 3090mg/kg, which was approximately 1000 fold 
higher than on the label. The complete diet was analysed and 
found to have a selenium content of 42.6mg/kg. 
Discussion
The clinical signs, histopathological fi ndings, blood and liver 
selenium levels were consistent with a diagnosis of selenium 
toxicity. The source was confi rmed to be a feed supplement, 
which had been contaminated with a high level of selenium due 
to an error at the production plant.
As the pigs were destined for the food chain at 24 weeks of age 
the Food Standards Agency (Scotland) was informed of the 
incident and the potential risk to food safety. They advised a 114 
day withdrawal period from the time the pigs last consumed the 
contaminated feed and if this was not possible the off al had to 
be discarded at slaughter. The long withdrawal period meant 
that the pigs would be overweight for their market specifi cation 
and only suitable for the cull sow market but they would not 
have been suitable for the export market due to the selenium 
exposure. Removing the off al at the abattoir posed practical dif-
fi culties and the risk that misidentifi cation could occur for which 
there could have been liability. There was also concern over 
potential damage to the reputation of the Scottish pig industry 
if it became known that the pigs had entered the food chain. All 
416 exposed pigs were euthanased on farm and their carcases 
disposed of. 
The cost incurred per pig was calculated as CAD$39 (GBP23.32). 
The culled pigs were valued at CAD$63500 (GBP38040). The 
compensated loss was CAD$192 (GBP115) per exposed pig. 
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O.060
A case on chronic salt intoxication in growing pigs
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1. Cooperativa d’Ivars, Ivars d’Urgell, Spain; 2. CRESA, Barcelona, Spain
Introduction
Sodium (Na+) is necessary for the electrolytic balance in ani-
mals. Most ion sodium in the diet of diff erent livestock species, 
including swine, is given by means of salt (sodium chloride). The 
standard recommendation of 0.2-0.25% meets the dietary Na+ 
and Cl- requirements of growing and fi nishing pigs for most 
meal diets. Sodium ion toxicosis is also called water depriva-
tion or salt poisoning, and it is rather well documented in swine 
(1). The occurrence of this toxicosis is inversely related to water 
intake, usually related to water deprivation due to inadequate 
water supply or changes in husbandry. Based on available data, 
salt intoxication results in an acute or sub-acute clinical problem. 
Chronic salt toxicity has not been reported so far in pigs. There-
fore, the objective of the present study is to report the clinical, 
pathological and laboratorial fi ndings of a chronic salt intoxica-
tion case in growing pigs. 
Materials and Methods
Pigs from a single-origin fattening farm located in North Eastern 
Spain displayed increased mortality. Historical mortality records 
in the fi nishers ranged between 5-7%, but in May 2008, mortal-
ity percentage increased dramatically to 49%. Approximately, 
30% of the pigs developed central nervous disorders and 70% of 
them respiratory problems. Aff ected pigs displayed hyperesthe-
sia, paddling and, usually, lack of palpebral refl ex, with no fever. 
Animals with respiratory clinical signs (dyspnea) adopted dog-
sitting position. Also, aff ected pigs showed paleness of the skin, 
and diarrhoea was identifi ed occurring in all pens of diseased 
animals. A number of pigs were on-farm necropsied. Based on 
gross fi ndings, oedema disease, postweaning multisystemic 
wasting syndrome (PMWS) and porcine reproductive and res-
piratory syndrome (PRRS) were suspected, besides the existence 
of concomitant bacterial-like pneumonia. Based on suspected 
etiologies, antibiotic was prescribed in water (neomycin) and 
several drugs were used parenterally (including enrofl oxacyn, 
fl orfenicol and apramycin) in the diff erent groups of aff ected 
animals. No signifi cant response to antibiotic treatment was 
noted after 5 days of application. A number of laboratorial stud-
ies were implemented, including necropsy and histopathology 
of two pigs with central nervous clinical signs, antibody profi le 
against PRRS virus, and urea and creatinine levels in serum. 
Further studies included determination in feed of heavy metals 
(cadmium and mercury), vitamin E, vitamin D, selenium, ochra-
toxine, oxalates and sodium chloride content were measured. 
Results
The most signifi cant pathological fi ndings in both animals were 
a severe, bilateral, diff use interstitial fi brosis in the middle and 
deep area of the renal cortex, with loss of glomeruli and glom-
erulosclerosis and a mild mononuclear multifocal meningo-
encephalitis with very occasional presence of eosinophils. Both 
pigs were also positive to PRRS virus detection in lungs. Both 
pigs had very high levels of both urea and creatinine. Obtained 
results so far, mainly the diff use renal fi brosis, pointed out to 
a potential chronic toxicity scenario. Among the feed analyses 
performed, all determinations were within the normal ranges, 
but the sodium content of the ration, which was 2 21% on dry 
matter (those pigs ingested 30 times more sodium than that 
recommended for dry feeding with free access to drinking water 
(2). To determine the origin of these abnormally high salt levels, 
feed mix compounds were analysed for sodium chloride. Among 
8 sources of whey, 2 of them had values of 17.2 and 21.3% of salt 
on dry matter; the remaining whey samples had values from 3.5 
to 10.6% on dry matter.
Discussion
The present case report describes a complex situation in which 
clinical signs pointed towards an acute process, while kidney 
pathological features suggested a potential chronic toxicity 
process. Therefore, once the clinico-pathological fi ndings were 
obtained, laboratorial investigations were directed towards a po-
tential intoxication process. The confi rmation of extremely high 
levels of salt in the diet, not previously reported in the literature 
as far as the authors’ know, allowed confi rming a diagnosis of 
salt toxicosis in the aff ected herd. Moreover, the presence of an 
apparent novel kidney lesion (characterized by diff use cortical 
fi brosis and glomerulosclerosis) associated to this intoxication 
let us classify the clinical problem as chronic. 
References
1.  Carson TL. 2006. Diseases of Swine. pp,980.
2.  Nutrient Requeriments of Swine, National Research Council, Tenth 
Revised Edition, 1998.
.
Practitioner Line - Toxicity/Defi ciency/EMC
99
Oral Presentations
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010
O.061
Carbon monoxide intoxication in weaned pigs
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Introduction
Carbon monoxide intoxication in pigs, although not often 
observed, occurs in connection with dysfunction of heating 
devices and poorly ventilated compartments. Depending on the 
level of carbon monoxide in the air and the time of exposure 
it can take peracute to chronic courses. This case report de-
scribes the occurrence of acute carbon monoxide intoxication in 
weaned pigs. It points out the course of actions to approach the 
diagnosis. 
Materials and Methods
In February 2009, on a piglet production farm almost all piglets 
of one batch, which was stocked in one compartment, died 
within few hours after weaning. The pig farmer had not noticed 
any symptoms of disease at the point of weaning. In addition to 
a clinical observation of the piglets in all compartments of the 
stable, six of the dead piglets were subjected to a pathological 
and histopathological examination. Furthermore, a thorough 
examination of the environment of the animals was conducted, 
comprising a simulation of the climatic conditions in the unit 
on the day of re-stocking. Therefore the gas-fi red heater, which 
was used to heat up the compartment on that day and had been 
maintained recently, was put into operation. After some hours, 
the concentration of carbon monoxide in the air of the compart-
ment was measured via gas detection pump under strict safety 
precautions, supervised by experts from the local fi re depart-
ment. 
Results
The examination of the animals in the barn did not give any clin-
ical evidence; the piglets did not show any specifi c signs of dis-
ease. Feed and water could be excluded as source of the disease 
for the piglets had still not received feed, and the water was the 
same as in other compartments. During pathological examina-
tion of six piglets there could not be detected any abnormalities 
that could have explained the cause of death. Especially the 
colour of blood and tissues could be ascertained as physiologic-
al. Also the fi ndings in the histopathological examination were 
unspecifi c. The measurement of the carbon monoxide content 
in the air during simulation of the climatic conditions in the 
compartment revealed a concentration of 3000 ppm. 
Discussion
Contrary to expectations, pathological as well as histopatho-
logical examination did not contribute to the diagnosis of car-
bon monoxide intoxication. None of the symptoms described in 
literature as typically being related to carbon monoxide poison-
ing, such as cherry-red blood, rose-coloured tissues or menin-
goencephalitis, could be detected in the examined animals. 
The diagnosis was only made after intensive examination of the 
environment, including running the gas-fi red heater which was 
used in the relevant compartment. The measured concentration 
of 3000 ppm was clearly above the minimum lethal concentra-
tion of 1000 ppm. This demonstrates that in cases of suspected 
carbon monoxide intoxication it is indispensable to take even 
more elaborate diagnostic measures like the described recon-
struction of the climatic conditions in the compartment: In the 
absence of clinical and (histo)pathological fi ndings this might 
possibly be the only successful way to confi rm and prove the 
diagnosis.
The excess in carbon monoxide in the unit was attributed to a 
malfunction of the gas-fi red heater. Especially in combination 
with very low ventilation rates as common during winter time, 
this can easily lead to high carbon monoxide levels in the air of 
the compartment. Therefore veterinarians should urge pig farm-
ers to exercise due care in the use of these devices, not only for 
reasons of animal welfare but also for their own safety. 
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Assessment of vitamin E levels, selenium levels and presence of viral 
pathogens as the etiology of mulberry heart disease
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Introduction
Mulberry heart disease (MHD) in swine usually manifests as sud-
den death in young, fast-growing, apparently healthy pigs. The 
hallmark lesions are acute hemorrhagic myocarditis and myocar-
dial necrosis resulting in heart failure. It has long been sus-
pected that MHD is linked to defi cient levels of vitamin E and/or 
selenium (3,4,5,6). However, the exact relationship is still unclear 
and vitamin E and selenium defi ciency are not observed in all 
cases of MHD (3). Furthermore, recent evidence suggests that 
infectious disease may be associated with similar heart lesions 
in pigs (1,2). We investigated the relationship between MHD and 
vitamin E, selenium, and 13 other mineral levels in heart and 
liver tissues. Additionally, several PCR assays were conducted 
on heart tissues to explore a possible relationship between viral 
pathogens and MHD.
Materials and methods
Tissues were collected at the Iowa State University Veterinary 
Diagnostic Laboratory from 83 pigs representing 38 farms. On 
the basis of histological examination 42 of the pigs were clas-
sifi ed as MHD-aff ected and 41 classifi ed as MHD-unaff ected. 
The farms ranged in size from 800 to 4,500 head and most had 
a history of increased incidence of MHD. Mineral panels were 
completed on all heart and liver tissues using a Varion 820 
ICP- Mass Spectrometer. The panel included tissue levels for 
cadmium, calcium, chromium, cobalt, copper, iron, magnesium, 
manganese, molybdenum, phosphorus, potassium, selenium, 
sodium and zinc. In addition, vitamin E levels were also obtained 
from heart and liver tissues. Seventy-seven of the 83 heart tis-
sues were tested using real-time and conventional PCR assays 
for pan-morbillivirus, pan-coronavirus, pan-pestivirus, porcine 
enterovirus (PEV), pan-herpesvirus, porcine circovirus type 1 
(PCV1), PCV2, porcine parvovirus (PPV), European and North 
American porcine reproductive and respiratory syndrome virus 
(PRRSV), Bungowannah virus (BGWV) and West Nile virus (WNV). 
Pairwise t-test was used to analyze the data. A P value < 0.05 was 
considered signifi cant. 
Results 
Signifi cant diff erences (P < 0.05) were observed in levels for 
sodium, copper and vitamin E in heart tissues and sodium, 
magnesium, phosphorus, selenium and vitamin E in liver tissues. 
Mean values were often higher in aff ected pigs compared to 
non-aff ected pigs; however, they were still within the normal 
parameters reported for tissue levels in healthy pigs (3). Vitamin 
E levels for both groups also resided within the normal range 
(3). Aff ected pigs had a trend for a higher incidence of PEV (P = 
0.25), and pan-herpesvirus (P = 0.25)
Discussion
The diff erence between aff ected and unaff ected groups ob-
served among heart vitamin E, liver vitamin E, and liver selenium 
is in agreement with the traditional etiology of MHD (3,4,5,6). 
While many of the pathogens were isolated from several pigs 
among the groups, they did not appear to be associated with 
MHD status in the pigs. Although selenium defi ciency has not 
been shown to cause MHD, it has once again been illustrated 
that MHD is associated with decreased selenium levels. There 
does seem to be a relationship between MHD and PEV and 
herpesvirus. This needs to be further explored experimentally as 
it could provide researchers a better model to study MHD and 
eventually provide producers tools to prevent its occurrence.
References
1.  Kirkland, P.D. et al. (2007) Virus Res 129:26-34.
2.  Opriessnig, T. et al. (2006) J Comp Path 134:105-110. 
3.  Pallares, F.J. et al. (2002) J Vet Diagn Invest 14:412-414.
4.  Sharp, B.A. et al. (1972) Can J Comp Med 36:371-376.
5.  Sharp, B.A. et al. (1972) Can J Comp Med 36:393-397.
6.  Van, F. et al. (1970) JAVMA 157:1208-1219.
.
Practitioner Line - Toxicity/Defi ciency/EMC
101
Oral Presentations
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010
O.063
First record of a clinical outbreak of EMCV in The Netherlands
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Introduction
Encephalomyocarditis virus (EMCV) is endemic on many pig 
farms worldwide. EMCV is a Picornavirus and may infect a wide 
variety of animals like rodents, pigs and also man. Most import-
ant features in porcine EMCV infection are myocarditis and 
reproductive failure. Most clinical outbreaks in Europe were 
reported during the 1990’s in Belgium, Italy, Greece and Cyprus 
(1). Many Dutch sow herds have antibodies against EMCV (2), 
but neither clinical signs nor pathological lesions were reported 
until now. 
Materials and methods
The infected herd of this study has two separate sites located 
80 km from each other in the southern Netherlands. The main 
location is a 1400 sow herd while the other location houses all 
breeding stock for replacement. Mated gilts are transported to 
the main farm and added to the herd after a six-week quaran-
tine period. Signs of EMCV were noted from March 2008 on by 
farmer, veterinarian and veterinary consultant. Necropsies were 
performed at the Faculty of Veterinary Medicine in Utrecht and 
at the Central Veterinary Institute in Lelystad. EMCV RT-PCR 
was performed by CODA-CERVA (Veterinary And Agrochemical 
Research Centre, Belgium) 
Results 
In March 2008 a high mortality was observed in newborn piglets 
of multiparous sows. Apparently healthy well-grown piglets 
with good body condition died without previous clinical signs. 
Some litters stayed unaff ected, while mortality of 2 to 4 days old 
piglets in other litters went up to 100 %. Sows showed no clinical 
signs. Cross-fostered piglets from unaff ected litters stayed 
unaff ected. Four piglets that died were necropsied. These piglets 
were pale, with severe hydrothorax, hydropericardium and pul-
monary edema. Myocardia were severely pale with occasional 
petechia. Histological examination displayed a severe lympho-
histiocytic myocarditis and a mild lymphocytic meningitis. EMCV 
was demonstrated in myocard by RT-PCR. 
During March 16 abortions occurred, and involved 3 sows and 
13 (81%) gilts. Herd performance data were negatively infl u-
enced from March till May (fi gure 1). Surprisingly, only litters 
of multiparous sows were aff ected by sudden death of piglets, 
whereas none of the litters of gilts were aff ected. 
Piglet mortality by sudden death persisted for 3 months. There-
after, signs of EMCV-infection faded away and technical per-
formance of the herd returned to pre-infection levels. 
Figure 1: Technical performance data 2008
Discussion
Sudden death of suckling piglets from multiparous sows was the 
major clinical sign of this outbreak. Retrospectively, these signs 
appeared to be preceded by an increased abortion rate, mainly 
in gilts. No diagnosis was made upon the cause of abortions, 
and EMCV may be involved. 
As litters of fi rst parity sows stayed unaff ected, we assume that 
these piglets were protected against EMCV by maternal derived 
antibodies. 
In most cases rodents introduce and spread EMCV in swine 
herds (3). On this farm vermin is strictly controlled. Direct trans-
mission of EMCV between pigs is in most cases limited, but may 
occasionally cause a large EMCV-outbreak (4). Although EMCV 
is endemic in many herds in The Netherlands, clinical signs of 
EMCV are rare. The outbreak of EMVC in this herd is most likely 
due to presence of high numbers of susceptible sows that were 
infected during late gestation. Theoretically, this can be an 
introduction of EMCV in a naïve herd, or an introduction of an 
EMCV strain that diff ers in pathogenicity and immunogenicity 
from endemic EMCV strains. Closer monitoring might elucidate 
whether a new more virulent strain of EMCV circulates in The 
Netherlands. Therefore, veterinarians and veterinary patholo-
gists should consider EMCV as a diff erential diagnosis in case of 
mortality in suckling piglets and abortions. 
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Investigation of risk factors for porcine circo virus type 2 (PCV2) following an outbreak of Post-
weaning Multi-systemic Wasting Syndrome (PMWS) on a large commercial pig farm
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Royal Veterinary College, Hatfi eld, UK
Introduction
Porcine circo virus type 2 (PCV2) has been widely acknowledged 
as the necessary agent for post-weaning multi-systemic wasting 
syndrome (PWMS) in pigs. Various studies have identifi ed poten-
tial risk factors, but it is still not fully understood what triggers 
the onset of this multi-factorial disease. 
The present study aimed at evaluating the presence of porcine 
circovirus 2 (PCV2) and other pathogens before and during an 
outbreak of PMWS on a large commercial pig farm in the UK. 
Further we investigated the eff ect of environmental conditions 
and the parity and PCV2 immune and infection status of sows on 
presence of PCV2 in growing pigs.
Material and Methods
The study was based on data collected in two diff erent research 
projects ongoing on a large commercial farm when a PWMS 
outbreak hit the farm. One project was a large scale experiment-
al study on the impact of environmental conditions (dust and 
ammonia) on the onset of respiratory disease in 960 weaned 
pigs divided in 8 batches, batches were run one at a time over 
2 years. At the end of the 42 day exposure experiment, serum 
samples were collected and post-mortem carried out on ran-
domly selected pigs. The other project was a longitudinal study 
on the reproductive performance during the fi rst three parities 
and involved 188 gilts originating from eight diff erent breeders. 
Serum samples of 371 growing pigs, aged 10-12 weeks, were 
tested for antibodies to PCV2 and other endemic pig patho-
gens. In addition, presence of PCV2 antigen was determined by 
semi-quantitative PCR. Fifty gilts and sows produced 135 of the 
371 growing pigs of which serum samples had been collected. 
These 50 gilts and sows had been repeatedly sampled at diff er-
ent time points in the reproduction cycle resulting in a total of 
296 samples which were tested for PCV2 antibodies and PCV2 
antigen.
Results
Results show that PCV2 sero- and PCR-positive pigs were already 
present on the farm long before the actual PMWS outbreak. 
Prevalence of PCV2 antibodies and antigen in growing pigs 
was low in the fi rst batches of the respiratory experiments, but 
reached up to 100% in the late batches. The weight gain in PCV2 
PCR positive pigs was signifi cantly lower than in negative pigs 
(p<0.01) and PCV2 PCR positive pigs had a signifi cantly higher 
overall pathological score in the post-mortem examination with 
a mean of 10.8 compared to 8.5 in PCR negative pigs (p<0.01). 
In sows, diff erences is sero-prevalence was observed for diff er-
ent stages in the reproduction cycle and sows in the second half 
of gestation and around farrowing seemed more likely to have 
measurable titres of PCV2 antibodies. Over a period of two years, 
most sows showed fl uctuations in PCV2 antibody titres. When 
combining laboratory results of sows and growing pigs, growing 
pigs had higher odds to be PCV2 PCR positive if the sow tested 
positive for PCV2 antibodies in the time period around farrow-
ing (OR 24.5, p=0.01), the sow was of parity 3 or higher (OR 
40.9, p<0.01.) and were less likely to test PCR positive if the sow 
originated from certain breeders (OR 0.04, p<0.01).
Discussion
Through previous research it is well understood that maternal 
PCV2 antibodies prevent onset, or delay onset, of PMWS in the 
weaner. The results of this study further highlight the role of the 
sow for PCV2 in weaners (parity, PCV2 status around farrowing 
and breeding background). Our results indicate that in future 
studies on PMWS more sow data should be included. The trend 
of increased sero-prevalence in the second half of gestation and 
around farrowing may indicate latent PCV2 infection in sows 
and that increased stress levels result in reactivation of PCV2, 
followed by the observed PCV2 antibody response.
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PCV2 in extended pooled semen from US boar studs
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Introduction
Prior studies have demonstrated PCV2 DNA and the virus itself in 
raw and extended semen from healthy naturally or experiment-
ally infected boars [1-4]. To provide an epidemiological context 
to this fi nding, our group recently reported that of 472 German 
and Austrian raw semen samples screened for PCV2, 86 (18.2%) 
were found to be positive [4]. In our continued work to provide 
a more global perspective of the epidemiology of PCV2 in boar 
semen, a cross-sectional study was performed to determine the 
occurrence of PCV2 in extended semen produced in US boar 
studs.
Materials and Methods
Randomly selected extended pooled semen samples (n = 198), 
18-30 hours post-processing, originating from 17 studs located 
in diff erent states of the US were tested for PCV2 using a nested 
PCR technique [4]. Extended-chilled samples submitted to the 
Andrology Laboratory at the University of Pennsylvania were 
centrifuged at 4,000 rpm for 10 min to produce sperm-rich and 
supernatant fractions. Fractions were cataloged and then stored 
at -20 degree C until subsequent analysis. For all sample posi-
tives, all fragments obtained with the internal nested PCR were 
additionally sequenced to confi rm PCV2 identity. A chi-square 
test was used to determine diff erences (P < 0.05).
Results
A total 49 (24.7%) extended pooled semen samples were PCV2 
positive (Table 1). Samples from 5 studs were negative; all other 
studs had at least one positive sample (range: 10 – 50%). Positive 
results were more often obtained with the sperm-rich pellet 
(n = 34) than with the supernatant (n = 8). A small number of 
samples (n = 7) were positive for both the sperm-rich pellet and 
corresponding supernatant. 
Discussion
This study confi rms that PCV2 is shed in semen and can still be 
detected after semen is extended and stored for 18-30 hours. 
The percentage of samples found positive corresponds well 
with previous results from North America and Europe [1–4]. Of 
particular interest in the present data set was the diff erences 
observed between studs. Also, the fact that most samples 
were positive in sperm-rich pellets may indicate that the virus 
is sperm associated rather then a loose component in seminal 
plasma. All semen samples tested in this study were pooled 
semen originating from several boars. It is thus not known if 
one or more boars contributed to the PCV2 contamination. 
Also virus quantifi cation was not performed which might have 
been necessary in order to better determine the risk of venereal 
transmission.
Table 1. Results of analysis of extended semen samples for PCV2 by 
nested PCR and sequencing (n = 198)
Stud ID Pellet S-tant* Both# Total
(n) n n n n
1 (3) 0 0 0 0
2 (17) 3 0 0 3 (17.6)
3 (6) 0 1 0 1 (16.7)
4 (21) 3 1 0 4 (19.0)
5 (34) 4 1 4 9 (26.5)
6 (28) 5 4 0 9 (32.1)
7 (12) 6 0 0 6 (50.0)
8 (12) 5 0 1 6 (50.0)
9 (9) 1 0 2 3 (33.3)
10 (6) 0 0 0 0
11 (2) 1 0 0 1 (50.0)
12 (4) 1 0 0 1 (25.0)
13 (19) 3 1 0 1 (25.0)
14 (5) 0 0 0 0
15 (6) 1 0 0 1 (16.7)
16 (4) 0 0 0 0
17 (10) 1 0 0 1 (10.0)
Total 34a 8b 7b 49 (24.7)
*Supernatant; #Both supernatant and pellet were PCV2 positive; (a,b) P < 0.05.
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Use of IgG and IgM diﬀ erentiation of antibodies to detect primary and 
secondary immune response to Porcine circovirus type 2 (PCV2)
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Introduction
PCV2 is the causative agent for porcine circovirus associated 
diseases (PCVAD), which clinically aff ect pig herds worldwide.1 
As antibody titres are usually high in aff ected and in not aff ected 
herds2 serological tests are not suitable for laboratory diagnos-
tics for PCVAD. Recently commercial vaccines to protect pigs 
from PCVAD became available3. In this study IgG and IgM type 
antibodies to PCV2 in vaccinated and not vaccinated pigs were 
examined to demonstrate the eff ective priming of the immune 
system for contact to the pathogen.
Materials and Methods
In a GCP conform fi eld trial on a Japanese pig farm a group of 
animals were vaccinated against PCV2 at 3 weeks of age (Ingel-
vac CircoFLEX®, Boehringer Ingelheim). A not vaccinated control 
group was housed comingled. Blood samples from 20 randomly 
selected pigs each from both groups were taken at the time of 
vaccination (3 weeks of age) and 4, 6, 8, 10 and 12 weeks after 
vaccination. All samples were tested for antibodies specifi c to 
PCV2 ORF2 antigen using a commercially available ELISA kit 
(INGEZIM CIRCOVIRUS IgG/IgM ELISA, Ingenasa, Madrid, Spain). 
The ELISA was performed according to the manufacturers 
instructions. In addition PCV2 genome load was quantifi ed in 
the samples using a quantitative real-time PCR according to the 
method published by Brunborg et al.4 
Figure 1: Results of the ELISA (n positive results) and qPCR (% PCR 
positive pigs) tests for vaccinated and not vaccinated pigs (n=20 per 
group).
Results
Results of the tests are summarized in fi gure No. 1. Four weeks 
after the vaccination in both groups two animals were positive 
in the IgM specifi c ELISA. At this time the fi rst samples from 
the control group were detected to be positive for PCV2 virus 
genome in the qPCR. In the following weeks the percentage of 
viremic animals in the control group increased. In parallel the 
number of IgM positive pigs rose in the control group. In the 
vaccinated group no more IgM positive samples were detected, 
but the number of IgG positive samples rises. Twelve weeks after 
vaccination still three samples from the control group were posi-
tive for IgM. The number of IgG positive samples was compar-
able in both groups at this time.
Discussion 
The results presented in this study clearly demonstrate the ef-
fective priming of the porcine immune system after vaccination 
against PCV2. Not vaccinated pigs react against fi eld virus ex-
posure with the production of IgM (primary immune response), 
whereas vaccinated pigs react with a secondary immune re-
sponse (predominantly IgG). The detection of many IgM positive 
animals in a group of pigs indicates a primary immune response. 
As the majority of vaccinated pigs does not react with IgM, but 
with IgG (secondary immune response) to clinical exposure to 
PCV2, the diff erentiation of IgG and IgM against PCV2 could be 
used as a diagnostic tool to diff erentiate not vaccinated groups 
of pigs from vaccinated ones.
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Diagnosis of Porcine Circovirus Diseases (PCVDs) by serology and qPCR
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Introduction
Porcine circovirus type 2 (PCV2) is considered the essential infec-
tious agent of postweaning multisystemic wasting syndrome 
(PMWS). PCV2 is an ubiquitous virus and most if not all pigs 
become infected during their life, but only a proportion of them 
develop PMWS (1,2). A threshold of 7 log10 PCV2 DNA copies/
ml serum has been suggested to establish a PMWS diagnosis 
(2-4), however limited information are available on the use of 
PCR in the diagnosis of other PCV2 related diseases (PCVDs). The 
present study describes the results of serological and virological 
profi ling from 14 Danish herds with symptoms of PCVD.
Material and Methods
Sixteen Danish swine herds were included. Fourteen of herds 
had one or more of the following clinical symptoms in wean-
ers, growers and/or fi nishers: Pneumonia, diarrhea or unspecifi c 
symptoms and/or wasting. None of the herds vaccinated the 
pigs against PCV2. The last two herds were control herds without 
any symptoms of PCV2 related diseases. In each herd, informa-
tion on production type, health status, number of pig produced, 
mortality, weight gain, antibiotic usage and clinical symptoms 
were recorded. Blood samples were taken from 5 pigs from each 
of 6 age groups: 3-4 weeks after weaning, 2 weeks before trans-
fer to the fattening unit, 1-2 weeks and 7-8 weeks after transfer 
and fi nally just before slaughter. Serum was separated and kept 
at -80oC until test for antibodies against PCV2 using an in house 
ELISA and for PCV2 virus load by qPCR (5)
Results
Several diff erent serological and virological profi les were found 
in the 16 herds, however basically the profi les could be grouped 
into two groups represented by herds 5 and 11 (fi gure). This 
grouping was independent of production type, size, health 
status etc. Apart from one herd, no virus was found in the 
samples taken 3-4 weeks after weaning. In the group of herds 
represented by herd 5, PCV2 viraemia and increased level of 
PCV2 antibodies were observed in weaners. In the other group 
of herds, represented by herd 11, viraemia and increased levels 
of antibodies were seen in older pigs – either in growers early 
after transfer or in fi nishers. In general, increased levels of 
antibodies were concurrent with increased PCV2 load. The level 
of antibody and virus in serum were very uniform within the 
sampling groups. The level of virus in serum were in most of the 
viraemic pigs between 4-6 log10 DNA copies/ml, however, a few 
pigs in some groups had higher levels (7-9 log10/ml). In some 
herds increased viral load in serum were seen in the groups of 
pigs concurrent with appearance of clinical signs whereas no 
correlation was seen in other herds. Furthermore, comparable 
levels of viraemia were also seen in the two control herds.
Discussion and conclusion 
The present study showed that PCV2 profi les on serum for the 
diagnosis of PCV2 related diseases in herds can be a valuable 
tool to confi rm that PCV2 is circulating. However, the results of 
the profi ling should be carefully accessed and related to herd 
management factors, the presence of other pathogens and the 
clinical symptoms. Increased serum PCV2 load in itself are not 
diagnostic for clinical PCVD. 
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Comparison of PCV2 viremia between heavy and light weight pigs at 
marketing age in farms with routine PCV2 vaccination
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Introduction
Because of the economic signifi cance, PCV2 vaccine is now 
routinely used on most US swine farms. Although vaccinated 
pigs perform signifi cantly better in terms of survivability and 
growth performance, subpopulations of light weight pigs in late 
fi nishing phase still are observed in farms with routine PCV2 
vaccination. Swine producers and veterinarians have expressed 
concerns over this problem and questioned whether protection 
by the PCV2 vaccine may be inadequate to prevent poor growth 
in some cases. Therefore, it is hypothesized that a protection of 
light weight pigs could be attributed to PCV2 infection at late 
fi nishing age. This preliminary study was designed to compare 
PCV2 viremia and the antibody status of the lightest weight 
and the heaviest weight pigs at the marketing age in farms that 
routinely vaccinated against PCV2. 
Materials and Methods
Seven diff erent fi nishing farms that routinely used a commercial 
PCV2 vaccine and were experiencing no evident PCV2 associ-
ated clinical disease were selected. Within 2 weeks before the 
marketing on each farm, 30 lightest and 30 heaviest pigs in a 
group were identifi ed visually by each farm manager, and blood 
samples from these 60 pigs in each farm were collected. PCV2 
IFA titer was tested by a protocol used routinely in our labora-
tory. A diff erential nested PCR assay for PCV2a and 2b was con-
ducted as the method previously described1. For PCV2b specifi c 
real-time PCR, a PCV2b specifi c primer set was used, and the 
assay was performed using PerfeCTa SYBR Green SuperMix and 
Mx3005P. One-way repeated measure ANOVA and Student t-test 
was used to test for statistical signifi cant diff erences. 
Results
Overall, the IFA titers of the light pigs were higher than those of 
the heavy weight pigs (Fig. 1). Percentages of PCV2a and PCV2b 
viremic pigs in the 7 diff erent fi nishing units tested by nPCR are 
shown in Table 1. There was no signifi cant diff erence in PCV2a 
viremic pigs between the light and the heavy weight groups. 
However, percentages of PCV2b viremic pigs were higher in 
the light pigs than the heavy pigs in 6 of the 7 farms. The real-
time PCR results for the pigs in each farm showed that average 
amount of PCV2b genomic DNA was higher in the light pigs 
than in the heavy pigs.
Fig. 1. Comparison of the mean PCV2 IFA titers between light and 
heavy weight pigs at marketing age.
Table 1. Numbers and percentages of viremic pigs with PCV2a and 2b 
in fi nishing pigs
Discussion 
The present results indicate a potential association between 
PCV2 infection and the marketing weight in swine farms. Nega-
tive eff ects on production may still occur from PCV2 infection 
of vaccinated pigs when clinical diseases are not apparent. 
Although statistical signifi cance was not always observed, 
higher PCV2 IFA titers and more viremic pigs were evident in 
the light weight pigs at marketing age. This fi nding also support 
a greater role of PCV2b compared with PCV2a suggesting that 
PCV2 vaccination should be focussed on the protection from 
PCV2b genotype infection. We could not determine when pigs 
may have been exposed to PCV2 on these farms but vaccination 
program may need to be adjusted to protect pigs from PCV2 
infection until late in the fi nishing phase. 
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Distribution of ORF2 and ORF3 genotypes of Porcine Circovirus Type 
2 (PCV2) in wild boars and domestic pigs in Germany
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Introduction
Porcine circovirus 2 (PCV2), the essential infectious agent in 
PCVAD (porcine circovirus associated diseases) circulates at high 
rates among domestic pig and wild boar popula¬tions. Wild 
boars may be viremic and shed the virus with excretions and 
secretions, and thus serve as a reservoir for domestic pig PCV2 
infection. We hypothesize that PCV2 strains circulating in wild 
boars and in domestic pigs are signifi cantly diff erent and thus, 
partially inde¬pendent. To prove this hypothesis, the distribu-
tion of ORF2 and ORF3 genotypes of PCV2 within wild boars and 
domestic pigs from overlapping greater areas of Germany was 
investigated.
Materials and Methods
Samples from 40 wild boars from 17 diff erent hunting grounds 
and tissue samples of 60 apparent¬ly healthy domestic pigs 
from 18 provenances located in the same greater areas as the 
wild boars were analyzed. PCV2-specifi c DNA was ampli¬fi ed 
by nested PCR (nPCR). PCV2 genotypes were classifi ed based 
on ORF2 sequences as described by Olvera et al. (2007) and 
Segalés et al. (2008). ORF2 and ORF3 genotypes were detected 
by pyrosequencing on a PyroMark ID (Biotage, Sweden) system. 
Genotypes were compared with PCV2 sequences from the Gen-
bank database (520 entries). 
Results
Two ORF2 and nine ORF3 genotypes were detected in twelve 
combinations, with signifi cant diff erences between wild boars 
and domestic pigs. Distribution among the federal states did 
not diff er signifi cantly within species. PCV2-2b was the most 
common genotype in both species. Almost 60% of the infected 
wild boars but only 4.8% of the infected domestic pigs car-
ried the PCV2-2a subtype. ORF3 genotype frequencies diff ered 
also signifi cantly between wild boars and domestic pigs. Some 
ORF3 genotypes were detected in domestic pigs only, others 
exclusively in wild boars. The genotypes of domestic pig PCV2 
samples were dominated throughout the country by 2b/ORF3-1 
and 2b/ORF3-3 types. PCV2 genotypes of the wild boars were, 
however, more heterogeneous than those of domestic pigs. 
Two diff erent PCV2 genotypes in one animal have been isolated 
from 27% and 4% of wild boars and domestic pigs, respectively 
(P<0.001), and at least two diff erent PCV2 genotypes have been 
isolated from 90% of hunting grounds and 50% of domestic pig 
provenances. The fi ve Genbank database PCV2 sequences from 
German domestic pigs (from 1999/2000) diff ered signifi cantly 
from the “domestic” sequences of the present study (2004/2007) 
and from 124 sequences obtained from diff erent European 
countries. However, European and the “domestic” sequences of 
the present study were in good agreement. The six Genbank 
sequences of European wild boar isolates agree with the major 
genotypes of the wild boars of the present study. Some of the 
wild boar derived genotypes are not present or very rare among 
“domestic” and wild boar Genbank sequences worldwide. 
Discussion
Diff erences in “domestic” PCV2 genotypes of the present study 
and Genbank entries from Germany may indicate the general 
switch from PCV2-2a to genotype PCV2-2b after the year 2003 
that has been generally described by Dupont et al. (2008). 
Diff erences and conformity of PCV2 genotypes derived from 
wild boars and domestic pigs, either from this study or from 
European Genbank database entries, indicate that wild boar and 
domestic pig PCV2 do coexist with some exchange. More than 
50% of the wild boar PCV2 genotypes are extremely rare in do-
mestic pigs in Europe (Genbank) and Germany (this study), even 
worldwide, inferring a certain independence of wild boar and 
“domestic” PCV2 genotypes. The fact that genotype 2a is preva-
lent in wild boars (57.5%), but rare in domestic pigs (4.8%) and 
that genotype 2b is the almost exclusive genotype in domestic 
pigs and also prevalent in wild boars, argues for the hypothesis 
that exchange of PCV2 between both species emerges primarily 
from domestic pigs to wild boars and less in the reverse direc-
tion. This hypothesis is supported by the fi nding that PCV2 loads 
of wild boars are signifi cantly lower than those of domestic pigs 
(see abstract on the opposing page). 
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Evaluation of alternative vaccination programs to control PCVAD
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Introduction
Porcine circovirus 2 (PCV2) is the primary pathogen associated 
with PMWS and porcine circovirus associated disease (PCVAD; 1). 
In North Carolina, the primary clinical manifestation of PCVAD 
was marked mortality in grower-fi nishing facilities. Producers 
dramatically reduced the mortality associated with PCV2 by vac-
cinating pigs; however, the costs of vaccinating nursery pigs can 
be overwhelming. Therefore, the primary goal of this study was 
to examine a less expensive approach by vaccinating sows with 
products intended for nursery pigs. 
Materials and Methods
The study was conducted on commercial sow, nursery and fi n-
ishing farms. Three commercial vaccines, approved for nursery 
pigs, were given to sows at 5 and 3 weeks prior to farrowing. For 
each vaccine, at least fi ve gilts and fi ve 4+ parity sows were vac-
cinated and farrowed. In addition, two control groups (6 sows/
parity) were injected with saline. At 7 days after farrowing, two 
lightweight piglets and two heavy piglets from each sow were 
weighed and ear tagged. Due to attrition in the sows from death 
or abortions prior to farrowing, only 45 sows farrowed and a 
total of 180 piglets were used in the study. Blood samples were 
collected from the sows prior to the fi rst vaccination and before 
farrowing. Blood samples also were collected from piglets at ap-
proximately 7, 14, 52, 70 and 155 days of age. All serum samples 
were submitted to Iowa State University for the determination of 
PCV-2 SP ratios. 
Results
From birth until 155 days of age, mortalities for pigs from sows 
vaccinated with Vaccines 1, 2, 3 and 4 (controls) were 13.6%, 
10%, 18.2% and 19.2%, respectively. The “heavy” and “light” 
pigs weighed 3.2+0.08 kg and 2.1+0.05 kg at 7-10 days of age, 
respectively. There were no diff erences in body weights among 
piglets from sows given the diff erent vaccines. PCV2 titers did 
not diff er between 4th parity sows and gilts prior to vaccination 
(1.03+0.03) and sow titers increased slightly after vaccination 
(1.10+0.04). Piglets from vaccinated sows had higher (P<.05) 
titers than piglets from the control sows at 7-10 days after birth 
(Fig 1). With the notable exception of 155 d, this diff erence was 
evident for most time points. At 14-16 days after birth, PCV2 
titers were greater in piglets from sows vaccinated with Vaccine 
2 than in piglets in the other three groups. This was also evident 
at 70 d (1 wk after placement in the fi nishing sites). At 155 days 
of age, PCV2 titers were the lowest in pigs from sows vaccinated 
with the Vaccine 2, while pigs from control sows had the highest 
titers. 
Fig 1. PCV2 titers (SP ratios, mean+SEM) in pigs from sows receiving 
two vaccinations before farrowing. Means diff ered (P<.05) between 
controls and vaccine groups at 7-10 days, and the four groups diff ered 
at 155 d. 
Discussion 
The results indicate that gilts and older parity sows had prior 
exposure to PCV2. Based on a previous report (2), low sow anti-
body titers against PCV2 increased the risk of pigs subsequently 
dying from PCVAD. It was evident that the titers of young pigs 
(7-10 days) were greater when the sows were vaccinated for 
PCV2, particularly with Vaccine 2. The decrease in titer with age 
represents declining maternal antibodies. Perhaps the most 
striking results were the PCV2 titers in pigs at 155 days of age. 
The PCV2 titers continued to decrease in pigs from sows vaccin-
ated with Vaccine 2, thereby indicating that the pigs were not 
actively challenged with wild virus or that they were protected 
when exposed to wild virus. In contrast, the titers of control 
pigs and pigs from sows vaccinated with Vaccine 3, increased 
dramatically while in the fi nishing phase. Evidently, these pigs 
responded to exposure to wild virus during fi nishing. Overall, 
the results demonstrated that PCV2 vaccination of sows has 
potential to reduce losses associated with PCVAD. 
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A comparison between sow and piglet PCV2 vaccines; eﬀ ects on pig 
performance and viraemia in three crossbred types
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Introduction
The eff ects of PCV2 have devastated the pig industry in recent 
years. PCV2 infection increases mortality and feed costs and 
reduces growth rate and feed effi  ciency. Two diff erent types 
of vaccine are now available to counteract this disease; one is 
given to the sow prior to farrowing, hence acting to provide 
passive immunity via colostrum, and the other is given directly 
to individual piglets. These vaccines were compared on a PCV2 
aff ected farm where post weaning mortality had been steady 
at around 12% for the previous two years. Three crossbred 
genotypes, Large White, Hampshire and Pietrain, were used in 
the experiment to determine the impact of the vaccines on the 
health and performance of diff erent genotypes. It has been sug-
gested that PCV2 vaccination will be more benefi cial to Large 
White type pigs as these are considered to be more susceptible 
to PCV2 associated diseases.
The objectives of the experiment were to compare the effi  cacy 
of the two vaccines when delivered either singly or in combina-
tion; to investigate the eff ect of vaccination on the virology of 
PCV2 and to compare the response of diff erent genotype cross-
breeds to vaccination.
Materials and Methods
The experimental design was a 2 x 2 factorial generating the fol-
lowing 4 treatments:
•  Unvaccinated piglets from unvaccinated sows (unvaccinated 
control)
•  Unvaccinated piglets from vaccinated sows
•  Vaccinated piglets from unvaccinated sows
•  Vaccinated piglets from vaccinated sows
Sows were batch farrowed in groups of approximately 24 every 
3 weeks; sow vaccination status was applied across a whole 
batch generating 4 unvaccinated batches and 4 vaccinated 
batches. Within each litter in all batches every second piglet was 
vaccinated against PCV2 at 3 weeks of age. A total of 183 Large 
White x Landrace sows were used in the experiment divided 
across the two vaccination treatments so that the parity profi le 
was similar in both groups. Sows were mated to Large White, 
Pietrain or Hampshire type boars. 
Cross-sectional blood sampling performed prior to the start of 
the experiment established that PCV2 viraemia occurred after 
12 weeks of age in growing pigs. During the experiment six 
sows per batch were blood sampled on transfer to the farrowing 
house and 48 pigs per treatment were blood sampled at 3, 9, 12, 
15 and 18 weeks of age.
Results
Both vaccines were eff ective in improving lifetime performance 
and shortening time to slaughter. Interestingly the eff ect of the 
sow vaccine was most pronounced during the early growth of 
the pig, whereas, piglet vaccination, but not sow vaccination, 
signifi cantly improved growth rate between 7 weeks of age and 
slaughter. Maximum eff ect was gained when the two were used 
together which resulted in 6 days advantage in slaughter age 
over the unvaccinated animal. Using either vaccine singly halved 
this advantage.
Overall post weaning mortality declined from 12 % to 6 % dur-
ing the experiment however there was no signifi cant benefi t 
associated with any particular vaccination strategy. PCR analysis 
indicated that peak viraemia was evident after 15 weeks of age 
(ie later than in the pre-experimental sampling) and that viral 
load was signifi cantly reduced in animals which had received 
the piglet vaccine. 
Both genotype and pig sex infl uenced the response to vac-
cination. In contrast to our initial hypothesis that Large White 
type pigs would benefi t more from PCV2 vaccination in fact the 
opposite was observed: The Large White showed the poorest 
response to vaccination with a reduction in slaughter age of 5.7 
days between unvaccinated female and double vaccinated male, 
a similar comparison in the Hampshire reduced time to slaugh-
ter by 12.4 days and in the Pietrain by 15 days.
Discussion
Vaccination resulted in improved performance throughout the 
growing period and not specifi cally during the period of max-
imum viral load in agreement with Cline et al. (2008). The best 
vaccination strategy for maximizing performance was to use the 
sow and piglet vaccines together, also reported by Pejsak et al. 
(2009). However the level of improvement that can be expected 
is further infl uenced by the pig genotype, therefore the cost 
eff ectiveness of a double versus a single vaccination strategy 
should be considered with this in mind. 
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One-dose vaccination against Mycoplasma hyopneumoniae and Porcine Circovirus Type 2
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Introduction
Mycoplasma hyopneumoniae (M.hyo) and Porcine Circovirus 
Type 2 (PCV2) are the two most prevalent pathogens that are 
encountered in the pig industry. Vaccination against M.hyo is al-
ready standard practice, and the same will be the case for PCV2. 
As vaccines against these two pathogens are preferably given at 
a young age, it would be advantageous if vaccinations against 
these two pathogens are combined. However, no interference 
between vaccinations is acceptable as that could lead to poor 
vaccine effi  cacy. In a previous study, it has been shown that 
the ISPAH vaccines Porcilis M Hyo and Porcilis PCV can be given 
concurrently without any negative consequences for the effi  cacy 
(1). Also, the effi  cacy and safety of simultaneous use (mixing) of 
both vaccines has been evaluated in the fi eld without evidence 
of interference or apparent safety problems (2). Here, we report 
a series of studies on possible interference between vaccina-
tion with Porcilis PCV and M+PAC, and the effi  cacy of especially 
prepared ready-to-use M. hyo-PCV2 combination vaccines. 
Materials and Methods
Groups of 8 conventional piglets, with maternally-derived 
antibodies against both M.hyo and PCV2, were vaccinated at 
weaning (3-4 weeks of age) with M+PAC (and Porcilis PCV), or 
with ready-to-use M.hyo-PCV2 combination vaccines. At 7 weeks 
of age, the pigs were infected with an M.hyo fi eld isolate. Chal-
lenge infection was performed with a culture of strain 98 (ob-
tained from Dr. N. Friis, Danish National Veterinary Laboratory) 
by intratracheal inoculation on two consecutive days, followed 
by necropsy to evaluate M.hyo-induced lung lesions (LLS) three 
weeks later. 
Serum samples taken at the time of vaccination and at 10 weeks 
of age were analyzed for antibody titers against PCV2 in a 
specifi c ELISA.
The vaccines were based on M+PAC (Emunade adjuvant) and 
Porcilis PCV (X-solve adjuvant). Both adjuvants are emulsions of 
light mineral oil in water, but Emunade also contains alhydrogel, 
and d,l- α-tocopheryl acetate is part of the X-solve adjuvant. 
Combination vaccines were formulated with the same antigens 
that are used in the single vaccines. For M. hyo either the anti-
gen that is used in M+PAC (Mh1) or in Porcilis M Hyo (Mh2) was 
used.
Results and Discussion
As shown in Table 1, all vaccines tested provided similar levels of 
protection against M.hyo (53% - 61% reduction in lung lesions) 
after challenge at 7 weeks of age. There were no signifi cant 
diff erences between the vaccinated groups. Whereas the mean 
antibody titers against PCV2 had declined in the M+PAC only 
and control groups from 7.4 log2 at the time of vaccination to 
3.8 and 3.7 at 10 weeks of age, all animals that had been vaccin-
ated against PCV2 showed a titer increase at 10 weeks. Piglets 
that have an antibody titer of 11.9±2.1 at 10 weeks of age after 
vaccination with Porcilis PCV at 3 weeks are protected against 
PCV2 challenge at the end of the fattening period (3). In the 
present study, all groups were at or above that antibody level. 
Table 1. M.hyo-induced lung lesions (LLS) and PCV2 antibody titers 
(log2) at 10 weeks of age. LLS according to Goodwin & Whittlestone 
(1969).
Vaccine(s) M. hyo LLS Reduction PCV2 titer
M+PAC 7.0a±5.4 59% 3.7a±0.6
M+PAC and Porcilis PCV separately 8.0a±4.4 54% 14.1b±1.8
Mh1+PCV/EMUNADE ready to use 8.2a±7.4 53% 12.5b±1.7
Mh1+PCV/XSolve ready to use 7.1a±4.3 59% 13.5b±1.7
Mh2+PCV/EMUNADE ready to use 7.8a±3.9 55% 11.8c±1.7
Mh2+PCV/XSolve ready to use 6.8a±5.6 61% 13.6b±2.5
Control 17.3b±6.4 - 3.8a±2.5
Groups with diff erent superscripts are signifi cantly diff erent (p<0.05, Mann Whitney U-test for 
LLS and 2-sample t-test for PCV2 antibody titer). LLS were corrected for outliers. 
It can therefore be concluded that there is no immunological 
interference between the M.hyo and PCV2 antigens of M+PAC, 
Porcilis M Hyo and Porcilis PCV, independent of whether they 
are given concurrently as separate single vaccines or combined 
in a ready-to-use vaccine with either Emunade or X-solve as the 
adjuvant.
Further proof for lack of interference comes from a recent fi eld 
study in which M+PAC and Porcilis PCV were mixed just before 
administration (4). There was no signifi cant diff erence between 
the anti-PCV2 antibody titers in groups of pigs that were vaccin-
ated with the mixed products or that received the two vaccines 
by separate injections.
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Results of one-shot piglet vaccination at 0.5 ml with Circovac® assessed by viremia and 
seroconversion in a farm aﬀ ected by porcine circovirus type 2 diseases (PCVD)
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Clinic for Swine, Vienna, Austria
Introduction
Circovac® (Merial, Lyon, France), an inactivated PCV2 vaccine, 
was previously evaluated under fi eld conditions in piglets (1). In 
order to assess the eff ect of the vaccination on seroconversion 
and viremia in piglets, serum samples were analyzed serologic-
ally for the presence of PCV2 IgG and IgM antibodies and for the 
presence and the quantity of specifi c PCV2 DNA. Furthermore, 
the reduction of infection pressure after vaccination was inves-
tigated.
Materials and Methods
A controlled, blinded and randomized fi eld study was performed 
on an Austrian 250-sow farrow-to-fi nish farm that experienced 
severe problems with PCV2 and 1105 piglets were included in 
this trial. Three consecutive batches were included at birth and 
piglets were randomly allocated to a Circovac® or to a placebo 
treated control group. Vaccination was performed at three 
weeks of age. Control and vaccinated piglets stayed inter-
mingled. Only batch 1 and batch 3 were chosen for collection of 
laboratory data in order to assess the impact of vaccination on 
viral pressure over time. Blood samples were collected regularly 
and serum samples of Circovac® vaccinated (1st batch: n = 20, 3rd 
batch: n = 18) as well as of control animals (1st batch: n = 20, 3rd 
batch: n = 15) were analyzed via the Ingezim Circovirus IgG/IgM 
ELISA kit (Ingenasa, Madrid, Spain) and quantitative PCR (qPCR). 
Results
The median logarithmic values of copies/ml serum of the 
Circovac® and the control group of both batches are presented 
in fi g. 1. Between week 14 and 22, the pigs of the control group 
of batch 1 were viremic. The vaccinated pigs of batch 1 showed 
peaks only in week 16 and 20, which were lower than the one of 
the control group at the respective points of time. The control 
animals of batch 3 underwent a shorter and lower viremic phase 
than the ones of batch 1. The median values of the vaccinated 
group of batch 3 remained completely at the baseline. Accord-
ing to the qPCR results the main viremia period occurred around 
the weeks 14 to 20. Fig. 2 a,b shows the percentage of pigs posi-
tive for specifi c PCV2 IgG and IgM antibodies of the vaccinated 
and the control group of batch 1, fi g. 2 c,d for the animals of 
batch 3. The vaccinated animals had a general lower incidence 
of IgM antibodies than the controls. Batch 3 showed a lower 
percentage of positive animals than batch 1 in both control and 
vaccinated pigs. 
Figure 1: Median values of qPCR of Circovac® and control animals of 
batch 1 (left) and batch 3 (right)
Figure 2: Percentage seropositive of Circovac® (a,c) and control (b,d) 
animals of batch 1 (a,b) and of batch 3 (c,d)
Discussion
According to viremia and seroconversion results, a positive 
eff ect of the vaccination of piglets with Circovac® has been 
observed. Vaccinated animals had a lower incidence for PCV2 
specifi c IgM antibodies and the vaccination seemed to reduce 
the viral pressure in the facilities, as the occurrence of positive 
animals was in general lower in the 3rd batch. This observation 
is supported by the qPCR data, which showed, that vaccinated 
animals had a lower serum viral load. Those facts suggest a 
reduction of virus shedding after vaccination in this trial. 
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Introduction
Porcine Respiratory Disease Complex (PRDC) is a continuing 
problem in the swine industry. PCV2-associated disease (PCVAD) 
such as post weaning multisystemic wasting syndrome (PMWS) 
has emerged as a serious complicating factor. Vaccination has 
been found to be eff ective in controlling PCVAD. The objective 
of this trial was to evaluate the fi eld effi  cacy of Suvaxyn PCV2 
based on reducing mortality and the cost of managing PRDC on 
a commercial farm in South East Asia.
Material and Methods
The trial involved a very large commercial piggery with a history 
of unacceptably high mortality in the grow-fi nish pigs (including 
respiratory distress and poor weight gain). Post mortem/lab-
oratory testing indicated the presence of PRRS, MH and APP. In 
addition, histopathology and PCR results indicated the presence 
of PCV2. Most of the pigs examined became viraemic with PCV-2 
by 13 weeks of age.
There were 9,289 piglets enrolled in the study (see Table 1). All 
piglets in the vaccinated group were administered intramuscu-
larly with a single 2 mL dose of Suvaxyn PCV2 at 5 weeks of age. 
Serum samples were collected just prior to vaccination and at 4 
weeks post vaccination (9 weeks of age) for serological testing. 
PCV2 viraemia in sera was detected using the PCV2 specifi c PCR 
(serum from batch B pigs only). Average body weights were 
recorded at marketing age; pig mortality and rejects were also 
recorded. 
Table 1. Suvaxyn PCV2 Field Effi  cacy Trial Design
Herd Barn Number of Pig Enrolled Treatment Dose Age
Batch A 1a 979 Suvaxyn PCV2 1x2mL 5 weeks
2a 993 Suvaxyn PCV2 1x2mL 5 weeks
Batch A 1b 963 Control - -
2b 990 Control - -
Batch B 3a 2664 Suvaxyn PCV2 1x2mL 5 weeks
3b 2700 Control - -
Results and Discussion
Herd performance
Vaccination improved the performance of the herds (see Table 
2). All vaccinated groups demonstrated a remarkable decrease 
in mortality (4.05% and 11.04% reduction for Batch A and Batch 
B respectively). The vaccinated group in Batch B also showed 
better body weight gain (additional 4.11kg per pig) and a 
lower number of rejected pigs. The calculated return on invest-
ment (ROI) was 2.7:1 and 18.2:1 for Batch A and B vaccinates 
respectively (based on Margin over feed costs=50%). There was 
a noticeable saving in antibiotic treatment, especially in Batch A 
(US$0.20 per pig).
Table 2. Average Body Weight, Percent Mortality and Number of 
Rejected Pigs at Marketing Age
Herd Group
Number 
of Pigs 
Enrolled
Number of 
rejected 
pigs
Average 
Harvest 
Weight (Kg)
Mortality (%) Between 
Vaccinates and 
Controls
Batch A Suvaxyn PCV2 1972 0 80.87 4.05
Control 1953 0 80.92
Batch B Suavxyn PCV2 2664 60 86.97 11.04
Control 2700 140 82.86
PCV2 Serology and Viraemia
The vaccinated groups showed stronger antibody production to 
PCV2 at 9 weeks of age (4 weeks post vaccination). The PCR re-
sults at 9 weeks of age demonstrated that the vaccinated groups 
had a much lower rate of PCV2 viraemia (17.2%) as compared to 
the controls (77.8%).
Figure 1. PCV2 Viraemia in Sera from Batch B Pigs at 9 weeks of age
Conclusion
These results demonstrate that vaccination using Suvaxyn PCV2 
in pigs, reduced PCV2 viraemia, total mortality and the cost of 
managing PRDC, as well as improving the growth performance 
on a commercial farm in South East Asia.
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Long term evaluation of using PRRS MLV and a subunit PCV2 
vaccine to reduce post-weaning loss in Thailand
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Boehringer Ingelheim (Thai), Bangkok, Thailand
Introduction
PRRSv and PCV2 are the two major pathogens causing swine 
production loss worldwide.
The objective of this study was to confi rm the consistency and 
long-term effi  cacy of a PRRS MLV and a subunit PCV2 vaccine to 
reduce post-weaning losses (mortality and culls) on a commer-
cial pig farm in Thailand. 
Materials and method
The single site conventional commercial farm, 1,700 sows 
level was positive for PRRS. In November 2006 – March 2007 
this farm experienced a PRRS outbreak in the breeding herd 
causing reproductive failure followed by high post weaning 
losses (mortality and culls) caused by PRDC in nursery pigs and 
grower-fi nishers from January to August 2007. Average nursery 
and grower-fi nishers loss in this period was 9.76% and 9.30% 
respectively. Clinical signs observed in nursery pigs started from 
5-6 weeks of age with thumping, eyelid edema and conjunctiv-
itis, in line with seroconversion in nursery pigs at 7-8 weeks as 
measured by PRRS ELISA (HerdChek PRRS 2XR, IDEXX labora-
tory). PRRS vaccination (Ingelvac® PRRS MLV) started in sows, 
gilts and piglets in September 2007. Piglets were vaccinated at 
an age of 10-14 days .
Breeding herd vaccination resolved the reproductive prob-
lems and reduced losses in nursery pigs. However the grower-
fi nishers loss remained at a high level. Clinical signs, including 
wasting, paleness, PRDC, jaundice and diarrhea, started in 12-14 
week old animals. Some pigs showed signs of PDNS skin lesion. 
Main lesions found in post mortems were spleen and kidneys 
enlargement, swelling of inguinal and enteric lymphnodes, 
indicating PCV2 infection.
As a consequence, PCV2 piglet vaccination (Ingelvac CircoFLEX®) 
at 21 days old was introduced to control PCVAD problems in 
grower-fi nishers period. 
Weekly post weaning losses of 124 batches (about 99,000 pigs) 
were evaluated between January 2007 to October 2009, divided 
into 3 phases: Jan 07-Aug 07 (before vaccination), Sep 07–Jul 08 
(PRRS vaccination) and Aug 08 – Oct 09 (PRRS + PCV2 vaccina-
tion). 
Results
Average nursery mortality decreased from 9.76% to 2.70% after 
introduction of PRRS MLV vaccination (Fig. 1), while average 
grow-fi nish mortality remained at 7.53% in PRRS vaccinated pigs 
(Fig. 2). In PRRS plus PCV2 vaccinated piglets, nursery mortality 
further decreased to an average of 1.83%. A more pronounced 
eff ect was observed in grow-fi nish, with an average mortality of 
2.84% in PRRS+PCV2 vaccinated piglets (Fig. 2).
Average post-weaning (wean-to-slaughter) losses were 19.2% in 
non-vaccinated batches, 10.2% in PRRS vaccinated and 4.6% in 
PRRS+PCV2 vaccinated batches. 
Figure 1: Nursery mortality
Figure 2: Grow-fi nisher mortality
Discussion and conclusion 
This farm was co-infected with PRRSv and PCV2. PRRS vaccina-
tion had a clear and consistent eff ect on nursery losses, but it 
could not control the losses in grow-fi nish due to PCV2 infec-
tion. Only when piglets were vaccinated against both, PCV2 and 
PRRSv, post-weaning mortality was reduced consistently. PRRS 
and PCV2 vaccination were shown to be very eff ective providing 
consistent protection in this long-term evaluation.
.
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Introduction
Antimicrobial resistance (AMR) in the human and animal 
population is an issue of increasing public concern. The misuse 
of antimicrobials in human medicine has been associated with 
AMR but there is also concern with antimicrobial use in the 
food animal population. The Public Health Agency of Canada 
and its federal and provincial partners developed the Canadian 
Integrated Program for Antimicrobial Resistance Surveillance (CI-
PARS) to monitor AMR and antimicrobial use (AMU) in humans 
and the agri-food sector in Canada (1). The program includes 
active surveillance of cattle, swine and broiler chicken at abattoir 
and at retail. In addition, there is active surveillance of swine at 
the farm level. The primary organisms of interest are Salmonella, 
E.coli, Campylobacter, and Enterococcus. The focus of this work is 
antimicrobial resistance in E.coli and Salmonella from swine at 
the retail, abattoir and farm levels. 
Materials and Methods
Samples and data for this work were collected in 2008 through 
CIPARS. CIPARS Retail conducts weekly/bi-weekly sampling of 
pork chops from retail food outlets in randomly selected census 
divisions, weighted by population, in the Atlantic Provinces, 
Quebec, Ontario, Saskatchewan and British Columbia. CIPARS 
Abattoir samples cecal contents from swine at 13 federally regis-
tered abattoirs in 8 provinces. The number of samples per abat-
toir is proportional to annual slaughter volume. CIPARS Farm is 
based on sentinel grower-fi nisher swine herds in the 5 major 
pork producing provinces. The number of herds per province 
is proportional to the number of grower-fi nisher units in each 
province. The program is administered through 29 herd veterin-
arians who have enrolled 108 herds. Pooled pen fecal samples 
are collected from pigs at >175 lbs once per year. All samples 
were cultured for generic E. coli and Salmonella using standard 
CIPARS methodology (1). Susceptibility testing was performed 
on 3 E. coli and 1 Salmonella isolate per sample. Minimum inhib-
itory concentrations (MIC) for 15 antimicrobials were established 
for all isolates using the Sensititre® Microbiology System (Trek 
Diagnostic Systems, Cleveland, OH, USA). CIPARS results are cat-
egorized according to the individual antimicrobial’s importance 
to human medicine as determined by the Veterinary Drug Dir-
ectorate (VDD) of Health Canada (2). The antimicrobials tested 
are categorized as Category I: Very High Importance (amoxicillin-
clavulanic acid, ceftiofur, ceftriaxone, ciprofl oxacin), Category 
II: High Importance (amikacin, ampicillin, cefoxitin, gentamicin, 
kanamycin, nalidixic acid, streptomycin, trimethoprim-sulpha-
methoxazole), Category III: Medium Importance (chlorampheni-
col, sulfi soxazole, tetracycline), and Category IV: Low Importance 
(no antimicrobials tested). 
Results
CIPARS 2008 surveillance of swine resulted in 318 E.coli isolates 
from Retail, 150 from Abattoir and 1425 from Farm. In addi-
tion there were 151 Salmonella isolates from Abattoir and 61 
from Farm. The prevalence of Salmonella from retail pork in the 
CIPARS program was 2%, which did not result in suffi  cient iso-
lates for meaningful AMR evaluation. The top three Salmonella 
serovars from Abattoir were Derby (33 isolates, 21.9%), Typh-
iumurium var 5. (31 isolates, 20.5%), Typhimurium (17 isolates, 
11.3%). The top three Salmonella serovars from Farm were 
Typhimurium var 5. (17 isolates, 27.9%), Brandenburg (9 isolates, 
14.8%), and Derby (7 isolates, 11.5%). Resistance to ceftriaxone 
and ciprofl oxacin was only found in E.coli isolates from retail 
pork (prevalence = 0.3%). There was no resistance to amikacin in 
any E.coli or Salmonella isolates. There was no resistance to nalid-
ixic acid in Salmonella isolates from Farm or Abattoir and less 
than 2% resistance to this antimicrobial in E.coli isolates from 
Farm, Abattoir, and Retail. Less than 5% of E.coli and Salmonella 
isolates from all sectors were resistant to amoxicillin-clavulanic 
acid, ceftiofur, cefoxitin, and gentamicin. There was a substantial 
percentage of E.coli and Salmonella isolates that were resistant 
to kanamycin (range: 3.1-21.3%), ampicillin (range: 17.3-34%), 
and streptomycin (15.1-44.4%). The most common resistance in 
E.coli and Salmonella from all sectors was to tetracycline (range: 
37.4-84.7%). 
Discussion
The presence of resistance to all Category I antimicrobials in re-
tail pork is of signifi cance due to the proximity of these samples 
to the consumer and the importance of these drugs in human 
medicine. Current levels of resistance in these antimicrobials 
are very low, which is consistent with previous CIPARS results 
but continued monitoring is essential (1). The low prevalence of 
Salmonella in retail pork is important from a food safety perspec-
tive.
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Introduction
Antimicrobial resistance (AMR) reduces our ability to eff ectively 
treat bacterial infections in animals and humans and is an issue 
of increasing public concern. AMR has been associated with the 
misuse of antibiotics in the human population but there is also 
concern with antimicrobial use (AMU) in agri-food production. 
The Public Health Agency of Canada and its federal and prov-
incial partners developed the Canadian Integrated Program for 
Antimicrobial Resistance Surveillance (CIPARS) to monitor AMR 
and AMU in humans and the agri-food sector in Canada (1). The 
CIPARS Farm component was implemented in 2006 to provide 
information on AMR and AMU in swine at the farm level. It also 
has provided information on the role of AMR on arrival at the 
grower-fi nisher (GF) unit on AMR at Close-to-Market (CTM).
The objective of this study was to investigate the associations 
between AMR in fecal E. coli from groups of swine entering the 
GF unit and the same group of pigs at CTM. 
Materials and Methods
Samples and data for this work were collected in 2007 through 
the CIPARS Farm Program. There were 108 herds enrolled in 
the 5 major pork producing provinces of Canada; AB, SK, MB, 
ON and QC. In each province, the number of CIPARS herds 
is proportional to the national total of GF units. To provide 
producer anonymity, herd veterinarians selected the producers 
and participated in the sample and data collection. Twenty-nine 
swine veterinarians from private and corporate practice have 
enrolled producers that are CQA® validated, produce more than 
2000 market hogs/year, and are representative of herds in the 
veterinarian’s swine practice. Herds that were regarded to be 
organic, feeding edible residual material or pasture-raised were 
excluded. These criteria helped ensure that the program was 
representative of the majority of hog production in Canada. In 
a subset of 66 herds, pooled fecal samples were collected from 
two pens of pigs at arrival in the fi nisher unit and from the same 
two pens at CTM (>175 lbs). In the remaining herds, samples 
were collected at CTM only and those results are not included 
in this analysis. All fecal samples were cultured for generic E. coli 
using standard CIPARS methodology (1). Susceptibility test-
ing was performed on 3 E. coli per sample. Minimum inhibitory 
concentrations (MIC) for 15 antimicrobials were established 
for all isolates using the Sensititre® Microbiology System (Trek 
Diagnostic Systems, Cleveland, OH, USA). AMU data (feed, water 
and injectables), management and production information was 
collected using questionnaires. The relationship between AMR 
at Arrival and at CTM was investigated using multilevel logistic 
regression models with random intercepts for pen and herd. The 
outcome of interest was resistance to a specifi c antimicrobial 
in fecal E. coli from pens of CTM pigs, while the main potential 
risk factor of interest was resistance to the same antimicrobial 
among fecal E. coli from pens of pigs at arrival.Other potential 
risk factors that were investigated included season of sampling, 
barn capacity, number of pigs per pen, number of pigs at risk, 
biosecurity variables, barn fl ow (all-in-all-out or continuous) and 
the use of antimicrobials (feed, water, injection), the use of the 
same antimicrobial, the antimicrobial class and the number of 
antimicrobial classes used. 
Results
There were 28 herds that provided matching Arrival and CTM 
samples in 2007, resulting in 164 Arrival and 168 CTM E.coli 
isolates. Twenty-one herds provided AMU data. No Arrival 
samples and only three CTM samples were susceptible to all 
antimicrobials tested. At the herd level, all herds were resistant 
to at least one antimicrobial at Arrival and at CTM. Resistance 
to ceftiofur(TIO), amikacin (AMK), cefoxitin (FOX), and genta-
micin (GEN) was found in Arrival samples but not CTM samples. 
No resistance was found to ceftriaxone (CRO) and ciprofl ox-
acin (CIP). Of 9 models that were examined only 3 models 
(kanamycin(KAN), trimethoprim-sulphamethoxazole(SXT), 
streptomycin(STR)) still included a variable representing AMR at 
Arrival either as a signifi cant variable (P < 0.05) or a confounder 
(> 20% change in the coeffi  cient). The fi nal model for KAN CTM 
isolate resistance included the number of antimicrobial classes 
used on farm and arrival pen resistance to KAN. Having two or 
more SXT resistant isolates in the arrival pen was the only signifi -
cant variable for SXT resistance at CTM. Arrival pen resistance to 
STR was a confounder for the relationship between the use of 
antimicrobials in water and STR resistance at CTM. 
Discussion
Based on these results, AMR data from pigs arriving in the GF 
unit provides limited information regarding AMR at CTM for 
specifi c antimicrobials. Resistance at Arrival is generally more 
prevalent than at CTM. The absence of resistance to CIP and CRO 
in CTM samples is of signifi cance due to the proximity of these 
animals to the food chain and the importance of these drugs in 
human medicine.
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Introduction.
Salmonella is an important cause of illness among swine and 
can cause foodborne illness in people1. There is growing global 
concern for the amount of resistance to antimicrobial drugs 
among Salmonella isolates. Many groups have called for more 
surveillance of antimicrobial resistance and the identifi cation 
of factors that play a role in the emergence or amplifi cation of 
resistance in populations including people, pets and animals 
used for food. Previous studies have been primarily confi ned to 
using established antimicrobial concentration cutoff s to declare 
isolates susceptible or resistant. 
The objective of this study was to use survival analysis to identify 
factors associated with changes in concentrations of antimicrob-
ials that inhibit Salmonella isolates with various MIC to better 
understand the ecology of antimicrobial drug resistance among 
salmonellae on swine farms.
Materials and Methods
Questionnaire data and fecal samples were collected as part of 
the National Animal Health Monitoring System’s (NAHMS) Swine 
2006 study. Fecal samples were collected from the pen fl oor 
for grower/fi nisher pigs. Up to 60 fecal samples per farm from 
a maximum of 10 pen fl oors containing late fi nishers (20 to 32 
weeks of age) were collected and tested for Salmonella as previ-
ously described2. 
Salmonella spp. antimicrobial susceptibility testing was con-
ducted using a semi-automated system (SensititreTM, TREKTM 
Diagnostics, Inc., Cleveland, Ohio) as previously described2. S. 
Derby, the most common serotype isolated (29.6% of isolates), 
was selected for this analysis. Two antimicrobials (Amoxicillin/
Clavulanic Acid and Ampicillin) were chosen from among a 
panel of 15 antimicrobials tested to demonstrate the technique. 
Survival analysis was done using Cox proportional hazards mod-
eling using previously described methods3. 
Results
Of the 173 S. Derby isolates that were tested in increasing two 
fold concentrations (from 1 to 32 μg/ml) most (134 for Amoxicil-
lin/Clavulanic Acid and 129 for Ampicillin) were either inhibited 
at the fi rst concentration or not at all even at the highest con-
centration (32 μg/ml). Because of this highly skewed distribution 
of the MIC values for these isolates, we dichotomized the MIC 
values. Concentration until event (inhibition) for each antibiotic 
was tested for change with farm level factors: herd size, total 
confi nement of grower/ fi nisher pigs and usage of compliment-
ary antimicrobials in the nursery or grow/fi nish phase in feed or 
water in the study. Farm of origin of the isolates were treated as 
random eff ects
For the S. Derby and Amoxicillin/Clavulanic Acid model, the haz-
ard or rate of inhibition was reduced nearly 100% when grower/
fi nisher pigs were housed in total confi nement or Amoxicillin 
was used during the nursery or grower/fi nisher phase. As herd 
size increased by 500 pigs the hazard of inhibiting S. Derby with 
Amoxicillin/Clavulanic Acid increased by 31%. The proportion 
of variance at the farm level (intra-class correlation coeffi  cient) 
or correlation of results within herds was 0.74. The results with 
these variables were similar but less dramatic for the S. Derby 
and Ampicillin model. 
Discussion
Survival analysis methods show some promise for analysis of 
MIC data. Management confi nement methods and the use of 
select antimicrobials in feed or water in the nursery or grow 
fi nisher phase increased survivability of S. Derby to these two 
antibiotics. Additional research is planned to continue analyzing 
antimicrobial use and inhibition data using these techniques. 
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An experimental Helicobacter suis infection reduces daily weight gain in pigs
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Introduction
Helicobacter suis (H. suis) is a Gram negative, long, spiral-shaped 
bacterium colonizing the stomach of more than 60% of pigs at 
slaughter age3. The prevalence is very low in sucklings, increases 
from the time of weaning and is highest in adult animals. This 
bacterium is considered to be one of the risk factors associated 
with gastric ulcers in pigs2. Recently, H. suis has been success-
fully cultured in vitro1. The purpose of this study was to evaluate 
the eff ect of an H. suis infection on the daily weight gain in pigs.
Materials and Methods
In 5 diff erent experimental set-ups, a total of 44 medicated 
early weaned piglets were intragastrically (n=39) or orally (n=5) 
inoculated once (n=30) or thrice (n=14) with a fresh (n=24) 
or frozen and thawed (n=20) culture of H. suis strain 5 at the 
age of 3 (n=5), 6 (n=14), 7 (n=10), 8 (n=5) and 9 (n=10) weeks. 
All animals were euthanized 4 (n=39) or 6 (n=5) weeks post-
inoculation. All experimental set-ups included medicated early 
weaned animals as negative control groups (N=29) that were 
sham inoculated with sterile culture medium. The animals were 
fed a fi nely ground feed (n=34), coarsely ground feed (n=5) or 
milk replacement (n=5). All animals were housed under identical 
environmental conditions. Each animal was weighed at the time 
of inoculation and at euthanasia. Daily weight gain was calcu-
lated over the period after inoculation. In the combined results 
of the 5 experiments, the eff ect of inoculation with H. suis on the 
daily weight gain of inoculated animals was compared to the 
non-inoculated animals using a multivariable linear regression 
model including all variables that varied between the experi-
ments as co-variables to correct for their eff ect (SPSS 17).
Results
After correcting for the eff ect of experimental set-up, type of 
feed, age at the time of inoculation, weight at the time of inocu-
lation, number of inoculations, and the period after inoculation, 
there was a signifi cant reduction of approximately 20 g/day 
(5%) in the daily weight gain of experimentally infected animals 
compared to the non-infected control animals. 
Discussion
Results of the present study indicate that an H. suis infection 
reduces daily weight gain in pigs and thus may result in substan-
tial economic losses. Clearance of infection with this bacterium 
may therefore have an economically benefi cial eff ect. 
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Occurrence of MRSA in conventional and organic pig herds as well as in wild boars in Germany
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Introduction
The occurrence of MRSA (Methicillin-resistant S. aureus) as nasal 
colonizer of pigs in conventional herds has been reported in sev-
eral countries with quite often a very high intra-herd prevalence 
(1, 2, 3). Little is known about the frequency of MRSA in organic 
pig herds. Furthermore, there is only one report on a lower fre-
quency of MRSA as nasal colonizer in “organic pig farmers” com-
pared to “conventional pig farmers” (4). There are no publications 
on the occurrence of MRSA in wild boars. The objective of our 
study was to increase the knowledge on the occurrence of MRSA 
in diff erent pig husbandry systems (organic and conventional) 
as well as in wild boars.
Materials and Methods
Our investigations on the occurrence of MRSA in diff erent pig 
populations with diff erent husbandry systems were carried out 
as follows:
• Occurrence of MRSA in collective dust samples (one pool of 
dust from diff erent sample sites) from 85 conventional and 27 
organic pig herds
• Occurrence of MRSA as nasal colonizer of pigs in 26 conven-
tional and 20 organic pig herds by testing herd-size adjusted 
random samples to detect at least a 5% intra-herd prevalence 
of MRSA by testing 10 to 60 pigs per herd (in total 1760 nasal 
swabs), as well as of 120 hunted wild boars. All samples were 
collected, selectively enriched and cultured according to the 
EU- guidelines (SANCO/3100/2007 – Rev.2).
Results
The occurrence of MRSA in dust samples from conventional and 
organic pig herds are shown in Table 1.
Tab. 1: Occurrence of MRSA in collective dust samples
Husbandry system No. of tested herds No. of MRSA-positive herds
conventional 85 67 (79%)
organic 27 4 (15%)
The frequency of MRSA-positive herds, identifi ed by nasal swabs 
is demonstrated in Table 2. A herd was defi ned as MRSA-positive, 
if one nasal swab turned out to be MRSA-positive.
Tab. 2: Occurrence of MRSA in nasal swabs from conventional and 
organic pig herds, and from wild boars
Pig population No. No. of MRSA-positive
conventional 26 herds 24 (92%)
organic 20 herds 3 (15%)
wild boar 120 animals 0 (0%)
Nine of the 120 tested wild boars (8%) were carrier of Methicillin-
sensitive S. aureus (MSSA) in their nasal cavity.
Discussion
In our still ongoing studies, the MRSA results (nasal swabs and 
dust samples) in conventional husbandry systems point to a 
measurably higher MRSA frequency than the MRSA results in or-
ganic husbandry systems. This preliminary assumption needs to 
be verifi ed by further comparative studies. Possible reasons for 
the expected higher MRSA detection rate in conventional than 
in organic pig herds could be the circulation of MRSA between 
conventional herds (animal movements from conventional to 
organic herds are very seldom), the higher animal density in 
conventional herds (i.e. better transmission conditions), and the 
diff erences in the use of antibiotics in the two diff erent husband-
ry systems. The fact that no MRSA, but MSSA were found in wild 
boars shows that there is no natural non-susceptibility of the 
wild boar for S. aureus. The diff erences in the MRSA frequency 
found in our studies do not jutify a direct link between the oc-
currence of MRSA and the actual use of antibiotics at a specifi c 
farm, since the spread of MRSA between conventional herds and 
the lack of this spread to organic pigs and to wild boar alone 
can suffi  ciently explain the diff erences as well. More detailed 
research into the risk factors of MRSA is presently carried out.
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MRSA in herds of fattening pigs in Germany: Typing results and 
factors associated with the detection in herds
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) has been 
demonstrated to be endemic in pig herds in Europe, Canada and 
the USA, posing a risk for colonization and infection to people in 
contact with these animals.
Materials and Methods
To assess the situation in herds of fattening pigs in Germany, 
dust samples (n=5) of 290 farms from diff erent regions in Ger-
many were collected in 2008. A questionnaire provided informa-
tion regarding herd characteristics and management practices. 
Dust samples were pooled per farm and cultured using select-
ive enrichment and chromogenic media. Presumptive MRSA-
isolates were confi rmed by triplex-PCR for the detection of 16S 
rRNA, nuc and mecA genes. Confi rmed isolates (1/herd) were 
tested for antimicrobial resistance, spa- and SCCmec typed. 
Selected isolates were also MLST-typed. 
Results
MRSA were identifi ed in 152 herds (52.4%). Univariate analysis 
revealed an association of a number of factors with the detec-
tion of MRSA on a farm. 
Larger herds were more likely to be positive for MRSA. Herds 
that had used antimicrobials on a group level, were also more 
likely to be positive. Tetracyclines (28.3 % of herds), amoxicillin 
(19.7 %) and tylosin (17.6 %) were most frequently used. The oc-
currence of diseases in the herd was not related to the detection 
of MRSA.
Buying pigs from several diff erent farms or from weaner to grow-
er operations was associated with MRSA in the herd. Type of pig 
farm was closely related to this factor. Farrow to fi nish units were 
less likely to buy pigs from several sources than weaner to fi nish 
or grower to fi nish operations.
Fully slatted fl oors and an all in / all out pig fl ow were associ-
ated with the isolation of MRSA from dust. Multivariate analysis 
revealed multicollinearity between variables. For example larger 
herds used antimicrobials more often and bought pigs from 
more sources. In the fi nal model, only farm size and farm type 
remained as signifi cant risk factors. However, it can be assumed, 
that other related factors contributed to the eff ect of these two 
factors.
Twelve diff erent spa-types were identifi ed in the tested isolates. 
All isolates were belonged to spa-types related to the multi-
locus sequence type ST398, with t011 (66.4%) and t034 (23.0 %) 
as the predominant spa-types. There were substantial regional 
diff erences in the spa-type patterns. In one region, more than 
90 % of the isolates were spa-type t011 while in others, t011 and 
t034 were of similar frequency. 
Most isolates (85 %) carried SCCmec-type V, 11 % belonged to 
SCCmec-type III that has been shown to carry features of type V 
and type III. 
Discussion 
The results are in line with studies in slaughter pigs that were 
carried out in the North-West of Germany and with the results of 
the EU-baseline survey on MRSA in breeding herds (EFSA 2009, 
Tenhagen et al. 2009)
The latter has shown that MRSA is also prevalent in herds with 
breeding pigs in most European countries with an intensive pig 
production. From breeding herds, MRSA can easily be transmit-
ted to fattening units via colonized weaners or growers. With a 
given proportion of positive herds in the population any further 
herd that pigs are bought from increases the risk, that one of the 
herds is positive for MRSA. Biosecurity protocols of pig farms so 
far did not include S. aureus as it was not regarded as a major 
pathogen for pigs. In fact, MRSA is only associated with clinical 
disease in pigs in exceptional cases and this study showed no 
relation between the disease status of herds and the prevalence 
of MRSA. 
The risk factor having the strongest association with a positive 
test result was herd size. This might be due to buying more pigs 
in larger herds increases the risk of introduction of MRSA into 
the herd via colonized pigs. 
Antimicrobial use was not a signifi cant risk factor in the multi-
variate model. Apparently the introduction of the resistant clone 
is most likely to occur via colonized animals. Antimicrobials 
may add to the within herd spread, but this was not measured 
using the dust sample. In a Dutch study on veal calves that 
considered risk factors on animal level, antimicrobial use in the 
group proved to be a signifi cant risk factor (Wagenaar and van 
de Giessen 2009).
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Prevalence study and risk factor analysis on MRSA in sow-herds
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Introduction
In 2005 a distinct clone of methicillin resistant Staphylococcus 
aureus (MRSA ST398) was found in pigs and people in contact 
with pigs (1). Several studies report prevalences of MRSA-posi-
tive farms and identifi ed risk factors for people working with 
pigs (2,3). Little is known on risk factors associated with MRSA on 
pig farms. The objective of this study was to estimate a reliable 
prevalence for MRSA-positive farms and to identify and quantify 
risk factors. 
Materials and Methods
During 2007 and 2008 a study on 202 pig farms, 171 farms with 
sows and 31 farms without sows, was performed. On these 
farms a nasal swab was taken from 60, randomly selected, pigs. 
Additionally, 5 environmental samples were taken. On the fi rst 
50 farms, the people working and/or living on the farms and 
the sample takers were sampled (nasal swab) as well. These 
results were published by Van der Broek et al (2). Information 
was gathered on farm characteristics (e.g. management, hygiene 
and antimicrobial use). Microbiological analysis was done on 
individual environmental samples and pooled pig samples (6 
swabs per pool; per pool one age-category). A farm was classi-
fi ed positive if at least one of the samples was MRSA-positive. 
Statistical analysis to identify risk factors was done on data from 
171 sow-farms.
Results
The overall prevalence of MRSA-positive farms was 68.3%; for 
farms without sows the prevalence was 71.0% and for sow-farms 
the prevalence was 67.8%. On positive sow-farms, on average 
63.3% of the pools and 33.8% of the environmental samples 
was MRSA-positive. In total, 18 diff erent spa-types were identi-
fi ed, t011 and t108 being the most frequent ones, resp. 52.5% 
and 34.1%. Ninety-eight percent of the MRSA-isolates belonged 
to ST398. All ST398-isolates were sensitive to mupirocin and 
linezolid and resistant to tetracycline. Resistance to other 
antimicrobials varied between and within spa-types. In the fi nal 
statistical model, 2 risk factors were associated with MRSA: herd 
size (number of sows) and time (months). Prevalence of MRSA-
positive farms increased in time: from approximately 30% at the 
beginning of 2007 to approximately 75% at the end of 2008. 
Prevalence of MRSA-positive farms increased when the number 
of sows on a farm increased: approximately 40% of small herds 
(< 250 sows) was MRSA-positive versus > 80% of large herds (> 
500 sows). Other risk factors, e.g. presence of fi nishing pigs, pur-
chase of gilts, rodent control and hygiene, dropped out of the 
statistical model but were associated with herd size. Antimicrob-
ial use and MRSA on a farm were not signifi cantly associated, 
though antimicrobial use was associated with herd size. Farms 
that apply antimicrobials as group medication have signifi cantly 
more sows (486 sows) than farms that use antimicrobials just in 
case of disease (415 sows). Farms that use no antimicrobials at all 
were the smallest farms (355 sows).
Discussion 
MRSA is present on a large number of Dutch sow-farms and the 
prevalence increases in time. Most likely MRSA was spreading 
among Dutch pig herds during the study period. A plausible 
transmission route seems to be the trade of animals, however 
farms without supply of pigs were found to be MRSA-positive as 
well (4,5). Large herds have a higher risk, which can be explained 
by herd size itself and by the factors that are associated with 
herd size, e.g. antimicrobial use, the purchase of gilts and rodent 
control. The same positive association between herd size and 
disease has been reported for other swine diseases, e.g. infl u-
enza and pseudorabies (6-8). Herd size is therefore a compilation 
of several risk factors, which makes that larger farms are more 
often MRSA-positive. 
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Prevalence of MRSA among Danish participants at a conference for Danish pig producers
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Introduction
In 2008, the presence of MRSA CC398 was confi rmed in several 
Danish pig herds. All participants at the yearly conference for 
Danish pig producers, were off ered a test for MRSA, to gain an 
estimate of the nasal carrier status of MRSA among persons 
working in the Danish Pig Production. A total of 1945 persons 
working within various fi elds of pig production (pig producers, 
veterinarians, consultants etc.) participated in the conference.
Materials and Methods
Participation was on a strictly voluntary basis. Nasal sampling 
was performed by swabbing both nostrils. Prior to sampling a 
standardized questionnaire on profession (farmer, veterinarian, 
consultant or other), weekly hours of contact with pigs, working 
within sow units, fi nisher units or both, visits to pig units abroad 
and previous hospitalisation of the participant was completed. 
All swabs were screened for MRSA using incubation in enrich-
ment broth followed by plating on chromogenic agar. MRSA 
was confi rmed by PCR, typed by sequencing the staphylococcal 
protein A (spa) gene and susceptibility tested.
Results
Questionnaires and samples were obtained from 791 persons, 
of whom 22 were excluded (13 were foreign visitors and 9 did 
not complete the questionnaire). The remaining 769 persons 
comprised 487 farmers, 109 agricultural consultants, 25 veterin-
ary practitioners and 150 persons working in other fi elds. The 
distribution of MRSA-positive persons on professions is shown 
in Table 1. Of the 19 CC398 isolates, 3 belonged to spatype t011, 
the remaining 16 to spatype t034. Two persons, both farmers, 
carried other MRSA-types (t032 and t044). All MRSA CC398 
positive persons had weekly contact with pigs. However, the 
duration of contact with pigs was not statistically associated 
with the MRSA CC398 carrier status. Persons working only in fi n-
isher units had a signifi cantly lower risk of carrying MRSA CC398 
compared with persons working in sow units.
Table 1. Nasal carriers of MRSA among participants at the conference
n tested MRSA CC398 MRSA CC22 or CC80
Farmer 487 15 (3.1%) 2 (0.4%)
Consultant 109 2 (1.8%) 0 (0%)
Veterinarian 25 0 (0%) 0 (0%)
Other fi elds 150 2 (1.4%) 0 (0%)
Total 769 19 (2.5%) 2 (0.3%)
 
Discussion and Conclusion
The results implied that MRSA CC398 carriage is more frequent 
among persons working within the Danish pig industry than in 
the population in general. However, the CC398-prevalence of 
3.1 % among Danish pig farmers was much lower than those 
reported from e.g. Holland and Canada (app. 20%) 1, 2. Also, a 
newly published report 3 establishes that Danish herds have a 
low prevalence of MRSA compared to other comparable Euro-
pean countries. Working in sow units increased the risk of being 
an MRSA CC398 carrier. These fi ndings support previous reports 
4, indicating that intensive and regular exposure to pigs increas-
es the risk of humans getting colonized with CC398. 
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Introduction
Recently, Methicillin-resistant Staphylococcus aureus (MRSA) 
have emerged in pigs in most European countries (1,3). Pre-
dominantly, porcine MRSA colonization and infection is caused 
by an MRSA clone characterized by clonal complex (CC) 398 
as determined by multi-locus sequence typing (MLST) and 
Staphylococcus aureus protein A (spa) types t011, t034, t108 
and relatives. This MRSA clone was hitherto rarely observed 
among patients in German hospitals (5). Since numerous studies 
indicated a frequent exchange of MRSA between animals and 
humans, we investigated the prevalence of MRSA CC398 in pig 
holdings in the area characterized by the highest pig density in 
North Rhine-Westphalia (NRW), Germany, and patients admitted 
to acute care hospitals in this region.
Methods
Within the framework of the Euregio project SafeGuard VetMed-
net, fi ve dust samples were collected in a total of 86 pig hold-
ings in the Euregio (NRW part) in 2009 using a sterile wipe and 
sampling a standardized area of 50cm x 50cm. MRSA diagnostic 
was performed using a double enrichment in selective broth 
(Phenol Red Mannitol Broth with 5 mg/L ceftizoxime, 75 mg/L 
aztreonam) and plating on a chromogenic medium (Brilliance 
MRSA, Oxoid, Wesel, Germany). MRSA was confi rmed using 
coagulase tube test and mecA-PCR All MRSA isolates were typed 
using the Staphylococcus aureus protein A (spa) approach (4).
Human samples were derived from inpatients attending the 
acute care hospitals in the Euregio participating in a network 
for the prevention and control of MRSA (EUREGIO MRSA-net). In 
2009, every fi rst MRSA isolate per patient from nasopharyngeal 
and cutaneous screening specimens and from blood cultures 
was spa typed and entered into a common MRSA database 
(www.mrsa-net.eu). Clustering of spa types in spa clonal com-
plexes (spa-CCs) was performed using the Based Upon Repeat 
Pattern (BURP) algorithm of the Ridom StaphType software.
Results
We identifi ed MRSA in dust samples from 51 pig holdings (59%). 
Among 103 MRSA isolates we found seven diff erent spa types 
including t011 (69%), t034 (20%), t2510 (5%), t1456 (3%), and 
t108, t588, t1606 (each 1%).
A total of 1,695 human isolates from screening specimens as 
well as n=38 blood culture isolates were obtained in the MRSA-
net hospitals in 2009. Among the isolates from screenings 305 
(18%) were associated with spa-CC398 (spa types: t011, t034, 
t108, t1197, t1451, t1580, t1793, t2011, t2330, t2346, t2582, 
t2741, t3934, t567, t571). Among n=38 blood culture isolates 
only one (2.6%) was associated with spa-CC398 (t011).
Discussion
The prevalence of MRSA CC398 in environmental samples from 
pig holdings in the Euregio VetMed-net is higher than the overall 
prevalence for Germany observed in a recent report published 
by the European Food Safety Authority (1). As in other countries 
it was shown that the spa types t011 and t034 are predominant 
(3). This confi rms the results of previous investigations (2).
MRSA CC398 are frequently introduced in to German hospitals 
located in an area with a high density of pig-production by 
inpatients colonized at admission. Despite the high burden of 
colonization, invasive human infections due to MRSA CC398 are 
rare until now.
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Introduction
Although Staphylococcus aureus belongs to the common skin 
fl ora of animals and humans this opportunistic pathogen can 
cause various skin and organ infections [1]. In particular methi-
cillin resistant S. aureus strains (MRSA) gain more attention in 
recent years. In pig production units in Europe and Canada the 
special sequence type (ST) 398 was detected [2, 3] which can 
colonize animals and humans and is transmissible between 
them. To investigate the spread and transmission of MRSA fast 
and reliable methods are required by which these bacteria 
can be detected and monitored on pigs and in their housing 
environment. This paper reports about fi rst results from investi-
gations in piggeries comparing the effi  ciency of swab sampling 
at fi ve locations on the pigs and of seven sampling methods to 
detect MRSA in the housing environment.
Materials and Methods
31 farms (15 fattening farms and 16 breeding farms) were 
presently sampled. Nasal swabs were taken from 60 randomly 
selected animals of all farms and examined as pooled samples 
(fi ve swabs per pool). Skin swabs were taken from the neck 
region of 60 animals from 13 farms and were also analyzed as 
pool samples (fi ve swabs per pool). Vaginal swabs were collected 
three to fi ve times from four selected sows of 11 farms during 
the investigation period from September to December 2009. In 
three of these farms also the perianal region and the teats of the 
same sows were sampled with swabs.
From 26 piggeries pooled dust samples were taken from fi ve 
diff erent locations (sampling area approx. 500 cm2, at least 15 ml 
dust per pool). Sedimentation dust was sampled in the center of 
four animal houses in two meters height on sterile surfaces with 
a defi ned area of 0.4 m2 (sampling time about 28 days). In 25 
barns boot swabs were taken by walking with one pair of boots 
twice along the middle corridor. Pooled fecal samples and feed 
samples from feeders were taken from 13 farms and swabs from 
drinking nipples were sampled in 5 holdings. In 11 pig houses 
airborne bacteria were sampled by impingement (AGI-30) and a 
fi ltration method.
MRSA were grown after selective enrichment and direct plating 
on CHROMagar. Coagulase positive Staphylococci were identi-
fi ed with biochemical tests and the isolates were confi rmed as 
MRSA by a triplex PCR method.
Results
MRSA was found in 27 (87%) out of 31 investigated farms in at 
least one sample. The detection effi  ciencies of samplings from 
pigs and of samples from the housing environment in relation 
to positive tested farms were: Nasal swabs = 100%; Skin swabs = 
100%; Vaginal swabs = 73%; Perianal swabs = 67%; Teat swabs = 
67%; Pooled dust = 78%; Sedimentation dust = 33%; Boot swabs 
= 91%; Pooled fecal = 60%; Drinking nipples = 0%; Feed = 56%; 
Air = 100%.
Discussion
MRSA was found in 87% of the investigated piggeries. The ef-
fi ciency of the sampling locations on the animals and the meth-
ods used for environmental sampling varied considerably. Nasal 
swabs and swabs of the neck seem to be more effi  cient to detect 
MRSA on a pig than samples from vagina and teats. 100% of 
the air samples were MRSA positive followed by boot sampling, 
pooled dust, feces and feed. Less successful was the detection 
in sedimentation dust which may has to do with the sampling 
period and the survival of Staphylococci in dust. No MRSA were 
found at drinking nipples.
The high air contamination and the contamination of surfaces 
in the direct environment of the pigs may contribute to the high 
positive results from nasal and skin swabs. Positive feed samples 
may also be a consequence of environmental contaminations. 
The results of this current study indicate that the most promis-
ing sampling locations to detect MRSA on pigs are the nose 
and the skin on the neck. For environmental sampling air, boot 
swabs and dust can be recommended.
The current investigations continuous and more detailed results 
will be presented on IPVS in 2010. 
This study funded by the German Federal Ministry of Food, Agri-
culture and Consumer Protection.
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The over-muscled sow syndrome: a new emerging syndrome in a hyperproliﬁ c 
sow herds: Preliminary observations on farrowing duration  
Thierry Solignac1 Alassane Keita2 Eric Pagot2 G-P Martineau3
1. Coopagri Bretagne, Landerneau, France; 2. CTPA Zoopole, Ploufragan, France; 3. Ecole Vétérinaire, Toulouse, France
Introduction
Many factors can aff ect duration of farrowing such as breed, lit-
ter size, parity, body condition and housing (Farmer and Robert, 
2002, Oliveiro et al., 2008). Fat sows are classically reported 
having long farrowing but the correlation was not very high 
(Oliveiro, 2009).
We reported the emergence of a new building syndrome that 
we call “Over-muscled sow syndrome” (Solignac and Martineau, 
2010a). It emerges as a consequence of the selection for depos-
ition of lean meat and hyperprolifi cay (Tribout et al., 2003, Bazin 
et al., 2003). 
Materials and Methods
Duration of farrowing has been registered from 482 sows of 14 
commercial herds in Brittany (France) with diff erent hyperpro-
lifi c genetic. For each sow, we measured body fat (BF) and body 
muscle (BL) (Noveko AC037L, 3.5 MHtz) on site P2 at farrowing. 
Each sow was then classifi ed according to the BF and BL median 
values of data: BL+ when the value was above the median value 
and BL- when it was below. The same procedure was applied for 
BF (Table 1). Data were analysed using a 3 factorial (BF, BL and 
genetic line, coded A, B and C) ANOVA test with p<0.05 as level 
of signifi cance.
Table 1: Morphotype characteristics of sows (n=482) 
at farrowing
Morphotype Nb sows % Genetic(A/B/C) Mean Parity
Mean 
BF(mm)
Mean 
BL(mm)
BF+/BL+ 154 40/32/28 3.2 24.5 57.7
BF+/BL- 85 34/39/27 2.9 23.5 49.1
BF-/BF+ 104 27/36/37 2.9 17.1 57.1
BF-/BL- 139 44/34/22 2.5 15.9 47.6
Results
Major results are reported in Figure 1. There is a statistically 
signifi cant eff ect of BL on duration of farrowing (p=0.04). BL+ 
sows showed a farrowing duration of 3.9 versus 3.6 for BL- ones. 
The eff ect of BF (p=0.599) and that of genetic (p=0.790) are not 
signifi cant. 
Figure 1: Morphotype and duration of farrowing
On the fi gure 2, is shown the distribution of Back lean (BL) ac-
cording to Back fat (BF).
Figure 2: Correlation between BF (x) and BL (y)
The correlation coeffi  cient is 0.328 and the coeffi  cient of 
determination is 0.108, which means that only 10.8% of BL are 
explained by BF and vice versa.
Discussion and conclusion
In 2005, Foxcroft et al., wrote: “Accepting the risk of being con-
sidered some what heretical, most of our recent experiments 
with the lactating and weaned sow lead to the conclusion “that 
from a fertility and prolifi cacy perspective, fatness is simply not 
the key risk factor”. 
We would like to add that over-muscled sows are candidates 
to long farrowing. Management of lean deposition is of crucial 
importance. There is a need to modify our paradigmatic view of 
sow nutrition according only to their needs. Indeed, we have to 
take into account the fact that selection for high capacity of lean 
deposition has negative consequences on many parameters 
(Solignac and Martineau., 2010a,b). 
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Chronopart in catheterized commercial sows in conventional herds: Physiological, 
biochemical and hormonal follow-up in “easy” farrowing and “diﬃ  cult” farrowing sows
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Introduction
Observational study on enzootic neonatal diarrhea (END) in 
Britanny lead to a link between END and the processus of 
parturition (Sialelli et al., 2009, Bories et al., 2010). Pre-partum 
investigations are mainly limited on experimental sows (Oliviero 
et al., 2007). 
Intensive physiological investigation have been registered in 4 
commercial hyperprolifi c herds (>14 TB) selected according to 
history of farrowing diffi  culties, high stillbirth (>1.2/litter), and 
good records. 
Material and methods
Sows (19 P1 and 9 P2) were catheterized at day 109 (Figure 1) 
and intensively followed before and during farrowing. Accord-
ing to speed of farrowing, sows were classifi ed in three groups: 
<3hrs (SF for short farrowing), between 3 and 4 hrs (IF for inter-
mediate farrowing) and > 4hrs (LF for Long farrowing). Stillborn 
and manual assistance were also taken into account. 
Finally, sows classifi ed with an “easy” farrowing are sows having 
a SF or IF without manual assistance and only stillbirth piglets 
at the end of farrowing. Sows with a “diffi  cult” farrowing are LF 
and IF with manual intervention and stillbirth during farrowing 
(Table 1).
Sequence of sampling is reported on Figure 1A:Sampling 
procedure in catheterized sows; vertical arrow correspond to a 
blood sample. 
Physiological, biochemical and hormonal investigations: Rectal 
temperature, hematocrit (Ht) and Hemoglogin (Hb, test Hémo-
Cue®) were performed on farm. Plasma progesterone (P4), 
Estradiol (E2), Glucose (Glu), total magnesium (Mg), total calcium 
(Ca), Non Esterifi ed Fatty Acid (NEFA), total protein (Prot), lactate 
(Lact), bicarbonate (HCO3) and creatine phospho-kinase (CK) 
have been determined using commercial kit. 
Results and discussion
The progress of parturition (prolonged fast, uterine and mus-
cular contractions, stress and hyperventilation) creates the 
conditions to a mobilization of the reserves and to a metabolic 
acidosis (fast increase of NEFA, lactate and bicarbonate in the 
beginning of birth, followed by a high level during all partur-
ition). The signifi cant correlation between the levels of lactate 3 
hrs after the fi rst piglet and the duration of parturition (r=0,580 
p < 0,01 and r=0,326 p=0,09) suggests a high risk of weakness in 
long farrowing. 
Figure 1B: Follow-up of progesterone (left) and rectal temperature 
(right) by % of sows with t° > 39.5°C) according to “easy” and “diffi  cult” 
farrowing. Figure 1C: Calcium follow-up according to “easy” and “dif-
fi cult” farrowing
Conclusion
Pre-farrowing high blood progesterone may have consequences 
on uterus myometre and thereafter on farrowing. Other analysis 
are in progress (ocytocin, albumin, …) and will be reported. 
Understanding of pathophysiology is probably the fi rst step for 
the control. 
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Birth weight implications for postnatal development of the reproductive tract in gilts
Fernanda R. Almeida; Ana Luisa N. Alvarenga; Leticia P. Moreira; George R. Foxcroft; Helio C. Garcia
Universidade Federal De Minas Gerais, Belo Horizonte, MG, Brazil
Introduction
Selection for prolifi cacy appears to have created an imbalance 
between the number of conceptuses surviving to the post-
implantation period and uterine capacity. These animals show 
characteristics of Intra-Uterine Growth Restriction (IUGR) due 
to a great competition among fetuses for nutrients and oxy-
gen, resulting in lighter fetuses at term. The eff ects of IUGR on 
development of the reproductive tract in gilts have not been 
demonstrated so far. The present study evaluated those eff ects 
on the reproductive tract of light-weight off spring.
Material and Methods
New-born female pigs (n = 28; DanBred X PIC terminal line), 
born to 4th- 6th parity sows and in litters of 10 to 15 pigs, were 
identifi ed as falling into two birth weight groups: high (HW: 
range 1.8 to 2.2 kg) and low (LW: range 0.8 to 1.2 kg) . They were 
reared until the fi nishing period (~150d) and data on growth 
performance were collected. Gilts were slaughtered at 150 days 
of age and their reproductive tract was collected. The param-
eters measured were: length of the vaginal canal, uterine body 
and uterine horns. Additionally, the whole reproductive tract 
was weighed. Data were analyzed as a fully randomized design 
and the comparison between means was performed by t-test. 
Results
HW gilts had a higher postnatal growth performance compared 
to their LW counterparts (P<0.05 – Table 1). Moreover, the bio-
metric data of the reproductive tract showed that the vaginal 
canal length was lower in LW gilts (P<0.05). However, the other 
parameters measured were similar between the experimental 
groups (Table 2).
Discussion
Evidence of a better growth performance in high birth weight 
animals has been previously demonstrated (1). Additionally, 
high growth rate gilts attain puberty earlier than low growth 
rate gilts (2). In fact, gilts that attain puberty earlier are the most 
fertile in the breeding herd. Moreover, these results suggest that 
light birth weight animals have a smaller vaginal canal. It has 
been shown a positive relationship between the vaginal canal 
length and the total number of pigs born (3). Therefore, light 
birth weight gilts may have poor reproductive performance.
Table 1  Mean body weight (wt) of HW and LW gilts from birth to 150 
days
Parameter HW (n=14) LW (n=14) SEM P<
Birth wt, kg 2.0 1.0 0.03 0.01
Weaning wt, kg 8.8 6.5 0.4 0.01
Wt at 63d, kg 32.6 25.5 1.0 0.01
Wt at 110d, kg 75.6 63.6 1.7 0.01
Wt at 150d, kg 113.3 98.4 2.4 0.01
Table 2  Biometric data of the reproductive tract (RT) in HW and LW 
gilts
Parameter HW n=14 LW n=14 SEM P
RT wt, kg 0.21 0.18 0.02 0.2
Mean ovarian wt, g 4.3 3.7 0.2 0.06
Vaginal canal, cm 32.9 29.5 0.7 <0.01
Uterine body, cm 32.6 25.5 1.0 0.2
Mean uterine horns, cm 75.6 63.6 1.7 0.7
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Eﬀ ects of birth weight and prenatal maternal dexamethasone treatment on leukocyte subsets in piglets
John Harding; Crissie Auckland; Cheryl L. Waldner
University of Saskatchewan, Saskatoon, SK, Canada
Introduction
In humans, adverse events impacting fetal and infant growth are 
associated with the onset of metabolic1 and autoimmune2 dis-
eases later in life. In developing nations, maternal malnutrition 
is associated with increased risk of infection-related death3, de-
creased response to S. typhi vaccination4, and decreased thymo-
poeitin production (a thymic growth marker)5 in adolescence. 
In swine, prenatal maternal stress occurring in late gestation 
decreased the off springs’ lymphocyte proliferation response to 
T- and B-cell mitogens in early life6,7. The objective of this experi-
ment was to assess the relationship between leukocyte subsets 
and birth weight, and to determine if prenatal dexamethasone 
treatment in early- and mid-gestation aff ects leukocyte numbers 
in 2 week old pigs. 
Materials and Methods
Pregnant PIC sows were given dexamethasone at a high anti-
infl ammatory dose8 (0.2 mg/kg) IM daily for 7 days; on gestation 
days 30-36 (Dex30; n = 27) or 60-66 (Dex60; n=27). Treated and 
non-treated control (CTR; n=25) sows were induced to farrow on 
day 115. Judicious cross-fostering was encouraged to ensure the 
best perinatal conditions supporting piglet survival and growth. 
Blood was collected from 3 sibling piglets of low, average and 
high birth weights (BW) between 11 and 14 days of age. Com-
plete blood counts and fl ow cytometry for CD3+, CD21+, CD4+, 
CD8+, monocyte, granulocyte and gamma-delta leukocytes were 
performed. The absolute number of leukocytes in each subset 
was calculated (subset proportion x total WBC x109). Generalized 
linear mixed models were used to estimate the diff erence in cell 
numbers across treatment group. Estimates were adjusted for 
clustering within litter by including a random intercept for litter 
in the model (PROC MIXED). Potentially important co-factors 
including BW category and birth week were retained in the fi nal 
model if they changed the regression coeffi  cient by more than 
10% or if statistically signifi cant (P < .05). 
Results
CD8+ lymphocytes were signifi cantly lower in the Dex60 (0.50 
x109/L; P = 0.01) and trended lower in the Dex30 (0.53 x109/L; P 
= 0.07) compared to CRT (0.63 x109/L). No other dex-treatment 
group diff erences were found. Total white blood cell (WBC), 
CD3+, CD21+, CD4+, CD8+ and gamma-delta lymphocytes were 
signifi cantly lower in low versus high BW piglets (Table 1). CD3+, 
CD8+ and gamma-delta lymphocytes were signifi cantly lower in 
average versus high BW piglets. Neither dex-treatment nor birth 
weight impacted monocyte or granulocyte number.
Table 1. Mean absolute leukocyte counts (x109/L) in low, average and 
heavy birth weight piglets
Birth Weight Category
Low Avg High P value
n=76 n=76 n=76 (model)
Birth weight (kg) 1.24 1.62 1.96
Total WBC (no.) 9.5a 10.1ab 10.7b .046
CD3+ (T cells) 1.77a 2.0a 2.23b <.001
CD21+ (B cells) 0.37a 0.43ab 0.47b .01
CD4+ (T-helper) 0.80a 0.86ab 0.93b .049
CD8+ (cytotoxic) 0.49a 0.51a 0.62b .002
Gamma-delta 0.44a 0.55b 0.64c <.001
Columns with diff erent superscripts within rows diff er statistically at P < .05
 
Discussion
While changes in absolute lymphocyte numbers may not refl ect 
altered immune function, these results provide evidence that 
the immune response may be compromised in fetal growth re-
tarded piglets. Moreover, dexamethasone treatment, a proxy for 
prenatal maternal stress, may adversely aff ect the development 
or maturation of CD8+ lymphocytes. More research is warranted 
to characterize functional immunologic changes associated with 
restricted fetal development. Immunologic programming has 
substantial implications for both the swine industry and public 
health in terms of disease control, food safety and zoonosis. 
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Eﬀ ects of short-term prenatal maternal dexamethasone treatment on piglet growth from birth to day 50
John Harding; Crissie Auckland; Cheryl L. Waldner
University of Saskatchewan, Saskatoon, SK, Canada
Introduction
The performance and health of livestock species is infl uenced 
by prenatal events, such as maternal malnutrition, stress and 
placental insuffi  ciency that adversely aff ect embryonic and fetal 
development during sensitive periods. Humans at greatest risk 
of metabolic programming experience poor fetal and infant 
growth, rapid weight gain in childhood and obesity in later life1. 
These metabolic changes may be mediated directly or indirectly 
by excessive fetal glucocorticoid (GCC) exposure2. In swine, 
restricted fetal growth results in similar postnatal metabolic 
programming, aff ecting birth weight, survivability, growth rate, 
muscle development, glucose metabolism, blood pressure, and 
the stress response (as reviewed by Harding3). The objective 
of this experiment was to determine the eff ect of short-term 
prenatal dexamethasone treatment occurring in early- and mid-
gestation on birth weight and early postnatal growth. 
Materials and Methods
Pregnant PIC sows were given dexamethasone at a high anti-
infl ammatory dose4 (0.2 mg/kg) IM daily for 7 days; on gestation 
days 30-36 (Dex30; n = 27) or 60-66 (Dex60; n=27). Treated and 
non-treated control (CTR; n=25) sows were induced to farrow 
on day 115. On the day of birth (D0), and prior to any cross 
fostering, the litter size was recorded, and the body mass index 
(BMI; birth weight/crown rump length squared) determined. 
Judicious cross-fostering and split suckling was encouraged to 
ensure the best perinatal conditions supporting piglet survival 
and growth. Piglets were weaned at 19-22 days and piglets were 
sorted by size, treatment group and gender into nursery pens 
containing 10-13 pigs depending on the production week. Piglet 
weights were measured on day 0, 20, 34, and 50 and the average 
daily gain (ADG) calculated. Generalized linear mixed models 
(SAS) were used to estimate the diff erence in birth weight and 
ADG across treatment groups. Estimates were adjusted for 
clustering within litter by including a random intercept for litter 
in the model (PROC MIXED). Biologically relevant co-factors 
were tested and retained in the fi nal model if they changed the 
regression coeffi  cient by more than 10% or if statistically signifi -
cant (P < .05). 
Results
Birth weight, litter size and body mass index did not diff er be-
tween groups. The ADG was higher in the Dex60 off spring than 
CTR between D20-50 and D0-50, and was higher in Dex60 than 
Dex30 between D34-50 and D0-50 (Table 1). The ADG of the 
Dex30 and CTR off spring did not diff er statistically. 
Table 1. Birth weight (kg) and average daily gain (ADG; grams/day) in 
off spring of dams treated with dexamethasone between gestation day 
30-36 (Dex30) or 60-66 (Dex60)
Dex30 Dex60 CTR P value
n=293 n=329 n=310 (model)
Birth Weight 1.64 1.48 1.53 ns
ADG
 Day 0-20 285 269 261 ns
 Day 20-34 268 280 257 0.15
 Day 34-50 544a 575b 546ab 0.02
 Day 20-50 415ab 437b 412a 0.04
 Day 0-50 365a 372b 353a 0.02
Columns with diff erent superscripts within rows diff er statistically at P < .05
Discussion
Excess fetal GCC exposure aff ects the development of all tissues 
and organ systems, and is the most likely hormone to metabolic-
ally program in-utero. Moreover, fetal GCC exposure permanent-
ly resets several endocrine axes, including those involved in fetal 
and postnatal growth (i.e. GH-IGF-1), potentially altering the 
postnatal growth trajectory in situations when caloric intake is 
restored5. This present research provides experimental evidence 
of “catch-up growth” during the fi rst 30 days post-weaning in 
piglets exposed prenatally to a potent GCC for a short-term per-
iod. However, the eff ects of prenatal GCC exposure on post-natal 
growth appear to be gestation-stage dependent. Importantly, 
evidence of a prenatal mechanism causing an altered postnatal 
growth trajectory in pigs that is potentially independent of birth 
weight may further explain causes of biological variation in 
growth in commercial pork production. 
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Parity of the rearing dam can inﬂ uence progeny innate immune responses
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Introduction
Progeny from gilts have greater susceptibility to disease both 
pre- and post-weaning compared to sow progeny (Miller, 2006). 
This could result from diff erences in innate (non-specifi c) or 
adaptive immune responses in gilt compared to sow progeny. 
The aim of this experiment was to determine the innate immune 
responses of piglets born to or raised on gilts compared with 
sows. The null hypotheses were that innate immunity does not 
diff er between progeny: (1) born to gilts and sows or (2) in the 
pre- and post-weaning period irrespective of the parity of the 
rearing dam.
Materials and Methods
This experiment was designed to diff erentiate between eff ects 
due to birth and rearing dam parity by cross-fostering progeny 
pre-suckling. Gilts (parity 0) and sows (parities 2-5) were induced 
to farrow on Day 114 of gestation. Piglets were collected pre-
suckling and individually weighed and ear-tagged before being 
randomly transferred to a gilt or a sow. Sixteen gilt and 16 sow 
litters were assembled, each consisting of 5 gilt-born and 5 sow-
born piglets. No piglets were returned to their birth dam. No 
deformed piglets or piglets <900 g live weight were kept on trial. 
A blood sample was collected from 3 gilt-born and 3 sow-born 
piglets per litter at 2 and 7 weeks of age in lithium heparin blood 
tubes for the following tests:
Immune cell stimulation - Whole blood from each animal was 
stimulated with pokeweed mitogen (PWM; general immune cell 
stimulant) or phosphate buff ered saline (PBS; negative control). 
The IFN γ concentration was measured in the supernatant using 
a sandwich ELISA (Miller, 2008). A sample to positive (SP) ratio 
(%) was calculated for each sample.
Phagocytic assay – Whole blood was mixed with a solution of 
killed yeast spores. A blood smear was stained with Diff  Quik. 
The phagocytic index was determined, after counting 100 cells, 
from the proportion of cells containing yeast spores and the 
yeast spores/cell.
Diff erential cell count – Whole blood was mixed with Turks solu-
tion and the total number of white blood cells/mL blood was 
counted. A blood smear was stained with Diff  Quik and a diff er-
ential cell count done on 200 white blood cells (morphologically 
identifi ed).
All statistical analyses were done using REML linear regression in 
Genstat Release 10. For each analysis, birth dam parity, rearing 
dam parity, pre- or post-weaning, and birthweight were in-
cluded as fi xed eff ects. Random eff ects included litter and shed/
pen eff ects.
Results and Discussion
Birth dam parity had no signifi cant eff ect (P>0.05) on any piglet 
innate immune system measures indicating that adaptive im-
munity or rearing dam parity was likely to be more important in 
disease susceptibility. 
Rearing dam parity only infl uenced the phagocytic index; gilt-
reared progeny had a signifi cantly (P<0.05) higher percentage of 
active phagocytes compared to sow-reared progeny both pre- 
(39% and 34%) and post- (48% and 43%) weaning. Phagocyte 
activity can be stimulated by infl ammation which also leads to 
the production of acute phase proteins (APP). These results may 
therefore support fi ndings by Morales et al. (2006), where it was 
concluded that gilt-reared piglets, who had a higher concentra-
tion of APP compared to sow-reared progeny, had greater anti-
genic challenge to their immune system. While further research 
is required, this higher antigenic challenge could result from the 
comparatively reduced eff ectiveness of the maternal antibody 
and cell protection that progeny receive in colostrum and milk 
of gilts compared to older parity sows allowing disease to occur. 
Alternatively, there may be more pathogens being shed by gilts 
than sows but this is only likely to aff ect pre-weaning disease 
susceptibility.
Piglet age had a signifi cant eff ect on all innate immunity meas-
ures with a greater number and activity of immune cells post-
weaning compared to pre-weaning (Table 1). This was expected 
as immune system maturity occurs over the fi rst 7 weeks of life 
(Stokes et al, 2004) and confi rmed that the tests were capable of 
detecting this change in innate immunity.
Table 1. Model-based means for piglet innate immune system 
parameters
2 weeks old 7 weeks old
Number of cells (x106 cells/mL blood)
Lymphocytes 5.2 a 6.2 b
Phagocytes (monocytes + neutrophils) 4.1 a 7.4 b
Immune cell responsiveness 
(IFN γ; SP ratio %)
Pokeweed mitogen (PWM) 34.7 % a 78.9 % b
Phagocytic Index
% Phagocytes with yeast spores 36 % a 45 % b
Number of yeast spores/cell 1.9 a 2.5 b
ab Diff erent superscripts within row are signifi cantly diff erent (P<0.05)
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O.093
Eﬀ ect of housing system on reproductive performance of gestating sows
Annop Suriyasomboon; Mongkol Techakumphu
Chulalongkorn University, Bangkok, Thailand
Introduction
There are several factors that infl uencing the pig reproduction 
such as breeds, parity number, nutrition, season, and temper-
ature. The harsh climate condition was a major disadvantage 
for pig producing in tropical climate, such as Thailand, which 
resulted in lower reproductive performance of sows (1, 2, 3). In 
recent years, a new closed housing system, evaporative system 
(EVAP), has been introduced to improve the microclimate for 
pig farms in Thailand. EVAP is aimed to reduce the temperature 
inside the building by a humidifi cation process. Some pig farm-
ers already applied this system with the boar (4). The gestating 
and lactating sows were also using this housing system. To my 
knowledge, no comprehensive study on the eff ect of temper-
ature and humidity, based on daily recordings within the EVAP 
stable, on the reproductive performance of gestating sows 
has been performed. This study was to investigate the eff ect 
of housing systems on reproductive performance of gestating 
sows in Thailand. 
Materials and Methods
Data were collected from 13 pig farms (range from 1,000-5,000 
sows) in the intensive pig raising area in Thailand during the 
period September 2007 to August 2008. Seven of these farms 
had conventional (CON) housing system and six farms had 
EVAP housing system for the gestating sows. All herds had been 
operating for at least 5 years and the EVAP herds had used this 
system for at least 2 years before the start of this study. Tem-
perature and humidity were recorded automatically inside the 
gestating housing by using Hobo® data logger. Reproductive 
data were obtained from the pig’s herd management program 
i.e. PigLIVE®(Version 2.0, Live Informatics Co., Ltd., Thailand). Data 
were statistically analyzed using the SAS program (Version 9, 
SAS Institute Inc., Cary, NC, USA). ANOVA was applied to the litter 
size, total number of piglets born, in relation to the climate at 
previous weaning, at mating (NTB-m), and at farrowing.
Results
There was a higher variation and range of the maximum tem-
perature and the minimum humidity in the CON system than 
in the EVAP system in all three seasons. The average maximum 
temperature was lower, and the average minimum humidity was 
higher in the EVAP system than in the CON system. There was no 
signifi cant eff ect of housing system on any of the reproductive 
variables analyzed. However, the interaction between hous-
ing system and 2-month periods was signifi cant (P<0.01). The 
litter size of sows kept in the EVAP system was higher than sows 
kept in the CON system over the year. Increasing temperature 
resulted in lower subsequent litter size and number of born 
alive piglets (NBA) (P<0.05). Increasing humidity in the hous-
ing resulted in decrease NBA and increase number of still born 
piglet (P<0.05). 
Figure 1. Combined eff ect of season and housing system on litter sizes 
of sows.
Discussion 
The overall results reveal that not only elevated temperature but 
also elevated humidity has a negative impact on reproductive 
performance in sows. In this study, there was a signifi cant inter-
action between housing system and 2-month periods on NTB-m, 
which indicates diff erences between seasonal variations in the 
ovarian function from the sows kept in the two housing systems. 
The smaller litter size in the CON system might be explained by a 
poor fertilization rate, high embryonic death, and more discom-
fort and/or heat stress of the sows. Thus, using the EVAP system 
might be an alternative choice for improve the reproductive 
performance of gestating sows. 
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O.094
A retrospective analysis of results from laboratory tests to assess the cause of reproductive failure in sows
Heiko Nathues1 Regina Tegeler2 Elisabeth Grosse Beilage1
1. Field Station for Epidemiology, University of Veterinary Medicine Hannover, Bakum, Germany; 
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Introduction
Diagnosis of the cause of reproductive failure in sows is seldom 
straightforward and is frequently unsuccessful (1). In order to 
confi rm or to rule out infectious agents as the cause of a repro-
ductive failure, practitioners often tend to submit material from 
abortions, cervical swabs, organs of the genitourinary system 
from slaughtered sows or serum samples for further examina-
tion to a laboratory. The aim of this study was to analyze data 
from a nationwide operating laboratory for routine diagnostics, 
where samples had been examined by standardized methods 
for various infectious agents that might be involved in repro-
ductive diseases.
Material and Methods
A retrospective analysis was applied to data obtained by routine 
diagnostics over four consecutive years in Northwest Germany. 
All laboratory work was conducted and documented as speci-
fi ed in the ISO/IEC 17025:2005. Material from abortions (fetal 
lung, liver, kidney, spleen and heart muscle or placenta) was 
examined for the presence of PRRSV EU genotype and NA geno-
type (in Germany exclusively Ingelvac PRRS MLV), PCV2 and PPV, 
as for Leptospira and Chlamydia species by single PCR tests or by 
PCR screening (all fi ve PCR tests from fetal liver). These PCR tests 
were performed by IVD-GmbH (Hannover, Germany). The cer-
vical swabs and smears of organs from the genitourinary system 
were tested for presence of various bacteria by standard cultural 
methods. Serum samples were only submitted to PRRSV (EU and 
NA genotype) and PCV2 specifi c PCR tests. Data were stored in 
and later extracted from a SQL database.
Results
Material from abortions (n=788) was examined as often as 
cervical swabs (n=881). The detection rate for viral and bacter-
ial pathogens by PCR was low in material from abortions (Tab. 
1). On the opposite, 75.1% of all cervical swabs were tested 
positive for the presence of potentially pathogenic bacteria (E. 
coli, Streptococci, Staphylococci, etc.). However, in 52.9% of all 
positive swabs 3 or more bacteria were identifi ed (Fig. 1). The 
samples from the genitourinary organs were positive for one 
or two bacteria in 49.9% of all cases (Fig. 2). In serum samples, 
mainly originating from (weak born) suckling pigs, the average 
detection rate of PCV2, PRRSV EU genotype and PRRSV NA geno-
type was 41.6%, 23.1% and 12.9%, respectively. During the same 
period, the detection rate of PCV2, PRRSV EU genotype and 
PRRSV NA genotype in material from abortions was 14.7%, 6.8% 
and 1.3%, respectively.
Discussion
This study corroborates the diffi  culties in diagnosing the cause 
of reproductive failure by laboratory examination. When PRRSV 
is suspected causing reproductive failure, the impracticability of 
examining material from abortions compared to serum samples 
from (weak born) suckling pigs should be taken into account. 
Considering the high number of cervical swabs contaminated 
with 3 or more bacterial agents, standard bacteriological exam-
ination is more feasible on genitourinary organs.
Tab. 1: Detection rate of diff erent pathogens by PCR during 2006 and 
2009
Agent Average detection rate (2006 to 2009)
Range 
(2006 to 2009)
Chlamydia species 1.4 0.0 - 7.7
Leptospira species 0.7 0.0 - 7.5
PCV-2 16.3 3.8 - 37.5
PPV 2.7 0.0 - 2.9
PRRSV (EU genotype) 6.4 4.4 - 15.1
PRRSV (NA genotype) 1.3 0.0 - 4.8
Fig. 1: Results from bacteriological examination of cervical swabs
Fig. 2: Results from bacteriological examination of smears from 
genitourinary organs
References
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O.095
Synchronizing ovulation for ﬁ xed time artiﬁ cial insemination in 
cyclic gilts with Porcine Luteinizing Hormone (pLH) 
Audrey C. Cameron1 Jennifer Patterson1 Divakar J. Ambrose2 George R. Foxcroft1 Michael K. Dyck1
1. University of Alberta, Edmonton, AB, Canada; 2. Alberta Agriculture and Food, Edmonton, AB, Canada
Introduction
Optimal timing of artifi cial insemination (AI) in breeding pro-
grams is crucial to ensure successful fertilization and effi  cient 
production1. Variation in the duration of standing estrus, which 
has direct implications for timing of ovulation, has been well 
established in swine2. Although a relationship between the 
time of ovulation after the onset of estrus, and estrus duration, 
has been reported in both sows3 and gilts4, no other factors 
seem to relate to the timing of ovulation5. The recorded onset 
and duration of estrus also depends on the frequency of estrus 
detection and the observational skills of the stockperson1. The 
use of exogenous hormones to control the timing of ovulation 
can eliminate the need for heat detection and facilitates the use 
of fi xed-time AI procedures. Recent research has demonstrated 
that porcine luteinizing hormone (pLH) (Lutropin-V, Bioniche) 
can reliably synchronize ovulation in weaned sows6 and gilts7 
as a part of fi xed time AI protocols. The primary objective of this 
study was to refi ne existing ovulation induction protocols to al-
low for implementation of a single fi xed time artifi cial insemina-
tion (sFT-AI) program in cyclic gilts using porcine luteinizing 
hormones (pLH).
Materials and Methods
A total of 100 known-cyclic gilts were synchronized using oral 
progestagens (altrenogest, 15 mg/d x 18/d; Regu-Mate, Intervet 
Canada) and were then randomly assigned to three diff erent 
breeding protocols: 1) Control-1 (CON1) gilts received a single 
insemination at 158 h following the last altrenogest treatment 
(CON1, n=30); 2) Control-2 (CON2) gilts were bred using a stan-
dard 2 insemination breeding protocol. The fi rst insemination 
occurred at the initial detection of standing estrus, and then 
again every 24 h later. (n=35); 3) Gilts in which ovulation was 
induced (pLH) received 600 IU equine chorionic gonadotropin 
(eCG; Folligon, Intervet Canada) 24 hrs after last altrenogest. 
They then received 5 mg of pLH (Lutropin-V, Bioniche Animal 
Health Canada) 72 hours later and a sFT-AI performed 32 hours 
after the pLH injection (n=35). Estrus detection and transcuta-
neous real-time ultrasonography were performed every 8 h 
(8:00, 4:00, 12:00) beginning 24h after the last altrenogest treat-
ment to determine time of onset of estrus and ovulation. 
Results
LH gilts showed shorter intervals (P<0.01) between the end 
of altrenogest treatment and the onset of standing estrus 
(135.8±0.13 h) compared to CON1 and CON2 gilts (155.0±0.13 
and 153.7±0.12 h, respectively) and between the end of al-
trenogest treatment and ovulation (154.8±0.12 vs.187.41±0.12 
and 187.1±0.17 h, respectively). Furthermore, LH gilts show 
the least variation in the altrenogest to ovulation interval, with 
all gilts ovulating within a 31.9 h period, compared to 51.6 h 
and 72.2 h periods for the CON1 and CON2 animals. The AI to 
ovulation interval was also shorter (P<0.01) for the pLH animals 
when compared to the sFT-AI for CON1 and fi rst AI for CON2 
(23.4±2.75 vs. 35.2±2.84 and 31.4±2.74 h, respectively). There 
was no signifi cant diff erence in pregnancy rate between treat-
ments with an overall average rate of 88%. Similarly treatment 
did not aff ect litter size or the number of piglets born alive with 
overall averages of 12.5±0.7 and 11.8±0.7, respectively.
Discussion 
These results indicate that pLH is appropriate for use in cyclic 
gilts, and can reliably synchronize ovulation, while shortening 
the period between AI and ovulation. Furthermore, the applica-
tion of this ovulation induction protocol in combination with 
sFT-AI did not detrimentally infl uence pregnancy rate or litter 
size and therefore provided acceptable reproductive perform-
ance and effi  ciency. This suggests that pLH based sFT-AI proto-
cols could be successfully applied in gilts, thereby decreasing 
the amount of semen needed to breed a single female and allow 
for the more effi  cient use of superior sires.
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O.096
The eﬀ ect of PG600 at weaning on primiparous sow performance
Jennifer Patterson1 Audrey Cameron1 Taylor Smith1 Aline Kummer1 Rydell Schott2 Laura Greiner3 Joseph Connor3 George Foxcroft1
1. University of Alberta, Edmonton, AB, Canada; 2. PIC North America, Hendersonville, TN, USA; 3. Innovative Swine Solutions, Carthage, IL, USA
Introduction. The principal goal of commercial breeding herds 
is to consistently meet weekly breeding targets. Weaned sows 
failing to return to estrus within 7 d after weaning contribute 
to missed breeding targets and increased non-productive sow 
days. However, in well managed contemporary sow farms, more 
than 90% of sows may return to estrus within 3 to 5 days after 
weaning (1). The primary objective of the present study was 
therefore to determine the response to gonadotrophin treat-
ment (GT) at weaning in contemporary parity 1 commercial 
sows with lactation lengths typical of the North American swine 
industry.
Materials and Methods
Primiparous crossbred sows were blocked by genetic line (Pig 
Improvement Company (PIC) C22, n = 261; and PIC C29, n = 114), 
estimated post-farrowing weight and total born at parity 1 and 
then randomly allocated within block to either receive a com-
bination dose of 400 IU eCG and 200 IU hCG (PG600, Intervet, 
USA, De Soto, KS) I.M. in the neck on the morning of weaning 
(PG group; n = 168), or to be uninjected controls (CON group; n 
= 207). From the day after weaning (D1), all sows were provided 
twice daily fence-line contact with mature boars for stimulation 
and detection of estrus. Sows were bred by artifi cial insemina-
tion (AI) according to established herd protocols. Reproductive 
parameters analyzed were estrus synchronization rate (ESR) 
determined as the number of sows with fi rst observed estrus 
within 7 d after weaning, weaning-to-estrus interval (WEI), pro-
portion of sows bred that farrowed (FR), total litter size born (TB) 
and born alive piglets (BA) at farrowing. In addition, within each 
treatment, the synchrony of sows returning to estrus was deter-
mined as the proportion of sows in estrus within a 3-d period (d 
4, 5 and 6 for CON vs d 3, 4 and 5 for PG sows) (BRD3). 
Results
Parity 1 total litter size (12.2 ± 0.2 vs 12.0 ± 0.3) and estimated 
farrowing (194.0 ± 1.7 vs 192.1 ± 1.9 kg) and weaning (189.6 ± 
1.4 vs 189.3 ± 1.6 kg) weights, were similar (P>0.05) in CON and 
PG sows, respectively, indicating balanced allocation of sows 
across treatment. Lactation length (19.5 ± 0.1 vs 19.1 ± 0.1 d) 
and estimated weight loss in lactation (4.6 ± 1.3 vs 2.8 ± 1. kg) 
were also not diff erent (P > 0.05) in CON and PG sows, respect-
ively.
Considering data from all sows only results on the signifi cant 
main eff ect of treatment are presented. Treatment did not aff ect 
ESR or BRD3 (Table 1). However, the timing of this 3-d breeding 
window (d 4, 5 and 6 for CON vs d 3, 4 and 5 for PG sows) re-
fl ected a shorter (P ≤ .001) WEI in PG compared to CON sows. FR, 
TB and BA were not diff erent. As an overall comparison of sow 
productivity between CON and PG sows, a combined Fertility 
Index (FI) was calculated and indicated no gain in productivity in 
response to GT treatment.
Table 1: Eff ects of treatment with exogenous gonadotropins (PG600) 
in primiparous sows at weaning or untreated controls (CON), on vari-
ous parameters for those sows bred within 7 days after weaning.
CON PG600 P-Value
ESR, % 87.4 92.3 .26
WEI, d 4.4 ± 0.07 4.0 ± .08 ≤.001
BRD3, % 82.1 87.8 .65
FR, % 88.8 87.7 .85
TB 12.8 ± 0.3 12.4 ± 0.3 .36
BA 12.1 ± 0.3 11.8 ± 0.3 .47
SB 0.5 ± .06 0.4 ± .07 .30
FI 993 1004 -
Discussion
In the current study, excellent lactational and post-weaning 
management resulted in excellent fertility in untreated CON 
sows. Although GT treatment shortened the WEI, there was no 
eff ect on farrowing rates or subsequent litter sizes. GT treatment 
in more adverse times of the year may still be benefi cial in terms 
of inducing more sows to show standing heat within the 7-day 
breeding week after weaning.
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O.097
Fertility and proliﬁ cacy following ovulation induction (by PG600 or hCG) and a single ﬁ xed time AI
H.M J.M. Swarts1 M.A. Driancourt2 S. Ferchaud3 P. Guillouet3 K. Pere3
1. ISPAH, Global Marketing Swine, Boxmeer, Netherlands; 2. ISPAH R&D Pharmaceuticals, Beaucouze, France; 3. I.N.R.A., Rouillé, France
Introduction
The objective of the present study was to test the effi  cacy of two 
treatments for ovulation induction (PG600® (400IU PMSG and 
200IU HCG) and hCG (Chorulon®) followed by a single artifi cial 
insemination (AI), on fertility and prolifi cacy of gilts previously 
synchronised with Matrix®. Target is to obtain high reproductive 
performance while simplifying fertility-management (less time 
spent for oestrus detection, less AIs and a more predictable tim-
ing of farrowing).
Materials and methods
The study was performed by INRA Rouillé (France). Thirty-six 
(36) Large White X Landrace pubertal gilts (129 kg average BW 
and 180 days old) were randomly assigned to three treatment 
groups, each including 12 animals. All gilts were synchronised 
by oral administration of Matrix® (15 mg altrenogest/animal) 
once daily for 14 consecutive days. Four days (96h) after the last 
administration of Matrix® (Day 0), animals were treated for ovula-
tion induction as follows:
•  Group 1: Non-treated animals (control)
•  Group 2: I.m. administration of PG600 
•  Group 3: I.m. administration of hCG (500 IU)
At thirty-two hours after ovulation induction, gilts from groups 
2 and 3 were inseminated once, while those of group 1 (control) 
were inseminated twice, 12 hours apart, at detected estrus. 
Ovaries were scanned (ultrasonography) starting immediately 
before treatment and then twice daily for the next 48 hours 
in order to check ovulations (based on the disappearance of 
the large preovulatory follicles present at earlier scans). Blood 
samples were collected before treatment, and 2, 4 and 7 days 
later, to assess changes in plasma progesterone concentrations 
and to document the quality of ovulation. Twenty-two days after 
AI (Day+23), the pregnancy status of the gilts was checked by 
ultrasonography. At about thirty days after AI, all pregnant gilts 
were slaughtered, their ovaries collected and the numbers of 
total and normal foetuses were determined.
Results
A few gilts were not successfully synchronized by Matrix®, re-
ducing group size to n=9 in all three treatment groups.
At 48 hours after treatment, ultrasonographic scans demon-
strated that ovulation was successfully induced over a 16h time 
window in 100 and 78% of the animals treated with hCG and 
PG600 respectively. Only 22% of the control gilts ovulated dur-
ing the same time window. AI was closely synchronized with 
ovulation in all hCG treated gilts and in 6/9 PG600 treated gilts. 
The remaining PG600 treated gilts ovulated respectively 12(N=2) 
and 24 hours (n=1) later. 
There was no treatment eff ect (P=0.11) and no treatment by 
time interaction (P=0.09) for changes in progesterone concen-
trations. Progesterone concentrations were low on day 0 and 2, 
and increased similarly in the three treatment groups to reach 
22.8± 6.6, 18.8± 4.2 and 21.0± 5.0 ng/ml in gilts treated with 
hCG, PG 600 and placebos respectively.
When the reproductive features of the gilts of the three groups 
were compared, no signifi cant diff erences were demonstrated 
for fertility assessed by ultrasound 23 days after insemination or 
for the number of corpora lutea and live embryos observed 29 
days after insemination.
A summary of the data describing ovulation rate, fertility, 
number of live embryos at slaughter and of embryonic survival 
(ratio between ovulation rate and total number of embryos at 
slaughter) is presented in the table below:
Table 1:
PG600 hCG Control
% of ovulation 48hrs after 
treatment 78% 100% 22%
Fertility (ultrasound at 
Day+23) 8/9 (89%) 7/9 (78%) 9/9 (100%)
Nb of Corpora lutea 19.0 ± 2.2 21.7 ± 3.0 21.7 ± 3.1
Nb of Live embryos 15.3 ± 5.1 16.0 ± 4.9 17.0 ± 5.3
% embryonic survival 80% 74% 78%
Discussion and Conclusion:
These results show the ability of an injection of PG600 or hCG to 
induce ovulation (when injected 96h after the end of Matrix®), 
hence allowing to obtain high fertility and prolifi cacy after a 
single fi xed time AI (similar to that generated by multiple AIs at 
detected estrus). Although these fi ndings need to be confi rmed 
on a larger sample, this study establishes that the LH activity 
intrinsic to the hCG and PMSG molecules is suitable for ovulation 
induction in swine.
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O.098
Eﬀ ect of altrenogest on prevention of early parturition and reproductive performance in sows
Caroline Vanderhaeghe1 Jeroen Dewulf1 Jan Jourquin2 Dominiek Maes1
1. Facutly of Veterinary Medicine, Department of Reproduction, Obstetrics and Herd Health, Merelbeke, Belgium; 
2. Janssen Animal Health, Beerse, Belgium
Objectives
The purpose of this study was to investigate whether the ad-
ministration of altrenogest during late pregnancy was eff ective 
to prevent early parturition (< 114 days of gestation) and to 
improve the reproductive performance in sows.
Material and Methods
The experiment was conducted in 4 commercial pig herds 
located in Flanders, Belgium. Within each herd, random strati-
fi cation based on parity was used to allocate the sows (n=329) 
into a treatment or control group. Oral administration of 20 
mg of altrenogest (Regumate®, Janssen Animal Health) was 
performed on day 111, 112 and 113 of gestation, based on the 
sow’s individual insemination date. Reproductive parameters 
recorded were: farrowing date, number of live born piglets, 
stillborn piglets, mortality of weak born piglets during the fi rst 3 
days postpartum, cross-fostered piglets, pre-weaning mortality, 
number of weaned piglets. Statistical analysis was performed 
by means of analysis of variance taking herd into account as a 
random factor (SPSS 16.0). 
Results
Early parturition (<114d) was found in 14.1% of the control sows 
(Fig. 1). The reproductive performance of sows with an early 
parturition (C1) was signifi cantly lower compared to sows with 
a normal gestation length (≥114d, C2) and compared to sows 
treated with altrenogest (T) (Table 1). 
Fig 1: Frequency distribution of gestation length in 329 sows.
Table 1: Reproductive performance (mean (s.d.)) of the sows in the 
treatment group (T) and the control sows either with early parturition 
(< 114 days) (C1) or with a normal gestation length (≥ 114 days) (C2).
Parameter C1, n=23 C2, n=140 T, n=166
Gestation length (Days) 111.9 (1.4)a 115.2 (1.2)b 115.3 (1.2)b)
Total litter size (No) 14.9 (4.9) 14.2 (3.9) 14.4 (3.9)
Live born piglets (No) 11.6 (4.2) 13.0 (3.7) 12.8 (3.7)
Stillborn piglets (No 3.4 (3.4)a 1.2 (1.4)b 1.6 (1.9)b
Pre-weaning mortality (No) * 2.7 (2.7) 1.7 (1.7) 1.8 (1.9)
Mortality of weakborn piglets (%)* 20.7 (31.2)a 5.9 (8.9)b 6.4 (15.8)b
Weaned piglets (No)* 8.1 (5.0)a 10.7 (2.1)b 10.5 (2.9)b
Within a row, signifi cant diff erences are marked with diff erent superscripts (P<0.01)
* Sows with a correct record of cross-fostered piglets and pre-weaning mortality (n= 17, 91 and 
130 for C1, C2 and T, respectively)
Gestation length was signifi cantly diff erent between the treat-
ment group and the total control group (C1 + C2) (115.3 ± 
1.23 and 114.7 ± 1.69 days, respectively P < 0.01). In the treat-
ment group, none of the sows started farrowing during the 
altrenogest treatment. For the other reproductive parameters, 
no signifi cant diff erences were found between the treatment 
group and the total control group (C1 + C2) and between the 
treatment group and the control group with a normal gestation 
length (C2) (P > 0.05).
Discussion and conclusion
The present study demonstrates that early parturition adversely 
aff ects the reproductive performance of the sows. The adminis-
tration of altrenogest at D111, 112 and D113 of gestation is an 
eff ective and safe method to prevent early parturition and can 
counteract the reproductive losses due to premature farrowing. 
However, it does not signifi cantly infl uence the reproductive 
performance parameters compared to non-treated sows with a 
normal gestation length.
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O.100
Eﬀ ect of vaccination against experimental infection with highly and 
low virulent Mycoplasma hyopneumoniae strains
Iris Villarreal; Dominiek Maes; Katleen Vranckx; Dries Calus; Frank Pasmans; Freddy Haesebrouck
Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
Introduction
Mycoplasma hyopneumoniae (Mh) is the primary agent of enzo-
otic pneumonia (EP), a contagious respiratory disease with ma-
jor economical impact for the pig industry. Vaccination of piglets 
is widely practiced as a control strategy for this disease. How-
ever, the currently available vaccines do not induce a complete 
protection against colonization and transmission (2). Virulence 
diff erences (3) and protein variability (1) between Mh strains 
may indicate that vaccination effi  cacy could vary depending 
on the strain. The aim of this study was to assess the eff ect of 
vaccination with a commercial bacterin vaccine against low and 
highly virulent Mh strains at 4 and 8 weeks post infection (PI). 
Materials and Methods
Ninety, 3-week-old, cross-bred (Rattlerow Seghers), Mh and 
PRRSV free, weaned piglets were moved to the experimental 
facilities of the Faculty of Veterinary Medicine, Ghent University, 
Belgium. After one week acclimatization, they were randomly 
allocated to 10 diff erent groups housed in absolute fi lters (HEPA 
U15) to avoid spread of the pathogen between groups. Forty 
piglets were vaccinated (v) with a one-shot vaccine (Stellamune 
One, Pfi zer), 40 were left unvaccinated (nv) and 10 were assigned 
to the negative nv and non-challenged (NC) control group. The 
experimental design is summarized in Table 1. One low (LV) and 
one highly (HV) virulent Mh strain were used for experimental 
infection. After anesthesia, the pigs were inoculated intratra-
cheally with 7 x 107CCU of Mh in 7ml inoculum or with 7ml of 
sterile culture medium. Half of the piglets were euthanized at 
4w PI and the other half at 8w PI. The severity of coughing was 
assessed daily using a respiratory disease score (RDS) (values 
from 0-6). At necropsy, macroscopic lung lesions were quanti-
fi ed using the lung lesion score diagram of Hannan et al. (1982), 
ranging from 0-35. Additionally, lung tissue samples were taken 
from each pig to assess the severity of histopathological lesions 
(score from 0 to 5). Nasal swabs and bronchoalveolar lavage fl uid 
(BALF) were collected after euthanasia and analyzed using nPCR 
to confi rm presence of Mh.
Results
At 4w PI, the vHV group showed signifi cantly milder respiratory 
symptoms and signifi cantly lower macroscopic and microscopic 
lesion scores than the nvHV group (P<0.05). The vLV group 
showed no signifi cant diff erences for RDS, macroscopic and 
microscopic lesions scores, compared to the nvLV group. At 
8w PI, both vHV and vLV groups had signifi cantly lower RDS 
scores in comparison to the nvHV and nvLV groups, respectively 
(P<0.05). Only the vHV group showed signifi cantly lower macro-
scopic lesions in relation to the nvHV group. Results are summar-
ized in Table 2. As expected, all pigs, except for the nvNC group, 
were positive by nPCR on BALF and nasal swabs. 
Discussion and conclusions
The results confi rm the diff erence in virulence between the two 
strains (3), when measured during a period of either 4 or 8 weeks 
PI. Vaccination signifi cantly reduced the severity of disease in 
the vHV group at 4 or 8 weeks PI for most parameters. Vaccina-
tion was also benefi cial in the LV groups, but the eff ects were 
less pronounced and depended on the measured parameter. 
Further research is warranted to assess the precise eff ect of 
vaccination on individual strains under fi eld conditions, since 
combined infections might lead to more severe clinical disease 
in a pig herd (4). 
Table1: Experimental design and number of pigs in each group.
Group Nb pigs Vacc. Challenge Necropsy
D7 D28 4wPI 8wPI
nvLV-4 10 - LV + NA
nvLV-8 10 - LV - +
nvLV-4 10 - HV + NA
nvLV-8 10 - HV - +
vLV-4 10 + LV + NA
vLV-8 10 + LV - +
vLV-4 10 + HV + NA
vLV-8 10 + HV - +
nvNC-4 5 - medium + NA
nvNC-8 5 - medium - +
PI: post infection; v vaccinated , nv non-vaccinated; LV low virulent strain, HV highly virulent 
strain; NC non-challenged, NA not analyzed
Table 2: Average respiratory disease score (RDS), macroscopic and 
microscopic lung lesions scores in the diff erent groups
Parameter weeks PI nvNC nvLV nvHV vLV vHV
RDS 4 0.00a 0.07a 0.45b 0.07a 0.12a
8 0.00A 0.24B,D 0.44B 0.05A 0.30C,D
Macrosc. 
Lesions 4 0.00
a 2.38a,b 6.9b 0.93a 0.11a
8 0.00A 1.20A 5.60B 1.74A 1.99A
Microsc. 
Lesions 4 1.17
a 2.90b 4.04c 3.10b 3.02b
8 1.17A 2.92B 3.62B 3.41B 3.35B
Diff erent lowercase letters correspond to signifi cantly diff erent values between the groups at 
4w PI;
diff erent capital letters indicate signifi cantly diff erent values between the groups at 8w PI
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Introduction
Infections with Mycoplasma hyopneumoniae (Mh) occur world-
wide and cause major economic losses to the pig industry. 
Knowledge about the infection pattern of this pathogen in 
young piglets is essential for the implementation of appropriate 
control measures and optimization of vaccination strategies. The 
aim of the present study was to investigate the prevalence of 
Mh infections in piglets at 3 weeks of age in diff erent European 
countries by analyzing nasal swabs using nPCR. In addition, pos-
sible risk factors associated with Mh infection in young piglets 
were investigated.
Materials and Methods
The study was conducted between May 2008 and March 2009 
in 9 European countries namely Belgium, Denmark, France, 
Germany, Hungary, Italy, Poland, Spain and The Netherlands. In 
each country, 6 single-site farrow-fi nish or sow herds were in-
cluded (4 herds included in Germany). Selection criteria included 
herds of minimum 100 sows, presence of clinical respiratory 
problems related to Mh (coughing) in grow-fi nishing pigs, and 
no antimicrobials used against Mh in piglets less than 3 weeks 
of age. Thirty nasal swabs were collected per herd from piglets 
of 21±3 days of age. The piglets were randomly selected from as 
many diff erent sows as possible. A nested PCR (nPCR) based on 
a modifi ed protocol (3) described by Stärk et al. (1998) was used 
for detection of Mh DNA. A questionnaire of 38 questions re-
lated to respiratory disease and herd management practices was 
completed during the herd visit. The questionnaire was subdiv-
ided in six categories including herd information, sow popula-
tion, purchase policy, housing conditions, feeding management 
and health control strategies. The statistical analysis was based 
on a generalized mixed model using the PROC GLIMMIX pro-
cedure (SAS 9.2., 2008) with country and herd nested in country 
as random eff ects. Herd positivity was the dependent variable, 
whereas diff erent potential risk factors served as independent 
predictor variables (P≤ 0.10) in the univariate model, and were 
subsequently included in the multivariable analysis (P≤ 0.05).
Results
In total, 52 herds and 1555 piglets were sampled for presence 
of Mh. The average percentage of positive pigs within the herds 
was 11% (95% CI 7.4-14.2). The min. and max. within-herd preva-
lence was 0 and 37%. The percentage of herds with at least one 
positive tested pig was 68% (95% CI 51.7-83.4). In 32% of the 
herds, more than 10% of the piglets tested positive. France, The 
Netherlands, Italy and Germany had the highest percentage of 
Mh positive herds. Only in France, 100% of the herds were posi-
tive. The highest within-herd prevalences were found in Italy, 
France and Germany (Table 1). From the 38 variables analysed, 
only SIV sow vaccination was signifi cant (P≤ 0.05) and positively 
associated with a higher risk of a suckling piglet being Mh posi-
tive (OR= 3.12. 95% CI 2.03-4.21).
Table 1: Prevalence of M. hyopneumoniae in nasal swabs of 3-week 
old pigs in diff erent EU countries. Fifty-two herds were sampled, 30 
piglets in each herd.
Country
Nb of positive herds/ 
nb of herds sampled
Nb (%) of positive 
piglets
Min.-max. % of posi-
tive pigs
Belgium 4/6 6 (3.3) 0.0-10.0
Denmark 3/6 3 (1.7) 0.0-03.3
France 6/6 38 (21.1) 10.0-30.0
Germany 3/4 23 (18.7) 0.0-26.7
Hungary 3/6 18 (10.0) 0.0-30.0
Italy 5/6 40 (22.1) 0.0-26.7
Poland 4/6 17 (9.7) 0.0-20.0
Spain 2/6 9 (5.0) 0.0-20.0
The Netherlands 5/6 14 (7.7) 0.0-16.1
Total 35/52 (67.8) 168/1555 (10.7) 0.0-36.7
Discussion
The results showed that in two thirds of the study herds, there 
was evidence of Mh infection in 3-week old piglets. In most of 
the positive herds, the prevalence was between 1 and 10%. In 
some herds, more than 30% of the piglets was already positive. 
This suggests that in the selected herds, early infections with 
Mh are important (1,2) and that infections commonly occur in 
European pig herds suff ering from respiratory disease in the 
grow-fi nishing pigs. The higher risk of a piglet being Mh positive 
in case of SIV sow vaccination is diffi  cult to explain, but it may be 
due to the fact that pig herds with respiratory symptoms may 
tend to vaccinate against SIV, overlooking the possible infl uence 
of other respiratory pathogens such as Mh. 
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Introduction
Enzootic pneumonia (EP), also called mycoplasmal pneumonia, 
is recognized as one of the most economically signifi cant swine 
respiratory diseases. The etiological agent of this disease (M. 
hyopneumoniae, Mh) attaches to the ciliated epithelial lining of 
the respiratory tract, resulting in impairment of the mucociliary 
mechanisms, predisposing to secondary bacterial infections. 
Vaxsafe®MHP is a temperature sensitive Mh strain that is being 
developed by Bioproperties Pty Ltd (Australia) as the fi rst live 
vaccine against EP. 
Materials and methods
Forty (40) SPF pigs 3 weeks of age were used in this study. All 
pigs were ear tagged with an individual number, weighed and 
assigned to 4 study groups each containing 10 pigs. All groups 
were housed under the same conditions in negative pressure 
isolation rooms. Pigs were acclimatized for 3 days before treat-
ment. Group 1 was the Negative control. Pigs within this group 
were administered vaccine diluent. Group 2 was vaccinated with 
Vaxsafe® MHP. Pigs within group 3 were vaccinated with a com-
mercial inactivated vaccine. Group 4 was the positive control. 
Vaccination day was designated as “days post vaccination-zero” 
(DPV-0). Vaccination with Vaxsafe® MHP was performed by 
intranasal spray and the commercial vaccine by intramuscular 
injection. Vaccinated pigs were allowed to develop immunity 
over a period of 22 days and then challenged with live cultures 
of Mh IOWA strain 194 administered by aerosol at a dose of ~10 
6.0 ccu/mL/45 minutes in an aerosol chamber. On the fi rst round 
pigs were challenged three times at 4 days apart DPV-22,-27 and 
-32. All groups were then subjected to second round of chal-
lenge with a similar culture of Mh on 3 consecutive days (DPV-
84, -85 and -86). Post-mortems were performed 18 and 19 days 
after the second round of challenge. A number of parameters 
were measured including daily monitoring for clinical signs and 
temperature and periodic collection of nasal swabs (nPCR) and 
blood sampling (ELISA).
Results
Particular attention from a safety perspective was taken in the 
period between vaccination and immediately prior to the fi rst 
challenge regime. During that period, no mortalities or clinical 
signs (coughing, sneezing, fever or loss of appetite) were ob-
served in either the negative control or the vaccinated groups. 
Blood samples (2-5 ml) were collected from all pigs at the start 
of the study and at several intervals including post mortem. All 
samples were subjected to ELISA analysis to detect antibodies 
against Mh.
Table 1. Clinical observations.
Group Clinical signs at various intervals
Antibody 
detection at 
postmortem
Detection in nasal 
swabs (nPCR) 
8 dpv
Fever (various 
intervals)
Negative Control 0% 0% 0% 0%
Vaxsafe®MHP 0% 12.5% 55.5% 0%
Commercial 
vaccine 0% 77.8% 0% 0%
Positive Control 42% at 102 DPV 42.9% 0% 0%
 
Nasal swabs were collected from all groups at the start of the 
study (DPV-0) and at DPV-8. Swabs were subjected to nPCR 
analysis. Mh was not detected at DPV-8 (before challenge) in 
pigs within the negative control group as well as groups 3 and 
4. However, Mh was detected in 55.5% of pigs vaccinated with 
Vaxsafe® MHP (group 2) showing what appears to be a mild and 
transient colonization of the upper respiratory tract. (Table 1). 
None of the negative control pigs had detectable antibody. Pigs 
vaccinated with the inactivated commercial vaccine demon-
strated serological response (77.8%) while only 12.5% of the pigs 
vaccinated with Vaxsafe® MHP had demonstrable antibodies. In 
contrast 42.9% of the positive control group showed antibodies 
against Mh. at postmortem.
Conclusions
No adverse eff ects of any kind were observed during this study. 
Vaxsafe® MHP proved to be safe when applied in SPF pigs for the 
control of M. hyopneumoniae infection.
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Introduction
Mycoplasma hyopneumoniae (M. hyo) is an important cause of 
pneumonia in swine around the world. M. hyo can be challen-
ging to identify during the early stages of infection due to its 
often slow spread within a population. Currently, ante-mortem 
diagnosis relies primarily on detection of serum antibodies that 
may take weeks to months to become detectible by ELISA, or on 
nested PCR from nasal swabs which has lower sensitivity than 
samples collected from the lower respiratory tract1. Increas-
ing the sensitivity of testing by nasal swabs would improve the 
utility of this sample. Recently, oral fl uids have been described 
for the detection of PRRS in pig populations2. Oral fl uids are 
easy to collect and capable of surveying a large number of pigs 
in a short period of time, but its usefulness for the detection of 
M.hyo has yet to be determined. This study sought to optimize 
testing for ante-mortem detection of M. hyo. 
Materials and Methods
Samples were collected as part of a vaccine study in which 2 
seeder pigs from each of 6 pens of 52 pigs were challenged 
with an intratracheal inoculum of strain 232 lung homogenate. 
Within each pen, serum and individual nasal swabs were col-
lected from 10 pigs (excluding seeder pigs), and an oral fl uid was 
collected from each pen at the following six time points: 4 weeks 
pre-challenge; at challenge; 2, 4, 8, and 12 weeks post-challenge 
(oral fl uids were not collected at 4 weeks pre-challenge). Oral 
fl uids were collected in each pen by allowing pigs to chew on 
a cotton rope for 30 minutes. During the collection period the 
two challenged pigs were removed from the pen. Oral fl uids 
were squeezed from the rope, transferred to a snap-cap tube 
and frozen until tested. Swabs and oral fl uids were extracted by 
both a bead-based extraction method (Ambion Mag MAX-Viral 
Isolation Kit) and a spin-column extraction method (Qiagen 
QIAmp DNA mini kit). Extractions performed using the Ambion 
kit followed the oral fl uid and total nucleic acid purifi cation 
protocol. Extractions using the Qiagen kit followed the blood 
and body fl uid protocol. Extractions were tested by a previously 
described primer and probe set targeting the mhp183 gene of 
M.hyo3. PCR was performed using two diff erent master mixes 
(Ambion VetMAX-Plus qPCR master mix or AB TaqMan Universal 
PCR master mix) to further optimize the assay.
Results
The two extraction methods for oral fl uids were compared 
and the spin-column kit resulted in lower Ct values (ie. greater 
sensitivity) as compared to the bead-based extraction method. 
The opposite was true when extraction methods for nasal swabs 
were compared. Based on these results, oral fl uids were ex-
tracted using the Qiagen QIAmp DNA mini kit and nasal swabs 
were extracted using Ambion MagMAX kit. When the two diff er-
ent PCR reagent mixes were compared the Ambion VetMAX-Plus 
qPCR master mix gave the most sensitive results regardless of 
sample type tested. 
Signifi cant numbers of PCR positives were not detected until 
8 and 12 weeks post-challenge for both oral fl uids and nasal 
swabs. Positives attributed to maternal antibody transfer were 
detected by ELISA at the earliest time points and the post vac-
cination/challenge antibodies appeared at 8 to 12 weeks, similar 
to the PCR results. Due to the limited number of collection time 
points in this study all 3 sample types detected positives post 
challenge at the same time point (8 weeks post challenge). 
Therefore, it was not possible to determine which of the sample 
types was able to detect positives at the earliest timepoint post-
infection. However, diff erences in the sensitivities of these assays 
and sample types were observed. At eight weeks post challenge, 
45% of serum, 72% of nasal swabs, and 100% of oral fl uids were 
identifi ed as positive. Stronger PCR positives were detected from 
oral fl uid samples than from nasal swabs. 
Discussion
In this study we optimized both the sample collection procedure 
and DNA extraction PCR protocols for nasal swabs and oral fl uids 
and compared these results to serology. Future studies applying 
these techniques in the fi eld will be needed to confi rm these 
results, but demonstrate the potential for monitoring shedding 
of M.hyo through oral fl uids or nasal swabs in the fi eld.
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Introduction
Vaccination against Mycoplasma hyopneumoniae (M hyo) is 
widely used in the pig industry to increase the performance of 
pigs. During the last years, vaccination against PCV2-virus has 
become more and more common, and in herds vaccinating 
against PCV2, the usual M hyo vaccination might seem unneces-
sary, because the pigs perform very well with PCV2 vaccination 
only. This side-by-side study evaluates the benefi ts of vaccinat-
ing against M hyo in a Swedish herd already vaccinating against 
PCV2-virus.
Material and Methods
The study took place in a Swedish 2-site herd with groups of 45 
sows farrowing every 5th week. One batch of pigs was divided 
in 2 groups; 291 pigs were vaccinated against M Hyo and PCV2 
(Ingelvac MycoFLEX® together with Ingelvac CircoFLEX®) and 
156 pigs were vaccinated against PCV2 only (Ingelvac Cir-
coFLEX®). Pigs were vaccinated at 3 weeks of age, weaned at 39 
days of age and moved to the fattening site at 10.5 weeks of age. 
Each group of pigs was tattooed with diff erent delivery numbers 
before slaughter. For each pig, slaughter date, carcass weight, 
meat % and carcass price was recorded at the slaughterhouse, 
and average daily weight gain (ADWG) (birth to slaughter) was 
calculated. Comparison of pigs vaccinated with 2 vaccines to 
pigs vaccinated with PCV2 only was done with Students t-test 
for ADWG, weight, meat %, and price and with W-W runs test for 
days (signifi cance level p=0.05).
Table 1: Performance from birth to slaughter.
Vaccination PCV2 +M hyo PCV2 Diff .
ADWG (g/day) 653.9 632.1 +21.8*
Time to slaught (days) 172.3 175.6 -3.2*
Carcase weight (kg) 84.8 83.3 +1.5*
Price of carcase (€/pig) 107.9 105.8 +2.1*
*=Statistically signifi cant diff erence between means
Results
Pigs vaccinated with against both PCV2 and M Hyo showed a 
statistically signifi cant improvement of performance measured 
as ADWG, time to slaughter, carcase weight and carcase price (p-
values 0.001, 0.050, 0.014 and 0.011), compared to pigs vaccin-
ated only against PCV2 (table 1). The meat percentage was not 
infl uenced by M hyo vaccination (p=0.558). In fi g. 1, the faster 
growth of pigs vaccinated with both vaccines is visualized. The 
increase in the price of the carcases was 3.6 times as high as the 
vaccine price.
Fig. 1: Number of days from birth to slaughter
Discussion and Conclusions
The present herd had a good performance with PCV2 vaccina-
tion only, shown by an average daily weight gain of 632 g/
day from birth to slaughter. There was no evidence of M hyo 
problems, neither clinically or in the carcass remarks from the 
slaughterhouse. 
Still, the performance was signifi cantly improved by M hyo vac-
cination, increasing the mean price of the carcass by 2.1 € per 
pig. Furthermore, the pigs grew faster, meaning that the farmer 
would also save food expenses and empty the barn sooner to 
put in new pigs.
Therefore, vaccination against M hyo on top of the PCV2 vac-
cination gave a payback of more than 3.6 times the investment 
in the M hyo vaccine.
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Introduction 
Mycoplasma hyopneumoniae continues to be an economically 
important respiratory infection in swine. There are a number 
of diff erent ways to eradicate Mycoplasma from herds. Adapta-
tions to the Swiss method have also been successful at eradica-
tion. These would include herd closures allowing the herds to 
continue to farrow during the process1, 2. Vertical transmission 
studies demonstrate that transmission occurs up to 8 months 
post infection3. Herd closures have typically been 8-9 months 
duration and may or may not have off  site breeding projects 
incorporated. These procedures have included a whole herd 
medication program at the end of the closure. 
Another method is whole herd medication without herd closure 
using a long acting antibiotic such as Draxxin® (10% Tulath-
romycin, Pfi zer), treating all pigs on site with an injection and 
repeating in 2 weeks4. The advantage of this approach is that 
the herd returns to negative status faster.
This study looked at results of herds that have been through 
various versions of Mycoplasma hyopneumoniae eradication 
procedures and the duration of time that the herds have stayed 
negative.
Materials and Methods
•  Identifi ed 23 herds that had been through a Mycoplasma 
hyopneumoniae eradication procedure.
o 16 herds used a herd closure and whole herd medication 
program.
o 7 herds did a whole herd injection of medication program 
and no closure. 
• All farms had negative replacement breeding stock available.
•  Herd’s mycoplasma status where monitored using: pigs in the 
fi nishing fl ow and blood testing just prior to marketing.
o Clinical signs of Mycoplasma (coughing) in sow herds or 
fi nishing pigs.
o  Serology of pigs at the end of the fi nishing phase.
o  Using IDEXX test if vaccinated
Results
Herd closure and medication (C) and whole herd medication 
using Draxxin® (M) were 81% and 57% successful overall respect-
ively, and 94% and 71% successful for a period greater than 1 
year. The average “survivability” of herds in the study was 31 and 
20 months respectively as shown in Table 1.
Discussion
Herd closure and medication (C) has been more success-
ful, although both methods of Mycoplasma hyopneumoniae 
eradication were successful over time. However implementing 
herd closure takes longer to obtain Mycoplasma negative pigs, 
and depending on the economic advantage the whole herd 
medication may be more attractive. Each farm will have its own 
unique goals and limitations that must be considered but these 
23 herds represent what can be done with the various programs 
being used in the fi eld in pig dense areas of production.
Table 1. Mycoplasma hyopneumoniae eradication success in 23 farms 
by type: herd closure and medication (C); medication (M) 
Date # Sows Type Pos Neg >1Yr Months
Dec 03 2500 C 1 74
Apr 06 1200 C 1 46
May 04 2500 C 0 1 49
Sep 06 2500 C 1 41
Sep 06 600 C 1 41
Mar 06 1350 C 0 1 18
Sep 07 5000 C 1 29
Apr 06 2500 C 1 46
Apr 06 900 C 1 0 3
Sep 06 2500 C 1 41
Apr 07 900 C 1 34
Sep 07 2500 C 1 29
May 08 2500 C 1 21
Sep 08 1700 C 1 17
Sep 09 2500 C 1 5
Sep 09 1350 C 1 5
Total 33000 1 13 2 495
Success at herd level 81% 94% 31
Population 29150 32100
Success at population 
level 88% 97%
Aug 06 3500 M 1 42
Sep 06 900 M 0 1 13
Nov 06 3500 M 1 39
Oct 07 1350 M 1 0 10
Nov 07 900 M 1 0 9
Sep 08 900 M 1 17
Mar 09 900 M 1 10
Total 11950 4 1 139
Success at herd level 57% 71% 20
Population 8800 9700
Success at population 
level 74% 81%
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Introduction
The timing of the Mycoplasma hyopneumoniae vaccine was 
changed from weaning to 30 kg live weight and then the vac-
cine was stopped.
Materials and methods
A 140 sow weekly batch outdoor unit was selected for the trial. 
1330 pigs a batch were weaned. The unit was PRRSv and SIV 
negative. No PMWS had been diagnosed on the farm. The farm 
was Mycoplasma hyopneumoniae and Actinobacillus pleuro-
pneumoniae 1 and 15 positive. A few cases of Glässer’s were 
seen. Post-weaning mortality was normally 3% primarily associ-
ated with enzootic pneumonia complicated with pasteurella and 
streptococci and hind limb weakness and lameness.
A change in vaccination timing from 4 weeks (farrowing) to 10 
weeks of age (nursery) was made in response to stockpeople’s 
request.
Following a 17 weeks trial the timing was moved back to 4 
weeks of age. At this stage it was agreed to examine the impact 
of non vaccination – thus providing a 6 week non-vaccinated 
group. The pigs were monitored by clinical signs, post-weaning 
mortality and slaughterhouse examination.
Results
Change of timing of vaccination
The arrow indicates the start of the trial to administer vaccine at 
10 weeks of age
There was no impact on postweaning mortality with vaccine 
timing changed from 4 to 10 weeks of age.
The lower line is the mean post-weaning mortality at 3%, the 
upper line 2sd above the mean. At no point was the production 
system “out of control”.
Slaughterhouse examination
There was no change in any slaughterhouse parameter as-
sociated with the change of timing from 4 to 10 weeks of age. 
However, the stockpeople complained of the increased eff ort in 
vaccination.
Cessation of Mycoplasma vaccination
To restore the vaccination at weaning a 6 week period of non 
vaccination was practiced. 
The arrow indicates the 6 batches fi nishing without vaccine.
The lower line is the mean the upper line 2sd above. The system 
was out of control 4 out of 6 batches (big dots). Over the 6 
weeks a post-weaning mortality of 5.4% cf. normal 3% (p=0.007). 
The mortality occurred in 85 to 95 kg pigs with clinical signs of 
severe complicated pneumonia.
Slaughterhouse examination
Enzootic pneumonia score: 
Q1 3 Q2 3 Q3 4 Q4 1.5 Q1 12 Q2 2.5 Q3 3.5 Q4 0.5
In addition to increase in enzootic/mycoplasma pneumonia 
scores, pleurisy increased to 35%, normal less than 2%. Pleuro-
pneumonia like lesions increased to 10% normal less than 1%. 
Pericarditis increased to 6% normally less than 1%. There was no 
change in dermatitis, white spot, nephritis or ileitis scores.
Cost implication: ($Au)
Extra-mortality – loss of 2,605kg deadweight/ batches - @ $3.40 
a kg cost of production, removing the food not eaten - $7,781 
loss/batch
Loss of production – a 12 lung score equates to an increase in 
FCR of 0.15. Thus an extra 21 tonnes per batch - @$370 a tonne 
$7,789 extra per batch
Additional costs per batch - $15,869 or $12.30 a pig.
Cost of the Mycoplasma vaccine - $1.70 (including labour and 
equipment) – with 1330 pigs a batch weaned – total costs - 
$2261 a batch.
Extra medication are not included in these costs.
Discussion
There was a 7:1 benefi t of vaccination with the Mycoplasma hyo-
pneumoniae vaccine. The benefi t was shared between the cost 
of mortality of a nearly fi nished pig and the poorer food conver-
sion of the remaining pigs. There was no impact, in a PRRSv 
negative herd, of vaccinating at weaning or 10 weeks of age.
Please visit our website www.portec.com.au
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Application of Mycoplasma hyopneumoniae P146 genotyping to an outbreak investigation
Daniel Linhares1 Simone Oliveira2 Montserrat Torremorrell1
1. College of Veterinary Medicine, University of Minnesota, St Paul, MN, USA; 
2. Veterinary Diagnostic Laboratory, College of Veterinary Medicine. University of Minnesota, St Paul, MN, USA
Introduction
Enzootic pneumonia (EP) is an important respiratory disease of 
swine caused by Mycoplasma hyopneumoniae (Mh). EP impacts 
the performance of growing and fi nishing pigs by reducing 
growth rate, increasing mortality and worsening feed effi  ciency. 
Mh negative pig farms have productivity advantages compared 
to positive systems. Therefore there is a premium in maintaining 
systems Mh negative. However, negative systems may become 
contaminated and in those cases it becomes critical to under-
stand the source of Mh infection. 
P146 is a lipoprotein that plays a role in Mh adhesion. It is lo-
cated in the surface of the bacterial cell and contains a series of 
serine repeats. The gene that codes for these serine repeats was 
recently used for characterization and comparison of Mh isolates 
from diff erent European herds and also from diff erent contin-
ents (Mayor et al, 2007; 2008).
This study describes a case where Mh genotyping using sequen-
cing of the P146 gene was used to investigate the source of 
contamination of a Mh negative system.
Materials and Methods
Herd A is a 1,000 daughter nucleus sow herd that delivers gilts 
and boars to multiplier and commercial farms. Herd A was mon-
itored on a regular basis by weekly veterinary visits and monthly 
serology screening including Mh. Additionally, slaughter checks 
were also performed on a monthly basis. 
On August 2007, 2 out of 30 pigs tested positive by serology in 
the routine herd testing. No lung lesions or clinical signs were 
observed at that time. Discrete clinical signs were observed on 
nursery pigs in early September. Infection was confi rmed when 
additional samples tested positive and clinical signs of Mh infec-
tion were evident by the end of September.
Herds B, C and D were 800, 750 and 1,000 sow farms respectively 
that had Herd A as the only source of replacement animals for 
at least 2 years. These herds were also Mh negative based on 
at least 4 years of regular serology and clinical monitoring. The 
last animal introduced in herd B was 5 boars (July 07), 63 gilts in 
herd C (June 07) and 30 gilts in herd D (May 07). Herds C and D 
did not have quarantine and received animals directly into their 
herds. Herd B had a quarantine unit where animals were allowed 
to enter the herd after completion of Mh serology in 100% of the 
animals. 
On September 07 herds C and D started developing clinical 
signs suggestive of Mh infection. Infection was confi rmed by 
serology and positive PCRs of pneumonia lesions. In Herd B, 
however, no clinical signs were observed until December 07, 
when Mh infection was confi rmed by serology and PCR of lungs 
of coughing pigs. 
On December 07, lungs from two coughing pigs were collected 
in all aforementioned farms and also from eight Mh positive 
herds that were unrelated to those farms. Positive samples were 
sequenced by targeting the P146 gene segment and results 
were compared among all isolates. Diagnostic testing was con-
ducted at the U of Minnesota Veterinary Diagnostic Laboratory.
Results and Discussion
Considering that Herd A was the only source of replacement 
animals for Herds B, C and D, Herd A was considered the most 
probable source of contamination for these herds. However, the 
timing of seroconversion and development of clinical signs did 
not match the current knowledge of Mh disease incubation, 
especially regarding Herd B that received animals in July but 
clinical signs and evidence of infection was not detected until 
December. This delay may be explained by the low number of 
animals introduced, only 5 boars, and the slow spread of the 
infection in that population.
Considering this unusual situation, we needed a new approach 
to help the investigation and to answer whether the Herd A was 
indeed the source of infection of the other farms. The Mh isolate 
sequence of Herds B, C and D matched the sequence informa-
tion of Herd A. These results suggested that the most likely 
source of infection in the studied herds was indeed the direct 
introduction of animals from Herd A. In addition, six out of the 
eight isolates recovered from the unrelated herds had a diff er-
ent sequence indicating that P146 gene sequencing had a good 
discriminatory ability to detect genetic diff erences among Mh 
isolates. In conclusion, P146 sequencing appears to be a useful 
tool in the aid of investigating Mh infections. 
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Comparison of mycoplasmal lung lesion scoring methods
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Introduction
There are several methods available for determining the level 
of pneumonia in swine lungs. These methods are often based 
on assessing the amount of visible lesions on the surface of the 
lung followed by calculating the percentage of the lung surface 
that exhibits the lesions to provide an overall lung score. The 
main methods evaluated in this paper included: 1) sketching 
the lesions onto a standard diagram followed by digital im-
age analysis in order to determine the percentage of the lung 
surface that exhibits lesions1; 2) the “PigMon” method where the 
extent of lesions in each of the seven lung lobes is estimated 
followed by placing these scores into a formula that represents 
the relative contribution of each lobe to the total lung area2; and 
3) a method used by the fi rst author where each lobe is scored 
separately followed by incorporation into a formula based on 
the relative weight of each of the lobes to the total lung weight.3 
In addition, a diff erent formula (BC) was used to calculate the 
total score from the individual lung lobe scores.4
Materials and Methods
The lungs (n = 58) evaluated in this study were part of a Myco-
plasma hyopneumoniae vaccination/challenge study. At nec-
ropsy, lesion observations were done by: 1) Sketch- lesions were 
recorded onto a standard diagram; 2) VR (Veterinary Resour-
ces)- percent lesions in each lobe was recorded by the “PigMon” 
evaluator (third author); 3) BT- percent lesions in each lobe was 
recorded by the fi rst author (BT) and 4) BTSK- sketches were 
scored using the BT observation method. This raw data was then 
incorporated into three formulas (PigMON, BT, BC) of which the 
contribution of each lobe to the total lung is presented in Table 
1. An overall lung score was also assigned by the fi rst author 
(BT/Total). The sketches were analyzed by digital imaging and 
the percent lesions generated by this method were considered 
the standard value for comparison with the other scoring 
methods. The scores generated using the various combinations 
of observation methods and overall score calculations were 
compared against the standard value on an individual pig basis. 
The percent diff erences between methods were calculated and 
correlations were performed.
Results
The overall lesion scores (% pneumonia) by each method, dif-
ferences between the methods and correlations to the standard 
values are presented in Table 2. The overall percent pneumonia 
by the standard method (Sketch-Image) was 8.46%. The aver-
age scores by the other methods varied from 5.99% (-2.47%) to 
9.89% (+1.43). R-square values (correlation) varied from 0.844 to 
0.986.
Discussion
The best combination of observation and calculation methods 
appeared to be the BT observation method from the sketch 
(BT-SK) along with the BC formula to generate the overall score. 
Accordingly, this method can be used in place of the digital 
image analysis which is fairly expense. In addition, the sketch 
provides a permanent record of the lung lesions which enables 
evaluation at a later time.
Table 1: Lung lobe contributions for calculations (%)
Lobe PigMon BT BC
Left Cranial 10 4 5
Left Middle 10 9 6
Left Caudal 25 25 29
Accessory 10 5 5
Right Cranial 10 7 11
Right Middle 10 15 10
Right Caudal 25 35 34
Table 2: Comparison of scoring methods
Observation Calculation Pneum % Diff . vs. Image R-square vs. Image
Sketch Image 8.46 NA NA
VR PigMon 7.44 -1.02 0.922
BT Total 9.12 +0.66 0.931
BT BT 9.48 +1.02 0.948
BT-SK BT 9.89 +1.43 0.986
VR BT 7.20 -1.26 0.925
BT BC 8.37 -0.09 0.950
BT-SK BC 8.76 +0.30 0.986
VR BC 5.99 -2.47 0.930
BT PigMon 9.71 +1.25 0.844
BT-SK PigMon 9.73 +1.27 0.978
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Comparison of four ELISAs for detection of antibodies against diﬀ erent 
genetic subtypes of European genotype PRRSV
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Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV) 
strains belong to the two genotypes which are antigenically 
diff erent. The genetic diversity in the European genotype (EU-
PRRSV) is much higher than in the North American genotype 
(NA-PRRSV) (3). The evidence of the restricted serological cross 
reactivity between the genetic subtypes exists (1, 3) but it is 
unknown whether it impacts the sensitivity or specifi city of the 
ELISA diagnostic tests methods. To address this problem 175 
sera from farms where diff erent genotypes and genetic sub-
types circulated were tested with three commercial and one in 
house ELISA tests. 
Materials and Methods
Serum samples were obtained from 3 Polish, 4 Belarusian and 1 
Ukrainian farms, where diff erent genotypes and subtypes circu-
lated as it was determined by PCR and DNA sequencing. In 2 of 
3 Polish farms subtype 1 of EU-PRRSV circulated. In one farm the 
NA-PRRSV strain was present. In Belarusian and Ukrainian farms 
diverse East European subtypes circulated (3). Additionally, 31 
samples from pigs from farms free from PRRSV were used. They 
included 17 sera from Sweden that earlier were found to react 
false positive in HerdChek PRRS 2XR (IDEXX) ELISA and negative 
in IPMA test. The samples were tested with HerdChek 2XR and 
3X (IDEXX), Ingezim PRRS DR (Ingenasa) and the in house test 
produced in our laboratory. The Ingezim test is specifi c for EU-
PRRSV while the remaining tests are specifi c for both genotypes. 
Results were compared for each pair of ELISA tests separately 
using McNemar’s test.
Results
All ELISAs detected PRRSV specifi c antibodies in sera from all 
farms were EU-PRRSV infection was present. Both IDEXX tests 
and the in house ELISA detected antibodies to NA-PRRSV in all 
sera from the Polish farm were this genotype circulated while 
Ingenasa test detected seroconversion in only 5 of 12 of the 
samples. In case of samples from one Ukrainian farm infected by 
EU-PRRSV subtype 2 the Ingezim test appeared to be signifi cant-
ly more sensitive than PIWet and HerdChek X3 tests. The analysis 
of the specifi city proved it to be highest in case of the HerdChek 
X3 test. The HerdChek 2XR test gave false positive results with 
most of the Swedish sera as it was found before.
Discussion
Very high genetic diversity of PRRSV poses a serious problem 
for PCR diagnosis, especially for the detection of the European 
genotype. However, our preliminary data show that it does 
not infl uence serological diagnosis by ELISA. All tests used in 
the study were sensitive in detection of antibodies induced by 
diff erent, diverse genetic subtypes of EU-PRRSV. However, the 
3X test seemed to be slightly less sensitive than the older 2XR 
test and the Ingezim DR. The 3X test was the most specifi c test 
of all. Further studies are necessary to fully evaluate the impact 
of the antigenic diversity of the EU-PRRSV on sensitivity and the 
specifi city of the serological methods of PRRS diagnosis.
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Farm and 
genotype
Number of 
samples
PIWet
HerdChek 
2XR
HerdChek 
X3 Ingezim DR% of positive 
samples
PL1 (EU sub 1) 10 80.0 90.0 80.0 100.0
BY1 (EU) 6 100.0 100.0 100.0 100.0
BY2 (EU sub 3) 9 100.0 100.0 100.0 100.0
PL2 (EU sub 1) 24 95.8 91.7 95.8 87.5
BY3 (EU) 8 62.5 87.5 50.0 100.0
BY4 (EU sub 3) 28 67.9 75.0 57.1 67.9
PL (NA) 12 100.0 100.0 100.0 41.7
UA (EU sub 2) 16 56.3 75.0 62.5 100.0
BY (EU) 31 90.3 96.8 96.8 96.8
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PRRSV-neutralization test - a tool for quality control?
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Introduction
Vaccination against PRRSV is frequently practised in Germany to 
control PRRSV. Attenuated live vaccines of the North American 
(NA) and European (EU) genotype are used. Early after infec-
tion antibodies are detected in ELISA, however neutralizing 
antibodies (nAb) are detected only at low titre and late (>28 
days) after infection. Additionally, detection of nAb depends 
on the virus isolate. Assuming that induction of homologous 
nAb against vaccine virus after vaccination is a positive quality 
criterion, a PRRSV-neutralization test (NT) using vaccine virus 
was established. Data obtained by analysis of fi eld cases will be 
presented. 
Material and Methods
NT with 100 CID50 of NA- and EU-vaccine virus, respectively, was 
performed on Marc145 cells with 2% guinea pig complement 
(BÖTTCHER et al., 2006). Culture was checked for CPE until day 6. 
Results are given as titre: <2, 2, 2.8, 4, 5.6, 8, ≥11.2. 
Sera were tested by PRRSV-ELISA (Idexx) according to manufac-
turer’s instruction. A nested RT-PCR was performed according 
to PESCH et al. (2000). Blood was collected from gilts, sows at 
1. and 5. parity and piglets after weaning 4, 8, 12 weeks of age. 
10 animals per group were tested. For calculation of geometric 
mean of NT-titre a titre of ≥ 11.2 was scored as 11.2.
Results
1.  In herds with an acute outbreak of PRRSV and absence of 
vaccination with NA-PRRSV, sera with high EU-NT-titres 
(≥11,2) were negative for nAbs to NA-PRRSV. Sera with high 
NA-NT-titres (≥11,2) from herds free from EU-PRRSV and 
vaccinated with NA-PRRSV were negative in EU-NT. Thus 
cross-neutralization between genotypes seems unlikely.
2.  Comparison of ELISA and NT revealed that 30% of ELISA-
negative sera were positive in at least one EU- or NA-NT; in 
contrast 67% of ELISA-positive sera were positive in NT, too. 
This diff erence between tests is explained by longer persis-
tence and late induction of nAb, respectively.
3.  As a consequence of an acute PRRSV-outbreak high NT-titres 
were observed in sows; maternally derived nAb (MDnAb) 
controlled infection in piglets until 12th weeks of age. PRRSV 
was detected in piglets with MDnAb by PCR when the geo-
metric mean of the NT-titre dropped below 4. 
4.  Regarding vaccination 90% of piglets free of MDnAbs at 
vaccination (14-21 days p.n ) were positive in PCR until 8 
weeks of age. A slight increase of NT-titre was observed until 
the 12th week of age. In contrast, only 10% of piglets with a 
mean NT-titre of MDnAb of 7 at vaccination were positive in 
PCR two days p.vacc.
5.  Low or no NT-titres were frequently detected month after 
vaccination.
6.  Sows of 5th parity had generally lower titres than sows of 
1st parity, unless recent acute outbreaks in the herds were 
reported. Vaccination every 4 month was not eff ective in rais-
ing NT-titres in these animals. As a consequence off springs of 
these sows are earlier susceptible to infection.
Discussion and Conclusions
PRRSV NT is a powerful tool in order to determine at least one 
side of PRRSV immunity; however, it is laborious and expensive. 
As a consequence NT should be substituted by an appropriate 
ELISA. 
It is questionable if vaccination in the presence of homologous 
nAb is eff ective. This is especially important for piglets with MD-
nAb. Thus prediction of an optimized time-point of vaccination 
is necessary. Additionally, gilts should be checked by NT before 
they are introduced into infected herds.
Extend of cross-neutralization within genotypes especially EU is 
still not suffi  ciently analysed. If antigenic heterogeneity of PRRSV 
isolates due to its high frequency of mutation is a real problem 
like in Infl uenzavirus A, Bluetonguevirus, Foot-and-Mouth-Dis-
ease Virus etc., serotypes have to be established. NT is the test of 
choice for establishment of serotypes.
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IL-10 and TGFβ expression in the lung and tonsil of pigs experimentally 
infected with porcine reproductive and respiratory syndrome virus
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Introduction
Porcine Reproductive and Respiratory Syndrome (PRRS) is 
characterized by inducing an equivocal immune response (1). 
Immunomodulatory cytokines, namely IL-10 and TGF β, are 
able to inhibit the expression of several other cytokines and the 
onset of an effi  cient immune response (2), and they are con-
sidered as possible key mediators in the impairment of host im-
mune response observed in PRRS (1). Therefore, the main goal of 
this study was to study the expression of IL-10 and TGF β in the 
lung and tonsil of pigs experimentally with PRRS virus (PRRSV). 
Materials and Methods
Thirty-two 5-weeks-old pigs from a high-healthy farm historic-
ally seronegative for PRRSV were used for the experimental 
infection. Twenty eight pigs were randomly distributed in 
batches of four, inoculated by the intramuscular route with 1 
ml of 103.0 TCID50 PRRSV strain, and killed at 3, 7, 10, 14, 17, 
21 and 24 days post-inoculation (dpi). The four remaining pigs 
were used as controls, inoculated with 1 ml of sterile medium 
and killed at the end of the study (24 dpi). At the necropsy lung 
and tonsil samples were collected and fi xed with 10 % neutral 
buff ered formalin and Bouin solution, for the histopathological 
and immunohistochemical studies, respectively. In the immuno-
histochemical study the following primary antibodies were used: 
anti-PRRSV (SDOW17/SR30; Rural Technologies Inc.); anti-porcine 
IL-10 (AF693; R&D Systems Inc.); anti-TGF β (AB101NA; R&D 
Systems Inc.), as previously described (3). Immunolabelled cells 
were counted and morphologically identifi ed as macrophages, 
lymphocytes or neutrophils.
Results
A higher expression of IL-10 was observed at 7 dpi in the lung 
parenchyma of PRRSV-inoculated pigs, whereas TGF β was 
enhanced at 3 and 10 dpi, and at the end of the study (24 dpi). 
In addition, the expression of PRRSV antigen peaked at 7dpi, 
showing a positive correlation with respect to the pulmonary 
expression of IL-10 and TGF β (r = 0.77 and r = 0.76, respectively).
On the other hand, both IL-10 and TGF β showed an undulant 
expression in the tonsil of PRRSV-inoculated animals. Interest-
ingly, PRRSV antigen displayed a similar kinetics than the one 
observed for IL-10 (r = 0.76), but no correlation was observed 
with respect to the expression of TGF β in the tonsil.
IL-10 was mainly expressed in the cytoplasm of macrophages 
from the alveolar septa, however, TGF β was chiefl y expressed 
by pulmonary alveolar macrophages (PAMs). In the tonsil, the 
expression of immunomodulatory cytokines was observed in 
the cytoplasm of macrophages of the lymphoreticular areas, 
and secondly by lymphocytes. TGF β was also expressed in the 
cytoplasm of few neutrophils.
Discussion
The correlation and similar kinetics observed between the 
expression of IL-10 and PRRSV antigen in lung and tonsil sug-
gests that PRRSV replication may induce the expression of 
this cytokine. On the other hand, the expression of TGF β and 
PRRSV antigens was correlated only in the lung but displayed 
a diff erent kinetics. Thus, an indirect pathway to induce TGF β 
may be activated by PRRSV. Nowadays, the regulatory T cells are 
considered as possible source of IL-10 and TGF β and their role in 
the immune response is being studied in PRRS (4). 
We have previously reported that septal macrophages were the 
main cells expressing IL-10 and proinfl ammatory cytokines (3). 
Interestingly, PRRSV and TGF β antigens were chiefl y expressed 
by pulmonary alveolar macrophages (PAMs). Thus, TGF β may 
avoid the lung expression of proinfl ammatory cytokines and 
other cytokines by PAMs in PRRSV-infected pigs.
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Introduction
A basic requirement of live vaccine virus strains is that natural 
transmission of vaccine virus is minimal or non-existent (3). The 
objectives of this study were (a) to determine the frequency 
of the EU and the NA genotype PRRS vaccine viruses in a large 
sample of pigs from North-Western Germany, (b) to assess the 
association between vaccine isolate detection and vaccination 
history and (c) to characterise the identifi ed vaccine isolates 
considering their origin.
Material and Methods
During January and December 2007, 1,970 pigs were submitted 
to the Field Station for Epidemiology for post-mortem examina-
tion. Nine hundred and two of these pigs aged between 1 and 
25 weeks of life had a history of respiratory disease and/or ema-
ciation and were included in the study. The 902 pigs originated 
from 439 herds and were submitted by 141 diff erent veterinary 
practices. Lung tissue from these pigs was tested for PRRSV by 
a nonaplex RT-PCR. Those samples positive for PRRSV were se-
lected for further examination and genetic typing. The vaccina-
tion history was obtained from the veterinary surgeons who had 
submitted the pigs. Telephone interviews were conducted that 
followed a standardised questionnaire consisting of six closed 
(predefi ned range of answers or yes/no) questions on PRRS 
vaccination management/history of the herds of origin. It was 
hypothesised that these variables were related to the detection 
of the vaccine and/or wild-type viruses.
Results
Overall, 18.5% of the samples were positive for the EU wild-type 
virus. EU genotype vaccine virus was detected in 1.3% and the 
NA genotype vaccine virus in 8.9% of all samples. The produc-
tion stage-specifi c detection rates for EU wild-type virus and NA 
genotype vaccine virus showed the highest values in weaning 
and growing pigs (Fig. 1).
Material from 168 of the 259 samples found positive in the diag-
nostic laboratory was available for genetic typing by amplifying 
and sequencing the ORF5. Of these, 104 were of the EU geno-
type, and 64 of the NA genotype. The ORF5 nucleotide sequence 
of 11 of the EU genotype isolates had 99.1–100%, identity with 
the corresponding ORF of the Porcilis PRRS DV strain. Nucleo-
tide identities of the remaining EU genotype isolates with the 
Porcilis PRRS-DV strain were between 85.3 and 91.7%, allowing 
their classifi cation as EU wild-type virus. Nucleotide identities 
of the ORF5 of the NA genotype isolates with the Ingelvac PRRS 
MLV vaccine strain were between 96 and 100%. The detection 
of the EU vaccine was signifi cantly higher in pigs vaccinated 
with the corresponding vaccine (OR = 9.4). Pigs vaccinated with 
NA genotype had signifi cantly higher detection chances for the 
corresponding vaccine virus when compared to non-vaccinated 
animals (OR = 3.34) animals, however, NA vaccine was also fre-
quently detected in non-vaccinated pigs.
Fig. 1: Production stage-specifi c detection frequencies (nonaplex RT-
PCR, DV-PCR) for PRRS EU wild-type virus, PRRSV EU live vaccine virus 
and PRRSV NA live vaccine virus.
Discussion
The spread of vaccine virus within herds has been demonstrated 
in several studies (1, 2). However, data on age-dependent detec-
tion rates of live PRRS vaccine virus have not been published. 
The evident similarities in the dynamics of the NA genotype vac-
cine virus and the EU wild-type virus strongly support the con-
tention that spontaneous transmission of the Ingelvac PRRS MLV 
is a common occurrence in those countries using this vaccine. 
Known that an eradication of PRRSV from infected herds would 
require a fundamental knowledge of the dynamics of PRRS virus 
infection and epidemiology, the results of this study show that 
this is not only needed for the PRRS wild-type virus but also 
for live vaccine viruses. Obvious diff erences in the potential of 
spontaneous spread of diff erent PRRS vaccine viruses should be 
considered when choosing vaccines to be used in an eradication 
program.
References
(1)  Botner A. et al. (1997) Vet Rec 141
(2)  Botner A. et al. (1999) Vet Microbiol 68
(3)  Mateu E. et al. (2008) Vet J 177
PRRS Diagnostic/Immunology
149
Oral Presentations
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010
O.115
PRRS virus vertical transmission dynamics in a sow herd
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1. Boehringer Ingelheim Vetmedica, Inc., St Joseph, MO, USA; 2. College of Veterinary Medicine, University of Minnesota, St Paul, MN, USA
Introduction
After the introduction of porcine reproductive and respiratory 
virus (PRRSv) into a susceptible breeding herd, reproductive fail-
ure and an increase in pre-weaning mortality may be observed. 
Within a few months, the production parameters of the breed-
ing herd may return to levels similar to those prior to infection. 
However, the presence of persistently infected individuals1 and 
the continuous introduction of susceptible pigs perpetuate viral 
transmission2. Questions regarding the prevalence of PRRSv 
shedding in endemically infected breeding herds and transmis-
sion of the virus in the farrowing room over time remain unan-
swered. Therefore, the objective of this study was to determine 
the prevalence of PRRSv infected piglets and litters at birth and 
at weaning in an endemically infected breeding herd.
Materials and Methods
A PRRSv-naïve 1500 sow farrow-to-wean farm became infected. 
The owners and the veterinarian decided to inject 1 mL of serum 
containing 101.6 TCID50 of the herd-specifi c PRRSv isolate to all 
sows in an attempt to hasten the spread of the virus3. During the 
4th wk post-inoculation (PI), 59 sows farrowed. To estimate the 
prevalence of PRRSv infected litters, blood was collected from all 
pigs in a random sample of 38 litters at birth and again at wean-
ing. The sample size was based on a desired confi dence level of 
95%, an expected prevalence of 6.3%, and 1.66% (1 positive / 60 
litters) as the lowest possible prevalence (EpiInfo 6, Stone Moun-
tain, GA). The expected prevalence of 6.3% infected litters per 
farrowing group was calculated based on detection of one posi-
tive pool by the “traditional sampling protocol”, testing 4 pools 
comprised of 5 piglet samples by PCR (Pool Prevalence Calculator, 
AusVet, Animal Health Services, Australia). The sampling/testing 
process was repeated on litters from another group of farrowing 
sows 12 wks PI. These two farrowing groups were selected as be-
ing representative of epidemic (4 wks PI) and endemic infection 
(12 wks PI). Serum samples were randomly pooled in groups of 5 
and tested by RT-PCR. All samples in a positive pool were tested 
individually. Proportion of PCR-positive piglets and litters were 
compared using Fisher’s Exact Test (Statistix® 8).
Results
At 4 wks PI, 26% of the litters were PCR-positive at birth and 55% 
at weaning. At 12 wks PI, 8% of the litters were positive at birth 
and 31% at weaning. A signifi cant reduction in the prevalence 
of positive litters at birth (P=0.03) and at weaning (P=0.04) was 
observed from 4 to 12 wks PI. The prevalence of PCR-positive 
piglets at 12 wks PI was signifi cantly lower at birth and weaning 
than at 4 wks PI (P<0.01). Both at 4 and 12 wks PI, the prevalence 
of positive piglets (P<0.05, Figure 1) and litters at weaning was 
signifi cantly higher than at birth. Between 52% and 77% of the 
PCR-positive litters at birth or at weaning had only 1 or 2 posi-
tive piglets within the litter.
Figure 1. Prevalence of PRRSv PCR-positive piglets
Discussion 
The results demonstrate transmission among litters in the same 
farrowing room and support the sampling of piglets late during 
lactation as a tool to monitor PRRSv transmission. The fact that 
PRRSv vertical transmission may occur in as few as one newborn 
piglet of a litter, and that this very low within-litter prevalence 
of infection can be maintained until weaning, makes it neces-
sary to reassess the sampling approach used today for breeding 
herds. The results of this study demonstrate that PRRSv infection 
prevalence in suckling piglets in an endemically infected breed-
ing herd decrease to such levels that the “traditional monitoring 
protocols” will have insuffi  cient sensitivity to determine the true 
infection status of the herd. 
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Investigation of factors associated with porcine reproductive and respiratory syndrome (PRRS) 
herd status for production sites in a low density area of swine production in Quebec, Canada
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Introduction
Transmission of PRRS virus can occur by diff erent ways and sev-
eral factors may increase the risk of contamination of a herd. The 
objective of this exploratory study was to identify and quantify 
the eff ects of potential risk factors on PRRS status.
Materials and Methods
All premises containing sows in a low density area of swine pro-
duction (Estrie) were included. A questionnaire was developed 
to assess the principal potential risks factors reported in litera-
ture for introduction of PRRS virus on a site or within a herd. The 
questionnaire was completed by the owner (independent farm) 
or by the employee (for farm under contract) and fi lled out by a 
single interviewer. Answers were obtained by phone and during 
a farm visit and included information about herd characteristics, 
geographical coordinates of the site and biosecurity require-
ments (layout of the site, entrance protocol, transportation of 
animals, dead pig disposal, pest management, feed and semen 
deliveries, manure management). Biosecurity was described as 
measures implemented by producer to limit introduction of dis-
eases on the site and inside units. PRRS status was determined 
by ELISA (IDEXX HerdChek-PRRS 2XR) or qRT-PCR according to 
clinical signs observed. Associations with PRRS herd status were 
assessed by simple logistic regression for the following variables: 
herd size expressed in HPU as previously described (1), distance 
from the nearest site and from the public road, 22 biosecurity 
variables and a global biosecurity index (low or high: generated 
by two-step clustering procedure in SPSS with the 22 biosecur-
ity variables). Two multivariable (backward selection) logistic 
models were built using SAS (SAS institute Inc., 1989) in order 
to compare the impact of a global biosecurity index vs. single 
biosecurity variables. 
Results
On 54 production sites (participation rate of 79%), 15 and 39 
were negative and positive to PRRS virus, respectively. Signifi -
cant variables associated with herd status in univariable analysis 
are shown in Table 1. Results of multiple logistic regression for 
both models are shown in Table 2.
Table 1: Factors associated with PRRS herd status using univariable 
logistic regression (p<0.15)
Flori et al. 1995. Prev Vet Med 25: 51-62.
Variables Description
HPU1,2 >300 HPU (~1000 sows)
Neighbour1,2 <1500 m from nearest pig site
Road1,2 Public road < 300 m from unit
No Protocol1 Absence of shower or clear separation between contam-inated and clean area
Index2 Low biosecurity level
1 Variable used in model 1.
2 Variable used in model 2. 
Table 2: Factors associated with PRRS herd status using multivariable 
logistic regression
Model Variables Betas OR 95% CI (OR)
1 Neighbour -1.83 6.2 1.2-33.3
No Protocol -1.49 4.5 1.1-17.5
2 Neighbour -2.02 7.5 1.4-40.0
HPU -1.57 4.8 1.1-21.2
Intercept: Model 1: 2.79, Model 2: 3.43
Discussion
For both models, having a site closer than 1500 m signifi cantly 
increased the odds of being PRRS positive. From model 1, 
absence of an entrance protocol was also an important factor 
for positivity (OR=4.5). HPU was not kept in the fi nal, having a 
p=0.0517 in the last alternative model of the model building 
strategy (OR=4.8, CI=1.0-23.8). In model 2, the association with 
the biosecurity index was not signifi cant when adjusting for 
other predictors (HPU, Neighbour). The global index being a 
composite of 22 diff erent variables of which several were not 
signifi cantly associated in the univariable analysis might explain 
the lack of association with PRRS status in the fi nal model.
Conclusion
In this low density area, sites without an entrance protocol or lo-
cated within a short distance from neighbouring pig operations 
were more likely to be PRRS positive. Further analyses will be 
performed to investigate the eff ect of pig-site density in order to 
clarify associations found with neighbourhood. 
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Dynamics of virus excretion and transmissibility of European-type PRRSV isolates of high and low virulence
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Introduction
Porcine reproductive and respiratory syndrome (PRRS) is a 
disease causing high economic losses worldwide. The etiological 
agent, PRRS virus (PRRSV), is highly heterogenic. This variability 
of PRRSV has resulted in the emergence of strains diff ering in 
virulence. Previous studies carried out with American-type iso-
lates have demonstrated that the degree of virus transmission 
and aerosol shedding are related to isolate pathogenicity (1). 
However, similar studies have never been done using European 
isolates. The objective of this study was to determine whether 
diff erences in virulence of European-type isolates signifi cantly 
aff ect the frequency of shedding and transmission to sentinel 
pigs.
Materials and Methods
Four diff erent isolates were used in this study: one highly 
virulent isolate, one isolate of low virulence, the vaccine strain 
included in PorcilisPRRS vaccine, and an attenuated version of 
the highly virulent isolate obtained after 20 passages on Marc-
145 cells. 
Sixty 3-week old PRRSV seronegative piglets were randomly 
divided into 4 treatment groups. On day 0 of the experiment 
fi ve pigs per group were isolated and inoculated intramuscularly 
with 105 TCID50 of one of the isolates used in this study. After 
two days of isolation, the remaining ten pigs of each group were 
housed with the inoculated pigs. Blood samples were collected 
from all pigs on days 0, 3, 6, 10, 14, 19 and 24 post-infection (p.i.). 
Nasal, oral and rectal swabs were obtained the days of blood 
collection from principal pigs. Virus isolation was carried out 
on porcine alveolar macrophages (PAM) or Marc-145 cultures 
depending on the challenge isolate. All swabs were tested by 
RT-PCR for the presence of PRRSV RNA. For antibody detection, 
serum samples collected on Day 24 were analyzed by a commer-
cial ELISA. 
Results
Viremia in principal pigs was a frequent fi nding in our study. 
Specifi cally, virulent isolate and its attenuated version were 
detected during the entire experimental period; virus of low 
virulence was mostly detected from 3 p.i. to day 14 p.i. and vac-
cine strain was detected only sporadically. In addition, PRRSV 
was shed by diff erent routes by pigs of all experimental groups, 
although the frequency of shedding diff ered signifi cantly 
between groups. In this sense the highly virulent isolate was 
detected in most of the swabs obtained between days 3 and 14 
p.i. and less frequently thereafter. The highly virulent adapted to 
growth in Marc-145 cells was also frequently detected although 
the frequency of dtetion was lower than in its parental virus. On 
the contrary, low virulent isolate was only detected sporadic-
ally and mostly in days 6 and 10 p.i. Likewise, vaccine strain was 
detected sporadically being the less frequently isolated virus. 
Finally, transmission to in-contact pigs, measured either by de-
tection of viremia or seroconversion, was detected in all experi-
mental groups. However the frequency of transmission diff ered 
signifi cantly between diff erent experimental groups. Particularly, 
all and nine out of ten pigs were infected in groups exposed to 
highly virulent isolate and its attenuated version, respectively, 
while only two pigs exposed to low virulent isolate and vaccine 
strain became infected.
Discussion 
The objective of this study was to evaluate the impact of PRRSV 
isolate virulence on shedding by diff erent routes and transmis-
sion to in-contact pigs. Our initial hypothesis was that highly 
virulent isolates would replicate more effi  ciently in pigs and con-
sequently would be shed in higher amounts and readily trans-
mitted to susceptible animals. This theory was confi rmed by the 
fact that all in-contact pigs exposed to pigs infected with highly 
virulent isolate became infected while only two were infected 
among those exposed to either pigs infected with an isolate of 
low virulence or vaccinated pigs. The highly virulent isolate was 
adapted to grow in Marc-145 cells with the purpose of limiting 
its ability to replicate in natural target cells, hampering in this 
way its transmission capability. However our results indicate that 
after 20 passages in Marc-145 cells the isolate retains its parental 
ability to replicate and be transmitted.
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The impact of respiratory disease on production in the pig industry in Great Britain
Charlotte M. Evans1 Graham F. Medley2 Laura E. Green2
1. BPEX, Kenilworth, Warwickshire, UK; 2. University of Warwick, Coventry, UK
Introduction
Respiratory disease is the most signifi cant cause of morbid-
ity and mortality in pigs post-weaning. This project used data 
gathered as part of a DEFRA/BPEX-funded project on post 
weaning multisystemic wasting syndrome (PMWS) to investigate 
respiratory diseases in 116 pig herds. The specifi c aims of the 
project were to: 1) Estimate the prevalence and incidence of 
common respiratory diseases in England and investigate their 
associations with one another and with post-weaning mortal-
ity; 2) Investigate antibody profi les for porcine reproductive and 
respiratory syndrome virus (PRRSV)-infected herds and to deter-
mine management factors associated with diff erences in profi les 
between herds; 3) Investigate how PRRSV could persist within 
infected herds using mathematical models and available data; 4) 
Determine the impact of PRRSV infection on disease and explore 
theoretically how this could be reduced by diff erent control and 
elimination strategies 
Materials and Methods
Questionnaires were completed by veterinarians that attended 
116 pig herds in GB. Management factors were collected from 
on-farm interviews with unit managers. Management factors 
were investigated for their association with the within and 
between-herd variability in pig antibodies to PRRSV in 103 pig 
herds. To investigate the mechanisms that could lead to fade out 
of PRRSV, within-herd transmission dynamics were investigated 
using a mathematical model.
Results
From the results, it was shown that PRRS was frequently associ-
ated with raised mortality and morbidity when present with 
other disease causing agents in a herd. Antibody profi les for 103 
herds were investigated (50 pigs were sampled in each herd). In 
35 herds no pigs had PRRSV antibody. These were considered 
PRRSV negative. These herds were more likely to have less than 
250 sows and be located more than two miles from another pig 
farm. Sixty eight herds had pigs with antibody to PRRSV (twenty 
seven of which were vaccination). Higher antibody levels were 
present in antibody positive herds that did not isolate gilts 
for >6 days. In 39% of antibody positive herds that were not 
using vaccination, only breeding sows were antibody positive, 
suggesting that there was antibody on the farm but no virus 
because the growing pigs were antibody negative. This is indica-
tive of fade out of virus, i.e. its disappearance from a herd in 
which it has been present. In our mathematical models fade out 
was also more likely in small herds with little/no reintroduction 
of infectious stock. 
To investigate the mechanisms that could lead to fade out of 
PRRSV, within-herd transmission dynamics were investigated 
using a mathematical model. When virus was introduced into a 
herd via gilts there was a high frequency of fade out in breed-
ing pigs before the virus reached young stock. Once the virus 
had reached young stock there was an increased probability 
of virus persisting in the herd. This was also more likely in large 
herds, herds with increased contact between age groups and 
herds that had frequent re-introduction of virus (for example 
through purchasing infectious pigs, or wind borne spread). The 
results highlight the importance of determining whether a herd 
is truly infected or not and appropriate sourcing and isolation of 
new stock. The patterns observed suggest that the processes of 
re-introduction, persistence and fade-out of PRRSV play critical 
roles in the spread of PRRSV throughout the pig industry.
Mathematical models were also used to investigate the range of 
clinical disease observed as a result of infection with PRRSV and 
the result of strategies for control and elimination. PRRSV was 
diffi  cult to eliminate without targeting both rearing pigs and 
sows. Rapid vaccination of sows once there was an increase in 
stillbirths reduced the risk of spread of virus to rearing pigs but 
not in all simulations. 
Discussion
In areas where the density of herds is low it might be possible to 
control PRRSV by elimination in individual herds. In larger herds 
in pig dense regions, elimination might be diffi  cult and control 
of disease might give more stability. The long-term benefi ts of 
elimination will depend on the risk of re-introduction of virus 
into the herd. 
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Long distance airborne transport of viable PRRSV and Mycoplasma hyopneumoniae 
from a swine population infected with multiple viral variants
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Swine Disease Eradication Center, University of Minnesota College of Veterinary Medicine,, St. Paul, MN, USA
Introduction
Airborne transport of porcine reproductive and respiratory 
syndrome virus (PRRSV) and Mycoplasma hyopneumoniae (M 
hyo) has been reported out to 4.7 km (1). The objectives of this 
study were to simulate clinical conditions observed in the fi eld 
through the creation of a mixed infection of heterologous PRRSV 
variants in conjunction with M hyo in a population of growing 
pigs. We planned to use this unique model to evaluate the long 
distance airborne transport of these agents out to and beyond 
4.7 km and assess their viability in long distance air samples. The 
study was based on the hypothesis that long distance airborne 
transport of PRRSV is not variant-specifi c.
Materials and Methods
To accomplish this goal, a mixed infection of 3 PRRSV variants 
(1-8-4, 1-18-2 and 1-26-2) and M hyo 232 was established in a 
source population of growing pigs. Over 21-day period, air sam-
ples were collected from the source population and at designat-
ed distances from the herd, ranging from 1.4 to 10.2km from the 
source facility. A cyclonic collector (Midwest Microtek, Brook-
ings, SD, USA) capable of collecting 400 L of air per minute was 
used to collect air samples. The collector was placed downwind 
from the source facility in accordance with one of the 4 cardinal 
directions: north (N), south (S), east (E) and west (W) and the 4 
intermediate directions: northwest (NW), northeast (NE), south-
west (SW) and southeast (SE). Four long distance samples were 
collected each day, i.e. SW-4km, SW-3km, SW-2km and SW-1km 
from the source facility. Samples were tested for PRRSV RNA and 
M hyo DNA by PCR and if positive, were sequenced (PRRSV: ORF 
5, M hyo P146 gene) and quantifi ed (PRRSV only). In addition, 
viability assessments were made of PCR-positive samples using 
modifi ed swine bioassay (2,3).
Results
On day 7 PI, all 3 PRRSV variants were detectedin the herd; 
however, by day 21 PI only PRRSV 1-8-4 was found in sera and 
tissues from source population animals. Cinical respiratory 
disease indicative of PRRS and enzootic pneumonia increased 
from 27 cases on day 0 PI to 82 cases on day 10 PI. In exhaust air 
from the source population, PRRSV and M hyo were detected in 
21/21 and 8/21 air samples, respectively. Of the 21 samples, 18 
contained PRRSV 1-8-4 and 3 contained PRRSV 1-18-2. The mean 
quantity of infectious virus across all 21 samples was 9.3x104 
TCID50/mL (range = 1.0x101 TCID50/mL to 6.3x105 TCID50/mL). 
Five of 114 (4.4%) long distance air samples were positive for 
PRRSV and 6 of 114 (5.2%) were positive for M hyo. The 5 PRRSV-
positive samples were collected at 2.3, 4.6, 6.6 and 9.1 km from 
the herd. All contained viable virus (range = 1.0x101 TCID50/mL 
to 2x102 TCID50/mL) and were > 99.2% homologous to PRRSV 
1-8-4. No evidence of PRRSV 1-18-2 or 1-26-2 was detected in 
long distance samples. All 6 M hyo-positive samples were 99.9% 
homologous to M hyo 232 and 3 samples (collected at 3.5, 6.8 
and 9.2km from the herd) were infectious as determined by the 
presence of M hyo DNA in nasal swabs, tracheal and-bronchial 
swabs as well as evidence of gross and microscopic lesions sug-
gestive of M. hyo infection in bioassay pigs 
Discussion
These results are the fi rst proof of airborne transport of these 
pathogens in a viable state over this distance. The origin of these 
pathogens was confi rmed to be the source population, since the 
PRRSV 1-8-4 RNA and M hyo 232 DNA present in long distance 
air samples was homologous to that found in experiment-
ally inoculated animals and in exhausted air. In addition, the 
quantity of infectious PRRSV was determined by virus titration 
in all 5 samples and viability of both pathogens in long distance 
air samples was further confi rmed by swine bioassay. Whether 
either agent could have been transported over greater distan-
ces than those reported here cannot be answered at this time; 
therefore, future studies are required. In conclusion, his new 
information will assist swine veterinarians in the development of 
sustainable area/regional programs for the control and eventual 
eradication of these economically signifi cant diseases of pigs.
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The characteristic of High Pathogenic PRRS 2009 outbreak epidemiology 
and pathogenesis in middle Shandong area
Sidang Liu; H Li; L Nie
College of Animal Science, Shandong Agricultural University, Shandong, China
Porcine reproductive and respiratory syndrome virus (PRRSV) is 
the causative agent of PRRS, a disease characterized by repro-
ductive failure and respiratory distress in swine[1]. The RNA virus 
feature made PRRSV highly mutational and thus result various 
virulence diff erences among strains [2]. The so-called “High 
Fever Disease” emerged in southern China in June 2006 and 
rapidly spread to the whole country. This “High Fever Disease” 
was characterized by fast transmission, acute infection, high 
morbidity and mortality (20-30% average and in some cases 
over 50% and even reach 100%). Following research and diagno-
sis indicated the Disease is caused by “High Pathogenic Strain of 
PRRSV” with a 30 amino acids deletion in NSP2 [3].
After a two-year’s stable phase, the High Pathogenic Strain 
of PRRS again busted out in the summer of 2009, including 
Jiangsu, Anhui, Henan, Shandong and Hebei provinces. In this 
report, we analyze the epidemiology of the disease in Shandong 
and lesions of infected pigs as to better understand the disease 
characters for future control.
Epidemiological investigation: Samples of 100 scaled pig farms 
and 200 backyards from 10 areas in Shandong were collected 
for serology analysis. Meanwhile, relevant information including 
vaccination procedure against PRRS, mortality and morbidity 
during the outbreak were also investigated by visit or by phone 
of the farms. The investigation clearly showed that the outbreak 
emerged in backyards below 50 sows fi rst. These farms barely 
have any vaccination program against PRRS and the morbidity 
can reach up to 70%. But, comparing with backyards, outbreaks 
in scaled farms (48/100) in general were postponed somehow. 
We listed the morbidity and mortality with the diff erent types of 
farm with their PRRSV vaccine in use below (Table 1).
Clinical symptoms and lesions: Finishing and sow herd were 
infected fi rst, infected pigs showed high body temperature, 
wasting and emaciation. Most infected pigs showed dark red 
skin (skins colors around belly and peripheral extremities even 
turned purple), ear cyanosis; thumping, coughing and irregular 
breathing; snivel and conjunctivitis; constipation, turbid and 
dark color urines. Pigs with long disease course would turn pale 
and show anemia, some could not stand till death. In some 
cases, sow abortions at 100-110 days post pregnancy, mummifi -
cation and death fetus or weak piglets could also be observed. 
Conclusion and Discussions
Comparing with the 2006 “High Pathogenic PRRS”, the epidemic 
situation this time showed many diff erences: fewer farms were 
infected, low morbidity, salutatory spread, slow transmission, 
more sensitivity of pregnant sows and gilts, mortality varied 
much and had a longer disease course.. This can be explained 
by the acquired immunity of herds survived from last out break. 
However, earlier infections and more severe loss in household 
farm remain the same between two outbreaks, suggesting fac-
tors like poor feeding, management and bio-security measures, 
inappropriate medication program and confection with other 
diseases are also main cause of the diseases. 
The macroscopical and microscopical lesions of the two breaks 
are almost the same, while herds vaccinated against PRRS or 
survived from last PRRS outbreak showing less severe and un-
typical lesions. Moreover, Mycoplasma hyopneumoniae, PCV2, 
CSFV coinfection lesions become quite common, while bacterial 
secondary infections, like Pericarditis serofi brinosa and pleuro-
pneumonia, were rare. Rare bacterial secondary infections were 
due to the massive use of antibiotic in the epidemic.
Field experiences demonstrated that killed vaccines against 
PRRS are safe but the effi  cacy is limited. Despite the homo-
geneity diff erence between classical and high pathogenic 
strains, the fi eld practice revealed the eff ective cross protection 
provided by classical strain vaccines. Especially, in our investiga-
tion, we found that farms vaccinated with Boehringer Ingelheim 
PRRS MLV have much easier days in the break. Whether the 2009 
strain possesses new mutations regarding to virulence is still 
under study. 
Table 1. 
Type of farm (Number) Morbidity % Mortality %
Scaled Farm No vaccination (8) 87.5 32.52
Local mineral oil vaccine (10) 70 27.10
Local freeze dried vaccine (21) 42.85 17.52
BI PRRS MLV (12) 16.67 9.32
BI PRRS MLV in sows; local freeze 
dried vaccine in commercial herd 
(49)
26.53 13.21
Backyards No vaccination (71) 85.92 41.12
local mineral oil vaccine (16) 50 29.23
local freeze dried vaccine (13) 30.77 19.50
Total Scaled farms (100) 38 9.32-32.52
Backyards (200) 76 13.50-41.12
BI PRRS MLV=Ingelvac PRRS MLV
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Prevalence of subclinical urinary tract infections in the Belgian sow population
Frédéric A. Vangroenweghe1 Tamara Vandersmissen2 Evelyne De Graef1 Ellen Van Driessche1 Frans Castryck1
1. DGZ-Vlaanderen, Torhout, Belgium; 2. DGZ-Vlaanderen, Lier, Belgium
Introduction and Objective
The prevalence of urinary tract infections (UTI) in sows in 
Belgium is not well known. In the neighbouring countries, the 
prevalence of (subclinical) UTI is estimated to be up to 20% (1). 
Urinary tract infections are responsible for sow mortality (2,3) 
and also have an impact on the breeding performance of the 
sow (1,4). Total born litter size, live born litter size and weaning 
litter size appeared to be lower in sows with UTI, while the wean-
to-oestrus interval and the wean-to-farrowing interval increases 
in these sows.
To investigate the prevalence of (subclinical) UTI in Belgium, a 
screening on Belgian sow herds was performed (project ‘Veepeil-
er-varken’ funded by the Sanitary Fund)
Materials and Methods
Twenty-fi ve Belgian pig herds, with at least 100 sows and no 
clinical signs of UTI, were selected to participate in this screen-
ing. Drinking water supply was continuous in 11 farms, but it 
was restricted in 14 others. In each farm between 9 and 21 late-
pregnant sows were sampled. A total of 353 urine samples was 
collected. Urine samples were collected in the morning, the fi rst 
jets of urine were avoided. Bacteriological study of the urine was 
performed by inoculating 2 diff erent media: Columbia sheep 
blood agar (Oxoid) and McConkey agar (Oxoid). After overnight 
incubation at 37°C in an atmosphere with 5% CO2, identifi cation 
of grown colonies was performed. Quantitative examination was 
performed through dilution of the urine samples in maximum 
recovery diluent (Oxoid) and subsequent inoculation of plate 
count agar (Biorad). After overnight incubation at 37°C under 
aerobic conditions, colony counting was performed. Nitrite 
detection was performed using the strip-test (Merckoquant; 
Merck).
Results
The predominant germs in the urine were E. coli (27%), Strep-
tococcus sp. (15%) and Staphylococcus sp. (14%). In 38% of the 
cases no growth could be observed. In total, 19% of the sows 
showed urine bacterial counts higher than 10E5 CFU/ml, which 
should be interpreted as indicative of UTI. In 16% of the cases, an 
UTI could be suspected since the urine bacterial counts varied 
between 10E4 to 10E5 CFU/ml (Figure 1). At herd level, 0 to 43% 
of the sampled sows could be demonstrated to suff er from a 
subclinical UTI. Comparing sows with continuous or restricted 
drinking water access, a slight but non-signifi cant diff erence in 
the prevalences of urine bacterial counts of higher than 10E5 
CFU/ml could be observed , with 17% and 20% of urine samples 
of sows with continuous and restricted access, respectively, 
showing counts indicative for UTI. The strip-test, which is indica-
tive for an E. coli infection, demonstrated 10% nitrite positive 
urine samples.
Figure.1 Distribution of urine samples according to the urine bacterial 
count. Unsuspected (< 10E4 CFU/ml); suspected (10E4-10E5 CFU/ml); 
infected (> 10E5 CFU/ml)
Discussion and Conclusions
The prevalence of subclinical UTI in the Belgian sow population, 
based on bacterial counts, is comparable to prevalence ob-
served in neighbouring countries. Based on the strip-test, only 
half of the sows with a subclinical UTI can be detected. However, 
not all germs responsible for UTI have the capacity to produce 
nitrite. Essentially, E. coli can produce nitrite, whereas Strepto-
coccus sp. and Staphylococcus sp., which can also provoke UTI, 
do not have a nitrite producing capacity. 
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A new method for oestrus synchronizing of gilts in group housing systems
Leo Suls; Jan Jourquin
Janssen Animal Heatlh, Beerse, Belgium
Introduction
Oestrus synchronization of breeding gilts with altrenogest is 
a common practice on many breeding farms, especially when 
a batch management system is used. The synchronization 
protocol implies a treatment of 18 consecutive days with an oral 
dose of 20 mg oil-based altrenogest solution (5 ml product). It 
is imperative that a correct daily dose is administered. When the 
gilts are housed in individual stalls, the product is easily dosed 
on the feed. For welfare reasons, sow stalls are banned or limited 
to the fi rst 28 days of gestation. This calls for alternative ways for 
successfully synchronization of the gilts. 
A new application method has been developed for Regumate® 
that allows individual treatment of gilts kept in groups.
Materials and Methods
For a farm expansion, 896 gilts were synchronized in a group 
housed situation administering altrenogest directly in the 
mouth. 
The preconditions for a new method are demanding. Repetitive 
administration of the right dose to an individual animal, housed 
in group, without disturbing the group, but also convenient for 
the animal caretaker. 
Janssen Animal Health developed a special dosing gun. This 
gun has a standard 5 ml dose and can be easily connected to 
the 1 liter Regumate® bottle. This gun allows a fast and accurate 
dosing with ample freedom of movement. Gilts have a very curi-
ous nature and they are very keen on soybean oil, the carrier of 
altrenogest. A 2-day training with a cheap vegetable oil prior to 
start of treatment is all that is needed. During the training period 
a person steps into the pen and waits until the gilts are calm and 
curious enough to approach. Gently one tries to squeeze a dose 
of oil into the mouth of all gilts. In the beginning this will take a 
bit of time, but after two days most animals will come spontan-
eously to ask for their dose of oil. After the short training, more 
than 99% of gilts will take the dose directly in the mouth.
Results
When the product is correctly applied, up to 95% of gilts come 
to oestrus within seven days after the last dose. 896 gilts were 
synchronized with the new method. Of these 844 gilts (94.2%) 
came on heat within the seven day period. This is comparable to 
the results achieved in individual stalls (1).
Once the training period was over, there was no need to enter 
the pen as all gilts lined up, eager to get their dose, making this 
a convenient routine.
Discussion 
This new method is a safe, accurate, eff ective and labor spar-
ing alternative for gilt synchronization, and not only in group 
housed systems. It is also a convenient method where gilts are 
still kept in stalls. 
Extensive experience in Germany, The Netherlands and England 
shows many advantages in the fi eld. No product is spilled during 
application or leaks back from the mouth of the gilt. Administra-
tion is done very fast. Once the gilts are trained, 15 to 20 animals 
per minute can be dosed. 
The oestrus synchronization results obtained with this new ap-
plication method in practice appears to be at least as good as 
with the conventional on feed application.
An additional important benefi t is the socializing aspect. During 
the short training and the 18 consecutive treatment days the 
gilts develop a very positive bond with the animal caretaker. 
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Nitrite test for UTI diagnosis in sows: are we wrong?
Guy-Pierre Martineau; Berengere Fabre; Herve Lefebvre
National Veterinary School, Toulouse, France
Introduction
In France, urinary tract infection (UTI) is routinely screened in 
sow herds using nitrite dipstick testing (Sialelli, 2004). Despite 
a low prevalence of clinical UTI, the rational for such screening 
remains controversial (Martineau et al., 2007). High water intake 
in pregnant sows, and consequently high urine dilution, may 
lead to false negative results. For unknown reasons, there is also 
an increase of positive results in late gestation (Sialelli, 2004). 
The objectives of this study were i) to evaluate the day-to-day 
variability of the nitrite test and urine specifi c gravity (USG) in 
late gestating sows, ii) to compare nitritre test to semi-quantita-
tive bacterial count, and iii) to assess the eff ect of urine dilution 
on the nitrite test results.
Materials and Methods
The herd- The study was performed in the same herd of 600 
sows, free for clinical UTI, managed in a 7 batch farrowing 
system. Liquid feeding (dilution of 4L/kg of feed plus one extra 
“water meal” of 3L/day for a given sow). 
Selection of animals- For 3 consecutive weeks, urine was col-
lected before feeding (before 6.00 am) in 130 late gestating 
sows. 15/130 sows in which urine had a nitrite positive test and 
USG ≥1.015 (refractometry) were included in the study. 
Study design- For each included sow, urine was collected at 
least 3 times over the same week (same conditions as described 
above). USG and nitrite test was performed on each individual 
sample every day. The pink colour change of the reagent pad 
was assessed by the same investigator using a -/+/++/+++ scale. 
Moreover, a semi-quantitative microbiological culture (Count 
Exact®) was done on the fi rst positive sample in each animal. 
Furthermore, a 2- and 4-fold dilution of each fi rst sample with 
NaCl 0.9% was performed and nitrite test repeated again on the 
so diluted samples. 
Results and discussion
There was no association between strong nitrite positive urine 
(+++) and USG. Day-to-day variability of positive nitrite test re-
sults was high (Figure 1A) in 8/15 sows, suggesting that diagnos-
tic interpretation from a single sample may be misleading.
The relationship between nitrite test results and semi-quantita-
tive bacteriological counts was poor (Table 1). 
Some mildly nitrite positive urine has a relatively high bacteria 
counts and inversely.
Dilution induced also a decrease in positivity of the nitrite test 
(Figure 1B). 
Table 1: Relationship between semi-quantitative bacteriological 
counts and nitrite test (n=15 sows)
Figure 1A: Day-to-day variability of nitrite test (n=15 sows) Figure 1B: 
Eff ect of dilution on nitrite test
Conclusion
The poor relationship between positive nitrite test and semi-
quantitative as well as the large day-to-day intra-individual 
variability in nitrite positive test indicates that nitrite dipstick 
testing for screening UTI sows is questionable, especially when 
performed on a spot urine sample. Moreover, USG should be 
used to interpret adequately any positive results, as dilution of 
urine secondary to high water intake can lead to false negative 
results.
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Shoulder lesions in loose-housed lactating sows on partly slatted ﬂ oors
Nils Holmgren2 Nils Lundeheim1
1. Swedish University of Agric. Science, Uppsala, Sweden; 2. Swedish Animal Health Service, Skara, Sweden
Introduction
Shoulder lesions (SL) were on average found in about 1/3 of 
loose-housed lactating sows in 78 Swedish herds (3). Main risk 
factors are poor body condition, parity number, lameness and 
MMA (1,2). In addition, environmental factors such as fl oor type 
may contribute to the development of SL during lactation (1,2).
Material and methods
The trial was conducted as a prospective cohort study in a piglet 
producing herd. Consecutive batches of 40 loose-housed sows 
farrowed in pens with partly slatted fl oors. Half of the pens had 
1.3m2 concrete lying area for sows and 2.8m2 plastic slatted 
fl oors (open area 34%) with square formed 3mm raised edges. 
Remaining pens in the same barn had 2.1m2 concrete lying area 
and 2.8m2 plane slatted fl oor (open area 34%). Sows allocated 
into diff erent pen types had no SL before farrowing, were 
matched for parity numbers and had all good body condition 
scores. Six times, once before farrowing and at weekly intervals 
until weaning at 5w, body condition scores and SL were mon-
itored. At this occasion, 1h after morning feeding when all sows 
laid down, the lying position of the sows was recorded: heads 
and shoulders on concrete area or slatted fl oor located (SFL). 
Temperatures in barn were also measured. Diff erences in preva-
lences were studied by chi-square test. 
Results
Prevalences of sows with SL increased linearly during lactation 
and reached 35-45% at weaning. Size of concrete lying area 
(2.1m2 or 1.3m2) and structure of slatted fl oor (edges or plane) 
did not signifi cantly infl uence on the occurrence of SL.
Before farrowing, 10- 20% of the sows were SFL and from 2w 
after farrowing until weaning, 40-50% of the sows were SFL 
(Fig.1). When barn temperature was 18-21oC during lactation, 
signifi cantly (p<0.05) more SFL sows (41%) were observed com-
pared to when barn temperature was 17oC, (31%). 
For each sow, sum of SFL sows was calculated (0-6 for each sow). 
Among sows often in SFL-position, prevalence of SL at weaning 
was signifi cantly higher compared to sows that were in SFL-
position more seldom (Fig.2).
Discussion
At farrowing, sows prefer to lie on a warm area of the pen (5). 
Due to increased feed consumption and metabolic activity 
during lactation, the body temperature will increase (4). A high 
temperature in barn will contribute to this. To maintain thermal 
comfort during lactation the alternative for the sow is to lie on 
the slatted fl oor area. This is especially comfortable for loose-
housed sows in modern farrowing pens as the slatted fl oor area 
is usually larger than the concrete lying area. However, increased 
pressure from slatted fl oors on shoulder tissues will result in SL 
(6).
In conclusion, to prevent SL in loose-housed lactating sows, slat-
ted fl oor areas should be made uncomfortable to lie on and the 
concrete lying area should be made as large and comfortable as 
possible.
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Hemoglobin varies with parity and stage in cycle
Inge Larsen1 Flemming Thorup2
1. LVK, Oestervraa, Denmark; 2. Pig Research Centre, Danish Agriculture and Food Council, Copenhagen, Denmark
Introduction
Various reference values are published for hemoglobin, however 
very few references distinguish between young and mature 
animals, nor to the diff erent stages in a sows reproductive cycle. 
Table 1. Reference values for hemoglobin from diff erent sources.
g/ dL Reference
10.6 – 15.9 Central Laboratory, Life/ KU, 2009 (1)
12.6 Schalm´s Veterinary Haematology, 2008 (2)
9.0 – 13.0 The Merck Veterinary Manual, 2008 (3)
10.8 – 14.8 Idexx VetMedLab, 2007 (4)
The objective of this study was to determine the level of 
hemoglobin in Danish gilts and sows at diff erent stages of the 
reproductive cycle.
Material and Methods
This study was performed in one Danish 360 sow herd partici-
pating in the Danish SPF programme. The farm was free from 
Mycoplasma hyopneumoniae, PRRS and Actinobacillus pleuron-
eumoniae (AP) type 2, but AP type 6 and 12 positive. 
Blood was collected during pregnancy and lactation from 152 
sows between April and December 2008. 900 bloodsamples 
were included in the calculations.
Bloodsamples were mailed by post, and analysed one or two 
days later at Idexx VetMedLab in Germany. Statistical analysis 
were carried out using Microsoft Offi  ce Excel 2007.
Results
The average level of hemoglobin of all bloodsamples in this 
study was 10.4 g/dL (900 samples) with a standard deviation 
(st.d.) of 1.1.
The average level of hemoglobin in gilts was 11.0 g/dL (st.d. = 
1.0) (31 gilts, 193 samples). The average level of hemoglobin in 
pregnant 2nd to 9th litter sows was 10.2 g/dL (st.d. = 1.0) (101 
sows, 625 samples). The diff erence was statistical signifi cant (p= 
2 x 10-21).
Figure 1. Hemoglobin (g/dL) in gilts and sows by day after fi rst 
insemination. *
The level of hemoglobin was signifi cantly higher in pregnant 
gilts than in sows at all points during gestation, while the level in 
gilts approaches the level of sows during lactation.
Discussion
When is a pig anemic? 
To render a sow anemic or normal, should be based on an 
evaluation of what level of hemoglobin has an eff ect on sow 
welfare and productivity.
In this study no negative correlations were observed between 
level of hemoglobin end frequency MMA treatments, nor to the 
level of still born piglets.
The present experiment is extensive but performed in one herd 
only. A study in more herds, preferably covering more countries 
or continents are needed, to cover management, feeding and 
genetic diff erences as well.
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Facilitation of nursing behavior in primiparous sows during colostrum phase improves piglet condition
Jorge Miquet1 Gustavo Viana2
1. I.P.B.-C.I.C.V.-INTA, Morón, Argentina; 2. Janssen Animal Health Argentina, Buenas Aires, Argentina
Introduction
The development and wellbeing of a piglet are determined by 
its ability to fulfi ll the need for homeostasis, growth and resist-
ance to sanitary challenges. Early colostrum intake is the key for 
success. For the fi rst two days of their lives, colostrum provides 
the required nutrients to the piglets and during their fi rst weeks, 
the immunoglobulin (Ig) fraction passively protects the piglets 
from disease (1). Critical factors for early life survival are the abil-
ity of the piglet to suckle, the available volume of colostrum, the 
udder quality and the behavior of the sow during the colostrum 
phase. For primiparous sows, farrowing is a stressful new experi-
ence which can result in savaging and crushing of neonatal pig-
lets. The introduction of the group housing system potentially 
increases this problem, as primiparous sows get confi ned for the 
fi rst time in their life at parturition. Azaperone is a sedative used 
to calm pigs at stressful moments, such as transport, regrouping 
and aggression. 
In this study, the eff ect on piglet development after an injection 
of azaperone at the end of the partus of primiparous sows, was 
investigated in two farms with diff erent housing systems. One 
farm had conventional farrowing crates (CF) the other outdoor 
huts (OH).
Materials and Methods
50 primiparous sows per farm were included in the study. Both 
farms (BF) belonged to the same organization, with comparable 
genetics, nutrition and health care plan. Half of the sows were 
randomly allocated to either a azaperone treated group (AZA) or 
a non-treated reference group (NT). The AZA group was injected 
IM, 2 mg azaperone per kg body weight (BW) (= 5 ml Stresnil® 
per 100 kg BW) at the moment of expulsion of the placenta. To 
assess the condition and health status of the piglets in fi eld con-
ditions, mortality rate and weight gain were used as parameters. 
The piglets were weighed and identifi ed individually at birth 
and at weaning. Farrowing and weaning date, number of piglets 
born alive (BA), pre-weaning piglet mortality, mortality reason 
and number piglets weaned (W) were recorded.
A t-test was used for comparison of continuous variables and a 
Chi-square test for comparison of categorical variables (Statistix 
1.0 for Windows).
Results
Lactation length and BA were comparable in both groups (Table 
1). Mortality however, was higher in the NT group. Mortality 
reasons were similar for both groups, except for crushing (NT 
n=35, AZA n=16) and cannibalism (NT n=7, AZA n=0), which 
was signifi cantly higher in the NT group (p<0.01). There was an 
increase of W and the average weaning weight of the piglets 
was higher in the AZA group. 
Table 1: Piglet data comparison 
Data presented in bold are statistically diff erent (p<0.05)
This resulted in a signifi cantly higher litter weight at weaning in 
the AZA group in both housing systems. The number of piglets 
weaned and the average individual weaning weight of the 
treated animals was signifi cantly higher for AZA in BF. 
Discussion
The present study showed the benefi t of an azaperone injection 
of primiparous sows at the end of the partus. Piglet survival in-
creased and they thrive better, resulting in a 11.3% litter weight 
increase at weaning. 
In conventional farrowing crates, the diff erence was mainly due 
to an increased weight gain of the piglets, while in outdoor huts, 
a decrease of early mortality was the cause of the diff erence. 
Calm sows in the fi rst hours after farrowing are less likely to kill 
their piglets and they allow them access to the colostrum. Not 
only more piglets survive, but they develop better during lacta-
tion, a clear sign of their wellbeing.
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A study to evaluate the use of Elastrator® rings for treatment of umbilical hernia
Kaj Vestergaard1 Kristian Viekilde2 Poul Bækbo1
1. Pig Research Centre, Danish Agriculture & Food Council, Copenhagen, Denmark; 2. PORCUS Pig Practice, Ringe, Denmark
Introduction
Umbilical hernia is one of the most frequent developmental de-
fects in pigs. Most investigators have hypothesized that hernia is 
inherited, although there is dispute about the mode of inherit-
ance (1). Umbilical infections have also been claimed to cause 
umbilical hernias in pigs (2). In other species, breed and sex have 
been identifi ed as risk factors, but no association between um-
bilical infection and umbilical hernias has been detected (3). The 
disease causes signifi cant losses due to decreased productivity, 
including increased mortality, and, above all, umbilical hernia 
has important implications for pig welfare. For that reason, 
PORCUS Pig Practice and Pig Research Centre initiated a study to 
evaluate the effi  cacy of using Elastrator® rings to treat umbilical 
hernias in young pigs (4).
The purpose of the study was to determine whether surgical 
treatment of umbilical hernia using Elastrator® rings increased 
the pig’s chance of reaching slaughter weight. 
Materials and Methods
The study was conducted under the authorization of the Danish 
Animal Experiments Inspectorate. A total of 192 pigs with um-
bilical hernia were collected from herds throughout Denmark, 
independent of herd management and health status. On arrival 
at the research farm, the umbilical hernia of each pig was exam-
ined to determine whether the hernia was reducible through 
the abdominal wall. Pigs with irreducible hernias were excluded 
from the study. The pigs included in the study were randomly 
divided into two groups:
Group A: Treatment with Elastrator® rings
Group B: No treatment
An Elastrator® ring was fi xed on the hernial sac close to the ab-
dominal wall. All other medical treatments and causes of death 
among the pigs were recorded. The data analysis was conducted 
using R version 2.9.2. A logistic regression model described the 
risk of death from umbilical hernia, with treatment, sex and 
weight as explanatory variables. The design of the study had a 
power of 80% to show a 50% reduction in death from compli-
cated umbilical hernia.
Results and Discussion
The lower number of male pigs included in the study (Table 1) 
was mostly due to the risk of placing the Elastrator® ring close to 
the prepuce. 
Table 1. No. of pigs with umbilical hernia 
Table 2. No. of dead and surviving pigs in groups A & B
The results of the logistic regression showed a signifi cant 
increase in mortality in the control group compared to the treat-
ment group. The odds ratio was 4.75 (1.40, 18.72). Furthermore, 
the greater the start weight, the lower the risk of dying. The odds 
ratio was 0.87 (0.78, 0.95). Sex did not infl uence the risk of dying 
from umbilical hernia
Of the 20 pigs that died during the trial period, 9 were put down 
and 11 were found dead. The death of four pigs (two from each 
group) seemed to be unrelated to complications due to the um-
bilical hernia. The mortality among the excluded pigs (127; Table 
1) was the same as for the pigs in group B (45%). The 43 pigs that 
survived were all approved for slaughter, but they all received a 
remark by the meat inspectors at the slaughterhouse concern-
ing internal signs of umbilical hernia.
Even though the study showed a signifi cant result in favour of 
using Elastrator® rings, one has to be aware of the number of 
pigs that were excluded. According to this study, out of nearly 
800,000 Danish pigs developing umbilical hernia every year, 
only one third (264,000 pigs) can be given the treatment. Never-
theless, the results from this study indicate an additional survival 
of 76,000 pigs per year, which can be estimated to provide the 
Danish pig farmers with a bonus of € 4,500,000.
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Piglet serum IgG, a non disruptive method to measure colostrum distribution
Jan Jourquin1 Marrit van Engen2 Lieve Goossens1
1. Janssen Animal Heatlh, Beerse, Belgium; 2. FarmulaOne, Best, Netherlands
Introduction
Colostrum intake is critical for the survival of the piglet. The fi rst 
2 days of their lives, colostrum provides the nutrients to fulfi ll 
the piglets needs for homeostasis and growth and during their 
fi rst weeks, the immunoglobulin (Ig) fraction passively protects 
the piglets from disease (1). It is estimated that a piglet needs 
160 to 170 ml of colostrum per kg bodyweight to survive (2). 
Immunoglobulin G (IgG) is absorbed by the gut wall during 24 
to 48 hours, but the IgG content of the colostrum decreases 
quickly after birth (1). Next to total colostrum yield and IgG con-
centration, the distribution of the available quantity amongst 
the diff erent littermates is becoming more important with 
increasing litter size. Several methods to estimate colostrum 
intake have been described in the past but they all share one 
disadvantage being the extensive manipulation of piglet and or 
sows during the colostrum intake phase. To eliminate the impact 
of manipulation on sow and piglet behavior, an alternative 
method without extra manipulations is required. 
In this study, a method based on piglet serum IgG concentra-
tion was used to measure the impact of litter size on colostrum 
distribution.
Materials and Methods
In a commercial sows farm, 114 litters were included in the 
study. The farm data recording system was used to retrieve the 
relevant reproductive data. All normal farm procedures were 
continued. At tail docking (day 3 post partum) a blood drop of 
the remaining tail bud from six randomly chosen litter mates 
was sampled. These samples were analyzed with a DAS-ELISA 
test (3) (Colostrum Quality CounterTM). There is a great variability 
in colostrum yield and colostrum IgG concentration between 
sows. Therefore the absolute IgG concentrations have poor 
predicting value on colostrum intake. Within the litter however, 
these variables are not relevant. In order to be able to compare 
the distribution for colostrum between sows, the coeffi  cient of 
variation of the piglet serum IgG (CV IgG) was calculated. This is 
the standard deviation divided by the average of that litter.
The statistical analysis was performed with the SAS® program. A 
Poisson regression model on the number of died piglets per sow 
was used. The total number of piglets with the sow was included 
as covariate.
Results
It was demonstrated that the variation in IgG levels increased 
with litter size (Figure 1).
Figure 1: Impact of litter size on IgG distribution and piglet mortality
The mortality rate over all litters is strongly correlated with litter 
size (p < 0.0001). Lower birth weight and vitality compromise 
the colostrum intake. With an increasing number of piglets, total 
colostrum volume becomes a second critical factor. The distribu-
tion of that colostrum should therefore be optimal. However, the 
data show that the distribution gets worse with increasing litter 
size. All measures that increase the colostrum production and 
facilitate the distribution of the colostrum increases the chance 
of the piglets to survive. 
Discussion 
In this study, it is shown that by using serum IgG concentra-
tions of three day old piglets, the distribution of the colostrum 
can be estimated. Both pre-weaning mortality and variation in 
colostrum uptake (represented as CV IgG) are positively correl-
ated with litter size. This underlines the increasing importance of 
individual colostrum uptake with increasing productivity of our 
sow farms.
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Comparison of body surface temperature and rectal temperature 
after administration of pyrogenic lipopolysaccharides
Jan Bernardy
University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic
Introduction
Aim of the study was to contribute to the assess-ment of the 
feasibility of using infrared thermography as a method for 
routine diagnosing and treatment decision of diseased pigs 
and animal welfare monitoring. Infrared thermography is a 
non-invasive method, able to measure the surface temperature 
via emitted energy (infrared radiation) from the surface of the 
animal body(1).
However the method brings time-savings and facilitate handling 
with animals, it is still seldom used, partially due to conserva-
tive approach of veterinary surgeons, partially due to missing 
relevant data of veterinary infrared thermography. Lipopolysac-
charid was used to induce pyrogenic reaction and compare 
core and surface temperature reactivity, and both values were 
compared.
Material and Methods
Twelve piglets 8 weeks old were used and randomly allocated 
into the two groups, a trial group and controls (n=5). Temper-
ature was measured at both groups either by infrared therm-
ometer at thorax (measurement IR-LPS at trial group and IR-C 
at control group) or rectally (measurement TR-LPS at trial group 
and measurement TR-C at control group). Pyrogenic agent 
(lipopolysaccharide from Escherichia coli 0111:B4, lyophilized 
powder, sample No L2630, Sigma-Aldrich) was dissolved and 
administered intravenously to the trial group in amount of 
0.1ug per kg of body weight. Temperature was measured every 
30 minutes for 8 following hours. The data were evaluated by 
non-parametric Wilcoxon pair test, Spearman correlation and 
visualized by Statistica v.9 software.
Results and Discussion
Both values of temperatures measured rectally and superfi cially 
showed signifi cant Spearman correlation rate (0.703, calculated 
at level of signifi cance p<.05), and diff erence between measure-
ment at the hour 0 and 1 or between hour 1 and 8 showed sig-
nifi cance higher than p<.05). However some papers did not fi nd 
correlation of skin and rectal temperature not satisfyinh enough, 
increased correlation in the postparturient period was noted (2) 
another papers assessing wound severity with colour and infra-
red imaging of reactive hyperemia (3), life-threatening complica-
tion (4) or signifi cant linear relationship was observed between 
ambient tem-perature and mean body surface temperature at 
inoculated febrile pigs(5). The results obtained in the trial imply 
possibility to rely on correlation between rectal and superfi cial 
temperature. However there are some physical values to be 
considered, as airfl ow, humidity and some other values, refi n-
ing and improvement the method of body surface temperature 
measurement in pigs would be helpful diagnostic tool.
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Evaluating PCV2 immune status of a herd and determining the value of vaccination
Cristina Venegas-Vargas; Barbara Straw
Michigan State University, East Lansing, MI, USA
Introduction
Porcine Circovirus type 2 is an important viral pathogen world-
wide. PCVAD was fi rst described in Canada in the early 1990s 
as PMWS1,2. The Michigan State University swine herd experi-
enced moderately severe PMWS accompanied by 5-10% nursery 
mortality. A vaccination program was initiated in 2007. Signs of 
clinical disease disappeared after implementing the program 
and remained inapparent for the next 2 yrs, and mortality of pigs 
in the nursery remained below 2%. Potter et al. (2009) docu-
mented reduction in viral load following vaccination. There is 
the assumption that vaccination could minimize viral shedding 
and reduce environmental contamination to a no-eff ect level; 
allowing elimination of vaccination programs3,4. Two ways of 
determining if infectious levels of virus are present in a vaccin-
ated herd were compared; monitoring disease in sentinels and 
recovery of virus through PCR. 
Materials and Methods
Three replicates of 20 pigs each and one replicate of 22 pigs 
were weighed and ear tagged at weaning for use in the study. 
Pigs were matched in pairs by sex, weight and dam. Matched 
pairs of pigs were randomly allocated to sentinel (non-vaccin-
ated) and control groups. Control pigs received a Killed Baculo-
virus vector PCV2 vaccine at weaning and 2 wks later per label 
directions. Blood samples were taken at weaning, 9 and 20 wks 
of age. ELISA, IFA-4 dilution and PCV2 PCR (Pools of 2 animals) 
were performed. Twelve ropes were placed in pens of common 
vaccinated pigs four times at one-month intervals. PCV2 PCR 
was performed. Pigs were weighed again at completion of the 
trial (20 wks of age) and ADG was calculated.
Discussion
 Monitoring sentinels did not demonstrate presence of virus in 
the herd either through reduced pig performance, ELISA test-
ing or PCR serum samples at normal cut off s (35 Ct). But it did 
through IFA-4 dilution, and PCR serum samples at a later Ct cut 
off s (40 Ct). Sentinel monitoring required 4 months to complete 
while oral fl uid PCR results were available immediately. Cut off  
value of PCR test on saliva and serum in a vaccinated herd may 
need to be changed. 
RESULTS Week Sentinel Control P-value
ELISA (S/P) 3 0.4499 0.4602 0.8591
9 0.1927 0.7829 0.0001
20 0.1067 0.9630 0.0001
IFA-4 dilution 3 1.0
9 0.0001
20 0.0001
ADG (g) 713.5 695.4 0.4552
Mortality 7.32 4.89 1.0
PCR Sentinel Control
Serum Ct cut off 35 40 35 40
Positives 3 0/15 1/15 0/14 2/14
9 0/19 1/19 0/19 2/19
20 0/18 0/18 0/19 1/19
Oral Fluid 35 Ct 40 Ct
Positives 1st 1/12 9/12
2nd 1/12 4/12
3rd 3/11 6/11
4th 0/11 0/11
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Eﬀ ect of CIRCOVAC® vaccination of sows on their reproductive performance
John Hayden1 Ricardo Neto2 François Joisel3
1. Integra Veterinary Services, Mundford, Thetford, UK; 2. Merial Animal Health Ltd, Woking, UK; 3. Merial S.A.S., Lyon, France
Introduction
Recent studies have shown that PCV2 is involved not only in 
PMWS, but also in several other disease presentations, including 
reproductive disorders, deteriorating sow performance (1, 2). 
The objective of this study was to assess the impact of CIRCO-
VAC® on the reproductive performance of a sow breeding unit 
weaning pigs on-site and selling them at 35kg.
Material and Methods
A 1000-sow outdoor breeding unit started vaccinating the 
breeding animals in May 2007 with a PCV2 inactivated vaccine, 
CIRCOVAC. The fi rst vaccinated sows farrowed in July 2007. PCVD 
has been clinically diagnosed on the nursery and fi nishing units. 
The number of pigs born alive per litter and weaned per litter 
was routinely recorded using herd management software.
Historical data, since 2005 were collected. The data were divided 
into blocks of 6 months from the start of vaccination for the per-
iods before and after. The data were also compared for a period 
of 1 year before and after PCV2 vaccination was implemented. 
Statistical analyses were undertaken using the two sample t-test 
with unequal variances and a two-factor (month and year) analy-
sis of variance. Tests were carried out using proprietary statistical 
software.
Results 
Live born piglets per litter after CIRCOVAC vaccination were 
increased by 1.425 pigs, p<0.001 (t-test) compared to the period 
before (2004 to July 2007). 
Analyzing the data before and after July 2007 by a t-test shows 
that there is an improvement in the mean number of pigs of 
1.066 pigs weaned per sow per litter after CIRCOVAC vaccination 
started. 
Regarding pigs weaned per sow per litter, (Table 1) there was 
no signifi cant diff erence between the fi rst 6 months of 2005, 
2006 and 2007 (before vaccinated sows started farrowing) but 
these were signifi cantly diff erent to the fi rst 6 months of 2008 
and 2009 (CIRCOVAC vaccinated sows started farrowing in July 
2007), p<0.001. Similarly that there was no signifi cant diff erence 
between the second 6 months of 2004, 2005 and 2006 (before 
vaccinated sows started farrowing) but these were signifi cantly 
diff erent to the second 6 months of 2007 and 2008.
®CIRCOVAC is a registered trademark of Merial in Canada and elsewhere.
Table 1: Six month periods with mean number pigs born alive per 
litter.
January - June July - December
2004 9.901a
2005 10.07a 10.048a
2006 10.2a 9.78a
2007 10.27a 11.07b 
2008 11.69b 11.24b 
2009 11.82b 
Diff erent superscripts (a,b) indicate signifi cant diff erence (p<0.001).
 
The use of CIRCOVAC resulted in an improvement of 0.8 pigs 
born alive between the 6 months before the use of vaccine and 
6 months after, from 10.27 to 11.07 respectively.
The number of piglets weaned per sow per litter was signifi -
cantly diff erent between the fi rst half of the years 2005, 2006, 
2007 and the fi rst half of 2008 and 2009, the mean number of 
pigs weaned per litter for the periods of July to December 2004 
and 2006 was signifi cantly diff erent to the same periods in 2007 
and 2008, Table 2.
Table 2: Six month periods with mean number pigs weaned per litter.
January - June July - December
2004 8.892a
2005 9.672a 9.22
2006 9.847a 8.685a
2007 9.842a 10.07b 
2008 10.767b 10.14 b
2009 10.923b 
Diff erent superscripts (a,b) indicate signifi cant diff erence (p<0.001).
Discussion and conclusion
This study shows the impact of using CIRCOVAC on the repro-
ductive performance of vaccinated sows.
Improving the number of pigs weaned per sow per litter opti-
mizes the sows’ performance. This increase reduces the cost of 
production and considerably increases profi tability. 
The constant number of pigs born alive and weaned per litter 
during the post vaccination period indicates that the improve-
ment achieved with CIRCOVAC vaccination resulted in a stable 
and sustained increase of the number of piglets born alive and 
weaned per litter.
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Eﬃ  cacy against porcine circovirus type 2 of a single dose of Porcilis PCV 
given to MDA-positive piglets of either one or three weeks of age
Andreas Palzer1 Beate Rist2 Mathias Ritzmann3, 2 Christiane Lang3 Stefan von Rueden4 Karl Heinritzi2 Alex Eggen5 Jos Smeets5
1. Tierarztpraxis Scheidegg, Scheidegg, Germany; 2. Clinic for Swine of the LMU Munich, Oberschleissheim, Germany; 3. Clinic for Swine of the VUW, 
Vienna, Austria; 4. Intervet Deutschland GmbH, Unterschleissheim, Germany; 5. Intervet/Schering-Plough Animal Health, Boxmeer, Netherlands
Introduction
Infections with Porcine Circovirus type 2 (PCV2) are ubiquitous 
in the swine population and are associated with many disease 
complexes. The object of this study was to compare the effi  cacy 
of a single dose of Porcilis PCV (Intervet/Schering-Plough Animal 
Health), with a placebo, Diluvac Forte®. The study was performed 
on a German 500-sow farm on which PMWS had been diag-
nosed clinically as well as by pathology, and the presence of 
PCV2 confi rmed by serology. Vaccination of sows with Circovac® 
had ceased 7 months before the trial began.
Materials and Methods
In this partly blinded study, a total of 416 piglets were selected 
to receive a 2 ml dose i.m. of either Porcilis PCV or of placebo 
(Diluvac Forte®) at 1 and 3 weeks of age (Table 1).
The piglets were weighed at 1, 3, 11 and 24 weeks of age. All 
the individual piglet treatments were recorded as a measure of 
morbidity. Post-mortem examination was performed on each 
piglet to determine the cause of death. Average daily weight 
gain (ADG), morbidity and mortality were compared between 
groups, analyzed using ANOVA and the Chi-square test.
Blood samples (serum) were taken from 20% of each group at 
intervals of 2 weeks until the start of the fattening period, and 
every 4 weeks thereafter. The sera were tested by ELISA for anti-
bodies against PCV2 (log2) at the R&D Service Laboratory (Box-
meer, The Netherlands) and by Ingezim Circovirus IgG/IgM (pos/
neg., Ingenasa, Madrid, Spain) at the Clinic for Swine, University 
of Veterinary Medicine, Vienna. Viremia was determined by qPCR 
(log10 copies/ml) at the Clinic for Swine in 17 samples from each 
group taken in weeks 3, 7, 11, 14, 18, 22 and 25.
Results
During the fattening period, pigs in group A (vaccine at 3 weeks 
old) performed signifi cantly better than those in Group C (pla-
cebo) and group B (vaccinated at 1 week of age). The diff erences 
were 32.1 gm/day (p=0.0110) between groups A and C, and 26.7 
gm/day (p=0.0416) between Groups A and B. 
There were 9 deaths in each group. In the most cases the pigs 
were culled because of locomotion problems (n=13). Group C 
(placebo) had more PCV2-related cases (n=5) than the other two 
groups (A: n=2; B: n=1). 
The mean PCV2 antibody titer across all groups at 1 week of age 
was high at 12.4. It declined until week 18, but at that time was 
higher in Group A (6.3) than in Groups B (4.3) or C (2.7). Then, 
because of an active PCV2 infection the mean titer increased to 
11.6 in week 25. 
Only the piglets of Group A had a detectable IgM titer (Ingezim 
Circovirus IgG/IgM) between weeks 5 and 11 which was a reac-
tion to vaccination. However, after the fi eld infection, animals in 
Group A (vaccine at 3 weeks) had less IgM than those of Group C 
(placebo) or Group B (vaccine at 1 week). 
Pigs of 22 weeks of age in the placebo group had the highest 
PCV2 viral load. In groups A and B, viremia was signifi cantly 
reduced compared to the placebo group. These results demon-
strate that there was a PCV2 infection towards the end of the 
fattening period, and that the vaccinated pigs were protected.
Study Group 1 week of age 3 week of age
A Porcilis PCV 3 weeks Diluvac Forte Porcilis PCV
B Porcilis PCV 1 week Porcilis PCV Diluvac Forte
C Placebo Diluvac Forte Diluvac Forte
Discussion
The effi  cacy of vaccination was clearly shown by the signifi cantly 
improved weight gain during the growing period, as well as the 
low percentage of PCV2-PCR positive animals in the group vac-
cinated at 3 weeks. 
The vaccination of piglets with Porcilis PCV at 3 weeks of age 
was more eff ective than that at the age of 1 week. The results of 
this study indicate that high levels of maternally derived anti-
body can interfere with early vaccination at 1 week of age.
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Duration of Immunity induced by a single dose of 2 ml Porcilis® PCV 
when administered to piglets at 3 weeks of age
Alexander A. Eggen1 Ulrike Schmidt1 Frank Roerink2
1. Intervet/Schering-Plough, Boxmeer, Netherlands; 2. Intervet/Schering-Plough, DeSoto, KS, USA
Introduction
Porcine Circovirus type 2 (PCV2) infection in pigs is regarded 
as the most important causative factor in the development of 
Porcine Circovirus Disease (PCVD). The fi rst description of PCVD 
(initially called PMWS) involved young pigs (Harding 1998). 
More recent articles describe infection in older pigs and it is not 
uncommon to observe PCVD in late stage fi nishers (Palzer 2009). 
Under fi eld conditions the timing of PCV2 virus infection is often 
unknown, therefore it is important that pigs are protected for 
the whole of the fattening period. 
PCV2 virus is widespread, and infection in sows leads to varying 
antibody levels in blood and colostrum. Pigs can be vaccinated 
early in life against PCVD in the presence of MDA. The object 
of this study was to demonstrate the effi  cacy of Porcilis PCV in 
piglets with MDA against PCV2 virus, following a single dose of 2 
ml at 3 weeks of age. At 25 weeks of age, vaccinated and control 
animals were challenged with wild type PCV2 virus to investi-
gate the extent of protection. 
Materials and Methods
Progeny of SPF sows with PCV2 antibodies (ranging from 7.1 to 
11.4 ELISA log2 at farrowing) were studied. Piglets were assigned 
to diff erent groups of 10 piglets, so that littermates were spread 
evenly over the groups, with equal numbers of males and fe-
males per group. At 3 weeks of age, Group 1 was vaccinated with 
2 ml of Porcilis PCV and Group 2 with placebo. At 25 weeks of 
age, the pigs were challenged intranasally with a heterologous 
wild type PCV2 challenge virus strain I-12/11. 
All animals were observed daily for clinical signs and weighed 
several times during the study. Three weeks post challenge 
all animals were necropsied. At post mortem, mesenteric and 
inguinal lymph nodes, tonsil and spleen were sampled for the 
determination of PCV2 antigen and nucleic acid. Serum samples 
were taken at vaccination, at 10 weeks of age, at challenge and 
weekly thereafter until necropsy. Fecal swabs were taken at 
challenge and every week thereafter. Statistical analysis of the 
serology employed Tukey’s multiple comparison. Q-PCR data 
was analyzed by ANOVA using a linear mixed model, assuming a 
constant correlation of the repeated measurements of a subject.
Results 
No diff erences were found between the groups for clinical signs 
or bodyweight, either after vaccination or after challenge. 
Serology; at the time of vaccination the average titer in the PCV 
vaccinated group was 7.2 log2 and in the controls 7 3 log2, both 
above the protective antibody level (Fort 2009). By the time of 
the challenge, the controls had no detectable antibodies, where-
as the vaccinates had titers of at least 6.9 log2 (P<0.0001). After 
challenge, a clear antibody response was seen in the controls 
but hardly any reaction in the vaccinated pigs (see table 1).
Table 1: Development of antibody titers
Weeks of age 3 10 25 26 27 28
Group/////wpc* 0 wpc* 1 wpc* 2 wpc* 3 wpc*
Porcilis PCV 7.2±1.9 11.9±2.1 7.8±0.7 8.1±0.9 8.5±0.9 9.0±1.1
Control 7.3±1.8 3.0±1.9 1.0±0 1.0±0 5.8±2.1 10.2±3.4
*wpc weeks post challenge
 
Q-PCR on serum, fecal samples and lymphoid tissues. At the 
time of challenge, none of the samples of either group con-
tained detectable amounts of PCV2 DNA. After challenge, a sig-
nifi cant reduction in the PCV2 load was found in serum, inguinal 
lymph nodes, spleen and tonsils of the vaccinates (P<0.05). No 
PCV2 DNA was detected in any of the feces samples from this 
group. However, PCV2 DNA was found in fecal swabs of the 
challenged control animals (P<0.0001). Similar fi ndings in data 
generated under fi eld conditions were reported by Toki (JSVSC 
2008) and by Larsen (IPVS 2010). 
Discussion 
Porcilis PCV induces strong humoral and cellular immunity (Fort 
20009, Martelli 2010 in press). Vaccination of MDA-positive 
piglets of 3 weeks of age with a single 2ml dose protects them 
from a heterologous challenge at 25 weeks of age. There was a 
signifi cant reduction of virus shedding and PCV2 DNA load in 
lymphoid organs. The duration of immunity covering the whole 
fattening period, induced by a single dose, in the presence of 
MDA, is unique to Porcilis PCV. This feature has been confi rmed 
by several fi eld reports from diff erent countries and forms part 
of the label claim for Porcilis PCV. 
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Assessing the impact of maternally derived immunity on active immunization of pigs against PCV2
Angela Baysinger1 John Waddell2 Edgar Diaz1
1. Boehringer Ingelheim Vetmedica, Inc., St Joseph, MO, USA; 2. Sutton Veterinary Clinic, Sutton, NE, USA
Introduction
Porcine circovirus associated disease (PCVAD) is caused by por-
cine circovirus type 2 (PCV2). Most sows and gilts develop anti-
bodies after natural exposure to or immunization against PCV2 
that become passively acquired by their nursing off spring.1 The 
objective of this study was to assess potential maternal inter-
ference with active immunization when vaccinating weaned 
piglets around 3 weeks of age against PCV2.
Materials and Methods
Piglets were weighed and ear tagged within 24 hours of birth 
and weaned at approximately 3 weeks of age. All pigs were 
individually blood sampled for PCV2 IFA antibody measurement 
and classifi cation as low (≤1:320) or high (≥1:640) titer just prior 
to vaccination at approximately 3 weeks of age (Day 0) based 
upon previously reported experiments.2,3 Four treatment groups 
were created balancing for pig weight and gender: low pig titer/
non-vaccinated pigs (L-NV), high pig titer/non-vaccinated pigs 
(H-NV), low pig titer/vaccinated pigs (L-V), and high pig titer/
vaccinated pigs (H-V). Vaccinated groups were intramuscularly 
injected with 1mL of Ingelvac CircoFLEX® (Boehringer Ingelheim 
Vetmedica, Inc., St Joseph, MO). Body weights were individually 
recorded at pre-determined intervals and a subset of pigs were 
serially blood sampled for diagnostic serology. Pigs from all 
groups were commingled within nursery and fi nishing pens. 
Individual pig was the experimental unit with Day 0-128 average 
daily gain as the primary outcome of interest. The main eff ect of 
Day 0 pig PCV2 IFA titer and pig treatment were assessed using 
ANCOVA with the model including dam parity, pig gender, and 
day 0 pig weights as co-variates. Pairwise comparisons utilized 
Tukey HSD (JMP v8.0).
Results
Mortality rate did not diff er between treatment groups, consist-
ent with the classifi cation of this fl ow as subclinically aff ected 
by PCVAD. Vaccination of pigs signifi cantly increased D0-128 
weight gain parameters compared to non-vaccinates regardless 
of pig PCV2 IFA titer status at the time of vaccination at 3 weeks 
of age (L-V vs L-NV; H-V vs H-NV; Table 1). D0-128 weight gain 
parameters did not diff er among vaccinated groups from low or 
high PCV2 IFA titer groups of pigs (L-V vs H-V; Table 1).
Table 1. Least square means for performance data by main eff ect of 
pig PCV2 IFA (L≤1:320, H≥1:640) titer at 3 weeks of age and pig treat-
ment (V=vaccinated; NV=non-vaccinated).
Parameter L-NV H-NV L-V H-V
Number of pigs 239 222 174 286
Body weight, D128, lbs 218.86b 219.25b 226.57a 225.61a
ADG, D0-128, lbs 1.59b 1.59b 1.65a 1.64a
ab Means with diff erent superscripts within a row diff er signifi cantly (Tukey HSD, P≤0.05).
Discussion 
High levels of maternally derived PCV2 IFA antibodies (> 1:640 or 
>1:320) did not interfere with achieving signifi cantly increased 
weight gain by active immunization of piglets with Ingelvac Cir-
coFLEX at 3 weeks of age. Groups of pigs with subclinical PCVAD 
perform signifi cantly better if vaccinated.
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Impact of 1- OR 2-dose PCV2 vaccination regimens on wean-to-ﬁ nish performance
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Introduction
The objectives of this study were to compare wean-to-fi nish 
growth performance and effi  ciency in commercial pigs admin-
istered commercially available porcine circovirus type 2 (PCV2) 
vaccines used in either one or two dose vaccination regimens.
Materials and Methods
The study was conducted in a large production systems wean-
to-fi nish research site. A randomized block design was used 
to allocate pigs to pens by gender and weight. Approximately 
2000 pigs were weaned at an average of 21 days of age from a 
single PRRS negative sow source and placed in 77 pens across 
two barns over a 4 day period. There were six full and one partial 
block in one barn and fi ve full and two partial blocks in the other 
barn. Each pen contained approximately 26 pigs. Six treat-
ment groups consisted of 12 pens of non-vaccinated controls 
and 13 pens of 5 diff erent vaccinated groups with pen as the 
experimental unit (Table 1). Two pigs per pen were serially blood 
sampled every 4 weeks for serologic monitoring of PCV2 viremia 
by quantitative PCR. 
Table 1. Study design
Group # pens (n) Treatment Description
1 (NVC) 12 Non-vaccinated Controls
2 (CF1) 13 Ingelvac CircoFLEX 1 full dose at 3 weeks of age
3 (CF2) 13 Ingelvac CircoFLEX 1/2 dose at 3 and 6 weeks of age
4 (CV2) 13 Circumvent 1 full dose at 3 and 6 weeks of age
5 (SV1) 13 Suvaxyn 1 full dose at 3 weeks of age
6 (SV2) 13 Suvaxyn 1/2 dose at 3 and 6 weeks of age
Performance data was analyzed in a blinded manner using a 
randomized design. When the ANOVA P value was less than 0.05 
for ADG and FCR, Tukey’s HSD was used to discern diff erences 
between the vaccine treatments. The Chi square test was used to 
evaluate mortality rate.
Results
Natural exposure to PCV2 infection was confi rmed by PCR. 
All vaccination regimens signifi cantly reduced the incidence 
and magnitude of PCV2 viremia at 14, 18 and 22 weeks of age. 
All vaccination regimens except Suvaxyn 1 dose signifi cantly 
improved the rate of day 0-178 average daily weight gain com-
pared to non-vaccinated controls (P≤0.05, Table 2). Only Ingelvac 
CircoFLEX 1 dose signifi cantly improved day 0-178 feed conver-
sion effi  ciency compared to non-vaccinated controls (P≤0.05, 
Table 2). Day 0-178 mortality rate was not aff ected by treatment.
Table 2. Performance results
Group Average Daily Gain, lbs Feed conversion ratio Mortality rate, %
1 (NVC) 1.26a 2.85a 7.69
2 (CF1) 1.36b 2.73b 4.14
3 (CF2) 1.33b 2.78ab 6.21
4 (CV2) 1.34b 2.79ab 4.71
5 (SV1) 1.32ab 2.79ab 7.03
6 (SV2) 1.33b 2.76ab 6.80
ab: means within a column diff er signifi cantly Tukey HSD P≤0.05. 
Discussion
Ingelvac CircoFLEX administered as a single full dose to pigs at 
3 weeks of age was the only vaccination regimen to signifi cantly 
improve both rate of weight gain and feed conversion effi  ciency. 
Utilization of an eff ective single dose vaccine also maximizes 
time and labor utilization effi  ciency while imposing less stress 
on pigs.
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Comparative eﬃ  cacy of PCV2 and Mycoplasma vaccination regimens
Joel Nerem
Pipestone Veterinary Clinic, Pipestone, MN, USA
Introduction
The objective of this study was to compare the effi  cacy of vari-
ous vaccination programs against PCV2 and Mycoplasma hyo-
pneumoniae. The study was supported by Boehringer Ingelheim 
Vetmedica, Inc.
Materials and Methods
A 3200 sow farrow to wean facility and a downstream nursery/
fi nishing site was used in the study. The system is PRRS virus 
positive, but stable (producing PRRS PCR negative weaned pigs) 
and is Mycoplasma hyopneumoniae (M hyo) positive. The off -site 
fi nishers had consistently suff ered clinical porcine circovirus as-
sociated disease (PCVAD) losses with mortality rates of 10-15%. 
The system historically used a combined half dose of RespiSure 
One (Pfi zer 1-dose M hyo vaccine) with a full dose of Circumvent 
(Intervet 2-dose PCV2 vaccine) at processing (3-5 days of age) 
and weaning (17-22 days of age). To reduce labor and stress on 
the pigs, they wanted to evaluate using a 1-dose vaccination 
program with the Ingelvac® CircoFLEX - MycoFLEX™ mixture 
, given either at weaning (~21 days of age) or processing (~5 
days of age). They also wanted to evaluate the eff ectiveness of 
a split-dose program of 1⁄2 dose of the Ingelvac® CircoFLEX - 
MycoFLEX™ mixture at processing and at weaning.
Vaccinations, tagging and the fi rst two weights were taken at 
the sow farm. At weaning, pigs were moved to an off -site 3 barn 
nursery-fi nishing site. Pigs were fi rst housed in a power venti-
lated nursery for 40 days. From day 40 to day 150, pigs were 
housed in two curtain-sided fi nishing barns. 
Five treatment groups (Table 1) were balanced for sow-of-origin 
parity with approximately 400 pigs assigned to each treatment 
group. Individual pig was the experimental unit. Pigs were ear 
tagged at processing and randomized by pen placement in nurs-
eries and fi nishers with all fi ve treatment groups represented in 
each pen. Final weighing occurred just prior to fi rst pigs being 
sold to market. Average daily gain was evaluated along with 
mortality rate, culling rate and % prime marketed pigs.
Table 1: Study design
Group Treatment
1 Non-vaccinated Control
2 Full dose Ingelvac CircoFLEX-MycoFLEX at weaning
3 Full dose Ingelvac CircoFLEX-MycoFLEX at processing
4 Half dose Ingelvac CircoFLEX-MycoFLEX at processing and weaning
5 Full dose Circumvent - Half dose RespiSure One at processing and weaning
Results
No diff erences were observed between treatment groups during 
the nursery phase. Clinical PCVAD was observed in fi nishing and 
was confi rmed diagnostically. Comparisons between the M. hyo 
vaccines used could not be made because clinical and serologic-
al results revealed no signifi cant M. hyo exposure. The Ingelvac® 
CircoFLEX - MycoFLEX™ mixture administered at 3-5 days of 
age was not statistically diff erent than controls for any param-
eter (Table 2). All other treatment groups produced better rate 
of gain, cull rates and % prime marketings than controls. Only 
Ingelvac® CircoFLEX – MycoFLEX™ given at weaning reduced 
mortality rate.over controls.
Table 2: Finishing performance results 
Group Average Daily Gain, lbs Mortality, % Cull, % Prime Marketings, %
1 1.45a 3.7a 15.3a 79.40a
2 1.59b 1.3b 5.7b 92.95b
3 1.50a 3.8a 12.2a 84.07a
4 1.64b 3.0ab 3.7b 93.37b
5 1.63b 5.1a 4.6b 90.33b
Values in columns with diff erent letters are signifi cantly diff erent at P ≤ 0.04 (Fisher’s exact 
test).
Discussion
Vaccination at 5 days of age was not successful. The only group 
that performed signifi cantly better than controls for all 4 per-
formance parameters was a single dose of Ingelvac® CircoFLEX 
- MycoFLEX™ mixture at weaning.
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The importance of on-farm monitoring after sow vaccination (CIRCOVAC®) 
for successful control of porcine circovirus disease (PCVD)
Keiri Tokuyama1 M. Kagawa2 Y. Saito3 S. Ogino3
1. Merial Japan Ltd, Tokyo, Japan; 2. Kagawa Livestock Clinic, Gunma, Japan; 3. Nippon Zenyaku Kogyo Co., Ltd., Fukushima, Japan
Introduction 
When vaccination against PCV2 is implemented, failure of PCVD 
control is often conceived as lack of vaccine effi  cacy. Since it is 
known that multiple pathogens are usually involved in PCVD (1), 
it is important to continuously monitor post-vaccination status 
for successful control. The objective of this study is to show the 
benefi t of sow vaccination and on-farm monitoring practices. 
Materials and methods
A 120 sow farrow-to-fi nish farm located in central Japan, was 
selected for the study. Sows were mass-vaccinated twice 4-week 
apart for PCV2 with CIRCOVAC (Merial) thereafter 2-4 weeks be-
fore parturition. Blood samples from sows and pigs were tested 
for PCV2 antibodies (IFA), PPRSV (ELISA), M. hyo (ELISA), and 
PCV2 viral load (RT-PCR). All clinical incidences, post-weaning 
mortality and days to market were recorded during the course of 
the study for approx. one year. Chi-test and Student-t test were 
used for statistical comparison of one year before and one year 
after vaccination. 
Results and Discussion
Noticeable clinical signs were mainly due to diarrhea and/or di-
gestive disorders during weaning, leading to increased mortality 
and runts. Although the mortality rate contained those losses, it 
stayed statistically lower than the previous year. Days to market 
were reduced by 10 days (Table 1).
Table 1: Post-weaning mortality and days to market
2008 2009 Diff .
Post-weaning mortality (%) Weaners 13.6% 4.1%* -9.5%
Post-weaning mortality (%) Finishers 2.5% 2.0% -0.5%
Days to market 177 ± 6.7 167* ± 6.4 -10.0
*statistically signifi cant (P<0.01)
One year after vaccination sows had markedly lower PCV2 viral 
load and higher antibody titers (Fig. 1a). In pigs, PCV2 DNA was 
detected before vaccination at 8-13 wks, but one year after vac-
cination viremia was detected at the fi nishing stage (17-22 wks) 
(Fig.1b). Despite viremia at 21-22 wks, no particular clinical signs 
were observed, and days to market were reduced by 10 days. 
Mortality in the fi nishing period was reduced to 2.0%. 
As opposed to the pre-vaccination year, pigs seroconverted 
against PRRSV and M. hyo around mid-fi nishing in the year post 
vaccination. Both pathogens are known to negatively impact 
immune functions, and enhance PCV2 replication (2, 3). These 
co-factors may have played a role in the asymptomatic raise of 
PCV2 viremia in the late fi nishing stage. Mortality and growth 
improvements clearly indicate that PCVD was well controlled in 
this farm. The rise in M. hyo and PRRS ELISA titres indicate that 
continuous monitoring is necessary since farm epidemiology 
can change over time. Monitoring thus enables quick implemen-
tation of appropriate measures. 
In terms of effi  cacy, cost and labor, sow vaccination is practically 
one of the most useful options when monitoring is carefully 
implemented as in the present study. 
Figure 1: a) PCV2 IFA titer (left) and PCV2 viral load (right) in sows; 
b) PCV2 viral load (left: log10) and PCV2 IFA titer (right) in fattening 
pigs
Figure 2: ELISA titers of PRRV and M. hyo.
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Willingness to approach behaviour in weaned piglets following vaccination 
with two diﬀ erent PCV2 vaccines in a Japanese commercial farm
Mali Miyashita1 Y Takahashi2 Takeshi Yamaguchi1 Yasuko Shimomura1
1. Boehringer Ingelheim Vetmedica Japan Co. Ltd., Tokyo, Japan; 2. Shokukanken Inc., Gunma, Japan
Introduction 
Adapted from the animal observation section of the 2003 Swine 
Welfare Assurance Program (SWAP), willingness to approach 
observations have been used to evaluate pig behaviour after 
vaccination (1,2). The objective of this study was to compare the 
willingness to approach behaviour in pigs following vaccination 
with two diff erent PCV2 piglet vaccines that are commercially 
available in Japan. 
Materials and Methods
A 450 sow PRRS positive farm with a past history of PMWS lo-
cated in Ibaraki, Japan, was selected for the study. A total of 871 
weaned piglets aged 3 to 4 weeks, were included for observa-
tion. At weaning pigs were allocated to pens of approximately 
20 pigs each. After an average acclimation time of 1 week, half 
of the pens (22) received 1ml of Ingelvac CircoFLEX (group A), 
while the other half received 2ml of Porcilis PCV (group B). Vac-
cines were administered according to manufacturer instructions. 
There was no diff erence in average weight, age or sex between 
vaccine groups. An adaptation of the animal observation sec-
tion of the 2003 SWAP was utilized to evaluate willingness to 
approach behaviour (WTA) of piglets pre- and post vaccination. 
After entering the pen, sitting down and waiting a 15 second 
period, the blinded observer counted all pigs that approached 
and/or were in eye contact to him. These counted pigs divided 
by the total number of pigs in the pen resulted in the % willing-
ness to approach (% WTA). The initial observation (base line) 
was conducted at 4pm on the day prior to vaccination. On the 
following day, vaccination of pigs was completed by 10am, and 
WTA observations were conducted at 6 hours (4pm) post vac-
cination. The change in post vaccination % WTA was compared 
to the baseline for each vaccine group and between groups. The 
% WTA compared to baseline between groups was analyzed by 
the Pearson Chi-square test. Results were considered signifi cant 
when P values were equal to or less than 0.05.
Results
Results are summarized in table 1. Six hours post vaccination, 
there was a statistically signifi cant diff erence (p‹0.0001) in the % 
WTA compared to baseline between groups (83% and 27% for 
groups A and B, respectively).
Table 1. Willingness to approach before and after PCV2 vaccination
Group A Group B
No. of pens observed 22 22
No. of pigs observed 423 448
Baseline pre-vaccination behaviour (%WTA) 69% (293/423)* 66% (297/448)*
Six hour post-vaccination behaviour (%WTA) 57% (242/423)* 18% (81/448)*
Six hour post-vaccination behaviour compared 
to baseline 83%
A (242/293)** 27%B (81/297)** 
A—B: p‹0.0001
*Number of approaching pigs/Number of pigs observed
**Number of approaching pigs/Number of pigs that approached at baseline
Discussion and conclusion
Using the willingness to approach model, it was previously 
shown that Ingelvac CircoFLEX was not diff erent to saline (2), 
for which reason a control group was not included in the study 
protocol. In this study pigs from group A showed more willing-
ness to approach 6 hours post vaccination, compared to those 
of group B, indicating that depending on the type of PCV2 piglet 
vaccine used, diff erences can occur in the behaviour of piglets at 
6 hours after vaccination. Willingness to approach observations 
utilize the natural behaviour of pigs by assessing their level of 
interest to a person in the pen, thus providing a certain indica-
tion as to the well-being of those pigs. Based on the results of 
this study, willingness to approach observations may provide a 
useful tool to objectively assess the potential welfare impacts of 
diff erent vaccines on pigs.
References
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Direct and indirect transmission of four Salmonella enterica serotypes in pigs
Julia Österberg; Susanna S. Lewerin; Per Wallgren
National Veterinary Institute, Uppsala, Sweden
Introduction
The Salmonella serotypes commonly detected in raw feed 
materials in Sweden often diff er from the serotypes most often 
isolated from animals and humans. Why only few of the “feed-
associated” serotypes seem to reach or spread within the animal 
population has not been suffi  ciently investigated. In the present 
study we have performed comparative examinations of two 
serotypes commonly isolated from pigs (S Typhimurium and 
S Derby) and two “feed associated” seotypes (S Yoruba and S 
Cubana) by studying their ability to infect pigs in a direct and 
indirect transmission situation aiming to investigate possible 
diff erences among serotypes. 
Materials and Methods
In total, 48 ten-weeks-old pigs, deriving from a Swedish nucleus 
herd, were split into eight groups. Each group was housed in a 
separate room in a pen with solid concrete fl oor. Sawdust bed-
ding covered half of the pen and the dung was cleared out twice 
daily. 
Direct contact transmission (DT) was studied by mixing six pigs 
with two seeder pigs, aged 18 weeks, in each of four cleaned 
and disinfected pens. The two seeder pigs in each group had a 
well documented history of long-term faecal excretion of one 
of the four selected serotypes of Salmonella, as they had been 
inoculated with 109 colony forming units (cfu) of the serotype 8 
weeks earlier (1, 2).
Indirect transmission (IT) was studied in six pigs in each of 
four pens were Salmonella infected pigs had previously been 
housed. The infected pigs had been inoculated with 109 cfu of 
the serotype eight weeks earlier and their faecal excretion of Sal-
monella had been monitored for eight weeks before the naive 
pigs replaced them in the unwashed pens (1, 2).
All pigs in the eight rooms were monitored for two weeks with 
respect to their faecal excretion of Salmonella and the presence 
of serum antibodies. In total, eight faecal samples and three 
serum samples were collected from each pig. In addition, eight 
tissue samples per pig were collected at necropsy.
Results
The results from culturing the faecal samples and the samples 
collected post mortem are shown in Figure 1. 
All pigs remained serologically negative throughout the study, 
except four pigs in the two Yoruba-groups that expressed anti-
body levels just above the cut-off  in the in-house ELISA con-
structed to detect antibodies to S Yoruba.
Figure 1. Number of Salmonella positive faecal samples per week 
and post mortem samples from eight tissues; tonsil (to), liver (li), spleen 
(sp), colon wall (cw), three lymph nodes: mandibular (ml), ileocecal (il) 
and colonic (cl), and cecum content (cc). DT=direct transmission trial, 
IT=indirect transmission trial.
Discussion and Conclusions
The rate of transmission was apparently low in both the direct 
and the indirect transmission situation, and no diff erences 
between the four serotypes could be concluded with respect 
to the faecal shedding of Salmonella. In contrast, a diff erence 
between serotypes was indicated by the results from the IT post 
mortem samples, as S Typhimurium was re-isolated from four 
pigs housed in the contaminated environment.
In conclusion, the overall low level of transmission of all four 
serotypes in both trials most probably refl ected a low dose 
exposure. Pigs shedding Salmonella at detectable but low levels 
may not necessarily transmit the pathogen to its pen mates, not 
even in a solid fl oor environment. This high-lights the import-
ance of hygienic measures, in order to keep the shedding and 
re-circulation of Salmonella spp. low in infected herds. However, 
isolation of S Typhiurium from especially the ileocecal lymph 
nodes can be expected even in herds with a very low load of S 
Typhimurium. 
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A review on Salmonella control in fattening pigs through the use of 
potassium diformate (KDF) - European case studies
Christian Lückstädt; Peter Theobald; Horst Auerbach
ADDCON, Bonn, Germany
Salmonella control has a high priority in European pork produc-
tion. It is a signifi cant cause of human Salmonellosis and causes 
major economic losses in the pork production chain, through 
reduced productivity, increased veterinary and hygiene control 
costs. Preventing the spread of salmonella to the consumer 
requires special control measures during slaughter and process-
ing. The extra cost of these controls is increasingly being trans-
ferred back to the producer in the form of fi nancial penalties or 
the loss of the market for contaminated pigs. 
Gut health is increasingly being shown to be eff ective against 
intestinal pathogens, a strategy that has only really been made 
possible through the removal of antibiotic growth promoters 
in feed. Creating and maintaining a healthy intestinal environ-
ment has become essential to productivity and food safety 
programmes alike.
S. enteritica typhimurium is the predominant serotype found 
in pig carcasses in Europe, accounting for around 71% of cases. 
Several serotypes are resistant to antibiotics, putting increasing 
pressure on producers to prevent contamination. While salmon-
ella cannot be eradicated in pig units, it can be controlled to 
minimise the risk to consumers. Biosecurity plays a signifi cant 
role in salmonella control. In feed compounding, although heat 
treatment is eff ective in reducing contamination of feed leav-
ing the feed mill, this eff ect does not persist during transport, 
storage and subsequent outfeeding. When conditions within 
the feed are less conducive to bacterial infection, salmonella 
contamination can be reduced. The next critical control point is 
within the pig’s gut itself, where conditions for bacterial growth 
may once again be optimal. Salmonella growth requires warmth 
(35-37°C is optimal), a moisture content greater than 12% and 
a pH between 4.5 - 9.0. It is no coincidence that the pig gut can 
provide salmonella everything it needs to thrive.
While biosecurity and hygiene in the feed mill and on farm are 
essential, the acidifi cation of feed ingredients or fi nished feeds 
with organic acids also off ers considerable benefi ts to salmon-
ella control. Feed acidifi cation is not only eff ective within the 
feed; possibly its biggest benefi t occurs within the pig itself. Re-
search trials in the UK, France and Ireland with 0.6% potassium 
diformate (KDF) feed additive, showed signifi cantly reduced sal-
monella count in the feed as well as in the gut of pigs. This eff ect 
is particularly well illustrated by data collected on 12 farms in 
Ireland (Lynch et al., 2007). The main objective of this investiga-
tion was to evaluate the effi  cacy of salmonella control measures 
on highly infected farms. Salmonella control has been compul-
sory under Irish law since 2002 and farm status is categorised by 
the percentage of positive pigs in a herd according to the Danish 
mix-ELISA test. Category 3 (>50% positive) farrow-to-fi nish farms 
and their associated fattening units were selected for the study. 
All the farms that were treated with KDF alone; or a combination 
of KDF with improved hygiene and biosecurity measures had 
notable improvements in both bacteriological and serological 
prevalence of Salmonella spp. All but one farm in which KDF 
was used ended the trial with a much improved salmonella 
status, with bacteriological prevalence also low on most farms. 
Using improved hygiene and biosecurity measures alone also 
improved salmonella status, but to a much lesser extent. The 
reduction in prevalence obtained by KDF alone, compared to 
the two farms which also implemented additional hygiene and 
biosecurity, demonstrates the additive’s effi  cacy.
These fi ndings are not unique, however. Studies by Dennis and 
Blanchard (2004) in the UK as well as most recently in France 
(Correge et al. 2010) concluded potassium diformate, to be an 
eff ective tool in a salmonella control strategy in commercial 
farms, reducing the percentage of salmonella positive pigs by 
50% and in pork meat juice ELISA scores by 46%, respectively 
in grower fi nisher pigs. The UK trial also showed an improve-
ment in daily gain of 7.7%, reduced mortality and a reduction in 
medicinal intervention compared to the rolling average for that 
unit. The economic benefi t of implementing salmonella control 
was also evaluated. 
Correge et al. (2010). Eff ect of acidifying fattening feed to reduce car-
riage of Salmonella in high prevalence pig herds. Journees Recher-
che Porcine, 217-218.
Dennis and Blanchard (2004). Eff ect of feeding potassium diformate 
on incidence of salmonella infection on a commercial unit. The Pig 
Journal 54, 157-160.
Lynch et al. (2007). Development of on-farm control measures for the 
reduction of Salmonellosis in slaughter pigs. Teagasc. 54 pp..
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Comparison of risk factors and bacteriological ﬁ ndings in the environment 
of pig herds with high or low Salmonella prevalence
Verena Gotter1 Amely Ovelhey3 Sarah Kösters3 Thomas Blaha1 Günter Klein2
1. University of Veterinary Medicine Hannover, Field Station for Epidemiology, Bakum, Germany; 2. University of Veterinary Medicine Hannover, 
Institute for Food Quality and Food Safety, Hannover, Germany; 3. University of Veterinary Medicine Hannover, Department of Biometry, 
Epidemiology and Information Processing, Hannover, Germany
Introduction
With the introduction of a national, serological Salmonella 
monitoring-program in Germany in 2007, the knowledge of risk 
factors for Salmonella infections in pigs in conventional hus-
bandry systems reached a new level of meaning for the veterin-
ary practitioner. In order to help those of his clients whose herds 
have a high Salmonella prevalence, he must be able to devise a 
strategy using the multitude of risk factors mentioned in litera-
ture as basis. However, the importance of individual risk factors 
is highly debated even among the scientifi c community (1), with 
few results from various studies being generally accepted, one 
being that since Salmonella ssp. does not require an animal host 
to survive, the indirect transmission plays a signifi cant part (2, 3). 
The goal of this study was therefore to establish on a wide basis 
the validity and signifi cance of known risk factors by compar-
ing herds of high (category III) and low (category I) serological 
prevalence via questionnaire and to reinforce the fi ndings with 
bacteriological samples from the environment of the animals. 
Following completion of the study the results are then to be 
published as guidelines for the veterinary practitioner.
Material and Methods
A 23page questionnaire with six parts and fi ve attachments 
was validated and sample sites were chosen as accordingly. In 
category I 67 herds were examined; in category III 103 herds. 
All herds were situated in an area of high pig herd density in 
northwestern Germany. Only a fraction of the asked questions is 
presented in this abstract:
1.  Are the driving boards cleaned and disinfected before each 
fattening batch?
2.  Are the loadings ramps cleaned and disinfected before each 
fattening batch?
3.  Is the central hallway of the barn cleaned and disinfected 
before each fattening batch?
Samples were taken by swabbing the area in question with 
a sterile, BPW (buff ered peptone water)-enriched tissue. The 
samples were examined via RT-PCR (real time polymerase chain 
reaction), after an 18 hour enrichment phase in BPW at 37°C at 
the Field Station for Epidemiology in Bakum. 
Results
An excerpt of the results of the samples is presented in Table 1.
Sample N Total % posi-tive
Cat. I % posi-
tive
Cat. III % 
positive
driving boards 239 20.5 10.2 26.5
loading ramps 54 27.8 15.0 35.3
central hallway 175 30.9 17.5 37.3
Discussion
These samples show that in herds in category III have about 
double the amount of positive samples (in percent) than herds 
in category I. This supports the belief that herds in category III 
indeed do have more Salmonella in the environment surround-
ing the pigs. These three exemplary risk factors may belong to 
the crucial group of risk factors, which must be considered when 
implementing a strategy against the Salmonella problem of a 
herd, as further results may show when the detailed inspection 
of all answers of the survey, cross-referenced with the sample 
results become available. This may also answer the critical ques-
tion whether this discrepancy between the herds is due to the 
individual execution of cleaning and disinfection or to the exist-
ence of such procedures per se. 
References
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Does pre-slaughter stress aﬀ ect pork safety risk?
Marcos H. Rostagno; Susan D. Eicher; Donald C. Lay, Jr.
USDA-ARS-LBRU, West Lafayette, IN, USA
Introduction
Food safety is a defi ning issue in the global pork market today, 
and Salmonella contamination is a major concern for the pork 
industry all over the world. Although much of the Salmonella 
contamination of pork occurs within abattoirs, infected pigs 
leaving the farm are considered as the original source of abattoir 
contaminations. According to Berends et al.(1996), live animals 
that carry Salmonella at the time of slaughter are 3-4 times more 
likely to produce positive carcasses. Furthermore, it is reasonable 
to assume that the extent of carcass contamination is also de-
termined by the levels of Salmonella entering the abattoir in the 
intestinal tract of slaughtered pigs. Therefore, two experiments 
were designed to determine if common stressors occurring 
prior to slaughter aff ect the prevalence and levels of Salmonella 
in market weight pigs, and consequently, the associated pork 
safety risk.
Materials and Methods
Initially, a fi eld study (i.e., under commercial conditions) was 
conducted to determine the eff ect of transportation from the 
production farm to the abattoir, and pre-slaughter lairage on the 
frequency of Salmonella shedding in market pigs. In this study, 
5 Salmonella-positive fi nishing lots were used. From each lot, 
30 pigs were randomly selected from Salmonella-positive pens, 
transported in a clean and disinfected livestock trailer for 1.5 
hour, and subjected to 2 hours of pre-slaughter lairage. Individ-
ual fecal samples were collected immediately prior and after 
transportation, and after lairage. All samples were processed for 
the isolation and identifi cation of Salmonella enterica. A follow 
up study was conducted under controlled conditions, with the 
objective of determining if feed withdrawal and transportation 
aff ect the levels of Salmonella in the intestinal tract of market-
weight pigs. Three replicates with 20 market-weight pigs each 
(5 pigs/treatment) were conducted, including the following 
treatments; Control (no stress), feed withdrawal (12 h), transpor-
tation (1 h), and feed withdrawal (12 h) followed by transporta-
tion (1 h). Pigs were individually challenged with a Salmonella 
Typhimurium Nalidixic acid-resistant strain 3 days prior to the 
experiment, and euthanized immediately after the treatments 
for necropsy. All samples were processed for the isolation and 
enumeration of the challenge strain.
Results
In the fi rst study, signifi cant increase (P<0.05) of Salmonella 
shedding prevalence was observed from pre-transport (11.3%) 
to post-transport (20%), and from post-transport to post-lairage 
(42%). In the second study, feed withdrawal by itself or com-
bined with transportation caused increased levels of Salmonella 
in the ileum (P<0.05), whereas only the combination of feed 
withdrawal and transportation caused increased levels of Sal-
monella in the cecum of market-weight pigs (P<0.05).
Discussion 
Studies of the eff ects of pre-slaughter stressors on food safety 
risk in market pigs are scarce. Taken together, our studies show 
that a signifi cant increase of Salmonella shedding and its levels 
in the intestinal tract of market pigs occurs between the produc-
tion farms and the abattoirs. We have already shown that an 
increase of Salmonella prevalence occurs due to rapid infec-
tions during pre-slaughter lairage (Hurd et al.,2001; Rostagno 
et al.,2003). Besides of confi rming this occurrence, these studies 
show that the process of moving market pigs from the produc-
tion farm to the abattoir also contributes to increase pork safety 
risk. Although many can argue that transporting pigs from the 
farms to the abattoir is a process that cannot be avoided, it is im-
portant to keep our minds open to potential changes or modifi -
cations. For instance, transportation conditions can be manipu-
lated to minimize stress, and/or the gastrointestinal microbial 
ecosystem can be made more resilient to changes (or stabilized) 
through the use of probiotics, prebiotics or other alternatives.
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Relationship between serological status of sows and the assignment as 
Salmonella risk farm in the Belgian Salmonella control program
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Introduction
Salmonella is considered as one of the most important food 
borne pathogens that has potential implications for human 
health (1). To control Salmonella at the pre-harvest stage, the 
implementation of a surveillance and control program has been 
established in the diff erent EU Member States. Since 2005, the 
Belgian Federal Agency for the Safety of the Food Chain (FASFC) 
implemented a National Salmonella surveillance and control 
program in pigs, the Salmonella Action Plan (SAP), which be-
came compulsory by means of a Royal act in July 2007 (2). Since 
July 2007, Belgian pig farms can be assigned as Salmonella-risk 
farms, based on serological analysis of blood samples collected 
from the fattening pigs.
This study was conducted to evaluate the serological status of 
the sows on Salmonella risk farms compared to non-assigned 
farms.
Materials and methods
With a 4-month interval, every Belgian pig farm needs to collect 
blood samples from 12 fattening pigs for the National Aujeszky-
disease monitoring program. All samples are analyzed using an 
indirect LPS-Salmonella ELISA (Idexx). Since July 2007, farms are 
identifi ed as risk farms if the mean S/P-ratio, from 12 fattening 
pigs, is equal to or higher than 0.6 for 3 successive sampling 
events.
For this study blood samples (n = 1138) of sows were randomly 
collected on 100 diff erent farrow-to-fi nish herds. To this end, 583 
samples were obtained from 50 Salmonella risk farms, identifi ed 
as farms with a mean S/P-ratio equal to or higher than 0.6 for 
3 successive sampling events; and 555 samples were obtained 
from non-risk farms, identifi ed as farms with a mean S/P-value 
lower than 0.2 for 3 successive sampling events.
A statistical analysis (Mann–Whitney–Wilcoxon test) was per-
formed to compare the mean S/P ratio in both sow groups.
Results
The results show that the mean S/P ratio obtained from the sows 
of the Salmonella risk-farms (1.138 ± 0.026 SEM) was signifi cant-
ly higher (P < 0.0001) compared with the non-risk farms (0.702 
± 0.021 SEM). The mean S/P-ratio for the 1138 sows was 0.925 ± 
0.018 SEM. In this study there was a presence of Salmonella anti-
bodies in 98.7% of the sows. At a cut-off  of S/P = 0.6 we found 
63.6% of the sows to be positive.
Table 1. Number of samples sows and their mean S/P value ± SEM for 
Salmonella in blood
Number of sows Mean S/P-value
Risks farms 583 1.138 ± 0.026
Non-risk farms 555 0.702 ± 0.021
Total 1138 0.925 ± 0.018
 
Discussion and conclusions
Sows play an important role in the maintenance of Salmonella 
infections in farrow-to-fi nish herds (3). The increasing number of 
sows on a farrow-to-fi nish farm was recently identifi ed as a risk 
factor associated with higher average S/P-values on a farm (4). In 
this study we could clearly show that the infection status of the 
sows plays a signifi cant role in the assignment as a Salmonella 
risk farm in the Belgian Salmonella control program, which is 
based on sampling of fattening pigs. Control of Salmonella on 
farrow-to-fi nish herds is now almost only done by implementing 
measures in the fattening unit. It is clear that further studies are 
needed to evaluate intervention measures in the sow unit. Vac-
cination could be one of these intervention options.
In conclusion, it is clear that the role of the sows and their sero-
logical Salmonella status is a potential infl uencing factor for the 
assignment of Salmonella risk farms, which is principally based 
on sampling of fattening pigs.
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Use of workshops and face-to-face interviews to teach smallholder pig 
farmers about how to prevent disease due to Taenia solium
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Introduction
Neurocysticercosis is the major preventable cause of adult-onset 
epilepsy in developing countries. Epilepsy is caused by the 
neurocysticercosis form of Taenia solium. The life cycle includes 
the pig as an intermediate host having larval cysts (Cysticercus 
cellulosae) and the human as the defi nitive host, having adult 
tapeworms (taeniasis). Humans also act as intermediate hosts if 
they consume T. solium eggs.
The purpose was to describe changes in and retention of know-
ledge and changes in behaviours of pig farmers after providing 
workshops using the training of the trainers model followed by 
one-on-one farmer training. 
Materials and Methods
A random sample of 282 pig farmers in the Busia and Kakamega 
Districts of Western Kenya were included in the study beginning 
in 2006. Each farm was visited 3 times at 4-7 month intervals. 
Data was collected from farmers in face-to-face interviews at 
each farm visit. The authors presented a one-day workshop 
about pig management, feeding, housing, and the lifecycle of 
Taenia solium and its association with epilepsy to government 
livestock, veterinary and public health offi  cers (staff ). Then, the 
staff  taught this material during one-day farmer workshops. 
Three farms visits that were 5 months apart enabled research-
ers to conduct one-on-one training. Farmers were asked what 
management changes they made as a result of the research and 
workshops during 2008 &2009 workshops. 
Proportions of correct answers to questions regarding the life-
cycle and prevention of disease due to T solium in people and 
pigs were compared amongst three groups of farmers based on 
training; those who attended workshops and those who were 
given one-on-one training. Acquisition of knowledge was com-
pared within respondent from the 2nd to the 3rd farm visit using 
a McNemar’s chi-square test. 
Results
Many farmers (51%) have seen tape worm segments in their 
own stool. Most farmers (89%) knew that if they saw these 
segments, they should seek medical treatment. However, few 
farmers knew how people became infected with the tapeworm. 
Male farmers were 9 times more likely to have seen a pig with 
cysts than female farmers. 
Farmers were 3.7 times more likely to know how people become 
infected by T solium after the one-on-one training (60%) than 
before this training (50%). Farmers with at least a grade 8 educa-
tion were more likely to understand the life cycle than farmers 
with less education. Farmers were more likely to tether their 
pigs 100% of the time after the workshop (51%) than before the 
workshop (34%) and still more likely after the one-on-one train-
ing (63%) (P<0.02). At the end of the study, 79% of farmers were 
keeping their pigs tethered 75% of the time. More than half ( 
59% ) of the farmers knew how to make the pork safe to eat if 
it was infected with cysts. This proportion was higher (66%) for 
those farmers who received the one-on-one training. 
Discussion
Education is the primary method of reducing the prevalence of 
diseases due to Taenia solium in developing countries. Work-
shops and one-on-one training increased the level of knowledge 
and changed the behavior regarding confi ning pigs. The life 
cycle of T solium is diffi  cult to understand. Farmers with a grade 
8 education and those with individual training were most likely 
to understand the cycle and therefore know how to prevent the 
disease. Individual training is expensive but may be necessary to 
reduce the prevalence of epilepsy due to this disease.
.
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Toxoplasma gondii Seroprevalence on U.S. swine operations in 2000 and 
2006 and factors associated with changes in prevalence in 2006
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Introduction.
Toxoplasma gondii is a protozoan parasite capable of infecting 
most warm blooded animals, potentially resulting in the disease 
toxoplasmosis. It is estimated that 60 million people in the U.S. 
are infected, although few demonstrate symptoms1. Cats can 
serve as the host and shed oocysts in the feces for approximate-
ly 1-2 weeks. These oocysts then sporulate in 1-5 days follow-
ing deposition1,2. Swine, can be infected by ingesting material 
contaminated with the oocysts. It has been estimated that up 
to 25% of apparently healthy pigs in the United States have 
positive antibody titers3. While few pigs display clinical signs, the 
parasite can persist in the edible tissues of pigs. 
Our fi rst objective was to compare sample and farm level preva-
lence of exposure to Toxoplasma (as measured by antibodies) 
in 2000 and 2006 from the National Animal Health Monitoring 
System’s (NAHMS) swine studies and associated herd factors. 
The second objective was to present factors associated with 
the number of positive Toxoplasma test results within farms 
sampled in the 2006 study.
Materials and Methods
Questionnaire data and blood samples were collected as part of 
the NAHMS Swine 2000 and 2006 studies. Producers participat-
ing in the NAHMS Swine 2000 and 2006 studies were able to 
submit up to 15 and 35 blood samples, respectively from fi nisher 
pigs to be tested for antibodies to Toxoplasma. In 2000, 5,718 
samples were collected from 394 swine sites and tested using a 
modifi ed agglutination test (MAT) test. In 2006, 6,238 samples 
were collected from 185 sites and tested using an enzyme linked 
immunosorbant assay (ELISA). 
Results
Overall, 0.9% of grower/fi nisher pigs sampled were positive 
for Toxoplasma antibodies in 2000 and 2.7% in 2006. Smaller 
herds (<2K head) appeared to have more positive samples than 
medium (2-4.9 K head) and larger herds (5 K head plus) in both 
years. The number of fi nisher pigs housed in total confi nement 
comprised a lower percentage of positives in 2000 compared 
with 2006.
The average within herd prevalence in positive (had at least one 
positive sample) and negative herds in 2000 was 1.8% of fi nish-
ers overall and in positive herds was 23.5%. In 2006 the corres-
ponding average within herd prevalence was 4.6% and 17.4%, 
respectively. Overall, 7.5% of sites were positive for Toxoplasma 
antibodies in 2000 and 26.8% of sites were positive in 2006. 
Similar to the sample level results, smaller herds appear to be 
aff ected more often in both years but the prevalence in confi ne-
ment vs. not confi ned herds seemed to be diff erent only in 2000.
For the 2006 samples we used a method of modeling called zero 
infl ation to detect herd level practices associated with counts of 
positive samples4. For farms that buried dead weaned pigs off  
site, the count of Toxoplasma positives was 7.2 times higher than 
when they were not buried off  site. When a farm composted 
dead preweaned pigs on site the incidence rate of Toxoplasma 
positives went up 83 percent, while the use of traps, bait, poison, 
exterminator or some other method besides cats or dogs for ro-
dent control on the farm reduced the prevalence of Toxoplasma 
by 63 percent.
Discussion
It is likely that since there was less sampling of fi nisher pigs in 
2000, the incidence has not gone up so much as there wasn’t 
suffi  cient sampling in 2000 to fi nd a diff erence. However, for 
2000 and 2006 it would be possible to get estimates of true herd 
prevalence based on published test accuracies for the MAT and 
ELISA tests. The results of modeling suggest there is an unmeas-
ured eff ect since one would expect that burying pigs off -site 
would decrease positive counts. 
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Prevalence, detection and isolation of Toxoplasma gondii in swine tissue 
samples from a slautgerhouse in Bogota-Colombia
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Introduction 
Toxoplasmosis is a zoonotic disease caused by infection with 
the protozoan Toxoplasma gondii. Infections by this parasite are 
widely prevalent in humans and other warm-blooded animals in 
all continents. In humans, infection occurs either by consump-
tion of uncooked meat containing cysts or ingesting or drink-
ing contaminated food with sporulated oocysts. Studies have 
demostrated that toxoplasmosis in pregnant women is gener-
ally related with uncooked meat consumption( Kapperud et al., 
1996; Baril et al., 1999; Cook et al., 2000). It is important to study 
the prevalence of this protozoon in pork as it is a major source 
of infection. The seroprevalence in pigs was reported to be 29% 
worldwide. (Kim & Weiss . 2008)
To guarantee the destruction of the parasite, the meat must be 
properly cooked until it reaches a temperature of 67ºC or must 
be frozen at freezing temperature lower than -10ºC for a period 
of 48 hours. (Kijlstra & Jongert, 2008)
Materials and Methods
80 pig samples of tongue, heart and blood were collected in a 
slaughterhouse in Bogotá- Colombia. 
DNA extraction of tissues samples of heart and tongue was 
performed by the method of salting out. The amplifi cation of a 
532 bp fragment of B1 gene was performed by nested PCR to 
evaluate the presence of the parasite (Boothroyd & Grigg 2001). 
For the isolation of native strains, subcutaneous inoculation of 
the processed material in CFW and Swiss mice was performed. 
Infection was assessed by analyses of mice sera by Western-blot 
technique using an anti-mouse IgG secondary antibody labeled 
with peroxidase.
Seroprevalence in pigs was assessed. The presence of antibodies 
againts T. gondii and Trichinella in blood samples of pigs were 
analyzed using an ELISA kit (ID Screen toxoplasmosis indirect 
multi-species, and ID Screen Trichinella indirect), produced by ID 
VET innovative diagnosis (Montpellier- FRANCE).
Results
Analysis of the samples obtained by B1 gene amplifi cation 
showed a 40% prevalence of T. gondii in pig tissue in 66 samples 
analyzed. Seroprevalence analysis showed 37% presence of 
antibodies againts T. gondii in 80 swine serum samples, where 
22 samples were positive by ELISA and PCR. Serum analysis for 
Trichinella gave negative in all cases. 
The sera of mice infected with PCR positive swine samples were 
tested using Western blot to evaluate the possibility of infec-
tion. After 6 months only one mouse was Western blot positive, 
showing the presence of a native avirulent strain. This mouse 
serum showed reactivity to tachyzoite proteins of RH strain. The 
presence of cysts in brain were also detected in this mouse using 
PCR. 
Conclusions
Using amplifi cation of gene B1 it was possible to detect the 
presence of the parasite in 27 of the 66 samples from a slaugh-
terhouse of Bogota, Colombia. This represents a 40% prevelence 
of T. gondii in swine tissue.
In the 80 samples analysed by the ELISA technique, the sero-
prevalence was 37%, coinciding with previous reported studies.
The tecnifi cation of the production plants has allowed better 
control of some diseases transmitted by swine. Nevertheless 
the present Colombian legislation for the proper handling of 
swine is still too lax to control infection by certain mechanisms 
of control of T. gondii, for example the presence of cats in the 
production area.
According to the FAOSTAT Studies done in Colombia in 2005, 
the total consumption of pork and its derivatives corresponds to 
10% of the total meat consumption. This, together with the high 
prevalence of T. gondii in the country, shows the urgent need for 
better methods of control.
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Isolation of immunogenic glycopeptidolipids of Mycobacterium avium subsp. hominissuis
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Introduction
Mycobacterium avium (MA) is an important pathogen in both 
animals and humans which belongs to the M. avium complex 
(MAC). Diagnosis of MA-infections in pigs is traditionally based 
on the detection of granulomatous lesions in lymph nodes seen 
by eye at slaughter. Since sensitivity and specifi city of this ap-
proach is questioned (Komijn et al., 2007) we developed as an 
alternative a serodiagnostic ELISA assay on the basis of a polar 
lipid fraction from MA (Wisselink et al., 2009). We isolated glyco-
peptidolipids (GPLs) from M. avium subsp. hominissuis (MAH) 
and analyzed them for their suitability for serodiagnosis of MA 
infections in pigs. 
Materials and Methods
MAH serotype 4 strain 17404 was grown at 37°C in Dorset Henry 
medium. Glycolipid antigens were extracted, analyzed by one 
and two dimensional thin layer chromatography (TLC) and 
further purifi ed (Nishiuchi et al., 2004; Papa et al., 1993; Kitada 
et al., 2002). As reference, GPLs from a MAH serotype 4 strain 
were used (Kindly supplied by Y. Nishiuchi, Osaka, Japan). The 
immunogenicity of the GPLs was evaluated in ELISA tests using 
reference serum samples obtained from pigs held under experi-
mental and fi eld conditions. 
Results
The TLC-pattern of GPLs from MAH strain 17404 and the refer-
ence GPL (Nishiuchi et al., 2004) showed both a Retention Factor 
(Rf ) value of 0.42 (Fig. 1)
Fig.1. One – dimensional (A) and two-dimensional TLC analysis (B and 
C). Reference GPLs from MAH serotype 4 (lane 1) and MAH serotype 4 
strain 17404 (lane 2) had both a Rf value of 0,42. The purity of GPLs was 
examined by two-dimensional TLC (B: MAH strain 17404; C: reference 
GPL).
To evaluate the GPLs for their immunogenicity the cut-off  value 
for negative and positive test results was calculated (Wisselink et 
al., 2009) which appeared to be 24.5 percentage positivity (PP). 
In all eight sera of pigs, experimentally infected with MA, high 
anti-GPL antibody titers were found. On the two infected farms 
10.6 % (11/104) of the pigs tested serologically positive and on 
the fi ve farms, free for an MA infection 3.3% (3/92) pigs (Fig. 2).
Fig. 2. Results of ELISA tests with 1 ug GPLs per well from MAH using 
serum samples from pigs experimentally infected with MA (A; n=8), 
from two farms with pigs known to be infected with MA (B; n=104)) and 
pigs from fi ve farms free for an MA infection (C; n=92).
Discussion
Earlier we developed an ELISA test on the basis of polar lipids 
for serodiagnosis of MA infections in pigs. Here we show that 
purifi ed GPLs can also be used as antigen in a serodiagnostic 
test because of its clear recognition by serum antibodies in 
experimentally infected pigs. For use under fi eld conditions, the 
results of the GPL-ELISA indicate that MA-infected farms can be 
discriminated from MA-negative farms. Further work is needed 
to optimize and evaluate the GPL-ELISA for use in the fi eld.
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EU consumer reactions towards the vaccine method versus physical piglet 
castration with anesthesia: A quantitative cross-country study
Wim Verbeke; Filiep Vanhonacker
Ghent University, Gent, Belgium
Introduction
In most countries, rearing male piglets are castrated to avoid 
boar taint, an unpleasant odor that can be released during 
the cooking of pork from entire boars. In the European Union 
(EU), physical castration is as yet the most common practice. 
This method is increasingly criticized for its violation of piglet 
welfare, integrity and health. Alternative methods are being 
researched and evaluated in terms of practical and economic 
feasibility, production effi  ciency and animal welfare.1 One 
promising alternative pertains to the vaccination with Improvac 
(® registered trade mark of Pfi zer). The vaccine stimulates the 
pig’s immune system to produce specifi c antibodies against the 
Gonadotropin-Releasing Factor (GnRF), hence inhibiting the 
production and accumulation of androstenone and skatole that 
cause boar taint. This so-called ‘vaccine method’ has been shown 
to improve production effi  ciency, and to be benefi cial from an 
animal welfare and environmental perspective.2 The vaccine 
has received a marketing authorization of use in the EU market 
in March 2009. However, its successful introduction and adop-
tion by stakeholders in pig supply chains is expected to depend 
among others on a favorable reception by consumers. Several 
qualitative3, sensory4 or quantitative single-country5,6 studies 
have already been reported. The present study adds to this body 
of evidence from the EU consumer point of view towards piglet 
castration, through providing a large-scale quantitative cross-
country approach, including the identifi cation and profi ling of 
cross-cultural pork market segments. 
Material and Methods 
A cross-sectional quantitative survey was conducted with rep-
resentative consumer samples in Germany, France, the Nether-
lands and Belgium. In total 4,031 pork consumers responded on 
an online interview. The data is weighted per country to refl ect 
the demographics of pork consumers in terms of age, gender 
and education. Key questions pertained to the awareness and 
acceptance of the method of castration (measured on a 7-point 
scale from 1= ‘completely unacceptable’ to 7= ‘completely ac-
ceptable’), and the preference of the vaccine method relative 
to physical castration (measured on a 7-point scale from 1= 
‘strongly prefer physical castration’; 4= ‘neutral’; 7= ‘strongly 
prefer the vaccine method’). Participants were informed about 
boar taint, physical castration with anesthesia, and the vaccine 
method after some introductory questions.
Results
Signifi cantly higher acceptance scores were reported for the 
vaccine method (μ=5.38, SD=1.61) versus physical castration 
with anesthesia (μ=3.74, SD=1.74). Acceptance scores increased 
from Germany, over France and Belgium, to the Netherlands. 
About 70% preferred the vaccine method over physical castra-
tion with anesthesia; another 20% reported a neutral position. 
When informed about the two methods, 45% of the pork 
consumers intended to seek out pork produced using the 
vaccine method, while 33% indicated to intend avoiding pork 
produced using physical castration. Three distinct market seg-
ments were identifi ed based on importance attached to pork 
taste, price, health, animal welfare and environmental issues. 
The largest segment (59.2%; relatively higher share of females 
and >55 years) reported a strong interest in ethical attributes 
and production method, along with interest in price, taste and 
health. Another segment (21.6%; relatively higher shares of 
heavy pork consumers, males, <35 years, lower income, Dutch) 
focused mainly on price. The third segment (19.2%; relatively 
higher shares of males, French and Germans) scored in between 
the previous segments on most attributes. The ethics oriented 
segment reported a lower confi dence in the effi  cacy of physical 
castration, while the reported confi dence levels that the vaccine 
method will avoid boar taint were similar across all segments. 
The two largest segments strongly rejected physical castration, 
while all three segments preferred the vaccine method to the 
same high degree. 
Discussion 
This cross-country study shows that uncertainties with respect 
to EU consumer acceptance of the vaccine method are void. 
A vast majority of pork consumers accept the vaccine method 
and strongly prefer this method over physical castration with 
anesthesia. The fi nding that confi dence, acceptance and prefer-
ence for the vaccine method do not diff er between pork market 
segments indicates that the adoption of this method is unlikely 
to result in loss of any particular target market. 
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Eﬀ ects of GnRH down-regulation using deslorelin (Suprelorin®) on sexual function in boars
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Introduction
Immunization against GnRH has been proven eff ective for boar 
taint removal [1], and long term treatment with GnRH analogues 
has been shown to down-regulate GnRH and to suppress GnRH 
dependent reproductive processes in several species [2]. This 
study was conducted to down-regulate GnRH in boars using Su-
prelorin® which is an implant that contains 4.7 mg of the GnRH 
analogue deslorelin, and to test the eff ects on sexual function.
Materials and Methods
Five boars had the implant inserted intramuscularly at the age 
of 5 weeks and the eff ects studied until market age at 26-27 
weeks. Surgically castrated (n = 4) and intact boars (n = 3) served 
as controls. Parameters assessed included health, testes growth 
and libido. Boars were trained to mount the dummy at the age 
of 180 days, and if mounted, were collected 3-6 times for semen 
analysis. Animals were bled twice at the age of 26 and 27 weeks, 
and serum analyzed for the concentration of testosterone, 
estrone, estrone sulphate and estradiol 17β, respectively. All 
intact and implanted animals were surgically castrated at the 
end of the experiment and the testes as well as the epidiymides 
subjected to histological evaluation. 
Results
None of the boars that received the implant exhibited nega-
tive eff ects on general health or local reactions at the site of 
implant insertion. Four out of the 5 boars with the implant had 
only marginal testicular growth (Figure 1). These 4 boars did not 
show libido and did not mount, had low or undetectable con-
centrations of steroid hormones similar to what was observed in 
surgical castrates, and histological evidence of a ceased sperm-
atogenesis. In the remaining fi fth boar (#9), the testes started to 
grow around week 17 (Figure 1). Steroid hormone concentra-
tions were as high as in intact boars or higher. This boar also 
showed libido and could be collected; however, semen quality 
was bad for the fi rst three ejaculates but then improved, reach-
ing normality with the sixth ejaculate at the age of 34 weeks. 
Figure 1. Mean (± SD) testis length. Boars that received Suprelorin® 
had either marginal (n = 4; open squares) or distinct testis growth 
(boar #9; triangles). Non-treated intact boars (n = 3; diamonds) tripled 
their testis size. Their testes were bigger then of boars with the implant 
(except boar #9; P < 0.05–0.0001).
Discussion
This study has shown that, if fi ve week old boars were treated 
with the implant Suprelorin® containing 4.7 mg of the GnRH 
analogue deslorelin in order to down-regulate GnRH, the testes 
only grow marginally and both the spermatogenesis as well 
as the steroidogenesis is inhibited. This is similar to what has 
been observed in male dogs [2]. Since these eff ects can last for 
an extended period up to the boars’ market age, GnRH down-
regulation, as carried out in this study, may have potential for 
boar taint removal. However, since the eff ect does not seem to 
be sustained consistently in all boars, treatment may need to be 
refi ned. 
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Eﬀ ects of Ractopamine Hydrochloride on growth performance of 
Barrows, entire boars and boars vaccinated with Improvac™
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1. Pfi zer Animal Health, Kalamazoo, MI, USA; 2. Integrall Soluções em Produção Animal Ltda., Patos de Minas, MG, Brazil; 
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Introduction
Ractopamine (RH) is a β-adrenoceptor agonist known to en-
hance weight gain, leanness and feed effi  ciency in both bar-
rows and gilts (1,2). Barrows (physical castrates) are known to 
consume more feed, grow slower, and to have proportionally 
more fat compared to boars (3). An alternative to physical castra-
tion for the control of boar taint is vaccination against GnRF (also 
known as immunological castration) (4). Compared with bar-
rows, boars that are raised with the use of vaccination are leaner 
and have better feed effi  ciency (5). The goal of the present study 
was to evaluate possible interactions between vaccination 
against GnRF and the use of ractopamine in fi nishing pigs.
Materials and methods
A total of 360 healthy crossbred Landrace x Large-White pigs 
from DanBred genetics were randomly allocated to one of six 
treatments, soon after birth. The study had a randomized com-
plete block design with sub-sampling, with body weight being 
the blocking factor. Treatments were arranged in a 3x2 factorial 
design: T1 (barrows + saline), T2 (barrows + RH + saline), T3 
(vaccinated boars), T4 (vaccinated boars + RH), T5 (boars + RH + 
saline) and T6 (boars + saline). Vaccination was performed using 
ImprovacTM (Pfi zer Animal Health) which was administered as 
two subcutaneous injections in the neck at 15 and 19 weeks of 
age. Day 0 was defi ned as the day when pigs were moved to the 
grower facility (approximately 9 weeks of age). Slaughter took 
place on Day 98 at approximately 23 weeks of age. The use of 
RH was in accordance with label recommendations, i.e., 5 ppm 
in-feed during the last 28 days before slaughter. All animals were 
fed ad-libitum and weighed at 9, 15, 19, 21 and 23 weeks of age. 
Feed disappearance was measured daily. Diets fed during the 
last 28 days had 18% Crude Protein (CP) and 1,0% total Lysine for 
treatments T2 to T6, while the diet used for T1 had 15% CP and 
0,8% total Lysine. 
Results
Following the second vaccination with Improvac, vaccinated ani-
mals showed higher feed intake (p<0,05). In this same period, T4 
(Improvac + RH) had signifi cantly higher daily gain than all other 
groups, being 18,6% higher than T2 (barrows + RH + saline) and 
8,5% higher than T3 (Improvac only). During this period, the 
addition of RH to the diet improved feed conversion of vaccin-
ated boars by 12,2%.
Analyzing the complete trial period (Day 0-98), entire boars 
were the most feed effi  cient (Table 1), but presented substan-
tial incidence of boar taint at slaughter. Taking only vaccinated 
pigs and barrows (T1 to T4), the Improvac + RH group (T4) had 
signifi cantly better feed effi  ciency than the others (p<0,05). 
The administration of RH to Improvac vaccinated boars (T4) 
improved feed conversion by 4,3% when compared to Improvac 
alone (p=0,018). The use of Improvac and RH together improved 
feed effi  ciency by 6,9% (p=0,0007) when compared to barrows 
given RH (T2).
Table 1- Average daily gain (ADG), feed conversion and average daily 
feed intake among treatments for the whole trial period (Day 0 to Day 
98)
Weight day 98 
(kg)
ADG 
(kg/day) Feed Conversion
Feed Intake 
(kg/day)
T1 116,19a 0,980a 2,62a 2,55a,b
T2 119,44a,b,c 1,000a,b 2,60a,b 2,61a
T3 119,95a,b,c 1,010a,b 2,53b 2,52b
T4 122,57c 1,040b 2,42c 2,49b
T5 121,17b,c 1,030b 2,30d 2,33c
T6 117,05a,b 0,980a 2,40c 2,34c
Treatments that share the same letter are not signifi cantly diff erent from each other at 
alpha=0.05
Discussion/Conclusions
The addition of RH to the diet signifi cantly improved feed ef-
fi ciency of Improvac vaccinated pigs, when compared to pigs 
given Improvac alone. Besides that, the addition of RH during 
the last 28 days before slaughter produced similar qualitative 
eff ects in barrows, Improvac vaccinated pigs and entire boars, as 
described by a previous study (6). Comparing only the treat-
ments which produced non-tainted meat, T4 (Improvac vaccin-
ated boars + RH) resulted in the best feed effi  ciency.
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Introduction
Since the meat of boars is often tainted with an unpleasant 
odor, most countries of the world castrate pigs at a young age. 
However, as well as being a welfare concern, physical castration 
of young pigs impairs growth performance. Improvac is a novel 
immunological product which induces male pigs to develop 
antibodies to GnRF, consequently blocking testicular steroid 
synthesis and subsequent boar taint production prior to slaugh-
ter.1 Improvac is injected in the late stage of the grower-fi nisher 
period, and permits improved growth performance by retaining 
the advantages of intact males over most of the pig’s life.1-2 The 
objective of this study was to evaluate the production benefi ts 
of using Improvac in male pigs raised under Canadian (Quebec) 
standards.
Materials and Methods
Animals and trial design: Male pigs from 4 high health commer-
cial farrowing units from 4 diff erent genetic lines (one per farm) 
were blocked by litter and randomly allocated to 2 treatment 
groups: 1. 126 were physically castrated at 4 days of age; 2. 126 
dosed with Improvac (the second 2 mL dose given at least 4 
weeks after the fi rst dose and at least 4 weeks before slaughter). 
After weaning at 22 days of age, pigs were transferred to the re-
search unit. Treatment groups were not commingled. During the 
trial period, pigs were tended according to the guidelines and 
principles outlined by the Canadian Council on animal care. 
Growth performance: Pigs were individually weighed on Days 
0 (23 days of age), 41 (1st dose and transfer to grower-fi nisher), 
71, 99 (3 days after 2nd dose in heavy pigs), 112 (2 days after 
2nd dose in light pigs), and Days 123, 130, 137 and 144 (1st, 2nd, 
3rd and 4th shipments to slaughter days). All pigs were fed ad 
libitum with feed rations meeting boar nutritional requirements. 
All the groups received the same rations during the same period. 
Feed consumption was recorded by pen. 
Serology: Blood samples taken 1 day before second injection and 
5 days before slaughter were assayed for anti-GnRF antibodies. 
Behavior: Behavior assessment occurred 16-17 days post 2nd 
dose (aggression, mounting, physical appearance).
Carcass assessment: Carcass quality was assessed by measure-
ment of hot carcass weight, carcass yield, back fat thickness, lean 
yield, loin eye area, leg, loin, shoulder and belly yields, 24 hour 
loin and leg pH, loin drip loss, ham yield and loin and leg Minolta 
color. 
Statistical analysis: Data were analyzed using a general linear 
mixed model for repeated measures or for a single time point as 
appropriate. 
Results
Growth performance: The mean live bodyweight at slaughter of 
Improvac pigs was signifi cantly higher than for physically cas-
trated pigs (P <0.05). Other growth data are given in Table 1.
Table 1. Growth performance – Least squares means
Group Days 0-123
Days 
0-130
Days 
0-137
Days 
0-144
Days 0 - 
slaughter
Daily gain 
(kg/day) 1 0,88
a 0,88a 0,89a 0,88a N/D
2 0,90b 0,92b 0,93b 0,94b N/D
Feed intake (kg/
day) 1 1,90
a N/D N/D N/D 1,98a
2 1,77b N/D N/D N/D 1,91b
Feed conversion 1 2,18a N/D N/D N/D 2,25a
2 1,98b N/D N/D N/D 2,09b
abFor each growth variable, values with diff erent superscripts within column diff er signifi -
cantly (P<0.05) N/D – Not Done
Serology: The mean anti-GnRF antibody level at slaughter was 
signifi cantly higher for the Improvac pigs than for the physically 
castrated pigs (P <0.05).
Behavior: None of the Improvac pigs showed any signs of boar 
behavior post 2nd dose.
Carcass assessment: Improvac pigs had signifi cantly lower 
carcass and belly yields than physically castrated pigs (P <0.05). 
However, shoulder and ham yields were higher for the Improvac 
group (P <0.05). No signifi cant diff erences were observed for any 
other parameter.
Discussion
The results indicate that male pigs injected with Improvac de-
veloped a strong immune response to GnRF. The Improvac pigs 
had signifi cantly better growth (live bodyweight, average daily 
gain, feed conversion) than physically castrated pigs without any 
eff ect on carcass quality. 
Conclusion
The use of Improvac can allow productivity benefi ts in intact 
male pigs raised under Canadian standards without aff ecting 
carcass quality.
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Histomorphology of testes and epididymides of unvaccinated and Improvac® vaccinated slaughter boars 
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Introduction
Active immunization against gonadotropin-releasing factor 
using a GnRF analogue-protein conjugate, (Improvac®) is an 
alternative to surgical castration. Usually, vaccination is recom-
mended twice, at least 4 weeks apart, with the second injection 
given 4–6 weeks before slaughter (1). Studies suggest that the 
immune response is temporary. In pigs kept longer than 7–8 
weeks after the second dose, anti-GnRF antibodies may decline 
below eff ective levels, allowing return of testicular function and 
the risk of boar taint accumulation. Therefore, the timing of vac-
cination in the fattening period is of high practical relevance.
The objective of this study was to evaluate testes and epididy-
mides size and morphology as well as boar taint in intact and 
Improvac vaccinated boars receiving the 2nd vaccination either 6 
or 10 weeks prior to slaughter. 
Materials and Methods
From a typical Austrian swine unit, 22 and 28 Improvac vaccin-
ated males, receiving the 2nd vaccination 6 and 10 weeks prior 
slaughter, respectively (2) were investigated. 17 intact boars 
were included as control animals. Testes and epididymides were 
collected at slaughter and measured (maximum length, width) 
using a calliper and all carcasses were organoleptically assessed 
(2). For histological evaluation, 1 * 1 cm pieces of testis and 
epididymidis were cut out, fi xed, sectioned and stained with 
hematoxylin-eosin. 
Results
Testes with and without adjacent epididymides were small-
est in the group of the animals that were vaccinated 10 weeks 
before slaughter, followed by animals vaccinated 6 weeks before 
slaughter, and biggest in intact boars (table 1). Carcass weight 
and age of the animals at slaughter are shown in table 1.
Organoleptic abnormalites (i.e., pronounced sexual odour) were 
not detected in any of the carcasses from vaccinated animals. 
In contrast, carcasses of 4 of the 17 intact boars did have strong 
boar taint and were therefore condemned.
In the testes of all vaccinated boars, the number of spermato-
gonia and Sertoli cells in the Tubuli seminiferi was distinctly 
reduced. Leydig cells were degenerated and reduced in number. 
Spermatides and sperm were completely absent. Unlike boars 
vaccinated 6 weeks before slaughter, which had no spermato-
cytes, boars vaccinated 10 weeks prior to slaughter had single 
spermatocytes in the Tubuli seminiferi. In boars vaccinated 6 
weeks before slaughter, the collagen fi bers in the connective 
tissue between the Tubuli seminiferi showed a distinct reduc-
tion in number and size. In boars vaccinated 10 weeks before 
slaughter, beginning of the remodelling of the connective tissue 
was visible. 
In the epididymides of all vaccinated boars no sperm was visible. 
In the major part of the Ductus the stereocilia were completely 
eliminated. Whereas secretion was completely absent in boars 
vaccinated 6 weeks prior to slaughter, it was present in boars 
vaccinated 10 weeks before slaughter. 
Table 1: Carcass traits, testes size with and without epididymides 
in intact boars and boars that received the 2nd Improvac dose 6 
or 10 weeks prior to slaughter 
6 weeks prior 
slaughter
10 weeks prior 
slaughter intact boars
days at fattening 105 117 91
carcass weight kg 104.0 106.0 91.9
testes with epididymides
length 109.3 93.0 141.1
width 56.0 52.2 75.5
testes without epididymides
length 76.9 67.2 104.8
width 48.2 41.1 66.5
Discussion 
Boar taint was completely eliminated in animals receiving the 
2nd Improvac dose 6 weeks or 10 weeks prior to slaughter. Vac-
cination induced a complete inhibition of testicular function. 
However, the eff ects of vacciantion seem to be reversible, since 
animals started to restore testicular and epidydimal function at 
week 10 after second vaccination.
References
1.  Dunshea et al. J Anim Sci 2001;79:2514–2535.
2.  Schmoll et al. J Swine Health Prod 2009;17:250–255.
Production - Intact boars
187
Oral Presentations
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010
O.153
Gestating sows’ use of feeding stations and correlation between 
sows’ deviant eating behaviour and heat/disease
Lisbeth U. Hansen; Jens Vinter
Pig Research Centre, København, Denmark
Introduction
Electronic sow feeding (ESF) is a common feeding principle for 
group-housed gestating sows. With ESF it is possible to feed the 
sows individually and to check if the sows have been given their 
entire ration of feed. Studies have demonstrated that individual 
feeding of sows – particularly in the implantation period – is es-
sential for satisfactory production results (1).
Pig houses with ESF often house large dynamic groups, which 
can make it diffi  cult to supervise the individual animals. It is 
therefore necessary to have a tool that can provide the staff  with 
information on sows with deviant behaviour, such as heat or 
disease.
Materials and Methods
In a one-year period in 5 production herds, data was compiled 
on the sows’ use of the feeding stations, heat and health prob-
lems and production data. 
The pens were equipped with large nesting boxes with bedding 
and slatted fl oor in the activity area. The sows were transferred 
to group-housing after service. There were 65-80 sows per feed-
ing station. Every 14 days, a technician from Pig Research Centre 
visited the herds. 
Results
3.3 million observations/visits to the feeding stations were com-
piled corresponding to data from 18,300 cycles/ sows.
Visits to the feeding station
Regardless of the sow’s age, the daily feed ration was eaten in 
one visit – typically the fi rst. Gilts and young sows tended to 
have more visits to an empty feeder compared with older sows. 
This is most likely related to hierarchy. 
Time of visit to feeding station
During the fi rst 14 hours of the feed day, there was an even 
number of visits to the feeding stations. The sows had fi nished 
eating after approx. 19 hours. As the sows ate their feed ration, 
the frequency of unsuccessful visits to the feeding stations 
increased. Visits to the feeding station may have a facilitating 
eff ect on other sows in the group. Consequently, it must be ex-
pected that fewer unsuccessful visits reduce activity in the pen 
and thereby the risk of aggressive behaviour by the stations.
Choice of feeding station
Generally, the sows did not switch feeding stations from day to 
day in terms of feed visits. They stayed “loyal” to the feeding sta-
tion they had chosen. In terms of unsuccessful visits, they were 
less “loyal” and used several feeding stations. 
Number of sows per feeding station
More sows failed to eat their ration when there were more than 
65 sows per feeding station.
Heat and health problems
A correlation was observed between changes in feeding time 
and heat. The sensitivity expressing the percentage of detected 
observations related to the ”true” number of observations was 
0.58-0.75. Unfortunately, the error rate (false alarms) was high, 
but can probably be reduced if surveillance was only made 
around expected heat. 
The correlation between changes in feeding time and health 
problems only showed a low sensitivity, but can probably be 
improved by including information on sows’ temperature and 
movement patterns (2)(3).
Discussion 
More knowledge on sows’ use of feeding stations coupled with 
more knowledge on sows’ movement patterns and the use of 
GPS systems will give pig producers greater opportunities for 
detecting sows with deviant behaviour.
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Eﬀ ects of losing body condition scores during lactating period on blood concentrations 
of glucose, urea nitrogen and non-esteriﬁ ed fatty acid in sows
Teera Rukkwamsuk; Supatee Kitkha; Pariwat Poolperm; Preeyaphan Udomprasert
Kasetsart University, Nakornpathom, Thailand
Introduction
The sows required higher energy during lactation for milk pro-
duction. (1) At least 70% of energy requirement (2) and 90% of 
absorbed amino acids (3) needed for mammary growth and milk 
synthesis. Therefore, excessive mobilization of body reserved 
may occur if the sows inadequately intake nutrients, which 
resulting in poor lactation performance and infertility problems 
(4, 5) 
Body condition scoring, body weight loss during lactation can 
be practically evaluated. It is interesting to investigate if the loss 
of body condition score (BCS) observed on a farm can be mon-
itored by using blood metabolites. The aim of this study wanted 
to compare the concentration of glucose, non-esterifi ed fatty 
acid (NEFA) and blood urea nitrogen (BUN) between the sows 
losing ≥ 1 point of condition score and the sows losing < 1 point 
of condition score.
Materials and Methods
The study was conducted in a 1,000 sows farm with an opened 
system and traditional 2 site production during May – July 2009. 
Individual sow was given a BCS on farrowing day and weaning 
day and then categorized into two groups, based on the dif-
ference of BCS at weaning and farrowing date, for BCS loss < 1 
groups (group1) and BCS loss ≥ 1(group 2). 
A total of 70 cross-bred sows with parity average of 2.8 were 
randomly selected. Blood samples were collected at 84 days of 
gestation, 2-3 days after farrowing and 1-2 days before wean-
ing to evaluate the concentration of glucose, NEFA and BUN by 
using enzymatic spectrophotometry. Two-Sample t Test and 
correlation analysis were used for data analysis.
The gestation and lactation diet were formulated, based on 
broken rice, rice bran, soybean meal vitamin and mineral pre-
mixes, to contain 14.02% CP, 3,075 Kcal/kg ME and 0.85% Lys. 
and 18.1% CP, 3,300 Kcal/kg ME and 1.12% Lys, respectively. 
Results 
The concentration of glucose and NEFA between the sows in 
group 1 and the sows in group 2 were not diff erent. However, 
the concentration of BUN in group 2 at 2-3 days after farrowing 
and at 1-2 days before weaning were lower than those of group 
1 (p = 0.004 and 0.030 respectively) (Table1). 
Table 1 Blood glucose, BUN and NEFA concentrations during 
pregnancy, weaning and farrowing between 2 diff erent BCS loss 
during lactating groups (Mean ± SEM).
Table 1 Blood glucose, BUN and NEFA concentrations during preg-
nancy, weaning and farrowing between 2 diff erent BCS loss during 
lactating groups (Mean ± SEM).
Blood metabolites BCS loss<1 BCS loss ≥ 1 p - value
Glucose  (mg/dl)
84 d of gestation 89.40 ± 2.25 94.67 ± 3.19 0.194
2 - 3 d after farrowing 111.38 ± 4.02 104.27 ± 3.97 0.213
1 - 2 d before weaning 113.38 ± 2.61 110.35 ± 3.86 0.522
NEFA (mmol/l)
84 d of gestation 0.21 ± 0.02 0.21 ± 0.03 0.808
2 - 3 d after farrowing 0.24 ± 0.02 0.30 ± 0.04 0.212
1 - 2 d before weaning 0.38 ± 0.04 0.41 ± 0.07 0.719
BUN (mg/dl)
84 d of gestation 16.00 ± 0.37 16.84 ± 0.64 0.238
2 - 3 d after farrowing 20.05 ± 0.69 16.48 ± 0.88 0.004
1 - 2 d before weaning 20.34 ± 0.44 17.69 ± 1.07 0.030
Discussions
BCS loss could refl ect a negative energy balance condition 
of sows during lactation period. Sows in group1 had less BCS 
loss than sows in group 2, and had higher serum BUN during 
lactation. The increased BUN might be caused by increased 
protein intake (6). In this study, sows having less BCS loss may 
have higher feed intake, consequently enhanced metabolism of 
protein which resulted in increasing of BUN.
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Prevalence of lameness in farrowing and weaned gilts and sows in Ontario commercial hog operations
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Introduction
Lameness is a welfare and economic concern in hog production. 
Lame sows and gilts require treatment or removal from the herd. 
Early culling of sows is an economic cost for a hog producer. 
Lame sows are 1.7 times more likely than non-lame sows to be 
removed from a herd within 350 days of initial lameness assess-
ment (Anil 2009). In 2007, American commercial herds partici-
pating in the PigCHAMP datashare program reported locomotor 
disorders including lameness and down sows as the reason for 
14.5% of removals (Engblom 2009). Lame sows may also have 
poor reproductive performance including reduced number of 
pigs born alive compared to non-lame sows (Anil 2009). If lame-
ness persists in a herd, it becomes a serious welfare issue and 
correcting it may require expensive modifi cations of housing 
areas. The prevalence and severity of lameness in gilts and sows 
has not been well documented. In the United Kingdom, the 
prevalence of abnormal gait in pregnant gilts and sows is 14.4% 
and 16.9% respectively but corresponding data for Ontario has 
not been collected (Kilbride 2009). To address this, the Ontario 
Ministry of Agriculture, Food and Rural Aff airs has undertaken a 
surveillance project to determine the prevalence and severity of 
sow lameness on Ontario hog farms. 
Materials and Methods
A scoring system was devised to score a sow or gilt’s gait based 
on three categories: no lameness, mildly lame and clearly lame. 
To apply this scoring method, as sows and gilts enter and exit 
the farrowing room(s), they are scored a 0 (no lameness), 1 
(mildly lame) or 2 (clearly lame). The scoring system focuses 
on the gait of the sow or gilt and does not ask the evaluator 
to identify the cause of lameness, if observed in the animal. A 
lameness scoring video was created that provides a tutorial on 
using this 0, 1, 2 lameness scoring system. The video is avail-
able from P. Canning (email address: canninp@gmail.com) and 
it helps standardize how producers score lameness on their 
farm. A survey form has been created for use with Episurveyor® 
on a Nokia 8086 and e71 cellular phones that asks producers to 
evaluate the soundness of sows and gilts as they move into and 
out of farrowing rooms each week, based on the 0, 1, 2 system. If 
a sow or gilt is scored mildly lame (1) and clearly lame (2), her ID 
tag number is recorded to track changes in her lameness score 
over the course of the study. Producers complete the survey on 
the cell phone and then send in the data to an internet-based 
server for analysis each week. Participants may also email, fax or 
mail in a paper copy of the lameness survey. On each farm, the 
study will continue for at least six months.
Results
Currently we are receiving weekly data from six hog operations 
in southwestern Ontario. Participants indicated that they found 
the 0, 1, 2 system and scoring video easy to understand and 
apply. Data has been collected on 1932 sows entering farrow-
ing rooms and 1910 sows leaving the farrowing rooms. During 
the study period, 14 sows have died in the farrowing rooms for 
reasons unrelated to lameness. Below is a summary table of 
average prevalence data for enrolled herds.
Average for all 
herds (n=6) Range
Females to farrow
Score 0: no lameness 97.67% 94.64% - 99.30%
 Score 1: mildly lame 1.26% 0.43% - 4.17%
Score 2: clearly lame 0.51% 0.00% - 1.26%
Females exiting farrowing room(s)
Score 0: no lameness 95.76% 91.94% - 98.53%
 Score 1: mildly lame 2.36% 0.61% - 3.92% 
Score 2: clearly lame 0.49% 0.00% - 1.61%
Discussion
The prevalence of lameness in gilts and sows in the six study 
farms is low. All herds experience some level of mild lameness, 
and a lower prevalence of clearly lame females. Comparatively, 
prevalence of abnormal gait in the U.K. for gilts and sows is 
14.4% and 16.9% respectively (Engblom 2009). Although the 
scoring method used in this study diff ers from the 0, 1, 2 system 
applied here, these results could indicate that in Ontario, lame-
ness prevalence is comparatively low.
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Production performance among lactating loose housed Norwegian hybrid sows: Feed 
consumption, weight loss, litter gain and the eﬀ ect of extra water access
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Introduction
Farrowing crates for lactating sows have been prohibited in 
Norway since 2003. The Norwegian Landrace/Yorkshire (LY) 
sow is a highly productive sow that performs well under loose 
housed conditions, but factors such as parity number and water 
access can infl uence this performance. Leibbrandt (1989) found 
that limiting the water access to lactating sows led to reduced 
feed intake and the catabolism of body reserves to maintain 
milk production. The objective of this trial was to investigate the 
eff ect of parity number and extra water access on the sows’ feed 
consumption, weight loss and production (in terms of litter gain) 
during lactation.
Materials and Methods
Data were obtained from 50 dry fed loose housed Norwegian 
LY sows from a commercial swine herd. Sows were fed using a 
pelleted lactation feed containing 9.86 MJ NE/kg feed and 8.26g 
Lysin/kg feed. 25 sows were placed in pens with access to water 
only through drinking nipples in the rear part of the pen; and 25 
sows had water access in the trough in addition to the water nip-
ples. Sows were randomly distributed to the pens, but fi rst and 
second parity sows were evenly distributed between the two 
treatments. Within 12-36 hours after parturition (day 1) number 
of liveborn piglets was recorded along with litter weight and 
weight of the sow. Sow and litter were weighed again on day 19, 
and the day before weaning and day of weaning, respectively. 
Daily feed consumption of the sows was recorded, and piglets 
were given access to creep feed from week two. The data was 
analysed using Proc GLM in SAS 9.1 2003 edition. One sow was 
emitted from the study due to abortion. Fixed eff ects included 
parity number and water strategy. Length of lactation was used 
as a covariate. Weight loss was corrected for weight at day 1. 
Results
The average weight on day 1 for 1st parity sows was 223.3 ± 21.5 
kg, for 2nd parity sows 259.5 ± 22.0 kg and older sows 279.8 ± 
24.4 kg. Average number of weaned piglets was 11.2 ± 1.0 for 
1st parity, 11.9 ± 1.5 for 2nd parity and 11.7 ± 1.7 for older sows. 
Average length of lactation regardless of parity number and 
treatment was 31.7 days. Piglet mortality (not including still-
births) was 8.2%
Table 1: LS means for eff ect of parity number and water strategy on 
feed consumption, weight loss and litter gain.
Parity: n
Average 
feed cons. 
(kg) during 
lactation 
± SE 
Average 
weight loss 
(kg) at day 
19 ± SE
Average 
weight 
loss (kg) at 
weaning 
± SE
Average 
litter gain 
at day 19 
(kg) ± SE
Average 
litter gain 
at weaning 
(kg) ± SE
1st 15 214.3 ± 6.9 a 21.0 ± 2.9 a 26.5 ± 4.0 a 52.9 ± 2.3 a 91.0 ± 2.9 a
2nd 14 267.4 ± 6.7 b *** 12.1 ± 2.5 
b * 22.1 ± 3.5 a 59.9 ± 2.4 b * 113.2 ± 2.9 b ***
3rd-7th 20 276.2 ± 5.7 b *** 4.9 ± 2.3 
c ** 11.4 ± 3.2 b * 57.9 ± 2.0 ab 106.6 ± 2.5 b ***
Treatment:
Water in 
trough 25 255.6 ± 5.0 
a 12.5 ± 2.0 a 20.2 ± 2.7 a 57.8 ± 1.8 a 106.1 ± 2.2 a
No extra 
water 24 249.6 ± 5.4 
a 12.8 ±2.0 a 19.8 ± 2.7 a 56.0 ± 1.9 a 101.1 ± 2.3 a
Between parities and between treatments, LS means with diff erent lettering within the same 
column diff er signifi cantly from each other. * p<0.05, **p<0.001 and ***p<0.0001
Discussion 
1st parity sows eat less (p<0.0001), loose more weight (p=0.02) 
and have a lower litter gain (p<0.0001) during lactation, than 
2nd parity and elder sows. This suggests a lower feed intake cap-
acity in gilts than elder sows, and that one should be cautious 
not to overexert the sows during their fi rst parity. Water access 
in the feed trough could not be shown to signifi cantly aff ect the 
feed consumption and weight loss of the sows, nor did it aff ect 
the litter gain, although a numerical trend was present at wean-
ing. The lack of a statistical diff erence in litter gain could be due 
to the limited number of sows in this trial. 
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A tool to assess the economic impact of pleurisy in slaughter pigs
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Introduction: Pleurisy is an easily detectable indicator of poor 
respiratory health in pigs at slaughter and is a common reason 
for carcase trimming and rejection. Although prevalence in the 
UK was estimated, at individual pig level, to be around 12.5% 
for the period 2005-2009, surveillance data shows that for the 
same period around 87% of all assessed slaughter consignments 
(18,648) were aff ected by pleurisy to some extent, with 38% of 
assessed batches recording pleurisy prevalence at >10% (BPEX 
Pig Health Scheme). Recent work by Wellenberg et al (2010) 
proposed a 4 Euros cost per fi nisher in batches experiencing at 
>10% prevalence, based on reduced daily live weight gain. Here 
we report the development of an economic tool for estimation 
of pleurisy associated costs based on average age at slaughter 
and post-trimming carcase weights. As part of the development 
we investigated the importance of recording pleurisy severity 
in addition to prevalence within the batch. Understanding the 
economic impact of pleurisy is essential to assist producers in 
justifying implementation of expensive disease control methods 
(e.g. all-in all-out production).
Materials and Methods: Correlation between pleurisy severity 
and individual carcase weight: 30 batches of slaughter pigs from 
grow to fi nish management systems were recruited over a 9 
month period at a single abattoir and 40-50 pigs were assessed 
in each batch (a total of 1366 pigs). The presence and severity of 
pleurisy in each of the assessed pigs was scored as 0 (no pleur-
isy), 1 (visceral pleurisy), 2 (parietal pleurisy <25% of dorsolateral 
(DL) surface area, 3 (parietal pleurisy 25 – 50% of DL surface 
area), 4 (parietal pleurisy >50% of DL surface area). Mean post-
trimming carcase weights were calculated for pigs aff ected by 
pleurisy of increasing severity using a multiple regression model 
(adjusted for the diff erent mean weight in each batch using a 
zero-mean batch-level random eff ect). 
Batch level correlation between pleurisy prevalence and on-farm 
performance: Eighty batches of slaughter pigs were recruited 
(a total of 96687 pigs in batches ranging from 198 – 4671 pigs). 
Three diff erent integrators (each with diff erent management 
systems) were represented including continuous fl ow (15 
batches), wean to fi nish all-in all-out (35 batches) and grow to 
fi nish (30 batches). Performance data including average batch 
level post-trimming carcase weight (kg) and average batch 
level age at slaughter (days) were recorded. One consignment 
of each batch was randomly selected for pathology assessment 
at slaughter with 50 pigs being assessed for the prevalence of 
pleurisy in the representative consignment of each batch. We 
calculated the means and 95% confi dence intervals for the eff ect 
of pleurisy prevalence on performance parameters using a mul-
tiple regression model including adjustments for an integrator-
level random eff ect and diff erent variance components for each 
integrator. 
Results
 Analysis of the impact of increasing severity of pleurisy on post-
trimming carcase weights revealed that the main eff ect on car-
case weight was whether a pig had any type of pleurisy rather 
than the severity of that pleurisy. For this reason, in the batch-
level study, we focused only on pleurisy prevalence, and not 
severity. For the 80 batches studied, pleurisy prevalence ranged 
from 0% to 46%, batch mean post-trim carcase weights ranged 
from 71.8 – 83.1kg, and batch mean slaughter age ranged from 
139 – 183d. Our model indicated that for each 1% increase in 
pleurisy at batch level there was a 0.07kg decrease in post-trim 
carcase weight (95% CI: 0.14 – 0.00 kg; p=0.04) and a 0.26d (95% 
CI: 0.09 – 0.44d; p=0.00) increase in mean slaughter age.
Discussion: We found that it was not necessary to record ex-
tensive information on the severity of pleurisy, beyond, simple 
prevalence, in order to detect a relationship between pleurisy 
and performance. This simple model of the impact of pleurisy on 
performance was based solely on UK data and diff erent relation-
ships might be found in other production contexts. However, 
based on prevailing price estimates in April 2009, it allowed 
us to estimate that for a pleurisy prevalence of 10% of a given 
batch the cost for every pig slaughtered in that batch was £2.26. 
At a 20% prevalence this cost increases to £4 52 per pig. 
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Prior colonization with an avirulent Haemophilus parasuis isolate prevents disease 
from a subsequent virulent challenge with a heterologous isolate
Susan L. Brockmeier; Crystal L. Loving; Michael A. Mullins; Karen B. Register; Tracy L. Nicholson
National Animal Disease Center, Ames, IA, USA
Introduction
Haemophilus parasuis causes Glasser’s disease in swine char-
acterized by systemic invasion and bacteremia resulting in a 
polyserositis syndrome. H. parasuis can also cause pneumonia 
in swine. Disease patterns suggest that maternal antibody 
may protect pigs early, allowing them to be colonized without 
resulting disease while developing an active immune response. 
This is supported by studies examining the practice of exposing 
neonatal piglets to the predominant virulent strain on the farm 
as a method of prophylaxis.1 Reports have been mixed as to the 
degree of heterologous protection among strains.2 This may 
be due to relatedness of the strains, exposure to live bacteria 
on a mucosal surface versus bacterins given parenterally, and 
colonization status of the animal. 
Materials and Methods
Pigs ranging in age from 5 to 10 weeks of age were obtained 
from an experimental barrier herd that has tested free of known 
swine pathogens. The pigs were distributed into 5 groups with 5 
pigs per group and challenged intranasally with 106.5 CFU of 1 of 
4 isolates of H. parasuis (29755, 12939, MN-H, and SW114), all of 
diff ering serotypes, or sham inoculated with PBS. If pigs showed 
signs of Glasser’s disease, they were euthanized and swabs 
of the respiratory tract and systemic sites were collected and 
cultured on Casman’s plates with added NAD. One week after 
challenge, a control pig was placed in with a healthy appearing 
survivor in 2 of the groups. Three weeks after challenge all sur-
viving pigs were rechallenged with isolate 12939.
Results
Pigs challenged with 3 of the 4 H. parasuis strains developed 
signs of Glasser’s disease, including joint swelling and lameness, 
tremors, depression, and reluctance to move. All pigs challenged 
with isolate 12939 died peracutely or were euthanized due to 
signs of Glasser’s disease and 4 of the 5 pigs inoculated with 
isolates 29755 or MN-H were euthanized due to signs of Glasser’s 
disease between 2 and 5 days post infection. One pig each from 
the 29755 and MN-H challenged groups and all pigs challenged 
with isolate SW114 remained healthy and showed no signs of 
disease throughout the experiment, but H. parasuis was isolated 
from nasal swabs of these pigs. 
One week after challenge, one control pig was placed in with 
each of the survivors that had been challenged with isolate 
29755 or MN-H to determine if the infected but healthy pig 
would transmit H. parasuis to the naïve pig and whether disease 
would result. Five and 7 days after placing the control pigs in 
with the MN-H and 29755 survivors, respectively, the contact 
pigs showed signs of Glasser’s disease and were euthanized and 
H. parasuis was isolated from systemic sites. 
Three weeks after primary challenge, the 10 surviving pigs 
(3- control pigs, 5- SW114 pigs, 1- 29755 pig, and 1- MN-H pig) 
were all rechallenged intranasally with the 12939 isolate of H. 
parasuis. All control pigs were euthanized between 1 and 3 days 
post-challenge due to signs of Glasser’s disease. Gross pathol-
ogy fi ndings and culture results were similar to those obtained 
from the pigs originally challenged with this isolate. The 2 pigs 
previously inoculated with isolates 29755 or MN-H and the 5 
pigs previously inoculated with SW114 remained healthy. These 
pigs were euthanized 10 days after secondary challenge, and no 
grossly visible lesions were noted. H. parasuis was isolated from 
the nasal cavity of 3 of these pigs and the lung of 1 of the pigs.
Discussion
Pigs from an experimental herd that is free from known swine 
pathogens were used in a study with several H. parasuis isolates 
in an eff ort to identify isolates of varying virulence. Three of 
the 4 isolates caused systemic disease, with pigs showing signs 
of disease from 1 to 5 days post infection. One isolate, SW114, 
caused no observable clinical signs; however, H. parasuis was 
isolated from nasal swabs from these pigs indicating they were 
colonized. The MN-H and 29755 survivors were able to directly 
transmit H. parasuis to naïve pigs which became ill with signs of 
Glasser’s disease. The pigs colonized with SW114 were protected 
from challenge with a heterologous virulent strain. Thus, pigs 
within susceptible groups can remain healthy and serve as 
reservoirs for transmission, and heterologous protection using 
avirulent isolates is possible. 
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Avirulent live Haemophilus parasuis vaccine induces cross-serotype immunity
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Introduction
Haemophilus parasuis is the causative agent of Glässer’s Disease, 
a primary problem for swine producers worldwide (1).
The National Animal Health Monitoring Service reports a sharp 
increased incidence of H. parasuis in U.S. swine herds from 
2000-2006 (2). The incidence in nursery pigs has risen from 7.3% 
to 17.4%, and it has risen in grower/fi nisher pigs from 5.4% to 
18.7%. 
Fifteen serovars of H. parasuis have been defi ned. This diversity 
makes it diffi  cult for the current commercial inactivated bac-
terins to provide cross-serotype protection. This lack of cross-
serotype protection led to the development of an avirulent live 
culture vaccine that is able to induce cross immunity for multiple 
serotypes. 
Materials and Methods
An avirulent live culture H. parasuis vaccine was developed and 
evaluated for effi  cacy in susceptible pigs. Pigs 17-21 days of 
age were divided into two groups. One group was immunized 
once with the avirulent live culture vaccine; the control group 
received a placebo. All animals were challenged with virulent 
serotype 5. 
In a second study, three groups of susceptible pigs were vaccin-
ated once with the live culture vaccine, while three other groups 
received a placebo. Animals were challenged with virulent H. 
parasuis serotype 4, 5, or 13. 
In a third study, animals receiving oral antibiotic treatment 
(Carbadox or Denagard/chlortetracycline) were placed on the 
antibiotic seven days prior to vaccination. Two additional groups 
of pigs received either Draxxin or Excede one day prior to vac-
cination. Five weeks following vaccination, all animals were 
challenged with H. parasuis serotype 5.
In these studies, pigs were observed daily for mortality and clin-
ical signs of disease. Average daily gain was also determined. 
Results
In these studies a typical, highly lethal Glässer’s Disease was 
induced by experimental challenge of susceptible commercial 
pigs. A signifi cant number (p< 0.05) of vaccinated animals were 
protected from death. Arthritis was signifi cantly lower in vaccin-
ated animals, as was the average total number of gross lesions. 
Seventy-fi ve percent of animals receiving the placebo vaccine 
died. 
The average daily gain in vaccinated animals ranged from 0.99 
to 1.65 lbs/day, compared to -2.34 lbs/day for surviving controls. 
No vaccinated animals had a fever following challenge.
Antibiotic treatment did not interfere with the effi  cacy of the 
vaccine, as >90% of immunized animals were protected from 
death and lesions typical of H. parasuis infection. The mortality 
rate in those animals receiving the placebo was 80%. 
Discussion
A signifi cant number of commercial pigs given ParaSail (the fi rst 
avirulent live culture Haemophilus parasuis vaccine) were pro-
tected against experimental infection with H. parasuis serotypes 
4, 5, and 13. Immunized animals had reduced mortality and 
gross lesions as well as increased average daily gain compared 
to sham inoculated animals. These results suggest that the live 
vaccine expressed a wide variety of outer membrane proteins, 
which are thought to be required for the induction of cross-
protective immunity (3,4). 
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Introduction
Glässer’s disease is caused by the bacterium Haemophilus 
parasuis. Several commercial vaccines are available but none 
of these protects against all pathogenic strains. This is good 
justifi cation to attempt the identifi cation of genetic factors that 
aff ect susceptibility to this disease and utilize them in marker 
assisted selective breeding schemes. Previously, statistical dif-
ferences in the severity of Glässer’s disease in the off spring of 
diff erent boars were observed, indicating a genetic component 
to susceptibility1. This project used microarrays to look for gene 
expression diff erences in the lung tissue of animals exhibiting 
diff erent susceptibilities to Glässer’s disease.
Materials and Methods
Off spring of 6 boars from a Landrace-Duroc breed cross were 
decontaminated, screened as free from H. parasuis, and reared 
without maternal colostrum in an isolation facility. Animals were 
inoculated at 21 days with a pathogenic strain of H. parasuis 
serovar 5 (strain 29755). Controls were mock-inoculated with 
saline. Pigs were scored for clinical signs of the disease by obser-
vation. Approximately equal numbers of pigs were euthanized 
at 24, 48 and 72 hours post inoculation. At necropsy, animals 
were scored for the severity of lesions at aff ected sites and lung 
tissue samples stored in RNA Later (Ambion). In total, samples 
were obtained from 129 inoculated and 29 control animals1. The 
scores were used to classify animals into diff erent susceptibility 
categories, and pigs from the two categories which exhibited 
the largest diff erence in susceptibility (‘Fully Resistant’ (FR) and 
‘Susceptible’) were chosen for gene expression profi ling by 
microarray. 
RNA was isolated from lung samples of individual ‘FR’ and 
‘Susceptible’ animals (n = 6) at two diff erent time-points (24 
and 72 hours), and from pools of ‘Control’ animals matched for 
sire and time-point. This was reverse transcribed into cDNA and 
amplifi ed using the SMART-PCR system (BD Biosciences). The 
products were labelled with fl uorescent Cy-3 or Cy-5 conju-
gated nucleotides and hybridized to pig oligonucleotide arrays 
(Operon). Labelled cDNA from individual ‘FR’ or ‘Susceptible’ pigs 
was hybridized to a reference sample from the pool of mock-
inoculated ‘Control’ animals. After hybridization, the arrays were 
washed to remove non-specifi c signal and scanned on an Axon 
A4100 scanner. Signal intensities were quantifi ed using Bluefuse 
software and diff erentially expressed (DE) genes were identifi ed 
using the programme ‘limma’.
Results 
Lists of DE genes produced by the analysis were used to identify 
the subsets of genes that were diff erentially expressed in ‘FR’ 
compared to both ‘Control’ and ‘Susceptible’ animals (the ‘FR’ 
gene expression profi le) and in ‘Susceptible’ compared to both 
‘FR’ and ‘Control’ animals (the ‘Susceptible’ expression profi le) 
at both time-points. These genes were of most interest as they 
were potentially regulated diff erently in response to H. parasuis 
in ‘FR’ and ‘Susceptible’ animals. The expression profi le of the ‘FR’ 
pigs contained 21 and 22 genes at 24 and 72 hours respectively. 
The expression profi le of the ‘Susceptible’ animals contained 58 
and 347 genes respectively. 
Discussion
‘FR’ animals at 24 hours exhibited an increased expression of 
genes encoding extracellular matrix components, possibly 
indicative of tissue repair following the successful early resolu-
tion of infection. The gene expression profi le of ‘FR’ animals at 72 
hours supported the hypothesis that higher levels of antibacter-
ial activity could have been responsible for the ‘FR’ phenotype, 
possibly due to an increase in the production of innate ‘natural’ 
antibodies and decreased signalling by the immunoregulatory 
transcription factor peroxisome proliferator-activated gamma 
(PPAR- γ). The expression profi le of ‘Susceptible’ animals at both 
time-points was characterized by an imbalance in signalling 
between pro and anti-infl ammatory cytokines, with the pro-
infl ammatory cytokine genes resistin (RETN) and interleukin 
1-beta (IL1B) particularly highly expressed. At 72 hours, a reduc-
tion in the expression of genes involved in antigen presentation 
by both MHC class I and II molecules was observed, which could 
have contributed to the inability of ‘Susceptible’ animals to clear 
infection. In conclusion, this study identifi ed several candidate 
genes and pathways associated with susceptibility to H.parasuis 
infection. 
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Introduction
Glässer’s disease, caused by Haemophilus parasuis (HP), was 
once considered a sporadic disease of young pigs compromised 
by stress. Introduction of HP may result in systemic disease of 
high morbidity and mortality, aff ecting swine at any stage of 
production. HP is a contributor in the porcine respiratory disease 
complex (PRDC) as a predisposing agent, a secondary invader, or 
a primary pathogen involved in pneumonia (1).
Actinobacillus pleuropneumoniae (APP) is the etiological agent 
of pleuropneumonia in pigs and also the contributor in PRDC. It 
can cause pneumonia, clinical disease, or subclinical disease and 
causes losses from death, reduced production, and increased 
costs of medication or vaccination (2). 
Treatment of PRDC varies with each individual production unit 
and system. Serology can gather information on which patho-
gens are circulating in a herd (3). Serum profi le is testing groups 
of pigs at specifi ed ages to detect when seroconversion to a 
pathogen is occurring in the unit. The most common method 
is to collect samples from several age groups on a single day. A 
less common but more accurate method is to follow individuals 
over time as they grow. The purpose of this study was to prepare 
serum profi les for HP and APP for one large farm.
Materials and Methods 
39 serum samples from individual animals were tested on APP 
(ApxIV factor) and HP. Serum samples were taken at age of 2, 
4, 6, 8, 11, 14, 17, 22 and 28 weeks. Pigs were raised in large 
Slovenian pig farm with 6000 breeding animals. For detection 
of specifi c antibodies against APP and HP commercial ELISA 
kits were used: The CHEKIT-APP-ApxIV ELISA test kit (IDEXX) and 
Haemophilus parasuis Antibody test kit (ELISA) Swinecheckâ 
HPS (Biovet).
Results
Colostral antibodies to HP were detected only in 5.1% at age 2 
weeks. We detected antibodies in 25.6% at age 11 weeks, then 
prevalence increased to 94.7% at age 28 weeks (Figure 1). Anti-
bodies to APP were detected in 100% till 4 weeks, then preva-
lence decreased to 53.8% at age14 weeks, and then increased to 
100% at age 22 and 28 weeks (Figure 2).
Figure 1. Serum profi le of HP
Figure 2. Serum profi le of APP
Discussion
Farm animals were not vaccinated against HP and APP. Colos-
tral antibodies against HP were found only in 5.1% in 2 weeks 
old piglets. Circulating antibodies as consequence of natural 
infection were detected from 11 weeks (25,6% prevalence) to 28 
weeks old pigs (94,7% prevalence). Colostral antibodies against 
APP persisted for about almost 8 weeks (94,8% prevalence). The 
lowest prevalence was detected in 14 weeks old pigs (53,8%), 
and the highest in 22 and 28 weeks old pigs (100%). 
The results can enable the best time for vaccination which is 2-3 
weeks before active antibodies appear. The best time for vac-
cination in this farm against HP is around 8-9 and against APP 
around 11-14 weeks of age. 
Serum profi le is a method which can help create an eff ective 
specifi c vaccination program on farm. 
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Introduction
Respiratory tract infections are of major importance for the pig 
industry. One possibility of limiting the spread of respiratory 
tract disease may be the breeding of pigs with increased resist-
ance to respiratory tract pathogens. Therefore the FUGATO-IRAS 
project and the follow-up project RePoRI work on the identifi ca-
tion of genetic markers responsible for an increased resistance 
towards Actinobacillus (A.) pleuropneumoniae infection. 
Materials and Methods
Within IRAS 106 pigs of 4 breeding lines (German Landrace, 
Piétrain, Hampshire, Large White) were infected. The aerosol 
infection was performed using A. pleuropneumoniae serotype 
7 strain AP76. Sampling (BALF, blood) and phenotyping were 
carried out twice (day 4 and day 20 post infection [p.inf.]). Pigs 
were euthanized immediately after the sampling, lung lesions 
were scored during necropsy by the Lung Lesions Score accord-
ing to Hannan et al. (1), and lung tissue was taken. For additional 
phenotyping a Respiratory Health Score (2) was used. Acute 
phase proteins were determined (blood, BALF), glycoproteins 
(BALF) were analyzed via diff erential two-dimensional gel 
electrophoresis (2D-DIGE) and RNA expression was investigated 
using the Aff ymetrix GeneChip® porcine Genome Array. In addi-
tion, a consumer study investigating the allele diversity within 
German pork was realised and SNPs for candidate genes, derived 
from known human genes, were detected and characterised. 
The aim of the RePoRI-project (ongoing) is the validation of 
possible marker genes, the establishing of genetic markers and 
the modelling of the host reactions based on the IRAS results. To 
achieve these aims a QTL-analysis based on the F2 generation 
of a Hampshire (F0 male) -German Landrace (F0 female) cross, 
the development of a custom-buildt expression array (includ-
ing candidate genes, selected ORFs of A. pleuropneumoniae and 
Mycoplasma hyopneumoniae) as well as pathway analysis using 
ConsensusPathDB and association studies by FAMHAP®-software 
are performed. 
Results
Within IRAS there were 7 main results: 1) Severity of disease 
is highly dependent upon the innate immune system. 2) The 
Hampshire-line came out to be the most resistant and the 
German-Landrace-line to be the most susceptible. 3) The level 
of haptoglobine in blood plasma correlates with the course of 
disease. 4) The level of hyaluronidase in BALF increases after 
pathogen contact and therefore might be a possible health 
marker. 5) The combination of a high level of Fetuin A and a low 
level of Surfactant-D-protein in BALF correlates with the absence 
of lung lesions and therefore might a marker for breeding 
selection. 6) There is no depletion of allele diversity within the 
German pig population. 7) 1597 potential genetic markers could 
be detected. 
Within RePoRI so far, 188 microsatellites were established and 
mapped and an average distance of 14,5 cM could be realised. 
One Pathway (Toll like receptors) of importance was detected, 
and within the FAMHAP®-Analysis of the genotypes there were 
signifi cant diff erences (p<0,05) found for 7 marker loci (mainly 
focussing on Transferrin- and Interferon receptors) between pigs 
with mild and severe pleuropneumonia. 
Discussion
Although these studies for experimental reasons are limited to 
interactions between pigs and A. pleuropneumoniae they might 
be an essential fi rst step in the development of genetic markers 
for DNA-based breeding selection aimed at the increased resist-
ance towards lung infections. The fi rst candidate markers might 
be available for testing under production condition within the 
next two years. Before applying these markers for selection in 
breeding programmes a thorough investigation is required to 
avoid unwanted adverse eff ects on wanted traits. 
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Introduction
Respiratory diseases in swine are often caused by several patho-
gens and triggered by a multitude of other environmental and 
management factors1. Diff erent kinds of lesions in the lung and 
the surrounding tissue lead to a multi-factorial syndrome with 
respiratory symptoms and poor growth described as Porcine 
Respiratory Disease Complex (PRDC). The aim of this study was 
to investigate the eff ects on health and performance of a tiamu-
lin (Denagard®, Novartis Animal Health Inc.) treatment in nursery 
pigs suff ering from PRDC.
Materials and Methods
The study was conducted at a farrow to fi nish farm. Piglets were 
vaccinated against PCV2 and Mycoplasma (M.) hyopneumoniae 
(two-shot). Respiratory symptoms occurred in the nursery 
between 8 and 12 weeks of age. 173 piglets at 9 weeks of age 
were randomly divided into two groups. Piglets of group TIA (n 
= 88) received 15 mg/kg/day tiamulin by water over 14 days. All 
animals of group CONT (n = 85) were left untreated. Both groups 
were housed in diff erent pens within one room. All animals were 
weighed before treatment (day 0), at the last day of treatment 
(day 14) and on day 21. On day 0, 1, 2, 3, 5, 7, 9, 11, 13, 14, 15, 
17, 19 and 21 a cough index was calculated for both groups. 
30 piglets from each group served as sampling animals (SAs). 
Bronchoalveolar lavage fl uid (BALF) was collected from the SAs 
on day 0, 14 and 21. BALF was used for bacteriological investiga-
tion (BI) of various lung pathogens and for PCR-testing to detect 
porcine mycoplasmas2.
Results and Discussion
In group TIA the amount of Haemophilus parasuis (HPS) isolated 
from BALF was signifi cantly reduced on day 14 and 21 compared 
to day 0. In addition (in group TIA) the amount of α-haemolytic 
Streptococci was signifi cantly reduced on day 14 compared 
to day 0 and M. hyorhinis was detected in signifi cantly higher 
amounts on day 14 than on day 21. In group CONT only the 
amount of HPS was signifi cantly higher on day 0 than on day 
14 and day 21. At day 0 the amounts of all pathogenes men-
tioned above were higher in group TIA compared to group 
CONT. Actinobacillus pleuropneumoniae, M. hyosynoviae and/or 
β-haemolytic Streptococci were only isolated in the BI of a few 
SAs on day 0. All tested animals were free of those pathogens on 
day 14 and 21. The amount of other detected pathogens includ-
ing Pasteurella multocida and Bordetella bronchiseptica in BALF 
did not diff er signifi cantly between the three sampling days. The 
cough index measured in both groups showed an estimated de-
crease of 50 % after 6.1 days in group TIA and 25.9 days in group 
CONT, respectively. The decreasing rates diff ered signifi cantly 
between the two groups.
Figure 1: Estimated cough index
The mean body weight did not diff er signifi cantly between 
groups on day 0 (TIA: 20.10 kg, CONT 19.22 kg). During the trial 
period (day 0-14/0-21) the average daily weight gain was signifi -
cantly higher (p < 0.001) in group TIA (731/722 g/day) compared 
to group CONT (640/651 g/day).
The trial data verifi ed the positive eff ect of tiamulin treatment 
on the health status and performance of nursery pigs suff ering 
from PRDC. The lower pathogen burden after treatment correl-
ated with a signifi cantly faster reduction of the cough index and 
a signifi cantly higher daily weight gain in group TIA. Treated and 
untreated animals were housed within one room. On one hand 
this might be an explanation why some positive eff ects could 
also be seen for the untreated animals (e.g. reduction of HPS). 
On the other hand this might have caused a constant reinfection 
of group TIA by the untreated animals (CONT) or other vectors, 
including the farmer.
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Introduction
Respiratory infections are an important problem in pig industry, 
especially at weaning, when passive maternal immunity decays 
and immune maturation is still incomplete (1-2). Vaccination 
is a successful strategy to prevent and control these maladies; 
however, intramuscular administration induces solid systemic 
immune response but poor mucosal protection. Mucosal 
vaccination has no practical use since it requires high doses 
of antigen, bacterial toxins as adjuvants or multiple doses (3). 
Thus, the design of eff ective mucosal immunization strategies 
is of paramount importance to control respiratory and mucosal 
diseases in the young pig. 
Aims
To develop novel strategies of immunization to induce systemic 
and mucosal immune response in weaned pigs.
Material and methods
A total of 20 four weeks-old weaned, conventionally reared 
healthy pigs, from an experimental farm (CEIEPP-UNAM), free of 
zoonotic diseases and with no vaccination protocols running, 
compiling with academic and federal regulations of animal care, 
were divided in four groups of fi ve animals each. Animals were 
immunized with ovoalbumin (OVA, Sigma, USA) three times, 10 
days apart, by diff erent routes as follows: subcutaneous (SC)/ 
transcutaneous (TC)/TC (8 mg/pig each time); SC/TC/intranasal 
(IN) and SC/SC/IN. A SC group was inoculated with PBS and ad-
juvant (GIBCO) as control. Samples of serum, nasal secretion (NS) 
and saliva were taken on days 0, 10, 20, 27 and 57 after the fi rst 
inoculation and specifi c anti-OVA IgG and IgA were measured by 
quantitative ELISA.
Results
Anti-OVA IgG: All immunization protocols induced serum 
response after the second inoculation, peaking at 27d (SC/TC/
IN, P<0.05 & SC/TC/TC, P<0.01, Figure 1A). No IgG anti-OVA was 
detected in NS and saliva. Anti-OVA IgA: Again all protocols 
induced signifi cant IgA response in serum after the 2nd im-
munization, peaking at 27d (P<0.01). The SC/TC/IN group kept 
signifi cance until day 57 (P<0.001, Figure 1B). In NS the response 
was evident after the 3rd immunization in groups SC/TC/TC 
(P<0.023) and SC/SC/IN (P<0.037) and maintained diff erences 
to control until 57d (Figure 1C). All protocols induced immune 
response in saliva after the 2nd inoculation, with peaks at 27d 
in groups SC/SC/IN and SC/TC/IN (P<0.001), which kept the 
response until 57d (P<0.03) (Figure 1D).
Discussion
It has been reported that systemic and local immunization with 
live modifi ed vaccines induces immune response in serum and 
mucosae (4). However, using inactivated vaccines the mucosal 
immune response is less successful (5). Our results show that 
using a combination of parenteral (SC/TC) and mucosal (IN) im-
munization, systemic and local specifi c IgG and IgA are eff ect-
ively induced in weaned pigs, even when a poorly immunogenic 
protein is used (OVA). IN and TC immunizations were eff ective 
only with previous parenteral sensibilization (SC), suggesting 
that circulating memory cells are able to migrate to mucosal 
sites after a local challenge. These immunization protocols may 
provide an eff ective way to induce integral (systemic/mucosal) 
immune response in young animals to prevent diseases.
Figure 1. Anti-OVA concentration of IgG (A), IgA (B) in serum, IgA in 
nasal secretion (C) and saliva (D) from parenteral/mucosal immunized 
weaned pigs (n=5/group). Each point is the mean plus/minus SEM. 
t-Student test. *P<0.05, **P<0.01, ***P<0.001.
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Introduction
Porcine mycoplasmal pneumonia is one of well-known respira-
tory diseases. Mycoplasma hyorhinis is easily isolated in the 
upper respiratory tract and tonsil of swine unlike Mycoplasma 
hyopneumoniae. The ability of M. hyorhinis to cause pneumonia 
is unclear (1), but the pig with M. hyorhinis is simultaneously 
infected with porcine reproductive and respiratory syndrome 
virus (PRRSV). In previous study, we could fi nd that M. hyorhinis 
may potentiate PRRSV-induced pneumonia in vivo. The aim of 
this study was to see if mycoplsmal lesion is prevented by vac-
cination to M. hyorhinis.
Materials and Methods
Sixteen weaned pigs free of M. hyorhinis, PRRSV and M. hyo-
pneumoniae antibodies were randomly divided into 3 groups as 
shown in Table 1. 3 X 1010 CCU of M. hyorhinis was immersed in 
the mixtures of oil and water with a ratio of 50:50.
Table 1. Experimental design
Group No. of pigs Vaccination Challenge
A 6 + M. hyorhinis
B 6 - M. hyorhinis
C 4 - -
Pigs in group A were intramuscularly vaccinated with M. 
hyorhinis vaccine. Pigs in groups B and C were received with 
saline. After 4 weeks, 1010 CCU/ml of the M. hyorhinis was 
administered through trans-trachea to pigs of groups A and B. 
Clinical signs of the infected pigs were observed for 4 weeks 
after vaccination. Sera were collected weekly. Antibody response 
was measured by ELISA. Animals were sacrifi ced 4 weeks after 
challenge and the macroscopic lung lesions were evaluated as 
described in previous study (2). We performed Mann-Whitney 
U test and Fisher’s exact test to show the statistical diff erences 
of clinical signs and macroscopic lung lesions, and antibody 
responses between groups A and B by using SAS 9.2 software 
package (SAS Institute Inc, Cary, NC).
Results and Discussion
All pigs in group A and C showed neither any clinical signs nor 
mortality, but pigs in group B showed signifi cant symptoms of 
respiratory disease including dyspnea, cough, fever and rough 
hair coat (Table 2). 
Especially one of pigs in group B died of pneumonia showing 
typical mycoplasmal lesion on the lung, and we found more 
serious macroscopic lung lesions in group B than group A. 
Table 2. Clinical signs and macroscopic score
A B C
Clinical signs 0 5.53** 0
Macroscopic score 0.22 1.0* 0
*p < 0.01, ** p < 0.001 for diff erences between A and B by Mann-Whitney U test
No pigs in group A developed glanuroma tissue and fever on the 
site of vaccination for the entire experiment period. Five pigs in 
group B did not develop antibodies until the end of this study, 
whereas only one pig showed immune response at 2 weeks after 
challenge and then its antibody disappeared 1 week later. How-
ever, pigs in group A showed antibody response at 2 weeks after 
vaccination, Those antibody titers were increased until 6 weeks 
after vaccination and then reached fl at till end of the experi-
ment. We found statistically signifi cant diff erences from 7 weeks 
between groups A and B. 
Figure 1. Immune responses after vaccination to M. hyorhinis 
The results indicated that mycoplasma vaccine may be used to 
prevent mycoplasmal lesion and disease.
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Introduction
PRRS eradication is a future USA pork industry goal. One con-
sideration is the prevalence and distribution of infected animals 
in at-risk populations. This study from Midwestern (9) and non-
Midwestern (3) market swine abattoirs assists understanding of 
area prevalence of PRRS generally and for defi ned sized produ-
cers within the population. This information refi nes the scope of 
epidemiological diverse populations for PRRS. An observed dif-
ference between regions or herd sizes relative to PRRS exposure 
potential off ers the opportunity to consider appropriate control/
eradication strategies in larger groups than individual hers/sites. 
Two time periods were utilized to determine whether a seasonal 
eff ect on PRRS antibodies could be observed. 
Materials and Methods
Each group of 10 or more swine (lot) at daily harvest on one 
shift in 12 cooperating abattoirs was sampled by USDA-APHIS-
VS employees. As a convenience sample, 50-75 gm pieces of 
diaphragm (crus) of fi ve carcasses per lot were obtained after 
evisceration, placed in whirl-pak bags and identifi ed with lot 
number, date and plant number. In two shift plants, sampling 
rotated with each two week pay period to assure that over time 
most producers submitting to each plant were tested. Cooperat-
ing plants supplied lot identifi cation, number per lot coupled to 
ownership information (name, mailing address and zip code) for 
lots daily. Such information enabled characterization of owner-
ship and production size. A 12 week evaluation period was 
chosen for each sampling period to assure that low volume pro-
ducers would submit multiple lots. All sampling was completed 
from November 2007 to October 2008. Meat juice samples were 
tested using the Herd Chek PRRS ELISA test, IDEXX Laborator-
ies, Westbrook, Maine USA according to serum instructions. A 
positive lot contained one or more positive samples in the fi ve 
tested for each lot. 
Results
A total of 24,890 samples from 4978 lots were tested in the two 
time periods of fall-early winter and winter-spring timeframes. 
By aggregating number of infected lots and their source charac-
teristics it was possible to develop information about distribu-
tion and prevalence of PRRS antibodies within the general popu-
lation and for selected subpopulations. Estimated annual herd 
production, and geographic area diff erences were observed for 
PRRS antibody prevalence. As herd size increased, irrespective 
of geographic location, the percentage of positive lots increased 
(Table 1). Plants that obtained pigs from swine-dense produc-
tion areas (Midwest =9) and North Carolina (1) had substantially 
higher prevalence than plants (2) drawing from less dense areas 
(Table 2). 
Discussion
Antibodies to PRRS are common in market swine throughout 
the USA. There is general acceptance that higher swine density 
areas results in higher prevalence for PRRS. The results outlined 
in this large survey would indicate an inability to demonstrate 
seasonality in PRRS prevalence, but show diff erences in annual 
production/producer and in regional catchment. Rates of anti-
body prevalence increased with each production size category 
over the same period confi rming the impression that increased 
system size maintains PRRS infections. Group categories above 
2001-4000 are likely to be multi-site production systems. The 
plant data confi rms the consideration that market swine from 
dense production areas are expected to be of higher prevalence. 
The plant in the North Eastern (NE) area had the lowest preva-
lence, followed by a catchment of primarily southeastern (SE) 
and north central USA areas. The Eastern Ia./Ill. plant is charac-
terized by purchase of small lots vs. truckload lots at most of 
the other Midwest plants, and as such refl ects the size but not 
location of production facilities serving the plant. The remainder 
of the Midwestern plants increased prevalence as catchment 
areas move into northern Iowa and larger producers were sup-
pliers. The North Carolina plant presents the highest prevalence, 
and was derived from larger production units. These observa-
tions may be useful in developing future PRRS surveillance and 
program development eff orts.
Table 1 - % positive lots by annual production classes
% positive lots
Ann. Prod. PRRS 2-1 PRRS 2-2 Ave. % pos. lots 
1-1000 57.5 64.9 60.8
1001-2000 69.3 68.5 69.0
2001-4000 71.1 71.7 71.4
4001-9999 75.6 75.8 75.7 
10000-1.5M 70.7 75.3 72.6
Largest 40 85.0 78.0 83.3
Table 2 - % pos. lots by processing plant location 
Market area PRRS 2-1 PRRS 2-2 Ave. % plant
NE 40.1 NA 40.1
SE (not NC) 61.2 53.8 57.6
Ea. Ia./Ill. 69.3 69.2 69.3
Midwest 76.4  71.4 74.3
Midwest 78.0  80.0 78.7
Midwest   80.6 81.0 80.7
Neb. area 83.4 80.5 82.5
Midwest  87.8 88.5 88.0
Midwest 92.2 87.3 89.4
Midwest 92.2 86.3 89.8
Midwest 95.2 88.5 91.1
N. Car. 97.4 93.9 95.9 
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Introduction
Previously, we described the use of pen-based oral fl uids to 
monitor PRRSV and/or PCV2 infections in wean-to-fi nish popula-
tions.1,2 The purpose of the present study was to evaluate the 
use of oral fl uids for the detection of PRRSV infection in individ-
ually-housed boars. 
Materials and Methods
The study was conducted using 72 boars ranging from 6 months 
to 3.6 years of age. Boar were under the ownership of PIC North 
America (Hendersonville, TN USA) and housing, study proced-
ures, and protocols were approved and supervised by the PIC 
USA Health Assurance and Welfare department. Boars were as-
signed in equal numbers (n=24) to three treatment trials (I, II, III). 
Boars in Trial I were vaccinated intramuscularly (IM) once with 
2 ml of MLV (RespPRRS®, Boehringer Ingelheim Vetmedica, Inc.
St.Joseph, MO 64506). Boars in Trial II were inoculated IM with 2 
ml of a Type 1 PRRSV. Boars in Trial III were inoculated IM with 2 
ml of PRRSV strain MN-184. 
Following exposure to PRRSV, boars were monitored for 21 
days. Oral fl uid samples were collected daily using 5/8”, 3-strand, 
100% cotton rope (Web Rigging Supply, Inc., Lake Barrington, 
IL 60010). Serum samples were collected from all boars on 
DPI -7, 0, 7, 14, 21. In addition, serum samples were collected 
from 4 randomly selected boars in each trial on DPIs 3, 5, 10, 
17. Additional data collected on a daily basis included ambient 
temperature (maximum and minimum) in the facility and clinical 
observations. Serum and oral fl uid were assayed for PRRSV RNA 
at Iowa State University (Ames, IA USA) using nucleic acid extrac-
tion and PCR protocols specifi cally optimized for porcine oral 
fl uids. 
All statistical analyses were performed using SAS® Version 9.2 
(SAS® Institute Inc., Cary, North Carolina, USA). Serum and oral 
fl uids results for real-time qRT-PCR were analyzed using a repeat-
ed measures analysis of variance (ANOVA) model run with the 
GLIMMIX procedure in SAS. 
Results
The analysis showed that PRRSV infection aff ected the volume of 
oral fl uid samples collected from individual boars (p = 0.0032), 
but did not impact the success rate for oral fl uid sample col-
lection. That is, boars continued to provide oral fl uid samples 
even during acute PRRSV infection, although less volume was 
collected.
Oral fl uid samples were qRT-PCR-positive from DPI 1 to DPI 21. 
Positive serum samples were detected from DPI 3 (fi rst collec-
tion) to DPI 21. Overall, 92 % of the results were in agreement, 
i.e., 218 serum samples and 238 oral fl uid samples were PCR 
positive. 
The concentration of virus in serum and oral fl uid samples fol-
lowed similar patterns over time, with oral fl uid containing less 
virus than serum before 14 DPI and equivalent levels of virus 
from 14 to 21 DPI. Boar age did not have a signifi cant eff ect 
on the quantity of virus present in oral fl uid samples, but the 
concentration of virus in both oral fl uids and serum was aff ected 
both by the virus strain (p = 0.0001) and DPI (p= 0.0001). 
Discussion 
The data reported herein provide evidence that oral fl uid 
samples are equivalent or superior to serum samples for the de-
tection of acute PRRSV infection by qRT-PCR. The use of oral fl uid 
samples off ers a signifi cant improvement in the ease, timeless, 
and cost of disease surveillance in commercial swine popula-
tions.
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Introduction Porcine reproductive and respiratory syndrome 
virus (PRRSV) can cause reproductive disorder in naïve dams 
infected in the third trimester of pregnancy. Severity of gross 
and microscopic lesions in fetuses depends on the virus proper-
ties and the age of the fetus [1]. Segmental, a perivascular and 
transmural haemorrhages and multiple edemas with necrotic 
arteritis of umbilical cord together with lesions in myocardium, 
lungs, brain and liver usually can be seen [2, 3] but are infre-
quent. Detection of PRRSV in fetal tissue is usually done by RT-
PCR [1]. Immunohistochemistchemical (IHC) detection of PRRSV 
antigen in fetal thymus can be also used [1, 4, 5].The aim of this 
study was to describe gross and microscopic lesion in fetuses 
from cases of abortion attributed to PRRSV and to evaluate the 
incidence of PRRSV detection by PCR and IHC
Material and methods For this study 83 fetuses from 8 large pig 
production units with signifi cant reproductive losses, aborted in 
late gestation were used. Every fetus came from diff erent sow.. 
In all of the farms presence of PRRSV was previously detected by 
serology, PCR and immunohistochemistry. During post-mortem 
examination, samples of brain, thymus, heart, lungs, liver, 
spleen, kidney, intestines, lymphnodes and umbilical cord (if 
was present) were collected and fi xed in 10% buff ered formalin 
for histopathological examination and IHC. For PCR detection 
samples of lungs, spleen and liver were stored in -70°C. All tissue 
sections were stained with hematoxilin and eosin and were ana-
lysed by IHC with anti-PRRSV monoclonal antibodies (Ingenasa®) 
according to previously described protocol [4]. For detection of 
PRRSV RT nested -PCR specifi c for ORF 7 was used on total RNA 
extracted from pooled homogenate of lung, liver and spleen as 
previously described [6].
Results PRRSV was detected by PCR in only 6 (7.23%) fetuses. 
The IHC detected PRRSV only in thymus of 19 (23.89%) fetuses. 
Three fetuses (3.61%) were PRRSV positive in both methods of 
detection. Altogether, 22 (26.51%) fetuses were positive in at 
least one of the methods while 61 (73.49%) were negative. Viral 
antigen in thymus was detected in follicular area in triangular 
cells, monocytes/machrophages and in Hassel’s bodies. A range 
of gross and microscopic lesions were observed in the fetuses 
(Table 1).
Discussion We were able to identify presence of PRRSV infection 
in only 26.51% of aborted fetuses from 5 Croatian pig produc-
tion units where PRRSV circulation was previously shown. In 
three farms no evidence of PRRSV in aborted fetuses was found. 
Most frequent lesion found in PRRSV infected fetuses was 
edema and haemorrhages of umbilical cord, lymphocytic hepa-
titis and liver hyperaemia. All other lesions were equally frequent 
found in PRRSV positive and negative or even more in negative 
fetuses so it can’t be considered as PRRSV related lesions. There 
is a clear discrepancy between the results obtained with the two 
PRRSV detection methods. This could be attributed to the fact 
that for PCR and IHC diff erent tissues were used. Thymus that 
appeared to be the only organ where PRRSV antigen was found 
by IHC, was not used for PCR. This study indicates that the tissue 
selection is crucial for diagnosis of PRRSV in fetuses by PCR and 
IHC.
Findings
% of fetuses 
with given 
lesion
% of PRRSV 
fetuses with 
given lesion
% of PCR 
postive 
fetuses 
with given 
lesion
% of IHC pos-
tive fetuses 
with given 
lesion
% of 
PRRSV 
negative 
fetuses 
with 
given 
lesion
Edema and 
haemorrhages of 
umbilical cordof 
umbilical cord
51.51% 100% 100% 100% 18.18%
Myocardial 
degeneration and 
necrosis
53.91% 45.45% 100% 26.32% 53.96%
Kidney cortex 
haemorrhages
72.29% 59.09% 100% 42.85% 74.60%
Spleen hyperaemia 31.33% 27.27% 100% 0% 31.74%
Microgliosis and 
brain edema
36.14% 36.36% 100% 15.79% 34.92%
Lymphocytic 
hepatitis
48.19% 68.18% 33% 73.68% 39.68%
Lung edema 61.46% 54.54% 0% 73.68% 61.90%
Liver hyperaemia 46.99% 59.09% 66% 57.89% 39.68%
Interstitial pneu-
monia
46.99% 36.36% 0% 42.85% 49.29%
Lung edemaEpicar-
dial haemorrhages
60.24% 27.27% 16.67% 26.32% 69.84%
References
1.  Benson, J.E., et al. (2002): J Vet Diagn Invest,. 14, p. 8-14.
2.  Lager, K.M. and P.G. Halbur (1996): J Vet Diagn Invest. 8: p. 275-82.
3.  Rossow, K.D., et al. (1996): Vet Pathol. 33: p. 95-9.
4.  Halbur, P.G., et al. (1994) J Vet Diagn Invest. 6: p. 254-7.
5.  Cheon, D.S. and C. Chae (2001) J Comp Pathol. 124: p. 231-7.
6.  Stadejek, T., et al. (2006): J Gen Virol. 87: p. 1835-41.
PRRS - Diagnostic
203
Oral Presentations
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010
O.169
Field trial of the speciﬁ city of an ELISA test for PRRS (IDEXX HERDCHEK® PRRS 2XR) high 
speciﬁ city conﬁ rmed, but varying behaviour according to the age of the animals 
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Introduction
The laboratory diagnosis of the Porcine Respiratory and Repro-
ductive Syndrome (PRRS) is mainly based on the use of sero-
logical ELISA tests and PCR diagnostics. The aim of this study was 
to assess the specifi city of a commercial ELISA test. In particular, 
the specifi city of the test is compared in two diff erent subpopu-
lations: adult breeding sows and young pigs.
Materials and methods
The study takes into account a set of results carried out on 
French pig farms that are considered free of the PRRSV and with 
a low risk of contamination (areas with a low pig density or air 
fi ltration system). The farms are tested at least three times a year.
The IDEXX HerdChek® PRRS 2XR is an indirect Elisa test for the 
detection of antibodies against the European and American 
strains of the PRRSV in the serum of pigs. Samples with an S/P 
ratio of 0.4 or more are positive. Those of less than 0.4 are nega-
tive. Only the fi rst results were included in the study, before 
carrying out any confi rmatory tests.
All farms with a positive result were checked to confi rm that 
the farm was indeed considered as free from the disease, and to 
check if at least one subsequent negative result allowed exclud-
ing the hypothesis of a recent contamination.
Results
Test results carried out between December 2007 and March 
2009 were taken into account. 641 adult animals (breeding 
sows) and 1017 young stock (between 80 and 150 days of age) 
were included in the study.
Specifi city was signifi cantly higher in young stock than in the 
adults (Chi2, p < 0.02, Table 1). Analysis of the S/P ratio distribu-
tions of adult and young pigs showed a diff erence between the 
two sub-populations (Figure 1). They diff ered in the average 
(Mann & Whitney test, p < 0.001) and in the standard deviation. 
The percentage of borderline-negative results (S/P between 0.2 
and 0.4) was higher in adult pigs. 
Table 1: Specifi city of the test in both populations 
Figure 1: Distribution of S/P ratios according to the age 
False positive results ranged from values very close to the limit 
(5 out of 16 with S/P < 0.45) to clearly positive values (5 out of 16 
false with S/P >1).
Discussion
The main diffi  culty of specifi city studies in the absence of a refer-
ence tests is to deal with a disease-free study population. In this 
study, the combination of a history of controls and a low risk of 
contamination allowed affi  rming that the positive test results 
were false positives. 
The observed values of specifi city are high and confi rm existing 
data obtained with a smaller sample (1). These specifi city values 
are higher than those obtained with other tests in national con-
trol programmes in a disease-free environment (2). The specifi -
city of a test should be put in balance with its sensitivity, as no 
test is 100% specifi c. 
The diff erence in specifi city between the two sub-populations 
(young stock and adult animals) studied is an original result. 
To our knowledge, this is the fi rst time it has been described in 
the context of PRRS. One hypothesis to explain this diff erence 
between the two age groups is the existence of “immunological 
background noise”, which increases with age due to the accumu-
lation of non-specifi c antigenic stimulation. It is surprising to 
note that this lesser specifi city of adult animals is not due to an 
increase of the S/P ratio but to their variability. It would be inter-
esting to have equivalent data for other pathological agents of 
pigs in order to determine whether this is a systematic phenom-
enon or only linked to PRRS.
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Use of stillborn (pre-colostral) piglets as a sample source to assess 
viral circulation in PRRSv positive sow herds
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Introduction 
Production of PRRS virus (PRRSv) negative weaned pigs and 
elimination of virus from breeding herds has been successful 
using methods like herd closure, mass vaccination and roll-
over.1-5 When gestating breeding animals become infected, 
PRRSv can subsequently infect their fetuses.6 Weaning age piglet 
monitoring is a relatively common procedure used to detect 
virus circulation in the breeding herd, but this procedure alone 
is incapable of distinguishing farrowing area circulation of virus 
from gestational circulation where susceptible sub-populations 
of gestating animals may exist. 
The objectives of this observational study were to develop and 
evaluate a procedure of monitoring stillborn piglets to detect 
gestational virus circulation. The combination of weaning age 
piglet monitoring and stillborn fetal piglet monitoring would 
support greater opportunities to detect and resolve sources of 
virus circulation within PRRSv-positive breeding herds. 
Materials and Methods 
PRRSv elimination projects utilizing herd closure and mass vac-
cination were conducted on three previously naïve sow farms 
that became infected with PRRS virus. 
Ten to twenty stillborn fetuses and 60 weaning age piglets from 
each farm were sampled monthly, and all samples were indi-
vidually tested by PRRS rtPCR. Selected stillborn fetuses were 
processed as follows: [1] swab both axillary spaces and place 
in a tube containing 1mL saline, [2] clean axillary spaces with 
disposable disinfectant wipes and dry with paper towel, [3] 
using a new scalpel cut open both axillary spaces, [4] squeeze 
thorax hard so blood pools in axillary spaces, [5] use a dispos-
able syringe to collect pooled blood, [6] transfer blood to serum 
separator tube, [7] open the thorax and check lungs for infl ation, 
[8] incise stomach and check for milk. A fetus was considered ac-
ceptable for sampling if it had a wet umbilical cord, non-infl ated 
lungs and no evidence of milk in the stomach. 
Results 
Serum and swab results from stillborn piglets from the three sow 
farms are shown in Table 1. Of the samples collected from 126 
stillborn fetuses, 20.6% (26) of sera and 31.0% (39) of skin swab 
samples tested PCR positive. Interestingly, the percent of PCR 
positive stillborn serum samples declined over time at a similar 
rate as those of weaning age piglets (Table 2). 
Table 1: Distribution of PRRSv PCR results for serum and skin swab 
samples collected from stillborn piglets.
Skin Swab - Skin Swab + Total
Serum - 83 (65.9%) 17 (13.5%) 100 (79.4%)
Serum + 4 (3.2%) 22 (17.5%) 26 (20.6%)
Total 87 (69.0%) 39 (31.0%) 126
Table 2: Percent PRRSv PCR positive serum results by month for serum 
from stillborn and weaning age piglets. 
Month 1 Month 2 Month 3
Stillbirths 74.3% 40.0% 7.5%
Weaners 58.1% 43.6% 8.9%
Discussion 
The axillary space was targeted for swabbing because of all the 
external surfaces on a stillborn piglet, the axillary space rep-
resents the cleanest skin surface to assess whether viral RNA 
acquired before or during parturition might be present on the 
exterior of a stillborn piglet. 
As a herd’s immunity develops following whole herd mass-
vaccination, the level of in-utero infection would be expected to 
decline, fall to and remain at zero as long as new wild type virus 
introduction is prevented. If proper piglet management proced-
ures are followed in the farrowing area7, the level and likelihood 
of new infection among and within farrowing rooms should also 
fall to and remain at zero.
The stillborn piglet sampling/testing procedure potentially 
complements PCR-testing of weaning age piglets to detect and 
pinpoint PRRSv circulation in the breeding herd. 
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Evaluation of a methodology for collection and PRRSV detection at swine herd level 
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Introduction
PRRS virus is usually detected in individual pig serum, but it is 
often diffi  cult to do at the herd level because of cost and the 
labour. Researchers have recently developed a new methodol-
ogy (1,2,3): the objective of this study was to compare this new 
method of detection of the virus in oral fl uid (OF) with the clas-
sical detection of PRRSV in serum.
Material and Methods
Animals: 3 replicates of 10 commercial pigs, housed in 3 separ-
ate pens, in strict isolation. 
Experimental design: at 12 weeks of age (Day 0) each pig 
received a 4-mL intranasal injection of the PRRSV challenge 
suspension.
Serum and OF samples collected at Day 0 were used to qualify 
the extraction method and the qRT-PCR test and to confi rm the 
absence of PRRSV.
OF and blood were collected from each animal at D0 (PRRSV 
challenge) and at D3, 7, 10, 14, and 21. A cotton rope (“Sani-
corde”) tied up to each pen partition for 30 minutes was used to 
collect OF Pigs actively sought out and chewed the rope (2). The 
Sanicorde were wrung, OF were harvested and stored at -80°C 
until use.
Lab investigations: Serum and OF samples collected at Day 0 
were used to qualify the extraction method and the qRT-PCR 
test and to confi rm the absence of PRRSV..extraction from OF 
and blood samples was performed with QIAamp® Viral RNA kit 
(Qiagen). OF samples were centrifuged to remove debris and 
PRRS virus load was evaluated by the qRT-PCR technique. 
Statistical methods: McNemar’s test for concordance between 
viremia and oral virus results; Binomial probability distribution 
to assess the minimum number of OF samples to detect at least 
1 positive sample.
Results
All blood and OF samples collected prior to virus inoculation up 
to Day 0 and all case control tested negative.
Comparison showed that the levels of virus in serum and OF 
samples in diff erent groups followed a similar pattern, with OF 
consistently containing a lower detectable concentration of 
virus (Figure 1).
Comparing the proportion of negative or positive results in 
OF and blood samples in the 3 groups, each as a whole, the 
correlation was signifi cant (p = 0.025) with 72% of concordant 
responses between blood and OF.
Figure 1: Average detection by qRT-PCR (maximum number of ampli-
fi cation cycles i.e. 40 - fi rst detection amplifi cation cycle = 40-CT) of 
PRRSV in serum and OF 
Ten of the 15 OF samples collected were found positive (67%). 
Thus, we calculated the probability of having at least one posi-
tive sample (detection of PRRS virus in OF with Sanicorde) for a 
number of samples from 2 to 6, and a ‘true’ percentage of posi-
tive pigs from 50% to 80%. 
With a 70%-prevalence of positive pigs in a group, 3 sequential 
OF samples collected each 3 to 7 day, are necessary to obtain at 
least 1 positive result with 95% chance of success (Table 1).
Table 1: Probability to detect at least one positive sample 
True % of posi-
tive samples in 
the pig group
True % of posi-
tive samples in 
the pig group
True % of posi-
tive samples in 
the pig group
True % of posi-
tive samples in 
the pig group
No of samples 50% 60% 70% 80%
2 0.75 0.84 0.91 0.96
3 0.88 0.94 0.97 0.99
4 0.94 0.97 0.99 1
5 0.97 0.99 1 1
6 0.98 1 1 1
Discussion and Conclusion
The qRT-PCR test we used was designed for blood tests; it had 
not been fully optimized for PRRSV detection in OF and requires 
improvements. However our results confi rmed that the collec-
tion of OF samples could be a useful and cheaper methodology 
to detect and monitor PRRSV infection at herd level. The results 
of this method have to be confi rmed in the fi eld.
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A comparison of individual versus pooled sample testing on pool-level and 
case-level PRRS virus PCR detection sensitivity and speciﬁ city
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Introduction
The time it takes to begin producing porcine reproductive and 
respiratory syndrome virus (PRRSv)-negative groups of weaned 
pigs following the new introduction of a non-resident PRRSv and 
related onset of a clinical reproductive PRRS outbreak in swine 
breeding herds has become an important means by which 
to assess the eff ectiveness of PRRS interventions applied to 
breeding herds. The measure “time-to-negative-pigs” (TTNP) is 
typically described as the number of weeks between the start of 
an intervention protocol (e.g., herd closure to new replacement 
introductions and/or mass vaccination) and the fi rst “consist-
ent” production of PCR-tested negative groups of weaned pigs. 
For estimating TTNP, the key measurement components are: 
sampling frame (e.g., piglets within 1 week or less of wean-
ing), sample selection (e.g., smallest barrow from gilt litters, 
one piglet per litter) sampling method (jugular venipuncture, 
ear notch), sample type (e.g., blood-to-serum, swab-to-saline), 
sample size, sampling interval, sample pooling (e.g., pooling of N 
individual samples), shipping materials and method, PCR assay, 
laboratory procedures, and the number of consecutive tested-
negative samplings. 
The objective of this study was to assess the eff ect of sample 
pooling of 5:1 and 10:1 on PCR detection sensitivity and specifi -
city at both the pool and case levels when estimating TTNP.
Materials and Methods
Two 5,000 sow PRRS-naïve breeding herds became exposed 
and infected with a wild-type PRRSv. A sampling-pooling-PCR 
testing evaluation was conducted on both farms. Sixty (60) due-
to-wean piglets were periodically sampled and tested by PRRSv 
PCR – initially per month, then, when the individual sample-level 
PCR prevalence was fi rst noted to be approximately 30% and 
less, 60 piglets were sampled per week until zero individual PCR 
positives were detected for at least six consecutive weeks. Due-
to-wean piglet selection targeted the smallest barrow suckling a 
gilt or youngest sow.1
PRRSv PCR testing was done on all individual samples collected 
as well as on pools composed of 5 and 10 individual samples. All 
pooling was done in the testing laboratory under a hood using 
special precautions to prevent cross-contamination. Where 
a pool contained one or more tested PCR-positive individual 
samples, the true state of the pools was defi ned as positive. Con-
versely, where a pool contained all tested PCR-negative individ-
ual samples, the true state of the pool was defi ned as negative. 
PCR detection sensitivity (Se) and specifi city (Sp) were evaluated 
at both the pool-level and case-level. The Se and Sp of the tested 
pool sizes were compared to the individual sample PCR testing 
results of the samples making up the pools. 
Results
The results show a comparable estimated pool-level sensitivity 
for pools of 5 (84.5%, 95%CI = 73.5% - 91.6%, n=274) and pools 
of 10 (82.0%, 95%CI = 68.1% - 91.0%, n=137) – a 15.5% and 
18.0% relative reduction in sensitivity for samples pooled 5:1 
and 10:1, respectively, as compared to the PCR testing results of 
the individual samples making up the pools. However, both the 
pools of 5 and 10 had 100% sensitivity and 100% specifi city at 
the case-level. 
At the pool level the specifi city estimates were 99.0% for pools 
of 5 and 97.7% for pools of 10. It is notable that all four “pool 
individuals-negative but pool-positive” (InPp) results occurred in 
the fi rst two sets of cases pooled, and in every instance the InPp 
pool was preceded by a pool that contained one or more posi-
tive individual samples. After the pooling process was reviewed 
and adjustments made, no further occurrences of InPp were 
detected. This indicates the importance of the pooling process 
in obtaining accurate pool-level results. 
Discussion
Based on these data, individual sample pooling up to 10:1 can 
off er comparable pool-level and case-level detection Se to 
that of pooling 5:1 and can further reduce testing costs when 
estimating TTNP.
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Infection dynamics of Porcine Reproductive and Respiratory Syndrome 
Virus (PRRSV) in vaccinated and non-vaccinated pigs
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Introduction
Piglets from a PRRSV (EU type) seropositive stabile sow herd 
were seronegative at weaning, but became infected with PRRSV 
EU after transfer to the fi nishing units located at the same site. 
To control PRRSV among the fi nishing pigs, vaccination with 
a modifi ed live virus PRRSV EU vaccine (Intervac PRRS) all pigs 
prior to transfer to the fi nishing stables were initiated from Oc-
tober 2008. In July 2009 it was decided to terminate vaccination 
of pigs at transfer. The aim of this study was to investigate if non-
vaccinated pigs could be inserted in an empty and clean stable 
without being infected despite the presence of vaccinated pigs 
in neighboring rooms. 
Materials and methods
The study was performed as an intervention study with two 
groups of pigs including 58 vaccinated and 20 non-vaccinated 
Danish Landrace, Yorkshire and Duroc crossbreeds. All pigs were 
identifi ed with ear tags. The vaccinated pigs were 8 weeks of 
age at the time of vaccination. Blood samples and nasal swabs 
were taken 0, 1, 2, 3, 8 and 13 weeks after vaccination. The non-
vaccinated pigs varied from 5 to 10 weeks of age at transfer to 
the fi nishing stable and were sampled 0, 5 and 10 weeks after 
transfer. Non-vaccinated pigs were transferred to a clean and 
disinfected stable three weeks after the vaccinated pigs were 
vaccinated. There was no physical contact between the two 
groups, that were separated by walls and a door that was kept 
closed during the study. All blood samples were examined for 
antibodies against the US and EU PRRSV types by a diff erentiat-
ing blocking ELISA (4) and for the EU PRRSV type by IPMA (1). 
A ratio (OD%eu/OD%us) was calculated if ELISA EU or ELISA US 
were positive (cut off : OD% ≤ 44). IPMA EU detected antibodies 
in four dilutions (1:50; 1:250; 1:1250; 1:6250). Serum samples and 
nasal swabs from vaccinated pigs were examined for PRRSV RNA 
by real time RT-PCR (3) and the ORF5 and ORF7 were sequenced 
from selected positive samples. 
Results
None of the tested non-vaccinated pigs seroconverted to PRRSV 
after transfer to the fattening unit despite the simultaneous 
occurrence of viraemia in vaccinated pigs housed in a neigh-
boring room. All vaccinated pigs were seronegative at the time 
of vaccination. After vaccination they developed an immune 
response, which resulted in 85.5 % pigs with IPMA EU titers ≥ 
1250 three weeks after vaccination. The mean ELISA OD%eu in 
week three was 42.3. Eight weeks after vaccination, all pigs were 
seropositive (mean ELISA OD%eu at 21.9) and 18 2 % of the pigs 
had IPMA EU titers above 1250. PRRSV RNA was detected in 
serum samples 1 to 3 weeks after vaccination, but could not be 
detected in nasal swabs at any time. The level of PRRSV peaked 
1 week after vaccination and then rapidly declined. None of the 
pigs had PRRSV viraemia at 8 and 13 weeks after vaccination. 
The virus was found to be identical to the vaccine virus (DV-MLV) 
by sequencing of ORF5 and ORF7. Thirteen weeks after vaccina-
tion, 94.5 % of the pigs had IPMA EU titers above 1250, indicat-
ing an acute infection. No clinical symptoms were observed at 
this time. The mean ELISA ratio in week 13 was 0.6 indicating a 
previous PRRSV EU infection. 
Discussion
The lack of transmission of PRRSV EU from vaccinated to non-
infected pigs in neighboring rooms, is of importance for herd 
eradication programs in which PRRSV vaccination is carried out 
in order to reduce clinical eff ect. Until 8 weeks after vaccina-
tion, the vaccine induced an immune response comparable to 
a natural infection as previously described (2, 5). Virus was not 
detected in serum beyond week 3 after vaccination, and virus 
was not detected in nasal swabs at any time. Thus, it seems to be 
safe to mingle pigs 8 weeks after vaccination which is routinely 
used in Denmark. To our surprise, the IPMA EU titers markedly in-
creased 13 weeks after vaccination indicating acute (re)infection. 
Although serum and nasal swabs were PCR-negative, this may 
be due to either an infection with a wild type virus or reactiva-
tion of the vaccine virus. Further studies are needed to elucidate 
if this is a general features in pigs vaccinated with live PRRSV 
vaccines. 
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Introduction
In Italy PRRSV infection is widespread and circulation of several 
viral strains occurs. In breeding herds the key to break virus 
circulation is to expose replacement animals to the farm specifi c 
PRRSV strain to induce a good immune response prior to their 
introduction into the herd. Therefore, a rigorous bio-security 
policy is needed to avoid the incoming of new strains into an 
infected farm (Pesente et al. 2006).
The aim of this study was to monitor the serological, virological 
and productive trends of an endemically PRRSV infected breed-
ing herd where the control of the infection was based on the 
implementation of an eff ective acclimatization program accom-
panied by strict bio-security measures.
Materials and Methods
The study was carried out in a 1500 sows farrow-to-wean farm, 
infected by PRRSV since 1995. As farmers decided not to vaccin-
ate for PRRSV, an acclimatization program was improved over 
time. 52 3-week-old PRRSV negative gilts were introduced into 
the farm every month and at once exposed to PRRSV through 
the contact with weaned pigs, used as donor sources of virus. 
During the last 3 months of acclimatization viremic pigs were 
turned over every 2 weeks and taken away one month prior to 
the introduction of gilts into the stimulation unit. The aim of the 
program is to fertilize 8-month-old gilts after they become im-
mune but no longer viremic.
For 24 consecutive months, from April 2007 to March 2009, sera 
samples were collected from 1185 gilts at the end of acclimatiza-
tion. In the same period, 5 cross-sectional surveys were carried 
out almost seasonally, on a total of 607 pigs. Between October 
and November 2008 a PRRS outbreak occurred in the farm and 
thoracic fl uid was collected from some aborted fetuses. PRRSV 
RNA was extracted from both sera and thoracic fl uid samples, 
analyzed by RT-PCR, purifi ed and sequenced in ORF7 region. 
Sera samples from gilts were also checked for the presence of a 
specifi c PRRSV immunity by an ELISA commercial kit. Perform-
ance Trend Analysis (PTA) was obtained using farm database, 
and analyzed statistically using Chi-square test for count data 
and one sample T-Test for continuous variables.
Results
After a fi rst period of low effi  cacy of the acclimatization program, 
especially in July and November 2007, both prevalence of sero-
positive gilts and mean s/p ratio increased in the subsequent 
months (Fig.1). This trend may be the consequence of seasonal-
ity and of a better management of the viremic pigs used as virus 
donors. The 100% virus positivity in pools from 3 groups of gilts 
during cold season together with the virological results of the 5 
cross-sectional surveys (ranging from 2/16 positive pools in July 
2008 to 23/23 in February 2009) confi rms that season plays a key 
role in the viral circulation. 
The outbreak consisted in a reproductive failure with 27 abor-
tions and in a signifi cant fall of the productive performance: 
number of farrowings, farrowing rate, piglets weaned, piglets 
weaned/sow/year, total born/litter, liveborn/litter, piglets 
weaned/litter. The comparison of these parameters before and 
after the outbreak didn’t show signifi cant diff erences, demon-
strating that in a well acclimatization system the return to nor-
mality can be achieved rapidly. Phylogenetic analysis assessed 
the presence of a single homologous PRRSV variant on the farm 
and revealed the incoming of a new strain (9,4-10,8% of nucleo-
tide p-distance) causing the outbreak and no longer detected in 
the following surveys.
Discussion
This study confi rms that an acclimatization program may be able 
to maintain the circulation in not reproductive units of a unique 
viral strain over time and that it may be able to restore promptly 
herd stability after an outbreak. Phylogenetic analysis is more 
and more often a useful tool to help farmers and veterinarians 
to understand the causes of the failures and to apply successful 
control measures.
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Introduction
Over the past 15 years, selection of hyperprolifi c sows has 
actually increased litter size but also increased heterogeneity 
of piglets’ weight at birth. However, piglet’s weight at birth by 
itself is not discriminating enough to predict the whole animal’s 
productive life (Litten et al., 2003). Immaturity corresponds to 
piglets with intrauterine growth retardation (IUGR) after 114 
gestational days, which present all the characteristics of runt 
piglets. The goal of this study was to determine a set of simple 
morphological criteria, backed-up by anatomical data, in order 
to allow the rapid identifi cation of immature piglets in the farm.
Materials and Methods
924 piglets (837 born alive, 87 stillbirth and 29 mummifi ed) from 
67 Topigs sows (Great Yorkshire /Large White type) and N-line 
(Dutch Landrace), were monitored at birth in a French herd 
for birth and weaning weight, vitality score within the fi rst 15 
seconds of life (Baxter et al., 2008), and qualitative morphologic-
al signs of maturity including head morphology (on lateral and 
dorso-ventral observations, Figure 1), head/body, and behavior 
(after a pre-study performed by Sacy (2008)). 
Figure 1: Dorso-ventral characteristics of normal (left), intermediate 
(middle) and IUGR (right) piglets
Piglets dead within 2 days post-farrowing (IUGR=147, con-
trol=282), including stillborn piglets, were necropsied and their 
vital organs weighed (brain, liver, heart and lungs). The brain is 
the fi rst vital organ to attain maturity, while other organs such as 
liver mature later. Therefore, the brain/liver ratio is a good indica-
tor of a piglet development stage. The higher the ratio, the more 
immature the piglet (Town et al., 2005):
Results and discussion
Morphology: IUGR piglets are generally lighter than the more 
mature ones (71 % of IUGR piglets <0.9 kg vs 2 % of the ma-
ture ones p<0.001), but some light weight piglets exhibit the 
morphological traits of mature piglets. 
Brain/Lung, Brain/Liver, and Brain/heart ratio: all ratios are highly 
signifi cantly diff erent between IUGR and control. Moreover, 
there is a correlation between the brain/lungs ratio criteria and 
morphological criteria of immaturity (Figure 2). Similar results 
were obtained with other vital organs such as heart: 5.21±1.95 
vs. 3.15±0.85 (r=-0.677, p<0.001). 
Behaviour: immature piglets exhibit typical behavioral criteria: 
they are usually found isolated from the other piglets, lying on 
their side, they have diffi  culties to suckle and are usually found 
where the farmer left them previously. They represented 11% of 
the live born piglets and it went up to 25% for older sows (par-
ity>5). 
Figure 2: Relationship between true stillborn piglets weight and their 
brain/lungs ratio (r=-0.701, p<0.001)
Growth and mortality: Survival rates of IUGR piglets in mater-
nity was lower than for mature piglets (62% vs. 89%, p<0.01). At 
weaning (3 weeks), IUGR piglets (n=54) have a lower live weight 
compared to control (n=642), 4.7 ±0.9 kg vs 5.7 ±1.2 kg, p<0.01. 
Conclusion
Until now, IUGR assessment was based on anatomic criteria 
(Town et al., 2005). This study combines morphological and be-
havioral criteria that refl ect piglets immaturity at birth, all criteria 
being validated by anatomical data.
From a producer point of view, quickly identifi cation of im-
mature piglets is essential. 
However, it would be of interest to pursue this work with other 
genetic lines as the morphologic piglets criteria for immaturity 
might diff er (according to the prolifi cacy).
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Introduction
In the Netherlands, group housing of gestating sows will be 
obligatory from 2013 onwards. In 2008, a Dutch farm expanded 
from 280 to 450 sows and converted to group housing with 
electronic sow feeding. In the fi rst 6 months of the new hous-
ing system, 59 animals aborted between 50 days until the end 
of gestation. The number of piglets weaned per sow per year 
dropped from 29 to 26.4 mainly caused by the abortions.
Material and methods
From 50 days of gestation onwards, 192 sows were housed in 
one group with four electronic sow feeders. Sows were custom-
ary vaccinated for PRRS, E.coli, Erisypelas, infl uenza and PPV. 
During the outbreak, diff erent diagnostic examinations were 
performed (table) and a variety of experts visited the farm. 
In the feeding stations, a feed data recorder was installed that 
made it possible to analyze feeding data.
Material Agent / substance Method
Blood H1N2, H1N2, H3N2 HAR1
Blood PRRS, Leptospira, Aujeszky, BVD ELISA1
Blood Hog Cholera PCR2
Blood PCV2, PRRS PCR1 PCR1
Blood EMCV Virus isolation and PCR3
Fetuses PCV2, PRRS, PPV PCR1
Fetuses Pathology, general histology HE1
Fetuses Chlamydophilia Chlamydophilia histology, IHC1
Placenta General histology, HE1
aborted sows General histology, HE1
Feed sample
DON, NIV, T2, Ochratoxine A, 
Fumonisin B1 and B2, Zeara-
lenone, and Afl atoxin B1
LC-MS1
Water Ammonium, Nitrite kca1
Water Nitrate, Chloride, Sulfate IC1
Water Iron, Mn, Na ICP1
Water pH
Water E. coli Bacterial examination1
 Animal Health Service, Deventer, The Netherlands
2 Central Veterinary Institute, Lelystad, The Netherlands 
3 CODA-CERVA,Ukkel, Belgium 
Results
The animals that aborted were sometimes slightly inert but ap-
peared clinically healthy. There were no signs of aggression. No 
infl uence of parity was found. The samples that were examined 
showed no (increase of ) antibody concentration. Aborted fetus-
es within a sow were all in one stage of development. Litter size 
of the other sows was not aff ected. Feed data analysis showed 
that several animals frequently visited the feeder for a very 
short time, but probably were not provided with feed. Further 
investigation showed that sometimes the feeders had a random 
reset and had a mechanical malfunction. After adjustment of the 
feeders no more abortions were observed.
Discussion
Low feed intake is a risk factor during the fi rst weeks of gesta-
tion (1). However, in this case abortion occurred later on. Since 
the sows were fed using electronic sow feeders, one would not 
expect a high risk of feed competition like in group housing 
systems with trough or fl oor feeding. (1). But due to the mal-
functioning of the feeders, the feed intake of some sows could 
have been very low, which might aff ect pregnancy. Valuable in-
formation on real feed intake can be obtained by data recording 
systems that some manufacturers provide. Veterinarians should 
use this information.
Another aspect of this case is the eff ect of stress. The detrimental 
eff ect of stress on (re)productivity of sows is hard to establish 
in experimental settings (2). However, stress has an eff ect on 
the hypothalamic–pituitary–adrenocortical axis and therefore 
probably on the maintenance of pregnancy (2). The fact that the 
feeders quite often randomly malfunctioned probably resulted 
in a lot of agitation and thus in (long term) highly unpredictable 
stress. Examination of sow behaviour could have given a clue.
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Introduction
ZEA is a mycotoxin that binds to the estrogen receptor and ex-
erts estrogen-like eff ects. Pigs are highly sensitive to ZEA [1] and 
can exhibit reproductive disorders if consume it. There is indica-
tion that ZEA is carried over to piglets in utero and through 
colostrum/milk, and may cause hyperestrogenism [2]. However, 
neither of both routes of carry-over has been conclusively 
demonstrated. This study therefore focused on the metabolism 
and carry-over of ZEA to piglets when fed to late pregnant and 
lactating gilts.
Materials and Methods
Gilts (n = 32) were hormonally synchronized for estrus and ovu-
lation, artifi cially inseminated and tested positive for pregnancy. 
They were fed crystalline ZEA (Sigma-Aldrich, Germany) from 
day 101 of gestation until days 20/21 of lactation in a concen-
tration of either 1.500 μg/kg feed/day (n = 7; EXP-H) or 250 μg/
kg feed/day (n = 9; EXP-L), while eight gilts served as controls, 
respectively (CON-H, CON-L). For application, ZEA was dissolved 
in ethanol and injected into muffi  ns that were individually fed 
to the gilts. CON animals received blank muffi  ns. Prior to fi rst 
colostrum uptake, female piglets were cross-fostered from the 
respective EXP to CON animals and vice versa, to obtain piglets 
that were diff erently exposed to ZEA: in utero only (IU), through 
colostrum/milk only (MI), in utero and through colostrum/milk 
(IU & MI), none (CON). Group size was 11–13 piglets, respectively. 
Colostrum/milk was collected four times in weekly intervals. 
First collection occurred after farrowing. Piglets were weaned on 
day 20/21 of lactation, then sacrifi ced and bile collected. Sows 
were sacrifi ced one day after weaning, and bile collected. All 
milk and bile samples were subjected to analysis for ZEA and 
its metabolites α- and β-zearalenol (ZOL) using HPLC and mass 
spectrometry.
Results
Median concentrations for both ZEA and α-ZOL in bile of CON-H 
and L groups were around 5 ng/ml and 2 ng/ml, respectively. 
Concentrations were > 250 x higher in in bile of EXP-H and 
30–100 x higher in EXP-L gilts for both mycotoxins. ZEA, but not 
α- and β-ZOL, was found in milk collected from EXP-H and L but 
also from the respective CON animals. Mean concentrations of 
ZEA (average of the values obtained with all milk samples) were 
higher for the EXP-H and L than for the CON-H and L group, 
respectively. In none of the piglets could β-ZOL be detected 
in bile. Almost all IU & MI and MI piglets belonging to both the 
H and L experiment were tested positive for ZEA and α-ZOL in 
bile. Only single piglets exposed to IU or belonging to CON were 
positive. Median concentrations of ZEA and α-ZOL were higher 
in IU & MI and MI than in IU and CON piglets in both experi-
ments, respectively (P < 0.0001). 
Discussion
Results confi rm that ZEA and its metabolites accumulate in 
bile of pigs and that the concentrations in bile depend on 
the amount of ZEA consumed [3]. The fact that non-exposed 
animals also had ZEA in bile albeit in very low concentrations 
indicates constant back-ground exposure. Data show clearly that 
ZEA can be encountered in colostrum/milk of lactating gilts. The 
fact that piglets nursed to ZEA-exposed gilts were preferentially 
ZEA positive in bile regardless of whether they were exposed 
also in utero or not, clearly demonstrates that carry-over of ZEA 
through colostrum/milk occurs in the pig. A recent study has 
shown altered expression of morphoregulatory important genes 
in those piglets [4]. 
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Risk factors associated with frequency of abortions
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Introduction
Current swine production is everyday more linked to a proper 
analysis and monitoring to maintain competitiveness. Despite 
of the fact that every farm has to improve taking into account its 
own results, in many cases general standards can be useful to set 
a quick reference in order to help to defi ne farm objectives and 
to compare performances through benchmarking processes. 
Literature has described references for most of the key indicators 
during the last decades, but some of the factors has not been re-
cently updated or explained in depth including interactions be-
tween them. Those risk factors related to frequency of abortions 
through several years in a large herd population are presented.
Materials and Methods
The objectives of the present study were to investigate the 
relationship between the relative frequency of abortion (per-
centage, AP) and number of parity (NP), weaning to fi rst mating 
interval (WSI), number of service (NS) and day of week for ser-
vice (DW). The present study used more than 870,000 mating re-
cords corresponding to four years (from 2005 to 2008) of about 
80,000 sows on 161 commercial farms from Spain, Portugal and 
Italy, monitored by PigCHAMP Pro Europa S.A. and registered 
with Pigchamp® software.
Each factor was categorized: four groups for NP: 1, 2, 3-6 and ≥ 
7 parity; three groups for NS: fi rst-serviced (FS), fi rst-reserviced 
(FRS) and second-reserviced (SRS); four groups for WSI: ≤3, 4-7, 
8-11 and ≥12; and two groups for DW: Weekday and Weekend. 
Data were analysed using the MIXED procedure of SAS (v 9.00). 
Results
Mean value (± SEM) of AP was 0.78 ± 0.03%. The main eff ects 
studied resulted as follows: Regarding NP, mean AP in parities 1 
and ≥6 was higher than those in parities 2 and 3-6 (P=0.0001), 
showing a quadratic eff ect that explains the higher risks in 
both gilts and old sows (fi gure 1). A lineal eff ect was found for 
WSI, when WSI≤7 was lower than those of WSI≥8 (P=0.0001); 
furthermore, AP depended on DW and it was higher for mat-
ings during the weekend: 0.70 vs. 1.05 % (P=0.0001). Finally the 
mean AP for NS increased with the number of oestrus repetition 
(fi gure 1), showing: 0.45, 2.87, 4 26% for FS, FRS, SRS respectively 
(P=0.0001). Through the time, only year 2006 showed a lower 
AP (0.68) being the other years quite stable (around 0.80 all of 
them). Therefore factors associated with a higher AP were being 
gilts or old sows (≥7th parity), a reservice occurrence, prolonged 
WSI and service during the weekend.
Some interactions between the main factors studied were 
found. The most interesting one is probably the one between 
WSI and DW; sows mated ≤3d after weaning showed no diff er-
ences between weekday or weekend, while sows with normal 
WSI (4-7 d) showed a higher risk during weekends (0.63 vs 1.29, 
p<0.0001), while later mated sows served 8-11 d post weaning 
performed better in matings during the weekend (1.24 vs 0.75, 
p<0.0001).
Figure 1 – AP frequency (%) depending on parity (left) and number of 
re-services (right)
Discussion 
Classical risk factors infl uencing.abortion and return to estrus 
are well known (e.g. Koketsu et al., 1997; Vargas et al., 2009). 
However these results add more information about the relative 
importance of some classical factors as NP, NS or WSI, and show 
a new factor as it is DW. Besides these results can be useful to 
defi ne with more accuracy the objectives of every farm and to 
avoid those factors that are largely infl uencing poor perform-
ance in order to keep continuous improvement and competi-
tiveness 
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Introduction
Although anaemia in sows is less studied than in piglets, it can 
be supposed that it is a key factor of the sow’s health status. The 
aim of this study is to describe levels of anaemia observed in 
hyperprolyfi c farms in France and to study the eff ect of inject-
able iron (GLEPTOSIL®) administration during gestation.
Materials and Methods
The study was carried out in 2009 in seven hyperprolyfi c farms 
(13.8 to 15.6 born piglets/sow/year) with a high percentage of 
stillborn (> 8%) and/or manual assistance at farrowing (> 15%). 
Sows (n=510) were individually randomised into two groups 
(Gleptoferron and Control), 7 weeks prior to farrowing after 
stratifi cation according to parity and the initial haemoglobin 
level. Sows from the Gleptoferron group received two injections 
of GLEPTOSIL® at 7 and 4 weeks before farrowing (10 ml per 
injection, i.e. a total of 4 g of gleptoferron).
The level of anaemia was assessed by haemoglobinaemia, 
measured with the Hemocue® Hb 201+ device. (1). Kinetics was 
observed by measuring the levels at four stages of the repro-
ductive cycle of each sow: seven and four weeks before farrow-
ing, after farrowing (between 48h and 5 days) and on day 20 
of lactation. Two measures of the backfat layer thickness (BFL) 
were carried out on each sow (four weeks before farrowing and 
at farrowing). Lme procedures (R 2.9.0) were used. Parity ranking 
and haemoglobin level at the start of the study were set as fi xed 
eff ects, farm and batch as random eff ects.
Results
Haemoglobinaemia is linked to the parity rank and decreases all 
along the career of the sows. The average BFL decreases from 
the fourth litter onwards. Sows with high haemoglobinaemia 
levels are fatter (Figure 1). This relation is signifi cant, even after 
adjustment for the parity (p=0.02). A positive eff ect of the 
gleptoferron injection is observed 3 weeks after the fi rst injec-
tion. However, there is an interaction between “Treatment” and 
“Parity” (Table 1).
Figure 1: Haemoglobin and BFL 4 weeks before farrowing 
Table 1 – Treatment eff ect on haemoglobinaemia (g/L) 4 weeks before 
farrowing
Discussion
The drop in haemoglobinaemia with an increasing parity rank 
was not reported in a similar study carried out 30 years ago 
(2). This newly discovered relation might be due to the dra-
matic increase in prolifi cacy over the past decades. The relation 
between haemoglobinaemia and BFL is signifi cant even after 
adjustment for the rank of parity, what strengthens its biological 
signifi cance. Though, the study does not allow establishing a 
causal link we favour the hypothesis of an insuffi  cient nutritional 
intake for both the build-up of body reserves and for restoring 
the haemoglobinaemia. The injection of gleptoferron allows 
partial compensation of the anaemia. This partial effi  cacy of 
gleptoferron could be explained by an insuffi  cient quantity of 
iron injected.
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Introduction
Sow mortality is generally neglected by pig advisers, despite the 
signifi cant losses incurred. According to offi  cial reports submit-
ted to the Danish Food Advisory Service by the Danish rendering 
plants, more than 156,000 sow carcases were processed during 
2009, indicating that Danish pig producers dispatched 14.4 % 
of their sows to rendering plants. The economic output gained 
from reducing this number would be considerable for most herd 
managers in Denmark.
The reasons behind the high sow mortality have been investi-
gated in Danish herds. The main purpose of Sow Life® was to 
gain an insight into the normal production strategy, to clarify the 
potential for improvements and then act upon this by establish-
ing a one-year strategy for the herds.
Materials and Methods
A total of 17 farms with above average sow mortality were 
selected for the investigation. All farms recorded productivity 
levels electronically and had a herd manager who was willing 
to spend time together with an advisory team consisting of the 
herd veterinarian, a local pig production adviser and a specialist 
from the Pig Research Centre.
Over a 3-month period, data from each herd were analyzed, 
technical errors were corrected, and the advisory team together 
with the herd manager then decided on a strategy to reduce the 
sow mortality and thereby increase the economic output. The 
strategy included a fi xed level for sow mortality. The production 
was closely monitored by the advisory team over the follow-
ing 12 months. Minor changes to the strategy were made if 
necessary. If the goals of the strategy were achieved within the 
12-month period, the herd manager and the advisory team 
would agree on new goals within the strategy. 
Results and Discussion
As can be seen in Figure 1, it was possible to reduce sow mortal-
ity on all 17 farms. Figures on productivity are shown in Table 
1. The three best farms increased their output by additional € 
59 - € 121 per year sow. Three farms were unable to increase the 
output by reducing sow mortality, one suff ered from problems 
in recruiting reliable personnel and the other two were put up 
for sale due to fi nancial problems. 
Figure 1. The black bars indicate the percentage of sows dying at 
the time of herd selection based on the results of 2007. The grey bars 
indicate the goals for sow mortality set by the herd manager together 
with the advisory team. The white bars show the results of 2009, after 
12 months’ work, of a strategy to reduce sow mortality.
Table 1. Economic output on the three best farms before and after 12 
months of Sow Life®
When dealing with an issue such as sow mortality, it is import-
ant to agree on a specifi c goal and on how to achieve it. Despite 
diff erent limits for sow welfare, 14 out of 17 farms achieved 
economic success through the planning process together with 
the advisory team.
The Sow Life® investigation has shown that by reducing sow 
mortality on Danish farms the herd managers would increase 
the output per year sow. 
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Introduction
The air in modern pig fattening units contains large numbers of 
bacteria [1]. They give cause for concern threefold: fi rstly, high 
concentrations of airborne bacteria can impair the respiratory 
health of the animals. Secondly, the health of animal caretakers 
can be compromised by these air pollutants, and thirdly harmful 
bacteria can be transmitted via the exhaust air to neighboring 
animal houses and residential dwellings where they are suppos-
ed to cause infections and contaminations in animal and man 
[2]. Of particular interest are possible MRSA (methicillin resistant 
Staphylococcus aureus) emissions from piggeries. Therefore it 
seems useful to reduce the concentrations of airborne bacteria 
already in the animal house air. 
This paper reports about experiments with a new air cleaning 
device in order to reduce the bacterial load incl. MRSA in the air 
of a commercial pig fattening unit.
Materials and Methods
The air cleaner consists of an air washer with an integrated 
UV (ultraviolet) irradiator (prototype developed by Hölscher & 
Leuschner Comp., Emsbüren, Germany). The device was placed 
in the center of an animal house with 600 fattening pigs. For the 
investigations the air fl ow through the system was adjusted to 
approx. 7000 m3 • h-1. To warm up the UV lamps the system was 
started 10 min before each sampling. Two samplings (no. 1 and 
2) were conducted in the 8th week, one in the 9th (no. 3) and 
one (no. 4) in the 10th week of the same fattening period. Air-
borne bacteria were sampled isokinatically and simultaneously 
using three impingers in the untreated air directly in front of 
the air cleaner and three impingers in the treated air behind the 
outlet of the system. Total airborne bacterial concentrations and 
airborne MRSA concentrations were determined as described by 
[3]. 
Results
In all samples a clear reduction of the total airborne bacteria 
concentrations were observed (about one log or average reduc-
tion rate and standard deviation of 93 ± 2% (Table 1). Similar and 
even better results are achieved for MRSA which are reduced by 
nearly two log or 98 ± 2% on average (Table 2). 
Table 1: Total airborne bacterial concentrations (average and stan-
dard deviation) before and after treatment with an air cleaning device 
in a piggery
sampling no. untreated air [cfu/m3] treated air [cfu/m3]
1 3.7 x 105 ± 1.1 x 105 3.3 x 104 ± 1.2 x 104
2 2.8 x 105 ± 1.5 x 105 1.9 x 104 ± 1.1 x 104
3 2.7 x 105 ± 3.3 x 104 9.4 x 103 ± 4.4 x 103
4 3.1 x 105 ± 6.6 x 104 1.2 x 104 ± 2.0 x 103
Table 2: Airborne MRSA concentrations (average and standard devia-
tion) before and after treatment with an air cleaning device in a piggery
sampling no. untreated air [cfu/m3] treated air [cfu/m3]
1 7.8 x 102 ± 6.0 x 102 3.4 x 101 ± 3.0 x 101
2 9.1 x 102 ± 1.2 x 103 1.8 x 101 ± 2.1 x 101
3 5.6 x 102 ± 1.5 x 102 0
4 7.4 x 102 ± 4.5 x 102 4 x 100 ± 6.0 x 100
Discussion 
The results demonstrate that the used air cleaning device is able 
to reduce the general bacterial load in the air of a commercial 
piggery signifi cantly by 93% or about one log and MRSA by 98% 
or nearly two log. This air treatment technique off ers the pos-
sibility to decrease bacterial loads in pig house air and bacterial 
emissions from pig farms. This would be benefi cial for the health 
of the animals, the work force and the neighborhood.
Conclusions
The presented air cleaning device has obviously the potential 
to reduce the bacterial load in the air of piggeries signifi cantly. 
Further investigations are necessary to confi rm the results and 
to clarify the respective retention effi  ciency of the washer and 
the UV radiation unit.
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Livehaul accident response
Jeremy S. Pittman1 Jennifer Woods2
1. Murphy-Brown, LLC, Waverly, VA, USA; 2. J. Woods Livestock Services, Blackie, AB, Canada
Introduction
A livehaul accident scene is never an easy sight, however a time-
ly and organized response can improve a bad situation to better 
for the industry. Twenty-seven percent of all livehaul accidents 
involve swine, 80 percent of which involve market animals.1 The 
number of trailers carrying livestock in North America, makes a 
small percentage of accidents appear to occur frequently. For 
example, the 3 main pork processing plants in North Carolina 
and Virginia receive 72,000 market trucks per year. The yearly es-
timated number of livehaul accidents in NC and VA is 24, which 
is only 0.03%. This paper outlines steps that should be followed 
when responding to a livestock accident. It is not a complete 
manual, but we have highlighted important areas based on prin-
ciples of incident command, training documents and personal 
experiences.
Responsibilities of Responders - 1) Safety of the driver, all 
personnel and the general public; 2) the welfare and humane 
treatment of animals; 3) protection of property and 4) ensure a 
positive public perception of the industry.
Basics of Incident Command - 1) One person in command; 2) 
teamwork is necessary; 3) chain of command must be respected; 
4) communication
Responders - Most emergency responders have little to no 
experience with handling livestock. Many transporters have little 
experience handling stressed livestock. Many livestock handlers 
have little to no experience in extraction. This requires team-
work, organization and a specially trained crew.
Local Responder Assistance - Law enforcement is responsible 
for public safety, traffi  c and crowd management. Fire depart-
ments are responsible for securing scene and vehicles, extrica-
tion if needed and water to cool animals. All others should be 
requested to leave the scene.
First on Scene - 1) Establish communication, exchange informa-
tion with authorities, 2) establish lead person; 3) move loose ani-
mals off  of the road; 4) provide assessment of scene to response 
team.
Rescue - It may take up to 2 hours before the actual extraction 
occurs, however response to the accident must occur prior to 2 
hours. The average response time and clean up is 6 hours. Set up 
containment area and corral loose animals. Once containment 
area is set up, proper equipment and adequate responders are 
available, begin extraction of the animals inside the trailer, not 
before! Animals are loaded onto a transfer trailer in accordance 
with standard loading procedures and downer policy. All ani-
mals must be accounted for prior to leaving the accident scene. 
Sort boards and rattle paddles are used when loading animals. 
Electric prods are discouraged. Care should be taken when load-
ing animals, take your time, show patience, composure, and use 
publicly accepted terminology.
Extrication - Rescue team should take ample time to assess acci-
dent scene and determine the best route/method of extrication. 
It must be determined if the trailer is stable to begin extrication, 
or a method of stabilization is determined. Never compromise 
the safety of the responders. Nearly 84% of trailers roll onto the 
right hand side1, making extraction more diffi  cult. When trailers 
roll on their side, fl oor space is cut in half at best. Be sure to stag-
ger work load to prevent exhaustion, accidents, injury.
Euthanasia - Safety comes fi rst! One person, primarily a veterin-
arian or trained professional, is assigned all euthanasia duties for 
the incident. Injured animals outside the trailer are euthanized 
as soon as possible. Injured animals inside the trailer are eutha-
nized as soon as they are safely accessible. Euthanize animals 
out of sight of the general public. Law enforcement should not 
be involved with euthanasia. Dead animals should be removed 
from the working area and covered.
Post Accident - Lead person should assess property damage, 
cleanup needs, removal of damaged vehicles and inspection 
of scene after completion. Response team completes accident 
reports and reviews incident and media response for recom-
mendations on continued improvement. We learn something 
new every time and try to be prepared for any situation.
Summary - Ability to comply with the above processes leads to 
an improved accident scene, improved response time, minimal 
expense and a positive perception to an otherwise negative 
event. More information on training can be found at www.
livestockhandling.net
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Vaccination implementation and compliance in a large production system
Jeremy S. Pittman1 Brad J. Thacker2 John K. Johnson3
1. Murphy-Brown, LLC, Waverly, VA, USA; 2. Intervet/Schering-Plough Animal Health, Desoto, KS, USA; 
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Introduction- Porcine circovirus Type 2 (PCV2) in growing pigs is 
associated with severe systemic and respiratory disease leading 
to high mortality and decreased growth performance. Historic-
ally, vaccination for swine diseases has focused more on popula-
tion immunity. However, the pathogenesis and epidemiology 
of PCV2 disease makes individual pig immunity important due 
in part to the ability of the virus to persist in the environment. 
Accordingly, any ability to measure and monitor compliance to 
PCV2 vaccination would be valuable for eff ectively controlling 
these diseases.
Compliance- Is defi ned as “the consistency and accuracy with 
which a patient follows the regimen prescribed by a physician or 
health professional.” Compliance has been associated with four 
key factors: 1) patient’s perceived susceptibility to the disease; 
2) patient’s perceived severity of the disease; 3) patient’s belief 
that the benefi ts outweigh the costs; and 4) whether the patient 
receives “cues to action” or reinforcement of the regimen.1 The 
potential exists for non-compliance in any health or production 
protocol.2 The most detrimental type of non-compliance is com-
plete neglect of the vaccination protocols where groups of pigs 
are left susceptible to disease. In most situations, compliance 
is based on employee adherence to the established protocols. 
Improving compliance is based on educating employees, mon-
itoring the vaccination process and protocol reinforcement.
PCV2 vaccination protocol- Piglet vaccination protocols in 
this production system are based on vaccine effi  cacy, economic 
return and compliance. Circumvent® PCV, along with MycoSi-
lencer® ONCE, is used on all farms, enabling sero-compliance 
monitoring. The fi rst doses are given at weaning (21 days), when 
the entire farm staff  is present. The second doses are given 21 
days later, on the same day of the week, when the farm team is 
already in a “vaccination” mindset. Giving two vaccines requires 
multiple employees to be present, improving compliance by 
“witness motivation”. The farm manager is mandated to be 
involved in the vaccination process, improving compliance by 
visual supervision and accountability.
Vaccine inventory management- A monthly report allows 
systematic monitoring of vaccine inventory, minimizes wastage, 
improves management of the product and reduces system vac-
cination cost. 
Serological compliance- The PCV2 Diff erential ELISA test 
available at the Iowa State University Veterinary Diagnostic 
Laboratory, Ames, IA, has been shown to be useful tool for 
compliance monitoring for the PCV2 vaccine used.3 Compliance 
is monitored monthly by testing 10, ten week-old nursery pigs; 
< 7 positive samples would trigger the following actions: 1) de-
tailed inventory accounting; 2) farm visit to review protocols; 3) 
additional serotesting to confi rm previous results and to identify 
other non- or poorly vaccinated, “at risk” groups; and 4) person-
nel action such as a written warning.
Non-compliance examples- Monitoring of Farm A found 
9/10 and 10/10 negative tests in subsequent months. Vaccine 
inventory review for the past 3 months discovered only 43% of 
required vaccine had been purchased. Farm visit revealed un-
acceptable practices by an employee. Manager was mandated 
to give all PCV2 vaccinations and subsequent testing returned 
to acceptable levels. Monitoring of Farm B found 10/10 pigs 
negative. Inventory report showed no issues. Farm investigation 
revealed the timing of second vaccination had drifted from 6 
wks to 9 wks of age. Initial samples were collected only 2 days 
after the second dose and thus were negative.
Discussion- Overall compliance to health and production 
programs is a major concern in large integrated systems and the 
ability to measure, monitor and assign accountability to those 
programs, including vaccination protocols, is of considerable 
value. Our monitoring program has helped us identify several 
key areas of vaccine implementation that have improved com-
pliance. 
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Accuracy of dosing pumps: inﬂ uence of type and maintenance
Anne Hemonic; Isabelle Corrégé; Nicolas Berthelot
IFIP-Institut du porc, LeRheu, France
Introduction 
Good practices when using medicines in farms are essential to 
get drug effi  ciency, to respect the maximum residue limits in 
meat and to prevent the development of antimicrobial resist-
ance. In particular, water medication administered with a dosing 
pump requires a well-dissolved and homogeneous solution 
at drinkers (1), a good regulation of the fl ow at drinkers and a 
reliable equipment. The aim of this study was to evaluate the 
dosing accuracy at farm levels, according to type of pumps and 
maintenance. 
Materials and Methods 
Three equipments were compared:
•  A hydraulic pump (HP1) used in a farm during 4 years without 
any maintenance.
•  HP1 after maintenance procedure (HP2).
•  An electric pump after maintenance procedure (EP).
Pumps were set up on an experimental pipe and tested with 9 
combinations of 3 pressures (3, 1.5, 0.5 bars) and 3 water fl ows, 
matching farm values: 600 l/h simulated high fattening fl ows (10 
drinkers set at 1 l/min and used simultaneously). 30 and 300 l/h 
simulated low and intermediate post-weaning fl ows (1 and 10 
drinkers in use and set at 0.5 l/min).
The dosing rate of the pumps was set at 5%, as it is the most 
frequently used on French pig farms (2). EP was also set at 10% 
to check how it aff ected the accuracy.
During each test, after fi lling up the tank with water, the weights 
of the stock solution (W1) and of the water collected down-
stream (W2) were recorded every 10 kg (20 measures). For an 
expected dosing rate of 5%, the observed one was calculated as: 
((initial W1 – fi nal W1) x 105)/W2.
We compared average observed dosing rates, coeffi  cients of 
variation (CV) and the percentage of the dosing rates, irrespec-
tive of the 5% margin error set by the manufacturer.
Results and discussion
At 300 and 600 l/h, HP1 had average dosing rates between 4.96 
and 5.10% with CV below 3% (Table 1), which is quite correct. On 
the opposite, at 30 l/h, results lied between 1.52 and 3.75% and 
CV reached 69% at 3 bars. A hydraulic pump that has worked 
regularly without any maintenance will underdose at low fl ows, 
sometimes injecting less than one third of the expected volume. 
HP2 was tested only at problem fl ow (30 l/h). Average dosing 
rates were between 5.17 and 5 27% with all CV below 3%. So, 
maintenance clearly improved dosage accuracy. 
EP, set at 5%, had correct results at 30 and 300 l/h (CV < 5%) with 
minor overdosing (between 2 and 5%). But at 600 l/h, EP under-
dosed and injected only 60% of expected volume. When the 
pump was set at 10%, the trends were the same. So, with post-
weaning fl ows, electric pump was less accurate than hydraulic 
pump, though still acceptable. However, EP was not suitable 
with high fattening fl ows.
Conclusion
The regular maintenance of the pumps is crucial to get correct 
dosage accuracy. It consists in rinsing out the system after each 
use and performing yearly maintenance work on the pump.
Moreover, hydraulic pump is suitable with post- weaning and 
fattening fl ows. But, electric pump is accurate only with post-
weaning fl ows. It would be of interest to reset the rhythm of the 
electric pulse in order to be more compatible with higher fatten-
ing fl ows and to avoid underdosing.
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Table1: Accuracy of dosing pumps
fl ow (l/h) 30 l/h 30 l/h 30 l/h 300 l/h 300 l/h 300 l/h 600 l/h 600 l/h 600 l/h
pump pressure (bars) 3 1.5 0.5 3 1.5 0.5 3 1.5 0.5
HP1 Avg. dosing rate / CV (%) 1.52/69 3.23/5 3.75/14 4.96/1 5.02/2 5.10/2 5.0/1 5.04/1 5.09/2
HP1 % dos. rate >5.25% / <4.75% 0/100 0/100 5/95 0/0 0/0 0/0 0/0 0/0 10/0
HP2 Avg. dosing rate / CV (%) 5.17/2 5.25/2 5.27/1 not tested not tested not tested not tested not tested not tested
HP2 % dos. rate >5.25% / <4.75% 5/0 42/0 55/0 not tested not tested not tested not tested not tested not tested
EP 5% Avg. dosing rate / CV (%) 5.10/2 5.35/4 5.39/3 5.14/1 5.37/1 5.50/2 2.87/23 2.84/13 2.86/4
EP 5% % dos. rate >5.25% / <4.75% 20/0 60/0 55/0 0/0 85/0 100/0 0/95 0/100 0/100
EP 10% Avg. dosing rate / CV (%) not tested not tested not tested 10.42/3 10.8/1 11.43/1 7.52/25 6.23/24 6.14/2
EP 10% % dos. rate >10.5% / <9.5% not tested not tested not tested 55/0 100/0 100/0 10/80 5/95 0/100
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Vaccination against Erysipelothrix rhusiopathiae in outdoor swine production
Fredrik Engström
Swedish Animal Health Service, Kristianstad, Sweden
Introduction
Joint disease is painful for the pig and causes 30 % of all con-
demnations at slaughter in Sweden. Most common reasons 
for joint disease are infectious arthritis and osteochondrosis. 
Erysipelothrix rhusiophatiae is one of the most common bacter-
ial agents involved in swine arthritis especially in outdoor pig 
production (1, 2). In comparison with conventional pig produc-
tion, outdoor pigs suff er 3 times more observations for arthritis 
at slaughter (3). Despite this there are relatively few producers of 
outdoor pigs that vaccinate their slaughter pigs against erysip-
elas. The aim of this study was to investigate the eff ect of vaccin-
ating outdoor slaughter pigs against erysipelas on the number 
of infectious arthritis seen at slaughter.
Materials and Methods
The trial was conducted as a prospective cohort study with vac-
cinated and control groups within 6 herds. Litters were split in 
half and groups were matched for gender and weight. In all, 903 
pigs were given 2 ml of Erysorb vet ® s.c. at 8 and 11 w of age 
and 905 unvaccinated pigs served as controls. Pigs were identi-
fi ed by ear tags and when slaughtered by tattooings. Those with 
acute arthritis were put to death and autopsied. Registrations for 
joint disease (infectious arthritis and osteochondrosis /arthrosis) 
were done at meat inspection. All data were collected from the 
abattoir and analysed by chi-square analysis.
Results
The pigs were slaughtered at two diff erent abattoirs, 1200 and 
598 pigs respectively. 10 pigs were put to death and autopsied 
due to acute arthritis. 
Data from abattoirs and autopsy combined: Out of 903 vaccin-
ated pigs, 33 (3.7 %) were registered for arthritis, and 27 pigs (3.0 
%) for osteochondrosis/arthrosis. 3 pigs were culled due to arth-
ritis. Of the 905 non vaccinated pigs, 57 (6.3 %) were registered 
for arthritis, and 17 pigs (1.9 %) for osteochondrosis/arthrosis. 10 
pigs were culled due to arthritis. Over all, the prevalence of arth-
ritis was signifi cantly lower among vaccinated pigs compared to 
among non-vaccinated pigs (Table 1).
In farms A and E the diff erences in number of observations for 
arthritis between groups were statistically signifi cant. Concern-
ing the other farms diff erences between groups were numerical 
or none.
Discussion
There is doubt if vaccination has any major eff ect against chronic 
erysipelas (4). The relatively high number (33) of observations 
made for arthritis in the vaccinated group may be explained by 
arthritis due to other pathogens or chronic erysipelas in spite of 
vaccination. This study shows that vaccination against erysipelas 
in outdoor swine production signifi cantly reduced the number 
of observations due to arthritis in pigs from some herds. Farmers 
that experience sudden onset of clinical joint disease and higher 
number of observations/culling due to arthritis at meat inspec-
tion are therefore advised to vaccinate against erysipelas.
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Investigation of a case of PCV2 vaccine dilution and theft
Gail L. Cunningham1 Mark Jacobson2 Ed Krol3
1. Boehringer Ingelheim Canada Ltd., Burlington, ON, Canada; 2. Warman Veterinary Services, Warman, SK, Canada; 
3. College of Pharmacy & Nutrition University of Saskatchewan , Saskatoon, SK, Canada
Introduction
The use of pig vaccines to control porcine circovirus type 2 
(PCV2) has proven to be both extremely eff ective in control-
ling disease and providing a return on investment to producers 
(1). This paper describes an unusual fi eld case where clinical 
signs related to PCV2 infection were observed in a herd where 
pigs had seemingly been properly vaccinated with Ingelvac 
CircoFLEX®. The investigation, triggered by the manager of the 
farm, revealed that the vaccine was not at fault. 
Case History
Two farm sites in Western Canada were involved in this case in-
vestigation: Farm 1, a 5200-sow, farrow-to-feeder (22 kg) system 
and Farm 2, a 1300-sow, farrow-to-fi nish operation. These farms 
were exporting 22 kg feeder hogs to the United Stated for fi nish-
ing. The following is an outline of the events of the case during 
2009.
May 13-The manager of Farm 1 called the herd veterinarian and 
described irregularities in their Ingelvac CircoFLEX® vaccine on 
the farm. For several weeks, a number of vials out of an unused 
case of vaccine stored in the barn had the stoppers punctured 
as if they had been put on an automatic syringe. However, the 
punctured vials were just as full as those that appeared un-
opened. The vaccine in the punctured vials was also lighter in 
color than bottles that had an intact stopper but the change was 
subtle. Dilution of the vaccine was considered at the time but 
discounted as a probability.
May 22 - The herd veterinarian received information from the 
producer that the US feeding operations were seeing pigs 
with PCV2-associated disease in the feeders from the fl ow of 
pigs from Farm 1. Mortality was up to 7.5% in some groups. 
Boehringer Ingelheim, the vaccine manufacturer was contacted 
at that time to evaluate the integrity of the potentially altered 
vaccine from Barn 1.
June 1 – 8000 doses of Ingelvac CircoFLEX® are discovered mis-
sing from Barn 1. All vaccine is locked up in the main offi  ce and 
not put in the barn after this theft.
June 13- The offi  ce in Barn 1 has a break-in but no materials were 
missing. No Ingelvac CircoFLEX® was in the barn at the time. The 
veterinarian was then made aware that 2400 doses of Ingelvac 
CircoFLEX® and 1200 doses of Ingelvac MycoFLEX® had also 
gone missing from Farm2.
July 22– One vial of potentially altered vaccine from Barn 1 and 
an unopened vial of the same serial number of Ingelvac Cir-
coFLEX® were submitted by Boehringer Ingelheim to the College 
of Pharmacy and Nutrition at the University of Saskatchewan for 
evaluation.
Materials and Methods
The vaccine samples were analyzed using an ultraviolet-visible 
(UV-Vis) spectrophotometric measurement (2). The measure-
ment technique is considered acceptable for determining the 
relative concentration of a protein. This technique allowed for 
the determination of relative protein concentrations of the ori-
ginal and the potentially altered sample but not for information 
on whether other contaminants had been introduced.
The assay utilizes absorbance readings at 260 nm and 280 nm in 
the following equation: [Protein mg/mL] = (1.55 x A280)-(0.76 x 
A260), where “A” is the absorbance reading.
The unopened sample of the same serial number as the poten-
tially altered vaccine was used to prepare 10 to 200 fold dilu-
tions using phosphate buff er. A calibration curve was prepared 
with the diluted samples of the original, (y=1.5522x+0.013, 
r2=0.9655), and the assay was determined to be linear in the 
indicated concentration range. The potentially altered sample 
was handled in an identical manner and analyzed by UV-Vis with 
the protein concentration determined using the above equa-
tion. The analysis was carried out in triplicate. 
Results and Discussion
The potentially altered sample fell below the level of the calibra-
tion curve and it was concluded this sample was at least 5 times 
less concentrated than the unopened original sample.
It is hypothesized that the tampered bottles had 80% of the 
vaccine removed and replaced with liquid to make them appear 
full. It is estimated that this went on for a minimum of 8 weeks 
with 500 doses per week removed if the dilution was consist-
ent. Between the diluted vaccine and that stolen from the barn, 
more than $22 000CDN of product was stolen. The outcome of 
the dilution will never be fully known as the production system 
ceased operations shortly after this investigation.
Past investigations of cases of vaccine failure have been at-
tributed to many causes including errors in shipping, storage, 
dosage and administration. Dilution may also now need to be 
considered when investigating perceived vaccine failure.
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Storage and detection of African Swine Fever Virus DNA in clinical material collected on FTA cards
Jovita Fernández-Pinero; Carmina Gallardo; Ana Robles; Gómez Concepción; Alejandro Soler; Marisa Arias
Community Reference Laboratory for African Swine Fever, CISA-INIA, Madrid, Spain
Introduction
African Swine Fever (ASF) is a highly contagious disease that 
remains endemic in large parts of Sub-Saharan Africa and in Sar-
dinia, producing great economic losses. In 2007, ASF emerged 
in the Caucasus for the fi rst time, and has since spread to several 
countries in the region, being a major epidemic threat to neigh-
bouring areas. As there is no vaccine available, rapid diagnosis of 
the disease is of outmost importance to contain its spread. Diag-
nosis is usually performed in equipped labs, although new tools 
for the on-site ASF virus (ASFV) detection are being developed. 
Key points of an accurate diagnosis include: appropriate collec-
tion and rapid convenient transport of suspicious samples to the 
lab, storage of samples in adequate conditions, and execution of 
suitable diagnostic techniques. 
FTA cards (Whatman) are made of special fi lter paper that con-
tains a chemically treated fi ber matrix. It is described that once 
a biological sample is applied to the FTA card, chemicals rapidly 
lyse cells, inactivate proteins and stabilize the DNA. This kind 
of cards are described for the simple collection and storage of 
clinical samples at room temperature, allowing long-term stabil-
ity and further detection of present DNA even for years (www.
whatman.com). 
Materials and Methods
Fresh EDTA-blood and serum samples collected at diff erent days 
from experimentally ASFV infected pigs were applied to FTA 
cards. They were allowed to completely dry and subsequently 
stored at room temperature. Small disks were punched from 
sample area and put in a PCR plate well. Optimisation of the fast 
procedure for viral DNA purifi cation on FTA cards was carried out 
to avoid cross contamination and to afterwards incorporate the 
PCR mix directly to the washed and dried disks. Conventional1 
and real-time PCR2,3 were run according to SOPs established in 
the lab (www.asf-referencelab.info). For a comparative study of 
the system convenience, aliquots of fresh collected blood and 
serum samples were also processed as usually to determine the 
presence of ASFV DNA following the reference PCR SOPs.
Results
Most of blood and serum samples collected on FTA cards, from 
diff erent ASFV experimental inoculations, were properly identi-
fi ed by both conventional and real-time PCR. Some higher Ct 
values were observed when compared real-time PCR results 
from fresh and FTA-card samples analysis. 
Analysing daily collected samples, positive results were obtained 
in fresh blood and serum samples from 1st and 3rd day post-
inoculation (dpi), respectively. Samples collected on FTA cards 
were ASFV positive from 2nd dpi in blood and 3rd dpi in serum 
after three years of room temperature storage.
Two ASFV positive EDTA-blood and serum samples were seri-
ally diluted in negative porcine blood and sera, respectively, 
and analysed for sensitivity studies, being detected as positive 
until 10-4 and 10-3, respectively. When FTA cards impregnated 
with these samples were analysed, 10-3 (real-time PCR) or 10-4 
(conventional PCR) was the detection limit for blood sample, 
whereas 10-1 was the lowest positive dilution for sera.
Discussion 
When clinical signs appear in ASFV infected animals and 
urgency for a rapid diagnosis is needed, the viraemia titre is suf-
fi ciently high to be detected by using FTA cards. The advantages 
of simple collection, transport and storage at room temperature, 
together with the non-infectious basis of samples collected 
on FTA cards, the easy treatment procedure and the potential 
combination with newly developed pen-side tests, show FTA 
cards as a possible convenient way to make real the ASFV DNA 
detection in basic/regional labs as a fi rst line tool for the rapid 
on site diagnosis.
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African swine fever: a high risk again
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Introduction
African swine fever (ASF) is one of the most important diseases 
of swine, due to the rapid and fatal spread causing great implica-
tions in international trade of swine products and animals (1).
Since the eradication of the disease from the Iberian Peninsula 
in 1995, ASF has been restricted to Sub-Saharan countries and 
Sardinia (Italy). However, in the last decade, the epidemiology 
and distribution of the disease changed with the increased num-
ber of outbreaks in African countries, and the new aff ected areas 
in the European continent (Russian Federation and Caucasian 
countries). 
The closeness of the European Union (EU) with these new af-
fected territories and the high probability of Russian Federation 
to become endemic due to the presence of infected wild boars 
and the huge volume of unauthorized trade and transport in the 
area (2), convert ASF as a potential risk for EU.
In order to prevent the potential entrance and the negative im-
pact of ASF within the EU borders, a risk assessment is necessary 
to detect the potential risk factors and to update the current 
surveillance and control programmes. This risk assessment will 
consider the following ways for the potential introduction of ASF 
in the EU: legal trade (live animals and products), illegal trade, 
wild animals, vectors and fomites. The study presented analyzes 
the risk of introduction of ASF in the EU by legal trade of live 
animals. 
Materials and Methods
The presented model is a stochastic model to quantify the risk of 
introduction of ASF in EU by the legal trade of live pigs, adapted 
from the model used by Martinez et al. (3) to quantify the risk of 
introduction of Classical Swine Fever in Spain. The probability of 
having an outbreak of ASF in the EU by legal trade of an infected 
animal was estimated per month, country of origin of pigs, and 
destination country. 
The input distributions were fi tted using @Risk v5.5 (Paladise 
Corp.), and the model was run 10.000 times using a Monte Carlo 
approach with @Risk software on Microsoft Excel®. The results 
obtained were mapped using the software ArcGIS 9.2 (ESRI®).
Results
The results of the model indicate that the mean risk of introduc-
tion of ASFV in the EU is 5.07x10-4, 95%IP (1.46x10-5, 1.85x10-3) 
which corresponds (if conditions remain constant), to approxi-
mately one outbreak in 1972 years. This risk is mainly concen-
trated in the countries of Slovenia, France and Belgium and in 
the month of May. The non-EU countries that mean a higher risk 
for the introduction of ASF in EU are Albania and Belarus.
Figure 1: Probability of introduction of ASFV in EU by legal trade of 
live animals.
Discussion 
Results from this study show that imports of live pigs do not 
represent a high risk for the introduction of ASFV in the EU. This 
result is consistent with previous epidemiological studies of 
the disease that identify contaminated garbage from airports 
and ports, as the main route for the introduction of ASFV in free 
areas (4). The other pathways of introduction such as illegal 
trade, wild boars, ticks and fomites have to be considered in 
further analyses in order to obtain a complete and useful risk 
assessment to prevent the introduction of ASF in the EU.
This work has been fi nanced by the European Community’s 
research project ASFRISK (FP7 KBBE-2007-1-3-05).
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Swine fever virus, a major health constraint to productivity of pig in Congo 
Tshibwabwa P. Nkambua
1. Laboratoire Veterinaire de Kinshasa, Kinshasa, Democratic Republic of the Congo; 2. Eau pour Tous, Kinshasa, Democratic Republic of the Congo
Porcine production represents an important component of the 
Congolese livestock production system, providing 12% of the 
value of livestock products consumed at the farm level and 
48% of the cash income generated. Democratic Republic of 
Congo is third in Africa and seventh in the world in terms of pig 
population. The country has, however, benefi ted little from this 
enormous resource owing to a multitude of problems, disease 
being the most 
important. Disease alone accounts for mortalities of 30% in 
Congolese pig population. One of the diseases appears to be 
the African swine fever virus (ASFV). The ASFV is the main DNA 
arbovirus and the sole member of the family Asfarviridae. The 
pathogenesis of ASFV is characterized by a low infectious dose, 
lifelong infection, effi  cient transmission to pigs , and low mortal-
ity until after the fi rst ovipositor. It causes a lethal, hemorrhagic 
disease in domestic pigs. Productivity losses attributable to the 
African swine fever virus are often substantial. A loss of US$ 
101.8 million is reported annually due to ASFV.
In a country confronted with challenges of an ever-rising human 
population and food shortage, such enormous losses caused by 
the swine fever virus are unacceptable. Therefore, swine fever 
virus control should receive special attention in poverty reduc-
tion strategies through improved productivity of livestock if 
the present and future challenges of food shortage are to be 
addressed.
This conference reviews extensive evidence demonstrating that 
swine fever virus is a major constraint to productivity of pig in 
Congo. It also discusses epidemiology and ecology of major 
swine fever virus in the country and suggests strategies for 
improved control in various agro-ecological zones and produc-
tion system.
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Analysis of antigenicity among various subgroups of classical swine fever virus
Chia y. Chang1 Chin C. Huang1 Yu J. Lin1 Ming C. Deng1 Fun I. Wang2
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Introduction
Classical swine fever virus (CSFV) is an enveloped positive-
stranded RNA virus in the genus Pestivirus of the Flaviviridae 
family. It is the causative agent of classical swine fever (CSF), a 
highly contagious disease in pigs. Major envelope glycoprotein 
E2 is exposed on the outer surface of the virion and induces neu-
tralizing antibodies during infection. Four antigenic domains, 
A to D, were identifi ed at the N-terminus of E2 and formed two 
independent structural units; one composes of domain B and 
C and the other contains the domain A and D (1). Although 
CSFVs consist of a unique serotype, they can be diff erentiated 
by diff erent patterns of reactivity with CSFV-specifi c monoclonal 
antibodies (mAbs) (2). The objective of this study was to further 
analyze the antigenic diff erences among various CSFV sub-
groups.
Materials and Methods
Three CSFV strains were used in this study, including a subgroup 
2.1 virus (TD/96/TWN), a subgroup 3.4 virus (94.4/IL/94/TWN), 
and a subgroup 1.1 vaccine strain (LPC/AHRI). Several truncated 
and site-mutated E2 proteins of three CSFV strains were ex-
pressed using baculovirus system and tested for their reactions 
to a panel of mAbs against diff erent epitopes and strains of 
CSFV. The reactivity was detected by indirect fl uorescent assay 
(IFA).
Results
The antigenicities of E2 glycoproteins of diff erent CSFV geno-
type subgroups can be distinguished by their variable reaction 
patterns between expressed B/C domains of E2 and a panel of 
mAbs. The mAbs against B/C domains were able to diff erentiate 
fi eld viruses TD/96/TWN and 94.4/IL/94/TWN from the vaccine 
virus LPC/AHRI. The smallest integral antigenic unit of the B/C 
domains was mapped to the N-terminal 90 residues between 
amino acids 690 and 779 (Table 1). Site-directed mutagenesis 
further showed that the residues 693C, 737C, 771L, 772L, 773F 
and D774 were critical for the reactivity of E2 protein with mAbs 
(Table 2). The D/A domains of various CSFVs were relatively con-
served and recognized by all mAbs against the A domain.
Discussion
Our study indicated that each of the four conserved residues, 
771L, 772L, 773F and D774 is important in maintaining the struc-
tural integrity of the B/C domains. Mutation of either 693C or 
737C abrogated the reaction with mAb, indicating that the disul-
fi de bond between 693C and 737C is essential for correct folding 
of E2 protein. Taken together, the reactivity of the epitope on 
B/C domains with mAbs depends on both the disulfi de bond 
and the motif 771LLFD774 located at 34 amino acids down-
stream of the disulfi de bond; the epitope is thus believed to be 
conformational and discontinuous.
Table1 
mAbs against 
E2
Domain Strain B/C domains B/C domains A domain
Group 1 Group 2
TD/96 — — —
B+C-80 94.4 — — —
LPC — — —
TD/96 + — —
B+C-90 94.4 + — —
LPC — + —
TD/96 + — —
B+C+D 94.4 + — —
LPC — + —
TD/96 — — +
D+A 94.4 — — +
LPC — — +
Table2
Residue no. Mutation mAbs against E2 mAbs against E2
B/C domains A domain
None None + +
693 Cys to Gly — +
737 Cys to Gly — +
770 Glu to Gly + +
771 Leu to Gly — +
772 Leu to Gly — +
773 Phe to Gly ± +
774 Asp to Gly ± +
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T cell and neutralizing antibody responses to synthetic dendrimeric peptides 
derived from E2 and NS2-3 proteins of classical swine fever virus
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Introduction
Classical swine fever virus (CSFV) is the causative agent of one of 
the most devastating porcine viral diseases; classical swine fever 
(CSF). There is a current need for effi  cient and safer marker vac-
cines to assist in the control of future CSF outbreaks (1). 
Multimerization is a nature-mimicking strategy of antigen pres-
entation. Indeed, pigs vaccinated with a dendrimeric peptide 
against foot-and-mouth disease virus, did not develop signifi -
cant clinical signs upon challenge and inhibited replication and 
excretion of virus (2).
Here, we describe the design and construction of three dendri-
meric peptide, that integrates B (three diff erent epitopes from E2 
protein) and T (from NS2-3 protein) cell epitopes, and their ca-
pability to induce T cellular and neutralizing hummoral immune 
responses against CSFV challenge in domestic pigs.
Material and methods
The dendrimeric peptides were synthezised by Stepwise Solid 
Phase Peptide Synthesis on a Rink Amide ChemMatrix resin 
using standard Fmoc chemistry, P1: 4B (aa 694-712)_1T (1446-
1460), P2: 4B (aa712-728)_1T and P3:4B (aa829-842)_1T. To 
evaluate the immune response induced by the dendrimeric 
peptides, four groups of six domestic pig were placed in four dif-
ferent section of the BSL3 animal house from CRESA (24 pigs in 
total). Three of these groups were inoculated twice, at day 0 and 
at day 21, by intramuscular injection (i.m.) with 1.4 mg of P1, P2 
and P3, respectively. Peptides were emulsifi ed with Montanide 
V206 adjuvant (Seppic). The fourth group of animals was used as 
the control (non-vaccinated pigs).
Ten days after the last immunization, all pigs were challenged 
with 105 DICT50 of CSFV (strain Margarita) (3). The clinical signs 
of disease were scored daily and pigs were bled weekly to fol-
low the specifi c neutralising antibody induction by neutralisa-
tion peroxidase-linked assay. Peptide specifi c antibodies were 
detected by indirect ELISA. E2 specifi c antibodies were detected 
using ELISA (IDEXX). Evaluation of the interferon gamma-produ-
cing cells was performed as described (4). The presence of CSFV 
RNA in serum was analyzed using the Q RT-PCR real time assay 
(5).
Results
Immunization of pigs with dendrimeric peptides induced 
dendrimer-specifi c antibodies in the three groups of immun-
ized pigs, mainly in those that received dendrimer P1. These 
dendrimer-specifi c antibodies not recognize the E2 CSFV protein 
in ELISA, and were not neutralizing. On the other hand, the three 
dendrimeric constructions were able to induce IFN gamma-pro-
ducing cells in immunized pigs after two doses, being the higher 
response also observed with dendrimer P1. After viral challenge, 
non vaccinated pigs developed fever and severe clinical signs of 
CSF from day 3 pi. Contrary, immunized groups showed lower 
score values, mainly in pigs immnunized with dendrimer P1 in 
two animals of this group. Induction of ELISA antibodies against 
E2 protein and neutralizing antibodies, as well as a decrease in 
viral charge at 13 dpi were observed. On the other hand, the 
highest values of IFN gamma-producing cells in these animals 
was observed at 13 dpi.
Discussion
Multimerization of peptides, such as that provided by dendri-
meric constructs, has been recognized as an eff ective tool for 
enhancing peptide immunogenicity (2). In this work, we report 
that inmunization of pigs with dendrimers P1, P2 and P3 induces 
non-neutralizing peptide-specifi c antibodies, as well as IFN 
gamma-producing cells, the latter probably due to the NS2-3 
T cell epitope included in their formulation). With the three 
dendrimers, a signifi cant lower score of CSF clinical signs after 
viral challenge was observed compared to that of naive animals. 
Interesetingly, two of the animals immunized with dendrimer 
P1 developed neutralizing antibodies and showed the high-
est values of IFN gamma- producing cells after CSFV challenge, 
suggesting that dendrimer P1 can induce effi  cient T cell and 
humoral responses that correlated with protection against CSFV.
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Classical Swine Fever vaccination: study of compatibility of mass 
vaccination in a sow herd and piglet vaccination
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Introduction:
Classical Swine Fever (CSF) is a contagious infectious disease 
aff ecting swine classifi ed in the A list of the OIE (International 
Offi  ce for Epizotics). Ceva Santé Animale has developed a live 
attenuated vaccine, COGLAPEST®, containing the Thiverval 
strain. This strain allows the vaccination of the sows during the 
gestation period 2 to 6 six weeks before farrow in order to enrich 
the colostrum with maternally derived antibodies (MDA). The 
timing for the piglet vaccination depends on the MDA level. The 
objective of this trial was to study whether, in mass vaccination 
conditions, a unique vaccination program can be defi ned for the 
piglets whenever the sows are vaccinated during the gestation.
Material and method
IIn a farrow to fi nish farm of 3000 sows in Thailand, three batches 
of 70 sows each have been constituted. The fi rst batch has been 
vaccinated with COGLAPEST® (2 ml intramuscularly) 100 days, 
the second batch 63 days, and the third batch 20 days before 
farrowing. 
Diff erent samples have been done: blood sample on the sows 
at farrowing and their fi ve fi rst born piglets at 14 days of age; 
colostrum after farrowing. The CSF antibody levels have been 
measured in all this samples by serumneutralization.
Results:
At farrowing, there was no signifi cant diff erence among the 
three groups of sows concerning their serum VN titers (table 1). 
A signifi cant diff erence existed between the groups vaccinated 
63 or 100 days before gestation for the colostrum as well as for 
the piglets serum VN titers. The group vaccinated 63 days before 
gestation had the highest level of VN antibodies both in the 
colostrum and in the piglets serum.
Concerning the sows of fi rst and second parity, there was no 
signifi cant diff erence among the groups.
Table 1
Group 20 
days
Group 63 
days
Group 100 
days p
Serology at 
farrowing Number animals 70 70 70
(log 2) 5.8a 5.9a 5.6a p>0.16
St dev. 1.46 1.59 1.41
Colostrum Number animals 66 66 67
(log 2) 9ab 9.4a 8.8b p<0.01
St dev. 1.42 1.27 1.19
Piglets Number animals 350 346 340
(log 2) 5.8ab 5.9a 5.7b p=0.04
St dev. 1.19 1.58 1.35
Correlation: (table 2). The three parameters studied - sow serol-
ogy, colostrums, piglet serology – are not strongly correlated. 
The best correlation is between the antibody level of the sows at 
farrowing and of the piglets.
Table 2
r= serology sow colostrum serology piglet
serology sow 1 0.47 0.64
colostrum 0.47 1 0.55
serology piglet 0.64 0.55 1
Discussion and conclusion:
The sow antibody level at farrowing is signifi cantly higher when 
the vaccination is done at 63 days before farrowing compared 
with a vaccination done at 100 days as well as at 20 days before 
farrowing.
Studies done on piglets show the highest level of antibodies 
usually appears 50 days after vaccination (M. Launais et al.). It 
could be hence interesting to compare the vaccination of sows 
at 63 days and at 42 days before farrowing to defi ne the best 
moment for the vaccination of piglets. The antibody level in 
piglets however is homogeneous enough in this trial to defi ne a 
unique vaccination program for the piglets at 4 and 7 weeks of 
age (fi gure 1).
This trial shows that the mass vaccination against CSF with 
COGLAPEST® is a possible practice that allows a common vac-
cination program for all the piglets.
Figure 1
References:
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strain in the presence and absence of colostral passive immunity 
– M. Launais, J.M. Aynaud, G. Corthier – Veterinary Microbiology, 3 
(1978) 31-43
Viral Diseases - Swine fever
227
Oral Presentations
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010
O.193
Isolation and initial characterisation of two unknown bocavirus-like viruses from swine in Northern Ireland
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Introduction
The genus Bocavirus consists of three members; bovine parvo-
virus, canine minute virus and human bocavirus. Recently a 
novel porcine boca-like virus was identifi ed in pigs in Sweden 
(PBo-likeV)1.
Recent research in our laboratories has isolated and identifi ed 
2 antigenically distinct novel bocavirus-like viruses in pigs (Sw-
BoV1 and SwBoV2) from farms in Northern Ireland with clinical 
postweaning multisystemic wasting syndrome. Purifi cation of 
the viruses followed by molecular cloning methods allowed 
partial sequencing of the two viruses. 
Materials and Methods
Tissue and faeces isolates were grown up in primary pig kidney. 
Isolates that exhibited a cytopathic eff ect (CPE) were screened 
for a range of common viruses using PCR. Several PCR nega-
tive isolates were sucrose purifi ed and put through a 1.16 g/
ml CsCl density gradient. An in-house antigen capture ELISA 
was developed and used to determine the virus-containing 
fractions. These were subject to electron microscopy (EM). 
DNA was isolated from the fractions using phenol/chloroform 
extraction and was electrophoresed on agarose. Bands were 
excised, purifi ed, restricted with HAE III and cloned into TOPO TA 
vector. After transformation into E. coli and overnight growth on 
agar, colonies were grown in broth and plasmids were purifi ed 
and sequenced with M13 primers. BLAST analysis was used to 
compare the sequences to GenBank. PCR primers were designed 
against the viral sequences and were used to produce amplicons 
spanning the clones. These were sequenced as before. Assem-
bled sequences were analysed in NCBI ORF fi nder for presence 
of putative open reading frames. Nucleic acid and translated pu-
tative protein sequences were BLAST analysed and compared to 
known bocavirus sequences using Clustal W. Phylogenetic trees 
were produced from SWBoV sequences and those of known 
bocavirus sequences from GenBank using Mega 4. An antiswine-
FITC conjugate was used to screen 370 swine sera using virus in-
fected coverslips. Monoclonal antibodies (MAbs) were produced 
for each of the SwBoVs.
Results
Two bocavirus-like viruses were isolated using virus culture. 
Small particles of about 20nm could be seen by EM. After 
molecular characterisation they were found to be related to the 
genus bocavirus and were designated SwBoV1 and SwBoV2. 
Currently 5082 bps (SwBoV1) and 4215 bps (SwBoV2) have been 
sequenced. ORF analysis predicted 3 putative ORFs (1 partial 
ORF for SwBoV2) with protein similarity corresponding to the 
NS1, NP1 and VP1/2 proteins of known bocaviruses. SwBoVs 1 
and 2 share 84% homology to each other and 39-49% homology 
with the other known bocaviruses, as determined by Clustal W 
analysis. Phylogeny of the partial DNA sequences grouped the 
SwBoVs with the other animal bocaviruses and that they were 
distinct from PBo-likeV (Fig. 1). Serological analysis showed that 
32 and 33 out of 370 sera tested were +ve for SwBoV1 and 2 
respectively. MAbs for the two SwBoVs do not cross-react.
Fig.1. Mega 4 bootstrapped neighbour joining phylogenetic tree of 
SWBoV partial sequences.
Discussion
Two-novel, antigenically distinct swine bocaviruses were 
isolated and partially characterised. These were related to the 
other known bocaviruses and distinct from another known 
boca-like virus, PBo-likeV from Sweden1. The prevalence, clinico-
pathological signifi cance, epidemiology and genetic diversity of 
SwBoV within the swine population are currently being investi-
gated.
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Genotype of Porcine Rubulavirus Isolates causing Blue Eye Disease
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Introduction
Blue Eye Disease (BED) was reported at the beginning of the 80’s 
in farms near La Piedad Michoacan, Mexico, characterized for af-
fecting pigs of diff erent ages, generating nervous signs and high 
mortality in piglets, corneal opacity and reproductive alterations 
in adult animals (Stephanoet al1981). The fi rst molecular char-
acterization was done by Moreno et al,(1986) and named LPMV, 
this is considered as the prototype of the genus Rubulavirus 
(Santos et al, 2004). The objective of our study was to determine 
and compare the genetic sequence of 13 fi eld isolates, but 
also to compare them with genetic information obtained from 
GenBank.
Materials and Methods
Viruses. 13 isolates obtained from 2000 to 2007 from 4 mexican 
states. The sequence for 7 viruses was gathered from GenBank 
(http://www.ncbi.nlm.nih.gov/) (see table 1).
Propagation. PK 15 cell monolayers were infected with each 
isolate and incubated at 37 C for viral replication.
Identifi cation by RT PCR. Amplifi cation and transformation of 
genetic material (RNA) was done by RT PCR in order to obtain 
cDNA. From cDNA, the amplifi ed fragment (HN) was visualized in 
agarose gel. Cortes et al(unpublished data).
Sequencing. The amplifi ed fragment was purifi ed and se-
quenced according to Cortes et al (unpublished data). The ob-
tained results were compared utilizing the Vector NTI Advance 
program (Invitrogen Corp 2007) in order to align and generate a 
dendogram.
Results of viral presence were confi rmed by Hemmaglutination 
Inhibition test (HI) and by RT PCR.
Table 1. Identifi cation of virus samples
Sample Id GenBank Sample Id GenBank
AVX1 Lab Isolate AVX11 Lab Isolate
AVX2 Lab Isolate AVX12 Lab Isolate
AVX3 Lab Isolate AVX13 Lab Isolate
AVX4 Lab Isolate LPHN1 EF413172
AVX5 Lab Isolate LPHN2 EF413173
AVX6 Lab Isolate LPHN3 EF413174
AVX7 Lab Isolate LPHN4 EF413175
AVX8 Lab Isolate LPHN5 EF413176
AVX9 Lab Isolate LPHN6 EF413177
AVX10 Lab Isolate LPHN7 EF413178
Results and discussion
Genetic homology is shown in table 2. The 13 fi eld samples 
showed a high homology when compared against LPMV 
(ranging from 97.9% to 100%) and from 98.0% to 100% for the 
7 sequences obtained from GenBank. The consensus of the 20 
sequenced data showed a high homology (98.94 to 100%) when 
compared against the original LPMV sequence (21st sequence 
shown in the dendogram). 
Table 2. Homology percentage among isolates and LPVM (GenBank)
Identifi cation Homology Identifi cation Homology
AVX1 99.7% AVX11 99.0%
AVX2 99.5% AVX12 99.0%
AVX3 99.4% AVX13 98.0%
AVX4 98.7% LPHN1 99.0%
AVX5 97.9% LPHN2 98.0%
AVX6 100% LPHN3 100%
AVX7 99.0% LPHN4 99.0%
AVX8 99.0% LPHN5 99.0%
AVX9 99.0% LPHN6 99.0%
AVX10 98.0% LPHN7 99.0%
 
We could also detect the formation of 6 groups (clusters) among 
the isolates (fi gure 1). It is important to mention that individual 
genetic diff erences found in some of the 20 analized sequences 
are equal or higher than 2%, when compared against the ori-
ginal sequence of LPMV, showing diff ering from previous report 
by Berg et al (1997), who reported diff erences of less than 2% 
comparing the same HN fragment.
Although we found diff erences up to 2.1%, these diff erences 
are not expressed as in vivo antigenic changes (Echeveste et al 
(2009), similar to what is usually found when compared to other 
Paramixoviridae virus such as Newcastle disease virus (Anónimo, 
ANECA 2000).
Figure 1. Dendogram .
LPMV is considered the original sequence and thus used as 
comparative.
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Comparison between Virus Neutralization (VN) test, ELISA test and Hemmaglutination 
Inhibition (HI) test for Blue Eye Disease (BED) diagnosis
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Introduction
Blue Eye Disease (BED) is caused by a Rubulavirus, characterized 
for producing nervous disorders in suckling pigs and reproduct-
ive problems in adult pigs. Serological diagnose is made through 
tests that quantify neutralizing or hemagglutinant antibodies 
(VN or HI tests), or based in a S/P relation (ELISA). The objective 
of this study was to compare the 3 diagnostic tests for BED.
Materials and Methods
Samples: Twenty three vaccinated animal sera, 17 negative sera 
from a BED free farm, along with 212 fi eld sera.
Virus Neutralization (VN) Test: It was conducted according to 
Burlesson et al (2002), the samples were diluted, added to mono-
layer cell cultures and incubated at 37.0 C.
Hemmaglutination Inhibition Test (HI): Samples were inacti-
vated and adsorbed in kaolin; bovine erythrocytes were applied 
according to the technique described by Ramirez et al (1996). 
Samples with a titer equal or higher than 1:16 were considered 
as positive.
Sera for ELISA were diluted 1:200 and tested according to the 
instruction of the kit developed by Aranda et al (unpublished 
data). Samples were considered positive when the s/p was equal 
or higher than 0.4.
All results were analyzed by descriptive statistics.
Results
Samples derived from vaccinated animals: On regards to sensi-
tivity, VN test detected 22 samples as positive with a sensitivity 
of 95.65%, while ELISA test detected less than 74%. On regards 
to specifi city, VN and HI resulted 100% negative with the nega-
tive samples while ELISA only 82.35%, as shown in Table 1.
Field samples: VN test detected the highest percentage of posi-
tivity (71.70%) compared to ELISA and HI tests, both with less 
than 47%, as shown in Table 2.
Table 1. Results of sensitivity on positive samples obtained from vac-
cinated animals and specifi city on negative samples obtained from a 
BED free farm.
Test (+) Sensitivity (-) Specifi city
VN 22/23 95.65% 17/17 100%
ELISA 17/23 73.91% 14/17 82.35%
HI 16/23 70.83% 17/17 100%
Table 2. Results of tests on fi eld sera samples.
Test Positive Negative
VN 152 (71.70%) 60 (28.30%)
ELISA 99 (46.70%) 113 (53.30%)
HI 85 (40.09%) 127 (59.91%)
Discussion:
In this study, VN showed the highest sensitivity in positive 
samples obtained from vaccinated animals, followed by ELISA 
and HI tests. This data agrees with previous reports. Hernandez 
et al (1992) obtained similar results with VN test from vaccinated 
animals in a disease free zone. Aranda et al (2006) found 77% 
sensitivity in vaccinated animals at 30 days post vaccination 
using the ELISA test. Hernandez et al (1998) found that the HI 
test detects lower antibody levels compared to VN using sera 
derived from BED challenged pigs. Gonzalez et al (2002) using 
fi eld sera samples were able to detect a higher number of posi-
tive samples using the ELISA test (58.18%) compared to HI test 
(55.49%). 
Conclusions.
All serologic tests are important and have diagnostic applica-
tions. It’s of capital importance to consider false positive or false 
negative results that every test can produce and this is why it’s 
necessary to evaluate and compare results of samples using 
diff erent tests. Not only sensitivity and specifi city must rule our 
selection criteria, also other parameters such as Positive and 
Negative Predictive Values and Total Effi  cacy of the test in order 
to choose the one that best suits our requirements.
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Introduction
There is no offi  cial eff ort to eradicate Aujeszky’s Disease (AD) in 
Asia but modifi ed live vaccines are successfully used to control 
clinical disease. In recent years, due to the increased pressure 
of PRDC and the emergence of PCV2, there is renewed interest 
in looking at the effi  cacy of AD vaccines under fi eld conditions 
in Asia. The objective of this trial was to evaluate the effi  cacy of 
three commercially available AD vaccines.
Material and Methods
The trial was conducted in a commercial farm in Taiwan. 300 
healthy piglets were randomly selected, ear tagged and as-
signed into 6 groups (see Table 1). Ten pigs were selected ran-
domly from each group and transferred to the holding facility 
for laboratory challenge. Three commercial vaccines were used 
in the study: Suvaxyn Aujeszky IN/IM; Suvaxyn Aujeszky NIA 783 
and Suvaxyn PRV gpI (3 groups, including with Suvaxyn O/W as 
diluent). The dose volume for all vaccines was 2 mLs. IN vaccina-
tion was done by the procedure described for administering the 
challenge virus.
All pigs were challenged with a local virulent strain (TNL) of AD 
at 28 days post-vaccination. Challenge dosage was 105 TCID50 
in a 2 mL volume. Each animal was challenged with 1 mL of 
inoculum per nostril administered over a 30 second period. Mor-
tality, clinical signs, serology and body weight were monitored. 
Table 1. Aujeszky’s disease Effi  cacy Trial Design
Group Vaccine Doses/Route Vacc..age 
1 Suvaxyn Aujeszky NIA3 783 1 (IM) 10 weeks
2 Suvaxyn Aujeszky IN/IM 1 (IM) 10 weeks
3 Suvaxyn PRV gpI- 1 (IM) 10 weeks
4 Suvaxyn PRV gpI - 1 (IM) 4 weeks
5 Suvaxyn PRV gpI-(+O/W diluent) 1 (IM) 10 weeks
6 Normal Saline 1 (IM) 10 weeks
Results and Discussion
Mortality and Clinical signs. Vaccinated groups survived the 
severe challenge (> 80%) while only one unvaccinated pig sur-
vived (Figure 1). Unvaccinated pigs developed high fever (>40o 
C) second day post challenge and showed respiratory (sneezing, 
dyspnoea, conjunctivitis) and nervous clinical signs (convulsion 
and paralysis). Post mortem fi ndings were consistent with AD. 
Only mild fever was detected in a few of the vaccinated pigs 
and subsided quickly . The growth rate of the vaccinated and 
challenged pigs was not severely aff ected by the challenge and 
was comparable to vaccinated and unvaccinated unchallenged 
pigs on the farm, which remained seronegative (gE antibody 
negative). In contrast, pigs challenged with virulent fi eld strain 
of ADV seroconverted (gE antibody positive) 2 to 3 weeks post-
challenge.
Figure 1. Survival curve of vaccinated and unvaccinated control pigs 
after virulent AD challenge
Serology All vaccinated groups showed a strong antibody 
response to AD 4 weeks post vaccination, with Suvaxyn Aujeszky 
NIA 783 stimulating the highest. Suvaxyn PRVgpI- in Suvaxyn 
O/W diluent induced a higher response than the same vaccine 
in water. 
Figure 2. SN titres following AD challenge
Despite the use of a very virulent challenge strain all 3 commer-
cial vaccines were eff ective in reducing or preventing clinical 
signs, mortality and other production losses associated with AD. 
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Introduction
Torque teno virus (TTV) is a non-enveloped virus with circular 
single-stranded DNA genome belonging to the fl oating genus 
Anellovirus. TTV was discovered in humans and later identifi ed 
in other species including pigs. 
In pigs, two diff erent genogroups have been described, geno-
group 1 (TTV1) and genogroup 2 (TTV2). Swine TTV infection 
is ubiquitous and species-specifi c (1). However, its potential 
role on disease occurrence is yet to be defi ned. TTV infection 
has been associated with pigs aff ected by postweaning multi-
systemic wasting syndrome (PMWS) (1,2) and linked with de-
velopment of a porcine dermatitis and nephropathy syndrome 
(PDNS)-like condition in pigs co-infected with TTV1 and porcine 
reproductive and respiratory syndrome virus (PRRSV) (3). Faecal-
oral transmission route is considered the most common route of 
TTV dissemination but vertical transmission route may play an 
important role (4). 
In the present work, a prospective study was designed to asses 
the prevalence of both swine TTVs in cases of abortions. Healthy 
foetuses collected from pregnant sows at slaughterhouse were 
used as age-matched controls. 
Material and Methods
A total of 98 abortions cases from 22 diff erent Spanish farms 
and 55 foetuses collected from pregnant sows (from 14 farms) 
at slaughterhouse were studied. Foetal age was estimated and 
foetuses collected were classifi ed according fi rst (A) or second 
half of gestation (B). 
All foetuses were necropsied and relevant tissues were collected, 
pooled and submitted to DNA extraction. In order to evaluate 
the presence of TTV1 and TTV2, samples were analyzed by a 
specifi c polymerase chain reaction (PCR). Contingency tables 
were used to compare prevalence of TTV1 and TTV2 in diff er-
ent samples and association between gestation stage and TTV 
infection. 
Results
Results on TTV prevalence are summarized in table 1. There were 
no statistically signifi cant diff erences when comparing preva-
lence of swine TTVs by type of sample or by gestation stage.
Table 1. Prevalence of swine TTV1 and TTV2 in foetuses coming from 
abortions and from slaughtered sows with no reproductive problems. 
Foetuses were classifi ed as from fi rst (A) and second half (B) of gestation.
Gestation TTV1 TTV2 Co-infected
Abortion cases (n=98) A (n=10) 2 (20%) 2 (20%) 0 (0%)
B (n=88) 15 (17.0%) 27 (30.7%) 5 (5.7%)
Foetuses (n=55) A (n=22) 2 (9.0%) 8 (36.4%) 0 (0%)
B (n=33) 4 (12.0%) 14 (42.4%) 3 (9.0%)
Discussion
The present work represents the fi rst description of swine TTV 
infection in pig foetuses at diff erent stages of gestation. Results 
obtained confi rm that vertical transmission is an important 
route of TTVs dissemination in swine. In addition, data ob-
tained suggest that swine TTV infection is commonly present in 
aborted foetuses and foetuses collected from slaughtered sows. 
However, TTVs should not apparently be considered as infec-
tious agents responsible for abortion occurrence. 
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Introduction
Torque teno virus (TTV) is a small, non-enveloped virus with a 
circular single-stranded DNA genome, belonging to the family 
Anelloviridae, genus Iotatorquevirus and widely distributed in 
diff erent animal species and humans. In swine, two genetically 
distinct genogroups have been identifi ed, Torque teno sus virus 
1 (TTV1) and 2 (TTV2). No clear-cut pathogenic role of TTVs has 
been demonstrated so far. However, it has been shown that 
TTV2 prevalence is higher in postweaning multisystemic wast-
ing syndrome (PMWS) aff ected pigs, and TTV1 has been linked 
to PMWS and a porcine dermatitis and nephropathy syndrome 
(PDNS)-like condition (1,2,3). Nevertheless, the TTV viral load in 
diseased animals has not been investigated. Therefore, the aim 
of the present study was to quantify TTV1 and TTV2 viral load 
in serum of PMWS-aff ected and healthy animals using a newly 
developed quantitative PCR (qPCR) method.
Materials and methods
Serum samples of sixty animals ranging from 11 to 21 weeks of 
age included in a previous study on Porcine circovirus type 2 
(PCV2) (5) were analyzed by TTV1 and TTV2 qPCRs. From them, 
29 pigs were diagnosed as PMWS by histopathology and PCV2 
in situ hybridization (ISH) (4), and 31 were healthy, age-matched 
animals.
A qPCR assay was developed using TTV1 and TTV2 D-Lux prim-
ers technology (Invitrogen). Standard curves were generated 
using ten-fold serial dilution (108 - 100 genomic equivalents) 
of purifi ed TTV1 and TTV2 whole genome plasmids. Serum 
samples as well as standard dilutions were run in triplicates. The 
average log10 copies of TTV1, TTV2 and PCV2 per ml of serum 
were compared globally, and between healthy and PMWS pigs, 
using Mann-Whitney’s U and Kluskal-Wallis test. Signifi cance was 
set at P<0.05. PCV2 viral load was obtained from data generated 
in the abovementioned study (5). 
Results
PCV2 log10 copies/ml from the previous published work (5) as 
well as TTV1 and TTV2 log10 DNA copies/ml of serum in PMWS 
and healthy pigs are represented in fi gure 1. TTV2 DNA was 
detected and quantifi ed in all the PMWS aff ected animals but 
not in all healthy animals. TTV1 was detected in most but not all 
the animals of both groups. In general, TTV1 viral loads in serum 
were similar in healthy and PMWS animals, with values com-
parables to TTV2 viral loads in healthy animals. On the contrary, 
PMWS animals had signifi cantly higher (p<0.05) TTV2 viral load 
than healthy animals. PCV2 viral load in healthy animals was sig-
nifi cantly lower than TTV2 loads. No signifi cant diff erences were 
found between PCV2 and TTV2 loads in PMWS animals. 
Discussion
Results from this study showed that TTV2 and TTV1 were highly 
prevalent among studied pigs. Moreover, the fact that TTV2 
loads in serum were higher in PMWS aff ected than in healthy 
pigs would support the previously suggested association 
between TTV2 and PMWS (1). On the contrary, this relation was 
not observed for TTV1. However, results obtained in this study 
encourage further studies on the role of TTVs in pig diseases or 
disease triggering. 
Figure 1: TTV1 and TTV2 log10 copies/ml of serum in PMWS and 
healthy pigs. PCV2 viral loads of studied animals are from Grau-Roma 
et al.
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Introduction
Proliferative enteropathy (PE) is an enteric disease of pigs caused 
by the obligate intracellular bacterium Lawsonia intracellularis.1 
Results of economic modelling conducted using the AUSPIG 
decision support system in 1996 estimated that PE cost pork 
producers up to $7.00 per pig, with most of the cost attributed 
to using antibiotics in the pig diets to treat and control PE..2,3 
This model did not take into account the economic impact of 
subclinical PE in a herd, and the potential for reduced antibiotic 
costs through the use of vaccine (Enterisol® Ileitis, Boehringer 
Ingelheim) to aid in the control of disease. This paper reports on 
recent simulations on the economic impact of L intracellularis 
infection. 
Materials and Methods
Growth and carcass data were from an experiment where 36 
entire male pigs (18 challenged, 18 controls) were challenged 
at 63 days of age with 5.85 x 109 L intracellularis bacteria. Feed 
intake was measured on 2 consecutive days every week from 2 
weeks before inoculation until 6 weeks after. Pigs were weighed 
each week from the day they arrived until slaughter at 106 days 
of age. Carcass composition data, including P2 backfat were 
sourced from CT scans conducted on pigs at 52, 85 and 106 days 
of age. Data on PE treatment and control costs were from 5 L. 
intracellularis-infected farms of varying health status. The AUS-
PIG simulations were based on a 1000-sow farm with commer-
cial Large White X Landrace genotype. Three infection categories 
(controls (non-challenged), sub-clinically and clinically-aff ected) 
were modelled. It was assumed that pigs were sold at a constant 
liveweight (approximately 104 kg). The impact of infection at the 
herd level was modelled by altering the proportion of control, 
subclinical and clinical pigs in three simulations and including 
50% females and 50% castrates. These proportions were based 
on results of a recent serological survey, where an average of 
84.2% of pigs within herds in Australia had antibodies to L. 
intracellularis.4 The “subclinical” simulation included 20% control 
and 80% subclinical pigs. The “clinical” simulation included 10% 
control, 74% subclinical, 16% clinical and an increase in grower 
pig mortality of 0.5%. 
Results
The growth performance of pigs for the three infection herd 
categories is presented in Table 1. Profi t (net revenue) in the 
control, non-infected herd was modelled at $25.31AUD per 
pig. Subclinical L. intracellularis infection reduced net revenue 
by $8.33AUD, whilst clinical infection reduced net revenue by 
$13.00AUD, relative to the non-infected “herd”. The cost of con-
trolling PE was $2.70AUD per pig. 
Table 1: Results from the AUSPIG growth simulation for control (C), 
subclinical (SI) and clinical (CI) pigs infected with L. intracellularis. 
Castrates Castrates Castrates Females Females Females
C SI CI C SI CI
Slaughter age (d) 147 147 192 147 147 189
Livewt. (kg) 104.3 102.6 104.4 104.6 102.9 104
P2 (mm) 12.1 12.2 14 12.6 12.8 14
FCR 2.37 2.44 2.95 2.4 2.47 2.92
Discussion
We used the AUSPIG decision support system to estimate the 
economic impact of L. intracellularis infection. This is similar 
to a previous estimate of subclinical PE costs.5 The impact of 
infection on growth and P2 backfat greatly out-weighed the PE 
control costs. Costs will vary among herds depending on the 
proportion of pigs infected, disease severity, treatment/control 
costs and eff ects on farm fl ow. Research is currently underway 
to refi ne the results of these simulations, including the growth 
response of pigs to vaccination/medication. 
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Introduction
Pigs clinically aff ected with proliferative enteropathy (PE) suff er 
diarrhoea, reduced growth and poor feed effi  ciency, which can 
cost Australian producers as much as A$7 per pig1. These costs 
do not include changes to body composition such as muscle 
growth. The impact of sub-clinical PE is diffi  cult to estimate be-
cause many producers are unaware of the problem. In this study 
we examined the impact of sub-clinical PE in real time on body 
composition, muscle growth and P2 backfat depth. 
Materials and Methods
Thirty six male hybrid weaner pigs (Large White x Landrace) 
were randomly allocated at 13.8 ± 1.0kg into 2 treatments: pigs 
infected with L.intracellularis, and a cohort of uninfected pigs. 
Pigs were housed in individual pens, with strict quarantine 
between treatments (separate rooms). Serology and faecal PCR 
monitoring of pigs prior to challenge indicated that all pigs 
were naïve to L.intracellularis. At 9 weeks of age, one group of 18 
pigs was orally challenged with 5.9 x 109 viable L.intracellularis 
extracted from a PE-aff ected mucosa, and the control group 
was inoculated with phosphate buff ered saline. The consistency 
of pig’s faeces was scored daily as either normal or diarrhoeic. 
Blood collected at 0, 28 and 38 days post inoculation (pi) was 
tested for L.intracellularis- specifi c IgG using an indirect fl uores-
cent antibody test (IFAT). Faeces collected twice per week from 
0 to 35 days pi was tested for L.intracellularis DNA by a conven-
tional PCR. The body composition of pigs was determined at 
14 days pre-inoculation and 21 and 42 days pi, using a Picker 
spiral CT scanner (Model PQ2000). Pigs were anaesthetized and 
cross-sectional images of the whole pig in 10mm sections (re-
constructed in 3 dimensions) were analysed to calculate tissue 
volumes of bone, muscle, fat, skin and water using described 
CT densities2. Muscle growth was defi ned as the diff erence 
in muscle volume divided by the number of days between 
CT scans. Tissue volumes were converted into a mass, using 
described tissue densities and calculated as a proportion of the 
total mass of the pig2. The P2 backfat was measured from the 42 
days pi CT image2. 
Results
L.intracellularis infection was demonstrated by faecal PCR and 
IFAT between 14 and 42 days pi in all pigs challenged with 
L.intracellularis. The majority of infected pigs (>80%) were sub-
clinically aff ected, but pigs inoculated with L.intracellularis had 
a signifi cantly higher probability of diarrhoea than control pigs 
between day 22 and 26 pi. L.intracellularis infection did not sig-
nifi cantly alter the mean tissue weights or proportion of tissue 
types. However, L.intracellularis infection did signifi cantly reduce 
the muscle growth in the late infection period. 
The totals of CT tissue weights were accurate compared with 
the actual body weights of the pigs (±1%). Muscle growth was 
highly correlated with feed intake and weight gains of pigs 
(r>0.80) and with the absence of diarrhoea (r>0.72) throughout 
the trial. L.intracellularis infection did not signifi cantly alter the 
P2 backfat depth.
Discussion 
While sub-clinical PE did not aff ect body composition or P2 
backfat depth, it did reduce muscle growth in experiment-
ally challenged pigs. Animal genetics, gender, diet and pig 
weight all play a signifi cant role in muscle growth. However, 
L.intracellularis-specifi c changes to the digestive and absorptive 
capacity of the intestine may also explain changes in muscle 
growth. Reduced amino acid absorption3 and reduced digestive 
enzyme activity4 have been described in pigs with PE. 
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Introduction
L. intracellularis is an obligate intracellular bacterium and causa-
tive agent of porcine proliferative enteropathy (PPE) (1). PE has 
been experimentally reproduced in pigs and hamsters, and 
similar lesions have been observed in both species (2). So far, 
the physiopathological mechanisms responsible for diarrhea in 
PE are unclear (3). The aim of this study was to experimentally 
reproduce PE in hamsters (M. auratus), evaluate the intestinal 
absorption and histomorphometric changes in infected animals.
Materials and Methods
Sixty Syrian hamsters were divided into two groups, inoculated 
(n=30) and control (n=30). The inoculum was prepared from 
segments of porcine intestines with PE lesions (1). Each hamster 
was intragastrically inoculated with 1.0 mL of inoculum using 
a gavage. On day 26 p.i., all animals were submitted to surgical 
procedures for evaluation of intestinal absorption. Two cannu-
lae were introduced in the small intestine and Tyrode solution 
containing twice the concentration of glucose, Na+, K+ and Cl 
was infused. Intestinal absorption was calculated by the diff er-
ence among infl ux and effl  ux content for each 10-min interval. 
Gross and histological lesions were evaluated and one section 
was stained by IHC (1). The amount of positive antigen labeled in 
the sections was graded according to Table 1. Additionally, intact 
and well oriented intestinal villi were selected for morphometric 
evaluation. 
Results
IHC results are summarized in Table 1. Five control and two in-
oculated hamsters died during the surgical procedure. Further-
more, three animals had no demonstrated positive antigen 
labeling and were excluded from the statistical analysis. The 
relevant results of intestinal absorption are demonstrated in 
Figure 1. There was no diff erence of villous height or crypt depth 
between groups. However, the infected group demonstrated 
positive correlation (p<0.02) between the intensity of positive 
antigen label by IHC stain and crypt depth. 
Table 1: Intensity of positive antigen label of L. intracellularis, in ham-
sters experimentally infected.
Group Grade 0* 1 2 3 4 Total +
Control 30 0 0 0 0 0
Infected 3 10 13 2 1 27
Grade 0= no positive antigen labeled; (1) = up to 25% of intestinal mucosa labeled; (2) = 25 
to 50% of intestinal mucosa; (3) = 50 to 75% of intestinal mucosa and (4) = more than 75% of 
intestinal mucosa.
Fig. 1. Intestinal absorption. Comparison among: infected and control 
group (* p<0.05); control and IHC label grade 1+ (a p<0.05); control and 
IHC label grade 2+ (b p<0.05) and IHC label 1+ and 2+ (c p<0.05). 
Discussion
This study described experimental reproduction of PE in 
hamsters which had signifi cant reduction of intestinal absorp-
tion of glucose and electrolytes (K+ and Cl-). We believe these 
fi ndings are relevant for the understanding of L. intracellularis 
pathogenesis. The poor intestinal absorption seems to be the 
main explanation for the lower performance of hamsters and 
pigs naturally aff ected with subclinical or clinical PE. Therefore, 
malabsorptive diarrhea appears to be the main process involved 
in physiopathology of PE diarrhea. 
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Introduction
Lawsonia intracellularis is an obligate intracellular bacterium and 
causative agent of porcine proliferative enteropathy (PPE). The 
isolation and growth of L. intracellularis in vitro require dividing 
eukaryotic cells in strict environmental conditions. The standard 
protocol for growth of this bacterium in monolayers has been 
described using a specifi c incubator (Tri-gas) with 83.2% nitro-
gen, 8.8% carbon dioxide and 8% oxygen and a temperature of 
37oC (2). This requirement has limited the maintenance of this 
microorganism in vitro to only a few research institutes. The aim 
of this study was to describe an alternative protocol for cultiva-
tion of L. intracellularis in cell monolayers providing necessary 
growth conditions without Tri-gas incubators. 
Materials and Methods
The L. intracellularis isolate PHE/MN1-00 previously isolated 
from a pig with the hemorrhagic form of PPE was used for 
evaluating growth under two diff erent environmental condi-
tions. The strain was grown in murine fi broblast-like McCoy cells, 
maintained in a cell culture system and stored at -72°C until use, 
as described previously (1). The frozen bacteria were thawed and 
grown in cell culture for three continuous passages in specifi c 
conditions, which are described below, in order to allow the bac-
teria to recover from the frozen stage. The infection was mon-
itored during every passage using immunoperoxidase staining 
with polyclonal antibody specifi c for L. intracellularis (1). After 
three passages, two 16-well tissue culture plates with one-day-
old McCoy cells were infected with bacterial suspensions con-
taining approximately 3.4 x 107 L. intracellularis organisms/ml. 
The method for quantifi cation was performed by direct count as 
previously described (1). One plate was placed in an anaerobic 
jar and the air was evacuated by vacuum pump to 500 mm Hg 
and replaced with pure hydrogen. The plate was then incubated 
at 37°C in a Tri-gas incubator for fi ve days (2). The other plate 
was placed in a plastic bag (Original Space Bag®) and hermetic-
ally closed. The air inside the bag was then removed by vacuum 
pump to 100 mm Hg. Afterward, the bag was infl ated through a 
cuff  connected to a gas cylinder containing 10% hydrogen, 10% 
carbon dioxide, and 80% nitrogen. Finally, the bag was incu-
bated in a conventional 37oC incubator for fi ve days. Every 24 
hours, the gas inside the bag was replaced. Carbon dioxide and 
oxygen percentages was monitored in both protocols using CO2 
and O2 indicators (FYRITE® Gas Analyzer) at the initiation of incu-
bation and every 24 hours during the fi ve days of incubation.
Results
After fi ve days, the McCoy cell monolayers in both plates were 
heavily infected by L. intracellularis demonstrating the success 
of the alternative incubation protocol. The infection rate was 
quantifi ed by direct counting of the number of heavily infected 
cells after immunoperoxidase staining (1,3). Four wells were 
counted for each incubation protocol. The average rate of infec-
tion of the monolayer was 78.9% (+1.3) in the Tri-gas incubator 
and 76.7% (+2.6%) in the bag incubation. The CO2 level meas-
ured between 11-12% in the Tri-gas incubator and 7.0-7.5% in 
the bag. The O2 level was 9.0% in the Tri-gas incubator in all 
measurements and ranged from 5.0 to 5.5% in the bag. 
Discussion
Incubation in the bag provided environmental conditions for 
L. intracellularis to infect and multiply in the cells, similar to 
the published protocol (2). Based on these preliminary results, 
we believe this approach can be used for static cultivation of 
bacteria without requiring a Tri-gas incubator. This fact cre-
ates a option for in vitro studies and gives an opportunity to 
engage more research institutes in this area. Other isolates of 
L. intracellularis have been cultivated with this approach with 
the results being analyzed. In addition, studies using various 
conditions for growth and incubation in the bags are being 
conducted. 
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Introduction
Diarrhea is an economically important disease, in grower-
fi nishers. Pigs with diarrhea may have impaired growth and feed 
conversion. The objective of this study was to estimate the eff ect 
of diarrhea on the average daily weight gain in grower-fi nisher 
pigs in 5 herds with diarrhea.
Materials and Methods
A prospective cohort study was carried out in fi ve grower-
fi nisher herds with a history of diarrhea and seroconversion to 
Lawsonia intracellularis and PCV2 virus in the pigs. The herds 
were selected by convenience. In each herd 60 pigs from four 
pens were individually ear tagged. The pigs were weighed at the 
beginning of the study and at the end of the six-week observa-
tion period. A total of 298 pigs, all approximately 12 weeks old, 
were included in the study during the fi rst week in the grower-
fi nisher barn. No routine fl ock medication against diarrhea was 
used in the observation period. Faecal samples from each pig 
were collected in week 1, 3, 5 and 7 during the observation per-
iod and scored visually. A faecal score was assessed on 0-3 scale 
(normal=3, loose=2, fl uid=1, fl uid+discoloration=0). Diarrhea 
was defi ned as faecal score ≤ 1. 
The impact of diarrhea on average daily weight gain was esti-
mated in a linear regression model with average daily weight 
gain (ADWG) as a dependent variable. Diarrhea at least once, 
diarrhea more than once, and start weight were included as 
systematic eff ects. The herd and pen were included as random 
eff ects. The analysis was carried out using the SAS©-system, ver-
sion 9.13, using Proc Mixed.
Results
The proportion of pigs with diarrhea in the observation period 
ranged from 3-28 % in the fi ve herds. A total of 9.7 % of the pigs 
had diarrhea on one or more occasions during the six-week 
observation period. The proportion of pigs having diarrhea 
on one occasion was 7.4 % while 2 3 % had diarrhea on two or 
more occasions. The variation in prevalence during the observa-
tion period is shown in Figure 1. A total of 26 pigs had missing 
observations. The statistical analysis including 272 pigs showed 
a signifi cant interaction between start weight and diarrhea on 
one or more occasions. (P<0.05). This means that the eff ect of 
diarrhea increases as the start weight increases. There was an 
additional eff ect of diarrhea more than once (p<0,0001). The 
start weight (P<0.0001), and squared start weight (P<0.0001) 
had signifi cant eff ects on the average daily gain. The results are 
shown in Figure 2. 
The graph in Figure 2 indicates that the average eff ect of having 
diarrhea (fecal score ≤ 1) on one or more occasions was a 118 g/
day reduction of growth rate in the observation period for a pig 
with a start weight of 35 kg. Pigs in the same weight category 
with a fecal score ≤ 1 on two or more occasions had an average 
growth rate reduction of 477 g/day in the observation period.
Figure 1. Prevalence of diarrhea (faecal scores ≤ 1.) in fi ve grower-
fi nisher herds
Figure 2. Eff ects of start weight and diarrhea on the estimated aver-
age daily weight gain
Discussion
It should be kept in mind that this study was based on a small 
number of herds and that most of the pigs with diarrhea origin-
ated from one herd only (fi g 1). 
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Antimicrobial susceptibility of Belgian Brachyspira hyodysenteriae isolates
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Introduction
Swine dysentery, a muco-hemorraghic colitis caused by Brachy-
spira hyodysenteriae, is responsible for substantial economic 
losses in aff ected herds. The prevalence of B. hyodysenteriae in 
Belgium has increased the last ten years1. Until 2004, isolates 
were characterized as susceptible to pleuromutilins. Since the 
appearance of pleuromutilin-resistant strains elimination at-
tempts at farm level have become compromised. Susceptibility 
testing prior to the start of treatment protocols is now inevit-
able. The present study summarizes the antimicrobial suscept-
ibility of B. hyodysenteriae isolates during 2008 and 2009.
Materials and methods
Sixty and 58 isolates of B. hyodysenteriae were collected for sus-
ceptibility testing in 2008 and 2009 respectively. Isolates were 
recovered from 49 and 52 diff erent farms in 2008 and 2009. The 
strains were isolated on modifi ed Trypticase Soy Agar (TSJ-BJ) 
with 5% sheep blood from feces or colon contents submitted for 
diagnostic purposes1,2. Susceptibility was determined using the 
agar dilution technique against valnemulin, tiamulin, tylvalosin, 
lincomycin and doxycycline as described earlier1,2. The tested 
concentrations (μg/ml) ranged in two-fold dilutions from 0.015 
to 2 for valnemulin, 0.03 to 16 for tiamulin, 0.25 to 32 for tyl-
valosin, 2 to 128 for lincomycin and 0.062 to 16 for doxycycline.
Results
Table 1 outlines the results of 101 isolates from diff erent farms. 
Similar results were obtained in 2008 and 2009. A high propor-
tion of isolates with decreased susceptibility was observed for 
pleuromutilins: 40-45% had MIC for valnemulin >= 2 μg/ml; 
45 – 50% had MIC >=1 for tiamulin. Results for both molecules 
were similar: a high MIC for tiamulin coincided with a high MIC 
for valnemulin. Forty isolates (40%) had decreased susceptibility 
for both pleuromutilins. Only three isolates had a lower MIC for 
tiamulin compared to valnemulin, once with more than a two-
fold dilution. 
For tylvalosin, MIC50 was 32 μg/ml. Two-third of the isolates was 
categorized as susceptible for this molecule (<=32 μg/ml). In the 
case of lincomycin, 15 to 18% of the isolates were considered 
susceptible3. Twenty-eight isolates showed decreased suscept-
ibility for both tylvalosin and lincomycin. Seventeen isolates, 
resistant to both pleuromutilins, had an MIC for tylvalosin of 
<=32 μg/ml. All four antimicrobials were considered ineff ective 
in 21 isolates. Considering doxycyline, 61% had an MIC<= 4μg/
ml and were considered susceptible.
For the 17 farms from which two or more isolates were tested, 
susceptibility patterns of the isolates were within one dilution 
for all antimicrobials.
Table 1: MIC50, MIC90 (μg/ml) and susceptibility of B. hyodysenteriae 
isolates for valnemulin (V), tiamulin (T), tylvalosin (A), lincomycin (L) 
and doxycycline (D)
2008 V T A L
n 49 49 49 49
MIC50 2 4 32 64
MIC90 >2 >4 >32 >128
susceptible n 27 27 33 9
% 55 55 67 18
reduced susceptibility n 22 22 16 40
% 45 45 33 82
2009 V T A L D
n 52 52 52 52 33
MIC50 0.25 0.5 32 64 4
MIC90 >2 >4 >32 >128 8
susceptible n 31 26 36 8 20
% 60 50 69 15 61
reduced susceptibility n 21 26 16 44 13
% 40 50 31 85 39
Discussion
The present data show the widespread distribution of decreased 
susceptibility to pleuromutilins in Belgian B. hyodysenteriae 
isolates. The decrease in susceptibility to both valnemulin and 
tiamulin refl ects the problems on farm when treating animals 
infected with these strains (P. Vyt, personal observations). On 
those farms a complete susceptibility panel to all antibiotics may 
reveal other treatment options. Although limited sensitivity data 
was available for tylvalosin, recent B. hyodysenteriae isolates 
from Spain4 had lower MIC values than in Belgium. Doxycycline, 
based on a limited number of isolates, could be used in aff ected 
farms. These data demonstrate that in nearly half the cases with 
pleuromutilin resistance tylvalosin could be an alternative treat-
ment. 
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Comparison of three commercial vaccines for the control of Salmonella spp in pigs
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Introduction 
Salmonellosis is one of the most common infections in swine 
production, leading to important economic loss due to mortal-
ity, morbidity and the cost of non-specifi c treatment. Attenu-
ated vaccines have been the main immunological basis for the 
control of these infectious diseases. In general, live attenuated 
vaccines induce a superior immunological response than the 
inactivated ones. Vaccination signifi cantly reduces clinical signs, 
and the colonization and excretion of Salmonella sp. The avail-
able bacterin vaccines stimulate a strong humoral response 
providing protection against the septicemic phase1,2. The aim 
of this study was to investigate the eff ect of three diff erent 
products on the shedding of Salmonella spp in feces, and on 
standard production parameters.
Materials and Methods 
The study was carried out on a farm in Mexico operating a 
continous production system. From weekly batches, pigs were 
randomly selected, individually identifi ed and assigned to one 
of four treatment groups, each of 20 piglets: three vaccinated 
with diff erent commercial vaccines, and an unvaccinated control 
group. Group 1: unvaccinated controls; Group 2: a modifi ed 
vaccinea from S. cholerae suis strain SC-54, for intranasal use in 
a single dose at one day old; Group 3: modifi ed vaccineb against 
S. cholerae suis, for oral administration in a single dose at three 
weeks of age; Group 4: a bacterinc vaccine against S. cholerae 
suis and S.typhimurium, for parenteral administration in two 
doses at 3 and 5 weeks of age. 
Rectal swabs were taken 5, 10 and 21 days post-vaccination 
for bacteriological analysis. Serum samples were collected at 
70, 109 and 154 days of age for the detection of S. cholerae 
suis antibodies by ELISA (HerdCheck™, Idexx, EE.UU). Pigs were 
weighed at birth, 21, 70, and 105 days old and when sold. Aver-
age daily weight gain (ADG) and feed effi  ciency were calculated 
for a series of growing periods. Data were evaluated by variance 
analysis with a Tuckey test using SPSS 15.0 statistics software. 
Results 
Graph 1 shows S.cholerae suis fecal shedding after vaccination. 
Chart 1 shows the production parameters (ADG by period, and feed 
effi  ciency), morbidity (signs of digestive disturbance) and mortality.
aBoheringer-IngelheimVetmedica,bIntervet-Schering-Plough 
c Novartis Animal Health Inc.
Average daily gain (ADG) Group 1 Group 2 Group 3 Group 4
Lactation 1-21 days age (kg.) 0.193 0.178 0.222 0.189
Weaning 21- 74 days age (kg.) 0.705 0.649 0.634 0.622
Growing 74 - 145 days age (kg.) 0.396 0.388 0.385 0.355
From 21 to 145 days 0.48 0.453 0.452 0.429
Feed effi  ciency 
From 21 to 38 days age 0.95 1 0.85 1.02
From 39 to 73 days age 1.41 1.91 1.42 1.56
From 74 to 144 days age 2 4.04 2.42 2.6
From 21 to 145 days 1.71 2.92 1.82 1.99
Morbidity
Digestive signs % 25 44.4 15 55
Mortality % 0 40 0 0
Discussion
Shedding in Group 3 was less than in the control group though-
out the cycle. Although all products led to reduced shedding, 
the single dose vaccine on the fi rst day of age (Group 2) ap-
plied to an immature intestine in the presence of high MDA 
seemed to compromise the health of the piglets, evident from 
low weight gains during the sucking and growing phases, with 
severe morbidity and mortality. 
The vaccine given at weaning (Group 3) produced the best per-
fomance with resepct to ADG, morbidity, mortality and Salmon-
ella sp shedding.
The use of a safe vaccine against Salmonella spp is a useful 
tool in the control of the disease. It helps reduce excretion and, 
together with biosecurity measures and good management, is 
the key to reducing damage and economic loss due to disease 
caused by Salmonella spp. 
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Vaccination to control Salmonella and improve weight gain in pigs
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Introduction
Immunization appears to be one of the most promising ap-
proaches for control of Salmonella on swine farms (1). Salmon-
ella Choleraesuis vaccines are commercially available (2-3), 
however S. Choleraesuis does not appear to be a common 
pathogen in Ontario swine herds any longer (4). On the other 
hand Salmonella Typhimurium var. Copenghagen has become 
the most frequent serovar recovered on Ontario swine farms 
(4). The objectives of the present study were i) to determine if 
an autogenous S. Typhimurium vaccine or a commercial live S. 
Choleraesuis vaccine can reduce the prevalence of Salmonella 
shedding in pigs, ii) to determine if Salmonella shedding is as-
sociated with weight gain in pigs.
Materials and methods
The trial was conducted on one farrow-to-fi nish pig operation 
with the history of salmonellosis. Nine cohorts of weaned pigs, 
with approximately 350 pigs in each group, were randomly as-
signed S. Typhimurium bacterin, S. Choleraesuis vaccine, or as 
the control group. A Salmonella Typhimurium var Copenhagen 
strain was used to prepare the autogenous vaccine. In each 
cohort, one pen was randomly selected in the nursery stage and 
30 pigs were ear-tagged and weighed. The tagged pigs were 
weighed again when marketing. Pooled fecal samples were 
collected bi-weekly from manure found on the pen fl oor and 
cultured for Salmonella. A Generalized Linear Latent and Mixed 
Models was used to compare the presence of Salmonella in the 
pooled fecal samples collected from the pens in three groups. 
A mixed linear regression method was applied to compare the 
average daily gain in the vaccinated and the control pigs. 
Figure 1: Proportion of Salmonella-positive samples in vaccinated 
and control pigs
Results
The prevalence of Salmonella shedding in each group is shown 
in Figure 1. The odds of Salmonella shedding during fi nisher 
stage in S. Choleraesuis vaccinated pigs [OR=5.2 (1.8, 15.5)] and 
S. Typhimurium vaccinated pigs [OR=3.3 (1.1, 9.9)] was higher 
than in the control group. The S. Choleraesuis vaccinated pigs 
were more likely to shed Salmonella compared to pigs which 
were vaccinated with S. Typhimurium bacterin. The control pigs 
which had the lowest average of Salmonella shedding showed 
the best growth performance compared to the vaccinated 
groups (Table 1). In addition, the pigs from pens with a higher 
Salmonella recovery rate were deemed to have a lower average 
daily gain. 
Table 1: The impact of Salmonella vaccination on average daily gain 
in pigs
Vaccine Coeffi  cient 95% CI P value
S. Choleraesuis -26.6 -53.0, 0.27 0.048
S. Typhimurium -90.8 -122.5, -59.0 < 0.001
Control Reference
Weight at weaning (Kg) 4.7 0.7, 8.7 0.022
Discussion
The prevalence of Salmonella shedding was initially lower in 
the control group. Younger pigs are more likely to shed Salmon-
ella than fi nisher pigs (5) and therefore our estimate of vaccine 
eff ectiveness may be biased because the decrease in shedding 
might be due to age. It is possible that vaccination was per-
formed after pigs had been exposed and that effi  cacy might 
have been improved had the pigs been vaccinated sooner. At 
least one study suggests that it might be prudent to establish a 
vaccination strategy for pregnant sows to control Salmonella in 
their piglets (6). Another signifi cant fi nding of this study is that 
pigs that appeared clinically healthy but were found to be shed-
ding Salmonella grew slower than pigs not shedding Salmon-
ella. This suggests that there is an economic cost to subclinical 
Salmonella infection and provides an economic incentive for 
producers to implement Salmonella control measures.
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Introduction
Gastrointestinal disease in weaners is the most common cause 
of antibiotic consumption in Danish pig production. Most 
antibiotics are used as recurring therapeutic batch medication of 
acute outbreaks of diarrhea. Clinical signs, pathology and micro-
biology of this type of outbreak have been poorly described. 
The objective of the current study was to estimate with-in batch 
prevalence of clinical signs in outbreaks of acute treatment re-
quiring diarrhea in pigs between 10 and 70 days post weaning. 
Results of the pathological and microbiological investigations 
are reported elsewhere in these proceedings.
Materials and Methods
A cross sectional study was conducted. Herds were selected by 
multistage sampling. All herds serviced by six specialized swine 
veterinarians from the same vet practice at Zealand and fulfi lling 
the inclusion criteria were selected. The criteria were recurring 
therapeutic use of in-feed or in-water medication for diarrhea at 
room level in pigs between 10 and 70 days post weaning. Only 
herds with modern intensive production systems were selected. 
One outbreak of acute diarrhea was investigated in each herd. 
Farmers and herd veterinarians notifi ed the authors at initia-
tion of an outbreak of acute diarrhea in a nursery room, where 
treatment by in-feed or in-water medication at the room level 
was necessary in their opinion. All herds were visited the day fol-
lowing notifi cation and the farmer was not allowed to medicate 
any pigs before the pigs were examined. If the pigs had received 
antibiotic batch medication with-in the last 7 days of the exam-
ination day, the outbreak was excluded from the study. A sample 
of 80 pigs in each herd was selected for clinical examination by 
systematic random sampling among all pigs in the nursery room 
where the outbreak of acute diarrhea occurred. The selected 
pigs were subjected to a clinical examination by the same 
observer. The observer’s diagnostic sensitivity and specifi city for 
detection of diarrhea was estimated by fecal dry matter (DM%) 
determination for a subset of the examined pigs (n = 773). DM% 
≤ 18.8 was considered as diarrhea (1).
Results 
A total of 20 herds were examined during outbreaks of acute 
treatment requiring diarrhea in 2009. On average the pigs were 
32 days post weaning (range: 12 to 63 days). Mean with-in batch 
prevalence of diarrhea (loose + watery) was 37% (range: 25% 
- 67%), Table 1. For detection of diarrhea the observer had a 
diagnostic sensitivity = 0.88 and specifi city = 0.91. 
Discussion 
The prevalence of diarrhea was higher than expected. The 
observer’s diagnostic sensitivity and specifi city gave an overesti-
mated prevalence (true prevalence = 35%, analysis not shown). 
The 24 hours between notifi cation and examination may have 
contributed to the higher than expected prevalence. The with-in 
batch prevalence of other clinical signs than diarrhea was low. 
This may be due to the study of the early part of the outbreaks. 
The diff erent with-in batch prevalence of clinical signs between 
herds may be due to diff erent treatment thresholds for the 
individual farmers. It may also be the result of diff erent etiology 
showing diff erent clinical behavior. Further analyses are planed 
to explore these aspects. The small sample of herds investigated 
in the current study only represents modern intensive produc-
tion systems. However, the results do imply that more pigs have 
diarrhea at initiation of antibiotic batch medication than is com-
monly believed.
References
1. Pedersen, K.S. et al., 2009. Proc 1st ESPHM: page 67.
Table 1. With-in batch prevalence of clinical signs in 20 herds with 
outbreaks of acute treatment requiring diarrhea 10 to 70 days post 
weaning (n = 1585 pigs)
mean min max p-value*
Diarrhea - Loose consistency 24% 16% 34% 1.0
Long hair coat 14% 5% 39% <0.01
Diarrhea - Watery consistency 13% 1% 33% <0.01
Mildly emaciated 10% 0% 35% <0.01
Perineal fecal stain 9% 0% 29% <0.01
Lumbar cavity 8% 1% 31% <0.01
Pot-bellied 2% 0% 9% 0.02
Fecal blood, mucus or necrotic 
material 1.4% 0% 9% <0.01
Pale 0.3% 0% 3% 1.0
Chi-sq or Fishers exact test for test of diff erent prevalence between herds. P-value adjusted by 
Bonferroni-correction for multiple comparisons.
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Introduction
The most common cause of antibiotic consumption in Dan-
ish pig production is gastrointestinal disorders in weaners. The 
largest part of the consumption is used as recurring therapeutic 
batch medication of acute outbreaks of diarrhea. It is generally 
believed that proliferative enteropathy associated with Lawsonia 
intracellularis is the major cause of these outbreaks of diarrhea. 
The objective of the current study was to describe the gross 
pathology in outbreaks of acute treatment requiring diarrhea in 
pigs between 10 and 70 days post weaning. Results of clinical 
and microbiological investigations of these outbreaks are re-
ported elsewhere in these proceedings.
Materials and Methods
A case control study was conducted. Herds were selected by 
multistage sampling. All herds serviced by six specialized swine 
veterinarians from the same vet practice at Zealand and fulfi lling 
the inclusion criteria were selected. The criteria were recurring 
therapeutic use of in-feed or in-water medication for diarrhea at 
room level in pigs between 10 and 70 days post weaning. Only 
herds representing modern intensive production systems were 
selected. One outbreak of acute diarrhea was investigated in 
each herd. All herds were visited the day following notifi cation 
from the farmer/veterinarian of an acute treatment requiring 
outbreak of diarrhea and the farmer was not allowed to medi-
cate before the pigs were examined. If the pigs had received 
antibiotic batch medication with-in the last 7 days of the exam-
ination day, the outbreak was excluded from the study. 
A sample of 80 pigs in each herd was selected by systematic 
random sampling among all pigs in the nursery room where 
the outbreak occurred. The selected pigs were subjected to a 
clinical examination and fecal samples were collected. Among 
the examined pigs a simple random sample of 8 pigs with diar-
rhea and 8 pigs without diarrhea was selected. The 16 pigs were 
killed and transported to DTU-VET for necropsy the following 
day. Fecal dry matter (DM%) was determined. DM% ≤ 18.8 
was considered as diarrhea (1) and was used (if necessary) to 
reclassify the pigs as diarrheic (cases) or non-diarrheic (controls) 
in the statistical analysis.
Results 
Twenty-four non-diarrheic and 12 diarrheic pigs (determined 
at clinical examination) were reclassifi ed according to the DM% 
determination. Seven pigs were excluded from analysis. Results 
of the gross pathological examinations are displayed in Table 1. 
Discussion 
Small intestinal lymph node hyperplasia, large intestinal mucosa 
hyperemia and proliferative enteropathy-like changes were 
found at low but signifi cantly higher levels in pigs with diarrhea 
than those without. The low prevalence of proliferative enterop-
athy-like changes implies that the importance of Lawsonia 
intracellularis in relation to diarrhea could be much lower than 
previously believed. Interestingly, obvious signs of infectious 
enteritis were rare and most of the other intestinal changes were 
equally prevalent in pigs with or without diarrhea. 
Further conclusion awaits results of histological and microbio-
logical examinations. 
References
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Table 1. Prevalence of gross intestinal changes* in 20 herds with 
outbreaks of acute treatment requiring diarrhea 10 to 70 days post 
weaning (n = 313 pigs)
Pigs with diarrhea 
(DM%≤18.8) (n=166)
Pigs without diarrhea 
(DM%>18.8) (n=147)
Small intestine:
Hyperemia 35% 32%
Flaccid 23% 24%
Lymph node hyperplasia 11%# 3%#
Blood tingled contents 6% 5%
Congestion of blood vessels 5% 4%
Thickened intestinal wall 5% 0.7%
Large intestine:
Hyperplasia of colon associated 
lymphatic tissue 26% 25%
Mesenteric edema 10% 16%
Lymph node hyperplasia 5% 3%
Mucosa hyperemia 5%# 0%#
Mucosa erosions, ulcerations and/
or necrosis 5% 3%
Proliferative enteropathy-like: 8%# 0.7%#
No intestinal changes: 32% 37%
Only the most prevalent changes are displayed. # P-value < 0.05 in Chi-sq or Fishers exact test 
for unconditional test of diff erent prevalence between pigs with and without diarrhea
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Validation of an animal-based welfare assessment tool for the New 
Zealand pork industry: a case-series of welfare conundrums
Eric J. Neumann; Ian W. Barugh; William F. Hall; Daan Vink
Massey University, Palmerston North, New Zealand
Introduction
An animal-based welfare assessment tool was developed to 
quantify welfare outcomes for pigs in NZ. The current 2005 New 
Zealand Code of Welfare (Pigs)1 was developed using traditional 
facility-based metrics that provides a means of collecting object-
ive but indirect measures of the welfare of farmed pigs. As part 
of an ongoing eff ort to improve well-being of pigs, the pig in-
dustry in 2009 undertook a review of the current Code with the 
aim of developing an evaluation tool that would directly assess 
the well-being of the pigs. The tool combines both subjective 
and objective measures of welfare based on direct observations 
of the pigs. As the current Code is still in eff ect and represents 
the “minimum welfare standards”, the proposed animal-based 
standards have been linked to applicable parts of the Code by 
which a farm would judged by a competent authority. As both 
the proposed animal-based criteria and the existing facility-
based criteria are visibly linked on the assessment tool, the 
assessor is able to conveniently judge the welfare of pigs using 
both systems concurrently. The animal-based welfare indicators 
include aspects of vocalisation, appearance, behaviour, mobility, 
and faecal consistency. Once the validation process has been 
completed by early 2010, a graduated approach to replacing 
the current Code with the new animal-based standard will be 
initiated.
Materials and Methods
Validation of the tool involved a one-day training session for the 
assessors. Following this, assessors visited farms having variable 
production practices, herd sizes, and housing systems in order 
to create a dataset suitable for an analysis of inter-rater reliability 
and repeatability. The tool allowed concurrent assessment of the 
farm based on the current welfare Code (PASS/FAIL grade on 20 
facility-based standards – ie m2/metabolic bodyweight, number 
pigs /feeder space, water fl ow rate, gestation stall width, etc) 
and the proposed animal-based standards (use of a “traffi  c light” 
system of green, amber, and red). 
Results
A total of 9 farms have been assessed and has included all 
stages production in both intensive and extensive production 
systems. The agreement between assessors was good but as 
all farms that have been assessed were in compliance with the 
current welfare regulations, statistical analysis of the data was 
uninformative.
Discussion
Analysis of the assessments demonstrated that, farms that ap-
peared to have welfare issues were consistently identifi ed by the 
assessors, and specifi c issues identifi ed on farms by the assessors 
were similar.
Use of the animal-based standards (specifi cally, the ability to 
evaluate a situation with the traffi  c light scoring) was uniformly 
praised by assessors as they had the fl exibility to interpret the 
welfare of a given situation in the context of the larger setting 
rather than having to singularly judge a pig or event as cause for 
PASS/FAIL of the entire farm. Examples of this included:
• Existence of a small proportion of gestation stalls 590mm 
wide (currently less than the codifi ed minimum width of 
600mm) could still be given a “green light” as the farmer man-
aged this by housing only gilts in the narrow stalls.
• Occurrence of dramatic vocalization by sows when an asses-
sor entered a barn of limit-fed gestating sows could be given 
a “green light” when viewed in light of the sows’ Pavlovian 
response to an anticipated feeding event.
However, use of the animal-based standards created several 
unanticipated conundrums for the assessors. Examples of this 
included:
• Reliance on the analogy that “good production levels must 
mean good welfare” had to be abandoned as its inverse 
(“poor production levels must mean poor welfare”) was not 
necessarily valid. This was apparent in the case of a small and 
ineffi  cient producer (30 sows producing only 7 pigs per sow 
per year) who’s sows were fat, content, and in an enriched en-
vironment (sic broken down machinery, expansive wallows, 
and every-other-day waste-food feeding) would have failed 
the codifi ed standards but received “green lights” across the 
board using the animal-based standards.
• In extensively housed sows, rock chewing was common 
on some farms. Assessors were unsure as to whether they 
should consider the behavior as stereotypic (“red light”) or 
was simply the sow making use of environmental enrichment 
provided by the farmer (“green light”).
Conclusion
It is unlikely that a purely animal-based or facility-based welfare 
assessment tool will accurately ascertain the true well-being 
of farmed pigs. A tool that uses a combination of these criteria 
is capable of identifying farms that compromise the welfare of 
pigs. 
References
1.  Anonymous. New Zealand Animal Welfare (Pigs) Code of Welfare 
2005. In. Wellington, New Zealand: Ministry of Agriculture and 
Forestry - National Animal Welfare Advisory Committee; 2005:63.
.
Welfare and Behavior
244
Oral Presentations
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010
O.212
Behavioural, clinical and clinical-chemical indices in pigs suﬀ ering from disease
Gerald Reiner; Katrin Hübner; Hermann Willems
Department of Veterinary Clinical Sciences, Justus-Liebig-University, Giessen, Germany
Introduction
In assessing the quality of life of farm animals, the absence of 
disease has been given highest priority (e.g. Dawkins 2006). 
However, a disease-free state cannot always be ensured. Thus, 
infectious diseases are major causes for pain and suff ering (Hart 
1988, Algers, 2004). During infection, sickness and suff ering 
refer to a coordi¬nated set of behavioural and physiolo¬gical 
changes, leading to the concept of sickness behaviour. Behav-
ioural indices are rarely assessed in conjunction with clinical 
diagnostics in more than a qualitative manner. Knowledge of 
the eff ects of model diseases on behaviour and on relationships 
among clinical/clinical-chemical parameters and behavioural 
indices would permit a better understanding and assessment 
of animal suff ering due to infectious disease. Therefore, the aim 
of this study was to describe the physiological and behavioural 
patterns and relationships in pigs before, and during the acute, 
subclinical and chronic stages of a model disease.
Materials and Methods
Based on a well defi ned model disease (Sarcocystis miescheri-
ana), we have studied behavioural patterns (lying inactive 
[LYWA], activity during lying [ADLY], feeding [FEED], drinking 
[DRNK], rooting [ROOT], walking [WALK], and social interactions 
[SOCB] of pigs during stages of health (day 0, before infection), 
acute disease (day 14 post infection [p.i.]), subclinical disease 
(day 28 p.i.), and chronic disease (day 42 p.i.). Data were cap-
tured from video records of 139 F2 Meishan x Pietrain crossbred 
pigs between 09:30 a.m. to 11:30 a.m. The time interval for 
observation was chosen so as to overlap with the fi rst activity 
peak in the morning and to avoid times of human interven-
tion. Behavioural indices were correlated with a set of clinical-
chemical parameters (red and white blood cells, serum enzymes, 
serum metabolites and electrolytes). 
Results
Before infection, respective time fractions were 56% (LYWA), 
21% (ADLY), 10% (FEED), 0.9% (DRNK), 6.3% (ROOT), 2% (WALK), 
and <1% (SOCB). This behavioural pattern changed distinctly 
during Sarcocys¬tosis. Overall activities were reduced from 44% 
(day 0) to 10% (day 14 p.i.), 34% (day 28 p.i ), and 20% (day 42 
p.i.). 
The development of diff erent stages of disease was accompan-
ied with distinct changes in clinical and clinical-chemical param-
eters. Deviation from the population´s “standard” activity (before 
infection) could be predicted with clinical-chemical parameters 
(e.g. alkaline phosphatase [AP]). 
Behavioural activities were generally reduced, whenever 
clinical/clinical-chemical traits changed to pathological values. 
A multivariate regression model revealed fi ve predictors to 
explain e.g. total activity. The model was statistically signifi cant 
with P < 0.0001 and explained 32% of the pigs’ total variance for 
this indicator (correla¬tion coeffi  cient 0 564). AP was the most 
important predictor. A decrease of 100 IU/l was associated with 
a reduction in activity of 7.8% during the observation period. 
A 10% reduction in leukocytes or 10 mmol/l less serum sodium 
ions were each equivalent to a more than 5% increase in activity. 
Increases of 10 μmol/l in serum creatinine or 1000 IU/l in serum 
creatine kinase (CK) were associated with an increase in inactiv-
ity by another 1.4 and 5.1%, respectively. 
Discussion
To date, most welfare research has been concerned with identi-
fying eff ects of housing conditions on welfare. The present study 
substantiates the role of infectious diseases in animal welfare. 
Taking into account the high prevalence of infectious diseases, 
it surprises that there is still very little research published on 
how diff erent common diseases aff ect an animals’ welfare 
(Algers, 2004). With more information about eff ects of defi ned 
model diseases on behaviour and on relationships among easily 
obtainable clinical/clinical-chemical parameters and behavioural 
indices, our understanding and assessment (eventually even 
under fi eld conditions) of animal suff ering due to infectious 
disease, even under subclinical conditions, might be decisively 
improved.
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Impact of physical castration and anti-GnRH vaccination (Improvac®) of boars on feeding 
behaviour and body lesion scores in single- and mixed-sex group housed fattening pigs
Tatjana Schmidt1 Mario Grodzycki2 Marleen Paulick1 Franziska Rau1 Eberhard von Borell1
1. Institute of Agricultural and Nutritional Sciences, Halle (Saale), Germany; 2. Pfi zer Animal Health, Berlin, Germany
Introduction
Physical castration of male piglets is common practice in many 
countries for the control of boar taint. A vaccine against GnRH 
(Improvac) is licensed in Europe as an alternative to this pain-
ful procedure. Vaccinated pigs behave like entire males up to 
the second vaccination and may potentially exhibit aggressive 
behaviour towards each other (von Borell et al, 2009). In this 
study we analysed feeding duration and indirectly measured 
agonistic interactions by shoulder lesion scores (Turner et al, 
2006) of physically castrated pigs (PC) and pigs vaccinated with 
Improvac (IC). We also examined if penning with females would 
aff ect these parameters in males. 
Material and Methods 
PC and IC males (Pi x[German LRxLW]) were either penned in 
single-sex groups of 10 (treatment T1 and T2) or mixed with 
females (5:5, T3 and T4). A total of 160 animals started the 
experiment in four replicate groups. 11 pigs were excluded due 
to health problems. Pigs were mixed after weaning at 4 wks 
of age and regrouped by weight at wk 11 for the start of the 
experiment (Vaccinations at 12 and 23 wks of age). An auto-
matic single-space feeder (IVOG®) per pen recorded the feeding 
duration (FD, minutes per day) of each pig. Shoulder lesions (LS) 
were scored weekly ranging from scratches (scores 1-2), abra-
sions (3-4) to severe wounds (5-6) and compared in 4 phases 
(P1-4). Mixed linear models with repeated measures design were 
used for statistical analysis with fi xed eff ects of treatment, pen 
and replicate for feeding data and an additional fi xed eff ect of 
observer for lesion score data as well as Tukey´s HSD test (JMP®, 
SAS Institute).
Results
T1 showed a greater FD (Table 1) than T2 in wk 14 and than 
T2&T4 in wk 20. There was no treatment eff ect in either FD in wk 
25 or LS (Table 2) in P4. LS were high for all treatments in P1 but 
decreased in P2-4 (except for T2). T2 showed higher LS than T1 in 
P2 and P3.
Table 1: Feeding duration (FD, minutes)
wk 14 wk 20 wk 25
T1 65.9±3.54 a 54.8±3.45 a 37.7±3.58 a
T2 51.4±3.97 b 38.3±3.97 b 42.7±3.97 a
T3 55.1±5.66 ab 46.7±5.66 ab 33.5±5.66 a
T4 55.5±5.27 ab 40.4±5.27 b 38.0±5.51 a
Least-Square means±95% CI, ab within wk, means lacking common superscript letter diff er 
(p<.05).
Table 2: Shoulder lesion scores (LS)
wk 11-13 (P1) 14-18 (P2) 19-23 (P3) 24-28 (P4)
T1 1.75±0.16 a 1.60±0.15 a 1.63±0.15 a 1.62±0.15 a
T2 1.97±0.16 a 2.06±0.15 b 2.02±0.15 b 1.65±0.15 a
T3 2.01±0.18 a 1.85±0.16 ab 1.83±0.16 ab 1.66±0.17 a
T4 1.98±0.17 a 1.81±0.15 ab 1.72±0.15 ab 1.37±0.15 a
Least-Square means±95% CI, ab within wk, means lacking common superscript letter diff er 
(p<.05).
Discussion
Georgsson & Svendsen (2002) found that feeding time was 
lower in pig groups when high levels of competition occurred 
at the feeder. This could indicate that competition for feeder 
access reduced FD in IC groups in wk 14&20. However, FD was 
only signifi cantly higher in single-sex, not in mixed-sex PC males 
compared with IC groups. 
In P1, shortly after regrouping of pigs, the LS were high in all 
treatments. Higher LS in single-sex IC males in P2 & P3 indicate 
more agonistic interactions. In contrast, LS of mixed-sex IC 
groups were not greater than in the PC treatments suggesting 
less aggression in mixed-sex groups compared to IC single-sex 
groups. No diff erences occurred in FD and LS after eff ective cas-
tration of IC males. In all groups, mean LS were only marginally 
>2, indicating almost no severe injuries. Therefore, the results of 
this study suggest that the impact of increased aggression in the 
IC males does not seem to constitute a major welfare problem.
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Free space utilisation of group housed sows
Fiona C. Rioja-Lang
Prairie Swine Centre, Saskatoon, SK, Canada
Introduction
With announcements by the largest producer/packers in both 
the USA and Canada that they will transition all of their produc-
tion facilities to group housing for sows over the next ten years, 
all N. American producers are anticipating a change to group 
housing. This study investigates the implementation of walk-
in/lock-in stalls in group housed sows. There is some concern 
regarding the degree to which sows use the free space areas in 
this system, and how to avoid excessive competition and ag-
gression.
The objectives of this study were to compare two diff erent pen 
confi gurations by determining the proportion and type (size/
parity) of sows that are using the free space areas of the walk-in/
lock-in stalls, and also how sows utilize the free space areas.
Methods
Eight groups of 25 sows (± 3; mean ± SD) were used in the 
study, and were housed in walk-in/lock-in stall gestation pens 
at the Prairie Swine Centre, Saskatoon. Each of the groups were 
exposed to one of two confi gurations of free space areas. The 
fi rst is referred to as the ‘I-pen’ as it consisted of an alley (3.0m x 
10.7m) with slatted fl ooring running between two lanes of 16 
stalls on each side. Any additional stalls, surplus to the group 
number, were locked off  for the purpose of the trial. The second 
pen confi guration is referred to as the ‘T-pen’ as it consisted of an 
identical alley with an additional solid fl oor loafi ng area at one 
end (3.8m x 7.1m). Pigs were individually marked and photo-
graphs were taken from a mounted camera every 2 minutes 
over a 24hr period every week, for 11 weeks through gestation. 
Measurements recorded from the photographs include the 
percentage of time spent out of the stall over 24hrs, and also the 
location and position of sows in the free space areas.
Results
The majority of sows did use the free space areas although not 
on a regular basis or for extended periods of time. Older, heavier 
sows appeared to use the free space area signifi cantly more than 
younger, small sows (P<0.0001).
Table 1. Average percentage of time spent in free access area for sows 
housed in ‘I-pen’ confi guration over 24hr period.
Table 2. Average percentage of time spent in free access area for sows 
housed in ‘T-pen’ confi guration 24hr period.
Discussion 
Although many sows did use the free space, it was at a much 
lower level than expected. This could be due to several pos-
sibilities, such as lower ranking animals feeling threatened by 
higher ranking sows, or larger sows utilizing the free space 
due crowding in the stalls. With the impending ban of gesta-
tion stalls it is important that we conduct adequate research to 
design the optimum group housing system which will facilitate 
positive social interactions and minimize levels of aggression 
and competition.
Future research is likely to involve methods for enticing the sows 
into the free space areas, including making the free space more 
comfortable to lie on with rubber mats, providing environment-
al enrichment, or possibly allowing sows access to the free area 
in diff erent social groups i.e. young and old.
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Examination of CO2 gas anesthesia during piglet castration
Isabel Mühlbauer1 Susanne Zöls1 Winfried Otten2 Andreas Palzer1 Mathias Ritzmann3 Karl Heinritzi1
1. Clinic for Swine, Oberschleißheim, Germany; 2. Leibniz Institute for Farm Animal Biology, Dummerstorf, Germany; 
3. Clinic for Swine Diseases, Vienna, Austria
Introduction
Whereas several countries are still seeking for an eff ective and 
practicable solution for piglet castration without any analgesic 
treatment , CO2/O2 gas anesthesia during castration is already 
performed in the Netherlands. 
This study appraises stress and pain of castration without any 
analgesic treatment and a potentially positive eff ect of CO2 
anesthesia by means of serum cortisol and plasma catechol-
amine measurements [1,3].
Materials and Methods
188 (n) three to fi ve day old clinically healthy male piglets for 
cortisol (co) and 39 piglets for norepinephrine (ne) and epineph-
rine measurements were randomly assigned by weight to four 
treatment groups (tab. 1). 
Table 1: Treatment groups
group treatment co (n) ne (n)
I Immobilisation 47 10
II Castration 46 10
III Immobilisation under CO2 gas anesthesia 48 9
IV Castration under CO2 gas anesthesia 47 10
Inhalation anesthesia was introduced with a 70%CO2:30%O2 
gas mixture using an anesthetic machine as in the Netherlands. 
After introduction time of 45sec, piglets were anesthetized for a 
maximum of 30sec during castration or immobilisation.
To evaluate postoperative castration pain, blood samples for 
cortisol were taken from each piglet before as well as 30min, 1, 
4 and 24h after treatment. Due to the short half-value periods 
of epinephrine and norepinephrine, blood samples from those 
piglets were taken 15min before, immediately and 2min after 
treatment. Signifi cant diff erences were tested with paired t-test.
Results and Discussion
Mean cortisol concentrations did not diff er in basal values 
between the four treatment groups (Fig. 1). 30min after castra-
tion, mean cortisol concentrations of uncastrated groups I and III 
were signifi cantly lower than mean concentrations of castrated 
groups II and IV. A signifi cantly higher mean value was observed 
1 h after castration in group II than in groups I, III and IV. 4 h after 
castration, cortisol levels of uncastrated groups I and III were still 
lower than of group II (p≤0.05). 
Fig. 1: Mean serum cortisol concentrations (+SD) before as well as 
30min, 1, 4 and 24h after treatment
In accordance with results from Schulz et al. (2007), immobilisa-
tion (group I) and castration (group II) caused a twofold increase 
of plasma norepinephrine concentrations to 4471 pg/ml and 
respectively 4871 pg/ml immediately after treatment (p≤0,001). 
In contrast, CO2 anesthesia induced a signifi cant and nearly 50-
fold increase of mean norepinephrine levels in groups III and IV 
immediately after treatment, and levels were still elevated 2min 
after treatment. These results are confi rmed by the results of 
epinephrine measurements.
Fig. 2: Mean plasma norepinephrine concentrations (+SD) before 
immediately after and 2min after treatment
Conclusion
Serum cortisol concentrations 1h after castration under CO2 
anesthesia indicate a small but signifi cant analgesic impact by 
the use of CO2. However, this eff ect was not detectable after 
30min. In contrast, the analysis of plasma norepinephrine and 
epinephrine revealed a tremendous additional stress for piglets 
from both CO2 groups independent from castration. Considering 
that the aim of anesthesia is to reduce pain and stress, and that 
the consumers´ demand for anesthesia during castration tends 
to increase animal welfare, CO2 anesthesia cannot fulfi l the 
requirements to the full extent.
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Pre-emptive meloxicam for postoperative analgesia in piglets undergoing surgical castration
Alassane Keita; Eric Pagot
CTPA Zoopole développement, Ploufragan, France
Introduction 
The welfare issues associated with surgical castration procedures 
in piglets is a growing concern within the public and European 
lawmakers. Castration of male piglets is a routine practice in 
most European countries, carried out to avoid boar tainting of 
meat (an unpleasant smell that sometimes arises when the meat 
of boars is heated). Current European directives make anaes-
thesia and prolonged analgesia only mandatory for castration 
of pigs over 7 days of age, the procedure being carried out by a 
veterinary surgeon. Countries like Norway or Switzerland have, 
however, already banned surgical castration without anaesthe-
sia and other countries may follow. It has been demonstrated 
that surgical castration was followed by an increase of plasma 
cortisol and plasma adrenaline via the activation of the adrenal 
and sympathetic axes [1, 2]. This paper reports the outcome of a 
study having investigated the eff ect of a pre-operative intra-
muscular administration of meloxicam on postoperative stress 
and pain induced by surgical castration in piglets.
Material and methods
Overall 150 young (mean age of 5.1 + 1.3 (SD) days and mean 
body weight of 2.4 + 0.6 kg) healthy male piglets, coming from 
3 diff erent commercial farms, were included into the study. The 
piglets were ear-tagged and allocated at random within litters to 
groups to receive one of the following treatments between 10 
and 30 minutes prior to surgical castration: a single intramuscu-
lar injection of 0.4 mg/kg meloxicam (i.e. 0.08 ml/kg of the prod-
uct Metacam® 5 mg/ml solution for injection) or 0.08 ml/kg of a 
placebo (saline). Behavioural parameters (vocalisation, tremors, 
urine or faeces emission etc) were evaluated in blind conditions 
at time of castration up to 24h post-castration. Blood samples 
were collected from 30 subjects selected at random from each 
group at 30 minutes and at 24 hours post castration. In addition 
blood samples were taken from 30 non-castrated contemporary 
piglets to provide baseline values for the concentrations of the 
evaluated hormones.
The piglets were individually weighed at the start of the study 
and again at weaning. The criteria were: blood cortisol and ACTH 
concentrations at 30 minutes post castration, blood Haptoglo-
bin concentration 24 h post castration, behavioural alterations 
up to 24 h post castration, weight gain between castration and 
weaning. ANOVA, Kruskal-Wallis and Pearson Chi-square tests 
were used to analyse the data with 5% as level of signifi cance.
Results
The mean age and body weight before castration were similar in 
the two groups.
The mean blood ACTH concentration at 30 minutes post castra-
tion (fi g. 1) was signifi cantly (p = 0,007) lower in meloxicam 
(17 pg/ml) and non-castrated (18,1 pg/ml) groups than in the 
placebo one (35,8 pg/ml).
The mean blood cortisol concentration was signifi cantly 
(p<0.001) lower in the non-castrated group (63 ng/ml) than in 
the meloxicam (206 ng/ml) and placebo (276 ng/ml) groups. The 
diff erence between meloxicam and placebo was also signifi cant. 
At both 2 and 4 hours post castration, the proportion of piglets 
showing no behavioural alterations was signifi cantly (p<0.05) 
higher in the meloxicam group (83%) than in placebo one (68%).
No signifi cant diff erence was observed between the mean blood 
Haptoglobin concentration and the weight gain of the two 
groups. 
Conclusion and discussion
This study suggests that pre-emptive administration of meloxi-
cam is able to produce an adequate postoperative analgesia 
after surgical castration of young piglet. Meloxicam can be pro-
posed as a safe and eff ective solution to control stress and pain 
associated with routine castration in piglets.
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Introduction
The common practice of castration of piglets without any anes-
thesia in the EU met with increasing criticism because of animal 
welfare reasons.
One of possible alternatives is the castration under general anes-
thesia using anesthetic gases [1, 2]. In the last years inhalation 
systems were established for automation the narcosis process. 
The present study should demonstrate the quality and depth 
of narcosis and the degree of reduction piglets´ pain during 
castration under isofl urane- or carbon dioxide- anesthesia. 
Furthermore the infl uence of NSAIDs on the anesthesia and pain 
reactions was tested.
Material and methods
In the study exclusively healthy anatomically normal piglets at 
the age of one to seven days were used. All piglets had a body-
weight between 1.5 and 2 5 kg.
Two kinds of commercial inhalation systems were tested; the 
fi rst one used an isofl urane insuffl  ation mixed with 30% oxygen, 
while the second one worked with a gas mixture of 70% carbon 
dioxide and 30% oxygen.
Altogether 246 piglets in 18 groups were tested to compare the 
two diff erent gas insuffl  ations to traditionally not anesthetized 
piglets. Furthermore the infl uence of NSAIDs (Flunixine) in a 
common dosage was investigated. Each of the three anesthesia 
groups was split up in groups that were injected 60 minutes and 
20 minutes before castration and a group without any NSAIDs. 
Additionally a sham group corresponding to every group 
existed, where the piglets were only handled in the same way 
without being castrated.
The most important method for recognizing the piglets´ pain 
was the electroencephalogram (EEG). Due to frequency analysis 
an EEG score expressed the depth of anesthesia, whereat a score 
of 3 or more represent an adequate narcosis. Furthermore an 
electrocardiogram (ECG) was recorded continually. The pulse 
and oxygen saturation of the blood were recorded at the begin-
ning and after the insuffl  ation. We used a score to defi ne the 
vocalization, the movements and the reactions to the manipula-
tions. The wound healing was observed for three weeks.
Results
As measured by EEG score about 90 % of the piglets of the 
carbon dioxide groups but only less than 40% of the piglets of 
the isofl urane groups did not show a suffi  cient narcosis. The 
treatment with NSAID had no infl uence on the depth of carbon 
dioxide narcosis. On the contrary NSAID infl uenced the depth of 
isofl urane narcosis signifi cantly;. the group without any fl unixine 
treatment showed a lower EEG score (score 2.7) than the treated 
group (score 3.0). In this context the moment of fl unixine appli-
cation, 20 or 60 minutes before castration, was indiscriminative.
Movements of the piglets, measured with EEG, which are longer 
than two seconds can not be pronounced as an unconscious 
reaction but point at a conscious defense reaction to the pain. 
Between both anesthetic groups a signifi cant diff erence could 
be recognized. The reactions to the emasculation were much 
greater in the carbon dioxide group than in the isofl urane group.
The ECG showed nearly no diff erences in pulse frequency and 
ECG waves between the status before and within the isofl urane 
anesthesia. In the contrary in many cases of carbon dioxide 
anesthesia a dramatic drop of pulse frequency from about 200-
230/min before anesthesia to 20-40/min 30 sec after carbon di-
oxide insuffl  ation could be measured. Additionally characteristic 
ECG changes probably point at hyperkalemia as a consequence 
of acidosis.
Conclusions
The fi rst results of our study showed that an isofl urane narcosis 
can reduce most of the pain originated in castration. It induces 
a mostly deep enough anesthesia, while the depth can be en-
hanced by the application of NSAIDs.
Carbon dioxide anesthesia - especially with this inhalation 
system - did not induce a suffi  cient narcosis in most cases. The 
consciousness is reduced but not enough to lock out the aware-
ness of pain.
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Comparison of diﬀ erent analgesic treatments to reduce the pain associated with tail docking in pigs
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Introduction 
Tail biting is a behavioural problem occurring in pigs that is a 
welfare problem and of economic concern for producers. Tail 
biting can not only aff ect the welfare of the pigs being bitten 
directly, but the procedure of tail docking as a means to control 
tail biting can cause acute pain which is also an animal welfare 
issue. Exactly what causes tail biting behaviour to break out 
among pigs remains elusive, but this behaviour has been at-
tributed to an array of factors including the environment, nutri-
tion, group size, genetics and lack of substrates. Tail docking is 
routinely used on farms in the US as a solution to this problem. 
The objective of this study was to evaluate the eff ectiveness of 
diff erent analgesics to reduce the pain induced distress caused 
by tail docking in piglets.
Materials and Methods
At approximately 3 days of age, piglets were allocated to one of 
fi ve treatment groups: 1) Sham tail docking (CON); 2) Tail dock-
ing using conventional cutting with side-cutting pliers (CUT); 3) 
Tail docking plus local anaesthetic administered immediately 
prior to tail docking (LA); 4) Tail docking plus topical anaesthetic 
applied to the wound after cutting (TOP); 5) Tail docking con-
ducted while the piglets were anesthetized with carbon dioxide 
(100% CO2 gas) using conventional cutting with side-cutting 
pliers (CO2). 
Prior to (baseline), and 30, 60, and 120 min after tail docking, 
piglets (10 pigs/treatment) were held in a supine position and 
blood was collected for a complete blood count and cortisol 
analysis. Piglet behaviour (10 pigs/treatment) was record using 
live observations for 60 min prior and 120 min after tail docking. 
Behaviours and postures measured included lying-alone, lying-
touching the sow or other piglets, nursing/massaging, stand-
ing, sitting, walking and pain-like behaviours and postures (e.g. 
hunching, scooting, and tail jamming). 
Data were subjected to analysis of variance using the mixed 
model procedure of SAS version 9.1 (SAS Inst., Inc., Cary, NC). 
Results 
Leukocyte counts, diff erentials, and the neutrophil to lympho-
cyte ratio did not diff er (P > 0.05) among treatments. 
Cortisol was greater (P < 0.05) in CUT, LA, TOP, and CO2 com-
pared with CON piglets 30 min after tail docking. Cortisol did not 
diff er (P > 0.05) among CUT, LA, and CO2 piglets 30 min after tail 
docking. At 30 min, TOP piglets tended to have lower (P = 0.067) 
cortisol than CUT piglets. Cortisol did not diff er (P > 0.05) among 
treatments at any other time point. 
The percentage of time pigs spent performing nursing behav-
iour after tail docking tended to be greater (P = 0.062) in CO2 
piglets compared with all other treatments. The percentage 
of time piglets spent lying alone was greater (P < 0.05) in CUT 
piglets compared with all other treatments 91-120 min after tail 
docking. 
Discussion
Tail docking without analgesia caused increases in cortisol 
concentrations and performance of lying-alone behaviour, 
which may be indicative of pain. Cortisol concentrations tended 
to be reduced in piglets that had topical anaesthetic applied to 
the tail wound after tail docking, but not in piglets given local 
anaesthetic or carbon dioxide anaesthesia. Therefore, applying 
a topical anaesthetic to the tail wound may provide some relief 
from discomfort caused by tail docking in piglets.
Applying a topical anaesthetic to the tail wound immediately 
after tail docking may be an eff ective and easy way to reduce 
the pain caused by tail docking, but more research is needed to 
study the eff ectiveness of diff erent analgesics that could be used 
to eliminate the pain caused by tail docking in piglets. 
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Periparturient analgesia: Does it improve neonatal survival and growth?
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Introduction
There has been an increase in the public concern over the 
welfare of farmed animals in recent times. Pain control is an im-
portant component of animal welfare and in swine production 
there are many areas where pain control could be addressed 
1,2 The process of farrowing is associated with pain and could 
be a welfare issue for the sow as well as aff ecting her ability to 
adequately nurse piglets, thus aff ecting performance. Farrowing 
intervention could be painful and could result in reproductive 
tract infections. In cattle, it is now common for analgesics to be 
administered around the time of parturition, and this practice is 
considered to improve milk production. Research fi ndings sug-
gest that the peri-parturient sow experiences discomfort, which 
causes her to change positions frequently, increasing the chance 
that she will crush her piglets3. A major cause of pre-weaning 
mortality is due to maternal crushing of pigs. Pre-weaning 
mortality due to crushing has been estimated to be between 
4.8 and 18 percent 4,5. Alleviating the sow’s pain might lead to a 
decrease in body position changes and a consequent decrease 
in crushing, addressing both a welfare and economic issue. 
Reduced restlessness in the peri-parturient period could result 
in uninterrupted nursing by piglets and consequently improved 
weight gain. Ketoprofen, (Anafen, Merial Canada Inc) an inject-
able non-steroidal anti-infl ammatory analgesic, is approved for 
use in swine in Canada. 
The objective of the study was to evaluate the eff ect of analgesia 
to the sow at farrowing on piglet mortality and performance.
Materials and Methods
A total of 223 sows were randomly assigned to the following 
treatment groups.
a. Sows allowed to farrow with no analgesia (n=105).
b. Sows treated with ketoprofen on the day before farrowing 
and on the day of farrowing (n=118).
Anafen dosage was 1.5 ml per 50 kg bodyweight. All piglets 
were ear notched for identifi cation and weighed on the day of 
birth and again at 21 days of age to determine average daily 
weight gain (ADG). The number of stillborn piglets (SB) as well as 
preweaning mortality (PWM) were recorded.
Results and Discussion:
There was no diff erence in ADG, SB or PWM between the two 
groups. Table 1 shows the means for these parameters.
Table 1. Sow and piglet performance for sows given ketoprofen at 
farrowing and control sows.
Control ketoprofen
ADG (kg) 0.24±0.04 0.25±0.05
PWM (%) 14 16
SB (%) 12.7 13.3
% crushed 3.3 2.7
Based on the results in this trial there does not appear to be an 
economic incentive for producers to use analgesia routinely at 
farrowing. Possibly, if analgesia had been used only in the case 
of gilt farrowings or in the case of dystocia, a diff erence might 
have been observed.
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Behavioural and physiological diﬀ erences in intensive stock-farming pigs
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Introduction
The well-being of swine has become a relevant issue because 
the quality of life of pigs seems to be associated with the food 
production and meat quality (2). The heavy selection aimed to 
obtain individuals with elevated reproductive and productive 
performances has often conducted farm animals to a poor state 
of health and welfere(3). The aim of this work is to study the 
eff ects of the environmental enrichment on the normal and 
abnormal behaviors and hematological parameters in a com-
mercial line of pigs.
Materials and methods
In the present study, rearing pigs housed in a commercial farm 
either in Standard or Enriched pens were followed up over a per-
iod of eleven weeks. 28 hybrid pigs with initial average weight 
of 32,5 ± 2 kg were used in this study. The day of arrival at the 
farm, the animals were randomly assigned to two experimental 
groups. 14 individuals were housed in a physically enriched pen 
(‘Enriched group’) and 14 animals were housed in a conventional 
pen (‘Standard group’). The pens contained a total of about 50 
individuals. The enriched pen contained 6 chains, 5 tough, non-
toxic plastic balls with stones inside, two hemp ropes hung from 
the ceiling and 6 rubber hoses placed on the fl oor. Behavioural 
data and blood samples were collected on day of arrival of the 
animals (T.0), 24 hours later (T.1), and two weeks (T.2), six weeks 
(T.3) and eleven weeks (T.4) from the arrival. These samples 
were used to determine a range of haematological parameters. 
All statistical analyses were conducted using Statview 5.0 (SAS 
Institute Inc.).
Results 
Results are shown in Table 1. Pigs from Enriched housing spent 
signifi cantly less time in abnormal behaviours than the animals 
raised in Standard condition. Blood samples from Enriched 
group showed lower levels of white blood cells (WBC) than the 
Standard counterpart (Tab.1). 
Discussion
Swine exposed to physical enrichments presented important 
and consistent reduction of abnormal behaviors. Furthermore, 
pigs housed in the enriched pen had a six times lower prob-
ability than those from standard condition to present skin body 
lesions. This study gives a clear indication that the presence of 
manipulative objects provides welfare advantages to the rearing 
pigs. Pigs from Enriched housing showed a signifi cant higher 
level of neutrophils than those from the Standard pen, whereas 
the percentages of circulating eosinophils in the blood samples 
of the Enriched individuals were signifi cantly lower compared 
with swine housed in the Standard pen, this fact may be reason-
ably ascribed to a diff erent parasitic status on individual basis 
(1). Both lymphocyte and monocyte levels were markedly lower 
in Enriched than in Standard group. Interestingly, the animals 
from Enriched housing showed a progressive reduction of these 
white blood cells from Time 2 to Time 4, whereas swine housed 
in the Standard pen showed an increment between Time 2 and 
3. This profi le can be a consequence of ongoing bacterial infec-
tions in progress, such as enzootic subclinical pulmonitis typical 
of intensive pig farming systems. With regard to haematological 
measures, all parameters considered showed signifi cantly lower 
levels in the samples from Enriched pen than in those from the 
Standard group, except the concentration of Red Blood Cells 
(RBC) that was not aff ected at all. However, the levels recorded 
fall all within the range reported in the literature in intensive 
farmed pigs and may be interpreted as small perturbation 
induced by the sub-clinical ongoing infl ammatory processes 
above reported. A monitoring of selected behavioral parameters 
and profi le progression overtime and skin lesion checks may be 
a use-friendly strategy of management in farms with elevated 
animal density and limited numbers of workers.
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Table 1
Standard Enriched 
WBC (103/ μL) 19.9 ± 0.5 17.8 ± 0.6*
Neutrophils (%) 36.3 ± 1.3 42.4 ± 1.5**
Lymphocytes (%) 57.3 ± 1.3 52.8 ± 1.4*
Eosinophils (%) 3.4 ± 0.3 2.4 ± 0.2*
Monocytes (%) 2.5 ± 0.2 1.9 ± 0.2*
Basophils (%) 0.3 ± 0.1 0.3 ± 0.1
HCT (%) 33.3 ± 0.5 31 ± 0.7*
RBC (%) 6.9 ± 0.1 6.7 ± 0.1
MCV (fl ) 48.4 ± 0.6 45.5 ± 1*
HGB (g/ld) 10 ± 0.1 9.4 ± 0.2*
Platelets (103/ μL) 470.2 ± 10.8 421.6 ± 19.5
Means±SE of the haematological parameters
* Signifi cant diff erence (p<0.05) 
** Highly signifi cant diff erence (p< 0.01) 
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Challenge of pigs with natural immunity to H1 and H3 swine inﬂ uenza 
virus with pandemic 2009 H1N1 inﬂ uenza virus
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Introduction
The emergence of the pandemic 2009 human H1N1 infl uenza 
A virus raised many questions about the implications for this 
virus in swine (1). One such question is, does prior exposure to 
infl uenza virus confer any protection against the new virus? This 
report describes a study to evaluate if natural exposure to swine 
infl uenza viruses confers protection against challenge with 2009 
H1N1 virus.
Materials and methods
Conventionally raised pigs were purchased from a sow herd 
negative for swine infl uenza A virus. Due to purchasing and 
shipping logistics, the pigs had been weaned and transported 
to a nursery facility that was geographically separated from 
the sow farm. Within 7 days of arrival at NADC most of the pigs 
were seropositive by the Avian Infl uenza MultiS-Screen ELISA 
(2) and virus was detected in the nasal swabs from a few pigs. 
Multiplex RT-PCR assays using four specifi c primers for H1 and 
H3, and N1 and N2 were performed (3). Twenty group 1 (G1) 
pigs were housed for 5 additional weeks (until approximately 10 
weeks of age) at which time they were challenged with 2 x 106 
TCID50 A⁄California⁄04⁄2009 H1N1 (CA09) by the intranasal route. 
Naive-age-matched pigs (n=4 pigs) or group 2 (G2) were also 
inoculated with CA09. Nasal swabs were taken on 0, 3 and 5 days 
post infection (dpi) to evaluate nasal shedding. Postmortem 
samples including serum, bronchoalveolar lavage fl uid (BALF), 
lung, trachea and nasal swabs were collected at necropsy at day 
5 pi. Serologic assays included hemagglutination inhibition (HI) 
assay (4) and ELISA (2). HI assays were used to evaluate 0, 3 and 
5 dpi serum samples against CA09 (H1N1), OH07 (H1N1), MN99 
(H1N1), and TX98 (H3N2) viruses. Real-time PCR assays were 
performed for quantitation of nucleic acids in BALF of pandemic 
H1N1 infl uenza virus (5), and for PRRSV, PCV2 and Mycoplasma 
hyopneumoniae using in house assays (6).
Results and discussion
All pigs were negative for PRRSV, PCV2 and M. hyopneumoniae 
nucleic acids in BALF at necropsy. Genetic analysis of viruses iso-
lated from nasal swabs and BALF samples from G1 pigs revealed 
the presence of simultaneous H1 and H3 virus infections prior 
to the start of the study at 5 weeks of age. After challenge with 
CA09, all naïve-challenged pigs (G2) had macroscopic lung le-
sions with an average lung involvement of 2.7%. The multifocal 
lesions appeared typical with well demarcated margins, purple 
in color. Nine of the 20 G1 pigs had detectable macroscopic lung 
lesions, but decreased in severity compared to the non-immune 
controls, with an average of 0.9%. The character of the G1 lung 
lesions was diff erent compared to G2. The macroscopic lesions 
were purple-grey in color; involving the tips of the apical and 
cardiac lobes with less distinct margins. G1 pigs had no detect-
able virus titers in the lung or nasal swabs (0, 3 and 5 dpi). How-
ever, G2 pigs had CA09 viral titers in the lungs and nasal swabs 
with average titers of 101.6 TCID50/ml (3 dpi) and 102.3 TCID50/
ml (5 dpi) in nasal swabs samples, and of 103.7 TCID50/ml BALF 
samples at 5 dpi. Real-time PCR for H1N1 pandemic virus in BALF 
(5 dpi) showed that 14/20 naturally immune pigs (G1) and 4/4 
naïve-challenged (G2) were positive for viral RNA. Quantitatively 
G2 samples presented an average of 9 x 106copies of viral RNA / 
microliter of template. In contrast, G1 had an average of 1.4 x 103 
copies, indicating a low viral replication in the lungs or residual 
RNA from challenge, confi rming the negative results of virus iso-
lation from nasal swabs and BALF. HI titers using the challenge 
virus (CA09) were not signifi cant for either group at 0 and 5 dpi. 
However, signifi cant HI titers against the γ-cluster SIV OH07 were 
detected in G1 pigs at 0 dpi. H3N2 HI antibodies against TX98 
were not detected in either group of pigs. These results indicate 
that pigs with natural immunity against γ-cluster SIV have sig-
nifi cant protection against infection with 2009 pandemic H1N1. 
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Pandemic H1N1 inﬂ uenza virus infection in a swine herd
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Introduction
In April 2009, an outbreak of human infl uenza was reported due 
to a novel H1N1 virus. On June 11th , 2009, the World Health Or-
ganization declared a global human pandemic of H1N1 (pH1N1). 
On May 2nd, 2009, the fi rst case of pH1N1 infection in swine was 
reported in small herd in Alberta, Canada. Symptoms developed 
in swine after a barn worker had returned from Mexico with 
infl uenza-like illness. Epidemiologic evidence supported human 
to swine transmission (1, 2). Little was known about the patho-
genicity of this novel virus in swine. The objective of this study 
was to describe the clinical progression and production impacts 
of second pH1N1 infection in a naturally infected sow herd.
Materials and Methods 
On June 16th, pH1N1 was confi rmed in two swine barn workers 
at a second farm in Alberta. Symptoms in swine began on June 
19th . The herd was a high health breeding herd of 300 sows, 
free of all major pathogens including PRRS. Sows were routinely 
vaccinated for classical swine infl uenza H1N1 and H3N2 viruses 
(Flusure, Pfi zer Animal Health, Kirkland, Quebec). The herd was 
well managed with excellent biosecurity and above average air 
quality. No new animals had been introduced since September 
2008.
Clinical signs in swine and humans were recorded daily dur-
ing the outbreak. Nasal swabs were taken from systematic-
ally selected swine on days -1, 11, 15, 25, 53 after the onset of 
symptoms. All swine nasal swabs were screened by RT-PCR at 
the Food Safety and Animal Health Division laboratory in Ed-
monton. Initial samples were sent to National Centre for Foreign 
Animal Disease (NCFAD) in Winnipeg, Manitoba for confi rma-
tion and molecular characterization. Molecular characterization 
and comparison to human virus isolates was done at St. Jude 
Children’s Research Hospital, Memphis, Tennessee. Reproductive 
performance records, feed intake and carcass quality data were 
obtained. 
Results
The fi rst clinical signs were observed in swine on June 19th, 
seven days after contact with the fi rst ill worker and four days 
after contact with the second aff ected worker. A non-productive 
cough with a moderate abdominal eff ort, mild to moderate 
depression, pyrexia and anorexia of 24-48 hours duration was 
observed in gestating sows. Most aff ected animals displayed 
anorexia and depression only. Animals previously aff ected com-
pletely recovered within 24-48 hours. By the second day, two 
percent (29/1450) of the herd was aff ected. Over the next seven 
days new cases were seen daily in gestating and lactating sows 
and gilts. No clinical signs were observed in piglets, weaned 
pigs or growing pigs. The proportion of the herd aff ected never 
exceeded two percent and declined to 0.5 percent by day eight. 
After day 36 no clinical signs were seen. The herd made a com-
plete recovery with no associated mortality. Positive nasal swabs 
indicated asymptomatic shedding and infection was likely oc-
curring in all classes of swine. 
Some reproductive impact on individual sows and boars was 
recorded.
The only symptoms of respiratory disease prior to this outbreak 
were in three animals in December 2008. At that time nasal 
swabs and lung tissue were negative for infl uenza by PCR. No 
other symptoms of respiratory disease have been recorded in 
this herd since 2003. 
Discussion
The mild clinical signs in this herd are in contrast to the more 
severe symptoms reported in the fi rst case of pH1N1 in swine 
(1). The absence of other respiratory pathogens, air quality and 
vaccination likely contributed to the milder clinical picture. This 
infection could escape detection in a less rigorously observed 
herd, creating challenges for surveillance. Subsequent growth 
and reproductive performance was negatively impacted in spite 
of lack of clinical signs. PCR results indicate that be infection and 
viral shedding may occur in asymptomatic animals. 
Molecular characterization of the virus indicates the same virus 
infected both the workers and swine. The chronology of symp-
toms in humans and swine supports human to swine transmis-
sion.
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Enhanced pneumonia with pandemic 2009 A/H1N1 swine inﬂ uenza virus in pigs
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Introduction
Swine infl uenza A viruses (SIV) in the major swine producing re-
gions of North America consist of multiple subtypes of endemic 
H1N1, H1N2, and H3N2 derived from swine, avian and human 
infl uenza viruses with a triple reassortant internal gene (TRIG) 
constellation.1 Genetic drift and reassortment has resulted in 
four H1 phylogenetic clusters designated as α, β, γ, and δ that 
co-circulate in U.S. swine.2 Control of SIV has relied on the use of 
commercially available or autogenous infl uenza vaccines in the 
U.S. swine industry. However, inactivated vaccines have demon-
strated poor cross-protection against heterologous homosub-
typic, or heterosubtypic SIV. The emergence of diverse genetic 
subtypes has increased the need for eff ective SIV vaccines with 
adequate cross-protection. In this report, we describe a vaccine-
heterologous virus challenge model demonstrating enhanced 
lung lesions in pigs given inactivated δ-cluster H1N2 vaccine 
(human seasonal H1-lineage HA) challenged with heterologous 
pandemic 2009 A/H1N1compared to non-vaccinated challenged 
pigs.
Materials and Methods
Twenty, three-week old conventional pigs free of SIV and PRRSV 
were randomly divided into two groups. The vaccinated and 
challenged (vax/challenge) group was vaccinated with 106.5 
50% tissue culture infectious dose (TCID50) units of A/SW/
MN/02011/08 ( δ-cluster) inactivated by UV irradiation with the 
addition of a commercial adjuvant. Vaccine was administered 
intramuscularly at six and three weeks prior to challenge. Vax/
challenge and non-vaccinated/challenged (non-vax/challenge) 
pigs were inoculated intratracheally with 2ml of 1x105 TCID50/
ml A/California/04/2009 H1N1 (CA/09). Five pigs remained non-
vaccinated, non-challenged controls. Pigs were observed daily 
for signs of clinical disease and fever. Serum samples were ob-
tained at each vaccination, challenge and 5 days post-infection 
(dpi). Nasal swabs were taken on 0, 3, and 5 dpi to evaluate nasal 
virus shedding. All pigs were necropsied at 5 dpi. Lungs were 
removed and evaluated for the percentage of lesions typical 
of infl uenza virus infection in pigs. Each lung was lavaged with 
50ml MEM to obtain bronchoalveolar lavage fl uid (BALF). 
Results
All pigs were free of infl uenza A virus and antibodies prior to 
vaccination. At 24 hours post-challenge, vax/challenge and non-
vax/challenge pigs had signifi cant (P<0.05) febrile responses 
compared to controls. At 72 hours post challenge, vax/challenge 
pigs had a signifi cantly elevated (P<0.05) febrile response to 
infection that persisted to 5 dpi compared to non-vax/challenge 
pigs. Febrile responses in non-vax/challenge pigs returned to 
normal at 72 hours. Vax/challenge pigs had signifi cantly higher 
(P<0.001) macroscopic pneumonia scores averaging 20.5 per-
cent of the lung at 5 dpi compared to an average of 8.9 percent 
of the lung in non-vax/challenge pigs. Macroscopic lesions were 
absent in negative controls. At 3 dpi, 7/10 and 5/10 pigs in the 
vax/challenge and non-vax/challenge groups, respectively, were 
positive for nasal shedding. By 5 dpi, both groups had 9/10 pigs 
positive for virus in the nasal cavity. Virus levels at 5 dpi in nasal 
secretions were signifi cantly less (P<0.001) in the vax/challenge 
group compared to non-vax/challenge pigs. Virus levels in the 
lung were not signifi cantly diff erent. Isolate specifi c hemagglu-
tination inhibition (HI) titers developed only in pigs primed with 
the δ-cluster killed vaccine and no cross-reactivity between sera 
from vaccinated pigs and CA/09 antigens were detected prior 
to challenge. Neutralizing antibodies (NA) against the δ-cluster 
virus were detected prior to challenge in the sera from vac-
cinated pigs although NA responses were lacking against the 
CA/09 virus at the same time. Additional antibody assays are in 
progress.
Discussion
This study demonstrates an enhancement of pneumonia in 
vaccinated pigs challenged with a heterologous, homosub-
typic virus, consistent with previous reports by our group.3 The 
enhanced pneumonia was signifi cantly greater compared to 
pigs challenged with the same virus without previous vaccina-
tion or prior SIV specifi c antibodies. Therefore, it is speculated 
that the vaccine-induced immune response in the lung contrib-
utes to the enhanced pneumonia. In addition, virus replication 
in the nasal cavity and lung were lower in vax/challenge pigs 
in spite of the enhanced lung lesions. To date, this phenotype 
has been experimentally reproduced when pigs are adminis-
tered an inactivated SIV H1 vaccine followed by heterologous 
homosubtypic challenge. This phenomenon has the potential 
to be realized in the U.S. swine population due to the exposure 
of genetically diverse H1 SIV currently circulating among swine 
vaccinated with inactivated heterologous virus vaccines. 
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Introduction
The fi rst outbreak of infection with pandemic infl uenza A (H1N1) 
2009 virus (H1N1/09 virus) in a Norwegian swine herd was 
recorded on 10th of October 2009. Until then the Norwegian 
pig population was considered free of swine infl uenza subtype 
H1N1 and H3N2, as documented by a serological surveillance 
program running since 1997 (1). This paper describes the results 
of a surveillance study in the Norwegian pig population from 
10th of October to 31st of December 2009. 
Materials and methods 
Herds. To investigate the extent of the H1N1/09 virus outbreak 
in Norway in October 2009, the Norwegian Food Safety Author-
ity initiated an increased surveillance targeted at the following 
categories:
• Herds where the pigs had been exposed to persons with veri-
fi ed H1N1/09 virus infection or to persons with infl uenza-like 
symptoms (ILI).
• Herds where pigs with ILI were observed.
• Herds with a history of contact with or close proximity to 
infected herds. 
• Serological screening of nucleus and multiplier breeding 
herds.
Sampling and tests. Initially most herds were tested by nasal 
swabs from 20 pigs. Detection of H1N1/09 virus was done at the 
Norwegian National Veterinary Institute, by real-time RT-PCR 
to detect infl uenza A virus (2). Positive samples were tested by 
H1N1/09 virus specifi c real-time RT-PCR (3). In addition, samples 
were tested at the National Veterinary Institute, Technical Univer-
sity of Denmark, by a H1N1/09 virus specifi c real-time RT-PCR (4). 
Later, many herds, including the nucleus and multiplier herds, 
were tested serologically by an enzyme-linked immunosorb-
ent assay (ELISA, ID Screen® Infl uenza A Antibody Competition 
test, IDVET) and haemagglutination inhibition (HI) test to detect 
antibodies against infl uenza A virus on at least 20 pigs per herd. 
In addition, a few tracheal and bronchial swabs from pneumonic 
lungs, from the slaughter house were tested by RT-PCR.
Diagnostic criteria. One PCR-positive sample or fi ve samples 
positive for antibodies against infl uenza A virus was defi ned as 
suffi  cient to confi rm a farm as positive. If less than fi ve samples 
were positive for antibodies with the ELISA, the herd was re-
tested. The farm is declared negative when the re-tested second 
samples were all negative. 
Results
Of the 114 herds tested by nasal swabs, 54 herds were positive 
for H1N1/09 virus, and 55 of the herds tested by serology were 
positive for antibodies against H1N1/09 virus as confi rmed by HI 
test (Table 1). 
Table1. Molecular and serology results for H1N1/09 virus surveillance 
in Norwegian swine herds from 10th of October to 31st of December 
2009. 
Samples Herds tested Herds positive n (%) Total samples
Positive 
samples
Nasal swabs 114 54 1628 440
Serology 140 55 2659 659
*Total 217 91 4287 1099
*Some herds were tested by both RT-PCR and serology.
Genome sequencing of the virus from one pig confi rmed it as 
identical to the virus from a sick farm staff  member at the same 
farm and that it is at least 99.8% similar to other pandemic 
viruses circulating in humans in Norway. 
Discussion
The majority of the positive herds, especially among the herds 
tested fi rst, had a history of contact between pigs and humans 
whom were diagnosed with pandemic infl uenza or people with 
ILI. This suggests infected humans to be the most likely source 
for transmission of H1N1/09 virus to positive pig herds. Ongoing 
studies will evaluate the risk factors for infection in pigs, and the 
hypothesis that humans transmitted H1N1/09 virus to pigs. The 
diversity of H1N1/09 virus in the Norwegian pig population will 
be studied by sequencing positive samples. 
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Introduction
Pigs are a signifi cant reservoir of H1N1, H1N2 and H3N2 infl u-
enza viruses, strains of which are endemic in pigs worldwide. 
Swine infl uenza virus (SIV) can also contribute to substantial 
economic loss in pig production due to respiratory disease. In 
order to monitor the SIV strains present in the UK, a national 
swine infl uenza surveillance programme was implemented in 
1991, since when avian-like swine H1N1 and H1N2 strains have 
been detected. The programme is based on passive surveillance 
and therefore the true proportion of farms in the UK exposed 
to the diff erent SIV strains and the prevalence of subclinical 
infection is diffi  cult to estimate. The emergence of the novel 
pandemic H1N1v strain in people in 2009 is also a substantial 
threat for the pig industry and infection studies have confi rmed 
the susceptibility of pigs to the virus and the ability to transmit 
from pig to pig. 
For the development of an eff ective active surveillance strategy 
to allow early detection of H1N1v in pigs and to inform prevent-
ive and control measures, the epidemiology of SIV in England 
needs to be better understood. The study presented here aimed 
to provide further key knowledge by investigating farm level risk 
factors for SIV infection in pigs. 
Material and Methods
In 2008/09, 146 farrow-to-fi nish farms were enrolled in a cross-
sectional study; the sample represented about 17% of the Eng-
lish pig herd. Of each farm serum samples of 20 animals of diff er-
ent age groups were tested for H1N1, H1N2 and H3N2 infl uenza 
viruses with haemagglutination inhibition (HI) assays. At the 
time of the farm visit, extensive data on herd management, herd 
health, reproduction management, production parameters and 
the farm environment was collected. Factor analysis was used to 
reduce the number of variables and to account for co-linearity 
in the dataset. To identify herd level risk factors, the identifi ed 
risk factors were tested for association with SIV infection using 
univariate and multivariate logistic regression models.
Results
Fifty-nine % of tested farms had at least one growing pig with a 
HI titre of 1/40 or at least two animals with lower titres. Avian-
like H1N1 was found to be the most common strain in England, 
followed by H1N2 and one farm tested positive for H3N2. Also 
18% of farms tested positive for H1N1 and H1N2, which could 
either be cross-reaction or infection with both strains. H1N2 
positive farms were found across the country. There was how-
ever, a signifi cant cluster of H1N1 positive farms in the Northeast 
of the country with farms located within the cluster having a 
relative risk of H1N1 infection of 4.63. Risk factor analysis identi-
fi ed association of farm size, location, and biosecurity measures 
in place with increased risk of infection with SIV. Also SIV positive 
farms were more likely to be infected with other endemic pig 
pathogens and had poor respiratory scores in slaughterhouse 
monitoring programmes.
Discussion
In conclusion the fi ndings of this study improve our understand-
ing of the current swine infl uenza situation in England. The 
prevalence found is much higher than expected and highlights 
the importance of subclinical infection, respectively that the 
importance of SIV as a signifi cant production disease has been 
underestimated in the past. The fi ndings of the risk factor analy-
sis provide insight in how spread of SIV in general, and spread 
of H1N1v in particular, can be prevented and will inform future 
surveillance activities.
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Introduction
Currently, four clusters of H1 swine infl uenza viruses (SIV) are 
circulating in the North American swine population. The most 
recent endemic H1 cluster to emerge is the human-like, or delta 
cluster, of H1N1 and H1N2 viruses that were fi rst reported in the 
eastern and western USA in 2003 and 2005.1,2 The delta cluster 
viruses, beta cluster viruses (reassortant-like H1) and gamma 
cluster viruses (H1N2-like) are currently co-circulating in the US 
swine population, while classic-like (alpha cluster) viruses are 
still occasionally isolated in the US and Canada.3,4
Materials and Methods
The hemagglutinin protein similarity of delta H1 viruses was 
determined by sequencing the HA1 portion of the gene then 
aligning with Clustal V. A neighbour-joining analysis was used 
to reconstruct phylogenetic trees with the DNASTAR computer 
program. The length of each pair of branches represents the 
distance between sequence pairs, while the units at the bottom 
of the tree indicate number of substitution events. To evalu-
ate the association of genetic relatedness to antigenic cross-
reactivity, SIV-negative pigs were vaccinated with two doses 
of monovalent, adjuvanted and inactivated vaccines prepared 
from diff erent delta cluster viruses.5 Sera were tested for hemag-
glutination inhibition (HI) antibody titers to homologous and 
heterologous delta H1 viruses. The animal phase of these studies 
was conducted according to the guidelines of Pfi zer Animal 
Health’s (PAH) Institutional Animal Care and Use Committee. 
Results
There are genetic diff erences among contemporary delta H1 
SIV (Figure 1). Viruses also diff ered in HI cross-reactivity to the 
homologous and heterologous viruses (Table 1). 
Table 1: Hemagglutination inhibition cross-reactivity of delta H1 
swine infl uenza viruses
Virus Antisera
Antigen 031 718 082 708 726
031 160 <10 40 40 10
718 <10 640 <10 <10 640
082 <10 <10 80 160 <10
708 <10 <10 160 40 10
726 10 320 10 10 1280
Values in bold are homologous titers.
Discussion 
We previously reported strong HI cross-reactivity between delta 
H1 viruses originating from US swine herds in 2005-2007.3,4 
The current results, evaluating additional H1 fi eld isolates from 
2008-2009, indicate both genetic and antigenic diversity among 
viruses within this cluster. These data are consistent with a re-
cent report that also demonstrated diversity among delta cluster 
viruses.6 Although HI cross-reactivity and HA similarity may be 
predictors of variability, vaccination and challenge studies are 
the best predictors of vaccine cross-protection.
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Introduction 
Prior to the introduction of the 2009 pandemic H1N1 virus (1) 
from humans into pigs in the U.S., four phylogenetic clusters of 
the hemagglutinin (HA) gene from H1 swine infl uenza viruses 
(SIV) co-circulated. Viruses from the classical H1N1 SIV lineage 
evolved over time to form α-, β-, and γ-clusters. SIV with HA 
genes most similar to human seasonal H1 viruses emerged in 
2003 to form the δ-cluster (2). All four HA cluster gene types can 
be found with neuraminidase genes of either N1 or N2 subtype. 
Limited information was available regarding the 6 genes that 
make up the triple reassortant internal gene (TRIG) cassette in 
contemporary H1 SIV. In addition, information regarding the 
antigenic relatedness of the H1 viruses and diagnostic reagent 
updates were in need due to the dynamic and variable nature 
of H1 SIV. We characterized 12 H1 isolates from 2008 by sequen-
cing and phylogenetic analysis of all eight gene segments and 
by serologic cross-reactivity in the hemagglutination inhibition 
(HI) assay. 
Materials and methods
Viruses. Swine infl uenza viruses isolated from outbreaks of 
respiratory disease in pigs were grown in Mardin-Darby Canine 
Kidney (MDCK) cells. Virus isolates were: A/SW/NC/02023/2008 
H1N1, A/SW/OH/02026/2008 H1N1, A/SW/MO/02060/2008 
H1N1, A/SW/IA/02096/2008 H1N1, A/SW/KY/02086/2008 H1N1, 
A/SW/MN/02011/2008 H1N2, A/SW/MN/02093/2008 H1N1, A/
SW/MN/02053/2008 H1N1, A/SW/NE/02013/2008 H1N1, A/SW/
NC/02084/2008 H1N1, A/SW/TX/01976/2008 H1N2, and A/SW/
IA/02039/2008 H1N2. 
Antigenic characterization. Four-week-old cross-bred pigs were 
obtained from a herd free of infl uenza virus and antibodies. Two 
pigs per virus were immunized with inactivated virus combined 
with commercial adjuvant by the intramuscular route. Two or 
three vaccinations were given approximately 2-3 weeks apart 
until homologous HI titers reached ≥ 1:80.
HI assays were performed with turkey RBC’s using panels of 
homologous and heterologous viruses and anti-sera with 
standard techniques. Quantitative analyses of the antigenic 
properties of swine infl uenza A H1 viruses were performed using 
antigenic cartography, previously used for human and swine 
infl uenza A (H3N2) viruses(3-4) and 2009 pandemic H1N1 (1).
Genetic characterization. Each virus isolate was concentrated 
and semi-purifi ed on a sucrose cushion followed by library 
preparation for de novo pyrosequencing on a Genome Sequen-
cer FLX system following the manufacturer’s recommendations 
with modifi cations. Briefl y, viral RNA was extracted, fragmented, 
reverse transcribed, and ligated to oligonucleotide adaptors 
containing multiplex identifi er (MID) labels. Pools containing 
MID-labeled viral cDNA were used to prepare sequencing beads 
via Roche’s GS-FLX standard chemistry emulsion-based PCR. 
Prepared beads were loaded into the small 16 regions on a GS-
FLX standard chemistry pico-titer plate and sequenced using 
the GS-FLX LR 70 standard chemistry. Sequencing reads were 
compared to an infl uenza database created from > 85,000 infl u-
enza sequences extracted from GenBank in Dec. 2008. Using the 
BLAST results, sequencing reads were fi ltered, infl uenza specifi c 
reads extracted, and extracted reads were assembled with the 
Roche GS De Novo Assembler (Newbler) version 2.0 applica-
tion. Gene segments with large gaps were closed by traditional 
primer based sequencing using an ABI 3100 genetic analyzer. 
The sequences were analyzed using SeqMan (DNASTAR). Phylo-
genetic analyses were conducted using MEGA version 4.
Results
Based on genetic analysis, each of the four previously described 
phylogenetic clusters of H1 SIV was represented in the 2008 
panel. Additionally, it was demonstrated that the δ-cluster HA 
diverged into sub-clusters δ-1 and δ-2. Serologic cross-reactivity 
paired with antigenic cartography demonstrated that the phylo-
genetic clusters are also divergent antigenically. The genes com-
posing the TRIG were all North American in lineage, although 
genetic variation was apparent.
Discussion
In 2008, fi ve genetic and antigenic clusters of H1 SIV co-circu-
lated in the U.S. pig population with limited HI cross-reactivity 
between them. Genetic diversity was demonstrated in all gene 
segments, but most notably in the HA gene. Gene segments 
from the 2009 pandemic H1N1 formed clusters separate from 
North American swine lineage viruses, suggesting this virus 
was not present in U S. pigs prior to 2009. The HA variability has 
important implications for diagnostic testing as well as vaccine 
development.
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Introduction
Swine infl uenza is caused by type A infl uenza viruses. The three 
commonest swine infl uenza virus (SIV) subtypes are H1N1, H1N2 
and H3N2 although other less frequent or sporadic subtypes 
can infect pig farms as well H4N61 In Spain, previous serological 
studies revealed high seroprevalences for H1N1, H1N2 and H3N2 
viruses in sows2 and fattening pigs3. Nevertheless, available in-
formation indicating risk factors for the introduction and spread 
of the infection in farms is very much scarce. The main objectives 
of the present study were to estimate the seroprevalence of 
H1N1, H1N2 and H3N2 subtypes in sows and fattening pigs and 
to explore the potential risk factors associated with seropositiv-
ity to SIV.
Material and methods
Between 2007 and 2009 a cross-sectional survey was carried out 
in swine farms of pig-producing regions of Spain. Sampling was 
designed to guarantee a 95% probability of detecting at least 
one positive animal for an assumed within-herd seroprevalence 
of 50%. As a result 100 swine farms located all over Spain were 
examined. Epidemiological data were gathered through on-farm 
interview of the farmer based on “closed-ended” questions. For 
each farm, blood samples were collected from 14 sows and 20 
fi nishers, totaling 2,249 pigs for the whole survey. 
Blood samples were analyzed by means of an indirect ELISA 
(CIVTEST Infl uenza, HIPRA) directed to detect antibodies against 
SIV nucleoprotein that was performed according to the manu-
facturer’s instructions. A hemagglutination inhibition (HI) test 
was standardized for H1N1 (A/swine/Neth/Best/96), H1N2 
(strain A/swine/Gent/7625/99) and, H3N2 (strain A/swine/
Neth/St.Oedenrode/96) according to procedures previously 
described4. IH titres ≥80 were considered as positive. SPSS 14.0 
statistical program was used to explore risk factors associated 
with swine infl uenza using the method of generalized estimat-
ing equations5 (GEE). 
Results
By ELISA, all farms had at least one seropositive animal, and in 
total 1,435/2,249 animals yielded positive ELISA results (63.8%; 
IC95%: 61.8-65.8%). Seroprevalence of sows was 77.8% (IC95%: 
75.5-79.9%) signifi cantly higher (p<0.05) than seroprevalence 
in fattening pigs (40.9%; IC95%: 37.6-44.2%). Average seropreva-
lence in positive farms was 68.3%. A total of 1,231 animals 
(54.7%; IC95%: 52.7-56.8%) were positive in the HI test. Again, 
sows had a signifi cantly higher (p<0.05) seroprevalence com-
pared to fattening pigs (72.9%; IC95%: 70.6-76.3 against 24.7%; 
IC95%: 21.8- 27.6). Table 1 summarizes the results obtained by 
individuals and age group. In the epidemiological analysis, four 
variables (open vs. solid partitions between pens, pig density, 
natural vs. forced ventilation and the percentage of replacement 
rate) were identifi ed as risk factors.
Table 1
Discussion
This results shows that SIV is widespread in Spain. The high 
seroprevalence observed against H1N1 and H3N2 compared 
to H1N2 could be explained by a reduced ability to spread the 
latter. The higher seroprevalence observed in sows could be 
explained by the fact that these animals have a long lifespan. As 
a consequence, sows would have more chances to be exposed 
to SIV. The epidemiological analysis also show results obtained 
in GEE have shown that major contact between animals favor 
SIV circulation. Low air renewal enhances a major concentration 
of SIV in environment, which explains higher seroprevalence in 
farms without forced ventilation. Finally, an increasing % of re-
placement, could favor a higher number of susceptible animals 
to SIV infection.
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Introduction
Pigs may act as “mixing vessels” and generate recombinant 
viruses of unknown pathogenicity for animals and humans, as 
refl ected with the last human H1N1 infl uenza pandemia. One 
of the main problems to obtain effi  cient vaccines against fl u is 
the high variability of the virus, limiting the protection to highly 
homologous viruses. 
In an attempt to identify potential cross-reactive epitopes within 
the H1 haemagglutinin (HA), a conformational spectrum analysis 
was done using sequences available in the GenBank database. 
One highly conserved peptide of 34 amino acids mapped in 
the fl anking region of the HA binding site from human A/South 
Carolina/1/18 (H1N1) (NF-34 peptide), was selected1. The object-
ive of this study was to test the protective eff ect of the synthetic 
HA-peptide based vaccine in vivo.
Materials and Methods
A total of eight 8 week-old conventional crossbreed pigs 
seronegative against swine infl uenza viruses (SIV) were ran-
domly divided into two groups (four pigs each). Each group 
was intramuscularly injected three times either with the NF-34 
peptide (10-15 μg per dose) (referred to as G1) or with phos-
phate buff er saline (referred to as G2) two weeks apart. One 
month after last dose, pigs were intranasally inoculated with 106 
tissue culture infectious doses 50% (TCID50) of the human H1N1 
pandemic virus (A/Catalonia/63/2009 strain). Six days later, pigs 
were sacrifi ced. Serum and peripheral blood mononuclear cells 
(PBMCs) taken before each immunization, before challenge and 
at 6 days post-challenge (necropsy day) were used to detect 
specifi c humoral and cellular responses, respectively. Specifi c 
antibodies were detected using a peptide-based ELISA or by 
the haemagglutination inhibition assay, while cellular responses 
were determined by IFN γ-ELISPOT after overnight stimulation 
with either the NF-34 peptide or with inactivated virus. After 
challenge with pandemic H1N1 virus, pigs were sacrifi ced at day 
6 post-challenge and viral loads checked by a real-time qRT-PCR 
in bronchoalveolar lavage (BAL).
Results
Pigs immunized with the NF-34 synthetic peptide developed 
peptide-specifi c antibodies. Also, G1 animals showed an anti-
body boost at day 6 post-challenge (lines in fi gure 1). Similarly, 
peptide-specifi c IFN γ-secreting cells were detected by ELISPOT 
before challenge, showing a clear boost by day 6 post-challenge 
(bars in fi gure 1). Specifi c T-cells did not only recognize the NF-
34 peptide but also the inactivated pandemic virus (data not 
shown). 
Despite the haemagglutination inhibitory antibodies induced 
after vaccination were relatively weak (data not shown), 50% 
(2/4) of G1 pigs showed lower viral load in the BALs compared 
with G2 pigs (Figure 2). 
Discussion
Current vaccines against infl uenza (including those against 
seasonal infl uenza in humans) are restricted to the predicted 
circulating strain at a given time in a specifi c world location. It 
is important to notice that even though only partial protection 
was aff orded in the present pig model, this was obtained against 
one of the most divergent H1N1 strains, with an HA diff ering in 
3 aminoacids from the peptide used to vaccinate. We suggest 
that this strategy could be appropriated to immunize against 
divergent strains by incorporating to the vaccine epitopes able 
to induce neutralizing antibodies enabling to obtain safe and 
effi  cacious subunit fl u vaccines.
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Human-like H1 (δ-cluster) swine inﬂ uenza virus (SIV) can eﬃ  ciently replicate, transmit, 
cause lung pathology and induce humoral immune responses in the swine host
Janice R. Ciacci-Zanella1, 3 Amy L. Vincent1 Eraldo L. Zanella1, 2 Susan Brockmeier1
1. Virus and Prion Diseases Research Unit, NADC, ARS, USDA, Ames, IA, USA; 2. College of Agronomy and Veterinary Medicine 
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Introduction
Genomic characterization of recently identifi ed H1 infl uenza A 
viruses demonstrated the viruses were triple reassortants with 
an internal gene constellation similar to contemporary U S. 
swine infl uenza virus (SIV) but hemagglutinin (HA) and neu-
raminidase (NA) most similar to human seasonal infl uenza virus 
lineages (1, 2). The HA gene of these viruses form the δ-cluster 
in phylogenetic analyses of HA genes from North American SIV. 
PB1-F2 is an infl uenza A virus protein encoded on gene segment 
2 and described to be a virulence factor in other host species, 
but its role in swine is currently unknown (3). The δ-cluster H1 
SIV was demonstrated to contain segment 2 encoding PB1-F2 
proteins with and without premature truncations (3). The object-
ive of this work was to study the pathogenesis and transmission 
of δ-cluster H1 SIV in swine. 
Materials and methods
Three δ-cluster H1 SIV grown in MDCK cells were used in this 
study. Two isolates, A/sw/MN/07002083/07 H1N1 (MN07) and 
A/sw/IL/00685/05 H1N1 (IL05), were chosen due the absence 
of the full-length coding sequence for PB1-F2, whereas A/sw/
TX/01976/08 H1N2 (TX08) contains the full-length PB1-F2 se-
quence. Forty-nine pigs were divided in seven groups composed 
of 3 primary inoculated pig groups with each δ-cluster virus, 
three contact groups and one uninfected control group. Primary 
pigs (n=10) were infected intratracheally with SIV and naïve 
contact pigs (n=5) were co-mingled after 48 hours to be infected 
via natural transmission routes. Nasal swabs were taken on 0, 3, 
5, 7 and 9 days post infection (dpi) or days post contact (dpc) to 
evaluate nasal shedding. Oral fl uids were also collected on days 
3-10, 14, 18 and 20 dpi as described previously (4). Postmortem 
samples including serum, bronchoalveolar lavage fl uid (BALF), 
lung, trachea and nasal swabs were collected at necropsy at days 
5 and 21. Non-challenged age-matched negative control pigs 
were necropsied at 5 dpi (n=5 pigs). Serologic assays included 
the hemagglutination inhibition (HI) (5) assay and the Avian 
Infl uenza MultiS-Screen ELISA (6). In addition to homologous 
HI assays, 21 dpi and 19 dpc serum were evaluated against the 
studied viruses (TX08, MN07 and IL05) as well as a previously 
generated H1 serum panel in heterologous HI assays. Real-time 
PCR assays were performed for detection of SIV (oral fl uids) and 
of PRRSV, PCV2 and Mycoplasma hyopneumoniae nucleic acids 
in BALF using in house assays (3).
Results and discussion
All pigs were seronegative for specifi c antibodies to SIV by the HI 
assay and by ELISA prior to the start of the study. Pigs were also 
negative for PRRSV, PCV2 and M. hyopneumoniae nucleic acids 
in BALF at necropsy. All viruses induced SIV illness; however, 
clinical signs and macroscopic lesions induced by MN07 were 
reduced in severity as compared to TX08 group pigs in this 
study. MN07 infected pigs had lower virus titers in the lung and 
nasal swabs (day 5) than the TX08 and IL05 groups. However, 
on day 7 dpi all of the nasal swab samples from MN07 and IL05 
inoculated pigs were negative. In comparison, the TX08 inocu-
lated group had 80% of the pigs shedding virus in nasal swab 
samples on 7 dpi, with average titers of 101.2 TCID50/ml. In 
contrast to TX08, only contact pigs were still shedding on 7 dpc 
in MN07 (10%) and IL05 (20%) groups. These data demonstrate 
that all viruses were able to replicate and be shed, however 
TX08 was more effi  cient in nasal shedding with higher titers 
and an extended duration of shedding. Oral fl uids samples also 
showed lower however longer viral titers for MN07 (4-9 dpi) and 
IL05 (3-8 dpi) in comparison to TX08. Pigs in this study mounted 
a more robust humoral response to MN07 and IL-05 δ-cluster 
H1N1 compared to the TX08. This was statistically signifi cant for 
HI titers at days 14 and 21. Cross-HI using heterologous virus 
demonstrated little cross-reactivity between the TX08 anti-sera 
and the MN07 and IL05 δ-cluster H1 viruses. However, there 
was cross-reactivity between the MN07 virus and IL05 anti-sera. 
This is consistent with phylogenetic evidence of 2 sub-clusters 
of δ-H1 SIV. This study indicates that the δ-cluster H1 SIV can 
effi  ciently replicate, transmit, cause lung pathology and induce 
humoral immune responses in the swine host. However, the kin-
etics of virus replication, pathogenesis, as well as host humoral 
immune response diff ered between the 3 viruses. Two sub-clus-
ters of the δ-cluster SIV appear to have emerged simultaneously 
with limited serologic cross-reactivity between them. What 
role (if any) the full-length PB1-F2 present in TX08 played in the 
higher nasal shedding of virus remains to be determined.
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Selection of inﬂ uenza vaccine strains and rapid method for producing antigenically homologous vaccine
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Introduction
There are a wide variety of swine infl uenza viruses (SIV) occur-
ring in the United States swine population. The subtypes and 
variants present include 4 clusters of H1 - alpha, beta, gamma 
(which includes the pandemic H1N1 virus) and Hu H1 or delta, 
and one dominant H3N2 (cluster 4).1,2 Traditionally, nucleotide 
sequences of the fi rst 900 nucleotides (5’ end) of the hemag-
glutinin (HA) gene are utilized to classify subtypes of viruses; 
however, genetic similarity does not necessarily correlate with 
antigenic relatedness. When selecting vaccine strains used to 
prevent seasonal infl uenza in humans, a vaccine strain is up-
dated when there is an antigenic diff erence between the vaccine 
strain and a newly emerged strain of greater than 2 units (4-fold 
dilution) in the hemagglutination-inhibition (HI) assay.3 We 
report here the results of preparing antisera in pigs to recombin-
ant protein subunit HA antigens and determining the antigenic 
relatedness of fi eld strains of SIV by HI assay. 
Materials and Methods
Swine infl uenza virus negative pigs were vaccinated twice with 
adjuvanted vaccine consisting of either recombinant H1 beta, 
delta, gamma, pandemic, or Cluster 4 H3 HA subunit proteins 
for the preparation of cluster-specifi c antiserum. Serum samples 
with reciprocal HI titers of 160-320 were used for further HI test-
ing against fi eld strains of SIV. 
Results
Table 1 shows the HI results of 2 H1N1 beta viruses, A and B, 
from diff erent farms. Hemagglutination inhibition titers are 
similar for Farm A and Harrisvaccines (HV) Beta viruses (within 
2 antigenic units of the homologous reaction). Although all 
antigens were genetically similar, HI titers for Farm B are >2 anti-
genic units diff erent from the homologous titers. Table 2 shows 
the HI results of cluster 4 H3N2 antigens. Again, the HV, Farm 
C and Farm D antigens are genetically similar; however, in this 
case, there is little antigenic diff erence discernable by HI. 
Table 1. Reciprocal HI titers for antisera 1 and 2 against viruses Har-
risvaccine (HV) Beta 2009, Farm A 2007, and Farm B 2009. Percent nu-
cleotide similarities to HV Beta 2009 virus are also shown. Homologous 
reactions are in bold. 
HV Beta Virus (2009) Farm A Virus (2007) Farm B Virus (2009)
Antiserum 1 160 160 10
Antiserum 2 320 320 20
% Similarity 100% 97% 96%
Table 2. Reciprocal HI titers for antisera 1 and 2 against viruses HV 
Cluster 4 H3N2 2007, Farm C 2007, and Farm D 2009. Percent nucleotide 
similarities to HV Cluster 4 H3N2 2007 virus are also shown. Homolo-
gous reactions are in bold. 
HV Cluster 4 H3N2 
Virus (2007) Farm C Virus (2007) Farm D Virus (2008)
Antiserum 1 320 320 160
Antiserum 2 320 320 320
% Similarity 100% 97% 96%
Discussion
These antigenic results suggest that the HV beta vaccine would 
protect against a challenge with virus from Farm A but not 
Farm B, despite the high genetic similarity of the three viruses. 
Antigenic drift was detectable in H1 strains, but was limited in 
the H3 viruses evaluated in this study. The H3 viruses were both 
antigenically and genetically similar, suggesting that vaccina-
tion with the HV Cluster 4 H3N2 vaccine would provide cross-
protection against isolates from Farm C or Farm D. These results 
demonstrate that genetic similarity is not the sole indicator of 
possible vaccine protection, and should be combined with anti-
genic analysis to determine if a vaccine will be protective against 
fi eld isolates. Because HA genes can be rapidly exchanged for 
constructs used to produce recombinant HA protein subunits,4 
vaccines for prevention of infl uenza can be created quickly to 
match the strain occurring in the farm of origin. 
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Prior swine inﬂ uenza virus infection enhances pulmonary responses 
to secondary Haemophilus parasuis infection
Susan L. Brockmeier; Crystal L. Loving; Amy L. Vincent
National Animal Disease Center, Ames, IA, USA
Introduction
Swine Infl uenza virus (SIV) infection and associated complica-
tions are a leading cause of morbidity and mortality. It is ap-
preciated that SIV is often complicated by secondary bacterial 
infection. Tracheal epithelial cells (TEC) and pulmonary cells 
respond to infection with proinfl ammatory cytokines for con-
trolling pathogen spread; however, exacerbated responses can 
lead to immunopathology that may be detrimental to the host. 
The extent to which prior SIV infection alters host responses 
to secondary stimulation is poorly understood. Haemophilus 
parasuis is an important and common respiratory pathogen of 
pigs. The innate immune responses of the respiratory tract of 
pigs infected with SIV 5 days prior to secondary infection with H. 
parasuis were examined. 
Materials and Methods
Groups of 4 pigs were infected with SIV and 5-days later 
infected with H. parasuis (SIV/Hps). Non-infected, SIV-only 
and H. parasuis-only groups were included as controls. Pigs 
were necropsied 1 day following H. parasuis inoculation. Pigs 
were inoculated intranasally with 2 X 106 CCID50 of SIV (A/SW/
OH/511445/2007 H1N1) and 106 CFU of H. parasuis strain 12939. 
Nasal wash, tracheal wash and broncho-alveolar lavage (BAL) 
were performed and number of CFU of H. parasuis per ml of 
wash was determined. Levels of IL-8, IL-6, and IL-1 β in BAL fl uid 
and tracheal wash were determined by ELISA. mRNA expression 
of the cytokine genes from tracheal epithelium and BAL cells 
were determined using real-time RT-PCR.
Results and Discussion
H. parasuis colonization was higher in the nose and lungs of SIV/
Hps pigs compared to Hps-only pigs (Figure 1). These results 
indicate that infl uenza virus infection contributes enhanced 
bacterial colonization.
In SIV/Hps pigs, IL-8, IL-6 and IL-1 β protein levels were increased 
in the tracheal wash and BAL, and TEC and BAL cells IL-8, IL-6 and 
IL-1 β mRNA expression levels were signifi cantly increased over 
SIV-only and Hps-only pigs (Figure 2). 
These results support the hypothesis that prior infl uenza infec-
tion alters subsequent immune responses. In addition, the data 
provide evidence of a synergistic response to secondary bac-
terial stimulation in animals previously infected with infl uenza 
virus.
.
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Standard herd classiﬁ cation and related terminology for PRRS virus
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Introduction
For over two decades producers, veterinarians and research-
ers have spent, and continue to spend, impressive amounts of 
time communicating about porcine reproductive and respira-
tory (PRRS) virus. And yet the lack of standard clearly defi ned 
terminology, related to the virus as well as the PRRS virus status 
of herds continues to create confusion and ineffi  ciency. The 
purpose of this paper is to provide a standard herd classifi cation 
scheme describing the PRRS virus status of herds, and a set of 
related defi nitions that is consistent with the biology and ecol-
ogy of PRRS virus. 
Development was jointly undertaken by the American Associa-
tion of Swine Veterinarians (AASV) and the United States Depart-
ment of Agriculture (USDA) PRRS-CAP. A defi nitions committee 
chaired by Dr. Bob Morrison was formed to complete the task. 
The committee was composed of researchers and veterinar-
ians from private practice, universities and industry as well as 
representatives from AASV and the National Pork Board (NPB) in 
the U.S. 
Method for classiﬁ cation of herds
For breeding herds, with or without growing pigs on the same 
premises there are four categories, I to IV. Category II is further 
divided into two sub-categories (II-A and II-B). For premises with 
only growing pigs present there are two categories. 
The herd classifi cation is based upon the shedding and antibody 
status of the herd. The shedding status is classifi ed as nega-
tive, unknown or positive. An unknown shedding status means 
that diagnostic evidence is available to confi rm the sustained 
absence of viremia and there have been no clinical signs over 
a period of time. However, the possibility that virus may be 
present in other tissue of and shed from the tested animals or 
other animals in the herd cannot be ruled out with certainty and 
therefore the shedding status is unknown. The antibody status is 
classifi ed as negative or positive.
Results - Classiﬁ cation of breeding herds
Category I (“positive unstable”) breeding herds have a positive 
shedding and antibody status. It is the default category when a 
status has not been confi rmed. 
Category II (“positive stable”) breeding herds have an unknown 
shedding and positive antibody status. An absence of clin-
ical signs of PRRS in the breeding herd and confi rmation of a 
sustained lack of viremia in piglets, and if present growing pigs, 
for a minimum of 90 days is required. The antibody status of the 
herd remains positive. The possibility that animals in category 
II herds may still be infected and later shed the virus cannot 
be ruled out. A distinction is made between category II herds 
that are not undergoing PRRS virus elimination (II-A) and those 
that are (II-B). An elimination procedure begins when the herd 
is closed to introduction of breeding replacements that are 
not negative. Confi dence that the piglets and growing pigs in 
category II-B breeding herds are not shedding virus is higher 
than for II-B since additional steps are being taken to eliminate 
shedding. 
Category III (“provisional negative”) breeding herds have a 
negative shedding status and positive antibody status. Sus-
tained introduction of negative breeding replacements without 
seroconversion to the PRRS virus is required. Entering negative 
breeding replacements that have been in contact with previ-
ously positive animals and remain seronegative by ELISA for 
a minimum of 60 days is strong enough evidence to confi rm 
that the virus is no longer being shed in the herd. Some adult 
breeding animals in the herd may still have antibodies to the 
PRRS virus due to prior infections. If growing pigs are present, 
confi rmation of a negative antibody status in that subpopula-
tion is also required. Category III herds include those intention-
ally pursuing elimination via herd rollover by entering negative 
breeding replacements. 
Category IV (“negative”) breeding herds have a negative shed-
ding and antibody status. For herds established negative by 
herd rollover, all previously infected animals have been removed 
from the herd or alternatively all adult breeding animals in the 
herd are seronegative by ELISA. If growing pigs are present, con-
fi rmation of a negative antibody status in that subpopulation is 
also required. As with category III herds, sustained introduction 
of negative breeding replacements that remain seronegative 
is required. It also includes new premises startups that were 
populated with negative breeding replacements or premises 
that were completely depopulated and repopulated with nega-
tive breeding replacements that have remained seronegative by 
ELISA.
Results - Classiﬁ cation of growing pig herds
Herds with growing pigs only are classifi ed as either positive or 
negative. Positive herds have a positive shedding and antibody 
status. It is the default category when a negative status cannot 
be confi rmed. Negative herds have a negative shedding and 
antibody status.
Discussion
A standard, universally accepted herd classifi cation scheme and 
defi nitions related to PRRS virus are required to facilitate region-
al and national elimination eff orts. Equally important, they will 
improve communications between researchers, veterinarians, 
producers, genetic companies and other industry vendors by 
decreasing the amount of time required to communicate and 
reducing miscommunications. 
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Modelling PRRSv control within a pyramidal network of pig movements
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Introduction
Epidemiological models can help to improve pathogen control 
through the ex ante assessment of control measure effi  cacy at 
several scales. The pork primary production chain consists in 
pyramidal structures with herds having specifi c links between 
them, some being animal suppliers for others. Since animal 
movements are a key issue for pathogen spread, we elaborated 
a dynamic network model describing between-herd animal 
fl ows. We then tested by simulation the implementation of a 
control program combining both intra-herd control measures 
and restriction of animal movements depending on the sanitary 
status of herds for an important pathogen of pigs: the PRRSv. 
Materials and Methods
A stochastic network model with a one-week discrete time step 
was elaborated based on data collected by a group of French 
producers over 12 months. 256 herds were included in the 
model (4 nucleus herds, 17 multiplier herds and 235 produc-
tion herds). They were divided into four types: breeding (n=7), 
farrow-to-fi nish (n=176), post-weaning-fi nishing (n=5) and fi n-
ishing ones (n=68). Animals concerned by between-herd move-
ments were 8kg-piglets (n=346 movements during the study 
period), 25kg-piglets (n=371), reproductive gilts (n=2440). Herds 
were randomly categorized according to their PRRSv status 
(negative or infected). Nucleus herds were all negative and 
prevalence of herd infection was assumed to be 0.2 and 0.6 for 
multiplier and production herds respectively (Lebret, 2008). This 
status was evaluated every six months. To simulate the imple-
mentation of movement restrictions we generated two sub-
networks based on most connected herds using Unicet software 
version 6: “restricted” (n= 127 herds) and “non-restricted” (n=129) 
sub-networks. In the “restricted” sub-network, the infectious 
status of herds was checked before each movement and a PRRSv 
negative herd can be supplied by negative herds only. Moreover, 
herds of this sub-network may implement control measures 
aiming at reducing the probability of within-herd PRRSv persis-
tence. We assumed that these measures were of variable effi  cacy 
depending on their real implementation under fi eld conditions: 
probability of persistence of PRRSv between two tests (assumed 
to be equal to 1 without measure) could be reduced to 0.95, 0.9 
or 0.8.
Results
The numbers of infected herds observed after 520 weeks of 
control implementation for 100 simulations by scenario are 
presented in Figure 1. The restriction of movements taking into 
account the PRRSv status of herds leads to a slight decrease 
in the number of infected herds (mean values from 180.9 to 
152.4). Additionally when movement restriction was combined 
with within-herd persistence reduction, the decrease was more 
important, leading to a negative status of all herds of the “re-
stricted” network after 10 years if the persistence probability did 
not exceed 0.8.
Figure 1 : Distribution of the total infected herds and infected herds 
in the ‘non-restricted’ sub-network after 520 weeks of simulation under 
four scenarii: no measure, restricted purchases between herds in the ‘re-
stricted sub-network’, both restriction and a 0.95, 0.9 or 0.8 probability 
of the within-herd infection persistence in the ‘restricted subnetwork’
Discussion
Few data are available about the infl uence of control measures 
(biosecurity/vaccination) on the evolution of herd status over 
time. This model is a tool that can be improved if parameters 
of viral persistence can be more precisely determined. To reach 
this objective, data are currently collected. In the same way, 
although animal movements are crucial for herd contamination, 
other ways of viral spread will be considered. Another perspec-
tive is to combine this model with another one representing the 
within-herd viral dynamic. This new combined model will allow 
us to assess control measures implemented at both herd and 
production chain levels.
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McREBEL as a key component for the successful elimination of 
PRRS virus from very large swine breeding herds
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Introduction 
Successful elimination of PRRS virus (PRRSv) from large swine 
breeding herds using herd closure, mass vaccination and 
rollover has been previously described.1 While use of these 
methods have been shown to result in successful elimination of 
PRRS virus from very large breeding herds, consistent elimina-
tion success in very large breeding herds may also require use 
of other management methods that minimize opportunities 
for persistent circulation of virus among subpopulations of 
susceptible animals. An area within breeding herds that may be 
prone to persistent virus circulation is the farrowing area. A set 
of concurrently applied farrowing area management practices 
(McREBEL) have been previously described for use in breeding 
herds to reduce suckling piglet losses during clinical outbreaks 
of PRRS.2 
The objective of this observational study was to describe two 
cases where the discontinuation of McREBEL led to a recurrence 
of farrowing area PRRS virus circulation and the subsequent 
resumption of McREBEL resulted in the disappearance of virus 
circulation, and ultimately virus elimination in both farms. 
Materials and Methods 
In April 2008 two PRRSv naïve 5000 sow farrow to wean farms 
within the same production system and located 1.2km apart 
identifi ed PRRSv positive serum samples collected from gilts, 
sows and piglets by PCR and ELISA. Both farms instituted a herd 
closure, mass vaccination and rollover protocol to eliminate the 
virus. Also, strict McREBEL management practices were imple-
mented in an eff ort to control PRRSv circulation in the farrowing 
area of both farms. 
To assess progress with virus elimination, intensive sampling 
and PCR testing of breeding animal, stillborn fetus and due-
to-wean piglet sera was initiated. Sixty individual due-to-wean 
piglet samples from each farm were tested by PRRS PCR and the 
prevalence of positive samples was followed over time utilizing 
the method described by Cano et al.3 
Initial sampling and testing was conducted monthly, then as 
prevalence decreased to below 20% a weekly sampling and test-
ing frequency was initiated. 
Results 
Following initial herd closure and mass vaccinations, the percent 
of PCR positive piglets declined on both farms to 13.6% at 
Farm A and 3.3% at Farm B. During this time piglets throughout 
farrowing appeared healthy, exhibiting no detectable clinical 
signs of PRRS so farm personnel relaxed McREBEL practices. At 
the subsequent two monitoring periods, the percentage of PCR 
positive piglets on Farm B rose to 12.7% and 33.3%. For the same 
two periods at Farm A the percentage of positives declined to 
6.8% then rose to 30%. Even though piglet health remained 
excellent, McREBEL practices were resumed on both farms due 
to the increase in PCR positives at Farm B. Following the resump-
tion of McREBEL practices, the percentage of PCR positive 
piglets resumed a downward direction on both farms (Figure 1). 
McREBEL practices were continued thereafter until there were 
no detected PCR positive samples found in the sampled due-
to-wean piglets on each farm for at least six consecutive weekly 
samplings. 
Figure 1: Combined percent of PCR-positive individual piglets in two 
previously naïve 5000 sow farms newly infected with wild-type PRRS 
virus.
Discussion 
Individual piglet monitoring provided evidence that premature-
ly relaxing McREBEL protocols during PRRSv elimination can en-
able resumed farrowing area virus circulation among otherwise 
healthy appearing piglets and lead to an increase in PCR positive 
weaned piglets, thus extending the time to negative weaned pig 
interval. 
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Combining sow herd stabilization and nursery PRRS virus control 
methods to achieve improved nursery performance
Jose Angulo; John Kolb; Reid Philips
Boehringer Ingelheim Vetmedica, Inc., St Joseph, MO, USA
Introduction
Porcine Reproductive and Respiratory Syndrome Virus (PRRSv) 
is capable of causing severely negative biological and economic 
impact in nursery pigs. A recent analysis suggests a negative 
impact of US$3.35-$9.12/pig during the nursery phase.1 Nursery 
depopulation and PRRS modifi ed live virus (MLV) vaccination of 
pigs are eff ective tools to minimize the clinical and economic 
impact of PRRSv infection.2,3 The objective of this study was to 
evaluate the impact of sow herd stabilization, nursery depopula-
tion, and PRRS MLV pig vaccination on nursery performance. 
Materials and Methods
The study was conducted in a 3,000 sow three-site production 
system. The sow herd stabilization program included loading 
the farm with its anticipated 170-day need for gilts, closing the 
sow herd for 170 days and mass vaccination of the sow herd 
with Ingelvac® PRRS MLV (BIVI) soon after herd closure. Pig 
interventions included PCV2 vaccination (Ingelvac CircoFLEX®, 
BIVI), Mycoplasma hyopneumoniae (Ingelvac MycoFLEX®, BIVI) 
and PRRS MLV vaccinations in the nursery. Blood sampling was 
conducted monthly on 30 piglets from poor quality litters (1 
piglet sampled per litter) at the sow site, and 20 pigs at 10 weeks 
of age from hospital pens at the nursery site. Along with the 
pig vaccination process, the nursery site was depopulated and 
remained empty for 4 weeks. PRRS RT-PCR testing was con-
ducted on these sera including RFLP and ORF5 sequencing on 
PCR positive samples to diff erentiate wild type and MLV virus. 
The fi rst blood sampling was conducted one month before 
starting the interventions. Mortality rates and average daily gain 
were assessed with statistical process behavior charting using 
MINITAB 15 software. A process change was inserted at the time 
of nursery depopulation and the onset of pig PRRS vaccination, 
with 93 groups closeout data prior to and 77 groups closeout 
data charted after the interventions. 
Results
Wild type PRRSv was detected in 17% (5/30) of pre-weaning pigs 
and 100% of nursery pigs (n=20) the month pre-intervention but 
was not detected in any pigs during the 9 months post-interven-
tion. MLV PRRSv was detected in nursery but not pre-weaning 
pigs post-intervention. The mean nursery mortality rate de-
creased from 2.90% pre- intervention to 2.15% post-intervention 
(Figure 1). Mean average daily gain (ADG) increased from 0.822 
pre-intervention to 0.936 lb/day post-intervention (Figure 2).
Figure 1. Percent nursery mortality pre- and post-intervention.
Figure 2. Average daily weight gain (lbs) pre- and post-intervention.
Discussion
Sow herd stabilization, nursery depopulation and on-going MLV 
PRRS vaccination of nursery pigs were successful at controlling 
wild type PRRSv. 
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Herd closure as a strategy to eradicate PRRSV not always a success in large sow herds
Giampietro Sandri1 Patrizia Pesente2 Davide Giovanardi2
1. Agricola Tre Valli, Quinto di Valpantena - Verona, Italy; 2. Laboratorio Tre Valli, S.Martino Buonalbergo, Italy
Introduction
Understanding the dynamics of PRRSv persistence is essential 
for the development of successful PRRS control and eradication 
programs1. Among these, “Herd Closure” - a months long closure 
of the sow herd - is considered to be one of the most successful. 
It relies on consistent natural exposure that should provide a 
“sterilizing immunity” to all breeding stock on the farm lead-
ing to the natural disappearance of the virus by replacement of 
positive animals over time2. We decided to use Herd Closure as 
initial strategy to eradicate PRRS from three large sow herds (site 
one) in northern Italy with some disappointing results.
Materials, methods and case description
Serum samples at diff erent stages and places were tested for 
PRRSv antibodies by IDEXX PRRS Elisa. A conventional one step 
RT-PCR developed by Laboratorio Tre Valli was used for viral Rna 
detection. Sequencing in the ORF 7 region followed.
Farm M. (7.500 sows)
After experiencing a major PRRS outbreak during summer 
2004 and instability throughout December of the same year, 
gilt replacement was fi nally discontinued in January 2005. The 
last group of gilts was introduced in mid January 2005 and the 
following were all diverted to outside projects. The fi rst animals 
(pregnant gilts) were re-introduced on Dec.15 2005 leading to a 
total closure period of 11 months.
Farm SQ. (6.500 sows closed herd)
Major PRRS outbreak from October 2005 to January 2006. 
Internal gilt production was discontinued and off  site nursery 
and rearing projects were started with purchased PRRS nega-
tive animals starting from March 15th 2006. A Wean & Removal3 
program was started in September 2006. PRRS negative animals/
gilts were again introduced on March 1st 2007 leading to a com-
plete herd closure time of 12 months.
Farm A. (4.500 sow)
A severe PRRS outbreak occurred in this herd starting in April-
May 2008. It was soon decided to discontinue gilts replace-
ment in order to stabilize the herd and to prepare a possible 
future PRRS eradication project. The last 3 weeks old gilts were 
introduced on May 19th 2008 and soon were exposed (serum 
inoculated) – together with all the other gilts present in the 
nursery compartment – to the farm strain. After this point in 
time all replacement gilts were diverted to off  site nursery, 
growing and breeding projects.The fi rst group of PRRS negative 
pregnant gilts entered in this herd again on April 27th 2009 after 
a complete closure more than 11months long.
Results 
After closure Farm M. reached a reasonably good production 
level without signifi cant clinical problem but was never able to 
produce again PRRS negative piglets. When PRRS neg. pregnant 
animals returned to farrow on farm a contingency plan allowed 
good segregation of that population but unfortunately PRRSv 
started to re-circulate causing clinical problems early in April ’06. 
Farm S.Q. was more successful because stabilized reasonably 
soon and as early as July ’06 was able to consistently produce 
groups of PRRS neg. piglets with the exception of a few batches 
in Dec.’06 when a little re-circulation occurred. Thank to the 
intensive Wean & Removal program4 in place PRRS eradication 
was achieved anyhow. Also Farm A. reached a good stabilization 
after Herd Closure but was never able to produce again PRRS 
negative piglets. The PRRSv strains recovered from diff erent 
nursery sites always showed an almost complete homology with 
the farm strain. Not long after the fi rst pregnant gilts started to 
farrow on farm they showed some PRRS clinical signs. The PRRSv 
recovered showed over 99% homology with the previous one. 
In spite of Wean & Removal PRRS eradication did not succeed in 
this farm. 
Conclusions
Herd Closure after a major PRRS outbreak is defi nitely a good 
measure to speed up the return to clinical stability. Although in a 
number of diff erent occasions Herd Closure proved to be a suc-
cessful PRRS eradication tool it was not the case in our experi-
ences. Under the conditions described before, even after very 
long closure periods, the specifi c PRRS viruses were still present. 
Though we have no evidence that any single animal can carry 
PRRSv for such a long time (11 mo.), we think that large herds 
with a lot of buildings and compartments certainly provide a 
“favourable environment” for the virus to “survive and move 
around” end eventually start new outbreaks when large naïve 
populations are introduced again.
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Clusters of biosecurity in Ontario sow herds and their geographical distribution
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Introduction
Implementing good biosecurity has direct benefi ts at the herd 
level since it is critical in reducing the likelihood of introduction 
and spread of emerging or endemic animal pathogens. In addi-
tion, biosecurity standards are increasingly having an impact at 
the industry level. Management practices related to biosecurity 
could be used to defi ne a subpopulation and provide a basis for 
compartmentalization (1), to assist in the design of risk-based 
surveillance (2), or as an aid in regional disease control and 
eradication strategies. Studying biosecurity, however, is not 
without challenges. Several approaches and resulting assess-
ments have been previously reported. The aim of this work was 
to assess biosecurity practices in Ontario sow herds including 
the determination of best number of biosecurity classes, charac-
teristics of these classes, and their geographical distribution and 
association with herd density.
Materials and Methods
Questionnaire: The questionnaire used for this study was a part 
of the PRRS (Porcine reproductive and respiratory syndrome) 
Risk Assessment for the Breeding Herd (version 2) developed 
elsewhere, owned by the American Association of Swine Veter-
inarians and used extensively across North America (3). Three 
evaluators were trained and performed personal interviews 
with owners and herd veterinarians of 161 sow herds in Ontario 
during the summer of 2007. Herds were selected conveniently 
through herd veterinarians. The original questionnaire contained 
155 questions divided into internal and external risk sections 
and 24 questions related to the demographics of the site. 
Selection of variables for multivariate analysis: Out of all ques-
tions available, only 24 categorical variables were included in the 
statistical analysis. Variables were included if they were indica-
tive of the introduction of pathogens from external sources in-
cluding replacement animals and semen, management options 
related to acclimation and isolation units, site policies related to 
visitors, tools, sanitation, and protocols related to transportation 
of animals, feed, and people. Variables related to density of pig 
herds as well as variables related to herd type and demographics 
were excluded from this initial classifi cation step. All variables 
were categorical with 2 to 4 discrete levels.
Statistical analysis: Two classifi cation methods were used to clas-
sify the data: (i) two-step hierarchical clustering (SPSS 17) and (ii) 
latent class analysis (SAS 9.2, proc lca). Both of these methods 
have advantages over other classifi cation methods in that they 
use statistical criteria to determine the best number of sub-
classes and because they can directly analyze nominal variables. 
Best number of classes was determined using both methods, 
examined descriptively and agreement was assessed using 
the kappa statistic. Generalized additive models using logistic 
regression (R, package mgcv) were then used to map each of the 
biosecurity groups by displaying expected risk on a 10x10 km 
grid of Ontario. In addition, multinomial logistic regression (Stata 
10) was used to investigate the association between biosecurity 
groupings of sow herds and variables indicative of herd density 
obtained through the questionnaire.
Results
Three classes of biosecurity practices exist in Ontario sow herds. 
This number, determined using the two diff erent methods 
and classifi cation of herds was in almost perfect agreement 
(kappa=0.83). Best description of these three is: (i) “High” bios-
ecurity sow herds, (ii) “Low to moderate” biosecurity sow herds, 
and (iii) “Closed” sow herds. Proportion of sow herds that were 
classifi ed in the high biosecurity group was higher in areas of 
high swine herd density. This result was confi rmed independ-
ently by regressing the biosecurity group classifi cation against 
the number of swine herds within a 8 km radius from each site 
(Overall P=0.03). The probability of being a high biosecurity herd 
was lower than the probability of being a low biosecurity herd 
in areas of low pig-herd density. In contrast, the probability of 
being a high biosecurity herd was higher than the probability of 
being a low biosecurity herd if number of neighbouring herds 
was high. 
Discussion
These results contribute to our understanding of the types of 
herds that currently exist in Ontario, and the identifi cation of 
practices in each group that should be prioritized for further 
improvement. Another important fi nding was the association 
between high biosecurity and high density of pig herds. The 
establishment of a high biosecurity herd in a pig-dense area 
may be facilitated through two diff erent processes: (i) neces-
sity of protecting animal populations in a herd located in a pig 
dense area, (ii) available expertise typically present in such areas. 
However this fi nding could impact the design of regional dis-
ease control strategies and needs to be evaluated in other swine 
producing regions. 
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Using air ﬁ ltration to reduce the risk of PRRS introduction
Darwin L. Reicks
Swine Vet Center, St. Peter, MN, USA
Introduction
There is a signifi cant economic advantage to maintaining a PRRS 
negative herd, whether it is a boar stud, sow farm, nursery, or 
fi nish. As aerosol transmission of PRRS, Swine Infl uenza, and 
Mycoplasma diseases are being accepted as reality, any means 
to prevent aerosol transmission of these agents is of great inter-
est. Our practice has taken an aggressive approach with our pro-
ducers on air fi ltration systems. Six farms implemented fi ltration 
in 2005, fi ve in 2006, eleven in 2007, and twelve in 2008, two in 
2009, and two in 2010. 
Materials and Methods
There are 21 boar studs, 12 sow farms, 3 research barns, and two 
fi nishing sites. Small and large farms have been fi ltered. Nine 
of the sow farms are over 2500 sows. The other three are 700 
– 1200 sows. Six of the boar studs are air conditioned. Aerosol 
transmission of PRRS virus can be repeated experimentally and it 
is becoming widely accepted to be a common way that negative 
farms become re-infected.1,2 One challenge for implementation 
of air fi ltration is the number of fi lters needed to obtain ad-
equate air fl ow through a barn during summer time ventilation. 
Fifteen of the fi ltered farms are partial fi ltered, where air is not 
fi ltered during the summer months when ventilation rates are 
high. Rather than using a true HEPA fi lter, we have utilized a fi lter 
with slightly lower effi  ciency, either the L9 or L6 fi lter from Cam-
fi l Farr. This is the same fi lter used successfully in experiments.1,2 
The cost to fi lter a farm depends on the fi lter used (L9 is more 
restrictive so more fi lters are needed), and whether air enters 
the farm the same way year round or whether there is a diff erent 
ventilation system for summer (i.e. tunnel ventilation) than for 
winter. In general, fi lters last about 3 years, and the cost per pig 
over a 10 year period ranges from $1.00 to $1.60 per pig in US$. 
Results
The fi rst boar studs in our practice were fi ltered in August 2005. 
Since implementation of air fi ltration, we have had four PRRS 
breaks on farms using partial fi ltration. Three were infected 
when the air was not being fi ltered, and one was when the air 
was fi ltered, but a signifi cant amount of air was back drafting 
through non-operational fans. We have had two PRRS breaks 
on farms with 100% fi ltration, although we believe that was the 
result of a transportation biosecurity breach or the result of hav-
ing a number of heavily damaged fi lters in use. We have had two 
Swine Infl uenza breaks on 100% fi ltered farms. We have not had 
any Mycoplasma hyopneumoniae breaks on any of the fi ltered 
farms, although most are vaccinated. An important considera-
tion for us from the start has been that we shouldn’t expect to 
never have a PRRS break just because we installed air fi ltration. 
However, if we can reduce the incidence of PRRS breaks sig-
nifi cantly, it would be good return on the investment. This has 
proven to be the case, in our experience. Most of the farms that 
have fi ltration had a previous history of multiple PRRS breaks. I 
have been tracking the results of fi lter farms for the 5 years prior 
to, and after fi ltration and updating the results quarterly. The fol-
lowing table shows the results through 1st quarter 2010 for 38 
Swine Vet Center client farms. The # of Farm Years indicates the 
number of years the farm was in existence in the fi ve years prior 
to implementing fi ltration, since some farms were less than fi ve 
years old at the time of fi ltration.
# of Farms 38
# Farm years prior to fi ltration 152
# PRRS breaks in 5 years prior to fi ltration 51
Break Rate per year 34%
# Farm Years with 100% Filtration 50
# PRRS breaks in 100% fi ltered farms 2
Break Rate per year 100% fi ltered farms 4%
# Farm Years with partial fi ltration 51
# PRRS breaks in partial fi ltered farms 4
Break Rate per year partial fi ltration 8%
Discussion
Air fi ltration systems have been in place in our practice for nearly 
5 years, in a wide variety of farms. For boar studs, fi ltration has 
become the standard. To date, fi ltration has reduced the annual 
break rate on 38 farms from 34% prior to fi ltration to 8% after 
fi ltration for partial fi ltered farms and to 4% for 100% fi ltered 
farms.
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A PRRS vaccination strategy to create PRRS-negative growers/gilts in SPF herds (re)infected with PRRS
Geertjan van Groenland1 Toine Cruijsen2 Victor Geurts2
1. TOPIGS S&D, Helvoirt, Netherlands; 2. Intervet-Shering Plough, Boxmeer, Netherlands
Introduction:
PRRS infections still lead to severe economic losses in the pig 
industry (1). It is possible to create PRRS-negative farms by 
depopulation and repopulation with negative piglets and gilts 
from PRRS-free farms. Despite stringent hygienic procedures 
on these farms, it is diffi  cult to keep them PRRS-free in pig 
dense countries like the Netherlands. Between Febr-2006 and 
May-2008, 5 farms in the Netherlands became PRRS-free by 
depopulation and repopulation with SPF- pigs or by introducing 
SPF pigs in a new farm, and all of them became infected after 
6 to 22 months. The PRRS-infection-route could not always be 
identifi ed. Therefore, farmers choose to produce PRRS-negative 
growers and gilts via a system of vaccination together with 
testing and optimization of biosecurity. Vaccination of piglets 
was ceased as soon as there could not be detected PRRS-fi elds 
virus anymore in the outfl ow (by serological and virological 
tests). A conventional boar-producing farm followed the same 
strategy. The chosen PRRS vaccine (Porcilis® PRRS) reduces verti-
cal transmission and reduces virus circulation in the population 
following vaccination [Ro <1] (3, 4). Furthermore, to reduce the 
risk of transmission between pigs by needle injection, a needle-
less vaccination system was used (IDAL®, intra dermal applicator 
of liquids, Intervet/Schering-Plough animal health). The vaccine 
had already been eff ective in eradicating PRRS from farms(5).
Materials and methods:
Step 1. Once PRRS infection had been diagnosed on SPF farms, a 
cross-section of sows, piglets, fatteners and breeding gilts were 
sampled in combination with pooled virus isolation or PCR in 
order to investigate the spread. All biosecurity measures were 
checked and optimized and all pigs older than 2-weeks were 
vaccinated (herd vaccination, i.e. all sows, gilts, piglets, growers, 
fatteners). Sows were vaccinated 2-4 times with intervals of 2-4 
weeks, thereafter all sows/gilts were vaccinated in mid-gestation 
(day 60) and during lactation (day 6). After the initial herd vac-
cination piglet vaccination was started at 14-21days of age. On 
farm 3, only (pregnant) gilts and boars were present that were 
vaccinated only once.
Step 2. After 3-6 months, again sows, breeding gilts, and pigs of 
4, 10, 16, and 22-26 weeks of age were sampled for serological, 
and virus isolation or PCR. When the tests for PRRS fi eld virus 
were negative, piglet vaccination was ceased. 
Step 3. Farms which had stopped piglet vaccination were 
monitored by the same sampling procedure as in Step 2, every 4 
months.
Results:
Until now (February 2010), fi ve out of six farms succeeded in 
producing PRRS negative gilts/growers/boars. Only one farm got 
re-infected during the trial, the isolated strain was an US-type 
PRRS strain. No vaccinations were added after this herd became 
re-infected (sow/gilts vaccination was continued) partly due to 
the fact that no clinical signs were seen after re-infection and 
the spread was limited (most cohorts were PRRS negative). From 
September on sera from 10-weeks-old pigs tested negative for 
PRRS. 
Farm PRRS-free Re-inf. Type Source
Neg.
outfl ow 
again
Re-
infected
Type
1 New Feb-06 Mar-08 EU ? Jan-10 no
2 Convent. Mar-06 EU ? Dec-07 no
3 New Nov-05 Aug-06 EU ? May-07 no
4 De-pop 
Re-pop
Aug-06 Dec-07 EU ? May-08 Dec-08 US
5 De-pop 
Re-pop
Feb-08 Feb-08 EU Neighbour Q04-2009 no
6 De-pop 
Re-pop
May-08 Jan-09 EU Gilt Suppl. Oct-09 no
Conclusion and discussion:
Via testing, adjustments to biosecurity and targeted vaccination, 
it was possible to create PRRS-negative pigs from SPF farms that 
were infected with PRRS. In a pig dense country as the Nether-
lands where the estimated introduction risk of PRRS is high, this 
system proved to be eff ective in controlling PRRS.
On all farms, except for farm 3, sow vaccination (day 6- day 60) 
was continued to minimize the risk of vertical transmission 
because viremic born piglets will further spread the infection 
through the herds.
Sequence analyses on farms helps to identify the likely routes of 
re-infection. Two such routes were discovered during this trial/
survey: (i) an aerosol infection originating from a neighboring 
farm and (ii) via infected replacement gilts. Because almost all 
SPF-farms in the Netherlands became infected after depopula-
tion/repopulation it seems that (i) either regional approach or 
(ii) air-fi ltration of incoming air will be necessary for farms in pig 
dense areas such as The Netherlands to remain PRRS-free(2). 
In the meantime vaccination of sows and gilts, together with 
well-defi ned internal biosecurity can be used to produce PRRS-
negative off spring in infected breeding farms as well as in farms 
that are “at risk”.
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PRRS modiﬁ ed-live virus mass vaccination and its potential role in regional control programs
Jean P. Cano; Laura Batista; Enrique Mondaca; Reid Philips; Dale Polson
Boehringer Ingelheim Vetmedica, Inc., St Joseph, MO, USA
Introduction
Mass vaccination combined with unidirectional fl ow, herd 
closure and/or partial depopulation has been used success-
fully for porcine reproductive and respiratory syndrome (PRRS) 
control and eradication.1-3 However, the eff ects of therapeutic 
vaccination on the infection dynamics at a population level had 
not been studied. Two large scale experiments were conducted 
under commercial conditions in order to evaluate the eff ect of 
PRRS modifi ed live virus (MLV) mass vaccination on wild-type 
virus transmission and pig response to a highly virulent heter-
ologous challenge.4,5 In these studies, pigs were infected with a 
homologous4 or heterologous5 PRRS virus (PRRSv) isolate prior 
to therapeutic MLV vaccination. The model also simulated the 
introduction of a new highly virulent strain to pig populations 
with diverse “exposure backgrounds”.4,5
Materials and Methods
For the heterologous study, 80 PRRSv-naïve pigs per group (A-D) 
were inoculated intranasally (IN) with PRRSv MN 30-100. At 7 
days post-inoculation (DPI), pigs were vaccinated IM with Ingel-
vac® PRRS MLV vaccine. Group E was designated as the negative 
control. Pigs in group F received only vaccine. To evaluate viral 
transmission, sentinel pigs were introduced periodically to each 
group and sacrifi ced-sampled 30 days later. To evaluate persis-
tence, 10 pigs per group were sacrifi ced-sampled at diff erent 
DPI. At 98 DPI, 10 pigs per group were transported to isolation 
facilities and inoculated IN with PRRSv MN 184. A naïve pig was 
introduced to each of the rooms with 5 inoculated pigs 3 days 
after the MN 184 challenge.
Results
Consistent with the homologous study, but in a more fi eld rel-
evant scenario, heterologous therapeutic vaccination:
• Avoided wild-type virus transmission to naïve-sentinel pigs 
after 97 DPI.
• Did not “displace” the wild-type virus from the population, or 
reduce the proportion of persistently infected pigs within 127 
DPI.
• Did not reduce the viral load in lymphoid tissues of persis-
tently infected pigs. 
Previous exposure to PRRSv, including one dose of Ingelvac® 
PRRS MLV (group F), signifi cantly reduced clinical signs and 
increased post-challenge weight gain, but infection or shedding 
of a highly virulent heterologous isolate was not prevented. 
Pigs in group E remained ELISA and PCR negative through the 
duration of the study.
Discussion
These results represent a detailed and controlled evaluation 
of the benefi ts and limitations of the use of PRRS MLV mass 
vaccination under controlled fi eld conditions involving a large 
population of pigs. Therapeutic vaccine intervention prevented 
viral shedding to naïve pigs and signifi cantly improved clinical 
protection against a highly virulent heterologous challenge. 
Therefore, therapeutic vaccination may be used in combination 
with other strategies to reduce duration of PRRSv transmission 
and to increase the resistance of pig herds under certain scen-
arios in the fi eld. This is especially relevant in a regional control 
context, where reducing shedding from infected populations 
and increasing resistance of susceptible populations is crucial 
for success. Potential applications of PRRS MLV mass vaccination 
intervention in regional control programs include: 
• sow-herd mass exposure prior to a herd closure strategy, 
• gilt acclimation programs,
• reduction of susceptibility of PRRS naïve-pigs placed into 
high prevalence areas, and
• reduction of infectiousness (shedding of wild-type virus) of 
PRRS infected-pigs placed into low prevalence areas. 
Further epidemiological investigations need to be conducted 
to better understand the benefi ts and limitations of PRRS MLV 
mass vaccination intervention on a regional scale. 
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Advancing PRRS area regional control in the state of Sonora, Mexico
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1. Boehringer Ingelheim Vetmedica, Inc., St Joseph, MO, USA; 2. Comite de Sanidad Porcina de Sonora, Sonora, SON, Mexico
Introduction
The global swine industry faces economically devastating 
diseases such as porcine reproductive and respiratory syndrome 
(PRRS)1, porcine circovirus associated diseases (PCVAD), and 
new variants of infl uenza. Consequently, veterinarians have 
developed diff erent means for individual or groups of farms 
to control and possibly eradicate diseases. However the risk of 
re-infection remains high even with the best current biosecur-
ity practices.2 This has led to the consensus that more coordin-
ated, or ‘regional’, approaches must be taken to combat PRRS 
and other emerging swine diseases, rather than isolated eff orts 
on individual farms which are often frustrated by the reappear-
ance of a disease. Therefore, the objective of this study was to 
establish a PRRS regional control program in the State of Sonora, 
Mexico to reduce the economic impact of this disease in the 
Sonoran swine industry.
Materials and Methods
In September 2008, producers from the state of Sonora in 
northwest Mexico decided to organize to implement a regional 
PRRS control program. The region of 182,554 sq km, included 
74 independently owned production systems with various 
production structures (i.e. farrow to fi nish, three site, and 
multisite production) with a total of 134,000 sows. The program 
was divided in three phases: phase 1 (September 2008-March 
2009), data collection, understanding of the state’s production 
industry organization, mapping, clusters and working groups 
establishment; phase 2 (April -September 2009) estimation of 
PRRS prevalence and virus sequencing analysis, individual farm 
risk assessment using the AASV PADRAP tool3, establishment of 
the program’s website, and monthly continuous education and 
communication meetings with producers and veterinarians; 
phase 3 (October 2009-September 2011), pig and transportation 
route planning and implementation of farm and region control 
strategies.
Results
As of October of 2009, phases 1 and 2 have been successfully 
completed. The state was divided into three geographical 
regions with a 95% state PRRS prevalence. Twenty three working 
groups, including 91 clusters, were established and sequencing 
information allowed the identifi cation of 5 major PRRS virus 
families. One hundred and twenty four PADRAP evaluations 
were completed and individual and regional analyses were 
performed.
Discussion 
Information collection is a cumbersome and sometimes frus-
trating task, however, without the completion of phases 1 and 
2 it would have been very diffi  cult to establish solid bases to 
design and implement farm and regional PRRS control strat-
egies. Disease control programs rely on accurate epidemiologic 
surveillance, access to appropriate tools for diagnosis and con-
trol, and adequate fi nancial and human resources. To date, we 
have identifi ed 3 major components leading to the successful 
advancement of this program. One, producer and veterinarian 
leadership and involvement; 2, regular informational meetings 
with local producers and veterinarians addressing advances 
of the program, continuous education, issues related to con-
fi dentiality, access to data, etc.; and 3, the establishment of a 
producer-paid economic fund, in the case of Sonora a fee is paid 
per sacrifi ced animal, which allows the advancement of the pro-
gram. If we are able to foster producers participation, set aside 
individual interests and use valid knowledge and understanding 
of pathogen transmission and how to prevent it, understand the 
impact of geographical location and implement eff ective rather 
than “psychological” biosecurity strategies, we can help our 
producers with the battle against PRRS virus and other econom-
ically important pathogens. Successful implementation of PRRS 
area regional control holds the potential to restore success and 
profi tability to the swine industry of Sonora.
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Introduction
Swine producers and veterinarians have several options to man-
age a herd when facing a PRRS outbreak. Some will allow the 
disease to follow its course while trying to address the clinical 
signs with individual or population treatments, others will use 
vaccination with commercial vaccines or expose all sows to PRRS 
virus recovered during the outbreak, while others will use tilmi-
cosin in the immediate 4 weeks following the PRRS onset with 
or without virus exposure. The objective of this project was to 
evaluate production loses and economic effi  ciency of common 
intervention strategies.
Materials and Methods
Veterinarians in Ontario and Quebec (Canada) were asked to 
provide computer records from sow farms that experienced 
PRRS outbreaks since January 2004 and to fi ll a questionnaire 
with demographic, diagnostic and intervention data. Computer 
records were extracted and collapsed to weekly averages or 
counts, as appropriate. Temporal iterative multivariate scan sta-
tistics (SatScan 7.0) was used to determine onset and duration 
of outbreaks. This was confi rmed with the questionnaire data. 
Weekly data were then summarized to three periods for each 
farm: (i) 6-months pre-outbreak, (ii) outbreak, (iii) 6 months 
post-outbreak. Proportional change in number of pigs weaned 
was calculated for each period, relative to pre-outbreak level. 
Cost of intervention was calculated from quantity of substances 
spend in the sow herd. Best fi tting distributions were deter-
mined within each intervention category and stochastic partial 
budgeting model was constructed (@Risk 5.0). Proportion of 
sows that farrow per week and average number of pigs weaned 
per litter were estimated using random intercept linear model; 
intercept (mean) and residual standard deviation were used in 
the economic model to obtain a range of scenarios. Scenario 
evaluated was based on fi xed herd size of 1000 sows, 36$CND 
for a weaned pig, and 32 weeks after the start of outbreak. In 
economic model, “Late homologous exposure” and “Tilmicosin 
with or without homologous exposure” strategies were evalu-
ated using “No intervention” strategy as a baseline. Although 
other interventions strategies were used, they were not included 
because of insuffi  cient number of cases available to produce 
input distributions. 
Results
Assuming each piglet would be sold at $36, we estimated that 
if a farm chooses to do nothing, a PRRS outbreak will typically 
result in a loss of $80/sow/outbreak in potential revenue from 
reduced weaned pig sales over a period of 6 months. At the 
extremes, in the best case a farm will lose as little as $29/sow/
outbreak while the worst case, a farm will lose as much as $158/
sow/outbreak when no treatment is selected. The farms under 
study that chose to do nothing still incurred additional expenses 
from increased number of individual treatment. These comfort 
treatments cost on average $2.60/sow/outbreak. In farms that 
chose to try a PRRSV exposure control strategy, the PRRS out-
break either was shorter in duration or fewer piglets were lost. 
This resulted in higher revenue from wean piglets sale. The farms 
that exposed sows to PRRS virus, showed $20 higher revenue/
sow/outbreak on average, than farms that chose to do nothing, 
while farms that included tilmicosin in the gestation diet after 
the outbreak, showed an average of $55 higher revenue/sow/
outbreak than farms that chose to do nothing. Total intervention 
expenses related to individual animal treatment on farms that 
chose to expose sows with the PRRS virus averaged $2.90/sow/
outbreak while farms that chose Pulmotil showed total average 
medication expenses of $12.80/sow/outbreak. Herds apply-
ing late homologous exposure strategy were expected to have 
lower revenue than herds without any intervention in 35% of 
cases. Herds applying tilmicosin strategy, with or without hom-
ologous exposure, were expected to have lower revenue than 
herds without any intervention in 13% of cases.
Conclusions
Under conditions evaluated in this study, no-intervention 
strategy seemed to be the most costly approach of manag-
ing PRRS outbreak in a sow herd. Management of PRRS under 
alternative, and more costly strategies, was expected to yield 
higher revenues on average; although none of the strategies is 
better under all scenarios. Under ideal conditions, collection of 
data that could be used for economic analysis would be a part of 
every routine outbreak investigation in swine herds.
.
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Introduction 
Throughout the second half of 2006, large-scale, devastating 
outbreaks of porcine reproductive and respiratory syndrome 
(PRRS) aff ected several provinces of China1. That epidemic 
was linked to a hypervirulent genotype-II PRRS virus (PRRSV) 
harboring a distinctive deletion1. Economic losses from those 
outbreaks results from deaths but also from loss weight and 
impaired performance. Control of such outbreaks proved dif-
fi cult and those hypervirulent strains spread in Asia. At present, 
genotype I strains are also present in diff erent countries of Asia. 
AMERVAC®-PRRS (a genotype-I vaccine) is being marketed in 
Asia for the prevention PRRS virus infections. Is feasible that 
some herds vaccinated with AMERVAC®-PRRS could confront the 
infection with a hypervirulent Asian strain. The present study 
was intended to determine if vaccination with AMERVAC®-PRRS 
could produce some benefi cial eff ect on performance of pigs 
infected with the hypervirulent strain.
Material and Methods
Twenty-one 4-week-old, PRRSV-naïve pigs were randomly 
divided into three groups (G1 n=8, G2 n=8 and G3 n=5) and 
housed separately in isolation facilities (BSL3 at CReSA, Barce-
lona, Spain). Animals in G1 received intramuscularly (day 0) 2 ml 
of a European-type modifi ed live PRRS vaccine (AMERVAC®-PRRS 
containing 104.6 TCID50/ml). G2 and G3 pigs remained unvaccin-
ated. At day +32, pigs in G1 and G2 were intranasally inoculated 
with 2 ml of 1x105 TCID50/ml of the strain PRRSV21 that was 
isolated from a highly virulent case of PRRS in Asia and share 
99% similarity in ORF5 with other highly virulent genotype-II 
Chinese PRRSV strains. Pigs in G3 remained uninfected along the 
trial. Weekly body weight (BW), average daily feed intake (ADFI) 
and clinical signs were assessed during the 21 days of the chal-
lenge phase of the study. Statistical analyses were done using a 
non-parametric Mann-Whitney test. 
Results 
After challenge, pigs in G2 suff ered an evident respiratory 
distress starting the 5th day post-inoculation (dpi) and lasting in 
most animals until the end of the trial. In G2, two animals died 
before the end of the study (25%). In G1 pigs showed milder 
respiratory signs and suff ered no losses. Regarding BW, groups 
were equal before the challenge but by 7 dpi animals in G2 
showed a lower BW compared to G1 and G3 (p<0.05) and these 
diff erences remained statistically signifi cant along the trial. 
Signifi cant reduction in ADFI was recorded in G2 pigs from 7 dpi 
to the end of the study. ADFI diff erences were remarkably high 
at the end of the trial (G2=0.44; G1= 1.57 and G3= 1.97 kg/day/
animal). Thus, on average, comparing G1 pigs with unvaccin-
ated-challenged pigs, vaccine prevented mortality (0/8 vs. 2/8) 
and allowed 8.9 kg more of weight gain for the 21 days period 
examined. 
Figure 1: Body weight of pigs vaccinated once with AMERVAC®- PRRS 
and challenged with PRRS21 strain, compared with unvaccinated and 
PRRSV-naïve pigs.
a,b = p < 0.05; G1= vaccinated-challenged; G2=Non-vaccinated-
challenged; G3= Non-vaccinated-non-challenged.
Discussion
PRRS21 infection severely aff ected the growth performance of 
non-vaccinated pigs (G2), as expected from the virulent nature 
of that strain. In contrast, vaccinated pigs (G1) showed a better 
performance and lesser mortality indicating that vaccination 
with AMERVAC®-PRRS was able to keep productive performance 
in the challenge model. The present results suggest that under 
fi eld conditions, this vaccination may provide benefi cial eff ects 
in economic terms if a vaccinated herd should confront an infec-
tion with a hypervirulent genotype-II strain.
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Introduction
Organic pig production is still a small-scale produc-tion, 
achieving, however, increased interest by con-sumers who are 
concerned about the conventional production method. The EU-
Regulation (EEC-No. 1804/1999) on organic livestock production, 
now replaced by EEC-No 834/2007, was introduced to provide 
a framework ensuring living conditions for organic livestock to 
be better than those in conven-tional systems and to harmonize 
the rules across member states. Scientifi cally based information 
on how and to what degree the EU-Regulation contrib-utes to 
the objective of a high status of pig health in organic farming is 
scarce. Further information is needed to assess whether con-
sumer expectations in organic pig production in Europe are met. 
Material and Methods
An epidemiological study was performed on 101 organic sow 
herds in 6 European countries (Denmark, Germany, Austria, 
Sweden, Italy and France). 13 to 20 farms per country were as-
sessed. On-farm data included a comprehensive interview with 
the herd manager in relation to housing conditions, feeding 
regime, data acquisition, cleaning and disinfection measures, 
medicine usage, culling reasons, vaccina-tion protocols, etc.. 
Recorded livestock data included: liveborn and stillborn piglets/
farrowing, weaned pig-lets/sow/year, piglet losses/farrowing, 
losses of weaned piglets, litters /sow lifetime, and the preva-
lence of diseases according to the treatment records. Data from 
all countries were merged into one joint database and analysed 
statistically. 
Results
Although dedicated to the same minimum standards, the farm 
structures were characterised by a huge heterogeneity. 67 farms 
were keeping their sows outdoors while 34 farms were indoors 
with outside runs. Group suckling was implemented on 52% of 
the farms. The degree of specialisation was compara-tively low. 
About 40% of the farms had another economically relevant live-
stock enterprise on the farm apart from keeping pigs. Farmers 
diff ered widely in their feeding regimes, in making use of phase 
feeding and diet calculations. Moreover, the farms varied in the 
cleaning management and in the implementation of disinfec-
tion measures. The study also revealed large diff erences in 
animal health management with respect to the use of quaran-
tine, availability of hospital pens, presence of the farmer during 
farrowing, and regarding routine measures such as castration, 
teeth reduction, and iron supple-mentation of piglets. For 50 
% of the farms the abattoirs provided feedback of pathological 
fi ndings for slaughtered sows, and 80 % for fattening pigs. Huge 
diff erences were detected in the perception of the farmers with 
regard to health problems on their farm and with respect to the 
availability of laboratory results. 
Mean mortality rates of piglets until and after wean-ing aver-
aged 19.7 ± 9.7% and 4.9 ± 5.4% resp., showing clear diff er-
ences between countries and farms. Mean values for the annual 
replacement rates of sows and litters per sow lifetime were 32.4 
± 14.3% and 6.3 ± 2.3 resp. According to the treatment records, 
metritis and mastitis appeared as the predominant diseases of 
the sows, nearly all treated with antibiotics, followed by cases of 
lameness and abscesses. In the case of suckling piglets, diar-
rhoea, arthritis and respiratory diseases were predominant. Also 
the weaned piglets suff ered primarily from diarrhoea. Farms 
showed an incidence of 27.6 ± 34.3%. of piglets treated with 
antibiotics against diar-rhoea.
Conclusions
The results indicated that in general the status of animal 
health in organic pig herds was comparable to data found on 
conventional farms. Diff erences between farms appear to be 
greater than those between production methods. Obviously, 
the production method defi ned by standards does not provide 
a homogenous outcome with respect to the animal health 
status. Diff erences in management practices and in feedback 
and control mechanisms within the farm system might be the 
main reasons for substantial variation in the prevalence rates of 
diseases. Any improvements in organic pig production require 
the use of feedback mechanisms and a clear defi nition of the ex-
pected results with respect to the outcome of the farm system. 
Conse-quently, there is a need for a change in the paradigm 
from standard and resource oriented to a result and outcome 
oriented approach. The implementation of a monitoring system 
including on farm clinical assessment, abattoir data and review 
of treatment data, concepts to deal with potential problems (e.g. 
health planning strategies, HACCP protocols, etc.) and a defi n-
ition of the expected results with respect to the output of the 
farm system might be a way forward for organic farming ensur-
ing a high status of animal health and welfare. 
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Introduction
Intensive pig farming in many developing countries is thought 
to be stagnant (1). Most pigs in Kenya are exotic breeds raised 
on commercial piggeries (2, 3). Farmers in Western Kenya keep 
local pig breeds that are raised using traditional methods of 
tethering and free ranging (4). These breeds possess a number 
of advantages, among them good adaptation to prevailing con-
ditions (5). Understanding how such pigs are managed aids in 
farm planning and decision making. Improved pig productivity 
will greatly enhance the income of resource-poor farmers. In this 
paper, we discuss pig management practices in two districts of 
Western Kenya. We also explore opportunities for improved local 
pig production while safeguarding human health. 
Materials and methods
A total of 288 randomly selected pig farms were visited three 
times in the course of the study period (June 2006 to October 
2008). We used questionnaires administered in face-to-face 
interviews to gather data on how farmers managed their pigs. 
Pigs were examined for Taenia solium cysts using the lingual 
palpation method. Data were analysed in Stata®.
Results
Most farms had no pig barn (73%; 209/288). These farmers said 
they lacked the skills to build the barn (11%; 23/209) and had no 
money to purchase construction materials (45%; 93/209). Kaka-
mega farmers were more likely to construct pig barns than those 
in Busia (OR=5.4; CI 3.1-9.7). Tethering of pigs was more frequent 
than free ranging or confi nement to barns during the planting 
(91 %; 263 / 290), growing (90 %; 263 / 290) and crop harvesting 
seasons (78 %; 227 / 290). Prevalence of cysticercosis in pigs was 
4% (52/1290). Average land size per farm was 2.33 (SD=2.01) 
acres. Pork was the second most preferred meat (31%; 91/288) 
after beef. Most families consumed pork (74 %; 212 / 288), 40 
% (n=212) included families that consumed pork once a week. 
The mean number of pigs owned per farm was 4.6 (SD=3.4), 
1.8 (SD=1.2) and 1.5 (SD=0.9) for the pre-weaned, growing 
and adult pig categories. Farmers in Busia had been keeping 
pigs for fewer years (6.3 SD=5.6) than those in Kakamega (11.4 
SD=8.7) (P<0.05). Spraying (29 %; 128 / 438), dipping (24 %; 101 
/ 438) and deworming (26 %; 116 / 438) were among the most 
frequent routine practices observed in Busia District. 
Discussion 
Improving pig management practices leads to improvements 
in farm performance and reduces costs in production. Failure to 
confi ne pigs is a risk factor for important zoonotic diseases such 
as T. solium (6). Small-holder farming is important in enhancing 
rural livelihoods; addressing issues related to pig feeding, teth-
ering, marketing, disease and sow breeding will greatly promote 
pig farming in rural districts Western Kenya. 
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Introduction
Sow batch management systems (BMS) become more popular 
because of advantages in labour planning, batch size of piglets, 
strict all-in all-out practices and health management. The 4- 
and 5-week BMS have advantages compared to a 3-week BMS, 
especially with regard to general health (1). Weaning piglets at 3 
weeks of age in large batches creates possibilities for a signifi -
cant improvement of the general farm health status. However, 
exact data on a health bonus with these management systems 
are not available. Therefore, a fi eld study (project ‘Veepeiler-
varken’ funded by Sanitary Fund) was designed to measure the 
health bonus for pig farms when changing from a conventional 
1-week management system to a 4- or 5-week group manage-
ment. 
Materials and Methods
Ten Flemish wean-to-fi nish pig farms, changing from a conven-
tional 1-week management system to a 4- or 5-week BMS were 
included in the trial. The average farm size was 227 sows, with a 
minimum of 130 and a maximum of 500. Samples were collected 
before and 2 years after fi nishing transition to the BMS. The type 
of samples and the diff erent analysis are described in Table 1.
Table 1. Sampling schedule before and  2 years  after transition
Sample type Animal category Type of analysis** Number of samples
blood/serum gilts PIA - PRRS - Mhyo 10
sows (> 3 litters) Mhyo 10
piglets (10 wks) PIA - PRRS - App - Mhyo 10
growers (14 wks) PIA - PRSS - App - Mhyo 10
fi nishers (> 80 kg) PIA - PRRS - App - Mhyo 10
nasal swabs piglets (6 wks) PCR DNT* 12
piglets (10 wks) PCR DNT* 12
growers (14 wks) PCR DNT* 12
mixed fecal samples 
(max. 5 animals) growers (14 wks) PCR Brachyspira sp. 1
fi nishers (> 80 kg) PCR Brachyspira sp. 1
* DNT = Pasteurella multocida dermonecrotic toxine
** ELISA test on serum samples
The following ELISA-tests were used: PIA – Bioscreen Enterisol® Ileitis ELISA, PRRS – Idexx 
HerdChek PRRSv Ab test, M. hyopneumoniae – Idexx HerdChek M. hyopn. Ab testkit and A. 
pleuropneumoniae – Idexx Chekit – App – ApxIV ELISA.
Results
The results of the serological screening are presented in Table 
2. The nasal swabs were all negative for Pasteurella multocida 
DNT on all herds screened. No clinical signs of atrophic rhinitis 
were present on these herds. All faecal samples were negative 
for Brachyspira hyodysenteriae. Nevertheless, minor pathogenic 
species of Brachyspira were detected, both before and after the 
transition.
Table 2. Results of serological analyses, expressed as percentage of 
positive animals before and after transition to a 4- or 5-week batch 
management systes and % change
Disease Animal group
% postive 
before 
transition
% positive 
after transi-
tion
% change 
before-after
PIA gilts 90 90 0%
piglets (10 wks) 22 5 -77%
growers (14 wks) 52 30 -38%
fi nishers (> 80 kg) 64 70 +9%
PRRS gilts 90 83 -8%
piglets (10 wks) 54 61 +13%
growers (14 wks) 80 72 -10%
fi nishers (> 80 kg) 80 89 +11%
M. hyopneumoniae gilts 51 49 -4%
sows (> 3 litters) 16 36 +125%
growers (14 wks) 51 32 -37%
fi nishers (> 80 kg) 71 46 -40%
A. pleuropneumoniae piglets (10 wks) 55 65 +18%
growers (14 wks) 40 35 -13%
fi nishers (> 80 kg) 74 51 -31%
Discussion and conclusions
Transition to BMS seems to postpone and or slow down the 
seroconversion for PIA, M. hyo and App. This allows the farmer to 
vaccinate the pigs before they come in contact with the patho-
gen. It also allows more time for the pigs to build up immunity. 
Weaning age, maternal protection and transmission of patho-
gens from the sows to the piglets determine the speed and 
level of horizontal transmission within the batch. The degree of 
separation of the batches from each other then determines the 
vertical transmission between the batches.
In conclusion, the results show a clear health bonus for pig herds 
when changing from a 1-week BMS to a 4- or 5-week BMS.
References
1.  Mekerke B., Leneveu P. 2006 AFMVP 7-8/12/2006, Toulouse, France. 
p. 49-64.
Practitioner Line - Economics
280
Oral Presentations
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010
O.248
Economic impact of intensive consultancy on 35 Danish ﬁ nisher farms
Elisabeth O. Nielsen; Lisbeth Jørgensen; Henriette Steinmetz
Pig Research Centre, Danish Agricultural & Food Council, Copenhagen, Denmark
Introduction
Variation in productivity among Danish fi nisher farms implies 
that improvements can be made on many farms. Although 
Danish pig producers normally receive veterinary advice on a 
monthly basis, specifi c consultancy on feeding and housing is 
rarely provided. Cooperation between veterinarians and agri-
cultural advisers is eff ective in some areas – such cooperation 
and thereby coordinated intensive consultancy formed the core 
of a project called “Plus €3.3 per produced pig”. Our aim was to 
improve the productivity of fi nisher farms and thereby improve 
the economic output of the pig producer.
Materials and Methods
A total of 35 Danish fi nisher farms participated. Records of 
the productivity were required for participation. The intensive 
consultancy was carried out over a one-year period by a veter-
inarian and an agricultural adviser for each farmer. The project 
plan included three visits by both, and three single visits by the 
agricultural adviser and nine single visits by the veterinarian. The 
farmer paid for the intensive consultancy. Prior to the year of 
intensive consultancy, all farms were visited by a team from the 
Pig Research Centre (PRC) consisting of a specialist on feeding, 
a specialist on housing and ventilation and a veterinarian. This 
visit was part of the project, at no cost to the pig producer. The 
PRC team and the two local advisers drew up a detailed action 
plan for improved productivity for each farm. The purpose was 
to improve productivity (feed conversion, mortality, growth rate 
and slaughter weight). Only minor investments were suggested. 
The year of intensive consultancy was initiated when the pig 
producer had approved the plan of action. The consultancies 
were initiated during the year 2007 and ran to the end of 2008. 
The production results in the year of intensive consultancy were 
compared with those of the previous year.
Results
Twelve pig producers achieved an improvement in productiv-
ity of more than €3.3 per produced pig. The average economic 
improvement was €2.5 per produced pig. Increased consultancy 
and investments amounted to €0.9, resulting in a net improve-
ment of €1.6 per produced pig. The farms produced between 
2,000 pigs and 11,500 pigs per year. The action plan included 
between 10 and 31 separate actions: some involved changes of 
daily routine, while others needed to be addressed just once. On 
average, 71% of the separate actions in a plan were carried out. 
The plans were unique, though the following features were in-
cluded in many of the plans: improving feed hygiene (especially 
in liquid feed systems), making the unit ready (clean, dry and 
warm) for new pigs, and putting more eff ort into the daily sur-
veillance for diseased pigs or pigs in need of special attention. 
Eighteen out of 35 pig producers received four or more advisory 
visits from the agricultural adviser; the remaining seventeen pig 
producers received only two or three visits. All herds received a 
monthly visit from the veterinarian.
Table 1. Average productivity in 35 Danish fi nisher herds
One year before Consultancy year Change
Start weight (kg) 30.4 31.1 +0.7
Slaughter weight (kg) 80.9 82.1 +1.0
Daily gain (gram) 817 883 +66
Feed conversion (kg feed/kg gain) 2.65 2.57 -0.08
Mortality (%) 4.9 4.0 -0.9
Economic output 
(euro/prod. fi nisher*) 14.7 16.3 +1.6
*A fi ve-year average of prices is used 
Discussion 
The whole action plan had to be cost-eff ective. However, it 
was, for example, easier to convince producers of better feed-
ing regimes than to improve the climate by better ventilation. 
The individual actions had to be simple and practical, and the 
personnel carrying them out had to recognize their importance. 
We did not achieve this in all cases, since on average only 71% of 
the separate actions were carried out. Half of the farmers chose 
to have only two or three agricultural consultancies, which may 
have resulted in poorer productivity results. A certain degree of 
cooperation between more veterinary and agricultural advisers 
was achieved. This will improve the quality of the veterinary and 
agricultural consultancy.
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Introduction
Modern swine production systems rarely undertake economic 
analysis using anything other than the arithmetic mean for 
production or economic performance metrics when needed in 
calculations. This is because modern systems are built and oper-
ated in such a way that collecting the data necessary to measure 
the variance of almost any metric is not practical in a commercial 
setting (e.g., measuring individual daily feed intake and weight 
gain for each animal in fi nishing) 1.
While farms measure and report their average feed effi  ciency, 
average daily gain, average market weight, cost of produc-
tion etc, very few if any know the underlying variance of these 
distributions. For this reason, farms evaluate a host of economic 
decisions such as target market weight, the adoption of a new 
technology, vaccine and/or pharmaceutical, whether to replace 
aging equipment, etc. by comparing the average expected 
benefi t per unit (head, kg, cwt) of production with the average 
additional cost per unit. A question arises as to how important 
the variance of the distribution generating the average is in 
making the correct decision. 
Materials and Methods
To gain insight into this issue, a comprehensive simulation 
model was used to test the eff ect on net price received, total 
feed cost and return over feed cost associated with changes in 
the variance of pig weights at marketing. The weight and lean 
percent of ten thousand pigs randomly drawn from correlated 
distributions fi t to annual marketing’s of a large U.S. farm were 
used for the analysis. Average cost per ton (US) for each diet, 
wean-to-fi nish, was obtained from the producer and total feed 
cost per head was estimated from slaughter weight, a standard 
growth curve (ADG) and feed effi  ciency average curve (FCR) 
adjusted to match the historical closeout data of the farm (2.5 
kg/kg as FCR, 774 g/day as ADG - Average feed cost/US ton 
W-F $180;base carcass price: $1.43/kg). The actual average live 
weight and standard deviation of live weights marketed by the 
farm over the test year were 122.4kg/12.28kg.
Diff erent scenarios of reduction in variation of the weights at 
marketing from 5%, 10%, 20% & 30% were simulated (table 1 & 
2). The change was carried out by reducing the distance to the 
mean by x% for each individual animal weight in the dataset 
so the reduction in variation was symmetrical to the mean. 
Estimated individual animal lean and yield percents were each 
adjusted to the new weights by a separate constant estimated 
by regression.
Results
Table 1: Variance of the production metrics for each simulation 
(average remains identical)
Weights FCR ADG
Actual 12.28 0.18 36.64
StDev -5% 11.67 0.17 34.91
StDev -10% 11.04 0.16 33.17
StDev -20% 9.79 0.14 29.64
StDev -30% 8.50 0.13 26.02
A 5% reduction of the standard deviation of slaughter weights indicates a return of $85.99/hd. 
It reaches $87.44/hd by a reduction of 30%.
Table 2: Financial results of the diff erent simulation
Avg Net Carcass 
Price Received/kg Feed Cost /hd $
Return over Feed 
Cost /hd $
Actual $1.539 $58.59 $85.65
StDev -5% $1.541 $58.54 $85.99
StDev -10% $1.544 $58.41 $86.43
StDev -20% $1.549 $58.15 $87.16
StDev -30% $1.553 $57.82 $87.74
Discussion 
The simulation model focuses on the slaughter weight as it is 
the most common source of individual data in pig production. 
Thereafter each individual pig can be assigned their individual 
metrics (FCR & ADG) based on the adapted standard curves.
Simulation suggests that the standard deviations of the distribu-
tion of FCR & ADG are important determinants of cost of produc-
tion and therefore infl uence profi tability. A reduction by 10% 
of the standard deviation of slaughter weights improves return 
over feed cost by $0.78/hd. In addition, reducing variance results 
in a higher optimal weight which has not been accounted here.
Conclusion
By only accounting for the mean and changes in the mean in 
economic calculations, producers are missing important eco-
nomic impacts associated with treatments or strategies which 
aff ect the variance of marketing weights.
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Introduction
Viremia results in immune system activation that leads to a re-
direction of nutrients that may result in a decrease in ADG and/
or an increase in feed-to-gain ratio.1 Subclinical infections with 
PCV2 are common2,3 They are known to occur if vaccination 
does not prevent viral replication4. These PCV2 subclinical infec-
tions do not require co-infections. 
The objective of this paper is to describe the prevalence and 
production impact of viremia in pigs while comparing two com-
mercial circovirus vaccines or a placebo under fi eld conditions. 
Materials and Methods
A PRRS- and M. hyopneumoniae-free system was used for the 
study. At weaning, pigs were randomly assigned to be vaccin-
ated with a one dose commercial PCV2 vaccine (n=1026) (1D); 
a two dose commercial PCV2 vaccine (n=1020) (2D); or saline 
as a placebo (n=100) (control). Both PCV2 vaccines were used 
according to manufacturer’s label recommendations. Individual 
pig weights were collected when pigs were 3, 11 and 19 weeks 
of age and just prior to market at about 110 kg. Individual ADG 
was determined between each pair of weights.To determine 
extent of PCV2 viremia, blood was collected from a random 
sample of 122 pigs at 3, 9, 15, 19, and 23 weeks of age and dur-
ing the fi nal week of shipping to market. Serum was tested with 
a qPCR. The proportion of viremic pigs at each sampling point 
by treatment group was determined. Diff erence in proportions 
was determined with a chi-square test. ADG was compared by 
group and by viremia status using a multiple linear regression 
after controlling for weaning cohort and starting weight.
Results
Starting weights did not diff er by group. More pigs in the 1D 
(47%) and control groups (85%) were viremic than in the 2D 
group (8%) (p<0.01). More control pigs (73%) were viremic on at 
least 2 samples than 2D pigs (0%) or 1D pigs (24%) (p<0.05). Pigs 
that were viremic more than once, tended to have a lower ADG 
(by 33.8 gm/d) than pigs that were never viremic (p=0.11). The 
proportion of viremic pigs remained at 3% to 4% for the entire 
grower-fi nisher phase for the 2D pigs. However, this proportion 
increased from 11% to 39% for the 1D pigs and from 53% to 
63% for the control pigs from 15 to 19 weeks of age. The ADG in 
the 2D group was 42g / day higher than in the 1D group from 
19 weeks to market age (p<0.01). The coeffi  cient of variation of 
ADG in the 2D group (19%) was lower than that of the 1D group 
(28%) indicating that there was more variation in the growth of 
1D group.
Implications and Conclusions
The proportion of viremic pigs was higher in the control group 
than in the vaccinated pigs. The pigs receiving the 2D vaccine 
maintained a low level of viremia throughout the fi nisher phase 
whereas the pigs in the 1D group exhibited a rising proportion 
of viremia toward the end of the fi nishing phase. This viremia 
was associated with a lower ADG and more variation in growth 
performance, particularly during the fi nal phase of production. 
This is the least effi  cient time of growth, feed conversion and 
facility use. This variation extends the time for marketing. Hence, 
viremia contributes to the overall cost of production in the 1D 
group. 
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Introduction 
Experimental infections, using several routes of virus inoculation 
in pregnant animals brought at parturition (1, 2, 3, 4), dem-
onstrate the role of the PCV2 on reproductive pathology. It is 
known that in utero death of foetuses producing dead or mum-
mifi ed piglets at delivery infected with PCV2 can be assessed in 
tissues (1, 3, 5). In PCV2 associated reproductive pathology the 
presence of uterine or placental lesions are scantly documented. 
We developed an original experimental model of PCV2 infec-
tion by artifi cial insemination of conventional sows with PCV2 
infected semen and in this paper we present and discuss the 
PCV2 tissue distribution and the associated lesions of the sow 
and foetuses after post-mortem samplings.
Material and Methods
The experimental design and the results of the in vivo investiga-
tion are contextually presented (6). Necropsy was performed on 
all the not pregnant (n=3) and pregnant (n=6) animals. Several 
tissues of the sows and of each foetus (heart, lung, liver, placenta 
and amniotic fl uid) were collected (Table 1) for real time-PCR, 
histology and immunohistochemistry (IHC). The correspond-
ing uterine tract and the placenta were collected together with 
foetus sampling. Real time-PCR analyses were in accordance 
to the method by Olvera et al. (7). Samples for histology were 
stained with haematoxylin and eosin (H-E). IHC was performed 
using 1/100 PBS-diluted PCV2 antibody (Mab F217, by Dr. G. 
Allan (Belfast, UK)), as previously described (8) but using a 
streptavidin-biotin-peroxidase polymeric complex (SuperPicture 
kit peroxidise, Zymed® Lab).
Results
In the sows, at necropsy, the only lesions recorded included 
mild to moderate chronic fi brous pleuritis and/or pericarditis. 
One animal showed enzootic pneumonia. One case of a mild 
sero-fi brinous peritonitis and two cases of white spotted liver 
were observed. Two out of the 3 non-pregnant sows showed 
congestion and oedema of uterine mucosa. Three out of 6 
infected sows were pregnant and had respectively 16, 11 and 
7 foetuses, whereas two out of the 3 controls 11 and 8. One 
control sow aborted but any PCV2-DNA was evidenced in the 3 
aborted foetuses. In only one placenta (positive for PCV2 DNA 
with moderately high viral load, >108 genome copies/ml) mild 
focal necrosis of the chorionic epithelium resulted positive by 
IHC for PCV2 antigen localized in the cytoplasm of the cells. The 
foetus showed also IHC positive reaction in the cytoplasm of 
hepatocytes.
Table 1: RT-PCR results of tissue sampling
Infected Control
pregnant not pregnant pregnant
Sow ID 25 26 29 27 32 33 28 30 31
Number of foetuses 16 11 7 0 0 0 11 0* 8
Tonsil - - - + - - - - -
Uterine left lymph node + - - - - - - - -
Uterine right lymph node + - - + - - - - -
Tracheo-bronchial lymph 
node
+ - - / - / - - -
Cervix - - - - + - - - -
Foetuses (pos./total) 10/16 - 3/7 - - - - - -
Amniotic fl uids (pos./total) - 1/11 - - - - - - -
Foetus and corresponding 
uterine tract (left)
7 - - - - + - - -
Foetus and corresponding 
uterine tract (right)
1 - - - - - - - -
* Aborted 3 foetuses before necropsy 
Discussion 
The present investigation suggests the protective role of the 
anti-PCV2 antibodies in preventing foetal infection even in case 
of intrauterine route of infection. Sow n. 25, with the lowest 
anti-PCV2 titre (beginning of the experiment) (6) and viremia 
for two successive samplings, had also the highest number of 
positive foetuses and concordance with corresponding uterine 
tract positivity. Moreover, the results seem to demonstrate that 
PCV2 replicates also in chorionic epithelium where it was the 
possible cause of necrosis. As well as viral load in foetal tissues, 
also placenta lesions can account for foetus death. This study 
evidenced that not all foetuses are positive for PCV2, it should 
be recommended to send the whole litter to the lab for a correct 
diagnosis of PCV2-related reproductive failures.
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Introduction
Porcine Circovirus Type 2 (PCV2) infection is endemic in pig 
herds in most countries. Initially, PCV2 was linked to post-wean-
ing multi-systemic wasting syndrome (PMWS). More recently, 
other disease syndromes have been associated with PCV2, and 
PCV2 has been reported to cause lesions similar to those of 
Lawsonia intracellularis (L. intracellularis).1 Our hypothesis was 
that there is an association between the quantities of PCV2 in 
serum and faeces, L. intracellularis in the faeces and diarrhoea in 
grower (>10 weeks) pigs.
Materials and Methods
Forty grower pigs were selected on six farms in Denmark for a 
case-control study. Each pig was ear-tagged and assessed for 
faecal consistency (normal, loose, fl uid). Approximately half of 
the pigs had loose or fl uid faeces and were classed as “diar-
rhoeic”. Blood and faecal samples were collected from each pig 
and tested using real-time PCR specifi c for PCV2 (blood and 
faeces) and L. intracellularis (faeces only).2,3 The associations 
between diarrhoea (+/-) and serum and faecal PCV2 quantity 
(negative/low versus moderate/massive), and between diar-
rhoea and L. intracellularis bacterial quantity (negative/low ver-
sus moderate/massive) were analysed. The association between 
the quantity of PCV2 in blood and PCV2 in faeces, and between 
the quantity of PCV2 in faeces and L. intracellularis in faeces were 
analysed. All analyses were conducted using generalized linear 
mixed models, with farm as a random eff ect (Genstat 11th edi-
tion). 
Results
Two farms had no pigs with moderate/massive PCV2 results 
in blood or faeces. One farm had no pigs with a negative/low 
faecal PCV2 result. Two farms had pigs with no moderate/mas-
sive L. intracellularis results. Pigs with diarrhoea were no more 
likely than pigs without diarrhoea to have moderate/massive 
quantities of PCV2 in blood or faeces (p>0.05). Pigs without 
diarrhoea were no more likely than pigs with diarrhoea to have 
negative/low quantities of PCV2 (p>0.05). Pigs with moderate/
massive quantities of L. intracellularis had 1.91 times the odds 
(95%CI 1.04 3.49) of having diarrhoea than pigs without diar-
rhoea (p<0.05). The farms where no pigs had moderate/massive 
quantities of PCV2 and/or L. intracellularis were excluded from 
analyses of associations between the two pathogens. Pigs with 
moderate/massive quantities of PCV2 in serum had 14.4 times 
the odds (95%CI 1.08 191.6) of having moderate/massive quanti-
ties of PCV2 in faeces than pigs with low/negative PCV2 serum 
results (p<0.05). There were no signifi cant (p>0.05) associations 
between PCV2 quantities in blood or faeces, and L. intracellularis 
quantities in faeces. 
Discussion
These preliminary results suggest PCV2 was not associated with 
diarrhoea in pigs on the six farms studied Pigs with diarrhoea 
shed moderate/massive quantities of L. intracellularis in their 
faeces. There was no evidence of co-infection between PCV2 
and L. intracellularis. PCV2 results for blood and faeces from the 
same pig suggested that either clinical sample may be tested 
with a similar result. As there was evidence of Brachyspira spp. 
infection in euthanized diarrhoeic pigs on all farms (data not 
shown)4, the interaction between L. intracellularis and Brachy-
spira spp. warrants investigation. 
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Introduction
Postweaning Multisystemic Wasting Syndrome (PMWS) is as-
sociated to porcine circovirus type 2 (PCV2), and as neutralising 
antibodies prevent pigs from developing PMWS (1) transfer of 
maternal antibodies to PCV2 may protect the off spring from 
developing PMWS. We therefore scrutinised the maternal im-
munity to PCV2 in two herds diagnosed with PCV2, but not with 
PMWS.
Materials and Methods
The studies were carried out in a nucleus herd with 180 Yorkshire 
sows, and in an SPF herd established by caesareans in 1988 with 
170 Landrace, Yorkshire and hybrid sows. (2). The SPF herd was 
infected by PCV2a in 1993, certainly through semen. The herd 
experienced a reproduction disorders for around six months fol-
lowing the introduction of PCV2 (3), but has stayed healthy since 
then. PCV2a was demonstrated in both herds prior to initiating 
the studies. Neither sows nor piglets were vaccinated against 
PCV2, and PMWS had not been diagnosed in any pig.
Six piglets from 4 litters in each herd were given an identity. 
Blood was collected from these piglets weekly from birth to 9 
weeks of age. Presence of serum antibodies to PCV2 was ana-
lysed in two-fold dilutions with an IPMA-technique. The amounts 
of antibodies are presented as Log10-values.
Results
As seen in fi gure 1, piglets in both herds received maternal 
antibodies to PCV2 with a mean log10-titre of 3.8 ± 0.6. The 
titres decreased signifi cantly in both herds, but the decrease was 
more pronounced in the SPF herd from 5 weeks and onwards. 
Four piglets from two litters in the conventional herd serocon-
verted at 6, 7, 7 and 9 weeks of age, whereas only one pig in the 
SPF herd seroconverted to PCV2 at the age of 9 weeks.
Figure 1. Mean antibody titres to PCV2 in 24 piglets from 4 litters in an 
SPF herd (○) and in a conventional herd (■).
The mean antibody titres never diff ered between the herds, but 
when the off spring to diff erent sows were compared signifi cant 
diff erences between litters were at hand within both herds (Fig 
2).
Figure 2. Mean antibody titres to PCV2 in piglets from diff erent litters 
in an SPF herd (upper part) and in a conventional herd (lower part). 
Breed of the dams; ○ = Landrace, ◊ = Yorkshire, □ = LY-hybrid. Open 
symbols = 1st parity, grey symbols = 3rd parity and black symbol = 7th 
parity. Dotted lines = pure bred litter, Full lines = crossbred litter.
Discussion and Conclusions
The results showed that all piglets received a maternal transfer 
of antibodies to PCV2, and that the level of antibodies not was 
infl uenced by the rearing system. Nor was any infl uence of breed 
indicated since maximal levels of antibodies (Log10 = 4.3) was 
measured in off spring to both pure bred Landrace and Yorkshire 
sows.
In contrast, signifi cant diff erences in antibody levels were 
recorded between litters belonging to the same farrowing batch 
within each herd, and the lowest levels of maternal antibodies 
was measured in the off spring to the 7th parity sow. In the 
conventional herd, piglets that received low amounts of anti-
bodies commenced to seroconvert to PCV2 already at 6 weeks 
of age, indicating an active infection with PCV2. Such piglets 
may thus increase the PCV2 load concurrently to the decline of 
maternal immunity in other litters. Therefore sows that transfer 
a low maternal immunity may jeopardise the health status of a 
herd because piglets will meet the PCV2-infection at a younger 
age. The results obtained indicate that old sows may contribute 
to such risks, and vaccination of old sows may be of particular 
interest.
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Introduction
Postweaning multisystemic wasting syndrome (PMWS) was 
fi rstly diagnosed in Spain in 1997 (3). Since then, the number 
of disease diagnoses increased signifi cantly, reaching a peak 
between years 2000-01 (2), and then decreased over time. After 
2007, the number of PMWS diagnoses started increasing again, 
basically due to the advent of porcine circovirus type 2 (PCV2) 
vaccines in the market. Therefore, it seems that the number of 
PMWS diagnoses in a given period depends on several factors. 
Firstly, a diagnosis in front of a novel disease was needed (mainly 
between 1997 and 2001). Secondly, once the disease was known 
and no practical solutions did exist, the interest of laborator-
ial diagnosis decreased (2002-2006). This latter situation was 
coupled with the evolution of severe disease outbreaks to a 
more enzootic, chronic form of the disease. However, with the 
abovementioned introduction of PCV2 vaccines, the interest of 
a precise diagnosis of PMWS raised again among veterinarians 
(2007 to date). In such framework, a general perception was 
that the initial acute disease largely died down over time and 
since then veterinarians and producers face with the chronic ef-
fects of PMWS. Such situation leaded to the opinion that PMWS 
resulting mortality occurred at older ages in the chronic form of 
the disease (3). Therefore, the objective of the present study was 
to assess if such PMWS age-shift presentation took place over 
the years in Spain. 
Material and methods
A total of 650 pigs diagnosed as PMWS at the Pathology Diag-
nostic Service at the Universitat Autònoma de Barcelona (Spain) 
with an unequivocally known age were included in this study. 
These animals were diagnosed as PMWS based on the three 
internationally accepted case defi nition criteria (4) between 
1998 and 2008. The number of pigs available per year was vari-
able, ranging from 9 in 2006 and 134 in 1999. The average num-
ber of pigs per year was around 60. Diff erent ages were meas-
ured in months and for statistical purposes, a single number 
was given for all age groups included (i.e, age 1 corresponded 
to pigs between 1 and <2 months of age, age 2 corresponded to 
animals between 2 and <3 months of age, and so on). 
Diff erences in the PMWS age presentation among years, and 
between the overall and yearly average age were tested by 
means of several chi-square and Kluskal-Wallis tests. Statistical 
signifi cance level was set at p<0.05. Confi dence intervals (95%) 
for every year are presented in Fig.1
Results 
The youngest age recorded corresponded to 11 1-month-old 
piglets, while the oldest animals diagnosed as PMWS included 
13 6-month-old pigs. More than 80% of the pigs fall between 
2 and <4 months of age (532 out of 650 animals). Fig. 1 shows 
the evolution of the average age of pigs diagnosed as PMWS 
between 1998 and 2008. Signifi cant diff erences in age presenta-
tion were overall obtained, mainly due to the average age in two 
years: younger pigs in 2001 and older pigs in 2005. However, the 
average age evolution between 1998 and 2008 did not signifi -
cantly increase.
Fig. 1. Average age evolution of pigs diagnosed as PMWS between 
1998 and 2008.
Discussion
With the emergence of new diseases, it is expected that initial 
severe outbreaks are followed by a more chronic, not as severe 
form of the clinical problem. Such situation has been described 
for PMWS. It has been claimed that the development of the 
so-called “herd immunity” has been the main reason for disease 
evolution as well as the assumed shift in age presentation (1). 
However, the present data do not fi t with this general opinion, 
and points to a relatively constant average PMWS age presenta-
tion throughout time. 
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Introduction
F18-fi mbriated Escherichia coli are associated with porcine post-
weaning diarrhoea (PWD) and oedema disease. Adhesion of F18-
fi mbriated bacteria to the small intestine of susceptible pigs is a 
primary event in the infection process. However, the target cell 
receptor for F18+ E. coli (F18R) has remained unidentifi ed. The 
objective of our study was to unravel the carbohydrate-binding 
specifi city of F18-fi mbriated E. coli and to examine whether 
these F18R molecules can inhibit the interaction between F18+ 
E. coli and the pig small intestine. 
Materials and methods
To identify the F18R molecules, mixtures of glycosphingolipids 
(GSLs) isolated from pig intestines were separated on thin-layer 
plates, followed by a chromatogram binding assay with radio-
labeled F18+ E. coli. In addition, the inhibitory capacity of the 
F18R molecules was assessed using an in vitro villous adhesion 
assay.
Results
We report that F18-fi mbriated E. coli selectively interact with 
GSLs having blood group ABH determinants on type 1 core 
chains, and blood group A type 4 heptaglycosylceramide. F18-
binding GSLs were isolated from the small intestinal epithelium 
of blood group O and A pigs, and characterized by mass spec-
trometry and proton NMR. The only GSL with F18 binding activ-
ity of the blood group O pig was an H type 1 pentaglycosylcera-
mide (Fuc α2Gal β3GlcNAc β3Gal β4Glc β1Cer). In contrast, the 
blood group A pig had a number of F18-binding GSLs, with the 
A type 1 hexaglycosylceramide (GalNAc α3(Fuc α2)Gal β3GlcNAc 
β3Gal β4Glc β1Cer) being the predominant one.
The minimal binding epitope was identifi ed as the blood group 
H type 1 determinant (Fuc α2Gal β3GlcNAc), while an optimal 
binding epitope was created by addition of the terminal α3-
linked galactose or N-acetylgalactosamine of the blood group B 
type 1 determinant (Gal α3(Fuc α2)Gal β3GlcNAc) and the blood 
group A type 1 determinant (GalNAc α3(Fuc α2)Gal β3GlcNAc), 
respectively.
Using the in vitro villous adhesion assay, the inhibitory cap-
acity of several blood group sugars on F18+ E. coli adhesion 
was examined. Strong inhibition of F18+ E. coli adherence was 
observed after pre-incubation of F18+ E. coli with 1 mg of the 
blood group H (52.4%, S.D. = 19.9), blood group A (72.9%, S.D. = 
15.5) and blood group B sugar (86.8%, S.D. = 11.4), whereas the 
negative control sugar lacto-N-tetraose did not inhibit (-2.8%, 
S.D. = 12.4) the interaction of F18+ E. coli with the intestinal villi. 
Discussion
A highly specifi c interaction of the F18-fi mbriated bacteria with 
GSLs having blood group ABH determinants on type 1 core 
chains was demonstrated. In addition, we showed that F18R 
molecules could be used to inhibit the interaction of F18+ E. coli 
with the porcine intestinal epithelium using an in vitro assay. In 
our future work, in vivo experiments will be performed to inves-
tigate whether these F18R molecules, when supplemented in 
pig feed, could provide a safe and effi  cient anti-adhesive therapy 
against F18+ E. coli infections in pigs. 
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Eﬀ ect of toltrazuril in Isospora suis oocyst excretion from naturally infected nursing piglets
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Introduction 
Currently, farm control of Isospora suis infection depends almost 
completely on the early routine treatment of piglets with 
toltrazuril. Its effi  cacy has been demonstrated mostly in experi-
mentally infected piglets (Mundt et al., 2003). In this fi eld trial we 
simultaneously evaluated toltrazuril effi  cacy in reducing both 
the odds and the level of oocyst excretion, from the 6th day 
post-farrowing (pf ) until weaning at 29 days pf.
Materials and Methods
The study was conducted in a commercial farrow-to-fi nish herd 
with 300 sows, farrowing weekly all year round. The farm had 
a history of clinical diarrhoea in piglets, but no anti-coccidial 
compounds had been used. Prior to the initiation of the study, 
the presence of I. suis parasitism on the farm was parasitologic-
ally confi rmed. Twenty-fi ve litters with a total of 246 piglets 
were randomly allocated to either the treated (13 litters-128 
piglets) or the untreated (12 litters-118 piglets) group. Piglets in 
the former, on the 3rd day pf, were orally treated with toltrazuril 
(BAYCOX® 5%) at the dose rate of 20 mg per kg bw, whereas 
those in the latter litters received no treatment. At least half a 
gram of faeces was collected individually from the rectum of 
each piglet daily from 6- until 13-days-old and thereon, every 
second day until weaning (i.e., 15 samples/piglet). Oocyst 
excretion (expressed as oocysts per gram of faeces (OPG)) was 
recorded for all samples. Because OPG counts were semi-con-
tinuous data (Liu et al., 2008), to evaluate the eff ect of treatment 
on the longitudinal OPG counts we fi tted a two-part model in 
the aML software. Presence or absence of oocyst excretion was 
the response variable in the fi rst part of the model, while the 
natural logarithm of the non-zero OPG values was used in the 
second part. Treatment and time were included as covariates 
in the model. Random eff ects were incorporated in the model 
to account for the within litter and within piglet correlation of 
observations. We adjusted for the cross-equation correlation ( 
ρCEC) of the litter- and piglet-level random eff ects between the 
logistic and linear part of the model to capture the biologically 
plausible fact that higher rates of excretion may also have higher 
mean OPG counts. Subsequently, we quantifi ed the litter- and 
piglet-level unexplained variation via estimation of variance 
partition coeffi  cients (VPC)(Kostoulas et al., 2009).
Results and Discussion
Parameter estimates from the model are in the table. Treated 
piglets had 66.5 (95% C.I.:10-500, P<0.001) times lower odds 
of excretion than the untreated ones. The mean diff erence in 
the amount of OPG in any day between treated and untreated 
piglets was 55.5 (95% C.I.:6-518, P<0.001). Piglets with higher 
odds of excretion tended to excrete more oocysts ( ρCEC=0.99, 
P<0.001). Litters with higher odds of excretion also tended to 
have more oocysts excreted ( ρCEC=0.55, P<0.001). VPCs were 
40 and 23% and 26 and 17% for the litter- and piglet-level vari-
ance for the logistic and linear part of the model, respectively.
Toltrazuril treatment reduced both the odds of excretion and 
the mean amount of excreted oocysts. Estimated VPCs revealed 
that the greater portion of unexplained heterogeneity of oocyst 
excretion lies at the litter-level, highlighting the need of studies 
to identify litter-level risk factors for I.suis control.
The eff ect of toltrazuril treatment on the odds and level of oo-
cyst excretion (logistic and linear part of the model, respectively) 
adjusting for piglet’s age.
Logistic 
Coef. 95% C.I. P
Treatment -4.2 -6.2 ; -2.3 <0.001
Piglet age 0.10 0.08 ; 0.11 <0.05
Linear*
Treatment -4.0 -6.2 ; -1.9 <0.001
Piglet age -0.01 -0.05 ; 0.04 >0.05
*Estimates of the linear part of the model were based on the analysis of the natural logarithm 
of OPG. 
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Evaluation of the colostrum phase in 10 French pig herds dealing with enzootic neonatal diarrhea
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Introduction
Enzootic neonatal diarrhea (END) is occurring in 15 to 20% 
of French farrow-to-fi nish pig farms1. Dealing with this issue, 
veterinarians have to work on the aggression side i.e. control 
of pathogens and on the defense side i.e. control of immunity. 
During the fi rst weeks of life, piglet immunity is mainly providing 
by colostral antibodies and cells. In this paper, we focus on the 
colostrum phase in pig farms dealing with END.
Materials and Methods
The study was conducted in 10 French farrow-to-fi nish pig farms 
during 2006 and 2007. Selection of farms was performed ac-
cording to their history of END for more than 6 months. For the 
purpose of this study, one of us (TG) spent 7 consecutive days on 
each farm, starting the fi rst day of farrowing as all farms operate 
on batch farrowing system. 
For sows farrowing from 7 am to 7 pm, colostrum were manu-
ally taken from cranial mammary glands before the 3rd piglet’s 
birth and kept at 5°C until laboratory analysis. For each farrow-
ing, data were recorded: length of gestation (calculated from 
the fi rst day of AI), parity and emergence of neonatal diarrhea 
(determined by a clinical examination 3 times a day and during 
7 consecutive days). Clinical as well as laboratory investigations 
are also registered2. At the end of the investigation week, 4 
whole litters were blood-sampled, 2 control litters and 2 litters 
with diarrhea. In each farm, we select those 4 litters on 3 criteria: 
litters for which the sow was sampled for colostrum, litters that 
were 4 to 6 days old and litters in which we had less than 4 cross-
fostering piglets.
IgG dosages were performed at LDA22 (Ploufragan, Côtes 
d’Armor, France) using a Pig IgG ELISA Quantifi cation Kit® 
(BETHYL Laboratories, inc. Montgomery, Texas, USA). 
Results
Piglet’s sera from 16 “diarrhea litters” (n=178) and from 22 “con-
trol litters” (n=244) were collected for evaluation of IgG ([IgG]
sera, mg/ml). The mean of [IgG]sera for “diarrhea litters” is 22.2 
mg/ml (SE=0.84; CV=0.50) while the one for “control litters” is 
24.8 mg/ml (SE=0.83; CV=0.52). There is no signifi cant diff erence 
(p>0.05).
Colostrum (n=135) from mixed-parities and mixed-genetics 
sows were collected for evaluation of IgG ([IgG]colostrum, mg/
ml). When data from the 10 herds are pooled, we found that the 
mean of [IgG]colostrum is 81.3 mg/ml (SE=2.5; CV=0.32). There is 
a signifi cant diff erence (p=0.005) in the [IgG]colostrum between 
sows with “diarrhea litters” (41 sows, mean=70.8 mg/ml, SE=3.5) 
and sows with “control litters” (94 sows, mean=85.8 mg/ml, 
SE=3.1). There is also a signifi cant diff erence (p=0.001) in the 
[IgG]colostrum between sows farrowing at 114 days (mean=72.6 
mg/ml, SE=4.1) and sows farrowing at 116 days (mean=104.8 
mg/ml, SE=6.7). Finally, there is no parity eff ect (p>0.05) re-
garding [IgG]colostrum. As expected, there is a good positive 
correlation (r2=0.73) between [IgG]colostrum and average [IgG]
sera of the litter.
Discussion
In our study, the colostrum phase was evaluated indirectly by 
the [IgG]sera of piglets. Within the same litter, [IgG]sera are in 
the 2/1 to 3/1 scale. This variation is not limited to aff ected litters 
or in some special litters. It is of concern in all litters. How can 
we explain this very important variation of colostrum intake 
between piglets? Two studies3,4 found that piglet’s vitality, birth 
weight and birth order are factors explaining a part of colostrum 
intake variation between piglets. 
In our study, the colostrum immune quality was evaluated by 
the [IgG]colostrum. First, we found a relationship between low 
[IgG]colostrum and occurrence of diarrhea in the litter. Then, 
neonatal diarrhea is generally more frequent in gilts like for 
neonatal E. coli diarrhea5. However, in our study, there is no 
parity eff ect (p>0.05) regarding [IgG]colostrum. Another study3 
showed that parity rank explains only a small part of the colos-
trum yield variation. Finally, Devillers et al.3 show an impact of 
farrowing induction (probably by an indirect eff ect on gestation 
length) on colostrum yield variation. Our study tends to show 
the same impact on [IgG]colostrum but with the same confusion 
between gestation length and farrowing induction.
During the colostrum phase, a lot of changes occur for the sows 
and for the piglets. The regulation of these changes is called 
homeorhesis i.e. orchestrated changes for the priorities of a 
physiological state. A better understand of the colostrum phase 
is needed to improve the performance in farrowing units. 
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Neonatal diarrhoea in piglets from E. coli vaccinated sows in Sweden
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Introduction
The importance of virulent E. coli in the pathogenesis of neo-
natal diarrhoea in piglets has been well established since the 
1960´s. The development of vaccines and proper vaccination 
routines of sows combined with good hygiene standards have 
reduced the problems with neonatal diarrhoeas to a minimum. 
However, despite proper vaccination routines the incidence 
of neonatal diarrhoeas has increased during the last years in 
several countries. This syndrome have been suggested the name 
New Neonatal Porcine Diarrhoea (NNPD). The aim of the present 
study was to search for possible causes for such diarrhoeas in 
Sweden.
Materials and Methods
Faecal samples, collected by The Swedish Animal Health Service, 
were taken from pens with clinically manifested diarrhoea in 
piglets less than 3 days of age despite E. coli vaccinations of 
their sows. In total 17 samples from 6 herds were investigated (3 
samples from 5 herds and 2 samples from 1 herd).
The following analyses were performed; 
•  Defi ning the 4 most abundant aerobic bacterial species in 
each pen sample.
•  Presence of 9 virulence factors (F4, F5, F6, F18, F41, LT, STa, 
STb, VT2) by PCR in the two dominating E. coli isolates/pen.
•  Presence of 75 virulence factors in the two dominating E. coli 
isolates/pen using a microarray kit (Identibac EC Array Tube).
•  The coliform fl oras were biochemically fi ngerprinted to de-
fi ne eventual common clones (Pheneplate®) (1) 
•  Determination of the resistance pattern of the two dominat-
ing E. coli isolates from each herd (Vetmic®).
•  Presence of Clostridium perfringens type A (CpA) and Clostrid-
ium perfringens type C (CpC) by anaerobic culturing and PCR.
•  Presence of genes for enterotoxin (cpe) or beta2 toxin (cpb2) 
in isolated CpA by PCR (2).
Results
No unexpected bacterium was found in any sample. E. coli, Ente-
roccoccus spp. and CpA were found in abundance in all samples.
As for E. coli no common virulence factor was found. In fact, only 
one of all the isolates was diagnosed with a virulence factor 
(STb) by the PCR technique. The microarray did not reveal any 
common pattern among the E. coli isolates. In total 18 virulence 
factors of the 75 possible were found in a random pattern 
among the isolates. Furthermore, no common phenotypic clone 
of E. coli could be demonstrated neither between nor within 
herds. The resistance pattern of all tested isolates of E. coli was 
normal for Swedish conditions (3).
All isolated CpA had genes for cpb2 but no one had genes for 
cpe. CpC was not isolated from any sample.
Discussion 
In an international perspective neonatal diarrhoea is associated 
to infection/overgrowth of E. coli, CpC, CpA, Salmonella or corona 
viruses such as TGEV and PED. Neither CpC nor Salmonella was 
found in the herds included in this trial and TGEV and PED have 
never been isolated in Sweden.
Piglets are born with a sterile gastrointestinal tract (GIT) and the 
low production of gastric acid (HCl) and pH dependent gastric 
proteases give almost free access for invading microbes to 
colonise the animals GIT. They are therefore dependent on the 
colostrum from the sow to be able to establish a normal gastro 
intestinal fl ora. To accomplish this sows are vaccinated against 
pathogenic E. coli 5-3 weeks prepartum.
Despite the well known importance of E. coli in neonatal diar-
rhoea, no common E. coli associated explanation to the diar-
rhoeas could be found in the study.
The role of CpA on the other hand is not all clear. The bacterium 
is ubiquitous in gut content and soil and part of the normal fl ora. 
The genetic ability to produce cpb2 may be a sign of pathogen-
icity (4), but the importance of cpb2 is still under discussion.
So far, our results have excluded a number of microbes as likely 
causes of the neonatal diarrhoeas recently diagnosed in these 
herds with E. coli vaccinated sows.
Considering that this phenomenon has been observed in several 
countries, eff orts to defi ne microbes associated to such diar-
rhoeas ought to be intensifi ed.
References
1)  Kühn et al., 1995. Microecol & Therapy. 23: 140-148
2)  Engström et al., 2003, Vet microbial. 94: 225-235. 
3)  www.sva.se (Serach for SVARM REPORT)
4)  Båverud et al., Proc IPVS 18. (1) 327.
Enteric Diseases - Piglets and weanling pigs
291
Oral Presentations
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010
O.259
The eﬀ ect of Saccharomyces cerevisiae on the occurrence of enteropathogenic E. coli in weaned piglets
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Introduction
Probiotics, including live yeast and lactic acid bacteria cultures, 
have been reported to improve performance of weaned piglets 
(1, 2). Piglets fed by milk replacer supplemented with Sacchar-
omyces cerevisiae Sc 47 (SC) show an increased postweaning 
growth and reduced TNF- α expression in the intestinal and liver 
tissues, suggesting an important immunomodulatory role of the 
treatment (3). 
E. van Heugen et al. evaluated the eff ects of SC supplementa-
tion on faecal microfl ora and assessed whether live yeast could 
replace antibiotics and growth-promoting eff ect of Zn and Cu 
in nursery pigs. They found variable responses, and determined 
the conditions under which a measurable response can be 
expected (4). The objective of the present study was to evalu-
ate the eff ect of SC dietary supplementation on the presence of 
enterotoxigenic E. coli (ETEC) strains and Clostridium perfringens 
in faeces, general signs of diarrhea and performance of post-
weaning piglets.
Material and methods
The experiment was conducted under fi eld conditions at the far-
row to fi nish unit with 600 sows, with farrowing, post-weaning 
and fi nishing departments placed in separate buildings. The 
trial included two batches of piglets, from weaning at 25 days 
of age to the end of the post-weaning period at approximately 
80 days of age. The piglets were housed in rooms with pens (25 
piglets per pen) and slatted fl oor. The fi rst batch (SC treatment) 
received mash liquid feed supplemented with SC culture at 1000 
ppm (Actisaf Sc47, Lesaff re Feed Additives, France). The second 
batch (Control) was fed the same mash liquid feed without SC 
supplementation. Each treatment included 200 piglets. From 
each treatment, 10 piglets were randomly selected, ear-tagged 
and subjected to closer monitoring. They were weighed and 
taken rectal swabs on weekly basis, starting 11 days (Day 1) after 
the weaning. All the piglets in each treatment were subjected to 
daily diarrhea scoring (score 1 – no diarrhea signs; score 2 - pasty 
faeces, active piglets; score 3 - watery faeces, active piglets; 
score 4 - severe diarrhea, apathy piglets. Each entire batch was 
weighed at the beginning and end of the post-weaning period. 
The culling and mortality rates were summarized after the de-
parture of the experimental piglets for the fi nishing department.
Results
The diarrhoea in weaned piglets is mainly caused by ETEC, how 
the results confi rmed. The pathogenic strains E. coli were found 
in two piglets on Day 14 in the control group O141:F18, VT2e+ 
and O149:F4, STa+, LT+. In SC group no pathogenic strains were 
found.
Piglets were diagnosed in 98,12% Clostridium perfringens posi-
tive in the fi rst sampling and 100%positive in the later samples 
regardless of treatment.
Table 1
Group Days (d) ADG (g) No of piglets (n)
SC 55 413 280
Control 56 405 206
Discussion
In contrast to our fi ndings (5), some researchers (6) re-ported 
that the yeast strain in their studies did not seem to aff ect any of 
the microbial groups tested incl. E. coli.
The mash liquid diet supplemented with SC showed a tendency 
( p<0.05) to increase daily weight gain by 8 g as compared with 
the untreated Control group (Table 1). The SC dietary supple-
mentation may have reduced pathogenic E. coli strains and diar-
rhea occurrence. The diarrhea scores of the SC group diff ered 
signifi cantly from those of the Control on days of the trial 11 to 
13 (Figure 1).
Figure 1
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Factors associated with pre-weaning piglet mortality due to crushing 
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Introduction
The average preaweaning piglet mortality in US herds in the fi rst 
quarter of 2009 is reported to be 12.2%1. It has been reported2 
that one-fi fth of all fetuses fully formed at the end of gestation 
die before weaning. Thus preweaning piglet mortality is an 
important cause for economic loss in swine production systems. 
Injuries and crushing due to the sow falling on the piglets while 
making postural changes constitute a major cause for prewean-
ing piglet death. Claw lesions in pigs are putatively painful. Sows 
with severe claw lesions may be restricted in making the neces-
sary postural adjustments while attempting to lie down within 
the limited space inside the farrowing crate. In pigs the support 
role is more important in the front limbs which are nearer to the 
center of gravity. Further, observation of a sow lying down also 
suggests more movements associated with front limbs than the 
hind limbs. It is important to understand the factors associated 
with piglet death due to crushing to minimize the loss of live 
born piglets. The objective of the present study was to analyze 
the association of preweaning piglet death due to crushing with 
factors such as claw lesions, parity of the sow and gestation 
housing system.
Material and methods
This study involving 611 parity records of sows housed in group 
pens with electronic sow feeders (ESF) and 399 parity records 
of sows housed in conventional gestation stalls was conducted 
at the University of Minnesota, Southern Research and Out-
reach Center at Waseca. The lesions in the claws of these sows 
were examined at mid-gestation using a mechanical restraint 
designed for the purpose in one, two or three consecutive par-
ities. The total claw lesion scores for front and hind limbs were 
obtained3 by adding the lesion scores in diff erent claw areas 
(side wall, heel, sole, heel-sole junction, and white line) of lateral 
and medial claws. Information on reasons for preweaning piglet 
mortality, parity of the sow and housing system were collected 
from the PigCHAMP database of the unit. The association of 
number of preweaning piglet mortalities due to crushing with 
the parity of the sow, claw lesion scores in front and hind limbs, 
and gestation housing system was analyzed (Proc genmod, SAS 
v. 9.1) analysis with sow as a repeated measure. For analysis, par-
ity of the sow was categorized into parities 1 and 2, 3 to 5 and 
>5. 
Results
In this study 24 % of preweaning piglet mortality was found to 
be due to crushing. Analysis indicated signifi cant association 
between number of preweaning piglet deaths and parity of the 
sow, claw lesions and housing system. Sows of parities 1 and 2 
and parities 3 to 5 had 61 and 36% lower piglet death due to 
crushing respectively, compared to sows of parity >5 (P<0.05 for 
both). For every unit increase in claw lesions in front limbs, the 
number of preweaning piglet death due to crushing increased 
by 8% (P<0.05). A higher hind limb claw lesion score was also 
associated with higher number of piglet death due to crush-
ing, though this association was not signifi cant (P>0.05). Sows 
housed in group pens had 39% less (P<0.05) piglet death due to 
crushing compared to sows housed in stalls during gestation.
Discussion
The positive association observed between parity and piglet 
death due to crushing could be due to the smaller litter size in 
younger parity sows. An increase in number of piglet deaths due 
to crushing being associated with an increase in front limb claw 
lesion score is interesting. This may be suggestive of restric-
tion due to pain in making the necessary postural movements 
to avoid uncontrollable falling within the farrowing crate, thus 
leading to a higher number of piglets being crushed. A higher 
number of crushed piglets in stall-housed sows could be related 
to a lack of exercise and consequent decrease in muscle weight 
and bone strength4 of these sows. 
Conclusion
This study indicated a positive association between higher pre-
weaning piglet death due to crushing and factors such as higher 
parity, stall gestation housing system and higher claw lesion 
scores in front limbs of sows. 
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Claw lesion eﬀ ects on piglets born alive of stall-housed sows in two sow herds
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Introduction
The number of piglets born alive per litter directly infl uences 
the average number of piglets weaned per sow per year (1). 
The aim of the present study was to evaluate the association of 
the productivity of stall-housed sows in terms of low litter size 
(≤10 piglets) with claw lesions scores, also considering stillborn, 
mummies, parity and sow herd. 
Materials and methods
The lesions of these sows were collected from a convenience 
sample of 343 stall-housed sows (parities 1 to 13) belonging to 
two sow herds (Herd A, n=145, Herd B, n=198; of 1500 sows each 
herd). These sows were scored for lesions in diff erent claw areas 
(side wall, heel, including overgrown heels, white line, heel-sole 
junction, and overgrown toes and dew claws). The claws were 
examined while the sows were in a recumbent position as there 
was no mechanical restraint to facilitate lesion scoring. The total 
score for each claw area was obtained by adding the scores 
for that area in the claws of front and hind limbs. For analysis, 
parity was categorized into parities 1 and 2, 3 to 5 and >5. A 
multivariate logistic regression analysis was performed to assess 
the association of lesion scores of diff erent claw areas, stillborn, 
mummies, parity and sow herd with number of piglets born 
alive (≤10 vs. >10) (Proc Logistic, SAS v 9.2). 
Results
A total of 105 sows (30.6%, mean=6.9, standard deviation=2.8) 
had ≤10 piglets born alive. The number of sows that had >10 
piglets born alive was 238 (69.4%, mean=13.2, standard devia-
tion=2.16). The total lesion score for all claw areas ranged from 0 
to 27 and only two sows had no lesions. White line lesions (odds 
ratio 1.151, range of lesions scores=0 to 10) and overgrown toes 
(odds ratio 1.154, range of lesions scores=0 to 10) were positive-
ly associated (P<0.05 for both) with the likelihood of having ≤10 
piglets born alive. The likelihood of having ≤10 piglets born alive 
increased with an increase in the severity of lesions in other claw 
areas as well (heel-sole crack and side wall), though the associa-
tions were not statistically signifi cant. The numbers of stillborn 
piglets were positively associated with the likelihood of having 
≤10 piglets born alive (odds ratio 1.298, P<0.01). Parity, number 
of mummies and sow herd were not found to be associated with 
piglets born alive in this study. 
Discussions
The small number of sows with no lesions is in agreement with a 
previous study which indicated a high number of stalled housed 
sows that had at least one claw lesion (2). White line lesions and 
overgrown toes were positively associated with the likelihood 
of having ≤10 piglets born alive; suggesting that productivity of 
sows can be negatively infl uenced by the development of severe 
claw lesions in sows. The results of this study are indicative of 
potential adverse eff ects of claw lesions on the productivity of 
sows. It is important to identify factors aff ecting sow productiv-
ity and to reduce early removal of sows due to low productivity.
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Better colostrum distribution increases piglet survival in high proliﬁ c sows
Jan Jourquin1 Johan Biermann2 Rainier van Gelderen1 Lieve Goossens1
1. Janssen Animal Heatlh, Beerse, Belgium; 2. DAP Helmond, Helmond, Netherlands
Introduction
Colostrum intake is critical for the survival of the piglet. During 
the fi rst days, the colostrum provides the nutrients for homeo-
stasis and growth. For a much longer period the colostrum 
immunoglobulin fraction passively protects the piglets from 
disease (1). Only during the fi rst 24 to 48 hours of life, these col-
ostrums IgG’s can pass the piglets gut. The colostrum intake per 
kg body weight (BW) ranges between 210 to 370 gram, but the 
capacity of a piglet to ingest colostrum is exceeding 450 gram/
kg BW (2). The total colostrum yield of sows varies between 1.91 
and 5.31 kg (3). Because litter size does not aff ect colostrum 
yield (3), in hyper prolifi c sow breeds, a high variation in colos-
trums uptake is diffi  cult to avoid. 
The aim of this study was to investigate the impact of colostrum 
distribution on pre-weaning piglet survival in high prolifi c sows. 
Materials and Methods
In a 1600 sow farm, the litters of 220 sows were included in the 
study. At 3 days of age, individual blood samples were retrieved 
from the docked tail of six randomly chosen litter mates. The IgG 
titre of the samples was measured with a DAS-ELISA test (Col-
ostrum Quality CounterTM). This IgG titre, determined after the 
phase of colostrums IgG passage through the gut, can be used 
as a measure of colostrum intake (4). Of each litter, the average 
IgG titre and the standard deviation was calculated. By dividing 
the standard deviation by the average, the coeffi  cient of vari-
ance of piglet serum IgG (CV IgG) was calculated. This coeffi  cient 
is a measure for variation in IgG intake within the litter, and 
therefore represents the variation of colostrum intake. During 
the lactation period piglet mortality in each litter was recorded. 
The statistical analysis was performed with the SAS® program. 
A Poisson regression model on the number of dead piglets 
per sow was used. The total number of piglets was included as 
covariate. 
Results
The CV IgG amongst litter mates ranged from 18 to 208%, with 
an average of 55%. In Table 1, the impact of colostrum distribu-
tion on piglet mortality is shown. Sows with a CV IgG of less than 
50% (average 36%) were compared to those with a CV IgG of 
more than 50% (average 76%). With the same average litter size, 
the mortality was found to be statistically signifi cant lower in 
litters with a low CV IgG. 
Table 1: Impact of colostrum distribution on pre-weaning piglet 
mortality
CV IgG Number of litters Piglets with sow Mortality (%)
≤50% 117 12.5 5.1a
>50% 103 12.6 7.7b
ab: diff erence with p-value of 0.0259
The mortality rate over all litters was highly correlated with the 
number of piglets with the sow (p < 0.0001).
Discussion 
These results clearly demonstrate that an even distribution 
of the available colostrum amongst littermates has a positive 
impact on the pre-weaning survival rate. The high number of 
piglets born alive, often in combination with low birth weight 
and low vitality as seen in highly prolifi c sows, reduces the 
chances of equal colostrums uptake amongst littermates. This 
leads to piglet loss mainly in the fi rst days after birth. The ability 
of the sow to give all her piglets equal drinking opportunity is 
therefore a key factor. Even with a good colostrum distribution, 
mortality increases with the litter size, demonstrating that an 
increasing number of piglets calls for a higher colostrum yield, 
an increasing number of functional teats and suffi  cient drinking 
space. On the other hand, piglet suckling might also be promot-
ed by reducing or eliminating all stress related behavior during 
the colostrum intake phase enabling the sow to optimally nurse 
her off spring. 
All measures that improve the transfer and equal distribution 
of the available colostrum to each piglet should be taken into 
account to improve piglet survival. 
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Eﬀ ect of a softer surface in the farrowing crate on the behavior of lactating sows
A. Da Silva; S.S. Anil; J. Deen; S.K. Baidoo
University of Minnesota, Saint Paul, MN, USA
Introduction
Lameness in swine herds is a common problem. Activity levels 
and frequency of standing may be higher during lactation (1). 
However, lameness, being putatively painful, may infl uence 
the frequency and/or duration of postural behaviors of the sow 
during lactation. Limited ability to make postural changes could 
in turn aff ect the quantity of feed and water consumed by the 
sow. Inadequate water intake has been suggested to cause low 
milk production (2) and reduced weight gain/death of pig-
lets. Similarly, low lactation feed intake can aff ect subsequent 
reproductive performance of the sow. The quality and type of 
the fl oor are important factors infl uencing sows’ standing and 
lying-down behavior (3). However, studies on the eff ect of fl oor 
type on lameness and its eff ects in behavior of sows are rare. 
The present study aims to explore the eff ect of providing rubber 
mats in farrowing crates as a measure to minimize the adverse 
eff ects of lameness on behavior.
Materials and methods
This study involved 70 lame and 70 non-lame gestating sows 
(gestation stall n=63 and group pens with ESF n=77) identi-
fi ed based on their ability to bear weight on all limbs without 
favoring any particular limb when they were moved from the 
gestation housing systems to farrowing rooms. Lameness in all 
the sows was assessed by the same person. Equal numbers of 
sows were randomly allocated to farrowing crates with cast iron 
fl oor or to crates with the cast iron fl oor covered with rubber 
mats (3cm thickness) on the posterior half. The behaviors of the 
sows while in the farrowing crates on day 3, 9 and 15 post-far-
rowing were recorded using cameras and a time-lapse VCR. The 
frequencies of behaviors (getting up, dog sitting, drinking water 
and eating) of lame and non-lame sows with and without rubber 
mats on these days were compared using separately models, 
controlling for the eff ect of housing system (Proc Genmod, SAS 
v 9.2). 
Results
The frequencies of getting up, dog-sitting posture, drinking 
water and eating on day 3, 9 and 15 post-farrowing were (0-31, 
2-48, 2-41, 0-29) respectively. The frequency of getting up was 
3% lower and 15% higher (P<0.05 for both) in stall-housed sows 
on d3 and d15 post-farrowing. Lame sows got up 12% fewer 
times on d9 post-farrowing. These sows also tended to have 
(P=0.05) 16% lower frequency of getting up on d3. On d9 post 
farrowing, the frequency of dog-sitting posture was 13% lower 
(P<0.05) in sows with rubber mat. Stall-housed sows adopted 
dog-sitting posture 16% and 44% more times (P<0.05 for both) 
on d9 and d15 post-farrowing. However, lame sows tended 
(P=0.08) to show this postural behavior less frequently than non-
lame-sows on d9. The frequency of drinking water tended to be 
lower for lame sows in comparison to non-lame sows (P=0.09) 
and higher for those sows housed in gestation stalls (P=0.08) 
on d3 post-farrowing. The frequency of drinking water was 14% 
lesser (P<0.05) among sows with rubber mats on d9 post-farrow-
ing. Sows housed in stalls drank 39% more times (P<0.05) than 
the group-housed sows on d15 post-farrowing. The frequency of 
drinking water tended to be higher in both lame sows (P=0.07) 
and those housed in stalls (P=0.07) on d9 post-farrowing. The 
frequency of eating was 11% less (P<0.05) among lame sows on 
d9 post-farrowing and the frequency tended to be less (P=0.08) 
on d3 post farrowing.
Discussions
In general, the results are indicative of the adverse eff ect of 
lameness on postural behavior and feed and water consumption 
during lactation. However, post-partum behavior of the sow and 
familiarity of stall-housed sows to postural changes in restricted 
space could have infl uenced the results. 
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Use of paper strips as nesting material in sows: eﬀ ects on abnormal 
behaviours, salivary cortisol and productive data
Paolo Candotti; Daniele Zappulla; Ivonne Archetti; Sara Rota Nodari
Izsler, Brescia, Italy
Introduction
In both wild and domestic pigs nest building is a natural, 
inherited behaviour that begins 24 h before farrowing. Stalling 
in single barren farrowing crates inhibits this behaviour and 
represents a source of mental stress in sows (Lawrence A.B. et 
al., 1994). The aim of this study was to compare salivary cortisol, 
abnormal behaviours and productive data of the litters in sows 
kept in barren farrowing crates and in sows given paper strips.
Material and Methods
91 sows of a farrow to fi nish farm of Northern Italy were selected 
for the study. The sows of the treated group (n=36) were given 
2kg of strips of paper at day 112 of gestation; the control group 
(n=55) were left without. Both groups were kept in traditional 
farrowing crates. Salivary cortisol was evaluated at day 101, 
107, 112 and 113 of gestation and at day 1 and 28 of lactation. 
Abnormal behaviours were recorded at day 107, 112-115 of 
gestation and at the 1st day of lactation. Productive data of the 
litters were also recorded.
Results and Discussion
Results reported in fi gure 1 show less abnormal behaviours in 
treated sows compared to control sows. Particularly, the treat-
ment was able to reduce oral stereotypes.
The salivary cortisol measured at day 101 of gestation was 
compared to the salivary cortisol measured at the other sam-
plings time points. Treated sows showed a lower increase in 
cortisol compared to control sows. In fi gure 2 the average level 
at day 101 of gestation and the diff erence with this basal level at 
the other samplings is reported. These fi ndings confi rm previ-
ous reports (Jarvis et al., 2001) that showed a positive eff ect of 
environmental enrichment on animals’ cortisol.
In table 1 the positive eff ect of treatment on the productive data 
of the litters is reported.
Table 1. Performance data of the litters 
Group BA Mean (SD) % CP/BA % SAV/BA % WP/BA
control 13.24 (3.21) 14 2.8 81
treated 12.25 (3.38) 9.3 0.4 89
Legend: BA = number of piglets born alive; CP = crushed piglets; SAV= piglets savaged by 
their sow; WP = total weaned piglets; SD= standard deviation
The overall eff ect of paper strips was positive on all the param-
eters recorded without adverse eff ects on the slurry system.
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Cross-reactivity and eﬃ  cacy of a monovalent swine ﬂ u vaccine containing the pandemic H1N1 2009 virus
Ralf Dürrwald1 Michael Schlegel1 Hans-Joachim Selbitz1 Andi Krumbholz2 Roland Zell2
1. IDT Biologika GmbH, Dessau-Roßlau, Germany; 2. Universitätsklinikum Jena, Institut für Virologie und Antivirale Therapie, Jena, Germany
Introduction
Since its fi rst emergence in the human population in spring 2009 
(1) infections with the pandemic H1N1 virus (cH1N1v) have been 
reported in pigs and other animal species in several regions of 
the world (2, 3). The pandemic virus can be experimentally trans-
mitted between pigs (4). Although vaccine strains of authorised 
swine fl u vaccines are cross-reactive to cH1N1v (5) a swine 
vaccine containing cH1N1v may be superior to the available vac-
cines. In order to investigate this in more detail hyper immune 
sera, post infection sera and a monovalent vaccine containing 
cH1N1v were produced and investigated for effi  cacy.
Materials and Methods
Hyper immune sera were established using a fourfold vaccina-
tion of pigs with antigens of H1N1 vaccine strains and a strain 
of the pandemic H1N1 virus using Freund’s adjuvant. Blood 
samples were taken 14 days after last immunization. A vaccine 
containing the pandemic H1N1 virus was produced. Swine fl u 
vaccines available in central Europe and the newly produced 
cH1N1v vaccine were administered to pigs. Blood was with-
drawn 7 days after second administration.
Furthermore an experimental aerosol infection was carried out 
using the parental strain of the most recent avian-like H1N1 
strain contained in a European swine fl u vaccine. Ten days after 
infection, blood samples were taken. Sera were investigated ap-
plying a neutralization test and hemagglutination inhibition (HI).
Results
The investigation of hyper immune sera revealed that there 
is neutralizing activity between the pandemic H1N1 virus 
and avian-like H1N1 European vaccine strains (A/sw/Nether-
lands/25/80, A/sw/IDT/Re230/92, A/sw/Haselünne/IDT2617/07) 
as well as with the New Jersey/8/76 (Fort Dix reassortant) strain 
at low level. A hyper immune serum established against the 
pandemic H1N1 showed cross-reactivity with European avian-
like H1N1 virus and very high titres against several pandemic 
H1N1 strains. The vaccines (Gripovac, Suvaxyn Flu, RESPIPORC 
FLU, RESPIPORC FLU3/Gripovac 3) also induced neutralizing 
antibodies against the pandemic H1N1 virus. However, the titres 
were lower in comparison to those obtained for avian-like H1N1 
and not all pigs did respond. The highest degree of cross neu-
tralization was achieved by experimental batches of a vaccine 
which contained the pandemic H1N1 virus strain (Tab. 1).
Tab.1. Antibodies induced by a swine fl u vaccine containing cH1N1v in 
comparison to an approved trivalent vaccine, mean HI titres reciprocal 
(pigs positive); avH1N1 avian-like H1N1, huH1N2 human-like H1N2, 
huH3N2, human-like H3N2
Vaccine No. of pigs cH1N1v avH1N1 huH1N2 huH3N2
cH1N1v 6 1093 (6) 13 (1) <20 (0) < 20 (0)
avH1N1, 
huH1N2+huH3N2 5 8 (1) 464 (5) 199 (5) 656 (5)
 
Discussion 
It is concluded that despite the cross-reactivity between avian-
like and classical swine H1N1 strains with the pandemic H1N1 
virus of 2009 a vaccine consisting of cH1N1v is superior in terms 
of effi  cacy in comparison to vaccines already licensed.
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Transmission dynamics of a H1N1 swine inﬂ uenza virus in a population 
previously infected with the 2009 pandemic H1N1 strain
Anna Romagosa; Monserrat Torremorell; Marie Gramer; John Deen; Han S. Joo
University of Minnesota, St Paul, MN, USA
Introduction
Little is known about the transmission and spread of swine 
infl uenza virus (SIV) in pig populations previously infected with 
the 2009 pandemic H1N1infl uenza strain. A transmission experi-
ment was performed to asses the transmission pattern of a 
triple reassortant H1N1 virus in pigs previously infected with the 
2009pH1N1 SIV strain.
Material and Methods
Two groups of ten 3-week-old pigs were placed in separate isola-
tion rooms. The groups were designated as control (C) or previ-
ously infected (I). Pigs in the control group were neither vaccin-
ated nor infected with SIV. Pigs in the I group had been naturally 
infected with the 2009pH1N1 SIV strain at about 4 weeks prior 
to the beginning of the study. These pigs were virus free and HI 
test positive (titers≥1:40) against the 2009pH1N1 at the time the 
study started. However, they were HI negative against the chal-
lenge strain (A/Sw/IA/0239/04).
In a separate room 2 naive pigs were challenged with the triple 
reassortant A/Sw/IA/0239/04 H1N11 which was genetically dif-
ferent from the 2009pH1N1. Twenty four hours post challenge 
the challenged pigs were confi rmed positive by nasal swab PCR. 
At 48 h one challenged pig was moved into each of the treat-
ment rooms and placed in direct contact with the pigs in group 
C and I. Transmission was evaluated by collecting nasal swabs 
from all pigs on a daily basis. Nasal swabs were tested individ-
ually by PCR until all pigs in each group tested positive or until 
14 days post contact (DPC) when the study was terminated. 
Blood samples were also collected at the beginning and the end 
of the study. 
Pigs were monitored daily and clinical scores based on cough-
ing, sneezing, lethargy, fever, nasal discharge and dyspnea were 
calculated. At necropsy the percentage of macroscopic lung 
lesions was recorded and tissues from the trachea, lungs, nasal 
turbinate, tonsils and lymph nodes were collected for PCR, virus 
isolation and histopathology. 
Results 
The transmission results are shown in Figure 1. Infl uenza virus 
was detected by PCR in all pigs in the control group by 5 DPC 
and pigs remained positive until necropsy (8 DPC). In contrast 
infl uenza virus was detected by PCR in only one pig in group I at 
1 DPC. Diff erences in transmission patterns between the groups 
were statistically signifi cant at p<0.001.
Figure 1. Cumulative number of infected pigs by group after mixing 
with the challenged pig. 
Figure 2. Average clinical scores for control and previously infected 
pigs.
Diff erences in clinical scores (fi gure 2) and gross lung lesions 
were also observed. Pigs in group C had an average clinical score 
of 1.54 compared to 0.78 in the I group (p≤0.01). The percentage 
of macroscopic lung lesions at necropsy in the control group 
was 14% ±4.52 and 2.38%± 1.38 in the I group.
Discussion
Results indicate diff erences in transmission and spread of SIV 
between groups. Although SIV could spread rapidly in a naïve 
population (control group), transmission in the previously 
infected group with the 2009pH1N1 was limited and infection 
could not become established. This study represents preliminary 
work to understand the dynamics of SIV transmission in the fi eld 
as represented by populations with diff erent immune status.
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Eﬃ  cacy of inactivated swine inﬂ uenza virus vaccines against 2009 H1N1 inﬂ uenza virus in pigs
Amy L. Vincent1 Janice R. Ciacci-Zanella1 Alessio Lorusso1 Philip C. Gauger2 Eraldo L. Zanella1 
Marcus E. Kehrli1 Bruce H. Janke2 Kelly M. Lager1
1. USDA-ARS National Animal Disease Center, Ames, IA, USA; 2. Iowa State University, Ames, IA, USA
Introduction 
The gene constellation of the 2009 pandemic H1N1 virus is a 
unique combination from swine infl uenza A viruses (SIV) of 
North American and Eurasian lineages, but prior to April 2009 
had never before been identifi ed in swine or other species (1). 
Although its hemagglutinin gene is related to North American 
H1 SIV, it is unknown if vaccines currently used in U.S. swine 
would cross-protect against infection with pandemic H1N1. The 
objective of this study was to evaluate the effi  cacy of inactivated 
vaccines prepared with U.S. swine infl uenza viruses as well as 
an experimental homologous vaccine to prevent infection and 
disease from 2009 pandemic H1N1. 
Materials and methods
Sixty three-week-old cross-bred pigs were obtained from a herd 
free of SIV and porcine reproductive and respiratory syndrome 
virus (PRRSV). A/California/04/2009 H1N1 (CA/09) was propa-
gated in Madin-Darby Canine Kidney (MDCK) cells for use in the 
study described below. Three inactivated vaccines (Vaccines A, 
B, and D) were selected based on serologic evidence of cross-
reactivity in a previous study(2). Commercial vaccines were 
supplied by the manufacturers for use in the study and admin-
istered as per label. Vaccine A (FluSure® XP, Pfi zer Animal Health, 
New York, NY) is a fully licensed trivalent commercial product 
containing cluster IV H3N2, γ-cluster H1N1, and δ-cluster 
H1N1 SIV as vaccine seed viruses. Vaccine B (MaxiVac Excell® 
5.0, Intervet/Schering-Plough, Boxmeer, The Netherlands) is a 
pentavalent product containing clusters I and IV H3N2 and β-, γ-, 
and δ-cluster H1 SIV as vaccine seed viruses. Vaccine D (Newport 
Labs, Worthington, MN) is a bivalent autogenous vaccine con-
taining β- and γ-cluster H1 SIV as vaccine seed viruses. A mono-
valent experimental vaccine (Vaccine E) was prepared from 
CA/09 at 8 HA units per 50 μL and 1 X 106.5 50% tissue culture 
infectious dose (TCID50) per mL with inactivation by ultraviolet 
irradiation and addition of a commercial adjuvant. Pigs (N=10 
per group) were vaccinated with 2 mL of each vaccine by the 
intramuscular route at approximately 4 weeks of age, boosted at 
7 weeks of age, and challenged at 10 weeks of age. 
Nasal swabs were taken at 0, 3, and 5 days post infection (dpi). 
At necropsy, lungs were removed to estimate the percentage of 
macroscopic pneumonia. Each lung was lavaged to obtain bron-
choalveolar fl uid (BALF). Virus titers in BALF were determined by 
serial dilutions added to MDCK cells in 96-well plates, and virus 
from nasal swab samples were isolated on MDCK cells in 48-well 
plates and positive samples titrated in 96-well plates. 
Hemagglutination inhibition (HI) assays were done to evaluate 
sero-conversion using challenge virus as well as a panel of North 
American H1 SIV isolates representing each phylogenetic cluster 
(3). 
Results
All vaccines tested provided partial protection ranging from 
reduction of pneumonia lesions to signifi cant reduction in virus 
replication in the lung and nose. Although the commercial 
multivalent vaccines demonstrated partial protection, none 
were able to prevent all nasal shedding or clinical disease. An 
experimental homologous 2009 H1N1 monovalent vaccine 
provided optimal protection with no virus detected from nose 
or lung at any time point in addition to amelioration of clin-
ical disease. The CA/09 vaccine induced high HI titers against 
homologous 2009 H1N1 as well as cross-reacting HI antibodies 
against α-, β-, and γ-cluster H1N1 SIV. Commercial vaccines 
that induced γ-cluster HI antibodies demonstrated statistically 
signifi cant reductions in virus titers.
Discussion
Based on cross-protection demonstrated with the vaccines 
evaluated in this study, the U.S. swine herd likely has signifi cant 
immunity to 2009 H1N1 from prior vaccination or natural expos-
ure, especially those demonstrating immunity against γ-cluster 
SIV. However, consideration should be given for use of homolo-
gous vaccines to best protect naïve swine herds and limit the 
potential transmission of 2009 H1N1 from herd to herd and from 
pigs to people.
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Eﬃ  cacy of swine inﬂ uenza virus vaccines produced using the alphavirus replicon system
Ryan L. Vander Veen1, 2 Mark A. Mogler1, 2 DL Hank Harris1, 2
1. Iowa State University, Ames, IA, USA; 2. Harrisvaccines, Inc., Ames, IA, USA
Introduction
Swine infl uenza virus (SIV) continues to circulate among most 
U.S. swine herds. The recent outbreak of pandemic H1N1 in the 
human population and its subsequent confi rmation in pigs 
has again highlighted the zoonotic potential of these viruses. 
Using alphavirus replicon technology, a recombinant pandemic 
H1N1 hemagglutinin (HA) subunit vaccine and a cluster 4 H3N2 
replicon particle (RP) vaccine were developed and effi  cacy was 
determined in swine vaccination-challenge models.
Materials and Methods
Hemagglutinin genes derived from A/California/04/09 and a 
fi eld strain of cluster 4 H3N2 were commercially synthesized 
and inserted into the alphavirus replicon system as previously 
described.1,2 The replicon system was utilized to express HA 
subunit in vitro (pandemic H1N1) or to produce a replication-de-
fi cient particle that produces HA protein in vivo (cluster 4 H3N2). 
Twenty pigs were randomized and divided equally among 4 
groups. One group served as non-vaccinated controls, while the 
remaining 3 received varying doses (high, mid, low) of pandemic 
H1 subunit vaccine. Pigs were challenged intratracheally with 
1x105 TCID50 of A/California/04/2009 and necropsied 5 days 
post-challenge. The H3N2 study consisted of 50 animals, with 
10 strict negative controls, 20 vaccinates and 20 non-vaccinates. 
The 20 RP vaccinated pigs received 2 doses of cluster 4 H3 RP 
vaccine. The 20 vaccinates and 20 non-vaccinates were chal-
lenged with 1x107 TCID50 of homologous H3N2 virus. Necropsy 
was performed 4 days post-challenge. In both studies, vaccin-
ated pigs received the fi rst dose of vaccine at 3-4 weeks of age, 
with booster vaccination given 3 weeks later.
Results
Pandemic H1N1 Study
All of the vaccinated groups developed positive (>1:40) mean 
homologous HI titers following two doses of HA subunit vaccine. 
At necropsy, lungs exhibited gross lesions typical of SIV. Lungs 
evaluated from the vaccinated groups had signifi cantly lower 
gross lung lesions, as well as histopathological lesions. Live virus 
titration performed on post-challenge nasal swabs demon-
strated that vaccinated pigs had reduced viral shedding when 
compared to non-vaccinated pigs. The group receiving the high 
dose HA subunit vaccine did not shed virus at a detectable level, 
while on days 3-5 post-challenge the low and mid dose vac-
cine groups demonstrated signifi cantly reduced viral shedding 
when compared to the non-vaccinated controls. In addition to 
reduced lung lesions and viral shedding, all vaccinated groups 
demonstrated higher average daily gain than the non-vaccinat-
ed group following challenge.
Cluster 4 H3N2 Study
All vaccinated pigs developed robust homologous HI titers 
following two doses of SIV RP vaccine. At necropsy, lungs 
evaluated from vaccinated pigs exhibited signifi cantly reduced 
gross lung lesions when compared to the non-vaccinated pigs. 
The non-vaccinated groups developed a febrile response 24 
hours post-challenge, while the temperature of the vaccinated 
pigs was signifi cantly lower at this time point. No live virus was 
detected in the broncho-alveolar lavage fl uid (BALF) collected 
at necropsy in any of the vaccinated pigs, while all of the non-
vaccinated pigs had detectable virus in the BALF samples. These 
results correlate with the reduced lung lesions observed in the 
vaccinated pigs. In addition, no live virus was detected from 
nasal swabs in any of the vaccinated pigs taken throughout the 
post-challenge period, while by days 3 and 4 post-challenge 
most of the non-vaccinated pigs had detectable live virus from 
nasal swab samples.
Discussion
These studies further demonstrate the applicability and effi  -
cacy of SIV vaccines produced utilizing the alphavirus replicon 
system. The pandemic H1N1 study demonstrated the rapidness 
with which this technology can be utilized to respond to emer-
ging strains of infl uenza, as the pandemic vaccine was available 
in less than 2 months after the public announcement of infec-
tion in humans. This is much quicker than traditional methods 
of infl uenza vaccine preparation. The rapid exchange of HA 
infl uenza genes in this system enables us to produce diff erent 
replicons which express the HA gene of all the diff erent clusters 
currently circulating in the U.S. swine population,3 as well as 
respond quicker to observed antigenic drift among infl uenza 
isolates. 
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In vivo evaluation of vaccine eﬃ  cacy against challenge with a contemporary 
ﬁ eld isolate from the alpha cluster of H1N1 swine inﬂ uenza virus
Susan E. Detmer1 Marie R. Gramer1 Sheerin Mathur2 Vicki J. Rapp-Gabrielson2
1. University of Minnesota, Department of Veterinary Population Medicine, St. Paul, MN, USA; 2. Pfi zer Animal Health, VMRD, Kalamazoo, MI, USA
Introduction
Infl uenza A virus vaccines currently contain a mixture of fi eld 
isolates that refl ect the genetic and antigenic characteristics of 
the currently circulating strains. In order to continue to provide 
protection, these vaccines need to be regularly updated. For 
North American pigs, swine infl uenza is a year-round respira-
tory disease caused by H1N1, H1N2 and H3N2 subtypes and 
within the H1N1 subtype there are 4 clusters designated α 
(classical swine infl uenza), δ (human-like swine infl uenza), β and 
γ (reassortant swine infl uenza viruses). For Canadian pigs, most 
of the currently circulating infl uenza A viruses are in the SwH1 
α cluster1. Therefore, this study was conducted to evaluate the 
effi  cacy of a vaccine containing a γ H1N1 virus (Flusure XP™) in 
pigs challenged with a contemporary α cluster fi eld isolate of 
Canadian swine origin. 
Materials and Methods
The animal phase of this study was conducted in accordance 
with the approval of the Institutional Care and Use Committee of 
the University of Minnesota. 
Vaccines and vaccination: Flusure XP™ was administered as per 
manufacturer label instructions. Three-week-old swine from a 
high-health herd free of infl uenza, Mycoplasma hyopneumoniae 
and PRRS virus were vaccinated 14 days apart with a 2 ml 
intramuscular dose and assigned to 2 treatment groups, and 
non-challenged pigs that were housed in 3 rooms in an isolation 
unit at the University of Minnesota as follows: 
Table 1. Vaccination treatment groups.
Room No. Group No. Swine Challenge 
1 No treatment 2 No challenge
2 No treatment 1 No challenge*
Vaccine 5 SwH1 α
Adjuvant alone 5 SwH1 α
3 No treatment 1 No challenge*
Vaccine 4 SwH1 α
Adjuvant alone 4 SwH1 α
Challenge and post-challenge procedures: Immediately prior 
to challenge, the no treatment pigs (*) in rooms 2 and 3 were 
removed for euthanasia and necropsy. Two weeks following the 
second vaccination, swine were inoculated 2 ml intratracheally 
and 2 ml intranasally with 105.5 TCID50/ml of infl uenza A/Swine/
IL/02450/2008 (H1N1), an alpha-cluster H1 of Canadian swine 
origin. Swine were monitored daily for clinical signs and nasal 
swabs were taken for virus isolation on MDCK cells. On day 5 
post-challenge, swine were euthanized for necropsy; bron-
choalveolar lavage fl uid (BALF) was collected, lungs were scored 
for gross lesions2 and lung samples were collected for histopath-
ology3 and virus isolation. All samples negative by virus isolation 
were retested by real time RT-PCR.
Hemagglutination Inhibition (HI) Antibodies: Blood was collected 
12 and 2 days before the fi rst vaccine, 1 day before the second 
vaccine, at challenge and 5 days after challenge. All sera were 
assayed for hemagglutination inhibition (HI) titers against the 
homologous virus in each vaccine and against the challenge 
virus.
Statistical analysis: Gross lung scores, HI titers and virus titers 
were evaluated by a general linear repeated measures mixed 
model using SAS (SAS Institute, Cary, NC). 
Results and Discussion
There were gross lesions present in the lungs of all pigs that 
were inoculated with the challenge virus. However, the chal-
lenge virus only produced mild clinical signs that included fever 
lasting 24-48 hours in a few pigs and rare coughing. The results 
of the nasal swab virus titers show that there was reduction in 
viral shedding for vaccinated swine compared to unvaccinated 
swine post-challenge. The virus titers for the BALF and lung sam-
ples were lower in the vaccinated swine than the unvaccinated 
swine. The vaccinated swine had HI titers > 40 for all vaccine 
viruses on challenge day and 5 days after challenge. All swine 
had an HI titer ≤ 40 for the challenge virus 5 days after challenge. 
These results indicate that vaccination with Flusure XP™ reduced 
virus isolation from nasal swabs, lungs and BALF in swine experi-
mentally challenged with a SwH1 α cluster virus that is genetic-
ally similar to those currently circulating in Canadian swine.
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Nanoliter real-time PCR: A new molecular platform for simultaneous detection of multiple pathogens
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Introduction
Many disease problems in swine production are often multi-
factorial, which can be a diagnostic challenge. A multiple 
pathogen detection system can be then of great help to accur-
ate and rapid diff erential diagnosis, simultaneous surveillance 
for various infectious agents, and studying interactions among 
diff erent pathogens involved in a disease complex (i.e., disease 
ecology). Although various multiplexing technologies have 
been developed and applied for these purposes, their applica-
tions have been somewhat limited due to the complexity of test 
development and maintenance: optimization of multiple assays 
in a multiplex system is very challenging; and addition of a new 
assay to the optimized system requires signifi cant time and ef-
fort for additional validation. Therefore, a new detection system 
in which multiple individual assays can be optimized and run 
independently, yet simultaneously and economically, needs to 
be explored.
High-throughput nanoliter real-time PCR (OpenArrayTM, 
BioTrove) [1] uses conventional SYBR Green or TaqMan real-time 
PCR formats. For each sample the system can run real-time PCR 
assays for up to 64 diff erent targets simultaneously as independ-
ent reactions in parallel. Each array slide can run 48 diff erent 
samples at the same time. The system is also considered to be 
economical since the total reaction volume for each assay is 
only 33 nanoliters, which is nearly 1000 times less than that 
of conventional real-time PCR assay. The following study was 
conducted to evaluate its utility and feasibility for veterinary 
diagnostic use.
Materials and Methods
The nanoliter real-time PCR system was evaluated for multiple 
pathogen detection in comparison with individual TaqMan 
real-time PCR assays which had been routinely used by the Iowa 
State University Veterinary Diagnostic Laboratory (ISUVDL) for 
various bacterial, viral and protozoan agents of various species. 
Primers and probes labelled with FAM or VIC for 28 real-time 
assays were prepared in a plate (i.e., array) for the nanoliter PCR. 
The system was then validated and optimized using 86 clinical 
samples archived from previous submissions to ISUVDL and 
known positive control for each of the target agents. All pro-
cedures were performed as per manufacturer’s recommended 
protocol.
Results
All of the 28 assays prepared in the nanoliter PCR simultaneously 
detected each target agent without generating false-positive re-
sults. Because preliminary evaluation revealed that the analytic 
sensitivity of the nanoliter PCR was 10-100 times lower than that 
of conventional TaqMan PCR assays, a universal extraction sys-
tem was developed in this study to prepare concentrated RNA 
or DNA of viral, bacterial, and protozoan pathogens from various 
sample matrices such as serum, oral fl uids, tissues, and feces. 
Combined with the universal extraction system, the nanoliter 
PCR showed sensitivity and specifi city equivalent to the corres-
ponding individual TaqMan PCR assays.
Discussion
The study demonstrated that a high-throughput nanoliter real-
time PCR system can simultaneously detect multiple infectious 
agents in a variety of sample matrices. Since the system is based 
on PCR amplifi cation, it can provide higher sensitivity as com-
pared to a conventional microarray system which is based on 
hybridization, not to mention faster turnaround. For epidemio-
logical or ecological research, substantial test cost saving can be 
expected with the nanoliter PCR system because of its capability 
for simultaneous detection of around 60 diff erent pathogens 
in parallel, when compared to the cost incurred by all those 
individual real-time PCR assays. Overall the system appears to be 
a valuable tool for veterinary diagnostics and epidemiological or 
ecological research. 
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Introduction
The American Veterinary Medical Association recently supported 
the establishment of a disease surveillance system for American 
swine operations (Snelson 2010). A comprehensive surveil-
lance system of this type aims to detect emerging, zoonotic and 
food-borne diseases central to current public and animal health 
issues. Disease monitoring frequently only refl ects reportable 
diseases and samples submitted to diagnostic labs. Certain 
subsets of swine producers in Ontario, however, do not typically 
utilize veterinary diagnostic services. Many of these producers 
also have limited access to modern means of communication 
such as a telephone or fax machine. Consequently, it is diffi  cult 
to assess changes in mortality and to promptly identify disease 
outbreaks if they occur on these farms. This presents a challenge 
for potential national or provincial animal health surveillance 
systems. To address this, a pilot project was designed to assess 
the feasibility of a broad based surveillance system including 
conventional and low diagnostic service user farms.
Materials and Methods
Enrolled producers submit weekly mortality and morbidity data 
from all areas of their production system (including the breed-
ing/gestation, farrowing, nursery, and grow/fi nish sections) 
using a mortality form. The recording form asks producers to 
record age of suckling pig deaths, number of piglets born alive, 
general comments, in addition to mortality rates in all applicable 
areas of production. Producers have the option to mail in hard 
copies of the form using provided postage paid envelopes or 
to use a Nokia 6086 or e71 cellular telephone to electronically 
submit the data. These phones operate an online surveillance 
software called Episurveyor® that allows users to create surveys 
accessible on the mobile phone. Producers record mortality 
data using this phone program and then send their completed 
weekly mortality forms to an internet database from the phone. 
Participants also fax their weekly submission to the OMAFRA 
offi  ce. Data received is compiled in a central database and ana-
lyzed weekly for increases in morbidity and mortality. If a change 
in herd health status is identifi ed, the farm’s veterinarian is 
informed. The veterinarian is compensated for professional ser-
vices and laboratory diagnostics associated with the surveillance 
study (provided by Animal Health Laboratory (AHL), Guelph). 
Consequently, veterinary services are off ered at a reduced cost 
to producers, thus signifi cantly increasing contact between the 
veterinarians and producers. The study began in June 2009 and 
new producers from three diff erent veterinary clinics are still 
enrolling. 
Results
This pilot project focuses on evaluating if this submission design 
and set of incentives is suffi  cient to generate regular reporting 
of disease events each week. Secondly, from a surveillance 
standpoint, mortality data is analyzed for abnormal fl uctuations 
as opposed to absolute numbers. Nine farms submit their data 
on time each week. For the remaining herds, receipt of data lags 
by one to three weeks between its completion on farm and ar-
rival at the OMAFRA offi  ce. Currently, 14 of 24 producers utilized 
diagnostic services at least once through their veterinarian in 
response to mortality and morbidity changes in their herd. Sub-
mission to AHL through this program increased after a meeting 
was held for each clinic where producers received farm specifi c 
mortality data reports and spoke with study coordinators about 
the project. Direct interactions between veterinarians, produ-
cers and study coordinators appeared to help with compliance 
and highlighted the benefi ts of regular sample submission and 
veterinary contact. 
Discussion
Currently, this pilot project is still active on participating farms 
and has generated useful data on herd health status. Due to the 
importance of catching emerging or zoonotic diseases early, 
timely data submission is crucial but has been problematic with 
some farms on this study. The Episurveyor® program has been 
functioning well on farm and data downloading has been suc-
cessful. Compliance does remain a challenge and highlights the 
need for incentives and demonstrating the benefi ts of regular 
data submission to participating veterinarians and producers. 
Although more accessible to study participants, mailing-in data 
creates a larger lag between recording and collection. This can 
hinder eff ective disease surveillance but helps generate broad 
based surveillance data. The surveillance project continues 
to operate and is due to be completed in July 2010. A second 
producer meeting is planned in the spring to hold discussions 
on the surveillance methods in use and on mortality issues for 
each herd.
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Testicles of castrated piglets an anachronism - but a powerful sample for disease surveilance in sow herds
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Bavarian Animal Health Service, Poing, Germany
Introduction
Collecting blood from adult sows is laborious; time consuming 
and sometimes hazardous to the veterinarian and/or the sow. Al-
ternative samples would be of benefi t. Some authors proposed 
colostrums as an alternative material, however antibody level in 
colostrums declines rapidly after parturition and due to high fat 
content samples have to be processed in the lab. Meat juice is 
a suitable sample for serodiagnosis in slaughtered animals (e.g. 
Salmonella enterica, PRRSV, Trichinella spp.). Therefore pieces of 
meat (4 cm3) are submitted to vials. After freezing and thawing 
meat juice is collected. As a general rule antibody concentra-
tion in meat juice is 1/20 of that in blood. In the present study it 
was analysed if tissue fl uid from testicles (TJ) of castrated piglets 
could serve as a sample to predict the dam’s seroreactivity. 
Material & Methods
The following ELISAs (Dilution of TJ) were used: PRRSV (1/10), 
SIV H1N1 (1/10), Salmonella (1/2), Mycoplasma hyopneumoniae 
(Mhyo; 1/10) supplied by Idexx and PCV2 (1/20), PPV (1/40) sup-
plied by Ingenasa. Except for the dilution of TJ tests were per-
formed according to manufacturer’s instructions. Results were 
expressed as titre (PCV2) or relative S/P-value after subtraction 
of the optical density of the negative control (other tests).
Blood and testicles were collected from piglets within the fi rst 
week of life (not necessarily the same animal!) and blood was 
collected from the dam. Mean reactivity of OD or geometric 
mean of titre per litter were calculated and compared with the 
dam’s value. Individual results were compared by kappa statis-
tics. Finally, serological classifi cation of herds based on testing TJ 
and dam’s blood was compared.
Results
For each test a positive correlation between serum samples of 
dams and mean TJ reactivity of the litter was observed. Data for 
the comparison TJ versus dam’s serum were summarized in the 
Table. Agreement of TJ with serum from piglets as determined 
by k-statistics was generally higher. 
PRRSV SIV PPV PCV2 Mhyo Salmonella
Sow/litters 246 180 221 193 181 266
herds 31 23 25 28 21 32
TJ-Cut-off 40% 60% 30% 422 (titre) 30% 40%
kappa 0.786 0.784 0.491 0.59 0.694 0.587
In the case of PRRSV, SIV and Mhyo 100% of the herds were cor-
rectly classifi ed. Agreement between dam’s serum and TJ was 
moderate for PPV, PCV2 and Salmonella. In the case of these 
infections pairs of samples with borderline reactivity tended to 
be misclassifi ed.
Discussions & Conclusions
TJ is an alternative sample for serology in sows. Although k-
values were sometimes below 0.8 one has to consider that mean 
reactivity per litter was compared. Agreement for PRRSV, SIV and 
Mhyo on herd level was excellent. Thus TJ-testing is a powerful 
tool especially for surveillance of PRRSV, SIV and Mhyo in sow 
herds. 
In the case of Salmonella the ELISA-cut-off  for meatjuice/serum 
was validated for slaughterhouse pigs and not for sows. The 
observation that ELISA-reactivity of piglets from negative sows 
(serum) was below 20% might indicate the need for an age-
related cut-off . Agreement was higher at a cut-off  at 60% for 
sow serum and 40% for TJ. Comparison of sample materials in 
the case of PPV and PCV2 were complicated by high numbers 
of samples with borderline reactivity. This might be explained 
by vaccination (PPV) or frequent infection (PCV2). Application 
of ELISA tests for detection of protective antibodies (e.g. cor-
relation with neutralizing antibodies) in the future might allow 
prediction of optimized time-points for vaccination of piglets.
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Pig health Surveillance in The Netherlands 2004-2009
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Introduction
Surveillance of the health status of pigs is very important for 
Dutch Pig farmers and the Dutch Government. Five years ago 
the Dutch Ministry of Agriculture and the Dutch Livestock 
Board (PVV) built a surveillance system for pig health in The 
Netherlands. The AHS was asked to carry it out. The goals of this 
system are 1) watching trends and developments, 2) detecting 
outbreaks of notifi able diseases and 3) detecting unknown 
diseases/problems. This paper shows how it works.
Materials and Methods
The surveillance system consists of a helpdesk for veterinarians 
and farmers (telephone and website), pathology and laboratory 
service, and herd visits, combined with specifi c disease surveil-
lance and data analysis (fi gure 1). Specifi c serological surveil-
lance is done for Pseudo Rabies (PR), Classical Swine Fever (CSF), 
Swine Vesicular Disease (SVD), Salmonella, and Brucellosis in 
commercial pig farms and PR, CSF, SVD, CSF, Foot and Mouth 
Disease and Trichinella in wild boar.
Figure 1. Schematic representation of the Dutch system.
Results
In the years 2004 – 2009 there were 11824 questions (75% by 
vets), 22706 autopsies and 696 herd visits. 
The occurrence of the most common non-notifi able diseases has 
been determined, fi gure 2 e.g. shows the declining trend in the 
occurrence of weaning diarrhea (enterotoxicosis) in autopsies in 
weaned piglets. Many hundreds of thousands of samples have 
been tested for notifi able diseases and no outbreaks have been 
detected. Occasionally, serological positives have been found for 
PR(n=2) in wild boar (close to the German and Belgium border), 
and for CSF from CSF vaccinated wild boar (n=4). The PR and CSF 
virus have never been detected.
Special results were e.g. an outbreak of Talfan in weaned piglets, 
Porcine Ulcerative Dermatitis Syndrome in sows, progressive 
posterior paralysis in sows with unknown etiology, two (in-
dependent) pigs with lymphosarcoma, broken legs as a result of 
low phytase in mixed feed and piglet mortality as a result of lack 
of vitamin D in mixed feed. 
Figure 2 Enterotoxicosis in weaned piglets (autopsies) in the period 
2004 - 2009.
Discussion
In the past years the system has shown that it is capable of 
detecting isolated incidents as well as surveillance of pig health 
in general. Specifi c parameters show a declining trend resulting 
in an improvement of overall pig health. 
Of course such a system has its strengths and weaknesses. 
Strengths are the aggregation of diff erent kinds of data. One 
of the weaknesses of the system is the dependency on prac-
titioners and farmers to send in animals for autopsy or blood/
faeces samples. In the next future attention will be paid to this 
“weakness”. Autopsies and analysis of samples are not for free. 
The Government and the Dutch Livestock Board pay part of it. 
The results of diagnostics will not only provide the veterinarians 
and farmers more appropriate information about the cause of 
the problem, it will also give some information about the health 
status of Dutch pigs. In the case outbreaks of known diseases 
or occurrence of new syndromes, the Government, the Board, 
practitioners and farmers will be informed immediately, in order 
to make the right decisions. Reports will be handed over every 3 
months
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Introduction
There is an increasing interest in obtaining farm level data 
through veterinarians for real time surveillance, due to the grow-
ing concern of emerging and re-emerging diseases in swine 
populations. Practicing veterinarians are often the fi rst to detect 
the initial cases of novel infectious diseases. Consequently, we 
undertook a twelve-month pilot study to determine the feas-
ibility of a veterinary-based surveillance system for Ontario (1). 
This pilot program was evaluated based on the level of compli-
ance among practitioners, and the timeliness and quality of data 
submitted to the program. Practitioners continued to participate 
in the program and the OSVS performance during the second 
year is presented in this study. 
Material and Methods
Seven veterinarians from fi ve clinics recorded and transmitted 
data from July 1, 2007 to June 31, 2008 using either paper forms 
or a personal digital assistant (PDA). In the second year of the 
study (July 2008 to June 2009), three additional practitioners 
joined the program. In addition, during the second year, OSVS 
recording forms were harmonized with clinic’s recording forms 
and/or billing systems and technical personnel were involved in 
the transmission of the data. 
The practitioners summarized the number of farm visits and 
calls according to the body systems aff ected and the manner in 
which production was aff ected. To estimate the level of compli-
ance among practitioners, the OSVS calculated the weekly ratio 
of the OSVS submissions to submissions made by the same 
veterinarians to the AHL. Completeness of data was assessed by 
measuring the frequency of data entered for each of the form’s 
fi elds/elements. The coverage of the program was assessed by 
determining the proportion of farms visited by practitioners 
compared to the number of farms registered in the Canadian 
Agricultural Census of 2006 in each agricultural region of 
Ontario. Timeliness was evaluated by calculating the diff erence 
between the date when the practitioners recorded the case and 
the date when the information was transmitted to the program 
coordinator. 
Results
For the pilot study, the average time to availability of data (TAD) 
was 22.1 days and the quality of compliance was variable among 
veterinarians and months. Timeliness improved by 8 days in the 
second year of the study. However, timeliness and compliance 
continued to be highly variable among veterinarians particularly 
during the summer. Over the course of the pilot study, a total of 
1,610 records were sent to the OSVS. The completeness of fi elds 
in the form ranged from 55-99%. Actual estimates of morbidity 
and mortality for disease visits/calls were rarely recorded during 
the pilot study. A total of 2,226 records were sent to the program 
during the second year. The completeness of fi elds in the form 
in the second year ranged from 73%-100%. Over the course 
of the pilot study, almost 24% of swine farms in Ontario were 
visited. After the pilot study, an increase in coverage of 13.6% 
was observed.
Discussion
Our results showed that it is feasible to administer a swine 
veterinary-based surveillance system in Ontario that is accept-
able to practitioners, and can produce useful surveillance data. 
The use of friendly recording systems adapted to each clinic’s 
management system and involving animal technicians in the 
regular transmission of clinicians’ data helped to improve timeli-
ness. However, fi nancial incentives may be needed to improve 
compliance and achieve a “real-time” surveillance system using 
practitioner data. 
Methods to assess diff erent aspects of a veterinary-based 
surveillance program must be established to determine which 
aspects of the program’s performance need improvement. 
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Introduction
Porcine circovirus associated disease (PCVAD) is caused by 
porcine circovirus type 2 (PCV2). Following natural exposure 
to or immunization against PCV2, Most sows and gilts develop 
antibodies that become passively acquired by their nursing 
off spring. The objective of this evaluation was to illustrate the 
immunological status of a sow herd, and to assess the correla-
tion of dam and off spring IFA antibody titers. 
Materials and Methods
A 4,200 sow, PRRS-negative farm was selected for this evalua-
tion. This herd had a young parity structure with no dams older 
than parity 3. Typical of commercial production, dams had been 
PCV2-vaccinated as weanling gilts but never booster vaccinated. 
Two hundred and fi ve gestating dams (sows and gilts) were 
blood sampled 2 weeks prior to scheduled farrowing. Sera were 
tested by immunofl uorescent antibody (IFA) assay at Kansas 
State University. Based upon these results, dams were assigned 
to either low titer (≤160) or high titer (≥1280) groups. Dams with 
intermediate titers (320-640), and their associated litters, were 
excluded from the evaluation. Piglets were ear tagged within 
24 hours of birth and the existing cross-fostering practices of 
the farm were allowed with the following restrictions: pigs 
could only be cross-fostered after 24 hours of age, and only to 
a dam of like-titer status (i.e. high-titer dam to high-titer dam or 
low-titer dam to low-titer dam). All pigs were individually blood 
sampled for PCV2 IFA antibody measurement and classifi cation 
as low (≤1:320) or high (≥1:640) titer at approximately 3 weeks of 
age based upon previously reported experiments.1,2 A contin-
gency table was constructed and dam titer-pig titer percent 
agreement and Kappa statistic were calculated. 
Results
The titer distributions of all dams are illustrated in Figure 1, 
while pig titers from only the designated low and high titer dam 
categories are represented.
Dam and pig titers by designated low/high categories appear in 
Table 1. Percent agreement of low dam-low pig and high dam-
high pig titers [(305 + 349)/921] was 71% with a Kappa3 of 0.42 
(SE 0.03). 
 
Figure 1. Distribution of dam* and pig** PCV2 IFA titers.
*All dams, n=205. **Pigs from designated low and high dam litters only, n=921.
Table 1. Contingency analysis between low and high dam and pig 
PCV2 IFA titers.
Discussion 
There was moderate strength of agreement3 between low 
dam – low pig and high dam – high pig titers. Low titer pigs 
from high titer dams may be explained by insuffi  cient passive 
transfer of maternal antibodies. High titer pigs from low titer 
dams are more diffi  cult to explain. A likely contributing factor 
is the designated pig IFA titer limits being only a single dilu-
tion apart (320:640) and the inherent subjectivity of reading IFA 
results. It may also be possible that some of the piglet antibody 
measured was of active (pig) rather than passive (dam) origin. 
Another explanation could be a higher antibody concentration 
in colostrum than in sow serum and a high uptake of colostrum 
in the high titer pigs. 
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Introduction
Porcine circovirus type 2 (PCV2) is considered the essential 
infectious agent of a series of diseases in swine that are now 
collectively termed porcine circovirus diseases (PCVD). Besides 
domestic pig production, PCV2 has also been detected in wild 
boars from several countries by serological studies, PCV2 anti-
gen and DNA detection, indicating that PCV2 circulates at a high 
rate among the wild boar populations in Europe. PMWS reports 
in wild boars are scarce, however.
In domestic pigs, the high incidence of subclinical infection and 
the stability of the virus complicate diagnostics and appraisal 
of PCV2 infection and PCVD. Diagnostics and prognosis based 
just on serology or conventional PCR overestimate the risk of 
developing PCVD. However, several studies have provided evi-
dence for the association between PCVD and the PCV2 load in 
serum or tissues of pigs (Brunborg et al., 2004; Olvera et al., 2004; 
Segales et al., 2005). 
Neither the PMWS status nor the quantitative load of PCV2 has 
been documented comprehensively in wild boar populations. 
We hypothesize that the countrywide prevalence of PCV2-
infected wild boars is high with low incidence of PCVD, and that 
the discrepancy between both is associated with low loads of 
PCV2. 
Materials and Methods
Samples from diff erent tissues of 531 wild boars from 46 dif-
ferent hunting grounds and of 308 apparently healthy and 40 
wasting (rejected at slaughter) domestic pigs from 48 proven-
ances located in the same greater areas as the wild boars were 
analyzed. PCV2-specifi c DNA was detected independently by 
nested PCR (nPCR) and by quantitative realtime PCR (qPCR). 
PCV2-specifi c tissue alterations were examined by histological 
(HE) and immunohistochemical (IHC) standard procedures. Pigs 
were classifi ed as PCVAD-aff ected (moderate to severe lympho-
cyte depletion and granulomatous infl ammation of the lymph-
oid tissue, and moderate to high amounts of PCV2 genome 
equivalents [at least 5x106 copies of PCV2 DNA/μg extracted 
DNA in at least one of the tissues]), subclinically infected with 
PCV2 (no or only slight lymphoid lesions, and a lower amount of 
viral genome copies), and non-PCVD (no lymphoid lesions and 
negative in qPCR) (Segales et al., 2005). The threshold of 5x106 
PCV2 DNA copies per μg of extracted DNA corresponds to 107 
copies of other studies??? (e.g. Harding, 2008).
Results
The average prevalence for PCV2 infection, determined by 
nested PCR, was 63.1% in wild boars and 100% in domestic 
pigs (p<0.001). Only 45.4% of the wild boars, but 98.8% of the 
domestic pigs were tested positive for PCV2 by qPCR. Wild boar 
prevalence in diff erent areas of the country varied signifi cantly 
between 36.2% and 87.5%. PCV2 loads diff ered signifi cantly 
(p<0.001) between wild boars and domestic pigs. The average 
viral load was 102.8 in tissues of wild boars and 104.2 in those of 
domestic pigs. None of the 349 wild boars did defi nitely show 
clinical symptoms of PCVAD, but one of them (0.3%) met the 
criteria for PCVD. Based on the same classifi cation, 8.7% of the 
domestic pigs from 15 of the 48 provenances were found to be 
PCVD-aff ected. None of the wild boars and 7.1% of the domestic 
pigs had PCV2 loads above 5x106 DNA copies per μg of DNA. 
The number of PCVD-aff ected and non-aff ected pigs did not 
diff er between pigs slaughtered and wasting pigs that were 
rejected at slaughter. 
Discussion
In conclusion, this is the fi rst study that describes the nationwide 
distribution of PCV2 in wild boars and domestic pigs qualitative-
ly and quantitatively. As the level of PCV2 load appears to be the 
critical step in the development of severe PCVD, qPCR proved to 
be well suited for the evaluation of PCV2 infection and PCVD in 
wild boar and domestic pig populations. 
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Introduction
Porcine circovirus 2 (PCV2), a single stranded DNA virus within 
the family Circoviridae, is now recognized as the aetiological 
agent of post-weaning multisystemic wasting syndrome (PMWS) 
(Chae, 2004). The virus is shed in body fl uids and has been iso-
lated from oropharyngeal and nasal swabs, faeces, whole blood 
and serum taken from experimentally infected pigs. Recently, 
PCV shedding was detected by polymerase chain reaction (PCR) 
in colostrum and milk from experimentally infected sows (Ha 
et al., 2008). The aim of the present study was to extend these 
observations by utilizing immunohistochemistry (IHC) and in-
situ hybridization (ISH) to determine the distribution of PCV2 in 
mammary tissue from experimentally infected sows. 
Materials and Methods
Sows were randomly allocated to an infected (n = 6) or control 
group (n = 2). Each animal was housed separately within the 
facility. The viral inoculum used for infection contained the PCV2 
strain SNUVR000470, at its third passage in PCV-free PK-15 cells. 
The six test animals were inoculated intra-nasally with 6 ml of 
tissue culture fl uid containing 1.2 x 105 tissue culture infective 
doses 50% (TCID50)/ml of virus. The inoculation was performed 
on day 93 of gestation. The two control sows were administered 
uninfected cell culture supernatant. Three days after parturition, 
the sows were sedated by intravenous injection of sodium 
pentobarbital and then euthanized by electrocution. The 
superfi cial inguinal lymph nodes, mammary gland, lung, liver, 
kidney, spleen, tonsil and ileum were also collected at necropsy 
and fi xed in 10% neutral-buff ered formalin before processing. 
IHC was performed with a primary rabbit polyclonal anti-PCV2 
antibody. ISH was performed with a PCR probe derived from the 
sequence of the open reading frame 2 (ORF2) of PCV2.
Results
PCV2 antigen and DNA were detected in the mammary tissue of 
all experimentally infected sows. Virus antigen was distributed 
throughout the mammary gland. Virus antigen and DNA was 
associated with cells with oval nuclei and abundant cytoplasm 
having morphological appearance consistent with macro-
phages. These cells were chiefl y located within the lumina of the 
glandular tissue. The epithelial cells lining these glands did not 
contain DNA or antigen. Mammary tissue from control sows did 
not contain PCV2 DNA or antigen. Virus antigen and DNA were 
also detected in the lymph node, liver, spleen, tonsil and ileal 
Peyer’s patches from all experimentally infected sows
Discussion
The results of this study confi rm that the sows were successfully 
infected following intranasal inoculation with PCV2. The virus 
appeared to infect macrophage-like cells in the mammary gland 
of these sows. Although monocyte-macrophages may not be 
the primary target for PCV2 replication in vivo, the simultaneous 
detection of PCV2 protein and DNA reported here suggests that 
the virus infects and replicates within these cells. PCV2 has been 
shown previously to replicate within macrophages (Kim et al., 
2003), and numerous macrophages may be found in the milk of 
sows.
PCV2 is known to replicate in the tonsil, entering the systemic 
circulation and the lymphoid organs such as lymph nodes and 
spleen (Kim et al., 2003). The virus is also present in circulating 
monocytes (Kim et al., 2003) suggesting that these cells act as 
vehicles for dissemination of the virus. We propose that these 
circulating monocytes may enter the mammary glandular tissue. 
Additional study is required to determine whether infectious 
PCV2 particles (as opposed to virus DNA) is present within the 
milk and whether any such virus may be shed directly within the 
milk whey or is contained within macrophages. 
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Introduction 
All pig-producing countries from around the world report the pres-
ence of Postweaning multisystemic wasting syndrome (PMWS.) 
This syndrome is regarded as a major problem in pig production. In 
America, PCV2 has been recognized in Canada, United States and 
Brazil. In Europe, France, Austria, Germany, United Kingdom and 
Sweden have detected the disease. In Asia, Japan, Taiwan and China 
have reported the disease’s presence too (1,2,3.) Knowledge con-
cerning the genetic sequences of PMWS has been very important 
in all these countries for establishing the homology level between 
the diff erent isolations and for learning more about of the disease 
(4.) In Mexico, there is no report describing the genetic sequences 
and variations of the PCV2 virus present around the country. For 
this reason, the main objective was to describe the homology and 
genetic sequences of the PCV2 virus obtained from diff erent regions 
of Mexico.
Material and Methods
10 samples from diff erent regions of Mexico were analyzed. DNA 
was extracted and the PCR was performed to amplify a fragment of 
506 pb of the ORF2. The PCR products were cloned into a commer-
cial plasmid vector and afterwards sequenced with ABI automated 
DNA sequencer. The sequences were compiled and aligned with 
the published in the GENEBANK, and fi nally were analyzed with 
the Basic Genebee CLUSTAL W 1.83 program in order to obtain the 
phylogenetic tree.
Results
10 sequences were identifi ed, the homologies of the Mexican 
PCV2 virus range between 89% and 99%. The majority of them are 
genotype “b” but the genotype “a” is also present. At the amino acids 
level, it ranges from 88% to 100%.
The phylogenetic analysis (Figure 1) shows that the Mexican PCV2s 
are divided into 3 principal clusters. The majority of the sequences 
are closely related with European PCV2s in the PCV2 group a; and 
the virus inside of PCV2 group b have relation with European, Asian 
and Canadian virus.
The analysis of the main changes between amino acid sequences 
shows that there are 20 changes in the capsid protein; the majority 
of these changes are in the domain region situated in the position 
from aa59 to aa91. Table 1 shows these changes in detail.
Table 1. Most frequent changes of amino acids in PCV2 sequences 
from Mexico. One interesting fi nding is that the sequence PCV2MXP-
BC_SC is diff erent in 8 amino acids when compared with the consensus 
sequences of the others samples that belong to genogroup b
Discussion
Since PMWS was described in Canada (1997) genetic analysis of 
PCV2 has been done in diff erent countries in order to understand 
the genetic variations and its implications (4.) According to our 
knowledge, there is not any report in Mexico about the genetic 
variations of Mexican PCV2. Our results show that the Mexican PCV2 
has genetic variations; two strains show a high variation. The per-
centage of the heterology found in this investigation is higher than 
other reports described in America. 
It is very important to establish whether the sequences of the Mex-
ican PCV2 virus have relation with the pathogenicity of the strains.
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Figure 1. Phylogenetic tree of Mexican PCV2 isolates and other PCV2 
viruses from around the world. The red boxes indicate the sequences 
from Mexico pertaining to subgenotype a and subgenotype b
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Introduction
PCV2 has been recognized as a causative pathogen of porcine 
circovirus associated disease (PCVAD), which is currently an 
important disease in the swine industry. The PCV2 capsid pro-
tein is the preferred antigen in a variety of serological tests and 
vaccines due to the strong immunogenicity (1). In this study, the 
recombinant NLS truncated capsid (NTC) protein was produced 
using E. coli expression system to prepare a subunit vaccine and 
examine the immunological response using an indirect in-house 
ELISA.
Materials and Methods
The NTC DNA fragment of PCV2 Thai isolate (07NP2) was ampli-
fi ed using PCR, cloned into the pGEX-5x-3 plasmid (GE Health-
care) and transformed into the E. coli BL21. For expression, 2 
liters of the recombinant E. coli was induced with 0.1 mM IPTG 
at 30 ˚C for 4 h (2). The bacteria was harvested and disrupted 
by sonication. The recombinant protein was purifi ed using GST 
purifi cation system (GE Healthcare). The expression of recombin-
ant NTC protein was determined using SDS-PAGE and Western 
blot analysis. The concentration of the recombinant protein was 
measured using the Bradford assay. 
To prepare a subunit vaccine, the purifi ed recombinant protein 
was mixed with a commercial oil adjuvant. The vaccine ef-
fi cacy was examined in the experimental pigs free from PCV2. 
Fourty-fi ve, 4-week-old pigs were allocated into 5 groups: group 
A (n=10) received a one-shot vaccination (5 μg/dose); group 
B (n=10) received a two-shot vaccination (5 μg/dose, 2-wks-
interval); group C (n=10) received a one-shot vaccination (50 μg/
dose); group D (n=10) received a two-shot vaccination (50μg/
dose, 2-wks-interval). Group E (n=5) was given only an adjuvant. 
The sera were collected before the vaccination (0 dpv) as the 
baseline and at 7, 14, 21, 28 and 42 dpv. Antibodies against 
recombinant NTC protein were detected using an in-house 
indirect ELISA (Chulalongkorn University-Veterinary Diagnostic 
Laboratory, CU-VDL). 
Results 
The expression of recombinant NTC protein from recombinant 
BL21 resulted in the production of the approximately 40 kDa 
protein (Fig.1, lane 2 and 3). This protein also reacted with the 
rabbit anti-PCV2 antibody (Fig.1, lane 4). Results from the vac-
cine trial study revealed that the one-shot group received 50 μg 
of the protein (group C) showed an increasing mean O.D values 
compared with the control group (Fig. 2). However, when
Figure 1: SDS-PAGE and Western blot analysis (arrow; 40 kDa marker)
 
Figure 2: Mean O.D. ELISA of the vaccinated groups at 0, 7, 14, 21, 28 
and 42 day post vaccination (dpv.) 
pigs were given a two-shot protocol, both the 5- and 50-μg/dose 
groups showed signifi cantly increased mean O.D. (Fig. 2, B and 
D). After the second vaccination, the levels of antibodies in the 
two-shot vaccinated groups were signifi cantly higher than those 
in the one-shot groups especially in the 50-μg/dose group (p < 
0.05). 
Discussion 
The results showed that the recombinant NTC protein expressed 
in the E. coli system could react with anti-PCV2 antibody and 
also induce the specifi c antibody responses in the experimental 
pigs especially in the two shot vaccinations of both concentra-
tions. Interestingly, the immune response was also detected in 
the one-shot protocol when given the high concentration of 
the protein indicating of dose dependent. Our subunit vaccine 
could be used as a potential vaccine candidate. However, fi eld 
trial of this subunit vaccine is needed for the future study.
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 Introduction
Porcine Circovirus type 2 (PCV2 infections )and its related Por-
cine Circovirus Disease (PCVD) is a major drawback in pig farms 
all over the world. Initially managerial measures were taken to 
reduce the impact. Last years the appearance of PCV- vaccines 
has been a milestone to really prevent the disease. Maternally 
derived antibodies (MDA) may interact with the take of the 
vaccine.(M Fort et all. Vaccine 2008, 2009) Also the moment of 
vaccination is critical: it should be weeks before the onset of 
infection. To be able to establish the optimum moment for vac-
cination it is of importance to have tools to measure antibodies 
against PCV2 Intervet Schering Plough Animal Health (ISPAH) 
developed an in house PCV2 antibody ELISA. Besides com-
mercial ELISA manufacturers also produced ELISA kits for the 
determination of PCV2 antibodies. The use of all these diff erent 
tests complicate the interpretation of articles and trials related 
to PCV2 infections and vaccination. ISPAH therefore compared 
its in house ELISA for the detection of antibodies against PCV2 
with the commercial available ELISA test of Synbiotics which is 
widely used in the fi eld.
Materials and Methods
77 serum samples of conventional sows that were known to 
have antibodies against PCV2 were tested in both tests in three 
independent runs.
Besides 20 sera of known negative PCV2 animals were tested 
in both ELISA’s. The selected commercial test is from Synbiotics 
SERELISA®PCV2 Ab Mono Blocking ELISA. The ISPAH in house 
ELISA has been developed in R&D of ISPAH and is not com-
mercially available. Since the results of the inhouse ELISA are 
expressed in Log 2 titers also the Synbiotic results are expressed 
in Log2-titers for this comparison.
Results 
In Figures 1 and 2 the mean results of the 77 sows in both ELISA’s 
are presented. In both tests the sera show a regular increase of 
titer when sorted ascending, although the slope of the synbiot-
ics test is more fl at compared to the inhouse test. The in house 
ELISA shows a range of 2-16 log 2 The titer range in the synbiot-
ics test was between 4 and 14 Log 2. 
In the in house ELISA all negative sera had a titer of <2Log2. In 
the Synbiotics test this was <4Log2. (individual data not shown)
Discussion 
Both the ISAPH in house ELISA as well as the Synbiotics PCV2 
ELISA show a regular increase of titer when sorting ascending.
and both can be used to establish the antibody level in pigs. 
The slope of the two test diff er which is important to realize 
when interpretating serological data; From in house data it is 
known that a 5Log2 titer in the ISPAH inhouse PCV2 antibody 
ELISA represents a protective level i.e. above 5 Log2 pigs will be 
protected. Since the slope of the two tests diff er probably higher 
titers in the Synbiotics test are needed for protection. From the 
ISPAH test it is known that high titers around 10-12 Log 2 at the 
moment of vaccination may lead to suboptimal vaccination 
results. It is to be expected that in the Synbiotics ELISA this can 
already be the case at a somewhat lower level.
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Figure 1: Mean titer ELISA PCV2 Synbiotics compared to mean titer 
ELISA PCV2 In House sorted ascending for ELISA PCV2 Synbiotics
(Error bars show the titer range)
Figure 2: Mean titer ELISA PCV2 Synbiotics compared too mean titer 
ELISA PCV2 In House sorted ascending for ELISA PCV2 In House
(Error bars show the titer range)
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Introduction 
Porcine circoviruses (PCV), members of the family Circoviridae, 
are composed of non-enveloped viruses with a single-stranded 
circular DNA. Two genetically and antigenically diff erent viruses, 
PCV1 and PCV2, can be distinguished. PCV1 is nonpathogenic, 
and PCV2 is associated with postweaning multisystem wasting 
syndrome (PMWS) (1).
 In Colombia, clinical PMWS associated with PCV2 infection was 
fi rst reported in 2006.The PCV2 antigen was detected in the 
91,2% of the 34 farms examined by IHC (2). This study reports 
the presence of PCV2 in Colombian swine herds prior and after 
PMWS outbreaks from 2006 - 2009.
Materials and Methods
Tissue samples (lymph nodes, lung, spleen, and kidney) were 
collected from nine farms with historical records of PMWS dur-
ing 2006 – 2009. The individual diagnosis of PMWS was con-
fi rmed for each case (3). Twenty serum samples collected from 
March 2004 to November 2005 from four farms located in three 
diff erent regions were also included. The samples were stored at 
-80°C until use.
DNA extraction was carried out using the QIAamp® DNA Mini kit 
(Qiagen, USA) according to the manufacturer´s instructions. The 
capsid gene was amplifi ed and sequenced from nucleotides 998 
to 1757 using specifi c primers capFw 5´ CTT TTT TAT CAC TTC 
GTA ATG 3´ and capRw 5´ CGC ACT TCT TTC GTT TTC 3 (4). Ampli-
cons were sequenced using an automatic sequencer (Applied 
Biosystems, Macrogen, Korea). Strain-specifi c sequence chro-
matograms generated using forward and reverse primers were 
assembled into individual contigs using SeqMan (DNASTAR). 
Resulting partial ORF2 sequences were aligned in ClustalX. The 
alignments was imported into CLC Sequence viewer for visual 
inspection, and the fi rst 30 bp and the last 20 bp of the full 
length ORF2 region were excluded. Phylogenetic trees were 
generated in CLC Sequence 
Viewer using the Unweighted Pair Group Method with Arith-
metic mean (UPGMA) method.
Results and Discussion
Preliminary analysis of 14 tissue samples from the fi eld cases and 
six serum samples from the retrospective survey were positive 
for PCV2 by PCR. The 20 sequences obtained could be divided 
into two main clusters supported by high confi dence values that 
matched the two genotypes defi ned previously; PCV2b (n=15) 
and PCV2a (n=5). Interestingly, all of the PCV2a sequences but 
only one PCV2b sequence were found in serum collected during 
2003-2005. All of the samples from 2006-2009 were PCV2b. The 
detection of PCV2b genotype since 2006 may explain the PMWS 
epizootic occurrence in farms of several states of Colombia. 
Additional sequencing is underway to expand these fi ndings 
and provide a more complete picture of the genotype distribu-
tion of PCV2 and his association with PMWS in Colombian swine 
herds. 
Figure 1. Phylogenetic tree of 20 Colombian samples based on ORF2 
sequence.
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Introduction
PCV2 is considered to be the essential infectious agent of post-
weaning multisystemic wasting syndrome (PMWS). Many studies 
have not found any relationship between PCV2 strains and the 
occurrence of disease (1-3). Nonetheless, a growing number of 
publications (4-8) reported a shift from PCV-2a to PCV-2b that 
may be related to the occurrence of PMWS outbreaks. 
Based on the existing evidence at diff erent coutry levels, the 
main objective of this study was to follow up the evolution of 
PCV-2 genotypes in two farms in Spain that undergone a PMWS 
episode, to examine the dynamics of PCV2 infection and its rela-
tionship with the appearance of PMWS at herd level. 
Material and Methods
A total of 51 samples (serum and PCV2 isolates from the PMWS 
outbreak) from Farm 1, collected from 1995 to 2009, and 87 
samples from Farm 2 (serum samples), collected from 1996 to 
2003, were analyzed. PMWS outbreak suspicion and diagnosis 
were confi rmed on May 2007 and March-April 2001 in farm 1 
and 2, respectively. Both were small experimental farrow-to-
fi nish (40-60 sows) operations, free from most of common swine 
pathogens, including porcine reproductive and respiratory 
syndrome virus. A fragment of 652 located between the Rep 
and the Cap protein of the PCV-2 genome was sequenced on all 
available samples.
Results
A sudden genotype PCV2a to PCV2b overturn was observed on 
Farm 1: 34/37 sequences were PCV2a before the PMWS outbreak 
in 2007, whereas all sequences after the outbreak were PCV2b 
(Figure 1). On Farm 2, the frequency of PCV2a decreased steadily 
from 1996 to 2003 and the frequency of PCV2b increased (Figure 
1). The chi-square analyses performed on both farm datasets 
yielded signifi cant results, statistically supporting the change 
of genotype from PCV2a to PCV2b in both herds at the time of 
PMWS occurrence.
Discussion
The genetic shift linked to PMWS epizootics has been described 
in several countries from Europe (5,7,8) and North-America (4,6). 
However, this is the fi rst report of a PCV2 genotype shift associ-
ated with PMWS appearance at individual farm level. Overall, the 
putative higher virulence of PCV2b strains seems to be sup-
ported by the present data. Both studies related the occurrence 
of PMWS epizootics to high frequencies of PCV2b and lower 
frequencies of PCV2a.
Figure 1. Historical histograms on PCV2 sequences detected in Farms 
1 and 2.
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Isolation and identiﬁ cation of Porcine Circovirus Type 2 (PCV2) from lymph node samples
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Introduction
PCV2 is an icosahedrical 17 nm circular shaped, naked virus with 
single stranded ambivalent DNA (Fenaux 2004). Virus Isolation 
(VI) is done mainly in PK 15 cell line and it is particularly tedious 
due to the fact that the virus requires cells in active mitosis that 
provide it with DNA polymerase, needed for the viral replication 
process (Tischer et al 1987). Its presence is demonstrated by 
Immunoperoxidase (IP), Immunofl uorescence or Molecular Biol-
ogy techniques since it does not produce citopathic eff ect.
Material and Method
Cell line: PK 15 PCV2 free cells were employed, with 24 hrs 
growth and sensitized with D – Glucosamine.
Samples: Lymph nodes gathered from animals of 3 diff erent 
farms, showing signs compatible with PCVAD. These samples 
were tested as 9 macerates for VI and 3 pools for PCRqrt.
Viral Isolation, all macerates were fi ltered at 0.22 μm and used 
to infect PK 15 cell cultures with the after mentioned character-
istics. Viral presence was confi rmed by IP tests (NVRI, Pulaway: 
Poland 2007).
PCRqrt: genetic material extraction was performed from the 
pools; viral particles present were amplifi ed and quantifi ed using 
the protocol developed by Cortes et al (unpublished).
Results
VI: From the 9 macerates, 7 yielded positive and 2 negative by 
the IP test (Table 1).
PCRqrt: All 3 pools were positive with a viral load between 102.0 
and 103.0 viral particles/mL (Table 2).
Discussion
In this case PCV2 could be isolated and identifi ed by IP and by 
PCRqrt showing an 80 – 100% positive respectively. These results 
confi rm viral presence in Mexico and agree with seropreva-
lence results presented by Ramirez et al (2008) where 97% of 
the tested sera were positive, for PCRqrt Hernandez et al (2008) 
reported viral loads from 103.0 to 107.0 vp/mL from tissues. Other 
investigators results are also confi rmed Trujano et al (2001) and 
Ramirez et al (2004), who reported viral detection by in situ 
hybridization and by viral isolation.It is noticeable the relation 
among the viral particles detected by PCRqrt with the positive 
results in VI and the stained nuclei detected by IP, where the 
higher the number of positive samples, higher the viral load and 
also the higher number of stained nuclei.
Table 1. Results by immunoperoxidase (IP).
Sample IP result Stained nuclei
1 Negative -
2 Positive ++
3 Positive ++
4 Positive +++
5 Positive +
6 Negative -
7 Positive ++
8 Positive +
9 Positive +++
- Negative; + Slight; ++ Moderate; +++ Abundant
Table 2. PCRqt results.
Sample Farm pool Quantifi cation (vp/ml)
1 Farm A 1.7 x 10 2.0
2 Farm A 1.7 x 10 2.0
3 Farm B 4.1 x 10 3.0
4 Farm B 4.1 x 10 3.0
5 Farm C 2.1 x 10 3.0
6 Farm C 2.1 x 10 3.0
7 Farm C 2.1 x 10 3.0
8 Farm C 2.1 x 10 3.0
9 Farm C 2.1 x 10 3.0
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Introduction
Porcine circovirus type 2 (PCV2) is the essential infectious agent 
of postweaning multisystemic wasting syndrome (PMWS). 
PMWS diagnosis is mainly established based on laboratorial cri-
teria, including histopathology and detection of PCV2 in tissues 
(1). Therefore, the objective of the present abstract is to summar-
ise the results of an international immunohistochemistry (IHC) 
ring trial performed in 18 diff erent laboratories across the world. 
Materials and Methods
The IHC ring trial was undertaken using 10, formalin-fi xed, 
paraffi  n-embedded tissues, including lymph nodes (n=5), lung 
(n=3) and thymus (n=2) from pigs with and without PMWS. The 
referral laboratory (laboratory 1) submitted the 10 tissue sec-
tions in duplicate to each laboratory (two laboratories contribut-
ed twice to the results). Each laboratory performed the IHC stain 
and evaluated the results blindly using a scale of 0 (negative), 
1+ (weak reactivity), 2+ (moderate reactivity), and 3+ (strong 
reactivity). 
Secondly, a written survey detailing 28 technical aspects of 
the IHC assays were also sent to all participants. To analyse the 
results, two multiple correspondence analyses (MDS) were 
performed, one using the discrepancies of the ring trial a second 
one comparing diff erences among IHC technical details and 
results among laboratories. 
Results 
Sixteen out of 18 laboratories had a mean number of discrepant 
results between 0 and 1 among slides; such number was 2 or 
higher in the other two laboratories. Of all participant laborator-
ies, only 14 sent the technique details survey completed. When 
the IHC result and IHC technique details were taken into account 
jointly, 12 out of the 14 submitting laboratories showed no 
signifi cant diff erences among them. 
Discussion
Overall, the present study indicates that most of the participant 
laboratories reported congruent results . Technical diff erences 
were not a major source of result disagreement.
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Introduction
Necrotizing lymphadenitis is a pathological feature observed 
in about 2% of postweaning multisystemic wasting syndrome 
(PMWS)-aff ected pigs. The pathogenesis of the lesion has been 
linked to a Porcine circovirus type 2 (PCV2)-related apoptosis-in-
duced mechanism (1), but no further studies have been focused 
on this topic. Therefore, the goal of this retrospective work was 
to gain further insights into PCV2-associated lymphoid necrosis 
pathogenesis in PMWS cases. 
Materials and Methods
Three groups of animals were selected: PMWS-aff ected pigs with 
necrotizing lymphadenitis (group 1, n=5), PMWS-aff ected pigs 
without necrotizing lymphadenitis (group 2, n=5) and healthy 
pigs with no PMWS-related lesions (group 3, n=5). Investigations 
performed included immunohistochemistry (IHC) of cleaved 
caspase-3 (to detect apoptosis) and von Willebrand factor (vWF, 
to detect this glycoprotein, which is involved in haemostasis), 
special stain for fi brin (Mallory stain) and in situ hybridization 
(ISH) to detect PCV2 genome. 
Results
Table 1 includes individual results of histopathological fi ndings. 
Fibrin deposition detected by Mallory stain was signifi cantly 
higher in PMWS-aff ected lymph nodes with necrosis compared 
to those with PMWS or normal lymph nodes. Lymph nodes from 
PMWS-aff ected pigs had signifi cantly higher PCV2 amount than 
those of healthy pigs. Otherwise, no signifi cant diff erences were 
observed between the two PMWS-aff ected groups in regards 
intensity, location or amount of PCV2 genome detected by ISH. 
Staining pattern of vWF in the PMWS-aff ected pigs with follicular 
necrosis was endothelial (peri-membranous), subendothelial 
(collagen bound), cytoplasmic and intravascular (circulating). In 
regards apoptosis, although labelled cells from PMWS-aff ected 
pigs with follicular lymphoid necrosis had a strong intracyto-
plasm staining, CCasp-3 staining pattern did not show diff er-
ences among the three groups of studied pigs. 
Discussion 
Necrotizing lesions in lymph nodes of severely PMWS-aff ected 
pigs usually show multifocal to coalescent areas of coagulative 
necrosis (in some cases, aff ecting the whole parenchyma of the 
lymph node) together with vascular thrombosis (3). This latter 
fact has been confi rmed in the present study by the presence of 
fi brin thrombi detected by the Mallory stain. Taking into account 
that vascular injury seems to be the primary determinant of a 
thrombotic response (2), the existence of marked thrombosis in 
PMWS-associated necrotizing lymphadenitis suggests certain 
extension of vascular damage in these pigs. Such damage 
evidence was supported by the high endothelium venule 
hypertrophy and the over-expression of vWF in subendothelial 
(collagen bound), cytoplasmic and intravascular (circulating) 
locations. Such fi ndings would account for the increase of 
intravascular fi brin deposition and, consequently, thrombosis. 
Therefore, obtained results would point towards a vascular ac-
cident with thrombi development and the subsequent follicular 
necrosis as the cause of necrotizing lymphadenitis in PMWS 
aff ected pigs.
Table 1. Results of histopathology, Mallory stain, PCV2 in situ hybrid-
ization, vWF and apoptosis scores in the three groups of studied pigs.
Group Case PMWS FN ISH CCasp3 vWF Mallory
1 +++ +++ +++ +++ +++ ++
2 +++ ++ +++ + ++ ++
1 3 +++ +++ +++ ++ +++ ++
4 +++ + ++ + + +
5 +++ + +++ + + +
6 ++ - +++ ++ - -
7 +++ - +++ ++ + -
2 8 +++ - +++ + ++ -
9 +++ - +++ + +/- +/-
10 +++ - +++ + + -
11 - - - + + -
12 - - - ++ +/- +/-
3 13 - - - +/- + -
14 - - - + + +/-
15 - - - + + +/-
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Clinical incidence and frequency of lesions associated to porcine circovirus 
type 2 in pigs of a farm in the state of Yucatan, Mexico
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Introduction
Serological studies have demonstrated that PCV2 is present in 
both aff ected and unaff ected farms with postweaning multi-
systemic wasting syndrome (PMWS) with a seroprevalence 
nearly 100%1. However, the incidence of PMWS on a farm 
is typically low, suggesting that PCV2 is not the only agent 
involved and that other factors are required for the presence of 
the PMWS; animals infected with PCV2 and parvovirus or PRRSV, 
immunosuppressive or immunostimulating agents2, so that the 
incidence of PMWS is variable between regions and between 
farms3. The objectives were to estimate the cumulative and 
true incidence, the lethality rates and the frequency of macro-
scopic and microscopic lesions of PMWS and porcine dermatitis 
nephropathy syndrome (PDNS) in pigs of a farm in the state of 
Yucatan, Mexico.
Materials and Methods
The studied population was divided in 2 groups. Monitored 
group consisted of a production batch of 235 pigs, which were 
observed from week 4 to 22 of age to determine the number of 
new cases compatible with the PMWS and PDNS that occurred 
weekly and the number of pigs that died of these syndromes. 
Sacrifi ced group was formed gradually during each of the visits 
to the farm in this group the frequency of lesions compat-
ible with the PMWS and PDNS was estimated, for which, post 
mortem studies were performed in all discarded pigs between 
4-22 weeks of age and with signs compatible with the syn-
dromes studied. Necropsy was performed in animals of both 
groups monitored and sacrifi ced. The organs inspected were: 
lymph nodes, spleen, liver, tonsils, ileum, lungs, kidneys and 
skin. Samples of all organs were obtained for histopathological 
studies
Results
14 pigs showed signs consistent with the syndromes mentioned, 
7 with the PMWS and 7 with the PDNS. The cumulative incidence 
and incidence rate for both syndromes were 0.06 and 0.0034 
respectively. 5 pigs died, lethality rates calculated for PMWS y 
PDNS were 0.4 and 0.3 respectively. Necropsy was performed 
at 80 pigs, 50 with signs compatibles with PMWS and 30 with 
PDNS. The most frequent macroscopic lesions in the PMWS were 
Lungs: lesions compatibles with interstitial pneumonia and 
supurative bronchopneumonia 94%. Kidney: Nefromegaly with 
white spots 48%. Lymph nodes: lymphadenomegaly and edema. 
Spleen decrease in size 68%. PDNS: Lungs: compatible with 
interstitial pneumonia and supurative bronchopneumonia80%. 
Skin: eritematous macules and plaques with crusted center 63% 
Kidney: nephromegaly with hemorrhage 87%. Lymph nodes: 
lymphadenomegaly and congestion 63% and Spleen: Spleno-
megaly 60%. There were no macroscopic lesions in liver, ileum 
and tonsils
Table: Frequency of microscopic lesions compatibles with PMWS and 
PDNS
MICROSCOPIC LESIONS PMWS n=50 PDNS n=30
LUNGS
Suppurative bronchopneumonia and histiocytic interstitial 
pneumonia 94% 80%
SKIN
Histiocytic dermatitis and neutrophilic vasculitis ——— 70%
KIDNEYS
Histiocytic interstitial nephritis 48% ———
Neutrophilic vasculitis ——— 37%
LIVER
Histiocytic hepatitis with lipidosis 78% 57%
LYMPH NODE
Histiocytic lymphadenitis and atrophy 76% 43%
Histiocytic lymphadenitis and hyperplasia 24% 57%
SPLEEN
Histiocytic splenitis and atrophy 64% 30%
Histiocytic splenitis and hyperplasia 18% 63%
TONSILS
Histiocytic tonsillitis and atrophy 50% 37%
Histiocytic tonsillitis and hyperplasia 30% 47%
ILEUM
Histiocytic ileitis and atrophy 66% 23%
Histiocytic ileitis and hyperplasia 20% 67%
Discussion
The PMWS and PDNS aff ect the population studied; with a slow 
diff usion, high mortality and the organ most frequently aff ected 
by the both syndromes were the lymph nodes (100%)
References
1 Larochelle R, et al, (2003) Can. J. Vet. Res. 67: 114-120
2 Krakowka S, et al.,(2001). Vet Pathol. 38:31-42.
3 Segalés, J., et al., (2003). Pigs New and Information.24:103-110 
Porcine Circovirus Associated Diseases (PCVAD) – General
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 319
Poster Presentations
P.013
Type of lesions and patterns associated on porcine circovirus type 2 
in organs of positive swine for immunohistochemistry
Monica Quintal2 Jose L. Guillermo1 Jorge C. Rodriguez1 Marco A. Torres1 Raquel Miranda1 Rafael Colin1
1. University of Yucatan, Merida, YUC, Mexico; 2. Patologia Animal, Merida, YUC, Mexico
Introduction
Porcine Circovirus type 2 (PCV2) is an emerging disease of swine 
that has been associated in the development of other diseases. 
Currently there are various diagnostic tools and techniques 
available for the detection of PCV2; however, the immunohisto-
chemistry (IHC) is considered the gold standard for the detec-
tion of this disease1.
The objectives of the present study were to demostrate the 
existence of the PCV2 antigen by IHC, and to determine the 
distribution patterns of histopathological lesions suggestive to 
PCV2 in diff erent organs and tissues. 
Materials and Methods
An observational study was realized on a farm with semitecnifi -
cated intensive production system and full breed cycle. The type 
of sampling was not probabilistic for convenience. Sample sizes 
were 22 pigs. Whereas a population of 1400 pigs, an estimated 
prevalence of 30%2, 3 and a confi dence level of 99.5% using 
formula: n = [1-(1-p) 1/D] [N-D/2] + 1] 64.
Post mortem studies were performed in discarded pigs between 
4-22 weeks of age. The method of euthanasia was electro-
stunning established by the NOM -033-ZOO 1997. Organs of 22 
pigs with macroscopic lesions suggestive to PCV2 were sampled. 
The organs studied were lymph nodes, spleen and tonsils, lung, 
kidney, liver, skin and ileum. The tissue sections were fi xed for 24 
hours in 10% formalin pH 7.4 processed by the standard method 
of embedding in paraffi  n, and stained with routine staining H 
& E, for subsequent microscopic observation. The PCV2 antigen 
was detected by IHC using the system avidin-biotin-peroxidase 
as described by Ramos-Vara5
Results
The microscopic lesions suggestive to PCV2 on lymphoid organs 
were: histiocytic infi ltrate 68% (15/22) on spleen, 63% (14/22) 
lymph node and 54% (12/22) tonsil, lymphoid depletion was 
observed 40% on lymph node, on 20% (4/22) spleen and tonsil. 
On epitelial organs the most common lesions were hepatitis 
lymphohistiocytic periportal, 77% (17/22) interstitial lympho-
plasmacytic nephritis with giant cells 36% (8/22) membranopro-
liferative; glomerulonephritis 13% (3/22), on ileum lymphoplas-
macytic enteritis 59% (13/22), depletion of mucosa associated 
lymphoid tissue (MALT) 22% (5/22) and multinucleated giant cell 
4.5% (1/22); on skin lymphoplasmacytic histiocytic perivascular 
dermatitis 31% (7/22); necrotizing neutrofi lic leukocytoclastic 
vasculitis 22% (5/22); on lungs lymphoplasmacytic histiocytic 
bronquitis and bronchiolitis 72% (16/22) and interstitial pneu-
monia 31% (7/22)
22 pigs evaluated by IHC technique, were positive, at least in one 
organ, where positive antigen-antibody reaction was detected 
on lymph node 98% (21/22), tonsils 98% (21/22), spleen 98% 
(21/22), lung 68% (15/22), ileum 68% (15/22), kidney 5% (1/22), 
and liver 4% (1/22). All skin samples resulted negative. 
The frequency of IHC positive cases by stage of production were: 
on weaning stage 8 (36%) positive tissues of lymph nodes and 
spleen and 9 (41%) tissues of tonsils. On feeding stage 11 (50%) 
positive tissues of lymph nodes and spleen and 10 (45%) tissues 
of tonsils
The grade of immunopositive observed in the lymphoid organs 
in weaning pigs were uniform for spleen, lymph nodes and 
tonsils, with ratings of mild, moderate and strong unlike feeding 
pigs where 27% (6/22) in the spleen, lymph nodes and tonsil, 
were strong grade.
The grade of immunopositive in epithelial organs were variable 
in ileums 27% (6/22) were moderate in the lungs 31% (7/22) 
were weak in the kidneys there were not diff erence 9% (2/22) for 
three categories and the liver with 4% (1/22) that corresponded 
to grade of strong immunopositive, skin tissues without positive 
reaction 
Discussion
The relevance of the present study has demonstrated that tissue 
samples from lymph node, spleen, tonsil, lung, liver, ileum, and 
kidney should be the collected for routine and specialized PCV2 
analysis. This study is the fi rst of its kind in Mexico
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Introduction 
Porcine circovirus type 2 (PCV2) is the causative agent of several 
diseases that are grouped as porcine circovirus(-associated) dis-
ease (PCV(A)D) (1). The diagnosis of PCVD is primarily based on 
the presence of high amounts of PCV2 antigen or nucleic acids 
associated with microscopic lesions in lymphoid tissues and/or 
the foetal/neonatal heart (1). For routine PCV2 quantifi cation, 
immuno-histochemistry, immuno-fl uorescence, antigen-capture 
ELISA, virus isolation (VI), in-situ hybridization (ISH) or quantita-
tive PCR (qPCR) are used (1). The present study aims to defi ne 
the correlation between qPCR and VI in tissues from naturally 
PCV2-infected pigs.
Materials and Methods
Thirty-one diff erent tissue samples from weaners and growers 
that were suspected of PCVD based on clinical symptoms and 
historical fi ndings,were collected and submitted to the regional 
laboratory for histopathological and virological analysis. Lymph 
nodes, spleen and/or lungs were homogenised and the tissue 
suspensions were titrated onto PK-15 cells. A titre of >=104.5 
TCID50/g tissue correlates well with histopathological lesions 
and was considered to be suggestive for PCVD (2). Simultan-
eously, tissue suspensions were analyzed by an ORF2-based 
real-time qPCR developed in the CODA-CERVA-VAR laboratory 
(home-made realtime-qPCR) and modifi ed from previously de-
scribed techniques (3,4). A Pearson’s correlation coeffi  cient with 
a 95% confi dence interval was calculated on the log10 trans-
formed values obtained in VI and RT-qPCR from all 32 samples. 
Results
The Pearson correlation coeffi  cient was between the log10 
transformed values of VI and qRT-PCR was 0.72 [0.49-0.86] and 
can be considered as large (Fig1). The highest mean virus titre 
was found in the lymph nodes [4.5 ± 1.9], followed by the lungs 
[3.6 ± 2.3] and the spleen [3.0 ± 1.6]. The same pattern was 
observed for the qRT-PCR : highest mean viral load found in 
lymph nodes [8.5 ± 3.5], followed by the lungs [8.2 ± 2.9] and the 
spleen [7.6 ± 4.3]. However, the diff erences between the sample 
tissues were not statistically signifi cant. 
Fig. 1. Correlation between viral load (log10 genome copies/g tissue) 
and virus titre (log10 TCID50/g tissue)
Discussion
Previously, it was shown that >=107 genome copies per 500 ng 
DNA is suggestive for PCVD and correlates well with the results 
of ISH (3,5). In this study, virus titres and the number of genome 
copies were both expressed per g tissue. We could correlate a 
PCVD-suspected virus titre of >=104.5 TCID50 with a viral load of 
>=1010 genome copies, suggesting that our newly developed 
high throughput qPCR may be a valid alternative for time con-
suming VI. Although no signifi cant diff erences could be found 
between the diff erent tissue samples, the highest virus titre and 
viral load was found in the lymph nodes, confi rming previous 
results (3).
Conclusion 
Based on the correlation between VI and qPCR and given that a 
titre of >= 104.5 TCID50/g tissue is suggestive for PCVD (2), we can 
conclude from this study that a viral load of >= 1010 genomes/g 
tissue can be suggestive for PCVD.
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Clinical case: porcine circovirus type 2 (PCV2) and mycotoxine presence in an abortion case
V. Muller1 Guillaume Perreul2 Jean-Bernard Herin3 Thaïs Vila4 François Joisel4
1. Réseau Cristal, SELARL Müller, Bazouges, France; 2. MERIAL, Lyon, France; 3. Merial S.A.S., Ancenis, France; 4. Merial S.A.S., Lyon, France
Introduction
Porcine circovirus type 2 (PCV2) associated to reproductive 
disorders must be included in the diff erential diagnosis of the 
reproduction infectious causes (1).
The objective of this clinical case description is to show the 
implication of PCV2 in a series of repeated abortions and the 
impact of CIRCOVAC® vaccination on this issue.
Case description
This PRRS-free 200-sow farrowing farm is well managed. Build-
ings are complying with the new welfare EU norms « 2012 » with 
boars and gestating sows loose on straw. Since 2007, around 
20 late abortion cases (3-4 weeks to 3-4 days before expected 
farrowing date) per year, independently of the parity were 
recorded. The number of mummifi ed foetuses was variable 
and could reach 0.6 per litter. Weaned piglets were well-formed 
but showed heterogeneity among litters. Post-weaning and 
fattening site are located off site at a several-km distance from 
the maternity and did not experience any PMWS signs. Sow 
fertility was good (90%). All laboratory investigation aiming at 
the detection of other infectious agents possibly involved in the 
reproductive disorders remained negative. 
Early 2009, 2 sows aborted without fever. A PCV2 quantitative 
PCR was performed on sera from and on the hearts and livers of 
their aborted foetuses. Sera of the sows and thoracic liquid of 
their aborted foetuse were also submitted for PCV2 ELISA (SERE-
LISA® PCV2 Ab Synbiotics, Lyon, France). 
Mycotoxin i.e. zearalenone (ZEA) and deoxynivalenol (DON) 
quantifi cation in straw was performed by a certifi ed laboratory.
Vaccination schedule
Primovaccination against parvovirosis and erysipelas used to be 
performed systematically in quarantine followed by a booster 
during further lactations. After PCV2 diagnosis was confi rmed, a 
vaccination with CIRCOVAC was carried out: 2 injections 3 weeks 
apart after pregnancy ultrasound check up due to practical sow 
containment aspects and a booster injection was administered 3 
weeks before farrowing.
Abortions dramatically dropped down after primo-immuniza-
tion from 3.6% to 1.3%.
Results
A high level of mycotoxines was revealed in the straw (see table 
1) in 2007 and 2008. After gestating sow feed was supplemented 
with appropriate concentration of anti-mycotoxines additives, 
mycotoxines level dropped down to acceptable levels.
A reduction in abortion rate was observed as soon as the fi rst 
batch was vaccinated, and then no abortion cases were noticed 
anymore.
Table 1: Mycotoxine detection in straw
Straw 2007 2008 2009 Reference
DON(μg/kg) 5410 5330 1940 900
ZEA (μg/kg) 1100 50 345 100
Table 2: PCR and ELISA PCV2 detection in aborted foetuses and serum 
of aborted sows
70343 Litter Heart PCV2 PCR +
70343 Litter mummifi ed pool -
70343 Litter 2 pools of normal aborted foetuses +
70343 Litter Antibodies -
70343 Dam Serum PCV2 PCR -
70343 Dam ELISA (Log10) 3.5
70344 Litter Heart and liver PCV2 +
70344 Litter mummifi ed pool +
70344 Litter 2 pools of normal aborted foetuses +
70344 Litter Antibodies 1+/10
70344 Dam Serum PCV2 PCR +
70344 Dam ELISA (Log10) 3.2
Discussion
Zearalenone is not known to be usually responsible for abor-
tions even at as high doses as 50mg/kg of feed which were far 
to be reached in this case (2). PCV2 is now well known to be 
a possible abortion agent (3) and diagnosis got on the farm 
showed its involvement in several aborted foetuses organ pools. 
Consequently, PCV2 can be considered as highly suspected to 
be responsible for the abortions. 
Conclusion
Altogether abortions occurring late in gestation, a positive PCV2 
diagnosis in sows and their aborted foetuses, poor antibody 
titres in sow sera along with no other pathogens are in favour of 
PCV2 implication in these abortions. The additional observation 
showing that abortions sharply stopped after CIRCOVAC vac-
cination contributed to incriminate PCV2 as the etiologic agent 
in this abortion episode.
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Genotype analysis of Chinese porcine circovirus type 2 in 2008-2009
Wenxiao Cui; Xin Guo; Xinna Ge; Hanchun Yang
China Agricultural University, Beijing, China
Introduction
Porcine circovirus type 2 (PCV2), a member of the Circoviridae 
family, is one of the most important pathogen aff ecting the 
swine industry worldwide.The genome of PCV2 is circular single 
stranded DNA with a size of 1767 or 1768 nucleotides (1, 2), 
which contains three major open reading frames (ORFs). The 
EU consortium proposes naming the three PCV2 genotypes 
as PCV-2a, PCV-2b and PCV-2c. Using this methodology, ORF2 
sequences of PCV2 are assigned to diff erent genotypes when 
the genetic distance between them is at least 0.035 (3). Our 
recent publication indicated that PCV2 strains in China could be 
divided into 5 major groups PCV-2a, PCV-2b, PCV-2d and PCV-2e. 
In this study, we analyzed the genetic variation and genotype of 
54 Chinese PCV2 sequences collected between 2008 and 2009.
Materials and Methods
Fifty-fi ve sequences of PCV2 were collected in 2008-2009 from 
11 pig-producing areas of China. Total DNA was extracted direct-
ly from each clinical sample. PCR was performed to amplify the 
complete genome of PCV2. The PCR product was purifi ed with 
a QIA quick PCR purifi cation kit (Qiagen, Germany) and cloned 
into the pGEM-T easy Vector System (Promega, USA) according 
to manufacturer’s instructions. For each genomic DNA ampli-
fi ed, two clones from each of two independent amplifi cations 
were sequenced on both directions using the ABI Prism 3730 
sequencer at Invitrogen (Beijing, China). The genomic homol-
ogy analysis and comparison among the PCV2 sequences were 
performed using the Lasergene Package (DNASTAR Inc). The 
deduced amino acid sequences of the encoded capsid protein 
were aligned using the Clustal W method. Genotype determina-
tion was done by the criteria described previously (3).
Results
Sequence analysis. A total of 54 PCV2 sequences were obtained. 
Pairwise comparisons of PCV2 complete genomic sequence, 
ORF1 gene, ORF2 gene, ORF3 gene among 54 sequences ex-
hibited that the nucleotide homology ranged from 94.7-100%, 
96.7-100%, 90.0-100%, 95.9-100%, respectively and the ORF1, 
ORF2, ORF3 amino acid homology was 98.7-100%, 86.8-100%, 
87.6-100% respectively. 
Genotype analysis. Of the 54 Chinese PCV2 sequences in this 
study, 42 sequences belonged to genotype PCV-2d, 10 sequen-
ces were cluster in genotype PCV-2b, and 2 sequences were clas-
sifi ed into genotype PCV-2e, indicating that genotype PCV-2d 
has become a dominating in China in 2008-2009. 
Discussion 
PCV-2d was fi rstly determined in China. This genotype of PCV2 
has not been documented in other countries (4). ORF2 gene 
clustered in genotype PCV-2d encodes 234 amino acids, and 
the remaining genotypes encode 233 amino acids. Since the 
last codon of ORF2 gene (TGG) mutated to AAG, this resulted 
in the change of the reading frame and the addition of a lysine. 
In addition, the amino acid variations of ORF2 were found at 
three positions 89 (I/R to L), 90 (S to T) and 169 (S to R), which 
were unique for genotype PCV-2d. In our study, 42 sequences 
belonged to genotype PCV-2d, suggesting that genotype PCV-
2d became dominating in China in recent two years. Therefore, 
much attention should be paid to the pathogenicity of this 
genotype to pigs.
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Evaluation of a SYBR green real-time polymerase chain reaction assay for 
the quantiﬁ cation of porcine circovirus 2 genotype b in serum
Kwang Soo Lyoo; Seung W. Kang; Han Soo Joo
University of Minnesota, St. Paul, MN, USA
Introduction
Porcine circovirus 2 (PCV2) is identifi ed as the major cause for 
post-weaning multi-systemic wasting syndrome (PMWS). The 
virus has now been classifi ed into 2 genotypes of PCV2a and 
PCV2b. PCV2b genotype has been more frequently isolated 
from pigs with clinical PMWS1,2,3,4. Therefore, PCV2b has been 
suggested to be more pathogenic, although it is still debatable. 
The PCV2 genomic quantifi cation test has become useful in the 
diagnosis of PMWS, because quantity of the viral genome in 
tissue samples from the aff ected pigs has been highly associated 
with the severity of PMWS. In this study, a SYBR green real-time 
PCR assay specifi c for PCV2b genotype was developed, and 
the results were compared to those by a nested PCR (nPCR). 
Although a PCV2 SYBR green real-time PCR assay was reported 
recently5, the assay was not aimed at diff erentiating between 
the two genotypes of PCV2.
Materials and Methods
Test sera were collected from 120 pigs in a Minnesota farm dur-
ing severe clinical PMWS. A nPCR assay was conducted by the 
method as described previously4. For a PCV2b specifi c real-time 
PCR, the DNA fragment of 361 base-pair on ORF2 was subcloned 
into pGEM-T Easy vector, and the plasmid was transformed in to 
JM109 cells. The copy number/μl was determined by the serially 
diluted plasmid. The real-time PCR assay was carried out using 
PerfeCTa SYBR Green SuperMix in a thermal cycler Mx3005P 
(Stratagene). All real-time PCR reactions were performed in 
triplicates in neighboring wells.
Results
The recombinant plasmid was constructed and the amount of 
input template copy numbers was calculated. The over range 
from 4.3x101 to 4.3x109 copies was obtained from the linear 
standard curve, which resulted in cycle threshold (Ct) values 
from 38.5 to 10.8 cycles and on the slope value of -3.49 (R2). 
The dilution factor from the original serum sample to real-time 
PCR reaction was taken into consideration when PCV2b copy 
numbers were calculating. In a comparison between quantita-
tive real-time PCR (qPCR) and nPCR, the real-time PCR was found 
to be 1,000 times more sensitive than the nPCR assay. A com-
parative result between the percentage of PCV2 viremic pigs by 
nPCR or qPCR, and the mean genomic copy number of PCV2b 
by qPCR using the same samples is shown in Table 1. Of the 120 
sera, 79 (65.8%) and 13 (10.8%) were positive by the nPCR for 
PCV2b and PCV2a genotype, respectively, whereas 98 (82%) 
sera were detected as PCV2b positive by qPCR assay. The copy 
number of PCV2b DNA ranged 3.66 - 10.01 log10 in 1ml of the 
serum samples. 
Table 1. Detection of PCV2 genotypes by nPCR or qPCR from sera of 
farm during clinical outbreaks of PMWS
Age of pigs (wks) Total
5 - 9 11 - 15 Pos (%) Neg (%)
nPCR-PCV2a 4 9 13 (11) 107 (89)
nPCR-PCV2b 27 43 79 (66) 40 (33)
qPCR-PCV2b 35 49 98 (82) 22 (18)
Mean DNA copy number (log10) 4.6 4.5 Total = 120
Discussion 
Higher prevalence of PCV2b genotype in association with 
clinical PMWS initially led us to develop a quantitative real-time 
PCR assay specifi c for PCV2b genotype. Most published real-
time PCR assays for PCV2 infection were aimed at quantifi cation 
of PCV2 without diff erentiation between the two genotypes. 
Development of a multiplex real-time PCR assay was reported 
to diff erentiate the two genotypes. However, the present SYBR 
green real-time PCR was found to be simpler to perform and less 
expensive when compared to the probe type in the multiplex 
PCR. In conclusion, the present assay could be highly valuable 
for PMWS diagnosis, especially if PCV2b genotype is more im-
portant factor for clinical PMWS. 
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Epidemiologic observation of PCV2 genotype infection and seroprevalence 
during and after clinical outbreaks of PMWS in commercial farms
Kwang Soo Lyoo; Nam H. So; Han Soo Joo; Peter Davies
University of Minnesota, St. Paul, MN, USA
Introduction
Post-weaning multi-systemic wasting syndrome (PMWS) has 
been an economically important disease in the U.S. since early 
2006. Commercial PCV2 vaccines have been widely used on 
pig farms to prevent the development of PMWS and to reduce 
the economic losses. It has been suggested that PCV2 viremia 
and the antibody responses are integral to the development of 
PMWS in pigs. In order to better understand these relationships, 
we compared the prevalence of the viremic pigs with PCV2a and 
2b genotypes and PCV2 antibody titers during (2006) and after 
(2008) clinical PMWS outbreaks on commercial swine farms. 
Materials and Methods
Five farms in Minnesota were selected based on the clinical 
histories of severe PMWS in 2006, and absence of clinical signs 
in 2008 following implementation of PCV2 vaccination. A total 
of 230 serum samples from pigs between 4 and 16 weeks age 
were collected from the 5 farms in 2006. In 2008, blood samples 
were collected from 322 pigs of the similar age groups at the 
same 5 farms. Diff erential nested PCR for PCV2 genotypes3 was 
performed to detect viremic pigs. PCV2 antibody titers were 
tested using both IFA and SN tests. The percentage of PCV2 
viremic pigs, mean IFA and SN antibody levels were analyzed 
by parametric and non-parametric test, respectively, using SPSS 
software to test the diff erences during and after the clinical 
PMWS in the 5 farms. 
Results
Across all 5 farms, the prevalence of PCV2a viremic pigs de-
creased from 11.1% in 2006 to 2.5% in 2008. Prevalence of 
PCV2b viremic pigs decreased markedly from 66.6% in 2006 
to 11.0% in 2008. Mean viremic pigs for both genotypes were 
signifi cantly (P<0.001) lower in 2008 when compared to those 
in 2006. The mean IFA titer of the grow-fi nish pigs was signifi -
cantly (P<0.001) lower in 2008 (7.6 log2) than that in 2006 (10.7 
log2) (Fig. 1). The mean SN titers for the nursery and grow-fi nish 
phases in 2008 were signifi cantly higher than those in 2006 
(P<0.001 and P<0.005, respectively) (Fig. 2).
Fig. 1. Comparison of mean PCV2 IFA titers 
Fig. 2. Comparison of mean PCV2 SN antibody titers 
Discussion
Both the prevalence and level of viremia were signifi cantly 
higher during clinical outbreaks in 2006 than following vac-
cination in 2008. The changes were more marked for PCV2b 
than PCV2a genotype supporting a greater role of PCV2b in the 
clinical outbreaks. This observation was similar to the previous 
fi ndings by others1, 2. The IFA antibody titers were higher during 
clinical PMWS in 2006 than in 2008 indicating evidence of PCV2 
infection. In contrast, SN antibody titers were higher in 2008 in 
the absence of clinical disease suggesting a likely protection 
eff ect against clinical PMWS. The higher SN antibody levels in 
the nursery pigs could be due to high maternal antibody and/or 
recent PCV2 vaccination. 
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Porcine Circovirus Type 2 (PCV2) In Utero Seroconversion, Early Viremia, 
And Serological Proﬁ le In Naturally Infected Piglets
Priscilla Gerber; Flávia Garrôcho; Zélia Lobato
Universidade Federal de Minas Gerais , Belo Horizonte, MG, Brazil
Introduction
Reproductive disorders associated with PCV2 are characterized 
by abortion, stillbirth and mummifi ed foetuses, with symptoms 
varying according to gestational age at the time of infection. 
Although PCV2 in utero infection was well characterized, little 
is known about its occurrence in naturally infected pigs and its 
consequence the onset of porcine circovirus diseases (PCVD) in 
the postnatal period. 
The aims of this study were to describe PCV2 peripartum infec-
tion and PCV2 serological profi le in naturally infected piglets. 
Materials and Methods
Twenty PCV2 sows vaccinated with CIRCOVAC (Merial) were 
studied. One hundred piglets (5 pigs/sow) were ear-tagged at 
birth. Colostrum, serum and piglets’ presuckle serum were col-
lected at the day of parturition (DP). Milk samples were collected 
at day post-partum (DPP) 20. Serum samples were taken and 
piglets were weighed at DPP 1, 20, 42, 63, 84. 
Colostrum and milk were evaluated for infectious PCV2[1], total 
(TA) and neutralising (NA) antibodies[2]. Serum samples were 
evaluated for PCV2 DNA[4], TA, NA, IgA and IgM anti-PCV2[3]. 
Non-normally distributed variables were analysed using the 
Mann–Whitney tests. Diff erences were considered signifi cant 
when P<0.05. 
Results
Sows had high levels of TA and NA in serum (11.63±1.32 log2; 
9.51±1.01log2) and colostrum (12.32±0.00 log2). However, 11 
out of 20 and 5 out of 20 colostrum and milk samples had infec-
tious PCV2 (1.96±1.02 log10 TCID50/50μl and 00.30±0.58 log10 
TCID50/50μl). PCV2 DNA was detected in serum of 17 out of 20 
sows (2.02±0.89 PCV2 log10 copies/ml of serum) in DP. 
Nine piglets were born with low levels of anti-PCV2 antibodies, 
ranging from 4.32 to 8.32 log2 TA titre. In DPP1, PCV2 DNA was 
detected in 29 piglets’serum samples, ranging from 2.00 to 
3.97 PCV2 log10 copies/ml of serum. There was no diff erence 
between the weight of viremic and non-viremic piglets (Table 1). 
Serological profi le of TA, NA and IgM anti-PCV2 are shown in Fig. 
1. IgM anti-PCV2 levels started to increase at DPP42, followed to 
seroconversion to TA and NA and decline of IgM levels at DPP84. 
Table 1. Weight of piglets viremic and non-viremic at DPP1 
Figure 1. Serological profi le of TA, NA and IgM anti-PCV2 titres from 
DPP 0 to 84
Discussion and Conclusions
Piglets were born with anti-PCV2 antibodies, indicating PCV2 
in utero transmission after the period of immunocompetence. 
This result suggests occurrence of vertical transmission even in 
farms where sows have high titres of anti-PCV2 antibodies and 
in absence of reproductive failure associated to PCV2 (data not 
shown).
Vaccination of sows could not prevent PCV2 shedding into 
colostrum and sow viremia at DP even in the presence of high 
levels of PCV2 NA. PCV2 in utero transmission or early infection 
resulted in viremia in the fi rst day of life of piglets. Even with the 
early PCV2 infection, piglets seropositive at birth and viremic at 
DPP1 had similar weight to non-viremic and seronegative pig-
lets, maybe due to low PCV2 DNA levels found, and the absence 
of PCVD clinical signs. 
Regardless of piglets’ early viremia, PCV2 IgM raised only at 
DPP42, suggesting that PCV2 was able to stimulate the immune 
system only after the passive antibodies decay at subprotetor 
levels (Fig. 1). Seroconversion to PCV2 TA and NA at DPP84 
coincides with the decline of IgM anti-PCV2 levels, apparently 
controlling PCV2 infection. 
In conclusion, vertical transmission of PCV2 may occur generat-
ing viable piglets at birth without losses in growth rate. Sows 
vaccination may not prevent PCV2 viremia at parturition and 
virus shedding into colostrum. 
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Naturally porcine circovirus type 2 (PCV2) exposed pigs generate a speciﬁ c antibody response 
able to neutralise diﬀ erent PCV2 isolates of diﬀ erent genotypes and geographic origins
Sherry Kurtz; Martí Cortey; Maria Fort; Marina Sibila; Joaquim Segales
Centre de Recerca en Sanitat Anima (CReSA), Bellaterra, Spain
Introduction
Porcine circovirus type 2 (PCV2) vaccines are able to induce a 
strong humoral immune response. Their neutralizing antibody 
response is apparently cross-protective against both predomin-
ant PCV2 genotypes (PCV2a and PCV2b) (2). Also, PCV2a infec-
tion protects against a subsequent PCV2b challenge, presum-
ably through cross-neutralizing antibodies (NA) (5). It is also 
known that there are several epitopes (detected by monoclonal 
antibodies) in the PCV2 Cap protein that are shared between 
diff erent genotypes, as well as PCV1 (4,6), which represents a pu-
tative basis for cross-neutralization. However, there were several 
strains for which there was little or no neutralization using the 
same antibody panel. This suggests the existence of antigenic 
variability between PCV2 genotypes. However, these studies de-
scribing antigenic variation have been done using monoclonal 
antibodies, which are specifi c for unique epitopes. Therefore, the 
objective of the present study was to further insight on PCV2 
antibody neutralization by using a pig sera obtained from fi eld 
studies to assess the level of antigenic variation by cross-neu-
tralization amongst diff erent isolates of PCV2. Viral isolates used 
were from diff erent geographical regions.
Materials and Methods
Serum samples. A total of 82 sera were used for the present 
study. A fi rst group of animals corresponded to PMWS aff ected 
pigs (n=20), which where found to be infected by PCV2b strains 
(3). A second group was composed of age-matched healthy 
pigs (n=17) from the same farms, and a proportion of them also 
infected with PCV2b strains. Finally, in order to get sera samples 
from animals that would have been exposed to PCV2 in the past, 
randomly sampled slaughter age pigs (n=45) were taken. 
PCV2 neutralization test. Neutralization assays were carried out 
as described (1) using two PCV2a (Burgos and Stoon-1010) and 
two PCV2b (MO/S-06 and Sp-10-7-54-13) isolates. Burgos and 
Sp-10-7-54-13 strains were isolated from postweaning multi-
systemic wasting syndrome (PMWS) aff ected pigs in Spain, while 
Stoon-1010 and MO/S-06 were isolated from PMWS in Canada 
and United States, respectively. 
Total PCV2 antibody test. An immunoperoxidase monolayer 
assay (IPMA) technique to detect antibodies to PCV2 (1) was also 
performed with all available sera and compared to the diff erent 
neutralization values obtained.
Results
Most of the sera were able to neutralise the four PCV2 strains 
used in the test, even they diff ered in their antibody titre. 
Globally, PCV2a genotype strains used in the test originated 
signifi cantly higher neutralising antibody titres when compared 
to those against the PCV2b genotype. No diff erences in NA titres 
were observed between PCV2 strains within the same genotype. 
In addition, NA titres detected in healthy and slaughterhouse 
animals were signifi cantly higher compared to PMWS aff ected 
pigs. No statistical signifi cant diff erences were detected in the 
neutralizing activity of sera obtained from either healthy, PMWS, 
or slaughterhouse pigs when tested to PCV2 strains of diff erent 
geographical origin. Finally, there was no direct correlation be-
tween IPMA and neutralizing titres detected in any of the animal 
categories. 
Discussion
The present study sought to examine the role of antigenic vari-
ability in the context of a natural infection. Pig sera of diff erent 
animal categories were able to neutralize PCV2 strains from dif-
ferent genotypes and geographical regions. This point seems to 
be extremely important, since would explain the fi eld evidence 
that PCV2 vaccines available in the market (all based on PCV2a 
strains) show effi  cacy in controlling PMWS independently of 
the causing genotype (2). However, the diff erences observed 
in the NA titres of the tested sera when either PCV2a or PCV2b 
strains were used as antigen in the test suggest the existence of 
antigenic variablility among those strains. 
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Infectious risk factors for postweaning multisystemic wasting syndrome (PMWS) development
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Introduction
Porcine circovirus type 2 (PCV2) is considered to be essential but 
not suffi  cient for postweaning multisystemic wasting syndrome 
(PMWS) development. Thus, several co-infections have been 
suggested as triggers for disease development in the fi eld (1). 
The aim of the present study was to gain further insights on in-
fectious agents as potential risk factors for PMWS development. 
Materials and Methods
Two longitudinal case-control studies in 13 PMWS-aff ected 
farms from Spain and Denmark were performed as previously 
described (2). Blood samples from pigs (approximately 100 
per batch coming from 10 sows) were longitudinally collected 
throughout their productive life. Pigs showing PMWS-com-
patible clinical signs were bled and euthanized together with 
healthy aged-matched pigs (ratio 2:1). PMWS was diagnosed 
and pigs were classifi ed into three categories: i) PMWS cases; ii) 
wasted non-PMWS cases; iii) healthy pigs (2). 
Serological analyses were performed in all collected serum 
samples to detect antibodies against Porcine reproductive and 
respiratory syndrome virus (PRRSV), Porcine parvovirus (PPV), 
Swine infl uenza virus (SIV) and Lawsonia intracellularis (Law) in 
both countries. Moreover, in Spain, antibodies against Myco-
plasma hyopneumoniae, Aujeszky’s disease virus and Salmonella 
spp. were also assessed. 
A Cox proportional hazards model was used to investigate the 
simultaneous eff ects of seroconversion and maternal immunity 
against the studied pathogens in each country. Data were ana-
lysed within a survival analysis framework, where development 
of PMWS was considered as death/failure. All analyses were car-
ried out using the Splus® software package, version 6.1.
Results
The number of studied pigs and their pathological classifi cation 
is displayed in table 1. 
Results from survival analysis showed that, for the Danish 
dataset, seroconversion against Law and PPV had a protecting 
eff ect. For animals that seroconverted against Law, the protect-
ive eff ect increased with the level of maternal immunity against 
this pathogen. Maternal immunity against PPV gave a protective 
eff ect in Spanish dataset. Moreover, high levels of maternal im-
munity against PCV2 had a protecting eff ect in both countries. 
Table 1. Number of studied pigs within each pathological category.
PMWS Healthy Wasted non-PMWS Total
Spain 35 29 43 107
Denmark 55 31 47 133
Discussion
Maternal PCV2 antibodies in both Danish and Spanish data 
showed a protecting eff ect against PMWS development, which 
is in agreement with previous studies (3). This situation would 
support the interest of PCV2 vaccination in sows in order to 
transfer a higher load of PCV2 antibodies to the off spring.
The protective eff ect of maternal immunity against PPV is in 
agreement with previous works suggesting PPV as a co-infec-
tious trigger (4). Besides, the fact that seroconversion against 
PPV and Law resulted protective for PMWS development could 
seem contradictory. However, the present analysis was based on 
antibody levels, and not on direct evidences of pathogen infec-
tion. Since it is known that PMWS aff ected pigs are immuno-
compromised (5), seroconversion may indicate a well-developed 
immune system, which in turn will make the animal less likely to 
develop PMWS.
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Theoretical and experimental approaches to estimate the usefulness of pooled serum 
samples for the diagnosis of postweaning multisystemic wasting syndrome (PMWS)
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Centre de Recerca en Sanitat Anima (CReSA), Bellaterra, Spain
Introduction
Traditional postweaning multisystemic wasting syndrome 
(PMWS) diagnosis requires the necropsy of suspicious animals 
and the access to histopathological expertise (1). One of the ma-
jor diff erences between PMWS-aff ected and non-aff ected pigs is 
porcine circovirus type 2 (PCV2) load in serum and tissues (2,3,4). 
Consequently, real-time quantitative PCR (qPCR) has been pro-
posed as a potential diagnostic alternative. However, sensitivity 
and/or specifi city of qPCR on individual basis are relatively poor 
(5). The main objective of the present study was to analyze the 
applicability of qPCR to detect PCV2 loads in pooled serum 
samples, with the purpose of increasing the diagnostic capacity 
of the qPCR technique. A second objective was to develop an 
easy-to-use PMWS qPCR-based diagnostic recommendation 
at the herd level, without the need to perform post-mortem 
examinations.
Material and Methods
Firstly, a theoretical model based on two qPCR viral load 
thresholds (3,4) to discriminate between PMWS aff ected and 
non-aff ected pigs was validated with an experimental pooling 
study considering pools of 3, 5, 10 and 20 randomly selected 
individuals. Secondly, pool sensitivities (PSe) and pool specifi ci-
ties (PSp) were estimated by means of Monte Carlo simulations. 
Such pooling included sera from diseased pigs with a PMWS 
diagnosis (PMWS), diseased pigs without fulfi lling the diagnosis 
of PMWS (wasted-non-PMWS) and healthy (healthy) animals. 
Using only the PMWS diagnosed individuals and the wasted-
non-PMWS, a second pooling approach considering targeted 
sampling (animals showing clinical signs compatible with 
PMWS) was simulated as an option to increase sensitivity at herd 
level. If targeted sampling is used, the probability of detecting 
the disease would be theoretically increased. The PSe and PSp 
obtained previously were used to estimate the sensitivities and 
specifi cities at herd level (HSe and HSp) for both approaches. 
Finally, we evaluated the capability of the model to discriminate 
between PMWS-aff ected and non-aff ected farms using qPCR 
real and simulated pools.
Results 
Several pools of 20 individuals did not report correct results 
in the experimental study, most probably caused by handling 
diffi  culties. Therefore, Monte Carlo simulations considered only 
pools of 3, 5 and 10 individuals. The best HSe and HSp estima-
tions were obtained using a single pool of 10 individuals or two 
pools of 5 individuals under the random sampling scenario. 
Targeted sampling reported worst estimations than random 
sampling, mostly because wasted-non-PMWS individuals 
showed higher qPCR values than healthy ones, making in this 
case diffi  cult the diff erentiation of truly aff ected and non-aff ect-
ed individuals. However, the model correctly discriminated and 
identifi ed most of the PMWS-aff ected and PMWS-non-aff ected 
farms despite some false-positives and false-negatives were 
reported.
Discussion
Assuming that the qPCR data used (3,4) are representative of 
the fi eld situation, present results suggest that sample pooling 
may be a suitable strategy for PMWS diagnosis. Sera pooling 
off ers several advantages compared with classical PMWS diag-
nostic methods. First, it represents a cost saving strategy, since 
more individuals can be analyzed using the same fi xed analysis 
expenses. Second, the use of qPCR is performed in an easy-to-
get sample and, therefore, it does not require histopathological 
expertise, indispensable with a necropsy based method. 
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Results of one-shot Circovac® vaccination at 0.5 ml in piglets on weight and mortality parameters
Bernhard Heissenberger; Andrea Ladinig; Christiane Lang; Christiane Püschel; Mathias Ritzmann
Clinic for Swine, Vienna, Austria
Introduction
Since the fi rst report in 1996 (1) porcine circovirus type 2 (PCV2) 
diseases had a major impact on the swine industry worldwide. 
Since June 2007 Circovac® (Merial, Lyon, France), an inactivated 
PCV2 vaccine for swine is centrally registered in Europe for pro-
tection of the off spring of vaccinated sows and gilts by passive 
immunization (2). 
The objective of this fi eld study was to evaluate the effi  cacy of 
Circovac® administered once to three week old piglets at a dos-
age of 0 5 ml intra-muscularly (i.m.).
Materials and Methods
The study was randomised, controlled, blinded and conducted 
on an Austrian 250-sow farrow-to-fi nish farm with severe prob-
lems especially during the fattening period caused by PCV2. 
In total 1105 piglets were included in this fi eld trial. They were 
randomly allocated to the vaccination group, which received 0.5 
ml Circovac® i.m. at weaning, or to the placebo treated control 
group. Control and vaccinated piglets stayed intermingled. The 
body weight was determined at birth, weaning (3rd week), the 
end of nursery (13th week), in the middle of the fattening period 
(21st week) and at the end of the fattening period (28th week). 
Wasting animals were defi ned as animals whose body weight 
was at least 25 % lower than the average of the respective 
group. All animals were monitored for clinical symptoms and 
mortality was recorded during the whole study period. 
Results
An important parameter of this study was the evaluation of aver-
age daily weight gain. A signifi cant diff erence of the daily weight 
gain between both groups occurred during the entire fattening 
period in favor of the Circovac® vaccinated group (+41.43g/d; 
p<0.0001). The main viremia period on this farm occurred dur-
ing the fi rst half of fattening (from 13th to 21st week), when the 
diff erence in ADWG was most obvious (+64.83 g/day, p<0.0001), 
which is shown in fi gure 1. The number of wasting animals was 
reduced by 5.15 % (p<0.044) in the Circovac® vaccinated group 
during the fi rst half of fattening (13th – 21st week), the period of 
main viremia. The mortality rate during the fattening period was 
signifi cantly reduced (-7.4%) in the vaccinated group (p<0.0001). 
As expected the diff erence in mortality was highest during the 
main viremia period. (Figure 2).
Figure 1: ADWG 13th-21st and 13th–28th week of life
Figure 2: Mortality rate according to the main viremia period
Discussion
Compared to a placebo treated control group, Circovac® vac-
cinated animals showed signifi cant improvements. Vaccination 
resulted in reduction of mortality rate, increase of daily weight 
gain and reduction of wasting animals during the course of the 
study and particularly during the main viremia period. 
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Analysis of occurrence of porcine circovirus type 2 (PCV2) in PMWS-like pigs from farms in Slovak Republic
Juraj Pistl; Tomas Csank; Michaela Vlasakova; Jana Pollakova; Anna Jackova; Stefan Vilcˇek
University of Veterinary Medicine and Pharmacy, Košice, Slovak Republic
Introduction
Circoviruses are small DNA viruses, which infect number of 
animal species. The most important circovirus in swine is porcine 
circovirus type 2 (PCV2), whereas, the most frequent clinical 
form of circovirus infection is the post-weaning multisystemic 
wasting syndrome (PMWS). The disease has been reported 
in most of the European countries (Segalés, 2007). Hitherto, 
the epidemiological situation of PMWS in Slovakia was not 
well understood and the country held unknown PMWS status 
(Segalés, 2007). Any offi  cial data about PCV2 detection and 
surveillance were missing. On this background, the research was 
focused on the detection and isolation of PCV2 from pigs with 
PMWS-like symptoms based on generally accepted scientifi c 
criteria (biological and moleculo-genetic methods), and preva-
lence of specifi c antibodies. 
Materials and Methods
86 post-weaning (42-50 days old, body weight 7.2–9.4 kg) Land-
race and Slovak Large White pigs suff ering from PMWS-like clin-
ical symptoms were selected from twelve pig farms from diff er-
ent regions of Slovakia. More than 40% morbidity and up to 15% 
mortality in weanlings was observed in the farms with wasting 
and respiratory disorders. Immunohistochemistry allowed us 
to prove PCV2 in cryosections of lymph nodes. Immunoperoxi-
dase test (IPMA) was used to confi rm PCV2 in cell culture PK-15 
(Sanchez et al., 2001). A 263bp fragment from the ORF2 genome 
region was amplifi ed using primers CF8 and CR8 (LaRochelle et 
al., 1999). Nucleotide sequences of PCV2 amplifi ed fragments 
were analyzed by BLASTn analysis to fi nd out similar sequences 
in GenBank. IgM and IgG specifi c PCV2 antibodies were detected 
by ELISA (Ingezin circovirus IgM/IgG, Ingenasa, Spain).
Results
All investigated pigs were clinically characterized by severe 
growth retardation, emaciation and marked spine. 52 weanling 
pigs (60.5%) were PCV2 positive. Massive occurrence of PCV2 
infected cells was particularly seen in inguinal lymph nodes. 
PCV2 virus positive macrophages were located mainly in medul-
lar cords along with paratrabecular sinuses of lymph nodes. The 
similarity search in BLASTn showed 100% sequence matches 
with Austrian AUT5 PCV2 strain (Accession number AY424405.1) 
and some Chinese strains as well. Based on the ratio of posi-
tivity/negativity, the coeffi  cient of infection rate in individual 
farm was calculated. In four farms from twelve the coeffi  cient 
of infection rate was 1.0, which indicates high prevalence of 
PCV2. In other farms coeffi  cient was between 0.40 – 0.71, which 
indices actual risk of PMWS. A zero coeffi  cient was present in 
only one farm. These results show high prevalence of PCV2 with 
occurrence of PMWS in pig farms of Slovakia. Prevalence of 
specifi c PCV2 antibodies in animals tested was 50.5%. In 51.5% 
of samples both IgM+IgG antibodies were detected. 13.2% of 
samples showed presence of IgM, while 35.3% samples had IgG 
antibodies. 
Discussion
In the Central Europe the diagnosis of PMWS and detection of 
PCV2 was reported fi rst time in Hungary (Kiss et al., 2000). Later 
the disease was reported in Austria (Schmoll et al, 2002), Czech 
Republic (Celer jr and Carasová, 2002) and Poland (Stadejek et 
al., 2006). The fi rst detection and isolation of PCV2 from PMWS 
animals in Slovakia based on the generally accepted diagnostic 
criteria (Sorden, 2000) was published in 2009 (Pistl et al., 2009). 
Present study was focused to provide data on the evidence of 
PCV2 in PMWS-like pigs from other Central European coun-
try – Slovakia. Our work demonstrates the evidence of PCV2 in 
the PMWS-like aff ected pigs, determined on the basis of highly 
suggestive clinical and pathological symptoms, antigenic and 
genetic methods that clear the epidemiological situation of 
PCV2 in the pig farms of Slovakia. 
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Presence of viral pathogens in cases of porcine respiratory diseases complex (PRDC) in central Italy
Stefano Petrini; Marta Paniccià; Valentina Silenzi; Sara Briscolini; Chiara Magistrali; Giovanni Filippini; 
Marco Sensi; Stefano Gavaudan; Francesca Ciuti; Manfredo Fortunati; Giovanni Pezzotti
Istituto Zooprofi lattico Sperimentale dell’Umbria e delle Marche, Perugia, Italy
Introduction
Porcine respiratory disease complex (PRDC) in pigs is one of 
the most relevant health concern for swine production today. 
As with respiratory disease in humans and other species, this 
complex in swine is often the results of the combined action of 
primary and opportunistic infectious agents. Primary agents in 
pigs include viral agents (1-2-3), like European type of Porcine 
Reproductive and Respiratory Syndrome Virus (PRRSV-EU), 
Porcine Circovirus type 2 (PCV2), Swine Infl uenza Virus (SIV) and 
Suid herpesvirus type 1 (SuHV-1). The objective of the present 
work was investigate the presence of these major viral infection 
agents in cases of PRDC in central Italy (Umbria and Marche 
Regions). 
Materials and Methods
A total of 527 pigs with PRDC were observed between years 
2007 and 2009, originating from 58 herds were no vaccination 
against the above mentioned viral agents was adopted. There 
was no epidemiological relation between these herds; however, 
a common clinical history was reported, with animals showing 
severe symptoms of respiratory disorder, high mortality and 
increased number of culled pigs. Morbidity ranged from 30% to 
70%, with an average mortality of 4% to 6%. Necropsy was car-
ried out at the Istituto Zooprofi lattico Sperimentale dell’Umbria 
e delle Marche where diff erent organs (lung, kidney, liver, spleen, 
palatine tonsil, lymph node, small intestine, uterus, ovary, abor-
tion) were collected for histology and virus isolation using NSK 
cell culture (4). In particular the presence of PRRSV-EU, PCV2, SIV, 
SuHV-1 was evaluated. 
Results
Most of the animal examined appeared in poor body conditions. 
Macroscopic lesions were essentially observed in the apical 
lobes of the lungs, showing pneumonitis, bronchial and bronchi-
olar necrosis, purulent bronchopneumonia, pulmonary haem-
orrhages and fi brous/fi brinous pleuritis. In the palatine tonsils 
petechial haemorrhages were observed while the bronchial 
lymph nodes appeared enlarged and pale. Histology confi rmed 
the presence of the lesions in the lungs, palatine tonsils and the 
lymphoid tissues were giant multinucleate cells, peribronchial 
mononuclear infi ltrates, fi brous bronchiolitis, granolumatous 
infl ammation, coagulative necrosis and haemorrhages were 
found. No signifi cant lesions were observed in other organs. Viral 
pathogens detected from the samples are summarized in Table 1.
Table 1. Viral pathogen/s detection results in 527 pigs with PRDC 
lesions
Pathogen/s No.Positive % Positive
PRRSV-EU only 209 39,65
PCV2 only 295 55,97
PCV2+PRRSV-EU 13 2,46
SIV N.I. N.D.
SuHV-1 N.I. N.D.
N.I., Not isolated; N.D., Not determined
Discussion 
The present study has contributed to clarify the role of the major 
viral agents in the occurrence of PRDC in pigs in the farms of 
central Italy. In particular, PCV2 was the most frequent agent, 
found in 55,97 % of the cases followed by PRRSV in 39,65 % of 
the animals. Only in few cases (2,46%) an association between 
these two viruses was found. Signifi cant diff erences have been 
therefore observed in respect to other geographical areas , such 
as Spain (5), where PCV2 has been found in lower percentages 
(39,2%) or Korea (3) where, instead a frequent (55%) co-infection 
of PCV2 and PRRSV has been described. No positive samples for 
SIV or SuHV-1 were recorded, demonstrating a minor epidemio-
logical role of these agents in the epidemiology of respiratory 
disorders in this area. Also in respect to this, diff erent situations 
have been described in Spain, where SIV occurred in 4,1% of 
the cases and SuHV-1 in 1,4% and in Korea, where 13,3% of the 
samples from resulted positive to SIV. 
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Discovery of antinuclear antibodies in pigs infected with porcine circovirus type 2
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Introduction
Porcine circovirus type 2 (PCV2) causes post-weaning-multi-
systemic-wasting-syndrome (PMWS), a swine disease fi rst ob-
served in Canada in 1991.1 It is characterized by general wasting, 
respiratory disease, jaundice and pallor in young pigs resulting 
in production losses and variable mortality. Since the discov-
ery of PCV2 in 1996, this virus has been linked to other disease 
syndromes (porcine dermatitis and nephropathy syndrome, 
reproductive failure, and enteritis) that are collectively known as 
porcine circovirus associated disease (PCVAD). PCV2 is ubiqui-
tous in swine herds around the world and endemic in most 
herds. The majority of pigs remain clinically unaff ected whereas 
a small proportion display severe clinical and sometimes fatal 
disease. We have experimentally reproduced PMWS using germ-
free piglets.2 An unusual feature of disease pathogenesis is a de-
layed onset of clinical disease following virus challenge and the 
subsequent rapid decline in the health of diseased piglets. Here 
we report evidence for development of antinuclear antibodies 
(ANA) in sera of germ-free pigs infected with PCV2.
Materials and Methods
A conserved amino acid sequence based on the published 
capsid protein sequence of PCV2a was used to make a synthetic 
peptide and to immunize rabbits for PCV2-specifi c antiserum 
production. 
A series of animal studies were conducted with germ-free 
piglets derived aseptically from crossbred sows by cesarean 
section.2 Piglets were housed in sterile, stainless-steel pentub 
isolators (4 pigs/isolator) and fed a commercially-available 
pasteurized milk diet. Each pig within an isolator received the 
same treatment, either PCV2 or a sham inoculation at about 7-10 
days of age. In comparative viral pathogenesis studies, diff erent 
groups of pigs were similarly challenged with swine infl uenza 
virus.
ANA were measured by two independent methods: 1) a fl uor-
escent microscope slide-based indirect immunofl uorescence 
assay (IFA) (SCIMEDX HEp2 ANA IFA, Denville, NJ) and an ANA 
ELISA (QUANTA Lite ANA, INOVA Diagnostics, Inc., San Diego, CA) 
modifi ed by using an anti-swine IgG secondary antibody (KPL, 
Inc., Gaithersburg, MD).
Results
To investigate PCV2 replication in tissue culture, a conserved 
peptide of the PCV2 nucleocapsid was produced to make 
polyclonal antisera in a rabbit. Initial testing with this antiserum 
revealed signifi cant background staining of a porcine kidney 
cell line (PK-15) used to propagate PCV2 in our laboratory. The 
staining was most prominent in the nuclear region of PK-15 cells 
and was present regardless of the PCV2 infection status of the 
cells, suggesting the antisera was recognizing nuclear antigens 
unrelated to PCV2. This led us to investigate the presence of ANA 
in piglet sera from prior germ-free isolator studies with PCV2 
and other viruses.
Thirty-eight pigs used in 3 separate studies were found to be 
free of ANA on the day of inoculation with virus. In these studies, 
21 of 38 piglets infected with PCV2 isolates developed detect-
able ANA of the IgG isotype based on the Hep-2 IFA ANA test. 
Most piglets that developed ANA did so by 18-25 dpi with PCV2. 
In contrast, 7 piglets infected in 2 separate studies with a swine 
infl uenza virus remained free of detectable ANA. To confi rm 
these semiquantitative fi ndings, a subset of samples from one 
germ-free study were tested by an ELISA that collectively detects 
total ANA against chromatin (dsDNA and histones), Sm/RNP, 
SS-A, SS-B, Scl-70, centromere and PCNA, as well as antibodies 
against cytoplasmic antigens such as Jo-1, mitochondria (M-2) 
and ribosomal-P protein. ELISA results demonstrated develop-
ment of increasing levels of ANA over the course of a study in 9 
of 12 piglets infected with PCV2 but not in 4 of 4 control virus-
free piglets. 
Discussion
Antinuclear antibodies are directed against normal nuclear 
antigens and are detected in sera of patients with autoimmune 
disease. Development of ANA in piglets infected with PCV2 
preceded onset of clinical disease but not all pigs with ANA died. 
Finding ANA and a PCV2 capsid peptide that induced anti-
bodies cross-reactive with porcine nuclear antigens suggests an 
autoimmune component to the pathogenesis of PCV2-induced 
disease in the germ-free pig model.
References
1.  Clark EG. Post-weaning multisystemic wasting syndrome. Proceed-
ings of the American Association of Swine Practitioners 1997;499-
501.
2.  Gauger P, Lager, KM, Vincent, AL, Opriessnig, T, Kehrli, ME, Cheung, 
AK: Reproduction of postweaning multisystemic wasting syndrome 
in germ-free swine with porcine circovirus type 2-group 1 and 
-group 2 virus. Vet Micro. (Submitted)
Porcine Circovirus Associated Diseases (PCVAD) – General
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 333
Poster Presentations
P.027
A study on the presence and DNA loads of porcine circovirus type 2 (PCV2) in feces samples 
Gerard J. Wellenberg; Frits Bouwkamp
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Introduction
Up till now, there is hardly any information on the role of porcine 
circovirus type 2 (PCV2) in the development of diarrhea (enter-
itis), or in diff erences in PCV2 DNA loads in feces collected from 
pigs with and without enteritis. This study was performed to 
examine the presence and PCV2 DNA loads in feces from pigs 
with and without diarrhea (enteritis). 
Materials and Methods 
Feces samples from 51 pigs (n=46 farms) with diarrhea (enteritis) 
and from 11 pigs (n=11 farms) without diarrhea were exam-
ined for PCV2 DNA loads by quantitative PCR. Feces samples 
from pigs with diarrhea were also analyzed for the presence 
of Lawsonia intracellularis, Brachyspira hyodysenteriae and B. 
pilosicoli by PCR, E. coli, Salmonella spp by bacterial cultivation, 
coccidia and/or other parasites by microscopical examinations. 
The Student t-test and the one-sided Proportion test were used 
for statistical analyses.
Results
PCV2 DNA was detected in 23 (45%) of the 51 feces samples 
from pigs with diarrhea and in 5 (45%) of the 11 feces samples 
from pigs without diarrhea (Table 1). 
Table 1: Results PCV2 DNA in feces from pigs with and without diar-
rhea (enteritis)
Diarrhea (enteritis) Without diarrhea P-value
PCV2 DNA (n) 23 (45%) 5 (45%)
Mean (log10 PCV2 DNA copies/
mgr) 4.43 (se*: 0.24) 3.03 (se: 0.28) 0.005
PCV2 DNA copies >104/mgr (n) 12 0 0.037
*: se: standard error of the mean
Twelve feces samples from pigs with diarrhea (enteritis) and 
none of the feces samples from pigs without diarrhea had PCV2 
DNA copy loads >104/mgr (P= 0.037). Co-infection of PCV2 with 
L. intracellularis, B hyodysenteriae, pathogenic E .coli, Salmon-
ella spp. and coccidia were found in 13 (25.7%) of the 51 feces 
samples from pigs with diarrhea. 
Table 2: Results of the 51 feces samples collected from pigs with diar-
rhea (enteritis)
Pathogens detected Total PCV2 DNA 
(n) (%) copies/mgr >104 (n)
No pathogens 14 (27.5%)
PCV2 10 (19.6%)* 4
PCV2 + L. intracellularis 5 (9.8%) 3
PCV2 + B. hyodysenteriae 1 (2.0%) 1
PCV2 + L. intracellularis + B. hyodysenteriae 1 (2.0%) 1
PCV2 + pathogenic E. coli 1 (2.0%) 1
PCV2 + pathogenic E. coli + S. Typhimurium 2 (3.9%) 1
PCV2 + pathogenic E. coli + B. hyodysenteriae 1 (2.0%) 1
PCV2 + Salmonella serovar B 1 (2.0%)
PCV2 + coccidia 1 (2.0%)
Pathogenic E. coli 2 (3.9%)
Pathogenic E. coli + B. hyodysenteriae 1 (2.0%)
E. coli + Salmonella serovar B 1 (2.0%)
L. intracellularis 6 (11.8%)
L. intracellularis + B. hyodysenteriae 1 (2.0%)
B. hyodysenteriae 1 (2.0%)
C. perfringens 1 (2.0%)
S. suis infection 1 (2.0%)
Totals 51 (100%) 12
*: 4 samples were examined for PCV2 only.
Discussion
PCV2 can be found in feces samples from pigs with and without 
diarrhea (enteritis), but; 
• The mean PCV2 DNA copy load in PCV2 DNA positive feces 
was higher in pigs with diarrhea, 
• and high PCV2 DNA copy loads (>104 copies/mgr) were found 
signifi cantly more often in feces from pigs with diarrhea (en-
teritis) 
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Introduction
The correlation between the PCV-2 ORF3 gene and viral patho-
genicity has been suggested previously. Three genogroups 
based on the ORF3 gene sequence (SG1, SG2 and SG3) were 
identifi ed in Sweden and correlated to the PCVAD occurrence. 
The aims of this work were to determine the ORF3-based geno-
types present in Brazilian herds, to establish their geographic 
distribution among main swine-producing states of Brazil and to 
correlate each genotype with lymphoid microscopic lesions.
Materials and Methods
Samples from 89 swines with clinical symptoms of PCVAD were 
collected in nine swine-producing Brazilian states. For histo-
pathological evaluation, 44 samples were processed and the 
lesions were classifi ed as discrete, moderate or severe. Thirty-
one additional samples were collected from the same farms in a 
diff erent time-point. DNA was extracted from the tissue suspen-
sion using guanidine thiocyanate and PCR product was purifi ed 
and sequenced. The amino acid sequence alignment of the 
samples was made using Clustal W and phylogenetic tree was 
constructed based on the Neighbour Joining (NJ) method with 
1000 bootstrap. Haplotype networks were constructed using the 
Network 4.2.0.1 software.
Results
The phylogenetic analysis of the ORF3 sequence allowed the 
identifi cation of three genogroups (3.4% SG1, 12.3% SG2 and 
84.3% SG3) and six subtypes (SG2A, SG2B, SG2C, SG2D, SG3A 
and SG3B). Furthermore, it was possible to observe that the 
majority of the samples were classifi ed within subtypes SG3A 
and SG3B. The average distance of the amino acids was closer 
between the SG1 and SG2 genogroups. There was also a greater 
genetic proximity between the SG2A and SG2B subtypes and 
the SG3A and SG3B subtypes. Variations between SG1 and SG2 
were detected at residues 41, 102, 103 and 104, and variations 
between SG1, SG2 and SG3 were detected at residues 41 and 
103. Finally, the distance measured by the branch size was low, 
indicating a genetic proximity among the individuals. In samples 
from the same farm collected at a diff erent time, 74.19% of the 
cases presented both samples were classifi ed within the same 
subtypes (67.74% in SG3B and 6.45% in SG2D), whereas the 
remaining 25.81% of the samples were classifi ed into diff erent 
subtypes. When lesion severity was correlated with the ORF3 
genogroup, subtypes SG1 and SG2 were associated with discrete 
lesions, SG3B was more frequently associated with discrete and 
moderate lesions, whereas SG3A was associated with moderate 
and severe lesions. Through the phylogeography analysis it was 
possible to group the sequences in 14 haplotypes. The H11 hap-
lotype (from SG3B) grouped 55 (61.80%) representative sequen-
ces from the nine states and was considered to be the ancestral 
haplotype for SG3 due its ample dispersion.
Discussion
Our fi ndings consist in the fi rst identifi cation of subtypes in SG2 
and SG3 based on amino acids 102 to 104 indicating the emer-
gence of PCV-2 genotypes in Brazilian herds. The presence of dif-
ferent ORF3 genogroups and subtypes in the nine states studied 
indicated the wide circulation of the PCV-2 variants. The change 
of genogroup in 32.26% of the samples from the same farms col-
lected at a diff erent time confi rms these results. The frequency 
of the histopathologic lesions corroborates literature results, 
which suggested that the genogroup classifi cation can be based 
on the description of the PCVADs present on the farm. Moreover 
it was also possible to observe that SG3A variants were more 
pathogenic than those in subtype SG3B. The detection of the 
SG1 genogroup in only three samples, which were associated 
with discrete lesions, is likely indicative of the low prevalence 
of this genogroup among animals with clinical signs of PCVAD, 
further it supports the hypothesis that genogroup SG1 is less 
pathogenic. The major number of samples was classifi ed in the 
SG3B subtype, and its wide distribution in the haplotypes sug-
gests that this PCV-2 variant circulated widely with only minimal 
alterations in the ORF3 sequences. 
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Introduction
The evolution of the PCV-2 genetic diversity has been intensely 
studied for a better understanding of the pathogenesis of 
the associated syndromes and development of prophylactic 
measures. The nonsynonymous, amino acid-altering/synonym-
ous, silent, substitution rate ratio (ω = dN/dS) provides a measure 
of natural selection at coding regions, where ω = 1 represents 
neutral evolution; ω > 1 states positive selection, caused by an 
excess of nonsynonymous polymorphism and consequently 
increasing the rate (ω), while ω < 1, indicating purifying selec-
tion, where the new mutations are eliminated, probably due 
their deleting nature. 
Materials and Methods
Alignment of the 27 ORF2 PCV-2 sequences plus 7 Genbank se-
quences (AY484416; AY682995; AY556476; AF117753; AY146993; 
AY256458; AF408635) were used. The amino acid sequence 
alignment was made using the CLUSTAL W software. The phylo-
genetic tree was constructed based on the Neighbour Joining 
(NJ) using the MEGA 4.0 software. Diff erent measures of poly-
morphism variability and several statistics employed in neutral 
tests using the program DNAsp v.4.50.3 were used. The program 
CODEML from the software package Phylogenetic Analysis by 
Maximum Likelihood v. 4.2b (PAML) was used to fi t models of 
sequence evolution to our circovirus type 2 dataset.
Results 
In ORF2 all values LRTs indicated signifi cantly better fi ts for the 
selection models M2 and M8 than the neutral models M1 and 
M7 respectively (Table1). Also, at the model M3, diff erent omega 
values along the sequence fi ts better than M0 which consider 
the entire sequence, evolving under only one omega value. The 
codons that showed high values of omega are (69 R, 101 P, 185 S, 
with Probability of (omega > 1) > 95%). In addition, to the previ-
ous results provided for the likelihood analysis, tests of neutrality 
based on the sequence frequency spectrum (Tajima’s D; Fu and 
Li’s F) also provided evidences that corroborate these fi ndings.
Discussion 
Our work provided evidence that the ORF2 had undergone posi-
tive selection and identifi ed 3 positively selected sites. Under-
standing the functional importance of these positively selected 
amino acid positions could help to predict possible changes in 
virulence, as well as responses to certain strains in future vac-
cination programs.
Table 1 Likelihood ratio test for the diff erent models tested on the PCV-
2 Open reading frame 2 (a LRT = -2* (H0-H1), b degree freedom, 
c for 0.05)
ORFs Models compared -2 Δl a d.f b p-value c
M0 vs. M3 181.62** 4 <0.00001
ORF2 M1 vs. M2 17.62* 2 0.000139
M7 vs. M8 36.16** 2 <0.00001
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Introduction 
Porcine circovirus type 2 (PCV2) is the cause of PCV2 associated 
diseases (PCVAD), a multifactorial disease that causes great 
economic impact on swine industry worldwide (2). Recently 
performed serological examinations indicated that this virus is 
widespread within the pig population (1). The aim of the present 
work was investigated the presence of antibodies against the 
PCV2 in pigs from commercial farms of the Northeastern States 
of Brazil detected by immunoperoxidase monolayer assay 
(IPMA). 
Materials and methods 
Herds and blood collection: 353 blood samples were collected 
from gilts with age between 20-28 weeks from 12 diff erent farms 
of Northeastern States of Brazil. The major criteria used for the 
selection of the farms in the study were agreement permission 
the owners and no use of vaccines against PCV2. Second, the 
herd should be of at least 100 sows and monitored for the pres-
ence of clinical signs of the PCVAD.
Serologic analyses: Serum samples were evaluated for the pres-
ence of antibodies to PCV2 by IPMC (3). Serial dilutions of sera 
were performed from 1:20 to 1:5120 on 96 well plates containing 
fi xed Swine Kidney (SK6) cells previously infected with PCV2. 
Titers equal or above 1:20 was considered positive and classi-
fi ed as low (1:20 to 1:160), medium (1:320 to 1:2560) and high 
(1:5120 or higher) titers.
Statistic analyses: The data were analyzed using the program R 
(R Foundation for Statistical Computing, 2009). 
Results 
The results show that 306/353 samples analyzed (86.7%) reacted 
against PCV2 antigens (equal or above 1:20). The results are 
summarized in Table 1 and Figure 1. 
Discussion
The present study represents the fi rst antibody survey against 
PCV2 in pigs on farms of the Northeast of Brazil. This ubiquitous 
infectious agent circulates in all farms, regardless of syndrome 
being present (1). The antibody profi le titer in non vaccinated 
farms can be used to guide vaccination programs. Lower titers 
against PCV2 can were observed between the ages of 23 and 25 
weeks. This result suggests that this period can be identifi ed as 
a window in the herd immunity and it is suitable to implement 
vaccination programs. 
Table 1. Distribution of antibodies titers against PCV2a per number of 
swine in farms located in Northeastern States of Brazil.
Classes of Antibody Titer
NRb Low Medium High
State n % n % n % n %
BA 11 23.4 47 38.5 45 27.6 6 30.0
CE 7 14.9 14 11.5 22 13.5 5 25.0
PB 7 14.9 8 6.5 16 9.2 2 10.0
PE 11 23.4 25 20.5 29 17.8 2 10.0
RN 11 23.4 28 23.0 52 31.9 5 25.0
Total 47 100.0 122 100.0 164 100 20 100.0
aPorcine circovirus type 2; bNon-reagent animals (Titer below 1:20) 
Figure 1. The relation between diff erent ages in relation to antibody 
titer (log transformed multiplied by –1) against PCV2 in Northeastern 
Brazilian pig farms.
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Introduction
Postweaning multisystemic wasting syndrome (PMWS) is a 
disease that aff ects late nursery and fattening pigs. Diagnosis 
of PMWS is based on the presence of compatible clinical signs 
(mainly wasting and respiratory distress), characteristic histo-
pathological lesions, and detection of PCV2 within characteristic 
lesions. Microscopically, the most relevant features are lympho-
cyte depletion and histiocytic infi ltrates in lymphoid tissues. 
Therefore, the sole detection of PCV2 antibodies in serum and/or 
viral DNA or antigen does not constitute PMWS diagnosis, since 
it only indicates evidence of PCV2 infection Histopathology and 
immunohistochemistry tests performed on a panel withdrawn 
from daily farm mortalities are fundamental tools for the diag-
nosis of PMWS. The objectives of this study were to evaluate the 
diff usion of PMWS in North-western Italy (Piedmont region) and 
the reliability of a histological grading in “farm diagnosis”.
Materials and Methods
Fourteen farms with clinical signs related to PMWS were se-
lected and a questionnaire to evaluate their clinical and man-
agement situation was drawn up.
Three to fi ve animals (4-16 weeks old) were necropsied and 
samples from lung, tonsil, tracheobronchial and superfi cial 
inguinal lymph node, spleen and ileum were collected from 
all pigs for histopathological and PCR analysis for PCV2. Por-
tions of tissues were fi xed in 10% neutral-buff ered formalin and 
processed by standard paraffi  n wax techniques for histological 
analysis. Samples were cut in 4±2 μm sections and stained with 
haematoxylin and eosin (HE) and immunohistochemically (IHC) 
using a monoclonal antibody against PCV2 (Ingenansa, Spain). 
Lung sections were scored for the presence and severity of 
interstitial pneumonia ranging from 0 (normal) to 6 (severe dif-
fuse); lymphoid tissues sections were evaluated for the presence 
of lymphoid depletion ranging from 0 (normal) to 3 (severe) and 
for histiocytic infl ammation and replacement of follicles ranging 
from 0 (normal) to 3 (severe).
In addition they were all tested by PCR for porcine reproductive 
and respiratory syndrome virus (PRRSV) and bacteriological and 
parasitological investigations were made on the basis of signs 
during necropsy.
Results
At post-mortem examinations some animals revealed mild to 
moderate hyperplasia in superfi cial lymph nodes and consoli-
dation of lungs in association with broncopneumonia. Five of 
the 14 farms resulted positive for PMWS with at least one piglet 
showing typical lesions and immunohistochemical and molecu-
lar positivity. Lesion score for depletion target from 1 to 3 and 
for histiocytic infl ammation from 1 to 2. Further 9 farms resulted 
negative for PMWS and lesion score resulted 0 or 1 for both de-
pletion and histiocytic infl ammation. Lesion score for lung was 
quite variable in all farm analyzed whit values from 0 to 6. PRRSV 
resulted also positive in all farms with PMWS and it was also 
present in eight of other farms. Only one showed no presence 
of viruses. Streptococcus suis, Pasteurella multocida, Haemophilus 
parasuis, Bordetella bronchiseptica, Salmonella tiphymurium were 
isolated form several collected organs.
Discussion
Histology and immunohistochemistry are considered essential 
for PMWS diagnosis. In this fi eld the lesion score could be useful 
to understand the evolution of the pathology within the farms. 
It is noteworthy that lesions with score 2-3 of lymphoid deple-
tion and 1-2 of histiocytic infl ammation were more frequently 
associated with immunohistochemical positivity. In our cases 
histiocytic infl ammation resulted from low to moderate but not 
severe and the depletion appeared to be the most frequent 
lesion. The lungs showed a variable score, in fact we observed 
severe interstitial pneumonia in subject with no also confi rmed 
PMWS , probably related to the diff use infection of PRRSV as de-
scribed previously. The results obtained from the analysed farms 
suggest to emphasize the role of PRRSV and the importance to 
keep it under control.
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Introduction
Porcine circovirus type 2 (PCV2) is a small DNA virus and is 
resistant to inactivation [1]. Spray-dried plasma (SDP) of porcine 
origin is widely used in modern swine production to improve 
growth and health. However, SDP has been proposed as a pos-
sible source of PCV2 transmission. Recently, PCV2 transmission 
was demonstrated using experimentally produced SDP from a 
clinically diseased pig and a laboratory spray-dryer [2]. Currently 
available results on infectivity of PCV2 present in commercial 
spray-dried products are confl icting and to date the import-
ance and impact of this route of PCV2 transmission is not fully 
understood. The objectives of this study were (1) to determine 
the amount and variation of PCV2 DNA and antibodies in com-
mercial spray-dried plasma products from diff erent geographic 
regions in the U.S. and (2) to determine if naïve pigs fed a diet 
containing 4% inclusion rate of PCV2-PCR positive commercial 
SDP become infected with PCV2.
Materials and Methods
Samples from 2 spray-drying facilities located in the US were col-
lected weekly for a 3 wk collection period. The samples included 
plasma from 14 diff erent slaughterhouses (PSla) representing 
the major swine producing regions across the US. Samples were 
collected from liquid pooled plasma as it entered the spray-
drying facility. In addition, concentrated plasma (Pliquid) and 
SDP (PDry) were collected at four diff erent time points in the 
process. The samples represented approximately 60% of a single 
day’s US swine slaughter. All samples were subjected to PCV2 
ELISA and quantitative PCV2a/b real-time PCR [3]. A feeding 
trial was conducted in order to further evaluate the infectivity 
of the PCV2 DNA present in commercially produced spray-dried 
porcine plasma. Nine PCV2 naïve pigs (65 kg BW) were randomly 
assigned to 1 of 3 groups of 3 pigs each including (1) negative 
controls, (2) positive controls, and (3) SDP pigs. The positive con-
trols were inoculated with an infectious PCV2 stock inoculum. 
Negative and positive control pigs were fed a diet free of animal 
proteins. The SDP pigs received a diet with 4% spray-dried por-
cine plasma for entire duration of the study. The SDP utilized in 
the feeding trial was selected based on presence of PCV2a and 
PCV2b DNA as determined by PCR. Blood was collected weekly 
from the pigs and the experiment was terminated 42 days post 
inoculation. 
Results
All collected samples (PSla; PLiquid; PDry) were positive for anti-
PCV2 IgG when tested with the PCV2 ELISA. In general, there was 
no signifi cant diff erence found between the S/P values of the 
PSla, PLiquid and PDry samples. PCV2a DNA was found in 0/52, 
0/32 and 2/32 of the PSla, PLiquid and PDry samples, respective-
ly. In contrast, PCV2b DNA was found in 31/52, 22/32 and 16/32 
of the PSla, PLiquid and PDry samples, respectively. Concurrent 
presence of PCV2a DNA and PCV2b DNA was found in 13/52, 
1/32, and 7/32 of the PSla, PLiquid and PDry samples respect-
ively. In the feeding trial, the positive control pigs became PCV2 
DNA positive by 7 days post inoculation and remained posi-
tive. In contrast, negative control pigs and SDP pigs remained 
PCV2 PCR negative through 28 days of the trial. The trial is still 
ongoing at the time of abstract submission and fi nal results will 
be presented. 
Discussion
The high prevalence of PCV2 antibodies in pooled plasma col-
lected in slaughter facilities from healthy animals across the U.S. 
is consistent with previous reports. Whereas PCV2a DNA was 
found only in a few of the SDP batches, most plasma samples 
tested were positive for PCV2b. This was similar across all stages 
in the SDP production process. This fi nding is especially interest-
ing as most grow-fi nish pigs in the U.S. are vaccinated against 
PCV2 (using a PCV2a-based product) and potentially indicative 
of a lack of thorough cross-protection between genotypes. Pre-
liminary results indicate that highly susceptible, PCV2 virus- and 
antibody-naive specifi c-pathogen-free pigs fed a high concen-
tration of spray-dried PCV2 DNA positive plasma over at least 
28 days remained PCV2-free. This evidence suggests that the 
commercial spray-drying process employed in the US is eff ective 
in eliminating the infectivity of PCV2, likely among the most dif-
fi cult pathogens to inactivate. 
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Introduction
Porcine circovirus associated diseases (PCVAD), caused by 
porcine circovirus type 2 (PCV2), has been considered one of the 
most important disease in swine industry worldwide. The char-
acteristic immunosuppressivity of the virus predisposes the host 
to secondary infections, increasing mortality in herds and the 
cost of production. Despite many eff orts, there are many ques-
tions to answer about occurrence, pathogenesis and epidemiol-
ogy of the infection yet, especially in Brazil. With the purpose to 
identify PCV2 DNA in the pigs from intensive production system 
in the State of Goiás, Brazil, a retrospective investigation on 
paraffi  n-embedded organs samples which had been submitted 
to histopathological diagnosis in Laboratory of Animal Pathol-
ogy (LAP / UFG) of Veterinary School of Federal University of 
Goiás was performed. 
Materials and methods
A total of 42 samples from 26 pigs necropsied during 2000 to 
2002 , were chosen from the archival collection of the LAP / 
UFG based on typical histopathological lesions of PCVAD, such 
as lymphadenopathy, interstitial pneumonia, hepatitis, enter-
itis and/or interstitial nephritis. Blocks are cutted in sections of 
10μm thin. First, sections were deparaffi  nized as described in 
Ciacci-Zanella et al (2006) and after, tissues were submitted to 
DNA extraction with standard phenol protocols. A polymerase 
chain reaction (PCR) using specifi c primers for the ORF2 of the 
PCV2 DNA according Kim et al. (2001) was used to amplify a 
PCV2 ORF2 fragment. A sample of PCV2 achieved from pig with 
clinical signs and lesions of porcine circovirosis (Barthasson, 
2009) was used as positive control and ultrapure sterilized water 
was used as negative control. 
Results
Specifi c PCV2 ORF2 DNA fragment were detected in 20 (47.61%) 
out of 42 samples from 17 (65,4%) animals. No samples of eight 
from 2000 analyzed showed positivity. In the samples obtained 
from 2001, 8 samples (66.7%) from 15 blocks were positive. 
These samples were picked up from 4 out of 5 pigs. Viral DNA 
was found in kidneys (n=2), spleen (n=2), liver (n=2), lymph 
nodes (n= 1), and lung (n=1). In 2002, viral DNA has been found 
in 12 (63.15%) out of 19 samples. Twelve out 13 pigs were posi-
tive. PCV2 DNA was found in lung (n=3), lymph nodes (n=3), 
liver (n=2), spleen (n=2), tonsils (n=2) and intestine (n=1) tissue 
fragments. 
Discussion
The state of Goiás is the third largest swine’s producer in Brazil. 
So far, porcine circovirosis was not confi rmed by any molecular 
or virologic test in this region. The results found in our study, 
confi rm the clinical and pathological evidence of PCV2 infec-
tion in Goiás. Although other Brazilians’ studies showed that the 
PCV2 is present in the country since 1968, we did not analyze 
samples prior 2000, but we can point that PCV2 circulates in 
Goiás pig herds at least since 2001. Other study conducted in 
back yard pigs from Goiás had already identifi ed PCV2 DNA in 
tissue samples, but to our knowledge, this is the fi rst identifi ca-
tion of PCV2 DNA in tissue from swine intensive production sys-
tem in the state of Goiás with clinical and pathological evidence 
of PCVAD. 
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Phylogenetic characterization of porcine circovirus type 2 in Brazilians between 2002 and 2009
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Introduction
Porcine circovirus type 2 (PCV2) is a non-enveloped, circular, 
single-stranded DNA virus of approximately 1.76 kb, belonging 
to the genus Circovirus in the family Circoviridae. The genome 
encodes three major open reading frames (ORFs) encoding the 
replicase proteins (ORF1), the viral capsid protein (ORF2), and a 
protein with suggested apoptotic activity (ORF3). The cap gene 
is considered a reliable phylogenetic marker for PCV2 strains 
since it was able to reconstruct the same tree as the whole viral 
genome (3). The aim of this study is to determine the clustering 
of PCV2 detected over this 7-year.
Materials and Methods
Twenty four ORF2 sequences were selected and multiple-
aligned with representative sequences of ORF-2 PCV2 available 
at the GenBank database using Clustal X v. 1.8. The analyses 
were with the following samples: 5 from 2002 (am2; am5; am13r; 
am22R; am25R); 6 from 2003 (am10; am3; am5; am9; am4; amC); 
4 from 2004 (am13; am15; am16; am21); 5 from 2007 (am148k; 
am182k; am61k; am62k; am7k) and 3 from 2009 (CINamF3; 
CINamF4; CINamF7). The identity among sequences at nucleo-
tide and aminoacid levels was determined using BioEdit v.7.0.5. 
The phylogenetic tree was performed using the distance based 
Neighbor-joining method and substitution Kimura 2-parameters 
model in the Mega v.2 package (Bootstrap 1000). 
Results
Variations in the aminoacid composition among the 24 sequen-
ces were distributed across the whole capsid protein sequence, 
but more concentrated between the 57 and 91 position. In the 
sequences from this study the most substitutions was observed 
in 57, 63, 80, 86, 88, 89, 91, 151, 190 and 191 position. Interest-
ingly, these regions were almost located in putative epitope 
domains of PCV2 capsid protein (Fig 1). The 24 sequences are 
distributed within both subgroup (PCV2-1 and PCV2-2) since 
2002 (e.g. am22r and am25R). Most of the sequences (14/24) 
are grouped in PCV2-1A/B group and one (am6) is in PCV2-2D 
group.
Discussion
This study confi rms that both, PCV2-1 and PCV2-2 are circulating 
in Brazilians swine herds since 2002 (1). The sequences obtained 
from samples collected recently (2007 – 2009) are grouped in 
PCV2-1 group. However some sequences (old and new) are still 
without classifi cation, creating a separated group within both 
PCV2 group (PCV2-1 and PCV2-2).
Figure 1: Variability of the amino acid sequence of ORF2 (Cap). The 
indicated sequence is a consensus from an alignment of the 24 Brazil-
ians sequences of PCV2ORF-2. The grey block represents the immuno-
genic regions identified by PEPSCAN (2). 
Figure 2: Neighbour-Joining tree of the PCV2 ORF-2 region. Numbers 
indicates values calculated on 1000 repeats of the alignment with the 
heuristic method. The following sequences were published (Am25R; 
Am13R; Am22R; AmC) (1)
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Eﬃ  cacy of Circumvent® PCV preventing PCVAD and maintain growth performance 
during an outbreak of PRRSv in a Canadian pig herd with a history PCVAD
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Introduction
The effi  cacy of Circumvent® PCV (Intervet Schering Plough 
Animal Health) was demonstrated during the severe PCV2 dis-
ease outbreaks in Canada (de Grau et al., 2007). Many off  these 
outbreaks involved co-infections with PRRSv, SIV, Mycoplasma 
hyopeneumoniae and other bacteria (Carman et al., 2006). 
PRRSv plays an important role in enhancing PCV2 replication 
and PCV2 viremia (Rovira et al., 2002). The objective of this fi eld 
trial was to compare the effi  cacy and performance of Circum-
vent® PCV in comparison to unvaccinated control pigs. A severe 
PRRSv outbreak occurred during the vaccination trial.
Materials and Methods
The trial was carried out using a randomized, non-blinded 
and controlled design. In total, 350 pigs were selected and ear 
tagged at three days of age (D) and allocated to one of two 
treatment groups, vaccinated (VAC) or control (CON) n = 175 
pigs. Vaccinations were performed per label recommendations 
at weaning (~18 D) with a booster 3 weeks later. All pigs were 
weighed at 3 D, weaning, end of nursery (56 D), 106 D, 143 D 
and slaughter (165 D). Individual pig treatments were recorded 
for assessing morbidity. A post mortem was performed on every 
dead pig. Blood samples were collected from 12 pigs per group 
at 3 D, end of nursery, 120 D, and slaughter to evaluate antibody 
titers by ELISA and viremia by qPCR. Viral presence in the nose 
at 120 D and slaughter and feces at slaughter was determined 
in the same pigs. All pigs were observed for local and systemic 
reactions during the fi rst 72 hours after each vaccination. At 
slaughter, carcass quality information was retrieved.
Results
Due to the PRRSv outbreak in the nursery, birth to fi nish mortal-
ity was approximately 14 % and did not diff er between treat-
ment groups. PRRSv was confi rmed by laboratory analysis (PCR, 
genotyping, histopathology) and caused a mortality peak in the 
fi rst third of the fi nisher stage. VAC pigs did not develop PCVAD 
and only CON pigs exhibited gross and microscopic lesions 
compatible with PCV2 infection. ADG, ELISA titers and viremia 
diff ered between the groups. In the fi nisher (20 to 120 Kg), ADG 
was 948g for CON pigs vs. 973g for VAC pigs (25 g diff erence). 
However, the diff erence in ADG between the groups during 
the highest PCV2 viremic period (106 D to slaughter) was 40 g 
(1,053g vs. 1, 013g). Grower-fi nisher ADG was lower in viremic 
pigs in the sampled group (925g) in comparison to non-viremic 
sampled pigs (994 g). ELISA titer patterns diff ered between CON 
and VAC pigs as CON pigs were seronegative during the disease 
challenge. PCV2 viremia was fi rst detected in CON pigs at 56 
D while no viremia was found in VAC pigs before the second 
dose or during the remaining of the grower-fi nisher period. At 
slaughter, 91% of CON pigs were viremic whereas low levels of 
PCV2 DNA were detected in 2 VAC pigs (17 %) (10E+04 genome 
copies) (p < 0.001). Nasal and fecal samples were qPCR positive 
for all pigs sampled. The CON pigs had much higher viral load in 
the nose. 
Discussion
The animals used in this trial originated from a pig fl ow that 
had been vaccinated to prevent PCV2 infection for more than 
18 months and PCV2 challenge appeared to remain high based 
on the reduced performance in CON pigs and the presence of 
PCV2 in feces and nose indicating a constant challenge due to 
shedding mainly by CON pigs. Vaccination appears to be an 
important tool to reduce shedding and prevent viremia even 
in presence of severe PRRS challenge. VAC pigs maintained an 
adequate ADG. Quantitative ELISA titers and qPCR levels appear 
to provide a good predictor and indicator, respectively of PCV2 
viremia prevention in vaccinated pigs.
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Comparative Eﬃ  cacy of Ingelvac CircoFLEX®-Ingelvac MycoFLEX® Combined vaccine 
versus Circumvent PCV2™ and Respisure ONE® in a Commercial Herd
Martin Misener
Linwood Veterinary Services, Linwood, ON, Canada
Introduction
Mycoplasma hyopneumoniae (Mhyo) vaccines have been 
routinely used in the growing pig population in North America 
for nearly two decades. Porcine circovirus type 2 (PCV2) pig vac-
cines quickly became incorporated as standard vaccination for 
growing pigs once their availability was established. Since vac-
cination against Mhyo and PCV2 is widespread for the growing 
pig it was a logical extension that these two vaccines would be 
combined to be delivered in a single shot (1). 
The objective of this study was to compare an off -label regimen 
which was being commonly used by veterinarians in Ontario at 
the time of the study to vaccinate against PCV2 and Mhyo with 
a combination recently licensed in Canada and the US, Ingelvac 
CircoFLEX-MycoFLEX. Effi  cacy and production parameters were 
evaluated in this study. 
Material and Methods
This study was conducted in an 1500-sow, commercial produc-
tion herd in Ontario, Canada, weaning about 600 pigs weekly 
at three weeks of age. A total of 1064, three-week-oil pigs were 
divided into two groups. 
Group 1: On the day of weaning, 532 pigs were vaccinated with 
1 mL of Circumvent PCV2™ and 1 mL of Respisure ONE®, both 
vaccines mixed in a single syringe and delivered as a single dose. 
Group 1 pigs were revaccinated 
three weeks later with 1 mL of Circumvent PCV2 and 1 mL of 
Respisure ONE®. Again, both vaccines were mixed in a single 
syringe and delivered as a single dose. Group 1 pigs received an 
off -label regimen which was being commonly used by veterinar-
ians in Ontario at the time of the study. 
Group 2: On the day of weaning 532 pigs were vaccinated with 
1 mL of Ingelvac CircoFLEX® and 1 mL of Ingelvac MycoFLEX® 
as a single 2 mL combined dose. After vaccination pigs were 
moved, over a two-week period to fi ll a one-room fi nisher barn. 
Group 1 pigs were placed in pens on one side of the barn and 
Group 2 pigs placed in pens on the other side of the same room 
in the barn, all pigs sharing the same airspace, and feed delivery. 
Measurements were average daily gain total weight gain, (ADG), 
feed conversion (FC) mortality, and carcass grade.
Results
At marketing, the end of the study period, total weight, ADG, FC 
and mortality were 136.6 kg vs 133.2 kg, 880.5 g/day vs 822.8 
g/day, 2.658 vs 2.742 and 2.63% vs 8.46%, for Group 2 –vaccin-
ated pigs vs Group 1 pigs, respectively (Table 1). Group 2 pigs 
attained a carcass grade of 103.0 vs 104.0 for Group 1 pigs. 
(Table 1). Group 2 pigs went to market 4.7 days faster than group 
1 pigs. Cost/ kg of gain was calculated to be 92.4c for Group 2 
pigs vs 95.3c for group 1 pigs (Table 1). The net advantage for 
vaccinating with the combined Ingelvac CircoFLEX-MycoFLEX® 
calculated to be $6.38 per pig.
Table 1. Production parameters for Circumvent PCV2™ and Respisure 
ONE® vaccinated pigs (group 1) vs Ingelvac CircoFLEX-MycoFLEX® 
(group 2).
Parameter Group 1 Group 2
# of pigs 532 532
Wt In (kg) 26.7 26.7
Wt Out (kg) 133.2 136.6
Wt Gain (kg) 106.5 109.6
ADG (g) 822.8 880.5
Feed conversion 2.742 2.658
Days to market 129.5 124.8
Grading 104.0 103.0
Mortality (%) 8.46 2.63
Cost/kg gain ($) 0.953 0.924
Loss/pig ($) 28.60 21.45
Vaccine cost ($) 1.28 2.02
Extra labour ($) 0.10
Net Advantage ($) - 6.38
Discussion and Conclusions
In this study, ADG was 57.7 g greater, total weight gain was 3.4 
kg more and days to market were 4.7 days faster for the Ingelvac 
CircoFLEX-MycoFLEX®-vaccinated pigs vs Circumvent PCV2™ 
and Respisure ONE® vaccinated pigs, respectively resulting in 
an overall net advantage of $6.38 for the Ingelvac CircoFLEX-
MycoFLEX®-vaccinated pigs. 
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Eﬀ ect of Ingelvac CircoFLEX® on the live weight and uniformity of pigs in a herd with mild PCVD
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Introduction
Infections with Porcine Circovirus Type 2 (PCV2) are widely dis-
tributed in the Belgian pig population, however in many cases 
without obvious clinical symptoms. The objective of this study 
was to determine the eff ect of PCV2 vaccination in a herd with 
mild PCVD. 
Materials and Methods
The trial was performed in a Belgian gilt multiplying herd. 
Two years earlier, severe PCVD problems were observed in the 
herd. The problems concerned high mortality at the end of the 
nursery and early fi nishing, PMWS and diarrhea. Due to several 
changes in management such as batch farrowing and all-in all-
out management, the problem became milder and at the start 
of the trial there was an absence of clinical signs associated with 
PCV2. 
Sows farrowed in batches, in a 3 week interval. In total 6 batches 
of piglets were involved in the trial. Of these batches, every 
other batch was vaccinated with Ingelvac CircoFLEX® at an 
average age of 19.5 + 2.1 days. The other batches were left as 
unvaccinated controls. 
The female piglets (future gilts) were individually eartagged and 
followed during the growing period. Individual live weight regis-
tration of the gilts was performed at selection, at an average age 
of 176.7 days for the Ingelvac CircoFLEX® and 176.3 days for the 
unvaccinated control group.
Results
At 25 weeks of age, the vaccinated pigs had a 7.5 kg higher live 
weight compared to the unvaccinated control animals (P<0.001) 
and there was a trend towards a lower variance (P=0.078) in the 
live weights of the vaccinated group (table 1). Both the higher 
live weight and better uniformity in the Ingelvac CircoFLEX® 
group are refl ected in fi gure 1. The distribution of live weights 
of the vaccinated animals is shifted to the right, indicating the 
7.5 kg higher live weight and is narrower, indicating the better 
uniformity of the animals.
Table 1 Live weight of gilts at 25 weeks of age
Control Ingelvac CircoFLEX® P-value
Mean live weight (kg) 114.4 121.9 <0.001*
Variance 185.9 157.2 0.078**
Standard Deviation 13.6 12.5 ——
N° of animals 165 192 ——
* t-test ; **Levene test for homogeneity of variances
Figure 1 Live weight distribution of gilts at 25 weeks of age
Discussion
The results of this fi eld study show that even in mild cases of 
PCVD, with no apparent clinical signs, PCV2 vaccination can 
result in a signifi cant improvement of production parameters 
such as daily gain. This better daily gain with tendency towards 
better uniformity may be a decisive argument for the use of the 
vaccine, in order to have an optimal expression of the genetic 
potential of gilts. 
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Safety of a single 2ml dose of Porcilis® PCV administered to pigs of 3 weeks 
of age under ﬁ eld conditions on a farm with conﬁ rmed PMWS
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Introduction
Porcine Circovirus type 2 (PCV2) infection is regarded as an 
important, but not the only, causative factor in the develop-
ment of Porcine Circovirus Disease (PCVD) in piglets. Many 
other pathogens, management factors and as well as immune-
stimulating compounds (Krakowka, 2001; Grasland, 2005) have 
been mentioned as contributory to the clinical expression of the 
disease. 
PCVD can occur in pigs of diff erent ages and under fi eld 
conditions, and the timing of the PCV2 virus infection is often 
unknown. Pigs are normally vaccinated early in life against PCVD 
all over the world. 
The object of this study was to demonstrate the safety of a po-
tent adjuvated vaccine (Porcilis PCV) in piglets of 3 weeks of age 
in the presence of PCV2 fi eld virus. 
Materials and Methods
The farm was selected because it had suff ered an outbreak of 
PCVD, confi rmed by clinical and post mortem investigations 
according to the guideline “PMWS case defi nition (herd level)”. 
PCV2 DNA was detected in pigs by Q-PCR prior to and during 
the study. 
In all, 2.5 production batches (517 piglets) were vaccinated 
and the parameters measured were compared with a reference 
group of 696 unvaccinated piglets from previous production 
batches. 
Porcilis PCV is a sub-unit vaccine containing the capsular pro-
tein coded by ORF2 of PCV2 virus in an adjuvant consisting of 
α-tocopherol and light mineral oil (X-Solve®). The product was al-
lowed to reach room temperature (20 -250C) and shaken before 
use. A 2ml dose was administered to piglets of 15-21 days of age 
in the farrowing unit, by intra-muscular injection with a needle 
25mm long. 
Sows were routinely vaccinated against PRRS, Parvo, Erysipelas, 
Glässer, E.coli, Clostridium and Infl uenza. Piglets were treated 
with amoxicillin on day 1 and on days 3-5 and with iron. No 
other vaccines were given concurrently.
The piglets were scored for local and systemic (general health) 
reactions at the time of vaccination, 4 hours later, and on Day 7 
and Day 14 following vaccination . Food intake was also scored 
during the same 14-day period. 
The individual pig served as the statistical unit and descriptive 
statistics were used to present and summarize the data. Mortal-
ity data were recorded for the whole period up until slaughter, 
as a general indication of the eff ect of vaccination on perform-
ance 
All management and other factors remained the same for the 
whole time the reference group and the trial group were on the 
farm. 
Results 
All piglets were healthy before the start of the study. 
Local reactions: none of the 517 piglets vaccinated with Porcilis 
PCV showed any reaction during the 14-day observation period.
Systemic reactions and general health: none of the 517 piglets 
vaccinated with Porcilis PCV showed any systemic reaction or 
deviation from normal health during the 14-day observation 
period.
Feed intake was normal for the age of the pigs, which reinforced 
the assessment of their good general health.
Mortality: the mortality in the reference group (n=696) was 
5.19%, 6 pigs died and 30 were culled. In the Porcilis PCV vac-
cinated group (n=517), 11 piglets died (2.13%) and none were 
culled.
Discussion 
Porcilis PCV is a highly effi  cacious vaccine based on the immuno-
genic capsular protein of PCV2 virus, with X-Solve as a potent 
adjuvant. This study shows that Porcilis PCV, although highly 
immunogenic, can be used safely on farms with confi rmed PCVD 
(PMWS). No adverse eff ects of the immune-stimulation, as de-
scribed by Krakowka, were noted, which accorded with Astrup’s 
(IPVS 2010) report of a safety study executed in Denmark involv-
ing diff erent breeds.
However, the package leafl et of Porcilis PCV (EMEA 2009) does 
contain a warning of possible local and systemic reactions fol-
lowing injection, and Astrup (IPVS 2010) found such reactions. 
It appears that diff erences between farms, and the health of the 
piglets at the time of vaccination, account for the diff erences in 
the degree and extent of the side-eff ects of vaccination (data on 
fi le). Nevertheless, the incidence of these side-eff ects is low, and 
piglets recover completely when no other debilitating factors 
are present. 
This study confi rms the safety of Porcilis PCV. The importance of 
the handling and administration of the vaccine in strict accord-
ance with the manufacturer’s instructions cannot be over-esti-
mated, and should always be brought to the attention of anyone 
involved in its administration. 
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Immunogenicity of “DS Circo Pigvac” in the Various Levels of Maternal 
Antibodies against Porcine Circo Type 2 virus ( PCV-2 ) 
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Dae Sung Microbiologicals Co. Ltd., Eui Wang, Kyung Ki Do, Korea
Introduction
Currently available circo vaccines in the market are classifi ed into 
two types. 
One type is vaccine for piglet mostly at three weeks old; another 
type is claimed for sow. 
The reasons for the claims can probably be attributed to the 
absence of the eff ective evaluating methods for the antibodies 
against circovirus after vaccination. 
In order to evaluate the immunogenicity of “DS Circo Pigvac,” we 
developed immunofl uorescent assay (IFA) against circovirus and 
applied to the fi eld test in post-weaning piglets with the various 
level of maternal antibodies after vaccination in the fi eld.
Materials and Methods 
1) Each group of piglets of 3 weeks old born from sero-positive 
sow against PCV-2 was selected and housed to estimate the 
level of the maternal antibodies in the isolator. 
2) A total 60 piglets of 3 weeks old were tested for the initial 
level of the maternal antibody titers against PCV-2 and mon-
itored for their antibody trends after vaccination. 
Results 
1) The maternal antibodies against PCV-2 were rapidly de-
creased in piglets. Initially log210 titer by IFA was decreased to 
log27 at 6 weeks old piglets. The piglets of negative titer showed 
the increase of antibody titer from 14 weeks due to the natural 
PCV-2 infection (Table 1). 
Table 1: Comparison of PCV-2 Maternal Antibodies ( MAb ) between 
Acquired and Naturally Infected Titer in Piglets 
Pig No. / 
Weeks Maternal 
Anti-
bodies  Titer by IFA(log2)
3 6 8 10 12 14 16
1 11 9 7 5 <3 <3 <3
2 10 7 6 <3 <3 <3 <3
3 9 6 <3 <3 <3 11 12
4 8 5 <3 <3 <3 12 12
5 7 <3 <3 <3 <3 12 >12
6 <3 <3 <3 <3 <3 11 12
2) The immunogenicity of “DS Circo Pigvac” in 3 weeks old 
piglets revealed that while piglets with maternal antibodies titer 
lower than log28 showed the increased antibody titers from 6 
week, the group with higher than log29 from 10 week after vac-
cination ( Table 2 ). 
Table 2. Immune Responses of “ DS Circo Pigvac “ Vaccination in 3 
Week-Old Piglets Showing Diff erent MAb Titer 
MAb / Weeks Titer after Vaccination by IFA(log2)
3 6 10 16
log210 10.00 6.25 7.25 11.00
log29 9.00 4.75 1063 10.50
log28 8.00 8.43 10.71 10.86
log27 7.00 10.22 10.78 11.00
Discussions 
Since the maternal antibodies was rapidly disappeared and 
showed the variable antibody levels by the colostral intake, the 
preventive strategies through maternal antibodies is not proper. 
Even in “DS Circo Pigvac” which has the enough antigen amount 
was also interfered with the immune responses of piglets about 
the maternal antibody titers more than log29 . 
However, it was found that the antibody titers were increased 
in piglets at 10 week mainly results from the oil adjuvant based 
formula. This result indicated the oil adjuvant effi  cacy in PCV-2 
vaccination. 
Moreover, the present data suggest the vaccination on pregnant 
sow is not proper strategy for the preventive measures against 
PCV-2. 
For the eff ective PCV-2 protection in the sow claim, actually pre-
mating vaccination is recommended than pre-parturition from 
our side.
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Field trial comparing two PCV2 vaccines on a farm with late PCV2 infection
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Introduction
This study took place on a farrow-to-fi nish farm of 700 sows 
in France. In Q3 2008, the mortality rate in fattening reached 
5.8% and average daily gain (ADG) over the same period 794 
g/d. Circovac® vaccination was routinely implemented in sows 
(2ml) since 2006 and in piglets of four weeks of age (0.5ml) since 
September 2007. A screening of the farm in September-October 
2008 demonstrated that the PCV2 infection was particularly 
high at the end of fattening. Necropies revealed typical PMWS 
lesions in lymphoid tissues which were also positive for PCV2 
antigen by IHC. From that time point, due to the continued oc-
currence of PMWS cases, the veterinarian in agreement with the 
farmer decided to change the routine PCV2 vaccination in pig-
lets to Ingelvac CircoFLEX®. Two months later, a study aiming at 
comparing the ability of both vaccines in preventing the impact 
of the PCV2 infection on growth performances and mortality, 
was implemented. 
Material and methods
The trial was conducted in compliance with the good clinical 
practice. A total of 1185 4-week-old piglets originating from Cir-
covac® vaccinated sows were included over three week groups 
(WG1, WG2 and WG3) and divided into two treatment groups: 
CircoFLEX® group (n=535) was injected with Ingelvac CircoFLEX® 
(1ml IM), Circovac® group (n=548) was injected with Circovac® 
(0.5ml IM). A control group (n=102) was included to demon-
strate presence of PCVD during the trial, control pigs were 
injected with water for injection (1ml IM). Groups were balanced 
with regard to initial body weight and litter assignment. All 
animals from the three groups were co-mingled throughout the 
study ensuring that all animals were under the same housing 
and infection conditions. Approximately 8% of the control ani-
mals were sampled at 5 time points (4, 10, 15, 19 and 22 weeks 
of age) to identify the time and profi le of the PCV2 infection 
by Real-Time PCR. All study animals were weighed three times 
(4, 11 and 23 weeks of age). Weight gain diff erences between 
groups were tested using analysis of variance and subsequent 
t-tests. Mortality between vaccinated groups were compared by 
Fisher’s exact test. 
Results
PCV2 infection was confi rmed to occur after 15 weeks of age 
(study week 11) with a peak at the end of fattening. The pres-
ence of PCV2 was further confi rmed in necropsies (including 
IHC). 
During the fattening period (11 to 23 weeks of age) when the 
PCV2 fi eld infection took place, the mortality was signifi cantly 
reduced in the CircoFLEX® group (1.5%) when compared to 
the Circovac® group (3.7%, p=0.0338). The increase in mortality 
coincided with the onset of viremia (Figure 1). Over the same 
period, the CircoFLEX® and Circovac® groups out-performed 
the control group respectively by 1.75 kg (p=0.0640) and 1.46 
kg (p=0.1226). Weight gain between the two treatment groups 
did not diff er signifi cantly (p=0.5881). When interpreting the 
diff erences between the two treatment groups and the control 
group, it should be taken into account that the control group 
was primarily included for epidemiological reasons and only 
comprised 102 pigs.
Figure 1: Cumulative mortality in fattening.
Discussion
The presence of PCVD on the farm and the late onset of PCV2 
infection were confi rmed in control animals during the study, 
demonstrating that sow vaccination does not protect pigs 
through to slaughter. In addition, Ingelvac CircoFLEX® provided 
superior protection compared to Circovac® used in piglets, as 
shown by a signifi cant reduction in mortality. A signifi cant dif-
ference in weight gain between the two treatment groups was 
not expected as the PCV2 infection occurred late. Furthermore, 
it is likely that the higher mortality rate in the Circovac® group 
positively infl uenced the weight gain by eliminating the poor 
doers from the calculation. Beside the study results, the superior 
effi  cacy of Ingelvac CircoFLEX® is confi rmed by the consistently 
good performance after implementing piglet vaccination with 
Ingelvac CircoFLEX®. Indeed, in Q2 and Q3 2009 when all pigs 
where vaccinated with Ingelvac CircoFLEX® mortality in fat-
tening was 3.1 and 3.8%, compared to 4.9 and 5.8% in Q2 and 
Q3 2008 when only Circovac® vaccinated pigs where present, 
refl ecting a reduction in mortality of about 2%, very similar to 
what has been observed in this side-by-side study. 
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Value through vaccination: vaccination against ileitis and PCV2 in a Danish herd
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Introduction
Vaccination against either ileitis (1) or PCV2-virus (2) has proven 
to be economically effi  cient tools to increase the performance of 
pigs infected with ileitis or PCV2. Many herds are infected with 
both organisms, and the question is, whether the economical 
benefi ts will hold when using the 2 vaccines in the same herd. 
This paper evaluates the benefi ts of vaccinating against 
Lawsonia intracellularis and PCV2 in a herd aff ected by both 
pathogens. 
Materials and Methods
The study was carried out in a Danish SPF herd that received 
1000 weaners every 7th week. At 30 kg live weight, pigs were 
moved to fattening units at a diff erent site. Before the vaccina-
tion program, the pigs had reduced average daily weight gain 
(ADWG) and an increase in feed conversion rate (FCR) and mor-
tality. About 10% of the pigs became pale and lost weight at the 
end of the fi nishing period. After blood sampling, a high amount 
of PCV2-virus was detected by qPCR, and antibodies against 
Lawsonia intracellularis were found. Vaccination against PCV2 
and ileitis started at the same time, with Ingelvac CircoFLEX® 
(Boehringer Ingelheim) administered i.m. at 2 weeks of age in 
the sow herd, and Enterisol® Ileitis Vet. (Boehringer Ingelheim) 
given in the drinking water at 4 weeks of age after arrival to 
weaning unit. Every 7th week, production data was collected. 
Comparison of vaccinated and non-vaccinated pigs was done 
with ANOVA for ADWG, FCR and prescriptions of antibiotics, and 
with Fishers Exact test for mortality, using p≤0.05 as signifi cance 
level. The economical benefi t was calculated using key values 
from the Danish Pig Producers Organisation (3).
Results
A statistically signifi cant improvement of the performance 
of pigs vaccinated with the 2 vaccines was recorded for the 4 
parameters (table 1): ADWG, feed conversion, mortality and anti-
biotic expenses (p-values 0.0130, 0.0010, <0.0001 and 0.0156). 
The economic value of the improvements exceeded the vaccine 
cost, with a positive return of investment (ROI) of 1:2.5.
Table 1: Performance of non-vaccinated and double vaccinated fi nish-
ers (Ileitis and PCV2-vaccine). 
Mean/period Non-vacc. Vacc. Diff . Value (€/pig)
ADWG (g/day( 928 972 +44* 0.59
FCR (FE/kg) 2.85 2.72 -0.13* 2.43
Mortality (%) 3.4 1.6 -1.79* 1.34
Antibiotics (€/pig) 2.18 1.02 -1.15* 1.15
Total value 5.50 €/pig
*Values with a signifi cant diff erence (p≤0.05). 
Discussion
This study shows that it is economically benefi cial to vaccinate 
against ileitis and PCV2. Every € spend on vaccines is paid back 
2.5 times due to an increased ADWG and reductions in FCR, 
mortality and antibiotic expenses.
Fig. 1: Mortality of fi nishers before and after vaccination against Ileitis 
and PCV2.
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Introduction
Porcine Circovirus 2-associated disease has clearly become a 
major and complex international problem (1). It is also a com-
mon disease in swine farms in the Philippines. This disease can 
create problems in the farm like increase post-weaning mortality 
(Post W.M.) and decrease average daily weight gain (ADWG). This 
study evaluates the benefi ts of using Ingelvac CircoFLEX on a 
1,100 sow farm.
Materials and Methods
The farm is positive for PCV2, Haemophilus Parasuis, Actinobacil-
lus Pleuropneumoniae, Mycoplasma Hyopneumonia. The farm 
implemented Ingelvac Circofl ex vaccination, 1ml at day 21, in 
December 2008. Weaning day is at day 28-30. The farm records 
from June 2008 to October 2009 were compiled into a longi-
tudinal study. Except PCV2 vaccination, no other major changes 
occurred on the farm The monthly data of ADWG and Post W. M. 
was evaluated through Statistical Process Control (SPC, Statis-
tica v8.0). Data from June – November 2008, December 2008 to 
April 2009 and May 2009 to October 2009 were grouped into 
three periods namely Pre-vaccination, Transition and Vaccination 
respectively. The Transition period was included to ensure that 
only fully vaccinated groups were compared to completely non-
vaccinated ones.
ADWG is evaluated by Simple ANOVA, and adjusted by the Dun-
nett test. Mortality is evaluated using a Chi-square test. All are 
tested for an Alpha value equals 0.05. 
Results and Discussion
The wean-to-slaughter ADWG of the farm during the vaccinated 
period is 545 grams/day. It has improved by 39 grams/day as 
compared to the ADWG during the Pre-vaccination period (p < 
0.0004, fi g. 1). Mortality in nursery was not signifi cantly diff erent 
between the two groups (4.6% vs. 5.9%, p=0.17) In contrast, the 
grow-fi nisher mortality was signifi cantly reduced after introduc-
tion of PCV2 vaccination by 50% from 10.4% to 5.2% (p< 0.004, 
fi g. 2). 
Figure 1. Control chart of growth over the 3 periods.
 
 
Figure 2. Controls chart for the grow-fi nisher mortality over the 3 
periods.
 
Conclusion
Introduction of PCV2 piglet vaccination signifi cantly reduced 
mortality and improved performance on the farm. 
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Eﬃ  cacy of Ingelvac CircoFLEX® in mild forms of PCVD in Thai swine farms
Nathaya Duangwhae; Lerdtida Meedacha; Sopon Kongtes; Jitjaroen Channarong
Boehringer Ingelheim (Thai), Bangkok, Thailand
Introduction
Recently several PCV2 vaccines have been launched in Thailand. 
The introduction of PCV2 vaccines has allowed greater control 
of PCVD. Signifi cant reduction in mortality and improvement in 
fi nishing production parameters of swine herds using a single 
dose PCV2 piglet vaccine, Ingelvac CircoFLEX®, were observed 
throughout Thailand, even though most farms had both PRRSv 
and PCV2 infection. 
The objective of this study was to compare fi nishing perform-
ance parameters in non-vaccinated and Ingelvac CircoFLEX® 
(Boehringer Ingelheim) vaccinated groups of pigs on two farms, 
with low mortality in fi nishing (< 2%).
Material and method
Two conventional, fi nishing pig farms, farm A and B, were in-
cluded in this evaluation. Both farms have used Ingelvac® PRRS 
MLV and are PRRS stable. The piglets in these farms are sero-
logically negative to PRRS up to 16 weeks of age but seroposi-
tive to M. hyopneumoniae and PCV2 virus. Piglets are weaned at 
3 weeks of age, raised in the nursery then moved to the fi nishing 
site when 8-10 weeks old. This study included, 1,152 non-PCV2 
vaccinated pigs (before vaccination) and 1,161 vaccinated pigs 
(after vaccination). Vaccinated pigs received a single dose 1 ml 
IM of Ingelvac CircoFLEX® at 21 day of age. Parameters recorded 
in fi nishing farms included ADG, total losses, mortality and cull-
ing rate, i.e. pigs euthanized before slaughter. The diff erence in 
total fi nishing losses (mortality plus culls) was statistically evalu-
ated using a Chi-square test (Statistica, v.8.0) 
Results 
Performance data of the vaccinated and the non-vaccinated 
pigs are shown in Table1. The ADG of the vaccinated groups was 
higher than in the non- vaccinated groups, +56g on farm A and 
+81g on farm B. Total losses were signifi cantly reduced in vaccin-
ated groups on both farms: 1.65 vs 4.51 % (p=0.002) on farm A 
and 2.69 vs 5.49% (p=0.04) on farm B.
Table1. Performance parameter comparison between vaccinated and 
non-vaccinated pigs.
No. of pigs Mortality (%) Culls (%) ADG (g/day)
Farm A Nx 732 1.78 2.73 664
Vx 721 1.25 0.40 720
Diff -0.53 -2.69 56
Farm B Nx 420 1.19 4.3 720
Vx 440 0.68 2.0 801
Diff -0.51 -2.3 81
Discussion and conclusion 
 Vaccinating piglets with Ingelvac CircoFLEX® in PCV2 infected, 
PRRS stable herds with low mortality improved fi nishing 
performance parameters. This comparison clearly shows the 
economic benefi t of Ingelvac CircoFLEX® under fi eld conditions 
in face of mild form of PCVAD in fi nishing period. 
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Field Experience with a subunit PCV2 vaccine in a Chinese Farm with severe PCVD
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Introduction
Porcine Circovirus type 2 (PCV2) is widespread and is recognized 
as the causal agent of post weaning multisystemic wasting 
syndrome (PMWS) [1] [2]. PMWS was fi rst described in Canada in 
1996. Nowadays PMWS and other PCV2 related diseases (PCVD) 
are present in virtually all pig producing countries [3], causing 
huge losses to the global swine industry if not eff ectively con-
trolled. In China PCVD also has a great negative impact on the 
domestic pig industry. In this study, the effi  cacy of an imported 
PCV2 subunit vaccine was investigated in a severe case of PCVD 
in China. 
Materials and Methods
A one-site production system farm of 1200 sows in Shandong 
suff ered from PCVD. Production performance was severely dam-
aged by the PCV2 infection. High culling and death rates in the 
nursery and fattening stages were the main causes for econom-
ical losses. The farm was positive for PRRSV, PCV2-a, CSFV and 
Haemophilus parasuis (HPS). The farm started piglet vaccination 
against PRRS (Ingelvac® PRRS MLV) and HPS (Ingelvac®HP-1) 
around 7-10 days old from November 2008. However, produc-
tion performance did not recover to the optimum level. In 
January 2009, a side-by-side trial was carried out including a 
total of 800 piglets in two weekly batches. Piglets in the vaccin-
ated group (n=380) received an imported PCV2 subunit vaccine, 
Ingelvac®CircoFLEX, at 14 days old. The control group comprised 
380 non-vaccinated pigs. Average daily weight gain (ADWG), 
mortality and FCR were recorded in nursery and fattening. 
The average daily weight gain (ADWG) was analyzed by t-test, 
mortality by Chi-square test.
Result
The results are summarized in Table 1 (nursery performance) and 
Table 2 (fattening performance). Performance was signifi cantly 
improved in vaccinated pigs, both in nursery and fattening 
stages. In nursery mortality was reduced by about 80%, from 
22.2 to 4.7% in vaccinated pigs, whereas ADWG was improved 
by more than 40g/day. Mortality in fattening was reduced by 
about 70% from 7.4 to 2.3% and ADWG increased by about 70g/
day.
Table 1. Average growth performance (Nursery) 
V.G. C.G. Diff 
ADWG (g/day) 376.5 327.9 +45.7**
Mortality 4.7 22.2 -17.5**
FCR 1.89 2.25 -0.36
*p<0.05 **p <0.01
V.G.: Vaccinated Group C.G.: Control Group
Table 2. Average growth performance (Fattening)
V.G. C.G. Diff .
ADWG (g/day) 774 705 +69**
Mortality (%) 2.3 7.4 -5.1*
FCR 2.66 2.95 -0.29
*p<0.05 **p <0.01
V.G.: Vaccinated Group C.G.: Control Group
Discussion and Conclusion 
In this farm with severe PCVD problems piglet vaccination with 
a PCV2 subunit vaccine showed excellent effi  cacy: it eff ectively 
controlled the negative impact of the PCV2 infection, signifi -
cantly reduced PCV2 related mortality, improved the ADWG 
in nursery and fattening stages, fi nally stabilized whole herd 
production. Therefore, it can be concluded that proper use of 
PCV2 piglet vaccination can eff ectively control PMWS, PDNS and 
other PCV2 related diseases, with signifi cant benefi ts for Chinese 
pig farms. 
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Serological timeline of Circumvent® PCV and MycoSilencer® ONCE compliance monitoring
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Introduction
Previously it has been shown that the PCV2 Diff erential ELISA 
and Mycoplasma Tween 20 ELISA available at Iowa State Univer-
sity, Veterinary Diagnostic Laboratory (ISU-VDL) can be useful 
tools for vaccination compliance monitoring.1,2 Further value 
could be gained if these tools could be used retrospectively in 
an investigative manner to determine if groups of sick pigs had 
not been vaccinated properly. Accordingly, the objectives of this 
study were to determine the longevity of vaccine induced anti-
bodies and potential development of “background” antibodies.
Materials and Methods
A total of 150 pigs from 30 litters were used. Within each litter, 
one pig (control – CON) was vaccinated at weaning (3 weeks of 
age) with single dose PCV2 and Mycoplasma hyopneumoniae 
(Mhyo) vaccines that do not induce measurable antibodies. 
The other 4 pigs were vaccinated with Circumvent® PCV and 
MycoSilencer® ONCE at weaning and 21 days later (VAC). At 15 
weeks of age, 15 CON and 25 VAC pigs were vaccinated with 
Circumvent®PCV and are designated as RE-CON and RE-VAC, 
respectively.
All samples were tested at the ISU-VDL by PCV2 Diff erential 
ELISA and Mhyo Tween 20 ELISA.3,4 The PCV2 test was modi-
fi ed to measure antibodies to the baculovirus portion of 
Circumvent®PCV. In addition, the BV titer (BV S:P) is reported as 
an S:P ratio generated by dividing the BV optical density (OD) 
value by the OD value of serum pool obtained from Circumvent® 
PCV vaccinated, CDCD pigs. The positive/negative cut-off s were 
0.250 and 0.240 for the PCV2 and Mhyo ELISAs, respectively.
Results
The BV S:P results are presented in Table 1. Four weeks after the 
second Circumvent® PCV, 95.8% of the pigs were positive while 
none of the controls were positive. Control pigs remained nega-
tive throughout the study while the BV titers of vaccinated pigs 
declined. Re-vaccination greatly boostered BV titers in previ-
ously vaccinated pigs and controls showed some titer increase.
The Mhyo titer results are presented in Table 2. Four weeks after 
the second vaccination, 85.0% of vaccinated pigs were positive 
while none of the controls were positive. The seroconversion 
rate in vaccinated pigs was 73.3% and 88.9% for seropositive 
and seronegative pigs at 3 weeks of age, respectively. Most vac-
cinated pigs remained positive while 51.1% of the control pigs 
seroconverted.
Discussion
The data provides fi eld based confi rmation of the usefulness of 
the two ELISAs for monitoring vaccination compliance for both 
vaccines when pigs are sampled 4 weeks after their second vac-
cination. For retrospective investigations, interpretation of data 
is less straightforward based on the decline in BV titers over time 
and the frequent fi eld exposure of pigs to Mhyo.
Table 1. Baculovirus titer over time
Age Group BV S:P No. Pos.
3 (wks) VAC 0.012 3/120
CON 0.012 0/30
10 VAC 0.624 115/120
CON 0.043 0/30
15 VAC 0.316 59/120
CON 0.032 0/30
19 VAC 0.190 24/99
CON 0.023 0/14
RE-VAC 1.033 20/20
RE-CON 0.242 6/14
Table 2. Mhyo titer over time
Age Group OD Value No. Pos.
3 (wks) VAC 0.176 31/120
CON 0.180 10/30
10 VAC 0.480 103/120
CON 0.027 0/30
15 VAC 0.466 99/120
CON 0.062 1/30
19 VAC 0.832 115/119
CON 0.361 16/28
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Introduction
PCV2 related diseases (PCVD) have fi rst been described in 
Canada in 1996, and nowadays are a major threat to the global 
swine industry. PCVD can have a huge economic impact on 
farms via increased mortality, reduced growth rate and poorer 
feed effi  ciency. Prevalence in China can reach up to 100%[1].The 
purpose of this study was to evaluate effi  cacy of a single-dose 
PCV2 vaccine (Ingelvac CircoFLEX®, Boehringer Ingelheim) on a 
PCVD aff ected farm in Northern China. 
Materials and Methods
The study was conducted on a single site, farrow-to-fi nish farm 
of 1800 sows in Shandong. The farm was PRRSv positive. Clinical 
signs on the farm included: Fever, thumping, jaundice, growth 
retardation, wasting, lethargy can be observed. Herd perform-
ance improved when vaccination with Ingelvac® PRRSV MLV was 
introduced, but did not reach an optimal level and was variable. 
Further diagnostics confi rmed presence of PCV2. Based on that 
a fi eld study was initiated, with a total of 693 pigs comprising 
two weekly batches. Half of the pigs (n=347) received a single 
dose (1 ml) of Ingelvac CircoFLEX® at 3 weeks of age, while the 
other half (n=346) remained unvaccinated and served as control 
group. Pigs were weighed individually at weaning, transfer into 
fattening and at slaughter. Mortality was recorded in nursery 
and fattening stages. Feed consumption was measured per 
group to determine FCR (feed conversion ratio). ADG in the two 
groups were compared with t-test and mortality by Chi-square.
Results
The results (Table 1 and Table 2) indicate signifi cant improve-
ments of vaccination groups in both nursery and fattening 
stages. During the nursery phase, ADG (average daily gain) in 
the vaccinated group improved by +40g/d improvement and 
mortality was reduced from 13.7% to 9.2% reduction; in the fat-
tening phase as well, the vaccinated group showed signifi cant 
advantages compared to the non-vaccinated group (+34g/d 
ADWG, -9.5% in mortality). 
The high mortality in the nursery during this trial, even in the 
PCV2 vaccinated groups, can be explained by a PEDV outbreak 
in the fi rst week group. Mortality in nursery in the fi rst week 
group was 16.2% in the vaccinated pigs and 21.3% in non-vac-
cinated pigs. Whereas in the week group mortality in vaccinated 
pigs was only 1.8% and 5.8% in the control group.
Table 1. Performance in Nursery
Vac Control Diff .
Num. of Pigs 347 346 /
ADG (g/day) 407 367 +40*
Mortality (%) 9.2 13.7 -4.4*
FCR 1.84 2.05 0.19
*p<0.05 **p<0.01
Table 2. Performance in Fattening
Vac Control Diff .
Num. of Pigs 314 302 /
ADG (g/day) 694 660 +34*
Mortality (%) 4.1 13.6 -9.5*
FCR 3.22 3.39 -0.17
*p<0.05 **p<0.01
Discussion
Ingelvac CircoFLEX® eff ectively controlled PCVD on the farm and 
signifi cantly improved the production performance of the herd. 
However, the high mortality due to a PEDV outbreak in the nurs-
ery indicates, that only comprehensive disease control strategies 
targeting all major diseases together with good management 
can result in optimal performance. 
References
[1]  Wang Z., Yang H., Guo X., et al (2002) Chinese Journal of Veterinary 
Medicine, 38(10). 
Porcine Circovirus Associated Diseases (PCVAD) – Control
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 353
Poster Presentations
P.047
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Introduction
Piglet vaccination has been proven to be very successful in con-
trolling Porcine Circovirus Type 2 (PCV2) related diseases. Mostly 
vaccination is carried out around weaning. In many cases, vac-
cination has a very positive eff ect already on nursery mortality 
and performance1, and protection last through fi ninishing until 
slaughter. However, it has been shown previously that a single 
dose vaccine, Ingelvac CircoFLEX® can be used successfully at 6 
weeks2 or even as late as 9 weeks3 of age, if pigs get infected in 
grow-fi nish only. In cases where pigs are traded, and are not ac-
cessible for vaccination early, it might be necessary to vaccinate 
piglets at placement into grow-fi nisher.
This fi eld case describes the benefi ts of vaccinating early fatten-
ers against PCV2 on a Korean grow-out farm. 
Material & Method
Two successive weekly batches of pigs, a total of 594 animals, 
were included in this fi eld observation. One batch of pigs 
(n=349) was left non-vaccinated, the next batch (n=245) was 
vaccinated with Ingelvac CircoFLEX, 1 ml i.m., at placement on 
the grow-out farm. Pigs were placed at 71 days with an average 
weight of 29.8kg (controls) or 72 days and an average weight of 
31.3kg (vaccinates) on the farm. Vaccinated and non-vaccinated 
piglets were kept under comparable conditions in two separate 
buildings on the same site and where sourced from the same 
piglet producing farm. Pigs seroconvert to PCV2 between 60 
and 90 days of age, as determined by Synbiotics ELISA. 
Various production parameters, including mortality, ADG and 
medication costs were recorded for the 2 treatment groups 
(Table 1).
Results
Results are summarized in Table 1. 
Table 1: Production parameters.
Control Vaccinates Diff 
Pigs (n) 349 245
Mortality (%) 9.6 6.5 -3.1
Light pigs (%) 3.94 0.81 -3.13
Medication cost (won*/pig) 2515 1050 -1465
FCR 3.14 2.98 -0.16
ADG (g) 670 704 +34
Days in fi nisher (days) 118.5 112.7 -5.8
Interval between fi rst and last 
market day (days) 57 37 -20
Benefi t per pigs (won*/pig) 20,000 29,000 +9,000
*1 $ = 1,150 Korean won 
Discussion and Conclusion
All parameters pointed in favor of the vaccinated group. This 
amounted to a total advantage of 9,000 KRW/pig.
In this farm with a late onset of PCV2 infection, vaccination with 
Ingelvac CircoFLEX at 10 weeks was still benefi cial. However, 
vaccinating early fatteners is usually a compromise, as often 
infection occurs in late nursery and optimal performance would 
only be achieved by vaccinating around weaning.
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Eﬀ ect of a single dose of Porcilis PCV at weaning on daily growth on a Danish high health herd with PCVD
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Introduction 
Circovirus type 2 (PCV2) is one of the agents responsible for 
PMWS and PCVD, major causes of losses in pig production. 
Porcilis PCV has been developed to reduce the losses due to in-
fection with PCV2. Vaccination of piglets with a single 2 ml dose 
at 3 weeks of age results in both humoral and cellular immunity 
(1). The purpose of this study was to investigate the effi  cacy of 
Porcilis PCV vaccination of piglets in a fi eld case of naturally oc-
curring PCVD. 
Materials and method
A Danish pig farm received 250 piglets every other week from 
the same sow herd. For the fi rst 8 weeks, the 250 piglets were 
housed in a separate section containing nine pens, which had 
previously been cleaned, disinfected, dried and heated. At 
around 30 kg, the pigs were moved to fi nishing accommodation 
operating continuously.
The herd’s general health was very high (Danish SPF-declaration: 
SPF +AP12 - meaning free from all serotypes of A pleuropnu-
moniae (except serotype 12), M hyopneumoniae and PRRS. Three 
months before the start of the trial, classical PMWS was diag-
nosed in piglets 4 weeks after introduction onto the farm. When 
the trial began, the clinical picture had changed, and the disease 
was classifi ed as PCVD. 
Out of a batch of piglets delivered to the farm, 100 pigs were 
vaccinated with 2 ml of Porcilis PCV on the day of arrival, and 
100 pigs were left unvaccinated. These 200 pigs were randomly 
allocated to pens of 32-34 piglets each, thus mixing vaccinated 
and unvaccinated pigs in the same pen. This scheme was re-
peated with the next batch of piglets delivered two weeks later, 
in a separate section, thus providing, in all, 200 vaccinates and 
200 unvaccinated controls. 
For each batch, 3 vaccinated and 3 unvaccinated pigs from each 
pen were bled on days 0 (day of vaccination), 18, 56 and 109. The 
samples were analyzed by qPCR for PCV2 virus. On days 0, 56 
and 109, all the pigs were weighed individually. 
Statistical analysis of the ADG was by varians analysis (multi-
factorial ANOVA, Statgraphics software), and of mortality by the 
Chi-square test.
Results
During the trial, serious tail-biting occurred in one pen. Half of 
the deaths recorded were the result of euthanasia as a sequel to 
tail-biting and lameness. Apart from this, most cases of lameness 
and meningitis were cured by appropriate antibiotic therapy. 
The blood samples showed that the pigs were viraemic from day 
56 onwards, throughout the trial period. Vaccinated pigs had 
lower levels of virus than the unvaccinated controls (Data not 
shown).
Table 1: Average Daily Gain (ADG) in grams for diff erent growth per-
iods and overall mortality.
Period Porcilis PCV Control P-value
ADG 0 - 8 weeks (No) 369 (195) 356 (192) NS
ADG 8 - 16 weeks (No) 792 (186) 753 (183) 0.0091
ADG 0 - 16 weeks (No) 587 (186) 561 (183) 0.0143
Mortality (all pigs) 11/200 18/200 NS
Figure 1. ADG of diff erent growth classes.
The distribution shows a shift to the right for the pigs vaccin-
ated with Porcilis PCV, indicating the better performance of the 
vaccinated pigs.
Discussion
The results showed that, even in a contaminated environ-
ment, with vaccinated pigs in direct contact with unvaccinated 
viraemic pigs, Porcilis PCV vaccination at weaning resulted in a 
signifi cantly better ADG of 39 g during the fi nishing period. This 
is in accordance with the claim, in the SPC for Porcilis PCV2, that 
vaccination reduces weight loss due to infection with PCV2 (2). 
Since no other serious pathogens were present in the farm, the 
eff ect is related to vaccination against a ‘pure’ PCV2 infection. 
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Safety of Porcilis PCV in pure breed Danish pigs
Peter Astrup; Kirsten V. Larsen
Intervet/Schering-Plough Animal Health, Skovlunde, Denmark
Introduction
Porcilis® PCV is an inactivated vaccine containing a killed 
baculovirus vector carrying protective antigen against Porcine 
Circovirus 2 (PCV2) in Microsol Diluvac Forte® adjuvant. Porcilis® 
PCV is widely used in the pig industry because circovirus type 2 
(PCV2) is considered to be the aetiological agent of postwean-
ing multisystemic wasting syndrome in pigs, a widespread and 
debilitating condition. Furthermore, it is considered the aetio-
logical agent in porcine circovirus disease (PCVD), known as 
porcine circovirus associated disease (PCVAD) in the USA.
The data sheets for Porcilis® PCV warn against adverse reac-
tions, which fall into two groups. Firstly, a transient, immediate 
systemic hypersensitivity-like reaction, and secondly, a transi-
ent, painless local swelling, sometimes in the order of several 
centimetres in diameter. These adverse reactions are to be 
distinguished from transient, very focal, erythema seen at the 
site of vaccination (1). 
This study reports an investigation into the frequency and char-
acterisation of these two adverse reactions in nucleus pigs from 
three pure breeds and one cross breed. The investigations were 
initiated due to speculations from the fi eld, that pure breeds 
would have a high incidence of local reactions 
Materials and Methods
Four hundred and sixty nine growing pigs between 21 and 40 
days of age on two diff erent breeding farms were selected. 
All were injected with Porcilis® PCV I/M and were observed 2, 
15 and 60 minutes and 24 hours after injection for systemic 
reactions, and at days 1, 8 (or 11 on Farm two), 15 (or 18 on 
Farm two) and 42 after injection for signs of depression and of 
local swelling at the injection site. 469 pigs were included: 252 
Yorkshire (YY), 119 Duroc (DD), 50 Danish Landrace (LL) and 48 
crossbreeds of Yorkshire and Landrace (LY).
Results 
Two of the 469 pigs showed mild, transient systemic side eff ects, 
within 15 minutes of injection. Transient, local swellings were 
observed to begin within twenty four hours after injection and 
of 469 vaccinated pigs 0.6 % showed reactions on day 1, 17.9 % 
on day 8/11, 34.4 % on day 15/18 (with the majority of reactions 
classifi ed as a type B or C) and 0.8 % day 42 (Figure 1).
Local swellings occurred signifi cantly more rapidly, and cleared 
more quickly, in DD pigs. Furthermore, LL, YY and LY groups 
exhibited signifi cantly higher frequency of swellings than the 
DD group. 
Nine (2%) of the pigs died during the trial: six from the YY group 
and 3 from the DD group. Post mortem examination found no 
evidence that vaccine reactions contributed to the cause of 
death (data not given)
Discussion
The purpose of this trial was to investigate the frequency and 
severity of adverse reactions to Porcilis® PCV vaccine in three dif-
ferent breeds of pigs and cross breeds of these. The reactions to 
vaccinations seen in this study were as expected from the data 
sheet advisory, i.e. mild, transient, immediate post vaccination 
shivering or depression and transient local swellings. 
In no cases could treatment or mortality be related to the vac-
cination with Porcilis PCV. During autopsy of all dead YY-pigs it 
was judged probable, that deaths were not caused by the vac-
cination with Porcilis PCV. 
Figure 1. The incidence of swellings in all pigs at Day 0, Day 1, Day 8 
(and 11), Day 15 (and 18) and Day 42. 
A: no lesions; B: lesions less than 3 cm diameter; C: lesions between 3 and 8 cm diameter; D: 
lesions greater than 8 cm diameter
Conclusion
In this study swellings were seen after vaccination, but they were 
transient and did not negatively impact the vaccinated pigs.
Hypersensitivity reactions were absent except for minor depres-
sion and shivering in two pigs.
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Evaluation of the eﬃ  cacy of an adjuvanted subunit vaccine (Circumvent® PCV) 
in the prevention of PMWS under ﬁ eld conditions in Vietnam
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Introduction
PWMS, largely caused by Porcine Circovirus Type 2, is endemic 
on pig farms in Vietnam.  This study was designed to evaluate 
the effi  cacy of Circumvent PCV in protecting pigs on suspected 
PMWS farms. Circumvent PCV contains a PCV2 viral subunit 
(ORF2 protein) in X-Solve adjuvant. The antibody response was 
measured at the time the vaccine was given at 14 or 21 days of 
age, and again at 42 days. 
Materials and Methods
The study was carried out on two commercial farms (Farms A 
and B with 400-1000 pigs) in two provinces in Vietnam. Both 
farms practiced  21-25 day weaning. Pigs were assigned ran-
domly to either a vaccinated or a control group. On Farm A, 
396 piglets of 14 days of age from various litters, were divided 
equally between vaccinated and control groups. On Farm B, 
194 piglets of 21 days old, also from various litters were divided 
equally between vaccinated and controls. 
All pigs in the vaccinated group were injected with Circumvent 
PCV (Intervet Schering-Plough, The Netherlands), on Farm A at 
14 and 42 days of age, and on Farm B at 21 and 42 days of age.  
The trial vaccine was given intramuscularly on one side of the 
neck, and Mycoplasma vaccine on the other side. The controls 
did not receive Circumvent PCV. Pigs were observed daily for 
signs of illness and were weighed at 14, 28 (weaning), 75 and 
120 days old on Farm A, and at 21, 84 and 165 days old (slaugh-
ter) on Farm B. 
Blood samples were collected immediately prior to vaccination 
on Farm A (Days14 and 42) and at 75 and 168 days of age.  On 
Farm B, blood samples were also taken prior to vaccination (Days 
21 and 42) and at 84 and 165 days of age. The sera were tested 
for antibodies against PCV2 by ELISA (Serelisa®, Synbiotics). The 
result was taken to be positive when SNc<0.5 and titers were cal-
culated from OD at three dilutions of serum, as recommended. 
For the statistical analysis, all data were presented as means. 
Variation between groups was determined by one-way ANOVA 
analysis and the diff erence between means by Turkey’s multiple 
comparison test using Minitab Statistical Software 13.20 (USA). 
In all cases, P<0.05 was considered to be signifi cant.
Results
On both farms, the vaccinated pigs had better ADG across the 
age range, and lower mortality, than the controls.  
Figure 2.  Serological data from Farm A. Vaccinations on days 14 and 42 
Figure 3.  Serological data from Farm B. Vaccinations on days 21 and 42
Discussion
On both farms, vaccination with Circumvent PCV clearly resulted 
in sero-conversion after the second dose, indicating protection 
against PCV2 virus (Fort, 2009). This was further evidenced by a 
better ADG resulting in heavier slaughter weights (2.0% on Farm 
A and 3.5% on Farm B), lower mortality (4.5% (A) and  15% (B)) 
and a reduced incidence of clinical disease (25% (A), 12% (B)) 
compared to the controls. 
Several individual parameters were statistically signifi cantly 
better in the vaccinated pigs, e.g. post vaccination antibody 
titers and mortality. More importantly for the pork producer, the 
overall technical and economic performance improved on both 
farms. 
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Figure 1. Percentage mortality in vaccinated and control groups on 
Farms A and B 
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Successful PCVD control on a pig farm in Southern China 
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Introduction
Porcine Circovirus type2 (PCV2) is the causative agent of various 
PCV2 associated diseases, including PMWS, PDNS, PRDC and 
PCV2 related reproductive failure or enteritis. 
 A recent epidemiological study revealed severe prevalence of 
PCV2 infection in China. Positive rates for samples tested for 
PCV2 in 2002-2003, 2004-2006 and 2008 reached 71 %, 81.2 % 
and 100% respectively [1]. This paper reports a successful case 
of PCVD control in a 900-sows pig farm suff ering from PMWS in 
Guangdong, a southern province in China.
Materials and Methods
A one site production 900-sows farm built up in 1994 suff ered 
severe PCVD. The breeding herd is vaccinated against PRRS, 
PRV, Atrophic rhinitis, CSFV, PPV, JEV and Streptococcus (Str.) 
suis, while piglets are vaccinated against PRV, CSFV, PRRSV, 
Haemophilus parasuis and Str. suis. Severe PMWS signs emerged 
since February 2009. Symptoms in late nursery included growth 
retardation, wasting, lethargy, anorexia and fever, while in the 
fattening herd, jaundice, diarrhoea, enlargement of inguinal and 
mesenteric lymph node, enlarged spleen with infarcts, enlarged 
kidneys with tan and waxy appearance and petechial haemor-
rhages and PDNS skin lesions were observed. The average mor-
bidity and mortality ranged between 30-50% and 25-40%. 
In May 2009, the farm started to use Ingelvac CircoFLEX in 
piglets around 14 days old. In total 40 weekly batches of piglet, 
20 before vaccination (n= 3769), 20 vaccinated with Ingelvac 
CircoFLEX® (n= 3927) were included in the evaluation. Diseased 
pigs (morbidity) as well as dead pigs (mortality) and culls were 
recorded per batch.
Frequencies of morbidity, mortality and culling were analyzed 
by Chi-square test.
Results
Since piglet vaccination with Ingelvac ® CircoFLEX, the health 
status of the vaccinated batches were signifi cantly improved. 
Morbidity, mortality and culling were signifi cantly reduced in 
vaccinated pigs, in nursery as well as in fattening (Table1 and 
Table2). PMWS, PDNS and PCV2 related enteritis was eff ectively 
controlled in the farm.
Table 1 Average performance in Nursery (25-75 days old)
Nursery Herd
Pre-Vx Post-Vx Diff .
Pigs (n) 3769 3927 /
Morbidity (%) 20.8 4.5 16.3*
Mortality and culling rate (%) 18.9 3.5 15.4**
*p<0.05 **p<0.01
Table 2 Average performance in Fattening (76-120 days old)
Fattening Herd
Pre-Vx Post-Vx Diff .
Pigs (n) 3057 3791 /
Morbidity (%) 14.5 2.5 12.0**
Mortality and culling rate (%) 11.8 1.8 10.0*
*p<0.05 **p<0.01
Discussion
This farm was severely aff ected by PCVD as indicated by a high 
mortality and culling rate in the nursery and fattening period. 
PRRSV and CSFV were already controlled through vaccination.
Piglet vaccination with Ingelvac CircoFLEX® successfully con-
trolled PCVD, as demonstrated by a signifi cant reduction in 
morbidity, mortality and culling rate. 
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The impact of PCV2 sow vaccination on PCVD in grower and ﬁ nisher pigs
Jake Waddilove
Eastgate Veterinary Group, Bury St Edmunds, UK
Introduction 
Porcine Circovirus Disease (PCVD) has a major impact on pig 
health and production throughout the world. It aff ects every 
category of pig, with its major impact being in the growing herd. 
Where disease is more established the focus often moves to 
older pigs. Costs of PCVD in the EU have been estimated at €562 
– 900 million/year (1). Control has been achieved by vaccination 
of sows &/or pigs. The benefi ts of sow vaccination have been 
shown to extend well beyond the predicted duration of mater-
nally derived antibodies (2). This fi eld study further investigates 
the benefi ts of sow vaccination on the progeny of these sows.
Materials and Methods
The study took place in a 600-sow farrow-to-fi nish herd housed 
in a combination of straw based and slatted buildings. Grow-
ing pigs were housed in all-in, all-out rooms to 50kg, and then 
semi-continuous buildings. The herd had been aff ected by PCVD 
for several years. This combined with PRRS and Mycoplasma 
hyopneumoniae to lead to signifi cant PRDC problems.
Additionally Streptococcus suis meningitis and Haemophilus 
parasuis problems occurred up to 50kg. Attempted control had 
been by vaccinations for PRRS (MLV), M.hyopneumoniae and at 
times H.parasuis, plus various antimicrobial programmes. Results 
were of limited success.
In the study sows were vaccinated for PCVD using CIRCOVAC® 
(MERIAL) in addition to existing vaccines. A primary course given 
6 and 3 weeks before farrowing was followed by boosters 3 
weeks before farrowing. Progeny from these sows were mon-
itored for pig health, medication, mortality and various slaugh-
ter parameters and results compared with previous throughput.
Results
Progeny from vaccinated sows reached the weaners on 08/05/08 
and the fi nishers on 13/08/08. There was a progressive improve-
ment in pig health. Levels of pneumonia and coughing reduced 
especially in fi nishers. Streptococcal meningitis in growers 
dropped to nearly zero, but increased when corrective medi-
cation was removed. It reduced again once medication was 
returned. Clinical evidence of H.parasuis decreased. The costs of 
medication (in feed, soluble & injectable) fell from 79p per pig in 
the 3 months before the pigs came through to 41p in the next 3 
months & then 31p. Mortality (graph 1) progressively improved 
except for the temporary increase due to S.suis meningitis.
Slaughter house fi ndings (graph 2) showed less pleurisy, peri-
carditis and peritonitis confi rming reduced H.parasuis infection. 
Growth rates of pigs were not accurately recorded, but days to 
slaughter fell by approximately 5 days.
Discussion
These results show that vaccination of sows using Circovac can 
have benefi ts in their progeny though to slaughter. Control 
of complexed PRDC was improved while reductions in S.suis 
meningitis and H.parasuis problems suggested that vaccination 
helped reduce the impact of PCV2 on the immune competence 
of these pigs. These results further indicate that sow vaccination 
for PCV2 reduces PCVD in the fi nishing herd.
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Prevalence of circovirus (PCV2) in vaccinated and non vaccinated swine’s 
from diﬀ erent Brazilian farms. January 2008 to August 2009
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Introduction 
Porcine circovirus type 2 (PCV2) was fi rst described in 1998 and it 
was associated with a newly observed sporadic wasting disease 
in weaned pigs in Canada, USA (California), and France (ALLAN 
and ELLIS, 2000). Actually is known as one of the most important 
viruses in the global pig industry and the acronym PCVAD is rec-
ommended besides PMWS (systemic infection or postwean¬ing 
multisystemic disease) and others PCV2-associated diseases 
as pneumonia, enteritis, reproductive failure, dermatitis and 
nephropathy syndrome (OPRIESSNIG et al., 2007). Clinical signs 
and lesions are observed in late nursery (8-10 weeks of age), and 
fi nisher pigs (2–3 wks after placement) (BATISTA, 2007; BRUN-
BORG et al, 2004)
Brazilian isolates of PCV2 were sequenced, analyzed and com-
pared with isolates from other countries and the phylogenetic 
analysis showed that mostly variants were grouped as PCV2-1 
(CIACCI-ZANELLA et al, 2009). 
Material and Methods
Study design: this study included 2090 animals from 93 farms 
with medium level of biosecurity measures and clinical signs of 
PCVAD located in 6 states of south, south-east and west-center 
regions of Brazil (Paraná/PR, Rio Grande do Sul/RS, São Paulo/
SP, Santa Catarina/SC, Mato Grosso do Sul/MS and Minas Gerais/
MG). There were vaccinated 940 animals and 1150 were main-
tained as control. The SUVAXYN@ PCV2 chimeric vaccine was 
applied intramuscularly in animals aged between 21 and 28 
days and serum samples were examined 40, 60, 80 and 100 days 
after vaccination to quantify viral load by TaqMan© real time 
PCR assay (BRUNBORG et al, 2004). Statistic procedures were 
the test for diff erence of the parameters of two proportions for 
prevalence’s and the Mann Withney test for two median values 
diff erences (SIEGEL, 1975) and fi xed α = 0,05. 
Results 
There were considered positive all serum with 4500 or more 
DNA copies of PCV2. Among vaccinated pigs the frequency of 
positives samples at 40, 60, 80 and 100 days were respectively, 
22,5%, 14,7%, 23,6% and 13,3%. Among non vaccinated pigs 
the frequency of positives samples at 40, 60, 80 and 100 days 
were respectively, 36,2%, 22,5%, 35,4% and 58,2%. The Graphic 
1 illustrates the variation of frequencies in vaccinated and non 
vaccinated and age of serum examination. 
Discussion
In vaccinated and non vaccinated animals, the statistical com-
parison of frequencies between successive ages (40 with 60 
days, 60 with 80 days and 80 with 100 days) revealed a decreas-
ing except at 80 days that could be explained as a result of high 
challenge due to placement to fi nishing houses with mixture of 
animals of diff erent growing rooms. These results permit to do 
inference about the role of natural immunity among non vaccin-
ated pigs and the effi  cacy of SUVAXYN®PCV2 in the vaccinated 
group in farms were de PCV2 is endemic. These results reveal 
a widespread PCV2 virus in Brazil mainly in areas of important 
swine industry similarly to mention by OPRIESSNIG et al (2007). 
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Serological response and inﬂ uence on virus load in pigs vaccinated with Porcilis PCV
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Introduction 
Circovirus type 2 (PCV2) is one of the agents responsible for 
PMWS and PCVD, major causes of losses in pig production. 
Porcilis PCV has been developed to reduce the losses due to in-
fection with PCV2. Vaccination of piglets with a single 2 ml dose 
at 3 week of age results in both humoral and cellular immunity 
(1). The purpose of this study was to investigate the effi  cacy in 
controlling viraemia of Porcilis PCV vaccination of piglets in a 
fi eld case of naturally occurring PCVD.
Materials and Methods
The trial involved two high-health (SPF + AP12) farms. Farm 
1 was a wean to slaughter herd and had vaccinated and un-
vaccinated pigs in the same pen. Farm 2 was a sow herd which 
produced 350-400 weaned piglets every third week, which were 
moved into clean, disinfected, all in/all out accommodation. 
They had no contact with other pigs until sold at 30 kg (half 
of them) or slaughtered at 105 kg. Pigs from two consecutive 
batches comprised one block and were randomly allocated to a 
treatment group (2ml Porcilis PCV, 4-6 days before weaning) or 
an unvaccinated control group. In all, 6 blocks (12 batches) were 
studied. 
In each batch, 5 pigs were blood sampled four times in the 
growing phase (at treatment time, and at around 6, 12 and 18 
weeks after weaning). Samples from the fi rst 4 batches (20 pigs) 
were analyzed individually by ELISA for antibodies against PCV2. 
From all 8 batches, virus particles/ml were measured by real 
time PCR performed on pools of 5 samples from the same batch. 
(ELISA and PCR to National Veterinary Institute, DTU standards.) 
On Farm 1, 6 vaccinated and unvaccinated 6 pigs from the mixed 
groups were also sampled, at weaning (day 0), days 18, 53 and 
109. 
Results
All vaccinated pigs in both farms seroconverted to levels of 
1:250 – 1:31250 within the fi rst 6 weeks after vaccination. These 
levels were slightly declining, anyway all, but one, stayed at at 
least 1:250 throughout the observation period. Non-vaccinated 
reached a higher level of serological response
Figure 1: Shows antibody level in individual pigs at farm 1. Light 
rows are non-vaccinated, dark are vaccinated. 1-6 indicates levels of 
antibodies from 1:10 through to 1:31,250.
Table 1. Number of PCV2 copies (log(10)) from pools of 5 pigs from 
individual batches at farm 2. A-F = Blocks of 2 batches. V=Vaccinated, 
N=Non-vaccinated. Week = Week post weaning.
Batch A A B B C C D D E E F F
Week V N V N V N V N V N V N
0 0 0 0 0 0 0 0 0 0 0 0 0
6 0 0 0 0 0 0 0 0 0 0 0 0
12 0 4.2 0 5.2 0 6.4 0 5.0 0 0 0 6.9
18 0 3.7 0 4.5 0 5.9 0 6.1 0 6.4 0 6.1
Number of PCV2 copies were signifi cantly lower in vaccinated 
pigs that were co-mingled with non-vaccinated (farm 1; data 
not shown) and no copies (above the detection limit of 1 x 103) 
were found in vaccinated that were housed separated from non-
vaccinated. 
Discussion
Vaccination with Porcilis PCV is shown to elicit an equal and safe 
immuneresponse in vaccinated pigs. Even though PCV2 virus is 
shown to circulate in vaccinates at low numbers the measured 
response seems to be protective against any further stimula-
tion of the immunesystem, indicating that the vaccination have 
induced an immuneresponse strong enough to avoid the pro-
liferation of virus in infected pigs housed with highly infected 
littermates.
If pigs are housed only with other vaccinates the vaccine is able 
to protect pigs from having any development of virus at all. 
These results show that the strong cellular and humoral immune 
response developed by vaccination with one dose of 2 ml of 
Porcilis PCV in pigs older than 3 weeks, that Fort et al (1) found 
under laboratory conditions, are highly protective under fi eld 
conditions.
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Introduction and Objectives
Recent studies have shown the eff ectiveness of vaccines for 
control of diseases associated with Porcine Circovirus Type II 
(PCV2). The goal of this study is to demonstrate the effi  cacy of 
an autogenous vaccine against PCV2 for the control of Porcine 
Multisystemic and Wasting Syndrome (PMWS) in a commercial 
1000 sow farrow to fi nish operation in Venezuela. 
Materials and Methods
The study was performed in one pig farm positive to PRRS, 
Mycoplasma hyopneumoniae, Glasser disease and PMWS. 
Samples were collected from animals with PMWS clinical signs 
in order to be evaluated by histopathology and immunoperoxi-
dase assay (1). Tissues from animals identifi ed as positive were 
used as source of virus for the killed autogenous vaccine.
Seven hundred forty 4 week-old-piglets were randomly selected 
and divided in two groups:
Group A: 370 piglets were vaccinated with 2ml of the PCV2 
autogenous vaccine at four and six weeks of age; 
Group B: 370 piglets were injected with 2ml of saline solution at 
4 and 6 weeks of age. 
Both groups were divided in 10 pens with 37 animals per pen, 
and were fed and managed under the same conditions. A clinical 
evaluation was assessed to each group weekly. The parameters 
evaluated were as follows:
Cough index, sneezing index, prevalence of depression, lame-
ness, conjunctivitis, diarrhea, wasting, skin lesions, pig size 
uniformity in the same pen and mortality rate. 
Results
A summary of the results is shown in Table 1. A higher percent-
age of wasting pigs, presence of conjunctivitis and sneezing pigs 
was observed in the control group as compared to that detected 
in the vaccinated group. On the other hand, a lower mortality 
rate was observed in the vaccinated group (2.16 vs 5.40).
No evidence of diarrhea was observed in any of the groups 
under study.
Table 1. Comparison of clinical parameters of pigs vaccinated with an 
autogenous killed PCV2 vaccine against control non vaccinated pigs. 
Parameter Group A vaccinated % Group B control %
Cough index 4a - 11b -
Sneeze index 24a - 60b -
Depression 0 0 0 0
Lameness 1 0.13 4 1
Conjunctivitis 5a 1.33 15b 4.0
Diarrhea 0 0 0 0
Wasting pigs 2a 0.54 43b 11
Skin lesions 1a 0.13 11b 2.9
Deaths 8a 2.16 20b 5.4
Values with diff erent superscripts diff er signifi cantly; a,b: p<0.05.
Discussion and Conclusions
The effi  cacy of commercial vaccines for the control of PCV2 
associated diseases have been previously demonstrated (1). A 
signifi cant diff erence in the mortality rate was observed in the 
vaccinated group as compared with the control non vaccinated 
group. Even though the weight of the pigs was not evaluated, 
the proportion of wasting pigs was signifi cantly higher in the 
control group. These fi ndings suggest the effi  cacy of the use of 
an autogenous vaccine for the control of PMWS.
On the other hand, a higher percentage of pigs with conjunctiv-
itis, skin lesions and sneezing were observed in the control non 
vaccinated group, signs that could be associated with a synergic 
eff ect of PCV2 with other infectious agents. 
References
1 Arnold J. et al. (2008) 20th IPVS Durban South Africa. p. 37. 
2 Yaeger, M. Diagnosis of PCV2 associated disease a diagnostic path-
ologist’s perspective. American Association of Swine Veterinarians. 
2007; 519-524. 
Porcine Circovirus Associated Diseases (PCVAD) – Control
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 362
Poster Presentations
P.056
Evaluation of the safety and and the immune response after diﬀ erent 
vaccination schedules in sows: preliminary results
Eric Pagot2 Florian Voisin2 Anne Trotel2 Alassane Keita2 François Joisel1
1. Merial S.A.S., Lyon, France; 2. CTPA Zoopole développement, Ploufragan, France
Introduction 
Post-weaning Multisystemic Wasting Syndrome (PMWS), Parvo-
virosis, Erysipelas, Neonatal Colibacillosis are major diseases 
in pig farms worldwide. Previous internal trials which tested 
the eff ects of simultaneous vaccination of gestating sows/gilts 
(non-published data) with either PMWS (CIRCOVAC® coded CIR, 
Merial) and Parvovirosis/Erysipelas (PARVORUVAX® coded PAR, 
Merial) or CIR and Colibacillosis (NEOCOLIPOR® coded NEO, 
Merial), both vaccination schemes did not raise safety concerns. 
This paper reports a study which was conducted in a larger scale 
under fi eld conditions in France, and evaluates the safety of the 
two simultaneous vaccination schemes in comparison with the 
recommended schedules.
Material and Methods
Overall 181 sows, coming from 2 diff erent commercial farms 
usually vaccinated with CIR and PAR were included into the 
study. In each farm, sows of each farrowing batch were random-
ly assigned to one of three identical treatment groups according 
to parity: Group 1 (G1): simultaneous vaccination with CIR,PAR 3 
weeks before farrowing, and with NEO 2 weeks before farrowing. 
Group 2 (G2): simultaneous vaccination with CIRC,NEO 2 weeks 
before farrowing, and with PAR during lactation. Group 3 (G3) 
was the control group: CIR vaccination 3 weeks before farrow-
ing, NEO 2 weeks before farrowing and PAR during lactation. The 
study was planned to vaccinate the sows for 2 breeding cycles. 
Systemic and local site reactions as well as rectal temperature 
were checked during the fi rst cycle on D0, D0+4H, D1, D2 and 
D7 after each injection. Statistics (1) used ANOVA (or Kruskall-
Wallis test if non-normal data) and Mantel Haenszel chi-square 
test with p<0.05 as level of signifi cance.
Results
The results for the second cycle are not yet available, only those 
from the fi rst cycle are shown. 
The baseline criteria (parity distribution, median parity and 
rectal temperature at inclusion) were similar in the three groups. 
Rectal temperatures were compared within physiological 
periods. First period (P1) was 3 weeks before farrowing (G1 with 
CIR,PAR vs G3 with CIR), second period (P2) was 2 weeks before 
farrowing (G2 with CIR,NEO vs G1 and G3 with NEO) and third 
period (P3) was 2 weeks after farrowing (PAR vaccination, G2 vs 
G3).
The course of rectal temperature is shown in table 1. Depending 
on the periods, the temperature values were consistently in the 
normal physiological range for sows: 38.0°C to 38.6°C before and 
38.9°C to 39.5°C after farrowing. 
Table 1: Adjusted mean rectal temperature (in °C) by group over time
Group D0 D0+4h D1 D2 D7
Period 1 - G1 38.1 38.5 38.3 38.0 38.1
Period 1 - G3 38.1 38.4 38.3 38.1 38.1
Period 1 - 
Statistics NS NS NS NS NS
Period 2 - G1 38.1 38.3b 38.2b 38.2 38.1
Period 2 - G2 38.1 38.6a 38.4a 38.1 38.1
Period 2 - G3 38.1 38.4b 38.2b 38.2 38.1
Period 2 - 
Statistics NS p<0.001 p<0.001 NS NS
Period 3 - G2 39.0 39.4 39.1 39.0 38.8
Period 3 - G3 39.0 39.5 39.1 39.0 38.9
Period 3 - 
Statistics NS NS NS NS NS
a,b Diff erent superscripts in the same column mean signifi cantly diff erent values.
NS: non signifi cant
For P1 and P3, no signifi cant diff erence was observed between 
the rectal temperatures of the three groups. For P2, at D0+4h 
and at D1, a signifi cant higher temperature was observed in 
the group 2 compared to the groups 1 and 3. However, it was 
moderate (0.2°C to 0.3°C more) and very transient, temperatures 
being similar in all groups after D1.
At any time point of the study, no signifi cant diff erence was 
observed between groups in general condition.
No signifi cant diff erence was observed between the numbers of 
piglets born alive per sow of the three groups: respectively 13.3, 
14.3 and 13.4 in the groups 1, 2, 3.
No signifi cant diff erence was observed between groups in the 
proportion of sows with local reactions after vaccination. 
Discussion and Conclusion
A moderate and transient higher temperature was observed in 
the group receiving CIR,NEO 2 weeks before farrowing, with no 
impact on the general condition. Since no adverse reaction was 
observed in born alive piglet, these results support the safety of 
the diff erent simultaneous vaccination schedules.
Reference
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Introduction
Recommended vaccination schedules for Mycoplasma hyopneu-
moniae (M. hyo) and porcine cirovirus type 2 (PCV2) for piglets 
may overlap. The administration of diff erent vaccines simultan-
eously often gives rise to concerns about safety and effi  cacy. 
The present study was conducted to determine the safety and 
the serological response after simultaneous administration of 
SPRINTVAC, an oil adjuvanted bacterin vaccine against M. hyo 
and CIRCOVAC, a killed PCV2 vaccine containing Immuneasy®, 
the same adjuvant, in piglets. 
Method and material
A batch of thirty four 4-week old weaners from a farm known to 
be free of Aujeszky’s disease, Porcine Respiratory and Reproduct-
ive Syndrome (PRRS) and classical swine fever were randomly 
allotted to 4 groups (Table 1). When simultaneous vaccination 
was performed, the vaccines were injected on opposite sites on 
the neck region. Vaccines were given intramuscularly at 4 weeks 
of age. All pigs were housed in adjacent pens and managed in 
same manner throughout the trial period. 
Table 1. Group of experimental pigs
Group Vaccination N
S+C SPRINTVAC and CIRCOVAC 10
S SPRINTVAC only 8
C CIRCOVAC only 8
Control None 8
Serums collected weekly from 4 to 10 wks of age and then at 12 
and 20 weeks of age were tested for antibodies to M. hyo and 
PCV2 using the IDEXX test kit, and Synbiotics SERELISA PCV2 test 
kit respectively. The eff ects of local site reactions and anorexia 
were observed for up to 3 weeks after vaccination.
Results and Discussion
The serological profi les for M. hyo and PCV2 antibodies are 
shown in Figures 1 and 2.
Three weeks after vaccination, 100 % and 87.5% of pigs in the S 
and C+S groups were tested positive for M. hyo antibodies and 
had similar profi les throughout the period of the trial. Pigs in the 
C and Control group were negative for M. hyo antibodies until 
10-12 weeks of age most likely due to exposure to fi eld M. hyo 
infection. 
All piglets were positive for the presence of maternal antibodies 
to PCV2 titer at the beginning of the trial. As the pigs aged, 
reduction in the PCV2 antibody titer was observed in pigs from S 
and Control group from 8 weeks of age. In the C and C+S group, 
PCV2 antibody titers were maintained at high levels up to 20 
weeks old when the study was terminated.
There were no adverse local reactions to the vaccinations or 
anorexia observed post-vaccinations
Conclusion
In this study, no adverse local reactions or anorexia were 
observed with the simultaneous vaccination on two diff erent 
sites intramuscularly in the neck muscles of 4 week-old piglets 
with SPRINTVAC and CIRCOVAC. The present study showed that 
simultaneous vaccinations using the vaccines that were tested 
induced similar serological responses as vaccines used separ-
ately. 
® SPRINTVAC, CIRCOVAC and Immuneasy are registered trademarks of 
MERIAL in the United States of America and elsewhere.
Figure 1: M. hyo antibody serological profi les Figure 2: PCV2 serological profi les
Porcine Circovirus Associated Diseases (PCVAD) – Control
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 364
Poster Presentations
P.058
The impact of PCV2 viremia in a high health Canadian swine herd, a 
vaccination trial comparing two commercial vaccines
Melissa Reindl1 Cate Dewey1 Kevin Vilaca2 Francisco de Grau3 Karen Richardson1 Zvonimir Poljak1
1. University of Guelph, Guelph, ON, Canada; 2. Maitland Veterinary Professional Corp., 
Listowel, ON, Canada; 3. Intervet Canada, Kirkland, QC, Canada
Introduction
Subclinical infections with PCV2 are common1,2 and can occur in 
the absence of co-factors or if vaccination does not prevent viral 
replication3. PCV2 viremia produces immune system activation4 
which causes the redirection of nutrients intended for growth 
to counteract disease challenge5. The objective of this fi eld trial 
was to compare the productivity of nursery and grower-fi nisher 
(G-F) pigs vaccinated with a labeled dose of one of two commer-
cial circovirus vaccines or a placebo. Productivity was measured 
as average daily gain (ADG), feed disappearance, and mortality.
Materials and Methods
A total of 2,146 pigs were selected from a PRRS- and M. 
hyopneumoniae-free herd. The pigs were assigned to one of 
three treatment groups: 1. One dose (1-D) pigs vaccinated with 
Circofl ex® BIVI (n=1026); 2. Two dose (2-D) pigs vaccinated with 
Circumvent® ISPAH (n=1020); and 3. Controls injected with saline 
(n=100). Pigs were individually weighed at approximately 3, 11 
and 20 weeks of age as well as prior to slaughter (at least 107 
kg). Blood samples were taken from a random sample of 122 
pigs at approximately 3, 9, 15, 19, and 23 weeks of age and also 
during the fi nal week of shipping. Viremia was measured using 
qPCR. 
Results
Throughout the entire G-F phase, the ADG of vaccinated animals 
outperformed that of unvaccinated controls (p<0.01). Also dur-
ing this time, controls had a higher mortality (5.1%) than 1-D 
(1.7%) and 2-D (1.6%) pigs (p<0.05). 
While the control group had a higher percentage of viremic pigs 
during the G-F phase compared to the vaccine groups (p<0.01), 
the 1-D vaccinated pigs were also more likely to be viremic com-
pared to the 2-D vaccinated pigs (p<0.01). 
In the second half of the G-F phase, when qPCR results indicated 
the highest natural PCV2 challenge, the ADG of the 1-D pigs 
began to decrease. From 19 weeks of age to slaughter, the 1-D 
vaccinates had an ADG that was 42.3 g/day lower than the 2-D 
vaccinates (p<0.01) after controlling for starting weight and 
weaning cohort. In addition, the 1-D vaccinates and 1-D controls 
had a higher amount of feed disappearance compared to the 
2-D vaccinates and 2-D controls throughout the G-F phase. This 
means that, although the 1-D pigs were growing at a slower rate, 
they were potentially eating more feed than the 2-D pigs. 
Implications
Overall, vaccination reduced mortality and increased ADG. 
However, only the 2-D vaccine was able to control viremia and 
maximize ADG during the high PCV2 challenge in the fi nisher 
phase. 
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Introduction 
A new emerging disease termed “post-weaning multisystemic 
wasting syndrome” (PMWS) was identifi ed and reported in 
Canada. PMWS manifests as systemic disease characterized by 
weight loss, a relatively high mortality rate among pigs in the 
10-to 17-week-old age group and lymphadenopathy causing 
immunosuppression. PMWS diagnosis is based on the presence 
of characteristic histopathological lymphoid lesions and PCV2 
within these lesions. Also, the presence in a sample of animals 
of high PCV2 loads is suggested as indicating the presence of 
PMWS lesion using real time PCR. Thus, this study was to evalu-
ate whether vaccination against PCV2 can reduce PCV2 load or 
not.
Materials and Methods
159 piglets from 3 diff erent farms, Farm A, B, and C located in 
Hongsung-gun, Choongnam province, Korea, that had a history 
of PCVD will be included in this study and divided into 2 groups, 
vaccinated and placebo. Pigs in the vaccination group were 
given CIRCUMVENTTM PCV (Intevet Schering-Plough) IM in 3 
and 6 weeks of age. Control pigs were handled in a similar man-
ner as vaccinated pigs with saline. For quantifi cation of the PCV2 
viral load in serum, serum samples were analyzed by TaqMan 
real time PCR as described previously (A. Olvera et al. 2004)
Table 1. Primer and probe designed for the real time PCR
Oligo Sequences
PCV2F CCAGGAGGGCGTTGTGACT
PCV2R CGCTACCGTTGGAGAAGGAA
PCV2S AATGGCATCTTCAACACCCGCCTCT
Results and Discussion
The profi le of PCV2 load during the course of the study is de-
scribed in Fig. 1, 2 and 3. All of the farm hadthe presence of high 
maternal derived antibodies against PCV2. Peak level of PCV2 
positive animals were reached when animals were approxi-
mately 10-16 weeks of age in placebo-treated group. In vac-
cinated group, level of positive animal decreased dramatically 
than placebo-treated group. Animals with high viral loads (106 
PCV2 genome/ml in serum) were observed in the acute phase 
when is 10 to 16 weeks of age. Compared to the placebo-treated 
group the proportion of PCV2 positive animals in the vaccin-
ated group was signifi cantly lower (P=0.0021, Farm A; P<0.0001, 
Farm B; P<0.0001, Farm C). Based on the results, vaccination with 
CIRCUMVENTTM PCV would reduce PCV2 load in serum. 
References
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Figures 1–3.
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Introduction
PCVAD is now well established as a wasting disease associated 
with PCV2 and has rapidly become one of the most devastating 
and economically important concerns in all pig-producing areas 
of the world. And PCV2 could be an important contributor to 
PRDC characterized be slow growth, decreased feed effi  ciency, 
and increased clinical sign index, such as lethargy, anorexia, 
fever, cough and dyspnea. In this disease, although the exact 
pathogenic mechanisms responsible for these diseases are 
unknown, several studies have suggested that PCV2 infects 
macrophages and B lymphocytes, inducing apoptosis of the B 
cells and the damage of lymphoid tissues resulting in extensive 
lymphocyte depletion. immunosuppression is believed to be 
a key of PCVAD. The purpose of this study was to evaluate the 
eff ects of inactivated PCV2 vaccine in Korean commercial farms 
that had a history of PCVD.
Materials and Methods
50 piglets from a farm, located in Choongnam province, Korea, 
that had a history of PCVD will be included in this study and 
allocated into 2 groups equally, vaccinated and placebo. Pigs 
in the vaccination group were given the PCV2 vaccine IM in 
approximately 3 weeks of age. On the other hands, Control pigs 
were handled in a similar manner as vaccinated pigs with saline. 
ADG was obtained by dividing weight gain by the number 
of days from vaccination to the end of the nursery phase, by 
number of days from the end of the nursery phase to the entry 
into the fi nishing phase. Immune response in serum sample was 
analyzed using IFA. Mortality rate was calculated for each group. 
For statistical analysis, student t-test or Wilcoxon Mann-Whitney 
test was used in order to assess diff erences with regard to ADG 
and serology. Fisher’s exact test was used to investigate possible 
diff erences in mortality. 
Results
Mean ADGs during the overall period for experiment were 
increased by 19.2% in vaccinated group. compared with placebo 
group. Vaccinated group had consistently a signifi cantly higher 
mean PCV2 antibody titer than placebo group in 10 weeks of 
age when is the onset of PCV2 viremia. During the period follow-
ing the vaccination placebo group had an 24.0% higher mortal-
ity rate than it of vaccinated animals. 
Table 1. Average daily weight gain (g/day) during diff erent intervals
Period Vaccine (95% CI) Placebo (95% CI) Diff erence P-value
3-6 209.5 (185.1-234.0) 227.6 (199.6-255.6) -18.1 0.6575
6-10 458.2 (429.8-486.6) 416.8 (385.9-447.7) 41.4 0.0476
10-13 685.9 (656.0-715.9) 500.3 (432.9-567.7) 185.6 <0.0001
13-16 855.5 (818.6-892.4) 716.4 (570.8-862.0) 139.1 0.0661
3-16 562.6 (538.7-586.3) 469.2 (422.7-515.9) 93.4 0.0008
Table 2. The mortality rates (%) of vaccinated group and placebo-
treated group
Group Mortality rate
Placebo-treated group (%) 24.0*
Vaccinated group (%) 0.0
* P<0.01.
Figure 1. Comparison of the PCV2 viral load in vaccinated and 
placebo-treated group.
Discussion
Based on the results, Vaccination against PCV2 would be helpful 
for improving growth performance and reducing mortality rate 
as it signifi cantly maintained antibody titers against PCV2 in the 
point when is the entry of the fi nishing phase. 
Reference
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Introduction 
PCVAD is now well established as a wasting disease associated 
with PCV2 and has rapidly become one of the most devastating 
and economically important concerns in all pig-producing areas 
of the world. In this disease, although the exact pathogenic 
mechanisms responsible for these diseases are unknown, several 
studies have suggested that PCV2 infects macrophages and B 
lymphocytes, inducing apoptosis of the B cells and the damage 
of lymphoid tissues resulting in extensive lymphocyte deple-
tion. immunosuppression is believed to be a key of PCVAD. The 
purpose of this study was to evaluate the immune response of 
inactivated PCV2 vaccine in Korean commercial farms.
Materials and Methods
159 piglets from 3 diff erent farms, Farm A, B, and C located in 
Hongsung-gun, Choongnam province, Korea, that had a history 
of PCVD will be included in this study and divided into 2 groups, 
vaccinated and placebo. Pigs in the vaccination group were 
given CIRCUMVENTTM PCV (Intevet Schering-Plough) IM in 3 
and 6 weeks of age. Control pigs were handled in a similar man-
ner as vaccinated pigs with saline. Immune response in serum 
sample was analyzed using SERELISA PCV2 Ab Mono Blocking 
(Synbiotics, Frence) according to the manufacturer’s instructions.
For statistical analysis, student t-test or Wilcoxon Mann-Whitney 
test was used in order to assess diff erences with regard to serol-
ogy. Statistical analyses were performed using SAS software 
release 8.2.
Results
Maintenance of antibody responses in vaccinated group had 
been continued with high antibody level until 16 weeks of age 
in Farm A and 24 weeks of age in Farm B and Farm C by vaccina-
tion. However, infectious antibodies in placebo-treated group 
were confi rmed at 13 or 24 weeks of age. Interestingly, at 24 
weeks of age, the lower antibody response was observed in vac-
cinated group than in placebo-treated group.
Discussion
Analysis of immune response against PCV2 revealed that vac-
cinated group had the higher immune response more than 
placebo-treated group at 10 to 16 weeks of age when is the 
period of acute infection with PCV2. In conclusion, vaccination 
against PCV2 would have an eff ect to activate immune response 
against it.
Reference
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Introduction 
Porcine circovirus type 2 has been reported throughout the 
world since it is fi rst described in Canada in the early 1990s. 
Recently, these diseases are also called as porcine circovirus 
associated disease (PCVAD) PCVAD has been reported with 
increasing frequency in swine herds in Western Europe, North 
America and eastern Asia. The problem with PCV2 is similar to 
previous results reported in above country. The introduction of 
PCV2 vaccines is contributing to reduce the incidence of PMWS 
and their associated diseases. However, there have been a few 
investigations demonstrating the effi  cacy of PCV2 vaccine and 
no published study on commercial Korean farms. The purpose 
of this study was to further investigate the eff ects on growth 
performance and mortality of vaccination against PCV2 on com-
mercial Korean farms having positivity for PCV2
Materials and Methods
159 piglets from 3 diff erent farms, Farm A, B, and C located in 
Hongsung-gun, Choongnam province, Korea, that had a his-
tory of PCVD will be included in this study and divided into 2 
groups, vaccinated and placebo. Pigs in the vaccination group 
were given a single dose of the PCV2 vaccine (Intevet Schering-
Plough) IM in 3 weeks of age. A second dose of vaccine was 
administered 3 weeks after the fi rst dose. Control pigs were 
handled in a similar manner as vaccinated pigs with saline. The 
individual body weight of all study animals was measured at 3, 
6, 9, 13 16 and 24 weeks of age. Mortality rate was calculated for 
each group. For statistical analysis, student t-test or Wilcoxon 
Mann-Whitney test was used in order to assess diff erences with 
regard to ADG. Fisher’s exact test was used to investigate pos-
sible diff erences in mortality. Statistical analyses were performed 
using SAS software release 8.2.
Results
As seen average daily weight gain, it was considered to be an 
objective measurable parameter to determine the severity 
of PCVAD and the eff ects of vaccination in a large number of 
animals. Vaccinated groups had signifi cantly improved growth 
performances more than placebo-treated group in either or 
both Entry into the fi nishing phase or/and midpoint of the fi n-
ishing phase. The total of mortality rate from vaccinated group 
was signifi cantly lower during the fi nishing phase, compared 
with placebo-treated group.
Discussion
Pigs vaccinated against PCV2 showed more increased ADGs and 
more reduced mortality rate with statistical diff erences in the 
fi nishing phase compared with placebo-treated group. Thus, 
vaccination against it can reduce economic losses from PCV2 
infection To our knowledge this is the fi rst report of the effi  cacy 
of vaccination against PCV2 in Korean fi eld farms.
References
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Reduction of lung lesions in vaccinated pigs with CircumventTM PCV
Yeong Hun Kim1 Myung Hyee Kim2 Jeong Hee Han1
1. School of Veterinary Medicine and Institute of Veterinary Science, Kangwon National 
University, Chuncheon, Korea; 2. Intevet Schering-Plough, Seoul, Korea
Introduction
Porcine circovirus type2 (PCV2) is the primary causative agent of 
porcine circovirus-associated disease (PCVD), which is recently 
replaced from postweaning multisystemic wasting syndrome 
(PMWS). PCV2 is required to cause the characteristic lymphoid 
depletion of PCVAD. Coinfection with several other viral and 
bacterial pathogens has been shown to cause an increase in 
incidence and a markedly more severe clinical course of disease. 
The agent implicated as creating the greatest risk is porcine 
reproductive and respiratory syndrome virus (PRRSV), porcine 
parvovirus (PPV), and Mycoplasma hyopneumoniae. Therefore, 
This study performed to evaluate whether vaccination against 
PCV2 reduce mycoplasmic lung lesions in pigs or not.
Materials and Methods
100 piglets from 2 diff erent farms, Farm A and B located in 
Hongsung-gun, Choongnam province, Korea, that had a history 
of PCVD will be included in this study and divided into 2 groups, 
vaccinated and placebo. Pigs in the vaccination group were 
given CIRCUMVENTTM PCV according to manufacturer’s instru-
ment. Control pigs were handled in a similar manner as vaccin-
ated pigs with saline. For lung lesion analysis, at 24 weeks of age, 
macroscopic lung lesions were estimated based on the amount 
of lung parenchyma aff ected by lesions according to Straw et al 
(1986). Statistical analysis performed with Wilcoxon Mann Whit-
ney test for lung lesion analysis.
Results and Discussion
In case of farm A, piglets in vaccinated group had a signifi cant 
lower (P<0.05) mean of lung lesions score (1.4±0.7) than piglets 
in placebo-treated group (2.7±1.3). Vaccine effi  cacy in reducing 
lung lesions score was 48%.
In case of farm B, although there was no signifi cant diff erence 
in lung lesions between treatment groups, piglets in vaccinated 
group had lower mean of lung lesions score with placebo-treat-
ed group and vaccinated group being 1.8 and 2.5, respectively. 
Under the conditions described in this study, vaccination against 
PCV2 in piglets would reduce lung lesions at slaughter. 
Figure 1. Lung lesion scoring in vaccinated pigs and placebo-treated 
pigs at market age (Farm A).
Figure 2. Lung lesion scoring in vaccinated pigs and placebo-treated 
pigs at market age (Farm B).
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Detection of Mycoplasma hyopneumoniae from porcine nasal cavity in vaccination against PCV2 in Korea
Seung Hyuk Yang; Yeong Hun Kim; Jeong Hee Han
School of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, Korea
Introduction
Mycoplasma(M) hyopneumoniae, the primary pathogen of 
enzootic pneumonia, is an integral component of the porcine 
respiratory disease complex(PRDC). M. hyopneumoniae causes 
to increase susceptibility to other respiratory disease. The vac-
cination is easy to control MH infection. Porcine circovirus type 
2(PCV2) is considered to be the causative agent of PMWS. PCV2 
infection aff ects pig’s immune system and increases susceptibil-
ity of other viruses and bacteria. PCV2 is widely prevalent in pigs 
with PRDC and should be considered a major respiratory patho-
gen. The interaction of PCV2 with other respiratory pathogens 
plays an important role in developing PRDC. The PCV2 vaccina-
tion reduces clinical signs of respiratory and the detection rate 
of other respiratory pathogens in vaccinated pigs. The inter-
actions with diff erent respiratory pathogens, porcine reproduct-
ive and respiratory syndrome(PRRS), swine infl uenza virus(SIV) 
and Actinobacillus pleuropneumoniae (APP) were studied. It was 
the purpose of this study to evaluated the detection rate of M. 
hyopneumoniae from nasal swabs in vaccination against PCV2.
Materials and Methods
A total of 40 3-week-old piglets were allocated into 2 groups and 
either vaccinated against PCV2(DSPCV2 ®,Korea) and treated 
with a placebo. Pigs were inoculated intramuscularly with 2.0 ml 
either the vaccine or saline at three weeks of age. Blood samples 
were collected in each pigs at four diff erent points during their 
growth period: 3, 6, 9, 16 weeks of age. Antibody titers were 
evaluated by using ELISA Kit(Mycoplasma hyopneumoniae Anti-
body Test Kit (IDEXX,USA). Intranasal swabs were collected from 
nine pigs of vaccination groups and eight pigs of placebo group 
at 3, 6, 9, 16 weeks of age. M. hyopneumoniae DNA was ex-
tracted by using Accuprep® Genomic DNA extraction kit(Bioneer, 
Korea) and detected with nest-PCR and conventional PCR. For 
statistical analysis, student t-test or Wilcoxon Mann-Whitney test 
was used in order to assess diff erences with regard to serology. 
Statistical analyses were performed using SAS software release 
8.2. 
Results
The infection of M. hyopneumoniae was demonstrated by ELISA 
in serum and PCR in nasal swabs. The high antibody titers of 
M. hyopneumoniae were detected in non-vaccinated group 
against PCV2 compared to vaccinated group (table 1). M. hyo-
pneumoniae seroconversion was observed at 9 weeks of age in 
non-vaccinated group against PCV2. M. hyopneumoniae DNA 
was detected in 37.5% at 9weeks of age , 25% at 16weeks of 
age in non-vaccinated group. M. hyopneumoniae DNA was only 
detected in 11% at 9weeks of age in vaccinated groups against 
PCV2 using nested PCR (table2). 
Table 1:
Age 3 6 9 16
Vaccinated group 0.132±0.024* 0.281±0.139 0.428±0.082 0.259±0.159
Non-vaccinated group 0.123±0.021 0.363±0.110 0.528±0.176 0.276±0.133
P-value 0.4273 0.3578 0.1706 0.6912
Table 2: 
Age 3 3 6 6 10 10 16 16
PCR Con Nested Con Nested Con Nested Con Nested
PCV2 
vaccine 0/9 (0.0) 0/9 (0.0) 0/9 (0.0) 0/9 (0.0) 0/9 (0.0)
1/9 
(11.0) 0/9 (0.0) 0/9 (0.0)
Placebo 0/8 (0.0) 0/8 (0.0) 0/8 (0.0) 0/8 (0.0) 0/8 (0.0) 3/8 (37.5) 0/8 (0.0)
2/8 
(25.0)
Discussion 
The infection and antibody titers of M. hyopneumoniae de-
creased in the PCV2 vaccination group. The high titers of PCV2 
antibody is intended to decrease antibody of M. hyopneu-
moniae and decrease of detection of M. hyopneumoniae 
antigen in nasal swabs. The PCV2 is supposed to infl euence the 
infection of M. hyopneumoniae. In addition, the nest-PCR is 
eff ective method to detecting M. hyopneumoniae DNA in nasal 
swabs. 
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Eﬃ  cacy of PCV2 Vaccination on Morbidity under Philippine Field Conditions
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Introduction and Objective
In the Philippines a phylogenetic analysis of the sequences of 
PCV2, isolated from PMWS aff ected local farms, allocated isolates 
into a PCV2 subgroup with Canadian and European isolates (1). 
Suvaxyn® PCV2 (Fort Dodge Animal Health, USA) is the Chi-
meric PCV1-2 vaccine containing immunogenic capsid gene of 
PCV2 cloned into the backbone of the non-pathogenic PCV1. 
Experimental vaccination with the chimeric PCV1-2 signifi cantly 
reduced viraemia and decreased the risk of clinical diseases (2). 
It is on this basis that an effi  cacy study was performed to meas-
ure the diff erence in morbidity cases between vaccinated and 
control animals under Philippine fi eld condition.
Material and Methods
Three farms were selected where PMWS had been positively 
identifi ed through the analysis of clinical signs, histopathology 
lesions and a specifi c PCV2 antigen fl uorescent antibody test. At 
each trial site the pigs were individually ear tagged, numbered 
and colour coded to indicate the treatment group. Codes were 
not known to the farms and the identity of the vaccines (Su-
vaxyn PCV2 or placebo) was blinded when administered. 
Individual animals were clinically evaluated on days 0, 21 and 
84 post vaccination. The signs evaluated were body condition, 
presence of respiratory and digestive clinical signs (coughing, 
dyspnea and diarrhea) and behaviour. Pigs’ body condition 
was recorded by applying a numeric value ranging from 1 to 6, 
based on individual evaluation of the pelvis, vertebrae and ribs 
(3). Presence of coughing, dyspnea, diarrhea in the animals and 
their behaviour was recorded (4) with a numeric value ranging 
between 0 and 2. The clinical score (CS) was calculated as:
CS = [(numeric value of diarrhea + numeric value of behaviour + 
numeric value of coughing + numeric value of dyspnea divided 
by 4) + (6 - numeric value of physical condition)].
Morbidity, expressed as a percentage of the group was calcu-
lated as the number of animals with a CS higher than 0, divided 
by the total number of pigs of the clinical study on days 0, 21 
and 84 of the study.
Result and Discussion
Morbidities (%) recorded on each farm are shown in Table 1. 
These percentages refl ect the number of pigs transferred to 
nursery or hospital pens during the course of the trial.
Table 1. Percent morbidities.
Farm Name Replicates Vaccinated (Nos.) Control (Nos.)
Farm 1 1 6.7% (8/120) 9.2% (11/120)
2 5.0% (6/120) 8.3% (10/120)
Total 5.8 % (14/240) 8.8 % (21/240)
Farm 2 1 6.7% (8/120) 13.3% (16/120)
2 4.1% (5/122) 9.8% (12/122)
Total 5.4 % (13/242) 11.6% (28/242
Farm 3 1 7.6% (9/119) 12.5% (15/120)
2 7.6% (10/130) 14.6% (19/130)
Total 7.6 % (19/249) 13.6% (34/250)
The vaccinated groups had overall signifi cantly reduced inci-
dence of morbidity (one sided p < 0.001). The controls were 
1.90 (95% confi dence limits = 1.31, 2.77) times as likely to have 
morbidity.
These diff erences were not signifi cant (p = 0.15) on piggery Farm 
1, but they were on Farm 2 (p = 0.01) and Farm 3 (p = 0.02). 
Thus on the majority of the farms there was a signifi cant reduc-
tion in the levels of morbidity in the Suvaxyn PCV2 vaccine 
group. These results are consistent with an immune response 
that acts to lessen the impact of the presence of PCV2 on pig 
growth. 
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The reproduction and production improvements in a South African commercial 
piggery after introducing whole herd vaccination against PCV2
Pieter J. Grimbeek
Private Practitioner, Potchefstroom, South Africa
Introduction
A wide range of clinical signs and diseases can be associated 
with PCV2 infection, including PMWS, PDNS and reproductive 
failure. While piglet vaccination has been proven to be the most 
eff ective tool to control losses attributable to PCV2 infection 
in grow-fi nish pigs (1), sow and gilt vaccination might have a 
positive eff ect on reproductive performance (2). This is the fi rst 
report evaluating the benefi ts of whole herd vaccination (sows, 
gilts, boars and piglets) with Ingelvac CircoFLEX®, a subunit 
PCV2 vaccine that became available in South Africa mid 2008 
under a special import permit. 
Materials and Methods
The piggery is a 4500 sow continuous fl ow, farrow to fi nish unit. 
Most if not all the modern diseases except for PRRS and SIV are 
present. 
During the fi rst quarter of 2008 a nutritional insult resulted in 
poor on farm performance that was exacerbated by an acute 
PCV2 challenge with subsequent clinical outbreaks of PMWS 
and PDNS. PCV2 infection was confi rmed by both serology 
and immunohistochemistry. A Ingelvac CircoFLEX® vaccina-
tion program was then implemented in September 2008. All 
piglets were vaccinated at 18 days of age. As the reproduction 
parameters were severely challenged and had in fact been 
under pressure for some time a calculated decision was taken to 
vaccinate the breeding herd as well. All the gilts, sows and boars 
were vaccinated once with one ml of CircoFLEX® intramuscu-
larly, irrespective of their status, and repeated with the same 
dosage when the sows were 90 days pregnant. All future gilts, 
when entering the herd as maidens, were vaccinated at 168 days 
of age and then, if successfully mated, repeated at 90 days of 
pregnancy. 
Farrowing rate, number of piglets born alive and weaned/litter, 
pre wean mortality for the eff ect of breeding herd vaccination 
and post wean mortality for the eff ect of piglet vaccination were 
evaluated before and after implementation of PCV2 vaccination 
with one-way ANOVA, pairwise comparison, using vaccination 
status as variable factor, and the Dunnett’s Test as a post hoc test 
(Statitistica® v8.0, Statsoft®, USA). 
Results
Accurate and comprehensive on farm records are kept depicting 
all actions and performance levels. Results are summarized in 
table 1. Figure 1 demonstrates that not only the number of pig-
lets weaned per litter increased, but consistency of production 
improved as well.
Table 1: Performance parameters before and after implementation of 
PCV2 vaccination in sows and piglets. 
Before CircoFLEX® After CircoFLEX® 
Farrowing rate 82a 88b
Born alive 10.7a 11.1b
Weaned/litter 9.2a 9.7b
Pre wean mortality 15.0a 14.2a
Post wean mortality 6.3a 3.2b
a,b: fi gures with diff erent superscripts are signifi cantly diff erent (p< 0.05)
Figure 1: Monthly records of weaned pigs/litter. 
Discussion
The results of this fi eld observation confi rm that PCV2 piglet vac-
cination is a very eff ective tool to control PCVD in wean-to-fi nish 
pigs. PMWS and PDNS disappeared from the herd and post-
wean mortality was reduced signifi cantly. Furthermore, in this 
case the improvement in reproductive performance indicates 
that vaccinating the breeding herd with Ingelvac CircoFLEX 
might have additional benefi ts on top of piglet vaccination. 
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Eﬀ ects of PCV2 vaccination on market weights and mortality rates on commercial farms in the Philippines
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Introduction and Objective 
Porcine Circovirus Associated Diseases (PCVAD) is a broad cat-
egorization of multi-systemic diseases that can be sub-clinical 
or cause a severe economic impact due to its ability to cause 
high mortality and lowered growth performance (1, 2). The main 
causative agent of the disease is Porcine Circovirus Type 2 (PCV2) 
but other factors are required for clinical signs and lesions to 
appear (3). In the Philippines a phylogenetic analysis of the 
sequences of PCV2, isolated from PMWS aff ected local farms, 
allocated isolates into a PCV2 subgroup with Canadian and Euro-
pean isolates (4). Suvaxyn® PCV2 (Fort Dodge Animal Health, 
USA) is the Chimeric PCV1-2 vaccine containing immunogenic 
capsid gene of PCV2 cloned into the backbone of the non-
pathogenic PCV1. Experimental vaccination with the chimeric 
PCV1-2 signifi cantly reduced viraemia and decreased the risk of 
clinical diseases (5). This study determined the eff ects of PCV2 
vaccine on market weight and mortality in commercial farms in 
the Philippines.
Material and Methods
Three 500 sow level farms in Luzon (the Philippines) were as-
sessed for PCVAD using clinical signs, histopathology lesions 
and a specifi c PCV2 antigen fl uorescent antibody test. A total 
of 770 piglets from the three farms were included in the study 
(Table 1). All piglets in the vaccinated group were given a 2mL 
Suvaxyn PCV2 intramuscular injection at 28 days of age. Harvest 
weights were taken at 165 days. Mortalities from day 28-150 
were recorded.
Results and Discussion
Table 1. Average weight at harvest and percent mortalities
Farm Type Number of Heads Average Harvest Weight (kg) Mortality (%)
Farm 1 Control 80 69.54 14
Vaccinated 80 74.21 8
Farm 2 Control 93 72 16
Vaccinated 130 78 12
Farm 3 Control Previous Average Performance 87 22
Vaccinated 387 92 7.29
All vaccinated groups on the three farms showed a marked 
improvement in harvest weight and a signifi cant decrease in 
mortalities compared to controls (Table 1).
The farms also noted that they experienced less respiratory 
problems and decreased incidence of slow growers in the vac-
cinated groups.
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Impact of CIRCOVAC® sow PCV2 vaccination on piglet weaning weight
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Introduction
Early exposure to PCV2 compromises the ability to respond to 
infectious agents (viral and bacterial) if the pig is exposed to 
PCV2 without the presence of protective passive immunity. The 
objective of this study was to evaluate the eff ect of CIRCOVAC® 
sow vaccination on the pre-weaning performance of the pigs.
Material and Methods
The chosen farm was a 1,270-sow indoor breeding unit farrow-
ing 60 sows per week and weaning off  site. 
PCVD haven’t been previously diagnosed on the progeny of this 
breeding unit and no PCV2 vaccine was being used before this 
study.
Dam line gilts were weaned before the weighing and were not 
included in this study.
The average weaning age before and after was approximately 
28 days. Sows started being vaccinated with CIRCOVAC in June 
2008, following the recommended protocol. 
To evaluate the impact of PCV2 sow vaccination on piglet wean-
ing weight 1,007 piglets from non-vaccinated sows and 955 pigs 
born from vaccinated sows were weighed at weaning. The skew-
ness and kurtosis values of the weights at weaning were studied 
following a normal distribution (at 95%) and the live weaning 
weight (LWW) before versus after vaccination was compared 
using the following statistical tests, Bartlett test, student t-test 
and Kruskal-Wallis one way analysis of variance.
The distribution of pigs in diff erent weaning weight groups was 
also evaluated using chi2 test.
Results
The number of total pigs born alive per litter for a period of 35 
weeks before and after CIRCOVAC sow vaccination started, was 
11.1 and 11.3, respectively. The number of pigs weaned on aver-
age per litter for the same period was 9.5 and 9.4, respectively. 
This was due to the PRRS problems that aff ected the sow herd 
and impacted in the general sow health.
The results of the analysis of the data collected can be seen 
on table 1. A signifi cant improvement in the average weaning 
weight after the use of vaccine of 0.93 Kg was showed (student 
t-test and Kruskal Wallis tests; p<0.001 and <0.001 respectively).
Table 1: Evaluation of the weaning weights before and after sow vac-
cination
Before vaccination 
(n=1,007)
After CIRCOVAC vaccina-
tion (n=955) Delta
Mean 7.73 8.66 0.93 (p<0.001)
Std 1.486 1.424
The percentage of pigs weighing less than 6, 7 or 8 kg of LWW 
can be seen on table 2.
Table 2: Percentage of pigs weighing less than 6, 7 or 8 kg of LWW
Before Vaccination 
(n=1,007)
After CIRCOVAC Vaccination 
(n=955)
% pigs < 6kg LWW 12.1a 1.8b
% pigs < 7kg LWW 33.5a 11.6b
% pigs < 8kg LWW 56.4a 32.8b
a,b Diff erent superscripts in the same row mean signifi cant diff erence (Chi2 test; p<0.001).
Discussion 
Lighter weaning weights and percentage of small pigs are as-
sociated with higher mortality and slower growth. Heavier pigs 
perform better from weaning to slaughter, result of higher daily 
live weight gains (1, 2). 
A signifi cant improvement in the mean weaning weight of 0.93 
Kg was observed in this study. 
Reduction of the number of pigs with a low weaning weight 
have the advantage of making multi-site systems easier to man-
age (2) and may also represent a direct fi nancial improvement to 
the breeding herd as some weaner producers receive premiums 
based on weaning weights.
In this study, the use of CIRCOVAC resulted in the reduction of 
the percentage of pigs weighing less than 6 kg from over 12.1% 
to 1.8%. The improvements observed may be attributed to the 
protection granted by maternally derived immunity against 
PCV2 challenge, which improves the health of the animals from 
birth, improving the growth of the animals, resulting in a higher 
weight at weaning.
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Comparison of CIRCOVAC® (Merial) and a recently licensed PCV2 weaner vaccine in UK condition
Frank Tobin
Holmefi eld Farm Services, Agriculture House, Murton, UK
Introduction
The fi rst cases of PCV2 associated diseases (PCVD) in the UK 
occurred in 1999. The cost of PCVD to European pig producers 
was calculated to reach 562-900 M€ per year (1). PCV2 vaccines 
proved to be an effi  cient tool to control PCVD. 
The fi rst available vaccine, CIRCOVAC® (Merial) (CVAC) was 
licensed for use in breeding animals but was used to vaccinate 
piglets at weaning in cases where management factors would 
compromise the effi  cacy of sow vaccination. The objective of 
this study was to assess the impact of a recently licensed piglet 
vaccine (FVAC) on pig performance compared to the perform-
ance achieved using the previous PCV2 vaccine licensed for 
breeding animals (CVAC).
Material and Methods
A 700-sow indoor unit was chosen for this study. Pigs were al-
located to either group randomly and individually weighed at 
weaning (W), end of the grower stage (EF) and before slaughter 
(S). The allocation of pigs was blinded to farm management. Pigs 
from 2 batches were individually identifi ed and received either 
0.5 ml of CVAC or 1 ml of FVAC administered deep intramuscu-
larly at W. 91 pigs were included in the FVAC group and 100 
pigs were included in the CVAC group. 20 pigs were bled at W 
and at the following weightings. The samples were tested by 
qPCR for quantifi cation of PCV2 genome (minimum detection 
level 2x103/ml) and qELISA for quantifi cation of PCV2 specifi c 
antibodies.
Both vaccines were compared on the following parameters: 
average daily weight gain (ADWG) in post-weaning, ADWG in 
fi nishing, ADWG from weaning to slaughter, weight at entry in 
fi nishing stage and slaughter weight. 
Two-tailed student t-test was used to compare the diff erent 
parameters of the 2 vaccines for each farm, separately.
Results
The mean parameters values of CVAC groups are always slightly 
higher than FVAC groups values in both farm (table 1), but 
there was no statistically signifi cant diff erence between the two 
groups (CVAC and FVAC) for the ADWG. The diff erence between 
both vaccines is signifi cant for the slaughter weight parameter 
only (p=0.040), in farm 1. Piglets vaccinated with the CVAC 
presented higher slaughter weight, in average, than the ones 
vaccinated with the FVAC.
The results of the blood samples can be seen on table 2. Both 
groups had high titres of antibodies at weaning. All pigs tested 
were negative at W and EF for qPCR, with 23.5% and 6.7% posi-
tives (of the sampled pigs) at S for FVAC and CVAC respectively, 
with 1 pig in the group FVAC above 106 PCV2 genome copies.
Table 1: Results of the weighing of each individual pig and the ADWG 
for farm 1 and 2
CVAC FVAC Dif
Farm 1 ADWG wean-slaughter g/day 741.4 728.9 12.4
Farm 1 ADWG fi nishers g/day 929.9 919.4 10.5
Farm 1 ADWG growers g/day 560.0 547.3 12.8
Farm 1 Weight entry fi nishing Kg 48.1 47.9 0.1
Farm 1 Slaughter weight Kg 110.9 105.2 5.7
Farm 2 ADWG wean-slaughter g/day 669.2 653.1 16.1
Farm 2 ADWG fi nishers g/day 769.6 750.3 19.2
Farm 2 ADWG growers g/day 523.4 509.7 13.7
Farm 2 Weight entry fi nishing Kg 39.0 38.1 0.96
Farm 2 Slaughter weight Kg 105.3 102.6 2.7
Table 2: Results of the qPCR and qELISA tests at diff erent stages, qPCR 
at slaughter and qELISA at W, EF and S
qPCR qELISA
Positive >106 W EF S
CVAC 6.7% 0% 2686.89 3742.63 2863.00
FVAC 23.5% 5.9% 1569.63 1088.95 3172.41
Discussion and Conclusion
Due to the small number of animals involved in this study it was 
not possible to show a statistical diff erence, except for slaughter 
weight in farm 1. Nevertheless average values of ADWG at all 
stages of production and the slaughter weight parameter are 
always slightly higher in CVAC vaccinated groups in both farms. 
In one of the vaccinated groups, FVAC had a slightly higher level 
of viremia, but this was not associated to disease (2, 3).
These results indicate that both vaccines are effi  cient tools for 
the control of PCV2, resulting in performance improvement.
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Introduction
Porcine circovirus diseases (PCVD) have been described in Brazil 
since 2000. PCV2 vaccination effi  cacy with CIRCOVAC® has been 
extensively confi rmed (1, 2) so it has been decided not to carry 
out a trial with negative control.
The objective of this study was to evaluate the eff ect of CIRCO-
VAC vaccination over wasting versus 2 other commercial PCV2 
vaccines marketed in Brazil, under Brazilian fi eld conditions.
Material and Methods
The experiment was carried out in a commercial farm with PCVD 
clinical diagnosis previously established. A total of 1,800 3-week-
old piglets were individually weighed and randomly allocated 
into 3 groups (600 per treatment) vaccinated at weaning:
Treatment 1 (T1): CIRCOVAC, 0.5 ml once
Treatment 2 (T2): Vaccine X, 2 ml once
Treatment 3 (T3): Vaccine Y, 1 ml once
Serology was performed by ELISA using the IT-BAN-028-ELISA-
Test (Nano-Core®, NJ, USA). Three hundred serum samples were 
collected before vaccination i.e. at 21 days of age and at 36, 66, 
96 and 126 days. The experimental unit was the animal for the 
daily weight gain (DWG), and the pen (40 heads) for the feed 
conversion evaluation. Animals were fed throughout the experi-
ment with ration according to the Brazilian charts values of 
poultry and swine (3). Feed consumption per pen was evaluated 
weekly.
The software package statistical analysis for genetic epidemiol-
ogy (S.A.G.E.) was used for variance analysis and mean compari-
son. For mortality rates, Chi2-test and non-parametric tests like 
Kruskall-Wallis were used.
Results and Discussion
No diff erence in weights at weaning was found between groups 
while piglet vaccination signifi cantly aff ected the nursery exit 
weight (p<0.05). CIRCOVAC vaccination and T3 led to higher 
weight gains at nursery and slaughter (see Table 1). T1 and T3 
showed globally better growth performances than T2 (see Table 
1). Performing serologies at diff erent piglet ages, T1 showed 
higher titres and all treatments showed a signifi cant increase 
starting at 66 days of age, which led to the hypothesis of wild 
virus exposition from that day on. In all groups a signifi cant 
increase in the antibody titres for PCV2 was observed and these 
were kept high until 126 days (see Figure 2).
Figure 1: Serology results: mean of antibody titres per treatment at 
diff erent ages
Conclusion
CIRCOVAC-vaccinated piglets (T1 group) and T3 induced similar 
weight performance. T1 group showed a stronger seroconver-
sion after vaccination and kept higher ELISA antibody titres up 
to the end of the experiment compared with the 2 other treat-
ments.
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Table 1: Growth performance at nursery stage (until 65 days of age) and globally until the end at 145 days of age and mortality
Treatment Mortality rate
Weaning 
weight (kg) Nursery exit weight (kg)
Nursery DWG 
(kg)
Nursery feed 
conversion ratio
Final weight 
(kg)
Global DWG 
(kg)
Global feed con-
version ratio
Total consumption 
of ration
T1 3.16% 5.222 a20.829 a0.354 1.504 a90.565 a0.688 2.242 191.339
T2 3.33% 5.243 b20.306 b0.342 1.574 b88.580 b0.672 2.244 187.008
T3 2.5% 5.233 a20.905 a0.356 1.511 a90.226 a0.685 2.270 192.934
Variance analysis: diff erent superscripts in the same column mean signifi cantly diff erent values (p<0.05).
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Report on the impact of early exposure by PCV2 in a vaccinated ﬂ ow
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Introduction
Porcine circovirus associated diseases (PCVAD) have had a mas-
sive negative impact on the global pig industry.1 The availability 
of effi  cacious commercial vaccines has vastly reduced the clin-
ical signs associated with PCVAD, especially the high mortality 
rates, wasting and increased frequencies of co-infections with 
other pathogens.2 In this case report we describe the impact of 
shifting PCV2 infection dynamics in a herd in which PCVAD had 
previously been well controlled by pig vaccination at fi ve weeks 
of age.
Case History
This case involves a PRRS naïve and Mycoplasma hyopneumoniae 
(M. hyo) positive, single site, 1100 sow farrow to fi nish facility. 
Pigs are weaned at three weeks of age. Nursery rooms are fi lled 
by two weaning events per week. Piglets are vaccinated with 
Ingelvac CircoFLEX® and Ingelvac MycoFLEX® at fi ve weeks of 
age. The index nursery room was fi lled with weanings on August 
3rd and August 6th. An increased mortality rate was observed 
beginning three weeks post weaning. The average mortality for 
the nursery stage had been 2.51% but increased to 10.8 % for 
the index room. The average mortality for the fi nisher stage had 
been 1.77%, which increased to 4 25% in the room housing pigs 
from the index nursery room. 
The clinical signs in the index nursery room included wasting 
body condition, respiratory distress, and acute mortality. On 
September 15th, tissue samples, nasal swabs and serological 
profi ling diagnostics of the nursery pigs were performed. The 
average pig age for the index room was 60 days. The results from 
this initial workup showed moderate amounts of PCV2 antigen 
using IHC staining in the lung and lymphoid tissues confi rming 
a systemic PCV2 infection. Bacterial pneumonia was also present 
and Streptococcus suis was isolated. M. hyo PCR testing was 
negative. Thirty gestating sows were then serologically profi led 
(September 17th) from diff erent breeding weeks and various 
parities. The sow sera were tested using PCV2 quantitative PCR 
(qPCR) and all samples were below the detectable level of <4 
logs/mL serum. Additionally, 60 total serum samples were col-
lected (15 for each age) from randomly selected pigs 21, 31, 41 
and 47 days. The growing pig sera were tested using PCV2 qPCR 
and only one sample in the 47 day of age group had detectable 
viremia (>4 logs of genetic copies of PCV2 virus/mL serum). On 
September 22nd, a more encompassing tissue collection from 
pigs 31, 41, and 68 days of age was performed. PCR results indi-
cated PCV2 genetic material presence in pooled tissue samples 
of all ages. Tissue PCV2 IHC results were negative for PCV2 anti-
gen in the 31 day and 41 day of age tissues but strongly positive 
in the lung and lymphoid tissue from the 68 days of age group. 
Swine infl uenza, PRRS virus, M. hyo and other respiratory patho-
gens test results were negative. The laboratory diagnosis was 
severe interstitial pneumonia associated with PCV2 infection 
and a mild enterocolitis was also associated with PCV2 infection. 
PCV2 was detected at high levels in the tissue pools; therefore 
the diagnosis was confi rmed to be PCVAD. 
Although reproductive symptoms of PCV2 infection are some-
times hard to detect, and no abnormal reproductive clinical 
signs were observed, a parity 1 female aborted her developing 
litter on October 21st, 2009. Six fetuses were collected and 
submitted for diagnostic testing. Results for PCV2 IHC on heart 
samples were positive (3+) and multifocal areas of mineraliza-
tion were present in multiple heart sections.
A diagnostic investigation that included intense profi ling of 
sows in farrowing and their off spring was initiated. The colos-
trum from 30 sows was collected immediately after farrowing. 
Twenty-fi ve pigs were selected from diff erent litters, tagged 
and serially serum profi led at seven days of age, weaning (ap-
proximately 20 days of age), and again at 42 days of age. One 
colostrum sample was positive for PCV2 virus by qPCR, 30% of 
the piglets were positive by qPCR at 20 days of age, although 
there were no positive piglets detected at either 7 or 42 days of 
age by qPCR.
Discussion and Conclusions
PCV2 exposure does occur in the adult swine herd, although 
the results of the infection may be reproductively inapparent. 
Infection of the adult herd may result in viral transmission from 
the sow to her off spring.2 A comprehensive diagnostic program 
is necessary to understand PCV2 infection dynamics in cases of 
early clinical symptoms of PCVAD.3 Early exposure in this case 
(prior to planned vaccination) resulted in increased mortality 
and poor growth performance beginning in the nursery which 
persisted into the fi nisher stage. Although mass PCV2 vaccina-
tion of the sow herd and moving piglet vaccination earlier (to 
the time of weaning at 3 weeks of age) was followed by dis-
appearance of clinical signs, additional work is needed to fully 
understand the risk factors involved in this case.
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Protection of viral shedding after challenge with porcine circovirus type 2 (PCV2) 
inactivated bivalent vaccine in vaccinated speciﬁ c pathogen free (SPF) pigs
Hyoung Joon Moon; Dae Sub Song; Tae Hoon Oh; Min Joo Yeom; Bo Kyu Kang; Jong Man Kim
Research Unit, Green Cross Veterinary Products, Yong In, Korea
Introduction
Porcine circovirus 2 (PCV2) is non enveloped single stranded 
DNA virus cause the complicated syndrome called porcine 
circovirus-associated disease (PCVAD) which is one of the issue 
in pig industry in the world. To reduce the economic loss from 
PCVAD, many kind of eff ective PCV2 vaccines have been de-
veloped and used[2]. This study is aimed to evaluate the vaccine 
effi  cacy through viral shedding in nasal discharges and feces 
after challenging to piglets which were vaccinated with inacti-
vated PCV2 vaccine containing both PCV2a and PCV2b strains 
isolated in Korea. 
Materials and Methods
Experimental design
The details of the experimental designs were presented in table 1.
Vaccination* Challenge† Heads of pigs‡
Twice§ PCV2 4
Non PCV2 2
Non Non 1
*: PCV2 inactivated bivalent vaccine (PCV2a+PCV2b) from Green Cross 
veterinary products co. ltd. (GCVP)
†: Field isolates PCV2b, 105.0TCID50/ml, Two weeks after booster.
 ‡: 3-week old SPF pig, §: Two weeks interval, 1ml/dose, IM
Clinical signs and sampling
Clinical signs had been observed for 14 days after challenge. In 
order to measure the titers of released virus, nasal swabs and 
rectal swabs were collected at the day of challenge, 3, 7, 10, 14, 
17, 20, 25 days after challenge. 
Virus shedding
Shedding of PCV2 was measured using quantitative SYBR real 
time PCR in nasal swabs and rectal swabs. The released viral titer 
was converted to immune fl uorescent assay (IFA) titer using 
standard curve. The viral titers in each group were compared 
statistically. 
Results
Clinical signs
There were no clinical signs in vaccinated and PCV2 challenged 
group, however pathognomic signs of PCV2 infection including 
anorexia, mild loose feces, wasting were shown in some pigs 
which was challenged without vaccination.
Virus shedding
Viral shedding in nasal discharges and feces were low and 
stopped until 14 days after challenge in vaccinated group (vac-
cinated and challenged). However, the viral shedding in non 
vaccinated group was high and lasting more than 31 days after 
challenge in both nasal swabs and rectal swabs.
Discussion 
So PCV2 is transmitted via fecal oral infection that this experi-
ment was focused on viral shedding. The results of this experi-
ment were nearly corresponded with previous study in viral 
shedding in nasal discharges and feces[1]. Unfortunately, this 
study did not cover with viremia and serology like in former 
study. However, as presented in this study this vaccine could ef-
fi ciently reduce the viral spreading through the nasal discharge 
and feces. Reduction of the viral shedding could relieve the 
chance of the transmission of PCV2 to nascent pigs, and prevent 
the risk of PCVAD in pig heard. To our knowledge, this small 
experiment is the fi rst report about the effi  cacy test of PCV2 
inactivated vaccine including inactivated whole viruses of both 
PCV2a and PCV2b strains. 
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Figure 1. Shedding of PCV2 in nasal discharges (A) and rectal swab (B) in PCV2 inactivated bivalent vaccine in pigs. The mean titer in vaccinated 
group was 100.82TCID50/ml and 101.13TCID50/ml after challenge in nasal swabs and rectal swabs, respectively.
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Seroproﬁ le survey of anti-PCV2 blocking Elisa antibodies of non-vaccinated 
and CIRCOVAC® vaccinated pigs in PCVD-aﬀ ected SPF farm
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Introduction
Infections of pigs with porcine circovirus 2 (PCV2) is associated 
with a broad spectrum of clinical conditions recognized as Por-
cine circovirus diseases (PCVD). Under certain circumstances the 
illness could be observed in the farm of specifi c pathogens free 
status (SPF), where low infection pressure and good standard of 
management are expected (1). The objective of this fi eld obser-
vation was to describe the changes of the health situation in SPF 
pig farm caused only by PCV2 infection shortly after repopula-
tion and to show an eff ect of sow vaccination by CIRCOVAC® on 
serological profi les in pigs of diff erent age, on clinical changes 
and production results.
Material and Methods
The farrow-to-fi nish pig farm was repopulated in the end of year 
2005. New health status of the farm was free of PRRSv, M.Hyo, 
APP, Swine dysentery and P. multocida DNT+. About 1 year after 
repopulation sporadic health disorder (suddenly died suckings, 
wasting and icteric postweaners, suddenly died boars) and 
decrease of production results (total born and weaned piglets/
sow) were observed. Investigation was focused on PCV2 infec-
tions using IHC method in lympho-nodes, quantitative PCR and 
competitive blocking ELISA (CB-ELISA) to show the dynamics of 
PCV2 antibodies (seroprofi les) in pigs before and after vaccina-
tion by CIRCOVAC® (batch vaccination and revaccination of preg-
nant sows and gilts). Blood samples were collected the same day 
from 5 pigs per group at 4, 8, 12 and 16 weeks of age and from 
5 sows according the parity and from 5 gilts (70kg). Pigs from 
each group were bled before initialization of vaccination and at 
3 and 6 month after the beginning of vaccination. CB-ELISA uses 
an HRP-labelled specifi c anti-PCV2 monoclonal antibody (1C6) 
as a conjugate which compete with serum antibodies for PCV2 
antigen determinants on immobilized PCV2 proteins. Blocking 
PCV2 antibody titres were measured at three diff erent dilutions 
1:100, 1:1000 and 1:10000. Any serum sample presenting ≥ 40% 
of blocking activity at appropriate dilution was considered posi-
tive for the presence of PCV2 antibodies, any sample presenting 
<40% of blocking activity were considered negative. Mean anti-
body titres and standard deviation in each group were tested 
using a Student T-test between two groups for each defi ned age.
Results
PCVD diagnostic in SPF herd was confi rmed by both IHC and 
quantitative PCR methods according to internationaly recog-
nized procedures (www.pcvd. org). Seroprofi les based on the 
mean of CB-ELISA PCV2 antibody titres in sows and their pro-
geny are shown in Figure 1. 
Figure 1. 
a, b: diff erent superscripts at the same age group mean that PCV2 antibody levels are signifi -
cantly diff erent.
Dynamics of antibody response to PCV2 infection (round points) 
in piglets and growing pigs show an initial drop of anti-PCV2 
antibody levels to be the lowest at the age of 12 weeks. Further 
stage of monitoring using CB-ELISA exhibits a sharp seroconver-
sion reaching the peak at the age of 16 and more (70 kg gilts). 
Similar seroprofi le was seen in pigs born to vaccinated (squared 
points) sows but PCV2 antibody levels were signifi cantly higher 
at the age 4 and 8 weeks after 3 month since the beginning of 
CIRCOVAC® application and the active PCV2 antibody increase 
started at the age of 16 weeks but this increase was gradual. The 
PCV2 antibody level was signifi cantly higher in the blood of vac-
cinated sows at 1.+2. and ≥5. parity both 3 and 6 month since 
the beginning of Circovac application.
Discussion and Conclusion
Except of health status and production parameters improve-
ments, the eff ect of sow vaccination by CIRCOVAC® was ob-
served in serological profi les comparable with other authors 
(2): i) the mean of CB-ELISA PCV2 antibody titres were more 
homogenous in vaccinated sows of all parity and in their piglets 
till 8 weeks of age, ii) the active PCV2 antibody increase in pigs 
born to vaccinated sows occured later in life and it was gradual 
indicating lower PCV2 infection pressure within the herd.
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Introduction
Porcine circovirus (PCV) is one of the factors involved in the 
disease entity known as porcine respiratory disease complex 
(PRDC). When it was introduced into the country, it provided 
Thai pig producers with a unique challenge in diagnosis and 
control. 
Current PCV2 vaccination has reduced the problem markedly 
(Thanawongnuweach, R., 2009). Circumvent PCV was introduced 
into Thailand in May 2009, and is the vaccine of choice. The aim 
of this study was to compare performance before and after insti-
tuting a vaccination program with Circumvent PCV.
Materials and Methods
This trial was carried out on a 4,000-sow farrow–to-fi nish farm, 
on which pigs were weaned at 24 days of age on average, and 
kept in the nursery for 3-4 weeks, before being moved to the fi n-
ishing house where they remained until slaughter at an average 
24-25 weeks old. The farm was experiencing a severe problem 
with PRDC. 
Pigs were vaccinated with 2ml Circumvent PCV 4 and 6 week of 
age. Pigs were observed for local or systemic reactions following 
vaccination, culling and mortality rates (% Loss), average daily 
weight gain (ADG) and feed conversion ratio (FCR) were all re-
corded. These performance data were compared with the same 
parameters before the start of Circumvent PCV vaccination. 
Results and Discussion
Local reactions were observed in 0.8% of pigs after the fi rst 
Circumvent PCV dose, and 0.16% after the second. 
The performance data are compared in Table 1. 
Table 1: Comparison of performance data before and after the Cir-
cumvent PCV program
Before Circumvent PCV Diff .
% Loss 13.41 5.68 7.73
FCR 2.44 2.40 -0.04
ADG (g) 738 759 21.00
The Circumvent PCV vaccination program led to a lower per-
centage mortality (and fewer culls), lower FCR and greater ADG 
when compared with the period prior to the use of the vaccine 
(Francisco de Grau, A. et al., 2007; Thacker, B. et al., 2008). 
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Eﬀ ect of Piglets PCV2 Vaccination with CIRCOVAC® in the Farm with Severe 
Porcine Circovirus Type 2 Disease (PCVD) in Post-Weaning
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Introduction
Porcine multisystemic wasting syndrome (PMWS) is well known 
and described as caused by porcine circovirus type 2 (PCV2) in 
post-weaning period of piglet rearing (1,2). The main clinical 
symptoms are wasting, daily weight gain (DWG) depression, 
heterogenity in size, high mortality and outbrake of co-infec-
tions. CIRCOVAC®, an inactivated, adjuvanted vaccine is pos-
sible to use successfully in sows in accordance with the leafl et 
recommendations (3). PCV2 vaccination of piglets may also be 
an eff ective way to prevent PMWS. 
The objective of this fi eld study was to analyse the eff ect of 
CIRCOVAC® piglets vaccination in a farm with clinical symptoms 
of PMWS and high viral pressure.
Material and Methods
The studied farm is a conventional 100-sow farrow-to-prefatten-
ing farm where clinical signs of PMWS were observed and PCV2 
presence was confi rmed. Clinical symptomatology, DWG and 
mortality were recorded in 4 batches and compared to results of 
the following post-weaner batches under CIRCOVAC® vaccina-
tion. The farm was serologicaly ELISA-positive to PRRS, M. Hyo, 
APP 2,9,11, bacteriologically Str. Suis, H. parasuis, and S. typhy-
murium were earlier identifi ed. 
Sow vaccination schedule: commercial vaccines EC+Clostridium, 
Ery+Parvo, APP in label recommendation, live PRRS vaccine 14 
days after farrowing.
Piglets vaccine schedule: Respisure One (Pfi cer Animal Health), 
APP at 9+12 weeks of age. CIRCOVAC® vaccine 0,5 ml, IM at 
21 days of age, into neck behind the ear. No new changes of 
husbandry (Madec´s point) had been implemented during the 
study.
Lab investigations: presence PCV2 in lesions was confi rmed by 
immunohistochemistry (IHC) and qPCR (4,02E7 – 4,19E9/.
Statistical analysis: a Student t-test was used to compare the 
DWG, and a Chi-square test was used for mortality rate compari-
son. Statistical analyses were performed with STATGRAPHICS 
5.1 (for Windows) and SAS 9.1 (SAS Institute, Cary, NC) software. 
Statistical signifi cance is based on a two-tailed test of the null 
hypothesis resulting in p-values of 0.05 or less.
Results
The production result comparison is shown in table 1. The eff ect 
of vaccination was noticed in the fi rst vaccinated batch of post-
weaners. Absence of wasting, better homogenity in pig size, 
better vitality, less cases of post-weaning diarhoea and sharp de-
crease of mortality were observed. Polyserositis were found less 
frequently during necropsy in the group of vaccinated piglets.
Table 1: Production results comparison of vaccinated and not vaccin-
ated piglets 
No PCV2 vaccine CIRCOVAC p value
Mortality rate in post-weaning(%) 13.35 3.68 <0.001 1
DWG in post-weaning (g) 359 434 <0.001 2
Mortality rate in fattening (%) 6.46 4.32 <0.001 1
DWG in fattening (g) 766 752 0.369 2
1 Chi-square test. 2 Student t-test.
Discussion
Nowadays the use of vaccines is very eff ective tool in prevention 
of PCVD. The use of this vaccine in piglets signifi cantly reduced 
mortality in both sections and dramatically increase DWG in 
post weaning stage. DWG during fattening showed an import-
ant variability due to other cause (checking of diff erent feedstuff  
formula in last period of fattening due to its price) and the dif-
ference between vaccinated and control did not appeared to be 
signifi cant. 
Conclusion
In this study, very signifi cant and quick eff ect on DWG and 
mortality rate was confi rmed when using CIRCOVAC® in piglets 
in age 21 days of age, in the farm with high disease incidence in 
the postweaning sections where the disesase was most promin-
ent. 
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Further development of a diﬀ erential ELISA for PCV2 vaccination compliance
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Introduction
Previous work has shown the potential for our PCV2 Diff erential 
ELISA as a compliance monitoring test for PCV2 vaccination by 
measuring antibodies that are uniquely induced by PCV2 vac-
cination.1 This test is based on using a coating antigen (PCV2 
ORF2 expressed in baculovirus grown in SF9 insect cells) that is 
similar to the antigen used in some commercial vaccines plus a 
coating antigen that lacks the ORF2 expression (referred to as 
the wild type antigen, WT).2 This system has worked well when 
pigs are tested 3-4 weeks after vaccination with a two dose 
product (Circumvent® PCV, Intervet Schering Plough Animal 
Health). However in some operations, non-vaccinated pigs will 
develop antibody to the WT antigen as they progress through 
the fi nishing phase. We presume that this non-specifi c titer is 
due to exposure to cross-reacting insect antigens. Our objective 
was to determine the components of the immune response in 
vaccinated pigs and if accounting for SF9 antigen cross-reaction 
could improve test specifi city.
Materials and Methods
Samples from a variety of previous fi eld and laboratory studies 
that were used to develop the PCV2 Diff erential ELISA test were 
tested by ELISA in duplicate using ORF2, WT and SF9 coating 
antigens. Representative data is reported here. Samples origin-
ated from pigs vaccinated with Circumvent PCV at 3 and 6 weeks 
of age or non-vaccinated control pigs. For the ELISA, appropriate 
controls including serum from vaccinated and non-vaccinated 
CDCD pigs were used on each plate. Calculation of the net optic-
al density (OD) due to baculovirus (BV) was done by subtracting 
the SF9 OD from the WT OD. Results are reported as the group 
mean average optical density value (ODV). Positive/negative 
cut-off s for the WT antigen and the BV calculated values were 
0.300 and 0.100, respectively. 
Results
Table 1 presents WT, SF9 and BV results from 3 separate experi-
ments. Sample times were at vaccination and 3 weeks after the 
second vaccination for PRE and POST, respectively. Table 2 pre-
sents BV results from two fi eld studies where the pigs were bled 
periodically until near market weight. Background BV antibodies 
were detected in Herd A at 15 and 21 weeks of age but not in 
Herd B at 14 and 25 weeks of age. BV titers and the percentage 
of positive animals were similar. 
Discussion
Vaccination with Circumvent PCV induced titers to the ORF2 
and WT antigens but not the SF9 antigen, indicating that SF9 
antigens may not be a major component in the vaccine or are 
not suffi  ciently immunogenic to induce a measurable antibody 
response. This fi nding suggests that the vaccine induces anti-
bodies mainly to ORF2 and BV but not SF9 (insect cell) antigens. 
Overall, the calculation of the BV net OD (WT minus SF9) ap-
pears to improve the specifi city of the test and may provide a 
better method for compliance monitoring compared to the WT 
antigen alone. However, the utility of the BV titer in older pigs 
is questionable due to the decline in titers observed 6 weeks or 
more after the second vaccination (both herds) and the develop-
ment of positive BV titers in non-vaccinated pigs in Herd A.
Table 1: Summary of three experimental studies
WT SF9 BV
GRP/TIME ODV POS ODV ODV POS
VAC/PRE 0.155 1/18 0.164 0.009 0/18
VAC/POST 0.616 35/41 0.245 0.371 38/41
CON/PRE 0.132 0/17 0.131 0.001 0/17
CON/POST 0.224 5/23 0.199 0.026 1/23
Table 2: BV titers over time in two fi eld studies
AGE HERD A HERD B
GRP (WKS) ODV POS ODV POS
VAC 3 0.011 0/16 -0.002 0/32
VAC 6 0.120 12/16 0.057 3/32
VAC 9 0.512 32/32 0.383 31/32
VAC 15/14 0.157 9/16 0.235 27/32
VAC 21/25 0.200 12/16 0.147 15/30
CON 3 0.001 0/16 0.000 0/6
CON 6 0.016 0/16 0.011 0/6
CON 9 0.027 0/16 0.026 0/6
CON 15/14 0.120 7/16 0.062 0/6
CON 21/25 0.140 12/16 0.030 0/5
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Evaluation of a commercial ELISA method for measuring PCV2 antibodies
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Introduction
Several tests have been developed for measuring antibodies to 
porcine circovirus Type 2 (PCV2). In the Unites States, the main 
tests currently in use include an ELISA and an indirect immuno-
fl uorescence antibody (IFA) test. These tests are routinely 
performed in several state/university diagnostic laboratories. 
Recently, a competitive ELISA based on a three dilution method 
has been developed and marketed by Synbiotics Corporation. 
This three dilution method enables calculation of a titer which 
provides a quantitative evaluation of PCV2 antibody levels. In 
this report, we present data generated from testing samples of 
vaccinated and non-vaccinated pigs over time.
Materials and Methods
The samples originated from several previous studies and had 
been stored at -20 C for up to 2 years prior to testing. Vaccina-
tions were done per label directions with Circumvent®PCV. Pigs 
were vaccinated at 3 and 6 weeks of age. Sows were vaccinated 
twice at a 3 week interval. Blood was collected prior to vaccina-
tion. Post vaccination sample times are listed in the result tables 
The competitive ELISA uses a single well blocking technique. The 
test is performed in three serum dilutions. Wells are incubated 
for 1 hr followed by a wash. Peroxidase conjugate PCV-2 Mab 
is added and incubated for 1 hour. After a second wash, TMB 
substrate is added and incubated for 30 minutes. Stop solution 
is added and the optical density is measured. Each value is com-
pared to a linear model using a logistic regression model and 
interpolation between the three results is correlated to a titer. 
Group results are expressed as geometric mean titers (GMT).
Results
Table 1 presents titer data in non-vaccinated pigs from Herd A 
over time. Maternal antibody levels decline to their lowest level 
at 9 weeks of age and then seroconversion due to fi eld exposure 
results in increased titers at 12 weeks of age.
Table 2 presents titer data in vaccinated and control pigs from 
Herd B over time. In vaccinates, seroconversion started after the 
fi rst vaccination and the highest titers were observed 3 weeks 
after the second vaccination. Titers in control pigs indicated that 
seroconversion due to fi eld exposure occurred later relative to 
Herd A.
Table 3 presents titer data in sows and pigs from Herd B prior 
to vaccination and at 3 weeks after their second vaccination. 
Sow titers prior to vaccination along with relatively high titers 
after vaccination indicate previous exposure to PCV2. Pig titer 
responses are consistent with the data presented in Table 2.
Table 1: Titers in six non-vaccinated pigs over time
Age (wks) Titer Age (wks) Titer
3 1,078.5 12 1,011.6
6 284.0 15 4,919.4
9 81.7 21 5,367.4
Table 2: Titers in vaccinated and control pigs
Age (wks) VAC (n=8) CON (n=6)
3 383.3 257.7
6 1,574.8 49.4
9 6,621.7 88.8
14 5,243.5 179.4
25 1,789.3 1,0815.2
Table 3: Titers in vaccinated and control sows and pigs (8 per vaccine 
by age group)
Age Sample VAC CON
Sow
Pre 1,718.6 1,078.2
Post 10,597.1 1,428.7
Pig
Pre 666.4 544.5
Post 4,770.4 350.2
Discussion
The PCV2 antibody titers generated with this test were consist-
ent with the vaccination status and age of the pigs. We conclude 
that this 3 dilution format provides an eff ective method for 
measuring PCV2 antibodies.
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A ﬁ eld study to assess the eﬃ  cacy of the PCV2 sow vaccine Circovac® in a Danish sow herd
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Introduction
PCV2 is the cause of economic losses to the pig producers all 
over the world. Vaccines against PCV2 are now available and 
used world wide. The fi rst licensed vaccine on the marked was 
a killed PCV2 vaccine for use in sows (Circovac®, Merial). The ob-
jective of this study was to assess the effi  cacy of Circovac® . The 
study was carried out in three herds – two herds with focus on 
weight gain and one with focus on mortality. Only results from 
the latter will be presented here.
Materials and Methods
The study was designed as a randomised, controlled, and 
blinded trial comparing the off spring of vaccinated and placebo 
injected groups of sows. The study was performed in a Danish 
sow herd where Post Weaning Multisystemic Wasting Syndrome 
(PMWS) was diagnosed according to the EU defi nition (www.
pcvd.eu). 
The study herd was a two-site farrow-to-fi nish herd accommo-
dating 260 sows and with a wean-to-fi nish mortality above 8% 
at the time of selection of the herd for the trial. The sows and the 
weaners up to appr. 30 kg were on one site and the fi nishers on 
another site. The herd was infected with M. hyopneumoniae but 
free from pleuropneumonia and PRRSV. 
In each farrowing batch the sows were allocated at random to 
one of two experimental groups. Group GREEN (165 sows) was 
vaccinated with 2 ml Circovac® 6 and 3 weeks before expected 
farrowing. Group WHITE (164 sows) was injected with a placebo 
(saline) at the same time. Cross fostering of piglets was only al-
lowed within the two sow groups and only for the fi rst 24 hours 
after farrowing. At farrowing all piglets were given individually 
numbered ear tags in colours GREEN or WHITE according to the 
mother sow colour. At weaning the pigs were moved to nursery 
units and housed in separate pens according to ear tag colour. 
The pigs were individually weighted three times: at weaning (4 
weeks of age; 6.2 kg), at transfer to the fi nishing units (10 weeks 
of age; 31.5 kg) and just before shipment to slaughter (20 weeks 
of age; 94 kg). All dead pigs and the number of individual anti-
biotic treatments were recorded from weaning to slaughter.
The statistical analysis was done in SAS®, version 9.13 using a 
logistic regression model for mortality and number of antibiotic 
treatments (PROC GENMOD) and a linear model (PROC MIXED) 
for growth (average daily gain (ADG)).
Results
No side eff ects after vaccination were observed.
Weaners after vaccinated sows had a signifi cant reduced mor-
tality of 1.1%, an increase in ADG by19 g/day and a reduced 
number of antibiotic treatments compared to pigs after non-
vaccinated sows (Table 1).
Table 1. Mortality, ADG, and number of individual antibiotic treat-
ments of weaner pigs (6.2-31.5 kg) after vaccinated and non-vaccinat-
ed sows. 
N Mortality ADG (g±SD) Antibiotic treatments
Pigs after vac. sows 2329 1,7% 467±22 g/day 0,35
Pigs after non-vac. sows 2233 2,8% 448±21 g/day 0,42
P-value 0,01 <0,0001 0,0008
For fi nishers the mortality was 0,2% lower (1.9% versus 2.1%), 
and the ADG 14g higher (910 versus 896 ) for pigs after vaccin-
ated pigs compared to non-vaccinated pigs, but none of these 
diff erences were signifi cant (P: 0.59 and 0.15, respectively). The 
number of antibiotic treatments was the same in the two groups 
of fi nishers.
Discussion
As it will be noted, the overall wean-to-fi nish mortality dropped 
from above 8% when the herd was selected to around 5% when 
the study took place. This not uncommon when doing clinical 
trials. 
However the vaccine was still able to signifi cantly increase the 
productivity in the weaner phase of the production, but only 
marginally in the fi nishing phase of the production. 
The size of eff ect of the vaccine shown in this study is in good 
accordance with some preliminary results from a Swedish trial 
in one herd (1), but in farms with high losses a numerical higher 
reduction in mortality might be expected as indicated in a 
Japanese study in one herd (2)
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Evaluation of the performance of growing pigs after a single dose of Porcilis® PCV 
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Introduction
Nowadays, Porcine Circovirus type 2 (PCV2) is considered to 
be key to many of the important economic losses in the swine 
industry, mainly in its relationship with Porcine Circovirus As-
sociated Disease (PCVAD). This syndrome leads to considerable 
performance failures in weaning and fattening pigs due to in-
creased mortality rates and reduced feed conversion effi  ciency.
Materials and Methods 
This fi eld study took place on a multi-site 800-sow farm. It 
involved 192 piglets from 18 litters of a single weaning. The herd 
was experiencing clinical signs compatible with PCV2 infection. 
The presence of PCV2 was confi rmed by direct quantifi cation of 
viral load by qPCR.
At vaccination, the litters were weighed and divided into two 
uniform groups of 96 piglets with an average age of 24 days. All 
animals with a low birth weight and/or clinical problems were 
excluded. 
Group 1: Vaccinated simultaneously with Porcilis® PCV and Por-
cilis® M Hyo (average weight - 7.15 Kg).
Group 2: Vaccinated with Porcilis® M Hyo (average weight - 7.28 
Kg) as controls.
All piglets were monitored for signs of local and systemic reac-
tions in the 14 days following vaccination.
When transferred to the fattening site, the pigs were re-weighed, 
mortality recorded, and the uniformity of the batches assessed. 
During the fi nal stage of the fattening period, randomly selected 
pigs were blood sampled periodically and tested for PCV2 anti-
bodies by ELISA. At 23 weeks of age, all the animals from both 
groups were individually weighed. 
Statistical analysis was carried out using the T-test.
An economic analysis was undertaken to quantify the return on 
investment based on current average meat price, fi nancial loss 
from deaths/culls (60€ per pig) and vaccination cost.
Results
No abnormal clinical signs or local reactions were observed after 
vaccination.
As can be seen in Table 1, the vaccinated group had a better 
ADG and lower mortality/culling rate, which amounted to a 
benefi t over the controls of 4.21€ per pig sold. The diff erence in 
body weights between the groups (+ 4.35 Kg) was statistically 
signifi cant (p=0.0043).
Table 1: Technical and economic data
Parameter PCV Control Diff 
Finished weight (Kg) 97,18 92,83 4,35 (a)
ADG (g) 639 607 32
Total mortality & culls 7% 8% -1%
Pig Value (euro) 100,50 96,29 4,21
Figure 1 shows that the fi nished weights of the PCV vaccinated 
group (●)were higher and comprised a more homogeneous 
distribution than those of the control group (▲).
Figure 1: Individual weight distribution 
 
Discussion 
Both technical and economic parameters were superior in the 
group which received a single dose of Porcilis PCV, with signifi -
cant diff erence with respect to end weight.
There was also greater homogeneity in the PCV vaccinated 
group. This is an important feature for profi table pig production. 
The data collected in this study showed that a single dose of Por-
cilis® PCV is eff ective in improving the performance of growing 
pigs. 
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Serological response in piglets to PCV2 and Mycoplasma hyopneumoniae 
vaccines administered separately and simultaneously
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Introduction
The use of vaccines to control diseases associated with PCV2 
infection (PCVAD) has increased the number of times piglets 
need to be handled. Agents often associated with PCV2, such 
as Mycoplasma hyopneumoniae, have been shown to increase 
the severity of clinical signs, as well as the damage caused by 
PCV-21. 
The need to avoid the unnecessary handling of piglets while 
maintaining eff ective protection has led to the use of vaccines 
with combined antigens or multiple application systems. The 
combination of PCV2 and Mh antigens is not available in a 
commercial vaccine, and the the possibility of combining both 
agents without aff ecting individual responses is being evalu-
ated2,3. The aim of this study was to compare the results of 
applying two diff erent antigens to piglets, either separately or 
simultaneously.
Materials and Methods 
A weekly production batch of 49 of piglets of three weeks of age 
were identifi ed individually, and assigned randomly to one of 
four treatment groups, as follows: 
Ta: vaccinated against PCV2 (Circumvent PCV©); Tb: vaccinated 
against M.hyopneumoniae (M+Pac©) ; Tc: vaccinated against 
both PCV2 and M.hyopneumoniae; and Td: Control group 
injected with 2ml of sterile diluent. All injections (vaccines and 
placebo) were administered at 3, 6 and 12 weeks of age. The 
simultaneous adminstration was given using Dua Vac© equip-
ment (NJ Phillips Ltd). 
The piglets were bled prior to the fi rst dose and again at 6, 13 
and 15 weeks of age. The sera were analyzed for antibodies 
against M.hyopneumoniae using the ELISA test (IDDEX - s/p < 
0.4 was taken as the cut-off ), and PCV2 by means of an ORF-2 
antigen blocking ELISA (Synbiotics - s/p ≤ 0.15 was taken as the 
cut-off ). 
The data were analyzed by means of an ANOVA test of two fac-
tors (treatment and time) using the SPSS version 15.0 software.
Results 
The following graphs show anti-PCV2 and anti- Mh titers.
 
Discussion 
There are no statistically signifi cant diff erences between the 
responses to the PCV2(ORF-2) and the M.hyopneumoniae 
antigens at the recorded times. However, these responses both 
diff er signifi cantly from those of the unvaccinated controls (p≤ 
0.05). The titres against Mycoplasma sp are positive (s/p ≥ 0.4) at 
week 6 and 15 of age. 
Several diff erent authors report that the response to the anti-
gens of PCV-2 and Mycoplasma sp do not alter whether the 
vaccines are given individually or simultaneously. Givng the vac-
cines at the same time is thus a possible option for the producer, 
as long as the vaccination regimes are not interefered with by 
passive immunity (MDA), especially in the case of PCV2 for which 
the dose is given at weaning (Mycoplasma spp vaccination is 
given during the fi rst week of life). Both vaccines can be applied 
simultaneously between 3 and 4 weeks of age, either in individ-
ual or combined programs.
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Economic evaluation of a combined vaccination against PCV-2 and Mh on a commercial farm
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Introduction
One of the agents most commonly involved in PRDC is Myco-
plasma hyopneumoniae (Mh). Its eff ects on the defense mech-
anisms of the respiratory tract mean it is the major cause of eco-
nomic loss, worldwide. Its co-infection with Porcine Circovirus 
Type 2 (PCV2) increases the severity of disease, both clinically 
and pathologically1. Vaccinating piglets against Mh has been 
common practice all over the world. 
Every vaccination has the potential to be yet another stressor 
on piglets in the production cycle. Because some farms were 
experiencing both PCV2 and Mh infections, it was decided to 
vaccinate piglets simultaneously against PCV2 and Mh2,3. The 
aim of this trial was to investigate the economic eff ect of the 
combined vaccination against PCV2 and Mh on a commercial 
farm.
Materials and Methods
The trial was conducted on a 500-sow farm operating a continu-
ous fl ow system. 60 piglets of 26 days of age were chosen from a 
weekly production batch. Each piglet was identifi ed individually, 
and randomly assigned to one of two treatment groups. Group 
1 was vaccinated against PCV2 (Circumvent© PCV). Group 2 
was vaccinated against PCV2 but also against Mycoplasma spp 
(M+Pac©). Both groups were vaccinated at 26 and 42 days of 
age. The simultaneous application of the products was carried 
out using a double syringe system (Dua Vac© NJ Phillips Ltd). 
All the piglets were weighed at 26, 73 and 146 days of age. The 
average daily weight gain (ADG) was calculated separately for 
the periods 26 to 73 days and 73 to 146 days of age. Feed intake 
was measured in each pen for each growing phase, and the total 
weight for each pen was used to calculate the feed effi  ciency. All 
deaths were recorded. 
The data were analyzed by student t-test, and variance homo-
geneity was analyzed using the SPSS program version 15.0. The 
economic analysis was carried out at 146 days of age, before the 
largest pigs had been selected. The cost of feed and vaccination 
was deducted from the gross income to determine the gross 
margin.
Results
Chart 1 shows the mortality and production parameters for each 
group. Chart 2 shows the economic analysis for both groups. 
Discussion
The synergistic eff ect between PCV2 and Mycoplasma sp has 
been well reported. However, the eff ect of PCV2 is currently 
more often associated with the growth and fattening phases, 
when replication is related to the circulating pathogens. With 
respect to Mycoplasma sp it is the prevalence around the time of 
weaning that will determine the overall eff ect. 
From 26 to 73 days when feed-effi  ciecy is greatest and the piglet 
tends to gain more weight, the simultaneous vaccination group 
performed better than the single vaccine group. 
Most producers vaccinate against PCV2, but many fail to do 
so against M. hyopneumoniae, and the synergy of the com-
bined infection has a greater impact on herd health. The use of 
simultaneous vaccination against both organisms will improve 
production performance. 
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Chart 2. Economical analysis in each group
PCV 26-40d Mh+PCV 26-40d
# pigs at beginning 30 30
Total mortality (%) 10 0
Sell kg (bodyweight) 2270.5 2726
Feed cost US$ $ 1,852.70 $ 1,843.50
Mh Vaccine cost US$ $ 0 $ 21.92
PCV2 vaccine cost US$ $ 59.13 $ 59.13
Feed + Vaccines cost US$ $ 1,911.83 $ 1,924.55
Feed effi  ciency 3.02 2.46
Quality sales distribution
Premium US$ $ 1,167.94 $ 2,770.08
Lightweights US$ $ 1,734.96 $ 867.18
Total US$ $ 2,902.90 $ 3,637.25
Gross margin $ 991.07 $ 1,712.70
Margin per kg. Sold $ 0.44 $ 0.63
Chart 1. Production and mortality parameters in each group. 
Average Daily weight gain1 PCV2 26-40d Mh+PCV2 26-40d
From 26 to 73 days age (kg.) 0.520 (±0.0138) 0.554 (± 0.146)
From 73 to 146 days age (kg.) 0.706 (±0.0184) 0.789 (± 0.019)
From 26 to 146 days age (kg.) 0.696 (± 0.0149) 0.752 (±0.015)
Feed effi  ciency
From 26 to 146 days age 3.02 2.46
Mortality
From 26 to 73 days age (total) 0 0
From 73 to 146 days age (total) 3 0
Total mortality in % 10 0
1 Average ± standard error
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Comparison of production performance between pigs vaccinated 
with a single-dose or a double-dose PCV2 vaccine
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Introduction 
The attention of swine producers all over the world has long 
been directed against diseases associated with PCV2 (Porcine 
Circovirus type 2). Their detrimental eff ect on production been 
led to various vaccination schemes being considered. Two-dose 
regimes are aimed at generating a memory response to inacti-
vated antigens, giving rise to a more lasting response, providing 
protection during both growth and fattening. In spite of the 
need to handle piglets twice, this system represents both health 
and economic advantages to justify its use1. 
The aim of this study was to compare the performance of a 
single-dose vaccine with a double-dose product in four con-
secutive production cycles.
Materials and Methods 
On a multipurpose farm in Mexico, 3,684 piglets were chosen 
from four consecutive production runs. Two of these groups 
(1,887 piglets) were vaccinated with Suvaxin Respifend® PCV: a 
single intramuscular dose of 2 ml in the base of the neck at 21 
days of age. The other two groups (1,797 piglets) were vaccin-
ated twice with Circumvent®PCV: two 2ml doses at 21 and 42 
days of age on alternate sides of the neck. 
The evaluation was carried out in two phases, from 21 to 86 days 
of age and from 86 to 156 days of age (fi nished weight). The 
averages for each group were taken for the purposes of com-
parison. 
Results
Total mortality in the single-dose Suvaxin Respifend® PCV group 
was 6.31% and in the double-dose Circumvent®PCV group, 
7.16%. Total of culled and runt pigs was 10.64% and 3.91% in the 
single- and double-dose groups respectively. Table 1 shows the 
feed cost for each treatment group.
Table 1. Total feed intake, effi  ciency and cost in each group. 
Vaccine Single-dose Double-dose
Total start weight in kg. 11,606.0 10,694.0
Total sales weight in kg. 177,736.0 163,080.0
Total weight gain in kg. 166,130.0 152,386.0
Total feed intake at weaning in kg. 96,063.1 93,558.0
Total feed intake at fi nishing in kg. 275,144.0 234,026.0
Total feed intake in kg. 371,207.1 327,584.0
Feed effi  ciency 2.23 2.15
Average feed cost in US$ by kg. $ 0.29 $0.29
Total feed cost in US$ $ 108,811.85 $96,024.62
Table 2 shows the cost-benefi t analysis for each treatment 
group.
Table 2. Cost benefi t analysis in each treatment.
Group Single dose Double-dose
Feed cost (US$) $ 108,811.85 $ 96,024.62
PCV2 vaccine cost (US$) $ 2,444.78 $ 3,017.86
Subtotal US$ $ 111,260.63 $ 99,042.49
Total kg at sales. 177,736.0 163,080.00
Total sales in US$ $ 257,785.04 $ 236,528.24
Gross margin in US$ $ 146,524.41 $ 137,485.76
Gross margin by produced US$/BW/kg $ 0.82 $ 0.84
Discussion 
During the fi rst production phase (21 to 86 days of age) the 
groups behaved alike. The diff erences between them arose dur-
ing the second phase (86 to 155 days of age). The percentage of 
culled pigs and runts was critical because of the eff ect on feed 
effi  ciency. 
After deducting the cost of the vaccines, the double-dose 
Circumvent®PCV group showed a 2.2% better profi t per kg sold 
than the single-dose Suvaxin Respifend® PCV group. This trial 
demonstrated that Circumvent®PCV had a benefi cial eff ect in 
the older pigs conferring an obvious advantage in terms of the 
economics of production.
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Introduction 
The use of vaccines in the control of diseases associated with 
PCV2 (PCVAD) has been shown to off er health and production 
benefi ts in farms in Canada, USA and Mexico, and has become 
common practice. Most of the current products are single-dose 
vaccines. 
Intervet-Schering-Plough has developed a double-dose vac-
cine, the purpose of which is to reduce the risk of interference 
from maternally derived antibodies, and to produce a booster 
response, thus reducing viremia1 in the growth and fattening 
phases. The aim of this study was to compare the eff ect on pro-
duction and health of a single-dose vaccine (Respifend® PCV-2), 
with that of a double-dose product (Circumvent® PCV).
Materials and Methods On a commercial farm in Mexico, one 
group of 238 piglets was vaccinated with Respifend® PCV-2 (a 
single 2ml dose by intramuscular injection in the neck at 29 days 
old). Another goup of 309 piglets was vaccinated with Circum-
vent® PCV (2ml by the same route at 23 and 43 days of age).
From each group, 30 piglets were chosen at random, individually 
ear-tagged, weighed at 99 and 155 days of age and their daily 
weight gain calculated. Mortality was also recorded. At the end 
of the cycle, age and weight at sale, and feed effi  ciency were 
recorded. The data were analyzed by T-test using SPSS 15.0 
software.
Results 
Mortality began in week 6 in both groups, reaching a peak in 
weeks 7 and 11. The disease aff ected the alimentary system, and 
was characterized by progressive wasting. At the necropsy of 3 
pigs, Salmonella cholerae suis was isolated from the liver and 
iliocecal valve. Table 1 shows the mortality results: 
Table 1. Mortalityresults in each group
Weaning Single-dose Double-dose
Total born piglets 238 309
Total weaned piglets 211 272
Total deaths 27 37
Mortality in % in weaning phase. 11.3a 11.9a
Growing and fattening
Pigs entering growingphase 211 272
Total sales pigs 184 252
Total deaths 27 20
% mortality 12.8a 7.3b
Diff erent superscript letters inthe same row indicate signifi cant diff erences
The economic analysis utilized diff erent prices at sale for pigs 
over 80kg and those under 80kg, the latter being considered 
second class. Feed effi  ciency was calculated for each group. 
Table 2 shows the performance data and the gross margin per 
kg sold for each group.
Table 2. Economic analysis between 2 groups
Group Single-dose Double-dose
Total weight at start (kg). 1519.2 1915.8
Total sales weight (kg). 15150.5 19554.25
Total weight gain (kg). 13631.3 17638.45
Total feed consumption (kg). 38167.6 48505.7
Feed effi  ciency 2.8 2.7
Feed cost in US$ $ 13,111.02 $ 16,662.28
Vaccines cost US$ $ 257.71 $ 456.79
Subtotal $ 13,368.73 $ 17,119.07
Premium price sales (US$). $ 20,054.27 $ 26,766.95
Second class sales (US$) $ 2,307.19 $ 2,315.15
Subtotal $ 22,361.47 $ 29,082.1
Gross margin $ 8,992.74 $ 11,963.03
Gross margin per kg sold. $ 0.59 $ 0.61
Discussion 
There were signifi cant diff erences in mortality between the two 
vaccine systems. In the Circumvent® PCV group, the second dose 
reinforced the immunity leading to better mortality rates after 
week 10, in the critical growth and fi nishing stages. 
The inferior performance of the Respifend® PCV-2 group was not 
only evident in the higher mortality rate, but also in the weights 
at sale which were lower than the Circumvent® PCV group (84.52 
and 90.25 kg respectively). However, the wide variation in the 
end weights in the Respifend® PCV-2 group led to the trial being 
abandoned when the fi rst pigs were sold, otherwise the diff er-
ences would have been even greater. 
The pigs vaccinated with Circumvent® PCV had heavier end 
weights. The other group had more second class pigs and thus 
poorer feed effi  ciency. The profi t per kg sold is a measure of the 
better performance of the pigs vaccinated with Circumvent® 
PCV.
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Clinical case: improved sow fecundity after CIRCOVAC® vaccination
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Introduction
Porcine circovirus type 2 (PCV2) is well known to be involved 
in reproductive disorders. The objective of the present paper is 
to describe a clinical case in which PCV2 was suspected to be 
involved and vaccination with CIRCOVAC® brought an improve-
ment in the reproductive indexes.
Farm/Case Description/Methods and Actions
Farm: 450-sow 1-week farrowing batch management PRRS-
negative operation. Weaning at 24 days; new buildings and 
good husbandry practices. AI with semen collection on farm.
Case description: poor reproduction indexes for 12 years; high % 
of returns to oestrus mainly in parity 4 & 5 with fecundity as low 
as 72 %; 1% abortion and good global productivity: 27.7.
Diff erential diagnosis and corrective measures: for the last years, 
a lot of work has been done to optimize reproduction, mainly in 
depth review of on farm AI management, full review of the feed-
ing system and full revaccination against Porcine Parvovirus.
PCV2 suspicion: based on big size mummifi ed piglets >0.5 per 
litter, hyperthermia and anorexia at mid-lactation, high preva-
lence of ear necrosis in 10 of the 7-week-old piglets and pig size 
heterogeneity in the fl ow.
PCV2 antibody titration in sows: Serelisa® PCV2 Ab (Synbiotics, 
Lyon, France).
Vaccination: CIRCOVAC was implemented in sows and gilts as 
recommended. Boars were vaccinated twice, 2ml IM.
Fecundity: results were recorded using the batch fi les collected 
on farm. Returns to oestrus were recorded on 5-month periods, 
before and during the vaccine implementation.
Statistical analysis: fecundity indexes were compared using a 
Yates-corrected Chi2 test.
Savings per avoided return to oestrus was evaluated at 57€ 
according to the reference given by the French Institute for Pig 
Industry (www.ifi p.com) IFIP, Paris, France.
Results
The sow PCV2 Ab profi le before vaccination is shown in Figure 1. 
Titres are heterogeneous with only 40% at 4log10 or more.
Figure 1 : PCV2 Ab titers in sows (ELISA unity log10) accordig to sow 
parity.
 
Figure 2 : Month results for fecundity (1st AI).
 
Fecundation after 1st AI was signifi cantly improved from 76.0% 
to 83.5% after vaccination (Yates-corrected Chi2 test; p<0.01). 
Percentage of returns to oestrus before and during the vaccina-
tion of the sows with CIRCOVAC signifi cantly dropped down 
from 21.15% to 13.51% respectively.
Discussion
Heterogeneity of PCV2 ELISA titres showed an inconsistent im-
mune status. A confi rmation of the presence of high quantity 
of PCV2 in late mummies would have been interesting to make 
sure PCV2 involvement. However, since vaccination of sows 
with CIRCOVAC, the number of return to oestrus dramatically 
dropped down. This is coherent with Mateusen et al. (1) fi ndings 
which showed that embryos were susceptible to PCV2 as soon 
as they get rid of the zona pelucida. Unfortunately today, no 
conclusive diagnosis tool does exist for evidencing PCV2 involv-
ment in early embryo death. Only based upon returns to oestrus, 
CIRCOVAC vaccination brought savings of around 10€ per sow 
per year.
References
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Onset of Immunity induced by Porcilis® PCV in MDA positive pigs given at 3 weeks of 
age by a single dose of 2 ml and challenged with PCV2 virus at 5 weeks of age
Alexander A. Eggen1 Frank Roerink2 Ulrike Schmidt1
1. Intervet/Schering-Plough, Boxmeer, Netherlands; 2. Intervet/Schering-Plough, DeSoto, KS, USA
 Introduction
Porcine Circovirus type 2 infection in pigs is regarded as the 
causative factor for development of Porcine Circovirus Disease 
(PCVD). PCVD occurs in pigs of diff erent ages. Infection of piglets 
is associated with low levels of Maternally Derived Antibodies 
(MDA) and the presence of PCV2 virus. Under fi eld conditions 
timing of PCV2 virus infection is often unknown. It is important 
that pigs are protected early and for the whole fattening period 
(Eggen). Pigs will be vaccinated early in life against PCVD in the 
presence of varying levels of MDA. The object of this study is to 
demonstrate effi  cacy against PCV2 virus of a single dose of 2 ml 
Porcilis PCV in piglets of 3 weeks of age with MDA. At 5 weeks of 
age, 2 weeks after vaccination, vaccinated and control animals 
were challenged with PCV2 virus. 
Materials and Methods
Progeny of SPF sows with PCV2 antibodies were studied. Male 
piglets were spread across litters to make 2 uniform groups of 
10 piglets. At 3 weeks of age, Group 1 was vaccinated with 2 ml 
of Porcilis PCV and Group 2 with placebo. At 5 weeks of age the 
pigs were challenged intranasally with 4.5 log10 TCID50 of a 
heterologous wild type PCV2 challenge virus strain I-12/11. All 
animals were observed daily for clinical signs and were weighed 
at critical times. 
Three weeks post challenge all animals were necropsied. At post 
mortem, mesenteric lymphnodes and tonsils were sampled for 
the determination of PCV2 antigen. Serum samples were taken 
at vaccination, at challenge, one week later and at necropsy, 
and were examined for PCV2 antibodies and nucleic acid. Fecal 
swabs were taken at challenge, one week later and at necropsy, 
and were examined for PCV2 nucleic acid. Statistical analysis of 
the serology employed Dunnett’s multiple comparison method. 
Q-PCR data was analyzed by ANOVA and Dunnett using a linear 
mixed model assuming constant correlation of repeated meas-
urements of a subject.
Results 
All piglets were healthy before and after vaccination. Body-
weight gain did not diff er signifi cantly between groups at time 
of challenge or for the period between challenge and necropsy 
(see table 1).
Table 1: Bodyweight development (kg)
Weeks of age// wpv* 5 (2 wpv) 8 (5 wpv) Gain (kg) ADG (g/day)
Group /////////wpc** 0 wpc 3 wpc
Porcilis PCV 9.5±1.6 17.5±3.5 7.9±2.1 378±101
Control 9.8±1.8 17.2±2.5 7.4±1.3 351±61
* wpv = weeks post vaccination ** wpc= weeks post challenge
Serology (see table 2)
Table 2: Antibody titer development (ELISA log2 values)
Weeks of age///(wpv) 3 (0 wpv) 5 (2 wpv) 6 (3 wpv) 8 (5 wpv)
Group////////wpc 0 wpc 1 wpc 3 wpc
Porcilis PCV 3.0 7.7 10.1 10.7
Control 4.1 4.0 3.3 4.3
* wpv = weeks post vaccination ** wpc= weeks post challenge 
At challenge, the average PCV2 antibody titer was signifi cantly 
higher in the vaccinated group (P<0.0004) 
Q-PCR: At the time of challenge, the amount of viral DNA was 
negligible in both groups. Three weeks after challenge, the 
amount of virus in sera of the vaccinated group was signifi -
cantly lower than the control group (P<0.05). No PCV2 DNA was 
detected in feces of this group one week after challenge, and in 
signifi cantly lower amounts at 3 weeks post challenge (P<0.05), 
the amount of PCV2 nucleic acid in tonsils and mesenteric 
lymph nodes was signifi cantly lower (P<0.05). 
Discussion 
A single 2ml dose of Porcilis PCV in piglets of 3 weeks of age 
induced a rapid and strong immunity. Piglets were protected 
when challenged at 5 weeks of age. This was confi rmed by the 
signifi cant reduction in virus shedding and the PCV2 DNA load 
in lymphoid organs. The MDA titers in the piglets were pur-
posely low. MDA titers >5log2 present at 5 weeks of age can be 
protective and these MDA infl uence the take of the challenge 
virus (Fort, 2009) which will result in no PCV2 load in the controls 
leading to inconclusive results. This rapid onset of immunity by a 
single dose in the face of MDA is a feature unique to Porcilis PCV.
References 
Fort; Vaccine 2009.
Eggen; IPVS 2010. 
Porcine Circovirus Associated Diseases (PCVAD) – Control
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 392
Poster Presentations
P.086
Eﬀ ect of Porcilis® PCV on mortality in ﬁ nishers in the presence of late severe PCVAD
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Introduction
In Spain, porcine circovirus-associated disease (PCVAD) is seen 
less frequently than in the fi rst few years after the initial reports 
of the disease. The aim of this study was to assess the effi  cacy 
of vaccination with Porcilis® PCV in the presence of late severe 
PCVAD.
Materials and Methods
The study was performed on an 800-sow farm operating a 
closed cycle, three week batch system. Pigs were weaned at 28 
days of age, and the farm had facilities to fatten 40% of its pro-
duction. The other 60% were fattened on other farms. The farm 
was positive for PRRS and Mycoplasma.
In 2008, mortality rates in the fatteners varied between 3 and 
5%, and there were approximately 1% of runts. At the begin-
ning of 2009, there was a notable increase in mortality rates and 
percentage of runts, reaching a peak of 13.3% mortality, 16.4% 
for deaths and runts together. The clinical presentation began 
at 13 weeks old, the signs being pallor, general enlargement of 
lymph nodes, stomach ulcers and a variable number of pigs with 
porcine dermatitis and nephropathy syndrome (PDNS).
From April onwards, blood samples were taken at 4, 7, 10, 13, 
16, 19 and 21 weeks of age. Serum was tested for PCV2 IgG and 
IgM antibodies (Ingezim PCV2 ELISA®, Ingenasa), and showed 
that seroconversion coincided with the start of the clinical signs 
(Graph 1).
Graph 1: Percentage of samples positive for IgG/M/age
 
In the light of this, it was decided to vaccinate as many pigs as 
possible in the shortest possible time. Thus, all batches of pigs 
at either 45 or 70 days of age were vaccinated with Porcilis®PCV. 
Thereafter, all pigs were vaccinated at weaning (28 days old). 
[Data from this latter vaccination regime were incomplete at the 
time this abstract was submitted.] The results of the following 
groups were compared: 
• Controls: unvaccinated animals (from 10 batches)
• Porcilis PCV (A): a single 2 ml dose of Porcilis®PCV given to 
pigs 70 days old (note that the disease was probably already 
present in most of these animals).
• Porcilis PCV (B): a single 2 ml dose of Porcilis®PCV given to pigs 
45 days old.
• The Pearson’s chi-square test was used to compare the treat-
ments (percentages), using the SPSS 15.0 software package.
Results
There was a statistically signifi cant reduction in mortality rates 
during fattening in both vaccinated groups compared with the 
unvaccinated controls (p<0.001), the best results being in the 
pigs vaccinated closer to the recommended schedule (at 3-4 
weeks of age). The percentage of runts was also signifi cantly bet-
ter in the Porcilis PCV (B) group (p<0.05). 
Table 1: Production Results
Control Porcilis PCV (A) Porcilis PCV(B)
No.animals 7177 1196 865
% deaths fi nishing 8.7 4.9** 1.6**
% low-weight pigs 2.1 1.6NS 0.9*
% low-weight + deaths 10.8 6.5* 2.5**
Porcilis PCV (A) & (B) groups compared with controls: (NS: p>0.05; *: p<0.05; **: p<0.001). 
Graph 2: Percentage mortality and runts during fi nishing 
 
Discussion
The effi  cacy of Porcilis®PCV was demonstrated using diff er-
ent administration protocols. Vaccination with a single dose of 
Porcilis®PCV was found to be very eff ective in the presence of 
late severe PCVAD. 
Better uniformity was observed in the vaccinated pigs; the lower 
percentage of runts being one of the reasons.
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Eﬃ  cacy of diﬀ erent vaccines against Porcine Circovirus type2 administered as single 
shot to 3 week-old piglets with high maternal derived immunity against PCV2
Ulrike Schmidt; Melanie Sno; Alexander A. Eggen
Intervet/Schering-Plough, Boxmeer, Netherlands
 Introduction
Porcine Circovirus type 2 (PCV2) is widespread and has, as major 
causative agent for development of Porcine Circovirus Disease 
(PCVD), great economic impact in the swine industry. Infection 
of sows with PCV2 leads to varying antibody levels in blood and 
colostrum. High levels of maternal derived antibodies (MDA) can 
prevent PCV2 infection of piglets during fi rst weeks of life, but 
may interfere with active immunization of piglets against PCV2 
(Palzer,IPVS 2010). In recent years, several vaccines against PCV2 
were brought to the market. All piglet vaccines can be given as a 
single shot vaccination from 2 or 3 weeks of age, when MDA can 
still be on a high level. Thus, it is essential that this single vac-
cination at young age is effi  cacious against possibly high levels 
of MDA. 
The objective of this study was to compare the effi  cacy of 
commercially available PCV2 vaccines in piglets with high MDA 
against PCV2 after a single vaccination at 3 weeks of age. 
Materials and Methods
Fifty piglets from sows with high PCV2 antibody titres (9.8 to 
12.5 log2 ELISA units before farrow) were available for this study. 
Allocation of piglets to fi ve groups of 10 was done across litters 
the way that average MDA titres per group were comparable. 
At three weeks of age one of the following PCV2 vaccines was 
injected:
Group 1 was vaccinated with 2 ml of Porcilis PCV(subunit vac-
cine), group 2 received 2ml of a PCV2 vaccine containing inacti-
vated chimeric PCV1-2 virus as antigen, group 3 was injected 
with 1ml of a PCV2 subunit vaccine, group 4 received 0.5ml of 
an inactivated whole virus vaccine and group 5 was treated 
with 2ml of a physiological salt solution and served as negative 
control group. At 12 weeks of age, all piglets were challenge in-
fected with wild type PCV2 challenge strain I-12/11 by intranasal 
route. 
All animals were observed daily for clinical signs and blood 
samples were taken on several time points. Three weeks post 
challenge all animals were necropsied and tonsil, mesenteric 
lymph node and lung were sampled for determination of PCV2 
viral nucleic acid by Quantitative PCR (QPCR). Serology data at 
time points >3 weeks were analysed by Analysis of Covariance 
(ANCOVA) by time point using the titre at time of vaccination 
and sow as covariate. Equality of serum antibody titre prior 
to vaccination was checked by ANOVA. Tukey’s multiple com-
parison method was used to compare treatments. Descriptive 
statistics were used to summarize QPCR results on organs.
Results 
No clinical signs were observed throughout the study. 
Serology: at time of vaccination the piglets had individual PCV2 
antibody titers between 9.3 and 15.5 log2 ELISA units, resulting 
in mean group titres of around 11 log2 ELISA units.
Fig 1: Development of PCV2 antibody titres
From week 9 post vaccination until the end of the study, average 
antibody titre of piglets vaccinated with Porcilis PCV was signifi -
cantly higher than in the other groups (Porcilis PCV/group 2 p< 
0.0014; group 3 p<0.0155; group 4 p< 0.0037; control p<0.0001). 
No statistically signifi cant diff erence in PCV2 antibody titres 
could be found at any time point between other vaccinated 
groups or unvaccinated controls. 
QPCR on organs revealed that piglets vaccinated with Porcilis 
PCV had the lowest mean load of PCV2 DNA in all tested organs. 
Fig. 2: Mean PCV2 nucleic acid load in organs
Conclusion
In this study, a single vaccination with Porcilis PCV induced a 
signifi cantly higher humoral immune response in piglets with 
high MDA as compared to other PCV2 vaccines. The excellent 
protective effi  cacy of Porcilis PCV was confi rmed by the low load 
of PCV2 DNA in all tested organs upon challenge infection.
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Evaluation of three commercial PCV2 vaccines in a commercial swine farm
Kwang Soo Lyoo1 Brian Caldwell2 Hyeon Bum Kim1 Jerry Torrison1 Peter Davies1 Han Soo Joo1
1. University of Minnesota, St. Paul, MN, USA; 2. Choice Connection, Mapleton, MN, USA
Introduction
Three commercial PCV2 vaccines have been licensed in the U.S., 
and all of them are widely used on commercial swine farms. 
The effi  cacy of these vaccines is well documented, and all of the 
vaccines reduced mortality and improved growth performance 
under fi eld conditions1,2,3. However, the 3 vaccines vary in the 
nature and concentration of the antigen, the type of adjuvant, 
and the dose of administration. At present, no report is available 
on the comparative effi  cacy side by side of the 3 vaccines under 
conventional fi eld conditions. The purpose of this study was to 
compare clinical signs, viremia, antibody responses, and average 
daily gain (ADG) of conventional pigs following vaccination at 
3-weeks of age with the respective commercial PCV2 vaccines. 
Materials and Methods
At a commercial farm in Minnesota, 4 pigs of similar body 
weight were selected from each of 20 litters and ear tagged. 
Three pigs from each litter were inoculated intramuscularly 
at 3 weeks of age with PCV2 vaccine A, B, and C, respectively. 
The fourth pig from each litter remained unvaccinated con-
trols. All 80 pigs were moved into one pen of a wean-to-fi nish 
barn together with 520 pigs housed in other pens. The 20 pigs 
inoculated with vaccine A were revaccinated at 6 weeks of age 
(3 weeks after the fi rst vaccination) according to the manufactur-
er’s recommendation. All pigs in the barn were monitored daily 
for clinical abnormalities by the farm manager. Blood samples 
from each pig were collected at 3 weeks intervals. All pigs were 
individually weighed at 3 weeks and 24 weeks of age. Antibody 
responses of each pig were measured by indirect fl uorescent 
antibody (IFA) test. Serum samples were also tested for viremia. 
The mean antibody titers, viral load, and body weight between 
the groups were analyzed by student t-test. 
Results
There were no clinical signs observed in any of the pigs in the 
vaccinated and control groups, although 2 pigs in group B were 
found dead overnight from unknown causes during the fi rst 3 
weeks of the experiment. No medication was used for pigs dur-
ing the study. ADG for all 4 study groups was calculated for the 
interval 3 to 24 weeks of age (Table 1). There was no signifi cant 
diff erence in the mean body weights among the 4 groups at 
3 weeks of age. The ADG of pigs in groups A (0.81kg ± 0.03, P 
<0.016) and B (0.80kg ± 0.05, P <0.048) were signifi cantly higher 
than ADG of the control group (0.74kg ± 0.05). The ADG of pigs 
of the group C (0.78kg ± 0.05) did not diff er signifi cantly from 
the controls (P =0.132) or the other vaccinated groups (P >0.173)
Table 1. Comparison of the mean body weights at 3 and 24 weeks of 
age and ADG between the pig groups 
Group (weight Kg)
Age A B C Control
3 weeks 7.09 7.42 7.32 7.05
n=20 n=19 n=20 n=18
24 weeks 126.41 126.95 123.21 117.98
n=19 n=16 n=19 n=18
ADG 0.81a 0.80a 0.78 0.74a
aStatistically signifi cant of group A and B at 24 weeks of age and ADG were P <0.05 when 
compared to those in control group.
Discussion 
The present study found diff erences in growth performance 
and body weight at marketing age among the study groups. 
Mean ADG and body weight just before the marketing of all 3 
vaccinated groups were numerically higher than those of the 
control group, although statistically signifi cant diff erences were 
observed only for groups A and B. The diff erences were concord-
ant with the results for viremia which showed higher levels of 
viremia in the control at several time points. The study confi rms 
likely production benefi ts from PCV2 vaccination even in the 
absence of clinical PCV2 related diseases. 
References
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Eﬃ  cacy of Porcilis® PCV in pigs confronted by a severe porcine circovirus infection late in production
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Introduction
The aim of the present study was to evaluate the safety, effi  cacy 
and economic benefi ts of vaccination with Porcilis® PCV when 
pigs are confronted by a severe porcine circovirus infection late 
in the production cycle.
Materials and Methods
The study was carried out on a closed-cycle 650-sow farm in 
central Spain, producing pigs in weekly batches. Piglets are 
weaned at 21 days old, and moved to separate barns for the 
nursery, growing (10-16 weeks of age) and fi nishing periods. The 
farm suff ered confi rmed PRRS, and also Mycoplasma, for which 
piglets were vaccinated in their fi rst and third week of age. 
Clinical signs associated with PCV2 were more evident from 14 
weeks of age onwards, that is, mostly during growing and fi nish-
ing. The average mortality rate (weaning-slaughter) of piglets 
born in 2008 was 13%, with a peak of 16%. The problem was 
aggravated by a high percentage of runts (culls).
Prior to vaccination, a serological profi le was obtained monitor-
ing the optical density ratios for IgG and IgM (Ingezim PCV Elisa), 
which demonstrated seroconversion from 15 weeks of age, still 
evident at 19 weeks.
Initially, all animals between 21 and 70 days of age were vaccin-
ated. Thereafter, pigs were vaccinated 4 days after weaning with 
a single 2 ml dose of Porcilis® PCV. Mortality rate, percentage of 
runts, weight at slaughter and days to slaughter were recorded 
for the following groups: Control Group: unvaccinated. Group 
A: vaccinated with Porcilis® PCV between 55 and 70 days of age. 
Group B: vaccinated younger with Porcilis® PCV: slightly more 
than 2/3rds of the group at 21 days old (the recommended age 
according to the leafl et instructions), and the rest (4 batches) be-
tween 32 and 55 days of age. During the whole study period, no 
relevant management changes were implemented on the farm. 
The diff erent treatments were compared using the Pearsons’s 
chi-square test (proportions) and the Levene test (variances), 
together with an ANOVA (means), using the SPSS 15.0 software 
package.
Results
No local or systemic reactions were observed in the vaccinated 
animals, regardless of the time of vaccination.
PCV2 was considered to be involved during the growing and 
fi nishing periods. The recorded production data are shown in 
Table 1. For Group B, compared to the controls, the number of 
culls, and the mortality rate were reduced signifi cantly during all 
the production phases (p<0.001), leading to greater uniformity 
at slaughter. 
Also a notable improvement in Average Daily Gain (ADG) was 
discovered later when the ANOVA test was used to compare 
slaughter weight, with days to slaughter as a covariant - an extra 
8.070 ± 1.800 kg was estimated for Group B. 
Later vaccination, as practised in Group A, also proved eff ective, 
though there were fewer benefi ts than with early vaccination. 
Compared with the controls, Group A performed statistically 
signifi cantly better in respect of all recorded parameters, except 
for mortality during the nursery period and days to slaughter. 
Overall, Group B performed better than Group A. The combina-
tion of Days to Slaughter and Slaughter weight (kg) shows the 
clear economical advantage of Porcilis PCV vaccination at the 
recommended age (Group B). 
Table 1: Production Results
Control Porcilis PCV (A) Porcilis PCV (B)
Number of animals 1719 688 3254
% Mortality nursery 3.49 2.18NS 0.80**
% Mortality growing 3.14 1.45* 0.89**
% Mortality fi nishing 6.4 1.6** 1.44**
% Total mortality 13.0 5.73** 3.10**
% culled pigs 7.27 3.05** 0.98**
%culled + deaths 20.27 8.42** 4.12**
Days to slaughter 186.8 188NS 178**
Slaughter weight (kg) 97.86 102.32 101.71
In the statistical comparison of Groups A & B with the Controls - 
NS: p>0.05; *: p<0.05; **: p<0.001.
An economic model taking account only of (i) the diff erences 
in mortality rate and percentage of runts during the growing 
and fattening periods (but not those the nursery period) (ii) the 
improvement of days to slaughter, and (iii) the costs of vaccine 
and labor, yielded fi nancial benefi ts of vaccinating (Groups A & 
B) over not vaccinating (Controls): Late vaccination (Group A): 
+10.17€/pig. Earlier vaccination (Group B): +12.24€/pig. Thus, in 
both cases there was a good return on investment. 
Discussion
The present study demonstrated that vaccination of pigs with 
Porcilis® PCV is safe, eff ective and profi table, even in the face of 
a severe PCV2 infection, late in the production cycle, contribut-
ing to a reduction in production losses caused by PCV disease. 
Regardless of the age at vaccination with Porcilis PCV, it was 
shown to be highly profi table, yielding a substantial return on 
investment.
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Safety and eﬃ  cacy of PCV-2 inactivated vaccine in weaned piglets under ﬁ eld conditions in Brazil
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Introduction
In July 2007, the fi rst commercial vaccine against Porcine Circo-
virus type 2 (PCV-2) was launched in Brazil. This vaccine consists 
of inactivated PCV-2 in oil adjuvant, recommended for gilts and 
sows, protecting the piglets through passive transfer of anti-
bodies (1). Sow vaccination has given good results in farms with 
PCVAD. However, diff erent serological titration profi les against 
PCV-2 were observed in farms in Brazil and indicated diff erent 
exposure and viral circulation. (2). Due to the limited availability 
of other conventional PCV-2 vaccines in Brazil and the concern 
regarding the development of the disease in fattening pigs, this 
vaccine started to be empirically used in weaned piglets. Thus, 
this fi eld study was conducted in order to evaluate the safety 
and effi  cacy of this procedure.
Materials and Methods
A total of 1140 piglets, males and females, were divided into two 
groups: vaccinated (single dose, 0.5 ml of vaccine) and control 
(not vaccinated), blocked by gender. All animals were evaluated 
from the application of the experimental treatment until market. 
Safety was evaluated by clinical and body temperature daily 
examinations in the four days after vaccination. Effi  cacy was 
based on comparison of performance (body weight and average 
daily gain), mortality, antimicrobial usage, diarrhea, coughing 
and sneezing indexes. Post examination was performed in all 
dead animals, followed by histopathology and PCV-2 immuno-
histochemistry evaluation. Lung lesions were evaluated at 
slaughter. Blood samples were collected at weaning, at the end 
of nursery and before slaughter and used for IgG serology using 
IPMA.
Results
No adverse eff ects were observed after vaccine application. Vac-
cinated males had a higher slaughter weight (2.73 kg, p = 0.029) 
and a higher average daily gain (0.025 kg, p = 0.027) when com-
pared to control males. In contrast, females had no diff erence 
in body weight or average daily again between vaccination and 
control groups. However, there was a greater fi nal body weight 
of 1.50 kg (p = 0.07) in vaccinated females compared to the con-
trol group. There was no signifi cant diff erence between groups 
regarding mortality and culling rates, coughing, sneezing or 
diarrhea indexes, medication use, pneumonia index, pathologic-
al and histopathological lesions, and antibody titration. 
Discussion
Vaccination did not induce any signifi cant adverse eff ect, as 
observed by others (3). The results of daily weight gain, slaugh-
ter weight and mortality rate in this study agreed with other 
reports under fi eld conditions (3; 4). As there was no reduction 
in mortality, it was suspected that other conditions were playing 
an important role. 
The absence of statistical diff erence in the fi nal weight of 
females (p= 0.07) can be explained by the diff erence in housing 
conditions compared to males, as the females were continuous 
in feces contaminated solid fl oors, were in more densely popu-
lated pens and were managed much more often for breeding 
selection. 
PCV2D lesions and PCV2 antigen were observed in both vaccin-
ated and control groups from both genders with no diff erence 
among them. If animals had been randomly selected for eutha-
nasia, as was done by Segalés et al. (6), we may have seemed 
diff erence between groups. 
These data indicate that vaccination against PCV-2 is safe and ef-
fective in improving the fi nal weight and the average daily gain 
in piglets vaccinated under fi eld conditions in Brazil. 
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Introduction
The control of PCVD is based on management strategies, reduc-
tion of co-infections and vaccination. Under fi eld conditions, 
all commercial PCV2 vaccines lead to reduced mortality and 
cull rates, and signifi cantly improved weight gain, along with a 
reduction in co-infections in PMWS-aff ected herds (Kixmoller et 
al., 2008; Segalés et al, 2009). 
The object of the present study was to investigate the effi  cacy 
of a single dose of PCV2 subunit vaccine on two diff erent farms 
suff ering from PCVD by monitoring mortality and culling rates, 
average daily gain and carcass weight at slaughter. 
Materials and Methods
A double-blinded, randomised and controlled fi eld trial was con-
ducted on two farms with a history of PMWS (Farm 1: 900-sow 
farrow-to-fi nish herd; Farm 2: 3-site 1850-sow herd). A total of 
818 piglets were included in this study and distributed between 
two treatment groups.
At inclusion (weaning at 21±3 days of age), a total of 408 animals 
(Group B) received a 2ml intramuscular dose of Porcilis PCV®, a 
commercial PCV2 capsid-based subunit vaccine expressed in 
inactivated baculovirus. To act as controls (Group A), 410 pigs 
received 2mls of the adjuvant Diluvac Forte®, by the same route. 
All animals were individually identifi ed, and their weights were 
recorded at inclusion, and at 12 and 26 weeks of age, and the 
average daily gain (ADG) calculated. The carcass weights of the 
pigs from Farm 2 were recorded at slaughter (274 days old). All 
dead animals (died or were culled) were submitted for post-
mortem diagnostic investigation, in order to classify them as 
PMWS-aff ected (according to the accepted case defi nition) or 
not. 
To estimate the eff ect of vaccination on the probability of a pig 
dying, a mixed eff ect logistic regression model was constructed 
to take account of the non-independence of repeated meas-
urement of the same subjects and the eff ect of the sow (litter 
eff ect), using the ‘lme4’ package. 
Results
Total losses from PMWS were 9.02% and 0.2% in control and 
vaccinated groups, respectively. For fatal conditions other than 
PMWS, the proportion of pigs lost were 7.3 and 7.8 in Groups A 
and B, respectively. 
The estimated Hazard Ratio for losses related to PMWS in Group 
B as against Group A was 0.082 (c.i.95%: 0.030-0.229; p< 0.0001). 
 
The ADG and carcass weight at slaughter for both groups are 
shown in Table 1. 
ADG (g) A B Diff . p value
3-12 weeks of age 481 478 +3 < 0.05
12-26 weeks of age 811 881 -70 < 0.001
CARCASS (kg) 140.5 145.0 +4,5 < 0.012
Discussion 
In this study, the probability of a pig vaccinated with a single 
dose of Porcilis PCV at 3 weeks of age dying from PMWS was 12 
times less than that of an unvaccinated control pig. Moreover, 
vaccination improved the average daily gain when animals 
became infected with PCV2. 
In addition, the diff erence in average carcass weight (+4.5 kg in 
vaccinated) in pigs slaughtered at 274 days of age demonstrated 
the long term positive eff ect of Porcilis PCV vaccination on pro-
ductive performace.
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Introduction
The aim of the present study was to compare the effi  cacy of 
Porcilis®PCV with another commercial vaccine, under fi eld condi-
tions, with respect to health and production, on a farm with a 
history of severe losses caused by porcine circovirus-associated 
disease (PCVAD).
Materials and Methods
The study was performed on two diff erent sites of a 1000-sow 
farm in northern Spain. The farm had a history of PCVAD-related 
problems, with an average 5% mortality rate in the nursery, 
a 6-8% mortality rate in fattening pigs, with 4% referrable to 
PCV, and a late clinical picture appearing from 14 weeks of age 
onwards, and persisting up to 18-20 weeks of age. The farm had 
tested positive to Mycoplasma and PRRS (unstable and with 
resurgence at 7, 9 and 16 weeks).
Before the start of the study, PCV2 had been confi rmed by clin-
ical signs and gross pathology in diseased pigs, virus isolation 
from 3 of 4 culled pigs, and clear evidence of seroconversion 
by 18 weeks of age. After confi rmation of the diagnosis, piglets 
from two weekly batches were selected (a total of 829 piglets) 
and randomly allocated into 3 groups according to gender, dam 
and weight, individually identifi ed, and treated at 3 weeks of 
age. 
Group 1: 272 piglets vaccinated with a single 2ml dose of Por-
cilis® PCV; Group 2: 276 piglets vaccinated with a single 0.5ml 
dose of another commercial vaccine (Vaccine B); Group 3: 281 
piglets injected with 2 ml Diluvac Forte® as placebo, acting as 
controls.
In addition, 60 piglets were selected (20 piglets per group), for 
serological controls at 3, 7, 10, 14, 18, 22 and 25 weeks of age. 
After weaning, the pigs were housed in the same barn, with 
each group in a separate pen. At 10 weeks old, they were moved 
to the fattening barn, again penned separately in their groups. 
Temperature and humidity were recorded throughout, as well as 
individual treatments and mortality. All pigs were weighed at 3, 
10, 18 and 25 weeks of age (earliest slaughter date).
Statistical analysis was performed using the General Linear 
Model (GLM, SPSS 15.0 for Windows).
Results
At 3 weeks old, all three groups had high levels of MDA with no 
signifi cant diff erences between them (p=0.601). At 7 weeks of 
age, Group 1 had 94.7% and 84.2% animals positive for IgG and 
IgM, respectively, signifi cantly diff erent from the other groups 
(p<0.001). At 14 weeks, the percentage of pigs positive for IgM 
increased (see other paper of proceedings of this congress from 
same aurhors) signifi cantly in Groups 2 and 3, whereas Group 1 
remained negative. As there had been no signifi cant diff erences 
in average weight (p=0.429) and variance of weights (p>0.05) at 
the start, all groups were comparable.
During the nursery period no signifi cant diff erences were found 
for growth, mortality or treatments (p>0.05).
Table 1: 
Control Vaccine B Porcilis PCV
Kg gained 70.95 ±0.67 72.67 ±0.69 74.09 ±0.55
ADG 651 ±0.006 667 ±0.006 680 ±0.005
% Mortality 4.0 4.8 1.5
% Pigs treated/ week 12.3 10.5 8.1
% Total treatments 40.4 33.9 25.7
Group 1(Porcilis PCV) was 1.42kg, 13g/day better than Group 2 
(p=0.09), and 3.14kg, 29g/day better than Group 3 (p<0.001). 
Group 1 had signifi cantly fewer treatments than the other two 
groups (p=0.01). Group 1 was signifi cantly better for all param-
eters than the controls, whereas Group 2 (Vaccine B) performed 
no better than the controls. 
A clinical picture compatible with PCV was found in 41.4 % of 
dead pigs. Laboratory diagnosis (IHC) confi rmed the presence of 
PCV in none of the Porcilis® PCV group, 3.45% of the Vaccine B 
group, and 10.3% of the control group.
Discussion 
Vaccination of a high percentage of the pigs commingled in the 
same house probably improved the results of the control group 
due to a reduced infection pressure, otherwise greater diff er-
ences would have been expected between groups. 
The use of Porcilis® PCV in this situation led to an improvement 
in all the recorded health and production parameters, not only 
compared to the control group but also compared to the other 
commercial vaccine (Vaccine B). In addition to this, the robust 
seroconversion induced in the presence of maternally derived 
immunity allows the fi rm conclusion that Porcilis®PCV was the 
better choice of vaccine to protect against a severe, late problem 
with PCVAD.
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Introduction
Porcine Circovirus Type 2 (PCV2) is involved in the development 
of several diseases of swine and is undoubtedly of major clinical 
importance in modern pig production. Vaccination against this 
pathogen is therefore a very common precaution, usually piglets 
at weaning.
There are four available vaccines, and as with other products, 
the main selection criteria used by veterinarians are effi  cacy and 
safety. The object of this trial was to compare the safety of piglet 
vaccination with a subunit vaccine (Porcilis® PCV) with another 
PCV vaccine by monitoring local and systemic reactions under 
fi eld conditions (1).
Materials and Methods
Porcilis® PCV is a subunit vaccine containing the viral capsular 
protein coded by the ORF2 of the PCV2 genome in an adjuvant 
containing dl- α-tocopherol acetate and paraffi  n (Xsolve). The 
effi  cacy of this vaccine has been demonstrated previously (2) 
The vaccine was tested on the piglets of a 1000-sow herd in the 
province of Zaragoza, in north-east Spain, managed on a two-
phase production system. The piglets suff ered a PCV2-related 
disease from 14 weeks of age.
829 piglets of about 3 weeks of age were randomly assigned to 
three groups: 
Group 1: 272 piglets vaccinated with a 2ml dose of Porcilis® PCV.
Group 2: 276 piglets vaccinated with 0.5ml of another PCV vac-
cine (Vaccine B).
Group 3: 281 piglets injected with 2ml Diluvac Forte, a dl- 
α-tocopherol acetate based adjuvant, acting as controls. 
The animals were observed for local and systemic eff ects for 1-2 
hours post injection, and at 24 hours, and 7 and 14 days after 
vaccination. 
All the pigs were individually identifi ed, and weighed at 3 weeks 
old (vaccination time) and 10 weeks old (at the end of the post-
weaning period) and the average daily gain (ADG) of each group 
was calculated.
Statistical analysis was performed using the General Linear 
Model (GLM-SPSS 15.0 for Windows). The means and variances 
were compared using the ANOVA and Levene tests.
Results
No local reactions were observed in any of the groups post vac-
cination. In Group 1, 0.7% of the piglets showed mild systemic 
signs that disappeared spontaneously a few minutes after injec-
tion. 
In Group 2, vomiting was observed in 3.5% of the piglets about 
10 minutes post vaccination. The animals recovered between 5 
and 15 minutes later. No systemic signs were observed in Group 
3.
There were no signifi cant diff erences between any of the groups 
with respect to ADG between 3 and 10 weeks of age. Table 1 
summarizes the performance data of the three groups.
Table 1: Performance Results
Group 1 Group 2 Group 3
Parameter//Test group Porcilis PCV Vaccine B Control
Weight at 3 weeks of age 5.9±0.76 5.9±0.8 5.8±0.77
Weight gain (3-10) weeks of age 12.1±0.17 12.2±0.22 12.3±0.24
Average Daily Gain 269±0.004 273±0.004 275±0.004
There was no signifi cant diff erence in performance between the 
three groups (p = 0 307).
At the end of the trial (25 weeks of age) Group 1, however 
showed signifi cant diff erences for all parameters in comparison 
to the control group (Group 3), whereas Group 2 (Vaccine B) did 
not present signifi cant diff erences vs the control group.
Discussion
There were no local reactions to the simple vaccination of con-
ventional piglets with Porcilis® PCV. There were a few systemic 
reactions after vaccination, but they were very moderate and 
transient. 
There was complete equivalence between control and vaccin-
ated piglets as regards growth during the nursery period. Ac-
cording to this study, the vaccination of piglets of 3 weeks of age 
with Porcilis® PCV has no negative eff ect on performance, in the 
few weeks following vaccination.
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Introduction
Pig producers selling at the same average weight may have 
widely diff erent profi t outcomes depending on the fraction of 
production which qualifi es for the highest price sections of the 
buying grid. The main reason for this is variation in slaughter 
weights. It is not unusual for modern production systems to 
have a range of 45kg (100 lb) live weight between the largest 
and smallest animals sold at the time of slaughter. Slaughter-
house pricing schemes provide the highest prices in a relatively 
narrow range of weight and lean percent combinations to incen-
tivize producers to produce and market animals which bring the 
highest returns to the processing and up-chain sales activities. 
Pigs falling outside this range are subjected to increasingly se-
vere discounts as they depart farther from the ideal weight and 
lean parameters1.
It is therefore crucial for pig producers to measure, understand 
and control the variance of production2. Many factors contrib-
ute to variation in fi nal kill weights including natural variation 
inherent in biological production processes. Insults to the pigs 
during the production process (such as feed out events, lack of 
proper ventilation etc.) as well as disease increase the variation 
of fi nished weights as each animal varies in its growth and qual-
ity response to challenges in the growing environment. Disease 
is thought to be the most important cause of variation in fi nal 
slaughter weights. Vaccination measures can aff ect the standard 
deviation of the distribution of weights and other production 
parameters by reducing disease pressure. This paper investigates 
the economic impact of two vaccination protocols taking into 
account only the reduction in standard deviation of slaughter 
weights between the two groups. 
Materials and Methods
A 5,000 head nursery-fi nish unit in Brittany, France receives 
weekly, 21-day-old piglets from a unique 900-sow unit. In this 
side-by-side trial, pigs were randomly assigned at weaning to 
two treatment groups, Circovac® (CV) or Ingelvac CircoFLEX® 
(FLEX). Pigs of both groups were kept in separate pens, but in 
the same rooms 3. The producer was blind to the treatments 
and employed his standard selection and marketing procedures 
to both groups. At slaughter, individual data were gathered for 
all pigs marketed. While actual average slaughter weights per 
group were nearly identical, carcass weight standard devia-
tions were signifi cantly diff erent in favor of the FLEX group. 
10,000 paired carcass weights and lean percents were randomly 
drawn from correlated distributions estimated from the actual 
sales data for each group. The total feed costs were estimated 
from standard growth and intake curves adjusted to match the 
historical closeout data of the farm (average feed cost/Mton W-F: 
€200; base carcass price: €1.30/kg). All observations in each set 
of sampled observations were priced in the French slaughter-
house grill (matrix) to which the farm sold pigs.
Results 
Standard deviation of weight at slaughter was 16.7% lower in 
the FLEX group generating an “as marketed” advantage of €1.85/
head for the FLEX group.
Table 1: Economic returns over feed/hd for both groups
FLEX Group CV Group Diff erence per head
Avg Carcass (kg) 91.04 90.50 0.60%
StDev 6.06 7.28 -16.7%
Avg price Received €1.429 €1.413 €0.016
Revenue/head €130.31 €127.73 €2.58
Feed cost/head €59.92 €59.18 €0.74
Return over Feed/head €70.40 €68.55 €1.85
Discussion & Conclusion
The above diff erential return takes only into account the reduc-
tion in standard deviation of slaughter weights and does not 
include other production parameters e.g. mortality or growth 3. 
However pig producers evaluate diff erent strategies based on 
the most commonly available information, such as the average 
of production parameters (feed effi  ciency, etc.) and overlook 
the hidden economic benefi t generated from reduced variation. 
More understanding of variation at slaughter is critical to captur-
ing more profi t, and since slaughter data is for many farms the 
only availability of individual animal performance data, it is cru-
cial to collect and analyze this important metric. In this trial a dif-
ferential return of €1.85/hd was generated by a 16.7% reduction 
in standard deviation of slaughter weights for the FLEX group.
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Introduction
The aim of the study was to compare the development of 
specifi c humoral immunity (IgG and IgM) against PCV2 over the 
whole production cycle of animals vaccinated with two diff erent 
commercial vaccines and unvaccinated animals, taking account 
of possible interference with maternally derived antibodies 
(MDA).
Materials and Methods
The study was performed on two diff erent sites of a 1000-sow 
farm in northern Spain. The farm had a history of PCVAD-related 
problems, with an average 6-8% mortality during fattening, and 
a late clinical picture appearing from 14 weeks of age onwards 
which persisted up to 18-20 weeks old. Prior to the study, PCV2 
was confi rmed by clinical signs and gross pathology in diseased 
animals, isolation from tissues of 4/5 culled piglets, and serocon-
version evident at 18 weeks of age. 
60 three week old piglets were individually identifi ed and ran-
domly allocated to three groups of 20 animals each, according 
to dam, sow parity, gender and weight. The pigs were treated 
at 3 weeks old as follows: Group 1 was vaccinated with Porcilis® 
PCV (single 2ml dose); Group 2 with a single 0.5ml dose of an-
other commercial product, Vaccine B; Group 3, the controls, were 
injected with 2ml Diluvac Forte®. Blood samples were taken at 
3, 7, 10, 14, 18, 22 and 25 weeks old. Serum was tested for PCV2 
IgG and IgM antibodies (Ingezim PCV2 ELISA®, Ingenasa). 
Results
At 3 weeks of age, the animals of all three groups had high levels 
of MDA, with a high percentage being positive for IgG, but with 
average optical density (OD) titers showing no signifi cant dif-
ferences between the groups (p=0.601). (Group1: 0.7191±0.1; 
Group 2: 0.853±0.11; and Group 3: 0.758±0.1). All the groups 
were negative for IgM at this age. 
At 7 weeks old, the piglets of Group 1 had 94.7% and 84.2% 
animals positive for IgG and IgM, respectively, statistically signifi -
cantly greater than the other groups (p<0.001), and an average 
1.36 ± 0.11 OD titer compared with that of the other groups 
which fell below the threshold. 
At 10 weeks old, IgM had disappeared from all groups, but 
Group 1 had 87.5% animals IgG positive, signifi cantly more than 
the other groups (p<0.001) which were nearly negative, and 
remaining so until 25 weeks of age. 
At 14 weeks old the percentage of IgM positive animals in 
Groups 2 and 3 increased signifi cantly, while Group 1 animals 
remained negative.
Graph 1: Percentage samples positive for IgG
 
Graph 2: Percentage samples positive for IgM
 
Discussion and Conclusions
At 3 weeks old, the IgG levels represent the level of MDA, when 
all piglets were negative for IgM. Unlike the Porcilis® PCV vaccin-
ated group, the Vaccine B group did not seroconvert at 7 or 10 
weeks of age, and the control group did not do so until 14 weeks 
of age, on contact with fi eld virus. This indicates that all previous 
immune responses had been induced by the vaccine without 
interference from MDA (1). A high percentage of the Porcilis® 
PCV vaccinates continued with positive IgG titers until week 25, 
whereas the other two groups needed the fi eld virus challenge 
to induce seroconversion. After challenge, the increased per-
centage of IgM positive pigs in the Vaccine B and control groups, 
but not in the Porcilis® PCV group, demonstrates the priming 
induced by this vaccine.
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Introduction
The clinical presentation of porcine circovirosis has modifi ed 
over recent years, with cases often being less severe, and arising 
at the end of the production cycle. Nevertheless, the virus still 
causes signifi cant production losses which it is very important to 
avoid. The aim of the present study was to assess the benefi ts of 
vaccination with Porcilis® PCV against late, subclinical PCVAD.
Materials and Methods
The study was carried out on a 1500-sow farm in northern Spain, 
managed in 2 week batches, in a two-phase production system. 
The farm, which uses LW*LD genetics, fi nishing with halothane-
negative Pietrain, had tested negative for PRRS and Aujeszky’s 
Disease, but positive for Mycoplasma, against which piglets were 
vaccinated. The average mortality rate had been 3.5% and cull-
ing rate 1.3%. 
The clinical presentation of Circovirus was mild and occurred 
between 20 and 22 weeks of age (the end of fattening period). 
Prior to this study, PCV2 had been identifi ed by in situ hybridiza-
tion (in two unthrifty pigs which were culled), and confi rmed by 
high levels of maternally derived antibodies in young animals 
and seroconversion to PCV2 at 18 weeks of age. 
At 3 weeks of age, the pigs were randomly allocated to two 
equivalent groups of 750 animals each, according to gender 
and weight. The treatment group received a single 2 ml dose of 
Porcilis®PCV; the control group was left unvaccinated. In the pre-
fattening period, the groups were kept in separate barns, and 
during the fattening period they were housed in two twin barns, 
each holding 750 animals. Handling, feeding and treatment pro-
cedures were similar for both groups. Blood samples taken from 
10 animals of each group at 5, 7, 10, 14, 18 and 26 weeks of age, 
were assessed for IgG and IgM (Ingezim PCV Elisa).
Results
Serology shows that Porcilis®PCV vaccination at 3 weeks old, 
even in the presence of medium-high levels of MDA, led to sig-
nifi cant increases in mean IgG and IgM values, which persisted 
to 14 weeks old, before decreasing. The unvaccinated pigs had 
lost their IgG titers (MDA) at 7 weeks of age and continued with 
low levels until seroconversion in week 18 (Graphs 1&2). This 
indicates that MDA did not interfere with the vaccine take. 
Animals vaccinated with Porcilis®PCV also showed improve-
ments in various production parameters, including optimal end 
weight and better carcass yield at slaughter.
Table 1: Production results
Vaccinated Controls
% Mortality 1.73 2.40
% culled pigs due to PCVAD 0 0.93
ADG (grams/day) 793 766
Feed Conversion rate 2.73 2.8
Treatment costs/pig 1.77€ 2.01€
Carcass yield 81.25 80.88
% Pigs out of range 3.33 6.67
The Return on investment (ROI) by using Porcilis® PCV was 3,19 €.
Discussion
Pigs showed clear evidence of seroconversion after Porcilis®PCV 
vaccination, even in the presence of high levels of maternally 
derived antibodies.
Vaccination with Porcilis®PCV has been proven to be eff ective 
even with late onset and mild, subclinical infections, thus con-
tributing to reduced production losses caused by PCV2.
Graph 2. IgG/M values. Vaccinated group
 
Positive result: IgG index >0.455 and IgM index >0.494
Graph 1. IgG/M values. Control group
 
Positive result: IgG index >0.461 and IgM index >0.558 
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Introduction
Porcine circovirus type2 (PCV2) is the primary causative agent 
of porcine circovirus-associated disease (PCVAD) PCVAD has 
been reported with increasing frequency in swine herds. It is 
diffi  cult to recognize and diagnose because the exact patho-
genic mechanisms responsible for the disease are still under 
review. Nevertheless, immune suppression is considered to be a 
key factor. Clinical signs of pigs with PDNS include weight loss/
unthriftiness, dyspnea, enlarged lymph nodes, diarrhea, pallor 
and jaundice, with an increased mortality rate. However, the 
introduction of PCV2 vaccines is contributing to the reduction of 
the incidence of PMWS and its associated diseases. The purpose 
of this study was to further investigate the eff ects on PCVAD of 
CIRCUMVENTTM PCV on commercial Korean farms testing posi-
tive for PCV2.
Materials and Methods
159 piglets from 3 diff erent farms with a history of PCVD (Farms 
A, B, and C located in Hongsung-gun, Choongnam province, 
Korea), were included in this study, and divided into 2 groups, 
vaccinated and placebo. Piglets in the vaccinated group received 
CIRCUMVENTTM PCV (Intervet Schering-Plough) IM at 3 and 6 
weeks of age. The placebo-treated controls were treated in a 
similar manner but with saline instead of vaccine. 
All the pigs were weighed, blood samples were taken, and nasal 
and fecal swabs collected at 3, 6, 9, 13, 16 and 24 weeks of age. 
The mortality was recorded and the rate was calculated for each 
group. Sera were analyzed to measure the immune response 
using SERELISA PCV2 Ab Mono Blocking (Synbiotics, France). The 
PCV2 viral load was quantifi ed by TaqMan real time PCR. Lung le-
sions were assessed according to Pointon et al (1982) at moment 
of slaughter. 
Statistical analysis was by student t-test. Wilcoxon Mann-Whit-
ney test was used to assess diff erences with respect to ADG, 
serology and lung lesions. The ˚C2-test and Fisher’s exact test 
were used to investigate possible diff erences in PCV2 viremia 
and mortality. Statistical analyses were performed using SAS 
software release 8.2.
Results
Average daily weight gain (ADG) was considered to be an 
objective measurement by which to determine the severity 
of PCVAD and the eff ect of vaccination in a large number of 
animals. The vaccinated group had signifi cantly better ADG than 
the placebo group either at entry to the fi nishing phase or at the 
midpoint of the fi nishing phase, or both. 
The mortality rate in the vaccinated group was signifi cantly 
lower during the fi nishing phase, compared with placebo group. 
Pigs on all the farms had high levels of maternally derived 
antibodies against PCV2. The vaccinal antibody response in the 
vaccinated group continued at high levels until 16 weeks of age 
on Farm A and 24 weeks of age on Farms B and C. However, fi eld 
virus antibodies in the placebo group were confi rmed at 13 or 
24 weeks of age. Interestingly, at 24 weeks of age, there was a 
lower antibody response in the vaccinated group than in the 
placebo group. 
In the real time PCR, PCV2-positive animals reached a peak at 
approximately 10-16 weeks of age in the placebo group. In the 
vaccinated group, the level of positive animals decreased more 
dramatically than in the placebo group. Animals with high viral 
loads (106 PCV2 genome/ml in serum) were observed in the 
acute phase at 10 to 16 weeks of age. Compared to the placebo 
group the proportion of PCV2-positive animals in the vaccin-
ated group was signifi cantly lower (FarmA: P=0.0021; Farm B: 
P<0.0001; Farm C: P<0.0001). 
There were no signifi cant diff erences between the groups 
overall in respect of lung lesions, but on Farm C, the vaccin-
ated group had signifi cantly lower lung lesion scores than the 
placebo group.
Discussion
Based on these results, vaccination with CIRCUMVENTTM PCV 
was shown to reduce economic losses from PCV2 infection. 
This appears to be the fi rst report of the effi  cacy of vaccination 
against PCV2 on commercial Korean farms.
Reference
1.  Horlen KP., et al. 2008. JAVMA, 232, 906-912.
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Introduction
Porcine circovirus type 2 (PCV2) is associated with several swine 
diseases such as PMWS (Post weaning Multisystemic Wasting 
Syndrome), PDNS (Porcine Dermatitis and Nephropathy Syn-
drome), and reproductive and intestinal failures.
The object of this study was to demonstrate a reduction in mor-
tality in a herd aff ected by PCV2 virus circulation, using a single 
2ml dose of Porcilis® PCV (Intervet/Schering-Plough Animal 
Health), mainly by reducing the number of PDNS cases. 
Materials and Methods
The study was carried out on a large German pig herd (6,000 
sows and 29,000 fi nishers) with a high PCV2-related mortality 
rate during the fi nishing phase (beginning around the 55th day 
of fi nishing). The presence of PCV2 was confi rmed by histologic-
al and serological examination.
The farm operated three separate production lines. To evaluate 
the eff ect of Porcilis® PCV on mortality, the piglets from one of 
these lines were vaccinated with a single 2ml dose of Porcilis® 
PCV before weaning at three weeks of age. On the same day, the 
piglets were also vaccinated with Porcilis® PRRS intra-dermally 
with IDAL equipment (Intra Dermal Application of Liquids).
During the nursery and fi nishing phases, mortality and other 
disease data were monitored for every batch according to the 
farm’s usual routine. Each nursery unit could accommodate ap-
proximately 660 animals and each fi nishing unit, approximately 
550 animals. The data were collected over three periods:
1)  The pre-study period: no PCV2 vaccination (March - October 
2007)
2)  The study period: only batches of piglets from production 
line 1 were vaccinated with Porcilis® PCV. The piglets from 
production lines 2 and 3 served as controls (October - De-
cember 2007).
3)  The post-study period: piglets of all three production lines 
were vaccinated with Porcilis® PCV (December 2007 - Febru-
ary 2008).
To determine the eff ect of herd vaccination on the incidence 
of PDNS, the data from the pre- and post-study periods were 
compared, the pre-study period serving as historical control. 
The total mortality data per production line were analyzed for 
variance (ANOVA) with production line as the independent vari-
able. The PCV2-related mortality data were analyzed using the 
one-sample T-test.
Results
During the study period, 43 batches of piglets were included 
in the trial (27 nursery batches and 16 fi nishing batches). In all, 
5,796 vaccinated animals were involved in the batches used for 
the analysis. The total mortality during the nursery phase was 
not signifi cantly diff erent (ANOVA: P-value 0.1078) between 
the vaccinated line 1 (0.96%) and control lines 2 and 3 (0.68% 
and 1.34% respectively), and no PCV2-related mortality was 
recorded.
However, during the fi nishing phase of the study period, the 
total mortality was signifi cantly lower (ANOVA; P-value 0.0004) 
in the vaccinated line 1 (1.66%) than in the unvaccinated line 
3 (3.93%). In production line 3, the PCV2-related mortality was 
1.22%, while 0.04% PCV2-related mortality with respect to PDNS 
was recorded in the vaccinated line 1 (ANOVA; P-value 0.0012).
A total of 21,703 vaccinated animals were included in the batch-
es used for the historical comparison. This analysis showed that 
the average total mortality was reduced from 4.77% in the pre-
study period to 1.61% in the post-study period when all three 
production lines were vaccinated. The PCV2-related mortality 
decreased from 2.22% (pre-study) to 0.04% (post-study).
Discussion
The effi  cacy of single-dose vaccination at 3 weeks of age was 
clearly demonstrated by the signifi cant reduction in total 
mortality by more than 50% during the whole fi nishing phase: 
1.66% in the vaccinated line against 3.93% in the controls. The 
reduction in PCV2-related mortality was even clearer in the com-
parison between the vaccinated post-study period (1.61%) and 
control pre-study period (4.82%). 
It can be concluded that there was a highly signifi cant decrease 
in PDNS losses in the fi nishing phase after PCV2 vaccination 
with Porcilis® PCV. In the control group however, signs related to 
PDNS were evident in the majority of the pigs which died. 
The economic benefi ts due to a single 2ml dose of Porcilis® PCV 
realized in this trial were considerable: 3.22 € (study period) and 
4.74 € (pre-study versus post-study period) per fattening pig. 
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Introduction
Postweaning Multisystemic Wasting Syndrome (PMWS) in pigs 
became worldwide one of the most economical important dis-
eases. In Europe annual losses associated with PMWS amount to 
500 to 900 million Euros (Armstrong and Bishop, 2004). 
The objective of this study was to investigate the effi  cacy of the 
vaccine Circovac® Merial SA Lyon in a small subclinically infected 
herd under fi eld conditions and to test the eff ect on reproduct-
ive parameters, daily weight gain, days to slaughter, mortality 
rate and farm economics under Swiss commercial conditions.
Materials and Methods
This study was conducted in a small breeding herd with 90 sows 
in 2007. Piglets were sold every week to a regional fi nisher at the 
age of approximately ten weeks and with a body weight of 23 
to 27 kg. In 2006 only sporadic cases of PMWS had occurred on 
the breeding herd, but there had been considerable losses in the 
fi nishing farm 
Randomly sows were chosen either for vaccination or were in-
jected with Circovac® adjuvans as control group. In the vaccinat-
ed group the sows were vaccinated with 2 ml Circovac® two and 
four weeks before artifi cial insemination and in the 12th week 
of gestation. Parity number, litter weight, number of live and 
dead piglets, number of mummies, number of piglets weighing 
below 1kg, piglet losses during the nursing period and the cause 
of piglet death were recorded for each sow. The carcass weight 
was considered to represent 78% of the live weight at slaughter 
and was used to calculate the average daily weight gain (AWDG, 
g/d). A feed price of 0.43 €/kg, a feed conversion rate (FCR) of 
1.7 kg feed/kg body weight, a price for slaughtered pigs of 2.87 
€/kg and a price of 3.47 €/kg per piglet at 25 kg were taken as a 
basis for the calculation (average Swiss market prices from 2006 
- 2008). The vaccination costs were calculated on a base of 7.00 € 
a dose, 2.3 parities/year and 33 % replacements of young sows. 
Results
There were no signifi cant diff erences of litter size, litter weight, 
number of live and dead piglets, and number of mummies, 
number of piglets weighing below 1kg and number of lost pig-
lets during the nursing period between off spring of vaccinated 
and non-vaccinated sows.
Table 1: Average daily weight gain (ADWG)
Vac. sows Non-vac. sows
ADWG g/d (birth-105kg) 626±10* 593±10
ADWG g/d (25 -105 kg) 786±20* 734±20
Ø Slaughterage (d) 168±2* 177±2
However there were signifi cant diff erences (* p≤0.05) in ADWG 
between off spring of vaccinated and non-vaccinated sows. The 
feed costs in the vaccinated group were 4.10 €/pig lower than in 
the non-vaccinated group respectively 9254 € for all produced 
piglets in this farm in 2007.
Table 2: Mortality rate before and after vaccination (2007)
Before vaccination During vaccination 
Weaned piglets/sow 25.3 27.3
Weaned piglets/year 2277 2457 
Mortality (weaning-25 kg) n=73 (3.2%) n=75 (3.0%) 
Mortality (25-105 kg ) n=134 (6.1%) n=53 (2.2%) 
ØSlaughterage (d) 182 168
Moreover, during the vaccination period the mortality rate 
dropped signifi cantly from 6.1 % (before vaccination) to 2.2 % in 
the fattening farm and after weaning from 3.2% to 3.0% (Table 
2). The higher mortality rate corresponded to losses of about 
25`664 €.
Discussion
The lower mortality rate and feed costs of the piglets of the 
vaccinated sows were producing an economical benefi t about 
34`918 € even in a subclinically infected breeding farm. The 
investment for vaccination in 2007 amounts to 3360 €. Hence it 
resulted a Return on Investment of (ROI) on 1: 10.4.
References
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The eﬀ ect on PCV2 viremia in pigs vaccinated with a single dose of Porcilis PCV® 
Paolo Martelli1 Paolo Bonilauri2 Stefano Gozio3 Alberto E. Cevidalli4 Stefano Guazzetti5 Antonio Caleffi  6 Paolo Borghetti1
1. Dept. Animal Health - University of Parma, Parma, Italy; 2. IZSLER, Reggio Emilia, Italy; 3. Intervet/Schering-Plough A.H., Boxmeer, 
Netherlands; 4. Intervet/Schering-Plough A.H., Milan, Italy; 5. ASL, Reggio Emilia, Italy; 6. Veterinary Practitioner, Mantua, Italy
Introduction
PCV2 vaccines have been demonstrated to reduce losses (mor-
tality and culling rates), and signifi cantly improve the average 
daily gain, while reducing the frequency of co-infections. More-
over, they are claimed to reduce virus load and viral-induced 
lymphoid lesions.
This study was aimed at investigating the eff ect of a single dose 
of a PCV2 subunit vaccine administered at weaning, by measur-
ing the proportion of viremic animals and the PCV2 virus load 
in two herds suff ering from PCVD in pigs older than 15 weeks of 
age. 
Materials and Methods
A double-blinded, randomised and controlled fi eld trial was 
conducted on two farms with a history of PMWS in pigs older 
than 15 weeks (Farm 1: 900-sow farrow-to-fi nish herd and Farm 
2: 3-site 1850 sows herd). 
A total of 818 piglets (males and females) was enrolled in the 
study and distributed between two treatment groups. At inclu-
sion (weaning - 21±3 days of age), a total of 408 animals (Group 
B) received a 2ml intramuscular dose of Porcilis PCV®, a commer-
cial PCV2 capsid-based subunit vaccine expressed in inactivated 
baculovirus. To act as controls (Group A), 410 pigs received 2mls 
of the adjuvant Diluvac Forte®, by the same route. 
On Farm 1, 22 piglets/group were bled at 3 weeks (inclusion /
weaning /vaccination), and 4, 5, 6, 7, 9, 12, 15, 16, 17, 18, 19, 
20, 22, 26 and 35 weeks of age. On Farm 2, blood samples were 
collected from 22 animals/group at 3 weeks of age (inclusion /
weaning /vaccination), and at 4, 6, 12, 16, 18, 20, 22, 24, 26, and 
35 weeks of age. 
Real-time quantitative PCR (qPCR) was performed according to 
Olvera et al. (2004), and the results expressed as the number of 
PCV2 genome copies/ml of serum. 
To estimate the eff ect of vaccination on the probability of a pig 
becoming viremic, a mixed eff ect logistic regression model was 
constructed to take account of the non-independence of the 
repeated measurement of the same subjects and the eff ect of 
the sow (litter eff ect) using the “R” software.
Results 
The onset of PCV2 viremia was observed on both farms at 16-17 
weeks of age in the control pigs and two weeks later in the vac-
cinated group. The proportion of PCV2-positive animals in the 
vaccinated group was statistically signifi cantly lower than that 
of the controls (p< 0.001). Vaccinated pigs, when Q-PCR positive, 
never had a viral load higher than 106. 
Figure 1: Proportion of viremic pigs in vaccinated and control animals 
in Farm 1 (upper graph) and Farm 2 (lower graph)
Discussion 
The present study confi rms that a single dose of Porcilis 
PCV®administered at 3 weeks of age signifi cantly reduces the 
proportion of viremic pigs and the viral load. 
These reductions were associated with an absence of clinical 
signs, improved daily gain and reduced mortality and are correl-
ated with an increase in the antibody response.
References
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Introduction
Under fi eld conditions, PCV2 vaccines improve performance, 
reducing mortality, clinical signs, the frequency of co-infections, 
viral load and viral-induced specifi c lymphoid lesions. Some 
studies indicate that these eff ects are related to total and neu-
tralising antibody responses, as well as to cell-mediated immun-
ity (Fort et al., 2009). The present study was aimed at investigat-
ing the antibody response and the PCV2 IFN-g secretion (by 
ELISpot) after vaccination and exposure to a natural infection, 
under fi eld conditions. 
Materials & Methods 
A double-blinded, randomised and controlled fi eld trial was 
conducted in a 900 farrow-to-fi nish sow herd with a history of 
PMWS in pigs older than 15 weeks. A total of 411 piglets (males 
and females) were enrolled in the study. At inclusion (wean-
ing - 21±3 days of age) 205 pigs (vaccinated group) received a 
2ml intramuscular dose of Porcilis PCV®. To act as controls, 206 
pigs (placebo/control group) were injected with 2mls of Diluvac 
Forte®. Thirty randomly selected piglets (20 controls and 10 
vaccinated) were bled at 3 (inclusion /weaning /vaccination), 
and 4, 5, 6, 7, 9, 12, 15, 16, 17, 18, 19, 20, 22, 26 and 35 weeks of 
age. The sera were tested with a blocking ELISA for the detec-
tion of PCV2-specifi c antibodies in porcine sera, and the titers 
expressed as log2. The levels of IFN- γ secreting cells (SC) in the 
peripheral blood of pigs were determined according to Martelli 
et al. (2009). The in vitro recall response was stimulated by the 
addition of a wild PCV2 strain (I12/11) solution. A mixed eff ects 
regression model was fi tted to take into account the hyerarchical 
structure of the observations, using the “nlme” package within 
the R. 
Results
Vaccination elicited a rapid increase of antibodies with a tripling 
of titres within 6 weeks, even in pigs with the highest levels of 
maternally derived antibodies (MDA) at the time of vaccination. 
In the controls, passively acquired antibodies gradually declined, 
disappearing altogether by 12 weeks of age. Three weeks post-
vaccination the number of IFN-g SC peaked with an average of 
120 cells. At 16-17 weeks of age, when the PCV2 fi eld infection 
occurred, the antibody levels increased in both groups. In the 
controls, a marked IFN-g secretion was detectable (190-240 
cells) within 3 weeks of the fi eld infection. Conversely, the infec-
tion stimulated only an erratic course of IFN-g SC response in the 
vaccinated, clinically protected animals. 
Figure 1: Plot of geometric mean of ELISA titers in vaccinated and 
control pigs.
Figure 2: Plot of the number of IFN- γ SC/106 PBMC after vaccination 
and after infection. 
Discussion
After vaccination, there was a rapid and remarkable PCV2-specif-
ic IFN-g secretion, as well as a signifi cant increase in antibodies. 
After infection high levels of antibodies in the vaccinated 
animals were associated with a reduced or absent PCV2 viremia, 
and a lack of specifi c clinical signs. Comparing our results with 
those of Fort et al. (2009) in experimentally challenged pigs, it 
could be proposed that the intensity of IFN-g secretion depends 
on the in vitro stimulation (in this case, whole PCV2), as well as 
on the type of isolate, viral load and replication in vivo. 
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Introduction
Porcine Circovirus Type 2 (PCV2) and M.hyopneumoniae vaccines 
are probably the most frequently used in the pig industry all 
over the world. As both vaccines are very often given at wean-
ing, their simultaneous use would simplify herd management 
and improve animal welfare. The simultaneous administration of 
various commercial products has previously been shown to be 
eff ective (1). The object of this trial was to demonstrate that the 
simultaneous administration of Porcilis® PCV and M+PAC® is safe 
and effi  cacious in terms of serological response.
Materials and Methods
The trial was performed on a 250-sow farrow-to-fi nish herd in 
north-east Spain, in which piglets had been routinely vaccinated 
with another PCV2 vaccine at 4 weeks of age, but had not been 
vaccinated against M.hyopneumoniae. 
Porcilis® PCV is a subunit vaccine containing the viral capsular 
protein coded by the ORF2 of the PCV2 genome adjuvanted in 
X-Solve®. M+PAC® is an inactivated M.hyopneumoniae vaccine in 
Emunade®, an oil-in-water dual-action adjuvant. 
A total of 397 four-week old piglets were allocated to two ex-
perimental groups:
Group 1: 197 piglets, vaccinated with a mixture of 2ml 
Porcilis®PCV and 2ml M+PAC® injected in a single site on the left 
side of the neck. 
Group 2: 200 piglets were vaccinated with 2ml Porcilis® PCV and 
2ml M+PAC® in separate sites on either side of the neck.
All animals were identifi ed individually by ear tag, and 10 ani-
mals of each group were bled at 4, 7 and 10 weeks of age. 
All the pigs were monitored for signs of local or systemic reac-
tions. 
The immune response to Porcilis® PCV was evaluated comparing 
the PCV2 IgG and IgM titers of each group using Ingezim® PCV-
ELISA (Ingenasa, Madrid, Spain).
Levene test was used for the comparison of variances and Mann-
Whitney U-test for the comparison of means.
Results
No local or systemic reactions were observed in any of the 
animals of Group 1 (mixed vaccination). One piglet of Group 2 
(separate vaccinations) exhibited a transient systemic reaction 
which rapidly disappeared without any remedial action needed.
Graph 1 shows the PCV2 serology. There were no statistically 
signifi cant diff erences between groups either for IgM or IgG at 
any age (p>0.1). 
Graph 1. PCV2 IgG and IgM seroconversion
 
ELISA Ingezim PCV IgG index >0.520 and IgM index >0.66 – positive 
result
No clinical signs of PCV2 or M.hyopneumoniae infection were 
detected in any treatment group.
Discussion
This trial has demonstrated the compatibility of Porcilis® PCV 
and M+PAC® in terms of safety and the immune response 
against PCV2 IgG and IgM, even in the presence of maternally 
derived antibodies. 
Although further studies will be needed to confi rm effi  cacy in 
the fi eld, these data suggest a way herd vaccination strategies 
might be simplifi ed and animal welfare improved. 
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Introduction
M.hyopneumoniae and PCV2 infections are widespread in pig 
populations, which are frequently vaccinated against both 
pathogens. However, as these vaccines are commonly adminis-
tered at weaning, it is important that they do not interfere with 
each other. The effi  cacy of the simultaneous administration of 
Porcilis®PCV and Porcilis®MHyo has been previously demonstrat-
ed under laboratory conditions (1). The aim of this study was to 
confi rm the same under fi eld conditions.
Materials and Methods
The trial was performed in a 250-sow farrow-to-fi nish herd 
in north-east Spain, in which piglets had been routinely vac-
cinated against PCV2 at 4 weeks of age, but not against 
M.hyopneumoniae. 
The trial vaccines were Porcilis®MHyo (a 2-dose inactivated vac-
cine against M.hyopneumoniae with dl- α-tocopherol acetate 
as adjuvant) and Porcilis®PCV, a subunit vaccine containing the 
viral capsular protein coded by the ORF2 of the PCV2 genome, 
adjuvanted in dl- α-tocopherol acetate and paraffi  n.
All the trial pigs received a 2ml priming dose of Porcilis®MHyo at 
1 week of age. At 4 weeks old, 515 piglets were allocated to one 
of two experimental groups: 
Group 1: 325 piglets were vaccinated with a mixture of 2ml 
Porcilis®PCV and 2ml Porcilis®MHyo injected in a single site on 
the left of the neck. Group 2: 190 piglets were vaccinated with 
2ml Porcilis®PCV and 2ml Porcilis MHyo in separate sites on 
either side of the neck.
All animals were individually identifi ed by ear tag, and 10 of 
each group were bled at 4, 7 and 10 weeks of age. All the pigs 
were examined post mortem, at slaughter. 
Safety was assessed by monitoring the piglets for any local or 
systemic reaction. 
All sera were examined for PCV2 IgM and IgG antibodies 
(Ingezim PCV-ELISA), and the antibody response of the groups 
were compared. 
The effi  cacy of Porcilis®MHyo was assessed by scoring the 
severity (0-5) of any post mortem lung lesions typical of enzo-
otic pneumonia. Lung lesion scores were compared with those 
observed in contemporary, but unvaccinated, animals from the 
same farm. For practical reasons not all piglets vaccinated were 
scored at the slaughterhouse. Statistical analysis was performed 
using the Levene test, Mann-Whitney U-test and Pearson’s chi-
square test.
Results
No local or systemic reactions were observed in any of the 
animals of Group 1. Five piglets of Group 2 showed a transient 
systemic reaction that rapidly disappeared without any remedial 
action needed.
Graph 1 shows the results of PCV2 serology. No signifi cant dif-
ference was found in IgM response between the groups, at any 
age. Although there was a statistically signifi cant diff erence in 
IgG response (p=0.049) at 7 weeks of age, it had disappeared 3 
weeks later. No clinical signs of PCV2 infection were detected in 
any treatment group.
Graph 1. PCV2 IgG and IgM seroconversion
IgG index >0.460 and IgM index >0.518 – positive result
Lung lesion scores are summarized in Table 1. No signifi cant 
diff erences were found between the two vaccinated groups, but 
the scores of both groups were signifi cantly statistically diff erent 
compared to the unvaccinated animals (p<0.001).
Table 1. Lung lesions at the slaughterhouse:
Lung Lesions Unvaccinated Group 1 (mixed) Group 2 (separated)
Nº animals observed 254 92 99
% aff ected lungs 72.57a 43.48b 38.38b
Average score 1.11c 0.66d 0.63d
a, b, c,d: values with diff erent superscripts in the same row are statistically signifi cantly 
diff erent: a, b: p<0.001, c, d: p<0.01
Discussion
The simultaneous use of Porcilis®PCV and Porcilis®MHyo has 
been shown to be safe and effi  cacious under fi eld conditions, 
with no statistically signifi cant diff erences between being mixed 
and injected in a single site or injected separately in two distinct 
sites, even in the presence of MDA. These results might be used 
to simplify herd vaccination strategies and improve animal 
welfare. 
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Eﬃ  cacy of 3 PCV vaccines in a commercial farm situation
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Introduction 
The use of vaccines to control diseases associated with the infec-
tion caused by Porcine Circovirus type 2 (PCV-AD) generally has 
resulted in success. In some farm situations however response 
to vaccination has been disappointing necessitating a change of 
PCV vaccine. This study reports such an occurrence.
Background
The farm has 300 sows, weaning occurs weekly at 4 weeks of 
age, progeny are fi nished on site at 100 kg live weight. Pigs are 
PRRS and M.hyo positive. In December 2006 wean – fi nish mor-
tality was 15% when breeding stock vaccination commenced 
to control PCV2 infection in piglets; this resulted in wean-fi nish 
mortality reducing to 6% for 7 months to August 2007. Mortality 
then started to increase to 15%, and whilst previously in pigs at 
7-10 weeks of age was now seen later in pigs at 13-14 weeks of 
age. Piglet PCV vaccination was then instigated using a chimeric 
PCV1/PCV2 vaccine at 7-8 weeks of age due to concerns about 
interference from maternally derived antibody (MDA); mortal-
ity then decreased to 10%. When sow vaccination had been 
stopped for more than 6 months, piglets were PCV vaccinated 
at 3 weeks of age. Mortality then increased to 15% during early 
2009, and then declined to 10% in early summer 2009, before in-
creasing dramatically to 28% in autumn 2009 despite antibiotic 
use. PCV-AD was confi rmed via post mortem examination, histo-
pathology, virus isolation and immunohistochemistry Porcilis® 
PCV vaccination at weaning commenced autumn 2009.
Materials and Methods
Two pigs were bled from each of 10 litters at approximately 3 - 4 
weeks of age prior to vaccination with Porcilis® PCV, the same 
pigs were then sampled later at 8, 12 and 15 weeks of age. The 
serum was analysed to detect antibodies against PCV2 using an 
ELISA test (Boxmeer R&D labs). Samples were also q-PCR tested 
for PCV virus at VLA Weybridge, as were samples from pigs vac-
cinated with the fi rst chimeric PCV piglet vaccine. Pig mortality 
was recorded on a monthly basis.
Results 
The following graph shows PCV2 antibody titers at 4 and 8 
weeks of age after Porcilis PCV vaccination at 3 weeks of age, on 
a Log2 scale. 
 
Littermate pairs showed similar PCV2 antibody titres. Response 
to Porcilis® PCV vaccination in pigs with medium levels of MDA 
showed a strong positive humoral response. 
Antibody titres remained particularly high and uniform at 12 
and 15 weeks, and all exceed the protective antibody titre level 
of 5 Log2 (Fort, Vaccine 2009) Signifi cant challenge occured in 
pigs at 13 weeks of age on transfer to fi nishing; whilst q-PCR 
showed that all pigs that had been vaccinated with Porcilis® 
PCV were PCV virus free at 12 and 15 weeks of age, and clinical 
signs of PCV-AD were absent in these pigs. Pigs vaccinated with 
the initial piglet vaccine had 40% of pigs q-PCR positive for PCV 
virus associated with clinical signs of PCV-AD. Pig mortality has 
been reduced from 28% to 5% within 6 months, growth rate has 
increased by 14% and medication in fi nishing diets has been 
discontinued since commencing vaccination using Porcilis® PCV.
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Shedding of Infectious Porcine Circovirus 2 (PCV2) Into Colostrum And Milk 
Of Vaccinated And Non-Vaccinated Naturally Infected Sows
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Universidade Federal de Minas Gerais , Belo Horizonte, MG, Brazil
Introduction
Porcine circovirus type 2 (PCV2) has been associated with swine 
diseases, collectively referred to as porcine circovirus diseases 
(PCVD). Epidemiological studies have demonstrated that clinical 
manifestations of PCVD can be infl uenced by non-infectious 
factors such passive immunity and maternal viremia in the peri-
partum [1]. Recently, the PCV2 DNA was detected in colostrum 
and milk [4]. 
The objective of this study was to evaluate the profi le of anti-
PCV2 immunoglobulins and the presence of infectious PCV2 in 
colostrum and milk of vaccinated and non-vaccinated naturally 
infected sows. 
Materials and Methods
Forty-one sows from 8 conventional farrow-to-fi nish herds were 
sampled, 21 non-vaccinated and 20 vaccinated with CIRCOVAC 
(Merial) at 30 and 15 days before parturition. Serum samples 
(n=41) were collected on parturition day. Milk samples (n=20) 
were collected 10 days post-partum. 
Serum and colostrum were tested for total (TA) and neutralising 
(NA) anti-PCV2 antibodies as described elsewhere [3]. PCV2 iso-
lation in lacteal samples was performed as previously described 
[2]. PCV2 titre was expressed in TCDI50/50μl. The results of the 
NA and TA was tested by IPMA and expressed as the average of 
log2 titre. Mann-Whitney test was used to analyse the diff erence 
in the antibody levels and the viral titres between the vaccin-
ated and non-vaccinated groups. Diff erences were considered 
signifi cant when P<0.05. 
Results
Infectious PCV2 was detected in 22/41 (53.6%) of colostrums 
samples, and a diff erence was observed between vaccinated 
(7/20, 35%) and non-vaccinated sows (15/21, 74%) (P=0.02). 
Vaccinated sows excreted a minor amount of infectious PCV2 
into colostrum, compared to in the non-vaccinated sows 
(100.50±081 vs. 101.63±1.20; P<0.01). PCV2 was isolated in 5/20 
(25%) of milk sampled. There was no correlation between the 
PCV2 titre in colostrum and milk samples or PCV2 titre and the 
level of anti-PCV2 immunoglobulins.
There was no diff erence between TA and NA titres in colostrum 
of vaccinated and non-vaccinated sows, although vaccinated 
sows had an higher serum NA titre compared to the non-vaccin-
ated sows (P=0.048). 
Discussion 
In this study, we observed that PCV2 is shed into milk from 
vaccinated and non-vaccinated naturally infected sows, even in 
the presence of high neutralising antibodies titres. Despite the 
fact that the vaccination of the sows did not prevent the PCV2 
shedding in those secretions, it was capable of reducing PCV2 
shedding into colostrum. 
PCV2 was detected more frequently in samples of colostrum 
than milk. This diff erence may be related to PCV2 associated 
with monocytic lineage cells shedding (Park et al., 2009) that are 
present in a greater number in the colostrum. The association of 
PCV2 in the cellular fraction of milk may have an important role 
in the viral protection against the NA present in those secretions. 
The importance of PCV2 shedding into colostrum in the early in-
fection of piglets needs further investigation, especially because 
herds in which the piglets are infected earlier with PCV2 have 
a higher risk of developing PCVD. Also, it has previously been 
shown that sow PCV2 viremia was related to piglet mortality [1]. 
In conclusion, PCV2 can be shed into milk and colostrum of 
naturally infected sows even in the presence of high titres of 
neutralising antibodies. Vaccination of sows can reduce viral 
shedding in milk secretion, but cannot eliminate it. 
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Introduction
Porcine circovirus type 2 (PCV2) is the causative agent for 
postweaning multisystemic wasting syndrome (PMWS) and is 
considered to be one of the most important viral pathogens 
of pigs in many countries. PCV2 has also been associated with 
additional diseases, referred to as PCV associated diseases 
(PCVAD) which include PMWS, PDNS, some types of pneumonia, 
enteritis and also reproductive failures (1). In Switzerland a 
PMWS epizooty commenced at the end of 2003 (2). However we 
observed cases of reproductive failures in Swiss sows for the fi rst 
time in autumn 2008.
Materials and Methods
In April 2008 gilts originating from a jointly held mating and ges-
tation facility (ringsystem) in 4 farrowing to wean farms showed 
raised numbers of mummifi ed and stillborn piglets (Ø 0.6 dead 
piglets and 2 mummies per litter whereas the pluriparous sows 
had Ø 0.3 stillborn piglets and 0.3 mummies). All gilts had been 
vaccinated twice against parvovirus and erysipelothrix before 
insemination.
In August we received tissue fl uids to check for PCV2 from 2 
mummies from two litters (farm A) which were negative for 
parvovirus by virological examination. Our quantitative PCR 
detected high PCV2 titers (4-9x106 templates/μl tissue fl uid). 
Subsequently we investigated 3 cases with mummies and/or 
stillborn piglets from 3 other farms (farms B, C, and D) belong-
ing to the same ringsystem. Unfortunately, we did not receive 
further mummies from the fi rst farm (farm A) but a 3 weeks old 
dead litter mate and blood of the two sows that produced the 
mummies mentioned above 3 weeks after gestation. Altogether 
we investigated 2 mummies (16 and 25 cm) from farm B, a non-
mummifi ed fetus (23 cm) from farm C and 4 mummifi ed fetuses 
from farm D (13, 17, 22, 22 cm) by necropsy, histology, virologic-
al methods for parvovirus detection, immunohistochemistry 
(IHC) for PCV2 (F217 monoclonal antibody (3)) and conventional 
PCR for PCV2. A quantitative PCR for PCV2 was achieved on 
the blood samples of the two gilts. We also performed electron 
microscopy on 2 mummies.
Results
All fetuses were negative for parvovirus or antibodies against 
parvovirus. The 3 weeks old littermate from farm A, as well as 
the non-mummifi ed fetus from farm C were IHC negative for 
PCV2. The fetus showed no infl ammatory reaction anywhere and 
the 3 weeks old littermate had died from an intestinal obstruc-
tion (invagination). The tissues of both mummies from farm B 
and 3 mummies out of 4 from farm D were highly IHC positive 
for PCV2. However, the fourth mummy was IHC negative. In 
some cases the myocard was the most positive organ but also 
lymphatic tissues (lymph nodes and spleen) as well as liver, lung, 
kidney and lamina propria of the gut could be very highly posi-
tive, sometimes even more so than the heart. An infl ammatory 
reaction could no longer be detected in the mummifi ed tissues, 
but multifocal distrophic calcifi cation in the myocard was a 
prominent change in 3 of the 5 PCV2 positive hearts. Interesting-
ly, the electron microscopic preparation of mummifi ed paraffi  n 
embedded tissues revealed paracristallinic arrays of icosahedral 
viral-like particles as described for PCV2 inclusions (4). These 
were at least still preserved in the liver of one of the investigated 
mummies. All positive fetuses harbored a PCV2b genotype. Only 
one of the two gilts mentioned from farm A was slightly viremic 
3 weeks after gestation (500 templates/μl blood)
Discussion
Gilts only had raised numbers of mummies and stillborn piglets. 
The problem diminished half a year after but only vaccination 
against PCV2 of all sows fi nally solved the problem.
Mummies showed always high PCV2 IHC positivity and never 
moderate or low signals. Myocarditis was not seen due to the 
poor tissue conservation, however, distrophic calcifi cation in 
the myocard was prominent. Well preserved viral particles were 
found by electron microscopy even in these mummifi ed tissues. 
Interestingly, surviving littermates in aff ected litters developed 
normally. 
The implication of PCV2 in reproductive failures has still to be 
estimated in Switzerland.
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Retrospective ﬁ eld study of the evolution of growth performances after piglet vaccination against PCV2 
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Introduction
In the mid nineties, when PMWS appeared in France, mortality 
in aff ected herds was frequently above 10 % during the post-
weaning period. Fifteen years later, the disease caused by PCV2 
looks very diff erent. Post-weaning losses have decreased to 
normal range in most herds. Few pigs exhibit clinical or post-
mortem signs linked to PCV2 infection but poor growth rates 
resulting in high within-batch weight variability are frequent. 
Consequently many vets advise farmers to vaccinate piglets 
when growth heterogeneity is high even without clear evidence 
of PCV2 associated disease. In that context, we wanted to evalu-
ate the impact of piglet vaccination against PCV2 on pig growth 
in a group of herds. 
Materials and Methods
The study took place between March and August 2009 in 69 
farrow-to-fi nish herds. For each herd we compared data from (i) 
three batches before and (ii) three batches after the implemen-
tation of vaccination. Piglets were vaccinated either with Cir-
cofl ex ® (1 ml), or Circovac ®, (0.5 ml).The criteria analysed were: 
Average Daily Gain from birth to slaughter (ADG), mortality rate 
from 30 kg to slaughter (MR), lean thickness (M2), percentage 
of pigs with carcass weight below 80 kg (CW<80). For several 
reasons (quality of recording, batch mixing, other management 
change during the study) only 23 herds were included in the 
analysis and some criteria were not available for all herds. Mann-
Withney test was used to compare the three batches before to 
the three batches after vaccination. 
Results
In nearly half of the herds an increase, or a trend, of growth rate 
after vaccination was observed. This proportion was the same 
for both vaccination programs. In these herds, the average 
increase was 29 g/day and a positive impact on lean thickness 
was observed. The proportion of underweight pigs was also 
improved in six out of 15 herds. Nevertheless we didn’t observe 
a decrease of mortality rate during the fattening period.
Table 1: Evolution of performances after vaccination (number of herds 
in each category)
 
Discussion
An improvement of technical performances after vaccina-
tion was observed only in approximately half of herds. This is 
probably related with the fact that most often PCV2 associated 
diseases had not been clearly diagnosed. Our study did not 
demonstrate an eff ect of vaccination on mortality rate. This can 
be linked to some diffi  culties to collect reliable data on mortal-
ity. Additionally, in France, mortality rate associated with PCV2 
are currently less important than ten years ago. 
Our study has some limitations. It did not compare contempor-
aneous batches. Consequently results are dependent on other 
changes in the farm during the study period such as manage-
ment changes or sanitary events. Nevertheless data obtained 
here are complementary to those collected in fi eld trials as-
sessing simultaneously several treatments in the same herds. 
Other limit of our study is the number of herds that were fi nally 
included since 46 herds had to be removed because of lack of 
reliable data. 
To conclude, our results suggest that circovirus vaccines can be 
of economical interest by improving technical performances. 
However a more accurate diagnosis of PCV2 infection leading to 
a more relevant vaccine indication could result in a higher suc-
cess rate of vaccination. 
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Long term ﬁ eld observation using diﬀ erent PCV2 vaccines on a 2000 sow farm in Thailand 
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Introduction
Porcine Circovirus type 2 related diseases (PCVD) are a major 
threat for pig production all around the globe. Fortunately, in 
recent years PCV2 vaccines became available and piglet vaccina-
tion has proven to be very eff ective in controlling losses associ-
ated with PCV2 infection (1,2). 
This long term fi eld observation evaluates the performance of 
fatteners from a 2000 head sow farm using diff erent PCV2 piglet 
vaccines. 
Material and method
The fi eld observation included in total more than 85,000 pigs 
from a 2,000 head sow farm in Thailand. Pigs are transferred 
from the sow farm to the fattening units at about 8 weeks of 
age. PCV2 piglet vaccination was fi rst introduced in Spring 2007. 
The fi rst vaccine used was ChoongAng vaccine (produced in 
Korea), mid 2007 the farm switched to Suvaxyn PCV2 and about 
a year later Ingelvac CircoFLEX was introduced. Pigs were vaccin-
ated with all vaccines at about 3 weeks of age. 
Mortality, culls (pigs euthanized during fattening), and average 
daily gain (ADG) were recorded per fattening unit. Total loss is 
the sum of mortality and culls, i.e. the pigs not reaching slaugh-
ter age. 
The diff erences between treatment groups in average perform-
ance variables (ADG, mortality, culls and total loss) were evalu-
ated using pair-wise Wilcoxon test with a Bonferroni adjustment 
(SAS System, SAS Inst., Cary, North Carolina, v 8.2). 
Results 
Finishing mortality, culls and total loss were signifi cantly re-
duced in CircoFLEX vaccinated pigs compared to the other two 
groups, while ADG was signifi cantly improved (table 1). 
Table 1. Average performance in fattening units.
Choong Ang Suvaxyn PCV2 CircoFLEX
Fattening units (n) 21 79 82
Pigs (n) 9,932 37,152 38,479
ADG (g/day) 673a 679a 710b
Mortality (%) 2.64a 3.13a 1.37b
Culls (%) 1.70a 2.52b 1.40a
Total loss (%) 4.35a 5.65a 2.77b
a,b: Values with diff erent superscripts diff er signifi cantly (p <0.05/3)
Figure 1 shows that not only average mortality was signifi cantly 
lower in the CircoFLEX vaccinated units, but that variability in 
mortality was reduced as well. 
Figure 1. Total loss (%) per fattening unit. 
A=ChoongAng, B=Suvaxyn PCV2, C=CircoFLEX.
Discussion and conclusion 
PCV2 piglet vaccination has become global routine use (3). The 
data of this fi eld observation indicates that the choice of vaccine 
might signifi cantly infl uence production performance. Ingelvac 
CircoFLEX vaccinated pigs performed signifi cantly better than 
pigs vaccinated with two other PCV2 vaccines. 
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Comparative humoral immunity response to vaccination with Porcilis® 
PCV, a second commercial vaccine and unvaccinated animals
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Introduction
Monitoring the correct humoral immune response to vaccina-
tion is important when using routine vaccination procedures 
at early ages (3-4 weeks of age). This can be considered as the 
fi rst step to assess possible interferences of vaccination with 
maternally-derived antibodies, and gives an indication about 
the response that will be obtained in subsequent production 
phases. 
Materials and Methods
The study was performed in a farm housing 1680 sows, located 
in central Spain. Pigs from this farm showed evident PCVAD-
related problems during fattening. The symptoms appeared at 
fi rst at 13 weeks of life, and the most critical phase of the disease 
concluded 4 weeks later. Sixty-three animals with a mean age 
of 24 days (2 days before weaning) were selected for the study. 
The animals were uniquely identifi ed using double ear-tags and 
were randomized into 3 groups, according to their dam and its 
parity, and piglet weight and gender, as follows: 
• Porcilis®PCV group, single 2 ml dose, 21 piglets.
• Vaccine A group, single 1 ml dose, 23 piglets.
• Control group, single 2 ml dose of Diluvac Forte® (as a pla-
cebo), 19 piglets.
A commercial test was used for the detection of IgG and IgM 
(Ingezim PCV2 ELISA®, Ingenasa), comparing the results ob-
tained at 3, 7 and 9 weeks of age. The cut-off  thresholds diff ered 
for each antibody detection time: from the 1st to the 3rd sam-
pling, the values for IgG were 0,7, 0.69 and 0.65, respectively and 
1.02, 0.74 and 0.71 for IgM, respectively.
Statistical evaluation was performed using the Kruskall - Wallis 
test, the Pearson’s chi-square test, the Fisher’s exact test and the 
Mann-Whitney-U test.
Results
The fi rst sampling time coincided with the administration of 
the three treatments, and all the groups presented high levels 
of maternally-derived immunity, as shown by the high mean 
optical density ratio (OD) values and the high percentage of ani-
mals positive for IgG (Graph 1). Very low or negative values were 
found for IgM. All the parameters were comparable (p<0.05).
The second sampling at 7 weeks showed a stronger IgG re-
sponse to vaccination in the Porcilis®PCV group, with signifi cant 
diff erences for the percentage of positive animals compared 
to the other two groups (p<0.05). Vaccine A did not present 
signifi cant diff erences vs. the Control group for both param-
eters (p<0.05). The Porcilis®PCV group showed a stronger IgM 
response (Graph 2), with signifi cant diff erences when comparing 
the percentage of positives vs. the Control group (p<0.05) and 
vs. Vaccine A (p<0.001), with no diff erences between the Vaccine 
A and Control groups. The percentage of animals of the Vaccine 
A group positive for IgM at 4 weeks post vaccination was 0% At 
week 9, a marked increase of the mean OD values was found 
in the Porcilis®PCV group vs. the other two groups (p<0.001), 
and for the percentage of positives vs. the other two groups 
(p<0.05). No signifi cant diff erences were found for both param-
eters between the other groups. A strong IgM response occurred 
in the Control group. Signifi cant diff erences were found vs. the 
Porcilis®PCV group (p<0.05) and the Vaccine A group (p<0.001). 
No signifi cant diff erences occurred between both vaccinated 
groups (p<0.05). 
Graph 1: % Samples positive for IgG
 
Graph 2: % Samples positive for IgM
 
Discussion and Conclusions
The strong response to the Porcilis® PCV vaccine obtained 4 
weeks after vaccination, contrary to the fi ndings for the Vaccine 
A and Control groups, indicates a correct immunisation of the 
animals, thus preventing interferences with maternally derived 
immunity.
Even though the farm had a history of late problems, the in-
crease of IgM values in the Control group at week 7, which was 
more evident at week 9, probably was due to contact with the 
fi eld virus.
.
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Introduction
Porcine Circovirus type 2 associated diseases (PCVD) is the cur-
rent name for those pathologies directly related to PCV2. Apart 
from the classical clinical expression formerly called postwean-
ing multisistemic wasting syndrome (PMWS), has been describe 
a wide range of diseases, including reproductive alterations 
(1,2). The launch of vaccines against PCV2 has off ered a very use-
ful tool to manage the PCVAD, but there is no wide knowledge 
about the improvement of reproductive performances directly 
derived of the vaccination (3, 4). On the other hand, there is 
much less knowledge about the eff ect on Iberian pig breed, a 
Spanish minority indigenous breed.
The aim of this study was to assess the eff ect of the vaccination 
against PCV2 with Circovac® on reproductive performance in 
Iberian gilts and sows.
Material and Methods
The experience was carried out in a large unit of Iberian pig pro-
duction (850 sows) in multiple-sites-production. The breeders 
were mass vaccinated and revaccinated in a period of 3 weeks. 
Subsequently, the animals were revaccinated every gestation at 
least 3 weeks before farrowing expected date. The reproduction 
is completely based on artifi cial insemination, and every ejacu-
late is tested using classical seminal quality tests. Gilts and sows 
are vaccinated against PRRSv three times per year, alternating 
modifi ed live and killed vaccines. Boars remained unvaccinated. 
The reproductive performance recorded during one year before 
vaccination and revaccination were used as control.
The analyzed data were: fertile inseminations unfertile insemina-
tions, number of inseminations, return to estrus and type of 
return to estrus depending on the day returning; early (0-17 dpi), 
early cyclic (18 to 24 dpi), early acyclic (25-30 dpi), later acyclic 
(31-38 dpi), later cyclic (39-43 dpi) and later (>44 dpi). A total of 
2,741 and 2,897.inseminations performed in control and vaccin-
ated groups, respectively, were analyzed. All data were analyzed 
using the SPSS v. 15.0 software (SPPS Inc, USA).
Results
Data obtained from gilts and sows in both experimental groups 
are shown in the following table:
Group AMG FM NFM
Control
Gilts 1.34 71.9 28.1
Sows 1.15 84.1 15.9
Vaccinated
Gilts 1.18 77.4 22.6
Sows 1.08 87.4 12.6
Signifi cance p<0.001 p=0.002 p=0.002
Where AMG: average mating per gestation, FM: fertile mating, NFM: non 
fertile mating.
There was no diff erence for the frequency of each return-to-es-
trus type neither for gilts nor sows (p=0.47 and p=0.45, respect-
ively). Early and cyclic returns in gilts and sows from both groups 
were the most frequently types found.
Discussion
There is controversy regarding the eff ect of PCV2 on repro-
ductive performance, even when some negative eff ects have 
been described by practitioners. This trial shows an improve-
ment in parameters such us average mating per gestation, 
fertile inseminations and non-fertile inseminations, resulting in 
reduction of production costs. These fi ndings suggest that the 
PCV2 could be producing a subclinical eff ect on reproductive 
performance and the improvement of health status in sows and 
gilts derived from PCV2 vaccination could result in these better 
performances in Iberian pigs reared under intensive conditions. 
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Introduction
Porcine Circovirus Diseases (PCVD) is the current name for those 
pathologies directly related to PCV2. Apart from the classical 
clinical expression formerly called postweaning multisistemic 
wasting syndrome, has been describe a wide range of diseases, 
including reproductive alterations (1, 2).
The aim of this study was to assess the eff ect of the vaccination 
against PCV2 with Circovac® on farrowing performance in Iber-
ian gilts and sows.
Material and Methods
The experience was carried out in a large unit of Iberian pig pro-
duction (850 sows) in multiple-sites-production. The breeders 
were mass vaccinated and revaccinated in a period of 3 weeks. 
Subsequently, the animals were revaccinated every gestation 
at least 3 weeks before farrow expected date. The reproduction 
is completely based on artifi cial insemination (AI), and every 
ejacule is tested using classical seminal quality tests. Gilts and 
sows are vaccinated against PRRSv three times per year, alternat-
ing modifi ed live and killed vaccines.
As control the reproductive performance recorded during one 
year before vaccination and revaccination were used. The ana-
lyzed data were: length of gestation (GL), live born piglets (LBP), 
stillborn piglets (SBP), weaned piglets per litter (WPL) and mor-
tality during suckling (MS). All data were included in a SPSS data 
base analyzed using the SPSS v. 15.0 software (SPPS Inc, USA) 
by means of ANOVA. Results from 2,273 and 2,317 farrowings 
in control and vaccinated group, respectively, were analyzed. 
In control group 515 and 1,580 farrowings from gilts and sows, 
respectively, and in vaccinated groups 361 and 1,956 farrows 
from gilts and sows, respectively, were recorded.
Results
There was no diff erence for lactation length (22.3 vs 22.6 and 
21.5 vs. 22 for sows and gilts, respectively). Data obtained for 
gilts and sows are shown in the table 1. 
Table 1: Reproduction parameters in vaccinated and control groups, 
for sows and gilts
Parameter
Control Vaccinated Signifi cance
Gilts Sows Gilts Sows Gilts Sows
GL 113 112.4 113.5 113.7 NS P<0.001
ABP 6.7 7.11 6.7 7.18 NS NS
DBP 0.28 0.52 0.28 0.35 NS P<0.001
WPL 6.5 6.37 6.3 6.47 NS P=0.036
MS 12.9 17.2 12.2 9.9 NS P<0.001
Where GL: gestation length ALV: alive born piglets, SBP: stillborn piglets, WPL: weaned piglets 
per litter and MS = mortality during suckling. NS: not signifi cant.
Discussion
The length of lactation did not infl uence other parameters. We 
have found diff erences for all studied parameters except for ABP 
in sows, but, there was no diff erence in gilts. To have a clear idea 
it should be taken into account that Iberian pigs show a lower 
reproductive performance than commercial crossbreds. How-
ever, there were important advantages derived from the vac-
cination with Circovac® in sows: the reduction of SBP and mor-
tality during suckling result in a signifi cant increase in weaned 
piglets per litter. There is also an interesting result: the increase 
of gestation length in more than one day. This could result in a 
better vitality and maturity of piglets. The most important diff er-
ence was mortality during suckling in sows, showing a decrease 
of more than 57% (17.2 vs 9.9% in control and vaccinated group, 
respectively) which could be a direct result of immunity against 
PCV2 derived from specifi c colostral antibodies against the 
virus, in agree with several previous studies. The lack of eff ects 
in gilts group could be explained because gilts are vaccinated 
only when they are included in the breeder group. So, despite 
the vaccination every farrow, the sows would have immunity 
produced by mass vaccinations.
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Introduction
Postweaning Multisystemic Wasting Syndrome (PMWS) in pigs, 
caused by porcine circovirus type 2 (PCV2), has become one of 
the most important diseases in swine. Pigs are most commonly 
aff ected at 5 to 12 weeks of age. PCV2-specifi c antibodies can 
be detected in almost all pigs. In 2008 Circovac®, (Merial SAS, 
Lyon) was introduced in Switzerland. Circovac® is used to vac-
cinate pregnant sows to increase the concentration of colostral 
antibodies.
Materials and Methods
In this study we used Circovac® in two diff erent farms with a his-
tory of naturally occurring PMWS. Herd A was a breeding herd 
with 90 Yorkshire sows. Piglets were sold to a regional fi nisher at 
the age of approximately ten weeks and at a body weight of 22 
to 27 kg. Only sporadic cases of PMWS had occurred in herd A 
since 2006, but there had been considerable losses in the fi nish-
ing operations. 10 to 15% of these pigs developed PMWS. Herd 
B was a breeding herd with 150 Yorkshire x Landrace crossbred 
sows. Approximately 5-20% of the pigs had low daily weight 
gain and profuse untreatable diarrhoea with a herd mortality 
rate of 5-10%, also indicators to a serious PMWS problem. 
Randomly sows were chosen either for vaccination or were 
injected with Circovac® adjuvans as control group. Sows were 
vaccinated with 2 ml Circovac® two and four weeks before artifi -
cial insemination and in the 12th week of gestation. 10 ml blood 
was collected from the jugular vein from of all sows immediately 
before the fi rst injection, four weeks after the second injection 
and two weeks after the third injection. 2-5 ml blood was col-
lected from 100 individually tagged piglets at the age of 3, 10, 
31, 42 and 63 days p.p. An improved competitive ELISA (SEREL-
ISA® PCV2 Ab Mono Blocking Systems (Synbiotics Corporation 
Europe SAS, Lyon) was used for antibody detection. The carcass 
weight represents 78% of the live weight at slaughter and was 
used to calculate the average daily weight gain (AWDG, g/d).
Results
Figure 1. In both farms the vaccinated sows showed a signifi cant 
increase of PCV2 antibody titre from the fi rst to the second vaccination 
(** p≤0.001) 
Figure 2. Off spring of vaccinated sows had signifi cantly higher anti-
body titres against PCV2 until day 63 after birth (* * p≤0.001) 
Table 1. Performance parameters for the control group compared to 
the vaccinated group (* p≤0.05) 
ADWG ADWG (g/d) Slaughter
(g/d) 25 -105 kg age (d)
Control A 593 734 177
Circovac A 626* 785* 168*
Control B 565 696 189
Circovac B 585* 726* 183*
Discussion
We succeeded by vaccination in elevating antibody titres in 
sows. At day 42 off spring of vaccinated sows had nearly the 
same antibody titres as piglets from non-vaccinated sows at day 
3 pp. These higher antibody titres ameliorated growth param-
eters of piglets in both farms.
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Introduction
Proliferative enteropathy caused by Lawsonia intracellularis (Li) 
and porcine circovirus associated diseases (PCVAD) caused by 
porcine circovirus type 2 (PCV2) are two of the most important 
swine-diseases in Switzerland. The objective of this study was to 
investigate the effi  cacy of the vaccines Enterisol® Ileitis against 
Li and Ingelvac CircoFLEX® against PCV2 under fi eld conditions 
and to test whether there is an additive eff ect on perform-
ance parameters when using both vaccines. The absence of 
Mycoplasma (M.) hyopneumoniae and porcine reproductive 
and respiratory syndrome virus (PRRSV) in Switzerland allows a 
proper investigation of the impact of vaccination against these 
two pathogens.
Materials and Methods
This study was conducted in a 200 sow farm operating in a 
weekly rhythm with eight farrowing sows per batch and a 
fi nishing site with 800 places. The sites were tested negative 
for PRRSV, M. hyopneumoniae, Salmonellae, Brachyspira (B.) 
hyodysenteriae and B. pilosicoli. PCV2 was confi rmed by dissec-
tion and IHC, Li by faecal PCR and ELISA. In total 1405 piglets 
were included into the study, 384 vaccinated with Enterisol® 
Ileitis and Ingelvac CircoFLEX® (EI + CF), 376 with Ingelvac 
CircoFLEX® (CF), 318 with Enterisol® Ileitis (EI) and 327 with 
oral and parenteral placebo (Control). Because of the unbal-
anced genetics and the small number of sows per week group, 
all piglets of two consecutive batches were included into one 
treatment group. This resulted in 24 week-groups with three 
repetitions of eight weeks, where the sequence of the treatment 
groups per repetition was random. Piglets were vaccinated at 
an average age of 23.5 days. Average Daily Weight Gain (ADWG) 
was calculated from individual weight measurements at four 
time points (week 3, 12, 18 and slaughtering) during the entire 
study. Almost all dead animals were dissected and tested for 
PCV2 and Li. Blood and faecal samples were taken from at least 
10 pre-selected animals per batch at 3, 7, 12, 15 and 18 weeks of 
age. Blood samples were tested by qPCR for PCV2 and by ELISA 
for anti-Li antibodies. Faecal samples were tested by PCR for Li.
Results
The results from serology and PCR indicate an infection of Li and 
PCV2 at the end of the nursery/beginning of fattening (data not 
shown). 
The mortality rate and the ADWG of the fattening period are 
indicated in table 1.
Table 1: The mortality rate and the ADWG of the fattening period. Dif-
ferent letters (a/b/c) indicate a signifi cant diff erence (P≤0.05).
Parameter EI+CF CF EI Control
Mortality(%) 1.1a 2.5a 2.3a 6.3a
ADWG (g) 792a 772b 774b 751 c
For the control and the EI group 18 and 10 death losses were 
after necropsy diagnosed to be related to PCV2 whereas for 
the PCV2 vaccinated animals none of the losses were related to 
PCV2. Li was detected in four dead animals but was never seen 
as the cause of death. 
Discussion
The observed eff ects of the mono applications (CF and EN) dur-
ing the fattening period were comparable with other effi  cacy 
studies1, 2. The data indicates that the concurrent application of 
Enterisol® Ileitis and Ingelvac CircoFLEX® had additive eff ects on 
pig performance parameters. It was also demonstrated that the 
use of both vaccines was profi table3. The results of this study 
indicate that after introduction of PCV2 vaccination ileitis vac-
cination has still a signifi cant impact on performance param-
eters even when Li is sub-clinically present in a farm. 
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Introduction
Proliferative enteropathy caused by Lawsonia intracellularis (Li) 
and porcine circovirus associated diseases (PCVAD) caused by 
porcine circovirus type 2 (PCV2) are two of the most important 
swine-diseases in Switzerland. The objective of this study was to 
investigate the effi  cacy of the vaccines Enterisol® Ileitis against 
Li and Ingelvac CircoFLEX® against PCV2 under fi eld conditions 
and to test whether there is an additive eff ect on performance 
parameters when using both vaccines. This abstract covers the 
impact of the ileitis and PCV2 vaccination on fattening perform-
ance and farm economics under Swiss commercial conditions.
Materials and Methods
This study was conducted in a 200 sow farm operating in a 
weekly rhythm with eight farrowing sows per batch and a fi nish-
ing site with 800 places. The farms ware tested negative from 
porcine reproductive and respiratory syndrome virus (PRRSV), 
Mycoplasma hyopneumoniae, Salmonellae, Brachyspira (B.) 
hyodysenteriae and B. pilosicoli. PCV2 was confi rmed by nec-
ropsy and IHC, Li by faecal PCR and ELISA. In total 1405 piglets 
were included into the study, 384 vaccinated with Enterisol® 
Ileitis and Ingelvac CircoFLEX® (EI + CF), 376 with Ingelvac 
CircoFLEX® (CF), 318 with Enterisol® Ileitis (EI) and 327 with 
oral and parenteral placebo (control). Because of the unbal-
anced genetics and the small number of sows per week-group, 
all piglets of two consecutive batches were included into one 
treatment group. This resulted in 24 week-groups with three 
repetitions of eight weeks, where the sequence of the treatment 
groups per repetition was random. Piglets were vaccinated at 
an average age of 23.5 days. Average Daily Weight Gain (ADWG) 
was calculated from individual weight measurements at four 
time points (week 3, 12, 18 and slaughtering) during the entire 
study. All dead animals were recorded. The economic impact 
of the fattening farm (week 12 to slaughtering) is expressed by 
the return on investment (ROI) per year, i.e. the extra profi t of 
X Swiss francs generated per 1 Swiss franc invested. A price for 
slaughtered pigs of 3.60 sfr/kg (2.40 €/kg), a price of 4.40 sfr/kg 
(2.93 €/kg) per piglet at 30 kg and a price of 6.00 sfr (4.00 €) for 
both vaccines in total were taken as a basis for the calculation.
Results
The comparison of the control group and the PCV2 vaccinated 
group is showed in table 1. The pigs vaccinated with Ingelvac 
CircoFLEX® (CF) had a signifi cant higher ADWG (+ 21 g/d) and a 
signifi cant lower mortality rate (- 3.8 %).
Table 1: Performance parameter and economic impact for the control 
group compared to the CF group.
Control CF Δ
ADWG (g/d) 751 772 21
Mortality (%) 6.3 2.5 3.8
ROI 3.6:1
Fattening pigs vaccinated with Enterisol® Ileitis and Ingelvac 
CircoFLEX® (EI + CF) had a signifi cant higher ADWG (+ 20 g/d) 
and a lower mortality rate (- 1.4 %) compared to the animals vac-
cinated with Ingelvac CircoFLEX® (CF). The economic benefi t of 
Enterisol® Ileitis illustrated with the ROI was 2.1:1 (table 2).
Table 2: Performance parameter and economic impact for the CF 
group compared to the EI + CF group (Enterisol® Ileitis group).
CF EI+CF Δ
ADWG (g/d) 772 792 20
Mortality (%) 2.5 1.1 1.4
ROI 2.1:1
Discussion
The comparison of the ROI of the PCV2 and the additional Ileitis 
vaccination indicates the economic relevance of both vaccina-
tions. On this farm, the eff ects of the PCV2-vaccine against the 
clinical PCVAD were a decisive reduction of mortality and an 
improvement of the ADWG. Despite the fact that the ileitis infec-
tion was subclinical vaccination with Enterisol® Ileitis was highly 
profi table. 
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Introduction
PCV2 infections are ubiquitous among pigs worldwide. 
Olvera (2004) and Krakowka (2005) showed that there is a rela-
tionship between viral load and the occurrence of disease. High 
infection levels lead to clinical disease while lower levels induce 
a subclinical course. The latter may however induce signifi cant 
economical losses.
The majority of pigs in Belgium are subclinically infected with 
low levels of PCV2. Even without clear signs of PMWS or PDNS, a 
subclinical infection with PCV2 often has a negative impact on 
average daily weight gain, feed conversion, days to slaughter 
and/or slaughterweight. 
The timing of a PCV2 virus infection is often unknown under 
fi eld conditions. It is important that pigs are protected as early as 
possible and for the whole of the fattening period (Eggen IPVS 
2010). 
In the present fi eld study three week old piglets were vaccinated 
once with Porcilis PCV vaccine. The objective was twofold. It was 
intended to measure the eff ect of this Porcilis PCV one shot vac-
cination on slaughter weight, as well as to evaluate the mortality 
rate during the growing period, with respect to unvaccinated 
controls. 
Materials and Methods
A large conventional closed farm with hypothetical subclinical 
problems of PCV2 was selected. 
At 3 weeks of age, group 1 was vaccinated with 2 ml of Porcilis 
PCV and group 2 was indicated as a control group. Group 1 
contained 572 animals and group 2 contained 714 animals. All 
animals were observed daily for clinical signs and mortality. 
The body weights were measured at slaughter. Mortality rates 
between vaccinated and unvaccinated controls were compared 
and evaluated by the non-parametric test of Kruskal-Wallis. 
Diff erences in weights at slaughter were examined using the 
one-way Anova. 
10 serum samples for each were taken at vaccination, at 10 
weeks of age, at 14 weeks of age and one week before slaughter. 
These samples were examined for PCV2 and PRRSv antibodies 
and nucleic acid of PCV2. 
Results 
All piglets were healthy before and after vaccination. Slaughter 
weights were scored individually for group 1 and 2 and the 
mean and standard deviation are shown in Table 1. The mortality 
rate is shown in Table 2.
Table 1: Growth performance and slaughter weight (kg)
Group Porcilis PCV Control 
N* 472 647 
BW at 10W(kg)** 20.15 20.79 
Days to slaughter***
Average weight at slaughter + 
standard deviation
141 
a92.1 +/- 10.75
142 
b90.0 +/- 10.96
a,b p<0.05; * numbers refers to numbers of slaughtered animals, **BW= Body Weight at 10 
weeks, ***from 10W of age on.
Table 2: Mortality rate of Porcilis PCV vaccinated piglets and control 
group
Group N Alive Dead % mortality
Porcilis PCV 572 560 12 a2.09
Control 714 681 33 b4.6
a,b p<0.05
The Porcilis PCV-group showed a signifi cant diff erence of 2.1kg 
in slaughter weight within the same fattening period (p<0.05).
The mortality rate in the Porcilis PCV group was signifi cantly 
reduced to 2.09%, which is a decrease of 54.5% (p<0.05).
Discussion 
A single 2ml dose of Porcilis PCV in piglets of 3 weeks of age, 
used in subclinical fi eld conditions, led to signifi cantly higher 
slaughter weights within the same fattening period. This result 
could justify a vaccination with Porcilis PCV at three weeks of 
age in subclinically infected farms.
Although, the mortality rate in the control group was reason-
ably low, it was even 54,5% lower in the Porcilis PCV vaccinated 
group.This may indicate that the vaccine was able to signifi cant-
ly reduce mortality, resulting from a subclinical PCV infection.
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Introduction
Porcine circovirus infection causes important production losses. 
Over recent years the disease has been found to occur with an 
increasingly later onset, with negative eff ects on the fattening 
phase of production. Vaccination against this disease, which 
is usually carried out at an early age, may reduce these losses, 
but on some farms it will coincide with high maternally-derived 
antibody (MDA) levels. The aims of the present study were to as-
sess the improvement in production parameters resulting from 
a Porcilis®PCV vaccination program and to evaluate the possible 
interference by maternally-derived immunity. 
Materials and Methods
The study was undertaken on a 2,600-sow farm in North- East 
Spain (LD x LW, fi nished with Pietrain), operating a two-phase 
production system. The herd was positive for M. hyopneumoniae 
(M. hyo), PRRSv and circovirus. The onset of clinical PCV2 oc-
curred at 17 weeks of age.
Production results were compared of a total of 33,580 piglets 
which entered phase two between January and September 
2009. The animals were housed in diff erent fattening units. The 
16,120 pigs entering the units between January and April were 
not vaccinated with Porcilis® PCV, used as controls. The 17,460 
pigs entering the units between May and September were vac-
cinated against PCV2 (Porcilis® PCV: single 2 ml dose) at weaning 
at 3 weeks of age. All the animals in the study were also vac-
cinated against M. hyo (M+PAC®: single 2 ml dose) at 3 weeks 
of age. The vaccinated group thus received two vaccines at the 
same time, in separate injections.
Average production indicators for all the animals were recorded 
over the whole fattening phase (feed conversion rate, ADG, % 
mortality, % runts, treatment cost/pig). A cross-section sero-
logical study was also carried out on 10 animals of each group 
at diff erent ages during the cycle. A commercial test was used 
to assess PCV2 antibodies in the serum (Ingezim PCV2 ELISA®, 
Ingenasa), for the detection of IgG and IgM. 
Results
Porcilis®PCV vaccination at 3 weeks of age, even in the presence 
of high levels of MDA, led to signifi cant increases in mean IgG 
and IgM values at 10 weeks of age, before they declined. The 
control group had lost their IgG titers (MDA) at 7 weeks of age 
and continued with low levels until seroconversion at 17 weeks 
of age (Graphs 1&2). This indicates that MDA did not interfere 
with the immune response to the vaccine. 
Graph 1. IgG/M values. Control group
Positive result: IgG index >0.827 and IgM index >0.915
Graph 2. IgG/M values. Vaccinated group
Positive result: IgG index >0.416 and IgM index >0.520
Table 1: Production results
Control group Vaccinated group
No.piglets 16.120 17.460
Feed Conversion 2.81 2.71
ADG 683 702
% Low-weight pigs 6.9 3
% Mortality (fi nishing) 7.4 4.1
Treatments/pig 2.31 € 1.79 €
Discusssion 
Vaccination with Porcilis ®PCV at 3 weeks of age, even in the face 
of high levels of MDA and the occurrence of a late, severe clinical 
PCV2 infection, improved the production indicators of the farm, 
leading to signifi cant economic benefi ts with a 8.8 ROI.
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Introduction
Combating other diseases and improving management routines 
has decreased the impact of Post weaning Multisystemic Wast-
ing Syndrome (PMWS) (1). PMWS is associated to porcine circo-
virus type 2 (PCV2), and the impact of PMWS has been further 
decreased following introduction of vaccines directed against 
PCV2 (2). The present study aimed to scrutinise the relevance of 
vaccinating against PCV2 in a herd previously aff ected by PMWS, 
but declared free from clinical disease. 
Materials & Methods
The study was carried out in a gilt producing herd previously 
deemed for PMWS, but declared free from PMWS at herd basis 
since one year. Batches of 24 sows farrowed every third week in 
previously emptied and cleaned units. Piglets born were weaned 
at the age of 6 weeks and kept as intact litters in the unit until 
the age of 12 weeks. At that age barrows were sold, while gilts 
were transferred to a growing unit with continuous production.
At three weeks of age, 12 litters of one farrowing batch were 
vaccinated against PCV2 (Ingelvac Circofl ex, BI-Vet). The other 
12 litters remained unvaccinated. All piglets were weighed at 
weaning and at 11 weeks of age. The gilts that remained at the 
herd were also weighed at the age of 21 weeks. Blood from two 
pigs per litter was collected at 5, 8, 12 and 16 weeks of age and 
analysed for presence of serum antibodies to PCV2 with an IPMA 
technique.
Results
Figure 1. Log antibody titers to PCV2 in vaccinated (◊) and unvaccin-
ated ( )  pigs.
The decreasing levels of serum antibodies to PCV2 from 5 to 
12 weeks in the control group indicated a low PCV2-load in the 
farrowing unit. The vaccinated pigs seroconverted at the age of 
12 weeks, while the unvaccinated pigs that seroconverted at 16 
weeks of age.
There were no signifi cant diff erences in mean body weights 
between the groups at any occasion (Figure 2). However, vaccin-
ated gilts gained signifi cantly more weight from 11 to 21 weeks 
of age. None of the 48 vaccinated gilts weighed less than 70 kg 
at 21 weeks of age. In comparison, 6 out of 54 unvaccinated gilts 
weighed less than 70 kg at 21 weeks of age. Out of 53 weaned 
vaccinated gilts, 48 were still at the herd at the age of 21 weeks 
(92%). The corresponding fi gure for the control group was 54 
out of 60 (90%).
Figure 2. Body weights of pigs vaccinated or not against PCV2 at three 
weeks of age
Discussion & Conclusions
We saw no eff ect of the vaccination in the farrowing unit were 
the PCV2-load according to the serology was low. Thus, vaccina-
tions against PCV2 with the aim of protecting weaned pigs in 
such units appear pointless.
However, vaccinated gilts seroconverted earlier when they 
met PCV2 in the unit with continuous production, indicating a 
positive eff ect of the vaccination. They also performed better 
(p<0.05) from 11 weeks of age, which was achieved by a lower 
number of poor performing pigs.
The results obtained support theories of improved performance 
following PCV2-vaccination also in herds without clinical PMWS. 
However, it ought to be remembered that this herd eff ectuated 
continuous production from 12 weeks of age, which coincided 
with the time when the pigs appeared to meet the infection 
with PCV2. Therefore, further studies ought to be made in herds 
with batch wise production to confi rm the true relevance of vac-
cinating young pigs in herds without presence of clinical PMWS. 
Not the least since a decrease in number of underweighted 
pigs has a potential to shorten the eff ective rearing time for the 
entire batches. 
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Vaccination against Porcine Circovirus type 2 and Lawsonia intracellullaris in a two-
site production system with subclinical manifestations of the microbes 
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1. Dept of Animal Health and Antimicrobial Strategies, Uppsala, Sweden; 2. Swedish Animal Health Service, Ängelholm, Sweden
Introduction
The superior growth of SPF pigs has raised questions on the 
impact of subclinical infections on the growth of pigs. Vac-
cines have recently been registered for the common microbes 
Porcine Circovirus type 2 (PCV2) and Lawsonia intracellullaris. The 
present study aimed to scrutinise the relevance of vaccinating 
piglets against these microbes in a two-site production system 
with presence of these microbes, but without obvious problems 
with either of them.
Materials & Methods
The study was carried out in a piglet producing herd with 1,000 
sows that farrowed in batches of 43 sows every week, and in a 
fattening herd recruiting full batches from the sow herd at an 
age of 11 weeks. The herds were free from clinical PMWS and 
proliferative enteritis, but PCV2 and Lawsonia were demonstrat-
ed by serology. All piglets in one farrowing batch were given 
a unique identity. Piglets in each litter were allotted into three 
groups. At four weeks of age, group A was vaccinated against 
PCV2 (Ingelvac Circofl ex, BI-vet), group B against Lawsonia 
(Enterisol Ileitis, BI-Vet), and group C was left as an unvaccin-
ated control. However, gilts had been vaccinated twice against 
PCV2 (Circovac, Merial), and all sows were revaccinated during 
pregnancy.
All pigs in the experimental batch were weighted at 4, 10 and 22 
weeks of age. Blood was collected from ten pigs per group (from 
diff erent litters) at 4, 7, 10, 13, 16 and 19 weeks of age. Serum 
was analysed for presence of antibodies to PCV2 by IPMA (1) and 
Lawsonia by a commercial ELISA (BioScreen, Münster, Germany).
Results
All piglets received a high maternal protection to PCV2. Piglets 
vaccinated for PCV2 increased the amount of antibodies to PCV2 
at 13 weeks of age and the other groups at 19 weeks of age (Fig. 
1). No pig showed any sign of PMWS.
All piglets were seronegative to Lawsonia at 4 weeks of age (Fig 
1). At 16 weeks of age, three pigs vaccinated to Lawsonia were 
seropositive (PI>34) to Lawsonia compared to one pig in each of 
the other groups. At 19 weeks of age, three vaccinated pigs were 
still seropositive compared to 5 or 6 in the other groups. The 
mean PI-values never diff ered statistically between groups.
The growth rate was equal for the three groups from 4 to 10 
weeks of age (Fig 2). The weight of the pigs was equal for also 
groups also at the age of 22 weeks.
 
Figure 2
Body weights Piglets vaccinated
PCV2 Lawsonia Control
Weight (kg) (n=152) (n=150) (n=142)
 4 weeks 8.3±1.9  8.6±2.2  8.3±1.9
10 weeks 29.4±5.4 30.5±6.4 29.9±5.7
22 weeks 98.7±11.0 99.1±11.8 98.4±11.8
Discussion & Conclusions
Piglets vaccinated for PCV2 seroconverted between 10 and 13 
weeks of age, indicating that PCV2 became activated at that 
time. However, antibody levels had not increased at 16 weeks 
in the other groups, indicating a low load of PCV2, presumably 
achieved by the vaccination of sows and the high amounts of 
maternal antibodies. Thus unvaccinated pigs seroconverted at a 
high age when they are less likely to develop PMWS. 
Likewise, the serology indicated only a limited load with 
Lawsonia prior to 16 weeks of age. A protective role of the vac-
cine may be indicated by somewhat lower PI-values at 19 weeks 
of age in vaccinated pigs. 
We saw no diff erence in weight gain between the three groups. 
Thus, vaccinations against PCV2 or Lawsonia with the aim of pro-
tecting recently weaned pigs in apparently healthy herds appear 
pointless, and a true signifi cance of these microbes ought to be 
proven before expecting any eff ect in fattening enterprises.
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Field experiences with Ingelvac CircoFLEX® in mild cases in Spain
Jose L. Lorenzo; Marisa Rosas
Maporc s.l., San Cristobal de Segovia, Spain
Introduction
PCVD is a worldwide disease and PCV2 is present in nearly all 
swine herds. Luckily for technicians and producers, in last years, 
very eff ective vaccines have been developed and using Circo-
virus vaccines has been shown to be very profi table (1). Even in 
cases of mild disease, return of investment of vaccinated animals 
justify the use of the vaccine (2).
The objective of the present fi eld observation was to evalu-
ate the eff ect of PCV2 vaccination in mild to moderate cases of 
PCVD on 3 diff erent farms in Spain. 
Materials and Methods
This fi eld observation included 3 sow farms and 5 fattening 
units that suff er mild-moderate problems of PCVD. In all cases, 
peak of signs were observed between 14 and 16 weeks of age. 
Animals were vaccinated at 3 weeks of age using one shot of 
1ml of Ingelvac CircoFLEX® (Boehringer Ingelheim) following 
label recommendations. Piglets were moved at 10 weeks of 
age to the fattening units. Control groups were non vaccinated 
animals grown in the same building just before vaccinated ones, 
during 2009. Health status is similar in the three farms: PRRS and 
Mycoplasma positive (vaccination at 3-4 weeks of age) and APP 
negative. 
Case 1: Farrow-to-fi nish farm with 550 sows, producing weekly 
batches of 240 piglets in an AIAO system. Performances in the 
nursery are really good but animals suff er from respiratory signs 
and wasting starting at 14 weeks of age. 
Case 2: Farrow-to-fi nish farm with 600 sows, producing weekly 
batches of 270 piglets. Final Boar is Pietrain. In the nursery there 
are some problems of Glässer and Streptoccocus suis disease 
but there are no clinical signs of PCVD in the fattening, only few 
wasting pigs. 
Case 3: Farrow-to-fi nish farm with 650 sows with genetic nucle-
us, producing weekly batches of 300 piglets. Final Boar Pietrain. 
Good performances in nursery and fattening, mild PCVD case 
with few respiratory problems.
Mortality in controls and vaccinated animals were evaluated 
using a Chi-square test. 
Results
Case 1: Performance after vaccination on this farm was improved 
substantially (table 1). Weight gained in the fattening unit was 
5,45 kg more in the vaccinated group spending the same num-
ber of days in fattening. 
Vaccinated pigs were slaughtered 10 days younger than the 
control group. 
Table 1. Relevant parameters in Case 1
Control Vaccine Diff erence
# piglets tested 3036 950
Mortality (%) 5.4a 3.1b -2.35
ADG (g/day) 708 789 +81
FCR (kg/kg) 2.576 2.374 -0.202
Case 2: Vaccinated pigs performed much better than the con-
trols (Table 2). Weight gain in the fattening period was 3kg more 
in the vaccinated pigs in 21 days less.
Case 3: The results (Table 2) in this case are the mean from 3 dif-
ferent batches in 3 diff erent fattening units. 
Table 2. Relevant parameters in Case 2 and Case 3
Case 2 Control Vaccine Diff erence
# piglets tested 917 964
Mortality (%) 4.36a 2.70b -1.66
ADG (g/day) 534 756 +222
FCR (kg/kg) 2.480 2.490 +0.010
Case 3 Control Vaccine Diff erence
# piglets tested 2240 2218
Mortality (%) 5.0a 3.8b -1.2
ADG (g/day) 612 752 +140
FCR (kg/kg) 2.817 2.454 -0.363
a,b: values with a diff erent superscript, diff er signifi cantly (p< 0.05)
Discussion
Several authors showed improvements of performance in 
animals vaccinated with Ingelvac CircoFLEX in diff erent systems 
around the world (1-6). Data presented in this article confi rmed 
the effi  cacy in 3 farrow-to-fi nish farms in Spain. In mild or mod-
erate cases, where mortality is not the main goal, we can appre-
ciate that ADG could be increased by more than 100 grams/day 
and FCR could be reduced by more than 0,2. 
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Eﬀ ect of vaccination against PCV2 and Lawsonia intracellularis administered concurrently 
Gonzalo Cano; Joan Sanmartin
Optimal Pork Production, S.L., Lleida, Spain
Introduction
Prevention of endemic diseases in farms should be the main ob-
jective of the veterinarians in the next years. PCV2 and Lawsonia 
intracellularis are two of the most widely spread infectious 
disease in Spain. Both are endemic in all major pig producing 
countries (1,2). Clinical presentations in farms are variable de-
pending to external factors like nutrition, facilities, co-infections 
or climatic conditions. Successful experiences with Ileitis vac-
cination or PCV2 vaccination have been reported in numerous 
cases. (3-10). 
The objective of this study was to evaluate the eff ect of concur-
rent PCV2 and Ileitis vaccination administered few days before 
weaning on performance parameters in fattening. 
Materials and Methods
The study took place in two sow units of the same company, one 
unit with 4.900 sows and the other one with 2.200. Both units 
were producing weekly batches and shared gilt source (same 
quarantine) and did have the same health status: PRRS, APP, and 
Ileitis positive. Sow and piglet vaccination program were identi-
cal and management in both units was very similar. 
Performance parameters in the sow farms were good. Piglets 
were weaned between 21 and 24 days, allocated in nursery until 
10 weeks of age and then moved to diff erent fattening units in 
an all-in/all-out regime (each origin in a separate fattening unit). 
Identical feed programs and in-feed medications were applied 
for sows, piglets and pigs. 
The before-after study included 18.381 animals divided in 4 
groups: non vaccinated, vaccinated against Ileitis (Enterisol® 
Ileitis, 2ml via drench at 17 days of age), vaccinated against PCV2 
(Ingelvac CircoFLEX®, 1ml IM at 17 days of age) and vaccinated 
against Ileitis+PCV2 (both vaccines administered concurrently at 
17 days of age). 
All data presented is from diff erent fattening units of the same 
production system. All batches of all groups were entered 
simultaneously in fattening units between late November 2008 
and late January 2009. Mortality rate was compared between 
treatment groups using the Chi-square test. 
Results
Performance results show an improvement in each vaccinated 
group compared to non-vaccinated animals, with, the best 
results in the group vaccinated with both vaccines (table 1). 
In the group vaccinated against Ileitis and PCV2 compared to 
the group with Ileitis vaccination only mortality was reduced by 
43% and medication costs by 36%. Comparing the group with 
concurrent Ileitis and PCV2 vaccination with the group vaccin-
ated against PCV2 only, the improvement is obvious in FCR and 
medication costs.
Table 1: Performance parameters in fattening units comparing 4 
groups of vaccination
Non vaccinated Ileitis PCV2 Ileitis+PCV2
Num piglets 5.469 5.313 3.749 3.850
Mortality (%) 9.31a 5.01b 2.85c 2.81c
Days in fattening 144 138 132 134
ADG (g/day) 640 672 674 678
FCR (kg/kg) 2.880 2.710 2.770 2.700
Medication costs 
(€/pig) 2.28 1.26 1.19 0.81
a,b,c: values with a diff erent superscript, diff er signifi cantly (p< 0.05)
A return of investment of 3,84:1 was calculated for the concur-
rent ileitis and PCV2 vaccination when compared to the non-
vaccinated animals. 
Discussion
The data presented in this study demonstrate that vaccinating 
pigs concurrently against Ileitis and PCV2 improve the fattening 
performance compared to non-vaccinated animals and animals 
vaccinated against only one of the diseases. ROI for using both 
vaccines was 3.84:1 compared to non-vaccinated pigs.
Finally, in this case, both vaccinations were done at the same 
time, one orally by drench and the other IM. No adverse reaction 
was observed. This is an example how producers can benefi t of 
doing two treatments together, saving stress to the animals and 
saving money.
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PCV2 vaccination prevented clinical PCVAD and reduced PCV2 viremia and semen virus 
shedding in boars concurrently infected with PCV2b and Mycoplasma hyopneumoniae
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Introduction
It has been determined that porcine circovirus type 2 (PCV2) 
DNA is shed in semen of naturally and experimentally infected 
boars (1). Recently, it also has been shown that PCV2 DNA 
present in semen is infectious in a swine bioassay model (2). 
However, under experimental conditions the amount of PCV2 
shed in semen is low and not suffi  cient to be transmitted into 
naïve breeding animals (2). In the growing pig model, Myco-
plasma hyopneumoniae infection has shown to potentiate PCV2 
replication, PCV2-associated lesions, and disease (3). Under fi eld 
conditions, young boars that enter boar studs are often ex-
posed to infectious agents (i.e. M. hyopneumoniae) for the fi rst 
time, are given multiple adjuvanted vaccines, and are exposed 
to other stressors (mixing, transportation) that are thought to 
enhance PCV2 replication in growing pigs. The main objective 
of this study was to determine if the amount of PCV2 shed in 
semen can be increased in boars experimentally coinfected with 
M. hyopneumoniae and immune-stimulated via killed parvo-
virus-leptospira-erysipelothrix (PLE) vaccination. In addition, we 
wanted to determine if PCV2 vaccination of the boars prior to 
PCV2 exposure will reduce PCV2 viremia and virus shedding in 
semen. 
Materials and Methods
Twelve specifi c-pathogen-free PCV2 and M. hyopneumoniae 
naïve boars were randomly divided into one of four groups with 
three animals in each group. Half of the boars were vaccinated 
against PCV2 35 days before PCV2 challenge using a com-
mercially available inactivated product (Suvaxyn® PCV2; Fort 
Dodge Animal Health Inc). Fourteen days before and at the day 
of PCV2 inoculation all 12 boars were vaccinated per label with 
a commercially available PLE vaccine (FarrowSure®, Pfi zer Inc.). 
In addition, 14 days before PCV2 inoculation, 6/12 boars were 
intranasally inoculated with M. hyopneumoniae. All boars were 
challenged with PCV2b on Day 0 of the study. Semen and serum 
samples were collected on a weekly basis and all boars were 
euthanized 35 days post-PCV2 inoculation. All samples were 
analyzed for the presence of anti-PCV2 IgG antibodies by ELISA 
and for the presence and amount of PCV2 DNA by quantitative 
real-time PCR as described (1). 
Results
All vaccinated boars had seroconverted to PCV2 by the time of 
PCV2 challenge, whereas non-vaccinated boars were seronega-
tive. After M. hyopneumoniae challenge, inoculated boars de-
veloped moderate respiratory disease characterized by cough-
ing, respiratory distress, and mucopurulent nasal discharge. 
After PCV2 challenge, one of three coinfected, non-vaccinated 
boars became lethargic, lost condition, and died. M. hyopneu-
moniae infected boars had signifi cantly (p<0.05) higher PCV2 
DNA levels in serum compared to boars singularly infected with 
PCV2. Non-vaccinated boars had signifi cantly (p<0.05) higher 
PCV2 DNA loads in serum compared to vaccinated boars. More-
over, PCV2 vaccination resulted in signifi cantly (p<0.05) reduced 
incidence of shedding of PCV2 in semen. 
Discussion
In this study we showed that boars experimentally infected with 
PCV2 and M. hyopneumoniae can develop clinical manifestation 
of porcine circovirus associated disease (PCVAD). In addition, 
PCV2 vaccinated boars did not develop clinical disease and 
had signifi cantly reduced PCV2 viremia and PCV2 shedding in 
semen. This information will guide boar stud owners in their 
decision process when considering PCV2 vaccination.
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Attenuated vaccine against PCV2 infection by abrogation of ORF3 function
Jimmy Kwang
Temasek Life Sciences Laboratory, Singapore, Singapore
Introduction
Porcine circovirus 2 (PCV2) is a pathogen causing signifi cant 
economic impact on swine production. Interestingly, the virus is 
one of the smallest known viruses with a genome of 1.7 kilo-
bases and has only three identifi ed genes. This virus infection 
has a high morbidity and leads to severe pathogensis in more 
than 20% of the infected pigs. The principle feature of Porcine 
Circovirus associated Diesease (PCVD) is the compromise of the 
immune system, marked by lymphadenopathy, lymphocyte 
depletion and lymphoid organ destruction. The PCV2 infection 
is usually found with other viral and bacterial co-infections. Our 
lab identifi ed a novel gene in the PCV2 genome, ORF3, which 
plays a central role in the apoptosis induced by the virus infec-
tion. 
Results 
PCV2 open reading frame 3 (ORF3) codes a 105 amino acid 
protein that causes apoptosis of PCV2 infected cells. In infected 
cells, the ORF3 causes the accumulation of p53 by interacting 
with pPirh2 and possibly by disrupting the association of p53 
and pPirh2 (J.Virol.81(2007)9560). Mutant PCV2 lacking the 
expression of ORF3 are infectious and replicate in cells in vitro, 
but do not cause apoptosis of the infected cells. The ORF3 of 
PCV2 has been shown to be involved in pathogenesis of the 
virus in mice model (J. Virol. 80(2006)5065). The pathogenicity of 
the ORF3 defi cient virus is attenuated in the piglets. The mutant 
virus did not cause any observable disease or perturbation of 
the lymphocyte count in the inoculated piglets and elicited an 
effi  cient immune response. When compared with the wildtype 
virus infection, the mutant virus infection was characterized by 
mild viremia and absence of pathological lesions. The lymphoid 
organ depletion in the ORF3 defi cient virus was almost absent 
as opposed to the wildtype virus infection, which resulted in 
the characteristic loss of lymphnode architecture. The fi ndings 
highlight the role of ORF3 in the pathogenesis of PCV2 infection 
in its host.
Porcine Circovirus Associated Diseases (PCVAD) – Control
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 429
Poster Presentations
P.123
Piglet vaccination against PCV2 with CIRCOVAC® (Merial) in 59 German herds: 
evaluation of the eﬀ ect on mortality in weaners and fatteners
Ariane Schade2 Zrinjka Bradaric2 Julie Venet1 Thaïs Vila1 Sophie Longo3 François Joisel1
1. Merial S.A.S., Lyon, France; 2. Merial GmbH, Munich, Germany; 3. BPC, Labruguière, France
Introduction
CIRCOVAC® has been registered in mid 2007 in the European 
Union for the use in sows. Piglet vaccination has been imple-
mented in Germany under special allowance according §17c.
Abs.2 TSG since May 2008. Vaccination under special allowance 
requires collection and report of information on the outcome of 
the vaccination to authorities. The effi  cacy of CIRCOVAC sow vac-
cination in preventing porcine circovirus type 2 (PCV2) infections 
in piglets and therefore in improving production parameters 
of their off spring has been extensively proven (1). However in 
some cases, e.g. piglets from diff erent origins being grouped for 
fattening, piglet vaccination can be useful (2).
The objective of this study is to evaluate the eff ect of one-shot 
vaccination of piglets with 0.5 ml CIRCOVAC from 2 weeks of age 
when used in fi eld conditions.
Material and Methods
Veterinarians taking part in the fi eld study completed ques-
tionnaires provided by Merial for vaccine evaluation including 
questions on production data of the herds before and during 
CIRCOVAC piglet vaccination.
The analysis was performed in 59 herds from which evaluable 
information on production data before and during CIRCOVAC 
piglet vaccination under special allowance was provided. In 
some herds PCV diseases (PCVD) have been presumed before 
vaccination as the data showed high mortality and high num-
bers of wasting animals and animals aff ected by PDNS. So the 
vaccination was intended as metaphylactic approach. On other 
farms vaccination was implemented without presumption of 
PCVD and with already good performance parameters. Reasons 
for this could be a preventive approach or the fact that PCV2 
piglet vaccination is often requested by swine marketing organi-
sations. Such farms were not excluded from this analysis.
The types of farms are shown in Table 1.
Table 1: Number of present herds by production type
Production type Number of herds % of herds
Farrow-to-fi nish (FF) 28 47.5%
Sows+Weaners (SW) 23 39%
Weaners (W) 5 8.5%
Fatteners (F) 3 5%
Total farms 59 100%
Mortality data and percentage of wasting pigs were obtained 
from the records on each farm, if they were available. The param-
eters were analyzed for nursery and fattening period. 
Means of each variable were compared between the two dif-
ferent periods of time (before and during vaccination) using 
Student t-test and/or Kruskal-Wallis test. The level of signifi cance 
was 5% for all the tests.
Results
Mortality rates are signifi cantly decreased after CIRCOVAC vac-
cination (table 2).
Table 2: Mortality improvement, before versus during vaccination 
(STD= standard deviation)
Mean (%) STD Decrease of mortality during vaccination
Piglets in 
nursery Before 3.95 2.81
During 2.53 1.61 -1.42% (p=0.016)
Fattening pigs Before 3.35 1.91
During 2.21 1.17 -1.14% (p=0.024)
Further, the incidence of wasting was lower in both weaners and 
fatteners after vaccination (-1.6% in both periods). The diff erence 
was close to signifi cance in fatteners (p=0.060).
Conclusion
CIRCOVAC piglet vaccination induced a distinct improvement 
with a signifi cant decrease in mortality. This large study dem-
onstrates the positive impact of CIRCOVAC piglet vaccination. 
For the interpretation of the results, it needs to be taken into 
account, that farms which vaccinated in a preventive approach 
were not excluded from the statistics. Therefore it can be hy-
pothesized that restricting the analysis to farms with diagnosed 
PCV2 problems and reduced performance could lead to even 
better results.
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Evaluation of the safety of an inactivated porcine circovirus type 2 vaccine 
(CIRCOVAC®) administered to boars: absence of impact on spermatogenesis
Thaïs Vila; Valérie Cozette; François Joisel
Merial S.A.S., Lyon, France
Introduction
Porcine circovirus type 2 diseases (PCVD) have been reported 
throughout the world as a major cause of losses in pig herds (1). 
PCV2 can clearly be associated with some cases of reproductive 
failure. Furthermore, the presence of infectious PCV2 in semen 
has been demonstrated (2,3,4). Consequently, PCV2 boar vac-
cination is commonly used in pig farms. This study was designed 
to assess the safety of CIRCOVAC® administered to reproductive 
boars.
Material and Methods
The study was performed in a European artifi cial insemination 
center. A total of 15 9-month-old boars provided by the same 
nucleus farm were included in the study and randomized as 
follows: 5 boars vaccinated twice 3 weeks apart with CIRCO-
VAC, 2 ml (group 1); 5 boars vaccinated according to the same 
protocol and treated with paracetamol dose for 3 days since the 
day before vaccination (group 2); 5 boars non vaccinated but 
injected with NaCl 0.9%, 2 ml twice (group 3). Boar semen was 
sampled once a week from 3 weeks before 1st vaccination to 8 
weeks after 2nd vaccination. The criteria followed up were: body 
temperature and semen quality (volume, spermatozoon con-
centration, motility, abnormality, viability and healthy spermato-
zoon per ejaculate meaning mobile, with normal mobility and 
non agglutinated). A one-way analysis of variance (ANOVA) was 
used to compare temperature results between groups. Semen 
parameters were compared by a Student t-test after pooling 
both vaccinated groups 1 and 2 (vacc.) which were similar. 
Results and Discussion
Body temperature was slightly increased after vaccination (4 
boars out of 5 were above 39.5°C in group 1); this was limited to 
1 and 3 boars respectively after 1st and 2nd injection in group 2 
treated with paracetamol.
Semen quality parameters for each period (before, during and 
after vaccination) for the vaccinated and control groups are 
presented in table 1. No group eff ect was evidenced whatever 
the period (p>0.05).
Table 1: Semen parameters according to the treatment group (mean 
value ±standard deviation)
Semen 
parameters
Concentration 
(Million/ml)
Healthy spz 
(Milliard/ejaculate) Viability (%)
Groups 
(Nb of boars) V (10) C (5) V (10) C (5) V (10) C (5)
Before vaccina-
tion (5 weeks) 201.9± 31.2 180.4± 40.8 47± 13.1 45.7± 25.0 85.5± 2.1 86.4± 1.6
During vaccina-
tion (4 weeks) 246.5± 62.6 213± 36.4 60.3± 14.1 51.2± 22.4 86.1± 1.8 85.3± 3.1
After vaccina-
tion (6 weeks) 201.7± 40.6 191.9± 36.9
59.5± 12.5 
(9 boars) 49.5± 18.3 85.1± 2.6 85.1± 2.4
V: vaccinated; C: controls
Only one boar in group 2 had a lower semen concentration dur-
ing vaccination period. The statistical analysis only evidenced 
higher values for spermatozoon concentration and viability for 
vaccinated groups.
Very few impact of CIRCOVAC vaccination was observed in this 
study on semen quality parameters over a period of 10 weeks 
after 1st injection. 
Conclusion
CIRCOVAC vaccination showed no impact on spermatogenesis 
as far as semen parameters of reproductive boars are concerned.
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Introduction
Several studies have demonstrated that PCV2 vaccines increase 
the level of antibodies in the pigs and reduce the severity of the 
injuries associated to this virus. In the human specie the TH2 
response is mainly regulated by the interleukins (IL) IL4, IL5 and 
IL13. Sometimes the ELISA technique is not enough sensitive 
to detect cytokine levels in culture supernatants (1). Nowadays 
there is no kit for pig IL5 and the ELISA for IL13 is brand new and 
has never been demonstrated to work with antigen specifi c re-
sponse. Quantitative PCR (Q-PCR) is a specifi c and sensitive tech-
nology to quantify the gene expression of mRNA (2). The aim of 
the present study was to evaluate the TH2 immune response of 
PCV2-vaccinated pigs when their peripheral blood mononuclear 
cells (PBMC) are stimulated with antigenic peptides of the open 
reading frame 2 (ORF2) of PCV2. 
Material and Methods
Ten SPF 10 weeks old Large White pigs were divided in two 
groups: vaccinated (n=5) and control (unvaccinated, n=5). 
Animals in the fi rst group were vaccinated the day 0 of the 
experiment with CIRCOVAC® (Merial, France). The day 21 of the 
experiment a blood sample was obtained and two and a half 
million PBMC were cultured per well in a total volume of 1 ml 
complete RPMI under two diff erent conditions: stimulation with 
PCV2 ORF2 antigenic peptides and a non activation condition 
where the culture media was composed exclusively by complete 
RPMI. Gene expression was determined at 24h poststimulation. 
RNA was extracted and retrotranscribed into cDNA. Relative 
gene expression was calculated using the 2- Δ ΔCt method. 
Q-PCR for IL4, IL5, IL13 and cyclophilin was developed using 
published sequences (3, 4) in a 7500 real time PCR system (Ap-
plied Biosystems, EEUU).
Results
Major gene expression changes were observed for IL13 com-
pared to IL4 and IL5 in PBMC. No diff erence for interleukin gene 
expression at day 0 between both groups was observed. At day 
21 when the cells were stimulated with PCV2 ORF2 peptides a 17 
times higher response of IL4 and a 21 times higher synthesis of 
IL13 was detected in the vaccinated group. 
Discussion
At day 0 of the experiment no specifi c lymphocytes existed 
circulating in the blood because no change in IL gene expres-
sion was detected after stimulation with PCV2 ORF2 peptides. 
At day 21 a greater response in the synthesis of IL4 and IL13 was 
detected in the PCV2 vaccinated group when their PBMC were 
stimulated with PCV2 ORF2 peptides suggesting that specifi c 
lymphocytes have been developed against the vaccine antigens. 
IL5 gene expression did not show statistical diff erences between 
both experimental groups indicating that this IL is low expressed 
in the pigs as Levast et al., (5) previously demonstrated. Some 
authors have described that Large White pigs do not express 
IL4 (6), but the results of the present study showed that gene 
expression of IL4 took place in the Large White pigs analyzed, 
suggesting that diff erences could exist among diff erent Large 
White genetic lines. Bautista et al., (7) suggested that IL13 could 
replace IL4 functions in the pig, but our results showed IL13 and 
IL4 gene expression changes in response to PCV2 ORF2 peptides 
in the vaccinated group indicating that both IL could be import-
ant in the pig TH2 response.
References
1.  Díaz I & Mateu E (2005) Vet Immunol Immunopathol 106:107-112. 
2.  De Boever S, Vangestel C, De Backer T et al., (2008) Vet Immunol 
Immunopathol 122: 312-317.
3.  Dawson HD, Beshah E, Nishi S et al., (2005) Infect Immun 73: 1116-
1128.
4.  Flores-Mendoza L, Silva-Campa E, Reséndiz M et al., (2008) Clin Vac-
cine Immunol 15: 720-725.
5.  Levast B, De Monte M, Melo S (2010) Dev Comp Immunol 34:102-
106.
6.  Raymond C & Wilkie B (2004) Vaccine 22: 1016-1023.
7.  Bautista EM, Nfon C, Ferman GS (2007) Vet Immunol Immunopathol 
115: 56-57.
®CIRCOVAC is a registered trade mark of Merial in Canada and else-
where.
.
Porcine Circovirus Associated Diseases (PCVAD) – Control
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 432
Poster Presentations
P.126
Swine herd with a prevalent PCV2 subclinical infection: diagnostic 
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Introduction
Porcine circovirus type 2 (PCV2) may cause a variety of diseases 
(PCVAD - Porcine Circovirus Associated Disease), including post-
weaning multisystemic wasting syndrome (PMWS) (1). Because 
subclinical infections are common, diagnostic methods used 
should be able to perform the PCVAD diagnosis and also evalu-
ate the PCV2 viremia in pigs. In the present longitudinal study 
the Authors described the use of a diagnostic approach, before 
and after the PCV2 vaccination, in a herd where PCV2 subclinical 
infections were prevalent. 
Materials and Methods
The clinical case took place between March and June 2008 
in a farrow to fi nish herd with 170 sows in the Northern Italy. 
The clinical symptoms of the disease were mainly observed in 
pigs 12 weeks old and were characterized by loss of appetite, 
rough hair, paleness, dyspnoea, cough and diarrhoea. Total 
losses reaching over 7% in some batches. Before vaccination 
against PCV2, blood samples and lymph-nodes (Ln. inguinales 
superfi ciales) were collected from 15 pigs 5, 12 and 19 weeks 
old (5 pigs for each age) without clinical signs and from 10 pigs 
12 weeks old with clinical signs PMWS compatible. Cytology 
and histology of lymph-nodes were respectively performed 
on air dried impression smears and on formalin-fi xed, paraffi  n-
embedded tissue sections. Cytological and histological slides 
were stained by the May-Grunwald Giemsa and Ematoxilin-
Eosin methods respectively (2). Immunohistochemistry was 
performed on the same paraffi  n embedded tissues using a 
home made monoclonal antibody against PCV2. Real time PCR 
was performed on blood (sera) samples described above, using 
primers and probe designed by Olvera et al. (2004). Vaccina-
tion against PCV2 was performed using a one-shot commercial 
vaccine, administered to piglets 3 weeks old. Post vaccination, 
blood samples and lymph-nodes (Ln. inguinales superfi ciales) 
were collected from 15 pigs 5, 12 and 19 weeks old (5 pigs for 
each age) and submitted to the same investigations described 
above.
Results
No microscopic lesions were observed in the lymph-nodes 
belonging to pigs without clinical signs. No PCV2 viral load was 
observed on sera of pigs 5 weeks old. Real time PCR logarithmic 
values (PCV2 genomic copy no./gr.) of sera belonging to pigs 12 
and 19 weeks old, without clinical signs, showed moderate (4.7, 
5.8, 5.9, 6.1, 6.8) and absence or mild viral load (0, 0, 0, 5.1, 5.1) 
respectively. On 10 pigs with clinical signs PMWS compatible, 
only 4 animals showed characteristic PMWS microscopic lesions 
of lymph-nodes and high sera viral load (the real time PCR 
logarithmic values - PCV2 genomic copy no./gr. were 7.5, 8.3, 9.0, 
7.5). The diagnosis was confi rmed by immunohistochemistry. 
The others results of real time PCR on pig sera belonging to this 
group showed moderate viral load (the real time PCR logarith-
mic values - PCV2 genomic copy no./gr. were 5.1, 5.6, 5.9, 6.1, 6.9, 
7.0). No viral load was observed on 15 pig sera samples collected 
2, 9 and 16 weeks after PCV2 vaccination. 
Discussion
The fi eld study was conducted to investigate the use of a 
diagnostic approach, based on cytology and histology of 
lymph-nodes and sera PCV2 real time PCR, on pigs belonging 
to an herd showed prevalently a subclinical PCV2 infection. The 
study was performed before and after the PCV2 vaccination. The 
results of this study suggested that in herds in which a sub-
clinical PCV2 infection is present, real time PCR on sera seems 
to represent the better approach to understand the disease de-
velopment and the subclinical PCV2 infection severity. Two, nine 
and sixteen weeks after the vaccination, pigs showed no viremia, 
as well as a signifi cant improvement of productivity perform-
ances with a consequent reduction of herd losses (<3-4%). This 
indicates that in absence of obvious clinical PCVAD signs, the 
virus still induced a detrimental eff ect on growth and mortality. 
However, the results of real time PCR on pig sera after vaccina-
tion, need to be further investigated and must not be used to 
evaluate the vaccination effi  cacy.
References
1.  Krakovka S., Ellis J.,McNeilly F.,Waldner C., Allan G. (2005). J.Vet. 
Diagn Invest, 17:213-222.
2.  Luppi A. (2003). Veterinary Record, 152, (5), 148.
3.  Olvera A., Sibila M., Calsamiglia M., Segalés J., Domingo M. (2004). J. 
Virol.Methods, 117 (1):75-80. 
 
Porcine Circovirus Associated Diseases (PCVAD) – Control
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 433
Poster Presentations
P.127
Duration of immunity by PCV2 challenge in 17 week-old conventional 
piglets vaccinated at 3 weeks of age with CIRCOVAC® (Merial)
Mathieu Chevalier1 Laurent Fischer2 François Joisel2
1. Merial CRSV, Saint-Vulbas, France; 2. Merial S.A.S., Lyon, France
Introduction
The aim of this study was to demonstrate, in conventional pig-
lets, the duration of immunity conferred by vaccination with the 
inactivated adjuvanted PCV2 vaccine CIRCOVAC. 
Material and Methods
Three-week-old piglets were randomly assigned in 2 groups: 
15 piglets vaccinated once with CIRCOVAC 0.5 mL, IM and 12 
piglets injected with 0.5 mL of PBS as control. Both groups were 
kept in isolation and subsequently challenged at 17 weeks of 
age with an infectious PCV2b fi eld strain. The 2 groups were 
compared according to body weight evolution and PCV2 viral 
load in sera and faeces.
Results
Before challenge, body weights of vaccinated and control 
animals were similar. After challenge, vaccinated animals were 
heavier although not signifi cantly (ADWG p=0.116) than con-
trols: +2.4 kg in average at D28 post challenge (Figure 1).
Figure 1: Evolution of average body weight after challenge
Further, post challenge PCV2 viral DNA load in the sera of vaccin-
ated piglets was signifi cantly reduced as compared to the viral 
load in the sera of placebo-injected animals (Figure 2a).
The mean viral load during the whole monitoring period as area 
under the curve (AUC) was signifi cantly lower for vaccinated 
piglets compared to control animals (Student t-test p<0.001) 
(Figure 2b).
Vaccination also contributed to a signifi cant reduction of post 
challenge viral excretion in faeces (Figure 2c). 
The mean viral load during the whole monitoring period (AUC) 
was signifi cantly lower for vaccinated piglets compared to con-
trol ones (one-tailed student t-test p=0.011) (Figure 2d).
Discussion and Conclusion
All together, these results demonstrated a signifi cant reduction 
of PCV2 viral load in sera and in faeces, in CIRCOVAC vaccin-
ated animals after PCV2 challenge at 17 weeks of age. A growth 
improvement (+2.4 kg in 28 days post challenge) in vaccinated 
animals has been also observed.
 
Figure 2: a) evolution of PCV2 viral load in the sera during challenge; 
b) distribution of the AUC PCV2 viral load in sera in control and vaccin-
ated groups; c) evolution of mean PCV2 excretion in faeces; d) distribu-
tion of the AUC PCV2 viral excretion in faeces in control and vaccinated 
groups
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Introduction
CIRCOVAC has been registered in Europe for sow vaccination 
since 2007 and has proved effi  cacy to reduce mortality rate 
from birth to slaughter (1), improve growth performance (2) 
and reproductive parameters (3). In an attempt to control PCVD 
in already born when sow vaccination is started, piglets can be 
temporarily vaccinated up to the batch of piglets born from 
completely (2-times vaccinated) sows reaches weaning. This suc-
cessful method was already described earlier (4).
The objective of this study was to evaluate the eff ect of this CIR-
COVAC vaccination programme under Portuguese conditions.
Material and Methods
The study was performed in 10 farms located in Azores and 
Continental Portugal, with clinical PCVD signs after weaning: 8 
farrow-to-fi nish farms and 2 farrow-to-post-weaning units. Farm 
size ranged from 220 to 1,551 sows, average: 557 sows/farm.
PCV2 sow vaccination was implemented from September 2007 
to April 2008 as follows: mass vaccination of all sows, 2 injections 
of CIRCOVAC (2 ml) 3 weeks apart, and a booster 15 days before 
farrowing. At the same time, temporary piglet vaccination was 
implemented in 8 farms as follows: piglets from weaning to 
7 weeks of age were injected with CIRCOVAC once, 0.5ml. All 
weaned piglets born from non 2-time-vaccinated sows were 
vaccinated. Then, piglets vaccination was stopped as soon as 
piglets born from sows vaccinated twice reached weaning. 
A total of 5,573 sows, 138,017 weaned piglets and 131,925 
slaughter pigs were monitored. Eff ect evaluation was based 
on post-weaning and fattening mortality rates and on weaned 
piglets/sow/year that summarizes all aspects of reproduction. 
A questionnaire was sent to the vets in charge of 33 farms that 
started CIRCOVAC vaccination between 09/2007 and 04/2008. 
Global data concerning the diff erent parameters were collected 
from farm software.
Two similar periods of time were compared for each farm: before 
the date of fi rst vaccination and during vaccination starting at 
the date of mass vaccination (duration: 13 to 52 weeks accord-
ing to available data). Mortality rates were compared using a 
Kruskal-Wallis test and number of weaned piglets a Student 
t-test. 
Results and Discussion
Mortality rate in post-weaning decreased in every single farm, as 
well as the average mortality went signifi cantly down, p=0.023 
(Table 1). In fattening, completed data were obtained only for 
the 8 farrow-to-fi nish farms. Mortality rates decreased in 7 of 
them. In one farm, mortality that was very low before vaccina-
tion (0.42%) went up to 0.91% due to a S. suis outbreak in the 
period during vaccination. Average decrease of mortality in fat-
tening was not statistically signifi cant due to the small number 
of farms but the improvement magnitude confi rmed what was 
already seen (1). 
The number of weaned piglets/sow/year was improved in 9 out 
of 10 farms (Table 2). One farm experienced a slight decrease 
(-0.19) due to a Swine Infl uenza outbreak during vaccination 
period. Increase in weaned piglets/sow/year was not found sta-
tistically signifi cant but the improvement magnitude confi rmed 
what was already seen (3).
Table 1: Mortality rate before and during vaccination (*STD: standard 
deviation)
Farms 
(n=) Mean (%) STD* Mortamity Decrease
Post-weaning Before 10 5.18 3.08 2.72 ± 2.02 (p=0.023)
Post-weaning During 10 2.46 1.10 2.72 ± 2.02 (p=0.023)
Fattening period Before 8 4.81 3.72 2.40 ± 2.03 (p=0.208)
Fattening period During 8 2.40 1.87 2.40 ± 2.03 (p=0.208)
Table 2: Weaned piglets/sow/year before and during vaccination 
(*STD: standard deviation)
Farms (n=) Mean STD* Improvement
Before 10 22.6 1.47 +1.1 ± 0.70 (p=0.147)
During 10 23.7 1.83 +1.1 ± 0.70 (p=0.147)
Conclusion
The benefi cial impact of CIRCOVAC using a vaccination pro-
gramme including short-term piglet vaccination and long-term 
sow vaccination has been confi rmed in this study. Return on 
investment must include the decrease of mortality rates and 
the improvement in reproduction as shown by the increase of 
weaned piglets/sow/year which was welcomed as an unexpect-
ed additional benefi t.
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Monitoring PCV2 viremia in pigs on Canadian farms after using PCV2 vaccination
Francisco de Grau
Intervet Canada Corp, Kirkland, QC, Canada
Introduction
Since PCV2 discovery in the early 90’s, by Harding1, PCV2 was 
commonly found in blood samples from Canadian pig farms 
with PCVAD and on farms where no clinical signs were observed 
2. PCVAD occurred sporadically in Ontario and Quebec before 
2004 2,3, 4. However, a PCVAD outbreak occurred in these 
provinces in the winter of 2004 and spread to the rest of Canada 
in 2005. A new strain of PCV2 (2b) was associated with these 
outbreaks 5. PCV2 vaccination was introduced in Canada in the 
spring of 2006. Mortality decreased signifi cantly after vaccina-
tion. However, subclinical presentations are still a common prob-
lem. The objective of this study was to determine the prevalence 
of PCV-2 viremia after 3 years of the use of PCV-2 vaccines in 
Canadian farms.
Materials and Methods
Twelve swine veterinarians from four veterinary practices and 
fi ve private companies participated in this study. The data was 
collected from 23 swine herds from across Canada. All herds 
were routinely vaccinating with commercial PCV2 vaccines. 
Practitioners collected 50 pooled blood samples from randomly 
selected pigs on each farm: 10 pigs at weaning, 10 pigs at the 
mid nursery stage, 10 pigs at the end of the nursery stage; 10 
pigs at the middle of the grower fi nisher period, and 10 just 
before slaughter to determine the vaccine program effi  cacy and 
viremia control. Blood samples were centrifuged and the sera 
recovered. Serum samples were sent to the diagnostic lab for 
PCR testing.
Results
In total 1260 pigs were sampled. The average herd size was 
1580 sows with a range of 170 – 6000. Forty-four percent of the 
farms were farrow-to-fi nish and 56% multiple-site production. 
Twenty-two herds were using a commercial vaccine to control 
PCV2. Viremia was found on 14 (61 %) herds. According to the 
practitioner reports, 40% of these farms reported clinical signs of 
PCVAD. Ninety percent (9/10) of the farrow-to-fi nish farms, and 
38% (5/13) of the multi-site operations presented PCV2 viremia. 
A total of 65% (14 /23) farms sampled were PRRV+. Within these 
farms, PCV2 viremia was found on 71 % (10/14). A total of 61% 
(14/23) of the herds were Mycoplasma positive. Within these 
mycoplasma positive farms 57 % (8/14) had PCV2 viremia. 
Thirty-fi ve percent (8/23) of the nurseries, and 48% grower-fi n-
isher (11/23) were positive for PCV2 viremia. Eighty percent of all 
the viremic samples were from grower-fi nisher barns pigs. More 
than half of the positive samples 8/14 (57 %) were found to be 
positive in more than one production phase.
Sixty one percent (14/23) herds reported using the vaccines off -
label. Fifty seven percent of them were positive for PCV2 viremia. 
PCV2 viremia was found on 57% percent of the herds where 
PCVAD signs had been observed. 
PCV2a was found on 26% (6/23) of the herds, PCV2b on 39% 
(9/23) herds, and both strains were found in only one herd. PCV2 
was not detected on 7 farms (30 %). Three out of 7 herds nega-
tive to PCV2 viremia were also negative for PRRS and Myco-
plasma. Only one herd negative to PCV2 viremia was a farrow-
to-fi nish operation.
Conclusions and Implications
The data revealed higher PCV2 viremia in grower-fi nisher pigs. 
PCV2 viremia is more prevalent on farms positive for PRRSv and 
Mycoplasma. PCV2 viremia was found on more than half of the 
farms where vaccines were used off  label.
PCV2a was found on 25 % of the farms ninety percent of these 
farms were located in Western Canada (Alberta, Manitoba). 
This study shows that PCV2 still present in the fi eld even after 
three years after PCV2 commercial vaccine introduction and use. 
The Practitioners participated voluntarily and farms were not 
selected randomly therefore these results may be biased and 
cannot be extrapolated to all farms in Canada.
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Introduction
PCV2 has been associated with reproductive disorders and is 
regarded as a causative agent of foetal death in swine (1, 2).
The objective of the present paper is to report a clinical case 
in which CIRCOVAC® vaccination gave an improvement in the 
reproductive parameter in a farm where PCV2 was suspected to 
be involved in abortions.
Farm description
These results come from a 1600-sow farrow-to-fi nish French 
farm, having faced reproductive disorders on the long run. 
Litters coming from non-vaccinated gilts and sows did not 
show any PMWS clinical signs. This closed farm observes strict 
2-month quarantine. The farm productivity was below its 
potential, and abortions occurred regardless sow parity. But the 
fertility rate (> 92%), the number of mummifi ed foetuses (0.3/lit-
ter) and stillborns (0.73/litter) consistently remained at a normal 
level. Piglets used to be weaned at 21 days.
Gilts are raised in a specifi c unit away from the rest of the other 
pigs of the farm. The routine vaccination program of the farm 
use to count a mass-vaccination with PROGRESSIS® against PRRS 
every 31⁄2 months, GRIPOVAC® vaccination against swine fl u, 
and vaccination against parvovirus and erysipelas.
Case Description – Diagnosis
For the last years, lots of changes were carried out to improve 
the farm reproductive parameters, mostly to reduce the abor-
tion rate.
No other classical abortion infectious causes were identifi ed ex-
cept Leptospira sp. which were found to be the causative agents 
of abortions (PCR-positive). Repeated antibiotic metaphylactic 
treatments were put and kept in place (2 to 3 times / year) and a 
strict control of rodents was implemented. 
Despite these measures, abortions up to 80 gestation days 
still occurred. Thus, PCV2 infection was suspected: at the fi rst 
attempt, 4 aborted foetuses hearts were found PCV2 negative 
by PCR. A second analysis was performed 1 year later and large 
amounts of PCV2 was found by IHC or qPCR in hearts or livers of 
8 aborted foetuses from 4 sows.
PCV2 vaccination
It was decided to carry out a mass-vaccination of all breeding 
animals with CIRCOVAC. All pens were vaccinated starting with 
a primo-vaccination of gilts in quarantine followed by a second 
injection 3 weeks before the insemination.
Results
Reproductive parameters of gilts are shown in table 1. After 
CIRCOVAC vaccination, four reproductive parameters were 
improved although non-signifi cantly: abortions rate, return of 
oestrus rate, farrowing rate and the weaning to eff ective service 
interval at the 1st weaning.
Table 1: Reproductive parameters before and after CIRCOVAC vaccina-
tion (p=Chi-square test p-value)
Non-vaccinated gilts CIRCOVAC vaccinated gilts P
No gilts (15 gilts/pens) 165 165 -
% farrowing 83.9 90.5 0.072
No abortions (%) 12 (7.3%) 6 (3.6%) 0.146
% return to oestrus 5.1 1.8 0.125
Weaning-to-eff ective 
service interval at 1st 
weaning (days)
8.7 5.5 NA
No mummifi ed/litter 0.3 0.3 -
No stillborn/litter 0.8 0.8 -
No diff erence in mummifi ed and stillborn per litter was noticed 
between vaccinated and non-vaccinated gilts.
Discussion and Conclusion
Although none of the diff erences before and after vaccination 
in gilts seem to be statistically signifi cant, most probably due to 
the low number of animals, the improvement looked quite spec-
tacular for the farmer. It may be hypothesized that gilts raised in 
a premise separated from the rest of the farm had minimal con-
tact with PCV2 during their pre-mating life. Then, the suddenly 
increased viral pressure when they joined back the sow herd 
may have been the cause of the abortions. At least, a systematic 
vaccination of the whole herd with CIRCOVAC seemed to have 
solved the reproductive issue. 
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Immediate eﬃ  cacy of CIRCOVAC® (Merial) administered to 3 week-
old SPF piglets against a challenge at 5 weeks of age
Mathieu Chevalier1 Laurent Fischer2 François Joisel2
1. Merial CRSV, Saint-Vulbas, France; 2. Merial S.A.S., Lyon, France
Introduction
The aim of this study was to demonstrate, in SPF piglets, the 
onset of immunity conferred by vaccination with the inactivated 
adjuvanted PCV2 vaccine of Merial: CIRCOVAC®.
Material and Methods
Three-week-old piglets were randomly assigned in 2 groups: 
15 piglets vaccinated once with CIRCOVAC 0.5 mL, IM and 15 
piglets injected with 0.5 mL of PBS as control. Both groups were 
kept in isolation and subsequently challenged at 5 weeks of age 
with an infectious PCV2b. The 2 groups were compared accord-
ing to body weight evolution, and PCV2 viral load in sera and 
faeces.
Results and Discussion
After challenge, the median RDWG was signifi cantly higher for 
vaccinated piglets when compared to controls (Mann-Whitney 
test; p=0.030) (data not shown), leading to a diff erence of 1.5 kg 
between the average weight of vaccinated and control animals 
at D42 (Fig. 1). 
Figure 1: Evolution of body weights before and after challenge (D14)
Further, post-challenge PCV2 viral DNA load in the sera of vac-
cinated piglets was signifi cantly reduced as compared to the 
viral load in the sera of placebo-vaccinated animals (Fig 2a). Both 
vaccinated and control piglets had no detectable PCV2 in serum 
before challenge. 
The mean viral load on the whole monitoring period (AUC) was 
signifi cantly lower for vaccinated piglets compared to control 
animals (one tailed Student t-test p=0.003) (Fig. 2b).
Vaccination also contributed to a signifi cant reduction of post-
challenge viral excretion in faeces (Fig. 2c). The mean viral load 
on the whole monitoring period (AUC) was signifi cantly lower 
for vaccinated piglets compared to control animals (one tailed 
Student t-test p=0.004) (Fig. 2d).
Conclusion
Collectively, these results demonstrated a signifi cant reduction 
of viral load in blood and faeces of PCV2 and a signifi cant diff er-
ence of the median RDWG (relative daily weight gain) between 
Figure 2: a) evolution of the mean PCV2 viral load in the sera; b) 
distribution of the AUC PCV2 viral load in the sera according to groups; 
c) evolution of the mean PCV2 viral excretion in faeces; d) distribution of 
AUC PCV2 viral excretion in the feces according to groups
vaccinated and controls piglets leading to a diff erence of +1.5 
kg of body weight in average at the end of the animal phase in 
CIRCOVAC vaccinated animals against a virulent PCV2 challenge 
performed only two weeks after vaccination, i.e. at the age of 5 
weeks.
®CIRCOVAC is a registered trademark of Merial in Canada and elsewhere.
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Clinical and pathologic lesions after simultaneous vaccination with 
PCV2 and Mycoplasma vaccine in 3 week old piglets
Alvaro Ruiz2 Juan M. Palacios1
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Introduction
The use of simultaneous PCV-2 and Mycoplasma sp vaccines has 
been a common practice in order to reduce piglet management 
and stress, both vaccines are used in a similar age at weaning, 
even there is no a commercial vaccine that combines both 
antigens the products can be injected each at one neck side or 
in the same point. The objective of this trial was to evaluate the 
safety of a simultaneous use of a PCV2 vaccine1 and a Myco-
plasma sp bacterin2. 
Materials and Methods
311 piglets, with 3 weeks of age, from a conventional herd were 
utilized; piglets were vaccinated with 2.0 ml of PCV-2 vaccine 
and 1.0 ml. of Mycoplasma bacterin one day after weaning fol-
lowed by a second vaccination at six weeks of age. Vaccination 
was performed using an automatic double syringe (NJ Phillips 
Ltd) at the same site of the neck (fi rst dose at the right site, 
second dose 3 weeks alter at the left site). Another group of 26 
animals received the vaccines separately (fi rst PCV-2 dose at the 
right site of the neck and Mycoplasma sp bacterin at the left site) 
and the second dose 3 weeks later. All animals were observed 
for two days following each vaccination for changes in general 
condition (e.g. feed intake) and local reactions at the injection 
site. Any abnormality or alteration observed during the further 
test period were recorded. In addition, 5 animals per group were 
euthanazied and necropsied at 10 weeks of age to perform an 
histopathological analysis in the injection sites.
1 PCV2 vaccine : Circumvent PCV (Batch no. 213893207). 
2 Mycoplasma sp bacterin; M+PAC (Batch no. 05605). Intervet 
Schering-Plough A.H.
Results and Conclusions
After vaccination, no systemic or local reactions were observed. 
The histopathological observations did not reveal any infl amma-
tory or necrotic lesion that could be related to vaccination with 
PCV-2 and/or Mycoplasma sp bacterin. These fi eld data, demon-
strate that concurrent administration of PCV-2 and Mycoplasma 
sp bacterin whether using an automatic syringe which injects 
the two vaccines on the same side of the neck, or injecting them 
each to one side of the neck, did not induce any systemic or 
local reaction. In conclusion, concurrent use of PCV-2 with Myco-
plasma sp is safe in pigs from 3 weeks of age.
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Serological follow-up in SPF piglets vaccinated with CIRCOVAC® (Merial) at 3 weeks of age
Mathieu Chevalier1 Laurent Fischer2 François Joisel2
1. Merial CRSV, Saint-Vulbas, France; 2. Merial S.A.S., Lyon, France
Introduction
The aim of this study was to monitor the serological response 
in SPF piglets vaccinated with the inactivated adjuvanted PCV2 
vaccine CIRCOVAC.
Material and Methods
A group of 8 piglets was vaccinated with 0.5ml of CIRCOVAC by 
intramuscular route at 3 weeks of age, and a group of 3 piglets 
was left as an unvaccinated control.
The two groups were kept in isolation and compared according 
to PCV2 anti-ORF2 ELISA and PCV2 seroneutralizing antibody 
titres.
Results
Animals from both groups were seronegative for anti-ORF2 
PCV2 antibodies measured by ELISA at D0. Control piglets 
remained seronegative throughout the study (D42). A sero-
logical response was clearly observed for piglets belonging to 
the group vaccinated with CIRCOVAC. All vaccinated piglets had 
detectable level of anti-ORF2 ELISA antibodies one week after 
vaccination except one piglet that exhibited detectable level of 
anti-ORF2 antibodies at D14 and one piglet that showed detect-
able level of anti-ORF2 at D42 only. Evolution of anti-ORF2 PCV2 
antibody titres per group is presented in Figure 1.
Figure 1: Evolution of the mean anti-ORF2 PCV2 antibody titres 
(ELISA)
 
Figure 2: Evolution of the mean anti-PCV2 antibody titres (seroneu-
tralization)
 
Conclusion
The seroconversion induced in SPF piglets vaccinated at 3 weeks 
of age with CIRCOVAC was demonstrated by ELISA and seroneu-
tralization techniques.
®CIRCOVAC is a registered trademark of Merial in the Canada and else-
where.
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Improved production parameters and proﬁ t as a result of PCV2 piglet vaccination in the United Kingdom.
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Introduction
Porcine Circovirus Disease (PCVD) was fi rst described in the UK 
in 1997.1The introduction of PCV2 vaccines has allowed greater 
control of PCVD; a signifi cant reduction in mortality and an 
improvement in production parameters in herds throughout 
the UK.2This study looks at the reduction in mortality, improved 
performance and additional gross margin following the intro-
duction of Ingelvac CircoFLEX® (Boehringer Ingelheim) to a farm 
in the UK. This farm is part of a 28 breeding unit pyramid.3
Materials and Methods
Routine PCV2 piglet vaccination (a single, 1ml, dose at weaning) 
was introduced to a 900 sow, outdoor pig unit in East Anglia, 
England, in May 2008. The farm practiced a 3-week batch cycle 
and piglets were weaned and transported to one of fi ve all in/
all out, rearing units (wean to slaughter). Pig performance was 
closely monitored on the rearing units from Nov 2007 to Feb 
2009 (before and after vaccine introduction). Data collected 
included post weaning mortality (PWM), average daily weight 
gain (ADWG), feed conversion ratio (FCR) and veterinary costs 
per pig. Eleven batches of pigs (11,075 in total) before vaccina-
tion and seven batches of pigs (5,851 pigs in total) after vaccina-
tion were monitored. Veterinary costs were also compared and 
these comprised of veterinary visits (routine and emergency) 
and total antibiotic expenditure per pig. Additional gross margin 
per pig was calculated on the basis of the average improve-
ments observed after vaccination and the reduction in antibiotic 
expenditure (assuming a slaughter live weight of 100kg; prices: 
feed - £170/t, weaner - £36/pig & carcass - £1.23/kg).
Data was also collected from the top performing rearing unit 
(subclinical PCVD farm).
No other signifi cant management, genetic or nutritional chan-
ges occurred on these rearing units during that period.
Results
The average mortality of successive batches of pigs showed 
a statistically signifi cant decline from 6.4% to 2.8% (fi gure 1) 
due primarily to the disappearance of PDNS and the improved 
control of respiratory disease. ADWG per pig increased from 
669g/day to 729g/day and FCR reduced from 2.53 to 2.44kg/
kg. Variation was reduced for all parameters measured. The top 
performing unit experienced a reduction in mortality of 25%, an 
increase in ADWG of 36g/day and a reduction in FCR of 0.6 after 
vaccination. In addition, veterinary costs were reduced by 22% 
per pig, following PCV2 vaccination.
Based on the average improvement observed, the increased 
gross margin was calculated at £6.77/pig.
Figure 1: Average batch mortality over time
Discussion
The introduction of PCV2 vaccination to pigs at weaning re-
sulted in a statistically signifi cant reduction in mortality, the dis-
appearance of PDNS, an improvement in ADWG and FCR and an 
additional gross margin of £6.77 per pig, from wean to slaughter. 
In addition, there was a reduction in veterinary costs of 22% per 
pig. Substantial improvements in production were also observed 
in the rearing unit with subclinical PCVD.
References
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Full dose vs half dose of Ingelvac CircoFLEX: ﬁ eld data in Spain
Joaquim Bringas
Sat Suis, Banyoles, Spain
Introduction
Every day more, PCVD vaccination is becoming a routine in pig 
production, in some countries, vaccination rates are reaching 
extremely high percentages, like in US, about 95% in early 2010. 
Effi  cacy and return of investment have been demonstrated in 
several cases of PCV2 vaccination (1, 2). 
On the other hand, since 2006, huge economical and fi nancial 
crisis is aff ecting pig producers all over the world. Reducing 
input costs is one of the main objectives, therefore some produ-
cers in Spain decided to cut doses of PCV2 vaccines. 
The objective of this study is to compare the effi  cacy of a PCV2 
vaccine, Ingelvac CircoFLEX® (Boehringer Ingelheim) at full dose 
in comparison to half dose in mortality, medication costs and 
fattening performance. 
Materials and Methods
This study was performed in a farrowing farm with 750 sows. 
This site one is producing approximately 23 piglets/sow/year, 
which is not as good as should be due to a high mortality in 
farrowing period. The herd is PRRS positive, sows are vaccinated 
against Aujeszky’s disease, Parvovirus and porcine Erisypelas. 
Gilts come from external source and before entering the farm, 
are vaccinated against Aujeszky’s, Parvovirus, Erisypelas and 
PRRS.
Piglets are weaned between 21 and 24 days and delivered to 3 
nursery farms. All piglets are vaccinated against Mycoplasma at 
7days of age and against PCV2 at weaning.
Piglets remain in the nursery farm until they reach 20kg of live 
weight, when they are moved to fattening units. In fattening, 
animals suff ered moderate problems of PCVD. Peak of clinical 
signs were observed between 16 and 17 weeks of age. Before 
introduction of PCV2 vaccination mortality in fattening aver-
aged at about 6% with medication costs of more than 3€ per 
pig, animals did not react to antibiotic treatments for secondary 
infections.
A total of 4.250 animals were included in this before-after study. 
First, 3 fattening batches (1.700 animals) were vaccinated at half 
dose (0,5ml per piglet) of Ingelvac CircoFLEX® off  label. After 
that, 4 batches (2.550 animals) were vaccinated at full dose (1ml 
per piglet) following label recommendations.
All data presented is from fattening units. Mortality in both 
groups were evaluated using a Chi-square test. 
Results
Animals vaccinated with full dose perform better than animals 
with half dose, (table 1). Weight gained in the fattening unit was 
1,8 kg more in the vaccinated group with full dose spending 2 
days more in fattening. 
Diff erence in mortality was highly signifi cant (p<0,001), ob-
taining a reduction of 56% in the group vaccinated with full 
dose in comparison with the results with half dose. Medication 
costs were reduced by 41% in the group of full dose.
Table 1. Relevant parameters 
Half dose Full dose Diff erence
# piglets tested 1700 2550
Mortality (%) 4.8a 2.1b -2.7
Weight gain (kg) 94.1 95.9 +1.8
Medication costs 
(€/pig) 2.59 1.53 -1.06
a,b: values with a diff erent superscript, diff er signifi cantly (p<0,001).
Discussion
When comparing data of non vaccinated animals with animals 
vaccinated at half dose, some improvement was observed, but 
the clinical situation and mortality was still not satisfactory. Data 
presented in this fi eld study, demonstrate that using full dose of 
Ingelvac CircoFLEX® instead of half dose improved the perform-
ance and lead to a signifi cant reduction in mortality. 
Based on reduction in mortality and medication costs, a yearly 
return of investment of 5,07:1 for every extra € spent on vaccine 
was calculated when moving from half to full dose of Ingelvac 
CircoFLEX. 
The results of this study show that using full dose of Ingelvac 
CircoFLEX (compared to half dose) is improving the health situa-
tion on the farm and provides signifi cant economic benefi ts. 
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Evaluation of CIRCOVAC® one shot vaccine applied in three-week-old piglets on production parameters 
in farms with and without a diagnosis of postweaning multisystemic wasting syndrome (PMWS)
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Introduction
Porcine circovirus type 2 (PCV2) vaccines have demonstrated to 
be very effi  cient to control postweaning multisystemic wast-
ing syndrome (PMWS) under experimental and fi eld conditions 
(1,2,3). Vaccination of sows and gilts increases PCV2 antibody 
titres in serum or colostrum providing protection of piglets 
against disease development (4). CIRCOVAC® is registered in 
many countries to be used in sows and gilts with the former 
indication. The objective of the present study was to evaluate 
the effi  cacy of the above-mentioned vaccine in farms infected 
with PCV2 and with or without a PMWS diagnosis.
Material and Methods
CIRCOVAC® was tested in 17-26 day-old conventional pigs of 2 
diff erent Spanish farms. Both farms were selected by their previ-
ous recent PMWS history. In each farm, about 300 pigs received 
one single dose of 0.5 mL of CIRCOVAC®, while 300 control 
animals received the same amount of placebo. Also in each farm, 
50 pigs from each group were bled and a rectal swab was also 
taken. PCV2 viral load in serum and rectal swab (real-time PCR) 
were investigated at 3, 6, 10, 14, 17, 20, 23 weeks of age and 
before slaughter (S). All animals were weighed and scored for 
physical condition at 3 and 10 weeks of age and S. Average daily 
gain (ADG) for the whole postweaning period was calculated. All 
pigs were necropsied and sampled for a PMWS diagnosis assess-
ment (histopathology and PCV2 in situ hybridization, ISH).
Analysis of variance with Bonferroni multiple comparisons (for 
normally distributed variables) and Kruskal-Wallis and Mann-
Whitney tests (for non-normally distributed variables) were used 
to compare ADG, PCV2 DNA loads in sera and faeces between 
vaccinated and control animals in each sampling time.
Results
PCV2 infection was demonstrated to occur in both studied farms 
(measured by qPCR and ISH in tissues). PMWS individual case 
defi nition was fulfi lled only in farm 1, while no cases accomplish-
ing the diagnostic criteria were found in farm 2. ADG was signifi -
cantly higher in vaccinated versus control animals in farm 1 and 
2. Moreover, PCV2 viral load in serum was signifi cantly lower (1-2 
log) in vaccinated compared to control animals in most sam-
pling times after PCV2 exposure in both farms. A similar result 
was obtained regarding PCV2 viral load in faeces.
Discussion
Vaccination with CIRCOVAC® in piglets under fi eld conditions 
was able to signifi cantly improve production parameters and 
reduce signifi cantly PCV2 viremia and faecal load. These results 
agree with other publications using piglet vaccination in PMWS 
aff ected farms by means of diff erent vaccine approaches, such 
as a PCV1-2 chimera vaccine (5) and a subunit vaccine based on 
PCV2 ORF2 protein (1). The present results support the idea that 
production parameters are suitable indicators of PCV2 vaccine 
effi  cacy. 
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Eﬀ ect of PCV-2 vaccination protocols on late term mortality
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Introduction
 PCV-2 associated diseases and related losses might occur in 
high health status herds. With the advent of PCV-2 vaccines, 
these losses can be successfully reduced. In this study we have 
observed the eff ects of diff erent vaccination protocols on late 
term mortality in a gilt development unit of a high health status 
breeding herd in Hungary.
Materials and Methods
 PCV-2 related problems were detected in the gilt development 
unit (GDU) of a large breeding complex in Hungary. Pigs were 
transferred to the GDU at approximately 80 days of age (~35 kg 
bw). PCVAD was manifested mainly in PDNS and gastric ulcera-
tion possibly related to systemic illness. The majority of losses 
occurred between approx. 140-170 days of age (Figure 1.). The 
herd was free from PRRSV, M. hyopneumoniae, and pathogenic 
APP strains. No lesions related to these agents were found in 
necropsy.
From the beginning of 2009, we have tested two diff erent vac-
cines and three protocols in order to prevent PCV-2 associated 
losses in the GDU. We have tested Circovac® (Merial) in 0,5 ml/
pig dose, CircoFLEX® (Boehringer-Ingelheim) in 1 ml/pig dose 
applied at two diff erent ages, and also observed unvaccinated 
groups of animals. The sole measure of vaccine effi  cacy was 
mortality in the GDU (between ~85-190 days of age). Dams of 
all pigs in this study were vaccinated with Circovac® according 
to the manufacturer’s instructions. All groups entering GDU 
received the same medication regime against proliferative 
enteropathy. No major changes in feed composition of feeding 
technology occurred in the study period. Mortality data were 
collected for all groups for their entire stay in the GDU. Mean 
mortality fi gures were compared by nonparametric statistics 
(Kruskal-Wallis test with Dunn’s multiple comparisons test). 
Results are summarized in Table 1.
Discussion 
From these mortality data it appears, that on this farm the 
best protection from PCVAD in the 140-170 days age group 
was achieved with CircoFLEX® vaccination at approximately 22 
days of age. Other vaccination approaches did not decrease 
total mortality rate compared to unvaccinated controls. It also 
appears, that vaccination of dams alone or in combination with 
late vaccination of pigs with CircoFLEX®, or with Circovac® did 
not aff ect total mortality rates. This observation is in line with 
fi ndings from other studies (Guillaume et al., 2009).
References
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Table 1
Treatment Circovac(R) CircoFLEX(R) CircoFLEX(R) Unvaccinated
Age at vaccination, days (median, range) 39 (25-45) 66 (65-67) 22 (19-27) -
Number of groups 4 4 7 2
Vaccinated animals (sum) 1666 2135 3794 1082
Dead animals, sum (median, range) 99 (18.5; 18-49) 105 (21.5; 16-46) 83 (12; 6-15) 56 (81; 79-83)
Mortality % (median, range) 5.94a (5.49; 3.32-9.04) 4.92a (3.97; 3.13-8.48) 2.19b (2.21; 1.10-2.76) 5.18a (5.18; 4.07-6.28)
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Immunization program to control PCV2-associated reproductive 
failure in sows using a commercial vaccines
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Introduction
Porcine circovirus type 2 (PCV2) has been related to reproductive 
failure (RF) in sows, resulting in infertility, abortions, stillborns, 
increased non-viable piglets.1,2,7,8 PCV2 detection in stillborn, 
and newborn piglets, transplacental transmission without 
participation of other infectious agents and RF experimentally 
induced have been documented.3,4,5,6,7,8 It has been proved 
that PCV2 replicates in heart, lung, liver, kidney and lymphoid 
tissues by intrafetal inoculation. The most consistent neonatal 
and fetal are non-suppurative myocarditis and encephalitis as-
sociated to PCV2 detection by immunohistochemistry and/or 
in situ hybridization (ISH).8 Regarding vaccination, an improve-
ment of reproductive parameters has been confi rmed after 
vaccination with an inactivated PCV2 vaccine.2
Material and methods 
The aim of this work was to evaluate an immunization program 
and its eff ect on controlling RF in a herd with history of PCV2 
associated RF (PCV2-RF). The present study was done in a farm 
with 2800 sows of central Mexico with reproductive problems 
such as low parturition rate, late-term abortions (up to 7% in 
aff ected groups), and 3-7% mummifi ed fetuses. The PCV2 pres-
ence was confi rmed by diagnosis of non-suppurative myocar-
ditis on histopathology examination and ISH PCV2 detection in 
aborted fetuses. In addition, the farm has history of positivity to 
PRRSV, H1N1 infl uenza virus, and porcine parvovirus. The herd 
was massive immunized with a commercial vaccine (Baculo-
virus-expressing PCV2 capside protein). The data prior vac-
cination and after vaccination of 21 groups were compared as 
follow: parturition rate (PR), born alive piglet total average (BAT), 
born alive piglets (BA), stillborns, and mummifi ed fetuses (MF). 
Results were analyzed by central tendency tests, and media 
comparison. 
Results
The values from all evaluated parameters are shown in Table 1. 
Table 1. 
Parameter Prior vaccination Post-vaccination
PR 81.31 (± 3.29)* 6.71 (± 2.89)
BAT 11.3 (± 0.26) 11.4 (± 0.24)
BA 10.16 (± 0.20) 10.45 (± 0.15)
Stillborns 6.0 (± 0.35) 5.45 (± 0.58)
MF 3.65 (± 0.87) 3.6 (± 0.56)
Fertility % 89.6 93.8
Abortion % 1.75 1.64
*Data between brackets depict to standard deviations 
Discussion 
Based on the results, a signifi cant improvement of PR after vac-
cination (over 5.4%) was observed. The diff erences regarding 
BAT and BA were no signifi cant and minimal. A similar fi nding 
was observed in BA and stillborns with no signifi cant variation. 
The standard deviation of mummifi ed fetuses was open with 
a tendency to narrow after vaccination. These fi ndings are in 
agreement with reported data2 which there was an improve-
ment of 2.1 in PR, and marginal improvements of BAT and BA. 
The latter were higher than our results. Regarding abortion 
percentage no signifi cant variation was determined as opposed 
to reported data. 
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Immunity induced by recombinant adenovirus expressing capsid protein of porcine circovirus 2
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Introduction
Porcine circovirus associated disease (PCVAD) caused by porcine 
circovirus type 2 (PCV2) was one of the most important diseases 
currently threatening global swine industry. To prevent and con-
trol this disease, various types of vaccine have been developed 
and tested for their immunological eff ects. This study investigat-
ed the immune response induced by a recombinant adenovirus 
(reAdV) expressing the capsid protein, which is involved in the 
production of protective antibody against PCV2. 
Materials and Methods
The ORF2 gene from fi eld isolate was altered to replace with the 
codons preferred in mammalian cell for its high-level expression. 
The replication-defective reAdV was created by homologous 
recombination in E. coli using human adenovirus serotype 5 
DNA deleted the early transcribed E1 and E3 genes. The capsid 
protein expressed in 293A cell was identifi ed with immuno-
chemical assay and western blotting. Groups of four female mice 
were immunized with ten-fold serially diluted reAdV (1 * 107 - 1 * 
104 TCID50/mouse) given intramuscularly. Mice were periodically 
bled under anesthesia by retro-orbital puncture. The antibody 
titers were detected by IFA test and ELISA.
Results & Discussion
The reAdVPCV2cap was produced by homologous recombina-
tion of a transfer vector, pAdenoVatorCMV5 and adenovirus 
DNA, pAdenoVator ΔE1/E3. At 6 days post-transfection in 293 
cells, the typical CPE was observed. The titer of purifi ed adeno-
virus was fi nally 1 * 109 TCID50/ml. The recombinant capsid 
protein was expressed in infected 293A cells by investigation 
of staining with specifi c MAb (12C48) against capsid protein of 
PCV2. In addition, bands corresponding to a molecular weight of 
about 28 kDa were detected in the 293A cell lysate with western 
blotting. 
The immune response induced by reAdVPCV2cap was inves-
tigated with IFA test and ELISA. The results of IFA test showed 
that PCV2-specifi c antibodies were detected in two mice groups 
inoculated with 1 * 107 and 1 * 106 TCID50/mouse of reAdVP-
CV2cap, whereas no immune response was found in two mice 
groups treated with 1 * 105 and 1 * 104 TCID50/mouse and 
control group (Fig. 1). In mice group inoculated with highest 
titer (1 * 107 TCID50/mouse), the average antibody titers were 
1:128, 1:1024, 1:2436, 1:2048 and 1:2436 at 10, 20, 30, 60, 90 days 
after immunization, respectively. In mice group inoculated with 
1 * 106 TCID50/mouse titer, the average antibody titers showed 
more than 1:256 at 30 days after immunization. These results 
indicated that virus titer of at least more than 106 TCID50/mouse 
was required to induce the hummoral immune response in mice 
with the reAdVPCV2cap. The results of ELISA analysis also were 
similar to those of IFA test (Fig. 2).
Fig. 1. Analysis of PCV2 antibody response in mice immunized with 
reAdVPCV2cap using IFA test. Because no PCV2-specifi c antibodies 
(<1:16) were detected in mice inoculated with 1 * 105 and 1 * 104 
TCID50/mouse, and PBS, the data were excluded in this fi gure. 
 
Fig. 2. Analysis of PCV2 antibody response in mice immunized with 
reAdVPCV2cap using ELISA. Antibody titers of individual mouse (A) and 
mean titers of each group (B).
Although titers of antibodies varied in individual mouse, 
geometric mean titers of each group showed dose dependent. 
These results show that the reAdV can eff ectively produce the 
capsid protein of PCV2 and induce suffi  cient immune responses. 
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Introduction
Porcine circovirus type 2 associated diseases (PCVAD) has be-
come one of the most concerned diseases in swine industry (4). 
Though the novel PCV2 vaccines have shown good protection 
for PCVAD control, implementation of a strict biosecurity and 
enhancement of host innate immunity are also very important in 
PCVAD control (2, 3). Sugar cane extract (SCE), a natural product, 
has displayed immunostimulating eff ects on porcine leukocyte 
functions (1). Therefore, this study was aimed to evaluate the 
eff ects of SCE and managerial improvement on PCV2 and/or 
PRRSV infection.
Materials and methods
Experimental design: The study was conducted on two separ-
ated experiments. In experiment I, the experimental pigs were 
weaned at 18 days old and moved into an experimentally 
controlled house to avoid PRRSV infection. In experiment II, the 
experimental pigs were weaned and raised at the original farm 
with PRRSV endemic until 8 weeks old for PRRSV natural expos-
ure and then moved into experimental house. Experimental pigs 
were grouped and treated as indicated in table 1.
Table 1 Grouping and treatment
Group No. SCEA PCV2 chal.D PRRSV inf.
Exp I  NEG-1 4 No No 0/4
  POS-1 6 No Yes 0/6
Exp II  NEG-2 3 No No 3/3
  Pre-SCE 5 YesB Yes 5/5
  Post-SCE 5 YesC Yes 5/5
  POS-2 5 No Yes 5/5
A, Provided by Shin Mitsui Sugar Co. Ltd., Japan; 500mg/kg.bw
B, 3 consecutive days every two weeks before PCV2 challenge.
C, 3 consecutive days after PCV2 challenge
D, Pigs were challenged with PCV2 at 9 weeks of age.
Evaluation:
1.  Clinical record: The body temperatures (BT) were recorded 
daily and fever was determined by the BT > 40°C. Body 
weight was weighted weekly.
2.  Pulmonary impairments (PI, %) were scored depending on 
the area of bronchopneumonia (%, grossly) and the severity 
of interstitial pneumonia (%, microscopically) at the end of 
experiment, i.e. 4 weeks post PCV2 challenge.
3.  PCV2 virus loads were determined by real time PCR.
Results
Pigs in group POS-1 that weaned early and segregated to the 
clean house had signifi cantly lower PRRSV infection and ~21.5% 
lower MDWG after PCV2 challenge. In contrast, pigs in experi-
ment II were all naturally exposed to PRRSV infection. After PCV2 
challenge, all pigs were more seriously aff ected by PRRSV and 
PCV2 synergistic infection, with a decrease of 44.6% in MDWG 
(POS-2). However, SCE administration showed 9.4% to 20% 
improvement on the decreasing injury caused by PRRSV and 
PCV2 synergistic infections (table 2).
Table 2 Summary of the two experiment Results
Group MFDA PI(%)B PCV2(log10) MDWG(gm)C Aff ected(%)
NEG-1 0 3.6 - 0.65 0
POS-1 2.7 17.8 10.42 0.51 -21.5
NEG-2 0 4.3 - 0.61 -6.2
Pre-SCE 3.0 28.5 11.03 0.49 -24.6
Post-SCE 4.0 23.7 10.98 0.42 -35.2
POS-2 7.0 34.3 11.20 0.36 -44.6
A, MFD: mean fever day; B, pulmonary impairment (%); C, MDWG: mean daily weight gain
Discussion 
Administration of SCE can decrease the injury, but may not avoid 
the eff ect of PRRSV and PCV2 synergistic infection. In contrast, 
early weanling and segregation system can effi  ciently decrease 
or control PRRSV infection and also decrease the eff ect of PRRSV 
and PCV2 synergistic infections.
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Introduction and Objective 
Porcine circovirus type 2 (PCV-2) has been reported as the cause 
of PMWS and others syndromes (1,2,3). This virus was identifi ed 
in Mexico during 2001 (4) and diff erent reports show the current 
presence of PCV-2 in Mexico. Nevertheless, there is not enough 
information about the prevalence and distribution in Mexico, 
just some reports of antibodies’ presence (5). The main objective 
of this study was to establish the prevalence of PCV2 in diff erent 
regions of Mexico using the PCR technique.
Materials and Methods
The study was conducted in 34 farms located in 10 diff erent 
regions of Mexico. In 20 of these farms, the pigs showed clinical 
PMWS, according with the case defi nition (4). The sampling 
period was from January to September of 2006, collecting serum 
(n=3094), organs (n=122) plus lymph node, lung, ileum, and 
fecal swab samples (n=437.) The samples were pooled in accord-
ance with the type of sample. There were 888 pools in total. The 
conduction of a PCR test amplifi ed a fragment of 506 nucleo-
tides of the ORF2. 
Results
The number of samplings was 89 with 72 samplings equal-
ing 80.89%, testing positive. The analysis showed that 33 of 34 
farms, equaling 97.06%, were PCV2 PCR positive.
Table 1. Results of PCV2 analysis for farms and Mexican state
STATE No. farms analyzed PCV-2 Status
COAHUILA 1 NEGATIVE
GUANAJUATO 4 POSITIVE
JALISCO 4 POSITIVE
MICHOACAN 1 POSITIVE
MONTERREY 1 POSITIVE
PUEBLA 7 POSITIVE
QUERÉTARO 3 POSITIVE
SONORA 4 POSITIVE
VERACRUZ 1 POSITIVE
YUCATÁN 8 POSITIVE
The analysis for each Mexican state shows that 9 out of 10 states 
are positive; this represents the 90% of positives. The only nega-
tive state was Coahuila. Nevertheless, for this state only one farm 
(3 samples) was subject to analysis. 
Table 2 shows the results for each type of sample. In this case, 
the samples showing more fi ndings that are positive were rectal 
swabs with 56 %, and the ones showing fewer positives were 
semen samples with less than 10%.
Table 2. Results of PCV2 analysis from diff erent samples
SAMPLE NO. SAMPLES NO. POOLS NO. POSITIVES %
SERUM 3094 682 268 39.3
TISSUE 122 110 43 39
SEMEN 22 11 1 9.01
RECTAL SWABS 437 85 48 56.47
Discussion
PCR is a sensitive diagnostic method widely used for patho-
gen detection, including PCV2. Since PMWS was described in 
Canada (1997), PCV2 has been isolated from diff erent samples 
in Germany, France, Spain, Korea, Japan and other important 
pig-producing countries (3.) In America, there are reports of 
the presence of PCV2 in United States, Canada and Brazil, but 
in Mexico there is only one report of the antibodies’ presence 
and few reported cases have been isolated. Our results are the 
fi rst report of the incidence and distribution of PCV2 in Mexico’s 
commercial farms (using the PCR method), and show that PCV2 
virus is distributed throughout all of Mexico’s territory. In this 
research there was no diff erence between tissue samples and 
blood samples. The best samples for diagnostic purposes were 
found to be rectal swabs (56 per cent positives) and the worst 
were semen (almost 10 per cent positives). Nevertheless all the 
diff erent sample types analyzed showed positive results. 
The percentage of positives found during this investigation is 
similar at other reports from around the world. 
It is very important to research the sequences of the Mexican 
PCV2 virus in order to determinate the homology with other 
PCV2 virus distributed around of the world.
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Introduction 
In recent years Post Weaning Multisystemic Wasting Syndrome 
(PMWS) has become of signifi cant concern in the swine indus-
try in many countries, particularly Canada, United States of 
America, Europe, Asia and South America. The syndrome aff ects 
pigs mainly between 6 and 14 weeks of age. It is characterized 
by wasting or unthriftiness, dyspnea, jaundice and enlarged 
lymph nodes. The syndrome was been associated with myocar-
ditis fi nding in aborted or stillborn piglets due to PCV2, it was 
also observed in 8-day-old piglet with PCV2 association (1) The 
present study was performed in piglets located in 2 porcine 
farms from Central State of Venezuela (Aragua/Carabobo).
The fi rst description of the syndrome in Venezuela was in 2003 
(4,5). Therefore in this report we focus on describe the heart 
histopathological fi ndings in young pigs naturally infected in 
two Venezuelan pigs farms with sudden death piglets, both 
farms were free from classical swine fever, Aujeskys disease, 
Porcine reproductive respiratory syndrome and encephalo 
myocarditis
Material and Methods
The present study was performed in 20 piglets of 6 to 10 weeks 
of age from 2 pig farms placed at Central States of Venezuela 
(Aragua/Carabobo).All piglets showed signs of wasting, pal-
lor, dyspnea, diarrhea and enlarged superfi cial inguinal lymph 
nodes and has history of sudden and unexplained death.
Each pig was necropsed and tissue samples were collected for 
the histopathological evaluation, fi xed in 
Buff ered formalin 10%, processed by rutinary methods, and 
stained with Hematoxilin-Eosin.
In situ hybridization studies (IHS) were performed on those 
specimens with histological evidence of PCV2 (heart included) 
as described by Segalés et al (3)
Results and Discussion
Clinical aspects: All the evaluated piglets (20) showed signs of 
wasting, pallor, respiratory distress, diarrhea, and sudden death.
At necropsy there was evidence of pneumonia with non-colaps-
able lungs as well as inguinal, mesenteric and tracheobronchial 
lymph nodes enlargement, heart showed focal to locally exten-
sive hemorrhagic areas in myocardium with white spots areas.
The histopathology study showed lymphoid depletion, with 
loss of follicles architecture in lymph nodes, spleen, and Peyers 
patches, histiocityc infi ltration, basophilic cytoplasmatic inclu-
sions in histiocitic cells, and syncytial cells. These fi ndings de-
scribed were suggestive of PMWS. (3). The heart study showed 
focal to locally extensive areas of myocarditis and fi brosis. Other 
areas showed degeneration of myocardium and infi ltration of 
macrophages and lymphocytes in the heart (Fig.1). In this areas 
cross striation in cardiomyocytes have disappeared and necroses 
foci were seen and could explain heart failure and sudden death 
(Fig 2)
The sample tissues specimen processed by a technique of IHS 
(Fig.3) revealed the presence of PCV2 in aff ected lymphoid tissue 
and heart and confi rmed the diagnosis of PMWS.
Conclusions
The results confi rmed the existence of PCV2 associated with 
nonsuppurative myocarditis as an important cause of sudden 
heart disease of young piglets in Venezuela
Micrographies
Fig. 1 
Fig.2
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Introduction
Porcine circovirus 2 (PCV2) is associated with Postweaning Multi-
systemic Wasting Syndrome (PMWS) and other Porcine Circo-
virus Associated Diseases (PCVAD), but also is frequently isolated 
from healthy swine1,2. PCVAD threatened the swine industry 
in Europe and later North America for about 15 years. In North 
America in 2006 effi  cacious PCV2 vaccines was introduced. How-
ever, little research to answer basic questions on the disease has 
been done since 2006.
Molecular biologists warn that this lack of understanding 
weakens our ability to respond to new outbreaks1. We need to 
increase our understanding of PCVAD should current control 
strategies fail.
Our objectives were to retrospectively:1. Determine the National 
Prevalence of PMWS and 2. the National Weaned Pig Mortality 
from PMWS, 3. Determine the Prevalence of PCV2 (Antibodies 
and PCR) and 4. Develop National Estimates for the impact of 
farm and animal level factors on incidence of PMWS.
Materials and Methods
Questionnaire data and blood samples were collected as part 
of the NAHMS Swine 2006 study3. Questionnaires administered 
during personal interviews with farm personnel were used to 
gather data on housing, health management and health status. 
Blood samples were collected from up to 35 grower/fi nisher 
market pigs (20-32 weeks old) on 185 farms in 16 states. A new 
ELISA (n=6,046) was used to test for the presence of PCV2 anti-
bodies and a new PCR (n=4,147) was also used to test whether 
PCV2 DNA was present in the sera of these pigs. In a separate 
study, these tests’ accuracy was determined using Bayesian 
analysis. For the ELISA, the Sensitivity was up to 90% while that 
of the PCR was up to 92%. 
Results
Nationally, approximately one in three sites with weaned market 
pigs reported PMWS during the 12 months prior to the inter-
view, ranging from 29.7% of small sites (<2,000 head) to 59.9% 
(>4,999 head) of large sites. On sites that reported PCVAD in 
weaned market pigs, 15.4% of these pigs were aff ected and 
again, larger sites had more pigs aff ected (19.8% vs. 7.7%)3. 
Out of 6,046 samples 78.8% were positive for PCV2 antibodies 
and out of 4,147 samples 82.6% were positive for PCV2 DNA. 
Over 80% of samples tested using both tests were positive for 
antibodies and DNA. All but two farms had one or more samples 
positive for PCV2 antibodies and all but one for PCV2 DNA.
We used a weighted logistic regression that generates estimates 
that can be directly extrapolated back to the population (>93% 
of the farms nationally with 100 or more pigs) rather than just 
the sample it comes from4. When farms had one respiratory 
disease (such as PRRS) the odds of PMWS being present went up 
almost 14 times compared to when no respiratory disease was 
present. If there were two or more respiratory diseases the odds 
went up over 30 times.
Discussion
Prior to the use of vaccines, more large farms than small farms 
had PMWS-aff ecting more animals. PCV2 elicits a humoral im-
mune response yet fails to clear the virus for some unknown 
reason. Anecdotally, it was believed that PCV2 was ubiquitous 
but there has not been a study of this magnitude to give more 
accurate estimates.
Should the vaccines available now begin to fail to control PMWS 
or more broadly PCVAD, then we must return our eff orts to 
reducing the impact of these respiratory pathogens modeled 
such as PRRS. 
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Introduction
The clinical expression of PCVAD embraces a complex of signs 
including those related to the respiratory system. The authors 
are not aware of any reports relating polyserositis directly to 
PCV2 infections. Experimental PCV2 infections in Specifi c Patho-
gen Free (SPF) pigs has led to severe respiratory signs with high 
mortality including lung edema, hyperemia of the lungs, icterus, 
lymphadenopathy and edema of the mesentery (1). In 2009 on 
2 locations SPF fattening pigs from one origin suff ered from se-
vere respiratory symptoms (dyspnea, coughing), high fever and 
a high level of mortality in spite of vaccination at 4 and 6 weeks 
of age against Haemophilus.parasuis (Porcilis®Glässer). Necropsy 
revealed polyserositis with negative bacteriological results, 
hyperemia of the lung, and interstitial lung edema. Organs were 
highly positive for PCV2 by IHC. Paired serological investigation 
of acutely sick pigs, only revealed seroconversion to PCV2. This 
strongly suggests that the clinical signs were related to PCV 2 
infections in a similar situation as described in experimentally 
infected SPF pigs by Gauger et al(1). A PCV-vaccination trial was 
set up in order to help the farm and to explore the relationship 
between the signs observed and PCV2 infections. After this trial, 
all new piglets that entered the fattening units were vaccinated.
Materials and Methods
In a batch of 350 piglets, 197 were vaccinated with a single 
dose of Porcilis® PCV at 10 weeks of age, on their arrival in the 
fattening unit. The rest were left unvaccinated. Vaccinated and 
unvaccinated pigs were housed site by site in three diff erent 
units. Mortality was recorded and in each trial group serum of 10 
pigs was sampled at 10-, 14-, 18- and 22-weeks of age. Sera were 
tested on antibodies against PCV2 (Synbiotics), PRRS(Idexx), H. 
parasuis (Biovet), M. hyopneumoniae (Idexx) and the 42 kD outer 
membrane protein of A. pleuropneumoniae (2). Sera were also 
tested on PCV2 virusload by qPCR. Average daily intake (ADI), 
feed conversion rate (FCR) and average daily gain (ADG) during 2 
months after the start of the vaccination was compared with the 
results of not vaccinated pigs during 2 months before the trial.
Results
All samples were negative against PRRS and M. hyopneumoniae. 
Also A. pleuropneumoniae titers stayed at low levels in both 
groups. Some sera of the 10- and 14-week old fatteners were 
positive against H. parasuis in both groups. These positive results 
were likely due to the early vaccination beause all 22-week old 
fatteners became negative.
Conclusion and Discussion
The clinical signs (respiratory distress and polyserositis) on 
this farm were likely caused by PCV2, no other causative agent 
was found in the diseased pigs and vaccination against PCV 
was successful in preventing the disease. Pigs vaccinated with 
Porcilis® PCV had a reduced mortality, a clear humoral response 
to vaccination and the amount of PCV2 virus positive pigs was 
reduced. The historical data show a clear improvement in ADG, 
ADI and FCR after starting the vaccination. The respiratory signs 
in this clinical fi eld trial with SPF pigs were similar to those of 
experimentally infected SPF pigs after PCV 2 challenge (1). The 
authors are not aware of any reports relating polyserositis to 
PCV2 infection. A possible explanation for this feature could be 
a co-infection with Mycoplasma hyorhinis (3, 4), an opportunist 
which is capable of causing polyserositis. Its involvement may be 
triggered by the immune suppression caused by PCV 2 infec-
tion. The practical implication of the results of both this and the 
Gauger trial is that PCV 2 can be the cause of acute respiratory 
signs with high fever and high mortality levels.
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Introduction
Porcine circovirus type 2 (PCV2) is the etiologic agent of 
postweaning multisystemic wasting syndrome (PMWS) in pigs. 
However, PCV2 co-infection with some viral and bacterial agents 
may potentiate PMWS development (1). Particularly, a previ-
ous infection with Mycoplasma hyopneumoniae (M.) has been 
shown able to trigger PMWS in subsequently PCV2 infected pigs 
(2). The objective of this work was to study the eff ect of concur-
rent PCV2 and MH co-inoculation in conventional piglets. 
Material and Methods
Thirty six 6-week-old male conventional piglets were divided 
into 4 groups: control (n=6, receiving 2 ml of PBS); PCV2 (n=6, 
intranasally challenged with 1 ml of 105 TCID50 PCV2b per 
nostril); MH (n=12, intratracheally inoculated with 5 ml of MH 
107 CCU on two consecutive days); and PCV2+MH (n=12, same 
inoculum conditions as above). Clinical signs, rectal temperature 
and body weight were recorded during the study period. Blood 
samples, faecal and nasal swabs were collected on 0, 7, 14 and 
21 dpi. At necropsy (21 dpi), tracheal and bronchial swabs were 
also taken. Extension of cranio-ventral pulmonary consolidation 
lesions (CVPC) was assessed (3). Moreover, lymphoid tissues and 
lungs were collected and fi xed in 10% buff ered formalin. Sera 
were examined for PCV2 (total and neutralising (4)) and MH 
antibodies. DNA extracted from serum samples, nasal and faecal 
swabs were analyzed by a PCV2 quantitative PCR (Q-PCR) (5). 
PCV2 in situ hybridization (ISH) from lymphoid tissues and lung 
was performed (6). MH DNA from nasal, tracheal and bronchial 
swabs was analyzed by Q-PCR.
Results
PCV2 infection remained subclinical although mild PMWS-like 
microscopic lesions were observed in two PCV2 pigs and in one 
PCV2+MH animal. PCV2 was detected by ISH in 3 PCV2 and in 4 
PCV2+MH challenged pigs. No signifi cant diff erences on mean 
body weight and rectal temperature were observed among 
the 4 groups. Total antibody and NA titres were similar in both 
PCV2-inoculated groups. Number of PCV2 Q-PCR positive pigs in 
serum was higher but not statistically signifi cant in all samplings 
in PCV2+MH than in PCV2 inoculated pigs. No signifi cant diff er-
ences in viral loads on diff erent sampling days and duration of 
viremia were detected among PCV2 inoculated groups.
Coughing was observed in 3 piglets from the MH group and in 
6 PCV2+MH pigs but it was absent in non-MH inoculated pigs. 
Proportion of MH Q-PCR positive pigs and mean bacterial DNA 
load in nasal cavity were similar in MH and PCV2+MH groups. 
On the contrary, mean MH DNA load at bronchial and tracheal 
swabs was higher in the PCV2+MH group compared to the MH 
one. No signifi cant diff erences on percentage of MH seropositive 
pigs among MH inoculated groups were observed. Eight pigs 
from MH group and nine from PCV2+MH group showed CVPC. 
No signifi cant diff erences in mean lung scoring between MH 
group and PCV2+MH group were observed.
Discussion
In a previous study, MH inoculation two weeks before PCV2 
challenge resulted in an increase of PCV2-associated lesions 
severity, amount of PCV2 antigen and incidence of PMWS in pigs 
(2). In the present study, the concurrent inoculation of MH and 
PCV2 did not produce that synergic outcome. These divergent 
results may be explained by the diff erent timing of infection but 
also by the source of the animals used. In the present study, the 
inoculated animals were seropositive to MH- and PCV2 while in 
the previous one (2) the challenged animals were seronegative 
against both pathogens. Taking into account that infection with 
both agents was successful, the present study suggests that tim-
ing and initial pig serological status may be the most important 
issues for the fi nal outcome of the co-infection. 
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Introduction 
Porcine Circovirus Associated Diseases (PCVD) have been associ-
ated with high mortality rates but PCV2 infection itself hasn’t 
been proved to be a risk factor for develop them (1, 2, 3). Some 
management practices, most be triggering the disease once 
PCV2 infects the pig. The main objective in this study was to 
determine what kind of swine industry practices and/or produc-
tion indicators are associated with extremely high mortalities 
rates in Colombian swine herds.
Materials and Methods
Sample size was calculated in 70 herds considering a 95% 
confi dence level, 10% precision and 50% prevalence. Herds were 
randomly selected from 163 farms located in the three major 
swine rearing areas in Colombia, with 200 or more sows that rep-
resent the 74% of national inventory. An epidemiological survey 
was applied, and extremely high mortality in the nursery and 
fi nishing was defi ned as mean plus 2 standard deviation of the 
sample without extreme values when calculating it. 43 serum 
samples were collected per production cycle and analyzed for 
PCV2 antibodies (SERELISA® PCV2 SYNBIOTICS). Samples of 
death animals were collected when present and analyzed for 
PCVD lesions and PCV2 antigen was identifi ed by Immunohisto-
chemistry (IHQ) within compatible lesions. 
Statistical analysis was performed using STATA 9 ®. The null 
hypothesis was that exposure to any of the variables included 
in the survey do not modifi es the risk of developing extremely 
high mortality rates. Association between high mortalities and 
exposure variables were assessed through a logistic regres-
sion model estimating relative risk adjusting it for variables like 
clinical disorders or previously diagnosed diseases; backward 
stepwise regression analysis was performed for each outcome 
(high mortality in nursery and fi nishing).
Results
High positive ELISA reactivity was found in the sow herd (95.3%) 
without signifi cant diff erences between proportions, within par-
ities in the tested animals (p>0.05). High positive ELISA reactivity 
were also found in growing pigs 94, 90.7, 83.7, 89.8 and 93.6% 
for 1, 5, 10, 15 and 20 weeks of age respectively, being diff erent 
the proportion of positive animals between animal 5 and 10 
week of age (p=0.009) and between animals 10 and 15 weeks of 
age (p=0.026). 
Mean mortality rate in the nursery was estimated in 1.41% SD 
0.74 and 2.2% in the fi nishing pigs SD 1.45. The risk to have ex-
tremely high mortalities in the nursery was estimated to be 17.5 
(IC 95% 1.8, 168.2; p=0.01) higher when farms don’t use shower 
baths at the entry to the nursery if the polyserositis (OR 6.1, 
IC95% 1.06-35.3; p=0.43) and low consumption (OR 25.3 IC95% 
2.3 – 274.0; p=0.008) eff ect was controlled in the logistic model; 
all other variables were dropped off  the model because they 
lost signifi cance when the eff ect of this three was controlled. All 
of the variables included in the second model lost signifi cance 
when the eff ect of low consumption was controlled in fi nishing 
pigs; it was estimated that fi nishing pigs have a risk 18.8 times 
higher to develop high mortality if low consumption was re-
ported (IC95% 1.7 – 203.2; p=0.016). PCVD has been diagnosed 
and PCV2 has been identifi ed within lesions in some farms but 
not all result where available at the time of this preliminary re-
port. PCV2 exposure was determined in all farms evaluated and 
vaccination didn’t modify the risk of developing high mortality 
rates. 
Discussion
PCV2 exposure itself was discarded to be associated with high 
mortality rates in the nursery and growing to fi nishing in farms 
with more than 200 sows in Colombia. Poor management prac-
tices could make possible that other swine pathogens, including 
PCV2, alter pig´s health status in such a way that high mortal-
ities appeared. The diff erence between proportions in positive 
animals to PCV2 during the nursery and fi nishing period may be 
related to high mortalities in certain ages. 
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Growth depression after severe outbreak of porcine circovirus associated 
disease (PCVAD) in the ﬁ nishing unit: case history 
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Vet-Com, Olsztyn, Poland
Introduction
The fi rst reports about confi rmed PCV2 in Polish swine herds 
date back to 2000 (1,2). The aim of the investigation was to 
determine the impact of outbreak of severe porcine circovirus 
associated disease (PCVAD) on the performance in the fi nishing 
unit. 
Materials and Methods
The investigation was conducted in a fattening farm located in 
the western part of Poland. The farm consisted of three barns for 
2000 fi nishers with pens for 30-120 animals. Pigs for this study 
were sourced from a high health farm without clinical signs 
of PCVAD. They were not vaccinated against PCV2. A total of 
1600 pigs were moved to the fi nisher farm at 40 kg of weight. 
The factors which aggravate problems were high temperature 
during transport and the quality of the feed in the beginning, 
which caused outbreak of watery, yellowish or grey diarrhea 
which aff ected up to 50% of the animals. After two weeks 
persistent cough appeared in 30-35% of pigs and the fi rst cases 
of death were recorded. Numerous symptoms of PMWS and 
the fi rst PDNS cases occurred. Weekly mortality increased to 
5-10 pigs. Post mortem examination showed cachexia, pale-
ness of the skin, reddish or blackish foci of cutaneous necrosis 
located mainly in the area of rump, neck and ears, enlargement 
of inquinal and mesenteric lymph nodes, various infl ammation 
of digestive and respiratory system. Three sick pigs were culled. 
Their lymph nodes, samples of ileum, cecum, spiral colon and 
kidneys were analysed microscopically and tested by in situ 
hybrydysation for PCV2(1,2). Additionally intestine samples 
were examined by PCR for Lawsonia intracellularis and Brachy-
spira hyodysenteriae. PMWS typical histopathological lesions 
and PCV2 DNA were detected in the submitted material. The 
result for Lawsonia and Brachyspira was negative. After two 
weeks with many cases of diarrhea and coughing treatment was 
started with Tiamutin 45% (tiamulin 8mg/kg for 6 days) and then 
Soludox 50% (doxycyclin 10mg/kg for 6 days) was administered 
in the drinking water. Such therapy only stopped the progress 
of disease for two weeks. After this time treatment had to be 
repeated. Moreover every sick pig was put in hospital pens. All 
facilities were cleaned and disinfected every day. Additionally 
all animals in hospital pens (300 pigs at the peak of disease) got 
TiaClor (CTC and Tiamulin) and Paracetam(NSAID) in the feed 
for 21 days. The weight of the pigs was recorded at introduction 
to the fi nishing unit and at slaughter. Average daily weight gain 
(ADWG) was calculated and number of days to slaughter were 
recorded. Performance of pigs aff ected with PCVAD was com-
pared with pigs non-aff ected with PCVAD. Group A consisted of 
healthy pigs without any clinical symptoms of PCVAD and group 
B consisted of pigs with PCVAD.
Results
During the fattening period clinical signs of PCVAD infection 
occurred in 82% of the pigs (Group B). Only about 13% were not 
aff ected (Group A). Total mortality rate was 4.8%. The ADWG of 
pigs with PCVAD (Group B) was reduced compared to non af-
fected (Group A) by 244g/day. Number of days to slaughter was 
extended by 21 days for group B compared to Group A (Table 1). 
Table 1. Comparison between two groups of fi nishers. Group A pigs 
without any clinical sings of PCVAD and Group B pigs with clinical sings 
of PCVAD.
A B
Number of pigs 206 1317
Average weight at the beginning (kg) 40 40
ADWG (g) 952 708
Number of days to slaughter 75 96
Discussion
Outbreak of PCVAD infection had serious fi nancial conse-
quences, reduction of DWG by 244g/day and extension of feed-
ing days by 21 for pigs with PCVAD and the loss was estimated 
at 35,200 USD or about 27 USD per pig. Had these treatments 
with antimicrobials, isolation of aff ected pigs in hospital pens, 
cleaning and disinfection of pens not been carried out losses 
would have been higher. 
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Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) 
and Porcine circovirus type 2 (PCV2) are currently a major con-
cern for the swine industry worldwide. A lot of fi eld surveys have 
indicated that dual PRRSV and PCV2 infection is common in pigs 
(3, 4). However, whether the immunosupression, in particular in 
alveolar macrophages, is stronger compared with the singular 
infection is still unknown. 
Materials and Methods
Porcine alveolar macrophages (PAM) were isolated from lungs of 
5-week-old piglets as Chang (2005) description. For subsequent 
experiments, PAMs were seeded at 24-well plates and infected 
with PCV2, PRRSV, PCV2+PRRSV (simultaneously inoculation) 
and PCV2 followed by PRRSV infection at 6hr later. The uninfect-
ed PAMs served as blank control. The supernatant and pellet of 
infected cells were collected at 0, 12, 24, 48, 60hpi. 
We used quantitative real time PCR and indirect immunofl uor-
escence assay (IFA) to analyze the adhesion and replication of 
PCV2 on PAMS, the cytopathic eff ect (CPE) and livability of PAMs 
were monitored and calculated by Typan Blue Staining Cell Vi-
ability Assay Kit, and mRNA levels of the cytokines (TNF- α, IFN- 
γ, IL-8) in PAMs were detected by semi-quantitative real-time 
PCR.
Results
The infection of PAMs with PRRSV neither increased the ad-
hesion nor the replication of PCV2, but the distribution of PCV2 
was changed in PAMs. PCV2 could not replicated nor induced 
CPE in infected PAMs, whereas the co-infected with two viruses 
could induce the cell death compared to single virus infected 
group. The expression of TNF- α,IL-8 in PAMS induced by co-
infected group (diff erent orders) were found to signifi cantly in-
crease and the increase was stronger than singular virus infected 
groups(p<0.001). However the co-infected group inhibited 
the expression level of IFN- γ compared to virus infected alone 
(p<0.001).
Discussion
The object of our work was to study the eff ect of PRRSV and 
PCV2 co-infection on PAMS. The results showed that no replica-
tion of PCV2 in PAMs was observed and this phenomenon was 
not associated with the present of PRRSV or not, PCV2 probably 
evade the immune systems through low-dose infection. As to 
the diff erence of PCV2 distribution between co-infected groups 
and single virus infection, more evidence is needed to explain 
this consequence. Besides, the addition of PRRSV to PCV2 
caused more severe cell death and increased the expression 
of TNF- α, IL-8 than single virus infection, the results indicated 
co-infection may cause more serious pulmory pathological le-
sions. IFN- γ is the broad-spectrum anti-virus agent, the stronger 
inhibition of expression caused by co-infected groups indicated 
PCV2 and PRRSV co-infection caused more severe immune sup-
pression than infection with PCV2 or PRRSV alone.
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Introduction
Porcine circovirus type 2 (PCV2) is the causative agent for post-
weaning multisystemic wasting syndrome (PMWS) and is con-
sidered to be one of the most important viral pathogens of pigs 
in many countries. PCV2 has also been associated with addi-
tional diseases, referred to as PCV associated diseases (PCVAD) 
which include PMWS, some types of pneumonia, enteritis, 
reproductive failures and another distinct disease condition, the 
porcine dermatitis and nephropathy syndrome (PDNS). In Switz-
erland a PMWS epizooty commenced at the end of 2003 (1). We 
attempted to reconstruct this epizooty and the retrospectively 
reevaluated PDNS cases are presented here. 
Materials and Methods
The Institute of Veterinary Pathology, Zürich, is the only lab-
oratory in Switzerland which diagnoses PCV2 infections by 
immunohistochemistry (IHC) with the monoclonal antibody 
F217 according to the rules of the sixth framework program 
(2). A retrospective investigation of all available cases from our 
archive and the archives of other Swiss laboratories between 
2003-2006 were used to elucidate the Swiss PMWS epizooty, 
which began at the end of 2003. In this material only 14 of 538 
declared PCV2 infected animals were IHC negative after reevalu-
ation. 131 cases had a low PCV2 antigen load in the lymphatic 
tissues and 383 moderate to high. For this communication we 
selected the cases where PDNS was diagnosed using the “typ-
ical” glomerulonephritis as the diagnostic criterion.
Results
PDNS was diagnosed in 43 out of 538 animals. 21 PDNS cases 
had only minimal PCV2 antigen in lymphatic tissues and 22 had 
a moderate to high PCV2 antigen load. The PMWS animals were, 
as expected, signifi cantly younger than those with PDNS. The 
PDNS pigs with low PCV2 antigen load in the lymphatic tissues 
were the same age as those with moderate to high antigen load 
(Ø 17 weeks) but they had signifi cantly higher body weights (Ø 
44.1 kg, n=19 with available data) than those with moderate to 
severe PCV2 antigen load (Ø 29.8 kg, n=13 with available data) 
(Table 1). The cases with moderate to high PCV2 antigen content 
also showed depletion and histiocytic infi ltrates in lymphatic 
tissues similar to PMWS.
Not all cases had skin lesions.
Table 1: Mean age and body weight of animals with PMWS and PDNS 
with low PCV2 content and PDNS with high PCV2 content (* P < 0.001)
Diagnosis Age (weeks) Body weight (kg)
PMWS 10.5 ± 3.8 * (n=167) 14.6 ± 8.8 (n=276) 
PDNS: low PCV2 antigen content 17.0 ± 4.2* (n=9) 44.1 ± 20.7* (n=19)
PDNS: moderate to high PCV2 antigen content 
”mixed PDNS-PMWS” 17.5 ± 4.2 (n=6) 29.8 ± 11.9* (n=13)
Discussion
PDNS is suspected to be PCV2 induced (3), however we were 
not able to demonstrate any PCV2 antigen signal or DNA signal 
(by insitu hybridisation) within the glomerular lesions. PCV2 
antigen signals were primarily in lymphatic tissues. However low 
PCV2 antigen load in lymphatic tissues is not defi ned as PCV2 
disease because low quantities of PCV2 may be found in healthy 
animals.
Our set of PDNS cases was clearly divided into two subsets. One 
comprised PDNS animals with no to scarce PCV2 antigen and 
good body condition, the other subset suff ered from PMWS 
(with high PCV2 antigen content and lesions in lymphatic tissue) 
followed by renal failure. We called these cases “mixed PDNS-
PMWS”.
PDNS cases were infrequent in this investigation probably be-
cause the easily recognizable typical cases with dermatitis were 
not submitted for necropsy by the owners.
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Introduction
Porcine circovirus type 2 (PCV2) is acknowledged as the es-
sential infectious agent of postweaning multisytemic wasting 
syndrome (PMWS)1. However, it has been noted that PMWS may 
not develop even though a pig has been infected with PCV23. It 
is possible that other agents may contribute to the development 
of PMWS. A possible potentiating co-factor in the development 
of PMWS by immunologic dysregulation is Torque teno virus 
genogroup 1 (g1-TTV), even though it is not considered a dir-
ectly causative agent3. Another candidate which may play a role 
in PMWS development is a recently discovered porcine boca-like 
virus (PBo-likeV), identifi ed by high-throughput sequencing 
in lymph nodes taken in a Swedish study from PMWS-aff ected 
pigs2. Here we investigate the distribution of PCV2, TTV and the 
new PBo-likeV in archival serum and tissue samples recovered 
from pigs from 5 UK farms in 2002.
Materials & Methods
37 sera samples were collected from pigs on all 5 UK farms, 2 of 
which were known to be non-PMWS-aff ected and the other 3 
PMWS-aff ected. 21 pigs from 3 PMWS-aff ected farms also had 
tissue samples collected. Tissues included lung, liver, kidney, 
spleen and lymph nodes from each pig. Viral nucleic acids were 
extracted from sera and homogenised tissue samples. All sera 
and tissue samples were analysed by PCR for the presence of 
PCV2 using ORF2 specifi c primers1. Where possible, resultant 
amplicons were sequenced to ascertain the PCV2 genotype5. 
The samples were also assessed for the presence of g1-TTV4, 
g2-TTV and PBo-likeV2 using real-time PCR. g2-TTV was detected 
using a set of primers kindly provided by Dr. Annette Mankertz 
(Robert Koch-Institut, Berlin, Germany) (data not published).
Results
Tissue sample PCR results were pooled due to little variation in 
virus presence from tissue to tissue. The percentage distribution 
of viruses detected in the samples are detailed in Tables 1 and 2. 
Table 1. Distribution of PCV2, TTV & PBo-likeV in sera from PMWS-
aff ected & non-PMWS-aff ected farms (%).
Sera Results PCV2 +VE g1-TTV +VE g2-TTV +VE PBo-likeV +VE
PMWS +VE 22% 0% 0% 0%
PMWS -VE 61% 50% 56% 0%
Table 2. Distribution of PCV2, TTV & PBo-likeV in PMWS-aff ected & 
non-PMWS-aff ected tissues from PMWS-aff ected farms (%).
Tissue Results PCV2 +VE g1-TTV +VE g2-TTV +VE PBo-likeV +VE
PMWS +VE 100% 60% 90% 100%
PMWS -VE 100% 64% 46% 82%
Discussion
The disparity in virus distribution evident in the sera samples 
could result from the PMWS-aff ected samples being comprised 
of sera from the 1st week of life which would limit pig exposure 
time to these viruses. However, non-PMWS-aff ected samples 
also included terminal bleeds at 12 weeks of age. It is apparent 
from the tissue samples that g2-TTV and PBo-likeV were more 
prevalent in PMWS-aff ected pigs. It is also of interest that PCV2 
genotype 2a was present in sera samples from non-PMWS-
aff ected farms although genotype 2b was exclusively found in 
tissues from PMWS-aff ected farms5. Further statistical analysis 
of these results is required to assess if incidence of a virus or 
specifi c genotype can be signifi cantly related to disease status.
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Serum endotoxin in pigs aﬀ ected by wasting syndromes
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Introduction
Postweaning multisystemic wasting syndrome (PMWS) is one 
of the disease syndromes which have been collectively named 
porcine circovirus diseases (PCVD). PMWS mainly aff ects nursery 
and/or fattening pigs and wasting is considered the most 
representative clinical sign of this disease. It is considered a 
multifactorial disease in which other factors in addition to PCV2 
are needed, in most cases, to trigger the clinical disease. These 
factors haven’t been clearly identifi ed yet.
The aim of this study was to examine the levels of serum endo-
toxin in weaning piglets from farms with clinical symptoms of 
wasting compared to the levels in pigs from healthy farms.
Materials and Methods
Five (control farms) healthy farms and 13 (case farms) with 
a wasting syndrome that could be attributed to PMWS were 
selected for the study. Diagnosis of clinical PMWS and exclusion 
of other wasting agents was made through anamnesis, clinical 
fi ndings and anatomo-pathological examination. Ten wean-
ers were blood sampled in each farm (in control farms: animals 
perfectly healthy; in case farms: animals with a severe wasting 
syndrome). Blood samples were tested for lypopolisaccarides 
(LPS) with a Kinetic Cromogenic Assay.
Results
Mean and standard deviations (SD) of serum LPS (EU/ml) in the 
diff erent farms are reported in table 1.
 
In fi gure 1 the graph of sensitivity-specifi city and the cut off  
value is reported.
 
Discussion
The correlation between the presence of the disease and the 
level of LPS was statistically signifi cant. The average LPS level in 
healthy animals was 0.34 EU/ml (CI 95%: 0.08-0.59) while in wast-
ed animals 0.92 EU/ml (CI 95%: 0.76-1.08). In presence of wast-
ing, LPS was on average 0.58 EU/ml higher (CI 95%: 0.28-0.88; 
p<0.001). The cut-off  value identifi ed for LPS was 0.44 EU/ml.
The limitation of these fi ndings is that PMWS was not confi rmed 
by histopathological examination of lymphoid tissues and 
detection of PCV2 in damaged tissues. However, these results 
could be useful in identifying triggering factors in animals af-
fected by wasting syndromes that can’t be attributed to specifi c 
pathogens and are clinically attributed to PMWS.
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Introduction 
Since 1999, fi eld evidence of transplacental infection by PCV2 
and reproductive failure has been reported (1). Several experi-
mental studies were performed: trans-uterine inoculation of 
fetuses (2), oronasal inoculation of pregnant SPF (3) or conven-
tional (4) sows, intra-uterine inoculation of SPF sows (5). The 
objective of this study was to evaluate the clinical and patho-
logical consequences of PCV2 infection in conventional pigs by 
artifi cially infected semen.
Material and Methods 
Nine prepubertal conventional pigs were randomly divided: 3 
controls and 6 infected. Hormonal estrus synchronization was 
followed by artifi cial insemination (AI) with a single dose semen 
added with 10 ml of a PCV2 suspension. After ultrasonography 
at 29 day post-insemination (DPI), empty sows were euthanized 
at 30 DPI whilst pregnant ones between 52nd and 56th DPI. Cer-
vix, nasal and rectal swabs, and blood samples were weekly col-
lected from -2 DPI till the end of the experimental period. Serum 
samples were directly and indirectly tested for PCV2, PRRSV, 
PPV and ADV. Serum antibody titres were determined by testing 
serial dilutions of each serum, by competitive ELISAs (6, 7, 8). The 
protocol described by Olvera et al. (9) was employed for PCV2 
real time-PCR. Serum progesterone levels were measured by 
radioimmunoassay (10).
Results
At the -2 DPI, none pig presented viremia for all tested virus. All 
animals showed a high anti-PCV2 antibody level at -2 DPI (range 
1/1000-1/10000), but only one sow had a lower titre (1/100). 
Four out of 6 infected sows displayed viremia at 7, 21, 28 and 35 
DPI (the subject with the lowest anti-PCV2 level kept showing 
positive blood results for two successive samplings at 21 and 35 
DPI). This latter was also the only sow showing a positive swab 
(rectal, 35th DPI). The anti-PCV2 antibody proved a decline after 
7 DPI followed by a plateau in controls, whereas in infected 
animals were recorded values higher than controls that declined 
only after 42 DPI (Figure 1). 
No sows showed any signs of estrus after AI. Pregnancies were 
established in 3 out of the 6 infected sows and in 3 out of the 3 
controls (one control sow aborted 3 fetuses at 21 DPI). Serum 
antibody titres against PPV, PRRSV and ADV (total and anti-gE) 
decreased between -2 DPI and at the last DPI. Progesterone was 
absent in all gilts at insemination and in all animals increased 
after estrus induction but in the three non-pregnant infected 
animals never raised until the 28 DPI.
Figure 1: Mean anti-PCV2 antibody titre in infected (IG) and control 
groups (CG)
Discussion 
In the present study the assessment of a fi eld situation em-
ploying conventional pigs and intrauterine PCV2 exposition 
was investigated. Viremia was recorded in 4 out of 6 infected 
animals, besides mean antibody titre higher only in exposed 
subjects. Three infected sows out of 6 were not pregnant, unlike 
controls were all pregnant. Moreover, it should be emphasized 
that only the infected sow with lower PCV2 antibodies titre at 
-2 DPI showed simultaneously viremia and fecal virus spread. 
Therefore, i) the PCV2 infection is possible in conventional sows 
by intrauterine exposition; ii) low antibody titres increase the 
probability of the infection; iii) PCV2 infection close to insemina-
tion reduces the pregnancy rate.
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Occurrence of PCV2 and TTV genotypes from fetus and from nursery and ﬁ nishing animals 
Kledna C. P. Reis; Jose L. Santos; Walter V. Guimaraes; Lucas F. Santos; Mayka R. Henriques; Daniel L. Santos
Microvet, Vicosa, MG, Brazil
Introduction
Swine with Postweaning Multisystemic Wasting Syndrome 
(PMWS) under PCR analysis yields both Porcine Circovirus geno-
types (PCV2a and PCV2b) as well as association with Torque Teno 
Virus (TTV), PRRSV, Parvovirus (PPV), Swine Infl uenza, Corona-
virus and also E. coli, Streptococcus suis, M. hyopneumoniae, H. 
parasuis and A. pleuropneumoniae (1,2,3). This work was done 
to verify the occurrence of PCV2 and TTV genotypes in samples 
from swine with PMWS and possible other virus and bacteria 
co-infections.
Material and Methods
Eighteen samples from swine suspected of PMWS, collected 
during 2009 in Brazil, were analyzed. Ten samples were from 
fetus (group I) and eight from nursery/fi nishing animals (group 
II). Lymph nodes, lung/heart were investigated by PCR analyses 
for PCV2a, PCV2b, TTV1, TTV2 and PPV. The DNA extraction and 
the PCR analyses were done according to Kim et al. (2003). The 
secondary bacteria infection diagnosis was done by Microvet 
laboratory (Brazil).
Results
PCV2b was the most prevalent in both groups. Two samples 
from group I were positive for PCV2a/PCV2b but this co-
infection was not detected in group II. In both groups the most 
common co-infection was PCV2b/TTV2 followed by PCV2b/PPV. 
Twenty percent of samples from group I and 50% from group 
II had TTV1/TTV2 co-infection (Table 1). In group I, 60% of the 
samples were co-infected with one bacterium, mainly, alpha 
hemolytic E. coli and in group II diff erent species were detected 
(Table 2).
Table 1. PCR results for 18 samples from fetus and nursering/fi nishing 
animals
PCR positive virus Group I (fetus) Group II (nursery/fi nishing
PCV2b 8/10 (80%) 8/8 (100%)
PCV2a/PCV2b 2/10 (20%) 0/8 (0%)
PCV2/PPV 3/10 (30%) 6/8 (75%)
PCV2b/TTV1 2/10 (20%) 4/8 (50%)
PCV2b/TTV2 9/10 (60%) 7/8 (87.5%)
TTV1/TTV2 2/10 (20%) 4/8 (50%)
Table 2. Bacterial species associated with PCV2 in 18 samples from 
fetus and nursering/fi nishing animals
Groups Bacterial secundary agent
Group I E. coli (6/10); S, suis 1/10
Group II E. coli (2/8);S. suis (2/8); M.hyorhinis (1/8); L. intracellulares (1/8)
Discussion
The viral and bacterial co-infections are common in PMWS 
(1,2,3). The occurrence of PCV2 and TTV genotype infections 
could be related to diff erences in pathogenesis or animal 
origin. According to Horlen et al (2007) both PCV2a and PCV2b 
genotypes were found in isolates from PMWS-aff ected pigs. In 
this study the presence of PCV2a and PCV2b in group I needs 
more investigation since they were absent in group II. The PCV2a 
could be an antecessor in the primary infection or related to 
abortion or fetus anomalies when in association with PPV and 
TTV2. The presence of TTV1 and TTV2 in both groups was high, 
essentially the TTV2. The analysis of infection sequence in ani-
mals with PMWS can give interesting clues for the role of the TTV 
during infection. Taira et al. (2009) using nested PCR found posi-
tive results for TTV1 and TTV2 in diff erent organs form PMWS 
swine. More studies are required to determine if other endogen-
ous or exogenous cofactors are involved in the pathogenesis of 
PCV2a and PCV2b. In conclusion it can be stated that PCV2b and 
PCV2b/TTV2 were frequently observed and co-infection with 
bacteria were common in swine with PMWS.
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Association of PCV-2 with porcine respiratory disease complex (PRDC) in 
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Introduction
The porcine circovirus diseases (PCVD) rarely occur as a result 
of the infection from one infectious agent, like PCV-2, alone. 
Usually several pathogens work together with the PCV-2 to 
break down defenses leaving the respiratory tract suscept-
ible to pathogenic organisms. The PCV-2 has been identifi ed 
in association with lesions in swines with porcine respiratory 
disease complex (PRDC). The aim of this work was to investigate 
the presence and distribution of PRDC bacterial coinfections in 
swines with clinical signals of the PCVD among Brazilian states.
Materials and Methods
Samples from 150 swine lungs with clinical symptoms of PCVD 
were studied. The samples were originally from fi eld infections 
collected in 9 diff erent swine-producing Brazilian states and 
have been previously confi rmed to be positive for PCV-2 by PCR. 
All samples were submitted to microbiological standard tests for 
bacteria isolation and identifi cation. Histopathological evalua-
tion was carried out in 71 of the 150 samples and microscopic 
lesions were correlated with presence or absence of associated 
bacteria.
Results
Forty two samples (28.0%) did not present any bacterial agent 
associated. In 108 (72%) samples at least one of the following 
agents was detected: P. multocida type A, P. multocida type D, B. 
bronchiseptica, H. parasuis, A. pleuropneumoniae, S. suis, E. coli. 
Sixty-seven samples (44.7%) presented one bacterial agent only, 
while 41 (27.3%) had more than one. The bacterial frequen-
cies among the 67 samples were: 18/67 (26.9%) of S. suis, 7/67 
(10.4%) of A. pleuropneumoniae, 22/67 (32.8%) of P. multocida 
type A, 6/67 (9.0%) of P. multocida type D, 3/67 (4.5%) of B. bron-
chiseptica, 7/67 (10.4%) of H. parasuis and 4/67 (6.0%) of E. coli. In 
the 41 samples with more than one of these bacteria, 24 diff er-
ent pathogens combinations were observed. The distribution of 
the bacteria in the Brazilian states studied showed diversity. The 
most prevalent bacteria associations were A. pleuropneumoniae 
and P. multocida type A; S. suis and P. multocida type A; S. suis and 
P. multocida type A and H. parasuis. Minas Gerais state showed 
the major prevalence of bacterial associations. The pulmonary 
histopathological lesions observed in samples were grouped 
as: (i) positive association with bacterial infections (47.89%), 
(ii) negative for bacterial association (52.11%). In the negative 
group, interstitial pneumonia with thickening of interalveolar 
walls and infl ammatory cells in the alveoli were observed. It was 
also observed peribronchial and perivascular lymphohistiocytic 
infi ltrates with syncytial cells. In the positive group, pulmonary 
lesions similar to those from the negative group were observed 
in 12 samples, while pulmonary lesions with characteristics of 
bacterial infection were seen in 22 samples.
Discussion
In the present study we observed a wide dispersion of pulmon-
ary bacteria across diff erent swine-producing farms from nine 
Brazilian states. Furthermore, the frequence of association 
between PCV-2 and PRDC bacteria was high, suggesting that 
the PCV-2 immunossuppression can facilitate these pathogens 
infection. The results confi rm that the respiratory infections 
are widely spread out among Brazilian herds. Our data are in 
accordance with previous studies that indicated that pulmonary 
lesions associated with PRDC had prevalence taxes of the 19.7% 
to 75.7% in swine from diff erent Brazilian states. The high num-
ber of diff erent bacterial associations with PCV-2 found reinforce 
current literature data that demonstrated that the PRDC is a 
multifactorial disease. It is also important to observe that Minas 
Gerais is one of the major swine producer states and that its 
herds are distributed for diff erent states which could explain the 
dispersion of PCV-2 infection with bacterial associate.
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Superﬁ cial inguinal lymph node inv various PCVD conditions
John Carr
Portec Australia, Belmont, WA, Australia
Introduction
An increase in size of the superfi cial inguinal lymph node is 
described as a clinical sign of Post-weaning Multisystemic Wast-
ing Syndrome (PMWS). However, examination of the physical 
properties of the superfi cial inguinal lymph node indicates 
that rather than enlargement, the lymph node becomes more 
prominent as the “fl are fat”, around the lymph node, disappears 
with the loss of weight associated with PMWS and other Porcine 
Circovirus Diseases (PCVD). In Porcine Dermatitis and Nephrop-
athy Syndrome (PDNS), there was a true enlargement of the 
superfi cial inguinal lymph node both in terms of length, width 
and depth.
It is essential, when describing pathology, to avoid terms like 
“enlargement” without providing physical dimensions.
Materials and Methods
Normal population: Superfi cial inguinal lymph nodes were col-
lected from a slaughterhouse or a feed-trial in Western Australia 
from a variety of live-weight pigs. All the pigs were passed 
suitable for human consumption or had no gross pathology. The 
lymph nodes were measured for their length, width and depth. 
Western Australia was selected because the area is free of many 
viral pathogens that cause changes in lymph node sizes – par-
ticularly Porcine Reproductive and Respiratory Syndrome virus.
Number of animals in each normal group:
10 to 30 kg live weight: 107 pigs
40 to 60 kg live weight: 312 pigs
90 to 110 kg live weight 125 pigs
Abnormal population: Superfi cial inguinal lymph nodes were col-
lected from cases of PMWS, PCVAD and PDNS. 
Porcine Circovirus Associated Disease (PCVAD) is defi ned as pigs 
from farms where there was a PCVAD score ≥1 but there was no 
clinical evidence of PMWS on the farm.
Count:PCVAD: 33 pigs; PMWS: 17 pigs; PDNS: 10 pigs
Approximate age of the pigs in each group and normal weight 
range for the age group
PCVAD:  8 to 10 weeks  22 to 30 kg
PMWS:  8 to 16 weeks  22 to 65 kg
PDNS:  16 to 20 weeks  65 to 95 kg
Results
Length of the superfi cial inguinal lymph node:
Mean mm Standard deviation Range mm
10 to 30 kg 38 7.4 20-66
40 to 60 kg 56 8.9 34-80
90 to 110 kg 61 9.3 22-85
PCVAD 32 7.4 18-50
PMWS 44 8.7 32-63
PDNS 90 21.7 50-110
The relative length of the superfi cial inguinal lymph node in the 
normal pig and various abnormal states
Discussion
The normal inguinal lymph node increases in size as the pig 
grows from a mean length of 38 mm in pigs less than 30 kg to 61 
mm in the 110 kg fi nisher pig
The superfi cial inguinal lymph node is quite large and is nor-
mally virtually invisible; covered by fat.
In cases of cachexia the ‘fl are fat” disappears around the super-
fi cial inguinal lymph node, which then becomes clinically very 
apparent.
In cases of PCVAD and PMWS the lymph node is not enlarged, 
when compared to the normal pig. However, it becomes more 
prominent because the surounding “fl are fat” is lost. 
The superfi cial inguinal lymph node is enlarged – in terms of 
length, breath and depth in cases of PDNS. P<0.001. As the tis-
sues of the skin around the perineal region are infected in cases 
of PDNS, an enlargement of the draining lymph node is to be 
expected.
Please visit out website: www.portec.com.au
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Acute Pulmonary Edema (APE), a New Porcine Circovirus Associated Disease??
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Introduction
We are investigating an on-going case involving porcine 
circovirus (PCV) and PRRS that has striking clinical diff erences 
compared to outbreaks before the advent of circovirus vaccines. 
Historically clinical circovirus is seen in 8-20 week old pigs with 
lesions of depleted lymphoid tissue in many organs. Gross path-
ology is varied and the clinical course is chronic, debilitating and 
progressive. Implementation of PCV vaccine decreased morbid-
ity and mortality dramatically. In our case the clinical presenta-
tion diff ers with acute death pigs in good body condition. The 
consistent gross lesion, severe interlobular pulmonary edema, is 
distinguishing. The aff ected animals have been vaccinated with 
a product and protocol that has proven highly eff ective in the 
past. This particular animal group is suff ering from severe dis-
ease while cohort animals, raised on other sites, remain normal. 
At 21 days of age weaned pigs from two separate PRRS negative 
breed-to-wean farms move to one of 20 separate growing facili-
ties, either stand-alone nurseries or nursery-fi nishing sites. Pigs 
in 9 of the 20 sites remain PRRS negative through their growth 
period while PRRS infection and seroconversion frequently 
occurs at 8-10 weeks of age in the other eleven sites. APE as-
sociated losses occur in both PRRS positive and PRRS negative 
populations. The 20 sites are fed by six separate and non-
affi  liated feed mills. All grain used has been 2008 grain sources. 
The four aff ected sites are fed by three diff erent mills. None of 
the aff ected sites are located near one another. All pigs were 
immunized at four and seven weeks of age with Circumvent PCV 
vaccine (Intervet Schering-Plough Animal Health) Immuniza-
tion protocol has remained unchanged since 2007 and has been 
highly effi  cacious. Groups aff ected range from 7-14 weeks of 
age at onset of clinical signs. In severely aff ected lots mortality 
ranged from 13-21%. Predominantly the mortality is acute and 
associated with APE, however some chronic and debilitated 
animals developed in certain groups.
Materials and Methods
Fresh and fi xed tissues were collected from seven pigs of seven 
weeks of age and weighing approximately 35 lbs. Three pigs 
were found dead the morning of necropsy. The four remaining 
pigs were selected as “clinically normal” controls based on clin-
ical evaluation. None of the other pigs in this four room nursery 
were coughing. They were clinically normal and were highly 
active. Pigs were sedated with 1ml of pentobarbital via jugular 
venapuncture. Seventy mls of blood was collected into 10ml 
serum separator tubes via an intracardiac stick. Animals were 
then euthanized with 1.5 mls of pentobarbital and necropsied. 
Gross pathology, histopathology including IHC for Circovirus, 
diff erential and quantitative PCR for PCV and PRRS, IFA anti-
body titers for PCV, viral genome sequencing and compliance 
antibody diff erential sampling with baculovirus antibody testing 
was conducted. 
Results and Discussion
On the basis of the viral genome sequencing the circovirus and 
PRRS viruses present are very similar to those historically known 
to this region and production fl ow. Compliance antibody evalua-
tions exhibited responses to vaccination and several groups that 
exhibited disease appeared to have been well vaccinated based 
on compliance testing. Through IHC, histopatholgy and PCR 
testing circovirus was also demonstrated as the agent associated 
with the pulmonary pathology, including necrotizing vasculitis, 
which is not commonly seen with PCV2. The concentrations of 
circovirus detected in the tissue and the serum were considered 
extremely high in most cases with Ct <10 for many tissues and 
Ct < 20 for serum pools. 
While interlobular edema is an occasional manifestation of circo-
virus the pulmonary edema is not. Noncardiogenic pulmonary 
edema is characterized by diff use alveolar damage, increased ca-
pillary permeability and accumulation of protein rich fl uid in the 
alveoli. The fl uid accumulation ultimately results in decreasing 
oxygenation. This can be caused by either direct alveolar dam-
age i.e. diff use pulmonary infection or indirectly i.e. severe sepsis 
resulting from the over expression of the normal infl ammatory 
response. Commonly all of this occurs within 24 hrs manifesting 
as respiratory failure and acute death a,b.
The consistent lesions of acute death, interlobular edema, nec-
rotizing vasculitis pleural transudate accompanied by very high 
concentrations of virus in tissues appears clinically to be a new 
manifestation of PCV2b viremia. Several laboratory tests are still 
pending. 
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Co-infections in PMWS ﬁ eld cases in Italian herds
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Introduction and Objectives
Porcine Circovirus type 2 (PCV2) is a worldwide endemic viral 
pathogen of swine, associated with Postweaning Multisystemic 
Wasting Syndrome (PMWS). PCV2 infection is essential to the 
development of PMWS, but other co-factors can infl uence the 
evolution of PCV2 infection (1). Between these co-factors there 
are co-pathogens. An enhancement of PCV2 viral load, severity 
of the lesions and incidence of PMWS have been highlighted 
when PCV2 co-exists with other swine pathogens like PRRSV 
or Mycoplasma hyopneumoniae (2,3). Through the diagnostic 
outcome of investigations, carried out between January 2007 
and August 2009 at IZSLER-Brescia, the aim was to determine 
the prevalence of several viral and bacterial swine pathogens, 
frequently associated with PCV2 in PMWS cases. 
Material and Methods
193 PMWS aff ected pigs, from 92 farms, were investigated for 
other swine pathogens. For diagnosis of PMWS was applied a 
protocol according to Opriessnig et al., 2007(1). For PRRSV was 
applied a reaction One-Step RT-PCR multiplex with specifi c prim-
ers, described by Persia et al., 2001(4). For SIV a RT-PCR accord-
ing to the protocol described by Spackman et al., 2002(5). For 
Mycoplasma hyopneumoniae a PCR according to the protocol 
described by Stakenborg et al., 2006(6). For Lawsonia intracellu-
laris a PCR as described by Jone et al., 1993(7). For Haemophilus 
parasuis was applied a PCR described by Angen et al., 2007(8). 
Isolation of bacterial agents was performed by routine culture 
procedures. 
Results and Discussion
The viral and bacterial pathogens identifi ed in PMWS aff ected 
pigs are reported in the table below. 
The co-pathogens association are shown in Graphic 1.
Farms with PMWS problems in which also PRRSV was high-
lighted were 81/92 (88%); 68,9% was previously described in 
PMWS aff ected Italian farms (9). PRRSV was detected in 91,2% of 
PMWS aff ected pigs. PRRSV was the pathogens more frequently 
associated with PCV2 also in fi eld cases in US (51,9%) and in 
Netherlands ( 83%) (10,11). In case of septicemia and enteritis 
E.coli was the most frequent bacteria, in pneumonia cases P. 
multocida . PCV2 alone was highlighted only in the 2,1% of 
PMWS cases, which is consistent with the theory according to 
which other co-factors are required for PMWS development. 
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Introduction
There is pressure to minimize antibiotic use in food-producing 
animals due to the risks of selecting resistant strains of bac-
teria. In Denmark, pressure to reduce macrolide antibiotics has 
resulted in a tendency to increase the use of tetracyclines.1 Most 
antibiotics are used to treat intestinal infections of grower (>10 
weeks) pigs, thought to be caused by Lawsonia intracellularis 
(L. intracellularis) and/or Porcine Circovirus Type 2 (PCV2). Our 
hypothesis was that individual treatment of diarrhoeic pigs for 
three days with an oxytetracycline antibiotic would reduce diar-
rhoea and the faecal shedding of L. intracellularis and/or PCV2.
Materials and Methods
Forty grower pigs were selected on each of six farms (total of 
240 pigs) in Denmark for a case-control study. Each pig was ear-
tagged and assessed for faecal consistency (normal, loose, fl uid). 
Approximately half of the pigs had loose or fl uid faeces and 
were classed as “diarrhoeic”. Faecal samples were collected from 
each pig and tested using real-time PCR specifi c for PCV2 and L. 
intracellularis.2,3 Half of the pigs in each group were randomly 
selected on Day 1 and injected for three consecutive days with 
oxytetracycline (Engemycin, Intervet). Pigs were re-assessed on 
Day 4, when repeat faecal samples were collected. The eff ect of 
oxytetracycline treatment on faecal PCV2 quantity (negative/
low versus moderate/massive), and L. intracellularis bacterial 
quantity (negative/low versus moderate/massive) on Day 4 were 
analysed, with diarrhoea status (+/-), PCV2 quantity and L. intra-
cellularis quantity on Day 1 included as fi xed eff ects. All analyses 
were conducted using generalized linear mixed models, with 
pen and farm as random eff ects (Genstat 11th edition). 
Results
Two farms had no pigs with moderate/massive PCV2 results in 
faeces. One farm had no pigs with a negative/low faecal PCV2 
result. Two farms had pigs with no moderate/massive L. intra-
cellularis results. There appeared to be within-pen clustering of 
PCV2 infection on Day 1, with all or no pigs in some pens being 
infected. This was also true for L. intracellularis on Day 4. Hence, 
pen was removed from subsequent analyses involving these 
variables. Pigs that had diarrhoea on Day 1 and had not been 
treated with oxytetracycline had 2.6 (95%CI 2, 3.2) times the 
odds of having diarrhoea on Day 4 than pigs that were treated 
(p<0.05). The farms where no pigs had moderate/massive quan-
tities of PCV2 and/or L. intracellularis were excluded from analy-
ses of associations between the two pathogens. Oxytetracycline 
treatment and PCV2 quantity on Day 1 did not aff ect PCV2 
quantity on Day 4 (p>0.05). There were no signifi cant associa-
tions between the quantities of L. intracellularis bacteria on Days 
1 and 4 (p>0.05). However, treated pigs had 0.076 (95% CI 0.03, 
0.19) times the odds of having moderate/massive quantities of L. 
intracellularis on Day 4 than non-treated pigs. 
Discussion
These preliminary results suggest that oxytetracycline treat-
ment of growing pigs did not aff ect the quantity of PCV2 shed 
in faeces. Treating pigs for three consecutive days with inject-
able oxytetracycline reduced the incidence of diarrhoea and the 
quantity of L. intracellularis shed in faeces, suggesting that this 
pathogen played a role in causing diarrhoea, and that the treat-
ment was eff ective. 
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Presence of porcine circovirus type 2, Lawsonia intracellularis and 
Brachyspira hyodysenteriae in pigs with diarrhoea
Anna Szczotka; Jacek Zmudzki; Zygmunt Pejsak; Tomasz Stadejek
National Veterinary Research Institute, Pulawy, Poland
Introduction
The aim of the study was to analyze the presence of porcine cir-
covirus type 2 (PCV2) in cases of antibiotic non-responsive diar-
rhoea and to evaluate the possible role of the virus in develop-
ment of enteritis in pigs. For diff erential diagnosis identifi cation 
of Lawsonia intracellularis (L. intracellularis) and Brachyspira 
hyodysenteriae (B. hyodysenteriae) was performed.
Materials and Methods
Internal organs and feces were collected from 76 pigs, 5 – 19 
weeks old, from 50 farrow-to-fi nish farms, PMWS-positive or 
PMWS-suspected. Sections of lymph nodes and intestines 
(ileum, caecum and colon) were analyzed for presence of 
PCV2 DNA by in situ hybridization test (ISH) (2). They were also 
hematoxilin-eosin (HE) stained for standard histopathological 
examination. Addtionally, fecal samples were tested for presence 
of B. hyodysenteriae and L. intracellularis by PCR (3).
Results
In samples from 37 pigs, 10 – 17 weeks old, large amounts of 
PCV2 DNA, typical for PMWS, were detected in lymph nodes 
by ISH. In this group, in samples from 19 pigs, PCV2 was also 
found in abundant amount in samples of ileum. The remaining 
18 pigs, PCV2-positive in lymph nodes, were negative in ileum. 
In samples from only 1 animal lymph nodes were negative for 
PCV2 in ISH, but virus was detected in considerble amount in 
ileum. In HE stained sections of lymph nodes histopathological 
lesions characteristic for PMWS were identifi ed. Similar lesions 
were observed in PCV2-positive samples of ileum. Seventy 
samples of feces were negative in PCR for B. hyodysenteriae 
and L. intracellularis. DNA of L. intracellularis was found in feces 
from 3 pigs and mixed infection caused by both bacteria was 
detected in 3 animals
Discussion 
According to the obtained results in PMWS-aff ected pigs similar 
lesions could be observed both in lymph nodes and in ileum 
and they correlate with clinical outcome of disease. Also, it was 
found that presence of PCV2 in ileum could be correlated with 
diarrhoea in PMWS- free animal, which confi rms that the emer-
gence of this virus as an intestinal pathogen may represent a 
new phenomenon (1). In the animals negative for B. hyodysente-
riae and L. intracellularis and PCV2 other causative agents of 
diarrhoea should be considered. Futher investigation on larger 
number of samples needs to be performed to confi rm the role of 
PCV2 as an etiological agent of diarrhoea in pigs.
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Co-infection between porcine circovirus type 1 (PCV1) and genogroups 1 and 2 of porcine 
torque teno virus (TTV) in fetuses naturally infected by porcine circovirus type 2 (PCV2)
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Introduction 
Porcine circovirus 2 (PCV2) associated diseases (PCVAD) in-
cludes reproductive failures (1). PCV2 DNA has been detected 
by nested-PCR in organs of fetuses naturally infected (8,5). In 
contrast PCV1 has not been associated with pathologies in pigs. 
Another DNA circular virus, porcine torque teno virus has also 
been detected in swine, with at least two genogroups, TTV1 and 
TTV2 (7). Recent studies have shown a possible role of TTV in in-
creasing clinical signs and severity of lesions caused by PCV2 on 
piglets (3). The objective of this work is to study the co-infection 
of both porcine circular DNA viruses, TTV1, TTV2 and PCV1 in 
organs from fetuses naturally infected by PCV2, aiming to verify 
the importance of them.
Material and Methods
Organs from 29 fetuses, previously tested for PCV2, from 11 
swine farms, were processed to detect PCV1, TTV1 and TTV2 
nucleic acids. Samples of heart, lung, liver, kidney, lymphoid 
organs and nervous tissues were tested by nested-PCR. Nested-
PCR reactions were performed using specifi c primers to detect 
sequences of PCV1, TTV1 and TTV2 as previously described (3, 
4). 
Results
Organs samples of 29 fetuses were tested by nested-PCR and 
PCV1 DNA was detected in 8 (27.6%) of them. In addition, TTV1 
and TTV2 was detected in 7 (24.1%) and 24 (82.8%) fetuses 
respectively (Figure 1), and viral sequences were found in several 
tested organs. 
Discussion
These results show the occurrence of TTV1 and TTV2 in analyzed 
samples, indicating its importance of TTV co-infections with 
PCV2. In swine, TTV alone has not showed to be pathogenic, but, 
its role in co-infections with other pathogens has been investi-
gated. 
Recent studies showed the fi rst indications of TTV in utero 
transmission to piglets (6). Other studies claim that TTV is widely 
spread in Spain and could be associated with PCV2 infections 
(5). Porcine TTV infections are also widespread in herds of the 
USA, Canada, China, Korea and Thailand (9). Multiple infections 
of novel four U.S prototypes of porcine TTV in a single pig also 
have reported (10), suggesting that these co-infections are 
important for disease severity. The co-infection of TTV and PCV2 
in piglets from Brazilian herds has also been reported (2). These 
fi ndings raise the question of the importance of PCV and TTV 
co-infection in the pathology of PCVAD associated reproductive 
failures and vertical transmission in swine farms.
Figure 1. Detection of PCV1, TTV1 and TTV2 DNA in organs samples 
from PCV2 positive fetuses.
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Relationship of histopathology and PCV2 detection in fetal and neonatal 
myocardium from cases of reproductive failure in sows
Karina Enriquez; Victor Quintero; Ignacio C. Rangel-Rodriguez; Yolanda Romero; Miguel A. Perez-Razo; Lucia A. Garcia-Camacho
FESC-UNAM, Cuautitlán, MEX, Mexico
Introduction
Porcine Circovirus type 2-associated reproductive failure (PCV2-
RF) is characterized by increased abortions, stillbirths and neo-
natal mortality. Transplacental trasmission is acknowledged and 
the most consistent lesion in the fetus of PCV2-RF is a non-sup-
purative myocarditis with intralesional PCV2 5, 6, 7 PCV2-RF has 
been described without co-infection with porcine parvovirus 
(PPV), encephalomyocarditis virus (EMCV) and porcine respira-
tory and reproductive syndrome virus (PRRSV)1,5 The aim of the 
present work was to determine PCV2 role in RF development. 
Materials and Methods
In order to assess the role of PCV2 in reproductive failure in 
Mexico, 107 hearts (predominantly fetal samples) with presump-
tive diagnosis of PCV-RF were evaluated by standard proced-
ures of histopathology and in-situ hybridization (ISH) using a 
digoxigenin-labelled PCR- derived probe specifi c for PCV2. Cases 
were grouped as follows: Fetuses with myocarditis (Group 1), 
fetuses without myocarditis (Group 2), stillborns/neonates with 
myocarditis (Group 3), and stillborns/neonates without myo-
carditis (Group 4). Among these 107 cases, 50 were selected to 
perform nested PCR from paraffi  n-embedded samples. The data 
were analized by Chi-square test, Cramer coeffi  cient and analysis 
of variance for categorical data. The later was used to evaluate 
cardiac lesion degree and PCV2 distribution. 
Results
Microscopically, 48 cases (45%) exhibited non-suppurative 
myocarditis, of which 35/48 were PCV2 positive (73% of cases 
with myocarditis, 32.7% overall) and 13 were PCV2 negative 
(27% of cases with myocarditis, 12.4% overall). There were 5 
(4.67%) fetal cases PCV2 positive by ISH with no myocarditis. 
A diagnosis of myocarditis and a positive ISH showed a high 
relationship (J2<0.005 y Cramer coeffi  cient= 0.64) revealing that 
both tests are comparable for disease diagnosis. Twenty out of 
107 additional cases, regardless of myocarditis, were detected by 
PCR, increasing to 55 (51.4%) the cases positive to PCV2, 42/107 
(38.75%) with miocarditis and 13 cases (9 fetal) without myocar-
ditis. In total, 50 fetal cases were PCV2 positive. The myocarditis 
severity was mild to moderate in groups 3 y 4, and moderate 
to severe in fetal tissues. The lesion severity was statistically 
signifi cant, showing values of P=0-04 y P= 0-0001 for 1-3 and 2-4 
groups, respectively. The HIS signals were mild, variable sized 
and randomly distributed (Figures 4-5), precluding a statistical 
analysis. 
Discussion
The use of histopathology as screening test is highly recom-
mended but association to PCV2-RF must be confi rmed by ISH 
and/or PCR. Few viral agents produce both non-suppurative 
myocarditis and RF1,7 Therefore, 33-39% cases are compatible 
to PCV2-RF, based on criteria diagnosis, and the vertical trans-
mission was of 46.72% (50/107 fetal samples) which is higher 
than previous reports2,3,4,9 Cases with myocarditis but PCV2-
negative suggest a separate, unknown etiology. Furthermore, no 
other viruses could be examined since only cardiac tissues were 
submitted, Therefore, co-infection cannot be entirely excluded. 
PCV2 relies on cell mitotic activity and DNA polymerase avail-
ability7,8,10 Our fi ndings are in agreement, because the lesion 
severity was age-dependent. The ISH signals suggest low viral 
load. Thus, real-time PCR is being performed to assess the rela-
tionship between lesion severity and viral load. 
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Natural infection of porcine circovirus type 2 (PCV2) in fetuses from sows with reproductive failures
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Introduction 
Porcine Circovirus Type 2 (PCV2), etiologic agent of PCVAD 
or PCV2 associated diseases, can cause reproductive failure 
in swine (1, 4, 5). PCV2 has been detected in farms with high 
occurrence of aborted, mummifi ed and stillborn fetuses, and 
viral DNA and antigen has been detected by nested-PCR and 
immunohistochemistry (IHC), respectively, in organs from fetus-
es naturally infected (4,6). In order to study the pathogenesis of 
the disease in Brazilian swine herds, the objective of this work is 
to study the natural infection of PCV2 in organs of fetuses from 
sows with reproductive failures.
Material and Methods
Samples from fi eld cases, as aborted fetuses, mummifi ed, still-
born and fragile piglets were collected and processed in order 
to detect PCV2 DNA and antigens. Samples were collected from 
21 farms previously identifi ed with occurrence of reproductive 
losses, and a total of 169 fetuses were necropsied. Fragments 
of organs, including heart, lungs, liver, kidney, lymphoid organs 
and nervous tissues were processed for viral and histopatho-
logical diagnostic. For viral isolation, DNA was extracted and 
nested-PCR reactions were performed using specifi c primers 
to detect sequences of PCV2 as previously described (3). For 
histopathological examination, organs were fi xed in 10% buf-
fered formalin and embedded in paraffi  n, sectioned at 5μm thick 
and stained with hematoxylin and eosin for light microscopical 
examination. Moreover, viral presence was confi rmed by IHC, 
carried out as previously described (2) and performed in tissues 
that resulted positive by PCR.
Results
Organs samples of 169 fetuses were tested by nested-PCR and 
PCV2 DNA was detected in 29 (17.1%) of them. Viral sequences 
were found in several tested organs. Microscopic lesions were 
found in 15.4% of the samples, mainly on heart and lymphoid 
organs, with the presence of infi ltration of infl ammatory cells, 
syncytial cells and varying degrees of lymphocellular depletion. 
In addition, IHC was performed and viral antigen was detected 
in 17 out of 29 positive fetuses (58.6%).
Discussion
These results show the occurrence of natural infection of PCV2 
in analyzed samples, confi rming the importance of PCV2 infec-
tion in reproductive failures. Among the analyzed samples, heart 
was the organ where PCV2 DNA was most frequently detected, 
following by lymphoid organs and nervous tissues, which 
agree with results reported by others studies (5,6). Genomic 
sequencing analyses are underway to classify the diff erent PCV2 
isolates. By IHC staining it was observed a variable amount and 
distribution of viral antigen in tissues, and positive cells were 
found most commonly on macrophages (Figure 1). These fi nd-
ings raise the question of the importance of PCVAD associated 
reproductive failures and vertical transmission in swine farms.
Figure 1. Detection of PCV2 by nested-PCR and IHC in organs from 
fetuses
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Distribution of porcine parvovirus type 2 (PPV2, Myanmar erythrovirus) and porcine 
hokovirus (PHoV) in pigs from post-weaning multisystemic wasting syndrome (PMWS)-
aﬀ ected and non-aﬀ ected farms in archival samples from UK and Republic of Ireland
John McKillen1 John P. McKillen1 Michael McMenamy2 Irene McNair1 Gordon Allan1
1. Agri-Food & Biosciences Institute, Belfast, UK; 2. Department of Veterinary Science, The Queen’s University of Belfast, Belfast, UK
Introduction
In 2001 PPV21, a novel parvovirus related to the genus erythro-
virus, family Parvoviridae was detected in swine from Myanmar. 
PHoV2 is also a member of the family Parvoviridae and along 
with bovine hokovirus (BHoV) and PARV4 form a distinct cluster 
within the family Parvoviridae. This has been proposed as a 
separate genus, Hokovirus. Porcine circovirus type 2 (PCV2) is 
the causative agent PMWS3. PMWS does not however, always 
occur in PCV2 infected pigs. It is likely that other agents may 
contribute to the development of PMWS. Here we investigate 
the distribution of PPV2 and PHoV in archival PMWS-aff ected 
and non-aff ected tissue and serum samples recovered from pigs 
in the UK and Republic of Ireland from 2000 to 2006. 
Materials & Methods
44 sera samples were collected from pigs on PMWS-aff ected 
UK farms. Also tissues were taken from 64 PMWS-aff ected pigs 
and 55 non PMWS-aff ected pigs, from the UK and Republic of 
Ireland. Tissues included lung, liver, kidney, spleen and lymph 
nodes. Viral nucleic acids were extracted from sera and 10% 
homogenised tissue samples using Roche MagNA Pure LC. All 
tissue and sera samples were analysed by real-time QuantiTect 
SYBR Green I PCR for the presence of PPV2 and PHoV using 
in-house specifi c primers designed against deposited GenBank 
sequences. Between 1 and 4 tissues were tested for each animal. 
A selection of positive amplicons was cloned into TOPO TA vec-
tors and sequenced using standard protocols. Sequences were 
compared to GenBank using nucleotide BLAST.
Results
With one exception all tissues tested positive in any positive 
animal. Generally PPV2 was present in signifi cantly higher 
amounts than PHoV as judged by Ct values, as well as being 
more prevalent. Both PPV2 and PHoV were more prevalent in tis-
sues of non-PMWS-aff ected pigs. Sequencing of the amplicons 
confi rmed the specifi city of the PCR. No data was available for 
sera from PMWS -ve farms. Tables 1 and 2 show the % of animals 
testing +ve for the two viruses in relation to their PMWS status.
Table 1. % of PMWS-aff ected and non-aff ected pigs with tissues test-
ing PCR +ve for PPV2 and PHoV.
Tissue Results PPV2 +ve animals PHoV +ve animals
PMWS +ve 26.6% (17/64) 4.9% (3/64)
PMWS -ve 54.5% (30/55) 9.1% (5/55)
Total 39.5% (47/119) 6.7% (8/119)
Table 2. % distribution of PPV2 & PHoV in sera from PMWS- aff ected 
farms.
Sera Results PPV2 +ve PHoV +ve
PMWS +ve farms 18.2% (8/44) 15.9% (7/44)
Discussion
PHoV was detected in only 6.7% of tissue samples and 15.9% of 
sera samples tested in this study. In Hong Kong2 44.4% of por-
cine samples tested +ve for PHoV. PPV2 was detected in 39.5% 
of the tissues tested and 18.2% of the sera, as opposed to 10.5% 
of tested sera from Myanmar1. These preliminary studies suggest 
that the distribution of these viruses could be widespread and 
that the extent and geographical range should be further inves-
tigated. The signifi cance of these viruses in terms of swine health 
is not known. Their role as potential pathogens or as co-factors 
in other disease complexes such as PMWS merits further inves-
tigation although higher prevalence in PMWS-aff ected animals 
and farms has not been shown in this study.
References
1.  Hijikata, M. et al. 2001. Jpn. J. Infect. Dis. 54, 244-245.
2.  Lau, S.K.P. et al. 2008. J. Gen. Virol. 89, 1840-1848.
3.  Allan, G.M. et al. 2007. J. Vet. Diag. Inv. 19, 668-73.
Porcine Circovirus Associated Diseases (PCVAD) – Clinical
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 470
Poster Presentations
P.164
Reproductive failure associated to PCV2 and its distribution in the Mexican Republic
Victor Quintero; Yolanda Romero; Karina Enriquez; Lucia A. Garcia-Camacho
FESC-UNAM, Cuautitlán, MEX, Mexico
Introduction
Porcine circovirus type 2 (PCV2) has been associated to repro-
ductive failure (RF) promoting increases of infertility abortions, 
stillborn, mummifi cations as well as a marked increase on pre-
weaning mortality. 1,4,5 The most consistent microscopic lesions 
are non suppurative miocarditis with perivascular and instertitial 
mononuclear infi ltrates, degeneration and necrosis of myocytes 
and myocardium fi brosis. The association to PCV2-RF is con-
fi rmed by reproductive failure to PCV2 is by immunohistochem-
istry, in situ hybridization (ISH), and PCR in cardiac samples.1,3,5
Material and methods 
The aim of this work was to determine the non-suppurative 
myocarditis positivity and PCV2 status as well as the locality of 
origin of cases presented for histopathology diagnosis in the 
Pathology Department of FES-Cuautitlan, UNAM during the 
period of 2006-2008. The heart samples were formalin-fi xed 
and paraffi  n-embedded for routine microscopic evaluation. The 
PCV2 detection from non-suppurative myocarditis positive cases 
was done by ISH using a specifi c digoxigenin-labelled PCR- de-
rived probe. 
Results
A total of 269 heart samples from fetuses and stillborn from 
39 cases from diff erent Mexican states were microscopically 
evaluated. The case distribution regarding origin, myocarditis 
positivity and PCV2 status is shown in Table 1. Microscopically, 
120 cases (44.6%) exhibited varying degree of non-suppurative 
myocarditis, of which 100/120 were PCV2 positive (83.3%) by 
ISH. The lesions consisted of perivascular and/or interstitial 
accumulation of lymphocytes and macrophages, myocardial de-
generation, necrosis, and/or fi brosis. Additionally, subepicardial 
and subendocardial congestion, edema and hemorrhage were 
observed. Concerning the sample origin, the states with higher 
case frequency, such as Veracruz and Jalisco, exhibited lower 
proportion of myocarditis. 
Discussion
Our fi ndings strongly support the role of PCV2 as a cause of 
RF in Mexican farms since PCV2 was detected throughout the 
country. In fact, PCV2 was present in the Mexican central states, 
such Guanajuato, Michoacan and Jalisco where are located the 
main porcine production areas. Furthermore, the proportion 
of PCV2 in fetal and neonatal tissues is in agreement of reports 
elsewhere.2,5 In this study, no other viruses could be examined 
since the submitted samples were exclusively hearts. Therefore, 
co-infection cannot be entirely excluded. In fact, the low ratio of 
myocarditis and/or PCV2 positive cases in states with high case 
frequency suggests that the cause of abortion must have been 
diff erent from PCV2. Thus, co-infection with other agents such as 
PRRSV, porcine parvovirus, Aujezsky virus and porcine rubula-
virus must be considered. 
Table 1. Relation of Study Cases (Period 2006-2008) 
STATE Nº SAMPLES MYOCARDITIS (+) ISH (+)
CHIAPAS 18 8 8
EDO MEX 18 13 9
GUANAJUATO 17 9 7
HIDALGO 10 7 6
JALISCO 48 18 14
MICHOACAN 38 20 17
NAYARIT 2 2 1
PUEBLA 2 2 2
QUERETARO 8 5 4
SONORA 21 16 13
VERACRUZ 83 18 17
YUCATAN 4 2 2
TOTAL 269 120 100
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Introduction
Several reasons determine the removal of sows from a swine 
herd. Sows are culled when they are considered unsuitable for 
further production and reproductive failure is the predominant 
cause, ranging between 13 – 49% of removals (1). Infectious 
causes of reproductive failures vary, however many can be due 
to viral agents (1). Among them the single stranded DNA (ss-
DNA) viruses play an important role in the co-infections of these 
diseases. Porcine circovirus 2 or PCV2 (2), porcine parvovirus or 
PPV (7) and porcine torque teno virus (TTV) with at least two 
genogroups, TTV1 and TTV2 (3) have been identifi ed in swine 
fetuses and sows tissues as the cause of infectious reproductive 
failures. Although a member of the Circoviridae family, PCV1 has 
not been associated with pathologies in pigs, but it is also an 
agent to be included in co-infections. Other viral agents, such 
as porcine reproductive and respiratory virus (PRRSV) can cause 
signifi cant losses, but are not present in Brazilian swine herds 
(4). Thus, the objectives of this work is to detect the infection 
by porcine ssDNA viruses, PCV2, PCV1, PPV, TTV1 and TTV2 in 
reproductive organs of culled sows, aiming to verify the import-
ance of them in those sites.
Material and Methods
Reproductive organs from 83 culled sows, from four slaughter-
houses of Santa Catarina State, were collected. The reason of 
their removal was not particularly due to reproductive failures. 
A total of 71 samples of ovarian follicular fl uid (OF) and 83 frag-
ments of ovaries and 83 fragments of uterus were processed for 
DNA extraction followed by amplifi cation of PCV2, PCV1, PPV, 
TTV1 and TTV2 nucleic acids. Nested-PCR reactions were per-
formed using specifi c primers as previously described (5, 6, 7). 
Results
Organs samples such as ovaries, uterus and ovarian follicular 
fl uids (OF) of 83 culled sows were tested individually by nested-
PCR for ssDNA viral amplifi cation of PCV2, PCV1, PPV and TTVs. 
PCV1 DNA was detected in 14 (16.9%) of sows organs. Nucleic 
acids of PCV2 were amplifi ed from 5 (6.0%) sows. TTV1 and TTV2 
were detected in 25 (30.1%) and 41 (49.3%) sows respectively. 
For TTV2 particularly, 27 samples (38%) tested positive in OF, 
19 (23%) in ovaries and 14 (17%) in uterus. Viral sequences of 
PPV were amplifi ed in 6 (7.2%) sows. In some cases, the occur-
rence of co-infections between viral agents in sampled sows was 
observed.
Discussion
The present study demonstrates the occurrence of infection of 
porcine ssDNA viruses in reproductive organs of culled sows. 
These results show higher prevalence of TTV1 and TTV2 in ana-
lyzed samples, indicating its importance, mainly in co-infections 
with PCV2. TTV2 is more frequently related to PCV2 associated 
diseases (PCVAD) compared to TTV1 in Spain (77% prevalence) 
(5). Other reports indicate that TTV1 viral infection facilitates 
PCVAD (8). In swine, TTV alone has not showed to be pathogen-
ic, but, its role in co-infections with other pathogens has been 
investigated. Recent studies showed the fi rst indications of TTV 
in utero transmission to piglets (3). PPV has been associated with 
PCV2 and other swine virus such as PRRSV in samples of piglets 
born from sows with reproductive failure from China and Korea 
(9, 10). These fi ndings raise the question of the importance of 
these viral infections in the pathology of reproductive failures 
and vertical transmission in swine. 
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Introduction 
Porcine circovirus diseases (PCVDs) are nowadays considered as 
a signifi cant international problem due to increased mortality 
rates and reduced feed conversion effi  ciency in weaning and 
fattening pigs at the worldwide (Segalés et al., 2005). The Post-
weaning multisystemic wasting syndrome PMWS is economic-
ally the most important disease included within this group. This 
new disease syndrome was fi rstly identifi ed in Canada in 1991 
(Clark, 1997; Harding, 1997) since then, the PWMS has been 
report in many part of the word (LeCann et al., 1997; Segalés et 
al., 1997; Kennedy et al., 1998). 
Materials and Methods
Thirty three pigs from fi ve farms were investigated. Clinical signs 
evaluated included body condition, presence of respiratory and 
digestive clinical signs (coughing, dyspnea and diarrhoea), be-
haviour (depression), skin pallor, and enlargement of superfi cial 
inguinal lymph nodes. The farms were located in three diff erent 
provinces of Cuba. Aff ected pigs were aged 7–15 weeks. Morbid-
ity on the fi ve farms ranged from 10–25%; mortality was at least 
50% of aff ected animals on all farms. Samples of tonsil, lung, 
kidney, spleen, jejunum, ileum, colon, liver and lymph nodes 
(including superfi cial inguinal and mesenteric) were collected 
and fi xed by immersion in 10% neutral buff ered formalin. One 
section was processed for routine histopathology and stained 
with haematoxylin and eosin. The second tissue section was 
processed for PCV2 nucleic acid detection by in situ hybridiza-
tion (ISH). On the other hand the other section was processed 
for immunohistochemistry. Tissues were evaluated for presence 
or absence of the PMWS (Segalés et al., 2005) specifi c lesions.
Results
The discoveries anatomophatology included the widespread 
increase of the lymph nodes, especially superfi cial inguinal and 
mesenteric, witnesses of whitish diff use stains in the liver and 
kidneys and, consolidation of the lobes lung. Histopathological 
changes were characterised by depletion of lymphocytes in the 
interfollicular areas and follicular centres. Infi ltration by macro-
phage and multinucleate giant cells were also observed in the 
lymph nodes. 
Porcine circovirus (PCV-2) antigen and nucleic acid were regu-
larly found in lymphoid organs. In lymph nodes, depletion was 
observed within lymphoid follicles or in the paracortical zones. 
PCV-2 antigen was detected in 23 pigs. In all tissues examined 
was most frequently seen in the cytoplasm of cells. Nuclear 
labelling was less commonly seen but occasionally appeared 
to be almost as abundant as cytoplasmic labelling. The smooth 
muscle trabeculae of the spleen were occasionally labelled. 
PCV-2 nucleic acid was detected in most of the pigs was found 
mostly in the cytoplasm of infected cells, and to a lesser extent 
in the nucleus. 
Discussion
This is the fi rst diagnostic of the PMWS in Cuba, based on all 
three accepted diagnostic criteria (Segalés et al., 2005) for the 
case defi nition of this disease syndrome. The pigs evaluated 
showed the clinical signs compatible with this illness. Besides, 
lesions on lymphoid tissues were found. Moreover, the presence 
of the PCV2 within these lesions in moderate or high amounts 
of the virus was observed. This study describes the pathological 
fi ndings in 23 natural cases of PMWS, together with the tissue 
distribution of PCV antigen and nucleic acid. Pigs were classifi ed 
as cases of PMWS on the basis of macroscopical and microscop-
ical lesions, and the detection of PCV antigen or nucleic acid 
(Segalés et al., 1997).
In Cuba, PCV2 infections of the swine herds have been described 
recently (Pérez et al., 2009). In addition, co-infection PCV2/PPV in 
several farms of the diff erent geographic region of the coun-
try was found (Pérez et al., 2009). On the other hand, classical 
swine fever is an endemic disease in Cuba. The use of vaccina-
tion is an important tool for combat against outbreaks of this 
disease. Nevertheless, if the vaccinations against classical swine 
fever virus can act as trigger fact of PMWS will be needed to be 
explained. 
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Introduction
Porcine circovirus type 2 (PCV2) is ubiquous in swine herds over 
the world. It is associated with diff erent disease and syndromes 
in pigs mainly to postweaning multisystemic wasting syndrome 
(PMWS). In Brazil, PCV2 was fi rst identifi ed in South region,, in 
2000 and in other regions later on. All Brazilian’ studies were 
conducted in commercial and intensive raising systems animals 
(Ciacci-Zanella et al., 2003; Ruiz et al., 2004). In peripheral areas 
of large cities in Brazil, it is common to create a few pig herds 
(backyard pigs), for own consumption, under poor hygienic and 
sanitary conditions and in close contact with others animals 
species and humans. This swine population is a unique type of 
extensive raising swine system (ERSS). At our knowledge, no 
other study was done to verify PCV2 infection in these swine 
population. The present study was performed to identify PCV2 
DNA in clinical specimens of pigs in Goiás State, Brazil ERSS’s. 
Material and Methods
A total of 200 serum samples from swine of diff erent age groups 
were collected from 25 ERSS in Goiás state. Tissue samples 
(lymph nodes, lungs, liver, brain, kidney and spleen) from 5 pigs 
with growth impairment and 6 pigs with signs of neurological 
disease were also included. Viral DNA was extracted with stan-
dard phenol-chloroform-isoamyl alcohol extraction procedure. 
Previous described specifi c primers to ORF2 region of PCV2 
[F5’-CGGATATTGTAG TCCTGGTCG-3’] and [R5’-ACTGTCAAGGC-
TACCACAGTC A-3’] and PCR conditions were used for DNA PCV2 
identifi cation (Kim et al., 2001). A fragment of 480pb length was 
expected. 
Results and Discussion
Out of the serum samples, 57 (28.5%) were positive. This fre-
quency is lower than that observed in other studies (Casalmiglia 
et al., 2002; Grau-Roma et al., 2008) although it may represent 
the occurrence of PCV2 infection in this particular type of 
swine herd. Seven (63.6%) of the eleven animals tested showed 
positivity in at least one tissue sample. Viral DNA was found in 
inguinal nodes (6/7), lung (1/7) and kidney (1/7). Other authors 
also found high frequency of identifi cation of PCV2 DNA in 
inguinal lymph nodes and assert that they are one the main tar-
gets for PCV2 replication (Yu et al., 2007). Despite viral DNA had 
been found in two fragments of pigs with growth impairment 
it is not enough to ensure the occurrence the syndrome. This 
also should be associated with clinical signs and pathological 
fi ndings (Segalés et al., 2003). The results here presented may 
point out that PCV2 occur in pigs under extensive raising system 
in Goiás, Brazil. 
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Introduction
Torque Teno virus (TTV) is a non-enveloped, circular, single 
stranded DNA virus that may infect human, non-primate and 
domestic species including swine. Two TTV genogroups (TTV1 
and TTV2) have been described in pigs. TTV is considered non-
pathogenic, but a recent study has shown an increased preva-
lence of TTV2 in PCV2-associated diseases compared to non-
aff ected ones (2,3). In Brazil PCV2-associated disease is expected 
to diminish with the introduction of PCV2 vaccination. However, 
PCV2-associated disease is still a problem in swine herds. Since 
the main virus, PRRS, involved in the co-infection of PCV2 to the 
development of the disease, is absent in Brazil, others agents 
became important. Nowadays, there are few information about 
TTV in Brazilian swine herd. Therefore, the aim of this work is to 
describe, for fi rst time, the detection of co-infections of TTV2 
and PCV2 in a high health swine herd. 
Materials and Methods
Twenty and six serum samples were collected from sows from 
a high health herd located in São Paulo state, Brazil. DNA was 
extracted from serum using the phenol:chloroform Proteinase 
K protocols. TTV DNA was amplifi ed a fragment of 250 bp using 
a PCR with primers targeting two conserved domains within an 
untranslated region of the viral genome (4). The detection of 
PCV-2 was performed by PCR using primers Fa/Ra that amplify 
a 476 bp fragment (1). One sample was randomly selected and 
sequenced. Nucleotide sequences were aligned with sequences 
contained at the GenBank database of the swine TTV and phylo-
genetic tree constructed. 
Results
TTV2 was detected in 14 (58.3 %) out of the 24 serum samples 
examined. Among the 14 TTV2 positive samples, fi ve (5/9) was 
co-infected with PCV2. PCV2 alone was detected in fi ve sow 
serum samples (Fig. 1). The alignment of the TTV2 sequence ob-
tained in this study showed nucleotide and amino acid identities 
values of 91.6 % to 82.4 % and 61.0 to 64.6 % with available Gen-
Bank sequences of TTV2 and TTV1, respectively. A Neighbour-
Joining tree was assembled and showed that this sequence had 
been classifi ed TTV2 group (Fig. 2). 
Figure 1: Demonstration of TTV2 and PCV2 positive serum samples 
collected in a high health herd in São Paulo state, Brazil.
Figure 2: Neighbour-Joining tree of the TTV2 non-coding region 
Numbers indicates values calculated on 1000 repeats of the alignment 
with the heuristic method. Sequences are indicated by their GenBank 
access number.
Discussion
This is the fi rst report of TTV-2 and PCV2 co-infections in Brazil-
ians pigs. The alignment of one sample confi rms that the TTV 
detected belongs to group 2. These results, also, demonstrated 
that TTV2 is circulating in high health swine herds in Brazil. 
Previous research showed higher prevalence of TTV2 in PMWS-
aff ected pigs than in healthy ones (2). The involvement of TTV2 
in the development of diseases associated with PCV2 is not clear, 
but the absence of PRRS in Brazil and the low detection of PPV 
in PCV2-associated disease, make TTV a possible candidate to be 
involved in disease cases.
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Introduction 
The temporal frequency and dynamic rate with which PRRS 
virus (PRRSv) transmits within and among swine populations is 
related to: [1] the inherent infectiousness of a particular PRRS 
viral isolate, [2] a plethora of environmental factors that infl u-
ence contact events and rates between infected and susceptible 
animals, and [3] host animal factors which enable or impede the 
occurrence of infection events and the resultant magnitude and 
duration of further transmission risk. Thus, one key compon-
ent of PRRSv transmission risk within a population would be 
the magnitude and duration of viral presence occurring within 
and emanating from infected pigs within a population. In turn, 
transmission risk among populations would be infl uenced by 
the magnitude and duration of viral presence occurring within 
and emanating from infected populations within areas, regions, 
fl ows and networks. The pig and population viral magnitudes 
and durations will be termed as “viral load”. To monitor transmis-
sion risk of PRRSv within and among areas, regions, fl ows and 
networks – as well as assess the impact of pig, population and 
area/regional-scale interventions – requires a means with which 
to reasonably estimate “viral load”. 
Estimation and monitoring of “viral load” in human medicine has 
moved beyond the confi nes of experimental research applica-
tion into routine operational use, having become a standard 
method with which to monitor the care of HIV patients and 
eff ectiveness of antiretroviral therapies.1 As in human medicine, 
monitoring of PRRS viral load holds potential for routine oper-
ational use to monitor the PRRS-related ‘care’ of populations, 
areas/regions and networks; and to assess the eff ectiveness of 
PRRS control and elimination interventions.
For PRRSv, quantitative RT-PCR (qRT-PCR) is currently used in a 
relatively limited manner to quantify viral load of experimentally 
challenged pigs. One factor that has limited broadening the use 
of qRT-PCR to a more routine operational use is the assay’s cost 
and diffi  culty with its interpretation. In contrast, the result of a 
non-quantitative real time RT-PCR assay (rtRT-PCR) is simply re-
ported as a Ct (cycle threshold) value.2 Although not technically 
a quantitative measure, Ct values have been used as a means 
with which to quantify a sample’s genetic material.3 
Materials and Methods 
Serum samples from three experimental PRRSv inoculation 
studies were obtained. Both PRRS qRT-PCR (Lab A) and rtRT-
PCR Ct (Lab B) testing were done on all samples and the results 
compared.
Results 
Figure 1: Scatterplot of 599 paired PRRS rtRT-PCR Ct and qRT-PCR 
Log10 testing results (R = -0.961, P<0.001).
Discussion 
Although not technically a quantitative measure Ct values gen-
erated by rtRT-PCR assays for PRRSv detection hold potential for 
use as a key component for monitoring viral load and tracking 
progress where PRRS control and elimination are being pursued. 
Clearly, further evaluation and refi nement is needed before 
rtRT-PCR Ct values are ready for broad application to monitor 
PRRS viral load within and among pig populations, across areas 
and networks, and over time. Standardization of methods for 
quantitative viral load estimation using Ct values will be needed 
within testing laboratories over time and among testing labora-
tories and the various rtRT-PCR assays – including accounting 
for the infl uence of PRRS genetic variation and assay component 
(e.g., primers) detection variation. Further, standardized (as well 
as inexpensive and convenient) sample procurement methods 
as well as methods for calculating valid aggregate viral load met-
rics progressing from animals within sampling, samplings within 
population, and populations within areas will be required. 
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Introduction
The points of interest of PRRS control programs are an early 
detection of disease, a rapid laboratory confi rmation and a 
reliable confi rmation of a negative herd status. The most used 
serological diagnostic tool for PRRS monitoring is the ELISA. A 
new product, the Ingezim PRRS DR (Ingenasa, Madrid, Spain) 
was developed, which is able to detect not only IgG but also 
IgM antibodies, which occur earlier in the course of infection. 
Furthermore, the high specifi city of this test should minimize 
the risk of false positive results in negative herds. The purpose 
of this study was to evaluate the performance of four European 
commercial tests. 
Materials and Methods
In total, 478 pig sera were analysed via four diff erent ELISA test 
systems (Ingezim PRRS DR (ING-DR) and Ingezim PRRS Universal® 
(ING-U), Ingenasa, Madrid, Spain, IDEXX HerdCheck® Porcine 
Reproductive and Respiratory Syndrome Virus Antibody Test Kit 
(ID), IDEXX Laboratories, Wörrstadt, Germany, Civtest suis PRRS 
E/S (CIV), Laboratorios HIPRA, S.A., Amer, Spain) according to 
the manufacturers’ specifi cations. 353 of these serum samples 
had been collected during routine diagnostic of 148 farms, 
16.4 % could be defi ned as “outliers”. An “outlier” was defi ned as 
possible false positive sample, which means single samples of 
randomly tested herds that were positive, while all other ana-
lysed samples were negative and showed a S/P (sample/positive 
control) ratio < 0.4 in the IDEXX ELISA. 125 sera were collected 
during a PRRSV challenge.
Results
The analysis via ING-DR showed a seroprevalence of 67.6 %, 
via ING-U of 56.3 %, via ID of 59.2 % and via CIV of 29.9 %. The 
correlations of the diff erent test systems and sample sets were 
expressed as Spearman’s coeffi  cient of correlation ρ (Table 1). 
When results from the four diff erent tests were compared, it was 
found that 24.1 % were positive in all four tests and 21.6 % were 
negative in all tests. 45.1 % showed no corresponding result. 
16.1 % of these non-corresponding results were outliers. 
Table 1: Spearman’s coeffi  cient of correlation ρ of the positive/
negative decisions of the complete sample set (a), outliers (b), sample 
set excluding the outliers (c) and challenge samples (d) (*level of 
signifi cance < 0.010)
ING-DR ING-U ID
(a) ING-U 0.678* —- —-
(a) ID 0.425* 0.513* —-
(a) CIV 0.414* 0.392* 0.421*
(b) ING-U 0.487* —- —-
(b) ID -0.344* -0.123 —-
(b) CIV 0.589* 0.553* -0.019
(c) ING-U 0.705* —- —-
(c) ID 0.525* 0.608* —-
(c) CIV 0.390* 0.375* 0.469*
(d) ING-U 0.917* —- —-
(d) ID 0.824* 0.869* —-
(d) CIV 0.444* 0.492* 0.532*
Discussion
This study underlines the complexity of PRRSV serology. The 
analysis of the coeffi  cient of correlation of the complete sample 
set showed diff erences between the ELISAs, which were even 
more distinctive comparing only the outliers. In contrast, the 
results improved essentially, when outliers were excluded of the 
calculation. The best correlation could be found evaluating the 
samples of the challenge, which were defi ned positive or nega-
tive. The ING-DR resulted in the highest seroprevalence because 
of its ability to detect IgM and IgG, but nevertheless its specifi -
city of 97.3 % should be suffi  cient to minimize the risk of false 
positive results. The diff erent answers to diff erent ELISAs could 
also be related to signifi cant fi eld strain diff erences, to the phase 
of the infection or other factors (1).
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Introduction 
Routine diagnosis of PRRS is generally done by means of anti-
bodies detection against the virus, most often using indirect 
or blocking ELISA. With those tests seroconversions are usually 
detected at +14 post-inoculation (1,2). In other instances, RT-PCR 
is chosen as diagnostic test for PRRS. RT-PCR usually allows and 
earlier detection of infected animals compared to serology. Early 
diagnosis of PRRS is particularly crucial in two circumstances: 
entry of gilts in PRRS-free farms and testing of boars. INGENASA 
has recently developed a new ELISA based on the concept of 
double recognition (DR) of the antigen (3). In the Ingezim PRRS 
DR (11.PRS.K0) (Ingenasa) for PRRS, plates are coated with the 
viral protein N. Serum and protein N conjugated to horseradish 
peroxidase are added to the coated plates in one-step incuba-
tion. If PRRS virus (PRRSV)-specifi c antibodies were bound to the 
plate, the free binding sites of those antibodies will be able to 
bind the conjugated N-protein and thus, an increased sensitivity 
will be obtained after revealing the reaction with a colorimetric 
substrate. The aim of the present study was to evaluate the per-
formance of the DR for early detection of anti-PRRSV antibodies 
raised against diff erent genotype-I strains in experimental or 
fi eld conditions. Comparison with HerdChek 2XR® (Idexx Labora-
tories) was also performed.
Material and Methods
ELISAs. Two diff erent ELISAs were used in the present study. In all 
cases, sera were examined by Ingezim PRRS DR (11.PRS.K0) (IN-
GENASA) and for particular comparisons HerdChek 2XR® (Idexx 
Laboratories) was used. All tests were used as recommended by 
the manufacturer. Results were expressed as a ratio of the op-
tical density (OD) of a given sample over the OD of the positive 
control provided by the test (S/P ratio).
Sera from experimental infections. Sera (n=38) obtained from fi ve 
experimental infections (days 0 to 28 post-inoculation) of piglets 
(4 week old) with diff erent PRRSV genotype I strains (S1-S5) were 
used. Selected strains shared from 90.6% to 96.0% of similarity in 
protein N. In all cases, animals were intranasally inoculated with 
≥1x105.0 TCID50/ml. All sera were analyzed using DR. Samples for 
strains S4 and S5 were also examined by the HerdChek ELISA®.
Cross-sectional profi ling of an endemic farm. A cross-sectional 
serological profi ling was comparatively performed in an en-
demic farm (pigs of 3, 6, 9, 12, 15 18 and 21 weeks of age) using 
both ELISAs.
Results 
Sera from experimental infections. At day +7 PI, DR detected 
29/38 sera as positive. Interestingly, for strains S4 and S5 Herd-
Chek® did not detect any positive pig by day +7 PI while DR 
recognized all animals infected with S4 (8/8) and one pig in the 
group infected with S5 (1/8). By day +14 PI, all sera were positive 
in both HerdChek® and DR tests.
Cross-sectional profi ling. Both DR and HerdChek® showed that 
PRRSV did spread explosively around 9-12 weeks of age as indi-
cated by the seroprofi le but DR had an increased sensitivity for 
detecting low levels of maternal antibodies or early infections 
as seen in 3-week-old piglets and in the higher proportion of 
seropositive pigs from week 15 afterwards (Figure 1).
Figure 1. Cross-sectional profi ling of a PRRS endemic farm using DR-
ELISA and HerdChek®.
Discussion
DR-ELISA allowed an earlier detection of experimentally infected 
pigs (76% at 7 PI). On the basis of the results in fi eld conditions, 
DR also showed some enhanced sensitivity related to Herd-
Chek®. Present results indicate the suitability of the DR-ELISA for 
early detection of PRRSV infection. 
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Introduction
Heparan sulfate is known as a receptor for PRRSV attachment 
(1). The heparin is a soluble form of heparan sulfate. A recent 
study showed that the use of heparin with virus-like particles as 
an antigen was eff ective to reduce non-specifi c ELISA reaction 
especially originated from antigenic linearization during coat-
ing process in order to detect human papillomavirus-specifi c 
antibodies (2). Therefore, this study was performed to estimate 
the property of the use of heparin with whole viral antigen in 
PRRSV-specifi c ELISA. 
Materials and Methods
At fi rst, heparin-binding assay of PRRSV was performed using 
slightly modifi ed method (two times diltion of whole viral 
antigen & 20 times dilution of sera) of previous report about 
heparin-based ELISA (2).
MARC-145 cell-derived whole viral antigen was mixed with 1mg/
ml of heparin in PBS in 1:8 ratio and coated on 96well plates 
(polysorb, Nunc). After fi xing with cold ethanol, the plate was 
blocked with 10 % Horse serum and used as an ELISA reaction. 
For serum dilution, swine sera was 40 times diluted with a 1:1 
mixture of 10% Horse serum in PBS-T and culture supernatant. 
After fi nal colorimetric reaction, the O.D values at 450 nm of viral 
antigen and cell control coating wells were estimated.
After experimental infection of type I PRRSV, LCS-EU (105 
TCID50/ml) and type II PRRSV, CP07-401-9 (105 TCID50/ml), the 
collected sera until 21 days post challenge (dpc) were tested 
with commercial ELISA kit (Herdcheck PRRS 2XR, IDEXX) and 
heparin-ELISA system. The sera were also tested by modifi ed 
serum neutralizing test (SN test). The heparin-ELISA was tested 
with not only experimental sera, but also fi eld sera.
The sensitivity and specifi city of heparin ELISA were calculated 
using 310 fi eld swine sera, when IDEXX kit was used as the gold 
standard. IFA test was also included to confi rm true positive or 
negative in 28 mismatched sera between IDEXX and heparin-
ELISA.
Results
 Heparin-specifi c PRRSV binding was observed in the heparin-
PRRSV binding assay with the diff erent concentrations of 
heparin (fi g. 1). In heparin-ELISA system, some unexpected non-
specifi c reactions found in cell control wells were also reduced in 
heparin-coating system of this ELISA. (data not shown)
In the experimental infection study, PRRSV-specifi c IgG began 
to be detected from 18 to 21 dpc by heparin-ELISA, and from 9 
to 10 dpc by IDEXX ELISA. During the study, serum neutralizing 
ability was not proven by conventional SN test. However, when 
modifi ed SN test (3) was applied, serum neutralizing ability was 
detected around 8-9 dpc and 18-21 dpc. In the fi eld sera, IgG 
detected by heparin ELISA was increased after the viremia of 
wild type PRRSV.
When IDEXX (2XR) ELISA was regarded as gold standard, the 
sensitivity and specifi city of heparin-ELISA were 89.6 % and 92 5 
%, respectively (0.81 of kappa value). Although 91% (10/11) of 
false positive in heparin-ELISA was confi rmed by IFA test, 60% 
(9/15) of false negative in heparin ELISA was true negative by IFA 
test.
Figure 1. ELISA reaction in diff erent concentration of heparin. VC+PS, 
Viral antigen coating and positive serum; VC+NS, Viral antigen coating 
and negative serum; CC+PS, Cellular antigen coating and positive 
serum; CC+NS, Cellular antigen coating and negative serum
 Discussion
Heparin treatment could be useful for specifi c detection of IgG 
specifi c for PRRSV and theologically protect viral proteins from 
linearization during the coating process (2). The detection time 
of IgG for PRRSV by heparin-ELISA was delayed compared to 
IDEXX ELISA, but correlated with the appearance of neutralizing 
antibodies that was detected by modifi ed SN test (3). With the 
fair sensitivity and specifi city, the heparin-ELISA was easy to 
prepare and may provide another approach for PRRSV serology.
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Rapid Detection of Porcine Reproductive and Respiratory Syndrome Virus 
by Reverse Transcript Loop-mediated Isothermal Ampliﬁ cation
Shangjin Cui
Harbin Veterinary Research Institute of CAAS, Harbin, China
In order to establish a reverse transcript loop-mediated iso-
thermal amplifi cation method for the rapid detection of porcine 
reproductive and respiratory syndrome virus, 4 primers specifi c 
to 6 regions of N gene were designed. After amplifying in an 
isothermal water bath for 1 h, the ladder-like products would be 
generated with those porcine reproductive and respiratory syn-
drome virus positive samples while no product was generated 
with porcine parvovirus, porcine circovirus, classic swine fever 
virus, pseudorabies virus and swine testis cells. The sensitivity 
and specifi city of this assay were evaluated by comparison with 
reverse transcript polymerase chain reaction. The detection 
limit of the assay was shown to be equivalent to 1x100~1x101 
PRRSV copies/reaction, was about 100 times more sensitive than 
RT-PCT reaction. The coincidence ratio was showed to be 96.2%. 
Due to its specifi city and simplicity, the assay could be a useful 
diagnostic tool for the diagnose of PRRSV infection.
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Introduction
Since it was fi rst discovered in United States in 1987, PRRS has 
spread worldwide and become one of the most devastating 
diseases of swine. The causative agent, PRRSV is divided into two 
distinct groups: the European (Type 1) and the North American 
(Type 2). It is well defi ned about the marked genetic diff erences 
between the two genotypes as well as among viruses within 
each genotype. To identify PRRSV, RT-PCR is one of methods 
that has been widely applied. However, because of the high 
degree of sequence variation, the accuracy of RT-PCR might be 
infl uenced, especially if mutations are located in the primer or 
probe binding regions of PCR (3). To overcome those diffi  culties, 
previous studies prefered designing primer to amplify part of 
conserved region of PRRSV genome: ORF1b and ORF7 (1,5).
In this study, a PRRSV detection and typing Multiplex PCR was 
developed. In our system, the primers were designed to co-
amplify conserved regions ORF1b and ORF7. In addition, primer 
set for ORF7 amplicon was type specifi c that make it possible for 
diff erentiation between PRRSV Type 1 and Type 2.
Materials and Methods
PRRSV reference strains: Type 1 (105.0 TCID50/ml), Type 2 
(104.5TCID50/ml, passage 7 on MARC-145 cell).
Primer design: primers were designed based on PRRSV com-
plete sequence of Type 1 and Type 2 (Genbank: M96262.2, 
AF046869.1). In details, the following amplicons were amplifi ed: 
615bp of ORF1b by CF: IAGGACCATCCTGGGCACCAACA, CR: 
IIGACGGTTTT CTTTGGGTCCGT; 425bp of Type 1 ORF7 by N26: 
GCCCTAATTGAATAGGTGAC, FT1: AGAAAAAGAAA
AGTACAGCTCCGAT; 265bp of Type 2 ORF7 by N26/FT2.1: GTGAG-
CGGCAATTGTGTCTGTCG. 
RNA extraction and cDNA synthesis: RNA was extracted using 
Trizol-Chloroform method. cDNA was synthesized by M-MLV 
reverse transcriptase kit (Invitrogen, USA) using random hexam-
ers method.
Multiplex PCR reaction: Multiplex was set up according the 
guidance of previous paper (2) using i-StarMaster mix PCR kit 
(iNtRON Biotechnology, Korea).
Results
Specifi city and sensitivity of primer set: PCR product was not 
generated with test RNA virus (TGEV, PEDV) and DW as negative 
control. In addition, there was no cross reaction of type specifi c 
primers. Taken into account with sequencing target bands (data 
not show), the specifi city of primer set was confi rmed. By serial 
10 fold dilution known titration of PRRSV, the sensitivity of 
primer set was 102.5TCID50/ml (Type 2), 103.0TCID50/ml (Type 
1) and 103.5TCID50/ml (mixing of Type 1 & 2).
Sensitivity (Sn) and specifi city (Sp) of Multiplex PCR: total 214 
fi eld samples (tissue and pool sera originated from diff erent 
farms) were screening. Comparing to Nested PCR for PRRSV typ-
ing (4) (rountine in our lab), 150/214 samples was judged PRRSV 
true positive. Also, there was no confl ict in typing result between 
Multiplex and Nested PCR. Interestingly, there were 5 tissue 
samples showed both Type 1 and Type 2 positive. The Sn and Sp 
of Multiplex PCR was 94.34% and 90.91% respectively. 
Discussion 
Previous study evaluating RT-PCR method for PRRSV detection 
(6) concluded that ‘the majority of incorrect diagnoses were 
false-negative results’. One main reason might be the occur-
rence of mutation that drives a genetic heterogeneity within 
annealing region of primers. To our knowledge, the probability 
of false negative will be minimized when more than one con-
served regions were co-amplifi ed in PCR. This is partly refl ected 
by the high degree of agreement between new Multiplex PCR 
and Nested PCR (Kappa value: 0.83). Also, this is the fi rst time 
Multiplex PCR was set up to co-amplify both conserved regions 
of PRRSV genome. Slightly high of Sn and Sp might cause by the 
appropriate primer to the sequence of circulation PRRSV strains. 
Therefore, more labor is needed in order to get more suitable 
primer set with recent prevalence PRRSV, Korean strains.
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Introduction
Porcine reproductive and respiratory syndrome (PRRS) is one of 
the most important diseases in pig farms almost worldwide (1). 
The PRRS virus (PRRSV) causes severe economic losses due to 
reproductive failures in sows and gilts and respiratory distress in 
piglets and fattening pigs (1). We analyzed results of diagnostic 
testing for PRRS in order to obtain current information about 
PRRS in German pig herds and to determine any associations 
between diff erent test results, motivation for examination, pig 
farm type, and the animals’ vaccination status.
Material and Methods
A total of 27,077 serum samples from pigs in Germany were ana-
lyzed from October 1, 2007, to September 30, 2009. Antibodies 
against PRRSV were detected by IDEXX HerdChek* PRRS 2XR 
Antibody ELISA as described by the manufacturer. Three to fi ve 
individual serum samples from a single farm were pooled, and 
these pooled samples (6,246) were also analyzed by PCR based 
on the ORF7 gene (2). In order to compare the two methods, 
the individual ELISA results from each pool were averaged to 
give a pooled ELISA result. From January 1, 2009, data were also 
collected on herd (type and size, motive for examination, PRRS 
vaccination status).
Results
ELISA tests for PRRSV were positive in 52 5% (n = 14,213) of all in-
dividual pig serum samples (n = 27,077), whereas PCR tests were 
positive in 29.0% (n = 1,816) of all pooled samples (n = 6,346).
Of the pooled samples from vaccinated pigs (n = 477), 42.1% 
tested positive by both ELISA and PCR, and 9.9% tested negative 
by both methods. Only 2.5% of the serum sample pools from 
vaccinated pigs tested positive by PCR, but negative by ELISA. Of 
the serum pools from vaccinated animals, 45.5% tested positive 
by ELISA only (and negative by PCR). On the other hand, 31.0% 
(n = 52) of the pools from unvaccinated pigs (n = 522) tested 
positive by both ELISA and PCR, and 42.7% tested negative by 
both methods. Of the pooled samples from unvaccinated pigs, 
5.4% tested positive by PCR but negative by ELISA, while 20.9% 
of these samples tested positive by ELISA only (and negative by 
PCR). (Tab. 1)
Most testing of pig serum samples (55.0%) was conducted as 
part of herd monitoring (n = 4,595).
Most animals (75.2% and 66.5%) from fattening units (n = 427) 
or multipliers (n = 161), respectively, were unvaccinated, while 
half (50%) of the animals from breeding herds (n = 2,575) or 
nursery units (n = 423) were unvaccinated.
Table 1: ELISA and PCR results of vaccinated and unvaccinated pigs
ELISA results - - + + Number of pigs 
PCR test results - + - + tested (100%)
Vaccinated pigs (%) 9.9 2.5 45.5 42.1 477
Unvaccinated pigs (%) 42.7 5.4 20.9 31.0 522
Individual ELISA tests were positive in 59.8% of unvaccinated 
pigs from fattening units (n = 321), whereas these were positive 
in only about 40% of unvaccinated pigs from breeding herds (n 
= 1277), nursery units (n = 217) and multipliers (n = 107). PCR 
tests were positive in 36% of the pools from unvaccinated pigs 
from breeding herds (n = 275) and nursery units (n = 47). The 
most positive PCR results were found in unvaccinated pigs from 
fattening units: 46.7% (n = 35; total n = 75).
Discussion
As expected, we found that vaccination had a very strong ef-
fect on the number of positive ELISA tests in pigs. PCR was also 
aff ected by the vaccination status of animals, but to a lesser de-
gree. Nevertheless, 57.3% of the unvaccinated pigs tested posi-
tive by ELISA and/or PCR, and thus were shown to be infected 
with PRRSV.
The vaccination status of the animals depended on the type 
of pig farm. Most animals (75.2%) from fattening units were 
unvaccinated; at least 50% of these animals were infected with 
PRRSV. Half (50%) of the pigs from breeding herds or nursery 
units were unvaccinated; and at least 36% of these animals were 
infected with PRRSV.
Many more interesting associations were discovered in the com-
parison of test results in regard to vaccination status in combina-
tion with herd type and motivation for testing.
References
1.  Zimmermann et al. (2006) in: Straw et al. (eds.), Diseases of Swine, 
9thed., 387-417
2.  Pesch (2003). Diss. Vet. Fac. University of Leipzig, Leipzig, Germany
Porcine Reproductive and Respiratory Syndrome (PRRS) – Diagnostics
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 482
Poster Presentations
P.176
Analysis of ampliﬁ cation of North America PRRS virus RNA from serial diluted oral ﬂ uid samples
Ricardo A. Munoz1 R Shah1 R.R. Rowland2 J. El-Attrache1 J. Zimmerman3
1. Applied Biosystems, Austin, TX, USA; 2. Kansas State University, Manhattan, KS, USA; 3. Iowa State University, Ames, IA, USA
Introduction
Porcine Reproductive and Respiratory Syndrome Virus (PRRSv) 
surveillance for the purpose of monitoring herd status requires 
frequent sampling and testing. Less invasive techniques are 
continuously being explored such as passive blood collection, 
as well as the use of swabs to collect matrices that contain swine 
pathogens. Recently, more innovative monitoring techniques 
and protocols, such as oral fl uid collection, have been developed 
for the swine industry that notably mirror the techniques of 
pathogen detection employed for human medicine.
The oral fl uid is a combination of saliva and “oral mucosa 
transudations”. Saliva is produced by the salivary glands; oral 
mucosal transudations enter the mouth via the buccal mucosa 
from the blood capillaries1. The purpose of this study was to 
fi nd a reference performance of sampling protocols in terms of 
PRRSv North America (NA) strain potential amplifi cation from 
oral fl uid samples after artifi cial dilution of the original oral fl uid 
samples, using PRRSv negative oral fl uid samples. The intention 
was to mimic what could happened in the fi eld, when just one 
pig could get infected at the beginning, and other factors, such 
as the number of negative pigs chewing the rope.
Collection of oral fl uids1:
• Use cotton rope, it is more absorbent than synthetic fi ber.
• Use 1/2” rope for nursery and 5/8” for growth and fi nishers.
• Place the ropes in a clean area, away from water and feed 
sources.
• Hang the rope at pig shoulder height (do not allow to contact 
dirt or feces).
• Squeeze the rope inside a plastic bag, avoiding contacting the 
rope with your exposed hands (to reduce the risk of cross-
contaminations).
• Cut one of plastic bag corners and pour into a tube, if there are 
visible particles, then centrifuge for approximately 10 minutes. 
• Maintain cold chain (4 to 7 °C) prior to sample submission
Oral fl uids are managed the same as serum samples.
Materials and Methods
Samples were obtained from a virus challenge study conducted 
at Kansas State University. In a single experiment, 190 pigs 
were divided among 12 pens and experimentally infected with 
105 TCID50 of a PRRSv 97-7985 strain (NA like virus). Oral fl uid 
samples were collected from each pen and individual animals 
were bled in intervals over 42 days.
Serial Dilution Experiment: 
Take high titer sample (~15 cts) and make a 12 point serial dilu-
tion of the sample using negative oral fl uid. Dilution series will 
include 10 fold, 4 fold and 2 fold dilution points. Isolate diluted 
samples using AM1836 and obtain results using RT-PCR. 
This experiment will give us the linear amplifi cation range of and 
also tell us important dilution information such as, the sample 
that is a 20 fold dilution of the stock will equate to a sample from 
one positive pig that has been pooled with 19 negative pigs, 
assuming they all contribute the same amount of oral fl uid to 
the mix. 
Pooling Experiment: 
Take a high titer sample and dilute it in 5, 10 or 20 diff erent 
negative samples to simulate a high positive pig in a pen with 
4, 9 or 19 negative pigs. Isolate and run Real-Time PCR to get 
results. Do the same for a low titer sample to simulate a low posi-
tive pig with 4, 9 or 19 negative pigs in a pen. This will give us 
information about detection limits within pens and how many 
samples can be tolerated before loss of amplifi cation.
Some pigs may contribute a higher amount of oral fl uid com-
pared to others. These experiments assume that the same 
amount of oral fl uid is contributed by each pig
Summary
The presence of PRRS virus RNA was identifi ed in an early infec-
tious stage utilizing oral fl uids as a sample matrix. Real-time PCR 
can be eff ectively utilized to amplify PRRS virus RNA obtained 
from oral fl uids samples. Predictably, this type of analysis could 
provide an enhancement to the routine monitoring and surveil-
lance of populations .
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Introduction and Objectives
PRRS (Porcine Reproductive and Respiratory Syndrome) control 
in swine farms is an ambitious challenge that has to be based on 
diff erent measures and intervention strategies and that, because 
of the high amount of diagnostic samples required, is often cost 
prohibitive (1). The selection of oral fl uid as diagnostic specimen 
is likely to be a promising alternative to serum. At present, there 
are experimental evidences that porcine saliva is a valuable 
alternative to serum for detection of PRRSV genome (2,3). The 
main purposes of the present experimental study was to mon-
itor PRRSV infection towards a longitudinal sampling of sera, 
according to the traditional diagnostic protocols, and match 
individual serum with collective pen-based oral fl uid results. 
Material and Methods
Four site-2 swine commercial farms site in North Italy partici-
pated in the study. On each of them, 4 pens of 30 piglets were 
selected and, at 3, 5, 7 and 9 weeks of age, the following speci-
men were collected: individual serum samples of 10 ear-tagged 
pigs/pen and collective oral fl uid samples (1 cotton rope/pen). 
The serum were analysed individually. The presence of PRRSV 
RNA was shown using a real-time qRT-PCR (Applied Biosystem 
TaqMan NA/EU PRRSV Kit). 
Results 
Comparison showed a good agreement (87,5%) between PRRSV 
detection in porcine pen-based oral fl uid and individual serum 
samples, as visualised in Figure 1 and 2.
Figure 1
Figure 2
Despite oral fl uids constantly contained a lower concentration 
of virus compared to individual positive serum, the level of virus 
showed a similar temporal course in both specimen. 
Discussion
Our data corroborates that oral fl uid samples can be considered 
a valuable and promising alternative to serum to track PRRSV 
fi eld infection. Moreover, compared to drawing blood speci-
men from individual pigs, pen-based saliva off ered signifi cant 
advantages, such as reduced costs, less labour and simplicity. 
Preliminary data on the diagnostic sensitivity of the quantitative 
RT-PCR on oral fl uids, compared to the gold standard (RT-PCR 
on individual serum samples), can be accounted as satisfactory. 
Further analyses are in progress in order to validate saliva qRT-
PCR at pen level.
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Introduction
Oral fl uids have been reported to be useful specimens for the 
detection or diagnosis of infection,1,2,4 including PRRSV.5,6 
Our initial work revealed a low sensitivity for PRRSV PCR on 
swine oral fl uid samples using extraction methods established 
for serum samples. This sample matrix-related diff erence has 
been reported by others, as well.1-3 Thus, oral fl uid samples are 
known to inhibit PCR effi  ciency.1,3 
Preliminary work at the ISU-VDL found that an extended lysis/
processing adaptation to an existing extraction method im-
proved improve test sensitivity (Stensland, unpublished data). 
In this study, we sought to continue to improve PRRSV PCR for 
oral fl uids. Specifi cally, we evaluated 5 nucleic acid extraction 
protocols and assessed the presence of PCR inhibition in swine 
oral fl uids through the use of an internal PCR control. 
Materials and Methods
Oral fl uid samples (n = 106) were randomly selected from an 
earlier study in which pigs were inoculated with PRRSV.5 The 
sample set included 63 pen-based oral fl uid samples collected 
between 7 DPI and 29 DPI and 43 samples from negative 
control pens. These samples were used to compare 5 extraction 
protocols based on commercially-available kits using magnetic 
bead-based extraction (protocols 1 through 4) and spin-column 
based extraction (protocol 5).
1.  Applied Biosystems MagMax™ Viral RNA Kit – ISU-VDL modi-
fi ed protocol;
2.  Applied Biosystems MagMax™ Viral RNA Kit – High-volume, 
ISU-VDL modifi ed protocol;
3.  Qiagen BioSprint® Vet One-For-All Kit;
4.  Applied Biosystems MagMax™ Total Nucleic Acid Isolation 
Kit;
5.  Qiagen QIAmp® Viral RNA Mini-Kit.
PRRSV RNA was detected using Applied Biosystems Ag-Path 
PRRSV real-time PCR reagents, which contains an internal control 
for detecting failed reactions. Initially, a standard master mix was 
prepared according to the instructions from the manufacturer. 
Later, PCR was re-run using modifi ed master mix with double 
the amount of enzyme mix (containing both reverse-transcript-
ase and Taq polymerase enzymes).
Results
Results indicated signifi cant diff erences among extraction 
protocols in the level of detection in PRRS-exposed pen samples, 
ranging from 17% to 43%. In general, doubling the PCR enzyme 
resulted in improvements in detection among all extraction 
protocols, ranging from 32% to 56%. The internal control data 
suggested a diff ering level of failed reactions among the extrac-
tion protocols tested, suggestive of PCR inhibition, although 
the results were not statistically signifi cant. All protocols had 
reduced number of failed internal controls when enzymes were 
doubled. 
Discussion
The oral fl uid sample matrix is known to inhibit PCR test pro-
cess1-3. Cumulatively, our work confi rmed this observation and 
demonstrated that not all extraction methods work equally with 
the oral fl uid matrix.
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Brazilian bioassay model to investigate PRRSV on imported swine semen
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Introduction 
Porcine reproductive and respiratory syndrome virus (PRRSV) 
is a widespread viral disease in the pork industry (Greineir et 
al., 2000) and causes a potentially devastating disease in swine 
herds (Wills et al., 2000). Because its potential for rapid spread, 
signifi cant production and economic losses is considered the 
most economically important viral disease at swine production. 
PRRSV has been recorded in most major pig-producing areas 
throughout the world. However the disease is considerate as an 
exotic disease in Brazil.
Nowadays, in order to improve the genetics of Brazilian breed-
ing herds, producers imported genetic material (semen and 
live animals) origination from countries which are recognized 
by their genetic technology. This trade can lead serious prob-
lems for the health status of the piggery because is well know 
that PRRSV can be shed and transmitted through boar semen 
(Christopher-Hennings et al., 1996).
The aim of this study was to perform a swine bioassay (in vivo) 
to test the safety for PRRSV on imported semen from Germany 
to be used in swine genetics too Topgen Ensure the safety
Materials and Methods
Six pigs were randomly assigned and kept in fl yer-proofed isola-
tions pens. Four piglets were inoculated intraperitoneally which 
a pool of 2 ml of porcine German imported semen provide from 
TOPGEN swine Genetics. The other two animals were designed 
as negative control. Rectal body temperature and PRRS clinical 
sings (fever, anorexia, lethargy, diarrhea, respiratory symptoms, 
chemosis, tremors) were done daily from those pigs. Blood 
samples with EDTA were collected from the sow and each pig 
at weaning, immediately before PRRSV inoculation an on days 
7, 14, 21 post inoculums (PI). Blood samples were analyzed for 
hematological parameters. At the same day serum samples were 
collected too in order to test serum-conversion by the PRRS 
using a commercial Kit - Idexx - Herdcheck PRRS 2XR ELISA. Two 
piglets were euthanized on day 7PI and 21 AI at the necropsy 
room at Laboratório de Sanidade de Suínos at São Paulo State 
University by electrocution and the necropsy were performed 
immediately as performed by Ciacci-Zanella et al 2004. At the 
necropsy, all of the swine were thoroughly examined, blood, 
serum and organs were collected for histopathology and viral 
tests.
Results
For the period of 21 days, nome of the inoculated piglet pre-
sented characteristic PRRS symptoms. The blood parameters 
were normal. At the necropsy, no pathological lesions (macro or 
microscopic) were found by histopathology. Also the tested pigs 
were negative to the ELISA test methods. 
Discussion
The goals of this work were achieved. The safety of the semen 
demonstrates the effi  ciency of government agencies that over-
see the transit of animals and their products through constant 
monitoring. Swine bioassay is an excellent tool for detecting 
PRRSV although it is laborious (Christopher-Hennings et al., 
1996). The trial period had time for a possible seroconversion 
that occurs between 14 and 28 days (Wills et al., 2000).
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Introduction
Porcine Reproductive Respiratory Syndrome (PRRS) was a 
problem, is a problem and will be a problem in pig farming. The 
aim of the vet who is facing this disease is to get a PRRS stabil-
ize population of animals. PRRSV serologic screening results are 
essential to understand the PRRSV epidemiology in the farm, 
which is necessary to take the proper decisions in each PRRSV 
infection scenario. So, in the pig veterinary practice, transversal 
serum profi les are usually implemented to take most proper 
decisions in order to control PRRSV.
Materials and Methods
200 transversal serum profi les from 200 diff erent farms located 
in Spain, Hungary, Poland, Czech Republic, Slovaquia, Italy and 
Denmark were analysed. Each serum profi le was made from 
serum samples collected from diff erent pig groups (gilts, sows, 
piglets and fattening pigs). The sows were grouped together by 
age (by parities), they were sampled from day of gestation 70 to 
100. Piglets and fattening pigs were sampled by weeks of age 
(4,7,10,13,16,19,21 and 24). The sample was blood sera and the 
amount of samples per group depended on the size of the farm 
and the estimated infection prevalence. The average number 
of serum samples per group was 7. Serology analysis was made 
with ELISA (CIVTESTsuis PRRS/ES Laboratorios Hipra, Amer, 
España) following the manufacturer instructions. From each 
monitored farm was noted the productive data, the vaccination 
program and the clinic situation.
Results
After testing and analyzing 200 farms, we could determine 3 
clear PRRSV infection patterns which let us to defi ne 3 diff erent 
PRRSV epidemiologic status: 1. Clinically not stable and sero-
logically not stable, (42 farms out of 200) (Graphic 1); 2. Clinically 
stable and serologically not stable, (112 out of 200) (Graphic 2); 
3. Clinically stable and serologically stable, (36 farms out of 200) 
(Graphic 3). 10 farms could not be classifi ed in any of these 3 
patterns.
Discussion
Samples results from pigs at 7 weeks of age became essential 
information. Passive immunity does not reach with high IRPC 
levels to 7 weeks of age 1 .If we observe high antibody titers at 
this age we can suspect that the piglets were already viraemic at 
weaning and for this reason, we can suspect that. So sows were 
probably farrowing infected PRRSV piglets. In farms where the 
piglets were vaccinated, we could not determine any pattern, 
because vaccination serology response could be confused with 
a serology positive result due to a wild PRRSV infection. However 
PRRSV sow vaccination does not interfere with this classifi cation, 
since we observe that the serology response induced by vac-
cination does not result in IRPC values higher than 100. Recent 
wild virus infection induces IRPC values higher than 100. We 
observed that the evolution of PRRSV infection in farms followed 
these 3 statuses, evolving from one status to the other within 
6 to 12 months period. We do not observe diff erences among 
the farm status from diff erent countries. We observed that most 
of the farms that implemented at least vaccination in sows 
belonged to the second PRRSV infection pattern (Graphic 2). To 
sum up, according to this classifi cation, swine vet specialists can 
monitor and take their proper decisions to control PRRSV.
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Porcine reproductive and respiratory syndrome (PRRS) on a large pig farm in Slovenia
Zdravko Valencak1 Alojz Pertoci2
1. Veterinary Faculty, Ljubljana, Slovenia; 2. Panvita, Veterina, Beltinci, Slovenia
Introduction
PRRS is an economically signifi cant viral disease of swine (1). 
Slovenia was PRRS free country and later on country with low 
seroprevalence to PRRS in small pig farms (2). In last years sero-
prevalence to PRRS increased on small farms and also large pig 
farms became positive. Vaccination after PRRS outbreak is used 
control measure (3). In 2008 in one of the large one site pig farm 
production results and increased mortality leaded to suspision 
of PRRS. PRRS was confi rmed in May 2008 with testing of 152 pig 
with ELISA, from which 112 were positive to PRRS. Farm started 
with control measures.
Materials and Methods
Vaccination programme
• June 2008 all sows on the farm were vaccinated with inacti-
vated vaccine in three weeks.
• August 2008 vaccination with live vaccine. Sows were vaccin-
ated 6 th day after farrowing and 60 th day of pregnancy.
• From July to November piglets were vaccinated with live vac-
cine at beginig all and after at age of 14 days.
• December 2008 piglets were vaccinated at age of 24 days.
• From may 2009 till October piglets were not vaccinated.
• From August 2009 in sows at 60 th day of gestiation the inacti-
vated vaccine was used.
• October 2009 all sows were vaccinated with live vaccine in 2 
days and all piglets were vaccinated at weaning.
• In January 2010 all sows were vaccinated with live vaccine. 
Serological control
In year 2008 were tested 101 samples from June to December, 
and in 2009 562 samples with IDEXX PRRS ELISA.
Selected production Results
Results of 2007, 2008 and 2009 were compared (abortions, far-
rowing rate, mating rate, weaned piglets per litter, preweaning 
mortality, postweaning mortality).
Results
In 2008 only 48 samples (47,5%) were seropositive. In 2009 537 
(95,5%) sera reacted positive.
Table 1: Comparison of production Results
2007 2008 2009
Abortions/month 14,17 43,83 66,25
Farrowing rate (%) 83,74 80,11 69,78
Mating rate (%) 84,81 83,31 74,31
Weaned/litter 9,68 8,94 8,58
Preweaning mortality (%) 12,10 8,55 20,20
Postweaning mortality (%) 4,95 5,58 7,20
Average number of abortions per month in year 2008 from Janu-
ary to October was 14,8 but increased in November to 153 and 
in December to 212. In 2009 average number of abortions from 
January to October was 59,7 monthly, but in November 102 and 
in December 23.
Discussion
PRRS reached culmination in November in December 2008 in 
spite of used programme of vaccination. Success of vaccina-
tion in 2009 was not satifactory. In October 2009 the vaccina-
tion scheme was changed fundamentaly. With vaccination of 
all breeding sows in short interval stabilization of herd was 
expected. Preliminary results shows that number of abortions 
decreased signifi cantly and number of seropositive animals is 
improving. Results in January 2010 indicates that vaccine did not 
achieve long lasting immunity and PRRS virus still circulates in 
breeding herd and that repeat vaccination of all sows is appro-
priate measure to improve production results.
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Introduction
Since the fi rst appearance of porcine reproductive and respira-
tory syndrome (PRRS) in 1987 in the USA and in the early 1990’s 
in Europe PRRSV has become endemic in most pig producing 
countries and causes high economic losses (1). PRRSV causes 
a persistent infection and virus excretion can be detected over 
several months post infection (2). However, data to substantiate 
the role of PRRSV on reproductive performance of sows in Aus-
trian pig herds were not available. Due to the diff erent structure 
of the farms, the data obtained from other countries with much 
higher concentrated pig herds and higher numbers of animals 
per herd are not directly comparable to the situation in Austria. 
So the aim of the study was to evaluate the eff ect of PRRSV on 
the reproductive perfomance of Austrian sow herds.
Materials and Methods
140 Styrian (South-East Austria) production herds were ran-
domly selected. The mean number of sows per herd was 74 
animals. The main inclusion criteria were that the farmers had to 
use the SPon Web soft-ware for reproductive management and 
to be a member of the Styrian animal health service. On each 
farm 14 random blood samples were collected. These samples 
comprised 4 sows, 4 gilts, 4 growers, and 2 boars, if available. All 
samples were analysed by the IDEXX Herdchek® PRRS Antibody 
(Ab) test kit. 
Then, the farms were divided into three groups: PRRSV-Ab-posi-
tive (at least one animal seropositive, no history of vaccination, 
n=66), PRRSV-Ab-negative (n=60) or vaccinated (EU-strain MLV 
vaccine, n=14). Following, reproductive performance data were 
compared between these three groups.
Results
No signifi cant diff erence in the number of live born piglets per 
sow and year could be found between the PRRSV-Ab-negative 
(median=27.4) and the PRRSV-Ab-positive (median=27.0) 
group. In contrast the vaccinated herds exhibited a signifi cantly 
(p<0.05) worse productivity with a median of 25.2 live born 
piglets. However, the PRRSV-Ab-positive herds showed a trend 
towards greater losses in the suckling period (median=14.6) 
than PRRSV-Ab-negative (median=13.2) and vaccinated herds 
(median=11.4). 
Discussion
This study shows that the results from the USA are not directly 
comparable to the situation in Europe, especially to the one 
in Austria with its diff erent structure of swine herds. Our data 
show, that PRRSV-Ab-positive and PRRSV-Ab-negative herds can 
obtain nearly the same reproductive performance, given PRRSV 
infection is stable. Interestingly, the number of live born piglets 
was signifi cantly lower in vaccinated herds. There are several 
possible explanations for this fi nding, for example the vaccine 
does not cover all relevant strains or vaccination regimens were 
not optimal. However, vaccinated herds achieved better results 
during the suckling period, which could be a consequence of 
the initially smaller litter sizes in vaccinated sow herds. 
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Comparison of temporal variation of blood parameters between PRRS naive “5 kg” 
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Introduction
As a method of gilt acclimatization to porcine reproductive and 
respiratory syndrome virus (PRRSv), many swine producers com-
mingle naive “5 kg” replacement gilts (NG) with their PRRS posi-
tive resident nursery pigs. Surprisingly, the NG often perform 
better than the resident piglets (RP). The objective of this study 
was to describe and compare temporal variation of hematologic, 
serologic and viremic characteristics between NG and RP.
Materials and Methods
RP and NG were introduced in an all-in-all-out nursery (d0) at 
approximately 20 and 40 days of age, respectively. They were 
transferred to a grow-fi nishing (GF) unit at d45 of the study. A 
total of 24 piglets were selected, 12 NG and 12 RP. Blood was col-
lected at d0, d6, d13, d20, d27, d42, d48, d55 and d95. Selected 
piglets were housed in 6 pens (3 for NG and 3 for RP) of 4 piglets 
in three diff erent rooms of a capacity of 72 piglets each. NG 
were in separate pens but they had nose-to-nose contact with 
RP through the fence. All 24 piglets were weighed and scored 
for clinical signs (1: normal; 2: unthrifty; 3: sick) at each sampling 
day of nursery. Presence in serum of PRRSv and antibodies 
against PRRSv were tested by a quantitative RT-PCR (qPCR) and 
IDEXX-2XR ELISA on all samples. Serum protein electrophoresis1 
and complete hematologic profi le were done on most sampling 
days. Finally some sera (d6, d13, d27 and d42) were screened for 
infl uenza H1N1 and H3N2 antibodies (IHA). Diff erences between 
groups of pigs, sampling days and interaction were tested with 
mixed models2.
Results
Viremia for PRRSv (qPCR positive) was observed in only 2 RP at 
d0 and in 3 RP at d20. From d42 to d48, most piglets became 
viremic (PRRSv peak), but no clinical signs were observed on 
neither group of pigs during this period. All piglets had sero-
converted (ELISA) by d95. Clinical signs (mainly dyspnea and 
unthriftiness) were observed between d13 and d20 on most 
piglets and were found to be related to the circulation of H3N2 
infl uenza virus (paired sera). Clinical signs were less severe in 
NG. However, piglets in both groups had similar nursery growth 
rates (ADG=0.487 kg).
Most hematological parameters varied over time in both groups 
but the dynamics were diff erent between groups. The main 
variations were observed for cellular immunity and globulins 
(see table 1).
 
Discussion
Almost no viral circulation of PRRSv was observed among 
selected piglets until the end of the nursery period (d42); infec-
tion of NG occurred later than expected even though there was 
nose-to-nose contact with infected piglets. In this study, NG 
were less aff ected by the infl uenza virus than RP and showed 
diff erent immune responses (cellular and humoral). It could be 
that NG had a more mature immune system than RP because 
they were older when introduced in the nursery. Also NG had a 
higher health status than RP; their immune resources were pos-
sibly more readily available to fi ght pathogens.
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Introduction
The aim of this study was to evaluate the time-course of the 
immune response to PRRS virus in two PRRSV-positive farms. 
Gilts came from a PRRS-free herd and the purpose was to house 
them without causing PRRS outbreaks in the two farms under 
study. For this reason, two diff erent strategies were adopted: 
vaccination in farm 1 and direct contact with viremic animals in 
farm 2. The cell-mediated immune response was evaluated by 
a PRRSV-specifi c interferon-γ release assay; also, an ELISA assay 
was performed to detect PRRSV-specifi c IgA Abs in saliva, the 
assessment of which could be useful in association with other 
routine diagnostic tests.
Materials and Methods
Animals. Two PRRS-positive farms, hereunder named 1 and 2 
were chosen for the study. Gilts came from a PRRS-free herd, 10 
animals from farm 1 and 15 animals from farm 2, respectively. 
Pigs from herd 1 were primo-vaccinated i.m. with MLV Porsilis® 
PRRS Intervet at 5 weeks of age, and a second vaccination with 
KV Progressis® Merial was carried out by the same route on 
5-months old animals. In herd 2, animals were housed with vir-
emic pigs until they were 5 months old. In farm 1, blood samples 
were collected twice: T0, 60 days after MLV vaccination and T1, 
60 days after KV vaccination. In farm 2, blood samples were 
collected three times: T0 (3- month old animals), T1 (5-months 
old animals during contact with viremic pigs), T2 (9-months 
old animals). Moreover, these animals were checked for PRRSV-
specifi c IgA Abs in saliva samples at T1 and T2. Laboratory an-
alyses. Blood samples were collected in tubes with and without 
lithium-heparin, in order to obtain both serum (for anti-PRRSV 
IgG, RT-Real Time PCR, anti-SIV Ab) and plasma samples (for 
IFN-γ assay). The IgG Abs ELISA was performed as recommended 
by the producer (Herdcheck® IDEXX Porcine Reproductive and 
Respiratory Syndrome Antibody Test Kits); moreover, sera were 
used in RT-Real Time PCR to detect PRRSV RNA (3) and inhibition 
of haemoagglutination (IH) for infl uenza virus type A/SW/H1N1, 
A/SW/H1N2 and A/SW/H3N2 (4). After incubation of whole 
blood with PRRSV and mock antigens, IFN-γ was measured by 
sandwich ELISA using anti-swine IFN-γ capture mAb P2F6 and 
biotinylated, anti-swine IFN-γ mAb MP701B (Thermo Scientifi c, 
Rockford, IL). Swine IFN-γ was revealed by HRP-conjugated 
streptavidin, and ortho-phenilenediamine as substrate of the 
color reaction. Samples were scored positive if the OD cor-
responding to PRRSV-stimulated whole blood was higher than 
that of mock-stimulated and unstimulated blood by 20 mOD 
at least. PRRSV-specifi c IgA in saliva samples was investigated 
by an ELISA assay; samples were reacted with sucrose-purifi ed 
type I PRRSV and mock antigen, respectively. Mucosal Abs were 
revealed by an anti-swine IgA, HRP-conjugated antiserum and 
ortho-phenilenediamine. Samples were scored positive if the OD 
corresponding to PRRSV antigen was higher by 20 mOD at least 
(background level shown in SPF pigs).
Results
Animals remained healthy until the end of the study. In farm 1 
all pigs, but one, were PRRSV-negative in RT-Real Time PCR at 
T0 and T1, while they were IgG-positive at both T0 (except 1 
animal) and T1; a PRRSV-specifi c IFN-γ response was absent at 
T0. Instead, there were 4 specifi c and 2 non-specifi c responses at 
T1. These animals also showed a seroconversion to H2N1 SIV. In 
farm 2, RT-Real Time did not reveal any PRRSV-positive sera; IgG 
ELISA indicated instead a seroconversion at T1 (except 1 animal), 
and low Ab titres at T2, too. The IFN-γ response was absent at T0; 
then, 3 PRRSV-specifi c and 3 non-specifi c reactions were scored 
at T1 and T2, respectively. The IgA ELISA assay revealed 10 and 
3 positive reactors at T1 and T2, respectively, with an inverse 
frequency ratio to IgG reactors in serum.
Discussion
In both farms, the cell-mediated immune response occurred 
at low intensity as opposed to the Ab response. This fi nding 
confi rms the results by other authors (1, 2), i.e. the discrepancy 
between humoral and CMI response to PRRSV following both 
vaccination and direct contact with viremic animals. Also, these 
preliminary data indicate a diff erent time-course between IgA 
and IgG Ab responses, as a possible strategy of PRRSV to escape 
immune pressure.
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Introduction
Porcine Reproductive and Respiratory Syndrome was fi rst 
described in 1980 in North America, following (from 1990) in 
Europe. From here PRRS occurs worldwide in most major swine-
raising countries.
Both domestic and wild boars were the known susceptible spe-
cies at PRRSV in natural condition.
There are kits to detect specifi c antibodies against PRRSV in 
serum samples. The most used kits are: indirect immunofl uores-
cent antibody (IFA), ELISA and serum neutralization.
The formation and decline antibodies kinetic in IFA and ELISA 
are similar. The ELISA advantages are: rapid execution, low re-
sults variation comparing with results interprets by a technician.
Materials and Methods
For antibodies detection was samplings sows from breeding 
farm and from pigs from fattening unit that belongs to the 
anterior mentioned farm. From sows are sampling in the fi rst 
period of gestation and from fattening pigs at 2, 3 and 5 months 
of age.
The trials were performed using PRRS IDEXX ELISA (HerdCheck 
IDEXX Laboratories Switzerland AG.), and xChek (Laboratories 
IDEXX) software.
Results and discussions
In the breeding farm were observed more reproductive disor-
ders, and there were serological tested against PRRS.
Figure 1
The obtained results are presents in table 1. As it could be ob-
served, in breeding farm and in fattening farm both are present 
the PRRS infection.
Table 1
Farm 1 - 
breeding
Farm 3 - 
fattening
Farm 3 - 
fattening
Farm 3 - 
fattening
1st sampling 2nd sampling 3rd sampling
Tolal 25 15 20 12
Negative samples 5 4 6 1
Positive samples 20 11 14 11
Infection % 80 75 70 91
In breeding farm, 80% from samples were positive. In fattening 
farm, at fi rst sampling 75% samples were positive, at second 
sampling, 70% samples were positive and at third sampling, just 
after slaughtered, 91% samples were positive. This proved the 
seroprevalence rising.
Graphic 1. Dynamic of positive samples in fattening pigs 
Conclusions
The breeding farm was positive in a signifi cant proportion (80%). 
Also, all three samplings from fattening farm revealed positive 
reactions, as it follows: 75% at 2 months old, 7o% at 3 months 
old and 91% at 5 months old.
Early identifi cation of PRRS infected herds is essential for epi-
demiological surveillance and disease control. The herds moving 
is necessary to be done only between herds with the same im-
mune status, through this disease spreading is limited. 
References
1.  BENFIELD, D.A., NELSON, C., STEFFEN, M., ROWLAND, R.R.R. (2000) - 
Proc Annu Meet Am Assoc Swine Pract, pp. 405-408.
2.  CA˘TANA˘, N., POPA, VIRGILIA, HERMAN, V., FODOR, IONICA (2007) –, 
Lucr. S¸t. Med. Vet. Timis¸oara, vol. XL, 131-134.
3.  MURTAUGH, M.P. (2004) - American Association Of Swine Veterinar-
ians, 359-368.
4.  ROTARU, ELENA (2005) – Sindromul tulbura˘rilor respiratorii s¸i de 
reproduct¸ie al porcinelor, În: Boli virotice s¸i prionice ale animalelor, 
sub redact¸ia Moga Mânzat R., Ed. Brumar, Timis¸oara, 245-261.
5.  OIE (2004) - Porcine reproductive and respiratory syndrome. In 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Part 
2, Section 2.6., Chapter 2.6.5. https://www.oie. int/eng/normes/
MMANUAL/A_00099.htm.
6.  http://www.idexx.com/view/xhtml/en_us/livestock-poultry/swine/
prrs.jsf (accesat 15.02.2010).
Porcine Reproductive and Respiratory Syndrome (PRRS) – Epidemiology
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 492
Poster Presentations
P.186
Risk factors for the porcine high fever disease in a region of Vietnam
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Introduction
Porcine high fever disease (PHFD) emerged in 2007 as a large 
and rapidly evolving outbreak aff ecting most of China, and 
subsequently, Vietnam (1). The disease was characterized by 
fever, depression, anorexia, and respiratory distress; with high 
morbidity. One genotype of the porcine reproductive respiratory 
syndrome virus (PRRSV) was considered to be the etiological 
agent, possibly with involvement of other pathogens, because 
of the disease’s unusual characteristics (1). However an inter-
action between PRRSV and other pathogens was not confi rmed. 
It is important to understand the epidemiological characteristics 
of PHFD. This study’s objective was to evaluate the distribution 
of, and risk factors for, the occurrence of PHFD in a region of Viet-
nam which underwent a recent outbreak. 
Materials and Methods
Study area: The area of interest was a district of a province of 
southern Vietnam that had reported the outbreak of PHFD dur-
ing 2008. A study area, approximately 10x10 kms in dimension, 
which contained 5 communes and a total of 37 hamlets, was 
selected.
Data collection: A survey was conducted in the study area to col-
lect information about the swine health problems during 2008. 
A group of trained interviewers went to almost all households 
having pigs with local veterinarians to fi ll questionnaires, which 
included 3 sections: general information, clinical signs of disease 
in pigs, and production factors hypothesized to be risk factors.
Defi nition of case at household level: Based on clinical signs from 
the literature (1,2), and opinions of experts and experienced 
veterinarians in the area, cases were defi ned as households that 
experience a pig that died or aborted accompanied by one of 
the suspected signs, including: high fever (41.5oC), blue ear, 
respiratory problems in sows, stillbirths, pre- and post weaning 
death up to 20%, or with mortality over 10% accompanied by 
fever and respiratory symptoms in other pigs 
Data analyses: Questionnaire data were entered into EpiData 
3.1 (EpiData Association, Odense, Denmark). Logistic regression 
with a random intercept at the hamlet level was used to assess 
risk factors for PHFD at the household level using Stata 10 (Stata 
Corporation, Texas, USA).
Results
Of 955 households with questionnaire data, 33.4% were clas-
sifi ed as cases. Cases occurred over the entire year (2008) with 
peak frequency in June. In addition to clinical signs defi ned 
for cases, agalactia and lameness were observed in sows while 
trembling and excessive wasting were observed in suckling 
and nursery pigs. Diarrhea and redness of skin were observed 
in fi nishing pigs. The risk factors associated with the occurrence 
of cases were: higher number of sows and fi nishing pigs (log 2 
transformed), receiving pigs from an external source, and the 
interaction between using “water green plants” (WGP) as pig 
feed and owning ducks with/without contact with pigs (duck ct/
duck nct) in the household (Table 1).
Table 1. Factors associated with being a case of PHFD at household 
level in fi nal model 
Parameter Coeffi  cient 95% CI (lower) 95% CI (upper) p value
Fixed eff ect
Intercept -1.50 -1.85 -1.16 <0.001
Log sow 0.39 0.28 0.51 <0.001
Log fi nishing pig 0.05 0.01 0.09 0.047
WGP * Duck
WGP 0.04 -0.34 0.43 <0.001
Duck nct -0.26 -0.70 0.18
Ducks ct 0.18 -0.49 0.86
WGP-duck nct 0.63 0.01 1.26
WGP-duck ct 1.04 0.04 2.03
Receiving pigs 0.53 0.15 0.91 <0.001
Random eff ect
Variance of intercept 0.07 0.02 0.32 0.020
Discussion 
Number of sows and fi nishing pigs were used in the model to 
control for confounders. The fi nal model fi tted suggested that 
the movement of pigs (i.e. receiving nursery pigs form another 
farm) might be a risk factor with OR=1.70 (1.16-2.48). This fac-
tor might have contributed to the observed pattern of disease 
transmission over the area. The interaction between duck and 
feeding WGP suggested that potential pathogens originating 
from a water source, and which further multiplies in ducks, could 
contribute to occurrence of PHFD. 
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Introduction
Porcine reproductive and respiratory syndrome (PRRS) is a dev-
astating disease in intensive pig production and is an endemic 
disease in most farms in the world, but triggering factors for 
outbreaks should be studied for each scenario.
The objective of this study was to assess the factors linked with 
PRRS outbreak presentation in fi eld conditions.
Material and Methods
Forty-three Spanish farms, belonging to the same company and 
with a census between 100 and 5,250 sows and gilts (mean±SD: 
643±1,012) were surveyed during a minimum period of 3 years 
(and a maximum of 10 years) (total of 397 farm-years) in a pro-
spective observational study.
Twelve variables related to farm facilities, stocking management, 
health status and strategies were studied.
Four diff erent strategies for PRRS control were used in these 
farms: S1: PRRS-Positive Gilts, Live Vaccine and No Infection with 
Piglets; S2: PRRS-Positive Gilts, Live Vaccine and Infection with 
Piglets; S3: PRRS-Positive Gilts, Killed Vaccine and Infection with 
Piglets; and S4: PRRS-Negative Gilts, Killed Vaccine and Infec-
tion with Piglets. Live vaccine was AMERVAC®-PRRS (HIPRA) and 
killed vaccine was PROGRESSIS® (MERIAL). They were applied 
according to producer specifi cations. A commercial indirect-
ELISA test was used to confi rm PRRS diagnosis (Ingezim PRRS K1, 
Ingenasa). 
In this study, a PRRS outbreak was defi ned as the sudden oc-
currence of reproductive problems associated to an abrupt 
increase of seroprevalence to this disease. Comparison of 
outbreak frequencies was performed with Likelihood Ratio test 
(for more than 2 frequencies) or Fisher’s exact test (for 2 frequen-
cies). Relative Risk and 95% confi dence interval were calculated 
for signifi cant associated variables. Error α was established at 
0.05. All statistical analyses were carried out with SPSS® 15.0 for 
WINDOWS®.
Results and Discussion
During the study period only 7 PRRS acute outbreak were re-
corded. The only variable signifi cantly associated with outbreak 
risk was the stock variation (see Table 1), so an increase of census 
led to a higher probability of PRRS outbreak occurrence (40%) 
versus a probability of 1.3% when no changes in census; that 
corresponded to a signifi cant Relative Risk of 31.2 (95%CI: 7.8 
– 124.3). It means, that there is 31 2 times more risk for PRRS 
outbreak to occur in farms that undergo a relevant increase of 
population size, than in farms with constant census.
Other variables had not been associated with PRRS outbreak 
(Table 1). In this study, we didn’t fi nd any signifi cant impact of 
the type of vaccine used (live or killed) on the outbreak risk. 
However several variables could be related to outbreak risk, but 
the very low number of outbreaks did not allow us to get signifi -
cant results (i.e. existence of infected piglets in post-weaning, 
use of outsource gilts and presence of in-farm AI station).
Table 1: Relationship between productivity & health management 
variables and PRRS acute outbreak
Variable Category N Outbreak p
Fattening unit Absence 328 1.8% >0.9992
Presence 69 1.4%
Post-weaning unit Absence 10 0.0% >0.9992
Presence 387 1.8%
In-farm AI station Absence 377 1.9% >0.9992
Presence 20 0.0%
In-farm gilts rearing No 358 1.7% 0.5182
Yes 39 2.6%
Stock variation Decrease 2 0.0% <0.0011
No changes 390 1.3%
Increase 5 40.0%
Gilt source Out 363 1.9% >0.9992
In 34 0.0%
PRRS status of gilts Negative 178 2.2% 0.7052
Positive 219 1.4%
Gilt infection with piglets No 69 1.4% >0.9992
Yes 328 1.8%
Type of vaccine for gilts Live 164 1.2% 0.7052
Killed 233 2.1%
Killed vaccine use Only gilts 357 1.4% 0.1502
All breeders 40 5.0%
Infected piglets in post-
weaning No 26 0.0% 0.289
2
Yes 46 8.7%
Health strategy for gilts S1 67 1.5% 0.8961
S2 96 1.0%
S3 54 1.9%
S4 177 2.3%
Total 397 1.8%
1 Likelihood Ratio test p-value; 2 Fisher’s exact test p-value
Conclusion
Increase of the population size is a critical risk factor for acute 
outbreak in farms with endemic PRRS independently of imple-
mented health strategies.
®PROGRESSIS is a registered trademark of Merial in France and else-
where.
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Introduction
The transmission of PRRSv between herds can occur over long 
distance by the introduction of infected animal or semen (1), 
but also over short distances by mechanisms such as aerosols 
or various mechanical/biological vectors (2). Short distance pro-
cesses of transmission could be largely enhanced in high density 
production area, complicating PRRS control at a herd level. 
PRRSv strains sharing a high level of homology are suggestive of 
a common source of infection, and thus can be used to explore 
the temporal and geographical spread of the virus. The objective 
of our study was to determine the correlation between genetic, 
temporal and geographical distances of PRRSv strains in a high 
density area of swine production. 
Materials and Method
As a part of a larger study on the transmission and control of 
PRRS, a census of production sites was conducted in 10 muni-
cipalities located in a high density area (Monteregie) between 
February 2005 and June 2007. PRRS herd status was determined 
by ELISA and qRT-PCR and when PCR positive, sequencing of 
ORF5 was performed. For each production site, geographical 
coordinates were obtained using GPS at the closest building 
from public road. A pairwise alignment of all ORF5 sequences 
obtained was generated in Bionumerics software and genetic 
distances were calculated from nucleotides. Euclidian and 
temporal distances were calculated in SAS (SAS Institute 1989). 
Mantel test procedure was computed in R software to examine 
the correlation among genetic, geographical and temporal dis-
tances. P-values were computed based on 999 permutations.
Results 
PRRS herd status was determined on 191 of the 200 participat-
ing sites, of which 176 were positive for PRRSv. One sequence 
was identifi ed for 132 production sites, which were attended 
by 25 diff erent veterinarians. Independent and integrated 
producers (7 production systems) accounted for 61% and 39% 
of the total. Sequences were identifi ed on farrowing /farrow-to-
fi nish and on weaner/fi nisher sites in a proportion of 58% and 
42%, respectively. Table 1 shows descriptive results of pairwise 
distances included in the distance matrices used to compute 
the Mantel test. The bivariate Mantel test revealed a signifi cant 
association between genetic and temporal distances (rM=0.06 
p=0.04). No signifi cant relationship was found between geo-
graphical distance and either genetic (p=0.68) or temporal 
(p=0.60) distances.
Table 1: Descriptive results of pairwise distances between production 
sites included in the continuous distance matrices (n=8646)
Distance variable mean sd min - max
Euclidean (m) 14957 8458 43-45726
Sampling time (day) 214 159 0-852
Genetic (%) 12 3 0-19
Discussion 
The correlation observed between genetic and temporal distan-
ces revealed that sequences isolated far away in time showed 
more genetic diversity, suggesting possible genetic evolution 
of the virus during the study period. The absence of correlation 
between genetic and geographic distances as previously re-
ported (3) suggests that many processes could be involved in the 
between-herd transmission of the virus at both short and long 
distances. Further analyses will be performed to take into account 
other factors such as corporate organization membership.
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Introduction
Although Porcine Reproductive and Respiratory Syndrome 
(PRRS) and Porcine Circovirus Disease (PCVAD) induce severe 
economical losses in domestic pig farms, most research are con-
centrated on the diagnosis of the causative agent and there is a 
need for more studies on epidemiological analysis of risk factors 
related to the transmission of these diseases. In this study, we 
conducted a survey to identify risks factors for PRRS and PCV2 
infection in pig farms in Korea.
Materials and Methods
Survey was conducted from July 2008 to December 2009 
through on-farm visits and use of questionnaires which were 
designed based on risk factors identifi ed during previous 
epidemiological investigations conducted for Foot-and-Mouth 
Disease and Classical Swine Fever. Also, swab samples were 
collected from various key areas and equipments in the partici-
pating farms and tested to identify the degree of PRRS and PCV2 
contamination during each season in 2009. Samples were tested 
using RT-PCR and nested PCR.
Results
A total of 58 pig farms in 9 provinces were surveyed. In our sur-
vey, the percentage of farms that disinfected the farm entrance, 
pig house entrance, inside of the pig house and farm surround-
ings were 36%, 26%, 22% and 16%, respectively. For tools, equip-
ment and feces removal vehicles, disinfection was conducted in 
93%, 93% and 69% of the farms, respectively when entering the 
farms. In contrast, disinfection was conducted in only 42%, 38% 
and 42% of the farms, respectively when leaving the farms. For 
refrigerators used to store veterinary drugs, 29% of the farms 
responded that they conducted disinfection.
Samples were collected from pig farms during spring, sum-
mer, autumn and winter, which were totals of 6, 14, 24 and 21 
farms, respectively. The percentage of farms where PRRSV and 
PCV2 were detected were 83.33% and 10.00%, respectively 
during spring, 3.35% and 16.32%, respectively during summer, 
19.62% and 38.06%, respectively during autumn, and 39.94% 
and 54.45%, respectively during winter. In particular, investiga-
tion of refrigerators in 6 pig farms during each season showed 
PRRSV and PCV2 contamination in 100% and 33.3% of the farms, 
respectively during spring, 0% and 16.7%, respectively during 
summer, 0% and 66.7%, respectively during autumn, and 0% 
and 80.0%, respectively during winter. Viruses were consistently 
detected from shoes, vehicles or various tools and equipment 
such as wheel barrows and shovels used in the farms, although 
there were slight variations depending on the season. Also, 
there was persistent detection of viruses from the fl oor of pig 
houses.
Discussion 
This study demonstrated that pathogens can be transmitted 
during the movement of people or equipment associated or 
used in pig farms, and the rates of detection of these two viruses 
were diff erent according to the season. Refrigerators could 
become an important source of diseases as viruses in refriger-
ators would be less infl uenced by the diff erence in the season. 
On a positive note, the rates of detection of viruses were lower 
on the secondary tests after the farm had been educated, than 
on the primary investigation. The method used in this study 
including sample collection and epidemiological investigation 
can be applied to the standard surveillance for porcine diseases 
conducted in Korea. Widespread use of this method in the por-
cine industry would result in a more scientifi cally sound surveil-
lance allowing for more eff ective disease control measures to be 
implemented.
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Introduction
 Modeling the spatiotemporal distribution of porcine reproduct-
ive and respiratory syndrome virus (PRRSV) is important in the 
pursuit to understand how PRRS spreads in a population of pig 
herds. The distribution in space and time of PRRSV describes 
part of a set of connections between herds. The objectives of 
this study are to search for trends and clusters in space and time 
of a common genotype of PRRSV in Ontario and to assess the 
importance of ownership structure in of PRRSV genotypes in 
Ontario.
Methods
Herds were eligible for inclusion in the study if a PRRSV positive 
diagnostic sample was identifi ed at the Animal health Labora-
tory at the University of Guelph between Sept 2004 and Aug 
2007. Herd managers who were willing to participate were 
interviewed to determine herd ownership. The ORF5 gene of 
the PRRSV positive sample was sequenced and the RFLP type 
according the University of Minnesota method was determined. 
Spatial and temporal autocorrelation and clustering of the most 
common type, Minnesota RFLP type 1-18-4, were investigated 
using the space-time k-function and the SaTScan Bernoulli 
model. The distribution in space and time was modeled using 
the generalized additive model (GAM). The eff ect of ownership 
on the space-time distribution was tested using fi xed eff ects in 
the GAM for the owners with the largest number of members.
Results
The k-function showed that autocorrelation was present in 
PRRSV type 1-18-4 up to a distance of 6 km and 45 days as well 
as a distance of 12 km and 15 days. A cluster of cases was found 
in the eastern part of the study period lasting 4 months from 
Nov/2005 - Feb/2006 (P=0.046). A trend in the spatial distribu-
tion of type 1-18-4 was found using the GAM (P=0.001) and 
no signifi cant temporal trend was found (P=0.09). An associa-
tion was found between ownership of herds and the presence 
of type 1_18_4 (P=0.005). When ownership was added to the 
space-time model the shape of the spatial trend did not change. 
Two owners had OR= 7.3 (P=0.004) and OR=6.7 (P=0.02) of 
having type 1-18-4, where small owners, those with less than 
6 herds in the study, were at reduced odds, compared to large 
ownerships, of having type 1_18_4 (OR=0.12, P<0.001). 
Discussion
The autocorrelation in cases of 1-18-4 indicates that herds up to 
6 km from a case herd are more likely to be cases if tested within 
45 days of each other but also out to as far as 12km if they are 
tested within 15 days of each other. Type 1-18-4 was also not 
uniformly distributed in Ontario during the study period (Fig 
1a). Although, some of the variation can be explained by the 
ownership structure, a spatial trend remains after accounting 
for ownership (Fig 1b). The shape of the spatial trend did not 
change after accounting for ownership; this is an indication that 
Figure1: GAM of the spatial distribution of RFLP type 1-18-4. The 
ellipse indicates the location of the signifi cant cluster of cases. The top 
fi gure (a) is the smoothed distribution of type 1-18-4 without account-
ing for ownership. The bottom fi gure (b) is the predicted distribution of 
RFLP type 1-18-4 for the owner with OR= 7.3
the spatial eff ect and the eff ect of ownership are not confound-
ed, meaning that the spatial eff ect is not explained by owner-
ship. Further investigation is needed to shed light on the origin 
of this trend. The spatial pattern could be a result of similarities 
of breeding stock, animal or semen suppliers between herds or 
be an indication of transmission between herds. The variables 
describing herd suppliers could not be adequately accounted 
for using these methods and future work will address these con-
nections.
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Introduction
Porcine reproductive and respiratory syndrome (PRRS) is a clinic-
ally variable disease. Clinical signs that are recognized by the 
producer include abortion and anorexia in sows, stillborn and 
mummifi ed piglets, dyspnea, respiratory disease and increased 
mortality in all ages of pigs (1). Isolates of PRRSV are genetic-
ally variable in the ORF5 gene. The association between clinical 
disease and the ORF5 gene have been infrequently investigated 
under fi eld conditions (2). The objectives of the present study 
were to measure the association between RFLP type and clinical 
signs of PRRS in the herd and to assess the association between 
clinical similarity between herds and the similarity of PRRSV 
isolates from the herds. 
Materials and Methods
 Herds were eligible for the study if a PRRSV PCR test result from 
the Animal Health Laboratory at the University of Guelph was 
found between Sept 2004 and Aug 2007. Herd managers were 
surveyed about clinical signs of PRRS in the herd and ORF5 of 
the PRRSV isolate was sequenced. The RFLP type of the virus 
was determined and the genetic similarly of all virus pairs was 
calculated. The similarity of each clinical sign was determined to 
be either similar or dissimilar for all pairs of herds. 
The association between RFLP type and clinical disease was 
tested by regressing each clinical sign on the RFLP types using 
logistic regression (P<0.05 was signifi cant). The association 
between sequence similarity and clinical similarity was tested by 
the Mantel test and the generalized additive model where the 
outcome was similarity of a given clinical sign and the independ-
ent variable was the similarity of the ORF5 gene. 
Results
RFLP type 1-0-4 was associated with increased probability of 
abortion, sows off -feed, stillbirths, weak-born pigs, sow/boar 
mortality, and preweaning mortality. RFLP type 1-0-2, was as-
sociated with clinical disease in the farrowing phase of produc-
tion and type 184 was signifi cantly associated with increased 
abortions. 
The GAM models indicated a signifi cant association between 
PRRSV sequence similarity and similarity of both abortions and 
stillbirths and that the chance of similarity of these clinical signs 
was signifi cantly increased when sequences were >92% similar 
(Fig 1). Including vaccine like viruses in the analyses caused simi-
larly model to decline at the upper end of homology.
Figure 1: GAM models for the association between virus similarity 
abortion similarity and stillbirth similarity.
Discussion
These results indicate that variation in clinical signs of PRRS 
is caused in part by variation in the PRRSV. For abortions and 
stillbirths, PRRSV isolates of >92% homology of the ORF5 gene 
are associated with similar clinical signs. This is in contrast to the 
benchmark where viruses of <98% ORF5 sequence similarity 
are considered diff erent (3). Presence of vaccine type virus in a 
population can have an impact on the interpretation of PRRSV 
epidemiology. Removal of vaccine type observations before an-
alysis may be necessary to interpret studies such as this because 
vaccine isolates are genetically similar but are not expected to 
be associated with similar clinical signs of disease. 
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Introduction
Porcine Reproductive and Respiratory Syndrome (PRRS) is a 
swine disease produced by PRRS virus (PRRSV), which is anti-
genically and genetically heterogeneous (1). PRRSV variability 
extends also to pathogenicity and highly and moderately viru-
lent isolates have been described within the American genotype 
(2). The infection by highly virulent isolates produces severe 
clinical signs, signifi cant gross lung lesions and high levels of vir-
emia (2, 3). In a previous study, we characterized the pathogen-
icity of seven European-type isolates including one isolate which 
virulence was comparable to that described for American type 
isolates (4). The aim of this study was to compare the pathogenic 
properties of this isolate with that exhibited by a European type 
isolate of remarkable low virulence.
Materials and Methods
Two European-type isolates were used in this study. Additionally 
a modifi ed live vaccine strain, Ingelvac PRRS, was used as an at-
tenuated control. European isolates were propagated in porcine 
alveolar macrophages (PAM) and the fi fth passage was used for 
pig inoculation. Vaccine strain was used directly from the bottle. 
For pig inoculation, a total of 45 3-week old piglets seronegative 
to PRRSV were divided into 3 groups. On Day 0 of the experi-
ment piglets of groups A, B and C were inoculated intranasally 
(IN) with 5 x 105 TCID50 of highly virulent isolate, low virulent 
isolate and vaccine strain, respectively. All pigs were examined 
daily for clinical signs and rectal temperatures were recorded 
until the end of the experiment. Biological samples, including 
serum, nasal and rectal swabs were collected every three days. 
Five piglets per group were sacrifi ced on days 7, 14 and 21 post-
infection (p.i.) and diff erent tissue samples were collected. At 
necropsy macroscopic lung lesions were evaluated. Determina-
tion of viremia and organic distribution were carried out by virus 
isolation as previously described (5) on cultures of PAM in the 
case of fi eld isolates and MARC 145 in the case of vaccine strain. 
Clinical and viremic results for each pig were converted to an ap-
proximate area under the curve (AUC) and a complete statistical 
study was carried out to estimate diff erences between groups. 
Finally, a cluster analysis of clinical and virological parameters 
was performed.
Results
After inoculation, severe clinical signs were observed in pigs ex-
posed to highly virulent isolate, leading to a AUC values of 5.13, 
8.0 and 0.4 on the fi rst, second and third week p.i. On the con-
trary, pigs infected with low virulent isolate and vaccine strain 
remained clinically normal throughout the experiment, refl ected 
in AUC values that never exceeded 0.5. Seemingly, fever was 
only recorded in pigs exposed to highly virulent isolate, namely 
from day 2 p.i. to day 10 p.i. Consistently with the clinical score 
macroscopic lung lesions were more severe in pigs inoculated 
with the highly virulent isolate.
Looking at the virological parameters, viremia was more intense 
with statistically signifi cant diff erences in those pigs inoculate 
with highly virulent isolate. Additionally, highly virulent virus 
was isolated more frequently from tissue samples than low 
virulent or vaccine strain, being viral load also higher in the 
former group. Finally, remarkably low virulent isolate was never 
detected in any swab, indicating a very low shedding rate. 
The apathogenic phenotype of the low virulent isolate was con-
fi rmed by the grouping of pigs of this group with those infected 
with the vaccine strain in the cluster analysis.
Discussion
This is the fi rst description of the existence of highly pathogenic 
and apathogenic PRRSV isolates within the European type. The 
ultimate causes of the diff erences in pathogenicity between 
these two isolates were not elucidated in our study. However, 
there are strong indications that the replication rate of the iso-
lates and the organic distribution in the pigs upon inoculation 
can determine their virulence.
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Genetic variation and pathogenicity of the recently isolated PRRSV in Korea
Hyun Jang; Ji-Youl Jung; Sung-Su Park; Seong-cheol Moon
Komipharm International Co. LTD, Gyeonggi-do, Korea
Introduction 
The porcine reproductive and respiratory syndrome virus 
(PRRSV) is the causative agent of porcine disease, which has 
respiratory failure in neonate and abortion in sow. The PRRS is 
one of the most serious endemic diseases to swine producing 
countries and heavy economic burden due to the high mortal-
ity rate in infected pig. PRRSV is a positive sense single stranded 
RNA virus of the family Arteriviridae. The genome of PRRSV con-
sist nine ORFs. Among nine ORFs, ORF5 and Nsp2 gene show the 
highest genetic variations. Especially ORF5 gene encodes GP5 
major surface protein, which is major inducer of neutralizing 
antibodies in vivo. GP5 protein is presumed to interact with sia-
loadhesin. Recently isolated PRRSV show diff erent glycosylation 
pattern in the GP5 protein and is also related with pathogenicity 
of PRRSV. The aims of this study are analyze genetic variation 
in the ORF5 gene and its relation to pathogenicity of recently 
isolated PRRSV in Korea 
Materials and Methods
PRRSV isolated lung tissue samples from pig, which was show 
typical clinical signs of PRRSV infection in the fi eld. Homogenate 
lung tissue clarifi ed by centrifugation and supernatant fi ltered 
using 0.22 μm membrane fi lter and then inoculate into mono-
layer forming Marc145 cell. 3 to 5 days after inoculation, virus 
harvested and quantifi ed virus concentration. GP5 protein gene 
amplifi ed using PCR method and sequenced and then analyzed 
and compared with previous reported GP5 gene sequence. 
PRRS negative pigs were inoculated intratrchealy with isolated 
PRRSV (Komi-NA263, Komi-NA316 each virus titer adjusted 105.0 
TCID50/ml) for pathogenicity test. After challenge clinical signs, 
body temperature and virus shedding observed every day and 
autopsy was performed for examination of pathological lesions. 
Results
Two fi eld isolated PRRSV Komi-NA263 and Komi-NA316 ORF5 
gene sequence show 94 % and 87 % respectively. But both 
strains was show identical pathogenicity, such as high fever, 
virus shedding through nasal and respiratory distress. Grossly 
there was pulmonary edema and multifocal red spots in the 
lung. Enlargement of spleen and lymph nodes were also 
observed. Viral antigens in the lung also detected by immuno-
histochemical staining. GP5 amino acid sequence at 34 and 35 
of the both strains was asparagine and serine respectively. This 
positions were major glycosylation site at ectodomain of the 
GP5 protein. 
Discussion 
The major envelope protein GP5 is the most variable structural 
protein in PRRSV. In this study virulence of the PRRSV was related 
to specifi c amino acid sequence change by the accumulation of 
mutations rather than overall genetic variations
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PRRS strain diversity in a European pig production area 14 years after the primary infection
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Introduction
The porcine reproductive and respiratory syndrome (PRRS) 
virus is widely distributed over the various pig production areas 
worldwide.
The diversity of the American PRRS strains has been well docu-
mented. That of the European strains has been described only 
recently (1, 2). The aim of this study was to describe the diversity 
of the PRRS strains present in a European pig production area 
that was contaminated in 1991 and has around 7000 pig farms.
Materials and Methods
The study carried out used the blood samples of piglets (9, 12 
and 15 weeks of age) of breeder-fattener farms, taken over a 
period of 4 months (December 2004 to March 2005). The farms 
were known to be infected and had or had not observed signs 
that could be attributed to PRRS (in breeding animals and grow-
ing pigs). After screening the serum samples using a PCR kit 
allowing the detection of European and US strains of the PRRS 
Virus (Adiavet®PRRS), amplifi cation and sequencing of ORF7 
and ORF5 genes were carried out for each farm (one sample per 
farm). Sequence alignment and analysis was carried out using 
CLUSTALW (1.82), Lasergene (DNAStar) and PHYLIP 3.67 program 
packages. For the comparative analysis, selected sequences 
representing the full range of European genotype diversity were 
used.
Results
In total 51 ORF7 and 46 ORF5 were obtained. All sequences 
obtained were of the European genotype. The identity with the 
Lelystad strain was 91 to 100% for ORF7 and 82 to 98% for ORF5. 
These sequences were also highly similar to the FR/IV4A strain, 
isolated 14 years earlier at the time of the introduction of PRRSV 
in the region (Fig. 1).
No clusters were found in association with the clinical signs 
observed or with the geographical proximity of the farms.
Discussion 
The results of this study underline the very high genetic identity, 
both between the isolated strains and compared to the Lelystad 
strain. This fi nding is rather unique considering the genetic 
diversity in many European countries (3,4), where the hetero-
geneity of the strains is much higher. In the region studied, the 
initial outbreak occurred in 1991 with a strain closely related to 
the Lelystad strain (5). It can be concluded that the great major-
ity of the farms in this region were infected at the time of the ori-
ginal outbreak or later but with the strains originating from the 
original introduction. Only in 4 farms the strains were found to 
be unrelated. Since 1991, no new strains have been introduced 
and the original strains seem to have undergone a ‘natural drift’.
Figure 1. Phylogenetic tree based on the ORF5 sequence of the strains 
studied. 
References
1. Stadejek, T .et al.(2002). J.Gen.Virol. 83, 186-1873
2. Mateu, E. et al.(2003). J.Gen.Virol. 84, 529-534
3. Stadejek, T. et al. (2006). J. Gen. Virol. 87, 1835-1841
4. Cay, AB.et al.(2006). Proc.19th IPVS Vol.2, 9
5. Albina E. et al. (1998). Vet. Res. 54, 1.
Acknowledgements
Intervet and Merial are acknowledged for their fi nancial support.
.
Porcine Reproductive and Respiratory Syndrome (PRRS) – Genetics
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 501
Poster Presentations
P.195
Genetic diversity and evolution of Porcine Reproductive and Respiratory 
Syndrome virus in a large sequence data set from Quebec swine herds
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Universite de Montreal, St-Hyacinthe, QC, Canada
Introduction
Porcine reproductive and respiratory syndrome virus (PRRSv) 
is known to be genetically highly variable; knowledge of this 
diversity within a geographical region may help to understand 
the epidemiology of the disease as well as the evolutionary drift 
in GP5 amino acid sequences. The purposes of our study were 
to classify the genetic diversity of PRRS in subgenotype clusters 
for various strains aff ecting herds in the Province of Quebec, and 
also to evaluate amino acid (a.a.) variation in vaccine-like strains 
found in the fi eld. 
Materials and Methods
As part of a PRRS surveillance project, samples were submitted 
by veterinarians over an 11-year period. Samples originated 
either from herds 1) experiencing reproductive or respiratory 
problems, 2) monitoring regularly their PRRS status, or 3) partici-
pating in a research project on risk factors for PRRS (see abstract 
by Lambert et al. in this IPVS proceeding). A total of 1345 ORF 
5 sequences from 659 production sites were obtained. RT-PCR 
and sequencing were done to obtain ORF5 gene. A dendrogram 
was made by phylogenetic analysis with the Neighbor-Joining 
algorithm in the Bionumerics software. Two diff erent subsets 
were constructed and analyzed by phylogenetic alignment and 
selective evolutionary pressure by non-synonymous to syn-
onymous rate, dN-dS (SNAP web utility and PAML 4.3) 
Results
The fi rst and largest dataset consisted of 520 sequences ob-
tained after excluding redundant sequences, e.g. those with 
more than 98% of homology. Following a clustering analysis, 
28 diff erent groups were obtained. Half of the clusters were 
primarily composed of cases submitted in the earlier part of the 
surveillance project (2004-2006), whereas some others mainly 
included more recent cases (2007-2009), suggesting temporal 
variations in strain proliferation and consequently, its evolution. 
Some geographical clustering could also be observed. Amino 
acid non-synonymous substitution was generally high in the 
GP5 peptide signal region but also in two hypervariable regions 
(HVR) located between aminos 32-35 and 57-59 for all clusters. 
Very few amino substitutions were observed in the principal 
neutralizing epitope (PNE) between aminos 36-52, which is 
fl anked by both HVR.
The second dataset extracted from the database focused on 
PRRS vaccine and vaccine-like strains. A total of 159 PRRS MLV-
like and 46 PRRS ATP-like deduced a.a. sequences were obtained. 
A comparison of these strains found in the fi eld with both vac-
cines and their parental strains (VR2332 and JA142) showed that 
a single amino, F101, was conserved when compared to actual 
and past wild-type fi eld strains. Also, separate comparison of 
both vaccine-like fi eld strains collected revealed that MLV-like 
had undergone very little a.a. variations in the last 2/3 of the GP5 
amino acid sequence, as compared to ATP-like strains which had 
undergone more variation thru synonymous mutations (nega-
tive selection) and some non-synonymous mutations (positive 
selection). Positive selective pressure was statistically signifi cant 
([1-P] value was ≥98.5%) for 7 a.a. sites in MLV-like (3, 13, 32-34, 
58 and 151) and 5 a.a. sites in ATP-like strains (32, 57-59 and 102).
Discussion
The interpretation of low or high PRRS subgenotype viral spread 
through time in aff ected regions can possibly help in predicting 
trends in emerging strain clusters. Even though some clusters 
could be attributed to temporal evolution or geographical 
area, the proportion or importance of each of these factors 
will have to be estimated. Further analysis of these clusters by 
SNAP showed PNE region to be relatively well conserved among 
clusters (1). This might indicate molecular constraints in possible 
viral receptor recognition site as seen for other RNA viruses (2,3).
The mutation found on almost all vaccine and vaccine-like 
strains can help distinguish fi eld strains from vaccine derived 
fi eld strains, therefore fulfi lling a need for a typing tool, this is 
particularly important considering possible reversion to viru-
lence by these vaccine like-strains (4). Analysis of these clusters 
by SNAP showed slightly diff erent patterns of evolution. Position 
of sites under selective pressure might indicate a link between 
PNE (conserved region) and adjacent HVR. The factors implicat-
ed in selective pressure and evolution of vaccine derived strains 
remain to be clarifi ed.
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Genetic analysis and typing of PRRSV isolates in ORF5 and ORF7 
originating from pig farms in Central Europe
Stefan Vilcek; Anna Jackova; Michaela Vlasakova; Valeria Leskova
University of Veterinary Medicine and Pharmacy, Kosice, Slovak Republic
Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV) 
is emerging pathogen causing serious clinical problems in pig 
farms around world. The viral genome consisting positive-single 
strand RNA is evolutionary diverse. PRRSV exists in two geno-
types: European (EU) genotype, type 1 (PRRSV-1) and North 
American (NA) genotype, type 2 (PRRSV-2). Based on nucleotide 
sequence variability EU genotype is genetically divided (Stadej-
ek et al., 2006) forming three subtypes (Stadejek et al., 2008). The 
aim of this work was to contribute to genetic characterization of 
PRRSV isolates collected in Central Europe, namely in Slovakia, 
The Czech Republic and Austria by their analysis in ORF5 and 
ORF7 regions.
Material and Methods
Ten viral samples (serum, lymph nodes, and lung) from pig farms 
in Slovakia, 10 viruses from The Czech Republic and 10 viral 
samples from Austria were collected in the period of last 5 years 
from clinically suspicious animals showing respiratory problems. 
The total RNA was extracted using Trizol reagent (Invitrogen) ac-
cording to the manufacturer´s manual. The cDNA was prepared 
using gene specifi c primer and SuperScript reverse transcriptase 
(Invitrogen). ORF5 and ORF7 fragments were prepared by a 
nested RT-PCR using outer and inner primers according to Olek-
siewicz et al. (1998) and Drew et al. (1997). Purifi ed PCR products 
were sequenced using automatic sequencer ABI PRISM. Partail 
ORF5 sequences (432 nt) and entire ORF7 were assembled using 
SeqMan. The alignment was carried out and percentage of nu-
cleotide identity were calculated using MegAlign (DNASTAR). 
Results
All 30 PRRSV strains from Slovakia, The Czech Republic and 
Austria were typed in both genomic regions, e.g. ORF5 and 
ORF7, as EU genotype (PRRSV-1), subtype 1. No geographic 
distribution of PRRSV isolates were observed in the phylogenetic 
trees. However, the grouping of viruses according to farms, espe-
cially with isolates from Slovakia was observed. Percentage of 
nucleotide sequence identity in ORF5 between Slovakian strains 
varied in the range 83.6-100 %, Czech strains – 82.6-100 % and 
Austrian strains – 84.5-98.1 % . Similar values were obtained 
when sequences were compared to the European genotype 1 
prototype strain Lelystadt: 85.4-89.1 %, 85.0-98.6 %, 89.4-98.6 %. 
Corresponding values in ORF7 were as follows: 87.3-100 %, 87.6-
100 % and 91.5-100 %, to Lelystadt strain: 90.7-93.3 %, 89.4-100 
% and 94.6-98.7 %.
When compared amino acid sequence (aa) for entire ORF7 
region, in all strains analyzed the size of this region was the same 
- 128 aa. However, the polymorphism in ORF7 size reaching 132 
aa in two isolates from a pig farm in Slovakia was observed. The 
size was not the result of insertion/deletion of amino acids but 
longer ORF7 at C-terminus.
Discussion
Our work contributes to information on genetic characteriza-
tion of PRRSV isolates in pig farms of Central Europe. The isolates 
belong to EU genotype, as it is prevalent in other western Euro-
pean strains (Fosberg et al., 2002) independently if they were 
analyzed in ORF5 or ORF7 genomic regions. On the other hand 
our results revealed new and the fi rst time observed polymorph-
ism on ORF7 size since two isolates had ORF7 size 132 aa, diff er-
ing from standard size – 128 aa for PRRSV-1, subtype 1 isolates. 
Recently it has been suggested that the ORF7 size 128 aa can 
be used as characteristic parameter for typing of EU genotype 
(PRRSV-1), subtype 1 strains (Stadejek et al., 2008). The results of 
our work indicate that two strains from Slovakia failed this criter-
ion. Reason for ORF7 size polymorphism is not clear at present.
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Genetic diversity of European genotype PRRSV in Central and Eastern Europe – An update
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Introduction
A high degree of variability exists within European genotype 
of porcine reproductive and respiratory syndrome virus (EU-
PRRSV). The EU-PRRSV strains can be grouped into several sub-
types based on the sequence of the ORF7 gene coding for the 
capsid protein (2). While in majority of Europe relatively similar 
strains circulate, having ORF7 387 nucleotides long (subtype 
1), the East European countries like Latvia, Lithuania, Belarus, 
Ukraine and Russian Federation harbor extremely diverse strains 
with ORF7 size from 375 to 393 nucleotides that belong to mul-
tiple genetic subtypes (2, 3). Exploring variability of the ORF7 
is of major importance because it can infl uence the sensitivity 
and specifi city of the PCR and serological diagnostic methods (1, 
2). Here we determined the ORF7 sequences of PRRSV from re-
cently obtained samples from Latvia, Lithuania, Belarus, Ukraine, 
Russia, Poland, Hungary, Croatia and Serbia.
Materials and Methods
Samples of serum, aborted fetuses or lungs were submitted for 
diagnosis to the authors’ laboratories. Total RNA was extracted, 
complete ORF7 sequences were amplifi ed and sequenced with 
diff erent methods used in the laboratories. The sequences were 
assembled and analysed using programs from the Lasergene 
program package, (DNASTAR) and the CLC Sequence Viewer 
(CLC Bio). As a reference, a set of 69 ORF7 sequences repre-
senting the full range of EU-PRRSV diversity was used.
Results
A total of 28 complete ORF7 sequences representing fi eld PRRSV 
strains from, Latvia (1), Lithuania (3), Belarus (3), Ukraine (1), 
Poland (5), Hungary (8), Croatia (4) and Serbia (3) were obtained 
and all of them were classifi ed to the European genotype. Their 
analysis showed that Polish, Hungarian, Croatian and Serbian 
strains were closely related and had ORF7 consisted of 387 nu-
cleotides characteristic for subtype 1 strains. On the other hand, 
the new Latvian, Lithuanian, Belarusian and Ukrainian ORF7 
sequences were distantly related to those from abovementioned 
countries and exhibited extensive but expected size polymorph-
ism (375, 378 or 387 nucleotides) as it was shown before (2, 3). 
Discussion
This collaborative report provides another evidence for already 
well documented extreme diversity of EU-PRRSV. The position of 
the most diverse strains in the countries formerly being part of 
the Soviet Union (Latvia, Lithuania, Belarus, Ukraine and Russia) 
indicates that the EU-PRRSV could have emerged there. Pos-
sibly only a single variant of the genotype diff used westward 
giving the origin to the presently globally spread subtype 1. The 
oldest serological evidence of PRRSV in Europe comes from East 
Germany from 1986. The fi rst PRRS outbreak in Europe occurred 
also in Germany at the time of the country’s re-unifi cation in 
1989. These two pieces of evidence suggest that the source 
of virus for the fi rst outbreak could be in East Germany. PRRS 
was recognized in Central Europe a few years later than in West 
Europe and several anecdotal reports pointed that the infection 
occurred after importation of pigs or contaminated semen from 
West Europe. However, it cannot be excluded that before the 
European epidemic PRRSV was present not only in East Germany 
but also in other countries of Central Europe. In summary, the 
presented data confi rm that the strains from Central and West-
ern Europe are closely related and have common origin while 
the strains from East Europe are much more diverse. 
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Broad cross protection against PRRS induced by chimeric viruses containing mixed 
structural gene fragments from distinct heterologous PRRS viruses
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Introduction
PRRS virus (PRRSV) is one of the economically signifi cant patho-
gens in the swine industry throughout the world. Vaccines can 
be an intervention tool, but a high degree of genetic variation 
among PRRSVs makes the protection induced by a monovalent 
vaccine limited to its homologous virus strains, impeding eff ect-
ive prevention of PRRS. Thus vaccines that can produce broad 
protection against heterologous viruses are highly desired for 
better control of the disease. 
PRRSV GP5 is known to play a major role in the induction of anti-
PRRSV neutralizing antibody. Yet, our recent study has demon-
strated that GP3 and M also signifi cantly contribute to cross-
neutralization between diff erent PRRSVs.1 Furthermore, GP3 was 
more critical than GP5 or M in overall virus neutralization against 
a PRRSV strain whose GP5 is highly glycosylated. Therefore, it 
was hypothesized that a chimeric virus of 2 distinctive PRRSVs 
can confer better cross-protection against those viruses if neces-
sary genes from the 2 viruses are put together in a structured 
manner based on their prime role in virus neutralization. 
Materials and Methods
To test the hypothesis, 3 chimeric viruses designated as JAP5, 
JAP56 and JAP2-6, respectively, were generated from the 
VR2332 infectious cDNA clone by replacing its ORF5, ORFs 5 and 
6 or ORFs 2-6 with that/those of the JA142 strain that is genetic-
ally and antigenically distinct from the VR2332 strain. A total of 
114, 3-week-old pigs were divided into 6 groups and each group 
was inoculated with one of the chimeric viruses, VR2332, JA142, 
or sham inoculum. At 44 days post inoculation (dpi), 8 pigs each 
within each group were randomly selected, housed separ-
ately and challenged intranasally with VR2332, JA142, or sham 
inoculum to determine if protective immunity was conferred by 
inoculation of the chimeric viruses. All pigs were bled periodic-
ally until 72 dpi and tested for viremia and antibody response. 
Half of the pigs in each room were necropsied at 14 days after 
the challenge and the remaining at 28 days for pathological 
evaluation.
To further assess the validity of chimeric virus strategy, 12 addi-
tional chimeric viruses randomly combining ORFs 2-4 and ORFs 
5-6 of four antigenically and genetically distinct PRRSVs (1648-
02, 17198-2, MN184 and SDSU73) were constructed using the 
VR2332-backbone infectious clone. Antisera against each donor 
virus were generated in 3-week-old pigs which were euthanized 
at 45 dpi. Neutralizing activity of each serum against each of the 
chimeric viruses was tested in vitro by a two-way fl uorescent-
foci neutralization assay.
Results
JAP56 was well neutralized in vitro by antisera raised against 
each of the donor strains whereas each donor strain was neutral-
ized only by the homologous antisera. In pigs, the prior inocula-
tion with JAP5 or JAP56 eff ectively protected the pigs from the 
challenge with VR2332 while the pigs inoculated with JAP56 or 
JAP2-6 demonstrated excellent protection against JA142 infec-
tion, suggesting that the JAP56 chimeric virus may be used as a 
vaccine candidate to induce broad cross-protection against both 
VR2332 and JA142.
As observed with the VR2332 and JA142 chimeric viruses, 
antisera generated against other donor viruses neutralized each 
of the chimeric viruses containing ORFs 2 to 4 from one strain 
and ORFs 5 and 6 from another as eff ectively as the homolo-
gous donor virus, while little cross neutralization was observed 
among the donor viruses.
Discussion
These observations suggest that the strategy of constructing 
chimeric viruses by combining structural genes from distinct 
heterologous strains in an organized manner can provide broad 
protection and can be widely applicable as a novel vaccine 
platform for PRRSV.
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type porcine reproductive and respiratory syndrome virus isolates
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Introduction
One of the main characteristics is its great variability. The 
extensive heterogeneity observed at the genomic level is likely 
to cause wide antigenic diff erences among the diverse PRRSV 
isolates and, in fact, signifi cant diff erences have been reported 
between diff erent isolates (1). However, current knowledge of 
antigenic variability of PRRSV is rather limited compared to the 
existing information on genomic diversity. Consequently, the 
main objective of the present study was to characterize Euro-
pean-type porcine reproductive and respiratory syndrome virus 
isolates by means of cross-neutralization assays, studying the 
possibility of the existence of serogroups, and to verify whether 
genotypic relationship refl ect antigenic associations between 
PRRSV isolates.
Materials and Methods
Twenty nine PRRSV isolates were used in this study, of which one 
belonged to genotype II and was isolated in Denmark and 28 
belonged to the European genotype. Of these 17 were Span-
ish isolates, 5 originated from Western Europe, 4 from Italy and 
2 from Poland and Czech Republic, respectively. These isolates 
were adapted to replication in MARC-145. ORF5 of all isolates 
were amplifi ed and sequenced and a phylogenetic tree was 
constructed. Monoespecifi c antisera against these isolates were 
produced in 6-month-old PRRSV seronegative pigs and used in 
seroneutralization (SN) assays performed as described by Yoon 
et al (2). Homologous SN titers were adjusted to a titer of 1:128 
either by dilution or concentration by antibodies precipitation 
using ammonium sulphate. All sera were used in cross neutral-
ization assays, and heterologous titers were used to estimate 
antigenic similarity coeffi  cients (R) that were used to construct a 
dendogram (3).
Results
The dendrogram obtained shows that the PRRSV isolates are 
antigenically diverse and are segregated into a considerable 
number of groups. When we use R values ≥ 25, which have been 
previously associated with signifi cant antigenic diff erences (3), 
19 diff erent groups are defi ned, of which only 5 comprise more 
than one isolate. The comparison of antigenic and genomic 
dendograms indicates that there is no correlation between 
antigenic and genomic clustering of PRRSV isolates. Analysis 
of ORF5 and particularly of neutralizing epitope sequences 
or potential N-glycosilation sites is not predictive of antigenic 
similarity.
Discussion 
The results of our study show that antigenic diversity among 
European isolates is signifi cant and that no clear antigenic 
groups can be defi ned. Additionally the comparison of the anti-
genic and genomic dendograms indicated a lack of correlation 
between antigenic and genetic classifi cation of PRRSV isolates. 
Figure 1. Antigenic dendogram of PRRSV isolates
 
Figure 2. Genomic dendogram of PRRSV isolates
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Introduction 
The objective of this research was to quantify the likelihood of 
PRRSV transmission via aerosols as a function of exposure dose. 
This data is critical to understanding of airborne transmission of 
PRRSV between pigs, within herds, and betwe en herds. 
Materials and methods 
The study used PRRSV isolate MN-184 (kindly provided by Dr. 
Scott Dee, UMN). All procedures were approved by the Iowa 
State University IACUC committee (#9-07-6429-S). All pigs were 
confi rmed PRRSV negative prior to commencement of the 
experiment and were housed in HEPA-fi ltered isolation units 
throughout the experiment to avoid inadvertent transmission of 
pathogens. 
The study was conducted in 10 replicates, 10 pigs per replicate, 
with pigs randomly assigned to treatment. One negative control 
pig and one positive control pig were included in each repli-
cate. The negative control pig was used to validate biosecurity 
procedures, i.e., was present in the laboratory during the aerosol 
exposure treatments, was housed in the same room as pigs 
exposed to PRRSV aerosols, and was monitored throughout 
the observation period. The positive control pig was inoculated 
intramuscularly with 10 ml of fl uid from the last air sample in 
each run to prove that infectious, airborne PRRSV was in the air 
to which pigs were exposed throughout the experiment.
Figure 1: Cartoon depiction of aerosol exposure. [A] Nebulizer with 
PRRSV, [B] Impinger for sampling cloud, [C] Aerosol reservoir, [D] Spi-
rometer
To conduct the experiment (Figure 1), PRRSV MN-184 was aero-
solized [A] into a dynamic aerosol toroid [C]. Pigs to be exposed 
to the PRRSV aerosol were anesthetized, fi tted with a canine 
surgical mask attached to a pediatric spirometer [D]. Each pig 
respired 10 liters of virus aerosol. Air samples [B] were collected 
before and after each pig were used to estimate the exposure 
dose. Serum samples collected 5 and 10 days post-exposure 
(DPE) were tested for the presence of PRRSV to determine 
whether exposure resulted in infection. The dose-response 
curve for exposure to airborne PRRSV was derived from the 
proportion of pigs infected by dose. 
Results
Three replicates were disqualifi ed due to failure to meet quality 
criteria; therefore, the infectious dose 50 (ID50) estimate was 
based on 7 replicates. Initial analysis showed that the infective 
dose 50 (ID50) of MN-184 under the parameters of this study 
(pig body size and age, exposure dose and time) was <1 x 101 
TCID50. 
Discussion
Under comparable conditions, the ID50 estimate we report 
for MN-184 is lower than the ID50 estimate for isolate VR-2332 
(Hermann et al., 2009). The data suggest that the ID50 for air-
borne PRRSV may vary among isolates and supports reports of 
transmission of PRRSV via aerosol (Dee et al., 2005). 
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Introduction 
The FAO (1999) estimates that at least 25 % of world grain and 
seed production is contaminated by fungi and their mycotoxins, 
and are considered as one of the greatest risks that aff ect human 
and animal health (1). The fumonisins have been associated with 
certain diseases in animals such as the leucoencefalomalacia 
in equines (ELEM) and pig lung edema (PLE) (3). The porcine 
reproductive and respiratory syndrome (vPRRS) has economic-
ally impacted the national and international swine industry, for 
20 years
Material and Methods
The reference Strain ATCC 2332 of the PRRS virus was cultivated 
in MA-104 African Green monkey kidney cells, and the pigs were 
challenged with 104 TCFF50 /ml. The FB1 used was a standard 
(SIGMA), in 5 mg and 10 mg vials with 98 % purity. A stock solu-
tion was prepared at a concentration of 87ppm in distilled water. 
The FB1was administered to weaned pigs in 12ppm (mg/kg live-
weight) by the oral route by means of a probe.
Experimental animals: Twenty fi ve recently weaned pigs 22-36 
Days of age, with a weight of 4.17 to 7.6 kg, from a vPRRS free 
farm were used. The animals were distributed into 5 groups; 
each group consisting of fi ve pigs Group A: negative Control. 
Group B: Treated with FB1 12 ppm on day 0 (beginning of the 
experiment). Group C: inoculated with PRRSv on day 8. Group D: 
inoculated with vPRRS on day 0 and simultaneously intoxicated 
with FB1 12ppm. day 0 day 0. Group E: intoxicated with FB1 
12ppm on day 0 and inoculated with vPRRS on day 8. Blood was 
collected in vacuum tubes containing EDTA on days 0, 8, 16 and 
18, for processing by the nested RT-PCR technique to identify 
the PRRSv. For the histopathological study samples of kidney 
were collected and fi xed in 10 % buff ered formalin for further 
processing (4) and fi nally stained with hematoxylin and eosin.
Results
The nested RT-PCR was negative for groups A and B. For groups 
C, D and E which were inoculated with PRRSv were positive. 
Histopathology in Group A was without evi9dent pathological 
changes. The kidney damage was observed in groups B, D and 
E, and was characterized by basophililic cytoplasm in the cells 
of the tubules, suggestive of immature cells in the process of 
repair, on these tubules in presented polyploidy and in most of 
the observed lesions the tubules did not showed light (aberrant 
repair, non functional). These are located next to the glomerulus 
and areas of straight interlobulillar tubules, so probably corres-
pond to the proximal convoluted tubules. In most cases, it was 
observed mononuclear cell infi ltration in association with these 
damaged nephrons. At the glomerular level very cellular and 
swollen glomeruli were observed, suggesting proliferative glom-
erulitis. We also observed in lesser quantities retracted, smaller 
atrophied glomeruli. In some sections the interstitial cortical 
area showed mononuclear infi ltration, but rarely the medullary 
level.
Discussion
The kidney lesions observed are suggestive of toxic processes, 
apparently in proximal convoluted tubules, that can relate to the 
presence of FB1, of which there are no previous reports in pigs, 
only in rodents (5), so we suggest conducting trials to evaluate 
these eff ects. Glomerulonephritis and the PRRSv can lead to a 
hipoproteínemia and to the development of edema. In Group 
C, where only PRRSv was applied, we also noted kidney injuries, 
it was noteworthy since the presence of these alterations in this 
pathology is not common. It has been reported kidney lesions 
associated with infection of the PRRSv, showing infl ammatory 
infi ltration observed in renal cortex and Medulla, as well as renal 
vascular changes (2). 
Conclusions
It would be desirable to focus an investigation that concentrates 
in assessment of renal damage in pigs by FB1
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Introduction
Apoptosis is a strictly regulated mechanism of cell death that 
involves a complex network of biochemical pathways. Whether 
a cell undergoes apoptosis or not depends on a delicate balance 
of anti- and pro-apoptotic stimuli (1). This phenomenon can 
be induced by two diff erents pathways: intrinsic and extrinsic 
pathways (2, 3). The main aim of this study was to determine the 
ideal fi xative and antigen retrieval method in porcine paraffi  n 
embedded tissues for the immunohistochemical detection of 
apoptosis mediators, from both extrinsic and intrinsic pathways. 
Materials and Methods
To carry out this study we used 5 week old pigs from a previ-
ous experiment (4) in which the animals were inoculated with 
a European PRRS virus strain. From this previous experiment 
we selected animals that were caspase 3-positive and TUNEL-
positive. At the necropsy samples from the lung, tonsil and 
retropharyngeal lymph node were collected and fi xed in diff er-
ent fi xatives: 10% neutral buff ered formalin, Bouin´s solution 
and Zinc salts solution. Four μm sections were performed and 
6 primary antibodies were used for the immunohistochemical 
study: caspase 3, caspase 8, caspase 9, bcl-2, Fas, iNOS; and a kit 
for TUNEL technique. Diff erent antigen retrieval methods were 
carried out: no pretreatment, Tween 20, Citrate microwave and 
Proteinase K. All the samples were evaluated determining the 
intensity of the positive reaction as well as the background. In 
addition, the number of cells per mm2 or structure (lymphoid 
follicle, paracortex, or medulla) and the main cells immuno-
labelled against each antibody were examined 
Results
The best fi xative and antigen retrieval method for the antibodies 
against caspase 8 and Fas (extrinsic pathway of apoptosis) were 
Zinc salt fi xative and Citrate microwave unmasking technique. 
To determine the intrinsic pathway the ideal fi xative and antigen 
retrieval method for each antibody was as follows: for caspase 9, 
fi xation in Zinc salt solution and antigen retrieval with Tween 20; 
for Bcl-2 and iNOS the optimal immunolabelling was observed 
in 10 % neutral buff ered formalin fi xed samples and with Pro-
teinase K and Citrate microwave as antigen retrieval methods, 
respectively.
The main cells immunolabelled against each antibody were 
macrophages and lymphocytes from paracortical areas (T-cell 
areas) of lymphoid organs and from the alveolar septa of the 
lung. Occasional immunolabelled cells were also observed in the 
lymphoid follicles (B-cell areas) of the retropharyngeal lymph 
node and tonsil and in the alveoli of the lung. Few neutrophils 
showed positive immunostaining against caspase 9 and iNOS 
antibodies.
Discussion
Our results show useful new tools which may be used to study 
apoptosis phenomena and to deep in the knowledge of the 
pathogenesis of several porcine diseases.
References
1.  Costers et al. (2008) Arch Virol 153:1453-1465.
2.  Roy et al. (2000). J. Exp. Med. 192, F21–F26.
3.  Mitchell and Cotran (2007). Basic Pathology, 8th Edit., pp. 19-22.
4.  Gómez-Laguna et al., 2009. J Comp Pathol 
 
Porcine Reproductive and Respiratory Syndrome (PRRS) – Pathology
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 509
Poster Presentations
P.203
PRRSV is the most frequently diagnosed respiratory pathogen in Austrian pigs
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Introduction
Respiratory diseases cause important economic losses in in-
dustrialized pig production. As respiratory diseases are mainly 
caused by multiple infections, these are referred to as porcine 
respiratory disease complex (PRDC). Viral pathogens, especially 
the Porcine Reproductive and Respiratory Syndrome Virus 
(PRRSV) and the Porcine Circovirus Type 2 (PCV2), are important 
players within the pathology of PRDC (1-3). Therefore an exact 
etiological diagnosis is of great importance for eff ective man-
agement of respiratory diseases.
Materials and Methods
A total of 677 pigs (494 weaned piglets, 151 fattening pigs, 11 
gilts, 21 sows), which had been submitted to the clinic for swine 
of the University of Veterinary Medicine Vienna for diagnostic 
reasons due to respiratory distress in the course of three years, 
was sacrifi ced and post mortem analysed by means of standard 
bacteriological analyses and serological measurements using 
commercially available ELISA kits. 
Results
Most frequently, PRRSV could be identifi ed as etiological agent 
in weaned piglets (34.7 %) as well as in fattening and breed-
ing pigs (50.5%). A. pleuropneumoniae was isolated out of 21.3 
% of weaners and 31.1 % of pigs over 30 kg BM. In weaners, 
α-hemolysing streptococci could be isolated out of 20.6 % and 
P. multocida out of 16.6 % of cases, whereas in fattening and 
breeding pigs the corresponding percentages were 17.4 and 
26.6. The seroprevalence of SIV-antibodies was approximately 
the same in all age groups (14.4-14.7 %). Also for H. parasuis no 
marked diff erences (weaners: 11.6 %, fattening and breeding 
pigs: 12.6 %) could be found. A. pyogenes, B. bronchiseptica, and 
mycoplasmae were isolated at even lower percentages.
The most frequent lung lesions were interstitial pneumonias 
(weaners: 79.1 %, fattening and breeding pigs: 68.9 %), followed 
by fi brinous-purulent broncho-pneumonias and hyperemic 
districts in weaners (25.9 % each). In fattening and breeding pigs 
emphysemas could be diagnosed quite often (38.3 %). These 
could be found to a lesser degree in weaners (21.1 %). Other 
pathologic lung lesions, such as purulent catarrhalic pneu-
monias, fi brinous pleuropneumonias, and pleuritides could be 
diagnosed less frequently.
Discussion
The results highlight the drawbacks of nowadays routine diag-
nosis as only in 43 % of investigated pigs one or more specifi c 
pathogen(s) could be identifi ed. This could be the consequence 
of an antibiotic treatment prior to submission to the clinic, or the 
missing of a more intense diagnostic search for viral pathogens, 
such as PCV2. The high incidence of viral diseases can also be 
delineated from the high incidence of interstitial pneumonias. 
Interestingly, the comparison of pathogen incidences in the two 
age groups (weaners on the one hand and fattening and breed-
ing pigs on the other hand) clearly shows very similar distribu-
tions. Out of these reasons, increasing attention should be paid 
to (I) more sophisticated diagnostic procedures and (II) proper 
vaccination and management strategies against viral respiratory 
pathogens.
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Introduction
An important challenge for swine practitioners is to determine 
whether porcine reproductive and respiratory syndrome virus 
(PRRSv) transmission is occurring in the sow herd. A “traditional 
monitoring protocol” used in North America is to sample 20-30 
piglets at weaning, pooling the samples in groups of 5, and 
testing them by PCR.1,2 However, if the prevalence is very low, 
the probability of detecting infected piglets with this protocol 
is also very low. “Targeted sampling” has been used to increase 
the likelihood of detecting low prevalence diseases in animal 
populations.3,4 This strategy focuses sampling on high-risk indi-
viduals in which specifi c risk factors exist. It was hypothesized 
that pigs with specifi c attributes were more likely to be infected. 
The objective of this study was to identify those factors and their 
distribution across infected and non-infected piglets and litters.
Materials and Methods
A 1500 sow farrow-to-wean farm originally populated as PRRSv-
naïve became infected. The owners and the veterinarian decided 
to inject serum containing the herd specifi c PRRSv isolate to all 
the sows in an attempt to hasten the spread of the virus. This 
decision provided an opportunity to conduct the proposed 
study. To estimate the prevalence of PRRSv infected litters and 
piglets, blood was collected from a random sample of 38 lit-
ters at birth and again at weaning. All piglets in selected litters 
were sampled. Two farrowing groups were selected as being 
representative of epidemic (4 weeks post-inoculation / PI) and 
endemic infection (12 wks PI). Serum samples were randomly 
pooled in groups of 5 (1 mL of serum per piglet) and tested by 
RT-PCR. All samples in a positive pool were tested individually. 
Clinical signs and production parameters were examined by the 
same investigator every sampling day. Litter attributes included 
size, weight, gilt-origin litter and diarrhea. Piglet attributes were 
gender, weight, light piglet, diarrhea, paleness, fuzziness and 
dome head. The association between attributes of the piglets 
or litters and the detection of PRRSv was screened by univariate 
and multivariate logistic regression analyses (SAS/STAT 9.1). 
Results
During the study, 133 PCR-positive results were obtained from 
1,507 piglets at birth and weaning. In the univariate logistic 
regression analysis, litter indicators including, light average litter 
weight and gilt litters were associated with the detection of 
PRRSv in at least one of the sampling times (P≤0.1). Signifi cant 
piglet indicators included being a barrow, having a dome shape 
head and having a fuzzy hair coat (P≤0.1). The odds for a barrow 
sampled from light litters to be detected as PCR-positive was 
6.86 (CI: 2.4 - 19.6) times higher than for the rest of the piglets 
sampled at weaning 12 wks PI (Table 1). 
Table 1. Multivariate logistic regression analysis for attributes associ-
ated with PRRSv detection 12 wks PI
Attribute Birth (n=421) Wean (n=379)
Litter level
Litter size NI NI
Gilt litter (1=gilt) 77 (1.5-1000)* NI
Light litter 0.4 (0.01-33.3) 4.1 (0.6-25)
Presence of diarrhea NR NR
Individual level
Gender (barrow=1) NI 5.4 (2.6-11.1)*
Weight (kg) NI NI
Light piglet NI NI
Presence of diarrhea NR NR
Paleness NR NR
Fuzziness 4.7 (2.7-8.3)* NR
Dome shaped head 0.73 (0.4-1.4) NR
Values are Odds ratios (95% CI)*, OR (P < 0.05).
NR=not reported, NI=not included (P>0.1 univariate)
Discussion
Alternative sampling protocols should consider targeted sam-
pling of piglets with attributes associated with infection. In our 
study, sampling barrows from light litters at weaning increased 
the probability of detecting PRRSv by PCR. However, further 
investigation is required to validate attribute associations and to 
improve monitoring programs. 
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Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV) 
causes severe respiratory diseases in nursery and growing-
finishing pigs and has a major role in porcine respiratory disease 
complex (PRDC). Outbreaks of PRRS in Taiwan swine herds 
between July 1991 and June 1993 incurred signifi cant economic 
loss to the local pig industry (1). Following Vietnam, the Philip-
pines was the second country experience a serious outbreak 
of the disease. Philippine pig herds were infected with highly 
pathogenic PRRSV in 2008, which has a 98% sequence similar-
ity with the Chinese type and is characterized by high fever and 
pathogenic clinical syndrome (4). The growing commodity trade 
between Taiwan and Southeast Asian countries has increased 
the risk of importing PRRSV into Taiwan. This study collected 
serum samples from northern Taiwan pig farms to test for PRRSV 
antibody. Oral-nasal swabs were collected from sero-positive pig 
farms and PRRSV was detected by molecular diagnostic method. 
The data revealed the distribution of European, North American 
or China strain of PRRSV in Northern Taiwan.
Materials and Methods
The epidemiological survey of PRRSV was performed using 
nationwide stratifi ed random sampling method. The sample 
size of 15 pigs per herd was tested that is intended to detect 
PRRSV at 95% confi dence interval with a 20% infection rate. The 
serum samples were tested for PRRSV antibodies using a com-
mercially available enzyme-linked immunosorbent assay (ELISA) 
kit (IDEXX PRRS Ab test kit), and a ratio higher than 0.4 was 
considered seropositive for PRRSV (2). Three farms were selected 
from each county that was seropositive for PRRSV, and 10-15 
porcine oral-nasal swabs were collected from each farm for 
testing by reverse transcription and polymerase chain reaction 
(RT-PCR) to determine whether PRRSV was European type (EU) 
(3), North American type (NA) (3) or China type (CN)(4). All PCR 
products were sequenced and compared with PRRSV sequences 
obtained from Genbank.
Results
The epidemiological survey conducted in 2009 estimated the 
herd prevalence of PRRSV in northern Taiwan. Sixty-fi ve random-
ly selected herds and 953 blood samples were examined in this 
study. The overall PRRSV herd prevalence was 80% (52/65) and 
sero-prevalence was 62% (595/953). The within-herd prevalence 
in the fi fty-two sero-positive herds was 100% in twenty-four 
(37%) herds, between 50% and 100% in sixteen (25%) herds, 
and less than 50% in twelve herds. From each of twelve selected 
farms, 12-15 oral-nasal swabs were collected from nursing and 
growing-fi nishing pigs. Only one swab sample was positive for 
PRRSV NA type by RT-PCR. Sequence analysis of PCR products 
showed that the PRRSV was 91% homologous to VR-2332 (NA 
stain). No EU or CN type was detected in the study.
Discussion
Analysis of 953 blood samples taken from sixty-fi ve northern 
Taiwan pig herds revealed a 62% sero-prevalence of PRRSV 
antibody, which was slightly lower than the 64-86% prevalence 
reported in a 1996 investigation (5). None of the sampled swine 
herds had received PRRSV vaccine within the previous year. 
The 80% herd prevalence of PRRSV could be considered the 
actual fi eld PRRSV infection rate. Only one PRRS vaccine (Ingel-
vac® PRRS MLV) has been used in the fi eld in Taiwan recently. 
Ingelvac® PRRS MLV is a modifi ed live vaccine based on VR-2332 
strain. However, sequence analysis demonstrated a substantial 
diff erence between VR-2332 strain and PRRSV detected from 
swab in swine herds, indicating that the status of PRRSV in swine 
herds had changed in Taiwan. Fortunately, no CN-type PRRSV 
was found. However, continuous tracking of PRRSV surveillance 
is essential. 
References
1.  Chung WB et al. Can J Vet Res. 61: 292-298, 1997.
2.  Wasilk A et al. J CLIN MICROBIOL 42:4453-61, 2004. 
3.  Huang TS et al. Exp Rep NIAH .36: 23-28, 2000.
4.  Feng Youjun et al. Emerging infectious diseases 14: 1774-1776, 2008.
5.  Huang TS et al. Exp Rep TAHRI. 32: 9-16, 1996.
Porcine Reproductive and Respiratory Syndrome (PRRS) – Surveillance
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 512
Poster Presentations
P.206
Oral ﬂ uid diagnostic samples can be collected from individually-penned adult swine
Jeremy Johnson1 Mark Engle2 Apisit Kittawornrat1 John R. Prickett1 Trevor Schwartz1 Dan 
Whitney1 Chris Olsen1 Kent Schwartz1 Chong Wang1 Jeff rey J. Zimmerman1
1. Iowa State University, Ames, IA, USA; 2. PIC North America, Hendersonville, TN, USA
Introduction 
Cumulatively, the literature supports the implementation of oral 
fl uid-based diagnostics as a method to monitor infectious dis-
eases in swine populations: (1) oral fl uid samples are quickly and 
easily collected; (2) detectable levels of pathogen-specifi c IgA, 
IgM, and IgG antibodies are present in oral fl uids; (3) a variety of 
infectious agents are shed in oral fl uid, including highly signifi -
cant pathogens of production animals, e.g., FMDV, CSFV, PRRSV 
(Prickett et al., 2008a), and PCV2 (Prickett et al., 2008b). Previous 
experiments used pen-based oral fl uids to monitor PRRSV and/
or PCV2 infections in wean-to-fi nish populations (Prickett et al., 
2008a,b). The objective of this study was to determine if oral 
fl uids could be collected from individually-housed boars.
Materials and Methods
The study was conducted using boars owned by PIC North 
America (Hendersonville, TN USA). Housing, procedures, and 
protocols were approved and supervised by the PIC USA Health 
Assurance and Welfare department. Three trials of 24 boars (6 
months to 3.6 years of age) were conducted. Trial 1 used only 
select (young) boars; Trials 2 and 3 included both select and cull 
boars. Samples were collected for 8 days using 5/8”, 3-strand, 
100% cotton rope was cut into 22” lengths. One end was un-
twisted, soaked overnight in a fl avoring solution (unsweetened 
apple juice with 50% (v/v) sucrose) and air-dried. Ropes were 
placed in brackets, threaded through the pipe, and knotted to 
prevent slipping. Boars had access to the ropes for 20 minutes. 
To recover the sample, a 6” segment of the “boar end” of the 
rope was cut, inserted, and sealed into a re-sealable plastic bag. 
Oral fl uid was extracted by passing the plastic bag, with the rope 
inside, through a hand wringer, allowing the fl uid to accumulate 
in a bottom corner of the bag. The bag was then cut and the 
contents decanted into a 50 ml tube.
Results 
Among 576 attempted oral fl uid samples (8 days x 24 boars x 
3 trials), 524 (91%) samples were collected. Among a potential 
total of 192 potential samples in each trial, 188 (98%) samples 
were collected in Trial 1, 155 (81%) in Trial 2, and 181 (94%) in 
Trial 3. The rate of successful collection initially increased during 
the observation period and then stabilized. Analysis of these 
data showed that trial (p = 0.0339) and observation day (p < 
0.001) were statistically signifi cant sources of variation, but boar 
age (p = 0.9525) was not. 
The average volume of oral fl uid collected per boar across all 
trials was 17.9 ml (range: 1 to 39 ml). Analysis of the sample vol-
ume data showed that day (p < 0.0001), age (p = 0.0127) and in 
the interaction of trial x sampling day (p < 0.001) were statistic-
ally signifi cant sources of variation.
Conclusions and Discussion
Oral fl uid samples can be collected from individually-housed 
adult animals. Improvements in the success rate through the use 
of attractants or fl avorings needs to be evaluated. As opposed to 
pen-based oral fl uid testing, oral fl uid samples from individual 
animals provide the opportunity to evaluate individual re-
sponses to infection under experimental and/or fi eld conditions. 
This approach could off er signifi cant improvement in the ease, 
timeliness, and cost of disease surveillance. 
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Introduction
PRRS is probably the most important swine disease of the last 
half-century. PRRS has been observed in the majority of Euro-
pean countries. In Romania, the disease has been continuously 
spreading in the pig population since it was fi rst diagnosed by 
Stanuica and col. 1998. The PRRS virus is an enveloped RNA virus 
in the genus Arterivirus, classifi ed in the virus family Arteriviridae 
and produce reproductive disorders in breedings farms and 
respiratory disorders in fi nishing farms. 
An important feature of the PRRS virus is its ability to persist 
in long-term carrier pigs, greater than 200 days. The aim of the 
present study was to a cross-sectional study on 6 fattening farms 
to estimate the seroprevalence of antibodies directed against 
PRRSV in 4 week-old pigs, 12-13 week-old pigs and 20-27 week-
old pigs.
Materials and Methods
There were tested 262 blood samples from 6 fi nishing farms 
at diff erent times. Samples were analyzed for the presence of 
antibodies against PRRS by PRRS IDEXX ELISA (HerdChek® PRRS 
2X, IDEXX, Switzerland). The presence or absence of antibody 
to PRRS in the sample is determined by relating the value of the 
unknown to the positive control mean by calculating the sample 
to positive (S/P). An S/P ≥ 0.4 was considered seopositive. Sta-
tistical analysis was performed using the xChek IDEXX (vers. 3.3 
2003). Studied herds were unvaccinated for PRRS. 
Results 
Serology is an essential part of a PRRS diagnostic and control 
program. ELISA antibodies are not detectable until 9-10 days 
post infection and persist for longer periods, at least 5-6 months. 
The seroprevalence of PRRSV in studied farms was 51,5% (135 
samples positive from 262 tested).
The seroprevalence of PRRSV in 4, 12-13 and 20-27 weeks-old 
pigs’ varied between all the three samplings for each farm. In 
the farm 1 and 2 seroprevalence of PRRSV in the younger pigs (4 
week-old pigs) was signifi cantly higher suggesting the pres-
ence of maternal antibodies, and high prevalence in the other 
category (12-13 and 20-27 weeks-old) show that PRRS infection 
or reinfection taken place in fattening units.
A high seroprevalence in 12-13 week-old pigs and 20-27 week-
old pigs to indicate an active immune response to PRRSV, this 
fact it could be observed in farms 3, 4 and 6, showing a recent 
infection. Persistence of infection may be associated with large 
herds in pig-dense regions with repeated reintroduction.
Table 1
Farms 1st sampling 2nd sampling 3st sampling
No. sample positive /No. sample tested
1 10/10 6/10 10/10
2 10/10 5/10 10/10
3 14/40 13/20 21/28
4 7/19 5/15 10/10
5 0/10 2/11 2/19
6 0/10 1/10 9/10
Total positive samples/ 
Total samples tested 135/262
In farm 5 the infection percent was lower than the other studied 
farms, that means the herd became free of infection or the ani-
mals was recently infected and is undergoing seroconversion. 
Discussion
We conclude that most farms pigs wean to fi nish are seroposi-
tive for PRRSV. they indicate that the prevalence of PRRSV 
antibody in the swine populations tested was relatively high. 
Method ELISA may be helpful in confi rming the seropositivity 
and to indicate high levels of antibody in recent infections. An 
accurate diagnosis is essential to confi rm presence PRRSV and 
may serologic profi le of pigs in the various stages of produc-
tion. The lack of an antibody response in recently weaned pigs 
indicated the absence of PRRSV infection in the breeding and 
farrowing populations. 
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Monitoring of PRRS control protocol in two farrow-to-ﬁ nish herds during three years in high risk area 
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Introduction
In France, PRRS mass vaccination with a modifi ed live Vaccine 
(MLV), Porcilis® PRRS, Intervet / Schering-Plough, have been 
already described (1, 2).
This study presents a three years monitoring PRRS control pro-
gram used in two farrow-to-fi nish herds in PRRS high risk area.
Material and Methods
The trial was performed in two farrow-to-fi nish herds: Herd A 
(180 sows) known infected with PRRS virus since 1994; herd B 
(350 sows) since 2002. 
From June 2005, a vaccination scheme was established as fol-
lows: Gilts: one injection at arrival in quarantine. Sows and boars: 
“mass vaccination” three times a year. Piglets: one injection 
between 5 and 6 weeks of age.
Serological monitoring data from February 2005 to December 
2006 showed that PRRSv was under control since November 
2005 (1). Monitoring was extended from 2007 to 2009 (3 years) 
in two ways: 
• Serological monitoring: every 3 or 4 weeks, ELISA individual 
serology on sera sample (IDEXX Herdcheck PRRS 2XR) were 
done on a minimum of 10 non-vaccinated piglets. Each piglet, 
was identifi ed by an ear tag. So a new cohort of ten piglets 
was chosen every six months and was followed from 70 to 140 
days old. 
• Virological monitoring: every 3 weeks, PCR tests (ADIAVET 
PRRS = RT-PCR EU and US strains qualitative test) done on 2 
pools of three sera taken on 140 days old vaccinated piglets. 
All sera were analyzed by LDA 22 (laboratory, Ploufragan, 
France). 
Results
In total, from January 2007 to December 2009, 630 non-vaccin-
ated growing pigs were controlled by serology, and 585 vaccin-
ated pigs by PCR. No positive results linked with PRRSv infection 
were observed (Table 1 and Table 2). The only serological posi-
tive results (farm B, fi rst semester of 2007) were linked to indirect 
contacts of non-vaccinated piglets with vaccinated ones. In table 
1: *2 positive sera, tested with other kit (AFSSA antigen): 1 nega-
tive, 1 inconclusive and negative by PCR; **13 positive sera, also 
positive by PCR, but 100% homology with the vaccine strain by 
PRRSv ORF7 sequencing.
Table 1: Non-vaccinated piglets serological Results
 
Table 2: Vaccinated pigs virological Results
Discussion and Conclusion
Regular controls showed no circulation of PRRSv “wild” or vac-
cine strain during 3 years. Since 2007, the sensibility of sero-
logical monitoring was increased: to avoid contact with vaccin-
ated piglets, the non-vaccinated monitored piglets were split 
with other non-vaccinated piglets (80 piglets in total). In case of 
PRRSv infection, virus multiplication would probably be more 
important according to the high number of animals without 
vaccine protection. This fi eld data confi rm effi  ciency of Porcilis® 
PRRS in reducing signifi cantly viral excretion after infection, and 
to control virus shedding within these two farms located in high 
risky area. Even if, we can’t claim eradication, results show that 
it might be a mean to start or even to achieve eradication, espe-
cially in geographic area where infection prevalence is low. 
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Introduction
Porcine reproductive and respiratory syndrome (PRRS) is a 
devastating disease caused by PRRS virus (PRRSV). Farmers and 
veterinarians require having access to state of the art read-
ily available diagnostics in order to respond rapidly to disease 
treats. FTA cards consist of a cellulose-based matrix paper con-
taining chemicals that lyse the cells in the sample while preserv-
ing the nucleic acids and are available for the safe transfer of 
diagnostic samples. Because these chemicals render bacteria 
and viruses inactive, samples embedded in FTA cards are not 
infectious. Samples in FTA cards can be shipped and stored at 
room temperature because the nucleic acids are protected from 
degradation and clinical samples can be stored in a safe non-
biohazard way suitable for molecular diagnostics. Data from a 
previous study has shown that PRRSV is detectable by RT-PCR 
from FTA cards (Inoue, 2000). However this study failed to valid-
ate the methods to properly assess the diagnostic sensitivity of 
RT-PCR in samples embedded in FTA cards.
The objective of this study was to evaluate the analytical sensi-
tivity (limit of detection) and stability of FTA cards containing 
serum and oral fl uid samples spiked with PRRSV under con-
trolled laboratory conditions. 
Materials and Methods
Porcine sera and oral fl uid samples were spiked with a concen-
tration of 10^5 TCID50 of PRRSV. Samples were diluted in 10-fold 
dilutions (from 10^5 to 10^-2 TCID50/ml) and used to inocu-
late FTA cards. Each sample from each dilution was inoculated 
in duplicate in 2 FTA cards and let dry at room temperature 
overnight. One FTA card embedded sample was tested dir-
ectly at 24 h post inoculation. The other card was kept at room 
temperature and tested after 2 weeks. Oral fl uids were evaluated 
directly and following a pre-processed protocol which consisted 
of treatment with a lysis solution before the extraction protocol 
(Prickett et al. 2008).
To elute the RNA from the FTA card, the RNA Rapid Extraction 
Solution (Ambion-Applied Biosystems) was used as recom-
mended by the manufacturer. RNA was then purifi ed and con-
centrated using high throughput magnetic bead-based technol-
ogy (Ambion-Applied biosystems). The RT-PCR protocol used 
was a real time TaqMan-based multiplex protocol that detects 
both North American and European Strains of PRRSV (NAEU 
PRRSV) (Dee et al. 2009).
Results and Discussion
Results in table 1 indicate the minimum concentration of PRRSV 
detected by RT-PCR in samples embedded in FTA cards. Under 
the conditions of this study, the analytical sensitivity of PRRSV 
detection by RT-PCR from serum embedded-in FTA cards was 
reduced 10 times compared to detecting the virus directly from 
serum. However, the virus could still be detected at a very low 
concentration in FTA cards (10^1 TCID50). Moreover, there was 
no loss of sensitivity when comparing detection on FTA cards at 
24h or 14 days of storage
Table 1. PRRSV minimum concentration (in TCID50/ml) detected by 
RT-PCR.
Direct FTA 24h FTA 2 wk
Serum 10^0 10^1 10^1
Oral fl uids neg 10^3 10^5
Oral fl uids (pre-
processed) 10^0 NA NA
Sensitivity of oral fl uids in pre-processed samples was compar-
able to that of serum but was poor when testing was done 
directly. 
In summary, this study provides preliminary data that indicate 
that the use of FTA cards is a sensitive tool to store and submit 
pig serum and saliva samples for PRRSV molecular diagnostics. 
Further validation is in process to evaluate the suitability to 
transport samples under fi eld conditions.
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Modiﬁ ed live PRRS virus vaccination as a key component in nursery pig performance improvement
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Introduction
Two sow farms had experienced continual PRRS instability (large 
periodic increases in abortion rates) due to multiple PRRS virus 
isolate introductions over the past several years. The highest 
mortality rates in grower pigs occurred in the fi rst 8 weeks post-
weaning with mean mortality rates in excess of 6% in nursery 1 
fl ow for the previous 24 months and 12% during the previous 
12 months in nursery 2 fl ow. The objective of this study was to 
determine if stabilization of the sow herd along with vaccinating 
pigs pre-weaning (5-10 days of age) with Ingelvac® PRRS ATP 
could reduce mortality in the fi rst 8 weeks post-weaning.
Materials and Methods
The study was conducted in two 3,250 sow farrow to wean farms 
located in Iowa and Minnesota. 
The breeding herd PRRS stabilization program followed a “Load/
Close/Homogenize” approach. A 200 day supply of gilts was 
entered into the farms which were then closed to new animal 
entries for a minimum of 200 days. All breeding animals includ-
ing developing gilts were mass vaccinated twice 30 days apart 
with Ingelvac® PRRS ATP (Boehringer Ingelheim Vetmedica, Inc., 
St Joseph, MO). Both herds practiced industry standard MCREB-
EL methods with no piglet cross-fostering after 24 hours of age 
for at least 30 days. 
Piglets were vaccinated at 5-10 days of age with the same vac-
cine. On most continuous fl ow sites, mass vaccination of all pigs 
occurred twice 30 days apart when the fi rst PRRS vaccinated 
weaned pigs entered the site. PRRS PCR testing was conducted 
every 2-4 weeks on 20 poor quality pigs aged 5 days and 
younger pooled in groups of 5. “Sow herd stability” was defi ned 
as negative results on two consecutive PRRS PCR tests on these 
pooled piglet sera. PRRS PCR testing of 15 pigs (3 pools of 5 from 
sick pens) from each group at 4-8 weeks post weaning was done 
and PCR positives were sequenced. An in-process intervention 
analysis was done using statistical process control methods on 
mortality for the fi rst 8 weeks post weaning.
Results
Pig mortality rates during the fi rst 8 weeks post-weaning were 
signifi cantly reduced from 6.4% to 2.84% and 12.6% to 3.0% 
from Farms 1 and 2 respectively. 
Figure 1. Farm 1 pig mortality rates the fi rst 8 weeks post-weaning 
before/after intervention.
 
Figure 2. Farm 2 pig mortality rates the fi rst 8 weeks post-weaning 
before/after intervention.
Discussion 
The sow herd stabilization program along with vaccination 
of pigs at 5-10 days of age has proven to be very eff ective in 
reducing mortality during the fi rst 8 weeks post weaning. This 
occurred in spite of wild-type virus, including highly virulent iso-
lates 1-18-2 and 1-8-4, persisting on or being laterally introduced 
to twelve of the nursery sites.
.
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Introduction
Highly Pathogenic Porcine Reproductive and Respiratory Dis-
ease (HP PRRS), which caused great economic losses in Chinese 
hog industry, induces reproductive failure in sows and high 
culling rate in fatteners(1). To prevent viral disease like PRRS, vac-
cination is the optimum choice (2). The present study evaluated 
the eff ect of Ingelvac® PRRS MLV in a pig farm in Guangdong 
Province, China.
Materials and Methods
The 700-sow farm in Guangdong was built years ago with poor 
ventilation. Killed PRRS vaccine had been used before March 
2006 but performance kept low. PCR test results confi rmed PRRS 
positive before PRRS MLV vaccination.
From March 2006, mass vaccination program for breeders with 
Ingelvac® PRRS MLV started: 3 times per year in sows and twice 
per year in boars. 5 month later, in August 2006, piglets started 
to be inoculated with Ingelvac® PRRS MLV 1 dose/pig at 14 days 
of age. Replacement gilts were vaccinated twice before mating, 
with one month interval. 
Results
Table 1. Reproductive performance during 2005-2008
2005 2006 2007 2008
Conception rate(%) 95.24 94.88 96.09 94.42
Farrowing rate (%) 88.90 88.55 88.41 86.02
Reheats (sows) 75 80 61 81
Abortion (litters) 24 26 23 12
Pseudopregnancy (sows) 19 20 19 16
Culled sows 56 50 73 56
Piglets/litter 10.44 10.85 11.02 10.9
Piglets born alive/litter 9.5 9.73 9.91 9.94
Farrowing interval (days) 151.7 150.4 150 151.3
Weak piglets (%) 0.01 1.67 1.53 1.39
Deformity (%) 5.01 4.18 4.39 3.81
Stillborn (%) 2.65 3.71 3.17 2.85
Mummies (%) 1.27 0.76 1.00 0.83
Pre-weaning mortality (%) 3.92 4.48 4.17 3.68
* In 2008, sow feed had been contaminated by mycotoxin for 2 
months, causing poor reproductive performance.
Figure 1. Survival rate of commercial pigs after PRRS KV and MLV 
vaccination
Great increase is seen in average fattener survival rate by 9.23% 
since Aug. 2006(fi gure 1). The other parameters remained stable 
even despite a Mycotoxin problem in 2008.
Discussion
In this study, PRRS MLV vaccination improved sow reproductive 
performance in conception rate, abortion, pseudopregnancy, 
live and weak born, more than KV (table 1). Much more pigs 
were marketed after vaccination changed from KV to MLV (fi gure 
1). Feed free of mycotoxin is an important contributor to stable 
reproductive performance (2).
In conclusion, Ingelvac® PRRS MLV vaccination program and 
good feed and health management are essential to achieve 
good performance in PRRS positive farms.
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Introduction
Porcine High Fever Disease(PHFD), the primary pathogen of 
which is highly virulent porcine reproductive and respiratory 
syndrome virus (HP PRRSV), causes huge economic losses be-
cause of high morbidity and mortality in all infected Chinese pig 
farms(1). An outbreak of HP PRRS in a 1200 sow pig farm started 
in April of 2008 in Guangdong province, and it was controlled by 
Ingelvac® PRRS MLV mass vaccination one month later.
Materials and methods
This pig farm was built in 1990,, with two units of 600 sows each, 
continuous fl ow management. Two-hundred newly purchased 
gilts were introduced into the breeding herd without acclima-
tion in Jan.2007. PHFD broke out with evident clinical signs from 
Apr. 20th, whereby all animals seemed to be aff ected with fol-
lowing clinical signs: Anorexia, lethargy, dyspnea, hyperthermia 
and discolouration of the skin. On April 25th, abortion, preterm 
birth and stillbirth started. Until Apr. 30th, 80 sows aborted and 
120 sows were culled. 
On 26th, 40 blood samples and 5 tissue samples from the 
abortion embryo and stillbirth were sent to Guangdong swine 
disease diagnosis center for antibody and antigen test.
On May 1, all no-sign breeders, healthy suckling piglets were 
vaccinated with Ingelvac® PRRS MLV. Then breeders were given 
second shot 4 weeks later. Replacement gilts were vaccinated 
twice at a 4 -week interval before mating. Piglets were given one 
shot at 2 weeks of age. Antibiotics were administered in water or 
feed against bacterial infection at same time.
Results
Table 1. Lab diagnosis results before Ingelvac PRRS MLV vaccination
PRRS Antibody Test HP PRRSv PCR test
samples positive samples positive
40 20 5 5
On May 10, sows started returning to normal appetite. Abor-
tion reduced to 20 litters and no death was observed following 
start of vaccination. All pigs recovered in July. Reproductive 
performance of all sows in each quarter was getting better and 
better after vaccination, and even better than that before PHFD 
outbreak. 
Table 2. Average reproductive performance each quarter in 2008
Jan-Mar Apr-Jun/Apr Jul-Sept Oct-Dec
Farrowing (%) 81 70/14 83 85
Abortion (%) 4 21/72 3 3
Pigs born alive/litter 9.2 7/4.5 9.6 9.5
Stillbirth (%) 8.8 20/35 6.7 5.8
suckling interval (%) 93 85/70 93 94
Nursery survival (%) 95 88/65 93 96
sows culled 93 214/150 94 90
sows died 8 20/18 0 0
*PHFD broke out on Apr.20. Ingelvac® PRRS MLV intervention 
started from May 1.
Discussion
Analyzing the data recorded in 2008, we found that Ingelvac® 
PRRS MLV improved the reproductive performance by two times 
of vaccination in 4 weeks. One shot of Ingelvac® PRRS MLV to 
piglets obviously reduced the mortality and morbidity in nurs-
ery. Ingelvac® PRRS MLV provided cross-protection against HP 
PRRS in the farm. In conclusion, Ingelvac® PRRS MLV is a useful 
tool to control and prevent PHFD.
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Introduction
In previous studies in Asia, in spite of the increasing new PRRSV 
strain diversity3, vaccination programs with a live PRRS European 
(EU) strain vaccine could reduce the mortality in piglets1 and in 
growing-fi nishing pigs2. The objective of this study was to mon-
itor the eff ect in pre-weaning and post-weaning mortality rates 
of a modifi ed live virus PRRS EU strain vaccine (AMERVAC®-PRRS) 
program in sows and piglets.
Materials and methods
A 4000 sow level farm located north of Manila, Philippines, had a 
complaint of high pre-weaning (weaning at 4 weeks of age) and 
post-weaning (4-10 weeks of age) pig mortalities. PRRSV diagno-
sis was confi rmed with the use of a commercial serology ELISA 
kit (CIVTEST ™suisPRRS E/S, HIPRA) an early serum conversion 
at 6-7 weeks of age. Gestating sows farrowed infected piglets 
which infected other litter mates before weaning time. So after 
veterinary advice, two mass vaccinations with a live PRRSV vac-
cine (AMERVAC®-PRRS) in breeders within 4 weeks interval were 
implemented in November 2007. At the same moment sows 
were administered with the second mass vaccination (December 
2007), piglet vaccination started. Every piglet at 25 days of age 
was vaccinated intramuscularly with one shot of the same live 
PRRSV vaccine. Pre-weaning and post-weaning pig mortality 
rates were compared between batches of pigs 6 months before 
and 6 months after the implementation of the second mass vac-
cination in sows (December 2007).
Results
Mortality rates were signifi cantly decreased (P<0.001; t test) after 
the vaccine program implementation (Table 1). Pre-weaning and 
post-weaning mortality rates decreased 75% and 80% respect-
ively. 
Table.1. Monthly mean (Mean±SD) pre-weaning (Pre) and post-
weaning (Post) pig mortality 6 months before and 6 months 
after PRRSV vaccine implementation. 
Treatment % Pre. Mortality % Post. Mortality
Before vaccination 20.0±3.27 9.9±1.83
After vaccination 5.06±1.48* 1.8±1.16*
*Results were signifi cantly diff erent, P<0.001.
Discussion
We can observe that as in previous fi eld trials4,5, a mass vac-
cination in breeders with a live PRRSV vaccine resulted in a 
sow protected population, which farrowed healthier new born 
piglets and consequently induced a decrease of pre-weaning 
and post-weaning mortality rates. Vaccinated pigs at 3 weeks of 
age showed a lower post-weaning mortality rates that may be 
Graphic 1. Monthly mean (Mean±SD) pre-weaning (Pre) and post-
weaning (Post) pig mortality 6 months before and 6 months after 
PRRSV vaccine implementation.
maintained during fattening period as in Guerzón, V. et al, 2008. 
In spite of the increasing diversity of PRRSV strains described 
worldwide3, in this fi eld experience in Asia, a PRRSV vaccine, 
available in the fi eld for more than 10 years (AMERVAC®-PRRS) 
was able to induce enough protection to reduce the negative 
impact of a PRRSV infection. Actual PRRSV strain classifi cation 
according to genetic sequence of the ORF 5 RNA fragment of 
the PRRSV genome is not useful to forecast cross protection6. 
Previous studies confi rmed that distant PRRSV strains accord-
ing to this ORF 5 sequence classifi cation, contrary to what was 
expected, can present clear cross protection7. Therefore, further 
studies are needed to disclose either viral structures or immune 
path ways or genetic markers that may determine cross protec-
tion between PRRSV strains.
Conclusion 
Within these fi eld conditions a vaccination program in sows 
and piglets with an EU MLV PRRSV vaccine (AMERVAC®-PRRS) 
reduced pre-weaning and post-weaning pig mortalities caused 
by a PRRSV infection. 
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Vaccination eﬀ ect with a live attenuated PRRSV vaccine “AMERVAC®-PRRS” in sow farrowing rates
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Introduction
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is 
one of the primary precursors of economic losses2 in pig produc-
tion. Acute impact costs range from $236-502 per sow per year3. 
Clinical signs include decreasing farrowing rates, abortions, 
stillborns and increase of respiratory clinic problems in pigs.
The objective of this fi eld experience is to assess the eff ect of 
a live PRRSV European (EU) vaccine (AMERVAC®-PRRS) in the 
monthly farrowing rates in a farm endemically infected by 
PRRSV. 
Materials and methods
A 2500 sow farm with a 2 site production system that is lo-
cated in the southern Philippines had a complaint of unstable 
and variable farrowing rates. PRRSV diagnosis was based on 
Polymerase chain reaction technique3(PCR) from lungs and 
lymph nodes from stillbirths and 1 day old weak born piglets. 
A PRRSV vaccination program was implemented in sows at Octo-
ber 2007, using a modifi ed live PRRSV European (EU) vaccine 
(AMERVAC®PRRS). Every batch of sows was vaccinated with one 
dose at 60 days of pregnancy and another dose 7 days after each 
farrowing. Farrowing rates from April 2007 until December 2009 
were monitored. Farrowing rates from April to October 2007 
were compared with farrowing rates from November 2007 till 
December 2009 (unpaired t test).
Results
Variable and unstable farrowing rates were monitored from 
April to October 2007. The monthly farrowing rates after vaccine 
implementation became less variable and were signifi cantly 
higher (Table 1) along the whole monitored period than in previ-
ous unvaccinated sows.
Table 1. Monthly mean (Mean±SD) sow farrowing rates before and 
after PRRSV vaccine program implementation in sows.
Groups % Farrowing rate
Before vaccination 75.7±7.08*
After vaccination 82.3±3.58*
*Results were signifi cantly diff erent, P<0.001. 
Graphic.1. Monthly sow farrowing rates evolution from April 2007 to 
December 2009. Discontinuous line marks the beginning of the vaccine 
program.
Discussion
The monthly farrowing rates seem to get stabilized around 3-4 
months after the beginning of the vaccine program implemen-
tation (graphic.1.). This slow recovery may be related with the 
necessary time to administer at least one vaccine dose to all 
the sows in the farm. Contrary to this experience, mass PRRSV 
vaccination programs in sows are more usually applied1. Mass 
live PRRSV vaccination may build up faster vaccine immune 
response in the whole sow population just with the fi rst dose. 
Nevertheless in the case of PRRSV infection the time needed to 
come back to normality after PRRSV infection depends also on 
some other factors, which are not directly related to vaccines or 
vaccination programs.
Conclusion
The PRRSV vaccination program implemented within these fi eld 
conditions achieved to improve and stabilize sow monthly far-
rowing rates along the whole experiment. 
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Pedro U. Sánchez3 Ramón G. Riquelme1 Sergi D. Bruguera1 Pere P. Riera1 Dani G. Torrents2 David V. Llopart1
1. HIPRA. Technical Services, Amer, Spain; 2. HIPRA China. Technical Services, Beijing, China; 
3. Piensos Garla S.A. Technical Director, Huercal Overa (Almeria), Spain
Introduction
Sows infected by Porcine Reproductive and Respiratory Syn-
drome Virus (PRRSV) reduce farrowing rates and farrow infected 
piglets that will suff er higher pre-weaning and post-weaning 
mortality rates. The objective of this fi eld experience was to 
assess the eff ect of a PRRSV vaccination protocol in multiparous 
(MS) and fi rst pregnancy sows (FPS) in a PRRSV infected farm.
Materials and methods
The study is carried out in a 4000 sow farm located in South East 
Spain, endemically infected with a PRRSV. This is a farm that rears 
pigs only till 20Kg live weight (8-9 weeks of age). Gilts (G) and 
FPS are segregated and they remain separated from MS. From 
June 2008 return to oestrus % (RTO%) increased either in MS or 
FPS. Besides this, born alive piglets per litter (TAL) and weaned 
piglets per litter (TWL) decreased. From August to October 2008 
post-weaning (from 3 to 8-9 weeks of age) mortality % (PM%) in-
creased dramatically in pigs from both FPS and MS. PRRSV infec-
tion diagnosis was confi rmed with the use of a commercial serol-
ogy ELISA kit (CIVTEST ™suisPRRS E/S, HIPRA) in sows and PCR 
PRRSV detection from stillbirths and dead pigs. In September 
and again in October 2008, a mass vaccination was implemented 
in all MS, FPS and G with a live PRRSV vaccine (AMERVAC®-
PRRS). Afterwards a mass vaccination with AMERVAC®-PRRS was 
implemented regularly every 4 months in MS and FPS. Every 
new batch of G was vaccinated twice with AMERVAC®-PRRS one 
moth apart before the fi rst mating. In this fi eld experience we 
monitored monthly RTO%, TAL, TWL and PM%.
Results
TWL improved in MS and in FPS but the improvement was 
more remarkable in FPS (Graph.2). RTO% (Graph.1) decreased 
constantly from the fi rst mass vaccination program in MS. RTO% 
from FPS decreased every month but in February 09 RTO% of 
FPS increased again till 28,2%. After this increase all the MS and 
FPS were vaccinated again (defi ned in material and methods) 
and the next month RTO% in FPS was reduced back to normal-
ity. Pigs in post-weaning period from non-yet vaccinated MS and 
FPS suff ered a peak of mortality in September and October 08 
(Graph.3). Weaned pigs from vaccinated sows may be healthier 
and PM% decreased markedly from November 2008 till the end 
of the study. 
Discussion 
The decreasing RTO% and the clear increasing trend of TWL in 
pigs from MS and FPS indicate, as in previous experiences1,2, 
that the immune response induced by the vaccine may build up 
a protection in sows that reduced the birth of infected piglets2. 
This eff ect probably reduced also the PM%, especially in batches 
of weaned piglets from FPS (Graph.3). According to these results 
FPS and their progeny seemed to suff er more severely during 
a PRRSV infection. This observation occurs frequently in the 
practice and recalls the need to submit new replacement gilts to 
proper acclimatisation procedures against PRRSV, previous to be 
introduced in an endemically PRRSV infected farm.
Conclusion
Within these fi eld conditions, a vaccination program with 
AMERVAC®-PRRS in sows induced an immune response that 
reduced markedly the negative impact of a wild PRRSV infection 
in sows and their progeny. 
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Graph 1. Return to oestrus % in MS (RTO% MS) and FPS (RTO % FPS). 
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Evaluation of a porcine reproductive respiratory syndrome virus (PRRSV) vaccination 
program with a modiﬁ ed live PRRSV Vaccine during 3 consecutive years in a Polish farm
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Introduction
Porcine reproductive and respiratory syndrome is an economic-
ally signifi cant disease. Polish farms have suff ered the two forms 
of this syndrome either from reproductive or respiratory clinic 
episodes 1. Modifi ed live vaccines (MLV), in several fi eld and 
experimental cases, have induced enough protection to control 
the negative clinic signs of PRRSV infection 1. The objective 
of this study is to evaluate the effi  cacy of a PRRSV vaccination 
program, in sows and pigs, with a modifi ed live European (EU) 
PRRSV vaccine (AMERVAC®-PRRS Laboratorios HIPRA S.A.) along 
3 consecutive years. 
Materials and Methods
This study was performed in a one site farrow to fi nish farm 
with 2000 reproductive sows, located in Swidwin, Poland. We 
evaluated the PRRSV situation through several transversal 
serumprofi les (CIVTEST™suisPRRS E/S ELISA). The fi rst serumpro-
fi le was performed in November 2005, in this moment the farm 
were suff ering high pre-weaning and post-weaning mortality, 
and acute reproductive failure in sows. The second serumprofi le 
was performed in October 2006, and the last one in October 
2007. The reproductive parameters in sows, pre-weaning and 
post-weaning pig performance parameters were monitored 
from November 2005 to October 2007. On December 2005 sows 
were vaccinated with a mass vaccination with a MLV vaccine 
(AMERVAC®-PRRS). One month after the mass vaccination sows 
were vaccinated with the following regular vaccination program: 
Gilts: One vaccine dose at 22 weeks of age and a second dose at 
25 weeks of age in gilts. Sows: They were vaccinated in each ges-
tation at 56 days of pregnancy, and once again in lactation per-
iod at 6 days after farrow. Piglet vaccination didn’t start till March 
2006; piglets were vaccinated with one dose of AMERVAC®-PRRS 
at 26-28 days of age. 
Results
After the implementation of the vaccination the farm became 
stabilized clinically and serologically, with a relevant reduction 
every year of % piglet mortality (Graphic 1 and Table 2), % mum-
mifi ed piglets, % stillbirth, % weak born piglets and the number 
of pigs in hospital pens.
Moreover a signifi cant increase of average piglet weight at 
birth and at 10 weeks of age was recorded (Table 2). Sows also 
increase clearly the farrowing rates during the three year period 
(Table 1).
Table 1.
SOWS 2005 2006 2007
% return to 
oestrus 26,2 20,4 18,4
% farrowing rate 68,4 75,2 78
Table 2
PIGS 2005 2006 2007
Total born 10,1 10,9 11
Total born alive 9,41 10,3 10,5
Mummifi ed piglets 0,2 0,1 00,5
Stillbirth 0,7 0,6 0,5
% Weak born piglets 14 10 10
% pre-weaning mortality 13,5 10,4 8,9
% post-weaning mortality 10,8 6,2 4,3
% piglets treated 18,6 12,1 9,4
Number of pigs in hospital pens 40 25 18
Average piglet born weight 1,32 1,44 1,48
Average pig weight at 10 weeks 23,8 24,9 26,2
Discussion
MLV vaccine effi  cacy in pigs and in sows has been also described 
previously. In spite of these positive long lasting results, PRRSV 
control depends also on other important factors rather than 
vaccines or vaccination programs as proper gilt replacement 
policies or strict biosafety measures. Regardless the increasing 
diversity of PRRSV strains described recently in Poland 2, a PRRSV 
vaccine, available in diff erent European and Asian countries for 
several years (AMERVAC®-PRRS) was able to induce enough cross 
protection to reduce the negative impact of a PRRSV infection. 
Conclusion
We concluded that the use of a MLV vaccination program in 
sows and piglets during the whole studied period resulted in 
the control of the negative eff ects of a PRRSV infection and 
improved sows and piglets performance. 
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Introduction
In Asia, nowadays, pig producers need to protect their pigs and 
sows against several pathogens. Many vaccination programs 
have to be implemented in specifi c close periods during the 
pigs’ life either whether it is in sows during the gestating or 
lactating period or whether it is during the fi rst weeks of life in 
pigs. Then the possibility of reducing or administering vaccines 
simultaneously can potentially improve either the pig welfare 
status or the labour effi  ciency. Therefore, the objective of this 
trial is to fi nd out if the attenuated PRRS vaccine virus VP046-BIS 
(AMERVAC®-PRRS) can keep alive when it is reconstituted with an 
inactivated Haemophilus parasuis vaccine (HIPRASUIS®-GLÄSSER) 
as a previous step to try in vivo the actual eff ect of these com-
bined vaccines.
Material and methods
Material: 50 dose freeze-dried tablets of AMERVAC®-PRRS vac-
cine (attenuated PRRS virus), 50 dose of inactivated Haemophilus 
parasuis vaccine HIPRASUIS®-GLÄSSER, 100 ml aqueous solvent 
vials and CLON8 cell line.
Methods: Two tablets of AMERVAC®-PRRS were reconstituted 
with HIPRASUIS®-GLÄSSER and with aqueous solvent respect-
ively. After 0, 2, 4 and 6 hours post reconstitution the virus was 
titred in CLON8 cell line.
Results
Table 1. Results of titres per dose of PRRS vaccine virus VP046-BIS. Vac-
cine virus titres VP046-BIS per dose (2ml) (TCID50/dose). Regarding by 
CPE (Cytopathic Eff ect).
Hours at standard Temperature 25ºC 
after reconstitution AQUEOUS SOLVENT
HIPRASUIS®-
GLASSER
0 104.4 104.5
2 104.3 104.4
4 104.2 104.2
*6 *104.1 *104.1
* PRRS vaccine virus VP046-BIS (AMERVAC®-PRRS) kept viable 
and with a dosage titre value equivalent or higher of 103.5TCID50 
(minimum necessary eff ective concentration as product 
manufacturer recommendation) at 6 hours after reconstitution 
with the inactivated Haemophilus parasuis vaccine HIPARSUIS®-
GLÄSSER (100ml). The same results were obtained when mixed 
with the usual prescribed aqueous solvent (100ml).
Discussion
This in vitro trail experience may be also applicable in vivo as 
in Roof et al 2000. In Roof et al 2000, there was no interference 
between vaccine antigens either when a live PRRSV vaccine 
was reconstituted with a multi-antigen inactivated vaccine and 
administered in pigs.
Conclusion
HIPRASUIS®-GLÄSSER vaccine allows the viability of the attenuat-
ed PRRS vaccine virus VP046-BIS (AMERVAC®-PRRS) even 6 hours 
after the reconstitution. Further studies in vivo are required to 
discard any vaccine incompatibility.
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Introduction
Needle-free injection devices deliver product by pressure dir-
ectly into subcutaneous or muscular tissue layers. This technol-
ogy has been used in human and veterinary medicine since mid 
1900’s, off ering some advantages over conventional medicine 
delivery methods: elimination of broken needles, consistent 
vaccine delivery, elimination of accidental worker needle sticks, 
elimination of needle disposal, and less pain and stress1. It also 
has an signifi cant potential as a tool when population-based 
injectable interventions are suitable for large livestock systems 
such as area/regional disease control programs. Some of their 
disadvantages include the relatively large initial fi nancial invest-
ment in equipment and the need for technical training. Another 
potential disadvantage is the eff ect of the device’s high pressure 
on the integrity of viral particles when applying modifi ed live 
vaccines.
The aim of this study was to determine if the needle-less injector 
AcuShot™ (AcuShot, Inc., Winnipeg, CA) aff ects the viability of 
Ingelvac® PRRS ATP (Boehringer Ingelheim Vetmedica, Inc., St. Jo-
seph, MO) vaccine virus by comparing samples obtained directly 
from the bottle of vaccine to samples obtained through 10 of 
the AcuShot™ devices.
Materials and Methods
A TCID50 assay was run at the Virology Laboratory of the Univer-
sity of Minnesota on samples of Ingelvac® PRRS ATP vaccine virus 
obtained through: AcuShot™ devices, conventional needle-
syringe, and pipetted directly from the vaccine bottle (controls). 
Thirty fi ve samples were taken from each of the 12 treatments 
in study: AcuShot™ devices (10), conventional needle-syringe 
(1), and pipetted directly from the vaccine bottle (control, 1). A 
sample size of 35 was determined applying Minitab® software 
version 15.1.0.0 (Minitab Inc., State College, PA), to detect a 
maximum diff erence between means of 0.3 log10 or about half a 
recommended dose of vaccine at P<0.05, and power >80%.
The statistical analysis was run with Minitab® applying ANOVA 
and Tukey’s test for comparison of means.
Results
TCID50 mean values (log10) did not diff er signifi cantly between 
any of the eleven treatments (ten Acushot devices and one 
needle/syringe) and the Control (samples pippeted directly from 
the bottle). The 95% confi dence interval for all eleven treat-
ments included zero, indicating no diff erence at P<0.05 from the 
Control (Figure 1). 
Figure 1. 95% confi dence intervals for the diff erences in mean TCID50 
values from Controls.
A01-A10=AcuShot; Ndl=Needle. 
Discussion 
The results of this study indicate that the viability of Ingelvac® 
PRRS ATP vaccine is not aff ected when applied through AcuSh-
ot™ needleless devices. Further evaluation of needleless devices 
under fi eld conditions is warranted to ensure their suitability for 
use in swine production.
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Introduction
Porcine Reproductive and Respiratory Syndrome (PRRS) is an 
economically important disease in pig production, mainly due 
to losses related to reproductive failure in sows and high mortal-
ity rates in commercial pigs from lactation to growing- fi nishing 
phase. In Venezuela, PRRS virus (PRRSV) was fi rst identifi ed in 
19961 and nowadays is and endemic pathogen2 causing big 
impact on the productive parameters of swine farms in Vene-
zuela3. The objective of this study was to monitor the eff ect of a 
live European (EU) PRRSV vaccine (AMERVAC®-PRRS) program on 
mortality rates in pigs at 3 diff erent periods: pre-weaning, post-
weaning and growing-fi nishing period.
Materials and methods
An 800 sows farm located in Venezuela, had a complaint of high 
pig mortalities. PRRSV diagnosis was confi rmed with PRRSV 
antibody detection in serum samples with a serology ELISA kit 
(HerdChek® PRRS 2XR, IDEXX) in sows and pigs at early ages. 
After veterinary advice, in October and November 2008 within 
a 4 weeks interval, two mass vaccinations with a live PRRSV 
vaccine (AMERVAC®-PRRS) were implemented in breeders. From 
January 2009 onwards, every piglet at weaning was vaccinated 
intramuscularly with one shot of the same live PRRSV vaccine. 
Mortality rate was compared between batches of pigs 6 months 
before and 8 months after the implementation of the second 
mass vaccination in sows (November 2008).
Results
Mortality rates were signifi cantly decreased (P<0.05 or P<0.001; 
unpaired t test) after the vaccine program implementation 
(Table 1). Pre-weaning, post-weaning and growing-fi nishing 
mortality rates decreased 45%, 46% and 34% respectively. 
Table 1. Monthly (mean±SD) pre-weaning (Pre), post-weaning (Post) 
and growing-fi nishing (G-F) pig mortality rates (%) 6 months before 
and 8 months after PRRS vaccine implementation (November 2008).
Period Before vaccination After vaccination
% Pre 15.5±1.1 8.6±1.4**
% Post 4.8±0.3 2.6±0.8**
% G-F 8.9±0.2 5.9±2.8*
* Results were signifi cantly diff erent, P<0.05
** Results were signifi cantly diff erent P<0.001
Figure 1. % Pig mortality evolution from July 2008 till August 2008. 
Mass vaccination in breeders (*) set up on October 2008. Piglet vaccina-
tion at weaning set up on January 2009.
Discussion
Within these fi eld conditions, we can observe that as in previous 
fi eld trials4,5,6, a live PRRSV vaccine program resulted in a sow 
protected population, which farrowed healthier new born pig-
lets that may respond properly to a intramuscularly live PRRSV 
vaccine dose and consequently induced a decrease of mortality 
rates during the whole growing period. In spite of the increas-
ing diversity of PRRSV strains described worldwide7, in this fi eld 
experience in Venezuela, (AMERVAC®-PRRS) was able to induce 
enough protection to reduce the negative impact of a PRRSV 
infection. 
Conclusion 
Within these fi eld conditions a vaccination program in sows 
and piglets with an EU MLV PRRSV vaccine (AMERVAC®-PRRS) 
reduced pig mortalities caused by a wild PRRSV infection in a pig 
farm in South America. 
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Introduction
PRRSV is a common pathogen causing respiratory and repro-
ductive clinic signs in Malaysian pig farms. PRRS vaccination in 
sows with AMERVAC®-PRRS has been used in pig farms in diff er-
ent countries and the benefi ts have shown to be encouraging 
(Quilitis2 et al. 2009; Rodriguez3 et al. 2009). The objective of this 
trial is to monitor the eff ect of AMERVAC®-PRRS vaccination on 
sows’ reproductive performance in an infected PRRSV farm and 
to determine whether there is any adverse reaction observed in 
pregnant sows post vaccination.
Materials and methods
A 1800 sow commercial farrow-fi nish pig farm located in Se-
langor state, Malaysia, was diagnosed with a PRRSV infection by 
means of the PRRSV antibody detection from serum samples 
with an ELISA kit test (Herdcheck 2XR, Idexx) and by PRRSV 
detection with a PCR technique (data not shown). Serology 
results indicated the presence of active PRRSV infection in the 
sows’ population. On veterinary prescription, all breeders (sows 
and gilts) were vaccinated with a live European PRRS vaccine 
(AMERVAC®-PRRS) on September 2008 and boosted with the 
same vaccine 1 month later. Sows were then vaccinated regular-
ly once every 4 months with AMERVAC®-PRRS. The farm is using 
Pig Champ® recording system to monitor production perform-
ance of the farm. Reproductive performance data for a period 
of 5 months before and after AMERVAC®-PRRS vaccination was 
collected and analyzed. The parameters and results observed are 
stated in Table 1.
Results and Discussion
There were no adverse reactions observed in sows after any of 
the vaccine inoculations. Reproductive parameters improved 
signifi cantly after the vaccine program was implemented. A sig-
nifi cantly improvement (P<0.05) in farrowing rate (+ 6%) and the 
average piglets born alive per litter (+0.54) was observed. The 
Return to estrus rate and average pigs weaned per sow per litter 
were improved but the results were not signifi cantly diff erent 5 
months after vaccine implementation. These results confi rmed 
previous positive fi eld experiences in Asia after the use of a live 
European PRRSV (genotype-I) vaccine in sows1, 2. 
Table.1. Sows’ reproductive performance before and after vaccination 
with AMERVAC®-PRRS. 
Parameters Before After Diff erence
% Sows on estrus within 7 days 
after weaning 83.52 88.03 +4.51*
% Sows Return to estrus 24.12 18.23 -5.89%
Farrowing rate % 67.45 73.45 +6%*
Average piglets born alive per 
litter 9.83 10.38 +0.54*
Average piglets weaned per sow 
per litter 8.14 8.70 +0.56
*P<0.05
Conclusions
Vaccination in lactating and gestating sows with AMERVAC®-
PRRS did not induce any adverse eff ect and improved reproduct-
ive performance in an endemic PRRSV infected farm in Malaysia. 
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Introduction
Epidemic of highly virulent PRRS caused by atypical virus of 
North American (NA) genotype was registered in China and 
Vietnam in 2006-2007 (Tian et al., 2007; To et al., 2007). In August 
2007 the similar virus - “Irkutsky 2007” strain - was isolated in 
the Irkutskaya Oblast of Russia, where the fi rst outbreak of new 
atypical PRRS outside South-East Asia was registered (Kukushkin 
et al., 2008). The purpose of our study was to compare resistance 
of pigs to challenge with highly pathogenic Chinese-type PRRS 
virus after seroimmunization and vaccination with commercial 
vaccines from European, North American PRRSV genotypes and 
a vaccine from a homologous strain.
Materials and Methods
Twenty-six 4-month-old PRRS-seronegative piglets were divided 
into fi ve groups: Group 1 (6 piglets) was single immunized with a 
commercial live vaccine from North American PRRSV genotype; 
Group 2 (5 piglets) was twice immunized with an inactivated 
vaccine from a homologous PRRSV “Irkutsky 2007” strain; Group 
3 (4 piglets) was twice immunized with a commercial inactivated 
vaccine from European PRRSV genotype; Group 4 (8 piglets) was 
immunized with hyperimmune (positive) serum to a homolo-
gous PRRSV “Irkutsky 2007” strain at a dose of 1 ml/kg before 
challenge; Group 5 (3 piglets) was a non-immunized control. 
After immunization all piglets were intranasally challenged with 
a highly pathogenic Chinese-type PRRS virus “Irkutsky 2007” 
strain. Blood sera collected before and 16 days after inoculation 
were tested for PRRSV antibodies using ELISA (IDEXX, West-
brook, ME, USA). All animals were slaughtered on day 16 after 
challenge for examination of lung lesions score according to 
Halbur et al. (1995). 
Results
Hyperthermia was registered in all groups. The most lasting 
hyperthermia was observed in Groups 3 and 5 (12-15 days, max-
imum 41.7ºC), hyperthermia of medium duration was recorded 
in Groups 2 and 4 (11-12 days, maximum 41.8-41.9ºC), the 
shortest hyperthermia was in Group 1 (7 days, maximum 40.7-
41.0ºC). Disease clinical signs and their duration between groups 
were analogous to the manifestation of hyperthermia. Less 
pronounced clinical signs were present in the Group immunized 
with a commercial live vaccine.
The highest level of lung lesions was in Groups 5 and 3, the 
lowest level was in the Group immunized with a commercial live 
vaccine from N. American genotype (Table 1).
Group Number of piglets
Mean antibody level in 
ELISA IDEXX, s/p
Average lung 
lesions, %
before challenge after challenge
Live vaccine from NA 
genotype 6 0.85±0.65 1.25±0.58 0.38±0.72
Inactivated vaccine 
from a homologous 
strain
5 1.51±0.99 2.35±0.23 12.03±12.80
Inactivated vaccine 
from European 
genotype
4 2.70±0.08 2.97±0.73 28.69±17.63
Hyperimmune serum 
to a homologous strain 8 0.02±0.03 1.42±0.53 7.13±11.86
Non-immunized 
control 3 0.00±0.00 1.35±0.43 39.67±31.63
Discussion and Conclusion
Testing results showed that the best protection of piglets 
against challenge with highly virulent PRRS virus was provided 
by a commercial live vaccine from N. American genotype. In-
activated vaccine and hyperimmune serum from a homologous 
strain provided middle protection of lungs but did not prevent 
the appearance of clinical signs.
References
Halbur, P.G., et al., 1995. Vet. Pathol. 32: 648-660.
Kukushkin, S.A. et al., 2008. In: Proc. 2008 International PRRS Sympo-
sium, Chicago, Illinois, p. 23.
Tian, K. et al., 2007. PLoS ONE. 2(6), e526.
To, L.T. et al., 2007. In: Proc. 2007 International PRRS Symposium, Chi-
cago, Illinois, p. 74. 
Porcine Reproductive and Respiratory Syndrome (PRRS) – Vacccination
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 528
Poster Presentations
P.222
PRRSV (type I) challenge in vaccinated and non-vaccinated pigs 
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Introduction
Recently it has been demonstrated that signifi cant diff erences 
can be observed among Type 1 PRRSV isolates (1). Previous stud-
ies demonstrated that genetic diversity within European geno-
type may aff ect the effi  cacy of currently available vaccines (2). 
The aim of the present study was to investigate the pathogen-
icity of a recently isolated virulent PRRSV Type I, subtype 1 fi eld 
strain by evaluating the clinical outcome of the infection as well 
as the pathological lung lesions in vaccinated and non-vaccinat-
ed growing pigs. 
Materials and Methods
Thirty-six 3-week-old PRRSV negative pigs were randomly as-
signed to three treatment groups with 12 pigs each. Group 3 
was vaccinated with a commercial live PRRSV Type 1 vaccine (DV 
strain). Five weeks after vaccination pigs of groups 2 and 3 were 
challenged with 2.2 * 105 TCID50 of a Type 1, subtype 1 viru-
lent PRRSV fi eld isolate. The challenge isolate and the vaccine 
strain shared 89 % nucleotide and 91 % amino acid identity on 
ORF5 (GP5) and 95 % nucleotide and 96 % amino acid identity 
on ORF7 (N). Group 1 served as a negative control. During the 
course of the study, viraemia, serology, clinical signs, rectal 
temperature and average daily weight gain were monitored. 
Animals were euthanized on 10 DPI (n=6 per group) and 21 
DPI (n=6 per group). Severity of macroscopic and microscopic 
lung lesions was scored (0-3). The microscopical evaluation was 
performed as a blinded analysis. 
Results
All group 3 animals became viremic following vaccination and 
all group 2 animals became viremic following challenge. Sero-
conversion was observed within one week after onset of PRRSV 
viraemia. Following challenge on SD 35, a signifi cant (p≤ 0,05) 
increase in number of animals with fever (≥ 40,5°C) occurred in 
the vaccinated group in comparison to the control group be-
tween SD 39-44, while a signifi cant increase was observed in the 
challenged group between SD 42-44. Coughing was observed 
in more than 60% of animals in group 2 and 3 but in less than 
10% of group 1 animals. Within the fi rst 10 days following chal-
lenge, group 1 animals showed a signifi cant higher body weight 
gain (6.8 kg) than group 2 (3.9 kg, p<0.001) and group 3 (5.0 
kg, p=0.004) animals. Average daily weight gain of all 3 groups 
before and after challenge is presented in Figure 1.
Concerning lung lesions, signifi cant diff erences (macroscopic le-
sions: p ≤ 0.0285, microscopic lesions: p ≤ 0.0001) were observed 
between challenged animals (group 2 and group 3) and the 
negative controls (group 1). In contrast to that, summarized lung 
score values of vaccinated (group 3) and non-vaccinated pigs 
(group 2) were not signifi cantly diff erent (macroscopic lesions p 
≥ 0.0607, microscopic lesions: p = 0.7144). 
Figure 1: Average daily weight gain before and after challenge.
 
Discussion
The data demonstrate that a recent PRRS Type 1 fi eld strain is 
able to induce clinical signs and macroscopic and microscopic 
lung lesions upon experimental challenge of growing pigs. The 
fact that no signifi cant diff erences were observed between vac-
cinated and non-vaccinated challenged pigs is in line with other 
reports indicating that available live modifi ed PRRS vaccines do 
not always provide complete protection against all types of cur-
rently circulating PRRS strains (2).
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Introduction
Successful control of PRRS often involves strategies for immun-
izing gilts and maintaining immunity in sows. The choice of a 
given strategy depends on the safety/effi  cacy balance. Objec-
tions about using a live PRRSV strain in gestating sows - except 
in the case of a severe PRRS outbreak- may coexist in the same 
farm with the use of live PRRSV. In Spain, another approach was 
tested in which gilts are fi rstly immunized by using live virus and 
then booster vaccination of sows is performed using PROGRES-
SIS®. This may avoid the use of live PRRSV in gestating sows. The 
present report examines the effi  cacy of such approach.
Material and Methods
Thirty-two high health pigs free from all major pig diseases 
were selected at weaning in a PRRSV-free farm. Animals were 
confi rmed to be free of PRRSV by ELISA (HERDCHEK 2XR, IDEXX 
Laboratories) ear-tagged and let to acclimatize for two weeks. At 
six weeks of age, piglets were randomly allocated in four separ-
ated groups of eight animals: A, B, C and D and vaccinated with 
an adjuvanted modifi ed-live PRRSV vaccine (MLV) or a placebo. 
Three months later, piglets were PROGRESSIS-revaccinated 
(once or twice) or with a MLV as shown in Table 1. At 6.5 months 
of age, all pigs were intranasally challenged with 1x106 TCID50 (2 
ml) of a Lelystad-like PRRSV strain and were followed for 21 days. 
Humoral response was evaluated by ELISA and the frequency of 
PRRSV-specifi c IFN- γ cells in blood was measured by ELISPOT 
as reported before (1). After challenge viremia was examined by 
RT-PCR at days 0, +3, +7, +10, +14, +21. Statistical analysis was 
done using StatsDirect v2.7.5 by means of the Kruskal-Wallis test 
with multiple comparisons performed by the Connover-Inman 
test.
Table 1: Design of the experiment
Group/Months of age 1.5 4.5 5.5 6.5 7.5
A MLV KV Pl. Ch. End
B MLV MLV Pl. Ch. End
C MLV KV KV Ch. End
D Pl. Pl. Pl. Ch. End
KV= PROGRESSIS; Pl.=Placebo; Ch. = Challenge
Results
No reaction after vaccination was observed, showing safety of 
these treatments. Initial vaccination with the MLV produced 
seroconversion and raised the PRRSV-specifi c cell-mediated 
response (Table 2 and Figure 1). No diff erences were seen in the 
humoral response but the use of PROGRESSIS as a booster anti-
gen was equal or better than the use of a repeated MLV adminis-
tration (group B) in terms of maintaining the PRRSV-specifi c IFN- 
γ response. Thus, at the time of challenge, the IFN- γ response 
of group C was higher (p<0.05) than the IFN- γ frequencies in 
groups B and D. After challenge, the higher booster in IFN- γ was 
seen in group C as well. By the end of the experiment, group A 
showed the higher IFN- γ frequencies compared to other groups 
(p<0.05). RT-PCR results showed that all unvaccinated became 
viremic after challenge while in groups A, B and C only one or 
two pigs became infected by day 3 PI (data not shown).
Table 2: Serological evolution (ELISA) of pigs (S/P ratios)
Group/Months of age 1.5 2.5 3.5 4.5 5.5 6.5 End
A 0.05 1.2 2.9 2.8 2.8 2.7 2.5
B 0.04 1.1 2.4 2.0 2.5 1.9 2.3
C 0.07 1.2 2.8 1.9 2.7 2.4 2.2
D 0.07 0.1 0.1 0.1 0.1 0.1 2.1
Figure 1: IFN- γ response (ELISPOT) after vaccination
Conclusion
The present results show that the use of PROGRESSIS or MLV 
vaccine or combination of both gave similar results.
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Introduction 
The emergence of highly virulent PRRS virus (PRRSV) strains in 
China in 2006<sup<1,2 was a milestone in the epidemiology of 
PRRS in Asia. Nowadays, genotype II strains of diff erent virulence 
coexist with genotype-I strains3,4 in this continent. At present, 
AMERVAC®-PRRS (a genotype-I vaccine) is licensed and marketed 
in many countries of Asia and, therefore, contact of vaccinated 
herds with highly virulent genotype-II strains can be expected. 
The present study was aimed to explore the safety and potential 
effi  cacy of AMERVAC®-PRRS against highly virulent genotype-II 
strain.
Material and Methods
Twenty-one 4-week-old, PRRSV-naïve pigs were randomly 
divided into three groups (G1, n=8; G2 n=8; and G3, n=5) and 
housed separately in biosafety level 3 facilities at CReSA. Pigs in 
G1 were immunized intramuscularly with AMERVAC®-PRRS (2 ml 
of 104,6 TCID50/ml). G2 and G3 were kept as unvaccinated groups. 
At day 32 post-vaccination, G1 and G2 pigs were intranasally 
inoculated with 2 ml of (1x105 TCID50/ml) of the Asian highly 
virulent isolate PRRSV21 (99% similar in ORF5 to other highly 
virulent isolates of Asia). Pigs in G3 remained as uninoculated 
controls. For the following 21 days, pigs were clinically examined 
(C) and rectal temperatures (T) were taken. Blood samples were 
taken on days, 0, 3, 7, 10, 14 and 21 post-challenge (PC). RT-PCR 
was used to assess the virological outcome of the challenge. Pigs 
were euthanized and necropsied on day 21 PC. Statistics were 
done using StatsDirect 2.7.5 software.
Results 
Vaccination did not produce any adverse or side eff ect. All 
inoculated pigs became infected as determined by RT-PCR and 
developed fever but diff erences were noticed among groups 
(Figure 1). Thus, G1 pigs suff ered less days of fever (p<0.05) than 
G2 ones did. Also, naïve (G2) pigs developed evident respiratory 
signs from day 5 PC that often persisted until day 18 PC. Two 
G2 pigs died (25 %). In G1 pigs, signs were milder, of shorter 
duration and aff ected less number of pigs. At necropsy, lesions 
were more frequent and more severe in G2 pigs compared to G1 
(Table 1). Findings compatible with bacterial complications (i.e. 
polyserositis and bronchopneumonia) were more common in 
G2. 
Figure 1. Clinical signs and body temperatures. 
C1, C2, C3 (shadowed areas): % of pigs with clinical signs in groups G1, G2, G3. T1, T2, T3 (lines): 
average rectal temperatures in groups G1, G2, G3
Table 1. Main fi ndings in necropsies of G1, G2 and G3 pigs.
Lesion G1 G2 G3
Average pneumonia score (1-4) 1.0 2.2 0.0
Catarrhal bronchopneumonia 0/8 4/8 0/5
Interstitial nephritis 1/8 5/8 0/5
Gall bladder oedema 0/8 3/8 0/5
Fibrinous polyserositis 2/8 5/8 0/5
Arthritis 0/8 3/8 0/5
Discussion
Vaccinated animals had clinical protection against the virulent 
challenge in spite of the diff erent genotypes of the vaccine and 
the challenge isolate. This observation also suggests the exist-
ence of conserved epitopes among PRRSV genotypes.
References
1.  Tian et al. 2007. PLoS ONE, 2: e526
2.  Li et al. 2007. Vet J, 174 : 577-584.
3.  Nam et al. 2009. Arch Virol, 154: 629-638.
4.  Amonsin et al. 2009. Virol J, 16: 143.
Porcine Reproductive and Respiratory Syndrome (PRRS) – Vacccination
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 531
Poster Presentations
P.225
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Introduction
Needle-free injection devices deliver product by pressure direct-
ly into subcutaneous or muscular tissue layers. This technology 
has been used in human and veterinary medicine since the mid 
1900’s, off ering some advantages over conventional vaccine or 
medicine delivery methods: elimination of broken needles, con-
sistent product delivery, elimination of accidental worker needle 
sticks, elimination of needle disposal, and less pain and stress.1 
It also has signifi cant potential as a tool when population-based 
injectable interventions are suitable for large livestock systems 
such as area/regional disease control programs. Some of their 
disadvantages include the relatively large initial fi nancial invest-
ment in equipment and the need for technical training. Another 
potential disadvantage is the eff ect of the device’s high pressure 
on the integrity of viral particles when applying modifi ed live 
vaccines.
The aim of this study was to compare the post-vaccination 
seroresponse to Ingelvac® PRRS MLV (Boehringer Ingelheim Vet-
medica, Inc., St. Joseph, MO) in pigs vaccinated with either the 
traditional syringe and needle technology, or AcuShot™ (AcuS-
hot, Inc., Winnipeg, CA) needleless approach.
Materials and Methods
Forty 4-week old PRRS virus and M. hyopneumoniae negative/
naïve piglets were randomly allocated into two treatment 
groups: Treatment Group 1 (AcuShot) and Treatment Group 2 
(Needle), both with a sample size of 20 pigs. Each pig in each 
treatment group was vaccinated I.M. with a 2 mL dose of Ingel-
vac® PRRS MLV per label recommendations. Blood samples were 
collected at days 0, 7, 14, 28, 42 and 56 for assessment by PRRS 
ELISA, PCR and quantitative PCR (qPCR). 
The statistical analysis was run with Minitab® software version 
15.1.0.0 (Minitab Inc., State College, PA), applying Mann-Whitney 
and Two Proportions tests.
Results
No signifi cant diff erence was found at α=0.05 between treat-
ments for viral load as determined by qPCR (Table 1).
Table 1. Quantitative PCR mean values (log10) post-vaccination. Dif-
ferent superscripts within a column indicate signifi cant diff erences at 
P<0.05.
Day7 Day14 Day28 Day42 Day56
AcuShot 5.61a 5.79a 4.09a 3.97a 3.21a
Needle 5.45a 5.77a 4.71a 3.91a 3.48a
No signifi cant diff erences at α=0.05 were detected between 
treatments for PRRS ELISA S/P ratios or percent PCR positive 
samples post-vaccination (Figure 1).
Post-vaccination viremia was detected by PCR at day 7, and was 
still present in serum in 20-26% of pigs at day 56 post-vaccin-
ation. Post-vaccination ELISA positive samples were detected 
from day 14 to the end of the study at day 56 (Figure 1).
Figure 1. Percent of PPRSv PCR (+) samples and ELISA S/P post-vaccin-
ation mean values per treatment (AcS=AcuShot; Ndl=Needle).
Discussion 
Under the conditions of this study, no signifi cant diff erences 
were found between AcuShot and traditional syringe and nee-
dle in the Ingelvac® PRRS MLV post-vaccination seroresponses as 
measured by ELISA, PCR and qPCR.
Further evaluation of needleless devices under fi eld conditions is 
warranted to ensure their suitability for use in swine production.
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Introduction
Needle-free injection devices deliver product by pressure direct-
ly into subcutaneous or muscular tissue layers. This technology 
off ers some advantages over conventional vaccine or medicine 
delivery methods: elimination of broken needles, consistent 
vaccine delivery, elimination of accidental worker needle sticks, 
elimination of needle disposal, and less pain and stress1. Since 
it has been demonstrated that hematogenous transmission of 
porcine reproductive and respiratory syndrome virus (PRRSv) 
can occur from infected pigs to susceptible pigs via repeated use 
of the same needle2, another potential advantage of needle-free 
technology is the reduction of hematogenous transmission of 
PRRSv.
The aim of this study was to evaluate the ability of the AcuShot™ 
needle-less injection system (AcuShot, Inc., Winnipeg, CA) to 
reduce or eliminate the hematogenous transmission of PRRSv. 
Materials and Methods
Four replicates of this study were conducted, each involving 22 
four-week-old PRRSv naïve pigs. Each replicate consisted of 5 
groups, and each group was housed in a separate room in an 
isolation facility at the University of Minnesota. Group #1 (PRRSv 
source population) consisted of 10 pigs which were intranasally 
inoculated on day 0 with 2 mL of the MN-184 PRRSv isolate at 
a concentration of 104 TCID50/ml. Group #2 AcuShot, Group 
#3 conventional needle or positive control, Group #4 sham-
inoculated, and Group #5 negative control, each consisted of 
three pigs. All pigs in Group 4 (the sham-inoculated group) were 
intranasally inoculated with 2 mL of virus-free media. On days 
5, 6 and 7 post-inoculation (PI) of Group #1, pigs from groups 
#1, #2 and #3 were vaccinated with a killed Mycoplasma hyo-
pneumoniae (M. hyo) bacterin (Ingelvac MycoFLEX®, Boehringer 
Ingelheim Vetmedica, Inc., St. Joseph, MO). The same AcuShot 
device and needle/syringe used to initially M. hyo-vaccinate the 
PRRSv source pigs (group #1) on opposite sides of the neck were 
used to subsequently M. hyo-vaccinate pigs in groups #2 and #3, 
respectively. Serum samples were collected from all pigs on days 
0, 2, 5, 7, 12, 19 and 22 PI for PRRS PCR, and PRRS ELISA at days 
0 and 22. The statistical analysis was run with Minitab® software, 
applying Fisher’s exact test.
Results
At arrival (day 0), all pigs tested negative by PRRS ELISA and PCR. 
All Group 1 pigs tested PRRS PCR positive at days 2 and 5 PI. All 
12 pigs (4 reps of 3 pigs) injected with the conventional needle/
syringe became PRRS PCR-positive at days 12 and 19 PI, while 
4 out of 12 pigs injected by AcuShot tested PRRS PCR-positive 
by day 19 PI. The proportion of PRRS PCR-positive animals was 
signifi cantly lower in the AcuShot group compared with the 
needle/syringe group (P≤0.05, Table 1). On day 22 PI, the fi nal 
day of the study, all PRRSv source pigs tested PRRS ELISA-posi-
tive, as did the 12 animals injected with conventional needle/
syringe. Three of 12 animals treated using AcuShot and none of 
the negative controls or sham-inoculated pigs tested ELISA posi-
tive on day 22 PI.
Table 1. Proportion of PRRS PCR-positive pigs per treatment by testing 
day. 
Group D 7 D 12 D 19 D 22
3 Needle 9/12b 12/12b 12/12b NT
2 AcuShot 0/12a 2/12a 4/12a 3/12a
4 Sham-Inoc. NT NT NT 0/12a
5 Neg Control NT NT NT 0/12a
NT=No samples taken. Diff erent superscripts within columns indicate signifi cant diff er-
ences at P≤0.05.
Discussion 
The results of this study indicate that hematogenous transmis-
sion of PRRSv occurs from infected pigs to susceptible pigs via 
repeated use of the same needle and that needle-free systems 
reduce, but do not eliminate, the hematogenous transmission of 
PRRSv. Further research is needed to identify the mechanisms of 
PRRSv transmission by needle-free devices. Further evaluation of 
needleless devices under fi eld conditions is warranted to ensure 
their suitability for use in swine production.
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Introduction 
In the last years pig Vietnamese farms have suff ered the infec-
tion of very virulent PRRSV1 strains, which were responsible of 
important economic loses. The use of live PRRSV vaccines either 
of the genotype-I (European) or the genotype-II (American) 
family virus has been spread in Vietnam and other Asian coun-
tries in order to reduce PRRSV negative eff ects. Some Vietnam-
ese pig farms, which were endemically infected by PRRSV, have 
been already for more than 4 years vaccinating their sows with 
diff erent family type vaccines. The objective of this fi eld study 
is to compare reproductive sow performance data of a pig farm 
in Vietnam, in which sows and gilts were vaccinated regularly 
during two diff erent periods of time with live PRRSV vaccines of 
diff erent genotype family.
Material and Methods
The study was carried out in a one site production pig farm with 
3000 sows, which is located in Binh Duong province, Vietnam. 
In 2004 PRRSV was diagnosed and a vaccination program with 
a live genotype-II virus vaccine started. A vaccine dose was 
regularly inoculated in gilts at 80 days of age and sows were vac-
cinated once in each pregnancy on the 4th week of gestation. At 
the end of 2007 the live genotype-II PRRSV vaccine was replaced 
by a live genotype-I PRRSV vaccine. This new genotype-I vaccine 
is still used in the farm today (January 2010). The vaccination 
protocol implemented with the new vaccine was the same like it 
was with the genotype-II PRRSV vaccine. We have compared the 
average sow reproductive performance data between the last 2 
years implementation period of both the live genotype-II PRRSV 
vaccine (from 2006 to 2007) and the live genotype-I PRRSV vac-
cine (from 2008 to 2009). 
Results 
In spite of the already long time stable reproductive results with 
the use of a live genotype-II PRRSV vaccine in sows we observed 
that reproductive parameters were improved during the next 
2 years period, in which a live genotype-I PRRSV vaccine was 
used (Table 1). The only studied parameter that did not improve 
signifi cantly was the total number of born piglets per litter. 
Table 1. Monthly average reproductive performance results during 2 
years periods, from year 2006 to 2007 (use of live genotype-II PRRSV vac-
cine) and from year 2008 to 2009 (use of live genotype-I PRRSV vaccine).
Genotype-II vaccine Genotype-I vaccine
Farrowing rate % 77.60±4.59 *80.60±4.08
Born piglets /litter 10.99±0.30 11.00±0.51
Weaned piglets/litter 10.27±0.34 *10.54±0.52
% Litter scatter1 13.24±2.70 *11.03±3.47
*Signifi cantly diff erent (P<0.05, unpaired t test). 1Litter scatter <8 born 
piglets.
Discussion and conclusion
The use of a live genotype-I PRRSV vaccine improved results in a 
farm endemically infected with PRRSV, in which sows had been 
vaccinated with genotype-II PRRSV vaccine. Diff erent degree of 
effi  cacy was also previously observed2 with the use of 2 diff erent 
live PRRSV vaccines in experimental conditions against a patho-
genic PRRSV challenge in sows at 90 days of pregnancy. In this 
experience, lower % of new born viraemic piglets resulted also 
in a lower % of pre-weaning piglet mortality. So the vaccine that 
could reduce better vertical transmission from sows to foetus 
was also the one giving as a result healthier born litters with 
lower mortality. This fi eld experience is also indicating that other 
virus epitopes3 or other immune response factors, common 
in both genotype PRRSV families, could be related to vaccine 
protection features. 
Conclusion
A genotype-I PRRSV vaccine within these fi eld conditions 
seemed to induce better degree of effi  cacy against a PRRSV 
infection in sows, when used in an endemically PRRSV infected 
farm in Vietnam.
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Construction of attenuated porcine reproductive and respiratory 
viruses with a marker of Nsp2-coding region deletion
Aihua Fang; Xin Guo; Xinna Ge; Hanchun Yang
China Agricultural University, Beijing, China
Introduction
Porcine reproductive and respiratory syndrome (PRRS) is one of 
the most economically important diseases for the pig indus-
try worldwide. Non-structural protein 2 (Nsp2) of PRRSV is the 
most variable region that is able to tolerate natural and artifi cial 
amino acid deletion (1, 2, 3, 4). In the present study, we gener-
ated two candidates of PRRSV vaccine with a marker of Nsp2-
coding region deletion using the reverse genetic operation 
method, based on the attenuated PRRSV strain HB-1/3.9M which 
can provide suffi  cient protection for pigs against the Chinese 
highly pathogenic PRRSV
Materials and Methods
Cells and viruses. MARC-145 cells were used for propagation of 
PRRSV and transfection of full-length cDNA clones. An attenu-
ated PRRSV strain (HB-1/3.9M) was used for the study. 
Construction of full-length cDNA clones HB-1/3.9M. The con-
struction strategy of full-length cDNA clones for the virus was 
basically performed according to the methods previously de-
scribed (1). The full-length cDNA clone plasmid was designated 
pWSK-HB1-WT. 
Deletion mutagenesis of Nsp2-coding region of PRRSV HB-
1/3.9M. A plasmid pEB-A possessing the fi rst 3585 nucleotides 
of HB-1/3.9M was constructed, which contains partial Nsp2. To 
delete HB-1/3.9M Nsp2-coding region with 270 nt (Nsp2Δ1627-
1896) and 528nt (Nsp2Δ 1627-2154) respectively, overlapping 
extension PCR was performed on pEB-A. The PCR product 
was gel-purifi ed, digested with proper enzymes, and cloned 
into pEB-A, cut with the same enzymes. After confi rmation by 
sequencing, mutated fragment A insert into the infectious clone 
backbone to construct the fi nal full-length deletion clone desig-
nated as pWSK-HB1-D90 and pWSK-HB1-D176, respectively.
Recovery and identifi cation of the viruses. The viruses were res-
cued from each full-length cDNA clone according to the method 
previously described (3). The cytopathic eff ect (CPE) was daily 
observed. The rescued viruses were identifi ed by immunofl uor-
escence assay (IFA) using monoclonal antibody for N protein 
of PRRSV. Meanwhile, the genetic markers were detected to 
diff erentiate the rescued viruses and parental viruses. Growth 
characterization of the rescued viruses was determined.
Results
Viable viruses could be rescued from the full-length cDNA 
clones. A typical PRRSV CPE could be observed at the fi rst pas-
sage for the all full-length cDNA clones. The three rescued virus-
es designated as RVHB1-WT, RVHB1-D90 (90-aa deletion) and 
rVHB1-D176 (176-aa deletion) were identifi ed by IFA, genetic 
markers check and partial Nsp2 sequencing (data not shown). 
Growth characteristics of the rescued viruses. The rescued 
viruses could be passaged stably on MARC-145 cells with higher 
viral titres. All the three rescued viruses displayed the similar 
replication rate like their parental virus (Fig. 1). After 20 passages, 
the deletions in Nsp2 of rVHB1-D90 and rVHB1-D176 were exam-
ined by RT-PCR and followed by sequencing, indicating that the 
deletions stably exist.
Figure 1. Growth curve of the rescued viruses on MARC-145 cells.
Discussion
In recent years, the highly pathogenic PRRSV was pandemic in 
China and brought huge losses for swine production. Therefore, 
developing an attenuated vaccine with a marker is important 
for prevention and control of the virus. We have attenuated a 
strain of Chinese PRRSV HB-1/3.9M that presented satisfactory 
immune effi  cacy against highly pathogenic PRRSV infection. 
In the present study, we obtained two viruses (RVHB1-D90 and 
RVHB1-D176) on the basis of HB-1/3.9M by using infectious 
cDNA clones, which could be propagated stably in vitro. These 
viruses contain a deletion within the Nsp2-encoding region, 
respectively, suggesting that they are potential to be used as 
the candidates of PRRSV vaccine with a marker. Their immuno-
genicities and methods for detection of antibody to the deleted 
region of Nsp2 for diff erentiating vaccinated pigs from infected 
pigs by fi eld virus are still under investigation.
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Eﬃ  cacy of an attenuated live PRRS vaccine against a severe PRRS outbreak in sows and piglets
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1. SETNA NUTRICION-INVIVO NSA, Madrid, Spain; 2. Intervet/Schering-Plough AH, Cantabria, Madrid, Spain
Introduction 
Porcine Reproductive and Respiratory Syndrome (PRRS) is 
considered to be one of the most important causes of loss for 
the swine industry worldwide. Several techniques have been 
proposed not only to reduce the economic impact of this dis-
ease, but also to minimize PRRS virus circulation. Among them, 
vaccination with attenuated vaccines seems to be one of the 
most eff ective.
This paper describes fi eld experience with a vaccine based on an 
attenuated strain (Porcilis® PRRS), used in a sow herd with active 
PRRS virus circulation.
Materials and Methods
This study was performed in a closed cycle herd of about 500 
sows in the province of Toledo, in central Spain. Before the 
introduction of Porcilis® PRRS, replacement stock was vaccinated 
twice with an inactivated vaccine with a 3 week interval, during 
the quarantine period. This measure alone appeared unable to 
prevent new PRRSv circulation in the herd. This was evidenced 
by (between May and June 2009) more abortions, and weak 
born piglets and increasing mortality in lactating sows and 
weaned piglets associated with high levels of antibodies against 
PRRSv in the sows (Antibody test kit – IDEXX Laboratories Inc), 
and by the detection of PRRSv in piglets of 4 and 5 weeks of age 
(PCR and inmunoperoxidase test). 
The ORF-5 of the PRRSv strain involved in this disease was se-
quenced as 91.4% homologous with the Lelystad strain. 
Porcilis® PRRS (Intervet International BV, Boxmeer, NL) is an at-
tenuated live vaccine, based on a European strain of PRRS virus 
identifi ed as DV strain.
In July 2009, the whole herd was vaccinated twice with Porcilis® 
PRRS with a three week interval between doses. After October 
2009, sows were vaccinated according to a ‘5/50’ scheme (5 
days into lactation and 50 days into pregnancy). To complement 
these measures, no replacement stock were introduced for 5 
months, and the M. hyo and PCV2 vaccination of piglets ceased.
Statistical analysis was performed using the General Linear 
Model (GLM-SPSS 15.0 for Windows) and Pearson’s chi-square 
test was used for comparisons of means.
Results
Table 1 and Graphs 1 and 2 summarize the development of the 
main parameters recorded.
Table 1. The main parameters recorded over time
% % % Mortality % Mortality
abortions Still born Lactation Nursery
Jan to April 0.27** 1.85** 16.98 NS 2.9**
May to Aug 3.15 2.4 17.03 10.6
Sept to Dec 1.6* 1.95** 15.83 NS 4.5**
Comparing the fi rst and third periods with the second: NS: p>0.05; *: p<0.05; **: p<0.001). 
Graph 1. Abortion rate over time
 
After vaccination, the number of abortions and stillbirths and 
the mortality rate were clearly reduced during the lactation 
and post-weaning periods. In September, piglets of 9 weeks of 
age were found to be seronegative for PRRS, indicating that the 
improvements were related to the changing pattern of PRRSv 
circulation.
Graph 2. Mortality rate in weaned piglets over time
Conclusion
Vaccination with Porcilis® PRRS is an eff ective means of control-
ling PRRS clinically, as well as from an epidemiological view-
point.
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Case control and management of virulent PRRS in a commercial farm in the Philippines
Angel Antonio C. Manabat
PIC Philippines, Ortigas, Pasig City, Philippines
Introduction
For years, active PRRS infections in local swine farms have 
resulted in large economic losses for farmers because of poor 
breeding performances, high morbidities and medication costs 
and mortalities. In 2008, there were reports that PRRS strains 
similar to China were found in selected Philippine farms 2, which 
could have further increased the maginutde of this disease 
problem. 
There are many approaches in stabilising herds with PRRS, how-
ever for farms located in areas with high density pig population, 
a good vaccination program seems to be the main and possibly 
the only option to take1.We report here a case of a farm slowly 
getting back to profi tability after months and possibly years of 
frustrating management of their PRRS problem. 
Case description
An 800+ sow level farrow to fi nish operation located in a farm 
estate in Bulacan Province Philippines have been experien-
cing the eff ects of an active PRRS infection. Mortalities in the 
pre-weaning and post weaning have been in alarming levels 
for months, and there was a reported 15 abortions per month 
observed. Farrowing rates have stayed in the 50 to 65% rates for 
sometime. Other pig farms are located in the same farm estate, 
one even located just a few meters away, many reporting their 
own problems in dealing with a respiratory and reproductive 
problems in their herds. The farm has had many control and 
management measures implemented, strict adherence to all-in 
all-out loading, breeding audits, farm personnel trainings, stra-
tegic medication programs and was already on a breeder mass 
vaccination and piglet vaccination program for PRRS Modifi ed 
Live Vaccine (MLV) using a European strain vaccine. However, 
performances stayed at unsatisfactory levels.On September 
2008, the farm decided to implement a shift to another PRRS 
vaccine (Ingelvac PRRS MLV®, Boehringer Ingelheim). They mass 
vaccinated the breeding herd and placed the piglet vaccination 
on day 21, improvements in piglet mortalities would be their 
major evaluation factor.
Results 
A few months after the shift of PRRS vaccine used, the farm has 
reported a signifi cant decrease in mortalities of piglets in both 
the pre-weaning and post weaning stages (fi gure 1).
Figure 1. Statistical Process Chart Data of Mortality showing the 
period of vaccinating with the EU strain vaccine as against Ingelvac 
PRRS MLV
 
Farm also reported a reduction in abortion cases by half after 
initiating the program in September and partly due to this, far-
rowing rates are now improving and already reaching the 80% 
level.
Conclusion
Despite dramatic improvements, the farm is still a case-control 
in progress, vaccinating with Ingelvac PRRS MLV just barely 6 
months as of data availability. Inspite of a virulent PRRS that hit 
the herd, which wiped out the piglets before weaning, the use of 
a VR2332-strain MLV showed that it can bring back the perform-
ance particularly livability to more acceptable levels. 
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Comparison of serological and virological analysis for infection patterns of porcine 
reproductive and respiratory syndrome virus to establish a farm level control strategy
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National Veterinary Research & Quarantine Service, Anyangcity, Korea
Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV) 
has plagued pig populations worldwide causing severe econom-
ical impacts. In order to establish eff ective strategies for preven-
tion of PRRS, infection patterns on the herd level were primar-
ily evaluated. In the present study, therefore, serological and 
virological analyses were conducted in 20 pig farms suff ering 
from PRRS.
Materials and Methods
A total of 20 pig farms were selected that they were a 150-250-
sow, three-site multiplier herd. The blood samples were taken 
from sow, piglet, 40, 70, 100, 130 days-old pig groups. A com-
mercial kit for PRRS (HerdCheck; IDEXX Laboratories) was used 
for serological testing according to the manufacturer’s instruc-
tion. A reverse transcriptase-PCR (RT-PCR) was used to amplify 
open reading frame 7(ORF7) of PRRSV as previously described by 
Lyoo(1998). 
Results
Seroprevalence levels in each farm were grouped into 3 pat-
terns: SN (Stable sow groups/Not infected piglet groups), SI 
(Stable sow groups and Infected piglet groups), and UI (Un-
stable sow groups and Infected piglet groups). The rate of each 
serological pattern were 15% (n=3), 10% (n=2), and 75% (n=15), 
respectively. In addition, the pattern analysis was extended to 
virological monitoring on the same farms that further included 
suckling pig groups. As a result, the infection pattern was clas-
sifi ed into 4 categories: SNI (Stable sow groups/Not infected 
suclker groups/Infected piglet groups), SII (Stable sow groups/
Infected suckler groups/Infected piglet groups), UNI (Unstable 
sow groups/Not infected suckler groups/Infected piglet groups), 
and UII (Unstable sow groups/Infected suckler groups/Infected 
piglet groups). The rate of each viroprevalence were estimated 
at 50% (n=10), 30% (n=6), 10% (n=2), and 10%(n=2), respective-
ly. PRRSV viroprevalence results of suckling pig groups revealed 
that 8 farms were considered the virus positive. In 2 farms 
among these farms, PRRSV appears to be transmitted vertically 
to suckling piglets from their sows. In contrast, piglet-to-piglet 
horizontal transmission of PRRSV seems to occur in sucking 
herds of the remaining farms. Thus, this virological analysis on 
suckling piglets will provide useful information to understand 
PRRSV transmission routes during the suckling period and to 
improve a PRRS control program. 
Discussion
Our seroprevalence and viroprevalence data found that infec-
tion patterns between sow and piglet groups are not always 
coincident in the same farm. Remarkably, 15 farms belonging to 
the UI seroprevalence pattern showed four distinct viropreva-
lence patterns (SNI; 7, SII; 4, UNI; 2 and UII; 2). Among these 
farms, 11 farms with unstable seprevalence sow groups were 
further identifi ed as the stable viroprevalence pattern. These 
results indicated that despite the absence of typical seroconver-
sion, PRRSV infection was detected in several farms, implying 
the limitation of serological analysis. Taken together, our data 
strongly suggested that both seroprevalence and viroprevalence 
should be determined in parallel so that a PRRS control strategy 
could be effi  ciently developed on a farm level. 
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Evaluation of the eﬃ  cacy of PRRSV modiﬁ ed live vaccine in one-day old piglets
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Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV) 
causes major economic losses in the pig industry. It has been 
proven that the modifi ed-live vaccine (MLV) is one of the options 
to control PRRSV. The objective of this study was to evaluate the 
effi  cacy of using PRRSV-MLV in one day-old piglets to provide 
them with protective immunity in their nursery-growing stages.
Materials and Methods
The study was conducted in a conventional farm in Gunma, 
Japan (2 site system, 3,000 sows). A total of 25,000 pigs were 
born between February 2008 and June 2008, and the piglets 
received a half dose of PRRSV-MLV intramuscularly at 1-day 
of age. A total of 18 piglets were randomly bled prior to vac-
cination, at 28, 35 and 42 days of age. Sera were tested for 
PRRSV by ELISA and PCR. Samples that were PCR-positive were 
sequenced to determine the homogeneity of ORF-5 region of 
the viral nucleic acids. Additionally, tonsil, lymph nodes, lung, 
liver, spleen, intestines, kidney and brain were collected from 
one pig that died at 52 days of age. All the tissue samples were 
examined by histopathology. The same set of tissue samples 
was also collected from a 38-day old pig that was euthanized. 
All the tissue samples were tested for PRRSV by PCR. Production 
performance data including nursery mortality and average daily 
gain (ADG) were obtained, and compared with the data from the 
batches that were born prior to the vaccine implementation in a 
previous year (non-vaccinated controls). Statistical analysis using 
T-test was conducted to determine whether there was signifi -
cant diff erence between vaccinated piglets and non-vaccinated 
piglets.
Results
Prior to vaccination, no piglets showed viremia or any other 
clinical signs. The vaccinated pigs showed typical PRRS clinical 
symptoms in suckling and nursery periods. The sera and tissue 
samples from the vaccinated pigs at 28, 35 and 42 days of age 
showed viremia for PRRSV(11/18). (Table 1) ORF-5 sequencing 
revealed that 10 out of 11 PCR-positive samples were 99.2-99.8% 
homologous to MLV PRRSV strain, while 1 out of 11 was found 
to be a wild strain of PRRSV (87.7% homologous to PRRSV-
MLV strain ). Typical PRRS-like histopathological lesions were 
found from the tissues collected from the dead pig at 52-day 
old. PRRSV nucleic acid was detected by PCR from the lymph 
nodes collected from the euthanized pig at 38-day old. Nursery 
mortality and ADG were signifi cantly worse in vaccinated piglets 
compared to non vaccinated controls. 
sample ID days of age RT-PCR for sequence
homologous to 
PRRSV-MLV strain
P129-1 28 + 99.5%
P129-2 28 + 99.7%
P129-3 28 -
P129-4 28 -
P129-5 28 + 87.7%
P129-6 28 + 99.8%
P129-7 28 + 99.7%
P129-8 35 + 99.7%
P129-9 35 + 99.5%
P129-10 35 + 99.2%
P129-11 35 + 99.3%
P129-12 35 -
P129-13 42 + 99.7%
P129-14 42 -
P129-15 42 -
P129-16 42 + 99.7%
P129-17 42 -
P129-18 42 -
Discussion
Under the conditions of this study, it is concluded that vaccina-
tion of 1-day old piglets with PRRSV-MLV vaccine has negate 
eff ects on clinical signs, viremia, as well as production perform-
ance including nursery mortality and ADG.
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Eﬀ ect of vaccination using AMERVAC®-PRRS on diﬀ erent production 
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Introduction
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) 
has aff ected many farms in Asia including the Philippines. Clinic-
al signs observed include abortions, pre-mature births, inconsis-
tent farrowing rates and high mortality in sucklings, weanlings 
and growing-fi nishing pigs. As previously described, vaccination 
using a live PRRS vaccine (AMERVAC®-PRRS) has positive eff ects 
on diff erent production parameters as farrowing rates1,2 and 
mortality in growing pigs4. In this study, the objective is to as-
sess the eff ect of continuous vaccination using a Modifi ed Live 
(MLV) PRRS vaccine (AMERVAC®-PRRS) in diff erent production 
parameters in three Philippine swine farms. 
Materials and Methods
Three Philippine commercial farms with sow level ranging from 
1300 to 3000, one site production system are involved in this 
study. PRRSV diagnosis was carried out with PCR3 and an ELISA 
serology technique (CIVTEST™suis PRRS E/S) from necropsy fi nd-
ings and serum samples. 
Farm A: 1800 sows, one site production system located in south 
of Manila. The farm had complaint of abortion in sows and high 
mortalities in growing pigs in June 2008. Two mass vaccinations 
in sows with 4 weeks interval were implemented in July 2008 
with AMERVAC®-PRRS. Pigs from 18 to 70 days of age were also 
vaccinated once at the same time. Next batches of piglets were 
vaccinated once intramuscularly at 21-28 days of age.
Farm B: 3000 sows, one site production system located north 
of Manila had abortion storms in July 2008. High mortality in 
pre-weaning, weanling and growing-fi nishing pigs was also ob-
served simultaneous with reproductive failure in sows. Two mass 
vaccinations with 4 weeks interval were implemented in August 
2008. Pigs from 18 to 70 days of age were also vaccinated once 
at the same time. Next batches of piglets were vaccinated once 
intramuscularly at 21-28 days of age.
Farm C: 1300 sows, one site production system located south of 
Manila. It had complaint of abortions, erratic farrowing rate, and 
high mortality in growing pigs. Same vaccination program as in 
the farms A and B was implemented starting September 2008.
Average monthly Farrowing rate, Pre-weaning, Post-weaning 
and Growing-Finishing mortalities for the period of three years 
were obtained and summarized in the Table 1. 
Results
All the parameters monitored within this study improved con-
siderably in farms A, B and C during 2009. In 2009 all the sows 
and piglets had been already vaccinated. Reproductive perform-
ance stability was observed from the 3rd month after the begin-
ning of the vaccination program until the end of 2009. 
Table 1. Mean production data from three Philippine commercial 
swine farms. PRRSV vaccination program started in July 2008 in Farm A, 
in August 2008 in Farm B and in September 2008 in Farm C.
Production Parameters 2007 2008 2009
Average Farrowing rate % 77.64±7.02 68.85±4.63 80.00±4.63
Pre-weaning Mortality % 12.65±4.75 17.62±8.14 7.18±4.70
Nursery Mortality % 4.86±4.44 13.92±16.22 4.90±6.43
Growing-Finishing Mortality% 5.20±1.12 9.95±6.04 4.83±2.55
Discussion
Based on these specifi c results, the implementation of PRRS 
vaccination (AMERVAC PRRS®) in sows resulted in stabilization 
of breeding performance. It has subsequent positive eff ect in 
reducing pre-weaning mortality since vaccination lessens the 
negative eff ects of PRRS fi eld virus. Vaccination in piglets re-
duced substantially the mortality in growing-fi nishing stages. 
Conclusion
Based on the data presented, regular vaccination program with 
AMERVAC®-PRRS in sows and pigs improved production per-
formances and prevented the negative impact of a fi eld PRRSV 
infection.
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PRRS vaccine serological response of a live PRRSV vaccine (AMERVAC®-PRRS) in pigs 
when the diluents is a Haemophilus parasuis bacterin (HIPRASUIS®-GLASSER)
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Introduction
Combined administration of vaccines may be practical and con-
venient; however it may not be always possible. Haemophilus 
parasuis vaccine is most usually inoculated in pigs at 7 and 21-28 
days of age. Vaccination at 21-28 days of age with a live PRRSV 
vaccine is common practice in PRRSV infected farms. A previ-
ous study1 showed that PRRS vaccine virus of AMERVAC®-PRRS 
vaccine virus (VP046-BIS) could survive when the solvent used 
was a Haemophilus parasuis bacterin (HIPRASUIS®-GLASSER). 
In this study, the objective is to determine if PRRSV vaccine 
(AMERVAC®-PRRS) serological response in piglets when PRRSV 
vaccine is used in pigs after reconstitution with a Haemophilus 
parasuis bacterin in a commercial pig farm.
Materials and Methods
100 7 day-old piglets (Day 0) were randomly selected and al-
located in two groups.
Group A: (Hps + Amervac PRRS) 50 apparently 7 day-old piglets 
were allocated separately and ear notched. This group was 
vaccinated with 2ml dose of a Haemophilus parasuis bacterin 
(HIPRASUIS®-GLASSER) at 7 days of age. The same group of 
animals was vaccinated intramuscularly in the same point of 
injection, in the long neck muscle, with the PRRSV vaccine 
(AMERVAC®-PRRS), using the Haemophilus parasuis bacterin 
vaccine (HIPRASUIS®-GLASSER) as diluents at 21 days of age. 
15 piglets out of 50 were randomly selected for serial bleeding 
done every 2 weeks.
Group B: (Hps and Amervac PRRS) 50 apparently 7 day-old pig-
lets were allocated separately and ear notched. This group was 
vaccinated with 2ml dose of a Haemophilus parasuis bacterin 
(HIPRASUIS®-GLASSER) at 7 days of age. The same group of 
animals was vaccinated intramuscularly at 21 days of age with 
a PRRSV vaccine (AMERVAC®-PRRS) and a Haemophilus parasuis 
bacterin (HIPRASUIS®-GLASSER) in separate long neck muscles. 
15 piglets out of 50 would be randomly selected for serial bleed-
ing done every 2 weeks. Serum samples were taken at day 0, 
14, 28 and 42 and analyzed with a PRRSV Elisa kit (CIVTEST™suis 
PRRS E/S).
Results
Serological response to vaccination has no signifi cant diff erence 
in the two groups during the course of the trial. Similarly, no 
signifi cant diff erence was observed in terms of percentage of 
positive serum samples. 
Figure 1. Individual antibody levels in each group using (CIVTEST™suis 
PRRS E/S). Hps and Amervac (Group B); Hps + Amervac (Group A).
 
Discussion
Under fi eld conditions, simultaneous vaccination of a live PRRSV 
vaccine (AMERVAC®-PRRS) and a Hemophilus parasuis can 
reduce stress to the animals and maximize the time for farm 
personnel in the implementation of vaccination. Previous study2 
also concluded that simultaneous vaccination with the live 
PRRSV vaccine and another vaccine did not infl uence PRRS sero-
logical response in pigs. In another in vivo3 experience there was 
no interference with live PRRSV vaccine when reconstituted with 
a multi-antigen inactivated vaccine and administered in pigs. 
Conclusion
There were no diff erences observed on the serological PRRSV 
response in pigs when AMERVAC®-PRRS vaccine was inoculated 
separately or combined at the same inoculation point with 
HIPRASUIS®-GLASSER vaccine. This knowledge may have prac-
tical fi eld implications. Further immune response studies should 
be done to discard any negative immune response interferences 
between vaccines. 
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Introduction
With the advent of combination vaccines, conveniences in the 
administration and the effi  cacy under fi eld condition have been 
the primary concerns. Since the recommended vaccination 
program for Mycoplasma hyopneumoniae is at 7 and 21 days 
and for PRRSV is 21 days, then the second dose of Mycoplasma 
can be given simultaneous with PRRRSV vaccine. Previous study 
has demonstrated that PRRSV vaccine can survive under labora-
tory condition using a Mycoplasma bacterin as the diluents1. 
In this study, the objective is to determine if PRRSV vaccine 
(AMERVAC®-PRRS) could elicit serological response using a 
mycoplasma bacterin (MYPRAVAC® SUIS) as the diluents under 
fi eld conditions. 
Materials and Methods
100 7 day-old piglets were randomly selected and allocated in 
two groups.
Group A. (Mypravac suis + Amervac PRRS) 50 apparently 7 day-
old piglets allocated and ear notched. This group was vaccinated 
with 2ml dose of a Mycoplasma hyopneumoniae bacterin (MYP-
RAVAC® SUIS) at 7 days of age. The same group of animals was 
vaccinated with the combination of PRRSV vaccine (AMERVAC®-
PRRS) and Mycoplasma hyopneumoniae bacterin (MYPRAVAC® 
SUIS) at 21 days of age. 15 piglets out 50 were randomly selected 
for serial bleeding done every 2 weeks.
Group B. (Mypravac suis and Amervac PRRS) 50 apparently 7 day-
old piglets allocated and ear notched. This group was vaccinated 
with 2ml dose of a Mycoplasma hyopneumoniae bacterin (MYP-
RAVAC® SUIS) at 7 days of age. The same group of animals was 
vaccinated with a PRRSV vaccine (AMERVAC®-PRRS) and Myco-
plasma hyopneumoniae bacterin (MYPRAVAC® SUIS) in separ-
ate injection sites at 21 days of age. 15 piglets out 50 would be 
randomly selected for serial bleeding done every 2 weeks.
Blood samples were taken at day 0, 14, 28 and 42 of the experi-
ment.
Results
Vaccination with the combination and separate injection has no 
signifi cant diff erence in terms of serological response. 
Discussion
Under fi eld conditions, simultaneous vaccination of MLV PRRSV 
vaccine and Mypravac suis has been proven valid because it can 
reduce stress to the animals and can reduce cost. In this study, 
the combination of a MLV PRRSV vaccine (AMERVAC®-PRRS) and 
a Mycoplasma bacterin (MYPRAVAC® SUIS) can be useful tool to 
control the two diseases.
Figure 1. Individual antibody levels in each group using (CIVTEST™suis 
PRRS E/S). Mypravac suis + Amervac PRRS (Group A); Mypravac suis and 
Amervac PRRS (Group A).
Figure 2. Percent positive animals in each group in diff erent stages 
of experiment using (CIVTESTTMPRRS). Mypravac suis + Amervac 
PRRS(Group B); Mypravac suis and Amervac (Group B).
Conclusion
With the use of the two vaccination protocols, no diff erence was 
observed serologically in the two groups of animals. We can 
therefore recommend that the two vaccines (MYPRAVAC® SUIS 
and AMERVAC®-PRRS) can be used separately or in combination 
without reducing their effi  cacy. 
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Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV) 
can be detected in the lymphoid tissue of pig up to 8-9 months 
post infection (1). During this period, the virus can be replicated 
continuously at a low level and transmitted to susceptible 
animals via direct contact. In the PRRSV endemic herds, the 
present of PRRSV subpopulations (susceptible pigs) may lead 
to reoccurrence of the disease in the herds. Herd closure, gilts 
acclimatization and mass exposure have been recommended to 
eliminate the subpopulations (2). The use of vaccination to im-
munize the pigs has been evaluated, in most cases, at individual 
level. However, only few studies on the immune response of 
PRRSV in the infected herd have been evaluated. Earlier study 
has demonstrated that vaccination of the entire herd (mass 
vaccination) could reduce persistence and duration of shedding 
even though the wild type of virus was not eliminated from the 
pigs (3). However, the successful results are varied among the 
herds and a limited information on the immune response of 
PRRS modifi ed live virus (MLV) vaccine is available in pregnant 
gilts and sows. The present study aims to evaluate the humoral 
immune response of gilts/sows after mass vaccination of PRRS 
MLV vaccine in a PRRSV infected herd in Thailand.
Materials and Methods
The present study was conducted between May and September, 
2009 in a 1,200-sow inventory swine herd in Thailand, which pro-
duced their own replacement gilts. The herd has never been vac-
cinated the gilts and sows with PRRSV vaccine. An occurrence of 
abortion in sows was observed in January 2009 and an American 
strain of PRRSV was detected in serum of aborted sows using 
reverse transcription polymerase chain reaction (RT-PCR). Gilts/
sows were vaccinated against PRRS MLV vaccine (Ingelvac® 
PRRSTM MLV, Boehringer-Ingelheim, Vetmedica Inc., St. Josept, 
Missouri, USA) 2 doses 3 weeks apart and booster at 14 week 
and 3 months. Blood samples were collected from replace-
ment gilts and pregnant gilt/sow (36 samples) one day prior 
to fi rst vaccination (week 0) and subsequently at 2, 5, 9, 12 and 
18 weeks after vaccinations in the same animals. The sera were 
obtained for viral detection using RT-PCR technique (pooled 
serum) and analyzing antibodies against PRRSV using ELISA 
(HerdChek® PRRS virus antibody test kit 2XR, IDEXX Laboratories, 
Inc., USA). The percentage of sero-positive gilt/sow was com-
pared using logistic regression. The diff erences of means of the 
serum sample/positive control (S/P) ratio were compared using 
pair t-test. P<0.05 was considered as statistically signifi cant.
Results and Discussion
It was found that no viral shedding was detected during 2 to 
18 weeks post vaccination (Table 1). Before vaccination, 11.1% 
(4/36) PRRSV susceptible pigs were observed. The percentage of 
PRRSV subpopulation was reduced to 6.1% within 18 week post 
vaccination (P=0.401). The S/P ratio was slightly increased two 
weeks post vaccination and signifi cantly decreased at 5 weeks 
post vaccination (Table 1).
Table 1. The S/P ratio (means±S.E.M.), the percentage of sero-positive 
gilts and sows and the viral detection by weeks post vaccination
 
a,b diff erent letters diff er signifi cantly (P<0.05)
The present study demonstrated that mass vaccination of PRRSV 
MLV in pregnant gilts and sows did not cause viral shedding 
during 2-18 weeks post vaccination and might possibly mini-
mize the number of PRRS subpopulations in the PRRSV infected 
herds. However, the shedding of PRRSV during 0-2 weeks post 
vaccination and reproductive performance of pregnant gilts/
sows should be evaluated further.
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Introduction
Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) is 
one of the primary precursors of economic losses2 in pig produc-
tion. Only in Japan the annual cost of the disease in 2008 was 
close to 280 million USD<sup4. Clinical signs include decreasing 
farrowing rates, abortions, stillborns and increase of respiratory 
clinic problems in pigs. The objective of this fi eld experience is 
to assess the eff ect of continuous vaccination using a live PRRSV 
European (EU) vaccine (AMERVAC®-PRRS) in the monthly farrow-
ing rates in a farm endemically infected by PRRSV. 
Materials and Methods
A 2000 sow farm with a 2 site production system that is lo-
cated in the southern Philippines had a complaint of unstable 
and variable farrowing rates. PRRSV diagnosis was based on 
Polymerase chain reaction technique3 (PCR) from lungs and 
lymph nodes from stillbirths and 1 day old weak born piglets. 
A PRRSV vaccination program was implemented in sows at Octo-
ber 2007, using a modifi ed live PRRSV European (EU) vaccine 
(AMERVAC®PRRS). Every batch of sows was vaccinated with one 
dose at 60 days of pregnancy and another dose 7 days after each 
farrowing. Farrowing rates from April to October 2007 were com-
pared with farrowing rates from November 2007 until December 
2009 (unpaired t test).
Results
Variable and unstable farrowing rates were monitored from April 
to October 2007. The monthly farrowing rates became less vari-
able and were signifi cantly higher during the 25 months period 
after the implementation of the PRRSV vaccination program. 
Table 1. Monthly mean (Mean±SD) sow farrowing rates (December 
2009) before and after PRRSV vaccine program implementation in 
sows. 
Groups % Farrowing Rate
Before Vaccination 75.6±7.10*
After Vaccination 82.55±2.69*
*Results were signifi cantly diff erent, P<0.001
Graphic 1. Monthly sow farrowing rates evolution from April 2007 to 
December 2009. Red arrrow marks the beginning of the vaccination 
program.
Discussion
These results match with previous fi eld cases in Asia where 
PRRSV vaccination prevented against negative eff ects of a PRRSV 
infection in sows1. PRRSV regular vaccination after two years 
seemed to keep a degree of protection in sows that protects 
them again new reproductive clinic signs outbreaks due to the 
fi eld PRRSV in the farm and may reduce the economic losses 
provoked by unstable reproductive performance.
Conclusion
The continuous long term implementation of a PRRSV vaccina-
tion program in sows with AMERVAC®-PRRS was eff ective and 
improved the monthly farrowing rates in a PRRSV infected farm. 
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Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV) 
infection is characterized by reproductive failure in sows (1) and 
is associated with respiratory problems in pigs of all ages (2). 
The vaccines that are available give variable results regarding 
the effi  cacy against genetically diverse fi eld strains. At present, 
it is generally accepted that there is a need for new safe and 
eff ective vaccines that easily can be adapted to prevalent PRRSV 
strains. Recently, it was demonstrated that by the use of a new 
procedure, an inactivated PRRSV vaccine can be developed that 
induces virus-neutralizing antibodies and off ers partial protec-
tion upon homologous challenge (3). The aim of this study 
was to compare the effi  cacy of a homologous experimental 
inactivated PRRSV vaccine, with the effi  cacy of a heterologous 
(Lelystad virus) experimental inactivated PRRSV vaccine and 
commercially available, inactivated and attenuated vaccines 
upon challenge.
Materials and Methods
The following PRRSV vaccines were included in this study: a 
vaccine based on a circulating PRRSV strain 07V063 that was 
isolated from foetuses during reproductive failure in a vaccin-
ated herd and inactivated using the procedure described in 
Delrue et al. (4); a heterologous experimental inactivated PRRSV 
vaccine based on Lelystad Virus (3); a commercial attenuated 
European virus vaccine; a commercial attenuated American virus 
vaccine and a commercial inactivated European virus vaccine. 
Piglets from a PRRSV-free farm were vaccinated twice at 5 and 
9 weeks of age with the inactivated vaccines. The attenuated 
vaccines were given at 7 weeks of age. One group of pigs was 
kept unvaccinated and served as control group. All animals were 
challenged intranasally with 106.0 TCID50 of the virulent virus 
fi eld strain 07V063 at the age of 13 weeks. Sera were collected 
by jugular venipuncture at 0, 1, 2, 3, 4, 5, 6 and 7 weeks after 
(primo) vaccination and at 0, 1, 3, 5, 7, 10, 14, 21, 28 and 35 days 
post challenge. Virus-specifi c and virus-neutralizing antibodies 
were determined by an IPMA- and SN-test, respectively. Virus 
titers in serum were determined by virus titration on pulmonary 
alveolar macrophages.
Results
It was shown that all vaccines, except the commercial inactivat-
ed vaccine, induced virus-specifi c antibodies after vaccination 
and only the two inactivated experimental vaccines induced 
07V063-specifi c neutralizing antibodies after vaccination. Upon 
challenge, viremia was observed for 4 weeks in the control 
group and the groups that were vaccinated with the commer-
cial inactivated and the experimental heterologous inactivated 
vaccine. Vaccination with the attenuated vaccines reduced the 
duration of viremia with one week. The virological protection 
upon challenge was the best in the group receiving the experi-
mental homologous inactivated 07V063 vaccine (Fig. 1.).
Fig. 1. Viremia in all groups in function of time post challenge.
 
Discussion
The genetic diversity of PRRSV can cause problems with the ef-
fi cacy of the current available vaccines that are all based on one 
virus strain. In general, the advice is to use a vaccine strain that is 
homologous to the present PRRSV-isolate in the herd. A farm-
specifi c vaccine, based on the circulating PRRSV fi eld strain can 
be a solution on (vaccinated) farms with severe PRRSV-related 
problems. Future work will be done to investigate the effi  cacy of 
this kind of inactivated vaccine in the fi eld.
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Introduction
Porcine reproductive and respiratory syndrome (PRRS) virus 
causes abortion, anorexia and pneumonia. Due to the preva-
lence of the virus and the ineff ectiveness of current counter-
measures, it has become one of the most economically sig-
nifi cant threats to the swine industry. Current immunization 
strategies rely on autogenous killed-virus vaccine, modifi ed-live 
virus vaccine, or deliberate exposure to virulent virus. Each 
method has drawbacks, such as: ineff ective cross-protection, 
shedding of virus to penmates and piglets, and lack of sero-
logical diff erentiation between infected and vaccinated animals 
(DIVA). New vaccination strategies are needed to achieve the 
goals of local and regional elimination of PRRS virus.
One such method involves the use of replication-incompetent, 
alphavirus-derived, single-cycle viral replicon particle (RP) 
vaccines. These vaccines consist of a viral particle derived from 
Venezuelan equine encephalitis (VEE) virus containing a modi-
fi ed RNA genome that does not include the VEE structural genes. 
The lack of vector-encoded structural genes renders the vector 
unable to form a new particle once it enters the host cell. This 
feature adds to the safety of the vaccine and helps the vector 
overcome host anti-vector immunity.
Our group has evaluated RP vaccine candidates expressing open 
reading frame (ORF) 3, 4, 5, and 6 in a young-pig heterologous 
challenge model.
Materials and Methods
Replicon plasmids containing the PRRS virus genes of interest 
were created and used to generate RP vaccines for the study 
as previously described1,2. Briefl y, in vitro transcribed replicon 
RNA and helper RNAs were electroporated into Vero cells, which 
were then incubated for 18 hours. After incubation, packaged 
RP were harvested by affi  nity chromatography and formulated 
in phosphate buff ered saline with 5% sucrose and 1% swine 
serum. Safety tests were performed to ensure that no replica-
tion-competent virus existed in the batch of RP. Aliquots of RP 
were frozen at -80C until use in the study. On the day of each 
vaccination, RP were thawed and diluted to the desired dosage, 
then administered by intramuscular injection in the neck. Each 
formulated vaccine batch was titrated on Vero cells and quanti-
fi ed using an indirect fl uorescent antibody assay.
Forty piglets were obtained at three weeks of age from a 
herd serologically and clinically negative for PRRS virus, swine 
infl uenza virus, and porcine circovirus 2. Pigs were randomized 
into four groups of ten pigs each. Blood samples were collected 
at intervals throughout the study. At four weeks of age, pigs 
were vaccinated with the appropriate RP vaccine, and booster 
immunization occurred at seven weeks of age. At ten weeks of 
age, pigs were challenged intranasally with 2x105 TCID50 PRRS 
virus. Study termination and necropsy occurred at twelve weeks 
of age. Serum samples from throughout the study were used 
to determine the magnitude of antibody and cell-mediated re-
sponses, as well as post-challenge viremia. Gross and microscop-
ic pathology scores were determined by a pathologist blinded to 
the treatment groups.
Vaccine groups for the study were as follows: 1)RP expressing 
PRRS virus ORFs 3 and 4; 2)RP expressing PRRS virus ORFs 5 and 
6; 3)RP expressing PRRS virus ORFs 3, 4, 5 and 6; 4) Placebo. 
Results and Discussion
Prior to challenge, the majority of vaccinated pigs had a specifi c 
antibody response to the RP-expressed antigen in their vaccine, 
as determined by Western blot. Prior to challenge, no pigs had a 
positive anti-nucleocapsid antibody response, as determined by 
the IDEXX Herd-Chek ELISA at the ISU Diagnostic Laboratory.
An interferon-gamma ELISPOT assay was used to determine the 
magnitude of cell-mediated immunity on the day of challenge. 
These results indicated that vaccinates receiving RPs expressing 
ORFs 5 and 6 (with or without ORFs 3 and 4) had signifi cantly 
higher antigen-specifi c cell stimulation than placebo. The lack of 
seroconversion to the nucleocapsid antigen among vaccinates 
illustrates the DIVA capabilities of the RP vaccines. The induc-
tion of specifi c cell-mediated and antibody-mediated immune 
responses following vaccination with RP vaccines demonstrates 
their potential to overcome the limitations of existing vaccine 
technology.
Additional results will be reported at the meeting.
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Introduction
In the last years, porcine reproductive and respiratory syndrome 
virus (PRRSV) envelope glycoprotein GP5 has been a leading 
target for the design of new generation vaccines that solve 
safety problems of live attenuated vaccines and the limited 
effi  cacy of inactivated vaccines against PRRS. In a previous 
study, our research group identifi ed and characterized diff erent 
regions in the GP5 implicated in apoptotic processes (1). Taking 
advantage of this knowledge, EC1, a recombinant Aujeszky´s 
disease virus (rADV) which express a GP5 fragment deleting the 
fi rst 127 amino acids of the N-terminus of the original GP5, and 
EA4, a rADV which express a chimera fusing 32-69 amino acids 
fragment to the last 74 amino acids fragment of the original 
GP5, were generated (2). Therefore, the aim of the present study 
was to test the immunoprotective properties of EC1 and EA4 by 
immunization of PRRS-negative pigs.
Materials and Methods
The experimental design included eighteen six-month old 
PRRS seronegative pigs. Five pigs of group A were immunized 
with 106,0 TCID50 of the Spanish virulent strain Sp-3 (positive 
controls). Groups B and C, both of fi ve animals, were immunized 
intramuscularly with 106,5 TCID50 of EA4 or EC1, respectively. 
Three pigs of group D were not immunized but challenged 
(negative controls). The pigs were immunized on days 0, 21 and 
42 of the experiment. On day 70, all animals were challenged 
intranasally with 5x106,0 TCID50 of the Spanish virulent fi eld 
strain Sp-5. Twenty one days post-challenge all animals were 
euthanized and necropsied. Blood samples and oral, rectal and 
nasal swabs were collected on immunization days, on chal-
lenge day and every three days after challenge. Diff erent tissue 
samples were collected from all necropsied animals. All samples 
were tested for PRRSV detection by viral isolation. Specifi c anti-
bodies production against PRRSV was assayed by ELISA (CIVTEST 
SUIS PRRS E/S), Western-blot and virus neutralization assay. A 
T-lymphocyte proliferation assay and an ELISPOT assay (3) were 
also carried out on days 42, 70 and 90 to quantify the develop-
ment of cell mediated immune response.
Results
None of the vaccinated pigs showed any obvious clinical signs 
before challenge. After challenge, viremic animals were ob-
served among rADV vaccinated pigs through all the experiment 
(Table 1). Moreover, PRRSV was found in at least one of the tissue 
samples collected at necropsy from each pig (except in one pig 
of group C) and in nasal, oral and rectal swabs collected during 
the fi rst 15 days after challenge.
Table 1. Viremia results after challenge
Group Chall. 3dpcb 6dpc 9dpc 12dpc 15dpc 18dpc 21dpc
A 0/5a 0/5 0/5 0/5 0/5 0/5 0/5 0/5
B 0/5 5/5 * 5/5* 5/5* 5/5* 5/5* 2/5 3/5
C 0/5 5/5* 4/5* 5/5* 4/5* 4/5* 3/5 1/5
D 0/3 3/3* 2/3* 3/3* 3/3* 3/3* 2/3 2/3
a positive animals/total number of animals. b days post-challenge. * statistically signifi cant 
diff erences with group A (p<0.05). 
Detectable ELISA antibodies against PRRSV were found in one 
pig of group C at day 42 and in one animal of each rADV vaccin-
ated group on day 70. However, specifi c antibodies production 
in groups B and C could not be demonstrated by Western-blot 
or virus neutralizing assay. T-lymphocyte proliferation meas-
urement did not show any statistically signifi cant diff erence 
between groups but a statistically signifi cant diff erence between 
groups B and D (p<0.05) was found by ELISPOT on day 70. 
Discussion
Enhanced expression levels obtained in vitro after GP5 apoptotic 
region deletion encouraged the study of the potential immuno-
protective properties of EC1 and EA4 in pigs. However, both ex-
perimental vaccines failed to provide protection after challenge 
as demonstrate by virus isolation from experimental samples 
taken along the study. On the other hand, pigs immunized with 
a diff erent PRRSV isolate were fully protected. As no signifi cant 
diff erences in cell mediated immune response between rADVs 
vaccinated pigs and positive controls were found, protection 
failure elicited by rADVs could be related with the incapacity to 
observe neutralizing antibodies production. Although a neutral-
izing epitope has been described in the ectodomain of GP5, 
it is possible that conformational changes in the recombinant 
protein expressed by EA4 have prevented the recognition of this 
epitope by the immunized pigs. In the same way, EC1 has not 
this neutralizing epitope so the failure in protection conferred by 
rADV could be completely related with the absence or modifi ca-
tion of this epitope.
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Introduction
In the last years our research group has studied extensively the 
variability of PRRSV and obtained evidence of the existence of 
isolates with a greater ability to induce neutralizing antibodies 
capable to cross-react with diff erent strains than others (Mar-
tínez-Lobo et al., 2008). These results have encouraged the de-
velopment of a subunit vaccine expressing the GP5 of one of the 
pluripotent isolates described. On the other hand, no adverse 
eff ects have ever been observed after challenge of animals im-
munized with recombinant PRRSV vaccines and for this reason, 
the aim of the present communication is to report the exacerba-
tion of disease observed after challenge with a virulent PRRSV 
isolate in a group of pigs that had been previously immunized 
with a PRRSV GP5 subunit vaccine produced in E. coli.
Materials and Methods
Eighteen six-month old PRRSV seronegative pigs were divided 
into three groups. Six pigs of group A were immunized twice 
with 600 μg of rGP5 on day -42 and with 300 μg of rGP5 on day 
-21. Six pigs of group B were challenged but not vaccinated and 
six pigs of group C were not vaccinated and not challenged. 
Three weeks after immunization, pigs of group A and B were 
inoculated intranasally with 105 TCID50 of PRRSV strain 5710. 
Clinical signs, rectal temperature and food intake were evalu-
ated for each pig every day after vaccination and challenge. 
Blood samples and nasal culture swabs were collected in vac-
cination days and at various time points post-vaccination and 
post-challenge. All pigs were euthanized 18 days after challenge 
and diff erent tissue samples were collected at necropsy. Every 
collected sample was assayed by virus isolation and titration. 
Specifi c antibodies production against PRRSV was evaluated by 
ELISA (CIVTEST SUIS PRRS E/S) and virus neutralization assay. 
Tissues samples were collected for routine histopathological 
examination.
Results
No adverse reactions to immunizations were noted in pigs but 
after challenge, moderate to severe clinical signs were observed 
in pigs of groups A and B. These clinical signs were more severe 
in pigs vaccinated with rGP5 than in pigs of group B. Further-
more, signifi cant lower daily body weight gain and higher 
mean temperatures were found in pigs of group A. Pigs of both 
challenged groups exhibited high viremia titers through all 
the experiment and no statistically signifi cant diff erences were 
encountered at any time. PRRSV was detected at least in one of 
the tissue samples collected from each pig of groups A and B. 
On the day of challenge, only two pigs on group A had serocon-
verted by ELISA and none of them had neutralizing antibodies. 
After challenge an increase in antibody titre was observed in 
pigs of group A but no statistically signifi cant diff erences were 
observed between groups A and B in the neutralization assays. 
Pigs of groups A and B showed mild moderate to gross lesions, 
including areas of congestion in the lung and moderate enlarge-
ment and congestion of some lymph nodes. Microscopically, 
moderate subacute interstitial pneumonia was recorded in 
animals of group A.
Discussion
Results of the present study demonstrate that immunization of 
growing pigs with a recombinant fusion GP5 protein of PRRSV 
not only failed to provide protection, but appeared to result in 
an exacerbation of the acute disease produced by challenge 
with a virulent isolates of the virus. Exacerbation of disease can 
be mediated by diff erent mechanisms, including an antibody-
dependent enhancement (ADE) of infection (3) that facilitates 
viral uptaking and effi  ciency of replication in target cells. How-
ever, the exact mechanisms of in vivo vaccine-induced enhance-
ment observed remain uncertain since no association could 
be established between clinical severity and non-neutralizing 
antibody titers or viral burden in serum samples or tissues col-
lected at necropsy. 
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Elimination of PRRS with herd closure on small pig farm in Slovenia
Marina Stukelj; Zdravko Valencak
Institute for Health Care of Pigs, Ljubljana, Slovenia
Introduction
Porcine reproductive and respiratory syndrome (PRRS) has 
plagued the swine industry for the past two decades and is con-
sidered the most economically devastating disease of modern 
swine production (1). A variety of strategies has been described 
for PRRS eradication; total depopulation/ repopulation, partial 
depopulation, segregated early weaning, test and removal, mass 
vaccination with unidirectional pig fl ow and herd closure (2).
PRRS elimination protocols by the herd closure method have 
been developed from the knowledge that infected animals will 
recover from the infection and will eliminate the PRRS virus from 
the body’s tissue when interruption of the introduction of sus-
ceptible animals takes place. With herd closure the introduction 
of gilts is temporally stopped to allow the older sow population 
to produce antibodies and to eliminate the virus from the herd. 
It is known and actually happens quite often in Europe that 
the PRRS infection can sporadically disappear from small swine 
population (2, 3). Herd closure is fi nancially advantageous over 
depopulation because there is no required downtime, sows are 
not slaughtered, and there is no clean-up cost (1).
PRRS prevalence in Slovenia was according annual serological 
monitoring low before 2004. After joining to EU PRRS situation, 
worsen due to free trade of pigs. The aim of the study was to 
prove the eff ectiveness of herd closure in selected conditions on 
small pig farm on PRRS.
Materials and Methods
Farm
The study was conducted on one site pig farm with 50 sows 
and 3 boars, free of Classical swine fever and Aujeszky disease. 
Actual epizootiological data and increased mortality rate lead to 
suspicion of PRRS.
Sampling
• Nine blood samples (2 fatteners, 2 gilts, 2 sows, 3 boars) were 
taken after suspicion of PRRS.
• Three weeks later 15 blood samples (6 weaners, 5 fatteners, 4 
gilts) were taken.
• After two months blood was taken from all sows (50) and 
boars (3).
All serum samples were tested with IDEXX PRRS ELISA (Herd-
Chek, IDEXX LaboratoriesWestbrook, Maine, USA). Results were 
expressed in S/P (sample: positive) ratios.
Records of weaner succumbs and culls
Number of succumbed and culled weaners was recorded 
weekly.
Closure of the farm
After confi rmation of PRRS, farm was closed (no introduction of 
gilts and boars on the farm) for at least 3 months.
Results
First sampling confi rmed PRRS. S/P ratios were high (more 
than 2) in 8 samples. Second sampling showed high titers (14 
samples). Third sampling showed uniformly low S/P (less than 1) 
in all samples. Number of succumbs and culls at the beginning 
was 77 (16%) and decreased to 18 (6, 25%) after last sampling.
Discussion 
The eff ect of herd closure was evident by serological testing and 
with decreased number of succumbed and culled weaners. In 
future, we expect that farm will become PRRS negative if new 
PRRS virus will not be introduced on the farm. Strict biosecur-
ity procedures and isolation area for all replacement pigs are 
imperative for farm to keep its health status.
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Porcine Reproductive and Respiratory Syndrome regional elimination in Minnesota
Robert B. Morrison; Cesar A. Corzo; Scott Dee; Montserrat Torremorell; Peter Davies
University of Minnesota, St Paul, MN, USA
Introduction
Porcine reproductive and respiratory syndrome (PRRS) has 
become one of the most important diseases in swine produc-
tion around the world. PRRS was fi rst diagnosed in the United 
States in 1987.1 The disease is manifested by reduced reproduct-
ive performance, poor growth, decreased feed effi  ciency and 
increased mortality. Recently, the cost of this disease in North 
America has been estimated to cost US$ 560 million per year in 
the United States.2 Veterinarians and producers have been able 
to eliminate the from farms, however, some herds become re-
infected and aerosol3 transmission is often suspected. Therefore, 
a regional elimination approach may increase the odds of suc-
cess of eliminating pathogens among swine herds. 
Materials and Methods
In 2004, local producers in Stevens county a county located in 
west central Minnesota proposed to bring PRRS herd elimination 
to the next level and start a regional elimination project. This 
county has many breeding-stock herds with high biosecurity 
and health standards. The fi rst step was to contact all producers 
in the county to obtain their farm location as well as a basic 
description of the type of pigs being raised. Locations were plot-
ted on a map using ArcGIS 9.3 (ESRI, Redlands, CA). The second 
step was to obtain producer consent for testing and sharing of 
PRRS results. The third step was to have all herds tested through 
serology and PCR. The PRRS virus in infected herds would be 
further tested to characterize the strain present in the herd. Each 
location was classifi ed as positive, negative or unknown based 
on expert opinion of the local veterinarian or by diagnostic tests 
such as serology and PCR. Infected breeding herds would start a 
control program called herd closure to stop transmission within 
the herd. Sites with growing pigs eliminated the virus through 
depopulation or strict movement of pigs, personnel and equip-
ment. Quarterly meetings were held to share results, validate 
information and provide scientifi c information with regards to 
the latest PRRS fi ndings. 
Results and Discussion
A total of 89 farm locations, one truck cleaning facility, one truck 
service facility and one hog-buying station were plotted on the 
map. Of the 89 locations, there are 19 with sows, eight nursery 
sites, 40 fi nishing sites, two boar studs, two boar stud isolation 
units, two 4H fi nishing sites, 13 empty sites and 3 sites that have 
been abandoned. In 2004 there were 31 locations that were 
thought to have positive pigs. By 2006, the number of positive 
locations had decreased to 15 and in 2008 there were four posi-
tive locations. Presently, there is only one positive location that is 
under elimination planning (Table 1). A total of 18 PRRS isolates 
have been sequenced. Three sow sites eliminated the virus by 
serum inoculation and herd closure, two sow sites eliminated 
the virus through depop/repop and the remaining sites which 
were nursery/fi nishing sites have eliminated the virus through 
depop/repop. The project has been expanded to include six 
surrounding counties. To date, 85 additional locations have been 
identifi ed, of which three are positive, 18 are in the process of 
status defi nition and the remaining sites are negative. Due to the 
low density of these additional six surrounding counties and the 
low prevalence of positive herds, the project has been expanded 
once again to northern Minnesota where farm location and test-
ing has already started. To date, an additional 140 locations have 
been identifi ed of which 15 are positive, 30 are negative and the 
remaining are in the process of status defi nition. These results 
indicate that PRRS can be eliminated from a region. 
Table 1. Number of positive, negative and unknown locations in 
Stevens County and Northern Minnesota.
PRRS Status Stevens County 2004
Stevens 
County 2008
Stevens 
County 2009
Northern 
Minnesota
Positive 31 4 1 19
Negative 19 85 88 154
Unknown 37 0 0 141
Total 87 89 89 314
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Beneﬁ ts of using Pulmotil Premix® in swine production infected by PRRSV
Annick Saives1 Nathalie Gautier2
1. Elanco Europe, Brussels, Belgium; 2. Selas Veterinaire de la Hunaudaye, Lamballe, France
Introduction
Respiratory disease is one of the most important diseases in 
swine production, with major economic consequences. Porcine 
Respiratory and Reproductive Syndrome Virus (PRRSV) is one of 
the main agents. Treatments are mostly used when an outbreak 
appears, especially during the fattening phase. The present 
study aimed to evaluate the eff ects of a treatment with Pulmotil 
Premix™ in a farm with history of PRRSV, before the outbreak in 
fattening pigs. 
Materials and Methods
The swine facility is a farrow to fi nishing farm of 220 sows having 
a history of PRRSV symptoms at the end of post-weaning and at 
the beginning of fattening. PRRSV was diagnosed by laboratory 
analysis (Histology, March 2006).
Pulmotil Premix™ medication was implemented starting in 
March 2006 a dosage of 5 kg/T (200 ppm) in feed from 12 to 
20 kg of AW. The objective was to intervene before clinical 
symptoms appear, to improve the immunity of animals and 
to decrease the virus circulation, replication and virus expres-
sion. It was demonstrated before that tilmicosin has an eff ect in 
decreasing in vivo viral replication (1). Nothing else was changed 
during the follow-up period.
A monitoring technique was set up by comparing a time period 
before treatment (from 04/01/05 to 03/31/6), a transition period 
where all the pigs had not yet been treated (from 04/01/06 to 
03/31/07) and a fi nal period where all pigs received the treat-
ment (from 04/01/07 to 03/31/08).
A 4th treatment period was evaluated (from 04/01/08 to 
07/31/09), since the producer decided to continue the treatment 
to see if the improvement would continue. 
To evaluate the economic interest of using Pulmotil™ we 
referred to the latest estimates published by the French Pig 
Institute (IFIP) (2)
Results
Table 1 presents the technical criteria per time period used and 
Table 2 shows the improvement in each criterion and its eco-
nomic impact per pig.
Discussion and Conclusion
This study confi rms the advantage of using Pulmotil Premix™ for 
the treatment of respiratory diseases even within a viral context. 
The cost of treatment, being estimated at 1.39 € per 25 kg of 
feed consumed per pig, shows the return on investment using 
Pulmotil is therefore at 12.28/1.39=8.8
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In vitro eﬃ  ciency of a disinfectant (Virusnip™) on CSFV, PRV and PRRSV
Napawan Bunpapong1 Sasiwimon Talummuk2 Kai Sievert3 Penchan Chaiyanate2 Roongroje Thanawongnuwech1
1. Chulalongkorn University, Bangkok, Thailand; 2. Novartis (Thailand) Ltd, Bangkok, Thailand; 3. Novartis Animal Health, Basel, Switzerland
Introduction
Classical swine fever virus (CSFV), pseudorabies virus (PRV) and 
porcine reproductive and respiratory syndrome virus (PRRSV) 
are economically signifi cant pathogens in major swine raising 
countries including Thailand. Vaccination, quarantine regulation 
and management strategies have been practiced as preven-
tion and control strategies to improve the animal herd health 
status (1). Biosecurity using disinfectants is able to break the 
disease cycle by reducing the pathogen load in the environ-
ment. Disinfectants can be classifi ed into various groups such as 
phenol, chlorine-releasing, acid, alkalis etc (2). The objective of 
this study is to evaluate the in vitro effi  cacy of Virusnip (Novartis 
Animal Health) against the major swine pathogens (CSFV, PRV 
and PRRSV) in Thailand. 
Materials and Methods
Disinfectant: Virusnip, a commercial oxidizing disinfectant 
composed of Potassium monopersulfate. Viruses and cells: CSFV 
(ALD) and PRV (Tongsong) were prepared in SK6 cell line (2,3). 
PRRSV (01NP1) was prepared in MARC-145 with 5% fetal bovine 
serum (FBS) in growth medium incubated in 5%CO2 at 37ºC for 
48 hours (5).
Virucidal activity: Virusnip was prepared in a 2X concentration 
and mixed with the equal volume of the virus stock to yield a 
fi nal concentration of 1:100, 1:200 and 1:400. The mixtures were 
incubated at room temperature for 30 seconds and 5 minutes 
then were fi ltrated through SephadexTM column and titrated 
in a 10-fold dilution manner. The mixtures were inoculated into 
a 96 well microtiter plates then incubated in 5%CO2 at 37ºC 
for 1 hour. Maintenance medium with 2 % FCS was added and 
incubated in 5% CO2 at 37ºC for 48 hours. Indirect immunop-
eroxidase monolayer assay (IPMA) was performed for CSFV and 
PRRSV antigen demonstration to confi rm the infections. An 
evidence of cytopathic eff ect (CPE) was observed to determine 
the PRV-infected cell compared with the control. Virus titer was 
calculated by Reed and Muench method (4). The titers were 
expressed as TCID50/ml.
Results and Discussion 
The effi  cacy of Virusnip against CSFV, PRV and PRRSV is shown 
in Table 1. CSFV was completely killed at all dilutions tested 
within 30 seconds. However, PRV remained alive at all dilutions 
within 30 seconds but was completely killed at all dilutions by 
5 minutes. PRRSV was completely killed at all dilutions within 
30 seconds. CSFV, PRV and PRRSV are enveloped swine viruses. 
These swine viruses may be highly resistant in the suitable 
environment but are easily destroyed by lipophilic agent and 
very sensitive to acid or alkalis. Virusnip is able to kill CSFV, PRV 
and PRRSV at diff erent concentrations depending on the viral 
susceptibility. CSFV and PRRSV appeared to be more susceptible 
to Virusnip than PRV. Virusnip can be considered as an alterna-
tive disinfectant in the swine farms.
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Antiviral activity of Tilmicosin vs. European and North American genotypes 
of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)
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Introduction
Porcine reproductive and respiratory syndrome (PRRS) has 
spread to most pig-producing countries and has continued to 
evolve. Thus, vaccination for PRRS has been less eff ective than 
anticipated and the PRRS-associated economic losses continue. 
Since a satisfactory vaccine is currently absent, antiviral chemo-
therapy is a worthwhile consideration for PRRS. Tilmicosin is a 
macrolide antibiotic, which has been developed and marketed 
under the brand name Pulmotil® as a premix and Pulmotil AC® as 
an aqueous concentrate for swine respiratory disease. Tilmicosin 
has previously been shown to have antiviral eff ects on PRRSV 
in pigs, with improved clinical scores, feed consumption and 
gain, and a reduction in mortality and abortion rate in treated 
vs. untreated sows (1, 2, 3). Tilmicosin accumulates in macro-
phages at high concentrations (4), and since PRRSV preferably 
infects alveolar macrophages as the primary target cells, the 
inhibitory eff ect of tilmicosin in macrophages may explain the 
reduced clinical severity in vivo as observed in the tilmicosin-fed 
pigs. In the present study, the antiviral eff ects of tilmicosin were 
examined for both North American and European genotypes of 
PRRSV in porcine alveolar macrophages (PAMs), and the mech-
anism of action has been studied. 
Materials and Methods
Cells and viruses: PAMs were grown in RPMI1640 with 10% FBS. 
PA8 strain (5) was used as a representative virus for North Amer-
ican genotype PRRSV, and Lelystad virus (LV, 6) was used as the 
European genotype PRRSV. 
Determination for antiviral activity: PAMs were seeded in 96-well 
plates in a volume of 100 μl per well. Cells were treated with 
tilmicosin, and 24 h later, infected with 100 TCID50 of PA8 or LV 
in the presence of tilmicosin. Supernatants were collected and 
titrated by micro-titration infectivity assays 18 h post-infection. 
For real-time RT-PCR, viral RNA was extracted from cell culture 
supernatants and subjected to quantitative reverse transcription 
(RT)-PCR.
Results
Fig. 1. Antiviral activities of tilmicosin on the North American geno-
type (A, B) and European genotype PRRSV (C, D), as determined by virus 
titration (A, C) and quantitative RT-PCR for viral genomic RNA (B, D). 
Tilmicosin concentrations are indicated on the X-axis. Virus titers and 
relative amounts of RNA are indicated on the Y-axis. Star (*) denotes 
a statistically signifi cant diff erence (p<0.05). Each concentration was 
tested in triplicate, and the experiment was repeated twice.
Discussion 
The results show that tilmicosin inhibited replication of both 
genotypes of PRRSV, but was more potent vs. the European 
genotype. 
Conclusion
The data suggests that tilmicosin may be used as a preventative 
measure for pigs infected with either the European or North 
American PRRSV genotype.
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Development of a certiﬁ cation procedure for a PRRS-unsuspected status 
of AI-Stations – a project of the swine health services
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Introduction
PRRS has a high economic impact on swine production world-
wide (4). Eradication of the disease on a herd basis is described 
by diff erent groups (1,3,5). Every breeding organisation has its 
own strategy to clarify the being unsuspected status for PRRS of 
their farms, esp. AI-stations. The schemes, diagnostic tests and 
sample numbers can not be compared at this moment.
Materials and Methods
A PRRS working group of the swine health services of Germany, 
Austria, Switzerland, Luxembourg, Belgium and the Netherlands 
has developed a standard procedure of certifi cation for a PRRS-
unsuspicious status of AI-stations.
Auditing process:
1.  Requirements:
• Agreement with the local Swine Health Service
• Compliance with the biosecurity standards
• Clinical unsuspected for PRRS
• Unsuspected for PRRS by Serology and PCR
• Purchase livestock from unsuspected farms
• Quarantine
• No vaccination
2.  Biosecurity check
• Biosecurity check according to a specially developed 
checklist by a Swine Health Service Veterinarian
3.  Status survey
• AI-stations: serological survey of all boars on PRRS alterna-
tive 12x / year 1/12 of the herd, or 4x /year 1⁄4 of the herd 
or 2x / year 1⁄2 of the herd.
• All aquired boars 3x negative (PCR and serological)
• Minimum time between two surveys 4 weeks maximum 6 
months.
4.  Ongoing investigations
• Minimum 30 samples / epidemiological unit per 1⁄2 year 
(serological) (2) 
• 2 visits per year by a Swine Health Service Veterinarian or/
and offi  cial government veterinarian (guideline EU 90/429)
5.  Clarifi cation of  “false” positive Results
• Resampling of the positive animal within two weeks along 
with at least 10 contact animals (PCR and serological inves-
tigation)
• Again positive animals gets removed from the station 
6.  Certifi cation:
• Biosecurity-check positive
• Status survey all samples negative
• Ongoing investigations all negative or clarifi ed
• The certifi cate is valid for the last 1⁄2 year
Results
So far 15 AI-stations have joined the program.
Discussion 
The above procedure makes comparison between AI stations 
possible.by using same standards for biosecurity, numbers of 
samples, test procedures and frequencies of farm visits. Hence, 
this contributes towards a non-governmental approach to 
control PRRS.
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Introduction
Since the introduction of porcine reproductive and respiratory 
syndrome virus (PRRSV) in Europe at the beginning of the 90ths, 
the characterisation of diff erent virus strains demonstrated 
signifi cant genetic diff erences between isolated virus strains. It 
became clear that genetic diff erences were no longer observed 
between American and European strains (1), but also within 
European PRRSV strains. The aim of this study was to charac-
terise the ORF5 sequence of Dutch PRRSV strains and compare 
them with other EU and US strains. 
Figure 1: Parsimony tree using 200 bootstrap simulations, based on 
EU- and US-type PRRSV ORF5 sequences.
Materials and Methods 
Dutch PRRSV strains (n=284) were selected from PRRSV-positive 
samples during 2004-2009. Tissue samples or serum samples 
were originated from aborted fetuses or weak born piglets, and 
sera were also obtained from diseased and healthy (vaccinated) 
pigs. ORF5 sequence alignments and construction of parsimony 
trees were performed using the BioNumerics package (Applied 
Maths NV, Sint-Martens-Latem, Belgium).
Results
Two separate parsimony trees (Figure 1) were constructed based 
on the EU- of US-type PRRSV ORF5 sequences. The EU-type tree 
was constructed based on 262 fi eld strains, using the EU-type 
vaccine strain (DV), Lelystad virus (LV; M96262), Italian strains 
(AY035930 and AY739971), Belarus strains (DQ324677 and 
DQ324687), Lithuanian (DQ324667) and the Spanish strain (ESP; 
DQ345755) as reference strains.
For the US-type PRRSV, 22 fi eld strains (7.7%) were compared 
with the US reference strain VR-2332 (VR). Thirty strains (10.6%) 
were very likely EU modifi ed live vaccine strains (>99% homol-
ogy (NT) with DV) and all these 30 strains were isolated from DV 
vaccinated pigs (within 4 weeks post-vaccination). 
Clear genetic diff erences were detected in the remaining PRRSV 
strains (81.7%) with homologies ranging from 83 to 100% 
compared to the DV vaccine strain (DV) (Figure 2). The average 
in homology was 90% in 2005, and it decreased to 88% in 2007 
and 86% in 2009.
Figure 2: Percentages of Dutch EU-type PRRSV strains, expressed as 
percentages of homology to DV-ORF5 sequence, within the period 
2005-2009.
Discussion
The investigated ORF5 from Dutch EU-type PRRSV fi eld strains, 
detected in the period 2004 – 2009, are on average 88% hom-
ologous to DV, and LV was not found. Compared to the DV vac-
cine strain, the homology of ORF5 sequences of EU-type PRRSV 
fi eld strains might be decreased since 2005.
The spread of the DV strain appears to be very limited as it was 
found in DV-vaccinated animals (1-4 weeks pv). 
Whether new branches, e.g. ESP-branches, appear in the PRRSV 
parsimony tree in the Netherlands, or whether this is a European 
phenomenon, has to be investigated. 
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Abstract
This paper describes a newly started SPF-herd getting infected 
by an EU-strain of Porcine Reproductive and Respiratory Syn-
drome virus (PRRSv).The consecutive eradication strategy was 
based upon both vaccination and hygienic measurements to 
prevent the infection from becoming endemic and to produce 
PRRSv negative pigs again. Fade out of infection was extensively 
monitored by stratifi ed cohort sampling. A cohort consists of all 
piglets born in 1 farrowing compartment. Nine months after the 
initial outbreak no PRRS infected pigs were traced anymore.
Introduction
PRRSv is widely spread among Dutch sow herds. There is an 
increased demand for PRRS negative- breeding gilts and grower 
pigs. PRRSv-free herds risk introduction of virulent fi eld virus 
strains. Strategies to cope with PRRS may vary between herds 
and depend on estimated introduction risk and the ability to 
control endemic infections. Preferably, this strategy should lead 
to eradication of the fi eld infection from the herd. This study 
demonstrates how vaccination and well-defi ned internal bios-
ecurity are successfully combined.
Material and Methods
Herd: A 350 SPF-sow herd was started with caesarian derived 
piglets from various breeding-herds and combined with gilts 
form existing SPF-herds. Selected sows with a high genetic index 
produced the piglets for this new herd (1).
Monitoring: The herd was repeatedly (3 times/year) tested for 
PRRSv-antibodies (30 randomly selected pigs). In addition, all 
produced pigs that were sold for reproduction were tested. At 
August 2006, 10 months after the herd was started, 3 boars out 
a group of 16 were tested positive for PRRSv (Idexx Elisa). The 
oldest pigs at the farm then aged 9-10 months. All pigs from 
the herd were bled and tested for presence of PRRSv antibodies. 
Thirty-one out of 421 pigs were tested positive and culled. 
Three weeks later 380 pigs were retested and 28 animals tested 
positive. Positive tests, reconfi rmed by IFA, indicated the herd 
being infected by an eu-type PRRS-v. Approximately 8 weeks 
after PRRSv was diagnosed all pigs of the herd were vaccinated 
with Porcillis PRRS®(EU-live vaccine, Intervet/Shering-Plough) by 
IDAL (intradermal applicator of liquids) in an attempt to prevent 
further spread of the infection. Needle-free injection was used to 
avoid pig-to-pig transmission by needle.
Farm management and hygiene protocol: Stringent hygienic 
procedures were implemented: -the farrowing departments 
were strictly isolated by blocked corridors. -clothes were 
changed between farrowing compartments (max.10 sows per 
compartment), as well as surgical gloves, masks and hairnets. 
From each litter pooled blood samples of 4 piglets were tested 
by PCR to ensure absence of viremia. When negative by PCR, all 
piglets were tested serologically at 6 weeks and 10 weeks of age 
to ensure absence of PRRS. Only those cohorts of piglets that 
were tested negative for PRRS were allowed to be moved to the 
grower compartments.
Results
Initial introduction of PRRSv in this SPF-herd, did not coincide with 
clinical signs. The infection was detected by serology in August 
2006 (3 out of 16 boars). 3 weeks later 7% of the pigs in the herd 
tested serologically positive. After culling the positive pigs again 7 
% of the remaining pigs tested positive by Idexx 3 weeks later.
Two months later (October 2006), when the fi rst piglets were 
born, characteristic reproductive signs of PRRS were seen, like 
high numbers of still born piglets, mummies, weakly born 
piglets and high preweaning mortality. Thereafter these signs 
gradually declined. The course of infection was extensively mon-
itored by blood sampling of the newborn piglets by PCR.
From February 2007 on most of the cohorts were PCR negative. 
From May on, sera from 6 and 10 weeks old pigs, tested negative 
for PRRS.
Conclusion and Discussion
The vaccination and well-defi ned internal biosecurity were suc-
cessfully combined. In our strategy we assume that vaccination 
reduces vertical transmission of PRRSv and shortens the infec-
tious period of infected pigs. Together with compartmenting of 
the herd hygienic procedures will lower the risk for susceptible 
pigs of becoming infected (3). By combining vaccination and 
hygienic procedures the infection faded out, resulting in the 
production of PRRSv-negative pigs. 
Although introduction of PRRSv in a naive population may not 
induce clinical signs, the infection may continue to spread within 
the herd. Especially when no pregnant sows are present, a PRRSv 
infection may stay unapparent. Only during end-term pregnancy 
the virus will infect the placenta that leads to mummifi cation, fetal 
death and weakly born piglets. Viremic born piglets will further 
spread the infection through the herd. As a consequence the 
infection may become endemic in weaned piglet groups (2). 
In our study we prevented further spread of the infection by 
vaccination, internal biosecurity procedures, and the removal of 
viremic born piglets. The relative eff ect of these contributing fac-
tors cannot be calculated, and will need further research. 
Our data proved that this approach was successful in eradicating 
PRRSv from the off spring of a breeding-herd. 
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Antiviral eﬀ ect of dietary alminosilicate supplement against porcine reproductive 
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Introduction
Porcine reproductive and respiratory syndrome (PRRS), caused 
by PRRSV, is characterized by respiratory problems in growing 
and fi nishing pigs and reproductive failure in sows, with late 
term abortion, stillbirth and increased preweaning mortality.1 
Our previous study has demonstrated that dietary aluminosili-
cate (Al2SiO5) supplement (DAS) enhances immune activity in 
mice and reinforces clearance of porcine circovirus type 2 in 
experimentally infected pigs.2 The aim of the present study was 
to demonstrate the antiviral eff ects of the DAS against PRRSV in 
experimentally infected pigs.
Materials and Methods
Animals and diets
Conventional 6-week-old pigs were used to demonstrate 
antiviral eff ect of DAS against experimental PRRSV infection. All 
animals were confi rmed to be free of PRRSV, as determined by a 
commercial ELISA kit (IDEXX Laboratories, Westbrook, ME, USA). 
They were randomized into two groups of three pigs each. The 
control group received a commercial, nutritionally complete, 
swine feed. The experiment group received the same swine feed 
supplemented with 0.3% (w/w) DAS.
Virus titration and histological analysis
All pigs were acclimatized to the particular diet for 2 weeks be-
fore experimental virus infection. Five milliliters of the viral cul-
ture (1*107 pfu/ml) was inoculated intranasally in each nostril of 
each pig. All pigs were sacrifi ced at 12 day post-infection (DPI). 
Lymphoid tissues and lung were collected from each animal. Ti-
tration of PRRSV in each sample was performed by plaque assay. 
Histological analysis was performed as previously descisribed.2
Results
Virus quantity in various tissues
Virus titer in bronchial lymph node, tonsil, thymus and lung of 
the 0.3% DAS feeding group was signifi cantly decreased com-
pared with those of the control group at 12 DPI (P<0.05) (Fig. 1).
Fig. 1. Virus quantity in bronchial lymph node (BLN), inguinal lymph 
node (ILN), tonsil (TON), thymus (THY), mesenteric lymph node (MLN), 
spleen (SPN) and lung (LUN) at 12 DPI.
Histological analysis
Experimentally PRRSV infected pigs showed interstitial pneu-
monia. These lesions in the 0.3% DAS feeding group were milder 
(Fig. 2b) compared with in the control group (Fig. 2a). Addition-
ally, the 0.3% DAS feeding group shown less severe lymphoid 
depletion in thymus (Fig. 2d) compared with the control group 
(Fig. 2c).
Fig. 2. Histological features of lung (a, b) and thymus (c, d) in experi-
mental PRRSV-infected pigs.
Discussion
In the present study, titer of PRRSV in almost tested lymphoid 
tissues and lung of 0.3% DAS feeding group was signifi cantly 
decreased compared with those of the control group at 12 DPI. 
These results are similar to those of previous our study that 0.3% 
DAS reinforces clearance of porcine circovirus type 2 in experi-
mentally infected pigs.2 Previous studies have reported that 
Al2SiO5 act as nonspecifi c immunostimulators similar to super-
antigens.3 In addition, our previous study has also demonstrated 
that DAS enhances immune activity in mice.2 Therefore, antiviral 
eff ect of DAS may relate to nonspecifi c immunostimulatory ef-
fects of Al2SiO5. Taken together, these fi ndings suggest that DAS 
have an antiviral eff ect against PRRSV in experimentally infected 
pigs.
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Control of PRRS outbreak in a naïve herd using killed local US-strain PRRSv vaccine: A case report
Pariwat Poolperm; Kitcha Urairong; Preeyaphan Udomprasert; Worawidh Wajjwalku
Kasetsart University, Nakornpathom, Thailand
Introduction 
Porcine reproductive and respiratory syndrome (PRRS), caused 
by PRRS virus (PRRSv), is the most costly disease currently af-
fecting pig industry worldwide. PRRS outbreak seriously caused 
high losses in reproductive system, including highly increase in 
abortion, mummifi ed fetuses, stillbirth, weak piglets born and 
sow death. For a naïve herd, these losses are drastically high and 
need more intensive action to control and stop losses. Vaccine 
is one eff ective tool in controlling the disease. Commercial vac-
cines are available worldwide. Killed PRRSv vaccine was chosen 
due to the regulation of the company. However, killed PRRSv 
US-strain vaccine is not commercialized in Thailand. Therefore, a 
homemade killed vaccine using local US strain (KU-killed-PRRS) 
was developed at the faculty of veterinary medicine, Kasetsart 
University, Thailand. 
The objective of this study was to assess the effi  cacy of the 
KU-killed-PRRS vaccine in controlling PRRS outbreak in a naïve 
nucleus herd.
Materials and Methods
A 2,100 sows nucleus herd, had been free from PRRS for 6 
years, was serologically positive for PRRS antibody using ELISA 
(HerdChek 2XR Ab, IDEXX Lab., Westbrook, MA, USA) in March 
2009. The virus was determined as US strain using RT-PCR. Area 
veterinary consultants decided to use a vaccine, developed in a 
research project funded in part by National Research Council of 
Thailand, using local PRRSv US-strain (KU-killed-PRRS). The vac-
cine contains at least 106.5 TCID50/dose in oil-in-water adjuvant. 
Mass vaccination was applied to all sows twice using KU-killed-
PRRS vaccine, 4 weeks apart. Then vaccine was programmed 
at week 11 and 14 of gestation. In piglets, vaccine was pro-
grammed at 2 and 6 weeks of age to enhance antibody level for 
protecting early infection during suckling period. 
Serological profi les and RT-PCR were monitored on monthly 
basis. Sow reproductive performance, percentage of prewean-
ing and nursery losses were recorded.
Results
Sow reproductive and lactational performance parameters were 
shown in table 1. Serological profi les and RT-PCR results were 
positive in sows, suckling and nursery pigs. However, serological 
and RT-PCR results for suckling and nursery pigs turned to be 
negative in August, 6 months after vaccine was applied. During 
the outbreak, there was no increasing of losses in nursery pigs, 
however, the ADG was dropped about 26% during Apr-Jun 2009 
(ADG 460g/d to 340 g/d).
Table 1. Represents sow reproductive and lactational perform-
ance during Feb-Aug 2009. (sb=%stillbirth, mm=%mummies, 
pwm=%preweaning mortality, lwg=average daily litter weight gain 
(kg/d), ab=number of aborted sows, day=average gestation length at 
abortion)
Feb Mar Apr May Jun Jul Aug
sb 6.1 15.6 14.7 8.9 7.5 6.6 4.6
mm 7.9 22.3 36.1 44.1 19.0 12.8 14.9
pwm 18.0 34.2 49.6 21.6 16.3 12.5 9.1
lwg 1.97 1.14 0.7 1.32 1.44 2.04 2.34
ab 21 52 33 33 27 12 13
day 35.8 77.1 89.7 80.5 61.4 57.9 78.8
Discussion
The fi rst PRRS outbreak in a naïve nucleus herd caused severe 
abortion in all parity sows, as high as 10%. The most detrimental 
eff ects are during lactation period, including, high percentage of 
stillbirth, mummies and weak piglets consequently increase pre-
weaning mortality. Application of homemade killed local PRRSv 
US-strain vaccine could stop losses in an outbreak herd within 
two months and could produce PRRS free-infection for weaned 
and nursery pigs within 6 months. Off -site nursery is a recom-
mended strategy to achieve PRRS free herd in the future.
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Elimination of PRRS virus infection in a boar stud by vaccination and replacement
Michael Alt; Friedrich Delbeck
Chambre of Agriculture, Oldenburg, Germany
Introduction
As PRRS imposes high costs on pig production elimina-tion of 
PRRSV is the best response to the disease (1). Transmission of the 
virus also by airosols and insects is possible and re-infections are 
frequent so that eradication must be conducted on a regional 
basis. Although the risk of virus transmission by semen from in-
fected boars is low compared to other factors (2), negative herds 
should only be supplied from negative boar studs. If re-infection 
occurs, PRRSV should be eliminated immediately to prevent 
transmission to other farms. Successful eradications by vac-
cination with live vaccines have been reported from breeding 
herds (3), whereas for boars killed vaccines should be preferred 
because no adverse eff ects on semen quality nor shedding of 
vaccine virus were reported (4). A combined testing of blood 
samples by PCR and serological methods has been shown to be 
the safest method for monitoring boar studs (5).
Material and Methods 
A boar stud consisting of two parts was re-infected after a 
period of several years being negative. The infection was limited 
to one part consisting of 200 boars. In order to prevent the 
transmission to the other part that is situated only 150 m apart 
housing 100 boars, strict bio-security measures were imple-
mented including elimination of arthropods and rodents as well 
as separation of personal and feeding supply. For monitoring 
samples were taken every month and tested using a RT-PCR 
(blood and semen) and the IDEXX® Herd check ELISA 2X and X3. 
All young boars (60 % replacement/a) absolved a triple testing 
within 6 weeks in separate isolation farms situated at least 5 km 
apart. Two months after infection all boars of the infected stud 2 
were vaccinated applying a killed vaccine (PROGRESSIS®, Merial). 
The vaccination of this herd is repeated three times at an interval 
of three months. Young boars are vaccinated before introduction 
as well. Semen quality is controlled permanently. 
Results
Vaccinated boars of stud 2 revealed no adverse eff ects con-
cerning general behaviour or semen quality. All boars in stud 
1 remained free of infection until now. Whereas virus material 
could be detected by the PCR in blood samples only at the onset 
of infection, no PRRSV in semen occurred at any time. Initially 
high levels of PRRSV antibodies declined on a relatively low and 
stable level. All of the tested animals with the exception of two 
developed antibodies after vaccination.
Figure 1: ELISA Antibodies of boars in stud 2 after infection and vac-
cination with PROGRESSIS®
Table 1: PCR and ELISA Results in boar stud 1 (free) and boar stud 2 
(infected and vaccinated)
Total RT PCR blood RT PCR Semen ELISA serum
No. samplings No. sampless pos/neg pos/neg pos/neg
Boar stud 1 9 202  0/86 0/10 0/106
Boar stud 2 9 304 10/140 0/24 94/36
Discussion
No adverse eff ects of semen quality have been found following 
the vaccination. The spreading of the virus in stud 2 and trans-
mission of virus to stud 1 could be prevented. The vaccination 
antibodies declined. Newly introduced boars remained free of 
detectable virus material. The antibody level is expected to de-
cline after the end of the vaccination period. These preliminary 
results promise that elimination of the PRRSV can be achieved 
without depopulation. 
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Eradication of PRRSV: an approach using mass vaccination and high standard 
internal biosecurity without herd closure and partial depopulation
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Introduction
For the eradication of PRRS from infected farms methods as 
herd-closure, partial or total depopulation including strict 
biosecurity (1), and the use of vaccination (2) have proved to be 
eff ective. However, the costs of these methods, caused by loss 
of production and genetic material, question if other methods 
can be eff ective. Aim of this paper is to describe an attempt to 
eradicate PRRSV using all herd-vaccination combined with high 
standard internal hygiene and biosecurity procedures, without 
the use of (partial) depopulation. This approach was used on a 
breeding farm holding all sows, weaners, rearing and testing of 
breeding stock under one roof. 
Materials en Methods
A breeding farm with 500 sows and 2000 young breeding stock, 
that started in August 2006 on a new location with SPF PRRSV-
free gilts, was infected early 2007. March 2007 the diagnoses of 
an infection with an EU-type PRRS-virus strain was confi rmed 
by PCR and serology. Sows were vaccinated 4 times, all other 
pigs (piglets included) were vaccinated twice, starting from an 
age of 14 days, with an interval of 2 weeks. The used vaccine 
was Porcilis PRRS (Intervet/Schering Plough) administered using 
Intra-dermal application (IDAL-technique), to avoid the use of 
needles. After the initial mass vaccination, the sows were vaccin-
ated by 60 (gest.) – 6 (lact.) scheme, the piglets at 3 and 5 weeks 
of age. Vaccination of piglets was ended 6 months after the out-
break. For biosecurity four separate internal units were created 
with hygiene-barriers between them: a. sows and replacement 
gilts; b. farrowing rooms; c. weaned piglets; d. rearing testing 
stock. The hygiene-barriers included: changing of coveralls and 
boots, disinfection of hands and separated materials, including 
those for individual treatments. Unilateral fl ow and strict all in all 
out were standard procedures. The used sampling scheme was: 
a. monthly sampling of 20 non vaccinated weaners of 9 weeks 
of age (tested with Idexx ELISA Herdcheck PRRS 2XR), b. weekly 
sampling of 4 piglets per each newborn litter, samples pooled 
for rt-PCR-testing, c. all sold breeding pigs at individual level. 
Results
In table 1 the results of testing are provided. In total 4 litters, 4 
weaners and three 6 months old breeding pigs were found posi-
tive (Table 1).
Discussion
Although more than 99% of the tested animals became sero-
negative (weaners at 6 months and rearing stock at 12 months 
after the outbreak) the occurrence of a few infected pigs indi-
cates that eradication of PRRSV was not fully successful. Reasons 
for fi nding positive test-results could not be determined. Un-
fortunately sequen-cing of the EU-virus strain found in a breed-
ing pig in September 2008 was not possible due to technical 
reasons. Thus it could not be determined if a new strain had en-
tered the farm, and virus spread from persistently infected sows 
could not be ruled out. Possible reasons for new virus circulation 
could be: internal infl ux of gilts into the sowherd started again 
after 3 in stead of 6 months, and the fact that not all sows were 
culled which could account for a low level of virus circulation. In 
spite of these facts the used vaccination-protocol and the high 
level of internal biosecurity have contributed to a rapid decline 
in percentage of infected animals. 
Unfortunately the eff ect of the used approach could not be 
evaluated totally, because the farm got infected with a new 
PRRS-virus strain in December 2008, 96% homologous to the 
US-MLV-vaccine strain VR2332. Possible routes of this new virus 
introduction were considered to be: a) introduction of virus in 
incoming air either from neighbouring farms (500 m distance),b) 
from a slurry-container, c) non compliance to biosecurity proto-
cols for humans d) open doors when loading pigs for transport. 
Next to reconsidering biosecurity protocols, the farmer now 
considers the use of air fi ltration to prevent virus introductions 
in future. 
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Table 1: Results of sampling   
Age group Sampling period Number of bloodsamples/ Test
Pos 
samples
Litters 10-2007 / 07-2008 406 / PCR (pool) 4a
Weaners 9 wks old 10-2007 / 08-2008 319 / ELISA 4b
06-2008 / 08-2008 36 / PCR 0
Rearing Stock 02-2008 / 10-2008 305 / ELISA 3c
60 / PCR 0
a Dec 2007 and March 2008 bMarch 2008, cMay and Sept 2008; in September one 6 
months old breeding pig was found virus-positive (in the lung lymphnode, sequence 
of this virus could not be confi rmed).
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Potential positive eﬀ ect of commercial spray-dried porcine plasma on pigs challenged with PRRS virus
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Introduction
Spray-dried porcine plasma (SDPP) is used as a feed ingredi-
ent in diets of weanling pigs to provide benefi cial eff ects on 
productive parameters. Some epidemiological studies have 
described a signifi cant association of dietary SDPP with lower 
post weaning mortality1 and improved productive records in 
sows from a PRRS unstable farm2. According to these studies the 
positive eff ect of SDPP could be related to a modulation of the 
infl ammatory immune responses. The aim of the present study 
was to determine the eff ect of SDPP as a supplement in the diet 
on the outcome of experimental PRRS virus (PRRSV) infection.
Material and Methods
Experimental design. 55 three-weeks-old piglets obtained from 
a PRRSV-free farm were randomly distributed in three groups: 
pigs in I and II were intranasally inoculated with PRRSV (106 
TCID50/ml) and group III was kept as a control. Group I received 
a supplemented diet (8% SDPP, AP-820P from APC Europe, SA) 
from four days before challenge to 28 days post-inoculation (PI) 
and drinking water supplemented with 2% spray-dried porcine 
serum until 7 days PI. 
Clinical follow-up and sample taking. Individual body temper-
atures were measured daily (from 0 to 14 PI). Sera samples were 
taken from 0 to 28 days PI and analyzed for PRRSV viremia by 
nested RT-PCR (nPCR)3. The presence of antibodies to PRRS was 
checked by a commercial ELISA kit (HerdChek® PRRS 2XR, Idexx).
Histopathology. Serial examination of tissues was performed 
after humane killing of pigs at days 0, 3, 7, 14 and 28 PI. Severity 
of microscopic interstitial pneumonic lesions was semi-quanti-
fi ed following a previously reported scoring system4. 
Immunohistochemistry (IHC). IFN- γ, IL-1 and IL-10 were measured 
from apical and intermediate lobes of lungs by IHC as described 
before5.
Statistics. Statistical analysis was performed with StatsDirect 
2.7.5
Results
Clinical follow-up. Temperatures of both infected groups showed 
a biphasic pattern of two peaks (day 4 PI and day 8-12 PI) of 
fever (≥40ºC). All infected groups seroconverted at day 14 PI and 
were positive by nPCR until 21 PI. Five of six pigs in group II and 
only two of fi ve in group I were viraemic at day 28 PI (p=0.07).
Histopathology. Sum of interstitial pneumonia scores from day 3 
to 28 PI showed signifi cant diff erences among groups (II = 129 > 
I= 94 > III= 25; p<0.05).
IHC. Interestingly, higher frequency of cells expressing IFN- γ and 
IL-1 (day 3 PI and days 3, 7 and 14 PI, respectively) were detected 
in apical and intermediate lobes for group I (p<0.05) (Figure 1). 
No signifi cant diff erences were observed for IL-10.
Figure 1. Mean of cells by mm2 expressing IFN- γ and IL-1 in apical and 
intermediate lobes. 
* Group I > Group II (p<0.05)
Discussion
After the PRRSV inoculation, a signifi cant lower interstitial 
pneumonia was found in the group receiving SDPP (I) (p<0.05). 
Besides, this group also showed less nPCR positive pigs at day 
28PI (p=0.07). Both facts suggest that pigs fed SDPP may have 
an earlier virus clearance compared to non-SDPP challenged 
group (II). 
The increase of cytokine expression (IFN- γ and IL-1) in lungs of 
group I points to a Th1 enhancement that might be related with 
the data discussed above. 
Results of the present report indicate that SDPP used in the diet 
may have a potential positive eff ect during a PRRS challenge.
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Introduction
PRRS is a devastating disease for intensive pig production. Sero-
prevalence studies show that it is an endemic disease in most 
farms. Several control measures are currently used at farm level 
with variable results (1).
The objective of this study was to assess, under fi eld conditions, 
the eff ectiveness of diff erent health management strategies for 
PRRS control.
Material and Methods
Forty-three Spanish farms belonging to the same company and 
with a census between 100 and 5,250 sows and gilts (mean±SD: 
643±1,012), were surveyed during a minimum period of 3 years 
(maximum of 10 years) (total of 397 farm-years) in a prospective 
observational study.
Four diff erent strategies for PRSS control were used in these 
farms: S1: PRRS-Positive Gilts, Live Vaccine and No Infection with 
Piglets; S2: PRRS-Positive Gilts, Live Vaccine and back passage 
(infection) with viremic piglets; S3: PRRS-Positive Gilts, Killed 
Vaccine and Infection with Piglets; and S4: PRRS-Negative Gilts, 
Killed Vaccine and Infection with Piglets.
Live vaccine (AMERVAC®-PRRS (Hipra, Spain)) and killed vaccine 
(PROGRESSIS® (MERIAL)) were applied according to producer 
specifi cations in gilts in quarantine, except in some farms where 
adult sows were also vaccinated with PROGRESSIS.
In this study, a PRRS outbreak was defi ned as the sudden occur-
rence of reproductive problems associated to an abrupt increase 
of seroprevalence to this disease.
A commercial indirect-ELISA test was used for PRRS diagnosis 
(Ingezim PRRS K1, Ingenasa). Seroprevalences were calculated 
every year from min. 20 samples (max. 370) depending on farm 
size (48.3 ± 35.1).
Comparison of average year seroprevalences was performed 
with ANOVA or Student t-test (normality was previously checked 
with Kolmorogov-Smirnov test). Error α was established at 0.05. 
Statistical analyses were performed with SPSS® 15.0 (WIN-
DOWS®).
Comparison between outbreak prevalence was tested with clas-
sical percentage comparison.
Results
Using live vaccine and introducing PRRS-positive gilts (S1, 
starting point) gave us an average seroprevalence of 52% 
(minimum 11%). Further infection of gilts with positive piglets 
(S2) produced a signifi cant increment of seroprevalence (71.9%, 
minimum 28.6%). A change from live to killed vaccine (S3) led 
to a signifi cant decrease of seroprevalence (63.4%, minimum 
2%). Finally, introducing PRRS-negative gilts (S4) led to a further 
reduction of seroprevalence (47.4%, with some farms becoming 
totally seronegative) in spite of the infection of gilts with piglets 
(Table 1). 
However, some farms under S4 strategy still showed high sero-
prevalence as a probable result of PRRS virus circulation. Only a 
very low number of outbreaks occurred whatever the strategy 
(Table 2). 
Table 1: Average seroprevalences depending on control strategy
Seroprevalence (%)
Strategy N Mean±SD* Min Max
Strategy 1 67 52.0±26.6a 11.0 100
Strategy 2 96 71.9±17.8b 28.6 100
Strategy 3 54 63.4±24.3c 2.0 100
Strategy 4 177 27.5±30.2d 0.0 100
Total 394 47.4±32.4 0.0 100
*ANOVA p-value<0.001 (diff erent superscripts indicate signifi cant diff erences among sero-
prevalences applying Duncan’s post-hoc test)
Table 2: Relationship between seroprevalence and PRRS outbreak 
prevalence during the subsequent year
Use of a killed 
vaccine
PRRS 
outbreak
Seroprevalence 
(%)
N % Mean±SD p*
Only gilts No 351 1.71a 45.1±31.8
Yes 6 16.4±13.8 0.003
All breeders No 39 2.56a 69.6±28.6
Yes 1 95.0 0.386
Total No 390 1.79 47.6±32.3
Yes 7 27.6±32.3 0.106
* Student t-test p-value; a non signifi cantly diff erent 
Discussion and Conclusion
It is well known that ELISA antibodies are more of a proof that 
pigs have been in contact with the virus than related to protec-
tion (2) and that ELISA antibody response to PROGRESSIS vac-
cination are variable (3). The use of killed vaccine in seronegative 
gilts with infected piglets did lead to a signifi cant reduction of 
PRRS-seroprevalence in most farms due to no new virus brought 
through the incoming gilts and through the control of existing 
infection. This was confi rmed by the low overall number of 
outbreaks occurring during the study. The PRRS status reached 
in most of the farms could eventually let us consider an eradica-
tion program.
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Introduction
Swine infl uenza virus (SIV) causes outbreaks of pneumonia and 
respiratory disease of short course with high fever and morbid-
ity and mortality of less than 1%. Clinical signs generally are of 
respiratory type however it has also been reported as a cause of 
reproductive disease (1, 2, 3) and it is a public health concern. 
In this paper the isolation in Mexico of an infl uenza type A virus 
from pigs during a reproductive outbreak is described.
Materials and Methods
The outbreak took place in a 250 sow herd which produces only 
weaners, located in the State of Mexico and considered free 
of PRRSv and Porcine Rubulavirus. Antibodies against PRRSv, 
infl uenza virus (H1N1, H3N2) were measured by ELISA (IDEXX), 
for Parvovirus and Porcine Rubulavirus haemagglutination 
inhibition test (HI) was used. Tissues from dead newborns and 
semen from males were inoculated in PK15 and Vero cell line 
and in chicken embryos for virus isolation. Primers against the 
M gen (Matrix) were used for RT-PCR. From the isolated virus an 
inactivated vaccine was prepared with 1x105 50 IDCE and Freud 
adjuvant.
Results
Herd fertility decreased at the end of 2007 (fi gure 1), and born 
death and mummies increased. Mortality during the suckling 
period increased from 3% to 8% and piglets showed nervous 
and respiratory signs. An increment of repeating sows with 
irregular cycles, abortions and sudden dead were recorded. 
None of the males had apparent testicular abnormalities but 
some had azoospermia and others agglutination, low viability or 
death spermatozoa. Serology of sows and piglets was negative 
for Porcine Rubulavirus and PRRSv, and few sows had antibodies 
to parvovirus at low titers. Therefore these viruses were not cir-
culating in the herd. Antibodies against H1N1 and H3N2 SIV were 
detected only in 4th to 5th parity sows indicating that these 
types of infl uenza virus infected the herd in 2006. A haemag-
glutinating virus was isolated from lung tissue and semen. The 
isolated virus was positive to type A infl uenza virus by RT-PCR 
and was inhibited weakly with an specifi c anti H1N1 sera, but not 
with H3N2. By means of an HI test using the isolated virus, all par-
ity sows (1 to 5) had antibodies indicating that the new virus was 
infecting them. The inactivated vaccine was applied to gestat-
ing sows and males at the end of 2008 and fertility returned to 
normal values by mid 2009.
Discussion
The clinical presentation described has not been reported 
globally and it is very important to mention that it can only be 
diagnosed through molecular biology tests such as RT-PCR or 
Real-Time PCR, once the complete viral genome has been fully 
sequenced. The typifi cation and characterization of the virus is 
on its way, however, the search for new viral subtypes is needed 
because at the moment the reproductive clinical impact as-
sociated with the infl uenza virus still unknown; since, generally 
reproductive disorders are associated with other viruses such as 
Aujeszky, Parvovirus, Circovirus or PRRS, that means that we are 
identifying the infl uenza virus as directly responsible for the re-
productive failure. It was concluded that a type A infl uenza virus, 
diff erent to H1 or H3 subtypes, was involved in the reproductive 
outbreak described.
References
1.  Olsen, C. W., et al. (2006). Swine Infl uenza. In Diseases of Swine (9th 
edition). Straw, B. E., et al. eds. Blackwell Publishing, Ames, Iowa, 
USA. 2(28): 469–482.
2.  Stephano, H. A. (2004). Proceedings XXXIX AMVEC National Con-
gress (Mexico). 107–114.
3.  Woods, G. T. and Mansfi eld, M. E. (1974). Res. Commun. Chem. 
Pathol. Pharmacol. 10: 629–632.
.
Respiratory diseases – Swine infl uenza
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 563
Poster Presentations
P.257
An Outbreak of Inﬂ uenza Virus H3N2 Subtype in a farm in Argentina
Javier A. Cappuccio1 Ariel Pereda2 Lucas Insarralde1 María A. Quiroga1 Mariana Machuca1 María I. 
Craig2 Agustina Rimondi2 Lindomar Pena3 Jorge Mendez3 Daniel Perez3 Carlos J. Perfumo1
1. Cátedra de Patología Especial, Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata, La Plata, Argentina; 2. Instituto de 
Virología, CICVyA. INTA Castelar, Castelar, Argentina; 3. Department of Veterinary Medicine, University of Maryland, Blacksburg, MA, USA
Introduction
In South America, reports about swine infl uenza virus (SIV) are 
scarce. Serological surveys have revealed that SIV subtypes 
H3N2 and H1N1 are currently in circulation in Venezuela, Colom-
bia, Brazil and Argentina (1). However, as neither isolation nor 
sequence has been performed, subtype, genotype and source of 
virus remains unknown. In this work we describe the epidemiol-
ogy, clinical outcome, pathology and the techniques applied for 
isolation, subtype and sequence of infl uenza A virus outbreak in 
Argentina.
Materials and Methods
The disease appeared at the nursery barns of 3 site farrow-to-fi n-
ish farm with its own replacement gilts, located in Buenos Aires 
province. Each barn had an average of 3,000 pigs with a total 
pig population at risk of more than 21,000. The clinical signs 
such as cough, dysnea, off  of feed and fever aff ected 1,2% of 40 
days-old pigs and rapidly elevated up to 40% in pigs of 48-55 
days-old and almost disappeared at 83 days. The cycle of infec-
tion persisted for 8 weeks. Average weight of pigs was recorded 
by barns. Ten pigs were submitted for post-mortem studies. 
Lung samples were processed for histopathology and immuno-
histochemistry (IHC) against NP of infl uenza A viruses (2). Nine 
bronchial swabs and lungs samples from 45 to 50 days-old pigs 
with pneumonic lesions were processed by real time RT-PCR 
directed to the matrix (M) gene (3). Positive samples by rRT-PCR 
were processed for virus isolation in MDCK cells. The genome 
segments were amplifi ed by RT-PCR and directly sequenced 
with the BigDye terminator kit (Applied Biosystems™, Foster City, 
CA, USA). Partial sequences of HA, NP, NA, M1, NS, and PB2, PB1 
and PA were obtained. Genomic information was derived from 
overlapping sequences covered by forward and reverse primers. 
At least two independent RT-PCR reactions were produced for 
each gene and used for sequencing. Nucleotide BLAST analysis 
was initially used to identify the most closely related infl uenza A 
virus gene for each respective segment.
Results 
Overall average daily gain, feed intake and mortality records 
were not aff ected during the outbreak. However, in 9 post-
mortem examined pigs, body condition was under the target 
weight. All pigs had craneoventral plum colored consolidate 
areas. In 2 pigs, distinctive lobular consolidation like “chess-
board” distribution was observed. In 6/10 severe necrotizing 
bronchiolitis was a characteristic microscopic fi nding. Small and 
medium sized bronchioles were plugged with neutrophils, cel-
lular debris and proteinaceous exudates. IHC showed distinctive 
positive reaction only in the bronchial or bronchiolar epithelia 
that showed minimal changes. Seven samples were rRT-PCR 
positive to infl uenza A. Further, rRT-PCR procedure demonstrat-
ed H3N2 subtype. The partial sequence of the eight genome 
segments revealed a high nucleotide identity with wholly hu-
man origin infl uenza A H3N2.
Discussion 
Since 1970, infection of pigs with H3N2 viruses of human origin 
have been reported in Asia and Europe, but only after 1984 it 
was associated with clinical outbreaks (4). Currently, double and 
triple reassortant H3N2 viruses are the predominant in Europe 
and in North America respectively (5). However, wholly human 
infl uenza viruses are some times isolated from pigs without sus-
tained circulation. The origin of this isolate and its prevalence in 
Argentinean farms are yet unknown. From an epidemiological, 
clinical and pathological point of view the reported outbreak 
was in agreement with those described for endemic SIV. How-
ever cycle of infection and clinical signs persisted longer than 
those reported (5). The age-dependent susceptibility of pigs 
may refl ect a higher innate immune response to the virus in 
older pigs (6) or the decline of maternally acquired immunity. 
This is the fi rst report of SIV H3N2 isolated and genotyped from 
a clinical case in Argentina and South America. 
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Introduction
Swine infl uenza virus (SIV) subtypes H1N1, H1N2 and H3N2 are 
well established in the pig population worldwide. Since 1999, 
the H1N2 subtype has emerged and caused abortion storms 
in pregnant sows in the U.S. swine farms (1). In Thailand, H1N2 
SIV was fi rst isolated in the non-clinical swine farms in Saraburi 
province located in the central part in 2005 (2). It was not until 
2009 that we found the H1N2 SIV associated with severe respira-
tory distress in two pig farms in the eastern part of Thailand. The 
objective of this study was to characterize the major envelope 
glycoprotein genes, HA and NA of the re-emerging Thai H1N2 
SIV. 
Materials and Methods
Two separate pig farms in Chacheongsoa province located in the 
eastern part of Thailand, faced with respiratory problems in the 
nursery to early grower pigs (4-12 wk). The morbidity rate was 
over 50% and mortality rate was approximately 10-20 %. Fresh 
6 lung tissues were submitted to the Chulalongkorn University-
Veterinary Diagnostic Laboratory. Lungs were diagnosed of 
PRRSV, PCV2 and SIV by PCR. SIV subtyping and characterization 
of HA and NA gene were performed (1). 
Both SIV isolates designated as A/Swine/Thailand/CU-K4/09 
(H1N2) and A/Swine/Thailand/CU-CHL2/09 (H1N2) were charac-
terized.
Results
The nucleotide homology of the HA and NA genes of the two 
current H1N2 virus compared to the fi rst Thai swine H1N2 
isolated in 2005 (H1N2/2005) are 87.5-88.2% and 82.3-82.6%, 
respectively. HA genes of both 2009 isolates belonged to classic 
swine lineage similar to the H1N2/2005 but located in diff er-
ent clusters. The NA gene of both 2009 H1N2 belonged to the 
human-like SIV similar to the H1N2/2005 but also located in 
diff erent clusters.
Discussion 
Previous data indicated that the Thai H1N1 and H3N2 subtypes 
were separated into 2 clusters (a and b) (2). The Thai H1N2 SIV 
reported in 2005 contained a combination of H1N1 (H1-classical 
swine (Cl) b) and H3N2 (N2-human (H) b). The origin of the N2 
of both 2009 H1N2 viruses in this study appeared to be similar 
to the human-like in cluster a (Ha) closely related to the Thai 
human infl uenza viruses. Characterization of the internal genes 
is pending. No pathogenesis or epidemiological data was done 
with the 2005 H1N2 SIV.
Fig. 1: Phylograms of HA gene (A) and NA gene (B) of SIV H1N2.Both 
2009 H1N2 isolates were associated with the severe respiratory signs in 
pigs. This study demonstrates the presence and on-going diversity of 
the H1N2 SIV in the Thai swine population. The study also highlights the 
importance of SIV as a contributor to PRDC which remains as a major 
problem in the Thai pig industry
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Introduction
Swine infl uenza viruses (SIVs) represented by three diff erent 
subtypes, H1N1, H3N2 and H1N2 are now co-circulating in Euro-
pean countries (1). In France, according to recent virological and 
serological surveillance studies, H1N1 and H1N2 are the major 
subtypes and no or very few H3N2 viruses have been evidenced 
(2,3). 
The objective of this survey was to evaluate the seroprevalence 
of SIVs in farms aff ected with acute respiratory clinical signs in 
France.
Material and Methods
Experimental design: 29 farms (2 farrowing units, 17 farrow-
to-fi nish and 10 fi nishing herds) located mostly in Brittany and 
western part of France were investigated. These farms had been 
aff ected with acute respiratory clinical signs at least 3 weeks 
before sampling. Four farms used to vaccinate the sows against 
H1N1 and H3N2 strains; in these specifi c cases, only H1N2 sero-
logical results were considered on sow sera. Farms were sampled 
from January to June 2009 as follow: 10 sows of diff erent parity 
in farrowing units, 10 sows and 10 fattening pigs before slaugh-
ter in farrow-to-fi nish farms and 10 pigs before slaughter in 
fattening farms. In one farm, where fattening pigs showed fever, 
nasal swabs were collected for virus isolation. All sera and swabs 
were sent to IZLER laboratory at Parma, Italy, to be submitted to 
haemagglutination inhibition tests (HI) (4) and to virus isolation. 
The strains used for the HI test were H1N1 sw/Belgium/1/98, 
H1N2 sw/Scotland/41440/94, H1N2 sw/France/134240/09 (strain 
isolated on nasal swabs from one farm in Brittany during the 
study) and H3N2 sw/Gent/84. The results were analyzed accord-
ing to the following rules: samples were considered positive for 
one specifi c subtype if the titre is ≥1/20; one farm was classifi ed 
as positive against one given subtype if at least 2 sera showed 
an HI titre ≥1/20 against this subtype. Risks of misinterpretation 
due to cross-reactivity between H1N2 and H1N1 strains were de-
creased by considering negative for H1N2 a serum that showed 
higher (3 log2) HI titre against H1N1. 
Results and discussion
The serological results are presented in table 1. Globally, 96.6% 
of farms tested were positive for at least one SIV subtype. The 
use in the HI test of the strain H1N2 sw/France/13240/09, isolat-
ed in Brittany, increased the sensitivity of the HI test, as showed 
in the table 2. This observation confi rms the importance to use 
local strains in HI tests in SIV surveillance programme. Some 
farms were infected with both strains H1N1 and H1N2: this rep-
resents 38% of tested farms. One farm not vaccinated against fl u 
was found to show positive sera against H3N2, and another one 
was doubtful. H3N2 subtype infection has not been shown since 
many years in pigs in Brittany, the possibility that cross reactions 
could have been occurred must be considered. 
Table 1: positive serological results by HI tests (%)
Tested strain N° farms tested % positive farms
H1N1 sw/Belgium/1/98 29 72.4
H1N2 sw/Scotland/41440/94 29 13.8
H1N2 sw/France/134240/09 29 58.6
H3N2 sw/Gent/84 29 3.4*
*1 farm only was found positiveTable 2: H1N2 results in one farm: comparison of positive samples 
by strain used for the HI test
Table 2:
Titre <20 20 40 80 160 Total
H1N2 sw/Scotland 
/41440/94 20 0 0 0 0 20
H1N2 sw/France /134240/09 4 1 7 3 5 20
Conclusion
This serological survey confi rms the major role of SIVs in swine 
respiratory disorders in French farms. SIV of H1N1 and H1N2 
subtype are enzootic in swine producing region of Brittany, 
particularly about 50% of tested farms were found to be infected 
by H1N2 subtype when tested with a strain representative of the 
strains circulating in the region. 
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Introduction
Swine infl uenza (SI) remains one of the most important and 
worldwide prevalent viral respiratory diseases in pig population, 
causing economic losses in swine industry. It is also considered 
an important factor in public health concern. Therefore the 
regular monitoring of the epidemiological situation as well as 
rapid and sensitive detection of IV in clinical specimens is of 
great necessity.
The surveillance program for swine infl uenza was initiated in Po-
land at the end of 90s. The aim of this paper is to present both, 
the current epidemiological situation concerning SI in Poland 
and its retrospective analysis over 10 years period.
Materials and Methods
Serological survey. In total 33001 sera were tested, including 
30829 pig sera taken in slaughter houses located in all 16 dis-
tricts of Poland; 1477 blood samples taken from heart or pleural 
cavity of wild boars, hunted in 11 districts; and 695 human sera 
taken from volunteers (554 from producers or animal caretakers 
and 141 from veterinarians). The samples were tested according 
to the standard procedure in HI test against the reference viruses 
representing 3 subtypes (H1N1 - A/sw/Belgium /1/98, H3N2 - A/
sw/Flanders/1/98, H1N2 - A/sw/Gent/ 7625/99). All necessary 
reference sera, virus and RBC controls were included in each test. 
The sample was considered positive when the antibody titer was 
≥1:20. 
Virological survey. In total 421 samples were tested, including: 
312 nasal swabs, 49 lung tissue samples and 60 blood samples. 
The biological material was taken from pigs demonstrating 
infl uenza-like symptoms, raised in 41 farms located in 12 dis-
tricts. Additionally 4 aborted foetuses were taken from the sows 
demonstrating infl uenza symptoms. Virological investigations 
include: virus isolation in 10 days old embryonated SPF chicken 
eggs and tissue culture, detection of viral RNA by RT-PCR, mo-
lecular subtyping in mPCRs, and phylogenetic analysis.
Results
In serological investigation of the pig sera it was clearly demon-
strated that H1N1 subtype is dominated in Poland. In 2009 the 
seroconversion reached 14% of tested sera. The percentage of 
animals possessing antibodies against the mentioned subtype 
varied over the time, with the range from 5 to 14.4%. Within 
last fi ve years we observed about 2 fold increase of seroconver-
sion against H1N1. We also evidenced that the H1N1 subtype 
circulate at the higher frequency in the West part of Poland, in 
pig densely area where the pig production is better developed. 
The survey for H1N2 subtype performed in 2009 demonstrated 
9.4% of seropositive samples. It also varied over the time, 
ranging from 2.4 to 9.4%, with about 2-fold increase within 
last 5 years. The seroconversion to H3N2 antigen in 2009 was 
detected in 10.9% of tested sera. The signifi cant increase (about 
5 fold) of antibodies against H3N2 subtype was evidenced 
within last 5 years. In contrast to H1N1, H3N2 subtype circulate 
at the higher frequency in the East part of the country, where 
the small private farms are mainly located and pig production 
is less developed. The situation among wild boars was similar 
to that observed among pigs but the prevalence of antibodies 
was signifi cantly smaller. Interestingly the highest occurrence of 
antibodies against the tested SIV strains was evidenced in hu-
man. In 2009 seroprevalence for H1N1, H1N2 and H3N2 antigens 
reached 45.4%, 34% and 62.4%, respectively. Over the time it 
ranged from 9.4 to 45.4% in case of H1N1; from 14.3 to 37.5% for 
H1N2 and from 62.4 to 88.5% for H3N2 subtype.
Using conventional virology method 45 SIV isolates were 
obtained. RNA of SIV was detected in 127 (30%) samples (49% 
of tested lung and 33% of tested nasal swabs), originated from 
68.3% farms. In molecular subtyping 93% of isolates were deter-
mined as H1N1 subtype, 4.4% as H3N2 subtype and 2% as H1N2.
HA gene of Polish isolates have been derived from contempor-
ary strains of “avian-like” SIV. M1 gene may have originated from 
avian infl uenza viruses. H3N2 strain was located in swine cluster, 
in the main prevalent European group of H3N2 isolates (A/
PortChalmers/1/73-like lineage).
Discussion
Due to the fact that infections of pigs with H1N1 virus were 
described in most European countries intensively producing pig 
we can state that epidemiological situation of Polish pig herds 
concerning SI is similar to that observed in European countries 
but the prevalence of virus specifi c antibodies is smaller and is 
entirely diff erent from that observed in USA (66.3%-100%) and 
Asia (45%). 
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Introduction and objective
Swine infl uenza virus (SIV) causes an acute respiratory disease in 
pigs that occasionally can be transmitted to human. It is one of 
the major viral pathogen that contributes to porcine respiratory 
disease complex (PRDC) (1). In Thailand H1N1, H3N2 and H1N2 
SIV has been reported in the pig population. SIV-infected pigs 
shed virus for a short period. Therefore serological tests have 
been used as an indirect method to study SIV epidemiology 
in the Thai swine population. However the most updated SIV 
seroprevalence data was reported since 2005 (2). Previous gen-
etic data characterized Thai SIV H1 subtype into classical swine 
lineage which is subgrouped into two clusters; classical swine 
cluster a (Cla) and b (Clb). Thai H1 Cla and Clb were thought to 
have derived from a hypothetical Classical swine H1N1 common 
ancestor in 1981 and 1990, respectively. The Thai SIV H3 sub-
type belonged to human lineage and can be subgrouped into 
two clusters; human cluster a (Ha) and b (Hb). Thai H3 Ha SIVs 
were closely related to Thai human H3N2 virus isolated in 1997 
while Thai H3 Hb SIVs were closely related to human-like H3N2 
virus circulating in the early 1970s (3). This study, we provide an 
update data
of the SIV seroprevalence based on both clusters of H1 and H3 
SIV in pigs from the high pig population provinces in Thailand 
during June 2008 to May 2009. Materials and methodDuring 
June 2008 to 2009, 850 pig sera were collected from pigs of vari-
ous age in the four provinces that have the highest density of 
pigs in Thailand. Those provinces include, Ratchaburi, Nakhon-
Pathom, Chonburi and Chachoengsao. A standard hemagglu-
tination-inhibition (HI) assay was used to evaluate the antibody 
titer against Thai H1 and H3 SIV. HI test was performed, accord-
ing to WHO (4). All sera subjected to test with H3 virus were 
treated with receptor-destroying enzyme (RDE) and adsorbed 
with 50% chicken red blood (RBC) cells to remove non-specifi c 
inhibitors of agglutination and natural serum agglutinins. Sera 
subjected to test with H1 SIV were absorbed with 50% RBC with-
out RDE treatment. Positive SI was considered when HI titer was 
≥ 40. Virus antigen used for HI tests were H1N1 Cla and Clb and 
H3N2 Ha and Hb (3). 
Results and discussion
Table 1 shows the percentage of pigs with positive antibody to 
H1 and H3 SIV in each province. It was demonstrated that pigs 
in all provinces were antibody positive to both H1 and H3 SIV. 
However, overall the percentage of positive pigs to H3 Ha was 
signifi cantly higher than H3 Hb (p<0.01). There were geograph-
ical diff erences of seropositive pigs to diff erent clusters of H3. 
Pigs that were seropositive to H3 Ha in Nakorn-Pathom was 
signifi cantly higher than Chonburi and Chachoengsao (p<0.01). 
The percentage of seropositive pigs to H1N1 SIV was indiff erent 
between each province. However, percentage of seropositive 
pigs to H1 Clb was signifi cantly higher than Cla (p<0.01). The 
fi ndings indicated that Thai SIV currently circulating in Thai pig 
populations are diverse antigenically. The data highlights the 
importance of updating SIV test antigen used in serological test 
for diagnostic purposes. 
Table 1 Seropositive pigs to H1 and H3 SIV by HI test
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Development of Swine Inﬂ uenza Virus Nucleic Acid Puriﬁ cation Workﬂ ow for Surveillance
Angela M. Burrell; Weiwei Xu; Quoc Hoang; Rohan Shah; Manohar Furtado
Life Technologies, Austin, TX, USA
Swine Infl uenza Virus (SIV) is a (-) ssRNA, enveloped, Infl uenza 
A virus in the family Orthomyxoviridae. It is a continuously 
evolving virus that causes swine respiratory disease with fever, 
reduced activity and food intake, conjunctivitis, sneezing and 
coughing and nasal discharge. Respiratory disease can be 
caused by multiple SIV genotypes continuously undergoing 
changes by genetic drift and shift. SIV genotype is determined 
by the antigenic characteristics of two surface glycoproteins 
(hemagglutinin and neuraminidase). The three main genotypes 
currently present in the swine population are H1N1, H1N2, and 
H3N2. Monitoring/surveillance and genetic characterization 
of SIV in swine herds are critical for successful to control of the 
disease and are essential for selection of vaccine treatment and 
novel vaccine development.
The following data were fi led to support a Product License Ap-
plication fi led with the USDA, Center for Veterinary Biologics.
 Applied Biosystems developed an integrated workfl ow 
consisting of high throughput nucleic acid purifi cation, and 
TaqMan® RT-PCR for amplifi cation and genotyping of Swine 
Infl uenza. Nucleic acid is purifi ed using the MagMAXTM Nucleic 
Isolation Kit and purifi ed viral RNA is detected using the Vet-
MAXTM –Gold SIV Detection Kit. The SIV-A TaqMan assay targets 
multiple genetic regions of the Infl uenza A genome decreasing 
the likelihood of false negatives due to viral mutation. The assay 
is multiplexed with an internal control RNA, Xeno™RNA, to mon-
itor nucleic acid purifi cation effi  ciency, detect the presence of 
reaction inhibitors, and determine assay reagents functionality. 
The analytical amplifi cation limit is 50 copies of SIV-A transcript 
RNA per 25ul TaqMan PCR. 
 The performance of the SIV-A TaqMan reagents was compared 
to a published SIV screening protocol (Richt, et. al. 2004). Nucleic 
acid from an SIV vaccine (Novartis PneumoSTARTM vaccine) was 
purifi ed using the MagMAXTM -96 Viral RNA Isolation Kit. The 
purifi ed nucleic acid was then serially diluted to extinction and 
tested using both the VetMAXTM SIV screening reagents and the 
published assay protocol. SIV Cts using the VetMAXTM - Gold SIV 
Detection Kit were 4-5Cts earlier than the published protocol 
and detection sensitivity was approximately 64-fold better. To 
ensure the specifi city of the SIV screening reagents, RNA from 
fi eld samples containing other common porcine pathogens 
(PCV2, M.Hyopneumoniae, PRRSV) were purifi ed using Mag-
MAXTM -96 Viral RNA Isolation Kit and tested with the VetMAX™ 
SIV Detection Kit (n=3). No false positives were detected using 
the VetMAX-Gold SIV Detection Kit
 The performance of the workfl ow was evaluated using fi eld 
samples (n=60) of known SIV status and diverse reference SIV 
genotypes. RNA was isolated from swine nasal swabs, tonsil 
and lung tissue homogenates, virus, and cell lysate supernatant 
using MagMAXTM -96 Viral RNA Isolation Kit. The purifi ed RNA 
was utilized for TaqMan RT-PCR employing the SIV screening 
reagents on the Applied Biosystems 7500 Fast Real-Time PCR 
System. The SIV screening results showed 100% concordance 
with secondary laboratory PCR results. These results as well as 
the superior analytical sensitivity demonstrate that this method 
provides an economical and rapid solution for SIV identifi cation. 
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Identiﬁ cation of Swine Inﬂ uenza A Virus by RT-PCR 
Jae-Yeon Han1 Hyoung-Joon Moon2 Seong-Jun Park1 Hye-Kwon Kim1 Hyun-Ok Keum1 
Se-Mi Rho1 Van-Giap Nguyen1 Bong-Kyun Park1
1. Department of Veterinary Virology Lab, College of Veterinary Medicine and BK21 Program for Veterinary Science, 
Seoul National University, Seoul, Korea; 2. Research unit, Green Cross Veterinary Products, Yongin, Korea
 Introduction
Swine infl uenza is an acute respiratory disease caused by 
infl uenza A viruses . Infl uenza A viruses cause respiratory 
disease in humans. There are many sorts of assays to detect SIV.
Specially,The M gene is used commonly as PCR target for screen-
ing, as well as the NP whose sequences are highly conserved. 
The aim of this study was to report the prevalence of swine in-
fl uenza virus by targeting matrix gene which is highly conserved 
among Infl uenza A.
Materials and Methods
Virus isolation
 A total of samples, all tissues including lung were submitted 
from the swine farms in South Korea from July 2009 to January 
2010. About 20% suspension of lung tissue homogenate was 
prepared in PBS. Then, they were centrifuged at 3000rpm for 
10min., the supernatants were used for virus isolation and RNA 
extraction.
Viral RNA extraction
Viral RNA was extracted from virus suspension using Trizol 
LS .750ul of Trizol LS was mixed with 250ul of homogenized 
samples. 200ul of Chloroform was added and the suspension 
was centrifuged at12000rpm for 15min. The RNA-containing 
aqueous phase was 
precipitated with an equal volume (350ul) of isopropanol, main-
tained for 10min at room temperature, centrifuge at 12000rpm 
for 15min. The RNA pallet was washed by 75% ethanol, centri-
fuged at 12000rpm for 10min. Dried over 15min, resuspended 
by 30ul of DEPC-DW.
RT PCR
Table1. Primers sequences for m gene SIV RT-PCR. 
specifi city primer sequence 5’-3’
matrix gene MR ATGCTAAAGACAAGACCAA
MF TATAYCAGGCCCATCAA
The 2ul of template, 2ul of primer mix(1ul each),16ul of i-star 
master sol(intron). The 32cycles of denaturing at 94˚C for 5min, 
annealing at 53˚C for 30s and extension at 72˚C for 7min.
The PCR amplifi ed products were analyzed by 1% agarose gel 
electrophoresis.
Results
The sizes of amplifi ed products, determined by agarose gel 
electrophoresis were 280bp.Table2. Number of infl uenza virus 
isolates, 2009.7-2010.1
DATE NO.of RT-PCR positive samples
No. of RT-PCR positive samples/
 No. of samples(%)
09, July 5 5/49 (10%)
Aug 0 0/36 (0%)
Sep 16 16/63 (25%)
Oct 8 8/58 (13%)
Nov 15 15/51 (29%)
Dec 1 1/40 (2%)
10, Jan 1 1/31 (3%)
Of the 328 samples, 46 samples proved positive for matrix gene 
of infl uenza A virus. 
Discussion 
From July 2009 to January 2010, we collected tissue samples 
and placed them in PBS. In fi eld specimens selected at random 
from Korean farms, the infl uenza virus was detected in 46 of 
328 samples. As shown (table2), we could know the prevalence 
of Infl uenza A viruses. Infl uenza A was peaked from Septem-
ber to November which would be the change of seasons. The 
percentage of positive samples for Infl uenza A declined sharply 
for winter from November. The winter seanson would not be a 
multiplication period of Infl uenza A viruses. Acknowledgement
This study was supported by a grant (Code# 20070401034009) 
from the Biogreen 21 Program, Rural Development Administra-
tion, Korea.
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Swine inﬂ uenza virus detection and identiﬁ cation by the use of an integral diagnosis program
Pedro J. Pradal-Roa; Ivan Sánchez-Betancourt; Rolando Beltran-Figueroa; Maria E. Trujillo-Ortega; 
Roberto Martinez-Rodriguez; Marco A. Herradora-Lozano
Universidad Nacional Autónoma de México (UNAM), Facultad de Medicina Veterinaria y Zootecnia, 
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Introduction
Swine infl uenza virus (SIV) is an RNA virus that belongs to the 
Orthomixoviridae family. There are diff erent subtypes charac-
terized for their surface glycoprotein’s a hemagglutinin and a 
neuraminidase. The main viral subtypes aff ecting pigs are H1N1 
and H3N2 (2). The SIV is associated as a primary agent of the por-
cine respiratory complex and currently pigs have been identifi ed 
as intermediaries because in their respiratory tract they have 
epithelial cells of human and avian viruses. For this reason the 
diagnosis is important to understand the dynamics of infec-
tion by a serological profi le and by molecular diagnostic tools, 
identify specifi c viral RNA to implement prevention, control and 
treatment strategies.
Materials and Methods
A longitudinal study was carried out for the diagnosis of H1N1 
and H3N2 SIV subtypes. A total of 111 serum samples and nasal 
swabs were collected from pigs of 4, 8, 12, 16, 20, 24 weeks 
of age. Serologic diagnosis was made by Hemoagglutination 
inhibition (HI) test with a 1:80 cutting point, multiple RT-PCR 
technique (1) was applied for the molecular diagnosis from sera 
and nasal swabs. Titters from IH were transformed to a logarith-
mic base to apply statistical analysis using variance test between 
treatments (P<0.05). The mean diff erence was determined by 
Tukey test and Ji-square was used to evaluate the diff erences in 
the percentage of positive and negative animals per treatment.
Results
Serology showed 100% prevalence for the H1N1 subtype in 4 
week old pigs. In week 8 decreased to 73% for week 12 in-
creased to 94% and for weeks 16, 20 and 24 a 100% of samples 
were positive (Figures 1-2). For subtype H3N2 75% of seroposi-
tives were recorded in week 4, 36% for week 8 and 83% for week 
12 (Fig. 2). Signifi cant statistical diff erences (P<0.05) for the H1N1 
subtype were found between samples from week 8 and weeks 
4, 16 and 24; for subtype H3N2 signifi cant diff erences were found 
in week 8 when compared to 4, 16, 20 and 24 weeks, however, 
samples from week 8 did not showed diff erences with the 12 
week samples. RT-PCR identifi cation of viral nucleic acid for the 
H1N1 subtype was 1.8% from serum and 6.3% in nasal swabs, for 
the H3N2 subtype 5.4% was identifi ed in nasal swabs where sta-
tistical diff erences were signifi cant (P<0.05). All serum samples 
were negative for subtype H3N2.
Discussion
The co-existence of diagnostic techniques allows us identifying 
with a high sensitivity and a very timely manner any subtype of 
SIV present in a sample. Through the integration of diagnosis we 
are able to establish the dynamics of viral infection within the 
farm and allows us to identify the group of animals that carry 
the virus (PCR), as well as those animals that have already been 
aff ected by the virus and that are negative to PCR, but have 
antibodies (HI); both panoramas show us the dynamics of infec-
tion associated with the clinical signs, allowing us to understand 
the process of the disease in the herd. With this information you 
can intervene promptly to control and prevent the infection 
process.s
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Inﬂ uence of various adjuvants on antibody avidity and relative ratios of IgG2 to 
IgG1 (Th1 to Th2) in pigs after booster immunizations with SIV vaccines
Boh C. Lin; Karen K. Brown; Jack D. McGonigle; Leann M. Siedlik
MVP Laboratories, Inc., Omaha, NE, USA
Introduction
Since no single adjuvant is universally applicable for all antigens, 
it is critical to include diff erent types of adjuvant systems in an 
experimental vaccine for evaluation. In this study, an inactivated 
commercial swine infl uenza A (SIV) vaccine was used to evalu-
ate the infl uence of fi ve adjuvant systems on antibody avidity 
and the relative ratios of IgG2 to IgG1 (Th1 to Th2) in young pigs 
after booster immunizations. 
Materials and Methods
 Thirty six 21 day old pigs were assigned to six groups. Experi-
mental vaccines were prepared by mixing the manufacturer’s 
recommended amount of SIV antigens with one of fi ve adju-
vants supplied by MVP Laboratories, Inc. Pigs of group 1 through 
group 5 were given vaccines containing 20% Emulsigen®-D, 
12% Emulsigen®/4% Rehydragel, 20% Emulsigen®-BCL, 20% 
Polygen™, and an adjuvant supplied by the manufacturer of the 
commercial SIV vaccine respectively. Pigs of group 6 were given 
PBS only. On day 0, all of the vaccinated pigs were given a 2 ml 
dose intramuscularly. On day 21, all pigs were given a second 
dose. All pigs were bled on day 0, day 21, and day 42. The hem-
agglutination inhibition (HI) test was conducted by the Veterin-
ary Diagnostic Laboratory at Iowa State Univesity. The antibody 
avidity of each pig serum was measured using a thiocyanate 
elution ELISA as described (1). IgG1 and IgG2 were determined 
in pig sera by ELISA as described (2). 
Results and Discussion
Infl uence of adjuvant on relative ratios of IgG2 to IgG1 in pigs: 
Polygen™ induced the highest H1N1-specifi c and H3N2-specifi c 
IgG2 response (Table 1). This signals a Th1 response that leads 
to cell-mediated immunity. Furesz, et al, demonstrated that a 
high anti-hemolysin IgG2:IgG1 ratio correlated with hemolysin 
neutralization antibody titers and reduced lung lesion scores in 
A. pleuropneumoniae infected pigs (3). Emulsigen®-D and Emul-
sigen®/Rehydragel induced the highest levels of H1N1-specifi c 
and H3N2-specifi c IgG1. This indicates a Th2 response that leads 
to humoral immunity which is of importance in SIV infections.
Infl uence of adjuvant on antibody avidity: There is a signifi cant 
diff erence between the SIV-specifi c antibody avidity indices 
(GMAI) of the fi ve adjuvant groups with Emulsigen®-D produ-
cing the highest results (Table 2). It has been reported that 
higher serum avidity indices indicate more eff ective bactericidal 
activity of the microphages (2). This study indicates that the 
measurement of ratios of IgG2 to IgG1 and GMAI are useful as 
supplementary methods for predicting the properties of each 
test adjuvant in terms of their tendency to direct cellular (Th1) or 
humoral (Th2) immune response and antibody functional activ-
ity. These fi ndings suggest that Th1 or Th2 responses in pigs are 
determined by both the adjuvant and its co-injected antigen. 
Table 1. Adjuvant eff ects on relative ratios of H1N1-specifi c IgG2 to 
IgG1 and H3N2-specifi c IgG2 to IgG1.
Vaccine adju-
vant
H1N1-specifi c H3N2-specifi c
 IgG2:IgG1 
ratio HI titer
Response 
profi le
IgG2:IgG1 
ratio HI titer
Response 
profi le
Emulsigen®-D  0.81 1973 Th2 0.74 2133 Th2
Emulsigen®/
Rehydragel 0.73 347 Th2 0.81 200 Th2
Emulsigen®-BCL 1.09 987 Th1 0.92 480 Th2
Polygen™ 1.24 147 Th1 1.05 67 Th1
Control adjuvant* 1.00 427 Th1 0.81 280 Th2
* Control adjuvant was obtained from the commercial vaccine used in this study.
Table 2. Adjuvant eff ects on the geometric mean avidity indices 
(GMAI) of anti-SIV IgG antibodies in pigs after booster immunization.
Adjuvant GMAI (Range)
Statistical diff erence 
between Adjuvant (p 
value)
1. Emulsigen®-D 1.360 (1.200-1.400)
2. Emulsigen®/Rehydragel 1.100 (0.900-1.400) p=0.0101 (1 vs 2)*
3. Emulsigen®-BCL 0.970 (0.400-1.400) p=0.0331 (1 vs 3)*
4. Polygen™ 0.800 (0.600-1.000) p=0.0001 (1 vs 4)*
5. Control adjuvant 1.000 (0.900-1.100) p=0.0101 (1 vs 5)*
*Statistically signifi cant diff erence at p<0.05.
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Eﬃ  cient protection against heterologous H1N2 infection using a trivalent swine ﬂ u vaccine
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Introduction 
In the course of several reassortment events the novel swine 
infl uenza A virus subtype H1N2 emerged in Europe in the 1990s 
(1). Its lacking cross-reactivity to H1N1+H3N2 vaccines required 
the development of a new trivalent swine fl u vaccine (2).• 
Materials and Methods
Three strains of subtypes H1N1, H3N2, and H1N2 were se-
lected as vaccine strains. Viruses were grown in cell culture and 
inactivated. A substance from the carboxyvinylpolymers group 
was used as an adjuvant. Experimental batches were blended 
and investigated in laboratory and clinical trials. A major focus 
of investigation was the proof of effi  cacy against heterologous 
H1N2 fi eld strains in experimental infection trials. Five challenge 
experiments were conducted on a total of 158 pigs. Three re-
cently isolated fi eld isolates of subtype H1N2 were used for the 
experiments. The strains were sequenced and analysed phylo-
genetically. Pigs were vaccinated twice. For proof of effi  cacy an 
aerosol method was used in which high doses of fi eld viruses are 
sprayed by a generator. For comparison an additional intratrach-
eal infection was done in one trial.
Results 
Vaccinated pigs displayed neutralizing and hemagglutination 
inhibiting antibodies as early as 7 days after the second vaccina-
tion. 
Vaccinated animals had almost no clinical symptoms after infec-
tion, whereas unvaccinated animals exhibited fever, dyspnoea 
and sleepiness. The viral load in the lungs was signifi cantly lower 
in vaccinated pigs compared to unvaccinated animals. Lung 
lesions typical for infl uenza were observed in the apical parts of 
medial and cranial lung lobes of the control animals, whereas 
vaccinated pigs showed no lesions. Moreover, histological 
investigations revealed a higher degree of infl ammation in the 
unvaccinated pigs.Fig. 1: Viral lung load in egg infectious dose 
50 (EID50), clinical score and rectal temperatures of vaccinated 
and unvaccinated pigs after experimental infection with H1N2 
virus; Statistics: Mann-Whithney U test (p = statistical probability, 
≤ 0.05 signifi cant, ≤ 0.01 highly signifi cant, ≤ 0.001 very highly 
signifi cant); Clinical score: 1, enhanced abdominal breathing, 2, 
strong abdominal breathing, 3, severe breathing covering the 
whole body; Vaccinated, vaccinated pigs (2x 2.0 ml i.m ); Control, 
unvaccinated pigs (n=15 pigs in each group)
a) aerosol infection with strain Kitzen/IDT6142/07 (H1N2), arithmetic 
mean
Vaccinated Control Statistics, p
EID50/g, day 1 3388 38538 0.003
Clinical score, day 1 0.07 2.47 0.000
Temperature, °C, day 1 39.65 41.07 0.000
EID50/g, day 3 471 38857 0.003
Clinical score, day 3 0 0.93 0.004
Temperature, °C, day 3 39.67 40.56 0.004
b) intratracheal infection with strain Kitzen/IDT6142/07 (H1N2), arith-
metic mean
Vaccinated Control Statistics, p
EID50/g, day 1 525 12600 0.021
Clinical score, day 1 0.4 1.53 0.016
Temperature, °C, day 1 39.93 40.15 0.436
EID50/g, day 3 5 38857 0.001
Clinical score, day 3 0.29 1.71 0.007
Temperature, °C, day 3 39.7 40.19 0.026
Discussion 
Vaccinated pigs were protected against all three H1N2 fi eld 
strains used in a number of experimental infection trials. The 
very high effi  cacy of the vaccine against diff erent strains of Euro-
pean H1N2 viruses has been demonstrated.
References 
1  Brown IH, Harris PA, McCauley JW, Alexander DJ (1998) Multiple 
genetic reassortment of avian and human infl uenza A viruses in 
European pigs, resulting in the emergence of an H1N2 virus of novel 
genotype. J. Gen. Virol. 79: 2947-2955
2  Van Reeth K, Van Gucht S, Pensaert M (2003) Investigations of the ef-
fi cacy of European H1N1- and H3N2-based swine infl uenza vaccines 
against the novel H1N2 subtype. Vet. Rec. 153: 9-13
Respiratory diseases – Swine infl uenza
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 573
Poster Presentations
P.267
Field safety of the administration of a new swine inﬂ uenza virus vaccine 
Respiporc® Flu3/Gripovac® 3 in pregnant sows and gilts
Michael Schlegel2 Ralf Dürrwald2 Lothar Kreienbrock3 Thaïs Vila1 Hans-Joachim Selbitz2
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Introduction
The objective of these studies was to confi rm the safety of a new 
swine infl uenza vaccine including the 3 swine infl uenza A virus 
subtypes, H1N1, H3N2 and H1N2: RESPIPORC®FLU3/GRIPOVAC®3 
administered during gestation to sows and gilts in the fi eld.
Material and Methods
A total of 107 sows and gilts from several farrow-to-fi nish con-
ventional farms were used at diff erent stages of pregnancy. 
Experimental design
Sows T1 Sows T2 Sows T3 Gilts
Total sows in farm 206 530 200 530
Vaccinated sows n=12 n=14 n=12 n=17
Control sows n=12 n=16 n=11 n=13
Vaccination schedule
Group 1st inj./period in the repro. cycle 2nd injection
T1 sows D0=Gestation 1st to 38th day D21
T2 sows D0=Gestation 39th to 78th day D21
T3 sows D0=Gestation 76th to 114 day D21
Gilts D0 = 5 weeks before insemination 2nd inj. D21; 3rd inj. D133
Safety criteria were rectal body temperature, local reactions 
i.e. skin colour, swelling, abscess, and systemic reactions i.e. 
behaviour, respiration, digestion, skin, coughing, others. Clinical 
status was monitored every day throughout the study. Clinical 
observation: T1, T2 and T3 sow temperature was measured on 
D0, D0+4h, D1, D2, D21, D21+4h, D22 and D23. In gilts it was 
measured on D0, D0+4h, D1, D2, D21, D21+4h, D22, D23, D133, 
D133+4h, D134 and D135.
The local reactions have been monitored at the same time 
points and on D106 in T1 sows, on D100 in T2 sows, on D64 in T3 
sows and on D177 in gilts, i.e. the last day of the study in each 
case. Statistical analyses: A Student T test was used to compare 
the absence of diff erence between temperatures. The level of 
signifi cance was 5%.
Results
Neither relevant local nor systemic reactions were noticed. The 
temperature was signifi cantly non-diff erent both in vaccinated 
and control groups.
Figure 1: Temperature in sows
Figure 2: Temperature in gilts
Conclusion
The use of RESPIPORC FLU3/GRIPOVAC 3 is perfectly safe in 
pregnant sows and gilts, any time during gestation.
® RESPIPORC is a registered trademark of IDT. ® GRIPOVAC is a 
registered trademark of MERIAL S.A.S.
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Duration of clinical protection after vaccination with Respiporc® Flu3/Gripovac® 3
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Introduction
This paper summarizes several studies aiming at showing the 
duration of clinical protection after vaccination of piglets with 
a new swine infl uenza vaccine (RESPIPORC FLU3/GRIPOVAC 3) 
including the FLUAVsw subtypes H1N1, H3N2 and H1N2.
Material and Methods
Before vaccination, piglets were free of antibodies against H1N1, 
H1N2 and H3N2. The studies were blinded, placebo controlled 
and randomised. Challenge at more than 4 months after basic 
immunisation was done by aerosol nebulisation with heterolo-
gous strains from Central Europe isolated from pigs aff ected 
with severe respiratory illness as described in table 1.
Table 1: Study parameters
Subtype H1N1 H1N2 H3N2
No of pigs 26 30 30
Vaccinated 13 15 15
Control 13 15 15
Aerosol challenge 10
6.5 TCID50/ml 148 days 
after 2nd vaccination
106.75 TCID50/ml 126 
days after 2nd vac-
cination
107.5 TCID50/ml 126 days 
after 2nd vaccination
Vaccination schedule: vaccination after 56 days of age 2 ml, 
twice 3 weeks apart. Control piglets were injected with NaCl 
0.9%.Criteria of data collection: Temperature was measured 
twice a day. Dyspnoea was scored from 1 to 3: 1= enhanced 
abdominal breathing; 2= severe abdominal breathing; 3= strong 
breathing covering the whole body. 
Results
After challenge 4 months after vaccination, fl u-associated 
clinical signs as high temperature or dyspnoea were signifi cantly 
lower in vaccinated piglets than in control piglets (Figure 1 and 
table 2). 
Figure 1: Temperatures recorded after challenge for the 3 FLUAVsw 
subtypes: A)H1N1, B)H1N2, C)H3N2
Table 2: Dyspnoea scores after challenges H1N1, H1N2, H3N2
Challenge H1N1 24h 28h 45h 73h -
RESPIPORC FLU3 / 
GRIPOVAC 3 0.29 0.13 0 0 -
Control 1.46 1.75 1.08 0.5 -
p 0.002 0.002 0.065 0.394 -
Challenge H1N2 24h 27h 48h 53h 71h
RESPIPORC FLU3 / 
GRIPOVAC 3 0.48 0.36 0 0.07 0
Control 1.15 1.36 0.82 0.29 0
p 0.002 0.017 0.001 0.165 1.000
Challenge H3N2 24h 27h 48h 53h 72h
RESPIPORC FLU3 / 
GRIPOVAC 3 0.4 0.14 0.29 0.18 0.21
Control 2.33 2.64 2 1.64 1.5
p <0.001 0.001 0.004 0.017 0.017
Conclusion
Piglets vaccinated with RESPIPORC FLU3/ GRIPOVAC 3 after 8 
weeks of age were well clinically protected against H1N1, H1N2 
and H3N2 subtype challenges up to 4 months after the 2nd 
injection of the vaccination.
® RESPIPORC is a registered trademark of IDT. GRIPOVAC is a 
registered trademark of MERIAL S.A.S.
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Eﬀ ect of ibuprofen, aspirin or saline water medications on pigs challenged with swine inﬂ uenza virus (SIV)
Peggy Anne Hawkins1 Nathan Winkelman2 Michael Strobel1 Enrique Mondaca1
1. Veterinary Provisions, Inc., Northfi eld, MN, USA; 2. Swine Services Unlimited Inc., Rice, MN, USA
Introduction
Swine infl uenza virus (SIV) commonly infects growing pigs. 
Antibiotics are of no use against viral infections. However, anti-
infl ammatory products such as ibuprofen and aspirin are often 
proportioned to pigs through the water. The objective of this 
study was to evaluate the anti-infl ammatory action of ibupro-
fen (IB) or aspirin (SS) (sodium salicylate) or saline (SA) in pigs 
challenged with SIV. The ibuprofen signifi cantly reduced fever as 
compared to aspirin or saline. Additionally, the use of ibuprofen 
during a fi eld SIV outbreak that reduced death loss and signs of 
disease is covered in the discussion.
Materials and Methods
Sixty-three SIV-negative, M. hyopneumoniae- negative and 
PRRSV negative crossbred pigs were randomly assigned to 3 
treatments blocked by gender and weight and placed in 9 pens 
at 7 pigs per pen. Pens were randomized into treatments. Pigs 
were acclimated for 1 week and then challenged with SIV (H1N1 
sub-type, Asw Iowa 239:2004) provided by U of Minnesota. 
Treatments were dosed according to label directions. IB 16oz 
(473ml) per gallon stock solution (~6mg/lb). SS 8oz (236ml) 
per gallon stock solution (4mg/lb). SA 12oz (354ml) per gallon 
stock solution. Stock solution should then be metered at 1:128. 
Twenty-four (24) hours after inoculation, treatments were added 
to the water and remained in the water for 5 complete days. 
Individual measures of clinical observations, weight, rectal tem-
perature, nasal swabs, blood samples and lung lesions scores 
were recorded. Water and feed intakes were measure by pen (1).
Results
The SIV challenge was successful. On day three, 61 of 63 pigs 
had virus by nasal swab PCR or virus isolation. Virus was not de-
tected in 2 SA pigs. For this study, 103.5°F or less was considered 
normal rectal temperature. Across treatments, pigs started 
with a low- normal rectal temperature at inoculation (103.1°F). 
24-hours later all treatments spiked a fever (104.9°F). One day 
after treatment began the pigs in the IB group had a signifi cantly 
lower rectal temperature averaging 103.2°F compared to the SS 
(103.6°F) or SA (103.7°F) groups. On the 5th day of the study, the 
SS group spiked a fever. The cause was unknown (Fig. 1). **im-
age1** There were no diff erences between treatments in clinical 
observations, feed intake, water intake or weight gain. The IB 
group did have higher lung lesion scores on treatment day 10 
as compared to SA or SS. Wilcoxon rank sum test was used for 
analysis. A P value of <0.05 was considered signifi cant.
Discussion
Sodium salicylate (SS) was chosen over acetylsalicylic acid (ASA) 
as a result of work done by Patterson et al. showing that meas-
ureable plasma concentrations of SS and not ASA were found 
when administered at 4.5mg/lb body weight (2). In this study 
treatments were added 24 hours after inoculation to simulate 
a fi eld outbreak in which a producer would notice that pigs are 
sick and then would start treatment the next day. As a result of 
having the IB in the water, rectal temperatures were reduced to 
normal levels. Saline control and aspirin did not aff ect the rectal 
temperature. The number of pigs in this study limited the ability 
to see other signifi cant diff erences. In a related fi eld case, a 1000 
head barn lost 17 pigs in an outbreak of SIV. The herd veterinar-
ian put IB in the water for 5 days in 3 subsequent 1000 head 
barns and lost only 2 pigs to SIV. The cost of treatment with IB 
was about $0.75 per pig. Diagnosing SIV quickly is key to get-
ting IB in the water fast enough to stop/reduce death loss and 
morbidity.
 References
1.  Winkelman N, Hawkins PA, Strobel M, Mondaca E, Eff ect of ibupro-
fen water medication on pigs challenged with SIV, and a fi eld case 
study, AASV Proceedings, Omaha, NE. 2010 (in press) 
2.  Patterson AR, Karriker LA, Apley MD, Imerman PM, Plasma concen-
trations of sodium salicylate in nursery pigs treated orally, JSHAP. 
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Duration of clinical protection after vaccination of pigs at more than 
96 days of age with Respiporc® Flu3/Gripovac® 3 
Michael Schlegel1 Hans-Joachim Selbitz1 Thaïs Vila2 Ralf Dürrwald1
1. IDT Biologika GmbH, Dessau-Rosslau, Germany; 2. Merial S.A.S., Lyon, France
Introduction
This paper summarizes 3 vaccination studies aiming at showing 
the duration of clinical protection of RESPIPORC FLU3/GRIPOVAC 
3 vaccination in pigs vaccinated from 96 days of age against the 
3 swine infl uenza virus (FLUAVsw) subtypes: H1N1, H3N2 and 
H1N2.
Material and Methods
Piglets were obtained from farms free of infections with infl u-
enza viruses. The study was blinded, placebo controlled and 
randomised. A challenge was performed at more than 6 months 
after basic immunisation by aerosol nebulisation with heter-
ologous strains from Central Europe isolated from pigs aff ected 
with severe respiratory illness as described in table 1.
Table 1: Study parameters
Subtype H1N1 H1N2 H3N2
No of pigs 40 40 40
Vaccinated 20 20 20
Control 20 20 20
Aerosol chal-
lenge
106.25 TCID50/ml 
211 days after 
vacc.
106.5 TCID50/ml 
211 days after 
vacc.
108.75 TCID50/ml 
209 days after 
vacc.
Vaccination schedule: pigs were vaccinated from 96 days of age 
(including gilts) 2 ml, twice 3 weeks apart. Control pigs were 
injected with NaCl 0.9%.
Criteria of data collection: Temperature was measured twice a 
day. Dyspnoea was scored from 1 to 3: 1= enhanced abdominal 
breathing; 2= severe abdominal breathing; 3= strong breathing 
covering the whole body. 
Results and Discussion
Temperatures were found signifi cantly lower at several time 
points during the observation period in pigs vaccinated at 
more than 96 days of age and challenged with H1N2 and H3N2 
subtypes 6 months after vaccination compared to control pigs 
(fi gure 1).Regarding respiratory signs evaluated by dyspnoea 
scoring, pigs vaccinated with RESPIPORC FLU3/GRIPOVAC 3 were 
clinically protected. 
Figure 1: T° after challenge A)H1N1, B)H1N2, C)H3N2 in pigs vaccin-
ated at more than 96 days of age
Table 2: Dyspnoea scores
Challenge H1N1 24h 30h 48h 54h 70h
RESPIPORC FLU3/GRIPOVAC 3 0.88 0.5 0 0.1 0
Control 1.67 0.81 0.19 0.31 0
p 0.005 0.360 0.408 0.460 1.000
Challenge H1N2 24h 30h 48h 54h 70h
RESPIPORC FLU3/GRIPOVAC 3 1.35 1.1 0.2 0.2 0
Control 1.86 1.5 1.22 0.5 0.28
p 0.228 0.356 0.002 0.243 0.243
Challenge H3N2 24h 30h 49h 54h 72h
RESPIPORC FLU3/GRIPOVAC 3 0.47 0 0.22 0.06 0
Control 2.08 1.78 1.39 1.22 0.56
p 0.002 <0.001 <0.001 0.001 0.113
Conclusion
Pigs vaccinated with RESPIPORC FLU3/GRIPOVAC 3 from 96 days 
of age were protected against the 3 FLUAVsw subtypes H1N1, 
H3N2 and H1N2 up to 6 months after the 2nd vaccination.
® RESPIPORC is a registered trademark of IDT. GRIPOVAC is a 
registered trademark of MERIAL S.A.S.
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Development of a trivalent swine ﬂ u vaccine based on a safe adjuvant
Ralf Dürrwald1 Michael Schlegel1 Hans-Joachim Selbitz1 Andi Krumbholz2 Roland Zell2
1. IDT Biologika GmbH, Dessau-Roßlau, Germany; 2. Universitätsklinikum Jena, Institut für Virologie und Antivirale Therapie, Jena, Germany
Introduction
The introduction via reassortment of a human H1 hemagglu-
tinin into the European swine infl uenza A virus population that 
lacks cross-reactivity to avian and classical porcine H1N1 viruses 
has remarkably changed the otherwise epidemiologically very 
stable situation of swine fl u (1, 2). This stimulated the develop-
ment of a new trivalent swine fl u vaccine that provides protec-
tion against all three subtypes, including the new subtype H1N2, 
and improves safety through the use of a non-pyrogenic and 
non-virucidal adjuvant.
 Materials and Methods
A surveillance program for swine infl uenza in Germany was 
initiated which gave an overview on the epidemiological situa-
tion and led to the isolation of numerous viruses of all three 
subtypes. Three virus strains of subtypes H1N1, H3N2, and H1N2 
originally isolated in regions with dense swine populations were 
chosen as vaccine strains. A very effi  cient cell culture production 
procedure was developed. Viruses were produced and inactivat-
ed by ethylenimine. Experimental and production batches were 
blended. A substance from the carboxyvinylpolymers group 
was used as an adjuvant. Dose titration studies and safety and 
effi  cacy investigations were performed. The vaccination scheme 
comprises a twofold administration of 2.0 ml of the vaccine 
21 days apart intramuscularly. An aerosol-mediated challenge 
procedure was applied to investigate effi  cacy of the vaccine. A 
batch potency test was established which measures the geo-
metric mean of neutralizing antibodies in guinea pigs. Clinical 
trials were carried out.
Results
It was shown by phylogenetic analysis of the hemagglutinin and 
neuraminidase genes of the vaccine strains that all three strains 
fi t well with currently circulating swine fl u viruses throughout 
Europe. The production in cell culture provides virus harvests 
with titers up to 10 8.5 TCID50/ml within a short time. The viruses 
are inactivated rapidly by ethylenimine without infl uencing the 
content of antigen. The range of the immunostimulating activity 
of the adjuvant was shown to be very broad and the fi nal adju-
vant blending was chosen midway through. The optimal antigen 
content was determined in dose titration experiments. None of 
the vaccinated animals had elevated body temperatures after 
administration of the vaccine, not even in the critical phase of 
the fi rst 24 hours after vaccination in which mineral-oil adju-
vanted vaccines cause severe fever reactions up to 42 °C. Vaccin-
ated pigs display neutralizing and hemagglutination inhibiting 
antibodies as soon as 7 days after the second vaccination which 
is the onset of immunity. For proof of effi  cacy an aerosol method 
was developed in which fi eld viruses are sprayed by a generator. 
Vaccinated animals had no clinical symptoms or only slight ones 
after infection, whereas unvaccinated animals exhibited fever, 
dyspnoea and sleepiness, accompanied by varying degrees 
of loss of appetite. The viral load in the lungs was signifi cantly 
lower in vaccinated pigs compared to unvaccinated animals. 
The duration of immunity is age-dependent and lasts up to 6 
months in older pigs after two vaccination shots. A third vaccina-
tion stabilizes the immune response and prolongs immunity. 
The batch potency was determined. The vaccine induces at least 
10.22, 10.53 and 12.34 GMNU (Geometric Mean of Neutralizing 
Units log2) in guinea pigs against the H1N1, H3N2, and H1N2 
strains respectively.
 Discussion
A new trivalent swine fl u vaccine has been developed in re-
sponse to recent epidemiological events in the European swine 
infl uenza A virus population and an increased sensitivity of pigs 
to vaccinations. The high safety of the vaccine and its very high 
effi  cacy against each of the three subtypes currently circulat-
ing in swine has been demonstrated in a number of safety and 
infection trials. The vaccine went through a central registration 
procedure and was approved in 2010.
References
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genetic reassortment of avian and human infl uenza A viruses in 
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Serological response to Respiporc® Flu3/Gripovac® 3 in pregnant 
sows against H1N1, H1N2 and H3N2 inﬂ uenza viruses
Ralf Dürrwald1 Michael Schlegel1 Lothar Kreienbrock2 Thaïs Vila3 Hans-Joachim Selbitz1
1. IDT Biologika GmbH, Dessau-Rosslau, Germany; 2. Tierärztliche Hochschule Hannover, Hannover, Germany; 3. Merial S.A.S., Lyon, France
Introduction
The prevalence of swine infl uenza viruses may be high with 60% 
of farms aff ected (1). Previous studies showed an increase in the 
prevalence of the H1N2 subtype (2). 
The objective of these studies was to show the serological 
responses in pregnant sows after vaccination of sows with a new 
swine fl u vaccine, RESPIPORC FLU3/GRIPOVAC 3 including the 3 
subtypes, H1N1, H3N2 and H1N2.
Material and Methods
For this blinded controlled trial, 77 swine fl u-antibody-free or 
with very low antibody titres sows from several farrow-to-fi nish 
conventional farms were used at diff erent stages of pregnancy 
(Table 1). 
Sows were kept in the farm of origin.
Table 1: Experimental design
Sows T1 Sows T2 Sows T3
Total sows in farm 206 530 200
Vaccinated sows 12 14 12
Control sows 12 16 11
T1=1st third of pregnancy. T1=2nd third of pregnancy. T3=3rd 
third of pregnancy.Antibodies were titrated using a HI test 
(Haemagglutination Inhibition) on blood samples involving 
homologous vaccine strains.
Table 2: Vaccination schedule and lab investigations
T1: study day D0 D21 D28 D78 D106
Vaccination X X
Blood sampling X X X
T2: study day D0 D21 D28 D72 D100
Vaccination X X
Blood sampling X X X
T2: study day D0 D21 D28 D35 D64
Vaccination X X
Blood sampling X X X
T1: D0=from day 1 to day 38 of pregnancy
T2: D0=from day 39 to day 78 of pregnancy
T3: D0=from day 76 to day 114 of pregnancyStatistical analyses: Fisher’s exact test was used to 
compare the titres. Signifi cance: p<0.01.
Results
Mean antibody titres after vaccination versus control are shown 
in Figure 1: in the 1st third, only H1N2 titres are signifi cantly 
diff erent. They are all signifi cantly diff erent in the 2nd third. And 
both H1N2 and H3N2 titres are signifi cantly diff erent in the 3rd 
third.
Figure 1 a,b,c: Mean HI antibody titres against the diff erent subtypes 
at diff erent pregnancy stages in sows 
No diff erence was noticed between vaccinated and control sows 
in all groups for performance parameters such as:
•  Live born piglets
•  Still born piglets
•  Weaned piglets
•  Suckling piglets loss
Conclusion
These studies show this vaccine ability to induce a signifi cant 
seroconversion in pregnant sows against the subtypes H1N1, 
H3N2 and H1N2 of swine infl uenza A virus.
References
1.  Madec et al., (2004) Journées de la Recherche Porcine, 36, 353-358.
2.  Van Reeth K et al., (2003) Infl uenza and other Respiratory Viruses 
DOI: 10.1111/j.1750-2659.2008.0043.® RESPIPORC is a registered 
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S.A.S.
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Safety of the administration of a new swine inﬂ uenza vaccine: 
Respiporc® Flu3/Gripovac® 3 in sows during lactation
Olaf Lüder1 Guntram Hagemann1 Michael Schlegel1 Hans-Joachim Selbitz1 Lothar Kreienbrock2 Thaïs Vila3 Ralf Dürrwald1
1. IDT Biologika GmbH, Dessau-Rosslau, Germany; 2. Tierärztliche Hochschule Hannover, Hannover, Germany; 3. Merial S.A.S., Lyon, France
Introduction
The objective of this study was to evidence the safety of the vac-
cination with a new swine infl uenza vaccine RESPIPORC® FLU3/
GRIPOVAC® 3 including H1N1, H3N2 and H1N2 in sows during 
the lactation.
Material and Methods
Sows: a total of 13 conventional lactating sows, 7 vaccinated and 
6 control, were used in this trial.
Vaccination schedule: the 7 vaccinated sows were injected with 
a double dose of RESPIPORC FLU3/GRIPOVAC 3 just after farrow-
ing (D0) and a single dose of vaccine 3 weeks after. The 6 control 
sows were injected with NaCl 0.9% at the same time of the vac-
cinated sows.
Temperature monitoring: in vaccinated and control sows the 
temperature was measured on D0, D2, D4, D14, D18, D20, D21, 
D22 and D23. In gilts it was measured on D0, D0+4h, D1, D2, 
D21+2h, D21+8h, D22, D24 and D28.
Clinical observation: adverse clinical signs were monitored every 
day throughout the study until Day 35. Safety criteria were 
lactation performance (the day of farrowing (D0) and the day 
of weaning (D35): number and weight of weaned piglets) rectal 
body temperature, food consumption, local reactions, i.e. skin 
colour, swelling, abscess, and systemic reactions i.e. behaviour, 
respiration, digestion, skin, coughing, and other possible signs.
Statistical analyses: permutation tests (for non-parametric Behr-
ens Fisher problem) for equality were used in the study.
Results
Temperatures in vaccinated sows were not signifi cantly diff erent 
from temperature in control groups (Figure 1). No statistical dif-
ference was found between the 2 groups compared regarding 
neither reproductive parameters (Table 1) nor in the perform-
ance of their litter (Figure 2).
Neither local reactions nor systemic reactions were noticed at 
any time during the observation period.
Figure 1: temperature curves of vaccinated sows versus control
Table 1: lactation performance in control and vaccinated sows
Group RESPIPORC FLU3/GRIPOVAC 3 Control
Viable piglets per sow at farrowing 11.3 11.8
Weaned piglets per sow D35 10.7 11.0
Losses per sow at weaning 0.6 0.8
Figure 2: weight gains of piglets born from vaccinated and control 
sows
Conclusion
The administration of RESPIPORC FLU3/GRIPOVAC 3 in sows is 
safe during lactation.® RESPIPORC is a registered trademark of 
IDT.
 ® GRIPOVAC is a registered trademark of MERIAL S.A.S.
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Cross-protection of Respiporc® Flu3/Gripovac® 3 against swine ﬂ u: 
challenge trials with two recent European H1N1 strains
Ralf Dürrwald1 Michael Schlegel1 Hans-Joachim Selbitz1 Thaïs Vila2
1. IDT Biologika GmbH, Dessau-Rosslau, Germany; 2. Merial S.A.S., Lyon, France
Introduction
Swine infl uenza viruses of three diff erent subtypes, H1N1, H3N2 
and H1N2 are now co-circulating in European countries (1). The 
commercial vaccine based on H1N1 and H3N2 strains doesn’t 
protect against H1N2 infection (2). A new swine infl uenza 
vaccine RESPIPORC® FLU3/ GRIPOVAC 3 adapted to European 
epidemiology contains H1N1, H3N2 and H1N2 recently isolated 
strains. The objective of this study was to evidence the cross-
protection of this vaccine against recent H1N1 strains isolated in 
France.
Material and Methods
H1N1 strains from two diff erent genotypes of swine infl uenza 
viruses isolated in Brittany (France) were used in this study: A/
sw/Cotes d’Armor/0190/06 (reassortant H1N1=RA) and A/sw/
Morbihan/0070/05 (avian-like H1N1=AL) (3). The antigenic char-
acter of these strains was investigated by cross-neutralisation 
with specifi c hyper immune sera of pigs (Kuntz-Simon et al., in 
preparation). They were kindly provided by G. Kuntz-Simon, 
AFSSA-LERAPP, F-Ploufragan. Pig vaccination: All 49 experi-
mental pigs were seronegative against H1N1, H1N2 and H3N2 
prior to vaccination. Half of the pigs (N=24) were vaccinated 
with 2ml RESPIPORC FLU3/GRIPOVAC 3, IM twice, 3 weeks apart. 
The other half was injected with a placebo.Challenge: One week 
after 2nd administration of 2.0 ml of the vaccine, an aerosol 
challenge validated in previous studies was conducted.Viral load 
in lung tissue homogenates was quantifi ed by egg culture and 
expressed in number of egg infection dose 50% (EID50).
Results and Discussion
The challenge strain RA did not induce clinical signs of the dis-
ease (neither dyspnoea nor fever). Vaccinated pigs had signifi -
cantly lower viral lung load than not vaccinated pigs both 1 and 
3 days after challenge.
Figure 1: Mean viral load (EID50 in 10 mg lung tissue) after aerosol 
challenge with strain RA
Day 1: p=0.026; Day 3: p=0.021The challenge strain AL did 
induce only mild clinical signs of disease (mild dyspnoea but no 
fever), consequently no diff erence was observed between treat-
ment groups. 
Vaccinated pigs had a highly signifi cantly lower viral lung load 
than not vaccinated pigs (no virus in the lungs of the vaccinated 
pigs) both 1 and 3 days after challenge.
Figure 2: Mean viral load (EID50 in 10 mg lung tissue) after aerosol 
challenge with strain AL
Day 1 and Day 3: p=0.008
Conclusion
These experiments with heterologous swine infl uenza viruses 
challenge clearly show the cross-protection of the vaccine 
strains of RESPIPORC FLU3/ GRIPOVAC 3 with recent H1N1 Swine 
Infl uenza A fi eld strains from Europe.
References
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Cross-protection of Respiporc® Flu3/Gripovac® 33 against swine ﬂ u: 
challenge trials with two recent European H1N2 strains
Ralf Dürrwald1 Michael Schlegel1 Hans-Joachim Selbitz1 Thaïs Vila2
1. IDT Biologika GmbH, Dessau-Rosslau, Germany; 2. Merial S.A.S., Lyon, France
Introduction
Swine infl uenza viruses of three diff erent subtypes, H1N1, H3N2 
and H1N2 are now co-circulating in European countries (1). The 
commercial vaccine based on H1N1 and H3N2 strains doesn’t 
protect against H1N2 infection (2). A new swine infl uenza 
vaccine RESPIPORC® FLU3/ GRIPOVAC® 3 adapted to European 
epidemiology contains H1N1, H3N2 and H1N2 recently isolated 
strains. 
The objective of this study was to evidence the cross-protection 
of the vaccine against two H1N2 French strains.
Material and Methods
Two strains of the H1N2 subtype isolated in Brittany were 
used in this study: A/sw/Cotes d’Armor/0214/06 (genotype 
1 H1N2=G1) & A/sw/Cotes d’Armor/0113/06 (genotype 2 
H1N2=G2) (3). These strains are heterologous from the vac-
cine strain and belong antigenetically to the human-like H1N2 
subtype as confi rmed by cross-neutralisation (Kuntz-Simon et al., 
in preparation). They were kindly provided by G. Kuntz-Simon, 
AFSSA-LERAPP, F-Ploufragan.Vaccination and challenge G1: All 
pigs (N=28) were seronegative against H1N1, H1N2 and H3N2 
prior to vaccination. Half of the pigs were vaccinated twice 3 
weeks apart with 2ml of RESPIPORC FLU3/GRIPOVAC 3. One 
week after 2nd administration of the vaccine, an aerosol chal-
lenge was performed.Vaccination and challenge G2: All pigs 
(N=20) were seronegative against H1N1, H1N2 and H3N2 prior 
to vaccination. Half of the pigs were vaccinated with 2ml of RES-
PIPORC FLU3/GRIPOVAC 3. One week after 2nd administration 
of the vaccine, an aerosol challenge was performed.Viral load in 
lung tissue homogenates was quantifi ed 1 and 3 days (d1 and 
d3) after challenge by egg culture and expressed in number of 
egg infection dose 50% (EID50).
Results
The challenge with strains G1 and G2 induced typical clinical 
signs of infl uenza, i.e. dyspnoea and fever in control pigs. Vaccin-
ated pigs were protected against fever and other clinical signs 
(data not shown). Vaccinated pigs had very signifi cantly lower 
viral lung load than non-vaccinated pigs (Figures 1 and 2).
Figure 1: Mean viral load (EID50 in 10 mg lung tissue) after aerosol 
challenge with strain G1 H1N2 (d1 and d3: p=0.001)
Figure 2: Mean viral load (EID50 in 10 mg lung tissue) after aerosol 
challenge with strain G2 H1N2 (d1: p=0.016; d3: p=0.032)
Conclusion
Clinical and viral cross-protection of pigs vaccinated with RES-
PIPORC FLU3/ GRIPOVAC 3 with recent Swine Infl uenza A Virus 
H1N2 strains in Europe has been confi rmed in these challenge 
studies.
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Protective immune responses following vaccination of a consensus H1N1 
Swine inﬂ uenza DNA vaccine using electroporation in pigs
Douglas R. Kern1 Douglas R. Kern1 Amir S. Khan2
1. VGX Animal Health, The Woodlands, TX, USA; 2. VGX Pharmaceuticals Inc, The Woodlands, TX, USA
Over the last two decades, DNA vaccines have become a potent 
means of providing immune responses or protective immunity 
against viruses, bacteria and parasites. DNA vaccines comprised 
of plasmid DNA encoding proteins from pathogens, allergens, 
and tumors, are being evaluated as prophylactic vaccines and 
therapeutic treatments for infectious diseases, allergies and 
cancer. The use of DNA as a means of vaccination off ers advan-
tage in protective effi  cacy, cross-strain applicability, develop-
ment speed with lower manufacturing cost over conventional 
vaccines. DNA vaccines are known to be particularly eff ective in 
inducing antibody responses which are critical to fi ghting infec-
tions. 
Recently, the USDA reported there was limited cross-reactivity 
against the new 2009 A/H1N1 virus in pig herds vaccinated with 
existing swine infl uenza vaccines.
This presentation describes a study in which pigs were immun-
ized with consensus H1N1 infl uenza DNA vaccine candidate on 
day 0, day 14, and day 28. Sera collected on day 28 and day 42, 
after two or three doses of vaccine, respectively, showed hemag-
glutination inhibition (HI) titers above the protection threshold 
in 100% of the vaccinated animals against a swine H1N1 virus 
previously isolated from pigs (Swine 1999). In addition the 
immune sera were tested for responses against a virus isolated 
from the current circulating strain of swine origin infl uenza A/
H1N1 (Swine A/Mexico/InDRE4487/2009). Four of the six pigs 
immunized with the H1N1 vaccine developed HI titers exceed-
ing the 1:40 level commonly associated with protective immun-
ity (see Table 1 ).
These fi ndings have been verifi ed in other animal species. In a 
previous study, we demonstrated that mice immunized with 
SynCon™ H1N1 DNA vaccine provided 100% protection in a 
lethal challenge study against an unmatched H1N1 virus that 
caused the 1918 Spanish fl u, which killed over 40 million people 
worldwide. In addition, ferrets immunized with similar SynCon™ 
universal fl u vaccine combinations were 100% protected against 
death and sickness in a challenge with the A/H1N1 Mexico/
InDRE/4487/2009 pandemic swine-origin infl uenza. 
VGX Animal Health’s novel SynCon™ technology enables the 
design of DNA-based vaccines with the potential to protect 
against unmatched sub-types and strains of pathogens. Using 
a designer approach, VGX Animal Health can formulate these 
DNA plasmids together to rapidly develop a universal infl uenza 
vaccine potentially targeting all important strains. The resulting 
vaccine could target seasonal as well as pandemic-potential 
infl uenza strains such as avian infl uenza and swine fl u, which has 
already been designated pandemic status. Signifi cantly, being 
based on a common set of antigens derived from a broad range 
of fl u strains, such a universal vaccine would have the potential 
to provide greater protection against evolving, unmatched fl u 
strains in multiple species. 
Table 1 HI Titers to Swine 1999 and Mexico ‘09 (MX09)
Animal # Treated HI (Swine 1999) wk 10
HI (MX09) 
wk 6
HI (MX09) 
wk 10
HI (MX09) 
wk 14
107 Yes 160 <20 <20 <20
119 Yes 160 20 40 40
124 Yes 80 <20 <20 <20
131 Yes 160 40 80 80
140 Yes 160 20 40 40
158 Yes 320 20 40 40
116 No 10 <20 <20 <20
114 No 10 <20 <20 <20
137 No 10 <20 <20 <20
HI titers against Swine 1999 and Mexico 2009 for pigs immun-
ized with Swine H1N1 concensus DNA vaccine, Day 28 - 2 weeks 
post 2nd immunization; Day 56 - 2 weeks post 3rd immunization 
and Day 70 - 4 weeks post 3rd immunization
Respiratory diseases – Swine infl uenza
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 583
Poster Presentations
P.277
Pandemic (H1N1) 2009 inﬂ uenza a infection in pigs in Northern Ireland
Jesus Borobia Belsué
MOSSVET, Portadown, UK
Introduction
In October 2009 a 120 sow unit experienced an increase in ab-
dominal breathing, coughing and inappetance in the breeding 
herd and sucking piglets. The breeding herd and weaners are 0 5 
miles away from the growing/fi nishing accommodation.
Clinical signs started 4 days before vet visit.
A week earlier, 6 year old farmer’s daughter had a “cold”. All 
family members –except the farmer- contracted this illness.
Changeable weather conditions in the area two weeks earlier.
Materials and Methods
Clinical investigation consisted in a farm visit (27 Oct 2009). 
Rectal temperature was taken from aff ected animals. Two dead 4 
week old piglets from the same litter were post-mortemed and 
their lungs submitted to the laboratory (AFBI, Belfast, Northern 
Ireland) with 5 clotted blood samples of aff ected sows.
Two more farm visits were carried out (3 & 10 Nov 2009). More 
clotted blood samples were collected.
Results
During the fi rst farm visit, 5 lactating sows, 7 dry sows, 2 sows in 
service room and one boar had abdominal breathing, barking 
cough, inappetance and prostration. Piglets of aff ected lactating 
sows had abdominal breathing but good appetite. Five 4 week 
old piglets of a litter of 11 died. No fertility problems detected.
Rectal temperature ranged from 40 to 41.5ºC.
Growing/fi nishing accommodation did not have clinical signs.
Post-mortem examination of the lungs detected 30 – 40% lung 
consolidation of cranioventral lobes with interstitial pneumonia. 
Bronchiomediastinal lymph nodes were congested.
Histological changes of the bronchiole showed desquamation 
and necrosis of the respiratory epithelium, along with marked 
lymphocytic infi ltration of the lamina propia and submucosa. 
Furthermore, there was perivascular lymphocyte infi ltration in 
the lung.
Virology came back positive to FluMatrix RTPCR.
Serology came back negative to Aujeszky, PRRS and H1N1 
Belg/79. However, one sow was positive to PRCV and all were 
positive to H1N1 Eng/92. Serological progression is shown in 
Table 1.
Table 1. Serological results for H1N1 Eng/92 from clotted bloods
ANIMAL ID 27 Oct 2009 3 Nov 2009 10 Nov 2009
373 1/8 1/256 1/128
375 1/16 1/64 1/128
377 1/32 1/64 NT
355 IS 1/16 1/32
348 1/16 1/256 1/128
343 NT 1/16 1/64
IS= Insuffi  cient Sample NT= Not Tested
Discussion
SIV (Swine Infl uenza Virus) is an accute, infectious, respiratory 
disease caused by infl uenza A viruses. It causes a sudden onset, 
coughing, dyspnea, fever, prostration, followed by a rapid recov-
ery.
Northern Ireland has a high intensity of Pandemic (H1N1) 2009 
in human population (ECDPC, 2009).
Weather conditions were favorable for the spread of the virus 
during that period of time.
Likely humans infected pigs and/or airborne in this case.
Mortality was low. Taylor (1995) & Easterday et al. (1999) re-
ported <1% mortality unless intercurrent infections and/or pigs 
very young.
PRCV did not appear to exacerbate infection experimentally 
(Lanza et al., 1992; Taylor, 1995). 
SIV morbidity is reported near 100% (Taylor, 1995; Easterday et 
al., 1999). It was, however, 60% in this case. This could be related 
to the pathogenicity of the virus and/or prompt treatment by 
nursing care of warm environment, minimising stress and medi-
cating the sow’s diet.
No reproductive, farrowing and neonatal problems were 
reported in this case, contrary to Taylor, 1995; Muirhead et al., 
1997; Easterday et al., 1999 and Jackson et al. 2007).
Viral isolation and/or specifi c antibodies detection is necessary 
for diagnosis (Easterday et al., 1999).
Serum samples were positive to SI/A/Swine/England/92(H1N1) 
with rising titres the following weeks. Viruses with the same H 
(haemagglutinin) cross react with antibodies to related strains 
(Brown, 2002).
PCR in lung confi rmed Pandemic (H1N1) 2009.
Bacteriology was not performed because the laboratory had 
issues about hazards to staff .
SIV is not a Notifi able Disease (WHO, GB and rest of EU). How-
ever, Infl uenza A viruses are Notifi able Disease in Northern 
Ireland (The Disease of Animals (Northern Ireland) Order 1981).
Some authorities can over-react in this situation and there is 
some concern of the possible consequences on pig trade and 
consumption since fi rst signs in humans appeared in Mexico 
(April 2009).
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Outbreak of 2009 pandemic inﬂ uenza A H1N1 in Korean pigs
Seonghee Kim; C-I Yeo; C-W Bae; Y-K Song; K-K Lee; O-S Lee; Choi-Kyu Park
National Veterinary Research & Quarantine Service, Anyangcity, Korea
Introduction
Pigs could play the role of intermediate host as a “mixing vessel” 
which could give rise to an outbreak of new variants through the 
process of genetic reassortment event because their tracheal 
cells contain both human and avian infl uenza virus receptors. 
That is why continuous monitoring of infl uenza virus in pigs is 
signifi cant in terms of public health. To this end, National Vet-
erinary Research & Quarantine Service (NVRQS) in South Korea, 
starting the 2nd quarter of 2009, launched a nationwide disease 
prevention program and embarked on monitoring of pH1N1 in 
pig farms throughout the nation. In the case of commercial pig 
farms, 708 farms, 1,057 farms and 1,060 farms were monitored 
in the 2nd, 3rd and 4th quarter of 2009, respectively. Meanwhile, 
with respect to pig breeding farms, 198 farms were monitored in 
the 4th quarter of the year, since infl uenza viruses typically have 
high prevalence during winter season.
Materials and Methods
For test sample, seventeen nasal swab samples per one pig 
farm were collected from the pigs showing respiratory symp-
tom among weaners, growers and fi nishers. The samples were 
inoculated into each embryonated chicken egg and Madin-
Darby canine kidney (MDCK) cells. Total RNA was extracted, 
using RNeasy® Mini Kit (Qiagen), from the samples whose 
hemagglutination titers were higher than 2 times. Identifi cation 
of infl uenza virus among the extracted total RNA was run on a 
Roche LightCycler 2.0 using artus® Infl ./H1 LC/RG RT-PCR kit (Qia-
gen). Final confi rmation of the pH1N1 virus were done through 
sequence analysis of hemagglutine (HA), neuraminidase (NA) 
and matrix (M) region using the universal primers.
Results
As a result, while the pH1N1 virus was not found at the tests con-
ducted during the 2nd and 3rd quarters of 2009, it was detected 
from 17 farms during the period from the 4th week of November 
to December of the year. While most of pH1N1-positive farms 
were tested negative at the tests conducted a week after notifi -
cation of the virus infection to them, one pig-breeding farm still 
remained positive to the virus. After a week of suspension, addi-
tional antigen test was conducted for the pig-breeding farm. 
As the test did not detect any antigen, the farm was freed from 
the movement restriction. This fact indicates that, in the case of 
large-scale pig-breeding farms where biosecurity is relatively 
well managed at each breeding stage, the transmission speed of 
infl uenza virus is relatively slow, causing a continuous circulating 
virus infection to antibody-negative pigs.
The phylogenetic analyses on HA and NA gene of pH1N1 iso-
lated in South Korea found that they were similar to the pH1N1 
which is currently prevalent among humans. With the existing 
pH1N1 virus isolated from pigs in Canada, HA and NA nucleotide 
homology of 98.3-99% and 98.5-99.8% were observed, respect-
ively, with Korean isolates. Furthermore, HA and NA genes of 
Korean isolates showed homology of 98.7-100% and 98.5-100%, 
respectively, among themselves.
Discussion
Movement restrictions had been imposed on pH1N1-confi rmed 
pig farms for three weeks, during which antigen tests were 
conducted at the interval of one week and the restrictions were 
lifted for the farms that had been tested negative. For the pigs 
that were to be shipped out to market, the shipment, even dur-
ing the restriction period, was allowed to each individual pig, if 
tested negative for the pH1N1 virus. 
All things taken together, it is highly likely that the outbreak 
of pH1N1 in South Korea was caused by the transmission from 
infected humans to pigs as with other countries, given following 
factors: fi rst, the outbreak of pH1N1 in pigs was reported after 
the fi rst week of November 2009 when the rate of Infl uenza-like 
Illness of Koreans was at its peak of 50%. Second, any epidemical 
relevance indicating that the pH1N1 was transmitted by the 
movement of pigs of infected pig farms was not found. Even 
though an analysis on the full genome sequencing data of the 
pH1N1 isolated in Korea assures that so far there has not been 
any outbreak of new variant through genetic reassortment (data 
not shown), we can not rule out the possibility of emergence of 
those variants in the near future. Thus, continuous surveillance 
on the pig farms has been conducted to detect the emergence 
of any variants in South Korea, and the use of vaccine for pig 
against the pH1N1 which is at its fi nal stage of development is 
being carefully considered.
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Pandemic inﬂ uenza virus (A/ H1N1) outbreak in pig farm in north of Italy
Loris G. Alborali; Matteo Gradassi; Mariagrazia Zanoni; Anna Moreno Martin; Anna 
Catelli; Cristian Salogni; Enrica Sozzi; Emanuela Foni; Paolo Cordioli
IZSLER, Brescia, Italy
Introduction and Objectives
The swine infl uenza virus (SIV) frequently causes acute 
respiratory disease in pigs worldwide and is an important 
pathogen in the porcine respiratory disease complex (PRDC). 
SIV is one of the “door opener” and frequently is associated 
with viral (PRRSV,PCV2), bacterial respiratory pathogens and 
M.hyopneumoniae.(1). H1N1, H3N2 and H1N2 are the most com-
mon infl uenza subtypes isolated in Italian pig farms (2) In 2009 
a novel (H1N1)v infl uenza A virus caused annual worldwide epi-
demics . In Italy, in order to examine the emergence of the new 
pandemic virus and confi rm the recent reports about human 
to animal transmission (3, 4), all swine type A infl uenza posi-
tive samples were tested for (H1N1)v. The fi rst H1N1 pandemic 
outbreak in sow farm in Italy is described in this paper. 
Material and methods
On November 2009, in a Northern Italy farm clinical signs in 
sows and piglets were observed in farrowing units. The farm was 
a 1250 sows site with outside growing gilts- and weaning-units. 
Weekly clinical investigations were reported and performance 
data were collected to evaluate and quantify losses. Nine dead 
piglets and four nasal swabs from sows were submitted to the 
diagnostic laboratory. Lung homogenates were tested. Clinical 
specimens were screened for the presence of infl uenza A viruses 
by real time RT-PCR (6). Positive samples were further tested for 
the (H1N1)v by real time RT-PCR (rtRT-PCR), according to the 
CDC procedure (7). All samples were also cultured for the most 
common bacterial swine respiratory pathogens and tested for 
PRRSV, PCV2 and M. hyopneumoniae by using RT-PCR, multiplex 
PCR and PCR assays respectively (8,9,10).
Sera were collected in sows and piglets both when clinical signs 
were observed and 28 days P.I.. Specimens were examined by 
NPA-ELISA and HI tests swine antigen A/H1N1,A/H3N2,A/ H1N2 
and pandemic A/H1N1.
Results
Figure1: Total born, born alive and weaned piglets in 2008, 2009, 
November - January 2008/09 and 2009/10
Figure 2: Sow mortality and abortions % in 2008, 2009, 
November - January 2008/09 and 2009/10
Sows presented fever, depression, anorexia and agalactia, while 
5-10 days piglets diarrhoea and weight loss. The morbidity in 
sows was approximately 30-50% and the performance sow and 
piglets data are reported in Figure 1and 2. 
Gross lesions were catarrhal enteritis in 8 piglets and pneumonia 
with a purple area of consolidation in the apical lobes in one 
piglet. The latter and one of the two pools of 4 piglets were posi-
tive for type A infl uenza (H1N1)v assay. Only PRRSV European 
strain was detected from the fi rst pool, whereas other samples 
resulted negative for the tested pathogens.
Sow sera collected at 28 days P.I. were positive by NPA-ELISA and 
HI tests pandemic A/H1N1.
Discussion
The main clinical signs were depression and agalactia in sows 
during the fi rst week after farrowing. Diff erent weights were 
observed in litters and piglets showed wasting and dehydra-
tion. The loss interested litters and were quantifi ed in increased 
mortality in farrowing units, performance reduction in sows 
consisting in enhanced mortality and fertility rate reduction.
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Pigmeat price dynamics: eﬀ ects of Inﬂ uenza A H1N1 in Mexico?
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Introduction
Several factors can modify price fl uctuations in diff erent mag-
nitude and time. Mexico as all world, experimented a terrible 
human disease in middle 2009. At the beginning of the disease 
it was named swine disease, hog fever, and other names that 
contributed someway to increase fear for these products. Price 
fl uctuations are a discipline that combines historical dynamics 
and prospective analysis. The aim of these study was to evalu-
ate 2009 pigmeat price fl uctuations and identify the eff ect of A 
H1N1 Infl uenza disease.
Materials and Methods
2009 daily pigmeat, hog prices and slaughter were analyzed. 
Data were collected from Secretaria de Economía. A multiplica-
tive components model with a component separation was 
used. Y=T*S*C*I, where Y=variable; T=Tendency; S=Seasonality; 
C=Fluctuations and; I irregular movements.
Results
Both live hog and pigmeat price showed fl uctuations around 
10% in one year, percentage that destabilized the sector. Live 
price fl uctuation was 12.49% and began a negative dynamic 
from April 20th to May 31. Pigmeat fl uctuation was 11.87% all 
year but from April 12th to June 10th the variation was 10.70% 
(Fig 1). Figure 2 showed 2 diff erent negatives tendencies, the 
fi rst one from March 31 to April 9th and the second from April 
17th to June 3rd.
Discussion
Price fl uctuation more than 10%, can provoked wrong signals 
both consumer and producer at diff erent time. When a Pandem-
ic A H1N1 Infl uenza occurred, live hog price dropped and fl uctu-
ated more than 10%, and it happens in a short period of time, 
41 days. Mexican Pigmeat cycle is 42 month long (Martínez et al, 
2009). That means, the sector needs at least 21 months in order 
to recover the bad fl uctuation or vise versa. The eff ects that were 
observed during the Pandemic correspond with the negative 
live price fl uctuation. Some way it had aff ected Mexican hog 
production but it surly will have eff ect when the market it selves 
recovered or adjust the fl uctuation regular movements. Unfortu-
nately, this market arrangements represents the lost of many 
producers, and the federal policies implemented weren’t made 
to protect or stimulated pigmeat and Mexican hog sector.
Pigmeat fl uctuation ran with the same tendency, but the time 
registered wasn’t 41 days like live price, it was 10 days more, 
i.e. 51 days long, almost 2 months. Once price bottom it never 
recovered, the price average maintained below the no fl uctua-
tion value, i.e. CERO.
Figure 1. Live hog and Pigmeat price fl uctuations in Mexico. 2009.
Slaughter registered two negatives periods, the fi rst one is “regu-
lar” performance, because it coincidence with the Traditional 
Mexican “Seaman Santa” (Eastern break).
Figure 2. Slaughter variations in Mexico. 2009.
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Lung Histopathology from Naturally Infected Pigs with Pandemic H1N1 2009
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Introduction 
Swine infl uenza virus (SIV) is a primary pathogen of the res-
piratory tract of pig (1). The target cells of SIV are the epithelia 
lining the entire respiratory tract. However, a major pathological 
signifi cance are those located in the small airways (2). Young 
pigs are fully susceptible to the swine origin pandemic H1N1 
2009 infl uenza A as it was reported in several countries includ-
ing Argentina. Experimental infections with this novel virus 
induced mild clinical signs, however, virus shedding and lung 
lesions were similar to infection with SIV (3). The present work 
was aimed to review the histopathology (HP) and immunohisto-
chemistry (IHC) features of lung lesions of naturally infected pigs 
with the pandemic H1N1 2009 infl uenza A.
Materials and Methods
A total of 21 slide lung samples belonged from 9 naturally in-
fected pigs were examined. Cases were selected by gross lesions 
and rRT-PCR positive. For each, HP, and IHC studies were done. 
Morphometric study of changes at level of bronchi, bronchiole, 
alveoli, blood vessels and connective tissue was performed 
according with Richt et al (2). For statistical analysis, ANOVA test 
were used and, post hoc Fisher’s LSD analysis was applied when 
diff erences were detected.
Results
The histopathological hallmark was a severe necrotizing bron-
chiolitis. Small and medium sized bronchioles were plugged 
with neutrophils, necrotic epithelial cell and mucous exudates. 
Aff ected airways were denuded or lined by fl at epithelium. In 
few of them focal areas of metaplasia were seen. Bronchi and 
large bronchiole showed only minor changes. Alveolar infl am-
mation was distributed in a lobulillar or lobar fashion. In them, 
two coexisting patterns of response were observed in the same 
sample. The fi rst, infi ltrative non-exudative reaction with the 
presence of neutrophils and few macrophages within the alveoli 
or in the alveolar wall. The second was serofi brinous exudates 
into the alveoli with infl ammatory cells such as macrophages 
and neutrophils, hyaline membranes, capillary thrombosis 
and in few cases, focal necrosis. In 2 cases, lesions resembled 
infection by A. pleuropneumoniae. The ANOVA analysis showed 
signifi cant statistical diff erences among structure aff ected 
(p=0.0000). Bronchiolar lesions were statistically higher than 
others structures (p<0.05), followed by those seen in the alveoli 
and bronchi. Marked IHC labelling was observed in the severely 
denuded epithelial cells of bronchioles, pneumocytes and alveo-
lar macrophages of aff ected or normal alveoli. 
Discussion
The spectrum of pathological lesions in pigs appears to vary 
little among SIV subtypes (4). Epithelial cells necrosis of bronchi-
oles, airway plugging with desquamate cells, neutrophils infi ltra-
tion and mucus are the features of SIV infection (1,2). Changes 
such as hyaline membranes, capillary thrombosis and alveolar 
necrosis observed in the study are not commonly reported in SIV 
infection as has been in human infl uenza (5). These diff erences 
could be associated with the lack of immune response against 
this “new” subtype. Neutrophils were the common infl amma-
tory cells seen in the airways and alveoli. It may be the results 
of high level of cytokines secreted by the infected bronchiolar 
epithelial cells and macrophages which in turn is related with 
the virus load on these cells (4). In the examined samples, the 
higher bronchiolar scores were correlated with the more marked 
immunolabeling. However, secondary bacterial infection can 
not be excluded. More extensive studies are needed to evaluate 
the consistence of the above described lesions of the pandemic 
H1N1 2009. 
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Lung pathology in slaughtered pigs from Norwegian herds naturally 
infected with pandemic inﬂ uenza A (H1N1) 2009 virus
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Introduction
The Norwegian swine population has been considered free from 
infl uenza A virus infection documented trough a serological 
surveillance program running since 1997 (1). The swine popula-
tion is also documented free from PRRS-virus and Mycoplasma 
hyopneumonia (1, 2). The fi rst human cases of the pandemic 
infl uenza A (H1N1) 2009 virus infection in Norway were de-
tected in early May 2009. The fi rst porcine case was detected in 
October, and human to pig transmission was suspected (3). This 
paper describes the lung lesions in slaughtered fattening pigs 
from herds naturally infected with pandemic infl uenza A (H1N1) 
2009 virus. 
Materials and Methods 
The slaughtered fattening pigs originated from three herds. The 
lungs from pigs from herd 1 and 2 had been selected for exam-
ination because “new” types of lung lesions were observed at 
the meat inspection. From these herds, lungs from 9 and 10 pigs, 
respectively, were examined. Herd 3 had been tested positive for 
pandemic infl uenza A (H1N1) 2009 virus two weeks before the 
pigs were slaughtered, and 10 lungs were submitted for examin-
ation. From each examined lung one swab from trachea and one 
from a bronchus were submitted for virus detection by real-time 
PCR (4). One sample from the right cranial lung lobe was sub-
mitted for bacteriological examination. The gross pathological 
lung lesions were recorded. One sample from trachea and nine 
samples from diff erent lung lobes were fi xed in 10% buff ered 
formalin for 24 h and then transferred to 70% ethanol. The 
samples were routinely processed, and 3-4 μm sections were cut 
and stained with hematoxilin and eosin. Immunohistochemical 
examinations using monoclonal antibodies to detect infl uenza A 
virus (5) and PCV2 in the lung tissues were performed. 
Results
In herd 1 and 2 the pandemic infl uenza A (H1N1) 2009 virus was 
detected in 17 of 18 examined lungs. In herd 3 infl uenza virus 
was not detected in the fi ve examined lungs. The lungs from the 
three herds showed a multifocal, lobular pattern of atelectasis 
and dark red discoloration. The lesions were most pronounced 
in the cranioventral parts of the lungs. The areas with atelectasis 
were slightly fi rm compared to the surrounding tissue. In the 
bronchi there were varying amounts of mucus to mucopuru-
lent exudate. The tracheobronchial lymph nodes were slightly 
to moderately enlarged. Histological examination of the lungs 
from pigs from herd 1 and 2 showed comparable lesions but 
also revealed variation between animals and within the lungs. 
The main fi ndings in the aff ected lobules were atelectasis and 
moderate to intense infi ltration of leukocytes in the mucosa 
of the small bronchi and bronchioles. Attenuation of bronchial 
and bronchiolar epithelial lining was seen, but acute epithel-
ial necrosis was seldom identifi ed. Large peribronchiolar and 
perivascular infi ltrates of lymphocytes, and in some pigs, also 
lymphoid follicles were observed. There were increased numbers 
of leukocytes in the interalveolar septa, and varying numbers 
of granulocytes, lymphocytes and few macrophages were seen 
in the partial collapsed alveoli. In the lungs from pigs from herd 
3 the major fi ndings were atelectasis, prominent peribronchial 
and peribronchiolar lymphoid follicles and thickened interalveo-
lar septa. The bacteriological examination showed sparse to 
moderate growth of diff erent Streptococcus species or non-
pathogenic bacteria from the majority of the lungs. Infl uenza A 
virus was detected by immunohistochemial examination in the 
bronchiolar epithelium, in cellular debris in bronchiolar lumen or 
in scattered cells in the interalveolar septa in 5 of 9 pigs in herd 
1 and in 9 of 10 pigs in herd 2. PCV2 virus was not detected by 
immunohistochemical examination of the lung lesions. 
Discussion
The pandemic infl uenza A (H1N1) 2009 virus infection induced 
signifi cant lung pathology in the pigs from the three herds. 
The primary locations for lesions seemed to be small bronchi 
and bronchioles. In herd 1 and 2 the duration of the infection 
may have varied between 5-10 days prior to slaughter, and the 
lesions in most lungs were signifi cantly diff erent from the lungs 
from the pigs in herd 3 slaughtered 18 days after the detection 
of the virus in the herd. The lesions observed in the lungs were 
similar to the lesions described for “classical swine infl uenza”. 
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Development of a one-step RT-PCR assay for detection and diﬀ erentiation between 
swine inﬂ uenza H1N1 virus and pandemic H1N1 2009 virus in Thai swine herds
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Amonsin; Roongroje Thanawongnuwech; Kanisak Oraveerakul; Pravina Kitikoon
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Introduction and objective
A recently emerged infl uenza A H1N1 virus (pH1N1) spread 
globally from human-to-human causing the fi rst pandemic of 
this century (1). The pH1N1 originated from the reassortment 
of swine infl uenza virus (SIV) with human, avian, classical swine 
and Eurasian swine lineages (2). Since then reports of reverse 
zoonotic cases in avian species and pigs have been documented 
in the fi eld (3). These events raise concern of possible reassort-
ment between the pH1N1 and other SIVs that may cause a new 
virus with zoonotic potential. Rapid detection and diff erentia-
tion of the pH1N1 virus from swine H1N1 infl uenza virus (sH1N1) 
is essential for prompt preparedness for such events. Since the 
genome of pH1N1 is of swine origin, it is diffi  cult to diff erentiate 
pH1N1 from all sH1N1 currently circulating in pigs worldwide. 
Fortunately, the origin of PB1 gene in the Thai and European 
sH1N1 isolates are mainly avian-like while that in pH1N1 is 
human-like (4). In this study, a conventional one-step reverse 
transcriptase (RT)-PCR assay targeting PB1 gene was developed 
for detection and diff erentiation of pH1N1 from other sH1N1 
viruses. Additional RT-PCR assay targeting HA and NA genes was 
also developed and modifi ed for subtyping H1 of classical swine 
and N1 of European swine viruses. 
Materials and Methods
The two pairs of primers, PB1-P and PB1-S, specifi c for pH1N1 
and sH1N1 viruses, respectively were designed based on PB1 
gene. Additional H1 and N1 primers (N1 modifi ed from (5)) were 
designed for subtyping H1N1 viruses from all species. The prim-
ers are shown in Table 1. All primers used in this study run with 
the same condition allowing detection of diff erent genes simul-
taneously. The conditions are as follow: reverse transcription 
at 48°C for 45 min, initial denaturation at 94°C for 3 min and 40 
cycles of denaturation at 94 °C for 30 sec, anneal at 55°C for 30 
sec and extension at 72°C for 1 min, followed by fi nal extension 
at 72°C for 10 min. The sensitivity of this assay was tested. The 
specifi city of the assay was determined by testing with pH1N1, 
SIV subtype H1N1, H1N2 and H3N2, avian infl uenza H5N1 virus, 
seasonal human infl uenza H1N1 (huH1N1) virus and other swine 
respiratory viral pathogens. 
Results and Discussion
The results showed that the RT-PCR assay can be applied to 
detect and diff erentiate pH1N1 virus from other SIVs, including 
sH1N1 viruses and huH1N1 virus (Fig 1). This novel assay was 
sensitive and can detect 0.001 and 0.01 TCID50/ml of pH1N1 
and sH1N1 viruses, respectively. They showed 100% specifi city 
and did not amplify genetic material from other subtypes of SIV 
and other swine respiratory viral pathogens (data not shown). 
Overall, the results clearly indicated that the novel one-step 
RT-PCR assay has high sensitivity and specifi city to detect pH1N1 
virus. The assay can discriminate pH1N1 from huH1N1 virus, Thai 
sH1N1 and possibly European H1N1 SIVs since the PB1 gene is of 
the same avian-like origin. Moreover, the RT-PCR assay target-
ing H1 and N1 genes can be used to subtype the virus using 
the same PCR condition which allows rapid and simultaneous 
detection and diff erentiation of the infl uenza A viruses. In sum-
mary, this cost-eff ective assay can be used for rapid screening of 
current circulating SIV isolates for detecting pH1N1 in the swine 
population. 
Table1. Primers used in this study
Name Virus target Gene Sequence Product size (bp)
PB1-P-1038F Pandemic (H1N1) 2009 PB1 CGAGTGGTTCAGAAACATCC 408
PB1-P-1446R Pandemic (H1N1) 2009 PB1
CACTAACTTGCAGGTC-
CTGTAG
PB1-S-1036F Swine (H1N1) PB1 CCTGAATGGTTCAGAAAT-GTTTT 410
PB1-S-1446R Swine (H1N1) PB1 AACCAGTTTGCAGGTC-CTATAA
H1-231F All infl uenza (H1N1) HA1 GCATTTGGGTAAAT-GTAACATTGC 706
H1-937R All infl uenza (H1N1) HA1 GAAATGGGAGGCTGGT-GTTTAT
N1-F849 All infl uenza (H1N1) NA1 GAGGAATGTTCCTGTTACCC 309
N1-R1158 All infl uenza (H1N1) NA1 CATCCATTAGGATCCCAAATCA
Fig1. Detection, diff erentiation and subtyping of infl uenza A (H1N1) 
viruses by RT-PCR assay. Lane 1-6: PB1-P primer specifi c to pH1N1 virus. 
Lane 8-13: H1 primer for subtyping all H1 subtype. Lane M: 100-bp 
ladder.
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Analysis of cross reactivity of porcine sera in the haemagglutination inhibition 
assay using swine H1N1 or the new pandemic H1N1 inﬂ uenza virus
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Introduction
In April 2009, a new infl uenza A/H1N1 strain circulating in the 
human population was reported in Mexico. The new H1N1 virus 
was a triple swine/human/avian reassortant that afterwards 
spread pandemically. Fortunately, the virulence of the pandemic 
H1N1 (panH1N1) seems to be low but this episode made clear 
the need for a better surveillance of infl uenza A viruses infec-
tion. Swine infl uenza is most often caused by subtypes A/H1N1, 
A/H1N2 and A/H3N2. Hemagglutination inhibition test (HI) 
still is the serological assay of reference and it is assumed to be 
subtype-specifi c1. The main objective of the present work was 
to assess to what extent the use of diff erent strains of a same 
subtype may aff ect the outcome of HI when examining swine 
serum samples.
Material and methods 
Ninety-four serum samples were selected from a sera bank 
(2007-2009) corresponding to a cross-sectional study of swine 
infl uenza in Spain where sera had been tested in HI using an 
European avian-like A/swine/Neth/Best/96 strain (NLH1N1)(GD 
laboratories, Deventer, Netherlands). The group of selected sera 
included negative and positive anti-NeH1N1 sera (≤1:320) that 
were re-tested in HI using the Spanish avian-like H1N1 A/swine/
Spain /53207/2004 strain (ESH1N1) and the novel pandemic 
H1N1 (A/Catalonia/S2169/2009) strain (panH1N1) isolated from 
a human sample. Similarity of the predicted amino acid sequen-
ces of H1 were 89.3% between NLH1N1 and ESH1N1; 75.1% be-
tween NLH1N1 and panH1N1 and 71 5% between ESH1N1 and 
panH1N1. Sera were also examined using A/H1N2 and A/H3N2 
(A/swine /Gent/7625/99 and A/swine/Neth/St.Oedenrode/96)
(GD laboratories, Deventer, Netherlands) strains. Statistical analy-
sis was done with Statdirect 2.7.5.
Results
Figure 1 show the comparative distribution of HI titres using the 
diff erent H1N1 strains. Comparison of results of sera analyzed 
with NLH1N1 or ESH1N1 showed that both strains produced fair-
ly similar titres (r=0.79; CI95%:0.70-0.85). In contrast, regression of 
log-transformed titres for NLH1N1 or ESH1N1 and panH1N1 was 
non signifi cant, suggesting that antibodies towards panH1N1 
did not cross-react with other H1N1. No cross-reactivity between 
none of the A/H1N1 and either H1N2 or H3N2 was observed 
(data not shown). Interestingly, in 4 farms animals seropositive 
(≥1:40) against panH1N1 were found. In one of those farms (ana-
lysed in the fi rst quarter of 2009) 8 animals were positive (Table 
1); some of them reacted with other swine infl uenza strains.
Figure 1. Distribution HI titres against three diff erent H1 infl uenza A 
strains: a) ESH1N1 vs. NLH1N1; b) ESH1N1 vs. panH1N1 and, c) NLH1N1 
vs. panH1N1
Table 1. Results by HI with diff erent A/infl uenza strains of the 8 pigs 
seropositive to panH1N1.
Pig panH1 NLH1 ESH1 H1N2 H3N2
1 1:160 1:160 1:160 1:80 Neg.
2 1:80 1:80 1:80 Neg. Neg.
3 1:80 1:80 1:80 1:80 1:160
4 1:80 1:80 1:160 Neg. Neg.
5 1:80 1:40 1:160 Neg. 1:80
6 1:80 1:80 1:40 Neg. 1:640
7 1:80 1:160 1:160 1:80 1:160
8 1:80 1:80 1:40 Neg. 1:320
Discussion
The present results indicate that panH1N1 has little or no cross-
reactivity in terms of HI with other contemporary swine H1N1 
viruses. However, the results also showed that, most probably, 
H1 viruses cross-reacting with the panH1N1 strain already 
existed before or at the same time of the emergence of that new 
pandemic strain. Considering the limited virulence of current 
panH1N1 it can not be discarded that similar or cross-reacting 
H1N1 virus circulated completely unnoticed in pig herds. Also, 
raise the question of how to interpret the HI results obtained 
with a given infl uenza strain.
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Detection of Pandemic H1N1 2009 in swine herds
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Introduction
Pandemic H1N1 2009 was fi rst reported in human population 
in April, 2009 and on the same month, pig infection was also 
reported in Alberta, Canada. With the increasing number of 
human death toll and with more cases of swine infections all 
around the world, Korean government enlisted Pandemic H1N1 
2009 in notifi able animal diseases under the Act of ACT ON THE 
PREVENTION OF CONTAGIOUS ANIMAL DISEASES on August 
21, 2009 and started monitoring of Pandemic H1N1 2009 in pig 
nerds. Accordingly, the necessity of rapid and reliable detection 
method of swine infl uenza virus or antibodies in pig herds for 
a number of heads on a regular basis was increased. Here we 
present one-step M gene multiplex RT-PCR system which detect 
Pandemic H1N1 2009 from swine samples, one-step HA1/3 sub-
typing multiplex RT-PCR system and one-step NA1/2 subtyping 
multiplex RT-PCR system from swine infl uenza viruses.
Materials and Methods
Viruses
A human pandemic fl u virus (A/Korea/01/2009 (H1N1), isolated 
in Korea, a pandemic fl u virus (A/sw/Korea/J2/2009) isolated 
from pig, 10 various subtypes of endemic swine infl uenza 
viruses, and Reference infl uenza viruses (from HA subtype 1 to 
16) were used. Virus titres were measured by Hemagglutinin 
assay or Reed-Munch method using MDCK cells.Oligonucleo-
tides design
The matrix (M) genome sequences of Pandemic H1N1 2009 
infl uenza virus (A/California/04/2009), endemic swine infl uenza 
viruses and avian infl uenza A viruses were retrieved from the 
GenBank database and analyzed to select sites which is specifi c 
for pandemic fl u. Primers were also selected for the subtyping of 
HA1/HA3 or NA1/NA2 among endemic swine infl uenza viruses.
Results
One-step multiplex RT-PCR assay was performed with the RNA 
extracted from diluted pandemic fl u virus (titre of stock: 1 x 106 
TCID50/ml) at 10-1 to 10-8. A positive amplifi cation could be 
visualized up to 10-5-6dilution, which meant the lowest con-
centration with positive results was 1-10 TCID50/ml. One-step 
multiplex RT-PCR assay was also performed with RNA standard 
prepared to know the exact sensitivity as copy number. The 
minimum copy number of matrix gene RNA detectable with our 
system was approximately 101-2 copies of RNA. 
Specifi city of the system was tested using various endemic 
swine infl uenza viruses and reference viruses with diff erent HA 
subtype. All were negative for the pandemic H1N1 2009 virus 
specifi c bands. Bands for infl uenza A common M gene were only 
visible.
One-step HA1/HA3 subtyping multiplex RT-PCR system and one-
step NA1/NA2 subtyping multiplex RT-PCR system were also 
tested for the specifi city and sensitivity with a panel of infl uenza 
A viruses. The limit of detection was 101 TCID50/ml for HA1/HA3 
subtyping, and 101-2TCID50/ml for NA1/NA2 subtyping. 
Discussion 
Pig can be infected with avian, human or swine infl uenza A 
viruses, hence, is well known as a mixing vessel. With the advent 
of swine origin Pandemic H1N1 2009, the importance of national 
or international level of monitoring of swine infl uenza viruses is 
well appreciated. It is important to develop or update the virus 
or antibody detection method from pigs to know the exact 
situation of infl uenza virus infection. It is necessary to have a 
reliable and highly sensitive swine fl u detection method from 
pig herds since the viruses are cleared rather quickly from pigs. 
Monitoring of swine fl u on regular basis will contribute public 
health and pork industry at the same time. Our system will be a 
good tool for monitoring of Pandemic H1N1 2009 in swine herds 
on a regular basis.
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Introduction
First case of pig infection of Pandemic H1N1 2009 was reported 
in Canada in April, 2009 and aftermath, there were additional 
cases in more than 10 countries all around the world. Korean 
government practiced active monitoring of Pandemic H1N1 
2009 from May 2009. Approximately 10% of the fattening farms, 
which meant 10% of the total fattening farms and included 700 
farms, all breeding farms and all Artifi cial Insemination centers 
(200 locations) were monitored. 18 farms in diff erent places all 
around the country were found to have infected pigs. Since pigs 
were well known as a mixing vessel of infl uenza viruses, it was 
necessary to develop vaccines which can prevent pigs from be-
ing infected or producing reassorted pandemic fl u viruses. 
Materials and Methods
Generation of vaccine candidate viruses 
A/PR8/34 H1N1 infl uenza A virus, which is a backbone virus of 
seasonal human infl uenza vaccine and Pandemic H1N1 2009 
virus, A/sw/Korea/SCJ01/2009, isolated from pigs in Korea were 
co-infected in 9-10 day old embryonated SPF eggs to generate 
reassorted vaccine candidate virus(CL A/swine/Korea /SCJ01/09 
x PR8). Allantoic fl uid was harvested and plaque assay was per-
formed to select reassorted virus with 6 internal genes from PR8 
virus and with 2 surface glycoprotein (NA and HA) genes from 
pandemic fl u virus. Immunogenicity in mice and pigs
Immunogenicity of recombinant virus in mouse and in pigs 
was tested using concentrated viruses with 2% alum. Mice were 
immunized with 3.5ug inactivated vaccine two times with two 
weeks interval. Pigs were immunized with 7.5ug. Sera were col-
lected 2 weeks after each immunization and Hemagglutination 
inhibition (HI) tests were performed.Virus challenge and protec-
tion test
Two groups of pigs were immunized with diff erent type of vac-
cines two times. Group I was immunized with endemic swine 
infl uenza H1N1 vaccine and Group II were immunized with 
pandemic fl u vaccine candidate. Two weeks after the last im-
munization, both groups were challenged with 1ml pandemic 
H1N1 2009 virus in intranasal route at 1x105 TCID50/ml. For 
transmission studies, new group of pigs were housed aerosol 
contact with immunized and challenged groups a day after 
infection. Nasal swabs were collected p.i. 2, 4, 5, 6, 7, and 8 days 
from all animals to examine the ability of the vaccine to inhibit 
virus replication.
Results
Immunogenicity in mice and pigs
HI titer of one time immunized mice were 40-80. When immun-
ized two times, the titers were 160-320. In the case of pigs, HI 
titer of one time immunized pigs were 40-80, and 160-320 with 
two immunizations. Virus challenge and protection test
Both of the vaccine and challenged group started to shed virus 
2 days p.i. Much higher titer of virus was detected from pigs 
immunized with endemic swine infl uenza virus vaccine longer 
time. No virus was detected from contact group with pandemic 
fl u vaccine immunized group while virus was detected from 
contact group with endemic vaccine.
 
Discussion 
It is well known that vaccination for infl uenza A virus would be 
a good way to control transmission of viruses and overcome ill-
ness in humans. Vaccination of pigs will add up one more advan-
tage: inhibitions of possible generation of reassorted infl uenza 
A viruses by combination of endemic infl uenza A viruses and 
Pandemic H1N1 2009. Continuous monitoring of infl uenza A 
viruses circulating among pigs and application of right vaccina-
tion for the current strains will benefi t both public health and 
pork industry. 
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Spreading of Actinobacillus pleuropneumoniae in the pig farm. A ﬁ eld case
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Introduction
Actinobacillus pleuropneumoniae (App) is the etiologic agent of 
swine pleuropneumonia, a highly infectious, often fatal disease. 
The main route of spread is by direct contact from pig to pig or 
by aerosol within short distances. Although some authors (1, 2) 
reported that airborne transmission between closely located pig 
units is possible but rare. The objective of this study was to fol-
low up the spreading of App serotype 2 infection within a small 
pig herd.
Materials and Methods
A high-health multiplying farrow to fi nish herd (240 sows) was 
infected with App serotype 2 in August 2009. The herd was free 
of the major diseases including PRRS, EP and Actinobacillus 
pleuropneumonia. The farm consisted of two buildings 40 m 
from each other with no direct connection established between 
them. One building is devoted to grow-fi nish pigs managed 
AIAO by room and the other one is populated with sows and 
weaning pigs up to 7 weeks of age. The grow-fi nish building 
consisted of 4 rooms split, each containing 2 pens with 45 pigs 
in each. The infection entered into the building in one of the 
outer rooms which was separated physically from the other 
part with a solid wall. Once the fi rst symptoms of the infection 
emerged in pigs (temperature 41.5°C, coughing, lack of appetite) 
the facility was locked and the possibility to get in from outside 
was only used. All the animals in this room immediately were 
treated with tetracycline in the water for 7 consecutive days. 
Immediately extra biosecurity conditions (diff erent stockperson, 
separate shower facility, clothes and boots) were introduced 
into the farm. After the clinical signs declined and antibiotic 
withdrawn, all the animals from this room were slaughtered. 
Slaughtercheck was performed and tonsils from 15 randomly 
selected pigs with lung lesions were taken for PCR. The aff ected 
lung tissues were submitted to the laboratory for App culture. 
The empty pens were fi rst fumigated with 1% Virkon and left for 
5 days. The fl oor was soaked with a glutaryl aldehyde based dis-
infectant and left until completely dried. After 5 days the entire 
facility was cleaned, washed, disinfected, dried and left for 30 
days before new pigs were introduced. The pigs from the other 
3 rooms were observed clinically and were given tetracycline in 
the water for 7 consecutive days as prevention. From every pen 
15 randomly selected pigs were bled for serology. During the 
next 8 weeks all the animals from the fi rst building were grad-
ually slaughtered. Tonsils from 5 randomly selected pigs / pen 
were taken for PCR. In the meantime many precautions were 
undertaken to protect the sow building from contamination. Ten 
sentinels naïve for App were introduced into the breeding sector 
of the farm allowing them to have contact nose to nose with the 
local pigs. All sentinels were tested serologically twice: 1 and 2 
months after introduction. After two months from infection the 
blood from 45 randomly selected sows was taken for serology. 
For detection of antibodies against App serotype 2, a LC-LPS 
ELISA was used (Swine-Check App, Biovet, Canada).
Results
App serotype 2 infection was confi rmed by culture from lung 
lesions of pigs from the outer perimeter room. Pigs from this 
facility were sick with a typical clinical signs of pleuropneu-
monia. Slaughtercheck revealed typical lesions of App infection 
(abscess-like nodules present in the diaphragmatic lobes) in 35 
of 52 pigs. Two hundred and seventy pigs from the other three 
rooms gradually slaughtered did not show any lung lesions. The 
serology carried out in randomly selected pigs from every room 
revealed that all the results were negative for App serotype 
2. In total 90 pigs were bled for serological investigations. No 
clinical signs of respiratory problems were observed in sows and 
weaning pigs as well as sentinel animals. Serological investiga-
tions performed on 45 randomly selected sows shown all of 
them to be negative for App serotype 2. Tonsils of 15 pigs from 
the infected room were tested PCR positive. Tonsils of pigs from 
the other three rooms of the building were tested PCR negative. 
Sentinel pigs were tested serologically negative for App sero-
type 2 either 4 or 8 weeks upon introduction.
Discussion
Results obtained clearly show that App infects naïve pigs if there 
is direct contact with contaminated material. In this particular 
case the source of infection there was very likely the stockman 
(fomites) attending the loading process. Only the pigs in the 
outer perimeter room became infected with App serotype 2, of 
course the loaded animals get infected as well. It is worth noting 
that infection did not spread across the entire building. The swift 
actions undertaken upon the fi rst signs of infection appeared al-
lowed to protect pigs from the rest of the rooms of this building 
and other building from the App infection. This confi rms previ-
ous observations that airborn transmission of App is possible 
but limited (1, 2).
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Serotype determination of a collection of Actinobacillus pleuropneumoniae isolates from Argentina
Fernando A. Bessone1 María de la Luz Ducommun1 Gustavo C. Zielinski1 Javier E. Sarradell2
1. Instituto Nacional Tecnologia Agropecuaria, Marcos Juárez-Córdoba, Argentina; 2. FCV-Univ. Nac. de Rosario, Casilda-Sta Fé, Argentina
Introduction
Porcine pleuropneumoniae is a worldwide spread disease 
responsible for severe economic loss to pig producers because 
of mortality, lower weight gains and increased production costs. 
Its aetiological agent, Actinobacillus pleuropneumoniae (App), 
has 2 biotypes (I and II) dependent and non-dependent for 
“in vitro” growth of nicotinamideadeninedinucleotide (NAD), 
respectively. The species has been classsifi ed into serotypes 
1-15, according to composition of surface cell walls antigens 
(LPS). This is important for immunity and protection, since most 
of the serotypes do not cross-react immunologically, having dif-
ferent pathogenic potential. So that, knowledgment on relative 
prevalence of diff erent serotypes in a particular producing area 
is important for establishing preventive control strategies. The 
objective of this work was to classify a collection of argentinean 
isolates of App into serotype groups, based on PCR amplifi cation 
of selected sequences belonging to the omlA and apx genes. 
Material and Methods
Forty eight App cultures isolated from clinical cases of pleuro-
pneumoniae in swine farms from diff erent locations of the coun-
try were utilized. The strains were cultured and biochemically 
classifi ed by conventional bacteriology laboratory works and 
stored lyophilized. For serotype classifi cation by PCR, bacterial 
ADN was extracted by a commercial kit (Fermentas™) and ran 
using primers and conditions reported previously (1).
Results
Serotype group classifi cation and percentages can be ob-
served in the following table 1. In fi gure 1 can be visualized the 
geographical location within Argentina where the strains were 
isolated.
Table 1. 
Serotypes  n isolations %
1/9/11 26 54
2/8 0 0
3/6 15 31
4 0 0
5 0 0
7 7 15
10 0 0
12 0 0
15 0 0
Total 48 100
Figure 1. Spatial distribution of isolations in Argentina.
Discussion
It can be observed that the most frequent group of serotypes 
detected is 1-9-11, since the test does not discriminate among 
these particular serotypes. It was expected that serotype 1 
was the most prevalent since was described as it long ago 
(2). However, a relative high frequency of serotypes 3-6 was 
detected, which is not surprising since existance of serotype 3 
was previously described (3). This is an important fi nding, since 
no conventional vaccines containing App serotypes 3-6-8 exist 
in the argentine market. Serotype 7 also showed a relatively high 
prevalence within this collection, which is not surprising either, 
since it was previously isolated from a clinical case of pleuro-
pneumoniae (4). 
In this work, strains from the most important producer areas 
from Argentina were studied, such as showed in fi gure 1. In the 
future a higher number of isolates should be processed, so that 
a more complete map of App serotype distribution in Argentina 
will be obtained. This information will allow to improve control 
and preventive strategies for this disease.
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Animals infected with Actinobacillus pleuropneumoniae serotype 15 develop 
antibodies that cross-react with serotypes 3, 6 and 8 by LC-LPS ELISA
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Introduction 
Swine pleuropneumonia caused by Actinobacillus pleuro-
pneumoniae (App) is a contagious disease that may produce 
important economic losses. Clinical signs of acute disease are 
dyspnea, coughing, anorexia, depression, fever and sometimes 
vomiting. In the absence of treatment, the disease can progress 
very rapidly and death can occur within a few hours. Chronic 
infections are characterized by coughing and pleuritis in lungs. 
There are 15 serotypes of App described so far. Serotype 15, the 
last described serotype, was suggested as being present only in 
Australia1. In this country, it seems to produce important losses 
in the swine industry. However, strains have later been isolated 
in USA, Canada and Argentina2 and, more recently, in Japan3, 
causing sporadic disease. In the present study, we analyzed sera 
from naturally infected animals in Australia, as well as, sera from 
experimentally infected animals with the reference strain HS-143 
and with North American strains. In addition, we studied the 
genetic diversity of within USA App serotype 15 strains.
Materials and Methods
Strain and isolates: The reference strain of App serotype 15 
(HS-143) was kindly supplied by Prof. J. Frey, Switzerland. Other 
reference strains came from our own collection. A total of 22 
isolates recovered from diseased animals originated from the 
University of Minnesota Veterinary Diagnostic Laboratory. These 
isolates were sent to our diagnostic laboratory for serological 
characterization. 
Antigenic and genotypic characterization: Serotyping was 
carried out by coagglutination, immunodifussion and indirect 
hemagglutination tests. Hyperimmune serum against strain 
HS-143 was produced in rabbits. Toxine profi le was performed 
by PCR. Genotyping was carried out by ERIC- PCR and Random 
Amplifi ed Polymorphic DNA (RAPD).
Field and experimentally infected swine sera: Field serum sam-
ples from two Australian herds clinically infected with serotype 
15 strains (kindly supplied by Dr. Patricia Spicer) as well as sera 
from six experimentally infected pigs with strain HS-143 were 
tested by LC-LPS ELISA against serotypes 1 to 124. A LPS antigen 
for serotype 15 was produced as described before4 using the 
reference strain. Selective immunoblot tests, using diff erent 
antigens and sera, were also performed.
Results
• Serotyping: All fi eld isolated presented a strong and clear 
reaction with anti-serotype 15 rabbit serum. Most strains 
presented also cross-reactions with serotypes 3, 6 and/or 8 
with most techniques used. Some isolates presented cross-
reactions with serotypes 7 or 12. 
• Genotyping: A relative degree of heterogeneity, with at least 
7 diff erent clusters, was observed.
• Toxine profi le: apxIVA, apxIBD, apxIICA, apxIIICA and 
apxIIBD(production of ApxIV, ApxII and ApxIII). 
• Serology:
LC-LPS ELISA WITH ANTIGENS
Sera from 
infected animals App 15 App 3 App 6 App 8 App 7 App 12
App 15 +++ +++ +++ +++ - -
App 3 +++ +++ +++ +++ - -
App 6 +++ +++ +++ +++ - -
App 8 +++ +++ +++ +++ - -
App 7 - - - - +++ -
App 12 - - - - - +++
• Most fi eld sera presented a clear positive reaction with anti-
gens from serotypes 3, 6, 8 and 15. Common LPS epitopes in 
these serotypes was confi rmed by immunoblot.
Discussion 
• App serotype 15 infection is relatively common in North 
America.
• LPS from App serotype 15 is antigenically related to that from 
serotypes 3, 6 and 8, as previously suggested by chemical 
analysis5.
• A slight cross-reactivity at the capsular level is observed in 
serotying, which also can be explained by previous capsular 
structure analysis5.
• Strains presented in USA are not clonal .
• Serologic diagnosis of herds infected by these strains can be 
done by the LC-LPS ELISA test using either homologous or 
serotype 3, 6 or 8 antigen.
References
1. Blackall et al. Vet. Microbiol. 2002. 84:47-52.
2. Gottschalk, M. Proc. 38th AASV. 2007. 381-84.
3. Koyama et al. J. Vet. Med. Sci. 2007, 69:961-64.
4 Gottschalk et al.Vet. Microbiol. 1994. 42: 91-104.
5 Perry et al. Biochem. Cell Biol. 2004. 83:61-9.
Respiratory diseases – Actinobacillus pleuropneumoniae
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 596
Poster Presentations
P.290
An atypical biotype I Actinobacillus pleuropneumoniae serotype 13 is present in North America
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Introduction 
Swine pleuropneumonia caused by Actinobacillus pleuropneu-
moniae (App) is a contagious disease that may produce import-
ant economic losses1. Clinical signs of acute disease are dyspnea, 
coughing, anorexia, depression, fever and sometimes vomiting. 
In the absence of treatment, the disease can progress very rapidly 
and death can occur within a few hours. Chronic infections are 
characterized by coughing and pleuritis in lungs. There are two 
biotypes of App diff erentiated on the basis of their requirement 
for nicotinamide adenine dinucleotide (NAD). Biotype 1 strains 
require NAD, whereas biotype 2 strains can synthesise NAD in 
the presence of specifi c pyridine nucleotides or their precursors1. 
There are 13 serotypes of biotype I (serotypes 1 to 12 and 15), and 
2 serotypes of biotype II (serotypes 13 and 14), based on surface 
polysaccharide antigens. Some strains belonging to serotypes such 
as 2, 4, 7 and 9, mainly isolated in Europe, have been described as 
being either biotype I or biotype II. So far, in North America, sero-
types 1 to 3, 4 (Canada), 5 to 8, 10, 12 and 15 have been isolated2. 
We report here for the fi rst time the isolation of serotype 13 strains 
in USA and Canada. However, these strains are NAD-dependent 
and antigenically diff erent from the reference strain3. 
Materials and Methods 
Isolates: Two isolates (003-16 and 15816), from a Canadian and 
an USA herds, respectively, were characterized. Both isolates 
were recovered from animals presenting clinical signs and le-
sions compatible with swine pleuropneumonia. Both strains 
were shown to be a typical biotype I (NAD-dependant) App. 
Both strains were shown to be App by two species-specifi c PCR. 
Strain characterization: Serotyping was carried out by coag-
glutination (CoAg), immunodifussion (ID) and indirect hemag-
glutination tests (IHA). Toxine profi le was performed by PCR. 
Genotyping was carried out by Amplifi ed Fragment Length 
Polymorphism (AFLP)4.
Field and experimentally infected swine sera: Field serum 
samples from herds infected with strains 003-16 or 15816 as 
well as sera from three experimentally infected pigs (with strain 
003-16) were tested by LC-LPS ELISA against serotypes 1 to 15 
and against the homologous strains. Selective immunoblot tests 
using diff erent antigens and sera were also performed.
Results 
• Serotyping:
Antiserum against a
Strain Used Serotype 13 Serotype 10 Other serotypes
Reference serotype 13 ++b - -
003-16 ++b ++c -
15816 ++b ++/+d +/-e
aSera from 6 diff erent rabbits from 2 laboratories; bBy all techniques used; cBy ID only (LPS-
like reaction); dBy all techniques, although weak reaction by IHA was observed (LPS-like 
reaction by ID); eLight cross-reactions with serotypes 5, 6 and 8. 
• Sera from either naturally or experimentally infected animals 
presented a positive reaction using LC-LPS ELISA when either 
the homologous (high values) or serotype 10 (intermedi-
ate values) LPS antigen was used. Negative results were 
obtained with LPS from the reference strain of serotype 13. 
Immunoblot tests clearly indicated a reaction with sera from 
experimentally infected animals with serotype 10 LPS.
• Toxine profi le: apx ICA; apx IBD (ApxI production).
• Genotyping: Both strains clustered together with the same 
profi le, clearly diff erent from the serotype 13 reference strain.
Discussion 
• Although slight diff erences, both Canadian and USA strain 
are antigenically similar.
• These strains are diff erent from the reference strain: a) 
biotype I; b) LPS similar to serotype 10 App; c) Apx I toxin 
production; d) a diff erent genetic cluster.
• These strains probably possess a capsular type of serotype 13 
and a LPS of serotype 10.
• Serologic diagnosis of herds infected by these strains should 
be done by the LC-LPS ELISA test using the homologous 
(preferable) or serotype 10 antigen.
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Proﬁ les of Actinobacillus pleuropneumoniae serotypes in Dutch slaughter pigs
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Introduction
Although Actinobacillus pleuropneumoniae (App) infections have 
been evidenced in The Netherlands, the actual distribution of the 
diff erent App serotypes in Dutch pigs is unknown and so, it is not 
clear which types of App should be tested for App control or eradi-
cation programmes Therefore, a study was performed to get;
1. more insights in circulating App serotypes in Dutch herds 
with unknown history of App by performing a serological 
survey in slaughter pigs and
2. by characterisation of App strains isolated from clinical cases. 
Materials & Methods
500 serum samples from slaughter pigs, originated from 100 
ad random chosen herds (n= 5 per herd), were analysed for the 
presence of App antibodies using 7 diff erent ELISA’s. These ELISA’s 
were able to detect antibodies directed against lipopolysacchar-
ides (LPS) antigens of App, specifi c to one or a group of serotypes 
1 - 12 (Biovet, Canada). In addition, 24 serum samples collected 
from a swine herd, positive by Apx-IV Idexx ELISA but without App 
related clinical signs, were analysed using the LPS antigens ELISA’s. 
The Bayesian True Prevalence model was used for calculating the 
App antibody prevalences in Dutch slaughter pigs.
Within the period February – December 2008, 63 App strains 
were isolated from clinically aff ected swine after necropsy. The 
App strains were obtained from other herds than the herds de-
scribed above. App strains were serotyped by standard coagglu-
tination assay using a panel of type-specifi c anti-sera against all 
15 serotypes (National Veterinary Institute, Denmark). If neces-
sary the serotype of the App strains was further characterised 
by the immunodiff usion method and/or serotype specifi c PCR’s. 
The Apx-toxin profi les were determined by PCR. 
Results
Table 1 presents the results of serotype specifi c ELISA’s, includ-
ing the calculated App seroprevalences in Dutch slaughter pigs. 
In 142 (28.4%) of the 500 examined slaughter pigs, no positive 
reactions were recorded in any of the 7 App antibody ELISA’s. 
In at least 44% of the examined herds positive reactions were 
recorded in more than one of the 7 ELISA’s. 
Table 1: Results (n= 500 sera) of the App serotype or serogroup specifi c 
ELISA’s, and the calculated prevalences with 95% confi dence intervals (CI).
Serotype(s)
/ serogroup 
Positive sera
(n)
Prevalences
(%) [95% –CI]
LPS 1, 9, 11 33 3.6   [0.2 – 8.2]
LPS 2 180 29.1  [14.7 – 38.9]
LPS 3, 6, 8 105 19.4  [12.0 – 24.6]
LPS 4, 7 106 17.1  [9.6 – 23.5]
LPS 5a, 5b 12 0.4   [0.0 – 1.5]
LPS 10 5 0.3   [0.0 – 1.1]
LPS 12 146 21.6  [14.0 – 28.6]
In the 24 swine sera of one Apx-IV ELISA positive herd, anti-
bodies directed against App serotypes 3, 6, 8 (n=15), 4, 7 (n=3) 
and serotype 12 (n=5) were detected.
Sixty (95%) of the 63 App isolates were characterised as serotype 
2 (70%) or 9 (25%: Table 2). The Apx-toxine profi les of 61 (97%) of 
the 63 examined App isolates were similar to one of the sero-
types that were detected too by serotyping and/or App type-
specifi c PCR. 
Table 2: Results of the serotyping of the App strains and the Apx-toxine 
profi les (n=63).
No of isolates (n) Serotype Apx-profi le
44  (70% 2 2,4,6,8
16  (25%) 9 1,5,9,11
1   (2%) NT 7,12
1   (2%) 9/11 1,5,9,11
1   (2%) 13* 7,12
* NAD dependent App strain from the heart of a clinically aff ected pig.
Discussion
This study shows that Dutch slaughter pigs have:
• Rather high App antibody prevalences against serotypes 
2, 3/6/8, 4/7 and 12, and low antibody prevalences against 
serotypes 1/9/11, 5a/5b and 10.
• Herds could be positive for antibodies against more than one 
App serotype
• Antibodies against App serotypes 3/6/8, 4/7 and serotype 12 
were found in one herd without clinical signs related to App 
infections 
• The serological profi le of App serotypes in slaughter pigs dif-
fers from the App serotype profi le found in clinically aff ected 
pigs. In 95% of these pigs, originated from other herds, App 
serotypes 2 and 9 were found.
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Nils Holmgren2 Nils Lundeheim1 Sivert Johansson2 Leif Göransson1 Gösta Gustafsson4 Johan Ehlorsson3
1. Swedish University of Agric. Sciences, Uppsala, Sweden; 2. Swedish Animal Health Service, Skara, Sweden; 
3. Swedish Animal Health Service, Ängelholm, Sweden; 4. Swedish University of Agric. Sciences, Alnarp, Sweden
Introduction
Actinobacillus pleuropneumoniae causes pleuropneumonia (PP) 
in swine throughout the world and can cause severe economic 
losses (3). Acute outbreaks often appear unpredictable at the 
end of the fattening period (1). On average 0.6% of slaughter-
pigs in Sweden show acute PP, but the variation between herds 
is substantial 0-60% (5). Limited options are available to prevent 
the disease. Improvements in barn climate have not been evalu-
ated as preventive measures. Experiences made by practitioners 
indicate that feeding may infl uence on PP. Therefore, the aim of 
the present study was to look for climatologic and nutritional 
risk factors for PP.
Material and Methods
The trial was conducted as a case-control study in 25 barns with 
documented high, and in 25 barns with low prevalence of PP at 
slaughter. Averages by quarter of PP-prevalence (n=8) before, 
during and after the trial were in case-barns 4.6% (SD=0.2%) and 
in control-barns 0.2% (SD=0.1%). Case- and control-barns were 
matched for slaughter plants, and season at visit (April – Sept).
Measurements of climate and environmental factors were 
performed in a standardised way by an engineer specialised on 
climate in pig houses. Measurements taken at herd visits (pig 
age 20-24w) were: max. ventilation rate; air inlet capacity; under- 
pressure (Dwyer type Mark II); air velocity in the resting zones at 
diff erent ventilation rates (0-100%); balance between exhaust 
and inlet air; heat balance; sectioning between barns; air con-
tamination; functioning of climate regulation equipments; pen 
hygiene; concentrations of CO2 and NH3. The release (amount) 
of NH3 in relation to animal density (CR) was calculated (4). 
Composition of feeds and feed allowances during the fattening 
period was recorded at farm visits. The statistical analyses were 
performed by Students t-test and logistic regression, using the 
SAS software (PROC TTEST; PROC GENMOD; PROC GLIMMIX).
Results
On average, PP barns had more defi ciencies in air inlet and in air 
outlet capacities compared to control barns. These diff erences 
were however not signifi cant. There was a tendency for better 
control of air in- and outlet in control herds (p=0.07).
Analysed diff erences between case-control barns are presented 
in Table 1. In total, 9 possible risk factors diff ered signifi cantly 
between the two group of barns. When including all these risk 
factors as explanatory variables in the logistic regression, 3 of 
these factors had a p-value =<0.15 (Table 2). 
Discussion
Climate in barns had unexpected low impact on the occurrence 
of PP. However, a more intense feeding plan (+1MJ/pig/d) and 
use of many alternative feed-stuff s had negative impact on pen 
hygiene. In the fi nal model there were tendencies for alternative 
feeds and intense feeding to be risk factors for PP. If this is due 
to an increased metabolic stress in fast growing pigs is unknown 
and has to be elucidated by further investigations. The number 
of fatteners in herds had a strong impact on the occurrence of 
PP. The same risk factor has also been identifi ed for pleurisy in 
slaughtered pigs (2). 
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Introduction
Acute-phase proteins mirror the magnitudes of primary Actino-
bacillus pleuropneumoniae (APP) infections (1) which are infl u-
enced by early initiated antimicrobial treatments, and also cor-
related to the effi  cacies of such treatments (2). However, little is 
known about the acute-phase response following re-infections, 
especially how it is infl uenced by responses following previous 
treatments. Therefore we studied the acute-phase response after 
a re-challenge with APP in pigs treated with drugs of diff erent 
effi  cacies following the fi rst exposure.
Materials and Methods
30 nine week old SPF-pigs were allocated to 5 groups and 
housed in separate rooms with a high level of biosecurity. After 
acclimatisation, 4 groups were inoculated intranasally with 1011 
CFU of APP serotype 2 (APP2). At the onset of clinical symptoms, 
20 hours pi, the groups were either treated with enrofl oxacin, 
tetracycline or penicillin. One group served as an inoculated 
control and did not receive any treatment and one group served 
as an un-inoculated control group.
On day 28, all 5 groups were challenged with 1011 CFU of APP2. 
No treatments were carried out this time (3). 
Blood was collected once daily following inoculations and there-
after once or twice weekly (Fig 1). Haptoglobin and Serum amyloid 
A (SAA) in serum were analysed using commercial assay kits (PHA-
SETMRANGE, Tridelta), according to the manufacturer’s instructions.
Results
Results regarding clinical signs, antibody responses and post-
mortem fi ndings are well documented and published (3). Acute 
phase responses mirrored serology and clinical manifestations 
well (3). Following the fi rst inoculation, both haptoglobin and 
SAA-levels increased in all inoculated pigs while no changes 
were observed in the un-inoculated pigs (Fig. 1). Acute-phase 
responses were not observed in any of the previously inoculated 
groups except the enrofl oxacin treated group following the 
re-challenge. In contrast, increased levels were recorded in the 
previously un-inoculated control group and in the enrofl oxacin 
treated group (Fig. 1).
Discussion
Early medication with enrofl oxacin has proven very eff ective in 
treating acute actinobacillosis, preventing seroconversion (4). 
However, these pigs were unprotected upon re-challenge, de-
spite the initiation of an acute-phase response after the primary 
exposure to APP2 (3). This implies that early treatments with very 
eff ective antimicrobials prevent any immunological memory to 
develop. Consequently, an acute-phase response appears fol-
lowing re-challenge of such animals. 
Figure 1. Mean serum concentrations of haptoglobin (a) and SAA (b) 
following inoculation with A. Pleuropneumoniae serotype 2 on days 
0 and 28. Two groups served as controls, one was inoculated on both 
day 0 and 28 (◼), and one only on day 28 (◻). Three groups received 
antimicrobial treatments for 3 consecutive days after the fi rst inocula-
tion: (◇) enrofl oxacin, (⚪) tetracycline and (△) penicillin.
Early treatment with tetracycline was clinically eff ective, but 
pigs seroconverted to APP2 as did pigs in the other inoculated 
groups (3). The seropositive pigs remained unaff ected and did 
not express any acute-phase responses following the re-chal-
lenge with APP2. Thus, both haptoglobin and SAA appear to be 
sensitive indicators of ongoing infections with APP.
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Introduction
The severity of respiratory tract disease is essentially determined 
by the quality of immediately activated reactions of the innate 
immune system as the fi rst line of defense, which is also respon-
sible for naturally occuring disease resistance in breeding lines 
(1). Understanding local innate mucosal immune responses of 
the upper and lower respiratory tract will be the basis for the de-
velopment of new control strategies against disease. The tissue 
distribution of the antibacterial peptid PR-39 which has been 
found to be a local respiratory disease marker in BALF has been 
observed as an example for the constitutive defense readiness 
of the upper and lower respiratory tract. In addition systemic 
disease markers as acute phase proteins are involved also in lo-
cal immune defense mechanisms in the lung (2); they have been 
examined in this study in healthy pigs; and in pigs infected with 
Actinobacillus pleuropneumoniae (A.pp).
Materials and Methods
The immunhistochemical examination of tissue samples was 
performed in three healthy mock-infected pigs and six pigs 
infected with diff erent serotypes of A.pp in the acute (n=2) and 
chronic (n=4) stage of infection. Subsequently samples from the 
Concha nasalis, Tonsilla pharyngea, Trachea, Lung (Lobus cranialis, 
Lobus caudalis as well as from altered lung tissue at other loca-
tions) and the Lymphonodi tracheobronchales craniales were 
sampled. For the demonstration of PR-39, sections were stained 
with a monoclonal mouse anti-PR-39-antibody and a second-
ary peroxidase-coupled polyclonal goat-anti-mouse antibody. 
The determination of acute phase proteins Haptoglobin (Hp), 
C-reactive protein (CRP), pig major acute phase protein (pig 
MAP), serum amyloid A (SAA) and the LPS binding protein (LBP) 
in BALF and serum was performed prior to and at days 4 and 20 
after aerosol infection with an A.pp serotype 7 strain AP76. 
Results
PR-39 was detected in all tissue samples of healthy and pneu-
monic pigs. In healthy lung tissue a homogenous distribution 
of the peptide was found while a high increase of positive cells 
could be detected in pneumonic areas (Fig. 1a and b).
Hp, CRP and pigMAP were signifi cantly increased in BALF and 
serum at day 4 after infection, while HP concentrations in BALF 
further increased to day 21 after infection (Fig 2). SAA was only 
increased in serum at day 4 after infection, while LBP concentra-
tions showed no signifi cant changes.
Discussion
According to the tissue and cell distribution of PR-39 not only 
neutrophils but also other cells might be responsible for PR-39 
expression or uptake. An increase of Haptoglobin in BALF sup-
ports the hypothesis of a local production in lung cells, so that it 
can be considered also as a respiratory disease marker refl ecting 
lung tissue alterations. Day 4 after infection might have been 
too late to detect early changes in the LBP concentration as a 
proximate eff ector molecule of the innate immune system.
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Introduction
Actinobacillus pleuropneumoniae (AP) causes fi brinous, hemor-
rhagic, necrotizing pleuropneumonia in all ages of pigs. The 
Actinobacillus pleuropneumoniae exotoxins (Apx) are one of the 
major virulence factors of AP. Previous studies had revealed that 
pigs endotracheally inoculated with live AP bacteria resulted in 
the expression of proinfl ammatory cytokines in lungs, including 
IL-1, IL-8 and TNF- α; however, what types of cells and bacterial 
components involved in this process remained unidentifi ed (1, 
2). Therefore, the objective of this study was to examine whether 
AP serotype 10-derived exotoxin, ApxI, caused proinfl ammatory 
cytokines expression in porcine alveolar macrophages (PAMs), 
one of the fi rst line defense cells in lung.
Materials and Methods
PAMs were obtained from 3- to 6-week-old healthy piglets 
through lavage. ApxI was harvested from the culture super-
natant of AP serotype 10. For experiments, PAMs were treated 
with 0.5–1 CU/ml or heat-inactivated ApxI ( ΔApxI) in the pres-
ence of polymyxin B for 2–4 h. The mRNA and protein levels 
of cytokine expression were determined by real-time reverse-
transcriptase PCR (RT-PCR) and quantitative ELISA (Quantikine®, 
R&D system), respectively. Proinfl ammatory cytokines examined 
included IL-1 β, IL-8 and TNF- α.
Results
To examine the protein expression level of cytokines under treat-
ment with APP serotype 10 derived ApxI, cytokines IL-1 β, IL-8 and 
TNF- α were determined by quantitative ELISA. Signifi cant eleva-
tion of IL-1 β, IL-8 and TNF- α were found in culture supernatants 
of PAMs at 4 h after stimulation with ApxI (image1). Levels of these 
cytokines in ΔApxI-treated group did not diff er signifi cantly form 
untreated control group, suggesting that the induction of cyto-
kines was attributable to the bioactivity of ApxI.
To further examine the transcription levels of IL-1 β, IL-8 and TNF- 
α genes expression, PAMs treated with ApxI were subjected to RT-
PCR analysis. The results indicated that ApxI induced signifi cantly 
higher mRNA levels of IL-1 β, IL-8 and TNF- α in PAMs than that in 
ΔApxI or control group (image2). These data are consistent to the 
fi ndings in quantitative ELISA and indicate that AP-derived ApxI 
induces IL-1 β, IL-8 and TNF- α expression in PAMs.
Discussion
Overproduction of proinfl ammatory cytokines has been impli-
cated in the AP-induced lung damage (1). In this study, we dem-
onstrated that ApxI, in addition to its hemolytic and cytotoxic 
activities, induces the expression of IL-1, IL-8 and TNF- α in PAMs 
that might have a role in the pathogenesis of AP.
ApxI induced IL-1, IL-8, and TNF- α secretion from PAMs. PAMs were 
incubated with 1 CU/ml of ApxI or heat-inactivated ApxI ( ΔApxI) for 4 h. 
Protein levels of cytokines in culture supernatants were determined by 
quantitative ELISA. ***p < 0.001, n.s., no signifi cance.
ApxI induced gene expression of IL-1, IL-8, and TNF- α in PAMs. PAMs 
were incubated with 0.5 CU/ml of ApxI or heat-inactivated ApxI ( ΔApxI) 
for 2 h and subjected to RT-PCR analysis.
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Introduction
Respiratory tract infections in pigs pose a severe economic prob-
lem to farmers due to immense costs for antibiotic treatments 
and increased mortality rate among piglets. Vaccines developed 
so far only alleviate clinical symptoms but do not prevent col-
onisation by the pathogens. Therefore there is a strong interest 
in the identifi cation of genes which modulate the susceptibility 
of pigs to respiratory tract infections. This work was performed 
under the auspices of the project FUGATO-IRAS and the ongoing 
project RePoRI. The aim of the project is the development of 
genetic markers to predict resistance. By means of these markers 
a pre-selection of animals with reduced susceptibility to respira-
tory tract infections shall be enabled in breeding programs.
Materials and Methods
Highly informative microsatellite markers have been developed 
for 35 candidate genes. These genes belong either to the innate 
immune system (e.g. toll-like receptors) or are supposed to be 
directly related to an infection with A. pleuropneumoniae. For 
identifi cation of suitable microsatellite motifs within or in prox-
imity of the target gene genomic porcine sequences available in 
the NCBI database or shotgun genomic sequences from porcine 
BAC clones have been used. Genotyping was carried out using 
standardized PCR-techniques with subsequent direct-blotting 
and chemiluminescence detection of the products. By means of 
these markers two diff erent objectives were pursued. The fi rst 
aim was the investigation of the current gene pool in diff erent 
pig populations in Germany. The second aim was the com-
parative genotyping of pigs from four diff erent breeding lines 
with a mild or severe course of disease after infection with A. 
pleuropneumoniae in order to identify loci which modulate the 
susceptibility of the animals to respiratory tract infections. For 
the diversity study 74 samples from rare and / or old pig breeds 
and 69 samples from a consumer study (meat samples bought 
in supermarkets and butcheries in 30 cities all over Germany) 
were taken. For the association study 100 animals with defi ned 
phenotype after infection have been genotyped (infection 
model standardized by the Tierärztliche Hochschule Hannover).
Results
The diversity study revealed large diff erences of the allele distribu-
tion among the examined cohorts. The largest allele diversity was 
observed in the consumer study gene pool whereas the allele 
pool in the tested breeding lines showed less variation. Unique 
alleles were only observed in the wild boar population whereas 
the gene pools of the examined breeding lines represented parts 
of the consumer study gene pool at each marker locus. 
The analysis of the association study data revealed statistically 
signifi cant diff erences concerning the genotype distribution 
of the mildly and severely infected pigs at 7 marker loci mainly 
belonging to the interferon receptor and tumor necrosis factor 
receptor superfamilies.
Discussion
The next step will be the comparative sequencing of homo-
zygous carriers of risk or resistance alleles respectively at the 
pre-selected loci to enable the identifi cation of SNPs. With these 
data a haplotype analysis will be performed to minimize the 
genomic region responsible for the association.
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Introduction
Actinobacillus pleuropneumoniae (AP) is the causative agent 
of fi brinous, necrotic and hemorrhagic pleuropneumoniae in 
swine. Actinobacillus pleuropneumoniae exotoxins (Apx) are 
one of the major virulence factors of AP (2). Our previous study 
has demonstrated that native ApxI at low concentration causes 
apoptosis in porcine alveolar macrophages (PAMs), one of 
the fi rst line defense cells in lungs (1). However, the molecular 
mechanisms underlying ApxI-induced apoptosis are not well 
understood. Therefore, the aim of this study was to elucidate the 
signaling pathways mediating ApxI-induced apoptosis in PAMs 
with focuses on the eff ect of ApxI on mitogen-activated protein 
kinase (MAPK) and the role of MAPK in ApxI-induced apoptosis 
of PAMs.
Materials and Methods
PAMs were obtained from 3–6-week-old healthy piglets through 
lavage. The exotoxin ApxI of A. pleuropneumoniae serotype 10 
was prepared from bacterial culture supernatant. For experi-
ments, PAMs were treated with 0.5–1 CU/ml ApxI in the presence 
of polymyxin B for 0–6 h. The levels of active, phosphorylated 
MAPKs p38 and JNK were determined by Western blot analysis. 
PAMs were pretreated with a p38 inhibitor (SB203580) or JNK in-
hibitor (SP600125) for 1 h, followed by ApxI stimulation, Hoechst 
dye staining, and scored for apoptosis.
Results
To evaluate the potential role of MAPKs in ApxI eff ect, the phos-
phorylated p38 and JNK were assessed by Western analysis for 
the indicated time periods. The levels of phospho-p38 increased 
substantially and reached a plateau between 0.5 and 2 h post ApxI 
stimulation (Fig. 1A). The phospho-JNK isoforms were observed at 
1 h post-treatment with ApxI and persisted to 4 h (Fig. 1B). 
To further determine the involvement of p38 and JNK in ApxI-
induced apoptosis, selective inhibitors was used to pre-treat 
PAMs prior to stimulation of ApxI and scored for apoptosis. The 
results indicated that addition of p38 inhibitor and JNK inhibitor 
caused a ~45% and ~35% reduction in ApxI-induced apoptosis, 
respectively (p < 0.05; Fig. 2). Co-administration of SB203580 and 
SP600125 prevented PAMs from ApxI-induced apoptosis almost 
completely (p < 0.001). These results demonstrated that p38 and 
JNK both contributed to apoptosis of PAMs in response to ApxI.
Discussion
In this study, it was demonstrated that both p38 and JNK were 
activated in PAMs stimulated with ApxI. Blocking activities of 
these two kinases rescued PAMs from apoptosis by ApxI. These 
fi ndings suggest a crucial role of MAPK signaling in ApxI-mediat-
ed apoptosis. 
Figure 1. ApxI activated MAPKs p38 (A) and JNK (B) in PAMs. PAMs 
were treated with 1 CU/ml of ApxI or left untreated for 0 to 6 h and 
subjected to Western blot analysis for phosphorylated p38 (p-p38) and 
JNK (p-JNK). Beta-actin served as a loading control.
Figure 2. p38 and JNK inhibitors attenuated ApxI-induced apoptosis 
in PAMs. PAMs pre-treated with 20 μM of p38 inhibitor SB203580 (SB), 
JNK inhibitor SP600125 (SP), or both were stimulated with ApxI for 6 h, 
followed by apoptosis scoring. * p < 0.05; *** p < 0.001. V, vehicle DMSO 
used to dissolve inhibitors.
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Introduction
Actinobacillus pleuropneumoniae (APP) causes a highly conta-
gious pleuropneumonia in pigs with major economic losses in pig 
farming worldwide. The four major RTX toxins ApxI, ApxII, ApxIII 
and ApxIVA are secreted by the diff erent serotypes in various com-
binations. Compared to ApxI, ApxII and ApxIII, ApxIV is produced 
by all serotypes of APP, highly specifi c to APP and expressed only 
in vivo but not in vitro conditions. Based on the information in 
GenBank, apxIVA gene was sequenced after PCR amplifi cation 
from A. pleuropneumoniae serotype 2 Korean isolate. ApxIVA of 
Korean isolate was analyzed and characterized using determined 
amino acid sequences after sequencing of the gene. 
Materials and Methods
Primer sequences of apxIVA were designed according to the ref-
erence strain (GenBank assession No. AF021919). Primer walking 
method was performed for nucleotide sequences of unknown 
region of ApxIVA Korean strain. Extended PCR amplifi cation 
and sequencing except apxIVA were performed to confi rm 
sequences. ApxIVA of Korean isolate was determined amino acid 
sequences. Analyzed sequences of apxIVA were compared with 
the reference strains. In addition, the phylogenetic analysis was 
performed based on nucleotide and amino acid sequences com-
pared with 5 diff erent APP reference strains (GenBank assession 
No. AF021919, AF030511, CP000569, GQ332268 and CP000687) 
using MEGA 4.0 program. The regions of similarity between 
Korean isolate and the reference strains is represented by a dot-
plot. The percent identity was performed based on nucleotide 
sequences and amino acid sequences compared with reference 
strains using MegAlign 5.0 DNASTAR. The determined amino 
acid sequences were analyzed to characterize bioinformatics 
of ApxIVA Korean isolate using ProtScale, emboss polydot and 
Hphob. / Kyte & Doolittle program. 
Results
The full length nucleotide size of apxIVA was 5,856bps and con-
fi rmed by nucleotide sequencing. ApxIVA of Korean isolate was 
determined amino acid sequences with a predicted molecular 
mass of 218,124.77 Da and a theoretical pI of 4.76. ApxIVA Ko-
rean isolate gene is preceded immediately upstream by a ORF1. 
Upstream of ORF1, there is a stem loop structure. This stem loop 
structure is preceded the C-terminal end of mrp gene. LacZ gene 
is present the C-terminal of apxIVA. Stem loop structure is locat-
ed between C-terminal of ApxIVA and LacZ. ApxIVA of Korea iso-
late was closely related to 5 diff erent reference strains, showing 
96.4, 96.1, 96.4, 96.8 and 98.4% nucleotide homology. ApxIVA 
Korea isolate showed 100, 95.2, 95.3, 96.2 and 98.2% homology 
compared with China(CP000569), Switzerland(AF030511), Can-
ada, China(GQ332268) and Switzerland(AF021919) in amino acid 
level. Conserved region and repeats are easy to see in ApxIVA 
Korean isolate by dotplot program. The C-terminal part of Apx-
IVA Korean isolate contains 30 glycinerich nonapeptides with 
the consensus sequence L/V-X-G-G-X-G-N/D-D-X. The hydrop-
athy plot of ApxIVA Korean isolate was shown by Hphob. / Kyte & 
Doolittle program. This analysis revealved a hydrophobic region 
at the N-terminus and a hydrophilicity in general region. 
Discussion
The amplifi ed apxIVA Korean isolate from A. pleuropneumoniae 
serotype 2 was confi rmed and analyzed by sequencing. Nucleo-
tide and amino acid sequences of whole apxIVA of Korea isolate 
were similar to the reference strain. Conserved region and 
repeats are shown in ApxIVA Korean isolate by dotplot program. 
There are 30 glycinerich nonapeptides with the consensus se-
quence in the C-terminal part of ApxIVA Korean isolate. The hy-
dropathy plot of ApxIVA Korean isolate revealved a hydrophobic 
region at the N-terminus and a hydrophilicity in general region.
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Introduction
Saccharomyces cerevisiae has been used as a tracer for the oral 
application of vaccines and drugs because it is relatively stable, 
nonpathogenic and noninvasive in the gut compared with the 
other biodegradable vehicles. Oral vaccination of Saccharomy-
ces cerevisiae expressing full-genes of ApxIIA was previously 
reported and capable of inducing antigen-specifi c immune re-
sponses in murine model. In this study, S. cerevisiae was engin-
eered to anchor the neutralizing epitope of ApxIIA on the outer 
layer of the cell. Neutralizing epitope of ApxIIA was derived from 
Actinobacillus pleuropneumoniae serotype 2 Korean isolate. In 
vitro experiments using porcine alveolar macrophages, surface 
displayed ApxIIA in S. cerevisiae had eff ective immune-stimulat-
ing activity. Oral vaccination of surfaced ApxIIA in S. cerevisiae 
was investigated in piglets by comparing the systemic and local 
immune responses and clinical signs and pathologic lesions 
after challenge with A. pleuropneumoniae serotype 5 Korean 
isolate.
Materials and Methods
Porcine alveolar macrophages were obtained from 8-week-old 
healthy piglets through lavage and isolated using previously 
described procedures (Iglesias et al., 1989). The cells were dis-
pensed at a concentration of 1 x 106 cells/ml in 24 well micro-
plates. The cells were stimulated with 4 x 105 cells/ml of vector 
control- and surface-displayed ApxIIA in S. cerevisiae and 1 μg/
ml of LPS. After stimulation, the concentrations of secreted nitric 
oxide (NO), TNF- α and IL-6 were measured with ELISA (R&D 
SYSTEMS). 
Three-week-old piglets were used in this study. Each experi-
mental group consisted of 5 pigs was deginated into four 
groups; non-treated group, vector control group, oral vaccinated 
groups with surface-displayed ApxIIA in S. cerevisiae. This was 
followed by three-time administrations with gradually increas-
ing amount of the vaccines with 1 week intervals. After last 
boosting, pigs were challenged by intra-tracheal and intra-nasal 
injection with A. pleuropneumoniae serotype 5 Korean isolate. 
ApxIIA-specifi c immune responses were measured in sera, nasal 
wash and fecal samples by ELISA. Protectivity was investigated 
by comparing clinical signs, pathological lesions and histo-
pathologic analysis after challenge with A. pleuropneumoniae 
serotype 5 Korean isolate. 
Results
The amount of secreted NO, TNF- α and IL-6 in the supernatant 
of porcine alveolar macrophages were measured after stimu-
lation with vector control- and surface-displayed ApxIIA in 
S. cerevisiae, and LPS. While IL-6 and NO were not measured, 
the production of TNF- α from porcine alveolar macrophages 
increased time-dependently after exposure. 
Pigs immunized orally with surfaced-ApxIIA in S. cerevisiae 
maintained a higher ApxIIA-specifi c IgG response than the non-
treated and vector control group in serum. ApxIIA-specifi c IgA 
titers of the vaccinated groups were a little higher than the non-
vaccinated groups in serum and fecal sample. After challenge 
with A. pleuropneumoniae serotype 5 Korean isolate, scores of 
clinical signs and pathological lesions of vaccinated pigs were 
lower than those of the control group. Survival rate was high in 
the vaccinated group. 
Discussion
The secretion of TNF- α was evaluated as a parameter of macro-
phages stimulation. Higher secretion of TNF- α was showed in 
the supernatant of macrophages exposed to surface-displayed 
ApxIIA in S. cerevisiae. Porcine alveolar macrophages did not 
produce any NO after stimulation. Present result lends support 
to the theory that porcine macrophage are not able to pro-
duce NO in vitro. Although the secretion of IL-6 was not almost 
induced after 24h of stimulation, supplementary experiment 
needs such as arrangement of experiment schedule and the 
amount of stimulants for confi rmation of this conclusion. 
Pigs immunized orally with surface-displayed ApxIIA showed 
ApxIIA-specifi c immune response in serum and nasal wash. 
Although ApxIIA-specifi c IgA was not signifi cantly increased, 
protectivity was signifi cantly diff erent in the vaccinated group in 
the challenge. These results suggested that the feeding surface-
displayed ApxIIA in S. cerevisiae might be an eff ective vaccina-
tion strategy. Based on these results, more eff ective oral vaccina-
tion strategy should be established through further study.
Acknowledgements
This study was supported by ARPC (107034-03-3-CG000), BioGreen 21 
Program (20080401034048), BK21 for Veterinary Science and Research 
Institute of Veterinary Science, Seoul National University, Republic of 
Korea.
References 
1. Sung Jae Shin. et al. FEMS Immunol. Med. Microbiol. 43. (2005) 155-164.
2. Kyung-yeol Lee. et al. FEMS immunol Med Microbiol. 48(2006) 381-389.
3. Petra Zelnickova. et al. Nitric Oxide. 19 (2008) 36-41.
4. Maw-sheng Chien. et al. Vet. Microbiol. 135 (2009) 327-333.
Respiratory diseases – Actinobacillus pleuropneumoniae
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 606
Poster Presentations
P.300
Bioﬁ lm formation in ﬁ eld isolates of Actinobacillus pleuropneumoniae
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Introduction
Actinobacillus pleuropneumoniae is the causative agent of 
swine pleuropneumonia, a highly contagious and often fatal 
respiratory disease that aff ects pigs worldwide.
Biofi lms play a key role in the pathogenesis of many bacterial 
infections. As a fi rst step toward understanding the mechanism of 
A. pleuropneumoniae biofi lm formation and the role it may play 
in the pathogenesis of swine pleuropneumonia, we sought to 
develop methods to observe the biofi lm phenotype in the labora-
tory, and to determine the prevalence of biofi lm formation among 
various A. pleuropneumoniae fi eld isolates from Romania. In this 
report we show that A. pleuropneumoniae forms biofi lms in glass 
tubes. This phenotype is stable when A. pleuropneumoniae is cul-
tured on agar but is rapidly lost when cells are cultured in broth.
Material and Method
All fi eld isolates (30 strains) were from the lungs of pigs with 
swine pleuropneumonia. All isolates were tested for gram stain 
reaction and requirement for NAD. Bacteria were grown on 
BHI agar and broth or in Mueller Hinton broth. The media were 
supplemented with 0.1% of NAD. Cultures were incubated in air 
at 37ºC for 24 hours.
Results and Discussions
Strains formed thick biofi lms at the air–liquid interface when cul-
tured in glass tubes with agitation. The biofi lm formation pheno-
type was maintained indefi nitely when cultures were passaged 
on agar but was lost after one or two passages in broth. 
Our fi ndings indicate that biofi lm formation is a prevalent 
phenotype among A.pleuropneumoniae fi eld isolates, and that 
this phenotype may have been previously overlooked because 
of its tendency to be lost upon subculturing in broth. Biofi lm 
formation may have relevance to the colonization, pathogenesis 
and transmission of this bacterium.
Conclusions
Considering the ability of A.pleuropneumoniae strains to pro-
duce biofi lm on the walls of test tubes in which they had been 
cultivated in BHI broth, as a defi ning indicator of adesin produc-
tion linked pathogenity, there were found diff erences among 
the strains we isolated, only 56% of our strains had the ability to 
produce micro-colonies adherent to the tube walls, although all 
strains were hemolytic.
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Introduction
Porcine contagious pleuropneumonia is a severe infection 
caused by Actinobacillus pleuropneumoniae (APP). Timely 
implementation of eff ective antimicrobial treatment depends on 
rapid diagnosis. The apxIVA gene was showed highly specifi city 
in Actinobacillus pleuropneumoniae and does not exist in other 
species that closed to A.pleuropneumoniae. But not all the 
strains of A.pleuropneumoniae have high virulent, The strains 
that product APXI toxin were high virulent strains. Loop-mediat-
ed isothermal amplifi cation (LAMP) method was a novel nucleic 
detection method with high specifi city and sensitivity. Using 
the LAMP method targeting the apxIVA gene and apxI gene, we 
could rapidly and correctly detect A.pleuropneumoniae infec-
tion and the high virulent strains of A.pleuropneumoniae within 
1 hour which is more rapid than conventional PCR.
Material & Methods
LAMP was carried out in 25 μL reactions containing 1.6 μM of 
each inner primer (FIP and BIP), 0.2 μM of each outer primer (F3 
and B3), 0.4 μM of each loop primer (LF and LB), 1.4 μM deoxy-
nucleoside triphosphates, and 1 M betaine (Sigma). Each LAMP 
reaction also included 20 mM Tris-HCl (pH8.8), 10 mM KCl, 10 
mM (NH4)2SO4, 6 mM MgSO4, 0.1% Tween 20, 8 U of Bst DNA 
polymerase large fragment (New England Biolabs), and 1 μL of 
template DNA. The mixture was incubated at 63˚C for 30 min 
in a water bath and heated at 80˚C for an additional 10 min to 
terminate the reaction.
Results
The LAMP assay amplifi ed the target gene within 30 minutes, 
and required only a laboratory water bath for the reaction to 
occur. The apxIVA LAMP and apxI LAMP respectively successful 
amplifi ed all serovars of A. pleuropneumoniae and serovars of 
1,5,9,10,11 which were high virulent strains of A. pleuropneu-
moniae. A total of 100 lung samples were collected from 100 
pigs with apparent respiratory problems. The LAMP and PCR 
methods were also compared in fi eld trials. Eighteen lung tis-
sue samples tested positive for A. pleuropneumoniae by both 
apxIVA-nested PCR and apxIVA-LAMP methods. We also use apxI 
PCR and apxI LAMP for the 18 samples. Six samples were test 
positive by both apxI PCR and apxI LAMP. The PCR and LAMP 
have a great agreement. 
Discussions & Conclusions
The LAMP is a novel nucleic detection method with high 
specifi city and sensitivity. In our sensitivity test, we found that 
the sensitivity of LAMP assay is about 10 times more than that 
of conventional PCR. In the fi eld trail, ApxIVA-LAMP picked up 
10 additional positive samples that were missed by nested-PCR 
(p<0.0001,chi-square test). Based on the apxIVA gene and apxI 
gene, LAMP assay could detection of A. pleuropneumoniae 
infection and high virulent strains of A. pleuropneumoniae with 
1 hour which is more rapid than conventional PCR. So the LAMP 
method is a alternative method for detection of A. pleuropneu-
moniae.
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Introduction
Quantitative detection of Actinobacillus pleuropneumoniae 
(App) in live pigs is usually done by laborious and relatively non-
specifi c selective bacterial examination techniques (SBE). PCR 
techniques for identifi cation of App, described so far, are used 
for qualitative rather than quantitative detection. In this study 
we describe the design, development and validation of a quan-
titative real time PCR (qPCR) for the detection of apxIVA DNA, 
using previously described primers and a newly designed probe.
Material and Methods
BLAST homology search was performed in development of a 
probe sequence. A real time PCR protocol was developed for use 
in a IQ5 PCR machine. Commercially available hot start mix was 
combined with primers earlier described (APXIVANEST1-F and 
APXIVANEST1-R1) and a newly designed Taqman probe (with a 5’ 
FAM fl uorescent group and at the 3’ end a BHQ group), dissolved 
in TE-buff er. DNA from pure App cultures and samples from pigs 
infected with App were isolated according to Instagene™ Matrix 
protocol2. Negative and process controls of DNA isolation and 
qPCR reaction were included to detect possible contamina-
tion. App species specifi c reactions were determined by testing 
DNA from pure cultures of 15 reference App serotypes, several 
fi eld isolates of App and other Pasteurellaceae and bacterial 
swine pathogens. The analytical detection limit was determined 
with DNA from a 10-fold serial dilution of App serotype 1536 in 
saline, ranging from 1 – 5.0x106 CFU/ml. The infl uence of target 
clinical material was tested in spiking experiments using the 
same App1536 dilution series and added to tonsil scrapings. 
Intra- and inter-assay reproducibility was determined by testing 
duplet dilution series in triplets on diff erent plates (n=6). For 
validation with samples from pigs, material from live pigs was 
obtained from S. suis and App experimentally infected pigs 
using cotton swabs for samples from the ventral nasal meatus 
and toothbrushes for tonsil scrapings. Correlation of quantitative 
detection between SBE on CGVA plates3 and PCR was studied in 
samples from App infected pigs. For DNA quantifi cation a stan-
dard dilution series was included in each PCR run. The statistical 
analyses were performed using statistical software package R 
version 2.10.1. (The R Foundation for Statistical Computing). 
Linear models with threshold cycle as outcome and the log of 
the bacterial cell concentration, assay and spike and their inter-
actions as explanatory variables. Triplets within assay were ana-
lyzed separately as a random eff ect. The AIC criterion was used 
to select the best model. Linear regression models described the 
correlation between SBE and qPCR results in samples from App 
infected pigs.
Results
The qPCR product was 377 base pairs. In non App species 26/26 
PCR reactions were negative and in App reference serotypes 
15/15 PCR reactions tested positive. The analytical detection 
limit was 1-5 CFU/reaction. Analysis of linearity showed that the 
regression coeffi  cient of the slope = -3.30 (CI -3.36 - -3.25) and 
the intercept=42.77 (CI 42.5 – 43.0), with R2=0.99, corresponding 
to a PCR effi  ciency of 100% (CI 98.4 – 103.1%). Statistical analysis 
showed no signifi cant intra-assay variability. An eff ect of inter-
assay variability is observed on the intercept, showing the need 
to incorporate reference samples in each new assay. Small but 
non-signifi cant inhibitory eff ects were found for testing spiked 
DNA samples. Freezing (-20°C) of spiked samples before DNA 
isolation showed to be essential to prevent PCR inhibition. Opti-
mization and standardization of protocols have to be performed 
to minimize inter assay variability. Results from the correlation 
between qPCR and quantitative SBE of tonsil scrapings of App 
infected animals will be presented.
Discussion
The apxIVA qPCR could be a valuable alternative for quantitative 
SBE for the detection of App in samples from pigs. Strict compli-
ance to sample handling and DNA isolation protocols is a pre-
requisite for reproducibility. Future experiments have to provide 
more data on optimal sampling sites in live pigs to provide an 
appropriate estimate of the App infection status of a pig. Sensi-
tivity and specifi city of the qPCR have to be determined in fi eld 
validation experiments before implementation as a diagnostic 
assay can be considered. 
Intervet-Schering Plough, Boxmeer, the Netherlands and Central 
Veterinary Institute, Lelystad, the Netherlands are greatly ac-
knowledged for providing bacterial strains.
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Identiﬁ cation of strain speciﬁ c marker genes for Actinobacillus pleuropneumoniae infection in pig
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1. ATLAS Biolabs GmbH, Berlin, Germany; 3. University of Veterinary Medicine Hannover, Hannover, Germany
Introduction
Bacterial respiratory tract infections cause severe losses to the 
pig industry in the European Union and worldwide. Genetic 
traits associated with porcine host resistance have not been 
identifi ed to date. The aim of this project is the identifi cation 
of strain specifi c genetic markers, putatively associated with 
resistance to infection caused by the bacterial respiratory tract 
pathogen Actinobacillus pleuropneumoniae (APP).
Materials and Methods
For the identifi cation of candidate genes a well established 
aerosol infection model with APP was used. Pigs of three dif-
ferent strains (German Landrace, Pietrain and Hampshire) were 
infected, clinically monitored during the stages of infection and 
probed on day 4 (acute phase) post infection. 
The samples were used for transcriptome analysis using the 
Aff ymetrix Gene Chip Porcine Genome Array enabling a genome 
wide analysis of porcine gene expression. 
Results
In the course of the analysis we performed an intensive re-anno-
tation of Aff ymetrix probe sets since the incomplete sequence 
of the pig genome still poses a challenge in genome wide data 
interpretation. We then applied analysis of variance (ANOVA) 
in order to identify potential strain specifi c marker genes. The 
genes identifi ed as being strongly regulated post infection show 
important diff erences in the pig strains indicating strain-specifi c 
responses to APP lung infection. The candidates were further 
functionally characterised with enrichment analysis in order to 
identify aff ected molecular pathways. Here, we identifi ed pre-
dominantly pathway components of immune response related 
mechanisms. 
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Improvement of APP vaccine through adjuvant selection
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Introduction
Actinobacillus pleuropneumoniae (APP) is a gram negative bac-
terium responsible of severe respiratory disease in growing and 
in fi nisher pig. This disease is causing signifi cant loss to farmers 
particularly when fi nisher pigs are involved. Improvement of 
existing vaccine can be safety and/or effi  cacy improvements but 
also to provide longer lasting protection allowing single vaccine 
procedure for a lifetime pig protection. Our studies demonstrate 
the ability of various adjuvants from Montanide™ range to im-
prove the both safety and effi  cacy profi le of pig APP vaccines. 
Materials and Methods
Experimental vaccines: All experimental vaccine formulations 
were done by simple dilution of the antigenic media in the ad-
juvants under a gentle stirring. Various Adjuvants technologies 
were studied: oil in water emulsifi ed formula (Montanide™ ISA 
15 A VG), Polymeric adjuvant (Montanide™ Gel 01) and several 
nanoparticles based formula (Montanide™ IMS range). Two trials 
were performed to assess the safety and effi  cacy of experiment-
al vaccines.
Trial 1: Montanide™ Gel, Montanide™ ISA 15 A VG, Montanide™ 
IMS 1335 VG, Montanide™ 2215 VG and Montanide™ IMS 251 
C VG. A commercially available vaccine was used as positive 
control (oil in water emulsifi ed adjuvant) as well as an aluminum 
salts based formula. The antigen media injected in saline buff er 
was the negative control. APP seronegative (PCR and ELISA-test) 
pigs weighting 10 to 15 kg were vaccinated intramuscularly in 
the neck twice with 1ml dose, 28 days apart. Groups of 7 pigs 
were used except for the negative control group where 9 ani-
mals were inserted. 
Trial 2: Montanide™ Gel, Montanide™ ISA 15 A VG and Montan-
ide™ IMS 1335 VG. The adjuvant ratio was reduced compared 
to trial one. APP seronegative pigs weighting 40 to 45 kg were 
vaccinated with 1ml intramuscularly in the neck and injection 
site dissected 14 days after injection. Groups of 4 pigs were used.
Data collected: Rectal temperature and behavior of the animals 
were followed during 3 days after each injection. Loins were 
dissected at the slaughterhouse in order to look for intramuscu-
lar local reactions. An internal scale was created allowing the 
scoring of observed local reactions. Blood samplings were per-
formed before injection, 14 and 28 days after vaccine delivery. 
ELISA test on individual sera were performed at each sampling 
date to detect antigen specifi c IgG antibodies induced after 
vaccine injection. An infectious challenge was performed 38 
days after fi rst injection to assess the protection induced by the 
vaccines. Lung scoring was used to assess the level of protection 
in surviving pigs.
Results and Discussion
Trial 1: Pyrogenic reactions observed after vaccine delivery were 
insignifi cant whatever the vaccine (less than 1°C). Neverthe-
less, pigs showed a transient anorexia during 2 days after each 
injection. Two kind of local reactions were at the injection site 
observed: fi brosis and sterile abscess. Montanide™ IMS 251 C 
VG and aluminum based formula induced large local reactions 
while other formulation presented a low occurrence or even no 
local reaction. When comparing the ELISA results no signifi cant 
diff erences could be observed in between groups whatever the 
sampling date. On the opposite, the challenge demonstrated 
that only two formulations were able to protect at 100% the 
animals: those formulas were based on Montanide™ IMS 1335VG 
and ISA 15 AVG.
Trial 2: Pyrogenic reactions observed after vaccine delivery were 
unmodifi ed compared to trial 1. Injection site dissection showed 
that as early as 14 days post injection, the muscle presented a 
normal aspect at dissection for Montanide™ ISA 15 A VG and IMS 
1335 VG group while small granulomatous fi brosis was observed 
for the Montanide™ Gel based formulation. 
Montanide™ based formulations showed diff erent behavior; 
best results were obtained with Montanide™ IMS 1335 VG and 
ISA 15 A VG reaching a 100% of protection without any impact 
on the animal welfare or meat quality. Surprisingly, compared to 
previously published data, the Gel based formulation induced 
local reactions in the injected muscle. These fi ndings highlight 
the crucial importance of the antigenic media composition upon 
the vaccine performance.
Conclusion
Our study allowed identifying promising vaccine candidate 
compared to the existing vaccine available for pig farmers. 
The effi  cacy performances of our experimental formulations 
were identical to marketed vaccine while the local and general 
reactions were reduced these improvements of animal welfare 
also means a reduced risk of carcass blemish linked to vaccine 
adverse eff ect. Field experiments upon larger number of animal 
will now allow assessing the benefi ts of the new vaccine in terms 
of long term protection.
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Sensitivity of Actinobacillus pleuropneumoniae biovars to three cephalosporins 
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Introduction
Swine pleuropneumonia (SP) caused by Actinobacillus pleuro-
pneumoniae is traditionally controlled through antibiotic 
treatment. However, antibiotic resistance against widely used 
drugs like β-lactamics and tetracyclines has emerged (1). Cur-
rently, three generations of cephalosporins are recommended 
for the empirical treatment of SP. However, little is known about 
the quantitative activity of these compounds against A. pleuro-
pneumoniae biovar 1 [nicotinamide adenine dinucleotide (NAD) 
dependent] and even less against biovar 2 (NAD-independent) 
strains, which are prevalent in some regions (2). We aimed 
to compare the in vitro activity of cephalexin, ceftiofur and 
cefquinome against clinical isolates of A. pleuropneumoniae, 
representing most prevalent serovars in biovars 1 and 2. 
Materials and Methods
Minimum Inhibitory Concentration (MIC) determinations were 
performed by the macrodilution broth method with twenty-
nine A. pleuropneumoniae clinical isolates belonging to biovar 
1(n=19) serovars 2, 4, 5, 9 and 11, and biovar 2 (n=10) serovars 2, 
7 and NT (non-typable). Isolates (2002-2008) came from pneu-
monic lungs of pigs housed in fattening units located in seven 
Spanish provinces. 
Bacterial inoculums (5 x105 UFC/ml) were grown on Veterinary 
Fastidious Medium broth supplemented with 0.025% of NAD at 
37ºC, 5% CO2 for 24-48h (3). The MIC value of each drug tested 
corresponded to the lowest concentration of the compound 
that completely inhibited the visible growth of the tested isolate 
under the established conditions. The cut-off  for resistance of 
A. pleuropneumoniae to cephalexin and ceftiofur/cefquinome 
were MICs ≥32 μg/ml and ≥8 μg/ml, respectively.
Results and Discussion
Overall, cephalexin was the drug against which a higher number 
of isolates showed resistance and susceptible ones exhibited 
higher MIC values (always ≥1 μg/ml) (Table 1). 
Although only one strain was resistant to ceftiofur and cefquin-
ome, when CMI values were compared at the strain level for these 
two compounds (data not shown) lower MICs were obtained in 15 
isolates susceptible to ceftiofur, while cefquinome showed higher 
activity only against two isolates. The remaining 12 isolates that 
were susceptible to both drugs showed identical CMIs.
Figure 1. CMI values for 29 A. pleuropneumoniae clinical isolates. 
Shadow areas correspond to the range of drug dilutions tested and 
the number of isolates in each CMI; dotted lines indicate the cut-off  for 
resistance.
We tested few samples in each biovar to establish diff erences 
in sensitivity between them in a reliable way. However, we 
observed a trend towards a higher average MIC values for biovar 
1 isolates (data not shown). Ongoing work is focused on testing 
more isolates, particularly of the biovar 2 that seems to emerge 
as an important swine pathogen in some areas.
All together, these fi ndings indicate that ceftiofur is the most 
active antibiotic against A. pleuropneumoniae compared to 
cephalexin and cefquinome.
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Antimicrobial susceptibilities of Canadian isolates of Actinobacillus pleuropneumoniae
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Université de Montréal, St-Hyacinthe, QC, Canada
Introduction
Actinobacillus pleuropneumoniae is the causative agent of por-
cine pleuropneumonia, a severe and highly contagious respira-
tory disease responsible for economic losses in the swine indus-
try worldwide. To date, 15 serotypes have been described based 
on capsular antigens (1, 2). Although antimicrobial resistance in 
A. pleuropneumoniae has been recently reported in Europe (3-5) 
and in Japan (6), the current situation in Canada is unknown. The 
aim of the present study was to determine the antimicrobial sus-
ceptibility patterns of 43 strains of A. pleuropneumoniae isolated 
in Canada.
Materials and Methods
Bacterial isolates and growth conditions. A total of 43 isolates 
were recovered from swine herds in Saskatchewan, Ontario and 
Québec (Table 1). Isolates were cultivated overnight on chocolate 
agar plates supplemented with PolyVitex at 37˚C with 5% CO2. 
Table 1. Distribution of the 43 clinical isolates by serotypes and 
provinces.
1 5a 5b 3(8) 7 12 15
Québec1 1 3 2 1 5 - -
Ontaro2 4 - 4 - 4 - -
Saskatchewan3 2 3 4 - 3 1 6
1Dr. S. Messier; 2Dr. D. Slavic; 3Dr. M. Ngeleka.
Antimicrobial susceptibilities. The antimicrobial susceptibilities 
of the isolates were determined by the micro-dilution method 
using the commercial BOPO1F Sensititre 96-well microtitre 
plates (Trek Diagnostic Systems Inc., UK) in Veterinary Fastidi-
ous Medium in accordance with the guidelines provided by the 
Clinical and Laboratory Standards Institute (CLSI, M31-A3). The 
plates were incubated for 20-24h at 35˚C in 5% CO2. The minimal 
inhibitory concentration (MIC) value was considered to cor-
respond to the fi rst dilution at which no bacterial growth was 
detectable. The MICs that inhibited 50% (MIC50) and 90% (MIC90) 
of the isolates were also recorded. Resistance breakpoints were 
used according to the CLSI document M31-A3. 
PCR detection of resistance genes. PCR amplifi cation of resist-
ance genes was performed using Taq DNA polymerase and 
specifi c oligonucleotide primers.
Results and Discussion
All isolates were susceptible to ceftiofur, fl orfenicol, tilmicosin 
and trimethoprim/sulfamethoxazole (Table 2). The mean % of 
resistance to penicillin and ampicillin was 16% based on the 
presence of the gene blaROB-1 since there are no specifi c break-
points for A. pleuropneumoniae for these drugs. We observed a 
high level of resistance to chlortetracycline (88.4%) and oxy-
tetracycline (90.7%). The strains showing resistance to tetracy-
cline antimicrobials contained at least one of the following tet 
genes: tetB, tetO, tetC, or tetH. The high level of resistance to 
tetracyclines is similar to what was previously reported in Spain 
(3). A low level of resistance was observed toward tiamulin (7%). 
Five isolates showed multi-resistance to β-lactam, aminoglyco-
side and tetracycline antimicrobials.
Table 2 . MICs obtained for the 43 clinical isolates.
Antimicrobial MIC50 MIC90 % of resistance
Ampicillin 0.25 >8 16.3
Ceftiofur ≤0.25 0.5 0
Chlortetracycline 4 >4 88.4
Clindamycin >1 >1 nc
Danofl oxacin ≤0.06 0.25 nc
Enrofl oxacin ≤0.06 0.25 nc
Erythromycin >2 >2 nc
Florfenicol 0.25 0.25 0
Gentamicin >4 >4 nc
Neomycin >16 >16 nc
Oxytetracycline >4 >4 90.7
Penicillin 0.5 >4 16.3
Spectinomycin >32 >32 nc
Sulfachloropyridazine 64 >128 na
Sulfadimethoxine >128 >128 na
Sulfatiazole 128 >128 na
Tiamulin 16 16 7
Tilmicosin 8 8 0
Trimethoprim/Sulfa ≤0.25 ≤0.25 0
nc, no CLSI resistance breakpoints available for these drugs for A. pleuropneumoniae ; na, not 
available since the breakpoint is higher that the highest concentration tested in the range. 
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Actinobacillus pleuropneumoniae (APP) Elimination with injectable Enroﬂ oxicin and early weaning
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Introduction
Actinobacillus pleuropneumoniae (APP) is an economically 
signifi cant pathogen in the swine industry.(1) The control of APP 
associated disease through feed medication and delivery can 
be diffi  cult for some herds. The trial group was a 75 head sow 
herd farrow to fi nish operation composed of APP positive gilts, 
sows, and boars. The objective of this report was to eliminate 
APP serotype 3, 5 and 7 from the off -spring of an APP positive 
sow herd using only injectable antibiotics and early weaning. 
The APP negative off -spring would then be used to establish a 
new herd.
Materials and Methods
The APP elimination medication plan is as follows:
The fi rst step was a whole herd (sows, gilts, boars and growing 
pigs on site) injection with Baytril at 1 cc/29.4 lbs. (7.5 mg/kg). 
The whole herd injection with Baytril was repeated fi ve days 
later. Sows and gilts were injected again using the same dose 
two days prior to their projected farrow date throughout the 
duration of the elimination program. Piglets were given Naxcel 
(ceftiofur) per label dose at birth in combination with iron. 
Piglets were given 0.5 cc of Baytril at eight days of age and again 
at weaning. All piglets were weaned off -site by fourteen days of 
age into clean environments with limited risk for APP exposure. 
The fi rst two nursery diets had Denagard / CTC in the ration post 
weaning. The feed was non-medicated after the fi rst two rations.
The APP diagnostic test plan was as follows:
The fi rst diagnostic tests were a serological examination of the 
herd prior to purchase. Following purchase, tonsil scrapings 
were pooled in groups of three and submitted for APP PCR test-
ing to establish the current prevalence of positive pigs within 
the population. This same testing method was used for APP PCR 
testing of medicated early weaned pigs post-weaning. At matur-
ity gilts and boars were serologically tested using the Multi-APP 
screen to monitor for potential APP infection and/or spread.(2)
Results
Before implementation, the initial screening of the herd using 
APP serotype testing showed positive pigs for APP 3, 5 and 7. 
Post purchase 24/26 pools of sows, boars and gilts were posi-
tive for APP by PCR. Two of fi ve tonsillar pools from growing 
pigs, (6 to 14 weeks of age) were also positive. Approximately 30 
days after the second whole herd medication treatment, nine 
random tonsil scrapings were pooled in groups of three from 
the resident herd and were negative by PCR. The fi rst medicated 
early weaned pigs were sampled at approximately fi ve weeks 
post wean and were individually negative by APP PCR and APP 
culture on tonsillar scrapings. Three tonsils from adult breeding 
stock were submitted and were negative by APP PCR and for 
APP culture. Later, eight pools of tonsil scrapings from grow-
ing pigs were submitted for APP PCR and were negative. Five 
months after the fi rst pigs were weaned, serology was used to 
screen the oldest gilts. One positive test to the Multi-APP screen 
was found. Roommates were tested and 4/14 were serologic-
ally positive. The positive gilts were found to be positive for APP 
serotype 5 on further testing. PCR testing of ten pooled tonsil 
scrapings were negative in growing pigs. Due to the lack of 
spread between pen-mates and limited positive gilts on serol-
ogy and APP PCR, it was determined that all breeding age gilts 
would be screened using the Multi-APP test. Any suspects or 
positives were not used for the re-population of the new herd. 
Serological testing of the gilts at six to eight months of age 
using the Multi-APP test determined that 4/61 gilts would not be 
used. No antibodies have been detected in recent tests of gilts at 
6 to 7 months of age.
Discussion
APP negative gilts and boars were produced from the positive 
herd to establish an APP serotype 3, 5 and 7 free sow herd. Gilts 
have remained negative by PCR and culture of tonsillar scrapings 
for APP. The Multi-APP screening test detected some antibodies 
suggesting exposure in few individual gilts; however, there was 
no evidence of APP spread in pens, rooms or barns. On previous 
APP elimination trials Multi-APP serological screening has shown 
cross reactivity with other APP serotypes.(3) Test results indicate 
the herd has eliminated the APP 3, 5 and 7 from retained gilts 
and boars. The use of injectable Enrofl oxicin and early weaning 
was successful in limiting the vertical spread of APP.
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Eﬃ  cacy of COGLAPIX® in susceptible piglets against a challenge with Actinobacillus 
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Introduction
Actinobacillus pleuropneumoniae is a major pathogen of pigs 
causing porcine pleuropneumonia, which generates signifi cant 
economical losses for the swine industry. Among other viru-
lence factors, the APX toxins belonging to RTX toxin family play 
a signifi cant role in the pathogenesis of A. pleuropneumoniae. 
The combination of bacterins and inactivated APX toxins have 
been shown to be cross-serotype protective. The bacterin-toxoid 
vaccine, Coglapix®, using the optimal combination of somatic 
antigens together with Apx toxoids (ApxI, ApxII & ApxIII) has 
been developed to provide eff ective protection against infection 
caused by various serotypes of A. pleuropneumoniae. 
Materials and Methods
Coglapix® and a competitor vaccine was injected to 9-week-old 
A. pleuropneumoniae sero-negative piglets 2 times 3 weeks 
apart, using the recommended dose of the vaccines. A group of 
non vaccinated animals was also included. Each group consisted 
of 8 animals. Seven weeks after the 2nd vaccination, the animals 
were challenged intranasally with a broth culture of a virulent 
serotype-2 A. pleuropneumoniae strain in a dose of 5*106 col-
ony forming units per animal. Serum samples were taken on day 
(D) 0, D21, D35, D69 and D76. The animals’ immune response 
was followed with Swinecheck APP 2, Swinecheck APP 1, 9, 11 
(Biovet, Canada) and ApxI, ApxII and ApxIII in-house developed 
monoclonal-antibody based ELISAs. After the challenge (D69), 
the animals were monitored daily for the presence of general 
and respiratory symptoms. The rectal temperatures were also 
measured on a daily basis from D69 to D76. The body weight 
gain was recorded between D69 and D76. After 1 week, (D76) 
the animals were slaughtered and necropsied. The lung chan-
ges were scored according to EP:1360. The App bacteria were 
recovered from the lungs using suitable culture methods. The 
microscopic lung lesions were observed in paraffi  n-embedded, 
haematoxylin-eosin stained sections.
Results
In this study, both Coglapix® and the Competitor vaccine showed 
similar protection in terms of preventing from lung lesions.
The cumulative results of clinical and pathological observations 
are presented in Table 1.
Table 1. Average clinical and pathological scores of the non-
vaccinated controls and the animals vaccinated with Coglapix and the 
Competitor vaccine
Coglapix® Competitor Control
No. of pigs 8 8 8
Clinical score (m±sd) 2.0 ±2.0 3.4 ±2.9 6.8 ±10.7
Lung score (m±sd) 2.6 ±3.1 3.9 ±3.6 5.9 ±8.9
Histo-path. score (m) 4.6 5.5 5.4
The serological titers before vaccination have proven the sero-
negativity by all of the 5 ELISA systems used. 
The negative control group remained sero-negative until the 
date of challenge.
Both vaccines induced high titers already with fi rst vaccination, 
which was boosted by the second one.
In general, the Competitor vaccine induced higher antibody 
titers against somatic antigens. Overall, the Competitor induced 
higher anti-ApxI titers, the anti-ApxII titers were similar whereas 
Coglapix® induced higher anti-Apx III titers.
The bacteriological culture results showed higher recovery rate 
from the Competitor-vaccinated group then the Coglapix®-
vaccinated one, with a 2.25 times higher odds ratio.
Discussion
Coglapix® vaccine has proven to have similar protective features 
as the Competitor in this challenge. Further studies needed 
involving more challenge strains to prove the broad-range 
protective effi  cacy of the vaccine, which has already been shown 
under fi eld conditions 
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Introduction
A new Actinobacillus pleuropneumoniae (App) vaccine has been 
developed. The formulation of this new App vaccine was opti-
mized to obtain a good balance between safety and effi  cacy.
The vaccine was thoroughly evaluated in fi eld conditions, in pigs 
in The Philippines, using competitor vaccines for the comparison.
Materials and Methods
Coglapix® contains inactivated, native Apx antigens (ApxI, ApxII 
& ApxIII) and somatic antigens of App. The vaccine is adjuvanted 
with aluminium hydroxide gel. It is administered by IM route (2 
ml/pig) and two injections are given at 6 and 9 weeks of age.
This trial was carried out in The Philippines, in one farrow-to-fi n-
ish farm, positive for App. Altogether, 300 pigs were allocated in 
5 treatment groups (1 control and 4 vaccinated groups, Table 1.). 
Table 1: Vaccines used in the clinical fi eld trial
Group 1 Bacterin vaccine serotypes 1,2,3,4,5,7
Group 2 Toxoid and OMP vaccine
Group 3 Coglapix®
Group 4 Control group
Group 5 Toxoid and OMP vaccine
The vaccines were applied at 6 & 9 weeks of age. Precise clinical 
observations were performed on 15 pigs / group: general reac-
tions and rectal temperatures. The bodyweights of all pigs were 
measured regularly (5 times) and feed conversion rate (FCR) was 
also calculated.
The seropositivity for App was tested before vaccination on 15 
sows and 15 marketed hogs (5-6 months of age), using IDEXX 
CHEKIT APP-ApxIV ELISA kit.
From each group, 20 pigs were examined at slaughter where 
lung lesions were recorded using a scoring system of a max-
imum of 28/lung (4/lobe).
Results
Out of the 15 sampled sows 12 (80%), whereas from the 15 
sampled hogs 5 (33%) was seropositive. 
The average rectal temperature increase values by vaccine 
group are presented in Table 2.
Table 2: Summarized safety results of the fi eld trial
Group (n=60 
/ group)
Vaccine 
treatment
Temp. increase 
(in °C @ v1 & v2)
Post-vaccinal 
reactions Comments
1 s1,2,3,4,5,7 bacterin +0.7 +0.2 None /
2 Toxoid & OMP +1.2 +1.5 2/15 @ V1 & V2
Dyspnoea, depression, 
vomiting & skin 
discoloration
3 Coglapix® +0.7 +0.2 None /
4 Saline control -0.1 0.0 None /
5 Toxoid & OMP +1.4 +1.1 1/15 @ V1 Hyper-salivation & incoordination
No post-vaccinal adverse reactions were observed in Coglapix® 
vaccinated piglets unlike in the piglets from groups 2 and 5.
Table 3: Summarized effi  cacy results of the fi eld trial
Group (n=60 
/ group)
Vaccine 
treatment
ADG (g/d) 
weaning-slaughter
FCR 
(60d-market)
Lung score 
average (mean)
1 s1,2,3,4,5,7 bacterin 513 
a 3.24 5.95
2 Toxoid & OMP 506 a 3.26 5.85
3 Coglapix® 526 b 3.15 4.05
4 Saline control 500 a 3.36 7.45
5 Toxoid & OMP 517 a 3.21 5.35 
Coglapix® vaccinated pigs have shown a better productivity 
performance than the other groups.
Coglapix® vaccinated pigs have had the lowest average lung 
lesion score at slaughter.
Discussion
In this trial, Coglapix® has shown an improved safety with no ad-
verse reactions in minimum age piglets as well as the best trend 
of economical parameters.
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Introduction
A new Actinobacillus pleuropneumoniae (App) vaccine has been 
developed. The formulation of this new App vaccine was opti-
mized to obtain a good balance between safety and effi  cacy.
The vaccine safety of a dose and of an overdose was thoroughly 
evaluated in susceptible piglets in laboratory conditions, in 
Hungary.
Materials and Methods
Coglapix® contains inactivated, native Apx antigens (ApxI, ApxII 
& ApxIII) and somatic antigens of App. The vaccine is adjuvanted 
with aluminium hydroxide gel. It is administered by the IM route 
(standard dose: 2 ml/pig) and two injections are given from the 
age of 6 weeks to protect piglets as early as possible for the 
duration of the fattening period.
Safety of a maximum LPS content Coglapix® batch was evalu-
ated at the youngest age (6 weeks) recommended in suscept-
ible piglets as presented in table I. The serological status of the 
animals was tested with Swinecheck APP 2, Swinecheck APP 
1, 9, 11 (Biovet) and the CHEKIT APP-ApxIV (IDEXX) ELISA kits. 
Every pigs were observed for general and local reactions for 14 
days after each injection. The rectal temperature was measured 
3 days before vaccination, 2, 4, 6 hours after each injection and 
on the 4 consecutive days. Performance measurements were 
recorded (weight gain, appetite). The injection sites of each pig 
was palpated and examined at post-mortem, 2 weeks after the 
last injection (D28).
Results
Table 1: Summarized serological status of piglets before vaccination
Animal category Sample No.
App 1, 9, 11 
positive
App 2 positive 
(%)
Apx IV positive 
(%)
Piglets (5-6 weeks of age) 44 0 (0 %) 0 (0 %) 1 (0.4%)
* Pig status: S = susceptible (App 1, 9, 11, 2 and Apx IV commercial kits)
Table 2: Summary results of the safety studies performed in laboratory 
conditions
Treatment Pig No.
Mean max. temp. 
increase oC (± sd) 
V1@D0
Mean max. temp. 
increase oC (± sd) 
V2@D14
AWG* kg 
(D0-D14 
period)
AWG* kg 
(D14-D28 
period)
Coglapix® 
One dose 2 ml 13 1.0 (±0.5) 0.2 (±0.6) 8.51 11.35
Coglapix® 
Overdose 4 ml 
D0 2 ml D14
12 1.5 (±0.7) 1.1 (±0.5) 9.42 9.15
Control 12 0.3 (±0.5) 0.5 (±0.4) 9.84 9.43
*AWG: average body weight gain
In laboratory conditions, the maximum rectal temperature in-
crease after vaccination with Coglapix® was not higher than 1.5°C 
as required by the EU Ph even after the overdose administration.
No general adverse reactions were observed after the administra-
tion of Coglapix® in both standard and overdose administrations. 
Discussion
Coglapix® has shown a good safety even with a maximum LPS 
content batch in laboratory conditions.
References
1. Frey J. et al. (1993) J. Clin. Microbiol. 139, 1723-1728.
2. European Pharmacopoeia, 01/2008:1360.
®COGLAPIX is a registered trademark of CEVA SANTE ANIMALE.
Respiratory diseases – Actinobacillus pleuropneumoniae
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 617
Poster Presentations
P.311
Study on preventive eﬀ ects of garlic on pigs experimentally infected 
with Actinobacillus pleuropneumoniae serotype 2
Norbert Stockhofe-Zurwieden1 Henk J. Wisselink1 Monique F. Mul2 Petra M. Becker2 Carola van der Peet-Schwering2
1. Central Veterinary Institute of Wageningen UR, Lelystad, Netherlands; 2. Wageningen UR Livestock Research, Lelystad, Netherlands
Introduction
Actinobacillus pleuropneumoniae (App) can induce severe (per)
acute pleuropneumonia, but certain serotypes as serotype 2 
are more known to cause chronic disease resulting in pleuritis 
or focal pleuropneumonia, often without overt signs of clinical 
disease (1). 
Garlic is alleged to have antimicrobial properties (2) and anti-
microbial in vitro eff ects on App from garlic-derived volatile 
allyl methyl sulfi de (AMS) has been shown (3). In this study we 
wanted to investigate the possible preventive eff ect of garlic on 
the occurrence of clinical disease and pathology of a mild course 
of an experimental infection with App in pigs. 
Materials and Methods
In two diff erent studies pigs of about 7 weeks old from a herd 
free of App were used. Pigs were fed with a commercial freeze-
dried garlic powder (Enteroguard™garlic). Garlic was added to 
the diet in increasing concentrations during 6 days with fi nally 
5% or 10% at the day of challenge (Table 1). 
Table 1: Design experimental infections
Study Pigs [n] control/garlic
Garlic concentration 
in feed [w/w]a
Challenge dose in aerosol 
inoculum (CFU/ml)
Post infection 
phase (days)
Ia 5/5 10% 107 4
Ib 5/5 10% 108 4
II 15/15 5% 109 4
a Garlic concentration in feed at day of inoculation.
During the aerosol inoculation three pigs were housed per run 
for 20 (Study I) or 30 minutes (Study II) in a 0.6 m3 stainless steel 
chamber. Aerosols of App serotype 2 reference strain 17399 
were introduced with an Aeroneb™Pro micropump nebulizer 
(Aerogen Ltd., Ireland) from 5 ml inocula containing 107, 108 or 
109 CFU/ml (Table 1). During each inoculation run viability of 
bacteria was controlled by passing air from the aerosol chamber 
through an Anderson stage sampler. During the post infection 
phase of 4 days, pigs were monitored for occurrence of clinical 
signs, fever and changes in WBC. After euthanizing, pigs were 
examined patholocially and bacteriologically. In study II the 
relative lung weights were determined, comparisons were made 
between the treatment groups by using the Wilcoxson-Mann-
Whitney two sample rank sum test.
Results
In the fi rst study no clinical signs of an App infection were 
observed, fever was observed in 2 pigs from the garlic fed group 
and in 3 pigs of the control group. In 4 of 10 pigs of the control 
group and in 1 of 10 pigs in the garlic fed group small focal 
(pleuro)pneumonia was found at necropsy. In the second study 
one pig of the control group died 24 hours after inoculation 
due to a severe pleuropneumonia. No diff erences were found 
in clinical signs between the two treatment groups. At necropsy 
small focal lung lesions were found in 7 of 15 pigs in the control 
group and in 5 of 15 pigs of the garlic fed group. The relative 
lung weight was increased in the control group compared to the 
garlic fed group (p = 0,06).
Table 2: Results of in vivo studies in pigs to preventive eff ects of garlic
Study Fed with garlic
Clinical signs 
of disease (%)
Fever 
index (%)a
Leucocyte 
index (%)b
Rel. lung 
weigth (%)
Path. 
[n]c
Bact. 
[n]d
Ia
Yes 0 10 7 ND 0 0
No 0 5 13 ND 2 2
Ib
Yes 0 5 0 ND 1 2
No 0 10 20 ND 2 2
II
Yes 18 0 17 1.13 ± 0.10 5 5
No 17 4 23 1.21 ± 0.15 7 7
a Fever ≥ 40°C; b Relative occurrence of WBC of > 20G/L; c Pathology lung; d Re-isolation of App 
by culture
Discussion
A mild clinical course of infection was introduced in this aerosol 
challenge model of App. No clear diff erences in clinical signs 
were observed between the groups. A trend for an eff ect of 
garlic on pathology fi ndings was observed.
It has to be emphasized, that the used concentrations of 
Entergoguard™ garlic 5% to 10% far exceeded the concentra-
tions applied in practice of 1%.
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Study of some Actinobacillus pleuropneumoniae strains’ susceptibility at antimicrobials
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Introduction
The sensitivity of A.pleuropneumoniae to antibiotics and 
chemotherapics we studied showed a various and unstable be-
havior of this species, very diff erent in time and place, depend-
ent on the area and time of isolation, reason why the antibio-
gram represents an indispensable tool before a treatment is 
established in pig pleuropneumonia. 
The goal of our research was to determine actual sensibility to 
antimicrobials of A. pleuropneumoniae strains isolated from farms 
situated in the west part of country, used NCCLS methodology.
Materials and Methods
The A. pleuropneumoniae strains studied were isolate from ani-
mal with clinical symptoms of pig pleuropneumonia from wean 
to fi nish and fattening farms.
All 40 strains were identifi ed according well knowing methodology. 
After completion of the susceptibility testing of the test strains 
and the quality control strain, we record the obtained results 
using zone-diameter in millimetres and categorize each of the 
tested strains as either “resistant” (R), “intermediate” (I) or “sus-
ceptible” (S) against each tested antimicrobial agent.
Results and Discussions
In all the 40 strains we examined in this study, the best results 
we found with fl uorphenicol, tulathromycine, penicillin and 
tilmicozin. To be noticed that 3 of these belong to a newer class 
of antibiotics and only 66.6% of the strains were very sensitive 
to tilmicozin and 87.5% were very sensitive to fl uorphenicol. 
Toward lincozamide (lincomycin), some blactamine (amoxicillin), 
aminoglycosides (gentamicin, streptomycin) the strains we stud-
ied had a moderate sensitivity, while they had a noticeable re-
sistance toward amoxiklav, ampicillin, oxitetraciclin, enrofl oxacin 
and cephalosporins, fact that urge us to contraindicate these 
antibiotics and chemotherapics (enrofl oxacin) in the absence of 
an antibiogram which shows their sensitivity.
To be noticed that 20-30 years ago seemed an unquestionable 
truth the fact that all A.pleuropneumoniae strains are sensitive 
to penicillin, including the strains isolated in this area of the 
country, while nowadays 30% of the strains isolated by us are 
resistant to penicillin and it seems that is because of the exces-
sive usage of this antibiotic in time. In this matter our results are 
similar to those of other authors.
Conclusions
Our studies show that an excessive usage of some antibiotics 
and chemotherapics in order to prevent or treat pig pleuro-
pneumonia, especially using medicated food may have negative 
results, as the selection of resistant strains which in time may 
replace the sensitive strains to a certain antibiotic or chemother-
apic that is used at random, without knowing the sensitivity of 
germs from the population.
Also it is worth mentioning that changes of sensitivity toward 
some antibiotics – tetraciclins and chemotherapics – quinolons 
were revealed during the present investigation, comparing the 
results obtained on strains isolated from the same population 
at an interval of about 6-7 months in which the antibiotics were 
administered continuously. 
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Intradermal vaccination by low dosage of antigen, Actinobacillus pleuropneumoniae model
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Introduction
The objective of the presented study was to describe diff erent 
dynamics of humoral immune reply to intradermally (ID) admin-
istered gradually diluted antigen and fi nd out the lowest dose 
of antigen, administered ID, able to invoke measurable humoral 
immune reply. 
ID vaccination is known to be a very practical method of vac-
cination especially in pigs, able to save a lot of antigen and could 
increase the number of available doses of vaccine (1), easy to 
mass administer and without residual changes and/or absceda-
tion in the meet of food animals, and transmission of infectious 
diseases (2).
An experimental vaccine against APP was used and gradually 
diluted. The lowest dose of antigen APP was not disclosed. In 
concentration 3.104, decided as very low, the IgG and IgM reply 
was measured in levels comparable to higher concentrations of 
APP antigen.
Material and Methods
Seven groups of SPF piglets were used (n=6) at age of 6 weeks 
of life. Experimental vaccine, based on commercial toxoid vac-
cine Suivac APP ID (Dyntec, CZ) was used and gradually diluted. 
Group 1 was vaccinated by full ID dose of vaccine, containing 
6.0ug of equal mixture of APX toxoids, OMP and LPS. Groups 
2 to 5 were vaccinated and revaccinated three weeks later by 
gradually diluted antigen in the vaccine – 3x, 9x, 27x and 81x. 
Group 6 was vaccinated by standard IM dose of Suivac APP IM 
(positive control, containing the same amount of antigen as ID 
dose), and group 7 was negative control group. Piglets were 
blooded weekly for 6 weeks after prime vaccination. Specifi c 
antibodies to APP APX were determined in blood serum using 
indirect isotype-specifi c ELISA procedure. Statistical software 
Statistica 9.0 was used for evaluation of the data The results of 
serological examinations were expressed as arithmetic mean 
values of optical densities obtained by ELISA test. Signifi cance of 
between-group changes detected by ELISA were assessed with 
Kruskal-Wallis nonparametric test.
Results and Discussion
The very low dose of antigen (27x dilution) administered by 
intradermal route induced comparable immune reply either in 
fast immune response of IgM, either of more permanent IgG 
antibody response. All dilutions of antigen, used in the trial, 
involved measurable and mostly strong immune reply. The 
lowest dose of APX antigen was not disclosed. In concentration 
1:81, expected as very low, the IgM (data not shown) and IgG 
response (Figure 1) was measured in levels still comparable to 
higher concentrations of APP antigen.
Intradermal administration of vaccines was found not only 
involving measurable humoral protection (IgG and IgM) after ad-
ministration of highly diluted dose, it was very eff ective in pro-
moting a cytotoxic T cell response (data not shown). Attempts 
to dissect the mode of action of some intradermal administered 
vaccines by cytometric fl ow analysis of lymphocyte popula-
tions from the spleen, lung, liver and thymus revealed an eff ect 
of route of vaccine delivery upon the composition of specifi c 
lymphocyte subsets in these various organ compartments (3). In 
some cases lower dose of antigen in ID vaccination dose seems 
to be more eff ective in compare to standard IM dosage(4) . The 
very low concentration, 1:81 dilutions, seemed to be too low 
to stimulate any replyafter single administration of very low 
dose of antigen, but booster vaccination of the same thin dose 
involved measurable IgG and IgM response.
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Introduction
The modern pig industry is managed by practices geared for 
maximum production effi  ciency. Strategies to reduce the impact 
of diseases and to promote welfare of animals are essential to 
ensure business survival. Mycoplasma hyopneumoniae (Mh) is 
the most important respiratory pathogen in the Brazilian pig 
industry. It impairs production effi  ciency and increases produc-
tion costs. Better understanding of these costs associated with 
Mh outbreaks will assist Veterinarians and producers to come up 
with cost-eff ective biosecurity and health assurance programs, 
aiming to avoid or at least to minimize potential losses associ-
ated with outbreaks.
Considering the economic impact of Mh on pig industry world-
wide and understanding that controlling important diseases 
is cost-eff ective, the objective of this work was to estimate the 
economic losses of a Brazilian farm that experienced an out-
break of enzootic pneumonia, disease caused by Mh.
Materials and Methods
This study was conducted from September to December 2009 
in a 170 sows farrow-to-fi nish herd, located in the State of Goias, 
Brazil. This farm was free of Mh based on absence of clinical 
signs and routine serology monitoring. The clinical signs were 
fi rst recognized on August, when diagnosis was established 
by clinical examination, gross pathology and histopathology. 
The analysis and economic evaluation were based on the mean 
change of death rates of farrowing, nursery and growing/fi nish-
ing pigs, as well as the expenses of additional drugs, vaccines 
and feed intake. The periods used for comparison were (1) the 
average from April to July, when the farm was serologically free 
of Mh and (2) the average from September to December, period 
post infection.
Results and Discussion
The death rate of farrowing piglets rose from 7.2% to 12.37%. At 
nursery, the change was from 1.33% to 25.17% and at growing-
fi nishing period, the death rate jumped from 2.9% to 5.85%. The 
mortality rates before the outbreak were in accordance with the 
expected losses for Brazilian pig farms as suggested by Sobesti-
ansky et al (2007).
The phase that had the higher spike in mortality was the 
nursery, what was expected and can be explained by the fact 
that piglets probably got infected at the farrowing barns by 
their dams. The increase of mortality in preweaning piglets was 
higher than usual in a Mh outbreak and can be explained by 
the fact that the average weaning age of this farm was 30 days 
of age. We believe that interaction of other pathogens such as 
Circovirus and Pasteurella with Mh infection have contributed to 
the increase of mortality rates.
The expenses from September to December 09 with Mh-vac-
cines, anti Mh-drugs and with ration that was fed to animals that 
died with Mh clinical signs was computed U$ 33,600. When we 
consider that these extra animals that died after the outbreak 
could have been sold to slaughter at weight of 95 kg, after 
discounting the cost with feeding, the lost value was US$ 15,800. 
Combining both costs, the total loss with this outbreak from 
September to December was US$ 49,400.
Conclusion
The high economic losses associated with an outbreak of enzo-
otic pneumonia, in the form of deaths and cost of therapy, cor-
roborates the need for establishing eff ective preventive meas-
ures. Biosecurity protocols can prevent the entry of pathogens 
especially by the introduction of positive animals in the herd 
and control of fomites and transit of vehicles, since these pose 
potential risk of disease transmission.
Referencias 
1. Piff er, I. A. & Brito, J. R. F. Descrição de um modelo para avaliação e 
quantifi ação de lesões pulmonares de suínos e formulação de um 
índice para classifi cação dos rebanhos. Concódia, SC, Embrapa-
CNPSA, 1991. 12p. 
2. Sobestiansky, J. & Barcellos D. Doença dos suínos. Goiânia, Cânone 
Editorial, 2007, 768p.
Respiratory diseases – Mycoplasma hyopneumoniae
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 621
Poster Presentations
P.315
Colonization, serologic and parity state to Mycoplasma 
hyopneumoniae in vaccinated sows and their piglets
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Introduction
 Mycoplasma hyopneumoniae (Mh) is the etiologic agent to Enzo-
otic Pneumonia (EP). The transmission can occur horizontally from 
infected pigs to naïve pigs or vertically from sow to its piglets (1). 
It has been suggested that sow-to-piglet transmission may be in-
fl uenced by sow parity (2-4) but the results are controversial. Due 
the fact sow vaccination did not aff ect piglets` colonization (5) 
and the diff erent results about serologic and colonization status 
of sow and piglets according to parity distribution the objective 
of this study was to determinate colonization, serologic and parity 
status on Mh multiple-vaccinated sows and their piglets.
Materials and Methods
A 4100-sow, multiple-site herd was selected to carry out this 
study. Mh vaccination was used in sows, gilts and boars (at least 
with fi ve doses of vaccines against Mh ([RespiSureONE, Pfi zer, 
Argentina]). This vaccine scheme had been adopted since 3 years 
before. A longitudinal study was performed. Eighty-two sows 
were selected (being 15% of the weekly farrows).All parturition 
distribution was considered in each sampling time (1st- 9th). From 
each sow two piglets were randomly selected; (one hundred 
and sixty-four piglets). None of these piglets were cross-fostered. 
Blood samples for ELISA (HerdChek® Mycoplasma hyopneu-
moniae, IDEXX, Maine, USA) and nasal swabs for nPCR (6) were 
taken in the sows, at 0 day of gestation, at 8 weeks pre-farrowing 
and 2-5 days post-farrowing, and on the piglets at 2 weeks old. In 
order to study the eff ect of parity number, sows were divided into 
the following groups: A- low parity number (1-2), B- intermediate 
parity number (3-4), C-high parity number (5-6) and D-Very high 
parity number (7 or higher). The median Optical Density (OD) 
values of sera were calculated to compare seropositive sows and 
piglets according to diff erent parity distribution and to compare 
seropositive sows at diff erent sampling time.
Results
The results are shown in tables 1 and 2.
Table 2. Median and range of Optical density (OD) according to parity 
distribution in sows and their piglets.
Group
SOWS  OD PIGLETS   OD
n Median Range n Median Range
A 28 0.783 0.482-1.218 51 0.774 0.264-1.373
B 24 0.890 0.353-1.212 45 0.840 0.235-1.412
C 15 0.986 0.585-1.292 33 0.858 0.253-1.455
D 10 1.101 0.748-1.329 19 1.021 0.403-1.405
Discussion
The percentages of seropositive sows were higher than the ob-
tained in previous studies (6, 5). However, seronegative sows were 
found. This, may be explained by the fact that vaccine effi  cacy is not 
100%, in addition to the existence of subpopulations of susceptible 
animals (7), and/or diff erent responses to vaccination (8). Through 
diff erent sampling time, the proportion of seronegative sows in 
group B was greater than the others groups, these result are accord-
ing to previous studies (2, 4) and would indicate that young sow 
(Group B) are more likely to transmit Mh to their piglets. The highest 
level of nPCR positives was found at 8 weeks pre-farrow and in this 
sample the OD value (from seropositives sows only) was lowest. 
That suggests that while protective antibodies decreased, exists a 
major shedding of Mh due to the decline in vaccine antibodies (9) 
or the protective antibodies are transferred from the blood to the 
udder in agreement with previous studies (10). At post-farrowing 
sampling time, the OD values increase according to parity number 
of sows (and their piglets). This suggests that the increased mater-
nal antibodies concentration is not completely due to vaccination 
but also the repeated exposure of sows to Mh under fi eld condition.
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Table 1. Median OD at diff erent sampling time and positives/sampled (and percentage) of ELISA and nPCR at diff erent sampling time taking into 
account parity distribution.
GROUP
ZERO DAY OF GESTATION 8 WEEKS PRE-FARROW 2-5 DAYS POST-FARROW 2 WEEK OLD PIGLETS
ELISA nPCR ELISA nPCR ELISA nPCR ELISA nPCR
A 27/28 (96.4) 6/28 (21.4) 28/28 (100) 10/28 (35.7) 28/28 (100) 11/29 (37.9) 53/57 (92.9) 13/57 (22.8)
B 24/25 (96) 9/25 (36) 24/25 (96) 10/25 (40) 24/26 (92.3) 2/25 (8) 43/50 (86) 11/51 (21.5)
C 16/16 (100) 3/16 (18.7) 17/17 (100) 4/17 (23.5) 15/15 (100) 3/15 (20) 33/34 (97) 3/34 (8.8)
D 10/10 (100) 2/9 (22.2) 10/10 (100) 7/8 (87.5) 10/10 (100) 3/9 (15) 19/21 (90.4) 3/21 (14.1)
TOTAL 77/79 (97.4) 20/78 (26.6) 79/80 (98.7) 31/80 (38.7) 77/79 (97.4) 19/78 (24.3) 148/162 (91.3) 30/163 (18.4)
Median OD 1,016 0,893 0,950 0,873
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Introduction
Mycoplasma hyopneumoniae, the causative agent of porcine 
enzootic pneumonia, is predominantly transmitted through 
nose to nose contact between animals and more infrequently 
by aerosol, maintaining horizontal spread of the agent from in-
fected to naïve pigs of the same age, or via vertical transmission 
from sows to their off spring (2). If the latter occurs frequently, it 
is suggested that vaccination of suckling piglets during their fi rst 
days of life may assist M. hyopneumoniae control (1). However, 
only a few studies have surveyed the infection of suckling and 
nursery pigs under fi eld conditions and the results are inconsis-
tent. The main objective of our study was to evaluate the occur-
rence of M. hyopneumoniae infections in suckling and nursery 
pigs originating from a broad range of farms located in a region 
with intensive pig production and a high pig density.
Material and Methods
A retrospective analysis was applied to data obtained by routine 
diagnostics over two consecutive years from a laboratory work-
ing as specifi ed in the ISO/IEC 17025:2005. Herd parameters 
were amended on the basis of enquiries with the herd-attending 
veterinarians. A correlation between the detection of M. hyo-
pneumoniae in lung tissue on one hand and the vaccination 
history of the herd, the lung and pleura lesions examined during 
necropsy, and the detection of other bacterial and viral respira-
tory pathogens on the other hand was tested during further 
data analysis. The list of parameters was divided into suitable 
subsets and each individual parameter was considered initially 
by conducting a Chi-Square analysis to examine the independ-
ence of the respective parameter levels and the occurrence of a 
M. hyopneumoniae infection. A linear logistic regression model 
was then used to examine the relationship between the binary 
response of M. hyopneumoniae detection and a set of explana-
tory variables which were defi ned by all infectious agents that 
were found to be signifi cant (P<0.05) in the individual considera-
tions. The log odds function (LOGIT) was used as a link function.
Results
The occurrence of M. hyopneumoniae infections in young pigs 
was surveyed on 1,122 datasets, where either suckling or nursery 
pigs were examined for M. hyopneumoniae in lung tissue. Findings 
were correlated with lung lesions, detection of other respiratory 
pathogens, vaccination history and parameters describing the 
herd of origin. The prevalence of M. hyopneumoniae in lung tissue 
from suckling pigs (n=201) was 2.0% and, thus, signifi cantly lower 
than in lungs from nursery pigs (n=921), which was 9.3%. Previous 
use of antimicrobials and vital status of the pigs when delivered 
for necropsy did not infl uence the detection of M. hyopneumoniae 
infection. The presence of PRRSV-EU genotype, Pasteurella multo-
cida, Haemophilus parasuis, Mycoplasma hyorhinis or Streptococcus 
suis was correlated with a higher probability of also fi nding M. 
hyopneumoniae. Positivity for H. parasuis, M. hyorhinis and S. suis 
strongly indicated the presence of M. hyopneumoniae. Neither 
vaccination (yes/no), the time of fi rst/second application nor type 
of vaccine (one-shot vs. two-shot) infl uenced the detection of M. 
hyopneumoniae. Correlation between “type of herd” and presence 
of M. hyopneumoniae was statistically insignifi cant and no eff ect 
of farrowing rhythm could be confi rmed.
Discussion
The model of a retrospective study is, on one hand, lacking in the 
possibility of standardisation in sampling, e.g. number and age 
of animals, and, moreover, the possibility to further examine the 
samples. On the other hand, the analysis of datasets from routine 
diagnostics can provide representative data from the fi eld, if inclu-
sion and exclusion criteria are well chosen to rule out a selection 
bias (3). For the present analysis 1,122 dataset entries from a na-
tionwide operating laboratory were included, representing 27.5% 
of all examined pigs over a period of two entire years. This study 
corroborates the infrequent occurrence of M. hyopneumoniae 
infection in suckling and nursery pigs under fi eld conditions. It 
also underlines the low prevalence and rules out any signifi cant 
impact of vaccination on the frequency and time of the infection.
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Introduction
Mycoplasma hyopneumoniae is the causative agent of swine 
enzootic pneumonia (SEP), one of the most important chronic 
respiratory diseases that aff ects swine production worldwide. 
The pathogen results in considerable economic losses through 
retarded growth, poor food conversion and increased suscept-
ibility of pigs to infections by other organisms. Prevention of SEP 
may be achieved by improving hygiene and management in pig 
farms. In addition, vaccination is an eff ective strategy for control 
and prevention of SEP [1]. Commercial M. hyopneumoniae vac-
cines were prepared from killed bacteria (bacterins). However, 
mass production of M. hyopneumoniae vaccine employing the 
complicated cultivation method is expensive and time consum-
ing. The use of specifi c immunogenic proteins as subunit vac-
cines produced by recombinant DNA technology may be a pref-
erable alternative to the use of killed bacteria. In our previous 
research, 19 immunogenic proteins of M. hyopneumoniae PRIT-5 
were identifi ed using an immunoproteomic approach [2]. These 
immunogenic proteins are potential subunit vaccine candidates. 
In order to evaluate the immunogenic proteins as subunit vac-
cines, cloning and expression of genes encoding immunogenic 
proteins in heterologous expression systems is needed. In this 
report, we describe the cloning and expression of a gene encod-
ing immunogenic pyruvate dehydrogenase E1- α subunit (PdhA) 
from M. hyopneumoniae PRIT-5 in Escherichia coli.
Materials and Methods
The pyruvate dehydrogenase E1- α subunit gene (pdhA) was 
amplifi ed by polymerase chain reaction (PCR) from M. hyopneu-
moniae PRIT-5 genomic DNA template followed by TA-cloning. 
In order to replace mycoplasma -specifi c TGA (Trp) codons in the 
cloned pdhA gene, which did not allow its full length expression 
in E. coli, by the universal TGG codon, the overlap extension-PCR 
method was used. The silent mutated pdhA was cloned into 
pET29a-D. The resulting plasmid, pET-DPdhA, was transformed 
into E. coli BL21 (DE3) for expression of PdhA. Protein expression 
was induced with 1 mM isopropyl- β-D-thiogalactopyranoside. 
The cell pellet of E. coli was collected and analyzed by SDS-PAGE 
and western blot. Recombinant PdhA prodced by the E. coli 
expression system was purifi ed from cell pellet by immobilized 
metal-ion affi  nity chromatography (IMAC).
Results
The pdhA gene was cloned by PCR. DNA sequence analysis 
showed that the pdhA consists of an open reading frame of 1,125 
bp coding for a 374-amino acid residues and contains 8 TGA 
codons. The deduced amino acid sequence of M. hyopneumoniae 
PRIT-5 PdhA showed high degree identity (99%) compared with 
PdhA from other strains including J, 232 and 7448. In order to 
correctly express the PdhA in E. coli, all the TGA codons carried 
by pdhA were mutated in TGG. The mutated pdhA was further 
cloned into E. coli expression vector and expressed in E. coli as a 
recombinant fusion protein containing a hexahistidine N-terminal 
sequence and λ capsid protein D in insoluble form. Recombinant 
PdhA could be purifi ed from E. coli by IMAC (Figure 1). 
Discussion
In this study, we reported the successful cloning, expression and 
purifi cation of pyruvate dehydrogenase E1- α subunit from M. 
hyopneumoniae PRIT-5. The purifi ed recombinant PdhA will be 
further used for the purpose of immunobiological studies.
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Introduction
Enzootic pneumonia (EP), also called mycoplasmal pneumonia, 
is recognized as one of the most economically signifi cant swine 
respiratory diseases. The etiological agent of this disease M. 
hyopneumoniae (Mh) attaches to the ciliated epithelial lining of 
the respiratory tract, resulting in impairment of the mucociliary 
mechanisms, predisposing to secondary bacterial infections. 
Vaxsafe® MHP is a live temperature sensitive Mh strain that is 
being developed by Bioproperties Pty Ltd (Australia) as the fi rst 
live vaccine against EP. 
Materials and Methods
Forty (40) SPF pigs 3 weeks of age were used in this study. All 
pigs were ear tagged with an individual number, weighed and 
assigned to 4 study groups each containing 10 pigs housed 
under the same conditions in negative pressure isolation rooms. 
Pigs were acclimatized for 3 days before treatment.
Group 1 was the Negative control. Pigs within this group were 
administered vaccine diluent. Group 2 was vaccinated with 
Vaxsafe® MHP. Pigs within group 3 were vaccinated with an in-
activated commercial vaccine. Group 4 was the positive control. 
Vaccination day was designated as “days post vaccination-zero” 
(DPV-0). Vaccination with Vaxsafe® MHP was performed by 
intranasal spray and the commercial vaccine was administered 
by intramuscular injection. Vaccinated pigs were allowed to 
develop immunity over a period of 22 days, and subsequently 
they were challenged on two occasions with live culture of Mh 
IOWA strain 194 administered by aerosol at a dose of ~106.0 
ccu/mL/45 minutes in a chamber specifi cally designed for pigs. 
On the fi rst round pigs were challenged three times at 4 days 
apart ie. DPV 22, 27 and 32. All groups were then subjected to 
a second round of challenge with a similar live culture of Mh 
administered on 3 consecutive days (DPV-84, -85 and -86). Post-
mortems were performed 19 days after the second round of 
challenge (DPV-105). A number of parameters were employed in 
order to achieve the objectives of this study including assess-
ment of clinical signs, nasal swabs (nPCR) at post-mortem, gross 
lung lesions typical of Mh infection were recorded on lung lesion 
diagrams employing the planimetric method.
Results
The planimetric scoring method was used to determine the aver-
age percentage area of aff ected lung for each group. Small lesions 
(unrelated to Mh as demonstrated by nPCR results) were found 
in the negative control group. Pigs in the positive control group 
showed lesions aff ecting an average of 10.98% of the lung (Table 1).
A signfi cant reduction in the severity of lung lesions (1.34%) was 
observed in the pigs vaccinated with Vaxsafe®MHP. By com-
parison a higher lesion score (6.93%) was detected in the pigs 
vaccinated with the commercial inactivated vaccine. There were 
signifi cant diff erences (P≤0.05) in the severity of lung lesions 
between groups vaccinated with Vaxsafe® MHP and the posi-
tive control group. However, there was no signifi cant diff erence 
(P≥0.05) between group vaccinated with a commercial vaccine 
and the positive control group.
Table 1: Incidence and severity of lung lesions.
Group Incidence of lung lesions (as aff ected lungs %)
Severity of lung lesions (as 
surface of lung aff ected)
Negative control 57.14 1.7
Vaxsafe®MHP 75 1.34
Commercial vaccine 100 6.93
Positive Control 100 10.98
No signifi cant diff erence in the incidence of lung lesions was 
observed between the Vaxsafe® MHP and the commercial inacti-
vated vaccine groups.
ELISA tests performed on the two vaccinated groups showed 
78% positive for the inactivated vaccine but only 12.5% positive 
for the live Vaxsafe® MHP vaccine.
Conclusions:Following challenge, Vaxsafe® MHP provided a 
signifi cantly higher level of protection against severity of lung 
lesions compared with an inactivated commercial vaccine. This 
study also showed that ELISA (commercial) assay is not a good 
indicator for protection provided by this live vaccine.
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Introduction
Enzootic pneumonia (EP) of swine, also called mycoplasmal 
pneumonia, is recognized as one of the most economically sig-
nifi cant swine respiratory diseases. The etiological agent of this 
disease M. hyopneumoniae (Mh) attaches to the ciliated epithel-
ial lining of the respiratory tract, resulting in impairment of the 
mucociliary mechanisms, predisposing to secondary bacterial 
infections. Pigs aff ected with the disease show poor conversion 
and thus low weight gain. Vaxsafe® MHP is a temperature sensi-
tive Mh strain that is being developed by Bioproperties Pty Ltd 
(Australia) as the fi rst live vaccine against EP. 
Materials and Methods
Forty (40) SPF pigs 3 weeks of age were used in this study. All pigs 
were ear tagged with an individual number, weighed and as-
signed to 4 study groups each containing 10 pigs. All groups were 
housed under the same conditions in negative pressure isolation 
rooms. Pigs were acclimatized for 3 days before treatment.
Group 1 was the Negative control. Pigs within this group were 
administered vaccine diluent. Group 2 was vaccinated with Vax-
safe® MHP. Pigs within group 3 were vaccinated with a commer-
cial vaccine. Group 4 was the positive control. Vaccination day 
was designated as “days post vaccination-zero” (DPV-0). Vaccina-
tion with Vaxsafe® MHP was performed by intranasal spray and 
the commercial vaccine was administered by intramuscular in-
jection. Vaccinated pigs were allowed to develop immunity over 
a period of 22 days, and subsequently they were challenged on 
two occasions with live culture of Mh. IOWA strain 194 admin-
istered by aerosol at a dose of ~106.0 ccu/mL/45 minutes in a 
chamber specifi cally designed for pigs. On the fi rst round pigs 
were challenged three times at 4 days apart. DPV 22, 27 and 32. 
All groups were then subjected to a second round of challenge 
with a similar live culture of Mh administered on 3 consecutive 
days (ie. DPV 84, 85 and 86). Post-mortems were performed 19 
days after the second round of challenge (DPV-105). A number 
of parameters were examined in order to achieve the objectives 
of this study including assessment of growth performance.
Results
Vaccinated groups showed increased weight gain compared 
to the positive control group. However, analysis of variance for 
weight gain between the positive control group and the vaccinat-
ed groups indicated that the increase was signifi cant (P≤0.05) only 
for Vaxsafe® MHP and the negative control group (see Table 1)
Table 1 Weight values
Group
Total weight 
at 105 DPV 
(kg)
Diff erential weight at 
105 DPV compared to 
positive control (kg)
Diff erential weight at 105 
DPV compared to nega-
tive control group (kg)
Negative control 54.8 9.5 (0.001) 0.0 (NA)
Vaxsafe® MHP 52.74 8.5 (0.004) -2.0 (0.160)
Commercial vaccine 50.9 5.6 (0.315) -3.9 (0.463)
Positive control 45.2 0.0 (NA) -9.5 (0.001)
P values in parenthesis
No signifi cant diff erence (P≥0.05) in weight loss was observed 
between the vaccinated groups and the negative control group. 
Only the positive control group showed a signifi cant (P≤0.05) 
weight loss due to challenge (Table 1).
Conclusions
Vaxsafe® MHP showed a signifi cant diff erence with respect to 
weight gain in comparison to the commercial vaccine. An aver-
age increase in weight of 7.5 kg was observed for the group 
vaccinated with Vaxsafe® MHP compared to the positive control. 
The group vaccinated with a commercial vaccine on the other 
hand did not show any signifi cant diff erence in weight gain 
when compared to the positive control group. Compared to the 
negative control, the group vaccinated with Vaxsafe® MHP lost 
only 2 kg while the group vaccinated with a commercial vaccine 
lost 3.9 kg following challenge
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Introduction
M. hyopneumoniae (Mh) is the etiological agent of enzootic 
pneumonia (EP). The organism attaches to the ciliated epithelial 
lining of the respiratory tract, resulting in impairment of the 
mucociliary mechanisms, predisposing the lungs to secondary 
bacterial infections. Vaxsafe® MHP a temperature sensitive Mh 
strain that is being developed by Bioproperties Pty Ltd (aus-
tralia) as the fi rst live vaccine against EP. 
Materials and Methods
Forty (40) SPF pigs 3 weeks of age were used in this study. Group 
1 was the Negative control. Pigs within this group were adminis-
tered vaccine diluent. Groups 2, 3, 4 and 5 were vaccinated with 
Vaxsafe® MHP at 103, 104 , 105 and 106 ccu per dose, respect-
ively.Group 6 ws vaccinated with a commercial inactivated vac-
cine. Group 7 was the positive control. All the details concerning 
the vaccination and challenge processes are included in other 
papers of the series. Representative lung samples were collected 
and fi xed in 10% buff ered formalin. Routine paraffi  n inclusion 
and HE stains were performed.
Results
Histopathological examination of lesions showed typical bron-
chopneumonia with mononuclear and polimorphonuclear cell 
infi ltrate and BALT hyperplasia. A clear correlation was observed 
between the vaccine dose administered and the severity of the 
lesions. Increasing doses of vaccine resulted in milder manifesta-
tion of lesions with the highest vaccine dose resulting in a sever-
ity score of 1.34% (Table 1). The lowest dose of Vaxsafe® MHP 
resulted in a severity score of 4.38%. However, this will still lower 
than the severity of lung lesions observed for the inactivated 
vaccine (6.93%) which was delivered at the commercial dose. 
Negative control showed lung lesions unrelated to Mh infection 
as shown by nPCR test results.
Figure 1 Normal lung structures.
Figure 2 Normal epihelial cells with cillia.
 Figure 3 shows bronchopneumonia with abundant mononuclear 
(MN) and polimorphonuclear (PMN) cell infi ltrate. Bronchus associated 
Lymphoid Tissue (BALT) and other lung structures are diffi  cult to diff er-
entiate due to infi ltrate severity. Figure 4 shows the epithelial cells of 
bronchus still displaying some cilia but PMN infi ltrate is already present.
Table 1: Incidence and severity of lung lesions
Group Incidence of lesions (%) Severity of lesions (%)
Negative control 57.14 1.70
Vaxsafe® MHP 10 3 87.50 4.38
Vaxsafe® MHP 104 90 3.46
Vaxsafe® MHP 10 5 75 1.91
Vaxsafe® MHP 106 100 1.34
Commercial vaccine 100 6.93
Positive control 100 10.98
Conclusions
The use of Vaxsafe® MHP resulted in a notable reduction of 
severity of lung lesions (explained as percentage of lung area af-
fected), but not in the absence of lesions. This is in direct relation 
to the vaccine dosage.
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Introduction
The administration of diff erent vaccines simultaneously often 
gives rise to concerns about safety and effi  cacy. A previous study 
on the simultaneous use of MERIAL vaccines in sows showed 
no adverse eff ects on safety and similar immune responses (1). 
However, there has been no study on the simultaneous use 
of mycoplasma vaccines with swine fever vaccines in piglets. 
The present study was conducted to evaluate the safety and 
serological response induced by the two vaccines, SPRINTVAC® 
and PESTIFFA® (MERIAL) used for the control of swine enzootic 
pneumonia (SEP) and classical swine fever (CSF) respectively fol-
lowing simultaneous administration to piglets.
Material and Methods
Twenty four 4-week old weaners from farm known to be free 
of Aujeszky’s disease, Porcine Respiratory and Reproductive 
Syndrome (PRRS) and CSF were randomly allotted to 3 groups 
(Table 1). i.e. vaccinated intramuscularly (IM) in the neck with 
SPRINTVAC and PESTIFFA on the same day (Group S), vaccinated 
IM with PESTIFFA 5 days after SPRINTVAC (Group NS), and not 
vaccinated (Control group). When simultaneous vaccination was 
performed, the vaccines were injected on opposite sites on the 
neck region. All pigs were housed in adjacent pens and man-
aged in same manner throughout the trial period. 
Table 1: Groups of experimental pigs
Group Vaccination N
S (simultaneous) SPRINTVAC and PESTIFFA on the same day at 4 weeks of age 8
NS (non simultaneous) PESTIFFA vaccinated 5 days after SPRINTVAC vaccination 8
Control None 8
Weekly serum samples from 4 to 10 wks of age and at 12 and 20 
weeks of age were tested for antibodies to M. hyo and CSF using 
IDEXX test kit, and Hipra CIV swine fever test kit respectively. The 
eff ects of local site reactions and anorexia were observed for up 
to 3 weeks after vaccination.
Results and Discussion
The serological profi les for mycoplasma and swine fever anti-
bodies are shown in Figures 1 and 2.
Seven (87.5%) of pigs from Group S seroconverted to PESTIFFA 
2 weeks post vaccination. Only 25% of pigs from NS group sero-
converted at three weeks post vaccination. CSF antibodies were 
detected in all pigs at 4 weeks (Group S) and 5 weeks (Group NS) 
post vaccination. 
Figure 1: Swine fever antibody serological profi les
Figure 2: M. hyo antibody serological profi les
Three (37.5%) of the pigs from NS group seroconverted two 
weeks following SPRINTVAC vaccination while all but one 
(87.5%) of the pigs from S group seroconverted 3 weeks post 
vaccination. Seroconversion rate for both groups at 5 weeks post 
vaccination remain above 90% until the age of 20 weeks old. 
Seventy-fi ve per cent of pigs from control group were serocon-
verted at the age of 20 weeks old. This is ascribed to fi eld chal-
lenge of Mycoplasma hyopneumoniae. 
There were no adverse local reactions to the vaccinations or 
anorexia observed post-vaccinations
Conclusion
In this study, no adverse local reactions or anorexia were 
observed with the simultaneous vaccination SPRINTVAC and 
PESTIFFA. The serological responses were similar in both simul-
taneous vaccination and non simultaneous group.
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Safety and Eﬃ  cacy of a novel live vaccine for Mycoplasma hyopneumoniae: Vaxsafe® MHP
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Introduction
Vaxsafe® MHP is a live temperature sensitive vaccine developed 
by Bioproperties Pty Ltd for the protection against Mycoplasma 
hyopneumoniae (Mh) infection in pigs. Vaxsafe® MHP has been 
developed in two formats: wet frozen (WF) and freeze dried 
(FD). A number of in vivo studies have been completed which 
assessed safety, effi  cacy and colonization of Vaxsafe® MHP in 
target animals following intra-nasal administration. In this paper 
two regulatory based studies will be presented.
Materials and Methods
Study 1: Six-week-old healthy Mh free commercial pigs were 
used in this study. A dose of 109.3 ccu/mL of Vaxsafe® MHP (WF) 
was tested for safety. The regulatory guidelines for live vaccines 
stipulate that safety of a 10 times (10X) overdose should be 
tested. The dose of 109.3 ccu represents a signifi cant overdose 
of the vaccine surpassing the established 10X overdose by 1000 
fold. This study also investigated effi  cacy of Vaxsafe® MHP (WF) 
at doses of 105.7, 106.9 and 108.0 ccu/mL. Positive and negative 
control groups were included. At 22 days post vaccination (DPV), 
all groups except the negative control group were challenged by 
intra-nasal spray with Mh wild type strain. 
Study 2: Three-week-old healthy Mh free commercial pigs were 
used in this study. A dose of 105.0 ccu/mL of both the WF and FD 
formats of Vaxsafe® MHP were tested for effi  cacy. A group of pigs 
given a commercial inactivated vaccine as well as positive and 
negative control groups were also included in this study. Groups 
vaccinated on DPV-0 as well as the positive control group, were 
challenged by intra-nasal spray on two occasions (DPV-24 and 
-67) with Mh wild type strain. Post mortems were conducts at 
DPV-102. Safety of Vaxsafe® MHP (FD) was also investigated at a 
dose of 108 ccu/mL. This dose was at least 10-fold higher than 
the expected maximum release titre (MaxRT) of the vaccine. 
Results & Discussion
Study 1: The safety profi le indicated that despite the high over-
dose, Vaxsafe® MHP did not result in any deaths. Analysis of data 
revealed that no signifi cant diff erence in body temperature and 
weight gain existed between the vaccinated (safety group) and 
negative control group. At post-mortem, 2/10 pigs had a small 
lung lesion (not signifi cant (P>0.05) compared with the negative 
group). Also, the lesions did not translate to any adverse eff ect 
on weight gain nor on any clinical signs. At post mortem 4/10 
pigs in the unvaccinated, challenged control group presented 
with signifi cant lung lesions (~30% of the lung). No pigs in either 
the 105.7 or the 106.9 ccu/dose vaccinated groups showed 
any lesions. In the 108.0 ccu/dose vaccinated group, 1/10 pigs 
presented with a minor lung lesion (~7% of the lung). PCR an-
alysis of nasal swabs taken at DPV-21 prior to challenge showed 
presence of live Vaxsafe® MHP in 60% to 70% of pigs from each 
of the vaccinated groups. Tracheal colonization was investigated 
by taking swabs from the upper, middle and lower regions of 
the trachea at post-mortem (DPV-59). Swabs were only collected 
from the safety (unchallenged) group. Therefore, Mh detected 
would be due to Vaxsafe® MHP. Results obtained from PCR analy-
sis showed that Vaxsafe® MHP was present in the trachea of 60% 
of pigs in this group. This indicates that Vaxsafe® MHP is capable 
of colonizing the respiratory passages of vaccinated pigs for at 
least 8 weeks post vaccination. 
Study 2: The unvaccinated challenged group presented with 
lung lesions in 100% of pigs with a lung lesion score (planimet-
ric method) of 9.2%. At a dose of 105.0 ccu lung lesions were 
detected in 30% (WF) and 10% (FD) of vaccinated pigs postchal-
lenge with average lesion scores of 0.7% and 1.7% respectively. 
Presence of lung lesions in the commercial inactivated vaccine 
group was detected in 60% of pigs with an average lesion score 
of 8.5%. A direct comparison between the commercial inactivat-
ed vaccine group and the 105.0 ccu/dose Vaxsafe® MHP group 
showed a signifi cant reduction in both the incidence of lung 
lesions (60% to 10%) and in the severity of lung lesions (8.5% to 
1.7%), in the Vaxsafe® MHP vaccinated group. The 105 ccu/mL 
dose of Vaxsafe® MHP (FD) provided a protective index of 90% 
(incidence) and 81% (severity) of lung lesions. The commercial 
inactivated vaccine provided a protective index of 40% (inci-
dence) and only 8% (severity) of lung lesions. All indices were 
calculated in comparison to the positive control group.
Administration of an overdose of Vaxsafe® MHP did not result 
in pig mortalities, any adverse clinical signs, nor any signifi cant 
increase in the incidence or severity of lung lesions compared to 
the negative control group. A comparative study with a com-
mercial inactivated vaccine showed Vaxsafe® MHP to off er a 
higher level of protection following challenge. Overall, these two 
studies indicate that Vaxsafe® MHP to be a safe and effi  cacious 
live vaccine against M. hyopneumoniae infection.
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Introduction
Mycoplasma hyopneumoniae is considered one of the most im-
portant agents associated with chronic diseases in swine herds, 
and the primary agent of swine enzootic pneumonia (Meyns et 
al., 2006). Moreno et al. (1999) found a prevalence of 59.9% of 
farms aff ected by Mycoplasma hyopneumoniae in several Brazil-
ian states. 
The objective of this study was to evaluate the effi  cacy of vac-
cination of piglets with the vaccine SPRINTVAC®(Merial) com-
pared with the vaccine RESPISURE ONE®(Pfi zer Animal Health), 
combined with strategic medication in pulses, by measuring the 
weight gain, prevalence and extent of lesions in the respiratory 
tract, rates of occurrence of coughs and mortality rate.
Material and Methods
The experiment was conducted in a growing and fi nishing unit 
of a commercial farm, with a system of all in/all out. A total of 32 
pens with about 60 animals (i.e. 1,980 animals) were randomly 
divided into two groups: 
T1: 16 pens vaccinated with SPRINTVAC at 21 days of age. 
T2: 16 pens vaccinated with RESPISURE ONE at 21 days of age. 
Pulses with strategic medication occurred at the same time and 
same intensity for all groups. 
The cough index was determined throughout the experimental 
period, according to standard, scientifi cally validated methodol-
ogy (Mores et al., 1999). 
At slaughter 120 animals of each treatment were submitted to a 
lung lesion evaluation according to the methodology of Piff er & 
Brito (1991).
The software package statistical analysis for genetic epidemiology 
(S.A.G.E.) was used for variance analysis and mean comparison. 
Chi2-test and non-parametric tests like Kruskal-Wallis were used.
Results
As shown in table 1 no signifi cant diff erence in the weight 
output termination (p>0.05) and for GPD phases analyzed. Table 
1 also presents the prevalence of lesions of pneumonia, in addi-
tion to objective index to assess the extent of these lesions (IPP 
Index Pneumonia) and no signifi cant diff erence was observed 
between both groups (Chi2-test; p>0.05).
No signifi cant diff erence was found in mortality rates for the 
entire experimental period: 2.6% for animals vaccinated with 
SPRINTVAC and 2.85% for those with RESPISURE ONE (p> 0.05). 
As shown in table 2 related to the rate of cough there was no 
signifi cant diff erence between treatments (Chi2-test; p>0.05). 
Table 1: Performance (23 to 149 days) and evaluation of lung lesions 
at slaughter
Treatment
Performance 
(23 to 149 days) Evaluation of lung lesions at slaughter
P 149 days DWG Number of lungs No-lesion Lesion (IPP)
T1 101.130a 0.746a 126 11 (8.7%) 115 (91.3%) 1.26
T2 101.361a 0.748a 116 13 (11.2%) 103 (88.8 1.20
P=149 days weight at 149 days of age
DWG = daily weight gain throughout the experiment 
Same letters in the same column indicate the absence of statistical diff erence between values
Table 2: Index of coughing during the experiment
Phase-treatment Cough index
Nursery - T1 0.011
Nursery - T2 0.034
Growing - T1 0.226
Growing - T2 0.181
Finishing - T1 1.105
Finishing - T2 0.970
Conclusion
In the conditions of this experiment, the vaccination of piglets 
at weaning with SPRINTVAC and RESPISURE ONE showed no 
diff erence in performance (fi nal weight and DWG), slaughter 
lung lesions, mortality and number of antibiotic treatments (not 
shown).
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Introduction
Mycoplasma hyopneumoniae (M. hyo) is considered to be one of 
the most economically important pathogens in the swine indus-
try. The eff ectiveness of vaccination in reducing the economic 
impact of M. hyo has been shown previously (1, 2). 
The objective of this study was to evaluate the safety of SPRINT-
VAC® vaccination in piglets by the measure of piglet body 
surface temperature compared to body surface temperature of 
piglets treated with another current vaccination protocol.
Material and Methods
A total of 140 piglets from a 400-sow farrow-to-fi nish herd 
located in Brazil were used in this study. Piglets were randomly 
divided into 2 treatment groups: group T1 vaccinated with one 
dose of SPRINTVAC (2mL, IM), group T2 vaccinated with one 
dose of Suvaxyn® Respifend MH (Pfi zer Animal Health).
Piglet body surface temperature of piglets was measured with 
an infrared thermographic camera Testo® (fi gure 1).
Figure 1: Infrared thermografi c 
camera used to verify the distribution 
of temperature on piglet skin
All piglets were photographed at 
5 timepoints: before vaccination, 
30 min, 45 min, 24h and 48h after 
vaccination. Acquired images were 
processed and analyzed using the 
IRTesto® software to calculate aver-
age surface temperature. 
To compare piglets from both 
treatments, a polygon was drawn 
to cover the regions of their neck, 
fl ank and hind legs. From these 
regions, the average surface skin 
temperature of the left profi le of 
each piglet was extracted. The 
average temperatures were compared by Tukey’s test, after veri-
fi cation of normality of the data distribution. 
Results
Thirty minutes after vaccination, the average skin temperature 
of T1 animals was the same as the temperature measured before 
vaccination. The average temperature of T2 animals increased by 
1.6°C. Forty-fi ve min after vaccination, the average temperature of 
T1 animals increased by 0.8ºC compared to the average temper-
ature found before vaccination but stays 0.4ºC lower than in T2 
group. Twenty-four hours after vaccination, the average skin tem-
perature of T1 animals decreased by 1 3ºC compared the previous 
measurement. Piglets of T2 showed a decrease of a similar value 
(1.4ºC). At this point, animals from T2 kept their average temper-
ature (0 3ºC) a little higher than T1 animals. Forty-eight hours 
post-vaccination, piglets in both treatment groups showed an 
increase in their average temperature, being the highest increase 
in the animals from T2 (0.9°C against 0.5°C from T1).
At all time points, pigs from group T2 showed a numerically 
higher average temperature than in group T1, although, statis-
tical diff erences were found only at 30 minutes and 48h post-
vaccination (Table 1).
Table 1: comparison of average surface temperatures of piglets from 
T1 and T2
Moment from 
vaccination
T1 T2
Average surface 
temperature (°C) STD
Average surface 
temperature (°C) STD
Before 34.7 (+ 0.6)a 34.6 (+ 0.7)a
30 min after 34.7 (+ 1.0)a 36.2 (+ 0.8)b
45 min after 35.5 (+ 0.6)a 35.9 (+ 0.6)a
24h after 34.2 (+ 1.2)a 34.5 (+ 1.0)a
48h after 34.7 (+ 0.9)b 35.4 (+ 1.1)a
(a,b) diff erent letters in the same line indicate signifi cant statistical diff erence.
Discussion and Conclusion
Measure of piglet body surface temperature with an infrared 
thermographic camera seems to be a good tool limitating 
labour and pig stress. For a more precise evaluation, it would be 
necessary that the piglets would be under an effi  cient climatiza-
tion system, that more piglets would be studied and during 
more days.
It is believed that SPRINTVAC adjuvant gives a smoother 
response compared to the other studied vaccine, explaining 
the behavior of the lower surface temperature of the piglets 
vaccinated with this bacterin These results confi rm the safety of 
SPRINTVAC vaccine.
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Introduction
Atrophic rhinitis (AR) and enzootic pneumonia (EP) are two 
diseases aff ecting swine herds worldwide.
The vaccines against (EP) provide protection to swine by the re-
duction of lesions and improvement of the productivity indexes, 
although they do prevent neither the colonization by myco-
plasma nor the establishment of carrier swine (1). AR in swine 
is characterized by a deformation of snouts and a turbinate 
atrophy (2). Vaccination of sows is among the eff ective strategies 
used for the prevention and control of AR in piglets (3). 
The objective of this study was to evaluate a combined vaccina-
tion schedule with RHINIFFA®T in sows followed by SPRINTVAC® 
in piglets, compared to another currently applied protocol.
Material and Methods
Farm: A 400-sow farrow-to-fi nish herd located in Brazil and se-
lected on its previous historic of lung lesion condemnations was 
used in this study.
Experimental design: 3 replicates of 120 commercial pigs, 
housed in 3 separate pens, were used in the study. Each repeti-
tion was divided into 2 treatment groups. In the fi rst group (T1) 
piglets born from sows vaccinated with 2 doses of RHINIFFA T 
(MERIAL, 2mL, IM 6 to 8 weeks before farrowing and the 2nd 
dose was performed at 2 to 3 weeks before farrowing) received 
1 dose of SPRINTVAC (MERIAL - 2mL, IM, at 3 weeks of age) In 
the second group (T2) piglets born from sows vaccinated with 
RINIPRAVAC DT® (2mL, IM, 1st dose at 6 to 8 weeks and the 2nd 
dose at 2 to 3 weeks both before farrowing) were vaccinated 
with 2 doses of MYPRAVAC Suis® (2mL, IM, 1 dose at 7 to 10 days 
and the second dose at 28 days of age). 
Effi  cacy parameters: Pneumonia Index (PI) and Progressive 
Atrophic Rhinitis Index (ARI) were used to evaluate the vaccines 
protocols (4). PI is the numeric representation of the severity 
level of the pneumonic lesion incidence in examined animals, 
while ARI is based on the weighted average score of changes 
and lesions in nasal turbinates. The assessment of lung lesions 
and nasal turbinates was done by visual appreciation. 
Statistical methods: Chi-square Yates-corrected test for concord-
ance of lung and turbinate lesions between the two treatment 
groups was performed.
Results and Discussion
The prevalence of lung lesions was numerically found slightly 
higher in T2 animals (Table 1).
Table 1: Prevalence of lung lesions, nasal turbinate lesions, PI and ARI 
(averages).
Treatments
p
T1 T2
Prevalence of lung lesions (%) 39.9 44.9 0.369
Pneumonia Index (PI) 0.44 0.57 ND
Prevalence of nasal turbines lesions (atrophy) (%) 42.1 57.9 0.117
Atrophic Rhinitis Index (ARI) 0.52 0.82 ND
ND: not done.
PI and ARI average scores were 0.13 and 0.30 lower in the T1 
animals than in the T2 animal, respectively. It is usually admitted 
that PI scores are indicative of PI<0.56: herds pneumonia free; 
0.56< PI <0.89: Pneumonia is not a threat; PI > 0.90: there is a 
signifi cant pneumonia incidence (4). 
All repetitions show an about 16% higher prevalence of lesions 
in the nasal turbinates in T2 animals (close to a statistical trend).
It is interesting to note that in the T2 animals, some batches 
showed purulent lesions in the nasal turbinates. 
Conclusion
Numerical diff erences between the results of the two protocols 
were not found statistically signifi cant. Considering the lung 
lesion and nasal turbinate prevalence, in this study, T1 treatment 
provided a good protection against the two diseases. 
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Introduction
The objective of the study was to evaluate the safety and ef-
fi cacy of a single dose M+PAC® vaccination schedule compared 
with another single dose vaccine for prevention of M. hyopneu-
moniae (M. hyo) in a high infection pressure environment, to 
assess the real effi  cacy of both products.
Materials and Methods
The study was performed in a farm with 450 sows, using 3 week 
batches, which did not vaccinate for M. hyo before the study and 
presented a moderate level of pulmonary aff ection due to M. 
hyo: average score 0.91, using a 0-5 scoring system (1).
The piglets were divided into 4 groups, and the fi rst 3 ones were 
randomized according to the sow and piglet gender and weight 
(weights were comparable at the start of the study (p<0.05), Table 1:
a) M+PAC® (Intervet Schering-Plough), single 2 mL dose given 
at 3 weeks of age (121 animals).
b) Vaccine A, single dose vaccine, 2 mL given at 3 weeks of age 
(122 animals).
c) Control, 2 mL saline given at 3 weeks of age (236 animals).
d) Control A, not included in the study, with no individual 
animal identifi cation, used to increase the environmental 
infectious pressure (250 animals). 
The 4 groups were commingled in the same pens, keeping the 
same ratio of each group both during growing and fi nishing, 
so that the 2 vaccinated groups represented only 35% of the 
animals in each pen.
Statistical evaluation was performed using analysis of variance, 
together with the Levene test, Pearson’s chi-square test, Fisher’s 
exact test and Mann-Whitney-U test.
Results
Table 1
Control Vaccine A M+PAC
Weaning weight (kg) 6.49 6.61 6.74
Initial fattening weight (kg) 20.83 21.01 21.21
No statistical signifi cant diff erences were found for the initial 
fattening weight (55 days of age), which indicated the safety of 
M+PAC.
Table 2
Control Vaccine A M+PAC
ADG fattening (g/day) 663 690 705
End fattening weight (kg) 87.83 90.68 92.45
Concerning ADG during fattening (Table 2), the animals of the 
M+PAC® group presented higher growths than the control 
group (+42 g/day, p=0.02), and than the Vaccine A group (+16 g/
day, p=0.658). On the contrary, Vaccine A did not present a sig-
nifi cant statistical diff erence with the Control group (p=0.656).
The M+PAC® group showed statistically signifi cant higher aver-
age end of fattening weights (157 days of age) than the Control 
group (+4.62 kg. p=0.027), and than the Vaccine A group (+1.77 
kg. p=0.659). Vaccine A did not attain signifi cant statistical diff er-
ences vs the Control group (p=0 25).
The analysis of variance of both the ADG during fattening and 
the average end of fattening weights indicated better results 
of the group vaccinated with M+PAC® compared to the Control 
group (p=0.002 and p=0.011, respectively) but vaccine A did not 
present a statistical signifi cant diff erence vs the non-vaccinated 
animals (p=0.050).
No diff erences concerning mortality were found among the 
groups (p=0,835).
Table 3. Study of lesions at the slaughterhouse
Pulmonary lesions Control Vaccine A M+PAC
% aff ected lungs 53.5a 38.8b 32.2c
% lungs with highest score lesions 2.5a 2.5a 0a
Average score 0.86a 0.51b 0.37c
% lungs with pleuritis 6.4a 10.6a 1.1b
a, b, c: values with diff erent superscripts in the same fi le present statistically signifi cant 
diff erences: a, b: p<0.05, a, c: p<0.001.
M+PAC® produced the highest reduction of pulmonary lesions 
ascribed to M.hyo and pleuritis.
When grouping together the grade 0-3 scores and the grade 4-5 
ones (highest score lesions), the average ADG was 709 and 492g/
day, respectively (p=0.012), with the ADG during fattening relat-
ing with the severity of the pulmonary lesions which were found.
Discussion
Animals vaccinated with M+PAC® showed the highest reduction 
of pulmonary lesions, and both a higher ADG during fattening 
and end of fattening weight compared to the Control group, not 
occurring in the group vaccinated with Vaccine A.
Analysis of variance showed that the animals vaccinated with 
M+PAC® presented a more uniform growth and end weight than 
the Control group, which was not found for the Vaccine A group.
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Introduction
Respiratory disease is the most important pathology in modern 
swine husbandry in Europe. Mycoplasma hyopneumoniae (M.hyo) 
is a key player in the porcine respiratory disease complex (PRDC), 
a multi-factorial disease syndrome caused by several bacteria, 
viruses, management and husbandry factors. To control the clin-
ical expression of this syndrome and its negative impact on pigs’ 
performance, vaccination with M. hyo vaccines is a wide-spread 
practice in European swine farms. Vaccines against M.hyo are by 
far the most widely used swine vaccines in Europe.
Suvaxyn® MH-One (Fort Dodge Animal Health) is a one-shot 
vaccine against M. hyo to be administered by intramuscular 
injection in piglets starting from 3 weeks of age. The effi  cacy of 
this vaccine has been confi rmed under experimental conditions 
(1). The present study aimed to confi rm the effi  cacy of this vac-
cine under fi eld conditions by comparing its performance with 
another commercially available one-shot Mycoplasma vaccine.
Materials and Methods
The study was conducted in a closed breeding-fattening herd 
in France. Before the start of the study, piglets were vaccinated 
against M.hyo with a commercially available one-shot vaccine 
at 35 days of age (i.e. one week after weaning). Two consecutive 
batches with a three weeks interval were included in this study. 
The piglets of each of the two batches were divided into two 
groups: one group (n=182 in total) was vaccinated with Su-
vaxyn® MH-One at 5 weeks of age and the other group (n=170 in 
total) was vaccinated at the same age with another commercial-
ly available one-shot Mycoplasma vaccine (designated vaccine 
A), following the manufacturers’ instructions. The piglets did not 
receive any other vaccine throughout the study.
The effi  cacy of both vaccines was evaluated using clinical par-
ameters [morbidity (signs of respiratory disease), mortality, num-
ber of treatments if required], growth performance parameters 
[average daily weight gain (ADWG), feed conversion ratio (FCR)] 
and the results of post-mortem lung examinations at the slaugh-
terhouse. Lung lesions were scored from 0 to 4 per lung lobe. A 
fi nal score was obtained by adding the scores given to each lung 
lobe (between 0 and 28) (2). Pleurisy lesions were scored from 0 
to 2. The mean lung lesion scores and the percentage of animals 
having lung lesions were statistically compared using a one-way 
analysis of variance (ANOVA) and a Chi2 test, respectively.
Results
The results of the fi eld study are summarized in Table 1. No signs 
of respiratory disease were observed throughout the study. The 
mortality was the same in both groups (3 pigs in both vaccin-
ated groups).
There were no diff erences in the growth performance param-
eters ADWG and FCR between both groups.
There were no diff erences in the mean lung lesion scores between 
both groups (0.7 for the Suvaxyn® MH-One group and 0.9 for the 
vaccine A group) (P>0.05). The percentage of animals with lung 
lesions (i.e. animals having a score of >0) was somewhat lower in 
the Suvaxyn® MH-One group (23.5%) when compared to the vac-
cine A group (26.9%). However, this diff erence was not signifi cant 
(P>0.05). Five animals presented pleurisy at slaughter: 2 in the 
Suvaxyn® MH-One group and 3 in the vaccine A group.
Table 1. Clinical observations, growth performances and post-mortem 
lung lesions following vaccination with one-shot Mycoplasma vaccines 
in the fi eld.
Suvaxyn® MH-One Vaccine A
Batch 1 Batch 2 Batch 1 Batch 2
No. of pigs 99 83 87 83
Mortality rate 0% 3.6% 1.1% 2.4%
ADWG (g/day) 764.3 740.5 761.8 749.2
FCR 2.33 2.32 2.35 2.30
Mean lung lesion score 0.4 1.3 0.3 1.6
% of pigs with lung lesions 15.6 36.8 18.1 38.7
ADWG: average daily weight gain, FCR: food conversion ratio
Discussion
As no respiratory disease occurred throughout the study, the 
effi  cacy of Suvaxyn® MH-One could only be evaluated using 
growth performance parameters and the results of the post-
mortem lung examinations at slaughter. The analysis of these 
parameters did not reveal any diff erences between the Suvaxyn® 
MH-One-vaccinated pigs and the pigs vaccinated with the com-
petitor vaccine. The percentage of pigs presenting lung lesions 
and pleurisy was somewhat lower in the Suvaxyn® MH-One 
group, but these diff erences were not statistically signifi cant.
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Introduction
Mycoplasma hyopneumoniae (M. hyo) is the etiologic agent of 
mycoplasma pneumonia. The term enzootic pneumonia (EP) 
describes the epidemiological pattern of the disease in com-
bination with other etiological agents or lesions involved, (high 
morbidity including clinical respiratory signs such as prolonged 
non-productive coughing and areas of lung adjacent to normal 
tissue) (1, 2). The aim of this study was to determine the effi  -
cacy of a single dose of an aqueous inactivated M. hyo vaccine 
against EP, on the basis of reduction of frequency and severity 
of lung lesions and improvement of growth performance. The 
study was fi nanced by Intervet SPAH through the Research Com-
mittee of Aristotle University of Thessaloniki.
Materials and Methods
The study was carried out in a commercial farrow-to-fi nish pig 
farm, (900 sows under production) with confi rmed M. hyo infec-
tion. The intradermal vaccination was performed with an inacti-
vated aqueous vaccine containing M. hyo strain 11 inactivated 
M. hyo cells with a light paraffi  n oil and dl-α-tocopheryl acetate 
based adjuvant (Porcilis® M. Hyo one shot IDAL, Intervet SPAH, 
Boxmeer, The Netherlands). A total of 700 healthy suckling piglets 
at the age of 28±3 days were ear tagged and randomly assigned 
to one of two experimental groups: 346 piglets in treatment 
group (IDAL) which received a single vaccination at 4 weeks of 
age (start of the trial period), and 354 in control (C) group which 
received a placebo (dl- α-tocopherol-acetate based adjuvating 
solution). The effi  cacy of Porcilis M Hyo IDAL® one shot was as-
sessed on the basis of the reduction of lung lesions and improve-
ment of the average daily weight gain in the vaccinated piglets 
as compared to the controls. Pleuritis lesions, medication and 
mortality were evaluated as secondary parameters of effi  cacy. The 
statistical evaluation was performed with SAS® version 9.1.
Results and Discussion
The severity of lung lesions and pleuritis at slaughter were re-
duced signifi cantly in the IDAL group (Table 1) as compared to the 
controls. 
The ADG during the fi nishing period and the ADG over the total 
period were signifi cantly better in the IDAL vaccinated pigs than 
in the controls (Table 2). The improvement in the IDAL group 
was 27 g/day during the fi nishing phase and 23 g/day over the 
total period. 
No diff erence in medication was observed in the nursery, but dur-
ing the fi nishing phase signifi cantly less (chi-square test: p<0.001) 
IDAL vaccinated pigs were treated (5.1%) than controls (15.5%). 
Three quarters of all treatments during the fi nishing phase were 
given for the control of respiratory signs. Also the mortality was 
signifi cantly lower (Chi-square test: p=0.0208) in the IDAL vaccin-
ated pigs (4.7%) as compared to the control group (9.0%). 
It is concluded that a single intradermal vaccination of piglets 
with Porcilis® M Hyo IDAL at the age of around 4 weeks is eff ect-
ive against Enzootic Pneumonia in a farrow-to-fi nish swine unit 
infected with M. hyo. The prevalence and severity of lung was 
improved and the performance was improved.
Table 1 Trial group
Lung Lesion Score
IDAL Control
No lesions 58 a 17 b 
Score>0 267 293
Mean±SD 7.03±6.9c 13.13±7.3d
Pleuritis Score
No lesions 240 c 124 d 
Spots 67 142
Larger 17 44
ab: Chi-square test: p < 0.001 
cd: Rank Sum test: p <0.001
Table 2 Trial group
Period IDAL Control
ADG ADG
Nursery 473±85 461±88
Finishing 666±35a 640±37b
Total 623±33a 600±33b
Ab: Ancova: p < 0.001
References
1. Thacker, E.L., 2006. Diseases of Swine. Iowa State University Press, 
Ames, pp. 701–717.
2. Sibila M. et. al. 2007. Vet Microb 122: 97–107.
Respiratory diseases – Mycoplasma hyopneumoniae
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 635
Poster Presentations
P.329
Evaluation of peripheral lymphocytes after Weaning and vaccination for Mycoplasma hyopneumoniae
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Introduction
An early report indicated that vaccination against Mycoplasma 
hypopneumoniae (MHYO) or pathogen challenge failed to 
induce a nonspecifi c change in peripheral lymphocyte popu-
lations; however, interferon- γ (INF- γ) secreting cells were 
important to the protective response (1). Overall, a local mucosal 
humoral and a systemic cell mediated immune response are 
important to controlling mycoplasmal pneumonia in pigs (2). 
The porcine immune system is unique in the expression of 
CD4+CD8+ lymphocytes, which may be involved in the immune 
response to MHYO. Therefore, the primary aim of the study was 
to investigate immune cell populations following intramuscular 
injection with an one-dose MHYO vaccine and novel adjuvant.
Materials and Methods
The animal phase of the study was conducted at the Swine 
Teaching Unit, College of Veterinary Medicine. The unit has a 
high health status and approximately 40 sows. Based on previ-
ous serology, animals seroconverted to MHYO two months 
after placement in the fi nishing barn. Pigs (n=24 barrows) were 
selected at weaning (≈ 3 wks of age) and ear tagged for identifi -
cation. Eight pigs served as controls and 16 pigs were vaccinated 
with MYHO bacterin (PneumoSTAR™ Myco) at placement in the 
nursery. Blood samples were collected immediately before injec-
tion, and 3, 7, 14, 30, and 60 days after injection. Whole blood 
was used for complete blood counts (CBC’s) and preparation for 
the fl ow cytometry analysis. In addition, serum was collected to 
assess the humoral response to the vaccine or natural infection. 
Lymphocytes evaluated with fl ow cytometry included CD3+, 
CD4+, CD8+, CD4+CD8+, and CD21+ cells. Also, CD25+ cells, and 
cells expressing IgG and/or IgA were evaluated, but not included 
in the results. The statistical analyses used an analysis of variance 
for repeated measures and Tukey’s test to compare means. 
Results
Following vaccination, there were no apparent adverse eff ects 
in any of the pigs. The CBC’s did not diff er between the groups 
within day; however, total WBC, neutrophils, and lymphocytes 
increased (P<.05) from day 0 to day 30 (7.2+ 5 to 16.5+.7 x 103/
ul, 3.1+.3 to 6+.2 x 103/ul, 3.3+.3 to 9.3+.7 x 103/ul, respectively). 
An initial increase in CD4+ (Fig 1), CD3+ and CD21+ cells oc-
curred from day 0 to day 3 in both groups of pigs. The number of 
CD8+ and CD4+CD8+ lymphocytes increased during the initial 3 
days in the control group, but not in the vaccinated pigs (Fig 1). 
The SP ratios for MHYO remained at 0 for control pigs, whereas 
the titers increased to 1.4 at Day 30 in vaccinated pigs. 
Fig 1. Changes in CD8+ (top), CD4+CD8+ (middle) and CD4+ cells in 
pigs after MHYO vaccination (solid lines) or sham treatment (dashed 
lines). (* Within day, values diff ered P<.05)
Discussion
It was expected that the total WBC counts increased with age 
of the pigs. The increase in the three lymphocyte populations 
likely refl ects antigenic challenge resulting from the changes 
in diet and environment. The lack of change in the CD8+ and 
CD4+CD8+ lymphocytes in vaccinated pigs was surprising; 
however, it could be partially attributed to lymphocyte trapping 
in the lymph nodes and lymphatic system, and thus the number 
of these cells failed to change in the peripheral circulation. The 
diff erences between immune cells were observed shortly after 
vaccination (weaning) and prior to the increased ELISA titers. It 
is likely that the antigenic challenges associated with weaning 
confounded the response to vaccination. 
References
1. Thanawongnuweck R, et al. 2004. Clin & Diag Lab Immunol 11:901-
908.
2. Thacker E, et al. 2000. Am J Vet Res 61:1384-1389.
Respiratory diseases – Mycoplasma hyopneumoniae
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 636
Poster Presentations
P.330
Eﬀ ect of vaccination against Mycoplasma hyopneumoniae on its transmission under ﬁ eld conditions
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Introduction
Mycoplasma hyopneumoniae (Mh) is the primary agent of enzo-
otic pneumonia (EP), a contagious respiratory disease with ma-
jor economical impact for the pig industry. Vaccination of piglets 
is widely practiced as a control strategy for this disease. How-
ever, the currently available vaccines do not induce a complete 
protection against colonization and transmission (2). Virulence 
diff erences (3) and protein variability (1) between Mh strains 
may indicate that vaccination effi  cacy could vary depending 
on the strain. The aim of this study was to assess the eff ect of 
vaccination with a commercial bacterin vaccine against low and 
highly virulent Mh strains at 4 and 8 weeks post infection (PI). 
Materials and Methods
Ninety, 3 week-old, cross-bred (Rattlerow Seghers), Mh and 
PRRSV free, weaned piglets were moved to the experimental 
facilities of the Faculty of Veterinary Medicine, Ghent University, 
Belgium. After one week acclimatization, they were randomly 
allocated to 10 diff erent groups housed in absolute fi lters (HEPA 
U15) to avoid spread of the pathogen between groups. Forty 
piglets were vaccinated (v) with a one-shot vaccine (Stellamune 
One, Pfi zer), 40 were left unvaccinated (nv) and 10 were assigned 
to the negative nv and non-challenged (NC) control group. The 
experimental design is summarized in Table 1. One low (LV) and 
one highly (HV) virulent Mh strain were used for experimental 
infection. After anesthesia, the pigs were inoculated intratra-
cheally with 7 x 107CCU of Mh in 7ml inoculum or with 7ml of 
sterile culture medium. Half of the piglets were euthanized at 4w 
PI and the other half at 8w PI. The severity of coughing was as-
sessed daily using a respiratory disease score (RDS) (values from 
0 to 6). At necropsy, macroscopic lung lesions were quantifi ed 
using the lung lesion score diagram of Hannan et al. (1982), ran-
ging from 0 to 35. Additionally, lung tissue samples were taken 
from each pig to assess the severity of histopathological lesions 
(score from 0 to 5). Nasal swabs and bronchoalveolar lavage fl uid 
(BALF) were collected after euthanasia and analyzed using nPCR 
to confi rm presence of Mh.
Results
At 4w PI, the vHV group showed signifi cantly milder respiratory 
symptoms and signifi cantly lower macroscopic and microscopic 
lesion scores than the nvHV group (P<0.05). The vLV group 
showed no signifi cant diff erences for RDS, macroscopic and 
microscopic lesions scores, compared to the nvLV group. At 
8w PI, both vHV and vLV groups had signifi cantly lower RDS 
scores in comparison to the nvHV and nvLV groups, respectively 
(P<0.05). Only the vHV group showed signifi cantly lower macro-
scopic lesions in relation to the nvHV group. Results are summar-
ized in Table 2. As expected, all pigs, except for the nvNC group, 
were positive by nPCR on BALF and nasal swabs. 
Table 1: Results of the nested PCR on bronchoalveolar lavage fl uid 
(BALF) in the vaccinated (V) and non-vaccinated (NV) groups at 3 and 9 
of age and Rn values during nursery. 
Pigs age (weeks) at 
sampling
Number (%) of Mh nPCR positive pigs on BALF
P-value
V NV 
3 (weaning) 5/36 (14) 13/36 (36) ≥ 0.05
9 (end of nursery) 11/36 (31) 23/36 (64) ≤ 0.01
6 new infected 10 new infected
Rn 0.71 0.56 ≥ 0.05
Discussion and conclusions
The results confi rm the diff erence in virulence between the two 
strains (3), when measured during a period of either 4 or 8 weeks 
PI. Vaccination signifi cantly reduced the severity of disease in 
the vHV group at 4 or 8 weeks PI for most parameters. Vaccina-
tion was also benefi cial in the LV groups, but the eff ects were 
less pronounced and depended on the measured parameter. 
Further research is warranted to assess the precise eff ect of 
vaccination on individual strains under fi eld conditions, since 
combined infections might lead to more severe clinical disease 
in a pig herd (4). 
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Introduction
Mycoplasma pneumonia of swine (MPS) caused by Mycoplasma 
hyopneumoniae (Mhp) is one of major respiratory diseases in 
pigs all over the world. The susceptibility of Mhp fi eld isolates 
from Japan against valnemulin, the active ingredient of Econor®, 
has been confi rmed recently (1). The objective of this study was 
to evaluate the clinical effi  cacy of Econor® 1% premix for pigs af-
fected by MPS under fi eld conditions in Japan as part of routine 
post-approval regulatory requirements.
Materials and Methods
This study was conducted from October 2006 to November 2007 
at two diff erent farms in central part of Japan (Aichi Prefecture). 
Two farms were historically known as MPS-positive farms. Prior 
to the study, two pig farms were randomly selected for necropsy 
to confi rm the presence of typical macroscopic MPS legion in the 
lung and isolation of Mhp. Isolation of M. hyorhinis, Actinobacillus 
pleuropneumoniae and Pasturella multocida was also confi rmed. In 
total 105 crossbred pigs (80 to 100 days of age; 45 pigs at Farm A, 
60 pigs at Farm B) were randomly allocated to the following three 
groups; negative control (T1), Econor® 50 ppm (T2) and Econor® 
200 ppm (T3). Econor® was medicated in-feed for 7 consecutive 
days in accordance to the label in Japan. Body weight was meas-
ured at the start of study (Day 0), at the end of the treatment (Day 
7) as well as 7 and 14 days after the end of the treatment (Day 14 
and 21) to determine the weight gain. Twelve pigs (two pigs per 
group in each farm) were randomly selected at Day 9, two days 
after the end of treatment, for necropsy, and lungs were carefully 
examined to score the macroscopic lesion (score 0-4, 0=no lesion 
to 4=severe). Also, the area of MPS lesion in the lung was carefully 
measured to calculate the MPS-lesion ratio (%) in a whole lung 
surface. In addition, Mhp, M. hyorhinis, A. pleuropneumoniae and P. 
multocida were isolated when found.
Results and Discussion
The weight gain of pigs in the two Econor groups were signifi -
cantly higher than the gain of control group during Day 0-7 (T3: 
6.0 kg vs. T1: 4.4 kg) and Day 7-14 (T2 and T3: 5.6 kg and 6.0 kg 
vs. T1: 4.4 kg) (Table 1). With regard to the lung lesion score and 
MPS-lesion ratio, there were no signifi cant diff erences among the 
groups, although there was a trend that values for those at Econor 
groups were smaller than those of the control group (Table 1). At 
the necropsy before study onset, Mhp was isolated from all four 
pigs, and M. hyorhinis, A. pleuropneumoniae and P. multocida were 
also isolated from some pigs due to secondary infection, which is 
not unusual under fi eld conditions (Table 2). At Day 9, the control 
group had similar frequency and distribution of bacteria con-
cerned, whereas Econor® groups had tendency to reduce those 
bacteria from the level of Day 0. In the case of Mhp, reduction of 
isolation in three groups was dose dependent. It has to be noted 
that M. hyopneumoniae, A. pleuropneumoniae and P. multocida 
were not found and isolated from the lungs of pigs treated with 
Econor® 200 ppm for 7 consecutive days (Table 2). 
Conclusion
In a MPS-positive farm, Econor® has proven its clinical effi  cacy 
based on the improvement of body weight gain, the reduction 
of the bacterial load (Mhp) in the lung and the reduction of the 
MPS-lesion ratio. 
Table 1. Average weight gain and MPS-lung lesion
Pre
Day9 Day9 Day9
T1 T2 T3
M. hyopneumoniae 100 100 25 0
M. hyorhinis 50 50 25 25
A. pleuropneumoniae 50 25 0 0
P. multocida 25 25 25 0
* p<0.05
Table 2. The ratio (%) of bacteria isolation from the lung lesions
T1 T2 T3
Average weight gain(kg) Day 0-7 4.4 ± 2.5 5.7 ± 3.0 6.0 ± 2.4*
Average weight gain(kg) Day 7-14 4.4 ± 1.7 5.6 ± 2.1* 6.0 ± 2.1*
Average weight gain(kg) Day 14-28 8.4 ± 5.4 7.8 ± 4.0 9.7 ± 5.0
Average weight gain(kg) Day 0-28 17.6 ± 7.5 19.4 ± 8.0 21.7 ± 8.3
MPS-lung lesion Score 3.5 1.8 1.8
MPS-lung lesion Av. lesion ratio (%) 37.5 20.6 16.7
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Introduction
Porcine Mycoplasma including Mycoplasma hyopneumoniae 
(MH) and M. hyorhinis (MHR) concurrently cause respiratory prob-
lems as well as polyserositis/arthritis and lameness from fattening 
to breeder. Antigenic variation of the bacteria can lead to varia-
tion of the immune response and acquired resistance can cause 
failure in disease treatment and control. MIC (minimum inhibitory 
concentration) data are a trustworthy tool for the evaluation 
of antibiotics and their eff ect against Mycoplasma pathogens 
(1,2,4,6,7). The objective of this study was to determine the MIC 
of seven antimicrobials: tiamulin, valnemulin (pleuromutilins), lin-
comycin (lincosamides), tylosin (macrolids), enrofl oxacin (fl uoro-
quinolones), doxycycline (tetracycline), fl orfenicol – against Thai 
porcine Mycoplasma strains isolated during 2008-2009.
Materials and Methods
Twenty fi eld isolates of MH and MHR, were collected in 2008/2009 
from lungs, heart, brain or joints of pigs with lameness and pneu-
monia. Mycoplasmal identifi cation was done by PCR detection. 
Mycoplasmal isolates were diluted to a concentration of 5x105 
CFU/ml and were incubated at 35°C for 2 hours. MICs were carried 
out using microdilution protocol based on CLSI guidelines. The 
concentration of antimicrobials were serially two-fold diluted, 
from 0.006-12.5 μg/ml for doxycycline, fl orfenicol, lincomycin, 
tiamulin, valnemulin and tylosin, and from 0.024-50 μg/ml for en-
rofl oxacin. Mycoplasma growth was confi rmed by media indicator 
and microscopic observation. The lowest concentrations of each 
antimicrobial showing inhibition of visible color change were 
interpreted as the MIC values at 5th PI for MHR and 7th PI for MH. 
Results
The MIC values of the tested antimicrobials are shown in Tables 
1 and 2. 
Discussion
Low MIC90 values indicate high susceptibility of MH strains 
to valnemulin, tiamulin and tylosin. In contrast, high Tylosin 
MIC90 values show low sensitivity of MHR strains. Resistance 
to enrofl oxacin might be caused by the widely use in piglets to 
control E.coli. (7) MIC90 of fl orfenicol against MH and MHR was 
detected in a resistant range (breakpoint <2 μg/ml) and was 
higher than in previous studies (1,2,5,8). Increase of MIC values 
might be induced from the other antimicrobials that result in 
mutation at the 50s ribosomal subunit of bacteria (3). Valnemu-
lin showed the lowest MIC values against all tested Mycoplas-
mas and is considered as the most eff ective antibiotic in this 
study. Tiamulin inhibited MHR and MH at MICs lower than 0.1 
μg/ml - no trend of MIC increase was found. In conclusion, the 
Pleuromutilin antibiotics show the lowest MICs and are con-
sidered to be the most effi  cacious therapeutics for the control of 
Mycoplasmas in Thai pig farms. 
Table 1 MIC (μg/ml) values of 7 antimicrobial agents against Thai  
M.hyopneumoniae strains in 2008 and 2009
Drugs
M.hyopneumoniae(n2008=10; n2009=10)
MIC range MIC50 MIC90
2008 2009 2008 2009 2008 2009
Enrofl oxacin 0.048-6.25 <0.024-6.25 3.12 1.56 6.25 6.25
Doxycycline 3.12-6.25 1.56-6.25 3.12 3.12 6.25 6.25
Lincomycin 0.19-0.39 0.19-0.78 0.19 0.19 0.39 0.78
Tiamulin 0.048-0.097 0.048-0.19 0.048 0.048 0.048 0.097
Tylosin 0.097-0.19 0.048-0.19 0.19 0.097 0.19 0.097
Valnemulin <0.006 <0.006 <0.006 <0.006 <0.006 <0.006
Florfenicol 1.56-3.12 1.56-3.12 1.56 1.56 1.56 3.12
Table 2 MIC(μg/ml) values of 7 antimicrobial agents against Thai 
M.hyorhinis strains in 2008 and 2009
Drugs
M.hyorhinis(n2008=11; n2009=9)
MIC range MIC50 MIC90
2008 2009 2008 2009 2008 2009
Enrofl oxacin 0.78-25 0.78-50 1.56 3.12 3.12 50
Doxycycline 0.78-3.12 0.39-1.56 0.78 1.56 3.12 1.56
Lincomycin 0.39-1.56 0.78-3.12 0.78 1.56 0.78 3.12
Tiamulin 0.048-0.097 0.048-0.097 0.048 0.097 0.097 0.097
Tylosin 0.078-3.12 1.56-6.25 3.12 3.12 3.12 6.25
Valnemulin <0.006 <0.006 <0.006 <0.006 <0.006 <0.006
Florfenicol 1.56-3.12 1.56-3.12 3.12 3.12 3.12 3.12
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Introduction
Mycoplasma hyopneumoniae (M. hyo) is a highly prevalent insidi-
ous respiratory disease in pigs. Although mortality is low morbid-
ity can be high. It is a component of enzootic pneumonia and is 
also considered an initiator in secondary bacterial pneumonia of 
pigs which can cause increased mortality and decreased perform-
ance with associated higher production costs. Controlling M. hyo 
infections in pig herds should improve respiratory health and 
performance in growing pigs leading to lower production costs. 
Objective
To evaluate Denagard® 10 in-feed antibiotic at 137.5 ppm or 
165 ppm for a 14 day treatment period to control (M. hyoin an 
induced infection model.
Materials and Methods
Approximately 8 week old pigs (11 to 36 kg) serologically nega-
tive for M. hyowere endotracheal challenged with a M. hyo-
homogenate containing at least 109 organisms per mL. Once a 
minimum of four animals on a given day showed 5% or greater 
lung involvement through necropsy confi rmation, the treatment 
phase was initiated. Pigs were allocated to one of three treat-
ment groups (Control 0 ppm Denagard, 137.5 ppm Denagard 
for 14 days, or 165 ppm Denagard for 14 days). The pen was 
the experimental unit. The primary variable ‘total lung lesion 
percentage’ was transformed and analyzed using an analysis of 
variance with ‘Treatment’ as the classifi cation variable. Second-
ary clinical variables (depression score, respiratory score, and 
cough score), overall treatment success, production parameters 
(average daily gain, feed intake, effi  ciency), and mortality were 
also determined and statistically analyzed.
Results
The primary variable for effi  cacy determination of Denagard was 
the total lung lesion percentage at necropsy 72 hours post cessa-
tion of the Denagard application. Statistically signifi cant diff eren-
ces in favor of the Denagard treatment groups were noted in total 
lung lesion percentage when compared to the control (Table 1). 
Table 1. Summary Statistics for Percent Total Lung Lesion 
Treatments N (pens) Mean SD
Denagard 137.5 ppm 8 16.02 a 5.26
Denagard 165 ppm 8 11.76a 2.97
Control Group (0 ppm) 8 22.35 6.93
a  statistical diff erence from control (p<0.05)
As coughing is a primary clinical sign associated with M. hyo 
infection, the number of pigs coughing was further examined 
by time of day (Figure 1). Cough in the morning was diff erential 
between treatment groups with lower rate of increase in the 
Denagard groups over the trial period.
Figure 1. Regression analysis of the number of pigs coughing in the 
morning (AM) for each treatment group over the study period (Day 0 to 
Day 16)
Control vs Denagard 137.5 ppm p=0.0087, Control vs Denagard 
165 ppm p=0.0106, Denagard 165 ppm vs Denagard 137 5ppm 
p=0.0004 
No statistically signifi cant diff erences were observed for any of 
the secondary variables or production parameters, though the 
production parameters were numerically better in the Denagard 
treated animals. 
Discussion
Denagard when administered as an in-feed antibiotic at 137.5 
and 165 ppm for 14 days provides control of M. hyo infection 
based on the reduction in lung lesion percentage at 72 hours 
after in-feed antibiotic removal. Pigs that received Denagard had 
a lower rate of increase in the number of coughs in the morning 
over time when compared to control animals. The Denagard 165 
ppm group showed a lower rate of increase in coughing in the 
morning than the Denagard 137 ppm group. 
Conclusion
Denagard 10 (tiamulin in-feed antibiotic) at a dose of at least 
137.5 ppm reduced rates of coughing which is a positive clinical 
benefi t in pigs infected with M. hyo. Feeding Denagard 10 at 
either level signifi cantly decreases lung lesions resulting in 
improved lung health.
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Mycoplasma hyopneumoniae elimination in a 3800 sow, multi-site system
Jerome O. Geiger1 Doug Groth2
1. PIC-NA, Hendersonville, TN, USA; 2. Carthage Veterinary Service, Carthage, IL, USA
Introduction
Mycoplasma hyopneumoniae (Mh) was successfully elimin-
ated from a 3800 sow multi-site system. Several elements were 
considered important to the successful elimination: stabilization 
of the sow herd’s immunity, segregation of all nursery/fi nishing 
animals, strategic use of antibiotics in the sow herd and neo-
nates, complete depopulation of the nursery/fi nisher facilities, 
one-directional pig fl ow, and strict control of people traffi  c.
Materials and Methods
 A 3800 sow multi-site production system was stocked and 
operating >5 years as Mh negative based on monthly serol-
ogy, clinical signs and post-mortem examinations. The system 
was also negative for Porcine Reproductive and Respiratory 
Syndrome (PRRS). Breeding, gestation and farrowing occurred 
on Site 1. A gilt development unit (GDU) was also contained in 
Site 1. Except for the internal replacement gilts in the GDU, the 
weaned pig fl ow rotated around three facilities, 18-60 miles from 
the sow herd. 
In Jan.08, clinical signs indicated a change of health status in the 
sow herd. Mh was diagnosed by Dako ELISA serology and histo-
pathology in the sow herd and followed normal fl ows through 
the nursery/fi nisher system. All animals in the internal GDU and 
sow herd were infected by natural exposure. The breeding herd 
and GDU were vaccinated against Mh (M+PAC, Intervet) in late 
Jan.08 and again in Feb.08.
In Oct.08, eff orts began to eliminate Mh, starting with depopu-
lation of the GDU. The entire reproductive herd was vaccin-
ated against Mh in Dec.08 (M+PAC, Intervet) and again Jan.09 
(RespiSure, Pfi zer). During Jan.09, the breeding herd received 
Lincomycin (Lincocin, Pfi zer) through the water system and pig-
lets received a weight-appropriate dose of injectable tulathro-
mycin (Draxxin, Pfi zer, 2mg/kg) at birth and 11 days later. During 
Jan.09, weaning occurred at >18 days of age (average weaning 
age was 20.6 days). By Feb.09, all females in Site 1 breeding herd 
were >11 months of age. 
Starting in Feb.09, naïve replacement gilts entered the GDU and 
weaned pigs fl owed into depopulated facilities. Each site of the 
post-weaning facilities were empty >2 weeks, though individual 
rooms were empty much longer. 
Starting one month after the fi rst negative replacement gilts 
(sentinels) entered Site 1, random sentinels were serologically 
tested monthly. Random pigs were tested monthly in the down-
stream fl ow as well, allowing for maternal antibody degradation. 
Mh IDEXX ELISA was used as the screening test. Mh Dako ELISA 
was used as the diff erential/confi rmatory test on any positive 
IDEXX samples.
Results
Although sows infected naturally still exist in the breeding 
herd, shedding of Mh has apparently not occurred, based on 
continued monthly serologic sampling of sentinel animals and 
pig fl ow after the nursery depopulations. The absence of clinical 
signs and lack of Mh lesions on slaughter checks and routine 
necropsies (including Mh cultures, PCRs and histopathology) 
support this position. At the time of writing, serologic testing of 
sow herd sentinels at Site 1 has been Mh negative 12 months 
(>350 samples) and the off -site fi nishers have provided Mh 
negative slaughter-aged pigs six months (>100 samples). Tissues 
from >25 animals have been submitted for complete Mh an-
alysis. Three slaughter checks from two fi nisher sites (n=90 pigs 
total) have shown no Mh lesions.
Discussion
In this case, Mh was eliminated with the following key factors:
• Mh vaccination of the entire sow herd shortly after initial 
exposure and at end of elimination.
• Continuous matings and farrowings throughout elimination 
process.
• Youngest Mh positive animals were >11 months of age and in 
their second parity before introduction of Mh naïve replace-
ments and weaning of Mh (suspected) negative piglet fl ow.
• Lincomycin in water medication to breeding herd at end of 
elimination at Site 1.
• Tulathromycin injection of piglets at birth and 11 days later.
• Depopulation of nursery and fi nisher facilities before receiv-
ing Mh negative pigs. 
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Antimicrobial susceptibilities and molecular typing of Canadian isolates of Mycoplasma hyopneumoniae
Marie Archambault1 Audrey Charlebois1 Pierre Hélie1 Marcelo Gottschalk1 Carl A. Gagnon1 Corinne Marois2 Marylène Kobisch2
1. Université de Montréal, Saint-Hyacinthe, QC, Canada; 2. AFSSA, Ploufragan, France
Introduction
Mycoplasma hyopneumoniae is present in the majority of swine 
herds around the world. It is the causative agent of porcine 
enzootic pneumonia. Its importance is also linked to its ability to 
increase the severity of infections caused by viruses (1, 2), as well 
as bacteria (3). However, little is known about this microorgan-
ism in Canadian herds. The aim of this study was to evaluate the 
genetic diversity of M. hyopneumoniae and to determine their 
antimicrobial susceptibilities.
Materials and Methods
Bacterial isolates, growth conditions and PCR. A total of 160 
swine lungs with lesions suggestive of enzootic pneumonia 
were recovered from two slaughterhouses. They were cultured 
in Friis medium and tested by PCR or real-time PCR for M. hyo-
pneumoniae and M. hyorhinis (4) as well as PRRSV (Tetracore, 
USA), infl uenza and PCV2 viruses (5). Samples were also cultured 
for other commonly encountered swine pathogenic bacteria. 
Antimicrobial susceptibilities and resistance genes. Antimicrob-
ial susceptibilities were determined by minimum inhibitory 
concentration (MIC) for 18 antibiotics using the Sensititre® plates 
(#BOPO6F, Nova Century Scientifi c, Ontario, Canada) as de-
scribed previously (6) without the use of M. hyorhinis antibodies. 
PCRs were performed for previously described antimicrobial 
resistance genes tetM and ermB, and point mutations in L4, L22 
and 23S rRNA genes were investigated. 
MLVA and RFLP. PCR-RFLP analysis, primers and conditions 
for locus P97-RR1 and locus P97-RR2 were used as previously 
described (7). Primers and conditions for locus 1 and 2 were 
provided as a personal communication from C. Marois, Agence 
française de sécurité sanitaire des aliments (AFSSA), France. 
Cluster and data analysis. Digital images of PCR-RFLP gels and 
MLVA profi les were imported in the BioNumerics software (Ap-
plied Maths, USA) The Student “t” test was performed to evaluate 
signifi cance (p<0.05; SAS software v.9.1).
Results and Discussion
Ninety percent of the samples were positive for M. hyopneu-
moniae (Real-time PCR) while 5.6% were positive only for M. 
hyorhinis (PCR). Within the 25 selected M. hyopneumoniae 
positive lungs (culture or real-time PCR), 10 were in co-infection 
with P. multocida, 12 with S. suis, 9 with PCV2 and 2 with the 
PRRS virus. MLVA and PCR-RFLP analyses of M. hyopneumoniae 
showed a high diversity among fi eld isolates. However, there 
seem to be more homogeneity within the same herd. The MLVA 
analysis also demonstrated that almost half of the fi eld isolates 
had less than 55% homology with the vaccine and reference 
strains used in this study. The absence of amplifi cation of one 
locus (locus 1) of M. hyopneumoniae was signifi cantly associ-
ated with a reduced concentration of bacteria and a lower 
severity of the lung lesions. All M. hyopneumoniae isolates had 
low to intermediate MICs against the antimicrobial tested (Table 
1). Cultures with intermediate MICs for tetracyclines, macrolides 
and lincosamides were tested for the presence of previously 
described resistance genes tetM, ermB and L4, L22 and 23S rRNA 
point mutations. None of these genes were found but one point 
mutation, G2057A, was identifi ed. This mutation is respon-
sible for the intrinsic resistance of M. hyopneumoniae against 
14-membered macrolides. These results indicate that there is no 
acquired antimicrobial resistance within these isolates.
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Mycoplasma eradication using Draxxin® (Tulathromycin), Lincomix 44 Premix® 
(Lincomycin), and Respisure® in a 2750 sow isowean facility
Timothy P. Snider
Snider Veterinary Services, Steinbach, MB, Canada
Introduction
Mycoplasma hyopneumoniae is a primary contributor to the 
Porcine Respiratory Disease Complex (PRDC). (1) Its impact on 
the cost of fi nisher pig production makes eradication a serious 
alternative for profi table production. The possibility of produ-
cing eff ectively negative pigs following any one of several diff er-
ent eradication procedures has been well documented.(2)
Mycoplasma eradication procedures commonly involve steps 
that have a negative impact on effi  cient breeding herd produc-
tivity. Examples include: 1)restrictions on replacement gilt fl ows 
to allow for Mycoplasma exposure and cessation of shedding, 
and 2)periods with no farrowing or ultra early weaning to pre-
vent the infection of and shedding from piglets. (3) This paper 
describes a Mycoplasma eradication program that avoids these 
traditional pitfalls while rapidly achieving negative piglet pro-
duction utilizing sow herd treatment with injectable Draxxin®, 
feed grade Lincomix 44®, and Respisure® vaccine. The Draxxin® 
application to sows and piglets was a modifi cation of the proto-
col described by Yeske(4). The duration of Draxxin® application 
to piglets was extended in order to address the potential that 
recently exposed animals may continue to shed the organism 
for up to eight months. (5)
Materials and Methods
 A Mycoplasma outbreak was confi rmed in one of two naïve sow 
herds that combined their piglet production to produce market-
able groups of weaned piglets. The outbreak occurred following 
the introduction of infected replacement breeding stock.
At the time of the outbreak, these herds were about to change 
from commercial weaned piglet sales to retained ownership 
into several large continuous fl ow wean to fi nish facilities. These 
wean to fi nish facilities were well isolated from other pig pro-
duction and had a high likelihood of maintaining a Mycoplasma 
negative status.
The eradication protocol included the following steps:
• Herd wide vaccination with Respisure® at the onset of the 
outbreak and just prior to eradication;
• Herd wide Lincomix 44® treatment (220mg/kg) for 3 weeks 
prior to initial Draxxin® treatment and for 5 weeks following 
initial Draxxin® treatment;
• Sow Draxxin® doses (2 5mg/kg) estimated the day prior to 
mass treatment using fl ank taping;
• All breeding stock (ie sows and boars) and piglets were 
treated with Draxxin® on Day 1&2 of the procedure and again 
on Day 15&16 (14 day interval) if they were still present on 
the farm;
• For 5 months following the fi rst Draxxin® treatment, all pig-
lets received an injection with Draxxin® as soon as possible 
after birth and again at 12-14 days of age;
• Piglets were weaned at 18 – 21 days. No piglets were held on 
the farm beyond 24 days of age.
• All weaned piglets received Respisure® vaccination in the 
nursery for 5 months following the eradication procedure.
Mycoplasma naïve gilts entered the herd immediately following 
the second breeding herd treatment. Monitoring occurred using 
serology in Mycoplasma negative sentinel gilts. Post mortem 
sampling and the monitoring of clinical signs for Mycoplasma 
were also utilized.
Results
Piglets from the treated herd have been comingled with naïve 
piglets from another sow herd for 8 months. No Mycoplasma has 
been detected clinically or through other diagnostic methods.
Discussion
Although the cost of treating the complete sow herd was 
signifi cant, the shareholders immediately recognized the value 
of rapidly achieving Mycoplasma negative piglet production to 
the profi tability of the wean to fi nish system. Following the sow 
Draxxin® protocol, there continued to be a concern of shedding 
of Mycoplasma from parity 1 sows that entered the herd late in 
the process. The cost of a Mycoplasma outbreak in the large fi n-
isher operations would have been signifi cant. With the assump-
tion that Mycoplasma negative piglets can be produced using 
Draxxin® therapy in the event of shedding from their dams, all 
piglets were treated with Draxxin® for a period of 8 months after 
the last breeding animal was estimated to have been infected.
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The Norwegian program for eradication of Mycoplasma hyopneumoniae is successfully completed
Bjørn Lium1, 2 Anne Jørgensen2 Mona Gjestvang2
1. National Veterinary Institute, Oslo, Norway; 2. Animalia, Oslo, Norway
Introduction
In the early 1990s The Norwegian Pig Health Service conducted 
successful eradication programs for M. hyopneumoniae in several 
pig herds based on age-segregation and medication (1). Prelim-
inary serological surveys indicated that about 15 % of the pig 
herds in Norway were infected with M. hyopneumoniae. Based 
on this knowledge it was decided to initialize a program to 
systematically reduce the occurrence of, and from year 2000, to 
totally eliminate M. hyopneumoniae-infection in the Norwegian 
pig population.
Materials and Methods
Organization. The nation-wide eradication program was decided 
in a co-operation between the pig breeders’ and the slaughter-
house industry in 2000, and the Norwegian Pig Health Service 
was appointed to lead the operation. The program was based 
on voluntary participation, with some fi nancial support from the 
pork industry and an agricultural tax fund. The pig producers´ 
economic benefi t was a higher market price on live pigs in addi-
tion to an improved economic production yield on farm.
Classifi cation of herds. The nucleus and multiplier herds were 
classifi ed as free from M. hyopneumoniae if all of respectively 60 
and 40 blood or colostrum samples were negative for antibodies 
against M. hyopneumoniae. For conventional herds the initial 
classifi cation was based on blood or colostrum samples from 
at least 20 pigs (sows or slaughtered pig). Herds with 1 or 2 
positive samples were retested. To maintain status as free from 
M. hyopneumoniae, the nucleus and multiplier herds are tested 
annually (at least 10 pigs per herd). The conventional herds were 
also tested annually in the fi rst years of the program. The surveil-
lance of these herds is now based on clinical signs and control of 
lung lesions at slaughter. Herds with respiratory symptoms are 
tested serologically. 
Laboratory methods. The serum and colostrum samples have 
been analysed for the presence of antibodies to M. hyopneu-
moniaeby a monoclonal blocking ELISA (DAKO®, Denmark), 
which has a very high sensitivity and specifi city (2). 
Eradication programs. Most of the infected breeding and breed-
ing to fi nishing herds performed an eradication program based 
on a combination of age-segregation and medication (1). 
Finishing herds and some breeding herds were depopulated 
and restarted with pigs free from M. hyopneumoniae, and some 
herds gave up the pig production. 
Results
During the years 1994 to 2009 samples from 138 635 pigs from 
3247 diff erent herds were tested for antibodies against M. 
hyopneumoniae, 5538 (4 %) of the samples and 389 (12 %) of the 
herds were declared as positive. The prevalence of positive herds 
diff ered from 5.8 in the South region to 19.2 % in South-West 
region, Table 1. In 2009 all 9612 pigs tested from 839 herds were 
negative for antibodies against M. hyopneumoniae. 
Table 1. Screening for M. hyopneumoniae antibodies in Norwegian 
pigs during the years 1994 to 2009.
Region of Norway Herds tested n Herds positive n (%) Last positive test (year)
North 165 11 (6.7) 2002
Mid 649 67 (10.3) 2005
North-West 288 20 (6.9) 2007
South-West 1013 195 (19.2) 2008
South 291 17 (5.8) 2007
East 841 79 (9.4) 2006
All Norway 3247 389 (12.0) 2008
Discussion
A fundamental decision in our project was to start with estab-
lishing freedom from M. hyopneumoniae in all the nucleus and 
multiplier herds. With exception of the South-West region, 
which has a high density of pig farms, re-infections with M. 
hyopneumoniae has not been a problem in Norway. This may be 
explained by many small farms, long distances between farms, 
hilly landscape and a well-organised market for fatteners and 
gilts. In areas with a dense pig population we experienced that 
a strict regionalization of the eradication is crucial to succeed. 
Similar programs for eradication of M. hyopneumoniae have 
been implemented in Switzerland and Finland (3, 4). It is roughly 
estimated that freedom from M. hyopneumoniae means a bene-
fi t of 1-2.5 million euros per year for the Norwegian pig industry 
with a total of 1.5 million pigs slaughtered per year.
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Serotype distribution of A. pleuropneumoniae and H. parasuis in the Czech Republic
Linda Czanderlova; Marek Zizlavsky; Dita Kellnerova; Marcela Gambova; Svetlana Odehnalova; Jiri Odehnal
Sevaron Counselling, Brno, Czech Republic
Introduction 
Actinobacillus pleuropneumoniae and Haemophilus parasuis 
cause health problems in pigs with a worldwide economic 
impact on industrialized pig production. Precise serotype iden-
tifi cation is important for studying the epidemiology of these 
diseases, because the virulence and the prevalence of specifi c 
serotypes vary with geographic location (1). The knowledge of 
the predominant serotypes will facilitate the control of these 
diseases by vaccination, as strains can be then formulated in vac-
cines that will contain antigens homologous to those prevalent 
in the fi eld.
Materials and Methods
The study conducted in the year 2008 and 2009 included 203 
strains of Actinobacillus pleuropneumoniae and 53 strains of 
Haemophilus parasuis. All strains were isolated from the lungs 
of pigs showing clinical symptoms of respiratory diseases. A. 
pleuropneumoniae and H. parasuis were cultivated on chocolate 
agar based on Müller Hinton agar with 10% of ovine blood. The 
isolates of A. pleuropneumoniae and H. parasuis were serotyped 
by a standard coagglutination assay. The accuracy of the test 
was confi rmed using reference strains for each serotype. Sero-
typing of H. parasuis was carried out by the Veterinary Research 
Institute, Brno, Czech Republic.
Results
Table 1 shows the proportion of A. pleuropneumoniae isolates 
detected and typed in this study. Serotype 9, identifi ed in 129 
strains, i.e. in 63.5% of all examined strains, was found to have 
the highest prevalence. Serotype 2 was detected quite frequent-
ly (51 strains, 25.1%), serotype 11 was less frequent (13 strains, 
6.4%). Serotype 7 was identifi ed in 5 strains, all detections of 
this serotype were recorded in the year 2009. The isolation of 
serotypes 3 and non-typable (NT) was sporadic. Other serotypes 
of A. pleuropneumoniae were not recorded. 
Results of serotyping of H. parasuis are presented in Table 2. 
Serotype 4 was found to have the highest prevalence followed 
by serotypes 5 and non-typable strains. Serotypes 1, 2, 12 and 
13 were detected less frequently. The isolation of serotypes 3, 
7 and 9 was sporadic. Other serotypes of H. parasuis were not 
recorded.
Table 1 Serotyping of Actinobacillus pleuropneumoniae
2008 2009 Total
Serotype N°positive N°positive N°positive % positive
2 38 13 51 25.1
3 0 2 2 1.0
7 0 5 5 2.5
9 61 68 129 63.5
11 10 3 13 6.4
NT 2 1 3 1.5
Table 2 Serotyping of Haemophilus parasuis
2008 2009 Total
Serotype N°positive N°positive N°positive % positive
1 3 3 6 11.3
2 3 1 4 7.5
3 1 0 1 1.9
4 10 3 13 24.5
5 7 3 10 18.9
7 0 1 1 1.9
9 0 1 1 1.9
12 3 0 3 5.7
13 1 3 4 7.5
NT 5 5 10 18.9
Discussion
In the territory of the Czech Republic, the highly pathogenic 
serotype 9 is a dominant serotype of A. pleuropneumoniae 
followed by frequently isolated serotype 2. This fi nding is in har-
mony with preceding studies performed in the Czech Republic 
(2). In case of H. parasuis serotypes the situation is more varied. 
Nine diff erent serotypes and ten non-typable strains were 
recorded. This fi nding results in the need of careful laboratory 
diagnostics in pig production in case of vaccination against 
H. parasuis. Owing to the fact that the vaccination is eff ective 
against homologous strains, but ineff ective against heterogen-
ous strains, autogenous vaccines containing strains isolated in 
a given herd prevail. But autogenous vaccines must be updated 
frequently to cover the entire spectrum of strains occurring in a 
given herd. 
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Pericarditis by Mycoplasma hyorhinis
Lucas F. Santos; Kledna C. . Reis; Joao Paulo S. Castro; Daniel L. Santos; Mayka R. Henriques; Walter V. Guimaraes; Jose L. Santos
Microvet, Vicosa, MG, Brazil
Introduction 
Mycoplasma hyorhinis is a common agent found in the respira-
tory tract of pigs, and it can cause polyserositis when become 
systemic, especially in nursery and grower pigs (Rovira, 2009). 
Fibrinous pericarditis can be one of the clinical signs found at 
necropsy. (Buttenschøn et al.1997). The fi brinous pericarditis 
has been linked to various agents such as Haemophilus para-
suis, Pasteurella multocida, Actinobacillus pleuropneumoniae, 
Actinobacillus suis and Streptococcus suis (Mores, 2007). How-
ever, there are cases where you do not get the isolation of bac-
teria. Based on this aspect, we conducted a study to verify the 
presence of M. hyorhinis in pericarditis cases where the bacterial 
isolation was negative. 
Materials and Methods
We evaluated 40 cases of pericarditis from pigs with age ranging 
from 20 to 106 days, negative for bacterial isolation performed 
by Microvet laboratory. The DNA genomic samples were ex-
tracted using the kit PureLink Genomic DNA Mini Kit (Invitrogen) 
and polymerase chain reaction (PCR) was performed according 
to Assunção et al. 2005.
Results 
From the 40 samples studied, 67.5% were positive for M. 
hyorhinis, 7.5% for Mycoplasma hyopneumoniae, 7.5% for M. 
hyorhinis and M. hyopneumoniae, and 17, 5% negative for both 
agents (Graphic 1). 
Discussion 
It has been observed in recent years a considerable increase 
in detection of Mycoplasma hyorhinis in polyserositis cases, 
however always associated with another bacterial agent or 
associated with PCV-2 causing a severe respiratory syndrome 
(Santos et al.2008). Some authors consider this pathogen as 
the secondary agent of infection. This study showed that the 
M. hyorhinis can act as primary agent in some cases, mainly of 
fi brinous pericarditis. Another aspect to consider is in related to 
PCR technique, which proves to be very sensitive, rapid and less 
costly for diagnosis of this agent.
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Graphic 1: Results of PCR for and M. hyorhinis M. hyopneumoniae in 
pericarditis from pigs
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Prevalence of lesions of pleuritis at slaughterhouse
Jesus M. Bollo1 Rut Menjon1 Marta Jimenez1 Jesus V. Lopez1 Maria L. Perez-Brena1 Maria T. Tejedor2
1. Intervet Schering Plough. c/ Cantabria 2, Edifi cio Amura 28.108 Alcobendas, Madrid, Spain; 2. Dept. of Anatomy, 
Embryology and Genetics Unit of Genetics. Faculty of Veterinary Medicine, Zaragoza, Spain
Introduction
Pleuritis is a frequent fi nding in dead pigs whether they have 
died on farm or been killed in the slaughterhouse. The lesions 
are the result of infection by various respiratory pathogens, lead-
ing directly to economic losses, often price reduction or carcase 
condemnation. Thus it is important to investigate the prevalence 
of pleuritis.
Materials and Methods
The study was undertaken in Spanish slaughterhouses from 
2000 to 2010, examining 145,456 lungs from 1,085 slaughter-
house batches, originating from 451 farms.
Only the presence or absence of pleuritic lesions was recorded, 
without noting their position within the pulmonary lobes or 
whether in visceral or parietal pleura.
The aetiology of the lesions was not investigated, but it was 
suspected that the most probable pathogens were A. pleuro-
pneumoniae, P. multocida and H. parasuis.
Statistical analyses were carried out by using the SPSS 15.0 soft-
ware package. ANOVA was used for the comparison of means.
Results
The mean percentage of lungs with pleuritic lesions was 14.10% 
(± 0.34). Graph 1 is a histogram fi tted to a normal curve to show 
the distribution of the percentage prevalence of pleuritic lesions 
in the diff erent slaughterhouse batches assessed. 
Graph 1: Distribution of percentage of pleuritis in the assessed slaugh-
terhouse batches
For the 15% of batches with the lowest rate of pleuritis 
(≤ 3.84%; 162 batches), the mean percentage of lesions was 
2.06% ±0.09. For the 15% of batches with the highest rate of le-
sions (≥ 25.00%; 163 batches), the mean value was 34.52% ±.81.
Table 1 shows % pleuritis over the 11 years of the study.
Table 1: Mean % of pleuritis by year
YEAR No. of batches Mean % of pleuritis
2000 43 9.81± 1.21
2001 20 13.77 ± 2.22
2002 16 15.48 ± 2.78
2003 114 12.74± 1.03
2004 220 17.93± 0.74
2005 178 15.44± 0.87
2006 218 13.86± 0.69
2007 160 12.32 ± 1.01
2008 73 11.97± 1.31
2009 37 8.11± 1.20
2010 6 7.36 ± 2.33
 
Signifi cant diff erences (p<0.05) were found between the year 
2004 and the years 2000, 03, 06, 07, 08 and 09, and also when 
comparing the year 2005 with the year 2009.
When the results were grouped for the 316 batches of pigs 
which had been fattened during the winter months (December 
1 to March 31) for all the years, and compared with the results ob-
tained during the rest of the year (769 batches), the mean preva-
lence of pleuritic lesions was 15.11% and 13.69% respectively. 
There were no statistically signifi cant diff erences between these 
means, though the p value was close to the limit of signifi cance 
(F=3.556 NS; p=0.06). 
In the periods 2003-2005 and 2007-2009 there was an evident 
increase in the incidence of pleuritis during the coldest months, 
but this tendency was not repeated in any of the other years 
studied, which may explain the results obtained.
Discussion
Lesions of pleuritis are a common fi nding at the slaughterhouse. 
Important diff erences emerged between years in the extent of 
the lesions present, indicating a need to evaluate further the 
severity of the lesions found (1) and to diagnose the cause of 
the pleuritis when there is a high prevalence, in order to be able 
to implement eff ective control measures in herd and disease 
management.
In previous studies, the Slaughterhouse Pleurisy Evaluation Sys-
tem (SPES) and Actinobacillosis Pleuropneumoniae-Index (APPI) 
have been shown to be valuable tools in assessing pleuritis (1,2).
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Case report: Can a combination of PRRSv and Mycoplasma hyorhinis 
cause Enzootic Pneumonia-like lung lesions?
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ECO Animal Health Ltd, London, UK
Introduction
Mycoplasma hyopneumoniae is the primary pathogen associ-
ated with Enzootic Pneumonia in pigs, and causes characteristic 
lesions. We report a case in which similar lesions were associated 
with respiratory disease during a PRRS virus outbreak. These 
observations were recorded during a trial comparing the use of 
a macrolide, tylvalosin (TVN), with a combination of tylosin and 
doxycycline for control of respiratory disease1.
Material and Methods
A 3,500 fi nisher herd in the most densely populated pig area in 
The Netherlands had a history of PPE, PRRSv and multifactorial 
respiratory disease. PCR assay including multiplex PCR and Real 
time PCR for M. hyopneumoniae was carried out by the IVD Lab 
on endotracheal Bronchi-Alveolar Lavage Fluid (BALF). BALF 
samples were taken on arrival of the fi nishers at 10 weeks of 
age. ELISA (HerdChek* Mycoplasma hyopneumoniae Antibody 
and PRRS 2XR-Antibody Testkit, IDEXX) was used when the pigs 
were 17 weeks of age. Lung scoring was carried out during two 
slaughterhouse examinations when the pigs were ~ 24 weeks of 
age. 
Results
Diagnostic tests results
At 10 weeks of age all samples were positive for M. hyorhinis and 
PRRSv, but negative for PRCV, M. hyopneumoniae, SIV, PCMV and 
PCV-2. At 17 weeks of age there were no clear positives for M. 
hyopneumoniae (9 negative, 1 doubtful). 
Macroscopic lesions at slaughterhouse
Lungs (177 pigs in the fi rst batch, 131 pigs in the second batch) 
were scored as healthy, minor (10–50% of the lung tissue 
aff ected) or extensive (over 50% of lung tissue aff ected) with le-
sions of Enzootic Pneumonia (dark red/purple consolidation on 
the apical, cardiac and intermediate lobes). The number of lungs 
with lesions varied between the 2 batches, extensive lesions 
were present in 13/177 (7%) and 13/131 (10%). Minor lesions 
were present in 17/177 (10%) and 21/131 (16%). This resulted in 
17% and 26% of the total number of animals with macroscopic 
lesions of catarrhal bronchopneumonia in the two batches. The 
incidence of pleuritis was very low (2-3%) whereas 10-15%2 is 
typical. The incidence of pericarditis was 2-3%, and for abscessa-
tion 0-2%. 
Figure 1. Slaughterhouse results
Discussion and conclusions
These results suggest that M. hyopneumoniae did not play a part 
in the respiratory disease in this herd. M. hyopneumoniae was 
not found in BALF by PCR assay and the serum ELISA was also 
negative. M. hyorhinis has been shown in challenge studies to 
produce pneumonia3 with histological lesions similar to infec-
tion with M. hyopneumoniae4. PRRSv infection has been shown 
to damage lung tissue, permitting colonisation of the serous 
membrane by M. hyorhinis5. 
These diagnostic tests are frequently used in the fi eld. However, 
as the sensitivity of the ELISA for M. hyopneumoniae is relatively 
low and macroscopic lesions are non-specifi c a combination of 
diagnostic methods is advised3. BALF is recognized as a valu-
able diagnostic method for porcine respiratory disease, but the 
isolation of pathogens is not suffi  cient to diagnose the cause of 
respiratory disease on the farm6.
The diagnosis of M. hyopneumoniae, the pathogenesis of Enzo-
otic Pneumonia and the role of M. hyorhinis in EP is not clear and 
further research is needed. 
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Swine respiratory diseases in Aragon (Spain): economic, pathology 
and microbiological study during the year 2008
Juan Grandia1 Ana Cristina Berges1 María Victoria Falceto2
1. Agrotest Control. S.L., Zaragoza, Spain; 2. Faculty of Veterinary Medicine, Zaragoza, Spain
Objective
The objective was to evaluate the prevalence and economic 
impact of swine respiratory pathology in the region of Aragón 
(Spain).
The swine sector contributes greatly to the Spanish economy, 
since it has an annual production of more than 4,000 million 
euros/year. Spain is the second and fourth european and world 
swine producer respectively. Aragón contributes 18.60 % to 
the Spanish pig census. Aragón has 411861 sows and 1884649 
feedlot hogs (1). An important part of the economic losses of 
the Spanish pig sector are due to respiratory disease, leading to 
worsening conversion rates, loses of daily average gain, pro-
longed stays in the pig farm and increased mortality. (2)
Materials and Methods
The development of this investigation has been based on three 
sections:
1) Study of 52 surveys answered by Aragón veterinarians 
responsible for 216,085 sows and 2.039,255 hogs. In the 
survey farm’s productive data were asked: % mortality due 
to respiratory problems, treatment costs and vaccination, 
% of delayed pigs following respiratory disease, seizures at 
slaughterhouse, conversion rates and veterinarian’s time 
dedicated to respiratory problems. The data was processed 
in a computer simulator of costs and sales (SIP Consultors 
Model).
2) Pulmonary post-mortem inspection of 7,014 lungs of pigs 
sacrifi ced throughout the year 2008 was reported. An evalua-
tion of the lung was made to identify areas of pneumonia. A 
fast scale was used which allowed to obtain between 0 to 5 
points per lung. The scores were assigned according to the 
following criteria:
 0: Absence of pulmonary injuries
 I: Injuries just in the apical pulmonary lobes
 II: Small injuries in other pulmonary lobes
 III: Injuries in three pulmonary lobes.
 IV: Injuries in the intermediate lobe in addition to others. 
 V: Presence of injuries in all the lobes.
 The presence of pleurisy and/or pericardial diseases and 
other injuries were also documented.
3) Microbiological culture in 616 samples and detection of viral 
antigens by indirect inmunoperoxidase in 470 samples.
Results
After survey analysis, an economic estimate was obtained. A 
negative average of 13.72 € was found by each pig that goes to 
the slaughter house. 
After pulmonary inspection at the slaughterhouse, it was veri-
fi ed that during summer and winter, 32% and 43.70% respect-
ively, of the animals had healthy lungs (0). The pulmonary 
injuries were small (I) in 45.89% during summer and 62.54% 
during winter . The most serious pulmonary injuries (II) were 
55% during summer and 14.75% during winter. 
Table 1: Isolated bacteriological agents.
Isolated bacteriological agent % cases
Actinobacillus pleuropneumoniae spp. 5,43
Bordetella bronchiseptica 9,49
Escherichia coli 4,58
Haemophilus parasuis 6,1
Pasteurella spp. 16,44
Staphilococcus. coag. negative 4,58
Streptococcus spp. 31,52
Others 2,88
Isolated bacteriological agent 18,98
Table 2: Percentage of viral antigens detected.
Detected antígen %
Aujeszky gE 0,41
Coronav. resp. 0
Infl uenza 4,13
M.hyopneumoniae 71,07
M.hyorhinis 2,89
PCV-2 1,24
PRRS 20,25
Discussion
The animals that have more pulmonary injuries are those com-
ing from small capacity farms.
The low level of Aujeszky GE antigens indicates the eff ort made 
to eradicate this disease in Aragón.
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Introduction
Torque teno viruses (TTV) are viruses discovered in humans and 
several domestic and wild animal species including swine (1). 
The virus belongs to the fl oating genus Anellovirus. Two TTV 
genogroups are identifi ed in domestic pig as well as in wild boar 
(2, 3). Association between TTV and PMWS aff ected pigs has al-
ready been determined (4). In humans, also respiratory diseases 
linked to TTV have been described (5). In the present study a 
possible association between TTV and PCV-2 and respiratory 
pathogens was investigated. 
Materials and Methods
A total of 253 sera collected in 2008 were tested by conventional 
PCR (6) for TTV genogroups 1 and 2. Retrospectively, results of 
former diagnostic fi ndings of those samples were evaluated 
and possible association to TTV was investigated (Table 1). 
Furthermore, the association between the fi nal diagnosis PRDC 
and TTV as well as PCV2 was evaluated. The diagnosis PRDC was 
based on patho-morphological fi ndings (pneumonia, bronchitis, 
pleurisy). The percentage of corresponding results, the Pearson’s 
coeffi  cient of correlation and the level of signifi cance (p) were 
calculated. P-values less than or equal 0.05 were considered 
signifi cant.
Table 1: Pathogens, methods and number of analyzed samples
TTV1/TTV2 PCR 253
PCV2 In situ hybridization 136
PCV2-IgM ELISA 70
Mycoplasma (M.) hyopneumoniae Bacteriology 43
Pasteurella (P.) multocida Bacteriology 145
Haemophilus (H.) parasuis Bacteriology 145
Actinobacillus pleuropneumoniae (APP) Bacteriology 145
Results
Association between TTV and PCV2 is shown in table 2. There 
was no correlation between TTVs and P. multocida or APP. A 
negative correlation between both TTVs and M. hyopneumoniae 
(p > 0.05) as well as H. parasuis (p = 0.041) was found. Signifi cant 
correlation was found between TTV2 and the fi nal diagnosis 
PRDC (p = 0.000), whereas there was no association between 
TTV1 or PCV2 (ISH) and PRDC.
Table 2: Associations of TTV with PCV2
TTV1 TTV1 TTV2 TTV2
neg. pos. neg. pos.
PCV2 ISH neg. 48.5 % 22.8 % 44.9 % 26.5 %
PCV2 ISH pos. 15.4 % 13.2 % 5.2 % 23.5 %
Pearson 0.145 0.145 0.368 0.368
p 0.092 0.092 0.000* 0.000*
PCV2 IgM neg. 47.1 % 14.3 % 34.3 % 27.1 %
PCV2 IgM pos. 20.0 % 18.6 % 12.9 % 25.7 %
Pearson 0.258 0.258 0.219 0.219
p 0.031* 0.031* 0.068 0.068
Discussion
TTV in swine may have clinical relevance as a cofactor in multi-
factorial diseases. Association between TTV and PMWS aff ected 
pigs (caused by PCV2) has already been described. Also in the 
present study a signifi cant correlation between PCV2 IgM-Ab 
and TTV1 as well as PCV2 virus and TTV2 was detected. IgG-Ab 
were not included into the evaluation because they could have 
originated from vaccination, whereas IgM-Ab only rarely appear 
in context with a vaccination. No correlation between other 
respiratory agents and TTVs could be found, but an association 
between PRDC and TTV could be determined. To what extent 
TTV has to be considered as a cofactor for the development of 
respiratory diseases in swine still needs to be investigated.
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Pleurisy: characterisation of associated pneumonia and viral infections (PCV2, PRRSV, SIV)
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Introduction
Pleurisy is recognized as an important aspect of respiratory 
disease. There are insuffi  cient data on the extent of the rela-
tionship between pneumonia and pleurisy but it undoubtedly 
exacerbates the economic losses of respiratory disease due to 
consequent required carcase trimming at slaughter. A number 
of studies have identifi ed risk factors associated with pleurisy 
(environmental (1), bacterial (2), and recently viral (3)). This study 
explored the relationships between histological types of pneu-
monia and active or resolved pleurisy and investigated the role 
of viral infections (PRRS, PCV2, and infl uenza) in pleurisy.
Materials and Methods
A total of 79 pigs were selected for necropsy across 12 UK 
fi nisher units that reported a consistent pleurisy prevalence of 
>10% at slaughter. Pigs were selected on the basis of clinical 
respiratory signs and included the youngest pigs showing 
respiratory signs (such as dyspnoea and/or coughing). Pigs on 
3/12 units were vaccinated against PRRSV (18/79 pigs in study). 
On 10/12 units pigs were vaccinated against PCV2 (63/79 pigs) 
and PCV2 associated disease (PCVAD) was not reported as a 
clinical problem on any units. Each pig was allocated a pleurisy 
status based on a combination of gross and histopathological 
fi ndings (no pleurisy (NP), active pleurisy (AP), resolved pleurisy 
(RP)). Histopathological evaluation permitted each pig to be 
categorised as having no pneumonia (NPn), bronchopneumonia 
(BPn), broncho-interstitial pneumonia (BIPn), or interstitial pneu-
monia (IPn). Virology investigations in each pig comprised PCR 
on blood for PRRSV, histopathology and immunohistochemistry 
on lung for PCV2-associated pneumonia, and on inguinal and 
ileocaecocolic lymph node for PCV2-associated lymphoid chan-
ges, and virus isolation on pooled tonsil, trachea and lung for 
swine infl uenza virus (SIV).
Results
Of the 79 pigs, 23 had no detectable pleurisy (age range 
5-21wks), 25 showed active pleurisy (5-21wks) and 31 showed 
resolved pleurisy (10-21wks). AP and RP were found on all 12 
units. Histopathology revealed the following fi ndings: NPn – 8 
cases, BPn – 21 cases, BIPn – 45 cases, IPn – 5 cases. Twenty four 
of the 79 pigs had a PRRS viraemia, 11 had PCV2-associated 
pneumonia, and 13 had PCV2-associated pathology in lymph 
node. Analysis of the relationship between pleurisy and pneu-
monia revealed statistically signifi cant associations (p=0.0006). 
For the no pleurisy group, pneumonia types were broadly dis-
tributed across NPn (30%), BPn (39%), BIPn (17%) and IPn (13%). 
However, for the AP group there was a marked increase in the 
proportion of cases with broncho-interstitial pneumonia (NPn – 
0%, BPn – 28%, BIPn – 64%, IPn – 8%). This increased prevalence 
of BIPn was even more marked in the RP group (NPn – 3%, BPn 
– 16%, BIPn – 81%, IPn – 0%).Associations were found between 
pleurisy and infection by PRRSV and PCV2. For PRRSV viraemia, 
NP = 4 pos/23 (17%), AP = 9 pos/25 (36%), RP = 11 pos/31 (35%); 
p=0.03). For PCV2-associated pneumonia, NP= 0 pos/23 (0%), AP 
= 7 pos/25 (28%), RP = 4 pos/31 (13%); p=0.02). For PCV2 detec-
tion in lymph node, NP=0 pos/23 (0%), AP=7 pos/25 (28%), RP=6 
pos/31 (19%); p=0.02). SIV was found in 1 pig.
Discussion
This study focused only on pigs from production units with con-
sistently high pleurisy prevalence. Within these units we found 
that pigs aff ected by pleurisy were more likely to be aff ected 
by broncho-interstitial pneumonia than pigs on the same units 
without pleurisy. Furthermore, we found associations between 
pleurisy and PRRSV viraemia and pleurisy and PCV2-associated 
pneumonia or PCV2 pathology in lymph nodes. The majority of 
units undertook vaccination against PCV2-associated disease 
(PCVAD) and none reported clinically active PCVAD. These fi nd-
ings highlight the value of reviewing procedures to maximise 
PCV2 and PRRSV vaccine-induced protection as part of a strat-
egy to control pleurisy. 
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Introduction
Pleuritis and cranio-ventral pulmonary consolidation (CVPC) are 
the most frequent pathological fi ndings in pig lungs at slaughter 
(3). Several environmental factors and infectious agents have 
been associated with the occurrence of lung lesions in swine. 
Mycoplasma hyopneumoniae and Actinobacillus pleuropneu-
moniae are considered to be the most important primary 
bacterial respiratory pathogens (6). On the other hand, the acute 
phase protein (APP) response plays an important role in lung 
infection (5). Therefore, the purpose of this study was to inves-
tigate the relationship between the existence of lung lesions in 
pigs at slaughter and the concentration of three APPs, hapto-
globin (Hp), pig-major acute protein (Pig-MAP) and C-reactive 
protein (CRP).
Material and Methods
Twenty-four farms were used for the present study. Pleuritis 
lesions were assessed based on the Slaughterhouse Pleurisy 
Evaluation System (SPES score). An A. pleuropneumoniae index 
(APPI) was defi ned to provide information on the prevalence 
and severity of pleuritis lesions as previously described (1). 
Farms were classifi ed as “pleuritis negative (P-) or positive (P+)” if 
they had low or high APPI values, respectively. Moreover, farms 
were classifi ed also as “CVPC negative (M-) or positive (M+)” if the 
percentage of lungs with these lesions at farm level were lower 
or higher than 60%, respectively. CVPC lesions were evaluated 
using a previously described method (2). Selected farms were 
divided into four combined groups (P-M-, P-M+, P+M-, P+M+), 
including 6 farms per category. Blood from 20 randomly se-
lected pigs from each farm was collected and selected APPs de-
termined in serum. Hp was quantifi ed by a spectrophotometric 
method (haemoglobin binding assay). Pig-MAP levels were as-
sessed with an ELISA kit (PigCHAMP ProEuropa, Segovia, Spain). 
Finally, CRP was determined using a commercial immunoturbidi-
metric method (Olympus System Reagent, OSR 6147).
A non-parametric test (Mann-Whitney) was used to evaluate the 
eff ect of pleuritis or CVPC lesions on the concentration of APPs. 
Finally, a Receiver Operating Characteristic (ROC) analysis was 
carried out to determine the capacity of discrimination of APPs 
in farms classifi ed as P- or P+ or M- or M+ and when the four 
groups were taken into account (P-M-, P-M+, P+M-, P+M+). 
Results
All APPs concentrations were signifi cantly higher for M+ farms 
than for M- ones. However, only Hp and Pig-MAP showed sig-
nifi cantly higher values for P+ farms than for P- ones (p<0.05). 
Pig-MAP was the most sensitive indicator since it was able to 
clearly discriminate between P-/P+ and M-/M+ groups (p< 0.001 
in both cases). Hp was an excellent marker for pleuritis and good 
for CVPC lesions. CRP was able to discriminate for CVPC lesions 
but not for pleuritis. ROC analysis showed that Pig-MAP was the 
best biomarker, with 67.8% sensitivity and 78.8% specifi city to 
discriminate between P-M- and P+M+ farms. 
Discussion
There is little information in the literature about the relation-
ship between serum APP and the degree of lung lesions of pigs 
at slaughter (4). The present study shows that both Pig-MAP 
and Hp can be used as unspecifi c markers for the presence of 
pleuritis and/or CVPC lesions at slaughter. None of the tested 
APPs was able to discriminate both types of lesions; such result 
is not surprising, taking into account to their unspecifi c role in 
the infl ammatory response. It is very important, however, to 
note that pigs involved in the present study did not show any 
clinical sign of disease at slaughter, and lesions were identifi ed in 
a retrospective evaluation by abattoir surveillance.
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Introduction
Long pentraxin 3 (PTX3) is a conserved pattern-recognition mol-
ecule and a host-defense-related component of the humoral in-
nate immune system. PTX3 is produced in a variety of cell types 
and tissues, most notably dendritic cells (DC) and macrophages, 
in response to Toll-like receptor engagement and infl ammatory 
cytokines. PTX3 regulates the complement cascade, facilitates 
the pathogen recognition via cellular receptors (opsonisation) 
and plays a regulatory role during infl ammation. Moreover, PTX3 
is related to female fertility in human and mice (1, 2, 4).
PTX3 has an antiviral role in early host defence against infl uenza 
infections (5) and it might be a useful biomarker of acute lung 
injury (4) in mice. No information on PTX3 role in pigs is avail-
able at the moment.
The aim of our study was to investigate the role of PTX3 as a 
biomarker in vivo and in vitro in pigs.
Material and Methods
For in vitro study, porcine bone marrow-derived DC were gener-
ated and infected with a H3N2 swine infl uenza virus (A/Swine/
Spain/80598-LP1/2007).
For in vivo study, sixteen conventional pig farms with history of 
pleuritis lesions and cranio-ventral lung consolidation were used 
(3). Blood from 20 randomly selected pigs from each farm was 
collected and selected acute phase proteins were determined 
in serum. Hp was quantifi ed by a spectrophotometric method 
(haemoglobin binding assay). Pig-MAP levels were assessed 
with an ELISA kit (PigCHAMP ProEuropa, Segovia, Spain). Finally, 
CRP was determined using a commercial immunoturbidimetric 
method (Olympus System Reagent, OSR 6147). Moreover, sera 
from 48 conventional sows from parity one to eight showing 
high swine infl uenza virus (SIV) antibody titres were also used.
PTX3 concentration in sera and culture supernatant was deter-
minate by sandwich ELISA (2C3 and 6B11 antibodies) as previ-
ously described (8).
Statistical analysis was performed using SPSS 15.0 software 
(SPSS Inc., Chicago, IL, USA).
A linear regression between diff erent variables was carried out 
and a Kruskal-Wallis test was used to compare PTX3 serum levels 
between diff erent sow parities. All this statistical analysis was 
performed using SPSS 15.0 software (SPSS Inc., Chicago, IL, USA).
Results
The in vitro study showed that porcine myeloid bone marrow-
derived DC produced PTX3 after infection with porcine infl uenza 
virus H3N2.
The in vivo results have shown that PTX3 serum levels are correl-
ated neither with Hp, CRP or Pig-MAP nor with lung lesions score 
in conventional swine farms. PTX3 concentration in SIV antibody 
positive sera of studied sows increased with the parity number 
showing statistical tendency between the youngest and the old-
est sows (p=0.07). Moreover, there was no statistical correlation 
between SIV antibody titres and PTX3 amount in serum.
Discussion
PTX3 is produced by myeloid DC in human and mice and the 
present study confi rmed in vitro production on porcine myeloid 
DC. 
In vivo results have shown that PTX3 is not a good biomarker 
for chronic lung lesion status in swine farms when compared 
with Hp and Pig-MAP (7). However, PTX3 concentration in SIV 
antibody positive sera correlated with a greater exposure to 
infections, indicating that PTX3 might be used as a biomarker 
under certain conditions. Further studies should be performed 
to elucidate its possible practical application.
This is the fi rst analysis of PTX3 role in pigs and future studies 
will determine its contribution in porcine innate immunity.
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Development of lung macrophage subpopulations in potbellied minipigs after weaning
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Introduction
Respiratory diseases are one of the main problems in human 
and animal health. Several models to study the respiratory 
immune system has been used, but humans and pigs share 
the unique feature of a non-constitutive bronchus-associated 
lymphoid tissue (BALT) (1-2). In spite of its importance, no 
studies on lung macrophage (Mf) development have been car-
ried out. We examined the development of Mf in blood, bron-
choalveolar lavage (BAL) and lung parenchyma (LP) of pigs after 
weaning by fl ow cytometry.
Material and Methods
Five 5 weeks-old weaned pigs (WP), fi ve 3 months-old (3m) and 
four 5 years-old (adults) SPF potbellied mini pigs from the ani-
mal unit of CINVESTAV (UPEAL), compiling with local and federal 
regulations of animal care and with no vaccination protocols 
running, were used. PBMC were obtained by Ficoll/Isopaque 
gradient, BAL cells were obtained by tracheobroncheal lavage 
with PBS and lung parenchyma cells (LP) were obtained after en-
zymatic digestion of fresh tissue. Mouse monoclonal antibodies 
to pig CD172a (IgG1 -MIL-2-), CD14 (IgG2b -74-22-15-) and MHC-
II (IgG2a -MSA-3-) were used with fl uorochrome conjugated goat 
anti-mouse secondary antibodies (IgG1-PE, IgG2b-APC, IgG2a-
FITC). The cells were run in a FACScalibur (B-D) fl ow cytometer. 
Relative and absolute numbers of positive cells were calculated 
and the results were analyzed by ANOVA. 
Results
The proportion (%) of CD14+MHC-II+ Mf was higher in all tis-
sues of WP (WP>adults=3m) (Fig 1A). CD14+CD172a+cells were 
higher in 3m PBMC (3m>WP), and LP of adults (Adults>WP=3m) 
(Fig 1B). CD14+ double positive (DP) cells were higher in all 
tissues of 3m and adults (3m=adults>WP) (Fig 1C) and CD14+ 
double negative (DN) cells were higher in WP PBMC (WP>3m) 
and adult LP (Adults>3m) (Fig 1D). Absolute numbers of 
CD14+MHC-II+ were higher in PBMC (WP>3m), BAL and LP of 
WP (WP>3m=adults, Fig 1E). CD14+CD172a+ were higher in 
PBMC of 3m pigs (3m>WP, Fig 1F) only. CD14+DP cells were 
higher in 3m BAL (3m>WP) and LP (3m>WP=adults, Fig 1G) and 
CD14+DN cells were higher in WP PBMC (WP>3m=adults) and 
LP (WP>3m, Fig 1H).
Discussion
Mf subpopulations in the lung undergone important changes in 
proportion and number with age. At least four diff erent CD14+ 
subpopulations were identifi ed. MHC-II+ and CD172a+ cells may 
have diff erent roles since they tend to inversely change with age 
(Fig 1A, E & B, F). DP cells tend to increase with age (Fig 1C, G) in 
contrast with DN cells (Fig 1 D, H). MHC-II+ may correspond to 
activated Mf, CD172a+ is a SIRP molecule, related to activation 
control (3-5). DP cells may be related to fully diff erentiated Mf 
and DN to scavenger non-activated cells. Their role in lung pro-
tection remain to be elucidated. These data also show evidence 
of important diff erences among tissues.
Figure 1. Relative (A-D) and absolute (E-H) numbers of CD14+ 
macrophage subpopulations in PBMC, bronchoalveolar lavage (BAL) 
and lung parenchyma (LP) of weaned (WP), 3 months-old (3m) and 5 
years-old (adults) SPF potbellied mini pigs (n=5/group). Bars show the 
mean plus SEM. ANOVA test. *P<0.05, **P<0.01, ***P<0.001.
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Interaction between Mycoplasma hyopneumoniae and fumonisin B1 toxin in the porcine respiratory tract
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Introduction
Respiratory disease is one of the most important health con-
cerns for swine production. The term porcine respiratory disease 
complex (PRDC) refers to a condition in which an interaction 
between various pathogens and inappropriate environmental 
conditions lead to severe respiratory disorders (1).In this study 
we examined the possible synergy between M. hyopneumoniae 
(Mh) and fumonisin B1 (FB1) toxin in the lung of pigs. Computed 
tomography (CT) proved useful for imaging pneumonia (3). CT 
was applied to follow up the pathological events in the lung.
Materials and Methods
Twenty-eight 3-day-old pigs, obtained from a high health-status 
herd, were used in the study. The arrival of the pigs was day 0 
of the study. After an early weaning, the piglets were artifi cially 
reared receiving milk-replacer until day 16 and then appropriate 
solid feed until the termination of the experiment (day 58). Four 
groups of 7 pigs were formed: 
Group 1: uninfected untreated controls 
Group 2: uninfected - treated with FB1-toxin 
Group 3: infected with Mh - untreated 
Group 4: infected with Mh - treated with FB1-toxinGroup 3 and 4 
were infected with Mh (strain Mp 496) on day 30. The inoculum 
was prepared by suspending 1.5 g Mh containing lung tissue in 
13.5 ml phosphate buff ered saline (pH 7.2). Pigs were inoculated 
intra-tracheally with 0.5 ml of the suspension containing 109 
colour-changing units per ml. Groups 2 and 4 were fed with FB1-
contaminated feed (10 mg/kg) from day 16 until termination. 
The toxin was produced as described (2).CT images of the whole 
lung were acquired at days 16, 30, 44 and 58 using a SIEMENS 
Somatom Emotion 6 multislice CT scanner. At termination, 
the pigs were humanly killed and lung lesions were evaluated 
post mortem (4). CT images were analysed by Medical Image 
Processing V1.0 software. Aff ected were compared with and 
non-aff ected areas.
Results
From day 37 the infected animals showed clinical signs (cough-
ing, laboured breathing and huskiness). CT examination did 
not reveal lesions in the negative control pigs (group 1) and the 
FB1-treated group (group 2) suggesting that the toxin did not 
induce macroscopic lesion at this dose level. In the Mh infected 
groups (groups 3 and 4) lung lesions were found in all animals 
on day 44. The most pronounced lesions were observed in the 
cranial, middle, and the accessorial lung lobes and in the front of 
the caudal lobe. The lung lesions appeared fi rst around the small 
respiratory airway passages, later whole lobules and lobes be-
came aff ected. Necropsy did not reveal lung lesion in the nega-
tive control pigs (group 1). In group 2, mild interstitial oedema 
was observed in four animals. In the Mh infected groups (group 
3 and 4) we found acute catarrhal pneumonia in all animals. The 
macroscopic lung lesions were more pronounced in group 4 
than in group 3. Signifi cant diff erences were detected between 
non-infected and infected groups by CT evaluation
Discussion
The Mh infection produced lung lesions in young piglets that 
were increased by treatment with FB1 toxin. The only lethal case 
and the highest rate of lung lesions were found in group 4 that 
received FB1-toxin treatment beside the bacterial infection indi-
cating that the FB1-toxin increased the severity of pneumonia 
caused by the bacterial pathogen. These fi ndings confi rm the 
idea of PRDC that various factors may act in harmony to produce 
pneumonia. Our results also indicate that CT can be applied for 
studying the pathological conditions in the lower respiratory 
tract of swine.
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Virulence genes and PFGE types of Pasteurella multocida ﬁ eld isolates from pigs in South Korea
Aeran Kim; Ji Youn Lee; Chun Tae Lim; Kichan Lee; Suk Chan Jung
National Veterinary Research & Quarantine Service, Anyang, Korea
 Introduction
Pasteurella multocida is widely recognized as the causative 
agent of progressive atrophic rhinitis and hemorrhagic septi-
cemia in swine and is of considerable economic importance 
to the pig rearing industry through-out the world. The present 
study reports the frequency, features and molecular epidemiol-
ogy of P. multocida isolates from diseased and fi nished pigs.• 
Materials and Methods
A total of 140 P. multocida isolates was collected from 751 cases 
of diseased and fi nished pigs during 2007-2009 in South Korea. 
The isolates were analyzed by PCR for the capsular type (A, B, D, 
E, F) and the presence of virulence genes. The 4 virulence-asso-
ciated genes were detected with varying frequency. Genotyping 
of the isolates were performed by Pulsed fi eld gel electrophor-
esis (PFGE)
Results
The most prevalent capsular type among P. multocida isolates 
was capA (54.1%), followed by capD (45.9%) from diseased 
pigs. However, from fi nished pigs, the prevalent of capA (97.5%) 
was higher than capD (2.5%). A higher percentage of toxA was 
detected among diseased pigs (12.5%) compared with strains 
isolated from fi nished pigs (3.8%). Among clinical isolates hgbB 
and tpbA was more frequently identifi ed in strains isolated 
from diseased pig (95.8%, 54.2%) whereas 78.8% and 18.8% of 
the fi nished pig isolates harboured this gene. However, pfh A 
gene detected more frequently from fi nished pigs (50.0%) than 
diseased pigs (16.7%). The PFGE patterns of the isolates revealed 
fi ve diff erent genotypes.
Discussion 
These data enforce further virulence and epidemiological stud-
ies, examining the properties of porcine P. multocida strains as 
well as factors of the porcine hosts themselves, which might be 
involved in disease susceptibility.
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FUGATO RePoRI: Development of a powerful tool for the analysis of bacterial lung infections in pigs 
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Introduction
Lung infections have a great impact on the pig breeding and fat-
tening industries worldwide. Economical losses due to stunted 
growth of piglets or massive need of antibiotic treatment of 
infected herds along with the oftentimes missing alternative of 
vaccination strategies encouraged a change in strategy toward 
a breeding programme focusing on lung health. Therefore the 
FUGATO-IRAS project and the follow-up project RePoRI work on 
the identifi cation of genetic markers responsible for an in-
creased resistance towards bacterial lung infection by the use of 
the infection model Actinobacillus pleuropneumoniae (App).
Materials and Methods
Within IRAS 106 pigs of 4 breeding lines (German Landrace, 
Piétrain, Hampshire, Large White) were infected. The aerosol 
infection was performed using App serotype 7 strain AP76. 
Sampling (BALF, blood) and phenotyping were carried out twice 
(day 4 and day 20 post infection [p.inf.]). Pigs were euthanized 
immediately after the sampling, lung lesions were scored during 
necropsy by the Lung Lesions Score according to Hannan et al., 
and lung tissue was taken. For additional phenotyping a Res-
piratory Health Score (1) was used. Acute phase proteins were 
determined (blood, BALF), glycoproteins (BALF) were analyzed 
via diff erential two-dimensional gel electrophoresis (2D-DIGE) 
and RNA expression was investigated using the Aff ymetrix 
GeneChip® porcine Genome Array. In addition, a consumer 
study investigating the allele diversity within German pork was 
realized and SNPs for candidate genes, derived from known hu-
man genes, were detected and characterized. 
As tool for the analyses of the host-pathogen-interaction a 
versatile, multi-species microarray based on the CustomArrayTM 
platform of Aff ymetrix® was developed. Using extensive in silico 
analyses using BLAST and MUMMER (2) followed by hard and 
soft pruning, the resulting APP76PIG Chip contains the complete 
genome of 3 serotypes of App, the Mycoplasma hyopneumoniae 
strain 232 as well as the 1.500 most promising probes of the 
Aff ymetrix GeneChip® porcine Genome Array. Each gene is 
represented by 8 to 11 25mer probes as match and mismatch 
probe sets to subtract unspecifi c binding of labeled cDNA.
Results
Pair wise whole-genome comparisons of our infection model 
strain (App serovar 7) with App serovars 3 and 5 using the Max-
imal Unique Matching subsequence decomposition program 
MUMMER (Vers.3.0) delivered a number of serovar specifi c loci 
for each of the three genomes with 82 open reading frames 
(ORF) in serovar 3 and 68 ORF in serovar 5 which were not also 
present in serovar 7. Using BLAST and the Aff ymetrix® pruning 
software we condensed this list to 28 (serovar 3) and 49 ORF 
(serovar 5), respectively, which were unambiguous serovar 
specifi c and added these probes to the APP76PIG array. Now we 
are able to analyze the expression of three App serovars which 
diff er in their clinical severity in pigs.
Next we added all OST of Mycoplasma hyopneumoniae strain 
232, another important lung pathogen. This enables us to evalu-
ate our App derived results with another bacterial infection 
model.
In a fi nal step 1.500 probes of the porcine Genome Array 
representing the most promising potential genetic markers of 
FUGATO IRAS were added to the APP76PIG array. 
Discussion
With this powerful tool for expression analyses we are able 
to not only get a detailed picture of the bacterial expression 
of App but also, simultaneously, of the direct response of the 
porcine host, based on our previous results from FUGATO IRAS. 
Moreover, using e.g. fi eld samples of acute infections in pigs we 
should be able to compare these results with two additional 
serovars of App. Also, we can now get an impression detached 
from our chosen infection model by analyzing pigs infected 
with Mycoplasma hyopneumoniae and thereby ensure that our 
genetic markers are in fact lung specifi c and not App specifi c 
markers.
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Introduction
The chronic respiratory diseases cause serious economic loss 
in the pig farms for a long time. Especially, PRRSV, PCV2, MH 
(Mycoplasma hyopneumoniae) were main causative pathogens 
in respiratory diseases. Moreover, PMA (Pasturella multocida), 
APP (Actinobacilus pleuropneumoniae), HP (Hemophillus para-
suis) were also complex infective agents in chronic respiratory 
diseases in pig farms. It was diffi  cult to diagnose infection or im-
mune situation of herds. Most of diagnosis results were supplied 
as positive rates, individual antibody titers. These kinds of data 
mostly not useful in herd control for respiratory diseases. We 
need herd based overall statistical data to get information for 
profi ling of farm including immune status and infection ages.
Materials and Methods
Antibody tests: The several commercial ELISA kits were used for 
testing antibody level of PRRSV, PCV2, MH, APP, PMA and HP 
(JENO Biotech Inc. Korea). For PRRSV, IDEXX 2XR was also used 
for testing. 
Serum samples: 46 serum samples per herd according to age 
groups were collected from 200 or more farms in Korea. The age 
groups were divided with 7 groups by gilt, sow, suckling (20 days), 
weaner (40 days), early grower (70 days), late grower (100 days) 
and fi nisher (130 days). Serum samples were collected from 4, 10, 
12, 5, 5, 5 and 5 heads by each age group respectively. 
Statistical analysis: The several data including positive rate, mean 
SP value and CV% (Percentage Coeffi  cient variation) were ana-
lyzed by age group of each herd. Mean SP value and CV% were 
used to determine the antibody level and variation of pig herds. 
We determine the sero-conversion age group by comparing SP 
value and CV% of each age group. 
Software: Widows XP based standalone software was designed 
and used to analyze the ELISA results. It gets OD values from 
each ELISA and then transforms the data to report for herds.
Results
Total about 200 farms or above were tested and analyzed. Most 
of farm showed dramatic sero-conversion in specifi ed age 
groups. Generally, high-level maternal antibody was detected 
in sucking group and drop down the level on weaner or early 
grower group. Then it showed increasing antibody again on 
early or late grower group regardless vaccinated or not.
We can determine simply sero-converted age, mean antibody 
level and variation as fi gure 1. Most pathogens were positive by 
PCR or RT-PCR on before 2-3 weeks of sero-converted age (Data 
not shown). It means sero-converted age determined by mean 
SP is important parameter in herd. Most infected herds showed 
higher SP value and CV% than maternal antibody and increased 
continuously after sero-conversion. It means cyclic infection 
and unstable immunity of herds was suspected. From the report 
based on seroconversion, mean SP value and CV% of each age 
group, disease and immunity information could be supplied 
to fi eld veterinarian. It was consider as very eff ective to control 
respiratory diseases.
Fig.1. The reporting data example by PCV2 ELISA results by age group. 
(line: mean SP value, bar: CV%) 
Discussion
The respiratory diseases have many diff erences from the other 
pig diseases. We didn’t have ideal tool to evaluate immune and 
infection status. This novel model of computerized statistical ap-
proach can be applied to control swine respiratory diseases. 
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Introduction
Enzootic pneumonia (EP) is a chronic respiratory disease that causes 
considerable economic losses in the pig industry worldwide. Myco-
plasma hyopneumoniae (M.hyopneumoniae) is the aetiological 
agent of enzootic pneumonia in pigs (Assuncao and all).
Mycoplasma fl occulare (M.fl occulare) was, and is still con-
sider by majority of researchers a lack of patogenicity species. 
Anyway, some researchers (Armstrong and Friis) isolated this 
Mycoplasma species from lungs with characteristic lesions, 
which could sustain the hypothesis in which M.fl occulare has a 
patogenic potential, generate symptoms and gross lesions like 
M.hyopneumoniae.
Materials and Methods
In September-October 2009 period, in more pig farms from 
the west side of Romania were reported serious respiratory 
disorders, a low rate of average daily weight gain and low feed 
conversion effi  ciency. Breeding farms were vaccinated against 
M.hyopneumoniae. The serological tests revealed that farms 
with respiratory problems were positive at PRRS virus.
There were investigated a number of     lungs with lesions. From 
younger pings (10-12 week-old of age) from 8 lungs were made 
cultivations on PPLO broth and agar supplemented with horse 
serum. All cultures were incubated for 3-4 weeks at 37ºC. We 
can isolate only a strain which was subcultures in 3 tubes notes 
A, B, and C. Tube A contain the strain after 5 days of incubation, 
tube B contain the strain after 7 days of incubation, and tube C 
contain the strain incubated 7 days in PPLO broth supplemented 
with horse serum 5%.
This strain was identifi ed by Multiplex PCR in Laboratory of 
Molecular Biology at Pasteur Institute Bucharest. DNA extraction 
was made with QiAamp DNA mini kit (Qiagen,).
Amplifi cation was performed using illustraTMPuReTaqTM Ready-
To-GoTM PCR Beads (GE Healthcare 27-9557-01 UK).
Results
The isolated strain was identifi ed as Mycoplasma spp. based on 
cultural and morphologic aspects.
At Multiplex PCR result for genomic detection/ M.hyopneumoniae, 
M. hyorhinis and/or M.fl oculare typing was positive for M.fl occulare 
and negative for the other two Mycoplasma species.
All samples were generated unspecifi c amplicons for 
M.hyopneumoniae. It is recorded the amplicon by 754 pb specif-
ic for M.fl occulare only in one tube, in which was PPLO broth 
supplemented with horse serum. For the other two we consider 
that in these tubes was insuffi  cient DNA for testing.
Conclusions
Besides all unspecifi c amplicons for M.hyopneumoniae for all 
three samples, 754 pb specifi c amplicon for M.fl occulare was 
record only in a sample, cultivated in PPLO broth supplemented 
with horse serum 5%.
Isolation of M.fl occulare from specifi c enzootic pneumonia 
lesions could sustain the hypothesis of patogenicity of this spe-
cies, but more searching is demanding.  
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Introduction
As swine practitioners become increasingly involved in on-farm 
research trials, increase their practice geographic areas, and 
work around stringent biosecurity requirements, their ability to 
get to farms to perform hands-on necropsies becomes more dif-
fi cult. We evaluated a potential alternative to hands-on evalua-
tion of lung lesions in order to address these challenges. The 
objective of this study was to evaluate the inter-observer and 
inter-method reliability of visually scoring lungs for Mycoplasma 
hyopneumoniae lesions from digital images and from visual scor-
ing of actual lungs with the benefi t of palpation at necropsy.
Materials and Methods
This study evaluated lungs from 344 pigs in a M. hyopneumoniae 
challenge study.1 The lungs were from pigs in fi ve treatment 
groups; one strict control, one non-vaccinated and challenged, 
and three M. hyopneumoniae vaccinated and challenged groups. 
The pigs were euthanized and necropsied 28 days post M. 
hyopneumoniae intra-tracheal challenge. Removed lungs were 
observed and palpated by two veterinarians who independently 
scored each lobe as a percentage of the area aff ected by M. hyo-
pneumoniae (necropsy evaluation). M. hyopneumoniae-induced 
lesions were defi ned as dark-red-to-purple consolidated areas. 
Observations and digital images for each lung were completed 
within 15 minutes of being removed from the pig. The digital 
images were later presented to the same observers, who visually 
evaluated and scored the lungs as described above, without 
the benefi t of palpation (image evaluation). Lung scores were 
weighted by the approximate volume each lobe contributes 
to total lung volume to derive a value for total percent lung 
aff ected, as previously described.2 A linear regression model 
was used to determine the correlation of necropsy versus image 
evaluation as well as inter-observer reliability for both methods.
Results
The mean score across both observers for image evaluation was 
8.21%, while the mean score for necropsy evaluation was 6.21%. 
Means for image evaluation were 10.32% and 5.89% and for 
necropsy evaluation were 7.64% and 4.77% for observer 1 and 2, 
respectively. The linear regression showed a good fi t of the data 
for all three parameters, including image versus necropsy (ad-
justed R2=0.76, p<0.001), image between observers (adjusted 
R2=0.67, p<0.001), and necropsy between observers (adjusted 
R2=0.84, p<0.001). The correlation coeffi  cients were 0.873, 0.819, 
and 0.921, respectively, suggesting very good correlation. 
Discussion 
There was a high correlation between the image and necropsy 
evaluation and between the observers for both methods. There 
did appear to be a better correlation between observers when 
scoring at necropsy with the benefi t of palpation, suggesting 
that palpation remains a more consistent method of evaluat-
ing lung lesions. However, image evaluation appears to be a 
potential alternative to necropsy evaluation. Practitioners that 
are unable to necropsy pigs because of biosecurity or time 
restrictions now have another tool to evaluate the respiratory 
health of their client’s pigs. Practitioners may also utilize this tool 
to send images to experienced lung scorers to assist in their on-
farm research trials. Overall, visual evaluation with the benefi t of 
palpation is still the preferred method.
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Assessment of four sampling methods to detect Mycoplasma hyopneumoniae in live pigs
Christelle Fablet; Corinne Marois; Virginie Dorenlor; Florent Eono; Eric Eveno; 
Typhaine Poezevara; Marylène Kobisch; François Madec; Nicolas Rose
AFSSA-Site de Ploufragan, Ploufragan, France
Introduction
Mycoplasma hyopneumoniae (Mhp) is the primary aetiological 
agent of enzootic pneumonia in pigs and in association with bac-
teria and viruses is also involved in the Porcine Respiratory Disease 
Complex (PRDC) (1). The availability of accurate, rapid and easy 
to perform diagnostic tools is necessary for epidemiological and 
control purposes. For practical reasons, under fi eld conditions, the 
nasal cavities are the most frequently chosen sampling sites to 
assess Mhp contamination of live pigs. However, in experimental 
trials, tracheal and tracheo-bronchial washings are the most ef-
fi cient samples for detecting Mhp (2; 3). The aim of the study was 
to assess the abilities of four sampling methods to detect Mhp by 
nested-PCR on live pigs in a fi eld context.
Materials and Methods
The study was carried out on a herd chronically aff ected by 
respiratory disorders. A sample of 60 pigs was constituted by a 
random selection from a batch of fi nishing pigs. Each pig was 
restrained and submitted to 4 samplings: oral-pharyngeal brush-
ing, tracheo-bronchial swabbing, tracheo-bronchial washing and 
nasal swabbing. Mhp DNA was identifi ed by modifi ed nested-
PCR (4). The sensitivity and specifi city of each sampling method 
were estimated using a Bayesian analysis framework (5). Param-
eters distributions were based on previous external data. Since 
samples taken from SPF pigs gave negative results, a deterministic 
constraint was used for the specifi cities of all sampling methods 
which was taken as equal to one. The sensitivity of the parameter 
estimation to the choice of priors was assessed by comparing 3 
models incorporating diff erent sets of prior distributions ranging 
from vague priors (M1) to more informative ones (M3). Model con-
vergence was assessed using the Raftery and Lewis tests and the 
Gelman-Rubin diagnosis. The models were compared on the basis 
of the deviance information criterion, the number of parameters 
estimated in the model and of the Bayesian p-value. The models 
were run using the freeware program WinBUGS (6).
Results
Mhp was detected by nasal swabbing, oral-pharyngeal brushes, 
tracheo-bronchial washing and tracheo-bronchial swabbing in 
13.3%, 40.0%, 53.3% and 60.0% of the pigs respectively. What-
ever the model, nasal swabbing had the lowest sensitivity and 
tracheo-bronchial swabbing the highest with mean sensitivities 
of 19 % and 74 %, respectively (Table 1).
Discussion
Since the infection status of the pigs tested under these condi-
tions was unknown, and no gold standard is available, the 
sensitivities of the sampling methods were analyzed using a 
Bayesian approach. To the best of our knowledge, this is the fi rst 
fi eld study to use such an approach to evaluate four sampling 
methods for assessing Mhp infection in live pigs. The results 
of the present study indicate that tracheo-bronchial swabbing 
and washing, in combination with nested-PCR assay, were the 
most sensitive sampling methods for Mhp detection in natur-
ally infected live pigs, the sensitivity of the tracheo-bronchial 
swabbing being slightly higher. As far as practical aspects are 
concerned, swabbing the tracheo-bronchial area with a sterile 
catheter is almost as convenient as obtaining nasal swabs under 
fi eld conditions and only requires adding a gag to the sampling 
equipment. Tracheo-bronchial swabbing ensures a gain in diag-
nostic accuracy, being 3.5 times more sensitive than the nasal 
swabs commonly used in pig farms.
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Table 1: Mean and 95 % Credibility Interval of posterior distributions of the sensitivity of the four sampling methods of Mhp detection by nested-
PCR, according to the 3 models with diff erent prior distributions (60 pigs sampled, specifi city=1 for all models and sampling methods)
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Surveillance using oral ﬂ uid samples - PRRSV, SIV, PCV2, and TTV ﬁ eld data
Apisit Kittawornrat1 John R. Prickett1 Rodger Main1 John Johnson1 Roman Pogranichniy2 Amber Clark2 Jeff rey J. Zimmerman1
1. Iowa State University, Ames, IA, USA; 2. Purdue University, West Lafayette, IN, USA
Introduction 
Oral fl uid specimens have been used extensively in human 
diagnostic medicine, but only recently has the concept been 
investigated in production animals (Prickett and Zimmerman, 
2010). The objective of this research was to evaluate the use of 
oral fl uid samples for monitoring PRRSV, SIV, PCV2, and TTV in 
commercial pig populations.
Materials and Methods 
Experimental design: Oral fl uid samples were collected from one 
wean-to-fi nish barn on each of 10 sites across the Midwest, USA. 
At each site (i.e., barn), oral fl uid samples were collected from 
the same 6 pens at 2-week intervals from placement (~ 3 weeks 
of age) to slaughter. Oral fl uid samples were collected by farm 
personnel after a brief training session with the investigators. 
Thereafter, samples were assayed for PRRSV, SIV, PCV2, and TTV 
by PCR-based assays. Sample Collection: Standard operating 
procedures were developed to ensure the collection of uniform, 
clean, and clearly identifi ed samples. Investigators demon-
strated the fi rst two collections and trained site personnel in the 
procedure. Once trained, site managers were responsible for the 
timely collection and submission of samples. Sample collection 
“kits” containing all of the required materials were assembled 
and delivered to each site prior to the commencement of the 
study. Each kit included a pre-cut length of cotton rope, scissors, 
poly-boots, screw cap tubes, permanent markers, diagnostic 
submission forms, ice packs, zip-lock bags, and postage-paid 
addressed shipping containers. Upon arrival to the Iowa State 
University Veterinary Diagnostic Laboratory, oral fl uid samples 
were centrifuged at 9000 x g for 10 min. Prior to testing, all 
samples were completely randomized and re-labeled. 
Results
Data indicated that oral fl uid samples could be used to monitor 
the circulation of the targeted pathogens (Figure 1). Temporal 
patterns of pathogen detection suggests that oral fl uid could 
be used to routinely suveil for pathogens of interest in swine 
populations.
Discussion
Oral fl uid sampling off ers a cost eff ective solution to infectious 
disease surveillance in populations of growing swine and of-
fers a new tool for studying the disease causality, ecology, and 
economics of emerging (TTV) and endemic (SIV, PRRSV, PCV2) 
viruses in commercial swine populations. 
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Figure 1. Cumulative PCR results for the 10 studied populations by 
pathogen and sampling point.
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Computertomographic investigation on porcine pleuropneumonia
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Introduction
The aim of this study was to investigate the correlation between 
computertomographic (CT) and digital x-ray diagnosis, clinical 
as well as pathomorphological fi ndings during necropsy in pigs 
experimentally infected with Actinobacillus (A.) pleuropneu-
moniae. This investigation should lead to the development of a 
CT scoring system which might allow an objective interpretation 
of CT images of the pig lung and therefore could be used as a 
tool for an early stage diagnosis of lung alterations in pigs.
Materials and Methods
29 German Landrace pigs (age: 7 weeks, averaged weight: 
13,7kg) coming from an A. pleuropneumoniae free herd were 
infected. The pigs were randomized upon weight and sex and 
divided into four groups. For the infection A. pleuropneumoniae 
serotype 7 strain AP76 and two deletion mutants of diff erent 
virulence were used in an established aerosol infection model 
(1). One group was mok infected and used as control.
Diagnostic imaging was done twice, on days 7 and 21 post infec-
tion (p.inf.); the clinical monitoring of the pigs was performed 
daily. All imaging procedures were carried out under anesthesia 
(2mg/kg Azaperon im., 20mg/kg Ketamine im.). The pigs were 
euthanized on day 21 p.inf., and a necropsy with pathomorpho-
logical examination of the lung was done. 
For the radiographic examination 3 images were taken (2 later-
olateral, 1 dorsoventral; fi lm-focus distance: 150cm; 80kV and 
shutter priority [Precimat, Fa. Picker Int., München, Germany]). 
For the computertomographic examination a scanogram and 
transversal slices (7mm thickness) of the whole thorax using a 
single slice scanner of the 3rd generation (Tomoscan M, Fa. Phil-
ips, Hamburg, Germany) were performed. All acquired pictures 
were set in lung window (exposure settings: 120kV, 40mA). For 
interpretation of the CT images every single slice was related to 
its position (precardiac, cardiac, postcardiac) in the scanogram 
and divided into four quadrants.
For the quantifi cation of results of the clinical, the radiographic 
and the pathomorphological examination three diff erent estab-
lished scoring systems were used (2,3).
Results
During evaluation of the lung alterations visible in the CT lung 
window mainly ground-glass opacities and consolidations 
could be found. The density of the consolidations was > -150 
Hounsfi eld Units. The results of the CT examination are shown in 
Table 1. The results of the diff erent examination methods used 
as established controls are shown in Table 2. 
Table 1: Results of the computertomographic analysis. 
Number of animals with aff ected parts of the lung 
(precardiac, cardiac, postcardiac); n = 22
no 1 part 2 parts 3parts
day 7 p.inf. 4 5 7 6
day 21 p.inf.* 5 4 7 4
*2 animals euthanized between day 7 p.inf. and day 21 p.inf.
Table 2: Results of the clinical, radiographic and pathomorphological 
examination. 
Number of animals with pleuropneumonia; n = 22
Examination method no mild moderate severe
Clinical, day 7 p.inf. 3 19 0 0
Radiographic, day 7 p.inf. 4 11 5 2
Clinical, day 21 p.inf. * 15 5 0 0
Radiographic, day 21 p.inf. * 3 13 4 0
Necropsy, day 21 p.inf. 6 6 6 4
*2 animals euthanized between day 7 p.inf. and day 21 p.inf.
Discussion
Regarding the comparison of the computertomographic 
examination of the lung and the already established examina-
tion methods, the CT imaging is considered as a diagnostic tool 
of similar informative value. Therefore the development of a CT 
scoring system appears feasible and is the next step to be done. 
After fi nishing this development a second statistically approved 
assessment is necessary before application of the scoring system 
as a diagnostic tool.
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Medical infrared imaging of the porcine thorax for diagnosis of lung pathologies
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University of Veterenary Medicine, Hannover , Germany
Introduction
Respiratory diseases in pigs aff ecting pork production worlwide 
have an impact on consumer protection, live stock trade and 
animal welfare. The early, non-invasive detection of lung disor-
ders is a valuable tool for the maintanance of respiratory health 
in pig herds. A promising approach might be the quantifi cation 
of the skin surface temperature of the thoracic cavity, which is 
mainly determined by the heat exchange between skin and en-
vironment, metabolic activity, blood circulation and anatomical 
structures beneath the skin. Zapoudrina, et al., (2008) demon-
strated as part of a human medical study the good reproducibil-
ity of temperature distribution patterns in the central body area 
of 16 test subjects [1]. 
Materials and Methods
Thoracic imaging and examination of 17 pigs (German Landrace, 
age: 11 weeks) was performed before and after aerosol infec-
tion with Actinobacillus pleuropneumoniae (A.pp.) by passive 
infrared thermography for the recording of infrared (IR) images. 
After necropsy pathomorphological changes in the lung were 
evaluated according to a lung lesion score [2].
An infrared thermographic camera operating in the wavelength 
range from 8 to 12 μm was used (IR Flex Cam R2). The IR camera 
used a microbolometer array as the detector. The IR image ma-
trix of the camera was 160 x 120 pixels, which are interpolated 
internally to 320 x 240 pixels. The thermal sensitivity is, accord-
ing to the manufacturer’s specifi cations, 70 mK with reference 
to a temperature of the measured object of 30ºC. For the pigs’ 
skin an emissivity of 0.95 was assumed. Air temperature and 
humidity as well as body core temperature as well as heart and 
breathing frequencies were recorded. 
Medical imaging (IR and X-ray) 
a)  The recorded thoracic IR images were evaluated by means of 
the image viewer software IRBIS3plus, (colour temperature 
coding: combined rainbow colour and black/white-scale, 
narrow temperature range over 13ºC).
b)  Computed tomography (CT) images: CT images were 
scanned using the system Tomoscan M/EG Compact (Philips 
Medical Systems)- a single slice scanner of 3rd generation. 
Scans were performed at 7 mm slice thickness. All acquired 
pictures are set in lung window. Exposure settings: 120 kV, 40 
mA.
Results
IR images were suitable to visualize the location of the dia-
phragm (Fig. 1a,c yellow line) and abnormal warm regions of the 
thorax which correlate to infl ammatory alterations shown in CT 
images.
Discussion
The anatomical localization of infl ammatory processes leading 
to reduced ventilation in the outer lung regions can be deter-
mined under certain conditions (IR-image Fig. 1a). Pathological 
fi ndings (Fig. 1e) are visualized in the corresponding CT-images 
(Fig. 1d). The opposite region of the thorax is less warm (Fig. 1c, 
yellow circle) due to normal ventilation in the lung. The cool 
air breathed-in probably acts as a contrast agent, thus distinct 
anatomical structures become visible (diaphragm, Fig. 1a,c, 
yellow line). It can be assumed, that pathological changes in 
the peripherical (outer) lung regions characterized by reduced 
ventilation can be recognised non-invasively using passive IR 
thermography. A new generation of IR thermography and image 
processing might be a practical tool for the diagnostic of many 
cases of pneumonia in pigs. 
References
[1]  Zapoudrina N, Varmavuo V, et al. (2008) Reproducibility of infrared 
thermography measurements in healthy individuals, Physiol. Meas. 
29 515–524
[2]  Hannon PC, Bhogal BS, Fish JP: (1982) Tylosin tartrate and tiamultilin 
eff ects on experimental piglet pneumonia induced with pig lung 
homogenate containing mycoplasmas, bacteria and viruses, Res. 
Vet. Sci. 33: 76–88
Respiratory diseases – Surveillance
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 664
Poster Presentations
P.358
Evaluation of DRAXXIN® Injectable Solution for the control of swine respiratory disease
Michael Senn; Robert Nutsch; Merlyn Lucas
Pfi zer Animal Health, New York, NY, USA
Introduction
Swine respiratory disease (SRD) remains an important cause 
of disease and economic loss for swine producers worldwide. 
DRAXXIN® Injectable Solution (10% tulathromycin, Pfi zer Animal 
Health) is one of the newest anti-infectives for treating SRD. It is 
rapidly released and absorbed from the injection site and exten-
sively distributed, so the product acts quickly against respiratory 
disease, and provides an extended clinical duration of activity in 
pigs of at least nine days after a single dose1. The clinical effi  cacy 
of DRAXXIN® as a single IM injection for the control of naturally 
occurring swine respiratory disease was evaluated in a multi-
location study.
Materials and Methods
The study was conducted at 5 sites in North America 2 The 
animals at all locations were mixed sex commercial feeder 
pigs purchased from farms that had previously experienced 
swine respiratory disease. Pigs weighed between 9.3 and 44.8 
kilograms at enrollment. All pigs were individually identifi ed. 
(SRD) was defi ned as a pig that had a respiratory score of > 2 
, and a depression score of > 2 (both a scale of 0 to 3, where 
0 is normal), and a rectal temperature of > 104 ° F. On study 
day 0, the day that a pen had at least 15% of the pigs meeting 
the case defi nition for SRD, all individual pigs in the pen were 
randomly enrolled in one of two treatment groups. Treatment 
1 (T1), Saline, intramuscular, administered once, or Treatment 2 
(T2) DRAXXIN® Injectable Solution (tulathromycin), 2.5 mg / kg, 
intramuscular, administered once. Each study location enrolled 
2 pens with 30 to 40 pigs per pen. No concomitant medication 
of enrolled animals with systemic antimicrobial or anti-infl am-
matory agents was permitted during the study. Animals that 
exhibited clinical signs of disease other than SRD were removed 
from the study. Treatment groups were commingled within each 
pen, with the individual pig being the experimental unit. Gen-
eral health observations were performed twice a day on enrolled 
animals from Study Day 0 through Study Day 6, and the morning 
of Study Day 7. All study animals remaining on Study Day 7 were 
clinically evaluated for respiratory scores, depression scores, 
and rectal temperatures. On Study Day 7, all remaining enrolled 
animals were euthanized and necropsied to aid in characterizing 
the swine respiratory disease. An animal was classifi ed as a treat-
ment success if on Study Day 7; it was alive, had both a respira-
tory score and a depression score < 1, and a rectal temperature 
of < 104 ° F. Failure to meet any one of these criteria classifi ed 
the animal as a treatment failure. Secondary clinical endpoints 
assessed were mortality and lung lesion scores. 
This protocol was reviewed by the Pfi zer Animal Health Ethical 
Review Board and the Pfi zer Animal Health IACUC committee 
and is in compliance with their recommendations.
Results
Four hundred fi fty fi ve (455) animals were enrolled in the 
study; 228 in T1 (Saline) and 227 in T2 (DRAXXIN®). The number 
of animals classifi ed as a treatment success was signifi cantly 
higher, p < 0.05, for the animals administered DRAXXIN® (59.2%) 
vs animals administered saline (41 2%). The number of mortal-
ities found dead plus euthanized due to SRD was higher for the 
saline-treated animals (11/227, 4.8%) than the tulathromycin-
treated animals (4/226, 1.8%), but not signifi cantly diff erent, p 
= 0.0676. The back-transformed least squares mean percentage 
of total lungs with lesions was signifi cantly higher , p = 0.0096, 
for animals administered saline, (13.1%) vs animals administered 
DRAXXIN®, (6.6%).
Discussion
The results confi rm the value of using DRAXXIN® for the con-
trol of swine respiratory disease associated with Actinobacillus 
pleuropneumoniae, Pasteurella multocida and Mycoplasma 
hyopneumoniae. Treating groups when a percentage of the 
population is exhibiting signs of swine respiratory disease will 
help veterinarians to better manage respiratory disease out-
breaks. Veterinarians often rely on water medi¬cation for its ease 
of administration.3 Problems associated with water medication 
include variability in fl ow rates and inadequate consumption by 
ill pigs. 3 Variation in drinker fl ow rates and problems associated 
with dilution and delivery of antimicrobials create an important 
challenge for farm personnel. 4 DRAXXIN® provides high and 
long-lasting concentrations in the lung tissues providing for a 
complete treatment of individual pigs exhibiting swine respira-
tory disease, and excellent effi  cacy treating and controlling 
swine respiratory disease, ensuring instant compliance and fast 
long-lasting therapy, while reducing the need for extra labor and 
less handling of sick animals. 
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Health and performance improvements in pigs treated with Draxxin® Injectable 
Solution (tulathromycin) for swine respiratory disease (SRD)
John C. Johnson; Thayer C. Hoover
Outcomes Research Pfi zer Animal Health, Spirit Lake, IA, USA
Introduction
Draxxin® Injectable Solution is approved in the USA for single-
dose therapy of swine respiratory disease (SRD) caused by 
Actinobacillus pleuropneumoniae, Pasteurella multocida, 
Bordetella bronchiseptica, Haemophilus parasuis, and Myco-
plasma hyopneumoniae, and for the control of SRD caused by 
A. pleuropneumoniae, P. multocida and M. hyopneumoniae. 
Two studies were conducted, with the fi rst in a natural outbreak 
of SRD, comparing Draxxin to untreated pigs (saline), and pigs 
medicated using conventional therapy (penicillin G procaine). 
Variables included treatment response and weight gain. The 
second study compared Draxxin to untreated controls against 
induced SRD using a live M. hyopneumoniae challenge (MHYO). 
This study tracked performance (gain, feed effi  ciency) as well as 
clinical response. Study protocols were reviewed by the Pfi zer 
Animal Health Ethical Review Board, Kalamazoo MI to ensure 
that animal use was consistent with sound scientifi c practices 
and ethical considerations.
Materials and Methods
Study 1.1 One hundred seventy pigs (170) from two farms posi-
tive for various bacterial and viral respiratory pathogens were 
commingled with 200 single-source Isowean pigs of similar age 
and weight. Pigs (N=370) were housed in a conventional fi nisher 
equipped with an AutoSort food court providing feed and 
electronically capturing individual pig weights. Pigs with SRD (n 
= 135; 36% morbidity) were randomly assigned in a 1:2:2 ratio 
to one of three treatments: saline (negative control), penicillin 
G procaine (IM; 5 mL/45 kg/day for two [2] consecutive days), 
or Draxxin (IM; 1 mL/41 kg, once). Pigs were observed daily, and 
clinically re-evaluated and weighed seven and 56-days after 
treatment.
Study 2. 2 Two hundred (200) weaned pigs, sero-negative for 
MHYO were challenged intra-tracheally once daily for three con-
secutive days with a live culture of the organism. Ninety-six (96) 
pigs meeting SRD-criteria were enrolled and assigned to 24 pens 
according to a randomized block design. Each pen (the experi-
mental unit) contained pigs treated with saline or Draxxin. Pig 
weights and feed consumption were measured at 10, 20, 30, 45, 
and 60 days post-treatment; response to therapy was evaluated 
10-days post-treatment.
Results
Study 1. Compared to untreated pigs, Draxxin-treated pigs had a 
lower mortality rate the fi rst week post-treatment and a signifi -
cantly (P = 0.0360) lower mortality rate over the study. Further, 
pigs treated with Draxxin had a signifi cantly (P = 0.0409) higher 
mean gain (3.7 kg [8.3 lb]) compared to controls (2.8 kg [6.2 lb]) 
one week post-treatment. Mean weight gain in pigs treated 
with Draxxin was 4.5 kg (10 lb) over pigs treated with penicillin 
(P = 0.0597) and 7.2 kg (16 lb) over controls (P = 0.0268), when 
adjusted to the 75th percentile of mean weight at enrollment. 
Draxxin-treated pigs were 1.6 times less likely fail to respond 
to treatment than pigs treated twice with penicillin; and 1.85 
times less likely to fail than pigs that were untreated. The risk of 
treatment failure was reduced in the Draxxin group 36% com-
pared to conventional therapy, and reduced 46% compared to 
controls. In fi eld settings similar to this study, six pigs (6) treated 
with Draxxin would be projected as the number needed to treat 
to reduce or prevent one treatment failure using conventional 
therapy (penicillin G procaine).
Study 2. Pigs with SRD, treated with Draxxin had a signifi cantly (P 
= 0.0121) improved average daily gain ranging from 0.74 – 0.90 
kg/hd/day (1.63 - 1.99 lb) over controls ranging from 0.61 – 0.80 
kg/hd/day (1.35 - 1.77 lb). Feed consumption was higher in the 
Draxxin group with a corresponding improvement in Feed:Gain 
(1.26 kg feed/1.0 kg gain [2.78 lb/1.0 lb) compared to controls 
(1.62 kg [3.58 lb]; P = 0.1032). Treated pigs had a lower mortal-
ity rate (8.7% vs. 4.2%). Evaluated at 10-days, the proportion 
of Draxxin-treated pigs “normal” for attitude/depression and 
respiratory character was 11% and 24% higher compared to 
untreated cohorts, respectively.
Discussion
Pigs treated with Draxxin for SRD under fi eld conditions, or 
in an experimentally induced M. hyopneumoniae challenge, 
responded with one treatment. This reduces antimicrobial use 
as well as animal stress and handling using multiple day therapy 
regimens. One-time Draxxin treatment improved both health 
and performance in both studies. These results support that 
Draxxin is an eff ective health management tool for reducing 
sickness and death loss due to SRD, a cost eff ective alternative to 
conventional treatment[s] requiring multiple day administration, 
and may be an important aid to improve performance and prof-
itability in swine operations aff ected with respiratory disease. 
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Evaluation of two in feed medication therapeutic programs for the 
control of swine respiratory disease in nursery
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Introduction
Many studies showed that the initial prevalence of patho-
gens within the group plays a central role in the severity of 
the diseases and also that early interventions can reduce this 
prevalence(1). The objective of this study was to evaluate two 
diff erent in feed medication therapeutic programs at weaning 
for the control of swine respiratory disease in nursery. 
Materials and Methods
The study was performed on the nursery sector of a multisite 
farm in the north of Italy. After the confi rmation of respiratory 
disease two groups of around 170 pigs / group were evaluated 
from weaning (age: 21 days) to the end of the nursery period 
(age: 67 days). Fifty pigs per group were individually ear tagged, 
numbered and weighed at weaning and at the end of the nurs-
ery period. The pigs were divided in the two groups according to 
the type of medication included in their prestarter feed:
-  Pulmotil™ Group: Tilmicosin (Pulmotil™) 400 ppm,
-  Control Group: Sulfadimetossin 1400 ppm + CTC 560 ppm 
(Polisulfan™). 
The treatment period was the same (21 days after weaning) for 
both groups.
The parameters controlled and recorded were:
-  Number of pigs / group,
-  Average weight (kg) at weaning,
-  Average weight (kg) at weaning of individually weighed pigs,
-  Number of deaths + culls / group,
-  Average weight (kg) at the exit from the nursery sector,
-  Average weight (kg) at the exit from the nursery sector of 
individually weighed pigs.
Statistical analysis: means individual weights were compared 
between group by ANOVA one-way analysis when Bartlett’s 
test assess the homogeneity of variances and by Kruskal-Wallis 
test when homogeneity of variances was not demonstrate 
with Intercooled Stata 7.0 software. The signifi cant level for this 
evaluation was p=0.01.
Results and discussion:
The general collected results are summarized in table 1. At the 
exit from nursery the means weight of individually weighed 
animals was signifi cantly higher in the Pulmotil™ group (P) than 
in the Control group (C) (29.48 kg vs 25.92kg, Anova test F1,60 
p<0.01, Table 1 and Graphic 1).
Table 1. Results.
P C Diff .
Pigs Number 175 164 11
Days on nursery sector 46 46 /
Average weight (kg) at weaning 7.47 7.58 - 0.11
Average weight (kg) at weaning of 
individually weighed pigs 7.63 7.52 0.11
Average weight (kg) at the exit from 
nursery sector 29.15 26.65 2.50
Average weight (kg) at the exit 
from nursery sector of individually 
weighed pigs
29.48* 25.92 3.57
ADG (g/d) 470 410 70
Deaths + Culls (n) 3 3 /
*p < 0.01
Graphic 1. Weight distribution of individually weighed pigs at the end 
of the nursery period.
Conclusions
These results confi rm that Pulmotil™ increases the animal health, 
with better growing performances from weaning to the end of 
the nursery period. As reported on other studies(2), the better 
weight at this age may improve the performances in the fatten-
ing and increase the number of Full Value Pigs™ that arrive at the 
slaughterhouse.
References:
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Comparison of a soluble treatment with doxicicline or Pulmotil AC during a respiratory outbreak
Xavier de Paz2 Jose L. Lorenzo1 Miguel Abad2 Susana Lapuente2
1. Maporc, Segovia, Spain; 2. Elanco Animal Health, Madrid, Spain
Introduction 
Respiratory disease causes great economic losses in pig pro-
duction (1) and usually involves several pathogens, causing a 
signifi cant and quick increase in mortality and also aff ecting 
growth and feed effi  ciency of the animals (2). Soluble treatments 
are mostly used when an outbreak appears, especially during 
the fattening phase (3). The present study aimed to evaluate the 
eff ects of a soluble treatment with PulmotilAC™ during a respira-
tory outbreak in fattening pigs. 
Materials and Methods
Two groups of pigs were included in the study (C, n=998 and P, 
n=876). When pigs showed respiratory signs (around 100d of 
age) and several pathogens were found (PRRSV, M.hyo and App), 
the pigs were treated either with Pulmotil AC at 17mg/kg BW 
(P) or Doxicicline at 10mg/kg (C) in water for 5 days. Before the 
treatments started, the mortality rates were 1.0% and 1.3% for 
the control and the Pulmotil group respectively. During the 5 
days of treatment the mortality rates were 0.6% and 0.5% for the 
Control and Pulmotil group. The animals were monitored until 
the end of the fattening period. The variables collected and ana-
lyzed were mortality, average daily gain, feed conversion rate, 
and percentage of lightweight pigs at the end of the period. 
Also, a cost analysis calculation was done with the production 
results.
Results and Discussion
The treatment with PulmotilAC at the time of the disease out-
break decreased the mortality from 10.6% to 4.8%. Also, a diff er-
ence in pigs sold as lightweights was detected (fi g. 1), therefore 
the percentage of FVP™ was also impacted C=67.3%; P=88%.
Figure 1. Mortality and lightweight pigs
There was also a diff erence in average daily gain and a de-
crease of the FCR (table 1). This was highly aff ected because the 
weights of dead pigs (C=4456kg vs P=1801kg) were not used for 
the FCR calculation but the feed consumed was not excluded.
Table 1. Results during the fattening period.
Control Pulmotil
Nº Pigs 998 876
Weight in (kg) 31.01 27.98
Weight out (kg) 88.1 95.7
Days to market 183 181
ADG (g) 493 597
FCR 3.09 2.52
Table 2 includes the cost analysis performed; the numbers have 
been standardized for equal number of pigs to start. The main 
diff erences between both groups were basically: feeding costs 
(due to the great diff erence in FCR and mortality), pig cost (due 
to the mortality rate improvement), and fi xed costs (due to the 
improvement in ADG). As a consequence, the economic benefi t 
of using a soluble treatment with Pulmotil AC instead of Doxici-
cline during a respiratory outbreak in the growing-fi nishing barn 
was 16.03 €/pig sold.
Table 2. Total costs of production
Control Pulmotil
Feed, €/pig 55.34 43.83
Pig, €/pig 61.31 57.93
Fix costs, €/pig 12.77 9.96
Other, €/pig 2.22 3.88
TOTAL, €/pig 131.63 115.60
Discussion
When a respiratory outbreak appears during the growing-fi nish-
ing period, the animals treated with Pulmotil AC show an eff ect-
ive response. In this case the benefi ts were not only clinical but 
also in performance parameters and economic results. The pigs 
treated with Pulmotil in water improved the ADG, FCR and mor-
tality rates. In addition, more Full Value Pigs™ were produced.
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Early treatment with Pulmotil™ in piglets vaccinated against PCV-
II. Eﬀ ects on the performance of the piglets
Xavier de Paz1 Albert Vidal2 Jordi Bonet2 Hernan Torrelles2 Miguel Abad1 Susana Lapuente1
1. Elanco Animal Health, Madrid, Spain; 2. Vall-Companys, Lleida, Spain
Introduction 
The presence of respiratory disease increases medication costs 
but also causes a loss of performance (ADG and FCR) since 
energy and protein is diverted towards fi ghting disease (1). The 
standard use of Pulmotil™ at weaning to prevent respiratory 
disease was evaluated to see the eff ects in piglets vaccinated 
against PCV-II.
Materials and Methods
A comparison study was performed with two diff erent in-feed 
treatments for 3 weeks after weaning: a positive control, (C) with 
300ppm of amoxicillin against 400ppm of Pulmotil (P). In total, 
1440 21-day old piglets (C=721 and P=719) were individually 
tagged and weighed at weaning, at the end of the treatments 
(day 20), and at the end of the study (day 37). In addition, the 
feed also included 120ppm of colistin and 2500ppm of ZnO. 
After the fi rst 3 weeks, all the piglets received the same in-feed 
treatment with amoxicillin at 300ppm, colistin at 120ppm and 
ZnO at 2500ppm. Also, all the piglets were vaccinated against 
PCV-II with Ingelvac CircoFLEX™ (Boehringer Ingelheim). 
Performance and medication administration was evaluated. 
The data came from 2 consecutive replicas and were analyzed 
considering the variance (proc GLM of SAS). The treatments 
were balanced by sex and initial distribution was homogenous 
for both groups in both replicas, p=0.9114 (NS). 
Results and Discussion
The mortality rate in the Pulmotil group was slightly higher 
than in the Control group (C=2.99% vs P=3.71%; p=0.4522). The 
number of injections was not diff erent except for replica 1 the 
Pulmotil group received less treatments than the control (16.9% 
vs 12.5%; p<0.001).The initial liveweight (LW) of the piglets (fi g-
ure1) was not diff erent between both treatments (p=0.4901)
Figure 1. Average LW (kg) at day 0.
As can be seen in fi gures 2 and 3, the Pulmotil piglets were 
heavier at day 20 and 37 for both replicas (p<0.05).
Figure 2. Average LW (kg) at day 20 and 37.
The ADG of the piglets was higher in the Pulmotil group for all 
the periods of the study. 
Table 1: ADG and FCR for the diff erent periods.
Control Pulmotil
ADG, g (day 0-20) 199a 211b
ADG, g (day 20-37) 331a 355b
ADG, g (day 0-37) 259a 277b
FCR (day 0-20) 1.20 1.14 (p=0.1513)
Diff erent superscript letters are statistically signifi cant (p<0.05)
Conclusions
The inclusion of Pulmotil during the fi rst three weeks after 
weaning improves animal performance even in farms in which 
vaccination is being carried out against PCV-II:
- The pigs in the Pulmotil group grew more during the nursery 
and their fi nal weight was greater (p<0.001) increasing the 
Full Value Pigs™ in the fattening unit.
- This has been consistently seen in other studies (2). 
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Early treatment with Pulmotil™ in piglets vaccinated against PCV-II. Eﬀ ects 
on the weight distribution at the end of the nursery period
Xavier de Paz1 Albert Vidal2 Jordi Bonet2 Hernan Torrelles2 Miguel Abad1 Susana Lapuente1
1. Elanco Animal Health, Madrid, Spain; 2. Vall-Companys, Lleida, Spain
Introduction 
The presence of respiratory disease increases mortality and 
medication costs but also causes a loss of performance (ADG 
and FCR) (1). In this study, the use of Pulmotil™ after weaning 
was evaluated to see the eff ects on weight distribution of the 
piglets and on the percentage of lightweights at the end of the 
nursery. 
Materials and Methods
A comparison study was performed with two diff erent in-feed 
treatments for 3 weeks after weaning: a positive control, (C) with 
300ppm of amoxicillin against 400ppm of Pulmotil (P). In total, 
1440 21-day old piglets (C=721 and P=719) were individually 
tagged and weighed at weaning, at the end of the treatments 
(day 20), and at the end of the study (day 37). The rest of the 
treatments were the same for both groups, including a vac-
cination against PCV-II with Ingelvac CircoFLEX™ (Boehringer 
Ingelheim). At each weighing time, four diff erent quartiles were 
defi ned in order to have 25% of the total population was in each 
class (Light, Median1, Median2 and Heavy). The data came from 
2 consecutive replicas and was analyzed with an F-test. The 
percentage of animals in each category depending on treatment 
was analysed by an association chi-square test. 
Results and Discussion
At day0, the proportion of pigs in each weight class was the 
same for both treatments (p=0.9114); however, the treatment 
with Pulmotil reduced the proportion of “lightweights” at day 37 
(C=27.86% , P=21.79%, p<0.01). 
Table 1 represents the odds ratios of all the piglets for both 
groups. The main eff ects in the Pulmotil group were:
- The “Light” piglets at day 0 are more likely to be “Median 2” at 
the end of the study (p=0.05).
- The “Median 1” piglets at day 0 are more likely to be “Heavy” 
at the end of study (day 37) (p=0.02).
- The pigs classifi ed as “Median 2” at day 0 are more likely to be 
“Heavy” at day 37 (p=0.05).
Table 1. Percentage of pigs in each class on day37 depending on the 
class at day0 and treatment received
1Ratio of relative risk; a value higher than 1 indicates higher risk 
for piglets in the Control group. (* indicates p<0.05)
Conclusions
In piglets vaccinated PCV-II, the use of Pulmotil after wean-
ing to prevent respiratory disease in early age still reduced the 
percentage of lightweights and provided more Full Value Pigs™. 
The opposite eff ect was seen for the PCV-II vaccinate piglets that 
received a control treatment.
These eff ects are consistent with other studies (2). 
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Metaphylaxis with tulathromycin (Draxxin®) and therapeutic use of ceftiofur (Naxcel®) against Swine 
Respiratory Disease and Polyserositis Complex in pigs: comparison with the use of in-feed Amoxycillin
Ian A. Nanjiani1 Joaquin Morales2 Carlos Piñeiro2 Pascale Sierra3 JensChristian E. Jensen5, 4
1. Pfi zer VMRD, Sandwich, UK; 2. PigCHAMP Pro Europa SA, Segovia, Spain; 3. TVIVERITAS France, Gerstheim, 
France; 4. Pfi zer Animal Health EUAfME, Paris, France; 5. Orion Pharma Animal Health, Nivå, Denmark
Introduction
Swine respiratory disease (SRD) and polyserositis (PS) have 
substantial economic and welfare impacts on the European 
Swine industry. Disease control is generally achieved by environ-
mental control, vaccination and antibiotic treatment. This GCPV 
compliant study compared two post-weaning metaphylaxis 
programmes: 1 - SRD metaphylaxis with tulathromycin (2.5 mg/
kg Draxxin®, Pfi zer Ltd), followed by systemic treatment of SRD 
or PS clinical cases with ceftiofur injection (5 mg/kg Naxcel®, 
Pfi zer Ltd); 2 - SRD metaphylaxis with oral amoxycillin (400 ppm 
in-feed) followed by systemic treatment of SRD or PS clinical 
cases with long acting amoxycillin by injection (15 mg/kg); 3 - A 
sentinel group of animals (receiving no metaphylaxis treatment) 
included to confi rm disease; clinical cases in this group were 
treated with long acting amoxycillin injection (15 mg/kg). The 
study was conducted to demonstrate the value of responsible, 
targeted antimicrobial use in disease control under fi eld condi-
tions. 
Materials and Methods
Four-hundred piglets from two farms with a history of SRD & 
PS in the nursery period entered the study on the day follow-
ing weaning (the fi rst day of metaphylaxis treatment). During 
the nursery period (approximately 41 days) piglets were group 
housed in 40 pens, each of 10 animals. 
Animals were penned in four rooms and pens randomly as-
signed to one of the three groups in an 18:18:4 ratio ensuring a 
balance of treatments within each airspace. 
Animals were observed daily for signs of abnormal health; 
veterinarians conducting clinical examinations were unaware 
of the treatment group attributed to each pig. Animals were as-
sessed for SRD and PS using pre-defi ned criteria (a combination 
of clinical signs and pyrexia of >40°C). Animals were weighed 
at the beginning and end of the nursery phase, and feed intake 
measured on a pen basis.
Results
SRD and PS were observed and bacterial involvement con-
fi rmed by isolation from clinical cases (Pasteurella multocida and 
Streptococcus suis). The combined tulathromycin and ceftiofur 
programme signifi cantly reduced the incidence of SRD, number 
of antimicrobial treatment days, number of SRD or PS relapses 
and signifi cantly improved the feed conversion ratio when com-
pared to the amoxycillin metaphylaxis/therapy group (1.66 vs. 
1.83 respectively, P=0.02). A tendency towards reduced mortality 
was observed in T1 compared to T2 (least squares mean of pen 
values 0.67% vs. 4.30% respectively, P=0.071)
Table 1: Incidence of Swine Respiratory Disease (SRD) and Polyserositis 
(PS) (number and %)
Group (number 
of pigs) Number of SRD/PS cases
1, 3 Incidence of SRD/PS (%)2, 3
SRD PS TOTAL SRD PS
T1 (180) 23 5 6.91 6.07 0.55
T2 (180) 76 9 35.76 32.63 1.76
T3 (40) 19 0 49.06 49.56 0.02
T1 vs. T2 P-value N/A N/A 0.0005 0.0006 0.25
1 Some animals had both conditions concurrently; mortalities included
2 Incidence % calculated using Least Squares Means to reduce distortions produced by pen 
eff ects 
3 Statistical analyses conducted using the pen as the experimental unit (not the pig)
Discussion 
In-feed antibiotics are widely used for metaphylaxis due to their 
ease of administration and low cost. Potential interactions with 
other ration components, diffi  culties insuring drug homogen-
eity in feed and the inappetence of sick animals can result in 
individual animals being underdosed, compromising effi  cacy. 
The use of injectable antimicrobial products for metaphylaxis & 
therapy allow accurate, targeted dosing of the individual animal, 
particularly when the product chosen has a suffi  ciently long 
duration of activity to cover the period of expected disease and 
a suitable spectrum of activity. In the particular circumstances 
of this study, based on the drug and piglet (20-25kg live-weight) 
prices current in Spain at the time (making no allowance for 
labour costs), this disease management protocol provided a 
return of approximately €1.50 per pig compared to that used in 
group T02. 
References
Nanjiani et al 2009; Obiettivi e Documenti Veterinari 5, 35 - 43
Respiratory diseases – Control
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 671
Poster Presentations
P.365
A treatment protocol designed to control Mycoplasma hyorhinis infection in a 
commercial herd points out to a potential association with Streptococcus suis 
Charles Surprenant1 Marcelo Gottschalk2
1. F. Ménard Inc., Ange-Gardien, QC, Canada; 2. Université de Montréal, Saint-Hyacinthe, QC, Canada
Introduction
Mycoplasma hyorhinis was named and characterized by Switzer 
et al. in 19551. Since then, this microorganism has been as-
sociated with diff erent clinical conditions in pigs: pneumonia2, 
arthritis3, otitis4, eustachitis5. Over the past 5 years, commercial 
swine nurseries, negative for Mycoplasma hyopneumoniae and 
belonging to the same pyramid, experienced clinical losses 
caused by M. hyorhinis and/or Streptococcus suis. A treatment 
protocol was designed to reduce respiratory problems associ-
ated with M. hyorhinis infection. Materials and Method
Herd description: Since 2002, a multisite commercial pig fl ow 
has experienced clinical signs of respiratory and S. suis disease 
at the nursery level. The 1800 crossbred sow unit is negative for 
PRRSV. Each week, 800 5-kg piglets averaging 18 days of age are 
transferred to a 3 barn nursery site. Each barn is fi lled up over a 
period of 10 days and completely emptied 40 days after the fi rst 
pigs arrive. The sow herd is M. hyopneumoniae positive, however 
sows have been vaccinated at 3 weeks prior to farrowing for 
over 10 years in order to stabilize the herd. Piglets are vaccinated 
against M. hyopneumoniae at 3 and 6 weeks of age. 
Clinical Signs: Shortly after arrival, some piglets started to exhibit 
a dry cough and sneezing. These clinical signs became more 
severe and prevalent over time with some pigs developing 
pneumonia and/or a clinical syndrome associated with S. suis 
(meningitis, sudden death). Pig performance was adversely 
aff ected. Laboratory tests were always negative for M. hyopneu-
moniae (Table 1). However, M. hyorhinis and S. suis were found 
repeatedly in diff erent samples. 
Treatment protocol: After concluding that M. hyorhinis was 
the primary cause of the respiratory signs, a novel treatment 
protocol was implemented to control M. hyorhinis. All the piglets 
were injected once at weaning with 2.5 mg/kg of tulathromycin 
(Draxxin®) starting on February 3, 2009. No other changes were 
made. 
Statistical analysis: Although the implementation of the new 
treatment protocol was not designed as a clinical trial, a Wilcox-
on test was done using the median values of diff erent param-
eters to compare results for 9 pre-treatment pig lots versus 10 
post-treatment lots. 
Results
Shortly after the implementation of this new procedure, cough-
ing, sneezing and respiratory signs almost disappeared. Post-
treatment results show an improvement in feed conversion and 
average daily gain. The overall viability of the post-treatment 
lots was signifi cantly increased (P = 0.02). A reduction in the 
number of Penicillin V water treatments, the number of days on 
Penicillin V treatment and, surprisingly, in the frequency and 
severity of S. suis episodes was observed (Table 2).
Table 1. Laboratory tests
PCR test PCR test PCR test PCR test
Bacterial 
culture
Bacterial 
culture
Date Tissues
M. 
hyorhi.
M. hyo-
pneu.
H1N1 H3N2
S. suis 
(serovar)
Other 
(serovar)
07/06/07 Heart ND ND ND ND + (1/2) -
01/14/08 Lung - - - - + (1/2) -
02/18/08 Lung + - - - - Other Strep.
05/12/08 Lung - - + - ND ND
06/02/08 Lung + - - + ND ND
09/22/08 Lung + - - - + (1/2) ND
10/06/08 Lung + - - - ND ND
10/09/08 Nasal + - - - ND ND
11/24/08 Lung + - - - + (1/2) ND
02/02/09 Lung + - - - + (33) H. parasuis (7)
09/xx/09 Lung +* ND ND ND ND ND
* by bacterial culture
 
Table 2. Performance results
Number 
of pigs
Viability 
(%)
FC
ADG (g/
day)
S. suis* 
(dead/1000 
pigs)
Mean 
number of 
Pen V tx
Mean num-
ber of days 
on Pen V tx
Before 17149 97.8a 1.53 427 8.5 3.5 11.0
Draxxin® 17609 98.8b 1.46 429 3.3 2.3 7.3
ab Means with diff erent superscripts are signifi cantly diff erent (P< 0.05) 
* sudden death or meningitis
Discussion 
The injection of Draxxin® markedly improved the health status of 
these nurseries. M. hyorhinis was identifi ed as the primary agent 
and because tulathromycin is eff ective against M. hyorhinis and 
not against S. suis, it is believed that the improvement observed 
in pig performance was associated with the action of tulathro-
mycin on M. hyorhinis. A decrease in S. suis incidence was also 
observed. Can M. hyorhinis be a predisposing factor in the de-
velopment of clinical S. suis infection like some irritants6? Further 
work is needed to answer.
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Elimination of PRCV and H3N2 swine inﬂ uenza virus from a production 
network using a 4-week batch farrowing system
Manon St-Hilaire1 Desrosiers Robert2
1. Génétiporc Inc, St-Jean-Chrysostome, QC, Canada; 2. Boehringer Ingelheim, St-Hyacinthe, QC, Canada
Introduction
Porcine respiratory coronavirus (PRCV) is a pathogen of low eco-
nomic impact. Swine infl uenza virus (SIV) can produce losses but 
is also often present on farms without signifi cant clinical signs of 
the disease. Nevertheless, the presence of these two pathogens 
can, for certain farms with a high health status, constitute an ob-
stacle to exportation of breeding animals. This paper describes 
a production network using a 4-week batch farrowing system 
where both viruses were eliminated. 
Materials and Methods
Two high health sow herds (A and B) of 1200 sows each produced 
weaned piglets that went to a common nursery site, and from 
there to three diff erent fi nishing sites. Replacement gilts and 
boars used in herds A and B came from the three fi nishing sites. 
In June 2006 herd A became infected with PRCV, and within a 
month pigs on all sites became infected as well. The biosecurity 
level on these sites is very high and to date the source of initial 
contamination has not been found. In January 2007, following the 
introduction of replacement animals in herd B, coughing was ob-
served and determined to be caused by SI H3N2. Within a month, 
presence of the virus was detected in all sites. In January 2008 the 
owner elected to switch to a 4-week batch farrowing system for 
various reasons that included the possibility to more easily get 
rid of both viruses. An autogenous H3N2 vaccine was obtained 
for the vaccination of gilts (vaccinated twice in isolation and kept 
there for 8 weeks) and sows (vaccinated twice three weeks apart). 
Starting three to four weeks later sows were also vaccinated 
before farrowing in an attempt to maximize colostrum antibody 
content. Following that program, gilts were introduced in the two 
sow herds every four weeks. Circulation of the viruses within the 
herds was monitored using an IDEXX ELISA for PRCV and an IHA 
test, containing a H3N2 Quebec strain, for SI. Both pigs at the end 
of the fi nishing period and sentinels introduced in the two sow 
herds were tested. 
Results
After infection of the sow herds, both PRCV and SIV circulated in 
fi nishing pigs. The fi rst farrowings of the 4-week batch farrowing 
system occurred in June 2008 (batch 1). All 14 batches produced 
and tested so far, except batches 8 and 9, have remained nega-
tive to PRCV. The two infected batches are thought to have been 
infected at the fi nishing site from an indirect and undetermined 
cause. For SI the fi rst two batches were infected, but all others 
have remained negative since then. Negative sentinels intro-
duced in September 2008 in herd B, but not in herd A, serocon-
verted to PRCV. 
Those introduced in June 2009 did not. In October 2008 senti-
nels introduced in Herd B seroconverted to SI H3N2, but those 
introduced in February 2009 have remained negative. 
Discussion
Both PRCV and SIV are considered to be organisms that are usu-
ally shed for only short periods of time following infection. The 
4-week batch farrowing system allows a sow herd to be without 
suckling piglets on site every four weeks. If the herd is temporar-
ily closed to introduction of susceptible gilts and/or boars, this 
system should theoretically increase the chances of being able 
to get rid of pathogens, particularly those that are not shed for 
long periods of time following infection. This is because for a 
while there are no susceptible animals on the farm to maintain 
circulation of the organism.
In this study it was possible to get rid of both PRCV and SIV 
from two diff erent sow herds, the nursery site and the three 
fi nishing sites and this occurred following the implementation 
of the 4-week batch farrowing system. It is not sure if elimina-
tion of these two viruses was due mainly, partially or not at all 
to the use of that production system. In fact in the case of SIV 
an autogenous vaccine was used and may have contributed to 
the results obtained. Furthermore there are situations where 
SIV was eliminated from swine farms without doing anything, 
or by delaying the introduction of gilts to every two months.1,2 
This being said, the results obtained in this study as well as the 
theoretical advantages this system confers suggest, at the very 
least, that further studies should be conducted to determine to 
what extent it could improve the chances of eliminating some of 
the pathogens that have to be dealt with in swine production. 
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Palatability of Tilmovet® 250 mg/ml Concentrate for Oral Solution 
compared to a reference formulation containing tilmicosin
Alain Kanora; Henk Lecluyse; Koen De Gussem
Huvepharma NV, Antwerp, Belgium
Introduction
Tilmicosin is a semi-synthetic macrolide antibiotic obtained 
from tylosin which is aff ecting bacterial protein. Macrolides have 
a proven benefi t as treatment for a wide range of infectious 
diseases, with an increased interest for respiratory infections. 
The objective of this study was to compare the palatability of 
Tilmovet® 250 mg/ml Concentrate for Oral Solution with that of a 
reference formulation containing tilmicosin and to evaluate the 
impact on pig water consumption.
Materials and methods
On a Belgian fattening unit containing two open compartments, 
11 pens were selected, each containing 14 pigs with an average 
weight of + 60 kg. Two test groups of about 150 pigs each were 
identifi ed. Compartments had own dosing equipment installed 
at 1%. The water uptake of each group was monitored during 
5 days, split into 2 phases: 2 days of no medication (negative, 
control) and 3 days with medicated drinking water (Tilmovet® or 
a tilmicosin reference formulation). The inclusion rate of tilmi-
cosin was calculated based on the registered dose of 16 mg/kg 
bodyweight and the actual water intake of the pigs. Each day, a 
fresh solution was prepared and administered.
Results
During the fi rst phase of the trial period, temperatures ranged 
from 26° C to 30° C and for the animals receiving unmedicated 
drinking water in this phase, a daily water consumption was 
recorded ranging from 57 to 67 ml/kg bodyweight and both 
groups had very similar drinking water intake levels. In the 
second trial phase, in which the animals received medicated 
drinking water for 3 days, the registered temperatures ranged 
between 20° C and 23° C. During this phase, the Tilmovet® group 
had a somewhat higher daily water consumption intake level 
(53-68 ml/kg bodyweight, i.e. 3.18-3.81 liter/day/pig) than the 
group receiving the medicated drinking water with the tilmico-
sin reference formulation (49-60 ml/kg bodyweight, i.e. 2.47-
3.05 liter/day/pig) (Figure 1). In terms of dosing, the pigs in the 
Tilmovet® group consistently reached higher dose levels than 
the tilmicosin reference group. The registered minimum dose of 
16 mg/kg bodyweight was not reached in the tilmicosin refer-
ence group on any of the trial days, whereas in the Tilmovet® 
group, mostly higher dose levels were attained (Figure 2).
Figure 1. Daily drinking water consumption
Figure 2. Tilmicosin dose intake levels (mg/kg bodyweight) vs regis-
tered dose of 16 mg/kg BW
Discussion and conclusion
It can be concluded from this study that the overall daily drink-
ing water consumption is not infl uenced by Tilmovet® 250 mg/
ml Concentrate for Oral Solution and that the calculated concen-
tration of tilmicosin is fully compliant with the registered dose of 
16 mg/kg bodyweight.
.
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Treating weaned piglets with tilmicosin oral solution to prevent 
circulation of viral infection in a closed sow herd 
Jan Van Steelant1 Lieven Tanghe2 Henk Lecluyse2 Alain Kanora2
1. Voeders Depré, Vaart-Noord 11, Beernem, Belgium; 2. Huvepharma NV, Antwerp, Belgium
Introduction
The PRRS virus is one of the most important pathogens in the 
pig breeding business. In the fi eld, co-infections with multiple 
bacterial respiratory pathogens are commonly found, making 
eff ective treatment more diffi  cult. The objective of this trial was 
to use tilmicosin drinking water medication as an eff ective tool 
next to vaccination with a life vaccine to prevent PRRSV replica-
tion. This was done in a previously vaccinated, yet positively 
diagnosed sow herd.
Materials and Methods
A Belgian closed sow herd (n= 350), suff ering from early par-
turition (on average 2 days early) and having received multiple 
PRRSV vaccination (3 times in the previous year) after PRRSV was 
diagnosed with RT-PCR strain (in combination with infl uenza 
H3N2, H1N1 and H1N2) still had unusually high prevalence of 
abortions. Change in feed and feed supplier did not bring the 
expected result either. Blood samples were taken and through 
vertical serology the diagnoses of PRRSV circulating was re-
confi rmed (Figure 1). 
Figure 1. S/P ratio
Instead of re-vaccinating the herd (piglets) with the same vac-
cine, the vet decided to go for an alternative treatment with 
tilmicosin to lower the infection pressure in the farrowing house 
and battery. Four days after weaning, the piglets (each weighing 
+ 6 kg) were treated with tilmicosin (Tilmovet® 250 mg/ml Oral 
Solution – Huvepharma) for 3 to 5 days at a dose of 0.5 liter of 
tilmicosin per 1,000 liter. Mortality rates were then monitored 
and evaluated.
Results
Mortality rates dropped considerably in both the farrowing 
house and in the group of weaned piglets, respectively -2.30% 
and -1.40% (Figure 2).
Figure 2. Mortality rates (%), farrowing house and group of weaned 
piglets
Discussion
The 3-5 days treatment with tilmicosin oral medicated drinking 
water has successfully controlled the circulating viral infection of 
PRRSV in both farrowing house and within the group of weaned 
piglets. This was assessed by means of the piglet mortality rate 
which had dropped quite considerably.
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Economic beneﬁ ts from the eradication of enzootic pneumonia and PRRS from a new 800-gilt herd
David G. Burch1 Nigel J. Woolfenden2
1. Octagon Services Ltd, Old Windsor, Berkshire, UK; 2. Bishopton Veterinary Group, Ripon, N. Yorkshire, HG42QR, UK
Introduction
In 2008, due to a period of high feed prices and poor meat 
prices, it was decided to kill out one of three approx. 800 sow 
herds (Herd 1), which was badly aff ected with chronic porcine 
circovirus type 2 (PCV2), porcine reproductive and respiratory 
syndrome virus (PRRSV), enzootic pneumonia (EP) and Actinoba-
cillus pleuropneumoniae ST3. Herd 2, which was also positive for 
PRRS, EP & PCV2 but had a good reproductive performance and 
low post-weaning to slaughter mortality, was to be the source 
of gilts for Herd 1. It was decided to try to eliminate PRRS and EP 
through vaccination and medication prior to farrowing. Elimina-
tion of PRRS had been described (1) using gilt pool management 
and infection stabilization and Mycoplasma hyopneumoniae 
(Mhp) elimination by the use of tiamulin and chlortetracycline in 
combination (2).
Materials and Methods
Approximately, 50 cross-bred (LRxLWXLW) gilts/week were 
weaned at 4 weeks of age into straw-based accommodation 
over a 21week period from the start of 2008. The young pigs 
were vaccinated with a killed mycoplasma vaccine (Ingelvac® 
M Hyo) at 3 weeks of age and again at 8 weeks of age. A PCV2 
vaccine (Ingelvac® Circofl ex) was given also at 3 weeks of age. A 
live PRRS vaccine (Porcilis® PRRS) was given at 8 weeks of age. 
Following the closure of Herd 1 and the removal of all pigs at the 
beginning of June, the premises were thoroughly cleaned and 
disinfected. Three weeks later (21st June) the gilts were moved 
over in batches of 300 from Herd 2. Matings were started in the 
older gilts on the 11th of October and they were given Porcilis 
PRRS and a parvovirus and erysipelas vaccine (Porcilis® Ery + 
Parvo) 3 weeks before service. To ensure the required uniform 
immunity to PRRS, the whole gilt herd was vaccinated on 24th 
November with Porcilis PRRS (live), an inactivated PRRS vac-
cine (Progressis®) on the 15th of December and a fi nal Porcilis 
PRRS (live) on the 5th of January, 2009. Medicated feed was also 
started on the 5th of January, 2009 for 6 weeks and containing 
suffi  cient tiamulin (Denagard® Premix) at 500ppm and chlor-
tetracycline (Aurogran® Premix) 1500ppm to give 5 and 15mgs 
of active/kg bodyweight respectively. The fi rst farrowings com-
menced on the 3rd of February. The younger gilts (<300 days of 
age) and boars were also injected with tiamulin (Denagard 200 
injectable) at 15mg/kg bodyweight, 3 weeks into the in-feed 
medication period.
Blood samples were taken from 60 pigs (8-22 weeks old) on July 
14th and examined by ELISA tests for PRRSV (LSI Hipra) and Mhp 
(DAKO blocking). In December, an acute outbreak of coughing 
occurred in Herd 1 and a further 30 samples from 16-20 week old 
pigs were taken. A number of lungs at slaughter were also exam-
ined for EP lesions & pleurisy in July (240) and December (115).
Results
Table 1. Blood test results for PRRSV and Mhp. 
Blood test No of samples PRRSV +ve Mhp +ve
July 2009 60 0 0
Dec 2009 30 15 (50%) 0 (0%)
Table 2. Comparative production fi gures before and after PRRSV and 
EP eradication programme in Herd 1
Herd 1 Herd 1 Herd 2
Pre-prog 2007 Post-prog 2009 Original herd 2009
No born alive 11.9 13.4 12.0
Mort pre-wean 9.8% 8.5% 7.5%
Mort post-wean 11.4% 7.6% 3.5%
FCE 2.59 2.46 -
All of the lungs examined were free from EP lesions. Pleurisy had 
fallen from >30% in 2007 to <6% in 2009.
Discussion
The EP part of the programme appears to have been very suc-
cessful for over a year according to blood and lung lesion results. 
There appears to have been a breakdown in PRRSV in December, 
although the herd remained free clinically for over 10 months, 
suggesting the programme had been eff ective originally. Con-
taminated transport was the suspected cause. Number of pigs 
born alive/litter was increased by 1.5. Mortality was reduced 
in all stages of production by 5.1% but from post-weaning to 
slaughter by 3.8% or an extra 730 pigs sold resulting in a £25,500 
margin over feed. FCE was reduced by 0.13, which equated to 
savings of £34,944, and a combined total of £60,444. PRRS and 
EP medication costs were £11,970, so the med cost/benefi t ratio 
was 1: 5.
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Use of Tilmovet® 250 mg/ml Concentrate for Oral Solution in prefarrowing sows – a Danish ﬁ eld trial
Niels H. Rough1 Alain Kanora2 Koen De Gussem2
1. Samsvet, Tingvej 1, Samsoe, Denmark; 2. Huvepharma NV, Antwerp, Belgium
Introduction
Macrolides have been intensely studied in the past with regards 
to their eff ect on pig production parameters. A Danish sow 
farm suff ered from an outbreak of Mycoplasma hyopneumoniae 
including pregnant sows. To minimize the infection pressure in 
the farrowing house, all pregnant sows were given tilmicosin 
(Tilmovet® - Huvepharma)1,2. The objective of this fi eld trial was 
to control the Mycoplasma circulation in piglets by using tilmi-
cosin in prefarrowing sows.
Materials and Methods
The Danish sow farm (n= 680, races LY and Zig Zag cross) is 
located on the island Samsø. Every week, there are 29 farrowings 
(average of 6 months prior to current trial) and all gilts are pro-
duced on farm. Historical data on the number of piglets being 
born, weaned, pig weight and piglet mortality were available. 
During an 8 week period (1 October- 23 November), all sows 
received an individual treatment of tilmicosin (Tilmovet®) of 12 
ml per sow for 5 consecutive days prefarrowing. First pigs from 
treated sows were weaned around 28 days (28 October) and 
the last around 16 December. Weaning age was 28 days. Data 
on average piglet weight at time of weaning (data representing 
2970 pigs weaned) were then compared to historical data rela-
tive to 6,186 pigs weaned (period of 17 weeks) and to data from 
690 pigs weaned during the two weeks post treatment period. 
Secondly, piglet mortality data from the treated group were 
compared to the pre-trial historical data.
Results
In terms of average weight, the historical data showed an 
average weight per pig of 6.61 kg, whereas the piglets from 
the Tilmovet® treated group had an average weight of 6.81 kg, 
i.e. an increase of 2.92% (Table 1). During the post trial period 
of 2 weeks which was considered, the average weight per pig 
decreased again to 6.55 kg, being a decrease of 3.78% compared 
to the treated group.
Table 1. Avg. piglet weight, historical vs treatment
Data relative to period Number of pigs weaned
Weight of pigs 
weaned
Avg. weight per 
pig (kg)
Before tilmicosin 6,186 40,920 6.61
Tilmicosin treatment 2,970 20,220 6.81
Post trial (2 wk) 690 4,520 6.55
Secondly, the historical mortality data (over a period of 5 weeks) 
were compared to the mortality rate relative to the Tilmovet® 
treated groups. Taking into account the start and ending of the 
treatment, the fi rst weaned pigs from these groups were in week 
44 and the last ones in week 51. A clear tendency in mortality 
decrease in the treated groups can be noticed (Figure 1). The 
average mortality rate prior to this study was 16%, whereas the 
average mortality rate of the treated groups was 13.67%.
Figure 1: Post-weaning mortality rate (% of dead piglets)
Discussion
Historical data showed that untreated sows had piglets of 
inferior weaning weight. This observation clearly confi rmed the 
ability of tilmicosin to control the disease pressure. Secondly, it 
demonstrated the indirect eff ect on the average piglet weight 
of Tilmovet® treated sows when treated in the prefarrowing 
stage. Consequently, the average mortality rate of treated sows 
showed a tendency to be lower (in comparison to historical 
data). 
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Eﬃ  cacy of ﬂ orfenicol (Nuﬂ or 40 mg/g Premix for swine) for the control of 
porcine respiratory disease complex in an Iberian pig farm
Pablo Arevalo1 Antonio Palomo2 Jesus M. Bollo3 Ruth Menjon3 Marta Jimenez3 Jesus V. Lopez3
1. Granja Iberica Alcudia, S. Lu., Ciudad Real, Spain; 2. SETNA NUTRICION-INVIVO NSA, Madrid, Spain; 
3. Intervet/Schering-Plough AH, Cantabria, Madrid, SpainObjective 
The object of the study was to compare safety and effi  cacy 
of fl orfenicol (Nufl or 40 mg/g Premix for Swine) with that of 
Tilmicosin for prevention of porcine respiratory disease complex 
(PRDC).
Materials and Methods.
Study was performed on a farm with 3,000 Iberian sows cross-
bred with Duroc and Iberian boars in a closed production cycle. 
The farm had a history of PRDC with clinical and/or laboratory 
diagnosis of P. multocida, M. hyopneumoniae and S. suis. 
A total of 604 piglets from two consecutive weanings were 
included in the study (302 per group). Animals from both groups 
were randomized according to their weaning group, age, weight 
and gender.
The treatments to be compared were mixed with pre-starter 
feed as follows:
80 ppm fl orfenicol (Nufl or 40 mg/g Premix for Swine, 2 kg/Tm) 
during 14 days.
200 ppm tilmicosin (1 kg/Tm) during 14 days.
The mean age at weaning was 27 days, and the study lasted 42 
days, so piglets were 69 days old at end of study.
The pen was the experimental unit when weighing the animals 
(25, occasionally 26 pigs per pen). Pigs were weighed on day 0 
(at weaning, the start of medicated feed intake), on day 14 (at 
end of medicated feed intake) and on day 42 (at end of starter 
feed intake and entry to pre-fattening barn) and average daily 
gain (ADG) calculated. Feed intake was recorded and feed con-
version ratios (FCR) calculated. 
The statistical study was performed using ANOVA, Pearson’s chi-
square test and Fisher’s exact test. 
Results
Both treatments proved safe; no adverse eff ects were observed. 
The average weights of both groups at start of the study were 
comparable (p=0.677).
Table 1: Mean weights (kg)
Day 0 Day 14 Day 42
Florfenicol 7.46 10.85 23.15
Tilmicosin 7.55 10.44 21.7
The fl orfenicol group performed statistically signifi cantly better 
for average weight on day 14 (p=0.001) and on day 42 (p<0.01) 
(Table 1).
Better growth rates and weights were found in the fl orfenicol 
group, both during pre-starter and starter periods, and these dif-
ferences were statistically signifi cant in all cases (Table 2).
Table 2: Weight gains and growths per study period
Weight 
(kg)
Weight 
(kg)
Weight 
(kg) ADG ADG ADG
Period (Days) 0-14 14-42 0-42 0-14 14-42 0-42
Florfenicol 3.39a 12.30c 15.69e 242a 440c 374e
Tilmicosin 2.89b 11.26d 14.15f 207b 403d 337f
ª b(p=0.001), c d (p=0.002) e f (p<0.01)
The fl orfenicol group had a lower mortality rate (1.7%) than the 
tilmicosin group (4%) though this was not statistically signifi -
cant. However, signifi cantly fewer pigs in the fl orfenicol group 
(9.6%) received injectable treatment than in the tilmicosin group 
(14.9%) (p= 0.031).
Table 3: Production data
Florfenicol Tilmicosin
Feed intake (g) 583 579
FCR 1.56 1.72
Table 3 indicates a 9% improvement in FCR of the fl orfenicol 
group over the tilmicosin group (160g less feed per kilogram 
gained). This represents an extra intake of 2.26 kilograms of feed 
in the tilmicosin group during this period. 
Conclusions
It can be concluded that fl orfenicol (Nufl or 40mg/g Premix for 
Swine) in pre-starter feed for prevention of PRDC on an Iberian 
pig farm was safe. 
Also,compared to treatment with tilmicosin at recommended 
inclusion rate, fl orfenicol led to better mortality rate and FCR, 
and statistically signifi cantly better ADG, end weight, and %age 
animals receiving injectable treatment. 
The in-feed use of fl orfenicol can be recommended as eff ective 
in reducing the eff ects of PRDC (1).
References
1.  Palomo A. et al. 2nd Symposium Veterinary Sciences. Zaragoza 
(Spain) 2008, pag 37.
Respiratory diseases – Control
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 678
Poster Presentations
P.372
Draxxin® metaphylaxis against Swine Respiratory Disease (SRD) in 
suckling piglets: beneﬁ ts on performance and morbidity
Ian A. Nanjiani1 Joaquin Morales2 Carlos Piñeiro2 Pascale Sierra3 JensChristian E. Jensen4
1. Pfi zer VMRD, Sandwich, UK; 2. PigCHAMP Pro Europa SA, Segovia, Spain; 3. TVIVERITAS France, Gerstheim, France; 
4. Orion Pharma Animal Health, Nivå, Denmark
Introduction
Swine Respiratory Disease (SRD) is a complex multifactorial 
disease which has substantial economic and welfare impacts on 
the swine industry, particularly when present in young animals. 
Disease control is generally achieved by environmental control, 
vaccination and antibiotic treatment. This GCPV compliant study 
was conducted to investigate the eff ects of a metaphylactic 
treatment administered early to piglets at risk of SRD during 
their fi rst week of life on the disease and their subsequent 
growth when compared to a conventional “intervention” ap-
proach. 
Materials and Methods
One hundred and twenty litters containing 1170 Large White x 
Landrace piglets were included in fi ves batches on two com-
mercial farms sites in Spain with history of respiratory disease in 
young piglets. 
Litters were randomised within airspace to either: T01 - meta-
phylactically treated with tulathromycin (2.5 mg/kg Draxxin®, 
Pfi zer Ltd), at 3 days of age on Day 0 (60 litters, 582 piglets); or 
T02 - control group (60 litters, 588 piglets) individuals treated 
therapeutically with amoxycillin injection when showing signs 
of SRD. Animals were observed daily for signs of abnormal 
health; veterinarians conducting clinical examinations were un-
aware of the treatment group attributed to each pig. All piglets 
were weighed on Day 0 prior to treatment and on the day of 
weaning (Day 24 or Day 25). Any piglet (T01 and T02) diagnosed 
with SRD during the observation period was treated with amoxi-
cillin long acting injectable at the recommended dose rate of 15 
mg/kg repeated at a 48-hours interval if necessary.
The primary variable for Draxxin® metaphylaxis eff ectiveness 
was the average daily weight gain between Day 0 and wean-
ing (ADG). Secondary variables included the homogeneity of 
weaning body weight per litter, the percentage of pigs with SRD 
during the observation period, and the number of days and 
injections for treatment for SRD.
Results
Clinical signs of respiratory disease were observed in all study 
batches, though they were generally mild in character. Pas-
teurella multocida, Haemophilus parasuis and Streptococcus suis 
were isolated (nasal or lung swabs taken from pigs with SRD), 
and serological evidence of Actinobacillus pleuropneumoniae 
was present on both sites. 
Table 1. Homogeneity of fi nal body weight per litter, weaning weights, 
ADG & Proportion requiring therapy
Group (No. of pigs)
Homogeneity1 Body Weight ADG (g/day)
% needing SRD 
therapy
BW Day 0 BW Day 25
Initial 
Weight 
(kg)
Weaning 
Weight 
(kg)
T01 Draxxin (582) 82.04 80.68 2.286 8.092 237.3 3.09
T02 Control (588) 82.19 78.76 2.365 7.906 229.5 4.59
SEM 0.636 1.227 0.079 0.326 15.67 0.795
P-value 0.86 0.07 0.30 0.0627 0.0604 0.0825
1100 – Coeffi  cient of Variation of bodyweight (higher values refl ect greater homogeneity)
Discussion 
The use of injectable antibiotics for metaphylaxis allows the 
eff ective treatment of an at-risk group by ensuring accurate, 
targeted dosing of the individual animal. This study is consist-
ent with recent studies in showing respiratory problems early in 
current swine production systems. In this study, a tulathromycin 
metaphylaxis approach during a mild disease outbreak pro-
duced a tendency to better weight gain and higher bodyweight 
at weaning, more homogeneous litter weights at weaning and 
less need for subsequent antibiotic treatment in the meta-
phylactically treated group when compared to a conventional 
“intervention” approach. 
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On-farm comparison of the eﬃ  cacy and proﬁ tability of Draxxin® vs. medicated-
feed for the prevention of Swine Respiratory Diseases on weaners
Cyrille Malherbe2 Audrey Dedeurwaerdere1 Arlette Laval3
1. Pfi zer Animal Health, Paris, France; 2. Cabinet Vétérinaire Gâtines, Valençay, France; 3. ONIRIS National Veterinary School, Nantes, France
Introduction
The possible transmission of most respiratory pathogens and 
the heavy consequences of early SRD clinic on pigs’ perform-
ances make the weaning period the most critical moment for 
controlling SRD. This can be achieved using in-feed medication, 
a practical and often satisfactory way of preventing SRD on 
weaners. An alternative way is the use of single-shot, long-acting 
injectable antibiotics. In Europe Draxxin® (tulathromycin 100mg/
mL) is labeled for the treatment and prevention of SRD associ-
ated with Pasteurella multocida, Actinobacillus pleuropneumoniae 
Mycoplasma hyopneumoniae and Haemophilus parasuis. 
This study compared on-farm results of a single shot of Draxxin® 
at weaning to the normal farm practice using a tilmicosine - 
medicated starter. Focus here was on clinical effi  cacy and profi t-
ability at batch level, while a second trial investigated further 
clinical results at individual level. 
Materials and Methods
Herd history The farrow-to-fi nish herd, located in western France, 
showed a high SRD pressure: PRRS, PCV2 and Mhyo positive, 
plus history of App. Clinical outbreaks were under control via 
in-feed medication on weaners and occasional oral treatments 
on growers. Decreased performance and increased heterogen-
eity were reported in the post weaning units. Due to lack of 
palatability, the two-week administration of medicated starter 
(300ppm tilmicosine) was delayed one week from weaning (21 
to 28 days of age). 
Longitudinal study Five consecutive batches were included 
at 2-weeks interval of 21 days-old piglets between April and 
August 2009. The fi rst two batches (n=666) followed the normal 
farm practice (NF group). The other batches (n=938) received a 
single IM injection of tulathromycine at 2.5mg/kg on weaning 
day instead of the in-feed medication (Draxxin group). No other 
parameter changed. 
Data Mortality was registered at batch level during the 7.5 
weeks of post-weaning period. Average daily weight gain (ADG) 
and feed consumption ratio (FCR) were recorded at pen level 
from 21 to 42 days of age. These data were analysed with a T-test 
for independent populations. The ROI was calculated based on 
the 2008 French National references for farrow-to-fi nish farms 
and translated with Osiris® software (Pfi zer). Extra-labor and 
treatment costs were registered on-farm. 
Results
Performance data The mortality rate over the weaning period 
signifi cantly decreased by 1.2% in the Draxxin group. ADG and 
FCR showed no signifi cant diff erences.
Table I Comparison of the mortality rate, ADG and FCR [means (inter-
quartile range)] 
Mortality (%) ADG (g/d) FCR
NF group 1.95a 321.6 (70) 1.46
Draxxin group 0.75b 298.2 (40) 1.28
a,b : p-value<0.05
Return On Investment analysis In this case, the dispenser injected 
250 piglets per hour. Variations of performance results only be-
tween the groups added to 1.52€ gain/pig. Overall profi tability 
was 1.74€/pig for Draxxin group. 
Table II Variation of result and benefi t per ROI data
Diff erence NF/Draxxin 
groups
Gain/pig for Draxxin 
compared to NF group
Mortality - 1.2 % + 0.82 €
ADG - 23.4 g/d - 0.66 €
FCR - 0.18 + 1.36 €
Labor cost - 0.08 €
Treatment cost + 0.30 €
Discussion 
Although not a randomised study, this investigation included 
multiple batches and management was consistent between 
batches, so reliable conclusions can be drawn on the effi  cacy of 
the products. During this observation period the use of Draxxin® 
at weaning proved better clinical and economical results than 
normal farm in-feed medication. ADG was less variable and 
the feed-conversion effi  ciency was numerically higher in the 
Draxxin-treated batches. 
A possible explanation for these fi ndings may reside in treat-
ment compliance. Given the individual variations of feed intake 
(linked with observed lack of palatability), especially on young 
weaners of 21-days of age in case of high SRD pressure, a pro-
portion of piglets may not receive the calculated dose of oral 
medication. Thus it would lead to a fraction of poor-performing 
and unhealthy piglets, diminishing the general performances 
of the batch. This bias disappears with single-shot injectables, 
guarantying full compliance and superior overall effi  cacy of the 
treatment. 
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On-farm comparison of the clinical eﬃ  cacy of Draxxin® vs. oxytetracycline medicated-
feed for the prevention of Swine Respiratory Diseases in at-risk weaners
Cyrille Malherbe2 Audrey Dedeurwaerdere1 Arlette Laval3
1. Pfi zer Animal Health, Paris, France; 2. Cabinet Vétérinaire Gâtines, Valençay, France; 3. ONIRIS National Veterinary School, Nantes, France
Introduction
The possible transmission of most respiratory pathogens and 
the heavy consequences of early SRD disease on performance 
make the weaning period a critical time for controlling SRD. This 
is often achieved using in-feed medication, a practical and often 
satisfactory way of preventing SRD on weaners. An alternative 
way is the use of single-shot, long-acting injectable antibiotics. 
In Europe Draxxin® (tulathromycin 100mg/mL) is licensed for 
the treatment and prevention of SRD associated with Pasteurella 
multocida, Actinobacillus pleuropneumoniae Mycoplasma hyo-
pneumoniae and Haemophilus parasuis. 
This study compared the effi  cacy of a single shot of Draxxin® at 
weaning to the normal farm practice using a medicated starter, 
in two diff erent herds in normal farm conditions. The fi rst part 
of the trial (vs. tilmicosin, separate poster) addressed clinical ef-
fi cacy and profi tability at batch level. In this second herd clinical 
results were investigated further at individual level as well. 
Materials and Methods
Herd history The farrow-to-fi nish herd was located in Normandy, 
France and was positive for SIV, Mhyo and (historically) App. 
The farm was reported to be PRRS and PCV2 negative. Regular 
outbreaks of clinical respiratory disease occurred in the post-
weaning units, with high morbidity, individual weight loss and 
heterogeneity commonly reported. Normal farm practice sched-
uled preventive treatment for 3 weeks at weaning (medicated 
starter, oxytetracycline, 1000 ppm) then additional oral treat-
ment (20mg OTC/kg BW x 4 to 5 days) for therapy when needed. 
Longitudinal study Six consecutive batches of 21 days-old piglets 
were included at 1-week intervals between July and August 
2009. Three batches (n=944) followed the normal farm practice 
(NF group). The other batches (n=1155) received a single IM 
injection of tulathromycine at 2.5mg/kg at weaning (Draxxin 
group) instead of the starter medication. No other parameter 
changed. In one batch of each group 120 piglets from 10 litters 
were chosen at random by the dispenser and identifi ed for indi-
vidual observations. 
Data Mortality & additional oral treatment were recorded at 
batch level during the 7.5 weeks of post-weaning. Clinical 
examinations and weighings were recorded once a week up to 
21 days after weaning. Quantitative data were analysed with 
a T-test for independent populations, qualitative ones with 
Pearsonχ test. 
Results
Mortality rate decreased from 1.68% to 0.65% (p=0.021) and 
therapeutic oral treatment from 3.71 to 1.42 days/pig (p=0.007) 
in favor of the Draxxin group. Mean pen ADG refl ected the 
mean individual ADG recorded per 1-week period, signifi cantly 
superior in the Draxxin group. 
Table 1: Development over time of respiratory signs and ADG 
 
Mean coughing 
/2’/100pigs
Nb of pigs with 
dyspnoea (ind**)
Mean ADG 
(g/d/pig, ind)
NF group Draxxin group NF group
Draxxin 
group NF group
Draxxin 
group
D0 0.97* 0.10* 2* 3*
D7 0.32* 0.22* 16 5 73.5 157.6
D14 4.05 0.08 22 8 190.5 279.6
D21 13.77 0.98 30 16 358.8 441.9
p<0.025 p<0.025 p<0.0001
(D : Days after weaning; **ind: individual records on 120 piglets; *p>0.05)
Discussion 
Although not a randomised study, this investigation included 
multiple batches and management was consistent between 
batches, so reliable conclusions can be drawn on the clinical 
effi  cacy of the preventive treatments. Dramatic diff erence in 
individual weight gains in the fi rst days after weaning while no 
visible clinical sign (at individual or group level) was observed, 
supports the hypothesis of an early viral challenge, then of 
secondary respiratory infections noticeable at piglet level 7 days 
after weaning, and at group level after 2 weeks. 
The diff erence in clinical effi  cacy between the two preventive 
treatments may then reside in compliance. Indeed, early chal-
lenged piglets, even if not visibly sick, won’t eat their share. 
Added to the individual variations of feed intake, especially on 
newly weaned piglets of 21 days of age, one can assume that 
a proportion of piglets would not receive the calculated dose 
of oral medication. This would lead to a fraction of unhealthy 
and poor-performing piglets, diminishing the general perform-
ances of the batch – and increasing the risk of SRD transmission. 
This bias disappears with single-shot injectable antibiotics, 
guarantying full compliance and superior overall effi  cacy of the 
preventive treatment.
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Pulmotil® (Tilmocosin) in feed reduces clinical disease associated with 
PRDC resulting in increased nursery performance
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Introduction
Several reports suggest that the severity of PRDC associated 
clinical diseases reduced when Pulmotil® (Tilmicosin, Elanco 
Animal Health, Thailand) was used1, 2. The objectives of the 
study were to investigate the effi  cacy of Pulmotil® in feed as an 
early intervention regimen in the reduction of PRDC associated 
clinical disease and to observe the antibody response against 
PRRSV as measured by ELISA (Idexx, USA) in pigs administered 
Pulmotil® in feed. 
Materials and Methods 
PRRSV status of the experimental herd was considered stable/ 
inactive in which clinical diseases associated with PRRSV infec-
tion and PRDC were observed in the nursery period. 266 barrows 
were randomly selected based on the stratifi cation of weight 
and ear-tattooed. Pigs were allocated into 2 groups (Control 
and Pulmotil® groups. Pigs were weaned at 18-21 days of age 
into a wean-to-fi nish facility located few kilometers away from 
the sow herd. Upon arrival,each group was housed in 2 pens. 
Pigs in control group (n=140) were medicated in feed with 
Amoxycillin, Tiamulin and Colistin at the dosages of 200, 100 
and 80 ppm, respectively. Pigs in Pulmotil® group (n=126) were 
medicated in feed for 3 consecutive weeks with Pulmotil® and 
Colistin at the dosages of 200 and 150 ppm, respectively. All pigs 
were weighed individually at weaning and 8 weeks of age. Feed 
consumption was monitored daily. Average daily gain (ADG) and 
feed conversion ratio (FCR) were calculated. Death and cull were 
recorded. Ten same pigs were followed serologically for anti-
body response against PRRSV as measured by ELISA (Idexx, USA) 
at weaning and 8 weeks of age. At 8 weeks of age, 5 pigs were 
randomly selected from each group and necropsied to assess 
the pneumonic lung lesion. Bacterial culture was performed in 
all lungs. Bronchial alveolar lavage fl uid (BAL) samples were col-
lected and assayed for the presence of PRRSV by PCR. The study 
was done in duplicate. 
Results 
Nursery performance including antibody response as measured 
by ELISA is displayed in Table 1. Pigs on Pulmotil® in feed had 
ADG and % CV of age at 8 weeks of age slightly better than pigs 
in the control group and the diff erence was not statistically 
signifi cant. 
Parameters Control Pulmotil
Average Weight at 3 weeks (Kg) 6.15 6.14
Average Weight at 8 weeks (Kg) 21.3 22.9
Average weight Gain (Kg) 15.45 16.76
ADG (Kg/day) 0.51 0.51
FCR 1.2 1.2
% CV of Weight at 8 weeks 19.25 13.76
Average S/P ratio at 3 weeks 0.63 0.54
Average S/P ratio at 8 weeks 0.67 0.12
Bacterial Secondary bacterial infection was found in the control 
pigs and none was detected in the Pulmotil group. PCR results 
indicated that all BAL samples of the control pigs were posi-
tive for PRRSV, while that of Pulmotil® pigs were negative. In 
addition, most of the control pigs increased in their antibody 
response against PRRSV. The S/P ratio of the Pulmotil® pigs, how-
ever, decreased and was below the cut-off  level (0.4) 
Discussion 
The results of the study suggested that the administration of 
Pulmotil in feed reduced the severity of the clinical disease as-
sociated with PRRSV and PRDC resulting in increased nursery 
performance. 
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Porcine respiratory disease complex, from diagnosis to eﬃ  cient prevention: 
the role of infection dynamics and the quality of vaccination
Henri Guilmoto
Selas Vétérinaire de la Hunaudaye, Lamballe, France
Introduction
The practitioner needs perseverance and critical self-appraisal. 
This is illustrated by this case report which starts with a com-
plaint of a drop in carcass weight (CW) and mortality in spite of 
piglets PRRS vaccination.
Materials and methods
The case concerns a 350 sow breeding-fi nishing farm, 28 days 
weaning once a week, all in / all out post-weaning and fi nish-
ing, dynamic depression ventilation, in a low pig density area. 
Piglets are weighed at weaning and at the end of post-weaning. 
The farm is known to be infected by the infl uenza virus, M. hyop, 
PRRSV, H. parasuis and P. multocida. It is free from APP. The res-
piratory disease control plan includes vaccinations of the breed-
ing stock against rhinitis, infl uenza, and PRRS (live). This last is 
also used in piglets at 7 weeks of age. There is no Mh vaccination 
and no antibiotic prevention after the nursery feed.
June 05: PRDC, with the “18-week wall” and CW 6 kg less than 
before. Observations at the slaughterhouse and the absence 
of vaccination lead to the diagnosis of enzootic pneumonia. 
Mh vaccination was set up, and PRRS vaccination maintained. 
Situation did not improve. Flu-like episodes continued, and lab 
analysis indicated the presence of SI, PCV2, PRRS and Mh.
Dec. 06: Follow-up of 12 sentinel piglets showed a late circula-
tion of Mh and an early circulation of PRRSV. Necropsy and 
histology confi rmed Mh infection. Antibiotic prevention was 
set up during 22 weeks, while PRRS vaccination was suspended. 
In parallel, three further elements were examined (Jan.-Apr. 
2007): (a) colostrum analysis showed an absence of antibodies 
against atrophic rhinitis despite sow vaccination, (b) an analysis 
of weight at the start of fi nishing showed a sudden drop of over 
3 kg in 2005. In the same batches, a drop in carcass weight was 
observed, (c) PRRSV PCR in sentinel showed early circulation 
(6-10 wks).
April 2007. The following action plan was up: 
(a) Continuation of vaccination against Mh (PORCILIS M HYO at 
1 and 4 weeks of age), 
(b) earlier vaccination against PRRS (PORCILIS PRRS at 4 instead 
of 7 weeks of age).
Results
After adjusting the timing and quality of vaccination, a clear 
improvement was observed: improvement of mortality rates and 
lung scores (Figure 1), increase of body weight at the start and 
end of the fi nishing period (Figure 2). Taken over 6 years, data 
show that, after an important drop in performance between 04 
and 06, all indicators of 08 and 09 were better than in 04 (Table 
1). 
Figure 1: Losses and lung scores (Nov. 06 to Oct. 08) 
Figure 2: Body weights evolution (Nov. 06 to Oct. 08)
Table 1: Evolution of results over 6 years
04 05 06 07 08 09
BW start fi nish 42.6 39.0 40.3 41.5 43.4 43.5
Mortality fi nish 6.4 7.4 6.7 3.0 2.1 2.5
Carcass wt 86.9 84.7 84.2 85.6 88.4 89.8
FCR 2.93 3.04 3.16 2.90 2.85 2.8
Conclusion
-  Consider the impact of postweaning on fi nishing. 
-  Check quality of vaccination
-  Record technical and used them as a diagnostic tool.
-  Use diag. lab and observations in the slaughterhouse.
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Field observation of the eﬀ ects on the performance of weaned piglets of Pulmotil™ in large farms in Spain
Xavier de Paz1 Susana Lapuente1 Miguel Abad1 Joan Sanmartin2 Gonzalo Cano2
1. Elanco Animal Health, Madrid, Spain; 2. Optimal Pork Production, Lleida, Spain
Introduction 
The presence of respiratory disease increases medication costs 
but also causes a loss of performance (ADG and FCR) since 
energy and protein is diverted towards fi ghting disease (1). 
The objective of the present fi eld observations was to evaluate 
the eff ects of a standard medication with Pulmotil™ at weaning 
to prevent respiratory disease in two large farms in Spain.
Materials and Methods
Two diff erent in-feed treatment programs were compared after 
weaning: a control group (C) received a prestarter feed with 
120ppm of colistin and 3200ppm of ZnO and a pulmotil group 
(P) that received a prestarter feed which included 400ppm of 
Pulmotil besides 120ppm of colistin and 3200ppm of ZnO. Every 
piglet received 5kg of this prestarter feed. Also, all the piglets 
were vaccinated against M.hyo at one week of age. The data of 
these fi eld observations came from 18015 weaned piglets com-
ing from 2 diff erent sow farms during 10 consecutive weeks.
Farm 1: 2480 sow-farm where piglets are weaned at 21 days and 
moved to nursery facilities in another location for approximately 
6 weeks.
Farm 2: 4865 sow-farm where piglets are weaned at 21 days and 
moved to nursery facilities in another location for approximately 
6 weeks.Data was analyzed using the GLM procedure of SAS Sys-
tem. The model includes the treatment eff ect and batch was the 
experimental unit. No statistical diff erences were found neither 
for weight or age at start of trial so no covariate was included. 
Mortality was analysed using the logistic regression with treat-
ment as fi xed eff ect.
Results and Discussion
The global results are summarized in table 1. 
Table 1. Production parameters observed in the two nursery farms
Piglets in 
(n)
Piglets 
out (n)
Mortality 
(%)
Initial LW 
(kg)
Final LW 
(kg) ADG (g)
Control 9032 8931 1.12 6.10 18.01 304.39
Pulmotil 8983 8916 0.75 6.02 19.06 333.32
sig. (p=) 0.0098 0.52 <0.0001 <0.0001
The initial liveweight (LW) of the piglets was not diff erent be-
tween both treatments (p=0.52) but at the end of the nursery 
period (60.2 days of life) the piglets in the Pulmotil group were 
heavier (18.01kg vs 19.06kg; p<0.0001).
The ADG of the piglets was higher in the Pulmotil group (304g/d 
vs 333g/d; p<0.001). The mortality rate in the Pulmotil group 
was slightly lower than in the Control group (C=1.12% vs 
P=0.75%). 
The treatment with Pulmotil aff ect signifi cantly (p=0.0098) the 
mortality of piglets. Also, the odds ratio for mortality was 1.505 
(1.10-2.0 Confi dence interval at 95%) so Pulmotil piglets had less 
probability to die.
Conclusions
The inclusion of Pulmotil in the prestarter feed of piglets 
improves animal performance even in farms with good health 
status (around 1% mortality rate). As seen in other studies (2), 
the piglets in the Pulmotil group were heavier at the end of 
the nursery (1.05kg more at 60.2 days of life). Therefore, the 
piglets in the Pulmotil group grew more which enables them to 
increase the Full Value Pigs™ in the fattening unit.
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Relationship between lung lesions and haptoglobin serum concentration in slaughter pigs
Christelle Fablet; Virginie Dorenlor; Florent Eono; Eric Eveno; Jean-Pierre Jolly; Gaëtan Marquier; Eric Boilletot; François Madec
AFSSA-Site de Ploufragan, Ploufragan, France
Introduction
During the fi rst step of the immune defence, the concentrations 
of a group of plasmatic proteins called the Acute Phase Proteins 
(APPs) change. These APP seem to be sensitive and accurate 
biomarkers of pig health. Therefore quantifi cation of their con-
centrations in plasma or serum of pigs could provide valuable 
diagnostic information for prognosis and monitoring disease 
[1]. In intensive production systems, respiratory disorders are 
considered as the most serious problem aff ecting fi nishing pigs 
worldwide and represent one of the major health issues [2]. 
The aim of the study was to assess the relationship between 
macroscopic lung lesions and serum concentration of one APP: 
haptoglobin (Hp) in slaughter pigs.
Materials and Methods
A sub sample of 70 pig farms was selected from a sample of 125 
French farrow-to-fi nish herds included in an analytical survey 
designed to identify risk factors for Porcine Respiratory Disease 
Complex. The 70 farms were selected according to their pneu-
monia mean score, assessed on a sample of 30 slaughtered pigs:
-  mean score ≤1,7, 37 herds (mild pneumonia)
-  mean score ≥5,5, 33 herds (severe pneumonia)
For each herd, at the slaughterhouse, individual blood samples 
were obtained at exsanguination from a sample of 10 fi nishing 
pigs selected at random. For every pig the lungs were collected 
on the slaughter line and pneumonia, pleuritis and abscesses 
were recorded. As regard enzootic pneumonia, the lungs were 
scored [3]. In a second step, pigs were classifi ed into 4 groups 
according to the extent of pneumonia (0:no lesion, 1≤score≤4; 
5≤score≤8; score≥9). The serum level of Hp was measured by 
a spectrophotometric method using a commercial assay kit 
(Tridelta Development, Greystones, Ireland). Diff erences in 
serum Hp concentrations between healthy pigs vs those show-
ing pleuritis or abcesses were assessed using Mann and Whit-
ney test whereas Kruskal-Wallis test was used for pneumonia 
(p<0.05; SAS Inc.).
Results
Among the 700 selected pigs, the correspondence between 
blood and lung sampling was achieved for 517 animals. The lev-
els of Hp were not signifi cantly diff erent between pigs showing 
or not either pleuritis or lung abscesses (p>0.05, 
Table 1. Mean serum concentration of Hp was associated with the 
severity of enzootic pneumonia (p<0.05, 
Table 2.
Discussion 
The results of our study indicated that serum Hp concentration 
in slaughter pigs was higher in case of extended pneumonia 
whereas no relationships between Hp levels and pleuritis or 
lung abscesses were found. To the best of our knowledge, this 
is the fi rst report on Hp levels measured in a large sample of 
commercial pig farms in France. These fi ndings are partially 
consistent with those of Amory et al., [4] and Pallares et al., [5]. 
Nevertheless, infectious conditions other than respiratory ones 
or injury like lameness, diarrhoea, tail or ear biting may induce 
elevated levels of Hp [6]. As these conditions were not examined 
in the present study, it is likely that these kind of diseases have 
occurred in some pigs and may have induced an Acute Phase 
Response. This may be one explanation of the relative “high” 
mean value of Hp observed in the group of pneumonia free pigs 
when compared to values encountered in commercial healthy 
fi nishing pigs. This is in line with previous literature conclusions 
telling that Hp should be considered as a general biomarker 
rather than a specifi c respiratory infection indicator.
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Impact of porcine respiratory disease complex on the eﬃ  cacy of classical swine fever vaccination
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Introduction
Porcine respiratory disease complex (PRDC), an endemic disease 
caused by co-infection with several respiratory pathogens, 
typically adversely aff ects pig weaning and growth, leading to 
considerable economic losses worldwide. Porcine circovirus 
type 2 (PCV2) and porcine reproductive and respiratory syn-
drome virus (PRRSV) are the most common pathogens causing 
PRDC; these pathogens cause severe respiratory disorders and 
interfere with pig immune function. Classical swine fever (CSF) is 
a highly contagious disease. In many countries vaccination is the 
main strategy for protection against CSF. Notably, CSF vaccine 
is generally administered after weaning. Therefore, determining 
whether the CSF vaccine effi  cacy is infl uenced by PRDC in pigs is 
warranted. 
Materials and Methods
Based on routine pathogen screening and polymerase chain 
reaction (PCR) analysis results, this study selected 2 farrow-to-
fi nish pig herds with a history of PRDC infection for more than 3 
years. Thirty 4-week-old weaned piglets were selected randomly 
from each herd and ear tagged. Half of the pigs from each herd 
were housed in the same barn in independent pens with non-
tested weaned pigs (group A). The remaining tested pigs were 
transferred into barrier-separated animal rooms after weaning 
(group B). All tested pigs were provided the same feed. Food 
and water were provided ad libitum. Both groups were vaccin-
ated with 1 dose of Lapinized China (LPC) strain CSF virus at 6 
and 9 weeks of age. Blood samples were collected from each pig 
at 4, 6, 9, 12, and 15 weeks. Clinical signs were recorded during 
regular visits. Competitive enzyme-linked immunosorbent assay 
(ELISA) tests were performed to identify CSF-specifi c antibodies. 
All study protocols were approved by the Animal Care and Use 
Committee of National Pingtung University of Science and Tech-
nology. Data were analyzed using the Student t-test. Values of P 
< 0.05 were considered statistically signifi cant.
Results
Group A pigs from both herds presented marked clinical signs 
of respiratory disorder and had a high mortality rate (4/15; 26.7 
%) during the test period. The cause of death for both herds 
was diagnosed as PRDC, except for the case of 1 pig in herd B. 
However, pigs from group B in both herds did not show remark-
able clinical signs and only 1 pig died due to acute bacterial 
infection. The serologic profi les of pigs from both herds were 
extremely similar. Figure 1 shows the serological examination 
results of herd A pigs. The antibody titers of pigs in both groups 
were similar at diff erent time points; the titer decreased grad-
ually from weaning to 9 weeks of age, increased markedly after 
vaccination, and reached a maximum in 15-week-old pigs. The 
CSFV-specifi c antibody titer in group A and B pigs did not diff er 
signifi cantly at all tested time points. 
Discussion
This study housed 2 groups of pigs at diff erent levels in patho-
gens concentration. The pigs in group A had a higher mortality 
rate and clearer clinical signs of PRDC compared with pigs in 
group B. The CSFV-specifi c antibody titer in 4- to 15-week-old 
pigs did not diff er between the two groups. Unlike previous 
reports suggesting that some pathogens may alter pig immune 
function, this study shows that pathogenic agents have no or 
little eff ect on the effi  cacy of CSF vaccination in PRDC-aff ected 
pigs.
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Porcilis AR-T: uniformity of titers optimizing passive protection against Atrophic Rhinitis 
Marc Martens1 Alex Eggen2
1. Veterinarian, Nistelrode, Netherlands; 2. Veterinarian, Malden, Netherlands
Introduction
The infection in piglets that results in Progressive Atrophic 
Rhinitis (PAR) takes place in the fi rst weeks of life. Sorensen 
(1990) reported the relationship between high titers against 
Pasteurella Multocida Toxin (PMT) and the absence of turbinate 
atrophy. In the swine industry, uniformity of batches is import-
ant at all stages of production. To ensure this level of consistency 
throughout the production system, all piglets need to obtain the 
same high level of protection. 
Materials and Methods
Trial 1 Breeding stock was classifi ed according to their titer 
against PMT. (Ridremont, B. et al IPVS 2006). Serological profi les 
were undertaken on 135 farms, selected by veterinarians, with 
a history of persistent minor or major PAR problems in spite of 
vaccination with Porcilis AR-T. Anti-PMT titers were assessed 
and the animals were grouped according to titer and age. Farms 
were classifi ed according to the percentage of animals in the 
diff erent qualitative groups. Advice on the correct vaccination 
scheme was given to farmers and some farms were checked 
again, 6 or 10 months later, to determine whether the quality of 
the serological profi le had improved. The following classifi cation 
was used on both occasions. Excellent: when 80% of both age 
groups had a high titer; Good: when 50% of both age groups 
had a high titer; Average-1: when 30-80% in the old sows, and 
up to 30% in the young sows had a high titer; Average-2: when 
30-60% in the young sows and up to 20% in the old sows had 
high titers; Insuffi  cient: when less than 20% in both age groups 
had a high titer.
Trial 2 Gilts were vaccinated with either Porcilis AR-T or a 
competitor vaccine (Supat Suwanna et al IPVS 2008) and the 
resulting titers were measured. Both vaccines contain PMT and 
inactivated Bordetella bronchiseptica cells. Gilts of 120 days of 
age were randomly allocated to one of two groups of 12 and 
vaccinated with one or other vaccine in accordance with the 
manufacturer’s instructions and recommended vaccination 
program. The animals were grouped according to their titer 
measured on D42, 2 weeks after the second dose.
Results
Trial 1: In fi gure 1, there is clearly a wide variation amongst 
breeding stock in their titers against PMT, under fi eld conditions, 
despite vaccination. Figure 2 shows that the situation can be 
improved by adopting better vaccination schemes. 
Trial 2: Figure 3 shows the distribution of the gilts vaccinated 
with either Porcilis AR-T or the competitor product over the dif-
ferent log2 groups. 
Figure 1: Percentage of young (P1 and P2) and old sows (P≥3) classi-
fi ed according to their titer (for classifi cation criteria, see above)
Figure 2: Percentage of farms classifi ed according to their titer 
distribution. Arrows indicate improvement after either adjusting the 
vaccination scheme or improving on vaccination compliance 
Figure 3: PMT titers of the two vaccine groups
 Discussion 
The Trial 1data show improvement after an updated vaccination 
schedule with more farms achieving uniformly high titers across 
the diff erent age groups (See farms A and D). Trial 2 shows that 
vaccines diff er in their ability to induce homogeneous titers in 
sows. The combination of Porcilis AR-T achieving optimal titers 
and the correct vaccination schedule led to the best results.
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The prevalence of DNT and BfrZ genes in Bordetella bronchiseptica 
Iwona Markowska-Daniel; Katarzyna Stepniewska; Kinga Urbaniak; Zygmunt Pejsak
National Veterinary Research Institute, Pulawy, Poland
Introduction
Bordetella bronchiseptica (Bbr) is worldwide spread pathogen of 
pigs’ respiratory tract. When infecting the pig alone it may cause 
mild form of atrophic rhinitis (AR) called NPAR, while invading 
the respiratory tract in cooperation with Pasteurella multocida 
(Pm) it may cause progressive changes characteristic for PAR. 
Among diff erent factors infl uencing the pathogenic properties 
of Bbr dermonecrotoxin (DNT) possessing cytotoxic properties 
as well as the factor involved in iron acquisition and transport, 
necessary for Bbr replication and survival, are the most import-
ant (1, 2, 4). 
The aim of the study was the detection of the exogenous ferric 
siderophore receptor gene - BfrZ gene and DNT gene in Bbr 
strains existing in nasal cavities of healthy and diseased pigs and 
estimation the correlation between the presence of both genes 
in Bbr. 
Materials and Methods
Samples. The prevalence of BfrZ gene was checked in 280 DNA 
samples in total. From this number 150 DNA samples were 
obtained directly from nasal swabs of pigs, raised in 19 farms, 
located in 10 provinces. Because symptoms of PAR were ob-
served in some of the farms all DNA samples extracted directly 
from the swabs were previously tested by PCR with the primers 
specifi c for DNT gene of both, Pm and Bbr. 99 DNA samples were 
obtained from Bbr cultures on G20G agar base in which the 
presence of DNT gene was previously confi rmed. The remaining 
31 samples were obtained from Bbr cultures negative in PCR 
specifi c for DNT. 
PCRs. DNA was extracted using Genomic DNA Prep Plus Kit (A&A 
Biotechnology). Detection of DNT in Pm based on Register’s 
procedure with some ours modifi cations (5). Detection of DNT 
and BfrZ in Bbr based on PCR protocols elaborated by ourselves 
(3). The predicted sizes of amplifi ed DNA were 501bp, 224 bp 
and 368bp, for DNT Pm, DNT Bbr and BfrZ, respectively. The PCRs 
were performed in 25μl mixture containing 10xPCR Gold Buf-
fer, 25mM MgCl2 solution, polymerase AmpliTaq Gold 5U/mL, 
10mM dNTPs, 20pM of each primer and water free from DNAse 
and RNase.
Results
One hundred fi fty (100%) DNA samples extracted directly from 
nasal swabs were positive in PCR test for detection of DNT Bbr. 
From this number 59 samples (39.3%) possessed BfrZ gene. 
The presence of DNT Pm was evidenced in 23 out of 150 (15.3%) 
tested samples. 13 (8.6%) of them possessed also BfrZ gene. In 
10 remaining samples lack of BrfZ gene was evidenced. 
Among 99 Bbr isolates possessing DNT gene BfrZ gene was 
found in 51 samples (51.5%). The lowest number of positive 
results was obtained in case of Bbr strains which did not possess 
DNT gene. From 31 tested strains only in 5 (16.2%) the BfrZ gene 
was detected.
Discussion 
Bordetellaceae have wide range of ferric siderophore receptors 
genes but BfrZ gene, which was used in our study, is present 
only in Bbr genome so PCR test for its detection can be used as 
species specifi c assay.
The results obtained in our study demonstrate that over half of 
analysed strains (51.5%) have both, ferric siderophore receptor 
and dermonecrotoxin genes. Additionally we evidenced that 
BfrZ gene is present in both types of Bbr strains - those with, as 
well as those without DNT gene. However the highest number 
of positive results in PCR with primers specifi c to BfrZ gene was 
obtained in Bbr strains possessing DNT gene. Lower percent-
age of positive results in PCR test for BfrZ gene detection were 
obtained when PCR was performed with DNA extracted directly 
from nasal swabs. The lowest number of positive results was 
received in the group of Bbr strains, which don’t present DNT 
gene. 
Moreover, the correlation between the presence of BfrZ and DNT 
genes, especially in the case of bacterial culture, was evidenced. 
There is no doubt that among Bbr strains which don’t possess 
BfrZ gene there is high probability of occurrence of DNT gene. 
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Introduction
In Australia, increasing numbers of pigs are housed on bed-
ding (straw or rice hulls) in custom-built sheds (ecoshelters, 
hoops) instead of on concrete (partial or full slats) in ‘traditional’ 
sheds.1 A potential disadvantage compared with traditional 
sheds having under-fl oor effl  uent drains, is that the deep litter 
may only be cleaned out when the pigs are removed, giving 
the pigs ready access to their faeces for the entire period of 
their stay in the shed. Proliferative enteropathy (PE) is an enteric 
disease of pigs caused by the intracellular bacterium Lawsonia 
intracellularis (L. intracellularis). Its major eff ects include poor 
growth and diarrhoea or sudden death and dysentery.2 This 
project was designed to investigate the ecology of L. intracellu-
laris herd infection of pigs raised in ecoshelters on deep litter 
bedding, compared with those raised in ‘traditional’ pig housing 
(concrete-based).
Materials and Methods
Pigs (Large White x Landrace) were reared on 6 diff erent 2-site 
(weaner/grow-out) commercial farms. The study was repeated 
on 2 of the sites. Pigs were transferred at 8-10 weeks of age to 
grow-out farms (4 traditional, 4 ecoshelters). A group of 65 pigs 
per farm was identifi ed and blood samples collected at transfer 
to the grow-out farm, and at 16 and 22-24 weeks of age. Sera 
were tested using an ELISA according to the manufacturer’s in-
structions (BioScreen ELISA, Synbiotics, France). Factors aff ecting 
a pig being test-positive were analysed using logistic regression 
(Generalised Linear Mixed Model, GenStat Release 12). Housing 
(traditional/ecoshelter) and age of pig (weaner, grower, fi n-
isher) were included in the model as fi xed eff ects, and farm as a 
random eff ect. There was no interaction between housing and 
age of pig. The positive predictive value and negative predictive 
value of the ELISA were used to estimate seroprevalence and 
standard errors.
Results
There was no eff ect of housing type of test-positive status (F = 
0.00; df = 1, 14; P = 1.00). Mean seroprevalence was identical 
in pigs housed in traditional (36.3%, SE 19.8%) and ecoshelter 
(36.3%, SE 26.6%). There was a strong eff ect of age, with test-
positive status/seroprevalence increasing steadily with age (F = 
16.3; df = 2, 14; P = < 0.001 (Table 1). 
Table 1: Model-based test-positive results with standard errors, 
expressed as percentages from 8 groups of 65 pigs/group housed on 6 
farms for L. intracellularis-specifi c antibodies.
Age Test +(%) SE(%) Prevalence(%) SE(%)
Weaner 1.9 1.9 4.4 2.8
Grower 65.7 12.9 65.4 17.9
Finisher 81.1 9 80.2 12.4
Discussion
There were substantial increases in the seroprevalence of L. 
intracellularis–specifi c antibodies with increasing age of pigs. 
This appeared to be unrelated to the use of bedding at the fat-
tening stage i.e. under the conditions of this study, deep litter 
systems did not appear to pose a greater risk to pigs of infection 
compared with traditional concrete-based systems.
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Pig-associated Lawsonia intracellularis in various stages of on-farm Dipteroid ﬂ y species 
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Introduction
Insects on pig farms can cause loss in various ways, including 
a potential mechanical or biological vector ability to spread 
disease within and between farms. This may conceivably include 
re-infection of eradication or start-up project farms by insects 
travelling from adjacent farms when infected with the agent 
in question. Proliferative enteropathy (PE, or ileitis) is one of 
the most ubiquitous of pig infections worldwide, but there 
is little work on possible vectors, such as insects. Most infec-
tions in pigs are gained by pigs contacting infected faeces or 
faecal-contaminated materials. Other studies have indicated 
that fl ies and some fl oor-dwelling insects, such as cockroaches 
and beetles, may be capable of carrying other agents such as 
PRRS, pseudorabies (Aujesky’s disease), Salmonella and E coli 
for signifi cant periods on commercial pig and chicken farms. 
Increases in farm bedding usage will presumably also increase 
potential infected vectors. This study aimed to address if insects 
on pig farms could be infected with Lawsonia intracellularis and 
whether this was associated with specifi c insect types.
Materials and Methods
On 15 farm study sites within England and Ireland, invertebrate 
communities were regularly trap-collected, counted and sorted 
into genus and species groups. The fl y (Diptera) community was 
generally dominated by Musca domestica (house fl y, n=14 farms), 
but also included Muscina stabulans (false stable fl y, n=9), Ophyra 
spp (garbage fl y, n=10), Drosophila (fruit fl ies, n=8), Stomoxys cal-
citrans (stable fl y, n=2) and Syrphidae containing Eristalis species 
(hover fl ies, n=2); Blatta orientalis cockroaches were noted on 2 
farms. Total DNA was extracted from at least ten 12-week-old pig 
feces on each of the 15 farms and also from available adult, pupae 
and larvae samples of each Dipteroid group. Each DNA sample 
was tested for the presence of Lawsonia intracellularis DNA by 
specifi c PCR. A wide selection of Lawsonia-positive PCR products 
and controls, were tested by the variable number tandem repeat 
isolate typing (VNTR) method. This method distinguishes fi nely 
among isolates in intergenic Lawsonia DNA zones and so distin-
guishes between isolates from diff erent farm systems. This VNTR 
testing was conducted by blinded technicians who did not know 
the origin of each DNA sample.
Results
Lawsonia-specifi c PCR products were routinely detected in 
weaner-grower pig faeces on 13/15 farms. On these farms, 12 
were positive for numerous Musca domestica; total DNA ex-
tracted from the Musca collected on 5 farms where this was the 
dominant fl y type, was also positive for Lawsonia DNA PCR reac-
tions. All sets of adults, pupae and larvae of the Syrphidae hover 
fl y Eristalis sp, collected from the only two farms positive for this 
fl y, also had positive Lawsonia DNA reactions. Fruit fl ies were not 
found to be positive. Sub-typing of the Lawsonia DNA obtained 
from pigs and from insects by variable number tandem repeat 
analysis indicated that the same VNTR isolate type occurred 
within the positive farm pigs and the dominant pig-associated 
dipteroid fl y stages on the same farm. 
Discussion
This study indicates that the Dipteroid fl ies associated with 
pigs and pig bedding feed troughs and fl ooring, such as Musca 
domestica and Eristalis spp had the most likely potential to 
carry and transmit Lawsonia intracellularis. In contrast, Dro-
sophila fruit fl ies, which do not have signifi cant pig or pig faeces 
interactions on-farm were not found to be positive for Lawsonia. 
This suggests that a program aimed at reducing infection levels 
or re-infection with this agent should include not only Enteri-
sol ileitis™ vaccination and appropriate pig medication, such 
as pleuromutilins or macrolides, but also anti-insect popula-
tion control measures, targeted at those insects in association 
with pigs, particularly in summer months when fl y populations 
peak. The infection of Dipteroid fl y insects in diff erent stages of 
growth also indicates that some transmission between farms 
may be possible, including to nearby farms in start-up situations, 
by infected adult fl ies. We are continuing these studies with 
experimental challenge exposure studies in Musca fl ies.
.
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Introduction
Proliferative enteropathy (PE) varies in its clinical presentation, 
ranging from acute intestinal haemorrhage and sudden death of 
pigs, to diarrhoea and weight loss, or sub-clinical disease, where 
histological lesions of PE occur in the absence of diarrhoea1. 
Clinical PE is a costly disease because it reduces weight gains 
and feed conversion effi  ciency (FCE) in pigs by as much as 50% 
and increases variation in growth2. The impact of sub-clinical 
PE is diffi  cult to estimate because many producers are unaware 
that sub-clinical PE is present in their herd. The aim of this study 
was to quantify the impact of sub-clinical PE on feed intake and 
live-weight gain. 
Materials and Methods
Thirty six male hybrid weaner pigs (Large White x Landrace) 
were randomly allocated at 13.8 ± 1.0kg into 2 treatments: pigs 
infected with L.intracellularis, and a cohort of uninfected pigs. 
Pigs were housed in individual pens, with strict quarantine 
between treatments (separate rooms). Serology and faecal PCR 
monitoring of pigs prior to challenge indicated that all pigs 
were naïve to L.intracellularis. At 9 weeks of age, one group of 18 
pigs was orally challenged with 5.9 x 109 viable L.intracellularis 
extracted from a PE-aff ected mucosa, and the control group 
was inoculated with phosphate buff ered saline. The consistency 
of pig’s faeces was scored daily as either normal or diarrhoeic. 
Blood collected at 0, 28 and 38 days post inoculation (pi) was 
tested for L.intracellularis- specifi c IgG using an indirect fl uores-
cent antibody test (IFAT). Faeces collected twice per week from 
0 to 35 days pi was tested for L.intracellularis DNA by a conven-
tional PCR. Feed intake and pig weights were measured weekly 
but changes were analysed over 3 periods: pre-infection (day 
-14 to day 0), early infection (0 to 21 days pi) and late infection 
(21-42 days pi). 
Results
L.intracellularis infection was demonstrated by faecal PCR and 
IFAT between 14 and 38 days pi in all pigs challenged with 
L.intracellularis. The majority of infected pigs (>80%) were 
sub-clinically aff ected, but L.intracellularis infected pigs had a 
signifi cantly higher probability of diarrhoea than control pigs 
between day 22 and 26 pi. L.intracellularis infection did not 
signifi cantly reduce pig weights or weight gains, but did sig-
nifi cantly increase variation in pig weight in the early infection 
period, as seen in the error variance of random eff ect models 
predicting pig weight as a function of infection period. When 
L.intracellularis infected pigs started to recover, their rate of 
weight increase was signifi cantly greater (P<0.05) in the late 
infection period than in the early infection period, unlike for the 
uninfected pigs. L.intracellularis infection signifi cantly decreased 
feed intake over the early infection period (P=0.017), but not in 
the pre-infection or late infection periods (P= 0.668 and P=0.416 
respectively). Pig weight was a strong covariate for feed intake in 
each period (P<0.001).
Discussion
This study highlighted the reduced feed intake and the large 
variation in weight in a group of pigs sub-clinically aff ected with 
PE. While animal genetics plays a signifi cant role in weight gain, it 
alone can not account for the observed variation in pig weights 
with sub-clinical PE. It is likely that diff erences in the host’s im-
mune status or intestinal microfl ora may explain the variation in 
weight between infected pigs. Control of L.intracellularis infec-
tions in herds with sub-clinical PE can minimize production losses 
and improve profi tability for pig producers.
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Prevalence of Lawsonia intracellularis infection in grower-ﬁ nisher pigs in Thailand during 2008-2009
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Introduction
 Proliferative enteropathy (PE) or ileitis is an important enteric 
disease in swine industry worldwide. It is caused by an obligate 
intracellular bacterium, Lawsonia intracellularis (LI). In general, 
the specifi c immunoglobulin G (IgG) against LI infection is 
usually detectable 2-3 weeks after infection. This IgG response 
can be found in serum for upto 12 weeks after exposing to the 
bacteria, depending on the form of ileitis and the severity of the 
disease (1). 
This IgG response can be used as a marker for screening on the 
status of LI infection in the herd. Several serological tests have 
been developed and available for use. IleiTEST® is an indirect 
fl uorescent antibody test that are commercialy available. In 
Thailand, we have little information about the dynamic and the 
prevalence of LI infection in grower-fi nisher pigs. The objective 
of this study was to estimate the prevalence of LI infection in 
grower-fi nisher herds in Thailand using IleiTEST®. 
Materials and Methods
 This study was conducted in 40 commercial grower-fi nisher 
swine herds located in Northern, Southern, Western, Eastern, 
Middle and Northeast part of Thailand during 2008-2009. Eight 
blood samples were randomly collected from each age of pigs 
as cross-sectional at 4, 8, 12, 16 and 20 weeks of age. A total of 
1,600 blood samples were submitted to the diagnostic labora-
tory at Faculty of Veterinary Medicine, Kasetsart University, 
Kamphaengsaen campus. All serum samples were measured for 
serum IgG antibody against LI infection by using IleiTEST®, which 
was provided by Elanco Animal Health. 
Results and Discussion
 The specifi c antibodies against LI infection were found in 36 
of 40 (90%) grower-fi nisher herds in Thailand. In those positive 
herds, it shows that at least one-time point of pigs in the produc-
tion system was exposed to the bacteria. Eighty percents of herd 
were positive with the IleiTEST® at 4 weeks of ages (Figure 1). It 
is more likely that the positive results may be due to the passive 
antibody from sow to their piglets. Guedes et al (2002) found 
that passive immunity can be found in piglets up to 5 weeks of 
age (2). If this is the case, it indicated that most of the breeding 
herds in Thailand have the natural infection of LI.
The peak of herd prevalence was 85% when pigs were 12 weeks 
of age. Unfortunately, the prevalence of LI infection in grower-
fi nisher herd decreased to 62.5% at 20 weeks of ages. 
Figure 1. Herd prevalence of LI infection at each time points from 40 
herds of grower-fi nisher pigs in Thailand
Figure 2. The average of percent of positive samples from 40 herds at 
each time point 
Overall, the dynamic of LI infection in grower-fi nisher herd in 
Thailand was summarized in Figure 2. The results from this in-
vestigation suggested that the prevalence of LI infection is more 
likely increasing during 8-12 weeks of age of pigs. Therefore, 
several strategies for treatment and control of LI infection might 
need to be developed and applied during that period. 
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Introduction
Lawsonia intracellularis (L. intracellularis) is an obligate intra-
cellular bacterium causing porcine proliferative enteropathy 
(PPE), an enteric disease condition aff ecting growing and 
fi nishing pigs. The ileal mucosa is thickened due to proliferation 
of immature cryptal enterocytes (3). Porcine circovirus type 2 
associated diseases (PCV-AD) include systemic or localized infec-
tion. The later recognized: PCV-associated pneumonia, enteritis, 
reproductive disorders and dermatitis nephropathy syndrome 
(4). Main histological lesions consist of lymphocyte depletion 
together with histiocytic and multinucleate giant cell infi ltration 
in the lymphoid organs and, in a wide range of tissues with the 
presence in some cases of inclusion bodies (4).  
The aim of the present study was to report a case of granulo-
matous enteritis (GE) and regional granulomatous lymphaden-
itis associated with L. intracellularis infection in growing and 
marked pigs.
Materials and Methods
A total of 310 pigs (23.3 weeks-old) with an average of 113 kbw 
were examined in 2 slaughter inspections. Ileum samples, taken 
at 10 cm of the ileocecal junction and mesenteric lymph nodes 
were collected from 46 randomly selected pigs. Samples were 
fi xed in 10% buff ered formalin for histopathological (HP) and 
immunohistochemical (IHC) studies against PCV-2 and L. intra-
cellularis. HP results of intestine were evaluated for statistical 
association by Chi square test. 
Results
Characteristic histopathological lesions of PPE such as entero-
cyte hyperplasia with the absence of goblet cells were ob-
served at the level of cryptal epithelia. In the lamina propia and 
Peyer´s patches lesions consisted of infi ltration of histiocytes, 
multinucleate giant and epitheloid cells. In the regional mesen-
teric lymph-node lesions were similar to the above described 
with a diagnosis of granulomatous lymphoadenitis. There was 
statistical signifi cance association between PPE and granulo-
matous lesions (p = 0.0029). By IHC, strong immunolabeled of 
L. intracellularis antigen was detected in 34 samples of ileum 
(73.9%) and in 26 samples of mesenteric lymph-nodes (56.5%). 
Whereas, slight PCV-2 antigens was observed in 1 ileum (2.2%) 
and 3 lymph-nodes (6.5%) samples. These samples also showed 
a strong immunostaining against L. intracellularis. All samples 
were negative for Mycobacterium spp or fungi by PAS and Ziehl 
Neelsen stains. 
Discussion
Previously studies reported the identifi cation of L. intracellularis 
associated with granulomatous enteritis (2, 5). However, few 
samples were available and also PCV-2 antigen was identifi ed (2, 
5). In this study results showed statistical signifi cant association 
between PPE and GE lesions. Further, immunostaining against L. 
intracellularis was strongly positive in multinucleated giant cells 
and histiocytes. In addition, PCV-2 antigens were not found in 
Peyer´s patches with granulomatous lesions and only a few posi-
tive cells were observed in the lamina propria. Lesions induced 
by L. intracellularis are restricted to enterocytes, but ocassionally 
epithelial cells and bacterium were found in mesenteric lymph 
nodes (5, 6). In the study, granulomatous lesion in lymph nodes 
was also associated with strong immunostaining of L. intracellu-
laris in macrophages, histiocytes and giant cells. According with 
the pathogenesis of the granulomatous infl ammation (1), the 
above results might suggest that L. intracellularis may induce a 
granulomatous response, in absence of PCV-2 infection, when 
resolution of lesions and disappearance of the bacterium not 
take place. In this context, the granulomatous enteritis and 
lymphoadenitis could be considered as a part of PPE complex. 
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Introduction
Lawsonia intracellularis (Li), curved bacillus Gram (-), intracellu-
lar, does not grow on conventional media in vitro in the absence 
of enterocytes, their presence in the body produces a humoral 
response variable and short-term (1). Therefore, the study of 
cellular response is truly meaningful to characterize and under-
stand the pathogenesis, which has not yet been deepened. 
Aff ects several animal species, mainly in pigs, producing porcine 
proliferative enteritis (PPE) causing stunting and increased 
mortality. The objective of this study is to determine the re-
sponse characteristics of cells involved in the lesions of the small 
intestine (ID) of pigs who were diagnosed by immunoperoxidase 
technique (IPX) and PCR mucosa, the presence of Li.
Materials and Methods
Se trabajó sobre 20 establecimientos confi nados pertenecien-
tes a 7 de las provincias con mayor producción de cerdos de la 
República Argentina. Fueron muestreados los ileon de un total 
de 60 cerdos con diarrea. Por cada animal se tomaron dos mues-
tras, una a 50cm por delante de la válvula-ileocecal y otra a 10 
cm por delante de la misma, las cuales se procesaron para histo-
patología con H/E. Work was confi ned about 20 stores belong-
ing to 7 provinces with higher production of pigs in Argentina. 
The ileum were sampled a total of 60 pigs with diarrhea. For 
each animal were taken two samples, one at 50 cm anterior to 
the ileocecal valve, and another 10 cm in front of it, which were 
processed for histopathology with H / E. We searched for lesions 
compatible with EPP as villus atrophy, enlarged and branched 
crypts, hyperplasia of immature enterocytes in the crypts and 
absent or fewer goblet cells. The samples processed by IPX were 
considered positive when there was a brown color reaction in 
the luminal epithelium and criptal and special attention was 
paid to the mononuclear infl ammatory response in lamina 
propria and submucosa. In addition, samples were processed to 
determine the Li Ag by PCR mucosa.
Results
Five of the 60 pigs sampled were positive for IPX. Three of 
them showed hyperplastic reaction in the epithelium of the 
crypts elongated and branched in macrophages, activated 
macrophages reticular appearance and giant cells in the lamina 
propria. The other two animals showed no reaction in the deep 
epithelium, as these despite being enlarged but showed goblet 
cell hyperplasia. Was observed in these ID staining in a few 
macrophages and giant cells of the lamina propria and in some 
macrophages in the submucosa. Furthermore, in all the samples 
had large numbers of immature lymphocytes and plasma cells. 
In the epithelia of villi and crypts increased the number of 
intraepithelial lymphocytes. These 5 pigs were also positive with 
PCR mucosa (PCR F).
Portion of ileum HE IPX+ PCRM+
50 S/L (n=1) 0/1 0/1
50 C/L (n=60) 5/60 4/58
10 S/L (n=0) 0/0 0/0
10 C/L (n=60) 5/60 4/58
Discussion
It is noteworthy that the pathogenic action of Li can be deter-
mined by the histopathological lesions and the technique of IPX. 
However, the cellular response that has deserved special atten-
tion because it is an infi ltration and / or histiocytic proliferation 
and hyperplasia of intraepithelial lymphocytes that remain 
present even when the epithelial lesions have disappeared, as 
indicated in animals with hyperplasia goblet cells (2). It would 
be important to deepen the studies of the pathogenic mechan-
isms of Li mainly related to apoptosis, and cellular response it 
generates, through the marking of diff erent cell types acting. 
Thus diff erentiating it from other agents such as circovirus and 
/ or Yersinia that produce similar lesions and granulomatous 
responses (3). Moreover, these results related to the pathogen-
esis would allow us to begin to explore possible associations 
with Li circovirus in clinical presentation of PMWS as seen in the 
caseloads of our pathology and histopathology.
References:
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Detection of L. intracellularis, B. hyodysenteriae and B. pilosicoli in German wild boars
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Department of Veterinary Clinical Sciences, Justus-Liebig-University, Giessen, Germany
Introduction
Wild boars are recognized as a potential reservoir of pathogenic 
microorganisms for domestic pigs. Brachyspira hyodysenteriae (B. 
h.) and B. pilosicoli (B. p.) are important swine pathogens causing 
swine dysentery and porcine intestinal spirochetosis, respect-
ively. Because of diffi  culties in culturing Brachyspira species and 
due to the obligate intracellular parasitism of L. intracellularis 
(L. i.) (Ileitis), diagnostics of these bacteria primarily relies on 
the detection of genomic sequences. Small amounts of these 
bacteria can often be isolated from subclinical cases. Few data 
exist about the occurence of Brachyspira and Lawsonia spp. in 
wild boar populations. Infections with L. i. have been demon-
strated in single wild boars from Spain (Segalés et al. 2001), and 
Brasil (Zlotowski et al. 2008; commercial herd). Jacobson et al. 
(2005) did not fi nd Brachyspira spp. or L. i. in Swedish wild boar 
samples. L. i. was detected in 29.6% and 9.1% of free ranging 
and enclosed wild boars from Czech Republic (Tomanova et al. 
2002; Dezorzova-Tomanova et al. 2006). Nyree et al. (2009) found 
18.9%, 8.1% and 0.45% of 222 Australian feral pigs infected with 
L. i., B. h. and B. p. The aim of the present study was to determine 
the prevalence for the three species in German wild boars.
Materials and Methods
Samples from ileal mucosa of 165 wild boars were collected 
from 19 hunting grounds situated in fourteen of the 16 federal 
states of Germany between November 2005 and March 2006. 
The town states Hamburg and Bremen were not sampled. Wild 
boars were gathered after the hunting at central places. The 
wild boars were on average 12 months (1 to 84 months) old, 
with an average carcass weight of 34 kg (6 to 110 kg). Samples 
were taken half an hour to 2 hours after death with fresh, sterile 
disposable gloves and scalpels, and stored at -20 °C until further 
usage. DNA was extracted from 25-50 mg of tissue sample using 
the Qiagen Viral RNA Mini Kit (Qiagen, Hilden, Germany). Diff er-
entiating primers and probes for conventional and real-time PCR 
targeted the nox gene of Brachyspira spp. and the aspA gene of 
L. i. Real-time PCR was performed with 2.5μl of the isolated DNA 
on a 7300 Real Time PCR System (Applied Biosystems, Germany). 
The analytical sensitivity for the real-time PCR assay, expressed 
as limit of detection (LOD) was 14, 26, and below 10 DNA copies 
for B. p., B. h., and L. i., respectively. The analytical sensitivity for 
the conventional PCR assay was below 10 DNA copies for all 
three species.
Results
None of the intestines sampled did show any gross pathological 
signs of enteritis. Pathological histology was not available. The 
overall prevalence for L. i., B. h. and B. p. was 20.6%, 2.4% and 
12.1%, respectively. None of the three agents was detected 
in 68.5% of the wild boars; 17.0%, 1.2% and 9.7% were mono-
infected with L. i., B. h., and B. p., respectively; 2.4% and 1.2% were 
mixed infections with L. i./B. p. and L. i./B. h., respectively. 84.2% 
of the hunting grounds were found positive for at least one of 
the three agents; L. i., B. h. and B. p. were detected in 15.8%, 0.0% 
and 10.5% of the hunting grounds as monoinfections; 36.8% 
and 21.1% of the hunting grounds were positive with L. i./B. p. 
and L. i./B. h., respectively. Numbers of bacteria per sample were 
consistently low, and none of the positive samples was above the 
quantitation limit of 100 DNA copies per PCR reaction.
Discussion
This is the fi rst time that B. h. was detected in genuinewild boars. 
Detection rates substantiate a wide distribution of the three 
agents in wild boar populations. Prevalence of L. i. corresponds 
well with those reported for the Czech Republic and for feral 
pigs in Australia. The occurrence of B. h. is rather low. Missing of 
gross pathological lesions and the low number of bacteria per 
sample argue for a commensal role. Further research is needed 
to get insight into the epidemiological impact of these results.
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Mixed infections with L. intracellularis, B. hyodysenteriae, and B. pilosicoli in faecal ﬁ eld samples 
from German pig herds, simultaneously detected and quantiﬁ ed by realtime multiplex PCR
Gerald Reiner1 Marion Kixmöller2 Hermann Willems1
1. Department of Veterinary Clinical Sciences, Justus-Liebig-University, Giessen, Germany; 2. Novartis Animal Health, München, Germany
Introduction
Brachyspira (B.) hyodysenteriae and B. pilosicoli are important 
swine pathogens causing swine dysentery and porcine intestinal 
spirochaetosis, respectively. Because of diffi  culties in culturing 
Brachyspira species and due to the obligate intracellular parasit-
ism of L. intracellularis diagnosis of these bacteria primarily relies 
on the detection of genomic sequences. There is a close relation 
between the faecal load of B. hyodysenteriae and L. intracellularis 
and the clinical outcome of the infection (1, 2). Small amounts of 
these bacteria can often be isolated from subclinical cases and 
the positive result of a conventional PCR is often misinterpreted 
and does not lead to the causal diagnosis. Thus, to provide 
information from a clinical point of view, it is advisable to detect 
and quantify the putative agent of disease. We have developed 
a multiplex real-time PCR (mrtPCR) assay for the simultaneous 
detection and quantitation of L. intracellularis, B. hyodysenteriae 
and B. pilosicoli from faecal samples. The mrtPCR was applied 
to study qualitative and quantitative distribution of the three 
agents in commercial herds from Germany, in order to gain 
information on prevalences, bacterial loads, and the occurrence 
of mixed infections. 
Materials and Methods
A total of 1176 individual faecal samples from 95 herds (includ-
ing 33.000 sows, 64.000 piglets and 145.000 fattening pigs) were 
sent in by 48 practitioners in the course of a diagnostic study. 
All samples were accompanied by a detailed questionnaire. For 
DNA extraction 300 mg of faeces were thoroughly mixed and 
applied to a Quiagen extraction kit. Finally, DNA aliquots ex-
tracted from 12.5 mg faeces were used for mrtPCR. Primers and 
probes for real-time PCR were designed with the Primer Express 
software (Applied Biosystems) targeting the nox gene of Brachy-
spira and the aspA gene of L. intracellularis. Gene sequences 
were retrieved from the Genbank database. Real-time PCR was 
performed on a 7300 Real Time PCR System (Applied Biosystems, 
Germany). The limit of detection was below 1 x 103 cells/g of 
faeces for all three species.
Results
From the individual samples, 12.7, 8.3, and 3.2 percent were 
positive for L. intracellularis, B. hyodysenteriae and B. pilosicoli, re-
spectively. The relation of mono- to mixed infections per sample 
was 70.2%/29.8%. 
Regarding herds, 48.4, 24.2, and 31.6% were positive with L. 
intracellularis, B. hyodysenteriae, and B. pilosicoli, respectively. 
68.4% of the herds were infected with at least two of the three 
organisms. 60.1%, 82.6%, and 73.3% of infections with L. intra-
cellularis, B. hyodysenteriae, and B. pilosicoli, respectively, were 
mixed infections. Medians for the log number of cells/g of faeces 
(with 5% and 95% percentiles in brackets) were 3.3 (2.2-7.2), 5.9 
(2.9-7.5), and 3.2 (2.1-5.8) for L. intracellularis, B. hyodysenteriae, 
and B. pilosicoli, respectively. Incidence and severity of diarrhea 
were correlated with the quantity of B. hyodysenteriae and B. 
pilosicoli, but not with that of L. intracellularis. Haemorrhagic 
diarrhea was associated with the presence of B. hyodysenteriae 
and was most severe with mixed infections of the two Brachy-
spira species. Of the positive faecal samples, 60%, 60%, and 80% 
did not correspond with the tentative clinical diagnosis of ileitis, 
dysentery, and both diseases, respectively.
Discussion
In conclusion, the three economically important pathogens 
have been shown to have a wide distribution among herds. The 
overlapping clinical signs, the relatively high incidence of mixed 
infections and the occurrence of B. pilosicoli in herds can lead 
to signifi cant misinterpretations in the fi eld, underlining the 
impact of a fast and reliable molecular diagnosis. The introduced 
mrtPCR can be a relevant tool in the diagnosis and prognosis of 
infections with L. intracellularis, B. hyodysenteriae, and B. pilosicoli.
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Demonstration of Lawsonia intracellularis in necrotic ileitis cases by immunohistochemistry
Dinko Novosel1 Zoran Lipej1 Željko Grabarević2
1. Croatian Veterinary Institute, Zagreb, Croatia; 2. Veterinary Faculty, Zagreb, Croatia
Introduction 
Proliferative enteropathy (PE) caused by Lawsonia intracellularis 
is well known common intestinal and one of most economically 
important disease. There are several diff erent syndromes of PE - 
porcine intestinal adenomatosis, hemorrhagic enteropathy and 
necrotic enteritis [1]. Immunohistochemistry (IHC) continue to 
be golden standard as diagnostic tool [2]. Most typical histo-
pathological lesions is absence of goblet cells and little evidence 
of infi ltration of infl ammatory cells, which is not common [3]. 
The aim of this study was to detect and describe morphological 
fi ndings possible presence of PE syndromes in Croatian pig 
production units.
Material and Methods 
From three diff erent fattening farms was reported onset dying 
without clinical symptoms or with greyish diarrhoea shortly 
before death. Totally, 11 animals were necropsied and after com-
pletely post-mortem examination three samples of ileum, before 
ileocecal valve were collected in 10% buff ered formalin. Tissue 
was routinely processed until paraffi  n blocks. Stained with H&E 
and for immunohistochemical detection Lawsonia intracellularis 
is used anti Lawsonia intracellularis (Euroclone ®) monoclonal 
antibodies according previously described protocol [4].
Results 
In ileum of 5 animals strong Lawsonia intracellularis signal in 
enterocytes were detected by IHC (Fig. 1.). Histopathological 
lesions in all 5 positive animals were uniform in distribution. 
The mucosa is thickened by necrosis of apex of villi. The strong 
infl ammatory reaction with lymphocytes and globular leuco-
cytes between villi was clearly seen (Fig. 2). In crypts were still 
vital immature epithelial cells. The most prominent fi ndings 
were absence of goblet cells.
Discussion 
The present study describes the ileum lesions associated with 
Lawsonia intracellularis infection in fattening pigs. In our cases 
most prominent histopathological fi ndings were necrosis of 
apex of villi and absence of goblet cells. A strong infl ammatory 
reaction with lymphocytes and globular leucocytes was seen 
which is in contrast with previous studies which reported very 
mild infl ammatory infi ltration [3] 
According to histopathological fi ndings and positive IHC signal 
in enetrocytes of swine with necrotic ileitis are fulfi lled key 
criteria which confi rmed the fi rst objective fi ndings of Lawsonia 
intracellularis as PE causative agent in Croatia. As far as we know 
this is the fi rst report about necrotic ileitis in pig population 
in Croatia. Nevertheless, infection with Lawsonia intracellularis 
caused considerable economic losses in pig production during 
many years ago.
Figure 1. Positive signal in enterocytes. IHC anti-Lawsonia intracellu-
laris, 40x
Figure 2. Strong infl ammatory reaction and absence of goblet cells. 
H&E, 20x
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Prevalence of faecal Lawsonia intracellularis shedding in piglets: 
A European ﬁ eld study using Lawsonia FIRSTtest® 
Annick Saives2 Vincent Auvigne1 Susana Lapuente1
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Introduction
Lawsonia intracellularis (LI) is a major bacterial pathogen in pigs, 
responsible for ileitis (Proliferative Enteropathy), a digestive dis-
ease that greatly reduces the animal’s performance in the grow-
ing and fi nishing stage. The pathogen is endemic worldwide. 
The level of its excretion is variable and is linked to the severity 
of clinical signs (1). It is therefore important to gain a better 
knowledge of the epidemiology of the excretion of Lawsonia, for 
a better, targeted preventive and therapeutic approach. 
Materials and Methods
Lawsonia FIRSTtest® is a new ELISA diagnostic tool designed to 
detect LI in faeces (2). A qualitative result is obtained by com-
parison to a positive control by indication of a color change to 
blue. By validation testing comparing to PCR, it is determined 
that if more than 3 out of 10 samples are positives, the batch is 
considered as shedding LI with a prevalence of at least 40% (3). 
For most herds, a sample size of ten is adequate to determine if a 
farm is positive or negative.
The study was carried out in 2008 and 2009 in 12 European 
countries. 7362 growing pigs of 531 farms were included. On 
138 farms, two or more age groups were sampled. The aver-
age number of fecal samples per age and per farm was 10.8. 
Age (weeks of life) was available for 624 out of the 684 sampled 
batches. When more than one age group was sampled, the 
eff ects of age and herd were studied, using the Wilcoxon 
Match-Pairs Signed Ranks Test and Spearman’s rank correlation, 
respectively. 
Results
The overall individual and batch prevalence was 55% and 82%, 
respectively. The intra-batch prevalence (image. 1) shows a 
bimodal distribution with one subpopulation around the 50 
%-prevalence mark and another subgroup with a prevalence of 
90% or more.
The herd eff ect was confi rmed in this study: if pigs of 16 weeks 
and older were positive, pigs from the same herd in age groups 
11-13 weeks and 14-16 weeks tended to be positive as well. The 
age eff ect was also confi rmed: pigs aged 11-13 weeks shed sig-
nifi cantly less bacteria that those aged 14-16 weeks or 16 weeks 
and older (Tab 1).
Fig. 1: Distribution of the intra-batch prevalence
Table 1: Age pattern and age eff ect in herds with at least 2 sampled 
batches
Discussion
This study confi rms the high prevalence of LI on pig farms (4). 
However, shedding is not homogeneous, as shown by the herd 
and age eff ect. Shedding should therefore be evaluated herd 
level by measuring shedding in 2 diff erent ages in the same 
farm. Sampling should be suffi  cient to assess the intra-batch 
prevalence and to adjust the preventive and therapeutic ap-
proach. Sampling should be standardised to allow for a compari-
son of the results between farms.
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A longitudinal study comparing four diagnostic tests for Lawsonia intracellularis
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Introduction
Lawsonia intracellularis (LI) is a major bacterial pathogen in pigs, 
and is endemic worldwide. An accurate diagnostic is necessary for 
a targeted preventive and therapeutic approach. Available tests 
either measure the immune response or the faecal shedding. The 
aim of the study was to compare the results of four of them.
Materials and Methods
The study was carried out between Dec. 2008 and Apr. 2009, on 
a 300-sow breeding farm, with an all-in-all-out management 
from weaning to slaughter. At weaning (21 days), 20 piglets were 
randomly selected and individually double-tagged. Samples 
(blood and faeces) were taken every two weeks between 3 and 
21 weeks of age. The serological status was determined at the 
LDG lab (Barcelona, Spain), using an IFA test (Ileitest, Elanco) and 
ELISA test (Bioscreen) for LI. Faecal shedding was determined 
at the CReSA laboratory (Barcelona, Spain) using in-house PCR 
and at Labopat (Segovia, Spain) using FIRSTtest®. FIRSTtest® is a 
new antigen ELISA which uses magnetic beads technology. All 
results were qualitative. Doubtful ELISA results were considered 
positive.
Results
All piglets remained in good clinical condition and could be fol-
lowed up during the entire study period. All methods confi rmed 
that the farm was contaminated by LI, although there was a 
diff erence in the percentage of positive animals and the evolu-
tion of the infection depending to the tests. Faecal LI shedding 
was detected by the FIRSTtest® from 5 weeks of age. Between 
weeks 7 and 19, nearly all piglets were positive, although shed-
ding seemed to decrease by 21 weeks of age. PCR detected the 
fi rst excreting piglets by week 11, and shedding only became 
widespread (> 40% of positives) at 17 and 19 weeks of life. Four 
piglets were never found positive for PCR. ELISA only detected 
a few positive animals between 3 and 7 weeks of age, probably 
animals with remaining maternal antibodies. This was followed 
by a massive seroconversion from 13 weeks of age. Between 
13 and 21 weeks of age, the ELISA negative piglets were not 
systematically the same for all time points. The percentage of 
animals positive for IFA evolved little during the study period 
(minimum 30%, maximum 50%). However, two periods can be 
distinguished: between 3 and 9 weeks of age, there is a large 
variation between IFA test results of individual animals, from 
one time point to another. In contrast, between 9 and 21 weeks, 
there is little evolution in the IFA status of the individuals: posi-
tive animals remain positive and negatives remain negative.
Fig. 1: Comparative results of the four tests
Discussion
In the absence of a gold standard, this study has not allowed 
to reach a direct estimation of the sensitivity and specifi city of 
tests. Furthermore, diff erent biological parameters were used for 
the tests (immune response vs. faecal shedding). Nevertheless, it 
can be concluded that, under the study conditions, ELISA allows 
better than IFA to determine the time of seroconversion. The 
results obtained by PCR is consistent with another longitudinal 
study where PCR+ faeces were observed before ELISA serocon-
version (1). This inconsistency might be due to the presence 
of inhibiting factors in the faeces or to intermittent shedding. 
Finally, the FIRSTtest® seems a highly sensitive technique since 
shedding is detected as early as 5 weeks of age. 
These results might aid the veterinary practitioner in the choice 
of test to be used in the fi eld.
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Sub-clinical Ileitis: use of a diagnostic tool, Lawsonia FIRSTtest, to understand the 
excretion of sows and piglets and the impact of Tylan treatments on sows
Annick Saives
Elanco Europe, Brussels, Belgium
Introduction
Lawsonia intracellularis (LI) is a major bacterial pathogen in pigs, 
responsible for ileitis (Proliferative Enteropathy), a digestive dis-
ease that greatly reduces the animal’s performance in the grow-
ing and fi nishing stage. The pathogen is endemic worldwide. 
The level of its excretion is variable and is linked to the severity 
of clinical signs (1). The aim of this study is to control the level of 
shedding of sows and their piglets in 5 farms presenting signs of 
subclinical ileitis and to understand if a Tylan treatment on sows 
could decrease the shedding.
Materials and Methods
Lawsonia FIRSTtest® is a new ELISA diagnostic tool designed to 
detect LI in faeces (2). A qualitative result is obtained by com-
parison to a positive control by indication of a color change to 
blue. By validation testing comparing to PCR, it is determined 
that if more than 3 out of 10 samples are positives, the batch is 
considered as shedding LI with a prevalence of at least 40% (3). 
For most herds, a sample size of ten is adequate to determine if a 
farm is positive or negative.
Five farrow-to-fi nish herds with same gilt source demonstrating 
sub-clinical ileitis at the beginning of the fi nishing period, were 
selected. Baseline level of LI shedding in production sows and 
piglets from these sows after weaning (aged between 5 and 
7 weeks) was measured before treatment. Sample sizes were 
determined based on sow farm size and estimated prevalence. A 
Tylan premix treatment at 5mg/kg for 15 days was administered 
to the animals at the time of placing the sows before farrowing. 
Testing was repeated in sows and piglets to determine eff ect 
due to Tylan administration to sows. 
Percentages of shedding per animal category, before and after 
treatment, were analyzed by using the Mantel Haenszel Chi-
square test adjusted on farms (EPIINFO 3.5.1).
Results
The results of shedding levels for the 5 farms are presented in 
tables 1 and 2 by animal category, before and after treatment. 
Farms were pooled for analysis. Results are listed in Table 1, and 
shown graphically in Figure 1. The inclusion of Tylan in the sow 
ration for 15 days initiated prior to farrowing resulted in de-
creased prevalence of LI as indicated by fecal shedding in both 
sows and piglets.
Table 1: % of shedding level of sows and piglets 
Figure 1: % of shedding before and after Tylan treatment for each 
category of animal
Discussion and Conclusion
This study demonstrates that in herds with sub- clinical ileitis, 
the shedding of sows is an important factor and could contrib-
ute to the contamination of their young. The Tylan treatment 
of sows allowed a signifi cant reduction of the shedding level 
from 71.2 to 39.2%. The study showed that the shedding level 
also decreases in the young of the treated sows, without using a 
treatment, from 76 to 43.3%.
Lawsonia FIRSTtest® is an interesting tool in the understanding 
of Lawsonia shedding in herds with sub clinical ileitis and may 
allow a better understanding of bacterium circulation and its 
impact on farming.
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methods, such as serology, for the detection of antibodies to Lawsonia intracellularis in pigs. 
Magdalena Jacobson1 Per Wallgren2 Ann Nordengrahn3 Malik Merza3 Ulf Emanuelson1
1. Dept. of Clinical Sciences, SLU, Uppsala, Sweden; 2. National Veterinary Institute, Uppsala, Sweden; 3. Svanova Biotech, Uppsala, Sweden
Introduction
Diagnosis of Lawsonia intracellularis in live animals is based on 
the demonstration of microbial DNA in fecal samples, or the 
demonstration of L. intracellularis-specifi c antibodies in sera. The 
diagnostic sensitivity (DSn) and specifi city (DSp), used to assess 
the performance of a new method, are commonly evaluated 
by analysis of reference samples from animals with a known 
infectious status and compared to analysis by a gold standard. 
However, these reference samples may not refl ect the actual 
population for which the methods are intended and a true gold 
standard is not always available. The aim of the present study 
was to compare the results obtained by a blocking ELISA to an 
IFAT in the detection of serum antibodies to L. intracellularis. 
Materials and Methods
200 pigs from 25 herds were included. Sera obtained from three 
previous studies were stored at -80°C. The pigs in study (1) and 
(2) were 8-12 weeks old. Study (1) included 54 pigs from 9 herds 
with poor performance and diarrhoea in growers, and 12 pigs 
from 4 herds with good performance and no diarrhoea. In (2), 
110 pigs from 11 herds with diarrhoea and poor performance 
were selected. In (3), 24 six-week-old pigs from an SPF herd free 
from L. intracellularis, were included. 
Sera were analysed by two serological methods, an IFAT (4) and 
a blocking ELISA (5) using PI 35 as cutoff  value. The two meth-
ods were compared using pigs from study (1) and (2). The DSn 
and DSp were determined by a 2 * 2 table using either the IFAT 
or the ELISA as gold standard. Further, samples from ten pigs 
confi rmed to be infected with L. intracellularis by nested PCR 
on faeces, and the 24 pigs from herd (3), were used as reference 
samples and similarly compared. 
Results
As analyzed by the blocking ELISA, 32 of 66 samples from 
population (1) and 30 of 110 samples from (2) were judged as 
positive. As analyzed by the IFAT, 47 samples from (1) and 28 
samples from (2) were judged as positive. All samples from 
confi rmed cases of L. intracellularis were serologically positive 
and all samples from population (3) were deemed as negative by 
both methods.
Table 1. The diagnostic sensitivity and specifi city of the blocking ELISA, 
using the IFAT as gold standard and applied on pigs from population 
(1) and/or (2). 
ELISA
Population DSn DSp
(1) 0.64 0.89
(2) 0,79 0.92
(1) and (2) 0.69 0.91
Table 2. The diagnostic sensitivity and specifi city of the IFAT, using the 
blocking ELISA as gold standard and applied on pigs from population 
(1) and/or (2). 
IFAT
Population DSn DSp
(1) 0.94 0.50
(2) 0.73 0.94
(1) and (2) 0.84 0.82
Analysing reference samples from known L. intracellularis-posi-
tive and -negative animals, the DSn and DSp was 100 % for both 
methods.
Discussion
Experimentally, L. intracellularis-specifi c antibodies are detected 
2 weeks after challenge, but the time point of infection and the 
actual infectious status are usually unknown in clinical samples. 
Further, estimating the diagnostic sensitivity and specifi city by a 
2 * 2 table requires the use of a true gold standard with DSn and 
DSp close to 1.00. However, none of the tests applied in this study 
can be considered to be appropriate for that purpose. Hence, in 
the present study the diagnostic sensitivity and specifi city varied 
depending on the gold standard and on the population. In the ab-
sence of a true gold standard, Bayesian modelling techniques may 
be used to validate samples obtained from the target population. 
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Susceptibility of diﬀ erent mouse strains to Lawsonia intracellularis infection 
using intestinal mucosa homogenate and pure culture
Aline M. Viott1 Fabio A. Vannucci1 Juliana S. Oliveira1 Mirella C. Costa1 Connie J. Gebhart2 Roberto M. Guedes1
1. Universidade Federal de Minas Gerais, Veterinary School, Belo Horizonte, MG, Brazil; 
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Introduction
The susceptibility of laboratory mice to Lawsonia intracellularis 
infection has been demonstrated by experimental infection1; 
however, the occurrence of proliferative enteropathy (PE) lesions 
varies among diff erent mouse strains2. Moreover, Murakata 
et al.2 showed that there are diff erences with respect to the 
establishment of PE lesions in mice according to the type of 
inoculum used. The authors demonstrated that mice inoculated 
with intestinal mucosa homogenate extracted from PE-aff ected 
rabbits had more severe lesions than those inoculated with 
pig intestinal homogenate. The purposes of this study were 
to describe experimental infections of L. intracellularis in four 
diff erent mouse strains using intestinal mucosa homogenate 
(MH) extracted from PE-aff ected pigs and pure culture (PC) of 
the bacteria as inoculum and to evaluate fecal shedding of L. 
intracellularis in these animals.
Materials and Methods
Forty 3-to-4-week-old male mice of four diff erent strains (BALB/c, 
C57BL/6, DB/A2 and Swiss) were used. On D0, 16 animals of each 
strain were inoculated with 0.5 ml of L. intracellularis PC (7.75 
x 107)3, 16 with 0.5 ml of MH (8.9 x 108)3 and eight with sham 
inocula using an intragastric gavage. Four and two mice from 
the infected and control groups, respectively, were euthanised 
on D7, D14, D21 and D28. Intestinal samples from the mice were 
analyzed by histology and immunohistochemistry (IHQ)4. A pool 
of fecal samples was collected from each cage weekly and tested 
using a nested PCR assay5 for L. intracellularis. Fisher exact test 
was used for the statistical analyses.
Results
No diarrhea or other clinical signs were observed in these mice. 
Macroscopically, DB-A mice inoculated with PC had thicken-
ing of the cecum and ileum wall at 14D. According to the exact 
Fisher test, the histological lesions and IHQ were more severe 
in mice inoculated with PC than in those inoculated with MH. 
Strains DB-A and Swiss had more intense lesions and IHQ label 
than the other strains. Results of fecal PCR were refl ected the 
severity of the histologic lesions. Swiss mice inoculated with PC 
shed L. intracellularis on D7 and D14; those inoculated with MH 
shed on D14 only. BALB/C mice inoculated with either inoculum 
were positive by PCR only on D14. C57BL/6 mice inoculated 
with PC shed the bacteria on D7 and D14 while those inoculated 
with MH were negative throughout the experiment. PC and MH 
inoculated DB-A mice were positive by PCR on D7, D14 and D21. 
All control mice were negative in the analyses performed.
Discussion
Gross and microscopic lesions typical of L. intracellularis infec-
tion were successfully reproduced in the mice in this study. Our 
results demonstrate a signifi cant variation of lesion severity and 
of L. intracellularis infection among the four mice strains studied. 
DB-A and Swiss strains were the most susceptible to PE lesions, 
while the lesions in BALB/c and C-57BL/6 mice were mild. These 
diff erences in susceptibility to infectious agents have been 
previously known, but the genetic basis for these diff erences 
remains to be determined2. Typical major lesions and bacterial 
shedding occurred in mice strains on D14, similar to what is 
described in pigs6. DB-A and Swiss developed more severe PE 
lesions and shed more bacteria, especially when inoculated with 
PC. This information can be useful for the establishment of an 
experimental model for L. intracellularis infection in mice.
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Quantitative assessment of Lawsonia intracellularis in feces by real-time PCR
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Introduction
Conventional PCR tests designed for detection of Lawsonia 
intracellularis (LI) in feces may detect infections with or without 
eff ect on clinical disease and production parameters. Quanti-
fi cation of fecal excretion may therefore serve as a method to 
distinguish between clinically and economically signifi cant and 
insignifi cant infections. Recently a quantitative real-time PCR 
(q-PCR) for detection of LI has been developed (1). Repeatability 
is an important test characteristic for quantitative diagnostic 
tests. Q-PCR repeatability can be infl uenced by features inherent 
to the q-PCR assay, homogeneity of fecal samples and variation 
in level of excretion for the same pig within the same day. The 
objective of the current study was to investigate variation in 
fecal excretion of LI detected by q-PCR within one day. Variation 
in fecal dry matter was also determined for the same pigs and 
will be reported elsewhere in the proceedings. 
Materials and Methods
A cross-sectional fi eld study with follow-up was designed. A 
Danish farrow- to fi nish herd with a history of LI was selected at 
convenience. A batch of approximately 8 weeks old pigs having 
an outbreak of diarrhea was selected. The pigs had not received 
antibiotic treatment within the last 4 weeks and treatment of 
the current outbreak was not initiated before the fecal samples 
were collected. Thirty pigs were selected at convenience. Fecal 
samples were collected at 9am, 11am, 1pm, 3pm and 5pm from 
the rectum of each pig. The pigs were identifi ed with two identi-
cal ear tags. At each time point the pigs were examined in the 
same chronological order. All fecal samples were transported to 
DTU-VET, stored at 4oC and further processed the following day. 
All fecal samples were subjected to q-PCR testing designed for 
detection of LI (1). Fecal dry matter content (DM%) was deter-
mined by the microwave method (2). DM% of the fecal samples 
from the fi rst time point was used to stratify the pigs into 
non-diarrheic (DM%>18.8), semi-diarrheic (18.8≥DM%>13.1) or 
diarrheic (DM%≤13.1) in the statistical analysis (3). The data was 
analyzed in a linear regression model with a repeat measure-
ment structure using the mixed procedure in SAS, version 9.1. 
Results
A total of 29 pigs and 144 observations were included in the an-
alysis. Twenty-eight pigs had detectable levels of LI in feces at all 
time points. One pig was negative at one time point. Decreasing 
DM% was signifi cant associated with an increasing excretion of 
LI (p<0.001). A signifi cant eff ect of time on mean fecal excretion 
of LI was observed for non-diarrheic (p < 0.02), semi-diarrheic (p 
< 0.01) and diarrheic (p < 0.01) pigs, table 1. In all three groups 
the mean fecal excretion of LI was lowest at 1pm.The maximum 
individual change in fecal LI excretion between any time points 
was below one log unit for 25 of the pigs. The most extreme 
change observed was 1.09 log units. 
Table 1. Mean copies of Lawsonia intracellularis (Log10/ gram feces), 
in fecal samples from 29 pigs examined 5 times within one day (n = 144 
fecal samples)
Time point
9am 11am 1pm 3pm 5pm
Non-diarrheic (DM%>18.8) (n=7 pigs) 4.3a 4.2a 3.9b 4.3a 4.1ab
Semi-diarrheic (18.8≥DM%>13.1) (n=9 pigs) 5.3a 5.1ac 4.8b 5.0c 4.9bd
Diarrheic (DM%≤13.1) (n=13 pigs) 5.6a 5.4a 5.2b 5.6a 5.4ab
Time points with diff erent subscripts within rows are signifi cant diff erent (p<0.05).
Discussion
The increasing excretion of LI in pigs with decreasing fecal DM% 
indicates that quantifi cation of LI can be applied to distinguish 
between signifi cant and insignifi cant infections. The mean fecal 
LI excretion changed signifi cantly during the examination day. 
However, the change was small within each group of pigs and 
may not aff ect the potential of q-PCR as a group level test. At the 
individual level the change of more than one log unit in 14% of 
the pigs may indicate that within day variation is more import-
ant for application of q-PCR as a diagnostic test at the individual 
level. The lowest level of excretion was detected at time 1pm 
for all 3 groups. This implies that the other 4 time points better 
represents the mean fecal excretion of LI. This should be taken 
into consideration during collection and interpretation of q-PCR 
test results for detection of LI. 
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Identiﬁ cation of Lawsonia intracellularis in sections of intestines by immunohistochemistry
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Introduction
Proliferative enteropathy, caused by Lawsonia intracellularis 
(L. intracellularis), is one of the major diseases contributing 
to economic losses in intensive swine production worldwide. 
The recommended methods for diagnosis of the disease are 
polymerase chain reaction (PCR) or immunohistochemistry (1, 
2 ). The aim of the study was to develop immunohistochemistry 
(IHC) for L. intracellularis detection and to compare this method 
with PCR.
Materials and Methods
Field samples used in the study comprised of intestines (ileum, 
caecum and colon) and feces from 21 pigs with clinical symp-
toms of proliferative enteropathy, originating from 11 medium 
and large swine units. They were analyzed by PCR (5) for the 
presence of L. intracellularis. Also, intestines were fi xed in 10% 
buff ered formalin, embeded in paraffi  n, cut and tested in (IHC), 
according to avidin-biotin complex method.
Sections of intestines positive for L. intracellularis, kindly pro-
vided by dr. T.K. Jensen (Danish Institute for Food and Veterinary 
Research, Copenhagen, Denmark) and dr. Dinko Novosel (Cro-
atian Veterinary Institute, Zagreb) were used as positive controls. 
Sections of intestines from clinically healthy pigs, negative for L. 
intracellularis by PCR (5), served as negative controls. All the sec-
tions were additionally hematoxylin-eosin (HE) stained.
Results
DNA of L. intracellularis was found by PCR in samples of intes-
tines and in the corresponding feces from 16 pigs from 9 farms. 
L. intracellularis antigen was detected by IHC in all positive con-
trols and in sections from 9 diseased pigs, representing 7 farms. 
In the HE-stained sections of positive controls and IHC-positive 
fi eld samples enlarged and branched crypts with proliferating 
immature epithelial cells were found, which are characteristic 
lesions of proliferative enteropathy (4). The remaining 5 sections 
were negative in IHC and presented no lesions. 
Image: IHC. Immunolabelling within the apical cytoplasm of hyper-
trophic enterocytes, resulting in specifi cally stained rims around the 
crypt lumina. x 200
Discussion
The results of this study showed that L. intracellularis antigen 
could be detected in formalin-fi xed, paraffi  n-embedded tissues 
of pigs using monoclonal antibodies. The IHC test showed high 
specifi city but lower sensitivity than PCR. Most probably the 
samples with no obvious lesions characteristic for proliferative 
enteropathy, negative in IHC and positive in PCR most likely 
originated from chronic cases of disease or fi nal stages of recov-
ery, where bacteria were present in a small number or already 
absent in the tissue (3). 
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Development of SYBR green base quantitative-PCR for quantiﬁ cation of Lawsonia intracellularis
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Introduction
Lawsonia intracellularis (LI) is an obligately intracellular organ-
ism and is the causative agent of proliferative enteropathy (PE) 
in pigs and other animals. In many studies, the estimation of 
bacterial quantity or level of LI infection in samples (pig feces, 
intestinal tissue, gut mucosal homogenate, and pure culture) is 
required. However, we lack the assays for accurate quantifi ca-
tion of LI in those samples. Previously, estimates of LI loads were 
obtained using a cumbersome immunostaining procedure with 
specifi c antibody for LI (1). The objective of this study was to 
develop a quantitative PCR (qPCR) using SYBR green for quantifi -
cation of LI in feces and bacterial pure culture.
Materials and Methods
The LI strain PHE/MN1-00 was used for all steps in the develop-
ment and optimization of the qPCR. Specifi c primers were de-
signed using the aspA gene as a target. The size of PCR product 
is 162 bp. Serial 10-fold dilutions of pure culture samples and 
several sets of spiked feces in the range of 108 to 101 LI/ml and 
LI/g of feces, respectively, were tested for qPCR accuracy and the 
limit of quantifi cation. The specifi city of the primers was tested 
against 16 swine enteric bacteria using qPCR and conventional 
PCR. DNA of LI from pure culture bacteria and from fecal samples 
was extracted using the DNeasy® Blood and Tissue Kit and the 
QIAamp® DNA Stool Mini kit, respectively. qPCR was conducted 
using the Brilliant® II SYBR® Green Master Mix and 5 μl of DNA 
template in a fi nal reaction volume of 25 μl.The qPCR amplifi ca-
tion and quantifi cation were performed using an Mx3000P Real-
Time PCR System. The standard curve was constructed using the 
DNA of LI pure culture in which the fi nal bacterial concentration 
was determined using a direct count method (2) before DNA 
extraction. Several qPCR parameters were tested: the limits of 
detection and quantifi cation, the linear range, and the inter- and 
intra-assay repeatability.
Results and Discussion 
When detected from pure culture, the limit of detection and 
quantifi cation of LI was 5.1x101 LI/ml while the lower limit of 
the linear range of the assay was 5.1x102 LI/ml. In spiked feces, 
the limit of detection of LI was 2.55x101 LI/g while the limit 
of quantifi cation was 2.55x103 LI/g. A concentration between 
2.55x104 and 2.55x103 LI/g was the lower limit of the linear 
range. No cross-reactivity of qPCR was found when the assay 
was tested using the DNA extracted from 16 species of swine 
enteric bacteria. Coeffi  cients of variation of inter- and intra-assay 
reapeatability was lower than 10%. The dissociation curve of the 
aspA amplicon (Figure 1) showed a single melting temperature 
(Tm) peak at 79oC. In one of fi ve spiked fecal samples, a non-
specifi c peak could be found (Figure 2, right peak) but only at 
low concentration of 104 to 101 LI/g. This peak of incorrect Tm 
appeared only after cycle 36. 
Figure 1. Dissociation curve analysis of LI pure culture. 
Figure 2. Dissociation curve analysis of spiked feces. 
The results obtained from this assay are sensitive, specifi c and 
precise for the detection and quantifi cation of L. intracellularis 
in samples. This new qPCR assay will be helpful in future disease 
transmission and epidemiology studies. We will use this assay to 
determine the dynamics and quantity of LI excreted post-infec-
tion through feces after experimental and natural infections.
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Eﬃ  cacy of enterisol ileitis in a Chinese pig farm
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Introduction
Ileitis, caused by Lawsonia intracellularis (LI), is a widespread 
enteric disease in swine. It leads to reduced average daily gain 
(ADG), poor feed conversion in nursery and fattening and high 
variation of body weight at slaughter. McOrist (1) reported that 90 
% of pig farms in the world were LI infected. Most of the herds are 
only subclinically aff ected by ileitis meaning that the animals do 
not show any clinical signs but reduction and variability in growth. 
Wang et al. (2) tested 2,700 blood samples collected from 54 Chi-
nese pig farms with a blocking ELISA for anti-LI-antibodies. In their 
survey 70 % of the investigated farms were positive already at the 
end of nursery period. Adam (3) estimated that the economical 
impact of clinical and subclinical ileitis in Europe is in average 4.70 
and 3.47 Euro respectively per pig.
Materials and Methods
The trial was carried out in a Chinese pig farm in Guangxi 
Zhuang Autonomous Region from 2nd of March to 25th of June 
2008. Animals were assigned randomly into 2 treatment groups: 
the vaccinated group (Group V) and the non-vaccinated group 
(Group Nv). There were 489 pigs in Group V in replicating sub-
groups of 141, 142 and 206 pigs which were all vaccinated with 
Enterisol® Ileitis at 14 days of age. There were 489 pigs in Group 
Nv, which consisted of 3 replicating subgroups as well, with 
140, 141, and 208 pigs, respectively. Both Group V & Group Nv 
were housed in the same barn, provided with the same feed and 
health management. An infection of the trial animals with LI was 
conformed by clinical signs and serological testing.
Results
ADG of the vaccinated animals was 18.9 g higher and FCR was 
0.09 lower compared to the non-vaccinated animals. 
Overall mortality was lower in the vaccinated animals by 0.82 %.
An additional 46 Yuan/pig profi t was generated by vaccination, 
including: 
1. Feed consumption decreased by 2.16 kg (≈ 4 Yuan)/ V pig;
2. Final weight increased by 2.14 kg (≈ 28 Yuan)/V pig;
3. Mortality and culling rates decreased, saving about 14.6 
Yuan/V pig
Table 1. Eff ects of Enterisol® Ileitis on performance data
Group V Group Nv Diff erence
pigs included (N) 489 489
mortality (n/%) 16/3.27 20/4.09 -4/-0.82
pig with diarrhea (n/%) 145/29.7 160/32.7 -15/-3.07
average birth weight (kg) 1,40 1.43 -0.03
average post-weaning weight (kg) 6.42 6.48 -0.06
average fi nal weight (kg) 58.28 56.14 2.14
trial duration (d) 115 115 0
ADG (g) 494.61 475.74 18.87
feed consumption (kg) 107.98 110.14 -2.16
FCR (wean to growing) 2.08 2.31 -0.23
Discussion
Throughout the trial, animals of Group V showed a better 
growth performance than those of Group Nv. Findings in the 
present trial demonstrate that Enterisol® Ileitis can eff ectively 
protect pigs from clinical ileitis in Chinese farms. Moreover, vac-
cination can improve the production performance, as indicated 
by ADG, FCR and mortality, leading to a higher profi t margin. In 
conclusion, Enterisol® Ileitis is a powerful tool to control ileitis 
and boost profi tability of pig farms.
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Inﬂ uence of Ileitis vaccination on gross margin by improved uniformity
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Introduction
The vaccine Enterisol® Ileitis Vet. eff ectively controls ileitis 
caused by Lawsonia intracellularis (LI). In a pan-european survey, 
the gross margin (GM) increased 3-6 € per pig after vaccination, 
when benefi ts of increased average daily weight gain (ADWG), 
reduced feed conversion rate (FCR) and losses were valued (1). 
On top, the vaccine increases uniformity of pigs (2), and this 
parameter was not included in the calculations. As a rule of 
thumb for acceptable uniformity, the producers organisation 
in Denmark estimates, that every pig in a batch should have 
reached the minimal required weight (70 kg carcase weight), 
when half of the batch has been shipped for slaughter. Each kg a 
pig weighs below this minimal weight at this cut-off  day, the GM 
per pig decreases by 0,53 € because of extra costs in production 
or depreciation of carcass value (3). Hence, a thorough calcula-
tion of economical benefi ts should not only include values of 
ADWG, FCR and losses, but also value arising from increased 
uniformity. In the present study, losses in GM caused by lack of 
uniformity were calculated for vaccinated and non-vaccinated 
pigs by calculation of their weight at the cut-off  day, when 50% 
of the pigs had been slaughtered.
Materials and Methods
The study contained 9494 pigs from 3 Danish slaughter pig 
herds. From each herd, 16 batches of pigs were included, and 
pigs from every second batch (batch 1, 3, 5, 7, 9, 11, 13 and 15) 
were vaccinated against LI with Enterisol® Ileitis Vet. (Boehringer 
Ingelheim). Remaining batches were non-vaccinated controls. In 
herd 1 and 2, the vaccine was given in drinking water 1-5 days 
after weaning, and in herd 3, vaccine was administered orally 
by drench before weaning. Infection with LI was confi rmed by 
laboratory diagnosis on intestines. The date of weaning was 
recorded, and individual data for slaughter date and carcase 
weight were obtained from the slaughterhouse. The number 
of days to slaughter and ADWG was calculated for each pig. 
The carcase weight of pigs at the cut-off  day (when 50% of the 
pigs had been slaughtered) was calculated backwards from the 
cut-off  day using actual carcase weight and assuming an ADWG 
of 850 g/day from the cut-off  day until the actual day of slaugh-
ter. To put a value on (lack of ) uniformity, the diff erence ( Δ) 
between calculated carcase weight at the cut-off  day and 70 kg 
was calculated for each pig. Lost uniformity GM was valued per 
pig as Δ kg x 0.53 €. Comparison of vaccinated pigs and controls 
was made with Students t-test for ADWG and with Kruskal-Wallis 
test for lost uniformity GM (signifi cance level p≤0.05).
Table 1: Performance of pigs from weaning to slaughter. 
Herd 1 2 3
# pigs Vx 2083 1414 2436
Cx 1388 1129 1044
ADWG wean to slaughter (g/day) Vx 713 752 705
Cx 667 718 678
Vx-Cx 46* 34* 27*
Uniformity GM lost (€) Vx 0.19 0.17 0.40
Cx 0.78 0.59 1.29
Vx-Cx -0.59* -0.52* -0.89*
* = Statistically signifi cant diff erence (p < 0.05).
Results
In all 3 herds, vaccination gave a signifi cant improvement in 
ADWG (table 1). The improvement varied from 27 to 46 g/day, 
comparable to results from other trials (1). The reduction in lost 
uniformity GM was between 0.52 and 0.89 €/pig. Fig. 1 shows 
the improved uniformity of the vaccinated pigs in herd 1, where 
only 8% of vaccinated pigs were below 70 kg carcase weight at 
the cut-off  day, compared to 21% of non-vaccinated animals.
Figure 1: Lost uniformity GM from pigs in herd 1.
Discussion and Conclusion
Vaccination with Enterisol® Ileitis Vet. signifi cantly reduces losses 
in GM caused by low uniformity of pigs. To demonstrate full 
economical benefi ts of vaccination against LI, value of improved 
uniformity GM should be added to more traditional benefi ts, 
such as improved ADWG, FCR and mortality. 
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Vaccination against Lawsonia intracellularis in two Danish farms
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Introduction
Lawsonia intracellularis (L.i.) is the causative agent of porcine 
proliferative enteropathy (PPE). PPE is an economically import-
ant enteric disease, causing diarrhea and reduced weight gain in 
weaners and grower-fi nishers (1). Lawsonia is present in most pig 
producing countries. In a Danish study, L.i was detected in 93.7 
% of the tested herds (2). Together with management, antibiot-
ics have been used to control the disease. However, the use of 
antibiotics can cause an increased level of resistant bacteria, and 
this might cause public concern about the production method in 
the industry. Vaccination is a consumer-friendly alternative, and 
the objective of this study was to evaluate the impact of vaccina-
tion with Enterisol® Ileitis Vet. on the average daily weight gain in 
nurseries and fi nisher barns in two Danish pig farms. 
Materials and Methods
This study was conducted as a randomized blinded clinical trial 
with parallel treatment and a placebo group in two pig farms with 
clinical PPE problems. The time of infection was established by 
serological profi les using an ELISA (3) to detect antibodies against 
L.i. From both herds, two to four unthrifty pigs were submitted to 
a diagnostic laboratory to confi rm the PPE diagnosis by immuno-
histochemistry (4). The pigs were vaccinated orally by drench one 
to two weeks before weaning; half of the litters in each batch of 
pigs being vaccinated and the other half treated with placebo. In 
each of the two herds, approx. 250 vaccinated pigs and approx. 
250 placebo pigs were ear tagged individually and weighed at 
vaccination, at the end of the nursery period and at the end of 
the fattening period. Statistical analysis was performed by linear 
regression in SAS Proc Mixed with average daily gain (ADG) as the 
dependent variable, start weight, herd and observation period as 
covariates and batch as the random eff ect. Light pigs were arbi-
trarily defi ned as pigs weighing less than 67.5 kg live weight at the 
end of the fattening period. The study was performed in cooper-
ation with Boehringer Ingelheim and supported by grants from 
the EU and Danish Ministry for Food, Agriculture and Fisheries.
Table 1. Weight of pigs vaccinated against L.i. and pigs treated with 
placebo
N Placebo Vaccine
Start weight, kg 987 7.8 (1.8)a 7.3 (1.7)
End nursery weight, kg 815 29.5 (7.6) 31.7 (7.3)
End fattening weight, kg 607 85.6 (13.5) 87.6 (11.7)
a Standard Deviation
Results
The mean weight measurements of the pigs are shown in table 
1. In the nurseries, the vaccinated pigs grew signifi cantly faster 
in both herds. In herd 2, the vaccinated pigs also grew signifi -
cantly faster in the observation period 7-90 kg. The results are 
shown in Table 2.
Table 2. Results from analysis of vaccination with Enterisol® Ileitis Vet. 
on Average Daily Gain (g/day) in two herds
Placebo Vaccine Diff erence P value
7-30 kg
Herd 1 399 418 +19 0.05
Herd 2 494 525 +31 0.002
7-90 kg
Herd 1 691 686 -5 0.63
Herd 2 631 665 +34 0.005
Figure 1 shows the distribution of the weight of vaccinated 
and placebo pigs at the end of fattening in herd 2. The fraction 
of light pigs was lower in the vaccinated group of pigs. In this 
group 6 % had a weight below 67.5 kg, while 17 % of placebo 
treated pigs weighed less than 67.5 kg.
Figure 1. Distribution of weight measurements of placebo and vaccin-
ated pigs at the end of fattening in herd 2.
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Introduction
Lawsonia intracellularis (L.i.) is widely distributed among pigs in 
Germany and seems to play a dominant role in sows (1). The aim 
of this study was to eliminate L.i. from a breeding farm by medi-
cation with tiamulin (Denagard®10 % oral powder) combined 
with cleaning and disinfection. 
Materials and Methods
The eradication program was carried out in a breeding farm with 
2500 sows with production of 30 kg pigs. Six weeks before the 
program started the farm was completely depopulated, cleaned 
and disinfected and routine rodent control was carried out. 
Barns were repopulated with 2500 gilts aged 20 – 24 weeks (60 
– 120 kg) delivered in 5 consecutive batches (April to September 
2008). The delivery multiplier herd was infected with L.i.. Periodic 
outbreaks of PE (Proliferative Enteropathy) were observed and 
confi rmed by post mortem investigations and L.i. was detected 
in faeces by polymerase chain reaction (PCR). Before arrival, 10 
of 11 faeces samples from purchased gilts were positive for L.i.. 
The medication program was carried out in a quarantine stable. 
After each batch received the medication, the gilts moved to a 
new facility 9 km away. 
Medication
To reduce shedding of L.i. and to minimize the risk of contamin-
ating the quarantine area, the gilts were given a dosage of 8mg/
kg bodyweight/day (bw/d) of tiamulin (Denagard) orally three 
days before being transported from the farm of origin to the 
new facility. After arriving at the quarantine stable, the gilts were 
fed a dosage with 8mg/kg bw/day of tiamulin (Denagard 10% 
oral powder) for another 28 days. The dosage was calculated 
based on the heaviest gilt of approximately 120 kg. Tiamulin 
was given via wet feed twice a day. 4 mg/kg bw/d once in the 
morning and 4 mg/kg bw/d after 8-10 hours. 
Cleaning/Disinfection
Faeces was removed from the pens twice daily after each feed-
ing. Twice a week the whole pen was disinfected after cleaning 
with a disinfectant (Venno Vet 1 super). 
Monitoring
Since the eradication program was conducted in October 2008 
the herd has been clinically monitored twice a month for 15 
months. 50 faecal samples from progeny weighing 20 - 60 
kg were examined for L.i. by PCR and 56 blood samples from 
progeny (40-100 kg) were tested for specifi c antibodies for L.i. 
by ELISA test (2). Pigs showing the clinical symptoms of diar-
rhea were submitted to gross pathology for further laboratory 
examination. 
Results
There have been no clinical signs of PE since completing the 
eradication program. As shown in the Table, all 50 faeces sam-
ples tested negative for L.i., but 2 blood samples were positive at 
the cut-off  point which could be considered positive. 
Table: Monitoring for L.i. in faeces and blood of the off spring (weaners 
and gilts) by PCR and ELISA after eradication program was carried out
Date Number of positive/negative faeces samples tested by PCR
Number of positive/negative 
blood samples tested by ELISA
Nov. 2009 0/50 1/30
Dec. 2009 —— 1/26
Pigs with clinical symptoms which were submitted to laboratory 
examination were tested negative for L.i.. Furthermore, there 
were no lesions characteristic for PE. 
Discussion
This fi eld trial indicates that L.i. may be successfully eradicated 
from a breeding herd by the presented procedure of medication 
with tiamulin combined with cleaning/disinfection. The two very 
low reactions for L.i. antibodies in blood are diffi  cult to explain. 
It cannot be ruled out entirely that these two blood samples on 
the cut-off  point could have been false positives since all data 
are against any signs of PE and in large parts blood samples as 
well all faeces samples tested negative for L.i.. Further investiga-
tion both in faeces by PCR and by serology for L.i. will be carried 
out in the near future to ascertain the herd is free from L.i.. The 
results will be presented. 
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Introduction 
Proliferative enteropathy (PE) causes considerable economic 
losses to the swine industry worldwide.1 Judicious use of De-
nagard® has been shown to be an eff ective means of reducing 
economic loss due to PE.2 A pure culture seeder pig model was 
designed to show transmission of Lawsonia intracellularis (Li) 
infection from Li challenged pigs in a population to suscept-
ible pen mates. This model mimics the paradigm for natural 
transmission of the disease.3 The objectives of this study were 
to document the spread of Li infection from a seeder pig to 
multiple susceptible pen mates, document levels of shedding in 
seeder and susceptible pigs, and evaluate the eff ect of placing 
Denagard® at 38.5 ppm (35 g/ton) when a shedding threshold of 
30% in susceptible pig was reached. 
Materials and Methods 
Li was isolated from a fi eld case and cultured under conditions 
previously described4 and used as the challenge material for 
the seeder pigs. Sixty pigs were randomly placed into one of 
six pens. All pens were separated by an empty pen or a solid 
partition to prevent fecal oral contact between pens. The seeder 
pig to be challenged was designated as the pig closest to the 
median pig weight of each pen. Each seeder was challenged 
with 1.6x1010 Li via esophageal tube. Pigs were weighed and 
blood samples were collected once a week. Weekly blood 
samples were analyzed by the immunoperoxidase monolayer 
assay (IPMA) for the detection of circulating Li antibodies.  Fecal 
consistency, abdominal appearance, and demeanor scores were 
recorded three times a week. Fecal samples were analyzed by 
quantitative polymerase chain reaction (qPCR) to determine 
the amount of Li being shed per gram of feces. Denagard® at 
38.5 ppm (35 g/ton) was placed in three (treatment T2) of the 
six pens when 30% of the sentinel pigs were shedding Li as de-
tected by PCR. Three of the six pens remained untreated (treat-
ment T1) throughout the trial. Pen was used as the experimental 
unit in all analyses.
Results 
Fecal shedding of Li from 3 of the seeder pigs peaked on 21 
days post-challenge, the other 3 seeder pigs peaked on day 11, 
18, and 32. The highest amount of Li shed by a seeder pig was 
8.62x108 bacteria/gram feces on day 11 post-challenge. The 
highest amount of Li shed by a susceptible pigs was 1.52x109 
bacteria/gram feces on day 32 post-exposure to a seeder pig. 
There was a signifi cant diff erence in the percent of IPMA and 
qPCR positive pigs between Denagard® treated (T2) and control 
(T1) pens (Fig.1). There was a signifi cant diff erence in mean fecal 
consistency and mean abdominal appearance scores between 
T1 and T2 (Fig. 2). Numerically, T2 when compared to T1 had 
a lower percent of days with abnormal (score > 0) fecal con-
sistency scores (3.91% vs. 8.44%, respectively) and abnormal 
(score > 0) abdominal appearance scores (17.08% vs 38.89%, 
respectively). 
Discussion 
Spread of Li and levels of fecal shedding were documented in 
this pure culture seeder pig model. Direct challenged seeder 
pigs shed lower quantity of Li than susceptible contact pigs 
when shedding was detected. Use of Denagard at 38.5 ppm (35 
g/ton) in the model signifi cantly decreased the clinical eff ects of 
PE in the susceptible pigs. Fewer Denagard® -treated pigs tested 
positive by PCR or serology.
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Long term beneﬁ ts of Ileitis vaccination in a 5000 sow herd in Spain
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Introduction
Ileitis is an infectious endemic disease present in most of the 
Spanish farms (1) and all over the world. Multisite production 
systems have not been able to control the infection and the clin-
ical signs of the disease or to eliminate its negative economical 
impact in the fattening period.
Enterisol® Ileitis is the unique oral ileitis vaccine for controlling 
the negative impact of the disease. The objective of this study 
was to evaluate the eff ect of ileitis vaccination in a 5000 sow 
system one year after introducing the vaccine.
Materials and Methods
The study took place in a three site production system with a 
5000 sow farrowing site, 16,000 places in the nursery and 32,000 
fattening places. The system produced weekly batches of 2000 
piglets. Some of the batches went to external fattening sites.
At the beginning of the trial the performance of the sow herd 
and in the nursery were above the average level in Spain. Never-
theless the management was not satisfi ed with the performance 
achieved during fattening period especially concerning growth, 
mortality and cull rate. From 10-12 weeks of age onwards until 
end of fattening, animals had chronic diarrhoea and some 
animals showed clinical signs typical for Porcine hemorrhagic 
enteritis. Before ileitis vaccination was implemented Lawsonia 
intracellularis infection was confi rmed and the time of infection 
was determined by serology and PCR of fecal samples.   
In May 2007 ileitis vaccination with Enterisol® Ileits was imple-
mented and piglets were vaccinated via the drinking water in 
troughs between 3rd and 4th week of live, just after weaning. 
Later due to logistic reasons in farm, the animals were vaccin-
ated by drench. 
The study compares 6 batches of animals before implemen-
tation of ileitis vaccination (12,048 pigs) with 15 batches of 
vaccinated animals (29.221 pig as Enterisol® Ileitis group). All 
batches were kept under similar husbandry conditions. All data 
presented is from fattening period and dates in the SPC charts 
are starting dates of each batch in fattening. 
Performance of both treatment groups was compared by SPC 
(Statistical Process Control), using Statistica® Version 8.0, Statsoft. 
Return of Investment was calculated using pork and feed aver-
age prices of the dates that animals were slaughtered. 
Results
SPC analysis revealed a signifi cant increase in ADG in favour 
of the vaccinated animals (+70g, fi g. 1). The FCR was 0.4 kg/kg 
lower in the vaccinated animals compared to the non-vaccinat-
ed (fi g. 2). 
Figure 1. SPC chart of fattening Average Daily Gain (g/day).
Figure 2. SPC chart of fattening Feed Conversion Ratio (kg/kg).
The mortality rate was 1.3 % lower after implementation of ileitis 
vaccination (6.55 % in the control group and 5.28 % in the vac-
cinated animals).
Finally, the cost of medication for enteric problems in the fatten-
ing period was dramatically reduced by 89% by cutting out two 
routine antibiotic treatments that were established in the farm 
before the start of the study. These improvements in perform-
ance resulted in a Return of investment 8.6 : 1 per pig (including 
the vaccination cost).
Discussion
In the present study Enterisol® Ileitis vaccination improved signifi -
cantly the performance during fattening and was highly profi table. 
Fattening period is a critical point from an economical point of view 
and all the tools to improve its effi  ciency must be considered. 
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Introduction
Proliferative enteropathies (PE), also known as ileitis, are a group 
of acute and chronic conditions of widely diff ering clinical signs 
but with a common underlying pathological change visible at 
necropsy; a thickening of the mucosa of the small intestine and 
the colon. The primary causative agent is the obligate intra-
cellular bacterium Lawsonia intracellularis. Ileitis is a common 
disease which aff ects pigs maintained under various manage-
ment systems worldwide (1). The aim of this fi eld study was the 
assesment of the possible antimicrobial activity of Larch sawdust 
based on the reduction of proliferative enteropathies prevalence 
in growing pigs. This trial was part of the SAFEWASTES specifi c 
targeted research project fi nanced by the European Union (6th 
Framework Project).
Materials and Methods
This study was carried out on a commercial pig farm in north-
ern Greece with a capacity of 250 sows under production. The 
farm was selected due to previous history of PE occurrence. 
120 healthy of the same genetic background growing pigs at 8 
weeks of age were used. A randomized block design was used 
with 3 treatments and 4 replicates (pens of 10 pigs each with 
equal sex ratio) per treatment. A day before allocation, all pigs 
were weighed and monitored for diarrhea. They were allocated 
to diff erent groups, in order to achieve homogeneity in average 
weight, sex and diarrhea signs at the beginning of the trial.
The fi rst group, designated as negative control group received 
feed formulated with 99% basic diet (grower ratio of wheat/
barley/soya mix with no antimicrobial agents or performance 
enhancers) and 1% corn starch from trial day 0 until the end of 
the trial (6 weeks later). The piglets of the second group received 
feed formulated with 99% basic diet and 1% larch sawdust, 
while the third group was off ered feed formulated with 97.5% 
basic diet and 2.5% larch sawdust. Productivity parameters and 
diarrhea score (DS) were recorded daily, while blood samples 
from 10 pigs/group at days 0, 14, 28 and 42 were collected for 
the detection of L. intracellularis antibodies. 
Results and Discussion
The in-feed use of larch did not show a clear positive antimicrob-
ial eff ect against L. intracellularis infection in growing pigs, 
although the 3rd group (larch 2.5%) had less positive blood 
samples at 14th week relatively to the other 2 groups (p=0.114) 
(graph 1). However, for the overall trial period, productivity par-
ameters and DS of larch-fed pigs were improved relatively to the 
negative controls (tables 1 and 2). 
Graph 1: Serological results of L. intracellularis antibodies in blood 
samples (Number of positive samples)
Table 1: Average Daily Weight Gain (kg), Average Daily Feed Intake 
(kg) and Feed Conversion Ratio (Mean±SD)
Groups ADWG ADFI FCR
Negative control 0.589±0.068 (n=39) 1.323±0.023 (n=4) 2.24±0.03 (n=4)
Larch (1%) 0.604±0.094 (n=39) 1.340±0.014 (n=4) 2.22±0.07 (n=4)
Larch (2.5%) 0.607±0.084 (n=40) 1.334±0.010 (n=4) 2.20±0.02 (n=4)
Table 2: Diarrhoea score based on pen calculation for the total trial 
period (Mean±SD)
Groups Diarrhea score  (n=24)
Negative control 0.52±0.18
Larch (1%) 0.44±0.16
Larch (2.5%) 0.42±0.18
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Introduction
It is widely demonstrated that vaccination controls the eff ects 
of Lawsonia intracellularis (Li) infections allowing improved per-
formance (growth, feed effi  ciency, uniformity etc.) and generat-
ing higher profi tability 1, 2. However any established practice 
is challenged from time to time to save costs. This longitudinal 
case study describes changes in production parameters and 
therefore the economic impact of the implementation and 
termination of ileitis vaccination .
Materials and Methods
The study took place in a farrow-to-fi nish farm of 1,600 sows 
and 10,000 fattening places in Germany. All pigs were housed 
under identical conditions. Parameters monitored were record-
ed per batch. ADG (average daily gain), FCR (feed conversion 
rate), mortality, and amount of antibiotics used against enteric 
diseases (AB use) in the fi nishing unit were monitored by SPC 
methodology (Statistical Process Control) since 2004 3. ADG, FCR 
and antibiotic use were evaluated by one-way ANOVA, pairwise 
comparison and adjusted by Bonferroni approach. Mortality is 
evaluated using a Chi-square test. All tests were performed with 
the software Statistica® v8.0, Statsoft®. Two time periods were 
considered for evaluation of the ileitis vaccination impacts. Dur-
ing these two periods no other changes than implementation 
and withdrawal of ileitis vaccination were undertaken.
Implementation: August 2004 to March 2005 and March 2005 to 
November 2007 representing 95,134 animals. Sows were mass 
vaccinated against PRRSV every 4 month. Pigs were vaccinated 
against PRRSV (14 days of age) as well as against Mycoplasma 
hyopneumoniae (21 days of age). The producer added a third 
piglet vaccine, Enterisol® Ileitis in March 2005 (vaccination by 
drench, 14 days of age). 
Withdrawal: February 2008 to April 2008 and April 2008 to Sep-
tember 2008, representing 16,848 animals. Enterisol® Ileitis was 
taken out of the vaccination program by April 2008. 
The batches between these two periods were not taken into 
account since other changes were implemented in the vaccina-
tion protocol: vaccination with Ingelvac CircoFLEX® against PCV2 
(21 days of age) was started by December 2007, and by end of 
February 2008 vaccination against PRRSV was terminated as the 
fl ow became PRRSV negative. The overall performance improved 
by 10 % during this time.
Results
The improvement in performance following implementation of 
ileitis vaccination was similar to the decrease following with-
drawal (table 1). 
Table 1: Average performances and changes observed in ileitis vaccin-
ated and non-vaccinated pigs
Implementation Withdrawal
Vaccines M.hyo, PRRS M.hyo, PRRS, Ileits PCV2, M.hyo, Ileitis PCV2, M.hyo
ADG g/day 738 771* 811 781*
Diff . +33 -30
FCR 3.16 3.06* 2.80 2.97*
Diff . -0.10 +0.17
Mortality % 4.12 3.04* 3.15 3.47
Diff . -1.08 +0.32
AB use kg/group 2.23 0.91* 0 2.32*
Diff -1.32 +2.32
* signifi cantly diff erent with a p-value ≤ 0.05
Discussion
 The decline in performance after withdrawal of ileitis vaccina-
tion mirrors the gain observed three years earlier. Also the 
antibiotic use was reduced after implementation and increased 
again after withdrawal of ileitis vaccination. This indicates the 
consistent eff ect of the ileitis vaccination on performance par-
ameters. The results indicate as well that losses in performance 
due to Lawsonia infections in non-vaccinated animals could not 
be prevented by treatment with antibiotics. Furthermore the de-
cline in the second period indicates the potential additive eff ect 
of ileitis vaccination on top of PCV2 vaccination.
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Introduction
Porcine Proliferative Enteropathy (PPE or Ileitis) is due to the 
infection of Lawsonia intracellularis. It is a major factor aff ect-
ing intestinal health of growing pigs. The economic impact of 
ileitis has been reported in Australia to be AUD$15.00 /sow/year 
and AUD$141.00 /sow/year with the non-haemorrhagic and 
hemorrhagic PPE respectively 1. Sub-clinical ileitis was observed 
as uneven growth rates and longer time taken to reach market 
weights. Enterisol® Ileitis is a modifi ed live oral vaccine that of-
fers lifelong immunity to grower pigs. The objective of this study 
was to document the effi  cacy of Enterisol® Ileitis in a herd with 
subclinical Ileitis.
Materials and Methods
A fi eld evaluation was conducted in a 700 sow commercial pig-
gery in Queensland. The presence of Lawsonia was confi rmed 
by ELISA test. Seroconversion was found to be in late fi nisher at 
around 17 to 18 weeks of age. Clinical signs were not observed. 
However some variation in growth rate was observed regularly 
by the management. Two batches of vaccinated animals (Vx) 
were compared to two batches of non-vaccinated animals (CX). 
Pigs were vaccinated with Enterisol Ileitis at 14 days of age. Pigs 
were identifi ed by batch with ear tags. Pigs were housed by 
batch in separate rooms. Growth rates from weaning until 21 
weeks of age for 477 animals 
(2 batches) were calculated and compared to 544 non-vaccin-
ated animals (2 batches). An average weaning weight was col-
lected for each batch of the control groups (6.46Kg, 6.30Kg) and 
vaccinated groups (6.54 and 6.51 kg). Pigs were weighed at 21 
weeks of age in groups.
The farm used in-feed antibiotics against Lawsonia intracellularis 
infections in both treatment groups; OTC at 200ppm from 3 to 8 
weeks of age, Olaquindox at 50ppm from 12 to 14 weeks of age, 
and Tylosin at 100ppm from 18 to 20 weeks of age. No changes 
to in-feed medication or farm management were made during 
the trial. Data was analysed with Statistica® V 8.0. 
Results
Mean Growth rate of vaccinated animals from weaning until 21 
weeks of age was 726 g per day versus Non-vaccinates 678 g 
per day an improvement of 48 g per day. A frequency analysis of 
the data indicates that 61.5 percent of non-vaccinated animals 
grew at growth rates under 700 grams per day. In comparison, 
only 22% of vaccinated animals grew under 700 grams per day 
(p<0.000001). 
Figure 1: Distribution of wean to 21 week average daily weight gain in 
vaccinated and non-vaccinated animlas
Discussion
Vaccination with a live oral vaccine improved growth rate in 
fi nishing pigs and variation signifi cantly. The implications of this 
are that pigs will be turned off  more quickly, reducing feed costs 
and improving profi tability. A reduction of in-feed medications 
specifi cally targeting would also off er further cost savings.
Despite the use of in feed antibiotics, the long lasting protection 
though vaccination against Lawsonia intracellularis signifi cantly 
improved performance. Vaccination improved growth rates and 
variation which resulted in cost savings through reduced to days 
to market.
References
1. Holyoake P.K, Mullan B.P., and Cutler, R.S. (1996) Australian Veterin-
ary Journal; 73: pp. 89-92
Enteric diseases - Grower and fi nisher pigs – Lawsonia intracellularis
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 714
Poster Presentations
P.408
Tylvalosin (Aivlosin®) water medication for control of porcine proliferative 
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Introduction
Porcine proliferative enteropathy (PPE) is a ubiquitous and 
commercially important enteric disease of pigs, caused by the 
obligate intracellular bacterium Lawsonia intracellularis1,2. This 
is the fi rst report of water medication with tylvalosin to control 
PPE on a commercial pig farm. 
Material and Methods
This GCP-compliant trial was conducted in Denmark. Tylvalosin 
(TVN, Aivlosin® 625 mg/g Granules) was administered in drinking 
water at 5 mg TVN/kg bodyweight for 5 days and compared to 
water-soluble tylosin (TylanTM, Elanco). Tylosin is approved in 
Denmark at a dose rate of 5-10 mg/kg bodyweight for 5 days. In 
this study the highest approved dose of tylosin was used namely 
10 mg/kg. 
309 pigs, mean weight 11.5 kg, were allocated to two groups 
(TVN 155, tylosin 154 pigs). 
Within each group response to treatment was assessed (treat-
ment claim). The ability of each product to prevent PPE de-
veloping in clinically normal pen-mates was also assessed 
(prevention, or metaphylaxis claim). 
A diagnosis of PPE was made before the trial using clinical his-
tory, necropsy and faecal PCR. On the fi nal day of treatment (D5 
of the study) 54/78 (69%) faecal samples taken from pigs with 
positive faecal scores were PCR-positive for L. intracellularis. 
Medication started when 27% of all the pigs (85/309) had a 
faecal score of ≥2 (diarrhoea).These pigs were included in the 
treatment claim (TVN 46, tylosin 39 pigs) At this point 155 pigs 
had faecal scores of zero and were assessed for PPE metaphyl-
axis (TVN 72, tylosin 83 pigs). 69 pigs failed to meet the inclusion 
criteria for effi  cacy assessment but were treated and observed 
for adverse reactions. 
The primary effi  cacy variable for the treatment claim was 
faecal score, and for the metaphylaxis claim, the % of pigs that 
developed a faecal score of ≥2 during the study. L. intracellularis 
shedding, average daily liveweight gain, condition, demeanour, 
abdominal appearance and mortality were measured in both 
groups. 
Results
A clear clinical response was observed in the treatment groups. 
Mean faecal score was reduced from 2.13 to 0.24 in the TVN 
group, and from 2.08 to 0.25 in the tylosin group (89% and 88% 
reduction respectively). The clinical scores of the pigs in the TVN 
group were equivalent to those in the tylosin-treated group 
throughout the study. 
Treatment was followed by a signifi cant reduction in the propor-
tion of PCR-positive results in samples taken from pigs in the 
treatment groups (Table 1). 
Table 1: Shedding of L. intracellularis during the trial (% PCR-positive)
Days post-treatment Tylvalosin Tylosin
D5 29/44 (65.9%) 25/34 (73.5%)
D21 3/38 (7.9%) 4/36 (11.1%)
% reduction 88% 85%
In the metaphylaxis group, pre-treatment clinical scores sug-
gested that pigs had sub-clinical disease. Both products were 
very eff ective in preventing the development of diarrhoea dur-
ing the trial, with only one animal in each group developing a 
faecal score of ≥1. 
No pigs died during the study and no adverse reactions were 
observed.
Discussion
In this trial 5 mg tylvalosin/kg bodyweight given in drinking 
water for 5 days was eff ective for treatment of PPE. This dose 
also prevented development of disease in pigs exposed to chal-
lenge from infected pen-mates. Medication was followed by 
signifi cantly reduced shedding of L. intracellularis. 
In conclusion, tylvalosin given at half the dose of tylosin but for 
the same treatment period produced the same clinical eff ect. 
Such a reduction in antimicrobial use is an important objective 
in many European countries. 
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Introduction
Porcine Proliferative Enteropathy (PPE or Ileitis) is due to the 
infection of Lawsonia intracellularis. It is a major factor aff ecting 
intestinal health of growing pigs. The economic impact of ileitis 
has been reported in Australia to be AUD$15.00 /sow/year and 
AUD$141.00 /sow/year with the non-haemorrhagic and hemor-
rhagic PPE respectively 1. The aim of this study was to compare 
the growth performance of vaccinated animals with non-vaccin-
ated animals in a commercial environment. 
Materials and Methods
ELISA testing for serum antibodies prior to the experiment con-
fi rmed infection with Lawsonia intracellularis at about 11 to 12 
weeks of age. Pigs were showing clinical signs of diarrhoea and 
poor growth at 14 to 15 weeks of age. All animals were weaned 
to a separate site and data was collected from all male animals. 
The farm used in-feed antibiotics against Lawsonia intracellu-
laris infections in both treatment groups. Olaquindox at 25ppm 
from 12 to 14 weeks of age, OTC at 200ppm from 15 to 17 weeks 
of age and Tylosin at 50ppm from 18 to 19 weeks of age. No 
changes to in-feed medication or farm management were made 
during the trial. 
Females were not weighed as they were sent to other grow-out 
units for the grower-fi nisher stage. Pigs were housed in con-
ventional housing until 7 weeks of age, straw based shelters 
from 7 to 15 weeks of age. At 15 weeks pigs were moved into 
conventional grower accommodation until slaughter. All pigs 
had liveweight measured at 15 and 19 weeks of age in groups 
of 4 – 6 animals per weight group. Pigs were housed by batch in 
separate sheds. Growth rates of 900 animals (2 batches) vaccin-
ated at 14 days of age were calculated and compared to 1,425 
non-vaccinated animals (3 batches). Growth rates presented are 
calculated from mean liveweight of the group at weaning until 
the 19 week liveweight. An average weaning weight was col-
lected for each batch of the control groups (6.45, 6.42 and 7.16 
kg) and vaccinated groups (6.41and 6.71 kg). Data was analysed 
with Statistica® V 8.0. 
Results
Vaccinated pigs were signifi cantly heavier at both 15 weeks and 
19 weeks of age (Table 1: P<0.001) with liveweight improve-
ments of 3.19 kg and 3.33 kg respectively. Liveweight variability 
as measured by standard deviation was also lower for the vac-
cinated animals at both ages. Wean to 19 week growth rate was 
signifi cantly improved by 30 g/day in vaccinated pigs (Table 1: 
p<0.0005). 
Table 1: Liveweight at 15 and 19 weeks of age and wean to 19 week 
average daily weight gain in vaccinated and non-vaccinated animals
Control Vaccinated P-value
No. of pigs 1,425 900
liveweight 15 wks (kg) 44.73 47.92 0.0002
SD 6.51 5.83
liveweight 19 wks (kg) 71.13 74.43 0.0008
SD 10.82 7.19
Wean to 19 wk ADG (g/day) 589 619 0.001
Discussion
The study indicates that despite the use of in feed antibiotics, 
the lifelong protection though vaccination against Lawsonia 
intracellularis signifi cantly improved performance. Vaccination 
improved growth rates and variation which resulted in cost sav-
ings through reduced to days to market.
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Introduction
Prophylactic measures e.g. vaccination programs are of high 
importance in order to control disease. In the present case the 
eff ect of ileitis and PCV2 vaccination on fi nisher performance 
was examined in a pig fl ow that was already vaccinated against 
PRRSV and Mycoplasma hyopneumoniae (M. hyo).
Materials and Methods
The study took place in a farrow-to-fi nish farm of 1,600 sows and 
10,000 fattening places in Germany. All pigs were housed under 
similar conditions. During the entire evaluation period neither 
the genetics of the pigs nor the management were changed. 
Since 2004 ADG (average daily gain), FCR (feed conversion 
rate), mortality, and amount of antibiotics used against enteric 
diseases (AB use) were monitored batchwise by SPC methodol-
ogy (Statistical Process Control) for the fi nishing unit. ADG, FCR 
and antibiotic use were evaluated by one-way ANOVA, pairwise 
comparison and adjusted by Bonferroni approach. Mortality 
was evaluated using a Chi-square test. All tests were performed 
with the software Statistica® v8.0, Statsoft®. During period I of 
the study (August 2004 – March 2005, 32 batches, 16,032 pigs 
included) sows were mass vaccinated against PRRSV (Ingelvac® 
PRRS MLV) every 4 month. Pigs were vaccinated against PRRSV 
(Ingelvac® PRRS MLV, 14 days of age) as well as against M. hyo 
(21 days of age, M+Pac®). At the beginning of period II (March 
2005 – November 2007, 152 batches, 7,7731 piglets) a third pig-
let vaccine, Enterisol® Ileitis (vaccination by drench, 14 days of 
age) was added. At the beginning of period III (10 batches, 4,932 
pigs included) PCV2 vaccination (Ingelvac CircoFLEX®, same time 
but diff erent injection sites as M. hyo vaccination) was imple-
mented as a fourth vaccine.
Results
Following introduction of ileitis vaccination in 2005 signifi cant 
improvements were observed in ADG (by 33 g/day), FCR (by 
0.1 kg/kg) and mortality rate (by 1.08 %). At the same time, 
the amount of oral antibiotics used decreased by 59 % to 0.9 
kg per fattening group. In 2007 vaccination against PCV2 was 
implemented in addition to the three other vaccines generat-
ing further signifi cant improvements: ADG (+42 g/day) and FCR 
(-0.25 kg/kg).
Table 1: Average performances of pigs over the three periods of time
Period I II III
No. of batches 32 152 10
Vaccines M.hyo, PRRSV M.hyo, PRRSV, Ileitis M.hyo, PRRSV, Ileitis, PCV2
ADG g/day 738 a 771 b 813 b
FCR 3.16 a 3.06 b 2.82 c
Mortality % 4.12 a 3.04 b 3.47 b
AB use kg/group 2.23 a 0.91 b 0 b
Diff erent superscripts indicate a signifi cant diff erence with a p-value ≤ 0.05.
The mortality rate in the observation period III was numerically 
higher than in period II. The breakdown of causes of losses in 
the herd in suspected PCV2-related as well as non-PCV2 related 
cases confi rmed however that the increased losses were not 
attributed to PCV2. In period II (no PCV2 vaccination) every 4th 
loss was considered to be caused by PCV2. In the case of the PCV 
2 vaccinated animals only one pig from a total of 4932 pigs in 
period III could be attributed to a PCV2 infection. 
Discussion
The present work provides an example how additional signifi -
cant improvements in performance are made possible after 
implementation of a third and fourth piglet vaccination into 
an already established vaccination scheme. The two additional 
vaccines Enterisol® Ileitis and Ingelvac CircoFLEX® also increased 
profi tability by generating an overall additional revenue of 
€11.48/pig1. 
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Introduction
Porcine proliferative enteropathy (PPE) caused by Lawsonia 
intracellularis (Li) is one of the most important diseases econom-
ically in the swine industry worldwide (1). Control of the disease 
can be achieved by the use of antibiotics given either parenter-
ally, in feed or in water. The aim of this fi eld trial was to evaluate 
the effi  cacy of an in feed formulation of tylvalosin (TVN, Aivlosin® 
42.5 mg/g Premix, Eco Animal Health) in two diff erent dosage 
regimens at reducing the production losses associated with 
infection with Li.
Materials and Methods
The fi eld trial was conducted on a 1000 sow commercial gilt 
producing farm in Austria. Piglets became naturally infected 
with Li from 5 weeks of age as confi rmed by clinical signs (diar-
rhea, uneven growth), serology and fecal PCR for Li. In total, 782 
piglets, about 5 weeks old, were randomly assigned to three 
groups. The pigs of each group were housed in 8 diff erent pens 
in the same room. Group 1 (n = 262) served as the untreated 
control group. Pigs in group 2 (n = 252) were given feed con-
taining 42.5ppm TVN daily for 14 days. Group 3 (n = 268) pigs 
were given feed containing 85ppm TVN daily for 10 days. These 
inclusion rates were equivalent to dose rates of 2.125 and 4.25 
mg TVN/kg bodyweight for group 2 and group 3 pigs respect-
ively. TVN treatment was started at 5 weeks of age. All pigs were 
ear tagged and individually weighed 3 times: at the beginning 
of the trial (at 5 weeks of age), at 13 weeks of age (end of nursery 
period) and at 24 weeks of age (before slaughter). Data on feed 
intake by pen was available during the nursery phase only. For 
statistical analysis the pen and the pig were used as the experi-
mental unit. Pig uniformity was assessed from the coeffi  cients of 
variation of individual bodyweight by using F test.
Results
Diarrhea was not detected in the treated pigs.
The body weight (BW) at 13 weeks of age and the average daily 
gain (ADG) over the nursery period (G1vs G3 p = 0.0023; G1 
vs G2 p = 0.044) were signifi cantly higher in both TVN treated 
groups compared to the control when analyzing the data by 
pen. As the BW at 5 weeks of age was higher in group 3 the 
initial body weight was included as a covariate in the analysis. 
The Feed Conversion Ratio (FCR) was signifi cantly better during 
the nursery phase for pigs in group 3 vs. group 1 (2.06±0.04 vs. 
2.26±0.04; p = 0.0174). Individual pig analysis by analysis of vari-
ance showed an improvement in BW and ADG for both treated 
groups when compared with untreated control (see table 1). At 
24 weeks of age pigs in group 3 were signifi cantly more uniform 
than the control pigs (G1 vs. G3 Ratio 1.19; p = 0.0046). 
Table 1. Bodyweight (BW) and average daily gain (ADG). Least square 
mean ± standard error. G1: Control; G2: TVN (2.125 mg/kg); G3: TVN 
(4.25 mg/kg)
Group
SE1
p-value
G1 G2 G3 G1 vs G2 G1 vs G3 G2 vs G3
BW (kg)
5 wks 2 9.8 10.0 10.6 0.1 0.1422 <.0001 <.0001
13 wks 34.8 36.1 36.9 0.2 0.0001 <.0001 0.0095
24 wks 96.0 98.6 98.8 0.6 0.0032 0.0015 0.8152
ADG (g)
5-13 weeks 503 529 546 5 0.0001 <.0001 0.0095
13-24 weeks 733 749 741 6 0.0534 0.3128 0.3602
5-24 weeks 648 668 669 5 0.0030 0.0014 0.8097
1 Standard error. 2 BW at 5 weeks became covariate in the analysis.
Discussion
Tylvalosin has previously been proven to be eff ective against 
infection with Li using two diff erent dosage regimens (2, 3). In 
this trial the comparison of TVN at 2.125 mg/kg body weight 
for 14 days and 4.25 mg/kg for 10 days with a negative control 
confi rmed the eff ective reduction of production losses caused 
by Li. Pigs that received the higher dose were more uniform in 
weight at the time of slaughter. Analysis of the individual pig 
data between treatments confi rms that bodyweight at slaughter 
and the ADG during the whole trial period was better with both 
dosage regimens when compared to the control and not signifi -
cantly diff erent from each other. It appears that one well timed 
treatment with Aivlosin® can result in a reduction of productivity 
losses due to PPE.
References
1. McOrist S. 2005. Vet. J. 170, 8-9.
2. Guedes R.M.C. et al. 2009. Vet. Rec. 165, 342-45.
3. Pommier P. et al. 2008. Rev. Med. Vet. 159, 579-82.
Enteric diseases - Grower and fi nisher pigs – Lawsonia intracellularis
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 718
Poster Presentations
P.412
Denagard® (tiamulin) liquid concentrate dose titration in a Lawsonia intracellularis 
Mucosal Homogenate Ileitis challenge study - performance response
Nathan Winkelman1 Mark Hammer2 Linda Roycroft2 Ulrich Klein3 Connie Gebhart4
1. Swine Services Unlimited Inc, Rice, MN, USA; 2. Novartis Animal Health, Greensboro, NC, USA; 
3. Novartis Animal Health Inc., Basel, Switzerland; 4. University of Minnesota, St. Paul, MN, USA
Introduction
Clinical and subclinical ileitis (PPE) is ubiquitous in the global 
swine industry. Both forms have an economical impact on a 
swine unit’s profi tability. A Lawsonia intracellularis (Li) disease 
challenge model can reproduce both forms of the disease1. 
Denagard® administered in the water at 60 ppm is very eff ective 
in minimizing the negative impact of PPE on growth perform-
ance2. There is no information on the effi  cacy of higher doses of 
tiamulin (LC) to possibly eliminate PPE carriers during the course 
of treatment or after the treatment is withdrawn. The objective 
was to compare three treatment dose levels of tiamulin LC in 
pigs given a high dose Li mucosal homogenate challenge. 
Materials and Methods
One hundred and fi fty fi ve-week-old PPE naïve crossbred pigs 
were randomized by weight and gender into fi ve treatment 
groups of 30 pigs per group (6 pens with 5 pigs/pen): T1 was a 
strict negative control group (unchallenged, no medication), 
T2 was a positive control group (Li challenged, no medication), 
T3, T4, and T5 were all Li challenged groups receiving 60, 120, 
and 180ppm Denagard respectively. All pigs were individually 
infected by intraoesophageal gavage with 2.0 x 109 Li organisms 
per pig on Day 0. Treatment with tiamulin water medication 
was initiated on Day 7 (DM = fi rst day of medication) when 20% 
of pigs and 60% of the pens had a minimum fecal score of 1 
(semi-solid feces). Treatment continued to Day 12 (DM+5) when 
all pigs returned to non-medicated water for the remainder of 
the study. All surviving pigs were euthanized on Day 27 (DM+20) 
post Li challenge. Gross pathological PPE lesion scores were 
recorded for each pig on Day 27. Pigs were individually weighed 
and feed consumption per pen was recorded on Day -1 (acclima-
tion start), DM, DM+5, DM+10, DM+15 and DM+20 for individual 
average daily gain (ADG), pen Feed Conversion Ratio (FCR –feed/
gain) and Average Daily Feed Intake (ADFI) calculations. Pen was 
the experimental unit in all analyses.  
Results – Performance Variables
Body weights were signifi cantly higher in all treatment groups 
compared to the positive control from DM+10 to DM+20. 
Overall Average Daily Gain: (ADG from (DM to DM+20) was 
signifi cantly lower for the positive control group compared to 
all other groups and signifi cantly higher for the negative control 
compared to all groups. There were signifi cantly higher ADFI and 
improved FCR in all three  treatment groups compared to the 
positive Li challenged control groups. Gross Pathology: Signifi -
cantly lower PPE gross lesion scores in the ileum, jejunum, and 
colon in all treatments compared to the T2 challenged controls 
were found. There were also signifi cantly lower ileal PPE scores 
in the Denagard 120 ppm and Denagard 180 ppm compared to 
the Denagard 60 ppm treatment groups. The  lesion length was 
signifi cantly longer in the T2 challenged controls compared to 
all other treatment groups. The T1 non-challenged control group 
remained negative throughout the study as evidenced by no 
fecal PCR positives and lack of Li IPMA titers (not shown).
Discussion
There were no diff erences between the three tiamulin LC treat-
ments in performance variables. The results show excellent 
effi  cacy at the 60 ppm dose even when pigs were challenged 
with a high (109) Li mucosal homogenate in which PPE mortality 
occurred in the challenged controls. Ileum PPE scores were sig-
nifi cantly better in the 120 ppm and 180ppm groups compared 
to the 60 ppm group. No other group diff erences in pathological 
scores were identifi ed. 
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Introduction
Clinical and subclinical ileitis (PPE) is ubiquitous in the global 
swine industry. Both forms have a negative economical impact 
on a swine unit’s profi tability. A Lawsonia intracellularis (Li) dis-
ease challenge model can reproduce both forms of the disease1. 
Denagard® administered in the water at 60 ppm is very eff ective 
in minimizing the negative impact of PPE on growth perform-
ance2. There is no information on the effi  cacy of higher doses of 
tiamulin (LC) to possibly eliminate PPE carriers during the course 
of treatment or after the treatment is withdrawn. The objective 
of this trial was to compare three treatment dose levels of tiamu-
lin LC and control pigs given a high dose Li mucosal homogen-
ate challenge. The clinical data is shown in this abstract.
Materials and Methods 
One hundred and fi fty fi ve-week-old PPE naïve cross-bred pigs 
were randomized by weight and gender into fi ve treatment 
groups of 30 pigs per group (6 pens with 5 pig/pen): T1 was a 
strict negative control group (unchallenged, no medications), 
T2 was a positive control group (Li challenged, no medication), 
T3, T4, and T5 were all Li challenged groups receiving 60, 120, 
and 180ppm Denagard respectively. All pigs were individually 
infected by intraoesophageal gavage with 2.0 x 109 per pig Li 
organisms on Day 0. Treatment with tiamulin water medication 
was initiated on Day 7 (DM = fi rst day of medication) when 20% 
of pigs and 60% of the pens had a minimum fecal score of 1 
(semi-solid feces). Treatment continued to Day 12 (DM+5) when 
all pigs returned to non-medicated water for the remainder of 
the study. All surviving pigs were euthanized on Day 27 (DM+20) 
post Li challenge. Parameters recorded daily were mortality, ab-
dominal appearance score (AAS), pig demeanor score (DS), and 
fecal score (FS). Gross PPE lesion scores were recorded for each 
pig on Day 27. Pigs were individually weighed and feed con-
sumption per pen was recorded on Day -1 (acclimation start), 
DM, DM+5, DM+10, DM+15 and DM+20 for individual average 
daily gain (ADG), pen Feed Conversion Ratio (FCR) and Average 
Daily Feed Intake (ADFI) calculations. In addition, fecal samples 
were collected on all pigs on days DM, DM+5, DM+10, DM+15, 
and DM+20 for Li polymerase chain reaction (PCR) analysis. Li 
immunoperoxidase monolayer assay (IPMA) serum samples 
were collected from two pigs/pen on Day -1 and DM+20. Pen 
was experimental unit for all analysis. 
Results – PPE Mortality and Clinical Observations 
a,b diff erent letters between treatments are sign. diff erent p<0.05
*Abnormal Score % = % of pig-days with abn. score per pen. 
Mortality: There were three pigs which died due to PPE, all in the 
T2 challenge control group. Fecal Score: There was a signifi cantly 
higher average pen fecal score for the positive control group 
when compared to all other groups on all days after day DM+1. 
Abdominal Appearance Score: There was signifi cantly higher 
average AAS for the positive control group when compared 
to all other groups starting on DM+7 and continuing each day 
through DM+20. Demeanor Score: There was a signifi cantly 
higher average pen demeanor score for the positive control 
group compared to all other treatments from DM+10 through 
DM+20. 
Discussion 
There were no diff erences between the three tiamulin LC treat-
ments in clinical measures. The results show excellent effi  cacy 
even at the 60 ppm dose when pigs were challenged with a high 
(109) Li mucosal homogenate in which mortality occurred in the 
challenged controls. 
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Introduction
Porcine proliferative enteropathy (PPE), or ileitis, caused by the 
obligate intracellular bacterium Lawsonia intracellularis (Li), is an 
important enteric disease of swine1. In vitro studies have dem-
onstrated that tylvalosin accumulates rapidly in high concentra-
tions inside intestinal epithelial cells2, and has proven effi  cacy in 
the control of PPE when administered in-feed3-5. The objective of 
this study was to evaluate the effi  cacy of tylvalosin administered 
in drinking water for the treatment of PPE in weaner pigs. 
Materials and Methods
In this multi-centre study with three separate sites, 144 fi ve 
week-old weaned pigs at each site (Rice, Minnesota; Harrisonburg, 
Virginia; Burford, Ontario) were randomly assigned to one of three 
treatment groups: Challenged – Untreated, Challenged – Treated 
(50 ppm Aivlosin in drinking water) and Challenged – Treated (75 
ppm Aivlosin in drinking water). Pigs were orally challenged with 
Li from a fi eld case of PPE on Day 0. Drinking water was medi-
cated with Aivlosin® Water Soluble Granules (ECO Animal Health, 
London, UK) for fi ve consecutive days and treatment began when 
~15% of pigs had semi-solid feces. Body weights and feed con-
sumption were measured throughout the study. Twenty-two days 
after the start of treatment fecal samples were collected for PCR 
analysis and all surviving animals were euthanized. At necropsy, 
the intestinal tract was scored for gross lesions consistent with 
PPE and ileal samples were obtained for immunohistochemistry 
(IHC) analysis. Statistical analyses were conducted using analysis 
of variance and contingency table methods.
Results and Discussion
During the study, 14.9% of the untreated pigs died due to PPE 
infection. There was no mortality due to PPE in either of the 
treated groups, and this diff erence was signifi cant (P<0.01) 
when compared with the untreated group. Pigs in both treated 
groups had signifi cantly improved mean pen gross lesion scores 
(P<0.03), and pen production parameters (Table 1), compared to 
the non-medicated group. Signifi cantly decreased frequencies 
of Li positive fecal PCR and ileal IHC samples were found in the 
treated groups compared to the untreated group (Table 1).
Table 1. Mean pen average daily gain (ADG) and feed effi  ciency (gain/
intake) and proportion of pigs testing positive for Li by fecal PCR and 
IHC at study termination.
Treatment Groups
No medication Aivlosin 50 ppm Aivlosin 75 ppm
ADG (kg/pig/day) 0.31a 0.48b 0.49b
Feed effi  ciency (gain/intake) 0.41a 0.54b 0.56b
% positive PCR 73a 50b 52b
% positive IHC 91a 46b 39b
abRows with no common letters are signifi cantly diff erent at p<0.03
The decreased frequency of positive fecal PCR samples collected 
at the end of study indicates that fecal shedding of Li was re-
duced due to treatment when compared to the untreated pigs. 
Appetite may be depressed as a result of Li infection. Therefore 
administration of Aivlosin® in drinking water can be advanta-
geous as pigs can receive adequate uptake of the drug. Water 
medication also allows treatment to be initiated promptly once 
a diagnosis has been confi rmed and the relatively low dose and 
short treatment duration is consistent with prudent use of anti-
biotics6. This study demonstrates that tylvalosin administered 
in drinking water is eff ective in reducing mortality, intestinal 
lesions, fecal shedding of Li and growth suppression that are as-
sociated with PPE in pigs orally challenged with Li.
References
1. McOrist S, Gebhart CJ. Proliferative enteropathies. In: Straw et al., eds. 
Diseases of Swine. 9th ed.Oxford, UK. Blackwell Publishing. 2006.
2. Stuart AD, et al. Intra-cellular accumulation and trans-epithelial 
transport of aivlosin, tylosin and tilmicosin. Pig J. 2007. 60:26-35.
3. Guedes RMC, et al. Use of tylvalosin-medicated feed to control porcine 
proliferative enteropathy. Veterinary Record. 2009. 165:342-345 
4. Pommier P, et al. Comparison of Tylvalosin with Tylosin for the 
control of subclinical ileitis in swine. Revue de Medecine Veterinaire. 
2008. 159(11):579-582. 
5. Tasker JB, et al. Use of Aivlosin in feed for control of ileitis in USA and 
Europe. Proc IPVS Cong. Hamburg, Germany. 2004 (1):256.
6. Holyoake PM, et al. Identifying obstacles to reducing the use of anti-
biotics to control porcine proliferative enteropathy. Aust Vet J. 2009. 
87(1&2):33-34. 
Enteric diseases - Grower and fi nisher pigs – Lawsonia intracellularis
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 721
Poster Presentations
P.415
Eﬃ  cacy of Aivlosin® Type A Medicated Article for the control of porcine proliferative 
enteropathy in pigs challenged with Lawsonia intracellularis
Elizabeth M. Abbott2 Mark J. Gnozzio3 Rickie  J. Domangue4 Nate Winkelman5 Chris D. Eliopoulos3 Sharon A. Bauer6 Jeff  B. Wilson1
1. Novometrix Research Inc, Moff at, Canada; 2. Eco Animal Health, London, UK; 3. Eco LLC, Princeton, NJ, USA; 4. Statistical Consulting 
Services, Broadway, VA, USA; 5. Swine Services Unlimited, Rice, USA; 6. Novometrix Research Inc., Guelph, ON, Canada
Introduction
Porcine proliferative enteropathy (PPE), or ileitis, is a signifi cant 
enteric disease in swine. The obligate intracellular bacterium 
Lawsonia intracellularis (Li) is the etiologic agent, and the disease 
is characterized by a thickening on the mucosa of the small 
intestine and colon, evident at necropsy1. Tylvalosin, a macrolide 
antimicrobial, has demonstrated effi  cacy in the control of PPE2-4. 
The objective of this multi-site study was to evaluate the ef-
fi cacy of tylvalosin administered in feed for the control of PPE in 
weaner pigs challenged with Li. 
Materials and Methods
Two studies were conducted at separate sites in North America. 
144 four-week–old weaned pigs in each study were randomly 
assigned to one of two groups: treated (42.5 ppm tylvalosin in 
feed) or untreated (0 ppm). Pigs were orally challenged with Li on 
Day 0. Treatment began when ~15% of pigs had semi-solid feces 
and continued for 14 days. Pigs were scored daily for abdominal 
appearance, demeanor and fecal consistency. Body weights and 
feed consumption were measured throughout the study. Animals 
were euthanized 21 days after the start of treatment. At necropsy, 
the intestinal tract was scored for gross lesions consistent with 
PPE and ileal samples were collected for immunohistochemistry 
analysis. Data from the two study sites were analyzed separately 
using analysis of variance and contingency table methods.
Results and Discussion
Cumulative mortality due to PPE was lower in the treated pigs 
across the study sites, with statistically signifi cant (P<0.03, Table 
1) diff erences observed at one of the two sites. 
Table 1. Proportion of pigs that died due to PPE, mean proportion of 
pens with abnormal fecal scores and mean pen lesion scores for the 
treatment groups across both sites. 
Study Site Rice, MN Burford, ON
Treatment Group 0 ppm Aivlosin 42.5 ppm 0 ppm Aivlosin 42.5 ppm
PPE Mortality (%) 1.4 0.0 15.5a 4.2b
Pen fecal score (%) 51.4a 14.7b 67.7a 39.9b
Pen lesion score 0.61a 0.29b 0.89a 0.67b
abRows at each site with diff erent letters are signifi cantly diff erent at p<0.03
Pigs in the treated groups at both sites had signifi cantly improved 
mean pen gross lesion scores (P<0.03) and mean pen fecal scores 
(P<0.001) compared with the untreated pigs (Table 1). Pen feed 
effi  ciency was signifi cantly increased (P<0.05) in the treated pigs 
compared with the untreated (Table 2). Mean pen average daily 
gain was numerically greater in treated pigs and this diff erence 
was signifi cant (P<0.001, Table 2) at one study site.
Table 2. Mean pen average daily gain (ADG) and mean pen feed ef-
fi ciency (gain/intake) at 21 days after start of treatment.
Study Site Rice, MN Burford, ON
Treatment Group 0 ppm Aivlosin 42.5 ppm 0 ppm Aivlosin 42.5 ppm
ADG (kg/pig/day) 0.61 0.64 0.18a  0.34b
Feed effi  ciency (gain/intake) 0.50a 0.53b  0.24a  0.40b
abRows at each site with diff erent letters are signifi cantly diff erent at p<0.05
Treatment with Aivlosin® Premix for 14 consecutive days in Li 
challenged pigs was associated with signifi cantly lower gross 
PPE lesion scores in the treated groups when compared with 
untreated animals. Mortality due to PPE was decreased in the 
treated pigs compared with the untreated group. The treated 
groups showed improved performance in production param-
eters such as ADG and feed effi  ciency. 
Consistent with previous studies2-4, this multi-site study dem-
onstrates that Aivlosin® Premix is eff ective in reducing mortality, 
clinical signs, intestinal lesions, and growth suppression that are 
associated with PPE in weaner pigs orally challenged with Li.
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The prevalence of swine enteropathogens in Brazilian grow/ﬁ nisher 
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Introduction
Brazil is the fourth largest pig producer in the World, behind 
China, the European Union and United States. The state of Minas 
Gerais is the fourth largest producer of pork in Brazil, and the 
growth of pig production in the state has been increasing year 
after year. As a result, it is necessary to accurately detect and 
identify porcine pathogens in order to devise proper treatments 
and prevention programs1. Enteric infections are among the 
most frequent problems in pig production, being responsible for 
signifi cant losses. The purpose of this study was to determine the 
prevalence of the enteric pathogens and the occurrence of mixed 
infections in Brazilian growing/fi nishing pigs in herds with diar-
rhea or a history of diarrhea in the state of Minas Gerais, Brazil.
Materials and Methods
Forty-six farrow-to-fi nish herds; 31 with 101-500 sows and 15 
with >500 sows; with diarrhea or a history of diarrhea were ran-
domly selected from four diff erent geographical regions of the 
state of Minas Gerais, Brazil [south and southwest (SSW), metro-
politan area of “Belo Horizonte” (MBH), “zona da mata” (ZM) and 
Triangle mining and high “Paranaiba” (TMHP)]. Randomly were 
collected feces from rectum for approximately 10 animals of 
each property between 60 and 140 days old. Multiplex PCR was 
used for the diagnostic of L. intracellularis, B. hyodysenteriae and 
B. pilosicoli2 and for enterotoxigenic E. coli3. For the detection of 
Trichuris suis eggs in the swine faeces, the faecal samples were 
individually examined by fl otation technique (Willis-Mollay). Sal-
monella was isolated according Waltman, 20004. For statistical 
analyses Fischer’s exact test was used.
Results
A total of 512 faecal samples were examined. The analysis by 
the Fisher exact test showed no signifi cant association between 
the pathogen and the size of the farm. The only subspecies of 
Salmonella spp. found, potentially pathogenic for pigs, was 
Salmonella enterica subspecies Typhimurium. The results are 
demonstrated in Table 1. The mainly mixed infection observed 
was Salmonella Typhimurium associated with L. intracellularis 
present in 5 herds (10,8%). T. suis eggs and B. hyodysenteriae 
were not diagnosed. The B pilosicoli was observed in two farms 
with mixing infection cases. The most prevalent enterotoxigenic 
E. coli virotype was StaP-Stb-F18.
Table 1. Distribution of prevalence according to herd size and pathogen.
Herds
Pathogen 101-500 500 Total Prev.
No % No % No %
E. coli enteroxigenic 2 4.3 3 6.5 5 10.8
L. intracellularis 5 10.8 4 8.7 9 19.5
S. Typhimurium 1 2.2 2 4.3 3 6.5
Mixed infection 10 21.7 4 8.7 14 30.4
Discussion
The prevalence of herds only infected by L. intracellularis was 
19.5%. This result is in agreement with previously reports from 
other countries, where the prevalence of L. intracellularis varied 
between 15% and 93.7%5. The diff erences among prevalence 
indexes observed may be due to regional variations, diff erent 
swine breeding systems, antibiotics use and population sam-
pled. The prevalence of mixing infections was high in our work 
when compared with European data5. The overall prevalence 
for Salmonella Typhimurium alone (6.5%) was elevated mainly 
when we associate this bacterium to the cases of mixing infec-
tion. The presence of enterotoxigenic E. coli in grow/fi nishing 
pigs it is not clear. It seems that this pathogen may alter the eco-
logical gut fl ora, which would favor some pathogenic bacteria6.
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Introduction
Rodents have been identifi ed as potential vectors for a number 
of bacterial pathogens of pigs, including Lawsonia intracellularis1, 
Brachyspira pilosicoli, and B. hyodysenteriae2. Monitoring the 
dispersal of rodents between piggeries in relatively close proxim-
ity may be important in assessing the risk of transmission of these 
pathogens to naïve pigs, especially following disease eradication 
programs. The aim of this study was to use microsatellite markers 
to demonstrate the genetic diversity between rats trapped at two 
separate pig farms and therefore rodent dispersal. 
Materials and Methods
Twenty-eight black rats (Rattus rattus) were caught in snap traps 
over a three month period in two pig units separated by one kilo-
metre (sites A and B). During this period, pigs had been removed 
from site A as part of a swine dysentery eradication program. 
Both pig farms were surrounded by natural boundaries to rodent 
dispersal (roads and rivers) but alternate food sources were avail-
able at neighbouring pig farms (4 and 9km away). Genomic rat 
DNA was extracted from the rat’s ears using a QIAGEN tissue kit 
(DNeasy). Microsatellite markers were amplifi ed from the rat DNA 
as previously described3-4 using 8 sets of PCR primers (D5Rat83, 
D8Rat28, D11Rat56, D16Rat81, D18Rat75, Rr54, Rr107 and Rr114). 
PCR products were typed with an ABI genetic analyzer using the 
GeneMapper v3.7 software (Applied Biosystem). The genetic re-
latedness of rats was analyzed with STRUCTURE software5 trialing 
the number of populations (k=1-5).
Faecal samples were collected from pigs at site B at the comple-
tion of rat trapping. DNA extracted from pig faeces and rat 
intestines were tested for the presence of L.intracellularis, 
B.hyodysenteriae and B.pilosicoli by conventional PCR.
Results
All of the microsatellite loci except D8Rat28 were polymorphic in 
our rat populations. A total of 27 alleles were detected across the 
8 microsatellite loci in population A versus 26 alleles in popula-
tion B. However, 66% of alleles were common in both popula-
tions and 44% were diff erent between populations A and B. The 
genotypes of the 28 rats analyzed was best explained by one 
population (maximum log likelihood reached a plateau at k=1).
L.intracellularis DNA was detected in the faeces of the majority of 
the pigs sampled, but was not detected in the small intestine of 
any rats. B.hyodysenteriae and B.pilosicoli DNA were not detected 
in any of the porcine faecal samples or rat intestinal samples. 
Discussion
The genotype of rats trapped at the two units was similar, sug-
gesting that rats were able to interbreed, and could travel more 
than 1km. This was signifi cantly further than previously thought6, 
and may have been due to the scarcity of food at site A during 
the swine dysentery eradication program. While rats are unlikely 
to travel far from pig farms where food and shelter are provided, 
pig depopulation as part of a disease eradication program may 
provide the stimulus for dispersal. Although we didn’t fi nd porcine 
enteric pathogens in rats trapped at these pig farms, previous 
reports have found L.intracellularis and B.hyodysenteriae in rats 
trapped on pig farms1, 2. If rodents can travel more than 1km 
between pig farms, disease eradication programs may be more 
eff ective if performed on a regional basis.
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Introduction and Objectives
The research group at León University (Spain) is working on 
diff erent topics associated with swine dysentery (SD), a severe 
mucohaemorrhagic diarrhoeal disease that primarily aff ects pigs 
during the growing-fi nishing period caused by B. hyodysenteriae. 
We have found that more than 30% of Spanish farms and 12% of 
faecal specimens testing positive for B. hyodysenteriae (1). How-
ever, it is necessary to obtain information about the population 
structure of B. hyodysenteriae in Spain. A multilocus sequence 
typing (MLST) scheme was used as a tool for investigating the 
diversity of Spanish isolates of B. hyodysenteriae (2).
Material and Methods
In total, 50 Spanish and 1 Portuguese isolates of B. hyodysenter-
iae from 47 farms spread all around the country were included in 
the analysis. All isolates were recovered from pigs aff ected with 
SD between 2001-2007 and came from the collection held at the 
University of León. Isolates were obtained from the most import-
ant pig production regions of our country. Data from strain refer-
ence B204 were obtained from PubMLST (http://pubmlst.org) 
and included in the study. Seven MLST loci (2) were used and 
the MLST results were visualised by constructing a dendrogram 
using the unweighted pair-group method for arithmetic means 
(UPGMA) in START2 (3).
Results
Spanish isolates were allocated to 9 sequence types (STs), of 
which 7 were new with an allele frequency ranging from 2 to 8 
per locus. The predominat ST1 included 21 Spanish isolates from 
18 farms located in 8 diff erent autonomous regions distributed 
from the North to the South of the country. STs 2, 8 and 10 each 
also included several isolates from diff erent regions. ST8 is wide-
spread as well whilst ST2 appeared in the northen regions of the 
country. 4 singletons were identifi ed (4, 5, 6 and 9), one of them 
represented by the Portuguese isolate (H32). We confi rmed 
than B. hyodysenteriae got a moderate heterogeneity as previ-
ously described for Australian isolates (2). Based on the number 
of isolates the population had an Index of Association value of 
0.786 and 0.990 based on the number of STs. Signifi cant linkage 
disequilibrium was found in both analysis (P=0,000; P=0.001). 
For 5 Spanish farms where multiple isolates were available, 2 
of the isolates belonged to diff erent STs (1 and 8). The eBURST 
analysis (data not shown) indicated ST1 and ST8 do not belong 
to the same clonal complex pointing out that 2 isolates might be 
present in the same farm at the same time. When we combined 
our 51 isolates to the population as a whole (2) we found 3 
monophyletic clusters each including 3 STs.
Discussion
This study has gained an insight into the population structure 
of B. hyodysenteriae using a reliable method which provides use-
ful molecular epidemiological data to investigate the diversity 
of B. hyodysenteriae isolates, and allows the easy comparison 
of results between laboratories. The bacterial population was 
found to be clonal with evidence of likely transmision of strains 
between farms all around the country. Three major lineages of 
descent have been detected in Spain.
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Fig. 1 Dendrogram showing the relationships 
of 9 sequence types (STs) obtained from 51 B. 
hyodysenteriae isolates. Reference strain B204 
was also included.
Fig. 2 Map repre-
senting the autono-
mous regions of 
Spain. Regions where 
farms were located 
are coloured and the 
number of isolates/STs 
are indicated.
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ELISA using meat juice to detect herds with swine dysentery
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Introduction
Swine dysentery (SD) is a mucohaemorrhagic colitis resulting 
from infection of the large intestine with the anaerobic spiro-
chaete Brachyspira hyodysenteriae. Successful disease control 
programmes rely on accurate, cost-eff ective and timely detec-
tion of infected animals and herds. Recently an enzyme-linked 
immunosorbent assay (ELISA) using recombinant Bhlp29.7, an 
outer membrane protein of the spirochaete, has been shown to 
have potential to be used at the herd level as a routine sero-
logical surveillance test (1). The aim of the current study was to 
determine whether the ELISA could be used with muscle fl uid 
from pigs at slaughter to detect evidence of B. hyodysenteriae 
infection in herds with SD.
Materials and Methods
Pigs from two healthy herds, and three with a recent history of 
SD, were sampled. Disease in the infected herds was routinely 
controlled using in-feed medication. Diaphragm muscle from 50 
fi nisher pigs in each herd was collected at slaughter. A piece of 
muscle was excised and placed into the mouth of a sterile plastic 
funnel set over a sterile bottle. This was covered with plastic fi lm, 
held at -20°C overnight, and after thawing the passively-released 
muscle fl uid (“meat juice”) was collected. The samples were 
diluted 1:20 in PBS and were tested in two ELISAs for specifi c IgG 
and IgM against recombinant Bhlp29.7, as previously described 
(1). The optical density (OD) was measured at 450 nm on a 
microplate reader. For across-plate standardization, a positive 
control consisting of a meat juice sample collected from a pig 
that previously had recovered from SD, was added in triplicate 
to each plate. Calibrated ODs were calculated according to the 
following formula: (OD value of test sample - OD value of blank 
control)/average of (OD value of control sample - OD value of 
blank control). Cut-off  values were calculated as the mean plus 
three standard deviations of the readings from the samples from 
the two negative herds. Herds with any pigs with readings over 
that value were considered to be infected
Results
The diagnostic threshold values for the assays were set at ODs of 
0.68 ± 0.13 for IgG and 0.64 ± 0.12 for IgM. Using these criteria, 
the two negative herds were recorded as negative in both 
assays. Single serum samples from each of the three infected 
herds exceeded these cut-off  values in the two ELISAs. In each 
of these herds, diff erent serum samples werer positive in the IgG 
and IgM ELISAs. 
Discussion
Meat-juice ELISAs have been used in a number of sero-epi-
demiological studies and in surveillance for specifi c microbial 
diseases of pigs (eg 2). Taking muscle samples at the abattoir 
avoids on-farm biosecurity risks, and generally muscle samples 
are easier to collect at the abattoir than are blood samples. 
Although serological ELISAs previously have been developed for 
detecting SD at the herd level, this is the fi rst report where meat 
juice samples have been used as a source of antibodies. Under 
the test conditions, both the IgG and IgM ELISAs were specifi c 
and sensitive as herd tests. The IgM ELISA may detect more 
recent infection than the IgG ELISA.
Although Bhlp29.7 worked well as a plate-coating antigen in the 
current study, a recent report that the gene encoding Bhlp29.7 
could not be detected by PCR in 33 (45%) recent German iso-
lates of B. hyodysenteriae is of concern (3). Consequently, further 
work is required to identify additional specifi c B. hyodysenteriae 
antigens that can be used in meat juice (and serum) ELISAs.
In conclusion, meat juice samples from pigs in herds with SD 
contain IgG and IgM antibodies that react with B. hyodysenteriae 
antigens. As such, testing meat juice samples is a convenient 
way for screening herds for SD. Such testing could be integrated 
into other meat juice ELISA screening, for example for Salmon-
ella infections.
This study was supported by a grant from the Australian 
Cooperative Research Centre for an Internationally Competitive 
Pork Industry (“the Pork CRC”). 
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N-terminal amino acid sequencing of 22kDa protein in Brachyspira hyodysenteriae 
reacting strongly with convalescent antibody of pig aﬀ ected with swine dysentery
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Objectives
Presence of 22kDa has been discovered by using convalescent 
antibodies after recovering from swine dysentery. The antigen 
has been confi rmed among 11 serogroups and 17kDa antigen as 
well. However, we have never been studying on amino acid se-
quencing of the 22kDa protein and gene cloning. In this paper, 
we attempted amino acid sequencing of the protein.
Materials and Methods
ATCC27164, ATCC31212, B169, A1, WA6, Q16, NSW1, ATCC49887, 
and ATCC29796 were used in this test. SDS-PAGE was carried out 
according to Ochiai et al.(2000). 2D-PAGE were carried out as 
previously described(2000).Amino acid sequencing was carried 
out for the comparison of .the amino acid sequence among 
serogroups.
Results and Discussion
The 22 and 17kDa proteins of Brachyspira hyodysenteriae which 
reacted with convalescent antibody have been analyzed by a 
peptide sequencer after 2 dimension polyacrylamide electro-
phoresis. The results demonstrated the N-terminal amino acid 
arrangement was consistent among ATCC27164, ATCC31212, 
and B169 but it did not get any results by western blotting 
technique after SDS-PAGE. The amino acid arrangement was 
Met-Thr Val-Thr-Phe-Gln-Gly-Ala-The-Gln. These results indicated 
that 22kDa protein was species specifi c antigen of Brachyspira 
hyodysenteriae. Furthermore, the 22kDa protein has been found 
in every isolate of 11 serogroups of Brachyspira hyodysenteriae, 
they also reacted strongly with the infected piglet sera and they 
was also digested with poteinase K. Therefore, 22kDa protein 
was real protein and it also may play a role of the protection 
against swine dysentery . It may be like 16kDa antigen as de-
scribed by Sellwood(1995)( 1 ). 
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Introduction
Brachyspira hyodysenteriae, the etiological agent of swine 
dysentery, and less commonly Brachyspira pilosicoli, the infec-
tious agent of spirochaetal diarrhoea, are frequent causes of 
colitis and diarrhoea in grower and fi nisher pigs. Especially swine 
dysentery causes considerable economic loss for pig farmers 
due to reduced weight gain, mortality and cost-intensive treat-
ment, eradication and preventive measures. To get the disease 
under control, a quick and reliable laboratory diagnosis is a 
prerequisite. Up to date, culture is a very common since highly 
sensitive method, with the disadvantage of being extraordinar-
ily time-consuming and therefore leading to delayed diagnosis 
with all its negative consequences. The use of PCR as a very 
rapid method could solve the problem, given a similar sensitiv-
ity and specifi city to culture. However, veterinarians and farmers 
fear false positive results from PCR including all consequences 
for trading of piglets and gilts, and, therefore, sometimes prefer 
the cultural isolation. To evaluate the accuracy of PCR under fi eld 
conditions, PCR applied in routine diagnostics was compared to 
culture for its level of agreement.
Material and Methods
Data obtained from routine diagnostics between Jan 2006 and 
Dec 2009 in North-Western Germany was analysed retrospect-
ively: Results from faecal samples or anal swabs from pigs that 
were submitted to the Field Station for Epidemiology for the pur-
pose of detecting enteric pathogens were extracted from a SQL 
database. Datasets were further fi ltered for those where samples 
had been examined for the presence of Brachyspira species by 
both methods PCR and culture. The multiplex PCR assay applied 
to the samples detects specifi c genome fragments of Brachyspira 
hyodysenteriae and Brachyspira pilosicoli and additionally frag-
ments of Lawsonia intracellularis (Nathues et al. 2007). For cultural 
testing, identical samples were examined on Brachyspira selective- 
and Columbia Blood Agar incubated anaerobically at 42 degree 
Celsius for at least 6 days. Diff erentiation of Brachyspira species 
was based on biochemical reactions and nox-RFLP. For statistical 
analysis of the data SAS®, version 9.1., was used to calculate the 
κ-value as measure of concordance.
Results
During four consecutive years (2006-2009), 6,228 samples were 
tested for the presence of specifi c genome fragments of B. 
hyodysenteriae and B. pilosicoli by PCR. Overall, 184 samples were 
tested by both PCR and culture since the veterinarians and/or 
farmers did not rely on PCR alone. In 61 samples, unidentifi able 
Brachyspira spp. or others than B. hyodysenteriae / B. pilosicoli 
were detected culturally. These cases were excluded from fur-
ther analysis to maintain exact comparability. Of the remaining 
123 samples, 44 were positive for B. hyodysenteriae in PCR com-
pared to 55 in culture, resulting in detection rates of 35.8% (PCR) 
versus 44.7 % (culture). Twelve samples identifi ed as positive 
culturally were negative in PCR whereas one sample negative in 
culture resulted positive in PCR. The level of agreement is 80.1 %. 
Only in one sample B. pilosicoli was found (detection rate of 0.8 
%), this being positive in PCR and culture, resulting in an agree-
ment of 100%. The unweighted κ-value is 0.78, which is 96 % of 
the maximum possible κ-value of 0.82.
Table 1: Results for Brachyspira hyodysenteriae and Brachyspira pilosi-
coli from culture and PCR
PCR / 
negative
PCR / B. hyodysenteriae 
positive
PCR / B. pilosicoli 
positive
Culture / negative 66 1 0
Culture / B. hyodysenteriae 
positive 12 43 0
Culture / B. pilosicoli positive 0 0 1
Discussion
This retrospective analysis on a subset of data obtained by 
routine diagnostic indicates a substantial to almost perfect 
agreement between results from PCR and culture to detect 
B. hyodysenteriae and B. pilosicoli. As mentioned, culture was 
preferred in terms of suspicion of better specifi city than PCR in 
58 submissions comprising 123 samples. However, results show 
that specifi city of both methods were equal. Contrary, the PCR 
is lacking sensitivity when compared to culture, which might be 
caused by low concentration of the target in some samples or by 
inhibition of the PCR. Nonetheless, the PCR is a suitable alterna-
tive to cultural methods with comparable specifi city for the 
diagnosis of B. hyodysenteriae and B. pilosicoli, with the added 
advantage of more rapid results.
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Antimicrobial susceptibility of Brachyspira hyodysenteriae isolates from cases of 
swine dysentery in Italy recovered by diﬀ erent sampling procedures
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Istituto Zooprofi lattico Sperimentale Umbria e Marche, Perugia (PG), Italy
Introduction
Swine dysentery (SD) by Brachyspira hyodysenteriae is still a 
common disease and a major cause of production losses in 
Italian pig industry. Control of SD is based upon the use of 
antimicrobials, but few antibiotics are licensed for treatment; 
moreover, multi-resistant strains were recorded in Europe, 
Italy included. The aim of this work was to assess antimicrobial 
susceptibility of B. hyodysenteriae isolates from pigs in Italy. 
For this purpose, B. hyodysenteriae isolates were collected from 
culture collections of diagnostic laboratories (passive sampling) 
and from pigs aff ected by SD (active sampling). All the isolates 
collected were tested for antimicrobial susceptibility using the 
broth dilution method. 
Materials and Methods
Isolates for antimicrobial testing were recovered using two dif-
ferent procedures: passive and active sampling.
Passive sampling: B. hyodysenteriae isolates (n=27) were taken 
from bacterial collections in diagnostic laboratories. 
Active sampling: samples were collected from clinical cases of 
SD, following a standard sampling procedure, and a question-
naire was fi lled in. Thirty-nine herds were sampled, 28% of them 
were farrow to weaning, 33% fi nishing and 39% farrow to fi nish 
herds. The average number of sows/herd was 600, while in 
fi nishing herds the number of fi nishers was 2550/year on aver-
age. Regarding treatment, 54% of the herds used pleuromutilins 
either for medication purposes in the groups of pigs sampled. 
On each farm, animals showing symptoms suggestive of SD, or 
living in the same box of symptomatic pigs, were sampled. At 
least 9 fecal samples were taken from each herd, cultured anaer-
obically on TSA-BJ medium at 41,5 °C for fi ve days. Suspected 
colonies were isolated on Blood agar and typed by PCR. Thirty 
isolates of B. hyodysenteriae from active sampling and 27 from 
passive sampling were tested as described below.
Broth Dilution Method: was performed according to Rohde, 
2004 , using a standardized MIC panel for Brachypira spp. (Vet-
MIC TM Brachy ver 2, SVA, Uppsala, Sweden). The concentrations 
ranged from 8 μg/ml to 0.063 μg/ml (tiamulin), 4 μg/ml - 0.031 
μg/ml (valnemulin), 64 μg/ml – 0.5 μg/ml (lincomycin), 128 μg/
ml – 2 μg/ml (tylosin). The interpretation of MIC values for both 
strain collections was based upon MIC-breakpoint values re-
ported by Ronne & Szancer, as follows (1990).Tiamulin; ≤1μg/ml 
: sensitive (S); >1-≤4μg/ml : intermediate (I); >4μg/ml : resistant 
(R). Valnemulin: ≤1μg/ml : S; >1-2μg/ml : I; ≥4μg/ml :R . Linco-
mycin: ≤4μg/ml : S; >4-≤32μg/ml : I; ≥32μg/ml : R. Tylosin: ≤1μg/
ml : S; >1-≤4μg/ml : I; >4μg/ml : R.
Results
MIC values of tested antimicrobial agents for B. hyodysenteriae 
isolates from active and passive samplings are shown in Table 1 
and 2. 
Table 1: AB MIC values for B. hyodysenteriae isolates from active 
sampling  (n=30). 
0.031 0.063 0.125 0.25 0.5 1 2 4 8 16 32 64 128
Tiamulin 2 6 7 11 4
Valnemulin 3 4 2 1 3 8 9
Lincomycin 1 5 4 6 14
Tylosin 1 29
Table 2: AB MIC values for B. hyodysenteriae isolates from passive 
sampling (n=27). 
0.031 0.063 0.125 0.25 0.5 1 2 4 8 16 32 64 128
Tiamulin 1 2 6 2 5 5 1 5
Valnemulin 3 1 2 1 6 1 5 8
Lincomycin 1 1 6 6 4 2 7
Tylosin 2 1 24
Discussion
B. hyodysenteriae isolates from both active and passive sam-
plings were resistant to tylosin, confi rming results of previous 
studies reported, while most of them resulted in intermediate 
results to lincomycin. Regarding pleuro-mutilins, a diff erent 
picture was found by active and passive samplings: no tiamulin 
or valnemulin resistant isolate from active sampling was found. 
The presence of multi-resistant strains in Italy was confi rmed by 
passive sampling. Identifi ed MIC diff erences recorded for passive 
vs. active sampling may be due to a selection of isolates originat-
ing from farms with recurrent SD problems. Those samples are 
sent to diagnostic laboratories. The sensitivity to pleuromutilins 
of B.hyodysenteriae strains is good in the majority of farms in 
Italy. Emergence and spreading of multi-resistant strains must 
be kept under control by implementation of appropriate dosing 
regimes, biosecurity measures and continuous monitoring of 
the isolates.
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In vitro susceptibility of Brachyspira hyodysenteriae to a tiamulin-doxycycline combination
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Introduction
Swine dysentery is a serious hazard on swine health in aff ected 
farms1. The increasing resistance of the bacterium Brachyspira 
hyodysenteriae against pleuromutilins complicates treatment 
options on several farms2. Since elimination protocols are mainly 
based on the use of tiamulin or valnemulin, eliminating the 
disease on farms with a resistant strain becomes problematic. One 
option could be a higher effi  ciency of tiamulin. In literature, a syn-
ergistic eff ect of tiamulin and tetracylines is reported, more specif-
ically on respiratory pathogens in poultry and swine3,4. Therefore, 
the aim of the present study was to examine whether a combina-
tion of tiamulin and doxycycline resulted in in vitro susceptibility 
of B. hyodysenteriae at lower tiamulin concentrations.
Materials and Methods
Susceptibility of 26 Brachyspira hyodysenteriae isolates was 
determined using the agar dilution technique2. Minimal inhib-
itory concentrations (MIC) were determined against tiamulin 
(range 0.03 – 16 μg/ml), doxycycline (range 0.06 – 16 μg/ml) and 
against tiamulin (range 0.03 – 16 μg/ml) supplemented with 
respectively 16, 2, 1 and 0.5 μg/ml doxycycline. MIC was deter-
mined as the lowest concentration where growth was inhibited. 
Results
Table 1 represents the MIC values for the 26 isolates tested. Nine 
strains showed decreased susceptibility to tiamulin (MIC> 1 μg/
ml), eleven isolates had decreased susceptibility to doxycycline 
(> 4 μg/ml) and six to both antibiotics.
Table 1. MIC (μg/ml) of Brachyspira hyodysenteriae for tiamulin (T), 
doxycycline (D) and their combination
Molecule n range MIC50 MIC90
Tiamulin 26 <0.03 - > 16 0.250 8
Doxycycline 26 <0.06 - 8 1 8
T+D 16 μg/ml 12 <0.03 - <0.03 <0.03 <0.03
T+D 2 μg/ml 26 <0.03 - > 16 <0.03 8
T+D 1 μg/ml 24 <0.03 - > 16 <0.03 8
T+D 0.5 μg/ml 24 <0.03 - > 16 <0.03 8
Considering the combination of both antibiotics, growth was 
inhibited in all isolates when the concentration of doxycycline 
in the agar exceeded the MIC of the isolate, independent of the 
MIC for tiamulin. In case the MIC for doxyclin was higher than 
the agar concentration, a lower MIC for tiamulin when combined 
with doxycycline was noted in 33 to 68% of the isolates (Table 
2). When considering the strains with decreased susceptibility to 
tiamulin, two strains (22%) had a decreased MIC for tiamulin in 
combination with doxycycline. A diff erence of at least two dilu-
tions was considered valid when comparing MICs for tiamulin 
with or without doxycycline.
Table 2. Number of B. hyodysenteriae isolates where the MIC for 
tiamulin (T) was decreased when combined with doxycycline (D).
T+D 2 μg/ml T+D 1 μg/ml T+D 0.5 μg/ml
MIC D ≥ agar conc. (n) 15 16 18
MIC T+D < MIC T (n) 5 11 7
MIC T+D < MIC T (%) 33 68 38
Discussion
In the present study the in vitro susceptibility of B. hyodysenter-
iae isolates to tiamulin was compared with and without doxycy-
cline. There was no diff erence in MIC50 or MIC90 when all isolates 
were considered. When looking at the isolates with higher MIC 
than the concentration in the agar, these in vitro data demon-
strate a higher susceptibility to tiamulin in the presence of 0.5 
to 2 μg/ml doxycycline for one third of the isolates. From the 
strains with decreased susceptibility to tiamulin, two were in 
vitro susceptible when tiamulin was combined with doxycycline. 
Further examination is necessary to confi rm this combined ef-
fect of tiamulin and doxycycline on Brachyspira hyodysenteriae. 
Based on these limited in vitro data, a positive eff ect of combin-
ing both antimicrobials in the treatment of swine dysentery may 
be expected for some strains which can be helpful in treatment 
protocols.
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Eﬃ  cacy of Econor® (Valnemulin) for the treatment of swine dysentery under ﬁ eld conditions in Japan
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Introduction
Swine dysentery (SD) caused by Brachyspira hyodysenteriae (Bh) 
is one of the common and important enteric diseases world-
wide. The objective of this study was to evaluate the clinical 
effi  cacy of Econor® 1% premix in-feed medication against SD 
under fi eld conditions in Japan as part of routine post-approval 
regulatory requirements.
Materials and Methods
Sixty six SD-infected crossbreed pigs were enrolled from three 
geographically diff erent farms in Japan (Aichi, Kyoto and Ehime) 
from April, 2008 to April, 2009 (62 fattening pigs at age of 90 to 
160 days and 4 sows). SD was confi rmed by fecal microscopy and 
isolation of Bh. Other infections including parasites, Salmonella 
spp, Campylobacter spp, Clostridium perfringens and rotavirus 
were excluded based on additional tests. MICs of valnemulin 
(VAL), tylosin (TS), lincomycin (LCN) and tiamulin (TML) were 
evaluated using 46 Bh strains. The pigs were treated in-feed with 
Econor® at 30 ppm (n=33) or 100 ppm (n=33) for 7 consecu-
tive days in accordance to the label in Japan. No control group 
was established. Combined clinical scores or CC (min 0, max 
12) representing the fecal consistency (score 0-3, 0=normal to 
3=severe), pig demeanor (0-2), appetite (0-3), skin condition (0-2) 
and emaciation (0-2) was recorded daily (Day 0 to Day 9) and 7 
days after end of the medication (Day 14) to evaluate possible 
relapses of SD. Fecal swabs were collected from all pigs at 2 days 
after treatment (Day 9) to investigate the presence of Bh. Based on 
the individual CC at Day 0 (CCD0) and Day 9 (CCD9), the individual 
percentage of improvement (IC) as primary effi  cacy endpoint was 
calculated as 100%*(CCD0-CCD9)/CCD0, followed by categorizing 
each pig into one of four categories; (A) marked improvement (85-
100%), (B) good improvement (70-85%), (C) moderate improve-
ment (50-70%) and (D) little improvement (<50%). 
Results and Discussion
Both treated groups showed quick recovery from clinical signs 
with reduction of CC with more than 90% (Figure 1, Table 1). All 
pigs showed marketed or good improvement by treating with 
Econor®, and 75.8% of pigs with lower dose (30 ppm) and 87.9% 
of pigs with higher dose (100 ppm) were evaluated as marketed 
improvement at Day 9, which was 2 days after end of the medi-
cation (Table 2). None of the treated pigs was relapsed at Day 
14. Bh was not detected from faecal samples at Day 9. Bh isolates 
(n=46) showed high susceptibility against VAL and TML, and MIC 
of TS and LCM were both above 12.5 μg/ml (Table 3). 
Conclusion
The results demonstrate the superb clinical effi  cacy of Econor® at 
30 ppm and 100 ppm in-feed medication against SD. The results 
of MIC were in alignment with earlier published data (1, 2).
Figure 1. Average combined clinical scores during the study from Day 
0 to Day 9
Table 1. Combined clinical scores and IC at Day 9
30ppm 100ppm
Clinical score average score 17.1 12.7
Clinical score % improvement 92.2 95.5
Table 2. Distribution of IC at Day 9
Number of pigs in four improvement categories
(A) (B) (C) (D)
30 ppm 25 8 0 0
100ppm 29 4 0 0
Table 3. MIC tested of antibodies for Bh (μg/ml)
MIC Range MIC50 MIC90
VAL ≤0.00625~0.0125 ≤0.00625 0.0125
TS 12.5 ~> 100 100 >100
LCM 12.5 ~ 25 12.5 25
TML ≤0.00625~0.10 ≤0.00625 0.1
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Eﬀ ectiveness of two antibiotics against Brachyspira hyodysenteriae: a ﬁ eld study
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Introduction
Brachyspira hyodysenteriae (B. hyo) is the etiological agent of 
Swine Dysentery (SD), a disease responsible of high economic 
losses in the swine production. The objective of the present 
study was to compare the macrolide antibiotic Tylvalosin (Aiv-
losin® ECO Animal Health) with tiamulin by evaluating produc-
tion parameters, presence of the agent and SD clinical signs.
Materials and Methods
A longitudinal study was carried out in a 500-sows, farrow-to-
fi nish herd with antecedents of SD. All the pigs (250) weaning 
at 1, 3 and 5 and at 2, 4 and 6 weeks constituted the groups GA 
(Tylvalosin) and GT (Tiamulin) respectively. Pigs from week 7 
and 8 were used as control group (CG). The medication, 50 ppm 
of Tylvalosin and 100 ppm of Tiamulin, was given in the feed in 
3 periods of time, 21 to 42, 73 to 83 and 100 to 110 days of age. 
Five pigs per group were euthanized at 42 and 83 days old for 
necropsies and sampling for bacteriology and histopathology. 
All the pigs were weighed at weaning and at 42 days and were 
sent to slaughter at 105 kg bodyweight. Average daily gain 
(ADG) and feed conversion rate (FCR) were determined. The 
percentage of pigs with diarrhoea was recorded at 42, 60, 83, 
100 and 150 days of age. The percentage of unthrifty pigs and 
mortality was also recorded. At slaughter, pigs from the three 
groups were evaluated as per those euthanized earlier. 
Colon macroscopic lesions were recorded as follow: 1) Normal, 
2) Oedema, congestion and mucus, 3) Oedema, congestion and 
red-brown mucus. For histopathology: 1) Normal, 2) Hyperpla-
sia of crypts and calceiform cells and/or presence of abscess, 
3) Necrosis.  The 187 colon samples were inoculated in blood 
agar plate with antibiotics and in anaerobic atmosphere for 
6 days. Samples for DNA extraction for nox-specifi c PCR (1) to 
genera determination were taken with the aid of sterile fi lter 
paper when spirochete growth was detected. Duplex PCR for B. 
hyodysenteriae and B. pilosicoli diff erentiation (2) was per-
formed from the positive nox-specifi c PCR. Three strains were 
processed by biochemical assay.
Results
Tables 1 and 2 show the results of the diff erent determinations. 
The purifi ed strains were identifi ed as negative indol B. hyo. 
None of the samples were positive to B. pilosicoli.
Table 1. Production parameters for diff erent treatments 
PARAMETER GA GT GC
21 to 70 Days ADG 0.316 0.335 0.333
FCR 2.13 1.82 1.84
% Unthrifty 6 11.3 4
% Mortality 2.1 1.7 3
% Diarrhoea 0.66 1.33 -
70 to fi nish ADG 0.809 0.757 0.727
FCR 2.15 2.19 2.25
% Mortality 3.9 4.0 3.1
% Diarrhoea 4.0 7.3 -
Days to slaughter 176 181 186
Table 2. Gross and microscopic lesions and PCR at diff erent sampling 
times (positive/number samples)
Samples Group PCR Macro Micro
B. spp B. hyo 1 2 3 1 2 3
Day 42 GA 0/15 0/0 14 1 0 15 0 0
GT 1/15 0/1 14 1 0 15 0 0
 Day 83 GA 2/15 1/2 11 1 3 10 5 0
GT 5/15 5/5 5 1 9 5 9 1
Slaughter GA 6/50 4/6 39 10 0 42 6 1
GT 17/48 15/17 30 20 4 36 16 2
GC 15/29 12/15 15 10 4 18 9 2
Discussion
The presence of diarrhoea, the pathologic lesions and the isola-
tion of B. hyo indicated that the animals were aff ected of SD. 
The GA group presented fewer animals with clinical signs as well 
as less organism isolation and pathological lesions. This would 
explain the diff erence in ADG (52 and 82 gr) and the reduced 
days to slaughter (5 to 10 days) compared with the GT and GC 
respectively. The reason of the better activity of Tylvalosin in 
this fi eld trial could be a higher susceptibility of the brachyspira 
strain to this drug compared to Tiamulin taken into account 
the extensive use of the latter in Argentina for many years and 
particularly on the study farm. A higher Tylvalosin dose rate 
should be recommended for similar situations since SD was also 
observed on the GA group.
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Eradication of swine dysentery in an outdoor breeding herd and its production pyramid
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Introduction
The use of tiamulin (Denagard® - Novartis Animal Health Inc.) 
for the eradication of swine dysentery caused by Brachyspira 
hyodysenteriae in outdoor herds has been described (1). Herd 
eradication is usually planned to eliminate the infection from a 
chronically infected herd. The chance of success is greatest when 
high temperatures and dryness prevail (summertime) and at a 
time when the breeding herd is being moved to a new uncon-
taminated pasture; both will naturally assist the decontamina-
tion process. B. hyodysenteriae has been shown to survive in 
faeces and slurry for up to 60 days in cold conditions (2). 
Diarrhoea was fi rst noticed in a 1,500 sow outdoor breeding 
herd in mid-September 2008; the diagnosis was confi rmed by 
FAT, and cultures from faeces samples submitted by the private 
veterinarian in the course of a routine visit two weeks later. The 
MICs for two of the isolates against tiamulin hydrogen fumarate 
were 0.031 and 0.125 μg/ml respectively. It was thought that the 
infection had originated from a nearby farm (3km) which was 
known to be infected.
The aff ected unit formed part of a 10,000 sow breeder/nursery/
fi nisher operation comprising two separate production pyra-
mids. Progeny were routinely co-mingled at weaning with wean-
ers from three other unaff ected breeding units. This enabled 
the thirteen nurseries and 23 fi nisher sites in the pyramid to be 
fi lled quickly; stores moved to fi nisher sites at about 40kg and 
pig fl ow was truly “all in/all out” by unit. After consultation, an 
eradication programme commenced just as reports of diarrhoea 
were reported in some of the nurseries, which had been recently 
fi lled. At this stage there were no reports of dysentery in the 
fi nishers.
Materials and Methods
Medication programme
Breeders
The breeding herd was medicated with high levels of tiamulin 
(Denagard) at 8mg/kg bodyweight for 28 days, achieved by 
incorporation at 800ppm in the dry sow ration and 500ppm in 
the lactating sow diet. Resolution of clinical signs would trigger a 
reduction to 5mg/kg bwt for a further 28 days’ in feed medication.
Nursery pigs
Five nurseries had been recently supplied from the breeding 
unit and all feed on these units was medicated with tiamulin at 
10mg/kg bwt (200ppm). A thorough cleaning and disinfection 
programme was introduced between batches.
Finishers
Despite the absence of clinical signs, all the fi nisher pigs in the 
pyramid, except those selecting for slaughter, were medicated in 
feed with 10mg/kg bwt (200ppm) tiamulin for 4 weeks. Subse-
quent breakdowns on fi nisher sites led to the belief that infec-
tion had been present for longer than initially thought. A full 
cycle of in-feed medication (tiamulin at 10mg/kg bwt (200ppm) 
for 4 weeks, reducing to 5mg/kg (100ppm) for 4 weeks) success-
fully eliminated the infection from all the fi nisher sites.
The in-feed medication regime was complimented by parenteral 
and water medication with tiamulin (Denagard) in consulta-
tion with the private veterinarian to ensure rapid treatment of 
aff ected individuals.
Management
Pig fl ow was adjusted to separate the aff ected breeding unit 
and its progeny from all other pigs. Biosecurity procedures were 
reviewed and standard operating procedures tightened; risk 
assessments were undertaken and transport logistics were scru-
tinised and adjusted accordingly. Staff  were advised of the situa-
tion and movement between farms was limited and controlled. 
Clothing changes and boots were made available on every site 
for visitors and disinfectant foot baths were introduced.
Results and Discussion
Sows health improved rapidly and clinical signs resolved within 
a week of instigating the medication programme. October was 
a mild and dry month, but November was cold and wet. The 
clinical response was excellent on all nursery and fi nisher sites.
The pyramid has remained free of dysentery for over 12 months 
since the end of medication. Progeny from the aff ected unit had 
been considered to be the poorest in the company, but have 
subsequently outperformed all others (data available).
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Swine dysentery eradication by strategic medication without depopulation
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Introduction
Swine dysentery (SD) has a major negative eff ect on the 
productivity performance. The objective of this study was to 
eradicate Brachyspira hyodysenteriae from a multiplier herd by 
medication with tiamulin (Denagard® 45% WSG) without partial 
depopulation. 
Materials and Methods
The 910 sow multiplier herd was chronically infected by Brachy-
spira Hyodysenteriae over the past years. This resulted in recur-
rent outbreaks of dysentery in the summer and autumn of 2006. 
The weaners (8-25 kg) were therefore continuously medicated 
and the fi nishers at diff erent sites were underperforming. All 
sows and weaners were housed at one site. The diagnosis was 
made based on clinical symptoms, post-mortem fi ndings and 
confi rmed by detection of B.hyodysenteriae in fecal samples of 
fi nishers and sows by culture and PCR. 
The eradication program consisted of the medication of breed-
ing animals, suckling piglets and weaners combined with thor-
ough cleaning and disinfection of the stables. It was fi nancially 
impossible to carry out a total or partial depopulation.
Prior to the start of the program, biosecurity was improved, 
eff ective rodent control was started, no visitors were allowed 
and no new animals were introduced. All staff  was involved in 
establishing a cleaning and disinfection protocol.
To investigate if the eradication could be performed without 
feed medication, solubility and palatability of Denagard 45% in 
drinking water for gestation sows was tested. Most gestation 
sows showed a suffi  cient water intake with 650 gram Denagard 
45%/ 1000 l drinking water. So treatment was only by drinking 
water and injection. All sows and weaners were medicated with 
Denagard 45% 9 mg/kg bodyweight in drinking water for 14 
days, and then the dosage was reduced to 4.5 mg/kg BW for the 
next 14 days. This was followed by another 28 days medication 
with 2 25 mg/kg BW. Suckling piglets were treated with tiamu-
lin injections 10 mg/kg BW on day 1, 7 and 14 after the start of 
medication. All animals with reduced appetite were injected 
with tiamulin 10 mg/kg BW. During the program every day all 
manure was removed. Every 3 days all places possibly contamin-
ated with manure were cleaned and disinfected (Virocid). After 
fi nishing the program the herd was monitored on the presence 
of B. hyodysenteriae.
Results
The eradication program was completed in the beginning of 
2007. A few days after starting the medication there were no 
clinical signs of dysentery anymore. Every month the farm was 
monitored for clinical symptoms. Routine use of antimicrobials 
against enteric diseases was no longer required.
Fecal samples of sows, piglets and fi nishers were screened 
post-eradication for Brachyspira by PCR regularly (Jan 2008-June 
2009) and were all negative.
The reproduction performances improved (see table 1) and so 
did the growth of the piglets and fi nishers. After the eradication 
program the herd performance signifi cantly improved.
Table 1. Comparison of technical results before and after SD eradication 
2006 2008
No. of sows 929 1034
Farrowing rate 84.2 89.3
Live born piglets per litter 11.62 12.64
Weaned piglets/sow/year 21.89 24.39
Discussion
There are many closed herds for which it will be very costly to 
perform an eradication strategy with partial or total depopula-
tion. Successful eradication of B. hyodysenteriae without any 
depopulation is also a reasonable option as indicated by the 
results. Big advantage is that the pig fl ow is stable, which at the 
end translates into normal revenues for the farm. If biosecurity is 
kept at a very high level it is possible to keep the farm free of SD. 
All biosecurity measurements like cleaning and disinfection to 
prevent re-infection from the environment are as important as 
the medication strategy. 
Eradication of diseases fi ts the current approach of decreasing 
the use of antibiotics in the Netherlands. 
The study results confi rm previously published data on SD 
eradication with strategic medication combined with intensive 
cleaning and disinfection. In the project described here no par-
tial depopulation was performed. 
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Introduction
Brachyspira(B.) hyodysenteriae isolated from slaughtered 
pigs in Ibaraki Prefecture in Japan ,2008. The MIC values of 
B.hyodysenteriae isolates to 7 antibacteral agents have been in-
vestigated and were compared with those of previous results (1). 
Materials and Methods
Eighteen pig isolates of B. hyodysenteriae have been identifi ed by 
PCR using NOX primers and sequencing with primers 3F(5’-GG-
CGATGCGTCTTAAGC-3’) and 500R(5’ -AATCCGAGCAACGTTTG-3’) 
(2). Indole production test was used for identifi cation. The drug-
susceptibility test was performed as previously described (3) and 
carbadox, valunemulin, lincomycin, tylosin, tiamulin, penicillin G, 
and metronidazol were used.
Results and Discussion
The isolates with over 99.7% homology to B.hyodysenteriae 
ATCC27164 have been identifi ed as B.hyodysenteriae and 18 
isolates were B.hyodysenteriae. As shown in Table 1, carbadox 
and metronidazole were very eff ective and MICs were 0.01 > 
and 0.4>, respectively but carbadox was prohibited to use in pig 
herds. Valunemulin was eff ective to the isolates and MIC values 
were slightly higher than those of previous results (1). 
Penicillin G was also eff ective except for one isolate with MIC 
of 100 and 17 isolates were less than MIC of 0.4. MIC values of 
tiamulin were ranging from 13 to 0.1 and MIC values of 9 isolates 
were less than MIC of 0.4. On the other hand, MIC values of 
tylosin were ranging from 100 to 3.1 and MICs of tylosin were 
≥100 in most isolates. MIC values of lincomycin were ranging 
from 100 to 0.2. The isolates have acquired the resistance to 
tylosin and lincomycin and the values of MICs were similar to 
the previous values(1), while those isolates were still susceptible 
to valnemulin and tiamulin and the values were slightly higher 
than previous results(1).
Drugs MICs( μg/ml)
Range For ≥90%of the isolates
Penicillin G 100-0.2 ≤0.4
Valunemulin 6.3-0.1 ≤6.3
Lincomycin 100- 0.2 ≤25
Tiamulin 13-0.1 ≤6.3
Tylosin 100-3.1 ≥3.1
Metronidazol 1.6-0.1 ≤0.4
Carbadox ≤0.08 0.01
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Introduction
Antimicrobials are the most relevant tool to control swine 
dysentery caused by Brachyspira hyodysenteriae in pig herds. 
Pleuromutilins (tiamulin and valnemulin) and lincomycin are 
the most important agents used for this purpose, nevertheless, 
multi-resistant B. hyodysenteriae isolates have been reported 
in many countries, Italy included. Currently no standard anti-
microbial susceptibility testing method is internationally 
established . Agar dilution technique and broth dilution test 
methods are available. The aim of this work was to compare the 
two methods used for antimicrobial susceptibility testing of B. 
hyodysenteriae isolates in two diff erent Italian laboratories.
Materials and Methods
Isolates: twenty B. hyodysenteriae isolates from clinical cases of 
Swine Dysentery in Italian pig herds were used during the study. 
The isolates were tested independently and blindly by the two 
diff erent laboratories using the methods described below.
Broth Dilution Method: the broth dilution method was performed 
according to published literature (Rohde, 2004). Briefl y, approxi-
mately 106 of each isolate in 0,5 ml of BHI broth supplemented 
with calf fetal serum was added to each well of a MIC panel for 
Brachypira spp. (VetMIC TM Brachy ver 2, SVA, Uppsala, Sweden), 
and incubated on a shaker for 4 days in an anaerobic atmosphere 
(Genbox, Biomerieux, Lyon, France) at 37°C. Reference control 
strains were used as controls ( B. hyodysenteriae B78, ATCC 
27164). The concentration tested were from 8 μg/ml to 0.063 μg/
ml for tiamulin, from 4 μg/ml to 0.031 μg/ml for valnemulin and 
from 64 μg/ml to 0.5 μg/ml for lincomycin.
Quick-MIC agar dilution method: a simplifi ed agar dilution 
method using only antibiotic break point values was applied 
according to Ronne and Szancer (1990).
The interpretation of MIC values was based upon MIC-break-
point values reported by Ronne & Szancer, as follows (1990).
Tiamulin; ≤1 μg/ml : sensitive (S); >1-≤4 μg/ml : intermediate (I); 
>4 μg/ml : resistant (R). Valnemulin: ≤1 μg/ml : S; >1-2 μg/ml : I; 
≥4 μg/ml :R . Lincomycin: ≤4 μg/ml : S; >4-≤32 μg/ml : I; ≥32 μg/
ml : R. Tylosin: ≤1 μg/ml : S; >1-≤4 μg/ml : I; >4 μg/ml : R.
Results
The results are shown in Table 1 and 2. By broth dilution , 4 
isolates were classifi ed resistant to tiamulin, 6 to valnemulin and 
7 to lincomycin.
Table 1: MIC values of B. hyodysenteriae isolates by agar diff usion 
technique (n=20).
μg/ml <1 (S) 1-4 (I) >4 (R) 4-36 (I) <36 (R)
Tiamulin 5 10 5
Valnemulin 7 6 7
Lincomycin 12 8
Table 2: MIC values of B. hyodysenteriae isolates by broth dilution 
method (n=20).
μg/ml .031 .063 .125 .25 .5 1 2 4 8 16 32 64
Tiamulin 1 2 5 2 3 1 1 4
Valnemulin 2 1 2 1 4 1 3 6
Lincomycin 1 6 2 3 1 7
For tiamulin, 8 strains were classifi ed as intermediate by agar 
dilution, and sensitive by broth dilution, for valnemulin 5 and for 
lincomycin 7. The isolates classifi ed intermediate for tiamulin by 
agar diff usion and sensitive by broth dilution showed MIC values 
above 0,125 μg/ml in the broth dilution test . No isolate classi-
fi ed as sensitive by one of the two methods resulted resistant by 
the other one.
Discussion
The need of standardization and quality control for antimicrobial 
susceptibility testing of Brachyspira spp. has been repeatedly 
pointed out. Broth method has been reported to give MICs 
lower by one dilution step in literature. The trial results confi rm 
lower MIC values for the tested isolates by using broth dilution 
method compared to agar diff usion technique. Using the MIC 
breakpoints thresholds, some isolates classifi ed as intermediate 
to pleuromutilins and lincomycin by agar dilution technique 
were classifi ed as sensitive by broth dilution test. Nevertheless, 
no isolates were classifi ed as resistant by agar dilution technique 
and sensitive by broth dilution test or vice versa. In conclusion, 
classifi cation of isolates in diff erent susceptibility groups using 
the two test methods can occur, in particular for those showing 
intermediate values. 
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Evolution of recent antimicrobial sensitivity data of Brachyspira hyodysenteriae in Belgium
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Introduction
Evolution of antimicrobial resistance (AMR) of Brachyspira 
hyodysenteriae, especially to pleuromutilins, should be monitored 
regularly to update the actual treatment possibilities in case of 
clinical disease or eradication strategies. A study, using strains 
isolated in 2003, on the link between AMR and clinical eff ect of 
treatment to B. hyodysenteriae infections revealed that only 13% 
of the strains tested were susceptible to lincomycin and just 4% 
to tylosin (1). Since 2006, recent data are yearly available on B. 
hyodysenteriae AMR to tiamulin and valnemulin in Belgium. 
Materials and Methods
Strains of B. hyodysenteriae were isolated from routine diagnos-
tic samples during 2006-2008-2009 and immediately after isola-
tion, antimicrobial susceptibility testing was performed. Besides 
the fi eld isolates, available reference Brachyspira strains were 
also tested (2). Susceptibility testing was performed as previous-
ly described (1, 2). The MIC was recorded as the lowest concen-
tration at which no distinct hemolysis was seen in the spot. 
Results
The reference strain of B. hyodysenteriae (B78) was more suscept-
ible to valnemulin (MIC < 0.03) than to tiamulin (MIC = 0.06). Re-
sults of the fi eld isolates of the diff erent B. hyodysenteriae strains 
(n = 40 strains per year) are given in Figure 1 for tiamulin and 
valnemulin. Minimal inhibitory concentrations for 50% (MIC50) 
and 90% (MIC90) of the strains tested are also given in Table 1. 
Table 1. Minimal inhibitory concentrations of tiamulin and 
valnemulin required to inhibit 50 and 90% (expressed in μg/ml) of B. 
hyodysenteriae strains isolated in Belgium in 2006-2008-2009
Tiamulin Valnemulin
MIC 50 MIC 90 MIC 50 MIC 90
2006 0.25 2 0.03 0.50
2008 0.50 8 0.12 8
2009 > 8 > 8 8 > 8
Discussion and Conclusions
In comparison with previous studies (1), MIC50 and MIC90 
were signifi cantly increased for B. hyodysenteriae. Considering 
that isolates with MIC < 1 μg/ml should be regarded as not 
responding to therapy in vivo, more than 50% of all isolates ob-
tained in 2009 should be considered resistant to both tiamulin 
and valnemulin (1).
Figure 1. Percentage of strains with their respective minimal inhibitory 
concentrations of tiamulin (A) and valnemulin (B) for B. hyodysenteriae 
strains isolated in Belgium in 2006 (red) -2008 (green) -2009 (purple)
For valnemulin, the number of resistant strains (n = 27) sig-
nifi cantly increased last year and became nearly as high as for 
tiamulin (n = 29). The fact that an increasing number of strains 
reaches MIC-values beyond the highest concentrations ( MIC 
> 8 μg/ml) tested for both pleuromutilins is a serious concern 
for the Belgian pig industry. Especially in relation to eradication 
protocols, further research focussing at potential alternative 
control measures is necessary. Farms should be aware to further 
improve their external en internal biosecurity measures to pre-
vent introduction of new B. hyodysenteriae strains in the farm. 
In conclusion, antimicrobial resistance to pleuromutilins has 
evolved towards a higher prevalence of resistance and higher 
MIC50 and MIC90 values as compared to previous data. 
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Case report: therapeutical eﬀ ect of Vetmulin® premix on a clinical outbreak 
of Brachyspira murdochii in a fattening herd in Belgium
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Introduction
Spirochaetes belong taxonomically to the order Spirochaetes, 
which contains several genera such as Brachyspira and Lep-
tospira. The intestinal spirochaetes are included in the genus 
Brachyspira, which contains at present seven species, of which 
fi ve are known to be present in pigs: B. hyodysenteriae, B. 
pilosicoli, B. intermedia, B. murdochii and B. innocens. Porcine 
diarrheal disease in fatteners is mainly caused by B. hyodysente-
riae and B. pilosicoli. In Belgium, B. hyodysenteriae has been 
diagnosed in 16% of the fecal samples (n = 2264) analyzed 
through PCR during the last 3 years (1). In bacteriological 
culture, B. hyodysenteriae was present in 26% of the analyzed 
fecal samples (2). Besides the major pathogenic B. hyodysente-
riae, B. murdochii also occurs in 9% of the fecal samples ana-
lyzed through PCR and in 5% of the bacteriological cultures for 
Brachyspira species. Brachyspira murdochii is generally con-
sidered as a minor pathogen (3). The present case report focuses 
on clinical outbreak caused by B. murdochii in a fattening herd 
in Belgium.
Materials and Methods
A fattening herd of 600 fattening places went through a period 
of clinical diarrhea in the group of 60-70 kg. The piglets all 
originated from one single sow farm. Clinically speaking the 
diarrhea consisted of fl at feces with a slimy aspect without 
bloody contents. All fattening pigs were strongly contaminated 
with fecal material. Fecal samples of clinically aff ected pigs were 
collected for diagnostic purposes. The samples were cultured 
through standard anaerobic bacteriological Brachyspira culture 
and colonies were phenotypically identifi ed to the species level. 
Results
Bacteriological culture of Brachyspira resulted in the identi-
fi cation of B. murdochii in pure culture. As no other relevant 
bacterial species could be isolated from the fecal samples, it was 
considered to be the agent causing clinical diarrhea in the fat-
tening herd. Following the bacteriological diagnosis, antimicrob-
ial therapy with tiamulin (Vetmulin® premix; Huvepharma) at a 
dose of 10 mg active substance per kg live weight was started. 
The antimicrobial was administered through the feed for at 
least 7 days. Following the therapy, clinical recovery and normal 
fecal consistency could be observed after 5 days of treatment 
with Vetmulin®. After the treatment, clinical signs disappeared 
in the treated group. However, identical clinical symptoms were 
observed in other untreated fattening herds with piglets origin-
ating from the very same farm. In these fattening herds, similar 
therapy was introduced and resulted in identical therapeutical 
eff ect on clinical symptoms.
Discussion
The present case report clearly demonstrates that although B. 
murdochii is generally considered as a minor pathogen with-
out specifi c clinical symptoms, occasionally clinical outbreaks 
can occur. The absence of bloody contents in the feces could 
indicate that B. hyodysenteriae was not the etiological agent, al-
though clinical signs of B. hyodysenteriae in Belgium are not al-
ways associated with bloody feces. The importance of rapid and 
accurate diagnostics in order to install an effi  cient therapeutic 
plan is herewith demonstrated. The good therapeutic response 
of B. murdochii to the administration of tiamulin preparations is 
in accordance with several data on antimicrobial susceptibility, 
showing no signifi cant resistance to tiamulin (4,5). 
In conclusion, the present case report clearly shows that B. 
murdochii is not as apathogenic as generally accepted. A clear 
relation with other piglets originating from the same farm could 
be observed, which indicates a possible contamination during 
the suckling or post-weaning period.
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Introduction
The pathologies caused by the intestinal spirochaetes (IS) 
Brachyspira hyodysenteriae-swine dysentery and Brachyspira 
pilosicoli-porcine colonic spirochaetosis have been documented 
in pig production sector of many countries. These enteropatho-
gens have been identifi ed in México (2). Values for minimum 
inhibitory concentration (MIC) of the antimicrobials tiamulin, 
valnemulin and tylosin have already been reported (1,4). The aim 
of this work was to determine MIC values of the antimicrobials 
above for Brachyspira specimens isolated from pigs in México.
Material and Methods
A total of 19 Brachyspira specimens, B. pilosicoli (n=6), Weakly 
β-haemolytic IS (WBHIS) indol –ve (presumably B. pilosicoli, 
n=11) and B. hyodysenteriae (n=2) were used to determine 
MIC values of tiamulin (Novartis AH), valnemulin (Novartis AH) 
and tylosin (USP ref. std) using agar dilution method. Propaga-
tion of spirochaetes was done on blood agar plates (Columbia 
agar, Oxoid, UK + 8.0% horse blood) incubated for 3 days under 
anaerobic conditions using GasPak (AnaeroGen, Oxoid, UK) 
in jar. The harvest of those plates was used to make a work-
ing bacterial suspension adjusted to 1.0 MacFarland standard. 
Concentrations from 128 to 0.0125 μg/ml of the antimicrobials 
were obtained by dilution from mother concentrations of 10,000 
mg/l. Wilkins Chalgren (WC) [Anaerobe agar, (Oxoid UK) + 8.0% 
horse blood] plates containing the antimicrobial dilutions were 
prepared. Volumes of 10.0 μl of the bacterial suspension of each 
Brachyspira specimen and 2 replicates were inoculated on WC 
plates. Control plates (no antimicrobial) were also inoculated for 
viability of Brachyspira cells. WC plates were incubated at 38 ˚C 
under anaerobic conditions in jars for 48 hrs. MIC assays were 
repeated at least once.   
Results
MIC values >4.0 μg/ml are considered as resistant. The MIC val-
ues obtained for the antimicrobials of study are shown below. 
MIC values:
B. pilo (n=6) Tia 0.025-0.5 μg/ml Val 0.025-0.25 μg/ml Tyl 2.0-16 
μg/ml
WBHIS (n=11) Tia 0.5-4.0 μg/ml Val 0.01-0.5 μg/ml   Tyl    —
B. hyo (n=2) Tia 0.025-0.1 μg/ml Val 0.025-0.1 μg/ml  Tyl 2.0-128 
μg/ml
Tiamulin MIC values at the level of 4.0 μg/ml were observed on 
isolates of Brachyspira recovered from the same farm. Control 
inocula developed the Brachyspira characteristic growth showing 
that the assay conditions were appropriate and the purity of those 
cultures was confi rmed on Gram stained smear preparations. 
Discussion
The MIC values obtained for tiamulin and valnemulin in the 
present study are among those reported on previous studies 
(3,5). In the present study a MIC value at the level of 4.0 μg/
ml for tiamulin was obtained (that should be interpreted as a 
resistance value). Tiamulin resistance values have been reported 
by Czech Republic authors who have tested Brachyspira isolates 
(n=202) for a 10 year period (1). However in another MIC study 
using B. pilosicoli isolates obtained since 1996 no resistance was 
observed (5). The current study is the fi rst one on MIC values of 
tiamulin, valnemulin and tylosin for Brachyspira. The tylosin high 
MIC values (up to 16 for B. pilo μg/ml and up to 128 μg/ml for B. 
hyo) found in this study show resistance, A Brachyspira feature 
already reported elsewhere (1) and is consistent with results 
from other authors among the Brachyspira international group 
as discussed on the last biannual meeting. Performing MIC 
assays on WC agar implies to adapting cultures on this medium 
which takes time making the testing more costly.
Conclusion
The MIC values of tiamulin were in some cases at the level of 
4.0 μg/ml, this is at the limit of susceptibility-resistance. The 
MIC values of valnemulin were low (<0.5 μg/ml) showing that 
Brachyspira is far from being resistant. The technical informa-
tion presented in this study gives confi dence to the use of these 
anticmicrobials, particularly valnemulin for treatment of Brachy-
spira infections. 
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Activity of propyl propyl thiosulﬁ nate and propyl propyl thiosulfonate 
against Brachyspira hyodysenteriae ﬁ eld isolates
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Introduction 
Brachyspira hyodysenteriae is the causative agent of swine dys-
entery (SD), one of the most important gastrointestinal disorders 
in pigs. Treatment and control of SD involve mainly the use of 
antimicrobial as no commercial vaccines are available. However, 
fi eld isolates of B. hyodysenteriae with decreased susceptibility to 
one or more of the drugs commonly used for the treatment of 
SD have been reported (1, 2). These isolates represent a threat to 
the pig industry.
The antimicrobial properties of plants of genus Allium have 
been known for ages. Accordingly, the eff ectiveness of some 
garlic substances (Allium sativum) against some human gastro-
enteric bacteria have been reported previously (3, 4). However, 
knowledge on antimicrobial activity of these substances against 
animal pathogens is scarce.
This study aims to evaluate the potential use of two compounds 
of natural origin obtained from plants of genus Allium, pro-
pyl propyl thiosulfi nate (PTS) and propyl propyl thiosulfonate 
(PTSO), to assist in the treatment and control of SD.
Materials and Methods
Bacterial strains and growth conditions. Forty seven isolates of B. 
hyodysenteriae from the bacterial collection held at the Animal 
Health Department at the University of León, Spain, were used 
in this study. Bacterial isolates had been recovered from diff erent 
farms distributed across Spain between 2001 and 2009. Thawed 
isolates were grown on fastidious anaerobe agar supplemented 
with 5% horse blood in an anaerobic atmosphere (10% hydro-
gen, 10% carbon dioxide and 80% nitrogen) at 39ºC. 
Table 1. MIC50 and MIC90 (μg/ml) of PTS, PTSO and PTS+PTSO for 47 
Spanish fi eld isolates of B. hyodysenteriae.
PTS PTSO PTS + PTSO
MIC50 25 200 50
MIC90 100 >400 100
Range 12.5-100 ≤6.25->400 ≤6.25-200
Susceptibility panel and broth dilution procedure. A susceptibility 
testing panel was designed using twofold serial dilutions of PTS, 
PTSO and a combination of both called PTS+PTSO (17.5% PTS + 
82.5% PTSO) [DMC Research Center SL, Granada, Spain] ranging 
from 6.25 to 400 μg/ml. For this purpose, 48-well plates were 
used, following the broth dilution method described by Karlsson 
et al. (1, 2). Growth control wells were included in each plate. 
MIC was determined as the lowest concentration of Allium spp. 
derivatives that prevented visible growth. Absence of contam-
ination was checked by phase contrast microscopy.
Results and Discussion
The results and MIC distributions of the susceptibility test are 
shown in Table 1 and Figure 1, respectively.
Figure 1. Distribution of MIC of PTS, PTSO and PTS+PTSO for 47 Span-
ish fi eld isolates of B. hyodysenteriae.
Although susceptibility of Spanish B. hyodysenteriae fi eld isolates 
to PTS and PTSO were markedly diff erent, MIC distributions indi-
cated that growth of this bacterium was aff ected by the use of 
Allium spp. derivatives on their own or combined. PTS presented 
lower MIC50 and MIC90 than PTSO, showing a higher antimicrob-
ial activity against this spirochaete. Accordingly, PTS was able to 
prevent the growth of all isolates at the tested range of concen-
trations, while PTSO enabled the growth of more than 20% of 
the isolates at 400 μg/ml. The combination of both substances 
retained the PTS antimicrobial eff ect in spite of decreasing its 
concentration to 17.5%.
The results of the in vitro susceptibility testing suggest that 
clinical trials should be performed to evaluate the use of PTS and 
PTSO in the diet of pigs in order to treating and controlling SD. 
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Introduction
Several Brachyspira species cause disease in grow-fi nish pigs, 
notably B. hyodysenteriae and B. pilosicoli which cause colitis and 
typhlitis. B. innocens, B.intermedia and B. murdochii are generally 
considered non-pathogenic. Described herein are case submis-
sions from 2 unrelated farms experiencing a mucohaemorrhagic 
colitis associated with a novel Brachyspira species.
Farm D
Fresh and fi xed tissues from 3 grow-fi nish pigs exhibiting bloody 
diarrhea were submitted from a single source nursery-fi nisher 
barn (Table 1). Histologic examination confi rmed a necrotizing 
catarrhal colitis. Brachyspira sp. was not isolated by bacterial 
culture from any case. The aff ected pigs were PCV2-vaccinated 
and had been pulse medicated with 33g/T tylosine (1 week of 3) 
from 9 to 15 weeks of age. The incidence of bloody diarrhea in 
11 to 24 week old pigs was infrequent. Total annualized grow-
fi nish mortality was 3.5 to 4.5%. 
Farm H
Four submissions of various types were made from grow-fi nish 
pigs exhibiting bloody diarrhea in a single source fi nisher barn 
(Table 1). Histologic examination confi rmed a mucohaemorrhag-
ic and suppurative colitis. Aff ected pigs were 13 to 16 weeks old, 
and were PCV2 and erysipelas vaccinated. Diets were medicated 
with 44 g/T lincomycin from 10 to 16 weeks of age, and with 110 
g/T lincomycin for 1 week when signifi cant diarrhea was noted 
in a group, which included all groups during the submission 
period. The total mortality rate attributable to bloody diarrhea 
was estimated to be 1% to 2%. 
PCR and sequence analysis (colon)
Species-specifi c PCR assays targeting B. hyodysenteriae and 
pilosicoli were negative for all samples. PCR primers designed to 
amplify a region of the NADH oxidase 1 gene (nox1) of Brachy-
spira spp.1 yielded a fragment of the expected size and direct 
sequencing of the nox1 amplicons yielded identical sequences 
from all samples. The nox1 sequence detected had a maximum 
of 92% identity to any previously characterized species. Phylo-
genetic analysis of relevant sequences (Figure 1) shows that the 
case sequence is distinct from other species which exhibit very 
little intraspecifi c diversity, and that its distance from other spe-
cies is typical of interspecifi c distances for the genus Brachyspira. 
Table 1. Diagnostics of pigs with bloody diarrhea and colitis unrelated 
to B. hyodysenteriae and B. pilosicoli
Farm Case Sample Type 1 Colon Culture2 PCR Results3
Farm D
17757  Fr, Fx E, L, C Bh & Bp: Neg
22958  Fr, Fc Neg Bh & Bp: Neg
28573  Fr, Fx E Bnox: Pos
Farm H
26620  Fc S, A, E Bh & Bp: Neg
27021  Fc Neg Bnox: Pos
28403  Fx, Fc S, E All Neg
30446  Car B Bh & Bp: Neg 
Bnox: Pos
Legend:
1 Fr=fresh tissue, Fx=formalin fi xed tissue, Fc=feces Car=carcass
2 L=Lactobacillus spp., C=Campylobacter spp., E=E. coli, S=Streptococcus spp., A=Acinetobacter 
spp., B=Brachyspira spp.
3 Bnox=Brachyspira spp. nox1; Bh=B. hyodysenteriae, Bp=B. pilosicoli
Figure 1. Phylogenetic tree of 810bp nox1 gene sequence from colitis 
cases and published reference sequences.
Discussion
Our results indicate a putatively novel Brachyspira spp. associat-
ed with haemorrhagic colitis and diarrhea in grow-fi nish pigs in 
the absence of other known pathogens including B. hyodysente-
riae and B. pilosicoli. More studies are planned to determine its 
causality.   
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Eﬀ ects of diﬀ erent diets on pigs with naturally-acquired Brachyspira pilosicoli infection
Jill R. Thomson; Brian P. Murray; Lorraine E. Henderson; Joan Dick; Colin Morgan
Scottish Agricultural College, Edinburgh, UK
Introduction
The impact of diet on porcine colonic spirochaetal diseases has 
been demonstrated in a number of studies. Experimentally, 
Brachyspira pilosicoli-infected pigs developed milder disease 
when fed cooked rice as compared with wheat based diets 
(1,2), attributed to reduced colonic fermentation and sparse, 
dry colonic content in rice-fed pigs. Commercial pig grower 
rations in the UK are mostly wheat based, and those with higher 
non-starch polysaccharide content can be associated with 
nonspecifi c colitis (3). Whether such diets promote or enhance 
the impact of infectious forms of colitis is poorly understood. 
This study compared the eff ects of diff erent diets on pigs with 
porcine colonic spirochaetosis (PCS). 
Materials and Methods
Pigs were acquired from six units with outbreaks of B.pilosicoli in-
fection for a series of farm-specifi c studies. For each trial, twelve 
diarrhoeic pigs and four normal pigs (controls) were obtained 
from the farm in question and housed in individual pens for the 
duration of the study. All pigs were growers (weights between 
20 – 40kg at start). During acclimatisation, all pigs remained on 
the farm’s ration and were tested for enteropathogens, faecal 
%dry matter (%DM) and intestinal retention time (IRT). On Day 0, 
six aff ected and two control pigs were changed to the test ration 
while the other cohort of 6 aff ected and 2 control pigs remained 
on the farm’s ration. The test ration was comprised of barley, 
soya, fi shmeal with vitamin and mineral balancer formulated to 
the same nutritional specifi cation, and pelleted at the same mill 
as the farm’s ration. Faecal %DM and brachyspira cultures were 
carried out 3 times weekly and IRT measurement on days 6 and 
12. Mean IRT was measured by feeding known numbers of poly-
thene beads followed by 4-hourly faecal collections. Pigs were 
weighed on days 0 and 14. On day 15 all pigs were euthanased 
for pathological examination and bacteriology.
Results
B.pilosicoli was isolated from all diarrhoeic pigs during the course 
of the trials, but not from normal pigs. During acclimatisation, all 
aff ected pigs had typical clinical signs of PCS, with faecal %DM 
values ranging between 16–23%. In all trials, changing to the 
test ration gave a noted improvement in clinical appearance and 
an increase in faecal %DM from day 4. Signifi cant diff erences 
in mean IRT between the farm’s ration and the test ration were 
recorded for all trials (p<0.001)(Table 1). In normal pigs, the test 
ration gave an average increase in IRT of 4.8 hours as compared 
with the farms’ ration. In pigs with PCS, the diff erence was more 
marked, giving an average increase in IRT of 6.6 hours in pigs on 
the test ration. A signifi cant positive correlation was recorded 
between mean IRT and growth rate in pigs with PCS. On post-
mortem examination all aff ected pigs were confi rmed to have 
lesions of PCS. A histopathological scoring system for colonic le-
sions showed signifi cantly higher mean scores (i.e. worse colitis) 
for pigs on the farms’ ration as compared with test ration.
Table 1. Mean intestinal retention time in pigs with or without porcine 
colonic spirochaetosis (PCS) from 6 farms; comparison of farms’ ration 
versus test ration on day 12 of trials. n=number of pigs from each farm
Farm
Mean intestinal retention time
Farms’ rations Test rations
Normal n=2 PCS n=6 Normal n=2 PCS n=6
1 24.1 20.3 30.7 27.8
2 25.0 18.9 32.5 26.2
3 26.6 21.8 33.0 28.5
4 29.4 22.3 31.9 29.3
5 24.4 19.8 27.5 25.2
6 27.0 21.5 29.8 27.2
Average 26.1 20.8 30.9 27.4
Discussion
The improvement in the clinical parameters and IRT in pigs with 
PCS when fed barley-based ration as compared with wheat-
based rations suggested that the dietary constituents had direct 
eff ects on enteric physiological processes and disease expres-
sion. In view of the matched dietary specifi cations, the increased 
growth rates achieved by PCS-aff ected pigs that were fed the 
barley-based ration could be attributable to an increase in IRT 
and to a reduction in both the severity of diarrhoea and the 
colonic infl ammatory lesions.
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Spirochaetes isolated from pigs in Spain
Jesús Osorio; Ana Carvajal; Álvaro Hidalgo; Héctor Argüello; Sonia Álvarez; German Naharro; Pedro Rubio
University of León, León, Spain
Introduction and Objectives
The research group at León University (Spain) is working on 
diff erent topics associated with Brachyspira species. The bac-
terial genus Brachyspira consists of several species of intestinal 
spirochetes with the capability of colonizing a broad spectrum 
of hosts. B. hyodysenteriae and B. pilosicoli have been commonly 
detected in pigs suff ering gastrointestinal disorders in Spain (1). 
However, there is no information about other species within the 
Brachyspira genus recovered from swine faeces. The purpose of 
this study is to give an overview of the diff erent non-pathogenic 
Brachyspira species that we have detected in pigs from Spain.
Material and Methods
A total of 67 Spanish fi eld isolates of Brachyspira spp. from 54 
farms were included in the analysis. All isolates were weakly 
β-haemolytic, recovered from pigs between 2006-2009 and 
came from the collection held at the University of León. None 
of the isolates had been designed into the B. hyodysenteriae/B. 
pilosicoli species by culture and PCR detection routinely used in 
our laboratory (2, 3). A partial sequence of NADH oxidase (nox) 
gene was used for the identifi cation of the isolates. Sequence 
data for well-known isolates and reference strains retrieved from 
Genbank were also included in the study. Sequence and sequen-
cing analysis was performed according to previously described 
procedures (4). The genetic relationships between strains were 
visualised by constructing a dendrogram using the ‘maximun 
composite likehood’ model and the neighbour-joining tree in 
MEGA version 4 (www.megasoftware.net) (5).
Results
All the isolates used were pure cultures and PCR confi rmed as 
diff erent from B. hyodysenteriae and B. pilosicoli. Information 
of partial nox sequences allocated most of the isolates to the 
three non-pathogenic species B. murdochii (31), B. innocens (26) 
and B. intermedia (7). The three remaining isolates could not 
be included into any of the Brachyspira species which naturally 
infect pigs. Isolates H29 and H51 were recovered from Iberian 
pigs belonging to 2 diff erent herds. The analized nox sequence 
of isolates H29 and H51 got 63 nucleotide substitutions (7.4%) 
with regard to the sequence of the B. hyodysenteriae isolates. 
Nox gene information confi rmed previous classifi cations and 
showed larger heterogeneity in B. intermedia isolates than in the 
other species. None of the isolates were included in the strongly 
β haemolytic species B. hyodysenteriae and “B. suanatina” even 
though we have check that several of the weakly haemolytic 
isolates gave weak positive bands to B. hyodysenteriae PCR used 
for diagnostic purposes, mainly B. intermedia isolates. We have 
found B. murdochii and B. innocens much more prevalent that B. 
pilosicoli and B. intermedia in swine herds in Spain.
Discussion
The isolates were identifi ed as B. murdochii (46.3%), B. innocens 
(38.9%) and B. intermedia (10.4%). Three of the isolates (4.4%) 
could not be included into any of the Brachyspira species which 
infect pigs. Therefore, in this study on weakly haemolytic intes-
tinal spirochaetes in Spanish pigs, we have found new groups 
of intestinal spirochetes which diff er from previous descriptions 
and could possibly be proposed as new Brachyspira species. 
More isolates should be idenfi ed in order to confi rm this fi nd-
ing. The present study adds knowledge to the biodiversity and 
evolution of Brachyspira swine species in Spain.
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Fig. 1. Dendrogram based on 
partial nox DNA sequences from 
isolates belonging to all currently 
described Brachyspira species 
which colonize pigs.
Enteric diseases - Grower and fi nisher pigs – Other enteric spirochetes
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 743
Poster Presentations
P.437
A ﬁ eld experience using oregano essential oil in six swine herds with hemorrhagic bowel syndrome
Robert W. Evelsizer1 Darryl Sanden2 Martha A. Mellencamp1
1. Ralco Nutrition, Inc., Marshall, MN, USA; 2. PIGS Inc., Fairmont, MN, USA
Introduction
Hemorrhagic bowel syndrome (HBS) is a condition of fi nish-
ing pigs between 2 to 6 months of age that is known to cause 
sporadic, sudden mortality. It has been theorized that intestinal 
volvulus may account for most, if not all, of what has been de-
scribed as HBS (1). Some suggest that excessive gas production in 
the caudal intestine is the underlying cause of HBS. Post mortem 
observations include a pale carcass with abdominal distension 
and gas distended intestines that are markedly reddened and 
fi lled with blood-stained watery fl uid. The jejunum is thin walled. 
The stomach is fi lled with feed. In a recent paper, the name 
“Porcine Intestinal Distension Syndrome” (PIDS) was proposed to 
more accurately refl ect the nature and cause of this condition (2). 
Investigation of a condition known as “whey bloat”, which appears 
to be identical to HBS or PIDS, has demonstrated an increase in 
abdominal pressure suffi  cient to cause impairment of venous 
return through the mesenteric veins (3). This results in massive 
pooling of blood in the intestines and ultimately leads to multiple 
organ failure and sudden death. Actual volvulus is not neces-
sary for HBS and is absent in a majority of cases. Reduction of 
HBS mortality with in-feed administration of antibiotics has been 
reported (1). This paper describes a fi eld investigation in which 
oregano essential oil (OEO) was applied either in the water or feed 
in six herds that were experiencing HBS. Results showed signifi -
cant reduction in death loss on these farms. 
Materials and Methods
An experienced grow-fi nish fi eld supervisor (D.S.) who oversaw 
60,000 fi nishing pigs per week had commonly encountered HBS 
on several of his farms. Factors associated with HBS on these 
farms related to feed intake patterns. These included genetics, 
weather, diet changes, out of feed events, feeder type, and water 
intake. He had taken several approaches to resolving this prob-
lem, including increasing feed particle size, reducing out of feed 
events, water chlorination, and antibiotics. After noticing that a 
farm feeding an OEO product had a lower rate of HBS, he began 
to implement OEO in either feed or water on his other farms in 
an attempt to reduce HBS. 
Results and Discussion 
A summary of recorded deaths from six farms before and after 
OEO use is shown in Table 1. No changes in management or how 
deaths were recorded were made. OEO in the water or feed was 
associated with an 87.5% reduction of HBS mortality. Odds ratio 
analysis (4) showed that OEO-treated pigs were 8.5 times more 
likely to survive than untreated pigs (5% CI: 5.45 to 11.96). On 
one farm, OEO was fed in one barn, while the other barn served 
as the “control”. In the OEO barn, death loss from HBS dropped to 
very low levels, while the control barn continued to experience 
the same number of HBS deaths. OEO has been shown to inhibit 
many species of bacteria, including Clostridium perfringens (5). 
It is theorized that OEO may reduce gut fermentation due to 
alteration of intestinal microfl ora, resulting in a reduction in 
observed HBS.
Table 1. Recorded deaths from HBS with and without oregano es-
sential oil (OEO).
Parameter No OEO With OEO
Total number of pigs 14,090 17,923
Deaths listed as HBS (%) 182 (1.29) 29 (0.16)
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Investigation into the cause of hemorrhagic bowel syndrome in 
grower pigs on commercial farms in South Africa
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Introduction
Over the last fi ve years generally excellent pig farmers in South 
Africa, with optimal management systems, have reported to 
consulting veterinarians that some of their grower pigs die 
acutely without prodromal signs, especially during summer. 
Most of these pigs appear to die from what can be described 
clinically and pathologically as hemorrhagic bowel syndrome 
(HBS). It tends to aff ect the best grown pigs close to market age, 
making it an expensive disease. Because of this, it was decided 
to investigate the syndrome in more detail.
Experimental Design
37 Necropsies were done by pig veterinarians. Only those car-
casses that had marked intestinal congestion, with red contents, 
were selected for sampling: For histopathology a 1 cm thick slice 
of intestine was collected from the ileum (30cm proximal to the 
ileo-caecal valve), mid section of jejunum and from the duo-
denum (10 cm distal from the stomach) for histopathology. For 
bacteriology a 6cm piece of ileum, taken just cranial to the histo-
pathology sample, was removed. Once the intestinal contents 
had been removed, a mucosal scraping was made. The slide was 
stained using the Gram’s staining method. Another mucosal 
scraping was made by rubbing the ileal mucosa with a cotton-
tipped swab and cultured aerobically as well as anaerobically. 
Histology sections were made using standard methods and the 
sections were evaluated for the presence of lesions. 
Results
The average age of the sampled pigs was 16 weeks and the 
range was from 9 – 22 weeks of age. Mortalities tended to occur 
in the early hours of the morning. At necropsy the skin was 
usually pale, without signs of trauma. Bacteriology cultures only 
revealed C. perfringens in a heavy, almost pure culture, where it 
was cultured from 12 (40%) of the samples. Histological lesions 
characteristic for enterotoxigenic Clostridium infection were 
found. Large, Gram-positive bacilli were sometimes abundant 
in sections and mucosal smears of the intestine. The lesions 
included necrosis, haemorrhage and congestion 
Discussion
The discrepancy between the histological observation of Clos-
tridia-like bacteria and culture of C. perfringens was disappointing 
but not unexpected. This anaerobic bacterium can be overgrown 
by commensal bacteria. Furthermore, prolonged sampling times 
after death, and suboptimal preservation methods, may have 
negatively impacted on the viability of the bacteria. 
The most likely cause of HBS in this study is Clostridium perfrin-
gens. Modern genetics has resulted in a commercial pig with 
improved average daily gain (ADG), feed conversion ratio (FCR) 
and leaner meat but perhaps because of this they are more pre-
disposed to metabolically-induced diseases such as HBS. Farms 
included in this study had growth rates above the national 
average. The pigs are probably pushed to their physiological 
limits from an early stage.  These pigs are intolerant to mistakes 
in management or feeding2, especially when rations are high 
in carbohydrates (typical South African rations), which under 
certain circumstances can lead to the proliferation of C. perfrin-
gens11. The extremely high ambient temperatures experienced 
in summer on all of these farms can lead to a decreased appe-
tite during the day, with a compensatory increase in feeding at 
night. This could lead to over engorgement, with the delivery of 
increased amounts of intestinal carbohydrate and protein. This, 
in turn, could lead to enteric microfl ora proliferation, which is 
supported by the fact that most of the deaths are discovered 
early in the morning, with mortalities probably occurring early 
(04h00) in the morning. The above hypothesis might explain 
why HBS is more prevalent in summer. 
Conclusions
Clostridium perfringens most likely plays a major role in heamor-
rhagic bowel syndrome (HBS) in South African piggeries during 
the hot summer months in rapidly growing pigs. 
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Case report of Gastric Ulcers in grower pigs aﬀ ected with persistent 
Porcine Respiratory disease complex (PRDC) 
Sasiwimon Talummuk; Rapeepat Kunalintip; Metta Makhanon
Novartis (Thailand) Limited , Bangkok , Thailand
Introduction
Gastric ulceration is an important disease in pigs. It is a direct 
or indirect cause of pigs death. The gastric ulcer can aff ect pigs 
at any ages but the highest rate of ulceration occurs is in 3-6 
months of age. Lesion of gastric ulcer is sited at pars oesophagia. 
There are a lot of risk factors including some infectious agents 
such as PCV2 and Helicobacter –pylori-like-bacteria and non-in-
fectious causes such as stress, management, and nutrition(1, 3 ). 
However, there are also other unknown causes. Clinical signs are 
depended on the causes of disease and varied from no clinical 
sign to sudden death. Gastric ulcer is indirect cause of mortality 
in case of PRDC disease due to anorexia and stress from some 
pathogens including PCV2 (4). If the stomach is empty more 
than 24 hours, gastric ulcer can develop. This report is the case 
of severe death caused by gastric ulcer in a Thai pig farm and 
discuss how to handle the case successfully.
Materials and Methods
Farm history: the multiple unit fattening pig farm with conven-
tional housing(909 grower pigs per house) and commercial 
pellet feed is used. Herd heath status is positive to PRRSV and 
PCV2. There is no Mycoplasmal vaccination. Pigs showed respira-
tory and diarrhoeal signs one week after weaning with almost 
10 % mobility. The grower pigs show more severe clinical signs 
including fever(38°-39°C), nasal discharge, lethargy, labored 
abdominal-breathing, severe coughing, pale, feed intake drop to 
0.6 kg per days, and diarrhoea (Fig1). Highest morbidity (100%) 
and mortality (12%) is at 14 weeks old. Culling rate of the weak 
pigs is 27.93%. Total loss is 39.93%.
Necropsy fi nding: Post mortem two 14 wk old pigs. The lesion 
were pale skin, cranioventral pneumonia, total lung score approxi-
mately 50-60%(Fig 2), diff use blood in stomach(Fig 3), gastric ulcer 
score 3 (Fig 4) (2, 5), fl abby heart, pale kidney, no feed content in 
gastrointestinal organ, severe colitis and ulceration. Screening test 
by directed smear was positive to Balantidium coli.
Laboratory diagnosis: lung, blood content and large intestine 
are collected for bacterial culture. Pool organs of lung, lymph 
node, kidney, and spleen are collected for PRRS and PCV2 identi-
fi cation by PCR. 
Diff entrial diagnosis: PRDC, Helicobacter-pylori-like-bacteria, 
Clostridium perfringens, and Walfarin poisoning. 
Treatment: All pigs were individually injected with Denagard 
®(tiamulin) 20% injection at 10 mg/Kg body weight for 3 days 
and water medication with Denagard® (tiamulin) 45% at 10 mg/
Kg body weight for 5 days. 
Results
The organisms isolated from lung lesions are Mycoplasma 
hyorhinis, Pasturella multocida and Streptococcus suis. Alpha 
Hemolytis streptococcus is isolated from large intestine. PRRS 
and PCV2 are positive by PCR. Helicobacter-like bacteria can be 
cultured from blood content in stomach. Clostridium perfrin-
gens is not found. There is no Walfarin used in this farm. Clinical 
signs improve slightly after treatment at late time of infection.
Discussion
According to this case, PRDC can induce severe of gastric ulcera-
tion and cause of high loss due to the mortality, morbidity and 
culling rate(1, 3). Route of medical administration and early 
treatment are the key factor for the successful treatment. There-
fore, water medication and injection is more eff ective route 
when feed intake drop(4).
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Nuria Llanes1 Carmen Alonso1 Joaquim Segales1, 2
1. CReSA, Bellaterra, Spain; 2. Departament de Sanitat i Anatomia Animals, Bellaterra, Spain
Introduction
Gastric ulcers in pigs have been extensively studied (1). Annual 
mortality due to gastric ulcers is estimated to be between 0.5 
and 0.75%. Therefore, its economical weight on the pork indus-
try is high. The specifi c causes of gastric ulceration are not well 
known, but a number of factors have been pointed as risky (1). 
A severe case of acute gastric ulcers aff ecting several farms from 
an integration company located in a high density pig rearing 
area in North-Eastern Spain allowed the study of potential risk 
factors associated with such condition. 
Materials and Methods
An estimated number of 5000 pigs died because of acute gastric 
ulcers during a 4-month period. Pigs corresponded to a 40.000-
sow company that produce around 900.000 fi nishing pigs per 
year. It was known that other pig producing companies in the 
area had also a similar problem. The majority of aff ected pigs 
weighted between 30 and 40 kg and no previous clinical signs 
were found prior the gastric ulceration outbreaks. Most aff ected 
farms were in good health conditions before the appearance of 
the problem.
Acute gastric ulceration with massive haemorrhage appeared 
in 90% of the dead animals. Mesenteric oedema, hepatomegaly 
and soft, orange-yellowish livers were found also at necropsy 
in 80% of the deaths. Mortality rate rapidly increased from 0.5-
5% (normal mortality values in fatteners) to 30- 40% in most 
severely aff ected farms. 
A number of laboratorial analyses were performed, includ-
ing necropsy and histopathology (with in situ hybridization to 
detect Porcine circovirus type 2 (PCV2), haemogram, hepatic 
enzyme determination, measurement of vitamin E and selenium 
in blood and feed, mycotoxins in livers and raw feed material, 
heavy metals in liver and perirenal fat, and a general toxicologic-
al analysis on feed, raw feed material and livers.
In the meantime, in order to counteract the problem, the feed 
particle size was increased in size (from 700 to 800 μm). Con-
comitantly, a dramatic change in the diet formulation was 
performed: reduction of wheat content from 45 to 25%, a source 
of fi bre was added (soybean hulls at 2%), sodium bicarbonate 
was added at a dose of 10 kg/ton and levels of vitamin E and 
selenium were increased from 10 and 0.2 to 40 and 0.5 ppm, 
respectively. Feed were served in mash form in most aff ected 
farms. Moreover, vitamin E and selenium were also given in pigs 
as injection. Finally, ranitidine (inhibitor of gastric acid produc-
tion) was added in the water of some farms.
Results
Clinical response to farm actions: Injection of vitamin E and 
selenium had a positive response in some of the farms.
Pathology: Most consistent lesion, besides gastric ulceration, 
was massive hepatic centrolobular necrosis and or liver plate 
disruption with massive loss of hepatocytes, suggesting either 
a chronic intoxication or hepatosis dietetica. PCV2 was not de-
tected in tissues of aff ected animals.
Haemogram and biochemical determinations: Most signifi cant 
results were severe anaemia and increased levels of hepatic 
enzymes in serum 
Vitamin E and selenium determination: Low levels of vitamin E 
(<0.5μg/ml) and selenium (0.78 μg/ml) were found (2).
Other analyses: No signifi cant mycotoxins levels or heavy metals 
were detected in analysed samples. Toxicological analysis was 
indicative of peroxidation in the feed.
Discussion
Clinical response and performed analyses pointed to a defi cien-
cy in vitamin E and selenium. However, it is very likely that other 
factors were involved in the triggering of the problem due to the 
erratic appearance of the cases. Peroxidation and free radicals on 
the feed may have accounted as major predisposing factors for 
the clinical situation observed. 
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Occurrence of gastric ulcers in Swedish pigs
Katarina Karlsson; Malin Cerne
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Introduction
Gastric ulceration is common in pigs throughout the world. 
Increased incidence of gastric ulcers has paralleled intensive 
husbandry practices (2, 5). The syndrome may have an economic 
impact because of increased mortality rate (2, 4) and decreased 
weight gain (1, 6). It is also an issue of animal welfare as gastric 
ulcers may cause pain.
Abattoir surveys in diff erent countries demonstrate the preva-
lences of lesions of the pars oesophagea ranging from 32 - 99 % 
(2). In several surveys possible risk factors have also been investi-
gated. There is no published survey describing the prevalence of 
gastric ulcers among pigs in Sweden.
Materials and Methods
Our study was carried out during one week in September 2007, 
at the abattoir of Kristianstad in the south of Sweden. A total of 
19 360 fi nishing pigs and 436 sows were slaughtered during the 
same period. Out of these we examined a total of 3 858 stom-
achs, randomly selected, mostly from fi nishing pigs. The stom-
achs were examined directly after being cut open and emptied. 
Alterations of the pars oesophagea were graded according to 
Dansk Svineproduktiońs index of ulceration (3). The categor-
ies of alterations were; category 1 healthy stomachs, category 
2 stomachs with parakeratosis, category 3 stomachs with both 
parakeratosis and small erosions, category 4 extended erosions, 
ulcers and scares, category 5 strictures of various severities and 
category 6 bleeding ulcers. 
Results
Out of 3 858 stomachs, 1 893 (49.1 %) were normal without any 
alterations of the pars oesophagea. 1 260 (32.6 %) were judged 
as category 2 and 258 (6.7 %) as category 3. We found 379 (9.8 
%) in category 4 and 57 (1.5 %) in category 5. Finally 11 stom-
achs had bleeding ulcers (0.3 %). 
Discussion
Ulceration of the oesophageal region of the stomach is a com-
mon and well known condition of fi nishing pigs throughout 
the world. In our study we found about 49 % of the examined 
stomachs to be normal and without any alterations of the pars 
oesophagea but almost 51 % had some kind of alterations. Most 
of the alterations found were mild and are not considered to 
have any impact on the performance of pigs (2). Approximately 
12 % of the examined stomachs had serious alterations like 
extended ulcers, scars, strictures and in some cases bleeding 
ulcers. Stomachs with similar contents and similar alterations 
clustered, which indicates that they belonged to the same farms. 
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Gastric ulceration in 30 fattening herds in Sweden
Malin Cerne; Katarina Karlsson
Swedish Animal Health Service, Falkenberg, Sweden
Introduction
Ulceration of the oesophageal region of the stomach is a com-
mon condition of fi nishing pigs throughout the world. Increased 
incidence of gastric ulcers has paralleled intensive husbandry 
practices (2, 5).
Many abattoir surveys from diff erent countries have shown vari-
ous prevalences of gastric ulcers. In several surveys possible risk 
factors have also been investigated.
Well known risk factors for gastric ulcers in pigs include reducing 
particle size of the feed and pelleting, as does withholding feed 
for 24 hours (1, 6). Other factors that have been associated with 
the development of gastric ulcers in pigs are infection with 
helicobacter, infection with PCV2 (7) and treatment with NSAID. 
It also appears that access to straw may compensate for several 
of the risk factors.
In a pre-studie of the occurrence of gastric ulcers in Swedish 
Pigs, we found that stomachs with similar contents and similar 
alterations clustered, which indicates that they belonged to the 
same farms (3). 
Materials and Methods
Our study was carried out during one week in September 2007, 
at the abattoir of Kristianstad. We examined 460 stomachs from 
30 randomly selected farms. The stomachs were examined dir-
ectly after being cut open and emptied. 
The alterations of the pars oesophagea were graded according 
to Dansk Svineprouktions index of ulceration (4). We recorded 
six diff erent categories of alterations. Categories 1, 2 and 3 were 
healthy stomachs, stomachs with parakeratosis and stomachs 
with mild erosions in pars oesophagea respectively. These 
alterations are not considered to aff ect performance or wellbe-
ing in pigs (2). Categories 4, 5 and 6 were stomachs with severe 
erosions, ulcers, scars and strictures. These alterations are con-
sidered to aff ect the pigs in a negative way.
Results
405 stomachs were judged as category 1, 2 or 3. 
55 stomachs were judged as category 4, 5 or 6. 
70 % of the stomachs judged as category 4, 5 or 6 originated 
from 4 of the 30 examined farms (no 6, 10, 28 and 30), fi g 1.
Discussion
As several of the risk factors have something to do with feed, 
feeding or housing it is not surprising that pigs from the same 
farm have the same alterations in pars oesophagea.
In an Australian survey from 2002 one found diff erences in 
prevalences between farms, but also between regions/states (6). 
The regions had diff erent kinds of climate and diff erent condi-
tions for crops. There is probably a diff erence between regions 
in Sweden. The abattoir in Kristianstad serves the southern part 
of Sweden. In this area it is common to feed pigs with surplus 
products from the food industry, such as products from baker-
ies, dairies, distilleries, crisps- and chocolate producers. It has 
not been investigated what impact these products have on the 
prevalences of gastric ulcers.
Gastric ulceration has been reported frequently in PMWS-aff ect-
ed pigs, although no direct connection between PCV2 infection 
and this lesion has been established. At the time of our survey 
PMWS was widespread in the southern part of Sweden.
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Esophagogastric ulcer: diﬀ erences in hematological values comparing 
depending on non-glandular mucosa lesional stage
Guillermo Ramis1 Serafín Gómez2 Juan J. Quereda1 José J. Cerón3 Francisco J. Pallarés2 
François Joisel4 Catherine Charreyre4 Sophie Longo4, 5 Antonio Muñoz1
1. Universidad de Murcia, Murcia, Spain; 2. DPTO Anatomía y Anatomía Patológica Comparadas, Universidad De Murcia, Murcia, Spain; 
3. Hospital Clinico Veterinario, Universidad de Murcia, Murcia, Spain; 4. Merial S.A.S., Lyon, France; 5. BPC, Labruguière, France
Introduction
Esophagogastric ulcer is a widespread disease aff ecting pigs of 
diff erent ages, especially to fi nishers. The ethiology of the dis-
ease is multifactorial, infl uencing nutritional, genetic, pathologic 
and management factors on its development and severity. The 
pathogeny has not been completely understood yet (1). The 
aim of this study was to assess the hematological and blood 
biochemical values in animals showing diff erent esophagogas-
tric lesional stages. 
Material and Methods
Eighty commercial pigs 1, 3, 6, 9, 12, 15, 18 and 21-week old 
(n=5 each group), were randomly selected. The animals were 
humanely euthanized and a macroscopical evaluation of non 
glandularis mucosa lesional stage was carefully done. Blood 
samples were taken on EDTA and dry tubes to recover whole 
blood and serum from each pig. 
A complete hematological study was performed including white 
blood cells count (WBC), red blood cells (RBC), hemoglobin 
(HG), hematocrite (HT), mean corpuscular volume (MCV), mean 
corpuscular hemoglobin concentration (MCHC), platelets count 
(PTL), red blood cells volume distribution (RDW-SD), mean plate-
lets volume (MPV), and total proteins (TP), using an Automatic 
analyzer SYSMEX F-800 (Japan)
The macroscopical lesional stage results were included in two 
categories for statistical analysis: apparently normal (AN), and 
abnormal (ABN). The abnormal category included all the stom-
achs showing some kind of alteration, including pre-ulcerous 
changes as parakeratosis and erosions.
Data were analyzed by means of Student t-test comparation 
using SPSS v. 15.
Results
Twenty stomachs were macoscopically classifi ed as normal, 
while 60 stomachs showed some kind of non glandularis 
mucosa alteration. There were signifi cant diff erences between 
groups for RBC, MCHC, RDW-SD and MPV. The values for every 
parameter are shown in the following table:
Table 1.
Parameter Lesional stage Mean P
WBC
AN 4.79 N.S.
ABN 13.65
RBC
AN 3.85 <0.001
ABN 5.52
HG
AN 7.29 N.S.
ABN 8.12
HT
AN 24.15 N.S.
ABN 27.67
MCV
AN 64.32 N.S.
ABN 52.23
MCHC
AN 29.73 <0.001
ABN 28.73
PTL
AN 250.9 N.S.
ABN 184.7
RDW-SD
AN 43.9 0.003
ABN 37.74
MPV
AN 10.11 <0.001
ABN 7.7
TP
AN 5.88 0.04
ABN 6.44
N.S. = not signifi cant
Discussion
Some changes in hematological values such us decreased 
RBC or MCV had been previously described (2). We have found 
signifi cant diff erences in some hematological values comparing 
groups, but most of them (RBC, MCV, MCH and RDW-SD) are into 
the diff erent reference intervals published (3, 4). The MPV is the 
only value under references values in abnormal stomachs, and 
could be related to increased coagulation derived from slow 
continuous blood loss, suggested also by reduced (even not 
signifi cant) MCHC. The reduced MPV indicates a quick replace-
ment of platelets. 
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Introduction
Esophagogastric ulcer is a widespread disease aff ecting pigs of 
diff erent ages, especially to fi nishers. The ethiology of the dis-
ease is multifactorial, infl uencing nutritional, genetic, pathologic 
and management factors on its development and severity. The 
pathogeny has not been completely understood yet (1). The 
aim of this study was to assess the hematological and blood 
biochemical values in animals showing diff erent esophagogas-
tric lesional stages. 
Material and Methods
Eighty commercial pigs 1, 3, 6, 9, 12, 15, 18 and 21-week old 
(n=5 each group), were randomly selected. The animals were 
humanely euthanized and a macroscopical evaluation of non 
glandularis mucosa lesional stage was carefully done. Blood 
samples were taken on EDTA and dry tubes to recover whole 
blood and serum from each pig. 
A complete blood biochemical study was performed includ-
ing glucose, urea, cholesterol, triglycerides, creatinin, Gamma-
glutamil transferase (GGT), phosphorus, alanine aminotransfer-
ase (ALT), Alkaline Phosphatase (ALP), Aspartate amiontranferase 
(AST), creatine kinase (CK), albumin, bilirrubin, and iron by 
means of a COBAS MIRA PLUS analyzer (ABX Diagnostics, France)
The macroscopical lesional stage results were included in two 
categories for statistical analysis: apparently normal (AN), and 
abnormal (ABN). The abnormal category included all the stom-
achs showing some kind of alteration, including pre-ulcerous 
changes as parakeratosis and erosions.
Data were analyzed by means of Student t-test comparation 
using SPSS v. 15.
Results
Twenty stomachs were macoscopically classifi ed as normal, 
while 60 stomachs showed some kind of nonglandularis mucosa 
alteration. There were signifi cant diff erences between groups 
for cholesterol, creatinine, GGT, ALP, ALT, albumin, bilirrubin and 
iron. The values for those signifi cant diff erent parameter are 
shown in the following table:
Table 1.
Parameter Lesional stage Mean P
Cholesterol
AN 158.6 <0.001
ABN 104.8
Cratinine
AN 1.34 0.016
ABN 1.62
GGT
AN 42.65 0,.001
ABN 88.39
ALP
AN 811.18 <0.001
ABN 318.96
ALT
AN 62.21 <0.001
ABN 39.57
Albumin
AN 2.88 <0.001
ABN 3.56
Bilirrubin
AN 1.09 <0.001
ABN 0.58
Iron
AN 354.64 <0.001
ABN 69.12
Discussion
Even when signifi cant diff erences in some hematological values 
comparing groups have been found, all of them are into refer-
ence values (2, 3) except for ALP and iron. It should take into ac-
count that some biochemical values can vary over the life of the 
animals and we have analyzed animals from 1st to 21st weeks of 
life. The iron value is much lower in abnormal group compared 
with normal group, and this parameter could be related to 
chronic loss of blood. Another hypothesis would be a reduced 
iron content derived from feed defi ciencies for this metal. But, 
interestingly, has been previously recorded how the defi ciency 
in nutritional iron results in a signifi cant acid gastric secretion, 
reducing the lesional stage of the animals (4). So, in this case the 
lower iron value in lesionated animals should be related to iron 
losses. The iron seric value could be a help to diagnosis in cases 
of esophagogastric alteration.
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Neonatal Diarrhea in Danish pig farms – a questionnaire among veterinarians
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Introduction
During the recent years neonatal diarrhea of unknown etiology 
seems to have occurred in many sow herds. The disease can 
usually not be eff ectively controlled by known vaccination or 
treatment strategies (1). The aim of this investigation was to sys-
tematize the perception of the character of the disease among 
Danish veterinarians.
Material and Method
A questionnaire, considering diff erent management factors, 
clinical symptoms and laboratory as well as autopsy fi ndings was 
developed. Two technicians were trained in interviewing veterin-
arians with the questionnaire as basis. Interviews were made from 
March through August 2009. Sixty-four veterinarians specialized 
in pig production were interviewed about their perception, with-
out further documentation, of neonatal diarrhea in sow herds. 
Results
Sixty-one of 64 veterinarians knew of this disease in one or more 
of their herds. The veterinarians interviewed were estimated to 
represent more than 50 % of the Danish pig production. 
Based on the questions the following answers were given 
(brackets indicate the percentage of veterinarians approving the 
statement in question). 
• Neonatal diarrhea has increased during the recent years (95%)
• In aff ected herds the prevalence of litters with clinical signs is 
between 30 and 70% (66%).
• The piglet incidence in the litter is 70-100 % (61 %).
• There is no relation between litter size and clinical signs (79%).
• Mortality in the farrowing unit is increased with 0-5 %-point 
(56%), but can increase to more than 20%-point above normal.
• Diarrhea is yellow (100 %) and watery (99 %) in some cases 
foamy and pasty (15 %) and more seldom green colored (10%). 
• Onset of clinical signs is from immidiately after birth with 
maximum frequency 2-3 days after birth, where after fre-
quency decrease and diarrhea disappears 7-10 days after 
birth (table 1).
• Autopsy fi ndings are non-specifi c: Flaccid dilated intestines 
(93%) and hyperemic intestines with watery content (48 %).
• At laboratory examinations Clostridium perfringens type A 
(85%), Non-hemolytic E. coli (82%), Clostridium diffi  cile (16%) 
and a few hemolytic E. coli or rotavirus have been found. 
Clostridium perfringens type C has not been found.
• There is no obvious relation between use of sow vaccinations 
and clinical signs.
• No obvious relation between management and clinical signs 
(54%).
• Health status (95%), hygiene in farrowing unit (65%), hygiene 
in dry sow facilities (85%) and purchase of breeding stock 
(85%) has no impact on clinical signs
• Low age (gilts) increase the risk of clinical signs (73%).
• Poor feeding with colostrum is a possible or certain cause of 
clinical signs (74%).
• Quality or source of feed can not be related to increased inci-
dence (87%). Wet feed (31%), high protein in sow feed (34%) 
or toxins in feed (11%) might pose a risk. A few vets point at 
rapeseed as a specifi c risk factor.
Table 1. Number of vets out of 61 that see diarrhea on a specifi c day 
after birth.
Day 0 1 2 3 4 5 6 ≥ 7
No 30 47 53 51 45 33 23 12
Discussion and Conclusion
Based on the questionnaire the disease can best be described 
as a new type of diarrhea with increased incidence in Danish pig 
production. It is a watery to creamy diarrhea with non-charac-
teristic pathological fi ndings and without detection of a certain 
etiological agent. Nevertheless, Non-hemolytic E. coli and Clos-
tridium perfringens type A are isolated with high frequency.
The morbidity is very high and the mortality low. Especially lit-
ters after gilts and young sows are at risk of being aff ected. 
These fi ndings are in accordance with reports from other parts of 
the world with intensive pig production and underline the need 
for further investigations to clarify the nature of the disease.   
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Introduction
In some area of France, almost 20% of the farms are concerned 
with enzootic neonatal diarrhoea (END) (Sialelli et al., 2009). On-
farm investigations conclude that many diff erent bacteria such 
as Clostridium perfringens type A, Clostridium diffi  cile, Entero-
coccus durans and others may be isolated but not consistently 
(Gin, 2008). Our hypothesis is that END origin at the sow level. 
The aim of this study was to describe the parturition in herds 
with END in comparison of herds without END. 
Material and Methods
Selection of herds: among 100 herds from the same Coop 
(COOPERL-Arc Atlantique, Brittany, France), nine commercial 
herds were retained according to presence or absence of END 
but also on the level of productivity, hygiene, management and 
stockmanship: 4 herds were regularly aff ected by END and 5 
herds without any history of diarrhea. The farrowing has been 
followed in 26 sows (Table 1). 
Measures: chronoparts (individual time at birth of littermates), 
piglets’ weight at birth and at 24 h of age (in order to estimate 
colostrum production) and colostral data (IgG) were obtained. 
Table 1: Herds and sows selected according to presence or absence of 
END (Enzootic Neonatal Diarrhea) 
Results and Discussion
Only data on farrowing duration is reported. Data on IgG in 
colostrum and piglets’ sera has been previously reported (Sialelli 
et al., 2009).
Parities 1 and 2 sows presented more risk to develop piglets’END 
(OR=3.6, p<0.05). Duration of farrowing was longer in aff ected 
sows in aff ected herds than in unaff ected ones. In aff ected herds, 
the duration of farrowing of unaff ected sows was intermediate is 
between unaff ected sows and sows from control herds (Table 1). 
Pattern of farrowing is diff erent according to the size of the litter 
(Figure 1). 
Figure 1: Chronopart from sows in aff ected herds and control herds. In 
aff ected herds, sows are divided in unaff ected sows and aff ected sows
 
In litter ≤ 12 total born piglets, birth rhythm is similar for the 
beginning of farrowing whatever the status of the sows (END 
pos or neg) or herds (control vs aff ected). However, there is a dif-
ference after birth of the 5th piglet (Figure 1). In large litter (≥ 15 
TB), birth rhythm is always upper in sows from control negative 
herds. In aff ected herds, a signifi cant diff erence appears after the 
birth of the 8th piglet.
Conclusion
END is probably a consequence of a problem at the sow level. 
Investigations are under evaluation to approach farrowing in 
herds aff ected by long farrowing (Sialelli et al., 2010).
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Introduction
At weaning, the digestive fl ora of piglets is unstable and is con-
sidered as a key factor of enteric disease. Alternative solutions to 
antibiotics or other products such as ZnO are proposed and give 
eff ective and repetitive results.
Symbiotic (prebiotic and probiotic) are shown to be one of these 
solutions. To have the widest comprehensive of this approach, 
the practitioner has to mix physiology, bacteriology, pathology, 
immunology, etc. It is why we propose to summarize the control 
of enteric fl ora at weaning by a jigsaw with 7 diff erent pieces.
Control of enteric fl ora at weaning: the jigsaw
The seven pieces are illustrated in Figure 1. 
Piece 1: CBH action. 
Due to the manufacturing technique, some specifi c Lactic Acid 
Bacteria1 are adapted to starch medium and bring a lot of 
α-amylases. Lactic acid produced improves pancreas secretion and 
impact on assimilation of carbohydrate chain (CBH) metabolism.
Piece 2: Enterocyte energy management. 
Better balance of digestive fl ora which decrease basal energy 
metabolism needed and impact (improve) on FCR. 
Piece 3: Struggle between bacteria. 
The competition / exclusion eff ect and environmental changes 
impact on natural defense at the mucus level. 
Piece 4: Cell booster. 
Stimulation of cell mucine and defensine production and re-
inforcement of tied-junctions impact on natural defense at the 
cell level.
Piece 5: Cytokine release. 
Interaction with intestinal immune system modulating cytokine 
pro-infl ammatory synthesis, increasing APC (Antigen Presenting 
Cell) activity, stimulating cytokine IL-12 synthesis (linked to Th1 
and Th2 balance), improving IgA production and fi nally impact 
on gut immune system at the lamina propria level. 
Piece 6: Regulation. 
Regulation of oral tolerance, key of intestinal homeostasis, with 
improvement of cytokine IL10 secretion impact on gut immune 
system at the lamina propria level.
Piece 7: Greater TAS (Total Antioxidant Status)
Improving glucose assimilation, it improves NADPH regenera-
tion with anti-oxidant function, added to the anti-oxidant en-
zyme and scavengers brought by the Symbiotic impact on TAS 
(decrease deleterious eff ect of oxidative stress as catabolism). 
Discussion
According to recent results, we showed that it is worth to use 
symbiotic to get repetitive eff ectiveness than only prebiotic or 
probiotic. Although the interaction between Symbiotic and di-
gestive tract is complex, we are able to analyze via the proposed 
jigsaw. 
Using symbiotic1 as feed additive in trials, zootechnical eff ects 
has been statistically observed (FCR: Pelenc 2009; ADG: Criqui 
2003), as well as immune response (Borghetti 2009). During 
studies on other species we systematically showed a better total 
anti-oxidant status (Laude 2008). 
Conclusion
We can claim that the Symbiotic is acting on diff erent goals on 
the digestive tract.
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Introduction
Previously studies have reported variable intra- and inter-
observer agreement for assessment of fecal consistency (1, 2). 
Diarrhea is characterized by defecation of feces which contain 
decreased dry matter content. Therefore assessment of fecal dry 
matter is an objective measure of diarrhea. A microwave proced-
ure has recently been described (3). The objective of the current 
study was to evaluate repeatability, robustness and agreement 
with freeze-drying for microwave determination of dry matter 
content in feces from weaners and growers.
Materials and Methods
A normal household microwave oven with a maximum eff ect 
of 700 Watt was used in the study. Fecal samples were dried to 
constant weight using the procedure previously described (3). 
Fecal dry matter content was calculated as: Dry matter = (weight 
of container and dried feces – weight of container) / weight of 
wet feces.
Three diff erent studies were conducted. Study 1: Intra- and 
inter-serial variation were evaluated in a fractional three-way 
factorial design. The 3 factors were main fecal sample, operator 
and replica. Fecal subsamples (observational unit) were ob-
tained from 4 main fecal samples with diff erent consistencies. 
The analyses were repeated by 2 persons (operators). From each 
main fecal sample 8 fecal subsamples were heated together 
(replica). Coeffi  cient of variation (CV) for fecal dry matter content 
was calculated. Data were analyzed by a linear mixed model 
with main fecal samples and weight of wet feces included as 
fi xed eff ects. Operator and replicas were included as random 
eff ects. Study 2: Eff ect of weight of wet feces was evaluated. Two 
fecal samples representing 2 diff erent fecal consistency scores 
were prepared. A total of 80 subsamples representing 5 diff erent 
weights categories of wet feces were prepared. The categories 
were 0.5 gram, 1.0 gram, 1.5 gram, 2 gram and 3 gram. From 
each consistency score 8 subsamples from each weight category 
were heated together. All samples were evaluated by the same 
person. Data were analyzed by linear regression. 
Study 3: Agreement between microwaves and freeze-drying 
was evaluated. Eighty fecal samples representing diff erent fecal 
consistencies were collected in a herd. Two subsamples from each 
fecal sample were prepared and fecal dry matter was determined 
by microwaves and freeze-drying. A Band-Altman plot was con-
structed and Lin’s concordance correlation coeffi  cient for agree-
ment was calculated. Trends of agreement in relation to increasing 
dry matter content were further evaluated by linear regression. All 
statistical analyses were performed in STATA/IC 11.0.
Results
For the intra- and inter-serial variation an overall CV of 0.03 was 
determined. Replica and operator accounted for 12% of the varia-
tion while 88% of the variation was with-in replicas. Confi dence 
limits (95%) for any future fecal subsample examined by any oper-
ator in any replica was calculated to be +/- 0.85% dry matter. 
Weighing off  0 5 gram of wet feces gave signifi cant (p<0.001) 
diff erent dry matter content than the other weight categories of 
wet feces. The other weight categories gave the same dry matter 
content.
Lin’s concordance correlation coeffi  cient for agreement between 
microwaves and freeze-drying was 0.94. On average the dry 
matter values was 1.7% higher in freeze dried samples com-
pared to samples prepared by the microwave procedure. The dif-
ference was increasing by 0.18% dry matter (p<0.001) for each 
1% increase in fecal dry matter of the examined sample. 
Discussion
The observed repeatability for the microwave procedure was 
considered acceptable for determination of fecal dry matter. 
The variation distribution implies that homogenization of the 
original fecal samples before analysis is important and that the 
variation due to the microwave procedure it self and diff erent 
operators can be neglected. The microwave method gave con-
sistent results using 1 to 3 gram of wet feces for the determina-
tion. This implies that a minimum of 1 gram of wet feces should 
be used. The microwave procedure showed a high level of 
agreement with freeze-drying, although slightly higher dry mat-
ter values were obtained using freeze-drying. Neither method 
can be regarded as gold standard, but the current study show 
that similar results can be obtained with both methods. The 
increasing diff erence between the two methods with increasing 
dry matter content indicate that the results of the current study 
may only be valid for feces collected from weaners and grow-
ers. Feces from older pigs may contain a higher level of fecal dry 
matter which may infl uence the results.
In conclusion: The microwave procedure off ers a fast, repeat-
able, robust and accurate method for determination of fecal dry 
matter. 
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Diurnal variation of fecal dry matter in pigs
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Introduction
Classifi cation of pigs as having diarrhea or not is important for 
results and interpretation of research in enteric diseases. Recent-
ly an objective procedure for determination of fecal dry mat-
ter (DM%) based on microwave drying has been described(1). 
Diurnal fecal dry matter variation may infl uenza the outcome of 
clinical examinations and the results of research. 
The objective of the current fi eld study was to investigate the 
variation in fecal dry matter and diarrhea classifi cation with-in one 
day for pigs with and without diarrhea. The quantitative excretion 
of Lawsonia intracellularis from the same pigs was also deter-
mined and will be reported elsewhere in these proceedings. 
Materials and Methods
A cross-sectional study with follow-up was designed. A Dan-
ish farrow- to fi nish herd with a history of L. intracellularis was 
selected at convenience. Pigs were selected from a batch of 
350 pigs with an approximately age of 8 weeks. Within the 
batch, 20 pigs with diarrhea and 10 pigs without diarrhea were 
selected at convenience. Fecal samples were collected fi ve times 
(9am, 11am, 1pm, 3pm and 5pm) from the rectum of each pig. 
Defecation was triggered by rectal digital manipulation if neces-
sary. The fecal samples were at all times kept chilled. Fecal dry 
matter content was determined for all fecal samples 24 hours 
after collection by the microwave method as described previ-
ously(1). The examined pigs were re-classifi ed into non-diarrheic 
(DM%≥18.8), semi-diarrheic (18.8>DM%≥13.1) or diarrheic 
(DM%<13.1) based on DM%(2) of the fecal sample from the fi rst 
time point.
The data was analyzed in a linear regression model (LogDM% as 
outcome, time points as independent variables) with a repeat 
measurement structure using the mixed procedure in SAS, ver-
sion 9.1. 
Results
A total of 29 pigs and 144 observations were included in the 
analysis. Seven pigs were classifi ed as non-diarrheic, 9 were 
semi-diarrheic and 13 were diarrheic at the fi rst time point. A 
signifi cant change in mean DM% between time points was 
observed for both non-diarrheic (p = 0.01), semi-diarrheic (p = 
0.01) and diarrheic pigs (p = 0.02). The combined analysis of all 
pigs showed a signifi cant (p<0.01) lower mean DM% at the last 
time point (5pm-7pm) compared to the other time points.
Only one initial non-diarrheic pig stayed non-diarrheic all day. 
The other 6 initially non-diarrheic pigs changed classifi cation 
once or twice during the day. Five of the initial semi-diarrheic 
pigs stayed diarrheic all day. The other 4 pigs changed from 
diarrheic to non-diarrheic and back. Eleven initial diarrheic pigs 
stayed diarrheic all day while 2 pigs changed to non-diarrheic 
and back, table 1.
Table 1. Diurnal variation in classifi cation of diarrhea for individual pigs
Time point
Status at fi rst time point (9am) Status at later time 9am 11am 1pm 3pm 5pm
Non-diarrheic (DM%>18.8) Non-diarrhea 7 6 3 4 3
Diarrhea 0 1 4 3 4
Semi-diarrheic (18.8≥DM%>13.1) Non-diarrhea 0 4 2 1 0
Diarrhea 9 5 7 8 9
Diarrheic (DM%≤13.1) Non-diarrhea 0 0 1 2 0
Diarrhea 13 13 12 11 13
Discussion
The results of the current study shows that fecal dry matter con-
tent can change during the day and that time of day is import-
ant for classifi cation of pigs as diarrheic or not. This indicates 
that examination of pigs at the same time of the day may be 
important in research studies. It does also have implications 
for monitoring of diarrhea at both individual and herd level in 
veterinary practice. Stress caused by several times of handling 
and fi xation in a period of 10 hours may have contributed to the 
observed decrease in mean fecal dry matter content during the 
day. A larger sample of pigs is needed to determine whether a 
true diurnal variation in fecal dry matter exists. In conclusion, the 
current study supports the existence of a within day variation in 
fecal dry matter.
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Intestinal pathogens in acute diarrhea in weaners: A case control study in 20 Danish herds
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Introduction
Recurring therapeutic batch medication of acute outbreaks of 
diarrhea in weaners is a common cause of antibiotic consump-
tion in Danish pig production. The objective of the current study 
was to investigate the prevalence of selected pathogens in 
outbreaks of acute treatment indicated diarrhea in pigs between 
10 and 70 days post weaning. Results of clinical and pathological 
investigations are reported elsewhere in these proceedings.
Materials and Methods
A case control study was conducted. Herds were selected by 
multistage sampling. All herds serviced by six specialized swine 
veterinarians from the same vet practice at Zealand and fulfi lling 
the inclusion criteria were selected. The criteria were recurring 
therapeutic use of in-feed or in-water medication for diarrhea 
at room level in pigs between 10 and 70 days post weaning. 
Only herds representing modern intensive production systems 
were selected. One outbreak of acute diarrhea was investi-
gated in each herd. All herds were visited the day following 
notifi cation from the farmer/veterinarian of an acute treatment 
requiring outbreak of diarrhea and the farmer was not allowed 
to medicate before the pigs were examined. If the pigs had 
received antibiotic batch medication within the last 7 days of 
the examination day, the outbreak was excluded from the study. 
A sample of 80 pigs in each herd was selected by systematic 
random sampling among all pigs in the nursery room where 
the outbreak of acute diarrhea occurred. The selected pigs were 
subjected to a clinical examination and fecal samples were col-
lected. Among the examined pigs a simple random sample of 8 
pigs with diarrhea and 8 pigs without diarrhea was selected and 
euthanized. Intestinal content was examined for rotavirus by an 
ELISA method and Escherichia coli, Brachyspira spp. and Salmon-
ella spp by standard culturing methods. Dry matter (DM%) was 
determined for the fecal samples. DM% ≤ 18.8 was considered 
as diarrhea (1) and was used (if necessary) to reclassify the pigs 
as diarrheic (cases) or non-diarrheic (controls) in the statistical 
analysis. Chi-sq test was applied for unconditional testing of dif-
ferent pathogen prevalence in pigs with and without diarrhea. 
Results
Twenty-four non-diarrheic and 12 diarrheic pigs (determined 
at clinical examination) were reclassifi ed according to the DM% 
determination. Eight pigs were excluded from analysis. Results 
are displayed in Table 1. Infection with one or more of the listed 
pathogens was demonstrated in 76% of the pigs with diarrhea 
and 69% of the pigs without diarrhea. There were no signifi cant 
(p>0.05) diff erences between the prevalence of pathogens 
found in pigs with and without diarrhea Salmonella spp., B. 
hyodysenteriae and rotavirus were not detected. 
Table 1. Prevalence of selected intestinal pathogens* in 20 herds with 
outbreaks of acute diarrhea with indication of treatment 10 to 70 days 
post weaning (n = 312 pigs)
Pigs with diarrhea 
(DM%≤18.8) (n=166)
Pigs without diarrhea 
(DM%>18.8) (n=146)
Small intestinal content:
Hemolytic E. coli
Pure culture 8% 3%
Dominant in mixed culture 11% 7%
Non-hemolytic E. coli
Pure culture 7% 6%
Dominant in mixed culture 32% 37%
Large intestinal content:
B. intermedia 7% 5%
B. innocens, B. murdochii 29% 22%
B. pilosicoli 7% 3%
* Demonstrated by bacteriological culturing
Discussion
The non-signifi cant diff erences in the prevalence of pathogens 
found in pigs with and without diarrhea could imply that the 
detected infections were not the cause of diarrhea. It may also 
imply that the non-diarrheic pigs were in the incubation phase 
of diarrhea development or that some pigs were able to resist 
the infections without having diarrhea. In the latter case the 
results imply that it does not matter whether samples for micro-
biological examinations are collected from pigs with or without 
diarrhea. However, a quantitative evaluation of the pathogens 
present in the two groups might tell a diff erent story. Further 
conclusion awaits the remaining microbiological examinations 
by quantitative real-time PCR for detection of PCV2, Lawsonia 
intracellularis, B. pilosicoli and E. coli.
References
1. Pedersen, K.S. et al., 2009. Proc 1st ESPHM: page 67.
Enteric diseases - Suckling and weanling pigs – General
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 757
Poster Presentations
P.451
Frequency of enteropathogens in diarrheic and non-diarrheic neonatal piglets
Eduardo C. Cruz Jr.1 Felipe M. Salvarani1 Isabella S. Alberafo1 Rodrigo O. Silva1 Francisco F. Lobato1 Edel F. Stancioli2 Roberto M. Guedes1
1. Universidade Federal de Minas Gerais, Veterinary School, Belo Horizonte, MG, Brazil; 
2. Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
Introduction
Enteric diseases represent the most important cause of losses 
in neonatal piglets due to antimicrobial use, labor, reduced 
weaning weight and mortality (1). The most important agents 
involved with enteric disorders up to 7 days of age are entero-
toxigenic Escherichia coli (ETEC), Clostridium perfringens types 
A and C, Clostridium diffi  cile, Rotavirus and Isospora suis. There 
is little information regarding the frequency of these agents in 
Brazilian swine production systems. As a result, the aim of this 
study was to establish the frequency of enteropathogens in diar-
rheic and non-diarrheic neonatal piglets.
Material and Methods
Sixty 1 to 7-day-old piglets from 15 diff erent swine farms (2 
diarrheic and 2 non-diarrheic piglets, age matched, per farm) 
were euthanized and evaluated. A fresh stool sample was taken 
from each animal and submitted to diff erent analysis, such as: E. 
coli isolation and typifi cation using PCR multiplex for virulence 
factors (2); Rotavirus detection using poliacrylamide gel elec-
trophoresis (PAGE); C. diffi  cile toxins detection using an ELISA 
kit; C. perfringens isolation and typifi cation (type A or C) based 
on a multiplex PCR; and a fl otation fecal test for detection of I. 
suis oocists. Jejunum, ileum, colon and cecum segments were 
collected and formalin fi xed for histopathological evaluation. 
This project was approved by the ethics committee for animal 
experimentation of the Universidade Federal de Minas Gerais.
Results
C. perfringens type A was the most frequent agent detected, 
being present in 43.3% of the diarrheic piglets and in 83.3% of 
the non-diarrheic ones. However, for all C. perfringens type A, 
76.9% of the diarrheic animals were β2 gene positive, while 64% 
of the non-diarrheic animals had the β2 gene. No C. perfringens 
type C was detected. C. diffi  cile was the second most frequently 
detected agent, present in 23.3% and 10% of diarrheic and 
non-diarrheic piglets. Rotavirus and E. coli were the third most 
important enteropathogens (Table 1).
Eight piglets out of 10-ELISA positive for C. diffi  cile had signifi -
cant neutrophilic colitis. Three of four Rotavirus PAGE positive 
animals had necrosis of the tip of villi. Only one animal had coco-
bacilar bacterial colonies adhered to enterocytes compatible to 
ETEC. No histologic lesion was attributed to C. perfringens type 
A even though there were some positive β2 results.
Table1. Diagnostics of each piglet group
Diarrheic piglets Non-diarrheic piglets
C. diffi  cile 23.3% (7/30) 10%(3/30)
C. perfringens type A B2 33.3%(10/30) 53.3%(16/30)
C. pefringens type C 0% (0/30) 0% (0/30)
Enterotoxigenic E. coli 10% (3/30) 3.3% (1/30)
Isospora suis 0% (0/30) 3.3% (1/30)
Rotarvirus 13.3% (4/30) 0% (0/30)
Discussion
Our results were similar to YAEGER (3) who found 47% and 48% 
for C. perfringens type A and C. diffi  cile, respectively, in young 
piglets with diarrhea. However, one should be careful as C. per-
fringens type A and C. diffi  cile are part of the normal fl ora and 
were also detected in non-diarrheic piglets. As a result, there 
is no easy diagnosis and the results should be interpreted with 
cautious. Histopathological fi ndings should also be considered. 
Rotavirus was not highly prevalent but was present in a signifi -
cant number and should not be forgotten. ETEC frequency was 
low, as demonstrated in diff erent studies (3). It is important to 
emphasize the relevance of performing the detection of viru-
lence factors in order to diagnose relevant ETEC strains. 
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Introduction
Although non fatal, enzootic neonatal diarrhea (END) is still a 
problem in many French swine high producing herds[1]. Dealing 
with this issue, veterinarians have to perform a diagnosis in or-
der to well implement the treatment and the prevention. In this 
paper, we focus on the diagnosis approach of END.
Materials and Methods
The study was conducted in 10 French farrow-to-fi nish pig 
farms (see Materials and Methods in: Gin et al., 2010). In or-
der to identify the onset of diarrhea, piglets were watched 3 
times a day and during 7 consecutive days. Four piglets from 
2 diff erent litters, having diarrhea for less than 12 hours, were 
euthanized and on-farm necropsied. Microbiological analyses 
were performed on samples from the small and large intestine, 
kept at 5°C after the necropsy. Histological examinations were 
performed on samples (kept in formaline 10%) from duodenum, 
jejunum, ileum and helicoidal part of the colon. Microbiological 
and histological analyses were performed by LDA22 (Ploufragan, 
Côtes d’Armor, France) or by Labofarm (Loudéac, Côtes d’Armor, 
France), depending on the location of the farm. 
Results
Although herds were selected for END, 2 farms remained diarrhea 
free during the week of investigation. This is an illustration of END 
variability between diff erent batches within the same herd.
Clinical investigation highlights that END is an issue in very good 
herds (average of 11.4 piglets weaned per sow per litter) where 
producers and veterinarians are implementing a lot of interven-
tions: zootechnical interventions (cross-fostering, change of 
the processing date…) and medical interventions (antibiotics, 
symbiotics, autogenous vaccines,…). However, nothing seems 
to be working and, sometimes, it is getting worse.
Necropsies highlight prevalence of mesocolon edema observed 
in 6/8 herds (17/27 piglets) but with diff erent etiological diagno-
sis. Therefore, there is no link between a specifi c pathogen (like 
C. diffi  cile3) and mesocolonic edema.
On 8 etiological herd diagnosis, there were 2 cases of Enterococ-
cus durans, one case of C. diffi  cile, one case of both, C. diffi  cile 
and E. durans, 3 cases of C. perfringens type A, one case of 
rotaviral diarrhea and none with E. coli.
Discussion
In human medicine, especially in hospital, daily interventions can 
quickly spread a pathogen like C. diffi  cile for example[4]. Recently, 
it was shown that C. diffi  cile is a concern in intensive care units 
for cats and dogs5. In a given herd, a farrowing room could be 
compared to an hospital. The producer is like a nurse: he/she is 
going from litters to litters, moving animals and performing some 
treatments. During all these interventions (zootechnical and med-
ical), the producer can easily spread a “pathogen”. This is called a 
nosocomial disease and it may be a “new” risk factor of END.
Moreover, always in human medicine, antibiotics can induce 
diarrhea and Antibiotic-Associated Diarrhea6 starts to be better 
understood (Figure). This is called a iatrogenic disease and it may 
also be another “new” risk factor of END.
Finally, Enterococcus durans diarrhea occurs mainly in litters 
from parity 1 and 2 sows, 3 to 5 days after birth. Before having 
a very watery diarrhea, piglets are often vomiting. Usually, the 
whole litter is having scour and death occurs quickly if an ap-
propriate antibiotic treatment (such as fl orfenicol or amoxicillin) 
is not implemented. Acute enteritis with a small intestine full of 
water is observed during necropsies. Histological analyses reveal 
gram positive cocci bind to the jejunum and ileum epithelium.
To conclude, this fi eld study shows that neonatal diarrhea is 
changing with “new” pathogens (E. durans) and, beside other 
new identifi ed risk factor[1], other risk factors such as nosocom-
ial and/or iatrogenic diseases have to be considered.
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Diagnostic of post-weaning diarrhoea on the farm level 
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Introduction
Post-weaning diarrhoea (PWD) is a multi-factorial disease. 
Clinical symptoms are often linked to a com-bination of diff er-
ent factors such as low feed intake after weaning, low hygiene, 
low age at weaning, low piglet live weight at weaning, and a 
high number of piglets per pen (Madec et al., 1998). Associated 
with the myriad of stressors to which the piglets are sub-jected 
in the weaning process, are marked changes to the digestive 
and absorptive capacity. Therefore, intake of creep feed and diet 
composition can have severe impacts on the occurrence of PWD 
(Callesen et al., 2007) too. Although organically reared piglets 
are, in general, six weeks of age at weaning, and are kept with 
a high space allowance, post-weaning diar-rhoea is a severe 
problem in organic pig production (Bonde & Sörensen, 2006; 
Sundrum et al., 2010). Due to restrictions in the use of antibiotics 
in organic livestock production, there is a need to focus primar-
ily on the implementation of preventive measures. When health 
problems are recognised, it is of high importance to make an 
accurate diagnosis and iden-tify the farm-specifi c causes to en-
able the elimina-tion of relevant risk factors. The objective of this 
study was to assess, qualitatively, the possible causes of weaning 
diarrhoea in an on-farm approach on those organic farms which 
have previously reported about PWD problems.
Material and Methods
Case studies were performed on six organic sow herds in Ger-
many, aff ected with PWD problems. Clinical examinations and 
data on critical control points (CCPs) were assessed on the farms 
in an interval of 6 months. On the fi rst visit a comprehensive 
interview was carried out with the herd manager gathering 
information on performance level, mortality and morbidity rates, 
hygiene management, feeding re-gime, and medicine usage. 
Piglets were housed in stables with outdoor runs. Weaning age 
averaged 44.8 days. Feed was purchased from an independent 
feed mill, creep feed and post-weaning diets were analysed for 
crude nutrient content. 
Faeces were collected on each farm via swabs from fi ve clinical 
healthy and fi ve piglets suff ering from postweaning diarrhoea, 
respectively. Faeces were analysed microbiologically for content 
of haemolytic E. coli. Diff erential analysis includes salmonellosis, 
swine dysentery, porcine proliferative enteropathy and porcine 
colonic spirochetosis. 
Preliminary Results
The second visits on the farms have just started so that currently 
only preliminary results have been obtained. 
The examination of the CCPs showed that all farms showed 
more or less severe defi cits in the hygiene management and in 
the nutrient regime, although varying in their details consider-
ably between the farms. Laboratory analyses provided proof for 
the presence of diff erent strains of haemolytic E. coli, Brachyspira 
pilosicoli and Lawsonia intracellularis, independent of the health 
status of the piglets. 
After interpretation of all data, farm specifi c measures have been 
recommended to the farmers. Eff ects of the implementation of 
measures will be assessed on the second farm visit. 
Implications
Eff ective clinical management includes the iden-tifi cation of risk 
factors and the implementation of changes aimed at reducing 
the incidence of PWD. Further investigations should be directed 
towards the impact of hygiene management and feeding 
regime on piglet susceptibility to GIT disorders and enteric 
infections. The development of diagnostic tools to be used on 
the farm level should be enforced to enable appropriate and 
promptly counteractive measures. 
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Introduction
Enteritides continue to be amongst the most important factors 
that limit the profi tability and effi  ciency in pig industry. For this 
reason exact diagnosis is needed in order to avoid great eco-
nomic losses [1, 2]. Therefore the aim of this retrospective study 
was to look for possible relations between diarrhea-causing 
pathogens and pathological fi ndings of the gastrointestinal tract 
of swine suff ering from enteritis to possibly provide a useful tool 
for diagnosis in the fi eld.
Materials and Methods
Results of the clinical, pathomorphological, and bacteriological 
examinations from 444 pigs (29 suckling and 314 weaned pig-
lets, 88 fatteners, and 13 sows) all suff ering from diarrhea, which 
were submitted to the Clinic for Swine at the University of Vet-
erinary Medicine Vienna over a period of three years, were ana-
lysed with pathological fi ndings only being taken into account 
in cases of monoinfection. Pathological fi ndings were classifi ed 
as serous-catarrhalic enteritis, hemorrhagic-necrotizing enteritis, 
fi brinous enteritis, ulcerative enteritis, thickening of the ileal or 
colonic mucosa, mesenterial edema, lymphoplasmacytic enter-
itis, lymphocyte depletion of the MALT, and crypt abscesses.
Results
Infections with one or more bacterial pathogens could be de-
tected in only 72.1 % of investigated pigs. However, no causative 
pathogen was found in the remaining 27.9 %. Most frequently, 
E. coli could be isolated (59.0 %), followed by infections with L. 
intracellularis (10.4 %), Cl. perfringens (9.7 %), Brachyspira spp. 
(5.0 %) and Salmonella spp. (1.4 %). Monoinfections with one 
of these pathogens were determined in 122 animals. Patho-
morphologically, in most cases (63.9 %) a lymphoplasmacytic 
enteritis could be diagnosed irrespective of the pathogen. A 
reliable hint for a mutual occurence of a specifi c pathogen and 
a corresponding pathomorphological fi nding was only seen in 
infections with L. intracellularis. In the majority of these cases 
(87.5 %) the ileum exhibited a thickening of the mucosa. 
Discussion
The only correlation between a specifi c pathogen and a patho-
morphological fi nding could be demonstrated for L. intracellu-
laris-infections. Therefore, it can be concluded that all other 
bacterial pathogens causing enteritic infections in pigs do not 
go hand in hand with specifi c lesions.
In a large proportion of cases no causative pathogen could be 
isolated. When taking into account that in most cases a lympho-
plasmacytic enteritis could be diagnosed, an infection by some 
viral pathogen is conclusive. As a consequence these results may 
give a hint towards PCV2 being a possibly important pathogen 
also in cases of diarrhea. However, we did not prove this as-
sumption by further molecular diagnostic techniques.
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Introduction
Aetiology of Grey Scour Syndrom (GSS) is a matter of question in 
France. Lawsonia intracellularis (LI) and Brachyspira sp (Br) have 
been isolated from faeces of pigs with GSS in some cases but not 
in the majority of concerned farms (1). However, the seropreva-
lence of LI is as high as in the others countries (2). Escherichia 
coli is the most common pathogen found in GSS but its role as a 
causative agent is questionable. This paper discuss a case of late 
colibacillosis.
Materials and Methods
A fi eld investigation was carried out in a selected farrow to fi n-
ish farm (200 sows) concerned by GSS and heterogeneity. An 
outbreak of diarrhoea usually occurred during post weaning (8 
weeks of age) followed by GSS until 12 weeks. A batch of 308 
pigs was monitored from weaning to slaughter. Several clinical 
evaluations were conducted, with sampling of faeces and blood. 
If we observed an increase in GSS intensity or otherwise at the 
end of the follow up (145 days), it was planned to euthanize 9 
pigs at laboratory: 3 with clinical signs of diarrhoea or doubtful 
body condition, 3 lean pigs (lp) and 3 control pigs (without diar-
rhoea). Digestibility was evaluated by analyzing colonic content: 
fl ora, digestibility of organic material (DO, %) evaluated by the 
use of indigestible part of the feed as a marker and volatile fatty 
acids (Vfa, g/l).
Results
Two main outbreaks of liquid diarrhoea with general clinical 
signs occurred at 48 and 97 days of age respectively. For the fi rst 
one, 3 diff erent E. coli were found on 3 necropsied pigs. Only 
non typable E. coli has been identifi ed for the second one (sick-
est pigs were under treatment at sampling time). At each herd 
examination some pens were concerned by diarrhoea (evident 
or doubtful situation) with a maximum of 50% of the pens at 77 
days. As GSS was mild, pigs were euthanized at 145 days (Table 
1). Diarrheic pigs didn’t seem to be sick but E. coli F4 was found 
attaching the small intestine on the two heaviest. 
This farm was positive for LI and this batch had seroconverted 
between 109 days (1+/16 pigs. ELISA) and 145 days (6+/16). Nec-
ropsy of lean pigs didn’t give relevant information: peritonitis / 
no lesion / pneumonia and pleuritis respectively. No histological 
lesion of PCV2 was found on any pig.
Digestibility of organic mater wasn’t depreciated on these diar-
rheic pigs but their fermentation in colon was low (Vfa).
Table 1: Clinical and analytical observations for the 9 necropsied pigs 
(145 days).
Control 
pigs
Control 
pigs
Control 
pigs
Lean 
pigs
Lean 
pigs
Lean 
pigs
Diar-
rheic
Diar-
rheic
Diar-
rheic
A B C D E F G H I
As ws ws ws lp lp lp ws ws ws
W 85 77 92 57 47 53 103 93 81
CS - - - - - - D D D
E c F* Nt F4 Nt - - F4 F4 F4
LI - - + - - - - - +
Br - - +* - - - - - -
DO 75 80 84 79 85 80 83 77 85
Vfa 7 7 6 8 9 6 5 1 4
Abbreviations: As: aspect - CS: clinical signs - D: diarrhoea – E c: E. coli - F*: O141K85 - Nt : non 
typable - W: weight (kg) - ws: well shaped - *: Int- Innocens
Discussion
Normal digestibility on these diarrheic pigs is relevant with their 
weight and aspect. Hence, due to the lack of other clinical signs 
and their optimal weight, we can wonder on the real impact of 
this late colibacillosis. Moreover, the batch had not been treated 
and nothing happened. We can also wonder if the diarrhoea is 
due to the colibacillosis, to the lack of fermentation in the gut 
or the both. This case suggests then to minimize the import-
ance of E. coli isolated on fattening pigs not showing global 
clinical signs (situation diff erent from postweaning diarrhoea). 
Therefore one hypothesis could be a mix of diff erent profi les for 
GSS in France: profi le of economic importance when due to LI 
for example; profi le of more doubtfully economical importance 
when associated with E. coli only.
Authors thank Boehringer Ingelheim for its fi nancial support in this fi eld 
investigation.
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Prevalence of enterotoxigenic Escherichia coli (ETEC) virulence 
genes isolated from scouring piglets in Taiwan
YF Sun; MH Liao; MC Lee; SP Chen
ATIT, Miaoli, Taiwan
Introduction
Enterotoxigenic Escherichia coli (ETEC) are associated with 
diarrhea in neonatal and post-weaning piglets, and these infec-
tions constitute an important problem relating to farrowing in 
modern intensifi ed piggery management. The strains of ETEC 
associated with intestinal colonization in piglets resulting in 
hypersecretory diarrhoea express F4, F5, F6, F17, F18 and F41 
fi mbriae and/or STa, STb and LT enterotoxins. Most studies of 
the prevalence of fi mbrial adhesins and enterotoxins of por-
cine ETEC isolates have been conducted, until recently, by the 
use of polymerase chain reaction (PCR). Previous studies using 
enterotoxin genes cloned into a nontoxigenic fi mbriated strain 
have suggested that both LT and STb play an important role in 
dehydrating diarrheal disease in piglets <1 week old and also 
enhances bacterial colonization of the intestine. Little is known 
about fi mbriae associated with piglet ETEC-induced scours in 
Taiwan. Therefore, our aim was to investigate the prevalence of 
toxin and fi mbrial genes among E. coli isolated from diarrheic 
piglets obtained over a 3-year period (2007-2009) in Taiwan.
Materials and Methods
Between 2007 and 2009, a total of 426 E. coli strains were iso-
lated from piglets with diarrhea at suckling and weaning periods 
on 12 pig farms in Taiwan. After incubation at 37˚C for 18 hr on 
MacConkey’s and Blood agar plates, single colonies were se-
lected and identifi ed as E. coli. The identifi cation of β-hemolysin 
in all of E. coli strains were conducted visually after overnight 
growth on SBA. The detection of fi mbrial and enterotoxin genes 
was performed by PCR. E. coli reference strains were used as 
positive control for each virulence factor detected by PCR, and a 
non-pathogenic commensal E. coli strain was used as a negative 
control. PCR for the identifi cation of fi mbrial (F4, F5, F6, F41 and 
F18) and enterotoxin (STa, STb and LT) genes was carried out as 
previously described (Do et al., 2005). Amplifi cation procedures 
were carried out in a thermal cycler (TaKaRa, PCR Thermal Cycler 
Dice). Reactions were incubated at 94˚C for 3min for 1 cycle, 
then 94˚C for 30 sec, the melting temperature for 30 sec and 
72˚C for 90sec for 35 cycles, followed by a fi nal incubation 72˚C 
for 3min. The PCR products were analyzed by electrophoresis 
on 1.5% agarose gel, and the amplicons were visualized under 
ultraviolet light after ethidium bromide staining.
Results
A total of 426 E. coli isolates were screened for those genes by PCR. 
The prevalence of pathogenic ETEC among E. coli strains from fi eld 
isolates was 114(26.8%) strains in the present study. Of these 114 
isolates, 103 (90.4%) carried at least one ETEC virulent gene and 
44 (38.6%) carried genes for the fi mbrial adhesins. Percentages 
of E. coli strains carrying each virulence factors were as follows: 
F4 (6.14%), F5 (8.78%), F6 (13.16%), F18 (10.53%), STa (84.2%), 
STb (85.09%), LT (43.86%). We assessed whether the presence 
of enterotoxin genes (STa, STb, LT and Stx2) could be correlated 
with the presence of fi mbrial genes (Table 1). STa/STb enterotoxin 
genes were co-expressed in F5, F6 and F18 of the ETEC strains. 
STa/STb/LT were found to co-express with F4 and F41genes. STa 
enterotoxin was found to co-express with F6 and F18.
Table 1. Fimbrial and enterotoxin genes detected in 112 ETEC in 12 pig 
farms.
Enterotoxin genes F4 F5 F6 F18 F41 ND
STa/STb/LT 4 1 42
STa/STb 10 13 6 2
STb/LT 3
STa/LT
STb 3
STa 2 4 12
LT
ND
*ND: non-detected.
Discussion
The present study was conducted to provide baseline informa-
tion on the signifi cance of specifi c ETEC serogroups and patho-
types associated with diarrhoea in piglets. These results suggest 
Sta/STb was the most prevalent pathotype in diarrheal piglets, 
which is diff erent from the fi ndings in USA (Zhang et al., 2007). 
A highly prevalent toxin in USA is STb (72.6%). Diff erent patterns 
of fi mbrial gene expression were detected in ETEC from diff erent 
pig farms in Taiwan. Therefore, vaccination and vaccine develop-
ment based on fi mbrial adhesion antigens needs to consider the 
spectrum of these antigens detected in pig farms in Taiwan. 
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Prevalence of virulence genes of Escherichia coli isolated from diarrheic pigs in Korea
Byeong Y. Jung; Jae W. Byun; Ha Y. Kim; Dong H. Shin; Hyoung S. Kim; O S. Lee
National Veterinary Research & Quarantine Service, Anyang, Korea
Introduction
Escherichia coli strains such as enterotoxigenic E. coli (ETEC), and 
shiga toxin-producing E. coli (STEC) are associated with diarrhea 
and edema disease in pigs. Adherence factors (F4, F5, F6, F18, 
F51, adhesion involved in diff use adherence [AIDA]-I, and por-
cine attaching and eff acing-associated factor [paa]), heat-stable 
enterotoxins (STa and STb), heat-labile enterotoxin (LT), and 
enteroaggregative E. coli heat-stable enterotoxin 1 (EAST1) have 
been known to be virulence factors of ETEC (1). Shiga toxin 2e 
(Stx2e) produced by STEC plays an important role in the patho-
genesis of edema disease in postweaned pigs. The objective of 
this study was to determine the prevalence of virulence genes 
among E. coli isolated from pigs with diarrhea in Korea.
Materials and Methods
One hundred thirty fi ve E. coli were isolated from diarrheic 
pigs on diff erent farms in 2009 in Korea. Pigs were divided with 
four diff erent age groups, suckling (≤3 weeks of age, n=65), 
postweaning (>3 weeks to <10 weeks, n=40), growing (≥10 
weeks to <17 weeks, n=22), and fi nishing (≥17 weeks, n=8), 
respectively. After incubation at 37˚C for 18 hr on MacConkey 
agar plate, a single colony was pick up and identifi ed as E. coli 
by VITEK 2-Compact system (bioMerieux, France). β-Hemolysis 
was defi ned as a zone of complete erythrocyte lysis surrounding 
a bacterial colony observed after an overnight grown at 37˚C on 
a blood agar plate. The isolates were grown overnight in tryptic 
soy broth and stored at –80˚C after the addition of 10% glycerol 
until further use.
For PCR test, 12 sets of oligonucleotide primers (Bioneer, Korea) 
used to detect the genes encoding for the following virulence 
factors: adherence factors (F4, F5, F6, F18, F41, AIDA-I, and paa) 
and enterotoxins (STa, STb, LT, Stx2e, and EAST1). The PCR assay 
for detection of virulence factors of the isolates was carried out 
as described previously (2).
Results
Of 135 E. coli isolates, 78 (57.8%) were shown to be positive for 
the genes encoding more than one of the virulence factors. 
Forty eight isolates (35.6%) carried both adherence factors and 
enterotoxins. A presence of diverse patterns of genetic profi les 
in virulence was observed, and the most prevalent pathotype 
was EAST1 only (n=15, 11.1%), followed by EAST1/paa (n=11, 
8.1%), and paa only (n=7, 5.2%), respectively. 
The prevalent pathotypes were determined by age. F4, LT, 
EAST1, and paa pathotypes were detected all age groups of 
pigs, whereas F5 was not detected in this study. F4 was the most 
prevalent in the postweaning pigs (22 5%) compared with the 
suckling (13.8%), fi nishing (12.5%), and growing (9.1%), respect-
ively (P>0.05). 
Almost all the virulence genes tested (F4, F6, F18, LT, STa, Stx2e, 
EAST1, and paa) were more prevalent in β-hemolytic E. coli than 
in non-hemolytic E. coli (P<0.05). On the other hand, prevalence 
of STb and AIDA-I in this study was higher in non-hemolytic E. coli 
than β-hemolytic E. coli, but this diff erence was not signifi cant.
Discussion
The isolates showed the diverse patterns of virulence genes 
with LT/EAST1/F4 (n=5), followed by EAST1/F4 (n=3), EAST1/F4/
paa (n=3), STa/F6/F18/paa (n=3), and EAST1/STb/AIDA-I (n=3), 
respectively. The isolates of E. coli that harbor genes for adher-
ence factors or enterotoxins are classifi ed as ETEC, and patho-
genic ETEC that cause colibacillosis must have both of them 
(3). The EAST1 gene was reported commonly found in E. coli 
isolated from diarrheic pigs. Frydendahl (4) reported that 65.8% 
of the isolates carried the EAST1 gene, however, E. coli isolated 
from pigs without diarrhea also carried this EAST1 gene (5). On 
the other hand, paa gene was demonstrated to be necessary for 
development of lesion caused by EPEC strains (6). However, paa 
gene was detected nearly even in isolates from diarrheic and 
non-diarrheic pigs, suggesting that the paa gene may not be a 
virulence factor in diarrhea (5). 
In this study, we found that EAST1 was most prevalent in diar-
rheic pigs in Korea, followed by paa, and F4, respectively. And 
also, we found that almost all the virulence factors tested in this 
study were more prevalent in β-hemolytic E. coli than in non-
hemolytic E. coli.
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Seroprevalence of F4+ and F18+ Escherichia coli in Cuban young sows
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Introduction
In Cuba, gastroenteric disorders are the cause of the 31 % and 
37 % of mortality in suckling and weaned piglets respectively. 
Taking decisions when an outbreak starts is diffi  cult as specifi c 
diagnose of enteric pathogens is depressed (Cabrera and García, 
2009). The present survey has the aim of contributing to the 
knowledge of the colibacillosis epidemiology in Cuba, specifi c-
ally for F4+and F18+ Escherichia coli.
Materials and Methods
1044 sera samples were randomly collected from gilts (6-8 
months old) in 34 piggeries spread in the three main Cuban 
regions. The complement inactivated serum was treated with 
kaolin and tested for anti-F4 and anti-F18 Ig at the fi x dilution of 
1/15 in duplicates. Both fi mbriae were purifi ed by mechanical 
sharing protocol using the strains IMM01 (F4ac-LT-STb+) and 
107/86 (F18ab-SLTIIv+). For F4 it was followed an indirect double 
antibody ELISA and for F18 a direct one. For the data analysis, 
that included the optical density values (OD), was fi tted a mix-
ture modeling in R (package “fl exmix”)(Leisch, 2004).
Results
F4 and F18 are highly prevalent in Cuba. A three components 
model was fi tted for F4 as represented by the 3 thinner curves 
(Fig 1), while the thicker is the estimated mixture model. The cut-
off  points were given by the curves intersection: between weak 
and moderately positives was 0.775, while between moderately 
and highly positives was 1.343. Fig 2 shows the description of 
farms (fi nest cluster division) depending on the OD of serum 
samples, diff erent letters mean diff erent geographical areas. 
Piggeries were clearly distributed in each component show-
ing a diff erent epidemiologic situation. For F18 OD, only a one 
component model was found and the Box plot description was 
homogeneous. 
Discussion
Considering a no previous vaccination against F4, the distribu-
tion of F4 OD in three components with the 14 % and 42 % 
classifi ed as hard and moderately positive respectively, means 
that in Cuba is a high prevalence or association of F4+ E. coli in 
diarrhea episodes. From 1997 to 2001, Lazo et al., (2005) clinic-
ally reported a 43.8 % of morbidity and 29.3 % of lethality due 
to swine enteric colibacillosis in V. Clara, Cuba. Verdonck et al., 
(2002) mentioned that the slower immune response following a 
F18+ VTEC infection and the resulting longer excretion increases 
it’s spreading; it can justify in part the F18 OD distribution, but 
F18+ ETEC strains have to be considered. In a later study 
F4-STa-STb+, F18-VT2e+, F18-LT-STb+ E. coli were isolated from 
diarrheic piglets in a Cuban province (de la Fé, P., Butaye, P., God-
deeris, B., Cox, E., manuscript under preparation).
Conclusions
F4+ and F18+E. coli are widespread in Cuban piggeries as proved 
by serological survey and mixture modeling. A more eff ective 
diarrhea prevention and control is needed. 
Fig 1: Histogram for the F4 mixture model.
Fig 2: Box plot for F4 OD values grouped by piggeries.
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Inﬂ uence of diﬀ erent housing systems and feeding regime on E.coli 
problems of post-weaning piglets in Central Vietnam
Nguyen Quang Linh; Hoang Nghia Duyet; Nguyen Thi Thuy
Hue University of Agriculture and Forestry, Hue City, Vietnam
Introduction
Post-weaning diarrhoea (PWD) is a signifi cant gastrointestinal 
disease in pigs. It is considered a multifactorial disease associ-
ated with proliferation of enterotoxigenic Escherichia coli in the 
intestinal tract of aff ected pigs. The aim of this study was to 
analyse risk factors related to the occurrence of post-weaning 
diarrhoea on Vietnam piglet producing farms. In Central Viet-
nam, many pig farms have the problems for piglets after wean-
ing periods, there is no vaccine for the prevention and control, it 
was inpact on their farm’income and decrease pig production in 
Vietnam.
Materials and Methods
The data of a follow-up study of 72 conventional piglet produ-
cing farms was used in the case-control study. The selection of 
the 36 PWD case and 36 control piglets. All of piglets were raised 
on 6 pig farms that was based on the use of antimicrobials for 
treating diarrhoea in weaned pigs and the answers related to the 
occurrence of diarrhoea after weaning in the questionnaire. Four 
intermediate farms were excluded from the statistical analysis. 
Altogether 36 factors related to herd characteristics, weaner pig 
management and pig health were studied. The median number 
of sows was the same breed and feeding situation on the case 
and the control farms, respectively. The signifi cances of the uni-
variable associations between the explanatory variables and the 
outcome variable were tested, and in the multivariate analysis 
linear models were applied.
Results
An decreased risk of PWD was associated with the regimen of 
feeding levels, twice a day and feed restriction after weaning (P 
= 0.05; compared to feeding three or more meals a day or the 
use of ad libitum feeding) and with a rotation housing system 
of sows on the farm (P = 0.01; risk decreasing with increasing 
housing systems for sows removed from farrowing pens). Tem-
perature and huminity control was associated with a decreased 
risk of PWD (P = 0.03; compared to manual temperature and 
huminity control). 
Discussion 
Temperature and huminity for resistance to pathogenic bacteria 
that is a global threat and therefore increasing attention is being 
paid to the prudent use of feeding control[1]. Gastrointestinal 
diseases of growing pigs, which are economically important 
for pig production worldwide [2] and enteric bacterial infec-
tions. The total of feeding levels in pigs and that gastrointestinal 
diseases were the most common indications for prescriptions 
in this age group[1]. PWD is considered to be a multifactorial 
factors[2]. Recently weaned pigs are variously predisposed to 
enteric disorders. Newly weaned pigs are stressed by nutritional, 
psychological, environmental and physiological factors [3]. At 
weaning the feed is changed from milk to a weaner diet, piglets 
are separated from their sow and often moved from the farrow-
ing pen and mixed with unfamiliar pigs. Weaned pigs also lose 
passive intestinal immunity provided by antibodies in sow’s 
milk. After weaning there are alterations in stable in farrowing 
pens until 2 weeks after weaning. During the fi rst two weeks 
after weaning, pathogenic Escherichia coli plays a signifi cant role 
in the etiology of PWD [1,2], although infection with pathogenic 
E. coli does not unequivocally lead to the development of diar-
rhoea in weaned pigs. housing systems with pathogenic E. coli 
strains are likely sources of infection for weaned pigs, but the 
infection can also be acquired before weaning. The susceptibility 
for diarrhoea after weaning has been associated with manage-
ment related factors such as low feed intake during the fi rst 
week after weaning, excessive feed intake, low number of meals, 
the hygiene and management level, a low weaning weight and 
age, moderate cold stress, draught, texture of feed, number of 
feeder spaces per pen and vaccinating gestating sows against E. 
coli. A sastifi cation of temperature and humility in the housing 
during fi rst two weeks after weaning with a decreased risk of 
PWD. This study was done to provide information on risk factors 
related to the occurrence of PWD on weaning piglet producing 
farms.
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Introduction
Diseases caused by E. coli have been a recognised problem for as 
long as pigs have been raised. Diff erent categories of E. coli have 
been associated with diarrhoeal disease in animals worldwide 
with Enterotoxigenic E. coli (ETEC) and Shiga toxin-producing E. 
coli (STEC) being the most common (DebRoy & Maddox, 2001). 
The objective of this study was to compare the distribution of 
virotypes of pathogenic E. coli isolates from diseased pigs in two 
geographically distinct countries, Vietnam and Canada. 
Materials and Methods
E. coli isolates obtained from diseased pigs (diarrhea, sudden 
death or edema disease) in 2007 and submitted to the NIVR in 
Vietnam or the FMV in Québec, Canada, were initially tested 
by PCR for the presence of defi ning genes of ETEC and STEC 
pathotypes. They were then virotyped by colony hybridisation 
(Ngeleka et al., 2002) for detection of the presence of 20 viru-
lence genes most commonly found in animal pathogenic E. coli.
Table 1: Virotypes of ETEC-STEC isolates
ETEC-STEC pathotype
Number of isolates
Virotype Vietnam Quebec
ETEC-STEC F18
LT:STa:Stx2:Paa:F18 13 0
STa:STb:Stx2:AIDA:F18 4 0
STa:STb:Stx2:Paa:AIDA:F18 3 0
Other 6 0
Total ETEC-STEC F18 26 0
Other 1 4
Table 2: Virotypes of STEC isolates
STEC pathotype
Number of isolates
Virotype Vietnam Quebec
STEC F18
Stx2:Paa:AIDA:F18 4 2
Stx2:AIDA:F18 4 1
Stx2:EAST1:AIDA:F18 0 8
Other 2 3
Total STEC F18 10 14
Other 4 9
Table 3: Virotype of ETEC isolates
ETEC pathotype
Number of strains
Virotype Vietnam Québec
ETEC F4
LT:STa:STb:EAST1:Paa:F4 12 5 12 5
STa:STb:EAST1:F4 8 0
LT:STb:EAST1:F4 3 14
LT:STb:EAST1:Paa:F4 2 19
Other 2 8
Total ETEC F4 27 46
ETEC F18
STa:STb:AIDA:F18 3 0
LT:STa:STb:EAST1: F18 0 2
Other 3 1
Total ETEC F18 6 3
ETEC F5-F41
STa:Paa:F5 17 9
Other 0 4
Total ETEC F5-F41 17 13
Other
LT:STa:STb:EAST1: Paa 7 0
Other 13 63
Total 20 63
Discussion
Our results demonstrate that the most important pathotypes 
associated with diarrhea, ETEC F4, ETEC F18, and ETEC F5, and 
edema disease, STEC F18, are present in both countries. On the 
other hand, typing using additional virulence genes permitted 
further discrimination of the isolates, which demonstrated that 
distinct virotypes predominate in each country. Interestingly, 
the ETEC-STEC F18 pathotype, was very frequently observed in 
Vietnam, but was not identifi ed in isolates from Quebec. Thus, 
virotyping is a valuable tool for monitoring the geographical 
distribution of virotypes worldwide and the emergence of new 
pathogenic variants. We are presently setting up a database for 
the global surveillance of animal pathogenic E. coli.
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Identiﬁ cation of virulence genes of E. Coli in diarrheic pigs in the preweaning 
and postweaning period by simple and duplex PCR assay
Jorge R. Lopez
Universidad Nal. Autonoma de Mexico, México, DF, Mexico
Introduction
Diarrhea in pigs from the nursery and post-weaning are mainly of 
infectious origin and cause economic losses of great magnitude. 
Strains of enterotoxigenic E. coli (ETEC) and E. coli that produce 
Shiga toxins (STEC) cause this disease. The virulence factors such 
as fi mbriae and toxins produced by this bacterium are involved 
in the establishment of the disease. Fimbriae and most common 
toxins produced by E. coli are F4, F5, F6, F18, F41, STa, STb, LT and 
STx. In the present study, the aim was to identify virulence genes 
of E. coli associated with porcine diarrhea using PCR.
Material and Methods
One hundred and sixty six fecal samples obtained from pigs with 
diarrhea in fi ve Mexican farms, shows that 113 belong to pigs 
with diarrhea and 53 to pigs without diarrhea. E. coli strains were 
isolated in Eosin Methylene Blue (EMB) solid media and MacCon-
key subsequently underwent biochemical tests. The extraction 
of DNA from the isolates was done according to Zhang (5). PCR 
assay simple and duplex using eight specifi c oligonucleotides 
as primers were used for the identifi cation of the eight virulence 
genes (LT, STa, STb, Stx1, Stx2, F18, F41 and F4). The conditions 
of the PCR’s used were in accordance to what has already been 
reported, with some modifi cations (1, 2, 3, 4). Amplifi cation 
products were identifi ed by agarose gels and stained with 2% 
ethidium bromide. Reference strains were used as positive and 
negative controls for each one of the genes.
Results
One hundred and fi fty samples corresponded to E. coli, where 
110 (73.33%) were positive for one or more virulence factors of 
ETEC and EHEC, of which 30 (52.7%) were from nursing piglets 
and 41 of weaned pigs. Strains from piglets without diarrhea, 39 
(84.8%) had one of the genes studied (Table 1). 
Discussion
STa was the toxin detected in 31%, consistent with studies by 
Thuy N., Do et al., Cicuta M.E. et al. and Chen X et al. (6,7) The 
F41 fi mbriae gene was found in more than 59% unlike other 
countries where F41 is detected in less than 3%. This is of great 
importance, since it is a new fi nding and allows us to consider 
that the strains of E. coli isolated from pigs in Mexico, exhibit dif-
ferent virulence gene profi le from those reported by other coun-
tries (Table 2). There were 19 combinations; the most frequent 
was STa/F41 at 11.3%. This work is of great importance, since it 
is one of the fi rst made in Mexico on the detection of virulence 
genes of E. coli in nursing and weaned pigs, using this technique 
suggests that both the fi mbriae and toxins are important for 
the presentation of diarrhea in nursing and weaned pigs. For 
this reason, our work in a second step will allow us to develop 
a rapid and accurate diagnostic method of this enteric disease 
related to E. coli infections.
Table 1. Positive strains of E. coli in piglets with and without diarrhea.
Pigs Isolates of E. Coli Percentage of positive strains of E. Coli
Nursery 57 52.63
Weaning 47 87.23
Without diarrhea 46 84.78
Total 150 73.33
Table 2. Percentage of virulence factors in strains of E. coli.
Genes Identifi ed Presence of genes in E. Coli strains (%)
F41 59
STa 31
STb 18
LT, F18 8
STx2, F4 ≤ 6
STx1 0
References
1. Imberechts, H., Bertschinger, H. U., Nagy, B., Deprez, P., Pohl, P. 1997. 
Adv Exp Med Biol. 412: 175-183. 
2. Osek, J., Gallien, P., Truszczynski, M., Protz, D. 1999. Comp Inmmunol 
Microbiol Infect Dis. 22(3): 163-174. 
3. Ojeniyi, B., Ahrens, P., Meyling, A. 1994. Zentralbl Veterinarmed B. 
41(1): 49-59. 
4. Vu-Khac, H., Holoda, E., Pilipcinec, E., et al. 2006. Vet Res. 20; 2: 10. 
5. Zhang, W., Zhao, M., Ruesch, L., Omot, A. and D. Francis. 2007. Veter-
inary Microbiology 123: 145–152. 
6. Do T, Phu, Huyen X, Tuan X, Quy N, Steve J, et al. 2006. Journal of 
medical Microbiology 55: 93-99. 
7. Cicuta M. E, Parma A. E, Viñas M. R, Sanz M.E, Boeheringer S. I, et al. 
1999-2000. Rev. Vet 10/11, 1y2. 
Enteric diseases - Suckling and weanling pigs – Escherichia coli
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 768
Poster Presentations
P.462
Comparing PCR-methods diagnosing ﬁ mbriae and toxins with serotyping of E. coli
Sigbrit Mattsson; Lennart Melin; Per Wallgren
Dept of Animal Health and Antimicrobial Strategies, Uppsala, Sweden
Introduction
Serotyping of E. coli from piglets with diarrhoea gives a historical 
view of disease patterns, but is laborious as there are more than 
170 O-serotypes of E. coli (1). The panels used must for practical 
reasons be limited, and despite continuous updating around 
50% of the samples often turn out as O?. As the most essential 
for clinicians are to achieve knowledge of whether the strains 
are potentially pathogenic or not (2) diagnosing presence of ad-
hesion fi mbriae and enterotoxin production instead of serotyp-
ing is tempting. Thus, PCR-methods have replaced serotyping in 
many laboratories. 
Despite change of method, still only around 50% of the samples 
in Sweden were diagnosed as potentially pathogenic. When these 
PCR-positive isolates were serotyped, in general only O149 and 
O147 were diagnosed. Thus, it appeared that some information 
received by serotyping had been lost. Therefore the aim of this 
work was to serotype E. coli isolates previously diagnosed by PCR.
Fig 1. Serotypes vs toxins and adhesion diagnosed by PCR.
Materials & Methods
E. coli from pig herds with diarrhoea during 2009 were analysed 
for presence of toxins (LT, STa, STb, VT2e) and adhesion fi mbriae 
(F4, F5, F6, F18, F41) by multiplex PCR systems. All isolates were 
thereafter serotyped with a panel of 16 diff erent O-groups, pre-
viously confi rmed to be the most common in Swedish pigs with 
diarrhoea caused by E. coli. Also, the MIC-values to 12 diff erent 
antimicrobial substances were analysed (3).
Fig 2. Resistance to 12 substances in 306 E. coli strains. 
Results and Discussion
As seen in the Fig 1 & 2, serotyping identifi ed 126 out of the 306 
samples scrutinised (41%). The PCRs identifi ed 110 isolates as 
potentially pathogenic (36%). Generally these strains belonged to 
serotypes O149 or O147. Serotypes O8, O9, O45 and OX179 were 
never identifi ed by the PCR systems. Together PCR and serotyping 
identifi ed 149 strains as potentially pathogenic (52%).
The resistance pattern was favourable (3) and fairly equal for 
diff erent categories of E. coli (Figs 2 & 3). More than 91% of the 
strains were sensitive to 8 of the 12 substances tested. Sixteen 
strains (5%) were resistant to 4 substances or more. 
In conclusion, PCR will diagnose some E. coli strains that express 
common pathogenic factors. However, some potentially patho-
genic serotypes may remain undetected. Serotyping is still a 
diagnostic tool to use as a complement to PCR in herds with 
diarrhoeic problems.
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Vaccination with Coliprotec® vaccine for the prevention of post-weaning diarrhea 
associated with F4(K88)-positive enterotoxigenic Escherichia coli (ETEC) 
Eric Nadeau1 Danielle Tremblay1 John M. Fairbrother2
1. Prevtec Microbia, Saint-Hyacinthe, QC, Canada; 2. University of Montreal, Saint-Hyacinthe, QC, Canada
Introduction
ETEC harboring F4 (K88) fi mbriae are recognized as the major 
cause of post-weaning diarrhea (PWD) (1). A genetically inher-
ited receptor for F4 (F4R) located in the villous brush border fa-
cilitates binding of ETEC-F4 to intestinal villi leading to coloniza-
tion and disease. Antimicrobials are frequently used on farms to 
treat PWD but emergence of resistance has been observed for 
causative strains (2). The objective of this controlled challenge 
study was to evaluate the effi  cacy of a single oral dose of Coli-
protec® (Prevtec microbia Inc.), an avirulent live E. coli vaccine, 
to prevent PWD caused by ETEC-F4 in situations of low and high 
infectious pressure.
Materials and Methods
The study consisted of 2 trials, each including a group vaccin-
ated with Coliprotec® and a group receiving sterile water as a 
placebo. Trial A (low infectious pressure) consisted of 20 pigs 
per group with 5 and 8 RF4-positive pigs for the vaccinated and 
placebo groups, respectively. Trial B (high infectious pressure) 
consisted of 20 and 21 pigs, with 18 and 20 RF4-positive pigs, 
for the vaccinated and placebo groups, respectively. For both 
trials, weaned pigs of 18±1 days of age were introduced into 
isolation facilities on day 0. At day 1, pigs received an oral dose 
of the Coliprotec® vaccine using a syringe, as per label instruc-
tions, or placebo. On day 8, all pigs were challenged via gavage 
with the virulent ETEC-F4 strain EcL 8559. The challenge inocula 
contained 5x108 and 1x109 CFU per pig for the trials A and B, 
respectively. Necropsies were carried out on day 11. Effi  cacy 
parameters included ileal colonization of the challenge strain 
(day 11), fecal excretion of the challenge strain, accumulation of 
fl uid in the intestines (day 11; scored from 0 for normal to 3 for 
presence of more liquid or totally liquid), diarrhea (scored from 0 
for normal to 4 for totally liquid), and daily weight gain (DWG).
Results
Trial A: The prevalence of pigs excreting the challenge strain 
at days 9 and 11 was signifi cantly lower (p<0.0001) for vaccin-
ates (0 and 26%) than for placebo pigs (100% for both days). 
The colonization level of the challenge strain in the ileum was 
also lower (p<0.0001) for vaccinates (4.0 x 106 CFU/g) than for 
placebo pigs (1.4 x 108 CFU/g). Severity of diarrhea and accumu-
lation of fl uid in the intestine was signifi cantly lower for vac-
cinates than for the placebo group (Table 1). Finally, DWG was 
signifi cantly higher after challenge for vaccinates than placebo 
pigs (Table 1).  
Table 1: Severity of diarrhea and intestinal fl uid1 and DWG2 
Parameter Group3 Trial A Trial B
Diarrhea Vaccinates 1.5 a 2.0 a
Placebo 3.5 b 5.0 b
Intestinal fl uid Vaccinates 2.0 a 3.0 a
Placebo 6.5 b 10.0 b
DWG Vaccinates 410 a 400 a
Placebo 308 b 44 b
1 Median of cumulative scores for diarrhea (3 days post-challenge) or for content in the jejunum, 
ileum, colon, caecum, and rectum. 2 Mean daily weight gain (gram). 3 Groups included all pigs 
(RF4-positive and RF4-negative). a,b values in a row for a parameter with diff erent superscripts 
diff er signifi cantly (p<0.05).
Trial B: All pigs of both vaccinated and placebo groups excreted 
the challenge strain on days 9 to 11. However, vaccination sig-
nifi cantly reduced (p<0.0003 for each day) the level of excreted 
challenge bacteria in feces by 1.4, 1.7 and 2.5 LOG for days 9, 
10 and 11, respectively. The colonization level of the challenge 
strain in the ileum was also lower (p<0.0001) for vaccinates (8.5 x 
104 CFU/g) than for placebo pigs (4.1 x 107 CFU/g). As observed 
in trial A, severity of diarrhea, accumulation of fl uid in the intes-
tines and weight loss were signifi cantly lower for vaccinates than 
for placebo pigs (Table 1).  
Discussion and Conclusion
This controlled challenge study demonstrate the effi  cacy of an 
oral single dose of Coliprotec® to signifi cantly reduce intestinal 
colonization, excretion, accumulation of fl uid in the intestines 
and diarrhea when the overall infectious pressure is either low 
or high. In both situations, vaccination with Coliprotec® induced 
a signifi cant protection after virulent ETEC-F4 challenge in 18±1 
day-old weaned pigs resulting in normal growth rates after chal-
lenge compared to the rapid weight loss observed for unvaccin-
ated pigs. 
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Control of neonatal diarrhea with commercial vaccines
SeungYoon Lee; PilSoo Jeong
Hanbyol Farm Tech, Gyeonggi-do, Namyangju-city, Korea
Introduction
Neonatal diarrhea causes poor weaning weight and high pre-
weaning mortality. Recently, some farms have had this problem 
quite a long time. We tried to control piglet diarrhea with diff er-
ent commercial vaccine at two diff erent large herds. 
Materials and Methods
Two herds have around 1,500 sows each were selected for 
this trial. A herd has had piglet diarrhea problems for about 
one month(Fig1). B herd has had this problem for about one 
year(Fig1). Laboratory results of each herd show multiple bacter-
ial and viral infections(Table1). Three commercial vaccines were 
inoculated to pregnant sows in this trial(Table2,3). 
Fig 1. Clinical signs of piglet diarrhea (Top-A herd, Bottom-B herd)
Table 1. Lab. Results for feces of piglets
Herd E.coli Sal Clo TGE PED Rota
A Herd 0/4 0/4 2/4 0/3 0/3 3/3
B Herd 3/3(K88) 0/3 3/3 0/10 3/10 9/9
E.coli is hemolytic E.coli, Sal is Salmonella, Clo is Clostridium
Table 2. Commercial vaccines used for these trials
Vaccine Contents
A Modifi ed live TGE, Rotavirus(G&A), E.coli pilus antigens (K88,K99,F41,987P), Clostridium perfringens toxoid
B Modifi ed live TGE and Rotavirus
C E.coli bacterin, Clostridium perfringens beta toxin 
Table 3. Vaccine programs
Herd A herd B herd
Vaccine A B None A C
Program Two shot Two shot none One shot Two shot
Results (see below)
Fig 2. Diarrhea rate %, average weight of weaners and average num-
ber of wean piglets per sow of A herd (weaning age is around 26 days).
Fig 3. Diarrhea rate % of B herd.
Fig 4. Parity eff ect on diarrhea rate % of B herd.
Discussion
Neonatal diarrhea causes poor survival rate before weaning 
and weaning weight. Most of neonatal diarrhea in Korea caused 
by multiple agents including Rotavirus, Porcine epidemic 
virus(PED), Clostridium and pathogenic E. coli. Vaccine A contain 
multiple viral and bacterial antigen except PED virus and shows 
better results for controlling neonatal diarrhea in these two 
herds(Fig2,3). Weaning weight increased by 0.4kg per a head. 
Low parity sows shows neonatal diarrhea more often than high 
parity sows(Fig4).
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Eﬀ ects of Tilmicosin and Apramycin on proliferation of enterotoxemic 
Escherichia coli and release/production of shiga toxin 2e
Masuo Sueyoshi; Tomoko Kuroda; Ryoko Uemura; Hiroshi Nagatomo
Department of Veterinary Hygiene, Faculty of Agriculture, University of Miyazaki, Miyazaki, Japan
Introduction
 The fatal accidents of piglets resulting from treatment of edema 
disease with antibiotics have made vets to hesitate the use of 
antibiotics to this disease. Various eff orts have been made in 
the fi eld for the treatment of edema disease, but no control 
or treatment methods has been established. We reported that 
the susceptibilities of the isolated Enterotoxemic E. coli (ETEEC) 
had diminished in regard to antimicrobials[1]. Furthermore, 
we found that more shiga toxin (Stx) 2e accumulated in the 
bacterial cells than was released into supernatant[2]. There-
fore, evaluation of the direct eff ect of antibiotics to ETEEC in an 
experimental system will give useful information for selecting 
appropriate antibiotic in the fi eld. In this study, in vitro eff ects of 
Tilmicosin (TMS) and Apramycin (APM) on proliferation of ETEEC 
and release/production of Stx were investigated.
Materials and Methods
The strains used for this study were ETEEC MVH 269 (O 139 
serotype, stx2e+, fedA+, LT-, ST-, beta-hemolytic+) isolated from 
the pigs with E. coli enterotoxemia. As test antibiotics, TMS, APM, 
Ampicillin (ABPC) and Enrofl oxacin (ERFX) were used. For exam-
ination of MIC, agar plate dilution method was used, according 
to CLSI (2002). The organism was inoculated into BHIB (Difco, 
USA). The medicated BHIB was prepared at the fi nal concentra-
tions of *1 and *50 of MIC. Non-medicated BHIB was used as 
the control. The organism suspension was inoculated into each 
substance or control BHIB with fi nal bacterial concentration 
of approximately 8.0 log10cfu/mL and cultured in the shaking 
incubator for 4 hrs at 37C. Then, each BHIB was measured for the 
number of viable colibacilli. BHIB diluted properly with PBS was 
smeared to TSA (Difco). For the preparation of released Stx2e, 
after centrifugation (8,000rpm, 10 min) of BHIB, supernatant was 
fi ltered with a 0.20 um fi lter. For the preparation of produced 
Stx2e, after ultrasonic fragmentation in ice, BHIB was centrifuged 
and supernatant was fi ltered. Vero cell sheets were cultured on 
96 well microplate. After incubation for 72 hrs with 5%CO2 at 
37C, CD50 (50%Cytotoxicity Dose) was determined.
Results
MICs of ETEEC MVH269 for TMS, APM ABPC and ERFX were 64ug/
mL, 4ug/mL, 256ug/mL and <0.125ug/mL, respectively.
In the TMS medication, the number of viable colibacilli sig-
nifi cantly decreased at x50 MIC compared to the control. No 
signifi cant diff erences were observed in released Stx2e at both 
x1 and x50 MIC, whereas produced Stx2e decreased dose-
dependently (Fig. 1a, 1b). In the APM medication, the number 
of viable colibacilli decreased at 50x MIC (Fig. 2). The amount of 
released /produced Stx decreased compared to the control (Fig. 
2a, 2b). On the other hands, in the ABPC and ERFX medication, 
the number of viable colibacilli decreased signifi cantly at 1x MIC 
and 50x MIC. However, in the ABPC, the amount of released Stx 
markedly increased compared to control.
Discussion
ETEEC (MVH269) strain tested was not susceptible to ABPC, 
highly susceptible to ERFX and APM, and moderately susceptible 
to TMS. The reduction rate of viable colibacilli of TMS and APM 
were comparable to ABPC or ERFX, but the reduction rate of 
produced Stx2e was higher, suggesting the possibility that TMS 
and APM inhibited Stx2e production.
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Comparison of Porcilis® Coli 6C with another vaccine by measuring maternally 
derived antibody levels of E. coli virulence factors in piglets
Rut Menjon Ruiz1 Antonio Ubiergo2 Teresa Abizanda2 Jorge Sistac2 Jesus M. Bollo1 Marta Jimenez1 Jesus V. Lopez1
1. Intervet/Schering-Plough A.H., Alcobendas, Spain; 2. Piensos Mazana, Capella, Spain
Introduction
Enterotoxigenic E.coli associated with neonatal diarrhea may 
posses one or more F4(K88), F5(K99), F6(987p) and F41 fi mbriae, 
with K88 having the highest prevalence (1). Adequate immuniz-
ation of sows is fundamental for providing piglets with eff ective 
protection against this disease via the colostrum(2). 
The object of the study was to compare the levels of specifi c 
antibodies against the main E.coli virulence factors in piglets 
from sows vaccinated with Porcilis® Coli 6C and another com-
mercial vaccine with the same indication (vaccine B)
Materials and Methods
The study was performed during 2009 in two phases on a breed-
ing farm with 2400 sows in northern Spain.
Thirty sows from diff erent production cycles were selected 
together with their piglets: 20 primiparous sows and 10 mul-
tiparous (same parities per group). These were divided into two 
groups (Porcilis coli 6C and Vaccine B). The vaccines were admin-
istered at 70 and 90 days of pregnancy.
After farrowing, 3 piglets were randomly selected from each 
litter (n=90). Blood samples were taken at 7 days of age to meas-
ure the level of maternally derived antibody (MDA) specifi c for 
the main E.coli virulence factors, acquired via the colostrum . A 
specifi c ELISA test (internal ISPAH test) was used, which detects 
titers against K88ab, K88ac, K99, 987P antigens in serum or col-
ostrum. Titers are expressed in log2 titers. Titers lower than 6 log2 
are considered to be negative.
Statistical analysis was performed using the General Linear Mod-
el (GLM-SPSS 15.0 for Windows), the Mann-Whitney U-test. The 
Pearson’s chi-square test was used for comparisons of means, 
and the Levene test for comparison of variances.
Results
The results of the serum sample assays showed signifi cant diff er-
ences in the mean antibody titers of both groups.
Table 1: Mean log2  antibody titers  (± SD) 
K88ab K88ac K99 987p
Porcilis®Coli 6C 9.38ª±0.22 9.95c ±0.22 8.42 ª±0.21 8.63 ª±0.16
Vaccine B 7.84 b ±0.32 8.89d ±0.34 8.26 ª±0.25 8.56 ª±0.19
a, b, c, d: values with diff erent superscripts in the same columns represent statistically signifi cant 
diff erences:  a, b: p< 0.001, c, d: p< 0.05.
The distribution of the mean antibody titers for all the virulence 
factors studied was more uniform in piglets from the Porcilis® 
Coli 6C group (p<0,01), only the titers against K88ab in primip-
arous sows failed to show a statistically signifi cant diff erence 
(Graph 1,Graph 2). 
Graph 1: Distribution of Ab titers in multiparous sows 
Graph 2: Distribution of Ab titers in primiparous sows
When comparing animals with negative titers for K88ab and 
K88ac antigens, a higher percentage of negative titers was 
found in the group of piglets from sows vaccinated with Vaccine 
B (p<0,05) (Graph 3)
Graph 3: %age piglets with <6.00 Ab titers
Discussion
Porcilis® Coli 6C induced both higher MDA against the most preva-
lent E.coli virulence factors, and higher titers against the main viru-
lence factor (K88) than another vaccine with the same indication. 
Consequently, Porcilis® Coli 6C confers stronger protection against 
the main antigen involved in neonatal diarrhea in piglets.
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Vaccination with SUIVAC EDT® against oedema disease – a ﬁ eld study
Anne Jørgensen2 Magne Haugum1 Hilde M. Juul1 Anja Kristoff ersen1 Bjarne Bergsjø1 Bente Fredriksen2 Bjørn Lium1
1. National Veterinary Institute, Oslo, Norway; 2. Animalia, Oslo, Norway
Introduction
Oedema disease in pigs is usually caused by infection with F18-
positive and verotoxin 2e producing hemolytic E. coli O 138, O 
139 or O 141. In some herds this infection may cause consider-
able economical losses due to high mortality in pigs during the 
fi rst 1-4 weeks after weaning. This fi eld trial was performed to 
assess the effi  cacy and safety of a commercial vaccine against 
oedema disease in weaned pigs. 
Materials and Methods
Herds 
Two conventional herds where high mortality due to oedema 
disease in weaned pigs had been a persistent problem for some 
years were selected to participate in this trial. The diagnosis 
oedema disease was confi rmed by autopsy and bacteriology 
positive for haemolytic E.Coli O 138, O 139 or O 141.
Herd 1: integrated production with 22 week batches with 56 
sows per batch.
Herd 2: piglet production with 3 week batches with 48 sows per 
batch. 
Study design
A double blinded randomized block design study, with herd 
and litter as block factors, was performed in 2008-2009. A total 
of 1980 piglets were vaccinated at 2 and 4 weeks of age. Within 
each litter, the piglets were randomized to get either Suivac EDT 
(n=981) or placebo (phosphate buff ered saline) (n=999). Wean-
ing took place a minimum of three days after last vaccination. 
Clinical symptoms and adverse reactions were recorded from 
weaning to 30kg. Post mortem examination was performed on 
all piglets that died or were euthanized during the study period. 
Only pigs with characteristic pathological lesions, and from 
which haemolytic E. coli O 138, 139 or O 141 were isolated, were 
diagnosed as “dead due to oedema disease”.
Statistical analysis
To evaluate the association between the probabilities of getting 
oedema disease and placebo contra real vaccination, a mixed 
eff ect logistic regression model taking into account the eff ect 
of herd and litter was used. The analysis was done in R 2.9.1 (1), 
library lme4 (2). 
Results
A total of 82 pigs (4.1 %) died during the study period. Hae-
molytic E. coli O139 was identifi ed in 54 pigs with pathological 
lesions indicating oedema disease. Another 9 pigs had patho-
logical changes consistent with oedema disease but negative 
bacteriology. Nineteen pigs died of other reasons. Table 1 shows 
the distribution of confi rmed cases of oedema disease per herd 
and treatment
Table 1. Distribution of piglets n (%) that died of oedema disease.
Placebo Vaccine Total
Herd 1 37/740 (5.0) 13/733 (1.8) 50/1473 (3.4)
Herd 2 2/241 (0.8) 2/266 (0.8) 4/507 (0.8)
Total 39/981 (4.0= 15/999 (1.5) 54/1980 (2.7)
The odds ratio for getting oedema disease was 0.33 for vaccin-
ated animals (p = 0.002). When litter was used as random eff ect, 
herd did not contribute with further explanation in the model. 
The Suivac EDT vaccine was safe and did not produce marked 
adverse reactions. 
Discussion
In this fi eld trial the prevalence of postweaning mortality due to 
oedema disease was markedly reduced in pigs vaccinated with 
Suivac EDT compared to pigs in the placebo group. The results 
indicate that vaccination may be a good alternative to high 
doses of zink oxide as food additive or treatment with antiserum 
to prevent oedema disease in weaned pigs. A higher benefi cial 
eff ect of vaccination with VT2e-toxoid against oedema disease 
has previously been documented in a Danish study (3)
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Introduction
Escherichia coli is an important cause of a wide range of diseases 
in production animals and humans worldwide, including pigs. 
In certain cases, animals are a reservoir of infection for humans, 
either by direct contact, contamination of the environment, or 
via contaminated food. The objective of this study was to com-
pare the distribution of antimicrobial resistance of pathogenic 
E. coli isolates from diseased pigs in two geographically distinct 
countries, Vietnam and Canada, with diff ering antimicrobial use.  
Materials and Methods
E. coli isolates obtained from diseased pigs (diarrhea, sudden 
death or edema disease) in 2007 and submitted to the NIVR in 
Vietnam or the FMV in Québec, Canada, were initially tested 
by PCR for the presence of defi ning genes of ETEC and STEC 
pathotypes. They were then virotyped by colony hybridisation 
(Ngeleka et al., 2002) for detection of the presence of 20 viru-
lence genes most commonly found in animal pathogenic E. coli. 
The isolates were examined by the disk diff usion test to identify 
antimicrobial resistance.
Results
Table 1: Prevalence of antimicrobial resistance in pathogenic E. coli 
isolates 
Antimicrobial % of resistance
Canada (n=124) Vietnam (n=50)
Ceftiofur 5 0
Ampicillin 67 42
Apramycin 12 0
Spectinomycin 46 4
Gentamycin 7 14
Enrofl oxacin 0 20
Florfenicol 12 32
Trim-Sulfa 48 82
Neomycin 23 18
Tetracycline 95 92
Figure 1: Prevalence of antimicrobial resistance in porcine pathogenic 
E. coli isolates from Vietnam and Canada
Discussion
The antimicrobial resistance profi les generated can be con-
sidered to be representative of each geographical region. Some 
interesting similarities and diff erences were demonstrated 
between the two data sets. Overall, very high rates of resistance 
were found to tetracycline in isolates from both countries, Can-
ada and Vietnam (95 and 92%, respectively). Interestingly, all the 
Vietnamese isolates were sensitive to ceftiofur and apramycin, 
whereas no resistance was recorded for enrofl oxacin with the 
Canadian isolates. The similarities and diff erences in antimicrob-
ial resistance between the two countries could be attributed 
to variation in veterinary antimicrobial regulation and usage 
between Canada and Vietnam. This was defi nitely the case for 
tetracycline, ampicillin, and sulfa drug use in both countries, and 
ceftiofur and apramycin use in Canada, and enrofl oxacin use in 
Vietnam. Frequent usage of agents in the past, such as chloram-
phenicol in Vietnam and nitrofurantoin in Canada also was asso-
ciated with resistance. Other factors may include the distribution 
of serotypes and pathotypes between the two countries, and 
diff erences in farrowing shed management. 
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In vitro immune stimulating activities of Escherichia coli ﬁ mbriae encapsulated with thiolated Eudragit
Wonjung Lee; Seungbin Cha; minkyoung Shin; Yumi Roh ; Myunghwan Jung; Hansang Yoo
Seoul National University, Seoul, Korea
Introduction
Vaccination has been one of the most eff ective ways of pre-
venting disease. Oral delivery of vaccine induces both humoral 
and cellular responses against mucosal infections. Thiolated 
eudragit as delivery system have been known to exhibit pH 
dependent, permeation enhancing, enzyme inhibitory and 
mucoadhesive properties to improve the peroral absorption 
effi  ciencies. 
Intestinal infections with Escherichia coli are an important cause 
of diarrhea and mortality in pigs. Especially enterotoxigenic E. 
coli (ETEC) infections immediately after birth and weaning are 
responsible for signifi cant economical losses due to diarrhea, 
growth retardation, and mortality. The infections are mainly 
caused by the fi mbiral colonization factor F4 (K88) and F18 
(F107). In this study, Eudragit-cysteine conjugate were prepared 
and chacterized for the fi mbriae of E. coli.
Immune stimulating activity of F4 and F18–loaded thiolated 
Eudragit was checked in murine macrophage cell-line.
Materials and Methods
F4ac and F18ab and ac were detected by PCR amplifi cation 
from E. coli strains in Korea as described by Lee et al. The fi mbria 
proteins were purifi ed as described by Wim et al. Briefl y, the se-
lected E. coli strain were cultured in cultured in tryptic soy broth 
at 37˚C overnight with shaking. The bacteria were harvested and
suspended with PBS. F18 fi mbriae were purifi ed by heat shock 
(60˚C for 20min) and F4 fi mbriae by homogenizing the bacterial 
suspension using an Ultra Turrax at 24,000 rpm for 15 min. It was 
centrifuged at 8,500 rpm for 20 min and then 10,000 rpm for 40 
min. The solubilized fi mbriae were precipitated with 20% (w/v) 
ammonium sulphate. 
 Thiolated Eudragit were prepared according to the procedure 
previously developed by Quan et al. Raw 264.7 was cultured in 
12 well plates containing 2.2 X 105 cells per well with DMEM 
supplemented with 10% FBS at 37 ˚C under 5% CO2. After a 
18 h incubation, they were stimulated with 1 ug/ml of each 
fi mbria protein loaded TEMs. LPS (1 mg/ml) and unloaded TEMs 
were used as positive and negative controls, respectively. After 
stimulation, secreted concentrations of TNF- α and IL-6 were 
measured by ELISA method.
Results
Average particle sized of TEMs(thiolated Eudragit), F4 loaded 
TEMs and F18 loaded TEMs are 4.2 ± 0.75 μm, 4.7 ± 0.50 μm and 
4.5 ± 0 37 μm, respectively. The morphologies of TEMs, F4 and 
F18-loaded TEMs were observed as spherical shapes. The particle 
sizes of TEMs became bigger after loading of fi mbria proteins into 
TEMs. Production of TNF- α from raw 264.7 cells was increased in 
a time-dependent manner after exposure to F18-loaded TEMs, 
F4-loaded TEMs, TEMs and LPS. Secretion of IL-6 from raw 264.7 
cells was increased in a time-dependent manner after exposure to 
F18-loaded TEMs, F4-loaded TEMs and LPS.
Discussion
The size of microspheres is quite important to target vaccines for 
uptake into the mucosal associated lymphoid tissues (MALTs) of 
the gut. Also, the majority of the microspheres below 10 mm in 
diameter were needed to be transported through the eff erent 
lymphotics within macrophages. Therefore, it will be expected 
that F4-loaded TEMs and F18-loaded TEMs will be eff ective for 
delivery. Production of TNF- α and IL-6 in F4-loaded TEMs and 
F18-loaded TEMs were higher than production in only F4 and 
F18 proteins. Compared to F4 protein, F18 protein and F18-
loaded TEMs produced more TNF- α and IL-6. Therefore, F4 and 
F18-loaded TEMs could be considered as a candidate for oral 
vaccine of enterotoxigenic E. coli.
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Eﬃ  cacy of the booster dose of SUISENG® : a novel friendly adjuvanted 
vaccine against neonatal colibacilosis and clostridiosis
Nicolas G. Liaño; Xavier Gibert; Mercè Roca; Marta Sitjá
HIPRA, Girona, Spain
Introduction
This work shows the results of one study where the safety and the 
effi  cacy of SUISENG® (a vaccine against the Neonatal Piglet Coliba-
cillosis, C. perfringens and C. novyi enterotoxicosis) were assessed. 
Applying the basic vaccination and the Revaccination to preg-
nant sows, the effi  cacy was evaluated by means the serological 
response, the transfer of maternal immunity and the clinical signs 
in challenged piglets with two pathogenic strains of E. coli.
Materials and Methods
SUISENG® was used to vaccinate pregnant gilts. The basic vac-
cination scheme consists of two doses: the fi rst dose at ap-
proximately 6 weeks before farrowing and a second dose at 
approximately 3 weeks before farrowing. Revaccination on next 
subsequent gestation, administering one dose 3 weeks before 
the expected date of farrowing.
The piglets from the second parturition were challenged using two 
heterologous pathogenic strains to induce neonatal colibacillosis.
Table 1: Studies design
Study 1 Study 2
Nº Sows Vaccinated 5 Suiseng 5 Suiseng 
5 placebo 5 placebo
Nº piglets challenged 39 Suiseng 56 Suiseng 
52 Placebo 44 Placebo
Challenge Strain 1 Strain 2
Results
Serological response in sows and transfer of maternal immunity
Next is shown the IgG profi le against the F4ac in the sow sera 
after the immunization. The rest of valences included in the vac-
cine followed a similar profi le. (See fi gure 1.a)
The fi gure 1.b shows the presence of antibodies against each 
valence in the colostrum/milk samples of the sows. The serol-
ogy of the piglets sera demonstrated the presence of specifi c 
antibodies against all the valences.
Figure 1.a and 1.b.Serological response in sows and presence of 
antibodies a ainst each valence in the colostrum res ectivel .
Clinical sign of colibacillosis
The clinical signs after the challenge were evaluated by means 
a score record during 8 days. Next (fi gure 2.a) are the results of 
this score, signifi cant diff erences between treatments for both 
challenges were found (p>0,05).
In the same way, the mortality rates of each group are shown 
below (see fi gure 2.b). Signifi cant diff erences between the Su-
iseng and the Placebo were demonstrated for the two challenges.
Figures 2.a and 2.b. Clinical signs and mortality rates of each 
group respectively.
Discussion and conclusion
The results of this study demonstrated the effi  cacy of SUISENG® 
after a booster dose against the experimental infection with 
enterotoxigenic E. coli. The vaccination reduced signifi cantly 
the clinical signs and the mortality of the piglets suff ering from 
colibacillosis.
g p y
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Increased antimicrobial resistance for colistin of haemolytic Escherichia 
coli strains from clinical cases in Belgium using the E-test
Frédéric A. Vangroenweghe; Evelyne De Graef; Cora Miry; Frans Castryck
DGZ-Vlaanderen, Torhout, Belgium
Introduction
The last few years, acquired resistance to colistin in Escherichia 
coli (E. coli) has been described quite frequently. It has been 
shown that the standard agar dilution test is not a reliable method 
for the detection of colistin resistance in several bacterial species. 
Therefore, the need for a reliable test to check colistin suscept-
ibility of pathogenic E. coli strains in routine diagnostics was 
rather high. A practical study, comparing 4 diff erent antimicrobial 
susceptibility tests revealed that the E-test was the most reliable 
alternative agar-based colistin susceptibility testing method for 
use in E. coli strains (1). The objective of the present study is to 
evaluate the evolution of results obtained following the introduc-
tion of the E-test in the diagnostic laboratory procedure.
Materials and Methods
All samples from the content of the small intestine -positive for 
hemolytic E. coli- were tested using the E-test (AB Biodisk) with 
direct reading of the minimal inhibitory concentration (MIC) and 
expressed in μg/ml. The interpretation towards susceptibility or 
resistance was performed according to Table 1. 
Table 1. Interpretation of antimicrobial susceptibility testing to colistin 
using the E-test
Interpretation μg/ml
susceptible < 4
intermediately susceptible 4 - 16
resistant > 16
Results
The distribution of antimicrobial susceptibility testing of the 
(haemolytic) E. coli strains isolated from diagnostic bacteriology 
of samples from small intestines in the period 2006-2009 are 
presented in Figure 1. Overall, an evolution from 8% intermedi-
ately susceptible strains to colistin in 2006 to 28% in 2009 could 
be observed. On average, 150 strains of haemolytic E. coli were 
tested in routine diagnostics yearly. 
Discussion and Conclusions
Colistin is used worldwide as an oral antimicrobial agent for the 
prevention and treatment of neonatal and weaning-associated 
E. coli infections in piglets. 
Considering its extensive use and the fact that antimicrobial 
formulations are often underdosed (2), it is not surprising to fi nd 
an increasing colistin resistance in veterinary E. coli strains (3). 
Figure 1. Distribution of antimicrobial susceptibility results with the 
E-test obtained from (haemolytic) E. coli strains isolated in diagnostic 
bacteriology from 2006 till 2009. S: susceptible, I: intermediate, R: 
resistant
Following introduction of a more reliable antimicrobial suscept-
ibility testing method, using the E-test, the occurrence of a high 
percentage intermediately susceptible E. coli strains could be 
observed in Belgium. This is in accordance with the information 
provided by veterinary practitioners concerning the decreas-
ing effi  cacy of colistin in the treatment and prevention of E. coli 
infections, especially after weaning. Monitoring of the further 
evolution of antimicrobial susceptibility will be necessary in 
order to guarantee treatment success when applying colistin in 
antimicrobial formulations for piglets post-weaning.
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Eﬃ  cacy of SUISENG® : a novel friendly adjuvanted vaccine against neonatal colibacilosis and clostridiosis
Nicolas G. Liaño; Xavier Gibert; Marta Sitjá; Daniel Torrents
HIPRA, Girona, Spain
Introduction
This work shows the results of two studies where the safety and 
the effi  cacy of SUISENG® (a vaccine against the Neonatal Piglet 
Colibacillosis, C. perfringens and C. novyi enterotoxicosis) were 
assessed. Applying the basic vaccination scheme to pregnant 
sows, the effi  cacy was evaluated by means the serological re-
sponse, the transfer of maternal immunity and the clinical signs 
in challenged piglets with two pathogenic strains of E. coli. 
Materials and Methods
Suiseng was used to vaccinate pregnant gilts applying the the 
basic vaccination scheme consists of two doses: the fi rst dose at 
approximately 6 weeks before farrowing and a second dose at 
approximately 3 weeks before farrowing. 
The piglets of the sows were challenged using two heterologous 
pathogenic strains to induce neonatal colibacillosis. (See table 1)
Table 1. Studies design
Study 1 Study 2
Nº sows vaccinated 5 Suiseng 5 Suiseng
Nº sows vaccinated 5 Placebo 5 Placebo
Nº piglets challenged 39 Suiseng 59 Suiseng
Nº piglets challenged 52 Placebo 44 Placebo
Challenge Strain 1 Strain 2
Results
Serological response in sows and transfer of maternal immunity 
Two IgG serological profi les were observed. For the F4ab, F4ac, 
F5, LT and CpC valences high antibody titres were obtained after 
the fi rst dose of the vaccine. In the case of F6 and CnB valences, 
two doses of the vaccine were needed to achieve high antibody 
titres. (See fi gure 1.a)
The presence of specifi c antibodies was demonstrated in the 
colostrum/milk samples of the sows. The transfer to their off spring 
was confi rmed with the serology of the piglet sera. (See fi gure 1.b)
Figure 1(a-b). Shows the serological response in sows and the present 
of specifi c antibodies in the colostrum of the sows.
Clinical sign of colibacillosis
The clinical signs after the challenge were evaluated by means 
a score record during 8 days, as well as, the mortality rate (%) of 
each group. Next are the results of this score and percentages, 
signifi cant diff erences between treatments were found in all the 
studies. (See fi gure 2).
Figure 2 (a-b). Shows the clinical signs scoring and the mortality rate 
of each group respectively.
Discussion and conclusion
The results of the two studies demonstrated the effi  cacy of 
Suiseng (applying the basic vaccination scheme) against the 
experimental infection with enterotoxigenic E. coli. The vaccina-
tion reduced signifi cantly the clinical signs and the mortality of 
the piglets suff ering from collibacilosis.
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The eﬀ ect of Saccharomyces cerevisiae supplement on surviving and resistance in piglets before weaning
Jan Bernardy; Dana Kumprechtova
University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic
Introduction
Addition of Saccharomyces cerevisiae (SC) to the prestarter 
premix may provide early stimulation of the immune system 
of the piglets before weaning. Cell walls of SC contains beta-
glucans, an immunomodulator that can enhance the innate 
immune system providing protection against bacterial (1) and 
viral infections (2). Mechanisms of action include activation 
of macrophages, neutrophils, and NK cells, along with B and T 
lymphocytes and increased phagocytosis and cytokine produc-
tion in macro-phages (3). Our previous results show better abil-
ity of piglets stimulated by SC to reduce mortality and entero-
toxigenic E.coli strains (ETEC) in faeces of pre-weaning piglets. 
The objection of the study was not only confi rm our previous 
results(4), but also closer understanding of interaction between 
SC and ETEC and its impact to the resistance to the diarrhoea 
and chance of survival of piglets before weaning.
Material and Methods
Farrow to fi nish farm with 500 sows was used for the study, sep-
arated into multiple outlaying sections. Sows from two farrow-
ing sections were included into the trial, randomly allocated into 
the groups giving birth concurrently, 16 sows each. There were 
156 piglets live born in one group (avg 9.75 per sow) and 192 in 
another group (avg 12.00 per sow). The fi rst group (SC group) of 
breeding sows and piglets received standard feed and prestarter 
premix, supplemented with SC culture at 1000 ppm (Actisaf 
Sc47, Lesaff re Feed Ad-ditives, France) each. The second group 
of sows and piglets (C group) was fed by the same feed without 
SC supplementation.
Piglets and sows were rectally swabbed – sows before and after 
the farrowing and piglets every week until the weaning at 28 
days of age, cultivated and haemolytic strains of E.coli were 
further examined to the pathogenic factors. Symptoms of diar-
rhea and mortality were checked, as well as prestarter consump-
tion at daily basis; piglets were weighed weekly and ADG was 
calculated. The data were evaluated by non-parametric ANOVA 
Kruskal-Wallis test and visualized by Statistica v.9 software.
Results and Discussion
Number of enteropathogenic E.coli in SC group signifi cantly 
decreased in compare to Controls in the second and third week 
(p=0.030 and 0.044 respectively). The SC dietary supplementa-
tion reduced signifi cantly number of ETEC colonies at 2nd and 
3rd week about 8 and 14% (p=.03 and .044) respectively (week 
three - Figure 1), followed by lower or nil diarrhea symptoms and 
lower mortality, reduced about 1.03 piglet per litter (p=0.04) in 
SC group (Table 1). The major part of the response seems to be 
caused by changes in intestinal microbiology, including en-
hanced numbers of favourable microorganisms and decreased 
numbers of potentially pathogenic bacteria (E.coli, etc.) together 
with higher fermentation along the intestines. Some investiga-
tions have been made with varying diet composition or supple-
menting with diff erent substances of animal or plant origin. 
However, positive eff ects on the gut have often been more 
variable and sometimes inconsistent (5) . However, measurable 
eff ects of these factors on intestinal physiology and muco-sal 
immunology are not clear or at least diffi  cult to interpret, our re-
sults declare measurable impact on number of ETEC strains and 
lower pre-weaning mortality in the group fed by diet enriched 
with SC.
SC (n=16 litters) C (n=16litters)
Average StDev Average StDev
Live born (n) 9.75 3.21 12.00 2.76
Mortality (n) 1.67 1.12 2.70 1.25
Weaning age (d) 25.56 1.59 25.75 1.48
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Evaluation of the in feed use of pumpkin for treatment and 
prophylaxis of escherichia coli postweaning diarrhoea
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Introduction
Postweaning diarrhea due to Escherichia coli (PWD) is a transmis-
sible diarrhoea mediated by enterotoxins and observed mainly 
observes after weaning, causing major losses in weaned piglets 
worldwide (1). The aim of this fi eld study was the assessment of 
possible antimicrobial activity of Pumpkin based on the reduction 
of E. coli postweaning diarrhoea prevalence in weaned piglets. 
This trial was part of the SAFEWASTES specifi c targeted research 
project fi nanced by the European Union (Framework Project 6).
Materials and Methods
This study was carried out on a commercial pig farm in northern 
Greece with a capacity of 250 sows under production. The farm 
was selected due to previous history of E. coli PWD occurrence. 
Under a randomized block design 150 healthy and genetically 
similar weaned piglets at 4 weeks of age were divided into 3 
groups (5pens of 10 piglets each with equal sex ratio/group. The 
negative control group (NC), received feed formulated with 99% 
basic diet and 1% corn starch from trial day 0 (weaning day) until 
the end of the trial after 28 days. The second group received feed 
formulated with 99% basic diet and 1% pumpkin (P1), while the 
third received feed formulated with 97.5% basic diet and 2.5% 
pumpkin (P2.5) for the same time period. Average daily weight 
gain (ADWG), average daily feed intake (ADFI), feed conversion 
ratio (FCR) and pen diarrhea score (DS) were recorded. Addition-
ally, faecal samples were collected at day 0, 14 and 28 of the trial 
for E .coli shedding quantitative analysis (strains K88, K99, F18, 
F41, 987P) and Salmonella spp and Clostridium spp presence. 
Results and Discussion
The mean DS for the total trial period did not diff er signifi cantly 
between the 3 treatment groups, although there was a slight 
improvement in P1 and P2.5 groups (graph 1). Faecal analysis 
did not reveal the presence of Salmonella spp or Clostridium 
spp. Referring to E. coli shedding the P1 and P2.5 groups showed 
a better (not signifi cantly) performance (graphs 2a,b,c).
Graph 1: Daily DS per pen during the total trial period
Graph 2 (a,b,c): Quantitive analysis of E. coli shedding (1=<107, 
2=107-9x107, 3=108-9x108, 4=109-9x109, 5=1010-9x1010 cfu/grR) at 0, 
14th and 8th day of trial
Table 1: ADWG (kg), ADFI (kg), FCR (Mean±SD)
Groups ADWG ADFI FCR
NC 0.357±0.069 (n=44) 0.522±0.029 (n=5) 1.46±0.06 (n=5)
P1 0.360±0.061 (n=48) 0.527±0.021 (n=5) 1.48±0.05 (n=5)
P2.5 0.362±0.062 (n=47) 0.523±0.028 (n=5) 1.45±0.12 (n=5)
The results of the trial showed that pumpkin at 1% and 2.5% 
inclusion rates did not show a clear positive antimicrobial ef-
fect against E. coli infection in weaners. However, in P2.5 group 
scores of almost all the recorded parameters were better than 
the negative controls. 
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Oregano essential oil improves sow and piglet performance – a summary of three ﬁ eld investigations 
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Introduction
Oregano essential oil (OEO) is a phytogenic feed additive with 
a spicy, aromatic fl avor that stimulates appetite and promotes 
feed intake. OEO is being studied because of its well docu-
mented anti-bacterial, anti-fungal and anti-oxidant activities 
and for its ability to support a healthy gut (1). University of 
Minnesota research (2) showed that inclusion of OEO in sow 
gestation and lactation diets increased number of piglets born 
alive, increased litter birth weight and improved average daily 
gain of piglets. The authors attributed higher piglet growth to 
the higher quality colostrum (increased IgG and immune cells) 
produced from sows supplemented with OEO. This report sum-
marizes three fi eld investigations of the eff ects of OEO on sow 
and litter performance. In trials 1&2, OEO was fed in gestation 
and lactation diets. In trial 3, OEO was given in water for 10d 
at farrowing. Results showed that feed intake, reproductive 
performance and litter health were signifi cantly improved for 
OEO-fed sows compared with controls.
Materials and Methods
In trials 1&2, OEO or control diet were fed during gestation and 
lactation (Table 1). Feed intake and reproduction traits were 
used to assess sow performance. Litter health and perform-
ance were assessed by preweaning mortality, litter gain, and 
incidence of scours. In trial 3, OEO was delivered in water for 3d 
prior and 7d after farrowing, which allowed us to compare litter 
health only. Statistical analysis (Chi-square, ANOVA Proc Mixed, 
SAS) and odds ratios (3) were performed for each study. 
Table 1. Three trials to study the eff ects of OEO on sow and litter health.
Trial Location Number OEO inclusion rate
OEO Control Gestation Lactation
1 N. Carolina 192 199 440a 650a
2 Australia 162 146 250a 250a
3 Illinois 48 48 none 47b
aGrams/metric tonne; bMilliliters/liter of stock solution metered at 1:128.
Results
In trial 1, lactation feed intake was increased for OEO-fed sows 
compared with control sows (P<0.001) (4). OEO-sows weaned 
an additional 0.6 pigs/litter (P<0.001), and pre-weaning mortal-
ity was 3.3% lower than controls: 11.1% and 14.4%, respectively 
(P=0.06). OEO-fed sows had fewer litters aff ected by Isospora suis 
scours (P=0.001), and litter medications were reduced (P=0.027). 
Odds ratios showed that litters from control sows were 2 2 times 
more likely to scour than those from OEO-sows (95% CI: 1.42 to 
3.3). In trial 2, OEO-fed sows weaned an additional 0.38 pigs/litter 
(P=0.026), and litters were healthier, as shown by reduced scours 
(P=0.008). Litters from control sows were 3.5 times more likely 
to scour than those from OEO-fed sows (95% CI, 1 58 to 7.80). 
Trial 3 was conducted on a farm with lab-confi rmed neonatal 
scours caused by Clostridium perfringens type A. Results showed 
that OEO-sows weaned 0.74 additional pigs/litter than control 
sows (P<0.001). Pre-weaning mortality was reduced from 16.0% 
for control sows to 6.4% for OEO-sows (P<0.001). Odds ratios 
showed that litters from OEO-sows were 2.8 times more likely to 
survive than control litters (95% CI, 2.09 to 3.76). Financial analysis 
showed that return on investment ranged from 3.9:1 to 9.7:1.  
Discussion
These three studies demonstrated that dietary OEO improved 
sow reproductive performance and delivered better litter health. 
Litters from OEO-fed sows had reduced preweaning mortal-
ity, increased litter weights, and lower incidence of scours than 
litters from control sows. OEO litters were healthier and more 
robust than control litters. These results may be attributed to the 
anti-bacterial and anti-oxidant activity of OEO, which improves 
sow gut health and colostrum immunity, leading to healthier 
piglets (2). OEO is an economical way to deliver more full value 
pigs at weaning. 
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Introduction
The use of probiotics containing Bacillus cereus var Toyoi in 
weaners, fi nishers, sows and their litters has positive eff ects on 
their health and performance (1), as well as on the reduction of 
incidence and severity of PWDS (2). Recently, it was also no-
ticed that Benzoic Acid improved piglets’ performance (3). The 
purpose of this study was to assess the effi  cacy of a probiotic 
containing Bacillus cereus var Toyoi spores (Toyocerin®) and 
Benzoic Acid (VevoVitall®) on health and growth performance 
parameters in weaning pigs, against negative controls. The study 
was fi nanced by Rubinum SA through the Research Committee 
of Aristotle University of Thessaloniki.
Materials and Methods
The study was carried out on a commercial farrow-to-fi nish 
pig farm in Greece (420 sows under production). The farm had 
a history of PWDS due to E. coli and it was free of Brachyspira 
hyodysenteriae & pilosicoli, Salmonella spp., Cryptosporidium 
spp., rotavirus and coronaviruses.
The animals of each weekly batch were allocated into 4 experi-
mental groups [8 pens x 10 piglets/pen = 80 piglets/group x 4 
groups=320 piglets]. The trial groups were as follows: (a) NC: 
No treatment. (b) TOYO group: Same feed as in the controls 
plus Toyocerin® at a dose of 1 x109 B. cereus var Toyoi spores / 
kg feed, (c) BA group: Same feed as in the controls plus Vevo-
vital® at a dose of 5 kg/kg feed (5000 ppm benzoic acid) and (d) 
TOYO+BA group: Same feed as in the controls plus Toyocerin® 
at a dose of 1x109 B. cereus var Toyoi spores and Vevovital® at a 
dose of 5 g/kg feed. 
Morbidity, mortality and growth performance data including 
body weight (BW), average daily gain (ADG), average daily feed 
intake (ADFI) and average feed conversion ratio (FCR) were 
recorded at weaning day and then every 7 days (until 35th day) 
and for the total trial period. Diarrhoea score (DS) and daily DS/
pen was calculated on litter basis after a daily monitoring. On 
the day of weaning, 4 piglets/pen were randomly selected for 
faecal sampling. Samples were subjected to microbiological 
examination for the determination of E. coli counts, as well as for 
the presence of ETEC strains.
Results and Discussion
Morbidity rates were signifi cantly decreased in TOYO and 
TOYO+BA groups compared to NC (P<0.05), but there were no 
signifi cant diff erences in mortality rates. The mean DS for the 
total trial period is given in Table 1. E. coli ETEC strains presence 
and counts (x 106) in faecal samples are shown in Table 2.
TABLE 1 Experimental groups
NC TOYO BA TOYO+BA
Diarrhea score 0.322±0.050a 0.096±0.021bc 0,132±0.037b 0.064±064c
TABLE 2
ETEC strains 
Day 0 3.1% 0.0% 3.1% 3.1%
Day 14 6.9% 3.2% 3.4% 0.0%
Day 28 3.4% 0.0% 0.0% 0.0%
E. coli counts (x 106)
Day 0 9.09±19.45 11.48±24.71 11.24±35.09 14.03±26.83
Day 14 56.19±79.98a 14.73±30.02b 36.72±27.91ab 15.20±20.50b
Day 28 23.33±51.44 10.34±18.71 17.24±5.94 10.18±18.57
a,b,c Means with diff erent superscripts in the same row diff er signifi cantly
The mean BW of piglets increased signifi cantly in the 3 treat-
ment groups compared to NC group (P<0.05). There were no 
signifi cant diff erences in ADFI between all groups, except a 
reduction in BA group at the total period of day 0 – day 35 after 
weaning. The ADG and FCR were signifi cantly higher in all medi-
cated groups compared to the NC group (P<0.05). In conclu-
sion, the addition of Toyocerin® or Vevovital® in weaners’ feed 
improved their health and growth performance compared to 
the negative controls. However, the most benefi cial eff ects were 
obtained in the combination of Bacillus cereus var Toyoi spores 
with benzoic acid.
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Introduction
Probiotics are used on animal feeding with the aim of to increase 
meet, milk, eggs yield. Its utilization has been widely investigat-
ed, mainly during the last years, because of the forbiddance of 
any antibiotics as a growth promoter among all countries in the 
world (1). This study aimed to evaluate the effi  ciency of acidifi -
cants and probiotics as growth promoters in piglets. They were 
fed from 21 to 63 days of age to have investigate the perform-
ance or percentage of piglets delivered to units of growth and 
termination.
Materials and Methods
A total of 630 piglets (castrated males and females) from a 
commercial herd were weaned with 21 days of age, weighing in 
average 6.3 Kg. The randomized block design was used, being 
the pen with 14 pigltes the experimental unit, with 5 treatments 
performed in 9 replications and density being 0.33m32/pig. 
Piglets received water and ration ad libitum. Treatments were 
as following: 1 – Negative Control – Basal Diet (DB); 2- Antibiotic 
– DB + 20ppm doxiciclin; 3- Acidifi cant – DB + acidifi cant (4Kg/
ton of ration from day 21 to 49, and 2kg/ton of ration from day 
50 to 63); 4- Probiotic – DB + probiotc (Saccharomyces cerevisiae 
var. boulardii - 100g/ton of ration); 5- Probiotic + Acidifi ant – DB 
+ associations of treatments 3 and 4. The acidifi cant used was a 
blend of organic acids composed of 10% citric acid, 10% fumaric 
acid, 10% phosphoric acid, 30% benzoic acid and 40% of vehicle. 
The daily feed intake (CDR), gain of weight (GPD) and food 
conversion (CA) as well as the percentage of piglets delivered 
were evaluated in three periods: 1 (days 21 to 35), 2 (days 21 to 
49) and 3 (days 21 to 63). The percentage of piglets delivered 
was calculated based on the relation between piglets weigh-
ing 18Kg on day 63 and the total number of piglets used in the 
experiment 
Results and Discussion 
The CDR, GPD and CA for animals from the diff erent experi-
mental groups are showed on table 1. On period 1 only CDR 
was not infl uenced by treatments (P<0.05), being the highest 
GPD and CA, observed in piglets that were fed with antibiotic 
containing ration. The same group presented, on periods 2 and 
3 the highest (P<0.05) CDR and best GPD and CA in compari-
son to the others. The same way, the percentage of piglets to 
the units of growth and termination (Table 1) was infl uenced 
(P<0.05) by the treatments, being the group fed with antibiotics 
the one that showed the best performance. The low percentage 
of piglets delivered impairs the realization of effi  cient cleaning 
and disinfection, and dirty pens result in an increase of negative 
eff ects caused by infectious agents that are present. Animals 
maintained in such conditions tend to present sub-clinical or 
opportunist diseases, what might increase the rate of waste 
(refugo?) and increase the lot yield causing economic losses due 
to extra expenses with feeding, medicines and labor.
Conclusion 
Animals fed using antibiotics as growth promoters after wean-
ing obtained the best performance if compared to animals fed 
using acidifi cants and probiotics. 
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Table 1. Averages observed for CDR, GPD, CA, coefi cients of variation (CV), probability values (P) and % of piglets delivered, according to treat-
ments and experimental periods
Trat Period 1 Period 2 Period 3 % Of piglets delivered
CDR GPD CA CDR GDP CA CDR GDP CA
1 0,195 0,081b 2,536ab 0,353ab 0,196b 1,804b 0,493ab 0,287b 1,725b 51,2b
2 0,206 0,124a 1,754a 0,391ab 0,246a 1,605a 0,549a 0,351a 1,523a 75,4a
3 0,212 0,097ab 2,219ab 0,398a 0,211b 1,861b 0,527ab 0,294b 1,798b 52,8b
4 0,212 0,083b 2,669b 0,373a 0,192b 1,946b 0,502ab 0,270b 1,865b 51,7b
5 0,202 0,096ab 2,418ab 0,350b 0,188b 1,857b 0,487b 0,262b 1,862b 43,6b
cv% 2,28 8,00 7,13 9,93 10,97 8,09 9,19 11,07 8,50
P 0,56 0,01 0,04 0,03 <0,001 0,0008 0,05 <0,0001 0,0009
a,b Same letter in the same line do not diff er (P>0.05) according to Tukey test
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Introdução
To avoid weaning adverse eff ects and at the same time to work 
as growth promoters, sub-therapeutic levels of antibiotics are 
added to piglets feed and this might cause bacterial resistance 
to antibiotics (1). To avoid this issue probiotics and organic acids 
have been used as an alternative to the use of antobiotics. This 
study aimed to evaluate the effi  ciency of alternative additives, 
as growth promoters, instead of the use of antibiotics. Its eff ects 
on the occurrence of diarrhea and total and fecal coliforms were 
evaluated through the administration in piglets ration from days 
21 to 63 of age
Material and Methods 
A total of 630 piglets from a commercial herd were weaned 
with 21 days of age, weighing in average 6.3 Kg. The random-
ized block design was used, being the pen with 14 pigltes the 
experimental unit, with 5 treatments performed in 9 replications 
and density being 0.33m2/pig. Piglets received water and ration 
ad libitum. 
Treatments were as following: 
1-  Negative Control – Basal Diet (DB); 
2-  Antibiotic – DB + 20ppm doxiciclin; 
3-  Acidifi cant – DB + acidifi cant (4Kg/ton of ration from day 21 
to 49, and 2kg/ton of ration from day 50 to 63); 
4-  Probiotic – DB + probiotc (Saccharomyces cerevisiae var. 
boulardii - 100g/ton of ration); 
5-  Probiotic + Acidifi ant – DB + associations of treatments 3 and 4. 
The acidifi cant used was a blend of organic acids composed of 
10% citric acid, 10% fumaric acid, 10% phosphoric acid, 30% 
benzoic acid and 40% of vehicle. The occurrence of diarrhea was 
daily evaluated during the fi rst 15 days post-weaning, according 
to the scores: 0: fi rm stool, with normal consistency; 1: less con-
sistent stool; 2: loose stool; 3 liquid stools. Diarrheal stool were 
considered for scores 2 and 3 (2). On days 10 and 20 post-wean-
ing, 3 piglets per treatment were slaughtered and a portion from 
jejunum was aseptically collected refrigerated and sent to the 
laboratory for total and fecal coliforms counting (3).
Results and Discussion:
Table 1 shows data regarding the incidence of diarrhea for total 
and partial post-weaning periods. For the total period, from day 
1 to 15 post-weaning the lowest incidence of diarrhea (P<0.05) 
was observed for piglets that received ration added of antibiot-
ics. Table 2 shows data regarding the amount of fecal and total 
coliforms between days 10 and 20 post-weaning. An increase of 
fecal and total coliforms was observed for animals from all treat-
ments on day 10, which was followed by a reduction on day 20 
post-weaning. These results coincide with the incidence of diar-
rhea that has started on day 4 post-weaning, increasing until day 
10 and then reduced until day 15 being practically controlled at 
that point.
Table 1. Incidence of diarrhea on piglets during partial and total 
periods, according to the experimental treatments
Experimental 
treatments
Days post-weaning
1 a 5 6 a 10 11 a 15 1 a 15
Cn 13,0a 30,0a 23,0a 22,0a
Ant 7,0c 11,0d 20,0b 12,0d
Acid 8,0bc 17,0c 22,0ab 16,0c
Prob 10,0ab 22,0b 23,0ab 18,0b
Prob + ACid 11,0ab 27,0ab 25,0a 21,0a
a,b Same letter in the same line are not diff erent according to F-test (P>0.05)
Table 2. The Most probable number (NMP) for total and fecal coliforms 
(log CFU/g) in piglets between 10 and 20 days post-weaning, according 
to the diff erent experimental diets
NMP, Log UFC/g
Total Coliforms Fecal coliforms
Days post weaning
Treatment 10 20 10 20
Cn 7,00 5,09 5,92 1,25
Ant 6,49 2,84 6,49 0,73
Acid 5,09 2,60 5,09 0,00
Prob 7,00 1,75 6,16 0,87
Prob+acid 6,71 2,60 5,11 0,42
Media 6,46a 2,98b 5,75a 0,65b
CV% 44,90 51,44
Treatment Eff ect 0,49 0,68
Eff ect of age 0,0002 <0,0001
a,b Same letter in the same line are not diff erent according to F-test (P>0.05)
Conclusion
In commercial swine herds with high health challenge, the use 
of alternative products is not able to prevent post-weaning diar-
rhea in an appropriate
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Introduction
Since 2003, the incidence and severity of disease associated with 
toxigenic Clostridium diffi  cile (Cd) have increased in hospitals 
in North America (1,2). These increases have coincided with the 
emergence of a new, highly virulent, and more resistant epi-
demic strain (PFGE NAP1, Toxinotype III). The origins of this strain 
have yet to be determined. Various strains of Cd, including NAP1, 
can be isolated from food animals and retail meat (3-5); however, 
the predominant strain from food animals is NAP7 (3). Because 
Cd has been isolated from food animals and meat, it has been 
proposed that Cd may be transmitted via food sources (3-5, 6). 
The objective of the present study is to compare the prevalence 
of Cd in multi-age production groups within a Texas integrated 
swine operation.
Materials and Methods
Composite fecal samples (n = 2936, representing approximately 
10 pigs/sample) were collected monthly for 36 months (2004-
2006) from asymptomatic, clinically healthy, multiple-age 
swine from 12 separate farms at 3 geographical locations in 
Texas. Cultivation of Cd was accomplished by alcohol shock and 
enrichment techniques described for feces (3). PCR was used to 
characterize Cd for toxin A&B genes, tcdC gene deletion, tox-
inotype, binary toxin gene, and pulsed fi eld gel electrophoresis 
(PFGE) genotype (7). Cd isolates were tested for susceptibility to 
11 antibiotics. 
Results
In total, 252 Cd were isolated: 175 from farrowing, 37 from 
grower/fi nisher, 14 from nursery, and 26 from breeding animals. 
Of the isolates, 66 were PFGE pattern NAP7, 173 variant pat-
tern (with 91% similarity to NAP7), and 4 other patterns. There 
were 236 Toxinotype V, 7 Toxinotype V-like, 7 Toxinotype XI, and 
2 of unknown toxinotype; 250 isolates had the 39 bp deletion 
for the tcdC gene; 252 isolates were positive for binary toxin; 
and 238 were Toxin A+/B+, 7 were A-/B+, and 7 were A-/B-. All 
isolates were sensitive to amoxicillin/clavulanic acid, piperacillin/
tazobactam, and vancomycin; and the majority were sensitive 
to chloramphenicol, metronidazole, and tetracycline. The most 
prevalent resistance observed was for cefoxitin, imipenem, and 
ciprofl oxacin. Intermediate resistance was seen for clindamycin 
and ampicillin. 
Discussion
The majority of swine isolates came from the farrowing barn and 
this agrees with others in that young animals are more prone 
to be colonized with Cd than older ones (3,7,8). The predomin-
ant genotype among our isolates was PFGE pattern NAP7 and 
Toxinotype V, and this agrees with that reported for pig and calf 
isolates (6, 8). Although the predominant strain in our study has 
been recovered from humans (6), none of our isolates were of the 
human epidemic strain (NAP1, Toxinotype III). Antibiotic sensitiv-
ities were consistent with those reported in an earlier study (7). 
Our isolates appear to have less resistance than observed for hu-
man clinical strains (9). On the basis of our study, we conclude that 
young animals have a higher prevalence of Cd than older swine. 
If Cd is indeed a potential food-associated organism, the lower 
carriage rate of Cd in market-age pigs in our study would suggest 
a reduced transmission risk to the food chain.
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Introduction
Clostridium diffi  cile is among the 5 most important pathogens 
causing diarrhea in swine (Songer 2006). Vaccination is a promis-
ing measure in fi ghting the agent (Aboudola 2003, Ghose 2007). 
A reliable analytical tool for controlling the protective antigen(s) 
in production process is of paramount importance in vaccine 
development and production. We have developed a sandwich-
type ELISA for quantitative detection of C. diffi  cile toxin A (TcdA) 
using the same monoclonal antibody (mAb) as capture and de-
tector reagents. With this method we are able to quantitatively 
detect TcdA in the form of bioactive toxin as well as in the form 
of toxoid. 
Materials and Methods
Capture antibody: TcdA-specifi c mAb produced by the hybrid-
oma PCG-4 (ATCC access No: HB-8712). Detector antibody: 
biotin-labeled mAb PCG-4. Conjugate: Extravidine-HRPO (Sigma 
E2886). 
ELISA procedure: Each incubation step except with TMB sub-
strate is performed in a thermo-regulated shaker followed by 
4 washing cycles. Nunc Maxisorp ELISA plate is coated with 
capture mAb diluted 1:1000 in carbonate buff er (pH 9.6) for 60 
min at 37 °C. Standards and samples are incubated for 60 min at 
37 °C. Detector mAb is diluted 1:500 in PBS supplemented with 
0.05% Tween-20 and 0 5% milk powder, and incubated for 60 
min at 37 °C. Conjugate is used in 1:2000 dilution in the same 
buff er as above, and incubated for 30 min at 37 °C. TMB sub-
strate in 0.1 M acetate buff er (pH 5.5) is incubated for 30 min at 
RT in dark, and color reaction is stopped by 2 N sulphuric acid.
Results
Quantitation limit of the validated ELISA method determined by 
an eight-point standard curve (Graph 1) is 10 ng/ml. No cross-re-
action has been found with toxin B (TcdB). Intra- and interassay 
variation is within 10%.
Graph 1
Discussion
This ELISA is a reliable and convenient method for monitoring 
the optimization process of C. diffi  cile fermentation aiming at 
the most economical production of the protective antigen TcdA 
in vaccine development. The method is also used for the quanti-
tative detection of toxoid as long as the epitope conformation is 
preserved after formol inactivation of the bioactive toxin.
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Introduction
BMD® (bacitracin methylene disalicylate, Alpharma Inc., Bridge-
water, NJ) is approved by the FDA in the USA for the control of 
clostridial enteritis in suckling piglets caused by Clostridium 
spp. susceptible to bacitracin when fed to sows at 275 ppm 
(250 g/ton) starting 2 weeks prior to farrowing and throughout 
lactation. Thirteen previous studies1,2 have documented an 
improvement in pig weaning weights in those pigs nursing sows 
consuming BMD. This experiment was conducted to determine 
the eff ect of BMD supplementation in sow diets from day 99 
of gestation and throughout lactation on the immunoglobulin 
status of sows and piglets and sow milk nutrient composition. 
Materials and Methods
Crossbred sows (Topigs, Landrace X Yorkshire; n=16; par-
ities=2.4±0.28) were randomly assigned to one of two dietary 
treatments. Diet 1 was a non-medicated corn-soybean meal 
control diet and Diet 2 was Diet 1 supplemented with 275 ppm 
BMD. Sows were fed their respective diets from day 99 of gesta-
tion through weaning. Piglet blood samples (1 pig/litter/period) 
and sow blood and milk samples were taken on day 0, 9, and 18 
of lactation.
Results and Discussion
No diff erences were observed between treatments for sow milk 
crude protein, fat, ash or sow milk immunoglobulin status (Table 
1). The average sow serum immunoglobulin status was not af-
fected by treatment (Table 2). The average IgA content of piglet 
serum was not aff ected by treatment. However, the overall aver-
age IgG status in the serum of piglets nursing sows consuming 
BMD was signifi cantly (P=0.04) enhanced and was more than 
twice that of pigs nursing Control sows (Table 2). Because there 
is virtually no placental immunoglobulin transfer in pigs, the 
higher IgG serum content of pigs nursing sows consuming BMD 
had to be derived from the IgG of colostrum. The IgG concen-
tration of colostrum was numerically greater in BMD-fed sows. 
In conclusion, BMD supplementation did not aff ect sow milk 
nutrient composition nor sow milk or serum immunoglobulin 
status but did enhance the immunoglobulin status of piglets. 
The greater serum IgG concentrations of piglets nursing sows 
consuming BMD may contribute to the heavier pig weaning 
weights reported in previous research.
Table 1. Average sow milk nutrient and immunoglobulin 
concentration. 
275 ppm BMD Control
Sow milk crude protein, % 6.31 6.22
Sow milk fat, % 8.06 8.19
Sow milk ash, % 0.75 0.72
Sow milk IgA, mg/ml 2.38 2.15
Sow milk IgG, mg/ml 0.12 0.10
Table 2. Average sow and piglet serum immunoglobulin 
concentration.
275 ppm BMD Control
Sow serum IgA, mg/ml 0.26 0.34
Sow serum IgG, mg/ml 0.48 0.59
Piglet serum IgA, mg/ml 0.94 0.90
Piglet serum IgG, mg/mla 0.58 0.27
aP=0.04
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Antimicrobial susceptibility of Clostridium perfringens type A isolated from 
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Introduction
Clostridium perfringens a spore-forming anaerobic bacilli, Gram-
positive, and strictly-to-oxygen-tolerant, is widely distributed in 
the environment and in the intestinal tracts of domestic animals 
. It has been recognized as one of the most important causes of 
diarrhea in neonatal pigs. C. perfringens types A and C and C. 
diffi  cile are the main pathogenic clostridia in swine (5). Antibiot-
ics recommended for the treatment of C. perfringens-associated 
diarrhea include amoxicillin, tylosin, and tetracycline, but there 
are few data about this microorganism susceptibility to these 
substances, in Brazil. The aim of this study was to determine the 
in vitro susceptibility of C. perfringens type A to seven relevant 
antimicrobials for swine production.
Materials and Methods
Fifty C. perfringens type A isolates, each obtained from diff erent 
piglets (25 diarrheic and 25 non diarrheic) were evaluated. All 
strains were obtained in swine herds in Minas Gerais, Brazil. The 
following antibiotics, manufactured for analytical purpose, were 
tested: amoxicillin, ceftiofur, fl orfenicol, josamycin, lincomycin, 
tetracycline, and tylosin. Minimum inhibitory concentrations 
(MICs) were determined on Brucella’s agar plates containing 
doubling of the antibiotics, from 0.25 to 256.0μg/L, and with 
5% of sheep blood, vitamin K (1μg/ml), and hemim (5μg/ml). All 
strains were tested twice and, for negative control, Bacteroides 
fragillis (ATCC25285) was included in every test plate. All MICs 
values were determined using the National Committee for Clin-
ical Laboratory Standards (NCCLS) (3).
Results
MICs values of each antibiotic for C. perfringens type A are sum-
marized in Table 1. All isolates were susceptible to amoxicillin and 
ceftiofur. Forty four samples (88%) were considered susceptible to 
tylosin and only 6% of the strains were resistant. Thirty eight strains 
(76%) were susceptible to fl orfenicol but 10 (20%) were considered 
resistant. In contrast, 42 (84%) and 36 (72%) of the C. perfringens 
type A were resistant to tetracycline and lincomycin, respectively.
Table 1. MIC distribution of amoxicillin, ceftiofur, fl orfenicol, 
josamycin, lincomycin, tetracycline and tylosin for fi fty swine Clostrid-
ium perfringens type A isolates.
Antimicrobial Number of C. perfringens isolates with values (μg/ml)
0,25 0,5 1 2 4 8 16 32 64 128 256 >256 MIC50 MIC90
Amoxicillin 5 31 9 2 2 1 0 0 0 0 0 0 0,5 1
Ceftiofur 21 9 2 4 6 8 0 0 0 0 0 0 0,5 8
Florfenicol 0 1 2 24 9 2 2 2 8 0 0 0 2 64
Josamycin 0 0 0 2 3 16 5 0 1 0 5 16 16 >256
Lincomycin 0 0 0 7 7 8 3 0 0 0 6 19 16 >256
Tetracycline 0 0 0 4 0 4 21 2 0 4 15 0 16 256
Tylosin 14 22 5 2 1 0 3 3 0 0 0 0 0,5 16
Discussion
Several studies using diff erent C. perfringens samples also dem-
onstrated too high-level resistant (MIC > 16μg/ml) to tetracy-
cline, an antimicrobial commonly recommended for treatment 
of C. perfringens-associated diarrhea in animals including pig-
lets. Important to Clostridium species can carry tetracycline re-
sistance genes (2,4,6). Most C. perfringens strains from chickens 
and turkeys used by WATKINS et al (6) were considered resistant 
to lincomycin with high MICs (> 8 μg/ml). However the present 
study showed that amoxicillin, ceftiofur, fl orfenicol, and tylosin 
have a good eff ect against C. perfringens strains, as described 
elsewhere (1,4,6,7). These results emphasis the importance of 
conscious use of antimicrobials and the relevance of hygiene 
and vaccination as preventive measures.
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Implementing the 5-week BMD® feeding program produces heavier 
pigs at weaning than feeding BMD only during lactation
Daniel A. Nelson1 Roy A. Schultz2
1. Alpharma Animal Health, East Bethel, MN, USA; 2. Alpharma Animal Health, Avoca, IA, USA
Introduction
BMD® (bacitracin methylene disalicylate, Alpharma, Inc, Bridge-
water, NJ) is approved by the FDA in the USA for the prevention 
of clostridial enteritis in suckling piglets caused by Clostridium 
spp. susceptible to bacitracin when fed to sows starting 2 weeks 
prior to farrowing and throughout lactation. Thirteen previous 
studies1,2 have documented the benefi ts of feeding BMD during 
this 5-week period, including heavier piglet and litter weaning 
weights and reductions in piglet mortality and sow lactation 
weight loss. The 14-day pre-farrow BMD feeding period is some-
times perceived as too diffi  cult to implement. Therefore, two 
separate studies conducted by large swine integrators and re-
ported herein evaluated the benefi ts of feeding 275 ppm (250g 
BMD/ton) only in lactation or starting 2 weeks prior to farrowing 
and throughout lactation (5-week). 
Material and Methods
In the fi rst study a total of 106 sows were allotted to treatment 
(non-medicated or BMD in lactation) via parity and line. BMD 
was added to the lactation diets of test sows to provide 275 
ppm. BMD feeding began when sows were moved into far-
rowing rooms (an average of 2 days pre-farrow) and continued 
until weaning. Total number liveborn and stillborn pigs/sow, 
mortality/litter, number of piglets weaned/sow, individual live 
pig birth weight within 24 hrs post-farrowing, and individual 
weaned pig weight were recorded. The second study contained 
3 treatments: 1) Non-medicated 2) BMD only in lactation 3) BMD 
fed 2 weeks prefarrow and throughout lactation. A total of 568 
sows of common genetic base were blocked by location within 
farrowing room and balanced by parity to treatment. Similar 
gestation and lactation diets were fed to all treatment groups 
with the exception that BMD was added to supply 275 ppm for 
the treatment groups. Sows were individually weighed before 
farrowing and at weaning. Entire litters were weighed at birth, 
after fostering and at weaning. In lactation, sows were given ad-
libitum access to feed.
Results and Discussion
In Study 1, there were no diff erences between treatments in the 
total number of pigs born, the number of pigs born alive, the 
number of pigs that were stillborn, the number of mummies, the 
number of pigs weaned nor the number of pigs that died/litter. 
Weaning weights of pigs nursing sows consuming BMD were 
signifi cantly (P=0.02) greater (6.0 vs 5.8 kg/pig). In Study 2, net 
sow weight post-farrowing, post-weaning, and net sow weight 
loss in lactation were not diff erent among treatments. The num-
ber of pigs started and weaned/sow, and pre-weaning mortality 
were not diff erent among treatments. Adjusted 22-day piglet 
weaning weights were signifi cantly (P<0.05) greater (+0.3 kg/
pig) for pigs nursing sows consuming BMD for the 5-week per-
iod compared to pigs nursing Control sows (6.7 vs 6.4 kg/pig re-
spectively). The adjusted 22- day piglet weaning weights of pigs 
nursing sows fed BMD only in lactation were intermediate (6.5 
kg/pig) and not signifi cantly diff erent from pigs nursing Control 
sows or pigs nursing sows consuming BMD for the 5-week per-
iod. This is a logical observation as the two-week prefarrow BMD 
feeding period begins to reduce clostridial shedding before 
sows enter and “seed” the farrowing crate. In both studies, BMD 
increased pig weaning weight by 0.2 kg/pig when used only 
in lactation, and by 0.3 kg/pig when use for 2 weeks prefarrow 
and throughout lactation in Study 2 (Figure 1). In the presence 
of Clostridium perfringens type A and C, dietary supplementa-
tion of sow feed with 275 ppm BMD will improve the daily gain 
and weaning weights of nursing pigs. Implementing the 5-week 
BMD feeding program produces heavier pigs at weaning than 
feeding BMD only during lactation.
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In vitro susceptibility of porcine C. perfringens Type A isolates to tylosin in Czech Republic
Martina Masaříková; Jiří Smola
Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic
Introduction and objectives
Enteritis caused by the Clostridium perfringens Type A range 
among the most important piglets diseases in the Czech Repub-
lic. The causes underlying the spread of the infection are still un-
clear. Our hypotheses suppose a relation with the absence of the 
previously used antibiotic growth promoters, and a possible fall 
in sensitivity, alternatively an acquired resistance of the virulent 
isolates Clostridium perfringens to the antibiotics frequently used 
in therapy in pig herds. The aim of the study was to establish the 
MIC values of tylosin and to prove the emergence of resistance 
in the porcine Clostridium perfringens, isolated from piglets with 
enteritis. 
Material and Methods
The Clostridium perfringens isolates (280) were acquired in 2004-
2007 via cultivation of rectal swabs of piglets aged to 7 days 
with diarrhoea from 83 diff erent pig herds. The identifi cation of 
Clostridium perfringens was based on the demonstration of the 
species-specifi c gene (cpa) by PCR, another molecular genetic 
examination was performed to diff erentiate between Types A 
and C of Clostridium perfringens (1). Isolates of Clostridium per-
fringens Type A were selected as the basic set for further testing. 
The MICs of the tylosin (E. Lilly & Co., Elanco) were established 
using the agar dilution method according to CLSI M11-A5 
(2001), the interpretative criteria adopted from Prescott (2).
Results
In the year 2004, the largest group were susceptible isolates 
(43,9 %), followed with 38,2 % intermediate isolates, at least 
(17,9 %) were resistant isolates of Clostridium perfringens Type 
A. Next year get to signifi cant increasing (84,5 %) of susceptible 
isolates at the expense of isolates intermediate susceptible (3,4 
%) and resistant (12,1 %). In 2006 still predominated susceptible 
isolates (56,9 %), nevertheless others categories increased to ap-
proximately 20 %. In 2007, the largest group were continuously 
susceptible isolates (66,7 %), but resistant isolates increased too 
(25,9 %), see Graph 1. The assessment of the dynamics of the 
susceptibility and resistance of porcine Clostridium perfringens 
Type A isolates from the MIC90point of view shows resistance 
level to tylosin with the range from 8 to 16 mg.l-1, see Table 1.
Year n MIC50 MIC90 (mg.l -1 MIC distribution (mg.l-1
2004 123 1 8 0,125-≥16
2005 58 0,5 8 0,25-≥16
2006 72 0,5 16 0,125-≥16
2007 27 0,5 16 0,25-≥16
Discussion
Because of a lack of data on the susceptibility of Clostridium per-
fringens Type A isolates of porcine origin, we had to compare our 
results with the isolates obtained from poultry and dogs. For in-
stance in the USA was reported a few times lower MIC90of tylosin 
(2 mg.l-1) in chickens Clostridium perfringens isolates obtained 
from necrotic enteritis cases (3). MIC90of tylosin in Clostridium 
perfringens isolated from clinical cases of enteritis in dogs in USA 
was also lower, concretely 1 mg.l-1(4). MIC90of tylosin higher than 
those ascertained in our study have been published only in USA 
in Clostridium perfringens isolated from turkeys with necrotic 
enteritis (256 mg.l-1) (3). MICs of tylosin calculated in Belgium 
for poultry isolates of Clostridium perfringens ranged from 0.03 
μg.ml–1 to 1μg.ml-1, (5), while MIC values of our porcine isolates 
of Clostridium perfringens Type A in same year ranged from 0.125 
mg.l-1 to >16 mg.l-1. 
Conclusions
Obtained MIC90values (16 mg.l-1) of tylosin in isolates from 
newborn piglets are showing acquired resistance which is prob-
ably a result of frequent feed incorporation of the drug in swine. 
Furthermore acquired resistance had enabled to this subpopu-
lation of Clostridium perfringens to take selective advantage in 
intestinal microfl ora of gilts and saws fi rst in new born piglets.
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Clostridiosis in the farrowing room with an atypical onset: a clinical case 
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Introduction
Clostridia are large, gram-positive, spore forming rods. Clostrid-
ium perfringens type A and C are the most important species, 
producing toxins responsible of enteritis in pigs. Infection is 
transmitted from piglet to piglet and the sows are the most im-
portant source of infection (4). Antibiotics are used for therapy, 
in particular β-lactam antibiotics (2) and tylosin (3).
In this work the Authors describe a clostridial enteric disease in 
several suckling piglets (one-day old) occurred in a herd in the 
Northern Italy and characterized by an atypical onset. 
Materials and Methods
The clinical case took place between December 2008 and Janu-
ary 2009 with an increasing mortality rate in suckling piglets. 
Fourteen suckling piglets, belonging to a pig herd in Northern 
Italy and showing a syndrome characterized by death 12 hours 
after the onset of clinical signs, were submitted for necropsy to 
the Istituto Zooprofi lattico Sperimentale Lombardia and Emilia 
Romagna, Laboratory of Reggio Emilia. 
The intestinal contents and several organs were taken for micro-
biological cultures and histological examination. 
Histology was performed on formalin-fi xed paraffi  n-embedded 
tissue sections stained by Ematoxilin-Eosin and Gram methods. 
Genes for toxins α and β2 were detected, using a multiplex 
polymerase chain reaction method, from C.perfrigens isolated 
(see results) (2).
Toxicological investigations on sow feed were carried out to 
evaluate the presence of zearalenon, afl atoxins B1, B2, G1 and 
G2, ochratoxin A and fumonisin B1 and B2. 
Results
Clinical signs observed 24 hours after the birth in the suckling 
piglets, were characterized by jaundice, lethargy and diarrhoea. 
The death occurred during the 12 hours after the onset of clinic-
al signs. Gross lesions were characterized by necrosis of small in-
testine mucosa and liver degeneration with foci of parenchymal 
necrosis. Later, during the evolution of the clinical case, the dead 
piglets showed haemorrhagic-diarrhoea, intestinal hyperemia 
and mesenteric oedema, especially in jejunum and ileum. 
C.perfrigens was isolated from the small intestine of several 
piglets (1 x 107 ufc of C.perfrigens from each gram of intestinal 
content). Genes for toxins α and β2 were detected and the 
C.perfrigens isolated was genotyped as type A. Histological 
examination of samples collected during the necropsy showed 
vacuolar liver degeneration, necrotic enteritis and multiple 
gram-positive, spore-forming bacterial colonies in the lumen. 
The results of the toxicological investigations on sow feed 
showed values under the legislative about maximally allowed.
A drug-treatment against C.perfrigens, using a long acting 
macrolid on piglets in the fi rst 12 hours after the birth, led to a 
complete solution of the syndrome.   
Discussion
In this work the Authors described a syndrome characterized by 
death, 12 hours after the onset of clinical signs in the suckling pig-
lets. The syndrome did not appear to be related to dietary or any 
other specifi c management factor. The clinical signs of the disease, 
the gross lesions observed, the results of laboratory investigations 
and response to therapy suggested a diagnosis of clostridiosis 
due to a beta2 toxin-producing C.perfrigens type A strain.
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B. licheniformis for C. perfringens control in sows
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Introduction
Clostridium perfringens related scours is a form of diarrhea 
that aff ects young pigs and has been reported worldwide. The 
objective of this study was to determine the eff ectiveness of Ba-
cillus licheniformis (Chr Hansen strain) in reducing the shedding 
of Clostridium perfringens in sows and the resulting Clostridium 
perfringens related scours in baby pigs. 
Materials and Methods
The trial was conducted in the fall of 2009 in a 5,000 sow com-
mercial farrow to wean operation using PIC genetics and Akey 
nutrition. (Lewisburg, Ohio, USA) The sow farm had 2 separ-
ate gestation barns, and 1 farrowing building comprised of 16 
rooms of 64 farrowing crates each. The gestation barns had sep-
arate dedicated feed lines, 2 separate feed systems run through 
the farrowing facilities.
The entire herd was split into one of two groups. The groups of 
gestating sows were placed either on a standard control diet or 
on a standard diet containing B. licheniformis (1.6E+6 cfu/gram 
of feed). The sows were maintained on these diets throughout 
gestation. Once the sows entered the farrowing facilities, the 
groups maintained their integrity with the control sows being 
placed on a control farrowing and lactation diet. The sows that 
had received B. licheniformis in gestation continued to receive 
B. licheniformis (1.6E+6 cfu / gram of feed) in the farrowing and 
lactation diet. Both the control diet and B. licheniformis diets 
where identical with the exception of the B. licheniformis being 
added to the treatment diet.  
A total of 12 sows from each of the two groups were randomly 
selected for fecal sample collection Fecal samples were taken 
directly from the rectum of the sow and analyzed at the Iowa 
State University Veterinary Diagnostic Laboratory (Ames, Iowa, 
USA) to determine C. perfringens type and count. Samples were 
collected in gestation (approximately 38 days pre-farrowing and 
before the treatment group was placed on B. licheniformis), as 
sows were moved to farrowing (average 4.5 days pre farrow) 
and then again in lactation (average 2.5 days post farrow). In 
addition, feed samples where collected throughout the trial to 
determine the presence and level of B. licheniformis in the feed. 
At approximately 15 days of age, fecal samples were collected 
from at least 1 pig from each sow (both control and treated) to 
determine the presence of B. licheniformis in the pigs.
All samples were stored at -34 °C until shipment to the ISU VDL. 
Samples were shipped overnight, on dry ice, in insulted contain-
ers and placed at -70 °C upon arrival at the ISU VDL. Samples 
were thawed at room temperature; each sample was well mixed 
and immediately diluted for the standard plate count proced-
ure (Quinn et al. 1994). Any isolates with typical colony mor-
phology and double zone of hemolysis were gram stained for 
confi rmation as large gram positive rods. These were recorded 
as C. perfringens. Twenty four of the isolates were submitted for 
Genotyping by the “Multiplex polymerase chain reaction assay 
for genotyping C. perfringens (Meer and Songer 1997). 
Results
In gestation - treated sows (B. licheniformis) started with 5.6 
times more clostridium type A than the control group (7.7E+5 vs 
1.4E+5). NS 
In farrowing - treated sows had 1.3 times more clostridium 
(7.8E+5 vs. 6.0E+5). Treated sows increased their count from 
gestation at a rate that was 97% slower than that of the control 
group. 
P ≤ 0.05
In lactation - the treated sows had 49% the level of clostridium 
as the control sows (4.6E+6 vs. 9.2E+6). 
The treated sows increased in clostridium counts from Farrow-
ing to lactation at a rate that was 55% slower than that of the 
control. NS 
The rate of increase in clostridium in the fecal samples from ges-
tation to lactation grew in the treated group at a rate that was 
57% slower than that of that in the control group. P ≤ 0.05
All sampled pigs in the treated group had detectable B. licheni-
formis in their faeces compared to the control group pigs which 
had no detectable B. licheniformis. 
Discussion
In summary the results show that B. licheniformis has the ability 
to reduce shedding of C. perfringens in sows which could lead 
to a reduction in C. perfringens related scours in baby pigs. In 
addition, when fed to sows in lactation, B. licheniformis can be 
found in the faeces of pigs nursing treated sows.
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In Vitro Susceptibility of Tiamulin in Czech Isolates of Clostridium perfringens Type A
Martina Masaříková; Jiří Smola
Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic
Introduction and objectives
Neonatal enteritis in suckling piglets caused by Clostridium 
perfringens Type A is an important factor infl uencing economic 
effi  ciency of pig operations in the Czech Republic. Because Type 
A Clostridium perfringens is commonly present in swine intestinal 
content, it often becomes the unintentional target of peroral 
antimicrobial at the time of therapeutic interventions. One of 
antimicrobial substances that is very often used in pig herds to 
control swine dysentery and therefore could, in our opinion, 
infl uence susceptibility in Clostridium perfringens, is tiamulin. 
The aim of the study was to determine the minimal inhibitory 
concentration (MIC) of tiamulin in Clostridium perfringens Type A 
isolates from suckling piglets with diarrhoea between 2001 and 
2004.
Material and Methods
The set tested for susceptibility and resistance to tiamulin 
consisted of 213 Clostridium perfringens Type A isolates obtained 
from cases of diarrhoea in piglets under 7 days of age. The 
samples were taken at 83 diff erent farms. The tiamulin (Novartis 
AG) MICs were determined using the agar dilution method with 
blood Wilkins-Chalgren agar in accordance with CLSI recom-
mendations (1). As no interpretative criteria for the evaluation 
of MICs of Clostridium perfringens isolates to tiamulin have been 
defi ned yet, we have adopted criteria intended for porcine iso-
lates of Brachyspira hyodysenteriae (2).
Results
2001: MICs to tiamulin obtained in 30 selected Clostridium 
perfringens Type A isolates ranged from 2 to >32 mg.l-1. Suscept-
ibility and intermediate susceptibility were demonstrated in 14 
(46.7 %) of the isolates, 2 (6. 6 %) isolates were resistant. 
2002: MICs in 30 Clostridium perfringens Type A isolates ranged 
from 4 to >32 mg.l-1. Susceptibility was demonstrated in 4 
isolates (13.3 %), intermediate susceptibility in 9 (30.0 %) and 
resistance in 17 (56.7 %) isolates. 
2003: MICs range in 30 isolates was the same as in the year 2002. 
Susceptibility and resistance was demonstrated in 6 (20.0 %) 
isolates, intermediate susceptibility in 18 (60.0 %) isolates. 
2004: Susceptibility was found in 36 (29.2 %) isolates, resistance 
in 5 (4.1 %) isolates. The MIC values ascertained in most of the 
isolates 82 (966.7 %) were those corresponding to intermediate 
susceptibility; see Graph 1 and Table 1.
Discussion
Regardless of situation when tiamulin isn’t registered for treat-
ment of clostridial enteritis in piglets, were MIC90 surprisingly 
high (16 - >32 mg.l-1) in monitored period, in comparison with 
data obtained in Canada (MIC90 1 mg.l-1) (3). We believe that 
this unfavourable development was connected with intensive 
medication of pigs with tiamulin in breeding herds aff ected 
with swine dysentery (SD), because a gradual growth in tiamulin 
MICs was also observed in Brachyspira hyodysenteriae isolates 
in the same time (4). Also the decrease in MICs of tiamulin in 
subsequent years is probably due to the decrease in the use of 
tiamulin, because of clinical resistance of Brachyspira hyodysente-
riae at the period of treatment.
Conclusions
Based on the results of our study, we may assume a close rela-
tionship between bacteria forming part of intestinal microfl ora 
with respect to the establishment and development of resist-
ance to antimicrobials frequently applied in feed or in water. 
Even though tiamulin has not been employed in the therapy 
of enteric infections, isolates keep unexpected high value of 
resistance. Possible explanation for fi ndings sowing increasing 
MICs can consists in frequent use of tiamulin in the therapy of 
swine dysentery. Furthermore this fi ndings corresponds with 
decreased sensitivity of Brachyspira hyodysenteriae isolates in the 
same time.
2001
(n=30)
2002
(n=30)
2003
(n=30)
2004
(n=123)
MIC50 (mg.l
-1) 8 32 16 8
MIC90 (mg.l
-1) 16 >32 32 16
MICs range (mg.l-1) 2->32 4->32 4->32 <0,5-32
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Treatment with diclazuril 1,5% in a farm swine with history of isospora suis: 
eﬀ ect on the daily weight, diarrhea and mortality, from birth-weaning
Ismael M. Dolso; Gabriel Di Cola; Mercedes Vazquez; Silvia Romanini; Judhit Bertone
Universidad Nacional de Río Cuarto, Río Cuarto, Argentina
Introduction
Isospora suis is the causative agent of the swine neonatal coc-
cidiosis (1). The disease usually occurs during the second week 
of life and is characterized by the development of diarrhea, 
dehydration and loss of body condition (2, 3, 4). The study aimed 
to assess the eff ectiveness of the diclazuril on a pig farm with a 
history of Isospora suis and its eff ect on the daily gain weight, 
diarrhea and mortality from birth to weaning.
Materials and Methods
The experience was on a farm in 500 mothers, located south of 
the province of Córdoba, Argentina, with a history of Isospora 
since 2007. During three weeks of deliveries are weekly formed 
two groups of piglets, selected at random, belonging to 23 
mothers each group. A total of 517 piglets at 256 (49.51 %) is 
given by mouth, 1 cm3 of saline (group Control C). To 261 (50,49 
%) is given 2 cm3 1.5 %, (Group Treaty D) Diclazuril . Both treat-
ments were on the second day of life. All animals were heavy in-
dividually to the 1st, 7th, 14th and weaning at 19 days. Recorded 
the number of animals presented diarrhea and those who died 
with or without diarrhea.. All data were analysed and processed 
by the statistical programme SPPS.
Results
See the results in Table 1 and 2.
Discussion
Table 1 shows that animals treated with Diclazuril 1.5 % on the 
second day of life, obtained a better daily weight, while Table 2 
noted that it was eff ective to prevent the occurrence of diarrhea 
caused by Isospora suis, as well to reduce mortality.
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Table 1: Results of the study phase
Control Diclazuril
Births Live 256 261
Births Dead 9 9
Deliveries 23 23
Births Live/sow 11,13 11,34
Births Dead /sow 0.39 0.39
Births Totals /sow 11.52 11.73
Weaned 233 248
Average 10,13 10,78
Slaughtered 6 6
Dead 17 7
% Mortality 6,64 2.68
Quantity animals with diarrhea 13 2
Weight Average at birth (kg) 1,3474 1.29
Weight Average 7 days (kg) 2,226 2,295
Weight Average 14 days ((kg) 3,7546 3,8819
Weight Average to weaning (kg) 5,0126 5,3145
Gain daily average (kg) 0,1957 0,2133 *
Minimum daily gain (kg) 0.10 0.09
Maximum Daily gain (kg) 0.33 0.32
Off set Standat 0,03647 0,04726
Variance 0.001 0.002
* p <0.001
Table 2
Group Control Diclazuril
Weaned 233 248
Average 10,13 10,78
Quantity animals with diarrhea 13 2*
Quantity of dead pigs 17 7
% Mortality 6,64 2,68*
* P <0.005
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Eﬀ ect of diclazuril 1.5% on the uniformity of the litter to the 
weaning in a farm with Isospora suis antecedents
Ismael M. Dolso; Gabriel Di Cola; Mercedes Vazquez; Judhit Bertone; Silvia Romanini
Universidad Nacional de Río Cuarto, Río Cuarto, Argentina
Introduction
Isosporosis in piglets, caused by coccidium Isospora suis, is 
recognised as a disease having a signifi canrt negative impact 
on the pig industry, not as a cause of high mortality, but by 
reducing productivity and eroding the economic returns to 
pig producers (1). Piglet coccidiosis has been associated with 
descreased nutrient absorption, impaired immunocompetence, 
incresead susceptibility to secundary bacterial infeccion, uneven 
weigt gains and uneven litters at weaning (2,3).
The training target was to evaluate the eff ect of Diclazuril 1.5%, 
in a pig farm with antecedents of Isospora suis on the uniformity 
of the litter to the weaning.
Materials and Methods
The experience was realised in a farm of 500 mothers, located 
to the south of the province of Cordoba (Argentina), with 
antecedents of Isospora from year 2007. During three weeks of 
childbirths two groups of pigs, selected at random, pertaining to 
23 mothers were satisfi ed weekly each group. Of a total of 517 
pigs, to 256 (49,51%) it was administered to them by oral route, 
1cm3 of saline solution, (Group Control C). To 261 (50.49%) 2cm3 
of Diclazuril 1.5% was administered to them, (Treated Group D). 
Both treatments were realised to the second day of life. All the 
animal were heavy in individual form to the day of birth, and the 
19 days, age of weaning. All the data were analyzed and process 
by statistical program SPPS. 
Results
Table 1 shows the animal birth weight distribution.
Table 1: Distribution the weight at birth.
The birth weight Control Diclazuril
Grams % %
<800 3,13 2,68
801-1000 9,38 11,49
1001-1200 16,41 21,07
1201-1400 28,52 33,72
1401-1600 23,83 19,16
1601- 1800 12,50 9,20
>1801 6,25 2,68
N 256 261
Average Kg 1,347* 1,290
Minimun Kg 0,52 0,65
Maximum Kg 2,26 1,95
Desv. typically 0,29339 0,25074
Variance 0,086 0,063
The Group C, 71,09 % of animals were over 1200 grams, while in 
Group D, 64,75 % of the animals only achieved this weight to its 
time, the diff erence between the average weight at birth, were 
138 grams heavier Group C (* p < 0,01).
In Table 2 shows the animals at weaning weight distribution. 
Table 2: Distribution the weights of the animals at weaning.
Weight to the weaning Control Diclazuril
Grams % %
<3000 3,86 2,42
2001-400 10,73 10,48
4001-4500 11,16 11,29
4501-5000 19,31 12,10
5001-5500 28,76 16,53
5501-6000 15,45 18,95
>6000 10,73 28,23
N 233 248
Average Kg 5,012 5,314 *
Minimun Kg 2,44 2,38 
Maximum Kg 8,03 8,36 
Desv. typically 0,93753 1,12225
Variance 0,879 1,259
The Group C, 26,18 % of animals were in excess of 5, 501 kg 
While in Group D, 63,71 % of the animals they achieved this 
weight to its time, the diff erence between the average weights 
at weaning, were 302 grams heavier Group D (* p <) (0.01 ). 
Conclusion
One demonstrated that the animal of group D, that although 
they were lighter when being born, when applying Diclazuril 
1.5% to the second day of life, were but heavy to the wean-
ing and the litter but uniform it was compared with the group 
nontreated.
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Age, not infection dose, determines the outcome of Isospora suis infections in suckling piglets
Hans-Christian Mundt1 Hanna L. Worliczek2 Soelen Siemers2 Anja Joachim2
1. Bayer Animal Health GmbH, Monheim, Germany; 2. Institute of Parasitology and Zoology, 
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Introduction
In the fi eld, clinical presentations of neonatal isosporosis range 
from subclinical infection with oocyst excretion to excessive wat-
ery diarrhea with exsiccosis and unthriftiness within the same 
litter. Several publications on a small set of animals indicate that 
age is more important for the clinical outcome of isosporosis 
than the infection dose (Meyer et al., 1999; Martineau and de 
Castillo, 2000; Mundt et al., 2003). In this evaluation a larger data 
set from experimental studies under highly standardized condi-
tions was analysed retrospectively.
Materials and Methods
Data from 13 trials involving 124 suckling piglets experiment-
ally infected with Isospora suis were evaluated for the eff ects of 
infection dose and age at infection on the clinical and parasito-
logical outcome of infection in four diff erent models. Infec-
tions were carried out with single oral inoculations of diff erent 
numbers of sporulated oocysts of I. suis per animal at diff erent 
ages (days of life, d.o.l.): model 1: 1000 oocysts on the 1st d.o.l (9 
piglets from 3 litters); model 2: 1000 oocysts on the 4th d.o.l (25 
piglets from 11 litters); model 3: 1500 oocysts on the 4th d.o.l. 
(40 piglets from 20 litters); model 4: 10,000 oocysts on the 4th 
d.o.l (50 animals from 10 litters). Weights were determined on 
the day of birth and in weekly intervals. Faecal consistency and 
quantitative oocysts excretion were evaluated for 2 weeks start-
ing 4 days after infection (d.p.i.) as described (Mundt et al., 2006).
Results
Piglets showed typical weight depression in the second week 
of life during the acute phase of infection. This eff ect was most 
noticeable in model 1 (infection on the fi rst d.o.l.) where animals 
only gained 2.08x their birth weight until the 22nd d.o.l., com-
pared to 2.31 (model 2), 2.52 (model 3) and 2.38 (model 4) x the 
birth weight in the other groups.
This correlated with the occurrence of watery diarrhoea which 
was found in 37 % of the samples in the acute phase (4-11 d.p.i.) 
in model 2 but only 12-20 % of the samples in the other models. 
Oocyst excretion prevalences showed the earliest peak 5 d.p.i. in 
the group with the highest dose and the highest peak (100 % for 
2 days) in the group infected on the fi rst day of life. The aver-
age excretion days 5-11 d.p.i. were 41.3 % (mean OPG: 9189) in 
model 1, 30.0 % (mean OPG: 8545) in model 2, 39.5 % in model 3 
(mean OPG: 3143), and 75.2 % (mean OPG: 26 841) in model 4. 
Median oocyst excretion peaked earlier in the models with 
higher infection doses but reached the highest values in model 
1 (early infection).
Discussion
As in previous studies, this cross-sectional analysis of a larger 
number of animals confi rms the infl uence of age on the out-
come of isosporosis in suckling piglets, stressing the need to 
control the infection at an early life phase.
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Impact of piglet coccidiosis on the gut health and economic beneﬁ ts of the prevention with toltrazuril
Abdulkerim Deniz; Veerle Hamaekers
Bayer Animal Health, Monheim, Germany
Introduction
Piglet coccidiosis is a parasitic disease mostly aff ecting young 
and suckling piglets in the farrowing pens. The responsible 
agent is Isospora suis which is very reproductive protozoa 
with a prepatent period of 4- 6 days. It causes pasty yellowish 
diarrhoea, but it can also occur subclinically without any sing 
of disease. Isoporosis is prevalent around 74 % in German, 76% 
in Belgium, 79% in Greek and Austrian, 90% in Polish, 56% in 
French (1), 75% in Japanese (2) and 70 % in Canadian pig farms 
(3). Coccidiosis in suckling piglet is of economic importance due 
to retarded growth (4,5).
Impact of isosporosis on gut health
I. suis may cause fi brinous enteritis which mainly aff ects the mid-
dle and posterior part of the jejunum; villous necrosis and atro-
phy are frequently described (6). Serious damages on the villious 
and gut mucosa due to coccidiosis in pigs were already detected 
by diff erent scientists (6, 7). Coccidiosis can run concomitantly 
with Clostridium perfringens, E. coli, Rota virus, Adeno virus 
and salmonellosis (8). Primarily coccidiosis is also predisposing 
factor for the contaminant diseases. Typically the disease causes 
signifi cant weight gain decrease at weaning and also its impact 
can result in prolonged production period (slaughter age) up 
to 9 additional days and in high postweaning FCR (9, 10). This 
may be seen as primary reason why the piglets have frequently 
bacterial infections during the course of coccidiosis (10). A 
mixed infection of Clostridium perfringens and I. suis caused a 
mortality rate of 12,1 % in the fi rst week of life and 16,2 % up 
to weaning in Germany (8). This mortality rate due to mixed 
infection was reduced by 71% in the fi rst week of life and 64% 
up to weaning by preventative treatment of 3 days old pigs with 
toltrazuril 5 % suspension (Baycox). Prevention from the primary 
destructive aff ect of I. suis on the gut health with early toltrazuril 
treatment resulted in signifi cantly reduced mortality. Similarly 
in an experimental study (11) the same results were reproduced. 
Earlier coccidiosis episode predisposed pigs for postweaning 
Lawsonia infections which has been detected serologically in 
untreated pigs aged 21 to 105 days and resulted in higher FCR 
(10). However, not all treatment options give optimal results as 
reported by Mundt et al. 2007 (7). Sulphadimidine, diclazuril and 
toltrazuril (20 mg/kg one shot) were used to control isospor-
osis in suckling piglets, but none of the treatments other than 
toltrazuril were able to protect gut mucosa and to prevent from 
weight loss.
Economic benefi ts of the prevention
Even in subclinical coccidiosis the weight gain of pigs can be 
aff ected signifi cantly (5). Under subclinical coccidiosis pressure 
the preventative treatment with toltrazuril (Baycox 5%) resulted 
in €0,23 net profi t per piglet at weaning. Similarly, Scala et al. 
2009 (4) also stated that the early preventative treatment with 
toltrazuril in italian pig farm provides better returns (€10,64) 
than sulphonamide and trimetoprim combination (€8,57) and 
untreated control group (€9,72) based on the weight at wean-
ing day 28. Not doing preventative measurements against 
coccidiosis has prolonged the feeding time by around 12 days 
(9). This statement has also been supported by McOrist et al. 
2009 (10). The FCR of toltrazuril treated pigs between ages 21 
to 105 was 10% signifi cantly less than untreated pigs. Based on 
the increase of weaning weight (647 g) and including handling 
and treatment cost, Sepulveda et al. in 2008 (12) calculated a 
surplus of €1,09 for the troltrazuril treated pigs at weaning. The 
increase of weight gain up to weaning via toltrazuril preven-
tion is presented in fi gure 1. Prevention from coccidiosis at early 
ages can also reduce the frequency of antibiotic treatments up 
to weaning by around 88% (13), this can be explained by the 
improvement of gut health due maintenance of gut mucosa 
integrity and low diarrhoea incidence in those pigs treated with 
toltrazuril.
Conclusion
Isosporosis in suckling piglets has life long aff ects and should 
not be underestimated because it has economic impacts on pro-
duction parameters and can cause loss of profi t in pig rearing.
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Evaluation of eﬃ  cacy of oral toltrazuril (Baycox 5 %®) for the improvement 
of post-weaning gut health in pigs in Romania
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Introduction
Isospora suis disease often occurs around the second week of 
life, through to the normal pig weaning age of 3-weeks-old. It 
is characterized by yellowish pasty diarrhoea for one to several 
days. Oocysts can survive outside the pig, in the farrowing area, 
for many months. The time for intervention in piglets with a con-
trol strategy is critical; use of a preventive drug usually take place 
at 3 to 4 days of age so that it can kill appropriate stages of the 
parasite within newly infected piglets. In the European Union, 
the symmetrical triazintrione toltrazuril is the only coccidiocidal 
registered (since 2002) specifi cally for the control of porcine 
neonatal coccidiosis in a single oral dose format of 20mg per kg 
bodyweight. Clinical studies of toltrazuril after weaning have not 
been comprehensive - pigs are only considered to show limited 
compensatory growth. The exact reasons for this are not clear, 
but could include intestinal maturity and enzymatic activity and 
susceptibility to further post-weaning infectious agents. The aim 
of this on-farm study was to evaluate the effi  cacy of toltrazuril 
(Baycox® 5% oral suspension) for the improvement of gut health 
in a large-scale grower-fi nisher pig herd. 
Methods
Four-day-old matched piglets either received toltrazuril (Green, 
n=2,870) or placebo (Blue, n=2,812) via blinded colour-coded 
medications. The subsequent diarrhoea scores, growth perform-
ance, gut health and entero-pathogen load in each group was 
monitored by blinded observations, feed and pig weighing, 
faecal PCR tests for Brachyspira and Lawsonia and PCV2, culture 
for coliforms and Clostridia, as well as Lawsonia immunofl uor-
escence assay serology. Observations were made daily and 
measurements collected weekly from day 21 up to day 150 in 
the grower-fi nisher stage of farming. 
Results
There was a signifi cant drop in oocyst count in piglets around 
weaning in the Baycox™ treated group (p<0.01). There was mark-
edly improved feed conversion in treated weaner-fi nisher pigs 
(2.41 cf. 2.63). Weight gains were consistently and signifi cantly 
better through to day 150, see chart. Lawsonia serology results 
indicated a late (between day 84 and 105) and moderate on-
farm exposure, which was more severe in non-treated pigs.
Discussion
These results confi rm the protective eff ect of toltrazuril (Baycox™) 
for coccidiosis prior to weaning and demonstrate specifi c benefi -
cial eff ects on gut health and feed conversion after weaning. We 
also found that post-weaning enteric diseases including ileitis 
were more severe in pigs untreated for coccidiosis. 
We therefore suggest there are two main reasons why the 
lifetime eff ects of small weaning weight and peri-weaning 
infections of coccidia are so important and detrimental. First, 
there is an innate anatomical issue in that smaller, gut-damaged 
piglets being weaned with a limited supply of mature villi units, 
will grow more slowly and second, there is the likelihood that 
pre-weaning infections can carry forward into an increased 
number of post-weaning infections such as ETEC, Lawsonia and 
Brachyspira. 
In the past 5 years, novel and eff ective preventive programs 
for Lawsonia and Isospora been introduced, related to an oral 
live attenuated vaccine and the oral anti-coccidial medication 
toltrazuril (Baycox™), respectively. Unlike coccidiosis in chickens, 
no major vaccines have been identifi ed for coccidiosis in pigs. 
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Prevalence of Coccidia in piglets in Poland in years 2003-2009
Jacek Karamon; Zygmunt Pejsak
Nat. Vet. Res. Inst in Pulawy, Pulawy, Poland
Introduction
Coccidiosis caused by Isospora suis and Eimeria spp. is one of 
the common diarrhoeal diseases of piglets, occurring in all coun-
tries with intensive swine production. The fi rst clinical symptoms 
of this disease appear between 9 and 15 days of piglet life. The 
faeces are pasty at the beginning, and what is typical diarrhoeic 
piglets do not respond to antibiotics. The diagnosis is usually 
made by detecting of oocysts in faeces of the aff ected pigs. 
The reports about prevalence of piglet coccidiosis caused by I. 
suis demonstrate a high farm prevalence of the disease (45%-to 
90%).
The objective of this study was to summarize results of routine 
diagnosis for piglet coccidiosis performed in our laboratory dur-
ing the period from 2003 -2009.
Material and Methods
The study was carried out between 2003 and 2009, in 14 out of 
16 Polish provinces. Faecal samples were taken from 2-3 weeks 
piglets from 3 types of farms: large (>100 sows), medium (25 to 
100 sows) and small (<25 sows). In mentioned farms diarrhoea 
of suckling piglets at the age 8-15 days were observed in all of 
the examined herds, the antibiotic treatment of sick piglets gave 
non satisfactory results. Overall, 966 litters of suckling piglets 
from 132 farms and 273 mother sows, during mentioned above 
period, were examined. Faecal samples of 5 to 28-day-old piglets 
were collected directly from the rectum. Samples were taken 
from 3 to 5 piglets per litter and pooled. 5–10% of litters from 
each farm were investigated. The faeces were analyzed with the 
fl otation method. The saturated NaCl solution sugar enriched 
was used. The samples were examined at 100x-400x magnifi ca-
tion. Samples were mixed with 2.5% potassium dichromate 
solution and stored on Petri dishes at 25oC in order to induce 
the sporulation if unsporulated oocysts were present. The spe-
cies of coccidia were defi ned based on oocysts morphology and 
sporulation time.
Results and Discussion
Overall, I. suis infection was found in 286 litters of suckling pig-
lets (29.6%) from 88 farms (66.7%). The coccidia of Eimeria genus 
(E. debliecki, E. polita, E. suis) were detected in only 23 litters 
(2.4%) from 13 farms (9.8%). 
Comparison of the results from diff erent years indicated that 
percentage of positive farms in diff erent periods was similar. In 
any period percentage of I. suis did not exceed 74% (2005) and 
never was lower than 58% (2008).
Tab. 1. Prevalence of Coccidia in suckling piglets on diff erent types of 
Polish farms
Types of farms 
(no. of sows on 
farm)
% of farms infected 
with coccidia
% of litters infected 
with coccidia
I. suis Eimeria I. suis Eimeria
Large (>100) 91.1 6.3 33.3 1.1
Medium (25-100) 51.2 4.9 19.1 2.0
Small (<25) 27.3 54.5 13.2 28.9
Total 66.7 9.8 29.6 2.4
As shown in Tab. 1. in the large farms I. suis infection was de-
tected the most often (91,1% of farms, 33.3% of litters), whereas 
in the small farms frequency of this infection was found to be 
twice as rare. The situation with Eimeria spp. was just the oppos-
ite - for the large and medium sized farms Eimeria spp. oocysts 
were very uncommon, while on the small farms these infections 
were found in as many as 54.5% of farms, 28.9% litters. Similar 
results confi rming a higher occurrence of I. suis in large farms 
than in smaller ones were obtained in Nordic countries (1).
The examination of faecal samples collected from sows (mothers 
of examined piglets), yielded the following results: I. suis oocysts 
were found in 19 sows (7%) and Eimeria spp. (E. debliecki. E. 
polita, E. perminuta, E. suis, E. scabra) in 18 sows (6.6%). From 73 
sows delivering I. suis infected piglets just in 12 sows (16.4%) I. 
suis oocysts and in as little as 4 (5.4%) Eimeria spp. oocysts were 
found. In the remaining 56 sows (78%) no cases of coccidian 
infections were detected. Small number of sows excreting coc-
cidian oocysts and a lack of correlation between the presence of 
oocysts in the sows, and the I. suis infected piglets were demon-
strated also by other authors (2, 3)
Study concerning coccidiosis in piglets carried out during last 
7 years proved that I. suis and Eimeria spp. were quite common 
in piglets 2 – 3 weeks of age in all sizes of farms. It might be also 
stated that those intracellular parasitic species play an important 
role as a cause of diarrhoea in suckling piglets. The level of coc-
cidia infections seems to be stable during evaluated period.
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Prevalence of isosporidial infection in piglets with clininical signs of enteropathy
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Scientifi c Veterinary Institute of Serbia , Belgrade, Serbia
Introduction
The disease caused by coccidia Isospora suis has been de-
scribed as an important cause of suckling piglet diarrhea and 
reported from all types of farrowing facilities and under all types 
of management systems (2, 3). The developmental stages of 
Isospora suis occur both inside the host animal and outside, in 
the external environment. The target organ of this parasite is 
the small intestine, where it undergoes development within the 
mucosal tissue. Isospora suis can infect pigs of any age, but only 
causes clinical signs in piglets, usually those between the ages of 
7 and 14 days. Older pigs act as carriers. The sow plays a minor or 
nonexistent role in the transmission of Isospora suis. 
Depending on the rate of infection, the disease complexes can 
range from sub clinical infections to infections that include 
severe intestinal problems with severe lesions in the gastrointes-
tinal tract that can result in high mortality and/or a negative 
impact on the factors of production (2, 4). At same time, those 
parasites play important role at complex of neonatal entherop-
athy of piglets, spread together with other infectious agents (1, 
3). 
In this study we aimed to investigate about presence of Isospora 
suis prevalence in farm-farrowing conditions.
Materials and Methods
During 2007-2009 a total of 428 pigs, 2 days -21 weeks old, were 
exanimate in the laboratory of Scientifi c Veterinary Institute of 
Serbia. All of the examined pigs were sings of diarrhea. After 
routine necropsy, to parasitological examination we used faecal 
swab, gut contents and a mucous scrape of gut which we 
examined with Sheather’s sugar fl otation and in direct smears 
stained with Gimsa strain and Ziehl-Neelsen stain and examined 
by use of light microscopy. In addition section of jejunum, ileum 
and spiral colon from each pig were fi xed in natural buff ered 
10% formal in, embedded in paraffi  n, sectioned at 6 micrometer, 
stained with hematoxylin and eosin and examined by use of the 
light microscopy. At same time we examined 979 samples of 
faeces originated from various product categories (fating pigs, 
sows, board) a coprological examination was done within 24 
hours after sampling using fl otation method in Sheather’s sugar 
solution. 
Results and Discussion
The occurrence of Isospora suis was found to be highest in pig-
lets at the age of 7–15days. Isosporosis prevalence in piglets was 
highest on the second week of piglet age (32.8%) with the high-
est prevalence value on day 13 of piglet age (44.3%) In infected 
piglets the presence of I. suis was detected most frequently in 
connection with watery diarrheas (37.4%) and least frequently 
in piglets with shaped faeces (15.0%). In piglet with watery diar-
rheas only very weak isosporous infections were usually found, 
together with other enteropathogenic agents of bacterial or 
viral etiology contributed to the origin of diarrheas (like E.coli, 
C.perfrigens tip C rotaviruses, and etc.) in parallel infections in 
piglets to a large extent.
Reports on the presence, prevalence and epidemiology of 
Isospora suis have come from virtually every country in the 
world (4). Studies conducted in most countries have shown a 
high prevalence of the disease on farms (18-85%). Results of our 
examination are at similar range Reports on the highest occur-
rence of Isospora suis in relation to piglet age vary. The highest 
prevalence of isosporosis was reported most frequently at the 
piglet age of two in some cases also third week of life. During 
our examination most prevalence are fi nd at 13 days of piglet 
age. In our study we found sig¬nifi cant correlation between 
isosporosis and wa¬tery diarrhoeas because the highest iso-
sporosis prevalence was demonstrated in piglets with watery 
diarrhoeas. 
We found out total isosporosis prevalence 27.4% mostly in a lit-
ter housing system; these re¬sults document that in our condi-
tions there are not any signifi cant diff erences in the prevalence 
and time of occurrence of Isospora suis between diff er¬ent 
housing systems and time periods compared to the results 
obtained in a litterless system of piglet housing.
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Introduction
Piglet coccidiosis due to infection with Isospora suis is controlled 
by, among other measures, a single oral treatment with Baycox® 
5% suspension in the fi rst few days of life. The product was in-
vented and developed specifi cally for this purpose. Almost two 
decades of experience and expertise in epidemiology and con-
trol demonstrate that both coccidial infections and infections 
due to C. perfringens on problem farms are reliably controlled 
(Mundt et al., 2007; Mundt and Daugschies, 2007; Mundt et al., 
2008). Generic formulations containing toltrazuril have appeared 
in some countries since 2002. Their pharmaceutical parameters 
were analyzed and compared with the reference product (ap-
proved specifi cation of the pioneer formulation). The impact on 
practical clinical use is discussed.
Materials and Methods
A total of 108 generic formulations and/or diff erent batches 
were analyzed for their chemical, physical and microbiological 
properties. Investigations were carried out with HPLC (quantity 
of toltrazuril, impurities and by-products, preservatives), GC, 
analysis of color, density, sedimentation behavior, redispersibil-
ity, particle size (microscopy and measurement of particles and 
crystals), pH, microbiological status. In total, 10 to 15 analyses 
were conducted per sample. All methods were compliant with 
FDA, GMP and 21 CRF Part 11 requirements. Stability testing 
was performed at various temperatures in compliance with the 
most recent VICH guidelines in a GMP and cGMP environment. 
The clinical impact was additionally assessed in pharmacokinetic 
studies carried out by way of example with some formulations in 
piglets (comparison with the pioneer formulation).
Results
All the formulations tested were found to deviate from the 
specifi cation for the pioneer formulation. There were diff erences 
in terms of the active ingredient (impurities, content of methyl-
toltrazuril etc.), type and content of preservatives, particle size 
and distribution (some particles up to 300 μm, Figure 1), sedi-
mentation behavior, redispersibility among others. The diff er-
ences were confi rmed by the pharmacokinetic behavior of the 
products (Cmax, AUC).
Figure 1: Particle size of toltrazuril in pioneer (left; <10 μm) and gen-
eric (right) formulation
Discussion
The studies showed diff erences, some of them considerable, 
between the pharmaceutical quality of the generic formula-
tions tested and Baycox®. Their impact in terms of bioavailability, 
bioequivalence, effi  cacy, safety/tolerability, withdrawal time, 
convenience and cost-benefi t is discussed.
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Introduction
Isospora suis is the causal agent of coccidiosis, a frequent digest-
ive disease usually noted in 5 to 14 days old piglets. The disease 
is characterized by diarrhoea and growth retardation but no (or 
a few) mortality unless after secondary bacterial infection. It has 
a strong economical impact for the farmer and even more if the 
aetiology remains unknown, causing loss of time and money 
using antibiotics that will be ineff ective as the pathogen is a 
parasite. The objective of this work was to determine the preva-
lence of Isospora suis and the incidence of litters aff ected in pig 
farms of the South of Belgium - Wallonia. Epidemiological data 
were collected in each farm and compared (Table 1) to those 
reported in a previous study (Leten and al., 2002) performed in 
the North of Belgium - Flanders.
Materials and Methods
Faeces of three to fi ve 10-18 day old piglets per litter were col-
lected in 58 at random selected pig farms where 10 litters were 
available and no toltrazuril treatment (Baycox® 50 mg/ml, Bayer) 
was administered. Processing of faeces (1g per sample) was per-
formed using 7 ml of a saturated NaCl solution with 500g added 
glucose per litre (Henriksen and Christensen, 1992). An optical 
microscope 10 x 40 was used to detect oocysts. A positive diag-
nosis for a farm (F) or for a litter (L) was recorded when at least 
one (sporulated or not) oocyst was present. 
Possible relation between clinical signs (diarrhoea), cleaning and 
disinfection of the farrowing crate and the presence of I. suis or 
the percentage of infected litters were tested using ˚C2 test.
Results
Table 1 presents and compares results (NS not signifi cant) 
obtained in Wallonia and previously in Flanders (Leten and al., 
2002).
Table 1
 Flanders Wallonia
Year of faeces sampling 2000 2006-2007
Number of farms 30 58
Herd size (n sows) 100-450 20-250 (ñ=90)
Positivity criteria sporulated sporulated or not
Method of diagnostic Telemann modifi ed Henriksen
Positive farms F (%) 80 69
Positive litters L/F (%) 33 37
Relation diarrhoea-F or L NS NS
Cleaning crate eff ect on F or L NS NS
Disinfecting crate eff ect on F NS NS
Disinfecting crate eff ect on L p<0.005 NS
Discussion
Isospora suis has been shown to be a common parasite in 10-18 
day old piglets in the South of Belgium. Diarrhoea was not sig-
nifi cantly correlated with the presence of the coccidia. Perhaps 
the not quantitative method of diagnostic used and the high fre-
quency of diarrhoea – also due to other pathogens - in suckling 
piglets could explained this result. Cleaning and disinfecting the 
farrowing crate had no signifi cant eff ect on the occurrence of 
the infection. These results confi rm that if farm hygiene meas-
ures are important to control the infection pressure, they only 
reduce it. Whatever the diff erences between pig production and 
studies from both the North and South part of Belgium, similar 
results were obtained.
Acknowledgements 
Authors thank farmers and their veterinarians who made this 
study possible.
References
Henriksen S.A., Christensen J.P. Vet. Rec. 1992, 131, 443-444.
Leten J., Smets K., Claerebout E., Mundt H.C., Heesen H., Vercruysse J. 
Vlaams Diergeneeskundig Tijdschrift, 2002, 71, 63-67. 
Visa number of the study: VI VET 06/01/19/02. *Both authors brought an 
equivalent contribution to the study. 
Enteric diseases - Suckling and weanling pigs – Parasitic infections
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 803
Poster Presentations
P.497
Eﬃ  cacy of Virusnip® disinfectant and Quixalud® supplement against Balantidium 
spp. following the treatment of sows in a pig farm in Thailand
Woraporn Sukhumavasi1 Manop Muangyai1 Padet Tummaruk1 Metta Makhanon2 Sasiwimon Talummuk2 Kai Sievert3
1. Dept. of Obstetrics, Gynaecology and Reproduction, Faculty of Veterinary Science, Chulalongkorn University, Bangkok, Thailand; 
2. Technical Service, Novartis (Thailand) Ltd., Bangkok, Thailand; 3. Global Technical Service, Novartis, Basel, Switzerland
Introduction
Balantidium spp. is a ciliated binucleate protozoan parasite in-
fecting the large intestine of mammals including pigs, primates 
and humans. Representative, species of Balantidium in mam-
mals are B. suis, B. coli and B. caviae. Balantidiasis appears to be 
problematic mostly of developing countries in pig industry and 
zoonosis (1, 6). Previous report of B. coli prevalence in Thailand 
was 37.3% in fattening pig farms (4). In the case of preexisting 
pathogenic bacterial intestinal infection, Balantidium aggravates 
the ulcerative colitis lesion due to its hyarulonidase activity. The 
ciliated motile trophozoite and dormant cyst are two stages 
responsible for the pathogenesis and transmission, respectively. 
The cyst is environmentally resistant and capable of infecting 
the host due to its thick wall hence protecting it from desic-
cation and other environmental stress (5). The transmission is 
direct so the pigs become infected either from their sows or 
through contaminated water or coprophagy (6). To prevent the 
disease from spreading, farm sanitation and hygienic measures 
are important factor to control Balantidium apart from treating 
diarrhea pigs with antiprotozoal drug. Recent reports showed 
the in vitro activity of Virusnip® disinfectant to disrupt B. coli cyst 
wall (3) and the effi  cacy of Quixalud® for the treatment of diar-
rhea in fattening pigs caused by B. coli (2). The objective of this 
study is to test the activity of Virusnip®, a disinfectant composed 
of potassium monopersulphate (PMP), sodium dichloroisocya-
nurate (SDIC), sulphamic acid, water softener and surfactant, 
and Quixalud® (60% Halquinol), a combination of hydroxy quin-
oline derivatives, in reducing Balantidium spp. transmission from 
the sows to the nursery pigs in a pig farm as an environmental 
control and an antiprotozoal activity, respectively.  
Materials and Methods
The experiments were conducted in 4 groups of 30 pregnant 
sows composed of control (non-treated), Virusnip® treatment, 
Quixalud® supplement in feed, and Virusnip®/Quixalud® combin-
ation. Virusnip® was diluted with water to the working solution 
at 1:200 and 1:1000 in which it was used for disinfecting the far-
rowing pens (a week before bringing in the full-term sows) and 
pregnant sows (on the due date of farrowing), respectively. 180 
ppm of Quixalud® was supplemented in feed of sows between 
1 week pre- and post-farrowing period. The fecal samples from 
the control and treated sows at 1 wk post-farrowing and their 
weaning piglets at 4 wk and 8 wk-old were collected and quali-
tatively examined for Balantidium cyst by the direct fecal smear 
technique. The statistical analysis was carried out by using the 
Chi-square test.
Results and Discussion
After the Virusnip® treatment, 63.0% of the sows were found 
positive for Balantidium cysts. Interestingly, the percentage of 
Balantidium-positive samples from the 4 wk-old pigs born from 
this group was greatly reduced to 6.7% (p<0.0001) and there 
was a slight increase to 9.7% after following them up until 8 wk 
of age. However, there was no signifi cant diff erence between 
the last two groups (p>0.05). For the Quixalud®-treated group, 
the percentage of Balantidium cyst were 60.0%, 10.0% and 0% in 
sows, 4 wk-old pigs and 8 wk-old pigs, respectively. There were 
signifi cant diff erences in reduction of this protozoa between 
sows and both groups of their off springs (p<0.0001). For the 
Virusnip® and Quixalud® combination group, the percentage of 
cyst from sows and 4 wk-old pigs were decreased from 34.6% 
to 6.5% (p=0.0075). However, we found the increased percent-
age at 8 wk-old group up to 61.3%. The latter results need to be 
further evaluated other causative agents that could play a role 
in potentiating this fi ndings. This study is the fi rst to show the 
promising application of Virusnip® disinfectant and Quixalud® 
to reduce the level of Balantidium transferring from sows to 
nursery pigs in the farm. 
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Introduction
Balantidiasis is a disease caused by the ciliated parasitic proto-
zoan Balantidium spp. The large intestine of several mammalian 
hosts including pigs serves as its niche (6, 2). Although Balanti-
dium infection is usually asymptomatic, the trophozoite can in-
vade the epithelium during the concurrent pathogenic bacteria 
infection hence worsening the disease severity of ulcerative col-
itis resulting in diarrhea (7, 2). Pigs acquire the cysts, an infective 
stage, from the contaminated water or food or from their sows 
via fecal-oral route (6). In Thailand, the prevalence was 37.3% in 
fattening pig farms and increased with age correlating to the 
study in Oklahoma (5, 8). Since the Balantidium cyst wall is thick 
thus protecting it from the environmental stress, the measures 
for control this pathogen are recommended composed of sani-
tation, hygiene and farm management to prevent the pigs from 
succumbing to the infection by this secondary invader (1). Based 
on the recent fi ndings, Virusnip® disinfectant appeared to be 
eff ective in disrupting B. coli cyst wall in vitro (4). Also, another 
report showed the anti-protozoal activity of Quixalud® in treat-
ing diarrhea in fattening pigs caused by B. coli infection (3). The 
aim of this study is to test the activity of Virusnip® (Potassium 
monopersulphate) disinfectant and Quixalud® (60% Halquinol), 
a combination of hydroxy quinoline derivatives, in reducing the 
environmental contamination and infection of Balantidium spp. 
in the nursery pigs, respectively.  
Materials and Methods
The experiments were conducted in 4 groups of 30 nursery pigs 
composed of non-treated control, Virusnip® treatment, Quix-
alud® supplement in feed, and Virusnip®/Quixalud® combina-
tion. Virusnip® was diluted with water to the working solution 
at 1:200 and used for disinfecting the pens of nursery pigs three 
times a week starting from 5 wk old until 7 wk of age. 300 ppm 
of Quixalud® was supplemented in feed during the period of 
5 wk to 7 wk old. The control group was treated as the routine 
cleaning management and feeding. The fecal samples were 
collected before starting the experiment at 5 wk old and at the 
end of the treatment, 7 wk old. Direct fecal smear technique was 
used for qualitative examination for Balantidium cyst. The statis-
tical analysis was performed by using the Chi-square test. 
Results
Before the treatment, the percentage of Balantidium-positive 
pigs were similar in every group in which the percentage of 
control group, Quixalud®-treated group, Virusnip®-treated group 
and Quixalud®/Virusnip® combination was 10.0%, 13.3%, 13.8% 
and 16.7%, respectively (p>0.05). After the period of 2 wk-ex-
periment, the percentage of cyst-positive pigs in control group 
was increased twice (20%) compared to the 5 wk old control 
group whereas the slight reduction of positive sow percentage 
was found in Quixalud®-treated and Quixalud®/Virusnip® com-
bination group (10.0% and 6.7%, respectively) (p>0.05). For the 
Virusnip® treatment group, there was an insignifi cant increase 
from 13.8% to 19% (p>0.05). 
Discussion
Without the treatment, the control group revealed the increase 
in number of Balantidium-infected nursery pigs within 2 weeks 
correlating to the previous fi ndings in that the older pigs har-
bored higher loads of parasites (5, 8). In addition, there was a 
tendency in reduction of number of infected pigs after treat-
ment with Quixalud® or Quixalud®/Virusnip® despite the non-
signifi cant diff erences. This study provides a possible application 
of both Quixalud® and Virusnip® in control Balantidium in swine 
farm by reducing the environmental contamination, infection as 
well as improving the farm biosecurity.
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Introduction
Intestinal parasites of swine are still a concern in modern swine 
production and cause ill thrift, reduced growth rates, decreased 
feed effi  ciency, respiratory distress and condemnations of livers 
at harvest.1 Fecal fl otation methods for diagnosing intestinal 
parasites and monitoring eff ectiveness of deworming programs 
are commonly used in many areas of veterinary medicine and 
are easily implemented in any clinic or laboratory.2 Monitoring 
of swine populations for the presence of intestinal parasites 
using the Modifi ed Wisconsin Sugar Centrifugal-Flotation 
Method is the most sensitive and accurate method for detecting 
parasite eggs.3 The authors herein describe and discuss the 
“Waverly-Modifi ed” method of collection and processing of fecal 
samples for the detection of intestinal parasites in swine. 
Materials and Methods
For sampling a breeding herd, a 95 (% confi dence)/10 (minimum 
% prevalence) sampling scheme was used and 30 samples were 
appropriate for most sow herds. Sows were sampled post-far-
rowing, which has been shown in other species to be associated 
with a periparturient rise in egg counts.4 A fresh 2cc fecal core 
sample was taken from each sow, using a 10cc syringe cut at 
the needle hub end. A new syringe was used for each sample 
because of the potential high numbers of eggs in an individual 
sample and the “sticky” nature of parasite eggs which could 
cause cross sample contamination.
For growing pigs, a composite sample was prepared where 
one fresh 1cc sample was taken from fi ve separate fecal piles, 
totalling 5cc, within a single pen. The number of composites 
collected per barn was based on the capacity of the barn; 10 
composites from barns with up to 800 animals and 12 from 
barns with 800 to 1,200 animals. For barns above 1,200 animals, 
an additional composite was collected per 80 head up to a max-
imum of 24. By pen, the composite numbers provided a 95/22 
sampling scheme; by animal, a 95/6 scheme.
Each core sample was then discharged into a labelled 50ml 
conical centrifuge tube. This tube acts as the mixing container 
for the fi rst laboratory step, thereby reducing additional steps 
and equipment. The 50 ml tubes are returned to the labora-
tory, and the following steps are performed: 1) a concentrated 
sugar solution (0.45 kg in 354 ml water) is added to the fecal 
sample directly into the 50 ml tubes; 15 ml for sows, 20 ml 
for composites; 2) the fecal-sugar mixture is homogenized by 
shaking vigorously or using a wooden tongue depressor; 3) the 
fecal-sugar mixture is strained through a tea strainer into a 150 
ml waxed paper cup; 4) the remaining liquid is pressed through 
the strainer using a wooden tongue depressor; 5) the strained 
contents are transferred into a 15 ml conical centrifuge tube; 6) 
the tube is centrifuged for 5 minutes at 1,000 rpm; 7) the tube is 
placed in a test tube rack; 8) sugar solution is again added to the 
tube until a slight meniscus forms; 9) a 22 X 22 mm cover slip is 
placed on top and allowed to sit in place for 5 minutes; and 10) 
the cover slip is then placed on a microscope slide. Slides are 
read at 40X total magnifi cation on a binocular microscope with a 
movable stage. Starting at one corner of the cover slip, move in a 
vertical plane, counting any intestinal parasite eggs seen. When 
the end of the fi eld is reached, move the fi eld horizontally until 
in a new vertical plane. Continue this method for 5 total planes, 
allowing evaluation of the entire cover slip.
Results and Discussion
The protocol provided clean, easy to read cover slips for the 
accurate detection of Ascaris suum and Trichuris suis eggs in over 
3,000 samples. The modifi cations were made by the authors 
to standardize sample volume, collection methods, minimize 
excess fecal material and consolidate steps to allow for faster 
processing as part of a large scale intestinal parasite survey from 
which the results are reported in two accompanying papers. The 
above modifi ed method should allow any veterinarian or veter-
inary clinic to perform in-house diagnostic testing for intestinal 
parasites.
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Introduction
Historically, internal parasites have been a source of economic 
loss for the swine industry, estimated at $155 million annually.1 
The 2006 NAHMS survey indicated that 74.7% of breeding sites 
regularly gave anthelmintics.2 However, internal parasitism is 
a topic of little discussion or concern in many modern swine 
production systems. The overall prevalence of internal parasitism 
has likely declined with the advent of indoor rearing of swine and 
the application of more eff ective anthelmintics in parasite control 
programs. However, once a barn or premise is contaminated with 
the eggs of the key internal parasites of swine, namely Ascaris 
suum (Large Roundworm) and Trichuris suis (Swine Whipworm), 
there is continuous risk for reduced performance due to parasit-
ism. The objective of this study was to investigate the prevalence 
of internal parasites in a large integrated production system. 
Materials and Methods
A total of 1,197 individual sow fecal samples, from 40 sow farms 
within a common ownership and management structure, repre-
senting 44,050 breeding animals were collected and processed. 
In addition to sample collection, a questionnaire was completed 
for each sow farm to capture historical parasite status, current 
health and production parameters and facility design features 
to assess potential risk factors that might infl uence parasite 
burden. Sow parity and lactation age were collected for each 
individual sow sample. Data was analyzed by either linear or 
logistic regression depending on the parameter evaluated. All 
fecal samples were processed using a modifi cation of the Wis-
consin Sugar Centrifugation fl otation technique. Each sample 
was read and scored based on presence and total number of 
parasite eggs detected (0 = no eggs; 1 = <10 eggs per coverslip; 
2 = 10-49 eggs; or 3 > 50 eggs). The presence of any eggs was 
considered positive and a farm with at least one positive sample 
was considered positive.
Results
Ascaris suum was the only parasite detected. Overall, 25% of 
sow farms were positive, representing 12,000 breeding animals. 
Additional positive results by a selected subset of farm type, 
farm size and facility design are reported in Table 1. However, 
statistical analysis found no risk factors related to farm parasite 
status and overall sow farm health and production levels were 
not related to farm parasite status. 
Discussion
The prevalence of intestinal parasites within this system was 
higher than anticipated prior to performing the survey. The sys-
tem had quit deworming sows prior to farrowing approximately 
18 months prior to this survey based on not observing any adult 
worms and economic considerations. Selective treatment of posi-
tive sow herds along with implementing a continuous monitoring 
program is planned for this production system in the future.
Table 1. Prevalence of intestinal parasites by farm, farm type, farm size 
and parity
No. Farms No. Positive % Pos
Total 40 10 25.0
Farm Type*
FTF 30 7 23.4
FTFd 6 2 33.3
FTW 4 1 25.0
Farm Size (sows)
≤1000 33 8 24.2
>1000 7 2 28.6
Individual Animals By Parity
Gilts 192 5 2.6
1-2 340 8 2.4
3-4 308 8 2.6
5-7 285 1 0.4
8+ 42 2 4.8
Unknown 30 3 10.0
*Farm defi ned as: Farrow-to-fi nish (FTF), farrow-to-feeder pig (FTFd) or farrow-to-wean (FTW).
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Introduction
Historically, internal parasites have been a source of economic 
loss for the swine industry, estimated at $155 million annually.1 
The 2006 NAHMS survey indicated that 30.6% of grow-fi nish 
sites regularly administered anthelmintics.2 The overall preva-
lence of internal parasitism has likely declined with the advent 
of indoor rearing of swine and the application of more eff ective 
anthelmintics in parasite control programs. However, once a 
barn or premise is contaminated with the eggs of the key inter-
nal parasites of swine, namely Ascaris suum (Large Roundworm) 
and Trichuris suis (Swine Whipworm), there is continuous risk for 
reduced performance due to parasitism. The objective of this 
study was to investigate the prevalence of internal parasites 
in a large integrated production system, while also taking into 
consideration the facility design and production parameters of 
the various farms. 
Materials and Methods
A total of 1,697 composite fecal samples were collected, pro-
cessed and analyzed from fi nishing pigs. A composite contained 
a pool of 5 separate fecal samples from within the same pen. 
The total number of composites per barn ranged from 10 to 
24, depending on the capacity of the barn. The 1,697 fi nish-
ing composite samples represent 153 barns (33.2% of barns) 
and 91 fi nishing sites (100% of sites). The fi nishing pig samples 
represent 124,003 fi nishing spaces by barn and 367,758 spaces 
by sites. In addition to sample collection, a questionnaire was 
completed for each fi nishing barn sampled to capture historical 
parasite status, current health and production parameters and 
facility design features to assess potential risk factors that might 
infl uence parasite burden. Data was analyzed by either linear or 
logistic regression depending on the parameters evaluated. All 
fecal samples were processed using a modifi cation of the Wis-
consin Sugar Centrifugation fl otation technique. Each sample 
was read and scored based on presence and total number of 
parasite eggs detected (0 = no eggs; 1 = <10 eggs per coverslip; 
2 = 10-49 eggs; or 3 > 50 eggs). The presence of any number of 
eggs was considered positive and a barn with at least one posi-
tive sample was considered positive.
Results
Ascaris suum was the predominant parasite detected, while 
Trichuris suis was found in one fi nishing site. Overall 31.7% of 
barns and 38.1% of sites were positive, representing 37,911 and 
90,072 fi nishing spaces, respectively. Results by selected risk fac-
tors are shown in Table 1. Statistical analysis indicated that the 
presence of intestinal parasites was mainly infl uenced by fl oor 
type, waste handling system and previous detection. 
Table 1. Prevalence of intestinal parasites by farm and  facility type for 
fi nishing sites.
No. Farms/Barns No. Positive % Pos
Total
Sites 91 35 38.5
Barns 153 51 33.3
By Farm Type (Sites)
Farr-to-Fin 30 3 10.0
Finish only 61 32 52.5
By Floor Type (Barn)
Total Slats 114 25 21.9
Partial Slats 16 7 43.8
Solid Floor 23 19 82.6
By Waste Handling System (Barn)
Flush Under 86 11 12.8
Open Flush 22 18 81.8
Pull Plug 45 22 47.7
Discussion
In summary the prevalence of intestinal parasites within this 
system was high, especially in the fi nishing sites. The source of 
infestation appeared to be the facility itself and not the sow herd 
of origin. Facility factors and evidence of previous infestation 
were strongly associated with a site’s parasite status.
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Gastrointestinal nematodes in Swiss pig farms – an explorative overview
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Objective
Porcine gastrointestinal (GI) nematodes such as Ascaris (A.) suum, 
Trichuris (T.) suis, gastrointestinal strongyles, Strongyloides ran-
somi and others occur worldwide and can signifi cantly infl uence 
feed effi  ciency, daily weight gain, feed intake and the health 
status of the individual pigs as well as of the whole herd. In most 
Swiss fi nishing pig farms, deworming is not routinely performed. 
Recent prevalence estimates for intestinal parasites are lacking. 
The aims of our study were thus to exploratively assess preva-
lence data of porcine GI nematodes in Swiss pig farms and to 
identify potential risk factors for intestinal endoparasitosis. 
Materials and Methods
The study included 110 farms: 90 conventional and 20 outdoor 
farms distributed all over Switzerland. A total of 2762 (conven-
tional) and 291 (outdoor) samples was taken.
Rectal fecal samples were collected only in one weight group 
per farm during the farm visit. Four groups were formed: 
weaned with 4 weeks-40 kg (A), 41-60 kg (B), 61-80 kg (C) and 
> 80 kg (D). Distribution of herds was nearly equal between 
groups. 
Fecal specimens were analyzed in pools of 5 samples for the 
presence of parasites by a combined sedimentation and fl ota-
tion method using a 44% Zinc-Chloride solution. If a pool was 
positive, every single specimen out of that pool was individually 
retested. Farms were declared positive if one or more individual 
fecal samples were positive. A questionnaire was completed 
during a farm visit to identify potential risk factors. Statistics 
were performed using a multiple logistic regression model with 
p<0.05and CI of 95% (NCSS 2007). 
Results 
The number of collected samples ranged from 6 to 37 in out-
door housing farms and from 4 to 58 in conventional farms.
T. suis was the most prevalent GI nematode in conventional 
farms, followed by A. suum and gastrointestinal strongyles. Only 
one farm was positive for Strongyloides sp. (Tab. 1).
All parasites in conventional farms were found most frequently 
in group (D). Prevalence of T. suis and A. suum inclined continu-
ously from group (A) to group (D). T. suis was common in group (A) 
whereas A. suum was very rarely present in this group (Tab. 2).
In outdoor farms, T. suis was the most common GI nematode 
found, followed by A. suum, gastrointestinal strongyles and 
Strongyloides ransomi. In addition Metastrongylus sp. eggs were 
detected in pigs from 6 outdoor housing farms.
“Lack of visitor’s clothing”, “silage” and “no rodent control” could 
be identifi ed as risk factors for a farm being positive for GI 
nematodes. “Lack of visitors clothing”, “dirty boots and farmer’s 
clothing” and “no rodent and insect control” could be identifi ed 
as risk factors for an infection with T. suis.
Table 1: Percentage of outdoor and conventional herds infected with 
GI nematodes and Metastrongylus sp.. Multiple infections occurred. “-“: 
parasite negative.
T. suis A. suum GI strongyles Strongyloides sp. Metastr. sp.
Outdoor 60 % 35 % 20 % 5 % 30 %
Conventional 32.2 % 13.3 % 3.3 % 1.1 % -
Table 2: Percentage of infected conventional herds in diff erent age 
(weight) groups. “-“: parasite negative.
T. suis A. suum GI strongyles Strongyloides sp. Metastr. sp.
< 40kg 20 % 3 % - 3 % -
41-60kg 30 % 15 % - - -
61-80kg 40 % 15 % - - -
> 80kg 45 % 25 % 15 % - -
Discussion 
The study showed that GI nematodes are frequently found in 
outdoor and in conventional farms in Switzerland. Pigs from 
outdoor farms showed a higher worm burden than pigs from 
indoor housing. This can be explained by the higher expos-
ition of outdoor pigs to a possibly contaminated environment. 
Furthermore, T. suis seems to be the most common GI parasite in 
Switzerland. Its presence in conventional herds in all age groups 
indicates it being a problem already in breeding as well as in fat-
tening farms. On the other hand, the low prevalence of A. suum 
in age group (A) indicates it being a problem only in fattening 
herds .
Metastrongylus sp. infections were demonstrated for the fi rst 
time in Swiss commercial outdoor pigs. Wild boars are most 
likely to be the source of infection. All risk factors are related to 
general farm management.
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Endoparasite infections and hygiene management in organic fattening herds
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Introduction
Studies in diff erent European countries have revealed that 
infections with endoparasites are one of the most important 
health problems in swine herds (Roepstorff  et al., 1999; Eijck & 
Borgsteede, 2005). In organic pig farming, the regulation (EC) 
No 889/2008 includes several specifi cations which are expected 
to have severe impacts on parasite infection, i.e. straw bedding, 
access to outdoor run, addition of roughage to the daily feed 
ration and no prophylactic anthelmintic medication. Organic pig 
farms are also characterised by heterogeneous management 
practices and a lack in control measures (Ebke & Sundrum, 2004; 
Werner et al., 2009) providing a non-assessable risk for helminth 
egg contamination in the environment. The aim of the study was 
to assess the prevalence of endoparasite infections in fattening 
pigs on organic swine herds and to assess eff ectiveness and ef-
fi ciency of management measures with respect to the reduction 
of endoparasite infections. 
Materials and Methods
The study was performed in 17 organic swine herds in Ger-
many. An interview with the farmer was performed using a 
standardised questionnaire, containing closed and open-ended 
questions on anthelmintic treatment, cleaning and disinfectant 
measures, documentation of production and management data 
and diagnostic measures on farm-level. Furthermore, 10 faecal 
samples per farm, taken twice during spring and autumn, were 
collected from fatteners. They were examined within 12-24 h 
after collection for nematode egg counts per gram of faeces 
(EPG) and coccidian oocysts using the McMaster technique. A 
total number of 326 fatteners were sampled. Data were cat-
egorised to evaluate the relationship between hygiene manage-
ment and parasite infection. 
Results
Strongylid infections were detected in 58.8% of the herds with 
a mean within-farm prevalence of 30.3%. Ascaris (A.) suum 
and Trichuris suis eggs were detected in 21 and 9.8% of faecal 
samples of fatteners, respectively. Coccidia infections were diag-
nosed in 88% of the farms. Pigs were treated with anthelmintics 
(mainly fl ubendazol) on all farms. The hygiene management 
showed a high variation between the farms. Only half of the 
farmers performed wet cleaning in their fattening units (n=8), 
whereas two farmers did not clean the stables at all. 15 of the 
total number of 17 farmers made no use of chemical disinfectant 
measures versus endoparasites. However, no egg-shedding of 
A. suum and strongyles was detected in three of these 15 herds. 
Four additional herds were free of strongyles. 
Discussion
Results show that farms varied to a high degree with respect 
to the prevalence of endoparasite infection and the imple-
mentation of hygiene measures. In contrast to expectancy, the 
prevalence rate of Ascaris suum infection was on a low level 
in comparison to other studies (Carstensen et al., 2002; Eijck & 
Borgsteede, 2005). 
No correlation was found between hygienic procedures and the 
occurrence of parasite infection, confi rming previous results 
from Roepstorff  et al. (1999). Thus, those farms who use com-
prehensive hygiene measures are not necessarily gaining the 
best results with respect to parasite infection. It is concluded 
that farm specifi c control and feedback mechanism are required 
to minimize both endoparasite infections and eff orts to control 
them. 
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Routine deworming of pregnant sows in group housing systems
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Introduction
Group housing of pregnant sows is becoming more and more 
the norm in modern pig production. Although clearly benefi cial 
in view of animal welfare, this poses specifi c challenges towards 
day-to-day practicalities.
It not only involves the stressful event of grouping which has to 
be addressed to avoid a decrease in reproductive performance 
(1), but it makes it also much more diffi  cult to correctly admin-
ister routine treatments to the sows once they are grouped. 
Injection treatments become ‘rodeo-like’, dangerous and stress-
ful events for both animal and man. For in-feed medication it be-
comes more diffi  cult to get the dose correct as sows of diff erent 
parity, condition and gestation length have diff erent nutritional 
needs and it implies specifi c medicated feed deliveries posing 
additional logistic problems. Top dressing is not possible with 
feeding stations and becomes more diffi  cult if sows are not in-
dividually confi ned during meals. This leaves the drinking water 
as the most convenient and least stressful medium to administer 
routine medication, such as deworming. 
Solubenol® is a fl ubendazole based anthelmintic for drinking 
water application that recently was granted an authorization 
for use in pregnant sows. Flubendazole is a broad spectrum 
anthelmintic for pigs used for strategic deworming programs. In 
a target animal safety study (2), Solubenol® showed to be safe to 
the pregnant sow when given at multiple doses and occasions 
before, during and after pregnancy, indicating the absence of  
the risk for overdosing. 
This study was performed to evaluate its safety and convenience 
as a routine dewormer at the therapeutic dose, in a large group 
of sows at diff erent stages of pregnancy.
Materials and Methods
Four consecutive batches, each of approximately 110 sows of 
mixed parities and diff erent housing system were either treated 
with 5 mg fl ubendazole per kg body weight spread over 5 
consecutive days or left untreated. Sows were treated through 
the drinking water system in the group housed animals or 
individually dosed on the wet feed using a drenching gun in the 
individual pen housing (Table 1). 
Clinical observations of the sows and their piglets, monitoring of 
the litter size (total, live or stillborn and mummies) and viability 
(mortality up to weaning and piglets weaned) were the evalua-
tion criteria for the safety of the treatment. 
Table 1: Study design
Batch Stage gestation Number of litters (Solubenol®/Control) Application route
1 late 62 / 48 wet feed
2 late 56 / 47 water
3 mid 50 / 65 wet feed
4 early 70 / 45 wet feed
Results
In total, 238 sows treated with Solubenol® and 205 control sows 
were included. No abnormal clinical observations were present 
resulting from the treatment of the pregnant sows. No statistical 
signifi cant diff erences in the way of administration or litter size 
were present between both groups (total born 14.2 versus 14.4), 
although overall, somewhat more live born piglets and less still-
born piglets were present in the Solubenol® group (Table 2). 
Mortality up to weaning, as well as the number of piglets 
weaned was comparable between groups. 
Furthermore, there was no infl uence of the sow parity.
Table 2: Averaged production parameters 
Solubenol® Control
live born 13.1 12.7
stillborn 0.8 1.3
mummies 0.3 0.4
mortality 1.5 1.6
weaned 11.2 11.0
Discussion
From the results it is clear that the Solubenol® treatment, as 
a routine dewormer, is safe for use in every stage of the preg-
nancy. No diff erences in any of the parameters were detected 
between the results in the drinking water or wet feed treatment 
and the control. This renders both larger batch treatments as 
well as targeted individual treatments very convenient without 
causing additional stress to the sows. 
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Deworming via the drinking water system with ﬂ ubendazole, both safe and eﬃ  cacious
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Introduction
In pig industry, disease prevention has become a pillar for 
good veterinary practice. Biosecurity, housing and ventilation, 
vaccination and routine deworming all add up to successfully 
achieve that goal.
Routine treatment by injections are very labor intensive and an 
important stress factor for both pigs and caretaker. Vaccinations 
are usually done at a young age when piglets are still manage-
able. Routine deworming however is done in older pigs which 
make injections troublesome. In-feed medication is a good 
alternative but in many cases, there are logistical and legal 
constraints. This leaves the drinking water as the most conven-
ient and least stressful medium to deworm. More and more 
farms are equipped with a separate medicated drinking water 
system and dosing pumps are no longer exceptions. This off ers 
great fl exibility and the possibility of targeted treatments by 
the stockman. Solubenol® is a safe and effi  cacious fl ubendazole 
based anthelmintic for drinking water application for pigs of all 
ages. It is authorised at a total dose of 5 mg fl ubendazole per kg 
body weight (BW) to be administered over a 5-day period for the 
control of the economic most important Ascaris suum infections. 
Unlike levamisole, that has a narrow safety margin. 
In view of reducing labor pressure, an alternative dosing sched-
ule of the same total fl ubendazole dose, but administered over 
only 2 days was evaluated. This included two effi  cacy studies, a 
residue depletion and a target animal safety study. 
Materials and Methods
The fi rst effi  cacy study was run under controlled laboratory condi-
tions (UK). It included pigs with a confi rmed, naturally acquired 
Ascaris suum infection. They were divided in two randomised 
groups: one treated with Solubenol® at 2 5 mg fl ubendazole per 
kg BW on two consecutive days, the other group was left untreat-
ed. Effi  cacy was based on reduction in worm counts and faecal 
egg counts (EPG), one week after the last day of treatment. 
In the second effi  cacy study (France) the same groups were com-
posed but under fi eld conditions.
In the residue depletion study, concentrations of parent fl ubend-
azole and its major metabolite were determined in edible tissues 
over a period of 7 days after the last administration. 
The target animal safety study looked at changes in clinical, 
biochemical and hematological parameters after a treatment 
with 1, 3 and 5 times the 2.5 mg per kg BW dose over a 3-fold 
treatment duration. 
Results
The results (Table 1) indicated that the treatment was fully ef-
fective. 
Table 1: Effi  cacy study UK
Group Worm count Eff ectiveness (%) EPG Reduction (%)
Control 11 945.3
Solubenol® 0 100 0.9 99.9
p-value 0.0022 0.0152
The second effi  cacy study is ongoing at this moment. 
One day after treatment, major total residues were found in liver 
and kidney; relatively low residues were quantifi able in muscle 
and skin/fat. Residues declined rapidly in liver and kidney and 
were not quantifi able in muscle and skin/fat after 3 days. The 
concentrations determined in the edible tissues after the 2-day 
treatment did not compromise the withdrawal time of 4 days as 
also established for the 5-day treatment. 
The target animal safety study, conducted at 2.5, 7.5 and 12.5 
mg/kg BW/day for 6 days did not result in any abnormal clinical 
observations and demonstrated no relevant changes in none 
of the parameters measured. This indicates that this treatment 
schedule has a very large safety margin. No palatability issues 
were noted in any of the studies using a higher day concentra-
tion of Solubenol® in the drinking water. 
Discussion
From the results it is clear that a Solubenol® treatment, admin-
istered over two days while keeping the total fl ubendazole 
dose at 5 mg per kg BW, is eff ective, safe and does not imply a 
diff erent withdrawal period. This additional dosing schedule 
off ers more fl exibility in treatment duration. Accidental overdos-
ing if animals drink excessively or when diff erent age groups 
are treated at the same time, can be avoided with fl ubendazole 
which has a very high LD50. Therefore, Solubenol® is the safer 
choice for routine deworming of fatteners. 
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Introduction
Transmissible gastroenteritis virus (TGEV) has caused a dev-
astating enteric disease with acute diarrhea, vomiting, weight 
loss, dehydration and high mortality and resulting in severe 
economical losses to the aff ected farms [1]. The spike glycopro-
tein stimulates induction of neutralizing antibodies in the host. 
Moreover, the spike glycoprotein has been recognized as not 
only a tropism but also a virulence determinant [2]. The purpose 
of the present study was to investigate the genetic diversity 
among the Korean TGEV fi eld isolates and was to fi nd out more 
prevalent TGEVs in Korea, according to sequence and spike 
glycoprotein gene-based phylogenetic analyses with Korean 
and non-Korean TGEV and PRCV reference strains.
Materials and Methods
A total of 10 porcine samples (from 5 diff erent farms) including 
feces or intestinal contents had been taken from young piglets 
showing watery diarrhea, dehydration and high mortality. Five 
pairs of sense and anti-sense primers were designed based on 
the reference TGEV sequences and used to generate full spike 
glycoprotein gene of TGEV. The full spike glycoprotein gene 
of TGEV was amplifi ed by RT-PCR, gel extracted and directly 
sequenced. Nucleotide sequence of full spike glycoprotein 
gene was determined and phylogenetic tree was then gener-
ated using an alignment of spike glycoprotein gene nucleotide 
sequences with reference TGEV and PRCV strains by applying 
neighbor-joining method in the MEGA 3.1 program. To assess 
the relative support for each clade, bootstrap values were calcu-
lated from 1000 replicate analyses.
Results
Nucleotide sequences of the full spike glycoprotein genes of 
10 Korean TGEV isolates were determined and compared with 
one another, as well as with reference TGEV and PRCV strains. By 
phylogenetic analysis, all compared twenty-two viruses, includ-
ing 10 Korean TGEV isolates, 11 TGEV and 1 PRCV reference 
strains, certainly fell into two groups at the nucleotide sequence 
level. One group comprised KT2, KT3, KT4, HKT2, 133, MIL65-
AME, BRI70-FS, PUR46-MAD, NEB72, TOY56, HOL87 and 8 Korean 
TGEV isolates. Another group consisted of TFI83 and 2 Korean 
TGEV isolates.
Figure 1. Phylogenetic tree generated on the basis of nucleotide se-
quences of full spike glycoprotein genes of 10 Korean TGEV isolates with 
reference TGEV and PRCV strains.
Discussion
By spike glycoprotein gene-based phylogenetic analysis, all 
Korean TGEV isolates were divided into two groups. It was sug-
gested that recent, many Korean TGEV fi eld isolates are closely 
related to the group including KT2, KT3, KT4, HKT2, 133, MIL65-
AME, BRI70-FS, PUR46-MAD, NEB72, TOY56 and HOL87 rather 
than to the group including TFI83. It is notable that recently 
more prevalent TGEVs in Korea are especially close to the NEB72, 
respiratory Purdue type TGEV.
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Novel vaccine against swine transmissible gastroenteritis using Salmonella choleraesuis as a live vector
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Introduction
Swine transmissible gastroenteritis(TGE) is a highly contagious 
enteric disease in piglets causing high mortality rate of up to 
100% and resulting in severe economical losses to the aff ected 
farms. The currently commercial available vaccines could pro-
vide only partial protection, and this emphasizes the importance 
of developing a new vaccine to prevent this disease. The mu-
cosal immunity is required for protection. Salmonella has been 
proved as good vector that stimulates mucosal immunity. How 
to enhance expression of main antigen is a crucial strategy. Site 
A and site D in the spike protein (S) of transmissible gastroenter-
itis virus are the main inducer of neutralizing antibodies while 
Site A is a major B cell epitope. Peptide N321, which is located 
on the nucleoprotein (N), defi nes a functional T helper epitope 
eliciting T cells capable of collaborating with B cells specifi c for 
diff erent proteins of TGEV(1). 
Material and Methods
Antigen site A, site D and antigen site N321 of TGEV were 
combined by two Linker ((GGGGS)4 as a fusion peptide (SLN). 
By using SalI and XhoI site, two copies of SLN (2SLN) were 
constructed. Non-resistance expressing plasmids pYA-SLN and 
pYA-2SLN were constructed,respectively. The two plasmids 
were electrotransformated into Salmonella choleraesuis C500 
competent cells to construct the recombinant Salmonella strains 
C500 (pYA-SLN) and C500 (pYA-2SLN) respectively. We evaluated 
the immunogenicity and protective capacity of the recombin-
ant Salmonella strains through a vaccination and challenge trial 
in mice. Furthermore, fi eld trail of the recombinant vaccine was 
applied in a farm which was being aff ected by TGE which was 
confi rmed by our in-house RT-PCR in Jan. 2009 and the mortality 
rate was around 60%.
Result
We successfully constructed the recombinant Salmonella chol-
eraesuis strains C500 containing plasmid pYA-SLN) and pYA-
2SLN, respectively, in which the gene integrated could be highly 
expressed. Both of the recombinant Salmonella strain induced 
the immunized mice a high titer of serum IgG and gut mucus se-
creted IgA against the antigens of Salmonella and SLN-protein. A 
higher titer of IgG and IgA could be induced in mice vaccinated 
with recombinant salmonella choleraesuis containing pYA-2SLN 
than that containing pYA-SLN, indicating that a peptide antigen 
displaying repeating copies of SLN is a more potent inducer of 
TGEV-neutralizing antibodies than SLN alone. Furthermore, IgG 
subclasses, among which the IgG2a titer is higher than IgG1, 
were induced in mice immunized by Salmonella choleraesuis 
harboring pYA-2SLN. The sIgA could also be detected in mice 
four week after vaccination and peak at six week. The primary 
result of fi eld trail showed that by oral administration, no new 
cases were observed, and about 99% piglets recovered from 
diarrhea between 48-72 hours after oral administration of the 
new vaccine. 
Discussion
Due to the mucosal immunity is important factor in the protect-
ive mechanism of swine TGE which inactivated vaccine always 
lack. In this work, we used Salmonellas choleraesuis as a live vac-
cine to express main antigen protein of TGEV. The three eiptopes 
domains were combinaed, cloned and integrated the genes into 
non-resistance expressing plasmid, non-resistance recombinant 
Salmonella strains were successfully constructed and effi  ciently 
expressing the fragments integrated in. Furthermore, we evalu-
ated the immunogenicity and protective capacity of the recom-
binant Salmonella strains using a vaccination and challenge 
trial both in mice and in piglets. These results indicated that the 
recombinant C500(pYA-2SLN) vaccine showed the potential live 
vaccine against Swine transmissible gastroenteritis
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Genetic diversity of porcine rotaviruses in selected Korean pig farms, 2009
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Introduction
Rotaviruses(RV) are important causes of diarrheal disease in 
animals and humans and a common cause of gastroenteritis in 
sucking and postweaning pigs (1). Based on viral protein(VP) 6, 
major component of the inner capsid, RV are divided into seven 
distinct groups, A to G. Among them, group(G) A, B, C and E 
RV have been detected in pigs. GARV are the most commonly 
associated with diarrhea in pigs (1). GCRV were fi rst detected in 
pigs in 1980 and have been identifi ed as the causes of diarrhea 
in suckling and newly weaned piglets. In Korea, GARV and GCRV 
have been detected in pigs with diarrhea (2). GARV are classifi ed 
into G and P types based on the specifi city of two outer capsid 
protein VP7(glycoprotein) and VP4(protease-sensitive protein), 
respectively (1). The examination of the diversity and prevalence 
of G and P types is important to survey the contemporary circu-
lating strains.
Materials and Methods
Eighty nine intestinal or fecal specimens were obtained from 42 
pig farms in Korea between January and July 2009. All speci-
mens were examined by reverse transcription-polymerase chain 
reaction(RT-PCR) using group-specifi c primers for detection of 
GARV, GBRV and GCRV (2, 3). Positive samples for GARV were 
subjected to G genotyping by RT-PCR using type-specifi c prim-
ers (4). The RT-PCR products of VP6 of GCRV and VP7 amplicons 
from samples positive for G9 RV were sequenced and analyzed.
Results
Of 89 samples from 42 pig farms, 40 from 22 pig farms and 40 
from 21 pig farms were positive for GARV and GCRV, respect-
ively. No samples showed positive for GBRV. Twenty-three out 
of 40 GARV-positive samples were genotyped by RT-PCR. The 
G genotypes of 23 samples were determined as follows; three 
samples were G3, six were G5, nine were G9, three were G3+G5, 
one was G3+G9 and another one was G3+G5+G9. The identity 
of the partial nucleotide(nt) sequence of the VP6 gene from 20 
porcine GCRV detected in this study was 87-99% and that of the 
amino acid(aa) was 92-100%. By the phylogenetic analysis of the 
partial VP6 gene of 20 GCRV detected in this study and refer-
ence strains of human, bovine and porcine GCRV, it was found 
that 19 Korean GCRV belonged to the porcine lineage and one 
didn’t belong any porcine, bovine and human lineages. By the 
phylogenetic analysis of VP7 gene of G9 RV, four amplicons were 
shown to belong to lineage VI and sublineage b(VIb) and two 
amplicons were VIc according to the novel nomenclature for G9 
RV (6 lineages with 11 sublineages) (5).
Discussion
This study indicated that GCRV(50.3%) and GARV(52.3%) were 
widespread in Korean pig farms. Genetic analysis of partial VP6 
gene of GCRV showed that most GCRV belonged to the por-
cine lineage. However, relatively short nucleotide sequences 
of GCRV VP6 gene were analyzed due to the direct sequencing 
of detected amplicons. For further detailed genetic sequence 
analysis, the comparison of the extended or whole nucleotide 
sequence of GCRV VP6 gene will be necessary. The determina-
tion of G genotypes showed that G3, G5 and G9 types were 
prevalent in Korean pig farms examined in this study. To defi ne 
the more detailed diversity of circulating RV, P typing is abso-
lutely needed. Phylogenetic analysis of VP7 gene of G9 RV indi-
cated that seven isolates were close to the porcine G9 RV rather 
than human G9 RV. For further study, it is necessary to isolate 
the circulating porcine RV and characterize them genetically and 
serologically and develop the vaccine by the selection of the 
most prevalent and eff ective strains.
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Prevalence of rotavirus and coronavirus in piglet production herds in the Czech Republic
Linda Czanderlova; Marek Zizlavsky; Dita Kellnerova; Marcela Gambova; Svetlana Odehnalova; Jiri Odehnal
Sevaron Counselling, Brno, Czech Republic
Introduction
Pre-weaning diarrhoea in pigs is a complex problem involving 
a large number of causative agents. Multiple enteric infections 
can occur, often in association with non-infectious factors. 
Viruses can play an important role by modifying the intestinal 
mucosa and thus predisposing secondary infections (1). Group 
A rotaviruses have been detected most frequently in swine. 
Rotaviruses and TGE and PED coronaviruses are important swine 
pathogens in nearly all countries with an intensive pig produc-
tion. The signifi cance of rotavirus and coronavirus infections 
is frequently underestimated in practice and these viruses are 
not often included in the diff erential diagnostics of diarrhoeal 
diseases in suckling piglets.
The aim of this study is to report the data of identifi cation of 
rotavirus group A and TGE a PED coronaviruses in suckling pig-
lets with diarrhoea in the Czech Republic. 
Materials and Methods
The study included in total 98 pool samples of faeces taken from 
53 pig production herds in the territory of the Czech Republic in 
the year 2008 and 2009. The samples were taken from suckling 
piglets with clinical manifestations of diarrhoea at the age from 
2 to 28 days. All samples were tested for the presence of rota-
virus group A, TGE coronavirus and PED coronavirus. Commercial 
immunochromatographic tests Rota Ag test kit and TGE/PED Ag 
test kit (Bionote) were used to prove these viruses in laboratory. 
Results
Of 98 faeces samples included in the study, the presence of 
rotaviruses and/or coronaviruses was detected in 66 samples 
(67.3%). The capture of rotaviruses and coronaviruses in the 
year 2008 and 2009 is presented in Table 1. TGE coronavirus 
was diagnosed most frequently (51 positive laboratory diagno-
ses). PED coronavirus was detected in 41 cases, rotavirus was 
diagnosed less frequently (30 positive laboratory diagnoses). 
Monoinfections were detected only in 25 cases (37.8% of all 
positive laboratory diagnoses), mixed infections with various 
combinations of rotaviruses and coronaviruses were diagnosed 
in the remaining cases (see Table 2). The combination of TGE and 
PED coronaviruses was found to have the highest prevalence, 
followed by TGE monoinfection and combined infection of rota-
virus, TGE and PED coronavirus. 
Table 1. Capture of rotavirus group A and coronaviruses in the year 
2008 and 2009
2008 2009 Total % positive
Rotavirus 12 18 30 30.6
TGE 26 25 51 52.0
PED 18 23 41 41.8
Table 2. Prevalence of single infections and multiple infections caused 
by rotavirus group A and coronaviruses
N°positive % positive
Rotavirus+TGE+PED 15 22.7
Rotavirus+PED 6 9.1
Rotavirus+TGE 3 4.5
TGE+PED 17 25.8
Rotavirus 6 9.1
TGE 16 24.2
PED 3 4.5
Discussion
The acquired results indicate that the problem of viral diseases 
of digestive system in suckling piglets is still topical in the Czech 
Republic. These results and observations from farm audits sug-
gest that environmental conditions and husbandry practices 
(poor disinfection) may be predisposing suckling piglets to viral 
intestinal infection. Although the infections related to rota-
viruses and coronaviruses have an enzootic course in pig herds 
in the Czech Republic, they lead to atrophy and degeneration of 
enterocytes and aggravate the course of intercurrent infections 
(e.g. C. perfringens type A, C. diffi  cile, ETEC).  
When solving these viral infections in practice, vaccination of 
breeding stock sows before delivery, either by a commercial 
vaccine containing ETEC and the rotavirus group A, or by an 
autogenous vaccine with ETEC, rotavirus group A and TGE and 
PED coronaviruses proved good.
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Interspecies transmission of goat rotavirus to swine
Min-A Hwang; Jung-Ah Lee; Seung-Yong Park; Chang-Sun Song; In-Soo Choi; Joong-Bok Lee
Konkuk University College of Veterinary Medicine, Seoul, Korea
Introduction
Rotavirus A, the major cause of gastroenteritis in children and 
animals, is interspecies pathogen. The notion of interspecies 
transmission between porcine and human(1), porcine and 
equine(2), and porcine and bovine(3) was reported. Transmissi-
bility between porcine and goat was not reported up to date. An 
attempt was carried out to support the evidence that rotavirus A 
isolated from diff erent species may infect others by demonstrat-
ing that goat rotavirus may infect pigs. 
Material and Methods
Inoculum was 1ml of 104 TCID50 caprine rotavirus, GRV G3P5[3], 
that was isolated from fecal specimen of 3-month-old goat(4). 
GRV was orally administered to the 3-day-old piglets which were 
raised with replacement milk after ceserian section (GRV n=6, 
mock n=3). For six days, clinical sign was monitored by scoring 
diarrhea level (0=normal, 1=mild, 2=moderate, 3=severe). In or-
der to confi rm fecal shedding and to see if GRV is disseminated 
to other organs besides conventional infection site of rotavirus, 
fecal samples were sampled daily and then ileum, liver, brain 
and lung tissue were collected by the end of experiment period. 
NSP4 gene of rotavirus was amplifi ed by nested PCR to confi rm 
viral infection. In addition, mRNAs from spleens were collected 
to profi le mRNAs for innate immunity and pro-infl ammatory 
cytokines. Quantitative analysis using reverse transcription real-
time PCR using SYBR® green reagent was conducted..
Result 
Mild diarrhea began at day 1 post inoculation (PID 1) and got 
worse day by day till PID 3. The severe diarrhea peaked at PID 
4 and reached fl at for 24 hours. The PCR detection rate of PID 4 
and 5 were signifi cantly higher than the others (Fig 1).
Fig. 1. The mean diarrhea score (line) and density of PCR products 
(bar). 
As shown in Table 1, PCR products of GRV appeared at 50% of 
ileum, liver, lung, and brain, respectively. It is interesting that 
one of infected piglet did not shed, but spread virus to all of the 
tested tissue. 
Table 1. Detection of rotavirus RNA in varying organs of GRV-infected 
piglet
No.positive/No.tested (%)
Ileum Liver Lung Brain
GRV 3/6(50) 3/6(50) 3/6(50) 3/6(50)
mock 0/3(0) 0/3(0) 0/3(0) 0/3(0)
In GRV infected piglet, mRNAs of both type I and II interferon 
(IFN- α, γ, respectively) were elevated in parallel with increase 
of mRNAs for IFN –inducible antiviral molecules, OAS and PKR. 
mRNAs of TNF- α and IL-4 increased, while those of IL-6, 8, 10 
decreased slightly (Fig. 2).
Fig 2. Profi ling innate immunity and pro-infl ammatory cytokine 
mRNAs in spleen.
Discussion
This study directly support the possibility of interspecies 
transmission. Cytokine analysis also showed that GRV strain 
may evoke innate immunity to provide antiviral activity. In an 
attempt to control co-circulation of rotavirus infection in animal 
and/or human population, to understand mechanism by which 
transmission of interspecies occurs is important. 
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Development and validation of a quantitative PCR for the detection of Actinobacillus suis
Maria J. Clavijo; Simone Oliveira
University of Minnesota, Saint Paul, MN, USA
Introduction
Actinobacillus suis is an emerging pathogen considered to be a 
new threat for swine production. The isolation of this pathogen 
from tissues submitted to the University of Minnesota Veterinary 
Diagnostic Laboratory (MVDL) increased considerably in the past 
three years. In 2006, a 16s rRNA gel-based PCR was developed 
and since then requests for A. suis PCR testing have raised 
signifi cantly.1 This tool has been highly employed in protocols 
attempting to eradicate A. suis. However, complete elimination 
of the pathogen has not been achieved.2,3 Limitations of this gel-
based PCR include the non-specifi c amplifi cation of A. equuli and 
the lack of bacterial quantifi cation. Therefore, a more sensitive 
and specifi c quantitative diagnostic tool is needed to improve 
eradication protocols. The objective of this study was to develop 
and validate a sensitive and specifi c quantitative PCR assay for 
the detection of Actinobacillus suis in clinical samples.
Materials and Methods
Forward and Reverse primers and a TaqMan probe specifi c for 
the amplifi cation and detection of an A. suis housekeeping gene 
involved in thiophene oxidation (Thdf) were designed using the 
Primer 3 Software. Quantitative PCR conditions were optimized 
utilizing an ATCC A. suis reference strain. This strain was also 
utilized to evaluate the analytical sensitivity of the quantitative 
PCR by testing 10-fold dilutions of extracted DNA. The analytical 
specifi city was evaluated by testing 29 unrelated bacterial spe-
cies frequently isolated from swine in addition to A. equuli, which 
generated non-specifi c amplifi cations with the gel-based 16S 
rRNA PCR. The stability of the targeted gene sequence among A. 
suis fi eld isolates was evaluated by testing 70 diff erent isolates 
representing 12 genotypes circulating among U.S swine herds. 
Results
The newly developed quantitative PCR detected a minimum 
of 3.5 x 101 CFU/ml, compared to 7.2 x 102 CFU/ml detected 
by the 16S rRNA gel-based PCR test. The Thdf quantitative PCR 
was highly specifi c, detecting exclusively A. suis isolates. There 
was no non-specifi c amplifi cation of A. equuli DNA, as previous 
observed with the gel-based PCR. The new quantitative PCR 
amplifi ed the Thdf gene from all 70 A. suis fi eld isolates tested, 
indicating that this housekeeping gene is highly conserved 
among diff erent strains circulating in U.S. swine herds. 
Discussion
We have developed a more sensitive and specifi c quantitative 
PCR for detection of A. suis in clinical samples. This new test will 
allow swine veterinarians to perform a more comprehensive 
comparison of diff erent control and eradication protocols. All 
attempts to eradicate A. suis from endemically infected popula-
tions have failed so far. In most of these cases, A. suis was not 
detected at weaning following intensive antibiotic treatments, 
but was detected at the end of the nursery using the gel-based 
PCR. The new quantitative PCR, which is more sensitive and 
specifi c than the previous gel-based PCR, will allow a better 
characterization of prevalence at weaning. Quantifi cation of A. 
suis in tonsil swabs will also provide a more detailed character-
ization of treatment eff ect, and will allow swine veterinarians to 
evaluate the cost-benefi t of each protocol. We expect the new 
A. suis quantitative PCR to be an important aid in A. suis control 
and eradication. 
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Preliminary study of Actinobacillus suis colonization in upper and 
lower respiratory tract in naturally infected animals
Marina Sibila; Eva Huerta; Llorenç Grau-Roma; Virginia Aragón; Joaquim Segales
Centre de Recerca en Sanitat Anima (CReSA), Bellaterra, Spain
Introduction
Actinobacillus suis (A. suis) is considered an early colonizer of 
the upper respiratory tract, which may also cause fatal cases 
of septicaemia in young piglets. A. suis infection has been also 
described in adult animals with fever, inappetence and erypsela-
like skin lesions (1). However, in high-health farms this pathogen 
has been linked as well to diff erent pathological conditions 
including arthithis, pneumonia, enteritis, meningitis, abortion 
and endocarditis in pigs at diff erent ages (2). Besides, A. suis 
infection can cause very similar lesions to those of Actinobacillus 
pleuropneumoniae (App). In fact, both pathogens share some 
virulent factors including Apx toxins, urease, and iron-regulated 
outer membrane proteins. Moreover, distinction of A. suis 
isolates from App biotype II ones can be diffi  cult if it is not con-
fi rmed biochemically or by molecular biology techniques. This 
high similarity between both pathogens may sometimes lead to 
erroneous diagnosis (2). 
Little information on the A. suis prevalence in animals of diff er-
ent ages and clinical conditions is nowadays available. Therefore, 
the goal of the present study was to gain insight into A. suis 
prevalence in upper and lower respiratory tract samples from 
pigs with diff erent clinical conditions. 
Material and Methods
Forty seven pigs were included in this study. From these, 34 pigs 
(from 6 to 18 weeks of age) were submitted for necropsy to the 
Pathology Diagnostic Veterinary Service at the Veterinary School 
of Barcelona (Spain) with diff erent clinical signs (mainly, growth 
retardation, digestive and respiratory problems). The remaining 
pigs were 13 6-week-old healthy pigs. The following samples 
were collected from each animal: nasal swab (NS), tonsillar swab 
(TS), tonsillar brush (TB), tonsil tissue (T), bronchial swab (BS) 
and lung (L). TB was not taken in 9 of the 47 animals. Lung was 
always taken from the accessory lobe, independently on the 
presence or absence of lesion. 
DNA from swabs and tissues was extracted using commercial 
kits and processed according to the manufacturer’s instructions. 
In order to diff erentiate between A. suis and App, samples were 
tested with two PCRs. One to detect the Apx IV gene (3), present 
exclusively in all App serotypes, and another to detect the Apx 
II gene (4), present in A. suis and in most of App serotypes. The 
Apx IV PCR was done in a singleplex mode in all samples but 
when ambiguous results were obtained the nested PCR was 
performed (5). 
Results
Apx II and IV toxin genes were detected in a number of ani-
mals showing diff erent clinical signs. Positivity was found in 
samples from the upper (NS, TS, TB and T), but not in those from 
lower respiratory tract (BS and L). On the other hand, all tested 
samples from healthy animals were PCR negative to both toxins.
Apx II was more frequently detected (15 out of 47 [32%]) than 
Apx IV (9 out of 47 [19 %]). In both cases, the number of PCR 
positive samples per animal varied from one (mainly TS) up to 3 
(TS, TB and T or NS). From the 47 tested animals, 31 (66%) were 
negative to both Apx II and IV PCRs in all the tested samples. 
Nine (19%) out of 47 pigs were PCR positive to both Apx II and IV 
at least in one sample. Finally, 6 (13%) animals were positive only 
to Apx II PCR while only 1 (2%) was positive exclusively to Apx IV. 
Discussion
Detection of Apx II in absence of Apx IV amplifi cation in some 
samples would indicate A. suis infection in such animals. These 
preliminary results suggest that A. suis detection in upper 
respiratory tract by means of direct PCR is feasible and relatively 
frequent in animals of diff erent ages and showing diff erent 
clinical conditions. The best sample to be tested by direct PCR 
resulted to be the TS or TB.
The concomitant detection of both toxins in some animals 
together with the existence of an animal in which only Apx IV 
was found, indicated the presence of diff erent App serotypes in 
the samples.
More studies will be useful to assess the role and prevalence of 
A. suis in porcine respiratory pathologies.
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Detection of haemophilus parasuis requires strategic diagnostic
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Introduction
Haemophilus parasuis (HPS) is the etiological agent of por-
cine polyserositis and arthritis (Glässer’s disease). Despite the 
increased prevalance and severity of Glässer’s disease in recent 
years (1), diagnosis of Glässer’s disease is still a challenging task. 
Not only is the isolation and cultivation of the bacteria tedious 
due to its fastidious nature, but routine diagnostic methods are 
hampered by the heterogenic nature of HPS and its commensal 
status in the upper respiratory tract of healthy pigs (2).
The aim of this study was to evaluate the detection of HPS by 
PCR and bacterial culture (BC) in diff erent materials taken from 
weaned piglets that were experimentally infected with HPS sero-
var 5. 
Materials and Methods
36 piglets, approximately 3 weeks old, were obtained from a 
commercial farrowing farm which had no previous history of 
porcine reproductive and respiratory syndrome virus (PRRSV). 
Also, the animals were Mycoplasma hyorhinis PCR negative and 
HPS serologically negative. Piglets were housed in two separ-
ate units in a biosafety level 3 facility. After an acclimatization 
period of 17 days, 27 piglets were infected intratracheally with 5 
x 108 colony-forming units (CFU) of HPS serovar 5. The remaining 
9 animals served as control animals and received phosphate-
buff ered saline (PBS) instead. The study was terminated 15 days 
after infection. Dry swabs of the serosal surfaces (pleura, pericar-
dium, and peritoneum) and the brain, synovia and cerebrospinal 
fl uid (CF), and joint capsule were taken for PCR (3) analysis from 
each animal either at study termination or at removal. Further-
more, swabs from the serosal surface were investigated for 
bacterial examination.
Results
Results of the PCR and BC of the infected pigs are illustrated in 
Tab. 1. All sample materials from the control animals were nega-
tive by PCR analysis and BC. A total of 12 infected pigs died or 
were euthanized due to humane reasons within 10 days after in-
fection. HPS was more frequently isolated in samples from these 
animals than animals that died at study termination. The sample 
material and method with the highest HPS detection was the 
PCR analysis of serosal swabs. HPS genome was detected by PCR 
in the joint capsule of 5 animals, however, the synovia fl uid from 
these animals were HPS negative. Similarly, the synovia samples 
from four animals were PCR positive but the corresponding joint 
capsules from these animals were negative. Also, HPS genome 
was more frequently detected in the cerebrospinal fl uid than the 
brain swab by PCR testing. At study termination, HPS genome 
was detected predominantly in the synovia fl uid; all other 
sample materials were negative by PCR analysis and BC. 
Table 1: Results of PCR and bacteriological examination of samples 
from pigs infected with HPS serovar 5 
Day of 
study 
exit
No. of 
pigs
Serosal swab-
bacterial 
culture
Serosal 
swab-
PCR
Brain 
swab-
PCR
CF-PCR Synovia fl uid
Joint 
fl uid-
PCR
2 3 3/3 3/3 2/3 2/3 0/3 2/3
3 3 3/3 3/3 0/3 2/3 0/3 0/3
4 3 3/1 3/3 0/3 2/3 0/3 0/3
6 1 1/2 1/1 1/1 1/1 0/1 1/2
10 2 0/15 2/2 0/2 0/2 0/2 1/2
15 15 0/15 0/15 0/15 0/15 4/15 1/15
Discussion and Conclusion
In the current experiment, 12 pigs died within 10 days after 
infection. This study confi rms the fi ndings of Kielstein and 
Rapp-Gabrielson (4) who classifi ed serovar 5 as very pathogenic, 
capable of eliciting death within 4 days. Although this study was 
conducted with a relatively small number of animals, diff erences 
in HPS detection were found, particularly after comparing PCR 
and culture results between animals that died acutely or at study 
termination. Turni et al. (2) noted that sample material tends to 
yield diff ering results depending on if samples were obtained 
after a subacute, acute or chronic infection. 
Based on the results from this study, conclusive HPS detection 
is best achieved by examining samples from various sites using 
both PCR and BC. Furthermore, HPS detection is more successful 
in sample material from animals which are in the acute phase 
of infection. In this study, HPS genome was only detected in 
the synovia fl uid when animals were chronically infected. Also, 
PCR testing of CF was more successful at detecting HPS gen-
ome than a brain swab. Further investigations are necessary to 
confi rm these results.
References
1. De la Fuente et al. (2009) Res. Vet. Sci. 86: 230-234
2. Turni C. and Blackall P. (2007) Aust. Vet. J. 85: 177-184
3. Angen O. et al. (2006) Vet. Micro. 119: 266-276
4. Kielstein P. and Rapp-Gabrielson V. (1992) J. Clin. Micro. 30: 862-865 
Other bacterial diseases – Haemophilus parasuis
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 820
Poster Presentations
P.514
Rapid identiﬁ cation of Haemophilus parasuis by MALDI-TOF Mass Spectometry
Marie Helene Bayon-Auboyer; Marie Laure Malcoste; Rosine Danguy-des-Déserts; Herve Morvan
LDA22, Ploufragan, France
Introduction
Matrix-assisted laser desorption ionisation-time of fl y mass 
spectrometry (Maldi-TOF-MS) in combination with dedicated 
analysis software is a reliable method for the identifi cation of 
microoorganisms (1). 
The analysis software incorporates functionalities for the pro-
cessing of mass spectra as well as for identifi cation.
Identifi cation of bacteria is achieved by comparison of gener-
ated mass spectra with reference spectra stored in a ready to 
use data base which contains the characteristic spectra informa-
tion of species and subspecies. However, Haemophilus parasuis 
spectrum was not present.
We present here, the generation of a new reference pattern for 
H. parasuis and its use for a rapid identifi cation of H. parasuis 
strains in a clinical approach as an alternative to time-consum-
ing and expensive routine methods.
Materials and Methods
The bacterial strains used to evaluate the H. parasuis reference 
mass spectra were recovered from clinical diagnosis. They were 
identifi ed using traditional biochemical tests (4) and PCR (3). 
These bacterials strains were H. parasuis (29), A. pleuropneu-
moniae (1), Actinobacillus taxon C (1), Actinobacillus minor (6), B. 
bronchiseptica (1) and P. multocida (1). 
Bacterial strains were grown over night on diff erent media and 
under diverse culture conditions according to the microorganisms. 
To established a reference mass spectrum for H. parasuis, the 
well known and identify reference strain CIP 105098 was used 
(CIP : Pasteur Institute collection). A good average was achieved 
by the measurement of 24 spectra of the reference strain. The 
software automatically generated the peak lists from the whole 
set of the 24 spectra and extracted the typical peaks which were 
present in all the spectra to established the H. parasuis reference 
spectrum. This spectrum was added to the library.
Direct “cell smear”, a simple method applicable to many bacteria, 
was used. Small amounts of biological material (single colony) 
were smeared directly as a thin fi lm onto a Maldi target. One 
microliter of chemical matrix was deposited and allowed to dry 
down.
The samples were analysed in a Bruker Microfl ex (LT) Maldi-Tof 
Mass Spectrometer. 
The MALDI BioTyper™ software was used to process raw spectra. 
Identifi cation of the bacterial strains was performed by compari-
son with the library of reference spectra from Bruker and our H. 
parasuis reference spectrum. A matching score based on identi-
fi ed masses and their intensity correlation was generated and 
used for ranking of results.
Results
Traditional identifi cation of H. parasuis is based on colony 
morphology, Gram staining, NAD requirement and biochemical 
testing (4). However, those techniques remain time consuming 
and labor intensive procedures. H. parasuis identifi cation strain 
from clinical samples processing needs, at least, 3 days.
Starting from a few biological material, mass spectra could be 
observed for each bacterial isolate tested. Results were known in 
a few minutes 
In total, Maldi Tof MS identifi ed 29 of the 29 isolates H. parasuis 
(100%), concordant with traditional bacterial methods and PCR. 
The remaining tested bacteria were identifi ed at the species or 
genus level, but not as H. parasuis. Since the validation of the H. 
parasuis reference spectrum, numerous strains have been identi-
fi ed using this new method.
Discussion
These results show that it’s easy to create a new reference mass 
spectrum for H. parasuis which is nowadays used for routine 
and rapid identifi cation in our laboratory. Now, H. parasuis is 
identifi ed within 24 h rather than the 72 h or more needed for 
traditional bacteriological methods. Furthermore, samples prep-
aration and analysis do not exceed traditional methods cost. 
Thus, Maldi Tof MS off ers a good alternative to traditional labora-
tory methods in veterinary and environmental diagnostics (2). 
The speed and minimal sample preparation make it well suitable 
for routine use. Prerequisite is the establishment of high quality 
spectra libraries.
A further fi eld of application is the potential of lineage typing, 
analysis of taxonomic relationships.
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Serotyping of Haemophilus parasuis isolates from German pigs
Katrin Strutzberg-Minder1 Jan Boehmer1 David Goldstein1 Herve Le Galludec2 Matthias Homuth1
1. IVD GmbH Innovative Veterinary Diagnostics, Hannover, Germany; 2. Fort Dodge Animal Health, GM Naarden, Netherlands
Introduction
Haemophilus parasuis is the cause of Glässer’s disease (porcine 
polyserositis and arthritis) and other clinical disorders in pigs, 
but it can also be isolated from the upper respiratory tracts of 
healthy pigs.
Fifteen serotypes of Hps, defi ned by an immunodiff usion or 
agar gel precipitation test with heat-stable antigens, have been 
described by (1), and it has been shown that there is. an as-
sociation between serotype and the degree of virulence (2). A 
new indirect hemagglutination (IHA) test for serotyping of Hps 
isolates has also been developed and evaluated (3). The latest 
published data on the prevalence of Hps serotypes in Germany 
are from 1998 (4) 
Material and Methods
The IHA test was performed according to the method of (3). 
Antisera against all 15 serotype-specifi c reference strains were 
prepared as described (1) with some modifi cations.
A total of 96 strains isolated from German pig herds with clinical 
problems were typed by IHA, most of them with the objective of 
making a herd-specifi c vaccine. No precise data were available 
on the source tissue of the isolates and on clinical symptoms.
Results
The most prevalent Hps serotype was 1 (n = 18), followed by 
serotypes 2 (n = 16), 13 (n = 13), 4 (n = 12), and 5 (n = 9) (Fig. 
1). Less prevalent were the serotypes 12 (n = 5), 7 (n = 4), 9 (n 
= 2), 11 (n = 1) and 14 (n = 1). No Hps isolate was identifi ed as 
serotype 3, 6, 8, 10 or 15. In all, 15 of the Hps isolates showed no 
reaction with any of the 15 serotype-specifi c antisera and were 
thus not typeable (s. Fig. 1: n.t.). 
Figure 1: Frequency distribution of serotypes of Hps isolates from 
German pig herds. Striped columns represent serotypes associated with 
death, checkered columns, those with a moderate to severe degree 
of virulence, and completely fi lled columns, those associated with no 
lesions; source: (2)
Discussion
The most frequent serotypes 1, 2, 13, 4 and 5 (73.8%) are associ-
ated with a moderate to severe degree of virulence (2). Our data 
support the assumption that these isolates were involved in the 
clinical problems of the herds. The IHA test for serotyping Hps 
isolates is thus a useful tool for evaluating whether an isolate 
can be expected to have a clinical impact. 
The IHA test was originally developed as a new method for sero-
typing of Hps and was evaluated by determining the prevalence 
Hps in North America. More than 90% of the fi eld strains of 
Hps were found to be typeable by IHA, including those exhib-
iting cross-reactivity in immunodiff usion which fails to identify 
approximately 30% of fi eld isolates of Hps(3). In our study, 15 
(15.6%) fi eld isolates could not be identifi ed with any serotype, 
although 84.4% of the isolates were typeable. Since genotyping 
is not strictly correlated with serotyping and virulence is associ-
ated with serotype, there is still a need for antigen-based typing. 
Furthermore, despite great progress in genotyping techniques, 
antigenic characterization of prevalent strains of Hps is still es-
sential for the development of eff ective vaccines and serodiag-
nostic tests and for epidemiological analysis.
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A Modiﬁ ed Multi-Locus Sequence Typing (MLST) Scheme for Haemophilus parasuis
Karen B. Register; Michael A. Mullins; Darrell O. Bayles
USDA/ARS/National Animal Disease Center, Ames, IA, USA
Introduction
Haemophilus parasuis is the etiologic agent of Glässer’s disease 
and pneumonia in swine. Phenotypic classifi cation systems are 
of assistance in epidemiologic studies but molecular meth-
ods provide numerous distinct advantages. An MLST scheme 
proposed by others appears promising (4). However, recently 
acquired genome data (3,5) reveal the primers used, based on 
sequences of other bacteria, are not optimal for H. parasuis. 
Furthermore, several diff erent PCR mixes and cycling programs 
are required for amplifi cation of all targets. Here we report 
modifi cations to enhance and simplify the original method, 
thereby facilitating data acquisition and increasing accuracy. The 
modifi ed MLST was applied to a group of 35 diverse H. parasuis 
isolates and the results compared with those obtained using the 
original method.
Materials and Methods
Thirty-fi ve genetically distinct strains of H. parasuis, including 
the 15 serovar reference strains, were evaluated by the original 
(4) and modifi ed MLST methods. Amplicon sequences were 
trimmed, concatenated and used to construct Neighbor-Joining 
trees as reported (2). Target-specifi c alignments used to guide 
primer redesign included genome sequences of four H. parasuis 
strains (3,5). Vector NTI Advance was used for sequence editing 
and analysis and to assist in primer design.
Results and Discussion
Alignments of genome sequences from 7 target genes, atpD, 
infB, mdh, rpoB, 6pgd, g3pd and frdB, were examined for variabil-
ity and quality of match within the original primer-binding re-
gions (see Fig. 1 for an example). Ten of the 14 originally recom-
mended primers (4) were redesigned to eliminate mismatches 
and avoid regions of high sequence heterogeneity.
To simplify the method for end users, we standardized the Tm of 
all primers and identifi ed a universal PCR mix and set of cycling 
conditions that resulted in robust and reproducible amplifi ca-
tion of all targets.
The number and percentage of variable positions within the 
dataset obtained using our modifi cations (240 of 3154 positions; 
7.6%) is slightly less than for the original method (408 of 3806 
positions; 10.7%) but the grouping of strains in major clusters is 
nearly identical (Fig. 2). Analysis of H. parasuis genomes indicates 
some MLST targets are in close proximity along the chromo-
some (e.g., 6pgd and frdB are separated by ~10Kb), in opposition 
to general guidelines for MLST (1). Nonetheless, the discrimina-
tory power of the scheme proposed here suggests it is a highly 
useful phylogenetic and epidemiologic tool.
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Phylogenetic Analysis of Dutch and Belgian Haemophilus Parasuis Isolates Using ERIC-PCR
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Introduction
Haemophilus parasuis (H. parasuis), a ubiquitous bacterium in 
the upper respiratory tract of swine, is the causative agent of 
Glässer’s disease. To date, more than 15 H. parasuis serotypes 
have been described and isolates with the same serotype can be 
very heterogeneous in virulence (1). 
Several attempts have been made to improve the diff erentiation 
of fi eld isolates both on phenotypic and genotypic level. In this 
study, the Enterobacterial Repetitive Intergenic Consensus-PCR 
(ERIC-PCR) for fi ngerprinting of fi eld isolates has been used to 
identify separate lineages in Dutch and Belgian H. parasuis iso-
lates. ERIC-PCR lineages were compared with serotyping results.
Materials and Methods
From October 2007 until September 2009, 89 H. parasuis isolates 
have been collected from pigs which were presented at the 
Dutch Animal Health Service for postmortem examinations. 
Typical growth on chocolate (+NAD) agar plates, satellite growth 
without hemolysis on blood agar plates using Staphylococcus 
aureus nurse strain and a negative CAMP test were used for the 
identifi cation of H. parasuis. Ten H. parasuis reference strains and 
11 Belgian fi eld isolates were examined too. The serotypes were 
determined at the IVD GmbH (Gesellschaft für Innovative Veter-
inärdiagnostik, Germany) using type-specifi c antisera. ERIC-PCR 
was performed as described by Rafi ee et al (2). PCR products 
were visualized on a 2% agarose gel. Gel images were analyzed 
using the BioNumerics software package (Applied Maths NV, 
Sint-Martens-Latem, Belgium).
Results
Serotyping revealed in general the serotypes 1 (n=14), 2 (n=12), 
4 (n=29) and 13 (n=18), whereas serotype 5 was serotyped 8 
times. 
ERIC-PCR gel images of the 100 isolates were analyzed by the 
BioNumerics software. Similarities were determined using 
Pearson correlation and clustered using the UPGMA algorithm 
(Figure 1). ERIC-PCR revealed a very heterogeneous pattern. No 
clear correlations between serotypes and ERIC-PCR lineages 
were found. 
Figure 1: Dendrogram based on H. parasuis ERIC-PCR results 
constructed using Pearson correlation and the UPGMA algorithm.
Discussion
Diff erent H. parasuis serotypes and ERIC-PCR lineages were 
found in Dutch and Belgian isolates. The overall correlation 
between serotype and ERIC-PCR analyses was low. Isolates 
with diff erent ERIC-PCR patterns were found within the same 
serotype. Other techniques and further analyses of these isolates 
in correlation with clinical and pathological fi ndings will be used 
to identify more virulent isolates and to separate these from low 
virulent isolates. 
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Phylogenetic Analysis of Dutch and Belgian Haemophilus Parasuis Isolates Using HSP60 Sequence Typing
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Introduction
Haemophilus parasuis (H. parasuis) is the etiological agent of 
Glässer’s disease. Glässer’s disease is characterized by serofi brin-
ous and fi brinopurulent polyserositis, arthritis, meningitis which 
can also lead to acute death, especially in piglets. H. parasuis can 
also be isolated from lungs. 
At this moment, 15 diff erent serotypes are described (1). Certain 
serotypes may be associated with virulence but the link be-
tween serotype and virulence is often inconclusive. Several 
attempts have been made to improve the diff erentiation of 
fi eld isolates both on a phenotypic and a genotypic level. Partial 
sequencing of the heat shock protein 60 gene (hsp60 gene) 
proved to be a reliable marker for epidemiological studies of H. 
parasuis and showed that the analysis of its sequence is superior 
to other fi ngerprinting techniques (2). The objective of this study 
was to identify lineages of Dutch and Belgian H. parasuis isolates. 
These isolates, including 10 H. parasuis reference strains, were 
subjected to serotyping and hsp60 sequence analysis.
Materials and Methods
From October 2007 until September 2009, 134 H. parasuis 
isolates were collected from pigs which were submitted to the 
Dutch Animal Health Services for postmortem examinations. 
Typical growth on chocolate (+NAD) agar plates, satellite growth 
without hemolysis on blood agar plates using Staphylococcus 
aureus nurse strain and a negative CAMP test were used for the 
identifi cation of H. parasuis. Ten reference strains and 11 Belgian 
fi eld isolates were examined too. 
The serotypes were determined at the IVD GmbH (Gesellschaft 
für Innovative Veterinärdiagnostik, Germany) using type-specifi c 
antisera. The hsp60 universal PCR was performed as described by 
Goh et al. (3). PCR products were sequenced and sequence data 
was aligned and analyzed using the BioNumerics software pack-
age (Applied Maths NV, Sint-Martens-Latem, Belgium).
Results
Serotyping revealed in general the serotypes 1 (n=14), 2 (n=12), 4 
(n=29) and 13 (n=18), whereas serotype 5 was serotyped 8 times. 
Hsp60 partial sequences (498bp) of 145 isolates were aligned, 
and parsimony trees (using 200 bootstrap simulations) were 
constructed (Figure 1). Variations were detected at 116 nucleo-
tide positions and pair-wise similarities using Pearson correla-
tion ranged from 86 to 100%. In total, 56 diff erent sequence 
types (STs) were detected. Using 99% sequence similarity, as 
threshold for group separation, 4 separate clusters (I, II, II and IV) 
could be distinguished. When comparing STs with serotyping 
data no strong correlation was observed, except for a possible 
correlation between cluster I and serotype 5.
Figure 1: Parsimony tree using 200 bootstrap simulations, based on 
hsp60</em sequence analysis.
Discussion
Diff erent H. parasuis serotypes and hsp60 lineages were found 
after analysis of the 145 H. parasuis isolates. The overall correla-
tion between the two methods, serotyping and hsp60 sequence 
analysis, was low, except for serotype 5. A possible association 
between cluster I and H. parasuis serotype 5 and/or higher 
virulence will be examined furthermore based on the recorded 
clinical symptoms and pathological lesions.
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Identiﬁ cation of a novel immunogenic and species-speciﬁ c protein in Haemophilus parasuis
Nubia R. Macedo; Simone Oliveira
University of Minnesota, Saint Paul, MN, USA
Introduction
Haemophilus parasuis continues to be one of the most important 
causes of nursery mortality in modern swine production. One of 
the main challenges in H. parasuis control is the lack of a reliable 
serological test to characterize the development of antibodies in 
sows and piglets. This information is critical to understand herd 
immunity and to identify the best timing for vaccination. In this 
study we have identifi ed a highly immunogenic and species-
specifi c protein in H. parasuis. This protein is a strong candidate 
for the development of a H. parasuis-specifi c ELISA test and of a 
universal subunit vaccine.1,2
Material and Methods
Twenty pigs involved in an H. parasuis outbreak were selected 
based on clinical signs (fever > 105 F, respiratory distress, lame-
ness, CNS signs) for necropsy and H. parasuis isolation (n=10) or 
for antibiotic treatment to produce convalescent sera (n=10). 
Whole cell proteins obtained from H. parasuis isolates recovered 
from diseased pigs were probed with convalescent serum using 
Western blot. An immunodominant protein observed in all H. 
parasuis outbreak strains and 13 reference strains was identifi ed 
and sequenced. Specifi city of the highly immunogenic protein 
was tested by doing Western blot analysis using whole cell pro-
teins obtained from 10 additional bacterial species commonly 
isolated from swine tissues, including Actinobacillus porcinus, A. 
indolicus, A. minor, A. pleuropneumoniae, A. suis, Streptococcus 
suis, Bordetella bronchiseptica, Pasteurella multocida, Escherichia 
coli, and Salmonella choleraesuis. Pre-colostrum serum obtained 
from a 1 day-old piglet was used as a negative control in all 
Western blots.
Relevant results and discussion
The convalescent sera obtained from pigs that survived the H. 
parasuis outbreak recognized a wide range (27 kDa – 77 kDa) 
of whole cell proteins in both outbreak and reference strains. 
One single band with an estimated molecular weight of 52 
kDa was clearly immunodominant and it was observed in all H. 
parasuis strains tested. This protein was not identifi ed in any of 
the unrelated bacterial species, indicating that it was specifi c-
ally expressed by H. parasuis. Pre-colostrum swine serum also 
failed to detect this protein in all isolates tested. The 52 kDa 
immunodominant protein was identifi ed by sequencing as an 
oligopeptide permease ABC transporter membrane protein in H. 
parasuis (OppA). This protein has now been cloned and ex-
pressed in E. coli (Figure 1). We have identifi ed a novel immuno-
genic and species-specifi c protein in Haemophilus parasuis. This 
protein will now be utilized to develop a H. parasuis-specifi c 
ELISA test and will be evaluated as a potential universal subunit 
vaccine. 
Figure 1 – Haemophilus parasuis OppA protein expressed in Esche-
richia coli (arrow).
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Simultaneous infection by serotypes 4 and 12 of Haemophilus parasuis in a swine herd: a clinical case 
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The clinical expression of Haemophilus parasuis (HPS) in pigs is 
well described since many years, in the form of polyserositis and 
arthritis (Glässer’s disease) (4). Of the 15 known serovars, strains 
belonging to serovars 1,5,10,12,13,14 have been shown to be 
highly virulent, serovars 2,4 and 15 moderately virulent, serovar 
8 mild virulent while serovars 3,6,7,9 and 11 avirulent (3). The 
purpose of this paper is to report a clinical case where 2 diff erent 
pathogenic serotypes of HPS were isolated.
Materials and Methods
This clinical case took place between April and May 2009. The 
farm was a farrow-to-feed unit with 500 sows.  The piglets were 
vaccinated against PCV2 and Mycoplasma hyopneumoniae at 
3 and 5 weeks respectively. The clinical symptoms of disease 
started at 7 weeks of age and the mortality rate increased at 12 
weeks of age reaching over 10% in some batches. The symp-
toms observed were: loss of appetite, swollen joints, lame-
ness, dyspnoea, cough, sometimes nervous signs and sudden 
death. Seven dead piglets were submitted for necropsy to the 
Istituto Zooprofi lattico Sperimentale Lombardia and Emilia 
Romagna (IZSLER), laboratory of Reggio Emilia, following routin-
ary methods. From dead piglets several samples of aff ected 
organs were collected. Bacteriological cultures were performed 
using Gassner agar, nutrient agar and blood agar added whith 
nicotinnamide adenine dinucleotide (NAD). H.parasuis PCR was 
performed from pathological samples (fi brinous lesions in the 
lung and pericardium) collected and stored at -20°C (4). From 
six live piglets in the aff ected age groups, blood samples were 
collected and examined for antibodies against PRRSV (indirect 
ELISA IDEXX), against PCV2 (competitive ELISA IZSLER-Brescia) 
and for the presence of PCV2 and PRRSV using a rt-PCR and a 
real time PCR respectively (2,5). The strains of H.parasuis isolated 
were serotyped using the agar gel immunodiff usion test and 
by indirect haemoagglutination (1). Phenotypic methods were 
used to identify other bacteria isolated. 
Results
The gross lesions observed were: arthritis in the carpal and 
tarsal joints with fi brinous content, fi brino-purulent pneumonia, 
pericarditis and peritonitis with fi brin trends over the abdom-
inal organs in four pigs. Two of these showed also pleuropneu-
monia. Catarrhal bronchopneumonia without other lesions was 
observed in two pigs, while no lesions were observed in one pig. 
Two serovars of H.parasuis were isolated from diseased pigs. Two 
strains isolated from pigs with systemic disease (polyserositis) 
were serotyped as serovar 4, while another strain isolated from 
a pig with bronchopneumonia was serotyped as serovar 12. Two 
strains of Actinobacillus pleuropneumoniae biovar 2 serovar 7 and 
biovar 1 serovar 9 were isolated from the two lungs with pleuro-
pnemonia respectively. PCR results confi rmed bacteriological 
fi ndings and also demonstrate the presence of H.parasuis in two 
cases of polyserositis in which this pathogen was not isolated by 
culture. All sera samples showed antibodies against PRRSV (S/P 
values ranging between 1 and 2,5) and also antibodies against 
PCV2. Positive PRRSV rt-PCR (European strain) was observed in 
a pool of three sera, while all sera resulted PCV2 real time PCR 
negative. 
Discussion
The results agreed with the classifi cation of Kielstein and Rapp-
Gabrielson (1992), in which the serovar 12 has been shown to 
be highly virulent (generally isolated from pigs without polyser-
ositis), while serovar 4 moderately virulent (generally isolated 
from pigs with polyserositis). However, the connection between 
serovar isolated and gross lesions observed can be infl uenced 
by several factors (host factors, vaccinations and other bacterial 
and viral diseases). In this work H.parasuis coexisted with other 
pathogens like A.pleuropneumoniae and PRRSV. The results of 
this work showed the importance of isolates serotyping, mainly 
if the vaccination is used for the disease protection.
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Introduction
Haemophilus parasuis (Hp) is an important commensal op-
portunistic respiratory pathogen of swine. These organisms can 
potentially invade the host and cause systemic infection char-
acterized by fi brinous poliserositis, arthritis and meningitis. Hp 
usually in our country aff ects young pigs after 7 weeks of age in 
the nursery. Some serovars of Hp seem to be more virulent than 
other, but so far no true virulence factors have been identifi ed.
A tentative diagnosis can often be made on the basis of his-
tory, clinical signs and gross lesion observed during necropsy. 
Isolation and culture of this microorganism is considered the 
gold standard. To control this disease the characterization of the 
strains associated with systemic disease is required. The goals of 
this study were (i) to isolate Hps from intensive swine aff ected 
herds (ii) to apply the ERIC – PCR technique to detect the genetic 
diversity among the isolated strains.   
Materials and Methods
Samples were collected from eleven commercial farrow –to-fi nish 
pig farms located in three diff erent raising regions. The farms had 
a previous history of Glässer’s disease outbreak in nursery piglets. 
Clinical samples (joints, pericardium, pleural and abdominal 
fl uid swabs, lungs and spleen) were examined by isolation. Rou-
tine biochemical tests to identify H. parasuis were performed, 
although fi nal identifi cation was achieved by PCR [1,2]. Addition-
ally, to characterize the Haemophilus parasuis isolates ERIC-PCR 
was done as described. [3,4].
Results and Discussion
Haemophilus parasuis was recovered in pure culture from sick 
piglets (joint, pericardium, pleural cavity, abdominal fl uid and 
from some lungs). The DNA patterns (fi ngerprints) of the Hps 
strains were distributed in four clusters, indicated heterogeneity 
between herds (Figure1). Additionally, the isolates obtained 
from the respiratory tract didn’t diff er from those collected from 
systemic sites. The Hp strains obtained were not serotyped 
because of the lack of this type of reagents. 
The isolates F-R2 and F-S3 had the same ERIC-PCR profi le, 
because they were the only two strains isolated from the same 
herd, even through they were collected in diff erent dates. De-
spite of these preliminary results the information obtained with 
this procedure may be useful to understand the epidemiology 
in the Colombian swine farms and to suggest control measures 
using autogenous vaccines. 
Figure 1. ERIC-PCR fi ngerprints analysis. C+: positive control; FS: Farm-
Systemic sites; FR: Farm-Respiratory sites.
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Introduction 
Clinical and diagnostic evidence have suggested that porcine 
respiratory diseases are caused by an association of several 
viral and bacterial infections. The clinical symptoms like fever, a 
slower growth and a worse feed conversion lead to increasing 
economic losses. The aim of this study was to describe the sero-
logical and temporally course of a H. parasuis infection on three 
farms. Furthermore the infl uence of other agents, like PRRSV, 
PCV2 and M. hyorhinis onto the course of H. parasuis infection 
was proved.
Material and Methods
The study was conducted on three breeding farms and their 
fi nishing units. Clinical examination (based on a score system for 
body condition, gastrointestinal tract, respiratory tract and lame-
ness) and blood sampling were performed in two-week intervals 
between 1st and 11th. and in four-week intervals between 14th 
and 22nd week of life. Also the sows were sampled in the 1st 
week after farrowing. The samples were analysed via ELISA for 
antibodies against H. parasuis, M. hyorhinis, PCV2 and PRRSV.
Results 
A signifi cant correlation between the antibodies of the sows and 
their piglets was found for all agents in the 1st week of life. In the 
1st week of life, identical antibody values for H. parasuis were 
measured in the sows and piglets. The PRRSV and PCV2 antibody 
values of the piglets were even higher at this time. The decrease 
of antibody values in the following week of life depended on the 
specifi c agent and the basic antibody value of the piglet in the 
1st week of life. If in the fi rst week of life the antibody value was 
very high, the decrease was prolonged. In the three farms no 
uniform seroconversion time for the four examined agents could 
be determined. The highest antibody values could be detected 
in one pig during the 14 th to 22nd week of life:
On farm 1 25% of the pigs got seropositive for all four agents 
and 75% for three agents (H. parasuis, PRRSV, PCV2). Farm 2 was 
PRRSV negative and there 52% of the pigs got seropositive for all 
three, 29% for two (5% H. parasuis and PCV2, 24% M. hyorhinis 
and PCV2) and 19% for only one (PCV2) agent. On farm 3 55% of 
the pigs became seropositive for all four agents, 35% for three 
(M. hyorhinis, PRRSV, PCV2) and 10% for two (PRRSVand PCV2) of 
the tested agents.
On farm 2 the H. parasuis antibody values increased between 
the 7th and the 9th week of life and on farm 1 and 3 in week 11. 
The fi rst seropositive pigs were detected on all farms until the 
14th week of life. The H. parasuis seroprevalence on farm 1 was 
90% in the 18th and 100% in the 22nd week of life. At the same 
time the seroprevalence for H. parasuis on farm 2 was 50% and 
on farm 3 45%. 
Farm 1 had the highest score of lameness in the 14th week of 
life. The M. hyorhinis antibody titer increased from the 9th until 
the 22nd week of life. 
On farm 1 the PCV2 antibody titer increased between 18th and 
22nd week of life, on farm 2 between 9th and 18th, and on farm 
3 between 11th and 18th week of life. At the end of the fi nishing 
period antibodies against PCV2 could be detected in all study 
pigs.
On farm 1 the PRRSV antibody values increased between the 
18th and the 22nd week of life until 100 % of the study pigs 
were seropositive and on farm 3 between week 11 and 22.
Discussion 
The present study demonstrates the diffi  culty of the interpreta-
tion of serological profi les and indicates that an appropriate 
interpretation of the serological profi le can only be done when 
the clinical signs are also taken into consideration. A specifi c 
serological profi le on every single farm for each relevant agent 
should be provided.
The time point of infection with the four examined agents was 
diff erent on the three farms, but the study showed that the 
incidence of multiple infections increased during the fi nishing 
period. On farm 2 and 3 a simultaneous seroconversion time in 
the 9th and 11th week of life was detected for H. parasuis, M. 
hyorhinis and PCV2. The association between H. parasuis and 
PCV2 in the 18th week of life was signifi cant, which is an evi-
dence for a simultaneous infection time with those two agents 
on the respective farms. Also on farm 1 a simultaneous serocon-
version for PRRSV and PCV2 in the 18th week of life could be 
observed, but the association was not signifi cant.
Interaction between H. parasuis, M. hyorhinis and PCV2 is 
possible and between PRRSV and PCV2 even more likely. High 
antibody values in sows are the basic requirement for a good 
passive immunity of the piglets in the fi rst weeks of life and the 
maternal immunity against H. parasuis, PRRSV and PCV2 could 
be improved by sow vaccination.
.
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Introduction
For many years, Glässer’s disease has been considered of only 
minor importance, mainly seen at the end of the weaning or the 
beginning of the fi nishing periods. More recently, its incidence 
has increased, and the disease is frequently observed during the 
fi rst weeks of life. 
The effi  cacy of commercial vaccines has been controversial: 
some have proved very successful (1), while others have ap-
peared to be lacking. Various causes have been proposed, such 
as inappropriate vaccination program, lack of cross-protection 
between serotypes and defi cient immune response (2). The aim 
of this study was to show that sow vaccination with Porcilis® 
Glässer is an eff ective tool in the control of H.parasuis infec-
tion in young piglets, even against a heterologous challenge. 
Porcilis® Glässer is a vaccine based on an inactivated whole cell 
concentrate of Haemophilus parasuis serotype 5, strain 4800, 
mixed with dl- α-tocopherol acetate as adjuvant.
Materials and Methods
This study was performed in an 1100-sow herd, managed on a 
three site production system in the north-east of Spain. From 
January 2009, a high incidence of arthritis had been observed 
in young piglets. It was fi rst seen in piglets of 10 days old and, 
although no mortality was recorded during the suckling period, 
clinical signs increased at the start of weaning, leading to >7% 
mortality. The presence of H. parasuis was confi rmed from the 
results of bacteriological examinations of synovial fl uid and 
lungs of aff ected but untreated piglets. An indirect hemagglu-
tination test revealed the pathogen to be H.parasuis serotype 
15. 
The piglets were treated with 0.2ml long-acting ceftiofur at 
5 days of age, and then vaccinated at 3 weeks of age with a 
polyvalent inactivated vaccine available on the Spanish market, 
which included a H.parasuis bacterin, and some management 
improvements were implemented.
Clinical signs were still being observed in May 2009, and wean-
ing mortality remained above 6%. Consequently, the treatment 
regime was abandoned completely in favour of vaccinating the 
sows with two doses of Porcilis® Glässer, between 7 and 6 weeks, 
and again between 3 and 2 weeks, before farrowing. 
Clinical signs and mortality were recorded over a 5 month 
period for litters born from vaccinated sows, and were compared 
with the same parameters prior to the Porcilis® Glässer vac-
cination program. Statistical analysis was performed using the 
Pearson’s chi-square test and Fisher’s exact test. 
Results
No negative eff ects were observed on the health status of the 
vaccinated sows or their progeny. The clinical signs of Glässer’s 
disease were clearly reduced in both sucking pigs and weaners. 
In sucking pigs incidence of arthritis moved from 15% to 1% 
in piglets born from vaccinated sows. There was a statistically 
signifi cant reduction in mortality rates (p<0.001) after weaning 
(Table 1).
Table 1. Mean monthly mortality during weaning period of piglets 
born to vaccinated and unvaccinated sows.
Unvaccinated Jan Feb Mar Apr May Mean
Mortality (%) 4.8 7.6 3.5 6 6.2 5.62a
Vaccinated Jun July Aug Sept Oct Mean
Mortality (%) 2.5 2.4 3.8* 4* 2.4 3.02a
* Litters aff ected by an E.coli infection
a, b: values with diff erent superscripts represent statistically signifi cant diff erences (p<0.01).
Discussion
This study showed that the vaccination of sows with Porcilis® 
Glässer is a safe and effi  cacious treatment which can prevent 
Glässer’s disease in young piglets. 
These data obtained from fi eld conditions confi rmed previous 
laboratory results demonstrating that sow vaccination with 
Porcilis® Glässer increased H.parasuis colostral antibody levels, 
and that the transmission of these MDA could protect piglets up 
to 6 weeks of age (3). 
The effi  cacy of Porcilis® Glässer has been shown previously 
against homologous and heterologous serotypes 1, 5, 12, 13 and 
14 (4). The study reported here proves that Porcilis® Glässer can 
also provide eff ective immunity against a heterologous chal-
lenge with H.parasuis serotype 15. 
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Introduction and Objectives
The goal of our study was to evaluate the in vitro sensitivity 
pattern for Streptococcus suis strains isolated from pigs showing 
neurological clinical signs in porcine farms from Venezuela
Materials and Methods
A total of 9 strains of Streptococcus suis were isolated from brain 
tissue samples from 41 suspected cases coming from farms with 
histories of neurological signs in 5 to 12 week-old piglets be-
tween January 2005 and December 2008. For the purpose of this 
study, the piglet heads were transported to our laboratory were 
they were dissected under sterile conditions and samples were 
collected in selective media (blood agar) and then incubated in 
a microaerofi lic environment at 37 Celsius for 48 hours. Colonies 
were identifi ed considering their morphology and biochemical 
properties (Quinn, P.J. et al en 1994). An antibiogram from the 
isolated strains was done through the method of Kirby-Bauer 
(NCCLS, 1990, MA-A4). The antibiotics assessed in this study 
were enrofl oxacin, norfl oxacin, gentamicin, neomicin, sulfa-
methoxazole-trimethoprim, ceftiofur, amoxicillin, fl orfenicol, 
tetracyclin, lincomicin and penicillin. The interpretation of the 
antibiogram was performed according to the NCCLS (National 
Committee for clinical Laboratory Standards) standards (2). 
Results
The Streptococcus suis strains isolated in this study had the 
highest percentage of resistance to lincomicin, gentamicin, 
tetracyclin, neomicin, fl orfenicol and sulfa-trimethoprim and 
to a lesser degree to enrofl oxacin and amoxicilin. One hundred 
percent (100%) of the strains assessed were sensitive to Penicil-
lin and Ceftiofur. Likewise, it was observed that 100% of the 
evaluated strains had moderate sensitivity to norfl oxacin. Finally, 
100% of the strains in this study were resistant to lincomicin. The 
results are summarized in table 1.
Table 1. Percentage of sensitivity to antibiotics of Streptococcus suis 
strains isolated from January 2005 to December 2008. 
Antibiotic Sensitive Resistant Intermedium
Enrofl oxacin 33,3 11,1 55,6
Norfl oxacin 0 0 100
Gentamicin 11,1 88,9 0
Neomicin 11,1 88,9 0
Sulfa-Trimethoprim 33,3 56,6 0
Ceftiofur 100 0 0
Amoxicillin 55,6 44,4 0
Florfenicol 11,1 77,8 11,1
Tetracycline 11,1 88,9 0
Lincomicin 0 100 0
Penicillin 100 0 0
Discussion and Conclusions
In our study, a high percentage of Streptococcus suis strains 
were resistant to Sulfa-Trimethoprim. Our results diff er from 
those published by Tarradas M.C. in 1994 (3) who suggested 
the use of this drug as an alternative for Streptococcus suis 
control. Likewise, our results show a high percentage (44.4%) of 
resistance to Amoxicicillin which also diff ers from other studies 
(Ristow, et al., 2008) (4) which have shown less than 1% resist-
ance to this drug. Finally, we observed a high proportion of 
strains resistant to lincomicin, tetracyclin, gentamycin, sulfa-tri-
methoprim and sensitive to Penicillin as was shown in previous 
studies in Venezuela (Pineda, et al; 1996) (5). Based on our in 
vitro data, penicillin and ceftiofur appear to be the antibiotics 
of choice against Streptococcus suis infections in these farms; 
however, most previous studies show the highest susceptibility 
of this bacteria to amoxicillin when compared to penicillin. Dur-
ing the last years there has been wide spread use of amoxicillin 
in pre-initiation and initiation food in Venezuela which could 
explain an increase in resistant strains to this antibiotic. Dur-
ing this study, a total of 41 cases were assessed during a 4 year 
period and only in 9 of these, strains of Streptococcus suis were 
isolated. The low number of isolated strains is probably the 
consequence of the wide spread use of antibiotics in the food in 
farms in our country, which is a limitation for our study. 
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Maternal immunity to Streptococcus dysgalactiae subsp. equisimilis and incidence of lameness in piglets
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Introduction
Lameness is one of the most important animal welfare issues in 
suckling piglets and about every 10th piglet could be expected 
to be treated with antimicrobials because of lameness before 
being weaned (1). Despite this, lameness is only diagnosed in 
about every second litter, and the treatment incidence varies 
from one to all piglets in aff ected litters. Consequently, an eff ect 
of the sow could be expected. Streptococcus dysgalactiae subsp. 
equisimilis (SE) is commonly associated to arthritis in piglets and 
the aim of this study was to scrutinise the maternal protection to 
that microbe.
Materials & Methods
Three indirect ELISA-systems detecting antibodies to SE were 
designed by using sonicated fi eld strains of SE isolated from 
piglets diagnosed with arthritis in three herds. The three ELISA 
systems were used to defi ne the levels of serum antibodies 
to SE in three day old piglets from these herds in a cross-over 
model. Each serum was diluted 1/100 in PBS-T and analysed 
with respect to presence of antibodies to SE by all three ELISA 
systems.In addition, colostrum from sows that had been col-
lected from sows in the three herds at the day of farrowing were 
analysed for presence of antibodies to SE in whey diluted 1/50 in 
PBS-T employing the same ELISA systems.Finally, the amounts of 
antibodies to SE in colostral whey of the 93 sows in herd C were 
related to the incidence of lameness in the off spring. Also parity 
number and litter size were compared to the incidence of lame-
ness in the off spring.
Figure 1. Mean absorbance values of serum antibodies and whey 
antibodies to SE in 3 day old pigs and from sows at the day of farrowing 
from 3 diff erent herds detected by 3 diff erent antigens preparations. 
Results 
As seen in Figure 1, the amounts of serum antibodies varied 
somewhat due to herd and to antigen used in the tests. How-
ever, the optical density values were fairly constant in samples 
regardless of antigen used. In contrast, the levels of antibodies 
in colostral whey clearly diff ered between herds, but was again 
fairly nondependent of antigen preparation used.The standard 
deviation of the OD-values in colostral whey indicated a large 
variation between sows, and the levels of antibodies to SE, as 
well as litter size and party number were compared with the 
incidence of lameness in the off spring (Fig. 2).
 Figure 2. Lameness in the off spring to 93 sows in herd C, related to 
the amount of antibodies to SE in colostral whey, and to litter size and 
parity number of the sows. 
Discussion & Conclusions 
The results obtained indicate that an indirect ELISA-system 
detecting antibodies to SE based on a fi eld isolate from one herd 
could be used also in other herds. However, mean OD-values in 
piglets appear to be fairly equal between herds, and if the target 
is to identify piglets at risk each individual sample must be as-
sessed individually.We therefore paid attention to the levels of 
antibodies in colostral whey, with the aim of identifying litters at 
risk. Indeed, lameness were more rarely diagnosed in sows with 
high levels of colostral antibodies to SE (p=0.06 to 0.08). How-
ever, also litter size and parity numbers infl uenced the incidence 
of lameness (1), and it is striking that the only litter with 6 piglets 
treated for lameness included 16 piglets and emanated from 
a sow with low levels of antibodies to SE (OD-value 0.70).The 
results obtained indicate that high levels of colostral antibodies 
to SE can have a potential to decrease the incidence of lameness 
in piglets, and this ought to be further scrutinised.
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Introduction 
Streptococcus suis is one of the most important swine patho-
gens worldwide. It can cause septicemia, meningitis and other 
infections1. There are 35 serotypes described, with serotype 2 
considered as the most virulent and the most frequent type 
isolated from diseased pigs in Eurasia. However, its prevalence in 
North America is lower, and some other serotypes are also impli-
cated in clinical disease2,3. S. suis , especially serotype 2, has been 
pointed out as an emerging zoonotic agent. Recently, many 
streptococcal toxic shock like-syndrome (STSS) human cases 
with high mortality have been described1. This syndrome is char-
acterized by a short incubation time, an exaggerated infl amma-
tory response with massive organ failure and mortality. Serotype 
33 is not a common serotype, and it represents less than 1% of 
S. suis strains recovered from diseased animals in Canada2. In the 
present study, we report an atypical strain of S. suis serotype 33 
responsible for a STSS cases in pigs. 
Materials and Methods 
Herd: The aff ected herd is a multisite production system, with a 
sow herd of 1000 animals. Weaning is carried out at 18 days of 
age. Nurseries are operated All in All out per building. The herd is 
actively infected with PRRSV.
Health problems in nursery: Acute infections of PRRSV in 
the sow herd lead to abortion problems and weak piglets at 
weaning. During the fi rst 2 weeks post weaning (PW), piglets 
presented diff erent respiratory and intestinal clinical signs, 
accompanied by typical cases of septicemia and meningitis 
caused by S. suis . Response to antibiotic treatment (penicillin, 
amoxicillin or ceftiofur) was good. During weeks 3 to 6 PW, the 
clinical picture changed, with a relatively high proportion of 
animals presenting typical signs of a STSS, such as sudden death 
with septic shock, multi-organ failure, ventral edema with weak 
response to antibiotic treatments. 
Laboratory methods: S. suis isolation/serotyping were carried out 
as described2. In some experiments (comparison purposes), the 
reference strain of S. suis serotype 33 and a well characterized 
virulent strain of serotype 2 were used. Cytokine measurements 
in sera were performed by ELISA. Genotyping was performed 
by ERIC-PCR. Virulence was evaluated using a well standardized 
mouse model, with a dose of 5 X 107 C.F.U./mouse4.
Results 
Bacteriology: Two diff erent serotypes of S. suis were present: a) a 
serotype 4, usually isolated from meningitis cases (1-2 weeks PW); 
b) a serotype 33, responsible for most STSS cases (weeks 3-6 PW). 
Both strains were equally susceptible to the antibiotic used. 
Cytokine levels in swine sera: Sera from STSS caused by serotype 
33 aff ected animals presented in general higher levels of IL-6, 
IL-12 and IL-8 than healthy animals.
Genotyping: A single clone of serotype 33 was responsible for 
the STSS cases in the farm. The strain was genetically diff erent 
from the reference strain.
Figure1. Virulence in a mouse model of infection
Discussion  
• S. suis is able to induce a STSS in pigs, similar to that observed 
in humans in Asia, with high concentrations of pro-infl amma-
tory cytokines in serum of aff ected animals.
• An atypical highly virulent strain of serotype 33 (genotypic-
ally diff erent from the reference strain) was responsible for 
such cases, which hardly respond to antibiotic treatment.
• Serotypes diff erent from serotype 2 may cause important 
disease in North American herds, especially when an active 
PRRSV infection is present.
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Introduction 
Streptococcus suis is a major swine pathogen and a zoonotic 
agent causing mainly meningitis and septicemia. Serotype 2 
is considered the most virulent and the most frequently type 
isolated from both pigs and humans1. Mechanisms involved 
in the host innate and adaptive immune responses toward S. 
suis as well as the mechanisms used by S. suis to subvert these 
responses are unknown. The capsular polysaccharide (CPS) is 
the only proven critical virulence factor1. Dendritic cells are 
powerful antigen presenting cells that initiate the immune 
response against pathogens, and interactions between DCs and 
pathogens can strongly infl uence the outcome of a disease. DCs 
capture and process the antigens, and then migrate to the adja-
cent lymphoid organs where they activate T cells. In the present 
study, we used porcine bone marrow-derived DCs (bmDCs) to 
investigate the capacity of S. suis to interact with DCs and to 
induce their maturation and activation. 
Materials and Mathods 
Bacterial strains: S. suis serotype 2 virulent strain 31533, origin-
ally isolated from a case of porcine meningitis, and its isogenic 
CPS-negative mutant B218 were used .
Generation of bmDCs: Bone marrow was removed from femurs of 
7 week-old SPF piglets. Cells were obtained and characterized by 
morphology and appropriate receptors by FACS2.
Phagocytosis assay and intracellular survival: Bacteria were either 
not opsonized or pre-opsonized with complete normal serum. 
Phagocytosis was left to proceed for diff erent incubation times 
before antibiotics were added into the wells for 1h to kill extra-
cellular bacteria. Cells were then washed and lysed to determine 
viable intracellular bacteria. The intracellular survival of S. suis 
was performed in a similar manner, but antibiotics were added 
for a period times up to 6h. Cells were processed as described 
above. 
Microscopy analysis: The interactions between S. suis and bmDCs 
were analyzed by scanning electron microscopy (SEM). Internal-
ization of S. suis by bmDCs was confi rmed by confocal micros-
copy.
Cytokine measurement and expression of co-stimulatory molecules: 
Levels of IL-6, IL-8, IL-12 and TNF- α in cell culture supernatants 
following S. suis stimulation were measured by ELISA. The ex-
pression of MHC-II and CD80/86 were analyzed by FACS.
Results 
In vitro interactions: S. suis interacts with bmDCs. This interaction 
is modulated by the CPS, as shown by SEM.
Phagocytosis: The CPS interferes with the uptake of S. suis by 
bmDCs (Fig.1). Once internalized, both strains are equally de-
stroyed.
Fig 1: Interactions between S. suis strain 31533 and its non-encapsu-
lated mutant with bmDCs as observed by confocal microscopy. White 
arrows show bacteria.
Cytokines and co-stimulatory molecules: S. suis triggers the 
release of IL-6, IL-8, IL-12 and TNF- α as well as the expression 
of MHC-II and CD80/86 by bmDCs. However, the CPS-negative 
mutant induced higher levels of cytokine production and co-
stimulatory molecule expression by bmDCs than the wild-type 
strain.
Discussion 
• S. suis interacts with bmDCs, which results in an activation of 
these cells.
• The CPS highly interferes with S. suis internalization by and 
activation of bmDCs, as previously shown with other profes-
sional phagocytes1. 
• This reduced level of antigen uptake/activation due to CPS 
might lead to a reduced host immune response.
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Distribution of Streptococcus suis capsular types isolated from diseased pigs in 2008 and 2009 in Canada
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Introduction
Streptococcus suis is an important pathogen of swine caus-
ing meningitis, sudden death, septicemia, endocarditis, and 
pneumonia1. The distribution of diff erent serotypes varies 
depending on the geographical origin of the strains1. As a 
reference laboratory, we routinely perform serotyping of S. suis 
isolates recovered in Québec (and sometimes in other provinces 
of Canada) from tissue samples of diseased pigs. Exceptionally, 
samples from other animal species are also received. Serotype 
determination remains a valuable tool used by veterinary prac-
titioners and diagnosticians, to understand the epidemiology of 
a particular outbreak or to increase the possibility of success of a 
vaccination program within a herd. The present communication 
presents the distribution of the serotypes isolated in 2008 and 
2009 in Canada. 
Materials and Methods
Isolates: Animals from which these isolates have been obtained 
presented a variety of clinical signs, as for example, nervous 
signs, sudden death, arthritis, and/or respiratory problems. All 
but two S. suis strains were recovered from pigs. Although it is 
not possible to determine whether S. suis was the sole causa-
tive agent of the pathological condition, it was isolated in pure 
culture or in a signifi cant number to be considered involved in 
the pathology observed. One strain was isolated from milk from 
a caw presenting mastitis and one strain was isolated from a hu-
man case of meningitis. 
Laboratory analysis: Serotyping was carried out by using the co-
agglutination test with reference antisera. All reagents for sero-
typing are prepared in our laboratory according to a described 
procedure2. Serotype 2 strains were tested for the proposed viru-
lence markers muramidase-released protein (MRP), extracellular 
factor (EF) and suilysin (Sly) by PCR and/or red blood cell lysis 
and/or immunoblotting2. Non-typable (NT) or autoagglutinating 
(AA) isolates were confi rmed to belong to the Streptococcus suis 
species using a well described specifi c PCR3. Representative NT 
and AA isolates were tested for the presence of a capsule using 
electron microscopy and polycationic ferritin labelling. 
Results
Distribution of capsular types of S. suis in 2008 and 2009.
Year 2008 Year 2009
Capsular 
type
Number of 
isolates
% of total 
isolates
Capsular 
type
Number of 
isolates
% of total 
isolates
3 43 13.8 3 33 12.0
2 40 12.9 2 29 10.6
1/2 32 10.3 8 20 7.3
8 27 8.7 22 18 6.6
4 15 4.8 1/2 17 6.2
7 14 4.5 33 11 4.0
22 13 4.2 4 10 3.6
5 10 3.2 5 10 3.6
9 6 1.9 7 9 3.3
21 6 1.9 16 6 2.2
NT/AAa 56 18.0 NT/AAa 61 22.3
Others 49 15.8 Others 50 18.2
a non-typable or autoagglutinating isolates
• Most NT/AA isolates (including a bovine isolate) were con-
fi rmed to be S. suis by a species-specifi c PCR.
• Three representative NT/AA isolates were shown to be non-
encapsulated by electron microscopy.
• The human strain was shown to be a serotype 14.
• Most serotype 2 strains are MRP+/-, EF- and Sly-.
Discussion 
• The distribution of the most common serotypes in 2008/2009 
is comparable with that from previous years4.
• The prevalence of serotype 2 is much lower than that from 
European countries1.
• As most North American strains, serotype 2 isolates in 2008/2009 
do not carry European virulence markers MRP, EF and Sly1.
• The fi rst serotype 14 isolate recovered from human in North 
America was identifi ed.
• Most NT/AA isolates recovered from diseased pigs were 
shown to belong to the S. suis species.
• Many of these NT/AA isolates are non-encapsulated, indicat-
ing that they are probably not “new serotypes”: it is possible 
that they belong to known serotypes before they lost the 
capacity to express capsule.
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Preliminary report on the characterization of pathological lesions 
and serotype of Streptococcus suis infection in Serbia
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Introduction
Streptococcal disease is a worldwide problem in the swine 
industry. Among Streptococci, serogroups which are considered 
pathogenic in pigs belonged to Lancefi eld group D, E, C and 
occasionally other groups. In most parts of the world, Strepto-
coccus suis (S. suis) is the predominant agent of Streptococcal 
infection, which is associated with a variety of diseases including 
meningitis, septicaemia, arthritis, endocarditis and pneumonia 
(1). Thirty-three serotypes (types 1–31, 33, and 1/2) have been 
described based on capsular polysaccharides,polysaccharides, 
with serotype 2 being most commonly associated with diseases 
in pigs and humans, and also the most frequently reported 
serotype worldwide (2,3). The objectives of this study were to 
determine the anatomic distribution and pathologic conditions 
associated with S. suis infection and prevalence of S. suis strains 
isolated in pigs from Serbia.
Materials and Methods
The pigs were from 15 conventional farrow-to-fi nish pig farms 
which were submitted to the Pathology Department of the 
Veterinary Institute during 2008 - 2009. Over 600 pigs of diff er-
ent ages were necropsied including: 337 suckling piglets, 179 
nursing piglets, 107 grower/fi nisher pigs and 4 aborted foetuses. 
The samples for bacteriology were obtain from corresponding 
lesions and diff erent tissues including: joint, brain, heart, lung 
abscesses and blood as well as 39 samples of milk, 27 vaginal 
swabs from clinical cases of mastitis and endometritis and 38 
tonsils swabs from slaughtered pigs. The samples were cultured 
on Columbia blood agar base and base for blood agar (M 144-Hi 
Media) containing 5% defi brinated ovine blood. The plates were 
incubated at 37oC for 48 hours. Bacterial isolates were identi-
fi ed by biochemical tests and commercial kits (Api Strep.) and 
for Lancefi eld classifi cations, Slidex Strepto Kit (Biomerieux ref. 
58 810)). Serotyping of S. suis was carried out by a coagglutina-
tion test, using commercial specifi c sera against serotype 1–10 
(Statens Seruminstitut, Copenhagen, Denmark).
Results
Pathomorphological fi nding in suckling, nursring and grower/
fi nisher pigs and clinical conditions in sows associated with S. 
suis infections as well as total number of examined and number 
of positive isolates of S. suis according to site of isolation and 
clinical material were presented in table 1. Distribution of sero-
types of S. suis isolated from corresponding lesions and clinical 
material obtained from sows were presented in table 2.
Discussion
Overall, meningoencephalitis, septicemia and arthritis, otitis 
interna with encephalitis endocarditis and periarticular ab-
scesses and pneumonia, appeared to be most frequent patho-
morphological fi nding in suckling, nursing and grower/fi nisher 
pigs respectively and mastitis and endometritis are the most fre-
quent clinical conditions in sows associated with streptococcal 
infections of pigs from Serbia. These fi ndings are in concordance 
with described lesions in swine from other European countries 
(4), however, encephalitis and periarticular abscesses are most 
frequent pathological conditions in suckling and nursing piglets 
and seems to be main lesions of Streptococcal infections in 
Serbia in 2008 and 2009. 
From the distribution of S. suis strains in corresponding lesions, 
serotype 2 was the most frequently isolated strain, which is at 
this time main causal agent of Streptococcal diseases in Serbia. In 
addition, serotype 1⁄2 was also highly prevalent, and some gener-
ally acknowledgment invasive serotypes in European countries 
such as 9, 3 and 7 (2,4) were much less encountered in our study.
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Table 1 Pathomorphological fi ndings, clinical conditions, a total 
number of examined and number of positive isolates of S suis.
Category Pathmorphological fi ndings No of exam. No of pos. % of pos.
Suckling 
piglets
Mono./poly arthritis 84 23 27.3
Str. septicemia 30 11 37
Meningoencephalitis 43 27 63
Endocarditis 65 14 21.5
Nursering 
piglets
Meningoencephalitis 31 5 16.1
Pneumonia 57 7 12.2
Otitis interna 10 4 40
Periarticular abscesses 37 17 46
Grower/ 
Finisher
Pneumonia 39 4 10.5
Tonsils/swabs 38 11 28.9
Clinical conditions
Sows
Endometritis/vaginal swabs 27 3 11.1
Mastitis/milk 67 9 13.4
Abortion/tissue of fetuses 4 1 25
Total 532 136
 Table 2 Distribution of S. suis serotypes 
% type 2 type 1/2 type 1 type 4 type 7 type 9 type 5 type 3
Streptococcus 
suis 47 17 13 7 6 5 4 3
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Introduction
Streptococcus suis serotype 2 infection in pig herds has signifi -
cant health, economic and zoonotic implications (1, 2, 3) and 
therefore, disease freedom is essential for specifi c pathogen-free 
breeding pyramids. Starting new herds with caesarian-derived 
piglets is recognized to be the most successful method of 
achieving disease freedom but it is costly, slow and labour-
intensive. Disease eradication from established herds has been 
attempted by antimicrobial treatment (4) and medicated-early-
weaning programmes (5). However, the success rate has been 
generally poor, and attributed to subclinical carriage of infection 
in tonsil crypts resulting in failure to detect and eliminate carri-
ers (6). This paper describes a programme that aimed to elimin-
ate S. suis serotype 2 from a nucleus herd through assiduous 
testing of pigs and removal of carriers, medication, vaccination 
and herd relocation.
Materials and Methods
The herd: A 400-sow herd with valuable genetics, in an isolated 
location and area of low pig density. 
Strategy: Initially all sows were tested twice and any positives 
were culled, remaining sows were vaccinated twice (interval 4 
weeks) with Porcilis Strep suis (Intervet-Schering Plough Ltd), 
then all received in-feed medication with potentiated penicil-
lin for 6 weeks and were moved to a clean unit. However the 
herd continued to have evidence of S. suis serotype 2 infection, 
therefore the plan was amended, to create a clean, pure, nucleus 
herd from the progeny. All piglets received the above vaccine at 
14 and 28 days of age and moved to 4 separate sites at wean-
ing. All pigs in all batches were tested 4 times at a maximum of 
6 week intervals from 10 weeks of age onwards, and any batch 
with a positive result was culled in its entirety. From the batches 
that were negative after the fi rst 2 tests gilts were selected and 
moved into isolation for 8 weeks and were then moved to a 
further clean site to start the new herd. 
Testing: Initially this was by culture and immuno-fl uorescent 
antibody test on tonsil swabs and vaginal swabs from individual 
sows, and tonsil swabs from piglets. Testing then changed to 
PCR (7) on tonsil swabs and scrapings from growing pigs. Tonsil 
swabs and scrapings were collected from the palatine tonsils, 
applying as much pressure to the tonsils as possible. Mucus 
samples collected by scraper were transferred to swabs before 
submission to the laboratory.
Results
10 of the 400 sows were culled due to being positive on initial 
testing. Of the remaining 390 sows that moved to the clean 
site 4 were culled following subsequent testing. 9 batches of 
weaners in groups of 80-100 were tested and of those 4 groups 
were culled as positive. 5 batches comprising a total of 450 pigs 
were negative on two occasions. The selected gilts (approx 180) 
tested negative for a further two successive tests and were re-
tained to form the new herd. These gilts have been bred and are 
due to farrow in the coming weeks. To date they have remained 
disease-free.
Discussion
Repeating the same testing schedule on the fi rst crop of piglets 
should provide an indication of the initial success of the pro-
gramme. However, long term monitoring for both the agent and 
any clinical signs of infection will be needed before concluding 
whether the methods used were genuinely successful. If suc-
cessful, the key factors are considered to be eff ective sampling 
and testing methods that allow detection and elimination of 
pigs that remain carriers despite vaccination and medication. 
Use of the tonsil scrapers allow more pressure to be exerted on 
the tonsil tissue and better expression of mucus from the tonsil 
crypts. The change to PCR testing detected some positive ani-
mals that had previously tested negative by swabbing the tonsil 
surface and hence, aided the elimination of carriers. Establishing 
a practical and successful means of eradicating S. suis serotype 
2 from breeding herds without total depopulation or using 
caesarian-derived methods of piglet retrieval will be a valuable 
resource for companies undertaking radical health improvement 
programmes in the future.
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Development of immunohistochemistry for detection of Brucella 
suis type-2 in formalin-ﬁ xed tissues from pigs
Zeljko Mihaljevic; Dinko Novosel; Zoran Lipej
Croatian Veterinary Institute, Zagreb, Croatia
Introduction
The aim of this study is to develop an immunohistochemical 
method for detection Brucella suis type 2 and to compare this 
method with PCR detection and bacteriological isolation.
Material and Methods
Testis samples obtained from 10 naturally infected pigs that 
were PCR and bacteriologically positive to Brucella suis type 2 
were analyzed by immunohistochemistry (IHC). Demonstration 
of Brucella suis type 2 in formalin-fi xed , parafi n-embedded 
tissues was performed using polyclonal antibodies and positive 
samples kindly provided by Dr. Silvio Spicic (Croatian Veterinary 
Institute, Zagreb, Croatia). Testis tissue from clinically healthy 
pigs and PCR and bacteriologically negative tissue samples 
served as negative controls. Briefl y, 5 μm cuts were placed on 
silanized slides, section was deparafi nized in xilen and rehydrat-
ed through diff erent grades of ethanol. Endogenous peroxidase 
was blocked with 3% H202 in 0.5M/0.15M Tris/NaCl (TBS). Slides 
were pretreated with Proteinase K (Dako ® ) 3 min. on room 
temperature according manufacture instruction. Non-specifi c 
reaction was blocked with incubation 1 hour in 5% normal goat 
serum. Primary antibody was diluted 1/500 in 2% normal goat 
serum in TBS and incubated over night at +4°C. Anti-mouse 
secondary antibody marked with labeling polymer (Dako En-
vision) was incubated according with manufacture instruction. 
For visualization is used DAB chromogen, slides were counter-
stained with Mayer’s hematoxylin and then were dehydrated 
and mounted with DPX. 
Results
In testis of PCR and bacteriologically positive pigs Brucella suis 
type 2 was found in all diseased animals. In their testis samples 
large amounts of Brucella suis type 2 antigen were concentrated 
in the cells of the infl ammatory foci. All samples from healthy 
animals were IHC negative. 
Figure 1. IHC detection of Brucella suis type 2 antigen, Mayer’s 
hematoxylin counterstain. 40x. 
Discussion
An optimized IHC protocol was developed for the detection of 
Brucella suis type 2 in formalin-fi xed, paraffi  n-embedded tissues 
and its results were compared with those determined by PCR 
and bacteriological isolation. The results obtained show that 
the use of IHC test is a reliable detection method. In the present 
study observed infection pattern is consistent with similar stud-
ies. When only formalin-fi xed tissues are available, IHC would be 
useful diagnostic methods for the detection of Brucella suis type 
2. The high specifi city of IHC test for Brucella suis type 2 could be 
used in experimental studies of disease in pigs.
References
Bergagna et al., 2009. J Wildl Dis 45, 1178-1181.
Cvetnic et al., 2003. Acta Vet Hung 51, 465-473.
Cvetnic et al., 2005. Vet Rec 156, 584-585.
Delrue et al., 2004. FEMS Microbiol Lett 231, 1-12.
Foster, R.A., Ladds, P. W., 2007. Male genital system. In: Maxie, M.G. (Ed.), 
Pathology of Domestic Animals. Elsevier, pp. 585-587. 
Fretin et al., 2008. Vet Microbiol 131, 376-385.
Perez et al., 1998. Vet Diagn Invest 10, 17-21.
Thirlwall et al., 2008. Vet Res Commun 32, 209-213.
Other bacterial diseases – Other
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 838
Poster Presentations
P.532
Eﬀ ect of Erysipelothrix rhusiopathiae bacterial cell lysate on 
immunogenecity of swine erysipelas killed vaccine
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Introduction 
Swine erysipelas may occur as an acute septicemic disease or 
chronic disease typically characterized by endocarditis and 
polyarthritis. Previous research shows the protective antibodies 
were elected against 64-66 kDa and 40 kDa protein of the 
membrane component in E. rhusiopathiae. Mice immunized 
with the purifi ed 64-66 kDa proteins from E. rhusiopathiae were 
protected against challenge by the virulent strain. The 66-64 kDa 
protein appears to be most immunogenic when complexed with 
glycolipid. This may be due to an adjuvant eff ect of polysacchar-
ide antigens. Therefore cell homogenate of E. rhusiopathiae was 
very important component for eff ective vaccine development. 
In this study the eff ect of E. rhusiopathiae bacterial cell hom-
ogenate to the effi  cacy of the swine erysipelas killed vaccine was 
tested by challenge test using highly virulent E. rhusiopathiae T2 
strain and also we will determined which was the major antigen 
in cell homogenate using western blotting methods.
Materials and Methods
The bacterial strain E. rhusiopathiae SE9 was used in this experi-
ment. The initial culture was grown on solid BHI agar media con-
taining 5 % sheep blood. Bacterial cell number was expanded 
in the fl ask culture using semi defi ned and complex media. 
Measuring the optical density at 600 nm monitored bacterial 
cell growth. The concentrated bacterial cells were homogenized 
using high-pressure homogenizer and cell breakage determined 
by measuring viable cell count. Trial vaccines were made with 
inactivated cell homogenate, whole bacterial cell and mixture 
of the inactivated cell homogenate and whole cell bacterial cell. 
Immunoblotting, SDS-PAGE and ELISA assay were performed 
following general methods. Effi  cacy test of trial vaccines was 
performed by mouse challenge test. using E. rhusiopathiae T2 
strain.
Results
Antibodies to a 66-64kDa and 34 kDa proteins released from 
the cell surface have been shown to be involved in protective 
immunity. The effi  cacy of the vaccine using the bacterial cell 
homogenate was better than vaccine using the bacterial whole 
cell. 66-64kDa and 34 kDa proteins on the E. rhusiopathiae SE9 
are major antigen of the immune response in mouse 
Discussion
The results of this study provide important information for the 
development of safe and effi  cacious vaccine development. 
66-64kDa and 34 kDa proteins on the E. rhusiopathiae can act 
as an important antigen of the vaccine protectivity. In addition, 
66-64kDa and 34 kDa proteins can be used as a protein partner 
for glycolipid conjugate vaccine production.
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Analysis of the surface protective antigen (Spa) patterns of Erysipelothrix spp. 
isolates in tissues, environmental samples and vaccine strains obtained from 
vaccinated farms experiencing acute erysipelas outbreaks in the Midwest
Joseph Bender; Huigang Shen; Tanja Opriessnig
Iowa State University, Ames, IA, USA
Introduction
Erysipelothrix spp. isolates are divided into four groups (E. 
rhusiopathiae, E. tonsillarum, E. sp. strain 1, E. sp. strain 2) and 
28 serotypes (1a, 1b, 2-26, N) (6) Diagnostic investigations of 
U.S. fi eld cases have indicated that E. rhusiopathiae serovar 1a is 
typically the cause of acute septicemic erysipelas and serovar 2 
is most common in subacute and chronic cases of swine erysip-
elas. All other known serovars are thought to have low levels of 
virulence for swine (6). Currently available commercial attenuat-
ed-live vaccines against swine erysipelas are based on serovar 1a 
(3). Swine practitioners often rely on serotyping results to deter-
mine if a vaccine will be cross-protective. Recently, the surface 
protective antigen (Spa) protein of Erysipelothrix spp. was char-
acterized and shown to be highly immunogenic (2). Moreover, it 
was found that Erysipelothrix spp. isolates typically harbor one 
of three known Spa proteins (Spa A, Spa B, Spa C). There appears 
to be cross-protection between isolates within the same Spa 
type but not between Spa types (4). The objective of this study 
was to characterize the Spa types present in Erysipelothrix spp. 
isolates involved in suspected vaccine breaks.
Materials and Methods
Eighteen tissue samples and 126 environmental samples were 
collected from six farms in the Midwest experiencing erysipelas 
outbreaks in vaccinated animals. In addition, autogenous and 
commercially available modifi ed-live erysipelas vaccines that 
were used on the farms were included in the analysis. Tissue 
specimens were also included from cases submitted to the Iowa 
State University Diagnostic Laboratory where swine erysipelas 
was suspected (1). Enrichment broth-based isolation was used 
for detection of Erysipelothrix spp. (1). Further characterization 
was done by serotyping of the isolates (1). In addition, a novel 
multiplex real-time PCR method for simultaneous detection of 
Spa A, B1, B2, and C was used which was previously validated 
using 28 Erysipelothrix spp. reference strains (5). 
Results
Erysipelothrix spp was isolated from tissue samples obtained 
from all six farms which were investigated and included serovars 
1a, 2, 10, and 21. Environmental samples were positive for Ery-
sipelothrix spp on each farm; however in two farms the serovar 
identifi ed from the tissues did not correlate with serovars found 
in environmental samples. Spa PCR results on 109 selected tis-
sue and environmental isolates indicated that isolates identifi ed 
as E. rhusiopathiae serovar 1a, 2, 6, 9, 10, 11, and 21 all were posi-
tive for Spa A, while isolates identifi ed as E. tonsillarum serovars 
7 and 10 were negative for Spa A, B1, B2, and C. E. sp. strain 1 
(serovar 13) was also identifi ed on one of the six farms (negative 
for all Spa A, B1, B2, and C). All vaccines tested were found to be 
E. rhusiopathiae serovar 1a and were positive for Spa A.
Discussion
Previous investigations have shown Spa proteins to be highly 
immunogenic as antibodies are formed against these cell 
surface proteins (2,4). Current literature reports that each 
Erysipelothrix spp serovar is specifi c to a particular Spa protein 
based on analysis of reference strains (4). Results of this study 
indicate that variability exists between Spa proteins and sero-
vars, this conclusion is supported by the fact that the U.S. fi eld 
isolates investigated during this study diff ered in Spa type when 
compared to the Spa types reported for the reference strains. 
Currently available attenuated live vaccines in the US are based 
on E. rhusiopathiae serovar 1a, and contain Spa A. Studies have 
shown that there is cross protection within the same Spa type; 
however, minimal cross protection exists between Spa types. In 
the current study, the Spa type indentifi ed in the vaccines strains 
was not always identical to the Spa type identifi ed in the tissue 
and environmental samples. Further investigation is warranted 
to explore the cross protection provided between Spa types 
under fi eld conditions. 
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Post serological monitoring of a live vaccine implementation swine 
erusipela in piglets on a farm in Puebla State in Mexico
Oscar Huerta Alva; E. V. Vivanco; Y. L. Santos; L. Valencia
Laboratorios Sanfer SA de CV, Mexico, DF, Mexico
Erysipelas is a contagious infectious disease of pigs caused by 
the bacterium Erisipelothrix rhusiopathiae. The Swine Erysipelas 
is an actual disease, as reported Schwarts (AASV 2002) with 
the increase of cases at the University of Iowa, with economic 
impact in the herd losses may include loss of death (1%) - $ 
2.50dls/hembra ; treatment cost $ 1/hembra; abortion (4%) - $ 
5dls/hembra for a total of $ 10dls/hembra. Also in the growth 
stage - complete the death loss (3%) - $ 2.50dls; treatment cost 
$ 1dls; retarded (3%) - $ 1.25dls for a total of $ 4.75dls/cerdo the 
market. The cost of an outbreak can be high, and this does not 
include eff ects on carcass quality, or forfeitures. In 2008, in traces 
of Sonora, Queretaro and Mexico City for the confi scation of 
channels because of erysipelas (personal communication) has 
been frequent. 
Sierra (2006) reports that Erysipelas is the second most isolated 
bacteria in the presence of PRRS in farms of Guanajuato, Jalisco, 
Michoacan and Perea (2006) reports that 90% of animals tested 
in the State of Mexico are positive Erysipelas, Huerta (2006-2008) 
reported 80% incidence of seropositivity in Sonora. According to 
remarks by Dr. Calderon (personal communication) 75% of the 
farms of La Piedad and Tepatitlán have subclinical Erysipelas. 
Materials and Methods
The aim of this study was to monitor the serological to 5 piglets 
before and after application of a live vaccine and see if through 
the Elisa test (kit for the detection and / or quantifi cation of 
specifi c antibodies Erisipelotrix rhusiopathiae INGENASA pig 
serum) we identifi ed a serological response at 30 and 60 days 
after vaccination. The piglets are from a farm of 1,100 stomachs 
located in the State of Puebla, stable PRRS virus and by late last 
year introduced Erysipelas problems and proceeded to vac-
cinate the herd and piglets savanna around week 7 of age . 5 
piglets were selected at random, were identifi ed individually 
and they took blood samples at day 1 (before vaccination) and 
30 and 60 days after vaccination, sera were sent to Diagnostic 
Laboratory IASA, obtaining the following results.
# piglets 1 2 3 4 5
1st blood test 0.098 0.095 0.078 0.101 0.088
2nd blood test 0.095 0.100 0.130 0.088 0.084
3th blood test 0.111 0.113 1.0135 0.119 0.100
Graphically this is the result. 
Discussion
3 / 5 piglets showed a decrease in the immune response during 
the 2nd bleeding and 5 / 5 piglets have a greater serological 
response and uniform prior to vaccination. We believe that using 
the Elisa test for the detection and / or quantifi cation of specifi c 
antibodies in swine serum Erisipelotrix rhusiopathiae (INGEN-
ASA) can be used to measure the response post vaccination, but 
this work must be replicated again to set specifi c parameters 
post-vaccination response, since this kit is designed to identify 
negative animals, suspicious and positive in the presence of 
erysipelas in the fi eld, which we know will change the immune 
response towards each individual and the degree of infection 
present. For the third bleeding, we can see that there is a similar 
response in 5 cases. It is noteworthy that farm animals had clin-
ical symptoms of Erysipelas and after vaccination this extint. 
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Usability of quantiﬁ cation of interferon-gamma production after in vitro stimulation with 
Mycobacterium-speciﬁ c antigen in diagnosis of mycobacterial infection in pigs: a limited ﬁ eld study
Martin Faldyna; Eduard Gopfert; Hana Kudlackova; Marija Kaevska; Iva Slana; Ivo Pavlik
Veterinary Research Institute, Brno, Czech Republic
Introduction and Objectives
At present, there is no doubt that Th1-type immune response is 
crucial for the control of mycobacterial infections [1,2]. Inter-
feron-gamma (IFN- γ) is a key cytokine produced by Th1 lympho-
cytes. It plays a role in modulation of immune response associ-
ated with activation of macrophages [3]. Th1-type immune 
response is also associated with the 4th type of hypersensitivity. 
This fact has been used in intravital diagnosis of mycobacterial 
infections using intradermal administration of a specifi c antigen.
In the 1990, Wood and coworkers showed that quantifi cation of 
IFN- γ produced by lymphocytes after in vitro stimulation with 
a specifi c antigen is a useful tool for detection of tuberculosis in 
cattle [4, 5]. A similar test is used also in human medicine [6]. 
At the 20th IPVS Congress, we showed that IFN- γ release detec-
tion after in vitro stimulation could be used in pigs experiment-
ally infected with M. avium subsp. avium and hominissuis (MAA 
and MAH), with the latter having weaker production [7]. The aim 
of the present study was to ascertain whether the test is useful 
for individual diagnosis of naturally infected pigs.
Materials and Methods
Sixty-one clinically healthy pigs, aged 4-5 months, utilized in 
feeding experiments at the Veterinary Research Institute were 
used in the study.
One month before slaughter, samples of heparinised blood were 
taken from the pigs. The samples were in vitro stimulated for 
20 hours with M. avium - specifi c antigen. Produced IFN- γ was 
quantifi ed using available ELISA kit (BioSource International, Inc., 
USA) in accordance with manufacturer’s recommendations. 
Simultaneously, intradermal administration of antigen designed 
for such a type of test (Avitubal, Bioveta na Hane, Czech Repub-
lic, containing 28000 IU of M. avium antigen) was performed. 
Based on manufacturer’s recommendation, local lesions were 
evaluated 48 hours after administration.
In a slaughterhouse, carcasses were inspected and tuberculous 
lesions were evaluated by microbiological methods (Ziehl-Neel-
sen staining, culture examinations, qPCR).
Results
No animals were positive to intradermal tests, i.e. no local reac-
tion at the site of injection exceeded 2 cm in diameter 48 hours 
after administration.
Lymphocytes of 3 animals produced detectable amounts of 
IFN- γ, i.e. more than 18 pg/ml. Two of these 3 animals were 
bacteriologicaly proven to be infected with MAH. On the other 
hand, one pig infected with M. xenopi was not able to produce a 
detectable amount of IFN- γ.
Conclusions
Our results indicated that detection of IFN- γ production after 
in vitro stimulation with Mycobacterium-specifi c antigen could 
be used in diagnosis of mycobacterial infections in naturally 
infected pigs. It should be noted, however, that much lower 
amounts of IFN- γ were produced by naturally infected pigs than 
by experimentally infected ones [7].
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Testing immunogenicity of Mycoplasma hyosynoviae vaccine 
candidates; Induction of antibodies and IFNγ response
Klara T. Lauritsen; Ulla Riber; Jens Nielsen; Jeanne T. Jakobsen; Gregers Jungersen
National veterinary Institute, Technical University of Denmark, Copenhagen, Denmark
Introduction
Mycoplasma hyosynoviae (Mhs) is a signifi cant cause of acute 
arthritis in swine above 10 weeks of age. No eff ective prophylax-
is is available. Therefore attempts are made to develop a vaccine 
candidate with potential to protect against arthritis caused by 
Mhs. First step is screening of the immunogenic eff ect of Mhs 
antigen in combination with various adjuvants. Earlier studies of 
the infection have shown that antibodies can provide a certain 
degree of protection against the infection (Lauritsen et al., 2006), 
but a cell-mediated immune response has also been shown to 
play a signifi cant role in protection (Lauritsen, 2005). 
Materials and Methods
The four vaccine candidates tested, were based on the same 
formalin fi xed Mhs, but combined with various EMULSIGEN 
oil-in-water adjuvant formulations (MVP Laboratories). One dose 
contained 300 μg antigen in aqueous solution and adjuvant was 
added to 20% of the total volume. Eleven pigs at 12-weeks of 
age (one litter, from Mycoplasma free herd) were administered 
the primary vaccination i.m. (EMULSIGEN-D: 3 pigs, EMULSI-
GEN: 2 pigs, EMULSIGEN-BCL: 3 pigs and EMULSIGEN-P: 3 pigs). 
Revaccination was carried out with identical boosters after three 
weeks. Another three weeks later the pigs were killed. 
Mhs-specifi c IgG in serum was measured by ELISA (Nielsen et 
al. 2005). IFN γ measurements were included as an indicator of 
the ability of the vaccines to induce a cellular immune response. 
Mhs specifi c IFN- γ response was measured by ELISA (Riber 
& Jungersen 2007) in supernatants from stimulated heparin-
stabilised blood.
Results and Discussion
When measuring Mhs-specifi c IgG in serum, all pigs serocon-
verted from day 24 to 28 after fi rst vaccination (i.e. day 3 and 7 
after boost). Plateau was reached 7 to 14 days after boost, OD 
values ranging from 0.5 to 1.75. Measurement of IFN γ in super-
natants from whole blood cultures stimulated with Mhs antigen 
showed that all groups had pigs that reacted to vaccination with a 
very high IFN γ response. All pigs had IFN γ measurements reach-
ing beyond 500 pg/ml, in some pigs beyond 4000 pg/ml (Figure 
1). The negative control samples (PBS stimulated samples) did not 
exceed an IFN γ level of 102 pg/ml. However, no group of pigs had 
consistently higher IFN γ level than the others. 
Figure 1. Mycoplasma hyosynoviae-specifi c IFN- γ response. Type of 
vaccine used is indicated for each pig; Square; EMULSIGEN-D, Triangle; 
EMULSIGEN-BCL, Stippled line; EMULSIGEN, Line; EMULSIGEN-P. 
Earlier attempts to develop a vaccine against Mhs have focused 
on the serological response (Ross, 1978; Feenstra et al., 1994). 
Our experiment, however, focuses on the use of adjuvants that 
are reported to favour cell mediated immune response, while still 
giving rise to an antibody response. The investigation is a part of 
a larger initial screening for vaccine candidates against Mhs. Thus 
more candidates are to be tested, and fi nally a promising candi-
date, with ability to induce both serological end cell-mediated 
immune response, will be tested in challenge experiments.
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Test of vaccine against M.hyosynoviae; Induction of speciﬁ c B-cell memory
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Elisabeth O. Nielsen2 Poul Bækbo2 Sardar Ahmad1 Gregers Jungersen1
1. National Veterinary Institute, Technical University of Denmark, Copenhagen, Denmark; 2. Danish Pig Production, Copenhagen, Denmark
Introduction
Mycoplasma hyosynoviae (Mhs) causes arthritis in swine. Since an 
eff ective immunoprophylaxis against the disease is not avail-
able, the aim of this project was to attempt to develop one. 
Materials and Methods
Twenty-six Mhs-free cross-bred pigs (3 litters) from an infected 
herd were isolated from 31⁄2 weeks of age. A vaccine containing 
formalin inactivated Mhs (strain M60, 300 μg/dose) with EMUL-
SIGEN-BCL® (MVP Laboratories) as adjuvant was administered 
to 13 pigs at 7 and 10 weeks of age. 13 placebo pigs received 
adjuvant in saline. Intranasal challenge infection with Mhs was 
given 3 weeks after boost. 14-21 days after this, the pigs were 
autopsied.
Mhs-specifi c IgG in serum was measured by ELISA (Nielsen et 
al. 2005). IFN γ measurements were included as an indicator of 
the ability of the vaccines to induce a Mhs-specifi c cellular im-
mune response. Mhs specifi c IFN- γ response was measured by 
ELISA (Riber & Jungersen 2007) in supernatants from stimulated 
heparin-stabilised blood.
Results and Discussion 
Three pigs in the placebo group and one in the vaccine group 
developed lameness after inoculation. Eight vaccinated and 
10 placebo pigs had pathological changes in joints at autopsy. 
Primarily mild changes were seen. One day before inoculation 
a signifi cantly higher level of IFN γ was measured in super-
natants of antigen stimulated full blood in the vaccinated group 
compared to the placebo group. On day 6 after inoculation 
the placebo group had a signifi cantly higher IFN γ level when 
compared to the vaccinated group. Compared to placebo pigs, 
all vaccinated pigs had a more potent response in Mhs specifi c 
IgG in serum after challenge, with a more rapid onset and higher 
levels reached before autopsy (Fig 1). The latter results show that 
the vaccinated pigs have been primed to mount a more rapid 
specifi c antibody response when encountering the infection. 
Presence of diff erent levels of maternally derived antibodies in 
the three litters did not seem to interfere with this priming eff ect 
(Figure 1).
Figure 1: M. hyosynoviae specifi c IgG measured in serum of two of the 
litters during the experimental period. Stippled line; vaccinated pigs. Line; 
Placebo pigs. Note that level of maternally transferred antibodies varied.
In order to be able to conclude anything on the protective ef-
fect of the vaccine against clinical disease, larger experimental 
groups are needed.
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Novel vaccine against Mycoplasma hyosynoviae: The immunogenic eﬀ ect of iscom-based vaccines in swine
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Introduction
Arthritis in swine is frequently caused by Mycoplasma hyosyno-
viae (Mhs). For the development of an eff ective vaccine, we 
investigated the immunogenic eff ect of three vaccine prepara-
tions with the ISCOM adjuvant Posintro™ from Nordic Vaccine.
Materials and Methods
Vaccine A consisted of formalin fi xed whole-cells Mhs (300 μg/
dose) mixed with Posintro. Vaccine B consisted of Deoxycholate 
extracted lipoproteins from Mhs organisms (DOC-antigen, 300 
μg/dose) in Posintro and fi nally Vaccine C consisted of DOC 
antigen (50 μg/dose) in Posintro. Each vaccine-group contained 
three pigs. Vaccinations (i.m.) were performed at 12 and 15 
weeks of age. Three weeks after the last dose the pigs were 
autopsied. The presence of specifi c IgG in serum was measured 
during the experiment. Furthermore secretion of the cytokines 
IFN γ and IL-12p40 by stimulated blood cells was measured. IFN 
γ, was measured in supernatants of whole-blood cultured with 
Mhs-antigen whereas IL-12p40 was measured in supernatants 
from stimulated peripheral blood mononuclear cells. The latter 
two measures were included to describe the cell-mediated im-
mune response (CMI).
Results and Discussion 
Vaccine B induced a high level of specifi c serum IgG in all 
animals 1 week after boost. Vaccine C gave a variable response 
after boost, with two pigs seroconverting, while no response 
was seen by vaccine A. All pigs secreted IFN γ after primary 
vaccination followed by an increased production after booster 
vaccination (Fig 1). The CMI response was highest with vaccine B 
when compared to responses induced by vaccine A and C at one 
(P<0.01) and two (P<0.001) weeks after boost. IL-12p40 levels 
in the supernatants corresponded with the IFN γ responses. At 
autopsy only vague signs of tissue damage could be seen, and 
only in pigs that received A and C. 
Figure 1: Mhs specifi c IFN- γ response of the individual pigs after vac-
cination. Triangle; vaccine A, Square; vaccine B, Line; vaccine C
Clearly, Posintro™ Mhs-vaccines possess the potency to raise a 
high level of both a cellular and a humoral immune response. 
Whether the induced immune response prevents clinical disease 
after infection should be measured in a challenge study.
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Detection of Mycoplasma suis in healthy pig populations
Erin Strait; Nyssa Levy; Cassandra Roe; Alejandro Ramirez
Iowa State University, Ames, IA, USA
Introduction
Mycoplasma suis (formerly Eperythrozoon suis) is a blood-borne 
bacterial pathogen and causative agent of immune-mediated 
hemolytic anemia in pigs. Once infected, animals become life-
long carriers, causing a variety of signs that have been reported 
to include reproductive failure, hypoglycemia, general unthrifti-
ness, increased susceptibility to secondary infections, and even 
acute death1. Good diagnostics for this agent are currently lack-
ing, and because of this, the true prevalence and signifi cance of 
this disease is unknown. This organism is not able to be cultured 
in the laboratory, and until recently, diagnosis of M. suis was pri-
marily by acridine-orange staining of red blood cells; however, 
recent studies have shown this method to have limited sensitiv-
ity2. Recently, an intracellular strain of M. suis was identifi ed that 
was unable to be detected by this staining method. An ELISA 
test has been described, but is not commercially available. This 
highlights the need for a rapid and sensitive test such as real-
time PCR. A real-time PCR assay targeting the msg1 gene has 
been recently described, but can only be performed on a single 
instrument that is not widely used, thus limiting its application3. 
The main objective of this study was to develop a real-time PCR 
based on the msg1 assay that could be performed on a wide 
range of instruments and facilitate diagnosis of M. suis. In addi-
tion, a sampling of normal pig populations of various ages was 
performed to begin to assess the prevalence of this organism in 
US swine herds.
Materials and Methods
Blood samples were collected in EDTA and/or heparin tubes 
from apparently healthy pigs in 4 age groups, each from diff er-
ent herds: 3-day old piglets (n=13), 12-18 week old pigs (n=17), 
6-24 month old boars (n=23) and sows at time of slaughter 
(n=42). Additionally, meat juices (n=50) were obtained from 
muscle samples taken at the time of slaughter at 10 unique sites 
in 3 diff erent states and processed at the Iowa State University 
Veterinary Diagnostic Laboratory- Meats Laboratory. DNA was 
extracted by spin column (Qiagen QiAmp DNA mini kit) and/or 
magnetic bead-based protocol (Ambion Mag-Max kit). 
Results
We determined that extracting blood samples by the spin col-
umn method is the most sensitive protocol for positive detec-
tion of M. suis by real-time PCR. Positive samples were found 
within each sample group at various rates between 2-28.6%, 
except for the 3-day old piglets which were all negative. EDTA-
blood samples from PCR-positive (n=10) and PCR-negative 
(n=15) pigs were submitted for complete blood count analysis. 
While not statistically signifi cant due to low sample number, a 
trend for lower clinical blood values in PCR-positive samples was 
observed (Table 1). 
Table 1. Average clinical blood values from selected M. suis PCR posi-
tive or negative blood samples.
PCR result RBC # (x10^6/ul) [Hemoglobin] (gm/dl) Hematocrit (%)
positive 6.03 +/- SD 0.44 11.02 +/- SD 0.77 33.3 +/- SD 2.77
negative 6.20 +/- SD 0.44 12.2 +/- SD 0.66 35.8 +/- SD 2.38
Discussion
Results of this study suggest that the presence and impact of M. 
suis in otherwise healthy pigs may be currently underappreci-
ated. Further testing of both apparently healthy and clinically-
aff ected animals will be necessary to determine the true 
prevalence and signifi cance M. suis-induced disease in today’s 
swine industry. 
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Detection of African swine fever virus (ASFV) DNA in several cell-types from formalin-ﬁ xed 
paraﬃ  n-embedded infected tissues using a new in situ hybridisation (ISH) protocol
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Introduction
African swine fever (ASF) is a highly contagious hemorrhagic dis-
ease of domestic pigs. The disease was reported for the fi rst time 
in Kenya in the 1920s, and actually remains endemic in Sardinia 
and in East and Southern Africa, producing important econom-
ical losses in the pig industry (1). The recent outbreak in Geor-
gia last 2007, and its extension to some Russian counties, has 
increased the chances for the ASFV to be extended to European 
and Asian countries. Due to the absence of vaccines available 
against this disease, ASF control is based on an effi  cient diagnos-
tic and the slaughter of infected animals. 
The aim of the present work was to develop an optimized in 
situ hybridization (ISH) protocol to detect ASF virus genome in 
formalin-fi xed paraffi  n-embedded tissues.
Material and Methods
Animal samples. Tissue samples including liver, spleen, kidney, 
lung, and gastro-hepatic lymph node were obtained from 
experimentally infected animals using Ba71L and E75L virulent 
ASFV isolates. 
ISH method. Three diff erent digoxigenin (DIG) labeled probe 
approaches were used: a pool of DIG-oligonucleotide probes 
complementary to ASFV sequences, a 18.5kb SalI fragment 
(SD probe) of the genomic Ba71V DNA, and the total E75 viral 
DNA (CG probe). Two diff erent proteolytic treatments were also 
tested: proteinase K and pepsine digestion.
Combined ISH and immunohistochemistry (IHC): in order to 
verify the presence of ASFV DNA in the nucleus of lymphocytic-
like cells, a double ISH-IHC protocol was performed in diff erent 
tissues. T-lymphocytes were fi rst identifi ed by IHC using a poly-
clonal anti-human CD3 antibody (Dako). ISH was next performed 
using the CG probe after proteinase K digestion. 
Results
Positive specifi c ASFV signal was obtained in most of ASFV-in-
fected tissues tested either using SD or CG probes. Nonetheless, 
no signal was detected using the DIG-oligonucleotide probes. 
While the SD probe was able to detect the presence of ASFV 
DNA only in Ba71L infected tissues, the CG probe hybridized 
with both E75L and Ba71L infected tissues. Proteinase K treat-
ment resulted more effi  cient than pepsin digestion, yielding a 
better tissue integrity and a lower background.
Regarding ISH staining distribution, intranuclear and perinuclear 
positive signal was mainly found in cells of the monocyte-
macrophage cell lineage. Positive staining was also found in 
other cell types, including endothelial cells, hepatocytes, neutro-
phils, and T-lymphocytes (double staining performed).
Discussion
In the present study, a new optimised protocol to detect ASFV 
genome in formalin-fi xed paraffi  n-embedded tissues has been 
developed. The viral distribution described in this study is in 
accordance with that previously described (2). However, this 
is the fi rst time that intranuclear location of the AFSV DNA has 
been described in diff erent cell types, such as macrophages and 
T-lymphocytes, from ASFV-infected tissues. This surprising result 
might be the in vivo refl ection of an early step of intranuclear 
ASFV replication, as it has been previously described after the 
in-vitro infection of cell lines with the virus (3,4). 
Presented results indicated the utility of this ISH protocol to 
study ASFV pathogenesis and open new avenues to be used in 
the future as a diagnostic tool.
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African swine fever (ASF) is one of the most complex and lethal 
disease of swine. The disease transmission involves domestic 
pigs, wildboars, warthogs and bushpigs. ASFV usually induces 
unapparent infection in a variety African wildboar population. 
Soft ticks (Ornithodoros spp) act as reservoir and biological 
transmission vectors. 
ASF is endemic in the majority of sub-Saharan Africa. Within EU, 
it is confi ned to Sardinia. On June 2007, ASF was notifi ed in the 
Caucasus region, in Georgia. It was associated to a new isolate, 
related to p72 genotype II, circulating in East Africa. Since then, 
ASF progressed to neighbouring countries Armenia, Azerbaijan 
and Russian Federation, reaching the near border with Ukraine, 
and, on October 2009, jumping to St Petersburg in north-west-
ern Russia, in the Baltic Sea. Current situation of ASF threatens 
the EU countries, Eastern Europe, the Black Sea basin countries 
and - in the worst case scenario – central Asia and even China, 
which has the largest pig population in the world. 
 There is no vaccine available and control strategies are based 
on rapid laboratory diagnosis. But, are we ready to combat with 
ASF? Would current diagnostic techniques be sensitive enough 
taking into consideration the new circulating viruses? 
From 2000 to date, reliable, specifi c, and fast PCR tools have 
been developed and validated for virus detection. They have 
been shown to be highly sensitive for the detection of the new 
current circulating isolates in Europe and Africa. 
However, serological surveillance studies performed in East 
Africa among 2004-2009,  have shown low seroprevalence with, 
in contrast, a high incidence of virus in domestic pigs. This could 
be related to genome variability of antigenic ASF proteins in 
Eastern African isolates, the more variable and genotypically 
distant. To what extent current serological diagnostic techniques 
might be missing some of these new variants? 
To study these questions, diff erent ASFV were selected on the 
basis of genome variability criteria and date collection. Particular 
emphasis was placed to those belonging to p72 genotype X, the 
most variable, and p72 genotype II, current European circulating 
genotype. After successfully adapted to grow in COS cells, new 
soluble cytoplasmic antigens were used in indirect ELISA tests 
for initial standardization. To evaluate the capability and compe-
tence of these new tests with regards to the formal ASF sero-
logical tests, a comparative study is carrying out using a wide 
panel of serum comprising: i) experimental sera from “in vivo” 
experiments with East Africa and Caucasus ASFV circulating iso-
lates ii) fi eld sera from East-West Africa and Sardinia from 2004 
to 2009. The preliminary results using the new p72 genotype X- 
based antigen indicate correlation to those using OIE serological 
tests and INGEZIM PPA.K3 Compac®. It’s important to highlight 
the results achieved analysing negative serum samples from 
“apparently healthy” virus-positive pigs from East Africa. The ca-
pability of new others ASFV antigens from Africa and Caucasus 
to be used in ASF serological tests is under evaluation. 
Theses results together with those obtained from in vivo experi-
ments at CISA-INIA with recent isolates from East Africa and 
Caucasus regions, could be the fi rst approach demonstrating 
the capability of the formal diagnostic techniques to perform a 
serological diagnosis with high sensitivity, specifi city and confi -
dence, adapted to current epidemiological situations. 
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The role of sylvatic cycle involving wild pigs, ticks and domestic pigs 
in the epidemiology of African swine fever in Kenya
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Introduction
African swine fever (ASF) is a lethal, hemorrhagic disease of 
domestic pigs for which animal slaughter and area quarantine 
are the only methods of control. Since fi rst description of ASF 
in Kenya in 1921, the disease was maintained in African until 
the initial export in 1957 to Lisbon spreading between 1957 to 
1990 throughout Europe and America. Currently ASF is present 
in Sardinia, in Caucasus Republics and in most than twenty Sub-
Saharan Africa countries, where ASFV can infect hosts through 
either a domestic cycle or a sylvatic cycle involving warthogs 
and bushpigs as well as ticks of the genus Ornithodoros. 
In 2006, ASF broke out among commercial pigs in Kenya-Ugan-
da border and spread in 2007 to Central Kenya around the city of 
Nairobi, after an apparent absence from the entire country since 
2001. The outbreaks were traced to movements of domestic pigs 
and were not linked to warthogs or bushpigs. However, Kenya 
has had several outbreaks caused by regular reemergence of 
ASFV since its fi rst description in 1921. These outbreaks could be 
result primarily from direct contact between infected domestic 
pigs with tick-involvement. In addition, experimental evidence 
suggests that pigs can exceptionally become infected from 
eating infected warthog tissues playing an important role in the 
transmission of the disease in the country. We report the fi rst 
extensive study to investigate the role of sylvatic cycle involving 
warthogs, O. porcinus porcinus ticks and domestic pigs in the 
epidemiology of ASF in Kenya. 
Materials and Methods
Samples from 83 ASF asymptomatic domestic pigs, 51 warthogs 
and a total of 1,576 Ornithodorus porcinus porcinus ticks from 
26 independent warthog’s burrow were collected from area 
of interface between domestic and wild pigs in Central Kenya, 
where ASF had been reported.  Their infection status with ASFV 
was determined using combined p72-based PCRs, restriction 
analyses and virus isolation. In addition, sera from wild suids 
and domestic pigs were tested for anti-ASF antibodies using 
OIE serological prescribed methods. Diff erent ASFV isolates 
were selected for genotyping purposes using a combination 
of full length p54-gene and p32-gene sequencing [1, 2], partial 
p72-gene sequencing [3], and analysis of tetrameric amino acid 
repeat regions within the variable region of the B602L gene 
(CVR) [4]. 
Results
The presence of ASFV was determined in 62 of 285 (22%) O. 
porcinus pools, 3 of 51 (3.22%) warthogs serum samples and 
41 of 83 (49%) domestic pigs serum samples. Interestingly, no 
seropositive response was found in any domestic pig in contrast 
with the warthog’s results where all of them were seropositives. 
Twenty O. porcinus, twelve domestic pigs and three warthog 
ASFV isolates were selected for genotyping. Phylogenetic analy-
sis indicated that the ASFV isolates obtained in this study from 
ticks and healthy domestic pigs clustered in a sylvatic cycle P72 
genotype X, whose range encompasses viruses from Rwanda, 
Burundi, Tanzania and Kenya, whereas ASFV isolates collected 
from warthogs were placed into p72 genotype IX related to 
recent domestic pig outbreaks occurred in Kenya in 2007. 
Discussion 
The detection and characterization of ASFV in warthogs, ticks 
and domestic pigs in this study verifi es and expand on the fi rst 
report of the relevance of vertebrate and invertebrate hosts 
in the transmission and maintenance of ASF following disease 
outbreaks in Kenya. Together these results signal the possible 
establishment of domestic pig- warthog and domestic pig- tick 
cycle transmission playing an important role in the maintenance 
and possible reemergence of future outbreaks of the disease in 
Kenya. This highlights the complex epidemiological situation 
in Eastern African countries which complicate control of the 
disease in these regions and emphasize the requirement for 
improved regulation and monitoring of domestic pig as well 
as a most eff ectiveness control by preventing contact between 
domestic pigs and wild suids and their ticks. 
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Immunogenicity of commercial vaccines for the control of 
Porcine Rubulavirus causing Blue Eye Disease
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Introduction
Porcine Rubulavirus is the causal agent of Blue Eye Disease 
(BED). This is an endemic disease of the central area of Mexico, 
been the only country reporting the disease (Stephano et al, 
1981). The objective of this study was to analyze the capacity 
of commercial vaccines to stimulate the pig immune system to 
produce neutralizing antibodies.
Material and Method
3 weeks-old SPF piglets were divided in 2 groups. The fi rst group 
with a commercial inactivated vaccine A (n= 16) and the second 
group with a commercial inactivated vaccine B (n =16). Both 
groups were vaccinated at days 0 and 14 of the experiment with 
a dose of 2.0 mL. Blood samples were taken on days 0, 14, 21 and 
28 post vaccinations (PV). Antibody detection was done by means 
of Virus Neutralization (VN) test, with two-fold dilutions in a 12 
wells plaque. A positive result was considered when the sample 
reached a titer equal or higher than 1:16 (Ramirez et al, 1996).
Results
Twelve animals died due to causes not related to the trial. Group 
A started with 13 pigs and group B with 7. 
For vaccine A, sero-conversion was fi rst detected on day 14 PV 
(76.92%), and by day 28 PV all animals were positive, as shown in 
graph 1. 
For vaccine B, sero-conversion was fi rst detected on day 28 PV 
(28.57%), as shown in graph 1.
Discussion and Conclusions
Vaccine A showed a better capacity to stimulate the immune 
system of SPF pigs (antibody level was 1:128 at day 14, reaching 
1:2048 on day 28). Vaccine B showed a lower capacity to stimu-
late the immune system of SPF pigs (at day 28 antibody level 
varied from 1:16 to 1:256). Statistical diff erences were detected 
among both groups at days 14, 21 and 28 using a T test (P=0.05).
Serological response diff erences found for both commercial 
inactivated vaccines can be due to several factors such as the 
seed used, viral titer before inactivation, quantity and quality of 
antigen, inactivation process, production process and type of 
adjuvant, among others.
Graph1. Comparative neutralizing antibody levels induced by 2 ap-
plications of two commercial inactivated Blue Eye Disease vaccines.
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Cross serological reactions obtained in SPF pigs inoculated with 
diﬀ erent Rubulavirus isolates (Blue Eye Disease)
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Introduction
A controversy in Veterinary Medicine in reference to the exist-
ence of cross reaction or cross immunity exists, the fact that this 
phenomenon can aff ect the vaccination and diagnose process-
es. A classical example is Newcastle disease virus, any vaccine 
strain protects against any pathogenic isolate, independently of 
the homology percentage and is equally employed in laboratory 
tests. In pigs PRRS virus (1), which can or can’t protect against 
diff erent isolates when employed as a vaccine. In a negative 
sense we fi nd Bovine Viral Diarrhea (BVD) and Classical Swine 
Fever (CSF)(2), since the presence of BVD antibodies can yield 
a false positive result for CSF. The objective of this study was 
to acknowledge cross reactions that exists between antibody 
levels detected in serum of challenged animals and confronted 
with isolates of homologous and heterologous Blue Eye Disease 
(BED) isolates.
Material and Method
Nine SPF 8 weeks old pigs were employed distributed as follows: 
Group A (n=3), Group B (n=3) and Group C (n=3). The animals 
were challenged with isolates of BED virus, from 1999 (virus A), 
2000 (virus B) and 2006 (virus C). Challenge dose was 105.0 TCID 
50%/mL administered 1.0 mL/IM and 1.0 mL/IN. Blood samples 
were taken from 0 days post challenge (dpc) and up to 36 dpc, 
with intervals of 4 days. Virus sero neutralization test (VSN) was 
employed with serial double dilutions starting at 1:2 and up to 
1:4096; a positive result was considered with a titer of 1:16. For 
such test all 3 virus (A, B and C) were employed as test antigens 
(Ag) for the virus employed in the challenge (An antigen hom-
ologous to each challenge isolate) and also a 4th virus isolated 
in 1992 (virus D) (heterologous antigen for all the challenge 
isolates).
Results
At days 0 and 4 post challenge (PC) all animals remained nega-
tive. At day 8 PC group A became positive to Ag A and D but re-
mained negative to B and C; Group B became positive to Ag A, B 
and D but negative to C; Group C became positive to Ag A and D 
but negative to B and C. At days 12 and 16 animals form group A 
were negative to antigen C but positive to A, B and groups A and 
C, became positive to all 4 Ag used with mid to low titers. From 
day 20 to 36 all animals became positive to all four Ag with mid 
to high titers (see table 1). It was noticeable that challenge virus 
C was less antigenic than the other 2 towards the 4 tested Ag. It 
is also noticeable that using Ag D a higher titer of antibodies was 
reached, even in comparison with homologous reactions.
Table 1. Average serological results at diff erent days PC using VSN tests. 
Sampling Challenge Ag A Ag B Ag C Ag D
3 DPC Virus A 1:20 1:12 1:5 1:34
3 DPC Virus B 1:24 1:20 1:6 1:32
3 DPC Virus C 1;17.33 1:14 1:5.33 1:28
16 DPC Virus A 1:144 1:32 1:4 1:64
16 DPC Virus B 1:256 1:128 1:128 1:512
16 DPC Virus C 1:96 1:96 1:64 1:192
24 DPC Virus A 1:256 1:256 1:256 1:512
24 DPC Virus B 1:256 1:126 1:128 1:512
24 DPC Virus C 1:128 1:128 1:64 1:512
36 DPC Virus A 1:256 1:256 1:128 1:512
36 DPC Virus B 1:128 1:256 1:128 1:256
36 DPC Virus C 1:128 1:64 1:64 1:512
Discussion
Cross reaction is given in function to characteristic or antigenic 
distance between the virus that produces immunity and the 
employed virus, for the case, in VSN. For this study the cross re-
action was from low to negative intensity at 8 days PC, the anti-
bodies of the 3 challenged groups being able to detect A and D 
antigens but in low titers, 1:20 and 1:30 respectively. As days PC 
passed the antibody levels became mid to high, antibodies from 
all 3 challenged groups identifi ed all 4 Ag. C antibodies were un-
able to detect homologous virus in comparation to A and B Ag 
at 8 days PC. Antibodies had higher affi  nity to A and D from day 
8 PC and posterior samplings. The cross reaction can be linked to 
the viral capacity to stimulate high antibody titers as observed 
with Ag C, the less antigenic.
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Potency of a Blue Eye Disease commercial vaccine against 3 diﬀ erent viral challenges (Lung lesions)
Horacio Lara-Puente; Bernardo Lozano-Dubernard; David Sarfati-Mizrahi; Ernesto Soto-Priante; 
Francisco Quezada-Monroy; Ruben Echeveste-Garcia de Alba
Laboratorio Avi-Mex, S. A. de C. V., Mexico City, DF, Mexico
Introduction
Blue Eye Disease (BED) was observed in the 80´s in farms around 
La Piedad, Michoacan, Mexico. Aff ecting pigs of diff erent ages. 
Lung damage caused by the virus is of capital importance since 
the loss of pulmonary capacity repercutes in productive par-
ameters and days to market, impacts medication costs and pigs 
become diff users of the disease in the farm and the geograph-
ical zone (ISU 2006 and Hernandez et al 2004). The objective was 
to determine the lung lesion percentage produced by 3 diff er-
ent isolates of BED and to evaluate the protective response of a 
vaccine by reduction of lung lesions against these 3 genetically 
diff erent viruses.
Material and Method
Virus: 3 isolates collected in Mexico between 1980 and 2007. 
Animals: 28 SPF pigs between 5 and 6 weeks of age distributed 
in 7 groups, 4 piglets each, Negative Control (NC), Positive 
control Challenged with A virus (PCCAV), Positive Control chal-
lenged with B virus (PCCBV), Positive Control Challenged with 
C virus (PCCCV), Vaccinated Challenged with A virus (VCAV), 
Vaccinated challenged with B virus (VCBV) and Vaccinated 
Challenged with C virus (VCCV). All groups were maintained 
with strict biosecurity measures, with daily monitoring of rectal 
temperature and clinical signs. Blood samples were drawn at 
day 0 and repeated every 7 days. On day 0 pigs were vaccinated 
with 2.0 mL/IM of a commercial vaccine against BED, repeating 
at day 17. Challenge was performed 15 days post vaccination 
(pv) using 3 viral isolates (A, B, and C) with a genetic homology 
of 100%, 99.7% and 97.6% respectively, using 1.0 mL/IM and 1.0 
mL/IN at 10 5.0 CCID 50% mL. At day 18 pc all animals were sac-
rifi ced and necropsied, lung lesions were evaluated and blood 
was collected. Lung lesions were valorated by the planimetry 
method described by Ciprian et al (1988). An ANOVA test and 
Tukeýs test was done to the collected data.
Results
Lung lesions on pig groups PCCAV, PCCBV and PCCCV reached 
an average of 6.9%, 8.0% and 2.2% respectively. On groups 
VCAV, VCBV and VCCV this average lowered to 1.5%, 3.6% and 
0.3% that is a reduction of a least 55% (Table 1, Graph 1).
Table 1.  Lung Lesion Average.
Challenge 
virus
Negative 
control Challenged
Vaccinated 
Challenge
Reduction of 
lesion
A 0 6.9 1.5 78.3
B 0 8.0 3.6 55.0
C 0 2.2 0.3 86.4
Average 0a 5.7b 1.8c 73.2
Diff erent literals indicate statistical diff erences (P ≤0.05). 
Graph 1. Percentage of Lung Lesions
Discussion/Conclusions
 The commercial BED vaccine clearly showed eff ectively lung 
lesions reduction and protected independently to genetic 
diff erences of the challenge virus. No statistical diff erence was 
found between lesion reduction and viral genotype employed in 
challenge, however it was found between challenged pigs and 
vaccinated challenged pigs (P ≤0.05).
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Clinical response in SPF pigs challenged with isolates of Porcine Rubulavirus (Blue Eye Disease)
Ruben Echeveste-Garcia de Alba; Bernardo Lozano-Dubernard; David Sarfati-Mizrahi; Ernesto Soto-Priante; 
Francisco Quezada-Monroy; Horacio Lara-Puente
Laboratorio Avi-Mex, S. A. de C. V., Mexico City, DF, Mexico
Introduction
Porcine Rubulavirus aff ect swine and produces nervous signs 
and high mortality in 2 to 5 days-old piglets. It also produces 
reproductive failures. Aff ected sows increase the wean to service 
and repetitions rate, it also increases the number of stillbirths 
and mummies; in males, libido and semen quality are aff ected 
due to a permanent damage to testicular structures. In aff ected 
animals, regardless to their age, corneal opacity (blue eye) can 
be observed around 30 days post-infection in about 10% of the 
herd. The most important macroscopic lesion observed in pigs 
of all ages is pneumonia (consolidation zones) aff ecting the ven-
tral region of the cranial lobes. Such clinical sign depends on the 
age, immunological status, production system and concomitant 
infections present (Stephano et al, 2002). The objective of this 
study was to acknowledge the behavior of 3 Porcine Rubulavirus 
isolates in relation to days with fever and percentage of macro-
scopic lung lesions in order to correlate fever with lung damage.
Material and Method
Eight weeks old SPF pigs (Avifarma, SA de CV, Mexico) were 
divided in 3 groups and challenged with diff erent BED isolates. 
Group A (n= 3) challenged with isolate A (1999); Group B (n= 3) 
challenged with isolate B (2000), and Group C (n= 3) challenged 
with isolate C (2006). Challenge with any of all isolates was done 
with a 105.0 TCID50% administered by intramuscular and intra-
nasal routes (1 mL each). Rectal temperature and clinical signs 
were monitored daily. At day 18 post challenge (PC), one pig 
from each group was humanely sacrifi ced in order to evaluate 
lung lesions. At the end of the experiment on day 36 PC, all pigs 
were humanely euthanized and lung lesions were evaluated. 
Lung lesions score was performed according to the planimetry 
method described by Ciprian et al (1988). The correlation be-
tween fever and lung lesion was analyzed.
Results
Among the 3 viral isolates employed, virus B showed the highest 
number of days with fever (24) and also the highest percentage 
of lung lesion (8%), compared with the other 2 viruses employed 
(see graph 1), which indicates a direct correlation among fever 
and lung damage. Pigs also had a fever peak at day 3–5 PC in all 
3 groups.
Discussion
A direct correlation between days with fever and lung lesions 
was detected, the higher the numbers of days with with fever 
the higher the percentage of lesions. Pigs had a higher immune 
response towards virus A and B than to C. This is coincident with 
fi eld observations regarding clinical signs. Apparently signol-
ogy and clinical lesions diff er towards what was described in 
the initial reports of the disease in 1980. The lung damage and 
days with fever induced by Rubulavirus or any other pathogen 
has a lot of impact in pigs, due to the loss of lung capacity and 
appetite loss, which in time repercutes in productive parameters 
as daily gain, alimentary conversion and in consequence days to 
market, and also negatively impacts medication costs in order to 
control secondary pathogens.
Graph 1. Average of lung lesions and days with fever
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Impact in days with fever after the employment of a commercial 
Blue Eye Disease vaccine against 3 viral challenges
Horacio Lara-Puente; Bernardo Lozano-Dubernard; David Sarfati-Mizrahi; Ernesto Soto-Priante; 
Francisco Quezada-Monroy; Ruben Echeveste-Garcia de Alba
Laboratorio Avi-Mex, S. A. de C. V., Mexico City, DF, Mexico
Introduction
Blue Eye Disease (BED), was originally described in Mexico in 
the 80’s. Besides the lesions produced by the viral replication it 
is important to consider fever as a generator of productive loss-
es since an animal during this process eats very little or noth-
ing at all, situation that repercutes in its productive effi  ciency 
and also converts them into easy targets for other pathogens 
(Hernández, et al, 2004). The objective of this research was to 
evaluate the impact of the use of a BED commercial vaccine in 
days with fever in animals challenged with 3 genetically diff er-
ent BEDv isolates.
Material and Method
Virus: 3 BED isolates, obtained during 1999 – 2006 (Quezada, et 
al, 2008). Animals: Twenty eight SPF, 5 – 6 weeks old pigs, distrib-
uted in 7 groups of 4 pigs each: (NC) Negative Control, Positive 
control Challenged with A virus (CA), Positive Control challenged 
with B virus (CB), Positive Control Challenged with C virus (CC), 
Vaccinated Challenged with A virus (VCAV), Vaccinated chal-
lenged with B virus (VCBV) and Vaccinated Challenged with C 
virus (VCCV). All groups were maintained in strict biosecurity 
measures, with daily monitoring of rectal temperature and 
clinical signs. For temperature monitoring infrared thermom-
eters (Dottori UR 100), were employed, reading the temperature 
on the neck area posterior to the ear of the pigs. In order to 
determine presence or absence of fever the average daily tem-
perature of NC was employed, we determined a group average 
and Standard deviation (SD) was calculated, we added twice 
this value to the obtained average, all data above this rank was 
considered as fever. On day 0 they were vaccinated with 2.0 mL/
IM of a commercial BED vaccine, repeating it 17 after; challenge 
was done 15 after revaccination, using 3 diff erent isolates (A, B 
and C) with a genetic homology of 100, 99.7 and 97.6% respect-
ively, using 1.0 mL/IM and 1.0 mL/IN at 105.0 TCID50%/ml. At day 
36 post challenge all animals were sacrifi ced, and necropsied. 
Results
None of the NC group had fever or clinical signs at all. The per 
se eff ect of the vaccination on the pigs was minimal and was 
detected as fever 1 days PV that spontaneously receded without 
any other eff ect. On vaccinated/challenged groups with isolates 
A, B or C (VCAV, VCBV and VCCV) between 1 and 3 days with fever 
were detected (Table 1), on non vaccinated/challenged groups 
(CA, CB and CC) had between 15 to 24 days with fever (Graph 1)
Table 1. Days with fever
Virus Negative Control Challenged Vaccinated
A 0 18 1
B 0 24 3
C 0 15 3
Graph 1. Days with fever, challenged animals and vaccinated/
challenged animals.
Conclusions
Clinical manifestations of viral infection on SPF pigs were less 
severe than expected. It is probable that secondary infections 
in commercial pigs and other unfavorable environmental farm 
conditions become a factor in the clinical onset of the disease 
along with the pigs age. The decrease of the disease’s impact in 
the fi eld by employing a commercial vaccine is shown not only 
in the adverse eff ects of the infection but with a reduction of 
at least 80% of days with fever after challenge, which in turns 
manifests as a considerable improvement in the herd.
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Hemmaglutination inhibition test using diﬀ erent porcine Rubulavirus Isolates (Blue Eye Disease) 
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Introduction
Currently the diagnostic for Porcine Rubulavirus by antibody 
detection is done through diff erent serologic tests such as 
Immunoperoxidase, ELISA, Virus Sero Neutralization (VSN) and 
Hemmaglutination Inhibition (HI) test. HI has been widely em-
ployed for Blue Eye Disease (BED) diagnostics and seroepidemi-
ology due to its easiness of implementation and that the results 
are repeatable, reproducible, and of low cost, when compared 
to other tests (Gonzalez, 2002). The objective of this study was 
to compare the results obtained by HI tests using 2 diff erent 
isolates of Porcine Rubulavirus.
Materials and Methods
Samples: 144 fi eld sera.
Virus: two diff erent isolates of diff erent origin were employed.
Hemmaglutination Inhibition test (HI): All samples were inacti-
vated at 56° C for 30 minutes. Then adsorbed as follows: 100 μl of 
serum, 50 μl kaolin and 50 μl of 5% bovine erythrocytes resting 
all night. Once adsorbed, double serum dilutions were em-
ployed from 1:4 and up to 1:512, 8 HAU were added incubating 
30 minutes at room temperature, once fi nished bovine erythro-
cytes at 0.5% were added. Sample was considered positive when 
they showed a titer equal or higher to 1:16 (Ramirez, 1996).
Results
Using Virus A we detected 91 positive and 53 negatives sera; 
virus B detected 85 positive and 59 negative sera (Table 1). It was 
noticeable that in 80.56% of the samples there were no diff er-
ences in the dilutions or only one diff erence, with 2 diff erences 
13.19% and with 3 or more 6.25% (Table 2). To know if there 
were diff erences among results, a T student test was performed 
and did not found statistical diff erences among the results em-
ploying both viruses (p= 0.01)
Table 1. HI test results with diff erent isolates.
Virus Positives Negatives
A 63.19% 36.81%
B 59.03% 40.97%
Table 2. Diff erences in the number of dilutions among sera.
Diff erences Serum Samples
0 56 (38.89%)
1 60 (41.67%)
2 19 (13.19%)
3 7 (4.86%)
4 1 (0.69%)
5 1 (0.69%)
Discussion
In this study there were samples which did not completely 
agreed in their results using both viruses, 6.25% of the samples 
had 3 or more dilution diff erences, this may be due to the per-
centage of false positive and false negative inherent to the HI 
test (Hernandez, 1992).
We did not found any statistical diff erence employing both iso-
lates at the moment of the report of the results of the HI test, It 
has been said that result diff erences may exist in the test results 
using diff erent viruses (Sanchez, 2004), but our results agree 
with the theory that there are no antigenic variations among the 
diff erent isolates of Porcine Rubulavirus.
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Real time PCR diagnosis of Blue Eye disease
Alvarado I. Arcelia1 Cuevas R. Sandra1 Colmenares V. German1 A. A. Blormstron1, 2 Garcia F. Arturo1 Mejia S. Pedro1  M. M. Berg2
1. INFAP-CENID-Microbiologia Animal, México, DF, Mexico; 2. Upsala Sweden University, Suecia, Sweden
Introduction
Currently, Blue Eye Disease represents a barrier for the exporta-
tion of swine; it is a disease that aff ects pigs at diff erent ages, 
although 2 to 15 day old piglets are the most susceptible. Most 
notable symptoms are changes in behavior, nervous alterations, 
respiratory failure, and reproductive alterations in dams and 
sires and in some cases corneal opacity of one or both eyes. 
The objective of this study was the development of a sensitive 
and specifi c enough diagnostic method that could to detect 
pigs persistently infected with the porcine Rubulavirus (PoRV-
LPMV) that is the causal agent of this disease. 
Materials and Methods
This method was developed and standardized for the detection 
of the gene fragment that codifi es for the porcine Rubulavirus 
phosphoprotein, in tissue and blood samples. To read it, the 
assay was adapted to a Light Cycler 1.5 system. For standardizing 
this technique a plasmid developed in the University of Agricul-
ture of Sweden was used, which is formed by a 1384 base pairs 
of gene fragment that codifi es for the PoRV-LPMV phosphopro-
tein. Serial decimal dilutions were performed with this plasmid 
to establish the sensitivity of the assay and then the assay was 
tested on samples from naturally and experimentally infected 
animals in order to validate it.  
Results
Results obtained showed an assay sensitivity of 10 copies for 
detecting the positive plasmid control. Assay conditions were 
established according to the protocol corresponding to the 
Light Cycler TaqMan Master, whereby the presence of porcine 
Rubulavirus was established. The assay has 1.98% effi  ciency ac-
cording to the Light Cycler Instrument 1.5 equipment system.
Discussion and Conclusions
Real time PCR technique is effi  cient for detecting with high 
sensitivity animals that carry the porcine Rubulavirus since it is 
possible to carry out the diagnosis with up to a minimum of 10 
phosphoprotein gene copies. Technology developed may be 
transferrable to national diagnostic laboratories. 
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Introduction
Porcine rubulavirus (PoRV) is the etiological agent of blue eye 
disease (BED) of pigs that has been endemic in Mexico (Kirk-
land & Stephano, 2006). The clinical signs are age-dependent. 
Orchitis, epididymitis and decrease of seminal quality are 
presented in boars, eventually leading to infertility (Ramirez-
Mendoza et al., 1997; Solís et al., 2007). Viral RNA persistence has 
been documented in the central nervous system, lymph nodes 
and reproductive tract (Wiman et al., 1998; Cuevas et al., 2009) 
but not detected in semen and viral isolation not is record in 
persistent infection status in boars. The aim of the present work 
was to detect persistent PoRV in semen and reproductive tract 
of experimentally infected boars.
Materials and Methods
Nine 12-month-old York * Landrace boars were obtained from a 
PoRV free farm. Boars were inoculated by intranasal instillation 
with 5 ml 105 TCID50/ml of strain PAC-3 Jalisco/1992 (Ramirez-
Mendoza et al., 1997) and kept for 142 day post inoculation 
(dpi). Serum and semen samples were collected twice per week. 
Antibody response was evaluated by haemagglutination inhib-
ition (HI) and virus neutralization (VN) test. Boars were killed at 
10, 16 and 20 weeks post inoculation (pi) and testicle and epi-
didymis were collected. For PoRV RNA detection in serum and 
semen samples, RT-PCR was performed and amplifi ed 375bp of 
N gene. For viral isolation, semen and reproductive tissues were 
used and cultured in MDCK cell line in order to be stained by an 
indirect immunofl uorescence assay.
Figure 1. Antibody response from PoRV infected boars.
Results
PoRV infection caused clinical signs in day 5 pi, testicular swell-
ing and pathological changes in epididimys were observed 
as well as the spermatic concentration that was signifi cantly 
decreased. At necropsy three boars showed testicular and 
epididymal lesions. All boars seroconvert, HI and VN antibodies 
were detected in the second week pi, showing a high titer until 
the end of the experiment (Fig. 1). Viral isolation and PoRV RNA 
results showed in table 1.
Table 1. Detection of PoRV and viral RNA in samples collected from 
boars experimentally infected.
Number of positive 
boars Sample DPI Viral isolation RT-PCR
3/9 Serum 2-30 +
9/9 Semen + +
1/9 Serum 31-64* +
4/9 Semen + +
1/9 Testicle +
1/9 Epididymis +
0/9 Serum 65-110† -
1/8 Semen - +
2/8 Testicle +
2/8 Epididymis +
0/4 Serum 110-142† -
1/4 Semen - +
1/4 Testicle +
2/4 Epididymis +
*Tissues from one boar killed. †Tissues from four boars killed. 
Discussion
The nine boars exhibited testicular changes and negative ef-
fects in seminal quality. Antibody response in persistent status 
was demonstrated. These results were consistent with previous 
experiments (Ramirez-Mendoza et al., 1997; Hernandez et al., 
1998; Cuevas et al., 2009). Viral isolation is a novel report in per-
sistent status, though other researchers only detected viral RNA 
in epididymis in long time of infection and PoRV in semen in 
acute infection (Solís et al., 2007; Cuevas et al., 2009). Thus, these 
results confi rm that PoRV RNA persists in semen and the virus is 
present in genital organs during prolonged periods of infection. 
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Assay of humoral immunity to porcine rubulavirus (PoRV) experimental infection
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Introduction
Blue eye disease in pigs is an emerging and endemic disease 
in México. The causal agent is porcine rubulavirus a paramyxo-
virus isolated for fi rst time in La Piedad, Michoacan (Kirkland & 
Stephano, 2006). Humoral immune response in clinic phase has 
been identifi ed by conventional test, such haemagglutination 
inhibition (HI), virus neutralization (VN) and indirect fl uorescent 
antibodies (IFA) (McNeilly et al., 1997; Hernández et al., 1998) 
and persistent stage of infection with ELISA specifi c HN anti-
bodies (Cuevas et al., 2009). Quantifi cation of antibody response 
in persistent infection has not been investigated. The objective 
of this study was evaluated the humoral immune response in 
clinical and persistent experimental PoRV infection. 
Materials and Methods
202 serum samples were collected from pigs experimental 
infected (24 sera preinfection and 178 posinfection), analyzing 
two weeks pre and 20 pi.
Haemagglutination inhibition (HI) and virus neutralization (VN) 
test were carried according to previous standard procedures 
(Ramírez-Mendoza et al., 1996; Hernández et al., 1998) with next 
modifi cations for HI, 8 and 16 haemagglutination units were 
used with 1:8 and 0 cut point, respectively. For VN 0.5% chicken 
and bovine erythrocytes were used for measurement haemag-
glutination limit, all assays were performed in MDCK line cells. 
Immunoperoxidase monolayer assay was performed in MDCK 
cell line infected with PoRV at 0.01 MOI. Indirect fl uorescent anti-
bodies test was developed in same cell line, goat anti swine IgG 
conjugated with fl uorescein isothiocyanate was used. All sera 
were placed in double serial dilutions. The results were analyzed 
with SPSS 10.0 statistical package.
Results
The results showed in fi gures. For the IHA test shows no diff er-
ence in the two combinations. In SN diff erences were evaluated 
only three weeks, obtaining a lower antibody titter to observe 
cytophatic eff ect. The IPMA test was similar to the HI, showing 
diff erences only evaluated in one week. For the IFA test results 
are similar to the VN, except evaluated in two weeks, where the 
neutralizing antibody titter was lower.
Discussion
The humoral immune response begins in the fi rst week post-
infection and it maintained high titters for prolonged periods in 
the persistent phase of infection. Cuevas et al. (2009), it has been 
reported that animals retaining seropositivity during the per-
sistent phase of infection, but was not quantifi ed with standard 
methods. The results correspond to previously report by Hernán-
dez et al. (1998), which analyzed the humoral immune response 
by HI and VN in the clinical phase of disease. The results of the 
IPMA and IFA demonstrate the utility of fi xed and inactivated 
antigens in the development of serological diagnostic tests.
References
Cuevas, J. S., et al., 2009. Vet. Immunol. Immunopathol. 127:148-152. 
Hernández, J., et al., 1998. Vet. Immunol. Immunopath. 64: 367-381. 
Kirkland P. D. & Stephano A. 2006. Diseases of swine. 9th Ed. 
McNeilly et al., 1997. J Vet Diagn Invest 9:3-9. 
Ramírez et al., 1996. Vet Méx. 27:257-259.
Other viral diseases – Blue eye disease
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 858
Poster Presentations
P.552
Glycoprotein E2 of classical swine fever virus expressed in yeast protects swine from challenge infection
Guang-Jan Lin1 Maw-Sheng Chien2 Ting-Yu Liu1 Zeng-Weng Chen1 Chih-Chiang Cheng2 Ming-Chung Deng3 Chienjin Huang1
1. Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan; 
2. Graduate Institute of Veterinary Pathobiology, College of Veterinary Medicine, National Chung Hsing University, Taichung, Taiwan; 
3. Hog Cholera Division, Animal Health Research Institute, Council of Agriculture, Executive Yuan , Tansui, Taipei, Taiwan
Introduction
Classical swine fever (CSF) is an economically important swine 
disease worldwide. The glycoprotein E2 of classical swine fever 
virus (CSFV) is capable of inducing the production of neutraliz-
ing antibodies in the host (1). A CSF subunit marker vaccine has 
been developed which contains the E2 produced in insect cell 
by the recombinant baculovirus expression system (2). Recently, 
we have constructed a recombinant E2 protein using the yeast 
Pichia pastoris secreted expression system, and the yeast-ex-
pressed E2 protein (yE2) is able to induce a protective immune 
response against CSFV infection (3). The aim of this study was 
to determine the optimal dose of yE2 vaccine for conferring full 
protection against CSF.
Materials and Methods
Twelve 6-week-old specifi ed pathogen-free (SPF) piglets were 
randomly allotted to three yE2 vaccine groups and a control 
group. Concentrated secreted product from the recombinant 
E2-expressing yeast (yE2) was used for vaccine preparation with-
out further purifi cation steps. Each pig was immunized at 6- and 
9-week-old respectively intramuscularly in the pig’s neck with 2 
ml vaccine containing 200, 300, or 400 μg yE2 (yE2/200, yE2/300, 
and yE2/400 vaccine groups respectively) or normal saline 
(control group) in a 1: 1 water-in-oil emulsion with the adjuvant 
IMS 1113 (SEPPIC). The pigs at 12-week-old were challenged 
intramuscularly via the neck with a 1* 105 TCID50 dose of virulent 
CSFV strain. Serum samples were tested for their neutralizing 
activities by serum neutralization test. Neutralizing titers were 
expressed as the reciprocal of the highest dilution that cause 
complete neutralization.
Results
All yE2 vaccine groups including yE2/200, yE2/300, and yE2/400 
mounted anamnestic response after booster vaccination with 
the average neutralizing antibody titers of 64, 928, and 2683 
respectively. Neutralizing antibody titers of yE2 vaccine groups 
increased dramatically after challenge infection (Fig. 1)
The control pigs developed an acute febrile response after chal-
lenge infection and had to be euthanized because of severe clin-
ical symptoms by the post-infection day 10. None of the yE2/300 
and yE2/400 pigs became febrile (Fig. 2). All yE2-vaccinate pigs 
survived after challenge without any apparent clinical symp-
toms and post-mortem evaluation at 14 days post challenge 
revealed no evidence of CSFV infection.
Discussion 
All of three doses of yE2 vaccine could induce protective im-
mune response against CSFV infection. The optimal dose of yE2 
was recommended to be 300 μg of total secreted protein. The 
E2 constituted 5-10% of total secreted protein (300 μg) which is 
equivalent to 15-30 μg of E2 in one dose of yE2 vaccine. Yeast-
expressed E2 recombinant protein (yE2) represents an alterna-
tive subunit E2 marker vaccine candidate with advantages of 
easy manipulation and low cost.
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Gross and histopathological scoring systems to evaluate Classical Swine Fever virus infections
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Introduction
Classical swine fever (CSF) virus infections cause large economic 
losses in the pork industry and have profound social and welfare 
consequences. CSF has been reported in many countries through-
out America, Asia and Europe in the recent years. Control strat-
egies are based on stamping out as well as vaccination. Clinical 
and pathological diagnoses have proven to be very important in 
the early steps of an outbreak. However, many clinical signs and 
gross lesions cannot be diff erentiated from other porcine diseases. 
The characterization of CSF virus infections by diff erent isolates is 
key to identify the common and unique features associated with 
infection. Few clinical and very few and basic post mortem gross 
scoring systems have been applied to these characterization ex-
periments. In this paper we describe two detailed scoring systems, 
gross and histopathological, and their use in experimental infec-
tions with two genetically diverse CSF virus strains.
Material and Methods
Two diff erent animal experiments were carried out. Six 10 week-
old pigs were inoculated by the intranasal route with 105 TCID50 of 
the corresponding isolate (UK2000/7.1 and CBR/93) and housed 
with 3 animals used as “in contact” sentinels, while 2 animals were 
housed separately as non inoculated negative controls. Clinical 
signs were monitored daily and animals were euthanized at 18-21 
dpi. Post mortem examination was carried out following standard 
procedures and any observed lesion was recorded. 21 param-
eters were used for the gross pathology scoring system: body 
condition, skin and subcutis, tonsils, fl uid in body cavities, spleen, 
kidney, ileum (and ileocaecal valve), caecum and colon, brain 
and meninges, respiratory system, eight lymph nodes (precrural, 
inguinal superfi cial, mandibular, lateral retropharyngeal, medial 
retropharyngeal, prescapular, ventral cervical superfi cial and 
ileocaecal), urinary bladder, thymus and conjunctiva. Scores from 
0 (normal) to 3 (severe) were given to observed lesions for each 
parameter (e.g. hemorrhages, thymic atrophy, etc.)
Samples from tonsils, spleen, kidney, ileocaecal valve, colon, 
encephalon, lung, thymus, pancreas, liver, bone marrow and the 
eight lymph nodes were fi xed in buff ered formalin and embed-
ded in paraffi  n wax. 4 μm sections were stained with H&E for 
histopathological examination. 33 parameters were used for the 
histopathological scoring system and the severity of lesions was 
also recorded from 0 (no lesion) to 3 (severe). Data from both 
scoring systems were analysed by Kruskal–Wallis non-parametric 
mean comparison test and diff erences were considered signifi -
cant for P < 0.05(*).
Results
Results are summarized in fi gure 1 (A, B; gross pathology) (C, D; 
histopathology). Boxes represents percentile 25 to 75; whiskers 
represents maximum and minimum values; lines represent medi-
ans. No statistical diff erences were found between UK2000/7.1 
and CBR/93 inoculated or UK2000/7.1 and CBR/93 in contact ani-
mals. Signifi cant diff erences were observed between the 3 groups 
(inoculated, in-contact and control) within the same experiment.
Discussion
The extended gross and histopathological scoring systems 
described here have proven to be a valuable tool for systematic 
comparison and assessment of pathological fi ndings related to 
CSF infection.
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IFN-gamma immunodetection in tissues from pigs vaccinated (C-strain) 
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Introduction
Classical Swine Fever (CSF) is a viral haemorrhagic disease 
caused by Pestivirus within the Flaviviridae family. The disease 
is characterized by haemorrhages and lymphopenia, and the 
main target cell for the virus is the monocyte-macrophage. 
The attenuated C-strain is an eff ective vaccine, widely used in 
many countries but its use within the EU has been hindered by 
limitations in diff erentiating vaccinated from infected animals by 
serology. To investigate mechanisms behind the eff ective pro-
tection aff orded by this vaccine, we have studied the immuno-
histochemical detection of IFN-gamma within lymphoid tissues 
of pigs vaccinated and challenged with CSF virus.
Material and Methods
Groups of six, ten-week old pigs were vaccinated (V) with the 
Reimser C-strain vaccine by intramuscular route 5, 3 or 1 day/s 
prior to intranasal challenge (Ch) with UK2000/7.1 CSF virus 
strain. Four unvaccinated pigs were also challenged to control 
for infection (C+). In all cases, challenged animals were re-intro-
duced to unvaccinated, “in-contact” (IC) animals twenty-four 
hours post-challenge. Animals were monitored twice daily and 
blood samples were taken to assess viremia (RT-PCR). Animals 
were euthanized and gross and histopathological scores were 
calculated as described (see poster presented by this group). At 
necropsy, medial retropharyngeal lymph node, tonsil and spleen 
were also collected and fi xed with Bouin’s solution for immuno-
histochemical detection of IFNgamma (R&D Systems Inc.) by 
means of a modifi ed ABC technique.
Results
Unvaccinated animals developed clinical signs, viraemia and 
transmitted the virus to “in contact” animals within 14 days of 
inoculation. Animals vaccinated 5 days prior to challenge were 
completely protected. Five of the 6 animals vaccinated 3 days 
prior to challenge had only few clinical signs and pathological 
changes while half of the animals vaccinated 1 day prior to chal-
lenge were protected to some extent. Results of gross pathology 
and histopathology are summarized in Figures 1 & 2 respectively.
Results for IHC detection are summarised in Table 1 (-, less than 
5; +, 5-25; ++, 26-50;+++, >50 cells per sq. mm)
-5 V+ 
Ch -5 IC
-3 
V+Ch -3 IC
-1 
V+Ch -1 IC C+ Ch C+ IC C-
Lymph node
- Lymphoid follicles + - - - - - - - -
- Medulla +++ + + - + + + - -
Tonsil
- Lymphoid follicles + - - - - - - - -
- Interfollicular +++ + + + + + + + -
Spleen
- Red pulp ++ + - - - - + - -
- White pulp + - - - - - - - -
Immunohistochemical detection of IFNgamma displayed high 
levels in animals vaccinated 5 days prior to challenge, mostly in 
lymph node medulla, interfollicular areas of the tonsils and splenic 
red pulp. IFNgamma-expressing cells were reduced in numbers in 
all the other groups. The level of IFNgamma expression in animals 
showing some degree of protection was higher than those not 
protected within the group vaccinate 1 day prior challenge. 
Discussion
C-strain vaccination provides good protection against CSF virus 
infection by 5 days post vaccination and this protection is cor-
related with IFNgamma expression in lymphoid tissues. These 
results support the hypothesis that the presence of high levels 
of IFNgamma secreting cells provide a cell mediated mechan-
isms that are able to control CSF virus infection.
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Comparison of PCR methods for detection of classical swine fever virus and other pestiviruses
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Introduction
Classical swine fever virus (CSFV) is an etiological agent of an 
economically important notifi able pig disease - classical swine 
fever (CSF). Other viruses belonging to the same Pestivirus 
genus, border disease virus (BDV) and bovine viral diarrhoea 
virus (BVDV) types 1 and 2 are also able to infect pigs, some-
times causing lesions resembling infection with a low-virulent 
CSFV strain (1). Therefore, discrimination of these infections is 
important from epidemiological point of view. 
The aim of the study was to compare the usefulness of PCR 
methods for CSFV detection and diff erentiation from other 
pestiviruses. 
Materials and Methods
Viruses. Strains representing all species within Pestivirus genus 
were propagated in cell cultures and included into the study: 
CSFV (strain Alfort/187 of genotype 1 and fi eld strain 1795/94 of 
genotype 2), BVDV 1 (NADL), BVDV 2 (Short) and BDV (Moredun).
RNA extraction and reverse transcription. RNA was extracted 
using Total RNA Prep Plus kit (A&A Biotechnology) and eluted in 
100 μl of RNase-free water. Next, cDNA was synthesized using 
MMLV reverse transcriptase as described elsewhere (4). Tenfold 
dilutions of cDNA’s were aliquoted and stored at -70°C.
PCR methods. Two Real-Time methods and conventional one-
tube nested RT-PCR were applied for specifi c detection of CSFV. 
TaqMan I method was performed according to previously de-
scribed protocol (2). In TaqMan II assay csfv 6 and csfv 7 primers 
designed by Uttenthal et al. (7) and CSFV specifi c probe (Stadej-
ek et al., unpublished) were used. Nested PCR was based on Katz 
et al. (3) with later modifi cations (5) including immobilization of 
the inner primers pair in tube caps.
Additionally two pan-pestivirus specifi c methods, Real-Time 
SYBR Green I (6) and gel-based one-tube nested RT-PCR (8) with 
further modifi cations (5) were included into the study.
All PCR reactions were performed in triplicates. Real-Time PCR 
reactions were run on Stratagene Mx3005P system using Quan-
titect PCR Probe or SYBR Green I kits (Qiagen). CSFV-specifi c 
nested RT-PCR amplifi ed fragment of genome encoding E2/NS2. 
All other assays were designed based on 5’UTR genome region.
Results
The highest sensitivity in detection of CSFV was observed using 
TaqMan I method. Similar results were obtained by CSFV-specifi c 
nested RT-PCR. These methods allowed detection of the virus 
in examined samples containing 101 and 102 TCID50/ml of 
Alfort/178 respectively. 
Both pan-pestivirus specifi c methods were less sensitive in 
detection of CSFV. The virus was detected in samples containing 
105 and 103 TCID50/ml using SYBR Green I and nested PCR 
method respectively. Only the nested RT-PCR method detected 
BDV strain. Moreover, the sensitivity of this test for BVDV detec-
tion was 2 or 4 logs higher (depending on the strain) compared 
to SYBR Green I method. 
Discussion
In this study sensitivity and specifi city of 3 methods specifi c for 
CSFV and 2 methods specifi c for all persiviruses was compared. 
The results confi rmed that both, conventional and Real-Time 
PCR methods, are useful for detection of CSFV and discriminat-
ing from other pestiviruses. However, the compared methods 
diff ered in sensitivity to detect CSFV. The Reak-Time PCR method 
of Hoff mann et al (2) and conventional PCR of Stadejek and 
Pejsak (5) which employed primers described by Katz et al. (3) 
proved to be the most sensitive. 
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Introduction
Porcine Parvovirus (PPV) was described for the fi rst time in the 
60’s (1) and until today it is known as the main infectious agent 
associated with swine reproductive failures (2). In Brazil, the 
porcine parvovirus infection is diagnosed as the cause of repro-
ductive problems for at least 20 years (3). The fetal infection can 
occur through the placenta or from fetuses to fetuses (4) thus, 
those tissues are very important source of contamination (4, 5). 
Because it is an endemic disease in several countries, including 
Brazil, and recently another viral agents have been implicated 
as the cause of reproductive problems the purpose of this study 
was to investigate the presence and distribution of PPV in tis-
sues and in stomach liquid of stillbirth, mummifi ed and aborted 
fetuses from 27 swine farms with reproductive losses. In addition 
to that, the phylogenetic analysis of PPV isolated from fetal tis-
sues was also performed.
Material and Methods
A total of 230 stillbirths, mummifi ed and aborted fetuses were 
collected and necropsied from 27 selected farms. The farms of 
this study were located in the Southern States of Brazil and were 
chosen based on overall reproductive failure rates (6). Organs 
(heart, lung, liver, spleen, thymus, kidney, brain, cerebellum, 
spinal cord, submandibular lymph nodes, inguinal lymph nodes 
and mesenteric lymph nodes) from all 230 fetuses and the 
stomach fl uid of 109 of those fetuses were collected. DNA was 
extracted by proteinase K method (7) and further amplifi ed by 
nested-PCR using specifi c primers from the PPV nonstructural 
protein gene, NS1 (8). The positive samples were sequenced by 
the Big dye terminator method and phylogenetically analyzed.
Results and Discussion
PPV DNA was found in organs of six (2.6 %) out of 230 necrop-
sied fetuses by nested-PCR. The positive organs were cerebellum 
(50%), spinal cord (50%), brain (33.3%), lungs (33.3%), spleen 
(33.3%), inguinal lymph nodes (33.3%), mesenteric lymph nodes 
(33.3%), heart (16.7%), liver (16.7%) and kidney (16.7%). Stomach 
fl uid from the 109 fetuses were also analyzed by nested-PCR 
and the PPV DNA was detected in three (2.8%) of them. Those 
fi ndings confi rm the results obtained by other studies about 
the most frequently infected organ, as heart and lung (9) and, 
together with others factors can help the understanding of virus 
pathogenesis in fetuses. This study indicated a low frequency of 
the infection by PPV on the studied farms, although the disease 
is considered endemic in Brazilian swine herds. Thus, vaccina-
tion and management measures may be playing an important 
role controlling PPV infection in Brazil. Sequencing and phylo-
genetic analysis showed that PPV samples isolated from fetuses 
had 97 to 100% identity with classical PPV. These samples were 
grouped with isolates from China (ZJ-EU790642), South Korea 
(VR-1-AY390557), United Kingdom (CHALLENGE-AY684866) 
and Germany (IDT-AY684872) (Figure 1), indicating that similar 
isolates are present in the various countries.
Figure 1. Phylogenetic tree of samples sequenced in this study (24LM).
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Introduction
The aim of this study was to confi rm previous results (1), to 
include new vaccines in the comparison and to study the impact 
if any on feed intake. 
Material and Methods
The trial was a multicentric, randomised and positive controlled 
GCP study in three farrow-to-fi nish Spanish farms. Follow-
ing a simultaneous 4-weeks batch farrowing, each sow of one 
farrowing batch was randomly assigned to one of 3 treatment 
groups (PARVORUVAX®, and 2 other diff erent Parvovirosis and 
Erysipelas (P/E) vaccines coded VA and VB) according to parity. 
In total, 196 sows were included in the general study, and 95 of 
them in the part of the trial involving feed intake. Sows received 
a booster vaccination 1 week before weaning, being checked for 
rectal temperature and for swelling at the injection site before 
and after injection (at Day 0, Day 0 + 6 hours, Day 1 and Day 
2 after injection). Daily feed intake (from Day -2 to Day 2) was 
determined only in one of the farms using dried feeding. For 
this purpose the experiment in this farm was repeated in two 
subsequent batches. Site reactions were classifi ed in 2 categor-
ies: absent or infl ammation. The statistical procedures used for 
rectal temperature and feed intake was the variance analysis 
implemented by the MIXED procedure of SAS®. The statistical 
model included the sow, group, site, day and their interactions 
and local site reactions were analysed using a logistic regression 
implemented by the LOGISTIC procedure of SAS.
Results
At 6 h post-injection a signifi cant lower temperature was ob-
served in the PARVORUVAX group (P group) compared to vaccine 
VA, -0.33º C (P<0.0001), and a close to signifi cant diff erence, 
-0.16ºC (P=0.05) with vaccine VB. Signifi cantly, less local site reac-
tions at Day 0+6h were observed (p<0.01) in the P group (14.9%) 
compared to the VA (55.8%) and VB (51.0%) groups. This diff er-
ence persisted till the end of the experiment, at D2 (table 1).
Table 1: safety parameters values per group
Group No sows
T Day 
0*
T Day 
0+6h
T Day 
1
T Day 
2
LSR Day 
0+6h
LSR 
Day 1
LSR 
Day 2
P 64 38.59a 38.88a 38.68a 38.76a 14.9a 10.6a 0.0a
VA 65 38.55a 39.21b 38.89b 38.84a 55.8b 53.9b 26.9b
VB 67 38.53a 39.04b 38.79a,b 38.85a 51.0b 53.1b 44.9b
a,b values in the same column with diff erent superscripts were signifi cantly diff erent (p<0.05).
* Temperature on Day 0 was used to covariate the rest of temperature analysis
Feed intake was infl uenced by the type of vaccine used. As 
shown in Figure 1, sows vaccinated with vaccine VA and VB ate 
on the day of vaccination, 0.18 and 0.14 kg less than sows in P 
group (P<0.05 and P=0.05 respectively).
Figure 1: Time course of the feed intake (kg/sow/day) by group for 
sows receiving diff erent Parvovirosis-Erysipelas inactivated vaccines
Discussion and Conclusion
These results confi rm that the use of some Parvovirosis/Erysip-
elas vaccines may have a safety concern as it can have welfare 
and production negative consequences in practice. Our results 
not only confi rm the safety of PARVORUVAX compared to the 
vaccine VB, included in a former study, but also to vaccine VA, 
not analyzed previously. With our experimental design we have 
been able not only to reproduce the eff ects on rectal temper-
ature and site reactions but also to proof an impact of these 
products in feed intake witnessing a general reaction. While 
hyperthermia and local reactions have an obvious impact in the 
animal wellbeing, a transient reduction of feed intake during 
lactation could have further consequences such as reduction of 
milk production and consequently pre-weaning growth retarda-
tion in the litter.
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Introduction
Porcine parvovirus (PPV) is classifi ed in the genus Parvovirus, 
in subfamily Parvovirinae and the family Parvoviridae. The 
large ORF1 and the small ORF3 encode for the non-structural 
proteins NS1, NS2 and NS3. The ORF2 encodes the structural 
proteins VP1, VP2 and VP3. VP1 and VP2 are a result of alterna-
tive spliced RNAs, giving VP1 a specifi c N terminus of 150 aa. VP3 
is generated by proteolytic cleavage of VP2. Recently, PPV has 
gained importance as an agent able to potentiate the eff ects of 
porcine circovirus type 2 (PCV2) infection in the clinical course 
of postweaning multisystemic wasting syndrome, a signifi cant 
economical disease worldwide.We researched two strains in this 
study that PVK1 and SK2 strain isolated from abortion fetus of 
sows in 1980 and 2008, respectively. According to molecular an-
alysis of the two Korean strains and previous studied VRI-1 strain, 
we were to compare a genome characterization and virulence 
among other countries strains.
Material and Methods
Two Korean PPV sequences and 20 sequences from PPVs from 
around the world obtained from GenBank were aligned using 
the Clustal X 1.83 sequence alignment program. Nucleotide and 
amino acid sequence identities among the PPV strains were 
calculated using BIOEDIT 7.053. The phylogenetic tree was cre-
ated by neighbor-joining method using MEGA 4.0 software and 
bootstrap analyses were conducted using 1000 replicates. The 
recombination among PPV strains was analyzed by the recom-
bination detection program (RDP).
Results
Of six amino acid position sites within VP1/VP2 proteins, Korean 
SK2 strain was diff erent only one position (T365I) and VRI-1 
strain was just two positions (G528D and Q533H) comparison 
with Kresse strain whereas PVK1 strain was only two positions 
(T195S and R715K) comparison with NADL-2 strain. The sequen-
ces of NADL-2, POVNADL-2, POVG, SR-1, China and POVCAP in 
this region were the longest among the strains, and contained 
two identical 127-bp repeat units whereas strains 15a, 21a, 27a, 
106b, Kresse and Tornau contained only one complete 127-bp 
unit (Table 1). Strains SK2 and PVK1 lacked 75 bases from 74 to 
148 bases but VRI-1 strain cann’t analyzed due to data none. 
Phylogenetic tree analysis of VP2 protein of 22 PPV strains using 
a Neighbor joining (NJ) method in MEGA 4.0 software didn’t div-
ide clearly as the attenuated and moderate and highly virulent 
groups, but three Korean strains showed grouping similarly on 
tree topology.
Discussion
The genotypic grouping in this study could also be associated 
with neither clinical presentation nor geographical origin of the 
samples, whereas three Korean strains showed grouping simi-
larly on tree topology. In our judgment of three genome analysis 
(mutation amino acid of VP1/VP2 protein, a 127-bp repeat of 
ORF right and phyogenetic tree), three Korean strains are pre-
sumed to include a moderate virulence. On the other hand, The 
genomes among all strains by in GENECONV, SiSCAN, BootScan, 
MaxChi, and 3Seq methods in RDP program analysis weren’t 
determined a possiblie breakpoints of the two recombinants 
which are the major and minor parent strains. On accession of 
no breakpoint may be a very high homology among worldwide 
PPV strains as well as Korean strains.
In conclusion, two Korean strains have one or two diff erence of 
six amino acid position sites within VP1/VP2 protein with Kresse 
strain and on a 127 nt repeat after the right ORF encoding the 
VP1/VP2, strains SK2 and PVK1 lacked 75 bases. Three Korean 
strains on the phylogenetic tree analysis for VP2 gene were 
grouped similarly lineage. Korean PPV strains are presumed to 
include a moderate virulence. 
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Introduction
Aujeszky’s Disease (AD) or Porcine Pseudorabies (PR), which had 
been eradicated successfully in many countries of North- Amer-
ica and Europe(1), is still a widely spread viral disease in China 
(2). The use of a gene-altered vaccine makes it possible to iden-
tify infected pigs from vaccination population. Attenuated live 
marker vaccines are routinely used for a combined vaccination-
eradication program for PR eradication. Several kinds of marker 
vaccines, home-made or imported, are approved for PR control 
in China (2). In this study, effi  cacy of 2 imported marker vaccines 
was compared by gE-antibody test. 
Materials and Methods
A North Chinese pig company (3,500 sows) has 2 farms with 
2,000 sows in Farm 1 and 1,500 sows in Farm 2. There is 2 km 
between the two farms. Both farms implement continuous pig 
fl ow, all-in-all-out management. All sows are from same genetic 
farm and kept in same housing, feed and health management 
systems.
Both farms used home-made attenuated PRV vaccine. After 2 
years’ vaccination, more than 95% breeding animals were still gE 
positive, with poor reproductive and growth performance.
In early March 2008, both farms decided to replace the local vac-
cine with imported PRV vaccines. Farm 1 switched to vaccine B 
(Ingelvac® Aujeszky MLV, Bartha K-61 strain, with water adjuvant). 
Sows and boars were vaccinated 4 times per year. In piglets, an in-
tranasal vaccination was given at 1 to 3 days of age, and a second 
was given intramuscularly at 8 weeks of age. Farm 2 changed to 
vaccine M (another imported attenuated PRV vaccine, Bartha 
strain, with oil-in-water adjuvant). Sows and boars were vaccinat-
ed 4 times per year. In piglets, a fi rst intramuscular shot was given 
at 8 weeks of age, and a second at 12 weeks of age.
Blood samples from boars, sows, 40-55-day old piglets and 
130-150-day old fatteners, were collected from both farms in 
July–Oct. 2008 and May 2009. gE antibody were detected with 
IDEXX PRV-gE ELISA kit.
Results
Fig. 1 showed that the seropositive rate of fi eld strain decreased 
more by Vaccine B in farm1 than Vaccine M in farm2. In 5 
months, fatteners in farm 1 became gE antibody negative and 
that in farm 2 were not. 
Discussion
Piglets born to sows infected with wild type virus should acquire 
gE positive colostral antibody. We reckoned it was colostral anti-
body that caused piglet gE positive, and fatteners were negative 
while gE antibody disappeared and no wild virus infected the 
group pigs in farm 1. In farm 2, the fatteners were gE positive 
which indicated wild virus infected the pigs earlier. 
Intranasal vaccination is more eff ective than intramuscular 
vaccination by local replication and development of mucosal im-
munity in the presence of passively acquired colostral immunity. 
During acute infection, intranasal vaccine virus colonizers the 
trigeminal ganglia, and prevents infection and reduces latent 
infection (3) Two applications of intranasal and intramuscular 
vaccinations of Vaccine B ensure much better protection than 
two intramuscular vaccinations of Vaccine M. Vaccine B was 
more eff ective than Vaccine M in preventing latent infection. 
Figure 1. Seropositive rates of both farms in July, Oct. 2008 and May 2009
The eradication of PR can be most successfully achieved by the 
slaughter of all the seropositive animals, strict control of pig 
movement. However, this is not cost-eff ective. For most Chinese 
farmers, the optimal method of eradication is to implement 
combined vaccination-eradication program (1).
In this study, Vaccine B (Ingelvac® Aujeszky MLV) was proved a 
powerful tool for PR control and eradication. 
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Introduction
In Asia, nowadays, pig producers need to protect their pigs 
and sows against several pathogens. Vaccination programs to 
prevent Aujeszky disease virus and Glässer disease (Haemophilus 
parasuis) contemplate sow and gilt vaccination. The combina-
tion of both vaccines implemented simultaneously in the same 
inoculation point, saving two intramuscular injections, can 
potentially improve both the pig welfare status and the labour 
effi  ciency. Therefore, the objective of this trial is to fi nd out if the 
attenuated gE deleted Aujeszky virus Bartha K61 (AUSKIPRA®-
GN) can keep alive when it is reconstituted with a inactivated 
Haemophilus parasuis vaccine (HIPRASUIS®-GLÄSSER) as a 
previous step to try in vivo the actual eff ect of these combined 
vaccines.
Material and Methods
Material
50 dose freeze dried tablets of AUSKIPRA®-GN vaccine (attenu-
ated gE deleted Aujeszky virus), 50 dose of inactivated Haem-
ophilus parasuis vaccine HIPRASUIS®-GLÄSSER, 100 ml aqueous 
solvent vials and PK15 cell line.
Methods
Two tablets of AUSKIPRA®-GN were reconstituted with 
HIPRASUIS®-GLÄSSER and with aqueous solvent respectively. 
After 0, 2, 4 and 6 hours post reconstitution the virus was titred 
in PK15 cell line.
Results
Table 1. Results of titres per dose of vaccine virus BARTHA K61. Vaccine 
virus titres BARTHA K61 per dose (2ml) (TCID50/dose). Reading by CPE 
(Cytopathic Eff ect).
Hours at standard Temperature 
25ºC after reconstitution AQUEOUS SOLVENT HIPRASUIS®-GLASSER
0 106.2 106.2
2 106 106
4 105.9 106
*6 *105.9 *105.9
* BARTHA K61 vaccine virus Bartha K61 (AUSKIPRA®-GN) kept 
viable and with a dosage titre value equivalent or higher of 
105.5TCID50 (minimum necessary eff ective concentration as 
product manufacturer recommendation) at 6 hours after re-
constitution with the inactivated Haemophilus parasuis vaccine 
HIPARSUIS®-GLÄSSER (100ml). The same results were obtained 
when mixed with the usual prescribed aqueous solvent (100ml).
Conclusions
HIPRASUIS®-GLÄSSER vaccine allows the viability of the gE 
deleted Bartha K61 vaccine virus (AUSKIPRA®-GN) even 6 hours 
after the reconstitution. Further studies in vivo are required to 
discard any vaccine incompatibility.
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Suparlark Nuntawan Na Ayudhya1 Roongtham Kedkovid1 Kampon Kaeoket2 Roongroje Thanawongnuwech1
1. Chulalongkorn University, Bangkok, Thailand; 2. Mahidol University, Bangkok, Thailand
Introduction
Pseudorabies virus (PRV) is a cause of an important infectious 
disease in the pig industry known as Aujeszky’s disease. The 
disease is lethal in piglets; however, in older pigs, the disease is 
not lethal characterized by severe depression, anorexia, pyrexia, 
ataxia and pneumonia. In pregnant sows, the infection may 
result in abortion1. PRV eradication program is usually based on 
the use of the marker vaccine deleted in the non-essential glyco-
protein E (gE) gene2. The vaccinated pigs can be diff erentiated 
from the natural infected pigs by detection of anti-gE antibody, 
commonly done by the competitive ELISA. However, current 
ELISA assays have some limitations such as multi-step and time-
consuming procedures, requirement of an ELISA reader and 
other equipments and subsequent calculations to interpret the 
results. The immunochromatographic strip test is a new diagnos-
tic technique which has several advantages over the commercial 
ELISA, including less time-comsuming (immediate results) and 
no requirement for skilled technicians or expensive equipments. 
Thus, this assay has a potential to be used as a fi eld test. The ob-
jective of this study was to produce the recombinant gE protein 
for the immunochromatographic strip test.
Materials and Methods
The pseudorabies virus DNA was extracted and used for PCR to 
produce a partial gE fragment (coded for the major epitope do-
main of PRV gE gene, nucleotide position 156-714). The purifi ed 
PCR product was cloned into the pGEM®-T-easy vector (Promega, 
USA.) and then cut with EcoRI. The DNA fragment was inserted 
downstream to the TAC promoter of the expression vector pGEX 
5x-3, resulted in gE pGEX 5x-3. The recombinant plasmid was 
transformed into the E. coli Rosetta (DE3) pLysS strain (Novagen, 
USA.). For expression, the E. coli carrying recombinant plasmid 
was 1:50 (v/v) diluted into 1 liter of LB medium (with 100 μg/ml 
ampicillin and 34 μg/ml chloramphenical) and incubated at 37 
oC for 3 h. Then, the protein synthesis was induced by isopropy 
1- β-D-thiogalactopyranoside (IPTG, 0.1 mM fi nal conc.) and the 
bacteria were further incubated at 37 °C for 4 h. The bacteria 
were harvested and then disrupted by sonication. The size and 
the specifi city of the recombinant protein were examined using 
SDS-PAGE and western immunoblotting, respectively.
Results
The expressed products were determined by SDS-PAGE reveal-
ing the extra protein band of approximately 38 kDa molecular 
weight (Figure 1). The ability of the expressed product to bind 
with anti-gE antibody was further confi rmed by the western 
immunoblotting analysis Figure 1, lane 3) using the IDEXX ELISA 
gE positive pig serum as a primary antibody.
Figure 1. SDS-PAGE and western immunoblotting analysis of the 
recombinant protein. 
Expression of gE pGEX 5x-3 in E. coli showed an extra band by 
the SDS-PAGE (lane 2, ~38 kDa, arrow) compared with non in-
duced E. coli (lane 1). The ability to bind with anti-PRV antibody 
was showed by western immunoblotting analysis (lane 3). L = 
protein marker.
Discussion
The recombinant gE protein could be expressed in the E. coli 
system and this recombinant protein was able to stain with the 
IDEXX ELISA gE positive pig serum demonstrating its specifi city. 
This recombinant protein will be used for further study such as 
the checker-board titration and testing for the sensitivity and 
specifi city to ensure the effi  cacy of the developing immunochro-
matographic strip test. 
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Introduction
Aujeszky’s disease (AD or pseudo-rabies) is one of the most 
important swine diseases of the developing word. The disease 
has eff ects on both reproductive and fattening performance of 
the herds. Live, gene-deletant vaccine strains formulated with oil 
adjuvants, are considered the most effi  cient tools (by DIVA) for 
AD eradication programs in the European Union. AD eradication 
still remains a heavy task in Eastern-Europe and in Asia. Virus 
strain of Auphyl® Plus vaccine is a gE (gI) deletant, UL21 mutant 
and gC positive AD virus (ADV), which is a recombinant derivate 
of the Bartha’s strain (K/61).
Material and Methods: Minimum Protective Dose (MPD) trial was 
dedicated to confi rm the choice of vaccine dose of Auphyl® Plus 
in ADV sero-negative 8 week (w) old pigs. 
Study design: Four vaccine dose-groups and a control group were 
formed using 5 piglets in each. Pigs in Group 1 (G1) received one 
shot commercial dose (6.1log10 TCID50). Animals of G2, G3 and 
G4 received 1/10-1/1000 (5.1-3.1 log10 TCID50) doses. The chal-
lenge (ch) was performed 1 month after the intramuscular vac-
cination. The ch-virus, strain AyV-NIA-3 was applied intra nasally in 
2 ml/nostril. The re-titrated ch-dose was 6.7log10/ml TCID50. 
Clinical parameters: 1) symptoms of AD, 2) rectal temperature, 
3) body weight, 4) ch-virus re-isolation. Post-challenge (pch) 
observations were conducted till the 7th day (1) {European 
Pharmacopoea}. 
Results
1. Two control pigs died on the 5th or 7th pch days (pchD). 
Central neural symptoms were shown in all controls and 
none in vaccinates. Total cumulative respiratory symptom 
scores were between 8 and 10 in G1-G4 and 29 in G5. 
2. Rectal temperature increase of the controls was higher than 
in any of the vaccinates, but the diff erence was not signifi -
cant. See fi gure 1.
Figure 1: The group-mean rectal temperature (C°) of the pigs 
before and after the challenge
3. 
Daily body weight gain was almost equal (0.4-0.3 kg) between 
pchD0 and pchD7 in G1, G2 and G3. In G4 it was 0.1 kg. Con-
trols showed -0.4 kg daily body weight loss. See table 1. 
 Table1: Summarized effi  cacy results post-challenge
Group (vaccine) No. Death / Total ADWG D0-pchD7 
Ch-virus re-isolation 
(log10TCID50/ ml) @ 
pchD4
1 (Auphyl Plus) 0/5 0.3 1.9
2 (1:10) 0/5 0.3 2.6
3 (1:100) 0/5 0.4 3.2
4 (1:1000) 0/5 0.1 4.0
5 (controls) 2/5 -0.4 ND
 Among the vaccinates, the less protected pigs were those 
animals which received 1/1000 dose of the vaccine. 
4. Ch-virus re-isolation results (log10TCID50/ ml) on pchD4 
showed signifi cant diff erences between the treatment 
groups: average geometrical mean in G1= 1.9log10, 
G2=2.6log10, G3=3.2log10, G4= 4.0log10.
Discussion
Auphyl® Plus vaccine was protective against death and central 
neural symptoms even in 1/1000 dose (3.1 log10TCID50/ml). 
1/100 is the lowest dose which is protective against the signifi -
cant daily body weight loss in 8 w old pigs. 
Apply DIVA system. Due to these features the vaccine is recom-
mended to perform AD eradication programs. 
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Eradication of PRV in Chinese farm with Ingelvac® Aujeszky MLV
David Xu; Liande Zhu
Boehringer Ingelheim International Trading (Shanghai) Co. Ltd, Beijing, China
The objective of this project was to eradicate PRV (Pseudorabies 
Virus) form a 1500 sows farm by combining vccination with 
Ingelvac® Aujeszky MLV and positive animals elimination acc-
cording to serology diagnosis. It is a one-site production system 
farm located in Jiangshu province China, suff ered a severe loss 
due to PRV outbreak in 2003. Production performance after the 
outbreak could not reach back to normal level.
Materials and Methods
Pre eradication: Before eradication, 100 samples were randomly 
collected in each section for serology (HerdChek® PRV gB and 
HerdChek®* Anti-PRV gI(gE) from IDEXX)to analyze the wild PRV 
infection in the farm. The results showed an over 50% positive 
rate in all herd (Table1). 
Vaccinated program: Breeders: After fi rst massive vaccination, 
a booster vaccination was implemented in a month, then with 
regular vaccination every 4 months. Piglets: intranasal vaccina-
tion at 1 day old, with another intramuscular booster vaccination 
on 65 days old. Gilts: vaccinated twice before mating.
Management: Strict management according to Madec’s 20 was 
implemented in this farm at the mean time.
Measurement: New herds were isolated for 30 days before intro-
ducing to farm with a serology and PCR test against PRV (posi-
tive results would be tested twice for confi rmation). In the fi rst 
3 years blood samples were randomly collected from all herds 
of the farm to monitor the eradication eff ect (N=1,282 samples). 
In the 2nd year after the eradication implementation, all PRV-gE 
serological positive boars were eliminated; in the 4th year all 
PRV positive breeding swine (PRV-gE antibody and PCR tested) 
were eliminated; in the 5th year, randomly sampling from the 
whole herd for serology test to evaluate the eradication effi  cacy. 
Results
Before eradication, the average abortion rate of the sows was 
above 30%. Intractable diarrhea and severe respiratory problems 
were prevalent in the nursery and fattening herds. The clinical 
signs were reduced gradually since the eradication and after 1 
year, the whole herds were stabilized.
Serology surveillance was strictly implemented at the same time 
as vaccination began. During this period, seropositive animals 
were eliminated. Positive rate of the serology test decreased 
consistently and steadily every year. In the 2nd year and 4th year 
after eradication, 5 boars and 13 pigs were eliminated. Serology 
results showed the success since the 5th year (Table1). The all 
negative results indicated the success of the eradication. Since 
then, the farm stopped PRV vaccination in sows and piglets.
Table1. Positive rate of PRV-gE ELISA test Before/After Eradication 
Sows Suckling Nursery Fattening
Pre eradication 50% (50/100) 705 (84/120) 60% (66/110) 50% (50/100)
1st year post 
eradication 18% (20/111) 24% (25/104) 20% (30/150) 18% (15/83)
2nd year post 
eradication 4% (5/125) 7% (8/114) 6% (6/100) 5% (4/80)
3rd year post 
eradication 2% (2/100) 4% (5/125) 3% (3/100) 2% (2/90)
4th year post 
eradication 0 (0/100) 0 (0/115) 0 (0/90) 0 (0/100)
5th year post 
eradication 0 (0/100) 0 (0/110) 0 (0/100) 0 (0/110)
Discussion
This farm is now considered to be PRV negative. Vaccination 
with proved to be eff ective for the eradication of PRV in the fi eld 
in this case. 
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Safety of overdose, safety on pregnancy and progeny of Auphyl® Plus 
(deleted mutant live pseudorabies vaccine) vaccine on swine
József Herczeg1 Zsófi a Benyeda3 Tamás Szalai1 Diana Krassóvári1 Georges Országh1 Jérôme Thevenon1 
Jean deFoucauld1 János Benyeda3 Roman Krejčí2
1. CEVA-Phylaxia, Budapest, Hungary; 2. CEVA Sante Animale, Libourne, France; 3. Prophyl Immunolab, Mohács, Hungary
Introduction
Aujeszky’s disease (AD or pseudo-rabies, PRV) is one of the most 
important swine diseases of the developing word. The disease 
has eff ects on both reproductive and fattening performance of 
the herds. Several inactivated or attenuated live, oil adjuvated 
vaccines were developed against AD. Eff ect of oil adjuvant raises 
questions of general and local safety of the vaccine. Following 
topics are presented: i) safety of overdose of a gE (gI) deletant, 
UL21 mutant and gC positive virus strain MNC+ of Auphyl-plus 
vaccine strain and its solvent after the reconstitution, ii) safety of 
the vaccine on pregnancy and progeny. 
i) Overdose safety test was conducted on two batches of the 
vaccine to prove its general and local safety. 
Material and Methods
Three groups of 8 week old pigs were formed with 7 animals in 
each. Parameters of general and local tolerance: 1) rectal tem-
perature, 2) body weight gain, 3) appetite, 4) colour of reactive 
zone at the vaccination site, 5) diameter of the reactive zone. 
Results
1) Febrile eff ect of the vaccine batches was moderate (2.1°C and 
2.4°C) in two pigs for 1 day, only. Temperature decreased by 
0.7-1.0°C for the next day. The individual temperature increase 
values in each treatment group were calculated in comparison 
with the individual base line values. This parameter ranged be-
tween 0.6°C and 2.4°C. For another parameter, the group-mean 
increase values, non-signifi cant diff erence (p=0.1462) was found 
by ANOVA between of the treatment groups as the treatment 
stress has also caused temperature increase in the control group 
ranging between 0.5-1.3 Cº. 2) No remarkable break or decline 
and non-signifi cant diff erence appeared in the body weight gain 
tendency of the vaccinated groups (P=0.99 on D7 and P=0.93 on 
D14). 3) None of pigs showed remarkable feed refusal during the 
observation period. 4&5) None of animals showed colourisation 
reaction at the injection site after the vaccination and no any 
swollen local reactions appeared. 
Conclusion
Neither immediate general nor local lesions with intolerance 
attributable to the vaccine were seen. Mild fever reaction lasting 
more than 24 hours occurred in case of two animals only. Non-
signifi cant body weight gain diff erence between the treatment 
groups appeared. 
ii) Safety on pregnancy and progeny test was conducted to 
show the reproductive performance of sows and vitality of 
progeny piglets after use Auphyl-plus vaccination regime in the 
mothers. 
Material and Methods
14 gilts were vaccinated and 8 received placebo at 8 weeks of 
age with repetition 1 month apart. 4 pregnant gilts received a 
third vaccination 3 weeks before the farrowing and 4 pregnant 
gilts were kept for controls. Commercial dose of the vaccine was 
used in 2 ml containing 6.1 log10 TCID50 ADV. Test parameters 
of overdose safety were used and completed with monitoring 
of reproductive performance (6), progeny vitality (7) and body 
weight of piglets (8). 
Results
1) No fever appeared in any of the treatment groups. 2) All 
animals performed normal daily body weight gain in the rearing 
period enabling them to be inseminated after their heating 
period. 3) No remarkable feed refusal was recoded. 4-5) One gilt 
showed red spot 1 hour after the fi rst vaccination. This local re-
action disappeared by the next day. No other local reaction was 
recorded. 6) Same litter size was delivered by both treatment 
groups of the sows (43-43 piglets). 95.3% and 97.7% life born, 
7%-7% weak, 4.7%-2.3% still-born progenies were recorded, 
born from vaccinated and control sows, respectively. 7) Vitality 
of piglets was assessed by scoring of any clinical signs. Piglets of 
the vaccinated sows performed score value 21 while controls 18 
within the 1 week observation period. 8) Body weight of piglets 
at birth and on PpD21: this parameter didn’t show a signifi cant 
diff erence between the groups (P=0.13 and P=0.46). Mothers 
were also included in the calculation as they can aff ect the body 
weight of the new born piglets. 
Conclusion
No immediate post vaccination reactions and no adverse eff ect 
on the feeding behaviour were recorded. Very mild and tempor-
ary local post-vaccination reaction, rarely appeared, mild and 
transient fever, normal body weight gain tendency, and good 
reproductive performance of vaccinated gilts were seen. Assess-
ment of the litters of both groups showed good tolerance of 
vaccination from the progenies of vaccinated sows was proven. 
No adverse eff ect on vitality, normal body weight performance 
results of piglets originating from the vaccinates were recorded.
®AUPHYL PLUS is a registered trademark of CEVA SANTE ANIMALE.
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Study on seropositivity for Pseudorabies virus in swine farms in Pinerolo 
District: correlation with management and geographic factors
Giuseppe Martano; Giorgio Burzio
ASl TO3, Vigone, Italy
Introduction
The aim of this study is to evaluate PRV seropositivity in Pinerolo 
district and to underline the most probable risk factors about 
the seropositivity for Aujeszky’ s disease.
We collected data on potential risk factors for infectious disease 
in 41 pig farms in Asl To3, Pinerolo district, Northwestern Italy. 
UTM geographic coordinates were recorded for each farm and 
entered in a geographic information system ( GIS). Herds size 
ranged from 15 to 11.050 animal. Results of 6564 tests eff ected 
in the course of 613 herd’s visit have been compared in geo-
graphic areas of Asl To3, from 1997 to 2009. The number of PRV+ 
herds has clearly decreased from 1997, even though areas with 
higher risk exist.
Material and Methods
Aujeszky’ s disease is a viral disease due to porcine herpesvirus-1 
which belongs to the Alphaherpesvirinae subfamily, herpes-
viridae family.
In April 1997, a programme to eliminate Aujeszky’ s disease 
virus infection from the swine herds in Italy was initiaded. The 
programme was based on intensive compulsory vaccination, 
with gE-deleted vaccines of all pigs. From May 1997 to Decem-
ber 2009  we collected 6564 serum samples from pigs and they 
were tested for antibodies to pseudorabies virus (PRV) by the 
enzyme-linked immunosorbent assay (ELISA test).Every farms 
was tested at least one time for year. Also we collected data 
about management and biosicurity level in 41 farms. The data 
were deloped by Epi-info 6. UTM geographic coordinates were 
recorded for each farm and entered in a geographic information 
system ( GIS).
Results
Analysis of spatial arrangement shows that the farms PRV+ are 
closer together compared to all the farms. Proper application 
of the vaccination plan and observance of basic principles of 
biosecurity to ward off  the risk of infection.
Movement of infected pigs is considered the most likely route of 
Aujeszky ‘s disease route in PRV-free herds.
Farrow to growing farms were the fi rst to become PRV free. A 
high pig density in the area and presence of fi nishing pigs in 
farm was associated with a increase in odds of a herd being sero-
positive.
Figure 1. Seropositivity prevalence PRV in the partecipating herds.
1997 1998 1999 2000 2001 2002 2003
84% 77% 56% 58% 24% 19% 21%
2004 2005 2006 2007 2008 2009
12% 15% 18% 12% 8% 2%
In 1997 the seropositivity herd ‘s prevalence was 84 %, in 2009 
was 2%.
Figure 2. Seropositivity prevalence in single tested pigs.
1997 1998 1999 2000 2001 2002 2003
38% 30% 19% 18% 16% 18% 19%
2004 2005 2006 2007 2008 2009
10% 7% 6% 4% 4% 1%
The seropositivity prevalence in tested pigs decreased from 38 
% in 1997 to 1 % in 2009.  
Discussion
The results show that if a correct vaccination and satisfactory 
biosecurity level applied, the risk of viral circulation decreased 
rapidly in few years.
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Evaluation on seropositivity and antibody titre for Aujeszky’ s 
Disease in fattening and farrow to feeder pig herds
Giuseppe Martano; Igor Ferenaz
ASl TO3, Vigone, Italy
Introduction
In North-West Italy control and eradication for Aujeszky’s disease 
represents a target still to be reached. The aim of this work is to 
obtaine an evaluation for seropositivity prevalence Aujeszky’ s 
disease in farrow to feeder and fattening herds. The antibodies 
titres has been evaluated on pigs in fattening herds. The exam-
ination has been carried on 64 herds in the period 2007-2008.
Materials and Methods
In Italy, Aujeszky’s disease has been a subject of a mandatory 
eradication program since 1997. The vaccination program 
prescribes three inoculation/year for the sow and three inocula-
tion for the fattening pigs( the fi rst at 60-90 days, the second 30 
days later and the third at 180 days).We used a gE- delete dead 
vaccine in the farrow to feeder herds and a gE- delete live vac-
cine in fattening herds. In our district, the pigs were slaughtered 
at 270 days old. From January 2007 to December 2008 a survey 
was conducted in Pinerolo District, North-west Italy. Sixty four 
randomly selected farms was tested to evaluate the provincial 
pseudorabies virus ( PRV ) herd seroprevalence. The sample 
included 34 farrow to feeder herds and 30 fattening herds. The 
farms were randomly selected. Blood sample collection for each 
farm was calculated so as to detect disease with an estimated 
prevalence of 20 % and at a confi dence limit of 95 % .      2117 
pigs were tested during 152 inspections and they were tested 
for antibodies to pseudorabies virus (PRV) by the Enzyme-
Linked Immunosorbent Assay (ELISA test). Antibodies against 
PRV ( glycoprotein gB and glycoprotein gI ) were examined.
Results
Seropositivity prevalence in farrow to feeder herds was 6,1% and 
in fattening herds was 13,5%.
The seropositive pigs prevalence was 1,21 % in farrow to feeder 
herds and 5,34 % in fattening herds.
In seronegative fattening herds a signifi cant percentage of pigs 
with low antibodies titres ( glycoprotein gB ) has been observed.
negative samples 25,1 %
positive samples 1:8 9,5 %
positive samples 1:16 8,3 %
positive samples 1:32 28,4 %
positive samples 1:64 5,6 %
positive samples 1:128 17,1 %
positive samples 1:256 1,2 %
positive samples ≥ 256    4,8 %
Discussion
The target is to reduce seroprevalence in swine herds stopping 
the entry of the virus through latently infected pigs. 
The current report shows that in seronegative fattening herds 
a signifi cant percentage of pigs with low antibodies titres has 
been observed . This indicates that the herd immune status of 
the farms was insuffi  cient to prevent a fi eld virus infection. Prob-
ably the vaccination in some fattening herds is carried out not 
correctly. Fattening herds could became an important reservoir 
for pseudorabies virus.
It is necessary to use a correct vaccination program with man-
agement improvements and rigorous biosecurity measures. 
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Duration of immunity of Auphyl® Plus (deleted mutant live 
pseudorabies vaccine) in progeny of vaccinated sows
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Introduction
Aujeszky’s disease (AD or pseudo-rabies) is one of the most im-
portant swine diseases of the developing word. The disease has 
eff ects on both reproductive and fattening performance of the 
herds. Live, gene-deleted vaccine strains formulated with oil ad-
juvants, are considered the most effi  cient tools (by DIVA) for AD 
eradication programs in the European Union. AD eradication still 
remains a heavy task in Eastern-Europe and in Asia. Virus strain 
of Auphyl® Plus vaccine is a gE-deleted, UL21 mutant and gC 
positive AD virus (ADV), which is a molecularly modifi ed derivate 
of the Bartha’s strain (K/61).
Materials and Methods
Duration of Immunity in Progeny: DOI by maternally derived 
antibodies (MDA) in the progenies of vaccinated sows was 
tested by challenging 4- and 6-w-old piglets. 
Study design: 4 sows were vaccinated 3 times at 2, 3 months of 
age and 3 ws before farrowing. Their progenies (16 piglets) had 
no vaccination but were sero-positive due to the MAD transfer. 
Each of 8 piglets were challenged at 4 (G2) or 6 (G1) ws of age. 
8 piglets from the progenies (G3) of non-vaccinated sows were 
involved as ch-controls at 6 ws of age. 
Challenge circumstances and clinical parameters were the same 
as detailed in the MPD trial. 
Results
1. All control piglets (G3) died within 7 pchDs. All piglets of G2 
(4-ws-old) were protected but 2 out of 8 piglets from the G1 
(6-ws-old) died.
2. The ANOVA didn’t show any signifi cant diff erence between 
rectal temperatures of the groups (p>0.05). Note: the rectal 
temperature decrease in Group 2 is a virtual one as pre-mori-
bund or moribund animals showed lower rectal temperature 
a day or two days after their fever peak. All pigs from this 
group died one or two days after that their rectal temper-
atures declined. 
Figure 1: The group-mean rectal temperature (C°)
3. Mortality and post-ch average daily body weight (DBW) and 
the weekly body weight gain (WBWG): are shown in Table 1.
Table 1. No. Death / Total
DBW at 
chD0
DBW at 
PchD7
WBWG between 
chD0 and PchD7
Group 1/A (ch at 6 w) 2/8 10.14 11.24 0.16
Group 1/B (ch at 4 w) 0/8 4.91 5.71 0.11
Group 2, controls  (ch at 6 w) 8/8 9.04 7.33 -0.25
4. There was no signifi cant diff erence between MDA protected 
and control piglets in the excretion of the ch-virus on pchD4 
and pchD7.
Discussion
Auphyl® Plus vaccine was effi  cient to protect swine against 
death, nervous symptoms and body weight loss caused by Au-
jeszky’s disease. The vaccine used by the prescribed application 
regime, signifi cantly decreased the virus shedding. 
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Duration of immunity of Auphyl® Plus (deleted mutant live pseudorabies vaccine) in fattening pigs
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Introduction
Aujeszky’s disease (AD or pseudo-rabies) is one of the most 
important swine diseases of the developing word. The disease 
has eff ects on both reproductive and fattening performance of 
the herds. Live, gene-deleted vaccine strains formulated with oil 
adjuvants, are considered the most effi  cient tools (by DIVA) for 
AD eradication programs in the European Union. AD eradication 
still remains a heavy task in Eastern-Europe and in Asia. Virus 
strain of Auphyl® Plus vaccine is a gE-deleted, UL21 mutant and 
gC positive AD virus (ADV), which is a molecularly modifi ed 
derived of the Bartha’s strain (K/61). Duration of Immunity (DOI) 
in Fatteners test was conducted to show the level of protection 
in 6 month old pigs. 
Material and Methods: Study design: 8 pigs received primo-vac-
cination (G1) at 2 month-of-age and it was boosted one month 
later. 4 sero-negative, non- vaccinated controls were involved 
(G2) in the study, with same age. Challenge was performed at 6 
months-of-age, 3 months after the last vaccination.
Challenge circumstances and clinical parameters were the same 
as detailed in the MPD trial.
Results
1. No death occurred in control group within 7-day observation 
period. Central nervous symptoms were observed in each of 
the controls but not in any of the vaccinates. Total cumula-
tive respiratory symptom score was 15± in G1, 26± in G2. 
2. Rectal temperatures of controls (G2) were signifi cantly 
higher than in the vaccinates from pchD3 till pchD7 (p-value 
= 0.01). 
Figure 1: Rectal temperature results
3. Post-ch DBWG in vaccinated group was +0.34 kg versus -1.14 
kg in controls: Diff erence 1.48.Kg fulfi lling the requirement of 
the (1) European Pharmacopoeia. 
Table 1: Group mean body weight (GMBW) kg) of treatment 
groups and calculated daily body weight gains (DBWG)
Table 1. chD0 PchD7 GMBW: chD0 - PchD7 DBWG (group average values)
Group 1. 126.3 128.7 2.4 2.4/7 = 0.34
Group 2. 119.7 111.7 -8.0 -8/7 = -1.14
4. The ch-virus re-isolation results (log10TCID50/ml) of G2 were 
signifi cantly higher (5.2 on pchD4 and 3.3 on pchD7), than in 
G1 (3.8 on pchD4 and 0 on pchD7). 
Discussion
The 4 month duration of immunity of vaccine Auphyl® Plus was 
proven. It was protective against death and central nervous 
symptoms of AD. The vaccine diminished the fever response in 
challenged animals. The vaccine was highly protective against 
the body weigh loss and signifi cantly decreased the ch-virus 
shedding. 
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Introduction
Aujesky’s Disease or pseudorabies, is one of the oldest recog-
nized swine diseases. It is caused by pseudorabies virus (PRV), 
an alpha-herpesvirus that can induce respiratory disease, 
reproductive failure, and aff ect the central nervous system. PRV 
vaccines, in conjunction with serologic tests, have been used to 
eradicate the virus from swine herds and even from entire coun-
tries. One weakness in PRV control and eradication programs 
is the indigenous PRV infection of feral swine. This wild-life res-
ervoir is responsible for frequent infection of domestic swine.1 
A better understanding of this source of infection may lead to 
improved PRV control programs. This report summarizes stud-
ies investigating the pathogenicity and transmissibility of feral 
swine PRV isolates from the USA.
Materials and Methods
Seventy-three four-week-old pigs were randomly allocated to 
one of nine treatment groups, each housed in a separate isola-
tion room. Pigs in each group received either a low dose (LD - 
about 103CCID50) or high dose (HD - about 106CCID50) intranasal 
challenge of virus: Group 1 (n=7) LD feral swine isolate FS268; 
Group 2 (n=7) HD FS268; Group 3 (n=7) LD feral swine isolate 
C3R Ossabaw Is; Group 4 (n=7) HD C3R Ossabaw Is; Group 5 
(n=7) LD domestic swine isolate ISUVDL4892; Group 6 (n=7) HD 
ISUVDL4892; Group 7 (n=10) LD panther isolate of a feral swine 
virus FP117-05; Group 8 (n=10) HD FP117-05; Group 9 (n=11) 
controls that received three ml of cell culture media. Nasal swabs 
(NS) were collected on days 0, 2, 4, 7, 9, 11, 14, 21, and at nec-
ropsy 28 days-post-inoculation (dpi) at which time blood, lung 
lavage and tissues were collected for virus isolation and detec-
tion of viral DNA by real-time PCR.2
On 2 dpi, ten direct contact pigs (DC) were comingled with the 
pigs inoculated with HD C3R Ossabaw Is isolate, and fi ve DC pigs 
were comingled with the pigs inoculated with HD FP117-05. 
After fi ve days of contact the inoculated pigs were moved to 
diff erent rooms and each group of DC pigs was maintained for 
about 16 weeks.
Results
Clinical signs: Mean body temperature spiked 2 dpi in all PRV 
inoculated groups and returned to normal by 5-7 dpi. For each 
virus pair the HD pigs were more aff ected than LD pigs. By 1 dpi 
some pigs were lethargic and at 2 dpi respiratory distress (sneez-
ing, dyspnea, dysphonia (altered squeal (laryngeal edema)), 
congested nasal passages, and dog sitting) was observed. Transi-
ent anorexia was detected in most pigs. Central nervous system 
disease was observed in some pigs (ataxia, opisthotonos, pad-
dling, and seizure). Most pigs from the feral swine isolate groups 
recovered; however, six out of seven group 6 pigs were eutha-
nized or died in the fi rst 7 dpi. In group 4, two pigs and in group 
1, one pig were euthanized in the fi rst 8 dpi. Clinical signs in DC 
pigs exposed to C3R Ossabaw Is isolate were mild. In contrast, all 
DC FP117-05 exposed pigs had moderate to severe respiratory 
disease, but each pig did recover.
Virology: Virus was isolated from NS from 2-14 dpi with most 
positives between 2-9 dpi, and more frequently from the HD 
than LD challenge groups. Virus was isolated infrequently from 
28 dpi tissues. 
Serology: Based on a commercially available ELISA, all PRV-
inoculated pigs seroconverted by 14 dpi. Likewise, all DC pigs 
seroconverted by 14 days post contact and were seropositive 
throughout the duration of the study, about four months.  
Discussion   
Collectively, results from these studies indicate natural infec-
tion of domestic swine with feral swine PRV isolates should be 
detected either through detection of virus during the acute 
phase of the infection, or through detection of antibody in the 
convalescent phase of the infection. This conclusion supports 
many current control programs that screen sera for PRV-specifi c 
antibody, and may test tissues for virus by real-time PCR.
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Isolation and in vivo and in vitro characterization of the ﬁ rst Chinese porcine teschovirus strain (PTV-8)
Shangjin Cui
Harbin Veterinary Research Institute of CAAS, Harbin, China
Investigations were made to identify the causal agent of a case 
of acute diarrhea, respiratory distress and death in a swine farm 
in the Jilin Province, northern China. Only porcine teschovirus 
(PTV) was isolated from samples of organs and identifi ed as 
PTV-8. Presence of virus which was designated Jilin/2003, was 
confi rmed by the production of a specifi c cytopathic eff ect on 
susceptible cells and by the results from IPMA assay, polymerase 
chain reaction, and electron microscopy. Other main pathogenic 
agents causing diarrhea, respiratory distress and death (e.g., 
porcine rotavirus, transmissible gastroenteritis virus of swine, 
Porcine epidemic diarrhea virus, classical swine fever virus, 
pseudorabies virus, porcine circovirus, porcine reproductive 
and respiratory syndrome virus, Japanese encephalitis virus, 
mycoplasma, leptospira, Streptococcus, Listeria, and Brucella 
species) were eliminated as possible causal agents because they 
were not consistently associated with the disease of the pigs. 
The PTV-8 strain was adapted to growth in swine primary kidney 
(PK-15) cells and in a swine testicular cell line (ST cells). When 
inoculated into healthy pigs, PTV-8 Jilin/2003 caused the same 
symptoms as observed in the aff ected herd. We conclude that 
PTV-8 Jilin/2003 was the causal agent of this disease. To the best 
of our knowledge, few reports so far indicate that PTV strains 
infect swine in China. 
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Teschen Talfan Disease - contagious swine paralysis - a case report
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Introduction
The enterovirus encephalomyelitis of pigs (porcine enteroviral 
Polioenzephalomyelitis) rarely occurs in German pig population. 
The Tescher Disease, caused by porcine Teschovirus (PTV) Type 1 
hasńt been reported in Germany for over 20 years. It is a human 
analogue of the spinal polio disease, which mainly is caused by 
Porcine Teschovirus (PTV) strains. Porcine Teschovirus enters the 
body by oral route, reproduces in the gastro- intestinal organs 
and will be excreted by feces for up to 8 weeks. The majority of 
infected animals will not show any symptoms but will excrete 
the virus with the feces for weeks. If neurovirulent strains of the 
virus reproduce and spread in the brain, general illness with 
paralysis of diff erent degree can be the result. The animal’s 
awareness of the environment will not be infl uenced, sensitiv-
ity of the skin stays intact. An improvement of symptoms after 
a few days can be considered the rule. Usually an immunity to 
the virus within the contained group of animals will be estab-
lished within 6 weeks. If tonic-clonic muscle spasms, nystagmus 
and other paralytic symptoms appear during the course of the 
disease, morbidity and mortality will be high due to dyspnoea 
and cardial insuffi  ciency. Hardly any information about therapy 
of this disease can be found in literature. Diagnosis via PCR and 
serological determination of the type of virus will decide about 
the obligation to report, as is the case with PTV type 1. Only 
the virus extraction from the CNS can be considered proof, the 
antigen itself has to be traced. The large number of diff erent 
Teschovirus makes determination of types diffi  cult. For clinical 
considerations, proof of the species Teschovirus can be con-
sidered suffi  cient. In diff erential diagnosis, ESP and AD will have 
to be considered.
Material and Methods
The descripted farm has 160 sows in a closed system. Jung sows 
come from diff erent farms in denmark with a yearly replacement 
of 35%. Piglets are weaned after 28 days of nursing. First clinical 
signs can be observed 7 to 10 days later in fl atdeck. About 10% 
of a group show high degree paralysis of the limbs. Animals are 
aware of their environment, food and water intake appear to be 
normal. They show a swaying gait with dropping down in front 
while the hind quarters remain upright. Sensitivity of body sur-
face stays intact. In almost all aff ected animals edema of the eye 
lids is prominent. In some bad cases, animals are lying on the 
side with walking motion oft he legs, show opisthotonus, nys-
tagmus and tonic-clonic spasms. About 4% of aff ected animals 
die within 12 hours after onset of symptoms. The others recover 
within a few days. None of these animals show long term signs 
of paralysis. Treatment with cortisone und vitamines B did not 
change any of the clinical symptoms. In this farm is, however, no 
reliable inventory of immunity. There remain clinical symptoms 
in the piglets in fl atdecks. 
Results
By autopsy and following microbiological examination, porcine 
Enterovirus type 8,9 and 10 could be proven in organs and large 
intestine as well as PTV virus in the large intestine. Infection by 
ESP and AD could be excluded in blood samples. Cerebrum, 
cerebellum and brain stem showed low grade edema. The 
Bioscreen Laboratory in Münster examined organ matter for PTV 
virus (before: porcine enterovirus type 1 to7 and 11) and porcine 
enterovirus type 8,9 and 10.The examination was performed via 
multiplex PCR. A type determination of the diff erent PTV virus 
types is not possible in German laboratories. Thus it could not be 
proven if the isolated virus is PTV type 1.
Discussion
By defi nition of the government from 12.08.2005 the Tescher 
disease has to be proven by virus breeding and Type 1-identi-
fi ation. Additionally, histological proof of non-purulent polio-
enzephalomyelitis is needed. A durable immunity against the 
virus probably could not be established because too many 
strains were present in the contained group. A possible reason 
might be the acquisition of young sows from diff erent sources. 
There are no cross- immunities, so there will always be suscept-
ible animals supporting virus reproduction. As enterovirus is 
spread by the feces of sick animals, controlled access to the feces 
of older sows would be desirable to reach quick contamination 
of every animal. By this measure, maternal protection of piglets 
should be optimized, so a durable immunity can be established. 
It is important to keep access to the feces on a moderate level, 
since enterovirus may not only course neurological symptoms 
but also abortions.
Group- specifi c vaccines cannot be produced at this point of time.
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The distribution and genotyping of porcine teschovirus in Taiwan
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Animal Health Research Institute, Taipei County, Taiwan
Introduction
Porcine teschovirus (PTV), previously named porcine enterovirus 
1, causes disease in pigs (1). Based on serology more than 70% of 
the swine population in Taiwan were positive. The percentage of 
detected lesion samples in Taiwan from which PTV was isolated 
was higher than that of other swine viral pathogens (PRRSV etc).
The aim of this study was to assess the number of PTV serotypes, 
and their distribution, in Taiwan.
Material and Methods
A total of 525 swine fecal samples were collected from 5 pig 
farms of each county and city in Taiwan. Each fecal sample was 
mixed in MEM solution and a 10% mixture fi ltered through a 
fi lter membrane with a pore size of 0.22um. The fi ltrate was 
mixed with growth media (MEM) and incubated with PK 15 cells 
at 37oC in 3.5% CO2, for 3 days. Culture fl uid was analysed for 
the presence of PTV by RT-PCR.
The VP1 gene fragment of PTV was amplifi ed in a reverse 
transcription-polymerase chain reaction (RT-PCR) using ex-
tracted PTV viral RNA and PTV-specifi c primers. The PTV VP1 
amplimers were then purifi ed by gel fi ltration and sequenced. 
Using DNAstar software, phylogenetic analysis was carried out 
using the PTV VP1 sequences and sequence data obtained from 
web sources (4).
Results
A total of 58 samples positive for PTV, out of a total of 525, from 
21 counties and cities in Taiwan, were obtained by virus isola-
tion and RT-PCR. The phylogenetic analysis of the sequences of 
58 PTV isolates in Taiwan and 20 reference PTV strains covering 
11 serotypes of PTV showed that all the isolated PTV strains had 
sequence homologies similar to 10 diff erent serotypes of PTV 
(the exception of serotype 5). The 10 serotypes were distributed 
randomly around Taiwan (fi gure 1).
Discussion
In this study, 58 fecal samples out of 525 were positive for PTV. 
Infected pigs did not show any clinical symptoms, consistant with 
the fi ndings that PTVs specifi cally infect pigs and are shed in pig 
feces (5), and that PTV infections are most frequently asymptom-
atic (3,6). Previous workers have shown that specifi c PTV sequen-
ces equate to the serotypes 1-11 (2). The results of the phylogen-
etic tree analysis indicated that the 58 isolated PTVs, were aligned 
among 10 diff erent serotypes (PTV1-PTV4 and PTV6-PTV11) and 
these serotypes were distributed randomly around Taiwan. Many 
of the larger pig farms located in the prefectures within middle 
and southern Taiwan (TCP, NTP etc) had animals shedding more 
than 1 isolate serotype. However, there was only one serotype in 
some counties. We concluded that at least 10 diff erent serotypes 
of PTV existed in Taiwan now. The distribution of these serotypes 
was not restricted geographically.
Figure 1. The distribution of 10 diff erent serotypes PTV isolates in 
Taiwan. Full circle indicates the serotype that isolate of each county or 
city was classifi ed. U means unclassify
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Impact of Torque teno virus (TTV) on porcine dendritic cell function and activity
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1. Centre de Recerca en Sanitat Anima (CReSA), Bellaterra, Spain; 2. Institute of Virology and Immunoprophylaxis (IVI), Mittelhäusern, Switzerland
Introduction
Torque teno virus (TTV) is a small, non-enveloped single 
stranded circular DNA virus classifi ed in the fl oating genus An-
ellovirus, which infects several vertebrates including human and 
swine. Two genetically distinct genogroups have been described 
in swine, genogroup 1 (TTV1) and genogroup 2 (TTV2). TTV 
is ubiquitous and considered non-pathogenic but it has been 
linked to several diseases or pathological conditions in humans 
and, lately, in swine (1). To date, information related with the 
immunological events behind TTV infection is not available. 
Several viruses are known to modulate dendritic cell (DC) func-
tion. One example is porcine circovirus type 2 (PCV2), related 
genetically and structurally to TTV. It has been reported that 
PCV2 DNA is a potent modulator of DC and mediated inhib-
ition of IFN- α production by plasmacytoid DC (pDC) (2). In the 
present work, the role of viral DNA from two genetically distinct 
swine TTV genogroups was analyzed for its potential interaction 
and modulation of DCs activity. 
Material and Methods
PCV2 and TTV genomes were isolated by digestion from plas-
mids containing double-stranded DNA forms of the complete 
viral genomes. Peripheral blood mononuclear cells (PBMCs) 
were isolated by Ficoll-Paque diff erential centrifugation. pDCs 
were then enriched by magnetic antibody cell sorting (MACS). 
Enriched pDCs were incubated with decreasing amounts of 
PCV2, TTV1 or TTV2 DNA prior to stimulation with CpG-ODN. 
Supernatants from activated cultures were tested for IFN- α 
production by ELISA.
Results
Preliminary results showed that TTV1 and TTV2 viral DNA 
mediated inhibition of IFN- α production by CpG-ODN induced 
pDCs. The eff ect was dose dependent (Figure 1). TTV DNA was 
compared with DNA from PCV2, and it was observed that the 
inhibitory capacity of TTV1 was similar than the one observed 
for PCV2 and diff erent from that of TTV2 (Figure 2). 
Figure 1. IFN- α production by pDCs in the presence of linear PCV2, 
TTV1 and TTV2 DNAs. 
Figure 2. Percentage of IFN- α inhibition in the presence of liner PCV2, 
TTV1 and TTV2 DNAs, relative to levels obtained with CpG-ODN alone.
Discussion
TTV viral DNA was found to interfere in the ability of swine 
pDC to produce IFN- α in response to known CpG-ODN stimuli 
(2). This study also reconfi rms the eff ect or PCV2 DNA (2). The 
immunomodulatory eff ect observed for these viruses could 
potentially interfere in the development of effi  cient host innate 
and adaptative immune responses.
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Torque teno sus virus 2 (TTV2) in situ hybridization: from Durban 2008 to Vancouver 2010
Mario Aramouni1 Tuija Kekarainen1 Maria Ballester1 Gerard E. Martin-Valls1 Joaquim Segalés1, 2
1. CReSA/UAB, Bellaterra (Barcelona), Spain; 2. Departament de Sanitat i Anatomia Animals, Universitat Autònoma de Barcelona, Bellaterra, Spain
Introduction
Torque teno virus (TTV) is a non-enveloped, circular, single strand-
ed DNA virus that may infect human, non-primate and domestic 
species including swine. Two specifi c TTV genogroups (TTV1 and 
TTV2) have been described in pigs. Even though the infection in 
pigs is considered non-pathogenic, TTVs have been somewhat 
linked with porcine circovirus diseases like postweaning multi-
systemic wasting syndrome (PMWS) and a porcine dermatitis and 
nephropathy syndrome (PDNS)-like syndrome (1,2,3). 
Two years ago, at the IPVS 2008 in Durban (South Africa), an in 
situ hybridization (ISH) method was described for the detection 
of TTV2 in formalin-fi xed, paraffi  n embedded tissues (4). The 
study was performed on tissues of healthy, PMWS, and PDNS 
aff ected animals. Major conclusion of such study was: “TTV2 
amount, location and cell type labelled resembled substantially 
those of PCV2 in PMWS aff ected animals. These fi ndings raise 
the question on the potential role of TTV2, in co-infection with 
PCV2, in the pathogenesis of PMWS”. During the development of 
the technique, a number of positive and negative controls were 
used to validate the technique. Once presented as an oral com-
munication in the IPVS 2008, further validation studies were car-
ried out. However, by the authors’ surprise, diff erent validation 
results were obtained from the initial ones and investigating in 
depth it was concluded that the oligonucleotide probe to detect 
TTV2 was also detecting PCV2. The parallelism between TTV2 
and PCV2 amount was explained by the probe cross-reactivity, 
and presented results were discarded. Therefore, in view of these 
previous regrettable results, the authors further insight in the 
development of a new, specifi c ISH and fl uorescent ISH (FISH) 
method to detect TTV DNA in TTV-DNA transfected cells and 
formalin-fi xed, paraffi  n embedded pig tissues. 
Materials and Methods
Cells and tissues. PK-15 cells were transfected with 0.5 μg/well 
(six-well plate) of cloned TTV2 genome and fi xed on coverslips. 
Formalin-fi xed, paraffi  n-embedded tissues (lymph node, lung, 
kidney and liver) from healthy and PMWS pigs were tested with 
a TTV semi-quantitative PCR (data not shown) and tissues with 
the highest amounts of virus were selected for ISH and FISH.
ISH and FISH. To prepare TTV2 specifi c probe for hybridiza-
tions, total TTV2 viral DNA was labelled with digoxigenin (DIG), 
previous digestion with XhoII and SmaI. Negative controls and 
specifi city test of the TTV probe were: non transfected, pGFP 
(plasmid-green fl uorescent protein) transfected, and PCV2 
transfected PK-15 cells. The detection was made by an anti-DIG 
antibody and developed with NBT/BCIP as chromogen. The FISH 
method was performed using Cy3 labelled anti-DIG-antibody. In 
tissues, to enhance the signal, TSA (tyramine signal amplication) 
system was used. ISH and FISH methods were based on previ-
ously described protocols (5,6) respectively. 
Results
Both techniques, ISH and FISH, displayed positive cytoplas-
mic cell labelling using TTV2 probe on TTV2 transfected cells, 
while no labelling was observed in any of the negative controls 
including PCV2 transfected cells. Once a specifi c positive signal 
was obtained in the transfected cells, ISH and FISH methodolo-
gies were applied on formalin-fi xed, paraffi  n-embedded tissues 
carrying TTV2 (detected by PCR). No specifi c labelling was found 
in any of the tested tissues.
Discussion
ISH and FISH were successfully developed to detect TTV2 nucleic 
acid in PK-15 transfected cells. In contrast, no specifi c ISH and 
FISH positive signal was found in formalin-fi xed, paraffi  n embed-
ded tissues from TTV2 infected pigs. These tissues were posi-
tive by PCR; considering the lower sensitivity of ISH techniques 
versus PCR, it is likely that the TTV2 DNA amounts in the tissues 
were below detection limit of ISH. However, we can still not rule 
out if formalin fi xation and paraffi  n embedding alters the detec-
tion by ISH or FISH. Nowadays, experiments are being done to 
determine the detection limits of the technique. 
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Genetic variability and phylogeny of swine Torque teno virus 1 
(TTV1) and 2 (TTV2) based on complete genomes
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Introduction
Torque teno viruses (TTVs) are circular, single-stranded DNA 
viruses classifi ed in the fl oating genus Anellovirus. They are 
currently considered non-pathogenic although they have been 
lately linked to several diseases in human and swine (1-3). The 
aim of this study was to determine the level of genetic variability 
in full-length genomes of swine TTVs, study the types and ef-
fects of mutations and to determine phylogenetic relationships 
with all known swine TTV genomes. For these reason 13 novel 
full-length genomes of swine TTVs were obtained from Europe 
and analysed together with 10 published genomes.
Material and Methods
Sera samples used in the study were collected during 2005-2007 
and stored in the CReSA sera collection. Full-length genomes of 
TTV1 and TTV2 were amplifi ed with a proofreading DNA poly-
merase and sequenced by DNA walking.
Results and Discussion
TTV genomes presented an untranslated region and three 
potential ORFs. Conserved regions like Arginin rich N-terminus 
and rolling-circle replication domains were found in all swine 
TTV genomes. TTV1 genomes showed a high amount of variable 
positions compared with TTV2 (46.3% vs 23.9%), that were dif-
ferently distributed along the genome: lower in the UTR (13.2% 
for TTV1 and 11.4% for TTV2), and higher in the translated 
region (59.8% for TTV1 and 29.7% for TTV2). Low variability in 
the UTR region is most likely due to its importance in replication 
and transcription (4). The pattern of substitutions among ORFs 
was also diff erent, more skewed for ORF1 and more evenly dis-
tributed for ORF2 and ORF3. TTV ORF1 seems to be aff ected by 
stronger levels of purifying selection compared with ORF2 and 
ORF3, most likely caused by the function of the protein products 
encoded by every ORF (5). TTV1 and TTV2 should be considered 
as species confi rming the classifi cation proposed (6). The 
phylogenetic reconstructions indicate that TTV1 is divided into 
three types. One of them (1c) is being reported here for the fi rst 
time (Fig.1). Also, a certain kind of geographic structure among 
phylogenetic types may exist. Quite the opposite, the proposed 
subtypes for TTV2 clustered mixed and its defi nition was unclear.
Figure 1. Neighbor-Joining tree based on the percentage identity 
among 23 swine TTV genomes.
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Rolling circle ampliﬁ cation to detect anelloviruses in pig serum samples
Lisa Macera1 Martí Cortey1 Fabrizio Maggi2 Joaquim Segales1 Tuija Kekarainen1
1. Centre de Recerca en Sanitat Anima (CReSA), Bellaterra, Spain; 2. Retrovirus Centre and Virology Section, 
Department of Experimental Pathology, University of Pisa, I-56127, Pisa, Italy
Introduction
Anelloviruses are vertebrate infecting single-stranded circular 
DNA viruses which have been recently linked to swine diseases 
(1). In swine two genetically distinct Anellovirus genogroups are 
described, namely Torque teno virus 1 (TTV1) and 2 (TTV2) (2). It 
is probable that novel swine genogroups exist as shown in the 
human TTV counterpart. Rolling-circle amplifi cation (RCA) is a 
novel technique used to amplify circular DNA templates using 
random hexamers, yielding 109 or more copies of a circular se-
quence in about an hour (3). The potential of this technique has 
been shown to be increased when combining it with Sequence-
Independent Single Primer Amplifi cation (SISPA) (4). The aim 
of the present study was to apply the combined RCA-SISPA 
approach and optimize a novel RCA method using Anellovirus-
specifi c primers (Anello-RCA) to discover new members of the 
genus Anellovirus in pigs. Also, effi  ciencies of the two tech-
niques were compared.
Materials and Methods
A TTV2 positive swine serum sample (assayed by nested PCR) 
was selected to test the RCA-SISPA technique. Standard RCA 
involves the prolonged elongation of random primers bound 
to a circular DNA template by Phi29 DNA polymerase. The RCA 
products, that are tandem repeat copies of the viral complete 
genome, were used for the SISPA method, based on the use of 
endonuclease restriction of target sequences. These products 
were separated on agarose gel and diff erent length products 
were ligated to specifi c linkers followed by PCR amplifi cation 
and sequencing. 
Short Anellovirus-specifi c primers were designed corresponding 
to a highly conserved region among all full-lenght Anellovirus 
genomes from several species available in the GenBank. Anello-
RCA was optimized using short Anello-specifi c primers (6 nt) 
using swine sera known to contain TTVs. Furthermore, Anello-
RCA was applied using swine sera and plasma samples negative 
for TTVs. The resulting products from Anello-RCA were used as 
template in inverse-PCR with Anello-specifi c PCR primers (12 
and 15 nt in length). PCR products purifi ed from agarose gel 
were sequenced.
Results
Typically, the combined RCA-SISPA method resulted in several 
fragments of various lengths (Figure 1A). After sequencing 66 
fragments, 3 of them were positive for TTV2 demonstrating 
that the RCA-SISPA is applicable to detect TTV in swine sera. 
Anello-RCA approach resulted in fragments between 2 and 3 kb 
of length (Figure 1B); sequencing of 12 fragments yielded 5 as 
positive for TTV1 and 1 for TTV2.
 
Fig.1. Digestion products obtained using RCA-SISPA approach (A). 
Amplifi cation patterns from inverse-PCR on Anello-RCA product (B).
Discussion
Both described methods are applicable for Anellovirus detection 
in pig samples. The RCA-SISPA is more tedious than Anello-RCA 
due to the high number of diff erent size fragments to be ana-
lysed. Anello-RCA technique resulted in larger and fewer frag-
ments for analysis and is, therefore, more straightforward and 
less laborious. However, Anello-RCA detects only Anelloviruses 
while RCA-SISPA could detect any circular DNA virus present in 
a sample. Since primers used in Anello-RCA are located in the 
highly conserved region, this technique could be applicable for 
Anellovirus detection in other species as well. 
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Torque teno virus tissue distribution by a semi-quantitative PCR method
Mario Aramouni; Joaquim Segalés; Martí Cortey; Tuija Kekarainen
CReSA/UAB, Bellaterra (Barcelona), Spain
Introduction
Torque teno viruses (TTVs) are small, non-enveloped viruses 
with a circular single-stranded DNA genome, belonging to the 
family Anelloviridae, genus Iotatorquevirus. TTVs are widely 
distributed and may infect human, non-primate and domestic 
species including pigs. In swine, two genetically distinct geno-
groups have been identifi ed so far, TTV1 and TTV2 (1). The aim of 
the present study was to study the distribution and age-relation 
of swine TTV1 and TTV2 in tissues. Viral DNA obtained from tis-
sue extractions were tested by a semi-quantitative PCR for the 
presence of both TTVs. 
Materials and Methods
Thirty healthy animals corresponding to six diff erent age-groups 
(second and last third of gestation, 5 days and 5, 15 and 24 weeks 
of age), 5 pigs per group, were sampled for 9 diff erent tissues: 
brain, lung, mediastinal lymph nodes, heart, liver, spleen, kidney 
and bone marrow. Presence of TTV1 and TTV2 was tested with 
a semi-quantitative PCR, amplifying the virus in three diff erent 
dilutions of extracted DNA (90 ng, 9 ng and 0.9 ng) at 43 cycles 
(optimal cycling for detecting the lowest standard concentration 
of 101 molecules). Negative samples at 43 cycles were tested at 
50 cycles to enhance the detection sensitivity and ensure the 
negativity of the sample. The degree of TTV1 or TTV2 positivity 
was graded into highly positive (4), medium (3), low (2), very low 
(1), and negative (0). Contingency tables (Chi-square) were used 
to compare prevalence and grades of TTV1 and TTV2 in diff erent 
samples at the diff erent studied ages and in the diff erent tissues. 
Statistical signifi cance level was set at p<0.05. 
Results
No signifi cant diff erences were found between genogroup 
prevalence in the same tissue at any age, while the prevalence 
increased with the age reaching 100% in all the organs by 5 
weeks of age onwards. The fi rst three age groups had nega-
tive to low levels of virus, and the last three groups, medium to 
high levels. Negative tissues were only found in foetuses and 5 
day-old pigs. The only TTV1 PCR negative organs in some pigs 
were kidney, mediastinal lymph node, brain and heart. For TTV2, 
those negative tissues were brain and heart, mediastinal lymph 
node in some pigs.
Discussion
Both TTV genogroups followed similar infection dynamics in all 
the tested tissues, increasing progressively in prevalence and 
virus load over the time. The highest prevalence (100%) was 
reached at 5 weeks of age, and the highest loads of virus in the 
diff erent tissues were seen in the oldest animals (15 to 24 weeks 
of age). Those results are in agreement with an earlier study 
reporting increasing prevalence in sera in a longitudinal analysis 
(4). No animals were found to be negative to TTV, even foet-
uses, supporting the role of vertical transmission of TTV (2,3). 
In conclusion, the present study indicates that swine TTV1 and 
TTV2 can be found in tissues like brain, lung, mediastinal lymph 
nodes, heart, liver, spleen, kidney, mesenteric lymph nodes and 
bone marrow. Both swine TTV genogroups were present in high 
levels in most if not all adult animals while viral negative tissues 
were only found in 5 week-old pigs or foetuses. 
Figure 1. Mean grade of TTV1 (black bars) and TTV2 (grey bars) in 
diff erent age groups for some tissues. (IIG: 2nd third of gestation, IIIG: 
last third of gestation, 5D: 5 days, 5W: 5 weeks, 15W: 15 weeks, 24W: 24 
weeks). See defi nition of grading in Materials and Methods.
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Retrospective study on swine Torque Teno virus genogroups 1 and 2 and porcine 
circovirus type 2 coinfection in Italian pig sera (from 1990 to 2009)
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1. University of Parma (Italy), Parma, Italy; 2. Istituto Zooprofi lattico Sperimentale della Lombardia e dell’Emilia Romagna, Brescia, Italy
Introduction
Torque Teno virus (TTV) is a non-enveloped, circular, single-
stranded virus that has been detected in humans and animals, 
including pigs (1). Two swine TTV genogroups (TTV1 and TTV2) 
have been described (2) and the ubiquitous nature of this infec-
tion suggest that TTV have been infecting pigs for a long period 
of time. Moreover, recent studies suggest that swTTV could play 
an aetiological role in pig diseases, in particular PMWS (3). The 
main objective of this retrospective study is to asses whether 
there was a statistically signifi cant association between swTTV 
and PCV2 infection.
Materials and Methods
Ninety fi ve pig sera sampled between 1990 and 2009 were 
used in this study (no more information about these sera was 
available). A maximum of 10 pig sera per year were analysed. As 
much as possible, were analysed two year periods at the time 
(Table 1). Samples were stored at -80°C until analysed. Sera were 
tested to detect swTTV1 and swTTV2 using specifi c PCR meth-
ods. Moreover, some PCR products from both swTTV geno-
groups were sequenced and phylogenetically analysed
Results
Both swTTV genogroups were found in pig sera from the very 
fi rst year examined (Table 1).
Taking into account the whole period under study, 73 out of 95 
animals (76,84%) were infected with one or the other genogroup 
of swTTV, while 27 out of 95 pigs (28,42%) were co-infected with 
both genogroups. swTTV genogroup 1 (54 out of 95, 56,84%) 
was more prevalent than genogroup 2 (46 out of 95, 48,42%). 
Moreover, 41 out of 95 animals (43,16%) were also infected with 
PCV2 (Table 1). Moreover, 20 out of 95 animals (21,05%) were 
co-infected with swTTV1 and PCV2, while 27 out of 95 animals 
(28,42%) were co-infected with swTTV2 and PCV2 (Table 2). 
Phylogenetic analyses indicated no relationship between the 
date of virus detection and the cluster in the distance trees. 
year n TTV1 or TTV2
TTV1 and 
TTV2 TTV1 TTV2 PCV2
1990 10 4 1 3 2 0
1992 10 8 1 1 8 8
1996 5 1 0 0 1 1
1998 10 10 7 10 7 1
2000 10 10 5 8 7 5
2002 10 6 0 6 0 1
2006 10 6 0 5 1 1
2007 10 8 3 5 6 7
2008 10 10 7 8 9 9
2009 10 10 3 8 5 8
tot 95 73 27 54 46 41
% 76,84 28,42 56,84 48,42 43,16
% TTV1 TTV2
PCV2 21,05 28,42
Discussion
This study indicates that TTV genogroups have been circulating 
al least since 1990 in the Italian pig population. 
Moreover, these results indicate a statistically signifi cant as-
sociation between swTTV2 and PCV2 infection, but not between 
swTTV1 and PCV2 (Fisher’s exact test with p<0.05).
Phylogenetic analyses show no signifi cant changes in the pro-
portion of viral genogroups over time.
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Detection of TTV-2 by PCR in feces samples from diﬀ erent pig herds in São Paulo State, Brazil
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Introduction
Torque teno virus is a small non enveloped virus with circular 
single strand DNA genome classifi ed within the Anellovirus. 
Two distinct TTV genogroup were identifi ed circulating among 
domestic pig population, TTV-1 and TTV21. TTV have been de-
tected by PCR in lungs, lymph nodes, tonsil, ileum, serum, mar-
row bone, liver and kidney2,3,4. Swine TTV has been detected 
in serum, plasma, nasal swab, rectal swab and feces, indicating 
fecal-oral transmission as the most signifi cant way of spread-
ing5,6. The aim of this work was to detect TTV-2 DNA in fecal 
samples from pig herds in São Paulo state, Brazil
Materials and Methods
Ninety seven fecal samples were collected from two diff erent 
phases (nursery and growing) between 2009 and 2010 in three 
diff erent swine herds from São Paulo state, Brazil. The samples 
were frozen, thawed three times and DNA extraction was carried 
out by phenol:chloroform:proteinase K protocol. TTV2 amplifi ca-
tion was performed according to previous procedure described 7.
Results
Twenty six from a total of 97 fecal samples from three diff erent 
pig herds were positive for TTV-2 (27 %).The number of posi-
tive samples within each pig herd (1, 2 and 3) was 11/42 (26 %), 
13/40 (33 %) and 2/13 (13 %), respectively (Fig. 1). Considering 
breeding phase (nursery and growing) we found a interesting 
data, since the number of positive animals were 10/68 (15%) and 
16/29 (55%) for nursery and growing, respectively (Fig. 2)
Discussion
The presence of TTV-2 in three commercial pig herds from 
São Paulo state, Brazil was investigated and the proportions 
of infected animals shedding virus were 27 %. A study carried 
out on Canada with commercial swine herd showed a higher 
proportion of infected animals (60.3 %). According to the results 
obtained in recent researches, the proportion may vary due the 
phase of breeding. A higher percentage of positive animals for 
TTV-2 was seen in growing (55 %) than in nursery (15 %). This 
fi nding are agreement with the results published6 where <20 % 
of the rectal swabs were positive for TTV in pigs ranging from 1 
to 15 weeks. In conclusion our results contribute for the under-
standing of the dynamic excretion of the TTV. This is the fi rst 
description of excretion of TTV2 on feces in diff erent commercial 
swine herds from São Paulo state, Brazil.
Figure 1: Number of positive and negative TTV-2 in diff erent pig herds
Figure 2: Percentage of positive animals according to breeding phase 
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Prevalence and age distribution of porcine TT viruses
Vladimir Celer; Veronika Jarosova
University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic
Introduction
Torque teno sus virus 1 (TTSV1) and Torque teno virus sus 2 
(TTSV2) belong to the genus Iotatorquevirus within the family 
Anelloviridae (Carstens, 2010).
The role of swine TT viruses in the pathogenesis of swine 
diseases is currently being investigated. Although it seems that 
TTSV infection is not directly responsible for any disease, the 
possibility that they play a role in diff erent co-infections still re-
mains. In a recently published study a signifi cantly higher preva-
lence of swine TT viruses was found in sera from PMWS aff ected 
animals compared to non-aff ected animals. The main goal of this 
work was to estimate the prevalence of porcine TT viruses in the 
Czech Republic in diff erent age categories of pigs.
Materials and Methods
Samples
Two hundred twelve pig blood samples from pigs from 27 swine 
herds were tested to obtain an overview of the presence of TTSV 
in the Czech swine population. Samples originated from animals 
of diff erent ages (newborn piglets n = 66, weaned pigs (4-12 
weeks) n = 127, gilts n = 11, sows n = 8) and with diff erent health 
status with regard to PMWS infections. All specimens used were 
fresh or stored frozen before DNA extraction.
PCR
The sequence of primers for two rounds of amplifi cation was 
based on primers already published by Martinez et al. 2006.
Results
The results of snPCR testing performed on the panel of 212 
samples are shown in Table 1. TTSV1 was detected in 91 
samples. TTSV2 was found in 99 samples. In 66 samples both 
TTS viruses were detected together. The prevalence of indi-
vidual TT viruses in the Czech Republic could be estimated at 
42.9% (TTSV1) and 46.7% (TTSV2). The average prevalence of 
TTS viruses is thus 44.8%. 
The age distribution of both genogroups is shown in Table 1. 
TT viruses were not distributed equally in all age categories. 
Although the prevalence of TTSV1 and TTSV2 was determined 
to be 52.7% and 60.6% respectively in piglets at weaning, the 
percentage increased to 90.9% (TTSV1) and 63.6% (TTSV2) in 
gilts and 75% (TTSV1) and 87.5% (TTSV2) in sows.
Both viruses were detected in newborn piglets (1-2 days post 
parturition). In 59 samples from a group of newborn piglets 
TTSV was detected in 16 cases, which suggest possible transpla-
cental transmission.
TTSV1 (%) TTSV2 (%) Dual infection Total
Newborn pigs 8 (12.12) 8 (12.12) 4 (6) 66
Weaned pigs 67 (52.75) 77 (60.6) 50 (39.37) 127
gilts 10 (90.9) 7 (63.6) 6 (54.5) 11
sows 6 (75) 7 (87.5) 6 (75) 8
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Detection of Torque teno virus (TTV-2) by PCR in tissue samples from Brazilian swine population
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Introduction
Torque teno virus is circularized single stranded DNA viruses, 
classifi ed belonging to genus Anellovirus. Cattle, sheep, pigs, 
cats, dogs and chickens are described be infected with species-
specifi c TTV2,3. Two distinct TTV genogroup were identifi ed 
circulating among domestic pig population, TTV-13 and TTV24. 
TTV have been detected by PCR in lungs, lymph nodes, tonsil, 
ileum, serum, marrow bone, liver and kidney1,7,8. Prevalence 
varying between 24 % and 100 % in diff erent parts of the world 
are related1,5,6. The aims of this study were to standardizing a 
PCR and detect TTV-2 in samples from swine collected between 
2002 and 2003 in fi ve Brazilians states. 
Materials and Methods
The partial sequence of 250 bases of the non-coding region of 
swine TTV was amplifi ed8 and inserted into pTZ57R/T (In-
sTAclone - Fermentas®), according to the manufacturer’s instruc-
tions. Cloned DNA was selected and plasmid DNA quantifi ed 
with a NanoDrop 1000 (Thermo Scientifi c). Sensitivity of the PCR 
technique was performed with ten-fold dilutions of recombinant 
plasmid (10-1- 10-10). Threshold detection was 25 copies of virus 
DNA. Eighteen samples of tissue from fi ve diff erent Brazilian 
states (SP, GO, SC, MS and PR) collected between 2002 and 2003 
were homogenized by Stomacher 80 (Seward=Lab System) in 
20% (v/w) TE buff er. DNA extraction was carried out by phenol: 
chloroform: proteinase K protocol and the TTV2 amplifi cation 
was performed according to previous procedure described 8.
Results
TTV-2 was detected in 12 (67 %) out 18 tissue samples (67 %). 
Among the 12 TTV-2 positive samples, seven (7/7) belong to 
the fattening, three (3/6) to the growing and four (4/7) to the 
nursery pigs (Fig. 1). According to Brazilian states, the following 
distribution were observed: four belong to SP (4/4), one to MS 
(1/1), three to GO (3/4) and four to SC (4/8). The unique sample 
from PR was negative for TTV-2 (Fig. 2)
Discussion
This study represents the fi rst report of TTV-2 in swine tissues 
from diff erent Brazilian states. The results found in this work, that 
is, 67 % of positivity for TTV-2, are in agreement with the high 
percentage of this genogroup observed in pigs herd from Spain 
(over 70%)5. However, the high percentage of positive animals 
in the fattening pigs was not observed in Italy, which related a 
higher percentage on TTV-2 positive animals in weaners (57.4%) 
than fatteners (22.9%)6. 
Thus we conclude the TTV-2 is spread at least in four Brazilian 
states since 2002 and here to for there is no association with 
clinical disease. Future prospects about sites of viral replication, 
viral pathogenesis and TTV-2 relation to co-infection with TTV-1 
and PCV are necessary. 
Figure 1: Distribution of TTV-2 positive animals among nursery 
growing and fi nish pigs.
Figure 2: Number of infected TTV-2 animals according to Brazilian 
states.
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First report of TTV-2 DNA detection in samples from sows with reproductive failure in Brazil
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Introduction
Torque teno viruses (TTVs) are small, non-enveloped, single-
stranded, negative sense, circular DNA viruses, belonging to the 
genus Anellovirus. Swine are infected with the two identifi ed 
genotypes TTV-1 and TTV-21. Transmission route of TTV in pig 
population are mainly fecal-oral2 but there is evidence of vertical 
transmition. Recently, it has been verifi ed that colostrum is an 
important source of TTV infection on piglets3. Also, a high preva-
lence of TTV genogroups has been detected in boar semen4 and 
in utero infection was repoted as a commum event on multipar-
ous sows5. The aim of this study was the detection TTV-2 DNA in 
abortion, stillborn and mummifi ed fetuses.
Materials and Methods
Pool of tissues (heart, lungs, liver, kidney, and spleen) from 
fourty two fetuses were collected in diff erent pig farms located 
in São Paulo and Paraná state in Brazil. Samples were segregated 
in three fetal stages: abortion, stillborn and mummifi ed. The 
samples were homogenized by Stomacher 80 (Seward=Lab 
System) in 20% (v/w) TE buff er. DNA extraction was carried 
out by phenol: chloroform proteinase K protocol and the TTV2 
amplifi cation were carried out according to previous procedure 
described6.
Results
Fourteen of 42 tissue samples from diff erent animals were posi-
tive for TTV-2. Within the fetal stages, 6/8 (75 %) abortion, 8/25 
(32 %) stillborn and none mummifi ed fetuses were PCR TTV-2 
positive (Figure 1and 2). From all six abortion positive fetuses for 
TTV-2, a high detection was obtained in fetuses samples from 
sows in the last third of the gestational 4/6 (67 %) than on fi rst 
third of gestational 2/6 (33 %) period
Discussion
This is the fi rst report of TTV-2 infection in fetal stages in Brazil. 
PCR positive for TTV-1, 15 out of the 30 (50%) and for TTV-2, 2 
out of the 30 (7%) in serum from stillborn fetuses have already 
described3. However, our results showed a higher number of 
positive samples in stillborn tissues (30 %) probably due to the 
kind of the sample. Serum had higher virus quantities than tis-
sues, on other hand TTV-2 is easily found in tissues7. The lack of 
positive samples for mummifi ed fetus must be due the diffi  culty 
to separate suitable tissue. An interesting result was the higher 
prevalence of TTV-2 in aborted fetuses (75 %) occurring in the 
last third of the gestational period than in the fi rst. Further stud-
ies are necessary to confi rm this hypothesisis, but it is possible 
that TTV infection aff ects the development of fetuses and it can 
be responsible for mummifi ed, stillborn and weak piglets5.
Figure 1: Number of infected animals for TTV-2 according to fetal 
stages.
Figure 2: Percentage of infected animals for TTV-2 according to fetal 
stages.
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Inclusion Body Rhinitis and Porcine Cytomegalovirus in pigs in Denmark
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Introduction
Porcine cytomegalovirus (PCMV) was discovered in 1955 as the 
causative agent of inclusion body rhinitis (IBR) of pigs, and is 
closely related to human herpesviruses. Cytomegalovirus is as-
sociated with cytomegalic cells and large intranuclear inclusion 
bod-ies. In pigs, the turbinates and the respiratory tract are major 
sites of infection, and clinical signs may be fetal death, and rhinitis, 
pneumonia, reduced weight gain and death in piglets (1). 
It is stated that the herd prevalence in Europe is greater than 
90%, and that within herds, as many as 98% of pigs may be 
seropositive. PCMV can be transmitted horizontally or vertically, 
and in com-mercial farms the infection is believed to take place 
perinatally or early postnatally (2). 
There has been only one Danish study in fattening pigs to inves-
tigate the prevalence of PCMV. The re-sult was 43% PCR positive 
and 24% PCR positive in control and case groups, respectively 
(3). This paper describes the fi rst case of IBR diagnosed in suck-
ling pigs in Denmark.
Materials and Methods
The herd studied is a high health herd, which had been declared 
infected with APP type 6 and 12, M hyopneumoniae and PRRS 
genotype US. The 440 sows and pregnant gilts are fed and 
reared conventionally. Piglets are weaned at 7 kg and sold, after 
the nursery period, at 30 kg. Replacement gilts are selected from 
the nursery and reared on farm. The sows are routinely vaccin-
ated against Glässers disease, type C enteritis, E coli, PPV and 
erysipelas. 
The herd was investigated according to usual consul-tative clin-
ical procedures and submissions to The Pig Disease Laboratory, 
Danish Pig Producers, Kjellerup, Denmark. 
Results
In the farrowing unit, widespread sneezing and coughing was 
heard amongst the piglets. Pigs from 2 weeks old to weaning 
age showed nasal discharge, ill-thrift and dyspnea. Stenosis of 
the turbinates was audible on expiration. The litters were rela-
tively small with fewer than 13 live born pigs per litter, but the 
mortality rate was as low as 10%. 
The symptoms remained prominent for 2 weeks after weaning, 
but the pigs recovered clinically thereafter. The estimated mor-
tality rate in the nursery period was only 1%. 
Five pigs of 18 days of age were submitted for post mortem 
examination. They were in normal body condition, and most pigs 
exhibited macroscopically catarrhal bronchopneumonia, peri-
toneal edema, hepatic congestion and petecchial bleeding in the 
kidneys. Bacteriological examination of the liver, kidney and lungs 
revealed no specifi c pathogens, and nose swabs were negative for 
B bronchiseptica and P multocida toxin. Lungs tested negative for 
Mycoplasma spp. by cultivation, and negative for SIV, M hyopneu-
moniae, PCV2 and PRRSV by PCR. Nasal swabs tested negative for 
PRRS, but positive for PCMV by PCR. Finally, histological examina-
tion of nasal epithelium revealed mononuclear infi ltration in the 
lamina pro-pria and enlargement of the mucus gland epithelium 
cells with basophilic inclusion bodies.
Discussion
The histological fi ndings are considered pathognomonic, and 
the symptoms in general are in accordance with previous 
descriptions of infection with PCMV in pigs (1). Thus the proper 
diagnosis of the herd’s respiratory disease problems is IBR 
caused by infection with PCMV. Based on the clinical descrip-
tion, a number of Danish herds must be suspected of suff ering 
from IBR. 
No specifi c treatment or vaccination against PCMV is available. 
In order to control the infection, batch farrowing, all in/all out 
management and McRebel procedures are all recommended. 
Replacement gilts should be naturally immunized before mat-
ing, and secondary infections in general should be controlled by 
appropriate vaccination. 
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Introduction
Congenital tremor (CT) is a congenital abnormality caused by 
hypomyelination or demyelination of the brain and spinal cord. 
Unlike in splaylegged pigs where the defi cit in myelin formation 
specifi cally aff ects the motor system, with CT there is an overall 
reduction of myelin in the spinal cord (Lamar et al., 1975). CT in 
pigs is associated with myelin defi ciency and may be caused by 
genetic abnormalities (Harding et al., 1975), or in utero infec-
tion with classical swine fever virus (CSFV, Harding et al., 1966) 
or Aujeszky’s disease virus (ADV, Maré et al., 1974). In the recent 
investigations, porcine circovirus infection has been detected in 
tissues of CT pigs (Stevenson et al., 2001). 
Materials and Methods
January 2010 in Jeju, Korea, 1 day-old suckling pigs showed 
acute nervous signs including paddling, tremors, and clonic 
muscular contraction. Two suckling pigs were necropsied in the 
diagnostic lab of Jeju Veterinary Research Institute. After gross 
examination, brain, spinal cord, and internal organs were fi xed in 
10% neutral buff ered formalin, processed routinely and embed-
ded in paraffi  n wax. Sections (4μm) were cut and stained with 
Hematoxylin and Eosin (H&E) and Luxol Fast Blue (LFB) method 
for histological examination. For bacterial culture, the swabs 
from the cerebrums were inoculated on sheep blood and Mac-
Conkey agar and aerobically incubated for 48hr at 37˚C. Poly-
merase chain reaction (PCR) for porcine circovirus type II (PCV-2), 
CSFV, ADV, Japanese encephalitis virus (JEV), and porcine repro-
ductive and respiratory syndrome virus (PRRSV) were carried out 
on brains and spinal cords.
Results
Grossly, there were no lesions in cerebrums, cerebellums and 
spinal cords of suckling pigs. Histo-pathologically, there were 
no signifi cant lesions in brains. However marked hypomyelina-
tion was observed in the spinal cord of pigs. Hypomyelination 
is most evident and reduction in cross-sectional area is great-
est in the white matter of spinal cord. In bacterial examination, 
pathogenic bacterial colonies were not observed on blood and 
MacConkey agars. PCR analysis of brain and spinal cord resulted 
in amplifi cation of PRRSV-specifi c nucleotide sequence, but not 
in PCV-2, CSFV, ADV and JEV. 
Discussion
Based on the clinical and histo-pathological fi nding and LFB 
staining, this case was diagnosed as CT. Hypomyelination was 
predominant lesion in the white matter of spinal cords of two 
suckling pigs. PRRSV nucleic acid was detected in the brain and 
spinal cord. Therefore PRRSV should be considered as a possible 
cause of CT in suckling pigs. 
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Introduction
Porcine encephalomyelitis virus (PHEV), which belongs to the 
order Nidovirales, family Coronaviridae, genus Coronavirus, 
was fi rst isolated in Canada in 1962. PHEV infection is known to 
be widespread in worldwide and usually remains subclinical, 
because pigs are protected by colostral antibodies and subse-
quently they develop age-related resistance against PHEV. How-
ever when PHEV-seronegative piglets (less than 3 weeks old) 
are introduced to this virus, the mortality reaches almost 100%. 
This is signifi cant for gnotobiotic pig farms or SPF pig farms [1] 
where the pigs do not receive colostral antibodies. Also, even 
in not one of those specialized farms, nonimmune subpopula-
tion might be existed in a large gilt pool and they might act as 
potential sources of PHEV to induce clinical syndromes [2]. There 
are two types of clinical syndrome, the vomiting and wasting 
disease (VWD), and the encephalomyelitis form. There are not 
many isolates of PHEV which are registered in GenBank so our 
fi nal goal is to isolate new Korean strain of PHEV. To achieve this 
fi nal goal, we preferentially performed PHEV screening test from 
pig tissue samples and sequencing of specifi c gene, N gene, to 
compare with each other and existing strains.
Materials and Methods
From 2009 Nov. to 2010 Jan., a total of 90 swine tissue samples 
including solid organs and brains were tested for PHEV. The 
age range of these pigs was from suckling to fi nisher. They had 
respiratory, enteric or neurologic sings but some were unknown. 
Viral RNA of each samples were extracted from 10% homogenates 
and their cDNA were synthesized using specifi c external reverse 
primer of N (nucleocapsid protein) gene. The primers for RT-PCR 
and nested PCR of PHEV were based on the nucleotide sequen-
ces of nucleocapsid gene of the HEV-JT06 strain and designed as 
follows: NF(external forward primer) CAGGAGGGACTGTTGTACCC, 
NR (external reverse primer) CCCAACAAACAATGCA CTGT, N2F (in-
ternal forward primer) TGCACCA GGAGTCCCAT CTA, N2R (internal 
reverse primer) GCCAAGTTTTGC CAGAACAA. The size of amplifi ed 
product was 472bp. The fi nal PCR products were sequenced and 
aligned to evaluate the relationship with others using the Clustal 
X (1.83) multiple sequence alignment program and the phylogen-
etic tree was constructed by MEGA (4.1).
Results
Among 90 samples, 9 showed positive results for PHEV after 
performing nested PCR. The sequence results of these PCR 
products were confi rmed PHEV by BLAST, showing 97-98% nu-
cleotide identity. These sequences of the 9 samples were aligned 
with three reference strains, JT06, VW572 and IAF-404, and the 
sequence identities of the samples were the highest with IAF-
404. The 9 samples had their unique nucleotides compared to 
the reference JT06 strain in the region between 586 and 622. The 
phylogenetic tree was drawn below.
Discussion
This study showed that PHEV is actually present in some of 
the farms in South Korea. Even though the positive samples 
established a new group, there were not so much variations 
compared to existing PHEV strains. Since the use of gnotobiotic 
and SPF pigs for xenotransplantation and transformation is 
common these days, this virus is not negligible when handling 
PHEV-seronegative pigs.
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Introduction
The genus pestivirus contains four species currently recognised 
by the International Committee on Taxonomy of Viruses namely, 
Classical Swine Fever virus (CSFV or hog cholera virus), Bovine 
Viral Diarrhea virus Type 1 (BVDV-1) and Type 2 (BVDV-2), and 
Border Disease virus (BDV) of sheep. BVDV under natural condi-
tions mainly infects cattle and sheep; however, the virus has 
been associated with disease in goats and swine as well (1). 
Herd level prevalence of BVDV (in CSVF-free countries) has been 
reported anywhere from 2-43% with cattle implicated as the 
most common source of infection of BVDV in pigs (1).  Pestivirus 
infections in animals can lead to fertility problems, diarrhea, 
immuno-suppression, thrombocytopenia, and central nervous 
system disease. In pregnant animals, transplacental infection can 
lead to abortion, stillbirth, foetal malformation, and persistent 
infection of off spring (1).
Interest in the prevalence and clinical signifi cance of pestivirus’ 
in swine herds has recently been highlighted with the docu-
mentation of a neurologic and reproductive disease outbreak 
associated with a novel pestivirus in the USA (2) and a disease 
outbreak in Australia (3). Such novel strains of pestivirus have yet 
to be identifi ed in Ontario swine herds and the current preva-
lence of BVDV in Ontario swine herds is unknown. The objectives 
of this study were to determine the prevalence of neutralizing 
antibodies to BVDV type-1 and type-2 in Ontario swine herds 
and to determine if the presence of cattle on the same premise 
was a risk factor for seropositivity.  
Methods
Five hundred samples of stored fi nisher pig sera (10 samples 
per herd) were tested. The stored samples were from 50 swine 
herds that participated in a swine sentinel herd program at the 
University of Guelph in 2005 (4). The Ontario sentinel herds 
were distributed across the province and the program collected 
herd level information and blood samples from each herd. The 
samples were tested by virus neutralization (VN) for BVDV-type 1 
and BVDV-type 2 by the Animal Health Laboratory at the Univer-
sity of Guelph. The degree of contact with cattle for each herd 
was compiled from the sentinel project herd records.
Results
All 500 samples from, the 50 herds, tested negative (titres < 1:2) 
for antibody to BVDV-type 1 and BVDV-type 2. Of the 47 herds 
with information available on the presence of cattle, cattle were 
present on 27.6% of the farms. On the remaining 72.3% of the 
farms, only pigs were present.
Discussion
The results indicate that BVDV did not appear to be present 
in Ontario swine herds in 2005 regardless of the presence of 
cattle on the same premise. These fi ndings correspond to other 
fi ndings where the seroprevalence of ruminant pestiviruses in 
swine was found to be low (1, 5).  The Ontario swine industry is 
experiencing a rapid decline in the presence of mixed farming 
practices and has moved almost exclusively to species special-
ization of farms, a phenomenon witnessed in many parts of the 
world today.  It has been speculated that this trend in farming 
practices has resulted in the decline of BVDV in swine worldwide 
as supported by this study (1).
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Introduction
Poxvirus infections of pigs are either caused by Vaccinia virus 
and Cowpox virus (Orthopox) or by Swinepox virus (Suipox, SwP). 
SwP is a severe disease in young pigs [1]. Adult pigs generally 
develop a mild, self-limiting form of the disease. Morbidity can 
be up to 100% in pigs up to 4 months of age. Transmission by 
insects is less common; horizontal transmission between pigs 
may occur. Small skin injuries may facilitate the entry for Swine-
pox virus (SwPV). Macroscopic examination of skin lesions often 
leads to an insecure diagnosis. However, other methods that 
allow for a rapid and accurate diagnostic are appreciated. This 
paper describes the diagnostic procedure including electron 
microscopic analysis and a novel SwPV-specifi c PCR.
Materials and Methods
Between Nov. 2008 and March 2009 piglets in a German two 
side production unit showed clinical signs of red skin lesions fi rst 
at maculae stages, following by papula-, pustule and fi nally crust 
stages. The lesions were equally distributed over the entire body 
surface of the nursery piglets. Nearly 50% of the piglets were af-
fected. First symptoms were seen 1-2 weeks after relocation into 
the nursery. First macroscopical diagnosis was SwPV-infection. 
For PCR, scraped skin tissues from crusts as well as epidermal 
biopsies were collected. SwPV specifi c PCR primers (for: 5´-CC-
GAGGAGTATAGACGTGTTATCG-3´, rev: 5´-AGGAATCCGTAGATA-
CAGCCGA-3´) were designed (PrimerQuestSM, Integrated 
DNA-Technologies) based on published DNA-sequences of the 
thymidinkinase-gene (TK-gene) of the SwPV (GenBank: Acc.
Nr. AF410153, M64000 and M59931). Orthopoxvirus-DNA was 
included to exclude orthopox infections. PCR products were 
sequenced and aligned to confi rm identity of SwPV.
Electron microscopy (TEM) was performed by negative staining 
of sample suspensions including enrichment with ultracentrifu-
gation. Moreover, epidermal biopsies embedded in Epon were 
prepared for tissue sectioning. Ultrathin sections stained with 
UA were analysed in a TEM (Zeiss 906,80kv). 
Results
SwPV was confi rmed by PCR and sequencing of the TK-gene; 
PCR for Orthopox was negative. All amplifi ed products of the 
TK-gene were 473bp long and did show 100% homology to 
published sequences (Acc.Nr. AF410153, M64000 and M59931). 
Histology revealed marked ballooning cytoplasmatic degen-
eration and central nuclear cleaning of epidermal cells of the 
stratum spinosum. As revealed by TEM, infected epithelial cells 
were greatly distended by huge cytoplasmic lipid A-type inclu-
sion bodies, fi lled with mature virions and uniformly granular, 
electron dense material. Intracellular mature virions within inclu-
sions had gained additional outer coats formed by this granular 
material. Intracellular virus particles found in A-type inclusions 
have the typical structure of poxviruses; extracellular virus par-
ticles often exhibited a second outer virus membrane. Immature 
virions in B-type inclusions (= virus factories) developed by 
formation of dense foci of viroplasm were surrounded by cres-
cent shaped, phospholipid membranes later closing to circular 
membranes. Like in other poxviruses [2,3], virus crescents reveal 
no continuity between cellular intermediate compartment (IC), 
though proteins from IC are of the same origin. Like in other 
poxviruses, the transport of immature virions and crescents 
within the cell seem to be in accordance with fi laments seen 
in contact with virus stages. Early A-type inclusion formation 
involves the attachment of intracellular mature virions to small 
lipid globules. 
Discussion
PCR, sequence analysis and electron microscopic analysis helped 
to confi rm an infection with SwPV in the above mentioned herd. 
Electron microscopy confi rms the practitioner’s fi rst diagnosis. 
The descibed PCR-assay enables a rapid and an accurate diagno-
sis of SwPV, that my help to review management practices and 
the implementment of control measures and treatments. 
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Introduction
Retroviruses are RNA viruses that exist in two main groups: 
endogenous or exogenous retroviruses. Pigs carry porcine 
endogenous retroviruses (PERV) in their genome (1) and three 
PERV subtypes have been identifi ed to date, PERV-A, B, and 
C. PERV-A and PERV-B are present in genomes of all pigs. In 
contrast, PERV-C is absent from many pigs and this virus with 
its host range mostly restricted to porcine cells is not infectious 
to human cells (2). More recently, the possible existence of ex-
ogenous retrovirus; a recombinant between PERV A and PERV C 
(PERV A/C), as opposed to endogenous retroviruses in pigs was 
proposed (3,4). The objective of this study was to determine if 
there is a relationship between retroviremia and clinical disease 
in pigs by using real-time PCR methods to detect the diff erent 
PERV types on serum samples obtained from clinically healthy 
and clinically aff ected 3 to 25 week old pigs. 
Material and Methods
A total of 369 serum samples were collected from 204 pigs from 
three commercial swine operations in the U.S. during 2006 and 
2007. Farm 1 consisted of a total of 84 pigs with subclinical por-
cine circovirus associated disease (PCVAD). Farm 2 samples were 
obtained from 60 three-week-old pigs. Thirty of the 60 pigs were 
clinically healthy and the remaining 30 pigs suff ered from weight 
loss and diarrhea associated with Salmonella typhimurium and E. 
coli. Samples collected on Farm 3 were obtained from 60 25-week-
old pigs with a recent PCVAD outbreak resulting in 30% mortality. 
As with Farm 2, at the time of blood collection, 30 pigs were clinic-
ally healthy and 30 showed clinical signs consistent with lethargy, 
decreased weight gain or weight loss and respiratory disease. The 
presence of PRRSV, PCV2, and respiratory disease was confi rmed 
by routine diagnostics. The RNA of all samples was extracted and 
all samples were tested by three diff erent real-time PCR assays: A 
general PERV-ABC real-time RT-PCR, a real-time RT-PCR specifi c for 
PERV-C, and a quantitative real-time RT-PCR specifi c for PERV-A/C 
recombinants. Pairwise t-tests were used for data analysis with a 
level of signifi cance of <0.05.
Results
While all 369 samples were found to be positive for PERV-ABC 
RNA, PERV-C RNA and PERV-A/C RNA were detected in 24.1% 
(89/369) and 18.7% (69/369) of the serum samples respectively. 
Twenty percent (43/215) of the samples collected during the 
nursery stages (3-9 weeks of age) were found to be positive for 
PERV-A/C RNA versus 16.9% (26/154) of the samples collected 
during the grow-fi nish stages of production (12-25 weeks of 
age). When clinically aff ected pigs were compared to unaff ected 
pigs, 25.0% (15/60) of the samples from aff ected pigs were 
found to be positive for PERV-A/C RNA, whereas in clinically 
healthy pigs 8.3% (5/60) of the samples were found to be PERV-
A/C positive. Interestingly, PERV A/C was also identifi ed in the 
same pigs on more than one consecutive bleeding time.
Discussion
In this study, it was determined that 100% of the investigated 
pigs were positive for PERV-ABC as expected. PERV-C and PERV-
A/C were found in varying percentages (24.1% versus 18.7%) 
on all farms and production stages. Finally, when we compared 
clinically healthy and diseased pigs, in one of the two investi-
gated farms, evidence was found that clinically aff ected pigs 
had a higher incidence of PERV A/C. Since the current study was 
limited to selected farms further studies using sample sets from 
pigs with diff erent clinical expressions are warranted.
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Introduction
Two antigenically distinct swine boca-like viruses (SwBoV) have 
been isolated from pigs in Northern Ireland. The viruses were 
recovered from a small intestinal tissue and faecal specimen 
from two pigs on diff erent PMWS-aff ected farms by virus isola-
tion in primary cell cultures. Although both samples exhibited a 
CPE, PCR testing for a range of known porcine viruses failed to 
identify either agent. DNA sequencing and molecular charac-
terization subsequently established that both isolates share 
genetic homology and possible genomic arrangement with 
parvoviruses BPV-1, CMV and HBV. The isolates were designated 
as SwBoV1 and SwBoV2. The discovery of a novel porcine boca-
like virus (PBo-likeV) in PMWS-aff ected pigs in Sweden has also 
recently been reported1. Here we describe the development of a 
real-time PCR assay for the detection of SwBoV DNA.
Materials and Methods
Primers were designed against conserved nucleotide sequences 
of SwBoV1 and SwBoV2. Real-time PCR was carried out on a MJ 
Research Opticon 2 instrument using SybrGreen PCR master mix 
(Qiagen, West Sussex, UK) in 25 μl reaction volumes containing 
2 μl of template. Assay optimisation involved determination 
of optimal Ta, Mg2+ and primer concentrations. To determine 
assay sensitivity, serial dilutions of quantifi ed amplicons were 
prepared for each isolate. Assay specifi city was assessed against 
a number of cell lines, porcine and non-porcine DNA viruses. 
A 2.8Kb representative amplicon, derived from a UK sample, 
served as PBo-likeV positive control DNA. All nucleic acid extrac-
tions were performed using the MagNA Pure LC Total nucleic 
acid extraction kit (Roche, Burgess Hill, UK). 
Results
PCR optimisation resulted in an assay designed to work at a Ta 
of 52oC and 0.5 μM primer concentration. Amplifi cation was 
achieved using 40 cycles of 95oC for 30sec, 52oC for 30sec, 72oC 
for 30sec followed by a melt-curve between 60-95oC. Amplicons 
of 313-316bp, Tm of approximately 79oC and 78oC and detection 
limits of 2x101 and 2x102 copies/μl of PCR product were deter-
mined for SwBoV1 and SwBoV2, respectively. The specifi city of 
the assay was also confi rmed against a range of cell lines and 
DNA viruses. 
Fig. 1 Fluorescence v cycle no. for SwBoV PCR assay run against lymph-
oid tissue from fi eld samples.
The assay was applied to a number of archived fi eld specimens. 
Fig. 1 shows the results of positive samples, with Tm ranging 
from 78.1-79.5oC. Sequence analysis of two positive fi eld sam-
ples established that they shared >90% nucleotide homology 
with SwBoV1 and SwBoV2 within the 900bp region analysed. 
Nucleotide database searches (BLASTn) reported that the ampli-
cons most closely resemble HBV, CMV and BPV-1. DNA sequen-
cing analysis of the remaining positive samples is on-going.
Discussion
New and re-emerging pathogens continue to pose a risk to both 
human and animal health. Bocavirus infection is already associ-
ated with a number of disorders in other species2. The discovery 
of a SwBoV therefore warrants further investigation. The results 
suggest that this PCR assay may off er a sensitive method for the 
detection of SwBoV DNA. The development of a SwBoV-specifi c 
PCR assay provides a means to investigate the prevalence, 
clinico-pathological signifi cance, epidemiology and genetic 
diversity of SwBoV within swine populations.
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Introduction
Osteochondrosis (OC) is a major predisposing factor to lame-
ness, impairing growth performance and animal welfare. It is 
defi ned as generalized disturbance of the enchondral ossifi ca-
tion at predilection sites such as the articular cartilage and meta-
physeal growth plates. Little is known about the pathogenesis, 
and diverging views regarding the causes of the disease exist. 
Most reports focus on the articular lesions. In a feeding trial the 
hypothesis was tested that ad libitum feeding of a diet con-
taining excessive amounts of calcium (Ca) and protein combined 
with a high physical activity, i.e. risk factors for the development 
of canine panostitis1, cause osteochondrosis in growing pigs. 
Materials and Methods
From 25 to 105 kg body weight (BW), four groups of fi ve Large 
White pigs received either restricted amounts of feed containing 
the recommended nutrient level (“R”) or an enriched diet (“E”: 
Ca +30%, crude protein +20%, 2000 IU/kg vitamin D) ad libitum 
and were either individually housed in small (S) pens or group 
housed in large (L) pens (Table 1).
Table 1: Feeding and housing of the pigs
Group RS RL ES EL
Pigs (n) 5 5 5 5
Feeding restricted restricted ad lib ad lib
Pen small large small large
Every week, each pig was weighted and clinically monitored, in 
particular for lameness, leg deformities and accessory bursae. 
After slaughtering, one forelimb per pig was radiographed in 
lateral and antero-posterior position. Findings at the distal ulna 
growth plate (DUGP) were recorded. 
Two radiologically normal and four altered legs were histologic-
ally evaluated using light microscopy. For this, bones were 
sawed in 5mm slices in the area of the DUGP and fi xed in 70% 
alcohol. Bone sections were embedded in acryl and stained with 
Fuchsin/Acetic-Light Green.
Results
The ad libitum intake of feed E as well as housing in small pens 
signifi cantly increased the daily weight gain (ES 841g, EL 757g, 
RS 716g, RL 693 g).
Limping or stiff  walking were observed in 7 pigs from 16 weeks 
of age onwards but were always slight or moderate and dis-
appeared within one or two weeks without therapy. Bowed 
legs (17 pigs) and accessory bursae or callosities (20 pigs) were 
frequent and occurred in all 4 groups.
Radiographs showed OC lesions as radiolucent, widened and 
irregular growth plates and/or subchondral sclerosis in the distal 
ulna of 14 pigs. Four of the 14 pigs with radiologic changes had 
a history of lameness.
Histological fi ndings ranged from normal growth plates to 
severe lesions in the distal ulna. Irregular width, abnormal os-
sifi cation or mineralization, and separation in the area of the 
cartilage breakdown zone were observed. In one case, separa-
tion extended to the metaphyseal bone (Fig. 1). On the rims of 
the clefts, reparation processes occurred.
Fig. 1: Separation along the distal ulna growth plate (DUGP), 
extending in the metaphysis (M) of the distal ulna, 1.6x. 
Discussion
Severe lameness could not be provoked by the study de-
sign. Nevertheless, radiological and histological investigation 
revealed OC lesions in all 4 study groups. The separation in the 
distal ulna epiphysis (fi ssure) has been described in literature2, 
but recent reports are lacking. Thus, we want to draw attention 
to this histological fi nding as part of the OC features.
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Introduction
Infectious arthritis is one of the most common causes of 
antimicrobial treatment of nursing piglets with approximately 
10% of the piglets receiving antimicrobial treatment because of 
lameness (1, 2). Aff ected piglets mostly receive treatment during 
the fi rst three weeks of life. At present, there are few studies on 
the prevalence of pathogens isolated from aff ected joints of 
piglets with clinical signs of arthritis. 
As infectious arthritis causes both suff ering of the individual 
animal and economic losses due to reduced growth rate, in-
creased mortality, costs for treatments and increased labor, it is 
most important to initiate treatments as soon as possible with 
the most appropriate antimicrobial to minimize both losses and 
other negative eff ects. Therefore, the aim of this study was to, on 
a national level, obtain a basis for an optimal treatment regime.
Materials and Methods
From each herd with ≥100 sows (n ≈ 400), one nursing piglet (0 
to 35 days of age) with clinical signs of infectious arthritis such 
as lameness, fever and swollen joints were identifi ed by the 
regional Animal Health Service veterinarian on a regular visit. 
The piglets were euthanized with an intra peritoneal injection of 
barbiturates (≥ 1 ml/kg body weight) and then frozen at -20°C 
before being sent to SVA for necropsy.
At necropsy, two aff ected joints per piglet were sampled for 
bacterial cultivation including Mycoplasma sp., and Haemoph-
ilus sp. Antimicrobial susceptibility was determined by broth 
microdilution using VetMICTM (SVA, Uppsala). Epidemiological 
cut-off  values according to EUCAST were used to determine if 
the isolates were resistant or not (www.eucast.org). Isolates of 
Staphylococcus (S.) hyicus were in addition examined for penicil-
linase production by the “clover-leaf” method.
Results
The preliminary results from 36 herds, represented by 36 piglets 
and 72 joints, demonstrated bacterial isolation from 39 of 72 
sampled joints. The dominant fi nding was Streptococcus dys-
galactiae subsp. (S.) equisimilis isolated from 23 joints, followed 
by Escherichia (E.) coli isolated from 5 joints and then S. hyicus 
isolated from 4 joints. Mycoplasma sp. and Haemophilus sp. 
could not be isolated from any of the 72 sampled joints. From 
seven joints, the bacterial species have not yet been identifi ed.
In 10 piglets, the same bacterial species could be isolated from 
both joints sampled. S. equisimilis was isolated from both joints 
in eight piglets and E. coli in two piglets. In nine of 36 piglets, 
bacterial cultivation was negative from both joints.
All streptococci were susceptible to penicillin. Three of four 
S. hyicus isolates were penicillinase producers. However, all S. 
hyicus and E. coli isolates were susceptible to trimethoprim. 
Discussion
The isolation of the same bacterial species from both of the 
sampled joints in 10 piglets indicates a hematogenic spread of 
the infection which is in accordance with previous fi ndings (3). 
In four of the nine piglets where no bacteria could be isolated, 
lameness was most probably caused by trauma. The other fi ve 
piglets had gross pathological lesions indicative of arthritis.
This study shows that treatments with penicillin would be 
successful in 22 of 25 piglets, provided that treatments were 
initiated early on during the course of infection. However, as 
three S. hyicus were penicillinase producers, and three E. coli 
isolates were resistant to ampicillin, some cases of treatment 
failure using penicillin could be expected. Thus, given the re-
sults, trimethoprim-sulphonamides should be considered as the 
second hand choice after penicillin.
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Introduction
Locomotory disturbances in swine are a signifi cant and com-
mun problem in pigherds 1,2,3. Nutritional, bacterial and viruses 
infection are the main factors related to paralysis of hind legs in 
young pigs4,5. Even though the incidence of pathology is low6, 
no fi eld reports have been done so far. The aim of this study is 
to describe an outbreak of hind limbs paralysis in an pig farm in 
Venezuela.
Materials and Methods
The study was carry on in a 600 sows farrow to fi nish herd in 
the Cojedes State of Venezuela. A historical morbility records 
showed and incidence in 5 to 10 pigs with hind legs recum-
bence or paralysis in the last three months before to this study. 
An interview with the owner and stockmanship in the farrow-
ing and weaner areas was scheduled to assess the key factors 
intervening in the cases. Data of numbers of pigs suff ering this 
condition, mortality attributed to hind quarters paralysis was 
taken to determine the prevalence and incidences. Necropsy 
was performed in pigs and samples of limph nodes and spinal 
cord were taken for bacteriological and histopathological study.
Results
Interview results and management procedures in tha farrow-
ing area showed failures during piglets processing after farrow. 
Findings necropsy showed an intervertebral abscess at L4-L5. 
Nodular proliferative abscess were presented in the spinal cord 
canal (Fig. 1, ). Degenerative changes were manifest grossly as 
narrowing of the intervertebral space and conversion of the 
nucleus pulposus to a red dark, granular mass (Fig. 2). A mix 
of mononuclear and neutrophils infi ltration in spinal cord on 
microscopic view was observed.
Changes in proccesing piglets and an antimicrobial medication 
inyectable and in the weaner feed reduced the incidence of this 
pathology.
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Introduction
During the summer months lesions of the so-called ear necrosis 
syndrome can be observed frequently in weaners during the 
raising period. The stages range from mild epidermal changes to 
severe ulcers and necrosis (1). In the past, contaminants of feed-
ing stuff  have been discussed to be responsible for the develop-
ment of ear necrosis, but the exact etiology of this disease could 
not be determined. Aim of this study was the evaluation of 
bacteria, fungi and diff erent mycotoxins in feeding stuff  of pigs 
with ear necrosis syndrome.
Materials and Methods
A total of 15 farms were included in the study. Feeding stuff  of 
piglets with clinical signs of the ear necrosis syndrome in an 
initial stage was collected 3 times, once during summer time, 
when the symptoms occurred for the 1st time, once in winter 
after storage and once again in summer. The investigated par-
ameters are summarized in table 1.
Table 1: Contaminants in feeding stuff 
Bacteria Aerobe mesophile bacteria
Fungi Mould fungi, Aspergillus spp., Fusarium spp., Penicillium spp.
Mycotoxins T2 toxin, HT2 toxin, Diacetoxyscirpenol
Mycotoxins Deoxynivalenol (DON), Acetyldeoxynivalenol, Nivalenol, Zearalenone (ZON)
Mycotoxins Ergosin, Ergotamin, Ergocornin, Ergocryptin, Ergocristin
Results
Aerobe mesophile bacteria could be detected in a concentration 
between 1.0 x 104 to 3.0 x 107. Concentrations up to 106 are of 
no clinical relevance. 34.4 % of the samples had results higher 
than 106. Aspergillus spp., Fusarium spp. and Penicillium spp. 
were determined in a concentration of 103, which is not harmful 
to pigs. Only 1 sample exceeded a Penicillium and 2 samples a 
Fusarium amount of 104. Concerning the mycotoxin concentra-
tions, T2 toxin, HT2 toxin, Diacetoxyscirpenol, Acetyldeoxyni-
valenol and Nivalenol could not be detected. Table 2 shows the 
results of the other toxins.
Table 2: Mycotoxin concentrations in mg/kg
Toxin Max MV SD
DON 1.243 0.253 0.246
ZON 0.126 0.041 0.036
Ergosin 0.486 0.043 0.111
Ergotamin 0.241 0.025 0.053
Ergocornin 0.015 0.001 0.003
Ergocryptin 0.822 0.106 0.227
Ergocristin 2.015 0.372 0.583
Max = maximum, MV = mean value, SD = standard deviation
Discussion
Especially mycotoxins can cause ear necrosis. A good quality of 
feeding stuff  can be an essential prophylactic tool. The general 
hygienic status of the feeds tested in the present study was 
moderate, which could be an initiating factor for the develop-
ment of several diseases. Increased mycotoxin concentrations 
could also be detected. Whereas DON and ZON amounts were 
mostly tolerable, the detected alkaloid concentrations were 
unexpectedly high. If those concentrations are suffi  cient for the 
development of ear necrosis still needs to be investigated.
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Introduction
During the summer months lesions of the so-called ear necrosis 
syndrome can be observed frequently in weaners during the 
raising period. The stages range from mild epidermal changes 
to severe ulcers and necrosis (1). In the past, various pathogens 
have been discussed to be responsible for the development of 
ear necrosis, but the exact etiology of this disease could not be 
determined. Aim of this study was the data collection through 
questionnaires in farms with pigs with ear necrosis syndrome.
Materials and Methods
Questionnaires were sent to Austrian and German veterinar-
ians. The parameters of interest were kind of necrosis (tip of the 
ear (T), margin of the ear (M) or fl ank (F) necrosis) stadium of 
disease, severity, percentage of aff ected pigs, age and weight of 
pigs, additional symptoms, feeding, husbandry, positive experi-
ence with any treatment or prophylaxis, previous illness as well 
as occurrence of cannibalism.
Results
In total, 54 questionnaires were returned to the clinic for swine. 
88.7 % of them declared to see the ear necrosis syndrome often 
and 94 % estimated ear necrosis to be a considerable problem 
in swine production. 90.7 % reported to have problems with 
necrosis at the tip of the ear, 57.4 % with necrosis at the margin 
of the ear, and only 14.8 % with fl ank necrosis. Percentage of 
aff ected pigs, as well as age and weight of pigs are presented in 
table 1. Most of the animals, independent of the kind of necrosis, 
were in a chronic stadium of disease, there were only a few acute 
cases. The severity of disease was estimated as follows: fl ank 
necrosis: mild symptoms, both kinds of ear necrosis: moderate 
symptoms. In about half of the farms the pigs showed wasting, 
32.1 % had diarrhea. Concerning feeding, only one veterinarian 
reported a low quality of feeding stuff . 22.6 % associated the 
occurrence of ear necrosis with a change in the feeding strategy. 
Only 5.6 % observed a reduced feed intake. Related to husband-
ry the main problem was the pig density. All other parameters 
as temperature, cleaning, disinfection were not considered to be 
problematic. 72.2 % reported positive experiences with diff erent 
treatment or prophylactic measures (68.4 %: antibiotics, 2.6 %: 
vaccination, 2.6 %: management improvement, 28.2 %: com-
bination of diff erent measures). 22.2 % of the farms reported any 
illness previous to the occurrence of ear or fl ank necrosis (41.7 
%: bacterial infection (gram negative), 25.0 %: bacterial infec-
tion (gram positive), 8.3 %: viral infection, 25.0 %: multifactorial 
infection). Cannibalism was considered to be the reason for the 
occurrence of ear necrosis in 51.0 % of the cases.
Table 1: Statistical evaluation of collected data
Parameter Kind Min Max MV SD
Pigs aff ected (%) T 2 100 38.8 28.5
Pigs aff ected (%) M 2 100 34.3 27.7
Pigs aff ected (%) F 2 40 10.6 13.4
Age (weeks) T 5.5 15.0 7.9 1.7
Age (weeks) M 5.5 15.0 8.2 1.8
Age (weeks) F 10.0 15.0 11.0 2.2
Weight (kg) T 12.0 30.0 18.1 4.8
Weight (kg) M 10.0 27.5 17.7 4.3
Weight (kg) F 17.5 42.5 28.0 9.4
Min = Minimum, Max = Maximum, MV = Mean value, SD = Standard deviation
Discussion
The present study showed that ear and fl ank necrosis is of 
concern to swine practitioners. If ear necrosis appears, about 
one third of the pigs are aff ected. The economic losses increase 
because of concomitant symptoms as diarrhea and wasting. 
Not only infectious diseases seem to be relevant; management, 
feeding and husbandry are also signifi cant factors. The results of 
this evaluation pointed out clearly that ear and fl ank necrosis are 
mainly caused multifactorial as shown in other studies (2, 3).
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The occurrence of fungi and mycotoxins in swine feed in Korea
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Introduction
Fusarium spp. are recognized as a source of common myco-
toxins, and storage fungi include the genera Aspergillus and 
Penicillium, which account for several mycotoxins important in 
swine production. A few of signifi cant mycotoxins include afl a-
toxin and Ochratoxin A belonged to Aspergillus spp, ochratoxin, 
dexynivalenol, zearalenone, fumonisin and T-2 toxin belonged 
to Fusarium spp. Afl atoxin and ochratoxin mycotoxins, as well 
as Fusarium, have been shown to be the destruction of the im-
mune system and immunosuppressive. This study was to survey 
about fungi and mycotoxins occurrence in Swine Feed of diff er-
ent regions in Korea [1].
Materials and Method
A total of 202 feed samples were evaluated for survey of Fungi 
and Mycotoxins. Also all samples were classifi ed by growth 
period, regions. Culture processes of samples were performed 
by potato dextrose agar. Then microscopic examination was 
performed after staining process. The photomicrographs cap-
tured by OPTIMAS 6.1 were referred to mycology online and CAB 
International by E-mail. Simultaneity, the samples collected were 
examined by ELISA technique after processing. AgraQuant® 
Mycotoxin Test Kit was used to estimate mycotoxin ELISA titre.
Results
In morphologic diagnosis process, 3 types of fungi, Aspergil-
lus spp.,Fusarium spp. and Rhizopus spp. were identifi ed by 
microscopic examination. Aspergillus spp., Fusarium spp. and 
Rhizopus spp. were observed in 97, 25 and 19 samples, respect-
ively. The rests of 61 samples were unidentifi ed. By analyzed 
samples from various growth period, belonged to Aspergillus 
spp., in growing, fattening, pregnant, and farrowing were 17, 
32, 27 and 21, respectively. In Fusarium spp., were 2, 12, 9 and 2 
samples, in Rhizopus spp., were 1, 11, 4 and 3 samples, respect-
ively. By regions, belonged to Aspergillus spp., in Gangwon-do, 
Gyeongsang-do, Chungcheong-do, Gyeonggi-do and Jeolla-do 
were 37, 21, 19, 11 and 9 samples, respectively. In Fusarium spp., 
were 4, 5, 3, 7 and 6 samples, in Rhizopus spp., were 3, 5, 2, 3 and 
6 samples, respectively. By feeder type, 30 samples were dry and 
humid-typed feeder and 41 samples were dry-typed feeder. In 
dry and humid-typed feeder, Aspergillus spp., Fusarium spp. and 
Rhizopus spp, were observed in 12, 5 and 6 samples. Whereas, 
in dry-typed feeder, those were observed in 9, 4 and 4 samples, 
respectively. By ELISA analyze of mycotoxins, incidences of 
contaminated samples were 75.24% for afl atoxin, 5.94% for 
ochratoxin A, 47.02% for zearalenone, 68.31% for fumonisin, not 
detected for T-2 and 78.91% for deoxynivalenol, respectively. 
The mean value of contaminated samples were 7.67±1.86μg/kg 
for afl atoxin, 5.10±2.87μg/kg for ochratoxin A, 128.32±99.04μg/
kg for zearalenone, 880.00±800.00 μg/kg for fumonisin, not 
detected for T-2 and 510.00±210.00 μg/kg for deoxynivalenol. 
Eleven samples were against MEL regulation with those con-
taminated at a concentration of over 10ppb of afl atoxin. Among 
them, 6 samples had mixed contamination with zearlenone, 
fumonisin and deoxynivalenol. 
Conclusions 
The most of the fungi identifi ed from swine feed were Aspergil-
lus spp. By growth period, any fungi were not observed in feed 
of weaned pig. In rest period, 3 types of fungi were similarly ob-
served. But generally, a number of fungi were observed in feed 
of fattening pig. By province, the most of fungi were observed 
in Gangwon-do, Gyeongsang-do and Chungcheong-do. Eleven 
samples exceed maximum exposure limits regulation on afl a-
toxin, although T-2 has not been detected in our samples. Detec-
tion rates of humid-typed feeder were shown higher than those 
of dry-typed feeder. Based on the results, the development of 
mycotoxins might be associated with environment. Therefore, 
the management of feed would consider important to provide 
against the damage by mycotoxins, as environment and climate 
are responsible for the development of it.
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Introducción
The mycotoxins are secondary metabolites produced by fungi, 
of which the afl atoxin B1 (AFB1) and Fumonisin B1 (FB1) are 
important due to their toxicity and carcinogenicity. Afl atoxin 
aff ects negatively growth, feed conversion and consumption in 
pigs. The most aff ected organs are: the liver, and kidney. Fumo-
nisin on the other hand causes pulmonary edema (1,2,3).
Material y Methods
The FB1 used was a standard (SIGMA), in 5 mg and 10 mg vials 
with 98 % purity. A stock solution was prepared at a concentra-
tion of 87ppm in distilled water. The FB1was administered to 
weaned pigs in 12ppm (mg/kg live-weight) by the oral route 
by means of a probe. For AFB1we used a Sigma standard in 
presentation 5 mg per vial with a 98 % purity. A stock solution 
was prepared in benzene-acetonitrile. The administration of the 
AFB1 to weaned pigs was at a dose of 8 ppb (μg/kg live-weight) 
by mouth using a probe. The experimental animals were 16 pigs 
21 to 36 days of age of either sex, with an average weight of 7 
kg. The animals were distributed randomly into 4 groups, each 
group was composed of 4 pigs, with the following distribution: 
negative Group A: Control.; Group B: intoxicated with FB1. Group 
C intoxicated with 8ppb of AFB1. Group D: intoxicated with 
12ppm FB1and 8ppb.with AFB1.
The studied variables were body weight, the serum concentra-
tion of total proteins, albumin, the enzyme concentration of AST, 
( γ-glutamic tranferase) GGT, direct, indirect and total Bilirrubins. 
The data were evaluated by ANOVA with a 95 % signifi cance 
level, using the statistical programme Statgraphics Plus version 
5.0.
Resultados
The results of the measurement of daily weight gain were: 0.22 
kg for Group A, 0.043 kg for Group B, 0.074 kg for Group C and 
fi nally 0.002 kg for Group D. Evaluation of AST and GGT serum, 
results showed an increased activity in groups B, C and D. 
Protein levels showed no signifi cant changes. Levels of albumin 
showed a slight decrease in the group B. The bilirulubins were 
increased in groups B, C and D, and the eff ect was more marked 
in Group B.
Discusión
The daily weight gain showed signifi cant diff erences between 
group A and D, with values of 0.22 kg and 0.002 kg respectively. 
These results diff er from those reported by Zomborszky et al 4., 
where they cite that the diff erences in body weight gain was not 
statistically signifi cant at the end of the experiment. AST levels 
in groups, B, C and D showed increased values that is consistent 
with Dilkin, P. et al, 5 . The GGT levels reported in literature are 
very diverse, but all showed an increase in intoxication by myco-
toxins. The decrease in protein levels was notorious in group B 
compared with the other groups. The variability of values is due 
to the concentration of mycotoxins, time of exposure and age 
of the animals (6). The decrease in levels of serum albumin was 
more pronounced than total proteins. Albumin has a plasma 
half-life of 21 days, so that as a measurement of liver function is 
not very pronounced until three weeks of intoxication (6) that 
the liver failure is triggered. The decline of bilirubin was most 
signifi cant in Group B, this show that the FB1 aff ects the liver
Conclusions.
The assessment of biochemical parameters shows sensitivity 
and eff ectiveness to detect liver damage using small doses of 
mycotoxins. 
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Introduction
The Salinomycin ionophore is an antibiotic used as anticoccidial 
in poultry and as growth promoters in cattle, sheep and pigs (1). 
The tiamulin is used in treatments for respiratory and enteric 
complications (2) These, when used alone in appropriate doses, 
do not cause damage to animals, but ionophores are myotoxic 
in excessive doses (3). Poisonings occur because of mixing error 
of the drug with the feed (4), dosage error (5), use on non-target 
species (6), or normal doses associated with drugs that maxi-
mizing its eff ects, such as chloramphenicol and tiamulin . (7). 
The tiamulin acts by reducing the elimination of the ionophore, 
leading to intoxication (8). Clinical signs are characterized by 
vomiting, inapetency and locomotor disorders (9). The work 
aims at reporting an outbreak of natural poisoning by salino-
mycin associated tiamulin in pigs in Brazil.
Materials and Methods
Epidemiological data were obtained with the vet about the ani-
mals. Two pigs were euthanized for necropsy. Samples of viscera, 
brain, heart and skeletal muscles were collected, fi xed in 10% 
formalin, processed routinely for histological examination (10).
Results
A batch of 940 fi nishing pigs were fed with diets containing 30 
ppm of salinomycin. The pigs received tiamulin at a dose of 110 
ppm in-feed for eight days, for control of respiratory diseases. In 
the fi rst day after the end of treatment, one animal was found 
slumped. On the next day two animals showed coordination 
disorders, stiff  gait, reluctance to move, muscular trembling, 
depression, emaciation and recumbence. These animals were 
euthanized for necropsy, which presented slight pallor of the 
muscles of the leg, Histological examination showed, marked 
extensive hyaline necrosis of skeletal myofi bers with mild to 
moderate infi ltration of macrophages. The lesions were more in-
tense in longissima, diaphragm and masseter muscles. The heart 
had mild multifocal infi ltration of macrophages, loss of myofi b-
ers and areas with regeneration. The feed of the entire batch 
was replaced. On the following days, several animals showed 
locomotor disturbances and after the grace period of medicines, 
all animals were sent for emergency slaughter. 
Discussion
Epidemiological data, clinical and lesion sign observed and re-
ported are consistent with toxic myositis.and are similar to those 
described in ionophore poisoning in pigs (9). In this outbreak 
the doses of salynomicin and tiamulin were in accordance with 
the theurapeutic dosage for age and species when used alone, 
indicating that tiamulin probably interfered in the excretion of 
salinomycin. Concerning pigs in Brazil, the poisoning ionophore 
should be distinguished from Vit.E - Se defi ciency, where the 
muscle injuries are usually accompanied by cardiac and hepatic 
lesions similar to those observed in mulberry heart disease and 
hepatosis dietetica (11); Aeschinomene indica poisoning (12), 
where locomotor diffi  culties are secondary to specifi c neuro-
logical lesions and Cassia occidentalis (13) poisoning which can 
be distinguished through the epidemiological data of the supply 
of ionophore to animals or through the evidence of the plant 
mixed in the diet.
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Changes of interleukin-10 mRNA expression are predictive for 9-day survival 
of pigs in an emergency preservation and resuscitation model
Wolfgang Sipos1 Catharina Duvigneau1 Wolfgang Weihs2 Fritz Sterz2 Alexandra Graf2 Romana Hartl1 
Keywan Bayegan2 Andreas Janata2 Danica Krizanac2 Wilhelm Behringer2
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Introduction
Outcome after prolonged normovolemic cardiac arrest is poor. 
The technique of evaluating the neurologic state and the overall 
performance category in pigs resuscitated after cardiac arrest 
has already been optimized (1). Emergency preservation and 
resuscitation (EPR), which is the induction of hypothermia dur-
ing the arrest, followed by hypothermic stasis during transport 
to resuscitation with cardiopulmonary bypass (CPB), might be a 
new concept for patients with prolonged cardiac arrest. We have 
shown previously that induction of deep cerebral hypothermia 
via ice cold saline aortic fl ush during cardiac arrest just before 
resuscitation improved neurologic outcome in pigs (2). To avoid 
fl uid overload, we further developed a cardiopulmonary bypass 
cooling system (CPBCS) for rapid induction of hypothermia (3). 
We hypothesized that changes in cytokine expression during 
EPR could be predictive of resuscitability and 9-day survival.
Materials and Methods
21 Large White sows (31-38 kg BM) were subjected to 15 min of 
untreated ventricular fi brillation, followed by cooling with a CP-
BCS for 1, 3, or 5 min achieving brain temperatures (Tbr) of 30.4 
± 1.6°C, 24.2 ± 4.6°C, and 18.8 ± 4.0°C, respectively. After 40 min 
of rewarming with CPB, pigs were defi brillated and kept at Tbr 
of 34.5°C for 20 hrs, survival was for 9 days. Plasma samples were 
analysed for interleukin (IL)-6, tumor necrosis factor-a (TNF-a), 
and IL-10 levels by ELISA. Total RNA out of PBMCs was analyzed 
by real-time PCR for IL-1, IL-2, IL-4, IL-10, TNF-a, interferon- γ, 
iNOS, and heme oxygenase-1 (HO-1) gene expressions. 
Results
11 out of 21 pigs survived to day 9. In the plasma of all animals, 
a remarkable increase in proinfl ammatory cytokine levels could 
be observed following cardiac arrest and resuscitation. However, 
no signifi cant diff erences in cytokine expressions could be found 
as a consequence of diff erent intra-arrest hypothermia levels. On 
the other hand, IL-10 was identifi ed as prognostic marker with 
decreasing mRNA levels during cardiac arrest in 9-day surviving 
animals but increasing ones in the non-survivors.
Discussion
The systemic changes in the postresuscitation syndrome are 
mainly characterized by a proinfl ammatory state similar to the 
systemic infl ammatory response syndrome (SIRS) and thus 
termed a sepsis-like syndrome (4). Interestingly, SIRS is not only 
characterized by elevated infl ammatory cytokine levels includ-
ing IL-1, IL-6, and TNF-a, but also may be the consequence of a 
more profound dysregulation of the immune system, which is 
inferred from elevated IL-10 titers (5). Our study confi rmed that 
pigs upregulate markers of systemic infl ammation following 
cardiac arrest, intra-arrest hypothermia, and resuscitation, thus 
resembling the postresuscitation syndrome. The slight increase 
of IL-10 mRNA in non-survivors may account for a change in the 
functional properties of white blood cells. These fi ndings hope-
fully will lead to improved intervention methods for the benefi t 
of survival rate after restoration of spontaneous circulation fol-
lowing cardiac arrest.
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Chemotherapy induces partial remission of mast cell leukemia in a minipig
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Introduction
Mast cell tumors are classifi ed as cutaneous or systemic. 
Cutaneous mast cell tumors represent a comparably frequent 
malignancy in dogs and cats, but only single reports about cuta-
neous mast cell tumors in pigs and only one referring to a case 
of porcine mast cell leukemia (1) can be found in the literature. 
In the following, a chemotherapy in a porcine leukemia patient 
is presented for the fi rst time.
Case Report
This report describes a chemotherapeutic approach of treating 
mast cell leukemia in a three-year old, male-castrated Göttingen 
miniature pig weighing 27 kg. The animal had been submitted 
to the clinic due to a mildly depressed behaviour lasting for a 
month and a mild anemia. Hematologic analysis (Cell-Dyn 3500®; 
Abbott) including a modifi ed Wright stain led to the diagnosis 
of a mast cell leukemia. Three days after the diagnosis of mast 
cell leukemia, chemotherapy was started based on a protocol 
applied in dogs suff ering from cutaneous mast cell tumors (2). 
Induction therapy comprised weekly IV infusions of 2 mg/m2 
vinblastine sulfate for four weeks. Concomitantly, 2 mg/kg pred-
nisolone were given daily per os. IV infusions were performed 
under general anaesthesia achieved with IM application of 20 
mg/kg ketamine and 2 mg/kg azaperone. Combined chemo-
therapy led to a reduction of total leukocyte count from 30.6 G/l 
to 25.3 G/l and a reduction of mast cell count from 18.05 G/l to 
10.57 G/l. Animal’s behaviour became undisturbed again and no 
adverse side eff ects could be observed. For the next two weeks, 
no vinblastine was given. During this time, mast cell number 
increased to 35.34 G/l. As a consequence, weekly vinblastine 
applications were restarted and prednisolone was replaced by 
oral 50 mg cyclophosphamide boli supplemented by oral 20 
mg furosemide boli, both given every second day. Furosemide 
administration aimed at achieving an accelerated clearance of 
cyclophosphamide metabolites and at abrogating the establish-
ment of a hemorrhagic cystitis. Again, no adverse side eff ects 
could be recorded, but mast cell number continued to increase 
and peaked at 55.59 G/l one month thereafter. The multiagent 
protocol was applied for 6 weeks. Then vinblastine was given in 
a two-week interval. After 17 treatment rounds corresponding 
to an overall treatment period of half a year, overall behaviour 
became depressed again and feed consumption was decreased. 
At that point, total white blood cell number had increased to 
83.7 G/l with a mast cell count of 33.48 G/l. At the same time, red 
blood cell count had dropped markedly. Therefore, the owner 
decided to stop treatment and to euthanize the animal.
At necropsy a reduced body condition, an anemic state, a 
splenomegaly, and gastric ulcers were evident. Histologically, an 
infi ltration of inner organs as well as bone marrow by neoplastic 
cells, which stained multifocally positive for CD117 and more 
diff usely positive for chloroacetate esterase, could be found. 
Discussion
Minipigs, which are kept as pets, are increasingly cared for at a 
higher medical standard as conventional pigs (3). Unfortunately, 
there is a lack of suitable treatment regimens of systemic mast 
cell tumors. Therefore, humans suff ering from mast cell leuk-
emia are treated mainly by corticosteroids and antihistamines. 
Prognosis for human mast cell leukemia is poor. Also in dogs sys-
temic mast cell tumors are bad responders to chemotherapeutic 
interventions (4). In the presented case, the initial response to 
a vinblastine-prednisolone combination protocol was quite 
satisfying with mast cell number decreasing during the fi rst four 
weeks of chemotherapy. Due to the following relapse another 
cytotoxic agent, cyclophosphamide, was included, but was 
unsuccessful in averting tumor progression. 
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Improved neurologic deﬁ cit score for pigs in a cardiac arrest model
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Introduction
Cardiac arrest is unique in that when the heart stops, many 
otherwise healthy organs suff er injury, particularly the brain, 
the myocardium, and the endothelium. Therefore the goal of 
resuscitation is to restore victims to full health, including good 
neurological outcome. Resuscitation research studies the patho-
physiology of acute terminal states and clinical death. Acute and 
short-term experiments in animals help to better understand 
mechanisms of dying and to evaluate the short-time eff ect of 
new resuscitation protocols. To evaluate long-term benefi t of po-
tential new treatments on neurologic recovery in resuscitation 
research, clinically realistic long-term outcome studies including 
evaluation of neurologic and histologic brain damage in animals 
high on the phylogenetic scale are necessary. 
Recently, our group published a novel and reliable score for 
evaluation of neurologic outcome in pigs after cardiac arrest.1 
The neurologic defi cit score (NDS) consists of four equally 
weighted sections: mental status, breathing pattern, cranial 
nerve refl exes, and motor and peripheral sensory functions. Aim 
of this study was to re-evaluate and optimize the neurologic 
examination procedure in order to make it even more observer-
independent by elucidating and then topping off  the critical 
points of the NDS. 
Materials and Methods
16 female Large White pigs (32 kg in the mean) were put into 
ventricular fi brillation cardiac arrest of 15 min duration fol-
lowed by cooling to achieve diff erent degrees of preservative 
hypothermia for 40 min. After resuscitation (ROSC: restoration 
of spontaneous circulation), controlled ventilation was for 24 h, 
and intensive care for 3 days. Neurologic evaluation was done 
independently by two observers, blinded to the experiments, at 
72 h and 9 days post ROSC. The critical points of the NDS as pub-
lished by Sipos et al. (2008), namely the evaluation of the mental 
state and, interestingly, the breathing pattern, were optimized.
Results
A signifi cant diff erence in the NDS score between hypothermia 
groups was found (f-test p=0.0127). No signifi cant diff erence in 
the NDS score was found between the two observers. The ICC 
(intra-class correlation coeffi  cient) determined using analysis 
of variance components for the NDS score was 20.7 % indicat-
ing that 20.7 % of the total variability can be explained by the 
variability between the pigs. The largest contribution to the 
total variability came from the variability between time points 
(intervisit SD=68.22). Furthermore, a large contribution came 
from the variability between hypothermia groups (inter-treat-
ment SD=47.15). The large variation over days and treatments 
also explained the small ICC. Practically no contribution to the 
total variability came from the variability between the observers 
(interrater SD <0.001), which indicates a good repeatability of 
the score between observers.
Discussion
The evaluation of a pig’s mental state is very tricky under special 
situations, as for sure is the immediate post-no-fl ow time, as pigs 
are, by their nature, psychically very autonomous animals. How-
ever, the optimized NDS showed to be even more examiner-
independent than the already published one, as also the mental 
state as well as the breathing pattern were now judged the same 
by both investigators in the majority of cases. At the same time, 
also the published overall performance category (OPC) score (1) 
was optimized (data not shown). The OPC score gave nearly 100 
% identical results by both investigators and may be even more 
appropriate than the NDS in specifi c clinical settings.
References:
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Ovariectomy and calcium shortage have no obvious eﬀ ect on bone metabolism in adult sows
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Introduction
For a long time, osteoporosis was ascribed nearly exclusively to 
an increased activity of osteoclasts, but now it has been rec-
ognized, that also depressed osteoblastogenesis contributes 
to osteoporosis. Recently, osteoimmunology has emerged as a 
central area of interest as peripheral blood cells, cytokines, and 
other soluble immunomodulators exert their impact on a series 
of osteopathologies including osteoporosis (1). Thus, osteopor-
osis has been recognized to involve more than simply a skeletal 
system with decreased bone mineral density. Consequently, new 
therapeutic strategies need to be developed. To date, the major-
ity of basic osteologic experiments has been performed using 
rodents, which have a lot of advantages in terms of laboratory 
management, but also large animal models might be benefi cial 
for osteoporosis research due to biomechanical issues.
Multiparous sows – in contrast to nulliparous sows – being fed 
a standard diet containing 1.5 % calcium exhibited signifi cantly 
increased plasma PTH and calcitriol levels at 8 months post 
ovariectomy and alkaline phosphatase levels at 12 months post 
ovariectomy. No signifi cant changes concerning bone chemistry 
and histomorphometry could be observed (2). On the other hand, 
there have already been successful eff orts to establish an osteo-
porosis minipig model (3). Ovariectomy in 4 months old minipigs 
resulted in a 6 % decrease in bone mineral density (BMD), 15 % in 
bone volume, and 13 % in trabecular number, and an increase of 
15 % in trabecular separation, whereas ovariectomy in combina-
tion with a mild nutritive calcium shortage (0.75 % Ca2+) led to 
a 10 % reduction in vertebral BMD and signifi cant increases in 
fi nal erosion depth and vertebral marrow star volume. These data 
implicate, that an ovariectomy alone is suffi  cient to induce an 
osteoporotic phenotype in (mini)pigs, which can be even more 
pronounced by restricting calcium supply.
Materials and Methods
32 Large White sows aged 33.5 months in the mean were in-
cluded and distributed equally to four groups:
1. sham-ovariectomy, 0.75 % Ca2+
2. sham-ovariectomy, 0.3 % Ca2+
3. ovariectomy, 0.75 % Ca2+
4. ovariectomy, 0.3 % Ca2+
Blood samples were collected by venipuncture every 2 months. 
The experiment was terminated after 10 months. Serum levels of 
following bone metabolism markers were determined by com-
mercially available ELISA kits: receptor activator of nuclear factor-
κB ligand, osteoprotegerin, calcitriol, PTH, bone specifi c alkaline 
phosphatase, osteocalcin, CICP, pyridinoline, and crosslaps.
Results
Analyses of indicated marker kinetics revealed no meaningful 
trends in general or diff erences between the four groups and 
thus gave no evidence of any ovariectomy- or calcium shortage-
induced change in bone metabolism.
Discussion
Interestingly, ovariectomy and calcium shortage alone as well as 
a combination of these two did not lead to any eff ect on bone 
metabolism as delineated from the analysed marker kinetics. 
This is quite surprising, as other authors (2) found increasing 
PTH, calcitriol, and BAP plasma levels in sows of the same age 
group as the ones we investigated, although those were only 
ovariectomized but fed a standard diet. On the other hand, 
most investigators analysing the eff ects of ovariectomy and/or 
calcium shortage used minipigs or growing pigs, thus making a 
comparison with the data obtained from our study diffi  cult.
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Cytokine modulation of yeast derivatives investigated on a 
lipopolysaccharid-activated monocyte-macrophage cell line
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Introduction
Cytokines are signaling molecules which play an important role 
in cellular communication. Modulation of cytokine secretion 
may off er novel approaches in the prevention and treatment of 
a variety of diseases in human and veterinary medicine. TNF-
alpha, IL-1, IL-6 are important cytokines which are secreted by 
immune cells such as macrophages after endotoxin (LPS) expos-
ure and are involved in endotoxic shock which can cause severe 
economic losses in swine production. Therapeutical approaches 
in veterinary fi eld aim to minimize or to prevent infl ammatory 
parameters triggered by endotoxins. Counteraction of pro-
infl ammatory cytokines with feed additives such as yeast deriv-
ates might be an interesting approach.
Yeast derived beta-glucan fractions are described in the litera-
ture to interact with cytokines.
Aim of the present study was to investigate the eff ect of diff er-
ent yeast derivatives such as beta-glucans, whole yeast, yeast 
extract and yeast nucleotides on nitric oxygen (NO) production, 
pro-and anti-infl ammatory cytokine levels after LPS stimulation 
of the murine monocyte-macrophage cell line J774A.1. 
Materials and Methods
Monocyte-macrophage cell line: 
J774A.1 is a BALB/c mouse derived monocyte-macrophage cell 
line isolated from a tumour. Cells were cultured in tissue culture 
fl asks at 37°C in DMEM complete growth medium supplemented 
with 10% fetal bovine serum. Subcultures were prepared by 
scraping adherent cells 1 to 2 times per week and re-seeded 1:4 
into fresh media.
Cell culture assay:
J774A.1 cell number and viability were assessed by trypan 
blue dye exclusion on a Neubauer hematocytometer. For the 
experiment, cells were seeded at a concentration of 106 cells/
well in a 24-well tissue culture plate. Cells were incubated for 48 
hours with LPS of E. coli 0127:B8 and the yeast derivative, which 
was either yeast derived beta-glucan, yeast nucleotide, yeast 
extract or whole yeast (0.1%, 0.02%, 0.01% solutions in phos-
phate buff ered saline). Produced nitric oxygen was determined 
after 48 hours of incubation in the supernatant of the cultures 
using a Griess reagent which provides a colorimetric reaction. 
Pro-infl ammatory cytokines IL-1, IL- 6, TNF-alpha and the anti-
infl ammatory cytokine IL-10 were detected with ELISA assay 
(R&D Systems).  
Results
Yeast extract and yeast nucleotides inhibited LPS induced NO-
production between 20 and 50%; beta-glucan fraction up to 80% 
depending on the used concentration. Whole yeast did not aff ect 
LPS induced NO-production. IL-6 was inhibited between 20 and 
40% by beta-glucan, by yeast nucleotide around 20%. Whole 
yeast did not inhibit IL-6 on a notable level. IL-1 was inhibited to 
70% by a yeast nucleotide product, between 40 and 100% by 
beta-glucan and to 50% by whole yeast. TNF-alpha was inhibited 
around 40% by nucleotides, beta-glucans and also by whole 
yeast. All yeast derivatives tested induced IL-10 production.
Discussion
The present results revalue that yeast derivatives inhibited LPS 
induced pro-infl ammatory cytokines and elevate anti-infl amma-
tory IL-10 levels. However, the mechanism behind, the mode of 
action is not yet understood. A fully chemical characterization 
concerning mannan-and glucan content and nucleotide profi le 
might be illuminating.
In conclusion, yeast derivatives which interfered in this in vitro 
study with IL-1, IL-6, TNF-alpha and IL-10 might be an interest-
ing approach in the control and prevention of endotoxic shock 
in swine production and this might impact positively on animal 
health. However, it is too early to estimate to what extent these 
expectations are going to be fulfi lled in vivo. In any case they 
justify further multidisciplinary research in this fi eld.
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Introduction
Isoimmune thrombocytopenic purpura (ITP), fi rstly described by 
Stomorken et al. in 1963, is a sporadic disease aff ecting new-
born piglets, mainly from secondiparous or multiparous sows. 
Large White and Landrace are the most aff ected breeds. ITP is an 
immune-mediated disease subsequent to colostral transfer anti-
platelet (PLTs) antibodies produced by sow against the antigens 
originating from the boar semen (Saunders and Kinch, 1968). 
Multiple haemorrhages develop in piglets when platelets are 
lower than 30.000-50.000/ μl, leading to death the whole litter 
or a part of it. The Authors describe a case of ITP occurred in a 
farrow to fi nish pig herd. 
Materials and Methods
An hemorrhagic syndrome occurred in 28 litters of a farrow to 
fi nish pig herd between May 2008 and Jan 2009. Only one of 
the sows was primiparous. Sows had been inseminated during 
3 days using mixed semen from diff erent boars. During the fi rst 
week of age seventeen percent of the piglets showed haem-
orrhagic diathesis, characterised by multiple haemorrhages, 
spontaneous pethechiae and diff use ecchymoses. The death rate 
ranged from 0% to 50%. Six piglets were submitted to necropsy, 
histological bacteriological, virological and toxicological exam-
inations. Furthermore, 6 piglets with haemorrhagic syndrome 
and 3 coetaneous healthy piglets from the same farrowing batch 
were submitted to complete blood cell count (BCC). 
Results
Hemorrhagic lesions characterised by multiple haemorrhages, 
spontaneous pethechiae and ecchymoses were detected in 
piglet skin, subcutaneous tissue, inner organs and mucous/ser-
ous membranes. The most aff ected sites were head, abdomen, 
groin and soles. Kidneys and lymph nodes presented dissemin-
ated hemorrhages and hemorrhagic suff usions were evident in 
mesocolon and epicardium. Histology confi rmed the presence 
of multivisceral interstitial hemorrhages, extramedullary hema-
topoiesis and interstitial pneumonia. Bacteriological, virological 
and toxicological examinations provided negative outcomes. 
CBC results are presented in the following table.
Table 1.
ITP (mean) Healthy (mean)
Hemoglobin (Hb) gr % 5,5 9,3
Hematocrit (HCT) % 17,5 28,2
RBCs /mm3 2.525.000 4.390.000
PLTs /mm3 33.557 241.133
Leukocytes /mm3 6.750 4.833,3
MCV fL 69,9 64,3
MCHC gr % 32,2 33,1
MCH pgr 22,6 21,3
RDW % 22,1 19,2
NRBC/100 WBC 13,2 1,7
Reticulocytes % 12,2 2,35
Lymphocytes /mm3 2.358 1.692
Neutrophils /mm3 3.225 2.867
Eosinophils /mm3 113,05 120
Discussion
On the basis of laboratory results ITP was diagnosed. BCC 
showed a marked decrease in PLTs (absence of PLT aggregation), 
Hb, HCT and RBCs in aff ected animals. Moreover, a pattern of 
rigenerative anemia and reticulocytosis was detected. For dif-
ferential diagnosis, infectious and toxic diseases were ruled out. 
Combining all data a diagnosis of an immuno-mediated disease 
was suggested. The marked thrombocytopenia and the absence 
of direct or indirect signs of erythrocytolisis allowed to rule out 
the haemolytic disease of newborn pigs (Taylor 2008). From Jan 
2009 the insemination practice was modifi ed using the semen 
from one boar only for each sow. Consequently, one boar was 
associated with the occurrence of the diseases in off spring and 
it was culled.
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Agents isolated in pericarditis cases from pigs in the nursery, growing and ﬁ nishing in Brazil
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Introduction
Pericarditis in pigs can be caused by various pathogens, such 
as Haemophilus parasuis, Pasteurella multocida, A. pleuro-
pneumoniae, A. suis, Streptococcus suis and Mycoplasma sp 
(Mores, 2007). Pericarditis is the infl ammation of the parietal and 
visceral surfaces of the pericardial cavity. May occur independ-
ent of other lesions, but is often observed in association with 
a pleurisy. Among the various forms of pericarditis, fi brinous 
pericarditis is more commonly found. It’s characterized by the 
presence of a serous fl uid and marked fi brin deposition on the 
surfaces of the pericardium and epicardium, leading to heart 
failure (Jones et al., 2000). This study aims to identify the mainly 
agents involved in fi brinous pericarditis in pigs in the nursery, 
growing and fi nishing.
Materials and Methods
We evaluated 129 cases of fi brinous pericarditis in animals with 
ages raging from 20 to 106 days. Swabs were collected from 
pericarditis, then added 3 ml PBS and plated on blood sheep 
agar and blood sheep agar with staff  nurse. The plates were 
incubated a at 37° C for 24 to 48 hours. And were performed the 
morphology identication of the colonies and biochemical tests 
for confi rmation of the agent. And serology for H. parasuis and S. 
suis were performed in Microvet laboratory.
Results
We obtained a result quite varied among the several agents. The 
mainly agent observed was the H. parasuis (Hps) 38/129, distrib-
uted as: non serotypable (14/129), serotype 5 (10/129), serotype 
4 (4/129), serotype 1 (3/129), serotype 2 (3/129), serotype 12 
(2/129) and serotype 14 (2/129). Other agents were observed 
such as: P. multocida type A (Past A) 20/129 and P. multocida 
type D (Past D) 12/129. S. suis 8/129, distributed as: serotype 2 
(4/129), serotype 3 (2/129), serotype 7 (1/129) and serotype 8 
(1/129). A. pleuropneumoniae (APP) 4/129, A. suis (3/129). Some 
co-infection were observed between APP and the Past A (1/129), 
Hps serotype 12 and the Past D (1/129), Hps non serotype and 
Past D (1/129) and S. suis serotype 2 and Past D (1/129). And 40 
animals had were negative for bacterial isolation (Graphic 1).
Discussion
This study allows us to conclude that the onset of pericarditis is 
actually connected to various agents as described by Mores, in 
2007. However, it is noteworthy that the H. parasuis has a great 
contribution to pericarditis. The serotype 5 is closely associated 
to conditions of Glasser’s disease in Brazil (Santos et al. 1998), 
and was found in most reported cases of pericarditis caused 
by this agent, like H. parasuis non serotypable. Other agents 
such P. multocida A and D, can also has great importance in the 
development of fi brinous pericarditis.
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Graphic 1: Agents involved in pericarditis from pigs in Brazil
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Positional and functional genomics to resolve genetic disease resistance in swine
Gerald Reiner
Department of Veterinary Clinical Sciences, Justus-Liebig-University, Giessen, Germany
Introduction
This review deals with genetic disease resistance in pigs as a pro-
spective opportunity to improve swine production. Even under 
favourable terms of housing and management, infectious dis-
eases are wide-spread, and have to be ranked among the major 
sources for production losses, decreased production effi  ciency 
and suff ering in international pig production. Thus, breeding 
for disease resistance might be the prophylactic measure of fi rst 
choice. Increased resistance to a certain pathogen or even a 
group of pathogens would reduce infectious pressure, followed 
by a decreased incidence of disease. Using disease resistant 
breeds is already of considerable importance in some livestock 
species. Examples with highest signifi cance are the resistance to 
coccidiosis and Mareks disease in fowl, to trypanosomiasis and 
ticks in cattle, to mastitis in dairy cattle, and to gastro-intestinal 
nematodes in sheep. In pigs, however, examples of disease 
resistance in commercial breeding programs are sparse. The 
prime example is resistance to fi mbriated F18 Escherichia coli, 
the cause of postweaning diarrhoea and edema disease. It is an 
exceptional case of single-gene control of disease resistance. 
Other examples include the breeding for improved immune 
responsiveness, and resistance to fi mbriated F4 Escherichia coli 
(neonatal diarrhoea). Today worldwide eff orts are concentrat-
ing on marker development and genomic selection strategies 
to improve genetic disease resistance. In spite of the currently 
limited commercial application in swine, a wide range of genetic 
variation in disease resistance has been observed regarding 
diff erent bacterial, viral and parasitic diseases. The problem is 
to recognize breeding animals with favourable or unfavourable 
gene variants. Their identifi cation is impeded by highly variable 
and infl uential farm-specifi c environmental eff ects (e.g. load 
of pathogens, immunity, housing, feeding and management 
conditions), the polygenic mode of inheritance in most of the 
resistance traits, the limited availability of animal models, and 
the limited knowledge on pathogenicity of several porcine dis-
eases. Improved knowledge of the porcine genome combined 
with the tools and technologies developed in the context of the 
genome projects are creating new opportunities to dissect the 
genetic control of complex traits, including host responses to 
infection. Thus, one alternative might be to identify the gene 
variants responsible based on informative families tested under 
defi ned environmental conditions. Upon the development of a 
genetic marker for disease resistance, breeding stock could then 
be chosen by marker-assisted selection independently from 
environmental factors. The aim of our studies is to develop such 
animal models and to describe disease resistance on a molecular 
basis. Our models deal with the Pseudorabies virus (PrV; Reiner 
et al., 2002), Sarcocystis miescheriana (S.m.; Reiner et al., 2007), 
Salmonella typhimurium, PRRSV (Reiner et al., 2010), and A. 
pleuropneumoniae (APP). 
Materials and Methods
Potential host-pathogen models are studied based on accurate 
infection models with purebred breeds or lines. Functional gen-
ome analysis with DNA microarray techniques gives fi rst hints 
on candidate genes. They are combined with positional genome 
analysis (QTL[quantitative trait loci] analysis) to defi ne candi-
date genes worth looking for single nucleotide polymorphisms 
(SNPs) that might be useful as markers in future selection. 
Results and Discussion
Our results show marked diff erences in resistance to PrV, S.m., 
PRRSV and APP. Moderate to high heritabilities point towards 
favorable and unfavorable gene variants. QTL analysis has identi-
fi ed the chromosomal regions involved, and some candidate 
genes have been suggested for further research. In spite of the 
polygenic character of disease resistance, our results verify that 
also single outstanding loci, suitable for selection are involved. 
We have further provided evidence for common mechanisms of 
resistance in diff erent disease models. This is of high signifi cance 
for future breeding programs, because it implies that selec-
tion towards the resistance to a specifi c pathogen might also 
increase resistance against other pathogens. Although there is 
still a long way from the model to the marker, our results and 
those of others give hope for applicable functional markers in 
the near future.
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Unfolding the genetic architecture of clinical-chemical and haematological traits in swine
Gerald Reiner; Hermann Willems
Department of Veterinary Clinical Sciences, Justus-Liebig-University, Giessen, Germany
Introduction
Clinical-chemical and haematological traits are essential param-
eters for veterinary practice to evaluate the health status of in-
dividuals and herds. A major concern with the interpretation of 
haematological values is their pronounced variability caused to 
a great extent by non-systematic factors. Diff erences in clinical-
chemical and haematological traits within breeds and popula-
tions provide evidence for genetic factors as primary cause, but 
little is known about the genetic architecture underlying these 
traits, especially in swine. Involvement of additive genetic vari-
ance of some of these traits argue for the existence of favourable 
and unfavourable gene variants that are responsible for pheno-
typic variation. Identifi cation of these variants might improve 
the diagnostic use of such traits in the future. It might also 
provide a measure to advance general health of pig populations 
by selection. Linkage mapping using dense genetic maps is a 
straightforward approach to locate genes that control inherited 
diseases. The eff ects of gene loci contributing to this phenotypic 
variation were considered undetectable until the introduction 
of quantitative trait loci (QTL). QTL mapping may be a valuable 
fi rst step towards the identifi cation of genes and causal poly-
morphisms responsible for variability of clinical-chemical and 
haematological traits. The aim of the present study was to detect 
and evaluate QTL for such traits in swine, and to defi ne potential 
candidate genes.
Materials and Methods
The experiments were based on a Pietrain/Meishan F2 family. 
139 F2 pigs were consecutively included into the study. All pigs 
were clinically healthy at the start of the experiment and free 
of internal and external parasites. In the course of eleven study 
periods, groups of fi ve to eleven pigs were housed in tiled boxes 
of 16 m2 on straw beddings and fed ad libitum with a customary 
cereal diet (energy content: 11.5 MJ/kg) without food additives 
throughout the whole period of observation. Blood samples 
were taken at four time points, representing baseline values (day 
0, directly before challenge with Sarcocystis miescheriana), acute 
(day 14 post infection [p.i.]), sublinical (day 28 p.i.) and chronic 
(day 42 p.i.) stage of Sarcocystosis. Further details on clinical and 
clinical-chemical patterns of Sarcocystosis have been described 
elsewhere (Reiner et al., 2006). A broad aspect of clinical-
chemical and haematological traits was analysed by standard 
procedures. QTL analysis was based on 101 informative micro-
satellite markers using the web-based application “QTL express”. 
For more details see Reiner et al. (2007). 
Results
54, 38, 27, and 38 QTL for clinical-chemical, erythroid, blood 
gas, and leukocyte traits have been mapped, respectively. 15, 
9, 5, and 9 QTL, respectively were genome-wide signifi cant, the 
remaining showed chromosome-wide signifi cance. 30, 40, 42, 
and 45 QTL were associated with diff erent traits during basal 
stage, acute, subclinical and chronic disease, respectively. Many 
of the QTL involved were only detected under the burden of the 
model disease on the metabolism. A variety of candidate genes 
for diff erent traits has been defi ned based on their physiology 
and chromosomal location (e.g. erythropoietin and erythropoi-
etin-receptor: red blood cells; GOT1: aspartate-aminotransferase; 
and many others). SNPs identifi ed within such candidate genes 
signifi cantly improved the eff ects of the QTL and allowed to 
retrospectively detect QTL eff ects even on basal traits that had 
not been visible before. Also the confi dence intervals for the QTL 
were signifi cantly reduced.
Discussion
Our study confi rms that clinical-chemical and haematological 
traits in swine are infl uenced by multiple genes, partly repre-
senting reasonable eff ects on their traits. The data represent a 
signifi cant fi rst step to defi ne candidate genes and to identify 
the associated polymorphisms. Identifi cation of the molecu-
lar basis of this variation has the potential to improve future 
diagnostics. As individuals with sound values of crucial clinical-
chemical and haematological traits should need a higher burden 
to reach pathological thresholds, breeding animals with favour-
able gene variants might be selected for higher robustness of 
individuals and herds in the future.
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Development of genetic markers for the resistance against 
infections of the respiratory tract of swine (RePoRI)
Gerald Reiner; Natalie Bertsch; Hermann Willems; The RePoRI Consortium
Department of Veterinary Clinical Sciences, Justus-Liebig-University, Giessen, Germany
Introduction
Animal health is one of the major concerns in production 
economics, animal welfare, and food safety. Genetic predispos-
itions of diff erent breeds to infection is well documented for all 
major domestic species and for many diseases. RePoRI, which is 
processed in a network of six co-operating research facilities, is a 
follow-up project of IRAS (Infection and resistance in the respira-
tory tract of swine) which is granted by the Federal Ministry of 
Education and Research of Germany. In the scope of the RePoRI 
project following major tasks are to be conducted: 1) breed-
ing of a segregating F2 family from two pig breeds diff ering in 
susceptibility to Actinobacillus (A.) pleuropneumoniae, 2) aero-
gen exposure to the pathogen with clinical, phenotypical, and 
pathological-anatomical characterization of animals, 3) genotyp-
ing of the F0, F1, and F2 population, 4) expression analysis of 
the lymph nodes and/or lungs in the most extreme quartils, 5) 
QTL analysis and identifi cation of putative positional candidate 
genes, 6) eQTL analysis, 7) identifi cation and characterization 
of functional and pseudo-functional SNPs, and 8) modelling of 
host-pathogen interactions and developing of hypotheses ac-
counting for host resistance. 
The task of the present study is to provide information about 
positional candidate genes derived from QTL and eQTL analysis. 
To achieve this, the following objectives had to be established: i) 
a panel of informative microsatellite markers with a distance no 
more than 15 cM, ii) multiplex PCR conditions for marker amplifi -
cation, and iii) genotyping of the complete F2 pig families. Addi-
tionally, informative microsatellite markers should be positioned 
on the physical pig map.
Materials and Methods
The F0 family consisted of two (relative) resistant boars and 6 
susceptible dams which were mated to generate a F1 family 
with a total of 21 animals. Rearing and infection of the segre-
gating F2 population is in progress. Primers to amplify micro-
satellites were taken from the USDA list (www.marc.usda.gov/
genome/swine/swine.html) and were synthesized (biomers, 
Germany) with forward primers labelled with DY-780 or DY-680. 
In a fi rst PCR markers were tested for informativity with DNA 
extracted from blood of the 2 resistant boars and 6 susceptible 
dams. All PCR reactions were performed in a total volume of 10 
μl, consisting of 5 μl of 2 x Multiplex Mastermix (Qiagen, Ger-
many), 2.5μl of primermix (fi nal concentration [f.c.] 0.4 μM) and 
2.5μl of template DNA (50 ng). PCR products were run on 6% 
polyacrylamide gels and analyzed with 1DScanEX (Scanalytics). 
Only PCR conditions from markers with 100% informativity were 
optimized. Finally, multiplex PCRs were established combin-
ing primers with identical or nearly identical annealing tem-
peratures using the same PCR setup as described above. Only 
primer concentrations had to be optimized so as to generate 
bands with equal or nearly equal intensity.
Multiplex PCR reactions were run with three diff erent touch-
down protocols each consisting of 23 cycles. Denaturation (95°C, 
30 sec) and extension (72°C, 30 sec) steps were identical for all 
three protocols, only annealing temperatures varied. The fi rst 8 
cycles had annealing temperatures of 70, 65, and 63°C, the fol-
lowing 8 cycles 68, 60, and 59°C and the last 7 cycles 66, 55, and 
55°C, respectively with annealing times of 90 sec.
Results and Discussion
A total number of 434 microsatellites were tested for informa-
tivity, of which unexpectedly only 188 (43.3%) proved to be 
informative. The average distance of the microsatellite markers 
was 14.5 cM. Nevertheless, a few gaps with distances greater 
than 15 cM could not be closed because either the microsatellite 
markers were not informative or there were no further micro-
satellites available in the corresponding maps for the respective 
chromosomal region. 174 microsatellite markers were combined 
in 50 multiplex reactions with 3 to 4 markers per reaction and 
were tested with animals from the F0 and F1 generation. In con-
clusion, a panel of informative microsatellite markers has been 
established for the genotyping of F2 pigs from the ongoing 
challenge with A. pleuropneumoniae, in order to fi nd markers for 
the resistance to this important respiratory disease in swine.
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Mapping QTL for innate immune response in a Duroc x Pietrain resource population
Muhammad J. Uddin; Mehmet U. Cinar; Dawit Tesfaye; Ernst Tholen; Chirawath Phatsara; Christian Looft; Karl  Schellander 
Institute of Animal Science, Bonn, Germany
 Introduction
Cytokines and Toll-like receptors are basic components of the 
innate immune system. Immune responses are reported to be 
under the genetic control. QTL mapping and candidate gene 
studies have been widely used to investigate genetic variation, 
to identify genes and chromosomal regions contributing to im-
mune response. Therefore, this research was conducted to iden-
tify chromosomal regions controlling the variability in cytokines 
(IL-2, IL-10 and IFN- γ) and Toll-like receptors (TLR-2 and TLR-9) 
production by QTL analysis. 
Materials and Methods
A total of 334 Duroc x Pietrain F2 animals used for QTL analysis 
was genotyped by 82 genetic markers. Blood was collected from 
pigs at 52, 83 and 115 days of age and serum was separated for 
phenotyping. IL-2, IL-10 and IFN- γ were measured by sandwich-
ELISA (Invitrogen). TLR-2 and TLR-9 were measured by in house 
developed indirect-ELISA (CosmoBio). Descriptive statistics were 
performed by using SAS (vs. 9.2) whereas QTL Express (Seaton et 
al., 2002) was used for both single and two-QTL analysis. 
Results
The level of IL-10 and IFN γ were increased over the time from 
52 to 115 days of age. The variations of production were found 
signifi cant between 52 and 83 days for IFN- γ (P≤0.05) and 
IL-2 (P≤0.001). In case of IL-2, the diff erences between 83 and 
115 days, and between 52 and 115 days were also signifi cant 
(P≤0.001). In all time points, TLR-9 responses were higher than 
that of TLR-2. TLRs production variation between 52 and 83 days, 
and between 83 and 115 days were signifi cant (P≤0.001). Th1 
type cytokines (IL-2 and IFN- γ) were 5 - 6 times lower than that 
of Th2 type cytokine (IL-10). Date of sampling, month of birth 
and year of birth were found to have signifi cant eff ect on im-
mune traits. Parity, litter and sex had also eff ect on these innate 
immune parameters at some age points. A total of 67 single QTL 
were detected by QTL Express on almost all porcine autosomes, 
of which 38 for cytokines (IFN- γ, IL-2 and IL-10) and 29 for TLRs 
(TLR-2 and TLR-9). All the QTL were signifi cant at 5% chromo-
some-wide level, of which 12 and 52 QTL were signifi cant at 1% 
and 5% genome-wide level, respectively. A total of 38 QTL were 
detected for cytokines, of which 12, 9 and 17 QTL infl uenced 
IFN- γ, IL-2 and IL-10, respectively. A total of 29 QTL regions infl u-
encing Toll-like receptors were identifi ed, of which six for TLR-2 
and 23 for TLR-9. Besides single QTL, ten QTL were identifi ed 
by two-QTL model of which three were in coupling phase and 
two were in repulsion phase. Most of the QTL were identifi ed 
on SSC3, 5, 11, 12 and 17. IFN- γ, IL-10 and TLR-9 are found to be 
controlled by the chromosomal regions of their location but all 
innate immune traits are infl uenced by multiple chromosomal 
regions implying multiple gene action. 
Discussion
Most of our QTL are supported by the presence of genes which 
play immunologically important roles. TOLLIP, TRAF6, IRAK4 and 
CASP8 are found to be infl uencing TLRs production whereas 
IL3, IL5, IL13, IL10, IFN- γ and BPI are infl uencing cytokines in this 
study. The QTL knowledge of cytokines and TLRs may contribute 
towards a more complete understanding of the innate immune 
system in terms of whole animal physiology. Furthermore, these 
fi ndings will be helpful to research in these QTL regions to 
identify new cytokines and their utilization in marker-assisted 
selection to improve the innate immune response and disease 
resistance in pigs. 
Table: Summary of signifi cant QTL for innate immune traits using QTL 
Express under two-QTL model.
SSC Trait Position (cM) Position (cM) F-value F-value Sig a Sig a
QTLA QTLB 2vs1 2vs0 A B
5 TLR9 D-83 78 161 5.9 5 ** *
14 TLR9 D83 35 142 5.9 4.6 ** *
18 TLR9 D115-83 103 0 6.4 6.7 ** ***
18 TLR9 D83 9 100 6.4 4.7 ** *
18 IL10 D115 20 104 5.2 4.6 ** **
asignifi cant threshold of the F-value determines if the QTL reached the signifi cance level under 2 
vs 0 QTL (2 degrees of freedom), or 2 vs 1 QTL (1 degree of freedom); with *chromosome-wide P 
< 0.05; **genome-wide P < 0.05; ***genome-wide P < 0.01
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The comparison of the base alignments of D-loop region in the mitochondrial 
DNA of Ryukyu wild boars with those of the others
Yoshikazu Adachi; Chihiro Nagahama
School of Agriculture, Ibaraki University, Ami-machi, Japan
Objective
Small type wild boars and large types live in Japan and Ryukyu 
wild boars are small type. The range of Ryukyu wild boars is not in 
Taiwan, China, and the other east Asia. They were in Vietnam and 
were diff erent from those in Taiwan, China, and other east Asia. 
Our aim is to analysis the genetic diversity of Ryukyu wild boars.
Materials and Methods
Samples of Ryukyu wild boars have been collected in Ishigaki 
Island, Nago City and Kadena Cho in Okinawa Island while 9 
samples of wild boars in Honshu island e.g. Large type, were col-
lected in Yamaguchi, Ibaraki and Miyagi Prefectures.
DNA extract, PCR and sequencing: Template DNA extracted from 
the root of the hair was used for PCR and the primers consisting 
of ; Forward 5’-GGAGACTAACTCCGCCATCA-3’ and Reverse 
5’-TGTCCCGTAACCATTGACTG-3’ were used. Sequencing has 
been performed using BigDye Terminator V3.1 Cycle Sequence 
kit by ABI PRISM 3100 sequencer. PCR-RFLP has been studying 
on analysis of Hinf I digested PCR product.
Results and Discussion
The base alignments of D-loop region in the mitochondrial DNA 
of Ryukyu wild boars and others have been analyzed. Especially, 
the base alignment of Ryukyu wild boar was consistent among 
the Ryukyu wild boar, and the homology between the Ryukyu 
wild boar and Japanese wild boar was 98 % while a cluster 
unlike a Japanese wild boar on the phylogenetic tree based 
on D-loop was drawn. Ryukyu is a province name of Okinawa 
Prefecture in Japan and located on southern islands. On the 
other hand, the presence of a cross breed pig called Inobuta in 
the wild boar which was captured in Okinawa Prefecture was 
confi rmed and we perform attempted to perform PCR-RFLP 
using PCR products by Hinf I digestion of a D-loop part fragment 
with Hinf I site. The results, demonstrated the distinguishment 
of Ryukyu wild boar from other wild boars, Inobuta and a pig 
completely (Fig.1).
Figure 1 The profi les of Hinf I digested D-loop fragment with 227bp 
between Ryukyu wild boars and the other wild boar and pigs. 
1~4, Ryukyu wild boars; 5~11, Other wild boars including Inobuta. 
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Single-Nucleotide Polymorphisms in collagenous lectins and other innate 
immune genes associated with common infectious diseases of pigs
Brandon N. Lillie1 E. James Squires3 Natalie D. Keirstead2 Gordon E. VanderVoort3 Mohsen Jafarikia4 Brian Sullivan4 M. Anthony Hayes1
1. Dept. of Pathobiology, OVC, University of Guelph, Guelph, ON, Canada; 2. Ross University of Veterinary Medicine, Basseterre, Saint Kitts and Nevis; 
3. Dept. of Animal and Poultry Science, University of Guelph, Guelph, ON, Canada; 4. Canadian Centre for Swine Improvement, Inc., Ottawa, ON, Canada
Introduction
Pigs vary widely in their susceptibility to many common viral 
and bacterial pathogens, both between breeds and between 
diff erent litters on the same farm, suggesting there may be a 
genetic basis for the variation. If so, genetic selection for higher 
innate disease resistance should be possible. We have been 
identifying genetic defects in innate immune genes involved 
in innate resistance to infectious disease. Previously we identi-
fi ed porcine mannan-binding lectins (MBLs) and fi colins, two 
collagenous lectins, as bacteria-binding proteins in porcine 
plasma [1,2]. Within the genes encoding the two porcine MBLs 
we identifi ed single-nucleotide poly-morphisms (SNPs) similar 
to those found in the human MBL gene that predispose humans 
to infections [3,4,5]. Some SNPs alter the structure and function 
of the protein while others decrease the amount of the protein 
produced.  Earlier studies suggest these SNPs are more frequent 
in pigs having common infectious diseases [6,7]. This study 
looked for associations between these SNPs and SNPs found in 
other collagenous lectin genes with animals having common 
diseases and pathogens, as well as the eff ects of these SNPs on 
production. For comparison, we included known or newly iden-
tifi ed SNPs in other porcine innate immune genes.
Materials and Methods
DNA was collected from 1324 healthy Duroc, Landrace or York-
shire/Large White pigs from production facilities in Canada and 
the United States and 461 diseased pigs submitted to the Animal 
Health Laboratory (Guelph, ON). Pigs were genotyped for a panel 
of 27 innate immune SNPs by Sequenom MassARRAY (Analytical 
Genetics Technology Centre, Toronto, ON). Gross necropsy and 
histological evaluation were used to classify the pigs into disease 
groups, with pathogen grouping based on bacteriology and virol-
ogy tests as requested by the case pathologist. Genotype frequen-
cies (% of animals possessing the mutant allele) were compared 
between healthy pigs and pigs in disease and pathogen groups. 
Associations between SNPs and an array of production param-
eters were also examined (birth weight, days to 100 kg, litter size, 
backfat, carcass lean yield, mortality etc ).
Results
Of the 27 SNPs examined, three SNPs in three diff erent col-
lagenous lectin genes were most consistently associated with 
the disease and pathogen groups. In the MBL2 gene, encoding 
MBL-C, the A allele at position  -1081 in the promoter region was 
approximately twice as common in all disease groups (healthy: 
16.6%, diseased: 30.3-37.5%). The same allele was more frequent 
in 4 of 6 bacterial groups and in pigs with PRRSV identifi ed 
(pathogens: 36.9-44.1%). Similarly a miscoding SNP in the surf-
actant protein A gene was more frequent in all disease groups 
(healthy: 45.8%, diseased: 66.0-75.4%) as well as 4 of 6 bacterial 
groups and PRRSV and PCV-2 positive groups (pathogens: 72.0- 
83.0%). The third collagenous lectin SNP was in the MBL1 gene, 
encoding MBL-A. The T allele at position 273 was more frequent 
in all disease groups except serositis (healthy: 31.4%, diseased: 
50.5-54.7%), as well as in 4 of 6 bacterial groups and the PRRSV 
group (pathogens: 54.2-66.7%). In the other innate immune 
genes, the C(96)T SNP in galectin-4 (8 of 14 disease and patho-
gen groups) and the C(1919)T SNP in Toll-like Receptor 5 (7 of 14 
disease and pathogen groups) were signifi cantly more frequent 
most often. Signifi cant associations between SNP frequency and 
production parameters were rare.
Discussion
Out of 27 SNPs, fi ve were signifi cantly associated with most of 
the common diseases and pathogens of swine examined. The 
identifi cation of several mutations consistently more frequent in 
pigs with infectious diseases, but without signifi cant negative ef-
fects on production, suggests that genetic selection for disease 
resistance based on some innate immune genotypes might be 
possible. Further work to examine genetic defects in the entire 
set of genes involved in innate disease resistance is required. 
Innate immune genotypes that reduce the severity of infectious 
diseases might facilitate marker-based selection, decrease pro-
duction costs, improve animal welfare, and reduce antimicrobial 
use in pork production.
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Traceability and genetic evaluation in order to improve the swine products quality
Sam Balasch1 Joan Tibau2 Joaquim Soler2 Marina Gispert2 Maria Angels Oliver2 Agnès Juvanteny1 Glòria Cucurull1 Paula Grassi1
1. Alea! Technological Centre of the Animal Life, Masies de Roda, Spain; 
2. Institute for Food and Agricultural Research and Technology - IRTA, Monells (Girona), Spain
Introduction
The purpose of the Project is the development and implemen-
tation of a traceability system along the production process, 
starting in the focus of reproductive sows and fi nishing when 
the product arrives at the slaughterhouse as loin and ham. This 
traceability will allow us to evaluate the genetics provided by 
Gepork in a productive and a meat quality scale.
Total traceability will allow us to monitor the treatments that 
animals would have received along their productive lives and 
will allow us to obtain meat products free of antibiotic.
Finally, a customers’ survey will be done in order to discover the 
customers’ priorities referring to the gene of porcine stress.
Material and Methods
**Selection of 150 hybrid sows LDxLW and 45 boars, assigned for 
coverage.
**Specifi c software and devices (electronic eartags and reading 
terminals for the farms).
• Identifi cation by electronic eartags of all the animals taking 
part in the Project.
• Coverages in batches of 25 sows; with an interval of 6 weeks.
• Monitoring of many processes: gestation, birth, breastfeeding 
and weaning (feeding, weight, treatments, etc.).
• Extraction of a biological sample of each animal.
• Monitoring of diff erent indicators: daily growth, feeding daily 
consumption, corporal composition, etc. in 3 genders: male, 
female and immunocastrated male pigs. 
• Evaluation of the productive results of the descendants of the 
boars used in each one of the coverages of the 6 batches.
• Monitoring of some indicators in the slaughterhouse (individ-
ual weight before the slaughtering, carcass pork fl esh weight, 
fat thickness, etc.) and monitoring of the traceability in the 
slaughterhouse referring to loin and ham.
• Slaughtering in controlled conditions at 110 Kgs., including:
1. Analysis before slaughtering (alive animal weight, inter-
pretation of back fat and loin).
2. Analysis in the slaughterhouse (carcass pork fl esh 
weight, back fat thickness -G34FOM- and muscle 
-MFOM-, pH, etc.).
3. Analysis of carcass pork fl esh quality in the butchering 
room (pH and CE in loin and ham -pHuLT, pHuSM, CEuLT 
and CEuSM-, color, veined, muscle area in loin, etc.).
• Evaluation of the incidence of the porcine stress gene by 
means of the crossbreed of boars of the three genetics (NN, 
Nn and nn) with sows negative to the stress gene.
• Elaboration of a consumers’ survey about ham and fresh loin, 
addressed to 200 consumers.
Results
We got 100% of traceability in controlled conditions in the 
slaughterhouse and 97.01% of traceability in the commercial 
slaughterhouse. 
We discovered that genetics and gender aff ect the carcass pork 
fl esh (% loin and fat), as the descendants of NN animals have 
more fat thickness and less % loin that the descendants of nn 
genetics.
Referring to gender, female pigs have better values than entire 
male pigs (best carcass performance, % loin, fat thickness and 
muscle thickness -MFOM-). The immunocastrated male pigs 
have a bigger alive weight, but carcass performance is worse 
than females’ carcass performance, they are less conformed and 
MFOM values are just suffi  cient.
Conclusions and Discussion
First of all, we verifi ed that it is possible to ensure the traceability 
of the evaluated animals from the farm until the slaughterhouse.
Referring to carcass quality, the descendants of Nn boars can be 
placed between the descendants of NN and nn, but referring to 
meat quality values, the results obtained are better, overall in 
the NN boars that are descendants of the crossbreed of NNxNP, 
thanks to the analysis of Microsatellite Moleculars Markers 
(MMM).
Referring to conformation, the descendants of nn boars are 
more conformed than the descendants of NN boars.
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Introduction
There are several methods of extracting DNA, some fast, effi  cient 
and useful in the isolation of high-quality DNA extraction kits 
such as commercial. However, most of them are expensive and 
serve a small number of samples, since they have to standard-
ize, thus arises the need for DNA extraction methodologies fast, 
simple and low cost allowing genomic DNA obtained good qual-
ity, free of secondary compounds, proteins and polyphenols, 
which inhibit DNA The Mexican regulations restricts the mobil-
ization of semen and blood plasma within and between diff er-
ent regions of Mexico as a biosecurity measure, so the objective 
was to standardize a technique of extraction and purifi cation of 
DNA from hair, non-invasive technique which allows evaluation 
of animals from diff erent sources without being stressed at the 
time of sampling.
Materials and Methods
Diff erent farms were sampled in the country, pig hair was col-
lected from pulling back sharply with the thumb, index and 
middle, removing the hair bulb of about 50 hairs per animal. We 
obtained the DNA extraction and purifi cation from pig hair for 
being a non-invasive sample. The methodology developed was 
based on a combination of various pre-established protocols 
and modifi ed by reference to the proposal by Sambrook et al. 
(1994), which was to establish the extraction protocol in which 
they conducted a fi rst lysis step through the detergent SDS and 
subsequently for total DNA purifi cation method was applied to 
phenol-chloroform-isoamyl alcohol-enabling removal products 
degradation, which preserves the DNA for longer periods, fi nally 
washed with alcohol to eliminate waste and verify the quality of 
DNA in agarose gel 1%.
Results
The extraction method was effi  cient resulting standardized DNA 
integrity of a good quantity and quality, a technique that allows 
for non-invasive samples such as hair, thus avoiding sampling 
techniques that involve the capture or stress on animals. In this 
research, the electrophoresis gels show the specifi city of the 
DNA extraction technique hair of pigs used in this study (Fig. 1). 
The extraction of DNA from hair was standardized despite being 
listed as a protocol diffi  cult from the standpoint of DNA extrac-
tion methods, results revealed that it is highly reproducible 
and reliable “almost perfect”, in the form PCR amplifi cation, all 
samples were amplifi ed, these tests were conducted with the 
objective of fi nding a methodology to obtain samples without 
any restrictions.
Fig. 1. Agarose gel 1%; (M) 1kb marker; (1-7) DNA hair from pigs. 
Discussion
This standardized extraction method, will allow for non-invasive 
samples such as hair and although they usually do not recom-
mend this type of sample for extraction, were successful in 
securing a high quality genomic DNA, quantity and purity, 
Moller y Brinkmann (1994). Although it took a long period of 
incubation and careful series of steps to follow when handling, 
they showed a high specifi city of the technique (100%) and that 
often gets lost during the processing of samples, attributed per-
haps a shortage of nucleated cells containing the hairs, located 
in the bulge or the inhibitory eff ect of soluble melanins generat-
ed during the DNA extraction process. This option opened doors 
to sample farms which hardly can be entered for biosecurity
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Livia Moscati1 Marco Sensi1 Lorenzo Battistacci1 Massimo Amadori2
1. Istituo Zooprofi lattico Sperimentale Umbria e Marche, Perugia, Italy; 2. Istituto 
Zooprofi lattico Sperimentale Lombardia Emilia Romagna, Brescia, Italy
Introduction
Various environmental eff ects may adversely bear on welfare 
of farmed pigs under intensive farming conditions, which may 
cause chronic rather than acute stress as a long-term eff ect of 
modern husbandry techniques. These may in fact overtax the 
animals’ coping ability and force them to long-lasting homeo-
static control actions. 
Materials and Methods
This investigation was carried out in winter on pigs from Danish 
genealogy book in two fattening farms. Farm 1 consisted of two 
pens housing weaned and growing-fi nishing pigs. In this herd 
there were frequent arrivals of animals of various origins, so that 
no all-in-all-out housing scheme was applied during the trial. 
A chronic respiratory syndrome by Actinobacillus pleuropneu-
moniae had been present for a long time with high morbidity 
and mortality. Herd 1 was compared with herd 2, located in the 
same area and consisting of two fattening pens. In this latter 
farm pigs were born in the same breeding unit, moved to herd 
2 at a weight of some 30 Kg and further reared up to a slaugh-
ter weight of 160-170 Kg. An all-in-all-out housing scheme was 
routinely applied. The overall clinical conditions of pigs were 
satisfactory. The time-course of clinical immunology and clinical 
chemistry parameters was evaluated in the two herds with such 
a diff erent sanitary and management status. Blood samples from 
15 randomly chosen animals of the same age were collected 
in herds 1 and 2 at monthly intervals in vacuum tubes without 
anti-coagulant. l The following parameters were investigated: 
haemolytic complement activity (CH50/150μl) as previously de-
scribed by Barta (1), serum lysozyme (SL) (3), serum bactericidal 
activity (SBA) (2), haptoglobin (Hp) by a commercial kit (Tridelta 
Development Ltd).) zinc (Zn) and iron (Fe) were assessed by a 
Konelab 2001 biochemical analyzer. Resultes were submitted to 
a statistical examination was performed by ANOVA.
Results 
Results are shown in Tables 1 and 2. Animals of the herd 1 
showed at time 0 a signifi cantly higher serum haptoglobin 
concentration (P<0.01) about two weeks after a respiratory 
syndrome and a trend to high serum levels was evidenced at 
later samplings, too. Reduced plasma levels of iron and zinc 
were always evidenced in herd 1, as a possible indicator of a 
steady-state infl ammatory condition, the greatest diff erences 
being revealed at time 3 (p<0.001). Interestingly, animals of both 
“problem” and healthy herd showed low SBA and high lysozyme 
concentrations in later samplings (Table 2) as a possible out-
come of diffi  cult adaptation during the growing phase. 
Table 1. Results of the samplings ± ds
T.0 herd 2 T.0 herd 1 T.1 herd 2 T.1 herd 1
SBA % 40±32 27.1±14* 25±14 36±27
CH50/150 μl 37±26 53±14 50±5 55±11
SL μg/ml 5±1 5±2 7±2 8±5
Hp mg/ml 0.7±0.2 1.7 ± 1.2** 0.8±0.3 0.7±0.2
Zn μg/dl 76±24 59±28 76±18 17±6*
Fe μmol/L 19±7 17±5 20±8 68±8
Table 2. Results of the samplings ± ds
T.2 herd 2 T.2 herd 1 T.3 herd 2 T.3 herd 1
SBA % 25± 10 37±24 26±11 13 ± 11**
CH50/150 μl 62±0.2 61±2 47±11 56±11
SL μg/ml 6±1 3± 1* 2±0.4 5 ± 2**
Hp mg/ml 1.3±0.7 2.3±1.9 1.9±2 2,5±1,9
Zn μg/dl 80±13 64±27 121±22 81±33**
Fe μmol/L 25±5 19±7* 32±6 25±8**
* Signifi cant diff erence (p<0.05) ** Highly signifi cant diff erence (p< 0.01) 
Discussion
Our results indicate that animal health and welfare in pigs can 
be monitored by combining clinical, environmental and in-
nate immunity investigations, as a multi-disciplinary approach 
to animals’ environmental adaptation. Most important, the 
important role of immunological parameters for evaluation of 
welfare conditions confi rms that the eff ector mechanisms in the 
immune response are remarkably similar for both infectious and 
non–infectious stressors.
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The interferon-alpha response in piglets at weaning
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Introduction
Our interest into the functions of type I interferon (IFN) under 
health conditions was stimulated by established models of 
physiological IFN response (1) and constitutive expression in 
lymphoid and non-lymphoid tissues in the absence of any 
specifi c inducer (2), as well as from clinical studies documenting 
serious infl ammatory disorders in humans with a defective 
type I IFN response. In the veterinary fi eld, pigs under intensive 
farming conditions are an interesting model for such studies, 
since an IFN-α response following stressing events like weaning 
and truck transportation has been known for a long time (3). In 
the present study we investigated the IFN-α response in pigs 
weaned at diff erent ages.
Materials and Methods
The study was carried out in May-June 2008 on 40 Landrace x 
Large White, randomly selected piglets of four litters. Group 1 
(2 litters, 20 piglets) was weaned at 28 days of age, and group 
2 (2 litters, 20 piglets) at 22 days of age. All piglets were given 
the same starter feed containing amoxicillin (400 ppm), colistin 
(120 ppm) and zinc oxide (2000 ppm) over the fi rst 10 days after 
weaning. Pigs were clinically inspected and blood samples in 
vacuum tubes without anti-coagulant were collected at days 0, 
+6, +12 with respect to weaning, in order to evaluate the most 
common viral infections and IFN-α production. Viral infections 
were investigated by PCR and antibody assays whereas IFN-α 
production was tested by a cpe inhibition assay on MDBK cells 
with Vesicular Stomatitis Virus (VSV) (4). Other blood samples 
were collected in vacuum tubes with sodium heparin in order 
to assess intracellular porcine IFN-alpha and the expression of 
porcine IFN-alpha genes in peripheral blood mononuclear cells 
(PBMC). IFN-alpha in PBMC was investigated by fl ow cytometry, 
and gene expression by RT-Real Time PCR on 9 animals of group 
2 according to Cheng (5).
Results
All pigs remained healthy during the whole period of observa-
tion. In particular, there was no detectable clinical diff erence 
between the two groups under satisfactory hygiene and welfare 
conditions. There was no evidence of infection by the usual viral 
agents of swine (PRRSV, PCV2, SIV, PRV) in the fi rst 2 weeks after 
weaning (PCR and antibody assays). The sera of all piglets in 
group 2 and of 7 animals only in group 1 were IFN-α positive at 
day 6 after weaning. This result was confi rmed by a neutraliza-
tion assay of IFN-α on MDBK cells by a monoclonal antibody to 
porcine IFN-alpha1.
A small percentage of PBMC from several piglets at day +6 were 
also positive in a fl ow cytometry assay for intracellular porcine 
IFN alpha.4 and 10 animals in groups 1 and 2, respectively, were 
positive, and the prevalence of IFN alpha-positive PBMC showed 
no evident correlation with that of the sera.
The results of RT-Real Time PCR showed at day 0 the expression 
of the IFN alpha5 and 6 genes in 7 out of 9 piglets and of IFN 
alpha12, 1, 7, 11 and 2 genes in fewer pigs. All the above genes 
were not expressed at day +6, and expressed again at day +12. 
Discussion/Conclusions
Our results are in agreement with previous reports about con-
stitutive expression and secretion of IFN-alpha; in particular, the 
need for an IFN-α response to the weaning stress was shown to 
be much higher in 3, compared with 4-weeks old piglets. Tran-
scriptional control on gene expression in PBMC coincided with 
peak serum IFN-α titres. These fi ndings highlight the importance 
of type I IFNs as homeostatic agents in the response to environ-
mental, non-infectious stressors.
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Introduction
Previous studies characterized lymphocyte development and Ig 
production in fetal pigs (1,2). The porcine immune system is well 
developed prior to birth, but prenatal factors infl uence immune 
function in suckling pigs (3). Furthermore, in utero transmis-
sion of pathogens also altered piglet peripheral and tissue T 
lymphocytes (4). In contrast to controlled experiments under 
ideal conditions, our understanding of cell-mediated immunity 
(CMI) is limited for newborn pigs in commercial farms. Therefore, 
the primary goal of this study was to characterize peripheral T 
lymphocytes in neonatal pigs on a conventional sow farm. 
Materials and Methods
The animal phase of the study was conducted on a PRRSV-stable 
sow herd. Four sows (parity 1, 2, 3, and 6) were identifi ed prior 
to farrowing. Farrowing was closely supervised and birth order 
of the piglets was recorded. Whole blood samples were col-
lected from 12 piglets per sow prior to suckling (day 0), 24 hr 
after suckling (day 1) and at 7 days of age. Piglets were weighed 
at the time of each blood collection. Complete blood counts 
were performed on each sample. Samples were prepared for 
fl ow cytometry and the number and percent of CD3+, CD4+ 
and CD8+ lymphocytes were determined. Spearman rank cor-
relations were used to assess associations among piglet body 
weights, birth order and immune cell types. 
Results
Piglet body weight (BW) did not diff er between day 0 (1.3+.05 
kg) and day 1 (1.4+.05 kg), but increased (P<.05) at day 7 
(2.4+.08 kg). Total lymphocyte counts increased with age; 
however, the percentage of lymphocytes and neutrophils did 
not change with age. The number of CD3+, CD4+ and CD8+ 
lymphocytes increased with age (Fig 2). In contrast, the percent-
age of CD4+ cells decreased from day 0 to day 7. 
Prior to suckling, the % and number of CD8+ cells were positive-
ly correlated with birth order (r=0.47, P<.001 and r=0.28, P<.05, 
respectively) and the percent and number of CD3+ cells were 
positively correlated with body weight (r=0.32, P<.02 and r=0.48, 
P<.001, respectively). For the three days of blood samples, there 
was a positive correlation among the number of CD4+ and 
CD8+ cells with body weight and day.
Figure 1. Changes (mean+SEM) in number (top) and percentage 
(lower fi gure) of CD3+, CD4+ and CD8+ lymphocytes in neonatal pigs. 
Discussion
The percentages and numbers of CD4+ and CD8+ lympho-
cytes agreed with previous studies of PRRSV-free pigs (3,4). It 
is expected that the number of CD4+ cells decrease while the 
number of CD8+ cells continue to increase at weaning or shortly 
thereafter. The CD4+ TH1 and TH2 subsets bind to macrophages 
and antigen-specifi c B cells, respectively, and thus play roles in 
CMI. The CD8+ lymphocytes (cytotoxic T cells) are programmed 
to become eff ector cells and become more critical to immun-
ity as the pigs mature. As shown in previous studies (1,2), it is 
evident that newborn pigs in commercial farms are “armed” with 
the appropriate cells for CMI. However, our results showed that 
lighter piglets have lower immune cell numbers. These pigs will 
require additional care and perhaps, they are more susceptible 
to infections. 
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Introduction
Genetic diff erences in antibody and cell-mediated immunity 
have been described, and swine selection programs based on 
immune responsiveness have been proposed as a means of 
improving health status and growth performance1. The ob-
jective of this study was to evaluate the relationship between 
growth performance and an individual pigs’ general immune 
competence assessed using a novel mitogen-induced lympho-
cyte proliferation assay (Disease Resistance Assay for Animals; 
DRAA). These results are part of a larger study evaluating 
relationships among general immune competence, post-natal 
performance, and PCV2 risk. 
Materials and Methods
This study was performed in a 600 sow high health farrow-
fi nish farm using 45 PIC Camborough sows blocked by parity. 
Two male and 2 female piglets, representing small and large 
birth weight, were selected from each litter at birth and mon-
itored until 15 weeks of age. After weaning at 3 weeks of age, 
piglets were reared in conventional all-in-all-out nursery and 
grow-fi nish rooms and fed commercial diets typical of western 
Canada. Individual weights were obtained at birth, 3, 9 and 15 
weeks of age. The average daily gain (ADG) for each period was 
calculated. From each piglet, 5 ml heparinized blood was col-
lected at 3, 9 and 15 weeks of age. DRAA: The individual’s general 
immune competence was assessed using the DRAA (Metadis 
Inc.). Lymphocytes were isolated by density gradient centrifuga-
tion using ‘Lymphoprep’, then proliferative responses to a panel 
of mitogens were assessed as 6 replica of 104 cell aliquots. The 
mitogens in the panel were chosen in order to mimic a wide 
array of pathogenic stimuli and each was representative of a 
specifi c T-cell molecular signaling pathway and genetic signa-
ture. Since some of the elicited receptors respond to multiple 
mitogens, multivariate-based mathematical analysis was 
used to eliminate overlaps, leading to a measurable response 
along 3 fundamental T-cell pathways on which the blastogenic 
responses relied. For each pathway a TABI score was calculated 
refl ecting the strength of an individual’s expected immune 
response to a pathogen. TABI 1 encompasses general CD3+ 
T-cell responses. TABI 2 refl ects the ratio of given T-cell receptors 
specifi c to each individual animal. TABI 3 represents the nature 
of CD4+ subsets and the clonal expansion of B lymphoblasts 
present in the peripheral blood. Statistical analysis: Generalized 
linear mixed models (STATA v9, StataCorp, College Station, Tx) 
were developed to assess potential relationships between the 
week 15 TABI (1, 2, 3) scores and ADG. Two ADG periods (weeks 
9-15 and 0-15) were considered. The TABI 1, 2 and 3 scores 
measured at week 15 and biologically relevant cofactors that 
potentially impacted ADG including gender, birth weight and 
farrowing week were retained in the fi nal model if P < 0.05. 
 
Results
Mean birth weight was 1.4 ±0.3 kg. Mean body weight at 15 
weeks of age was 62.5 ±9.0 kg. Mean ADG 9-15 was 0.819 ±0.18 
and mean ADG 0-15 was 0.581 ±0.01 kg/day. The week 15 TABI 
1 scores ranged from -1.37 to 3.54; TABI 2 scores ranged from 
-2.16 to 3.1; and TABI3 scores ranges from -1.99 to 1.75. The TABI 
1 score was signifi cant and positively associated with ADG 9-15 
(r2 = 0.43; </\em>P < 0.001) and ADG 1-15 (r2 = 0.46; P < 0.001) 
(Table 1). TABI 2 and TABI 3 scores were not associated with ADG 
during either period, nor was gender.  
Table 1. Relationship between TABI 1 (wk 15) score and average daily 
gain from weeks 9-15 and weeks 0-15.
Beta (kg/d) 95% CI P value 
ADG 9-15
TABI 1_wk15 0.046 0.006 to 0.086 0.024
Birth wt (kg) 0.141 0.061 to 0.221 0.001
ADG 0-15
TABI 1_wk15 0.026 0.007 to 0.045 0.007
Birth wt (kg) 0.124 0.086 to 0.161 <0.001
Discussion
Many factors, including health, potentially impact the growth 
performance in fi nisher pigs. This study demonstrates that 
a vigorous and positive T cell response, as quantifi ed by the 
DRAA, is associated with enhanced growth rate. For each 1 point 
increase in the TABI 1 score, ADG 9-15 and 0-15 increased 46 and 
26 grams/day respectively, or about 4-5%. Of the 3 fundamental 
T-cell pathways evaluated, only the general CD3+ response path-
way was signifi cantly associated with growth. Surprisingly, ADG 
was not associated with gender in this study. 
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Introduction
The diffi  culty of sampling swine tonsils ante-mortem makes 
collection at the time of slaughter an obvious alternative for dis-
ease monitoring purposes (1). The funnelling of large number of 
animals during the slaughter process also provides an opportun-
ity to sample a wide range of animals and animal sources on one 
premise. The objectives of this 7-month study were to determine 
the prevalence of porcine pathogens of the tonsil of the soft pal-
ate at slaughter, to determine if sampling normal or abnormal 
hog carcasses provides diff erent microbiological profi les, and 
to determine if the slaughter plant provides a feasible sampling 
frame and environment for detecting and monitoring important 
pathogens in tonsils that have health implications for swine and 
humans.
Materials and Methods
Twenty (20) tonsil samples were collected every week for 20 con-
secutive weeks, June to December 2008, from swine carcasses at 
a federally inspected abattoir in southern Ontario, Canada. The 
sampling was performed by experienced abattoir staff  during 
normal slaughter operations. Microbiological analyses of the 
tonsils were conducted by the Animal Health Laboratory (AHL) 
at the University of Guelph. Guelph, Ontario. Testing included 
bacteriological culture and identifi cation, real-time PCR test-
ing for PPRS virus and IHC for Porcine Circovirus-2 (PCV-2). The 
relationship between fi nding a pathogen from pigs on the hold 
rail (abnormal carcasses) vs. normal carcasses was examined by 
logistic regression. A generalized mixed model using farm as a 
random intercept was utilized to determine whether there was 
any clustering at the farm level (2). 
Results
A total of 395 samples were collected of which 180 were tonsils 
from normal carcasses and 215 from carcasses that were on the 
hold rail. 264 diff erent farms were represented and no clustering 
occurred at the farm level. Most commonly isolated bacterial 
pathogens included: S. suis (53.7%), A. pyogenes (29.9%), P. 
multocida (27.3%), and S. porcinus (19.5%). PRRS virus and PCV-2 
were identifi ed in 22.0% and 11.9% of the samples respectively. 
Tonsils had 2 times greater odds (OR=2.16, CI 1.44-3.24) of be-
ing positive for S. suis if sampled from the holdrail vs. normal 
carcasses. Similarly, tonsils had an 8 (OR= 8.79, CI 4.24-18.23) and 
7 (OR=7.51, CI 2.89-19.54) times greater odds of being positive 
for S. porcinus and Staph hyicus respectively, if collected from 
the hold rail vs. normal carcasses. However, tonsils that were 
positive for PRRSV or PCV-2 were no more likely to be from the 
hold rail than from the normal carcasses. The odds were 2 times 
greater for tonsils that were PRRSV-positive for being positive for 
S. equisimilis (OR=2.15, CI 1.22-3.27). However, being PRRSV posi-
tive did not increase the odds of the sample being positive for 
any other bacteria or PCV-2. Tonsils that were positive for PVC-2 
had a 2 times higher odds of being positive for S. porcinus (OR= 
2.15, CI 1.10 – 4.22). However, being positive for PCV-2 did not 
increase the odds of a sample being positive for any other bac-
teria or PRRSV. Two samples (0.5%) were positive for Salmonella 
typhimurium and then further typed. One bacterium was Phage 
Type 104a and the other was Copenhagen Phage Type UT1. Bio 
and serotyping were undertaken for all of the Yersinia enterocol-
itica positive (1.8%) samples. Bio-serotype 4/0:3 was the most 
common type found in 5 out of 7 of the positive samples (71.4%) 
The remaining 2 positive samples were bio-serotype 2/0:5, 27.
Discussion
The sampling frame and sampling method proved to be an ef-
fi cacious way to collect swine tonsil tissue. Accurate tissue recov-
ery occurred (99.7%), the sampling protocol was not technically 
challenging, and plant production was minimally aff ected dur-
ing the sampling periods. Tissue collection during the slaughter 
process was a superior method of tonsil tissue collection com-
pared to reports of ante mortem techniques where only 48.9% 
of samples were correctly obtained by tonsil biopsy methods (1). 
Interestingly, tonsils that were positive for PRRSV or PCV-2 were 
not more likely to be positive for zoonotic pathogens or other 
swine pathogens with major production limiting implications.
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1. Iowa State University, Ames, IA, USA; 2. University of Minnesota, St. Paul , MN, USA
Introduction 
Oral fl uid specimens have been used extensively in human 
diagnostic medicine, but only recently has the concept been 
investigated in the production animal setting (Prickett and Zim-
merman, 2010). Two studies were conducted under experiment-
al conditions. The objective of the fi rst study was to determine 
whether porcine reproductive and respiratory syndrome virus 
(PRRSV) and/or specifi c anti-PRRSV antibodies were present in 
oral fl uids. The second study evaluated the detection of porcine 
circovirus type 2 (PCV2) and anti-PCV2 antibody in oral fl uids. 
Materials and methods 
Experiment 1 (PRRSV): The onset, level, and duration of PRRSV 
and anti-PRRSV antibodies in serum and oral fl uids was evalu-
ated in 3 age groups of pigs (4, 8, and 12 weeks of age). Each 
age group consisted of 16 pigs (12 PRRSV-inoculated, 4 negative 
controls) housed in pens of 4 pigs each. Pigs were inoculated 
IM on DPI 0 with 2 ml of inoculum containing 1 x 101.7 TCID50 
of PRRSV per ml. After PRRSV inoculation, serum, buccal swabs, 
and oral fl uids were collected at regular intervals for 63 days. 
Samples were assayed for PRRSV by qRT-PCR and specifi c anti-
PRRSV antibodies by ELISA. 
Experiment 2 (PCV2): The onset, level, and duration of qPCR-
detectable PCV2 and anti-PCV2 antibody in serum and oral fl uid 
were evaluated over time. Four treatment groups (6 pigs each) 
were evaluated: Group 1 - negative control; Group 2 - inoculated 
IM and IN with PCV2a (ISU- 40895); Group 3 - inoculated IM and 
IN with PCV2a (ISU-40895) at 0, 4, 8 and 12 weeks; Group 4 - 
inoculated IM and IN with PCV2a (ISU- 40895), then with PCV2b 
(PVG4072), and with PCV2a (ISU-4838) at weeks 0, 5, and 10, 
respectively. Serum from each animal and one oral fl uid sample 
per group were collected every other day through day 14 and 
weekly through week 14. Serum and oral fl uid samples were 
assayed for PCV2 by qPCR and anti-PCV2 antibody by ELISA. In 
addition, anti-PCV2 antibody isotypes (IgG, IgA, and IgM) were 
quantifi ed in oral fl uid samples. 
Results
Experiment 1 (PRRSV): PRRSV qRT-PCR results in oral fl uid 
samples were correlated with serum levels. 75% of the oral fl uid 
samples collected from PRRSV inoculated pens were positive 
through day 28. Likewise, PRRSV-specifi c antibody of the IgG, 
IgM, and IgA isotypes were detected in oral fl uid. 
Experiment 2 (PCV2): PCV2 was detected in oral fl uids in all 
inoculated groups by day 2 (fi rst sampling) with peak levels be-
tween days 10 and 21. Levels declined thereafter, but persisted 
through the end of the 98 day study. Analysis of PCV2 qPCR re-
sults found no statistically signifi cant diff erences among inocu-
lated groups either in oral fl uid or serum specimens. Likewise, 
there were no signifi cant diff erences among inoculated groups 
in the level of anti-PCV2 antibody in serum. Anti-PCV2 antibody 
was detected in oral fl uids and persisted throughout the 98 day 
study. Anti-PCV2 IgG, IgA, and IgM were present in oral fl uid by 
DPI 14 and persisted through the end of the study.
Discussion
The results of these two experiments showed that PRRSV and 
PCV2 infections were detectable in oral fl uid specimens using 
either PCR- or antibody-based assays. These results suggest 
that oral fl uid samples are a viable alternative to serum samples 
for the surveillance of PRRSV and PCV2. In the fi eld, oral fl uid 
sampling could form the basis of an effi  cient, cost eff ective, and 
practical approach to infectious disease surveillance.
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Introduction
Recording of gross lesions at slaughter has for many years been 
performed in Sweden by the offi  cial meat inspectors. This infor-
mation is stored in a databank run by the Swedish Animal Health 
Service, and is used to identify herds with health problems, to 
improve animal welfare, and also for epidemiological studies. 
In this report, variation in prevalence of, as well as correlations 
between, gross lesions are analysed.
Material and Methods
The analyses are based on data on all fattening pigs slaughtered 
during 2009 at the six largest slaughter plants in Sweden (n=2.4 
million pigs). Mean prevalence for each herd and slaughter 
month was calculated for seven pathological lesions (abscesses, 
arthritis, tail damage, enzootic pneumonia [SEP], pleuropneu-
monia [PP], pleuritis [Pl] and Ascaris [white spots in livers; WS]). 
In total, fi nal data comprised information on 729 herds and 7241 
herd-month averages (>50 pigs in each average).
Analysis of variance was applied, according to a statistical model 
including the fi xed eff ects of slaughter plant, month and herd 
size (4 classes: 500-999; 1000-1999; 2000-3999; 4000- fatten-
ers). The statistical model also included the random eff ect of 
herd. Correlations between prevalence of diff erent lesions were 
estimated as residual correlations, when the eff ect of slaughter 
plant was adjusted for.
Results
Slaughter plant had a signifi cant (p<0.001) eff ect on all preva-
lences analysed. Herd size had a signifi cant eff ect on the preva-
lence of Abscesses (p<0.05) and on PP, Pl and WS (p<0.001), see 
Tab. 1. 
Month had a signifi cant (p<0.001) eff ect on all traits analysed, 
except for PP (p<0.5), see Tab. 2.
The following correlations (r>0.1), between the prevalences of 
the lesions analysed, were highly signifi cant (p<0.001):
Tail damage – abscesses: +0.33 
Abscesses – arthritis: +0.14
Pleuropneumonia – Pleuritis: +0.30
SEP – Pleuritis: +0.19
SEP- WS: +0.14 
Discussion
This investigation identifi ed 4 primary pathological fi ndings at 
slaughter which should be focused on to improve herd health 
and animal welfare. According to Swedish legislation, no tail 
docking of piglets is allowed. Prophylactic measures against tail 
biting, such as adequate feed and feed allowance and supply of 
straw, will prevent secondary abscesses (4). 
PP, SEP and Pl may be controlled by strict age segregated pro-
duction (1). Vaccination against Mycoplasma hyopneumoniae 
reduces SEP and to some extent Pl. These measures are espe-
cially important in larger herds as they are associated with high 
prevalences of respiratory diseases (1,3). Condemnations of 
livers due to white spots can be prevented by strategic pre-far-
rowing treatments of sows with anthelmintics in age segregated 
productions systems (2).
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Prevalence of organ lesions in fattening pigs at slaughter recorded 
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Aim of the Study
Organ lesions of slaughtered pigs can be used eff ectively to 
assess the herd health status on preharvest level. The aim of this 
study was to record the prevalence of organ lesions in fattening 
pigs at slaughter in diff erent slaughterhouses in Switzerland, 
to assess their economic impact and to evaluate the introduc-
tion of a system based on codes, which will be used in all Swiss 
slaughterhouses.
Materials and Methods
Data were collected over the period of June 2008 until May 2009 
during meat inspection from 34’706 fattening pigs in four dif-
ferent slaughterhouses in Switzerland. Each lesion was recorded 
within a code system.
Results
In total, in 3’101 out of 24’426 organs, which were assessed dur-
ing meat inspection, lesions were found. The economic loss for 
the organs was calculated to 15’950 Swiss Francs. The following 
tables (Table 1-4) summarize the type of lesions in the diff erent 
organs.
Based on the recorded data during meat inspection, lesions on 
animal level were statically compared between label and non 
label pigs and pigs which attend the pig health service (PHS) 
and those pigs which did not attend. Both label and pig health 
service slaughtered pigs showed signifi cant less bronchopneu-
monia (Table 5).
Conclusion
Based on this project, a system recording systematically meat 
inspection data should be implemented in the future in Switz-
erland. The application of the evaluated system would help to 
monitor the herd health status on the preharvest level in the pig 
population and allow assessing the impact of the work of the 
pig health service.
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Introduction 
The demand for more organic pigs has increased in Sweden. 
Production structure has changed from small farrowing-to-fi nish 
outdoors organic (OO) herds to larger herds, and also some 
specialized organic fattening herds. In these herds the pigs 
are raised indoors (IO) with access to a small area and pasture 
outside the barn. Thus today a higher proportion of organic 
pigs in Sweden are kept indoors most of their lives. During 2009 
some organic farms started to raise IO pigs in accordance with 
the EU rules (3). The main diff erence between these systems is 
the access to pasture or not. The certifi ed “Swedish” organic pigs 
must have access to pasture four months of the year, whereas 
the EU-pigs (EO) must only have access to a small paddock area 
outside the barn.
The aim with this study was to analyse the prevalence of gross 
lesions at slaughter over time in organic and in conventional (C) 
Swedish fattening pigs.
Material and Methods
The analyses are based on data from a databank, comprising 
information on all fattening pigs slaughtered in Sweden. This 
databank is run by the Swedish Animal Health Service. Informa-
tion on all gross lesions found at slaughter is stored in this data-
bank. The Swedish organic pig herds are limited in number, and 
for 2009, data was available from 23 IO herds (15900 pigs), and 6 
EO herds (8000 pigs). Thus, the certifi ed organic pig production 
in Sweden is <1% of the total pig production. 
Results 
Prevalence of Swine Enzootic Pneumonia (SEP) decreased 
continuously in C pigs between 1997 and 2001 (1) and remained 
at about 4% until 2009. During the same period, prevalence of 
SEP increased steadily among OO+IO pigs (2) (Fig.1). In 2009, 
when EO-pigs were introduced, the prevalence of SEP among 
these pigs where 7.8%. In C-pigs, joint lesions have remained at 
a constantly low level (1-2%) during the last 10 years. However, 
these lesions are 3-4 times more prevalent among OO+IO pigs 
compared to C-pigs (Fig.2). In 2009, the fi rst year of Swedish EO-
pigs, the prevalence of joint lesions among them was 4.5%. 
Discussion 
OO+IO-pig production is seldom age segregated and the 
barns are seldom emptied or cleaned, and older pigs can infect 
younger ones. The change in raising system from OO to IO has 
increased the prevalence of SEP. The prevalence of joint lesions 
among OO and IO pigs increased 3-6 times during the period 
studied. The reason why joint lesions are more common in the 
organic production than in conventional herds is not completely 
understood. Osteochondrosis and Erysipelas infections are two 
etiological candidates. In conclusion, prophylactic measures 
against SEP may be done by applying strict age segregated 
production and /or vaccination against M.hyo. The etiology of 
the joint lesions needs to be further investigated. 
References
1. Holmgren N, et.al Swedish Vet. J. 2002, 10 469-474.
2. Heldmer E, et.al. Swedish Vet. J. 2006, 58,13-19
3. COUNSEL REGULATION (EU) nr 834/2007
Surveillance and Biosecurity – Surveillance
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 928
Poster Presentations
P.622
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Introduction
Pathologic-anatomic fi ndings of lung, pleura, pericard, liver, 
kidney and carcass in slaughtered pigs can be proper herd 
health status indicators. The aim of this study was, to deter-
mine whether there is a signifi cant relationship between farm 
management factors, husbandry type and pathologic-anatomic 
fi ndings in slaughtered pigs.
Materials and Methods
In the fi rst part of this study, the prevalence of pathologic-ana-
tomic lesions of lung, pleura, pericard, liver, kidney, muscle, joint 
and skin in 34706 pigs was documented on herd level in four 
Swiss slaughterhouses. 
In the second part 82 pig farms were selected to analyze 
whether certain farm factors can be linked to the fi ndings in 
slaughtered pigs. On the basis of their pathologic-anatomic fi nd-
ings, the farms were splitted into „case farms“ (more than 30% of 
the pigs from one farm had a pathologic-anatomic fi nding) and 
„control farms“ (less than 10% of the pigs from one farm had a 
pathologic-anatomic fi nding). The “case farms” were separated 
into farms with lesions at the pluck (S) (lung, liver, pleura, peri-
card) and at the carcass (T) (kidney). The category “pluck” had 
three subcategories: pneumonia (pn), pleuritis/pericarditis (pl/
pc) and milkspots (ms). In order to be allotted into one of these 
subcategories, the fi nding had to be present in at least 10% of 
the pigs from one farm. The subcategories were formed to fi nd 
potential risk factors for pathologic-anatomic fi ndings in the dif-
ferent organs. It was not necessary to form subcategories for the 
farms with fi ndings at the carcass because all “case farms” had 
only lesions in term of „white spotted“ kidneys. 
Results
See tables.
Discussion
Pathologic-anatomic fi ndings in slaughterhouses can be used 
as an objective indicator for diseases throughout the fattening 
period (Blaha, 1993). In Swiss slaughterhouses is a lot of poten-
tial herd health data available which could be of interest for the 
veterinarian and the pig health service. The 
data could be an assisting tool to monitor 
diseases, improve the herd health and to 
increase the food safety. So far, these data 
are only used for generation of bills. As it was 
presented before by diff erent authors, this 
study was able to show that several farm- 
and management factor can be linked to 
pathologic-anatomic fi ndings. 
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relation to disease outbreak information in Ontario (2005 - 2007)
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Introduction
Data sources for animal syndromic surveillance remain relatively 
unexplored, and may include veterinary records, and/or animal 
health laboratory submission fi les. High correlations between 
clinical signs on farms and the presence of lesions at slaughter 
have been reported. The objective of this study was to deter-
mine if changes in condemnations rates provide an additional 
data source for the surveillance of disease outbreaks in fi nisher 
pigs. We assessed the epidemiological relevance of these data 
by determining whether the timing of changes for particu-
lar pathological lesions were consistent with a documented 
outbreak of porcine circovirus associated disease (PCVAD) in 
Ontario that started in 2005 and was largely controlled by the 
introduction of eff ective PCV-2 vaccines in 2007.
Material and Methods
The data were obtained from the database of one large feder-
ally inspected packing plant in Ontario from January 2005 to 
December 2007. Using negative binomial models, we investi-
gated the association between year and quarter with the rate of 
condemnation for the following lesions that are associated with 
PCVAD: pneumonia, enteritis and nephritis. Predictive rates for 
each condemnation category were calculated and graphed by 
season and year from the fi nal model. Contrasts were performed 
to determine the diff erence of rates between season and year. 
Retrospective temporal scan statistics were performed to iden-
tify the most likely temporal clusters for each condemnation 
category using a Bernoulli model in SaTScan. The patterns of le-
sions and temporal clusters were compared to PCV-2 diagnostic 
reports of the Animal Health Laboratory (AHL), at the University 
of Guelph (2005-2007).
Results
Based on the negative binomial models, a signifi cant decrease in 
the rates of pneumonia was observed during the study per-
iod (Figure 1). In agreement with AHL reports, the pneumonia 
patterns refl ect fi eld infection of PCV-2 in 2005 followed by the 
increased and widespread use of PCV-2 vaccines in Ontario 
swine in 2007. In addition, we think that the initial decrease of 
pneumonia rates in the spring of 2006 may refl ect the initiation 
of PCV-2 vaccines in April of 2006 in Ontario (Figure 1). 
 Similarly, the most likely temporal clusters for pneumonia oc-
curred from January 2005 to March 2006. However, condemna-
tion rates due to nephritis and enteritis increased signifi cantly 
in 2007 compared to previous years (Figure 1). The most likely 
temporal clusters for enteritis and nephritis occurred near the 
end of the study period. 
Discussion
These results suggest that abattoir data have potential for the 
surveillance of emerging pathogens as refl ected by the pneu-
monia patterns. However, abattoir data may also suggest areas 
for enhanced surveillance for unexplained disease patterns 
not identifi ed by laboratory submissions. Further prospective 
studies are required to validate the utility of these data. Abat-
toir data would be of more value if it could be incorporated into 
a surveillance program, and validated with multiple sources of 
swine health data.
Figure 1. Predictive rates of condemnations due to pneumonia, 
enteritis and nephritis from the negative binomial models.
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Comparison of disease trends in swine of Ontario using active practitioner-based surveillance and 
passive laboratory-based surveillance (2007-2009) as sources of syndromic surveillance data
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University of Guelph, Guelph, ON, Canada
Introduction
The growing concern of emerging and re-emerging diseases 
in swine populations in Ontario in 2005, led to the decision to 
conduct a pilot study to determine the feasibility of an active 
veterinary-based surveillance system referred to as the Ontario 
swine veterinary-based surveillance system (OSVS) (1). The OSVS 
recorded the occurrence/incidence of diff erent syndromes 
and investigated potential outbreaks during the study period. 
However, the integration of OSVS data to additional data sources 
to validate the disease patterns observed was needed. The main 
objective of this study was to compare the disease patterns 
observed in the OSVS system with data obtained from case 
histories that accompanied laboratory submissions to an On-
tario regional laboratory, the Animal Health Laboratory (AHL). In 
addition, the passive data obtained from submissions by OSVS 
members to the AHL were compared to all passive data submit-
ted to the AHL. 
Materials and Methods
Multivariable negative binomial models were used to examine 
the impact of data stream, season-year and body system af-
fected (i.e., respiratory, digestive and reproductive) on submis-
sion rates. 
Results
Our results showed that generally higher rates of submissions 
were reported to the OSVS for the body systems compared to 
AHL over the study period. However, over the study both OSVS 
and AHL data captured similar long-term trends of disease 
(e.g., respiratory) (Figure 1a). Yet, the OSVS data were also able 
to capture potential outbreaks that were not refl ected in the 
laboratory-based submission data, such as a large increase in 
digestive cases in Summer 2008 (Figure 1b).
Discussion 
Laboratory-based data may be infl uenced by disease awareness, 
and more under-reporting compared to active surveillance. In 
addition, the rates of submissions may be infl uenced greatly by 
disease and non-disease factors that infl uence the total number 
of submissions to each data stream. The validation of active and 
passive syndromic surveillance data is necessary, and eff orts 
should be placed on integrating these types of data sources. 
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Figure 1a & 1b. Predicted rates of swine respiratory and digest-
ive submissions from three data sources (OSVS*, all AHL* and the 
subset of AHL from OSVS participating members) from Summer 
2007 to Spring 2009 in Ontario.
1a. Respiratory
1b. Digestive
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Introduction
Swine practitioners collect and maintain a large volume of 
health information as part of daily practice. However, the ability 
to compile, organize and use this information is often diffi  cult 
due both to volume and varied methods of collection and 
reporting. Swine Database Services (SDS) is a company that 
arose from a shared vision of private industry veterinarians who 
recognized the need to organize this information and use it to 
generate knowledge. Together this group has developed a real 
time online practice management database that collects and 
organizes data so it can be readily searched and accessed. This 
system has also allowed for the collection of real time on farm 
animal health data that can also be used for emerging disease 
surveillance.
Materials and Methods
A group of like minded veterinarians from Manitoba and Alberta 
came together because they shared the need to compile and 
organize the large volume of health information in their prac-
tices. Each group had independently started to develop a data 
collection database and quickly recognized the synergy to be 
gained in working together. In merging the two independent 
databases, the beginning of an innovative information manage-
ment tool was created. The services of an Information Technol-
ogy company were contracted to convert it to an online system 
that could be accessed, used and maintained in real time. The 
continued development of the database centers on using the 
data to create knowledge to accomplish the following goals:
• make better decisions for clients
• improve practice management and individual quality of life for 
swine practitioners
• improve epidemiological data to aid in disease investigation
• create consistent protocols, prescriptions, forms and reporting 
• use real time data in the real time surveillance of emerging/re-
emerging disease 
Results
The SDS database was created primarily to facilitate practice 
management. Key practice areas were identifi ed and modules 
created in the database for each area. The current modules in 
use include:
1.  Customer Contact Information 
2.  Standardized Herd Visit Documentation- veterinary medical 
records
3.  Diagnostic Information – summary of diagnostic information 
in a searchable format 
4.  Prescription Generation – injectable and feed which are 
standardized and error free
5.  Producer Medication and Vaccine Usage Plans – provide 
standardized medication information for clients 
6.  Quality Assurance Monitoring –notifi cation when CQA need 
to be done and correction action monitoring.
7.  Export Health Certifi cates to the United States 
Numerous reports are also available including electronic sig-
nature tracking, invoicing and practice effi  ciency. The practice 
effi  ciency can be used to benchmark customer service and 
overall practice performance. Health information can also be 
monitored including syndromic data (e.g. coughing), mortal-
ity and on farm diagnostics. Monitoring these parameters over 
time may provide important signals to changes in the health 
status of an individual farm and/or geographically or otherwise 
related farms. This allows the veterinarian to react proactively to 
these changes. The secondary objective of the database was to 
provide a real time on farm swine surveillance tool. Each farm is 
given a unique code known only to the veterinarian so if data is 
shared, the veterinarian becomes the “gatekeeper” of the infor-
mation and maintains farm confi dentiality. A pilot project with 
the Alberta Veterinary Surveillance Network (AVSN) was con-
ducted with SDS. Blinded data was analyzed starting in February 
2009 including key farm attributes & syndromic information col-
lected during farm visits. The goal of this surveillance is to more 
rapidly detect and respond to health events in order to protect 
our industry.
Discussion
The SDS database has been developed to generate knowledge, 
establish protocols and devise strategies that can help clients 
and veterinarians thrive in an increasingly challenging industry. 
The consumer demand to show a commitment to food safety 
and public health by monitoring the production of our food 
supply will continue to drive the need for disease surveillance. 
The SDS database can produce real time health information and 
reports that help provide assurance to markets about the health 
of our pigs. Maintaining this information in one comprehensive 
practice management database provides high quality data while 
improving practice life for the veterinarian. 
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Introduction
Livestock disease surveillance systems are necessary for coun-
tries to meet their OIE reporting requirements. Trading nations 
must be able to substantiate their claims about disease status 
and veterinary infrastructure. Surveillance systems must be able 
to detect OIE listed diseases as well as newly emerging diseases 
and changing endemic diseases. The Alberta Veterinary Surveil-
lance Network (AVSN) was developed to meet these needs.AVSN 
has three parts: disease detection, disease response and com-
munication. Veterinary Practice Surveillance (VPS) provides the 
system for veterinarians to report disease and non-disease data. 
Analysis of the data provides valuable demographic information 
and enhances early detection of important disease events.A VPS 
for cattle has been operational since 2006 with approximately 
30 practices participating (1). This paper describes a Veterinary 
Practice Surveillance (VPS) for Swine Pilot Project begun in 2009.
Materials and Methods 
A contract for data purchase was developed with Swine Data-
base Systems (SDS), a group of swine veterinarians in Western 
Canada. SDS had recently created an online database system 
for managing practice and animal health data (2). Three veter-
inarians from two swine only specialized practices submitted 
data weekly for one year. Data was provided weekly on all client 
interactions, including telephone and electronic consultations. 
Farm name, address, location and phone contacts are present 
in the SDS database but were not shared. A unique farm and 
visit identifi cation (ID) code was applied to each farm and only 
ID codes were included in the data submissions supplied to the 
AVSN. Defi nitions for each data fi eld were written in consultation 
with the SDS veterinarians.
Data were analyzed in Excel and reported to participating veter-
inarians.
Results
Data were submitted weekly for one year from visits to farms 
representing approximately 45% of the Alberta sow herd. Herd 
size and pig type on farm were included, but no other farm 
identifi ers. When unusual disease presentations were noted, the 
reporting veterinarian was contacted and the case discussed. 
Defi nitions were developed for the 13 types of submissions (visit 
reasons), 12 herd/operation types (eg. farrow to fi nish, wean to 
fi nish), 11 disease syndromes and four pig types (sows, piglets, 
nursery and growing pigs). The 11 disease syndromes reported 
were: coughing, sneezing, scours, neurological, skin, lameness, 
unthrifty, vices, sudden death, reproductive, and urogenital. 
Severity was reported by eight percentage ranges of animals af-
fected in each of four pig types in the syndrome categories: 0%, 
<2%, 2-5%, 5-10%, 10-20%, 20-40%, 40-60%, >60%. Total mor-
bidity and mortality for each class of pigs was also reported. This 
database allowed the description of veterinary infrastructure 
for swine in Alberta (ie. number of visits per farm, size of farms 
visited, and reasons for visiting farms). Changes in the number of 
on-farm visits and types of consults were monitored in response 
to a declining pork price. Consultations for respiratory disease 
were monitored during the pandemic H1N1 infl uenza outbreak.
Discussion
Because the database was designed primarily for improving 
practice effi  ciency, veterinary practitioner compliance and data 
quality were good. Reporting information back to practitioners 
can be valuable in assisting their decision making.The VPS for 
swine has the potential to generate useful information for sev-
eral purposes. It may be used to identify animal welfare issues 
and set baselines for welfare measurement. For international 
trade and food safety issues, this database may provide informa-
tion on the presence or absence of certain disease syndromes, 
detection of emerging health problems, setting of baselines 
for “normal” disease levels, recording the magnitude of health 
events and the strength of veterinary infrastructure. 
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A descriptive study of biosecurity measures in French farrow-to-ﬁ nish pig herds
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AFSSA-Site de Ploufragan, Ploufragan, France
Introduction
The term biosecurity in livestock production encompasses a 
broad spectrum of external and internal farm measures aim-
ing at protecting a herd from infectious agents (viral, bacter-
ial, fungal, parasitic…). Although the importance of eff ective 
biosecurity is underlined in numerous studies to reduce disease 
spread, few data on the implementation of such measures on 
pig farms are available [1]. The knowledge of currently biosecur-
ity precautions applied in farms might be helpful to determine 
to what extent appropriate measures are in place. This can in 
turn provide a baseline of information for veterinarians and 
producers to build herd health programmes in order to improve 
the degree of protection. The purpose of the study was to de-
scribe the situation vs some biosecurity measures in a sample of 
farrow-to-fi nish pig herds.
Materials and Methods
Data from 121 farrow-to-fi nish pig herds included in a survey 
designed to identify risk factors for respiratory diseases were 
used. Information related to the farm characteristics and the 
biosecurity measures were collected during a visit to each farm. 
In a fi rst step of the statistical analysis, an univariate analysis was 
performed. Secondly, for the variables with suffi  cient variability 
(category frequency>20%), a multiple-correspondence analy-
sis method followed by a cluster analysis was used to describe 
the relationships between the diff erent variables and to reveal 
groups of pig herds with similar biosecurity practices (SPAD 5.6, 
DECISIA Inc.).
Results
Three clusters of farms were constituted. The results of the clus-
ter analysis are presented Tables 1, 2 and 3. 
Table 1: Pattern of biosecurity practices of the herds belonging to 
cluster 1 
Tables 2 & 3.
Discussion
As incoming pigs constitute the main source of pathogens 
introduction into a herd, when dealing with biosecurity, the poli-
cies of replacement stock and quarantine management need to 
be considered. These factors were collected but were not taken 
into account in this fi rst approach. They will be added in further 
analysis. However, the results of the study indicate that the im-
portance given to the other aspects of biosecurity varies among 
farms, the larger herds paying the highest attention. Improve-
ments are specially needed in medium size herds to reduce the 
risk of disease introduction and spreading. Ribbens et al., [2] 
found that procedures for persons entering the herds are better 
applied in larger herds compared to smaller ones. In our study, 
the lack of control of fl ies is a main factor characterizing the 
groups. Since insects may be vectors of swine infectious agents 
like PRRS virus special attention must be placed to insect control 
in the diff erent rearing sections [3]. 
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Introduction
Biosecurity plays an important role in the pig production units 
because his close relationship with animal health, by ensur-
ing the pig products quality and improvement of production 
effi  ciency. It is important to know the level of biosecurity and 
technifi cation in pig producing areas to know the risk factors 
present that will lead to the presence of pathogens that cause 
disease and implement programs of biosecurity to control them 
(1); being the northwest of Mexico a high pig production area, 
we carried out an study to help understand the situation preva-
lent on biosecurity and use it as a guide to improve the health 
situation and pork production.
Materials and Methods
Forty-six farms were visited in the municipalities of Cajeme, 
Navojoa and Hermosillo (15, 14 and 17 respectively). Visual 
inspection and application of a questionnaire was carried out 
considering the basic points of biosecurity and technifi cation. 
Each question was designed with multiple-choice answers with 
value of 0, 5, 10, 15, 20 & 25 points each; questions closely re-
lated between biosecurity and technifi cations were considered 
for both variables (3). The values of each response on biosecur-
ity and technifi cation were summarized independently, getting 
a fi nal score for each variable in each farm. Statistical analysis 
in general and by municipality was carried out and Spearman 
correlation analysis was applied between Biosecurity (B) and 
Technifi cation (T).
Results
Farms with low-level of B and T, were not found so four types of 
farms are identifi ed: MT-MB, MT-HB, HT-MB, HT-HB (M = medium, 
H = high). The largest number of farms were found to be HT-HB 
(21). Navojoa has the highest percentage of farms with HB (64%) 
and HT (93%), Cajeme has the lowest HB (53 %) and Hermosillo 
in HT (53 %). The average Biosecurity in the study was 2481.71 
points (HB) and T values were 708.15 (HT), although by munici-
pality Cajeme has the lowest (2426.67) B points that placed it in 
a BM level, and Hermosillo has the highest B points (2554.41). A 
low correlation between B and T (r = 0.0567) was found indicat-
ing a relative correlation, but not signifi cant for being away from 
the confi dence level (P>0.05).
Discussion
High homogeneity was found in the pig farms from the north 
of Mexico, prevailing units with HT (2). Only four types of farms 
were found because that some state law sets that backyard pig 
units and all kinds of farms which do not meet the minimum 
standards of health (4) is prohibited. Correlation between B and 
T is very low so we can fi nd farms with equal level of technifi -
cation and biosecurity as farms with higher or lower level of 
biosecurity, in contrast with their level of technifi cation as found 
by Zamora (2006), although simple measures of biosecurity, can 
raise the level of this.
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Seasonal distribution and abundance of invertebrates captured on pig farms in England and Ireland
Steven McOrist; Ruth Blunt
University of Nottingham, Sutton Bonington, UK
Introduction
Insects on pig farms can cause loss in 4 ways. 
1. Biting fl ies such as Stomoxys stable fl ies and biting midges 
are known to be capable of causing direct losses due to le-
sions of direct damage and immuno-allergic reactions. These 
lesions cause specifi c losses due to trim loss and extra abat-
toir processing times, particularly in the summer months. 
2. Many common pests of stored products are found in on-site 
feed storage and feed mill areas on pig farms, such as in 
storage and hopper locations. Many insects are attracted to 
feed components and mixed feedstuff s stored on pig farms. 
These insects may cause direct losses by feed consumption 
but also reduced quality of feed.1 
3. High numbers of summer insects such as fl ies may ex-
acerbate minor wounds, disturb feed and rest periods and 
therefore compromise pig welfare. Very high levels of these 
pests may also disturb farm workers and nearby residential 
dwellings or businesses. 
4. Insects may spread disease within and between farms.2 This 
may include re-infection of eradication project farms by 
insects infected with the agent in question. 
Materials and Methods
15 representative pig farm study sites within England and Ire-
land were selected and studied in 2007 and 2008. Invertebrates 
were collected every 2 weeks at feed storage, breeder and wean-
er-fi nisher pig areas with aerial sticky traps, motorised vacuum 
devices, sweep nets and walk-in fl oor traps. Traps were placed 
in constant numbers and locations throughout farms to assist 
between-farm comparisons. Invertebrates were counted and 
sorted into genus and species groups by trained entomologists. 
The total DNA of insects and/or their intestines was extracted 
and tested for the presence of eubacterial DNA. 
Results
Comparison of the populations of invertebrates on each study 
site, via a dendrogram incorporating component similarity 
coeffi  cients indicated few major diff erences in the species 
evident at each site location across England. Despite the high 
levels of rainfall and lower than average temperatures in 2007 
and 2008, invertebrate group numbers peaked during the sum-
mer months. Of the Dipteroid fl ies, Musca domestica (house fl y, 
n=14 farms) was the most common, but also included Muscina 
stabulans (false stable fl y, n=9), Ophyra spp (garbage fl y, n=10), 
Drosophila (fruit fl ies, n=8), Stomoxys calcitrans (stable fl y, n=2) 
and Syrphidae containing Eristalis species (hover fl ies, n=2). 
The ground-dwelling beetles found were Carabidae (ground 
beetles), Curculionoidea (weevils), Staphylinoidea (rove beetles), 
Tenebrionoidea (darkling beetles) and Bruchidae (bean weevils). 
A wide variety of Lepidoptera (moths), Acari (mites), Araneae 
(spiders) and Isopoda (woodlice) species were also present. 
Other notable fi ndings included Blatta orientalis (oriental cock-
roach) on 2 farms. Other insect species found on only one or 2 
farms included Siphonaptera (fl eas) and parasitic wasps from a 
variety of families including Ichneumonidae and Chalcidae. PCR 
products typical of eubacterial DNA were confi rmed within the 
gastrointestinal tract of all fresh cockroaches tested and in over 
95 % of all fresh smaller whole insects tested. 
Discussion
A wide range of Dipteriod fl y, beetles, and cockroach activity 
was evident on many British and Irish pig farms, peaking in sum-
mer months as expected. Musca domestica was the most com-
mon dominant fl y type on the pig farms sampled. These often 
formed close associations with the farm pigs. We only found the 
garbage fl y Ophyra spp to be the dominant dipteroid fl y on one 
farm – these are considered competitive for Musca spp, in terms 
of fl y feeding ecology. We found Drosophila fruit fl ies to be the 
dominant fl y species on one farm, but these are not competi-
tive for other fl ies and are not closely associated with the pigs. 
A range of expected beetles and weevils associated with feed 
storage products were found. Cockroaches were noted on two 
farm – they form large indestructible communities on pig farms 
when they are introduced – usually via food waste or other 
waste products. Our trapping methods were not adequate for 
biting midge evaluations in this initial study. Our results indicat-
ed that Stomxys was a common but low-level presence on many 
farms. Some of these insects associated closely with pigs had the 
likely potential to carry and transmit bacterial and viral enteric 
pathogens, particularly fl ies and fl oor-dwelling insects such as 
cockroaches or Eristalis sp larvae. 
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UV254 inactivation of selected viral pathogens
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Introduction
UV254 has been a proven method of disinfection since the 
1930s (Wells and Brown, 1936). Since then, UV254 inactivation 
of airborne pathogens has been engineered into areas where 
people congregate, e.g., by placing UV254 light tube grids into 
existing ventilation ductwork (Walker and Ko, 2007). Data is 
available on the inactivation of several human viral pathogens, 
but little data is available on the UV254 inactivation of viral 
pathogens of animals.  
The goal of this research was to determine the UV254 dose 
required for inactivation of three common viral pathogens of 
animals:  swine infl uenza virus (SIV), porcine reproductive and 
respiratory syndrome virus (PRRSV) and bovine viral diarrhea 
virus (BVDV). Year One focused on UV254 inactivation of viruses 
under “static” conditions (virus in liquid medium) using off -the-
shelf UV hardware from commercial manufacturers (American 
Ultraviolet Co., Lebanon IN). Year Two (in progress) will focus on 
inactivation of airborne pathogens.
Materials and Methods
SIV, PRRSV, BVDV, and Reovirus suspended in media were 
exposed to specifi c doses of UV254 where dose is defi ned as 
(intensity x exposure time) and intensity is expressed as joules 
per cm2. Reovirus, highly resistant to UV254 inactivation, was 
included for the purpose of process control and comparison. 
The eff ect of UV254 exposure was quantifi ed by comparing 
virus titers in exposed vs. unexposed controls. Three trials were 
conducted at 9 exposure doses: 0.3000, 0.2500, 0.2000, 0.1500, 
0.1250, 0.1000, 0.075, 0.050, and 0.0250 J/cm2. Viruses (1.8 ml; 2 
mm depth) were placed in separate wells of modifi ed Nunclon® 
MultiDish™ 8-well plates (Nalge Nunc International, Rochester, 
NY). Plates were modifi ed by removal of two middle wells to 
accommodate the placement of a UV254 sensor (Technika, 
Phoenix, AZ). One well on each plate served as an unexposed 
control. Following UV254 exposure, the viral suspensions were 
placed in 2 ml cryovials and frozen at -80˚C until assayed for viral 
infectivity.  
Microtitration infectivity assays (TCID50) were conducted on 
samples in random order. The rate of inactivation was deter-
mined by plotting the survival fraction of each viral against the 
exposure dose.  
 
Results
Virus K Value 95% CI
Reovirus 0.0118 (0.0104, 0.0131)
BVDV 0.0401 (0.0322, 0.0480)
PRRSV 0.0371 (0.0360, 0.0483)
SIV 0.0298 (0.0204, 0.0371)
Discussion
Larger inactivation constants (K value) indicate greater suscept-
ibility to inactivation by UV254. Thus, in contrast to UV-resistant 
Reovirus (K value = 0.0118), PRRSV, BVDV and SIV were highly 
susceptible to inactivation by UV254. Year Two (in progress) will 
focus on inactivation of airborne pathogens using UV254. 
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Introduction
Compartmentalization based on biosecurity could be an import-
ant tool to manage disease within a region. The objectives of 
this study were to describe biosecurity groups and defi ne their 
distribution over two regions with diff erent pig-herd densities.
 
Materials and Methods
A high (HD: Estrie) and a low density (LD: Monteregie) areas 
were purposively targeted and all premises containing sows 
were included within these areas. A questionnaire was de-
veloped to assess the principal potential risks factors reported in 
literature for introduction of PRRS virus on a site or within a herd. 
The questionnaire was completed by the owner (independent 
farm) or by the employee (for farm under contract) and fi lled 
out by a single interviewer. Answers were obtained by phone 
and during a farm visit and included information on more than 
40 variables about herd characteristics, geographical coordin-
ates of the site and biosecurity requirements (layout of the site, 
entrance protocol, transportation of animals, dead pig disposal, 
pest management, feed and semen deliveries, manure manage-
ment). Biosecurity was described as measures implemented by 
producer to limit the introduction of diseases on the site and 
inside units. Diff erences between regions were assessed through 
Mantel-Haenszel chi-square, Fisher’s exact or Wilcoxon statistic 
as appropriate (p≤0.05). A two-step clustering procedure (SPSS) 
was performed to classify the farrowing sites in diff erent groups 
of biosecurity practices. Geographical distribution of sites 
belonging to the good biosecurity cluster was assessed in both 
regions using logistic generalized additive model and predicted 
values were plotted in commercial software (ArcGIS 9.3).
Results
Information was gathered on 71 and 54 sites in HD and LD, 
respectively. Classifi cation of the 125 sites was performed using 
22 variables pertaining to biosecurity and revealed two clusters: 
A (86 sites) and B (39 sites). Some biosecurity practices related 
to the entrance protocol are reported in Table 1 according to 
cluster and region. Signifi cant diff erences between HD and LD 
area were observed for the median sow inventory (180 vs. 235) 
and the median distance from the nearest site (400 vs. 2750 m). 
Sites belonging to cluster B had a higher proportion of good 
biosecurity practices and were more frequently located in the 
LD than in the HD area (62% vs. 38%). Heterogeneity of spatial 
distribution of sites in cluster B was observed, even in the LD 
area (Fig. 1).
Table 1: Biosecurity according to region and cluster (%)
Entrance protocol variables LD HD A B
No-entry sign on door 65* 39 35 84
Locked doors at any time 31 25 11 67
Doorbell at the entrance 37 31 16 72
Protocol (4 categories)
  0. Shower at the entrance 19* 3 0 31
  1. DE** + washing hands 2 4 0 10
  2. DE** 9 10 5 20
  3. Washing hands 7 6 3 13
  4. No protocol 63 77 92 26
24 hr downtime for visitors 59* 18 19 74
*Signifi cant diff erence between regions (p ≤0.05)
**Danish entrance: separated contaminated and clean area
Figure 1: Predicted probability of observing a site of cluster B in LD area.
Discussion and Conclusion
The higher frequency of good entrance protocol practices, the 
lower pig-site density and the longer distance from neighbours 
observed in LD may lower the risk of disease transmission com-
pared to HD. Based on entrance protocol and most other bios-
ecurity variables (not shown), sites in cluster B had overall higher 
standards than sites in cluster A. A knowledge of the distribution 
of sites with their respective level of biosecurity is important to 
implement regional control of diseases. 
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The use of an online scoring system for the quantiﬁ cation of the biosecurity status in pig herds
Maria Laanen; Stefaan Ribbens; Dominiek Maes; Jeroen Dewulf
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Introduction
In order to quantify the biosecurity situation on pig farms a 
biosecurity scoring system was developed by the Veterinary 
Epidemiology Unit of the faculty of Veterinary Medicine, Ghent 
University and incorporated in a free online application (www.
biocheck.ugent.be). 
Materials and Methods
The scoring system takes both external and internal biosecurity 
measures into account. Both parts are divided into 6 subcat-
egories each consisting of 2 to 13 questions. Each subcategory 
received a weight based on literature on pathogen transmission 
and general knowledge of infection risks. A score between 0 and 
100 is obtained for both external and internal biosecurity. The 
scoring system is adapted to be appropriate for every type of pig 
unit (fattening herd, breeding herd, mixed herd, etc). 
Results and Discussion
The scoring system has been available for pig farmers in Belgium 
for one year and 138 herds (i.e. 13 breeding herds, 6 fattening 
herds and 119 mixed herds) have fi lled in the questionnaire until 
January 2010. The average score for external biosecurity is 64 
(min 29; max 95). The score for internal biosecurity is lower in 
most farms (91%) with an average of 51 (min 18; max 89). There 
is a strong positive correlation (r=0.63) between the scores for 
external and internal biosecurity (see fi gure below). 
Figure 1 The correlation between the scores for external and internal 
biosecurity on Belgian pig farms.
Some selected results relating to external biosecurity show that 
81% of the herds purchasing new breeding animals use quar-
antine facilities for an average period of 36 days. 96% provides 
farm-specifi c clothing and footwear to visitors, but only 29% ask 
visitors to wash and disinfect their hands. Nevertheless, only in 
58% of the herds, the farmer and personnel also carry out these 
hygienic measures themselves before entering the stables.
Concerning internal biosecurity, only 38% of the farmers house 
diseased animals in separate hospital pens and 48% manipulates 
the diseased animals after the healthy ones. Suckling piglets are 
transferred between sows on 98% of the herds, of which 43% 
performs this operation after 4 days post partum. All-in all-out 
management is practiced in 82% of the herds in the nursery unit, 
70% of the herds in the fattening unit. Nevertheless, 21% puts 
smaller but older pigs together with the younger ones in the 
nursery and/or fattening unit. From all the herds, 62% cleans and 
disinfects every stable after a production round, but only very few 
(5) verifi es the effi  ciency of these measures. 54% always applies a 
sanitary stand empty period after each production round. 
The large variation in scores of diff erent farms shows that there 
is room for improvement in many participating herds. On 
average, the scores for external biosecurity, which are mainly 
measures related to infrastructure or measures imposable on 
other parties, are higher than the scores on internal biosecurity 
which are more related to the work and management strategies 
of the farmers themselves. As the results show, there are many 
biosecurity measures that have become common practice for 
farmers in Belgium; on the other hand, some eff ective biosecur-
ity measures should be more frequently practiced. It needs to be 
emphasized that these 138 farms voluntarily participated in this 
study and may therefore not be representative for all pig herds. 
Therefore it is likely that the general results are lower than the 
results presented here.
The biosecurity scoring system is used in another study (Laanen 
et al., 2010) to relate biosecurity in a quantitative way with 
health and production parameters.
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Preliminary results on the link between biosecurity status and herd 
characteristics, daily weight gain and mortality
Maria Laanen; Stefaan Ribbens; Dominiek Maes; Jeroen Dewulf
Faculty of Veterinary Medicine, Ghent University, Belgium, Merelbeke, Belgium
Introduction
It is believed biosecurity infl uences production results, never-
theless, few studies succeed in demonstrating this link. In order 
to quantify the biosecurity situation on pig farms a biosecurity 
scoring system was developed (Laanen et al., 2010). This scoring 
system was used to study the relation between the biosecurity on 
a farm and herd characteristics, daily weight gain and mortality. 
Materials and Methods
Thirty one randomly selected Belgian pig herds were visited. 
The herds had at least 80 sows and 500 fattening pigs. During a 
herd visit, the biosecurity status of the herd was quantifi ed by 
means of a biosecurity scoring system (Laanen et al., 2010). At 
the same time additional data concerning the herd and produc-
tion characteristics (number of sows, number of piglets, number 
of fattening pigs, age of the buildings, years of experience of the 
farmer, daily weight gain and mortality of fattening pigs) were 
collected.
Results
Herd characteristics:
A positive correlation was found between the number of sows 
on a herd and both the external (r = 0.43, p = 0.02) and internal 
(r = 0.34, p = 0.06) biosecurity. Also the number of piglets (< 
25kg) and the external biosecurity were positively correlated (r 
= 0.39, p = 0.03). The correlation with the internal biosecurity 
was only weakly positive (r = 0.19, p = 0.30). No correlation was 
found between the number of fattening pigs on a herd and the 
external or internal biosecurity.
Both the age of the buildings and the years of experience of the 
farmer were negatively correlated with the internal (r = -0.41, p 
= 0.02; r = -0.21, p = 0.27 respectively) and external (r = -0.14, p = 
0.46; r = -0.09, p = 0.64 respectively) biosecurity.
Performance of fattening pigs:
The daily weight gain of the fattening pigs was positively cor-
related with the external biosecurity (r = 0.28, p = 0.15), but no 
eff ect of the internal biosecurity (r = 0.03, p = 0.86) on the daily 
weight gain was found. No clear eff ects of the biosecurity status 
of the herd on the mortality of the fattening pigs were found.
Discussion
These results clearly indicate the existence of a positive correla-
tion between the number of sows or piglets on a herd and the 
level of biosecurity, indicating that farmers with larger herds pay 
more attention to biosecurity than those with smaller herds. The 
larger a herd becomes, it is more likely to be more professional 
and well managed. No comparable eff ect was seen for the num-
ber of fattening pigs on the herd. It should also be noticed that 
the found correlations are moderate to low.
It is also noticeable that the biosecurity increases with a decreas-
ing age of the buildings. This illustrates that in more modern 
infrastructure more attention is paid to biosecurity. The same 
holds for the years of experience of the farmer suggesting that 
younger farmers are more interested in, and willing to apply 
biosecurity measures. 
When evaluating the link with the daily weight gain of the 
fattening pigs it appears that this increases with an increasing 
external biosecurity, whereas for mortality no clear link could be 
identifi ed. This was also seen in a study by Maes et al. (2004). 
Several of the found correlations are not statistically signifi cant 
and therefore need to be interpreted with care. Yet in this study 
only the results of the fi rst 31 herds out of an ongoing study on 
100 herds are presented. Therefore it is believed that with in-
creasing sample size several of the observed trends will become 
statistically signifi cant. Moreover, the data will also be further 
explored to identify the parts of biosecurity that are the most 
infl uential on health and production parameters.
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Evaluation of mortality rate in fattening pig herds and respective correlation on biosecurity measures
Giuseppe Martano
ASl TO3, Vigone, Italy
Introduction
The aim of this study is to evaluate the mortality rate and cor-
relation with biosecurity level in 26 fi nishing pig herds and to 
obtain more knowledge about major risk factors.
Biosecurity is very important in the health management of 
intensive pig farms, to avoid introduction of pathogenic germs 
and to reduce microbial circulation in the herd.
Many swine herds could to improve their health standard 
through improved external and internal biosecurity measures.
Material and Methods
A survey was performed on 26 fattening pig herds located in Pin-
erolo District, Northwest Italy to describe their biosecurity status 
and mortality data, expressed as the number of dead pigs divided 
by the number of pigs placed in the growing-fi nishing unit .
The herds size ranged from 420 to 4050, for a total of 31,000 pigs.
All herds introduced pigs at age 70-90 days and the same were 
slaughtered not before 270 days old.
In order to collect data it has been used a questionnaire divided 
in diff erent sections regarding internal and external biosecurity, 
feeding and sanitary treatments .
It was collected data about mortality rate in the last four years ( 
from 2006 to 2009 ).
Results
Mortality rate has been evaluated for each farms.
The overall average mortality rate from 2006 to 2009 resulted 
4,41 per cent .
2006 2007 2008 2009 06-09
mortality rate 4,07% 4,77% 4,26% 4,55% 4,41%
standard deviation ±1,50% ±2,68 ±2,71% ±2,61 ±1,74
No statistical signifi cant diff erence from year to year for the 
totality of farms: nevertheless in some herds this index is very 
variable.
Mortality percentage in the single herds ranged from 1,28 % to 
9,12 %.
The standard deviation is high compared with the relative mor-
tality rate.
In this study, the season of the year had not a signifi cant impact 
on the mortality rate in fattening herds.
Many risk factors were investigated but the correlation was 
proved ( p<0,05) only between farms that introduced piglets 
from more than two origins herds and higher mortality rate. 
All in- all out is performed on 56 percent of the farm, in com-
bination with strict separation of age groups.
All farmers perform a cleaning and disinfection after every 
fi nishing cycle.
A specifi c compartment for housing diseased animal and quar-
antine is prescribed on 100 % of examined farms.
All farms have a refrigerated tank for removal dead pigs and the 
loading ramp is washed and disinfected every time is used and 
all of them have a rodent control program.
Discussion
Some potential risk factors were evaluated about high mortality 
percentage.
In this work we found farms that introduced piglets from more 
than two origin herds were associated with higher mortality. 
Also biosecurity level could infl uence the mortality.
Biosecurity on farm should be considered a dynamic process, 
which require recurrent improvements.
In this study, we found that some important strategic practices 
were not implemented in most of the pig herds.
In all farms the biosecurity level is susceptible of improvements.
Reduce mortality in the herds is a target to reach. 
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A study of cleaning methods on number of bacterial count on farrowing crates in pig farms
Pariwat Poolperm; Suwicha Kasemsuwan; Prapha Songjinda; Kanokkan Nunta; Peerakorn Jittrarak; 
Nisarat Iamnoi; Sakarin Praprut; Soraya Na-ranong
Kasetsart University, Nakornpathom, Thailand
Introduction
The important risk factor of infection for farrowing sows and pig-
lets is direct exposure to infectious microorganisms. The farrow-
ing crate fl oor is the main source of bacteria contamination and 
it is the fi rst surface piglets are directly exposed to after birth (1). 
Hence, the cleanliness of farrowing crate is vital to reduce the 
risk of MMA/PHS in farrowing sows and diarrhea in piglets. It is 
therefore of interest to assess the effi  cacy of cleaning methods 
that are using generally in pig farms in Thailand. 
The aim of this study was to evaluate the effi  cacy of diff erent 
cleaning methods on farrowing crates in pig farm considering 
the mean of total bacterial count (TC), coliform count (CF) and 
percentage of E. coli (EC) positive on the fl oor after cleaning.
Materials and Methods
A comparison of four diff erent cleaning methods; 1) using high 
pressure and washing with detergent (CT, n=4), 2) same as CT 
additional with pouring disinfectant one-time (T1, n=10), 3) 
same as CT additional with pouring disinfectant two-times (T2, 
n=10), and 4) same as CT additional with pouring disinfectant 
one-time and fl aming fl oor thoroughly (T3, n=10) were evaluat-
ed. The disinfectant (Beta-Q®) used in the study was glutaralde-
hyde base.
Five positions that towards each corner and one in the middle 
on the farrowing crate for each cleaning method were swabbed 
using wet and dry technique before cleaning (d-1), at 1-2 hours 
(d0), 1 (d1), 2 (d2) and 3 days (d3) after cleaning. Pooled samples 
for each crate were cultured onto PCA agar (Criterian®,Santa 
Maria, CA, USA) and coliform agar (Chromocult®, Merck KGaA, 
Darmstadt, Germany). Colonies of total bacteria and coliform 
were counted. E.coli was counted and reported as percentage of 
positive crate. Average of log10 bacterial counts of each clean-
ing methods were compared using repeated measure ANOVA.
Results
The results showed that total bacterial count (fi g.1) in CT group 
signifi cantly diff ered from T1, T2 and T3 (p=0.02). There were no 
signifi cant diff erences in the TC and CF among the T1, T2 and T3 
methods. Coliform was lowest on day 2 and increased signifi -
cantly on day 3 after cleaning, which was the same as % of E.coli 
positive crate that increased on day 3. The longer period after 
cleaning, the higher number of coliform and percentage of E. 
coli positive crate were found in this study. The percentage of E. 
coli positive samples in T1, T2, T3 and CT cleaning method were 
40%, 30%, 15% and 50%, respectively. T3 method showed the 
lowest percentage of E.coli.
Figure.1 Average of Log total bacterial count (CFU/cm3) in each round 
of sampling compared among 4 groups. 
Discussions 
This study demonstrated the benefi ts of cleaning practices with 
applying additional disinfectant and/ or fl aming step. Without 
disinfectant the fl oor was not effi  ciently clean using only high 
pressure and detergent washing. The proper cleaning method 
on farrowing crate could reduce bacterial contamination on the 
fl oor and reduce risk of sow being MMA/PHS during farrowing 
period. The longer period after cleaning was at risk of re-con-
tamination from moving sows in or out of the barn.
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Use of the AASV Production Animal Disease Risk Assessment Program to benchmark 
mortality disposal practices in United States swine production
Derald J. Holtkamp; Jamie Melody
Iowa State University, Ames, IA, USA
Introduction
Frequent transmission of PRRS virus from one premises to another 
has hampered control and elimination eff orts and suggests that 
current biosecurity practices are often ineff ective. Published infor-
mation on current biosecurity practices in the U.S. is limited. One 
of the few organizations which does publish such information is 
the USDA’s National Animal Health Monitoring System (NAHMS).1 
The most recent study published by NAHMS, the Swine 2006 
study, provided some information on biosecurity practices. 
Additional information would help producers and veterinarians 
benchmark biosecurity practices against others in the U.S. and 
help defi ne industry needs for biosecurity education. 
The purpose of this paper is to describe biosecurity practices 
related to mortality disposal in U.S. swine breeding herds using 
the database of assessments from the American Association 
of Swine Veterinarians (AASV) Production Animal Disease Risk 
Assessment Program (PADRAP). PADRAP is an epidemiologically-
based initiative to help producers and veterinarians manage dis-
ease risks. PADRAP is used by veterinarians as a tool to evaluate 
current biosecurity protocols and/or develop new biosecurity 
protocols to avoid risk. There are currently two risk assessments 
available within PADRAP; the PRRS Risk Assessment for the 
Breeding Herd and PRRS Risk Assessment for Growing Pig Herd.  
Methodology
The PRRS Risk Assessment for the Breeding Herd contains 
questions regarding introduction of a non-resident PRRS virus 
(external biosecurity) and management of a resident PRRS virus 
within a herd (internal biosecurity). Mortality disposal is one of 
14 categories of external biosecurity factors in the assessment. 
As of October 2009, the PRRS Risk Assessment for the Breed-
ing Herd (v2) database had 1749 risk assessments from 1017 
premises.  Of the 1017 premises, 68.0% are in the U.S., 18.3% in 
Canada, and 13.7% in Mexico. Only assessments on breeding 
herd premises in the U.S. completed between May 2005 and 
October 2009 were included in this analysis. 
Results
The 689 premises included in the analysis were completed 
for premises in 25 diff erent states and represent 1,567,889 
sows, which is approximately 26.8% of the national inventory 
(5,850,000)2. A majority (77.5%) of the premises are commercial 
breeding herds, including those with internal multiplication, 
and 22.5% are genetic breeding herds producing replacement 
animals for breeding purposes. Nineteen percent of the prem-
ises have fewer than 800 sows, 29% have 800 to 1999 sows, 31% 
have 2000 to 2999 sows, and 21% have greater than 3000 sows. 
Sixty percent of the premises are reported to be PRRS positive 
while 40% of the premises are PRRS negative.
Of the 689 premises in this analysis, 67.5% have on-site mortality 
disposal (i.e. buried, composted, or incinerated). On-site disposal 
is being used on 73.6% of the smallest breeding herds, with 
less than 800 sows, and less frequently (63.5%) on the largest 
herds, with more than 3000 sows. Premises that are PRRS nega-
tive utilize on-site mortality disposal (79.7%) of the time, more 
frequently than PRRS positive premises (59.3%). Of the premises 
with off -site mortality disposal the pick-up is usually located at 
the premises (73.2%) and 26.8% have a dedicated location for 
pick-up greater than 1⁄2 mile away. Sixty-three percent move 
dead pigs to another location for pick-up using equipment 
dedicated to the premises. Animals awaiting pick-up for off -site 
mortality disposal are usually stored in an enclosed box (77.2%) 
and of those, 20.2% are refrigerated boxes. 
Discussion
The authors are not aware of any studies that have shown that 
off -site disposal of mortality is associated with greater biosecur-
ity risks but rendering trucks picking up mortality for off -site 
disposal creates many opportunities for introduction of virus 
into a herd. If properly managed, on-site disposal by burial, 
incineration, or composting very likely creates fewer biosecurity 
risks. For the 32.5% of the premises in this analysis still using off -
site disposal there is an opportunity to improve their biosecurity 
by switching to on-site disposal. The opportunity is greatest 
for the largest herds where 36.5% of premises are using on-site 
disposal. Adoption of on-site disposal in large herds is compli-
cated by the larger volume of moralities making it increasingly 
more diffi  cult to manage. For those premises that cannot justify 
on-site disposal for management or economic reasons, there are 
still opportunities to reduce biosecurity risks by using enclosed, 
or in some areas refrigerated, boxes to store mortalities awaiting 
pickup. This study suggests that there are still signifi cant needs 
for educational eff orts that emphasize the importance of man-
aging biosecurity risks related to mortality disposal practices in 
U.S. swine production.
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Serology-based classiﬁ cation of pig herds into “zoonoses risk categories” 
and “herd health categories” by using meat juice as specimen
Diana Meemken; Juliane Nobmann; Thomas Blaha
Field Station for Epidemiology, University of Veterinary Medicine Hannover, Bakum, Germany
Introduction
The high number of foodborne diseases in humans such as 
salmonellosis and yersinioses, which leave no apparent or palp-
able alterations, proves that the traditional meat inspection as 
end product inspection is not able to control the risks of today 
(1). Therefore the European Commission has issued a new food 
safety legislation which regulates the transition of the traditional 
meat inspection, which demands inspecting each individual 
carcass in the same way, to a risk-based meat inspection, where 
the method and the intensity of the inspection are to depend 
on a risk assessment for human as well as for animal health. This 
risk assessment is based on the so called food chain informa-
tion which contains data such as the housing conditions, the 
use of antibiotics, the results of previous slaughter checks and 
the results of serological monitoring systems to detect zoonotic 
pathogens (2). The objective of this paper is to evaluate a set 
of serological tests, which provides a classifi cation of pig herds 
into “zoonoses risk categories” as demanded in the regulations 
and, into “herd health categories” by using meat juice. Collecting 
meat juice from carcasses at the slaughter line instead of taking 
blood serum from pigs in the barn by veterinarians implies an 
increased cost benefi t, especially by applying the once taken 
sample for various ELISA tests.
Material and Methods
To evaluate the general usability of meat juice as specimen for 
such ELISA tests, which are solely licensed for blood serum, 
several test runs with lower dilutions than prescribed for blood 
serum were conducted. Subsequently, a set of serological tests 
was selected, which provides results with relevance for human 
health (measuring antibodies of zoonotic pathogens) as well as 
for pig herd health (measuring antibodies of infectious patho-
gens for pigs). Altogether, blood sera and meat juices from 328 
pigs were collected at the slaughter line and tested with seven 
diff erent ELISA-tests, whereas meat juice was ten times fewer di-
luted than the prescribed dilution for blood serum, respectively. 
Results
The proportion of positive samples and the degree of correlation 
between the results with serum and meat juice as specimen are 
shown in Table 1.
Table 1: Correlation between ELISA test results with blood serum and 
meat juice of 328 slaughter pigs
Relevance 
for: ELISA-test for
Blood 
serum: 
Positive
Meat juice: 
Positive
Degree of 
Correlation
Human Health Salmonella spp. 17% (55) 14% (45) 94%
Human Health Yersinia enterocolitica 71% (233) 69% (227) 94%
Human Health Toxoplasma gondii 3% (9) 2% (5) 96%
Human Health Trichinella spiralis 0% (0) 0% (0) 100%
Herd Health Mycoplasma hyopneumoniae 57% (188) 50% (164) 86%
Herd Health Infl uenza A (H1N1) 31% (102) 17% (55) 84%
Herd Health Infl uenza A (H3N2) 14% (45) 8% (25) 85%
Discussion
The demonstrated high degree of correlation between the test 
results with sera and meat juice shows that it is possible to use 
meat juice for serologically evaluating the health status of a herd 
in the framework of the risk-based meat inspection. As for Yer-
sinia enterocolitica a serology-based classifi cation of pig herds 
may, despite the high seroprevalence of 70% become the start 
of a targeted search for risk factors. All in all, this ELISA-based 
approach with meat juice as specimen is feasible to detect herds 
with pig health and zoonotic problems. Targeted intervention 
measures can be established on the farms. The availability of 
standardised and validated herd health assessment tools is of 
an increasing importance, since there is a worldwide move from 
curing disease to prevention. 
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Presence of zoonotic interest bacteria in slaughter pigs
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Introduction
Animal slaughter is one of the professional activities with a 
higher degree of risk, with a very signifi cant role in the transmis-
sion of zoonotic diseases. Slaughterhouse operators, that are 
in direct contact with carcasses or viscera are the ones that are 
more at risk (1, 2, 3). Among the main bacterial zoonosis in swine 
are salmonellosis, brucellosis, yersiniosis and leptospirosis.
Material and Methods
Since the frequency of these organisms in swine in Mexico is not 
know, a pilot study with 20 samples was done to estimate infec-
tion frequency and based on this estimate the sample size (n) 
was established with the equation n=v2(p)(1-p)/T2.
The minimum sample size was estimated in 62 pigs, neverthe-
less it was increased to 100. 
The origin of the animals was the States of Jalisco, Guanajuato, 
Sonora and Michoacán. From each one of the slaughtered and 
apparently healthy animals samples were taken from blood, 
tonsils, ileum, kidney and spleen. 
Samples were individually deposited in sterile glass fl asks and 
plastic bags, properly identifi ed and preserved at refrigerator 
temperature (4oC). For brucellosis diagnosis, card test and 
bacteriology from spleen were performed. For leptospirosis a 
microscopy agglutination technique was used employing 13 
serovars of Leptospira interrogans and bacteriology from kidney. 
Bacteriology study was performed for Salmonella diagnosis 
using samples from ileum and tonsil samples were used for 
diagnosis of Yersinia enterocolitica.
Results and Discussion
Salmonella study results were negative for all animals. Five react-
ors were found for Brucella by serology (5%) but no isolation was 
achieved. Twenty-fi ve (25%) positive reactors to two serovars 
of Leptospira were found: L. bratislava 19 animals (19%) and L. 
panama 6 (6%) with no isolation of the bacteria. Twenty-two 
(22%) isolations of Yersinia enterocolitica biotype 1 serotypes 
0:3 and 0:9 were obtained; no crossed reaction was detected in 
the serology for brucella in the sera of the pigs where Yersinia 
enterocolitica was isolated. Positive animals came from the 
States of Jalisco and Guanajuato. It is concluded that of the four 
diseases that were studied, the one that had more relevance was 
Y. enterocolitica with 22% of isolations in slaughter swine that 
are apparently healthy. 
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Animal health and public health concerns of stakeholders in pig production
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Introduction
Animal health and public health are key issues in pig production 
for both economical and social reasons. Health management 
needs the implication of all stakeholders. The latter are more 
likely to feel involved if they are aware of the importance of the 
issues they have to control. 
The aim of this study was to determine through a survey which 
issues were regarded as matter of concern by agents involved in 
pig raising and health control in pig production.
Materials and Methods
The study took place between June and October 2009 in France. 
Seventy-three semi-structured interviews were carried out by 
a single investigator who met 45 veterinarians or scientists, 14 
farmers and 14 technicians. Veterinarians/scientists were se-
lected on a geographical basis (all over the north west of France, 
i.e. the main pig production area in the country). Some of them 
were asked to select one farmer and one technician they work 
with. During the interview, the agents were asked to identify 
what they consider as the main issues for animal health and 
public health in the pig production chain. They were addition-
ally demanded to explain why a given issue was regarded as a 
matter of concern.
Results
Seven items were the most frequently cited by agents. Diseases 
of pigs were the fi rst issue that they cited, among which the 
main items were PRRS, Porcine Circovirus Associated Diseases, 
colibacillosis (mainly oedema disease whose occurrence seems 
to be increasing), actinobacillosis and enzootic pneumonia. 
The matter of concern is the improvement of control measures. 
Salmonella is regarded as a public health concern in the control 
of which the all production chain should be involved. Many 
agents insist on the need to reduce the use of antimicrobials for 
both economical and social reasons. Infl uenza was categorised 
as a “mediatic” issue although agents notice that diagnostic tools 
and vaccines could be improved for this infection. Herd manage-
ment and biosecurity are cited as key tools for improvement of 
animal and public health.
Agents think that the pig production chain fails to communicate 
positively towards consumers.. Welfare regulations (especially 
sow group housing and piglet castration) are regarded as com-
plex to implement and likely to lower the economic sustainabil-
ity of the production chain. 
Table 1: Items most frequently cited and number of citations per 
category of agent
Vets (45) Technicians (14) Farmers (14)
Diseases of pigs 27 11 7
Salmonella 20 5 8
Use of anti-
microbials 28 9 6
Infl uenza 21 4 6
Management and 
biosecurity 12 6 5
Communication 19 9 10
Welfare 12 10 9
Discussion
We were interested in questioning agents involved in animal 
and public health management at several levels: advisors, 
supervisors or implementers i.e. vets, technicians and producers 
respectively.
Apart from pig diseases and their impact on animal health and 
welfare as well as on farm productivity, many stakeholders high-
lighted the lack of communication on animal and public health 
in the pig production chain. Consequently although stakehold-
ers feel more and more involved in the improvement of animal 
and public health, consumers seem not to be aware that these 
issues are taken into account. This point was raised as a specifi c 
item and was cited for Salmonella, use of antimicrobials, Infl u-
enza, welfare regulations.
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Use of antibiotics varies in Dutch pig nucleus herds 
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Introduction
Despite public opinion to minimize the use of antibiotics in 
food-producing animals, use of antibiotics in pigs, veal calves 
and poultry has been increasing during the last decennia (1). 
The aim of this study was to quantify the use of antibiotics in 
Dutch nucleus herds in 2007 and 2008. 
Materials and Methods
Thirty-seven nucleus farms of the Dutch breeding association 
TOPIGS were visited to collect data of the total quantity of 
antibiotics purchased in 2007 and 2008, and of the number of 
animals for each category (sows, weaned piglets, nursing piglets, 
gilts, fi nishing pigs). Additional data about management and 
medication regime were included in this survey. The quantity of 
antibiotics used was expressed in DD/ay (daily doses per animal 
year), which indicates with how many daily doses an ‘average’ 
animal of the farm is treated each year. The farms were divided 
into categories depending on health status: conventional (n=33) 
or SPF (n= 4). DD/ay was analysed using a linear mixed model (2) 
allowing for repeated measurements and random eff ects of farm 
(nested within health status). Eff ects of year, health status and 
farm size were included in the model. Data were not normally 
distributed and therefore log transformed.
Results
Average DD/ay did not diff er between 2007 and 2008. SPF farms 
have a lower mean DD/ay (2,21 ± 2,29) than conventional farms 
(14,04 ± 15,90) (r = 0,68, p<0.001). DD/ay was positively correl-
ated with the herd size (Figure 1).
Figure 1 Herd size in relation to DD/ay. The dashed line represents the 
regression line for data from 2007 (y = 0,0601x – 6,118 (R2 = 0,4422)), 
the solid line for the data from 2008 (y = 0,0512x – 5,8528 (R2 = 
0,5256)). White triangle = 2007, black dot = 2008
Discussion
There are huge diff erences in DD/ay between farms. These can 
partly be explained by health status and herd size. 
As expected, SPF farms have lower DD/ay compared to con-
ventional farms. This might be due to the absence of specifi c 
pathogens, and a strict hygiene. Strict hygiene itself may be a 
reason for lower prevalence of endemic infectious diseases, even 
in SPF herds. On conventional farms the diff erence in DD/ay be-
tween farms is striking. There is a more than 300-fold diff erence 
between the lowest and highest DD/ay.
The number of sows present on the farm is associated with the 
DD/ay. Data collected from individual farms showed that famers 
of large herds more often medicate pig groups routinely. Further 
analysis will be conducted to study the decision making with 
respect to group medication and its eff ect upon total DD/ay. 
The large diff erences between herds and the assumed large 
infl uence of group medication on the total DD/ay indicates that 
a strategy is feasible to minimize the use of antibiotics in the 
future. 
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Antibiotics in food-producing animals are often used to al-
low logistic effi  cacy in husbandry. This dictates a labor- saving 
strategy of group-medication to prevent disease. Risk upon 
infectious diseases, that are endemic, is managed by routine 
medication, and this preventive use of antibiotics has become 
a public health threat. The increase in prevalence of multi-re-
sistant bacteria in swine herds that may aff ect both animals and 
humans (1,2), urges to reduce the use of antibiotics. In contrast 
to the awareness of these risks the use of antibiotics in pigs, veal 
calves and poultry has been increasing during the last decennia 
(3). Therefore, a decision matrix was designed to get a transpar-
ent use of antibiotics in pig herds. 
By defi nition, bacteria are selected for resistance when ex-
posed to an antibiotic. Increase has been found in prevalence 
of animal-related Methicilline-Resistant Staphylococcus aureus 
(vMRSA) and Clostridium diffi  cile ribotype 078, that both have a 
resistant profi le that mimics antibiotics used in humans. 
Therefore, a convenant between the Royal Dutch Veterinary As-
sociation and the Ministry of Agriculture is signed in 2009, and 
aims to reduce the use of antibiotics in farm animals (5). Veter-
inarians have economic interest in selling antibiotics to farmers. 
Farmers have economic interest in preventive use of antibiotics 
as it can cover up shortcomings of their husbandry system. 
Ten TOPIGS nucleus herds were analyzed with respect to 
antibiotic use. Antibiotic use was expressed as DD/ay, which 
indicates with how many daily doses an ‘average’ animal of the 
farm is treated each year. The daily doses were calculated on 
label use of the antibiotics purchased at each farm. A huge varia-
tion was observed between herds: 0.7 -57 DD/ay. High antibiotic 
use was based upon preventive use in oral medications in 
feed or drinking water. Routine medication of weaned piglets 
strongly contributed to the excessive use. However, 4 out of 10 
of these nucleus herds had a DD/ay < 7. Use of cephalosporin or 
fl uoroquinolone, antibiotics that should be restricted to human 
use, was limited or absent in most of these herds. The observed 
variation in antibiotic use indicates that reduction in use is 
feasible. National and EU regulations with respect to antibiotic 
registration, hygiene conduct and animal welfare intend to limit 
antibiotic use and to optimize husbandry conditions.
A decision matrix for antibiotic prescription by veterinarians was 
designed, based upon national Dutch as well as EU regulations. 
Routine medications in feed or drinking water account for the 
major quantity of antibiotics used and routine medication is 
always preventive. National regulations, however, state that farm 
animals should be kept in an environment that does not harm 
their health. This legal obligation is used in the decision matrix 
as an incentive to improve animal husbandry conditions. Each 
preventive medication of pig groups is coupled with an assess-
ment of risk factors for infectious diseases present at the herd. 
Benchmarking of antibiotic use makes comparison of herds 
possible and transparent. Assessments with respect to working 
standards and education of farm workers are a consequence of 
use of the matrix, and essential to achieve reduction of antibiotic 
use. 
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Introduction
The use of antibiotics in food-producing animals has been 
increasing during the last decades in regions with intensive live 
stock production. The increase in prevalence of multi-resistant 
bacteria in swine herds that may aff ect both animals and hu-
mans, urges to reduce the use of antibiotics. In the Netherlands 
this has lead to an agreement between the most important 
players in the fi eld of live stock production. This will lead to a 
national registration of the use of antibiotics per farm expressed 
in the so called DD/ay (Daily Doses per animal year). These 
registrations will be followed by analyses and advises to come to 
a substantial reduction and a better awareness of proper use of 
antibiotics as a tool to treat diseased animals.
The extensive use of antibiotics can partly be explained by a 
number of factors among others:
• Use out of habit – “we have always done so”- often not realiz-
ing that the original cause of using the treatment has vanished 
already for a long time.
• Masking management failures. In using antibiotics often ne-
cessary changes in the farm and the management are delayed.
• Treatments have been shifted from curative to preventive 
where often such treatments are given without a real eff ect or 
even sometimes with negative side eff ects.
Registration of the use of antibiotics on farms
On 45 of the TOPIGS breeding farms in The Netherlands (almost 
50 % of the breeding stock) registration of the DD/ay has been 
done for the years 2007 and 2008. The same will be done for the 
year 2009. It is done in such a way that more extensive analyses 
per farm can be done:
• Registration per category of animals present (i.e. sows, suck-
ling and weaned piglets, rearing pigs and if present fi nishers).
• Registration of the administration route of the medication (i.e. 
in or over feed via drinking water in case of group medication, 
routine needle medication, individual treatments based on 
farm specifi c formularia).
• Registration of the used groups of type of medication.
Interventions and further actions
In close co-operation with farmers and their farm veterinar-
ians, a decision matrix will be implemented in order to omit all 
preventive treatments and mass medications and to exclusively 
use antibiotics for curative purposes that complies with Good 
Veterinary Practice. This will be achieved by:
• accurate instruction and training of herdsmen and farm work-
ers with respect to risks, precautions, side eff ects and adminis-
tration techniques. 
• the before mentioned intensive analysis, bench marking be-
tween the various breeding farms,
• a thorough analysis of the causes of disease problems that 
exist on the farm (with support of laboratory analyses),
• an intensive analysis of managerial improvement items. In this 
fi eld one can think of:
– internal bio-security improvements like age separation, 
prevention of mixing animals, working order, prevention of 
unnecessary contact structures, etc.
– changes in farm lay-out and housing aspects
• a critical evaluation and possibly adaptation of the vaccination 
program running on the farm
We realize that more factors will be taken into account in adapt-
ing the farms to a strategy that must lead to a change of mind in 
using antibiotics and preventive interventions by antibiotics will 
be avoided.
As a breeding company, being on top of the pyramid of produ-
cing meat for human consumption, we take our responsibility. 
We have to be ahead on the growing awareness in the Nether-
lands that social acceptance of meat production goes along with 
restricted use of antibiotics. 
Future developments
It will be clear that at this very moment of submitting the ab-
stract, implementing of the above described procedures is going 
on. In June 2010 new data of this project will be available and 
incorporated in our presentation at IPVS.
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Introduction
Staphylococcus aureus is a Gram-positive Bacterium, that occurs 
in man and practically all species of animals. Apart from clinic-
ally latent colonization of skin and mucous membranes, it is a 
potentially pathogenic bacterium, that causes a broad range of 
diseases. Methicillin resistant S. aureus (MRSA) isolates causes se-
vere nosocomial infections in humans.1 Recent studies demon-
strate, that MRSA has a very high prevalence in pigs.2,3 As so far 
no clinical disease can be linked to MRSA or methicillin sensible 
S. aureus (MSSA) in pigs, the pathological importance of the high 
prevalence of S. aureus in pigs is not clear. The aim of this study 
was to investigate the occurrence of MRSA and MSSA in lower 
respiratory tract of pigs.
Materials and Methods
230 BALF samples and nasal swabs were taken by the same 
veterinarian on 20 piglet producing farms and 6 connected fi n-
isher units. All samples were inoculated on Columbia blood agar 
plates, Columbia blood agar plates with CNA and a chromo-
genic selective agar for the isolation of MRSA (MRSA-Ident agar) 
(heipha Dr. Müller GmbH, Eppelheim, Germany) within 24 h 
after sampling. Plates were incubated at 37 °C. Bacterial growth 
was evaluated after 24 and 48 h of incubation. All suspicious 
Staphylococci were isolated. Biochemical identifi ed was done 
by the use of API ID 32 Staph (bioMérieux Deutschland GmbH, 
Nürtingen, Germany). S. aureus isolates were additionally identi-
fi ed by a S. aureus specifi c PCR and tested for the presence of 
the mecA gene.4 
Results
A total of 180 S. aureus were isolated in this study. The major-
ity of these isolates were MRSA (158 out of 180; 87,78%). MRSA 
could be isolated from 126 out of 230 nasal swabs (54.8%), 
whereas only 32 BALF samples from the same animals were 
positive for MRSA. A comparable number of both sample types 
were positive for MSSA: 12 (5.2%) of the nasal swabs and 10 (4.4 
%) of the BALF samples. Seven nasal swabs were positive for 
MRSA and MSSA (3.0%), but only in two BALF samples (0.9%) 
MRSA and MSSA were detected in parallel. One pig was positive 
for MRSA and MSSA in the nasal swab and the BALF sample. No 
S. aureus were detected in 99 nasal swabs (43.0%) and in 190 
(82.6%) of the BALF samples. In nasal swabs from 23 farms MRSA 
were detected (88.5%), whereas only 12 farms (46.1%) were 
positive for MRSA when examining the BALF samples. MSSA 
were detected in the nasal swabs from seven farms (26.5%) and 
in the BALF from fi ve farms (19.2%).
Discussion 
The majority of the S. aureus isolates found in this study were 
resistant to methicillin. Interestingly MRSA and MSSA were 
not present at the same ratio in nasal swabs (12.6 :1) and BALF 
(3.2:1) samples from the same animals. This indicates that MRSA 
colonizes preferably in the nasal cavity and has no tendency to 
colonize the lung alveola. Most of the nasal swabs, that were 
positive for MSSA in the nasal swab were also positive for MRSA 
(7 out of 12; 58.33%). This indicates, that antibiotic pressure is 
not the major cause for the high prevalence of MRSA in pigs. 
Although the prevalence of MRSA on pig farms and in pigs is 
very high, in this study 88.5 % and 54.8 % respectively, so far no 
clinical disease could be linked to MRSA in pigs. Further inves-
tigations will be necessary to understand the signifi cance of 
MRSA in pigs.
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Introduction
Since 2005 data on Methicillin-resistant Staphylococcus aureus 
(MRSA) isolated from farm animals have been published in vari-
ous countries (1,2,3). Most of these MRSA are of the spa-types 
which are associated with the Multilocus Sequence Type (MLST) 
ST398. This type was also found as nasal colonizer in farmers, 
veterinarians and slaughterhouse staff  (1,2). As in humans, the 
nasal colonization of MRSA in pigs is in most cases without clin-
ical symptoms. However, there are reports on MRSA as causative 
agent with clinical symptoms such as exudative dermatitis (4). 
Triggered by the fact that most researchers assume an emerging 
occurrence of MRSA ST398 since 2005 in farm animals, our study 
focuses on two questions: 
a)  Has MRSA ST398 only started to occur in pigs in 2005?
b)  Can MRSA be isolated from pathologically altered tissues in 
pigs?
This paper reports the results of reculturing S. aureus strains iso-
lated from infl ammatory lesions of pigs submitted for diagnostic 
purposes to the Field Station for Epidemiology of the University 
for Veterinary Medicine Hannover, Germany.
Material and Methods
In this study, 138 stored S. aureus isolates, collected between 
2004 and 2007 from various pathological lesions of pigs at 
necropsy, were recultured and potential MRSA were identifi ed 
by growth on selective chromogenic media. At the Federal 
Institute for Risk Assessment, Berlin, Germany, all presumptive 
MRSA isolates were analysed for confi rmation by a triplex PCR 
(5). Furthermore, spa-typing (6) of all confi rmed MRSA isolates 
was performed to determine whether the isolates belong to 
spa-types associated with the MLST-type ST398. Additionally, all 
138 cases were analysed whether S. aureus was found in pure or 
in mixed cultures. 
Results
Out of the 138 S. aureus strains, isolated from pathologically 
altered porcine tissues between 2004 and 2007, 60 isolates 
(43%) turned out to be MRSA (Tab. 1). The majority (57/60) of 
the MRSA-isolates found were spa-types associated with MRSA 
ST398. Three MRSA were ST97, a type that has not been de-
scribed as an MRSA in pigs before. The proportion of MRSA in 
the tissues are shown in Table 2.
Table 1: Annual distribution of MRSA among 138 S. aureus isolates 
and No. of MRSA pure in cultures
Year No. of S. aureus No. of MRSA No. of MRSA in pure cultures
2004 34 11 (32%) 4 (36%)
2004 30 15 (50%) 7 (47%)
2006 41 16 (39%) 6 (38%)
2007 33 18 (55%) 4 (22%)
Total 138 60 (43%) 21 (35%)
Table 2: The proportion of MRSA in diff erent tissues and the No. of 
MRSA in pure cultures
Tissue No. of S. aureus No. of MRSA No. of MRSA in pure cultures
Skin 49 23 (47%) 5 (22%)
Joint 25 12 (48%) 10 (83%)
CNS 24 8 (33%) 2 (25%)
Lung 15 8 (53%) 0 (0%)
Abscess 7 1 (14%) 1 (100%)
Pericardium 4 2 (50%) 1 (50%)
Others 14 6 (43%) 2 (33%)
Total 138 60 (43%) 21 (35%)
Discussion
Since MRSA ST398 isolates were found in similar frequency in all 
four years, we assume that MRSA in pigs may have occurred ear-
lier than 2004 and might be not really emerging, but rather have 
been overlooked until recently. Furthermore, MRSA ST398 is not 
only a nasal colonizer, but needs to be discussed as contributor 
(or even cause) of various lesions in pigs.
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Introduction
Resistant pathogens, especially coagulase-positive staphylo-
cocci are a major challenge in both human- and veterinary medi-
cine. The importance of MRSA in swine production for human 
medicine has grown in the last years (1,2). The aim of this study 
was to estimate the prevalence of MRSA in German pig farms 
in the Dutch-German border region (Euregio) of Lower Saxony, 
Germany.
Materials and Methods
From May to Oct. 2009 54 pig farms were tested for the presence 
of MRSA. Five barn dust samples or ten nasal swabs were taken 
per farm. After 24-h enrichment culture in selective broth, all cul-
tures were streaked onto Columbia-blood agar and a chromo-
genic medium for the detection of MRSA (bioMérieux, Marcy 
l’Etoile, France). Methicillin-resistance was tested by cefoxitin 
disc agar diff usion and was confi rmed by mecA-specifi c PCR (5) 
and all MRSA isolates were typed by S. aureus protein A (spa) 
sequence-based typing (6).
Results
31 farm were positive (57,4 %). Among these, 26 farms were 
detected positive by barn dust, 5 by nasal swabs. 22,2% of the 
barn dust samples were positive and 43,6% of the nasal swabs 
were positive. The geographic distribution of MRSA positive and 
negative farms is shown in Fig. 1.
Fig. 1: Location of the sampled and positive pig farms
Up to now spa-typing result of 25 farms are available (Table 1)
Table 1: Results of the spa-typing
Spa-type No. of farms In combination with
t011 15 1 x t108
t034 7
t108 1 1 x t011
t1451 2 1 x t3992
t2576 1
t3992 1 1 x t1451
Discussion 
Up to now no correlation between diff erent farms or types 
of farms could be found. Breeding herds as well as fattening 
farms had positive results. Also new built farms and high health 
herds were positive. No regional accumulation in relation to pig 
density could be found. Our fi ndings, including the spa-typing 
results, correspond well, to data of other authors (2,3,4).
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Introduction
Recently, Methicillin-resistant Staphylococcus aureus (MRSA) 
have emerged in pigs in most European countries (1,3). Pigs 
colonized with MRSA are found on 70% of pig farms in North 
Rhine-Westphalia, Germany (2). However, the dynamics of col-
onization among the animals is unclear and strategies for avoid-
ing the spread of MRSA between pig holdings are lacking.
We raised the question when gilts from a nucleus herd docu-
mented to be specifi cally “free” of MRSA get colonized, if they are 
introduced into MRSA positive farms.
Methods
Within the framework of the Euregio project SafeGuard VetMed-
net we identifi ed 2 MRSA free nucleus farms. We chose 3 farms 
on which MRSA had been detected before in animals or the 
environment and one farm which was free of MRSA when tested 
consecutively by pooled samples (n=5). One nucleus herd was 
build up PaR, PRRS and M.hyo. free after repop/depop in 2007. 
Since this time the farm is also free of MRSA. We analysed the 
colonization status of MRSA free gilts introduced into breeding 
herds known to harbour MRSA colonized pigs and herds which 
were tested negative for MRSA.
A total of 65 gilts tested negative for MRSA colonization, were 
introduced into three MRSA positive and one MRSA negative pig 
holdings. Immediately after the introduction of the gilts into the 
new herds, nasal swabs were derived from all 65 gilts. During 
a ten-week-period, swabs were taken 7 times with a sampling 
interval of 1-3 weeks. MRSA diagnostic was performed using 
a double enrichment in selective broth (Phenol Red Mannitol 
Broth with 5 mg/L ceftizoxime, 75 mg/L aztreonam) and plat-
ing on a chromogenic medium (Brilliance MRSA, Oxoid, Wesel, 
Germany). MRSA was confi rmed using coagulase tube test and 
mecA-PCR All MRSA isolates were typed using the Staphylococ-
cus aureus protein A (spa) approach (4).
Results
All gilts tested negative for MRSA colonization in the nucleus 
farms and introduced into the breeding herd in which MRSA had 
not been detected before, remained negative.
MRSA negative gilts introduced into MRSA positive herds, the 
gilts remained MRSA free again into the isolation pens. But 
immediately after introducing the gilts into the sows of the 
breeding stock, MRSA was detected. In the fi rst week an overall 
colonization rate of 61% was observed, followed by 49% after 2 
weeks, and 73% after 3 weeks, respectively.
Although colonization rate was fl uctuant, overall 88% of all 
MRSA negative gilts introduced into positive MRSA holdings 
were found to acquire MRSA at least intermittently. Clinical 
symptoms were not seen in any sow. Characterization of spa 
types identifi ed MRSA t011, t034 and t5838.
Discussion
We found that there are still MRSA negative pig production 
chains. Introduction of MRSA free gilts in positive herds led to 
frequent, but fl uctuating colonization of the individual gilts. 
Therefore, it is unclear to what extent the colonization is transi-
ent or persistent. Since there was no clear diff erence in the use 
of antimicrobials between the MRSA negative and positive 
farms, preventive eff orts will have to be set up for cleaning and 
disinfection schemes. 
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Introduction
The occurrence of one special clonal line of Methicillin-resistant 
S. aureus (MRSA) in farm animals, the so called livestock-associ-
ated MRSA ST398, is reported in several countries such as The 
Netherlands (1), Canada (2) and Germany (3). However, there are 
only few data illustrating the in-herd patterns of colonisation 
during the pigs’ lifetime. Our study presents information about 
the colonisation dynamics of MRSA in pigs from birth to the end 
of the nursery in two German pig herds.
Material and Methods
Data collection took place between November 2008 and May 
2009 on two independent pig farms in the Northwest of Ger-
many. Farm A is a two-site production system with 80 sows and 
farm B is a farrow-to-fi nish herd with 170 sows. On farm A, 58 
piglets (two piglets each from 29 sows) and on farm B 40 piglets 
(two piglets each from 20 sows) were earmarked and tested 
repeatedly at a three week interval for MRSA by pharyngeal 
or nasal swab from birth until the end of nursery. Additionally, 
nasal swabs were taken from the 29 sows in herd A and from the 
20 sows in herd B to learn more about the transmission of MRSA 
between the sow and its off spring.
Results
The proportion of MRSA-positive animals diff ered between the 
two farms remarkably (Tab. 1, Tab. 2).
Tab. 1: Microbiological results of nasal swabs of 29 sows and 58 piglets 
(two piglets each per sow) in farm A
MRSA-
positive
MSSA-
positive
MRSA- and 
MSSA-positive
S. aureus-
negative
sows (peripartal) 52% 7% 10% 31%
piglets (day 1-3) 16% 17% 0% 67%
piglets (day 21) 48% 26% 0% 26%
piglets (day 42) 19% 33% 7% 41%
piglets (day 63) 20% 33% 31% 16%
Tab. 2: Microbiological results of nasal swabs of 20 sows and 40 piglets 
(two piglets each per sow) in farm B
MRSA-
positive
MSSA-
positive
MRSA- and 
MSSA-positive
S. aureus-
negative
sows (peripartal) 0% 0% 0% 100%
piglets (day 1-3) 0% 10% 0% 90%
piglets (day 21) 7% 13% 0% 80%
piglets (day 42) 25% 3% 0% 72%
piglets (day 63) 8% 60% 0% 32%
While on farm A MRSA was detected in sows and piglets at the 
fi rst sampling date, positive results on farm B in piglets did not 
occur before three weeks of life. However, fi ndings of Methicillin-
sensitive S. aureus (MSSA) in combination with Methicillin-
resistant S. aureus at the same time are possible and can occur 
in quite high proportions as ascertained on farm A. Although S. 
aureus belongs to the normal porcine skin fl ora, an absence of 
S. aureus in the nasal cavity of sows and piglets is detectable in 
both farms, especially in farm B.
Discussion
The colonisation dynamics of MRSA and MSSA varies remark-
ably between farms. The MRSA colonisation status of pigs can 
change during the animals’ lifetime. The MRSA-status of the sow 
has a strong impact on the MRSA-status of the newborn piglet, 
and a weaker impact on the colonisation at later points in time 
during the animals’ lifetime. Futhermore, our results support the 
assumption that an early colonisation with MSSA might have a 
protective eff ect due to a phenomenon similar to a competitive 
exclusion between MSSA and MRSA. To be free from S. aureus 
early in life seems to lead to more MRSA fi ndings at older ages. 
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a leading 
cause of hospital-associated infections, and has emerged as a 
signifi cant pathogen in the community. In the last decade, com-
munity-acquired MRSA (CA-MRSA) clones have been increas-
ingly detected in companion animals and livestock. Recently, 
isolates belonging to MRSA Clonal Complex (CC) 398 have 
emerged in pig farming and it is now prevalent in farm animals 
in some countries of Central and Northern Europe (de Neeling et 
al., 2007). MRSA CC398 has also emerged as a cause of coloniza-
tion and infection in humans and it is responsible for >20% of 
all human MRSA in the Netherlands. The aim of the study was to 
estimate the herd prevalence of MRSA in fi nishing pig holdings 
in Italy, to provide phenotypic and molecular characterization of 
isolates for epidemiological purposes, and to gather information 
about their relationships and their possible origin. 
Materials and Methods
Herds were selected by a random sampling procedure (20% exp. 
prev.; 95% CL; 7.5% accuracy) from the national registry of hold-
ings rearing pigs for slaughter, at the base of the pig production 
pyramid. For among-herd prevalence estimates, 118 holdings 
from 29 provinces and 10 diff erent regions (Northern, Central 
and Southern, accounting for >90% of the Italian pig popula-
tion) were enrolled for the survey. Sixty nasal swabs per holding 
were sampled at slaughter, they were pooled (10 per pool) and 
cultured through a multiple step procedure (pre-enrichment, 
selective enrichment and selective plating).
Results
A total of 45 out of 118 (38.1%, 95% CI 29.4%-46.9%) holdings 
were positive for MRSA. Nearly 50% (22/45) of positive hold-
ings had only one positive pool. Eleven diff erent spa-types were 
detected, three of which never described before (t4794, t4795, 
t4838), and belonging to fi ve diff erent MLST profi les, ST398, ST1, 
ST9, ST97, ST1476. 7.6% of holdings had their animals positive 
for 2, 3 or 4 unrelated spa-types belonging to ST1, ST97, ST1476 
or ST398 in diff erent combinations. Twenty-eight percent of 
holdings were positive for pig-associated ST398 lineage and 
5.9% were positive for human-associated MRSA (t127, ST1 
SCCmec Type V). Fourteen holdings were positive for other 
lineages, one for ST9 (t4794), three for t4795, ST97 and ten for 
t1730. The most prevalent spa-type was t899, ST398, detected in 
22/45 (49%) positive holdings, with an overall holding preva-
lence of 18.6%. Cattle- and human-associated CCs (CC97 and 
CC1) were found in 40% of positive holdings. The most frequent 
SCCmec ccr and mec combination was Type V, detected in 77% 
of isolates. All isolates were resistant to tetracyclines, and high 
resistance rates to trimethoprim, erythromycin and ciprofl oxacin 
were detected. A pattern of tetracycline-erythromycin-ciprofl ox-
acin resistance was a common feature among ST1 and ST(CC)97 
lineages.
Discussion
This is the fi rst description of: MRSA among pig population 
in Italy; three novel spa-types (t4794, ST9; t4795, ST97; t4838, 
ST398); MRSA of ST1 ST1476 and ST97 lineages among pigs, and 
the fi rst report of MRSA ST9 in Europe. Spa type t899, ST398, was 
the most prevalent spa-type, although it had been considered a 
rare type in pigs until recent description in the Netherlands (van 
Duijkeren et al. 2008). The presence of unrelated spa-types with-
in the same holdings (up to four spa-types), either belonging 
to ST398, CC97 or to ST1, suggests subsequent introduction of 
new strains over time as the most common pattern of coloniza-
tion and diff usion among animals and holdings. This population 
study shows that pigs may be a possible reservoir for MRSA of 
the cattle-associated CC97 lineages, and for the human-associat-
ed ST1 (found in 6% of Italian holdings), and a source of expos-
ure for the community from a zoonotic pathogen that may need 
little or no adaptation to humans. The antimicrobial resistance 
profi les suggest that beside the use of beta-lactams, the amount 
and pattern of usage of other drugs should be investigated as 
a further important predictor in the spread of MRSA within and 
among Italian pig holdings.
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Introduction
In recent years a distinction was made between community 
acquired [1] and animal associated MRSA (methicillin-resistant 
Staphylococcus aureus), that are also spread in pig production 
[2]. However, the knowledge on occurrence and transmission are 
still scarce.
From 2009 to 2011 a nationwide joint research project on MRSA 
in livestock production in Germany is currently funded by the 
Federal Ministry of Food, Agriculture and Consumer Protection. 
This paper gives preliminary results on the incidence of MRSA in 
animal house air and in exhaust air from pig barns.
Materials and Methods
Sampled fl ocks
A representative number of pig barns of diff erent sizes and man-
agement schemes were investigated. MRSA positive and –nega-
tive barns were selected by initial screening of dust samples. 
Most barns were investigated once,some were chosen for long-
term studies and will be continuously observed for one year. 
Sampling methods
Environmental samples such as air samples, sock swabs, pooled 
samples from dust, faces and feed were collected. In addi-
tion swab samples of nose and skin of 60 pigs were taken in 
each barn. Air samples were collected in 1.50 m height above 
ground fl oor at three diff erent locations in the animal house. For 
sampling All-Glas-Impingers (AGI-30) and IOM samplers (poly-
carbonate fi lter) were used simultaneously. 
In barns chosen for the long-term-studies air samples of the ex-
haust air as well as sock swab samples from the ground outside 
the barn were taken. Air and sock swab samples were taken in 
diff erent distances from the barn (100 m Luv, as well as 50 m, 
150 m and 300 m Lee, respectively).
Laboratory methods
All samples were analysed qualitatively for MRSA. Additionally, 
quantitative analyses of the nose swabs and all air samples were 
performed. Swab samples of nose and skin were investigated 
individually and pooled. 
Selective agar (CHROMagar) in combination with a triplex-PCR is 
used for the identifi cation of MRSA. 
Results
Until now, MRSA was found in dust samples in 51.2 % of 43 initial 
investigated fl ocks.
92.5 % of the individual investigated nasal swabs of all observed 
fl ocks (n = 132) were MRSA positive, with a mean bacteria count 
of 860 Cfu per swab. However 99.3 % of the pooled samples of 
nasal swabs (n = 132), yield positive results. Concerning the skin 
swabs 88 % of individual analyzed samples (n = 132) and 99.3 % 
of pooled samples (n = 132) were MRSA positive. 
MRSA could be found in at least one of three air samples of 
every stable. In general, MRSA could be found in 78 % of the im-
pinger and 47 % of the fi lter samples from stable air. The mean 
counts of MRSA were about 435 Cfu / m3 for impinger and 452 
Cfu / m3 for fi lter samples.
MRSA was detected in each dust sample with a mean count of 
7.6 x 104 / g. 64 % of fecal samples and 55 % of the feed samples 
were tested positive for MRSA.
All samples taken of the exhaust air were MRSA negative. How-
ever, in sock swab samples outside the barn the detection of 
MRSA was regularly possible.
Discussion 
The present data show that a high rate of contamination of 
MRSA in pig barns exists.
Detection of MRSA in the air was possible in each investigated 
barn. Impingement turned out to be more effi  cient to detect 
MRSA than fi ltration. In the environment around the barn no 
MRSA could be detected in air samples, however most sock 
swab samples were positive. It seems that MRSA are emitted 
from the investigated barns by way of the air and deposited in 
the environment, however the currently used techniques were 
unable to sample MRSA directly from the air. 
The project continues and future investigations will also include 
techniques such as typing of MRSA strains which will lead to 
more information. 
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Introduction
For several years, MRSA are well known for nosocomial infec-
tions in hospitals and nursing homes. MRSA can cause wound 
infections, post operative complications or severe general illness 
including death. So far, only a few cases of livestock associated 
MRSA transmission to humans has been reported (1,2). The 
present study is an epidemiological risk assessment of current 
MRSA prevalence in Bavarian swine farms, swine producers and 
their extended family.
Material and Methods
Animals of Bavarian swine farms, the farm owners and their fam-
ilies were examined for MRSA prevalence. For this purpose, 634 
nasal swabs from pigs of 60 farms with diff erent swine produc-
tion systems as well as nasal swabs from 116 individuals from 57 
of these farms were bacteriologically examined. All Staphylococ-
cus aureus isolates were subjected to real time PCR for detecting 
the mecA-gene and orfX-gene, identifying methicillin-resistance 
and confi rming the species Staphylococcus aureus (3). Strains 
which were identifi ed by PCR were later characterized using 
spa-typing (4). A total of 63 strains were subjected to MLST 
(multilocus sequence typing). Furthermore, the presence of the 
Panton-Valentine leucocidin-gene (PVL) as a virulence factor for 
community-aquired MRSA was also examined. 
Results 
In the present study the MRSA herd prevalence of bavarian 
farms was 45.0% (see tab.1)
Table 1: Prevalence of MRSA positive farms and animals in current 
production systems in Bavaria
production system total number of MRSA prevalence of
farms animals farms animals
nursery 25 285 28.0% 28.8%
fattening 19 188 63.2% 41.0%
multi-site 16 161 50.0% 32.3%
total 60 634 45.0% 33.3%
Similar results were also reported by Khanna et al. (2008) after 
investigating farms in Canada (5). According to production 
systems 28.0% of the nursery farms, 50.0% of the multi-site 
farms and 63.2% of the fattening farms were MRSA positive and 
prevalence of nursery and fattening farms diff ered signifi cantly 
(P=0.006). The MRSA prevalence among all animals was 33.3% 
but diff ered considerably between production systems (nursery 
28.8%, fattening 41.0%, multi-site 32.3%).
The MRSA prevalence of the examined individuals was overall 
29.3% (see tab.2). The prevalence of the owners from multi-site 
farms was 50.0% and for the nursery and fattening farm owners 
26.9% and 21.4% respectively. 
Table 2: Prevalence of MRSA positive persons in current production 
systems in Bavaria
production system total number MRSA prevalence
nursery 52 26.9%
fattening 42 21.4%
multi-site 22 50.0%
total 116 29.3%
According to spa-typing of the isolated MRSA in pigs, spa-type 
t011 and spa-type t034 were identifi ed in 86.7% and 10.0% of 
the samples respectively. Similarly, spa-type t011 (88.2%) and 
spa-type t034 (9.0%) were predominantly isolated from farmers. 
62 of 63 strains belonged to MLST-type ST398. The Panton-Val-
entine leucocidin-gene was not identifi ed in any of the isolates. 
None of the examined animals and persons except for one 
person with folliculitis showed clinical symptoms indicative of 
MRSA related diseases.
Conclusion
The prevalence of 45.0% in bavarian pig farms and 33.3% in pigs 
shows the widespread and the frequent occurrence of MRSA. 
Due to the examination of the owners, this study confi rms that 
a MRSA transfer between pigs and humans within the produc-
tion chain is not a rare occurence. The spa-types t011 and t034 
dominate in swine population as well as among farm owners. 
However, in comparison to hospital-acquired and community-
acquired MRSA, low virulence is assumed due to the absence of 
the Panton-Valentine leucocidin-gene. But indiviuals should still 
consider undergoing a pre-operative MRSA screening before 
planning an operation to prevent MRSA introduction into hos-
pitals and to minimize the risk of falling ill to a MRSA infection 
themselves while in hospital.
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Introduction
Staphylococcus aureus including Meticillin-resistant S. aureus 
(MRSA) is frequently present on the skin, in the nose or in the 
mouth of human hosts without causing illness (Peacock et al., 
2001). However, in some instances, S. aureus can cause disease 
when it enters wounds or damaged skin leading eventually to 
abscesses, pneumonia, meningitis, endocarditis and septicaemia 
preferably in immune suppressed patients. Recently a specifi c 
clone (CC398) was identifi ed in nearly all production animals, 
particularly in pigs, across Europe and world wide that colonises 
also farmers and veterinarians, and concerns rise that it may 
enter hospitals and the food chain (EFSA, 2008). Clear abate-
ment strategies are not yet in place in animal production. This 
paper will describe control options on farms suitable to avoid or 
reduce transmission of these micro-organisms.
Short characterization of S. aureus 
Staphylococcus is a genus of Gram-positive bacteria that are 
coccoid (spherical) and approximately 1 micrometer in diameter, 
have thick peptidoglycan cell walls, have a low G + C content, 
and grow in clusters similar to grapes (staphyl = grape). They are 
commensals colonising as normal bacterial fl ora nose, throat, 
auxilla, rectum, perineum and gastrointestinal tract of mammals, 
but can also survive in a variety of environments and survive 
vastly desiccation. There are over 30 species of staphylococci, 
the most pathogenic species for humans is S. aureus. Infections, 
carriage or colonisation and contamination have to be carefully 
distinguished (EFSA, 2008).
Transmission routes
S. aureus is transmitted from human to human, animals to hu-
man and vice versa and through other viable or inanimate vec-
tors (Roberson, 1999) such as fl ies or ticks (Förster et al., 2007). 
Mechanical transmission occurs by means of body parts without 
a multiplication of the infectious agent (Last, 2000). Inanimate 
vectors could be medical devices, contaminated material or 
objects, food, milk and dust (Youngster et al., 2008). 
The transmission routes of methicillin-resistant S. aureus (MRSA) 
are probably similar to those of methicillin-sensitive S. aureus 
(MSSA) (Kawada et al., 2003) but there may be diff erences in the 
effi  ciency of host colonization due to genetic diversity. Examples 
of vector related transmission of MRSA strains will be given.
Prevention measures
In spite of the presently still limited understanding of the trans-
mission routes it is even more important to apply and constantly 
improve bio-security measures in order to avoid spread of MRSA. 
Such general measures on farm level can help to reduce the 
entrance and the spread of infectious agents in general both 
within and between herds (Hartung, 2005) and can be described 
as follows:
• Restriction of traffi  c of cars and trucks and people transporting 
in and bringing out animals, feed stuff , equipment, slurry or 
manure. 
• Avoid direct contact with animals. Provide protective clothing, 
gloves and breathing masks. 
• New animals have to undergo veterinary inspection, testing 
and a quarantine time before entering the herd. 
• Store fallen animals in separate and safe containers until 
removed as soon as possible by specialised companies. 
• Reduce contact with rodents, insects and wild birds on the 
premises in order to avoid transfer of infectious agents and 
MRSA from farm to farm and between herds in a farm. Prevent 
pets of the farm to have access to the pigs.
• Check regularly the health status of personnel with regard to 
MRSA and other zoonotic diseases.
• Apply continuously strict cleaning and disinfecting regimes to 
all pig houses on the farm. 
• In order to avoid airborne transmission of MRSA new farm 
buildings should be placed in suffi  cient distance to the next 
farm or residential dwelling (“safe distances”). 
• Air cleaners could be applied such as biofi lters or bioscrubbers 
(VDI) guidelines) to reduce or to eliminate bacterial emissions 
from farms (Seedorf and Hartung, 1999). However, experiences 
with these techniques are still underway for MRSA control. 
There is an urgent need for more research to better understand 
the transmission pathways and hence be able to develop pre-
vention and control strategies.
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Use of serological monitoring to detect infection with Salmonella spp. in fl atdeck piglets in Germany
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Introduction
Salmonella infections are still one of the most important food-
born diseases in humans. Pig meat is one of the sources for 
salmonella infections in humans. In many European countries 
programs are established to monitor and reduce infections with 
salmonella in pig herds. So far these programs focus on slaugh-
ter pigs.1 In this study pigs about 10 weeks of age were exam-
ined, to get more information about the status of Salmonella 
infections in the production system prior to the fattening units.
Materials and Methods
The blood samples were tested for the presence of antibodies 
against Salmonella spp. using a commercial ELISA kit (HerdChek 
Swine Salmonella, IDEXX). The ELISA was performed according 
to the manufactures manual. In brief a 1:20 dilution of the serum 
sample with sample diluent was incubated at room temperature 
(18 – 25 °C) for 30 min in the antigen coated wells. After washing 
away of unbound material by three washing steps, 100 μl of anti-
porcine horseradish peroxidase conjugate were added to each 
well. After a second incubation for 30 min at room temperature 
and additional three washing steps, 100 μl TMB were added to 
each well. Colour development was terminated by the addition 
of 100 μl stop solution to each well after 15 min incubation. The 
absorbance at 620 nm was measured for each well. Results were 
calculated as OD% in relation to the positive control samples on 
each plate. Interpretation of results war according to the manual 
and the German registration of the kit by the FLI (Zul. Nr.- BGVV-
B305). Samples with OD% value less than 10 % were considered 
negative. Samples with OD% values equal to or greater than 
10% were considered positive. 
Results
A total of 4269 samples were taken from piglets end of fl at-
deck (about 10 weeks of age). The samples originate from 427 
German pig farms. Antibodies against Salmonella spp. were de-
tected in 317 blood samples (7.43%). The positive blood samples 
originate from 118 farms (27.63% of the tested farms). Within 
the positive farms 26.86 % of the samples (317 out of 1180) were 
positive. In 44 farms (37,3% of positive farms) only low positive 
results (OD% 10%-20%) were detected. High positive samples 
(OD% > 40%) were found in 42 farms (35.59 % of positive farms; 
9.84 of all tested farms).
Discussion
The ELISA kit used in this survey allows to detect antibodies to a 
broad range of Salmonella serogroups indicating the exposure of 
a swine herd to the bacterium.2 The reliability and comparability 
of this ELISA has been verifi ed in an international ring test.3
The data presented in this study demonstrate the presence 
of antibodies specifi c to Salmonella spp. in German piglets at 
10 weeks of age. About 30% of the herds tested were positive 
for antibodies against Salmonella spp. at 10 weeks of age. This 
indicates that infection with Salmonella spp. does not only 
occur in slaughter pigs, but also earlier in production. So piglets 
should be considered as potential source of Salmonella intake 
in fi nisher units. However this result cannot be compared to the 
results from monitoring of slaughter pigs, which aim to categor-
ize the health status of the herds. In this study the diagnostic cut 
off  value of the ELISA was used to demonstrate exposure of the 
pigs to Salmonella spp. early in the production chain. 
It can be concluded from this study, that control of Salmonella 
infection in pigs needs highly sensitive diagnostic tools and has 
to cover the complete production chain from piglets to slaugh-
ter pigs. Serological examination provides a powerful tool to 
monitor infections with Salmonella, when the diagnostic cut-off  
value of the ELISA (≥ 10 OD%) is used. Serological monitoring of 
herds using diagnostic cut-off  values will not only raise aware-
ness of infections with Salmonella spp. in pigs, but also provide a 
basis for eff ective disease control. 
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Antimicrobial resistance related to class 1 integrons in porcine 
Salmonella enterica serotype Typhimurium isolates
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Introduction
Salmonella enterica serotype Typhimurium is one of the leading 
causes of food-borne disease in developed countries. Multidrug 
resistance is generally linked to the presence of integrons and is 
often related to antibiotic use in food animals. In this work, we 
investigated the frequency, features and molecular epidemiol-
ogy of class 1 integron-carrying porcine S. Typhimurium isolates.
Materials and Methods
A total of 128 S. Typhimurium isolates was collected from pigs 
and ducks during 2006-2007 in South Korea. Seventeen anti-
microbial resistances were determined by disk diff usion method. 
The isolates were screened for the presence of class 1 integrons 
by polymerase chain reaction (PCR) amplifi cation using specifi c 
primers aimed to detect the int1 gene. The number of integrons 
and the size of their variable region (VR) were analysed by PCR 
employing the 5’CS and 3’CS set of primers. Genotyping and 
phage typing of 19 typical class 1 integron-carrying isolates 
were performed by Pulsed fi eld gel electrophoresis(PFGE) and 
phage typing.
Results
The highest rate of resistance was tetracycline (77.3%), fol-
lowed by streptomycin (77.3%), nalidixic acid (76.6%), ampicil-
lin (50.8%) and sulfamethoxazole/trimethoprim (46.9%). A low 
frequency of resistance was found towards cefazolin (4.7%) 
and cefoxitin whereas all isolates were susceptible to amikacin, 
ceftaxidime, ciprofl oxacin and colistin. Only two diff erent VR 
and two diff erent integron profi les were identifi ed among the 
19 strains(14.5%) exhibiting class 1 integrons. Gene cassettes 
encoding resistance to streptomycin (3 isolates, aadA1), and 
trimethoprim (16 isolates, dhfr12) were observed. The PFGE 
patterns of 19 isolates revealed three diff erent genotypes and 
irrespective of their integron profi le and phage type.
Figure 1. Antimicrobial resistance rate of S. Thyphinmurium isolates
Figure 2. PFGE patterns of class 1 integron contained S. Typhimurium 
isolates
Conclusions
The results show a high percentage of resistance for some 
antimcrobials and the presence of integrons in strains of S. 
Typhimurium isolated from pigs. The prevalence of multidrug 
resistance in porcine S. Typhimurium isolates is associated with 
the presence of class 1 integrons, particularly with the integron 
containing aadA1 and dhfr12 VR, and is attributable to the 
spread of a clone.
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Introduction
Salmonella spp. is one of the most important foodborne 
pathogens and the causative agent of salmonellosis in humans 
and animals. Most serotypes can cause gastroenteritis when 
ingested by eating contaminated foods. Currently, much atten-
tion has been focused to improved food safety in Vietnam where 
most retail meats is sourced directly from abattoirs with no 
refrigeration, ie the kill during the night and the meat is sold the 
following morning. Here, we investigated standards of food hy-
giene in raw meat products as a fi rst step, and based on results, 
we will investigate hygienic levels of backyard marketplaces and 
identify epidemiological factors of foodborne salmonellosis due 
to ingestion of contaminated meat products. The objectives of 
the present study were therefore to determine the rate of con-
tamination and some characteristics of Salmonella spp. isolated 
from retail raw meat samples in Hanoi. 
Materials and Methods
Samples (n=100) of retail raw meat (beef, pork and chicken) 
were collected directly from open markets and supermarkets 
in Hanoi. The procedures for sample preparations, isolation and 
identifi cation of Salmonella spp. were based on the FDA method 
with some modifi cations according to Department of Applied 
Veterinary Science and Public Health, Obihiro University of 
Agriculture and Veterinary Medicine, Japan. PCR tests for rapid 
screening were performed to amplify DNAs coding for some 
virulence factors including enterotoxin gene (stn), invasion gene 
(invA) and 16S and 23S spacer region of ribosomal RNA (rRNA) of 
S. Typhimurium DT104 (104SR) according to Kishima et al. (2008)
Results
Table 1: Prevalence of Salmonella spp. in meat samples
Origin of samples
Type of samples Open markets Supermarkets Total
No. of pos 
samples %
No. of pos. 
sample %
No. of pos. 
samples %
Beef (n=50) 4/41 9.8 2/9 2.2 6/50 12.0
Pork (n=25) 11/20 55.0 3/5 60.0 14/25 56.0
Chicken (n=25) 6/17 35.3 1/8 12.5 7/25 28.0
Total 21/78 26.9 6/22 27.3 27/100 27.0
Table 2: Prevalence of selected virulence genes among Salmonella 
isolates selected by PCR
The presence of gene
Type of samples stn invA 104SR
No. of pos. 
samples %
No. of pos. 
samples %
No. of pos. 
samples %
Beef (n=6) 6 100.0 5 83.3 2 33.3
Pork (n=14) 14 100.0 10 71.4 0 0
Chicken (n=7) 7 100.0 4 57.1 0 0
Total 27 100.0 19 70.4 2 7.1
Table 3: Distribution of serovars among Salmonella isolates
Type of samples
No. Serovar Beef Pork Chicken Total (n=27) (%)
1 S. Derby 2 2 1 5 (18.5)
2 S. Newport 2 2 (7.4)
3 S. Rissen 1 2 3 (11.1)
4 S. Typhimurium 1 2 1 5 (18.5)
5 S. Paratyphi B 1 1 (3.7)
6 S. Anatum 3 1 4 (14.8)
7 S. Bargny 1 2 3 (11.1)
8 Untypeable 3* 2** 5 (18.5)
*: O4:- (1 isolate); O8: g:- (1 isolate); and O7, 8:- (1 isolate), **: O8: g:- (2 isolates)
Discussion
The present study demonstrated that meats commonly retailed 
in marketplaces in Hanoi were heavily contaminated with Sal-
monella spp., of which these bacteria were isolated signifi cantly 
more often pork (56%) than from chicken (28%) and beef (12%) 
(P<0.05). All isolates (100%) carry stn gene and only 2/27 isolates 
(7.4%) harbour 104SR gene. The number of isolates which were 
positive for invA gene varied among type of samples, in which 
57.1% isolates from chicken, 71.4% from pork and 83.3% from 
beef possessed this gene, though these diff erences are not 
signifi cant (P=0.58>0.05). Seven serovars were isolated from 
samples that were generic potential hazards in meat hygiene. 
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Adding of Novobiocin in non-selective pre-enrichment step provide a more suitable starting 
material for real-time-ttr-PCR assay for the detection of Salmonella enterica spp
Talal S. Salih
University of Mosul, Mosul, Iraq
Since the production of meat and meat product based foods 
are multistage processes, the need for on farm food safety risk 
assessment and quality assurance has greatly increased. Thus, 
for food safety, the availability of reliable, rapid sensitive and ac-
curate accepted test protocol to detect of Salmonella in exam-
ines samples became increasingly important for the agricultural 
and food industry, as well as the legislative quality control and 
public. 
In this work, 4 Salmonella specifi c isolation protocols: real-time 
ttr-PCR, ISO 6579:2002, MSRV and FD CEN/TR 15215-3 were 
evaluated for their abilities to detect the presence or absence of 
Salmonella in 275 naturally contaminated animal feed, feces and 
environmental samples that were collected monthly from two 
pig farms around the city of Stuttgart, Germany. The main aim 
was to investigate the eff ect of addition of 40 mg/l Novobiocin 
(NOV) to non-selective buff ered peptone water (BPW) for pre-
enrichment of Salmonella in combination with selective enrich-
ment in Rappaport-Vassiliadis soy broth (RVS). 
The result showed that all of the 7 samples that were Salmon-
ella-positive by conventional methods were also Salmonella-
positive by the ttr-PCR-RVS-NOV method, which also detected 
19 additional Salmonella-positive samples. Comparison with the 
conventional culture methods, the new ttr-PCR-RVS-NOV proto-
col has a sensitivity of 100% and no Salmonella false-negative 
was observed moreover, the McNemar test has showed a signifi -
cant diff erent . Thus, this method might be used as a meaningful 
tool in monitoring Salmonella-positive samples at farm level 
and thus, keeping them out of the food chain.The McNemar test 
did not show any signifi cant diff erent among the conventional 
culture methods, also it was no signifi cant diff erent and diff erent 
agreement values (kappa test) within the samples tested. 
Overall, the MSRV method proved to be the most reliable and 
sensitive method for detecting Salmonella in fecal samples. It 
detected 2 (50%) of the positive samples, whereas one (25%) 
detected by the both ISO 6579:2002 theFD CEN/TR. The addi-
tion of Novobiocin in FD CEN/TR method to BPW gave small but 
signifi cant increase in the total number of Salmonella isolates 
from environmental samples. In conclusion, the high sensitivity 
and the more Salmonella detected in this study maybe caused 
by the inhibitory infl uence of Novobiocin on a number of com-
petitive microorganisims in the samples leading to a higher ratio 
of Salmonella/non-Salmonella, which is likely to provide a more 
suitable starting material for real-time-ttr-PCR assay. 
Public health – Salmonella
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 962
Poster Presentations
P.656
Eﬀ ect of K-diformate in fattening diets on Salmonella carriage in high prevalence pig herds
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Introduction
The control of Salmonella carriage by pigs is one strategy for 
reducing the contamination of pig carcasses at slaughter. 
Several risk factors of high prevalence herds, mainly related to 
biosecurity and management have been identifi ed. The addition 
of acids or acid salts in water or feed also appears as a protective 
factor (5). A study was conducted in farms with high prevalence, 
to assess the infl uence of the inclusion of an organic acid salt in 
fattening feeds on the carriage of Salmonella at the slaughter-
houses.
Materials and Methods
Five farms with high Salmonella prevalence in fatteners were 
selected to evaluate the infl uence of 0.6% K- diformate (Formi 
®) addition in growing-fi nishing pelleted feeds. The Salmonella 
antibodies were analyzed with the IDEXX serological test on 50 
meat juice samples collected from pigs at slaughterhouse dur-
ing 9 months. An optical density reading of 40% or above was 
classifi ed as positive.
Then, the prevalence of three successive batches of pigs fed with 
the acidifi ed diet during fattening was calculated on 20 samples 
per batch. After that, the incorporation of K- diformate was 
stopped and the contamination of 2 new batches was evaluated, 
respectively 5 and 7 months after stopping. A monitoring was 
carried out on farms in order to take into account any change 
of health status, management or housing practices during the 
treatments.
Results and Discussion
Three patterns of the evolution of the Salmonella prevalence 
were obtained (Figure 1).
In the 1rst pattern (herd A): prevalence signifi cantly decreased 
during treatment, but increased after cessation and reached a 
level which was identical to the original one. The survey revealed 
no change in management that could explain these variations.
In the 2nd profi le (herds B and C): prevalence signifi cantly de-
creased during treatment but did not increase after cessation of 
treatment. Two assumptions are made:
1)  The acidifi cation limits the shedding and transmission of 
salmonellae during treatment but also after stopping the 
treatment.
2)  The status improvement may be independent of treatment. 
Indeed, the Salmonella infection in some farms may vary sig-
nifi cantly from one period to another, without any evidence 
of housing or management changes explaining these varia-
tions (1).
In the 3rd pattern (herds D and E), the prevalence was not modi-
fi ed during the treatment. It remained unchanged after the 
treatment for herd D, whereas it signifi cantly decreased after 
cessation of the treatment for farm E.
Figure 1: Evolution of Salmonella contamination
The addition of 0.6% K- diformate to the feed during the fatten-
ing period results, in some farms, in a reduction in Salmonella 
carriage during treatment, and sometimes in a reduced infection 
after the treatment. In other farms, we do not measure any eff ect 
on incidence. These facts confi rm previous studies: Papenbrok 
et al. (3) reported that the inclusion of 1.2% K- diformate in feed 
can reduce the faecal excretion ratio and shedding duration 
of infected piglets. However, other trials show that acidifying 
drinking water or feed has inconsistent eff ects (4) or sometimes 
no benefi cial eff ect (2). This study nevertheless illustrates the 
need for an integrated strategy in which acidifi cation should be 
included.
References
1.  Corrégé I. et al., 2006. Proc. 19th IPVS, 38, 379-386.
2.  Letellier A. et al., 2000. Can. J. Vet. Res., 64, 27-31.
3.  Papenbrock S. et al., 2004. Proc. 18th IPVS, 654.
4.  Van der Wolf P.J. et al., 2001. Vet. Quaterly, 23, 121-125.
5.  Wingstrand A. et al., 1997. Proc. 3rd Int. Symp. Epidem. Control 
Salmonella in pork, Copenhagen, 170-172.
.
Public health – Salmonella
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 963
Poster Presentations
P.657
Detection and characterization of Salmonella in lairage, intestines and on pig carcasses 
in ﬁ ve slaughterhouses using serotyping and macrorestriction genotyping
Emily V. De Busser; Dominiek Maes; Jeroen Dewulf; Kurt Houf; Lieven De Zutter
Faculty of Veterinary Medicine, Ghent, Merelbeke, Belgium
Introduction
In 2008, 3944 Salmonella infections in humans had been 
registered in Belgium, of which Salmonella Typhimurium (57%) 
was the most common serotype (1). As the consumption of 
pork meat is a major source for human infection, more insight 
is needed into the epidemiology and spread of this bacterium 
throughout the production chain. 
The aims of this study were to investigate the prevalence of Sal-
monella contamination along the slaughter line and to identify 
possible critical control points by performing serotyping and 
macrorestriction genotyping of the isolates. 
Materials and Methods
Five Belgian slaughterhouses (slaughter rate of 170-580 pigs/
hour) were visited twice. Faecal samples from pigs of diff er-
ent batches were taken at the lairage area using overshoes. At 
exsanguination, 30 pigs were individually identifi ed (total: 30 
pigs * 5 slaughterhouses * 2 = 300 pigs) and swab samples of 
the oral cavity were taken. These 30 pigs were further inves-
tigated at the slaughter line. Carcass swabs were taken after 
polishing, after splitting and after fi rst chill as well as content 
of duodenum, ileum and rectum and mesenteric lymph nodes 
of the corresponding pigs. All the samples were submitted to 
Salmonella isolation using standard procedures (ISO 6579:2002 
FDAM1). Prior to serotyping according to the Kaufmann-White 
scheme, isolates were clustered by the enterobacterial repetitive 
intergenic consensus PCR. Characterization at strain level was 
performed by pulsed-fi eld gel electrophoresis with the restric-
tion endonucleases XbaI (and BlnI for the serotype Rissen).
Results
In total, 276 samples (14.4%) were Salmonella positive, with 
48.2% of the pigs positive in at least one sample. The lairage area 
was highly contaminated, with a large variation (0-100% posi-
tive) among the slaughterhouses. In total, 13 diff erent serotypes 
were identifi ed with diff erences in occurrence between slaugh-
terhouses and slaughterhouse visits. Salmonella Typhimurium 
(58.7%) and Salmonella Rissen (17.4%) were the most common 
serotypes. The largest variation in serotypes was noticed in 
lymph nodes, rectum and ileum content. Genotyping of the 273 
isolates revealed 46 diff erent strains of which 32 for Salmonella 
Typhimurium, 4 for Salmonella Derby and 2 for Salmonella 
Rissen (by using BlnI). The same genotypes could be detected 
in the lairage as well as in the oral cavity (94.7%), in the lairage 
and in the gut content (65.5%), in the lairage and on the carcass 
(57.9%), but never in the lairage and the lymph nodes of animals 
held in these pens. In 82.7% the same genotype was found in 
the lymph nodes and gut contents of the same animal, whereas 
the same genotype was only found in 30% of the diff erent 
carcass samples (the other 70% harbored diff erent serotypes). 
In 55.5% the same genotype was found in the gut content and 
on the carcass. In 47.6% the same genotype was detected in the 
oral cavity as on the carcass. In 44.4% the same genotype was 
identifi ed in the lymph nodes as on the carcass.
Discussion and conclusions
Salmonella was commonly present in the lairage area, in 
the pigs’ intestines and on the carcasses along the slaughter 
line. No positive overshoe samples could be detected in one 
slaughterhouse where the lairage area consisted of a slatted 
fl oor allowing a minimum of contact with the feces. The results 
showed that the same pig could harbor diff erent serotypes and 
amongst the same serotype diff erent genotypes in the lymph 
nodes and gut content. Furthermore the study shows that pigs 
do take up Salmonella in the lairage area, where Salmonella. 
was already present in the environment or shed by pen-mates. 
There was however no association between the genotypes 
found in the lymph nodes and in the lairage. On the other hand 
more than the half of the genotypes found on the carcass were 
also detected in the gut content and in the lairage area. A good 
fasting procedure, prevention of accidental cutting of intestines 
and improved cleaning and disinfection of the lairage area are 
important factors to prevent contamination. As in 30% of the dif-
ferent carcass samples, the same genotype was detected, cross 
contamination and contamination out of the slaughterhouse 
environment does occur and are of major importance to reduce 
the Salmonella level of the end product.
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Serologic monitoring of salmonella in pigs of diﬀ erent productive systems from Argentina
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Introduction
The annual increase of human salmonelosis cases related to the 
consumption of pork has led countries worldwide to implement 
control programs of Salmonella spp in pork production (Hugas, 
2007). The Danish surveillance program for Salmonella in pigs 
uses a serologic monitoring system with classifi cation of herds 
in 3 levels: level 1, of low seroprevalence (index<40%), level2, 
moderate (40%≤index≤70%), and 3, high (index>70%), using 
an ELISA evaluated at a cut-off  20% Optical Density (OD) (Alban, 
2002). In Argentina offi  cial data about levels of Salmonella infec-
tion in herds do not exist. 
Due to its importance, this work tries to evaluate the sanitary 
situation of herds in the zone of greater pig production in 
Argentina, through serologic monitoring to diff erent ages, in 
diff erent production systems.
Materials and Methods
This work was carried out in 5 provinces of Argentina. Nineteen 
farrow-to-fi nish pig herds with indoor production systems (SC) 
(X¯=810 sows) and 11 with outdoors systems (SAL) (X¯=266 
sows) were selected. All herds were bred on an intensive basis, 
with weaning between 21 and 23 days of life, and averages of 
22.44 fi nished pigs/sow/year in SC and 18.05 pigs/sow/year in 
SAL. From each farm, samples were taken randomly to pigs of 8, 
15 and 21 weeks of life. A number of samples was taken neces-
sary to detect the presence of antibodies against Salmonella 
spp, with 40% of waited prevalence, 95% of Confi dence and 
5% of error. 40% represents the minimum prevalence to detect 
levels 2 and 3 of the Danish system (Alban, 2002). 
The serums were analysed using an ELISA Herdchek Swine Sal-
monella (IDEXX), for detection of antibodies against LPS antigen 
(serogrupos B, C1 and D) of Salmonella spp, measuring values at 
650 nm of absorbption. The results were evaluated at 3 cut-off  
values, namely 10, 20 and 40%OD. 
Results
A total of 504 serums were analyzed. The results of positive 
farms are shown in table 1.
Table1: Percentage of farms with positive pigs to ELISA for each sys-
tem, according to age and cut-off  value. 
System 8 weeks 15 weeks 21 weeks
10% OD 20% OD 40% OD 10% OD 20% OD 40% OD 10% OD 20% OD 40% OD
SAL 45% 18% 9% 100% 45% 27% 100% 91% 73%
SC 26.3% 5% 5% 47.3% 31.5% 15.7% 89.4% 68.4% 31.5%
The number of positive pigs by production systems is shown in 
graphic 1.
Graphic 1: Average positive pigs to ELISA using a cut-off  value of 
20%OD, with EE, according to age and production system.
According to Danish classifi cation system, 27% of SAL were level 
1; 18% level 2 and 55% level 3. As to SC, 53% were level 1; 16% 
level 2 and 32% level 3. 
Discussion 
Considering a cut-off  value of 20%DO, 68.4% of herds SC (13) 
and 91% of herds SAL (10) had positive pigs to Salmonella spp 
at 21 weeks of life. This seems to indicate an wide distribution of 
Salmonella in herds of the country. In addition, 40% (12), of the 
total herds were classifi ed as level 3 (high risk). 
Analyzing the number of positive pigs by herd (non published 
data), there were no signifi cant diff erences between systems at 
8 and 16 weeks of life. Nevertheless, at 21 weeks of life there was 
a greater number of positive pigs in SAL than in SC (p<0.05). As 
Baptista indicates (2009), this could be due to the presence of 
serotypes of Salmonella enterica of greater virulence in these 
systems or to a major number of re infections in SAL. The high 
intra-premises infection levels indicate the necessity to imple-
ment control strategies against Salmonella spp in herds from 
Argentina. Nevertheless, more accurate future works will be 
necessary to determine the serotypes circulating in the country 
and the risk factors involved in the dynamics of infection within 
each system. 
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Detection of salmonella in ﬁ nishing pigs on farms in the central zone of Yucatan, Mexico
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Introduction
The pig industry is aff ected by diseases caused by bacteria, virus, 
parasites and rickettsias. Among the organisms that cause those 
diseases are the bacteria of the genus Salmonella. Salmonella 
spp also aff ect the Public Health. In order to design programs 
for the control of this pathology, it is necessary to know the pres-
ence, distribution, and serotypes .The objectives of this study 
were: 1) to detect the presence of Salmonella spp in fattening 
pigs; 2) to identify the most frequent serotypes; 3) to determine 
the pattern of resistance to antibiotics. 
Materials and Methods
A cross-sectional epidemiological study was carried out on 
fi ve pig farms. The farms were located at the central region of 
Yucatan, Mexico. The sample size to detect the presence of 
Salmonella spp was calculated considering 5% prevalence and 
95% confi dence level. Feces (1 g/animal) were collected directly 
for the animal rectum. The samples were analized at FMVZ-UADY 
using the technique described by Rappapor-Vasiliadis cited by 
Fedorka et al. (1). The serotyping was carried out at the National 
Institute for Diagnosis and Epidemiological of Mexico.The 
antibiogram was conducted at the FMVZ-UADY.
Results
Sixty percent of the farms in this study result positive (fi g. 1). The 
week of higher risk to detect Salmonella spp was eighteen (fi g 2).
Fig1. Distribution of positive animals to Salmonella spp. on fi ve farms, 
in Yucatan, Mexico
Fig 2. Distribution of positive animals to Salmonella spp according to 
the age in Yucatan, Mexico 
The serotypes most frequent were S. Havana, S.Give y S. Typhy-
murium. These serotypes showed a diff erent resistant pattern. 
Only the Amikacin, showed effi  cacy against the isolates sero-
types (Table1).
Table 1. Antibiogram for diff erent serotypes of Salmonella spp
S . Havana
n=1
S. Give
n=1
S. Typhymurium
n=1
S. Typhymurium
n=2
ANTIBIOTIC Concentration 16 weeks age 18 weeks age 16 weeks age 18 weeks age
Estreptomicin 10 mcg I R R S
Amikacin 30 mcg S S S S
Sulfi sozasol 0.25 mcg R R R I
Ceftriaxone 30 mcg S I R S
Gentamicine 10 mcg S R S S
Ciprofl oxacine 5 mcg R S S S
I= Intermediate; S= Sensible; R= Resistant
Discussion
The farms that result positive in this study are indicating that the 
prevalence of Salmonella spp is 20% or higher. Those that result 
negative are indicating that, if Salmonella spp, is present, the 
prevalence will be below of 20%. Also the serotype S. Thyphy-
murium has been reported previously en this region (2).On 
the other hand it is the fi rst time that S. give and S. Havana are 
reported in this area. These have been reported in other areas 
and speciecs (3)(4). Finally, it can observe the high percent of re-
sistant of serotypes to varies antibiotics. It can be conclude that 
salmonellosis is present in the swine industry in this area 
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Probiotic eﬀ ects in swine in diﬀ erent post-weaning periods with Salmonella Typhimurium challenge
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Introduction
Probiotics are viable microorganisms that once ingested by 
humans and animals, produce benefi cial physiological eff ects 
by assisting in the establishment of an intestinal population1. 
The aim of this study was to asses the eff ect of two probiotics in 
diff erent inclusion periods during nursery, growing and fi nishing 
on the performance of swine.
Materials and Methods
One hundred sixty pigs from 23 to 138 days of age were used to 
evaluate two probiotics, one of them was composed by Bacil-
lus subtilis, Bifi dobacterium bifi dum, Enterococcus faecium, 
Lactobacillus acidophillus, Lactobacillus casei and Lactobacillus 
lactis (PA), and the other by Bacillus subtilis and Bacillus toyoi 
(PB). Both were tested with an inclusion in the diet in 3 diff er-
ent periods characterizing 8 treatments: PA44 (PA until 44 days 
of age and control diet after), PA65 (PA until 65 days of age and 
control diet after), PA138 (PA until 138 days of age), PB44 (PB 
until 44 days of age and control diet after), PB65 (PB until 65 
days of age and control diet after), PB138 (PB until 138 days of 
age), CTR (diet control without additives) and ATB (diet control 
with an antibiotic as growth promoter). At 51 days of age the 
programmed challenge with Salmonella Typhimurium (LSS – 
SR41) was given orally. Body weight (BW) at 23, 30, 37, 44, 51, 58, 
65, 79, 106, 112, 126 and 138 days of age and feed conversion 
(FC) corresponding these periods were evaluated. At weaning 
(23 days of age), pigs were blocked by body weight and sex, and 
placed in a nursery pen (4 pigs/pen). Datas were analyzed by the 
SAS2, and treatments were compared by orthogonal contrast 
method. The level of signifi cance considered was 5%. 
Results
The contrast 1 (C1), PA44, PA65 and PA138 vs ATB showed from 
37 (8,33Kg vs 9,54Kg, respectively) to 112 days of age (64,01 Kg 
vs 70,75Kg, respectively), the highest values for ATB regarding 
BW. Similar results were obtained for the contrast 2 (C2), PB44, 
PB65 e PB138 vs ATB from 37 (8,71Kg vs 9,54Kg, respectively) to 
106 days of age (60Kg vs 65,48Kg, respectively), demonstrating 
the superiority of ATB against probiotics. There were no signifi -
cant diff erences from the age of 112 days for C1 and 106 days 
for C2 until 138 days for neither of the groups. The FC showed 
signifi cant diff erence in C1 (1,78 vs 1,55, respectively) and C2 
(1,79 vs 1,55, respectively) at nursery period (23 to 65 days 
of age), with lowest values for ATB. During growing-fi nishing 
periods (66 to 138 days of age) the lowest values were found for 
probiotics on C1 (2,49 vs 2,63, respectively) and C2 (2,53 vs 2,63, 
respectively) with P=0.06 and P=0.16, respectively. These values 
emphasize a numerical advantage (140 and 100 grams for C1 
and C2, respectively) in favor of probiotics. 
Discussion
Although there was a signifi cant diff erence from nursery period 
until days 106-112 (C2 and C1 respectively) regarding BW, this 
variable did not show signifi cance until 138 days of age when 
probiotics and ATB were compared. Similar3 and contradictory4 
results were reported in literature, considering the nursery 
period,while during growing-fi nishing few evidences were de-
scribed5. The treatments PA65 and PB44 (98,87Kg and 97,33Kg 
respectively) showed equivalent body weights in comparison 
with the ATB (99,63Kg), indicating distinct actions depending 
on the probiotic’s inclusion time. In the programmed challenge 
at 51 days of age, signifi cant eff ects were observed regarding 
performance for C1 (21,74Kg VS 25,99Kg, respectively) and 
C2 (21,91Kg vs 25,99Kg, respectively), showing the probiotic 
treatments were aff ected by the challenge. The modifi cation 
observed in BW and FC in the growing-fi nishing suggested a 
recovery by unknown factors that could be connected to the 
microfl ora complex modifi cation. Considering the equivalence 
of the results on the performance and the economic aspects 
involving the inclusion of the probiotics, its use until 44 or 65 
days was better than until 138 days of age.
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Evaluation of risk factors and proposals for control of infection of Salmonella 
sp. in diﬀ erent production systems of Brazilian swine
Jalusa D. Kich2 Patrícia Schwarz1 Arlei Coldebella2 Luis Gustavo Corbellini1 Marisa Cardoso1
1. Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil; 2. Embrapa Suínos e Aves, Concórdia , SC, Brazil
Introduction
Studies of risk for contamination of meat along the production 
chain as well as the quantitative representation of their impacts 
have been conducted around the world (Dahl et al. 2000; Giova-
ninni et al. 2003). This study was carried out in order to identify 
factors associated with infection of herds and to suggest alterna-
tives to control the main pig producing regions of Brazil and in 
diff erent production systems.
Materials and Methods
In this study, 5 diff erent Brazilian pork production systems were 
chosen. They were evaluated for Salmonella prevalence. An 
epidemiological investigation and evaluation of risk factors were 
infered in 189 farms. The results of seroprevalence and risk fac-
tors of each farm were analyzed by logistic regression. The risk 
factors that were identifi ed were also inserted into a simulation 
model of intervention in swine.
Results
The main risk factors associated with high prevalence of Sal-
monella were pre-pit dirty, other animals on the farm in addi-
tion to pigs, the presence of intensive production of broilers in 
the same farm, post-weaning multisystemic wasting syndrome 
(PMWS) with high scores of mortality and culling and number 
of origins of animals housed in the same farm. The simulation 
models with values clonsidered protective for the risk variables 
that were found reached 11.20 to 44.89% prevalence of the 
mathematival model used. 
Discussion
The predisposing factors for infection of pig herds were de-
terminants variable of biosafety in the evaluated companies. 
Through simulation models, the combination of risk factors for 
the intervention of control of Salmonella sp. in farms producing 
pigs is proposed. In this study, the early phase of Salmonella 
infection was the fi nishing one, as previous studies conducted 
in Brazil by Müller (2007) and Schwarz et al. (2009), therefore this 
stage was the focus of the epidemiolocical assessment. The risk 
factor with the highest probability of infection was the pres-
ence of intensive production of broilers, indicating the possible 
contamination of one species to another in the same environ-
ment. The Pre-dirty pit was another source of infection for pigs, 
because the feces in the environment can be directed into the 
stalls by fomites. 
In these cases, the presence of other animals on the farm rep-
resents a threat to the swine herds, because the Salmonella sp. 
is widespread among most animal species (Popoff  et al., 2003). 
PMWS has been identifi ed as an important risk variable in 2 of 5 
companies analyzed. This interaction between this risk variable 
and high seroprevalence may be associated with biosecurity 
issues common to Salmonella infection and PMWS. 
Another risk factor identifi ed in this study was the number of 
sources of animals housed in the same farm. In Brazil, Kich et 
al. (2005) found that the number of sources of pigs and other 
animals on the farm as risk factors for infection with Salmonella 
sp. The number of sources of piglets can increase the chances of 
introducing new pathogens in the swine herds (Morés, 2003).
According to Davies et al. (1997), the limited number of days of 
fallowing (less than 7) was identifi ed as a risk factor in 2 com-
panies, as well as mixing animals from diff erent sources, also 
described by Quessy et al. (1999), and size of herds, cited by 
Carstensen & Christensen (1998). 
A comparative analysis of the seroprevalence of Salmonella 
among the companies in this study showed the diff erences 
between production systems (P <0.05), as well as diff erences in 
the distribution of identifi ed risk factors.
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Frequency of salmonella seropositive pigs in farms aﬀ ected by diﬀ erent severity 
levels of the post-weaning multisystemic wasting syndrome
Patrícia Schwarz; Jalusa D. Kich; Arlei Coldebella; Luis Gustavo Corbellini; Marisa Cardoso
Embrapa Suínos e Aves, Concórdia , SC, Brazil
Introduction
The post-weaning multisystemic wasting syndrome (PMWS) has 
caused considerable losses due to mortality and wasting of pigs, 
and has been often associated with co-infections with other viral 
or bacterial agents (2, 3). The aim of this study was to evaluate 
the Salmonella seroprevalence in swine herds that are aff ected 
by PMWS to diff erent severities.
Materials and Methods
Productive performance data and most prevalent symptoms 
were investigated in herds associated to 11 Brazilian swine 
companies that reported the occurrence of PMWS (1). Herds 
(n=188) were classifi ed according to the mortality and wasting 
frequency, and these data were considered as PMWS severity 
degrees (table1). Blood samples were taken from slaughter pigs 
of each herd and submitted to an indirect ELISA test against Sal-
monella sp. Statistical analysis was performed using chi-square 
test for linear trend to test the hypothesis of increased Salmon-
ella seroprevalence with levels of PMWS severity. The farms were 
divided in two groups according with the seroprevalence, ≤ 70% 
and > 70%. These groups were compared between the levels of 
PMWS severity. The analysis was performed using the software 
EpiInfo 6.0 (4).
Table 1: Classifi cation of farms in the intensity levels of involvement 
by PMWS
Level PMWS Mortality Culling
Level 1 below 2% below 2%
Level 2 2 to 3% 2 to 4%
Level 3 above 3% above 4%
Results
In all herds the appearance of PMWS was associated with a 
decrease in animal performance and a tendency of a higher 
frequency of enteric symptoms. Seroprevalence >70% against 
Salmonella was associated to higher PMWS severity (P=0.0001) 
(table 2).
Discussion
This result may be related to the immune impairment caused by 
PMWS that may predispose to Salmonella infection, as well as 
to the occurrence of common risk factors to both infections in 
aff ected herds (5). These factors include the size of the batch, the 
mixture of animals of diff erent origins and hygiene facilities (1). 
In conclusion, a high frequency of Salmonella carrier pigs may 
be an additional problem in farms severely aff ected by PMWS. 
Table 2: Salmonella seroprevalence in swine herd with diff erent sever-
ities of PMWS
Level of PMWS 
Sevetity N Herds
Seroprevalence of 
Salmonella (%)
Seroprevalence of 
Salmonella (%)
 ≥ 70% ≤ 70%
Level 1 32 15/46.9% 17/53.15%
Level 2 54 46/85.2% 8/14.8%
Level 3 102 81/79.4% 21/20.6%
Total 188 142/75.5% 46/24.5%
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Evaluation of a commercial acid mixture administered in drinking 
water as a control measure in swine salmonelosis
Héctor Argüello; Jesús Osorio; Álvaro Hidalgo; Sonia Álvarez; Mario Arcos; German Naharro; Ana Carvajal; Pedro Rubio
University of León, León, Spain
Introduccion
 Salmonella control programs have been developed in swine 
farms from several European countries[1]. Those farms with a 
high level of contamination will have to establish control meas-
ures to reduce the number of Salmonella infected animals [2]. 
We have carried out an interventional study in a pig fattening 
unit to assess the eff ectiveness of an acid treatment adminis-
tered in drinking water for the control of salmonellosis.
Materials and Methods
 The study was performed in a pig fattening unit infected by 
Salmonella Typhimurium housing 3,000 pigs distributed in two 
barns (1,500 pigs each). One of them was chosen as control 
group and received no treatment while the other was chosen as 
experimental group. Animals from experimental group were ad-
ministered a commercial acid, Acidvall®, composed of lactic acid 
(56 %), formic acid (23 %), propionic acid (13 %) and acetic acid 
(5 %), that was added to drinking water during the last 40 days 
of the fattening period at a concentration of 0.035%. Within each 
group, 40 animals were randomly selected and sampled through 
the experiment. Fecal samples and serum were collected the 
fi rst days of the fattening period, at the beginning of the treat-
ment, 20 days after(only blood samples) as well as at the last day 
of treatment (previous day to slaughter). Moreover, cecal con-
tent and ileocecal lymph nodes were collected from pigs of both 
experimental groups at the slaughter. Samples were submitted 
to the infectious animal diseases laboratory and processed. Bac-
teriological analyses were made using EN-ISO 6579:2002/Amd 
1:2007. Serological samples were tested with Idexx herdchek 
Swine Salmonella kit® according to manufacturer’s instructions.
Results
Results showed signifi cant diff erences in bacteriology (chi2=21,4 
p<0,001) and serology (chi2=71,45, p<0,001)between goups 
at the end of the fattening period (17.5 % shedders and 27.5 % 
seropositive pigs in treatment group compared to 50 % shed-
ders and 87.5 % seropositive pigs in control group). Similar re-
sults, near to signifi cance, were found out at the abattoir where 
Salmonella was detected in cecal content in 47.5% of the treated 
pigs versus 65 % of the control animals. Diff erences were also 
found in the prevalence of positive animals in ileocecal lymph 
nodes 55% of positive in the treatment group to 70% in control 
group.
Figure 1. Fecal shedding of Salmonella during fattening period.
Figure 2. Serological results during fattening period 
Discussion
Several studies have demonstrated that organic acids can be 
useful to reduce Salmonella contamination in swine farms 
[2,3]. In the present study the treatment, which was designed 
taking into account treatment economic feasibility (0.035 %, 
during forty days) has been able to demonstrate a reduction of 
the number of Salmonella shedders. Moreover, the number of 
Salmonella seropositive animals was also reduced. Despite that 
this results are promising further studies are required to confi rm 
them.
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Salmonella Typhimurium and Derby infection in weaned pigs
Jan Matiasovic; Hana Stepanova; Lenka Leva; Hana Havlickova; Frantisek Sisak; Ivan Rychlik; Martin Faldyna
Veterinary Research Institute, Brno, Czech Republic
Introduction
Salmonella Typhimurium (STM) and Derby (SD) are most com-
mon serovars in pig herds in Europe (EFSA 2008). Studies of STM 
shedding and serological response to Salmonella infection at 
herd and individual level were performed (Scherer et al. 2008), 
but little is known about the course of SD infection. Moreover, 
no information about competition between STM and SD is avail-
able. Here we show the kinetics of Salmonella fecal shedding 
and development of specifi c antibody response to SD, STM as 
well as mixed infection in weaned pigs.
Materials and Methods
Strains used were isolated from infected sows. STM was of 
DT104 phagotype. Weaned salmonella-free pigs were div-
ided into groups of fi ve animals for STM, SD and non-infected 
control. Another group consisting of 10 animals was infected 
with a mixture of STM and SD. Animals were infected per os 
with 108 bacteria per animal. Experiment was carried-out for 
28 days. Salmonella shedding was investigated in fecal samples 
by a standard culture method (EN ISO 6579:2002). Presence of 
antibodies against LPS O antigens (STM and SD share the same 
O antigens) in blood serum was evaluated by ELISA Salmotype® 
LDL (Germany). Sampling of feces and blood was done twice a 
week.
Results
Shedding of STM was observed in group infected with STM up 
to 14 DPI, in group with mixed infection up to 17 DPI. Shedding 
of SD was observed during all experiment in both groups in-
fected with SD (SD group and group with mixed infection). From 
14 DPI, the titers of SD in both groups were very similar or the 
same. Percentage of STM in isolates from mixed infection varied 
from 0% (14 DPI) to 50% (17 DPI). 
Antibodies against O antigens were detected at 14 DPI in 
three of fi ve animals in group infected with STM. At 28 DPI, 
four animals reached high antibody titer, but one animal from 
this group did not develop antibody response. In SD group, a 
low titer of antibodies was detected only at 28 DPI in three of 
fi ve animals. In group with mixed infection, antibody titer was 
measured only at 28 DPI; six of ten animals developed antibody 
response.
Discussion
Short fecal shedding of STM (up to 14 DPI) and early developing 
of antibody response (14 DPI) in group infected with STM was 
similar as it was previously shown (Scherer et al. 2008). Con-
trary to STM, the period of SD shedding was prolonged. SD was 
detected in feces during the entire experiment, but only in a 
low titer from 21 DPI. Contrary to that, antibody response to SD 
infection was slow and only three of fi ve animals developed low 
antibody titers at 28 DPI. In group with mixed infection, fecal 
shedding of STM was similar to group infected with STM only. 
Shedding of SD was nearly the same as in group infected only 
with SD and was also prolonged during all experiment. From this 
data we can conclude there is no competition between STM and 
SD.
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Eﬃ  cacy of vaccination with an inactivated vaccine to reduce salmonella prevalence in a pig fattening unit
Héctor Argüello; Sonia Álvarez; Álvaro Hidalgo; Jesús Osorio; Mario Arcos; German Naharro; Ana Carvajal; Pedro Rubio
University of León, León, Spain
Introduction
Immune response stimulation by vaccines has been a useful 
mechanism stand up to pathogens [1]. Vaccination can be a use-
ful tool for the control of swine salmonellosis and live vaccines 
are the fi rst choice, but they have several disadvantages like 
biosecurity, oral administration and higher prices. In the present 
study we have evaluated an inactivated vaccine of Salmonella 
Typhimurium, easy to produce and cheaper than lives vaccines.
Materials and Methods
The vaccine was prepared from a culture of Salmonella Typhi-
murium DT104 (109 UFC/ml) inactivated by formol and using 
hydroxide aluminum Al(OH)3 as adjuvant. A pig fattening unit 
infected by S. Typhimurium and S. 4,5,12:i:- was chosen for the 
experiment. Farm housed 2960 pigs distributed in two barns 
(1480 pigs each). One of them was chosen as control group 
and was not vaccinated while the other was chosen as experi-
mental group(vaccinated animals).Within the farm, animals 
were housed in two diff erent barns. Pigs from one of the barns, 
vaccinated group, were injected intramuscularly 2 ml of the 
inactivated vaccine at the beginning of the fattening period 
(70 days of life approximately) and 25 days later. Pigs from the 
second barn served as control group and receive no treatment. 
Both groups were monitored during the fattening period by col-
lecting serum and fecal samples that were used for serological 
and bacteriological detection of Salmonella infection. Moreover, 
cecal content, mesenteric lymph nodes and blood samples were 
collected after slaughter from both groups. In each sampling 
forty animals per group were included. Bacteriological analyses 
were made using EN-ISO 6579:2002/Amd 1:2007: Microbiology 
of food and animal feeding stuff s- Horizontal method for the de-
tection of Salmonella spp. In animal feces and in environmental 
samples from the primary production stage. Serological samples 
were tested with Idexx herdchek Swine Salmonella kit® accord-
ing to manufacturers’ instructions.
Results
 The percentage of Salmonella shedders was signifi cantly lower 
(Chi2=67.5 p<0.001) among vaccinated animals as compared 
with control pigs (18 % - 65 % in control group versus 0 % - 7.5 
% in vaccinated group). Abattoir study also revealed signifi cant 
diff erences in the prevalence of Salmonella positive samples 
among cecal content (Chi2=33.43, p<0.001) (55 % versus 15 
%) and mesenteric lymph nodes (Chi2=20 2, p<0,001) (55 % to 
22.5 %). Results of serological analysis were no so consistent 
although signifi cant diff erences (Chi2=49.6 p<0.001) in the per-
centage of seropositive animals were also detected at the end of 
the study (88 % of seropositive animals in control group versus 
44 % in vaccinated group).
Figure 1. Fecal shedding of Salmonella during fattening period in 
vaccinated and unvaccinated animals (day1 coincides with vaccination 
date).
Discusion
Despite of live vaccines and its cell mediated response provide a 
better protection [2,3], our study demonstrates that inactivated 
vaccines can be useful in the control of swine salmonellosis. 
Further investigations are needed to corroborate these results 
and particularly in farms infected by other serotypes diff erent to 
S. Typhimurium.
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Resistance patterns of Salmonella isolated from pigs and porc in Germany
Andreas Schroeter; Annemarie Kaesbohrer; Reiner Helmuth; Christina Dorn; Kirsten Heckenbach; Bernd-Alois Tenhagen
Federal Institute for Risk Assessment (BfR), Berlin, Germany
Introduction
Antimicrobial resistance in Salmonella spp. is a major public 
health concern in Europe and world wide. Although in the ma-
jority of cases Salmonella is not associated with clinical disease 
in pigs, studies have shown that they are prevalent at slaughter 
and enter the food chain. S. Typhimurium from pigs is estimated 
to be a major source of human salmonella infections. It was the 
purpose of this study to compare the resistance patterns of Sal-
monella spp. isolated from porc with those isolated from pigs. 
Materials and Methods
Salmonella isolates from pigs and porc submitted to the Nation-
al Reference Laboratory for Salmonella between 2000 and 2008 
were analysed for their susceptibility to antimicrobials using the 
broth microdilution method according to NCCLS/CLSI stan-
dards. Minimum inhibitory concentrations (MIC) were evaluated 
according to epidemiological cut off  values (www.eucast.org). 
Isolates with MIC above the cut off s were considered resistant, 
otherwise susceptible.
Results
Overall 1595 isolates from porc and 3820 isolates from pigs 
were tested. The majority of isolates from pigs were from three 
serovars, namely S. Typhimurium (67 %), S. 1,4[5],12:i:- (9 %) and 
S. Derby (8 %). The proportion of S. Typhimurium decreased 
from above 80 % in 2000-2002 to 44 % in 2008. In the same 
period, the proportion of S. 1,4[5],12:i:-increased from 0 to 21 
%. S. Derby on the other hand was constant in its share of the 
submitted isolates.
In porc, the same serovars dominated. S. Typhimurium had a 
proportion of above 60 % in 2000-2002 that decreased to 43 
% in 2008. Overall, 53 % of all isolates from porc were S. Typhi-
murium. S. 1,4[5],12:i:- (9 % of the isolates) was practically not 
observed in 2000 but had a share of above 20 % in 2007 and 
2008. S. Derby (10 % of the isolates was fairly constant between 
5 and 12 % of the isolates over the years.
The proportion of isolates that were susceptible to all anti-
microbials tested increased over the years in animals (10 % in 
2000-2002 to 22 % in 2006-2008) and the proportion of isolates 
resistant against more than one group of antimicrobials de-
creased slightly (78 vs. 71 %) in the same time period. 
In isolates from porc the changes were less pronounced. The 
number of isolates that were susceptible against all antimicrob-
ials tested increased only slightly (from 25 to 31 %). In contrast 
to the situation in animals, the proportion of isolates resistant 
against more than one group of substances increased slightly 
over the years (from 56.6 to 60.2 %). 
In S. Typhimurium from pigs, the resistance situation did not 
change very much over the years. From 2000-2002 to 2006-2008 
the proportion of susceptible strains increased slightly from 
6.0 to 10.5 % in pigs, but the high proportion of multiresistant 
strains remained unchanged (86.6 vs 85.2 %). In food, a diff erent 
situation was observed. The proportion of susceptible strains 
decreased from 21.5 to 14.8 % and the proportion of multiresist-
ant strains increased slightly (69.5 to 73.3 %).
Trends in resistance for S. 1,4[5],12:i:- cannot be described as 
there were practically no isolates in the fi rst years. However the 
vast majority of strains from pigs (86 %) and porc (83 %) were 
multiresistant and only few isolates (3 and 4 %) were susceptible 
to all antimicrobials tested.
S. Derby was less resistant to antimicrobials. Overall, 47 % of 
the isolates from pigs and 57 % of the isolates from porc were 
susceptibel against all tested antimicrobials. The proportion of 
multiresistant strains was substantially lower than in S. Typhi-
murium and S. 1,4[5],12:i:- (28% in pigs, 22 % in porc).
The highest resistance rates were observed for ampicillin, strep-
tomycin, sulfamethoxazole and tetracycline. The resistance rates 
to these antimicrobials were higher in isolates from pigs (60 to 
90 %) than in isolates from porc (40 to 60 %). The lowest resist-
ance rates were observed against gentamicin, colistin, and 3rd 
generation of cephalosporins (0 to 5 %).
Discussion 
The results underline that colonized or infected pigs are a likely 
source of contamination for porc indicating the need to control 
Salmonella pre- and at harvest to reduce this contamination. 
S. Typhimurium and S. 1,4[5], 12:i:- show multiresistance in the 
majority of the isolates which hampers treatment of infections in 
humans. Resistance to antimicrobials that are administered via 
animal feed, such as tetracycline and amoxicillin is widespread. 
It has been pointed out, that the use of these antimicrobials 
is associated with a higher risk of slaughter pigs to harbour S. 
Typhimurium in their ileocaecal lymph nodes (Tenhagen et al. 
2009).
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Identiﬁ cation of Salmonella Typhimurium genes induced in porcine tonsils and lymph 
nodes during long-term persistence using in vivo expression technology (IVET)
Alexander Van Parys; Filip Boyen; Elin Verbrugghe; Bregje Leyman; Freddy Haesebrouck; Frank Pasmans
Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
Introduction
Persistent Salmonella Typhimurium infections in pigs often 
result in asymptomatic carrier pigs and are a major concern for 
food safety and human health. Tonsils and lymph nodes play a 
key role in the persistence of Salmonella Typhimurium in pigs, 
but very little is known about the underlying mechanisms. For 
the identifi cation of Salmonella Typhimurium genes specifi cally 
induced in these organs, a genome-wide screening method was 
performed using in vivo expression technology (IVET) (Mahan et 
al, 1993).
Materials and Methods
We used a spontaneous nalidixic acid resistant derivative of a 
wild type Salmonella Typhimurium strain isolated from a pig 
stool sample. A ΔpurA deletion mutant was constructed in 
this strain using the Datsenko and Wanner method (2000). For 
proper use in the IVET protocol, we verifi ed that this mutant was 
signifi cantly impaired in comparison to the wild type strain in a 
preliminary in vivo mixed infection experiment. We constructed 
an IVET library as described earlier for Salmonella Enteritidis 
(Gantois et al., 2008), composed of approximately 12,000 diff er-
ent transformants, representing the major part of the Salmonella 
Typhimurium genome.
For IVET selection in pigs, 9 pigs were orally inoculated with ap-
proximately 108 CFU of our IVET library. Three weeks after inocu-
lation, pigs were euthanized and tonsil and lymph node samples 
were collected, processed and plated on selective MacConkey 
agar. White colonies, representing in vivo but not in vitro induced 
genes, were collected and the IVET fusions were sequenced 
as described before (Gantois et al., 2008). Identifi cation of the 
sequence of the cloned promoter was done by BLAST analysis.
Results
From the IVET selection experiment, 19 and 24 diff erent genes 
were identifi ed in the tonsils and lymph nodes, respectively (see 
Table 1 for a summary). The majority of these genes plays a role 
in Salmonella metabolism. One known virulence gene (sifB) was 
identifi ed, playing a role in formation and maintenance of the 
Salmonella-containing vacuole. AsmA, a gene important for the 
invasion of nonphagocytic cells, was upregulated in the lymph 
nodes. Furthermore, 2 genes were identifi ed that act in stress 
responses (htpG and dnaK). The fl agellin-producing operon 
fl iC/fl jB was induced in the tonsils, while rfaE, involved in LPS-
biosynthesis, was identifi ed in the lymph nodes. Finally, several 
genes with a yet unknown function were identifi ed in tonsils 
and lymph nodes.
Discussion
Using IVET, Huang et al. (2007) already identifi ed several Sal-
monella Typhimurium genes expressed in porcine tonsils at 2 
days post inoculation. These genes diff er from the genes that 
we were able to identify at 3 weeks post inoculation (except for 
rpoN). This suggests that diff erent sets of Salmonella genes play 
a role in short- and long-term persistence in pigs.
Although we identifi ed several Salmonella genes that might be 
important for long-term persistence in pigs, further research is 
needed to confi rm their exact function.
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Results Table.
Gene group Organ
Tonsils Lymph nodes
Metabolic efp artP efp pfl D
dnaC/dnaT kdgK dnaC/dnaT fnr
gyrB lysS gyrB rpoZ
rnt rnt nrdB
pfl C pfl C rpoN
rpsU aroK ssb/asmA
Virulence sifB sifB
Stress htpG htpG
dnaK
Motility fl iC/fl jB
LPS rfaE
Unknown function ygfA ygfA
ybjP citX2/citG2
STM4067 yaeT
ydeW yadF
yggE yhbG
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Introduction
Salmonellosis is the most important food borne disease in the 
North Hemisphere. There is a mortality of 0.1% in the European 
Union, mainly in children, elderly and inmuno-depressed pa-
tients, where antimicrobial therapy was no effi  cient enough. The 
main sources of infection are pork, eggs and poultry aliments 
(EFSA, 2009).
Material and Methods
Our strain collection consists in 144 “Salmonella enterica” strains 
isolated from slaughter house samples and clinical cases in 
Spain and Portugal. Minimum inhibitory concentrations (MICs) 
for ampicillin (Amp), amoxicillin (Amx), streptomycin (Str), 
spectinomycin (Spt), fl orphenicol (Fhl), chloramphenicol (Chl), 
tetracycline (Tet) and sulfametoxazole (Sul) were determined 
by microdilution broth. The screening for class 1 integrase gene 
(int1) was performed by PCR (Leverstein-Van Hall et al, 2002). A 
second PCR was used to amplify the conserved-cassettes (CS) 
inside the integrons which contains the antibiotic resistance 
genes. Finally, CS regions were characterized by RFLP analysis 
and sequencing (Levesque et al, 1995).
Results
Half of the collection (65 strains) was int1 positive. Majority of 
them (92%) were multidrug resistance (MDR) strains and only 
three were totally sensible. Among these strains, the most com-
mon MDR profi les were: AmpAmxStrSptChlSulTet (n=20) found 
in white swine (WS) and (n=10) in Iberian ones (IS); AmpAmx-
StrSptSulTet (n=6) and AmpAmxSptChlSulTet (n=5) in WS and 
AmpAmxStrChlSulTet (n=5) in IS. A total of 36 strains has both 
the penta-resistant phenotype (AmpStrChlSulTet) and the class 
1 integron. Nine CS profi les were described (from A to I). The 
conservative-cassettes contain the genes: blaOXA-30, blaPSE1 
(amoxicillin and ampicillin resistance); aadA1, aadA2 y aadA12 
(streptomycin and spectinomycin); dfrA1, dfrA12, dfr17 y dhfrVII 
(trimetoprim, a sulfonamides synergic antimicrobial). 
Discussion
Most class 1 integrons profi les are exclusively distributed among 
the two swine subpopulations studied, since only profi les D (5 
WS and 6 IS) and A (13 WS and 1 IS) are shared between them. 
The genes associated to the class 1 integrons indicates that 
these genetic elements might support almost all phenotypical 
resistance. The fi nding of new genotype/serovar combina-
tions, as far as (to our knowledge) the identifi cation of dhfrVII 
in Montevideo; dfr17 in Anatum and Bredeney; and dfrA1 in 
Hindmarsh, had never been reported. 
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Introduction
Serology is use in the last years to determine the prevalence of 
Salmonella on pig farms and has been adopted by several coun-
tries into national control programs. These programs designed 
to reduce occurrence of Salmonella on the farm and in pork (4, 
6). A national serologic surveillance program has been in place 
in Denmark since 1993 for breeding stock herds and since 1995 
for herds producing slaughter pigs. The prevalence of salmon-
ellae in Danish pork is reported to have declined from 3.5% in 
1993 to 0.7% in 2000 (2). 
The aim of the present study was to monitoring serological 
prevalence of Salmonella in four sows farms.
Material and Methods
A longitudinal study was carried out in 4 sows farms. There were 
tested a number of 304 samples and were made 3 samplings at 
diff erent times.
Serological monitoring was made October 2008 – May 2009. 
Samples were analyzed for the presence of antibodies against 
Salmonella by commercially available ELISA: HerdChek® Swine 
Salmonella, IDEXX (USA). Samples with OD% values equal to or 
greater than 10% (S/P=0.25) are considered positive. Interpreta-
tion results was made with xChek IDEXX software. 
Results
The HerdChek® Swine Salmonella allows rapid screening for the 
presence of antibodies to a broad range of Salmonella serogrups 
indicating swine herd`s exposure to the bacteria (1).
Monitoring of the immune status of a herd can be an import-
ant tool in the control of the disease. Serological monitoring of 
Salmonella infection of swine by standardized commercial ELISA 
is a fast, simple and economical.
Several studies have reported the variability of serologic re-
sponses in diff erent groups of animals sampled at the same time 
and at diff erent times. In the table is presents the samplings 
results.
The prevalence in each herd at the diff erent time sampling is 
shown in 
Table 1.
Farms
1st sampling 2nd sampling 3rd sampling
No. sample 
positive
No. sample 
tested
No. sample 
positive
No. sample 
tested
No. sample 
positive
No. sample 
tested
farm A 29 30 16 30 29 30
farm B 29 30 24 30 20 21
farm C 15 15 22 23 27 30
farm D 14 19 25 26 20 20
TOTAL 304
It could be observed that in all four sows farms are presents the 
Salmonella antibodies. Between collection of the second and 
third samples in the farms A the proportions of positive sero-
logic increased. 
Epidemiological screening about Salmonella antibodies in sows 
farms using HerdChek® Swine Salmonella ELISA kit, revealed that 
all 4 monitorised sows farms were high positive.
Serological tests for Salmonella antibodies in swine are inter-
preted by associating test results witth a reduction in prevalence 
of subclinical infection in pigs (2, 6) and reduced risk of carcass 
contamination at slaughter rather than with the presence or 
absence of disease.
The concept of serologic testing is most useful as an ongoing 
monitoring surveillance exercise (2). The sensitivity of the test 
increases with multiple sampling. The serologic response to sub-
clinical Salmonella infection may vary between farms of sows or 
even within the same group sampled at diff erent times.
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Serological study on hepatitis E infection in Croatian pig herds
Zoran Lipej; Besi Roic´; Dinko Novosel; Zˇeljko Mihaljevic´
Croatian Veterinary Institute, Zagreb, Croatia
Introduction 
Hepatitis E virus (HEV) is one of the most important causes of 
acute clinical hepatitis in human population. Swine HEV has a 
cross-reaction with human anti-HEV antibodies. Therefore pigs 
could be an animal reservoir, rendering hepatitis E as a zoonosis 
(3). HEV is an important public health problem specially in de-
veloping countries (1). The fi rst HEV strain genetically closed to 
human was described in swine (2). Serological studies reported 
that swine HEV infection is widespread in many European coun-
tries (4,5) The aim of the present study was to determine the 
prevalence of HEV in domestic pig population at diff erent ages 
in Croatia. 
Material and Methods 
During 2009 serum semples of 200 pigs were collected from 
four farrow-to-fi nishing farms located in continental part of 
Croatia. Blood samples were taken from 5o animals for each 
farm. Groups of animals were selected in 5 group by age and 
sex. Group 1 (n=10) gilts, group 2 (n= 10) sows, group 3 ( n=10) 
boars, group 4 ( n=10 ) pigs <12 weeks of age and group 5 ( n= 
10) pigs >12 weeks of age. All blood samples were deliverd to 
Virology laboratory of the Croatian Veterinary Institute and were 
stored at -20 o C before testing. Serum specimens were tested 
for the presence of specifi c anti-HEV IgG antibodies by enzyme 
linked immunosorbent assay (ELISA) according to the method 
decribed by (7) using a commercially available reagents (MP 
Diagnostics HEV ELISA, MP Biomedicals Suisse S.A., Switzerland) 
according to manufacturers instructions. The protocol used 
is designed for detecting HEV antibodies in human sera but 
adapted to animals using anti-pig IgG horsreadish peroxidase 
instead of ant-human conjugates. 
All swine sera were tested in duplicate at a dilution of 1:21. 
Serum samples were added to each well and incubated for 30 
min at 37 0C. Plates were washed 6 times with washing buf-
fer and conjugated with goat anti-swine IgG (H+L) (Jackson 
ImmunoResearch) was added of 100 μl/well. The optimal work-
ing dilution of conjugate was 1:1000. After incubation at 37 0C 
for 30 min and six washes 100 μl of substrate solution was add-
ed. The reaction was stopped after 15 min by adding 50 μl stop 
solution. The optical densiti of each serum sample was read at 
492 nm with a photometer and comparasion of the absorbance 
between test and control wells (Microplate Autoreader TECAN 
Sunrise –Magellan, Austria). Samples with OD values greater 
than or equal to the Cut-off  Value are considered reactive by the 
criteria of this HEV antibody ELISA kit.
Results and Discussion 
Among 200 serum samples collected from four pig farms overall 
seroprevalence was 89,5 % (200/179). Positive rate of HEV-specif-
ic IgG in all farms ranging from 86% to 92%. All four farrow-to-
fi nishing units located in diff erent geographical regions were 
HEV positive. The highest proportion of 100 % IgG positive 
animals comprised gilts and fi nishers. Seroprevalence was 85% 
in sows, 90% in boars and 72,5% in pigs <12 weeks of age. 
Table 1. Seroprevalence of HEV in pigs at diff erent ages in four pig 
production units in Croatia
Herd gilts sows boars pigs<12 weeks fi nishers No./positive(%)
No./
positive
No./
positive
No./
positive
No./
positive
No./
positive
Farm A 10/10 10/9 10/10 10/7 10/10 50/46 (92%)
Farm B 10/10 10/8 10/7 10/8 10/10 50/43 (86%)
Farm C 10/10 10/7 10/9 10/8 10/10 50/44 (88%)
Farm D 10/10 10/10 10/10 10/6 10/10 50/46 (92%)
TOTAL 40/40 40/34 40/36 40/29 40/40 200/179 (89,5%)
Our results show that HEV is present and widespread among pig 
population in Croatia at high HEV antibody prevalence (89.5%). 
These fi ndings correlate with the results of other studies (4,5,7). 
This is the fi rst evidence of HEV infection in Croatian domestic 
swine population. 
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Introduction
Hepatitis E virus (HEV) is a major cause of acute hepatitis in 
humans but the virus is also widespread in the pig population 
and HEV is considered a zoonotic agent (1,4). There are currently 
at least four known genotypes of HEV with one recognized sero-
type (5). Serological studies in swine are often conducted with 
in-house assays based on peptides and recombinant proteins of 
diff erent HEV genotypes and are mainly limited to research lab-
oratories (2,3). The objective of the current study was to deter-
mine the diagnostic accuracy of one commercially available and 
four in-house EIAs on samples from pigs experimentally-infected 
with genotype 3 human or swine HEV and genotype 4 human 
HEV. 
Materials and Methods
A total of 72 serum samples (18 obtained from gnotobiotic pigs 
and 54 obtained from conventional pigs) were tested by fi ve dif-
ferent assays. Twenty-six of the 72 samples were control samples 
from non-inoculated pigs, 16/72 samples were obtained from 
pigs experimentally inoculated with genotype 3 human HEV 
(US-2 strain), 14/72 samples were obtained from pigs experi-
mentally inoculated with genotype 3 swine HEV (Meng strain), 
and 16/72 samples were obtained from pigs experimentally in-
oculated with genotype 4 human HEV (Taiwan strain TW6196E). 
All serum samples were stored at -80˚C until processing. For the 
comparison, all samples above were tested with four enzyme-
linked immunosorbent assays (ELISAs) and one strip line 
immunoassay. The antigen used in the diff erent assays varied 
but all were derived from human HEV genotype 1 or genotype 3 
recombinant proteins. Plate-specifi c cutoff s were used for ELISAs 
1-3 and samples in ELISA 4 were considered positive if their 
optical density (OD) value was equal to or greater than 0.4. The 
strip line immunoassay results were read both visually by eyes 
and digital-interpretation. For the statistical analysis, the optimal 
cutoff  was determined using Receiver operator characteristic 
(ROC) analysis. The ROC analysis was based on known infection 
status of each pig and included data from days post inoculation 
(dpi) 35-56. This analysis provided ROC optimized cut-off  values 
that maximized diagnostic sensitivity and specifi city of each 
assay. 
Results
For the strip line assay samples that were considered positive by 
visual reading were also found positive when digital analysis was 
run. All 26 control samples were negative with all fi ve assays. In 
all experimentally-inoculated pigs, seroconversion was detected 
at the same dpi for each individual pig across all EIAs. All fi ve 
EIAs used in this study were found to be able to identify anti-HEV 
antibodies in pigs experimentally-inoculated with genotype 3 
and 4 HEV strains with varying sensitivity and specifi city accord-
ing to ROC analysis. The ROC analysis showed that the assay with 
the greatest sensitivity and specifi city was ELISA 4 when the 
optimized cutoff  was used; however, a small subset of samples 
was used and results may vary with a greater sample set. The 
ROC analysis also revealed that from dpi 35 to dpi 56 all four 
ELISAs had a sensitivity and specifi city of 100%.
Discussion
The similar seroconversion profi les obtained with the fi ve EIAs 
when used to test sera from the experimentally-infected pigs 
indicates that (1) each assay could reliably discriminate between 
the absence and presence of anti-HEV and (2) each antigen 
reacted with similar levels of sensitivity with diff erent genotypes 
(genotypes 1, 3 and 4). Since the capture recombinant antigens 
were from human HEV genotypes 1 and 3, the data suggests 
that these fi ve EIAs are eff ective for detecting antibodies against 
HEV viruses representing the 4 main genotypes. This is in agree-
ment with previous data indicating that only one HEV serotype 
exists (2,3). 
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Introduction
In Europe, imported human cases of hepatitis E virus (HEV) 
infection are declining while autochthonous cases although 
sporadic in nature have become more frequent (1). These 
autochthonous cases are most often caused by genotypes 3 
and 4 of HEV whereas in endemic countries genotypes 1 and 2 
are the commonest and cause epidemics transmitted through 
drinking water. In industrialized countries, the ubiquitous 
nature of the virus in domestic pigs and the genetic similarity 
between porcine and human HEV isolates support the notion 
of a potential zoonotic transmission of the infection. Thus, some 
human cases have been associated with the consumption of 
inadequately cooked meat products (2). In Spain, >90% of pig 
farms have HEV-seropositive pigs and the infection is suspected 
to be present from at least the decade of 1980 (3). The objective 
of the present study was to determine the percentage of pigs 
that could reach the abattoir being infected.
Materials and Methods
A longitudinal survey was conducted in six farrow-to fi nish 
swine herds. Farms had been previously diagnosed as HEV posi-
tive. Twenty piglets per farm were serologically monitored from 
nursery to slaughter age (3, 7, 13, 18 and 25 weeks (wk) of age). 
Sera were analyzed for anti-HEV IgM and IgG antibodies using 
an in-house ELISA. At slaughter, liver (n=96) and bile (n=80) were 
taken and tested by RT-PCR. In order to compare HEV sequences, 
serum and faeces collected at 13wk of age from positive animals 
at slaughter, were also analyzed by RT-PCR. 
Results
Anti-HEV IgM were fi rstly detected in pigs of 7wk of age in fi ve 
farms whereas in the remaining farm, animals did not show 
anti HEV IgM until 13wk of age (farm 6). At slaughter age, for 
the fi rst fi ve farms between 50%-100% of pigs had serocon-
verted for anti-HEV IgG whereas in farm 6 only 5% of pigs were 
IgG seropositive. Six out of 96 livers (6%) and fi ve out of 80 
biles (6%) were HEV positive by RT-PCR. None of the pigs was 
simultaneously positive in liver and bile and therefore, the total 
percentage of infected animals was the sum of both cases (12%). 
Interestingly, positive animals from fi ve farms had already sero-
converted at slaughter, whereas positive animals from farm 6 
-the one seroconverting late- had not seroconverted yet. All RT-
PCR product sequences corresponded to HEV genotype 3 and 
shared 83 5-98.7% nucleotide similarity among them or with 
other human or porcine HEV isolates. Three infected pigs (farms 
3 & 4) were also positive in faeces or in serum at 13wk of age. 
The sequences from one of them had 85.8% nucleotide identity 
between 13wk and slaughter sequences, whereas another pig 
had 93.3% nucleotide identity between them. 
 Discussion
The present study demonstrates that HEV could be present in 
slaughter age pigs (12%). Other papers reported values ranging 
from 1.3% to 11% (4-6). In the present case, three of the infected 
animals were already RT-PCR positive at 13wk. This fi nding sug-
gests either that HEV persisted in that pig longer than expected 
or that pigs might be infected more than once with the same or 
a diff erent HEV strain during its productive life. Also, as seen in 
farm 6, if infections take place late in the pig’s life, infected but 
seronegative pigs could reach the slaughterhouse. 
In Spain, consumption of viscera is very low (0-2.9 grams/per-
son/day) and thus, the risk of acquiring HEV by consumption of 
infected pig livers should be extremely low. However, manipu-
lation or cross-contamination of HEV infected livers could be 
considered a potential route of transmission.
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The prevalence and characterization of Shiga toxin-producing 
Escherichia coli and Stx-converting phage isolated from a pig 
farm near Shanghai, China was reported. From randomly col-
lected swine fecal samples (60 per month for 1 year), we isolated 
O157 and non-O157 STEC strains and Stx phage, and identifi ed 
bacterial virulence genes and Stx phage morphologies. 
In total, we found 8 STEC O157 (1.1%), 33 STEC non-O157 (4.6%), 
and 2 stx-negative O157 (0 3%) strains. Three virulence gene 
patterns were observed in the STEC O157 isolates—stx1-stx2-
eae (1), stx2-eae-hlyA (4), and stx1-stx2-eae-hlyA (3)—while 6 
virulence gene patterns were found in non-O157 STEC, most 
frequently stx1-stx2. Stx2-eae was in all STEC O157, whereas stx1 
was in most of the non-O157 isolates. 
We isolated 15 Stx1 and 57 Stx2 phages from fecal samples, and 
induced 1 Stx1 and 8 Stx2 phages from STEC O157 strains. In-
terestingly, all Stx1 phages had hexagonal heads with long tails, 
while Stx2 phages had 3 diff erent structures. Most STEC O157 
strains released more phage and Stx toxin after ciprofl oxacin 
induction. Upon infection with the recombinant phage ØMin27( 
Δstx::cat) for gene mapping, laboratory strains produced lyso-
genic and lytic phage, while 2 of the 8 O157STEC strains only 
produced lysogens. 
The lysogens from laboratory strains produced infectious par-
ticles similar to ØMin27 after norfl oxacin induction. The lysogens 
from STEC O157 isolates released Stx phage, although free 
ØMin27(Δstx::cat) particles were not detected. 
Our results showed that breeding pig farms are important 
reservoirs for O157 and non-O157 STEC, as well as Stx phage.  
Residual antibacterial agents may enhance the release of Stx 
phage and the expression of Stx, while higher virulence of new 
pathogen may be produced in clinical and experimental strains 
by phages lysogenic conversion. 
Therefore, in STEC monitoring of animal farms, attention must 
be given to antibiotic residues and Stx phage to improve the 
safety of animal related products.
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Introduction
Diagnosis of Mycobacterium avium (MA) infection in pigs is 
based on detection of granulomatous lesions in lymph nodes by 
incision and visual inspection by traditional meat inspection at 
slaughter. In certain cases MA bacteria can be detected whereas 
granulomatous lesions are absent (1). On the other hand also 
Rhodococcus equi has been frequently isolated from lymph 
nodes with lesions (2). In 2009 a serological monitoring has been 
implemented within a “risk based meat inspection” pilot in a ger-
man slaughterhouse as an alternative for detection of MA infec-
tions by traditional meat inspection. From each delivery of pigs 
from a pig producer to the slaughterhouse, a specifi c number 
of blood samples are examined for MA antibody titers (4). Test 
results from current and several previous deliveries were used to 
determine the MA risk level for each pig producer. On the basis 
of this serological monitoring 17 pig herds with a high risk for 
an MA infection were identifi ed. Here we describe experiments 
on two of these pig herds to confi rm their high risk status for MA 
infections. 
Materials and Methods
Two farms (A and B) with a high risk profi le for MA infections 
were selected. Pigs from both farms (A: n=58, B: n=19) under-
went an intradermal tuberculin test with 0,1 ml Avian Tuberculin 
PPD (25.000 I.U., ASG, Lelystad, The Netherlands). The presence 
of induration and erythema at the injection site was read 72 h 
after injection. After slaughtering, blood serum samples were 
taken and analysed by MA-ELISA (4). Submaxillary and mesen-
teric lymph nodes were collected as well at slaughter, and exam-
ined pathologically for granulomatous lesions and bacteriologic-
ally for M. avium. To identify colonies, Ziehl-Neelson staining 
(for acid-fast bacilli) and PCR for the presence of IS1245, which is 
characteristic for MA (3).
Results
In the tuberculin skin tests 72 h after injection approximately 44 
pigs from farm A 29 and 15 pigs from farm B reacted positive. 
The skin showed swelling, erythema and partial central necro-
sis and exsudation. Bacteriological examination of the lymph 
nodes showed that 66% (38/58) and 32% (6/19) of the pigs 
were positive for MA (Table 1). In farm A 26% (15/58) of the pigs 
tested positive in MA-ELISA and 28% (16/58) by pathological 
examination. In farm B pigs tested with 16% (3/19) positivity 
by serological and pathological examination. The sensitivity of 
the MA-ELISA in farm A was 21,6% and the specifi city 61,1%, 
whereas the sensitivity of the pathological examination was 
40,5% and the specifi city 94,4%. In farm B the sensitivity of the 
MA-ELISA and the pathological examination was 66,6% and the 
specifi city of both examinations was 92,3%.
Table 1: Results of pathological, serological and bacteriological exam-
ination of pigs for detection of M. avium infections.
Examination
Number of pigs (%) tested
Negative Positive ND Total (n)
Farm A
Bacteriological1 17 (29) 38 (66) 3 (5) 58
Pathological2 42 (72) 16 (28) 58
Serological 43 (74) 15 (26) 58
Farm B
Bacteriological1 13 (68) 6 (32) 19
Pathological2 16 (84) 3 (16) 19
Serological 16 (84) 3 (16) 19
1 Positive when M. avium bacteria were detected by bacteriological examination on 
submaxillary lymph nodes and mesenteric lymph nodes. 2 Positive when granulomatous 
lesions were seen in the submaxillary lymph nodes. ND not determined.
Discussion
Two pig herds with a high risk profi le for MA infections based on 
the serological monitoring had indeed an MA infection. Results 
of avian tuberculin testing on both farms showed already the 
presence of an MA infection, bacteriological examination of 
lymph nodes confi rmed it defi nitely. 
Specifi city and sensitivity of the pathological examination for 
MA infections at slaughter is questioned (2, 4). Here we show 
that serological monitoring for MA infections showed good 
perspectives to identify succesfully MA positive pig herds. 
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Introduction
Rhodococcus equi can cause disease in horses, especially in 
young foals. In humans, it mainly causes disease in those 
infected with HIV (Prescott et al., 1991). R. equi is also frequently 
isolated from granulomatous lesions in submaxillary lymph 
nodes of pigs (Komijn et al., 2007). R. equi strains diff er in viru-
lence. Virulent R. equi strains are isolated from horses and are 
characterized by the presence of virulence-associated 15- to 17-
kDa antigens (VapA). R. equi strains of intermediate virulence are 
identifi ed by a virulence-associated 20-kDa antigen (VapB) and 
are found in lymph nodes of pigs (Takai et al., 1996). Avirulent R. 
equi strains show no evidence of virulence-associated antigens 
or plasmid DNA and are widespread in soil. Humans can be 
infected with R. equi strains of the three virulence levels. The res-
ervoir for infection in humans is not clear. Earlier, the isolation of 
R. equi from lymph nodes of Dutch slaughter pigs was reported 
(Komijn et al., 2007). Here we describe the typing of these strains 
for virulence plasmids.
Materials and Methods
R. equi strains (n=46) isolated from lymph nodes of slaughter 
pigs originating from nine farms were used in this study (Komijn 
et al., 2007). Strain ATCC 33701 (virulent strain) and 27 represent-
ative strains of intermediate virulence were used as reference 
strains (Makrai et al., 2008). Plasmid DNA was extracted by an al-
kaline lysis method with some modifi cations and digested with 
the restriction endonucleases BamHI, EcoRI, EcoT22I and HindIII 
for detailed comparison and estimation of plasmid sizes (Takai et 
al., 1993, 1999). Samples of the plasmid preparations were separ-
ated in 0.7% or 1.0% agarose gels at approx. 5 V/cm for 2 h.
Results
None of the 46 R. equi isolates contained the vapA gene, 43 
isolates (93%) were positive for the vapB gene showing a 827-bp 
PCR product of the expected size. The 43 isolates of intermediate 
virulence contained seven diff erent virulence plasmids including 
three new plasmid variants (Table 1). On the basis of restric-
tion digestion patterns of plasmid DNAs, we tentatively desig-
nated these new variants as type 29, 30 and 31 (Table 1). R. equi 
strains with virulence plasmid 5 was most widespread, in strains 
isolated from pigs of eight of the nine farms this plasmid was 
found. In contrast, strains with plasmid type 1, 9, 29, 30 and 31 
were exclusively found in lymph nodes of pigs from single farms.
Table 1 Distribution of VapB-positive and negative plasmid types in 
R. equi strains isolated from lymph nodes of pigs originating from nine 
farms
Farm No. of strains containing plasmid type Total
No. 1 5 9 10 29 30 31 —
1 2 3 1 3
2 2 5
3. 2 2
4 2 1 3
5 3 3
6 4 1 2 7
7 1 1 10 12
8 2 4 2 8
9 3 3
Total 2 21 1 5 3 1 10 3 46
Discussion
In agreement with earlier fi ndings the R. equi strains isolated 
from lymph nodes of pigs appeared to be from intermediately 
virulence (Takai et al., 1996). In addition, compared to other 
studies, plasmid type 5 is the predominating one (Makrai et al., 
2008). 
Reports on R. equi infections in humans in the Netherlands are 
scarce. A further surveillance study among Dutch human R. equi 
strains is needed to answer the question to the risk of R. equi 
transmission from pigs to humans.
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Introduction
Toxoplasmosis is a worldwide zoonotic disease caused by 
Toxoplasma gondii, which infects most warm-blooded animals. 
In fact, human prevalence has been found worldwide in nearly 
one-third of the population (Tenter et al., 2000). 
The consumption of raw or undercooked pork meat containing 
tissue cysts is considered among the principal source for human 
infection (Dubey, 2009). Pigs can get infected with T. gondii 
through ingestion of sporulated oocysts in soil, vegetation or 
water, by ingestion of cysts in tissues of infected animals such as 
rodents, birds and other pigs, or congenitally (Dubey, 2009). 
The aim of the present study was to provide recent information 
on epidemiology and prevalence of T. gondii and the risk factors 
associated to this protozoan parasite in domestic pigs from the 
main swine producing regions of Spain.
Material and Methods
A cross-sectional study was conducted in 100 swine farms (83 
farrow-to-fi nish and 17 piglet production farms) located all over 
Spain between 2007 and 2009. 
Blood samples were collected from a total of 2,970 pigs. Four-
teen sows and 20 fattening pigs were randomly selected in each 
farrow-to-fi nish farm and samples from 14 sows were obtained 
from the piglet production farms. 
Presence of antibodies to T. gondii was tested by modifi cation 
agglutination test (MAT). The serum from each pig was tested at 
dilutions from 1:25, 1:50 and 1:500. Epidemiological data were 
collected through a structured fi lled-in questionnaire in order to 
provide information on exposure levels to potential risk factors. 
The eff ect of the exploratory variables on the response variable 
(seropositivity to T. gondii) was investigated by the method of 
generalized estimating equations (GEE). The statistical analyses 
were performed using SPSS v15.0.
Results
Antibodies (MAT 1:25 or higher) against T. gondii were detected 
in 492 (16.6%; CI95%: 15 2-18.0) of 2,970 pigs tested, with titers 
1:25 in 287 (58.3%), 1:50 in 171 (34.8%) and ≥ 1:500 in 34 (6.9%). 
Farm prevalence was 85.0% (CI95%: 78-92) and within-farm preva-
lence ranged from 2.9% to 92.8% (median= 17.6%). Signifi cantly 
higher seroprevalences were detected in Valencia Community 
(27.3%), Extremadura (23.3%) and Catalonia (21.2%) with respect 
to the other sampled regions. Sows with parity number higher 
than three had signifi cantly higher seropositivity to T. gondii 
compared to younger sows. The GEE showed that age sows 
compared to fattening pigs (OR= 2.9; CI95%=1.8 – 4.5), no rodent 
control (OR= 1.9; CI95%= 1.04 – 3.60) and presence of cats (OR= 
1.6; CI95%= 1.12 - 2.34) were risk factors potentially associated to 
T. gondii seroprevalence.
Discussion
The results showed widespread exposure to T. gondii among 
domestic pigs in Spain, with highly variable prevalence levels 
among farms and regions. The high seroprevalence rates indi-
cate that raw or undercooked pork could be a source for human 
infections in Spain and the need of consumption of properly 
cook pork, especially in pregnant women. 
Higher exposure was related to age of pigs, with the highest lev-
els observed in sows, and to poor management practices related 
to lack of rodent control and to the presence of cats in the farms. 
Therefore, in order to reduce the risk of infection by T. gondii 
in pig farms in Spain, adequate rodent control programs and 
restriction of cats in the farms should be advised, and especial 
emphasis of avoiding infection should be taken care in the sows.
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Introduction
Yersiniosis is the third most frequently reported human food-
borne gastroenteritis in Europe caused by Yersinia (Y.) entero-
colitica. Bioserotype 4/O:3 is the predominant type, which can 
be found especially in pigs’ tonsils and to a lesser degree in the 
intestine, the faeces and lymph nodes of slaughtering pigs (4). 
After evisceration, rinse water enables the spread of Y. enterocol-
itica to the organs of the pluck set, hanging on a hook beneath 
the tonsils (2).
The purpose of the study was to evaluate the prevalence and 
the resistant pattern of Y. enterocolitica isolated from liver 
surfaces of slaughtered pigs in order to estimate the risk of the 
consumer being infected with this zoonotic agent by off al of 
porcine origin.
Materials and Methods
In a slaughterhouse in Lower Saxony, 1,500 liver surfaces of pigs 
from 50 herds (30 livers from each herd) were swabbed during 
slaughtering process. Y. enterocolitica were grown in irgasan-
ticarcillin-potassium chlorate (ITC) broth, isolated on cefsoludin-
irgasan-novobiocin (CIN) agar, identifi ed with the API 20E system 
(bioMérieux, Nuertingen, Germany) and serotyped by slide 
agglutination (Sifi n, Berlin, Germany). Antimicrobial susceptibil-
ity was investigated by the broth dilution method following the 
instructions of the supplier (VetMICTMGN-mo-Plates, SVA, Upp-
sala, Sweden). Breakpoints to establish resistance were selected, 
based on CLSI recommendations for Enterobacteriaceae.
Results
Out of 1,500 swabs from liver surfaces, 70 (4.7 %) were positive 
for Y. enterocolitica O:3. No other serotype was identifi ed. At herd 
level, up to seven liver surfaces per herd were positive. From 22 
herds (44.0 %), Y. enterocolitica could not be isolated.
All isolates were resistant to ampicillin and sulfamethoxazole. 
Multi-resistance to four antimicrobials was observed in four 
strains (6.8 %).
Discussion 
Isolation of Y. enterocolitica O:3 was successful from liver surfaces 
of pigs from 56 % of the tested herds. However, sampling of liver 
surfaces does not consequently refl ect the prevalence on the 
farm, since cross-contamination in abattoirs may occur. Alto-
gether, not even fi ve per cent of the livers were contaminated, 
which does not seem to represent a high risk for consumers. But 
the psychotropic agent is able to grow at temperatures close to 
0°C. Therefore, low contaminated pork might reach a contam-
ination rate of clinically signifi cant levels during the course of 
storage period (3).
Monitoring of antimicrobial resistance became compulsory for 
the EU member states by the directive 2003/99/EC, because 
resistance of zoonotic pathogens may potentially reduce the 
eff ectiveness of antimicrobial treatment of foodborne disease 
if contracted by humans (1). Altogether, 27.3 % of the strains 
were resistant to three or more antimicrobials. Nevertheless, 
antimicrobials used for the therapy of extraintestinal Yersinia 
infections in humans, where third-generation cephalosporine or 
fl uoroquinolones are recommended, were not aff ected.
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Table 1: Antimicrobial resistance of 65 Y. enterocolitica O:3 isolates
Antimicrobial Agent Breakpoint (mg/L) Part of resistant strains
Ampicillin > 32 100 %
Ciprofl oxacin > 2 0
Nalidixic acid > 32 0
Gentamicin > 16 0
Ceftiofur > 8 0
Streptomycin > 16* 18.5 %
Tetracyclin > 16 0
Florfenicol > 8 13.8 %
Kanamycin > 64 0 %
Sulphamethoxazole > 512** 100 %
Trimethoprim > 16 7.7 %
Chloramphenicol > 32 0 %
Cefotaxime > 32 0 %
*Source: CA-SFM, **Breakpoint of sulfi soxazole
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Introduction
E. coli are the most frequent pathogens causing diarrhea in pigs. 
Besides diarrhea, they can also cause septicemias and cystitides. 
Suckling and weaned piglets most often suff er from diarrhea, 
whereas colitoxin shock is most often found in piglets short after 
weaning.
E. coli are gram-negative bacteria belonging to the family of 
Enterobacteriaceae. Classifi cation is based on O-, K-, H-, and F-
antigens. Additionally, E. coli are classifi ed as enterotoxic (ETEC), 
enteropathogenic (EPEC), necrotoxic (NTEC), and shigatoxin-like 
producing (STEC) strains due to their pathogenic factors. STECs 
are further divided into enterohemorrhagic (EHEC) and edema 
disease causing (EDEC) strains (1). 
Due to the clinical importance of these bacteria, large scale 
usuage of antibiotics is the consequence. As antibiotic usuage 
is an eff ective measure in the fi ght against bacterial infections 
if administered correctly on the one hand, but may lead to un-
favourable side-eff ects such as increasing antibiotic resistance 
if given careless on the other hand (2), the following data aim at 
helping the practitioner in his decision which antibiotic to use.
Materials and Methods
E. coli isolates out of 444 pigs (24 suckling piglets, 314 weaners, 
88 fattening pigs, and 13 sows) suff ering from diarrhea were 
tested for their antibiotic sensitivities by routine agar diff usion 
test. Following antibiotic substances were included: amoxicillin, 
cefquinome, colistin, enrofl oxacin, gentamicin, lincospectin, and 
sulfamethoxazole-trimethoprim.
Results
solates were most sensitive to cefquinome and enrofl oxacin. 
Thus, bacterial growth could be inhibited at 98.8 % by cefquin-
ome and at 89.9 % by enrofl oxacin. Sensitivities to the other 
antibiotics were less pronounced (lincospectin: 60.7 %, sulfa-
methoxazole-trimethoprim: 54.9 %, gentamicin: 40.9 %, colistin: 
36.2 %, amoxicillin: 21.0 %). Single isolates, which were addition-
ally tested for their sensitivites against neomycin and tylosine, 
were completely resistant against these substances.
Additionally, diff erences in the susceptibilities were found 
concerning the source, i.e. the diff erent age groups. 100 % of 
isolates derived from fattening and breeding animals were 
susceptible to cefquinome and 95.7 % of isolates from fatten-
ing pigs alone to enrofl oxacine. Nevertheless, susceptibilities 
to gentamicin and amoxicillin were reduced (25.5 %, 14.9 %) in 
these animals. Isolates of sows were comparably highly suscept-
ible to lincospectin (76.9 %) and those of suckling piglets to 
lincospectin, sulfamethoxazole-trimethoprim, and gentamicin 
(91.7 %, 87.5 %, 65.0 %). However, these age-dependent data are 
considered preliminary due to the small number of animals in 
the age groups of suckling piglets and sows.
Discussion
This study exhibited marked diff erences in the antibiotic sus-
ceptibility of fecal E. coli isolates. Importantly, isolates showed 
reduced sensitivities against the frequently applied substance 
colistin and also against the broad-spectrum antibiotic amoxi-
cillin. Cefquinome and enrofl oxacin were shown to be most 
eff ective against fecal E. coli isolates. 
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Introduction
Immunmodulatory eff ect of the combination butafosfan and 
vitamin B12 (Catosal®) in sheep (1), calves (2) and mice (3) was 
already reported. Benefi cial eff ect of Catosal® on metabolic 
function in the farrowing sows was also reported (4). The 
purpose of the present study was to investigate the eff ect of 
the metaphylactic treatment with Catosal® in pregnant sows on 
the immunoglobulines in colostrum and blood of sows and on 
newborn piglets. Furthermore, production paramaters were also 
investigated.
Material and method
Thirty randomly selected pregnant crossbred sows were allocat-
ed in one of two study groups equally. All sows were managed 
and treated with same standard routine applications during the 
pregnancy. Catosal® group was treated with 20 ml of Catosal® 
(100 mg butafosfan and 0,05 vitamin B12/ml) at 3 weeks, 2 
weeks and 1 week before farrowing start intramuscularly. And 
control group did not receive Catosal® but 20 ml saline. Colos-
trum and blood samples from all sows were collected at the 
start of farrowing to test the immunoglobulines (IgG, IgM, IgA). 
Blood was collected from new born piglets at 3 days of age to 
test above mentioned immunoglobulines (n=15 for each group). 
Farrowing and weaning performance of sows and piglets was 
evaluated. Commercial Indirect ELISA test kit (Bethyl Laborator-
ies Inc., Montgomery, TX) for analysis of the total immunoglobu-
lins (IgG, IgM, IgA) in the colostrums and blood was used. Plasma 
and colostral samples were diluted at 1:10,000 for the analysis. 
All piglets in the study groups had standard routine treatments. 
Data were analyzed statistically based on Wilcoxon-Mann-Whit-
ney-U Test, two sided, 95% CI.
Results
Mean number of alive born piglets in Catosal and control group 
litters was 10.8 and 10.9 respectively. Metaphylaxis with Catosal® 
had signifi cant benefi cial eff ect for the immunity (Table 1) and 
weaning weight of liveborn piglets (Figure 1). There was an 
increase by 6% (534 g) in the weaning weight of liveborn piglets 
in the Catosal group compared to control group (p<0,05). An 
increase (2,6%) in the survivability of alive born piglets up to 
weaning was observed in the Catosal group (91,4%), but this 
increase could not be proven statistically. In the fi rst week of life, 
piglets in Catosal® group had better fecal consistency, low diar-
rhoea incidence.
Conclusion
Metaphylaxis with Catosal® at prepartum period stimulated the 
immunity of sows that resulted in increased immunoglobulines 
in colostrum and consequently in piglets. An increased weaning 
weight was a signifi cant economic benefi t of the treatment.
Catosal Control p
IgG (mg/ml) Sow colostrum 60.46±3.738 54.54±4.218 <0.05
Sow serum 23.35±2.133 21.58±2.291 <0.05
Piglet serum 23.83±1.213 23.97±1.330 >0,05
IgA (mg/ml) Sow colostrum 7.78±1.437 6.53±1.079 <0.05
Sow serum 2.25±0.295 1.98±0.306 >0,05
Piglet serum 2.78±0.187 2.19±0.087 =0.0000
IgM (mg/ml) Sow colostrum 3.56±0.061 3.37±0.265 <0.05
Sow serum 2.98±0.168 2.92±0.304 >0,05
Piglet serum 1.33±0.081 1.28±0.096 >0,05
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Introduction
Valnemulin (Econor® - Novartis Animal Health Inc.), a 
pleuromutilin with exceptional activity against the gut patho-
gens Brachyspira hyodysenteriae and B. pilosicoli was reported 
to have good activity against Lawsonia intracellularis (Li), (1) 
the causal agent of Porcine Proliferative Enteropathy or ‘ileitis’. 
Valnemulin (VAL) has been shown to be highly eff ective in the 
treatment of ileitis (1) when given in feed. It was the purpose of 
this paper to look at the pharmacokinetics (PK) of VAL in the gut 
contents and relate these to the pharmacodynamics (PD) of VAL 
and its clinical eff ect against Li.
Materials and Methods
A) Pharmacokinetics (PK)
VAL concentrations were described in colon contents (2) follow-
ing in feed medication at approximately 75 and 200 ppm for 28 
days at 1.6 and 5.2μg/g. The relationship between colon and 
ileum contents was modelled (3) and it was estimated that an 
eff ective steady state concentration of approximately 29% of the 
colon contents was found in the ileum. These fi gures were used 
to determine the ileum contents concentration of VAL at 0.49 
and 1.5μg/ml, respectively.
B) Pharmacodynamics (PD)
A recent report (4) showed that VAL had a very low intracellular 
MIC 90 against 10 isolates of Li from the United States (n=6) and 
Europe (n=4), at ≤0.125μg/ml. This level was much lower than 
previously reported (1) at <2μg/ml. The in vitro method was 
slightly diff erent and used McCoy cells rather than rat entero-
cytes (IEC-18 cells) to grow the Li. They also used a wider range 
of diff erent concentrations (0.125-128μg/ml) than the original 
study, making a titration of low and high MICs possible.
C) Clinical eff ect
In an artifi cial challenge trial (1), VAL was given in feed at 25, 
37.5 & 50 ppm, from 2 days before challenge with Li strain 
LR189/5/83, with an intracellular MIC of <0.125μg/ml, until 
termination 21 days after infection. In the treatment challenge 
study (1), VAL was given 7 days after infection for 14 days until 
termination (see Table 1). 
Lesions in the ileum were examined grossly and histologically.
Results and Discussion
Eff ective concentrations of VAL are achieved in the ileum con-
tents, which inhibited the development of gross lesions of ileitis 
at 50 ppm. At 75 ppm VAL and above, no gross or microscopic 
lesions were observed (see Figure 1 & 2) following treatment. 
Table 1: Necropsy results (ileum) of the prevention (25, 37.5 & 50 ppm) 
and treatment (75 & 125 ppm) trial
Treatment Gross lesions Micro lesions
Infected control 5/7 6/7
VAL 25ppm (P) 2/7 6/7
VAL 37.5ppm (P) 1/5 2/5
VAL 50ppm (P) 0/7 1/7
VAL 75ppm (T) 0/7 0/7
VAL 125ppm (T) 0/7 0/7
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Introduction
Weight loss by the sow should not be more than 12% during 
lactating period, which will support good piglet assistance, 
a fast return to heat after weaning and a good reproductive 
performance in the subsequent parturition (1). The aim of 
this trial was to evaluate the impact of Catosal® (Butaphos-
phan 100mg and Cyanocobalamin 0,05mg/mL; Bayer Animal 
Health; in some countries available as Catosal®B12, Coforta® or 
Phosphorum®B12) in lactating sows on diff erent parameters, 
including feed intake and weight loss during lactation period. 
Materials and Methods
The experiment was conducted in a Brazilian commercial farm 
including 360 sows which were equally distributed in blocks ac-
cording to the parturition order: fi rst parturition, second partur-
ition, and between third and sixth parturition. These blocks were 
distributed into four treatments, with 90 repetitions, and each 
animal was considered an experimental unit. Around 110 days of 
gestation the sows were transferred to the farrowing facility and 
received the lactation diet in the restricted amount of 2.0 kg/
day. After farrowing, feed was distributed twice in a day, ad lib-
itum. The wet feed consisted of 58% feed and 42% water. Sows 
were weighted in the entrance and in the exit of the farrowing 
unit, and the feed intake was measured daily. The weaning was 
proceeded when piglets were 21 days old. The treatment groups 
were classifi ed as: T1 (negative control), T2 (10mL of Catosal®), T3 
(15mL of Catosal®) and T4 (20mL of Catosal®). The product was 
administered intramuscularly after detection of the fi rst signals 
of parturition.
Results
Average weekly feed intake was high for all treatments in the 
fi rst lactation week. However, the T4 group had statistically high-
er average feed intake (p<0.05) than the control group T1 on 
lactation week 1, 2 and 4 (Table 1) as well as total feed consump-
tion during lactation of T4 was signifi cantly higher than T1. For 
absolute values of weight loss, it was observed that the T4 group 
had a lower weight loss with statistical signifi cance (p<0.05) 
than the groups T1 and T2. The T3 group also had a lower weight 
loss with statistical signifi cance than the group T1. 
For the percentages of weight loss, only the T4 group had a 
lower weight loss with statistical signifi cance (p<0.05) than the 
groups T1 and T2. 
Table 1: Weekly feed intake (kg/day) of lactating sows and average 
consumption during lactation.
W1 W2 W3 W4 AC
T1 7.71 B 9.54 B 10.45 A 8.28 BC 9.28 B
T2 8.00 A 9.84 AB 10.45 A 7.86 C 9.40 AB
T3 8.07 A 9.76 B 10.50 A 8.70 AB 9.43 AB
T4 8.21 A 10.17 A 10.58 A 9.00 A 9.64 A
W = average consumption during a specifi c week of the lactat-
ing period; Number after W = week of the lactation period; AC = 
average consumption for the entire period of lactation. Diff erent 
capital letters in the same column indicate statistically signifi -
cant diff erence (p <0.05)
Table 2: Sow weight loss during lactation in kg.
Weight loss (kg)
T1 27.57 A
T2 26.39 AB
T3 24.36 BC
T4 22.43 C
Diff erent capital letters in the same column indicate statistically 
signifi cant diff erence (p<0.05).
Discussion 
Sows that received 15 and 20 mL of Catosal® at farrowing had 
lower weight loss during the suckling period with a diff erence 
from T1 such as 3.21 kg and 5.14 kg respectively. This fact is 
clearly associated with an increased feed intake (appetite) in 
these treatment groups. Catosal® application at farrowing stimu-
lates the appetite of sows during lactation and prevents from 
weight loss at the critical time point where sows should feed 
newborn piglets. 
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Eijalin Z. Bautista1 Zoilo M. Lapus2, 4, 3 Jomer B. Fule1 Serafi n Jr L. Garciano1
1. Bayer Philippines Inc., Laguna, Philippines; 2. Philippine College of Swine Practitioners, Quezon City, Philippines; 
3. Asian Pig Veterinary Society, Quezon City, Philippines; 4. Swine Consultant, Quezon City, Philippines
Introduction
In intensive pig production systems, pigs are exposed to 
multiple stressors such as handling, mixing with unfamiliar 
conspecifi cs, and movement to other buildings, all of which may 
adversely aff ect performance of the animals. Stress causes the 
release of catabolic hormones like cortisol which can negatively 
aff ect metabolism, leading to reduced weight gain in these 
growing animals (Ekkel et al., 1995). Coforta®/ Catosal® is a 
metabolic stimulant and tonic supplement containing 100 mg 
butaphosphan and 0.05 mg of cyanocobalamin per ml as active 
ingredients. It has been reported to reduce stress by reducing 
cortisol levels (van der Staay et al., 2006; de Groot et al., 2003). 
This fi eld study aimed to investigate the eff ects of Catosal® on 
the weight gain of pigs when given strategically during stress-
ful periods such as handling, movement and transfer to other 
buildings.
Materials and Methods
This fi eld study was conducted in a 300 sow level farm. Twenty 
clinically healthy, purebred sows and their piglets were divided 
into two groups, the treatment group (N= 108 piglets), and 
control group (N=111 piglets). In the treatment group, the sows 
received two injections of Catosal® at 20 ml per dose once at the 
start of farrowing and the second dose 28 days post-farrowing 
(weaning day). The corresponding piglets were given Catosal® 
at the following dosages and schedules: 1 ml at day 3 of age, 
coinciding with the administration of iron dextran and toltrazuril 
0.4 ml/ kg; 1 ml at day 28 (weaning day); 2 ml when the piglets 
were transferred from the farrowing building to the fl at deck, 
and 5 ml upon transfer from the fl at deck to the grower build-
ings. 
The sows and piglets from the control group remained untreat-
ed with any preparation similar to Catosal®, nor with a placebo, 
apart from a single dose of Catosal® given to the piglets at 10 
days of age, which was the usual farm program. 
All piglets were weighed at birth, at weaning, during transfers 
and upon market. 
Results and Discussion
The pigs in the Catosal® group had signifi cantly higher average 
daily gain (ADG) in the diff erent stages of production compared 
to the control group. Even by adjusting weight gain at 40 days 
and 80 days of rearing period in the fl at deck and grower-fi nish-
er buildings, respectively, and at 150 days birth-to-market rear-
ing period in order to have an equal basis of comparison, weight 
gain was signifi cantly higher in the group from post-weaning 
until market. By the end of the trial, the ADG of the Catosal® 
group was higher by 58 grams per day, which translated to an 
average of 8.5 kilogram-diff erence in the weight gain of the 
Catosal® group.
Table 1.
Control Catosal p-value
Ave. birth weight (kg) 1.50 (N= 111) 1.55 (N=108) >0.05
Ave. birth weight upon transfer to fl at 
deck (kg) 13.66 (N=96) 15.31 (N= 96)
Ave. daily weight gain (ADG) fl at 
deck (kg) 0.547 0.627 <0.05
Adjusted weight gain for 40-day 
rearing period in the fl at deck (kg) 21.90 25.08 <0.05
Ave. weight upon transfer to the 
grower building (kg) 35.7 (N= 96) 40.52 (N= 96)
ADG grower-fi nisher (kg) 0.761 0.831 <0.05
Adjusted weight gain for 80-day 
rearing period in the grower-fi nisher 
building (kg)
60.90 66.50 <0.05
Ave. market weight (kg) 92.49 (N= 96) 102.01 (N= 94) <0.05
Ave. market age 174.32 173.23 >0.05
ADG day 0 to market (kg) 0.523 0.581 <0.05
Adjusted weight gain at 150 days (kg) 78.44 87.09 <0.05
Conclusions
In this fi eld trial, Catosal® given to pigs during stressful periods in 
production resulted to a signifi cantly increased daily weight gain 
and market weight of pigs. This resulted, based on the return 
on investment calculation, to high profi tability for the farmers 
(17.02 USD per head under Philippine conditions). There were no 
treatment-related side eff ects neither in piglets nor in pigs.
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Introduction
Infection and environmental conditions make infl ammation a 
manifestation of respiratory disease in pigs that decrease the 
ability of the lungs to exchange gases. In fact, the infl ammatory 
response may become so overwhelming as to be life threaten-
ing in itself (1, 2). 
The benefi ts of therapeutic intervention with non-steroideal 
anti-infl ammatory drugs (NSAIDs) are because of their proper-
ties as inhibitors of the actions, synthesis or release of infl amma-
tory mediators. In addition, one of the eff ects of NSAIDs, such 
as acetylsalicylic acid (AAS), is to act as antipyretics, improve the 
general clinical status of animals and increase food and water in-
take. The aim of this study was to investigate the clinical effi  cacy 
of AAS as an adjunct to the antibacterial treatment of porcine 
respiratory disease. 
Material and Methods
142 piglets of 4 months of age were divided in two groups 
(experimental and control group). These animals were suff ering 
a respiratory disease. The inclusion criteria was the presence 
of pyrexia (>39.7 °C) in the animals. Experimental group (A) 
received Doxycline hiclate and AAS by drinking water at a dose 
of 10 mg/Kg (doxiporc®, Laboratorios Policherm, Spain) and 100 
mg/kg of body weight (fi ebrina porcino®, Laboratorios SYVA, 
Spain) for fi ve consecutive days, respectively whereas control 
group (B) received only the antibiotic treatment. The animals 
were clinically examined before treatment (day 1) and at 2, 3, 
4, 5 and 6 days after treatment for rectal temperature (°C) and 
abdominal breathing, cough and depression. Each parameter 
was scored using a scale of 0 = normal, 1 = slight or moderate 
and 2 = severe according to Moore et al. (1986). A statistical 
analysis was performed by paired t-test using the statistical soft-
ware SPSS System v15.The alpha level used for determination of 
signifi cance for all analyses was P < 0.05.
Results
The experimental group showed always a mean temperature 
lower than the negative control group (group B) throughout 
the trial (see fi gure) and this fever decrease for animals receiv-
ing AAS (group A) is statistically signifi cant at days 2, 5 and 6 of 
the trial (p<0.05) in comparison with animals not receiving AAS 
(group B). However, it was not observed signifi cant diff erences 
for respiratory symptoms throughout the trial between both 
groups.
Discussion
NSAIDs are used to block the production and/or the eff ects of 
infl ammatory mediators and modulators which may have a 
deleterious eff ect on alveolar exchange of gases (3). Results sup-
port the idea that AAS is an eff ective adjunct in the treatment of 
porcine respiratory disease complex to decrease fever. However, 
we did not observe a synergic eff ect to decrease respiratory 
symptoms in animals receiving antibiotic and AAS. Nevertheless, 
it was not possible to check the lung infl ammation to observe 
the anti-infl ammatory eff ect at lung level as observed in bovine 
for other NSAIDs (4).
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PK and PK/PD of Pharmasin® 250 mg/g Premix (tylosin phosphate) 
following multiple oral administration in pigs
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Introduction
In this study we determined some pharmacokinetic (PK) param-
eters of tylosin as Pharmasin® 250 mg/g Premix (Huvepharma 
NV) and related these to its pharmacodynamic (PD) with a view 
to a substantiated clinical use.
Materials and Methods
Eleven mixed breed pigs, weighing 20–25kg without a history 
of macrolide administration were enrolled in the study. Ten 
animals, equally male and female, received tylosin (as phos-
phate) at 10 mg/kg BW / 24h (Pharmasin® 250 mg/g Premix) via 
feed off ered ad libitum prepared daily at 6.00 am for 5 consecu-
tive days. During the treatment 40 heparinized blood samples 
were obtained from each pig at predetermined intervals. One 
pig received no drugs and served as negative control. On the 
5th day the treated pigs were euthanized: 2 animals at each of 
the 5 diff erent time points. Blood, organ and tissue samples 
from respiratory and GI tract were collected. Plasma and organ 
(tissue) tylosin concentrations were measured by validated HPLC 
method. 
Results
The plasma concentration-time profi le of tylosin showed nearly 
identical daily courses within the treatment period (Fig. 1). 
There were no signifi cant diff erences between the 4 daily peak 
concentrations (Cmax) and between Cmin or AUC values (Re-
peated measures ANOVA Scheff e post hoc test). However, the 
individual plasma concentration data were quite variable and 
showed that in 70% of the animals, steady state was reached 
at 54.4±7.7 h after administration initiation. After 4 days of 
treatment Cmax-ss was 0.55±0.04 μg/mL, Cmin-ss 0.30±0.03 μg/mL, 
Cav-ss 0.42±0.03 μg/mL and AUC0-24h 10.14±0.84 μg.h/mL. Steady 
state tylosin concentrations in lung tissue and bronchial mucosa 
and secretions peaked 4h after the 5th administration, being 
0.95±0.05 μg/g and 1.09±0.06 μg/g, respectively, and persisted 
to the last sampling point (12thh) being 0.85±0.06 μg/g and 
0.97±0.04 μg/g, respectively. The corresponding tissue/plasma 
ratios of AUC were 1.81 and 2.04.
Table 1. Steady state organ (tissue) pharmacokinetic parameters of 
tylosin (mean±SEM) in pigs, following 4-day p.o. administration at 
10 mg/kg / 24h of tylosin phosphate as Pharmasin® 250 mg/g premix 
(0–12h)
Parameters, 
units
Blood 
plasma
Lung 
tissue
Bron-
chial 
mu-
cosa*
Ileum 
wall
Ileal 
content
Colon 
wall
Colonic 
content
AUC0-12h, μg.h/
mL(g) 5.34 9.69 10.87 3.33 340.80 46.28 915.90
T/P1 ratio of AUC NC 1.81 2.04 0.62 63.82 8.67 171.52
Cmax, μg/mL(g) 0.53 0.95 1.09 0.33 31.4 4.76 89.4
Tmax, h 8.0 4.0 4.0 4.0 12.0 8.0 4.0
C12th h, μg/mL(g) 0.52 0.85 0.97 0.24 31.4 3.08 67.3
MRT, h 32.3 49.0 40.1 22.4 12.9 11.9 27.6
T/P1 ratio of Cmax NC 1.79 2.05 0.62 59.2 8.98 168.67
T/P1 ratio of C12th h NC 1.63 1.86 0.63 60.38 9.15 171.42
*Bronchial mucosa and secretions; 1Tissue/Plasma; NC, Not Calculated (each datum represents 
mean of 2 animals).
 Discussion and Conclusion
The mean plasma steady state values of Cmin-ss and of Cav-ss were 
higher than the MIC90 described for clinically important porcine 
bacterial pathogens of respiratory tract: M. hyopneumoniae – 
0.25 μg/mL1, E. rhusiopathiae – <0.13 μg/mL3, Leptospira spp. 
– 0.06 μg/mL3. This was valid also for organ (tissue) steady state 
concentrations in respiratory tract which were higher than those 
in plasma. The concentration in ileal and colonic content pro-
vided active levels against L. intracellularis–MIC90=4 μg/mL2 and 
some sensitive strains of B. hyodysenteriae – MIC90>16>256 μg/
mL2. The effi  cacy PK–PD breakpoint of macrolide antibiotics is 
a time above the MIC (T>MIC) of 50–80% of dosage interval4. In 
this study active tylosin antimicrobial levels persisted through-
out the period of administration. Therefore, tylosin phosphate 
as Pharmasin® 250 mg/g Premix at the dosage schedule tested 
complies with the requirements of PK–PD approach. This sup-
ports its clinical use in the control of respiratory and gastro-
intestinal infections.
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Introduction
Tylosin is a macrolide antibiotic that acts mostly against Gram-
positive bacteria and mycoplasmata. Although it has been used 
in veterinary medicine for a long time the data on its pharmaco-
kinetic (PK) properties in pigs are incomplete. This study aimed 
at providing PK data of tylosin as Pharmasin® 250 mg/g Premix 
(Huvepharma NV) that could aid PK–pharmacodynamic (PD) 
integration as a rational base for its clinical use.
Materials and Methods
Six healthy pigs, equally male and female, weighing 20–25 kg 
without a history of macrolide administration were enrolled in 
the study. The animals received by intubation a single p.o. dose 
of tylosin (as phosphate) 10 mg/kg BW (Pharmasin® 250 mg/g 
Premix), as water suspension. Heparinized blood samples (n=13 
per animal) were taken at predetermined intervals. Plasma 
tylosin concentrations were measured by a validated HPLC 
method. The results obtained for tylosin disposition were tested 
by compartmental method (using Akaike’s information criterion) 
and by non-compartmental approach as well.
Results
Plasma concentration vs. time data best fi tted applying the non-
compartmental model. The highest plasma concentration (Cmax 
= 1.08±0.08 μg/mL) was achieved 2h post administration. There-
after, plasma levels declined remaining higher than 0.38±0.017 
μg/mL at 12h post administration (Fig. 1). The half-life (t1/2 β’) 
was 6.66h. AUC0-tlast and AUC0-∞ were 8.2±0.49μg.h/mL and 
11.84±0.58μg.h/mL, respectively (Table 1).
 
Table 1. Pharmacokinetic parameters of tylosin in pigs following 
single oral dose of 10 mg/kg BW
Parameters, Units Tylosin, 10mg/kg BW
β´ (h-1) 0.105±0.002
t1/2β
´ (h) 6.66±0.17;6.64*
Cmax (μg.mL) 1.08±0.08
Tmax (h) 2.0±0
AUCtlast (μg.h/mL) 8.2±0.49
AUC0-∞ (μg.h/mL) 11.84±0.58
MRT (h) 10.32±0.23
tlast (h) 12.0
*Harmonic mean, each datum represents the mean ± SEM
Discussion and Conclusion
The elimination half-life of tylosin, calculated after single oral 
dose (6.66h), was higher than that reported after i.v. injection 
(4.5h)2 and the peak plasma concentration was comparable to 
the one found after i.m. injection (1.0 μg/mL)2. Throughout the 
period of determination plasma tylosin levels were higher than 
the MIC90 described for clinically important porcine bacterial 
pathogens: Mycoplasma hyopneumoniae - 0.25 μg/mL1, Erysip-
elothrix rhusiopathiae - <0.13 μg/mL3, Leptospira spp. – 0.06 μg/
mL3. 
A primary precondition in PK–PD approach for the eff ective-
ness of macrolide antibiotics is a time above the MIC (T>MIC) 
of 50–80% of dosage interval4. The results of this study show 
that tylosin PK at the dosage schedule tested complies with this 
requirement and can ensure therapeutically eff ective concentra-
tions throughout the 12h period of determination. This supports 
clinical use of tylosin phosphate as Pharmasin® 250 mg/g Premix 
in the control of respiratory and gastro-intestinal infections.
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Introduction
In this study we investigated the pharmacokinetic (PK) behavior 
of tylosin as Pharmasin® 100% w/w WSG (Huvepharma NV) in 
pigs in order to explore PK–pharmacodynamic (PD) integration 
as rational basis for its clinical use.
Materials and Methods
Eleven mixed breed pigs, weighing 20–25 kg without a history 
of macrolide administration were enrolled in the study. Ten 
animals, equally male and female, received tylosin (as tartrate) at 
10 mg/kg BW / 24h (Pharmasin® 100% w/w WSG) as medicated 
drinking water off ered ad libitum daily freshly prepared at 6.00 
am for 5 consecutive days. During the treatment 40 heparinized 
blood samples were obtained from each pig at predetermined 
intervals. One pig did not participate and served as negative 
control. On the 5th day the treated pigs were euthanized: 2 
animals at each of the 5 diff erent time points. Blood, organ and 
tissue samples from respiratory and GI tract were collected. 
Plasma and organ (tissue) tylosin concentrations were measured 
by validated HPLC method.
Results
The plasma concentration-time profi le of tylosin showed nearly 
identical daily courses within the treatment period (Fig. 1). 
There were no signifi cant diff erences between the 4 daily peak 
concentrations (Cmax) and between Cmin or AUC values (Re-
peated measures ANOVA Scheff e post hoc test). However, the 
individual plasma concentration data were quite variable and 
showed that in 70% of the animals steady state was reached at 
46.9±6.33 h after treatment initiation. After 4 days treatment 
Cmax-ss was 0.58±0.04 μg/mL, Cmin-ss – 0.28±0.03 μg/mL, Cav-ss – 
0.45±0.04 μg/mL, and AUC0-24h – 10.73±0.92 μg.h/mL. Steady 
state tylosin concentrations in lung tissue and bronchial mucosa 
and secretions peaked 2h after the 5th administration, being 
0.93±0.06 μg/g and 1.06±0.06 μg/g, respectively, and persisted 
to the last sampling point (12thh), being 0.67±0.12 μg/g and 
0.78±0.13 μg/g, respectively. The corresponding tissue/plasma 
ratios of AUC were 1.88 and 2.17. 
Table 1. Steady state organ (tissue) pharmacokinetic parameters of 
tylosin (mean±SEM) in pigs, following 4-day p.o. administration at 10 
mg/kg / 24h of tylosin tartrate as Pharmasin® 100% w/w Water Soluble 
Granules (0-12h)
Parameters, 
units
Blood 
plasma
Lung 
tissue
Bron-
chial 
mu-
cosa*
Ileum 
wall
Ileal 
content
Colon 
wall
Colonic 
content
AUC0-12h, μg.h/
mL(g) 5.19 9.75 11.28 2.87 288.55 38.36 816.85
T/P1 ratio of AUC NC 1.88 2.17 0.55 55.6 7.39 157.39
Cmax, μg/mL(g) 0.65 0.93 1.06 0.29 27.2 4.05 76.7
Tmax, h 2.0 2.0 2.0 8.0 4.0 4.0 4.0
C12th h, μg/mL(g) 0.32 0.67 0.78 0.24 20.8 2.48 71.3
MRT, h 14.1 17.0 16.2 13.1 18.0 13.6 11.1
T/P1 ratio of Cmax NC 1.43 1.63 0.45 41.8 6.23 118.0
T/P1 ratio of C12th h NC 2.09 2.44 0.75 65.0 7.75 222.8
*Bronchial mucosa and secretions; 1Tissue/Plasma; NC, Not Calculated (each datum represents 
mean of 2 animals).
Discussion and Conclusion
The mean plasma steady state values of Cmin-ss and of Cav-ss were 
higher than the MIC90 described for clinically important porcine 
bacterial pathogens of respiratory tract: M.hyopneumoniae – 
0.25 μg/mL1, E. rhusiopathiae – <0.13 μg/mL3, Leptospira spp 
– 0.06 μg/mL3. This was valid also for organ (tissue) steady state 
concentrations in respiratory tract which were higher than those 
in plasma. The concentration in ileal and colonic content pro-
vided active levels against L. intracellularis – MIC90 = 4 μg/mL2 
and some sensitive strains of B. hyodysenteria – MIC90>16>256 
μg/mL2.
Generally, PK–PD breakpoint for clinical and bacteriological ef-
fi cacy of macrolide antibiotics is a time above the MIC (T>MIC) 
of 50–80% of dosage interval4. In this study active tylosin 
antimicrobial levels persisted throughout the period of adminis-
tration. Therefore, tylosin tartrate as Pharmasin® 100% w/w WSG 
at the dosage schedule tested complies with the requirements 
of PK–PD approach. This supports its clinical use in the control of 
respiratory and gastro-intestinal infections.
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Introduction
Tylosin is a macrolide antibiotic that acts mostly against Gram-
positive bacteria and mycoplasma. Although it has been used 
in veterinary medicine for a long time the data on its pharma-
cokinetic (PK) properties in pigs are incomplete. The aim of this 
study was to obtain PK data intended to facilitate PK–pharmaco-
dynamic (PD) integration in clinical use of tylosin as Pharmasin® 
100% w/w Water Soluble Granules (Huvepharma NV).
Materials and Methods
Six healthy pigs, equally male and female, weighing 20–25 kg 
without a history of macrolide administration were enrolled in 
the study. The animals received by intubation a single p.o. dose 
of tylosin (as tartrate) 10 mg/kg BW (Pharmasin® 100% w/w 
Water Soluble Granules), dissolved in water. Heparinized blood 
samples (n=13 per animal) were taken at predetermined inter-
vals. Plasma tylosin concentrations were measured by a valid-
ated HPLC method. The results obtained for tylosin disposition 
were tested by compartmental method (using Akaike’s informa-
tion criterion) and by non-compartmental approach as well.
Results
Plasma concentration vs. time data fi t best by applying the 
non-compartmental model. The highest plasma concentration 
(Cmax = 1.10±0.08 μg/mL) was achieved 2h post administra-
tion. Thereafter, plasma levels declined remaining higher than 
0.31±0.2 μg/mL at 12h post administration (Fig. 1). The half-life 
(t1/2 β’) was 5.6h AUC0-tlast and AUC0-∞ were 7.79±0.58 μg.h/mL 
and 10.31±0.75 μg.h/mL, respectively (Table 1).
 
Table 1. Pharmacokinetic parameters of tylosin in pigs following 
single oral dose of 10 mg/kg BW
Parameters, units Tylosin, 10 mg/kg BW
β´ (h-1) 0.124±0.002
t1/2β
´ (h) 5.6±0.08;5.59*
Cmax (μg/mL) 1.1±0.08
Tmax (h) 2.0±0
AUCtlast (μg.h/mL) 7.79±0.58
AUC0-∞ (μg.h/mL) 10.31±0.75
MRT (h) 8.69±0.1
tlast (h) 12.0
*Harmonic mean, each datum represents the mean ± SEM
Discussion and Conclusion
The elimination half-life of tylosin, calculated after single oral 
dose (5.6h), was higher than that reported after i.v. injection 
(4.5h)2 and the peak plasma concentration was comparable to 
this found after i.m. injection (1.0 μg/mL)2. Throughout the per-
iod of determination plasma tylosin levels were higher than the 
MIC90 described for clinically important porcine bacterial patho-
gens: Mycoplasma hyopneumoniae – 0.25 μg/mL1, Erysipelothrix 
rhusiopathiae – <0.13 μg/mL3, Leptospira spp. – 0.06 μg/mL3. 
According to PK–PD approach the breakpoint for clinical eff ect-
iveness of macrolide antibiotics is a time above the MIC (T>MIC) 
of 50–80% of dosage interval4. The results of this study show 
that tylosin PK at the dosage schedule tested complies with this 
requirement and can ensure therapeutically eff ective concentra-
tions throughout the 12h period of determination. This supports 
clinical use of tylosin tartrate as Pharmasin® 100% w/w Water 
Soluble Granules in the control of respiratory and gastro-intes-
tinal infections.
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Introduction
Escherichia coli is regarded as a commensal and opportunistic 
pathogen of gastrointestinal tract. α-haemolytic E. coli (HEC) is 
clearly more potential to induce pathogenic lesion due to pos-
sessing of exotoxins (4) This causes colibacillosis and oedema 
disease and directly impacts to severe economic loss (5)
In Thai pig industrial, intensive use of antimicrobials is a com-
mon alternative for control of infectious diseases. There has 
been a dramatically increasing of resistant bacteria against 
antimicrobials such as beta-lactams, macrolides, fl uoroquinol-
ones, tetracyclines and lincosamides because of use of diff erent 
several antimicrobials during production periods other than 2 
weeks prior to slaughter. However, not only pathogenic bacteria 
are aff ected from the administration, but also enteric commen-
sal may rise up the risk of resistance in farm-level (6). Flavomycin 
is phosphoglycolipid antibiotic in fl avophospholipal group that 
has been approved as a feed additive. It is active against Gram’s 
positive bacteria and also inhibits in vitro conjugation of Gram’s 
negative bacteria such as E. coli. 
The current study was to evaluate minimal inhibitory concentra-
tion (MIC) to 6 antimicrobials of E. coli derived from weaner to 
fi nishing pigs that received fl avomycin as a feed additive. We 
also determined an effi  cacy of fl avomycin to 30 enterotoxogenic 
E. coli (ETEC) isolated from piglets. 
Materials and Methods
Sample collection. 10 ppm of fl avomycin was the addition of rou-
tine feed additive during 10 to 21 weeks of pig ages. Pig feces 
were collected and contained in transport media. 
Bacteria. 30 ETEC isolated from piglets with colibacillosis since 
2008, were derived from stock isolates of Dept Vet Micro. 63 E. 
coli comprising with 30, 16 and 17 isolates that were collected 
at 5, 15 and 25 week age, respectively. Haemolytic traits on 5% 
sheep blood agar were used for colony selective criteria. When 
HEC was not observed on the primary plate, non-HEC would be 
selected for MIC determination. 
MIC determination. 6 antimicrobials comprising with fl avomycin, 
colistin, chlortetracycline, enrofl oxacin, amoxicillin and oxacillin 
were used. Broth micro-dilution was carried out according to the 
recommendation of CLSI (2, 3). 
Results and Discussion
Range of MIC distribution is shown in Fig 1. The MIC values of 30 
ETEC against amoxicillin, oxacillin, and chlortetracycline, were 
over 256 ug/ml. They were inhibited by fl avomycin at 4-32 ug/
ml. Enrofl oxacin and colistin were the eff ective agents to the 
tested E. coli. 
HEC was mostly isolated from the period before adding of fl avo-
mycin and were disappeared in pig aged 15 week. The MIC50 of 
each batch of isolation is compared in Table 1.
Fig. 1 Distribution of MIC values of 30 ETEC against 6 antimicrobials 
Table 1 Presence of isolation rate and MIC50 of each batch
Isolation Pig ages (wk)
5 15 25
HEC 28 - 4
Non-HEC 2 16 13
Antimicrobial
colistin 0.5 0.5 0.5
enrofl oxacin 0.5 ≥0.25 ≥0.25
fl avomycin 4 16 32
chlortetracycline 256 256 256
amoxicillin 512 512 512
oxacillin 512 512 512
The MIC of 63 isolates was consistent to that of ETEC in 2008. 
beta lactam resistant bacteria may be a native clone in the area 
of study. Flavomycin clearly reduced HEC in fattening pigs and 
its susceptibility was lower in the fi nal week. These confi rmed 
a direct effi  cacy to pathogenic agents (1) and may be able to 
maintain susceptible level from weaner to fi nishing. 
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Introduction
The porcine respiratory disease complex (PRDC) is a leading 
cause of animal and economic losses in swine production6. 
Because bacteria are involved in this condition, antibiotics are a 
short-term measure in a multifaceted strategy of disease control. 
In the swine industry, tetracyclines have been applied particu-
larly for respiratory tract infections7. Doxycycline (DOX) is a 
semi-synthetic tetracycline and a broad-spectrum bacteriostatic 
antibiotic against Gram-negative and Gram-positive aerobic and 
anaerobic bacteria, Rickettsiae, Chlamydiae, mycoplasmas and 
some protozoa10. DOX is characterized by a better lipid solubil-
ity, greater tissue penetration, improved antimicrobial activity 
and a diff erent pharmacokinetic profi le1,2. The objective of this 
paper was to review existing literature data on pharmacokinetic 
(PK) and pharmacodynamic (PD) properties of DOX with a view 
to evaluate their relationships as a base for its clinical eff ect in 
PRDC as HydroDoxx® 500 mg/g Powder for use in drinking water.
Pharmacokinetics
The multiple oral administration of DOX at 6.6, 11.5 and 12.9 
mg/kg BW daily produces steady-state concentrations of re-
spectively 0 37-0.89, 0.56-0.87 and 0.71-1.14 μg/mL9. In another 
experiment steady-state plasma levels ranging between 0.9 and 
1.5 μg/mL have been observed during 8-day oral medication 
at a dosage regimen of 11.8-13.3 mg/kg/day5. Administration 
via drinking water at 10 mg/kg daily for 5 days results in mean 
plasma concentration at steady-state of 1.37±1.21 μg/mL10.
Pharmacodynamics
It was reported that MIC values of DOX for important porcine 
bacterial respiratory tract pathogens are 0.25 to 0 5 μg/mL8. In 
other studies, further values were determined3,10 (Table 1). 
Table 1. MIC values bacterial respiratory tract pathogens
Porcine pathogens MIC50 values, μg/mL MIC90 values, μg/mL
M. hyopneumoniae (Mh) 0.1 (10) 0.2 (10); 1.0 (3)
P. multocida (Pm) 0.106 (10) 0.517 (10); 1.0 (3)
B. bronchiseptica (Bb) 0.039 (10) 0.053 (10)
A. pleuropneumoniae (Ap) 1.422 (10) 2.387 (10); 2.0 (3)
PK-PD integration
Steady-state DOX plasma levels determined after oral medica-
tion with DOX at a dose of 11.5 mg/kg BW daily exceed MIC 
values 0.25 to 0.5μg/mL9. In conformity with the type of its anti-
microbial action, DOX belongs to concentration-time dependent 
(co-dependent) drugs with integrated PK-PD variables AUC/MIC 
and T>MIC with proposed values of 125 h and 50-80%. Based 
on this principle and analyzing the results obtained after 5-day 
administration of DOX via drinking water at a dose of 10 mg/
kg daily other authors assume that the calculated mean values 
of (AUCSS/MIC90) 24h and %T>MIC for Bb and Mh achieve the 
breakpoints for these indices10. For Pm the %T>MIC exceeded 
70%. Considering these results the authors conclude that DOX 
at 10 mg/kg daily should ensure the plasma concentrations 
required for successful therapy against Bb and Mh and possibly 
against Pm but probably not against App10.
Clinical eff ectiveness and conclusion
The results from clinical investigations of DOX under fi eld 
conditions in pigs showed that DOX after oral administration at 
a dose of 10 mg/kg BW was eff ective in controlling PRDC. The 
eff ect was demonstrated in the reduction of respiratory disease 
incidents, decrease in lethality and increase in economically 
signifi cant zootechnical parameters with signifi cant diff erences 
between the treated and untreated groups4,11. It can be con-
cluded that HydroDoxx® 500 mg/g Powder for use in drinking 
water administered to pigs at the recommended rate (10 mg/kg 
BW) is eff ective to prevent and treat PRDC.
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Introduction
The study objective was to determine the clinical effi  cacy of 
orally administered tylosin tartrate in growing pigs that have 
been artifi cially infected with Mycoplasma hyopneumoniae (Mh), 
compared to tylosin phosphate.
Materials and Methods
Four groups of 6 SPF pigs (Danube white), equal number of 
sexes (10.0-12.0 kg), 10 weeks of age, were used. All groups 
(I, II and III) were infected with Mh. Twenty-four hours after 
the challenge, the infected group (I) was treated via feed with 
tylosin (as phosphate) (Pharmasin® 250 mg/g Premix) and group 
II was treated through drinking water with tylosin (as tartrate) 
(Pharmasin® 100% w/w WSG). Both groups received a dose of 10 
mg tylosin per kg BW for 8 consecutive days, followed by 5 mg 
tylosin per kg BW until the end of the period of risk (14 days). 
The effi  cacy of the medication was assessed by observing the 
rectal temperature, clinical symptoms and gross lung lesions, 
histology, serology for detection of antibodies against Mh using 
an ELISA test (Dako Cytomation, Denmark A/S), nasal swabs and 
lung biopsy for bacteriological examinations (after euthanasia 
and necropsy of all pigs), bodyweight gain and feed conversion 
effi  ciency. The results of the examination were determined ac-
cording to t–test of Student–Fisher.
Results
Specifi c clinical symptoms of respiratory disease and gross lung 
and histological lesions were observed in the infected unmedi-
cated group (III). Tylosin (as phosphate) administration via feed 
in pigs of group I and tylosin (as tartrate) administration via 
water in pigs of group II both lead to a statistically signifi cant de-
crease in clinical signs and gross lung lesions (Table 1). Bacterio-
logical examinations of nasal swabs and lung showed a statistic-
ally signifi cant reduction in re-isolation rate of Mh (Table 1).
In both tylosin treatment groups, zootechnical parameters 
(bodyweight gain and feed conversion ratio) were statistically 
signifi cantly higher than those recorded in the infected unmedi-
cated group of pigs (Table 2).
Table1. Clinical signs
Groups
No. of animals 
with clinical 
signs
Total clinical 
scores
No. of animals 
with lung lesion / 
total number
Lung 
lesion 
scores
Re-isolation 
from nasal 
swabs of Mh
I 1 / 6 10a 1 / 6 2a 1 / 12a
II 1 / 6 9a 1 / 6 3a 2 / 12a
III 5 / 6 52b 5 / 6 21b 7 / 12b
IV 0 / 6 0a 0 / 6 0a 0 / 12 a
a,b p ≤ 0,05
Table 2. Zootechnical parameters
Groups ADWG, kg Between groups comparison p-value FC, kg
I 0.280±0.015 I / II; I / III; I / IV NS*; 0.05; NS* 2.200
II 0.282±0.014 II / III; II / IV 0.05; NS* 2.193
III 0.221±0.021 III / IV 0.05 2.463
IV 0.285±0.015 - - 2.170
* NS: not signifi cant; ADWG: Avg. daily weight gain; FC: Feed conversion
Discussion and Conclusion
Tylosin is one of the oldest antibiotics for veterinary medicine 
that is still frequently being used to treat enzootic pneumonia1. 
The results show that tylosin (as phosphate) administration 
via feed and tylosin (as tartrate) administration via water both 
have a signifi cant metaphylactic and therapeutic eff ect in 
experimentally challenged Mh infection in pigs. This is further 
confi rmed by the diff erences in clinical, bacteriological and 
zootechnical parameters witch were also signifi cantly diff erent 
compared to group III. The data obtained in this experiment are 
consistent with the results recorded in previous studies2,5. The 
signifi cant clinical effi  cacy of tylosin after oral treatment is due 
to the wide distribution of the drug in pigs and its reaching and 
accumulation in target tissues3,4. These results indicate that the 
use of tylosin administered as tartrate or phosphate can be suc-
cessfully used in strategic programs to control enzootic pneu-
monia caused by Mh in pigs.
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Introduction
Mycoplasmosis is one of major bacterial pneumonia in pigs, 
usually co-infected with other organisms leading to a complex 
of respiratory diseases or porcine respiratory disease complex 
(PRDC)1. Vaccination is a common tool for controlling the dis-
ease; however, the elimination of mycoplasma is still incomplete 
due to the nature of the organism. By administration of tiamulin 
(Denagard®), an eff ective pleuromutilin against mycoplasma2, 
the infection could be signifi cantly resolved. Additionally, a com-
bination of tiamulin with other antibiotics such as amoxycillin 
could facilitate the elimination of Mycoplasma hyopneumoniae 
and other concurrent pathogens. The objective of this study 
was to evaluate the effi  cacy of a combination of Denagard® 
and amoxycillin to control concurrent porcine mycoplasmosis 
in comparison with lincomycin combined with amoxycillin in a 
Thai pig farm.
Materials and Methods
A mycoplasmosis-aff ected pig farm in Thailand was selected 
based on clinical signs, bacterial culture results, slaughter check 
and serological profi le. Serologically, pigs were 100% sero-posi-
tive on Mycoplasma indirect ELISA test as early as 16 week-old. 
Evidently, PRRSV and PCV2 were also detected in this herd. A 
total of 180 pigs (10 week old) were allocated into 2 groups: 
Group A (n = 90) fed with Denagard® (100 ppm) and amoxicillin 
(300ppm) and Group B (n = 90) fed with lincomycin (110ppm) 
and amoxicillin (300ppm). Those pigs were randomly put into 
each pen in the same housing without the environmental eff ect. 
Treatment was conducted in the growing pig feed from 10 to 
14 week-old continuously (one week before the presence of the 
clinical signs). The clinical history and the production parameters 
were recorded during the study as well as the number of culled 
pigs until two weeks after the treatment. To measure average 
daily weigh grain (ADG) pigs were individually weighted each 
week from 10 and 14 weeks of age.
Results and Discussion
A higher number of clinically sick and culled pigs were observed 
in Group B (sick =19, culled pigs=3) than in Group A (sick =11, 
culled pigs =1) (n=90) during the studied period (10-14 week-
old). Similarly, ADG of Group A pigs receiving a combination of 
Denagard® and amoxicillin was signifi cantly better than in Group 
B using Mann Whitney test (P<0.01) (Fig. 1). Concurrent infection 
among PRRSV, PCV2, Mycoplasma and possibly other bacteria 
did exist in the studied farm. Interestingly, vaccination of those 
mentioned 3 major respiratory pathogens was not practised 
and the combination of Denagard® and amoxicillin did demon-
strate helping those treated pigs growing better than the other 
medicated group. Minimizing the negative eff ects of secondary 
bacterial infection using the drugs of choice in this farm is con-
sidered as an important management tool to eff ectively control 
PRDC. Unfortunately, the lung scores and other lab results were 
not available at the time of submission.
Fig. 1 Clinical signs (A) and average daily weigh grain (ADG) (B) in the 
treatment groups (10-14 wk). 
Figure 1A
Figure 1B
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Introduction 
On pig farms, collective treatments can be achieved by oral 
administration of medicines through drinking water with dosing 
pumps. Homogeneity of the medicated solution at the drinkers 
is a key factor for therapeutic success, respect of the maximum 
residue limits (MRL) in meat and prevention of antimicrobial 
resistance. The aim of this study was to assess homogeneity of 
an oxytetracycline (OTC) solution, according to type of stock 
solution tanks and to solubility of OTC.
Materials and Methods 
Homogeneity in the stock solution tank 
Three types of tanks commonly used on farms (1) were tested:
• One fl at-bottomed tank without stirrer,
• One fl at-bottomed tank with a motorized propeller,
• One conic-bottomed tank with a pump mixing the solution.
Each tank was fi lled up with a well-dissolved OTC solution. Sixty 
samples were taken 3, 5, 7 and 24 hours after the solution had 
been prepared at 3 heights of the tank (top, middle and bot-
tom).
Homogeneity at the drinker
Tests were conducted on an experimental pipe, simulating on-
farm conditions. An OTC solution prepared in a mixing tank with 
(solution A) or without solvent (solution B) was administered by 
a hydraulic pump to the drinkers. Fifty or 60 samples of 50 ml 
were taken at the drinker continuously or after a break, with 4 
combinations of water fl ows and pressures.
Concentrations of OTC were assessed by colorimetric analysis.
Results and Discussion
Homogeneity in the stock solution tank 
For the 3 tanks and at a given time, all the coeffi  cients of varia-
tion (CV) in the 3 heights and in the entire tank were below 5%. 
We concluded there was no concentration gradient in tanks at 
any given time, with or without a stirrer. These results completed 
those obtained during a test comparing the homogeneity of low 
or highly soluble preparations of amoxicillin (2).
Homogeneity at the drinker
With solution B, samples taken after each break showed increas-
es and drops of concentrations (fi gure1), certainly matching 
settling and releasing of OTC in the pipe. This didn’t occur with 
continuous sampling but in both cases, CV were up to 5% for the 
4 combinations of fl ows and pressures (Figure1). So, without any 
solvent, the solution wasn’t homogeneous at the drinker.
ÁWith continuous sampling of solution A, CV were below 5% 
and average concentrations were between 104 and 109% of 
the expected concentration (1g/l) (Table 1). This met the quality 
requirements of an industrial medicated feed.
Figure 1: Discontinuous sampling of solution B at a drinker: variation 
of OTC concentrations
Table 1: Homogeneity of an OTC solution at drinker
Without any solvent 
(solution B)
Without any solvent 
(solution B)
Without any solvent 
(solution B)
Water fl ow - pressure CV (%) of OTC concentrations CV (%) of OTC concentrations
Water fl ow - pressure Continuous sampling Discontinuous sampling
30 l/h - 0.5 bars 14.0 85.6
30 l/h - 3 bars 10.4 53.6
300 l/h - 1 bars 11.7 27.0
300 l/h - 3 bars 7.0 27.5
With a solvent 
(solution A)
With a solvent 
(solution A)
With a solvent 
(solution A)
Water fl ow - pressure CV (%) Ratio avg. /expected OTC concentrations (%)
30 l/h-0.5 bars 1.4 109
30 l/h-3 bars 3 108
300 l/h-1.5 bars 1.6 104
600 l/h-3 bars 1.4 106
After a 12 hour break of solution A, the fi rst samples showed 
concentration levels between 1.2 and 2.5 times higher than 
the average levels of the next samples. The involved volume 
(400 ml), corresponding to the pipe coming down towards the 
drinker, might globally match the fi rst morning-time drinking of 
one pig weighting 70 kg (less than 6% of its daily water intake). 
So, this doesn’t question the respect of the MRL.
Conclusion
Our results demonstrate that a well-dissolved medicated solu-
tion guarantees a correct homogeneity in the stock solution 
tank even without a stirrer. At the drinker, the homogeneity of 
such a solution meets the quality requirements of an industrial 
medicated feed.
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Stability of diﬀ erent amoxicillin medicated premixes in ﬂ our feed
Eric Bousquet1 Mehdi Laraichi1 Guillermo Cano2 Aurélien Guicherd3 Jacques Goutalier3
1. Virbac, Carros, France; 2. Tests and Trials, Lleida, Spain; 3. Phatophy, Lyon, France
Introduction
Interest of a specifi c coating process of amoxicillin (Suramox®) 
has been previously demonstrated in order to protect active 
ingredient degradation in medicated feeds and to insure that 
adequate amount of active ingredient is available for pigs (1-2). 
Diff erent comparative studies at laboratory, pilot or industrial 
scale in Europe showed a better protection of amoxicillin with 
this coating process against degradation during pelletization 
and storage of feeds (3).
As medicated feeds are also used in some countries as fl our 
feeds (without pelletization), objective of the present study was 
to compare stability of amoxicillin in fl our feed at industrial scale 
for diff erent medicated premixes registered in Europe.
Materials and Methods
Five products containing respectively 5% (Suramox®, A, B, C) and 
10% (D) of amoxicillin (expressed as base) were tested in the 
same Spanish feed plant. One batch of a pig grower feed was 
supplemented by each premix at the concentration of 400 ppm 
(mg of amoxicillin per kg feed). One blank feed batch was manu-
factured between 2 medicated batches to avoid cross contamin-
ation. Size of medicated feed batches was equal to 3 tons each. 
Mixing of raw materials lasted for 2.5 minutes in the mixer where 
each premix was added manually. Amount of each premix was 
accurately weighed in order to calculate exact concentration 
of amoxicillin in feed. Three samples of each medicated feed 
batch were taken at regular intervals covering the total empty-
ing time of the mixer and stored during 14 days in standardized 
conditions (respectively 30°C/65% of relative humidity (RH) and 
40°C/75% RH before assay). Amoxicillin concentrations in feed 
were determined by High Performance Liquid Chromatography 
with UV detection. Each sample was analyzed twice and mean 
concentration was calculated.
Results
Lower degradation rates were measured with Suramox® (6.1% 
and 13.9% after storage at 30°C and 40°C respectively) than with 
the other products (degradation ranging from 30.5% to 44.4% 
and from 45.2% to 60.3% after storage at 30°C and 40°C respect-
ively).
Table: Amoxicillin mean concentrations in feed after storage during 14 
days (expressed as percentage of theoretical concentration)
Product Storage at 30°C Storage at 40°C
Suramox 93.9% 86.1%
A 69.5% 54.8%
B 60.4% 50.9%
C 55.6% 42.5%
D 61.4% 39.7%
 Discussion
Degradation during storage has been previously shown at 
laboratory scale when fl our feed was stored during 15 days at 
40°C/95% RH : degradation was limited to 10% for Suramox® and 
around 50% for other products, consistent with present data (3).
This study confi rms that amoxicillin may be damaged in feed 
even without pelletization during transport and storage accord-
ing to temperature and humidity conditions found in Europe 
(particularly when feed is stored in silos during summer). A 
specifi c coating process of the active ingredient may reduce 
degradation in such conditions.
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Stability of tylosin in liquid feed used in commercial pig farms
Alain Kanora; Spas Petkov; Koen De Gussem
Huvepharma NV, Antwerp, Belgium
Introduction
In some countries, pig farms are using recyclable foodstuff  
originating from human consumption and are commonly being 
added as nutritional basis for liquid feeds. Farmers can also mix 
commercial feed with water to obtain liquid feed. These two 
feed systems have the benefi t that feed becomes tastier and 
more acid due to fermentation; both properties will increase 
consumption. The stability and activity of veterinary medicinal 
products (VMP) used in liquid feed are often not studied; par-
ticularly data on antibiotics are unavailable. 
VMD (UK) currently allows the use of in-feed antimicrobials in 
liquid feed in accordance with the cascade regulations, but 
veterinarians need to base their decision on the stability of the 
veterinary specialty fi rst before prescribing the use in liquid feed. 
In this way issues like overdosing, underdosing, resistance build-
up, etc. can be avoided. Therefore, the use of tylosin phosphate 
(Pharmasin® medicated feed premix) in liquid feed was studied 
by evaluating the impact on the active substance with regards 
to stability.
Materials and Methods
Locally collected dry feed from a GMP certifi ed production site 
was sourced and diluted at ration 2:1 with tap water to obtain a 
liquid feed matrix. 
Pharmasin® 250 mg/g and Pharmasin® 100 mg/g were added to 
the liquid feed in dosages providing 100 ppm in the feed based 
on dry matter. 
The mixtures were stored under normal environmental condi-
tions (20-25°C, ambient humidity) and sampled at 0, 1, 6, 24 and 
72 hours.
The samples were analyzed by a microbiologic assay for tylosin 
content. The method is a four-dose diff usion assay using Micro-
coccus luteus ATCC 9341 as a test micro-organism.
Results
The ppm levels of all tested Pharmasin® formulations remained 
perfectly stable for more than 5 hours. The VMD recommenda-
tion of 1h stability was perfectly matched and also the max-
imum meal contact time for pigs was prior to onset of a slight 
activity loss.
Table 1: Tylosin concentration (ppm) in liquid feed samples on dry 
basis
Hours
Product 0 1 6 24 72
Pharmasin® 250 115 114 111 102 94
Pharmasin® 100 114 111 112 101 96
Figure 1. Stability of Pharmasin® in liquid feed
 
Discussion and Conclusion
It can be concluded from this study that Pharmasin® Medicated 
Premix used in a responsible way in liquid feed remains perfectly 
stable and that there is no loss of activity of the used tylosin 
phosphate. Even after 24 and 72 hours, tylosin activity was in 
excess of 80% of the initial value.
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Pharmacokinetics and tolerance of Catosal® in pigs
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1. Bayer Animal Health GmbH, Leverkusen, Germany; 2. Bayer CropScience AG, Monheim, Germany
Introduction
Catosal® is a metabolic stimulant for use in numerous target 
animal species including the pig in many countries worldwide. 
It contains 100 mg of butafosfan and 0.05 mg of cyanocobal-
amin (vitamin B12) per ml. Experimental studies indicated that 
Catosal® attenuates stress responses of piglets (1), and reduces 
the prevalence of certain production diseases in sows and 
piglets (2,3). The present report documents the tolerance and 
the pharmacokinetics of butafosfan after a single intramuscular 
(i.m.) injection of Catosal® to piglets.
Materials and Methods
Two independent studies were performed in an accredited 
experimental animal centre in Germany. The fi rst one assessed 
the local and systemic tolerance of Catosal® in healthy German 
Landrace hybrid piglets (22.5 – 28,5 kg body weight (b.w.)). 
Catosal® was injected i.m. at the dosages of 0.1, 0.3, and 0.5 ml/
kg (N=6 per dose group). A control group of 6 piglets received 
saline at the dose volume of 0.5 ml/kg b.w. Between injection 
and the third day thereafter, the animals were closely monitored 
for clinical signs of intolerance and local reactions at the injec-
tion site. 
The second study assessed the pharmacokinetics of butafosfan 
in four Hamshire/Pietrain piglets weighing 36.5 – 47.0 kg. The 
animals received Catosal® at a dose volume of 0.1 ml/kg i.m., cor-
responding to 10 mg butafosfan/kg b.w. Frequent blood sam-
pling was performed over a period of 24 hours after treatment. 
Serum was analyzed for butafosfan concentrations using HPLC 
with tandem mass spectrometric detection. Relevant pharma-
cokinetic parameters were calculated using non-compartmental 
analysis and the linear/log trapezoidal rule. All results are given 
as arithmetic means ± standard deviation.
Results
Tolerance: No local reactions at the injection site, immediate sys-
temic reactions or other adverse events were observed in either 
study after i.m. injection. 
Pharmacokinetics: Based on the individual serum concentrations 
of butafosfan, the concentration-time profi les depicted in Figure 
1 were obtained. 
Figure 1 Individual butafosfan concentration-time profi les of pigs 
injected intramuscularly with Catosal® (0.1 ml/kg)
Group mean maximal concentrations of 35 ± 5.8 μg/L were 
measured 0.3 ± 0.1 hrs after administration. The elimination half 
life time was calculated to 3.5 ± 0.6 hrs. Within 24 hours post-
administration, serum butafosfan levels approached the limit of 
quantitation of 0.02 mg/L. The area under the curve extrapolat-
ed ad infi nitum was 72.5 ± 12.6 hr*μg/L. The distribution volume 
and clearance of the absorbed fraction were 775 ± 150 L/kg 
and 148 ± 20.6 L/hr/kg, respectively. The mean residence time 
extrapolated ad infi nitum was 2.7 ± 1.0 hrs. 
Conclusion
Intramuscular injection with Catosal® at a dose volume of 0.1 ml/
kg b.w. and 5 times thereof is well tolerated and safe in pigs. The 
pharmacokinetics of butafosfan show a fast and effi  cient absorp-
tion into blood, a high distribution volume and fairly rapid 
elimination from the porcine body.
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Stability of diﬀ erent amoxicillin medicated premixes in pelleted feed
Eric Bousquet1 Mehdi Laraichi1 Guillermo Cano2 Aurélien Guicherd3 Jacques Goutalier3
1. Virbac, Carros, France; 2. Tests and Trials, Lleida, Spain; 3. Phatophy, Lyon, France
Introduction
Interest of a specifi c coating process of amoxicillin (Suramox®) 
has been previously demonstrated in order to protect active 
ingredient degradation in medicated feeds and to insure that 
adequate amount of active ingredient is available for pigs (1-2). 
Diff erent comparative studies at laboratory, pilot or industrial 
scale in Europe showed a better protection of amoxicillin with 
this coating process against degradation during pelletization 
and storage of feeds (3-4).
Objective of the present study was to complete stability data of 
amoxicillin in pelleted feed at industrial scale for diff erent medi-
cated premixes registered in Europe.
Materials and Methods
Five products containing respectively 5% (Suramox®, A, B, C) 
and 10% (D) of amoxicillin (expressed as base) were tested in 
the same Spanish feed plant. One batch of a pig grower feed 
was supplemented by each premix at the concentration of 400 
ppm (mg of amoxicillin per kg feed). One blank feed batch was 
manufactured between 2 medicated batches to avoid cross con-
tamination. Size of medicated feed batches was equal to 3 tons 
each. Amount of each premix was accurately weighed in order 
to calculate exact concentration of amoxicillin in feed. Steam 
pressure was equal to 4 atm and temperature ranged from 53.7 
to 65.5°C before pelletization. Temperature ranged from 71.3 to 
75.2°C after pelletization. Six samples of each medicated feed 
batch were taken after cooling of the pellets at regular intervals 
covering the total batch delivery. Samples were analyzed at the 
time T0 of reception by the laboratory (Phatophy). In the mean-
time, aliquots of 3 out of 6 samples per batch were stored during 
14 days in standardized conditions (25°C/65% of relative humid-
ity (RH) before assay at T14). Amoxicillin concentrations in feed 
were determined by High Performance Liquid Chromatography 
with UV detection. Each sample was analyzed twice and mean 
concentration was calculated.
Results
Mean degradation ranged from 10.2% to 39.3% at T0. A further 
degradation was measured during storage for all products 
except Suramox® , leading to a total degradation between 18.3% 
and 53.1% at T14 for products A, B, C and D.
Table Amoxicillin mean concentrations in feed at T0 and after storage 
during 14 days (expressed as percentage of theoretical concentration)
Product T0 (n=6) T14 (n=3)
Suramox 89.8% 91.2%
A 87.6% 81.7%
B 75.6% 64%
C 60.7% 46.9%
D 68.7% 56%
Discussion
Degradation was limited around 10% for Suramox®, without 
signifi cant evolution during storage (variation within analytical 
variability). Degradation recorded for the other products was 
consistent with previous studies following pelletization and 
eventual storage of pig medicated feeds (3-4).
This study confi rms that a specifi c coating process of the active 
ingredient may reduce degradation after pelletization and stor-
age of feeds.
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Demixing by elutriation of diﬀ erent amoxicillin medicated premixes in feed
Eric Bousquet1 Mehdi Laraichi1 Carine Rousseau1 Christine Segot1 Aurélien Guicherd2 Jacques Goutalier2
1. Virbac, Carros, France; 2. Phatophy, Lyon, France
Introduction
Demixing of medicated feeds is a concern for feed millers and 
veterinary practitioners, leading to heterogeneous feeds and 
increase of antimicrobials dosage variability. Elutriation is a 
demixing phenomenon due to diff erent speeds of powder 
particles while falling through the air. A standardized test has 
been developed to assess elutriation of powders from previously 
described experiments (1). This test has been correlated with 
demixing of supplemented feeds in plants (2) and previously 
performed for a range of antimicrobials premixes (3-4). Object-
ive of this study was to complete elutriation tests on 4 amoxicil-
lin premixes registered in Europe.
Materials and Methods
Four products containing respectively 5% (Suramox®, A) and 
10% (B, C) of amoxicillin (expressed as base) were tested in a pre-
starter feed (median particle size : 390 μm ). Median particle size 
of the 4 products was determined by laser granulometry. Each 
product was then tested twice in order to allow statistical analy-
sis. Around 1 kg of fl our feed was supplemented by each prod-
uct according to incorporation rate recommended (400 ppm 
of amoxicillin in feed). A tracer was added in each feed sample 
at the concentration of 500 ppm in order to validate the tests. 
For each test a 300 ml feed sample was dropped in an 8 m high 
tube. After drop, top and buttom 50 ml feed samples were taken 
for tracer assay by colorimetry and amoxicillin assay by high 
performance liquid chromatography. In each test, an elutriation 
index (EI) was calculated from previously defi ned index (5) for 
the tracer and for amoxicillin (where Ct and Cb are respectively 
concentrations in top and bottom samples):
This index ranges from –200 to +200, extreme values corres-
ponding to maximal demixing whereas zero value corresponds 
to lack of demixing. A non parametrical analysis of variance on 
ranks was performed to compare EI between products.
Results
Amoxicillin EI was lower for Suramox® than for the other prod-
ucts.
Table: Median particle size of active ingredient and mean elutriation 
index of the 4 products tested
Product Particle size (μm) EI
Suramox 380 1.4 
A 878 -89.4*
B 902 -137.2*
C 188 95.1*
*, ** : signifi cantly diff erent from Suramox® (resp p<0.05 and p<0.005)
Discussion
For products with high negative EI, amoxicillin is more concen-
trated in bottom of the sample after test (amoxicillin particles 
too large or too dense falling more quickly within large feed 
particles). For products with high positive EI, amoxicillin is more 
concentrated in top of the sample after test (thin amoxicillin 
particles falling more slowly within thin feed particles). This 
is refl ected by median particle size higher than feed one for 
products with high negative EI (products A and B) and median 
particle size lower than feed one for product with high positive 
EI (product C). Lower demixing with Suramox® may be due to 
amoxicillin particle size with specifi c coating process (median 
particle size : 380 μm), consistent with feed median particle size 
(390 μm).
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Performance improvement of ﬁ nishing pigs fed Denagard (tiamulin) plus chlortetracycline 
in feed antibiotic vs. oxytetracycline in feed antibiotic or non-medicated feed
J. M. Hammer; Dean Dau
Novartis Animal Health US, Greensboro, NC, USA
Introduction
A synergistic eff ect has been demonstrated when Denagard® 
(tiamulin) and chlortetracycline (DEN-CTC) are used concurrently 
in-feed to address the eff ects of bacterial pneumonia.1 The eco-
nomic benefi t of administering DEN-CTC in-feed has been docu-
mented by others.2, 3 The purpose of this study was to evaluate 
the performance diff erences in disease control between pigs fed 
no in-feed antibiotic, OTC (oxytetracycline 440 ppm) or DEN-CTC 
(38.5 ppm tiamulin; 440 ppm chlortetracycline).
Materials and Methods
A total of 1344 weaned pigs (avg. age 21 days) were placed 
in one of two all-in all-out commercial wean to fi nish barns. 
Pigs were fed common diets throughout the nursery phase 
(D1(weaning)-D39). On day 39, pigs were mixed by gender and 
allocated to one of three treatment groups (3 x 2 factorial de-
sign): no medication, OTC or DEN-CTC. The in-feed antibiotic was 
fed for 17 days followed by a subsequent 17 days of no medica-
tion (total trial D39-D73). Data analysis for average daily gain 
(ADG) and feed effi  ciency (F:G) were done using all weight in, all 
weight out and total feed consumed. Pen averages were used as 
the experimental unit with 16 pens/treatment. 
Results 
The DEN-CTC group had an ADG advantage over the non-medi-
cated (0.07 kg/day) and the OTC (0.05 kg/day) groups for the 
entire 34 day trial (p < 0.001;Table 1). This resulted in the DEN-
CTC pigs being signifi cantly heavier than the non-medicated 
(2.59 kg) or OTC pigs (1.77 kg) at the end of the 34 day trial (p 
< 0.001) period. The DEN-CTC group showed an improved F:G 
compared to the non-medicated or the OTC group (p < 0.09). 
This resulted in the DEN-CTC pigs requiring 2.54 kg and 2.81 kg 
less feed to reach the same end weight as the non-medicated or 
OTC pigs, respectively. The in-feed antibiotic increases costs by 
$0.12 USD per head for the OTC pigs and, $0.61 USD per head 
for the DEN-CTC pigs. If one assumes a $140 USD per ton feed 
cost and a market price of $40 USD per hundred pounds, the 
DEN-CTC treatment returned $2.67 USD more per head than 
non-medicated and $1.99 USD more per head than the OTC 
treatment. Each Dollar spent on Denagard plus chlortetracycline 
returned $ 4 USD in improved performance over no medication 
or oxytetracycline in-feed medication. 
Table 1. Performance Eff ect by in feed antibiotic (D39-D73) applica-
tion Treatment
Parameter No Med OTC DEN-CTC
Start weight (D39) 25.92 25.97 25.92
ADG 0.75ab 0.77b 0.82b
F:G 2.05a 2.06a 1.96b
End Weight (D37) 51.62a 52.44a 54.21b
Mortality (%) 0.70 0.70 0.90
diff erent superscripts by row are statistically signifi cant at p< 0.05
Discussion
In the investigated production system the impact of Denagard 
plus chlortetracycline early in the grow fi nish phase had a sig-
nifi cant impact in improving performance during and after the 
in feed antibiotic application. The improvements in performance 
translate into improved return on investment for the production 
system of $4 USD per head over either the non medicated or 
OTC treatments.
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Monitoring of antimicrobial usage for pigs in Denmark
Helle Stege1 Claes Enoe2 Erik Jacobsen2 Lis Alban3 Jens P. Nielsen1
1. KU-Life, Copenhagen, Denmark; 2. Vetinst, Copenhagen, Denmark; 3. VSP, Kjellerup, Denmark
Introduction
The Danish system for monitoring of veterinary drug use, Vet-
stat, was implemented during 1999 - 2001 (1). Close to 100% of 
the drugs used in pig herds are provided on prescription, hence, 
reported to Vetstat from pharmacies. The aim of this presenta-
tion was to present the antimicrobial (AM) usage for pigs during 
2004-2009. 
Materials and Methods
The overall use of AM in Denmark (measured as kilo active 
compound) was downloaded from the Vetstat homepage. In 
general pigs account for 80% of the total usage of AM. The 
number of slaughter pigs produced per year (including export 
of live growers of 30 kg) was obtained from Danish Statistics. 
When Vetstat data from 2009 were extracted they only included 
entries until September so the total use of this year was esti-
mated by extrapolation (table 1). When comparing the AM use 
between farms and/or veterinarians, the total amount of active 
compound must be converted to “number of Animal Defi ned 
Daily Doses, ADD” (2), according to the products’ potency and 
concentration and the animal’s weight. The measure used to 
compare AM usage between farms/ veterinarians is “percentage 
animals treated per day” which is calculated as: Average number 
of ADDs used per day divided by the average number of animals 
present. ADD data on AM usage for pigs were extracted from 
Vetstat (User page). 
Results
Overall AM usage (kg) in Denmark, 2004-2009 is presented in fi g. 
1 and table 1. Apart from the increase from 2008 to 2009 (t-test; 
p = 0.02) there has been no signifi cant changes in the average 
AM usage (g/pig/year) during the years. The most-used-AMs for 
pigs were tetracyclines, penicillins, sulpha-tmps, macrolides and 
tiamulines. The main part of the AM was prescribed for per oral 
administration to growers for gastro-intestinal disorders. Based 
on ADD calculations, the present national average is 10-12% 
growers treated per day as opposed to 1.5-2% for breeding 
stock and 2% for fi nishers (data from Vetstat, User page, not 
presented).
Discussion
The overall AM usage is reported from the pharmacies (>95%) 
by automated transfer to Vetstat, based on their stock manag-
ing system. The conversion from actual prescription to amount 
of active compound is formalized and simple. Hence, these 
data are very reliable. The AM usage has been stable during 
2004-2009 with an average use of 3 5 - 4.0 g AM per produced 
slaughter pig per year (table 1). Similarly, the usage measured as 
ADDs or percentage animals treated per day have been reason-
ably stable during the years. However, ADD data are more prone 
to errors because of the assumptions and calculations involved. 
Fig. 1 Total AM usage (kg) – prescribed by veterinarians
Table 1. Overall use of AM (kg) per year - mean and stddev. Pigs ac-
count for 80% of total use. AM use per pig (g/pig/year) is presented. The 
apparent increase in AM/pig/year was tested (t-test) comparing 2007 
with 2009 and 2008 with 2009, respectively. 
2004 2005 2006 2007 2008 2009
Total (kgx1000) 113,897 114,173 116,475 122,438 121,435 131,132
Mean 9.491 9.514 9.706 10.203 10.120 10.928
Stddev 506,4 582,8 769,3 976,2 747,6 682,2
Pigs/year 24,9 25,8 25,7 26,3 26 26
G/pig/year 4,57 4,43 4,53 4,66 4,67 5,04
(x 80%) 3,66 3,54 3,63 3,72 3,74 4,03
ftest 0,318 0,814
ttest 0,073 0,020
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Assessment of exposure of Draxxin® compared to Draxxin plus iron administered to 3 day old piglets
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Introduction
Although undesirable from a pharmaceutical perspective, and 
usually off -label in terms of product directions, it is common 
farm practice in some countries for injectable products to be 
mixed immediately prior to administration. The advantage of 
this procedure is that it minimizes the number of injections 
that have to be given to animals. The downside is that it creates 
the possibility of interactions that could aff ect drug safety and/
or effi  cacy, both in the form of pharmacological interactions 
between the active ingredients and chemical reactions between 
the formulations. The latter are most likely to aff ect absorption 
kinetics from the site of injection and infl uence drug bioavail-
ability.
Iron injections are commonly given to piglets in the fi rst week 
of life to counteract the low iron content of the sows’ milk. 
Draxxin® (Pfi zer Animal Health) is an injectable formulation of 
the antibiotic tulathromycin that is sometimes given to piglets 
of the same age. There have been reports of producers mixing 
the products prior to injection. Although Draxxin is considered 
a long-acting product, the duration of activity derives from the 
intrinsically long half-life of tulathromycin, which accumulates in 
lung tissue and establishes therapeutic concentrations that per-
sist for many days. The formulation is an aqueous solution that 
allows rapid absorption of drug from the site of injection. The 
greatest pharmaceutical risk, therefore, is of an incompatibility 
that delays or prevents drug uptake and reduces bioavailability. 
This study was performed to investigate this possibility. Based 
on previous pharmacokinetic work, lung concentrations of tu-
lathromycin at 24 hours were used to assess the overall outcome 
of the drug absorption phase.
Materials and Methods
This two-treatment randomized parallel group study was 
designed to compare Draxxin (tulathromycin) mixed with iron 
to Draxxin alone when dosed intramuscularly to 3-day old 
Landrace/Duroc cross piglets. The doses were Draxxin 2.5 mg/
kg bodyweight and 200 mg iron (Ursoferran®)/animal. Sixteen 
piglets were randomized to each treatment group according to 
a generalized block design. Blocking was based on litter and pen 
location. At 24 hr, blood was collected for PK and necropsies per-
formed to harvest lung tissue. The plasma and lung homogenate 
samples were analyzed for tulathromycin concentrations by an 
LC-MS/MS procedure.
Results
The concentration data are summarized in the following table;
95% Confi dence Interval
Matrix Treatment† Least Squares Mean Lower Upper
Plasma (ng/mL) T01 37.8 22.3 63.9
Plasma (ng/mL) T02 35.4 21.0 60.0
Lung (ng/g) T01 3270 2990 3570
Lung (ng/g) T02 3290 3010 3600
†T01- Draxxin alone T02- Draxxin + Iron
Non-inferiority was demonstrated comparing Draxxin with iron 
(T02) to Draxxin alone (T01). The 95% confi dence intervals for 
the ratios of Draxxin with iron to Draxxin alone were 83 - 106% 
and 92 - 110% for tulathromycin concentrations in plasma and 
lung homogenate, respectively.
Discussion 
Both plasma and lung tissue concentration data show that T02 
(Draxxin administered with iron) was not inferior to T01 (Draxxin 
alone). This study demonstrated that the mixing of Draxxin with 
a commonly used commercial injectable iron solution did not 
adversely aff ect the lung and plasma tulathromycin concen-
trations at 24 hours post injection in 3 day old, commercially 
reared pigs. The study did not specifi cally address safety, but 
no adverse events were noted. Unapproved mixing of products 
is to be discouraged, but this study did not reveal any specifi c 
adverse impact.
Reference 
Benchaoui, H. A., et al. Pharmacokinetics and lung tissue concentrations 
of tulathromycin in swine. J Vet Pharm Therapeutics 2004; 27:203-
210.
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In vitro activity of Florfenicol with other antimicrobials
Timothy S. Kniff en1 Elliot Stevens2 Darin Madson3
1. Intervet/Schering-Plough Animal Health, DeSoto, KS, USA; 2. Rural Technologies, Inc., Brookings, SD, USA; 3. Iowa State University , Ames, IA, USA
Introduction 
Florfenicol is a broad spectrum antimicrobial approved for use 
in swine in most pig producing countries. It is approved for 
use variably as a premix, drinking water concentrate, and/or 
injectable formulation. Florfenicol is primarily used in swine for 
the treatment and prevention of respiratory disease. There is 
no guidance currently available to swine veterinarians concern-
ing the use of fl orfenicol sequentially with other antimicrobials. 
A checkerboard dilution technique was utilized to assess the 
activity of fl orfenicol with antimicrobial combinations against 4 
bacterial pathogens of swine. The results of this checkerboard 
evaluation provide the fi rst available guidance to swine veterin-
arians utilizing fl orfenicol sequentially with other antimicrobials.
Materials and Methods 
Bacterial Isolates:
Four bacterial isolates were used in this pilot project: Streptococ-
cus suis (Ss), Salmonella choleraesuis (Sc), and Bordetella bron-
chiseptica (Bb). Escherichia coli (Ec) was also included although it 
is not one of the respiratory pathogens for which fl orfenicol has 
been approved. All bacterial isolates were obtained from swine 
fi eld cases submitted to a diagnostic laboratory. 
Antimicrobials Evaluated:
Antimicrobial concentrations were tested with fl orfenicol as 
serial dilutions in the ranges indicated in Table 1.
Abbreviation Antimicrobial Dilution Range
Ffc fl orfenicol 0.25-8 μg/ml
Ce ceftiofur 0.12-8 μg/ml
Ctc chlortetracycline 0.5-8 μg/ml
En enrofl oxacin 0.12-2 μg/ml
Otc oxytetracycline 0.5-8 μg/ml
Tc tetracycline 4.0-32 μg/ml
Tm tiamulin 1.0-32 μg/ml
Ty tylosin tartrate 0.5-32 μg/ml
Tu tulathromycin 1.0-64 μg/ml
Bacterial Susceptibility:
The minimum inhibitory concentration (MIC) of each anti-
microbial tested was determined for each of the four bacterial 
isolates selected. The checkerboard dilution technique was then 
utilized to allow calculation of the fractional inhibitory concen-
tration index (FICI) for fl orfenicol in combination with other 
antimicrobial agents. The combinations were then categorized 
based on FICI results as synergistic (S), antagonistic (A), or indif-
ferent (I).
Fractional Inhibitory Concentration Index 
Ffc Ce Ctc En Otc Tc Tm Ty Tu
Ss I I I I I I I I
Sc I I I S I I I S
Ec I I I I I I I I
Bb I I I I I I I S
Discussion 
1.  Most antimicrobials tested in vitro in combination with fl or-
fenicol were indiff erent in eff ect.
2.  No antagonistic interactions were found between fl orfenicol 
and any tested antimicrobial in vitro.
3.  Synergistic relationships between fl orfenicol and OTC and 
between fl orfenicol and tulathromycin were detected in 
vitro.
4.  These in vitro results suggest that antimicrobials commonly 
used in swine medicine would have no anticipated antagon-
istic eff ects when used sequentially with fl orfenicol. 
References 
1.  Lorian, (1986) Antibiotics in Laboratory Medicine, 2nd edition, Balti-
more: Williams & Williams
2.  Odds, FC. Synergy, Antagonism, & what the chequerboard puts 
between them. Journal of Antimicrobial Chemotherapy 2003:52:1
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Monitoring of enroﬂ oxacine (Baytril®) sensitivity of clinical ﬁ eld 
bacterial strains from pigs in the Benelux using E testing
Dominique Gevaert
Bayer SA-NV, Diegem (Machelen), Belgium
Introduction
In veterinary routine diagnostic laboratories antimicrobial sensi-
tivity testing is performed by agar disc diff usion. The E test (AB 
Biodisk, Solna, Sweden) is a newer technique off ering technical 
and veterinary advantages, because the result is expressed as 
the minimal inhibitory concentration (MIC, μg/ml) rather than 
sensitive, intermediate or resistant. For concentration depend-
ent antibiotics such as fl uoroquinolones, AUC/MIC and Cmax/
MIC ratios have been described as predictive for the clinical out-
come and thus valuable indicators in routine veterinary practice 
(1). Bayer has established with the leading veterinary routine 
diagnostic laboratories in the Benelux a protocol to use the E 
test for enrofl oxacin (Baytril®, Bayer) on all bacteria isolated from 
routine samples against which Baytril is registered in swine.
Material and Methods
Between June 2005 and January 2010, the E test for enrofl oxacin 
was carried out routinely on all swine pathogens, isolated by 4 
laboratories in the Benelux and falling under the scope of the 
various marketing authorisations for Baytril in swine. Samples 
were submitted by practitioners. A bacterial suspension was 
spread onto Mueller-Hinton plates and the E test for enrofl ox-
acin was put on its surface. Enrofl oxacin concentration ranged 
from 0.002 up to 32 μg/ml. After overnight incubation at 37°C, 
the MIC was read where the zone of growth inhibition inter-
sected the MIC scale on the strip. The concentration inhibiting 
growth of at least 90% (MIC90) of the isolates was calculated. 
Results
In total 2339 swine pathogens examined. The MIC90 value 
and respective number of strains is as follows: Actinobacillus 
pleuropneumoniae: 0.094 (n=413), Bordetella bronchiseptica: 
1 (n=103), Escherichia coli: 1 (n=1116), Pasteurella/Mannheimia 
spp.: 0.032 (n=475), Salmonella spp.: 0.25 (n=232). A total of 87 
isolates with MIC exceeding 2 μg/ml were found (3.7%). No rel-
evant diff erences in sensitivity of strains between the participat-
ing laboratories were found.
Discussion
The E test is not often used for routine bacteriology because of 
the costs of the test. However, routine monitoring of has proven 
to be feasible under fi eld conditions. It supports swine veterinar-
ians in their treatment schedule: the lower registered dose of 2.5 
mg enrofl oxacin per kg bodyweight can still be recommended 
for infections caused by Actinobacillus pleuropneumoniae and 
Pasteurella/Mannheimia spp.. The registered higher dose of 5 
mg enrofl oxacin per kg bodyweight is recommended in infec-
tions caused by Bordetella bronchiseptica, Escherichia coli and 
Salmonella. Even after more than 20 years of use of Baytril in 
the Benelux, the registered bacteria remain highly sensitive to 
enrofl oxacin. However, this may change upon the introduction 
of several cheap generics, because generics have shown to lead 
to increase in use and, subsequently, the rise of resistance (2). 
References
Meinen J. 1995. Am J Vet Res 56, 1219-1224.
Hellman K. 2005. EMEA/CVMP/SAGAM/184651.
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Comparison of the eﬃ  cacy of a ﬂ orfenicol (Nuﬂ or®) feed premix with an analogous 
product in the treatment of Swine Respiratory Disease (SRD)
Alberto E. Cevidalli1 Ernesto Bongiovanni2 Marco Bosetti3
1. Intervet Schering-Plough Animal Health, Peschiera Borromeo, Italy; 2. Practitioner, Casalbellotto, Italy; 3. Practitioner, Soncino , Italy
Introduction
Florfenicol is a broad spectrum antibiotic of the phenicol group. 
Previous studies have shown it to be highly effi  cacious in the 
treatment of SRD, when administered intramuscularly (1,2,3,). 
The object of this comparative fi eld trial was to evaluate the ef-
fi cacy of fl orfenicol administered in feed at a dose rate of 10 mg/
kg body weight for fi ve consecutive days in the treatment of SRD 
under Italian fi eld conditions. 
Materials and Methods
The trial was carried out on the grower units of two farrow-to-
fi nish herds. If at least 10% of the pigs in a pen exhibited acute 
respiratory signs, the pen was included in the trial and randomly 
allocated to one of the following treatments: fl orfenicol medi-
cated feed 200 ppm (Nufl or premix Intervet Schering-Plough) or 
a feed containing a combination of two antibiotics (1400 ppm of 
sulfadimethoxine and 560 ppm of chlortetracycline). Pens were 
included independently of each other once the inclusion criteria 
had been met, and the treatment period was 5 days (days 0-4). 
The experimental unit was the pen and both populations (clinic-
ally ill and exposed) were commingled in each pen. 
The parameters on which effi  cacy was assessed included: rectal 
temperature, dyspnea, depression and Clinical Illness Index 
Score (CIIS). The animals were observed for 12 days (Day 0 to Day 
11). Success rates, i.e. therapeutic success for the ‘ill’ population, 
and the prevention of illness for the ‘exposed’ population, were 
recorded on Day 6 and on Day 11.
Results
Seven hundred and thirty-three pigs were included in the trial 
on Day 0: 117 were showing acute respiratory signs and 616 
belonged to the exposed population. Altogether, 422 pigs were 
treated with fl orfenicol-medicated feed and 311 with the control 
product.
With the exception of prevention in the exposed animals on 
Day 6 (when the success rates were equal for both groups), the 
fl orfenicol-medicated animals always performed better. With re-
spect to the individual parameters (rectal temperature, dyspnea, 
depression, CIIS), in general, fl orfenicol always showed better 
results, in some particulars with statistical signifi cance.
Table 1. Cumulative success rates of the two trial sites
 
Graph 1. Rectal temp. in clinically ill pigs (on Days 0-5)
Discussion
Statistical analysis of the primary end-points (success rates) 
demonstrated that fl orfenicol-medicated feed was not inferior to 
a medicated feed containing high levels of the control product. 
The analysis of the secondary end-points (clinical parameters) 
confi rms altogether greater effi  cacy for the fl orfenicol medica-
tion, some of the diff erences for individual parameters being 
statistically signifi cant. 
In respect of the treatment of ill pigs, the average rectal temper-
ature of the fl orfenicol-treated group was statistically signifi cant-
ly lower than that of the control group (p<0.05) over the period 
measured (days 1-5). 
References
1.  Glattleider D. et al. (2000) 16th IPVS Proc.: 107.
2.  Jackson J.A. et al. (1998) 15th IPVS Proc. vol. 3:187.
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Eﬀ ects on overall production of the treatment of piglets with 
NUFLOR®PREMIX on a farm with respiratory disease
Manolo Toledo1 Rut Menjon2 Jesus M. Bollo2 Marta Jimenez2
1. Piensos Jimenez S.L.,Lorca, Murcia, Spain; 2. Intervet Schering Plough, Madrid, Spain
Introduction
The aim of the study was to assess the effi  cacy of the in-feed 
treatment of piglets with fl orfenicol to prevent losses caused by 
swine respiratory disease, during both treatment and subse-
quent production phases. 
Florfenicol (Nufl or® 40 mg/g Premix for Swine), a new broad-
spectrum antimicrobial, is a 3rd generation phenicol, a fl uorin-
ated analogue of thiamphenicol obtained by substituting one 
hydroxyl group with fl uorine. A methyl sulfonyl group (CH3-SO2) 
replaces the p-nitro group (NO2) found in chloramphenicol, 
thus ruling out the risk of aplastic anemia. This also provides a 
broader spectrum of activity and prevents the chloramphenicol 
acetyltransferase (CAT) resistance problems of thiamphenicol 
and chloramphenicol (2).
Materials and Methods
The trial farm, in a high stock density area of southeast Spain, 
houses 2,000 sows in three cycles. The farm is positive and un-
stable for PRRS. Sows are blanket vaccinated four times per year 
against PRRSv (modifi ed-live vaccine without adjuvant). Replace-
ments are sourced from other units, and all animals entering the 
farm are vaccinated against PRRSv. 
The earliest clinical signs became apparent around the time 
of weaning. These included an unacceptable percentage of 
stillborn piglets, a high percentage of runts, non-specifi c diar-
rhea, loss of condition, nervous signs, arthritis and an increased 
mortality rate, all of which failed to respond to treatment with 
antibiotic (amoxicillin in the drinking water and by injection). 
PRRS was confi rmed by PCR in 1, 2, 3, 4 and 5 week-old animals. 
Samples from aff ected piglets revealed fl orfenicol-sensitive 
isolates of Streptococcus suis and Haemophilus parasuis. 
The existing in-feed antibiotic treatment (100 ppm tiamulin + 
80 ppm colistin in feed for 6 weeks after weaning), a previously 
tested schedule (1), was changed to 80 ppm fl orfenicol (2 kg/Tm 
Nufl or® 40 mg/g Premix for Swine) fed over the same period. The 
results of the two systems were compared, the previous treat-
ment acting as a control for the fl orfenicol regime.
Results
Nursery phase: Mortality rates fell from 3.7% to 1.8%. The per-
centage of runts decreased from 7% to 2%, and the uniformity 
of the batches sent to slaughter improved. No diff erences were 
found for Average Daily Gain ADG (294 g/day). The economic-
ally important results are shown in Table 1. The number and cost 
of treatments needed to be given via the drinking water or by 
injection was reduced (-1.17€). 
Table 1: Economic results in the nursery phase
Euro /piglet NUFLOR® Premix Control Diff erence
Feed 7.8 7.58 +0.22
Treatments (water & 
injectable) 1.04 2.20 -1.17
Fixed costs 3.49 3.71 -0.22
Cost per piglet 26.34 28 +1.66
TOTAL 38.67 41.48 -2.82
Fattening phase: The mortality rate from historical farm records 
was 7%. In the fl orfenicol-treated group (3600 animals) the mor-
tality rate was reduced by 4.5%. The feed conversion effi  ciency 
improved from 2.79 to 2.73, and the ADG increased from 638 
to 700 g/day. The economically important results are shown in 
Table 2. 
Table 2: Economic results in the fattening phase
Euro/piglet NUFLOR® Premix Control Diff erence
Feed 61.93 65.02 -3.09
Treatments (water & 
injectable) 1.7 2.18 -0.48
Fixed costs 14.09 15.91 -1.82
Cost per piglet 40.99 42.15 -1.16
TOTAL 118.71 125.26 -6.55
The total saving for the group treated with Nufl or ®40 mg/g 
Premix for Swine, over the course of the whole production cycle, 
was 9.37 € per pig.
Discussion
Piglets are susceptible to respiratory and digestive conditions in 
those production pyramids in which PRRSv has led to immune 
destabilization. This and severe secondary bacterial complica-
tions badly aff ect production. 
This trial demonstrated that the use of a broad-spectrum anti-
biotic such as Nufl or ®40 mg/g Premix for Swine, to which the 
most important respiratory bacteria are highly sensitive, is an ef-
fective solution. Both health and productivity improved though-
out the production cycle, resulting in considerable economic 
benefi ts. 
References
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Usage of homeopathy as treatment for several disorders in pigs in an organic production system
Roberto G. Martinez; Marisol Esquivel; Enedina Silva; Jorge R. Lopez; Mario E. Haro; Roberto Martinez-Rodriguez
Facultad de Medicina Veterinaria y Zootecnia. Universidad nacional Autonoma de Mexico, Mexico, DF, Mexico
Introduction
The necessity of healthy food creates diff erent systems of 
production; such as the case of organic production. Homeop-
athy medicine is ideal for this type of production owing to it is 
a medicine treatment that respects the natural reactions of the 
organism, and it is considered as a safe therapy par excellence. 
This is based on “The principle of Similarity”, and in order to this 
principle works it is necessary to have the infi nitesimal doses 
which are: The substances which in considerable doses are able 
to provoke in healthy individuals clinical manifestations, they are 
able to eliminate such manifestations in an unhealthy individual 
if they are prescribed in small doses.
Material and Methods
This research was carried out in a farm localized 100 km north-
west Mexico City, in an area which was adapted for the host-
ing sows in an organic production system. In this area were 15 
breeding sows with diff erent farrowing number and once farrow 
the piglets. All the animal were examined twice a day in order 
to identifi ed any health problem and be able to implement a 
specifi c treatment. The following diagnostics and treatments 
were carried out:
• Sows underwent a change of management and grouping, with 
treatment based on Aconitum napellus and Carbo vegetailis 
30 centasimal (c), administered twice a day, by 18 days.
• Abscesess in teats, in shoulder and in ham of an adult sow. 
Treatement Silicea terra 30c (three times per day) and Silicea 
terra 200c (every three days) from 5 to 20 days.
• Banged sows. Arnica Montana 30c (twice a day) per 18 days.
• Sow with severe burn in one foot. Belladona atropa 30c (twice 
a day) Cantharis 6x (topic) once a day.
• Obstetrical problems, retention of piglets, yellow vaginal 
secretion with bad smell and almost non appetite. Caulophyl-
lum 30c, Belladona atropa 30c and Arnica Montana 6c (every 2 
hours and decreasing the frequency until twice a day).
• Respiratory disorders in piglets froms 3 to 15 day of age and in 
one adult sow. Aconitum napellus and Belladona atropa 30c 
(three times a day per 4 days).
• Suckled piglets from 3 to 20 days, having yellow diarrhea. 
Arsenicum album 30c (three times a day, form 2 to 3 days).
• Castration injuries, Dye madre de caléndula once a day per 2 
days.
• Prevention of anemia ferropriva. Ferrum metalicum 6c (twice a 
day).
Results
In connection with the banged and under stress sows after 
the weaning there were a reaction in all of them (15 animals). 
Talking about the abscess it was a reaction in 2 out of 3 sows 
(66.6%). The burnt sow treated with Belladona and Cantharis 
responded favorably. All of the sows with postpartum disorders 
responded favorably (100%). The combination of Acotinum and 
Belladona had a response of respiratory disorders in 34 out of 40 
piglets (84%). Arsenicum alba had favorable response in suckled 
piglets with diarrhea, 14 out of 15 piglets (93%). None of the 
piglets had anemia.
Discussion
The results of this research carried out with the objective, they 
proved that it is possible to use homeopathy as a treatment of 
individual disorders in animals in an organic raising system. At 
the same time it is an alternative to the application of prophylac-
tic treatments in biggest populations of pigs. The implementa-
tion of the treatment did not show any problem with manage-
ment or containment of the animal.
References
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Eﬃ  cacy of Denagard 20®% Injection for Treatment of Polyarthritis in Nursery
Sasiwimon Talummuk; Penchan Chaiyanate; Metta Makhanon
Novartis (Thailand) Limited , Bangkok , Thailand
Introduction
Polyarthritis in suckling pig to nursery pig are very common 
clinical signs caused by pathogens including Mycoplasma 
hyorhinis (MHR), Haemophilus parasuis, and Streptococcus 
suis. These respiratory pathogens are transmitted from sows to 
piglets by direct contact. Infected piglets can be carriers after 
weaning (4). Early treatment by injection is the state-of-the art 
method for eff ective control of polyarthritis caused by the listed 
pathogens. Tiamulin provides pronounced eff ect for treatment 
of Mycoplasma and Gram positive bacteria like Streptococcus 
suis due to MIC studies (2, 3). However, there are many sources 
of Tiamulin injection in Thailand. The objective of this study is 
to compare the effi  cacy of Denagard® 20% injection, original 
Novartis-Sandoz, and the local generic tiamulin injection for 
treatment of polyarthritis in nursery (1).
Materials and Methods 
Farm history: A farrow to fattening farm was aff ected by serious 
polyarthritis problems, 20-30% mobility rate and 5-10% motality 
rate from suckling piglets to nursery (Fig.1). Preventive program 
was water treatment with amoxicillin after weaning for 5-7 days. 
Pigs show minor response. 
20 pigs with severe swollen joints and respiratory signs were 
selected and divided into two groups. Group 1 was treated by 
Denagard ®20% injection and Group 2 was treated by generic 
tiamulin injection for three days. Nasal swabs were collected 
from all pigs before onset of treatment to confi rm mycoplasma 
infection. Joint diameter of four legs was measured by verneir 
clipper before the fi rst tiamulin injection (day 1), the third injec-
tion (day 3) and two days after withdrawal of treatment (day 5). 
pH-value of the two diff erent tiamulin injection products was 
measured. Nursery signs of pain after injection was observed. 
Statistical analysis of the joint diameter was done by ANOVA at 
p<0.05.
Fig.1 
Results
MHR was isolated from all nasal swab samples. pH of Denagard® 
20% injection is 8.5 while the generic tiamulin is 2 2. Some of the 
pigs receiving tiamulin generic injection showed sign of pain.. 
Comparison of the mean joint diameter is summarized in Table 1. 
Table 1 Mean Diameter of joint (inch) before, during and after the 
treatment.
Legs Observed day Mean Joint Diameter (inch)
Denagard 20% Tiamulin generic
Right fore leg Day 1 2.73+/-0.33 2.83+/-0.23
Day 3 2.53+/-0.21a 2.82+/- 0.14b
Day 5 2.56+/-0.25 2.78+/- 0.20
Left fore leg Day 1 2.76+/-0.39 2.91+/- 0.20
Day 3 2.70+/-0.34 2.86+/- 0.14
Day 5 2.50+/-0.25a 2.86+/- 0.17b
Right hide leg Day1 3.21+/-0.56 3.40+/- 0.33
Day3 2.96+/-0.41 3.24+/-0.18
Day5 2.90+/- 0.38a 3.30+/-0.17b
Left hide leg Day1 3.41+/- 0.70 3.33+/-0.25
Day3 3.12+/- 0.59 3.20+/-0.13
Day5 3.10+/- 0.69 3.26+/- 0.20
ab p < 0.05
Discussion 
The mean joint diameter of Denagard® 20% injection treatment 
group show a gradual decrease from the fi rst to the last day of 
evaluation. Signifi cant diff erences of joint diameter were found 
from three legs on day 3 and day 5. Interestingly, MHR carriers 
status can be detected in all pigs from nasal swabs. The acidic 
pH in generic formulation and kind of active ingredient used in 
the generic products can infl uence the performance and effi  cacy 
and cause pain in sick nursery pigs at the site of injection. From 
this study it can be concluded that based on the higher prod-
uct performance Denagard® 20% Injectable application causes 
signifi cant reduction of swollen joints in nursery pigs suff ered 
from polyarthritis. Its signifi cant effi  cacy is showed during three 
to fi ve days after treatment. 
References
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Eﬀ ect of Polyﬁ l™ (8% Phosphorylcholamine and Vitamin B12, A and E) 
Injection on Blood Composition and Chemistry of Gilts
Chanathip Thammakarn1 Jamlong Mitchaothai2
1. School of Animal Production Technology and Fisheries, Faculty of Agricultural Technology, King Mongkut’s 
Institute of Technology Ladkrabang, Ladkrabang, Bangkok, Thailand; 2. Department of Clinic for Swine, Faculty 
of Veterinary Medicine, Mahanakorn University of Technology, Nong Chok, Bangkok, Thailand
Introduction
Supportive treatments to weak or sick pigs with effi  cient and 
feasible methods would lead to minimize the low pig pro-
duction. In principle, phosphorylcholamine (PC) is a phosph-
omonoester playing important role in membrane biosynthesis 
(1). Vitamin A, E and B12 are crucial vitamins for the metabolisms 
of pigs. Hence, this study was performed in order to evaluate the 
eff ect of administration of PC, vitamin A, E and B12 (Polyfi l™) on 
blood composition and chemistry of gilts.
Materials and Methods
Eighteen gilts were randomly selected for the present study. All 
experimental pigs were equally allotted into two groups; the 
control and the treatment. The pigs in the treatment group have 
got injection of Polyfi l™ (Laboratorios Ovejero, S.A., Spain) 5 ml 
once a week for 3 times weekly, while the pigs in the control 
group did not get any administration. Blood samples were col-
lected from all pigs in both experimental groups at before the 
start of this study and at 3 days after each Polyfi l™ injection. All 
blood samples were analyzed for blood composition (eryth-
rocyte concentration & indices and leukocyte concentration & 
proportion), thrombocyte concentration and blood chemistry 
(SGOT, SGPT, BUN, creatinine, calcium, phosphorus and total 
protein). The statistical analysis is Repeated Measurements.
Results
The results of the present study have been showed in the Table 
1. There was no eff ect of the administration of Polyfi l™ on eryth-
rocyte concentration and indices (HB, MCV, MCH and MCHC) and 
leukocyte concentration and proportion of leukocytes. The injec-
tion of Polyfi l™ signifi cantly increase (p<0.05) the concentration 
of blood phosphorus and signifi cantly lower (p<0.05) the level 
of BUN. However, there was no eff ect of the Polyfi l™ administra-
tion on other studied blood chemistry (SGOT, SGPT, Creatinine, 
Calcium, Total protein).
Discussion
Most of measured valued fell in the normal rages (2). The com-
position of blood and erythrocyte indices were not aff ected 
by administration of Polyfi l™, this might be explained that the 
ingredients in Polyfi l™ improve only composition of cell mem-
brane. The increase of phosphorus in blood would be the results 
of PC containing in Polyfi l™, which directly increase in blood 
stream or more incorporation into blood cells. The lower BUN 
of gilts in the treatment group indicated lower urea production, 
which might be the results of more utilization of amino acids. 
Therefore, the administration of Polyfi l™ in gilts increased blood 
phosphorus and lowers BUN.
Table 1 Blood composition and chemistry of all pigs
Item Group
Week Signifi -
cance-0 1 2 3
RBC, × 103/μl Cont 7.10 7.39 7.50 6.91 NS
Treat 6.89 8.00 7.35 7.59
HB, g/dl Cont 13.33 12.93 15.36 13.76 NS
Treat 12.61 13.32 15.19 15.70
MCV, fl Cont 59.28 54.37 59.41 63.08 NS
Treat 61.57 51.22 59.23 65.13
MCH, pg Cont 18.86 17.54 20.54 20.06 NS
Treat 18.42 16.58 20.64 20.71
MCHC, % Cont 30.07 32.29 34.58 31.19 NS
Treat 29.97 32.41 34.84 31.63
WBC, × 103/μl Cont 15.48 12.18 11.24 11.59 NS
Treat 12.16 12.11 14.35 14.56
Neutrophil, % Cont 27.00 32.56 39.56 38.38 NS
Treat 23.44 29.22 40.13 48.50
Lymphocyte, % Cont 62.44 59.22 54.22 56.75 NS
Treat 68.71 62.89 55.00 48.88
Platelet, × 104/μl Cont 10.58 11.00 16.99 20.48 NS
Treat 6.62 11.40 19.08 21.21
SGOT, IU/l Cont 38.31 34.28 28.02 33.80 NS
Treat 50.13 35.35 28.45 47.22
SGPT, IU/l Cont 48.50 47.10 42.68 45.26 NS
Treat 47.63 45.68 43.52 46.27
BUN, mg/dl Cont 20.92 19.48 16.50 12.97 p=0.015
Treat 18.18 16.57 13.75 10.25
Creatinine, mg/dl Cont 2.63 2.76 2.77 2.84 NS
Treat 2.75 2.72 2.85 2.73
Calcium, mg/dl Cont 7.98 9.14 10.17 7.42 NS
Treat 8.55 9.47 10.48 6.70
Phosphorus, mg/dl Cont 7.64 7.71 7.20 7.30 p=0.034
Treat 9.02 7.90 7.80 7.52
Total protein, g/dl Cont 8.24 8.11 7.59 7.56 NS
Treat 8.65 8.55 7.95 7.83
Cont = Control group, Treat = Treatment group, NS = Not signifi cance
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Introduction
Ceftiofur, a broad-spectrum cephalosporin is approved for the 
treatment of swine respiratory disease including Streptococcus 
suis (S. suis). Although Ceftiofur eff ectively reduced mortality 
associated with PRRSV and S. suis1, several fi eld investigations 
in Thailand have reported varying degree of success when cef-
tiofur is used to control S. suis infection in PRRSV infected pigs. 
Unsuccessful control in PRRSV infected herds could be due to in-
creased antimicrobial resistance, decreased pharmacokinetic in 
PRRSV infected pigs2 and etc. Although the in vitro antimicrob-
ial susceptibility of S. suis has been widely investigated, ceftiofur 
susceptibility of S. suis isolated from PRRSV positive swine herds 
has not been reported. The objective of this study was to investi-
gate the Minimum Inhibitory Concentrations (MICs) of ceftiofur 
againt S. suis isolated from Thai PRRSV positive swine farms. 
Materials and Methods
10 PRRSV positive swine herds located in the Eastern, Western, 
Northern and Southern regions of Thailand were recruited into 
the study. The PRRSV status of All 10 herds was considered 
PRRSV stable/ inactive, which PRRSV viremic phase and clin-
ical diseases displayed during nursery period. Seroconversion 
against PRRSV as measured by ELISA (Idexx, USA) was 6 – 8 
weeks of age. Necropsy examination was performed monthly for 
3 consecutive months on pigs displaying clinical diseases asso-
ciated with PRRSV and S. suis including respiratory distress, swol-
len joints and convulsion. Lung, tonsil and joint fl uid samples 
were subjected for S. suis isolation. 
Bacterial (S. suis) isolation was performed on sheep blood agar. 
Suspected colonies were separated by colonical morphology 
and confi rmed by biochemical characteristics including API20 
and Polymerase Chain Reaction (PCR). Ceftiofur susceptibility 
testing was performed using an agar dilution technique ac-
cording to the standardized method described by Clinical and 
Laboratory Standard Institute (CLSI)3. 
Results
A total of 119 Streptococcus spp. isolates were recovered from 
86 diseased pigs. The biochemical characteristics and PCR assay 
demonstrated that out of 119 Streptococcus spp. isolates, only 
17 isolates were S. suis and 2 of 17 were S. suis type 2. MICs val-
ues ranged from 0.125 - 256 μg/mL (Table 1). Considered MICs 
values of Ceftiofur be ≤0.03 μg/mL, most of the S. suis isolates 
demonstrated a high degree of ceftiofur resistance. A low de-
gree of resistance was found in only 2 herds. 
No. of 
S. suis isolates Regions MIC (μg/mL)
1 West >256
2 West >256
3 West >256
4 West >256
5 West >256
6 West 32
7 West 16
8 West 256
9 West 2
10 West >256
11 West 4
12 West 16
13 West >256
14 West 0.125
15 West 256
16 West 4
17 South 0.125
18 S. suis NCTC10234 4
* S. suis NCTC 10234: Standard Streptococcus suis capsular type 2
Discussion
The results of this study indicated an increased level of ceftio-
fur resistance of S. suis isolated from Thai PRRSV positive herds 
especially herds located in high proximity area and high level of 
antimicrobial usage. Factors associated with increased ceftiofur 
resistance in PRRSV positive herds should be investigated. In 
addition, the ceftiofur pharmacokinetics-pharmacodynamics 
data and its clinical outcomes should be used to justify the opti-
mum therapeutic regimen. 
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Introduction
Several investigators have reported a synergistic eff ect for BMD 
and CTC resulting in decreased resistance of several patho-
gens(1,2). Our previous studies suggest that the use of CTC in 
combination with BMD at the day of infection results in the 
signifi cant reduction of lung lesion associated with Mycoplasma 
hyopneumoniae induced pneumonia3. The objective of the 
study was to investigate the pharmacokinetics of Chlortetra-
cycline when fed in combination with BMD in pigs co-infected 
with PRRSV and Mycoplasma hyopneumoniae.
Materials and Methods
Ten 3 to 4 week-old PRRSV and Mycoplasma hyopneumoniae 
negative pigs were randomly assigned with stratifi cation by 
weight to 2 groups (A and B) of 5 pigs each. Pigs in both groups 
were challenged with both PRRSV and M. hyopneumoniae at 0 
days post infection (DPI). While PRRSV was administered to pigs 
intranasally, M. hyopneumoniae was given to pigs intratracheal-
ly. While group A received medicated feed containing chlortetra-
cycline (Aurofac®, Alpharma Animal Health, Thailand) at dosage 
20 mg/kg BW and (BMD®, Alpharma Animal Health, Thailand) at 
dosage 33 ppm, group B received medicated feed containing 
only chlortetracycline. All medicated groups received medicated 
feed from 0 through 14 DPI (14-day total).
The pigs were gruel-fed twice a day at 600 and 1200 hrs. The 
dosages of CTC and BMD given to the pigs were 20 mg/kg BW 
per day and 33 ppm per kilogram of feed intake per day, respect-
ively. The total amount of the drugs administered per day was 
calculated and separated into half to provide the pigs twice a 
day with gruel feed. 
On 3 and 7 DPI, blood was serially collected from the same pigs 
at 0, 1, 2, 4, 6, 8, 12, 16, and 24 hours post medication (starting at 
6oo hrs and fi nishing at 600hrs next day) into heparinized tubes. 
Plasma was separated and stored in 80 °C until analysis. All 
plasma samples were determine the concentration of CTC. The 
plasma concentrations of CTC were analyzed using a validated 
high-performance liquid chromatography assay. Plasma con-
centration data of CTC were subjected to non-compartmental 
analysis based on statistical moment theory. All pharmacokin-
etic calculations were performed using linear modeling software 
(WinNonlin Version 3.2, Pharsight, California, USA). 
Results
Pigs administered with the combination of CTC and BMD 
showed similar plasma drug concentration to pigs administered 
with CTC alone on 3 and 7 DPI. Although the average plasma 
CTC concentration of pigs administered with the combination 
of CTC and BMD was higher than that of pigs administered with 
CTC alone, the diff erence was not statistically signifi cant. The 
average plasma chlortetracycline concentration of infected pigs 
was similar to that of non-infected pigs. There was no signifi cant 
diff erence in Cmax, AUC, t1/2z and 1z between the two treat-
ment groups (p >0.05). No signifi cant diff erences in pharma-
cokinetic parameters were observed in pigs administered with 
either chlortetracycline alone or in combination with BMD (p 
>0.05) on 3 and 7 DPI. However, longer half-life was observed in 
the non-infected pigs administered with a mixture of CTC and 
BMD (26.1 h) compared to CTC alone (17.6 h). 
Conclusion
The results showed that administering BMD in combination 
with chlortetracycline had slightly infl uence on chlortetracycline 
absorption. BMD showed to aff ect the elimination of chlortetra-
cycline in the non-infected pigs, although the half-life values 
were not signifi cantly diff erent between pigs given CTC alone or 
in combination with BMD.
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Introduction
Previous studies have shown that the use of antibiotics in sows 
during the lactation diets reduces problems associated with 
infections peripartum and improves reproductive behavior. It 
reduces the transmission of pathogens of the sows to the piglets 
improving the health of these (1). This practice increases the 
survival of piglets and the produced kg per week at weaning 
and the fi nishing (2). 
The objective of this study was to assess the eff ect of the use of 
Pulmotil® (Tilmicosin) in females during the stage of lactation on 
their litters productive parameters.
Materials and Methods
A study was conducted in a pig farm with 900 sows in the state 
of Yucatan, México. Animals were positive to diseases related 
to respiratory and gastro enteric signs. The total of born piglets 
from six groups of sows was studied. Each group was formed 
with 40 sows. The groups were divided according to treat-
ment: 3 groups received 300 g of Tilmicosin (Pulmotil®) + 200g 
sulfamethoxazole and 50 g of Trimethoprin/ton of food. Other 
3 groups received a premix based on 400 g of Oxytetracycline + 
200 g of sulfamethoxazole and 50 g of Trimethoprin/ton (Other). 
Both treatments were managed in the diet a week before birth 
and during lactation. The piglets were individually identifi ed 
and compared the weight to the birth, weaning, daily gain, and 
mortality. Data were analyzed in computing programs: SPSS 15.0 
and WinEpiscope 2.0. 
Results and Discussion
The average birth weights of piglets from sows of both treat-
ments were compared. There was no signifi cant diff erence 
(p=0.144). The mortality rate of piglets of Pulmotil® group and 
the other group was 2.9 % y 3.4% respectively. Although there is 
epidemiologic association between the treatment and mortality 
rate (OR=0.78), there was not signifi cant diff erences because the 
confi dence interval include the number one (IC=0.49 <OR<1.26).
Table 1. Comparison of birth weight and weaning of pigs of both 
groups
Treatment N Mean (kg)
Estandar 
desviation
Coefi cient 
variation P value
Birth Pulmotil® 1229 1.420 0.322 22.68%
Other 1092 1.440 0.352 24.88% 0.144
Weaning Pulmotil® 1147 6.866 1.383 20.14%
Other 1022 6.242 1.508 24.17% 0.000
The average weaning weights of piglets were compared and 
there was a highly signifi cant diff erence (p=0.000). The average 
days of lactation of sows were 20.70 day for Pulmotil® group and 
19.98 days for the other group (table 2). 
Table 2. Comparison of gain weight of pigs during lactation
Treatment N Weight gain in the period
Average daily 
gain Lactation days P value
Pulmotil® 1147 5.436 0.262 0.262
Other 1022 4.790 0.239 0.239 0.000
The weight at 6 weeks of age was compared observing a better 
performance in the Pulmotil® group (9.61 kg) .in contrast to the 
other group (8.37 kg).These weight were fi tted to 39.9 days of 
age and 1.3 kg of weight birth; p= 0.000 . The mortality rate to 6 
week age was lower in the Pulmotil® group although there was 
not a signifi cant diff erence.
Table 3. Comparison of weight gain of pigs during growing period.
Treatment Weight average at sold (6 weeks)
Weights average 
at 10 weeks
Daily weight gain 
(born to 40 days) P value
Pulmotil® 9.615* 30.85** 208gr
Other 8.370* 30.40** 175gr <0.05
* Weight at sold (6 weeks) fi tted to 39.9 days and considering 1.3kg at birth
** Average weight fi tted to 74 days considering 1.4 kg of birth weight.
Conclusion
It can be concluded that addition of Pulmotil® to the diet of the 
sows prior and during lactation period had a signifi cant eff ect 
in the performance of their litters during lactation and weaning 
periods. As consequence a better performance is expected in 
the growing and fi nishing periods. 
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Introduction
Essential oils (EO) have been gaining growing attention in 
livestock feeding in the last few years. They are incorporated 
in animal feed to improve productivity of livestock through 
amelioration of feed properties and promotion of the animal’s 
production performance. The in vitro antimicrobial, antiviral, 
antifungal and antioxidant activities of EO are well described 
and backed up by numerous scientifi c reports (1, 2). In the 
meanwhile, an increasing number of studies addressing the 
gastro-intestinal eff ects of EO under in vivo conditions are avail-
able. The intestinal microfl ora, gut morphology, gastric empty-
ing, activity of endogenous digestive secretions and perform-
ance parameters are considered to be infl uenced by dietary EO 
(3). In studies with weaned piglets inclusion of the blend of EO 
investigated herein improved weight gain and feed conversion 
in comparison with pigs fed negative control diets or diets sup-
plemented with antibiotic growth promoters such as avilamycin, 
neomycin sulphate and oxytetracycline (4, 5). The present study 
was carried out to determine the eff ects of a blend of oregano, 
anis and citrus EO and fructo-oligosaccharides (Biomin® P.E.P. 
125) on performance of weaned piglets.
Materials and Methods
The trial was carried out in two consecutive periods with 168 
piglets (Adenia * Pietrain) in total at the experimental station 
of Primex S.A.S., Languidic, France. Piglets were 42 days old at 
the beginning of the experiment. In each period piglets were 
equally assigned to 14 fl oor pens. There were six piglets in each 
pen, resulting in 42 piglets per treatment. The treatments were: 
1: Control and 2: Supplementation with EO. Piglets in the Control 
Treatment 1 were fed a starter diet based on wheat, barley and 
soybean meal. Piglets in Treatment 2 were fed the basal diet sup-
plemented with the phytogenic feed additive Biomin® P.E.P. 125 
at a dosage of 125 g/t. Feed and drinking water were provided 
ad libitum. Individual body weights and pen feed intake were 
recorded at 42 and 62 days of age. The dataset was subjected to 
analysis of variance using the software Statgraphics Centurion 
and an LSD test ( α = 5 %). Data was analysed using either pen or 
pig as experimental unit. The model included eff ects of period 
and EO supplementation.
Results
Performance was not aff ected by period (P>0.05). Initial BW was 
12.4 kg and did not diff er between treatments (P>0.05). Using 
pen as experimental unit, average daily gain was 551 and 530 
g in Treatment 1 and 2, respectively, and did not diff er (P>0.05) 
between treatments. However, using pig as experimental unit 
revealed a signifi cant increase in average daily gain (555 vs. 527 
g, P<0.05) in pigs fed EO. Feed intake did not diff er between 
treatments (783 vs. 793 g, P>0.05). Furthermore, supplementa-
tion with EO improved feed conversion ratio (feed/gain) by 5.2% 
(1.42 vs. 1.50, P<0.05). 
Discussion
Addition of the blend of EO in starter diets for piglets at the age 
of 42 to 62 days signifi cantly improved growth performance. 
This data confi rms the fi ndings of a study with piglets weaned 
at 22 days of age, in which the inclusion of the blend of EO 
investigated herein improved weight gain and feed conversion 
by 6.2 and 3.5%, respectively, in comparison with a negative 
control (5). Further studies indicated reduced numbers of intes-
tinal microorganisms, enhanced nutrient digestibility and lower 
levels of ammonia and biogenic amines in pigs fed the same 
blend of EO (4, 6). Thus, the mode of action of EO is supposed to 
be related to a relief from the activity of intestinal microorgan-
isms and related intestinal immune stress (3). In conclusion, EO 
are regarded as potential performance enhancers in feeding 
programs for weaned pigs.
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Introduction
Albac® (bacitracin-zinc, Alpharma, Inc., Bridgewater, NJ) is ap-
proved for increased rate of weight gain and improved feed ef-
fi ciency when fed at 11 to 55 ppm (10 to 50 g/ton). Theoretically, 
these improvements can be equated to a metabolizable energy 
(ME) value contributed by the bacitracin. 
Materials and Methods
A total of 840 pigs (5 treatments, 8 repetitions/treatment, 21 
pigs/pen) were used during the period from approximately 28.0 
to 123.0 kg body weight. A 6-phase dietary grow-fi nish program 
was utilized. All diets were corn-SBM based and maintained 
a constant available lysine/calorie ratio. Dietary treatments 
contained 1.0, 2.0, 3.0, and 4.0 % added fat (Animal/Vegetable 
Blend). An additional treatment contained 1.0% added fat and 
27.5 ppm (25 g/ton) Albac. A standard curve was generated from 
these increasing levels of dietary fat and a regression line was 
created using average daily gain (ADG) and gain to feed as the 
response variables.
Results
Overall ADG, gain to feed and fi nal body weight (BW) increased 
linearly, and average daily feed intake (ADFI) declined linearly 
as the level of dietary fat increased in the diets, validating the 
model used in this experiment to estimate the ME contribution 
of Albac (Table 1). The cost/kg gain, mortality and removals, 
carcass backfat and lean yield were not diff erent (P>0.10) as the 
level of fat increased in the diet. Over the entire experiment, pigs 
fed the 1.0% added fat + 27.5 ppm Albac diet had a higher ADG, 
a heavier fi nal BW, and better feed effi  ciency than pigs fed the 
1.0% added fat diet (Table 1). Using overall ADG as the response 
variable, 27.5 ppm Albac was equivalent to 2.47% added fat or 
123.2 kcal ME/kg of complete feed. Using overall gain to feed 
as the response variable, 27 5 ppm Albac was equivalent to 
1.29% added fat or 64.4 kcal ME/kg of complete feed (Figure 1). 
Nutritionists can assign an ME value for Albac of 257,500 kcal/kg 
within feed formulation software.
Table 1. Overall pig performance with increasing dietary fat concen-
trations and 27.5 ppm Albac
Overall trial 1.0% Added Fat
2.0% Added 
Fat
3.0% Added 
Fat
4.0% Added 
Fat
1.0% Added 
Fat +27.5 
ppm Albac
Initial wt, kg 28.0 27.6 28.1 27.8 28.1
ADG, kg/da 0.89 0.89 0.91 0.92 .91A
ADFI, kg/db 2.43 2.39 2.41 2.33 2.43
Gain to feed, 
kg/kga 0.367 0.374 0.380 0.395 0.377
B
Final BW, kgb 121.5 123.2 122.8 124.1 124.3A
aLinear eff ect of fat, P<0.01; bLinear eff ect of fat, P<0.05
A1.0% Added Fat+27.5 ppm Albac vs 1.0% Added Fat, P<0.05; B1.0% Added Fat+27.5 ppm 
Albac vs 1.0% Added Fat, P<0.10
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retention of phoshporus and calcium in growing ﬁ nishing-pigs
Alain Kanora1 Monita Vereecken1 Koen De Gussem1 Cezary Purwin2 Krzysztof Lipiński2
1. Huvepharma NV, Antwerp, Belgium; 2. University of Warmia and Mazury, Olsztyn, Poland
Introduction
Most commercial diets for fattening pigs are formulated using 
cereals and oilseed meals, in which the bioavailability of the P is 
poor, thus requiring additional P supplementation. Phytase en-
zyme inclusion in pig diets is used to reduce the need for added 
inorganic phosphorus (P) from feed phosphates and animal 
byproducts. 
In this trial the eff ect of various doses of an Escherichia coli 
derived phytase (Optiphos®) on the digestibility and retention of 
phosphorus and calcium was studied in growing-fi nishing pigs.
Materials and Methods
This balance study was carried out with 24 growing pigs with an 
initial weight of 53 kg, individually housed in metabolic cages to 
allow quantitative collection of faeces and urine. The four dietary 
treatments included a positive control (total P 5.1 g/ kg; avail-
able P 2.5 g/kg and Ca 6.2 g/ kg), a negative control (total P 3.6 
g/kg, available P 1.0 and Ca 4.2 g/kg) and the negative control 
diet supplemented with 125 or 250 FTU/kg Optiphos® (con-
fi rmed by analysis). The experimental diets were fed for 16 days. 
The study consisted of a 10 days adaptation period followed by 
a 6 days period of total collection of faeces and urine. Concentra-
tions of P and Ca were examined in samples of feed, faeces and 
urine. Experimental results were processed statistically with the 
use of one-way analysis of variance and Duncan’s test.
Results
Supplementation of Optiphos® to the NC diet resulted in a 
signifi cant positive eff ect on phosphorus digestibility for both 
supplemented enzyme doses. The P retention refl ected the P 
digestibility in a consistent way. The eff ects of Optiphos® on Ca 
digestibility and retention showed similar trends as demon-
strated for phosphorus showing signifi cant improvements at 
125 FTU/kg or higher. 
Table 1: Faecal digestibility and Retention of P and Ca 
PC NC NC +125 FTU Optiphos
 NC+ 250 FTU 
Optiphos
Faecal Digestibility P (%) 22.9c 19.7c 28.6b 36.2a
P retention (%) 20.8c 19.0c 27.6b 33.5a
Faecal Digestibility Ca (%) 25.3c 30.6b 34.1a 36.8a
Ca retention (%) 24.6b 23.8b 29.7a 35.1a
a,b,c,d: values in a row not sharing a common superscript diff er signifi cantly (P ≤ 0.05)
Graph 1: Faecal digestibility and Retention of P and Ca 
Discussion
Dietary supplementation with Optiphos® at concentrations of 
125 and 250 FTU/kg improved phosphorus and calcium util-
ization in growing pigs fed corn-soybean meal diets. Phytase 
addition increased the total-tract digestibility and the retention 
of P and Ca.
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Introduction and Objectives
Subtherapeutic antimicrobials are customarily used in pigs to 
improve daily gain and feed utilization (Barton 2000). Despite 
their benefi cial eff ects, the recent concern on drug residues in 
food and the potential transfer of antibiotic resistance to human 
pathogens has directed scientists towards alternative solu-
tions such as probiotics. Probiotics are live cultures of harmless 
bacteria that equilibrate intestinal microfl ora to the benefi t of 
the animal (Fuller 1989). Calsporin® is a thermo-tolerant pro-
biotic product based on viable spores of the specifi cally-selected 
probiotic strain Bacillus subtilis C-3102. To support EU approval 
in piglets, the effi  cacy of Calsporin® was evaluated under typical 
European conditions in Greece.
Materials and Methods
This trial was conducted in a commercial farrow-to-fi nish pig 
farm with a capacity of 400 sows and its own feed-mill. After 
weaning at the age of 32±2 days, the piglets were transferred in 
fl at decks in pens of 7-11 animals, where they remained until the 
age of 74 days. To test the effi  cacy of Calsporin®, 2 trial groups of 
weaned pigs (32 to 74 days of age) were formed: a control group 
(T1) fed basal mash feed with no antimicrobials or probiotics, 
and a T2 Calsporin® group of piglets that received the same feed 
but supplemented with 3 x 108 cfu Bacillus subtilis C-3102 per 
kg of feed during fl at deck period. 
Two sets of experiments were performed, having the pen as the 
experimental unit: a fi rst summer set (May 2 to August 15, 2008), 
and a second winter set (December 4, 2008 to March 19, 2009). 
In order to achieve homogeneity of treatment groups and to 
avoid cross- contamination, a cross-over, blocked design was 
used. In the summer set of trials, pigs of weaning batch 1 were 
equally split in 2 rooms (in 6 out of 12 pens per room), while 
the same was repeated during next week (weaning batch 2). At 
the end of weeks 1 and 2, two treatment rooms each of 12 pens 
were formed with almost the same population composition with 
regard to initial bodyweight, age, gender, dam parity and litter 
of origin. The pigs of room 1 were served as T1 (control) group 
and those of room 2 as T2 (Calsporin) group. This format was 
repeated with weaning batches 3 and 4 at a later time block, 
with the exception that room 1 was then designated as T2 Cal-
sporin® and room 2 as T1 Control. The winter set of experiments 
employing another pair of experimental groups, had exactly the 
same design as the fi rst set. Thus, at the end of the trial, a total 
of 908 weaned pigs were used derived from 2 sets of experi-
ments (summer & winter) x 2 experimental groups (rooms) x 24 
replicates (pens) of weaned piglets. 
 Parameter  T1 control  T2 Calsporin
 Dam parity 5.3 5.2
 Initial bodyweight, kg 7.74 7.73
 Final bodyweight, kg 25.42 26.92*
 Average daily gain, kg 0.421 0.457*
 Average daily feed intake, kg 0.802 0.788
 Feed conversion ratio 1.907 1.725*
Results and Discussion
Feed and faecal sampling confi rmed the presence of Bacillus 
subtilis C-3102 in T2 feed and faeces at expected concentra-
tions, and the absence of cross-contamination to T1 Controls. 
There was no signifi cant diff erence in mortality or feed intake 
between groups. However, as presented in the Table 1, signifi -
cant improvement on production parameters (fi nal bodyweight, 
average daily gain and feed conversion ratio) were recorded 
after Calsporin® consumption. Thus, compared to T1 Controls, 
the T2 Calsporin® piglets were 5.9% heavier (P<0.0001), exhib-
ited 9.5% better growth (P<0.0001) and 9.9% improved feed 
effi  ciency (P<0.0001) after 42 days on trial.
Although these studies were carried out under commercial 
farm conditions, cross-contamination of Bacillus subtilis C-3102 
between Control and Calsporin® piglets was avoided by careful 
separation of treatments. A cross-over, blocked study design 
ensured the validity of the data and the best homogeneity of 
the groups. Calsporin® produced consistent improvements in 
zootechnical performance over 8 weanings involving around 
1,000 piglets, under both summer and winter production condi-
tions. The results of these studies illustrate the contribution of 
a stable, in-feed probiotic to effi  cient pig production without 
antibiotic growth promoters.
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A survey of free and conjugated deoxynivalenol in feed and feedstuﬀ s from Asian and Paciﬁ c countries.
Si-Trung Tran; Trevor K. Smith
University of Guelph, Guelph, ON, Canada
Introduction
Deoxynivalenol (DON, vomitoxin), one of the most important 
mycotoxins produced by many Fusarium species, is found as 
a common contaminant of crops worldwide. DON can reduce 
production effi  ciency and cause serious economic losses to 
livestock and poultry producers. Recent studies have described 
the presence of conjugated forms of DON (glycosides and fatty 
acid). The optimal conditions for conjugated DON hydrolysis 
with trifl uoromethanesulfonic acid (TFMSA) have also been 
determined. The aim of the current study was, therefore, to 
investigate the natural occurrence of free and conjugated DON 
in feed and feedstuff s from Asian and Pacifi c countries. 
Materials and Methods
One hundred forty-nine feed and feedstuff s samples were col-
lected from China, Indonesia, Malaysia, New Zealand, the Philip-
pines, Taiwan, Thailand and Vietnam in 2009. 
The conditions for conjugated DON hydrolysis with TFMSA used 
for corn were 0.5N TFMSA, 20 min and 22 °C while the conditions 
used for wheat were 0.5N TFMSA, 40 min and 40 °C. Free and 
conjugated DON in the current study were determined using 
ELISA kits (AgraQuant® DON test kits, Romer Labs Inc., Union, 
MO, USA).
Results
Free DON was found in all samples (116 corn, 21 wheat and 12 
feed samples). Conjugated DON, however, was not detected in 
39 of 149 samples. Levels of DON ranged from 0.05 to 6.70 μg/g 
in corn, from 0.02 to 0.71 μg/g in wheat and from 0.06 to 0.47 
μg/g in feed. 
The highest levels of free DON were found in corn samples from 
China and Indonesia while samples from Malaysia, Thailand and 
Vietnam were less contaminated. Conjugated DON was found 
mainly in corn from Indonesia with 12 of 20 samples showing 
high levels of conjugated DON (27- 84 %). Lower levels of conju-
gated DON (12 – 33 %) were detected in 14 of 20 corn samples 
from Malaysia. Conjugated DON was not detected in corn from 
the Philippines and in the majority of corn samples from New 
Zealand and Vietnam. Similarly, no conjugated DON was seen in 
15 of 21 wheat samples while high levels of conjugated DON (up 
to 67 %) were found in 9 of 12 feed samples.
Discussion
In the current study, increases in total DON compared to free 
DON in corn are of the same magnitude as those reported by 
Liu et al. (2005) for Fusarium head blight-infected wheat or 
Zhou et al. (2007) for barley. Samples highly contaminated with 
DON, however, did not necessarily show a high concentration of 
conjugated DON, in contrast to the fi ndings of Zhou et al. (2008) 
in barley and malt. Although signifi cant diff erences between 
free DON and total DON concentrations were observed, there 
was considerable variation between regions. The reasons for the 
diff erences between regions could be due to climatic conditions 
or plant genetics. 
The current survey of free and conjugated DON in feed and 
feedstuff s from Asian and Pacifi c countries emphasizes the 
potential challenges in understanding the hazard posed by 
feed and feedstuff s contaminated with DON. Although much 
research has been carried out since the original discovery of free 
and conjugated DON, the signifi cance of these mycotoxins for 
animal health remains to be determined.
References
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Eﬀ ect of phytase supplementation on the digestibility of phosphorus and calcium in lactating sows
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Introduction
The application of phytase in pig diets has become common 
practice to improve the bio-availability of phytate P and to 
reduce phosphorus excretion. The response of phosphorus 
digestibility to phytase depends on a number of factors, such as 
dose-rate, animal category and type of diet. In this trial the eff ect 
of various doses of an Escherichia coli derived phytase (Optiph-
os®) on the digestibility of phosphorus and calcium was studied 
in lactating sows.
Materials and Methods
The trial was conducted with 48 crossbred lactating sows (six 
treatments, 8 sows/treatment). The six dietary treatments 
included a positive control (total P 6,8 g/kg), a negative control 
(total P 4.2 g/kg) and the NC diet supplemented with 125, 250, 
500 and 1000 FTU/kg Optiphos® (confi rmed by analysis). The 
experimental diets, formulated on a corn-soybean basis, were 
fed from about 5 days before farrowing until 27 days post-far-
rowing. Animals were housed individually in pens to allow grab 
sampling of faeces between days 18 and 22 of lactation. Faecal 
collection by marker method was performed and chromic oxide 
was used as a marker to estimate total tract digestibility of P and 
Ca. The trial data were analyzed with ANOVA (SAS, 2004). In case 
of any signifi cant treatment eff ects the diff erences among the 
treatments were checked by LSD-test (SAS, 2004).
Table 1: Calculated P and Ca content of the basal diets
PC NC NC+Optiphos dosages
Total P in diet (g kg-1) 6.8 4.2 4.2
Dig.P in diet (g kg -1) 3.5 1.6 1.6
Ca in diet (g kg-1) 8.1 4.8 4.8
Results and Discussion
Supplementation of Optiphos® to the diet resulted in signifi cant 
positive eff ect on phosphorus digestibility for all supplemented 
Optiphos® doses. The digestibility of phosphorus improved up 
to a phytase dose of 250 FTU/ kg. A curvilinear dose response 
was observed, reaching a plateau at 250 FTU/kg. A similar trend 
was demonstrated for the eff ect of Optiphos® on Ca digestibility. 
(Graph 1and Table 2)
Table 2: Faecal digestibility of P and Ca at 18-22 days of lactation after 
supplementation of diff erent dosages of Optiphos®
PC NC
NC +Optiphos 
at concentration 
125 FTU
 NC + Optiphos 
at concentration 
250 FTU
NC + Optiphos 
at concentration 
500 FTU
NC + Optiphos 
at concentration 
1000 FTU
P (%) 31.7c 25.0d 37.7b 47.4a 48.0a 49.9a 
Ca (%)  29.6b 23.7c 29.8b 37.8a 39.8a 39.9a
Graph 1: Faecal digestibility of P and Ca at 18-22 days of lactation 
after supplementation of diff erent dosages of Optiphos®
The digestibility of P and Ca improved up to a dosage of 250 
FTU/kg. Phytase doses in excess of that level were not associated 
with further improvement of P or Ca digestibility. The poor dose-
response relation is very surprising, because in earlier experi-
ments with other phytase enzymes (Jongbloed et al., 2004) in 
sows clear dose-response eff ects were seen. 
Conclusion
Obviously, the enzyme Optiphos® is very effi  cient in generating 
digestible P at a low supplementation level in lactating sows.
Reference
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Inﬂ uence on fertility of Lianol® Solapro incorporation in lactation diet
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Introduction
At the end of lactation, sows are in a state of negative energy 
balance (NEB). The metabolic state is the key factor limiting the 
fertility and embryonic survival. The NEB reduces fertility and 
reproduction parameters. The inclusion of Lianol® Solapro in the 
lactation diet improves these parameters.
Material and Methods
Forty Belgian Landrace sows at CRA-W from three groups were 
distributed between two feeding treatments upon entering 
the farrowing unit seven days before expected farrowing: 
control and supplement. The supplement was Lianol® Solapro, 
a complementary feeding stuff  based on fermented potato 
protein. It was distributed manually as top feeding on the fi rst 
diet (14.1 MJ of ME/kg, EVAPIG®) at a rate of 10 g/day until three 
days after farrowing and thereafter it was added to the second 
diet (14.7 MJ of ME/kg, EVAPIG®) at a rate of 0.1%. The piglets are 
weaned at 4 weeks of age. Total energy requirement (TER, MJ of 
ME/d) of sows during lactation was calculated1. Energy balance 
(EB) was calculated by subtracting the calculated TER from the 
intakes. The plasma concentrations of IGF-I were determined in 
the plasma of sows at weaning. Elisa Kit (Mediagnost®) was used 
after cryo-precipitation of proteins: acid-ethanol method2.
After weaning, sows were managed in the same modalities of 
breeding until their next farrowing. The sows were scanned 
pregnant at 4 weeks. At next farrowing, the number of piglets 
born alive, stillborn and living at day 4 was recorded. Each piglet 
was weighed at 4 days of age. Data were analyzed by analysis of 
variance using the GLM procedure (Minitab® 15.1.30.0). Model 
included the eff ects of feeding treatment and group and the 
interaction between these 2 factors. A F-test allows comparing 
intra-litter variance (Excel®, 2003); intra-litter variance of control 
and Lianol® corresponds to the residual variance estimated from 
an analysis of variance with litter and group as factors.
Results
While the EB was more negative (P<0.10), Lianol® sows had 
higher plasma IGF-I at weaning. It resulted in higher rates of 
sows keeping pregnancy until birth. Similarly, Lianol® gave bet-
ter quality embryos that develop in stronger piglets. Indeed, 
the rate of survival born alive (P<0.10) or living at the fourth day 
(P<0.05) were higher for Lianol® sows. The piglets present at day 
4 had grown equally well in both groups, but while there were 
more survivors, the intra-litter variance of weight was lower 
(P<0.05); the litters were more homogenous.
Table 1. Reproduction performance
Control Lianol® Solapro s.e. Eff ect
No. of sows at weaning 22 18
NEB lactation, MJ EM/d -22 -28 1.8 T† 
IGF-I at weaning, ng/ml 45 66 3.9 T***
No. (%) of sows inseminated 19 (86%) 17 (94%) /
Weaning to estrus interval, d 4.7 4.6 0.13
No. (%) of sows pregnant at 
scanning 17 (77%) 17 /
No. of sows that farrow 16 (73%) 17 (94%) /
Avg. litter
 Total piglets born 12.5 12.4 0.6
 Piglets born alive 11.2 11.6 0.5
 % of survival/total born 89% 94% 1.5% T†;
 Piglets at 4 d 10.4 11.1 0.5
 % of survival/total born 83% 91% 2.0% T*
Piglet BW at 4 d, g
 Mean 2,124 2,126 68
 s.e. intra-litter 108 85 6 T*
No standardization of litter size, T=Treatment eff ect, G=Group eff ect, TxG=Treatment x Group 
interaction - † = P<0.10, * = P<0.05; *** = P<0.001
Conclusion
Lianol® Solapro is a fermented potato protein which is added 
to the feed of sows. This study confi rms its benefi cial eff ect on 
several sow fertility parameters and on the quality and survival 
of the piglets that are born in the subsequent litter.
References
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Inﬂ uence of Lianol® Solapro on sow milk production and piglet weight gain
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Introduction
Milk is a pivotal factor in piglet survival, growth, development 
and pre-weaning piglet body composition. The demonstra-
tion that heavier weaning piglets attain market weight faster 
than lighter weaning piglets1 has sparked increasing interest in 
exploiting the lactation period to enhance overall piglet growth 
and pork production. The incorporation of Lianol® Solapro in the 
sow’s diet increases milk production and feed effi  ciency.
Material and Methods
Forty Belgian Landrace sows at CRA-W from 3 groups were 
divided into a feeding control group and a Lianol® Solapro group 
upon entering the farrowing unit (7 days prior to expected 
farrowing). Distribution was done manually as top feeding on 
the fi rst diet (14.1 MJ of ME/kg, EVAPIG®, rate of 10 g/day) until 3 
days post-farrowing. Thereafter, it was added to the 2nd diet at 
0.1% (14.7 MJ of ME/kg, EVAPIG®). Piglets are weaned at 4 weeks 
of age. Sows were weighed and backfat thickness was ultrasono-
graphically measured on P2-site1 at the beginning and end of 
trial. Sow weight loss was determined by subtracting uterine 
weight content2. Piglets were weighed at birth and after 4 and 
24 days age. Total energy requirements (TER, MJ of ME/d) of 
sows during lactation were calculated3. The Energy Balance (EB) 
was found by subtracting calculated TER from the intakes. Milk 
production over the 1st 3 weeks was estimated from litter weight 
gain and litter size4. IGF-I concentrations were determined in the 
sow plasma when entering the farrowing unit and at 4 and 24 
days of lactation. Elisa Kit (Mediagnost®) was used after protein 
cryo-precipitation: acid-ethanol method5. Data are processed by 
variance analysis (GLM procedure, Minitab® 15.1.30.0). Included: 
eff ects of feeding treatment, of group and corresponding inter-
action.
Results
Litter size (total born, born alive, at 24 hrs) and the average 
weight of piglets per litter were similar. While the EB was more 
negative for Lianol® sows (P=0.07), they did not lose more 
weight and backfat thickness, weight of litter at weaning, litter 
ADG and milk production were not lower. Lianol® sows showed 
optimal feed effi  ciency. Sow plasma IGF-I was signifi cantly 
higher (P<0.001) at day 4 of lactation and at weaning.
Conclusion
Lianol® Solapro added to the feed of sows supports milk produc-
tion and increases litters of lactating sows.
Table 1. Growth performance
Control Lianol® Solapro s.e. Eff ect
Number of litters 22 18
Avg. litter size
At birth (born alive) 11.3 11.5 0.4
At weaning 10.0 10.4 0.3
Avg. litter weight, kg
At birth (born alive) 16.5 17.0 0.6
At weaning 67.5 72.0 1.8
Litter ADG, kg/d 1,956 2,129 0.063
TER, MJ EM/d 74 79 1.8
Intake, MJ EM/d 52 51 1.8
EB, MJ EM/d -22 -28 1.8 T†
BW of sows, kg
Beginning (calculated) 200 204 4.4
At weaning 184 177 4.8
Loss -26 -27 2.0 G***
Backfat thickness of sows, mm
Beginning 18.7 18.1 0.5
At weaning 13.2 12.9 0.4
Loss -5.5 -5.2 0.4 G**
Milk Production fi rst 3 wk, kg 133 143 3.6
No standardization of litter size, T=Treatment eff ect, G=Group eff ect, TxG=Treatment x Group 
interaction - † = P<0.01, * = P<0.05; ** = P<0.01, *** = P<0.001
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Figure 1. Sow plasma IGF-I
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Inﬂ uence of Lianol® Solapro on sow colostrum production
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Introduction
Suffi  cient sow colostrum production and colostrum intake 
by piglets are vital for the piglet immune status. Due to the 
increased prolifi cacy, the average weight of the piglets and their 
capacity to suckle and stimulate the sow colostrum production 
has decreased. This results in a diminished colostrum intake 
and poorer piglet immune status. Lianol® Solapro, a fermented 
potato protein added to the feed of sows, increases vigor and 
colostrum intake of piglets and sow colostrum production.
Material and Methods
Forty Belgian Landrace sows at CRA-W from three groups were 
divided into a feeding control group and a Lianol® Solapro group 
upon entering the farrowing unit (7 days prior to expected far-
rowing). Distribution was done manually as top feeding on the 
fi rst diet (rate of 10 g/day) until 3 days post-farrowing and there-
after it was added to the 2nd diet at a rate of 0.1%. Farrowings, 
number of piglets born alive and stillborn and feed intakes were 
monitored. To determine colostrum intake the interval between 
birth and fi rst suckling was measured, piglets were weighed 
at birth and 24 hrs later. The total sow colostrum production is 
found by adding piglet colostrum intakes1. The concentrations 
of IGF-I were determined in the sow plasma when entering the 
farrowing unit and at lactation day 4, in plasma of four 4-day old 
piglets of each litter but also in the colostrum whey (collected 
at parturition). Centrifugation to 13,000 g gave the whey. Elisa 
Kit (Mediagnost®) was used after cryo-precipitation of proteins: 
acid-ethanol method2. Data were processed by analysis of vari-
ance (GLM procedure, Minitab® 15.1.30.0). Included: eff ects of 
feeding treatment, of group and corresponding interaction.
Results
Litter size (total born, born alive, at 24 hrs) and the average 
weight of piglets per litter were similar. During the 1st 24 hrs, 
Lianol® piglets showed a higher weight gain (P<0.05) and had 
a higher colostrum intake (23%, P<0.05) than control piglets. 
Colostrum production was signifi cantly higher in Lianol® sows 
(+20%, P<0.01). They showed a plasma IGF-I concentration 
which was signifi cantly higher on day 4 of lactation (P<0.001). 
From entering farrowing to day 4 of lactation, Lianol® sows 
showed a signifi cant improvement in plasma IGF-I concentra-
tion (P<0.001). IGF-I is known to stimulate lactogenesis3. IGF-I 
in colostrum was not infl uenced by treatment. However, Lianol® 
piglets had signifi cantly higher plasma IGF-I until 4 days of age 
(P<0.001). Their daily weight gain was 22% higher during the 
fi rst 4 days of life (P<0.05).
Table 1. Growth performance and colostrum intake of neo-natal 
piglets and IGF-I concentrations
Control Lianol® Solapro s.e. Eff ect
Number of litters 22 18
Avg. litter size
Total piglets born 12.0 12.1 0.5
Piglets born alive 11.3 11.5 0.4
Piglets at 24 h 11.0 10.9 0.4
Piglet BW, g
At birth 1,490 1,504 39
At 24 h 1,556 1,629 42
Time fi rst suckling min 58 44 5
Piglet ADG 24 h, g/d 63 114 10 T*
Colostrum intake, g/24 h 293 353 14 T*
Colostrum production, g/24 h 3,064 3,770 141 T**, G*
Sow plasma IGF-I, ng/ml
Entering farrowing unit 35 38 2.6
At 4th lactation day 29 69 5.5 T***, G***
IGF-I concentration, ng/ml
Colostrum whey 19 18 0.9 G***
Piglet plasma IGF-I, ng/ml
At d 4 8 15 1.2 T***, G***
Piglet ADG 4 d, g/d 143 174 7 T*
No standardization of litter size, T=Treatment eff ect, G=Group eff ect, TxG=Treatment x Group 
interaction - * = P<0.05; ** = P<0.01, ***= P<0.001
Conclusions
Lianol® Solapro added to the feed of sows increased piglet vigor 
as well as colostrum intake and colostrum production.
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Introduction
Lianol® Ferti is a highly digestible fermented potato protein of 
which the use results in prometabolic peptides. The fertility 
eff ect of the Negative Energy Balance (NEB) can be countered 
by feeding Lianol® Ferti to sows, increasing peptide levels and 
enhancing milk production. These eff ects are mediated by an 
elevated IGF-1 level in serum, known to increase these param-
eters. Lianol® Ferti has the proven ability to enhance the heat to 
shorten the weaning to insemination period and to reduce the 
number of empty sows. This trial aimed at confi rming the infl u-
ence of Lianol® Ferti administration to sows around weaning on 
the number of piglets born in the next litter.
Materials and methods
A group of 30 F1 sows (Belgian landrace and French Landrace) 
on a Belgian breeding farm were equally split in an untreated 
control group (parity: 3.5) and a Lianol® Ferti group (parity: 3.7) 
receiving 10 g Lianol® Ferti per sow per day, during 5 consecu-
tive days, starting on Monday before weaning until Friday 
after weaning (weaning on Thursday). IGF-1 serum levels were 
measured at the start on Monday and again the next Monday, at 
insemination. Secondly, the number of piglets born and weaned 
in the next litter, were registered.
Results
The IGF-1 levels of the untreated control group showed an 
increase of 4.4 ng/ml, being 8.25%. However, the IGF-1 levels of 
the group having received 10 g of Lianol® Ferti for 5 days showed 
a noticeable increase of 14.0 ng/ml, which is an increase of 
30.2%.
Figure 1. Impact of Lianol® Ferti on IGF-1 levels (ng/ml)
Secondly, the litter size numbers of the consequent parturition 
were compared in terms of live born piglets, number of piglets 
weaned and mortality rate. The untreated group showed 11.36 
live born piglets whereas the treated group had 12.02 live born 
piglets, i.e. an increase of 5.8% or 0.66 piglet more at birth.
When evaluating the number of weaned piglets, the control 
group had a total of 9.95 piglets, whereas the Lianol® Ferti group 
produced 10.80 weaned piglets, i.e. an improvement of 8.54% or 
0.85 piglet more at weaning.
Moreover, the mortality rate in the Lianol® Ferti group (10.1%) 
was considerably lower than that of the untreated control group 
(12.55%).
Figure 2. Infl uence of Lianol® Ferti on litter size
Discussion and conclusion
IGF-1 infl uences the ovarian activity by increasing the sensitivity 
and response of the follicles to FSH and LH. It is also crucial for 
the survival and nidation of the embryo, but also for its quality. 
Therefore, the IGF-1 increase at insemination is clearly refl ected 
in the litter size of the parturition following Lianol® Ferti treat-
ment. 
The use of 10 g Lianol® Ferti per day per sow during fi ve days in 
the period around weaning was confi rmed to increase the IGF-1 
levels and the litter size.
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Introduction
Phytase enzyme inclusion in pig diets is used to reduce the need 
for added inorganic phosphorus (P) from feed phosphates and 
animal byproducts. In this trial the eff ect of various doses of 
an Escherichia coli derived phytase (Optiphos®) on the digest-
ibility and retention of phosphorus and calcium was studied in 
weaned piglets.
Materials and Methods
A balance study was carried out with 48 piglets (barrows) with 
an initial weight of 13.5 kg. Animals were housed individually in 
metabolic crates to allow collection of faeces and urine. The six 
dietary treatments included a positive control (total P 6.5 g kg-1; 
Digestible P 3.2 g kg-1, Ca 7.1 g kg-1), a negative control (total P 
4.2 g kg-1, Digestible P 1.6 g kg-1, Ca 4.9 g kg-1) and the NC diet 
supplemented with 125, 250, 500 or 1000 FTU kg-1 Optiphos®. 
Experimental diets were formulated on a corn– soybean basis. The 
study consisted of a 9 days adaptation period followed by a 5 days 
period of total collection of faeces and urine. At the end of the 
collection period the faeces and urine samples were melted, hom-
ogenized and prepared for laboratory analysis. The calcium and P 
content of the diets, the dry matter, P and calcium content of the 
faeces, and the P and calcium content of the urine samples were 
determined in accordance with the provisions of AOAC (1989). 
The trial data were analyzed with ANOVA (SAS, 2004).
Results
Supplementation of Optiphos® to the NC diet resulted in a 
signifi cant positive eff ect on phosphorus digestibility for all the 
supplemented enzyme doses. The P retention refl ected the P 
digestibility in a consistent way. The eff ects of Optiphos® on Ca 
digestibility and retention showed similar trends as demon-
strated for phosphorus although signifi cant improvements were 
noticed at 250 FTU kg-1 and higher. (Table 1 and Graph 1)
Table 1: Faecal digestibility and Retention of P and Ca 
PC NC
NC diet + 
Optiphos at 
concentration 
of 125 FTU
NC diet + 
Optiphos at 
concentration 
of 250 FTU
NC diet + 
Optiphos at 
concentration 
of 500 FTU
NC diet + 
Optiphos at 
concentration 
of 1000 FTU
Faecal 
digestibility 
P (%)
68.5bc 53.9d 63.6c 67.8bc 74.1ab 75.8a
Retention 
P (%) 67.2
bc 53.1d 62.6c 66.8bc 73.0ab 74.7a
Faecal 
digestibility 
Ca (%)
72.2cd 68.8d 74.2cd 75.9bc 80.9ab 82.1a
Retention 
Ca (%) 68.0
abc 59.4d 64.9cd 67.2bc 73.3ab 75.1a
Graph 1: Faecal digestibility and Retention of P and Ca 
Discussion
Due to the restricted dietary phosphorus supply, the piglets had 
a very limited urinary phosphorus excretion (data not shown). 
As a consequence, the P retention of the piglets showed similar 
trends to those of phosphorus digestibility. The urinary calcium 
excretion was higher than the characteristic (physiological) 
value of weaned pigs (data not shown).
This high urinary Ca excretion (hypercalciuria) indicates, that the 
digestible phosphorus content of the diets did not cover the 
requirements of the animals, and consecutively the absorbed Ca 
could not be retained in the bones due to a lack of phosphorus 
in the blood. 
As a conclusion supplementation of Optiphos® resulted in the 
improvement of the phosphor and calcium digestibility.
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Introduction
The development of the porcine immune system is not com-
plete at birth. Because of its maturation, the amount of leuko-
cyte (LEU) populations vary during life. According to our best 
knowledge, up today, there are no data about changes in pigs 
blood LEU during whole fattening period. Therefore, the aim of 
the study was to analyze data on the changes of LEU subsets 
from birth up to about 5 months of age. 
Materials and Methods
Study was conducted on healthy pigs (n=118), aged from birth 
to slaughter. Blood were collected 12 times. Samples were ana-
lyzed using hemocytometer and immunophenotyped in order 
to determine CD3+ (T LYM), CD21+ (B LYM), T LYM subset: CD4+, 
CD8+ and double positive (DP) - CD4+CD8+. Statistical analyses 
were performed with Statistica 8.0 (Statsoft, Poland).
Results
The number of LEU and LYM increased with age from 
12.38x109/L-1 on the fi rst day to 25.70x109/L-1 at the 5 month of 
life and from 5.11x109/L-1 to 9.64x109/L-1 respectively (p≤0.05). 
The percentage (%) of LYM was the highest around 14 days of 
life. The lowest % of LYM was observed at 84 days of life. 
The absolute size of granulocytes (GRA) decreased 1.5-fold just 
after birth, remained stable until 21 days, and subsequently 
increased from weaning to 5 months of age. Strong positive 
correlation (COR) was found between number and % of GRA and 
the pigs’ age. Starting from 70 day of life the % of GRA outnum-
bered about 1.5-fold the % of LYM. Just after birth the % of CD3+ 
cells increased over 20% and remained stable until 5 months of 
age. Positive COR between numbers of CD3+cells and the age 
was determined. Apart from a signifi cant increase between 14 
and 21 day old piglets (p≤0.05) no age-related changes were 
observed in the % of CD21+ LYM, but positive COR was found 
between their numbers and age. The numbers of CD3+ and 
CD21+ cells increased 2-fold from birth to 140 day of life. Just 
after birth, signifi cant increase of the % of CD8+was noted 
(p≤0.05). The % of CD4+ cells were the highest between 14 and 
21 days of ages, but these values did not diff er signifi cantly 
from the neighboring age groups. The numbers of DP cells 
increase with the age (p≤0.05) and positive COR was observed 
between their numbers and age. The absolute number of CD3+ 
cells increased 2-fold from birth to 2 weeks after weaning. After 
this time only CD4+ subset remained stable up to 5 month of 
life. The amount of remaining populations gradually increased 
1.5- and 2.5-fold from 6 week to 5 month of life, respectively for 
CD8+ and DP cells. Negative COR was evidenced between age 
and CD4/CD8 ratio.
Discussion
In pigs, as in diff erent species of animals, the LYM/GRA ratio 
revealed changes during life. On day fi rst GRA numbers were 
almost the same as LYM numbers. Over the fi rst 3 weeks of life 
a predominance of LYM were observed. Starting from 70 day of 
life GRA outnumbered LYM. Results demonstrated that % of LYM 
populations does not refl ect their actual size and is therefore of 
limited value. The increase of CD3+ cells numbers were caused 
by rising amounts of CD8+ and DP cells. The results of our in-
vestigation showed that just after birth the numbers of DP cells, 
containing activated and memory T cells, increased almost two-
fold. Directly after weaning the numbers of these cells increase 
again at about 40%. These data are in agreement with previous 
results, dealing about age-related changes in LEU counts in pigs 
up to 41 day of life (3). Till weaning the numbers of LYM were 
lower than in weaners (p≤0.05). From our results it follows that 
CD4+/CD8+ ratio decreases with age, which is in accordance 
with other studies (1, 3). The amounts of DP LYM in blood of pigs 
increase with age (1, 3). The % of DP LYM ranges from 4 to 60% 
(1). In our study the % of DP cells increased from 6.63% at birth 
to 17.48% in 20 weeks old pigs, while the absolute number in-
creased almost 5-fold. Age-dependent increase of DP LYM seem 
to be a result of antigen-dependent maturation of naïve CD4+ 
Th cells to antigen-specifi c memory Th cells (1). On the basis 
of this study we suggested that immunophenotyping of LYM, 
especially for diagnostic purposes, should base on the absolute 
size rather than on the % of LYM subsets, according to appropri-
ate age-matched reference values. Additionally, because there 
are age-related diff erences in LYM subsets distribution, there is a 
need to use appropriate age matched control group (as closely 
as possible) in the experiment with pigs, especially those which 
include immunophenotyping. 
References
Stepanova et al. Cell Immunol 2007, 249, 73-792. Joling et al. Vet 
Immunol Immunopathol 1994, 40,105-108. Borghetti et al. Vet 
Immunol Immunopathol. 2006, 110, 17-25.
Nutrition and growth
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 1029
Poster Presentations
P.723
Eﬀ ect of three diﬀ erent antibiotics on commensal intestinal microﬂ ora 
and on some productive traits of weaning piglets
Paolo Bosi2 Giuseppe Merialdi1 Lia Bardasi1 Salvatore Scandurra3 Mario Vecchi3 
Stefano Messori2 Paolo Ferro3 Irma Nisi2 Luisa Casini2 Paolo Trevisi2
1. Istituto Zooprofi lattico Sperimentale della Lombardia e dell’Emilia Romagna, Bologna, Italy; 2. Diproval, University 
of Bologna, Bologna, Italy; 3. Elanco Animal Health, Div. Eli Lilly Italia, Sesto Fiorentino (FI), Italy
Introduction
Weaning constitutes a critical situation in the life of pigs and it 
is associated with a number of stress factors, such as separation 
from the sow and abrupt change from milk to solid feed. These 
factors may aff ect the gut physiology, the gut microfl ora and the 
immune system of weaning piglets, leading to enteric disorders 
(1). Weaning piglets are frequently treated with antibiotics for 
diseases control. Antibiotics can have an additional detrimental 
eff ect on gut microfl ora, leading to decrease in lactic fl ora and 
increase in potential pathogenic Enterobacteriaceae concentra-
tions. An in vivo experiment was performed to study the eff ect 
of three diff erent antibiotics on gut microfl ora and on some 
productive parameters and in weaning piglets. 
Materials and Methods
Seventy-two newly weaned conventional piglets were received 
by an experimental unit at 24 days of life. They were randomly 
assigned to 4 diff erent diets: conventional weaning diet without 
antibiotics (C), diet T with tilmicosin (Pultotil TM®) supplementa-
tion (400 mg/Kg), diet A with amoxicillin (Gammamix®) supple-
mentation (400 mg/Kg) and diet D with doxiciclin (Pulmodox®) 
supplementation (300 mg/kg). The experiment had an overall 
duration of 4 weeks. Antibiotics were added to diets for 3 weeks. 
During the last week all groups were fed with diet C. The body 
weight and the feed intake of every single pig was recorded 
weekly. At day 0, 7, 14, 21 a fecal sample was collected from each 
pig for enumeration of Enterobacteriaceae and lactobacilli. At 
day 2 a blood sample was collected from each animal for IgM 
and IgA titration. A fecal score was recorded daily. 12 subjects/
diet and 6 subjects/diet were sacrifi ced after 3 and 4 weeks 
respectively and samples were taken to measure full and empty 
weight of the small intestine; jejunum content for the bacteria 
counts villus height and crypt depth on villi. 
Results
In the groups with antibiotic diets, average daily gain increased 
by 34.7 % and by 9.0 %, in the 1st week and in the 3 weeks of 
treatment, respectively. Feed intake was increased by the anti-
biotics in the 1st week and in the 3 weeks of treatment (+ 19%; + 
8.3%). (Table 1). Faecal Enterobacteriaceae counts were changed 
by the antibiotic treatments, and this eff ect was linked with diet 
T (Table 2). Lactobacilli were lower in A.
Table 1. Eff ect on ADG and FI
Diet p
C A D T C vs (A+D+T)
ADG (g) d 0 to 7 120 156 157 169 <0,01
ADG (g) d 0 to 21 310 332 346 334 <0,05
FI, g/d d 0 to 7 217 251 261 261 <0,01
FI, g/d d 0 to 21 433 457 477 473 <0,05
Table 2. Feacal bacteria counts
Diet p
C A D T T vs A+D A vs D
d 21 4,96 5,74 4,30 1,78 <0,01 <0,01
d 21 8,48 7,78 8,45 8,50 0,051 <0,01
Total IgM content in blood of all pigs after 21 days was averagely 
reduced in groups with antibiotic diet (P=0.012) while IgA total 
contents were not aff ected (data not shown). No diff erereces 
were recorded for other parameters (data not shown)
Discussion
The presented results suggest that antibiotics can have a dif-
ferent impact on gut miclofl ora in agreeement with previous 
observations (2). This should be taken in consideration in the 
choice of the antibiotic in such a critical moment as weaning.
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Introduction
Mycotoxins are substances produced by the metabolism of 
growing fungi. They can be present in grains under favorable 
conditions in the fi eld, storages and transportacion. Animals 
exposed to mycotoxins, even in low levels develop a wide range 
of clinical signs such as weight gain reductions, smaller off spring 
numbers, teratogenic eff ects and decrease of productivity in all 
animal species. The aforementioned represents economic looses 
for the producers. Council for Agricultural Science and Technol-
ogy (CAST,2003) refers that potential economic cost of crop losses 
from mycotoxins in the US only, are large with a mean of $ 932 
million per year. Mean mitigation costs were estimated to be 
about $ 466 million and the mean simulated livestock cost were 
$ 6 millions per year. This study focused on improving productive 
parameters by using a combination of mycotoxins binders (alum-
inosilicates (afl atoxins adsorbent) and organoaluminosilicates 
(zearalenone and mycotoxin adsorbent)). The farm subject of this 
study did not perform mycotoxins analyses in the past, and the 
addition of binders was used as a preventative measure. The farm 
currently adds 2.5 kg/ton of feed of Zeolex Extra more 1 kg/ton of 
ZEOTEK and use US # 2 quality grains (sorghum or maize). 
Objective
To demostrate that the addition of 0 5 kg/ton of ZEOTEK in the 
feed of breding sows improves their productive parameters and 
aff ord a positive cost-benefi t ratio for the production facilities.
Material and Methods 
The company subject of this study has around 4,000 breding 
sows. The experiment was made using two gropus of 1,800 
swine each for fourd months. The fi rst group was given a diet 
including 1kg of ZEOTEK per ton of feed (control group) while 
the other was given a diet including 1.5 kg of ZEOTEK per ton of 
feed (experimental group).
Results
Statistically signifi cant results were observed in the average 
feed consumption between the groups involved in the experi-
ment. The rest of the parameters evaluated only had numerical 
diff erences (fertility percentaje, piglets per birth, mortality of 
piglets, average age at weaning, piglest average age at weaning, 
weaned piglets per sow/yeaar, breding mortality, etc).  
Discussion
The continuous use of binders on preventive doses decreased 
the eff ects of mycotoxins presents in the grains used to make 
feed. Important facts were the sows consumed less feed dur-
ing nursing (3.4 kg/weaned piglet). The experimental group 
consumed an average of 9.3 USD less of feed per sow. Thus the 
addition of higher doses of mycotoxin binders decreased the 
amount of feed needed to maintain the productive parameters 
of the farm. These results have been report by many other stud-
ies in several species.
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Introduction
Sorghum is characterized for its low protein digestibility, which 
is attributed to tannins. However, tannins eff ect is observed only 
at high levels (1). Sorghum proteins are classifi ed in: albumins, 
globulins, prolamins and glutelins. Among them, kafi rins (pro-
lamins) are the most abundant. In low tannin sorghums (<1.0%) 
the low digestibility of their protein has been associated to the 
kafi rin content (1). In vitro studies report that digestibility of 
sorghum protein decreases when kafi rin proportion increase 
(2). The objective of this work was to evaluate in vivo the kafi rins 
eff ect on ileal apparent (IAD) and ileal standardized (ISD) digest-
ibility of sorghum protein in growing pigs.
Materials and Methods
A low tannin (<0.5%) sorghum hybrid was produced; half of the 
plot was over fertilized with nitrogen to increase the kafi rins 
level, in order to get the same hybrid with high and low kafi rin 
content. Four Duroc x Landrace pigs weighing 60 kg were fi tted 
with a “T” cannula at the ileal level. Pigs were placed in metabolic 
cages and fed twice a day (09:00h and 16:00h), at 2.5 times their 
Digestible Energy requirement. Experimental diets were fortifi ed 
sorghum. The experimental period lasted seven days (fi ve days 
for adaptation and two days for collection). Ileal digesta were 
collected in plastic bags during 24h and Frozen at -20 C. At the 
end of the experimental period ileal digesta were freeze-dried 
and ground. The next analyses were performed in diets and ileal 
digesta: Dry matter (DM), crude protein (CP), chromium and 
tanins. Western Blot analyzes, using an anti kafi rinas antibody 
previously produced, were performed on ileal digesta. IAD of 
CP and DM and ISD were also analyzed (1) using a “cross over” 
design with the “Mixed” procedure of SAS (3). 
Results
The CP content was similar, 10.4 and 10.0%, for the high and low 
kaffi  rin sorghum respectively. Tannin content was very low in 
both sorghums (<0.02%). However, the relationship between the 
fractions 2 (alcohol soluble) and 3 (alcohol plus reducing agent) 
of Landry-Moureaux was diff erent. The low kafi rin sorghum 
0.73:1 vs high kafi rin sorghum 0.5:1. The DM and CP ileal ap-
parent digestibility, as well as CP standardized ileal digestibility 
were lower in high- as compared with low kafi rin sorghum, 0.811 
vs 0.839 (P<0.10), 0.693 vs 0.745 (P<0.05) and , 0.813 vs 0.868 
(P<0.05), respectively. These results were supported by western 
blot analysis.
Discussion
The lower digestibility in high kaffi  rin sorghum is due to the 
higher content of disulfi de links, which negatively aff ect protein 
digestibility (4).
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Introduction
Dietary yeast derivatives such as yeast cell walls, beta-glucan 
fractions, yeast autolysate and yeast nucleotides have been 
proposed to improve piglet health by preventing infectious 
diseases, by modulating the immune system and by controlling 
pathogenic bacteria.
Although various yeast derivatives have been used as feed addi-
tives for a long time, their in vitro and in vivo mode of action to 
improve swine performance is still not well understood.
Target of the present study was to investigate a yeast autolysate 
in vitro for its chemical composition, for its microbiological bind-
ing capacity and immunological properties and in vivo for its 
eff ect on piglet health and performance.
Materials and Methods
In vitro
Cell culture studies: As an in vitro model a chicken bone marrow-
derived macrophage cell line (HD_11) was used. The nitric 
oxygen (NO) production was determined as an indicator for 
immune stimulation. It was determined after 48 h of incubation 
with yeast products in the supernatant of the cultures using a 
Griess reagent which provides a colorimetric reaction. Results 
were compared with the positive control (LPS E. coli 0127; 20ng/
mL +/-10 μMol NO) and calculated as a % of the positive control. 
Additionally the yeast autolysate was examined for its capacity 
to bind E. coli F4 with a quantitative microbiological microplate-
based assay by measuring the optical density as growth param-
eter of adhering bacteria. The growth rate of adhering bacteria 
correlates with the amount of adhering bacteria bound to the 
yeast product. Total mannan and glucan were determined by 
HPLC using an isocratic method and a Refractive Index (RI) De-
tector. Polysaccharides were hydrolyzed with 72% sulfuric acid; 
with a subsequent Carrez-precipitation interfering materials 
were removed. Total protein was determined by Total Kjeldahl 
Nitrogen (TKN).
In vivo
A feeding trial was conducted to evaluate the effi  cacy of yeast 
autolysate on performance and health status of weaning piglets 
in a 56 days study. 40 mixed sexed piglets weaned after 28 days 
were divided into 2 experimental groups with 2 replicates: con-
trol group A, group B (1kg yeast autolysate product/t feed). 
Statistical analyses were performed with t-test, SPSS 18.
Results
In vitro
Nitric oxygen production was enhanced up to 80 % compared 
to the positive control. Microbiological assay: E. coli F4 adhered 
with an amount of 1000000 CFU/mg to the yeast autolysate. 
Mannan content was 17%, glucan content 25% and total protein 
in dry matter 43%.
In vivo
In the course of the trial a clear positive infl uence could be 
observed by the addition of yeast autolysate. Live weight on 
day 56 (43.13 kg) and daily weight gain (604) were improved 
in comparison to the control (40.92 kg live weight day 56, P = 
0.048; 505 g dwg, P = 0.025). Feed consumption was increased (P 
≥ 0.05), FCR (kg/kg) of the trial group was 1.74, from the control 
1.71 (P ≥ 0.05).
Discussion
The present study revealed that yeast autolysate is an inducer 
of nitric oxygen production by macrophages. This stimula-
tion might improve animal health by alerting the immune 
system and preparing it to respond quickly to infections and 
to counteract the eff ects of weakened immunity. Additionally 
yeast autolysate containing mannan-oligosaccharides have 
been proposed to lessen the eff ect of enteropathogenic bacteria 
such as E. coli F4 by displaying alternative adhesion sites and 
thus binding such pathogens and moving them throughout 
the gut without colonization. Therefore enteric diseases can be 
prevented and piglet health maintained. Pathogen binding and 
modulation of the immune system, as shown in vitro, might 
have been reasons for the increase in performance of piglets in 
the feeding trial.
In vitro and in vivo results indicate that this particular yeast au-
tolysate product is a health and performance improving agent. 
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Introduction
Gram- negative bacteria associated diseases are a present issue 
in pig health causing economical losses in swine production. 
Finding a way to protect pigs against overwhelming bacterial 
growth in the gut and trying to minimize the symptoms is of 
great importance. 
Colistin (Polypeptidantibiotic) is said to be an eff ective antibiotic 
against gut infections caused by gram-negative bacteria (E.coli, 
Salmonella sp.) and in this relation neutralizing endotoxins. 
Endotoxins are of special interest, as cell wall parts of gram 
negative bacteria are known to be associated with diff erent 
disease patterns as MMA and sudden piglet death. Endotoxin as-
sociated diseases are very complex in their etiopathology due to 
diff erent modes of action in infl ammation cascades. Therefore it 
is very important to ensure an overall protection for the animal. 
On the one hand endotoxin counteracting feed additives should 
be able to bind toxins and bacteria and on the other hand keep 
infl ammation processes under control and modulate the im-
mune- system.
Aim of this study was to prove the positive eff ect of a feed for-
mulation containing a yeast-derivate, a clay mineral and a plant 
extract with anti-infl ammatory properties on health status and 
performance of weaning piglets.
Materials and Methods
90 piglets chosen from 15 litters were used for this experiment. 
A 3 x 3 – trial design was employed, meaning 3 groups with 3 
replications each.
The piglets were approx. 4 weeks of age with a mean initial 
weight of 8.39 kg. 
• Group A (control): standard piglet diet without any addition.
• Group B (positive control): standard piglet diet without any 
addition, but receiving 100 mg Colistin/litre drinking water 
for 21 days.
• Group C (treated) supplied with 0.2% of the feed additive 
formulation over the whole trial period.
A 2-phase feeding system was used, where starter diet was fed 
between days 1 – 14 and grower diet from day 15 until the end 
of the trial. Feed and water were supplied ad libitum intake. 
Clinical observation was done twice a day and all incidences 
recorded. Weight of each single animal was recorded at the be-
ginning, at days 14, 42 and 56. The amount of feed distributed, 
feeding frequency and mixing ratio were recorded automatically 
per pen and day. All animals were supervised by the responsible 
veterinarian on a regular basis. All data generated out of the trial 
was subjected to statistical analysis by means of PASW 18.0.
Results
On day 56 weight of piglets of group C was improved with a 
statistical diff erence of p=0.019 compared to the control group. 
Daily weight gain (dwg) (days 1 – 56) showed signifi cant diff er-
ences (p=0.007) between groups A and B and A and C. For feed 
conversion rate (FCR) and feed intake no statistical diff erences 
could be observed, but for group C FCR (1.77) was lower as for 
group A (1.83) and B (1.88). 
In group A one animal died without showing any symptoms. On 
day 7 single incidences of diarrhea occurred in some pens and 
lasted for 13 days in changing intensities: group A showed diar-
rhea for 8 days, group B for 7 days and group C only for 4 days.
Discussion
The present study shows that a natural feed additive composed 
of 3 synergistically acting ingredients can replace a feed anti-
biotic and results in better total end weight, dwg and FCR as well 
as reduced diarrhea incidences. Although most of the animals 
showed signs of diarrhea, the growth performance was within 
the standards. Results indicate that the additive supported the 
animals in a critical phase of weaning.
Clays binding toxins, yeast derivates binding bacteria as well as 
acting anti-infl ammatory and plant extracts acting anti and pro-
infl ammatory might have a synergistic eff ect in vivo and might 
have been the mode of action for a better performance in our 
study.
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Eﬀ ect of dietary crude protein level on villous morphology and diarrhea incidence in weaning pigs
Tercia C. Reis de Souza1 María de Jesús Guerrero Carrillo1 Araceli Aguilera Barreyro1 María Guadalupe Bernal Santos1 
Konisgmar Escobar García1 Gerardo Mariscal Landín2
1. Universidad Autónoma de Querétaro, Querétaro, QRO, Mexico; 2. INIFAP, Ajuchitlán - Querétaro, Mexico
Introduction
Post-weaning diarrhea is a problem in nursery pig nutrition and 
management, mainly after the elimination of in-feed antibiotics 
(1). The most important nutritional factor for reducing scouring 
in pigs is to reduce the dietary crude protein (CP) level; because 
it can reduce the severity and extent of post-weaning diarrhea 
(2,3). However, if the dietary CP level is too low, it may aff ect the 
growth of villi (4,5). The objective of this study was to measure 
the eff ect of dietary CP level on villous morphology, and severity 
of diarrhea during the fi rst 14 days after weaning.
Materials and Methods
Fifty pigs weaned at 20.2±2.0 d of age (initial BW: 6.34±1.09 kg) 
were allotted to 2 treatment groups based on litter of origin, and 
BW. There were 5 pigs per pen and 5 pens per treatment. Two 
antibiotic-free diets were formulated. The HCP diet contained 
19.4% CP, and the LCP diet contained 15.8% CP. The severity of 
diarrhea was based on a daily visual faecal consistency score 
(FS) on a scale from 0 to 3 (6). At the end of the experiment 5 
piglets by treatment were slaughtered by exsanguinations from 
the jugular vein, and the entire intestinal tract was excised for 
sample collection. One segment of intestine (5 cm) was removed 
from the duodenum, middle jejunum, and distal ileum. The 
intestinal samples were fi xed in neutral buff ered formaldehyde 
and embedded in paraffi  n, sectioned at 5 micron thickness and 
stained with hematoxylin and eosin (HE). Villous height and 
width, and crypt depth were measured on the stained sections 
under microscope. A minimum of 10 straight, intact villi in each 
intestinal position was measured for each piglet within each 
treatment. Villous height was measured from the crypt base to 
villous tip, and villous width at mid-section. All measurements 
were made in 10 micron increments.
Results and Discussion
There were signifi cant declines of villous height in the jejunum 
(P<0.001) and ileum (P<0.05) with the reduction of dietary CP 
(Fig. 1), however villous width and crypt deep were not aff ected. 
The intestinal villi increase the exchange area, thus enhancing 
both digestion and absorption, and they are very important 
for piglets to absorb nutrients (5). Decreasing dietary CP from 
19.4 to 15.8%, villous height of the jejunum and ileum decrease 
almost 50% in the current study, implying that severe protein 
defi ciency may have reduced villous growth (4,5) and functional 
development of intestinal epithelium (4). Protein content of the 
diet had a greater eff ect on villous morphology in the jejunum 
than in the duodenum in agreement with other observations (4).
Severity of diarrhea was not aff ected by the dietary CP level. 
There was a quadratic eff ect of the post-weaning day (P<0.0001, 
R2=0.94) on FS of piglets fed both diets described by the fol-
lowing equation: FS=-0.012+0.399d-0.022d2, where d= post-
weaning day (Fig. 2). FS increased during the fi rst nine days and 
decreased until day 15 post-weaning. 
Previous studies have reported that reduced CP diets benefi t to 
the health of piglets by reducing the diarrhea incidence (1,5,6). 
Nevertheless, our results can’t confi rm the above fi ndings. 
Probably, the reduction of intestinal functional area in piglets 
fed the LCP, increased the quantity of nutrient not digested and 
absorbed, which could be substrate for the fermentation by the 
microbiota, and consequently diarrhea. In conclusion, LCP diet 
decreased the villous height in jejunum and ileum and doesn’t 
have a positive eff ect in diarrhea control.
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Eﬀ ect on the number of stillborn when adding synthetic vitamin E or natural vitamin E to the sow diet
Jesper S. Olesen1 Claes Enoee2
1. Porcus Swinespecialists, Ringe, Denmark; 2. Veterinærinstitutet, Copenhagen, Denmark
Introduction
An ever rising number of total born piglets in modern swine 
production make both the number of live born rise but unfortu-
nately also the number of stillborn. When a sow herd experi-
ences a period with many stillborn it is often considered to be 
an infectious agent that causes the problem. This trial suggests 
that the cause of many stillborn also could be a physiological 
one. The thesis was that the muscle of the uterus with big litters 
was fatigued before the farrowing was fi nished and that the 
antioxidant eff ects of vitamin E could positively infl uence that 
process. It was shown earlier that diff erent amounts of selenium 
and vitamin E given during gestation can have eff ects on the 
number of stillborn (1). It is also shown that sows given a diet 
with natural vitamin E (d-alfa-tokoferol-acetate) have a higher 
concentration of the vitamin E in plasma and milk compared 
with sows given a diet with synthetic vitamin E (dl-alfa-tokoferol-
acetat) (2). Those two studies were background for this trial.
Materials and Methods
The study was a double blinded clinical trial with 2 treatment 
groups and 1 control group. The treatment groups received 1000 
mg vitamin E in minimum 7 days just before farrowing. One 
treatment group had natural vitamin E and the other treatment 
group had synthetic vitamin E. The control group received a 
placebo. In the 3 groups there were a diff erent number of far-
rowings: in the placebo group 148, in the synthetic group 147, in 
the natural group 140.
The statistics were done by Claes Enoee in SAS version 9.1.3 in 
PROC UNIVARIATE and PROC GLIMMIX.
Results
After analyzing the complete dataset the percent of stillborn 
was 10% in the group that received natural vitamin E and 11.7% 
in the groups that received synthetic vitamin E and placebo. 
After the initial descriptive analysis it was clear that the big dif-
ference in stillborn within the treatment groups was to be found 
among the older sows (third parity sows and older). 
In the younger sows (fi rst and second parity sows) the diff er-
ence between placebo and natural vitamin E was not signifi cant 
(p=0.37). In the older sows the diff erence between placebo and 
natural vitamin E was signifi cant (p=0.03). Analyzing the dataset 
with the older sows alone, the percent of stillborn was 12.4% 
in the group that received natural vitamin E and 14.8 % in the 
group that received synthetic vitamin E. Among the older parity 
sows that received placebo the percent of stillborn was 16.7%. 
See diagram 1.
Diagram 1.
Discussion 
This study showed that in one Danish sow herd adding of 1000 
mg natural vitamin E for a minimum of 7 days signifi cantly 
reduced the number of stillborn in older sows (3 litter sows and 
older sows).This proves the thesis of the trial that there might 
also be physiological reasons for high numbers of stillborn not 
only infectious ones. The number of stillborns was reduced from 
16.7% to 12.4% in the older sows.
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A UK farm study to evaluate productivity parameters following routine iron injection of outdoor piglets
Richard B. Pearson
George Veterinary Group, Malmesbury, UK
Introduction
The vast majority of indoor units administer supplementary iron 
to piglets in the fi rst few days of life. This is done to prevent iron 
defi ciency anaemia from occurring, which is characterised by 
hypochromic/ microcytic anaemia. Supplementary iron is usually 
provided in the form of 200mg of iron as iron dextran delivered 
by intramuscular injection. In contrast, it is quite rare for outdoor 
born piglets to receive routine iron, it being widely believed that 
access to the outdoor environment allows piglets suffi  cient soil in-
take to prevent iron defi ciency. The aim of this study was to evalu-
ate possible diff erences in productivity parameters arising from an 
intervention using routine iron injection of neonatal piglets on a 
large commercial outdoor unit in Southern England. If diff erences 
in productivity parameters were seen then the study was to be 
extended to include a comparison of haematological parameters 
between treated and untreated piglets.
Materials and Methods
The unit comprised an 1800 sow outdoor herd which was split 
into two 900 sow units (Units 1 and 2). Both units had the same 
management, feed, genetics, average weaning age (26 days) 
and soil type. Farrowed sows were group managed in paddocks 
containing 12 uninsulated arcs, with fenders attached. During 
the summer wallows were established in all farrowing paddocks. 
Prior to the start of this study iron injection of piglets was not 
practised. The treatment consisted of 200mg of iron as iron 
dextran (1ml of Uniferon- Pharmocosmos). In the fi rst instance 
Unit 1 was allocated to treatment and Unit 2 to control. For a 
period of 4 weeks (Batch 1) all piglets were treated on Site 1 at 
~48 hours old. Thereafter, treatment was switched to Site 2 for a 
period of 4 weeks with Site 1 acting as control (Batch 2). This for-
mat was continued for six batches. A total of 9897 piglets were 
born alive in litters to be iron treated and, 9365 piglets were 
untreated. Recorded parameters included number born alive, 
piglet mortality, number weaned, number ‘rolled over’ (deemed 
too small and back-fostered) and average weaning weight.
Results
Mean weaning weight was 7.37kg for the iron group and 7.11kg 
for the control group over the 6 month study. This diff erence was 
highly statistically signifi cant. There were no signifi cant diff er-
ences between the two groups for 
number weaned per sow, number ‘rolled over’ or piglet mortal-
ity. A strong seasonal eff ect was noted with batches born in the 
summer showing signifi cantly poorer results for weaning weight 
and number weaned per sow. The eff ect of iron treatment on 
weaning weight was more pronounced in the fi rst three batches 
of the trial (piglets born February, March and April). In February 
the diff erence between the two groups was just under 0.6kg. 
Blood parameters for the two groups showed signifi cant diff er-
ences for haemoglobin, MCH, MCV, PCV and RBC count.
Discussion
The overall results suggest a signifi cant benefi t from routine iron 
injection for weaning weight but no benefi t for the other par-
ameters measured. Changes in the behaviour of both sows and 
piglets are suspected to be responsible for the apparent seasonal 
eff ects noted. During colder weather sows and piglets spend 
longer inside their arcs rather than outside. In warmer weather 
sows, given the option, spend long periods of time wallowing and 
hence their skin surface is often covered in adherent soil. When 
these sows return to suckle their litters, the piglets obviously 
consume relatively large amounts of soil and their iron intake is 
therefore higher. The improvement in weaning weight would ap-
pear to be mediated through improved blood parameters in iron 
treated piglets. Improved weaning weight is strongly correlated 
with post weaning performance and on this unit iron treatment 
was estimated to provide an ROI in excess of 10:1.
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The eﬀ ect of a dietary supplementation of paylean on nitrogen 
retention and nitrogen excretion in growing pigs
Ryozo Takada
Niigata University, Faculty of Agriculture, Niigata City, Japan
Introduction
A diet supplemented with Paylean (Ractopamine HCl) for grow-
ing-fi nishing pigs is known to increase growth and the protein 
contents and to decrease the fat contents of dressed carcasses. 
We conducted a nitrogen balance test in growing pigs to assess 
the eff ect of Paylean supplemented in the diet on nitrogen 
retention and urinary excretion.
Material and Methods
Ten LWD barrows with a mean weight of about 53 kg were used in 
the experiment. The pigs were housed individually in cages. Dur-
ing the fi rst week of the experiment, all pigs were given the con-
trol diet ad libitum. In the second week, the pigs were allocated 
to the control group (5 animals), which was continuously fed 
with the control diet ad libitum, or the Paylean group (5 animals), 
which was given a diet supplemented 5 ppm of Paylean (Racto-
pamine HCl) into the control diet. During this period, feed intake 
was measured daily, while body weight was measured weekly. For 
the last 3 days of the second week, feces and urine were collected 
separately. Fecal samples were collected from the rectum every 
morning, while the entire volume of urine was collected every 
day. Chromium oxide (0.1%) was added to the test diets to deter-
mine nitrogen digestibility with the indicator method.
The control diet, a feed for growing pigs, was composed mainly 
of corn and soybean meal, with a crude protein (CP) level of 
15.5% and a lysine level of 0.92%.
• Urinary nitrogen was calculated by multiplying the urinary 
nitrogen content determined with an NC coder by the weight 
of the total urine collected over the 3-day period. Fecal nitro-
gen was calculated by multiplying the nitrogen intake for the 
3-day period by the nitrogen digestibility. Nitrogen retention 
was calculated using the following equation:
• Nitrogen retention (g) = Nitrogen intake - (Urinary nitrogen + 
Fecal nitrogen)
Results and Discussion
In the fi rst week, there were no diff erences between the control 
group and the Paylean group. In the second week, however, 
daily weight gain was signifi cantly higher (p<0.01) in the Pay-
lean group (1103 g/d) compared to the control group (880 g/d). 
There were no diff erences in daily feed intake between the 2 
groups. Feed effi  ciency was signifi cantly higher (p<0.05) in the 
Paylean group compared to the control group.
• No signifi cant diff erences were noted in nitrogen intake 
between the 2 groups, but somewhat higher mean value was 
observed in the Paylean group. Nitrogen retention (g/3 d) 
was signifi cantly higher (p<0.05) in the Paylean group com-
pared to the control group, and nitrogen retention effi  ciency 
(nitrogen retained/nitrogen intake) was more markedly 
higher in the Paylean group (p<0.01). Although no signifi cant 
diff erences were observed in urinary nitrogen excretion (g/3 
d), urinary nitrogen excretion (%) (Urinary nitrogen/nitrogen 
intake) was defi nitely lower in the Paylean group compared 
to the control group (p=0.01). There were no signifi cant dif-
ferences in nitrogen digestibility between the 2 groups.
• The above results revealed that dietary supplementation of 
Paylean increased the nitrogen retention and decreased urin-
ary excretion in growing pigs.
Table 1. Nitrogen balance test of growing pigs fed a diet supplemented 
with Paylean
Control Paylean
Intake of N (g/3d) 193 ± 22 220 ± 25
Absorbed N (g/3d) 155 ± 22 177 ± 25
Retained N (g/3d) 80 ± 8 109 ± 10*
Retained N/intake N 0.42 ± 0.02 0.50 ± 0.02**
Retained N/absorbed N 0.53 ± 0.03 0.63 ± 0.04*
Urinary N (g/3d) 75 ± 13 68 ± 16
Urinary N/intake N 0.38 ± 0.03 0.29 ± 0.04*
Urinary N/absorbed N 0.47 ± 0.03 0.37 ± 0.04**
N digestibility 0.79 ± 0.03 0.80 ± 0.02
Mean ± SE (n=5) **P<0.01 *P<0.05
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Defatted corn germ meal as a source of phytic acid associated 
with phytase enzyme to ﬁ nishing swine rations
Graziela D. Pacheco; Arturo P. Lozano; Caio A. Silva; Ana M. Bridi; Roberta A. Silva; Marina A. Tarsitano
Universidade Estadual de Londrina, Londrina, PR, Brazil
Introduction
The phytic acid is a component present in defatted corn germ 
meal (DCGM) (1), a strong chelation agent with activity on poly-
valent cations like calcium, iron, zinc, copper and manganese. 
So the use of phytic acid can be interesting to improve the pig 
meat, which has high level of iron, a potent cation involved with 
meat oxidation, where through the chelation of iron, the phytic 
acid reduces the damages of meat oxidation (2). Therefore this 
response also aff ects the availability of some minerals reducing 
their absorption, increasing the environmental pollution and 
aff ecting the animal performance. The low digestibility of phos-
phorus phytic increases the cost of ration because it is necessary 
to use inorganic sources of this mineral or to add phytase en-
zyme. The objective of this study was to evaluate the infl uence 
of phytic acid present mainly in DCGM, associated or no with 
phytase on the performance, mineral excretion, carcass, meat 
quality and serum parameters of fi nishing pigs.
Materials and Methods
Thirty six commercial pigs, 16 barrows and 16 gilts, with 60,31 
± 5,32 Kg BW, located on individual pens were distributed to 
randomized block design, factorial 2 X 2 X 2 (with and without 
DCGM, with and without phytase, barrows and gilts) establish-
ing four treatments: T1 - diet without DCGM and without the 
addition of phytase; T2 - diet without DCGM and with phytase 
(1000 PU); T3 - diet with 40% of DCGM and without phytase; 
T4 - diet with 40% of DCGM and with phytase (1000 PU). The 
commercial phytase used is NATUPHOS® 500, at 1000 phytase 
unit (PU). The rations and water were off ered ad libitum, been 
the rations isoenergetic and isonutrients. Were analyzed the per-
formance parameters (daily weight gain, daily feed intake and 
food conversion), carcass and meat characteristics and the meat 
oxidation (Longissimus dorsi muscle) through T-BARS method. 
Also were evaluated the serum values of calcium, phosphorus 
and iron. To determine the levels of phosphorus and calcium 
in the feces, was adopted the technique of partial collection of 
feces, using as marker the chromic oxide 0.3%. At 87.19 ± 7.08 kg 
BW, the pigs were slaughtered and submitted to evaluation of 
carcass traits and meat quality.
Results and Discussion
There was no diff erence in performance parameters and none 
negative infl uence between the factors on carcass characteris-
tics (P>0.05). The results of the fecal levels of phosphorus and 
calcium are showed on the Table 1.
*Factors Feces (mg/100g)
Fecal phosphorus Fecal calcium
DCGM
   without 1.55 b (0.5) 0.88 b (0.2)
   with 2.10 a (0.6) 1.03 a (0.3)
Phytase
   without 2.26 a (0.4) 1.03 a (0.2)
   with 1.38 b (0.4) 0.88 b (0.2)
Sex
   barrows 1.94 (0.5) 1.10 a (0.2)
   females 1.71 (0.7) 0.82 b (0.2)
VC (%) 13.7 14.7
Diff erent letters within the columns means diff erence by Duncan Test (P<0.5)
Animals that received the DCGM and that were fed with rations 
with phytase had a greater fecal excretion of phosphorus and 
calcium (P <0.05). The last result is according to Simons et al. (4).
The serum levels of phosphorus, calcium and iron were simi-
lar between the factors, but Gebert et al (5) observed that the 
pigs that received diets with phytase (1000PU) presented an 
increased of serum concentration of iron and phosphorus. There 
were no eff ects of the treatments on the meat quality, but to 
the meat oxidation the ration with DCGM (with greater level of 
phytic acid) shows a lower lipid oxidation than the diet with-
out DCGM (0.16 versus 0.21 mg/kg T-BARS). There results were 
similar to Harbach et al. (2) fi ndings. The phytase didn’t aff ect the 
oxidation of the L dorsi muscle. 
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Using enzymatic complex in feed containing defatted corn germ meal for pigs during growth and ﬁ nishing
Sylvia L. Vinokurovas; Caio A. Silva; Ana M. Bridi; Arturo P. Lozano; Marina A. Tarsitano; Roberta A. Silva; Danyel B. Dalto
Universidade Estadual de Londrina, Londrina, PR, Brazil
Introduction
In the Brazilian swine culture, the largest part of production 
costs is from food, basically constituted by corn and soybean 
meal. In this scenario, the search for alternative ingredients, as-
sociated to enzymatic complexes, is a very common procedure 
nowadays. Defatted corn germ meal (DCGM) is a co-product 
from the corn oil extraction, presenting several nutritional at-
tractions and signifi cant availability. Nutritionally, it has been 
indicated in the feed of pigs as an alternative product (1). 
However, there are restrictions on the high inclusions of DCGM 
due to the high levels of fi ber and low energy in its composition. 
The correction of these aspects might increase the cost of the 
feed. A solution is to reduce the negative eff ects caused by the 
excess fi ber with the addition of enzymatic complex. Then, the 
objective of this paper is to study the eff ects of including 20% 
DCGM and an enzymatic complex for pigs’ performance, carcass 
characteristics and meat quality.
Materials and Methods
A total of 50 pigs (PIC) were used, 25 castrated male and 25 
female, with initial average weight of 41.14 kg, kept in two 
animals per pen. The test was conducted during 83 days, been 
evaluated the performance, carcass characteristics, meat quality 
and the cost of the treatments The experimental design was in 
random blocks, with 5 treatments and 5 repetitions/treatment, 
being each pen considered an experimental unit. Feed named 
control was formulated based on corn and soybean meal and 
the remaining ones were made of corn, soybean meal and 20% 
DCGM. Two diets containing DCGM received a commercial 
enzymatic complex (Allzyme® SSF) on the dose of 0.02%, being 
that in one of the diets the matrix of the enzymatic complex was 
considered in the formulation. In the other, the complex was 
added on top, that is, out of the formulation. Then it was defi ned 
5 treatments: T1- control feed (corn + soybean meal); T2- feed 
with 20% DCGM; T3- feed with 20% DCGM + EC; T4- feed with 
20% DCGM without EC reformulated (discounting the nutritional 
matrix of the enzymatic complex); T5- feed with 20% DCGM + EC 
(in its additive form – on top ) 
Results and Discussion
Results for zoo-technical performance are presented in Table 1. 
Table 1 - Means of daily weight gain (DWG), daily feed consumption 
(DFC) and feed conversion (FC) for pigs submitted to feed with and 
without the inclusion of enzymatic complex 
Treatments
Parameters
DFC (kg) DWG (kg) FC
T1 2.38 0.68ab 3.53b
T2 2.43 0.71ab 3.43b
T3 2.26 0.66ab 3.40b
T4 2.79 0.64b 4.33a
T5 2.43 0.72a 3.36b
VC (%) 15.23 6.59 14.95
Duncan test (P<0.05
Signifi cant diff erence was verifi ed for DWG with advantages for 
T5 and worst results for T4. For FC, the worst result was veri-
fi ed in T4 (P<0.05) For the parameters related to carcass char-
acteristics, no signifi cant diff erences (P>0.05) were observed 
among the treatments. The highest fi nal pH values for meat 
were observed for T1, but infl uences from this parameter could 
not be verifi ed (in any of the treatments) on the quality of the 
meat. According to the conditions of this experiment and the 
prices for the ingredients, that the best economic and average 
cost indexes were those obtained for the treatment with DCGM 
with the inclusion of the enzymatic complex in diets based on 
soybean and corn in pigs in fi nishing phase. (2) have observed 
that the addition of the complex has possibly aff ected positively 
the DFC and FC, indicating greater effi  ciency through the usage 
of complex in feed, resulting in lower feed cost. The addition of 
enzymatic complex in diets with 20% DCGM for pigs in growth 
and termination phases has improved the mean weight gain, 
without aff ecting the characteristics of meat quality, as well as 
presenting better economic effi  ciency.
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Interactive eﬀ ect of Ractopamine and dietary energy density on performance 
and characteristics traits of pigs selected for fast weight gain
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Introduction
Progeny of Large White sire line evaluated in this work diff er-
entiate themselves in the market through high intake capacity, 
result of long of time of selection for feed intake capacity and 
speed of growth. In the initial period of growing, the high cap-
acity of consumption provides speed up weight profi t, however, 
in the fi nal phase of fi nishing this can result in excess of fat in 
the carcass. Thus, supplementation of ractopamine (RAC) in the 
diet has been an alternative to reduce the feed in this phase and 
increase the yield of carcass meat (2). However, more studies 
should be conducted to determine the best nutritional program 
supplementation with RAC for these animals, especially with 
regard to energy consumption. Due to changes in genetics and 
management practices within the swine industry, this study 
was conducted to evaluate the performance and carcass traits 
of fi nishing barrows and gilts, from crossbred sows x Large 
White terminal sires, receiving diets with diff erent metabolizable 
energy levels and supplemented with RAC.
Material and Methods
Animal care and experimental protocols were approved by the 
University of Lavras Interdepartmental Animal Care and Use 
Committee before initiation of this experiment. The experiment 
was conducted at the pig farm of the Department of Animal 
Science, Federal University of Lavras (UFLA), Lavras, MG, Brazil. 
A total of 88 crossbred pigs (from crossbred sows x Large White 
boars), 48 barrows and 40 gilts (initially 75 ± 6.5 Kg) were used. 
The experimental design was randomized blocks with time 
the treatments (8) were arranged as a 2x4 factorial (two sex-
ies – barrows and gilts - and four levels of metabolizable energy 
(ME) - 3000, 3150, 3300 and 3450 Kcal / kg) with 6 replicates 
for barrows and 5 for gilts. There were 2 pigs per pen. All diets 
(corn-soybean meal) met or exceeded NRC (1998) require-
ments, were supplemented with 10 ppm of RAC during the 28-d 
feeding trial. The data were subjected to ANOVA was generated 
using the GLM procedure (SAS Inst. Inc., Cary, NC). Least squares 
means were generated and separated using the LSD procedures 
when there was a signifi cant (P  0.05) F-test for a main eff ect or 
interaction. 
Results
The feed conversion (FC) decreased linearly with increased 
energy density of diet for barrows and gilts. There was no 
signifi cant interaction between energy level and sex. The other 
performance variables such as ADG and ADFI as well as carcass 
traits were not aff ected (P> 0.05) by levels of energy in the diets 
used in this study. In relation to sex, gilts shown lower fi nal 
weight (1.83%), lower average daily gain (6.55%), lower average 
daily feed intake (13.73%), better feed conversion (6.29%), lower 
backfat thickness (26.62%), larger longissimus muscle (9.40%) 
and higher meat yield (4.25%) all those signfi cative by (P<0.05).
Discussion
The increase in energy density in the fi nishing phase makes the 
voluntary intake of animals reduced, thus resulting in improved 
of feed conversion. However, as observed in other studies (1, 
3), increasing the energy level of diets supplemented with RAC 
improved feed conversion of barrows and gilts without aff ect-
ing feed intake. In relation to sex, the result shown that the 
effi  ciency of gilts to deposit lean tissue in the carcass should be 
due to the infl uence of hormonal activity, that increase basal 
metabolism and lowered the feed intake capacity. Results of this 
study indicate that including ractopamine (10 ppm) with higher 
ME levels in the diets could lower FC in both barrows and gilts 
in the fi nishing phase. However the inclusion of RAC with higher 
energy concentration in the late-fi nishing diet did not aff ect the 
others variables of growth performance as well as the carcass. 
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Introduction
Soft pork fat has become an economical concern of the Brazilian 
pork industry. Accordingly, progeny of Pietrain sire line evalu-
ated in this work is characterized by the excellent resulting in 
conformation and lean meat content in the carcass, result of 
the intense selection auto-restriction of feed. Moreover, includ-
ing Ractopamine (RAC) in swine fi nishing diets produces more 
muscular carcasses as well improve feed conversion including 
those with restrictive feeding regimes (1). It is well known, how-
ever, that the diff erences in feed intake and effi  ciency of protein 
deposition between barrows and gilts resultant of crosses 
between diff erent strains, especially with regard to energy con-
sumption can result in diff erent responses of these fi nishing pigs 
to RAC supplementation in the diet. The objective of this work 
was to evaluate the performance and carcass traits of fi nishing 
barrows and gilts, from crossbred sows x Pietrain sires, receiving 
diets with diff erent metabolizable energy levels and supple-
mented with RAC.
Materials and Methods
Animal care and experimental protocols were approved by the 
University of Lavras Interdepartmental Animal Care and Use 
Committee before initiation of this experiment. The experiment 
was conducted at the pig farm of the Department of Animal 
Science, Federal University of Lavras (UFLA), Lavras, MG, Brazil. 
A total of 88 crossbred pigs (crossbred sows x Pietrain terminal 
sires), 48 barrows and 40 gilts (initially 75 ± 5.5 kg) were used. 
The experimental design was randomized blocks with time the 
treatments (8) were arranged as a 2x4 factorial (two sex – bar-
rows and gilts) and four levels of metabolizable energy –ME 
(3000, 3150, 3300 and 3450 Kcal ME / kg) with 6 replicates for 
barrows and 5 for gilts. There were 2 pigs per pen. All diets (corn-
soybean meal) met or exceeded NRC (1998) requirements, were 
supplemented with 10 ppm of RAC during the 28-d feeding trial. 
The data were analyzed by ANOVA by using the GLM procedure 
(SAS Inst. Inc., Cary, NC), with the main aff ects of level ME and 
sex as well the Energy x sex interaction, included in the statis-
tical model. Least squares means were generated and separated 
using the LSD procedures when there was a signifi cant (P 0.05) 
F-test for a main eff ect or interaction.
Results
The data shown a signifi cant interaction (P<0.05) between sex 
and ME on feed conversion (FC). For barrows, the FC decreased 
linearly with increased ME of diet. However, we found non-
signifi cant diff erence (P>0.05) of energy levels on the others 
performance and carcass traits variables. In relation to sex, gilts 
shown lower fi nal weight (1.63%), lower average daily gain 
(5.26%), lower average daily feed intake (15.82%), better feed 
conversion (10.2%), less backfat thickness (17.79%) and higher 
meat yield (3.27%) all those signfi cative by (P<0.05).
Discussion
According to (3), regardless of supplementation with RAC, 
Increasing the energy density of swine diets has been shown to 
have no aff ect on feed intake, resulting in improvements in feed 
effi  ciency F:G. However, in the present experiment this eff ect 
was only observed for barrows. A possible explanation for this 
result would be a physical limitation of intake capacity of gilts as 
a observed by the smaller numerical variation in feed consump-
tion as a function of energy density. The greater effi  ciency 
in lean deposition and lower voluntary feed consumption of 
gilts should be explaining the other results (2). It is therefore 
suggested that supplementation of diets with RAC (10 ppm) 
with higher ME levels could lower FC in the fi nishing barrows. 
However the inclusion of RAC (10 ppm or 10 mg/Kg) with higher 
energy concentration in the late-fi nishing diet did not aff ect the 
others variables of growth performance as well as carcass traits 
of barrows therefore gilts shown better carcass traits in fi nishing 
phase. 
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Introduction
To date only few farms are using organic pig production in Mex-
ico. One of the main challenges facing producers during the pro-
cess of conversion to organic is the transition period, in which a 
decreased productivity is perceived in relation to the production 
parameters obtained before the process1. The major obstacle 
comes from the diffi  culty to fulfi ll all the regulations needed to 
obtain the organic certifi cation, like feeding and management2. 
The sows body condition and composition, can explain why the 
productive performance of the sows are aff ected during the 
transition period between a confi nement system to a free range 
with alternative feeding system1,3. The objective of this study 
was to evaluate the body condition and composition of gestat-
ing breeding sows during the transition period of tie used to 
implement a organic production system in a pig farm from the 
centre of Mexico. The production conditions including the feed-
ing and management systems were also monitored, to fi nd out 
how this change in procedures aff ects the sows.
Material and Methods
Fifteen York-Landrace sows with diff erent parity were allocated 
into 3 groups with diff erent treatments; organic management– 
alternative feeding (O-A), organic management- conventional 
feeding (O-C), and conventional management – conventional 
feeding (C-C). Two types of isoenergetic and isoproteic diets 
were used, one was “conventional” with sorghum and soy cake, 
and the other “alternative” based on lentil sprouts and banana-
potato silage. The organic management was carried out in ac-
cordance with the established by KRAV2. All sows were weighed, 
the back fat (BF) measured, and the body condition (BC) 
registered in four diff erent times, at the beginning of the study 
(m1), at the second third of pregnancy (m2), at the third (m3), 
and on 112 (m4). Two equations were employed to calculate 
the body fat (BoF) and the protean mass (PM). The data analysis 
was carried by means of orthogonal contrasts, and for the body 
condition a non-parametric test Kruskal-Wallis test was used.
Results
As for weigh and BF no diff erences were found throughout 
pregnancy (p > 0.05); however, the total weight gain showed 
some diff erences (p=0.001) in contrast “management eff ect” 
(O-C, O-A vs. C-C), with O-C (26.15±19.3 kg), O-A (10.62±14.7 kg) 
and C-C (48.5±11.9 kg). The BF measurements did not showed 
diff erences between groups (p > 0.05), until m4 in which the 
contrast “feed eff ect” (O-A vs. O-C) (p=0.035) obtained for C-C 
(21.16±1.69mm) was higher in comparison to O-C (20.7±2.2mm) 
and O-A (18±2.12 mm). The body composition (BoF, PM, the 
relationship between them and maternal gain MG), did not 
show diff erences (p>0.05); however, maternal fat gain showed 
diff erences for both contrasts (p<0.05) with O-C (9.8±5.7 kg), 
O-A (1.55±6.24 kg) and C-C (17.27±1.7 kg).
Discussion
Sows maintained with organic management showed less weight 
gain, from which a considerable portion was BoF. Despite the 
diets were formulated according to the established require-
ments of NRC 1998, they were not suffi  cient to satisfy the 
energetic demands of the animals, principally at the end of 
pregnancy, period of greatest nutrient demand of the products 
owing to their fast growth. Therefore, it can be concluded that 
it is possible to maintain an adequate body condition and com-
position with an alternative diet during the transition period to 
organic, as long as the feed’s energetic contribution is increased 
but not the protein, in such a way that these can be adjusted to 
the activity and thermoneutrality in this system.
Research supported by PAPPIT Project IN. 202128
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Introduction
Phosphorus (P), except calcium (Ca), is the most important 
component of an organism. Pigs body contains about 0.45 % 
of phosphorus, and 80% of that amount is present in bones, 
considerable concentration is in blood (6). 
Mono- (MCP) and dicalcium phosphates (DCP) are the most 
often used in pigs feeding, but phosphorus digestibility is very 
diff erentiated, e.g. 51-80 %. (5). Very important, except P, is cal-
cium content in feed (1, 3). 
The aim of the present study was to determine an infl uence of 
two diff erent feed phosphates (MCP and DCP) on P and Ca con-
tent in blood serum and thigh bones of fi nishing pigs. 
Materials and Methods
The material were 40 piglets (sow – Large Polish White x Polish 
Landrace) x boar (hampshire x pietrain) The fattening lasted 85 
days, i.e. to the body mass of about 110 kg. Group I was given 
MCP (Ca (H2PO4)2,, Finnish product) while group II – DCP (CaH-
PO4x2H2O, Polish product). The contribution of particular feed 
phosphates resulted from the optimization of P content in feed 
mixtures. It was assumed that mineral phosphorus makes up 
30% of the demand for an overall phosphorus. The nutritional 
value of starter, grower and fi nisher mixtures, with mineral com-
ponents was similar in I and II group (3). 
Blood for analysis was collected at 85th day of pigs life from the 
zygomatic vein. When determining the level of an inorganic 
phosphorus, the UV-VIS method was used, and while determin-
ing calcium level – photometric method was applied. 
Thigh bones were collected after the slaughter. Ring shaped 
samples of a thickness of 3 mm were collected from each bone. 
Double weighted amount, of a mass of 0.5 – 0.6 g each, were 
prepared. Samples subjected to analysis were mineralized using 
a microwave furnace. Determination of P and Ca content was 
conducted using atomic emission spectrometry (ICP – OES). The 
results were worked out statistically (Duncan’s test).
Results and Discussion
The feed phosphates used diff ered considerably as regards their 
physico-chemical features (2), but the level of P (and Ca as well) 
was similar in pigs diet (3). Phosphorus level in blood serum of 
pigs was similar in both groups (about 2.5 mmol/l), what was 
also observed in the case of calcium (about 3.1 mmol/l) (Table 1). 
The values were close to an upper limit of reference values (8). 
In the case of a bit lighter pigs (85 kg) the considerably higher 
values of P were obtained (over 4 mmol/l), but similar ones of 
Ca (7). Statistically higher (p<0.05) content of P (142,2) and Ca 
(261,2 g/kg) was in thigh bones in II group (DCP) as compared 
to group I (MCP). Another data in this range may be found in 
the literature (1,4), that proves numerous factors infl uencing P 
accumulation in pigs bones. 
Table 1. The content of P and Ca in pigs blood serum (n=12) and thigh 
bones (n=10) (x ± SD)
Element
Blood (mmol/l) Bone (g/kg) 
I -MCP II-DCP I -MCP II-DCP
Ca 2.58 ± 0.13 2.48 ± 0.15 250.6b ± 7.5 262.1a ± 9.1
P 3.03 ± 0.14 3.09 ± 0.38 118.6b ± 3.5 142.2a ± 2.4
a-b p<0.05
Generally it should be stated that the two diff erent phosphates 
used in the experiment did not signifi cantly infl uence the diff er-
entiation of P and Ca of blood of pigs, while the highest concen-
trations P and Ca in thigh bones of pigs that were given DCP may 
prove the better bioavailability of those building elements in pigs, 
that is of a special signifi cance in the fast-growing animals.
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Introduction
In response to global concern about climate change, there is 
pressure on the pork industry from the retail sector to measure, 
and over time, reduce the carbon intensity of pork. The National 
Pork Board is currently assessing the carbon footprint of US 
produced pork. Ractopamine (RAC; Paylean®) is a feed ingredi-
ent that when fed the last 28 days to fi nishing pigs results in 
enhanced feed effi  ciency, increased growth rate, and increased 
leanness(1). These benefi ts impact pork production by decreas-
ing feed utilization, days to market and by reducing the popu-
lation of pigs needed to supply the same quantity of protein 
produced from non-RAC-fed pigs. The purpose of this study was 
to quantify the cradle-to-gate GHG emissions savings resulting 
from the theoretical feeding of RAC to the 109.2 million head of 
pigs harvested in the US in 2008.
Materials and Methods
Using 2008 U.S. pork production statistics, the environmental 
benefi ts associated with the production effi  ciency of RAC were 
quantifi ed and assumed implementation of RAC in all fi nishing 
pig diets in the U.S. at 5 or 10 mg/kg diet(2). The derived benefi t 
of the increased leanness per pig resulted in fewer animals 
needed to produce the same amount of pork protein. In addi-
tion, pigs experienced greater feed effi  ciency as a result of RAC, 
and reach their market weight sooner for harvest(2). The model 
used to assess GHG emissions savings followed the same meth-
odology as a ‘cradle-to-gate’ Life Cycle Assessment and included 
all upstream and on-farm GHG emission savings. 
Results and Discussion
The leanness response of 109.2 million head of fi nishing pigs be-
ing fed 5 or 10 mg/kg RAC resulted in the same amount of pork 
protein being produced in 2008 with 5.8 and 6.9 million fewer 
fi nishing pigs and 310,000 and 369,000 fewer sows, respectively. 
The RAC-fed pigs reached market weight in 3.00 or 2.76 fewer 
days for the 5 or 10 mg/kg dose respectively.  
The reduced population of sows and fi nishing pigs, improved 
feed effi  ciency, and reduced number of days to market, resulted 
in GHG savings measured on a CO2-equivalent basis for the 
three major categories of production activity changes shown in 
Table 1. 
Table 1. Summary, Annual GHG Emissions Savings
Source of Emissions GHG emissions savings for 5mg/kg Dose (tCO2e/yr)
GHG emissions savings for 
10mg/kg Dose (tCO2e/yr)
Feed Production 586,246 738,828
Manure 1,204,221 1,367,944
Pig Housing 78,949 94,350
Paylean® GHG LCA -6.3 -12
Total 1,869,410 2,201,110
The avoidance of methane emissions from manure was over 
60% of the overall GHG emissions savings for both the 5 and 10 
mg/kg dose of RAC (due to its 25 times higher global warm-
ing potential compared to CO2). Over 30% of the GHG savings 
associated with both doses resulted from decreased upstream 
emissions resulting from reduced feed needed. The avoided 
emissions from pig housing energy demands was the third most 
substantial contributor to the over GHG savings for both doses 
with approximately 4% of the total savings. Overall, this is a very 
conservative estimate of the GHG emissions savings because 
none of the downstream GHG emissions savings were included 
such as post farm transport and processing of pigs. The carbon 
footprint of the manufacturing and distribution of Paylean to 
the entire pig population resulted in a fraction of GHG emissions 
attributable to pork production. 
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Introduction 
Piglets are most likely to develop anemia after birth since the 
iron requirement for red blood cell production is about 7-10 
mg/day while there is insuffi  cient amount of iron at 1 mg/day 
available in sow milk (1). Therefore, the supplementation of 
iron to piglets at a few days of age is of importance for anemia 
prevention. The iron supplementation can be given by oral or 
parenteral route, and its eff ectiveness was varied. Two doses of 
intramuscular injection showed higher hematocrit and hemo-
globin than two doses of oral administration and one dose of 
injection (2). The larger dosage of iron intramuscular injection 
promoting haemoglobin formation was also confi rmed (3). In 
the other hand, Miller, et al (4) showed that oral administration 
gave signifi cantly higher hematocrit than intramuscular injec-
tion.
The aim of this study was to investigate the eff ect of iron admin-
istration methods (oral versus intramuscular route) and number 
of times of iron administration (1 time versus 2 times dosage) on 
hematological values of piglets. Hematocrit (Hct), haemoglobin 
concentration (Hb) and erythrocyte count (RBC) were deter-
mined. 
Materials and Methods
In this study, new born piglets (n=45) were randomly assigned 
into 5 groups. Each group was given iron supplementation as 
follows: control group received no iron supplementation (C, 
n=5); piglets intramuscularly injected with iron dextran (Abi-
dex100®) 200 mg on day 4 (IM1, n=10), on day 4 and 18 after 
birth (IM2, n=10); piglets given 200 mg ferrous sulfate (Ferrous 
Booster®) orally on day 4 (OR1, n=10), on day 4 and 18 after birth 
(OR2, n=10). 
Blood from the piglets were collected weekly in EDTA, as anti-
coaggulant, for the period of 4 weeks. The blood samples were 
then examined for hematological indices including hematocrit, 
haemoglobin concentration and RBC count using Automated 
hematology analyzer (Abacus Junior Vet, Austria). The results 
were statistically analyzed by repeated measures analysis of 
variance.
Results
The hematological values of all the treatment groups were sig-
nifi cantly diff erent from that of the C group (P<0.05), except the 
RBC count of OR2 group. Meanwhile, Hct and Hb were similar 
for all treatment groups. Compared within route of iron admin-
istration, one-time and two-times administration had the same 
hematological values.
Table 1. Values of Hematocrit (%), Hemoglobin concentration (g/dl) 
and RBC count (x 106/μl) in trial groups. (mean±SEM)
Group Hematocrit Hb conc. RBC count
Control 25.3±1.0a 7.4±0.3a 5.1±0.2a
IM1 30.6±0.7b 9.6±0.2b 5.7±0.1b
IM2 32.1±0.7b 9.7±0.2b 5.7±0.1b
OR1 29.7±0.7b 9.2±0.3b 5.6±0.1b,c
OR2 29.9±0.7b 9.2±0.2b 5.3±0.1a,c
a,b,c = signifi cant diff erence within column (p < 0.05)
Discussion 
The results from this study indicated that iron supplementation 
to piglets was benefi t to piglet health on haematological values 
regardless of routes or number of times that piglets received 
iron supplementation. Oral administration of iron might be com-
promised with animal welfare for those piglets. 
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Introduction and Objective
The measurement of serum macro-element parameters of 
farm animals can provide important information on health and 
metabolism of several organ systems (1,2) Recently, an episode 
of reproductive problems was observed in several pig herds in 
Flanders, although no specifi c infectious causes could be identi-
fi ed. Besides infectious causes, feeding strategies and feed com-
position could have an impact on reproductive performance of 
the sows. Several components such as vitamin E, selenium (Se) 
and minerals (Ca, Mg, Mn, Cu and Zn) could have an infl uence 
on reproduction (1). However, to interpret the obtained results 
in serum macro- and micro-element analysis, reliable reference 
values should be available. Therefore, blood was collected from 
primiparous and multiparous sows in several farms with no 
reproductive problems in order to establish reference values for 
several minerals and vitamin E. The eff ect of stage of reproduct-
ive cycle was also evaluated.
Materials and Methods
Seven pig farms with at least 100 sows in a batch management 
system (BMS) were selected based on the absence of reproduct-
ive problems. Samples were collected from the same sows at 
60 ± 5 d of gestation, 3 ± 1 d after farrowing and at 3 ± 1 d after 
weaning. Analysis was performed as follows: Se (μg/l) and Mn 
(μg/l) using an atomic absorption technique and vitamin E (mg/
dl) using HPLC-analysis.
Results
Results expressed as mean and range (2.5-percentile and 
97.5-percentile) are given for primiparous and multiparous sows 
in Tables 1-3. 
Table 1. Reference values for serum macro-elements of the parity-one 
sows (n = 14) and parity ≥ 2 sows (n = 31) from 7 commercial pig herds 
at 3 ± 1 d of lactation
Parity-one sows Parity ≥ 2 sows
Mean Range Mean Range
Mn (μg/l) 1.07 0.45-2.14 1.24 0.34-2.70
Se (μg/l) 174.64 125.75-239.50 166.42 125.75-237.75
Vit E (mg/dl) 2.01 1.34-2.65 1.93 0.80-2.93
Table 2. Reference values for serum macro-elements of the parity-one 
sows (n = 14) and parity ≥ 2 sows (n = 31) from 7 commercial pig herds 
at 3 ± 1 d after weaning
Parity-one sows Parity ≥ 2 sows
Mean Range Mean Range
Mn (μg/l) 2.02 0.64-4.70 2.30 0.61-6.13
Se (μg/l) 188.73 141.75-237.50 177.84 135.75-234.25
Vit E (mg/dl) 3.61 1.88-5.12 3.44 1.72-5.32
Table 3. Reference values for serum macro-elements of the parity-one 
sows (n = 14) and parity ≥ 2 sows (n = 31) from 7 commercial pig herds 
at 60 ± 5 d of gestation
Parity-one sows Parity ≥ 2 sows
Mean Range Mean Range
Mn (μg/l) 1.93 0.68-3.49 5.66 0.39-23.94
Se (μg/l) 168.27 143.50-198.75 173.58 135.00-210.50
Vit E (mg/dl) 2.56 1.15-2.95 2.50 1.08-3.68
Discussion and Conclusions
It is diffi  cult to compare the obtained results with previous 
results due to diff erences in analytical techniques (3). The refer-
ence values obtained for vitamin E were lowest at parturition 
and increased at weaning. Selenium reference values had a quite 
stable kinetics with slightly higher values at 3 d after weaning. 
For Mn, the lowest reference values were observed at 3 d of 
lactation. Due to one farm with very high Mn-levels at 60 d of 
gestation, the reference value and range is much higher in mul-
tiparous sows. Overall, primiparous sows had lower reference 
values as compared to multiparous sows in all three production 
stages. 
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Introduction and Objective
The measurement of serum macro-element parameters of 
farm animals can provide important information on health 
and metabolism of several organ systems (1) and is a practical 
diagnostic tool for assessing pathological conditions in the live 
animal or for monitoring the health status of groups of animals 
(2). Recently, an episode of reproductive problems was observed 
in several pig herds in Flanders, although no specifi c infectious 
causes could be identifi ed. Also no major shortcomings were 
observed regarding management and housing conditions. 
Besides infectious causes of the reproductive problems, feeding 
strategies and feed composition could have an impact on repro-
ductive performance of the sows. Several components such as 
vitamin E, selenium (Se) and minerals (Ca, Mg, Mn, Cu and Zn) 
could have an infl uence on reproduction (1). However, to inter-
pret the obtained results in serum macro- and micro-element 
analysis, reliable reference values should be available. Therefore, 
blood was collected from primiparous and multiparous sows 
in several farms with no reproductive problems in order to 
establish reference values for several minerals and vitamin E. The 
eff ect of stage of reproductive cycle was also evaluated.
Materials and Methods
Seven pig farms with at least 100 sows in a batch management 
system (BMS) (3-, 4- or 5- week BMS) were selected based on 
the absence of reproductive problems. The herds had between 
200-450 sows. Samples were collected from the same sows at 
60 ± 5 d of gestation, 3 ± 1 d after farrowing and at 3 ± 1 d after 
weaning. All samples were stored at -20°C until the end of the 
sampling period and analysed subsequently in one single batch. 
Analysis was performed as follows: Na (mmol/l), Cl (mmol/l), K 
(mmol/l) using Vetlyte (Idexx), P (mmol/l) using Vettest (Idexx), 
Fe (μmol/l) using Diasys nl Iron FS Ferene (Konelab TX20), Cu 
(μmol/l) using Randox (Konelab TX20) and Ca (mmol/l) and Mg 
(mmol/l) using Siemens Medical Solutions (Konelab TX20) and 
Zn (μg/dl) using an atomic absorption technique.
Results
Results expressed as mean and range (2.5-percentile and 
97.5-percentile) are given for primiparous and multiparous sows 
in Table 1-2. The results of 3 d after weaning were comparable 
to those at 60 d of gestation and were therefore not presented 
here.
Discussion and Conclusions
It is diffi  cult to compare the obtained results with previous 
results due to diff erences in analytical techniques (3). The refer-
ence values obtained for most of the determined elements were 
slightly higher at 60 d of gestation as compared to 3 d in lacta-
tion. Moreover, the ranges are higher and narrower at 60 d in 
gestation, indicating less variation within the animal population. 
Overall, primiparous sows had higher reference values as com-
pared to multiparous sows in lactation and during gestation.
Table 1. Reference values for serum macro-elements of the parity-one 
sows (n = 14) and parity ≥ 2 sows (n = 31) from 7 commercial pig herds 
at 3 ± 1 d of lactation
Parity-one sows Parity ≥ 2 sows
Mean Range Mean Range
Ca (mmol/l) 2.58 1.97-2.88 2.63 1.65-3.07
P (mmol/l) 2.13 1.44-2.62 2.03 1.23-2.62
Mg (mmol/l) 1.13 0.75-1.52 0.99 0.39-1.26
Na (mmol/l) 138.3 101.5-151.0 139.2 84.2-154.3
Cl (mmol/l) 99.45 76.75-105.50 99.13 64.50-110.25
K (mmol/l) 7.85 5.12-12.23 6.75 3.60-47.13
Cu (μmol/l) 37.36 25.92-48.02 36.49 21.67-47.13
Zn (μg/dl) 78.64 49.25-111.00 71.16 44.75-116.25
Fe (μmol/l) 41.39 14.02-88.50 32.67 14.82-60.7 5
Table 2. Reference values for serum macro-elements of the parity-one 
sows (n = 14) and parity ≥ 2 sows (n = 31) from 7 commercial pig herds 
at 60 ± 5 d of gestation
Parity-one sows Parity ≥ 2 sows
Mean Range Mean Range
Ca (mmol/l) 2.67 2.32-3.01 2.74 2.44-2.98
P (mmol/l) 2.68 2.14-3.44 2.38 1.77-3.70
Mg (mmol/l) 1.19 1.06-1.32 1.14 0.98-1.39
Na (mmol/l) 145.3 137.5-152.3 144.5 133.2-150.3
Cl (mmol/l) 104.0 101.0-107.0 104.2 97.25-108.25
K (mmol/l) 9.00 6.70-12.77 8.17 5.07-13.25
Cu (μmol/l) 37.28 28.00-43.70 34.39 27.52-41.65
Zn (μg/dl) 84.64 66.45-118.25 77.26 52.50-100.75
Fe (μmol/l) 42.55 32.47-70.88 40.10 21.15-75.08
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Introduction
Ractopamine (RAC) is a phenethanolamine β-adrenergic recep-
tor agonist that is commercially available (Paylean®, PAY) for 
enhanced muscle protein growth in pigs. After the success of 
RAC hydrochloride (PAY®), several companies have commercial-
ized generic versions of the product. This trial was done to study 
growth performance and consistency of response between 
brands of Ractopamine (generic “GEN” vs. PAY), and also to 
determine the uniformity of response when comparing diff erent 
production batches of the same brand.
Materials and Methods
The experiment was conducted as a Randomized Complete 
Block Experiment. RAC source and batches (treatments) were 
present in all the blocks. A total of 240 pigs (half gilts and half 
barrows), were individually contained providing 2.09 m2 space 
per pig and were fed one of the RAC products (at 5 ppm) or 
a Control diet (C; with the same formula) during the last 28d 
of the fi nishing period. There were 48 pigs for the control diet 
and 24 for each of the 4 product batches within RAC source. 
Thus the Ractopamine source eff ect included 96 experimental 
units, and the source * batch (lot) interaction, 24. All Treatments 
were present in 4 blocks (block=week of birth). Animals were 
individually feed twice a day, weighed every week, and average 
fat free lean tissue growth (FFLTG) was estimated by real time 
ultrasound (Aloka 550 SD) measurements. Data was statistically-
analyzed under the restriction of a complete random block 
model, with 9 treatments and 4 blocks. General Linear Models 
(GLM, SAS) were used. Least square means from the variance 
analysis were presented.
Results
Initial body weight (76.6 ±8.32 kg) was similar (P<0.9) between 
Treatments. After 28d, average daily gain (ADG) diff ered be-
tween brands (1030; 1153, and 1115±202g/d; P<0.0001) respect-
ively for C, PAY and GEN. Interestingly, ADG response was not the 
same within the GEN batches: (C: 1033; PAY: 1161; 1149; 1171; 
1138; GEN: 1128; 1169; 1076; 1089±32g/d), respectively for the 
mean of each one of the production batches within Trt. Similar 
response was observed for feed effi  ciency (gain over feed; FE), 
where overall the use of RAC improved FE, but the response was 
dependent not only on the brand, but also was dependent on 
the production batch for the GEN (C: 361; PAY: 394; 404; 406; 407; 
GEN: 382; 390; 374; 373±8.4; P<0.0001). The FFLTG was improved 
by RAC (C: 355; PAY: 415; RAC: 394±6.8g/d; P<0.0001).
Discussion
Overall treatment responses were consistent (P<0.0001) for 
ADG, FE and FFLTG, although the response was better and more 
consistent when the PAY product was used. But the evaluation 
should also be done in probabilistic terms. Interestingly, two 
batches of the GEN product out of four, when compared to the 
Control, where not diff erent (P>0.6); meaning that the response 
to the GEN product could not be observed in 50% of the times. 
Diff erences in feed intake and ADG can be relatively small and 
hard to detect at the farm because of the variation inherent 
to the process. Feed effi  ciency is a more sensitive and reliable 
variable. Additionally, in times of expensive feed, feed effi  ciency 
is one of the most relevant variables in profi tability. Finally, as 
demonstrated in this trial, product consistency is a feature that 
producers should consider when evaluating diff erent products.
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Eﬀ ects of feed withdrawal/fasting prior to slaughter on dressing percentage and meat pH
Lorenzo Encinares
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This study explored the eff ect of pre-slaughter fasting on the 
pigs’ carcass value and weight. 
The optimum time of feed withdrawal before slaughter was 
determined. Findings will be useful to the pork industry in 
minimizing the decrease in carcass value particularly weight 
and therefore increase the amount of money a producer may 
receive, without compromising carcass value. 
Ninety (90) market weight pigs were divided into 3 treatments: 
0, 12 and 24 hour feed withdrawal prior to slaughter without 
restriction to water access. Each treatment was allocated with 
30 pigs irrespective of sex. The experiment was conducted in 
6 slaughter days, wherein 15 heads were slaughtered on each 
slaughter day. Carcass weight was recorded, along with the 
weight of body organs and digestive tract full and emptied. 
Meat pH was also measured 45 minutes post-slaughter to deter-
mine the eff ect of feed withdrawal on meat. 
There was an observed 2.6 kg body weight loss in the fi rst 
12 hour of fasting which increased to 4.7 kg after 24 hour of 
continued feed withdrawal. Total shrinkage of 55.3% occurred 
during the fi rst 12 hours, which was reduced to only 44.7% in 
the next 12 hours of fasting. Dressing percentage was observed 
to be higher in fasted animals compared to pigs not fasted 
before slaughter (P<0.01). It was estimated that the weight loss 
for every hour of feed withdrawal was 0.2791kg loss. This study 
found that a considerable live weight loss occurred when pigs 
are fasted over a 24 hour period. This loss translates to monetary 
losses to the producer. Within 12-24 hour period of feed with-
drawal, carcass losses also entail monetary losses on the part of 
the buyer. 
Regarding the current trend of buying and selling of fi nishing 
hogs in the market today, it seems that a lot of money is wasted 
due to improper fasting time of fi nishing pigs. In order to avoid 
unnecessary monetary losses, pigs should be fasted not more 
than 12 hours before the actual time of slaughter. It is also 
important to note that this study is limited to the eff ect of feed 
withdrawal only, so it could be assumed that additional weight 
losses can be incurred if transportation parameter is included. 
Ordinarily buyers purchase their pigs at long distances so drastic 
losses are expected. Highly signifi cant diff erences (P<0.0001) 
were observed in fasted and non fasted groups for the digestive 
tract, (full and emptied), residual gutfi ll, and liver weight. 
After 24 hour of feed withdrawal, when the digestive tract is 
fully empty, there was a progressive loss in liver weight with 
increased fasting time. Except for the liver being signifi cantly 
bigger in barrows than in gilts, there were no other carcass traits 
observed to be signifi cant between genders. No signifi cant 
changes were observed among body organs in the three treat-
ments. There are also no signifi cant diff erences in the initial pH 
of the meat at 45 minutes post-mortem among fasted and non 
fasted animal.
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Introduction
 The steady increase in demand by the world population explo-
sion, the unbalanced regional distribution and various forms 
of pollution have made water a scarce and precious resource. 
Nowadays, the use of water is an issue of great concern in all 
human activities due to its growing scarcity. Therefore all eff orts 
are relevant to optimize its use. Unfortunately, there is very little 
information on water use in swine production.
Aims
To determine the amount of water needed to produce a fi nished 
100 kg live weight pig, taking into account the water used by the 
pigs and cleaning activities on the farm.
Material and Methods
The study was conducted at the experimental farm of the 
Universidad Nacional Autónoma de México, wich is a 120 sows 
farrow to fi nish operation located in central México, with an 
average temperature of 18°C and average rainfall of 608 mm. 
The feed were based on sorghum and soybean meal. The pigs in 
the weaning and fi nishing stages are fed ad libitum. In all areas 
of pigs were used nipple type drinkers and had free access to 
water. Water meters were used for metrological class C, which 
measure 100 ml fractions. The washing of the pens was made 
with a pressure washing machine. Only in the area of early 
gestation was performed daily washing with a hose. During 
the study, said there were no leaks in the hydraulic installation 
of the farm. In the areas of breeding pigs, gilts, gestation and 
lactation was measured amount of water used and calculated 
how much each area contributes to produce a 21 days weaned 
pig. In the stages of weaning and fattening, was calculated the 
individual average water used by a pig during each stage. The 
amounts were added to the average water used for washing pig 
facilities in each stage, to fi nally get the amount of water used 
for production of a pig of 100 kg. The results were analyzed with 
descriptive statistics.
Results
Table 1 shows the average water used per individual in each 
stage of production and the individual average of water used for 
washing facilities. The average water used to produce a 21 days 
weaned pig was 894 23 liters. The average water used by the 
weaning and fi nishing pig was 1705.44 liters. The sum of these 
amounts represents the average water used for production of a 
pig of 100 kg, which was 2599.67liters.
Discussion
The results obtained should not be taken as a universal measure, 
but as a reference for estimating water needs for a pig farm, and 
to seek to reduce water consumption by specifi c strategies. Re-
sults of the study discovered areas where water use is too high, 
wich allows to identify critical points in wich to work to establish 
corrective actions. These measurements can be implemented 
relatively easily in pig farms. Future studies will be necessary to 
include the water used in bathrooms and offi  ces of the pig farms 
to obtain more complete information. Is suggested to perform 
jobs that are water ways to optimize every step of the produc-
tion process of the pigs, which is an important objective in rela-
tion to water use in the swine industry worldwide.
Table 1. Individual average daily liters of water used in each stage of 
production (AWP) and average water used for washing facilities (AWF).
STAGE AWP AWF
Boars 19.54 95
Gilts 20.79 95
Early pregnancy 63.46 297
Late pregnancy 36.14 95
Farrow 36.64 277.5
Nursery 4.06 43.4
Fattening 12.78 36.8
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Introduction and objectives
Piglets with low weights at birth are related with a decreased 
livability falling into hypothermia, starvation and death1. Lianol® 
(a fermented bioprotein by Ardol, The Netherlands) is supposed 
to have a positive eff ect in new born piglets from an increase of 
circulating IGF-I. The aim of the study was to evaluate the eff ect 
of supply orally Lianol® at fi rst day of live in mortality from born 
to weaning in piglets and to evaluate if this improvement could 
be done by and increase of serum IGF-I.
Material and Methods
391 newborn piglets were tagged, weighed and assigned to one 
of two groups during the fi rst 12 hours after birth depending 
on BW: piglets with BW higher or equal to 1.2 kg (BIG) or with 
BW lower than 1 2 kg (SMALL). Treatment were: i) 2 ml of Lianol® 
given orally in the mouth during fi rst 12 hours after birth (Li-
anol2), ii) 1 ml of Lianol® during fi rst 12 hours after birth plus 1 
ml 24 hours later (Lianol1+1) and iii) a negative control group 
(Control). Piglets were randomized to be assigned onto each 
treatment within BW group and sex. All animals were weighed 
again on days 3, 7 and 20 of live. 
181 randomized piglets were bled at the day 1, 7 and 20 of live. 
Number of piglets in every group and treatment is shown in table 1.
Blood samples were tested by enzyme-linked immunosorbent 
assay (ELISA) using established methods.
Piglet was the experimental unit. IGF-I, BW and ADG were analyzed 
with ANOVA. Mortality was analyzed using a logistic regression. 
Piglet uniformity was assessed from the coeffi  cients of variation of 
the individual BW and diff erences between treatment groups were 
analyzed using F test. The level of signifi cance was 5%.
Results and Discussion
Table 1 shows number of piglets included and mortality levels. 
Mortality was not statistically diff erent between treatments. 
However, we have observed a relevant reduction of 50% between 
Control and Lianol2 in BIG group and 46 % between Control and 
Lianol2 in SMALL group. These values were not statistically diff er-
ent but are a relevant data under commercial situations.
We found no diff erence between treatments in IGF-I levels any 
day of the study. Values of IGF-I have a high variability even 
when we compare same piglets in same circumstances. IGF-I 
values were agreed with scientifi c literature values. At day 0, 
IGF-I values were 59.56±5.05; 62.63±5.18 and 60.60±5.12 ng/
ml in BIG group for Lianol2, Lianol1+1 and Control respectively 
and 57.24±7.16; 44.63±8.48 and 61.33 ng/ml in the SMALL 
group for Lianol2, Lianol1+1 and Control. At day 20 IGF-I values 
were 76.28±5.01; 79.02±5.06 and 78.80 ng/ml in BIG group for 
Lianol2, Lianol1+1 and Control respectively and 79.77±7.07; 
80.98±9.01and 82.37 ng/ml in the SMALL group for Lianol2, 
Lianol1+1 and Control. Circulating IGF-I levels in piglets has a 
high variability depending on factors such as nutrition, season, 
management techniques and sex2.
We found neither statistical diff erence in BW nor in ADG. Piglet 
uniformity was not diff erent between treatments at day 20.
Implications and Conclusions
The supply of Lianol® after birth did not improve mortality 
statistically but the numerical improvement was relevant under 
commercial situations mainly in BIG piglets. IGF-I values, BW and 
ADG were not improved. More investigations should be done in 
order to know the relationship between IGF-I levels and piglet 
performances.
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Introduction
Cysteamine (CS) can be used as a feed additive for improving 
growth performance of growing pigs. Pigs obtaining CS would 
lead to lower level of somatostatin, resulting in elevation of 
growth hormone (GH) level (1). It has been known that GH 
increases muscle growth (2) and decreases deposition of fat in 
pigs (3). In fi nishing pigs, dietary CS supplementation improved 
protein deposition (4). However, the eff ects of dietary supple-
mentation on growing pigs raised under fi eld condition have 
not been reported. Thus, the current study aims to determine 
eff ect of dietary supplementation on growth performance and 
serum GH of starter-fi nishing pigs.
Materials and Methods
Three hundred and seventy fi ve starter pigs were randomly 
selected from a commercial pig farm for the current study. All 
experimental pigs were equally allotted into three groups; the 
control (CT), recommended level of CS (RC) and high level of 
CS (HC). Each experimental group contained 125 pigs, equally 
housed in 5 pens. The pigs in the CT were off ered control diet, 
which is normally used in the farm, while the pigs in the RC and 
HC were off ered the control diet with supplementation of CS 
at 300 and 500 ppm, respectively. The pigs were fed ad libitum. 
Live body weight of the pigs of each pen was measured at 
the start and the end of the study. Feed intake of the pigs was 
recorded throughout the experiment. Blood samples of 10 pigs 
from each group were randomly collected at 13.00 hours in 
order to quantify level of GH with RIA method. At the conclusion 
of the study, ADG, FCR and feed cost per body weight gain (FCG) 
were calculated. The statistical analysis is one way ANOVA with 
Duncan’s multiple comparison.
Results
The results of the growth performance have been demonstrated 
in the Table 1. There was no eff ect of dietary CS supplementa-
tion on ADG and FCG. However, the pigs fed on the RC diet had 
signifi cant lowest FCR (p<0.05), whereas the pigs fed on the CT 
and HC had no signifi cant diff erence. The levels of GH have been 
shown in the Table 2. The change of GH was greatest (42%) in 
value for the pigs fed on the CT diet, while the GH change in the 
pigs fed on the RC (22%) and HC (18%) diets were around half of 
the change of the CT group.
Table 1 Growth performance of the pig
Item CT RC HC
ADG (g/day) 625.17 670.75 654.11
FCR 3.19b 2.81a 3.09b
FCG (Bath/kg) 29.26 28.92 31.35
Table 2 Level and change of GH
Item CT RC HC
Initial GH (ng/ml) 0.19 0.41 0.17
Final GH (ng/ml) 0.11 0.32 0.14
Changed GH (ng/ml) 42.11 21.95 17.65
Discussion
In the current study, the FCR of the pigs fed on the dietary CS 
supplementation at recommended level, while there was no ef-
fect of the supplementation at recommended and high level on 
ADG and FCG. The diff erence of the results of ADG from earlier 
report (Yang et al, 2005) might be the results of wider range 
of pig age and uncontrollable environment conditions in the 
current study. However, dietary CS supplementation at recom-
mended level had the best improvement of growth perform-
ance values, which it is the similar direction with reports previ-
ously (1,4). Serum GH levels in this study was dramatically lower 
than previous experiments (5). This would be the results of more 
light exposure during blood sample collection (6). However, 
dietary CS supplementation at both levels had smaller values in 
decreasing GH, which might be used to explain improved values 
of growth performance.
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The eﬀ ects of a naturally contaminated diet with and without a mycotoxin 
deactivator on blood parameters of weaning piglets
Ursula Hofstetter; Sabine Masching
Biomin Holding GmbH, Herzogenburg, Austria
Introduction
When ingested, mycotoxins cause insidious losses, ill thrift and in-
crease disease incidence due to their immune-suppressive eff ects. 
In spite of all eff orts to prevent formation of mycotoxins in feeds, 
signifi cant contaminations still occur. While the use of products 
based on aluminosilicates gave good results in counteracting 
afl atoxins (1), the adsorptive deactivation of other toxins failed 
under fi eld conditions (2). A further effi  cient way of detoxifi ca-
tion of non-adsorbable mycotoxins is microbial or enzymatic 
biotransformation. It has been reported that an anaerobic rumen 
bacterium (Eubacterium BBSH797) is able to deactivate trichoth-
ecenes by biotransformation of their epoxide ring (3). A trial with 
weaning piglets was carried out to investigate the negative ef-
fects of deoxynivalenol (DON) on blood parameters and immune 
globulins and to prove the effi  cacy of a feed additive based on 
diff erent strategies to counteract these eff ects.
Materials and Methods
The trial was conducted at the Center for Applied Animal Nutri-
tion (CAN) in Austria with 14 pens for 10 piglets each, equipped 
with slatted fl oor, cup drinkers and a computer – operated feed-
ing system (Spotmix). Directly after housing all piglets were fed a 
prestarter for approx. 3 days and afterwards changed over to the 
experimental diets. A 2-phase feeding system was used, where 
starter diet was fed between d4-14 and grower diet from d15. 
Water and feed were provided ad libitum.
CG(-) Negative control group; no detectable mycotoxins, no additive.
ToG Toxin group; 2 ppm deoxynivalenol (DON).
TG Trial group; 2 ppm DON and 2 kg/mt feed additive. 
CG(+) Positive control group; no toxin but 2 kg/mt feed additive.
140 weaning piglets (mixed sex; age approx. 4 weeks, average 
weight approx. 8 kg) were delivered from one farm. All animals 
were ear-tagged, the weight of the animals recorded individ-
ually and the ten smallest and heaviest animals were separated 
from the trial to reduce the standard deviation. The remaining 
120 animals were allocated to 12 pens of 10 piglets each. All 
piglets were of the Austrian genotype Ö-HYB-F1[(Landrace x 
Large White) x Pietrain]. From day 6 on animals started with 
feed refusal and diarrhea and were treated with Enteroxid (colin 
sulfate + zinc oxide) for 4 days. Due to the fact that the general 
condition of the animals did not improve, all animals had to be 
treated with Paracillin (Amoxicillin-antibiotic; eff ective against 
Streptococci sp.). At day 38 animals started coughing and were 
treated with Pulmodox (Tetracycline-AB) for 8 days. For the rest 
of the trial period all animals remained stable, but were in a bad 
general condition. 
Results
Table1 shows all blood parameters with statistically signifi cant 
diff erences between the groups. The hematocrit value is an 
indicator for the concentration of erythrocytes and general 
water balance. In general all groups revealed hematocrit values 
close to the lower level of the reference values. This may be 
due to interference in water balance caused by diarrhea. The 
hemoglobin value is an indicator for the concentration of the 
iron-containing blood pigment. The high level of DON in the 
naturally contaminated diet caused an extreme activation of the 
immune system. In the toxin group the IgA value was signifi cant-
ly increased. IgA is with approx. 15% the main immune globulin 
in serum. In the trial group the immune suppression caused by 
DON was counteracted.
Hematocrit [l/l] Hemoglobin [g/l] IgA [mg/dl]
CG(-) 0.35a 106.67a 86.64a
ToG 0.34a 104.67a 638.22b
TG 0.35a 111.00a 126.44a
CG(+) 0.38b 120.67b 215.20ab
Reference value 0.33-8.10 108-148 50-500
a, b … signifi cant diff erence (P<0.05)
Discussion
Hematocrit values in the non-contaminated group with the feed 
additive were signifi cantly improved compared to the control 
and the naturally contaminated group. Hemoglobin values in 
the feed additive group were signifi cantly better compared 
to the control and all other groups. In the toxin group, DON 
activated the immune system and signifi cantly increased the IgA 
values. The feed additive counteracted the immune suppression 
caused by deoxynivalenol.
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Early feeding of ﬂ axseed leads to a permanent retention of n-3 fatty acids in pork tissues
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Introduction
Value added pork products may be produced by enriching pork 
with health benefi ts providing n-3 fatty acids (FA), such as eicosa-
pentaenoic acid (EPA; 20:5n-3), docosapentaenoic acid (DPA, 
22 5n-3) and docosahexaenoic acid (DHA, 22:6n-3) when these 
n-3 FA are incorporated into inter- and intra-muscular fats depots.
Several experiments have been conducted to assess the extent 
of incorporation of n-3 FA in pork products. However, little atten-
tion has been paid to determine the eff ect of feeding n-3 FA at 
diff erent stages of growth to pigs. 
Objective
To determine the incorporation of n-3 FA such as 18:3n-3 (ALA) 
and highly unsaturated n-3 FA (HUFA; 18:4n-3, 20:3n-3, 20:4n-3, 
EPA, DPA and DHA) in trimmed loin (L) and whole belly (B) of 
pigs fed fl axseed that contains high levels of ALA. 
Materials and Methods
A total of 24 purebred individually housed Yorkshire female pigs, 
weighing approximately 25 kg BW were allotted in one of three 
feeding programs (n = 8): T1, diet with 10% FS diet fed between 
25 and 50 kg BW, and control diets (C) low in n-3 FA fed there-
after until 110 kg BW; T2, C fed between 25 and 85 kg BW, and 
diet containing 6% FS fed thereafter until 110 kg BW; and T3, fed 
C between 25 and 110 kg BW. Feed intake was fi xed at 95% of 
the voluntary feed intake according to NRC (1998). Fat samples 
were extracted from 5 g of fresh L and B samples using chloro-
form/methanol (1:1 v/v) and then methylated using anhydrous 
methanol-HCl 5%. FA methyl esters were analyzed using a gas 
chromatography (Aligent Technolgies Model 6890N) equipped 
with a 100m CP-Sil 88 fused capillary column. The FA content in 
the tissues of pigs slaughtered at 110 kg BW was expressed as 
mg/100 g of fresh tissue. Results were subjected to analysis of 
variance using the Proc Mixed procedure of SAS v9.1 (SAS, Inst., 
Cary, NC). Pigs and block (pigs upon arrival, n = 2) were used as a 
random eff ect.
Results and Discussion
No treatment eff ect was observed on growth performance, 
carcass characteristics or loin meat quality (P > 0.05). Pigs on 
T1 and T2 consumed equal lifetime amounts of FS (5.1 vs. 5.2 
kg, P > 0.10). In L, ALA was higher (P < 0.05) for T2 than T1 and 
T3 (143, 76.4 and 37.0, respectively). In B, ALA was similar for T1 
and T2 (667 vs. 752; P > 0.10) and both were higher than T3 (207; 
P < 0.01). The main HUFA’s were 20:3n-3 (in B similar for T1 and 
T2, P > 0.10, and higher than T3: 104, 102, 31, respectively; and 
in L similar for T1 and T2, P > 0.10, and higher than T3: 12.5, 21, 
6.0), DHA (in B similar for T1 and T2, P > 0.10, and higher than T3: 
10, 8.3, 6.9, respectively; in L no treatment eff ect, 2.1, 2.0, 1.8; P 
> 0.05) and DPA (in B similar for T1 and T2, P > 0.10, and higher 
than T3: 40, 34, 20; in L similar for T1 and T2, P > 0.10, and higher 
than T3: 9.7, 11, 6.2). Total HUFA content was larger (P < 0.05) for 
T1 and T2 compared to T3 in L (30, 42, 18) and B (179, 168, 71). 
In T1 and T2 the n-6/n-3 ratio was lower than T3 in L (5.9, 4.0, 
12.7) and B (4.9, 3.8, 13 3; P < 0.001). These results indicate that 
feeding modest amounts of FS leads to a signifi cant enrichment 
of ALA and HUFA, in particular 20:3n-3 and DPA, in pork. The en-
richment of n-3 FA appears to be independent of time of feeding 
n-3 FA and provides fl exibility as to when n-3 FA can be fed for 
generating n-3 enriched pork. 
Key words: Pork growth, n-3 fatty acid, pigs
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Eﬀ ects of carbohydralase supplementation on gut microbiota and immunology of growing pigs
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Exogenous carbohydrolase enzymes used in feed to improve 
animal performance, hydrolyse non-starch polysaccharides 
(PNA) from raw materials. A study conducted in our laboratory 
has shown that this type of enzymes modify the intestinal micro-
biota of growing pigs (dos Santos et al. 2009). These changes 
in microbiota could play a positive eff ect on intestinal health 
as suggested by Kim et al. (2003). The aim of our study was to 
determine the eff ects of enzyme supplementation on gut micro-
biota and immunological parameters of growing pigs.
Thirty-six pigs (25 kg BW.) were fed during 28 days with one of 
4 diff erent treatments based on the type of diet (WBR or C) and 
the supplementation or not (+ or -) with enzymes. The pigs were 
slaughtered to obtain samples of serum, bile and ileal mucosa 
for immunological studies. In addition, samples of ileal and 
caecal digesta and ileal mucosa were collected for microbiota 
studies. The microbiota composition was studied by RFLP-PCR. 
The serum IgA, IgG and IgM and bile IgA were examined by 
ELISA. The terminal ileum was used to study some immunologic-
al cellular markers by immunofl uorescence (Table 1) and some 
morphological parameters by HE and PAS stains.
Table 1. Primary monoclonal and secondary conjugated antibodies 
used in the immunefl uorescence technique.
Primary mAbs Secondary mAbs
Mouse Isotype MoAb (Clon) Anti-mouse conjugate Dilution
CD3* IgG2B BB23-8E6 IgG2b-Cy3 1:500
CD4* IgG2B 74-12-4 IgG2b-Cy3 1:500
CD163* IgG1 2A10/11 IgG1-Cy3 1:500
CD172a(SWC3)* IgG1 BA1C11 IgG1-Cy3 1:500
SCW8* IgM MIL-3 IgGM-PE 1:200
IgA secretory IgG1 K60/1F1 IgG1-Cy3 1:100
*Dominguez (INIA, Madrid, Spain)
WBR+ diet presented an increase in the mucosal biodiversity and 
in the villous height:crypt depth ratio compared to WBR- diet 
(Table 2). These results are in accordance with the gut health 
concept: a higher microbiota biodiversity promotes a lower ag-
gression on the mucosa. The corn based diet supplemented with 
enzymes promoted an increase of neutral Goblet cells, a reduction 
of secretory IgA, intra epithelial lymphocytes (IEL) and CD3+ cells 
of villi compared to corn based diet without enzymes (Figure 1). 
An increase of secretory IgA, an increase of IEL and an increase in 
CD3+ cells can be indicative of a higher aggression of gut mucosa 
in the corn based diet without enzyme supplementation.
Table 2. Eff ects of the treatments on ileal immunological parameters.
Diets
C- C+ WBR- WBR+ p-feed p-enzyme
p-feed* 
enzyme
Villous height (μm) 412 420 367 428 0.4074 0.0523 0.1253
Crypt Depth (μm) 318 319 324 300 0.7398 0.2592 0.2973
VH:DC ratio 1.31ab 1.32ab 1.18b 1.46a 0.8789 0.0113 0.0271
Goblet cells* 9.5 9.3 8.0 9.4 0.2261 0.2425 0.1543
IEL** 4.8a 3.1b 2.8b 3.2b 0.0002 0.0144 0.0002
Neutral Goblet cells* 1.7 2.7 2.3 2.3 0.3141 0.0802 0.6641
Neutral Goblet cells** 7.7 8.8 8.7 9.7 0.2483 0.2725 0.9889
*number of cells per 100 μm of the crypt; **number of cells per 100 μm of the villous
Figure 1. Immunofl uorescence of the gut cells CD3+ (A) and 
s-IgA+SCW8 (B).
The biodiversity degree of ileal mucosa presented signifi cant 
correlation with the bile IgA concentration (R=-0.42, p=0.001), 
the IEL of villi (R=-0.43, p=0.008) and neutral Goblet cells 
(R=0.53, p=0.03).
Our results suggest that a more complex intestinal microbiota 
could play a positive eff ect on intestinal health. Changes on 
microbiota components can be induced by changes of feed 
components and by the addition of exogenous enzymes. The 
benefi cial eff ects of enzymes could be related with an improve-
ment of the adaptive capacity of commensal microbiota as a 
natural barrier defence against the overgrowth of pathogens.
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Introduction
The use of feed antibiotics as growth promotants (AGP), in farm 
animals has been a practice used for several decades. From a 
production standpoint, these molecules have been consistently 
shown to improve weight gain and feed effi  ciency (Gaskins 
et al., 2002). Despite of these benefi ts, there has been a ten-
dency to ban AGP in animal feed, which would have important 
economic implications in the cost of production. In the EU the 
ban of AGP was related to the alleged selection of antibiotic-
resistant bacteria (RB), which might infect human beings and 
produce non-treatable diseases, particularly with Gram negative 
bacteria (Butaye et al., 2003). However, the development of RB 
has not being conclusively related to the use of AGP. The correct 
use of AGP could reduce the risk of producing RB. Therefore, 
it is important to evaluate continuously diff erent molecules 
and administration programs that allow a correct use of APC 
in farms. The objective of this study was to compare the eff ect 
of enramycin and bacitracin methylene disalicylate over some 
important production parameters in growing pigs (30-55Kg).
Materials and Methods
Four hundred and fi fty mixed pigs (N=45 animals/pen, 255 pigs/
treatment, 5 repetitions/treatment), were assigned randomly to 
two treatments. Control group (C) was the basal diet plus 500 g 
of bacitracin methylene disalicylate/ton and the experimental 
group (E) contained the basal diet plus 120 g of enramycin 
per ton. The trial was conducted during the fi rst 35 days of the 
growing phase (30-55 kg). At the beginning of the study, 5 pigs/
pen were tagged and weight at the beginning and end of the 
trial. These data were used to evaluate average daily gain (ADG) 
average daily feed intake (ADFI) and feed conversion (F/G). These 
data were used to analyze the main eff ect of each treatment by 
mean comparison using the statistical program SPSS Statistics 
17, with a level of signifi cance of (P< 0.05).
Results
Production parameters are shown in table 1 and fi gure 1. The in-
itial and fi nal body weights during the growing phase were simi-
lar (P > 0.05) for both treatments (31.4 and 54.4 kg vs. 30.0 and 
55.7 kg for C and E pigs, respectively). It implies a mathematical 
improvement of 4 % in weight gain for the E pigs. The ADFI was 
smaller (P < 0.05) for the C than the E animals (1.5 vs. 1.6 kg/d, 
respectively). However, the ADG was greater (P = 0.08), for the 
E group (0.74 Kg/d), than the C group (0.66 Kg/d). Nevertheless, 
F:G ratio was similar (P> 0.05) for both treatments.
 
Table 1. Production parameters per treatment for pigs between 30 
and 55 Kg.
BW
Treatment
C(Bacitracin) E(Enramycin) P
Initial,Kg 31.4 ± 0.9 30.0 ± 0.9 0.12
Final,Kg 54.4± 1.8 55.7 ± 1.8 0.44
ADFI,Kg 1,5 ± 0.1a 1.6 ± 0.1b 0.01
ADG,Kb 0.66 ± 0.1 0.74 ± 0.1 0.08
F.G 2.3±0.1 2.2 ± 0.2 0.41
a,b Means with diff erent superscript letter diff er (P<0.05)
Figure 1. ADFI, ADG and F:G ratio for pigs during the growing phase.
Discussion
The addition of bacitracin and enramycin in the diet of grow-
ing pigs in this trial showed similar results to those observed by 
Silva et al. (2003), who reported that the addition of enramycin 
reduced ADFI and increased ADG; therefore improving F:G ratio. 
In this study, however, the improvement in F:G was not ob-
served. Therefore, it is conclude that enramycin used as a growth 
promotant improves the performance parameters of pigs during 
the growing phase.
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Eﬀ ect of peroral iron supplementation in piglets on health and production
Caroline Vanderhaeghe1 Jeroen Dewulf1 Frédéric Vangroenweghe2 Maarten Steyaert1 Ellen de 
Jong1 Irris Villareal1 Alfonso Lopez1 Ruben Del Pozo Sacristan1 Dominiek Maes1
1. Facutly of Veterinary Medicine, Department of Reproduction, Obstetrics and Herd Health, 
Merelbeke, Belgium; 2. Animal Health Care Flanders, Torhout, Belgium
Objectives
Piglets are born with only minor iron reserves and also sow 
milk contains very low amounts of iron. Therefore, if piglets in 
intensive pig herds are not provided with extra iron during the 
fi rst week after birth, they will become anaemic (1). Iron is com-
monly provided by means of intramuscular injection. However, 
if iron could be supplemented orally, it could save labour and 
also, the stress of manipulating pigs and injecting them could be 
avoided. The objective of this fi eld study was to investigate the 
effi  cacy of peroral iron (Fe) supplementation by means of health, 
performance and haematological parameters. Additionally, the 
correlation between the concentration of haemoglobin (=Hb) 
measured in the laboratory and measured on-farm using the 
HemoCue® test (HemoCue® Diagnostics B.V., Waalre, The Nether-
lands), was assessed.
Material and Methods
Three commercial pig herds (>300 sows) participated in the 
study. Within each herd, 40 sows with their litters were included. 
Blood samples of the sows for Hb concentration were obtained 
one week before farrowing. A droplet of blood was absorbed in 
a microcuvette by capillary action for quick Hb-determination 
by the HemoCue®. Within each herd, the litters of the 40 sows 
were randomly divided in two groups. Group 1 (G1) received the 
peroral iron supplement (40g for a litter of 12 piglets) (HemOral®, 
Biofi ber-Damino, Gesten, Denmark) on day 2-4, 5-7 and 8-12. 
Group 2 (G2) received an intramuscular injection with 200 mg 
Fe3+ on day 2-3 (Bastion 20%®, Intervet, Brussels, Belgium). 
Within each litter, 3 piglets were randomly selected and blood 
sampled just prior to iron injection and at weaning. Additionally, 
a droplet of blood was absorbed in a microcuvette by capillary 
action for quick Hb-determination (HemoCue®). All piglets were 
weighted at these two time-points, and the total feed intake 
was recorded for each group. Farrowing data of the sows and 
performance of the piglets during lactation were measured. 
Statistical analysis was performed by means of analysis of vari-
ance (SPSS 16.0), in which the eff ect of the herd was taken into 
account. 
Results
The sow farrowing data and the performance of the piglets are 
shown in Table 1. None of the parameters diff ered signifi cantly 
between the two groups (P>0.05). The time needed to treat a 
litter was signifi cantly lower in the HemOral® (G1) group than in 
the Bastion 20%® (G2) group (P<0.0001), but the diff erence was 
very small.
Table 1. Sow farrowing data and performance of the piglets (mean ± 
SD) receiving HemOral® (G1) or Bastion 20%® (G2)
Parameters G1 (n=44) G2 (n=44)
No of live born piglets 13.2 (3.21) 12.6 (2.69)
No of stillborn piglets 1.7 (1.15) 1.5 (0.66)
No of mummifi ed piglets 1.4 (0.79) 1.5 (0.69)
Pre-weaning mortality (%) 17.9 (14.65) 19.9 (22.63)
No of weaned piglets 10.5 (1.52) 10.4 (1.78)
Daily weight gain (g) 213.1 (54.7) 207.9 (50.8)
Feed intake (g) 165.1 (120.6) 196.0 (166.6)
Hb concentration 92.4 (24.6) 89.5 (21.0)
The correlation between the Hb concentration measured in the 
laboratory and measured on-farm using the HemoCue® test (n = 
1036 piglets) was 0.79.
Discussion and conclusions
The present study did not show signifi cant diff erences between 
oral or intramuscular supplementation of iron on performance 
of piglets during lactation. As oral supplementation is less time 
consuming and does not require individual injections, it may be 
the preferential method. It also appeared that the quick on-farm 
testing of Hb can be used reliably to assess the Hb concentration 
of the piglets.
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Introduction
In sows, body reserves (protein and fat tissues), at farrowing and 
feed consumption during lactation determine milk production 
capacity and future reproductive performance (McNamara and 
Pettigrew, 2002). Therefore, an inadequate feeding program dur-
ing the gestation and lactation periods, aff ects sow productivity 
and fi nally, farm output (Gill, 2006). However, in the majority of 
commercial farms, feed allowance during gestation is generally 
not focused on sow´s body reserves, but in easiness of delivery. 
Therefore, most sows are off ered a homogeneous amount of 
feed; practice that in short time, alter the reserves of nutrients in 
the body. The objective of this study was to evaluate three feed-
ing systems during gestation and their eff ect on body reserves 
of sows at farrowing and weaning 
Material and Methods
Four hundred sows from parity 0 to 5 were assigned randomly to 
three treatments: Tr. 1. feed allowance based on visual body con-
dition. Tr. 2. Feed allowance based on body condition evaluated 
by weight and backfat using ultrasound (Aloha 500), techniques. 
Tr. 3. Feeding was based on the expected weight gain (net 
maternal gain), during gestation established by the modeling 
software from the NRC (1998). Body condition was determined 
using Noblet (1990) formulas. The amount of feed distributed 
to each sow did not consider parity number. These data were 
analyzed by ANOVA using the statistical program SPSS 15.0, and 
with a signifi cance level of P < 0.05. 
Results and Discussion
In general, sows from Tr. 2 and 1 consumed the same amount of 
feed over gestation, which was lower than sows in Tr. 3. Weight 
and protein loss after the lactation period were reduced in sows 
of Tr. 2 and 3 (Table 1). Fat loss however, was higher in sows of 
Tr. 2. Reproductive performance seemed to be not aff ected at 
farrowing or weaning by any of the dietary treatments (Table 2). 
However, sows in Tr. 3 shown better (P > 0.05) numbers in total 
pigs born.
Body weight gain in gestating sows depends highly on the feed-
ing level. Therefore at a higher feed intake there is a higher weight 
gain. In the present study, however, sows of Tr. 3 had a greater 
feed intake (P<0.05) than sows of Tr. 1 and 2; but maternal weight 
gain did not show any diff erences for the three dietary treatments 
(Table 1). It was observed however, that sows in Tr. 3 had greater 
energy retention (fat), which agrees with results reported by 
Noblet et al. (1990), and Kusina et al (1999). As reported by Revell 
et al (1998) and Sinclair et al (2001), there were no eff ects of feed-
ing level and feed intake in gestation over piglets birth weight, 
because an increase in gestation feed intake enhances maternal 
weight gain but has little infl uence over piglets weight. 
Table 1. Eff ect of feeding system on feed intake, body weight gain and 
body composition of sows during gestation. 
Gestation day Treatment 1 Treatment 2 Treatment 3
Feed intake, Kg 263.7±1.3a 269.1±3.4b 287.8±1.2c
ME Intake, Mcal 817.4±4.11a 834.2±10.2b 892.1±3.8c
Excess of ME vs 
Requirements, % 2.4±1.5
a 2.9±1.5a 11.3±1.5b
Body Weight, Kg Gestation day, 0 193.7±3.0 197.6±3.6 198.0± 3.5
Gestation day, 112 253.8± 4.9 257.5±4.7 260.3±4.9
Total gain 60.2±2.1 59.5±2 62.3±4.9
Maternal weight 228.5±4.7 231.9±4.7 234.9±4.9
Maternal gain 34.8±2.0 34.3±2.0 36.9±2.8
Weaning weight 210.9±2.8 218.5±3.5 219.8±2.9
Weight loss (F-W) 17.6±1.6 13.4±1.4 15.1±2.0
Body protein, Kg Gestation gain 6.3±0.7 6.2±0.3 5.8±0.5
F-W loss 2.7±0.2 2.2±0.2 2.6±0.3
Body Fat, Kg Gestation gain 6.4±0.7a 9.1±0.8b 8.5±0.8a,b
F-W loss 6.8±0.6 7.2±0.5 5.9±0.7
a,b,c Means with diff erent superscript letter diff er (P < 0.05).
Table 2. Eff ect of feeding system over the reproductive performance.
Treatment 1 Treatment 2 Treatment 3
Total born 10.8±0.2 10.6±0.2 11.0±0.2
Born alive 9.7±0.2 9.6±0.2 10.2±0.2
Pigs weaned 9.4±0.1 9.6±0.1 9.7±0.1
Litter birth weight, Kg 14.6±0.3 14.6±0.3 15.3±0.3
Individual birth weight, Kg 1.53±0.02 1.54±0.02 1.52±0.01
Weaning weight, Kg 56.9±1.9 58.7±2.7 62.6±1.3
Weaning- Breeding Interval, d 4.2±0.1 4.1±0.1 4.5±0.1
References
Noblet et al. 1990. J.Anim:Sci.68:562-572.
McNamara and Pettigrew. 2002. J. Anim. Sci. 80:2442-2451.
Revell et al. 1998. J.Anim.Sci.76:1738-1744.
Sinclair et al. 2001. J.Anim.Sci.79:2397-2405.
Gill. 2006. J. Anim. Sci. 84:1926-1934.
Nutrition and growth
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 1059
Poster Presentations
P.753
Galactogeno use (product based organic fennel, and juniper alcarabea) 
as a stimulant in dairy production sows in maternity
Oscar Huerta Alva; FJC Crespo; N. Vázquez
Laboratorios Sanfer SA de CV, Mexico, DF, Mexico
Introduction
The improvement of productive and reproductive performance 
in pig farms is the work of every day, sometimes we have to use 
the tools available to improve results. Milk production allows us 
to have a good weaning weight of our pigs by ensuring better 
growth during the fattening. 
The galactógena, natural product made from fennel, caraway 
and juniper promotes glandular environment free of pathogens 
(bacteria, viruses and fungi) and ensures the rhythmic discharge 
from the alveoli, increasing milk production and thus improve 
weight weaning.
Materials and Methods
On a farm with a capacity of 1,200 bellies in western Mexico, it 
randomly selects a maternity ward with a capacity of 28 deliv-
eries, where the control and treated group received the same 
diet for 21 days, the treated group was given daily directly in the 
food 30 grams of galactógeno, divided into two served. The fol-
lowing table describes the groups: 
Group # of gilts Average parity # piglets
Initial 
Weight
Average 
weight
Control 13 6.14 119 224.30 1.69
Treated 13 4.28 128 231.95 1.62
Results
The following table integrating the fi nal results.
Group total initial weight fi nal weight total # piglets 
Group Initial weight
Final 
Weight
# of 
piglets
Average 
initial weight
Average 
fi nal weight 
Control 239.40 748 119 1.69 6.28
Treated 231.95 824.5 128 1.61 6.44
Dif -7.45 76.5 9 -0.08 0.161
Total fi nal diff erence (0.080+0.161) 0.241
As can be seen, the fi nal margin rate was 0241 g per piglet, 
considering the total number of piglets weaned, gained 30.9 kg 
piglet weight at weaning. 
The diff erence in these herds 0.241 gr weaning piglets, has a 
direct impact on market day, feed conversion and daily weight 
gain, as demonstrated by Mahan 2005. 
Conclusions
Based on the results, where female piglets children were treated 
with a fi nal weight Galctogeno accumulated 0241 kg, compared 
to children of female piglets of control, it is concluded that use 
of this product helps in improving the accumulated weight 
weaning. 
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Use of a product based organic fennel, and juniper alcarabea (galactogeno) as a 
stimulant in dairy production sows in maternity and a farm in the west of Mexico
Oscar Huerta Alva1 FJC Crespo1 N. Vázquez1 M Jimenez2
1. Laboratorios Sanfer SA de CV, Mexico, DF, Mexico; 2. Private practice, Mexico, DF, Mexico
Introduction
The improvement of productive and reproductive performance 
in pig farms is the work of every day, sometimes we have to use 
the tools available to improve results. Milk production allows us 
to have a good weaning weight of our pigs by ensuring better 
growth during the fattening. 
The galactógena, natural product made from fennel, caraway 
and juniper promotes glandular environment free of pathogens 
(bacteria, viruses and fungi) and ensures the rhythmic discharge 
from the alveoli, increasing milk production and thus improve 
weight weaning.
Materials and Methods
On a farm with a capacity of 850 stomachs in western Mexico, it 
randomly selects a maternity ward with a capacity of 22 births, 
designates a row for each group and treated control group re-
ceived the same diet for 28 days on average , the treated group 
was given daily live in food 30 grams of galactógena, divided 
into two served. 
Results
The following table integrating the fi nal results.
Treated Group
# Gilts # farrow @ piglets Initial weight @ weaned
Final 
weight
Lactation 
days
574 3 10 17 10 86 27
50 2 11 16.3 10 89 31
862 4 11 16.1 10 87 28
65 2 12 17.4 10 95 27
550 6 11 17.5 10 83 29
804 5 12 18.9 8 87 28
1066 5 11 16.5 11 97 30
871 7 9 16.2 9 90 30
378 6 10 17.2 10 88 29
532 6 11 15.3 6 71 30
772 5 11 15.3 8 76 28
Total 51 119 183.7 102 949 317
Average 4.64 10.81 1.54 9.17 9.3 28.82
Control Group
# Gilts # farrow @piglets Initial weight @ weaned
Final 
weight
Lactation 
days
2014 5 10 16.9 10 75 31
2004 5 10 19.3 9 73.8 28
144 5 10 19.6 9 92 27
612 5 10 21.1 8 1 28
844 4 10 17.8 7 47 27
112 5 10 16.5 10 99 28
417 5 11 17.3 10 77 28
385 4 12 20.4 9 85 28
1053 3 12 18.1 11 75 28
555 5 10 17.3 9 96 28
853 4 11 16.9 11 95 28
Total 50 116 201.2 103 895.8 309
Average 4.55 10.54 1.73 9.36 8.70 28.09
Group  Initial weight
Final 
weight
# Piglets 
weaned
Average 
initial weight
Average 
fi nal weight
Treated 183.7 949 102 1.540 9.300
Control 201.2 895.8 103 1.730 8.700
Dif. -17.5 53.2 -1 -0.29 0.610
Average total fi nal diff erence (0.290+0.610) 0.801
Total fi nal diff erence (17-5 + 53.2) 70.7 kg
As can be seen, the fi nal margin rate was 0801 g per piglet, con-
sidering the initial and fi nal average, because the piglets in the 
treated group started with lower weight. Considering the diff er-
ence of the total initial weight and fi nal weight total (17.5 +53.2) 
and divide by the total piglets have a diff erence of 0.693kg of 
diff erence for children piglets treated females. 
Conclusions
Based on the results, where children piglets galactógena treated 
females had the most weight at weaning compared to piglets 
from control female children, it is concluded that use of this 
product helps in improving the accumulated weight at weaning. 
References:
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TOPIGS: Feeding pigs according to the (genetic) requirements
Michiel Westerhof
KNMvD, Helvoirt, Netherlands
Introduction
For a major pig breeding company like TOPIGS, it is crucial that 
genetic progress achieved by breeding is expressed under 
practical conditions, the so called phenotypic expression. This 
phenotypic expression is a product of genotype and environ-
ment of the pig. The phenotype consists of the observable 
characteristics or traits, the genotype is the inherited instruc-
tions within the genetic code. By selection, TOPIGS is gradually 
changing the genotype, for instance into the direction of higher 
growth and a lower feed conversion. The problem is that en-
vironment (E) is not controlled by a genetics company , while E is 
very important to benefi t from the genetic progress. 
Most important factors in environment of the pig are: farm 
management, health, feeding and climate. In relation to feeding, 
TOPIGS decided to redefi ne the protein deposition capacity of the 
animals. Protein deposition is defi ned as PD = f (FI, W, NH| sire line, 
sex, ...) where FI stands for Feed Intake, W for weight and NH for 
nutritional history. When PD is estimated, one can calculate the 
lysine and energy requirements and thus the composition of the 
feed needed to achieve best results. PD is described by the Linear 
Plateau theory (Whittemore and Fawcett, de Greef), see fi gure 1. 
Figure 1. Protein and fat deposition as function of energy intake.
Materials & Methods
The TOPIGS specifi c protein deposition model is established by 
using the records of 15,000 animals in the breeding data base. 
Since TOPIGS is a worldwide operating breeding company, we 
collect data for breeding purposes in over 25 countries. At indi-
vidual animal level, feed intake, back fat and weight is measured 
and recorded and slaughter house data are available.
Results
Protein deposition for the diff erent sire lines and the sexes were 
estimated and the lysine and energy requirements were calcu-
lated. Figure 2 shows one example, diff erences between gilts 
and barrows In the TOPIGS feeding manuals for fi nishers these 
requirements are expressed for the diff erent genetic lines, the 
diff erent sexes and diff erent age groups.
Figure 2. Protein deposition for barrows and gilts at diff erent age.
Discussion
Feeding is an important aspect of getting optimal expression 
of genetic potential. If an animal is not fed according to its 
requirements it is not only unfavorable for economic results 
but it might also have negative impact on health and welfare. 
By having good estimations of the protein deposition capacity 
in diff erent stages of the life of the pig, the feed industry can 
manufacture feeds to fully exploit the genetic potential.
TOPIGS is in the process of using the data also to predict the 
eff ects of health status, of the use of growth promoters, of 
immuno-castration and of climate on the protein deposition 
capacity of our animals .
References  
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Impact of ﬁ neness of grinding of corn and high-moisture corn on growth performance, 
carcass characteristics and stomach lesions in liquid-fed growing-ﬁ nishing pigs 
Cuilan Zhu; Doug Wey; Robert Friendship; Cornelis F. de Lange
University of Guelph, Guelph, ON, Canada
Introduction
To minimize the energy cost in cereal grain milling and maximize 
feed utilization, much attention has been drawn to defi ning 
the optimum particle size for pig diets. In various studies it has 
been shown that reducing mean particle size of typical corn and 
soybean meal based diets to < 600 μm result in improvements 
in nutrient digestibility and feed effi  ciency in growing-fi nishing 
pigs (Wondra, 1995). Research conducted in the UK indicates 
that the optimum particle size for barley-based diets used in 
liquid feeding systems is larger than that in conventional dry 
feeding (MLC, 2005), and thus reduces energy costs of liquid 
feed preparation. No research has been conducted to establish 
the optimum fi neness of grinding of dry and high-moisture corn 
(HMCorn) that is used in swine liquid feeding. Two experiments 
were conducted to determine the impact of fi neness of grinding 
of corn and HMcorn on growth performance, carcass character-
istics and stomach lesions.
Materials and Methods
In experiment 1, a total of 96 Yorkshire pigs with initial BW 32.3 
kg (SEM 1.4) were randomly assigned to 6 pens per treatment 
and 8 pigs per pen. Two complete corn and soybean meal-based 
diets were formulated with dry corn hammer milled to two dif-
ferent particle sizes. Titanium was added as marker for deter-
mining fecal digestibility. Pigs were liquid fed using a computer 
controlled feeding system according to a two phase feeding 
program until pigs reached market weight (110 kg). Body weight 
was monitored at biweekly intervals and fecal samples were col-
lected during the growing period. Carcass quality was evaluated 
according to the standard Canadian carcass grading scheme.  
In experiment 2, 160 Yorkshire pigs with initial BW 33.8 kg (SEM 
0.63) were randomly assigned to 10 pens per treatment and 8 
pigs per pen. HMCorn was ground to two diff erent particle sizes, 
transferred to large fermentation tanks, mixed with water to a 
target of 26% dry matter (DM), and stored for a maximum of 
seven days until feeding. The feeding program and pig manage-
ment were as in experiment 1. The pigs’ stomachs were collected 
at the commercial slaughtering house and scored for lesions: 
1=normal, 2=erosions, 3=ulcers, and 4=severe ulcers.
Statistic analysis was done by using the GLM procedure of SAS 
v9.2 (SAS, Inst., Cary, NC). Initial BW used as covariate.
Results and Discussion
In experiment 1, dry corn particle sizes, coarse vs. fi ne, were 652 
μm (±47.5) vs. 525 μm (±22.6). Average daily gain (ADG), average 
daily feed intake (ADFI), and gain:feed were not aff ected by fi ne-
ness of grinding (P>0.5) with means of ADG 1.11 kg/d, ADFI 2.46 
kg/d, and gain:feed 2.22. There were no diff erences (P >0.05) in 
apparent fecal digestibilities of DM, crude protein, and ash, with 
means of 85.8%, 76.0% and 58.8%, respectively. Carcass weight 
and estimated carcass lean yield were not aff ected by treatment 
(P>0.05).  
In experiment 2, increasing mean particle size of ground 
HMCorn from 355 to 918 μm, did not impact growth perform-
ance (P>0.1), with mean ADG, ADFI and gain:feed of 1.03 kg/d, 
2.22 kg/d and 2.15, respectively. Carcass characteristics were not 
aff ected (P>0.1) either. However, more severe stomach lesions 
were observed when pigs were fed fi nely ground HMcorn. Of 
the 135 stomachs that were evaluated, for pigs fed the fi ne diet 
(65 stomachs), the number of observations for scores 1 to 4 were 
9, 11, 14 and 31, respectively; for pigs fed the coarse diet (70 
stomachs), the number of observations were 23, 20, 11 and 16, 
respectively. 
In contrast to the conventional dry feed practices (Wondra, 
1995), manipulating particle size appears to have little infl uence 
on performance of liquid-fed pigs. Coarsely grinding HMCorn 
has the benefi t of reducing stomach lesions.
Implication 
The optimum particle size of ground corn is larger in liquid feed-
ing than conventional dry feeding. Increasing HMCorn particle 
size to 950 μm did not infl uence growth performance and 
carcass characteristics, while the incidence of stomach lesions 
was reduced.
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Route of iron supplementation to piglets: eﬀ ects on hemoglobin, piglet growth and infectious diseases
Dan Rantzer; Mats Andersson; Jos Botermans; Anne-Charlotte Olsson; Jørgen Svendsen
Swedish University of Agricultural Sciences, Faculty of Landscape Planning, Horticulture and Agricultural Sciences, Alnarp, Sweden
Introduction
In modern production systems newborn pigs have no natural 
access to iron (Fe) in the environment and to avoid iron defi -
ciency they need an Fe supplementation which may be given as 
an injection or be based on voluntary consumption. It is gener-
ally accepted1 that hemoglobin (Hb) levels in piglets should be 
above 80-90 g/1000 ml blood and it is considered that higher 
levels should be aimed for. While early conventional Fe injection 
is a safe way of securing suffi  cient iron to all the suckling piglets, 
there is some evidence23 that early Fe injection as opposed to 
voluntary oral Fe intake may increase the risk of joint infections 
and generalized infectious diseases in the piglets. The aim of the 
present study was to further elucidate the eff ect the route of 
Fe supplementation may have on infectious diseases in piglets, 
and the relationship between Hb levels during suckling and 
growth from birth to slaughter. 
Materials and Methods
The treatments were a) early (d 1-4) and b) late (d 8-12) Fe 
inj (Pigeron® vet, Leo), 20 litters, c) oral Fe supplementation 
(Porcofer, Svenska foder, 20 litters, and TorvoJärn Extra, Lant-
männen, 20 litters) starting on d 3 and d) oral suppl. (as under c) 
and an early Fe injection. 
Observations: The pigs were individually marked, weighed and 
blood sampled on d 2, 9, 20 and at weaning (d 33), respectively. 
Hb level was determined (Hemo Cue®B-Hemoglobin Fotometer 
[Hemo Cue AB, Ângelholm, Sweden]). The presence of joint 
infections was checked daily and on d 9 more thoroughly. The 
pigs were individually identifi ed and recorded throughout and 
at slaughter. Mortality, treatments and morbidity were noted 
daily and all dead pigs in the trial were post-mortem examined.
Results and Discussion
There were signifi cantly more treatments for joint infections in 
pigs receiving an early Fe inj. than in the littermates receiving 
a late inj. (Table 1). Also, pigs only receiving Fe by oral supple-
mentation (Table 2) had signifi cantly fewer joint infections 
than littermates also given an early Fe inj. Hb was signifi cantly 
higher on d 9 and d 20 in pigs receiving an early iron inj. than 
in littermates receiving a late Fe inj. (Table 1) or only oral suppl., 
respectively (table 2). For the orally suppl. pigs, daily growth 
to slaughter, and mortality was the same for both treatment 
groups (Table 2); however, for the inj. groups (Table 1), growth 
from day 2 to slaughter tended to be lower for the late injection 
treatment group. The results support the proposal that early Fe 
inj. increases the risk of piglet joint infections usually occurring 
in the second week of life. There are no indications in this study 
that pigs with high Hb levels perform better than pigs with 
levels of 80-110. 
Table 1. Early vs late Fe inj. Split litter design. Individ. obs. corr. for 
start weight and litter. Means ±st. errors
Early Late Sign.
No. pigs at day 2 114 110
During suckling 
Hba) day 2 88±2 89±2 n.s.
Hba) day 9 98±1 57±1 ***
Hba) day 20 120±1 112±1 ***
With joint inf. (%) 17.5 8.2 *
Deaths due to inf. (%) Day 2 to slaughter 0.9 0.9
Growth (g/d) 625±7 605±7 +
Mortality (%) 8.8 9.1 n.s.
+ p≤0,1;  * p≤ 0,05;  ** p≤ 0,01;  *** p≤ 0,001;  n.s. p>0,1, 
ª)Hemoglobin contents (g/1000 ml)
Table 2. Oral supp. vs oral + early Fe inj. (oral+). Split litter design. 
Individ. obs. corr. for start weight and litter. Means ± st. errors
Oral Oral+ Sign.
No. pigs at day 2 223 228
During suckling 
Hba) day 2 85±2 84±2 n.s.
Hba) day 9 95±1 100±1 ***
Hba) day 20 113±1 126±1 ***
With joint inf. (%) 17.5 8.2 *
Deaths due to inf. (%) 9.2 16.4 *
Day 2 to slaughter 1.3 2.6 n.s.
Growth (g/d) 632±6 634±6 n.s.
Mortality (%) 12.1 11.8 n.s.
+ p≤0,1;  * p≤ 0,05;  ** p≤ 0,01;  *** p≤ 0,001;  n.s. p>0,1, 
ª)Hemoglobin contents (g/1000 ml)
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Eﬀ ect of dietary supplementation of humic substances on the concentration of some 
elements and antioxidant status in the small intestine of weaned pigs
V. Petrovič1 J. Novotný2 Lˇ. Lenhardt3 J. Bernardy4 G. Kováč1
1. University of Veterinary Medicine and Pharmacology, Košice, Slovak Republic; 2. Clinic of Ruminants, Košice, Slovak Republic; 
3. Department of Pathological Anatomy, Košice, Slovak Republic; 4. University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic
Introduction
Humic substances (HS) have relatively high molecular weight 
and include diff erent amounts of humic acids, fulvic acids and 
humins. HS contain up to 80% of organic carbon. The variety of 
molecular structures are presented in HS, such as alkylaromatic, 
quinoide and aliphatic structures in the core, amino acid and 
carbohydrates structures and carbonyl-, carboxyl-, phenyl-, 
hydroxyl groups in the periphery. These functional groups 
modulate their enzymes activities (Zeichmann 1996; Nardi et al., 
2002). In addition, they are capable to alter the bioavailability of 
nutrients. Herzig et al. (2001) and Laurberg et al. (2003) found 
the thyroid system aff ected by HS via signifi cantly reduced 
iodine bioavailability. The aim of this study was to determine the 
eff ect of dietary supplementation of humic substances on the 
concentration of Se, Zn, Fe, Cu, Mg, Ca and malondialdehyde, 
the number of Goblet cell and the activity of alkaline phosphat-
ase in the duodenum and jejunum of weaned pigs. 
Material and Methods
The twelve piglets Large White, were weaned at the age of 
32nd day and were randomly divided into 2 groups. Control 
group was fed with basal diet for weaned pigs and experimental 
group of pigs received the same basal diet supplemented with 
humic substances in the dose 5 g per kg DM for 60 days. At the 
age of 92 days, the pigs were weighed (the average body mass 
was 30 kg per animal). After the slaughter of pigs, the samples 
of duodenum and jejunum were taken, processed and stored 
under -60 °C till analyzed the concentration of studied elements 
and malondialdehyde. To obtain reliable microscopic pictures, 
the small excisions of the proximal duodenum and middle part 
of the jejunum were immediately harvested from carcass, the 
lumen rinsed in physiological solution, fi xed in 4% formaldehyde 
for 2 hours, processed for paraffi  n embedding and sectioned 
to slides at a thickness of 5-7 microns. The Goblet cells were 
counted in 10 longitudinal sections of intact duodenal and 
jejunal villi. Determination of alkaline phosphatase activity was 
performed by using a cytophotometrical method at a wave-
length of 480 nm. 
Results
The concentration of Se, Zn, Fe, Cu, Mg and Ca in duodenum 
did not reveal the statistical diff erence between both groups 
of pigs. However, a signifi cantly lower concentration of Fe 
(p<0.05) was determined in the jejunum of pigs fed basal diet 
supplemented with humic substances as compared with that 
of the control group of pigs receiving only basal diet. Similarly, 
no statistical diff erences in the number of Goblet cell and in the 
concentration of malondialdehyde were found in the duo-
denum of pigs in both groups. Whereas, the higher number of 
Goblet cell (p<0.01), higher concentration of malondialdehyde 
(p<0.001) and signifi cantly lower activity of alkaline phosphat-
ase (p<0.001) were found in the jejunum of pigs fed with the 
diet supplemented with humic substances.
Conclusions
Taken together, the presented data suggest that the supplemen-
tation of humic substances into the diet for pigs decreases the 
concentration of iron in the jejunum. On the other hand, humic 
substances could possess the property to increase the inter-
mediate metabolism in the jejunum of weaned pigs. A further 
research on pigs is needed before clearer conclusive statements 
can be made about the way how humic substances may cause 
the above mentioned changes. 
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Eﬀ ect of temperature and packing method on storage of boar semen
Ellen de Jong1 Jeroen Dewulf1 Ann Van Soom1 Candida Adriaens1 Wouter Deley2 Aart de Kruif1 Dominiek Maes1
1. Ghent University, Faculty of Veterinary Medicine, Department of Reproduction, Obstetrics and Herd Health, Merelbeke, Belgium; 
2. AI Centre Hypor, Olsene, Belgium
Introduction and objectives
Storage of semen has an irreversible eff ect on its quality (1). Boar 
spermatozoa are very sensitive to “cold shock” (2). If semen tem-
perature suddenly drops below 15°C, most spermatozoa do not 
survive (3, 4). After dilution, semen is cooled until 17°C. At this 
temperature, it can be stored without causing damage (5, 6). The 
purpose of this study was to investigate whether the storage of 
boar semen at diff erent temperatures and in diff erent packages 
infl uences sperm quality. 
Materials and Methods
The experiment was performed in April 2009. Ejaculates (dilu-
tion with Minitub BTS® until 2.5x109 at 26°C) of 6 Piétrain boars 
from a commercial AI centre (1 ejaculate/boar), were packed in 
2 dissimilar assemblages: blisters (most frequently used: 85% 
market share) and Gédis® (Genes Diff usion: 12% market share). 
The semen samples were transported to the laboratory of the 
Faculty of Veterinary Medicine in Merelbeke, kept at room 
temperature for two more hours and then stored at 3 distinct 
temperatures: 14°C, 17°C (standard) and 20°C. To determine the 
quality of the spermatozoa, the following aspects were inves-
tigated: motility, progressive motility, percentage normal and 
percentage live spermatozoa. The fi rst two parameters were ana-
lysed using the CASA (Computer Assisted Semen Analyzer) daily 
from D0 (semen collection) to D4. The percentage of normal 
and live spermatozoa was also examined daily in a blinded way 
using eosin-nigrosin staining. Statistical analysis was performed 
by means of a linear mixed eff ects model, in which boar was the 
random eff ect (S+).
Results
Table I shows the outcomes (mean over the fi ve days) of the four 
investigated parameters of the semen, stored at diff erent tem-
peratures in blisters. Table II shows the same, but with semen 
packaged in Gédis®. 
Over the fi ve days, a signifi cant lower percentage live and 
normal spermatozoa was seen in semen packed in Gédis® in 
comparison to that in blisters at 17°C (p < 0.05). 
In case of extended preservation of the semen (> 2 days), a 
signifi cant decrease in the percentage live (90.3% vs. 86.1%) 
and normal spermatozoa (84.7% vs. 80.4%), motility (67.1% vs. 
57.4%) and progressive motility (45.9% vs. 32.5%) was observed 
in both packing methods and at all temperatures (p < 0.01). 
Table I: Mean outcomes of semen stored in blisters
14°C (ref.) 17°C 20°C
% live spermatozoa 89.4 91.5* 91
% motile spermatozoa 63.5 60.3 57.9*
% progressive motile spermatozoa 36.1 37.3 37.3
% normal spermatozoa 83.3 85.7 86.1
*: signifi cantly diff erent from reference category within row (p < 0.05)
Table II: Mean outcomes of semen stored in Gédis
14°C (ref.) 17°C 20°C
% live spermatozoa 83.7 87.1* 84.1
% motile spermatozoa 64.6 61.9 59.4*
% progressive motile spermatozoa 40.4 37.4 38.6
% normal spermatozoa 78 81.5 78.6
*: signifi cantly diff erent from reference category within row (p < 0.05)
Discussion and conclusion
These results show that the quality of boar semen decreases 
when stored for a longer period than two days as well as when 
it is preserved at temperatures lower or higher than 17°C. The 
present study demonstrates also a better longevity when sperm-
atozoa are packed in blisters than in Gédis. To investigate the 
fertility results of semen stored in these conditions, more in vivo 
studies are needed.
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Adrenocortical activity of boars exposed to heat stress, supplemented with 
organic and inorganic trace mineral and its eﬀ ect on semen quality
Daiane Donin; Aline D. Viott
Universidade Federal do Paraná, Palotina, PR, Brazil
Seasonal high temperatures or inadequate nutrition can de-
crease reproductive effi  ciency in boars, especially through both 
a reduction in the number of ejaculate spermatozoal and abnor-
mal morphology. In these situations, animals are under stress, 
which can be defi ned as a body reaction to an adverse condition 
of the environment in an attempt to achieve thermoregulation 
and homeostasis. Several hormones, including adrenocortico-
tropic hormone (ACTH), glucocorticoids, catecholamines and 
prolactin are involved in stress response and can be measured 
to quantify this response. Environmental factors seem to be 
primarily responsible for the reproductive performance of boar 
and, among these factors stands out nutrition. Organic minerals 
contain a chain of minerals and amino acids and this associa-
tion enhances the absorption of minerals in the small intestine 
by protecting the metal in a complex in an inert chemical form 
due to covalent and ionic bonds between the ligands and amino 
acids. 
The aim of this study was to evaluate the eff ect of organic and 
inorganic trace mineral supplementation on adrenocortical 
activity in boars exposed to high environmental temperatures in 
Southern Brazil. 
Thirteen boars (± 2 years of age) were divided into three groups 
to receive inorganic (GIn, n=4), organic (GOr, n=4) mineral 
supplementation or a lactation control diet (GCo, n=5). Inorganic 
and organic diets were made of a premix of inorganic and 
organic trace minerals, respectively, with the same quantity of 
each trace mineral, based on NRC (nutritional requirements for 
boars). The lactation diet was based on NRC requirements for 
lactating sows and contained a higher level of inorganic trace 
minerals, protein and metabolic energy. For the cortisol analysis 
124 fecal samples were collected from organic and inorganic 
groups and 155 samples from the control group. To determine 
the concentrations of fecal corticoids, samples collected from 
the latest feces of the day from males from groups GIn, GOr and 
GCo, weekly, throughout the experiment from 11:00 to 12:00 h. 
Even though the fecal analysis represent a pool of concentra-
tions of metabolites, the time of collection was observed to 
avoid possible changes in cortisol concentration related with 
circadian variations,. The sample processing (extraction and an-
alysis by radioimmunoassay) was performed at the Laboratory of 
Hormone levels (LDH), University of São Paulo (USP), following 
the pattern described by Graham et al. (2001). Radioimmuno-
assay (RIA I125) was biologically validated for swine feces by 
administration of adrenocorticotropic hormone (ACTH) in two 
boars and fecal samples were collected prior to and one day 
after administration. Feces collection was done at the same as 
test animals stool collection. Fecal corticosterone metabolites 
were quantifi ed by radioimmunoassay double antibody, using 
commercial diagnostic kit, developed to measure corticosterone 
in human serum. Values of hormone metabolites were corrected 
for weight and dilution and expressed in nanograms per gram of 
wet feces (ng /g). Maximum mean environmental temperatures 
were higher than the normal thermal comfort temperature for 
boars (26oC) during the experimental period, and were associ-
ated with a reduction in semen quality. 
Results are expressed as mean ± SEM. Mean fecal corticoid con-
centrations, assessed by RIA in wet samples, were similar among 
groups (GIn 10,932.77 ± 12,332.00 ng/g; GOr 9,088.60 ± 8,748.61 
ng/g and GCo 9,988.20 ± 10,072.27 ng/g). However, negative 
correlations were found between fecal corticoids and normal 
spermatozoa percentage (P<0.05). Percentage of normal sperm-
atozoa, evaluated by humid preparation technique (KRAUSE, 
1966), was higher in the Organic group when compared with 
both Inorganic and Lactation groups (93.31 ± 5.20% versus 78.48 
± 12.15% and 82.59 ± 17.27%, respectively; P=0.00021). Levels 
of cortisol’s metabolites were found in the stools with a signifi -
cant negative correlation with the percentage of normal sperm 
(-0,353, p<0,05) so with the increased adrenocortical activity, 
there is a reduction in the production of normal sperm, with a 
consequent increase in the number of sperm morphological 
defects, when boars were subjected to a stressful situation. Or-
ganic mineral supplementation did not infl uence adrenocortical 
response to the stressor agent (heat stress) in this experiment, 
but was benefi cial to seminal quality, reducing some of the heat 
stress eff ects in exposed boars.
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Eﬀ ects of organic selenium supplementation on mitochondrial potential and 
integrity of plasma and acrossomal membranes in boar sperm
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Introduction
Selenium (Se) is an essential element playing an important role 
in animal reproduction. The selenoproteins participate in regula-
tion of various physiological functions including antioxidant 
protection, redox regulation of gene expression and sperm 
structure integrity maintenance1. Although there are some stud-
ies regarding the infl uence of the addition of selenium on the 
quality of boar semen, researchers did not examine the eff ects of 
selenium on membrane integrity of sperm cells and mitochon-
drial potential. Therefore, the aim of this study was to investigate 
the eff ects of organic selenium in spermatozoa quality of boars 
at 0, 24, 48 and 72 hours after diluting with a semen extender.
Materials and Methods
Fifteen boars were kept on the same conditions and were fed 
the same standard diet during training. The animals were fed 
with three experimental diets: 0.3ppm sodium selenite (Control); 
0.5ppm sodium selenite (Inorganic) and 0.5ppm selenium yeast 
(Organic). Ejaculates were collected from each boar once per 
week using the gloved-hand technique. Semen was diluted with 
standard extender to 3x109cells/dose and stored for 3 days at 
18ºC. For fl ow cytometry assessment of the integrity of plasma 
and acrosomal membranes and mitochondrial function, semen 
samples were diluted in a 37ºC prewarmed TALP sperm medium 
at a concentration of 5x106 sperms/mL. Thereafter, two aliquots 
(150 μL) were transferred to microcentrifuge tubes. One of these 
tubes was supplemented with 3 μL of propidium iodide-PI (0.5 
mg/mL) and 10 μL of fl uorescein isothiocyanate-conjugated 
Psium sativum agglutinin-FITC-PSA (100 μg/mL) to evaluate the 
integrity of plasma and acrosomal membranes, whereas the 
other received 2 μL of JC-1 (153 μM) to evaluate mitochondrial 
membrane potential. Samples were incubated in the dark for 8 
min at 37ºC, and then TALP was added to achieve an appropriate 
sperm concentration (2.5x106 sperms/mL)2,3. The experimental 
design was a randomised block. Data were analyzed using 
the PROC repeated from SAS4 and outcomes were compared 
among the three treatments by the orthogonal contrast method 
with p<0.05 level of signifi cance.
Results
Cells with both plasma membrane and acrosome intact (AIMI) 
did not diff er between treatments, but signifi cance was de-
tected according to time. The higher percentage of the AIMI cells 
was observed in 0 hours. Mitochondrial potential interaction 
between treatment and time was not observed, but there was a 
signifi cant eff ect for time. There was also a lower percentage of 
cells in the 24 and 48 hours after dilution. 
Discussion
Some studies have reported that the diet supplemented with 
sodium selenite has improved the quality of boar semen5. For 
the reason of environmental and toxicity concerns, however, the 
FDA6 allows a maximum of only 0.3ppm Se in swine diets, but 
studies have shown that 0.5ppm Se has improved the percent-
age of normal and motile sperm cells of boars5. This result is in 
agreement with our results, but when we assess more specifi c-
ally the sperm membranes we found that selenium supplemen-
tation did not aff ect these variables. In conclusion, the selenium 
yeast showed no better results in comparison to others treat-
ments in the seminal analyses.
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Sperm production in Duroc, Landrace, Yorkshire, Berkshire and Pietrain 
boars kept in evaporative cooling system in Thailand
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Introduction
The sperm production of the boars is aff ected by several fac-
tors such as, breed, season, nutrition and housing (1). Since the 
environmental temperature in Thailand is often over 30°C for 
several months of the years, a reduction of pig production and 
the reproductive performance are observed during hot periods. 
Nowadays, the evaporative cooling system (EVAP) is normally 
used for housing boars in Thailand. It has been suggested that 
this system help to reduce the seasonal variation of the sperm 
production in Duroc boars (2). However, the variation of sperm 
production among diff erent boar breeds used in Thailand has 
not been evaluated. The objective of the present study was to 
determine the sperm production of Duroc (D), Landrace (L), 
Yorkshire (Y), Berkshire (B) and Pietrain (P) boars kept in EVAP in 
Thailand. 
Materials and Methods
Semen production data from 377 boars used during a period 
from January 2003 to December 2009 in a commercial boar 
stud with diff erent breeds (i.e., 184 D, 45 L, 77 Y, 23 B and 48 P) 
were analyzed. Each boar was kept in each pen (9 m2/boar) and 
was fed with 2.2-3.0 kg/day of a commercial feed containing 
14-18% crude protein, and 3,000-3,200 kcal DE/kg. All boars 
were accessed to water ad libitum. The data set consisted 
of 20,643 ejaculates of semen. Semen parameters including 
volume (ml), sperm concentration (x106 spz/ml) measured by 
Spermacue®(Minitube, Tiefenbach, Germany), subjective motility 
and total number of sperm per ejaculates (x109 spz) were evalu-
ated. The sperm production data were analysed using general 
linear mixed model procedure (MIXED) of SAS version 9.0. The 
models included boar breeds, year and month in which the 
semen were collected as fi xed eff ect and included boar identity 
nested within breed as random eff ect. Least-squared means 
were obtained and compared among breeds using Tukey-Kram-
er test. P<0.05 was regarded as a signifi cant diff erence. 
Result and Discussion
The sperm production in each breed is presented in Table 1. 
Across the breeds, volume, concentration, total sperm per ejacu-
lates and subjective motility were 239.6±94.6 ml, 319.8±97.9 x 
106 sperm/ml, 71.7±25.4 x 109 sperm/ejaculate and 73.4±8.8% of 
motility, respectively.
Table 1 Means, standard deviation (SD) and range of sperm produc-
tion in Duroc (D), Landrace (L), Yorkshire (Y), Berkshire (B) and Pietrain 
(P) boars
Parameter Breed N Mean ±SD Range
Volume
(ml)
D 6,889 169.7±66.6c 50-497
L 2,553 294.2 ±76.7a 52-500
Y 8,858 278.4±88.2a 50-500
B 292 168.7 ±68.5c 56-481
P 1,725 250.7±76.1b 58-500
Concentration
(x106/ml)
D 6,317 375.990.2a 75-600
L 2,405 297.0±77.7c 96.8-600
Y 8,729 288.8±93.0c 51-599
B 217 295.5±108ab 135-600
P 1,610 305.3±82.7b 97-600
Total Sperm
(x109)
D 6,280 59.7±21.7a 12-255
L 2,383 85.3±24.0a 17-25
Y 8,564 76.8±25.1b 4-235
B 216 49.7±28.1ab 16-184
P 1,601 73.8±21.1ab 20-230
a,b Means with diff erent superscripts within column for each parameters are signifi cantly 
diff erence (p<0.05)
The sperm production of boars diff ered among the breeds. D 
and B boars had a lower semen volume and total sperm per 
ejaculate than L and Y boars. It has been demonstrated that both 
volume and concentration of the boar semen had a heritability 
of 0.58 and 0.49, respectively (3). Selection of boars, used in trop-
ical climates, based on sperm production is therefore important. 
In conclusions, the semen production of L and Y boars kept in 
evaporative cooling system in Thailand were superior to D, B and 
P boars.
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Introduction
Fluctuation of temperature and humidity cause a decrease of 
semen output in boar (1). It was found that high sperm produc-
tion was observed in autumn and winter but low sperm produc-
tion was observed in summer (2). In Thailand, evaporative cool-
ing system (EVAP) is commonly used for boar housing in order to 
minimize the seasonal eff ect of the sperm production. An earlier 
study in Thailand has demonstrated that the total number of 
sperm per ejaculate was 72.2 x109 and 74.9 x 109 sperm in boars 
kept in evaporative and in conventional open housing system, 
respectively and minor diff erence in the seasonal pattern was 
found between the two housing system in Thailand (3). How-
ever, high humidity negatively aff ect both semen volume and 
total sperm output (3). The objective of the present study was to 
investigate the seasonal infl uence on sperm production of boars 
kept in evaporative cooling system in Thailand.
Materials and Methods
Semen production data from 20,502 ejaculates of 554 boars 
(164 Duroc, 14 Yorkshire, 23 Berkshire, 31 Pietrain, 54 crossbred 
Pietrain x Duroc and 268 crossbred Landrace x Yorkshire) col-
lected during January 2006 - December 2009 in a commercial 
boar station were included. Each boar was kept individual pen (9 
m2/boar) and was fed with 2.2-3.0 kg/day of a commercial feed 
containing 14-18% crude protein, and 3,000-3,200 kcal DE/kg. 
The boars were accessed to water ad libitum. Semen param-
eters including volume (ml), sperm concentration (x106 spz/ml) 
measured by Spermacue®, subjective motility and total number 
of sperm per ejaculates (x109 spz) were evaluated. On average, 
the temperature (°C) and Humidity (%) in EVAP from Jan to 
Dec were 22.5/85.7, 23.8/82.2, 25/81.6, 25/82, 24.9/86, 25.1/85, 
25/86.3, 25/85.2, 24.8/85.4, 24.5/86.1, 22.6/ 85.6 and 21.8/85.5, 
respectively. The sperm production data were analysed using 
general linear mixed model procedure (MIXED) of SAS version 
9.0. The models included boar breeds, year and month in which 
the semen were collected as fi xed eff ect and included boar iden-
tity nested within breed as random eff ect. Least-squared means 
were obtained and compared among breeds using Tukey-Kram-
er test. p<0.05 was regarded as a signifi cant diff erence. 
Result and Discussion
On average, the semen volume, concentration, total sperm 
per ejaculates and individual motility were 249.4±97.9 ml, 
334.6±96.3 x 106 sperm/ml, 78.7±28.6 x 109 sperm/ejaculate, and 
73.9±11.1% subjective motility, respectively. The sperm produc-
tion by months is presented in Figure 1.
Figure 1 Least-squared means and standard error of total number of 
sperm/ejaculation by months. 
a,b diff erent superscripts are signifi cantly diff erence (p<0.05).
The total number of sperm production in March, August, Sep-
tember and October was signifi cantly lower than April, May and 
November (Figure 1). Since spermatogenesis spent 35 – 40 days 
for completing process, short day length during August-October 
might cause the decrease of sperm production. Furthermore, 
high humidity during rainy season (Jul-Oct) might also contrib-
ute to the seasonal infl uence on the sperm output of boars kept 
in EVAP in Thailand. It could be concluded that the seasonal 
infl uence on the sperm production was still observed in boars 
kept in EVAP in Thailand. 
References
1.  Kunavongkrit, A. et al. (2005). Theriogenology 63, 657-667.
2.  Ciereszko et al. (2000). Anim. Reprod. Sci. 64: 89-96.
3.  Suriyasomboon, A., Lundeheim, N., Kunavongkrit, A., Einarsson, S., 
2004. Livest. Prod. Sci. 89: 19-31.
.
Reproduction – Semen
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 1070
Poster Presentations
P.764
Reproductive failure associated with poor AI dilution
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Introduction
The preparation of diluent used in artifi cial insemination is a key 
component in processing semen.
Failure to achieve the correct osmotic pressure by incorrectly di-
luting the extender is more diffi  cult to detect during the semen 
examination. This paper reports a failure to achieve the correct 
dilution and subsequent eff ect on reproduction.
Clinical outline
A 32 sow 2 week batch farm practiced on-farm AI. Following a 
change in stockpeople, the farm suff ered a massive drop in far-
rowing rate.
Problems started in batch 22 and ended in batch 33 with a 
change in AI practice. Statistical process control clearly demon-
strates the production issue.
Detailed analysis of the semen processing revealed that the 
stockpeople has misread their instructions and were not diluting 
the extender properly. In general they were over-diluting – add-
ing 1.5 litres of distilled water to 50g of diluents instead of only 
1 litre.
AI semen samples were examined without any obvious abnor-
mality being detected. There were no change in live to dead 
ratios, semen abnormalities or semen movement. Visual analysis 
of the semen immediately post-dilution, the semen appeared to 
be stunned and did not move properly. However, within an hour, 
their movement became visually normal.
The diluents was examined for conductivity mS/cm 17°C where 
the failure of adequate dilution was confi rmed. The conductivity 
at various dilutions:
Water l 0.5 1.0 1.5 2.0 Water
Cond. mS/cm 12.83 8.01 5.88 4.60 0.01
The initial concern was noticed the stockpeople failing to detect 
3 and 4 week returns. The stockpeople subsequently mislead 
management about pregnancy results rather than believe the 
extreme poor performance.
Consequence and cost of the AI failure
The farm lost 780 weaners associated with this reproductive 
failure. At $AU 3.40 per kg deadweight costs this resulted in a 
$75,000 increase in fi xed costs – or $9 increase per pig sold over 
the next year. 
Detailed production results
The batch farrowing rate %
 The upper line represents the mean, the lower line 2sd below 
the mean
Pre-batch 22  Mean 80  Standard deviation 6.6
Batch 22 to 33  Mean 49  Standard deviation 17
Statistical process control indicates that from batch 23 the 
system was out of control 10/11 batches. Stastistical analysis 
indicate a p <0.001 diff erence between batches 22 and 33 and 
normal.
Piglets weaned per farrowing sow
The middle line is the mean. The two other lines represents 2sd 
above and below the mean
Pre-batch 22  Mean 9.1  Standard deviation 1.3
Batch 22 to 33  Mean 10.1  Standard deviation 2.0
Statistical process control indicates that from batch 22 to 33 the 
system was never out of control. Stastistical analysis indicate 
p = 0.14. There is no diff erence in numbers weaned between 
batches 22 and 33 and normal.
Discussion
Failure to adequately dilute semen resulted in a catestrophic 
failure of reproduction. The farrowing rate collapsed. The litter 
size – numbers weaned – did not statistically change. Those 
sows who became pregnant had normal litters.
The failure of dilution was confi rmed by monitoring the con-
ductivity of the diluent. As osmolarity is diffi  cult to measure in 
the fi eld, conductivity should be included in the standard AI 
investigation.
The stockpeople did not initially accept their failing and at-
tempted to cover up the problems.Please visit our website www.portec.com.au
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Introduction 
It has been demostrated (1, 2), the eff ect of environmental and 
genetic factors on the productivity of boars at two Genetic 
Transfer Centers (GTC), managed under an all-in all-out systems 
(AIAO), as well as some estimates of longevity, productive life 
and seminal output repeatability (3). The aim was to obtain com-
parative estimates for retention rate, live sperm production, and 
semen doses produced, in two GTC managed under an AIAO 
system, that were fi lled with boars sourced from a single genetic 
supplier. 
Materials and Methods
Data was obtained from two GTC established in Michoacan, 
Mexico, and located at 1020 15’N and 190 50’ W. GTC One (GTC1), 
operated from Sept 1, 2004 until Jan 31, 2007, with an initial 
inventory of 66 boars. GTC Two (GTC2), operated from Jun 1st , 
2006 until Dec 31 st 2008, with an initial inventory of 77 boars. 
Retention rate (RR) was analyzed by trimesters, in order to obtain 
Lineal Regression Models for each GTC. Sperm production 
analysis was carried out considering total sperm live concentra-
tion per ejaculate (TSLCE) and based on the interval between 
collections (CI). Annual semen doses production was calculated 
for each one of the GTC and the boar dose production was car-
ried out by percentile (100, 75, 50, 25). The whole analysis was 
performed using SAS System SAS (Ver.8.0, 1999). 
Results
For GTC1 and GTC2, 10, 086 and 11,997 ejaculates were pro-
cessed respectively. All boars were introduced on the same day 
and were fi rst ejaculated at an average age of 230.6±28.7 days. 
For GTC1, the obtained models for RR were 108.49**-7.21** (tri-
mester); R2=0.97, and for GTC2, RR were 109.27**-4.97** (trimes-
ter); R2=0.98. The obtained models for TSLCE did not explain the 
variation observed: GTC1: TSLCE=47114*+95.19* (CI); R2=0.003; 
and for GTC2: TSLCE = 46840**+194.3** (CI); R2=0.008, although, 
all coeffi  cients were signifi catively diff erent, indicating that for 
a longer collection interval, there will be an increase on TSLCE, 
therefore the importance of follow an adequate CI protocol.
Discussion 
For RR and considering regression trend, there was the same 
direction for both GTC, but not its magnitude, neither on 
its time-dependent distribution. Also, it was possible to see 
improvement in CTG2, maybe due to a better understanding 
and more experience gained. Regarding TSLCE and although, all 
coeffi  cients were signifi catively diff erent we conclude that for 
a longer collection interval, there will be an increase on doses 
produced, therefore the importance of follow up an adequate CI 
protocol. At each GTC, there were also productivity diff erences 
between periods and the same happened when doses produced 
per boar during his lifetime were evaluated (Table 2), where a 
declining trend was observed between RR, ejaculates processed 
and total doses produced at each GTC. In a previous study, it was 
established that a peak of doses produced was reached at 953 
days of age, with an average of 20.3 doses per ejaculated (1).
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Table1.
GTC 1 Ejaculates Doses GTC 2 Ejaculates Doses
2004 1,003 14,746 — — —
2005 4,333 75,609 2006 2,128 34,732
2006 4,608 75,604 2007 5,564 79,008
2007 142 2,630 2008 4,305 57,809
Total 10,086 168,319 11,997 171,550
Table2.
GTC1 GTC1 GTC2 GTC2
Percentile Ejaculates Doses Ejaculates Doses
Top 25 256 7,874 233 4,782
Averange 218 5,400 220 3,033
Low 25 174 4,100 165 2,263
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High levels of dietary Zn-Methionate increase sperm DNA 
fragmentation in the boar: A preliminary investigation
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Introduction
Zinc (Zn) is as a member of metalloenzymes (GP, SOD) whereby 
it operates as an essential trace element important to a range 
of the reproductive processes in mammalian species (1). This 
mineral is necessary for the stability of sperm chromatin and 
embryonic development (2). Studies have demonstrated an 
increase in a range of abnormal seminal parameters linked to 
defi ciencies in Zn concentration. The boar is susceptible to the 
adverse eff ects of Zn defi ciency, so that there is increasing inter-
est to understand the relationship between dietary levels of Zn 
sources and its eff ect on fertility. Rojas et al. (3) shown that there 
is a diff erence in the bioavailability of Zn source, well as the rate 
of absorption, transfer mechanisms, metabolism and storage 
(4). The aim of this investigation was to assess the infl uence of 
elevated concentrations of dietary Zn-Methionate (Zn-Met) on 
sperm DNA fragmentation (SDF). 
Material and Methods
This experiment was conducted using ten individually housed 
York-Landrace breed boars with an age average of 8 months. 
Five boars received a standard food ration (SFR) containing 
25 ppm Zn and were used as a control. The SFR was balanced 
according to NRC requirements (1998) using a premix of grain 
supplemented with soybean, vitamins and minerals. The ex-
perimental group consisted of 5 boars that were fed on a SFR 
containing a supplement of 200 ppm Zn (Zn-Met200). Boars 
were assessed for sperm DNA fragmentation (SDF %) over 6 
consecutive weeks. The levels of SDF were measured using the 
Sperm-Sus-Halomax assay (DNA Halotech SL, Madrid, Spain). 
SDF mean values were compared with Tukey’s test. 
Fig. 1. Graphic presentation of the varying levels of SDF in Control 
(grey line) and Zn-Met200 treated individuals (black line). Mean ± SE 
obtained for group are showed.
Results and Discussion
Fig. 1 shows the eff ect of increased dietary Zn on the SDF of 
boar semen collected over 6 consecutive weeks. On average the 
level of SDF for the control group was 2.91 ± 3.04%; this value is 
likely to be with the normal range for this species, i.e. <5% (5,6). 
However, boars receiving the Zn-Met200 diet showed average 
values for the SDF of greater than 15.01 ± 3.10 %, which was in 
the order of four times more intense that those values found in 
the Control (P=0.003) and values previously reported for boars 
(6). An interesting unexpected observation was the weekly 
rhythmic (10 to 20%) expression of SDF throughout the collec-
tion period (Fig.1). Although dietary Zn-Met200 in this experi-
ment resulted in signifi cant damage to the sperm DNA during 
the period of feeding, further studies are required to determine 
whether this eff ect is reversible if the animal is returned to a nor-
mal diet or whether the initial exposure to high levels of dietary 
Zn may interfere with future normal sperm development. Since 
a diet containing 200 ppm of organic Zn (Zn-Met) resulted in a 
signifi cant increase in boar sperm DNA damage, new ongoing 
experiments have been conducted to investigate the maximum 
level of Zn which does not interfere with the baseline level of 
SDF.
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Fertility of sows inseminated with extended semen stored at +50C or +170C
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Introduction
Cooling boar semen to lower temperatures is necessary for 
transport over long distances and exchange of material genetic 
as sperm cryopreservation remains suboptimal in this species. 
Moreover, temperature reduction has been used to prolong 
the sperm viability, as a result of decreased cellular metabolic 
processes and bacterial growth reduction. However, there are 
few studies related to the preservation of boar sperm at +50C 
and its eff ectiveness “in vivo”, involving the measurement of 
fertility parameters, such as farrowing rate, return to oestrous 
and litter size. Thus, the objective of the research was to evaluate 
the reproductive performance of sows inseminated with semen 
diluted in glycine-egg yolk extender (1) and cooled to +50C.
Material and Methods
A total of 70 primiparous and multiparous sows were distributed 
uniformly, after grouping by breed and parity, into two treat-
ments: TI (n=35) – sows inseminated with semen diluted in BTS® 
extender, submitted to stabilization period at room temperature 
(23±20C) for 2 hours, with subsequent storage at +170C (control 
treatment); and TII (n=35) – sows inseminated semen diluted in 
glycine-egg yolk extender (1), submitted to a stabilization per-
iod at room temperature (23±20C) for 4 hours, before cooled at 
+50C in previously described container (2). The females of both 
treatments were inseminated with doses containing 3x109 vi-
able sperm. The fi rst insemination was performed 12 hours after 
the onset of oestrous, and the subsequent every 12 hours, for up 
to three insemination. If still in oestrous within 24 hours of the 
third insemination, the sows also received a fourth insemination. 
The data were analyzed using the statistical program “Statistical 
Analysis System”, Version 5 - Microsoft® , with a signifi cance level 
of 95% (p <0.05). The data were submitted to the procedure 
GLM (General Linear Models) and the quantitative variables 
analyzed by SNK or Student’s t test, and proportional variables, 
by chi-square test (x2).
Results
The semen extended in glycine-egg yolk (TII) was superior 
(p<0.05) with regard to the maintenance of the physical 
characteristics (motility and vigor), after 19.79±7.06 hours of 
storage (TI=68.17±5.83% and 3.19±0.43; TII=75.47±3.78% and 
3.60±0.42). Regarding the sows reproductive performance, there 
was an infl uence (p<0.05) of treatment on the farrowing rate, 
from 77.14% with semen diluted in glycine-egg yolk and stored 
at +50C in special container to 97.14% when using the semen 
diluted in BTS® and stored at +170C. However, there were no 
signifi cant diff erences (p>0.05) between treatments regarding 
the average of total number of born piglets (14.87±2.85 vs. 
10.72±3.94) and born alive (13.26±2.89 and 10.12±3.53), for TI 
and TII, respectively.
Discussion
Studies related to cooling boar spermatozoa at +50C showed 
a farrowing rate of 85% (4) or 63% (1). Thus, the results found 
here are in agreement with those showed in the literature. 
Boar spermatozoa are sensitive to cooling below +150C (3), and 
membrane damages increasing with the storage time reducing 
the sperm longevity (5). Thus, one alternative to use of cooled 
boar semen will be the change in the site of sperm deposition in 
the female genital tract as have been made with cryopreserved 
semen in this specie.
Conclusion
The use of swine semen cooled to +50C proved to be viable 
using the glycine-egg yolk extender and container proposed 
(2). However, caution is recommended when used on a large 
scale in commercial herds, especially considering the excellent 
reproductive performance of sows submitted to intracervical 
insemination with sperm diluted in BTS® and kept at +170C. 
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Main bacterial species isolated from commercial seminal doses and antibiotic activity
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Introduction
Presence of bacterial contamination in pig seminal doses oc-
curs with some frequency in artifi cial insemination centres, and 
may have a negative eff ect on its durability, even using ejacu-
lates with good spermatic quality. Normally the source of this 
contamination is the own boar. However, distilled water used to 
elaborate the seminal doses can also be an important source of 
bacterial contamination. To overcome this problem it is essential 
to have a good hygiene and disinfection protocol. Moreover it is 
necessary to use extenders with an eff ective antibiotic com-
bination.The aim of this study is to observe the main bacterial 
species isolated from seminal doses and to assess the activity of 
antibiotics commonly used against these microorganisms, in the 
seminal doses production and swine reproductive infections.
Material and Methods
 The study was carried out with more than 170 diluted sperm 
samples from artifi cial insemination centres located throughout 
the Spanish geography. The sample cultures were routinely 
performed within 24 hours post-dilution (without any previ-
ous manipulation). Bacterial isolation and identifi cation were 
performed in TSA agar (incubation 24 hours at 37 ˚C ± 1˚ C). 
A kit API-20E was used to identify isolated bacteria, while the 
antibiogram was performed by diff usion in Mueller-Hinton agar 
(incubation 24 hours at 37 ˚C ± 1˚C). The antibiogram test was 
carried out using antibiotics routinely included in the elabora-
tion of seminal doses or pig reproduction pathology chemother-
apy. Statistical analysis was developed with relative frequency 
description for bacterial isolates (StatView 5.0 statistical pack-
age) and Chi-Square for antibiotics activity (WinEpi: Working in 
Epidemiology). 
Results
The most commonly bacterial species isolated in extended 
semen samples were those shown in Table 1. 
Figure 1 show the frequency which bacterial isolates present 
sensitivity (S), resistance (R) or intermediate-acting (I) against 
antibiotics commonly used in pig reproduction (diff erences 
among antibiotic activity: p<0.0001) 
Figure 1. Antibiotic activity against isolated bacteria.
Table 1. Main bacterial isolates in extended semen frequency 
Bacteria %
Serratia marcescens 24.0
Klebsiella oxytoca 6.0
Proteus vulgaris 5.3
Pseudomona fl uorescens 5.3
Escherichia coli 4.0
Pseudomona aeruginosa 4.0
Stenotrophomonas maltophilia 4.0
Enterobacter asburiae 2.7
Proteus mirabilis 2.7
Serratia liquefaciens 2.7
Serratia odorifera 2.7
Brevibacillus brevis 2.0
Burkholderia cepacia 2.0
Cedecea davisae 2.0
Citrobacter freundii 2.0
Enterobacter cloacae 2.0
Pseudomona oryzihabitans 2.0
Staphylococcus equorum 2.0
Others... 22.7
Discussion:Isolation of bacteria in seminal doses treated with 
antibiotics, indicate that it is produced a selection of bacterial 
species according to their susceptibility (resistance) to this anti-
biotics (i.e.: S. marcescens). Therefore, we consider essential to 
make an accurate bacterial type diagnostic and quantifi cation, 
in addition to, a proper antibiotic selection to use. Taking into 
account frequent apparition of bacterial species with resistance 
or intermediate susceptibility to some antibiotics, no randomly 
selected antibiotic combination with synergic activity may 
support a proper tool to guarantee the minimum detrimental 
eff ect caused by bacterial contamination in the seminal dose 
conservative period. In short, With the objective of fi nd more ef-
fi cient antibiotic combinations, we consider essential assessing 
the activity and the MIC (Minimum Inhibitory Concentration) to 
each antibiotic about no treated seminal doses.
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Introduction
Fertilizing potential assessment of an ejaculate or semen doses 
destinated for swine artifi cial insemination (AI) includes evalua-
tion of sperm quality traits like morphology, concentration, 
motility and functionality of sperm membrane. Nowadays, in 
Spain there are more than 60 boar stud supplying boar semen 
doses for farms, and in some cases, the distance between cen-
tres and farms is large. Nevertheless, semen doses should exhibit 
adequate fertilizing predictive parameters comply with standard 
limits. The aim of the present study was to assess sperm quality 
traits of seminal doses supplied by boar studs in Spain during 
last 5 years, and to investigate the correlations between these 
sperm parameters. 
Materials and Methods
8728 semen doses were obtained from 56 commercial AI boar 
studs between January 2004 and December 2009. Semen 
quality parameters: Motility, Concentration, Whole acrosoms, 
functionality of sperm membrane (Host), sperm abnormal forms 
(head, tail, mid-piece, proximal and distal droplets) and temper-
ature of semen doses reception in laboratory were checked. All 
analyses were carried out by the same person. Data were pro-
cessed by StatView 5.0 software (1). Model of Multiple Regres-
sions was used to test the correlation between all parameters 
and ANOVA test was applied to confi rm diff erences of variances. 
Signifi cant diff erences were considered when p<0.05.
Results
All sperm parameters analyzed were acceptable and accord-
ing standard limits, excluding, sperm abnormal forms which 
expressed mean value of 32 ± 7, superior to standard limit 
value (30%). Regression coeffi  cients between parameters are 
illustrated in table 1. Motility showed a correlation (R= 0.4) with 
whole acrosoms and negative slight correlation with total sperm 
abnormal forms and with abnormal tails. A great logical correla-
tion was observed between sperm abnormal forms and abnor-
mal tail, proximal droplets and distal droplets. 
In what concern temperature of semen doses reception in the 
laboratory, ANOVA analyses showed increased values from June 
until September, and decreased values from December to Mars. 
In parallel, functionality of sperm membrane (Host) changed 
similarly and inversely (P<0.0001, fi gure 1). Correlation between 
both parameters was negatively signifi cant R = - 0.4 (Table 1). 
Discussion
In this study, we observed some correlations between diff erent 
sperm quality parameters. Motility demonstrated a correlation 
with intact acrosoms and negative correlation with total abnor-
mal forms and specifi cally with spermatozoa with abnormal tails 
which appear coherent with requirements for propulsion and 
movement of sperm. Furthermore, sperm abnormal forms were 
clearly correlated with abnormal tails and presence of proximal 
and distal droplets. This fi nding corroborate that any change or 
infl uence of total abnormal forms of sperm can be explained 
by these three classes of sperm morphoanomalies: abnormal 
tails, distal and proximal droplets. It’s of utmost importance the 
good checking of abnormal forms, because negative association 
between morphological anomalies and fertility was observed in 
several studies (2, 3). Other parameter which showed a signifi -
cant variation is the temperature reception of seminal doses. 
Some diff erences found in Host values could demonstrate the 
importance of minimize the temperature variation during sperm 
processing and transportation, even the temperature inside de 
boar stud, because a signifi cant fall in this paramether during 
hot months can take place. Any change in this area can aff ect 
functionality of sperm membrane and consequently the poten-
tial fertility of semen doses. 
Table 1. Regression coeffi  cients matrix between all parameters 
studied.
T M C A Ht AF H T MP PD
T˚ 1 -0.4
M 1 0.4 -0.2 -0.3
C 1 0.2 0.2
A 0.4 1
HT -0.4 0.2 0.2 0.2
AF -0.2 0.2 1 0.2 0.6 0.2 0.6 0.6
H 0.2 1 0.2
T -0.3 0.2 0.2 0.6 1
MP 0.2 0.2 1
PD 0.6 0.2 1
DD 0.2 0.6 1
T˚: temperature of semen doses reception, M: sperm motility, C: concentration, A: whole 
acrosoms, Ht: Host:
AF: total sperm abnormal forms, H: head, T: tail, MP: mid-piece, PD: proximal droplets, DD: distal 
droplets.
Figure 1. Mean values of Host and temperature (Tº) of semen doses 
reception among months. 
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Fertility and proliﬁ cacy of boar semen extended with Duragen® and BTS
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IntroductionThe productivity of the swine industry is highly 
dependent on artifi cial insemination and consequently on the 
production and transport of boar semen. Technologies of swine 
reproduction has developed semen extenders based manly on 
salts and sugars denominated short term extenders, long-term 
and extra long-term extenders. Many of the commercial extend-
ers have been investigated in vitro for their fertilizing potential 
using some sperm parameters like motility. 
Duragen® is an example of these extenders, and it’s the unique 
extender which can preserve sperm parameters for 2 weeks. It 
has been demonstrated that Duragen® maintains a high degree 
of sperm fertility for more than 12 days (1) and increase the 
farrowing rate also at 1 day of sperm extension. Some studies 
in vitro about quality of sperm motility in extended semen with 
Duragen® (data not shown) suggest a down-regulation of sperm 
motility at 24 hours, since it was observed that sperm exhibit 
value of average head orientation change (AOC) lower than 
5, being characterized as immotile. The aim of this study is to 
investigate the fertilizing potential of extra-long term extender 
Duragen® after 24 hours of semen extension.
Materials and Methods
The sperm rich fraction of ejaculates from fertile boars were col-
lected, evaluated and pooled. Seminal heterospermic doses of 3 
billion spermatozoa in 90 ml were prepared with Duragen® and 
BTS extenders, and stored at 17ºC before being used for artifi cial 
insemination at 24 hours. 4464 multiparous crossbred sows 
(Landrance x Large White) were randomly divided in tow groups. 
Group1: BTS N=2303 and Group2: Duragen®, N=2161. Cervical 
Insemination was performed at 0 and 24 hours after external 
estrus signs observation. 2303 inseminations were carried out 
with semen extended with BTS and 2161 with Duragen®. Far-
rowing rate (FR) and total born piglets were checked. Data were 
processed by StatView 5.0 software (2). ANOVA test and post hoc 
analyse were performed to confi rm diff erences in variances of 
FR. Signifi cant diff erences are considered when p<0.05.
Results
1996 sows inseminated with semen extended with BTS get to 
farrows, showing a fertility rate of 86,67%. In parallel to this data, 
1917 sows inseminated with semen extended with Duragen® 
a higher signifi cant fertility rate 88,7% (P= 0,03) Tabe 1. In what 
concern total number of piglets and mean of born piglets per 
sow, no diff erences was found between both groups Duragen® 
and BTS (P=0.13).
Table 1. Farrowing rate and mean of born piglets per sow obtained in 
Duragen® and BTS groups
Extender Total AI Farrowing rate N
Farrowing 
rate % Post hoc 
Piglets
/sow 11.3±2.5
Duragen® 2161 1917 88.67 P = 0.03 11.2±2.4 P=0.13
BTS 2303 1996 88.7 11.3±2.5
Discussion
Fertility rate of sows inseminated with semen extended for 24 
hours with BTS and Duragen® was higher in Duragen® group. 
This funding demonstrate that Duragen® can be used at 24 
hours as short-term extender, even it is developed for extra-long 
term conservation of boar sperm. In addition, this exhaustive 
study with 4464 sows, demonstrate strongly the functionality 
of Duragen® at 24 hours excluding any doubt about fertilizing 
potential of Duragen® at 24h even the observation on quality of 
sperm motility at 24h. 
References
1.  Gómez-Rincón et al., 2009. Proc. VIII Int. Conf. Pig reproduction. 
P.128
2.  StatView, SAS institute Inc. Version 5.0
Reproduction – Semen
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 1077
Poster Presentations
P.771
Boar semen cryopreservation: eﬀ ects of straws types, number of spermatozoa, insemination site 
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Introduction
The objectives of this study are to check 2 types of French straws 
for boar semen cryopreservation: medium or 0.5 ml versus 
fi ne or 0.25 ml; the number of straws per dose (10, 5, 4 or 3); 2 
insemination sites: intracervical versus intrauterine (corpus); 2 
insemination volumes (100 versus 50 ml) with intracervical in-
semination. The goal is to decrease the number of spermatozoa 
per insemination dose and to have good results on the fi eld.
Materials and Methods 
210 sows have been inseminated with frozen semen in 2 farms. 
24 ejaculates of 7 Pietrain boar have been frozen with own 
method (1, 2). Each 0.5 and 0.25 ml straws contained respect-
ively 0.72 x 109 and 0.32 x 109 spermatozoa. The 0.5ml straws 
were thawed by immersing in a hot water bath at 55°C during 
12 seconds and the 0.25 ml straws in a water bath at 38°C dur-
ing ± 60 seconds (no risks of overheat). After that, the contents 
were directly poured into BTS at 38°C. Semen was thawed just 
before the insemination. Double AI has been made 5 days post-
weaning during the standing refl ex. We have used a foam tip 
insemination catheter for intracervical insemination (IC) and the 
same catheter equipped with a fl exible tube for the post cervical 
insemination (IU). 2 parameters have been measured: pregnancy 
rate with an ultrasound scan between 23 - 42 days post AI and 
the litter size or total piglets born per litter. Three trials were 
successively performed. The fi rst tested the eff ect of straws types 
and number of spermatozoa per dose (from 3.6 to 1.0 x 109); 
the second and third trials tested these same alternatives and 
insemination sites (trial 2) or insemination volumes (trial 3) on 
sows’ pregnancy rates and litters size.
Results
With IC insemination and 100ml insemination volume, the 
pregnancy rate (92.9%; n=141) was not infl uenced by the straws 
types and the number of spermatozoa. However it has signifi -
cantly decreased when IU inseminations were performed (60.0; 
n=30 versus 91.7%; n=180; p<0.05) and particularly with 1 x 
109 spermatozoa or 3 fi ne straws (50.0%; n=10). There was no 
signifi cant diff erence between the 2 volumes when IC insemina-
tions were performed 92.9; n=141 versus 87.2%; n=39) whatever 
the straws type and the number of spermatozoa per dose. The 
litter size was signifi cantly higher when sows were intracervic-
ally inseminated using 3.2 x 109 (10 fi ne straws) versus 1.0 x 109 
spermatozoa (12.3 ± 0.6; n=20 versus 10.6 ± 0.5; n=31; p<0.05). 
In the same way, the litter size tended to decrease when IU 
rather than IC insemination was performed (11.5 ± 0.2; n=156 
versus 10.2 ± 0.7; n=16; p= 0.08). There was no signifi cant diff er-
ence between results obtained when using 100 ml insemination 
volume (11.5 ± 0.2; n=139) versus 50 (11.0 ± 0 5; n=33) when IC 
inseminations were performed, whatever the straws type and 
the number of spermatozoa.
Discussion 
With IC insemination, the pregnancy rate is always above 86.8% 
despite the spermatozoa number and straw type, lower litter 
size is with 1 x 109 spermatozoa / dose. The IC insemination is 
not infl uenced by the volume (100 or 50 ml). With IU insemina-
tion, pregnancy rate and litter size are lower than IC insemina-
tion. 
So, with frozen semen, we recommend intracervical insemina-
tion with a minimum 1.3 x 109 spermatozoa / dose or 4 fi ne 
straws / dose
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processes as post-thawing solution: its eﬀ ect on sperm motility
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Introduction
Cryopreservation process damage the sperm plasma membrane 
by a number of reason, e.g. cold-shock eff ect, osmotic stress and 
oxidative stress from reactive oxygen species (ROS) which result 
in a decrease of sperm motility, viability and fertilizing ability 
(Kaeoket et al., 2008). It is evidence that seminal plasma able to 
arrest or reverse cryoinjury and perhaps extend the longevity of 
the sperm by inhibiting or reversing capacitation and acrosome 
reaction, and also by its antioxidant activity (Vadnais and Rob-
erts, 2007). The aim of this study was to evaluate the eff ect of 
post-thawing dilution with autologous and heterologous sperm 
supernatant on motility of frozen-thawed boar spermatozoa. 
Materials and Methods
During the cryopreservation, sperm supernatant (a combina-
tion of seminal plasma and semen extender, 50% v/v) or seminal 
plasma from 9 boars (Duroc, Large White and Landrace; 3 in 
each) was collected by centrifugation and stored frozen until 
using as post-thawing solution. Sperm pellet were further 
processed and cryopreserved using control rate freezer and was 
thawed at 50ºC for 12 sec. After thawing, frozen thawed semen 
was diluted with seminal plasma (group A), supernatant from 
Landrace (group B), supernatant from Large White (group C), 
supernatant from Duroc (group D) and Modena®semen ex-
tender (group E). Post-thawing motility was evaluated using a 
phase contrast microscope after thawing at 1, 10, 20 and 30 min. 
The present results show that at 1 min, a signifi cantly higher per-
centage (P ≤ 0.001) of progressive motility was found in groups 
B (53.3%) and C (53.9%) than the other groups. At 10 min, the 
highest (P ≤ 0.001) progressive motility was found in groups B 
(65%) and C (61%). At 20 and 30 min, a signifi cantly higher per-
centage (P ≤ 0.001) of progressive motility was found in groups 
B (58.9%), C (53.5%) and D (45.6%) than groups A (3.9%) and E 
(20.6%). 
Discussion
It is clearly showed, in the present study, that using autologous 
or heterologous sperm supernatant from cryopreservation pro-
cess as post-thawing solution yielded a superior frozen-thawed 
boar sperm motility (as high as 70%). This is in accordance with 
the studies in dog (Rota et al., 2007) and boar (Okazaki et al., 
2009) in which seminal plasma and prostatic fl uid, respectively, 
were added in post-thawing solution.
Conclusion
It can be concluded that supernatant from freezing processes 
(consisting of seminal plasma and Modena®, 50% v/v) had bene-
fi cial eff ect on post-thawing progressive motility of frozen boar 
semen.
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Post cervical artiﬁ cial inseminastion use of small volumes and sperms number with cervical stimulation
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Introduction 
Since 2000 when Gil et al. (1) published the fi rst reproductive 
results obtained by using Post Cervical Artifi cial Insemination 
(PCAI), was proved that the number of sperms that guarantees 
similar reproductive results to those used in the standard AI is 
1.0 billion (2). Also it is possible to obtain excellent results using 
doses of 15 ml and half billion sperms, but is it necessary to 
increase the inseminated volume by infusing 15 ml of extender 
after the semen introduction(3).
In 2006 we improved the technique by adding the cervical 
stimulation (4). The results obtained confi rm that this manage-
ment improves litter size.
After semen introduction, cervical stimulation could help the 
preovulatory pulsatile LH release that lead to the ovulation pro-
cess (5) and advance the ovulation or perhaps promote passive 
sperm transport by enhancement of uterine contractions.
Is it possible to inseminate less than 30 ml and obtain good 
results when stimulate the uterus by cervical stimulation? This 
paper shows the results. 
Material and Methods 
The trial was carried out in a 1700 sows farm. In this farm PCAI 
was used in weaned sows in a habitual way. After standing 
oestrus control, sows were randomly allocated to three treat-
ment groups. In group Mono-phase 30 (MPh30), sows were 
inseminated with doses of 30 ml and 1.0 billion sperms. In group 
Bi-phase 30 (BPh30) sows were inseminated with doses of 18 ml 
and 0.6 billion sperms and 12 ml of extender added after the in-
fusion of the dose. In group Mono-phase 18 (MPh18) sows were 
inseminated only with doses of 18 ml and 0.6 billion sperms.
To apply the semen it was used a combined catheter-cannula 
kit (Soft & Quick, Import-vet, Spain). In all groups, the sows 
received a cervical massage. After the infusion of the dose in 
groups MPh30 and MPh18 or the dose and the extender in 
group BPh30, only the cannula was removed and then with the 
catheter, still placed in the cervix, shaking it in a rotational way, 
the neck of the womb was massaged during fi ve to ten seconds. 
Once the massage was fi nished the catheter was also removed.
Results 
Table 1 shows that there isn’t relationship between the treat-
ments with the fertility and prolifi city levels. Farrowing rate is 
very similar in all groups, 89.74%, 92.11% and 89.74% in MPh30, 
BPh30 and MPh18. The best litter size, 12.20 total born and 12.11 
born alive, takes place in the MPh18 group, being very similar,+ 
0.17 total born and + 0.25 born alive, in MPh30 group and being 
considerably better, + 0.51 total born and + 0.65 born alive, than 
the BPh30 group, 11.69 total born and 11.46 born alive. 
Table 2 shows the percentage of litters according to the number 
of total born. It attracts our attention the diff erence in percent-
age of short litters , 11.5 vs. 5.8 in BPh30 and MPh18 respectively. 
The smaller number of short litters in MPh18 group increases the 
percentage of large litters 28.6 % vs. 20.10 % in BPh30 group.
Table 1 Reproductive results. 
Group Sows nº Pregnant % F. Rate % Born alive Total born
MPh30 39 94.87 89.74 11.86 12.03
BPh30 38 92.11 92.11 11.46 11.69
MPh18 39 92.30 89.74 12.11 12.20
Table 2 Total born litter scatter % 
Group ≤ 8 9 10 11 12 13 ≥ 14
MPh30 8.6 8.6 17.1 8.6 17.1 11.4 28.7
BPh30 11.5 5.7 11.4 17.1 22.9 11.4 20.1
MPh18 5.8 8.6 11.4 8.6 14.3 22.9 28.6
Discussion
The reduction of the percentage of short litters leads up to 
improve the litter size in MPh18 group.
These results suggest us that isn’t necessary a large volume so 
the uterus can absorb the semen when it’s properly stimulated. 
Cervical stimulation seems to promote passive sperm transport 
and allow excellent reproductive results with small doses of 
semen.
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Introduction
Since 2000 when Gil et al. (1) published the fi rst reproductive 
results obtained by using Post Cervical Artifi cial Insemination 
(PCAI), was proved that the number of sperms that guarantees 
similar reproductive results to those used in the standard AI is 
1.0 billion (2). Also it is possible to obtain excellent results using 
doses of 15 ml and half billion sperms, but is it necessary to 
increase the inseminated volume by infusing 15 ml of extender 
after the semen introduction (3).
In 2006 we improved the technique by adding the cervical 
stimulation (4). The results obtained confi rm that this manage-
ment improves litter size.
After semen introduction, cervical stimulation could help the 
preovulatory pulsatile LH release that lead to the ovulation 
process (5) or perhaps promote passive sperm transport by 
enhancement of uterine contractions.
Is it possible to inseminate less than 30 ml and obtain good 
results when stimulate the uterus by cervical stimulation? 
Material and Methods 
The trial was carried out in a 760 sows farm. PCAI was used in 
gilts and weaned sows in a habitual way. The trial was con-
ducted in three consecutive periods. In the fi rst, from 09/02/09 
to 15/03/09, sows were inseminated with doses of 45 ml and 1.4 
billion sperms. In the second, from 16/03/09 to 19/04/09, sows 
were inseminated with doses of 20 ml and 0.6 billion sperms. 
In the third, from 20/04/09 to 21/05/09, sows were inseminated 
with doses of 30 ml and 0.9 billion sperms. In all groups the fi rst 
insemination was done half a day after heat detection. In the 
fi rst group sows were inseminated three times every half a day. 
In the other groups sows were inseminated four times every half 
a day.
To apply the semen it was used a combined catheter-cannula kit 
(Soft & Quick, Import-vet, Spain). In all groups, the sows received 
a cervical massage. After semen infusion only the cannula was 
removed and then with the catheter, still placed in the cervix, 
shaking it in a rotational way, the neck of the womb was mas-
saged during 5-10 seconds. Once the massage was fi nished the 
catheter was also removed.
Results 
Table 1 shows that the fertility level and the farrowing rate are 
very similar in all groups, 90.55%, 89.29 and 91.79% respect-
ively. However, there is a diff erence in litter size according to the 
treatment. The best litter size, 12.55 total born and 11.58 born 
alive, takes place in the 20ml group, followed by 45ml and 30ml 
groups with 12.02 and 11.78 total born and 11.20 and 10,98 
born alive respectively. 
Table 2 shows the litter size by parity. In 45ml and 20 ml groups 
litter size was very similar in each parity. In group 30ml litter size 
was also very similar to other groups from 3 to 6 parities but was 
considerably lowest in parities 1 and 2.
Table 1 Reproductive results. 
Group Sows nº Pregnant % F. Rate % Born alive Total born
45ml 201 92.57 90.55 11.20 12.02
20ml 196 91.83 89.29 11.58 12.55
30ml 195 93.33 91.79 10.98 11.78
Table 2 Total born by parity 
Parity 1 2 3 4 5 6 7
45ml 11.8 11.4 12.9 13.4 12.8 11.9 16.0
20ml 10.2 10.8 12.7 13.1 12.5 11.1 -
30ml 11.6 11.4 12.7 12.7 11.4 12.0 -
Discussion
Inadequate management of nulliparous and primiparous sows 
during the period of 30ml group may have been responsible for 
this drop in production in parities 1 and 2.
The 20ml group results, better than those obtained in group 
45ml, suggest us that isn’t necessary a large volume so the uter-
us can absorb the semen when it’s properly stimulated. Insemin-
ate with low number of sperm in a normal dilution ratio, without 
the need of increasing the total volume, greatly facilitates the 
success of PCAI with low number of sperms.
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Use of P.G. 600® in replacement gilts with unknown reproductive 
status: Ovarian, estrual and fertility responses
Robert V. Knox
University of Illinois, Urbana, IL, USA
Introduction
Eff ective methods to induce and synchronize estrus in replace-
ment gilts are essential for controlling costs related to size of the 
gilt pool, days from entry to service, and fertility. We performed 
two experiments to evaluate ovarian and estrual responses to 
use of P.G. 600® in gilts with known or unknown reproductive 
status. 
Materials and Methods
Experiment 1
PIC gilts (n=15) >6 mo. of age and ~140 kg but of unknown 
reproductive status, were treated with MATRIXTM for 14 days. Fol-
lowing last MATRIXTM feeding (LMF) gilts were checked for estrus 
and ovarian status determined using ultrasound . All gilts diag-
nosed with or without corpora lutea (CL) were treated with P.G. 
600® (d 0). Ultrasound was performed every other day for the 
next 6 days and estrous detection was performed for the next 22 
days. Reproductive tracts were assessed at day 25. Experiment 2 
This study was performed in replicates using 123 prepubertal 
PIC terminal-cross gilts. All gilts were given P.G. 600® for initial 
induction of estrus at 168 d of age and 114 kg. Estrous detection 
was performed daily. Ten days following P.G. 600®, gilts were 
synchronized using MATRIXTM. In replicates 1-3, gilts received no 
P.G. 600® following LMF, and in replicates 4-6, all gilts received 
an injection of P.G. 600® 24 h following LFM. Estrous detection 
began after LMF and transrectal ultrasound was initiated at 
estrus to observe follicles and time of ovulation. Numbers of fol-
licles >5.0 mm were counted and digitally recorded at estrus for 
confi rmation of follicle number. All estrus gilts were inseminated 
and reproductive tracts collected at d 35. 
Results
Experiment 1
For gilts displaying estrus following LMF, all (12/15) had CL on 
their ovaries at time of P.G. 600® (d 0). None of these gilts had 
large follicles at time of treatment (d 0) but 75% developed 
large follicles over the next 6 days. All gilts maintained their CL 
for the next 6 d. Two gilts had cysts on d 0, and 3 had cysts on 
days 2-4, but none had cysts by day 6. None of the gilts showed 
estrus within 6 days. The interval from P.G. 600® to estrus aver-
aged 12 days and cyclic gilts treated with P.G. 600® showed an 
inter-estrus interval that averaged 22 days. The two gilts that did 
not display estrus following LMF and did not have CL on their 
ovaries, developed large follicles, ovulated, and expressed estrus 
within 3 days of P.G. 600®. The one gilt that failed to show estrus 
following LMF, but that did have CL at time of P.G. 600® treat-
ment, developed large follicles, but did not display estrus until 
13 d after P.G. 600®. At the end of this study, 92% of all gilts had 
expressed estrus, and 100% were cyclic.Experiment 2
Initial induction with P.G. 600® was 66% with an interval to estrus 
of 100 h, and an estrous duration of 42 h. All gilts were treated 
with MATRIXTM regardless of whether they expressed estrus or 
not. In replicates 1-3, gilts received no treatment following LMF 
but in replicates 4-6, P.G. 600® was given at 24 h following LMF to 
improve estrous synchrony. Expression of estrus following LMF 
was >85% for all replicates. Use of P.G. 600® following LMF short-
ened the interval from LMF to estrus (P<0.0001) in replicates 4-6 
(130 h) compared to replicates 1-3 (148 h). P.G. 600® following 
LMF also shortened the duration of estrus (P<0.0005) in repli-
cates 4-6 (42 h) compared to replicates 1-3 (52 h). However, the 
interval from onset of estrus to ovulation was not infl uenced by 
P.G. 600® (P>0.20), and averaged 33 h in replicates 1-3, and 34 h 
in replicates 4-6. The number of large follicles (>5 mm) counted 
using ultrasound at estrus was highly correlated to the digital 
recording (r=0.90, 19 follicles), but was unrelated to the fi nal 
number of CL at slaughter (17). There was no eff ect of P.G. 600® 
following LMF on pregnancy at slaughter (74%). 
Discussion
The results suggest that P.G. 600® can be used in gilts of un-
known reproductive status which are cyclic or acyclic gilts to 
improve farm estrus expression and synchrony without detri-
mental eff ect on fertility. Also, use of P.G. 600® in a puberty in-
duction program and followed by MATRIXTM regardless of estrus 
induction results in estrus expression and synchrony in >85% of 
replacement females. 
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Single ﬁ xed-time insemination protocol in weaned sows: synchronizing 
ovulation with porcine luteinizing hormone
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Introduction
Optimal sow fertility is achieved when insemination occurs up 
to 24 hours before ovulation. In practice, multiple inseminations 
are necessary to ensure good sow fertility as estrus to ovulation 
interval is unpredictable and depends on the wean to estrus 
interval (WEI) and estrus duration (ED). 
The inability to predict the moment of ovulation causes in-
effi  ciencies in current artifi cial insemination (AI) technology. 
Multiple inseminations necessitate extensive labour demands 
and result in ineffi  cient use of semen – which directly limits the 
wider application of genetically superior boars. Variation in the 
timing of the pre-ovulatory luteinizing hormone (LH) surge rela-
tive to onset of estrus causes the variation in time of ovulation. 
Ovulation is synchronized in sows1 and gilts2 by administration 
of porcine LH (pLH; Lutropin, Bioniche Animal Health, Belleville, 
Ontario, Canada), and occurs 38± 2.8 h later1. Recently Zak et 
al.,3 showed that administration of Lutropin at onset of standing 
heat (SH) in the weaned sow, followed by a double fi xed time AI 
(FTAI) within the period of optimal sow fertility, resulted in more 
pigs born compared to a conventional AI protocol. The present 
study in the sow, compared eff ectiveness of combining Lutropin 
administration at fi rst detection of SH followed by a single FTAI 
to results from sows conventionally managed and inseminated 
until they were no longer in SH. 
Materials and Methods
Sows were randomly assigned to treatment at weaning. Twice-
daily boar exposure facilitated estrus detection (8AM and 2PM). 
As was usual farm practice, untreated control sows (CONT) were 
inseminated at least twice, based on WEI and ED. Treated sows 
(LUT) were administered 5 mg Lutropin IM concomitant with 
detection of SH. Sows in estrus in the morning or afternoon 
were inseminated once, 24 hours after Lutropin injection. Semen 
was <3 days old when used, and contained a minimum of 3*109 
live spermatozoa per 80-mL dose. Eff ect of treatment on WEI, 
number of inseminations, total pigs born and litter weight were 
analyzed using a linear mixed eff ect model. Proportions of sows 
that were bred and farrowed were analyzed using a chi-squared 
test. 
Results
Results are shown for sows having a WEI between 3 and 7 days. 
Lactation length ranged from 14 to 24 days. Quality for all in-
seminations was routinely excellent. 
Table 1. Reproductive traits for sows bred according to a conven-
tional insemination protocol (CONT) compared to sows administered 
Lutropin at onset of SH and inseminated once 24 hours later (LUT). 
Variable Treatment P-Value
CONT LUT Treatment
n 129 109 NA
WEI (d) 4.8 ± 0.07 4.7 ± 0.07 NS
Number of inseminations 2.07 ± 0.02 1.00 ± 0.02 < 0.001
Total pigs born 12.21 ± 0.28 12.23 ± 0.30 NS
Litter Weight (kg) 17.9 ± 0.40 18.2 ± 0.42 NS
Farrowing rate (%) 85.3 90.6 NS
Figure 1. Total number of pigs born per AI dose for sows bred multiple 
times (CONT) or once (LUT). ab diff er P <0.001
Discussion
The control of ovulation using Lutropin followed by a Single-
FTAI is a breeding technology that can be easily applied at the 
farm level. Single-FTAI saves on labour and semen usage. It 
is a tool that increases the number of females bred per boar, 
allowing wider application of the best boar genetics within a 
breeding pyramid. 
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Improving gilt utilization on commercial swine farms
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Introduction
Gilt management should be a major focus for commercial sow 
farms. Too often, gilts are neglected and their reproductive 
performance is poor, resulting in ineffi  ciencies. P.G. 600® is often 
incorrectly used to compensate for “poor gilt performance”, com-
pounding the poor performance and a vicious cycle ensues. This 
scenario results in lost confi dence in gilts and P.G. 600®. Proper 
gilt management is even more essential with start-ups, depop-
repops, breeding projects and parity segregated production. 
This paper describes implementation of gilt development and 
estrus induction with P.G. 600® to improve gilt utilization and 
performance in a parity segregated commercial gilt herd.
System overview
The farm was a 1,000-gilt one-site farrow-to-fi nish commercial 
unit. The farm internally multiplied all replacement animals. It 
was essential that gilt breeding remain predictable, consistent 
and effi  cient. This was not the case the fi rst year of breeding 
internal gilts, leading to poor gilt utilization, ineffi  cient use of 
employee time and poor reproductive performance.
Gilt development and selection
All matings were with maternal semen, thus all progeny were 
potential replacements. Every 3 weeks, 180, 22 to 24 week 
old gilts were selected from fi nishing, sized into three equal 
groups, assigned to a “synch” week and moved to an acclimation 
barn. The heaviest group was the fi rst to be induced, allowing 
additional grow time for smaller groups. Gilts remained on a de-
velopment diet until breeding. A key component to the program 
was the controlled lack of boar exposure to insure that gilts are 
pre-pubertal prior to entering the next phase.
Estrus induction and synchronization
Each Wednesday, a new “synch” group was moved from acclima-
tion into a “synchronization” barn. Pens of gilts (10-15) were 
taken to an Intense Boar Exposure area (IBE), based on the BEAR 
system.1 In each IBE, 2 boar crates were placed in the middle of 
the pens, allowing 360 degree gilt-boar exposure. Boar expos-
ure was given from entry to Friday (3 days) for 15-20 minutes. 
Each gilt was observed for signs of heat during this period and 
recorded. On Friday, all gilts received a 5ml dose of P.G. 600®. It 
has been shown that 2-3 days of boar exposure may improve 
the percentage of gilts responding to P.G. 600®.2 The group 
of gilts received casual boar exposure over the weekend. The 
following week, each pen of gilts would return daily to the IBE 
for 15-20 min. Daily heat scores were recorded for each gilt (0 = 
no response; 1 = slight interest; 2 = interest, swollen vulva, no 
locking stance; 3 = full locking heat). Gilts achieving a score of 
2 or 3 were identifi ed as Heat No Service (HNS) and remained in 
groups for 2 weeks before being moved to the breeding barn. 
Gilts scoring <2 were mixed and provided physical boar contact 
until in heat was identifi ed or culled.
Results
Key performance parameters were compared between 52-weeks 
of the old program and the new “synch” program (Table 1).
Table 1. Comparison of of gilt performance between programs.
Parameter Old Program “Synch” Program Dif
1st services/wk 49.1 55.8 +6.7
Services/wk 56.6 60.6 +4.0
Pct multi matings 70.3 94.4 +24.3%
Pos preg check 79.9 87.9 +8.0%
Gilts farrowed/wk 41.6 48.8 +7.2
Farrowing Rate 73.1 80.9 +7.8%
Total pigs/litter 11.9 12.5 +0.6
Born alive/litter 10.7 11.0 +0.3
Pigs weaned/wk 346.0 398.8 +52.8
Pigs wnd/female/yra 10.9 12.5 +1.6
Pigs wnd/gilt entered 4.8 6.1 +1.3
Gilts entered/wk 71.5 65.9 -5.6
Gilts transferred/wk 38.8 45.9 +7.1
Gilt retentionb 71.5% 80.5% +9.0%
aNote females are removed from farm after fi rst farrowing.
bGilt retention = (Gilts farrowed/Gilts entered)*100
Discussion
Under the “Synchronization” system, gilt fl ow, pig fl ow and 
downstream P1 supply was more predictable, consistent and 
effi  cient than the previous system. The reproductive improve-
ments seen were most likely due to several factors associated 
with the P.G. 600® induction program. Estrus was induced and 
synchronized in large numbers of gilts, allowing for more pre-
dictable time and number of matings per week. Heat detection 
and timing of insemination was more accurate with induced 
HNS. Under this program P.G. 600® was being utilized consistent 
with the label, in gilts with a known reproductive state and not 
being misused or wasted.
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Use of a new GnRH to control reproduction in gilts
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Introduction
In pig production units controlling reproduction is widely used 
to optimize farm work fl ow and fertility performance of animals. 
This leads to better hygiene, supervision, health and output 
capacity. A new GnRH has been discovered in the sea lamprey 
(l-GnRH-III, INN: Peforelin) with proven selectivity for FSH release 
from male pigs’ hypophysis (1). Peforelin was registered last year 
in Europe and in some other countries for the indications oestrus 
induction in gilts after cycle blockade and in sows after wean-
ing. This paper reports about some experiences with Peforelin in 
mature gilts following a cycle blockade.
Materials and Methods
This surveillance was conducted from August 2008 to May 2009 
in a 220 sows unit in Germany. In total 110 sexually mature, 
healthy gilts (Danish landrace x Yorkshire) were included. Each 
gilt received 20 mg of Altrenogest per day orally for a period of 
18 d and was then randomly allocated to either Group I (n = 52): 
48 h after last treatment 150 μg Peforelin (= 2 ml Maprelin®) i.m. 
or Group II (n = 58): no further hormonal treatment. Oestrus 
detection was performed starting d 3 after cycle blockade twice 
daily in the presence of a mature boar. Gilts were artifi cially 
inseminated up to 3 times in intervals of 12 h. Sonographic 
pregnancy detection was performed 4 wk after insemination. 
Oestrus rate (OR8d = on heat by d 8), last Altrenogest-to-oestrus-
interval (AO8d = on heat by d 8 and AOall = all gilts), oestrus 
duration (OD), pregnancy rate (PR = percentage of mated sows 
that have been sonographically detected pregnant), farrowing 
rate (FR = percentage of inseminated gilts that farrowed), total 
born piglets per litter (TBP) and piglets born alive per litter (PBA) 
were recorded.
Results
OR was higher and AO was lower in group I than in group II (p 
≤ 0.05; see table) and the distribution of fi rst inseminations was 
more concentrated in group I (see fi gure). Taking into account 
only those gilts displaying oestrus within 8 d after cycle block-
ade the AO8d was shortened by 0.45 d. AOall was shortened by 
1.88 d (p ≤ 0.05). There were no signifi cant diff erences in PR 
between the groups; however, there was a tendency for higher 
PR in group I. From all sows inseminated (AOall), 9 gilts of each 
group returned to oestrus, 3 had abortions in group I and 5 in 
group II (PCV and PRRS were diagnosed). From the gilts on heat 
by d 8, 38 litters were born in group I and 32 in group II. The FR 
did not diff er between the two groups and was at a low level. 
The litter size (TBP and PBA) was similar in both groups (p > 
0.05). 
Distribution of fi rst inseminations
Group I Group II
OR8d* 96.2 %
a 81.0 %b
AO8d (mean ± SD)* 4.78 ± 0.95
b 5.23 ± 0.96a
AOall (mean ± SD) 5.19 ± 2.62
b 7.07 ± 4.87a
OD (mean ± SD)* 2.30 ± 0.61 2.30 ± 0.53
PR* 88.0 % 83.0 %
FR* 76.0 % 68.1 %
TBP (mean ± SD)* 14.11 ± 3.95 13.81 ± 2.35
PBA (mean ± SD)* 13.03 ± 3.61 12.22 ± 3.55
* gilts on heat by d 8 
a, b: Means between groups diff er signifi cantly (p ≤ 0.05)
Discussion
In comparison to untreated animals after the inhibition of cycle 
the Maprelin®-treatment yielded a signifi cantly higher oestrus 
rate, a signifi cant reduction of last Altrenogest-treatment-to-
oestrus-interval and thus an induction of oestrus with a clear 
concentration of insemination times. These results confi rm 
previous results (2, 3). In the following period a suitable vaccina-
tion programme was established that yielded in a considerably 
decreased number of returns and abortions.
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Introduction
Primiparous sows (fi rst litter sows) represent an age group of 
animals with special needs. Particularly in the summer time they 
may show a depression in fertility performance. Thus, especially 
in large sow herds, this group is often treated with pharmaceut-
icals to control reproduction. For oestrus induction a new GnRH 
is available. The substance originates from the sea lamprey 
(l-GnRH-III, INN: Peforelin) and has proven selectivity for FSH 
release from male pigs’ hypophysis (1). Peforelin is registered in 
Europe and in some other countries for inducing oestrus in gilts 
after a cycle blockade and in sows after weaning off  the piglets. 
This paper reports about practical experiences from primiparous 
sows and shows an example of a large farm.
Materials and Methods
The herd consists of sows of Danish genetics and is managed in 
a weekly-batch-farrowing system with 3 wk of lactation (wean-
ing: Thursday, 10.30 h). The farm managers used to apply equine 
chorion gonadotropin (eCG) for inducing oestrus in the weaned 
sows and started using the new Peforelin for this indication in 
January 2009. Thus, here a comparison of two production per-
iods is presented. The data of a total of 3498 primiparous sows 
are included.
Group I: From January to July 2008 the sows received 24 h after 
weaning 1000 IU eCG (Pregmagon®) i.m. (n = 2062). 
Group II: From January to July 2009 the sows received 24 h after 
weaning 37.5 μg Peforelin (= 0.5 ml Maprelin®) i.m. (n = 1436). 
The following parameters were recorded: Oestrus rate (OR = pro-
portion of sows with standing refl ex on Tuesday or Wednesday 
after weaning), farrowing rate (FR = percentage of inseminated 
sows that farrowed), total born piglets per litter (TBP), piglets 
born alive per litter (PBA) and piglet index (PITBP = TBP/100 in-
seminated sows; PIPBA = PBA/100 inseminated sows). The results 
were compared between the groups and in addition between 2 
seasons (A = insemination January to mid May, B = insemination 
mid May to July).
Results
In group II OR was signifi cantly higher than in group I. The far-
rowing parameters including litter sizes were similar in both 
groups.
Group I Group II
Treatment eCG Peforelin
Sows mated 2062 1436
OR 80.5 %b 87.0 %a
FR 88.3 % 89.6 %
TBP (mean) 13.79 14.62
PBA (mean) 12.89 13.43
PITBP 1218 1310
PIPBA 1138 1203
a, b: Means between groups diff er signifi cantly (p < 0.05)
In the comparison between seasons both groups had better 
results for OR in the cold compared to the warmer, while the far-
rowing parameters including litter sizes did not diff er between 
seasons. There was a tendency for better results for group I in 
the cold season and for group II in the warmer season.
Group I Group II
Treatment eCG Peforelin
Season A B A B
Sows mated 1291 771 901 535
OR 85.8 %b 71.6 %c 89.9 %a 82.2 %b
FR 88.5 % 88.1 % 88.8 % 91.0 %
TBP (mean) 13.85 13.68 14.47 14.86
PBA (mean) 12.95 12.78 13.27 13.70
PITBP 1225 1205 1284 1353
PIPBA 1146 1125 1178 1247
a, b, c: Means between groups diff er signifi cantly (p < 0.05)
Discussion
The results show at least equal effi  cacy of Peforelin in com-
parison to eCG and are in line with previous results yielded in 
Peforelin treated animals (2). In addition, Peforelin seems to 
be highly potent to overcome a possible depression of fertility 
performance in the warmer season.
Of course, the comparison of two years is limited for a scientifi c 
evaluation, because, e. g., climate and feeding conditions may 
vary between years. But it is a comparison of practice and should 
be allowed, because a producing company will always make 
comparisons between two years of production in order to assess 
its progress.
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Introduction
Controlling reproduction is crucial for economic success espe-
cially in large sow herds. Application of management tools like 
optimized feeding, batch farrowing, light regimes etc. alone 
are not in every case suffi  cient to meet the high performance 
expectations of farmers. Thus, pharmaceuticals to control 
reproduction are widely used to increase fertility performance 
of animals and to optimize economics. Today, a new GnRH is 
available for inducing oestrus in gilts after a cycle blockade 
and in sows after weaning off  the piglets. The substance was 
discovered in the sea lamprey (l-GnRH-III, INN: Peforelin) and has 
proven selectivity for FSH release from male pigs’ hypophysis (1). 
Peforelin is registered in Europe and in some other countries. 
This paper reports about practical experiences from pluriparous 
sows on a large farm.
Materials and Methods
The herd consists of sows of Danish genetics and is managed in 
a weekly-batch-farrowing system with 3 wk of lactation (wean-
ing: Thursday, 10.30 h). The farm managers used to apply equine 
chorion gonadotropin (eCG) for inducing oestrus in the weaned 
sows and started using the new Peforelin for this indication in 
January 2009. Thus, here a comparison of two production per-
iods is presented. The data of a total of 11852 pluriparous sows 
(more than 1 litter born) are included.
Group I: From January to July 2008 the sows received 24 h after 
weaning 800 IU eCG (Pregmagon®) i.m. (n = 6430).
Group II: From January to July 2009 the sows received 24 h after 
weaning 150 μg Peforelin (= 2 ml Maprelin®) i.m. (n = 5422).
Sonographic pregnancy detection was performed 4 wk after 
insemination. The following parameters were recorded: Number 
of sows showing standing refl ex on Tuesday or Wednesday after 
weaning (SR), Oestrus rate (OR = percentage of sows show-
ing standing refl ex on Tuesday or Wednesday after weaning), 
Pregnancy rate (PR = percentage of inseminated sows that have 
been sonographically detected pregnant), number of litters 
born, farrowing rate (FR = percentage of inseminated sows that 
farrowed), total born piglets per litter (TBP), piglets born alive 
per litter (PBA) and piglet index (PITBP = TBP/100 inseminated 
sows; PIPBA = PBA/100 inseminated sows).
Results
OR and PR were signifi cantly higher in group II than in group I. 
The farrowing parameters including litter sizes were similar in 
both groups.
Group I Group II
Treatment eCG Peforelin
Sows mated 6430 5422
SR 5837 4983
OR 90.8 %b 91.9 %a
Sows pregnant 5999 5147
PR 93.3 %b 94.9 %a
Litters born 5768 4883
FR 89.7 % 90.1 %
TBP (mean) 14.44 14.89
PBA (mean) 12.94 13.17
PITBP 1295 1341
PIPBA 1161 1186
a, b: Means between groups diff er signifi cantly (p < 0.05)
Discussion
The results show at least equal effi  cacy of Peforelin in com-
parison to eCG and are in line with previous results yielded in 
Peforelin treated animals (2).
Of course, the comparison of two years is limited for a scientifi c 
evaluation, because, e. g., climate and feeding conditions may 
vary between years. But it is a comparison of practice and should 
be allowed, because a producing company will always make 
comparisons between two years of production in order to assess 
its progress.
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Introduction
At the moment the discussion strikes large waves around the 
fertility rate of diff erent breeds. But, the goal must be to use 
the achievement potential of each existing genetic optimally. 
So, a method (AI monitoring) was developed to examine and 
improve the success of the artifi cial insemination. 
Material and methodsThe AI monitoring represents a control of 
the insemination times by the evaluation of the rate of farrow-
ing sows (based on the number of inseminated sows), litter size 
total and alive born piglets and piglet index in sows inseminated 
at certain times (HOY 2007). The precondition for a meaningful 
application of the AI monitoring is an accurate execution and 
documentation of the result of heat detection (standing: yes or 
no). The heat controls should begin at the third day after wean-
ing. When weaning is accomplished on Thursday morning the 
heat detection has to begin on Sunday afternoon or evening! 
The determination of the duration of heat is the crucial condi-
tion to estimate (afterwards) whether the insemination took 
place in the biologically optimal period (16 h before to 4 h after 
the ovulation). AI monitoring was tested in 8 farms with approxi-
mately 3000 inseminations. It is to be recognized that actually 
in each farm specifi c conditions are prevailed. All data provided 
by the farms were registered into an Excel table and statistically 
analysed. The AI data were divided in categories: too early, opti-
mally, too late. Beyond that we computed three goal sizes: 
-  percentage of sows with farrowing (based on all sows in-
seminated), 
-  litter size total and alive born piglets and
-  piglet index for the sows with diff erent time of AI (too early, 
optimally, too late – at least related to the fi rst AI). 
Results
Exemplarily the results of a farm are presented, which provides a 
very good documentation. A total of 829 inseminations of sows 
and 195 of gilts were evaluated. It could be shown that sows 
inseminated within the optimal time window (for AI 1) yielded 
the best fertility – both related to the farrowing rate (89.4 %) 
and to the litter size (11 3) thus leading to the highest piglet 
index (1006). A comparatively small diff erence of approximately 
3 percent in the farrowing rate led together with a lower litter 
size (around 0.83 piglets) to a diff erence of more than 100 alive 
born piglets per 100 inseminated sows (comparison: too early 
and at the optimal time inseminated sows). At this farm despite 
altogether very good achievements in the analysis period al-
most a fi fth of the sows was nevertheless inseminated too early 
- with appropriate eff ects on the fertility rate. The frequency of 
AI which was too late was low, led however also to clearly worse 
achievements (farrowing rate = 66.7 %, piglet index = 760)(p < 
0.05). 
A further evaluation was concentrated on the number of 
inseminations because about 12% of the sows (n = 97) was 
inseminated three times. Sows, which were inseminated twice, 
obtained the best achievement. With three inseminations the 
farrowing rate, litter size and therefore also the piglet index were 
lower than with two AI. However, this must not be the case in 
each farm. 
The fi rst evaluations at 195 AI in gilts showed, that gilts insemin-
ated three times had clearly worse performance data (farrowing 
rate = 70.9 %, piglet index = 749) than gilts inseminated twice 
(farrowing rate = 76.5 %, piglet index = 832). Here, further inves-
tigations must be done to analyse the cause. 
Discussion
Clear diff erences between the farms occurred in the insemina-
tion management (times, quality and documentation of heat 
detection; times and number of AI). The heat control (standing 
refl ex) (including also the registration of a possible standing 
after the last insemination as the precondition for the calcula-
tion of the duration of heat) is (more or less) in need of improve-
ment at the farms but at the same time a compelling require-
ment for the AI monitoring. The determination of farrowing rate, 
litter size and piglet index related to the onset and duration of 
heat and to the insemination date (in particular AI 1) allows clear 
statements for the optimization of the AI. 
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Introduction
The eff ect of a progestagen (Regumate®) induced prolonga-
tion of the lactation anoestrus to reproductive parameters 
in the subsequent parity was evaluated. The objective of the 
monitoring was to fi nd out whether Regumate® is indicated for 
the synchronisation of sow groups in a protocol to change the 
production rhythm and to analyse the eff ect of the blockade on 
the fertility performance in the subsequent parity considering 
the lengths of lactation.
Material and methods
In a 800 sow farm the change from a 1-week-group-manage-
ment-system to a 2-week-group-management-system was 
monitored. The total of 20 groups was reduced to a total of 
10 groups. This was realized by blocking the fi rst oestrus after 
weaning in every second group with a progestagen (Regumate® 
- Altrenogest) given up to one day before weaning the consecu-
tive group. The application started 24 h before weaning. The 
dosage was 20 mg Altrenogest per day (= 5 ml Regumate®/day) 
applicated 8 times. All sows of the new established group were 
artifi cially inseminated in their fi rst standing heat. Data records 
of 9 groups including 517 sows in the fi nal 2-week-system were 
analysed. As a benchmark fertility records out of an insemina-
tion monitoring programme conducted over 2 previous years in 
that farm including 659 sows with lengths of lactation between 
19 and 23 days were used. Statistical analyses were obtained 
by using the SPSS 15.0 statistical programme. The diff erences 
between the groups concerning litter size were tested by the 
multiple t-test. Diff erences in farrowing rates were tested by 
the Pearson’s chi-square test. The analysis of variance (ANOVA) 
was used to test the parameter litter size total born piglets 
under consideration of Regumate® treatment (yes/no), parity 
and length of lactation as independent factors to evaluate also 
interfering eff ects.
Results
Regumate® treated animals reached a signifi cantly higher far-
rowing rate (+8.5 %, p < 0.05) and an increased litter size (+ 0.65 
total born piglets, p < 0.052) compared with non-treated sows. 
The diff erence in piglet index was +157 in favour of the treated 
sows. The litter size of progestagen treated primiparous sows 
was signifi cantly higher in comparison to non-treated primip-
arous sows (+ 2.02 total born piglets, p < 0.07). The farrowing 
rate of the treated primiparous sows was increased by 12.8 % in 
contrast to the untreated primiparous sows (p > 0.05). Referring 
to the piglet index with Regumate® treated primiparous sows 
generated 300 total born piglets more per 100 fi rst insemina-
tions in contrast to the not synchronized animals. In the group 
with very short length of lactation (< 21 days) treated sows real-
ized a 12.8 % higher farrowing rate compared to the not treated 
sows. Treated sows with more than 21 days length of lactation 
performed 3.7 % more in the farrowing rate in relation to the not 
treated animals (p > 0.05). Pharmacologically synchronized sows 
generated 193 total born piglets more per 100 inseminations 
after a lactation length of 13-20 days than not-estrus-blocked 
sows. No diff erences in estrus behaviour or weaning-service 
interval between the treated and untreated group were found. 
Discussion
he conclusion is that Regumate® is indicated for the cycle 
synchronisation of sows in a protocol in order to change the pro-
duction rhythm. The prolongation of the lactational anoestrus 
by applicating Regumate® can also be recommended to ensure 
fertility performance after a previous very short length of lacta-
tion especially in primiparous sows. This study confi rms that 
a prolongation of the lactation anoestrus can be induced by 
starting the Altrenogest application one day before weaning. 
This result is in accordance with the results of other authors. It 
has to be respected that Regumate® is not registered for that 
indication. Local or national guidelines must be considered by 
veterinarians and by farmers.
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Introduction and objectives
Suboptimal reproduction results in modern pig herds are not 
only disease related. Many diff erent non-infectious factors such 
as length of lactation, body condition, season, and weaning 
management practices have an infl uence on the fertility of sows 
(1). The purpose of this epidemiological study was to investigate 
how weaning management infl uences diff erent reproduction 
parameters in commercial pig herds in Belgium.
Materials and Methods
In August 2009, a questionnaire was sent by conventional mail 
to 150 randomly selected pig herds in Flanders, Belgium, with 
exclusion of farms smaller than 80 sows. After one and a half 
months, all farms were contacted by phone and asked whether 
they were willing to cooperate. All cooperating farms were then 
visited individually by the same interviewer, starting in October 
2009. This paper shows the data gathered until January 2010. 
The questionnaire contained a variety of questions, related to 
gilt management, batch management system, weaning prac-
tices, heat stimulation and detection, insemination, farrowing, 
housing, climate, feeding, hygiene, vaccinations and fertility 
parameters. Each visit lasted approximately one hour.
Results
Table 1 shows the descriptive results of important parameters of 
30 herds located in three provinces in Flanders. These provinces 
represent 94% of the Belgian pig production. Of the 30 herds, 
37% were farrow-to-fi nish farms. An equal number of farms 
purchased gilts or selected their own gilts. Farm size distribu-
tion was as follows: 10% less than 150 sows, 63% between 150 
and 300 sows and 27% more than 300 sows. The majority (57%) 
of the farms used a batch management system, mainly 3 and 4 
week systems.
Table 2 shows the mean, standard deviation and range (min-
imum, maximum) of the major fertility parameters. 
Discussion and conclusion
As these are preliminary results on a limited number of farms, 
correlations are not yet clearly visible. By mid 2010, the study 
will be fi nalized and the fi nal results and a risk factor analysis will 
be presented.
Table 1: Descriptive results of 30 herds
Parameters %
Weaning < 21 days 7
21-24 days 43
25-28 days 50
Number of teaser boars per 20 sows < 1 23
1 40
2 23
> 2 13
Heat stimulation starting from the day of weaning 23
day 1 after weaning 50
> day 1 after weaning 27
Heat stimulation < 2x/day 43
2x/day 53
> 2x/day 3
First heat detection < day 4 after weaning 13
day 4 after weaning 70
> day 4 after weaning 17
Heat detection < 2x/day 17
2x/day 83
Light at sow-height in insemination unit
 > 150 lux 50
Feed weaned sows pregnancy feed 57
lactation feed 33
other 10
Table 2: Major reproduction parameters of 30 herds 
Mean Standard deviation Minimum Maximum
Weaned piglets/sow/year 25.82 2.78 21.32 31.44
Weaning-to-oestrus interval 6.18 1.19 4.64 9.27
Litters/100 inseminations 82.6 4.39 75.1 90.8
Pregnancy rate after 1st insemination 91.78 5.95 71.9 97.6
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Introduction
Weaning to estrus interval is a major measure of reproduct-
ive effi  ciency in a breeding herd. Failure to return, or delay in 
returning to estrus, after weaning increases the number of 
non-productive days, resulting in economic losses. Many studies 
have shown that the use of PG600® (400 IU of PMSG and 200 IU 
of hCG) at weaning increases the number of sows returning to 
fertile estrus and shortens the estrus to weaning interval (1). 
In Spain, there are other commercial products with the same 
composition and indication as PG600®. Previous data have 
shown that products with the same composition do not always 
perform as well as each other (2). The aim of this study was to 
compare the effi  cacy of PG600® in terms of the rate of return 
to estrus with two other commercial products with the same 
composition and indication. 
Materials and Methods
The trial was undertaken in July, August, September and Octo-
ber in two breeding herds of 750 and 3500 sows, in the north-
east of Spain. Due to the high summer temperatures in this 
area, these farms had a history of extended weaning to estrus 
intervals during these months. In an attempt to address this, all 
sows were routinely treated at weaning with PG600® during the 
summer months.
A total of 1910 multiparous sows were included in the trial over 
the period. Every week, sows were divided into three study 
groups, equalized for parity, in total numbers as follows:
• PG600 Group: 856 sows treated with PG600.
• Group A: 728 sows treated with product A (400 IU of PMSG 
and 200 IU of hCG)
• Group B: 326 sows treated with product B (400 IU of PMSG 
and 200 IU of hCG)
All products were administered on the day of weaning.
The number of sows in estrus in the 10 days following treatment 
was recorded, as well as the number of induced estrus which 
proved fertile and the number of piglets born at the farrowing 
following the induced estrus. 
The data obtained were subjected to statistical analysis using 
the Fisher’s exact test.
Results
Sows treated with PG600® at weaning came into estrus in statis-
tically signifi cantly greater numbers than the sows treated with 
either of the other two commercial gonadotropins (p<0.001) 
(Table 1).
Table 1. Reproductive data after treatments
PG600® Product A Product B
Nº sows 856 728 326
Nº sows in estrus 788 589 273
% estrus 92.05a 80.90b 83.74b
Nº sows pregnant 662 466 221
% fertility 84.01a 79.11b 80.95a
Total Born 11.02 10.76 10.84
a, b: values with diff erent superscripts in the same row represent statistically signifi cant 
diff erences (p<0.001)
Sows treated with PG600® also exhibited signifi cantly better 
fertility rates than those treated with product A (p<0.001), and 
better than those treated with product B, though the latter dif-
ference was not statistically signifi cant (p=0.26). 
Discussion
The results obtained in this trial are evidence that PG600® ad-
ministered at weaning is the most eff ective treatment to induce 
estrus in multiparous sows in herds with increased weaning 
to estrus intervals due to high temperatures. Estrus induced 
by PG600® are also more fertile than those induced by the two 
other tested products with the same composition, with con-
sequent improvements in the economic performance of the 
herd. PG600® is thus the best choice when induction of estrus is 
required in these circumstances.
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Introduction
Semen quality deteriorates during storage which can result in 
poorer sow fertility to artifi cial insemination (AI). To counter this, 
the usual recommendation is that semen should not be used be-
yond 48-72 hours from collection. This has a negative economic 
eff ect since it may result in the discarding of semen doses. When 
using aged semen, fertility aff ects can be reduced by inseminat-
ing am/pm, which increases costs from semen and labor but 
also implies that the semen doses do have viable sperm but pre-
sumably fewer of them. We hypothesized that the application of 
technologies that allow for AI of fewer sperm, such as intrauter-
ine insemination (1), will permit the maintenance of fertility with 
once daily AI of aged sperm. The aim of this present study was to 
test this hypothesis.
Material and methods
In 3 replicates, sows were induced into estrus by PG600 to 
remove confounding eff ects of WEI and sows estrous on days 
4 or 5 after weaning were assigned by parity to cervical AI on 
consecutive days with 1 and 2 or 2 and 3-d old semen (Con-
trol, n=29), or cervical AI with 4 and 5 or 5 and 6-d old semen 
(group1; n=30) or intrauterine (Deep Golden Pig; IMV) AI with 
4 and 5 or 5 and 6-d old semen (group2; n=29). Semen was 
extended in BTS and semen quality was assessed for days 2 to 6 
after collection. Sow performance was compared on the basis of 
pregnancy rate and subsequent litter size (at writing only 2 repli-
cates farrowed) using Fisher’s exact test and ANOVA in SAS 9.1.
Results
On days 2,3,4,5, and 6, percent sperm motility was 83,73,63,63 
and 60%; percent live sperm was 94,83,77,74, and 72% and 
percent normal sperm was 93,93,84,84, and 83%, respectively. 
Compared to the Control group, pregnancy rate of sows receiv-
ing a cervical AI of aged semen was lower (P=0.05). However, 
sows receiving an intrauterine AI with aged semen maintained 
their pregnancy rate (Fig. 1). Based on limited farrowings, litter 
size was lower (P=0.06) for sows receiving aged semen (11.4±0.6, 
8.7±1.0 and 8.6±0.8 for control and groups 1 and 2, respectively).
Fig.1 Pregnancy rate of the sows in each group
Discussions
The results of the present study confi rm that measures of sperm 
quality are lower by 2 or 3 days after collection and further 
declined to reach lowest quality by 4 days when extended in 
a short-term extender such as BTS. As noted by others (2) this 
age-associated eff ect on sperm quality was further evidenced 
by depressions in sow fertility when the sperm were deposited 
conventionally (ie. intra-cervical) and sperm was 4 days from 
collection. One explanation for this eff ect is that as the sperm 
age there is a growing proportion of sperm that are less able 
to support a normal fertilization, possibly because of age-
associated DNA damage such as may result from inadequate 
anti-oxidant capacity (Am-in et al. unpublished data). That viable 
sperm were still available in 4 and 5-day old semen is supported 
by the normal pregnancy rates when aged sperm were insemin-
ated intrauterine. We suggest that this is similar to the eff ect 
documented previously (1) whereby conventional insemination 
of fewer sperm resulted in poorer performance, which eff ect was 
prevented by intrauterine insemination. Interestingly, based on 
incomplete data collected to date, litter size was reduced in both 
aged semen groups. The etiology of the diff erential eff ects on 
pregnancy and litter size are not known.
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Introduction
Greater energy intake during late gestation have been linked to 
lower feed intake during lactation1, which in turn can lead to 
lower gonadotropin secretion2 and an unsatisfactory reproduct-
ive outcome. The aim of the study was to investigate the eff ects 
of gestational energy intake and exogenous gonadotropins at 
weaning on primiparous sow’s reproductive performance.
Materials and Methods
Twenty three out of thirty hybrid gilts, with 75 days of gestation, 
were fed according to 2 treatments until farrowing: (P, n=12) 
2,9kg of a pre-lactation diet (3203 kcalME/kg, 17,25%CP), and 
(G, n=11) 2,5kg of a gestation diet (2930 kcalEM/kg, 16,43%CP). 
At weaning, animals were split into 2 other groups: (H; n=12) 
administration of 600IU of eCG and, after 72 hours, 2,5mg of LH, 
and (C; n=10) control group, without hormonal protocol. Ani-
mals were weighed at the beginning of the trial, before and after 
parturition and at weaning (23,7±2,2 days after farrowing) and 
were fed to appetite during lactation. Pos-weaning estrus was 
determined by standing refl exes in the presence of adult boar, 
following artifi cial insemination. After 4,56±0,92 days, sows were 
slaughtered and had their reproductive tracts collected. Ovula-
tion rate was established and embryos were recovered and 
stained with Hoechst 33342 and propidium iodide for evalua-
tion of viable embryo cells through epifl uorescence microscopy. 
Experimental design was entirely casualized in a 2x2 factorial 
arrangement, analyzed with the PROC GLM of SAS5 
Results
Gilts fed the gestation diet (G) weighed 186,4±9,6 and 
220,1±13,7 kg at the beginning of the trial and at farrowing 
whereas treatment P gilts weighed 183,8 ± 7,1 and 229,1±10,2 
in the same periods (p>0,05). Daily weight gains during late 
gestation were 0,915±0,159 and 1,23±0,158 kg/day for G and 
P, respectively (p<0,001). Post farrowing and weaning weights 
were, respectively, 194,1±10,4 and 197±15,2 for treatment G 
and 199,7±8,8 and 195,3±12,2 for P (p>0,05). Mean lactational 
weight change was -4,7±-12,2kg for G and -5,3±-9,3 for P. Post 
weaning performance and embryo evaluation is presented in 
Table 1. The results indicated an interaction between factors for 
the percentage of fecundated structures, with values of 98, 55%, 
78, 97%, 96, 88 and 99, 09 for GC, GH, PC and PH, respectively
Discussion
The level of energy intake did not interfere on lactation weight 
losses, although researches have shown diff erent results1,2. 
Unlike other reports3,4, hormonal treatment did not infl uence 
WEI or enhance the ovulation rate. The literature4 mentions that 
an increase in the serum gonadotropins levels due to eCG and 
LH administration, could have led to the ovulation of immature 
follicles, resulting in oocytes and, hence, embryos of lower qual-
ity. At the same time, the higher weight at farrowing could have 
provided suffi  cient body reserves for the sows to cope with the 
metabolic demands of lactation, resulting in a lower impact of 
the hormonal protocol on the reproductive outcome signaled 
by the percentage of fertilized structures. Similar fi ndings were 
reported previously4 when using the same hormonal protocol 
combined with fl ushing in gilts. In conclusion, the condition 
associating body reserves at weaning and hormonal pattern in 
primarous sows can aff ect embryo viability. Further information 
is needed regarding the mechanism involved.
Table 1. Post-weaning performance and embryo quality for treat-
ments GC, GH, PC and PH
GC GH PC PH CV (%)
n 1 3 6 4 5
WEI (days) 1 4.3 4.3 4.3 4.2 10.8
Ovulation Rate 1 24.0 18.2 20.8 19.8 29.6
Number of Structures 1 22.7 15.7 15.8 14.8 41.6
Fertilized Structures (%) 2 98.6 79.0 96.9 99.1 19.3
Total Embryo Cells 1 29.1 14.7 17.8 21.7 143.7
Total Live Cells (%) 1 81.0 97.8 94.5 96.5 146.0
1- p>0,5;2- p<0,05 for interaction between factors
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Introduction
During oestrus, the expression of the oestrus symptoms is very 
important for the heat detection and timing of insemination. 
Oestrus symptoms are induced by the estrogens from the grow-
ing follicles. They prepare the sows for mating. During follicle 
growth, the oestrus production in the follicles increases and will 
eventually cause a luteinizing hormone (LH) peak that leads to 
ovulation. Follicular growth is regulated by the hypothalamus. 
Gonadorelin releasing hormones (GnRH) induce the release of 
follicle stimulating hormone (FSH) and LH from the pituitary. 
These hormones are responsible for the recruitment, selection 
and growth of the follicles. Peforelin (Maprelin®) is a synthetic 
GnRH that specifi cally induces the release of FSH is pigs (1). The 
product is used for the induction of oestrus (2). The aim of this 
study was to measure the eff ect on the timing and intensity of 
the heat symptoms in a high productive farm.
Materials and Methods
In a 2400 sows farm, 224 sows and 224 gilts were included in 
the study. All gilts were synchronized with a daily dose of 20 mg 
altrenogest (Regumate®) during 18 days directly in the mouth. 
The last dose of altrenogest was given the day before weaning 
of the sows. 48 hours after the last altrenogest dose, 112 ran-
domly chosen gilts were injected intramuscular with 150 μg of 
peforelin (2 ml Maprelin®) and 112 randomly chosen sows were 
injected with peforelin 24 hours after weaning. Primiparous 
sows received 37.5μg peforelin (0.5 ml Maprelin®) and multipar-
ous sows received 150 μg of peforelin (2 ml Maprelin®). From 
day 3 after weaning, twice daily oestrus control was carried out. 
A score from 1 to 5 was given: 1 no heat, 2 fi rst heat symptoms, 
3 pre-oestrus, 4 oestrus but not yet perfect and 5 for perfect 
oestrus. The weaning to oestrus interval (WOI) and the weaning 
to insemination interval (WII) was recorded. At the moment of 
submission of this abstracts, only partial pregnancy information 
testing and no farrowing data were available yet. The Wilcoxon 
Mann-Whitney U test between groups was performed in SAS® 
(version 9.1).
Results
The numbers of gilts coming in heat within 7 days after last 
altrenogest dose was 95.5% for the peforelin treated group 
versus 92.0% for the non-treated group. In multiparous sows, 
96.4% of both groups came on heat within 6 days after weaning. 
The pregnancy rate was slightly better for the peforelin treated 
group, both for the gilts (85.7% vs. 84.0%) and sows (92.4% vs. 
91.0%). The WOI and WII of sows and gilts coming in heat within 
the set range are shown in table 1.
Table 1: Impact peforelin treatment on WOI and WII
Number of sows WOI (days) WII (days)
Non-treated sows 108 4.41a 4.86c
Peforelin treated sows 108 4.15b 4.63d
Non-treated gilts 103 4.92 5.03
Peforelin treated gilts 107 5.03 5.16
ab:statistical diff erence p < 0.0148 
(based on ranked values)
cd: statistical diff erence p < 0.0135 
(based on ranked values)
Peforelin treated sows come into heat earlier and are insemin-
ated earlier. The diff erence in gilts is not signifi cant (p > 0.10). 
Figure 1 shows the oestrus score curve for both sows groups. 
The oestrus of peforelin treated sows peaks earlier and fi nishes 
earlier. 
Discussion
The results of this study show that the peforelin treatment 
has a positive eff ect on timing and intensity of oestrus in high 
performing farms. Improving results in high productive farms is 
a challenge. Early onset of a good quality oestrus facilitates the 
breeding management and often results in improved repro-
ductive performance. With only few animals remaining one 
week after weaning or synchronization, it is easier to cull and to 
reduce empty days. While in gilts, the use of peforelin seems to 
reduce the number of gilts not bred, this is hardly possible in the 
sows on this farm. In sows, WOI is shortened and more concen-
trated after the use of peforelin. 
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Introduction
Examination of the reproductive tracts of infertile sows and gilts 
is recognised as a valuable diagnostic aid (1,2). Between 2006 
and 2008, Scottish pig farmers were off ered examinations of 
reproductive tracts of sows and gilts culled for infertility reasons, 
including multiple returns to oestrus, pregnancy failure/not in 
pig and suspected anoestrus. The aims were three-fold; fi rstly 
to assist farmers and their veterinary advisors with understand-
ing the causes of infertility on their units, secondly to improve 
the reproductive performance of herds and thirdly, to carry out 
surveillance for any previously unrecognised or any new and 
emerging reproductive conditions.
Materials and Methods
After slaughter, the tracts were bagged, sealed, identifi ed by 
herd and animal number and delivered to one of two diagnos-
tic laboratories within 24 hours. Similar protocols were used 
by both laboratories including inspection of all parts of the 
reproductive tract and bladder (if present), counting the number 
of follicles, and other features on the ovaries (corpora lutea, 
corpora albicans, corpora haemorrhagica, cystic lesions), testing 
oviducts for patency, examination of uterine horns for preg-
nancy, infl ammation or other lesions, the cervical structure, the 
vagina and bladder for infl ammation or abnormalities. Swabbing 
of the uterine body anterior to the cervix for bacterial culture 
was done routinely by one laboratory, and only in the event of 
gross infl ammation or abnormal uterine contents, by the other. 
Selected cases were tested for Chlamydia species by PCR. Repre-
sentative samples were collected for histopathology.
Results
In total, 142 tracts were examined from 31 units. No abnor-
malities were evident in 58 of the tracts (23 units). These tracts 
showed normal ovarian activity with presence of corpora lutea. 
Nineteen tracts were pregnant (14 units); 11 were in early 
pregnancy (up to 6 weeks gestation), 4 were in mid-pregnancy 
(7 – 13 weeks gestation) and 4 were in late pregnancy (14 weeks 
or more, gestation).Two gilts were found to have congenital 
defects of the cervix or uterine horns. Twelve sows had cystic 
ovaries (10 units). Uterine bacterial infection was detected in 
32 tracts (13 units). Some cases showed gross infl ammatory 
changes associated with infection. Infections involved were as 
follows: E.coli (8 tracts, 5 units), Strep. dysgalactiae (6 tracts, 3 
units), other Streptococcus species (3 tracts, 3 units), Actinomy-
ces pyogenes (6 tracts, 1 unit), other infections including mixed 
environmental-type organisms, Fusobacterium species or Clos-
tridium perfringens (8 tracts, 6 units). Abscessation of the uterine 
wall was present in one sow. Evidence of anoestrus was found 
in 17 tracts (7 units). One anoestrus sow also had totally blocked 
oviducts. Two sows had severe cystitis. Both yielded the same 
bacterial isolates from their uterus and bladder suggesting a link 
between cystitis and the endometrial infection. No Chlamydia 
sp. were detected in any of the uteri tested.
Table 1. Findings in reproductive tracts of 142 sows/gilts culled for 
infertility from 31 units.
Feature Number of pigs %
Normal tract 58 41
Pregnant 19 13
Congenital defect 2 <1
Cystic ovaries 12 8
Uterine bacterial infection 32 22
Anoestrus 17 12
Cystitis 2 <1
Discussion 
This study allowed reports to be provided for individual sows 
and gilts including assessments in relation to last oestrus 
and service dates. Where the cause of infertility could not be 
determined from the slaughter examination, other means of 
investigation including serology were suggested. The culling of 
pregnant animals highlighted the need for better pregnancy 
testing and/or training on some farms. In herds with endo-
metritis, there was a tendency for particular organisms to be 
prevalent, for example streptococci or A. pyogenes. Coliforms 
and other environmental bacteria associated with endometritis 
suggested hygiene issues on some units. Happily, the study did 
not demonstrate any previously unrecognised or any new and 
emerging conditions on the farms.
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Introduction
Defi ciencies in management, particularly concerning estrus 
detection, have been reported as the main cause of low repro-
ductive performance when using artifi cial insemination (A.I.). 
It is known that the boar infl uences many physiological and 
reproductive processes in the female, thus having a positive ef-
fect on reproduction. Aiming to use the copulative and seminal 
plasma stimuli, while loosing none of the genetic benefi ts of 
A.I., many studies have been conducted to assess the eff ective-
ness of teaser or infertile males on increasing the fertility rates of 
inseminated females. The objective of this study was to evaluate 
the infl uence of using vasectomized boars or boars with devi-
ated preputial on estrus detection and reproductive perform-
ance of artifi cially inseminated sows.
Material and Methods
A total of 110 primiparous and multiparous females (parity 1 to 
11) and 12 boar teaser were used (fi ve were vasectomized and 
seven had preputial ostium deviation). Four fertile boars were 
used as semen donors. The vasectomized males presented olfac-
tory, visual, auditive and tactile (external and internal - by penis 
penetration) stimuli, in addition to the action of the seminal 
plasma. The males with preputial ostium deviation, on the other 
hand, provided no internally contact or seminal plasma. The fe-
males were randomly distributed to the three pre-insemination 
treatments: TI (n = 35) - females inseminated without direct 
male stimulation (control); TII (n = 38) - female stimulated and 
mated by males with preputial ostium deviation, immediately 
before each insemination; TIII (n = 37) - female stimulated and 
copulated with a vasectomized male, immediately before each 
insemination. Estrus detection was done three times a day - in 
TI was done with the females housed in individual pens, by 
the back pressure test in the presence of a boar (nose-to-nose 
contact); in TII and TIII the boar was kept in physical contact with 
the sows in the pen. Were performed up to three inseminations 
using insemination doses of 3x109 viable sperm, diluted in the 
MR-A® extender and stored at 170C for up to 12 hours. The data 
were analyzed by Analysis of Variance, and the averages com-
pared by SNK test. 
Results
The average duration of estrus was 67.53±16.42 hours, show-
ing a numerical superiority when identifi ed in the male’s pens 
(treatment II and III). The average weaning-estrus-interval was 
3.98±0.85 days, with a signifi cantly higher percentage (p<0.05) 
of females showing estrus between 1-3 days after weaning 
in the treated groups (24.66%), compared with the controls 
(8.57%). The percentage of females that showed estrus in the 
morning was 69.09%. Regarding sows reproductive perform-
ance, no statistically signifi cant diff erences (p>0.05) were 
found in any of the parameters measured. The farrowing rate 
was 88.18% and the average total number of piglets born was 
11.22±2.77. 
Discussion
The combination of the tactile, visual, auditive and olfactory 
stimuli increased the proportion of females in heat in accord-
ance with others studies (1). The group exposed to vasecto-
mized males presented the worst dates. Probably the amount 
of seminal plasma altered the sperm concentration in the doses 
and reduced the fertility. Also, these females had full contact 
with the boars and so, were exposed to stressful conditions (2).
Conclusion
The contact with the teaser boars immediately before the 
insemination not resulted in improvements in the reproductive 
performance in the females. Probably, the eff ect of vasecto-
mized boar use is not evident in farms that use artifi cial insemin-
ation and show rates of fertility and prolifi cacy close to ideal. 
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Introduction
Gilts may be covered naturally or inseminated artifi cially when 
they reached the live weight of 130 kgs being old 220 days 
at least (Hühn, 1999). Recently it was recommended the gilts 
would be covered old 220-240 days in order to farrow at the age 
of 335-355 days (Zootechnical Dpt., Biotechnical Faculty, Univer-
sity of Ljubljana, 2009). We decided to establish how many gilts 
became pregnant at the age of 220-240 days.
Materials and Methods
Data collected at the Family Farm Glavasˇic´ in Bizovac, Republic 
of Croatia, were the material used during this research. The farm 
bought 65 hybrid PIC gilts from farm “Belje” where they had 
been born during the period of August 21st till September 14th 
2008. Gilts were covered naturally or inseminated artifi cially with 
the boar’s semen obtained from the A.I. Center in Osijek so that 
they became pregnant during the period from February 18th 
till September 14th 2009. Litters from those females dropped 
in the period from June 11th 2009 till January 7th 2010. It was 
accounted how many days particular gilts was old at the start of 
her successful pregnancy and how many days particular female 
was old at the 1st farrowing. Numbers were elaborated using the 
methods described by Serdar (1959).
Results
Ten gilts from 65 or 15 38% of all observed females became 
pregnant at the age of 225-240 days giving the average of 234.9 
days.
Figure 1
 
These gilts farrowed at the age of 342-354 days, old 350.1 days 
on an average. The frequency distribution curves on the age 
of 65 gilts at the start of successful pregnancy observed and 
adapted to normal one can be seen at Figure 1. Gilts became 
pregnant old 172-386, 238.4 days on an average. They farrowed 
at the age of 287-501, giving the mean of 352.4 days.
Discussion
Gilts became sows as yearlings covered at the age of 225-240 
days or at the age of 172-386 days but in former case less than 
16% of all females in our research. Successful pregnancy of 65 
gilts in 2009 started at the age what was observed with the 
data on the age at the fi rst successful services of gilts born in 
1960-1962 (169-401 days - Sviben, 1967), when gilts reached 
89 kg at the age of 212 days on an average. Contemporarily 
bred pigs in appropriate circumstances reach the live weight of 
almost 140 kg on an average at the age of 154-175 days (Sviben, 
2007) when gilts are sexually mature. Pigmen have an interest 
to service gilts as early as possible what means at the age of six 
months (Legault and Dagorn, 1973).
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Introduction
Reproductive failure continues to be one of the most com-
mon reasons for culling sows from pig farms1. Reproductive 
slaughter checks have been conducted to determine the causes 
of urogenital infections, discharging sows and reproductive 
failures2,3,4. Nevertheless, a few studies been done on the pres-
ence of gross reproductive lesions at slaughterhouse and their 
application to solve reproductive problems in the Pigfarms. The 
aim of this paper was to schedule a systematic protocol to assess 
reproductive failure by using a spreadsheet as a procedure to 
analyze and to reduce reproductive problem in farms.
Material and Methods
Three Pigfarms with historical reproductive failure were se-
lected (Farm A= 4.000 sows, Farm B= 7.000 sows, Farm C= 2500 
sows). A longitudinal study was performed to determine the 
main reproductive problems in each farm. 20 to 30 culled sows 
or replacement were examine at slaughterhouse during April 
– November 2009 period. A systematic monthly or every two- 
three weeks inspection was performed to each pigfarms to as-
sess the evolution of each case. Post-mortem examination of the 
genital organs was carried out immediately after slaughtering. A 
detailed protocol was used to examine every part of the organs 
by using a technical inspection guide. Sample of several tissues 
were taken for histopathological and bacteriological studies. The 
inspection outcome were transferred to a specifi c spreadsheet 
designed to analyze the pathological fi ndings.
Results
Nine reproductive inspections were performed in 244 sows or 
replacement belongs to the three Pigfarms. The pathological 
fi ndings are shown in the Table 1. The main problem we found 
was a high percentage of pregnancy (13, 5 %), follow by inactive 
ovaries (13%) and pyometra and cystitis (10,60% each one). 8.6% 
of ovary inspected had multiple large cysts. Lithiasis was a non-
expected fi nding for us since it was higher in Farm A than the 
other ones (Fig 1). Farm C had the mayor reproductive problems 
with a high percentage of pyometra and pregnancy (data not 
shown). E. coli, Streptococcus spp and Proteus spp were the 
predominant bacteria isolated, respectively.
Discussion and Conclusion
The results were similar to those previous report3,4, however, 
the prevalence of pregnancy, cystitis and pyometra were higher. 
The systematic evaluation conducted in the reproductive tract 
on sow from the three pig farms in this study showed to be a 
worth tool to detect the main reproductive problems in those 
farms and to introduce management strategies to reduce the 
reproductive problems in this herds.
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Table 1
Type of Pathology %
Inactive Ovaries 13,00
Unilateral Cysts 6,90
Bilateral Cysts 6,30
Multiple Ovarian Cysts 8,60
Hydrosalpinx 3,50
Pyosalpinx 0,00
Endometritis 7,50
Endometrial Cysts 6,80
Metritis 5,50
Pyometra 10,60
Vaginitis 0,00
Cystitis 10,60
Lithiasis 7,20
Pregnancy 13,50
TOTAL 100,00
Figure 1
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Introduction
In today’s well managed sow farms, approaching 90% of sows 
can be detected in estrus within 3 to 5 days after weaning 
and pregnancy rates in these sows can be better than 90%1,2. 
However, the results of our recent studies suggest that although 
modern, primiparous sows can be consistently bred soon after 
weaning, the emerging pre-ovulatory follicles are of poorer 
quality, which may aff ect both the number and quality of pigs 
born. This study examined the eff ect of delayed breeding after 
weaning in primiparous sows, using either “skip-a-heat” breed-
ing or treatment with oral progestagen, on subsequent repro-
ductive performance.
Materials and Methods
In this study, 1st parity sows restricted to 60% of their ad libitum 
intake, and induced to lose 17.0 ± 4.1 kg of body weight during 
the last week of a 21-d lactation, were allocated as trios to one of 
3 breeding strategies at weaning (weaning weight = 160.2 kg): 1) 
CON (n=25) bred at the fi rst post-weaning estrus; 2) SKIP (n=23) 
bred at second post-weaning estrus; 3) ALT (n=23) oral proges-
tagen (altrenogest: ALT) treatment for 14 d starting the d of 
weaning and bred at the fi rst, but delayed, post-weaning estrus 
after ALT withdrawal. After weaning, sows were heat checked 
twice daily and bred by AI (using single sire AI doses, evenly 
assigned across trio). At day 30 of gestation, reproductive tracts 
were recovered after euthanasia and dissected on-site. 
Results
At breeding, SKP and ALT accumulated more non-productive 
days as measured by the wean-to-service interval (WSI) but the 
proportion of sows bred was similar (PBRD). ALT sows were bred 
as a more synchronous group (VAR) than either SKP or CON. 
Sow body weight at weaning, and total energy balance during 
lactation did not diff er among treatments. The longer delay to 
breeding resulted in greater weight at breeding (ALT: 169.4 ± 
21.4; SKP: 177.1 ± 22.3; CON: 162.1 ± 21.0 kg) and a more posi-
tive energy balance at breeding (ALT: 423.9 ± 12 2; SKP: 633.3 
± 14.0; CON: 196.2 ± 11.5) in SKP and ALT sows. Pregnancy rate 
(PR) was improved in SKP and CON sows. An improvement in 
follicular quality and corpus luteum function (total luteal weight 
(CLWT) and progesterone concentration (PCON)) was observed 
in ALT sows. Delaying breeding from 1st to 2nd estrus in SKIP 
sows increased the size of the pre-ovulatory follicle (FOLL) 
At d30 of gestation, no diff erences in ovulation rate (OR), live 
embryos (LE), embryo survival, embryo size (LEWT) or placental 
fl uid volume (PVOL) were detected (Table 3). A Fertility index (FI) 
was calculated as the percent of sows bred and pregnant per 
100 sows weaned x live embryos at d30. 
Results show that as a result of the exceptional performance of 
CON sows, the FI of ALT (1179) and SKP (1215) did not meet the 
performance achieved by CON (1406) sows.
Table 1: Eff ects of treatment in primiparous sows at weaning (ALT, SKP, 
CON), on various reproductive parameters at breeding and day 30 of 
gestation for those sows bred. 
ALT SKP CON
Breeding
WSI, d** 19.4 ± .2a 26.5 ± .3b 5.5± .2c
PBRD, % 90.1 80.8 91.3
VAR 0.42 a 1.42 b 1.20 b
FOLL, mm** 7.5 ± .3a 7.6 ± .3a 6.8 ± .4b
PCON, ng/ml* 11.4 ± 0.8a 9.3 ± 0.8ab 8.7 ± 0.8b
PR, %* 79.2a 95.2ab 100.0b
Day 30 of gestation
OR, # 20.0 ± 0.6 18.4 ± 0.6 19.1 ± 0.5 
LE, # 15.4 ± 0.7 15.8 ± 0.8 15.1 ± 0.7 
LEWT, g 1.8 ± 0.08 1.8 ± 0.07 2.0 ± 0.06 
PVOL, ml 220.3 ± 9.8 211.5 ± 9.8 243.8 ± 9.6 
CLWT, g* 7.7 ± 0.3 a 7.0 ± 0.3 ab 6.9 ± 0.2b
*P≤0.07, **P≤0.03
Discussion
Delayed breeding allows for additional time for the sow to re-
cover weight lost due to lactation catabolism. Altrenogest treat-
ment eff ectively synchronizes estrus after weaning and reduces 
the number of days in the breeding week. Delayed breeding, 
improves follicular quality, corpus luteum function and the syn-
chrony of sows bred. In the present study, the performance of 
Control sows, as measured by the Fertility Index was exceptional 
and no gain in estimated productivity was achieved by delaying 
breeding after weaning in sows.
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Introduction
Local pig farming is an important source of livelihood in many 
rural communities of Western Kenya (1, 2). Sows are important 
in sustaining this important sector. Data on their performance is 
currently lacking. Such information is crucial for the pig farmer 
to identify target areas for farm improvement. Studies on the 
performance of pigs have only been done on commercial farms 
keeping exotic breeds (3). The purpose of this study was to pro-
vide baseline information on the reproductive performance of 
sows raised by small-holder pig farmers in rural villages of Busia 
and Kakamega districts, Western Kenya. 
Materials and Methods
We studied a random sample of 288 local pig farmers in the two 
districts of Western Kenya. Farms were randomly identifi ed and 
visited three times in the course of the study period (June 2006 
to October 2008). Information on sow productivity was gathered 
by means of questionnaires administered to sow owners in face 
to face interviews. All data were managed and analysed in Stata® 
statistical software. Student’s t-tests were used to compare data 
between districts.
Results
The mean number of sows owned per farm per visit was 1.3 
(SD=0.62) on farms where at least one sow was present when 
the farm visit was made. Farmers in Kakamega bred their sows 
more times (2.4) compared to farmers in Busia (1.8) (p<0.05). 
The average prices for sows purchased as piglets (≤ 4 weeks), 
growing pigs (4 - 8 weeks) or adults were Ksh 619 (SD=178), 
Ksh 813 (SD=457) and Ksh 3060 (SD=684) respectively. Piglets 
were cheaper in Busia (Ksh 509 SD=57) than in Kakamega (Ksh 
777 SD=174) (p< 0.05). Pigs were weaned at an average age of 
5.4 (SD=3.3) weeks. The mean number of piglets born alive was 
7.87(SD 2.67) and the mean number of piglets weaned was 6.60 
(SD 3.25). A median and mean pre-wean mortality of 0% and 
13% (SD=26) was reported. The median and mean age for sows 
at fi rst breeding was 6 and 8.25 (SD=4.8) months, respectively. 
Sows were bred 1.95 1.64 months after piglets were weaned. 
Sows were sold at Ksh 2286 (SD=934), Ksh 2603 (SD=996) and 
Ksh 2830 (SD=1114) for the lowest, highest and expected price 
respectively. Most sows (91%; 74/81) were sold to pork butcher 
men who slaughtered them for immediate local consumption. 
Many sows were sold immediately after their fi rst litter (56%; 
33/59). Sources of breeding boars included; boars that were 
borrowed from a neighbour (77%), farmer’s-own boar (14%), 
group-owned boars (0.4%) and boars that were free-roaming in 
the villages (2%). 
Discussion 
This study has provided important production data that was 
previously lacking. Increasing the productivity and profi tability 
of small-holder pigs directly contributes to the social and eco-
nomic wellbeing of households in low-income countries. Some 
of the opportunities that may increase sow productivity include; 
improved sow feeding, shorter wean to breed interval, breeding 
more than one in an estrus, keeping sows for more than one lit-
ter by lowering the female culling rate, introduction of improved 
genetics with better litter size. There is need for more detailed 
research particularly on potential management factors infl uen-
cing sow productivity (number of born alive piglets, farrowing 
rate, sows age at fi rst farrowing and piglet mortality). 
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Reproductive parameters in pregnant sows adapted from a conventional system to an organic system
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An alternative to the industrial pork production is the develop-
ment of market niches. An example o f this is the production of 
organic pork meat, in order that a product goes through one 
system to another, it is necessary a conversion process. How-
ever, there is not study that indicates any change in breeding 
parameter with sows which have been adapted from one system 
to the other. It is known that sows in conventional system could 
have breeding problems when there are some food changes or 
environmental changes; that why the reason of knowing the 
breeding behavior in sows which have been adapted from a 
conventional system to an organic one.
Material and Methods
It was carried out in a pig farm localized 100 km northeast from 
México City in a separated area from the rest of the farm (term 
established by IFOAM). Six yard with concrete fl oor (28.26m2 
each one) and an outside area with land fl oor (197.62m2) were 
used for this research. This space fulfi lls the specifi cations that 
are established by certifying organizations (2.5m2/sow in inside 
area, and 1.9m2/sow in outside areas). It was used 17 adult sows, 
11 of them were placed in yards with outside area and the other 
6 in confi nement.
At the moment of weaning they were separated in 3 groups. A. 
6 sows in an organic management and also organic food; B. 6 
sows in equal conditions but conventional food. C. 6 sows in an 
intensive management.
It was registered number of births, number of services, length of 
estrus, length of gestation, physical conditions at the moment of 
birth, dorsal grease at the moment of birth, length of the birth, 
internal between birth, number of mail piglets meconium, total 
number of newborn piglets, number of dead piglets and weight 
at the moment of birth. Each variable was analyzed using AND-
EVA in a new design completely randomized.
Results
The result are presented in the following table.
Table 1.
Group A B C
Services 1.0 1.4 1.0
Estrus (hrs) 46.0 45.6 38.0
Gestation length (days) 116.3a 115.4a 113.8b
Backfat mm 17.8a 20.7b 20.7b
Colostrum (hrs) 26.1 37.4 12.1
Farrow lenght (hrs) 4.03ab 6.6a 2.9b
Birth Interval (hrs) 37.7A 31.9a 17.1b
Total born average 9.66A 12.6ab 13.5b
Dead born average 1.33 0.8 2.0
L.Meconium 0.33a 0.8a 3.33b
Weigh (kg) 1.58 1.55 1.60
Diff erent literals in the same line indicate (P<0.05)
Discussion
The sows in the organic system with both types of diet had 
similar parameters to the control sows, except with parameters 
related with the length of birth, they were higher than the con-
trols; the previous is related with less stress conditions at birth.
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Introduction
In general, the removal of sows from breeding herds consisted 
of planned (i.e., old and low productivity) and unplanned (e.g., 
reproductive failure, lameness, sudden dead) reasons (1). It has 
been demonstrated that at least three litters are required from 
sows before a positive cash fl ow could be obtained (2). Unfortu-
nately, 15-20% of the removal sows produced only one litter (1, 
2) and most of these were culled due to unplanned reasons (1). 
The objective of the present study was to evaluate the pattern 
and reasons for culling gilts and primiparous sows in swine 
herds of Thailand.
Materials and methods
Data from 38,323 gilts and sows culled from eight swine herds 
in Thailand between 2006 and 2009 were included. The herds 
are located in the eastern, western, middle, and northeastern 
parts of Thailand between latitude 14–17 °N and longitude 
102–103 °E. The sow on production in the herds was between 
1,600 and 4,000 sows. The sow breeds were chiefl y Landrace x 
Yorkshire (LY) crossbred and some were L and Y. Conventional 
artifi cial insemination (AI) was used in all herds. Most gilts and 
sows were housed in a conventional open-housing system with 
water sprinklers and fans. They were kept in individual stalls dur-
ing gestation and in individual farrowing pens during lactation. 
All herds produced replacement gilts within the herd by their 
own grandparent (GP) stocks (L and Y). In general, the gilts were 
mated at ≥32 weeks of age with ≥135 kg of body weight at the 
second or later observed estrus. Vaccination for gilts and sows 
included foot-and-mouth disease, classical swine fever, Aujesz-
ky’s disease, porcine Parvovirus, and arthrophic rhinitis. The gilts 
and sows received ad libitum water via water nipples. The feed 
was provided once or twice a day (about 1.5–3.5 kg/day/head 
during gestation and 5.0–7.0 kg/day/head during lactation). The 
feed was rice-maize-soybean-fi sh base containing 150–180 g 
crude protein, 12.1–13.4 MJ metabolizable energy and 8–10 g 
lysine/kg. Generally, the planned removal was performed after 
the sows reached the sixth parity.
Results and Discussion
Of all slaughtered females, 14.5% (n=5,543) and 13.8% (n=5,302) 
were removed as gilts and primiparous sows respectively (Figure 
1). Of all the removed females, 93.2% was sent to slaughter-
house, 6.8% was found dead, and 0.02% was euthanized. The 
reasons for culling of gilts and primiparous sows are demon-
strated in Table 1.
Figure 1 Percentage of gilts and sows removed from herds by parity 
number at removal (n=38,383 females)
Table 1 Reasons for culling in gilts (n=5,543) and primiparous sows 
(n=5,302) in 8 swine herds in Thailand
Reasons for culling Gilts (%) Primiparous sows (%)
Anestrus 26.5 14.3
Not pregnancy 22.2 10.4
Vaginal discharge 14.0 15.1
Abortion 11.3 6.1
Lameness 9.1 17.3
Illness 4.6 11.9
Others 12.2 25.0
The present study indicated that reproductive disorders are the 
most common reason for culling gilts and primiparous sows, 
in agreement with earlier studies (1,2). Most of the reproduct-
ive problems of the female included anestrus, not pregnancy, 
vaginal discharge, and abortion. In addition, it also indicates 
that at least 28.3% of the female produced only one litter or less 
when they were culled.
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Introduction
An alternative to increase the profi tability of hog farms is to 
increase the length of productive life (PL) of sows, which is 
interrupted by diff erent causes that aff ect their productivity. 
The establishment of the causes of removal of sows is critical in 
the culling and replacement programs to implement preventive 
measures. The aim of this study was to determine the eff ect of 
farm, number of piglets born alive at fi rst farrowing (NBA) and 
age at fi rst farrowing (AFF) on the length of the PL and number 
of parity (NP), and the main causes of removal sows.
Materials and Methods
We used data from four pig farms representative of the central 
area of Yucatan Mexico. The farms are of the intensive system 
and technically. Production records to estimate PL and causes 
of removal of sows were the year 2003-2009 and were obtained 
from Pigchamp program. The variables used were: identifi cation 
of farms and sows, NP, NBA, AFF, date and cause of removal. The 
PL was defi ned as the number of days between fi rst farrowing 
and removal, or termination of data collection (1). To determine 
the length of the PL and NP will use a model with fi xed eff ects 
of farm, NBA and AFF. The data of the causes of removal were 
analyzed in general and by NP using descriptive statistics. 
Resulted and Discussion
Table 1 shows the results for PL and NP of sows per farm, NBA 
and AFF. Other studies also reported an eff ect of these factors on 
the PL and NP (1, 2). The main causes of removal were repro-
ductive problems (26.75%), which agree with other studies (3, 4). 
The highest percentage of removal occurred in the parities 6 to 
14 with 28.7%, of which 83% were removal because of advanced 
age. In the party 0 the 51.3% of sows were removal for repro-
ductive reasons (Table 2). Similar results have been reported by 
other authors (3).
Table 1. Least Square Means and standard errors (±EE) for NP and PL 
of sow removal. 
Sources of 
variation n NP (±EE) PL (±EE)
Farm 1 3327 4.31 (0.04)a 0.6534.86(6.32)a0%
Farm 2 128 5.25(0.17)c 806.04(25.80)c
Farm 3 81 4.38(0.32)ab 751.47(49.32)bc
Farm 4 210 4.73(0.11)b 714.30(16.59)c
NBA ≤ 8 2069 4.49(0.10)a 675.11(15.15)a
NBA9-12 746 4.75(0.10)b 715.24(16.22)b
NBA ≥ 13 931 4.75(0.10)b 714.65(16.10)b
AFF≤ 330 1007 4.81(0.11)b 726.36(16.70)c
AFF331-347 1844 4.73(0.10)b 709.05(16.15)b
AFF ≥ 348 895 4.45(0.09)a 669.58(14.82)a
Diff erent literal in column indicates signifi cant diff erence (P <0.05).
Table 2. Frequency (%) of removal reason of sows by parity number 
(NP) at removal
Reasons of removal NP at removal Total
0 1 2-5 6-14 %
Reproduction 8.05 5.64 11.07 1.98 26.75
Locomotion 3.12 3.61 7.69 0.78 15.20
Productivity 0.04 2.59 9.27 0.72 12.62
Diseases 3.04 2.58 6.30 0.63 12.92
Old age 0.01 0.01 1.11 23.81 24.96
Miscellaneous 1.04 1.93 3.84 0.74 7.55
No. of Sows 1156 1206 2898 2116 7376
Total (%) 15.67 16.35 39.65 28.68 100
In conclusion diff erence was found between farms, NBA and AFF 
on the length of the PL and NP of the sows. The main causes of 
removal of sows were reproductive problems.
References
1.  Engblom et al., (2008) J. Anim. Sci. 86:432-411
2.  Serenius and Stalder. (2007) Animal. 1:745-750
3.  Lucia et al., (2000) Livest.Prod.Sci.63: 213-222
4.  Engblom et al., (2007) Livest.Sci.106: 76-86 
Reproduction – General
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 1103
Poster Presentations
P.797
Relationship among age, body weight and number of ovulation in 
Landrace x Yorkshire crossbred replacement gilts
Padet Tummaruk; Sawang Kesdangsakonwut; Atthaporn Roongsitthichai; Annop Kunavongkrit
Chulalongkorn University, Bangkok, Thailand
Introduction
On average, Landrace x Yorkshire (LY) crossbred gilts in Thailand 
attain puberty at 196 days and 106 kg body weight (1). In prac-
tice, replacement gilts are usually mated at the second or later 
observed estrus, about 7-9 months of age. The objective of the 
present study was to investigate the relationship among num-
ber of ovulation, age and body weight in LY crossbred replace-
ment gilts in Thailand.
Materials and Methods
Genital organs from 316 culled LY replacement gilts from 6 
swine herds in Thailand were collected at slaughterhouses 
between May 2005 and September 2008. The organs, including 
ovaries, oviducts, uteri, cervixes and vaginas-vestibules-vulvas 
were collected, placed on ice and transported to the laboratory 
within 24 h after culling. Historical data included herd, gilt iden-
tity, breed, date of birth, culling date and body weight at culling 
were collected. Age at culling was calculated. The ovaries were 
weighed by using an electronic balance (Precisa Instruments 
Ltd., Switzerland). Corpora lutea (CL) and corpora albicantia 
(CA) were counted. Number of ovulations was defi ned as total 
number of CL from both ovaries. Number of CA was regarded to 
the number of ovulations in the previous reproductive cycle. The 
gilts were classifi ed according to body weight (Table 1) and age 
at culling (Table 2). Number of ovulations was compared among 
groups by using one way analysis of variance. 
Results and discussion
On average, the gilts were culled at 302.4±51.5 days of age and 
the body weight at culling was 144.0±20.8 kg. Of the 316 gilts, 
23 gilts (7.3%) had multiple cysts, 17 gilts (5.4%) had single 
cyst, 2 gilts (0.6%) had unilateral ovo-testis and 7 gilts (2.2%) 
had miscellaneous abnormalities. Gilts with abnormal ovaries 
were excluded and 261 gilts (82.5%) were remained for further 
investigation. Of these gilts, 107 gilts did not ovulate (86 pre-
pubertal and 21 follicular phase) and 154 gilts (59%) having 
at least one CL were investigated. On average, the number of 
ovulations was 15.9±3.5 and the number of CA was 15.3±6.1. 
The number of ovulations was 8.1±2.9 on the left ovary and 
7.8±3.2 on the right ovary (P=0.380). The diameter of the CL and 
CA was 9.3±2.2 mm and 4.5±1.4 mm, respectively. The weight 
of the ovaries was 6.6±2.4 gram. The number of ovulations in 
relation to body weight of gilts is presented in Table 1. Gilts with 
body weight of 92-130 kg and 131-140 kg had 3.2 and 2.0 ova, 
respectively, which were less than those of 141-150 kg (Table 1). 
Number of ovulation of gilts with a body weight of 141 to 205 
kg did not diff er signifi cantly (Table 1). The relationship between 
age at culling and number of ovulation are presented in Table 2. 
Gilts aged 30-35 weeks had a lower number of ovulations than 
gilts aged 40-50 weeks (Table 2). The present study indicated 
that maximal number of ovulation of LY gilts in Thailand was ob-
tained at >141 kg body weight and at >36 weeks of age. There-
fore, to achieve high prolifi cacy, the gilts are recommended to 
be bred at a body weight of at least 141 kg.
Table 1 Number of ovulations in LY crossbred gilts in relation to body 
weight at culling 
Body weight (kg) N CL CA
92-130 65 13.5a 11.2a
131-140 38 14.7ab 15.2b
141-150 50 16.7b 16.7bc
151-160 49 16.6b 18.5c
161-205 52 16.9b 14.3ab
Table 2 Number of ovulations in LY crossbred gilts in relation to age at 
culling
Age (wk) N CL CA
30-35 14 13.8a 9.3a
36-40 31 15.5ab 14.4b
41-45 60 16.6b 16.4b
46-50 23 16.3b 15.6b
51-72 22 15.9ab 17.3b
a,b,c diff erent superscript within column diff ered signifi cantly (P<0.05)
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Association between lived weight and size of the uterus in Landrace x Yorkshire crossbred gilts
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Chulalongkorn University, Bangkok, Thailand
Introduction
In Thailand, replacement gilts are usually mated at the second 
or later observed estrus, about 7-9 months of age. The objective 
of the present study was to investigate an association between 
lived weight and size of the uterus (i.e., weight and length) in 
Landrace x Yorkshire (LY) crossbred replacement gilts in Thai-
land.
Materials and Methods
The study was conducted between May 2005 and September 
2008. Genital organs of 316 LY crossbred replacement gilts from 
six swine commercial herds in Thailand were examined. The 
herds, where the samples were collected, were located between 
latitude 13˚ and 17˚ N and between longitude 100˚ and 104˚ E. 
The gilts entered the gilt pool at body weight of 80-100 kg and 
were housed in an open-housing system. The genital organs 
were collected, placed on ice and transported to the laboratory 
within 24 h after culling. Data including herd, gilt identity, breed, 
date of birth, culling date and body weight at culling were col-
lected. Age at culling was calculated. The genital tract including 
ovaries, uteri and cervixes were dissected from the mesomet-
rium and examined macroscopically. The uterus from utero-
tubal junction to the uterine body was dissected and weighed 
by using an electronic balance. The length of the uterine horns 
was measured by using a metrical scale plastic tape. The meas-
urement was done by placing one end of the plastic tape at the 
junction of the uterine horn and uterine body and threading 
the tape along the horn between the thumb and fi ngers. The 
measurement was performed on both sides of the uterine horn 
and the uterine body. The sum of the length of each part was re-
garded as total length of the uterus. Stages of the reproductive 
cycle were defi ned according to an appearance of the ovaries, 
i.e., corpora lutea (CL), corpora albicantia (CA) and follicles (1). 
The gilts were classifi ed according to their lived weight at cull-
ing (Table 1). Weight and length of the uterus were compared 
among groups by using multiple ANOVA. 
Results and discussion
Of the 316 gilts, 36 gilts (11.4%) had endometritis, 15 gilts (4.8%) 
had congenital abnormalities and 9 gilts (2.9%) had miscellan-
eous abnormalities. Gilts with abnormal uterus were excluded; 
therefore 255 gilts were remained for further analyses. The 
average age at culling was 297.0±46.5 days and the body weight 
at culling was 144.6±20.5 kg. Of these gilts, 147 gilts (57.6%) 
were in luteal phase, 31 gilts (12.2%) were in follicular phase and 
77 gilts (30.2%) were in pre-pubertal phase. The weight of the 
uterus was 689.0±219.0, 727.6±315.0 and 127.7±70.8 g in luteal, 
follicular and pre-pubertal phases, respectively. The length of 
the uterus was 263.2±61.2, 200.4±35.2 and 123.3±25.4 cm in 
luteal, follicular and pre-pubertal phases, respectively. Since 
both weight and length of the uterus in pre-pubertal gilts was 
signifi cantly lower than in cyclic gilts, they were not included in 
the analyses. The weight and length of the uterus in relation to 
body weight at culling in cyclic gilts is presented in Table 1. Gilts 
with body weight of 92-130 kg had smaller uterus than those of 
141-150 kg (Table 1). Gilts with body weight of 161-205 kg had 
signifi cantly heavier and longer uterus than those of 92-160 kg 
(Table 1). The present study indicated that the maximum size of 
the uterus of LY gilts in Thailand was obtained at body weight 
of >161 kg. Therefore, breeding gilts at body weight of >161 kg 
may increase the number of piglets born per litter since a max-
imum uterine capacity was achieved.
Table 1 Weight (kg) and length (cm) of the uterus in LY crossbred gilts 
by body weight at culling (kg)
Body weight N Uterine weight Uterine length
92-130 27 573.4a 204.8a
131-140 28 624.4ab 226.9a
141-150 38 681.5bc 231.5a
151-160 35 736.3c 230.9a
161-205 41 872.3d 264.6b
a,b,c,d diff erent superscript within column diff ered signifi cantly (P<0.05)
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Introduction
Litter size in pigs is an important component of production 
effi  ciency (1) and sow genotype is one of the factors demon-
strated to have signifi cant eff ect on piglet litter size (2). However, 
other non-genetic factors including sow housing can cover up 
this benefi t. The aim of this study was to determine association 
between piglet litter size and genetic type of sows kept under 
the same housing conditions in order to eliminate the possible 
infl uence of housing conditions.
Material and Methods
Data were collected at a commercial pig farm and included two 
groups of 40 sows (Swedish Landrace, SL and Segers hybrid, 
SG) representing a part of the farm population (groups 1 and 
2). Group 3 of 28 sows (Swedish Landrace and Large White 
crossbreeds, SL*LW) represented the whole population of this 
genotype on the farm. All sows were kept under the same hous-
ing conditions during pregnancy and lactation. The average 
length of lactation was 25 days. Semen from the same boars 
was used for insemination of sows in all groups. Data on litter 
size included six parity records and were expressed as number 
of piglets born in total (NBT), number of live-born piglets (NBA) 
and number of still-born piglets per litter (NSB). Statistical an-
alysis was performed using the Statistica 8.0 (Statsoft Inc., 2008) 
statistical software and methods of variance analysis (one-way 
ANOVA and ANOVA Repeated Measures).
Results
Results are presented in Table 1.
Discussion
NBT was highest in the SL*LW sow population in sixth parity 
and signifi cantly diff ered from sixth parity of sow groups 1 and 
2 (P<0.05). Group 3 NBT diff ered signifi cantly in sixth parity due 
to the fi rst parity NBT in the same group (P<0.05). In all groups, 
NBA and NSB diff ered within the six parity cycles observed due 
to the sow genotype. Study results indicated the genotype of 
sows kept under the same housing conditions to infl uence the 
piglet litter size.
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Table 1. Litter size characteristics of diff erent genetic type of sows kept under the same housing conditions
SL (n=40) SG (n=40) SL LW (n=28)
Parity NBT NBA NSB NBT NBA NSB NBT NBA NSB
1 10.93±2.32 10.53 ±2.36 0.40 ±0.63 10.08 ±2.65 9.55 ±2.58 0.53 ±1.13 10.68* ±2.86 10.25* ±2.78 0.43 ±0.74
2 12.30a ±2.74 11.88b ±2.66 0.43 ±0.71 10.48a ±3.15 10.13b ±3.00 0.35 ±0.62 11.32 ±2.18 11.11 ±2.01 0.21 ±0.50
3 12.13 ±2.95 11.83 ±2.93 0.30 ±0.56 11.05 ±2.17 10.73 ±2.00 0.33 ±0.86 12.18 ±2.44 11.82 ±2.23 0.36 ±0.49
4 11.75 ±3.30 11.50 ±3.17 0.25 ±0.54 11.68 ±2.32 11.20 ±2.20 0.48 ±0.82 11.71 ±2.59 11.29 ±2.40 0.43 ±0.74
5 11.93 ±3.10 11.25 ±3.11 0.68 ±1.12 11.90 ±2.66 11.25 ±2.52 0.65 ±1.03 12.86 ±3.23 12.54* ±3.21 0.32 ±0.61
6 11.10a ±2.88 10.80 ±2.75 0.30 ±0.52 11.20b ±3.57 10.68 ±3.29 0.53 ±1.01 13.14a,b,*±2.34 12.46 ±2.19 0.68 ±0.94
Values are expressed as mean ± SD;
NBT=number of piglets born in total; NBA=number of live-born piglets; NSB=number of still-born piglets per litter
a,bmeans marked with the same letter (in the same row) statistically diff erent at the level of P<0.05
*means marked with asterisk (in the same column) statistically diff erent at the level of P<0.05
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Introduction
The purpose of farrowing synchronisation in sows is to concen-
trate births into a short period of time, benefi ting both produc-
tion and farm management. Grouping births during working 
hours is useful to enable proper assistance, reducing perinatal 
piglet mortality [1] and improving fostering. The duration of far-
rowing infl uences the rate of stillbirths: a prolonged farrowing 
(> 3 h) is more likely to result in stillborn piglets than a shorter 
farrowing [2]. This study compared two synchronisation proto-
cols, using a long-acting oxytocin (carbetocin) and a synthetic 
oxytocin in association with prostaglandin. 
Materials and Methods
The test was carried out in a 2,700 sow farm with weekly births 
in the Po valley in Italy. Births from 240 sows were analysed: the 
sows were divided into 3 groups (80 sows per group) at random: 
-  Group 1: 2 mg of alfaprostol (Gabbrostim®) i.m. at 11 am on 
the day before the expected birth date (approximately day 
113 of gestation) and 0.35 μg of carbetocin (Hypohysin® LA) 
i.m. at 7 a.m. the next day;
-  Group 2: 2 mg of alfaprostol (Gabbrostim®) i.m at 11 am on 
the day before the expected birth date and 10 iu of oxytocin 
i.m. at 7 a.m. the next day;
-  Group 3: 2 mg of alfaprostol (Gabbrostim®) i.m. at 11 am on 
the day before the expected birth date.
The following parameters were analysed: duration of farrow-
ing (from expulsion of fi rst piglet until expulsion of placenta), 
interval between administration of the drugs and time farrow-
ing started, number of liveborn piglets, weight of litter/number 
of liveborn piglets, stillborns, mummifi ed foetuses, inspections 
during farrowing (vaginal palpation if birth per piglet was more 
than 30 min) and mortality during lactation.
Results
The duration of farrowing was signifi cantly longer in group 2 
than in the other groups. The mean duration in group 1 was 3h 
41 min, the mean duration in group 2 was 4h 40 min, and the 
mean duration in group 3 was 4 h 4 min. The interval between 
administration of the carbetocin or oxytocin and the start of par-
turition was 1 h 59 min and 2 h 47 min respectively. The mean 
numbers of liveborn in groups 1, 2 and 3 were: 11.83, 11.66, 
11.63, respectively. The mean weight of the litter/number of live-
born piglets in each of groups 1, 2 and 3, expressed in kg, were 
1.70, 1.69 and 1.52 respectively. The mean number of stillborns 
and mummifi ed foetuses per group was 0.68. 0.88 and 0.74, for 
groups 1, 2 and 3, respectively. The mean number of stillbirths 
per litter for groups 1, 2 and 3 were 0.39, 0,55 and 0.61, respect-
ively. Inspections during farrowing were signifi cantly fewer 
in group 1 (p<0.01) with 14 inspections during 80 farrowing 
compared to 55 and 33 inspections in 80 farrowing for groups 2 
and 3 respectively. The mean number of piglets that died during 
lactation in groups 1, 2 and 3 were: 0.40, 0.56 and 0.65. 
Duration of farrowing h min No inspections/labours
Group 1 3.41a 14/80a
Group 2 4.40b 55/80b
Group 3 4.04a 33/80b
ab: indicates that the groups diff er signifi cantly (p<0.05)
Liveborn Mummies + stillborn Stillborn Total born
% stillborn / 
total born
Group 1 11.83 0.68 0.39 12.51 3.11%
Group 2 11.66 0.88 0.55 12.54 4.38%
Group 3 11.63 0.74 0.61 12.37 4.93%
Discussion 
The use of carbetocin in a birth synchronisation protocol 
showed a signifi cant reduction in duration of farrowing and 
number of inspections, compared to oxytocin. Besides this, there 
was a tendency for less stillborn piglets per litter after using car-
betocin (3.11%, 4.38%, 4,93% in Groups 1, 2 and 3, respectively). 
This test confi rmed [3] the effi  cacy of this molecule in inducing 
farrowing and positively infl uencing the productive perform-
ance of the sows. 
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Introduction
In maternity units, synchronising farrowings is undoubtedly ad-
vantageous. Concentrating farrowings into working hours and 
attendance at the farrowings reduces stillborns [1] and means 
that a higher number of sows are available for matching oper-
ations. The objective of this study was to compare two farrowing 
synchronisation programmes (prostaglandin associated with 
oxytocin or long-acting oxytocin), examining the most import-
ant production parameters, and specifi cally, weight at weaning, 
a fundamental piece of information for sites 1 (maternity unit).
Materials and Methods
The test was carried out in a 360 sow farm in the Po valley in Italy 
operating three weekly batch farrowing. A randomised double 
blind study was planned, in which the sows were divided into 
two groups:
• Group 1 (n = 52): intramuscular cloprostenol (Estrumate®) was 
administered the day before the scheduled farrowing day (ap-
proximately day 113 of gestation), and 35 μg of intramuscular 
carbetocin (Hypophysin® LA) the day after (24 h after clo-
prostenol).
• Group 2 (n = 59): intramuscular cloprostenol (Estrumate®) was 
administered the day before the scheduled farrowing day (ap-
proximately day 113 of gestation), and 20 IU of intramuscular 
oxytocin (Izossitocina®) the day after (24 h after cloprostenol).
The following parameters were evaluated: duration of farrow-
ing (the time from expulsion of fi rst piglet until expulsion of 
last piglet of the litter), number of liveborn piglets and weight 
on weaning; the weight determinations were performed every 
three batches, and the litters were selected randomly. A total of 
33 litters of piglets were weighed. The diff erences observed in 
duration of farrowing, number of liveborns and mean weight 
at weaning between the two groups were compared within 
ANOVA and the Kruskal-Wallis test with a level of signifi cance of 
p<0.05.
Results
The mean duration of farrowing was 122.12 minutes and 127.21 
minutes in group 1 and group 2 respectively; the mean num-
ber of liveborns was 13.71 and 12.73 in group 1 and group 2 
respectively (table 1). The mean piglet weight on weaning was 
statistically (p<0.05) higher in group 1 than in group 2, with 7.43 
and 6.80 kg respectively.
Table 1
Duration of farrowing (min) No. liveborn piglets per litter
Group 1: 122.12 13.71
Group 2: 127.12 12.73
Table 2
Mean weight at weaning per piglet (Kg)
Group 1: 7.43a ± 1.85
Group 2: 6.80b ± 1.39
ab: indicates that the groups diff er signifi cantly (p<0.05)
Discussion 
In this test, synchronising farrowings with prostaglandin associ-
ated with long acting oxytocin resulted in a weight at weaning 
that was signifi cantly higher than the association with oxytocin. 
An appropriate farrowing synchronisation protocol combined 
with the assistance required as necessary can increase piglet sur-
vival [1,2]; in addition, the short duration of birth ensuring the 
litter receives higher quantities of immunoglobulin, protein and 
fat, may explain the increased weight of the litter. This hypoth-
esis could be tested in the future. 
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Introduction
Besides its luteolytic eff ects, prostaglandin F2 α (PGF2 α) exerts 
contractile eff ect on uterine smooth muscle due to reduction of 
intracellular cyclic-AMP levels and increase of intracellular cal-
cium concentration (1). In sows, these contractions can be useful 
in facilitating elimination of uterine secretions and prevention of 
vaginal discharge (2). Aim of present study was to compare ef-
fects of cloprostenol (Planate®), a synthetic analogue of PGF2 α, 
on uterine smooth muscle of the sow with dinoprost, a product 
used for this indication.
Materials and methods
Seven 8-month old LDxLW prepubertal gilts were included in 
the study. After induction of fi rst estrus with 400 IU PMSG and 
200 IU HCG (PG600®), gilts were humanely killed on fi rst day of 
estrus (confi rmed by standing refl ex). Eff ects of cloprostenol 
and dinoprost on uterine smooth muscle was evaluated using in 
vitro organ bath technique. 
Eight 10 x 5 mm strips of myometrium were removed from each 
gilt, using the same protocol, and placed in Petri dishes in sterile 
saline. After recording exact weight and length of each strip, four 
were mounted in direction of the longitudinal fi bers and four in 
direction of circular fi bers, and placed in the organ bath vessels 
attached to an isometric transducer (Pioden UF1, Graham Bell 
House, Canterbury, UK). Krebs Ringer solution (5ml) was then 
added to each vessel. The following protocol was followed: 
1. Study of spontaneous motility of longitudinal and circular 
uterine smooth muscle in Krebs Ringer solution. After the 
stabilization period, the spontaneous motility of the prepara-
tions was recorded over about 10 minutes 
2. Study of the longitudinal and circular smooth muscle motil-
ity in response to dinoprost (571 mcg/ml. 10 minutes) and 
cloprostenol (Planate®) (10 mcg/ml 10 minutes) (3). The 
concentration was selected in the light of experience from 
previous studies, with similar proportions to those used 
systemically under fi eld conditions for both substances.
The mechanical activity of the preparations was amplifi ed (The 
MacLab Bridge Amp, AD Instruments Inc, Milford, Mass, EE.UU) 
and fi ltered (4). This mechanical signal was sent to an analog-to-
digital converter, and the data recorded numerically on com-
puter by a data acquisition and processing program (MacLab 
System), which was used to measure amplitude, frequency and 
area under the curve of induced uterine motility per unit of time 
(Interval/time/surface, Maximum-minimum, Interval/time) for all 
recorded preparations.
Statistical study included the Kolmogorov Smirnov test to assess 
the goodness of fi t of the variables to a normal distribution. An 
ANOVA test was then performed, and subsequently non-para-
metric tests (Friedman test and chi-square test).
Results
Contractions of the circular fi bers of uterine smooth muscle 
were quantifi ed (intensity, rhythm and duration) in the fi rst 
place, and no signifi cant diff erences were found for any of the 
parameters studied.
Table 1: Average (±SD) motility of circular fi bers.
Interval/time/surface Max-Min Interval/Time
Cloprostenol 0.023±0.006 0.99±0.19 0.99 ±0.17
Dinoprost 0.023±0.004 1.18±0.25 1.09±0.145
p=0.804 0=0.548 p=0.666
Nor were any signifi cant diff erences found in the quantifi ed 
contractions of the longitudinal fi bers.
Table 2: Average (±SD) motility of longitudinal fi bers.
Interval/Time/Surface Max-Min Interval/Time
Cloprostenol 0.059 ±0.011 3.89±1.03 2.7±0.46
Dinoprost 0.044±0.006 3.29±0.76 2.14±0.36
p=0.548 p=0.603 p=0.58
Finally, the values obtained for each of the gilts included in the 
study were compared, and again, no signifi cant diff erences were 
found between them.
Discussion
According to these results, cloprostenol produced the same ef-
fect as dinoprost on the contractions of uterine smooth muscle 
of sows, for both circular and longitudinal fi bers. This means that 
cloprostenol (Planate®) is a candidate for post partum use for 
prevention of vaginal discharge, as has been shown in previous 
fi eld studies (5). The fact that no signifi cant diff erences were 
found between the animals included in the study indicates the 
consistent repeatability of the results obtained with both treat-
ments.
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Introduction
Among its other properties, such as its luteolytic eff ect, prosta-
glandin F2 α (PGF2 α) induces contractions of the smooth muscle 
of the uterus. It has been reported that, in the sow, postpartum 
PGF2 α injection may cause a more rapid return to estrus after 
weaning, may increase prolifi cacy in subsequent farrowings 
and prevent uterine discharge, thus assisting in the reduction 
of premature culling or mortality. Furthermore, it may increase 
milk production and consequently reduce neonatal mortality(1). 
The aim of the present study was to assess the eff ects of post-
partum cloprostenol (Planate®), a synthetic analogue of PGF,2 α 
compared with dinoprost (Dinolytic®), another product with the 
same indication.
Materials and Methods
The study was undertaken on a 1400-sow farm on two sites in 
Navarra (northern Spain), which transfers two lots of 80 sows 
per week into the farrowing barn, and practises early wean-
ing at average of 19-21 days of age. The herd was negative for 
PRRSv, but had severe reproductive problems. In February 2009, 
the farm records showed that about 17.5% of sows returned to 
estrus after weaning, and 8-10% exhibited an abnormal post-
farrowing uterine discharge. 
452 sows were allocated to one of two groups: A Planate® group: 
220 sows, injected IM with 2ml cloprostenol (875 μg/ml); and 
a Dinolytic® group: 232 sows, injected IM with 2 ml dinoprost 
(5mg/ml). Untreated animals acted as controls using the farm’s 
historical data. In any week, all the sows which farrowed were 
treated 24-36h later with one or other product, the products be-
ing alternated week by week.
The following parameters were recorded: number of sows with 
abnormal vulval discharge during lactation and weaning, dur-
ation of lactation, number of weaned piglets, weaning to service 
interval, weaning to fertile service interval, and fertility. Sows 
were individually identifi ed and cross-fostering was only allowed 
among sows from the same treatment group. No oxytocics or 
NSAIDs were used during or after farrowing.
Statistical analysis was carried out using the General Linear Mod-
el (GLM-SPSS 15.0 for Windows). The Pearson’s chi-square test 
and the Breslow test were used for the comparison of means.
Results
A comparison, between groups, of the parities of the sows 
within them showed that they were fully comparable: 86.45% 
multiparous and 13.6% primiparous sows in the Planate® group, 
and 88.8% and 11.2%, respectively, in the Dinolytic® group, 
(p=0.1522).
Table 1: Comparative results for primiparous animals
Dinoprost Cloprostenol
No.weaned 11.31±0.34 10.97±0.2 p=0.63
Lactation days 19.08 18.98
% Fertility 96 96.6 p=0.93
% Vulvar discharge 4 0 p>0.05
WSI (fertile) 6.4 6 p=0.31
Table 2: Comparative results for multiparous animals
Dinoprost Cloprostenol
No. weaned 11.14±0.2 11.24±0.1 p=0.102
Lactation days 19.08 18.98
% Fertility 87.9 88.1 p=0.19
% Vulvar discharge 2.5 1.7 p=0.73
WSI (fertile) 12.7 11.9 p=0.18
The mean number of weaned piglets in untreated animals 
was 10.8. In the month before treatment, vulval discharge was 
present in 7% of untreated sows, and 60% of these returned to 
estrus.
Discussion
Postpartum reproductive parameters improved with both treat-
ments, especially fertility, weaning to fertile service interval, and 
number of weaned piglets, the most notable feature being the 
nearly complete absence of vulval discharges. As a result, an 
improvement in prolifi cacy could be expected in the next cycle 
(2). 
Therefore, the use of PGF2 α analogues after farrowing on a farm 
with a high prevalence of uterine discharge can be a very valu-
able treatment option, although other factors such as hygiene 
and general management still require proper attention.
There were no signifi cant diff erences between the treatment 
groups, thus it can be concluded that post farrowing treatment 
with cloprostenol (Planate®) is an option for the prevention of 
this type of reproductive disorder. 
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Introduction
Paracetamol has antipyretic and antalgic properties but has a 
specifi c pharmacological profi le(1,2) which explains paraceta-
mol’s good level of tolerance in pigs. The demonstration of the 
paracetamol’s safety for gestating and lactating sows(3) has 
allowed the inclusion of these two categories in the summary of 
product characteristics (SPC) for Pracetam® 10% premix. A fi eld 
trial has been carried out by the University of Parma within a 
conventional breeding unit to measure the interest of paraceta-
mol during peripartum period.
Materials and Methods
A hundred sows have been included in the trial, divided into two 
batches, control and treated. The treated batch (n =50) received 
a medicated feedstuff  containing paracetamol (Pracetam® 10% 
premix / 30mg of paracetamol per kg of body weight per day) 
during the peripartum period, over 6 days, 4 days before far-
rowing and 2 days after. The control batch (n=50) has received 
the same feedstuff  with no paracetamol. The sows have been 
intensively observed for the 6 days prior to farrowing, on the 
day of farrowing and during the post-partum period. In order to 
describe each criterion, they were marked 0, when normal and 1 
when they were considered as abnormal. For daily monitoring, 
the scores were totalled over the entire period covered. Unless 
stated to the contrary, the statistical analysis used the Mann-
Whitney test (Wilcoxon).RESULTS
On the day of inclusion in the study, none of the observed 
parameters was signifi cantly diff erent between the two batches. 
In addition, no diff erence was noted during the monitoring 
of the farrowing. The lactation anomalies were marked indi-
vidually and two classes were created: normal lactation and 
moderately abnormal lactation. For these two classes, there was 
no diff erence between the two batches (Chi 2 test, p=0.137). 
Three classes were created to mark the sows’ appetite: the ap-
petite was signifi cantly less disturbed in the batch treated with 
Pracetam® than in the control batch (Chi 2 test, p=0.033). In 
addition, the phenomenon of constipation was signifi cantly less 
frequent, particularly during the fi rst three days post-partum, in 
the treated batch (Chi 2 test, p<0.001). Moreover, the number of 
sows having presented abnormal faeces was signifi cantly lower 
than in the treated batch (Chi 2 test, p=0.010). The number of 
sows whose condition required medical intervention is also 
lower than in the treated batch (particularly during the fi rst 
three days post-partum, Chi 2 test p=0.044) (see fi gure 1).
 With regard to the piglets, the litters from the two batches 
presented no signifi cant diff erence in terms of mortality. Nor 
was there any signifi cant diff erence between the two batches 
with regard to the health of the piglets at three days of age, but 
there is a trend (Chi 2 test, p=0.07) of better health in piglets 
born of sows treated with Pracetam®. The same is also valid for 
the incidence of diarrhoea (Chi 2 test, p=0.059). Moreover, the 
number of piglets having to receive an individual treatment was 
signifi cantly weaker in the treated batch, particularly during the 
fi rst three days of life (55 compared with 36 piglets, Chi 2 test, 
p=0.037).
Discussion and Conclusion
The signifi cant diff erences observed in the sows from the treated 
batch (state of health, number of medical interventions) may be 
attributed to the eff ects of the paracetamol. As for the signifi -
cant diff erences recorded in piglets (state of health, number of 
treatments), they may be interpreted as a indirect consequent 
of the positive eff ects observed in the sows; the sows being in 
better health in post-partum period (less fever, less constipa-
tion, appetite regained earlier), they more voluntarily provided 
piglets access to the teat, which had a direct consequence on 
their health and their development.
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Porcine circovirus type 2 (PCV2) prevalence in abortions in France
Guillaume Perreul1 Bernard Fily1 Sophie Longo2 Thaïs Vila3 Jean-Bernard Herin1 Julie Venet3 François Joisel3
1. Merial S.A.S., Ancenis, France; 2. BPC, Labruguière, France; 3. Merial S.A.S., Lyon, France
Introduction
The role of porcine circovirus type 2 (PCV2) in reproductive 
disorders has been studied (1). The present paper reviews the 
results of the lab diagnosis collected through a MERIAL protocol 
« pack avortons » from June 2008 to June 2009.
Material and Methods
Aborted foetuses or weak piglets (AF-WP) include stillborns and 
weak piglets which breathed and/or suckled some colostrum 
before death. 
Macroscopic aspect was detailed for 271 AF-WP. Due to poor 
conservation, 25 AF-WP were not submitted for any analyses. 
PCV2, PPV and PRRSV diagnostics were performed on 296 
AF-WP from 93 sows in 30 farrow-to-wean and farrow-to-fi nish 
non-PCV2-vaccinated herds. 
Lab analyses for PRRSV and/or PPV were performed in 15 herds 
out of 30 on lung pools. In each herd, 1 pool (=3 AF-WP) for each 
test: all pools were PCR-negative. 
Diagnostics for PCV2 were completed in 266 AF-WP as follows: 
• by PCR on liver and/or heart for all pooled AF-WP (101 pools : 1 
pool=max 3 AF-WP from the same dam)
• in frozen AF-WP which did not drink or breathe totally: anti-
PCV2 antibody test performed on 135 AF-WP using thoracic 
and/or abdominal liquid (SERELISA® PCV2 Ab, Synbiotics, Lyon, 
France)
• by immunohistochemistry (IHC): 36 IHC were performed from 
individual AF-WP samples: 11 on livers and 25 on hearts.
A farm was considered as facing PCV2 reproduction disor-
ders when at least 1 AF-WP was PCV2 positive using at least 1 
method.
Results
Table 1: PCV2 prevalence in herds
No/Total Percentage (%)
PCV2-positive farms 12/30 40
PCV2-positive AF-WP 66/266 24.8
Table 2: Distribution of PCV2-positive AF-WP according to organ and 
analysis techniques
Clinical aspect of positive 
AF-WP(No)
%age + liver 
(PCR &/or IHC)
%age +heart 
(PCR &/or IHC)
Abdom. &/or thor. 
liquid (ELISA)
No lesion (31) 34.6 51.6 69.6
Lysed (11) 0 85.7 50
Mummifi ed (8) 100 75 0
Stillborn (8) 0 0 100
Lysed/discolored liver (3) 0 100 0
Breathed/No drink (5) 66.7 20 75
Total positive AF-WP (66) 29.1 51.6 61.5
In the 66 PCV2-positive/266 AF-WP (24.8%) PCV2 was found 
most frequently in hearts, except in stillborn AF-WP in which 
anti-PCV2 antibodies were found. Anti-PCV2 antibodies were 
found in all AF-WP types except in mummifi ed AF-WP and in AF-
WP with lysed/discoloured liver.
Discussion
The « pack avortons » was put in place to systematically confi rm 
or infi rm the involvement of the major reproductive pathogens, 
i.e. PPV, PRRSV and PCV2 in case they could be suspected. All 
analysis methods taken together, these results report a high 
PCV2 prevalence. Indeed PCV2 was evidenced in AF-WP in 40% 
(often several aborted litters per case) of herds where reproduc-
tion disorders were investigated. 
In addition, these results enabled to defi ne a diagnosis strategy: 
mummifi ed foetuses are more likely to be found PCR positive 
(mumifi ed piglets are often dry so no liquid can be harvested 
from them to perform ELISA) especially when they are not lysed 
whereas stillborn foetuses are more often ELISA-positive (i.e. 
anti-PCV2 antibodies detection). It is well-known that foetuses 
become immunocompetent from the last third of the gestation, 
i.e. about 70 days onwards. So age (>70 days of age, i.e. about 
17 cm long) and denaturation status of the conspectus could be 
used as choice criteria for the diagnosis method. 
Conclusion
PCV2 appears to be involved in a large number of reproductive 
disorder cases and has to be included in the diff erential diagnosis.
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Investigation of reproductive failures caused by porcine circovirus 
type 2 in large pig production units in Croatia
Zoran Lipej; Dinko Novosel; Jelena Balatinec; Besi Roic´
Croatian Veterinary Institute, Zagreb, Croatia
Introduction Porcine circovirus type 2 (PCV2) considered 
the causal agent of PMWS, has also been demonstrated to be 
involved in reproductive failure [1]. Congestive heart failure, 
excess fl uid in the thoracic and abdominal cavity, dilated and 
hypertrophied heart, fi rm and enlarged liver was frequent and 
the most prominent gross pathological fi nding in aborted and 
stillborn piglets [2]. Histologically, there were severe non-sup-
purative myocarditis and myocardial necrosis with fi brosis [1, 2]. 
The objective of this study was to investigate role of PCV2 in 
aborted and premature piglets connected with reproductive 
disorders on large pig production units in Croatia.
Material and Methods Eight farrow-to-fi nish farms with previ-
ous history of PMWS and reproductive failures were selected for 
the study. A total of 83 fetuses aborted in the last third of gesta-
tion and premature piglets submitted to the Croatian Veterinary 
Institute, were included in this study. 
Briefl y, a post-mortem examination was performed and samples 
of heart were collected in 10% buff ered formalin for histopatho-
logical examination and immunohistochemistry (IHC) and in situ 
hybridization (ISH). For PCR detection samples of lungs, spleen 
and liver were pooled and stored on -70°C. Tissue in fi xative was 
routinely processed and stained with H&E. Myocardium sections 
were proceeded by IHC detection with anti-PCV2 ORF2 mono-
clonal antibodies (Ingenasa®) according to previously described 
protocol[3]. In situ hybridization was performed with digoxi-
genin labelled 41base oligonucleotide probe on myocardium 
tissue according previously described protocol [4]. For detection 
of PCV2 ORF 1 is used Q-RT-PCR as previously described protocol 
[5].
Results Salient gross fi ndings demonstrated in aborted or still-
born piglets were diff use subcutaneous oedema, oedema and 
segmental haemorrhages of umbilical cord, hydrothorax, ascites, 
subepicardial haemorrhages and haemorrhages on kidney cor-
tex. Histopathologically, in 21 (25.30%) fetuses mild myocardial 
degeneration and mild myocardial necrosis without lymphocytic 
infl ammatory reaction were observed. All of tested samples of 
heart were negative for presence of PCV2 antigen by IHC and all 
of tested myocardium tissue was negative for presence of PCV2 
genome by ISH. In all 83 tested samples PCV2 genomic DNA is 
detected.
Discussion In this study gross lesions on fetuses characterized 
by severe, nonsuppurative myocarditis and myocardial necrosis 
with fi brosis reported as specifi c for PCV2 associated reproduct-
ive failure, were not found. 
Positive PCR fi ndings in all 83 samples of myocardial tissue are 
unexpected and surprising and in contrast with negative IHC 
and ISH results in same heart tissues. Therefore, all PCR positive 
results are considered as false positive or result of secondary 
contamination. Because of that sequencing of PCR products 
still need to be performed to confi rm it. According to absence 
of specifi c gross lesions on examined fetuses, no characteristic 
histopathological lesions and negative results of IHC and ISH in 
myocardial tissue we consider there is no evidence that PCV2 
caused reproductive failure in Croatian large pig production 
units. Based on our results, the lack of evidence of association 
between PCV2 and reproductive failure suggests that PCV2 is 
probably not an important abortifacient pathogen in Croatia. 
These results are in accordance with Spain researchers [6]
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Detection and prevalence of viral pathogens from aborted fetuses and stillborn piglets in Korea
Won Gwnag Lee; Tae Hun Woo; Jeong Hee Han
School of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon-si, Korea
Introduction 
Reproductive disease during the gestation in sows is usu-
ally manifested by abortion or stillbirth. Two major classes of 
reproductive failure are recognised in swine. A fi rst category is 
represented by infectious agents (considered responsible for 
30–40% of abortions, mummifi ed fetuses, and stillbirths) that 
cause primary infection of the reproductive tract and most 
of them are viruses. A second group includes toxins, environ-
mental and nutritional stresses, and systemic disease in the sow 
(considered responsible for the rest of the reproductive failure). 
A large number of viruses have been reported to aff ect porcine 
reproductive performance, and it is likely that any virus capable 
of causing clinical illness in adult swine, or crossing the placental 
barrier to infect the porcine conceptus, is a potential reproduct-
ive pathogen. This experiment was conducted to investigate 
the presence of recognised abortifacient viruses from aborted 
fetuses and stillborn in cases of reproductive failure in sows.
Materials and Methods
A total of 219 samples of aborted fetuses or stillborn, submitted 
to the Department of Veterinary Pathology of Kangwon National 
University between 2006 and 2009 May, were collected from 97 
commercial swine farms located in the fi ve provinces(Gyunggi, 
Gangwon, Chungcheong, Jeolla, Gyeongsang)
in Korea. Each samples were tested for abortifacient viruses such 
as PRRSV, PPV, ADV, JEV, EMCV, SIV and PCV2. The presence of 
virus in fetal tissues was determined by PCR or RT-PCR.
Results 
Abortifacient virus infections were detected in 82 out of 219 
aborted fetuses or stillborn(37.4%) as well as on 39 out of 97 pig 
farms(40.2%). The major viral infection were procine circovirus 
type 2 (PCV2), porcine reproductive and respiratory syndrome 
virus (PRRSV) and Aujesky’s disease virus (ADV) for which 46 
(21%), 19 (8.6%) and 16 (7.3%) were positive, respectively, with 9 
fetuses had complicated infection that 4 for PCV2+PRRSV, 3 for 
PCV2 + ADV, 2 for PCV2 + PRRSV + ADV. As minor viral infection 
SIV, PPV, JEV for which 8(3.6%), 3(1.3%), 1(0.4%) were detected. 
And EMCV was not identifi ed.
Conclusions
The result suggest that PCV2, PRRSV, ADV is apparently the most 
important viral infectious agents associated with fetal infection 
leading to abortion or stillbirth in Korea. Moreover, SIV, PPV and 
JEV might have a minor impact on reproductive disease.
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Gross morphology of the oviducts in slaughtered replacement gilts
Padet Tummaruk; Sawang Kesdangsakonwut; Paisan Tienthai
Chulalongkorn University, Bangkok, Thailand
Introduction
Retrospective studies based on slaughterhouse materials are a 
useful tool for the clinical diagnosis of reproductive disturbance 
in pigs (1, 2). In the pig oviduct, a lot of important reproduct-
ive events such as sperm capacitation, fertilization and early 
embryonic development take place (3). In Thailand, 47% of all 
culling replacement gilts are culled due to reproductive prob-
lems, i.e., anestrus, repeat breeding, not being pregnant, vaginal 
discharge and abortion (4). The objective of the present study, 
therefore, was to investigate gross morphology of the oviducts 
in gilts culled due to reproductive failure in Thailand.
Materials and Methods
Genital organs from 337 replacement gilts from 6 swine herds in 
Thailand were collected at slaughterhouses between May 2005 
and September 2008. The organs, including ovaries, oviducts, 
uteri, cervices and vaginas-vestibules-vulvae were collected, 
placed on ice and transported to the laboratory within 24 h after 
culling. Historical data included herd, gilt identity, breed, date of 
birth, culling date, body weight at culling and reason for culling 
were collected. Age at culling was calculated. The reproductive 
cycle of the gilts were classifi ed according to the appearance 
of the ovary as inactive, follicular and luteal phases (2). The 
abnormalities of the oviduct were investigated and analyzed 
by using frequency analysis. Pearson’s correlation was used 
to analyze the relationship between the length of the oviduct 
and body weight, uterine weight, length of the uterine horns, 
length of other genital organs and number of ovulations. Length 
of the oviduct was compared between left and right sides by 
using paired t-test. The infl uence of reproductive cycle and 
body weight on the length of the oviduct was analyzed by using 
multiple ANOVA.
Results and discussion
On average, the gilts were culled at 300.9±49.3 days of age and 
the body weight at culling was 145.5±20.2 kg. The reason for 
culling included anestrus (154 gilts), abnormal vaginal discharge 
(n=62), repeat breeding (n=41), abortion (n=27), not pregnant 
(n=20), non-reproductive problems, e.g., lameness, illness, and 
poor conformation (n=21) and miscellaneous (n=8). Of these 
gilts, 294 gilts (88.0%) had normal oviducts, 29 gilts (8.7%) had 
moderate to severe congestion of the oviducts, 4 gilts (1.2%) 
had salpingitis, 3 gilts had pyosalpinx (0.9%), 3 gilts (0.9%) had 
congenital abnormalities, i.e., unilateral hypoplasia, oviductal di-
verticulum and a remaining of epididymis in a true hermapodite 
gilt, and 1 gilt had blood clot obstruction in the oviduct. Of the 
anestrus gilts, 134 had normal oviduct, 12 had oviduct conges-
tion, 3 had congenital abnormalities, 2 had salpingitis and 1 had 
pyosalpinx. Of the gilts culled due to vaginal discharge, 54 had 
normal oviduct, 6 had oviduct congestion and 2 had pyosalpinx. 
Of the repeat breeding gilts, 33 had normal oviduct, 6 had ovi-
duct congestion, 1 had salpingitis, and 1 had blood obstruction. 
Of the aborted gilts, 25 had normal oviduct and 2 had oviduct 
congestion. Of the non-pregnant gilts, 17 had normal oviduct, 
2 had oviduct congestion and 1 had salpingitis. All of the gilts 
culled due to non-reproductive and miscellaneous causes had 
normal oviduct. Of the gilts with normal and congested oviducts 
(n=323), the length of the oviducts was 27.9±6.7 cm. on the left 
and 26.2±6.2 cm. on the right sides. The left oviduct was 1.7 cm 
longer than the right oviduct (P<0.001). The length of the ovi-
ducts during inactive phase was shorter than luteal and follicular 
phases (21.1 versus 28.7 and 31.3 cm, respectively (P<0.001). 
Gilts with a body weight of 92-130 kg had a signifi cantly shorter 
oviduct than gilts with a body weight of above 150 kg (P<0.008). 
The length of the oviduct was signifi cantly correlated with body 
weight (r=0.34, P<0.001), uterine weight (r=0.62, P<0.001), 
length of the uterine horns (r=0.54, P<0.001), length of the 
uterine body (r=0.44, P<0.001), length of the cervix (r=0.26, 
P<0.001), length of the vagina (r=0.31, P<0.001) and number of 
ovulation (r=0.21, P=0.003). The present study demonstrated 
some important gross morphology of the oviduct in slaughtered 
replacement gilts in Thailand.
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Urinary tract infections in sow herds with and without frequent puerperal diseases
Michael Wendt1 Jutta Verspohl2
1. Clinic for Swine and Small Ruminants, Hannover, Germany; 2. Institute for Microbiology, Hannover, Germany
Introduction
Uncomplicated infection of the lower urinary tract frequently 
occurs in sow herds. Clinical symptoms in sows are very mild 
and include urinary anomalies and vulvar discharges. How-
ever, urinary tract infections (UTI) are often associated with the 
development of puerperal endometritis and reduced fertility 
accompanied by increased rates of regular returns to estrus and 
repeat-breeder sows (1).
The aim of this study was to investigate the prevalence of UTI in 
sow herds with or without frequent puerperal diseases.
Materials and Methods
During farm visits as many mid-stream urine samples as possible 
were collected from a total of 34 sow herds by spontaneous mic-
turition of sows in dry sow, gestation and farrowing areas (herd 
size: group 1-50: n=3, group 51-100: n=8, group 101-250: n=16, 
group 250-500: n=7).
Urine samples were fi rst investigated by macroscopic examina-
tion (turbidity, irregular contents). Visually altered samples were 
selected and further controlled by test strips (pH, nitrite, protein, 
blood) as well as by microscopic investigation (crystalluria). 
Aerobic bacterial counts were estimated by dip slides, 105 cfu/
ml urine were taken as a threshold for a signifi cant bacteriuria 
(=UTI). Specifi cation of bacterial isolates was carried out by aer-
obic culture techniques in 129 samples (4 per farm on average).
Results
In total 1194 urine samples were collected; the mean percentage 
of sampled sows per farm was 20.3%, ranging from 8.2 to 64.8%. 
Macroscopic changes were detected in 500 samples (41.9%), on 
8 farms <30% of samples were altered, on 21 farms 30-60% and 
on 5 farms >60%. 435 out of 500 visually altered urine samples 
were investigated using dip slides, revealing 213 samples with 
signifi cant bacteriuria (49.0%). Severe crystalluria was a common 
fi nding in visually altered samples (37.7%; unspecifi c phos-
phates, triple phosphates, calcium oxalate), but only one third 
was accompanied by a bacteriuria.
The mean percentage of UTI for all herds was 20.9%; on farms 
without frequent puerperal problems UTI were detected, in 13.0 
(+8.1)% of the herd, on farms with frequent MMA problems UTI 
were present in 25.3 (+12.6)% of the herd. However, sample size 
for a prevalence survey (with 90% confi dence interval, 10% pre-
cision, estimated prevalence 20% >> sows per herd/sows to be 
sampled: 50/24, 100/31, 250/37, 500/40, >500/43) was fulfi lled 
only in 15 herds. The mean percentage of UTI for these 15 farms 
was 18.0 (+9.6)%, 5 herds without MMA problems and 10 herds 
with frequent MMA problems revealing 10.6 (+6.0)% and 21.6 
(+9.1)% UTI, respectively (p<0.05).
Results of test strips with regard to nitrite-contents were 
compared to results of bacterial counts (dip slides). Only 40.3% 
of urine samples showing signifi cant bacteriuria were nitrite-
positive.
Bacteriological investigation of 129 samples demonstrated in 
110 cases only one species with a bacterial count >105 cfu/ml; in 
19 cases two species with a high bacterial count were found. E. 
coli was isolated most frequently (n=96) followed by Enterococ-
cus spp. (n= 14) and alpha-hemolytic streptococci (n=7). 
Discussion 
Intensive sampling is necessary to obtain a suffi  cient number of 
urine samples for a conclusive UTI prevalence survey. The mean 
UTI percentage seemed to be overestimated when sample size 
was too small. UTI has to be supposed as an important risk factor 
for frequent MMA problems, if the prevalence in a herd exceeds 
20%. Ascending infection of the uterus follows uncomplicated 
UTI after farrowing (2). The bacterial fl ora found in the infected 
bladder in this study is often detected in puerperal endometritis 
of sows (3).
As signifi cant bacteriuria rarely occurs in urine samples without 
visual changes, only visually altered samples were selected for 
dip slide investigation; for this reason the percentage of UTI may 
be slightly underestimated. However, severe crystalluria was also 
a common reason for turbidity.
Nitrite content alone was not a suffi  cient diagnostic parameter 
for UTI, because 60% of UTI cases were not detected by this test.
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Relationship between seminal quality and leucocytes presence in ejaculate 
of experimentally infected boars with porcine rubulavirus
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Introduction
The leukocytes presence analyze, in boar semen, as a routine 
technique for quality control of seminal doses is not commune, 
however, in human is performed with strict care, because of its 
association with low fertility patients. Ramírez et al. (1) and Solís 
et al. (2) have indicated that the porcine rubulavirus pig has affi  n-
ity with epididymis and prostate declining the semen quality on 
boars, so a study was conducted to determine the relationship 
between leukocytes presence and ejaculate quality on boars.
Material and methods
Nine York-Landrace boars, aged 12 months, serologically free 
of reproductive diseases underwent two experimental phases: 
Phase I, before-infection, where 10 ejaculates per animal were 
obtained, and, Phase II, after-infection where boars were inocu-
lated intranasally with 5 ml 105TCID50/ml of strain PAC-3 Jal-
isco/1992, scoring 21ejaculates per animal. The boars ejaculates 
were evaluated without fractions: Volume (ml), sperm concen-
tration (spz ml-1) motility progressive (% MTP), abnormalities, 
and live sperm (% SL) were recorder. The leucocytes count (L x 
103mL) was conducted in two phase, using a Neubauer counting 
camera (3), and stained slides with Wright solution. Statistical 
analysis was a repeated measure design with SAS Mixed Model.
Results
Table 1 shows the quality and production values of boar’s sperm 
obtained during the evaluated phases. There were signifi cant 
diff erence (P<0.05) on abnormalities, spz ml-1 and leukocytes 
count. The volume, motility and SL were not diff erent (P>0.05).
 
Semen Quality Phase I Before-Infection Phase II After-Infection
Volumen ml 158 ± 151 152.33 ± 35
Spz. ml -1 829 ± 241 246-483 ± 78.25
% MTP 85 ± 3.8 84.75 ± 6.0 
Abnormalities % 18.4 ± 2.5 41.8 ± 6.6
SL % 80 ± 2.11 80.8 ± 6.5
L x 10 3 ml — 30.2 ± 21.66
Least square means within a row with diff erent subscript letter diff er (P<0.05)
Discussion
The production and semen quality of boars during Phase I was 
similar to healthy boars and weekly work rhythm, reported for 
Kolenbrander et al.(4). However, during Phase II, sperm produc-
tion (spz ml-1) decreased 66%, abnormalities rose twice, and 
the leukocytes presence beginning at eight days after-infection 
(P<0.05).There was a signifi cant increase on Leukocytes weekly, 
where its highest value occur at the eighth week, to gradually 
decline thereafter, reaching a level of 20 leukocyte x103 ml, hold-
ing constant these values the last fi ve weeks of the experimental 
work.
Conclusion
The inoculation of porcine rubulavirus had a negative eff ect on 
sperm concentration and abnormalities increase, but volume, 
live spermatozoa’s and motility remained without changes. In 
addition, leucospermia showed, which at least not disappear 
during the period under investigation and the semen quality 
never recovers.
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Inﬂ uence of maternal antibodies on PCV2 vaccine eﬃ  cacy
Brad J. Thacker; Warren D. Wilson
Intervet/Schering-Plough Animal Health, Desoto, KS, USA
Introduction
Vaccine interference due to maternally-derived antibodies 
(MDA) has been shown to occur in a number of species and with 
a number of diseases.1 The data reported in this paper was de-
rived from a previously reported study where Circumvent® PCV 
(Intervet Schering Plough Animal Health) was shown to be ef-
fective in controlling PCVD in a herd with a history of moderate 
PCVD.2 In this paper, we report the infl uence of MDA at weaning 
(time of fi rst vaccinatin) on the growth performance and mortal-
ity of vaccinated and non-vaccinated pigs.
Materials and Methods
The study was conducted in a 1700 sow herd that had experi-
enced a mild increase in mortality rates and a severe increase in 
cull rates due to PCVAD. This herd had not previously vaccinated 
for PCV2 so the dams of the pigs used for this study had never 
been vaccinated. Pigs were weighed, tagged and their gender 
was determined one day prior to weaning at approximately 23 
days of age. The pigs were allocated to vaccinated or control 
groups with stratifi cation by weight, gender and litter. The pigs 
were vaccinated per label directions at 3 and 6 weeks of age 
(VAC) or left as non-vaccinated controls (CON). The pigs were 
weighed at weaning with a fi nal weight at 21 weeks of age.
One pig per litter (the largest pig) was bled at weaning and peri-
odically thereafter. Antibody titers to PCV2 were measured using 
an indirect immunofl uoresence assay (IFA). Titers are reported 
as the highest dilution that inhibited fl uorescence. The IFA titer 
at weaning of the tested pig was used as a surrogate MDA titer 
for litter mates. Not all litters contained a pig that was bled and 
those litters were not included in the analysis. The growth rate 
and mortality from weaning to 21 weeks of age were evaluated 
by linear regression and Fisher’s exact test for each titer level, 
respectively. Previous studies indicated that an MDA titer of 
>=640 may interfere with vaccination based on post-vaccination 
serological responses so the data was grouped by MDA titers 
<=320 or >=640.3 These titer groupings were similarly evaluated 
by ANOVA and Chi Square.
Results
The number and percentage of pigs with each MDA titer is 
presented in Table 1. Table 2 presents growth and mortality data 
for vaccinates and controls overall and grouped by MDA titers 
<=320 or >=640. There was no infl uence of MDA titer on either 
growth or mortality rates. Overall, vaccination improved growth 
rate and decreased mortality.
Table 1. PCV2 MDA titers of pigs at weaning
MDA titer No. (%) MDA titer No. (%)
<1:20 43 (9.9) 1:160 98 (22.5)
1:20 38 (8.7) 1:320 74 (17.0)
1:40 51 (11.7) 1:640 59 (13.6)
1:80 52 (12.0) >=1:1280 20 (4.6)
Table 2. Growth and mortality by MDA titer and vaccination status
Group Parameter MDA <=320 MDA >=640 Overall
VAC No. of pigs 178 39 217
Daily gain 1.358 1.335 1.354a
Mortality 6.2% 5.1% 6.0%c
CON No. of pigs 178 40 218
Daily gain 1.313 1.329 1.316b
Mortality 11.2% 7.5% 10.6%d
a,b P value = 0.019; c,d P value = 0.060
Discussion
MDA titer at weaning (time of fi rst vaccination) with Circumvent® 
PCV appeared to have no impact on the subsequent perform-
ance of the pigs. Growth rate and mortality in the pigs that 
were sampled was not impacted by MDA titer as well (data not 
shown). The dams of the pigs used in this study had never been 
vaccinated. Both dam titers and pig MDA titers have been shown 
to be increased by vaccination of the dams prior to farrowing.3 
Vaccination of dams was not evaluated in this study. However, 
serological evaluations of young pigs from sows that were vac-
cinated as young pigs have yielded similar IFA titer patterns as 
reported in Table 1 of this study.
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Introduction
Leptospirosis is considered an important zoonosis as well as an 
emerging infectious disease. Pigs are among those domestic 
animals mostly aff ected by clinical disease, resulting from infec-
tion with pathogenic leptospires. Clinical signs of leptospirosis in 
pigs mainly include unspecifi c symptoms related to reproduct-
ive disorders, such as abortion, stillbirth, mummifi cation and 
birth of weak piglets [1]. Similar symptoms may also be caused 
by a variety of common infectious agents, making laboratory 
testing for leptospirosis essential for both clinical diagnosis as 
well as eradication of the agent from aff ected livestock. Import-
antly, Leptospira-infected animals may proceed to an asymptom-
atic carrier state, shedding infectious leptospires into the en-
vironment and thus providing a source of infection for humans 
[2]. In order to develop a rapid, simple and sensitive method for 
direct demonstration of leptospires in clinical materials, poly-
merase chain reaction (PCR) based methods have been propa-
gated in recent years. Among these, real-time PCR methods 
are especially attractive for clinical applications, because they 
allow not only qualitative, but also (semi)-quantitative detec-
tion of leptospiral DNA. However, only a few published real-time 
PCR protocols have been validated using clinical material from 
humans or livestock [3-5]. Here, we describe the design and 
validation of a novel real-time PCR specifi c for the detection of 
DNA from pathogenic Leptospira spp. and our experience with 
testing a variety of porcine clinical samples.
Materials and Methods
The LipL32 coding region that is only present in pathogenic 
Leptospira spp. was chosen as target region for the design of 
primers and hydrolysis probe for real-time PCR. Special care was 
taken to minimize the number of mismatches between primers/
probe and the available LipL32 target sequences. Real-time PCR 
kinetics and analytical sensitivity were evaluated by amplifying 
serially diluted DNA obtained from a culture of L. interrogans. 
Analytical specifi city was determined by analyzing nucleic acid 
extracted from non-pathogenic leptospires and Leptospira-
related bacteria as well as from a variety of viral, bacterial and 
protozoan infectious agents involved in clinical disorders of 
swine. Clinical material from pigs, such as EDTA-blood, serum 
and tissue samples was obtained in the course of routine testing, 
from private veterinary practitioners and from a private veterin-
ary laboratory. 
Results
Alignment of all Leptospira LipL32 sequences (n = 106), which 
were available from GenBank at the time of assay design 
revealed a maximum of 1 mismatch to the forward primer 
(13 sequences) and 4 mismatches to the reverse primer (1 
sequence). Eight sequences showed a single mismatch to the 
hydrolysis probe and 2 mismatches to the probe were evident 
in 9 sequences, all of which belonged to L. santarosai. Real time 
PCR analysis of a serial dilution of leptospiral DNA showed high 
sensitivity, linear amplifi cation within 5 orders of magnitude and 
acceptable real-time PCR kinetics (R2 > 0.99; PCR effi  ciency = 92-
94%), independent whether leptospiral DNA was diluted in yeast 
tRNA or in pig genomic DNA. The assay was capable of detecting 
all serovars of pathogenic leptospires tested (n = 13), while no 
positive signal was observed with any non-pathogenic member 
of the Leptospiraceae, or with any of the other infectious agents 
tested. Leptospiral DNA was detected in several clinical samples 
obtained from pigs.
Discussion
The real-time PCR assay described here was shown to be specifi c 
for the detection of DNA from pathogenic leptospires. The pres-
ence of pig genomic DNA in serial dilutions of leptospiral DNA 
did not infl uence real-time PCR performance, suggesting that 
the test can also be used for demonstration of leptospires in 
tissues from infected pigs. This is further supported by detection 
of leptospiral DNA in porcine clinical samples. Straightforward 
detection and quantifi cation of leptospiral DNA is necessary for 
clinical diagnosis and may also increase our understanding of 
the epidemiology of leptospirosis.
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Diagnostic investigations on mycobacterial abortion in a sow herd
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Introduction
Swine abortion associated with a mycobacterial infection is an 
uncommon fi nding (Ellsworth et al.). Since intradermal testing 
is time-consuming and therefore cost-intensive, alternative test-
systems are needed to get an economically justifi able overview 
of the situation in an aff ected sow herd.
Materials and Methods
Case history: In March 2009, three neonatal porcine fetuses were 
submitted for diagnostic investigations. The sow was necropsied 
one month later.
Histopathology: Samples were fi xed in 10% buff ered formalin. 4- 
μm-thick sections were cut and stained with haematoxylin and 
eosin, as well as Ziehl-Neelseńs stain.
PCR: DNA was extracted from fetal and maternal tissue with the 
DNeasy Blood and Tissue Kit (Qiagen, Hilden, Germany) follow-
ing the manufacturer´s instructions. Presence of mycobacteria of 
the Mycobacterium-tuberculosis-complex and Mycobacterium-
avium-complex were examined using the primers according to 
Rodriguez et al., Guerrero et al. and Kunze et al..
Immunological tests: Blood samples were collected from 30 
sows and 10 suckling, growing and fattening pigs, respectively. 
They were stimulated with phosphate-buff ered saline (PBS), 
Avian PPD (Prionics) and poke-weed mitogen (Sigma), respect-
ively. Thereafter plasma was analyzed for IFN- γ with Quantikine® 
Porcine IFN- γ Immunoassay (R&D Systems, Wiesbaden; Cut-off  
40 pg/ml). Serum was tested for antibodies with two prototype 
ELISA ID-Screen® Paratuberculosis Indirect Multispecies (IDVet-
MAP) and Mycobacterium avium hominissuis (IDVet-MAHS) 
ELISA (kindly provided by Philippe Pourquier, Montpellier).
Results
Necropsy and histopathology: The fetuses showed numerous, 
small (Ø 2-6 mm), white foci in the liver. Sow: Several white, 
small, fi rm nodules projected from the surface of the endomet-
rium. Several lymph nodes were enlarged. Multifocal, small (Ø 
2-4 mm), white, fi rm nodules were seen on the surface of the 
lungs and in the kidneys. Fetal livers and the aff ected organs of 
the sow showed a mild to severe, multifocal, granulomatous in-
fl ammation, multinucleated giant cells with single to numerous, 
intracytoplasmatic, acid-fast and rod-shaped bacteria.
PCR: M. avium ssp. hominissuis was detected in fetal liver and 
organs of the sow including endometrium, lung, kidney, tonsil 
and several lymph nodes. Mycobacteria of the Mycobacterium-
tuberculosis-complex were not detectable.
Immunological tests: Eleven of 27 sows (3x >1000; 4x 100-1000 
and 4x 40-100 pg/ml) and only one suckling piglet (104 pg/ml) 
responded to Avian PPD. Three sows had detectable antibodies 
(one positive in both ELISAs had to be excluded from IFN- γ-test; 
one positive in IDVet-MAHS and IFN- γ-test; one positive in 
IDVet-MAP and negative in IFN- γ-test). None of the other ani-
mals showed a serological reaction.
Discussion
Tuberculous lymphadenitis caused by M. avium ssp. hominissuis 
is common in swine but genital and/or systemic infections seem 
to be rare. Detection of subclinically infected animals is essential, 
as they could be a source of infection for others. Frequent infec-
tion of sows was demonstrated by IFN- γ-test (41 %). In contrast, 
antibodies were detectable only in single cases. Preliminary data 
are promising, but further investigations are necessary to valid-
ate this new test system. 
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A case report of porcine circovirus type 2 (PCV2) infection with 
many mummiﬁ ed in a newly started sow herd
Jesper S. Olesen
Porcus Swinespecialists, Ringe, Denmark
Introduction
This case report fully proves that PCV2 infection can result in 
many mummifi ed fetuses at farrowing and be a costly problem 
for the producer. The report describes in details a PCV2 outbreak 
in a newly started 550 head sow herd in Denmark autumn 2008. 
PCV2 is also described in the literature as the cause of return to 
estrus as well as mummifi ed and stillborn (1).
Materials and Methods
Data material consists of the production results from the fi rst 
399 inseminated gilts in a newly started sow herd. The results for 
each animal includes: identifi cation number, date of insemina-
tion, date of farrowing, liveborn, stillborn, and mummifi ed.Thirty 
mummifi ed fetuses from four diff erent sows were sent to the 
Veterinary Institute, Copenhagen for proper pathological test-
ing. The mummifi ed fetuses were tested in the following ways: 
1) bacteriological, 2) porcine parvovirus virus (PPV) by antigen-
ELISA, 3) PPV antibodies by immunofl uorescence, 4) amount of 
IgG by ELISA, and 5) PCV2 by immunohistochemistry.Three out 
of the four sows with mummifi ed fetuses sent to the laboratory 
were also blood tested. The blood was analyzed for: 1) PCV2 
antibodies by ELISA, 2) PPV antibodies by ELISA, and 3) PCV2 by 
PCR. 
Results
Out of the 399 inseminated gilts 356 farrowed (farrowing rate of 
89.2 %). The number of total born was 14.5 piglets, live born was 
12.8 (88.5 %), stillborn was 1.0 (6.8 %), and mummifi ed was 0.7 
(4.7 %). 
The average duration of gestation was 117 (± 1.7 days).There 
were mummifi ed fetuses in 86 (24.2 %) of the litters. The number 
of mummifi ed fetuses ranged from 1 to 15. More than 75 % of 
the sows had from 1 to 3 mummifi ed fetuses. The number of 
mummifi ed fetuses per litter was observed to be highest in a 
period of 4 – 6 weeks. There were stillborn in 182 (51.1 %) of the 
litters ranging from 1 to 10 piglets. More than 75 % of the sows 
had 1 to 2 stillborn.Out of the 30 mummifi ed fetuses was: 3 
examined bacteriological all negative for pathogene bacteria, 6 
examined for PPV virus all negative, 8 examined for PPV anti-
bodies all negative, 3 examined for the amount of IgG all normal, 
9 examined for PCV2 in the heart musculature all 9 was positive.
The 3 blood tested sows had low antibody titers for PCV2 and 
PPV infections. In the PCV2 PCR test two sows were negative and 
one sow had a low reaction. 
Discussion
The case report shows PCV2 can case many mummifi ed fetuses 
in a newly started sow herd. The diagnostics is best in the heart 
musculature on the mummifi ed fetuses using immunohisto-
chemistry. A diff erential diagnosis that should be taken into 
account in Denmark typically includes PPV. Blood testing of 
the sow with many mummifi ed fetuses is not a good choice if 
you suspect PCV2.With the production losses described in this 
abstract caused by a PCV2 infection, vaccinating gilts for PCV2 
before mating must be seriously considered when initially popu-
lating a newly started sow herd.
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Introduction
Mummifi ed fetus is one problem that aff ects number of pig-
lets born alive. Uterine space has been reported to be a factor 
increasing in percentage of mummifi ed fetuses (1, 2). Diseases 
could associate with mummy’s appearance in lower litter size 
sows (2). Several diseases cause fetal death including Porcine 
reproductive and respiratory syndrome virus (PRRSv), Porcine 
parvovirus (PPV), Porcine circovirus type 2 (PCV-2) and Japanese 
encephalitis virus (JEV). These viruses could be detected in 
mummifi ed fetuses by molecular biology methods such as 
polymerase chain reaction (PCR) and reverse transcription PCR 
(RT-PCR) (3). The objectives of this study were to investigate the 
presence of viruses in mummifi ed fetuses collected from sows 
using appropriated molecular biology methods and to study 
an association of the viruses found in sample with reproductive 
performance of those sows.
Materials and Methods
A total of 66 mummifi ed fetuses were collected from 5 com-
mercial pig farms, with percentage of mummies greater than 
3. The mummifi ed fetuses then were necropsied and collected 
tissue sample from lung, liver, spleen, kidney and brain. Lysate of 
collected tissue were extracted for RNA for PRRSv and DNA for 
PPV, PCV-2 and JEV. Specifi c primers were used in each reaction 
as follow; for PRRSv: W7PRRS-1 (ATGGCCAGCCAGTCAATCAGC), 
W7PRRS-2 (TCGCCCTAATTGAATAGGTGAC), W7USA (TG-
GAGTTTAGTTTGCCKACGCA) and W7EU (AAAACTGACCTTCCC-
GCTGGA), for PCV-2: PCV-2F (TAGGTTAGGGCTGTGGCCTT) and 
PCV-2R (CCGCACCTTCGGATATACTG), for PPV: NS1-142F (AGC-
CAAAAATGCAAACCCCAATA) and NS1-142R (CTCCACGGCTCCAA-
GGCTAAAG), for JEV: PWN - JE1 (GTGAAYATGACCAGCCAGGT) 
and PWN - JE2 (CATGAACCARATGGCYCTGC). All samples were 
required to run for beta-actin primer specifi c to nuclear receptor 
co-repressor 1 (NCOR 1) and mito-primer specifi c to cytochrome 
B (CB) to proof the presence of RNA and DNA, respectively. 
Sample products that had negative results for each primer were 
excluded from corresponded test. 
The reproductive performance parameters, including total born/
litter, born alive/litter, % stillbirth, average daily litter weight 
gain, wean to fi rst service interval and number of pig wean/lit-
ter, of sows that mummifi ed fetuses were collected from were 
recorded and analyzed for association with viral antigens found 
in those mummifi ed fetuses. 
Results
The results showed that 80% (4/5) of farm was positive to PRRSv 
and 60% (3/5) was positive to PPV. There were only 2 farms 
found both viruses. The results from PCR and RT-PCR showed 
that 17.95% (7/39) of the samples were positive to PRRSV and 
7.69% (3/65) were positive to PPV. All fetuses had negative 
results for PCV-2 and JEV. 
Statistical analysis revealed only an association between litter 
sizes at 13 or lower and the positive samples (p = 0.033). More-
over, sows with litter size of 13 or lower had an odd ratio=2.4 to 
have positive results comparing to sows with bigger litter size. 
Discussion
The results showed that PRRSv and PPV antigen were able to 
be detected in mummifi ed fetal organ. There was no evidence 
of PCV-2 and JEV in the participated farms. Meanwhile, there 
was no association of viral antigen found with sow’s breeding 
performances. However, mummifi ed fetuses in lower litter size 
(≤ 13) sows associated with number of positive samples (odd 
ratio=2.4). Virus infection might play a role in being an addition-
al cause of fetal death during gestation in low litter size sows.
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Clinical manifestation of reproductive failures is highly variable 
and may be presented by either a subclinical infection or by the 
termination of pregnancy. The etiology of abortions is usually 
diffi  cult and a conclusive diagnostic occurs in only 30-40% of 
cases (1). Several infectious agents are associated with abor-
tion and reproductive failures in swine production. In Brazil the 
porcine circovirus 2 (PCV2) associated diseases (PCVAD) are the 
most economically important viral disease for swine production 
and it is associated with reproductive losses. The objective of 
this study was to perform diff erential serology for pathogens 
that cause reproductive failure in sows from farms with a history 
of severe PCVAD in the last 12 months before the sampling. 
Material and Methods
Blood samples were collected from 120 sows which presented 
reproductive problems (mummifi ed, stillborn or unviable 
piglets). Samples were collected from 27 swine farms and up 
to 15 days following the farrowing or abortion. Analyzes were 
performed by routinely standardized laboratory tests and / or 
recommended by veterinarian surveillance authorities and OIE. 
Tests were performed at CEDISA, Embrapa Swine and Poultry 
Research Center or Veterinary Hospital from University of Passo 
Fundo, RS, Brazil. Serological tests used in this work included in 
house tests like immunocytochemistry or ICC for PCV2, Haem-
agglutination inhibition (HI) test for porcine parvovirus or PPV; 
Rose Bengal test (RBT) and the buff ered plate agglutination test 
(BPAT) to identify antibodies against Brucella suis; Microscopic 
agglutination test (MAT) for diagnostic of leptospirosis (antigens 
selected for use in the MAT included representative strains of 
the serogroups known to exist in the region) and commercially 
available tests such as the Elisa screening for Pseudorabies virus 
(IDEXX HerdChek* PRV gB Antibody Test Kit), followed by serum 
neutralization test; IDEXX HerdChek* Porcine Reproductive 
and Respiratory Syndrome Antibody Test Kit and for classical 
swine fever virus the IDEXX HerdChek* CSFV Antibody Test. For 
Toxoplasma gondii antibody detection the indirect hemagglu-
tination commercial kit Imuno-Hai from the Wama-Diagnostica 
Laboratories (SP, Brazil) was used (2). 
Results and Discussion
Antibodies against viruses (PCV2, PRRSV, PPV, PRV, CSFV); 
specifi c bacterial agents (Leptospira sp., Brucella suis) and proto-
zoa (Toxoplasma gondii) from selected sows with reproductive 
problems were investigated. All sows tested for PCV2 presented 
a positive reaction at ICC, but with diff erent titers (Table 1). Titers 
varied between 1:20 - 1:160 (+), 1:320 - 1:2560 (++) and above 
or greater than 1:5120 (+++). PPV antibodies were also very 
frequent whereas most of the sows (113 or 94.2%) were positive. 
High positive titers for PPV varied from 1:128 to 1:1024 (++) and 
1:2048 to > 1:8192 (+++) (Table 1). In contrast, 117 (97.5%) of 
sows presented no titer to leptospirosis, and 3 were reagent to 
serovar L. Bratislava with diff erent titers, one sample 1:100 and 
two samples at 1:400. All sows were negative for brucellosis, 
PRRSV, PRV and CSFV, confi rming the control and surveillance 
programs enforced in the country. No T. gondii antibodies were 
detected in the tested samples. 
Table 1 - Distribution of antibody titers for PCV2 and PPV 
Pos (+++) Pos (++) Pos (+) Neg (-)
PCV2 4 (3.3%)a 84 (70%)b 32 (26.7%) c 0d
PPV 44 (36.7%)e 69 (57.5) f 5 (4.15%)g 2 (1.65%)h
a greater than 1:5120 (+++); b1:320 - 1:2560 (++); c 1:20 - 1:160 (+); d below 1:20;
e 1:2048 to > 1:8192 (+++); f 1:128 to 1:1024 (++); g 1:64 (+); h 1:32 (-)
This study analyzed antibody response of individual sows with 
reproductive problems in order to investigate the possible infec-
tious cause. Results indicate indicated a low frequency of anti-
bodies for bacterial agents and a high frequency of antibodies 
for endemic viral agents such as PCV2 and PPV.
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Introduction
Members of Chlamydiaceae family are obligate intracellular 
pathogens with a broad host spectrum. They have been as-
sociated with a wide range of diseases, including enteritis, 
pneumonia, conjunctivitis, pericarditis, perinatal mortality, and 
reproductive disorders, particularly abortion and endometritis. 
Chlamydial species detected in natural infections in swine in-
clude Chlamydophila (Cp.) abortus, Cp. pecorum and a recently 
proposed species, Chlamydia (C.) suis, strains phylogenetically 
related to human C. trachomatis (Everett K.D. et al., 1999). The 
present study describes an outbreak of reproductive disorders 
associated to Chlamydophila abortus in a farm of Iberian pigs in 
Southwest Spain.
Materials and Methods
Farm characteristics.- The outbreak was conducted on a multi-
site farrow-to-fi nish farm with 2060 Iberian sows (nulliparous) 
introduced from a free disease’s farm in 2008. Animals were 
distributed weekly in 22 fl ocks. Natural mating is used and preg-
nancy is confi rmed by ultrasound between 21 and 24 days post-
insemination. The pigs were reared in semi extensive systems. 
Outbreak description.- Disorders were initially detected from 
fl ock 10 onwards in October 2009. They consisted of an de-
creased in farrowing rates (from 92% to 54%); decrease in piglets 
born alive/litter (from 7.03 to 5.69), increase in piglets born 
dead/litter and with low viability (from 14.05% to 25.05%) and 
decrease in the weaned piglets per sow (from 6.62 to 5.62). The 
last 3 fl ocks showed a higher rate in the return to oestrus, cyclic 
and acyclic (from 19.1% to 60.6%).
Bacteriology and virilogical examination.- Six fetuses were 
examinated for bacteriological and virological pathogens by 
standards methods. When the other aetiological agents were 
discarded, a screening for chlamydiae by PCR was perform-
ance, follow by the typing of chlamydial DNA. To get the DNA, 
a DNAeasy tissue kit (QIAGEN. Berlin. Germany) was used. DNA 
was amplifi ed with diff erent protocols and primers. Firstly, a 
family-specifi c PCR were carry out using CHYF and CHYR prim-
ers which target 16S rRNA gene of the Chlamydiaceae family, 
following the protocol described in Condon and Oakey (2007). 
After that, a specifi c PCR Chlamydophila abortus using primers 
pmp-F and pmp-R821 which target pmp 90/91 gene were used 
following the protocol described by Berri et al., (2009). 
Serological examination:A total of 53 sera from aborted sows 
with reproductive disorders were tested by an ELISA- rPOMP 
specifi c to Cp. abortus using the ELISA kit commercialized pby 
IDDEX Laboratories. An anti-Pig IgG- Peroxidase conjugated was 
used (Sigma). The results were expressed as optical densities 
(DO). In addition, 13 sera were tested a second time 17 days after 
abortion looking for sero-conversions.
Results
All six abortion cases tested were positive in stamp stain. 
The PCR showed 3/6 positive samples (samples a, b, c) and 3/6 
doubtful samples (samples d, e, f ) when DNA was amplifi ed with 
a family-specifi c PCR for the gene of the Chlamydiaceae family. 
However, when these samples were tested with a specifi c PCR 
Cp. abortus we only detected 2/6 positive results (samples e, f ). 
Fifty nine per cent of the sera were positive for specifi c anti-
bodies against Cp. abortus. Seroconversions 17 days post-abor-
tion were detected in 83% of the cases. 
Discussion
The results suggest that Cp. abortus may be a possible cause 
of returns to oestrus, abortion and increase of incidence of 
litters with stillborn piglets and piglets with low viability in 
Iberian sows (Camenisch et al., 2004). However, the positive 
samples amplifi ed with a family-specifi c PCR for the gene of 
the Chlamydiaceae family (samples a, b, c) and negative when 
were tested with a specifi c PCR Cp. abortus (samples a, b, c, d) 
suggest the involvement of other species included in the family 
Chlamydiaceae (C. suis, Cp. pecorum) as pathogen in porcine 
reproductive disorders.
The role of domestic or wild ruminants like sources of infection 
and their importance for transmission must be also studied. 
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Introduction
Porcine circovirus type 2 (PCV2) is widespread and has been 
associated with several disease complexes (3). Naturally occur-
ring reproductive diseases related to PCV2 infection have been 
reported and intra-fetal inoculation of PCV2 at various stages 
of gestation showed that virus replicates highly in fetal tissue 
eventually leading to fetal death (1, 2). The aim of this study was 
to identify the subtype of PCV2 and the co-agents involved in 
the reproductive failure in São Paulo state, Brazil.
Materials and Methods
One hundred sixty-eight samples from reproductive failure (44 
aborted and 124 stillborns) collected in positive PCV2 swine 
farms were examined between 2007 and 2009. The homogen-
ized pools of tissue were analyzed for PCV2 by PCR and the 
positive samples tested for PPV, Leptospira spp and Brucella 
spp by PCR to verify the presence of co-infection. To determine 
the extent of genetic diversity among PCV2 detected, a target 
segment encompassing the open reading frame 2 (ORF2) of the 
PCV2 genome was sequenced from nine samples.
Results
PCV was detected in 18 (10.7 %) out of the 168 samples exam-
ined. Among the 18 PCV2-positive samples, 14 were aborted 
fetuses and 4 stillborns piglets. The others agents detected were 
PPV (2/18) and Brucella spp (10/18). The Brucella spp (3/10) and 
PPV (2/2) positive samples were sequenced and compared with 
sequences contained at the GenBank database demonstrating a 
nucleotide identity of ≥ 95 %. The phylogenetic relationship of 
nine PCV2 positive samples showed nucleotide and amino acid 
identity values of 92.2 to 99.8 % and 91.3 to 99.5 %, respectively. 
A Neighbour-Joining tree was assembled and showed that six 
samples had been classifi ed in subgroup PCV2-1(A and B) and 
one in the PCV2-2E. Considering the phylogenetic analysis of 
representative sequences from the three Swedish genogroups 
(SG1-3), all samples were grouped in genogroup 3 (SG-3) (Fig. 1).
Discussion
The surprised results are that Brucella spp. is the main co-agent 
present in co-infection, since the São Paulo state participates 
of the national controlling program for Brucelosis. Therefore 
the positive farms are being oriented about this zoonosis with 
the objective to negative them. However PPV, the main virus 
involved in PCV2-associated disease since PRRVS is absent in 
Brazil, was detected in only two of 12 co-infected animals which 
demonstrates that the farms follow active vaccination program 
for the control of these viral infections. The almost PCV2-positive 
samples involved in reproductive disorders of sows in São Paulo 
state, Brazil are grouped in PCV2-1 subtype and SG-3.
Figure 1: Neighbour-Joining tree of the PCV2 ORF2 for genogroup 
(A) and subgroup (B) classifi cations with PCV1 as outgroup. Numbers 
indicates values calculated on 1000 repeats of the alignment with the 
heuristic method. Strains are indicated by their GenBank access number 
and subgroup or genogroup identifi cation between parentheses. 
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Eﬀ ect of vaccination against Swine Eryripelas in % of piglets born 
dead on a farm in Guanajuato State in Mexico
Oscar Huerta Alva; A. Ayllón
Laboratorios Sanfer SA de CV, Mexico, DF, Mexico
Introduction
The improved production is a constant that requires us competi-
tive in any market, the pig is no exception and towards more 
pigs sent per female fl ea per year, directly depends on the num-
ber of piglets born alive per litter and these is reduced by the% 
of stillborn piglets and mummies, the latter two are caused by a 
myriad of causes and in the specifi c case of stillborn piglets may 
be involved the Swine Erysipelas (personal communication from 
Drs C. Sanchez [2005] and R. Treviso [2007]) 
 The Swine Erysipelas is an actual disease, as reported Schwarts 
(2002), Sierra (2006), Perea (2006) and Hopkins (2006-2008), is a 
systemic disease and has a direct eff ect on blood vessels, caus-
ing more fragile cord cord, same as the time of delivery breaks 
more easily. 
Materials and Methods
By delivering a live vaccine against swine erysipelas 2 or 3 
weeks before delivery reduced the number of piglets born dead 
(personal communication of Dr. C. Sanchez [2005], R. Treviso 
[2007], in Monterrey 2007 staff  report) on this basis, the aim of 
this study is to confi rm the personal experiences of Sanchez 
and Huerta Treviso applying erysipelas live vaccine strain in two 
groups, one 2 weeks before delivery and another 3 weeks before 
delivery, on a farm of 650 stomachs located in the State of Gua-
najuato, as main problem is the number of piglets stillborn birth. 
The groups 16 and 17 were interviewed with the swine erysip-
elas live vaccine and compared against two previous groups (14 
and 15) and two subsequent groups (18 and 19). The farm was 
an outbreak of Swine Erysipelas 5 months ago. 
Results
In the table below we can see the results of group 14 to 19: 
Week 14 15 16 17 19 19
Farrows 30 31 29 30 29 30
TPborn 340 358 340 346 344 340
TPBorn L 295 318 312 324 309 309
Deads 29 31 15 14 23 22
Mummy 13 9 13 8 12 9
Ave TPB 11.3 11.5 11.7 11.5 11.8 11.3
Ave TPBL 9.93 10.26 10.76 10.8 10.66 10.3
% deads 8.53 8.66 4.41 4.05 6.69 6.47
% mummy 3.82 2.51 3.82 2.31 3.49 2.65
Discussion
In the weeks 16 and 17 where sows were vaccinated with a live 
vaccine strain vs. rhusiopathiae Erisipelothrix Koganei 65-0.15, 
females at birth had about 50% less stillborn piglets, compared 
with the two previous groups (14 and 15) and 36% less than 
groups 18 and 19. Consequently increased the number of piglets 
born alive. 
Conclusion
According to these results I conclude that vaccinating pregnant 
sows 2 to 3 weeks before delivery with a live vaccine against 
Erisipelothrix rhusiopathiae strain Koganei 65-0.15, declined by 
50% the number of piglets born dead. 
We must remember that the swine erysipelas is a systemic dis-
ease with high affi  nity to blood vessels (become friable) and at 
delivery, the umbilical cord to get power out piglets and is likely 
to be broken by the stress of labor. 
References 
1. Perea, CML, et al. Determinación de anticuerpos contra Erisip-
elothrix rhusiopathiae.en sueros de cerdos utilizando una prueba 
sencilla de aglitunación., Congreso AMVEC, 2006.
2. Huerta, AOF; Montaño MB, Reporte de casos de Erisipela porcina en 
el Estado de Sonora, Congreso AMVEC, 2006
3. Huerta, AOF; Montaño MB, Reporte de casos de Erisipela porcina en 
el Estado de Sonora, IPVS, 2008.
4. Schwartz, K.J.,2002, Erysipelas: an old disease returns to the swine 
industry or something NEW?, American Association of Swine Veter-
inarians.
5. Sierra, N., Multietiologías complejas de interacción entre PRRS y 
otros patógenos. Congreso AMVEC, 2006.
6. Wood, R.L., 1999, Erysipelas. In Diseases of Swine 8th Ed, ISU press, 
Ames Iowa
Reproduction – Disease
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 1126
Poster Presentations
P.820
Induction of ovulation in weaned sows: how much Buserelin is needed to get a normal LH 
surge and normal embryonic development in primiparous or multiparous females? 
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Introduction:
While the ability of 10μg Buserelin to induce ovulation in gilts 
has already been demonstrated, the dose of Buserelin needed 
to induce ovulation in weaned sows has not been established. 
The aim of this experiment was to assess the ability of diff erent 
amounts of Buserelin to induce a normal LH surge, ovulation 
and early embryo development and monitor whether parity or 
genetic line were modulating the response to Buserelin.
Materials & methods
On 77 hours after weaning, 64 sows received an intra-muscular 
injection of either 0 μg, or 6 μg, or 10 μg, or 16 μg of Buserelin. 
Sows were equally allocated to treatments based on parity 
(primiparous: parity 1 and multiparous: parity 3 to 6) and breed 
(TOPIGS20 and TOPIGS40, both from Topigs, Netherlands). Sub-
groups [dose of Buserelin * breed * parity] were therefore set to 
include four animals.
The end points used were (1) the detection of ovulation by ultra-
sonography at a specifi c time window (32-44h) after treatment, 
(2) the detection of an LH surge (and its magnitude) in blood 
samples collected 1, 2.5, 4, 12 and 24h following treatment, (3) 
the number of corpora lutea and viable embryos at slaughter 
5 days after the expected ovulation and (4) the progesterone 
secretion by the corpora lutea at slaughter. 
Results
As 2 sows had already ovulated within 85h after weaning and as 
5 others ovulated within 32h of injection, data from 15 control 
sows as well as 15, 11 and 12 sows treated with 6, 10 or 16μg 
Buserelin were used for statistical analyses.
Table 1: timing of ovulation
Timing* Controls Treated
primiparous multiparous primiparous multiparous
109-121 1 1 11 18
121-133 4 3
133-145 1 3 5 0
145-157 1 0
>157 1 0 4 0
* = Hrs after weaning
 
Of the Buserelin treated sows 76% were synchronized to ovu-
late between 32-44h after treatment. The proportion of sows 
successfully induced to ovulate was unrelated to the dose of 
Buserelin applied (73, 73 and 83% in sows receiving 6, 10 or 
16μg Buserelin). Parity however had a clear eff ect on treatment’s 
effi  cacy as 100% multiparous sows ovulated during this time 
window, while only 50, 50 and 67% of the primiparous gilts ovu-
lated following injection of 6, 10 or 16μg Buserelin
In all sows that ovulated during the 32-44h time window, a clear 
increase in LH concentrations was observed. Its magnitude 
(2.4ng/ml) was similar to that observed in the control group (2.8 
ng/ml) and unaff ected by the amounts of Buserelin injected. In 
control and treated sows that ovulated at the expected time, 
neither parity nor breed aff ected the features of ovulatory LH 
surge. In contrast, sows that ovulated late had a blunted increase 
in LH concentrationsThe number of corpora lutea (23.5 on aver-
age) was unaff ected by treatment (control vs treated) and by the 
amounts of Buserelin injected. Cyst formation was more com-
mon in primiparous gilts (4/8 and 5/7) injected with 6 and 16μg 
compared to those receiving 10μg Buserelin (1/6). Cyst number 
reached 7.3 ± 8.5 in the 6μg Buserelin group.
In contrast, the average number of good embryos (18.7) was 
unaff ected by treatment and by the dose of Buserelin applied.
No interaction between breed or parity and treatment was de-
tected for progesterone concentrations on day 5 post ovulation.
Discussion and conclusion
It is concluded that: 
(1)  In all multiparous sows of either breed, administration of Buserelin 
at 77h after weaning successfully triggered a full ovulatory process 
generating a normal number of good embryos.
(2)  In primiparous sows, injection of Buserelin may have to be delayed 
past 77h after weaning.
(3)  10μg Buserelin appeared the optimal dosage based on the occur-
rence and number of cystic follicles.
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Treatment of urinary tract infections in sows associated with E. coli
Isabel Radeloff 1 Klaus Hellmann1 Heinrich Greife2 Bernd Stephan2
1. KLIFOVET AG, Muenchen, Germany; 2. Bayer Animal Health GmbH, Leverkusen, Germany
Urinary tract infections (UTI) are a major health concern in 
breeding herds and one of the major causes of death or culling 
of female breeding pigs. Infections may be caused by ascending 
bacterial pathogens from the external genitalia to the bladder 
and kidneys as a consequence of coitus and parturition, and 
incomplete closure of the vulva and/or damaged or relaxed 
urethra. Intensive housing conditions where vulvas get in direct 
contact with faeces may lead to the infection with faecal fl ora. 
Several farms in Germany, the Netherlands and Slovenia, known 
to have a history of urinary tract infections in sows were in-
cluded in the study. Housing and management conditions were 
maintained stable during the clinical trial. 
Sows (sows and gilts) showing urinary tract infections associated 
with Escherichia (E.) coli were treated with Baytril® (enrofl ox-
acin) in a dosage of 5.0 mg/kg body weight. One group (T1) was 
treated for three consecutive days, 24hrs apart, and one group 
(T2) was treated twice, 48hrs apart. Both groups were compared 
to a control group (T3), dosed with 15.0 mg/kg bodyweight 
amoxicillin (Duphamox® LA) twice, 48hrs apart.
Sows were included in the clinical trial if at least 105 colony 
forming units (cfu) were detected per mL mid-stream urine, and 
at least one criterion related to macroscopic appearance of the 
urine was abnormal (pH≥8.0 or smell or cloudiness). The min-
imum bacterial count had to be fulfi lled in one of two systems: 
either in urine analysis of a native urine sample or in the Uricult® 
dip stick agar system. In addition, the general health was ob-
served and bacterial isolation and identifi cation was performed 
to identify the associated pathogen. E. coli (including haemolytic 
and mucoid growth) was identifi ed in 76.8% of the positive 
animals. Other bacterial species identifi ed were Enterobacter 
spp., Enterococcus spp., Klebsiella spp., Staphylococcus spp. and 
Streptococcus spp.
Pre-treatment clinical signs (general health) and urine assess-
ment were compared to post-treatment assessment of the 
same criteria three and 14 days after the start of treatment. The 
success criterion was the bacteriological cure rate on day 14 of 
animals bacteriologically positive for E. coli on Day 0, but nega-
tive on day 14 (animals with a bacteriological result of less than 
105 cfu/mL in both, Uricult® dip stick agar system and urinary 
analysis).
E. coli was eradicated in 46.4% of the animals in treatment group 
T1, in 53.1% of the animals in treatment group T2 and in 44.8% 
of the animals of the control group (T3). For the subgroup where 
mucoid growth of E. coli was identifi ed, the rate of eradication 
was 80.0% in T1 and 100.0% in T2 compared to 42.9% in the con-
trol group. Similar results were observed using the Uricult® dip 
stick agar system: E. coli was eradicated in 45.5% of the animals 
in the T1 group, in 36.8% of the animals in the T2 group and in 
43.2% of the animals in the control group. For the subgroup 
where mucoid growth of E. coli was identifi ed, the rate of eradi-
cation was 83.3% in T1 and 100.0% in T2 compared to 33.3% in 
the control group.
Assessing the urine pre (Day 0) and post treatment (Day 3 to 
day 14) using the Macroscopic Urine Score (MUS), calculated as 
sum of scores of the cloudiness (score 0 to 3) and foul smelling 
(score 0 to 2) of the urine, a signifi cant reduction was observed 
(p<0.05). On day 3 and day 14 the MUS was reduced signifi cantly 
within each treatment group as compared to day 0. General 
health was good at pre-treatment and was kept at this stage 
during the study.
Based on the results observed Baytril® 10% used as an anti-
microbial therapy for sows showing clinical signs of E. coli urin-
ary tract infection, was shown to reduce the infection pressure 
on animal and farm level and can help to interrupt infection 
cycles. Therefore, it should be part of an eradication program in-
cluding improvement of housing conditions, herd management 
and gestation programs in farrowing and nursing pig farms.
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Consumer research on attitudes to vaccination against boar taint in Denmark
Jens Christian E. Jensen
Orion Pharma Animal Health, Nivaa, Denmark
Introduction 
The vaccine against boar taint – Improvac® - was approved 
through central registration in the European Union in May 2009. 
The European licensing procedure includes a full assessment of 
food safety and the product is considered safe for consumers of 
pork. In many countries, however, including Denmark, informed 
consumers develop their own opinions about the use of new 
technical approaches in food production, taking into account 
both the possible eff ect on food and the impact on areas of 
ethical concern, such as animal welfare. To investigate consumer 
attitudes market research has earlier been carried out in other 
countries 1, 2. The aim of this investigation was to learn the 
reaction of Danish consumers to diff erent ways of controlling 
boar taint: castration without anesthesia, castration with pain 
relief (NSAID), castration with local anesthesia, and vaccination 
against boar taint.
 Material and Methods
Capacent, the leading Nordic business consultancy company 
was in charge of collecting, analyzing and reporting the results 
of computer assisted telephone interviews of 1012 persons 
with an age of 18 years or older. A random sample of consum-
ers was secured and only one person per household could be 
interviewed. A short factual description of each method was 
developed in collaboration with industry stakeholders and 
presented to the interviewed persons. Interviews took place 
between August 3rd and 16th 2009
Results
Asked how acceptable do you fi nd: 
1.  Castration of piglets without anesthesia or pain relief (named 
castration in the chart), the answers were 65% unacceptable, 
12 % neutral, 23% acceptable and don’t know 1 %.
2.  Castration of piglets with pain relief (named NSAID in the 
chart), the answers were 44 % unacceptable, 16 % neutral, 
39% acceptable and don’t know 2 %.
3.  Castration of piglets with local anesthetics (named Lidocaine 
in the chart), the answers were 43 % unacceptable, 18 % 
neutral, 37% acceptable and don’t know 2 %.
4.  Vaccination instead of castration, the answers were 16 % 
unacceptable, 9 % neutral, 73 % acceptable and don’t know 
3 %.
Asked which of the methods they would prefer for control of 
boar taint, vaccination was by far the preferred approach.
Discussion
Modern, educated consumers may question the use of new 
products in food production. However, there is also growing 
consumer concern about the pain and stress suff ered by piglets 
during and after physical castration. As in other consumer 
acceptance investigations 1, 2 the results here confi rm that 
when fully informed consumers prefer vaccination as the way 
of controlling boar taint, with their concerns about pork quality 
and animal welfare outweighing their caution about the use of a 
new technology. 
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Introduction
Surgical castration of male piglets is still a common procedure 
worldwide and is primarily done to prevent entire boars from 
developing an unpleasant taste and fl avour of meat. For animal 
welfare reasons, several countries are enacting new laws to ban 
surgical castration without anaesthesia (2). Immunisation with 
two doses of a gonadotrophin releasing factor (GnRF) vaccine 
against boar taint, the second dose given 4 to 5 weeks prior to 
slaughter, suppresses testicular function through the induction 
of antibodies against GnRF (1). The timing of vaccination makes 
it possible to maintain the economic advantages of boars for 
most of the fattening period, while also avoiding the presence of 
boar taint at slaughter. The objective of this study was to deter-
mine the eff ect of using a GnRF vaccine on growth performance 
of male pigs. Vaccinated pigs were compared with surgically 
castrated pigs and entire males under conventionally managed 
farm conditions.
Materials and Methods
Male pigs were randomly assigned to three treatment groups: 
pigs surgically castrated during the fi rst week of life (group „C“, 
n=274), pigs immunised twice during the fattening period with 
a GnRF vaccine (Improvac, Pfi zer Animal Health), the fi rst time 
when 13–14 weeks of age and the second time when 20–21 
weeks of age (group „V“, n=280) and entire males (group „E“, 
n=56). Average daily weight gain (ADG), mortality and medical 
treatment were measured during the study. Additionally, feed 
conversion ratio (FCR) was assessed during the fattening period.
Results
No diff erence in the ADG during the fattening period could be 
determined between „C“ and „V“ (Tab. 1). From the start of the 
study until slaughter at study day 160/173 the ADG in group „E“ 
was lower (625 g/day; P) than in group „C“ (681 g/day; P < 0.001) 
and group „V“ (675 g/day; P < 0.01). The FCR during the fatten-
ing period until study day 160, three days before the fi rst batch 
of pigs were slaughtered at 24–25 weeks of age, was higher in 
group „C“ (2.72 kg feed intake/ kg weight gain) compared with 
group „V“ (2.44 kg feed intake/ kg weight gain; P < 0.001) and 
group „E“ (2.44 kg feed intake/kg weight gain; P < 0.01). Pigs 
in group „V“ performed similarly to those in group „E“ until the 
second vaccination (day 135) after which time they showed a 
substantial increase in feed intake and ADG, while retaining an 
FCR advantage over group C (Tab. 2). The mortality from the 
start to the end was 10.6%, 11.8% and 8.9% in groups „C“, „V“ and 
„E“, respectively. During the same time period, pigs in groups „C“, 
„V“ and „E“ were medically treated 0.51, 0.63 and 0.29 times per 
animal.
Tab. 1: ADG (Means in g/day)
Period “C” “V” “E”
Study start to fattening unit entry 430.2a 405.3b 412.1b
Study start to second vaccination 631.8a 582.4b 588.4b
Study start to cut-off 675.1a 657.4a 625.3b
Study start to fi rst/second slaughter 681.4a 674.9a 625.3b
Fattening unit entry to second 
vaccination 1012.8
a 918.7b 925.5b
Fattening unit entry to cut-off 977.5a 970.6a 890.9b
Fattening unit entry to fi rst/second 
slaughter 971.2
a 982.6a 890.9b
Second vaccination to cut-off 897.2a 1056.5b 826.0c
Second vaccination to fi rst/second 
slaughter 887.9
a 1064.0b 825.9 c
Diff erent superscripts indicate signifi cant diff erences (P≤0.05)
Tab. 2: FCR (Means in kg feed intake per kg weight gain)
Period “C” “V” “E”
Entry to fattening unit until second 
vaccination 2.39
a 2.20b 2.19b
Second vaccination until cut-off 3.31a 2.71b 2.96b
Entry to fattening unit until cut-off 2.72a 2.44b 2.44b
Diff erent superscripts indicate signifi cant diff erences (P≤0.05)
Discussion
The present study supports in part earlier fi ndings that, by 
replacing surgical castration early in life with vaccination of pigs 
against GnRF during the fattening period, the feed conversion 
advantages of boars could be retained for pig production (1). 
Higher ADG of vaccinated animals compared with castrated ani-
mals could only be detected after the second vaccination. No ef-
fects of vaccination could be observed on the mortality or need 
of medical treatment over the whole lifetime. To take greater 
benefi t from the eff ect of vaccination on ADG, the second vac-
cination could be brought forward to the earliest possible point 
of time, although this study did not examine the possible nega-
tive eff ects of doing this, such as increased carcass fatness.
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Introduction
Surgical castration of male pigs is frequently performed due 
to the fact that entire male pigs have the potential to develop 
an unpleasant taste and fl avour of the meat. Vaccination with 
Improvac (Pfi zer Animal Health) suppresses testicular function 
through the induction of antibodies against gonadotropin-
releasing factor (GnRF). GnRF is released from the hypothalamus 
and stimulates the pituitary gland to release luteinising hor-
mone (LH) and follicle stimulating hormone (FSH) which controls 
the production and release of testicular steroids, including 
androstenone. Antibodies against GnRF disrupt this hypothal-
amic-pituitary-gonad axis and thereby reduce the production of 
testicular steroids (2). The objective of this study was to evaluate 
the eff ect of Improvac vaccination on the concentrations of LH 
and FSH in blood, the development of the testicles, and the sup-
pression of boar taint (3).
Material and Methods
A total of 610 males were randomly assigned to three treatment 
groups (T): 274 were surgically castrated in the fi rst week of life 
(T1), 258 (number then remaining) were vaccinated twice with 
Improvac during the fattening period, at 13–14 and at 20–21 
weeks of age, respectively (T2) and 56 were left entire (T3). From 
a subgroup of both T1 and T2 and from all pigs of T3, blood 
samples were collected immediately before second vaccination 
(T2) and again before slaughter at either 24–25 or 26-27 weeks 
of life to determine the serum concentrations of LH and FSH. 
Meat and fat samples were examined with the cold cooking and 
the melting tests. Length, width, weight and volume of testicles 
were determined after slaughter.
Results
Immediately before the second vaccination (T2 only) LH and FSH 
concentrations were not signifi cantly diff erent between T2 and 
T3 (Tab. 1). However, LH and FSH concentrations were signifi -
cantly higher in T1 compared with T2 and T3 at this time as well 
as before both slaughter dates. Before the fi rst slaughter date 
LH and FSH concentrations were signifi cantly lower in group T2 
than in T3.
Tab. 1: Concentration of LH & FSH in plasma (LS means)
Time T1 T2 T3
LH: Before second vaccination 1.84a 1.08b 1.02b
LH: Before fi rst slaughter batch 1.78a 0.75b 1.05c
LH: Before second slaughter batch 1.66a 0.67b
FSH: Before second vaccination 3.75a 0.60b 0.55b
FSH: Before fi rst slaughter batch 3.76a 0.45b 0.55c
FSH: Before second slaughter batch 4.17a 0.44b
Testicle size, weight and volume were signifi cantly lower in T2 
compared to T3 (Tab. 2). In the cold cooking test as well as in the 
fat melting test 100% (25% of total T1) of the samples of T1 were 
rated negative for boar taint. In T2, 98% were rated negative 
for boar taint, whereas in T3 94% were rated positive. In the fat 
melting test 97% of T2 were rated negative and 3% were rated 
positive, including the pigs testing positive in the cold cooking 
test. In T3 94% were rated positive. All pigs in T2 which were 
positive for boar taint in the cooking or melting test and that 
were tested had androstenone and skatole concentrations in 
backfat below threshold levels of 1 μg/g and 0.2 μg/g, respect-
ively.
Tab. 2: Testicles weight, volume, length and width (LS Means)
Variable Side T2 T3
Length (mm) Left 79 107
Length (mm) Right 77 103
Width (mm) Left 46 64
Width (mm) Right 46 63
Weight (g) Left 86 239
Weight (g) Right 83 226
Volume (mL) Left 114 270
Volume (mL) Right 110 257
Discussion
After vaccination with Improvac levels of LH and FSH in blood 
as well as testes size were signifi cantly reduced, consistent with 
mode of action. Of the vaccinated pigs, 98% (235/239) were 
rated negative for boar taint in the cold cooking test and 97% 
(232/239) in the fat melting test. The androstenone and skatole 
levels of the pigs testing positive for boar taint (7/239, 3%) 
were below the commonly accepted threshold levels for these 
substances (1).
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Introduction
Boar taint is related to sexual maturity and male hormones and 
is usually controlled by surgical castration. With growing focus 
on animal welfare, surgical castration without anesthesia has 
become controversial. Alternative approaches include immun-
ization against gonadotropin releasing factor (GnRF)1, which 
disrupts the hypothalamic-pituitary-gonad axis, thereby tem-
porarily suppressing testicular function and steroid synthesis. 
Our aim was to compare productivity, carcass quality and meat 
quality of pigs vaccinated against GnRF using Improvac against 
those of surgically castrated pigs under fi eld conditions.
Materials and Methods
The trial was conducted in a commercial farm in Lithuania. 
402 cross-bred pigs were split into two groups. Pigs in group 1 
(204) were castrated at 3 days of age. Pigs in group 2 (198) were 
vaccinated with Improvac at day 95 and day 140 of life. All pigs 
were fed the same farm-made diet depending on the growth 
phase. Animals were weighed in groups of 20-30 at weaning 
(d.28) entry to the fattening stage (d.60); fi rst vaccination (d.95), 
second vaccination (d.140) and on the day of slaughter (d.180) 
and daily weight gain (DWG) was calculated. Mortality was 
recorded and necropsies performed. Fat was measured using a 
Fat-o-Meater according to the routine slaughterhouse proced-
ures. Samples of longissimus dorsi were tested to assess meat 
quality.
Means, standard deviations and coeffi  cients of variation were 
calculated for the variables assessed. The unpaired t-test (MS Ex-
cell 2003) was used to test diff erences between the mean values 
of groups. P<0.05 was used as the signifi cance level.
Results
Castrates were signifi cantly heavier (74.1kg v 66.5 kg, P<0.05) 
at day140 but other diff erences were not signifi cant. Overall 
mortality rates from farrowing (Gp 1, 14.71%, Gp 2, 14.41%) were 
not signifi cantly diff erent. Lifetime DWG in vaccinated pigs was 
629.1g compared with 631 g in controls, with the diff erences be-
ing +69.73g, -40.56g, -143.85 and +125.07g for the four periods 
(Fig 1).
Vaccinated animals had reduced carcass fat thickness (P<0.001) 
as measured on 2 points of the carcass (22.79±3.93 and 
17.17±2.78 v. 26.2±5.2 and 19.2±3.7 mm). Lean meat in vaccin-
ated animals was greater by 1.9 percentage points (56.7±2.4% 
v 54.8±3.1%, P<0.001). Meat quality parameters did not diff er 
between the two groups (Table 1).
Animals Improvac Control P
Dry matter % 26.48±1.2 26.52±1.2 N.S.
pH 5.48±0.04 5.56±0.11 N.S.
Color 56.4±1.5 52.2±2.5 N.S.
Water binding % 55.6±5.5 55.8±5.1 N.S.
Cooking loss 26.1±2.13 25.0±2.0 N.S.
IM.fat % 2.34±0.73 1.9±0.45 N.S.
Discussion
Compared to boars, castrates are known to be fatter and less ef-
fi cient. Feed conversion was not assessed in this study but DWG 
showed distinct diff erences between the groups. It was initially 
lower in vaccinated pigs compared to castrates, but after second 
vaccination weight gain was superior and at slaughter pigs were 
heavier (not signifi cant). Other studies have reported a higher 
fi nal live weight in vaccinated pigs2. The higher growth rate 
following second vaccination was probably due to higher feed 
intake refl ecting reduced sexual and aggressive activity2. Use 
of vaccination reduced fat thickness and had a positive eff ect 
on muscling. Vaccination did not aff ect objective meat quality 
parameters.
Under the conditions of this study, Improvac appears to off er 
an alternative to physical castration that reduces back–fat and 
increases lean meat percent, while having no impact on meat 
quality. Further work may allow the diff erences in growth pat-
terns to be exploited to improve overall performance.
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Introduction
Entire male pigs are known to be superior to physical castrates 
with regards to lean meat production and growth perform-
ance, which could lead to more profi table pig production (1, 2). 
Nevertheless, physical castration of male pigs is still a common 
procedure in many countries in order to prevent an unpleas-
ant taste and fl avour of the meat of sexually mature boars. The 
main objective of this comparative study was to investigate 
the carcase characteristics of physically castrated pigs and pigs 
immunized with a gonadotrophin-releasing factor (GnRF) vac-
cine, which acts via the hypothalamic-pituitary-gonad axis and 
suppresses testicular function through the induction of anti-
bodies against GnRF. Pigs were raised under fi eld conditions in a 
conventionally managed farm in Germany.
Materials and Methods
Male pigs were randomly assigned to three treatment groups: 
pigs surgically castrated during the fi rst week of life (group T1, 
n=274), pigs immunised twice during the fattening period with 
a GnRF vaccine (Improvac, Pfi zer Animal Health), the fi rst time 
when 13–14 weeks of age and the second time when 20–21 
weeks of age (group T2, n=280) and entire males (group T3, 
n=56). All pigs were weighed individually three days before 
slaughter in either the 24th or 26th week of life. Pigs of groups 
T1 and T2 that weighed 110 kg or more on day 160 were slaugh-
tered in the fi rst batch. Overall, 242 pigs met these criteria. 
The remaining 241 pigs were slaughtered in the 26th week. At 
slaughter, testes were removed and hot carcase weight deter-
mined. Lean meat percentage, thickness of backfat and back-
muscle was measured. The boned ham, boned shoulder, loin 
and belly weights alongside the lean meat percentage of belly 
were measured with the AutoFOM ultrasound system. Carcases 
were categorised, using the EUROP grading system.
Results
There was neither signifi cant diff erence between the groups in 
terms of average liveweight nor in the hot carcase weight (Tab. 
1). The mean dressing percentage was 1.5% higher for T1 than 
for T2 (P<0.0001). The lean meat percentage was signifi cantly 
higher in T2 (P<0.0001). Backfat and backmuscle thickness were 
signifi cantly higher in T1 (P<0.0001 and P=0.0099, respectively). 
Within the EUROP grading (Tab. 1) vaccinated pigs were in fa-
vour (P=0.0034). There were no signifi cant diff erences using the 
AutoFOM system: weights of the boned ham, boned shoulder 
and loin (P=0.5102, P=0.8881 and P=0.1919, respectively). The 
weight of the belly was signifi cantly higher (P=0.0042) in T1 
while the lean meat percentage of belly was signifi cantly higher 
(P<0.0001) in T2.
Tab. 1: Eff ect of immunization with a GnRF vaccine on average live-
weight and carcase weight.
Parameter T1 / LS mean T1 / SE T2 / LS mean T2 / SE P-value
Liveweight, 24th 
week (kg) 110.2 0.97 107.6 1.01 0.0648
Liveweight, 26th 
week (kg) 120.7 1.00 121.3 1.07 0.6999
Carcase weight (kg) 91.5 0.62 89.8 0.62 0.0682
Tab. 2: Eff ect of immunization with a GnRF vaccine on EUROP grading 
of carcase; number of pigs (%).
Grading Physical castrates (T1) GnRF vaccinates (T2)
E 87 (36%) 118 (49%)
U 133 (55%) 113 (47%)
R 22 (9%) 9 (4%)
O - -
P - -
Discussion
In this study diff erences in carcase characteristics between phys-
ically castrated pigs and vaccinated pigs were evaluated. There 
were no statistically signifi cant diff erences between the physic-
ally castrated pigs and those immunized with a GnRF vaccine in 
terms of the average live bodyweight of pigs before slaughter. 
The immunization with a GnRF vaccine improves lean meat 
content, EUROP grading score and reduces backfat thickness. 
Despite a lower dressing percentage, no adverse eff ects on the 
weights of valuable parts of the carcase such as ham, loin and 
shoulder could be detected with the exception of a lower belly 
weight and a lower back muscle thickness. In conclusion, the 
use of a GnRF vaccine to control boar taint could contribute to 
producing pigs with leaner and more muscular carcasses.
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Welfare consequences of slaughter strategy in entire male pig production
Bente Fredriksen; Cathrine Hexeberg; Ola Nafstad
Animalia, Oslo, Norway
Introduction
Aggressive and sexual behaviour is more frequent in entire male 
pigs than in castrates, and might represent an animal welfare 
problem (EFSA 2004). While the incidence of unwanted behav-
iour might be kept on an acceptable level by measures in the 
herd, like sibling groups, the conditions during transport and 
lairage might be harder to control. In Norway, and probably also 
in other countries, a common practice is that the animals are 
sent to slaughter as they reach a certain weight. Consequently, 
not all animals from a pen are delivered to slaughter at the same 
time (split marketing). This practice causes a considerable mix-
ing of unfamiliar animals during transport and lairage. The aim 
of the study was to investigate the practical and animal welfare 
consequences of diff erent slaughter strategies in entire male pig 
production.
Materials and Methods
The study was performed as a fi eld study with two replicates in 
one herd in the period June 2008 – January 2009. A total of 134 
entire male pigs and 139 castrates, all Noroc hybrids (LYxLD) 
were included. The animals were regrouped by sex into pens of 
9 animals when transferred to the growing/fattening unit. In half 
of the pens within each sex, the animals were slaughtered by 
traditional split marketing while the other half were slaughtered 
pen-wise, without mixing with unfamiliar pigs during transport 
and lairage. Skin lesions were recorded regularly for all animals 
in the herd and also at the slaughter house. A four point scale 
was used for front, middle and back on both sides of the ani-
mals. Both total score and max-score were used for the statistical 
analyses. Behavour was also recorded both in the herd and at 
the slaughter house. A sexual index (S-Index) and an aggression 
index (A-Index) per pen were calculated in the following way:
Sexual index = (((number of fl ank pushes + 2x number of at-
tempts to mount + 3x number of mountings)/number of males 
in the pen)/number of minutes recorded) x 60.
Aggression index = (((number of head knocks + 2x number of 
bites + 3x number of fi ghtings)/number of pigs in the pen)/num-
ber of minutes recorded) x 60.**image1**
Figure 1. Mean total score for skin lesions in the herd at the diff erent 
registrations for castrates and entire males. 
B=last registration before fi rst slaughter in the pen, A=fi rst registration 
after fi rst slaughter in the pen. 
Figure 2. Aggressive behaviour recorded at the slaughter house, given 
as index per pen. 
Discussion 
Even though higher skin lesion scores as well as higher A- and 
S-indexes were recorded for entire males than for castrates, the 
eff ect of sex on parameters recorded in the herd was moderate. 
At the slaughter house, the eff ects of both sex and slaughter 
strategy were pronounced (Figure 2). Split marketing seems to 
have a negative eff ect on animal welfare, especially for entire 
male pigs. In addition, the fi ghting might aff ect meat quality and 
result in downgrading of carcasses because of skin lesions. When 
the animals were kept penwise during transport and lairage in 
the same units as in the herd, aggressive and sexual behaviour 
in entire males were reduced signifi cantly. 
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Introduction
The meat industry is highly competitive and is subject to two 
major drivers of change: new legislation and technological 
innovations. For meat processors, immunological castration 
provides better quality carcasses, with less fat, less wastage and 
thus higher value (1). The objective of this study was to evaluate 
the effi  cacy and production benefi ts of vaccination with Impro-
vac for the control of boar taint under fi eld conditions in Poland, 
Czech Republic and Hungary.
Materials and Methods
The study was performed at 4 commercial pig farms located in 
Poland (PL) (2 farms: PL-L and PL-S), Czech Republic (CZ) and 
Hungary (H). Male piglets (PL-L, 108; PL-S, 60; CZ, 119; and H, 83) 
were surgically castrated (T01). On each farm, the same number 
of piglets were vaccinated with Improvac subcutaneously twice: 
initially at ages 9–10 weeks (PL), 11–13 (CZ), 
20–23 (H) then again at ages: 20 (PL), 22–24 (CZ) and 24–27 (H) 
weeks (T02). Pigs were slaughtered at ages 24–26 (PL), 27–29 
(CZ) and 28–31 (H) weeks. Average body weight (ABW) at castra-
tion, 1st and 2nd vaccination, and slaughter was determined 
and average daily body weight gain (ADG) was determined for 
the periods: castration to 1st vaccination, castration to slaughter, 
1st vaccination to slaughter and 2nd vaccination to slaughter. 
Lean meat percentage was estimated at slaughter. 
Results
Compared with barrows (T01), ABW of pigs vaccinated with Im-
provac (T02) was comparable at castration, and 1st and 2nd vac-
cination, but 7% higher at slaughter on farm PL-L On farms PL-S, 
CZ and H, ABW was similar at castration, 1st and 2nd vaccination 
and slaughter (Table 1a).From castration to 1st vaccination, 
ADG of barrows (T01) and vaccinated pigs (T02) was compar-
able on all farms. From castration to slaughter, 1st vaccination 
to slaughter, and 2nd vaccination to slaughter, ADG was 7%, 9% 
and 32% higher respectively in vaccinated pigs than barrows on 
farm PL-S, and 5%, 9% and 7% higher respectively in vaccinated 
pigs than barrows on farm H. On farm L, ADG was marginally 
lower in vaccinated pigs compared with barrows from castration 
to slaughter and 1st vaccination to slaughter, but 5% higher in 
vaccinated pigs than barrows from 2nd vaccination to slaughter 
(Table 1b).Compared with barrows (T01), lean meat percent-
age of vaccinated pigs (T02) was 3% higher on farm CZ and 5% 
higher on farm H (Table 1c).
Table 1a. Average body weight.
Time
Average Body Weight (kg)
Poland Farm L Poland Farm S Czech Hungary
T01 T02 T01 T02 T01 T02 T01 T02
C 2.3 2.3 3.1 3.2 2.2 2.2 2.7 2.7
V1 23.4 23.1 30.6 30.6 32.2 33.1 76.4 73.9
V2 88.7 84.4 101 100 98.8 100 103 100
S 114 111 131 140 122 124 127 127
Table 1b. Average daily body weight gain.
Period
Average Daily Body Weight Gain (g)
Poland Farm L Poland Farm S Czech Hungary
T01 T02 T01 T02 T01 T02 T01 T02
C to V1 339 334 443 442 369 379 n.a. n.a.
C to S 661 643 757 810 610 616 605 604
V1 to S 848 823 939 1024 777 792 894 941
V2 to S 819 859 971 1288 691 738 864 943
Table 1c. Lean meat percentage.
Carcass Variable Mean 
Poland Farm L Poland Farm S Czech Hungary
T01 T02 T01 T02 T01 T02 T01 T02
Lean Meat Percent-
age 57.2 57.7 55.3 56.2 55.6 57.3 53.4 56.0
T01, barrows; T02, pigs vaccinated with Improvac; C, castration; V1, 1st vaccination; V2, second 
vaccination; S, slaughter; n.a., not measured.
Discussion
ADBWG was higher in pigs vaccinated with Improvac compared 
with barrows, especially following the 2nd vaccination. Vaccina-
tion resulted in a signifi cant increase in lean meat percentage.
References 
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Introduction
Hematological reference values for slaughter age boars are rare 
and none are published for boars vaccinated with Improvac® 
(GnRH-analogue vaccine against boar taint (1). The objective of 
the study was to determine and compare mean hematological 
values at slaughter in boars vaccinated with Improvac and con-
trols among two crossbreeds.
Materials and Methods
A total of 549 blood samples were collected by exsanguination 
from 410 Piétrain cross (96 entire boars and 314 boars vaccin-
ated with Improvac (1)) and 139 Duroc cross (42 entire boars and 
97 Improvac) boars. Mean body weights at slaughter were be-
tween 118.6 kg (Piétrain) and 119.9 kg (Duroc). Blood cells were 
counted using an ADVIA120 hematological counter (Bayer). Dif-
ferential white blood cell counts were estimated by microscopy. 
Results
Piétrain crosses had lower hemoglobin, MCV, MCH and MCHC 
than Duroc crosses. In Piétrain crosses, leucocyte count was 
higher in entire boars compared with boars vaccinated with Im-
provac driven by a higher lymphocyte, monocyte and eosinophil 
count in this group. The platelet count in Piétrain crosses was 
higher in entire boars than vaccinated pigs (table 1).
Discussion
Mean values for all groups were within existing physio-logical 
ranges of swine (2) except raised leucocytes in entire boars of 
both breeds. Further examination is needed to determine if this 
eff ect is boar specifi c. 
The vaccination of boars with Improvac had no impact on hema-
tology results.
Table 1: Hematology of entire boars and pigs vaccinated with 
Improvac at slaughter, by breed (mean; ± standard deviation). 
Piétrain Cross Duroc Cross
Boars Improvac Boars Improvac
n 96 314 42 97
erythrocytes (T/l) 8.05 ±0.61 8.02 ±0.62 7.9 ±0.52 8.07 ±0.53
hematocrit (l/l) 0.42 ±0.09 0.43 ±0.03 0.43 ±0.03 0.43 ±0.02
hemoglobin (mmol/l) 8.7 ±0.6 8.9 ±0.5 9.0 ±0.6 9.1 ±0.5
MCV (fl ) 52.5 ±2.9 53.4 ±2.9 54.3 ±2.6 53.9 ±2.5
MCH (fmol) 1.08 ±0.06 1.11 ±0.06 1.14 ±0.05 1.14 ±0.06
MCHC (mmol/l) 20.5 ±1.2 20.8 ±0.6 21.0 ±0.6 21.1 ±0.6
platelets (G/l) 426 ±131 386 ±117 267 ±120 318 ±121
leukocytes (G/l) 23.6 ±5.8 20.9 ±5.2 22.3 ±6.2 21.1 ±5.4
neutrophiles (G/l) 12.2 ±6.3 11.2 ±5.3 10.7 ±6.9 11.2 ±5.4
lymphocytes (G/l) 9.2 ±2.5 7.8 ±2.4 9.4 ±2.6 8.2 ±1.9
monocytes (G/l) 1.5 ±0.5 1.2 ±0.8 1.5 ±0.7 1.1 ±0.5
eosinophils (G/l) 0.4 ± 0.3 0.3 ±0.2 0.3 ±0.2 0.3 ±0.2
basophils (G/l) 0.2 ±0.1 0.2 ±0.1 0.2 ±0.1 0.2 ±0.1
neutrophils (%) 49 ±14 52 ±15 46 ±18 51 ±13
lymphocytes (%) 41 ±13 40 ±13 45 ±17 41 ±11
monocytes (%) 6.5 ±2.2 6.1 ±4.2 7.0 ±3.4 5.3 ±3.1
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Introduction
Blood markers of protein and mineral metabolism in swine are 
likely to be diff erent between breeds and gender (1). Reference 
values for slaughter age boars are rarely described and none are 
published for boars vaccinated with Improvac® (GnRH-analogue 
vaccine against boar taint). The objective of the study was to de-
termine and compare mean values of blood markers for protein 
and mineral metabolism at slaughter in boars vaccinated with 
Improvac and controls among two crossbreeds.
Materials and Methods
A total of 569 blood samples were collected by exsanguination 
of 425 Piétrain cross (96 entire boars and 329 Improvac) and 
144 Duroc cross (44 entire boars and 100 Improvac) male pigs. 
Boars had a mean body weight of 118.9 kg and a mean age of 
180 days at slaughter. The analysis of alkaline phosphatase (AP), 
measured at 37°C, urea, creatinine, inorganic phosphate (P) and 
calcium (Ca) were determined with an analysis automate Hitachi 
704 (Boehringer Mannheim). 
Results
Boars from both breeds had higher serum AP concentrations as 
well as lower serum creatinine and serum urea concentrations 
than boars vaccinated with Improvac.
Improvac vaccinated Duroc boars showed higher AP activities 
and lower Ca and P concentrations than the vaccinated Piétrain 
boars. The creatinine concentration was over all higher in Duroc 
boars than in the Piétrain boars (table 1). 
Discussion
Mean values for all groups were within previously reported 
physiological ranges of swine (2, 3) and were consistent with 
published reference intervals for boars from diff erent German 
boar studs and breeds (1). Pigs in this study were fed a standard 
diet (optimised for barrows and females and not for boars) but 
there was no evidence of an undersupply of nutrients. There 
was no evidence that vaccination with Improvac aff ected the 
variables measured.
Table 1. Hematological values of entire boars and pigs vaccinated 
with Improvac, by breed (mean; ± standard deviation).
Piétrain Cross Duroc Cross
Boars Improvac Boars Improvac
n 96 329 44 100
AP U/l 162 ±47 138 ±43 171 ±49 150 ±48
Ca mmol/l 2.65 ±0.1 2.67 ±0.1 2.65 ±0.1 2.63 ±1.2
P mmol/l 3.04 ±0.3 3.04 ±0.3 3.02 ±0.4 2.88 ±0.3
creatinine μmol/l 148 ±16 153 ±19 136 ±13 145 ±19
urea mmol/l 5.6 ±1.2 6.6 ±1.2 6.0 ±1.1 6.8 ±1.3
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A comparison of feed consumption and zootechnical performance of entire boars, boars 
vaccinated with Improvac™, barrows and gilts fattened on low and high energy diets
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Introduction
Typically, male pigs are physically castrated in Europe to control 
boar taint1. Use of Improvac allows male pigs to grow as ef-
fi ciently as boars until the time of second vaccination. This study 
examined the impact of feeding low and high density diets 
to entire boars, barrows, vaccinates and gilts after the second 
administration of Improvac to vaccinates.
Materials and Methods
A total of 179 F2 crossbred pigs aged 66 days from Yorkshire x 
Dutch Landrace sows sired by Piétrain boars were enrolled: 48 
gilts, 47 barrows, 42 entire boars and 42 boars vaccinated with 
Improvac at enrolment (day 0, 66 days of age) and day 84, which 
was approximately 6 weeks before slaughter (day 123). Pigs were 
grouped by weight within sex, and groups randomly allocated 
to pens so that there were 6 pens per sex fed a low energy (9.04 
MJ) and 6 pens fed the high energy (10.01 MJ) fi nishing diet. 
These diets were fed from day 84, after being fed the same boar 
ration. Pigs were weighed on days 0, 12, 34, 62, 84 and 123. Feed 
intake was monitored using a computerised feeding system and 
residual feed was weighed when pigs were weighed.
Results
Before the second injection of Improvac vaccinated pigs per-
formed similarly to boars: they were signifi cantly lighter than 
castrates, but also had signifi cantly lower feed intake and feed 
conversion. After administration of the second dose of Impro-
vac and partitioning of sex groups into low and high density 
diets, feed intake and average daily gain (ADG) of vaccinates 
increased markedly and their performance diverged from entire 
boars. Thus, fi nal bodyweights and overall study ADG values for 
barrows (874 g/d) and vaccinates (875 g/d) were similar. Overall, 
feed conversion ratio (FCR) was signifi cantly diff erent (p<0.05) 
between vaccinates (2.34) and barrows (2.66). Boars had the low-
est overall FCR (2.26). From day 84 to 123, there was a signifi cant 
eff ect of sex (P<0.0001) but not diet on ADG which was highest 
in vaccinated pigs. From day 84 to 123, the diff erence in ADG 
and feed intake between vaccinates on the LE and HE diets was 
not signifi cant but there was a signifi cant eff ect of sex (p<0.001) 
and diet (p<0.0001) on FCR.. From day 84 to 123, boars had the 
best feed conversion and barrows the worst, with FCR in vaccin-
ated boars being 17% lower than barrows on the LE or HE diets. 
In vaccinates and barrows, the HE diet resulted in a signifi cantly 
lower FCR. In barrows this was associated with a signifi cantly 
increased ADG, but in vaccinates it refl ected a small increase in 
ADG and a reduction in FI.
Table 1
Variable Barrow Boar Improvac Gilt
Bodyweight(kg)
Day 0 25.0a 23.6b 23.7ab 24.6ab
Day 84 97.7a 88.2b 87.3b 88.8b
Day 123 132.3a 127.4ab 131.3ab 122.9c
Days 0 to 84
ADG (g/day) 869a 770b 757b 765b
FI (g/day) 2068a 1637bc 1592c 1720b
FCR 2.38a 2.13c 2.10c 2.25b
Days 84 to 123
ADG 9g/day) LE 8321 1003 1115 864
HE 9332 1005 1140 888
all 883a 1004b 1128c 876a
FI (g/day) LE 2865 2573 3180 2458
HE 2878 2402 2929 2503
all 2871b 2487c 3054a 2481c
FCR LE 3.441 2.57 2.841 2.85
HE 3.102 2.41 2.572 2.80
all 3.27a 2.49c 2 70b 2.82b
All values are LS means.. LE=low energy diet, HE = high energy diet, All = both
a,b,c diff erent superscripts within row diff er signifi cantly (p<0.05)
1,2 – diff erent superscripts within NE/HE pair diff er signifi cantly
Discussion and Conclusion
After the 2nd Improvac vaccination feed intake increased tre-
mendously, even exceeding that of castrates. This was associ-
ated with a high ADG and favourable FCR, particularly when fed 
the high energy diet
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A comparison of carcass characteristics of entire boars, boars vaccinated with 
Improvac™, barrows and gilts fattened on low and high energy diets
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Introduction
Typically, male pigs are physically castrated in Europe to control 
boar taint1. However, entire male pigs have better feed conver-
sion and produce a leaner carcase than physically castrated pigs 
and gilts2. Use of Improvac allows male pigs to grow as effi  cient-
ly as entire males until the time of second vaccination. This study 
examined the impact of feeding low and high energy diets to 
entire boars, barrows, vaccinates and gilts after the time of the 
second administration of Improvac to vaccinates.
Materials and Methods
A total of 179 F2 crossbred pigs aged 66 days from Yorkshire x 
Dutch Landrace sows sired by Piétrain boars were enrolled: 48 
gilts, 47 barrows, 42 entire boars and 42 boars vaccinated with 
Improvac at enrolment and again 6 weeks before slaughter. 
Pigs were grouped by weight within sex, and groups randomly 
allocated to pens so that there were 6 pens per sex fed the low 
energy (9.04 MJ) and 6 pens fed the high energy (10.01 MJ) 
fi nishing diet. Pigs were fed the same diet until administration 
of the second dose of Improvac. Pre-slaughter live weight was 
taken before transport after 8 hours of fasting. Slaughter was 
at a commercial abattoir. Carcass lean meat and back fat were 
measured using a Hennessy Grading Probe. Lean meat % was 
calculated using a formula in EU Directive 2005/627/EG.
Results
Overall, liveweight and hot carcase weights were highest in bar-
rows and vaccinated pigs (P≤0.0041); killing out percentages were 
highest in barrows and gilts (P<0.0001); P2 backfat thickness was 
highest in barrows, and lowest in entire boars and gilts (P<0.0001); 
and meat percentage was highest in boars and gilts, and lowest in 
barrows (P=0.0024). In both the latter cases, Improvac vaccinated 
pigs were signifi cantly diff erent from other groups.
In gilts, lean meat percentage was 1.5 percentage points higher 
in those fed the low energy diet (P=0.018) and backfat was 14% 
thicker in those fed the high energy diet (P=0.0348) There was a 
signifi cant diff erence (P=0.033) in the killing out percentage be-
tween vaccinated pigs fed the low energy diet (79.5%) and those 
fed the high energy diet (80.5%) and in the carcass lean meat 
percentage (55.4% compared with 56.7% respectively).
Table 1
Carcass Variable Barrow Boar Improvac Gilt
Empty Live LE 128.2 128.0 127.3 119.9
Weight(kg) HE 131.6 123.5 129.8 123.2
All 129.9a 125.8ab 128.5a 121.6b
Hot LE 105.2 103.1 101.5 98.1
carcassweight HE 108.2 99.0 104.5 100.6
(kg)1 All 106.7a 101.0b 103.0ab 99.4b
Killing out % LE 81.9 80.5 79.51 81.8
HE 82.2 80.2 80.52 81.6
All 82.1a 80.3b 80.0b 81.7a
Backfat (mm) LE 20.1 15.0 18.0 14.01
HE 21.2 15.0 17.0 16.02
All 20.6a 15.0c 17.5b 15.0c
Meat LE 54.3 58.1 55.41 59.01
Percentage HE 53.5 57.9 56.72 57.52
All 53.9c 58.0a 56.1b 58.2a
Loin thickness LE 63.3 62.8 60.2 63.3
(mm) HE 62.5 61.2 63.2 64.1
All 62.9a 62.0a 61.7a 63.7a
LE=low energy diet, HE = high energy diet, All = both
a,b,c diff erent superscripts within row diff er signifi cantly (p<0.05)
1,2 diff erent superscripts within NE/HE pair diff er signifi cantly
Discussion and Conclusion
Diff erences between sex groups are consistent with published 
literature. The high energy diet was predicted to result in 
increased fatness in the Improvac pigs but this did not occur. 
In fact fat was numerically less and lean meat % signifi cantly 
increased. Dressing percentage was also improved, perhaps as-
sociated with the increased loin thickness. 
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A comparison of mortality (animal withdrawal) rates in male fattening pigs reared using either 
physical castration or vaccination with Improvac® as the method to reduce boar taint
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Introduction
In most of Europe, male piglets are physically castrated early 
in life. The procedure is traumatic and leaves an open wound, 
creating opportunities for bacterial infection and other com-
plications. Improvac is a vaccine alternative where male piglets 
are left entire but are administered two doses of vaccine later in 
life, the second 4 to 6 weeks before slaughter. The second dose 
results in a temporary suppression of testicular function and a 
reduction in boar taint. At this time pig behaviour also changes 
to become similar to that of physical castrates. The objective of 
this analysis was to compare the impact of these two approach-
es on pig mortality at various stages of the production cycle. 
Materials and Methods
A meta-analysis was conducted on data from 15 European fi eld 
studies comparing physically castrated and Improvac vaccinated 
pigs. The studies were primarily conducted to compare effi  cacy 
in the reduction of boar taint or to look at the impact of the two 
approaches on growth performance. In all cases piglets were se-
lected and randomly allocated to treatment groups at the time 
of physical castration. As part of normal procedure, records were 
kept of all animals that died or were withdrawn from the studies 
until the trials closed at slaughter, resulting in a database of 4393 
animal records, well balanced between physically castrated and 
vaccinated pigs. In general, study withdrawals were of animals 
considered too sick to continue or in such poor condition that a 
producer would not normally retain them, so would equate to 
mortality in commercial practice. To avoid introducing sub-
jective judgment all withdrawals were included in the analysis 
except those due to over-recruitment or logistical reasons. 
Data on mortalities-cum-withdrawals were analysed for four 
time periods: castration to weaning (C-W), weaning to 1st vac-
cination (W-V1) (typically entry to fattening), 1st vaccination to 
2nd vaccination (V1-V2), and second vaccination to slaughter 
(V2-S). he number and percentage of withdrawals were summar-
ised by study and overall. Only those pigs present at the start of 
a period were eligible for withdrawal within that period. 
Until fi rst vaccination the experimental unit was the pig and 
withdrawals were analysed in two pooled analyses within PROC 
GLIMMIX (SAS v9.1.3), with treatment as a fi xed eff ect, and 
study and study by treatment interaction as random eff ects. A 
binomial distribution and a logit link were used to force logistic 
regression for the model due to the dichotomous response for 
completion of a period. The ilink option was used to transform 
the LS mean model estimates into the estimated percentage 
removed for each treatment group during each time period.
From fi rst vaccination onwards, the experimental unit was the 
fattening pen and the percentage removals within each fatten-
ing pen was analysed with linear mixed models (PROC MIXED, 
SAS v9.1.3) for each study with treatment as a fi xed eff ect and 
random eff ects for fattening pen and where appropriate study 
site and fattening pen within study site, where the study was 
conducted in multiple locations. The LS means from each of 
these models were then used in meta-analyses to estimate the 
percentage removals from each treatment group. Three studies 
were not appropriate for these analyses due to the study design 
and data limitations.
Results
Records were available for 2196 physical castrates and 2197 vac-
cinated pigs. Comparative mortality-cum-withdrawal rates for 
the four periods are shown below. as percentages of the number 
of pigs entering that phase. The mortality-cum-withdrawal rate 
pre-weaning was signifi cantly higher in the castrate group. Dif-
ferences in other periods were not signifi cantly diff erent. 
Table 1: Pig Mortality-cum-Withdrawal by Production Period 
Physical. Cast. Improvac p-value
C-W 5.7 ± 1.08 4.1 ± 0.81 0.0245
W-V1 3.3 ± 0.89 3.5 ± 0.93 0.8384
V1-V2 1.6 ± 0.26 1.6 ± 0.29 0.7674
V2-S 1.9 ± 0.37 1.3 ± 0.35 0.2566
(back-transformed least squares means ± SE) (%)
Discussion and Conclusion
The design of Improvac fi eld studies and the large number of 
studies undertaken provide a unique database of pigs mon-
itored from a few days of age until slaughter. This analysis 
confi rms anecdotal reports that physical castration increases 
pre-weaning mortality in male pigs
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Impact of surgical castration of piglets on growth performance, feed eﬃ  ciency and health parameters
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Introduction
During the pre-weaning period, piglets are exposed to several 
challenges which can limit weight gain and also increase wast-
ing and mortality indexes. Surgical castration is a traumatic pro-
cedure that has been associated with infl ammatory conditions 
and impact on immune system development (1,2). Behavioral 
and physiological responses of castrates indicate that suff ering 
and pain are not limited to the few hours after castration and 
are still present up to 4 days after the surgical procedure (3). The 
goal of this study was to evaluate the impact of surgical castra-
tion on the growth performance of young pigs from pre-wean-
ing till the end of the nursery period.
Materials and Methods
The experiment was carried out in a commercial farm with 3400 
sows, in Santa Catarina state, Brazil. A total of 1024 four-day old 
piglets were individually weighed and randomly allocated into 2 
treatment groups: T1 (entire males) and T2 (surgically castrated 
males, castrated at 4 days of age). Weaning took place at 21 
days of age, and the end of nursery was on day 63 of age. After 
weaning, piglets were distributed into 16 pens (experimental 
units) within each treatment, being fi ve pens with 20 piglets and 
11 pens with 34 piglets each. During pre-weaning and nursery 
phases, the main parameters evaluated were piglet body weight 
at 4th, 21st, 35th, 49th and 63rd days of age, daily weight gain 
(DWG), mortality rate, incidence of wasting (runts), incidence of 
arthritis and diarrhea, mortality rate and number of piglets re-
ceiving additional injections treatment. For all these parameters 
the experimental unit was the individual pig. Also during the 
nursery phase feed consumption and feed conversion (experi-
mental unit was the pen). Analysis of Variance was performed 
for comparison between treatment means. For non-parametric 
data, Chi-square test and Kruskall-Wallis were used. 
Results and Discussion
Piglets which were surgically castrated required higher use of 
additional injectable treatments with antibiotics when com-
pared to T1 during nursery phase (p=0,016) and also throughout 
the whole trial period (p=0,004), as seen in Table 1. Mortality rate 
was lower for entire males before weaning (p=0,087) and also 
during the complete trial period (p=0,059). Weaning weight was 
higher for entire males when compared to surgically castrated 
males (p=0,071), with averages of 5,57 kg and 5,42 kg respect-
ively.
Table 1 – Mortality, additional injectable medication and weight at 
weaning for both treatments.
Group Mortality (D4-D63) 
Addition. 
Inject.
Weight at D-21 
(kG)
T1 (boars) 6.4%a 53,3%a 5,57a
T2 (castrates) 9.7%b 62,3%b 5,42b
Diff erent superscripts in the same column mean signifi cantly diff erent values (p<0.10).
There was no eff ect of treatments on the incidence of diar-
rhea and arthritis before weaning. During the nursery phase, 
there was also no eff ect of treatments on the occurrence of 
arthritis, but the incidence of diarrhea was signifi cantly higher 
for surgically castrated pigs (p=0,002). No statistical diff erences 
between treatments were detected for weight at 35th, 49th and 
63rd days of age, daily gain, feed intake and feed effi  ciency. A 
higher frequency of light-weight pigs was found among cas-
trated pigs, both at weaning (p=0,017) and at the end of nursery 
period (p=0,052), as seen on table 2. 
Table 2. Incidence of light-weight pigs at weaning (D-21) and at the 
end of nursery period (D-63)
Treatment D-21 D-63
T1 4,8%a 17%a
T2 8,7%b 22,2% b
Diff erent superscripts in the same column mean signifi cantly diff erent values 
(p<0.10).
Under the conditions of this study, surgical castration had a 
negative impact on weaning weight, mortality rate and inci-
dence of light weight pigs. Surgical castration at day 4 also 
increased the need for additional injectable medication before 
and after weaning, as well as the occurrence of diarrhea during 
the nursery phase. 
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Continuous throughput compared with ‘all in-all out’ in the management of a farrowing unit in Thailand
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Introduction 
An all in-all out production system minimizes the transmission of 
infection between diff erent age groups and batches of pigs. For 
a farm operating a continuous fl ow production system it is nor-
mally diffi  cult to change to and manage an all in-all out system, 
but the economic benefi ts can be signifi cant. Regumate® can be 
used to synchronize insemination and farrowing as a major step 
towards establishing an all in-all out system.
The aim of this study was to compare the production perform-
ance of a farrowing unit managed by continuous fl ow and by an 
all in-all out system.
Materials and Methods
This study was performed on a 400-sow farm arranged as fol-
lows. There were two farrowing houses each with 65 farrowing 
pens, and a dry sow house with 520 pens. Sows were served by 
AI (19-26 sows per week), and between 12 and 24 sows farrowed 
per week. The farm manager realized that this system did not 
allow for the proper cleaning and disinfection of the farrowing 
accommodation. 
A batch farrowing system was instituted in January 2008 with 
estrus synchronized on a 3-week cycle using Regumate®. There-
after 68-72 sows were inseminated every 3 weeks, and 55-65 
sows farrowed in the same period. So the fi rst batch of sows and 
gilts that was inseminated farrowed in March 2008 and their 
piglets were weaned in April 2008.
It is possible therefore to compare the performance of the 
farrowing unit between April 2007 and April 2008 (continuous 
production) and April 2008-April 2009 (All in-all out manage-
ment) (Fig 1).
Results
Twenty-one weeks after the change to batch farrowing, the farm 
could be divided into seven batches of 55-65 sows per batch. 
All the sows had been through the system, so the farrowing ac-
commodation could be emptied, cleaned and disinfected. Many 
performance indicators improved in 2008 even though Thailand 
experienced a PED outbreak. 
The performance in the farrowing unit is shown in Table 1.
Continuous All In - All Out Diff erence
No of sows AI 1,189 1,176 -13 (-1%)
No of weaned pigs 8,353 9,870 1,517 (+18%)
Farrowing rate (%) 84,4 86,3 1.9
Pigs born alive 10.4 11 0.6
Weaned pigs 9.3 9.9 0.6
Weaned weight (kg) 7.5 7.5 0
% loss before weaning 18.7 11.2 -7.5%
Discussion
After implementing all in-all out management a lot of improve-
ments were seen on this farm. 
In spite of 1% fewer sow inseminations, 18% more pigs were 
weaned. The farm was easier to manage. Inseminations were 
better planned and more controlled, and the labor force in-
volved were more focused and less stressed. 
The farrowing house could be properly cleaned and disinfected, 
and one of most important improvements was that the farm 
manager could organize and plan all aspects of production ac-
cording to a reliable timetable.
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Fig 1. Stock management before and after the change (each pig icon above represents fi ve pigs)
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Pig Flow - Managing the health of the business
John Carr
Portec Australia, Belmont, WA, Australia
Setting formal pig fl ow targets through batching allows a 
unique opportunity for veterinarians to help manage the health 
of their client’s pig and keep their own businesses healthy.
Batch farming sets targets, minimises variation and reduces 
under and overstocking – a major cause of disease, reduced 
performance and increase in costs.
A key control of the expression of the clinical signs of disease is 
through vaccination and prophylactic medication.
But – on many farms while a highly effi  cient preventative medi-
cine programme is designed by the veterinarian, it is on trust 
that this programme is used and implemented by the farm staff .
Setting pig fl ow targets allow at least purchases of health items 
to be monitored within pre-agreed parameters by the whole 
health team.
To set a pig fl ow model, the easiest initial point of reference is in 
the organisation of the farrowing house – the number of farrow-
ing places per batch.
Example of a pig fl ow medicine monitoring system using an 
Excel spreadsheet:
Average herd size 1773 sows/gilts
Farrowing places 75 per batch
Batch time 1 weeks
Wean/farrow place 10 weaners
Gilt replacement rate 40 %
Pigs per batch Year
Sows 61 3172
Gilts 14 728
Weaners 750 39000
Compliance required 95 %
Programme
Vaccine/medication Dose mls Bottle (mls) Gilts Sows Weaner
Parvovirus 2 100 1 0
Erysipelas/Lepto. 2.5 250 1 0 0
E. coli 4 500 2 1
HPS 2 100 2 1 0
PCV2 1 50 0 0 0
Mycoplasma 2 500 0 1
Ileitis 2 100 0 0
Coccidiosis 1 1000 1
PRRSv 2 100 0 0 0
SIV 2 100 0 0 0
Improvac* 2 500 1
Actual use and comment
Vaccine/medication Q1 Q2 Q3 Q4
Parvovirus 4 OK 8 OK 4 OK 4 OK
Erysipelas/Lepto. 1 Low 3 OK 6 High 2 OK
E. coli 14 OK 6 Low 7 Low 12 OK
HPS 21 Low 10 Low 24 OK 24 OK
PCV2
Mycoplasma 58 OK 29 Low 40 OK 40 OK
Ileitis
Coccidiosis 6 Low 15 OK 12 OK 8 OK
PRRSv
SIV
Improvac* 35 Low 36 Low 39 OK 40 OK
Discussion
The records clearly show that:
1.  Medicine compliance. The farm is PRRSv and PMWS free and 
vaccines are not used.
2.  There was a period of non-compliance in quarter 1 and 2 
which was associated with a particular stockperson and this 
was resolved with a training opportunity.
3.  The non compliance was associated with a reduction in 
health and performance.
4.  The Improvac errors are serious as they impact slaughter 
value (boar taint) and sales.
5.  There was a overuse of Lepto/ery vaccine in quarter 3 – farm 
playing catch up.
6.  Veterinary sales were lost due to poor compliance and this 
was rectifi ed. 17 HSP vaccine and 4 Improvac. This was a loss 
of $4000 Aus sales.
7.  The client’s satisfaction was ensured because of the pro-
active health management and attention to details provided.
8.  The system is easy to run and modify to other health product 
sales such as injection, water, feed medications or disinfect-
ants. 
Please visit our website www.portec.com.au
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Hygiene and the relevance of Endotoxins on swine producing farms
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Introduction 
Endotoxin associated diseases are a result of permanent existing 
endotoxin values in the gut and through outside infl uences like 
dust, feces, food and other organic materials. Small amounts 
stimulate the immune- system in a positive way but excess 
amounts lead to infl uenza like symptoms, shock and death.
As endotoxins are known to play a signifi cant role in diff erent 
pig associated diseases, especially in MMA in sows and the post-
weaning syndrome in piglets, a screening on piglet producing 
farms was performed to fi nd out if there is any correlation be-
tween detected endotoxin levels and the incidence of illnesses 
in the animals. 
Material and methods 
16 farms with documented MMA problems were chosen. 32 
mother sows (2 sows/farm) were sampled between the fi rst and 
third lactating week. One sow was without medical treatment 
and the other sow of the same farm was on treatment (antibiot-
ic) against MMA. Samples taken of the sow were milk, feces and 
urine. Environmental samples were taken from water, feed and 
air. Additionally temperature and humidity (EL USB-2 Data log-
ger, RS Components) were measured. For air collection a WISA 
suction pump with pyrogen free glass fi ber fi lters (Whatman) 
was used. All samples of the sows and environmental samples 
were tested with the kinetic chromogen Limulus- Amoebycat 
Lysat test (Charles River Laboratories). Feces, air and feed were 
extracted with Tween20 for 1 hour and dilution rows of all the 
samples were prepared within 12 hours after sampling. Dilution 
of the samples tested was chosen depending on the sample 
matrix, for example water samples were tested in a 1:10 dilu-
tion and feces samples in 1:10.000. All used material was proved 
pyrogen free. Performance Standards were valid with r2 > 0.97 
and the recovery of all samples ranged between 50 – 200%. 
Statistical analysis was done with SPSS 17.0 (Box plots, p-value, 
Regression). 
Results
Levels of endotoxin in the air revealed signifi cant diff erences 
(p=0.003) between farms with dry and wet feeding systems. 
Airborne endotoxin concentrations of farms washing their 
sows before moving them to the weaning boxes were lower 
compared to those not washing their sows. Disinfection of the 
stables before moving the sows seemed to reduce air endotoxin 
values as well, but there was no signifi cant diff erence compared 
to farms without disinfection. No positive correlations of endo-
toxin air levels and levels in feces (p=-0.052) or urine (p=0.124) 
could be observed. No correlation between stable temperature 
and air endotoxin values (p=0.641) nor humidity and air endo-
toxin values (p=0.617) could be found. Although water samples 
of one farm widely varied in their endotoxin values (SD=14.39), 
the design of the drinking troughs did not reveal any correlation 
(p=0.342) with detected endotoxins .
Discussion 
Management and hygiene have an impact on endotoxin air 
values and further consequences on humans and animals. Espe-
cially endotoxin levels in the air are an important issue not only 
for the animals, but also for the farmers because they spend a lot 
of time in the stable. 
In this study some interesting approaches for measuring pos-
sible risk factors could be observed. Dust seems to be a major 
source of endotoxin in the air according to the results of farms 
with diff erent feeding systems. Dry feeding produces more dust 
than wet feeding. Besides feeding, hygiene of the sows plays a 
major role as well. Disinfection of the stable does not seem to be 
as important as washing the sows before moving them into the 
weaning boxes.
This study could not prove the coherence of endotoxin values 
and the incidence of illness but showed clear trends concerning 
hygiene and endotoxin values. Results of this study will be veri-
fi ed in follow up studies on diff erent farms. 
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Application of mineral sorbents for reduction of odorous volatile compounds emitted from pig manure
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Introduction
Odors are specifi c air pollutants, since human nose is able to 
detect and diff erentiate odorous compounds even when their 
concentrations are below the threshold detectable by tech-
nical facilities, e.g. gas chromatography. It has been estimated 
that odor detection threshold by the human nose is as low as 
108-109 odorant molecules, while 1 g of ethyl mercaptan in the 
air contains 1016 molecules of this gas, which is 107–108 higher 
than the detection threshold [4, 5]. Major odorants emitted 
from animal breeding include ammonia and its derivatives, 
sulfur compounds (hydrogen sulfi de, mercaptans), volatile fatty 
acids and phenolic compounds, adversely aff ecting human and 
animal health [1, 2].
Many eff orts have been made to reduce the emission of odors 
from animal manure. One of the potential means of limiting 
odorants in the air of livestock buildings is the application of 
alluminosilicate sorbents.
The aim of the investigation was to study under laboratory 
conditions the infl uence of bentonite and halloisyte, added to 
pig manure, on the reduction of odorous volatile compounds 
emission.
Materials and Methods
The samples of fresh pig manure (50g) were placed in 9 cone-
fl asks (500 ml). The fl asks were divided into 3 groups and the 
sorbents were added as follows: group I – control - no sorbents, 
group II – raw bentonite (20 % of the manure mass), group 
III – raw halloisyte (20 % of the manure mass). The odorous 
compounds were extracted (sampling time = 30 min.) from the 
headspace of each fl ask at 30 0C after d 1, 4 and 8. The extraction 
of the substances was carried out using a manual SPME holder 
with StableFlex 50/30μm divinylobenzene/ carboxen/poly-
dimethylosiloxan. DVB/CAR/PDMS fi bers were used (Supelco, 
USA). The analysis of air samples was performed using a GC/MS 
method (Thermo Electron, Finnigan Focus Polaris Q type). Iden-
tifi cation of volatile odor substances was based on comparative 
analysis of mass spectra and NIST spectra database. 
Results and Discussion
40 volatile odor compounds (VOCs) were identifi ed in the sam-
ples collected from the air immediately above the manure. They 
included 4 sulfur organic compounds and alcohols, ketones and 
other derivatives, e.g. benzene and xylene. The identifi ed sub-
stances contained 7 compounds very poisonous to humans [3], 
i.e. trimethyloamine, cyclohexanone, toluene, methylpentanol, 
2-heptanone, chlorobenzene and 1,4-dichlorobenzene.
The sorbents used in the study, especially halloisyte, markedly 
reduced the emission of odorants from pig manure (Table 1). 
The greatest effi  ciency of the sorbents was observed on d 8. 
Reductions of volatile odor compounds accounted for 65.62% 
(bentonite) and 83.14% (halloisyte). On d 1 and 4 of the experi-
ment, halloisyte was the only sorbent that reduced the emission 
of odorants from the manure. In contrast, bentonite, applied at 
the same time, increased the quantity of VOCs. Signifi cant reduc-
tions were also observed by Turan et al. [4] who added 10% of 
aluminosilicate and vermiculite to poultry slurry. The reduction 
reported by them was comparable to the results observed in our 
study with the use of bentonite (61.53%). Summing up, it can be 
concluded that the greatest effi  ciency in reducing VOC emis-
sions from pig manure was achieved with the use of halloisyte 
(from 5% after d 1 to 83% after d 8). 
Table 1. The eff ects of bentonite and halloisyte on reductions (-) and 
increases (+) (%) in VOC’s concentrations.
Control group (I) Bentonite (Group II) Halloisyte (Group III)
after d 1 +43 -5
after d 4 +34 -40
after d 8 -66 -83
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Impacts of technological level on production eﬃ  ciency and economic variables in 
pork farms in the States of Guanajuato, Jalisco, Sonora and Yucatan, México
Juan Nava; Rafael Trueta
Universidad Nacional Autonoma De Mexico, Mexico, DF, Mexico
Introduction
The objective of the present study was technological level grad-
ing (high, intermediate and low) and its impact on production 
effi  ciency, defi ned as the number of animals sent to market per 
sow per year and on the main economic indicators, of a random 
sample of complete cycle pork farms in the four states of Mexico 
showing greater production. 31.1% of farms use high technol-
ogy, 39.9 % use low technology and the remaining 29.5 % can 
be described as semi-technifi ed. The Kruskall-Wallis non para-
metric statistical analysis provides conclusive evidence that high 
level yields a lower cost, MXP 9.45 vs 11.20 and 11.84 for the 
intermediate and low technology levels, respectively (P<0.01).
Materials and Methods
Data on technical, animal health, production and economic 
variables was obtained through surveys performed in a random 
sample of complete cycle swine farms. Farms were graded in ac-
cordance with their technological level taking into account the 
following parameters: a) biosafety, b) reproduction parameters, 
c) production parameters.
Results
Production effi  ciency
When farms were grouped by technological level, the number 
of animals sent to market yearly per sow was 18.60, 15.97 and 
11.67 (P<0.01).for high, intermediate and low technological 
levels, respectively.
Economic production variables
Production cost
Average cost of production per kg live weight when farms were 
grouped by technological level, those in the high technology 
bracket showed a lower CKg, MXP 9.45, while those in the inter-
mediate and low levels, showed MXP 11.20 and 11.84, respectively.
Revenue
Profi t per average kg live weight sold for the 61 farms was MXP 
4.93. At the high technology level Pkg was MXP 5.52, MXP 4.77 
for intermediate and MXP 4.59 for low technology.
Profi tability
Average profi tability per kg sold (RKg), the high technology 
level showed the higher Rkg, 64.9 %, well above the 49.1 % and 
49.9 % found for the intermediate and low technology levels, 
respectively.
Discussion
Obtaining profi ts (income – costs) is the most important goal of 
commercial farmers. One of the determining factors for improv-
ing economic effi  ciency is technology that manifests through 
multiple expressions. Results obtained in the present study 
confi rm this notion, because production costs of swine show an 
inverse relationship to the technological level of the farm.
In the interest to share this experience with other producers, we 
list the defi ciencies found in low technology farms studied: 100 
% did not have perimeter wall, 83.3 % did not have a sanitary 
moat; 66.6 % does not compel workers to bathe; 83.3 % al-
lows animals to enter the premises; 66.7 %did not use AI and 
66.7 % do not use balanced feed. Besides, none of them have 
systematic parasite and vaccination programs. Low technology 
farms acquire more competitive advantages when introducing 
technology than those of a higher level.
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The eﬀ ect of standard deviation reduction on optimal average slaughter weight
Dennis DiPietre3 Eric Lewandowski2 Remy Jagu2 Matthias J. Adam1
1. Boehringer Ingelheim Animal Health, Ingelheim am Rhein, Germany; 2. Boehringer Ingelheim Vetmedica , Pace, France; 
3. KnowledgeVentures, LLC, Columbia, MO, USA
Introduction
In a previous paper(1) we show the economic impact of re-
ducing the standard deviation of slaughter weights on overall 
farm profi tability as measured by return over feed costs. In that 
paper we present a side-by-side trial, where pigs were randomly 
assigned at weaning to two treatment groups, Circovac® (CV) 
or Ingelvac CircoFLEX® (FLEX). Pigs of both groups were kept in 
separate pens, but in the same rooms(2). The producer was blind 
to the treatments and employed his standard selection and 
marketing procedures to both groups. Though market weights 
for the two groups were almost identical, the standard devia-
tion of market weights was 16.7% less for the FLEX pigs. This 
was estimated to produce a €1.85/head advantage for the FLEX 
group. The amount of the increase in profi tability depends on 
the market price, cost of feed, and the particular buying matrix 
used. In this paper, we extend the analysis by examining how 
changes in standard deviation of marketing weights also change 
the optimal average weight of the distribution of pigs marketed. 
Materials and Methods
A stochastic simulation method was used to estimate the 
average carcass weight which maximizes expected return over 
feed costs for each group based on its distribution of slaughter 
weight at the time of marketing. Distributions were fi tted to the 
actual observations for carcass weight and lean percent in each 
group. These distributions were correlated to match the correla-
tion between weight and lean in the actual data. 10,000 pair 
of observations on carcass weight and correlated lean percent 
were then randomly drawn from each group’s estimated distri-
bution and used in the analysis. The optimal average weight for 
each group of 10,000 observations was determined through the 
use of a detailed simulation model employing growth and aver-
age daily feed intake functions matched to the farm and utilizing 
the actual pricing matrix in which the pigs were originally sold. 
The average feed cost per Mton wean-to-fi nish was $200 and 
the base carcass price was $1.30 per kg. The estimated optimal 
average weight was compared to the marketing weight chosen 
by the producer. In the original case, the producer was blind to 
the treatments and chose to market the pigs in both groups at 
essentially the same average weight. 
The model employed can be represented as follows:
Find mean average carcass weight Qj* of the distribution of 
weights marketed which maximizes return over feed cost:
Max Pj=∑i P Q i, L i Nj(Qi, L i) - TFCQ i, L i
Where:
J = the treatment group
P Q i, L i  = Grid determined price/kg (a function of current base 
carcass price and premium or discount associated with carcass 
weight and lean percent)
(Q,i, L,i) = Randomly selected carcass weight (kg) with its random-
ly selected, correlated lean percent from treatment group j
N(.) = Correlated distributions of carcass weights (kg) and associ-
ated lean percents estimated from the sales data for each of the 
treatment groups
TFC Q i, L i  = Estimated total feed cost to produce carcass Qi, Li
Results
Table 1: Economic returns over feed/hd for both groups
FLEX Group CV Group Diff erence per head
As Marketed Avg carcass (kg) 91.04 90.50 0.60%
As Marketed StDev 6.06 7.28 -16.7%
As Marketed Return over Feed/hd 0.40 68.55 1.85
Optimized Carcass (kg) 96.40 95.00 1.4 kg
Optimized Return over feed/hd €71.98 €70.23 1.75
Discussion
Profi t optimizing average weight results in an improvement 
in return over feed costs for each group. In this case, Q*FLEX = 
96.4kg with average return over feed costs per head of €71.98/
hd and Q*CV = 95.0kg with return over feed costs equal to 
€70.23/hd. This is an improvement from “as marketed” of €1 58/
hd and €1.68/hd respectively. In conclusion optimized carcass 
weights would generate substantial additional returns irrespec-
tive of treatment groups.
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The analysis of farm management factors aﬀ ecting the MSY in Korea’s hog industry
Hwa soon Kang
Cargill Agri Purina, Inc., Seongnam-si, Korea
The purpose of the hog farm operation is to maximize a profi t. 
But, compared to the advanced countries for pork production, 
Korean hog industry has faced the challenge to be sustainable 
and to be developed due to lower productivity. In addition, as 
the trade barrier between countries has been gradually lowered, 
Korean hog industry has been challenged seriously. Under the 
existing circumstances, to accomplish the objective of the hog 
farm operation and to grow sustainably, it is necessary to ana-
lyze the performance, to operate effi  ciently and to maximize the 
productivity level in each production stage. Therefore, it is ne-
cessary to analyze the factors aff ection the farm productivity to 
improve farm productivity, to grow sustainably, and to increase 
the competitiveness of the industry.
Previous studies on the farm productivity and the competi-
tiveness of the industry were conducted to measure the 
productivity level and recommend the ways for improvement 
by analyzing farm facility, farm management, disease control, 
management capability, each component adoption, profi t, and 
so on. However, in this study, it is assumed that all the factors 
aff ecting farm productivity level are compounded, as the hog 
industry has been integrated and been complex, and they are 
interconnected with one another. Additionally, biological indica-
tors, such as PSY and quantitative indicators, such as income and 
spending are limited to measure farm performance level and 
to represent fi nancial performance, respectively. And, there is a 
tendency that qualitative factors, i.e., technology adaptability 
and management capability, are individually analyzed to be indi-
cated in a quantitative manner. 
In this study, a diverse array of factors, such as facility, technol-
ogy, workforce, and management, are analyzed by considering 
eff ect of each factor on the farm productivity and qualitative fea-
ture. An indicator for farm productivity is determined to be an 
MSY, because there is no one solid standard to determine farm 
productivity, because it has not been feasible to collect realis-
tic data for profi tability and to use factors such as income and 
spending for evaluating productivity under the circumstance 
that every farm’s management type and fi nancial status are 
diff erent. Moreover, considering the accessibility and objectivity 
to the information, MSY, the number of pigs alive from birth to 
market per sow per year, is determined the most suitable indica-
tor for productivity eff ectiveness. The data used for analysis were 
gathered through a set of in-depth interviews with hog industry 
expert and farm owner while visiting on-site. The data collected 
were specifi cally on farm productivity level, farm workforce 
status, farm owner’s characteristics, facility and disease status. 
Through the Decision Tree used for the analysis, broad impacts 
of the factors mentioned above on productivity and interactions 
between factors were identifi ed. And, using the result from the 
Decision Tree analysis, variables for CARTEG using optimal scal-
ing were selected and using the optimal scaling while consid-
ering that the data from the interviews are three diff erent types, 
i.e. category, sequence, numeric value are blended, the conclu-
sion for CARTEG was drawn. 
Based on the this result, after setting average MSY as a primary 
basis to categorize the data set into two groups, the higher and 
the lower, respectively, the factors to infl uence on hog farm pro-
ductivity were identifi ed. In addition, while the higher and the 
lower groups were divided by MSY value, the variables aff ecting 
hog farm productivity for each group were fi gured out and the 
strategies to increase MSY value for each group were provided. 
For those farms on the bottom, they need to establish business 
plans while focusing more on avoiding exclusive management 
dependent on experience, systematic and regular participation in 
training, farm consulting, workforce management by capability, 
implementation of incentive program to promote longer years 
of service and high performance, broadening workforce benefi ts 
program, facility management, such as specialized access control 
system, all-in all-out system as well as site management, regular 
service call by specialized veterinarians, and prevention of anti-
biotics’ abuse. And then, to be more competitively in the future, 
farm owners or farmers’group have to set business plans and 
implement them while especially bearing in mind following areas: 
self-designed training program, customized training, business 
direction setting with farm consultants, farm analysis and record 
maintenance, long-term strategy for sustainable growth including 
operating principles and succession plans, as well as modernized 
and environmentally-friendly farm.
These kinds of strategies for higher MSY are useful not only to 
increase competitiveness of individual farms or farmers’groups, 
but also to establish the foundation of Korean hog industry to 
compete against the imports in the era of FTAs. Accordingly, 
primary purpose of this study is to enable individual farms to 
choose necessary strategies to manage farms eff ectively, leading 
to more income. And, the ultimate purpose of this study is to 
propose strategies for securitizing competitiveness of overall 
hog industry and for further development of the industry.
keyword : Hogindustry, Factors, MSY, CATREG, Decisiontree, Strategy
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Measuring full value pigs
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Introduction
The concept of capturing maximum profi t or full value from every 
pig that comes into a producer’s care has been discussed and 
developed over the last few years by Elanco Animal Health. All 
production outcomes less than full value are defi ned as lost op-
portunity, deviation from optimal or as attrition for a contempor-
ary group. Optimizing profi tability for a group of pigs means iden-
tifying the point at which the group’s marginal input cost equals 
marginal revenue. This requires knowledge of the production 
function to estimate the cohort’s marginal cost of gain and jointly 
determined market value. Although the underlying determination 
of profi t maximization is the same, the process for estimating it for 
a group is much more complex than for a single pig. 
Materials and Methods
The slaughterhouse is the only place in the current swine pro-
duction chain where every animal is individually weighed and 
assessed for quality. Information is often reported to producers 
in summary form, such as total animals sold, average weight, 
average price, average discount or premium and other as-
sessments.  Generally there is little or no reporting of group 
outcomes and the impact of variation on lost opportunity. The 
premium and discount schedules that buying programs provide 
vary across geographies and between pork processing compan-
ies and thus must be clearly understood prior to developing a 
marketing strategy or standard marketing procedure. Figure 1 is 
an example of actual market weight and selling price outcomes.
Figure 1. Actual Marketing Outcomes 
Results
The marketing decision for a single animal can be easily calcu-
lated and demonstrated by determining if adding another kilo 
of weight prior to marketing will add profi t margin. However, 
making the marketing decision for a truck load, building or en-
tire site can be diffi  cult due to discounts imposed on pigs in the 
tails of the target weight distribution. Producers can accurately 
identify weights of pigs to initiate the marketing process. This 
may be done by scaling pigs, visual appraisal or use of calen-
dars and growth curves to trigger marketing of animals within 
a group or barn. Accuracy of selection, both from an optimal 
weight perspective and minimizing variation within the group 
of pigs can be metrics used to score how eff ectively marketing 
decisions were implemented for each load and for the entire 
population of pigs evaluated.
Discussion
Developing targets or report cards for the team responsible for 
executing the marketing plan is critical for continuous process 
improvement and capturing opportunity costs. First, those who 
physically identify or mark pigs must have rapid and accurate 
feedback reporting achievement. Second, the load out crew 
must receive reports demonstrating how eff ective they are 
at placing the correct pigs on the transport vehicle. Third, the 
transportation team must have an understanding of transport 
losses that could impact fi nancial outcomes. And fi nally, farm 
managers responsible for marketing activities and fi nancial 
results must have reports indicating profi ts and identifying value 
opportunities. 
Creating a grade, metric or score that allows various levels of the 
farm organization to quickly and easily see how well the market-
ing activity is being executed is important to drive continuous 
improvement. We propose the metric, Full Value Pigs, to mean all 
animals marketed within a contemporary group which achieve 
at least 90% of the single pig optimal margin over feed cost.  
Establishing a score or rating allows a better understanding of 
system achievement and helps the entire team responsible for 
the marketing activities target and capture opportunities for 
continuous improvement. 
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Description of the economic impact of the political crisis on small-
scale pig farmers and butchers in Western Kenya
Cate E. Dewey1 Jared Wohlgemut1 Florence Mutua2 Mike Levy1
1. University of Guelph, Guelph, ON, Canada; 2. International Livestock Research Institute, Nairobi, Kenya
Introduction
Politically based violence followed the 2007 federal election in 
Kenya. This crisis caused the Nairobi Stock Exchange to drop by 
$600 million USD. In the fi rst week, the crisis caused the Nairobi 
Stock exchange to drop $600 million USD and costs due to crisis-
related damage was $1 billion US. Tourism was severely aff ected. 
Hotel occupancy rates dropped from above 80% to under 20% 
and 120,000 tourism-related jobs were lost. The purpose of this 
research was to describe the economic impact of this crisis on 
the smallholder pig farmers and pig butchers in Western Kenya.
Materials and Methods
In June 2008, face-to-face interviews were used to collect 
information from 100 farmers, 38 pig butchers, and 17 govern-
ment staff  in Busia and Kakamega Districts of Western Kenya. 
Farmers were randomly selected but butchers and government 
staff  represented a census. Farmers were asked what livestock 
they owned in June 2007 and June 2008 and the price they paid 
for raw meat before and after the crisis. Everyone was asked to 
describe the eff ect of the crisis on their businesses. The 2007 and 
2008 livestock numbers were compared with a paired t-test. 
The cost of meat before and after the crisis and from Busia to 
Kakamega was compared using Student’s t-tests. 
Results
Food became more expensive, additional family members 
moved in with the farmers to escape violence in the city, farm 
inputs became expensive and scarce, it was impossible to travel 
outside the village and off -farm jobs were lost. Farmers sold 
livestock to feed their families and because they had no food for 
the pigs. In Busia, ownership of sows, boars, growing pigs and 
piglets decreased by 41%, 32%, 42%, and 40% respectively. In 
Kakamega, sows and boars decreased by 27% and 46%; growing 
pigs and piglets decreased by 55% and 70% respectively. 
Many butchers (52%) had less business due to the crisis. More 
butchers in Kakemega (42%) closed for longer periods of time 
(40 +/- 19 d) than in Busia where 18% of butchers closed for 18 
+/- 19 d (P<0.001). Pork price increased from 105 to 119ksh/ kg 
in Busia and from 116 to 146ksh/kg in Kakamega after the crisis 
(P<0.0001). The live pig price did not increase.
Extension workers were unable to travel to farms. Pig mortality 
increased to due malnutrition and untreated diseases.
Discussion
The pig industry in this area of Western Kenya relies on trade 
within and between villages. The transport of pigs is done either 
on foot or using bicycles. Therefore, this drastic decrease in the 
numbers of pigs in the region will have a large impact on the 
industry. Sows are 12-14 months old when they wean their fi rst 
litter and pigs are 8 – 12 months old when they reach market 
weight. It will take more than a year to replace the pig herd to 
return to the previous population.
The closure of butcher businesses has left the butchers with little 
to no fi nancial reserve. There will be few pigs for the butchers to 
buy, which will put pressure on them to purchase smaller weight 
market pigs. With less pork to sell, the fi xed costs of slaughter 
will result in low to no profi t. 
The crisis had a severe impact on the pig industry’s sustainabil-
ity, shocking market equilibriums. The farmers needed to sell 
pigs to support their families when food prices were high. The 
current low breeding population has reduced the supply of pigs, 
forcing upward pressure on prices and jeopardizing long term 
sustainability. Improved breeding effi  ciency is now essential 
to ensure a renewed availability of pigs. The political crisis has 
negatively aff ected all of the industry’s stakeholders.
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Economic income of small pig production systems in Mexico.
Enriquez Celestino; Giovanna Penuelas; Francisco E. Martinez Castañeda
Universidad Autonoma del Estado de Mexico, Toluca, MEX, Mexico
Introduction
53% of Mexican population lives with some level of poverty 
and haungry. Backyard breeding animals is a central elemnt of 
estrategic and improving diversifi cating economies all around 
the world. The aim of this study was to evaluate the economic 
performance of small pig production systems in Texcoco México. 
Materials and Methods
With participative techniques we analyzed 53 small pig pro-
ducers in Texcoco, Central Valley of Mexico. Three Strata were 
defi ned according the number of sow and with a proportional 
allocation model: Strata 1: from 1 to 4 sow; Strata 2: form 5 to 10 
sow; Strata 3: from 11 to 16.
Results
Strata 1 had 80% of small production units with an economic 
income of 16% of total family income. Strata 2 got 12% of all 
producers and the economic income was 17%. Finally, Strata 3 
represent 8% only and 28% of economic income (Fig 1).
The animal inventory was 173 sow and 23 boars. 90% of pro-
ducers live in a nuclear family and only 10% were singles. Age 
average was 51 years old and we detected producers with more 
than 70 years old.
33% of all population analyzed produce complete cycle, 33% 
sell piglets, 14% fi nished piglets to market and less than 3% 
transform pigmeat.
Discussion
The best economic performance and income was for the bigger 
Strata 3. It is known as big is the enterprise more possibilities 
and access to resources can get. It is diffi  cult to establish scale 
economies in this kind of production systems, but it is also true 
that more animals in market, represents less variables costs.
One amazing data is the average of producers, because it seems 
that in general this economies strategies represents an import-
ant diversifi cation of incomes due to this producers are at the 
end of this working age. That way, small pig production systems 
can be not only an economic way of life.
Several authors mentioned the importance of this systems. We 
want to add the fact that the historical way of production is very 
important in the occupational health of families.
Figure 1. Income of small pig production systems.
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A combination of azaperone/butorphanole/ketamine to anesthetize piglets for castration
Iwan Nussbaumer; Niklaus Indermühle; Werner Zimmermann; Friederike Zeeh; Yvonne Leist
VITAL AG, Oberentfelden, Switzerland
Introduction
Since January 2010 surgical castration of male piglets without 
anesthesia is forbidden by federal law for the protection of 
animals in Switzerland. 
Due to ignorance to altenative methods avoiding surgical 
castration by the swiss meat industry, pig breeders are forced 
to perform surgical castration under general anesthesia. Pig 
producers can choose between using an inhalation device with 
isofl urane or anesthesia by intramuscular injection performed 
by the veterinarian.
Azaperon and Ketamin is the only registered drug combination 
to anesthetize pigs in Switzerland. The surgical tolerance of this 
combination is considered to be not suffi  cient for painful pro-
cedures. Our own experiences confi rm this estimation, especially 
if these drugs are given intramuscularly. We observed also ad-
verse reaction like excitement, hyperaesthesia and convulsions.
Consideration concerning improvement of this combination to a 
more balanced anesthetic protocol with better analgetic action 
led to a triple combination where a potent analgetic drug (e.g. 
opioid) by off  label us was added. 
Because of good experiences with this drug, butor-phanole was 
chosen.In a fi eld trial the security and effi  cacy of a combination 
of azaperone, butorphanole and ketamine for general anesthe-
sia by intramuscular injection to allow castration of piglets was 
tested.
Materials and Methods
Out of another study the optimal doses for the combination 
were found: 5 mg per kg bodyweight of azaperone, 0.2 mg per 
kg bodyweight of butorphanole and 15 mg per kg bodyweight 
of ketamine.
From three diff erent pig breeding units 140 male pigs (suckling 
piglets and weaners) received an intramuscular injection of 
the combination mentioned above, mixed in the same syringe 
and performed by the veterinarian. After reaching an adequate 
depth of anesthesia they were castrated by the farmer in the 
habitual manner.
For piglets older than 3 weeks of age an emasculator was used. 
Before administration of the drugs the pigs were shortly clinic-
ally examinated and alterations in health status were recorded. 
Introduction, surgical tolerance and recovery from anesthesia 
were judged using a score system (A= very good, B= good, C= 
fair) to evaluate the characteristics and the acceptability of this 
protocol for this purpose.
Results
Out of 140, 138 pigs reached within 5 to 10 minutes an adequate 
depth of anesthesia. Two pigs received an additional dose of 2/3 
of the original dose.
Eighteen, especially piglets weighing between 2.5 and 3 kg 
showed moderate struggling during tension on the funiculus. 
After a maximum of two hours all pigs recovered uneventful. 
There were no losses with coherence to the anesthesia. 
The older the pig was, it was more likely to be judged by score A. 
None of the pigs were judged by score C.
Discussion
This anesthesia protocol showed to be valuable for use in prac-
tice to provide general anesthesia allowing surgical castration 
of piglets. The experiences made showed relevant advantages 
in comparison of experiences made with azaperone/ketamine 
alone.
The ideal point in time to perform this procedure showed to be 
after a piglet’s age of three weeks.
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Clinical eﬀ ects of NSAID treatment in piglets with arthritis
Helena Frohm1 Magdalena Jacobson1 Mate Zoric2
1. Dept. of Clinical Sciences, SLU, Uppsala, Sweden; 2. National Veterinary Institute, Uppsala, Sweden
Introduction
In Sweden, approximately 10 % of all piglets are treated against 
arthritis. The disease is mainly caused by hemolytic streptococci 
and Staphylococcus spp (1, 4) and the piglets are usually treated 
with intramuscular injections of penicillin once daily for fi ve 
days. The disease causes suff ering to the aff ected piglets and 
it has become increasingly common to also include NSAIDs in 
the treatment. This regimen has however not been evaluated. 
The purpose of this study was to investigate the clinical eff ects 
of combining treatment of lame piglets with NSAID-drugs and 
penicillin and compare it to treatment with penicillin only. 
Materials and Methods
In this study 40 piglets (Group 1) with arthritis from four diff er-
ent herds in Sweden were treated with benzylpenicillinprokain 
(20 mg/kg bw) i.m. once daily for fi ve days. 43 piglets (Group 2) 
were treated similarly but with the addition of a subcutaneous 
injection of meloxicam (0.4 mg/kg bw) the fi rst day of treat-
ment. The piglets included were below three weeks of age with 
evident lameness. The rectal temperature, weight, degree of 
lameness and degree of joint swelling were recorded day 1, 2 
and 6 (the day after the fi nal treatment). The degree of lameness 
and joint swelling were scored none (0), mild (1), moderate (2) 
or severe (3) by a person blinded for treatments. In each pen, a 
matched, apparently healthy piglet was included as weight gain 
control. The results were analyzed by MannWhitney Rank Sum 
test (rectal temperature and weight), and Fischer’s exact test 
(lameness and joint swelling). Comparisons were made between 
the two treatment groups, between piglets included day 1-2 (i.e. 
pigs that might have been lame before the start of the study; n 
= 48; 58%) and those included day 3-7 (i.e. pigs that developed 
arthritis during the study), as well as between piglets with joint 
swelling in the claws and those with swelling of other joints. 
Results
In both groups, a decrease in rectal temperature was noted 
between day 1 and 2 (Group 1; P<0.01, Group 2; P<0.001) and 
day 1 and 6 (Group 1; P<0.05, Group 2; P<0.001). The diff erences 
between the groups were not signifi cant. Further, there was no 
diff erence between the groups in the decrease of swelling of the 
joints (Table 1). In both groups, the swelling persisted to a larger 
degree on day 6 among piglets included day 1-2 (P < 0.01) than 
among those included later. Within groups, the swelling was 
more pronounced day 6 among the piglets in group 1, included 
day 1-2 (P = 0.05). Swelling of the claw joints were more severe 
day 6 as compared to other joints (P < 0.001). There were no dif-
ferences with respect to weight gain or lameness between the 
groups (Table 1).
Table 1.
Weight (kg) Temp (°C) Swollen Lame
Group 1 2 3 1 2 1 2 1 2
Day 1 2.2 2.2 2.3 39.7 39.7 1 1 1 2
Day 6 3.2 2.9 3.3 39.4 39.5 1 1 0 0
Group 1= piglets treated with penicillin only for 5 days, Group 
2 = piglets treated with penicillin for 5 days + metacam the fi rst 
day of treatment. Group 3 = healthy weight gain control. Day 
1= median values measured before the fi rst treatment, Day 6= 
median values measured the day after the last treatment 
Discussion
Initiating treatment early in the course of disease is import-
ant to avoid persistent infection, haematogenous spread and 
further damage to the joints (3). This was also emphasized in 
the present study by the persistent swelling of the joints among 
piglets included early in the study, as these piglets may have 
suff ered from a more progressed infection. The results also 
indicate that the use of meloxicam may reduce joint swelling in 
these progressed infections. The signifi cance of persistent joint 
swelling needs further investigation but the degree of synovitis 
and amount of exudates may infl uence the ability to eliminate 
the infection with antibiotics (2). Further studies are also needed 
to investigate the poor response to therapy of piglets with claw 
joint swelling. No clinical signs of adverse eff ects were noted and 
in conclusion usage of meloxicam in piglets with arthritis can 
neither be supported nor rejected based on this study.
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Eﬃ  cacy of NSAIDs in treatments of lame piglets
Mate Zoric1 Eva Norling2 Ulla Schmidt2 Per Wallgren1
1. National Veterinary Institute, Uppsala, Sweden; 2. Swedish University of Agricultural Sciences, Uppsala, Sweden
Introduction
Joint swelling and lameness are the most obvious and persistent 
clinical signs of infectious arthritis in piglets (1). Prompt treat-
ment with antibiotics is required to achieve a positive treat-
ment eff ect in lame piglets that limp due to pain (2). Hitherto 
pain-reducing drugs have rarely been used within veterinary 
medicine, but the potential of recently introduced non ster-
oid anti-infl ammatory drugs (NSAID) is apparent from welfare 
aspects. However, pain prevents activity and pain-reducing may 
lead to over-activities with chronic injuries of aff ected joints as 
a consequence. Therefore, the aim of this study was to validate 
the clinical eff ects of concurrent treatment of lame piglets with 
NSAID-drugs and antibiotics to that of using antibiotics solely.
Materials & Methods
The study was carried out at the research station at Funbo-
Lövsta, Swedish University of Agricultural Sciences. The farrow-
to-fi nish herd comprised 110 sows and piglets were given 
individual identities at birth. The piglets were weighed at birth 
and at fi ve (weaning) and nine weeks of age. Records of disease 
and treatments were kept for each pig.
All piglets born alive during six months were included in the 
study. Piglets attended with lameness were randomly allot-
ted into one of two groups. Piglets in group I were injected 
intramuscularly with 20 mg benzyl penicillin (Penovet® vet., 
Boehringer IngelheimVetmedica) per kg bodyweight once a day 
for fi ve days. Piglets in group II were additionally injected with 3 
mg ketoprofen (Romefen vet., Merial) per kg bodyweight once a 
day for three days.
The occurrence of lameness was registered until the age of 5 
weeks and the clinical effi  cacies of treatment were assessed 
daily. Lameness and/or visibly swollen joints, as well as general 
condition were scored as 0 (good), 1 (almost good), 2 (not good), 
3 (not good at all). Groups were compared by Chi2-tests using 
two-by-two frequency tables.
Results
In total 93 out of 1572 liveborn piglets were diagnosed with 
lameness (5.9%). Around 85% of these diagnoses took place 
during the fi rst 3 weeks of life. As shown in Figure 1, the clinical 
response diff ered signifi cantly (p<0.05) between the two treat-
ment groups. The clinical status of penicillin and ketoprofen 
treated piglets (n=49) was improved daily during the fi rst four 
treatment days (p<0.05 to 0.01), whereas a signifi cant (p<0.01) 
improvement only was recorded between days 2 and 3 of piglets 
solely treated with penicillin (n=44).
Figure 1. The clinical effi  cacy of treatment for lameness.
The weights recorded at birth, fi ve and nine weeks of age are 
shown in Figure 2. Piglets that remained healthy were about 1.1 
kg heavier than piglets attended with lameness at 5 and 9 weeks 
of age. There was no diff erence between weights of the piglets 
treated for lameness regardless of treatment strategy.
Figure 2. Means bodyweight of piglets born alive.
Discussion & Conclusions
Like other diseases (3), lameness reduced the growth rate of the 
piglets. Despite the low number of pigs in this study, our results 
clearly indicated an earlier recovery among lame piglets treated 
with both antimicrobials and NSAIDs. Use of NSAIDs in combina-
tion with antibiotics as treatment for lameness in piglets ought 
therefore be considered for animal welfare issues.
No diff erence in weight gain between the treated groups were 
recorded, but the earlier recovery of piglets given NSAIDs may 
contribute to higher activity including suckling which could 
improve the general condition of aff ected piglets. This will be 
scrutinised in enlarged studies. However, it should be empha-
sized that pharmacological treatment of pain in sick piglets not 
can replace the management routines, fl oor quality and good 
care.
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Eﬀ ect of ibuprofen on pigs during routine vaccination and willingness to approach behavior
Peggy Anne Hawkins; Michael Strobel; Leah M. Erickson
Veterinary Provisions, Inc., Northfi eld, MN, USA
Introduction
Vaccinations are a necessary part of producing healthy pigs. To-
day, nearly all pigs receive some vaccinations during the nursery 
and/or grower phases of production. The objective of this study 
was to determine if ibuprofen administered in the water could 
reduce fever associated with vaccination of pigs as measured by 
rectal temperature. Additionally, a pilot study on the behavior 
known as willingness to approach was evaluated in pigs with 
and without ibuprofen at the time of vaccination. The ibuprofen 
group had signifi cantly lower rectal temperatures as compared 
to the non-medicated group.
Materials and Methods
One of two rooms was randomly assigned to receive the ibupro-
fen medication. And, fi fty (50) pigs within one randomly chosen 
pen in each of the two rooms were selected. Pigs were tagged 
for identifi cation 5 days prior to vaccination day. At ~3:00p.m. 
the day prior to vaccination, a stock solution of ibuprofen (Ve-
tRx®) was prepared according to label directions: 16oz (473ml) 
q.s. with water to 1 gallon and metered to the pigs at 1:128. 
Ibuprofen remained available to the pigs for 24 hours post-vac-
cination. The next morning at ~9:00a.m., pigs were vaccinated, 
booster dose, per veterinary recommendation (M+Pac® and Cir-
cumvent® PCV2; Intervet/Schering). Pigs were crowed in the pen 
and injected in the neck muscle. Immediately following vaccina-
tion individual rectal temperatures (RT) were measured. About 5 
hours after vaccination, the pigs were crowded in the pen again 
and RT were taken again. Pigs in the remaining pens of the room 
were used to evaluate willingness to approach as described by 
Baumert et al. (1). The baseline or pre-vaccination evaluation for 
the approach study was done the afternoon before vaccination. 
The post-vaccination evaluation was done the following after-
noon about 5 hours post-vaccination. 
Results
The non-medicated control pigs had an average RT 105.7°F and 
the ibuprofen group was 105.6°F immediately following vaccina-
tion. At 5 hours post-vaccination, non-medicated control pigs 
had an average RT 105.5°F and the ibuprofen group was sig-
nifi cantly lower at 104.8°F. Additionally, there was no diff erence 
between the immediate RT of either group and the RT of the 
control group after 5 hours (Fig. 1). Plots with diff erent letters are 
diff erent (P<0.05).
There was a signifi cant decrease in willingness to approach 
post-vaccination within both treatment groups. However, there 
was no diff erence in the decrease in willingness to approach be-
tween groups. The control pigs’ willingness to approach reduced 
by 16.6% and the ibuprofen pigs’ was reduced by 12.2%. There 
were too few pens in this pilot study to show a diff erence. All 
data were analyzed using Wilcoxon rank sum test. A P value of 
<0.05 was considered signifi cant.
Discussion
Vaccines stimulate and activate the immune system of pigs (2). 
The infl ammatory response is an important part of this develop-
ment (3). A febrile response is expected when a vaccine has 
done a good job of stimulating immunity. However, a very high 
fever response (>105.0°F) may do more harm than good for 
the animal. Ibuprofen is used eff ectively in human medicine to 
control vaccine induced fever. In this study, the increase in RT 
due to the stress of the vaccination process (crowding and injec-
tion) was not aff ected by having ibuprofen in the drinking water. 
But, at 5 hours after vaccination, the non-medicated animals 
continued to have an increasing RT with some as high at 108.0°F. 
Pigs with a high fever were less likely to exhibit willingness to 
approach behavior than pigs with RTs controlled by ibuprofen. 
Further work will be presented at the meeting.
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Investigations about the use of topical cryogen spray and local 
anesthetics for the castration of male suckling piglets
Daniela Schiele1 Tim Kilchling1 Susanne Zöls1 Mathias Ritzmann2 Andreas Palzer1 Karl Heinritzi1
1. Clinic for Swine, LMU Munich, Oberschleißheim, Germany; 2. Clinic for Swine Diseases, VU Vienna, Vienna, Austria
Introduction
In many European countries, the search for a reasonable alterna-
tive to piglet castration without analgesic treatment is ongoing. 
In Austria a new method was developed in 2008. It combines 
the application of topical cryogen spray on the scrotal area 
before skin incision and spraying local anesthetics (LA) on the 
fi xed spermatic cord after removal of the testes. Therefore the 
spermatic cord is fi xed with a clamp (1). The intent of the present 
study was to evaluate the impact of cryogen spray application, 
intraoperative fi xation of the spermatic cord and intraoperative 
application of local anesthetics on castration induced stress and 
pain. Similar to other studies, the dimension of stress was evalu-
ated by cortisol measurements (2,3).
Materials and Methods
A total of 221 clinically healthy male suckling piglets were ran-
domly assigned to eight diff erent treatments and groups 
(Table 1). 
Table 1: Treatment groups 1-8 and number of animals
group Treatment number
1 Fixation 29
2 Fixation, cryogen spray 29
3 Fixation, castration 28
4 Fixation, cryogen spray, castration 28
5 Fixation, castration, LA dropped into wound 28
6 Fixation, cryogen spray, castration, LA dropped into wound 29
7 Fixation, cryogen spray, castration, LA dropped into wound LA intrates-ticular, fi xation, castration 29
8 Fixation, cryogen spray, castration, fi xation of spermatic cord with clamp, LA dropped on fi xed cord 21
The cryogen spray (ethyl chloride) was applied on the scrotal 
skin from a distance of 10 cm until a skin temperature up to 
-12°C was achieved. Temperature of the scrotal skin was meas-
ured by a pyrometer. The local anesthetics (40 mg procaine-
hydrochloride with 0.05 mg epinephrine) were either dropped 
into the wound after removal of the testes (Group 5 and 6), 
injected into the testes 10 minutes prior to castration (Group 
7) or dropped on the fi xed spermatic cord after removal of the 
testes (Group 8). Blood samples taken from the cranial vena cava 
were collected from each piglet half an hour before and half an 
hour, one hour, four hours and one day after treatment. Based 
on cortisol measurements, the impact of the various treatments 
on pain and stress was examined.
Results
The average values of cortisol concentration of all groups are 
shown in Figure 1.
Figure 1: Average values of cortisol concentration before and 1⁄2 h, 1 
h, 4 h, 24 h after treatment
Fixation and application of cryogen spray (group 2) caused half 
an hour after treatment signifi cantly higher average cortisol con-
centrations than fi xation alone (group 1) (p ≤ 0.05). A minimizing 
eff ect on castration induced stress using a cryogen spray prior to 
castration was not evident (group 3 vs. group 4, p > 0.05).
Four hours after castration, the average cortisol concentration 
of Group 5, 6 and 7 were signifi cantly higher than that of Group 
3 (p ≤ 0.05). The application of cryogen spray combined with 
the use of a clamp to fi x the spermatic cord (Group 8) lead to a 
signifi cant increase in serum cortisol concentration one hour 
after castration compared with serum cortisol concentration of 
Group 3 (p ≤ 0.05).
The results of the cortisol measurements indicated that none 
of the examined castration methods (Groups 4-8) induced a 
signifi cant minor stress reaction than the conventional method 
of castration (Group 3).
Discussion
Results indicate that neither cryogen spray nor local anesthet-
ics as applied in this study cause an appropriate analgesia for 
piglet castration. Therefore, those techniques are not feasible as 
alternative to conventional piglet castration.
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Evaluation of diﬀ erent topical anaesthetics for pain reduction during surgical castration of male piglets
Karl-Heinz Waldmann1 Dina Rittershaus1 Manfred Kietzmann2 Birger Puppe3
1. Clinic for Swine and Small Ruminants, Hannover, Germany; 2. Department of Pharmacology, Toxicology and Pharmacy, 
University for Veterinary Medicine , Hannover, Germany; 3. Research Institute for the Biology of Farm Animals, Dummerstorf, Germany
Introduction
80 % of the male piglets in the EU and almost all male piglets 
in Germany are castrated to avoid unpleasant odour and taste 
of the meat of entire mal pigs [1]. According to European law, 
castration can be performed without anaesthesia during the fi rst 
7 days of the piglets´ lives. Various studies however documented 
painfulness of this procedure. Therefore diff erent research pro-
jects were started to fi nd an alternative to conventional castra-
tion of piglets. However, general anaesthesia showed some 
disadvantages [2] and for antiphlogistics, positive eff ects could 
be found merely on postoperative pain [3]. This study intended 
to test the ability of diff erent topical anaesthetic techniques for 
pain reduction during castration of male suckling piglets.
Material and Methods
193 male piglets at 6 or 7 days of age were included in the study 
and divided into 8 diff erent groups. There were 5 castration 
groups, in which the piglets were castrated conventionally or 
after use of chlorethyl spray, a combination of chlorethyl and 
lidocaine spray or EMLA-cream, which is an euthectic mixture 
of lidocaine and prilocaine. One group of piglets, which were 
castrated after intratesticular application of local anaesthesia in 
combination with an NSAID served as positive control. Addition-
ally, piglets of three control groups were either not medicated or 
treated with chlorethyl spray or EMLA-cream and fi xated but not 
castrated. For measurement of the impact of castration on the 
piglets, blood samples were taken pre OP and 1 and 24 hours 
after castration or fi xation with cortisol levels being measured 
afterwards. Vocalizations of the piglets were recorded and ana-
lyzed to detect pain during castration/fi xation. The piglets were 
followed up (wound control/weighing) for three weeks.
Results
In piglets castrated without anaesthesia, a signifi cant rise of cor-
tisol levels from the basal value to the value 1h after castration 
could be registered (p<0.05). Piglets which underwent topical 
anaesthesia had almost equally high cortisol levels (p>0.05). In 
contrast, piglets which received local anaesthesia before castra-
tion and uncastrated piglets had almost no increase of plasma 
cortisol levels. Animals of the castration groups showed distinct 
changes of vocalisation during the possibly painful surgery 
stages, which could not be found before or after castration. Al-
though sound analysis indicated pain reduction during surgery 
by use of chlorethyl spray, it also showed that application of 
chlorethyl spray itself is painful. Regarding EMLA-cream, sound 
analysis was suggestive of some anaesthetic eff ects on the skin, 
but not on the spermatic cord. On the contrary, in piglets, which 
were castrated under local anaesthesia, almost no changes of 
vocalization were detected. Wound healing showed no diff er-
ence between the control group and the treatment groups 
(p>0.05) except for piglets, which had received an injection of 
a local anaesthetic prior to castration, which had signifi cantly 
(p<0.05) increased wound healing disorders. 
Discussion
On the basis of increase of plasma cortisol levels, no stress 
reduction by the use of chlorethyl spray and just a small but not 
signifi cant improvement by using a combination of chlorethyl 
and lidocaine spray or EMLA-cream were discovered. Although 
analysis of the piglets’ vocalisations indicated some pain reduc-
tion during the skin incision and the emasculation by use of 
chlorethyl spray, it also showed that application of chlorethyl 
spray itself is painful. Regarding the usage of EMLA-cream, 
sound analysis was suggestive of some anaesthetic eff ects on 
the skin but not on the spermatic cord.
Altogether the results of this study show that none of the topical 
anaesthetic techniques is as eff ective for pain reduction as an 
intratesticularly applied local anaesthetic. Since local anaesthe-
sia prior to castration produced increased wound healing disor-
ders, further research is required to fi nd a practical and effi  cient 
alternative to conventional castration of piglets.
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Possibilities of pain reduction in tail docking in piglets
Tim Kilchling; Daniela Schiele; Susanne Zöls; Andreas Palzer; Matthias Eddicks; Karl Heinritzi
Clinic for Swine, LMU Munich, Oberschleißheim, Germany
Introduction
Tail docking is performed as a precautionary move to pre-
vent tail biting in pigs (1). According to the German Animal 
Rights Law, tail docking is only allowed without anaesthesia 
and pain medication until the fourth day of life. However, this 
procedure,appears to be painful for piglets.
The aim of this present study was to identify the pain caused by 
tail docking and the possibility of reducing this neuroendocrine 
stress reaction by administering a nonsteroidal anti-infl amma-
tory drug (NSAID) before tail docking. A further study evaluated 
the pain caused by tail docking based on cortisol values (2).
The evaluation of cortisol permits the measurement of the 
neuroendocrine stress reaction in animals (3). 
Materials and Methods
A total of 219 one-day old clinically healthy piglets were ran-
domly assigned to seven diff erent groups. A general overview of 
the seven diff erent groups, number of piglets per group, the tail 
docking method and the drug administered is depicted in Table 
1. Piglets from Group 1 served as controls and were manually 
restrained in the same position used for tail docking without 
having their tails removed.
Table 1: Treatment groups and tail docking method
 Group Tail docking method Treatment n
1 Control none none 32
2 Cauterisation Cauterisation none 32
3 Meloxicam / cauterisation Cauterisation 0.4 mg/kg Meloxicam 31
4 Flunixin / cauterisation Cauterisation 2.2 mg/kg Flunixin 31
5 Side cutting pliers Side cutting pliers none 31
6 Meloxicam / side cutting pliers Side cutting pliers 0.4 mg/kg Meloxicam 31
7 Flunixin / side cutting pliers Side cutting pliers 2.2 mg/kg Flunixin 31
The tail docking was always performed on the third day of life. 
On that day, approximately 2-3 ml of blood was collected from 
each piglet via the vena cava cranialis thirty minutes before tail 
docking. The cortisol concentration, determined from the serum 
samples taken 30 minutes before tail docking served as the base 
value. Following blood collection, piglets from Groups 3, 4, 6 and 
7 were administered their respective NSAIDs. After drug admin-
istration, the tails from piglets of all groups, with the exception 
of Group 1, were removed using the corresponding instrument. 
Thereafter, blood was collected from all piglets 30 minutes, 60 
minutes, four and 24 hours for cortisol measurement.
Results and Discussion
The average values of the serum cortisol concentration of all 
groups is shown in Figure 1.
Figure 1: Average values of Cortisol concentration (with 95% confi -
dence intervals) before, 30 and 60 minutes, four and 24 hours after tail 
docking
No diff erence could be found in the basal value (p>0.05) of each 
group. The cortisol concentration of Group 2 and Group 5 was 
signifi cantly (p<0.05) increased 30 and 60 minutes after tail 
docking when compared to the control Group 1. The cortisol 
concentration, measured 30 minutes after tail docking, was sig-
nifi cantly (p<0.05) lower in all groups that received NSAID prior 
to tail docking when compared to Groups 2 and 5. 60 minutes 
after tail docking, the cortisol concentration of Group 3, which 
received Meloxicam, was signifi cantly lower than that of Group 
2. Additionally, the cortisol concentration of Group 6 was also 
signifi cantly lower when compared to Group 5. After Flunixin 
administration, the cortisol concentration of Group 7 was signifi -
cantly reduced in comparison to Group 5.
Signifi cant diff erences between the both tail docking methods 
were not observed at any of the examined times. The serum 
cortisol concentration of Group 5 tends to be higher than that of 
Group 2.
Conclusion
The results of the study infer that the cortisol concentration 
caused by the neuroendocrine stress reaction is not infl uenced 
by handling or blood-sampling, but signifi cantly raised due to 
pain and distress like tail docking without any treatment. It can 
be reduced by the prior administration of an analgesic such as 
Meloxicam or Flunixin.
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A non-penetrating captive bolt (modiﬁ ed Zephyr) is eﬀ ective for euthanasia of neonatal piglets
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Introduction
On-farm euthanasia of low viability piglets is an inevitable task 
for producers, and it is essential that a humane and cost eff ect-
ive method be established. Any euthanasia method must ensure 
minimal pain, fear and distress as well as include considerations 
for the overall aesthetic acceptance of the procedure (AVMA, 
2007). Currently acceptable methods for piglets up to 12 lbs 
include carbon dioxide, anesthetic overdose, non-penetrating 
captive bolt, and the most common method, blunt force trauma 
(NPB-04259-01/09; AVMA, 2007). To be considered eff ective 
without a secondary step, the non-penetrating captive bolt must 
cause suffi  cient depression of the central nervous system and 
destruction of brain tissue to cause both immediate insensibility 
and rapid death (AVMA, 2007).Recent work comparing a non-
penetrating captive bolt (Zephyr, round head, 120 PSI) to blunt 
force trauma found that both methods rendered piglets immedi-
ately insensible, but some piglets showed signs of returning to 
consciousness when the Zephyr was used (Widowski et al, 2008).
Variation in depth of depression resulting from diff erent guns 
used in that study may have contributed to this fi nding. For the 
current study, the design of the nylon bolt head attachment 
for the Zephyr gun was modifi ed to a convex shape to increase 
the depth of depression when used at 120 PSI without causing 
penetration.Methods
All procedures were approved by the Animal Care Committee 
at the University of Guelph. Ten experienced stock people were 
trained to use the Zephyr, and each stock person euthanized 
10 low-viability or compromised piglets < 72h of age. Each 
stock person manually restrained the piglet on its sternum on a 
hard, fl at surface. Two shots were administered rapid fi re on the 
frontal bone (NPB-04259-01/09), followed immediately by one 
shot delivered to the back of the skull behind one ear. Piglets 
were assessed for signs of consciousness using brainstem and 
spinal refl exes: presence or absence of corneal refl ex, pupillary 
light response, jaw tone, and response to nose prick. Refl exes 
were repeatedly checked in that order every 15 seconds for at 
least 4 minutes. Clonic and tonic neuromuscular spasms (convul-
sions) were monitored along with the presence of breathing 
and heartbeat. Termination of tonic convulsions was used to 
estimate time of death (ETOD). Macroscopic scoring was used to 
assess skull fracture and hemorrhage at necropsy. Skull frac-
tures (SK) were recorded on a 5 point scale; 1 (no fracture) - 5 
(fully fragmented). Subcutaneous (SC), Subdural Dorsal (SD-D) 
and Subdural Ventral (SD-V) scores used a 6 point scale; 1 (no 
hemorrhage) - 6 (complete coverage). A brief questionnaire was 
provided to each stock person to assess individual experience 
and rate the method on a 10 point scale; 1 (completely ineff ect-
ive) - 10 (highly eff ective). 
Results
Data from 98 piglets showed that 100% were insensible immedi-
ately, and no piglets showed signs of regaining consciousness. 
ETOD averaged 225.9 ± 88.6 s (±S.D). Five of the 98 piglets re-
quired a secondary step (exsanguination) for cessation of move-
ment and were not included in the ETOD average. Macroscopic 
scores averaged 3.3 ± 0.5 (SK); 4.5 ± 1.1 (SC); 4.2 ± 0.9 (SD-D); and 
4.4 ± 0.8 (SD-V). Stock personnel rated the eff ectiveness of the 
Zephyr at 8.7 ± 1.6. 
Discussion
The modifi ed Zephyr used in this trial was a highly eff ective 
method of euthanasia for neonatal piglets less than 72 hours of 
age. The Zephyr caused immediate insensibility without return 
to consciousness in all 98 piglets and led to death without a 
secondary step in 95% of piglets. Macroscopic scoring indi-
cated that moderate to severe damage was infl icted to the skull 
and brain tissue of all piglets. The potential of the Zephyr for 
on-farm euthanasia was supported by a reasonable average 
ETOD (3m45s) and high stock personnel ratings. With additional 
modifi cations for safety and portability, the Zephyr has potential 
to be an eff ective and practical method of on-farm euthanasia 
within the swine industry. 
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Reduction of the discomfort at castration of piglets with azaperone
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Introduction
Castration of piglets is widely practiced throughout the world 
to avoid boar taint. Castration is performed at very young age 
and is recognized to be a painful experience for the piglets. To 
improve welfare, castration has been banned (UK) or is only al-
lowed when the piglets receive an analgesic (EU) or under local 
(Norway) or complete (The Netherlands) anesthesia. Today, there 
is also the option of immunocastration. 
A distinction is made between the direct pain during the act of 
castration and the pain after the procedure. Farmers are not al-
lowed to use anesthetics which raises the need for an alternative 
to reduce the discomfort at castration.
The aim of this study was to investigate if the use of azaperone 
(Stresnil®), a sedative registered for pigs and allowed to be used 
by farmers, could be a valid alternative to anesthesia of the 
piglets.
Materials and Methods
In the experimental farm of Lovenjoel, 392 piglets were included 
in the trial. As a reference group, 258 piglets were sham cas-
trated (REF). The negative control group consisted of 71 piglets 
castrated without any treatment (NC) and 63 piglets were in-
jected with 2 mg/kg azaperone IM 15 minutes before castration 
(AZA). Castration was performed during the fi rst week of life. 
Weight gain was measured at 23 and 63 days post castration. In 
21 NC and 16 AZA piglets, vocalization at handling, injection and 
castration was measured with a decibel meter. The behavior of 
the piglets was recorded every minute during 10 minutes after 
castration. Walking, sitting, standing, huddled up position, iso-
lated position, trembling and udder massage were categorized 
as negative behavior, while suckling, sleeping, lateral and ventral 
lying was categorized as positive behavior. 
The generalized linear model approach was perform in SAS® 9.1 
for the statistical analysis.
Results
There was no diff erence in weight gain 23 and 63 days post 
castration between the three groups. The vocalization results 
are shown in Table 1. Injection caused a signifi cant increase of 
screaming intensity compared to only handling, but the scream-
ing intensity was lower compared to screaming at castration. 
The screaming intensity at castration was signifi cantly reduced 
in the AZA compared to NC. 
Table 1: Vocalization (average decibel) 
Treatment No. piglets Handling Injection Castration
NC 21 75.9 - 99.2c
AZA 16 73.3a 89.0b 92.1d
ab: signifi cant diff erence p < 0.05 
cd: signifi cant diff erence p < 0.05
Figure 1 shows the evolution of negative behavior scores in the 
three groups during the 10 minutes after castration. Both REF 
and AZA show a signifi cantly lower number of negative behav-
ior scores (p < 0.05) compared to NC, while there is overall no 
diff erence between REF and AZA. There were more REF piglets 
standing and less huddled up however. 
Figure 1: Negative behavior score evolution 
All groups are signifi cantly diff erent for positive behavior. Both 
REF and AZA behave signifi cantly better than NC. REF sleeps 
and suckles more than AZA while more AZA are lying in ventral 
position.
Discussion 
An injection of azaperone 15 minutes before castration dimin-
ishes the screaming intensity at castration. The behavior of the 
piglet immediately after castration resembles that of a sham 
castrated piglet and is signifi cantly better than conventionally 
castrated piglets. 
Azaperone (Stresnil®) is a registered product for pigs and can be 
applied by the farmer. With a cost of less than 3 Eurocent per 
piglet, there is no economical constraint. 
In conclusion, the use of azaperone prior to castration could be 
taken into account as an alternative to anesthesia. 
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Biopsies for grading of shoulder ulcerations in sows
Henrik E. Jensen; Kirstin Dahl-Pedersen
University of Copenhagen, Frederiksberg, Denmark
Introduction
The presence of shoulder ulcerations in sows commonly de-
velop and signal poor animal welfare (1). Presence of shoulder 
ulcerations is due to pressure and is signifi cantly related to the 
laying bout duration (2, 3). Clinically, it may be diffi  cult to state 
the presence of an ulceration. Moreover, it is not always straight 
forward to deduct the progression of shoulder ulcerations (4). 
With reference to national strategies initiated towards limiting 
the presence of shoulder ulcerations, an intervention must be 
initiated when the ulceration has penetrated into the subcuta-
neous tissue. Therefore, diff erent para-clinical techniques should 
be evaluated for the characterization of ulcerations. Such tech-
niques should enable one to state the presence or absence of an 
ulceration and preferably aide for grading the ulceration.
Based on pathology, shoulder ulcerations are graded 1-4 accord-
ing to the progression into the diff erent anatomical structures 
of the shoulder region with the following characteristics (1,3): 
Stage 1) the ulceration is limited to the epidermis (necrotic or 
sloughed off ), and may be covered with a scab. Stage 2) the 
dermis is ulcerated and may be covered with a scab. Usually a 
small amount of granulation tissue or fi brosis is bordering the 
ulcer. Stage 3) the subcutaneous tissue is ulcerating and may be 
covered with a scab. It is accomplished by heavy formation of 
granulation tissue or fi brosis towards the surroundings. Stage 4) 
an ulceration with exposed bone (tuber spina scapula). Stage 4 
ulcerations are always accompanied by a heavy proliferation of 
new osseous tissue. Shoulders free of ulcerations are scored as 
stage 0 (3).
In the present study, the diagnosis of shoulder ulcerations 
based on the examination of a single biopsy taken from the skin 
overlaying tuber spina scapula, i.e. centrally from the ulcer when 
present, was compared with the classical method implying 
examination of cross-sectioned shoulder areas during necropsy.
Materials and Methods
Shoulder regions from 33 sows admitted to the department for 
necropsy were evaluated. Before cross-sectioning and grading 
the shoulder ulcerations, a punch biopsy (8 mm in diameter, 
KRUUSE, Denmark) was taken from the skin overlaying tuber 
spina scapula from animals without ulcerations, and centrally 
from the ulcer when present. Tissue specimens were fi xed in 
10% neutral buff ered formalin for 7 days, processed through 
graded concentrations of ethanol and xylen and embedded in 
paraffi  n wax. Tissue sections were cut at 4-5 μm and stained with 
haematoxylin and eosin (HE). The grading of ulceration stages 
from the biopsies was compared with the grading based on the 
cross-section method (3).
Results
The cross-section method revealed the following pattern of 
shoulder ulcerations: stage 0 = 16; stage 1= 0; stage 2 = 4; stage 
3 = 13; and stage 4 = 0. In fi ve cases, the stage of ulceration 
was based on gross examination because the sections taken 
for histology were all bordered by granulation tissue, i.e. the 
involved tissues of the skin could not be judged histologically. 
Presence (n=17) or absence (n=16) of an ulceration, as assessed 
by cross-sectioning the shoulders, was in all cases verifi ed in the 
biopsies. In the biopsies, four cases of both stage 2 and stage 3 
ulcerations were confi rmed, too. However, in four and fi ve cases 
of stage 3 ulcerations the biopsies deducted the ulcerations be-
ing stage 2 or at least stage 2 ulcerations, respectively.
Discussion
Examination of a single biopsy taken from the skin overlaying 
tuber spina scapula in all cases enabled one to settle whether 
an ulceration was present or not. Moreover, in eight sows with 
ulcerations a correct stage was documented in the biopsies.
In four out of nine stage 3 ulcerations, however, the biopsies 
showed a stage 2 ulceration, and in fi ve out of nine stage 3 
ulcerations the biopsies revealed stage 2 ulceration at least. Due 
to the limited tissue sampled by a punch biopsy, however, some 
ulcerations are diffi  cult to grade because the material is mainly 
made up by granulation tissue.
In conclusion, a single biopsy is suffi  cient for stating the pres-
ence of an ulceration and when a stage 3 ulceration is docu-
mented in a single biopsy it is in accordance with the cross-
section method. Moreover, a major advantage of punch biopsies 
is that they can be sampled from living animals.
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Clinical assessment of shoulder lesions in Danish sows
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Introduction
Decubital shoulder lesions in lactating sows may compromise 
animal welfare. Lesions with adherent crust/scar to the tuber 
spina scapula (TSS) and lesions penetrating to exposed bone 
are notifi able in Denmark and are here defi ned as pathological 
lesions. The severity of shoulder lesions may be diffi  cult to deter-
mine by clinical inspection and palpation ante mortem because 
the wound can be undermined and be more extensive than the 
mere penetration of the skin shows. The aim of this study was 
to identify combinations of simple clinical signs as markers of 
pathological shoulder lesions for veterinarians in an advisory 
situation. 
Materials and Methods
The study was observational and included 363 Danish culled 
sows sent to an abattoir during a two week period. Each sow 
was registered by sow- and herd-number and date of regis-
tration. All sows were examined ante mortem, a visual body 
condition score (1-5) was assigned and the following clinical 
signs were recorded: Skin-covered shoulder, i.e. “Normal” (no 
sign of epithelial defi cit); Skin alterations (Erythema; redness in 
the skin overlaying the TSS or peripheral to a crust/swelling and 
Crust; dried exudate overlying an epithelial defi cit); Swelling 
(soft or fi rm elevation of the skin); Adherence to the TSS (scar/
crust or swelling adherent to the underlying bony foundations 
by palpation); Scar (intact skin with scar tissue apparent at the 
site). Diameters of swellings and diameters of crust/scar (the 
largest width) were measured with callipers, using a hierarchy of 
swellings rather than crust/scar when both signs were apparent. 
After slaughter, the following pathological signs were recorded 
by post mortem examination: No lesions of the skin; lesions 
limited to the epidermis with or without a moderate crust; le-
sions involving the dermis with or without extensive crusting 
and with little fi brosis and/or granulation tissue; lesions pene-
trating to the subcutis with intense formation of granulation 
tissue; ulcer penetration to the bone or ulcer development with 
periosteal bony proliferation. A Bayesian network (1) modelling 
the causal relations between pathological shoulder lesions and 
ante mortem clinical signs was constructed. Furthermore, the 
body condition score (normal-to-fat vs. thin) was included as a 
risk factor.
Results
According to the post mortem examinations, 83 sows (22.9%) 
had shoulder lesions. Hereof 76 sows (20.9%) had mild le-
sions and 7 sows (1.9%) had pathological lesions. Among 
the 76 sows with milder lesions, 39 sows (51.3%) had no ante 
mortem fi ndings, 26 (34.2%) had skin alterations, 7 (9.2%) had 
skin alterations and fi rm swelling, 2 (2.6%) had skin alterations 
and adherence and 1 (1.3%) had fi rm swelling and adherence. 
Among the 7 sows with pathological lesions, 1 (14.3%) had skin 
alterations and fi rm swelling and 6 (85.7%) had skin alterations, 
fi rm swelling and adherence. The probability of having a patho-
logical lesion (as determined by post mortem examination) was 
calculated in the Bayesian model for all clinical signs, recorded 
ante mortem: Skin alteration = 11.7%; fi rm swelling = 21.8%; skin 
alteration + fi rm swelling = 71.1%. The probability of a shoulder 
lesion being pathological increased from 35.5% to 81.7% when 
increasing the width of the swelling from 30-35 mm to 60-65 
mm. Including Adherence resulted in a very high probability of 
the shoulder lesion being pathological (96.7%). Finally, when 
known state of the body condition was added to the evidence of 
a severe shoulder lesion the probability of having a pathological 
lesion by post mortem examination increased from 96.5% 
(normal-to-fat) to 98.4% (thin).
Discussion
Based on calculations in the Bayesian network, the best pre-
dictor of pathological shoulder lesions were; Firm swellings with 
a fair extent (>50 mm in width) and adherence of lesions to the 
underlying bony foundation. In summary, the condition of the 
skin (crust/scar) in itself was of little value if not compared with 
the palpable fi ndings in the tissue underneath, where especially 
fi rm larger swellings and adherence to the underlying bony 
foundation (TSS) were the most useful markers of pathological 
lesions. All the milder shoulder lesions were considerably 
smaller in extent than the pathological lesions, suggesting that 
pathological shoulder lesions may be diff erentiated from milder 
shoulder lesions by the size of the swelling involved.
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Rubber mats in farrowing pens as prevention of sow shoulder lesions
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Introduction
Shoulder lesions in sows are a common disorder in most 
countries with intensive pig production. It has been shown that 
rubber mats have a positive therapeutic eff ect compared with 
fully slatted fl oors in farrowing pens (1) (2). It has therefore been 
assumed that mats also are a way of preventing shoulder lesions 
from developing. The objective of this trial was to determine if 
rubber mats under the sow in farrowing pens were better than 
solid concrete fl oor in terms of prevention of shoulder lesions. 
Material and methods
The trial was carried out in two herds with crossbred sows (LY): 
herd A with 1700 sows and herd B with 800 sows. The farrowing 
pens had crates, liquid feed and partly slatted fl oor. The fl oor in 
the main part of the pen was made of solid concrete. The back of 
the pen had slatted fl oor (cast iron). The sows were placed in the 
pens app. one week prior to farrowing and remained there until 
weaning of the piglets 4-5 weeks after farrowing.Three groups 
were compared: Group 1: solid concrete fl oor (control). Group 2: 
rubber mat, solid, thickness: 17 mm. Group 3: rubber mat with a 
core of foam, thickness: 45 mm (centre), 17 mm (edges). 
Mats in groups 2 and 3 were placed on the solid fl oor under the 
sow during her entire stay in the farrowing pen.The eff ects of 
the fl ooring systems were compared with respect to shoulder le-
sions at weaning, body condition score (BCS) and scar tissue on 
the sow’s shoulder when entering the farrowing compartment.
Results
A total of 888 sows were included in the trial. The over-all preva-
lence of shoulder lesions was 16.3 percent in herd A and 15.2 
percent in herd B. Sows with poor BCS had a higher prevalence 
of shoulder lesions compared with sows in good body condition 
(p=0.07 in herd A and p= 0.02 in herd B). Sows with scar tissue 
had a higher prevalence of shoulder lesions than sows without 
scar tissue (p<0.0001 in herd A and p=0.002 in herd B). Overall, 
681 sows were regarded as “sows not at risk”, i.e. good BCS and 
no scar tissue. On average, only 10% of these sows developed 
shoulder lesions. The combina-tion of low BCS and scar tissue 
(207 sows) resulted in a prevalence of 35%. The eff ect of soft 
fl oor on the preva-lence of shoulder lesions was signifi cant in 
herd B, but not in A. However, the eff ect in herd B was primarily 
related to sows at risk (table 2). 
Discussion
Rubber mats in farrowing pens was eff ective in one of two trial 
herds in respect to prevention of shoulder le-sions. Only a min-
ority of sows that are not at risk of developing a shoulder lesion, 
do in fact develop a lesion. In contrast, app. one third of sows 
at risk develop a lesion. Therefore, rubber mats are primarily 
relevant for sows at risk. 
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Table 1: Percentage of sows that develop a shoulder le-sion. Herd A. ( ) 
= cases out of total no. of sows.
Group 1 Group 2 Group 3 p-value
Sows at risk 53a (18/34) 44a (15/34) 29a (8/28) NS
Sows not at risk 13b (19/146) 11b (16/149) 8b (11/142) NS
Table 2: Percentage of sows that develop a shoulder lesion. Herd B. ( ) 
= cases out of total no. of sows.
Group 1 Group 2 Group 3 p-value
Sows at risk 47a (16/34) 32a (13/40) 8b (3/37) P<0,05
Sows not at risk 15c (13/84) 10c (8/78) 0d (0/82) P<0,05
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Introduction
Tail biting continues to be a well-known and important problem 
in pig production. It is associated with considerable economic 
losses to the whole industry and decreased animal welfare. It has 
been found to be associated with carcass condemnations due to 
abscesses. Tail biting leads to the spread of infection and activa-
tion of the acute phase response (1). This study was carried out 
in order to describe pathological and haematological fi ndings in 
tail biters, victims and control pigs.
Materials and Methods
Tail biting and control pens were identifi ed with direct observa-
tion in a fi nishing herd with an ongoing problem with tail biting. 
Quartets of age and gender matched individuals were chosen: 
tail biter (TB, n=16), victim (V, n=16), a control pig in the pen 
with tail biting (Ctb, N=9) or control pig in pen without tail biting 
(C, n=14). Pigs were injected intramuscularly with midazolam, 
ketamine and butorphanol, after which a blood sample was 
collected from the vena cava cranialis while the animal was in 
dorsal recumbency. Immediately afterwards pigs were eutha-
nized with an intracardial injection of pentobarbital and taken 
to autopsy, which was performed the next day. The pathological 
fi ndings were analysed pair-wise using McNemar’s test for 
binomial and Wilcoxon rank sum test for continuous variables. 
Haematological values were analysed using a mixed model.
Results
The general trend seemed to be that pigs in all groups, except 
the controls in pens with no tail biting, had several pathological 
fi ndings. The haematological values did not diff er between 
groups (Table 1).
TB V Ctb+C
WBC, x 109/l 19.5+5.8 23.3+6.9 21.4+5.6
RBC, x1012/l 6.4+0.8 6.4+0.7 6.3+0.5
HCT 33.9+3.9 33.8+4.0 33.5+2.1
HB, g/l 104.7+11.4 104.0+13.1 103.1+7.2
TB tended to be heavier than Ctb (43.7±3.6 vs 42.4±4.9 kg, 
p=0.09). More V tended to have changes in the stomach wall 
(ulcers or mild lesions) than TB (38 vs 6% of the animals, p=0.06). 
A score classifying the severity of joint lesions (cartilage and 
joint capsule) tended to be greater in both TB (0.5+0.3) and 
V (0.3+0.2) pigs compared to C (0.0+0.0; p=0.1) pigs. The Ctb 
(0.4+0.3) pigs had a high level of joint lesions even if this diff er-
ence was not signifi cant. Infections in respiratory organs were 
more frequent in V than Ctb (63 vs 13% of individuals, p=0.03). 
Although scores of acute tail lesions (0=healthy to 3=severe) 
were signifi cantly worse in V (median (range) 3(1-3)) than TB 
(1(1-3), p=0.01) these scores were not signifi cantly lower in Ctb 
than V despite the fact that Ctb received signifi cantly fewer bites 
to the tail during the behavioural observations than V (bites 
received Ctb=0(0-1) vs V=11(1-31), p<0.01). 
Discussion
The pathological fi ndings were more frequent than anticipated, 
even considering that this farm had ongoing problem with tail 
biting. The pigs in tail biting pens seemed to suff er not only from 
tail biting but also from other health problems (stomach ulcers, 
joint lesions). However, cause and eff ect were not separated in 
this study. 
Haematology did not reveal problems in the organs. The 
variation in haematological values was large and the lack of a 
diff erence here may refl ect the relatively small sample size in 
the study. In contrast to our fi ndings, diff erences in blood values 
have been found (2), mostly in clinical chemistry. However, the 
same parameters were not investigated in our study.
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Eﬀ ect of zinc organic supplementation on feet lameness of sows
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Introduction
Feet and leg problems of sows were the major economic losses 
in pig industry. Many lameness sows usually were not seen in 
herds and underestimated. These lameness sows were aff ect-
ing on the herd productivity [1, 2, 3]. There were several factors 
contribute to lameness such as bacterial infections, genetics, 
management, and nutrition [1, 2, 3, 4]. Nutritional factors may 
contribute to lameness. The aim of this study was to investigate 
the eff ect of zinc supplementation on feet lesions of sows. 
Materials and Methods
Sixty crossbred (LR x LW) sows were divided into two groups, 
20 sows in control group (C) and 40 sows in treatment group 
(T). Sows in C and T group were accordingly classifi ed to parity 
number and location. Group C was gilt (P0) and sow in parity 1, 
and located in unit B. Group T was sow in parity 2 or more, and 
located in unit E. All sows were directly examined for the feet 
performances during the lactating or gestating periods. The feet 
lesions were classifi ed into three groups: heel over-growth and 
erosion (HOE), heel-sole crack (HSC), and white line (WL). The 
level of lesion scores were classifi ed into three levels: no lesion 
(0), mild (1), moderate (2), and severe (3). Sows had feet lesions 
were identifi ed and randomly selected for testing the feed addi-
tive supplement, Avila-Zn 120. The selected sows were taken 
pictures of the feet lesions and examined the lesion scores be-
fore giving feed additive. Sows in group C were received conven-
tional diets, and sows in group T were received daily of 40 ppm 
of Avila-Zn 120 by mixing in the conventional diets for 90 days. 
Feet performances and feet lesion scores were monitored at 1, 2, 
and 3 months after Avila-Zn 120 supplementation. The repeated 
sows and/or culled sows will be examined and taken pictures 
for checking the feet lesion improvement. Chi-square analysis 
(PROC FREQ) was used to analyze the frequency distribution of 
feet lesion scores. 
Results and Discussion
This study was investigated the eff ect of zinc supplementation 
on feet lesions of sows. At least one feet lesion was found in 
sows in both groups. Some sows had more than one feet lesions. 
In general, gilts and sows in parity 1 had lower feet lesions than 
sows in parity 2 or more. There was a trend (P=0.09) for higher 
proportion number of sows with more feet lesions in the C 
group (i.e. HOE). Moreover, there were lower proportion of sows 
with HSC in the T group (P<0.001). This improvement might be 
explained by the higher bioavailability of zinc in the feed. This is 
in agreement with a study performed in Danish sows herd [5]. In 
conclusion, the supplement of zinc organic might be an alterna-
tive choice to improve the feet quality of sows. 
Table 1. The proportion of sows with diff erent feet lesions.
* 0= no lesion, 1=mild, 2=moderate, and 3=severe
Figure 1. Feet lesions of control and treatment groups.
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Use of a subjective scoring system to describe leg and claw conformation and gait in gilts and sows
Elisabeth O. Nielsen; Flemming Thorup; Hansen U. Lisbeth
Pig Research Centre, Danish Agricultural & Food Council, Copenhagen, Denmark
Introduction
Lameness and claw lesions are frequent causes of discomfort or 
pain in gilts and sows (1-3). Lameness in sows reduces produc-
tivity levels and the longevity. Describing leg conformation and 
gait is necessary when selecting gilts to achieve strong breeding 
animals. Furthermore, descriptions of gait and leg lesions are im-
portant to identify individuals in pain or discomfort, indicating 
a need for treatment and movement to a hospital pen. Despite 
the inclusion of leg soundness in the Danish breeding index, the 
producers need an individual evaluation of each gilt to know 
which gilt to breed and which one to cull. The farmer must also 
evaluate the leg soundness of the sows before the next breed-
ing cycle.
The purpose of this study was to design a subjective scoring 
system to describe leg and claw conformation and gait in gilts 
and sows 
Materials and Methods
The subjective scoring system was based on previous descrip-
tions (4-6) of leg conformation and gait. The scoring system is 
used in ongoing studies. A training day for standardization is 
planned every six months throughout the studies. This paper 
presents scoring results for gilts and sows. A total of 255 gilts 
aged 9 months and 219 loose-housed gestating sows of dif-
ferent parities were scored. One technician scored gilts in one 
herd, and another technician scored gestating sows in another 
herd. Both herds had problems with lameness. All scorings was 
performed inside the pen. Scoring of one animal was completed 
in two to four minutes. The animal was evaluated both standing 
and moving slowly. Animals were not scored moving at high 
speed, because mild cases of lameness would not be easily seen. 
The pen fl oor was non-slip slats or solid fl oor. The animals’ feet 
were not cleaned before scoring the claws.
Results
The subjective scoring system includes 12 categories (Table 1). 
The categories describe diff erent features in claw and leg con-
formation. Length of claws and dewclaws are described as nor-
mal, long and very long. The movement categories (swaggering 
gait, stride length and lameness) describe increasing abnormal-
ity. Lameness ranged from normal= 0 to “not able to rise”= 3. The 
scoring results of 255 gilts and 219 sows are presented in Table 
1. A total of 18% of the gilts were lame to some degree, and 15% 
of the sows were lame to some degree. If the animal was lame, 
it was noted which limb(s) was aff ected, and acute lesions of the 
limbs were also noted (data not shown).
Table 1: Leg, claw and gait scoring in gilts and sows
Scores 0 = normal 255 gilts scores 219 sows scores
Fore limbs, front 0;1;2;3 246;0;8;1 185;0;33;1
Fore limbs, side 0;1;2;3 211;0;44;0 137;6;67;9
Hind limbs, back 0;1;2 246;1;8 216;1;2
Hind limbs, side 0;1;2;3 196;1;56;2 101;1;117;0
Back 0;1;2 253;1;1 214;2;3
Claws even size 0;1 221;34 191;28
Claw length 0;1;2 254;1;0 183;30;6
Dewclaw length 0;1;2 255;0;0 140;67;12
Missing dewclaws 0;1;2 254;1;0 206;10;3
Swaggering gait 0;1;2 238;17;0 200;19;0
Stride length 0;1;2 208;43;4 193;23;3
Lame 0;1;2;3 216;36;3 190;25;4;0
Discussion
A subjective scoring system was chosen, because it is easy to use 
and no instruments are needed. Although subjective scoring has 
inherent problems with repeatability (5,6), these problems can 
be overcome through repeated training of the observers. The 
scoring system must be simple, with clear defi nitions and good 
illustrations. Video sequences of the animals’ gait are useful. We 
plan to correlate the leg, claw and gait scores with the longevity 
of the gilts and sows. The scoring will then be refi ned and simpli-
fi ed for practical use in herds.
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Three-year study of lameness in piglets and piglets mortality at a herd following reparation of ﬂ oors
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Introduction
Many piglets die or are medically treated before they are 
weaned. The main causes of mortality are emaciation or crush-
ing by the sow when lying down (1). Lameness in suckling pig-
lets is another welfare issue in farrowing enterprises contribut-
ing to ill-thrift, piglet mortality, decreased growth and increased 
antimicrobial use (2). Environment can improve piglet survival 
(1), and the present study compared the prevalence of lameness 
and mortality in piglets during three years in farrowing units 
with diff erent fl oor surfaces.
Materials & Methods
The study was carried out at a herd with four identical farrowing 
units with solid concrete fl oor, embedded with 1kg chopped 
straw per sow and 1 hg per piglet and day. Two units were dedi-
cated as controls (■; ▲). In the third and fourth farrowing units, 
the fl oor surfaces were repaired with two-component materials; 
◆= Thorocrete SL® (Växa Halland, Sweden), a powder with ce-
ment, graded sand and additives and an acryl polymer emulsion, 
and; ●= Piglet Floor® (Flowcrete Sweden AB, Sweden), an epoxy 
free two-component solvent solution with natural quartz.
All of the 17,474 piglets born alive during three years were 
studied (■= 338 litters & 4425 piglets; ▲= 341 & 4333; ◆= 343 
& 4525; ●= 323 & 4191). Twenty-three farrowing batches were 
studied in each unit. Records of mortality and medical treat-
ments for lameness were kept for each piglet until the age of 4 
weeks.
Results
The mortality was defi ned as crushing and other causes of 
death. Up to 85% of the piglet losses occurred during the fi rst 
week of life and the majority of the deaths were attributed 
to crushing. There were large diff erences in the prevalence of 
piglets found dead on the diff erent types of fl oor (Fig. 1). Piglet 
born on the repaired fl oors had the lowest prevalence of mortal-
ity during the three-year study (◆p<0.05; ●p<0.01).
The mortality during the fi rst three days of life was high, but 
not correlated to lameness. In total, 971 piglets were treated for 
lameness, corresponding to 5.5% of the live born piglets. Ap-
proximately 85% of these diagnoses were made during the fi rst 
three weeks of life. As seen in Fig. 2, the prevalence of lameness 
was lower in the units with repaired fl oor (◆p<0.05; ●p<0.01) 
than in the control units (● and ▲).
Figure 1. Mortality pre-weaning (%) in four identical farrowing units 
with diff erent types of fl oor surface during three years.
 Figure 2. The prevalence of lameness in piglets during the fi rst four 
weeks of life in identical farrowing units with diff erent types of fl oor 
surface during three years.
Discussion & Conclusions
The mortality was highest during the fi rst week, and to be 
crushed under the sow when lying down was the most com-
mon source of death. Also the frequency of skin lesions was 
highest during the fi rst week. Lameness is associated to many 
factors out of which the fl oor is one (3). Maintaining the surface 
of concrete fl oors with these two commercially available solu-
tions decreased the mortality and the incidence of lameness 
in piglets.Thus, a proper maintenance of the fl oor will improve 
roughness and abrasiveness of the fl oor which in turn can con-
tribute signifi cantly to prevention of lameness and mortality in 
suckling piglets. The fl oor can also aff ect lying down behaviour 
of the sow (4), and this study revealed that the piglets mortality 
was lower in the pens with repaired fl oors. The results suggest 
that reparations of the fl oor and sustainability in three years will 
pay off  for both piglets and pig farmers.
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Analysis of the healing eﬀ ect of complexed trace minerals on claw lesions of 
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Introduction
Claw lesions are reported to be an important underlying cause 
for lameness in pigs in breeding herds. However, not all claw 
lesions cause lameness in pigs. The area aff ected and the sever-
ity of lesion may determine the progression towards lameness. 
Previous studies have indicated the positive relationship of side 
wall and white line lesions with lameness in pigs1,2. Housing 
and nutritional factors are associated with the development of 
claw lesions in pigs. Trace minerals such as Cu, Zn and Mn are 
important in the keratinization process3. The bioavailability of 
trace minerals depends on the quantity and the form (organic 
or inorganic) of these minerals. Despite the high prevalence of 
claw lesions in pigs, attempts to minimize the incidence of claw 
lesions or to reduce the severity of lesions are not implemented 
widely in swine herds. The objective of the present study was 
to understand the eff ect of feeding complexed trace minerals 
(CTM; Cu, Zn and Mn) in decreasing the severity of claw lesions 
in breeding female pigs housed in group pens with ESF in com-
parison to those fed with trace minerals in inorganic form (ITM).
Material and Methods
This study included 104 sows of mixed parities (ITM diet, n =59 
and CTM diet, n=45). Trace minerals supplemented in the ITM 
diet were Zn, 125 ppm, Mn, 40 ppm and Cu, 15 ppm, while CTM 
was a partial substitution of the inorganic minerals with com-
plexed minerals (Zn, 50 ppm, Mn, 20 ppm and Cu, 10 ppm) with 
isolvels of total trace mineral supplementation. The sows were 
fed the respective diets for a period of 3 parities. The fi rst claw 
observation was performed at mid-gestation in the fi rst parity. 
The claws of these sows were re-examined by the same person 
at mid-gestation in the subsequent third parity during the study 
period. Claw examination was facilitated by a mechanical re-
straint designed for the purpose. Diff erent claw areas (side wall, 
heel, white line, sole, heel-sole junction and overgrown toes and 
dew claws) were examined for lesions on a severity scale of 0 (no 
lesions noted) to 3 (severe) following the Zinpro FeetFirst claw 
lesion scoring system. The total score for each area was obtained 
by adding the scores for that area in diff erent claws of front and 
hind limbs. The proportions of sows showing either no change 
in lesion scores or a reduction in lesion scores in diff erent claw 
areas in the CTM and ITM groups were compared using 2-sam-
ple proportion test (SAS v 9.1).
Results
The results indicated a higher proportion (P<0.05) of sows fed 
CTM (91%) had either a reduction or similar lesion score for ver-
tical side wall cracks in the second claw examination compared 
to sows fed ITM (73%). The proportions of sows with similar or 
lower scores for total medial claw lesions, heel lesions and total 
side wall lesions were also higher in the sows fed CTM, though 
not statistically signifi cant.
Discussion
The present results are similar to a previous trial which indi-
cated a negative relationship between complexed trace mineral 
supplementation and number of lesions in diff erent claw areas4. 
However, this study had not considered the severity of lesions. 
The previous study showed that sows receiving inorganic trace 
minerals had more lesions on the hind limbs than the sows re-
ceiving complexed trace minerals4. The same study also showed 
that sows consuming inorganic trace minerals had more lesions 
on the sole than sows fed with complexed trace minerals. The 
results of this study indicated a benefi cial eff ect of feeding com-
plexed trace minerals in reducing the severity or preventing the 
worsening of vertical side wall cracks in breeding female pigs.
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Introduction
The benefi cial role of trace minerals in improving the perform-
ance of breeding females has previously been described1,2,3. 
The bioavailability of trace minerals depends on both the quan-
tity and form (organic or inorganic). Though the mechanism is 
not well understood, it has been reported that organic minerals 
are more soluble and may cross the intestinal wall more easily4. 
The objective of the present study was to compare the produc-
tion performance of stall-housed sows receiving a supplemen-
tation of complexed trace minerals (CTM) with those receiving 
trace minerals in inorganic form (ITM).
Material and Methods
This study conducted at the Southern Research and Outreach 
Center of the University of Minnesota at Waseca involved 229 
sows (ITM n= 113, CTM n= 116) housed in conventional gesta-
tion stalls. The sows were allocated randomly to two groups and 
fed either ITM (inorganic sulphate minerals, Zn, 125 ppm, Mn, 
40 ppm and Cu, 15 ppm) or CTM (containing complexed trace 
minerals as a partial substitution of inorganic minerals: Zn, 50 
ppm, Mn, 20 ppm and Cu, 10 ppm fed at isolevels of total trace 
mineral supplementation) diet. The analysis involved 399 parity 
records (ITM n=199, CTM n= 200) of these sows pertaining to 1 
or 2 farrowings during the study period. Information on farrow-
ing and weaning performances and lactation feed intake were 
collected from the PigCHAMP database of the research unit and 
sow cards and compared using 2 sample t-test (SAS V. 9.1).
Results
Sows fed CTM had more piglets born alive (P<0.05) compared 
to sows fed ITM (11.07 and 10.44 piglets per litter, respectively). 
However, the number of stillborn piglets per litter was higher in 
the sows fed CTM (1.0 + 0.12 vs. 0.70 + 0.09). Litter birth weight 
tended (P<0.07) to be higher in the sows fed CTM (37.45 + 0.68 
vs. 35.64+ 0.72 lbs). Other parameters such as average mummies 
per litter, wean litter weight, weight of the sow at weaning and 
average lactation feed intake were similar, regardless of trace 
mineral form.
Discussion
A previous study involving supplementation with complexed 
trace minerals indicated higher litter birth weights in supple-
mented sows3 though the number of live born piglets was not 
diff erent (P=0.2) in control (12.89) and treatment (13.37) groups. 
A higher number of stillborn piglets per litter in the sows fed 
CTM observed in the present study could be related to the 
higher number live born piglets per litter. Similarly, the higher 
litter birth weight in the sows fed CTM could also be related to 
higher number of live born piglets.
Conclusion
This study indicated a benefi cial eff ect of feeding complexed 
trace minerals in terms of higher number of piglets born alive 
per litter. 
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Eﬀ ect of the supplementation of complexed trace minerals on the healing of claw lesions in two sow herds
A. Da Silva; S.S. Anil; J. Deen; R.B. Morrison
University of Minnesota, Saint Paul, MN, USA
Introduction
Claw lesions are very common in sows. Claw lesions are reported 
to be associated with lameness (1), an important reason for pre-
mature removal of sows in swine breeding herds. Nutrition may 
play an important role in the development of claw lesions, since 
the quality of the claw depends on its physical structure and 
this is controlled by cellular processes aff ected by nutritional 
status (2). The importance of trace minerals in the keratinization 
process has been reported previously (3). Both the quantity and 
the form (organic or inorganic) of these minerals are crucial (4). 
However, the eff ect of these trace minerals in ameliorating claw 
lesions in pigs has not been well demonstrated. The objective 
of this study was to understand the eff ect of feeding complexed 
trace minerals (Cu, Zn and Mn) in reducing the severity of claw 
lesions in breeding female pigs.
Materials and Methods
Data for this study were collected from a convenience sample of 
43 stall-housed sows (parities 1 to 6) belonging to two sow herds 
(Herd A, n=28 and Herd B, n=15) which had high prevalence 
of claw lesions. These sows were scored for lesions in diff erent 
claw areas (side wall, heel, including overgrown heels, white line, 
heel-sole junction and overgrown toes and dew claws) twice. 
The fi rst observation was done in May 2009 while the sows were 
in the farrowing crates, prior to the start of feeding complexed 
trace minerals (Zn, 50 ppm, Mn, 20 ppm and Cu at 10 ppm). 
The second one was done when these sows were in farrowing 
crates in their subsequent parity (approximately after 140 days). 
The claws were examined while the sows were in a recumbent 
position as there was no mechanical restraint to facilitate lesion 
scoring. The proportions of sows showing either no change in le-
sion scores or a reduction in lesion scores in diff erent claw areas 
were analyzed using one sample proportion test (SAS v 9.1).
Table 1: Comparison of the number of sows showing improvement / 
no change in lesion scores in diff erent claw areas
Claw area
Herd A (n=28) Herd B (n=15)
Improvement / no change Improvement / no change
Toe 27* 12*
Dew claw 22* 10
Heel overgrown erosion 21* 10
Heel sole crack 25* 12*
White line 25* 9
Side wall horizintal crack 28* 15*
Side wall vertical crack 21* 14*
Total claw lesion 24* 8
* P-value<0.05
Results
In herd A, the proportions of sows with either similar or reduced 
severity of lesion scores in all claw areas were higher (Table 1) at 
the second claw examination (P< 0.05 for all). However, in herd 
B, similar results were shown only in the case of overgrown toes, 
heel-sole junction lesions and vertical and horizontal side wall 
cracks (P< 0.05). 
Discussion
The present results are similar to a previous trial which indicated 
that sows receiving inorganic trace minerals had more lesions 
on the hind limbs than the sows receiving complexed trace 
minerals (5). However, that study did not assess the eff ect on se-
verity of lesions. The same study also showed that sows consum-
ing inorganic trace minerals had more lesions on the sole than 
sows fed with complexed trace minerals. The non-signifi cant 
eff ects in herd B could be related to the small sample size. All the 
sows with baseline data could not be evaluated a second time in 
both farms as there was no mechanical device to facilitate lesion 
scoring in live animals. The results of this study are indicative of 
a preventive eff ect of feeding complexed trace minerals on claw 
lesions in breeding female pigs.
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Melatonin release patterns in pigs kept under diﬀ erent light regimens
Arie van Nes1 Maaike Pannekoek2, 1 Inge van Geijlswijk2
1. Department of Farm Animal Health, Utrecht, Netherlands; 2. Veterinary Pharmacy Division, Utrecht, Netherlands
Introduction
Melatonin is a hormone controlling the biorhythm of mammals, 
birds and fi sh and might be an indicator for harmony between 
individuals and their environment. The major ‘zeitgeber’ for the 
release of melatonin is environmental light. It synchronizes the 
melatonin secretion with the 24- hour day/night cycle. Normally, 
melatonin levels are high in the night and low during the day.
Melatonin is not only synthesized in the pineal gland, it’s also 
synthesized in the gastrointestinal tract, retina, skin, lympho-
cytes, platelets and bone marrow. Despite this, the level of circu-
lating melatonin is almost totally derived from the pineal gland. 
Melatonin is not stored in the pineal gland and the liver metab-
olizes the circulating melatonin rapidly. So levels of melatonin 
and its metabolite 6-sulfatoxymelatonin in blood plasma and 
saliva are representative for pineal biosynthetic activity (1). 
In Dutch pig husbandry, it is obligatory to have minimally eight 
hours light per day. Some pig owners have these lighthours 
divided in several periods per day (multiphase lightregime).
The goal of this study is: Do pigs in multiple phase light regimes 
have other melatonin release patterns compared to single phase 
lightregimes? Therefore, we measured the melatonin release 
pattern in pigs kept under a a single phase light regime to the 
melatonin release pattern in pigs kept under a multiple phase 
light regime.
Material and methods
 The pigs kept under a single phase light regime had twelve 
hours of natural light per day. The other group is kept under a 
multiple phased light regimen, three periods of three hours of 
light spread over 24 hours.
Each group of pigs were sampled during a 24 hour period, by 
a saliva sample taken every hour. Saliva samples are taken be-
cause levels of melatonin or its metabolite 6-sulfatoxymelatonin 
in saliva (or blood plasma) are refl ective of pineal biosynthetic 
activity, since there is no storage of melatonin in the pineal 
gland and circulating melatonin is rapidly metabolised in the 
liver.
Before the 24 hour sampling period, the pigs were trained for 3 
days by test sampling and animal handling, to prevent stress in 
the pigs during the experiment.
In the experiment we used animals of about fi ve months old. 
The animals were kept from the age of about two months under 
the multiple phase light regime. The pigs kept under the single 
phase light regimen, were at the time of sampling housed from 
birth under this light regimen. 
Piglets at an age of ten weeks already show a normal regular 
melatonin release pattern (1).
The samples were collected by having the pigs chew on saliv-
ettes® for 30 seconds. A salivette® is a roll-shaped saliva collector 
made by Sarstedt bv Etten Leur. The samples were stored at a 
temperature of 4˚C and centrifuged within 24 hours and then 
stored at a temperature of -18˚C. The samples were analyzed by 
Radio Immuno Assay (RIA) at hospital “Gelderse vallei” in Ede.
Results
 There was no diff erence in the mean melatonin concentrations 
of the two diff erent light regimens. The mean melatonin con-
centration in the single phase group was 12.34 ± 3.51 pg/ml, the 
mean melatonin concentration in the multiple phase group was 
12.95 ± 2.48 pg/ml. Mean concentration of melatonin during the 
light hours in the single phase group was 13.75 ± 11.08 ng/ml, 
versus 15.01 ± 9.95 ng/ml in the multiple phase group. During 
the dark phases the mean melatonin level was 11.15 ± 6.08 ng/
ml versus 11.07 ± 5.36 ng/ml. All concentrations were not signifi -
cantly diff erent. 
There was no diff erence in melatonin concentrations during the 
light hours compared to the dark hours in both groups.
Discussion
Unfortunately, there was no nocturnal rise of melatonin like we 
expected to fi nd in the control group, based on found literature 
(1,2). The curves were not fl at but all pigs had a diff erent mo-
ment of rise in melatonin concentration. Most peaks were found 
during daytime, when lights were on, which makes the melato-
nin concentration signifi cant higher during daytime than during 
the night. These results are in contrast to melatonin curves 
found in other studies in pigs (1,2) and found in other animals 
(3,4) and in humans (5). But other studies found melatonin 
curves in pigs like we found in our experiment.
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The inﬂ uence of close conﬁ nement of pregnant sows on cortisol and acute phase protein concentrations
Roman Kolacz; Michal Kulok; Zbigniew Dobrzanski
Wroclaw University of Environmental and Life Sciences, Department of Environmental Hygiene and Animal Welfare, Wroclaw, Poland
Introduction
Confi nement of pregnant sows to individual gestation stalls can 
be a major factor inducing stress responses, consequently aff ect-
ing animal health and causing disorders in reproduction (1). The 
results of extensive studies carried out on acute phase protein 
(APP) show a lot of discrepancies. Changes in APP concentra-
tions have been reported as a response to close confi nement or 
hierarching within a group (3, 4), commonly known to be stress-
ful for animals (5, 6), or a reaction to transport stress (2, 5). 
The purpose of the present investigation was to study the 
impact of immobilization of sows during gestation on their 
condition, measured by cortisol concentrations and APP profi le 
of the animals’ blood. 
Materials and Methods
The experiment was carried out on two farms with varied hous-
ing systems with respect to animal mobility. 
Experimental group (EG). The sows in this group were kept in un-
bedded individual stalls, with a pen fl oor area of 1.3 m2, from d 
1 to d 100 of gestation. On d 100, the sows were moved to a far-
rowing stall and kept there for the next 28 days. Getting up and 
lying down were the only movements possible for the animals. 
Control group (CG). The sows in this group were also kept in 
unbedded pens, from d 1 to d 100 of gestation, but in groups 
of 10, with a pen fl oor area of 2.25 m2 per animal. On d 100 
the sows were also moved to a farrowing stall, where they had 
comparatively reasonable space for exercising. Blood samples 
were collected 4 times in each group: 1) on d 30 of gestation, 2) 
on d 98 (36 h before moving the animals to the farrowing stalls 
and 3) on d 100 after mating (12 h after moving the animals to 
the farrowing stalls). 
The laboratory measurements included: 
a) cortisol in the serum determined using ELISA kits (Diagnostic 
Systems Laboratories, Inc. USA),
b) acute phase protein profi le; haptoglobin, amyloid A and 
C-reactive protein, determined using ELISA kits (Tridelta Ltd. 
Ireland). 
Both the cortisol concentrations and APP profi le were deter-
mined using a Bio Tek, Power Wave analyzer.
Results and Discussion
The results obtained in the study showed that keeping the 
sows in individual pens resulted in stress responses manifested 
by increased cortisol concentrations only in the fi rst month of 
gestation. In the next months, the cortisol concentrations were 
higher in the sows kept in groups, which was likely due to more 
frequent hierarchy confl icts (Table1).
Table 1. Cortisol concentrations of the sows’ serum [ng/ml]
Group n
Days of sample collection
30 98 100
EG 10 x 29,85 (A 1.4) 20,07 (a 1.2) 29,65 ( A 2.3)
SD 5.001 2.200 4.398
CG 10 x 20,05 (A 1*) 23,18 ( a 2) 38,62 (A1,2,3)
SD 2.893 2.423 4.497
The values in the same column designated with the same 
capital letters show signifi cant diff erences at P ≤ 0.01. The values 
designated with small letters show signifi cant diff erences at 
P ≤ 0.05. The values in the same rows, designated with the 
same numbers, show signifi cant diff erences at P ≤ 0.01, or * P 
≤ 0.05. Besides, the results showed that moving the sows from 
pig barns to the farrowing stalls (d 100 of gestation) induced a 
rapid elevation of cortisol concentrations (Table1). For the entire 
gestation period, haptoglobin concentrations in the two groups 
ranged from 1.1 to 1.6mg/ml; c-reactive protein ranged from 
35 to 37mg/ml; while serum amyloid A (SAA) was found within 
the ranges from 21 to 25mg/ml. No signifi cant diff erences in 
APP concentrations between the two groups and in consecutive 
months of gestation were observed.
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Oral interferon-alpha treatment and environmental adaptation of swine
Elisabetta Razzuoli; Silvia Dotti; Riccardo Villa; Enrico Sossi; Paolo Candotti; Massimo Amadori
Istituto Zooprofi lattico Sperimentale Lombardia Emilia Romagna, Brescia, Italy
Introduction
Weaning is a critical phase for piglets, in which infectious and 
non-infectious stressors exert their negative eff ects. Farmers are 
prone, for diff erent causes, to weaning 3-weeks old piglets, even 
though the above age does not seem appropriate with regard to 
inadequate immune system development and intestinal muco-
sal functions (1, 2). The aim of this study was to investigate the 
eff ects of an oral IFN- α treatment on the environmental adapta-
tion response in pigs weaned at 22 days of age.
Materials and Methods
The study was carried out on 40, Landrace x Large White, 
randomly selected piglets of four litters. Groups 1 and 2 were 
formed by 20 piglets each; all animals were weaned at 22 days of 
age: group 2 animals were orally treated with human interferon 
alpha at low-dose (1 IU Kg b.w./day) in drinking water for the 
fi rst 10 days after weaning. Also, all piglets were given the same 
starter feed containing amoxicillin (400 ppm), colistin (120 ppm) 
and zinc oxide (2000 ppm) over the fi rst 10 days after weaning. 
Pigs were clinically inspected, weighed, and blood samples in 
vacuum tubes without anti-coagulant were collected at days 0, 
+6, +12 and +26 with respect to weaning, in order to investigate 
the most common viral infections and IFN- α, IL-6, TNF- α. Viral 
infections were evaluated by PCR and antibody assays whereas 
cytokines were investigated by bio-assays. In particular, IFN- α 
was measured in serum samples by a CPE inhibition assay on 
MDBK cells (3); TNF- α and IL-6 were determined by a cytotox-
icity assay on WEHI 164 cells (4) and a proliferation test on 7TD1 
cells (5), respectively. TNF- α and IL-6 concentrations (pg/ml) are 
shown hereunder as 75% group percentile values.
Results
All pigs remained healthy during the whole period of observa-
tion. In particular, there was no detectable clinical diff erence 
under satisfactory hygiene and welfare conditions for all the 
pigs under study. No animals were infected by the usual viral 
agents of swine (PRRSV, SIV, PCV2, PRV) in the fi rst 2 weeks after 
weaning. The period from 22 to 48 days of age was divided into 
3 phases (22-28, 28-34, 34-48 days). In the fi rst one, weight gain 
was not signifi cantly diff erent between the two groups; in the 
second one, the daily mean weight gain of group 1 was greater 
than that of group 2, and vice versa in the 3rd period (Table 1). 
On the whole, IFN- α treated piglets showed on average 1.5 Kg 
more at 48 days of age (P<0.001). All piglets showed an IL-6 re-
sponse between day 0 and +6 with respect to weaning, then the 
levels decreased until day +26. The trend of TNF- α was opposite 
to that of IL-6, the highest concentrations being revealed at day 
+26. At this time point, all pigs of group 1 and 65% of group 2 
showed high serum concentrations of this cytokine; moreover 
concentrations were much higher in group 1 (12050 pg/ml) 
compared with group 2 (2613 pg/ml). The sera of all piglets in 
group 1 and of 18 animals in group 2 were IFN - α positive at 
day 6 after weaning. This result was confi rmed by a neutraliza-
tion assay of IFN- α on MDBK cells by a monoclonal antibody to 
porcine IFN- α1.
Table 1: Daily mean weight gains (grams) are shown as mean ± SD
Animals 22-28 days 21-34 days 34-48 days
Group 1 239 ± 123 g 171 ± 103 g 361 ± 99 g
Group 2 246 ± 72 g 123 ± 94 g 404 ± 105 g
Discussion
Our results indicate that an oral, low-dose IFN-alpha treatment 
can aff ect the adaptation response of piglets to the weaning 
stress. In fact, the treatment determined a better growth till day 
26 after weaning, probably related to a lesser TNF- α response. 
As in SPF pigs, oral administration of IFN-alpha is likely to reduce 
the IFN-gamma response at weaning and to control the related 
detrimental eff ects in terms of intestinal permeability in the 
post-weaning phase (2). These fi ndings highlight the import-
ance of type I IFNs as homeostatic agents in the response to 
environmental stressors.
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Evaluation of the pig welfare and its association with overcrowding
Martina Tarantola1 Laura Tomassone1 Igor Ferenaz1 Giuseppe Martano 2
1. University of Turin, Grugliasco (TO), Italy; 2. ASl TO3, Vigone, Italy
Introduction
Intensive swine breeding shows several critical points that can 
decrease animal welfare, such as microclimate, food manage-
ment, mutilation, staff  training, structure of buildings.
In the last years, diff erent methods for the evaluation of animal 
welfare have been studied and developed, mainly based on the 
observation of the animals and their reactions to stimulus and 
environmental variations (Smulders et al 2006). 
Diff erent behaviour anomalies and injuries have been recog-
nized to be stress indicators (Faucitano et al 2008, Velarde et al 
2007). Questions concerning the minimum space requirements 
for intensively bred pigs in relation to their welfare have been an 
issue of interest for many decades (Ekkel et al 2003).
The aim of this study was to evaluate pig welfare in farms in 
the North of Italy, using the method proposed by Candotti et al 
(2007), and to verify its association with overcrowding. 
Materials and Methods
We tested 33 breeding units within two Italian Provinces: 9 
farrow to breed herds and 24 fattening herds. The sample was 
further divided into: A) weaning piglets (28-55 days old) and 
B) pigs (55-120 days of life). A form containing specifi c items 
related to typical abnormal behaviour and presence of injuries 
was compiled. For each item, the frequency, prevalence and 
association with overcrowding was recorded (Directives 91/630/
EEC and 2001/93/EC lay down space requirements for pigs)
Finally, a “Global Score” was awarded to the studied herds, using 
the check list described by Candotti et al (2007), that assigns a 
score for each animal welfare item.
Higher scores always implied “better” welfare.
Results
Sample A (9 breeding units ) included 3 overcrowded breeding 
units (33.3%, 95% CI: 7.5-70.1).
Injuries against other pigs was signifi cantly more frequent in 
the overcrowded farms (p<0.05; Fisher Exact Test), while no 
association between other welfare items and overcrowding was 
detected. The mean welfare score in group A was 8.11 ± 2.96, 
ranging from 4.4 to 13.4. This score was signifi cantly higher in 
farms with adequate animal density (t test, p<0.01), having a 
mean value of 9.81 versus 4.70 in overcrowded breedings.
Sample B (29 breeding units) included 9 overcrowded farms 
(31.0%, 95% CI: 15.3-50.8). No association between overcrowd-
ing and welfare items was found. The mean welfare score was 
3.80 ± 1.6, ranging from 1.3 to 7.7. Again, the welfare score was 
higher in farms with adequate densities (t test, p<0.001; mean 
value: 4.49 versus 2.70). 
In both groups abnormal behaviours were observed: ear biting 
(sample A: 78 %; sample B: 93 %); tail biting (sample A: 67%, 
sample B: 59 %); ears lesions (sample A: 78%, sample B: 76 %); 
tails lesions (sample A: 67%). Moreover, 55 % of the group B 
units showed aggressive behaviour and 52% bar biting.
Discussion 
In our survey, a high percentage of anomalous behaviours was 
detected, indicating poor welfare. This result has a multi-factorial 
origin, but lack in space is one of the main causes.
The association between poor welfare, measured as a “Global 
Score”, and overcrowding, underlines the importance of ad-
equate room for this animal species. 
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The over-muscled sow syndrome: a new emerging syndrome in a hyperproliﬁ c 
sow herds: Clinical consequences: preliminary observations 
Thierry Solignac1 G-P Martineau2
1. Coopagri Bretagne, Landerneau, France; 2. Ecole Vétérinaire, Toulouse, France
Introduction
We report emergence of a new body building syndrome that we 
called “Over-muscled sow syndrome” (Solignac, 2009). “Over-
muscled sow syndrome” is the indirect consequence of genetic 
improvement for lean deposition and for hyperprolifi cacy 
(Solignac, 2008).
As a syndrome, there are consequences at diff erent levels such 
as farrowing (Solignac et al., 2010) or prolifi cay (Solignac and 
Martineau, 2010). 
Materials and Methods
A follow-up has been performed in 199 litters (≥ 15 TB/litter) 
from multiparous sows and categorized according to presence 
or absence of piglets less than 1 kg BW (Table 1). These sows 
belong to 14 herds with diff erent genetic lines. 
For each sow, we measured back fat (BF) and back lean (BL) 
(Noveko AC037L, 3.5 MHtz) at 4 diff erent period starting 3 weeks 
after farrowing, then 4 weeks after AI, 3 weeks before farrowing, 
and at the next farrowing (all measures at P2 site). 
Table 1: Litter performances in multiparous sows according to pres-
ence of absence of piglets ≤ 1 kg BW
At birth,piglets<=1kg BW/litter No Yes
No sows 124 75
Total born 17 17.3
Born alive 15.7 16
Stillborn 1.20 1.29
Weaned 11.4 11.5
No piglets<=1kg BW/litter 0 2.47
Results and Discussion
Results are presented in Figure 1. 
We report observations on some litter characteristics to propose, 
in a second time, some characteristics associated with morpho-
types according to BF and BL.
Beside hyperprolifi cacy, lean deposition is of major importance. 
However, as BL is not measured on a regular basis, we have only 
information on Back fat (BF). Therefore, there is no mention of 
this syndrome even if it is probably present in many countries. In 
France, during the last 2 years, we have been confronted to dif-
ferent herd problems around farrowing considered from the sow 
point of view (Solignac et al., 2010) and the litter point of view.
According to the classifi cation used for describe the eff ect of BF 
and BL on duration of farrowing (Solignac et al., 2010a), we pro-
pose a lecture of some common problems encountered in herds 
characterized by high level of performances, high technicity, and 
high management skills (Tables 2 ). 
Figure 1: Evolution of BF (A) and BL (B) in 199 sows classifi ed accord-
ing to presence of piglets less than 1 kg BM
Table 2: Morphotypes and some characteristics around farrowing and 
in lactation
Morphotypes 
at farrowing
Prepartum 
catabolism
Duration of 
farrowing
Neonatal piglets’ 
quality
Feed in 
lactation
Milk pro-
duction
BF+/BF+ No Increased Variable Low Low
BF+/BF- Moderate Normal Good Normal Normal
BF-/BF+ Increased Increased Bad Low Low
BF-/BL- Increased Increased Mean High High
Conclusion
Simultaneous BF and BL evaluation allows the combination of 
zootechnical and clinical evaluation of a sow herd. However, it 
questions the classical approach based on the sow nutritional 
needs. Therefore, we have to include an objective of BF/BL ratio 
to reconcile productivity, rusticity, and longevity. 
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The over-muscled sow syndrome: a new emerging syndrome in a hyperproliﬁ c 
sow herds: Eﬀ ect of back fat and back lean on proliﬁ cacy 
Thierry Solignac1 G-P Martineau2
1. Coopagri Bretagne, Landerneau, France; 2. Ecole Vétérinaire, Toulouse, France
Introduction
In another paper, we reported the eff ect of the “over-muscled 
sow syndrome” on farrowing duration and on some clinical par-
ameters around farrowing and in lactation (Solignac et al., 2010; 
Solignac and Martineau, 2010).
The objective is to report observational data on the eff ect of 
morphotype on prolifi cacy in herds with hyperprolifi c sows. 
Materials and Methods
Litter characteristics were obtained from 491 sows of 14 com-
mercial herds in Brittany (France) with diff erent hyperprolifi c 
genetic (see Solignac et al., 2010a). These sows are representa-
tive of the sow herds in Coopagri Bretagne (150 herds) (Table 1).
Data were categorized according to littersize : <13 TB, between 
13 and 15 TB and >15 TB per litter. 
For each sow, we measured back fat (BF) and back lean (BL) 
(Noveko AC037L, 3.5 MHtz) at P2 site at 4 diff erent period 
starting 3 weeks after farrowing, then 4 weeks after AI, 3 weeks 
before farrowing, and at the next farrowing. 
Table 1: Representativity of the choosen sample of 483 sows from 
Coopagri Bretagne (Brittany, France) 
Sample of 483 sows Coopagri 115 herds
Mean Total born 14.35 14.3
Mean born alive 13.46 13.1
Mean stillborn 0.9 1
Mean weaned 11.5 11.3
Results and Discussion
Globally, sows with litter <13 piglets were from morphotype 
BF+/BL+ (Figure 1) and sows with litter >15 piglets were from 
morphotype BF-/BL-. 
In sows with >15 TB, a muscular catabolism is starting as soon as 
mi-gestation until end of gestation 
The negative consequences on prolifi cacy in fat sows are prob-
ably an indirect consequence via the decrease of feed intake in 
lactation.
Therefore, management of lean deposition and fat deposition is 
of major importance during mi-gestation. 
Moreover, the management of lean and fat deposition is of cru-
cial importance as soon as in the gilt development unit. 
Conclusion
Consequences of the “over-muscled sow syndrome” are not 
limited at farrowing and in lactation. We agree with Foxcroft et 
al. (2005): “Accepting the risk of being considered some what 
heretical, most of our recent experiments with the lactating and 
weaned sow lead to the conclusion “that from a fertility and 
prolifi cacy perspective, fatness is simply not the key risk factor”. 
There is a dynamic of lean deposition, starting at the gilt level. 
We have to globally consider lean and fat deposition and to 
reconsider our paradigms regarding sow nutrition taking into 
account according to is the indirect consequence of genetic 
improvement for lean deposition and for hyperprolifi cacy.
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Figure 1: Evolution of Back fat (top, A) and back lean (bottom, B) at 
four diff erent stages starting 3 weeks after farrowing, then 4 weeks after 
AI, 3 weeks before farrowing, and at the next farrowing 
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Bacteriological analysis from milk of sows aﬀ ected and non-aﬀ ected by PDS 
(Postpartum Dysgalactia Syndrome) with special emphasis on Escherichia coli
Imke Gerjets1 Kerstin Reiners2 Nicole Kemper1
1. Institute for Animal Breeding and Husbandry, Christian-Albrechts-University Kiel, Kiel, Germany; 
2. PIC Germany GmbH, Schleswig, Germany
Introduction
The Postpartum Dysgalactia Syndrome (PDS) is an important 
disease in sows after farrowing. Serious economic losses come 
along with the disease due to reduced performance of the 
sows and increased mortality of the piglets. Prevalence in herds 
can be as high as 60% [1]. The etiology of PDS is multifactorial. 
Amongst others, management, feeding, hygiene and bacterial 
pathogens are regarded as infl uencing factors. This study exam-
ines the spectrum of pathogens involved in PDS und analyses 
risk factors concerning this complex puerperal disease.
Materials and Methods
Milk samples of 800 sows with PDS and 800 non-infected sows 
of diff erent age were taken on four piglet rearing and fattening 
units. Sows were identifi ed as PDS-aff ected when the measured 
rectal temperature was above 39.5°C. Additional criteria like the 
clinical appearance of the mammary gland and the behavior 
of the piglets were considered. Bacteria involved in the patho-
genesis of the MMA syndrome were identifi ed by advanced 
bacteriological analysis including molecular methods like PCR. 
The isolated Escherichia coli were analyzed for various virulence 
genes with two multiplex PCRs [2].
Results
A wide spectrum of pathogens was isolated, belonging mainly 
to Enterobacteriaceae, Staphylococcaceae, Streptococcaceae 
and Enterococcaceae. Escherichia coli played the most import-
ant role with isolation rates over 70% in both PDS-aff ected and 
non-aff ected sows. With regard to the virulence genes, signifi -
cant diff erences between strains from aff ected and non-aff ected 
sows were assessed for the virulence genes iron, kpsMTII, fi mC 
and traT.
Discussion 
Concerning the analysed bacteria spectrum, all species have 
been isolated in porcine mastitis before [3]. Coliform bacteria 
were found more often than the others pathogens. In particular, 
Escherichia coli represented the major part of all isolated bac-
teria. These results are in accordance with several other investi-
gations, showing that these pathogens are one causing agent 
in the etiology of PDS [3,4]. Concerning the signifi cant virulence 
factors detected in Escherichia coli, iroN and fi mC are associated 
with urinary tract infections in humans [5]. Escherichia coli iso-
lated from bovine mastitis possessed the gene traT [6], indicat-
ing a possible eff ect of this virulence factor.
Bacterial, environmental and animal factors may change the 
susceptibility for PDS. These factors are interdependent and 
the relative infl uence of each factor is related to the type of 
pathogens. Therefore, more comprehensive studies on virulence 
patterns are needed. However, the equal bacterial spectrum in 
diseased and healthy sows stresses the importance of the indi-
vidual resistance of the single sow. 
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Introduction
Of the piglets classifi ed as stillborn, 70 – 75 % on average die 
during the delivery, the rest of them die shortly after the par-
turition. In about 30 % cases, pathogenic agents are identifi ed 
as a cause of stillbirth (Vanroose et al., 2000), 70 % stillbirths are 
caused by various factors such as litter size, age and condition 
of the sow, birth weight of the piglet as well as internal temper-
ature in the farrowing house. The purpose of this study was to 
analyse the infl uence of diff erent air temperature of housing 
environment in the farrowing house for sows on the occurrence 
of stillborn piglets in purebred Landrace sows and gilts. 
Materials and Methods
Raw data were analysed for 236 litters during 14 month per-
iod. Pregnant sows were moved to farrowing pens cca 14 days 
before parturition. Sows were fed two times per day and quality 
of feed was not changed during the trial. Sows were not fed on 
the farrowing day. The air temperature was measured at hourly 
intervals by Datalogger (COMET), kept in the farrowing house in 
the sow living zone. Sow living zone is characterized by height of 
sow head (35 cm above fl oor). Temperature was measured every 
hour. From the values measured, average daily air temperature 
was calculated. The internal air temperature values were divided 
into the following intervals: optimal 16 – 23°C, elevated 23,1 
– 27,9°C, and high above 28°C, for the lactating sow. Reproduc-
tion parameters were evaluated with regard to average internal 
air temperature on the day of delivery - total number of piglets 
born, number of live born piglets, and number of stillbirths. The 
statistical evaluation of data observed was made by STATISTICA.
CZ software; method of ANOVA was used.
Results
The highest numbers of stillborn piglets occurred in the deliv-
eries that took place under high room temperatures (p<0,01); 
the lowest one was found in those taking place under the opti-
mal room temperature. If the numerical values were converted 
into percentage values there were 18.3 % stillbirths at high 
stable temperatures, 11.6 % stillbirths at elevated temperatures, 
and 6.9 % stillbirths at the optimal temperature, out of total 
number of piglets born.
Evaluation of the infl uence of average daily temperature in the 
parturition day on the piglet looses is mentioned in table.1.
Internal air temperature High above 28°C Elevated 23,1 – 27,9°C Optimal 16 – 22°C
Total born [pcs] 9,46 9,52 10,00
Live born [pcs] 7,73 8,42 9,31
Stillborn [pcs] 1,73 1,10 0,69
Stillborn [%] 18,3 11,6 6,9
Discussion
Real impact of high air temperatures of housing environment on 
the occurrence of stillborn piglets was improved by observing 
room temperatures in time of farrowing. By comparing these 
data with English and Edwards (1996) suggested an acceptable 
occurrence of stillbirth of 4-8 % out of total number of piglets 
born; this level was not exceeded only in the case of deliveries 
running at the optimal room temperature for lactating sows. 
Already by elevated temperature for lactating sows (23,1°C – 
27,9°C) was ratio for stillborn piglets double (11,66 %) and by 
high temperature nearly triple (18,3 %). 
Elevated room temperatures exert stress on the parturient 
sow. Adrenalin, excreted in the alarm phase, causes vasocon-
striction of vessels in the smooth muscle via the postsynaptic 
α1-receptors, consequently also in the uterine smooth muscle 
(Ruckebusch et al., 1991). Vasoconstriction prevents oxytocin 
from performing its uterotonic eff ect. Consequently, the partur-
ition is prolonged, and the secondary uterine hypocontractility 
develops. 
Acknowledgement
The study was supported from the project VZ MSM 6215712403 from 
Ministry of Education, Youth and Sports of the Czech Republic.
References
Vanroose, G. et al.(2000): Embryonic mortality and embryo-pathogen 
interactions. Anim. Reprod. Sci. 60-61, 131-143.
English, P.R., Edwards, S.A. (1996): Management of the nursing sow and 
her liter. In: Dunkin, A.C., Taverner, M. (Eds. Pig Production. World 
Animal Science, Vol. C10. Elsevier, Amsterdam. 113-140.
Ruckebusch, Y. et al. (1991): Physiology of small and Large Animals. B.C. 
Decker Inc. Philadelphia. 401. 
Welfare/Behaviour – Sow and litter
Proceedings of the 21st IPVS Congress, Vancouver, Canada – July 18-21, 2010 1178
Poster Presentations
P.872
The eﬀ ect of air temperatures in farrowing house for sows on occurrence of puerperal complications
Svetlana Odehnalová1, 2 Jiří Odehnal1 Marek Žižlavský1 Linda Czanderlová1 Antonín Vinkler2 Pavel Novák2 Josef Drábek2
1. SEVARON s.r.o., Brno, Czech Republic; 2. University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic
Introduction
In recent years was mentioned big improvement in production 
parameters of sows – number of produced pigs per sow per year 
(Whittemore, 2006). Nowadays epidemiologic data about occur-
rence of postpartal dysgalactic syndrome and existing possibil-
ities of risk factors related to management and feeding practice 
are narrow (Papadopoulos et al., 2009). The aim of this study was 
to analyse the infl uence of diff erent air temperature of housing 
environment in the farrowing house for sows and consequent 
changes in purebred Landrace dams. 
Materials and Methods
The observations were made in a commercial pig farm with 
during 14 month period. The external air temperature was 
measured by Datalogger (COMET), located in the farm prem-
ises. Temperature was measured at hourly intervals. Average 
daily temperature was calculated from 24 values measured. The 
period of mild winter (MW) was characterized by temperatures 
-10°C to 0°C, spring – autumn (SA) 0°C to 10°C, mild summer 
(MS) 10°C to 20°C, and hot summer (HS) over 20°C. The internal 
air temperature was also measured by Datalogger (COMET), 
kept in the farrowing house in the sow living zone (35 cm above 
fl oor). Temperature was measured every hour. There were 
chosen groups of 12 sows farrowing in each external temper-
ature period for periodic daily checking health status and meas-
uring the rectal temperature in fi rst 5 days after farrowing. 
Results
Measured data about external and internal temperatures in each 
period are noticed in table 1.
Period HS MS SA MW
External temperatures
Max.[°C] 39,2 28 16,7 12,0
Min.[°C] 8,5 0,6 -2,5 -16,3
Avg. [°C] 24,6 13,1 6,5 -2,5
Internal temperature
Max.[°C] 33,0 28,9 25,2 23,6
Min. [°C] 18,7 15,2 13,9 13,2
Avg. [°C] 26,4 23,1 18,7 20,0
Transparent evaluation of observed sows rectal temperatures 
and puerperal complications is registered in table 2.
Period HS MS SA MW
Rectal temperatures of 
sows - % of animals
38,9°C and less 25,0 0 41,6 41,6
39,0°C – 39,4°C 16,6 50,0 25,0 50,0
39,5°C – 39,9°C 25,0 16,6 33,3 8,3
39,9°C and more 41,6 33,3 0 0
Puerperal complication - 
% of animals 
Path. discharges 66,6 41,6 25,0 25,0
MMA syndrome 41,6 16,6 0 0
Indigestion 33,3 25,0 8,3 0
Discussion
Becker and Misfeldt (1995) indicate that very hot environment 
(27 – 32°C) for period 28 days after delivery increased rectal tem-
perature and have eff ect for certain immunological process in 
sow probably because of stress. This statement is in coincidence 
with occurrence of elevated rectal temperatures in hot summer 
(average internal temperature 26,0°C), but elevated rectal tem-
peratures in sows 5 days after farrowing were mentioned also in 
mild summer (average internal temperature 26,0°C). Negative 
infl uence of higher environmental temperatures was expressed 
also by higher incidence of pathological discharges from vulva 
and of incidence MMA syndrome in early puerperium. 
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Introduction
For hyperprolifi c sows, piglets vitality at birth is particularly 
important and is infl uenced by the quality of the farrowing 
process: the longer the worst it is for the piglets which face an 
increased risk of hypoxia. The reduction of oxygen supply to the 
fetus blood generates the set-up of an anaerobic metabolism 
with some subsequent modifi cations in the blood metabolites 
balance. Cortisol is usually associated to stress (van de Kar et al., 
1999) and used as an indicator of vitality (Canario et al., 2006). 
Materials and Methods
Herd: a typical French herd (400 sows) with hyperprolifi c sows 
(LWxL)x(PxL), 195 piglets (188 born alive + 7 stillborn) from 70 
sows were sampled for umbilical cord mixed blood within the 
fi rst minute after birth. Serum cortisol was analyzed accord-
ing to two classical techniques: radioimmunoassay (RIA) and 
luminoimmunoassay (LIA). The relationships with piglets status 
at birth (live weight, presence or absence of meconium, cord 
status, position at birth, birth rank) were established by analy-
sis of variance and correlations between parameters with the 
Pearson test (SPSS 17.0). Blood data exceeding the mean ± 3 
standard deviations were considered as outliers (n=4) and elim-
inated for the statistical analyses (P<0.05).
Results
The straightforward outcome concerns the dispersion of the 
analyzed values for both techniques (Figure 1), the latter’s 
remaining well.
Figure 1: Correlation between analytical techniques (RIA and LIA) 
(r=0.747, P<0.01).
 
Some weak (r<0.3) correlations (P<0.05) are measured with a 
higher cortisol level for the lightest piglets and for those born 
from the largest litters (Table 1).
Live piglets displayed higher (P<0.05) cortisol content than the 
stillborn (585.1±13.7 vs 427.5±32.9 ; 137.1±2.7 vs 104.2±13.7 
mg/mL for RIA and LIA, respectively). Cortisol RIA was increased 
(P<0.05) for the 115 vs 114 days gestation (648.8±28.6 vs 
560.0±15.3 mg/mL). 
Table 1: Umbilical cord cortisol (mg/mL) according to piglet weight 
(top) and total born litter size (bottom) (mean ± SEM; a,b diff er for 
p<0.05)
Cortisol RIA Cortisol LIA
<1kg (n=20) 715.7 ± 40.4a 162.0 ± 8.3a
1-1.2kg (n=27) 559.0 ± 35.4b 137.2 ± 7.1b
>1.2kg (n=147) 564.3 ± 14.9b 132.1 ± 3.1b
<14 TB (n=52) 494.9 ± 30.0a 120.8 ± 6.1a
14-16 TB (n=88) 583.2 ± 17.6b 134.1 ± 3.6a
>16 TB (n=54) 639.7 ± 25.2b 151.0 ± 5.0b
The presence of blood together with the meconium on the pig-
lets at birth indicated higher (P<0.05) cortisol LIA (140.0±38.1 vs 
132.3±37.3), but no eff ect of the rank at birth was measured, nor 
for the piglet’s position at birth (head vs back).
Discussion 
Weak vitality is often reported as a problem in small piglets, 
more numerous in hyperprolifi c sows. Thus, a strong correla-
tion could be expected with the cortisol and the indicators of 
low vitality. The absence of link between the cortisol and the 
piglet vitality, its rank at birth, the quality of the cord (regular 
vs twisted) or the presence of meconium does not support our 
initial hypothesis. Qualifying cord blood right after birth was 
quite innovative for this study, but it may also explain the high 
dispersion of the values as the level gets more stable after birth 
(Mc Cauley et al., 1984), where the few available studies were fo-
cused on. Therefore, cortisol cord level at birth does not appear 
relevant to characterize piglet vitality.
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Introduction
For hyperprolifi c sows, piglets’ vitality at birth is particularly in-
fl uenced by the quality of the farrowing process: the longer the 
worst it is for the piglets which face an increased risk of hypoxia. 
The reduction of oxygen supply to the fetus blood generates 
the set-up of an anaerobic metabolism with some subsequent 
modifi cations in the blood metabolites balance. 
Materials and Methods
Herd: a typical French herd (400 sows) with hyperprolifi c sows 
(LWxL)x(PxL), 195 piglets (188 born alive + 7 stillborn) from 70 
sows were sampled for umbilical cord mixed blood within the 
fi rst minute after birth (Giraudeau et al., 2009). Blood was then 
centrifuged (2900g, 12 min), plasma freezed until analyses. 
Vitality has been evaluated according to scale developed by 
Baxter et al., 2008 (grade 0 to 3).
Analysis: Na, Cl, K, Ca, P, glucose (Glu), bicarbonate (HCO3), pro-
teins, urea, uric acid and creatinin. The relationships with piglets 
status at birth (live weight, presence or absence of meconium, 
cord status, position at birth, birth rank) were established by 
analysis of variance (SPSS 17.0). Blood data exceeding the mean 
± 3 standard deviations were considered as outliers (n=4) and 
eliminated for the statistical analyses (P<0.05).
Results
Results (Table 1) are in accordance with other data (Tuchscherer 
et al., 2000) except phosphorus which was below (1.8 vs 4 
mmol/L).
Table 1: Averages of the analyzed cord blood parameters
Na K Cl Urea Creat. Uric ac.
Mean 138.4 5.1 99.7 4.6 259.6 29.8
SD 8.6 1.3 5.8 3.1 246.0 39.1
Glu HCO3 Ca P Prot.
Mean 2.7 23.8 3.2 1.8 21.8
SD 1.0 4.4 0.6 0.3 3.3
Piglets with very low vitality had higher glucose and P, and lower 
HCO3 than the more vigorous ones Ca and urea were higher 
(p<0.05) for the vitalities 0 and 1 as opposed to 2 and 3.
The eff ect of birth order is reported in Figure 1. Glucose and P 
content increase for the last third of the litter as does K, where 
more weak piglets are usually reported.
Figure 1: K, P and Glu blood cord level (mmol/L) per third of the litter 
(mean ± SEM) ; a,b, c diff er for p<0.05.
In stillborn, there are higher (p<0.05) K, P and Glu and a lower 
(p<0.05) HCO3. 
In hyperprolifi cacy litter (≥16), K is lower (p<0.05) as well as in 
light piglets (≤1kg), whereas Na increases with the litter size. 
In piglets with intact cords, K, Glu and urea are lower (p<0.01) as 
opposed to the broken ones, the fi gure being intermediate for 
the twisted cords. 
In piglets with presence of blood on the skin matches with 
higher (p<0.05) urea, creatinin, Ca, Glu and lower Na, Cl, HCO3; 
In piglets with meconium, there is less urea and more protein 
(p<0.05) in the blood than the others.
Discussion 
Vitality scoring is confi rmed through the cord blood profi le. 
Weak vitality is often reported as a problem in small piglets, 
also more likely to suff er from hypoxia (Herpin et al., 1996). Low 
HCO3, high Glu and K are good predictors of the level of intra-
partum anoxia (Trujillo-Ortega et al., 2007). When combined 
with the presence of meconium, the cord integrity, the rank at 
birth and the live weight, piglet vitality is well correlated with 
the cord blood profi le. 
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Introduction
Piglet mortality during lactation is a large problem in pig 
production. The nursing and suckling behavior of piglets follow 
a complex scheme and the milk ejection lasts for only 10-20 
seconds, once per hour. There is no transfer of antibodies across 
the placenta and the piglets are born with low immunity. Each 
piglet must thus have access to a functional teat for nourish-
ment and growth (3). One example of a non-functional teat 
is the inverted teat. The degree of inversion may diff er from 
slightly to totally inverted. The aim of this study was to evaluate 
the function of inverted teats identifi ed at 100 kg live weight, 
and to analyze diff erences between the mammary glands of in-
verted teats vs. normal teats. Further, the piglets’ ability to suckle 
an inverted teat and diff erences in daily weight gain that might 
be related to the presence of inverted teats was investigated. 
Material and Methods
Two Yorkshire gilts (a, b) and one Yorkshire*Landrace gilt (c) with 
4, 4 and 8 inverted teats at 100 kg live weight were inseminated. 
One week before expected farrowing the teats were palpated. 
After farrowing, to ensure that each piglet only had access to 
one teat, all excessive, functional teats (above the number of 
liveborn piglets) were blocked with adhesive bandage, begin-
ning with the posterior teats (1). The health status of the piglets 
and gilts were recorded daily. The piglets were individually 
marked and the teat order of the piglets was registered by 
videotaping. The piglets were weighed individually each day 
during the fi rst week and thereafter once a week until weaning 
at 4 weeks of age. The gilts were euthanized immediately after 
weaning and the mammary gland for each teat was weighed 
individually.
Results
One week before farrowing, two of the gilts (b, c) only had one 
single inverted teat left and gilt (a) had no inverted teats remain-
ing. All three gilts had 13 liveborn piglets each. The two piglets 
that suckled the inverted teats were euthanized 5 and 8 days 
after farrowing, respectively, due to loss of body weight. Both 
these piglets were still fi ghting for other teats the day they were 
euthanized, but necropsy revealed empty intestines and sparse 
amount of feed in the stomach. Both piglets still had some fat 
remaining in the coronary groove, but one piglet had serous 
atrophy of the bone marrow. Strong signifi cant positive correla-
tions (0.66***, 0.64***, 0.62**) between weight of mammary 
gland and daily gain of the piglets during the second to fourth 
week of lactation could be found. However, no signifi cant diff er-
ences in piglet weight gain between normal and previously in-
verted teats could be seen. The average mammary gland weight 
for normal teats was 606 gram and for previously inverted 570 
gram. 
Table 1. Piglet weight by type of teat used
Average piglet weight (kg)
Week Normal teats Previously inverted teats
1 2.45 2.21
2 4.45 4.18
3 6.45 6.20
4 8.66 8.51
Discussion 
This study clearly showed that inverted teats at farrowing are of 
low functional value and this does emphasize the importance of 
functional teats. Inverted teats can sometimes protrude close to 
farrowing (2), but it was unexpected that most of the inverted 
teats were normalized weeks before farrowing. To be able to 
demonstrate relationship between previously inverted teats and 
piglet daily weight gain, more data is needed. 
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Introduction
Perinatal mortality still plagues the swine industry despite the 
improving knowledge in neonatal physiology. Hypothermia is 
one of the most important factors, aff ecting colostrum intake 
and hence, its later health status and performance.
In this study, thermography was used as a new tool to determine 
hypothermia and its evolution in newborn piglets. Thermog-
raphy might provide high advantages in swine clinical practice, 
allowing the inspection of a high number of animals in few time, 
revealing lesions and risk factors that would remain hidden with 
other diagnostic systems (Friendship et al., 2009).
Materials and Methods
Twenty-two piglets from two diff erent litters entered the study 
at birth time. In each litter, half of the piglets were immediately 
dry using an absorbent material (paper). The other half was not 
manipulated at birth. A heat lamp and extra-paper (2 kg) were 
supplemented in both litters. 
Skin temperature was recorded from each piglet at birth and 
every 10 minute’s time during 1.5 hours using a thermographic 
camera (Fluke Ti45). Piglets were weighed at birth and at 2, 4 
and 9 days of life.  
In each picture, the average temperature in the back was meas-
ured. In fi gure 1 some examples of thermographic pictures are 
shown. 
Figure 1 – Thermographic pictures of newborn piglet 
Temperature and body weight (BW) evolution were analysed 
using the MIXED procedure of SAS (v 9.00). In the temperature 
analysis, the statistical model included the fi xed eff ects of treat-
ment (control vs drying with paper), time (10 minutes’ intervals) 
and their interaction and the block eff ect of litter within treat-
ment. In the BW analysis, the statistical model included the fi xed 
eff ect of treatment and the block eff ect of litter within treat-
ment. Initial BW was included as covariate in both models.
Results
Drying piglets immediately after birth increased the skin 
temperature in the fi rst 90 min of life (39.3ºC vs 37.8ºC in dried 
and control piglets, respectively; P=0.048). Evolution of the skin 
temperature was also diff erent between treatment (P treatment 
x time = 0.0001). Initial temperature was 39.3 ± 0.79 ºC, and was 
kept almost constant in the dried-piglets in the 90 min-interval. 
In the control group (non-attended piglets) skin temperature 
immediately decreased after birth and then increased progres-
sively and 90 min after farrowing temperature did not diff er be-
tween groups (P=0.27). Evolution of skin temperature is shown 
in the fi gure 2. 
Figure 2 – Skin temperature evolution in the back 
Body weight evolution did not diff er between treatments (2.71 
kg BW at 9 days of life).
Discussion
Drying piglets immediately after birth was eff ective to keep the 
body temperature. Preventing the perinatal hypothermia pro-
vides the piglet more possibilities to survive and reaching higher 
BW at weaning. Infrared thermography demonstrated enough 
accuracy to be considered as a new tool to complement other 
diagnostic tools.
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Introduction
Tilmicosin is a semi-synthetic macrolide antibiotic which is 
aff ecting bacterial protein synthesis. Macrolides have a proven 
benefi t as treatment for a wide range of infectious diseases, with 
an increased interest for respiratory infections. 
The aim of this study was to evaluate the eff ect of tilmicosin 
(Tilmovet® 250 mg/ml Concentrate for Oral Solution - Huveph-
arma) treatments and its capacity to prevent neo-natal piglet 
mortality.
Materials and methods
To set up this trial in a sow farm (n= 350), 60 pregnant and 
healthy sows (without health issues during the last gestation 
and regardless of parity) of around 110 days of gestation were 
provided a dose of 9 ml of Tilmovet® 250 mg/ml Concentrate 
for Oral Solution per sow per day for minimum 5 to maximum 7 
days through an individual medication system / sow. The total 
dose was split up and distributed twice a day (4.5 ml per dose). 
The fi nal day of treatment was the farrowing day. After farrowing 
and starting on the day of farrowing (day 0), milk samples were 
collected on day 2 and 4 with a minimum of 10 ml per sample. 
Samples were directly frozen after collection. From these 
samples, tilmicosin was extracted by means of liquid-liquid 
parturition, purifi ed by C18 SPE and identifi ed and quantifi ed 
through HPLC method. The HPLC method has been developed 
and validated for analysis of tilmicosin in milk. 
Piglet mortality and weight gain fi gures were recorded daily for 
a period of 14 days.
Results
The treated group of sows had 9.4% more piglets born (15.2 
vs 13.9) than the untreated sows (Table 1 and Figure 1). They 
also had 10% more live born piglets (14.3 vs 13.0) and the pre-
weaning mortality was clearly lower than in the control group 
(13.28% vs 16.92%).
The number of weaned piglets was similar in both groups, yet 
the Tilmovet® piglets were nearly 9.5% heavier at weaning.
Table 1. Piglet birth and growth
Average piglet weight (kg)
Week Normal teats Previously inverted teats
1 2.45 2.21
2 4.45 4.18
3 6.45 6.20
4 8.66 8.51
Figure 1. Pre-weaning piglet mortality and weight at weaning
Discussion and conclusion
Earlier research1, 2 has demonstrated the benefi cial eff ect of 
tilmicosin treatment on sow productivity and the prevention of 
postpartum infections through reduction of piglet pathogen 
transmission. The current study confi rms these fi ndings and indi-
cates that gestating sows being treated with Tilmovet® for 5 to 7 
days prior to farrowing suff ered less from neo-natal infections. 
This is a result from the tilmicosin concentration in the sow milk 
and consequent colostrum transmission. The impact of the ef-
fect in the treated group can be noticed in the higher individual 
piglet weights at weaning.
References
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Piglet survival depends on relative birth weight
Flemming Thorup1 Susanne L. Musse2
1. Center for Pig Production, Agriculture and Food Council, Copenhagen, Denmark; 2. PORCUS Svinefagdyrlæger & Agronomer , Ringe, Denmark
Introduction
Large size at birth is the primary indicator of high piglet sur-
vival (1). For high litter survival, uniform birth weights are more 
important. The Meishan show high piglet survival with low but 
uniform birth weights (2). We investigated piglet survival, when 
birth weights were decreased due to eighter low parity or high 
litter size.
Materials and Methods
Trial one included 1401 DanBred DxLY piglets born in two herds. 
Trial two included 1182 DanBred YxL female piglets born in one 
herd. Piglets were weighed and ear tagged at birth. Survival was 
registered at weaning. 
Results
Piglets born to 1st litter sows were 150 to 200 gram lighter than 
piglets born to older sows (Table 1). Piglet survival by birth 
weight and parity in trial 2 is shown in fi gure 1. Birth weights 
and piglet survival for piglets born in small litters (10-14 total 
born) and large litters (18-22 total born) is given in table 2. 
Piglets born in litters of 1-9, 15-17 or > 22 are excluded. Piglets 
born in large litters were app. 150 gram lighter than piglets born 
in small litters. Survival by birth weight and litter size in trial 2 is 
given in fi g. 2. More fi gures will be presented.
Discussion 
Despite having the same genotype, piglets born in 1st litter 
and piglets born in large litters were app. 150 gram lighter 
than piglets born in sow litters and piglets born in small litters. 
Restricted uterine capacity may cause this “piglet phenotype”, 
150 gram leighter, than the genetic merit would allow for under 
better uterine conditions. There were only small diff erences in 
piglet survival between the groups. Both 1st litter piglets and 
large litter piglets reached 100 per cent survival at a lower birth 
weight than piglets born by sows or born is small litters (see fi g. 
1 and 2). A level of survival is correlated to birth weight (geno-
type) and is still the same, if a piglets achieves a lower birth 
weight (phenotype), when born in a gilt litter or in a large litter. 
A reduced birth weight in fi rst parity or due to high litter size did 
not eff ect piglet survival.
References
(1).  Foxcroft G. R. et al., Soc. Reprod. Fertil. Suppl. (2009), 66, 213-31. 
(2).  Ford. S. P., Reprod. Fertil. Suppl. (1997), 52, 165-76. 
 Table 1. Eff ect of parity on birth weight and piglet survival
Parity 1 2-9 1 2-9 1 2-9
Factor No. piglets Birth weight, kg Survival %
Trial one 360 1244 1.24 1.41 93 87
Troal two 343 889 1.28 1.48 89 89
Table 2. eff ect of litter size on weight and piglet survival 
Litter size 11-14 18-22 11-14 18-22 11-14 18-22
Factor No. piglets Birth weight, kg Survival %
Trial one 360 566 1.47 1.32 89 84
Trial two 343 332 1.45 1.34 89 88
Figure 1.
Figure 2.
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Extreme uterine crowding in Proliﬁ c French York (PFY) sows
John Harding1 Crissie Auckland1 Jennifer L. Patterson2 George R. Foxcroft2
1. University of Saskatchewan, Saskatoon, SK, Canada; 2. University of Alberta, Edmonton, AB, Canada
Introduction
The selection for litter size without concurrent selection for uter-
ine capacity will intensify the adverse aff ects of uterine crowd-
ing, particularly in prolifi c and mid- to high-parity sows. Re-
cently, a prolifi c French York (PFY) dam line was imported from 
France into North America as a way of increasing the prolifi cacy 
of commercial sows. The objective of this study was to evaluate 
various reproductive attributes of the PFY dam-line at the end of 
the fi rst trimester. 
Materials and Methods
Gravid reproductive tracts, harvested from 34 healthy, vaccin-
ated (parvo, lepto, erysipelas) PFY sows of various parities, were 
slaughtered 26 to 40 days following insemination. All sows were 
designated for culling for non-reproductive reasons and had 
been bred specifi cally for this study. After humane slaughter 
the gravid uteri were removed and stored frozen at –20oC. After 
thawing, the corpora lutea (CL) were counted, the uterus incised, 
each conceptus removed, excess fl uid drained from the chorioal-
lantois, and the conceptus (embryo, amnion + drained chorioal-
lantois) weighed. The embryos were removed from placental 
membranes, weighed and the crow-rump length (CRL) meas-
ured. The conceptus was classifi ed as degenerate if the embryo, 
placental membranes, or both, showed gross signs of degenera-
tion as previously described1. In the event of twinning, each em-
bryo was counted and separate embryo mass and crown-rump 
lengths were obtained. Analysis: The total number CL on both 
ovaries was considered the ovulation rate. The estimated live 
embryonic survival rate was calculated (number assumed live 
embryos/number CL). The average live embryo CRL and weight, 
and the wet placental weight (total conceptus weight less 
embryonic weight) were calculated for each litter. Litters were 
categorized by gestation age (26-30, 31-35, 36-40), and group 
diff erences in the median scores for each reproductive attribute 
compared using a Kruskal-Wallis analysis of variance. P < .05 was 
considered signifi cant. 
Results
The median parity across all sows was 3 (range 1 to 7). Ovula-
tion rate and total embryo number ranged from 17-33 and 9-29 
respectively (Figure 1). Embryo and placental weight, and CRL 
increased with gestation age (Table 1), but the number of total 
and live embryos, and embryo survival rate were not aff ected. 
Figure 1. Distribution of ovulation rate (black) and total embryo num-
ber (grey) in 34 prolifi c French York sows
Table 1. Reproductive attributes by gestation age in 34 prolifi c French 
York sows
Gestation age (days)
Variable 26-30 31-35 36-40 Total
No. sows 16 11 7 34
No. CL 26 25 26 26
No. total embryos 21 16 19 18.5
No. live embryos 17.5 15 16 16.5
Embryo survival rate % 68.5 67.0 73.0 69.5
Avg placental wt (g) 16.5a 32.6b 50.2b 23.2
Avg. embryo wt (g) 2.0a 4.0b 6.8c 3.3
Avg. embryo CRL (mm) 25.6a 33.1b 45.5c 30.2
Superscripted letters within rows diff er statistically P < .05
Discussion
Previous research by our team demonstrated that when the 
number of viable embryos at gestation day 30 exceeded 9 to10, 
fetal development was adversely aff ected2. Our present results 
confi rm the combination of high ovulation and embryo survival 
rates in prolifi c French York sows results in extreme intrauterine 
crowding during the fi rst trimester. Its impact on postnatal per-
formance warrants continued investigation. 
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Bacterial pathogens present in the milk of healthy sows and sows with PDS (Postpartum 
Dysgalactia Syndrome): detailed analysis of isolated Aerococcus spp
Andrea Menrath1 Imke Gerjets1 Kerstin Reiners2 Nicole Kemper1
1. Institute for Animal Breeding and Husbandry, Christian-Albrechts-University Kiel, Kiel, Germany; 2. PIC Germany GmbH, Schleswig, Germany
Introduction
The porcine Postpartum Dysgalactia Syndrome (PDS) is a 
well known disease in sows 24 to 48 h post partum. The main 
symptom, the mastitis, is accompanied by fever and reduced 
milk production. Hence, decreased rates of growth and a higher 
mortality in piglets are the results.
The disease is multifactorial due to infl uences of management 
and feeding, but additionally, there is a relevance of individual 
factors of each animal and of the occurrence of diff erent patho-
gens in the infected mammary glands.
In the geMMA-project, the spectrum of pathogens in the milk 
of PDS-diseased and healthy sows was compared. In this special 
part of the study, the isolated Aerococcus (Ac.) species (spp.) 
were further investigated.
Materials and Methods
The sows were defi ned as PDS-diseased by several criteria. 
The identifi cation and subtyping of all isolates were performed 
by classical bacteriology, the API-system® of Biomerieux 
(Nürtingen, Germany) and PCR.
Results
In the milk of 344 (22.9%) of 1,500 examined sows, both PDS-
diseased and healthy, Aerococcus spp. were isolated.
This is the fi rst description of the isolation of Aerococcus spp. in 
the milk of sows. In this study, the isolated Aerococcus spp. be-
longed to Ac. viridians (285 isolates) and Ac. urinae (59 isolates) 
by biochemical diff erentiation. Further results of the advanced 
PCR-analyses will be represented. 
Discussion and Conclusion
Aerococcus spp. are ubiquitous in the environment and also 
in the air. The Genus Aerococcus includes seven species: Ac. 
viridans, Ac. urinae, Ac. sanguinicola, Ac. christensensii, Ac. 
urinaeequi, Ac. urinaehominis and Ac. suis. These Gram-positive, 
catalase-negative Cocci have been associated with disease 
in human (Ac. viridans und Ac. urinae), swine, and cattle (Ac. 
viridans und Ac. suis) (1, 2). In swine, Ac. viridans has been de-
scribed in association with arthritis, meningitis and pneumonia 
(2). Most recently, Ac. suis has been shown to cause arthritis, 
enteritis, meningitis and pneumonia in swine (3).
Due to the relation of Aerococcus spp. with mastitis in cows (1), 
the role of this pathogen in the pathogenesis of PDS is clearly 
worth further examinations, with this study as a fi rst step in this 
direction.
This study is part of the BMBF-supported FUGATO-plus-project 
‘geMMA - structural and functional analysis of the genetic varia-
tion of the MMA-syndrome’.
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Facilitating nursing behavior of sows at farrowing has a positive eﬀ ect on colostrum distribution
Johan Biermann2 Jan Jourquin1 Rainier van Gelderen1 Lieve Goossens1
1. Janssen Animal Heatlh, Beerse, Belgium; 2. DAP Helmond, Helmond, Netherlands
Introduction
Farrowing is a stressful event for sows, especially fi rst parity 
sows. In the most severe cases this leads to aggression and 
savaging of newborn piglets. Next to clear aggression, there is a 
range of less explicit unwanted behavior, negatively impacting 
the possibility for the piglets to take up colostrum. Bottle fed 
piglets ingest more colostrum in the fi rst day than naturally 
nursed piglets (1), indicating that the sows is a limiting factor for 
colostrum intake. 
Our investigations show that colostrum distribution is correl-
ated with piglet survival. We were also able to demonstrate that 
with an injection of azaperone of the sow just after farrowing, 
resulted in an increase of calm behavior and in an increase of 
number of piglets suckling during the fi rst hours after farrowing. 
The aim of this pilot study was to investigate if an injection of 
azaperone (Stresnil®) at the end of the partus had a positive ef-
fect on colostrum distribution. 
Materials and Methods
In a commercial sow farm, 193 fi rst and second parity litters 
were included in the study. The day time litters (n=98) were 
injected 320 mg of azaperone IM (8 ml Stresnil®) at the moment 
of expulsion of the placenta. The night time litters (n=95) were 
not treated. Gestation length and the number of piglets born 
total, born alive, fostered (±), dead and weaned were recorded. 
All normal farm procedures were continued. At tail docking (day 
3 post partum) a blood drop of the remaining tail bud from 6 
randomly chosen litter mates was sampled. The samples were 
analyzed with a DAS-ELISA test (2) (Colostrum Quality Counter-
TM). Piglet serum IgG concentration after gut closure can be used 
as a parameter for colostrum intake (3). In order to compare the 
distribution of colostrum between sows, the coeffi  cient of varia-
tion of the piglet serum IgG (CV IgG) was calculated. This is the 
standard deviation divided with the average of the litter.
The statistical analysis was performed with the SAS® program. A 
t-test on the log-transformed data was performed. 
Results
The mean (± standard deviation) of colostrum distribution (CV 
IgG) of the piglets of treated sows was 46.9 (± 20.4) compared 
to 55.2 (± 32.2) for non-treated sows. The diff erence is nearly 
statistically signifi cant (p<0.07). There was no diff erence in 
colostrum distribution between fi rst and second parity sows. 
Figure 1 shows the relation of variation in colostrum intake and 
the number of piglets born alive. The variation increases with 
litter size in non-treated sows, while the variation does not diff er 
between litter sizes in the azaperone treated sows. 
Discussion 
The results demonstrate that the behavioral change of the sow 
after injection of azaperone results in a better distribution of the 
available colostrum amongst the piglets. Increasing number of 
piglets born alive per litter had a negative impact on colostrum 
distribution in the non-treated group. In litters where the sow 
was treated with azaperone, the distribution of colostrum was 
not aff ected by the number of piglets born alive. This confi rms 
earlier fi ndings that the sow is a limiting factor for colostrum 
distribution. 
In this study, it was shown that one injection of azaperone to 
the sow at the moment of expulsion of the placenta, improves 
colostrum distribution amongst her piglets. The challenges 
caused by poor colostrum distribution are more relevant in high 
productive farms. 
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Facilitation of nursing behavior in sows during colostrum phase improves piglet condition
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Introduction
The development and the wellbeing of the piglet is determined 
by its ability to fulfi ll its need for homeostasis, growth and its 
ability to fi ght off  the sanitary challenges. Early colostrum intake 
is the key for success. For the fi rst 2 days of their lives, colostrum 
provides the nutrients to the piglets and during their fi rst weeks, 
the immunoglobulin (Ig) fraction passively protects the piglets 
from disease (1). Critical factors for early life survival are the abil-
ity of the piglet to suckle, the available volume of colostrum, the 
udder quality and the behavior of the sow during the colos-
trum phase. At parturition, the behavior of about 25% of sows 
prevents their piglets from suckling. 6 hours later this increases 
even to 30%. With an injection of azaperone (Stresnil®) at the end 
of the partus, sows become calmer and allow the piglets easy 
access to the udder.
In this study, the eff ect of an injection of azaperone at the end of 
the partus of all parity sows on piglet development was investi-
gated.
Materials and Methods
In a 3000 sow farm in Taiwan, 50 sows of all parities were in-
cluded in the study. They were randomly allocated to a treated 
group (25 sows) and a non treated reference group (25 sows). 
The treated sows were injected IM 2 mg/kg of azaperone (5 ml 
Stresnil® per 100 kg body weight) at the moment of expulsion of 
the placenta. To assess the condition and health status in fi eld 
conditions, early mortality rate and weight gain were used as 
parameters. The piglets were weighed and identifi ed individual-
ly at birth and at weaning. Fostering was allowed and recorded. 
Farrowing and weaning date, numbers born alive, pre-weaning 
mortality and numbers weaned was recorded.
A linear mixed model was fi t using the procedure MIXED in SAS® 
version 9.1.
Results
The number piglets born alive was 10.8 for the non treated 
group and 9.7 for the treated group. Pre-weaning mortality 
rate was similar for both groups (11.74% and 11.64%). Weight 
data are presented in Table 1. All litters were weaned at 28 days. 
While individual birth weights were not diff erent between both 
groups, weaning weight was signifi cantly higher in the azaper-
one treated group.
Table 1: Impact of azaperone treatment on weight gain 
Birth weight (kg) Weaning weight (kg) Weight gain (kg)
Azaperone 1.64 7.07 5.43
Non-treated 1.61 6.55 4.94
p-value 0.7478 0.0313 0.0132
In Figure 1, the impact of birth weight on weight gain is shown. 
Weight gain increases with birth weight.
The observed growth improvement in the treated group was 
seen in all birth weight classes.
Discussion
The present study showed the benefi t of an azaperone injection 
of sows at the end of the partus. Piglets thrive better, resulting in 
a 9.9% weight gain increase. 
The sedative eff ect of azaperone is limited to a few hours. The 
origin of any diff erence therefore lies in the early intake of 
colostrum. If enough colostrum is available, a good distribution 
increases the chances of all piglets. Stronger piglets increase 
the suckling impulse, which leads to a higher milk production. 
The antibodies acquired from the colostrum protect the piglets 
against disease. In this study, it results in a signifi cant increase of 
weaning weight of the piglets.
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Analysis of oligosaccharides in pigs’ colostral milk
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Introduction
Milk oligosaccharides (MOs) have been investigated in humans 
as well as in several other mammals, but studies of sows’ milk are 
lacking (Urashima et al., 2001).
Their prebiotic and antiadhesive eff ect for the newborns is well 
described for human milk oligosaccharides (Bode, 2009) and can 
be assumed for other species, too. Because of increasing litter 
sizes and the rising demand for milk substitutes in farrowing 
units, the composition of sows’ milk, including oligosaccharides 
as functional ingredient, is of peculiar interest. Furthermore, a 
possible anti-adhesive eff ect in sows’ mammary glands may play 
a role in the pathogenesis of mastitis as part of the Postpartum 
Dysgalactia Syndrome (PDS). 
This study therefore analysed MOs in sows’ colostral milk, consid-
ering also the clinical health status of these sows in the peripar-
turient period and bacteriological results of their milk samples.
Material and Methods
At the Institute’s research farm, 17 sows were examined clinically 
at the expected farrowing date and milk samples were taken. 
Five sows showed clinical signs of mastitis during the sampling 
time or developed mastitis post partum.
All sows were sampled during or directly after parturition, and 
all milk samples were obtained by hand milking without oxyto-
cin injection. Bacteriological analysis and species diff erentiation 
were performed by routine bacteriological diagnostics. At least 
one ml milk was stored at -20°C and MOs were isolated, reduced 
and permethylated. Analysis was performed by MALDI-TOF mass 
spectrometry. 
Results
All detected MOs were sialylated with terminal sialic acid 
(Neu5Ac). No fucosylated MOs were detected. The reducing 
end of the oligosaccharides is generally formed by lactose (Gal 
β1-4Glc) and in much lower abundance by lactosamine (Gal β1-
4GlcNAc). Sialyllactose (Neu5Ac2-[3/6]Gal β1-4Glc) was the most 
abundant structure in all samples. The carbohydrate portion of 
GM2-ganglioside (GalNAc β1-4[Neu5Ac2-3]Gal β1-4Glc) revealed 
the second highest peak in most samples, but was completely 
absent in one sample and just detectable in one other sample. 
Biantennary oligosaccharides formed the highmolecular fraction 
with monosialylated lacto-N-hexaose (Neu5Ac-Gal-GlcNAc-[Gal-
GlcNAc-]Gal β1-4Glc) being the third most abundant structure in 
most samples.
Discussion 
This is the fi rst study analysing MOs in pigs. The porcine MOs 
show some similarities with those of cattle (Tao et al., 2008). In 
both species sialylated MOs dominate and fucosylated MOs are 
absent. One main diff erence is the presence of high quantities 
of the GM2-ganglioside carbohydrate in pig MOs. Only traces of 
this structure are found in bovine MOs. Pig’s milk contains more 
complex high molecular weight biantennary MOs than bovine 
milk.
Like in other species the MOs in pigs are likely to act as prebiot-
ics by supporting the development of a benefi cial gut fl ora in 
piglets. The knowledge of the natural composition of porcine 
MOs could be the basis for further functional studies and also 
for a rational composition of food supplements for piglets and 
weaners. 
Possible changes in oligosaccharide patterns between healthy 
and diseased animals should be investigated in further studies.
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Impact of uterine crowding on fetal development and lactational performance
John Harding; Shrijana Dhakal; Yanyun Huang; Crissie Auckland
University of Saskatchewan, Saskatoon, SK, Canada
Introduction
Prenatal programming is a process by which stimuli during 
gestation establish permanent responses in the fetus that 
impact physiologic function later in life. In pigs, low birth weight 
or body mass index are associated with altered metabolism, fat 
deposition and stress response1,2. Uterine overcrowding reduces 
fetal weight, impairs myogenesis and organ development3. 
We are investigating the eff ects of uterine crowding on post-
natal health and performance. Reported herein are descriptive 
statistics highlighting the eff ects of uterine crowding on fetal 
development and lactational performance. 
Materials and Methods:
Right oviductal cauterization was performed 2 weeks post 
weaning on 13 multiparous PIC sows (CAUT). CAUT and 12 
control sows (CTR) delivered 10 to 17 total born on their previ-
ous parity and were in good body condition at weaning. After 
surgery, sows were heat synchronized and inseminated. Corpus 
lutea and embryo number were counted via laparotomy at 36 
±2 days of gestation. At farrowing, litter size, gender, individual 
birth weight, crown rump length (CRL), heart girth was recorded 
for live and stillborn pigs. Judicious cross-fostering between 
treatments ensured CAUT and CTR sows suckled piglets of the 
opposite group. Non-trial pigs were fostered onto trial sows as 
appropriate to ensure CAUT and CTR litter sizes were similar. 
Piglets were re-weighed at day 21. Sows were weaned and 
rebred, and farrowed a subsequent litter if they conceived. Lapa-
rotomies were not performed, but performance was monitored. 
Parametric and non parametric outcomes were compared 
between group using Student’s t-test or Mann-Whitney U test as 
appropriate.
Results:
The signifi cantly lower embryo numbers in CAUT (Table 1) 
provided an enriched uterine environment resulting in increased 
embryo survival, heavier and longer piglets with greater girth 
and BMI at birth (Table 2). The CAUT off spring had superior 21 
day survivability even though litter sizes after cross- fostering 
were numerically similar in CTR and CAUT sows. Lactational ADG 
and weaning weight were signifi cantly higher in CAUT off spring. 
Table 1: Ovulation rate, embryo number and survivability in unilateral 
cauterized and control sows
Variable CAUT CTR
No. sows 13 12
Ovulation rate 23.9 ±4.9 27.0 ±4.1
Ovulation rate (available ovary) 12.9 ±3.5d 27.0 ±4.1
Total no. embryos 9.1 ±3d 15.3 ±4.3
Embryo survival % (available ovary) 66 ±.20.4a 53 ±16
aP<0.05; b P<0.01, cP<0.005, dP<0.001
Table 2: Farrowing performance of unilateral cauterized and control 
sows and their off spring 
Variable CAUT CTR
No. sows 19 21
Total born/L 7.9 ±2.9c 11.2 ±3.2
Live born/L 7.6 ±2.9b 10.4 ±3
Birth wt (kg) 1.7 ±0.3d 1.4 ±0.3
D0 CRL (cm) 30.3 ±1.9c 28.4 ±2.3
D0 Girth (cm) 25.6 ± 1.6c 24.1 ±1.5
D0 BMI 0.18 ±.01a 0.17 ±.02
D0 post foster litter size 10.1 ± 1.7 11 ±1.8
Pigs/litter weaned 9.2 ±1.7 8.9 ±1.4
D21 survival (no. pigs/L) 8.2 ±2.3 7.0 ±2.6
D21survival (% of live born) 92.9 ±11.6c 82.1 ±2.5
D21 weight (kg) 7.9 ±.8c 7.0 ±0.9
ADG 0-21 (kg/d) 0.3 ±0.04a 0.3 ±0.04
aP<0.05; b P<0.01, cP<0.005, dP<0.001
Discussion: 
These preliminary results indicate fetal development was 
attenuated in the relatively crowded CTR sows resulting in 
disproportionate fetal growth and the birth of thin and slightly 
shorter pigs that had lower day 21 survival, weaning weight and 
lactational ADG. Additional analysis is planned to determine if 
these eff ects are dependent or independent of birth weight, and 
if uterine crowding aff ects post weaning health, stress response, 
growth and fat deposition. 
References:
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Introduction
The Postpartum Dysgalactia Syndrome (PPDS) causes important 
economical losses in the global swine industry. The clinical signs 
are characterized mainly by disorders of lactation and health 
status of sows, as well as from decreased litter performance (1). 
The aim of this fi eld study was the assessment of possible 
anti-infl ammatory activity of Larch sawdust, Echinacea, Pump-
kin, Salix, Sinupret and Grape Seed based on the reduction of 
PPDS prevalence in sows. This trial was part of the SAFEWASTES 
specifi c targeted research project fi nanced by the European 
Union (6th Framework Project). 
Materials and Methods
The trial farm had 900 sows under production and previous his-
tory of PPDS occurrence. Genetically similar sows were selected 
in terms of achieving homogenity of parity, bodyweight, previ-
ous production parameters and health status. Thus, 40 sows with 
no clinical signs of disease were randomly allocated in 8 groups 
of 5 sows each. The trial period was 35 days (from 7 days prior 
to farrow up to weaning day). Six compounds at the inclusion 
level of 1% were added to sow feed in order to be tested for 
anti-infl ammatory activity (gestation and lactation feed) as fol-
lows: 1) Control and Positive group: 99% Basic diet and 1% Corn 
starch, 2) Larch group: 99% Basic diet and 1% Larch, 3) Echinacea 
group: 99% Basic diet and 1% Echinacea, 4) Pumpkin group: 99% 
Basic diet and 1% Pumpkin, 5) Salix group: 99% Basic diet and 
1% Salix, 6) Sinupret group: 99% Basic diet and 1% Sinupret, 7) 
Grape seed group: 99% Basic diet and 1% Grape seed.
The positive controls were injected with a single 2 ml dosage of 
an anti-infl ammatory drug (meloxicam) at parturition day. The 
animals of all the other groups were injected with the same dose 
of normal saline at the same day. The milk production index was 
calculated. Production and health parameters of sows and their 
litters were also recorded. Blood samples were collected from all 
sows at allocation day and at 24 and 72 hours post partum (PP) 
for infl ammation markers evaluation (serum tumor necrosisfac-
tor-2/TNF-a, plasma interleukin-6/IL-6). The cytokines results 
were expressed as n-fold increase of cytokine expression in rela-
tion to untreated sows at allocation day.
Results and Discussion
Results showed that larch sawdust had particular anti-infl amma-
tory eff ect.
Figure 1: Mean rectal temperatures (0C) of sows 12 and 36 hours post 
farrowing
 Figures 2a, 2b: Average litter body weight at 21 days of age (kg) and 
average litter body weight gain (kg)
Table 1. Serum IL6 and plasma TNF- α at sows 24 h and 72 h PP
Sampling Group IL6 TNF- α
24 hours PP Controls 4.05±1.07 a 3.69±1.62 a 
Larch 1% 2.96±1.02 ab 2.11±0.71 b 
Positive controls 1.86±0.92 b 0.86±0.29 b 
72 hours PP Controls 2.48±1.71 a 2.68±1.32 a 
Larch 1% 1.59±0.86 a 1.07±0.55 b 
Positive controls 1.12±0.72 a 0.98±0.77 b 
a,b: p < 0.05 signifi cantly diff erent from control group
Sows fed with larch sawdust had an improvement tendency in 
performance and health parameters (eg. average litter body 
weight, PP temperatures) (Fig. 2a,b) compared to the control 
group. Additionally, there was a signifi cant decrease of serum IL6 
and plasma TNF α concentrations at 24 and 72 hours PP (Tab. 1), 
probably due to larch sawdust anti-infl ammatory activity.
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Introduction
The ‘fetal programming’ hypothesis states that the gestational 
environment of the embryo aff ects its development, and that 
this can have long-term consequences for the animal post-
natally. In swine, low birth weight animals exhibit an altered 
metabolism and stress response over a range of ages, and this 
could be programmed in utero1-2. To date, the potential of the 
uterine environment to infl uence the immune system of pigs 
has not been investigated. In this study, immune competence 
in the off spring of control sows from a commercial dam line was 
compared to immune competence in the off spring of sows from 
the same line that had undergone unilateral oviductal cauteriza-
tion surgery to artifi cially reduce the number of embryos in utero 
and provide an ‘enhanced’ uterine environment.
Materials and Methods
The experiment used PIC Line 42 parity 3-5 sows in good health 
and body condition that farrowed between 10 and 17 total born 
on their most recent parity. Right oviductal cauterization was 
performed on a group of 10 sows (CAUT). The oviducts of 11 
age-matched controls were not cauterized (CTRL). Following 
surgery, sows in both groups were estrus synchronized by treat-
ment with oral progestagen and bred. Farrowing was induced 
by cloprostenol to obtain a gestation length of 114 to 116 days. 
Individual gender and birth weight data were recorded for all 
piglets born. Blood samples were collected from 2 male and 2 
female piglets from each litter at 4, 9, and 15 weeks of age. For 
each sex, one piglet representative of above and one represent-
ative of below average litter birth weight was chosen. Animals 
at the extremes of birth weight were excluded. Lymphocytes 
were isolated by density gradient centrifugation using ‘Lympho-
prep’ (Axis-Shield), and 1 x 105 cells in triplicate were used to 
determine immune competence by measuring lymphocyte 
proliferation with or without addition of the B and T cell mitogen 
concanavalin A. Cells were grown in RPMI medium for 72 hours. 
Tritiated thymidine was then added and the cells were cultured 
for a further 18 hours, harvested, and incorporation of labeled 
thymidine was measured with a scintillation counter (TopPlate, 
Packard). Proliferation data were normalized by Log2 trans-
formation. Statistical analyses were performed using the MIXED 
procedure in Statistical Analysis Software (SAS 9.2, SAS Inc.).
Results
•  Litter average birth weight was greater in CAUT (1.74 Kg) than 
CTRL (1.40 Kg) litters (p = 0.004).
•  There was no overall eff ect of cauterization treatment on 
lymphocyte proliferation (p = 0.402).
•  Across all ages there was a positive correlation between birth 
weight and lymphocyte proliferation for the CAUT group (r = 
0.421; p = 0.008) but not for the CTRL group (r = -0.061; p = 
0.636). 
Figure 1. Relationship between birth weight and lymphocyte pro-
liferation in response to concanavalin A stimulation over a 90-hour 
culture period.
Discussion
The larger average birth weight of the CAUT compared to the 
CTRL pigs indicates that oviductal ligation successfully pro-
vided a uterine environment enhancing fetal growth of CAUT 
off spring. Although no overall diff erence in lymphocyte prolif-
eration in the off spring of CAUT and CTRL sows was identifi ed 
in this study, the positive correlation between birth weight and 
lymphocyte proliferation in the CAUT off spring and its absence 
in the CTRL off spring suggests that a combination of genetic 
and epigenetic factors may infl uence the post-natal immune 
capacity of pigs. 
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Introduction
Farrowing is a stressful event for sows, especially fi rst parity 
sows. In the worst cases this leads to aggression and savaging of 
newborn piglets. Next to clear aggression, there is a range of less 
explicit unwanted behavior negatively impacting the possibil-
ity for the piglets to take up colostrum. Bottle fed piglets ingest 
more colostrum in the fi rst day then naturally nursed piglets (1), 
indicating that the sows is a limiting factor for colostrum intake. 
The aim of two studies was to investigate if an injection of azap-
erone (Stresnil®) at the end of the partus has a positive eff ect on 
sow behavior and on sow-piglet interaction.
Materials and Methods
In a ﬁ rst study, 69 sows of all parities were injected with 320 
mg of azaperone (8 ml of Stresnil®) at the moment of expulsion 
of the placenta. Simultaneously in the same environment 81 
sows of all parities were enclosed in the study as non treated 
controls. At the expulsion of the placenta (0 hours) and 6 hours 
later, when the sedative eff ect of azaperone has worn out, the 
behavior of the sows was scored as follows. Calm: the sow is 
relaxed, lies on her side and the piglets have free access to the 
udder. Alert: the sow is alert, lies or sits. Stressed: the sow shows 
signs of unrest, rises and vocalizes at the slightest noise. Ag-
gressive sows during parturition were injected with azaperone 
on the spot and excluded from the trial. On each time point, 
statistical comparison between groups on the ordinal scores was 
performed by means of the Wilcoxon Mann-Whitney U-test.
In the second study, 22 sows of all parities were treated in the 
same way as the fi rst study and compared to 11 non treated 
sows. At 2, 4, 6 and 8 hours after expulsion of placenta, the 
position of the sow (standing, lying on fl ank or belly), the access-
ibility of the udder (fully, half or not accessible) and the number 
of piglets suckling was recorded. The statistical analysis was 
performed with SAS® version 9.1. A generalized linear model was 
performed to do statistical comparison between groups. 
Results
The outcome of the fi rst study is shown in Table 1. 
Non-treated sows show a decrease of calm behavior after far-
rowing, while the opposite is seen in the treated group. 
In the second study, no diff erence was recorded in positioning 
of sow except for a decreased number of azaperone treated 
sows lying on their belly compared to non-treated sows (14% vs. 
27%) at 4 hours. This also refl ected in less hidden udders in the 
azaperone treated group.
Figure 1 shows the evolution of percentage of piglets suckling at 
observation.
At 2 and 4 hours, there is a statistically signifi cant increase in 
piglets that are suckling in the azaperone treated group. 
Discussion 
The results indicate that sow behavior during the fi rst critical 
hours after farrowing infl uences the accessibility of the udder for 
the piglets. The azaperone treated sows allowed more piglets to 
suckle during the fi rst critical hours. This may impact the survival 
rate and piglet growth. The eff ect was independent of parity. 
The present studies showed that an injection of azaperone at 
expulsion of placenta has positive eff ect on sows behavior and 
on sow-piglet interaction, facilitating the piglets to suckle dur-
ing the early colostrum phase.
References
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Worliczek, Hanna L. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 796
Wu, Chi-Ming. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 601, 603
Xia, Luming  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 979
Xie, D  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 357
Xu, David. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 869
Xu, Lili. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 813
Xu, Weiwei  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 568
Yaciuk, Raúl  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 693
Yamaguchi, Takeshi . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104, 172
Yan, Yaxian . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 979
Yang, Cheng-Yao  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 511, 685
Yang, Hanchun . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .322, 350, 534
Yang, Hyoung-Seok. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 890
Yang, Il-Yung  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 556
Yang, Ping-Cheng  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 511
Yang, Seung Hyuk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 370
Yao-Horng, Wang. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 230
Yao, Longtao . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 350
Yeo, C-I . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 584
Yeo, Changil . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 445, 814
Yeom, Min Joo. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 378
Yeske, Paul E. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
Yong, Ming . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 112, 230
Yonkers, Therese K.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .75, 258
Yoo, Dongwan. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 552
Yoo, Han-Sang. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 604, 605
Yoo, Hansang. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 775
Yoon, Kyoung-Jin . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 302, 484, 504, 936
Yoon, Soon-Seek  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 591
Yoon, Sorah  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 591
Youil, Rima . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138, 624, 625, 626, 628
Yu, Joey . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 601, 603
Yuill, K. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
Zaff alon, Fabiane G.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70, 1067
Zager, Shelly A. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
Zak, Louisa J. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1082
Zanella, Eraldo L.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74, 253, 262, 299, 466, 875
Zanni, I.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 565
Zanoni, Mariagrazia  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 585
Zanzi, Claudia M.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149, 510
Zappulla, Daniele. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 296
Zaremba, Wolfgang. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1084, 1085, 1086
Zeeh, Friederike . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 808, 896, 1151
Zell, Roland  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .297, 572, 577
Zenker, Isabella . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 905
Zepperitz, Heiko. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1085, 1086
Zhang, Huanrong. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 977
Zhang, Huiying . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 979
Zhang, Kun. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 813
Zhou, Fanghong. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 936
Zhu, Cuilan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1062
Zhu, Liande  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . , 352, 865, 869
Zielinski, Gustavo C.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . , 594
Zilinskas, H.  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1131
Zimmerman, Jeff ery J.  . . . . . . . . . . . . . . . . 201, 482, 484, 506, 512, 661, 924, 936
Zimmermann, Barbara H. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 180
Zimmermann, W. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 808, 896
Zimmermann, Werner  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1151
Zini, Maurizio. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 954
Žižlavský, Marek . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .644, 815, 1134, 1177, 1178
Zmudzki, Jacek . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 465, 703, 1134
Zoels, Susanne  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 828
Zöls, Susanne. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .247, 956, 1155, 1157
Zoric, Mate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 831, 1152, 1153, 1166
Zotti, Everson  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1193
Zuccon, Fabio  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 337
Zundel, Etienne  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 945
Zutic, Milenko . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 800, 835
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